PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Han, AL; Veeneman, BA; El-Sawy, L; Day, KC; Day, ML; Tomlins, SA; Keller, ET				Han, A. L.; Veeneman, B. A.; El-Sawy, L.; Day, K. C.; Day, M. L.; Tomlins, S. A.; Keller, E. T.			Fibulin-3 promotes muscle-invasive bladder cancer	ONCOGENE			English	Article							INHIBITS CELL-MIGRATION; BREAST-CANCER; IN-VIVO; POOR-PROGNOSIS; GROWTH; GENE; METHYLATION; EXPRESSION; EFEMP1; IGFBP-5	Urothelial carcinoma is the most common type of bladder cancer and can be categorized as either non-muscle-invasive (Ta-T1) or muscle-invasive (>= T2). The majority of bladder cancers are non-muscle-invasive at presentation; however, the recurrence rate for these tumors is high and a subset can progress to T2. In this study, we aimed to identify genes differentially expressed between T1 vs T2 bladder cancer to identify key regulators of bladder cancer progression and/or invasion. We performed RNA-Seq on T1 and T2 bladder cancer tissues and used publicly available bladder cancer profiling studies to prioritize differentially expressed genes for validation and functional assessment. This integrative approach nominated an extracellular matrix glycoprotein, fibulin-3 (FBLN3, also known as EFEMP1), as being highly expressed in T2 vs T1 bladder cancer and aggressive vs indolent disease. We confirmed the overexpression of fibulin-3 in >= T2 vs non-muscle-invasive bladder cancer (NMIBC) by quantitative reverse transcriptase-PCR. Consistent with these findings, fibulin-3 expression level correlated with the invasive ability of several bladder cancer cell lines and modulation of fibulin-3 expression directly affected invasion. Fibulin-3 knockdown in bladder cancer cells decreased the incidence of MIBCs in a murine orthotopic bladder cancer model and decreased the expression of insulin-like growth factor-binding protein-5 (IGFBP5). Restoring IGFBP5 in these cells rescued their invasive and migratory potential. These results indicate that fibulin-3 serves as a pro-invasive factor in bladder cancer, which may be mediated through modulation of IGFBP5 expression. This also suggests fibulin-3 and IGFBP5 may have potential as biomarkers of aggressive bladder cancer or therapeutic targets.	[Han, A. L.; Tomlins, S. A.; Keller, E. T.] Univ Michigan, Sch Med, Dept Pathol, NCRC B14 RM116,2800 Plymouth Rd, Ann Arbor, MI 48109 USA; [Veeneman, B. A.] Univ Michigan, Sch Med, Dept Computat Med & Bioinformat, NCRC B14 RM116,2800 Plymouth Rd, Ann Arbor, MI 48109 USA; [El-Sawy, L.; Day, K. C.; Day, M. L.; Tomlins, S. A.; Keller, E. T.] Univ Michigan, Sch Med, Dept Urol, NCRC B14 RM116,2800 Plymouth Rd, Ann Arbor, MI 48109 USA; [Tomlins, S. A.] Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, NCRC B14 RM116,2800 Plymouth Rd, Ann Arbor, MI 48109 USA; [Keller, E. T.] Univ Michigan, Biointerfaces Inst, NCRC B14 RM116,2800 Plymouth Rd, Ann Arbor, MI 48109 USA; [El-Sawy, L.] European Egyptian Pharmaceut Ind, Alexandria, Egypt	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Keller, ET (corresponding author), Univ Michigan, Sch Med, Dept Urol, NCRC B14 RM116,2800 Plymouth Rd, Ann Arbor, MI 48109 USA.	etkeller@med.umich.edu	Keller, Evan T/M-1446-2016	Keller, Evan T/0000-0002-7592-7535	University of Michigan Comprehensive Cancer Center Research Grant; Robert M and Elizabeth C Teeter Bladder Cancer Research Fund; A Alfred Taubman Medical Institute; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER	University of Michigan Comprehensive Cancer Center Research Grant; Robert M and Elizabeth C Teeter Bladder Cancer Research Fund; A Alfred Taubman Medical Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the University of Michigan DNA Sequencing Core for the RNA-Seq. University of Michigan Comprehensive Cancer Center Research Grant (to ETK), the Robert M and Elizabeth C Teeter Bladder Cancer Research Fund (to SAT) and the MacLeod Family (to SAT). SAT is supported by the A Alfred Taubman Emerging Scholar Award from the A Alfred Taubman Medical Institute.	Almeida M, 2014, J CELL MOL MED, V18, P2287, DOI 10.1111/jcmm.12394; Arechederra M, 2015, J BIOL CHEM, V290, P4383, DOI 10.1074/jbc.M114.582239; Beattie J, 2006, BIOCHEM J, V395, P1, DOI 10.1042/BJ20060086; Botteman MF, 2003, PHARMACOECONOMICS, V21, P1315, DOI 10.1007/BF03262330; Camaj P, 2009, BIOL CHEM, V390, P1293, DOI 10.1515/BC.2009.140; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chang SS, 2016, J UROLOGY, V196, P1021, DOI 10.1016/j.juro.2016.06.049; Chen JJ, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/768756; Chen XJ, 2014, CARCINOGENESIS, V35, P1707, DOI 10.1093/carcin/bgu023; Choi W, 2014, CANCER CELL, V25, P152, DOI 10.1016/j.ccr.2014.01.009; COOPER MJ, 1994, ONCOL RES, V6, P569; Damrauer JS, 2014, P NATL ACAD SCI USA, V111, P3110, DOI 10.1073/pnas.1318376111; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Guo GW, 2013, NAT GENET, V45, P1459, DOI 10.1038/ng.2798; Hu B, 2012, CANCER RES, V72, P3873, DOI 10.1158/0008-5472.CAN-12-1060; Hu B, 2009, MOL CANCER RES, V7, P1756, DOI 10.1158/1541-7786.MCR-09-0207; Hwang CF, 2010, J PATHOL, V222, P367, DOI 10.1002/path.2776; Kim EJ, 2012, INT J ONCOL, V40, P402, DOI 10.3892/ijo.2011.1191; Kim IG, 2014, ONCOGENE, V33, P3908, DOI 10.1038/onc.2013.373; Klenotic PA, 2004, J BIOL CHEM, V279, P30469, DOI 10.1074/jbc.M403026200; Kricker JA, 2003, ENDOCRINOLOGY, V144, P2807, DOI 10.1210/en.2002-221086; Liang PI, 2013, J CLIN PATHOL, V66, P573, DOI 10.1136/jclinpath-2012-201278; McCaig C, 2002, J CELL SCI, V115, P4293, DOI 10.1242/jcs.00097; Nandhu MS, 2014, CANCER RES, V74, P5435, DOI 10.1158/0008-5472.CAN-14-0685; OH Y, 1993, ENDOCRINOLOGY, V132, P1337, DOI 10.1210/en.132.3.1337; Raitanen MP, 2001, ANN CHIR GYNAECOL, V90, P261; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Sabichi A, 2006, J UROLOGY, V175, P1133, DOI 10.1016/S0022-5347(05)00323-X; Sadr-Nabavi A, 2009, INT J CANCER, V124, P1727, DOI 10.1002/ijc.24108; Seeliger H, 2009, MOL CANCER RES, V7, P189, DOI 10.1158/1541-7786.MCR-08-0132; Sercu S, 2009, MATRIX BIOL, V28, P160, DOI 10.1016/j.matbio.2009.02.003; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sjodahl G, 2012, CLIN CANCER RES, V18, P3377, DOI 10.1158/1078-0432.CCR-12-0077-T; SOLOWAY MS, 1985, UROLOGY, V26, P18; Song EL, 2011, GYNECOL ONCOL, V121, P174, DOI 10.1016/j.ygyno.2010.11.004; Song EL, 2010, GYNECOL ONCOL, V117, P417, DOI 10.1016/j.ygyno.2009.12.016; Sureshbabu A, 2012, J CELL SCI, V125, P1693, DOI 10.1242/jcs.092882; Sylvester RJ, 2006, EUR UROL, V49, P466, DOI 10.1016/j.eururo.2005.12.031; Tian H, 2015, ONCOGENE, V34, P5635, DOI 10.1038/onc.2015.13; Tong JD, 2011, NEOPLASMA, V58, P441, DOI 10.4149/neo_2011_05_441; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang Z, 2012, PATHOL ONCOL RES, V18, P263, DOI 10.1007/s12253-011-9437-0; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Wu XR, 2005, NAT REV CANCER, V5, P713, DOI 10.1038/nrc1697; Xu S, 2014, ONCOL REP, V31, P79, DOI 10.3892/or.2013.2799; Zhang YW, 2010, EXP EYE RES, V90, P374, DOI 10.1016/j.exer.2009.09.018	49	25	25	1	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 14	2017	36	37					5243	5251		10.1038/onc.2017.149	http://dx.doi.org/10.1038/onc.2017.149			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FG8HT	28504717				2022-12-26	WOS:000410671700003
J	Lee, SM; Lee, JM; Kang, HJ; Yang, HK; Yoon, JH; Chang, W; An, SJ; Lee, KB; Baek, SY				Lee, Sang Min; Lee, Jeong Min; Kang, Hyo-Jin; Yang, Hyung Kung; Yoon, Jeong Hee; Chang, Won; An, Su Joa; Lee, Kyoung Bun; Baek, Seung Yon			Liver fibrosis staging with a new 2D-shear wave elastography using comb-push technique: Applicability, reproducibility, and diagnostic performance	PLOS ONE			English	Article							MAGNETIC-RESONANCE ELASTOGRAPHY; CHRONIC HEPATITIS-B; TRANSIENT ELASTOGRAPHY; CLINICAL-USE; NONINVASIVE EVALUATION; STIFFNESS MEASUREMENT; WFUMB GUIDELINES; RECOMMENDATIONS; ACCURACY; BIOPSY	Objective To evaluate the applicability, reproducibility, and diagnostic performance of a new 2D-shear wave elastography (SWE) using the comb-push technique (2D CP-SWE) for detection of hepatic fibrosis, using histopathology as the reference standard. Materials and methods This prospective study was approved by the institutional review board, and informed consent was obtained from all patients. The liver stiffness (LS) measurements were obtained from 140 patients, using the new 2D-SWE, which uses comb-push excitation to produce shear waves and a time-aligned sequential tracking method to detect shear wave signals. The applicability rate of 2D CP-SWE was estimated, and factors associated with its applicability were identified. Intraobserver reproducibility was evaluated in the 105 patients with histopathologic diagnosis, and interobserver reproducibility was assessed in 20 patients. Diagnostic performance of the 2D CP-SWE for hepatic fibrosis was evaluated by receiver operating characteristic (ROC) curve analysis. Results The applicability rate of 2D CP-SWE was 90.8% (109 of 120). There was a significant difference in age, presence or absence of ascites, and the distance from the transducer to the Glisson capsule between the patients with applicable LS measurements and patients with unreliable measurement or technical failure. The intraclass correlation of interobserver agreement was 0.87, and the value for the intraobserver agreement was 0.95. The area under the ROC curve of LS values for stage F2 fibrosis or greater, stage F3 or greater, and stage F4 fibrosis was 0.874 (95% confidence interval [CI]: 0.794-0.930), 0.905 (95% CI: 0.832-0.954), and 0.894 (95% CI: 0.819-0.946), respectively. Conclusion 2D CP-SWE can be employed as a reliable method for assessing hepatic fibrosis with a reasonably good diagnostic performance, and its applicability might be influenced by age, ascites, and the distance between the transducer and Glisson capsule.	[Lee, Sang Min; Lee, Jeong Min; Kang, Hyo-Jin; Yang, Hyung Kung; Yoon, Jeong Hee; Chang, Won; An, Su Joa] Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea; [Lee, Jeong Min; Yoon, Jeong Hee; Chang, Won; An, Su Joa] Seoul Natl Univ, Inst Radiat Med, Coll Med, Seoul, South Korea; [Lee, Kyoung Bun] Seoul Natl Univ Hosp, Dept Pathol, Seoul, South Korea; [Baek, Seung Yon] Ewha Womans Univ, Sch Med, Dept Radiol, Seoul, South Korea; [Lee, Sang Min] Hallym Univ, Sacred Heart Hosp, Dept Radiol, Anyang, South Korea; [Chang, Won] Seoul Natl Univ, Dept Radiol, Bundang Hosp, Seongnam, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Ewha Womans University; Hallym University; Seoul National University (SNU)	Lee, JM (corresponding author), Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea.; Lee, JM (corresponding author), Seoul Natl Univ, Inst Radiat Med, Coll Med, Seoul, South Korea.	jmsh@snu.ac.kr	Lee, Jeong Min/V-3429-2019; Yoon, Jeong Hee/ABA-5127-2021; Lee, Kyoungbun/J-2571-2016	Lee, Jeong Min/0000-0003-0561-8777; Yoon, Jeong Hee/0000-0002-9925-9973; Lee, Sang Min/0000-0001-7719-3849; Lee, Kyoungbun/0000-0001-8427-3003	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2013R1A1A2A10066037]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2013R1A1A2A10066037) http://www.nrf.re.kr/nrf_eng_cms/. The funder had no role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	[Anonymous], 2015, J HEPATOL, V63, P237, DOI 10.1016/j.jhep.2015.04.006; Barr RG, 2015, RADIOLOGY, V276, P845, DOI 10.1148/radiol.2015150619; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Blachier M, 2013, J HEPATOL, V58, P593, DOI 10.1016/j.jhep.2012.12.005; Bota S, 2013, LIVER INT, V33, P1138, DOI 10.1111/liv.12240; Carrion JA, 2007, GASTROENTEROLOGY, V132, P1746, DOI 10.1053/j.gastro.2007.03.041; Cassinotto C, 2014, J HEPATOL, V61, P550, DOI 10.1016/j.jhep.2014.04.044; Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008; Castera L, 2010, HEPATOLOGY, V51, P828, DOI 10.1002/hep.23425; Cosgrove D, 2013, ULTRASCHALL MED, V34, P238, DOI 10.1055/s-0033-1335375; Ferraioli G, 2015, ULTRASOUND MED BIOL, V41, P1161, DOI 10.1016/j.ultrasmedbio.2015.03.007; Ferraioli G, 2012, HEPATOLOGY, V56, P2125, DOI 10.1002/hep.25936; Fraquelli M, 2007, GUT, V56, P968, DOI 10.1136/gut.2006.111302; Friedrich-Rust M, 2008, GASTROENTEROLOGY, V134, P960, DOI 10.1053/j.gastro.2008.01.034; Friedrich-Rust M, 2016, NAT REV GASTRO HEPAT, V13, P402, DOI 10.1038/nrgastro.2016.86; Gareen IF, 2003, RADIOLOGY, V229, P305, DOI 10.1148/radiol.2292030324; Kudo M, 2013, J MED ULTRASON, V40, P325, DOI 10.1007/s10396-013-0460-5; Leung VYF, 2013, RADIOLOGY, V269, P910, DOI 10.1148/radiol.13130128; Lin ZH, 2011, HEPATOLOGY, V53, P726, DOI 10.1002/hep.24105; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Marcellin P, 2013, LANCET, V381, P468, DOI 10.1016/S0140-6736(12)61425-1; Martinez SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047715; Nierhoff J, 2013, EUR RADIOL, V23, P3040, DOI 10.1007/s00330-013-2927-6; Obuchowski NA, 2005, ACAD RADIOL, V12, P1198, DOI 10.1016/j.acra.2005.05.013; Palmeri ML, 2011, J HEPATOL, V55, P666, DOI 10.1016/j.jhep.2010.12.019; Pawlotsky JM, 2015, J HEPATOL, V63, P199, DOI 10.1016/j.jhep.2015.03.025; Piscaglia F, 2016, ULTRASCHALL MED, V37, P1, DOI 10.1055/s-0035-1567037; Poynard T, 2007, CLIN CHEM, V53, P1615, DOI 10.1373/clinchem.2007.085795; Poynard T, 2013, J HEPATOL, V58, P928, DOI 10.1016/j.jhep.2012.12.021; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Samir AE, 2015, RADIOLOGY, V274, P888, DOI 10.1148/radiol.14140839; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Seeff LB, 2010, CLIN GASTROENTEROL H, V8, P877, DOI 10.1016/j.cgh.2010.03.025; Shiina T, 2015, ULTRASOUND MED BIOL, V41, P1126, DOI 10.1016/j.ultrasmedbio.2015.03.009; Song PF, 2016, J ULTRAS MED, V35, P401, DOI 10.7863/ultra.15.03036; Song PF, 2015, IEEE T ULTRASON FERR, V62, P290, DOI 10.1109/TUFFC.2014.006628; Song PF, 2013, IEEE T MED IMAGING, V32, P1435, DOI 10.1109/TMI.2013.2257831; Song PF, 2012, IEEE T MED IMAGING, V31, P1821, DOI 10.1109/TMI.2012.2205586; Stotland BR, 1996, AM J GASTROENTEROL, V91, P1295; Venkatesh SK, 2013, J MAGN RESON IMAGING, V37, P544, DOI 10.1002/jmri.23731; Wong GLH, 2011, J GASTROEN HEPATOL, V26, P300, DOI 10.1111/j.1440-1746.2010.06510.x; Woo H, 2015, RADIOLOGY, V277, P881, DOI 10.1148/radiol.2015141975; Yoon JH, 2014, RADIOLOGY, V273, P772, DOI 10.1148/radiol.14132000	44	23	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177264	10.1371/journal.pone.0177264	http://dx.doi.org/10.1371/journal.pone.0177264			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28510583	Green Submitted, gold, Green Published			2022-12-26	WOS:000401485500019
J	Soler, X; Liao, SY; Marin, JM; Lorenzi, G; Jen, R; DeYoung, P; Owens, RL; Ries, AL; Malhotra, A				Soler, Xavier; Liao, Shu-Yi; Maria Marin, Jose; Lorenzi-Filho, Geraldo; Jen, Rachel; DeYoung, Pamela; Owens, Robert L.; Ries, Andrew L.; Malhotra, Atul			Age, gender, neck circumference, and Epworth sleepiness scale do not predict obstructive sleep apnea (OSA) in moderate to severe chronic obstructive pulmonary disease (COPD): The challenge to predict OSA in advanced COPD	PLOS ONE			English	Article							STOP-BANG SCORE; LUNG-DISEASE; GENERAL-POPULATION; OVERLAP SYNDROME; SEX-DIFFERENCES; RISK-FACTORS; PREVALENCE; ADULTS; DIAGNOSIS; SYMPTOMS	The combination of chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA) is associated with substantial morbidity and mortality. We hypothesized that predictors of OSA among patients with COPD may be distinct from OSA in the general population. Therefore, we investigated associations between traditional OSA risk factors (e.g. age), and sleep questionnaires [e.g. Epworth Sleepiness Scale] in 44 patients with advanced COPD. As a second aim we proposed a pilot, simplified screening test for OSA in patients with COPD. In a prospective, observational study of patients enrolled in the UCSD Pulmonary Rehabilitation Program we collected baseline characteristics, cardiovascular events (e.g. atrial fibrillation), and sleep questionnaires [e.g. Pittsburgh Sleep Quality Index (PSQI)]. For the pilot questionnaire, a BMI >= 25 kg/m(2) and the presence of cardiovascular disease were used to construct the pilot screening test. Male: 59%; OSA 66%. FEV1 (mean +/- SD) = 41.0 +/- 18.2% pred., FEV1/FVC = 41.5 +/- 12.7%]. Male gender, older age, and large neck circumference were not associated with OSA. Also, Epworth Sleepiness Scale and the STOP-Bang questionnaire were not associated with OSA in univariate logistic regression. In contrast, BMI >= 25 kg/m(2) (OR = 3.94, p = 0.04) and diagnosis of cardiovascular disease (OR = 5.06, p = 0.03) were significantly associated with OSA [area under curve (AUC) = 0.74]. The pilot COPD-OSA test (OR = 5.28, p = 0.05) and STOP-Bang questionnaire (OR = 5.13, p = 0.03) were both associated with OSA in Receiver Operating Characteristics (ROC) analysis. The COPD-OSA test had the best AUC (0.74), sensitivity (92%), and specificity (83%). A tenfold cross-validation validated our results. We found that traditional OSA predictors (e.g. gender, Epworth score) did not perform well in patients with more advanced COPD. Our pilot test may be an easy to implement instrument to screen for OSA. However, a larger validation study is necessary before further clinical implementation is warranted.	[Soler, Xavier; Jen, Rachel; DeYoung, Pamela; Owens, Robert L.; Ries, Andrew L.; Malhotra, Atul] Univ Calif San Diego, Dept Med, Pulm Crit Care & Sleep Div, San Diego, CA 92103 USA; [Liao, Shu-Yi] UC Riverside, Dept Med, Riverside, CA USA; [Maria Marin, Jose] Univ Hosp Miguel Servet, CIBERES, IISAragon, Pulm Div, Zaragoza, Spain; [Lorenzi-Filho, Geraldo] Univ Sao Paulo, Fac Med, Hosp Clin, Pulm Div,Sleep Lab, Sao Paulo, Brazil	University of California System; University of California San Diego; University of California System; University of California Riverside; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Miguel Servet University Hospital; Universidade de Sao Paulo	Soler, X (corresponding author), Univ Calif San Diego, Dept Med, Pulm Crit Care & Sleep Div, San Diego, CA 92103 USA.	xsoler@ucsd.edu	Lorenzi-Filho, Geraldo GLF/E-1062-2012	Lorenzi-Filho, Geraldo GLF/0000-0002-7011-7373; Marin Trigo, Jose Maria/0000-0001-9096-2294; Family Name Deactivated, Given Names Deactivated/0000-0002-0099-0847	Tobacco Related Disease Research Program (TRDRP) [KT-0014]; National Institutes of Health [UL1TR000100]; ATS Foundation Recognition Awards; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085188, K24HL132105, T32HL134632] Funding Source: NIH RePORTER	Tobacco Related Disease Research Program (TRDRP)(University of California System); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ATS Foundation Recognition Awards; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Xavier Soler was funded exclusively by the Tobacco Related Disease Research Program (TRDRP), New Investigator Award (KT-0014), http://trdrp.yes4yes.com/fundedresearch/person_ page.php?person_id=35105; a Center of Translational Research Institute (CTRI) seed grant, from the National Institutes of Health (grant UL1TR000100), http://www.ctri.ucsd.edu/funding/ Pilot-Projects/Pages/awardees-table.aspx; and the 2014 ATS Foundation Recognition Awards for Outstanding Early Career Investigators, http://foundation.thoracic.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 2016, AM J RESP CRIT CARE, V193, P813, DOI 10.1164/rccm.201512-2379ED; Bednarek M, 2005, RESPIRATION, V72, P142, DOI 10.1159/000084044; Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172; Biselli PJ, 1985, J APPL PHYSL; Bixler EO, 1998, AM J RESP CRIT CARE, V157, P144, DOI 10.1164/ajrccm.157.1.9706079; Bixler EO, 2001, AM J RESP CRIT CARE, V163, P608, DOI 10.1164/ajrccm.163.3.9911064; Bradley TD, 2009, LANCET, V373, P82, DOI 10.1016/S0140-6736(08)61622-0; Buysse D J, 1989, Psychiatry Res, V28, P193; Carmelli D, 2000, OBES RES, V8, P632, DOI 10.1038/oby.2000.81; CHAOUAT A, 1995, AM J RESP CRIT CARE, V151, P82, DOI 10.1164/ajrccm.151.1.7812577; Chung F, 2012, BRIT J ANAESTH, V108, P768, DOI 10.1093/bja/aes022; Chung F, 2013, OBES SURG, V23, P2050, DOI 10.1007/s11695-013-1006-z; CORMICK W, 1986, THORAX, V41, P846, DOI 10.1136/thx.41.11.846; DAVIES RJO, 1990, EUR RESPIR J, V3, P509; Dawson B, 2004, BASIC CLINICAL BIOST; Epstein LJ, 2009, J CLIN SLEEP MED, V5, P263; Fleetham JA, 2003, AM J RESP CRIT CARE, V167, P3, DOI 10.1164/rccm.2211003; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; FLENLEY DC, 1985, CLIN CHEST MED, V6, P651; Gottlieb DJ, 1999, AM J RESP CRIT CARE, V159, P502, DOI 10.1164/ajrccm.159.2.9804051; GUILLEMINAULT C, 1980, AM REV RESPIR DIS, V122, P397; GUILLEMINAULT C, 1976, ANNU REV MED, V27, P465, DOI 10.1146/annurev.me.27.020176.002341; Heinzer R, 2015, LANCET RESP MED, V3, P310, DOI 10.1016/S2213-2600(15)00043-0; Hessel NS, 2002, EUR ARCH OTO-RHINO-L, V259, P154, DOI 10.1007/s00405-001-0427-9; Ibrahim AS, 2008, ANN SAUDI MED, V27, P421; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kapur VK, 2005, SLEEP, V28, P472, DOI 10.1093/sleep/28.4.472; KATZ I, 1990, AM REV RESPIR DIS, V141, P1228, DOI 10.1164/ajrccm/141.5_Pt_1.1228; KINSMAN RA, 1983, CHEST, V83, P755, DOI 10.1378/chest.83.5.755; KLINK ME, 1994, CHEST, V105, P151, DOI 10.1378/chest.105.1.151; Krachman SL, 2011, COPD, V8, P182, DOI 10.3109/15412555.2011.560583; Krachman SL, 2016, ANN AM THORAC SOC; Lavie P, 2007, J SLEEP RES, V16, P128, DOI 10.1111/j.1365-2869.2007.00578.x; Lindberg A, 2005, RESPIRATION, V72, P471, DOI 10.1159/000087670; Loredo JS, 1999, CHEST, V116, P655, DOI 10.1378/chest.116.3.655; Machado MCL, 2010, EUR RESPIR J, V35, P132, DOI 10.1183/09031936.00192008; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Marin JM, 2010, AM J RESP CRIT CARE, V182, P325, DOI 10.1164/rccm.200912-1869OC; Martinez-Rivera C, 2008, OBESITY, V16, P113, DOI 10.1038/oby.2007.20; McNicholas WT, 2009, AM J RESP CRIT CARE, V180, P692, DOI 10.1164/rccm.200903-0347PP; Minino AM, 2011, NATL VITAL STAT REP, V59, P1; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Peppard PE, 2013, AM J EPIDEMIOL, V177, P1006, DOI 10.1093/aje/kws342; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Price D, 2013, INT J CHRONIC OBSTR, V8, P595, DOI 10.2147/COPD.S48570; Qaseem A, 2014, ANN INTERN MED, V161, P210, DOI 10.7326/M12-3187; Ruehland WR, 2009, SLEEP, V32, P150, DOI 10.1093/sleep/32.2.150; Sanders MH, 2003, AM J RESP CRIT CARE, V167, P7, DOI 10.1164/rccm.2203046; Sharma SK, 2004, SLEEP MED, V5, P351, DOI 10.1016/j.sleep.2004.03.004; Shepertycky MR, 2005, SLEEP, V28, P309; Soler X, 2015, ANN AM THORAC SOC, V12, P1219, DOI 10.1513/AnnalsATS.201407-336OC; STRADLING JR, 1991, THORAX, V46, P85, DOI 10.1136/thx.46.2.85; Tam A, 2016, AM J RESP CRIT CARE, V193, P825, DOI 10.1164/rccm.201503-0487OC; Teodorescu M, 2014, J CLIN SLEEP MED, V10, P183, DOI 10.5664/jcsm.3450; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Vogelmeier CF, 2017, RESPIROLOGY, V22, P575, DOI 10.1111/resp.13012; Weitzenblum Emmanuel, 2008, Proc Am Thorac Soc, V5, P237, DOI 10.1513/pats.200706-077MG; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	59	49	51	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177289	10.1371/journal.pone.0177289	http://dx.doi.org/10.1371/journal.pone.0177289			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28510598	Green Published, gold			2022-12-26	WOS:000401485500020
J	Zhang, HW; Lu, JQ; Lu, YY; Zhou, JY; Wang, ZH; Liu, HO; Xu, CJ				Zhang, Hongwei; Lu, Jiaqi; Lu, Yingying; Zhou, Jiayi; Wang, Zehua; Liu, Haiou; Xu, Congjian			Prognostic significance and predictors of the system inflammation score in ovarian clear cell carcinoma	PLOS ONE			English	Article							TO-LYMPHOCYTE RATIO; RESPONSE MARKERS; IMMUNE-SYSTEM; SERUM-ALBUMIN; CANCER-CELLS; NEUTROPHIL; CHEMOTHERAPY; PLATELET; SURVIVAL	Chronic inflammation is a well-known epidemiologic factor of ovarian clear cell carcinomas (OCCC), but has an uncertain role in prognosis. We developed a systemic inflammation score (SIS) based on preoperative serum albumin and neutrophil-to-lymphocyte ratio (NLR) for predicting progression-free survival (PFS) and overall survival (OS) in OCCC patients. A retrospective review was performed in 155 patients with OCCC undergoing primary debulking and chemotherapy at a single institute between 1995 and 2010. Cox regression models were fitted to analyze the effect of prognostic factors on PFS and OS. Harrell's concordance index was calculated to assess predictive accuracy. The SIS consisting of serum albumin and NLR was retained as an independent indicator adjusting for traditional clinicopathological features. A high SIS was significantly associated with aggressive tumor behavior, platinum resistance, and served as an independent predictor of reduced PFS (P = 0.006) and OS (P = 0.019). The SIS had a good discrimination ability for the predictive PFS (c-index = 0.712) and OS (c-index = 0.722). We have developed a system inflammation score for predicting prognosis of OCCC patients, which may help stratify patients for postsurgical management.	[Zhang, Hongwei; Lu, Jiaqi; Xu, Congjian] Fudan Univ, Obstet & Gynecol Hosp, Dept Gynaecol, Shanghai, Peoples R China; [Lu, Yingying; Zhou, Jiayi; Wang, Zehua; Liu, Haiou; Xu, Congjian] Shanghai Key Lab Female Reprod Endocrine Related, Shanghai, Peoples R China	Fudan University	Xu, CJ (corresponding author), Fudan Univ, Obstet & Gynecol Hosp, Dept Gynaecol, Shanghai, Peoples R China.; Liu, HO; Xu, CJ (corresponding author), Shanghai Key Lab Female Reprod Endocrine Related, Shanghai, Peoples R China.	liuhaiou@fudan.edu.cn; xucongjian@gmail.com	Liu, Haiou/AFS-2886-2022	Liu, Haiou/0000-0003-0200-8981	National Natural Science Foundation of China [31570803, 81272879, 81402151]; National Key Research and Development Program [2016YFC1303101]; Research Program of Shanghai Municipal Commission of Health and Family Planning [20154Y0049]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program; Research Program of Shanghai Municipal Commission of Health and Family Planning	This study was supported by grants from National Natural Science Foundation of China (31570803, 81272879, 81402151), National Key Research and Development Program (2016YFC1303101), Research Program of Shanghai Municipal Commission of Health and Family Planning (20154Y0049).	Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Asher V, 2011, CLIN TRANSL ONCOL, V13, P499, DOI 10.1007/s12094-011-0687-9; Ataseven B, 2015, GYNECOL ONCOL, V138, P560, DOI 10.1016/j.ygyno.2015.07.005; Campesi I, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-4; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Diakos CI, 2014, LANCET ONCOL, V15, pE493, DOI 10.1016/S1470-2045(14)70263-3; ELHAG A, 1987, J IMMUNOL, V139, P2406; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Goncalves RB, 2011, INFLAMM RES, V60, P409, DOI 10.1007/s00011-011-0308-7; Granot Z, 2015, CANCER RES, V75, P4441, DOI 10.1158/0008-5472.CAN-15-1502; Gupta D, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-69; Guthrie GJK, 2013, CRIT REV ONCOL HEMAT, V88, P218, DOI 10.1016/j.critrevonc.2013.03.010; Jayson GC, 2014, LANCET, V384, P1376, DOI 10.1016/S0140-6736(13)62146-7; Kim HS, 2016, CANCER RES TREAT, V48, P250, DOI 10.4143/crt.2014.324; Klink M, 2008, SCAND J IMMUNOL, V68, P328, DOI 10.1111/j.1365-3083.2008.02139.x; Ledermann JA, 2013, ANN ONCOL, V24, P24, DOI 10.1093/annonc/mdt333; LEE TH, 1985, NEW ENGL J MED, V312, P1217, DOI 10.1056/NEJM198505093121903; Nakamura K, 2016, ONCOL LETT, V11, P3975, DOI 10.3892/ol.2016.4513; Nielsen JS, 2012, CLIN CANCER RES, V18, P3281, DOI 10.1158/1078-0432.CCR-12-0234; Pearce CL, 2012, LANCET ONCOL, V13, P385, DOI 10.1016/S1470-2045(11)70404-1; PETRIE HT, 1985, J IMMUNOL, V134, P230; Powell DR, 2016, TRENDS IMMUNOL, V37, P41, DOI 10.1016/j.it.2015.11.008; Raungkaewmanee S, 2012, J GYNECOL ONCOL, V23, P265, DOI 10.3802/jgo.2012.23.4.265; Spiegel A, 2016, CANCER DISCOV, V6, P630, DOI 10.1158/2159-8290.CD-15-1157; Suryawanshi S, 2014, CLIN CANCER RES, V20, P6163, DOI 10.1158/1078-0432.CCR-14-1338; Templeton AJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju124; Turner TB, 2016, GYNECOL ONCOL, V142, P349, DOI 10.1016/j.ygyno.2016.05.007; Wang Y, 2015, CANCER CHEMOTH PHARM, V75, P255, DOI 10.1007/s00280-014-2622-6; Wang YQ, 2016, CLIN CHIM ACTA, V456, P163, DOI 10.1016/j.cca.2016.03.013; Wei S, 2012, ONCOIMMUNOLOGY, V1, DOI 10.4161/onci.19440; Williams KA, 2014, GYNECOL ONCOL, V132, P542, DOI 10.1016/j.ygyno.2014.01.026; Zhang WW, 2015, TUMOR BIOL, V36, P8831, DOI 10.1007/s13277-015-3533-9	32	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177520	10.1371/journal.pone.0177520	http://dx.doi.org/10.1371/journal.pone.0177520			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498842	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314500025
J	Inoue, M; Horimoto, K				Inoue, Masayo; Horimoto, Katsuhisa			Relationship between regulatory pattern of gene expression level and gene function	PLOS ONE			English	Article							GENOME-WIDE; UBIQUITIN; DNA; DEGRADATION; SEQUENCE; COMPLEX; DRAFT; MAP; P53	Regulation of gene expression levels is essential for all living systems and transcription factors (TFs) are the main regulators of gene expression through their ability to repress or induce transcription. A balance between synthesis and degradation rates controls gene expression levels. To determine which rate is dominant, we analyzed the correlation between expression levels of a TF and its regulated gene based on a mathematical model. We selected about 280,000 expression patterns of 355 TFs and 647 regulated genes using DNA microarray data from the Gene Expression Omnibus (GEO) data repository. Based on our model, correlation between the expressions of TF-regulated gene pairs corresponds to tuning of the synthesis rate, whereas no correlation indicates excessive synthesis and requires tuning of the degradation rate. The gene expression relationships between TF-regulated gene pairs were classified into four types that correspond to different gene regulatory mechanisms. It was surprising that fewer than 20% of these genes were governed by the familiar regulatory mechanism, i.e., through the synthesis rate. Moreover, we performed pathway analysis and found that each classification type corresponded to distinct gene functions: cellular regulation pathways were dominant in the type with synthesis rate regulation and terms associated with diseases such as cancer, Parkinson's disease, and Alzheimer's disease were dominant in the type with degradation rate regulation. Interestingly, these diseases are caused by the accumulation of proteins. These results indicated that gene expression is regulated structurally, not arbitrarily, according to the gene function. This funding is indicative of a systematic control of transcription processes at the whole-cell level.	[Inoue, Masayo; Horimoto, Katsuhisa] Natl Inst Adv Ind Sci & Technol, Mol Profiling Res Ctr Drug Discovery, Koto Ku, 2-4-7 Aomi, Tokyo 1350064, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Inoue, M (corresponding author), Natl Inst Adv Ind Sci & Technol, Mol Profiling Res Ctr Drug Discovery, Koto Ku, 2-4-7 Aomi, Tokyo 1350064, Japan.	inoue.m@aist.go.jp		Inoue, Masayo/0000-0002-2699-7879	National Cancer Center Research and Development Fund from National Cancer Center Japan [26-A-6]	National Cancer Center Research and Development Fund from National Cancer Center Japan	MI received The National Cancer Center Research and Development Fund (26-A-6) from National Cancer Center Japan (http://www.ncc.go.jp/en/index.html). This study is designed according to the plan document. The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B., 2008, MOL BIOL CELL, VFifth; Asher G, 2005, GENE DEV, V19, P316, DOI 10.1101/gad.319905; Autio R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S24; Bilban Martin, 2002, Current Issues in Molecular Biology, V4, P57; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; CRICK F, 1970, NATURE, V227, P561, DOI 10.1038/227561a0; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eser P, 2014, MOL SYST BIOL, V10; GOMPERTS BD, 2002, SIGNAL TRANSDUCTION; HOCHSTRASSER M, 1995, CURR OPIN CELL BIOL, V7, P215, DOI 10.1016/0955-0674(95)80031-X; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Irizarry AR, 2006, BIOSTATISTICS, V22, P789; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LATCHMAN DS, 1993, INT J EXP PATHOL, V74, P417; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447; Mata J, 2005, TRENDS BIOCHEM SCI, V30, P506, DOI 10.1016/j.tibs.2005.07.005; Munoz J, 2014, ANGEW CHEM INT EDIT, V53, P10864, DOI 10.1002/anie.201406545; Orntoft TF, 2002, MOL CELL PROTEOMICS, V1, P37, DOI 10.1074/mcp.M100019-MCP200; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; Shalon D, 1996, GENOME RES, V6, P639, DOI 10.1101/gr.6.7.639; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vogel C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.59; Wade M, 2010, TRENDS CELL BIOL, V20, P299, DOI 10.1016/j.tcb.2010.01.009; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	38	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177430	10.1371/journal.pone.0177430	http://dx.doi.org/10.1371/journal.pone.0177430			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28494005	Green Submitted, Green Published, gold			2022-12-26	WOS:000401314300107
J	Lloris-Carsi, JM; Barrios, C; Prieto-Moure, B; Lloris-Cejalvo, JM; Cejalvo-Lapena, D				Miguel Lloris-Carsi, Jose; Barrios, Carlos; Prieto-Moure, Beatriz; Miguel Lloris-Cejalvo, Jose; Cejalvo-Lapena, Dolores			The effect of biological sealants and adhesive treatments on matrix metalloproteinase expression during renal injury healing	PLOS ONE			English	Article							IN-VITRO; PARTIAL NEPHRECTOMY; TISSUE; CYANOACRYLATE; FIBROBLASTS; MMP-9; INFLAMMATION; MANAGEMENT; FIBROSIS; DISEASE	Background Renal injuries are relatively common in cases of abdominal trauma. Adhesives and sealants can be used to repair and preserve damaged organs. Using a rat model, this study explores the activity of different matrix metalloproteinases (MMP) during the healing of renal injuries treated by two biological adhesives (TachoSil and GelitaSpon) and a new synthetic elastic cyanoacrylate (Adhflex). Methods Renal traumatic injuries were experimentally induced in 90 male Wistar rats by a Stiefel Biopsy Punch in the anterior aspect of the left kidney. Animals were divided into five groups: 1, sham non-injured (n = 3); 2, non-treated standard punch injury (n = 6); 3, punch injury treated with TachoSil (n = 27); 4, punch injury treated with GelitaSpon (n = 27); and, 5, punch injury treated with Adhflex (n = 27). Wound healing was evaluated 2, 6, and 18 days after injury by determining the expression of MMPs, and the histopathological evolution of lesions. Findings Histologically, the wound size at 6 days post-injury was larger in Adhflex-treated samples than in the other treatments, but the scarring tissue was similar at 18 days post-injury. Only the MMPs subtypes 1, 2, 8, 9, and 13 were sufficiently expressed to be quantifiable. Both time since injury and treatment type had a significant influence on MMPs expression. Two days after injury, the expression of MMP8 and MMP9 was predominant. MMP2 expression was greater 6 days after injury. The Adhflex-treated group had a significantly higher MMPs expression than the other treatment groups at all healing stages. Conclusions All three sealant treatments induced almost similar expression of MMPs than untreated animals indicating a physiological healing process. Given that all renal trauma injuries must be considered emergencies, both biological and synthetic adhesives, such as Adhflex, should be considered as a treatment options.	[Miguel Lloris-Carsi, Jose] Univ Valencia, Dept Surg, Valencia, Spain; [Barrios, Carlos; Prieto-Moure, Beatriz; Miguel Lloris-Cejalvo, Jose; Cejalvo-Lapena, Dolores] Valencia Catholic Univ, Div Expt Surg, Valencia, Spain	University of Valencia; Universidad Catolica de Valencia San Vicente Martir	Lloris-Carsi, JM (corresponding author), Univ Valencia, Dept Surg, Valencia, Spain.	jm_lloris@mac.com	Moure, Beatriz Prieto/U-8171-2019; Lloris-Carsi, Jose/AAA-4891-2019; Cejalvo-Lapeña, D/AAA-4718-2019	Cejalvo-Lapeña, D/0000-0003-4825-1856; Lloris Carsi, Jose Miguel/0000-0002-8685-5936; Barrios, Carlos/0000-0002-6657-7246	Universidad Catolica de Valencia (Ayudas a la investigacion cientifica)	Universidad Catolica de Valencia (Ayudas a la investigacion cientifica)	The authors received funding by Universidad Catolica de Valencia (Ayudas a la investigacion cientifica 2015-2016).	Aslan G, 2005, INT J UROL, V12, P838, DOI 10.1111/j.1442-2042.2005.01169.x; Astrom P, 2014, EXP CELL RES, V328, P217, DOI 10.1016/j.yexcr.2014.07.010; Bathia SK, 2010, SPRINGER SCI BUSINES, P227; Beidler SK, 2008, WOUND REPAIR REGEN, V16, P642, DOI 10.1111/j.1524-475X.2008.00415.x; Brumann M, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/435463; Butt MU, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-19; Caron A, 2005, EXP CELL RES, V310, P105, DOI 10.1016/j.yexcr.2005.07.004; Catania JM, 2007, AM J PHYSIOL-RENAL, V292, pF905, DOI 10.1152/ajprenal.00421.2006; Consolo M, 2009, INT J MOL MED, V24, P143, DOI 10.3892/ijmm_00000217; Danielsen PL, 2011, SURGERY, V150, P897, DOI 10.1016/j.surg.2011.06.016; Davila F, 2009, REV SANID MILIT MEX, V63, P182; dos Santos OJ, 2012, ACTA CIR BRAS, V27, P624, DOI 10.1590/S0102-86502012000900006; Eddy AA, 2000, PEDIATR NEPHROL, V15, P290, DOI 10.1007/s004670000461; Gibson DJ, 2013, ADV WOUND CARE, V2, P18, DOI 10.1089/wound.2011.0359; Grinnell F, 1998, J INVEST DERMATOL, V110, P771, DOI 10.1046/j.1523-1747.1998.00192.x; Groen J, 2016, EUR UROL, V69, P324, DOI 10.1016/j.eururo.2015.07.071; Haas CS, 2004, CONNECT TISSUE RES, V45, P73, DOI 10.1080/03008200490442644; Hata S, 2014, J PHARMACOL SCI, V124, P230, DOI 10.1254/jphs.13209FP; Inkinen K, 2000, APMIS, V108, P318, DOI 10.1034/j.1600-0463.2000.d01-63.x; Johnston WK, 2006, J UROLOGY, V175, P2307, DOI 10.1016/S0022-5347(06)00282-5; Kang Young-Mi, 2016, J Bone Metab, V23, P165, DOI 10.11005/jbm.2016.23.3.165; Kim SH, 2009, KOREAN J RADIOL, V10, P377, DOI 10.3348/kjr.2009.10.4.377; Lanchon C, 2016, J UROLOGY, V195, P106, DOI 10.1016/j.juro.2015.07.100; Li HW, 2013, JAMA FACIAL PLAST SU, V15, P448, DOI 10.1001/jamafacial.2013.1211; Lloris-Carsi JM, 2016, WOUND REPAIR REGEN, V24, P568, DOI 10.1111/wrr.12424; Lloris-Carsi JM, 2016, EUR SURG RES, V56, P164, DOI 10.1159/000444320; Muto G, 2005, J UROLOGY, V174, P2239, DOI 10.1097/01.ju.0000181809.51544.20; Nessler MB, 2014, MED SCI MONITOR, V20, P91, DOI 10.12659/MSM.889135; Pursifull NF, 2007, CURR OPIN UROL, V17, P396, DOI 10.1097/MOU.0b013e3282f0d683; Ravanti L, 2000, INT J MOL MED, V6, P391; Salmela MT, 2004, SCAND J GASTROENTERO, V39, P1095, DOI 10.1080/00365520410003470; SALO T, 1994, LAB INVEST, V70, P176; Sheets AR, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0946-1; Shiomi T, 2010, PATHOL INT, V60, P477, DOI 10.1111/j.1440-1827.2010.02547.x; STERN R, 1990, Journal of Burn Care and Rehabilitation, V11, P7, DOI 10.1097/00004630-199001000-00003; Tester AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000312; Toriseva M, 2009, CELL MOL LIFE SCI, V66, P203, DOI 10.1007/s00018-008-8388-4; Toriseva M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042596; Toriseva MJ, 2007, J INVEST DERMATOL, V127, P49, DOI 10.1038/sj.jid.5700500; van der Wilden GM, 2013, JAMA SURG, V148, P924, DOI 10.1001/jamasurg.2013.2747; Warner RL, 2004, EXP MOL PATHOL, V76, P189, DOI 10.1016/j.yexmp.2004.01.003; Yamamoto K, 2015, MATRIX BIOL, V44-46, P255, DOI 10.1016/j.matbio.2015.02.007	42	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177665	10.1371/journal.pone.0177665	http://dx.doi.org/10.1371/journal.pone.0177665			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28494022	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314300150
J	Sung, W; Park, JI; Kim, JI; Carlson, J; Ye, SJ; Park, JM				Sung, Wonmo; Park, Jong In; Kim, Jung-In; Carlson, Joel; Ye, Sung-Joon; Park, Jong Min			Monte Carlo simulation for scanning technique with scattering foil free electron beam: A proof of concept study	PLOS ONE			English	Article							MODULATED RADIATION-THERAPY; TOTAL SCALP IRRADIATION; CANCER-TREATMENT; PHOTON BEAMS; RADIOTHERAPY; IMRT; OPTIMIZATION; DOSIMETRY; CARCINOMA; MLC	This study investigated the potential of a newly proposed scattering foil free (SFF) electron beam scanning technique for the treatment of skin cancer on the irregular patient surfaces using Monte Carlo (MC) simulation. After benchmarking of the MC simulations, we removed the scattering foil to generate SFF electron beams. Cylindrical and spherical phantoms with 1 cm boluses were generated and the target volume was defined from the surface to 5 mm depth. The SFF scanning technique with 6 MeV electrons was simulated using those phantoms. For comparison, volumetric modulated arc therapy (VMAT) plans were also generated with two full arcs and 6 MV photon beams. When the scanning resolution resulted in a larger separation between beams than the field size, the plan qualities were worsened. In the cylindrical phantom with a radius of 10 cm, the conformity indices, homogeneity indices and body mean doses of the SFF plans (scanning resolution = 1 degrees) vs. VMAT plans were 1.04 vs. 1.54, 1.10 vs. 1.12 and 5 Gy vs. 14 Gy, respectively. Those of the spherical phantom were 1.04 vs. 1.83, 1.08 vs. 1.09 and 7 Gy vs. 26 Gy, respectively. The proposed SFF plans showed superior dose distributions compared to the VMAT plans.	[Sung, Wonmo; Park, Jong In; Carlson, Joel; Ye, Sung-Joon] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Transdisciplinary Studies, Program Biomed Radiat Sci, Seoul, South Korea; [Kim, Jung-In; Park, Jong Min] Seoul Natl Univ Hosp, Dept Radiat Oncol, Seoul, South Korea; [Kim, Jung-In; Park, Jong Min] Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea; [Kim, Jung-In; Ye, Sung-Joon; Park, Jong Min] Seoul Natl Univ Hosp, Biomed Res Inst, Seoul, South Korea; [Park, Jong Min] Adv Inst Convergence Technol, Robot Res Lab Extreme Environm, Inst Smart Syst, Suwon, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Park, JM (corresponding author), Seoul Natl Univ Hosp, Dept Radiat Oncol, Seoul, South Korea.; Park, JM (corresponding author), Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea.; Park, JM (corresponding author), Seoul Natl Univ Hosp, Biomed Res Inst, Seoul, South Korea.; Park, JM (corresponding author), Adv Inst Convergence Technol, Robot Res Lab Extreme Environm, Inst Smart Syst, Suwon, South Korea.	leodavinci@naver.com	Sung, Wonmo/AAR-3980-2021	Sung, Wonmo/0000-0002-0172-0646; Park, Jong Min/0000-0003-3617-3870	National Research Foundation of Korea (NRF) - Korea government (MSIP) [2015R1C1A1A01054192]	National Research Foundation of Korea (NRF) - Korea government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2015R1C1A1A01054192).	Almond PR, 1999, MED PHYS, V26, P1847, DOI 10.1118/1.598691; Andreassen B, 2011, MED PHYS, V38, P4774, DOI 10.1118/1.3615059; Connell T, 2012, PHYS MED BIOL, V57, P3259, DOI 10.1088/0031-9155/57/11/3259; du Plessis FCP, 2006, PHYS MED BIOL, V51, P2113, DOI 10.1088/0031-9155/51/8/011; Eldib A, 2014, PHYS MED BIOL, V59, P819, DOI 10.1088/0031-9155/59/4/819; Hardcastle N, 2008, MED PHYS, V35, P5061, DOI 10.1118/1.2996288; Hyodynmaa S, 1996, MED PHYS, V23, P659, DOI 10.1118/1.597710; Inoue M, 2014, J APPL CLIN MED PHYS, V15, P152, DOI 10.1120/jacmp.v15i4.4786; Salguero FJ, 2010, PHYS MED BIOL, V55, P1413, DOI 10.1088/0031-9155/55/5/010; KARLSSON M, 1993, MED PHYS, V20, P143, DOI 10.1118/1.597162; KHAN FM, 1991, MED PHYS, V18, P73, DOI 10.1118/1.596695; Kim H, 2014, RADIAT ONCOL J, V32, P187, DOI 10.3857/roj.2014.32.3.187; Lee CY, 2015, PROG MED PHYS, V26, P9; Ma CM, 2003, PHYS MED BIOL, V48, P909, DOI 10.1088/0031-9155/48/7/308; McDowell MA, 2008, NATL HLTH STAT REP, V10, P1; Mihaljevic J, 2011, PHYS MED BIOL, V56, P829, DOI 10.1088/0031-9155/56/3/018; Nicolini G, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20120543; Olofsson L, 2005, PHYS MED BIOL, V50, P1191, DOI 10.1088/0031-9155/50/6/010; Park JM, 2012, BRIT J RADIOL, V85, pE323, DOI 10.1259/bjr/19088580; Park Jong Min, 2014, J Appl Clin Med Phys, V15, P4970, DOI 10.1120/jacmp.v15i6.4970; ROGERS DWO, 1995, MED PHYS, V22, P503, DOI 10.1118/1.597552; Rong Y, 2010, MED PHYS, V37, P5509, DOI 10.1118/1.3489379; TUNG SS, 1993, INT J RADIAT ONCOL, V27, P153, DOI 10.1016/0360-3016(93)90433-V; Valdes G, 2015, J APPL CLIN MED PHYS, V16, P322, DOI 10.1120/jacmp.v16i4.5363; Wang XC, 2005, INT J RADIAT ONCOL, V63, P594, DOI 10.1016/j.ijrobp.2005.06.006; Wu Q, 2013, INT J RADIAT ONCOL, V87, pS121, DOI 10.1016/j.ijrobp.2013.06.311	26	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177380	10.1371/journal.pone.0177380	http://dx.doi.org/10.1371/journal.pone.0177380			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493940	gold, Green Submitted, Green Published			2022-12-26	WOS:000401314300097
J	Kanomata, N; Matsuura, S; Nomura, T; Kurebayashi, J; Mori, T; Kitawaki, J; Moriya, T				Kanomata, Naoki; Matsuura, Shiro; Nomura, Tsunehisa; Kurebayashi, Junichi; Mori, Taisuke; Kitawaki, Jo; Moriya, Takuya			Preparation of a novel antiserum to aromatase with high affinity and specificity: Its clinicopathological significance on breast cancer tissue	PLOS ONE			English	Article							IMMUNOHISTOCHEMICAL LOCALIZATION; MONOCLONAL-ANTIBODY; ENDOCRINE THERAPY; HUMAN-PLACENTA; IN-SITU; EXPRESSION; CYTOCHROME-P-450; METAANALYSIS; TRANSCRIPTS; TAMOXIFEN	Aromatase inhibitors have been widely used for the endocrine treatment of estrogen-dependent breast cancer in postmenopausal patients. However, clinicopathological studies of aromatase have been limited due to unsatisfactory specificity and/or restricted availability of anti-aromatase antibodies. Here, we have generated a polyclonal antiserum with high affinity and specificity for human aromatase using a monoclonal antibody tagged immunoaffinity chromatography on an industrial production scale. Our preliminary immunohistochemical analysis of 221 invasive breast cancer cases indicated that 87.3% (193/221) had at least 5% aromatase positive cells. The histoscore for aromatase was inversely correlated with pT (p = 0.019), pN (p = 0.001), stage (p < 0.001), histologic grade (p = 0.003), lymphatic infiltration (p < 0.001), venous infiltration (p < 0.001), and Ki-67 index (p < 0.001). However, cancer aromatase expression was independent of estrogen receptor (ER), progesterone receptor (PgR), and human epidermal growth factor receptor 2 statuses. This antiserum will be applicable to clinicopathological examination of aromatase in addition to ER and PgR for an appropriate use of aromatase inhibitor on the treatment of breast cancer. Further studies on the relationship between Aromatase inhibitors have been widely used for the endocrine treatment of estrogen-dependent breast cancer in postmenopausal patients. However, clinicopathological studies of aromatase have been limited due to unsatisfactory specificity and/or restricted availability of anti-aromatase antibodies. Here, we have generated a polyclonal antiserum with high affinity and specificity for human aromatase using a monoclonal antibody tagged immunoaffinity chromatography on an industrial production scale. Our preliminary immunohistochemical analysis of 221 invasive breast cancer cases indicated that 87.3% (193/221) had at least 5% aromatase positive cells. The histoscore for aromatase was inversely correlated with pT (p = 0.019), pN (p = 0.001), stage (p < 0.001), histologic grade (p = 0.003), lymphatic infiltration (p < 0.001), venous infiltration (p < 0.001), and Ki-67 index (p < 0.001). However, cancer aromatase expression was independent of estrogen receptor (ER), progesterone receptor (PgR), and human epidermal growth factor receptor 2 statuses. This antiserum will be applicable to clinicopathological examination of aromatase in addition to ER and PgR for an appropriate use of aromatase inhibitor on the treatment of breast cancer. Further studies on the relationship between aromatase expression and aromatase inhibitors are warranted.	[Kanomata, Naoki; Moriya, Takuya] Kawasaki Med Sch, Dept Pathol, Kurashiki, Okayama, Japan; [Matsuura, Shiro] LSI Medience Corp, Corp Planning Dept, Tokyo, Japan; [Nomura, Tsunehisa; Kurebayashi, Junichi] Kawasaki Med Sch, Dept Breast & Thyroid Surg, Kurashiki, Okayama, Japan; [Mori, Taisuke; Kitawaki, Jo] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Obstet & Gynecol, Kyoto, Japan	Kawasaki Medical School; Kawasaki Medical School; Kyoto Prefectural University of Medicine	Kanomata, N (corresponding author), Kawasaki Med Sch, Dept Pathol, Kurashiki, Okayama, Japan.	kanomata_7@med.kawasaki-m.ac.jp	Moriya, Takuya/AAM-6974-2020	Kanomata, Naoki/0000-0002-0172-4524	Shiro Matsuura is an employee of LSI Medience Corporation, Tokyo, Japan; Grants-in-Aid for Scientific Research [15K10726] Funding Source: KAKEN	Shiro Matsuura is an employee of LSI Medience Corporation, Tokyo, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Shiro Matsuura is an employee of LSI Medience Corporation, Tokyo, Japan. The specific roles of this author are articulated in the 'author contributions' section. There was no additional external funding received for this study.	Berstein LM, 1996, J CANCER RES CLIN, V122, P495, DOI 10.1007/BF01187162; BULUN SE, 1993, J CLIN ENDOCR METAB, V77, P1622, DOI 10.1210/jc.77.6.1622; Burstein HJ, 2010, J CLIN ONCOL, V28, P3784, DOI 10.1200/JOP.000082; CHEN S, 1986, BIOCHEM BIOPH RES CO, V135, P713, DOI 10.1016/0006-291X(86)90987-3; Chen SA, 1998, FRONT BIOSCI-LANDMRK, V3, P922; Cuzick J, 2013, LANCET, V381, P1827, DOI 10.1016/S0140-6736(13)60140-3; Dowsett M, 2015, LANCET, V386, P1341, DOI 10.1016/S0140-6736(15)61074-1; ESTEBAN JM, 1992, AM J PATHOL, V140, P337; Geisler J, 2010, J STEROID BIOCHEM, V118, P237, DOI 10.1016/j.jsbmb.2009.10.010; Harada N, 1997, J STEROID BIOCHEM, V61, P175; Honma N, 2006, J CLIN ENDOCR METAB, V91, P607, DOI 10.1210/jc.2005-1967; Howell A, 2005, LANCET, V365, P60, DOI 10.1016/s0140-6736(04)17666-6; KITAWAKI J, 1992, ENDOCRINOLOGY, V130, P2751, DOI 10.1210/en.130.5.2751; Kitawaki J, 1996, ANTICANCER RES, V16, P91; Kitawaki J, 1997, BIOL REPROD, V57, P514, DOI 10.1095/biolreprod57.3.514; KITAWAKI J, 1989, ENDOCRINOLOGY, V124, P1417, DOI 10.1210/endo-124-3-1417; Lykkesfeldt AE, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-185; Miki Y, 2007, J STEROID BIOCHEM, V106, P97, DOI 10.1016/j.jsbmb.2007.05.007; Miki Y, 2007, CANCER RES, V67, P3945, DOI 10.1158/0008-5472.CAN-06-3105; MILLER WR, 1982, CANCER RES, V42, P3365; PEREL E, 1982, CANCER RES, V42, P3369; SASANO H, 1994, HUM PATHOL, V25, P530, DOI 10.1016/0046-8177(94)90127-9; Sasano H, 2005, J STEROID BIOCHEM, V95, P35, DOI 10.1016/j.jsbmb.2005.04.027; Sasano H, 1998, BREAST CANC RES T S1, V49, pS109; Sasieni PD, 2011, BRIT J CANCER, V105, P460, DOI 10.1038/bjc.2011.250; Sobin L, 2009, TNM CLASSIFICATION M; TAMURA T, 1992, J ENDOCRINOL, V135, P589, DOI 10.1677/joe.0.1350589; Utsumi T, 1996, J CLIN ENDOCR METAB, V81, P2344, DOI 10.1210/jc.81.6.2344; WASHIDA N, 1985, FED PROC, V44, P861; YOSHIDA N, 1991, BIOCHEMISTRY-US, V30, P3003, DOI 10.1021/bi00226a004; Zhang ZH, 2002, BREAST CANCER RES TR, V74, P47, DOI 10.1023/A:1016022314608	31	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177439	10.1371/journal.pone.0177439	http://dx.doi.org/10.1371/journal.pone.0177439			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489882	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314100075
J	Keogh, CE; Scholz, CC; Rodriguez, J; Selfridge, AC; von Kriegsheim, A; Cummins, EP				Keogh, Ciara E.; Scholz, Carsten C.; Rodriguez, Javier; Selfridge, Andrew C.; von Kriegsheim, Alexander; Cummins, Eoin P.			Carbon dioxide-dependent regulation of NF-kappa B family members RelB and p100 gives molecular insight into CO2-dependent immune regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED LUNG INJURY; HYPERCAPNIC ACIDOSIS; THERAPEUTIC HYPERCAPNIA; SIGNALING PATHWAYS; SUBUNIT RELB; INFLAMMATION; PROTEIN; VENTILATION; ACTIVATION; MECHANISM	CO2 is a physiological gas normally produced in the body during aerobic respiration. Hypercapnia (elevated blood pCO(2) > approximate to 50 mm Hg) is a feature of several lung pathologies, e.g. chronic obstructive pulmonary disease. Hypercapnia is associated with increased susceptibility to bacterial infections and suppression of inflammatory signaling. The NF-kappa B pathway has been implicated in these effects; however, the molecular mechanisms underpinning cellular sensitivity of the NF-kappa B pathway to CO2 are not fully elucidated. Here, we identify several novel CO2-dependent changes in the NF-kappa B pathway. NF-kappa B family members p100 and RelB translocate to the nucleus in response to CO2. A cohort of RelB protein-protein interactions (e.g. with Raf-1 and I kappa B alpha) are altered by CO2 exposure, although others are maintained (e. g. with p100). RelB is processed by CO2 in a manner dependent on a key C-terminal domain located in its transactivation domain. Loss of the RelB transactivation domain alters NF-kappa B-dependent transcriptional activity, and loss of p100 alters sensitivity of RelB to CO2. Thus, we provide molecular insight into the CO2 sensitivity of the NF-kappa B pathway and implicate altered RelB/p100-dependent signaling in the CO2-dependent regulation of inflammatory signaling.	[Keogh, Ciara E.; Selfridge, Andrew C.; Cummins, Eoin P.] Univ Coll Dublin, Sch Med, Dublin 4, Ireland; [Keogh, Ciara E.; Selfridge, Andrew C.; Cummins, Eoin P.] Univ Coll Dublin, Conway Inst, Dublin 4, Ireland; [Scholz, Carsten C.; Rodriguez, Javier; von Kriegsheim, Alexander] Univ Coll Dublin, Syst Biol Ireland, Dublin 4, Ireland; [Rodriguez, Javier; von Kriegsheim, Alexander] Edinburgh Canc Res Ctr, Edinburgh EH4 2XR, Midlothian, Scotland; [Scholz, Carsten C.] Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland	University College Dublin; University College Dublin; University College Dublin; University of Edinburgh; University of Zurich	Cummins, EP (corresponding author), Univ Coll Dublin, Sch Med, Dublin 4, Ireland.	eoin.cummins@ucd.ie	rodriguez, javier/AAB-1131-2019; Cummins, Eoin/S-7554-2019; Scholz, Carsten C./P-3185-2019; von Kriegsheim, Alex/C-2371-2016	rodriguez, javier/0000-0001-7467-8533; Cummins, Eoin/0000-0002-9346-8299; Scholz, Carsten C./0000-0001-6579-8015; Keogh, Ciara/0000-0002-5591-5633; von Kriegsheim, Alex/0000-0002-4952-8573	Science Foundation Ireland [15/CDA/3490]; University College Dublin School of Medicine; University College Dublin Research Grant [SF1146]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); University College Dublin School of Medicine; University College Dublin Research Grant	This work was supported by Science Foundation Ireland Grant 15/CDA/3490, University College Dublin School of Medicine, and University College Dublin Research Grant SF1146. The authors declare that they have no conflicts of interest with the contents of this article.	Abolhassani M, 2009, AM J PHYSIOL-LUNG C, V296, pL657, DOI 10.1152/ajplung.90460.2008; Ahmadi Z, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-30; Baglole CJ, 2008, J BIOL CHEM, V283, P28944, DOI 10.1074/jbc.M800685200; Basak S, 2007, CELL, V128, P369, DOI 10.1016/j.cell.2006.12.033; Bellet MM, 2012, CELL CYCLE, V11, P3304, DOI 10.4161/cc.21669; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Caamano J, 1999, J IMMUNOL, V163, P4453; Contreras M, 2012, CRIT CARE MED, V40, P2622, DOI 10.1097/CCM.0b013e318258f8b4; Costello J, 2009, CRIT CARE MED, V37, P2412, DOI 10.1097/CCM.0b013e3181a385d3; Crummy F, 2007, RESP MED, V101, P53, DOI 10.1016/j.rmed.2006.04.013; Cummins EP, 2016, EXP PHYSIOL, V101, P986, DOI 10.1113/EP085715; Cummins EP, 2014, CELL MOL LIFE SCI, V71, P831, DOI 10.1007/s00018-013-1470-6; Cummins EP, 2010, J IMMUNOL, V185, P4439, DOI 10.4049/jimmunol.1000701; DOBRZANSKI P, 1993, MOL CELL BIOL, V13, P1572, DOI 10.1128/MCB.13.3.1572; Fuller BM, 2017, J CRIT CARE, V41, P29, DOI 10.1016/j.jcrc.2017.04.033; Fusco AJ, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad9413; Gao W, 2015, ANESTHESIOLOGY, V122, P1235, DOI 10.1097/ALN.0000000000000627; Gates KL, 2013, AM J RESP CELL MOL, V49, P821, DOI 10.1165/rcmb.2012-0487OC; Ghosh S, 2012, IMMUNOL REV, V246, P5, DOI 10.1111/j.1600-065X.2012.01111.x; Hailfinger S, 2011, P NATL ACAD SCI USA, V108, P14596, DOI 10.1073/pnas.1105020108; Hailfinger S, 2009, P NATL ACAD SCI USA, V106, P19946, DOI 10.1073/pnas.0907511106; Helenius IT, 2009, P NATL ACAD SCI USA, V106, P18710, DOI 10.1073/pnas.0905925106; Horie Shahd, 2016, Intensive Care Med Exp, V4, P8, DOI 10.1186/s40635-016-0081-6; Jaitovich A, 2015, J BIOL CHEM, V290, P9183, DOI 10.1074/jbc.M114.625715; Kohnlein T, 2014, LANCET RESP MED, V2, P698, DOI 10.1016/S2213-2600(14)70153-5; Kuboki M, 2015, BIOCHEM BIOPH RES CO, V456, P810, DOI 10.1016/j.bbrc.2014.12.024; Labonte L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112965; Laffey JG, 2004, AM J RESP CRIT CARE, V169, P46, DOI 10.1164/rccm.200205-394OC; Leidner U, 2008, BIOCHEM J, V416, P117, DOI 10.1042/BJ20080432; Leidner J, 2014, J CELL BIOCHEM, V115, P1430, DOI 10.1002/jcb.24794; Li AM, 2010, CHINESE MED J-PEKING, V123, P2254, DOI 10.3760/cma.j.issn.0366-6999.2010.16.018; Li GY, 2006, J APPL PHYSIOL, V101, P1556, DOI 10.1152/japplphysiol.01031.2005; Lovas A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-606; Maier HJ, 2003, J BIOL CHEM, V278, P39242, DOI 10.1074/jbc.M301521200; Marienfeld R, 2001, ONCOGENE, V20, P8142, DOI 10.1038/sj.onc.1204884; Masterson C, 2016, CRIT CARE MED, V44, pe207, DOI 10.1097/CCM.0000000000001376; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Millet P, 2013, J LEUKOCYTE BIOL, V94, P941, DOI 10.1189/jlb.0513305; Moorthy AK, 2007, J MOL BIOL, V373, P723, DOI 10.1016/j.jmb.2007.08.039; Neumann M, 2011, ONCOGENE, V30, P2485, DOI 10.1038/onc.2010.580; O'Croinin DF, 2008, CRIT CARE MED, V36, P2128, DOI 10.1097/CCM.0b013e31817d1b59; O'Toole D, 2009, THORAX, V64, P976, DOI 10.1136/thx.2008.110304; Oliver KM, 2012, J BIOL CHEM, V287, P14004, DOI 10.1074/jbc.M112.347971; Otulakowski G, 2014, J PHYSIOL-LONDON, V592, P4507, DOI 10.1113/jphysiol.2014.277616; Otulakowski G, 2011, CRIT CARE MED, V39, P1581, DOI 10.1097/CCM.0b013e318215bb0a; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Roberts BW, 2015, RESUSCITATION, V91, P32, DOI 10.1016/j.resuscitation.2015.03.015; Rodriguez J, 2016, CELL REP, V14, P2745, DOI 10.1016/j.celrep.2016.02.043; Sharabi K, 2009, P NATL ACAD SCI USA, V106, P4024, DOI 10.1073/pnas.0900309106; Takeshita K, 2003, AM J RESP CELL MOL, V29, P124, DOI 10.1165/rcmb.2002-0126OC; Tando T, 2010, J BIOL CHEM, V285, P21951, DOI 10.1074/jbc.M109.087783; Tao ZH, 2014, P NATL ACAD SCI USA, V111, P15946, DOI 10.1073/pnas.1408552111; Taylor CT, 2011, J PHYSIOL-LONDON, V589, P797, DOI 10.1113/jphysiol.2010.201467; Tzeng YS, 2015, J SURG RES, V195, P351, DOI 10.1016/j.jss.2014.12.023; Wang NZ, 2010, FASEB J, V24, P2178, DOI 10.1096/fj.09-136895; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; Yilmaz ZB, 2003, EMBO J, V22, P121, DOI 10.1093/emboj/cdg004	57	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11561	11571		10.1074/jbc.M116.755090	http://dx.doi.org/10.1074/jbc.M116.755090			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28507099	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000405119600035
J	Perlenfein, TJ; Mehlhoff, JD; Murphy, RM				Perlenfein, Tyler J.; Mehlhoff, Jacob D.; Murphy, Regina M.			Insights into the mechanism of cystatin C oligomer and amyloid formation and its interaction with beta-amyloid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY CEREBRAL-HEMORRHAGE; ALZHEIMERS-DISEASE; CEREBROSPINAL-FLUID; FIBRIL FORMATION; ICELANDIC TYPE; CROSS-LINKING; L68Q VARIANT; WILD-TYPE; PROTEIN; ANGIOPATHY	Cystatin C (CysC) is a versatile and ubiquitously-expressed member of the cysteine protease inhibitor family that is present at notably high concentrations in cerebrospinal fluid. Under mildly denaturing conditions, CysC forms inactive domainswapped dimers. A destabilizing mutation, L68Q, increases the rate of domain-swapping and causes a fatal amyloid disease, hereditary cystatin C amyloid angiopathy. Wild-type (wt) CysC will also aggregate into amyloid fibrils under some conditions. Propagated domain-swapping has been proposed as the mechanism by which CysC fibrils grow. We present evidence that a CysC mutant, V57N, stabilized against domain-swapping, readily forms fibrils, contradicting the propagated domain-swapping hypothesis. Furthermore, in physiological buffer, wt CysC can form oligomers without undergoing domain-swapping. These non-swapped oligomers are identical in secondary structure to CysC monomers and completely retain protease inhibitory activity. However, unlike monomers or dimers, the oligomers bind fluorescent dyes that indicate they have characteristics of pre-amyloid aggregates. Although these oligomers appear to be a pre-amyloid assembly, they are slower than CysC monomers to form fibrils. Fibrillation of CysC therefore likely initiates from the monomer and does not require domain-swapping. The non-swapped oligomers likely represent a dead-end offshoot of the amyloid pathway and must dissociate to monomers prior to rearranging to amyloid fibrils. These prefibrillar CysC oligomers were potent inhibitors of aggregation of the Alzheimer's-related peptide, beta-amyloid. This result illustrates an example where heterotypic interactions between pre-amyloid oligomers prevent the homotypic interactions that would lead to mature amyloid fibrils.	[Perlenfein, Tyler J.; Mehlhoff, Jacob D.; Murphy, Regina M.] Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Murphy, RM (corresponding author), Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA.	regina.murphy@wisc.edu			University of Wisconsin-Madison; National Science Foundation [BIR-9512577]; National Institutes of Health [S10 RR13790]; Directorate For Engineering [1262729] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR013790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008293] Funding Source: NIH RePORTER	University of Wisconsin-Madison; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	CD data were obtained at the University of Wisconsin-Madison Biophysics Instrumentation Facility, which was established with support from the University of Wisconsin-Madison and National Science Foundation Grant BIR-9512577 and National Institutes of Health Grant S10 RR13790, with technical assistance provided by Dr. Darrell McCaslin. Randall Massey provided technical assistance with TEM.h-FTAA pre-amyloid dye was a generous gift from Drs. Peter Nilsson and Per Hammarstrom (Linkoping University, Sweden).	ABRAHAMSON M, 1991, BIOCHEM J, V273, P621, DOI 10.1042/bj2730621; Alvarez-Fernandez M, 1999, J BIOL CHEM, V274, P19195, DOI 10.1074/jbc.274.27.19195; Bennett MJ, 2006, STRUCTURE, V14, P811, DOI 10.1016/j.str.2006.03.011; Bergdoll M, 1997, STRUCTURE, V5, P391, DOI 10.1016/S0969-2126(97)00196-2; BJORK I, 1994, BIOCHEM J, V299, P219, DOI 10.1042/bj2990219; Bleiholder C, 2011, NAT CHEM, V3, P172, DOI 10.1038/NCHEM.945; Calero M, 2001, J NEUROCHEM, V77, P628, DOI 10.1046/j.1471-4159.2001.00256.x; Cantor C. R., 1980, BIOPHYSICAL CHEM 2, P549; CORIA F, 1987, AM J PATHOL, V129, P422; Davis PJ, 2015, J MOL BIOL, V427, P2418, DOI 10.1016/j.jmb.2015.05.014; Ekiel I, 1997, J MOL BIOL, V271, P266, DOI 10.1006/jmbi.1997.1150; Ekiel I, 1996, J BIOL CHEM, V271, P1314, DOI 10.1074/jbc.271.3.1314; Enerson BE, 2006, J CEREBR BLOOD F MET, V26, P959, DOI 10.1038/sj.jcbfm.9600249; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Fandrich M, 2012, J MOL BIOL, V421, P427, DOI 10.1016/j.jmb.2012.01.006; Filler G, 2005, CLIN BIOCHEM, V38, P1, DOI 10.1016/j.clinbiochem.2004.09.025; Gerhartz B, 1998, BIOCHEMISTRY-US, V37, P17309, DOI 10.1021/bi980873u; GHISO J, 1986, P NATL ACAD SCI USA, V83, P2974, DOI 10.1073/pnas.83.9.2974; Gosal WS, 2005, J MOL BIOL, V351, P850, DOI 10.1016/j.jmb.2005.06.040; Guo SL, 2014, CLIN J PAIN, V30, P331, DOI 10.1097/AJP.0b013e31829ca60b; Hakansson K, 1996, COMP BIOCHEM PHYS B, V114, P303, DOI 10.1016/0305-0491(96)00025-9; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hasegawa A, 2007, J NEUROCHEM, V100, P12, DOI 10.1111/j.1471-4159.2006.04169.x; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; Janowski R, 2001, NAT STRUCT BIOL, V8, P316, DOI 10.1038/86188; Kaeser SA, 2007, NAT GENET, V39, P1437, DOI 10.1038/ng.2007.23; Kayser V, 2004, J AM CHEM SOC, V126, P336, DOI 10.1021/ja035340+; Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X; Klingstedt T, 2011, ORG BIOMOL CHEM, V9, P8356, DOI 10.1039/c1ob05637a; Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007; Kremer JJ, 2000, BIOCHEMISTRY-US, V39, P10309, DOI 10.1021/bi0001980; Ladiwala ARA, 2012, J BIOL CHEM, V287, P24765, DOI 10.1074/jbc.M111.329763; Levy E, 2006, BRAIN PATHOL, V16, P60, DOI 10.1111/j.1750-3639.2006.tb00562.x; Levy E, 2001, J NEUROPATH EXP NEUR, V60, P94, DOI 10.1093/jnen/60.1.94; Li J, 2011, J BIOL CHEM, V286, P28988, DOI 10.1074/jbc.M111.261750; Luo JH, 2016, J BIOL CHEM, V291, P16485, DOI 10.1074/jbc.R116.714576; Lutgens SPM, 2007, FASEB J, V21, P3029, DOI 10.1096/fj.06-7924com; Mathews PM, 2016, AGEING RES REV, V32, P38, DOI 10.1016/j.arr.2016.06.003; McCarron MO, 2000, NEUROLOGY, V54, P242, DOI 10.1212/WNL.54.1.242; Mi W, 2007, NAT GENET, V39, P1440, DOI 10.1038/ng.2007.29; Mi WQ, 2009, J ALZHEIMERS DIS, V18, P273, DOI 10.3233/JAD-2009-1147; Migneault I, 2004, BIOTECHNIQUES, V37, P790, DOI 10.2144/04375RV01; Murphy RM, 2000, J STRUCT BIOL, V130, P109, DOI 10.1006/jsbi.2000.4253; Mussap M, 2004, CRIT REV CL LAB SCI, V41, P467, DOI 10.1080/10408360490504934; Nilsson M, 2004, J BIOL CHEM, V279, P24236, DOI 10.1074/jbc.M402621200; Orlikowska M, 2011, J STRUCT BIOL, V173, P406, DOI 10.1016/j.jsb.2010.11.009; Ostner G, 2013, J BIOL CHEM, V288, P16438, DOI 10.1074/jbc.M113.469593; Palsdottir A, 2006, BRAIN PATHOL, V16, P55; Pate KM, 2017, ISR J CHEM, V57, P602, DOI 10.1002/ijch.201600078; Pecora R, 2000, J NANOPART RES, V2, P123, DOI 10.1023/A:1010067107182; Perlenfein TJ, 2016, PROTEIN EXPRES PURIF, V117, P35, DOI 10.1016/j.pep.2015.09.023; Ristiniemi N, 2010, CLIN CHEM, V56, P1424, DOI 10.1373/clinchem.2009.141663; Sastre M, 2004, NEUROBIOL AGING, V25, P1033, DOI 10.1016/j.neurobiolaging.2003.11.006; Schagger H, 2001, METHOD CELL BIOL, V65, P231, DOI 10.1016/S0091-679X(01)65014-3; Selenica ML, 2007, SCAND J CLIN LAB INV, V67, P179, DOI 10.1080/00365510601009738; Sladewska A, 2011, J MOL RECOGNIT, V24, P687, DOI 10.1002/jmr.1100; Spector R, 2015, EXP NEUROL, V273, P57, DOI 10.1016/j.expneurol.2015.07.027; Sun BG, 2008, NEURON, V60, P247, DOI 10.1016/j.neuron.2008.10.001; Szymanska A, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00082; Szymanska A, 2009, ACTA BIOCHIM POL, V56, P455; Taupin P, 2000, NEURON, V28, P385, DOI 10.1016/S0896-6273(00)00119-7; Tizon B, 2010, J ALZHEIMERS DIS, V19, P885, DOI 10.3233/JAD-2010-1291; Tsiolaki PL, 2015, J STRUCT BIOL, V191, P272, DOI 10.1016/j.jsb.2015.07.013; Tsiolaki PL, 2015, FEBS LETT, V589, P159, DOI 10.1016/j.febslet.2014.11.041; Tsolis AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054175; Turk V, 2012, BBA-PROTEINS PROTEOM, V1824, P68, DOI 10.1016/j.bbapap.2011.10.002; van der Wel PCA, 2012, PRION, V6, P211, DOI 10.4161/pri.18987; Wahlbom M, 2007, J BIOL CHEM, V282, P18318, DOI 10.1074/jbc.M611368200; Wallin H, 2010, BIOCHIMIE, V92, P1625, DOI 10.1016/j.biochi.2010.08.011; Wang C, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.371641; Williams J W, 1979, Methods Enzymol, V63, P437; Wine Y, 2007, BIOTECHNOL BIOENG, V98, P711, DOI 10.1002/bit.21459; Xu YK, 2015, IMMUNOL CELL BIOL, V93, P442, DOI 10.1038/icb.2014.121; Xu YK, 2014, J BIOL CHEM, V289, P9730, DOI 10.1074/jbc.M113.538041; Yamada M, 2000, NEUROPATHOLOGY, V20, P8, DOI 10.1046/j.1440-1789.2000.00268.x; Zerovnik E, 2009, BIOESSAYS, V31, P597, DOI 10.1002/bies.200900012; Zhou YJ, 2015, PROTEIN EXPRES PURIF, V111, P18, DOI 10.1016/j.pep.2015.03.006	77	19	20	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11485	11498		10.1074/jbc.M117.786558	http://dx.doi.org/10.1074/jbc.M117.786558			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28487367	Green Published, hybrid			2022-12-26	WOS:000405119600030
J	Oberheide, K; Puchkov, D; Jentsch, TJ				Oberheide, Karina; Puchkov, Dmytro; Jentsch, Thomas J.			Loss of the Na+/H+ exchanger NHE8 causes male infertility in mice by disrupting acrosome formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRE RECOMBINASE ACTIVITY; SPERM; PH; EXPRESSION; GOLGI; PROTEIN; ACIDIFICATION; RETARDATION; MUTATIONS; DELETION	Mammalian sperm feature a specialized secretory organelle on the anterior part of the sperm nucleus, the acrosome, which is essential for male fertility. It is formed by a fusion of Golgi-derived vesicles. We show here that the predominantly Golgi-resident Na+/H+ exchanger NHE8 localizes to the developing acrosome of spermatids. Similar to wild-type mice, Nhe8(-/-) mice generated Golgi-derived vesicles positive for acrosomal markers and attached to nuclei, but these vesicles failed to form large acrosomal granules and the acrosomal cap. Spermatozoa from Nhe8(-/-) mice completely lacked acrosomes, were round-headed, exhibited abnormal mitochondrial distribution, and displayed decreased motility, resulting in selective male infertility. Of note, similar features are also found in globozoospermia, one of the causes of male infertility in humans. Germ cell-specific, but not Sertoli cell-specific Nhe8 disruption recapitulated the globozoospermia phenotype, demonstrating that NHE8's role in spermiogenesis is germ cell-intrinsic. Our work has uncovered a crucial role of NHE8 in acrosome biogenesis and suggests that some forms of human globozoospermia might be caused by a loss of function of this Na+/H+ exchanger. It points to NHE8 as a candidate gene for human globozoospermia and a possible drug target for male contraception.	[Oberheide, Karina; Puchkov, Dmytro; Jentsch, Thomas J.] Leibniz Forschungsinst Mol Pharmakol, D-13125 Berlin, Germany; [Oberheide, Karina; Jentsch, Thomas J.] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Helmholtz Association; Max Delbruck Center for Molecular Medicine	Jentsch, TJ (corresponding author), Robert Rossle Str 10, D-13125 Berlin, Germany.	Jentsch@fmp-berlin.de		Jentsch, Thomas/0000-0002-3509-2553; Puchkov, Dmytro/0000-0001-8341-4847	Deutsche Forschungsgemeinschaft [SFB 740, TP C05]; European Research Council [294435]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission)	This work was supported, in part, by Deutsche Forschungsgemeinschaft Grant SFB 740, TP C05 (to T. J. J.) and by the European Research Council (FP7 2007-2013) ERC-Advanced Grant 294435 'CYTOVOLION' (to T. J. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Arndt L, 2014, MOL BIOL CELL, V25, P948, DOI 10.1091/mbc.E13-09-0523; Bell SM, 1999, AM J PHYSIOL-CELL PH, V276, pC788, DOI 10.1152/ajpcell.1999.276.4.C788; Berruti G, 2016, SEMIN CELL DEV BIOL, V59, P46, DOI 10.1016/j.semcdb.2016.01.013; Berruti Giovanna, 2011, Spermatogenesis, V1, P95; Bourgeois S, 2010, J CLIN INVEST, V120, P1895, DOI 10.1172/JCI36581; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Cheng XP, 2010, FEBS LETT, V584, P2013, DOI 10.1016/j.febslet.2009.12.056; CLAGUE MJ, 1994, J BIOL CHEM, V269, P21; Condon KH, 2013, J NEUROSCI, V33, P3799, DOI 10.1523/JNEUROSCI.1930-11.2013; Cooke HJ, 2002, NAT REV GENET, V3, P790, DOI 10.1038/nrg911; Cox GA, 1997, CELL, V91, P139, DOI 10.1016/S0092-8674(01)80016-7; Dam AHDM, 2007, HUM REPROD UPDATE, V13, P63, DOI 10.1093/humupd/dml047; Dam AHDM, 2007, AM J HUM GENET, V81, P813, DOI 10.1086/521314; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Gilfillan GD, 2008, AM J HUM GENET, V82, P1003, DOI 10.1016/j.ajhg.2008.01.013; Goyal S, 2005, AM J PHYSIOL-RENAL, V288, pF530, DOI 10.1152/ajprenal.00229.2004; Goyal S, 2003, AM J PHYSIOL-RENAL, V284, pF467, DOI 10.1152/ajprenal.00352.2002; Hasuwa H, 2010, EXP ANIM TOKYO, V59, P105, DOI 10.1538/expanim.59.105; HOLSTEIN AF, 1973, DEUT MED WOCHENSCHR, V98, P61, DOI 10.1055/s-0028-1106747; Huang CJ, 2011, J BIOL CHEM, V286, P10058, DOI 10.1074/jbc.M110.197889; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; Inoue N, 2005, NATURE, V434, P234, DOI 10.1038/nature03362; Jadeja S, 2015, INVEST OPHTH VIS SCI, V56, P3015, DOI 10.1167/iovs.14-15735; Kang-Decker N, 2001, SCIENCE, V294, P1531, DOI 10.1126/science.1063665; Kierszenbaum AL, 2003, MOL BIOL CELL, V14, P4628, DOI 10.1091/mbc.E03-04-0226; Kondapalli KC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3510; Koscinski I, 2011, AM J HUM GENET, V88, P344, DOI 10.1016/j.ajhg.2011.01.018; Lawrence SP, 2010, MOL BIOL CELL, V21, P3540, DOI 10.1091/mbc.E09-12-1053; Lecureuil C, 2002, GENESIS, V33, P114, DOI 10.1002/gene.10100; Liu C, 2013, AM J PHYSIOL-CELL PH, V305, pC121, DOI 10.1152/ajpcell.00101.2013; Lou XH, 2011, AM J PHYSIOL-CELL PH, V301, pC1431, DOI 10.1152/ajpcell.00154.2011; Luzio JP, 2007, BIOCHEM SOC T, V35, P1088, DOI 10.1042/BST0351088; Maeda Y, 2008, NAT CELL BIOL, V10, P1135, DOI 10.1038/ncb1773; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; MEIZEL S, 1978, J HISTOCHEM CYTOCHEM, V26, P98, DOI 10.1177/26.2.24069; Modi S, 2013, NAT NANOTECHNOL, V8, P459, DOI [10.1038/nnano.2013.92, 10.1038/NNANO.2013.92]; Moreno RD, 2006, MOL REPROD DEV, V73, P1430, DOI 10.1002/mrd.20581; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; MORTIMER D, 1987, J REPROD FERTIL, V81, P127; Nakamura N, 2005, J BIOL CHEM, V280, P1561, DOI 10.1074/jbc.M410041200; Nakanishi T, 2001, DEV BIOL, V237, P222, DOI 10.1006/dbio.2001.0353; Okabe M, 2013, DEVELOPMENT, V140, P4471, DOI 10.1242/dev.090613; Orlowski J, 2007, CURR OPIN CELL BIOL, V19, P483, DOI 10.1016/j.ceb.2007.06.001; Orlowski J, 2011, COMPR PHYSIOL, V1, P2083, DOI 10.1002/cphy.c110020; Ouyang Q, 2013, NEURON, V80, P97, DOI 10.1016/j.neuron.2013.07.043; Qiu QS, 2010, J CELL SCI, V123, P3266, DOI 10.1242/jcs.067637; Ramalho-Santos J, 2009, HUM REPROD UPDATE, V15, P553, DOI 10.1093/humupd/dmp016; Rivinoja A, 2009, J CELL PHYSIOL, V220, P144, DOI 10.1002/jcp.21744; Roxrud I, 2009, EXP CELL RES, V315, P3014, DOI 10.1016/j.yexcr.2009.07.012; Sadate-Ngatchou PI, 2008, GENESIS, V46, P738, DOI 10.1002/dvg.20437; Schirren C.G., 1971, ANDROLOGIA, V3, P117, DOI DOI 10.1111/J.1439-0272.1971.TB02106.X; Schultheis PJ, 1998, NAT GENET, V19, P282, DOI 10.1038/969; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Scott CC, 2011, BIOESSAYS, V33, P103, DOI 10.1002/bies.201000108; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Wang D, 2003, NAT CELL BIOL, V5, P1117, DOI 10.1038/ncb1072; Wang D, 2007, P NATL ACAD SCI USA, V104, P9325, DOI 10.1073/pnas.0611296104; Xia CH, 2015, SCI REP-UK, V5, DOI 10.1038/srep09358; Xiao N, 2009, J CLIN INVEST, V119, P802, DOI 10.1172/JCI36230; Xu H, 2005, AM J PHYSIOL-GASTR L, V289, pG36, DOI 10.1152/ajpgi.00552.2004; Xu H, 2015, AM J PHYSIOL-CELL PH, V308, pC330, DOI 10.1152/ajpcell.00289.2014; Xu H, 2012, AM J PHYSIOL-GASTR L, V303, pG335, DOI 10.1152/ajpgi.00146.2012; Yao RJ, 2002, P NATL ACAD SCI USA, V99, P11211, DOI 10.1073/pnas.162027899; Zhang FP, 2001, MOL ENDOCRINOL, V15, P172, DOI 10.1210/me.15.1.172; Zhou Q, 2001, P NATL ACAD SCI USA, V98, P14132, DOI 10.1073/pnas.241245898	67	23	25	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					10845	10854		10.1074/jbc.M117.784108	http://dx.doi.org/10.1074/jbc.M117.784108			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28476888	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000404391000009
J	Niego, B; Lee, N; Larsson, P; de Silva, TM; Au, AEL; McCutcheon, F; Medcalf, RL				Niego, Be'eri; Lee, Natasha; Larsson, Pia; de Silva, T. Michael; Au, Amanda E-Ling; McCutcheon, Fiona; Medcalf, Robert L.			Selective inhibition of brain endothelial Rhokinase-2 provides optimal protection of an in vitro blood-brain barrier from tissue-type plasminogen activator and plasmin	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; RHO-KINASE; CEREBRAL BARRIER; CELL; ROCK2; FASUDIL; LOCALIZATION; PERMEABILITY; MODULATION; EXPRESSION	Rho-kinase (ROCK) inhibition, broadly utilised in cardiovascular disease, may protect the blood-brain barrier (BBB) during thrombolysis from rt-PA-induced damage. While the use of nonselective ROCK inhibitors like fasudil together with rt-PA may be hindered by possible hypotensive side-effects and inadequate capacity to block detrimental rt-PA activity in brain endothelial cells (BECs), selective ROCK-2 inhibition may overcome these limitations. Here, we examined ROCK-2 expression in major brain cells and compared the ability of fasudil and KD025, a selective ROCK-2 inhibitor, to attenuate rt-PA-induced BBB impairment in an in vitro human model. ROCK-2 was highly expressed relative to ROCK-1 in all human and mouse brain cell types and particularly enriched in rodent brain endothelial cells and astrocytes compared to neurons. KD025 was more potent than fasudil in attenuation of rt-PA-and plasminogen-induced BBB permeation under normoxia, but especially under stroke-like conditions. Importantly, only KD025, but not fasudil, was able to block rt-PA-dependent permeability increases, morphology changes and tight junction degradation in isolated BECs. Selective ROCK-2 inhibition further diminished rt-PA-triggered myosin phosphorylation, shape alterations and matrix metalloprotease activation in astrocytes. These findings highlight ROCK-2 as the key isoform driving BBB impairment and brain endothelial damage by rt-PA and the potential of KD025 to optimally protect the BBB during thrombolysis.	[Niego, Be'eri; Lee, Natasha; Au, Amanda E-Ling; McCutcheon, Fiona; Medcalf, Robert L.] Monash Univ, Australian Ctr Blood Dis, Mol Neurotrauma & Haemostasis, Melbourne, Vic, Australia; [Larsson, Pia] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med,Wallenberg Lab, Gothenburg, Sweden; [de Silva, T. Michael] La Trobe Univ, Sch Life Sci, Dept Physiol Anat & Microbiol, Victoria, Melbourne, Vic, Australia; [Au, Amanda E-Ling] Walter & Eliza Hall Inst Med Res, Canc & Haematol Div, Melbourne, Vic, Australia; [Au, Amanda E-Ling] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia	Monash University; University of Gothenburg; La Trobe University; University of Melbourne	Niego, B (corresponding author), Monash Univ, Australian Ctr Blood Dis, Mol Neurotrauma & Haemostasis, Melbourne, Vic, Australia.	beeri.niego@monash.edu	Niego, Beeri/AAG-5534-2019; Medcalf, Robert L/E-9632-2011	Niego, Beeri/0000-0001-6714-9131; De Silva, Travice/0000-0001-6351-7304; Au, Amanda/0000-0003-3656-2673	National Heart Foundation of Australia [100906]; National Health and Medical Research Council; High Blood Pressure Research Council of Australia; NHMRC	National Heart Foundation of Australia(National Heart Foundation of Australia); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); High Blood Pressure Research Council of Australia; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	B.N. is supported by a postdoctoral fellowship from the National Heart Foundation of Australia (https://heartfoundation.org.au/), award number 100906. T.M.D. is the recipient of a National Health and Medical Research Council (https://www.nhmrc.gov.au/) Early Career Fellowship and a High Blood Pressure Research Council of Australia (http://www.hbprca.com.au/) Early Career Research Transition Grant. R.L.M is a Principal Research Fellow of the National Health and Medical Research Council (https://www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; B.N. is supported by a postdoctoral fellowship from the National Heart Foundation of Australia (award number 100906). T.M.D. is the recipient of an NHMRC Early Career Fellowship and a High Blood Pressure Research Council of Australia Early Career Research Transition Grant. R.L.M is a Principal Research Fellow of the NHMRC of Australia. The authors wish to thank Monash Micro Imaging for their support with microscopy.	Allen C, 2010, STROKE, V41, P2056, DOI 10.1161/STROKEAHA.109.574939; Balami JS, 2013, CNS NEUROL DISORD-DR, V12, P155; Beckers CML, 2015, VASC PHARMACOL, V70, P45, DOI 10.1016/j.vph.2015.03.017; Boerma M, 2008, BLOOD COAGUL FIBRIN, V19, P709, DOI 10.1097/MBC.0b013e32830b2891; Bryan BA, 2010, FASEB J, V24, P3186, DOI 10.1096/fj.09-145102; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; De Silva TM, 2016, HYPERTENSION, V68, P809, DOI 10.1161/HYPERTENSIONAHA.116.07430; Dong MX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158848; Fu ZH, 2014, INT J CLIN EXP PATHO, V7, P7844; Fukuta T, 2017, FASEB J OFFICIAL PUB; Gibson CL, 2014, J NEUROCHEM, V129, P816, DOI 10.1111/jnc.12681; Greenidge AR, 2013, PATHOLOG RES INT, V2013; Hartmann S, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00276; Hirase T, 2001, J BIOL CHEM, V276, P10423, DOI 10.1074/jbc.M007136200; Iizuka M, 2012, CELL STRUCT FUNCT, V37, P155, DOI 10.1247/csf.12018; Ishiguro M, 2012, NEUROSCIENCE, V220, P302, DOI 10.1016/j.neuroscience.2012.06.015; Jeon BT, 2013, NEUROTOX RES, V23, P238, DOI 10.1007/s12640-012-9339-2; Larsson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031573; Lee JH, 2014, ANN CLIN TRANSL NEUR, V1, P2, DOI 10.1002/acn3.19; MAJOR EO, 1985, P NATL ACAD SCI USA, V82, P1257, DOI 10.1073/pnas.82.4.1257; Marcos-Contreras OA, 2016, BLOOD; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Melchor JP, 2005, THROMB HAEMOSTASIS, V93, P655, DOI 10.1160/TH04-12-0838; Mong PY, 2009, J IMMUNOL, V182, P2385, DOI 10.4049/jimmunol.0802811; Montalvo J, 2013, CURR MOL MED, V13, P205, DOI 10.2174/156652413804486296; Moretti A, 2015, PHARMACOL THERAPEUT, V153, P79, DOI 10.1016/j.pharmthera.2015.06.004; Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3; Newell-Litwa KA, 2015, J CELL BIOL, V210, P225, DOI 10.1083/jcb.201504046; Niego B, 2013, JOVE-J VIS EXP, V12, P81; Niego B, 2014, J CEREBR BLOOD F MET, V34, P1283, DOI 10.1038/jcbfm.2014.99; Niego B, 2012, BLOOD, V119, P4752, DOI 10.1182/blood-2011-07-369512; Noma K, 2012, J CARDIOL, V60, P1, DOI 10.1016/j.jjcc.2012.03.005; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Rikitake Y, 2005, STROKE, V36, P2251, DOI 10.1161/01.STR.0000181077.84981.11; Saal KA, 2016, BRAIN PATHOLOGY ZURI; Samson AL, 2008, J NEUROCHEM, V107, P1091, DOI 10.1111/j.1471-4159.2008.05687.x; Satoh S, 2001, LIFE SCI, V69, P1441, DOI 10.1016/S0024-3205(01)01229-2; Satoh S, 2010, BRAIN RES BULL, V81, P191, DOI 10.1016/j.brainresbull.2009.08.021; Shi JJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.10; Shi JJ, 2011, PEDIATR CARDIOL, V32, P297, DOI 10.1007/s00246-011-9920-0; Shibuya M, 2005, J NEUROL SCI, V238, P31, DOI 10.1016/j.jns.2005.06.003; Shimada H, 2010, J BIOL CHEM, V285, P12536, DOI 10.1074/jbc.M109.099630; Shimokawa H, 2005, ARTERIOSCL THROM VAS, V25, P1767, DOI 10.1161/01.ATV.0000176193.83629.c8; Shin HK, 2007, J CEREBR BLOOD F MET, V27, P998, DOI 10.1038/sj.jcbfm.9600406; Stamatovic SM, 2003, J CELL SCI, V116, P4615, DOI 10.1242/jcs.00755; Su EJ, 2008, NAT MED, V14, P731, DOI 10.1038/nm1787; Suzuki Y, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00002; Wang S, 2006, STROKE, V37, P1910, DOI 10.1161/01.STR.0000226923.48905.39; Wang YP, 2009, CIRC RES, V104, P531, DOI 10.1161/CIRCRESAHA.108.188524; Yaghi S, 2014, JAMA NEUROL, V71, P1181, DOI 10.1001/jamaneurol.2014.1210; Yano K, 2008, EUR J PHARMACOL, V594, P77, DOI 10.1016/j.ejphar.2008.07.045; Yao Y, 2011, J CELL SCI, V124, P1486, DOI 10.1242/jcs.082834; Zanin-Zhorov A, 2014, P NATL ACAD SCI USA, V111, P16814, DOI 10.1073/pnas.1414189111	53	28	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177332	10.1371/journal.pone.0177332	http://dx.doi.org/10.1371/journal.pone.0177332			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28510599	Green Published, gold			2022-12-26	WOS:000401485500023
J	Beckett, SJ; Weitz, JS				Beckett, Stephen J.; Weitz, Joshua S.			Disentangling niche competition from grazing mortality in phytoplankton dilution experiments	PLOS ONE			English	Article							MICROZOOPLANKTON; GROWTH; DYNAMICS; NITROGEN; PLANKTON; IMPACT; RATES; IRON	The dilution method is the principal tool used to infer in situ microzooplankton grazing rates. However, grazing is the only mortality process considered in the theoretical model underlying the interpretation of dilution method experiments. Here we evaluate the robustness of mortality estimates inferred from dilution experiments when there is concurrent niche competition amongst phytoplankton. Using a combination of mathematical analysis and numerical simulations, we find that grazing rates may be overestimated-the degree of overestimation is related to the importance of niche competition relative to microzooplankton grazing. In response, we propose a conceptual method to disentangle the effects of niche competition and grazing by diluting out microzooplankton, but not phytoplankton. Our theoretical results suggest this revised "Z-dilution" method can robustly infer grazing mortality, regardless of the dominant phytoplankton mortality driver in our system. Further, we show it is possible to independently estimate both grazing mortality and niche competition if the classical and Z-dilution methods can be used in tandem. We discuss the significance of these results for quantifying phytoplankton mortality rates; and the feasibility of implementing the Z-dilution method in practice, whether in model systems or in complex communities with overlap in the size distributions of phytoplankton and microzooplankton.	[Beckett, Stephen J.; Weitz, Joshua S.] Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA; [Weitz, Joshua S.] Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Beckett, SJ; Weitz, JS (corresponding author), Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA.; Weitz, JS (corresponding author), Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA.	stephen.beckett@biology.gatech.edu; jsweitz@gatech.edu		Beckett, Stephen/0000-0002-4410-2960	Simons Foundation [329108]	Simons Foundation	JSW was awarded SCOPE Award ID 329108 from the Simons Foundation (https://www.simonsfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agis M, 2007, J EXP MAR BIOL ECOL, V341, P176, DOI 10.1016/j.jembe.2006.09.002; ANDERSEN T, 1991, MAR ECOL PROG SER, V69, P67, DOI 10.3354/meps069067; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Barbeau K, 1996, NATURE, V380, P61, DOI 10.1038/380061a0; Beckett SJ, 2017, CODE DISENTANGLING R; Brum J.R., 2014, ECO DAS 9 S PROC, P16; Calbet A, 2004, LIMNOL OCEANOGR, V49, P51, DOI 10.4319/lo.2004.49.1.0051; Calbet A, 2013, J PLANKTON RES, V35, P1183, DOI 10.1093/plankt/fbt067; Caron DA, 2016, P NATL ACAD SCI USA, V113, P2806, DOI 10.1073/pnas.1600718113; Chen BZ, 2014, LIMNOL OCEANOGR, V59, P639, DOI 10.4319/lo.2014.59.3.0639; Dolan JR, 2005, OCEAN SCI, V1, P1, DOI 10.5194/os-1-1-2005; Evans C, 2003, AQUAT MICROB ECOL, V30, P207, DOI 10.3354/ame030207; EVANS GT, 1992, MAR ECOL PROG SER, V80, P285, DOI 10.3354/meps080285; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Follows MJ, 2007, SCIENCE, V315, P1843, DOI 10.1126/science.1138544; Kimmance SA, 2010, MANUAL AQUATIC VIRAL, P65, DOI [10.4319/mave.2010.978-0-9845591-0-7.65, DOI 10.4319/MAVE.2010.978-0-9845591-0-7.65]; Kirchman DL, 2010, MICROBIAL ECOLOGY OC, V36; LANDRY MR, 1982, MAR BIOL, V67, P283, DOI 10.1007/BF00397668; LANDRY MR, 1995, MAR ECOL PROG SER, V120, P53, DOI 10.3354/meps120053; Landry MR, 2014, LIMNOLOGY OCEANOGRAP, V59; Latasa M, 2014, LIMNOL OCEANOGR, V59, P1092, DOI 10.4319/lo.2014.59.3.1092; Lewis ND, 2012, BIOGEOCHEMISTRY, V110, P303, DOI 10.1007/s10533-011-9649-0; Lima-Mendez G, 2015, SCIENCE, V348, DOI 10.1126/science.1262073; Mills MM, 2004, NATURE, V429, P292, DOI 10.1038/nature02550; Sherr EB, 2002, ANTON LEEUW INT J G, V81, P293, DOI 10.1023/A:1020591307260; Strom SL, 2008, SCIENCE, V320, P1043, DOI 10.1126/science.1153527; Turner JT, 2015, PROG OCEANOGR, V130, P205, DOI 10.1016/j.pocean.2014.08.005; Verhulst P.F., 1845, NOUVEAUX M MOIRES LA, V18, P14; Ward BA, 2016, P NATL ACAD SCI USA, V113, P2958, DOI 10.1073/pnas.1517118113; Weitz Joshua S, 2012, F1000 Biol Rep, V4, P17	30	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177517	10.1371/journal.pone.0177517	http://dx.doi.org/10.1371/journal.pone.0177517			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505212	Green Submitted, Green Published, gold			2022-12-26	WOS:000401473500027
J	Li, YY; Zhao, Y; Wu, JP				Li, Yuanyuan; Zhao, Ying; Wu, Jianping			Serum HBV surface antigen positivity is associated with low prevalence of metabolic syndrome: A meta-analysis	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; NONALCOHOLIC FATTY LIVER; INSULIN-RESISTANCE; INCREASED RISK; INFECTION; DISEASE; SEROPOSITIVITY; STEATOSIS; ATHEROSCLEROSIS; STEATOHEPATITIS	Background and aim As there is conflicting evidence for the relationship between hepatitis B virus surface antigen (HBsAg) positivity and the prevalence of metabolic syndrome (MetS), we performed a metaanalysis to investigate whether HBsAg positivity affects the incidence of MetS. Methods Observational studies on the relationship between HBsAg positivity and MetS were obtained from PubMed, Web of Science, and the Cochrane Library in April 2016. The pooled odds ratios (ORs) of MetS and its components (central obesity, increased fasting glucose, increased blood pressure, dyslipidemia) for subjects with or without HBsAg positivity were synthesized. The standardized mean difference of MetS components between HBsAg-positive participants and healthy controls was calculated. Heterogeneity was explored with subgroup analysis and sensitivity analysis. Publication bias was detected using Egger's test and Begg's test. Results Thirty studies were eligible for meta-analysis. The MetS OR for HBsAg-positive participants was significantly decreased compared with the controls [OR = 0.80, 95% confidence interval (CI), 0.70-0.90]. The negative effect of HBsAg positivity on elevated triglycerides (OR = 0.62, 95% CI, 0.59-0.64) was strong, while that for increased fasting blood glucose was weak (OR = 0.94, 95% CI, 0.90-0.98). The pooled ORs of central obesity (OR = 0.97, 95% CI, 0.91-1.04), reduced high-density lipoprotein cholesterol (OR = 0.98, 95% CI, 0.83-1.14), and elevated blood pressure (OR = 1.00, 95% CI, 0.80-1.25) for HBsAg-positive participants were all not significantly different compared with the controls. No publication bias was detected. Conclusions Serum HBsAg positivity is inversely associated with the prevalence of MetS. Among the five components of MetS, elevated triglycerides had the strongest inverse relationship with HBsAg positivity.	[Li, Yuanyuan; Zhao, Ying; Wu, Jianping] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Lab Med, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Wu, JP (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Lab Med, Hangzhou, Zhejiang, Peoples R China.	jpwuzyyy@126.com			Medical Science and Technology Project of Zhejiang Province [2016KYB107]	Medical Science and Technology Project of Zhejiang Province	Support was provided by the Medical Science and Technology Project of Zhejiang Province (2016KYB107); [http://kj.zjwst.gov.cn/]. The funders played roles in decision to publish and preparation of the manuscript.	Ahmadieh H, 2014, DIABETES RES CLIN PR, V104, P53, DOI 10.1016/j.diabres.2014.01.003; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Chen JY, 2010, J GASTROEN HEPATOL, V25, P1763, DOI 10.1111/j.1440-1746.2010.06300.x; Cheng YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080191; Chiang CH, 2014, WORLD J GASTROENTERO, V20, P7213, DOI 10.3748/wjg.v20.i23.7213; Chiang CH, 2013, OBESITY, V21, P291, DOI 10.1002/oby.20000; Choi JS, 2015, J EPIDEMIOL, V25, P74, DOI 10.2188/jea.JE20140053; Chu CM, 2007, INT J OBESITY, V31, P871, DOI 10.1038/sj.ijo.0803479; Chung TH, 2014, KOREAN J FAM MED, V35, P81, DOI 10.4082/kjfm.2014.35.2.81; Dai Fu-hong, 2012, Zhonghua Gan Zang Bing Za Zhi, V20, P517, DOI 10.3760/cma.j.issn.1007-3418.2012.07.008; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Eckel RH, 2010, LANCET, V375, P181, DOI 10.1016/S0140-6736(09)61794-3; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fan JY, 2015, CANCER NURS, V38, P169, DOI 10.1097/NCC.0000000000000153; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Ha M, 2015, OBES RES CLIN PRACT; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Holstein A, 2002, J GASTROEN HEPATOL, V17, P677, DOI 10.1046/j.1440-1746.2002.02755.x; Hsieh PS, 2011, WORLD J GASTROENTERO, V17, P5240, DOI 10.3748/wjg.v17.i48.5240; Hsu CS, 2012, J VIRAL HEPATITIS, V19, pE48, DOI 10.1111/j.1365-2893.2011.01535.x; Hsu CS, 2015, HEPATOL INT, V9, P231, DOI 10.1007/s12072-015-9616-2; Huang CY, 2016, OBESITY, V24, P483, DOI 10.1002/oby.21333; Huang ZS, 2010, J GASTROEN HEPATOL, V25, P1420, DOI 10.1111/j.1440-1746.2010.06268.x; Ishizaka N, 2008, HEPATOL RES, V38, P775, DOI 10.1111/j.1872-034X.2008.00334.x; Jan CF, 2006, INT J OBESITY, V30, P794, DOI 10.1038/sj.ijo.0803204; Jarcuska P, 2014, EUR J INTERN MED, V25, P286, DOI 10.1016/j.ejim.2014.01.006; Jinjuvadia R, 2014, AM J MED SCI, V347, P23, DOI 10.1097/MAJ.0b013e31828b25a5; Karsen H, 2012, AFR HEALTH SCI, V12, P114, DOI 10.4314/ahs.v12i2.6; Katoonizadeh A, 2016, J MED VIROL, V88, P1230, DOI 10.1002/jmv.24466; Kim KH, 2007, GASTROENTEROLOGY, V132, P1955, DOI 10.1053/j.gastro.2007.03.039; Lee JG, 2012, WORLD J GASTROENTERO, V18, P6120, DOI 10.3748/wjg.v18.i42.6120; Li WC, 2013, LIVER INT, V33, P1194, DOI 10.1111/liv.12224; Lin YC, 2007, WORLD J GASTROENTERO, V13, P1805, DOI 10.3748/wjg.v13.i12.1805; Liu PT, 2013, METABOLISM, V62, P220, DOI 10.1016/j.metabol.2012.07.022; Locarnini S, 2015, J HEPATOL, V62, pS76, DOI 10.1016/j.jhep.2015.01.018; Luo BY, 2007, CLIN CHIM ACTA, V380, P238, DOI 10.1016/j.cca.2007.01.012; Machado MV, 2011, J GASTROEN HEPATOL, V26, P1361, DOI 10.1111/j.1440-1746.2011.06801.x; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; McManus DD, 2012, OBESITY, V20, P1882, DOI 10.1038/oby.2011.32; Moritani M, 2005, J GASTROENTEROL, V40, P1049, DOI 10.1007/s00535-005-1655-3; Park B, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000091; Patton HM, 2010, AM J GASTROENTEROL, V105, P2093, DOI 10.1038/ajg.2010.152; Qiao LP, 2008, DIABETES, V57, P1824, DOI 10.2337/db07-0435; Sheikh MY, 2008, HEPATOLOGY, V47, P2127, DOI 10.1002/hep.22269; Shlomai A, 2008, MED HYPOTHESES, V71, P53, DOI 10.1016/j.mehy.2007.08.032; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Su TC, 2004, J FORMOS MED ASSOC, V103, P286; Targher G, 2007, J HEPATOL, V46, P1126, DOI 10.1016/j.jhep.2007.01.021; Wang CC, 2008, J GASTROEN HEPATOL, V23, P779, DOI 10.1111/j.1440-1746.2007.05216.x; Wang CC, 2015, J GASTROEN HEPATOL, V30, P14, DOI 10.1111/jgh.12700; Wells G.A., NEWCASTLE OTTAWA SCA; Wong VWS, 2012, J HEPATOL, V56, P533, DOI 10.1016/j.jhep.2011.09.013; Wong VWS, 2010, AM J GASTROENTEROL, V105, P132, DOI 10.1038/ajg.2009.560; Yang KC, 2007, ATHEROSCLEROSIS, V195, P392, DOI 10.1016/j.atherosclerosis.2006.10.018; Yang KC, 2016, SCI REP-UK, V6, DOI 10.1038/srep27034	58	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177713	10.1371/journal.pone.0177713	http://dx.doi.org/10.1371/journal.pone.0177713			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505202	Green Published, Green Submitted, gold			2022-12-26	WOS:000401473500035
J	Michl, SC; Ratten, JM; Beyer, M; Hasler, M; LaRoche, J; Schulz, C				Michl, Stephanie Celine; Ratten, Jenni-Marie; Beyer, Matt; Hasler, Mario; LaRoche, Julie; Schulz, Carsten			The malleable gut microbiome of juvenile rainbow trout (Oncorhynchus mykiss): Diet-dependent shifts of bacterial community structures	PLOS ONE			English	Article							MULTIPLE CONTRAST TESTS; PLANT-BASED DIET; GLUCOSE-METABOLISM; FISH-MEAL; INTESTINAL MICROBIOTA; SALMO-SALAR; ZEBRAFISH; PROTEIN; REPLACEMENT; CARP	Plant-derived protein sources are the most relevant substitutes for fishmeal in aquafeeds. Nevertheless, the effects of plant based diets on the intestinal microbiome especially of juvenile Rainbow trout (Oncorhynchus mykiss) are yet to be fully investigated. The present study demonstrates, based on 16S rDNA bacterial community profiling, that the intestinal microbiome of juvenile Rainbow trout is strongly affected by dietary plant protein inclusion levels. After first feeding of juveniles with either 0%, 50% or 97% of total dietary protein content derived from plants, statistically significant differences of the bacterial gut community for the three diet-types were detected, both at phylum and order level. The microbiome of juvenile fish consisted mainly of the phyla Proteobacteria, Firmicutes, Bacteroidetes, Fusobacteria and Actinobacteria, and thus fits the salmonid core microbiome suggested in previous studies. Dietary plant proteins significantly enhanced the relative abundance of the orders Lactobacillales, Bacillales and Pseudomonadales. Animal proteins in contrast significantly promoted Bacteroidales, Clostridiales, Vibrionales, Fusobacteriales and Alteromonadales. The overall alpha diversity significantly decreased with increasing plant protein inclusion levels and with age of experimental animals. In order to investigate permanent effects of the first feeding diet-type on the early development of the microbiome, a diet change was included in the study after 54 days, but no such effects could be detected. Instead, the microbiome of juvenile trout fry was highly dependent on the actual diet fed at the time of sampling.	[Michl, Stephanie Celine; Schulz, Carsten] Gesell Marine Aquakultur mbH GMA Busum, Busum, Germany; [Michl, Stephanie Celine; Schulz, Carsten] Christian Albrechts Univ Kiel, Inst Anim Breeding & Husb, Dept Marine Aquaculture, Kiel, Germany; [Michl, Stephanie Celine] GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany; [Ratten, Jenni-Marie; Beyer, Matt; LaRoche, Julie] Dalhousie Univ, Halifax, NS, Canada; [Hasler, Mario] Christian Albrechts Univ Kiel, Lehrfach Variat Stat, Kiel, Germany	University of Kiel; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Dalhousie University; University of Kiel	Michl, SC (corresponding author), Gesell Marine Aquakultur mbH GMA Busum, Busum, Germany.; Michl, SC (corresponding author), Christian Albrechts Univ Kiel, Inst Anim Breeding & Husb, Dept Marine Aquaculture, Kiel, Germany.; Michl, SC (corresponding author), GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany.	michl@gma-buesum.de	Schulz, Carsten/C-2127-2017	LaRoche, Julie/0000-0003-4809-6411	Helmholtz Graduate School for Ocean System Science and Technology (HOSST); Geomar Helmholtz Centre for Ocean Research Kiel; NSERC CREATE Transatlantic Ocean System Science and Technology (TOSST); Dalhousie University; NSERC DISCOVERY; Land Schleswig-Holstein within the funding programme Open Access Publikationsfonds	Helmholtz Graduate School for Ocean System Science and Technology (HOSST); Geomar Helmholtz Centre for Ocean Research Kiel(Helmholtz Association); NSERC CREATE Transatlantic Ocean System Science and Technology (TOSST); Dalhousie University; NSERC DISCOVERY(Natural Sciences and Engineering Research Council of Canada (NSERC)); Land Schleswig-Holstein within the funding programme Open Access Publikationsfonds	SCM was supported by the Helmholtz Graduate School for Ocean System Science and Technology (HOSST); Geomar Helmholtz Centre for Ocean Research Kiel; http://www.geomar.de/ studieren/phd/hosst/. JMR was supported by the NSERC CREATE Transatlantic Ocean System Science and Technology (TOSST); Dalhousie University; http://www.tosst.org/; NSERC DISCOVERY grant to JLR. The authors also acknowledge financial support from Land Schleswig-Holstein within the funding programme Open Access Publikationsfonds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are very grateful for the support of the Skretting Aquaculture Research Centre (Stavanger, Norway) by providing the chemical analysis of dietary fatty acids and amino acids. There are no conflicts of interest. We would like to thank Jennifer Tolman for her assistance during DNA sample preparation, Jackie Zorz and Dhwani Desai for their help during the QIIME data processing and our colleagues from GMA for substantial support during sampling. We acknowledge financial support by Land Schleswig-Holstein within the funding programme Open Access Publikationsfonds.	Askarian F, 2012, AQUACULTURE, V326, P1, DOI 10.1016/j.aquaculture.2011.10.016; Atienza E, 2015, ANAEROBE, P7; Austin B, 2006, THESCIENTIFICWORLDJO, V6, P931, DOI 10.1100/tsw.2006.181; Bakke A, 2014, AQUACULT NUTR, V20, P381; Balasubramanian MN, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2804-1; Boutin S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084772; Bretz F, 2011, MULTIPLE COMP USING, DOI DOI 10.1201/9781420010909; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carroll R.J., 1988, TRANSFORMATION WEIGH; Comeau AM, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00127-16; Comeau AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027492; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Dawood MAO, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/514196; Dehler CE, 2017, AQUACULTURE, V467, P149, DOI 10.1016/j.aquaculture.2016.07.017; Desai AR, 2012, AQUACULTURE, V350, P134, DOI 10.1016/j.aquaculture.2012.04.005; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fang L, 2014, BRIT J NUTR, V111, P808, DOI 10.1017/S0007114513003243; Gajardo K, 2016, SCI REP-UK, V6, DOI 10.1038/srep30893; Geurden I, 2007, AM J PHYSIOL-REG I, V292, pR2275, DOI 10.1152/ajpregu.00444.2006; Geurden I, 2014, J EXP BIOL, V217, P3396, DOI 10.1242/jeb.106062; Geurden I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083162; Ghanbari M, 2015, AQUACULTURE, V448, P464, DOI 10.1016/j.aquaculture.2015.06.033; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Hanley B, 2010, BRIT J NUTR, V104, pS1, DOI 10.1017/S0007114510003338; Hardy RW, 2013, SPECIES PROFILE RAIN; Hartung J., 1999, MULTIVARIATE STAT LE, V6 th; Hasler M, 2008, BIOMETRICAL J, V50, P793, DOI 10.1002/bimj.200710466; Hasler M, 2014, INT J BIOSTAT, V10, P17, DOI 10.1515/ijb-2012-0015; Hothorn T., 2008, MULTCOMP SIMULTANEOU; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Ingerslev HC, 2014, AQUACULTURE, V424, P24, DOI [10.1016/j.actuaculture.2013.12.032, 10.1016/j.aquaculture.2013.12.032]; Ingerslev HC, 2014, FISH SHELLFISH IMMUN, V40, P624, DOI 10.1016/j.fsi.2014.08.021; Izquierdo MS, 2015, AQUACULTURE, V449, P18, DOI 10.1016/j.aquaculture.2015.03.032; JACKSON DA, 1993, ECOLOGY, V74, P2204, DOI 10.2307/1939574; KAUSHIK SJ, 1995, AQUACULTURE, V133, P257, DOI 10.1016/0044-8486(94)00403-B; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Le Boucher R, 2011, AQUACULTURE, V321, P41, DOI 10.1016/j.aquaculture.2011.08.010; Li TT, 2015, MICROB ECOL, V69, P25, DOI 10.1007/s00248-014-0480-8; Lowrey LT, 2013, FISH SHELLFISH IMMUN, V34, P1721, DOI 10.1016/j.fsi.2013.03.261; Merrifield DL, 2009, J FISH DIS, V32, P755, DOI 10.1111/j.1365-2761.2009.01052.x; NRC (National Research Council), 2011, NUTR REQ FISH SHRIMP; Oksanen J, 2022, R PACKAGE VERSION; R Core Team, 2006, R LANG ENV STAT COMP; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; Ringo E, 2016, AQUACULT NUTR, V22, P219, DOI 10.1111/anu.12346; Ringo E, 2000, J APPL MICROBIOL, V89, P317, DOI 10.1046/j.1365-2672.2000.01116.x; Rocha F, 2015, BRIT J NUTR, V113, P403, DOI 10.1017/S0007114514003869; Schaperclaus W, 1998, LEHRBUCH TEICHWIRTSC; Schmidt V, APPL ENV MICROBIOL; Shafaeipour A, 2008, AQUACULT NUTR, V14, P110, DOI 10.1111/j.1365-2095.2007.00509.x; Slawski H, 2012, AQUACULT INT, V20, P443, DOI 10.1007/s10499-011-9476-2; Tacon AGJ, 2015, REV FISH SCI AQUAC, V23, P1, DOI 10.1080/23308249.2014.987209; Thu TTN, 2011, AQUACULT NUTR, V17, P80, DOI 10.1111/j.1365-2095.2009.00732.x; van Kessel MAHJ, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-41; Verbeke G, 2000, LINEAR MIXED MODELS; Wiens JJ, 2011, Q REV BIOL, V86, P75, DOI 10.1086/659883; Wilkins LGE, 2016, MOL ECOL; Wong S, 2013, APPL ENVIRON MICROB, V79, P4974, DOI 10.1128/AEM.00924-13; Xia J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-634; Yan QY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030603; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	63	67	71	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177735	10.1371/journal.pone.0177735	http://dx.doi.org/10.1371/journal.pone.0177735			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498878	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000401314500044
J	Ferrando, C; Suarez-Sipmann, F; Tusman, G; Leon, I; Romero, E; Gracia, E; Mugarra, A; Arocas, B; Pozo, N; Soro, M; Belda, FJ				Ferrando, Carlos; Suarez-Sipmann, Fernando; Tusman, Gerardo; Leon, Irene; Romero, Esther; Gracia, Estefania; Mugarra, Ana; Arocas, Blanca; Pozo, Natividad; Soro, Marina; Belda, Francisco J.			Open lung approach versus standard protective strategies: Effects on driving pressure and ventilatory efficiency during anesthesia - A pilot, randomized controlled trial	PLOS ONE			English	Article							END-EXPIRATORY PRESSURE; RESPIRATORY-DISTRESS-SYNDROME; ALVEOLAR RECRUITMENT; MECHANICAL VENTILATION; GENERAL-ANESTHESIA; TIDAL-VOLUME; GAS-EXCHANGE; IMPROVES; OBESE; ATELECTASIS	Background Low tidal volume (VT) during anesthesia minimizes lung injury but may be associated to a decrease in functional lung volume impairing lung mechanics and efficiency. Lung recruitment (RM) can restore lung volume but this may critically depend on the post-RM selected PEEP. This study was a randomized, two parallel arm, open study whose primary outcome was to compare the effects on driving pressure of adding a RM to low-VT ventilation, with or without an individualized post-RM PEEP in patients without known previous lung disease during anesthesia. Methods Consecutive patients scheduled for major abdominal surgery were submitted to low-VT ventilation (6 ml.kg(-1)) and standard PEEP of 5 cmH(2)O (pre-RM, n = 36). After 30 min estabilization all patients received a RM and were randomly allocated to either continue with the same PEEP (RM-5 group, n = 18) or to an individualized open-lung PEEP (OL-PEEP) (Open Lung Approach, OLA group, n = 18) defined as the level resulting in maximal Cdyn during a decremental PEEP trial. We compared the effects on driving pressure and lung efficiency measured by volumetric capnography. Results OL-PEEP was found at 8 +/- 2 cmH(2)O. 36 patients were included in the final analysis. When compared with pre-RM, OLA resulted in a 22% increase in compliance and a 28% decrease in driving pressure when compared to pre-RM. These parameters did not improve in the RM-5. The trend of the DP was significantly different between the OLA and RM-5 groups (p = 0.002). VDalv/VTalv was significantly lower in the OLA group after the RM (p = 0.035). Conclusions Lung recruitment applied during low-VT ventilation improves driving pressure and lung efficiency only when applied as an open-lung strategy with an individualized PEEP in patients without lung diseases undergoing major abdominal surgery.	[Ferrando, Carlos; Leon, Irene; Romero, Esther; Gracia, Estefania; Mugarra, Ana; Arocas, Blanca; Soro, Marina; Belda, Francisco J.] Hosp Clin Univ, Dept Anesthesiol & Crit Care, Valencia, Spain; [Suarez-Sipmann, Fernando] Inst Salud Carlos III, GIBER Enfermedades Resp, Madrid, Spain; [Suarez-Sipmann, Fernando] Uppsala Univ Hosp, Dept Surg Sci, Hedenstierna Lab, Uppsala, Sweden; [Tusman, Gerardo] Hosp Privado Comunidad Mar Del Plata, Dept Anesthesiol, Mar Del Plata, Buenos Aires, Argentina; [Pozo, Natividad] Hosp Clin Univ, INCLIVA Clin Res Inst, Valencia, Spain	Hospital Clinic Universitari de Valencia; Instituto de Salud Carlos III; Uppsala University; Uppsala University Hospital	Ferrando, C (corresponding author), Hosp Clin Univ, Dept Anesthesiol & Crit Care, Valencia, Spain.	cafeoranestesia@gmail.com	Sipmann, Fernando Suarez/AAD-9104-2020; Leon, Irene/AAA-5711-2019; Belda, Javier/AAF-1597-2020	Sipmann, Fernando Suarez/0000-0002-7412-2970; Leon, Irene/0000-0003-2172-8933; Ferrando, Carlos/0000-0002-1907-5323	INCLIVA Biomedical Research Institute	INCLIVA Biomedical Research Institute	This work was funded by the INCLIVA Biomedical Research Institute.	Amato MBP, 2015, NEW ENGL J MED, V372, P747, DOI 10.1056/NEJMsa1410639; Bohm SH, 2009, ANESTH ANALG, V109, P151, DOI 10.1213/ane.0b013e31819bcbb5; Bohr C., 1891, UBER LUNGGEATMUNG SK, V2, P236; Borges JB, 2006, AM J RESP CRIT CARE, V174, P268, DOI 10.1164/rccm.200506-976OC; Borges JB, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1063-x; Cereda M, 2014, CRIT CARE MED, V41, P527; Duggan M, 2005, ANESTHESIOLOGY, V102, P838, DOI 10.1097/00000542-200504000-00021; Ferrando C, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0694-1; Ferrando C, 2014, ANESTH ANALG, V118, P657, DOI 10.1213/ANE.0000000000000105; FLETCHER R, 1981, BRIT J ANAESTH, V53, P77, DOI 10.1093/bja/53.1.77; Futier E, 2013, NEW ENGL J MED, V369, P428, DOI 10.1056/NEJMoa1301082; HEDENSTIERNA G, 1976, ACTA ANAESTH SCAND, V20, P334, DOI 10.1111/j.1399-6576.1976.tb05047.x; Jabaudon M, 2015, RESPIROLOGY, V20, P1131, DOI 10.1111/resp.12583; Kacmarek RM, 2016, CRIT CARE MED, V44, P32, DOI 10.1097/CCM.0000000000001383; Ladha K, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3646; Maisch S, 2008, ANESTH ANALG, V106, P175, DOI 10.1213/01.ane.0000287684.74505.49; Meade MO, 2008, JAMA-J AM MED ASSOC, V299, P637, DOI 10.1001/jama.299.6.637; Mercat A, 2008, JAMA-J AM MED ASSOC, V299, P646, DOI 10.1001/jama.299.6.646; Richard JC, 2001, AM J RESP CRIT CARE, V163, P1609, DOI 10.1164/ajrccm.163.7.2004215; Rusca M, 2003, ANESTH ANALG, V97, P1835, DOI 10.1213/01.ANE.0000087042.02266.F6; Serpa Neto A, LANCET RESP MED; Neto AS, 2015, ANESTHESIOLOGY, V123, P66, DOI 10.1097/ALN.0000000000000706; Severgnini P, 2013, ANESTHESIOLOGY, V118, P1307, DOI 10.1097/ALN.0b013e31829102de; SUTER PM, 1975, NEW ENGL J MED, V292, P284, DOI 10.1056/NEJM197502062920604; The PROVE Network Investigators, 2014, LANCET, V384, P495, DOI DOI 10.1016/S0140-6736(14)60416-5; TOKICS L, 1987, ANESTHESIOLOGY, V66, P157, DOI 10.1097/00000542-198702000-00009; Tusman G, 2004, CAN J ANAESTH, V51, P723, DOI 10.1007/BF03018433; Tusman G, 2004, ANESTH ANALG, V98, P1604, DOI 10.1213/01.ANE.0000068484.67655.1A; Tusman G, 2014, ANESTH ANALG, V118, P137, DOI 10.1213/01.ane.0000438350.29240.08; Tusman G, 2011, INTENS CARE MED, V37, P870, DOI 10.1007/s00134-011-2164-x; Tusman G, 2009, J CLIN MONIT COMPUT, V23, P197, DOI 10.1007/s10877-009-9182-z; Unzueta C, 2012, BRIT J ANAESTH, V108, P517, DOI 10.1093/bja/aer415	32	34	39	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177399	10.1371/journal.pone.0177399	http://dx.doi.org/10.1371/journal.pone.0177399			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493943	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314300102
J	Kurano, M; Nishikawa, M; Kuma, H; Jona, M; Yatomi, Y				Kurano, Makoto; Nishikawa, Masako; Kuma, Hiroyuki; Jona, Masahiro; Yatomi, Yutaka			Involvement of Band3 in the efflux of sphingosine 1-phosphate from erythrocytes	PLOS ONE			English	Article							MAP KINASE PATHWAYS; K562 CELLS; HEREDITARY SPHEROCYTOSIS; LYMPHOCYTE EGRESS; ENDOTHELIAL-CELLS; SPHINGOSINE-1-PHOSPHATE; TRANSPORTER; METABOLISM; PLATELETS; BUTYRATE	Sphingosine 1-phosphate (S1P) is a bioactive lipid mediator that is thought to be involved in various diseases. Although the main source of S1P in the plasma is erythrocytes, how S1P is exported from erythrocytes has not been elucidated. When we differentiated K562 cells into erythroblast-like cells with sodium butyrate, we observed that the efflux of S1P was increased without increased expression of previously proposed S1P transporters, while the expression levels of Band3 were increased. Therefore, in this study, we investigated the involvement of Band 3, the most characteristic membranous transporter for erythrocytes, in S1P efflux, using 4,4'-diisothiocyanatodihydrostilbene-2,2'-disulfonic acid, disodium salt (H2DIDS), which is an inhibitor of Band3. First, we treated human washed erythrocytes with H2DIDS and found that H2DIDS decreased the S1P levels in the supernatant, while it increased the cellular S1P contents. Next, when we injected H2DIDS into mice, the plasma S1P level was significantly decreased. Finally, when we overexpressed or suppressed Band3 in K562 cells, S1P efflux was enhanced or decreased, respectively, while the overexpression of Band3 in HEK293 cells did not modulate S1P efflux. These results suggested the possible involvement of Band3 in the transport of S1P, a multi-functional bioactive phospholipid, from erythrocytes.	[Kurano, Makoto; Nishikawa, Masako; Yatomi, Yutaka] Univ Tokyo, Grad Sch Med, Dept Clin Lab Med, Tokyo, Japan; [Kuma, Hiroyuki] Nagasaki Int Univ, Fac Pharmaceut Sci, Dept Clin Chem, Nagasaki, Japan; [Jona, Masahiro] Univ Tokyo Hosp, Dept Clin Lab, Tokyo, Japan	University of Tokyo; Nagasaki International University; University of Tokyo	Yatomi, Y (corresponding author), Univ Tokyo, Grad Sch Med, Dept Clin Lab Med, Tokyo, Japan.	yatoyuta-tky@umin.ac.jp		Yatomi, Yutaka/0000-0003-1719-4297; Kuma, Hiroyuki/0000-0003-2027-8790	Grants-in-Aid for Scientific Research [16H06236, 15H05897] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		ANDERSSON LC, 1979, NATURE, V278, P364, DOI 10.1038/278364a0; Arakawa T, 2015, SCIENCE, V350, P680, DOI 10.1126/science.aaa4335; Awojoodu AO, 2014, BLOOD, V124, P1941, DOI 10.1182/blood-2014-01-543652; Chiba K, 2006, CELL MOL IMMUNOL, V3, P11; Culliford SJ, 2003, CELL PHYSIOL BIOCHEM, V13, P181, DOI 10.1159/000072420; Delaunay J, 1996, ANN GENET-PARIS, V39, P209; Eber S, 2004, SEMIN HEMATOL, V41, P118, DOI 10.1053/j.seminhematol.2004.01.002; Fukuhara S, 2012, J CLIN INVEST, V122, P1416, DOI 10.1172/JCI60746; Goetzl EJ, 2001, PROSTAG OTH LIPID M, V64, P11, DOI 10.1016/S0090-6980(01)00104-6; Grebenova D, 2006, BLOOD CELL MOL DIS, V37, P210, DOI 10.1016/j.bcmd.2006.08.001; Igarashi J, 2001, J BIOL CHEM, V276, P12420, DOI 10.1074/jbc.M008375200; Ito K, 2007, BIOCHEM BIOPH RES CO, V357, P212, DOI 10.1016/j.bbrc.2007.03.123; Jonnalagadda D, 2014, BBA-MOL CELL BIOL L, V1841, P1581, DOI 10.1016/j.bbalip.2014.08.013; Kawahara A, 2009, SCIENCE, V323, P524, DOI 10.1126/science.1167449; Kawasaki N, 1996, ARCH BIOCHEM BIOPHYS, V328, P289, DOI 10.1006/abbi.1996.0175; Kobayashi N, 2006, J LIPID RES, V47, P614, DOI 10.1194/jlr.M500468-JLR200; Kobayashi N, 2009, J BIOL CHEM, V284, P21192, DOI 10.1074/jbc.M109.006163; Kurano M, 2015, J BIOL CHEM, V290, P2477, DOI 10.1074/jbc.M114.596445; Kurano M, 2012, J LIPID RES, V53, P2275, DOI 10.1194/jlr.M026575; Le Stunff H, 2004, J CELL BIOCHEM, V92, P882, DOI 10.1002/h=jcb.20097; Mitra P, 2006, P NATL ACAD SCI USA, V103, P16394, DOI 10.1073/pnas.0603734103; Ohkawa R, 2008, ANN CLIN BIOCHEM, V45, P356, DOI 10.1258/acb.2007.007189; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Proia RL, 2015, J CLIN INVEST, V125, P1379, DOI 10.1172/JCI76369; Reithmeier RAF, 2016, BBA-BIOMEMBRANES, V1858, P1507, DOI 10.1016/j.bbamem.2016.03.030; Sato K, 2007, J NEUROCHEM, V103, P2610, DOI 10.1111/j.1471-4159.2007.04958.x; SCHOFIELD AE, 1992, NATURE, V355, P836, DOI 10.1038/355836a0; Sutter I, 2014, J LIPID RES, V55, P1730, DOI 10.1194/jlr.M050021; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; Takabe K, 2010, J BIOL CHEM, V285, P10477, DOI 10.1074/jbc.M109.064162; Venkataraman K, 2008, CIRC RES, V102, P669, DOI 10.1161/CIRCRESAHA.107.165845; VILLEVAL JL, 1983, EXP CELL RES, V146, P428, DOI 10.1016/0014-4827(83)90145-3; Williamson RC, 2008, BLOOD CELL MOL DIS, V41, P35, DOI 10.1016/j.bcmd.2008.01.001; Witt O, 2000, BLOOD, V95, P2391, DOI 10.1182/blood.V95.7.2391.007k21_2391_2396; Xiang YQ, 2014, J CLIN INVEST, V124, P4823, DOI 10.1172/JCI77685; Yatomi Y, 2006, CURR PHARM DESIGN, V12, P575, DOI 10.2174/138161206775474404; YATOMI Y, 1995, BLOOD, V86, P193, DOI 10.1182/blood.V86.1.193.bloodjournal861193; Yatomi Y, 2008, BBA-GEN SUBJECTS, V1780, P606, DOI 10.1016/j.bbagen.2007.10.006; Zhang Y., 2014, EURASIP J ADV SIG PR, V2014, P1, DOI DOI 10.1016/J.ENGGE0.2014.08.024	39	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177543	10.1371/journal.pone.0177543	http://dx.doi.org/10.1371/journal.pone.0177543			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28494002	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314300133
J	Niewieczerzal, S; Sulkowska, JI				Niewieczerzal, Szymon; Sulkowska, Joanna I.			Knotting and unknotting proteins in the chaperonin cage: Effects of the excluded volume	PLOS ONE			English	Article							MONTE-CARLO SIMULATIONS; STRUCTURE-BASED MODELS; FOLDING MECHANISMS; TOPOLOGICAL FRUSTRATION; MOLECULAR-DYNAMICS; ESCHERICHIA-COLI; IN-VITRO; CONFINEMENT; KNOTS; THERMODYNAMICS	Molecular dynamics simulations are used to explore the effects of chaperonin-like cages on knotted proteins with very low sequence similarity, different depths of a knot but with a similar fold, and the same type of topology. The investigated proteins are VirC2, DndE and MJ0366 with two depths of a knot. A comprehensive picture how encapsulation influences folding rates is provided based on the analysis of different cage sizes and temperature conditions. Neither of these two effects with regard to knotted proteins has been studied by means of molecular dynamics simulations with coarse-grained structure-based models before. We show that encapsulation in a chaperonin is sufficient to self-tie and untie small knotted proteins ( VirC2, DndE), for which the equilibrium process is not accessible in the bulk solvent. Furthermore, we find that encapsulation reduces backtracking that arises from the destabilisation of nucleation sites, smoothing the free energy landscape. However, this effect can also be coupled with temperature rise. Encapsulation facilitates knotting at the early stage of folding and can enhance an alternative folding route. Comparison to unknotted proteins with the same fold shows directly how encapsulation influences the free energy landscape. In addition, we find that as the size of the cage decreases, folding times increase almost exponentially in a certain range of cage sizes, in accordance with confinement theory and experimental data for unknotted proteins.	[Niewieczerzal, Szymon; Sulkowska, Joanna I.] Univ Warsaw, Ctr New Technol, Banacha 2c, PL-02097 Warsaw, Poland; [Sulkowska, Joanna I.] Univ Warsaw, Dept Chem, Pasteura 1, PL-02093 Warsaw, Poland	University of Warsaw; University of Warsaw	Sulkowska, JI (corresponding author), Univ Warsaw, Ctr New Technol, Banacha 2c, PL-02097 Warsaw, Poland.; Sulkowska, JI (corresponding author), Univ Warsaw, Dept Chem, Pasteura 1, PL-02093 Warsaw, Poland.	jsulkowska@cent.uw.edu.pl		Sulkowska, Joanna/0000-0003-2452-0724	National Science Centre [2012/07/E/NZ1/01900]; European Molecular Biology Organization (EMBO) [2057]	National Science Centre(National Science Centre, Poland); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO))	This work was supported by National Science Centre 2012/07/E/NZ1/01900, https://ncn.gov.pI/?language=en and European Molecular Biology Organization (EMBO) Installation Grant 2057. JIS is a principal investigator of both grants.; This work was supported by National Science Centre 2012/07/E/NZ1/01900 and EMBO Installation Grant 2057.	Andersson FI, 2009, FEBS J, V276, P2625, DOI 10.1111/j.1742-4658.2009.06990.x; Beccara SA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003002; Best RB, 2013, P NATL ACAD SCI USA, V110, P17874, DOI 10.1073/pnas.1311599110; Brinker A, 2001, CELL, V107, P223, DOI 10.1016/S0092-8674(01)00517-7; Cheung MS, 2006, J MOL BIOL, V357, P632, DOI 10.1016/j.jmb.2005.12.048; Clementi C, 2000, J MOL BIOL, V298, P937, DOI 10.1006/jmbi.2000.3693; D'Adamo G, 2015, MACROMOLECULES, V48, P6337, DOI 10.1021/acs.macromol.5b01323; Dai L, 2016, MACROMOLECULES; Dai L, 2015, MACROMOLECULES, V48, P2812, DOI 10.1021/acs.macromol.5b00280; Ewing B, 1997, PROGR KNOT THEORY RE, V56, P51; FREYD P, 1985, B AM MATH SOC, V12, P239, DOI 10.1090/S0273-0979-1985-15361-3; Gosavi S, 2006, J MOL BIOL, V357, P986, DOI 10.1016/j.jmb.2005.11.074; Grosberg AY, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.217801; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hu W, 2012, CELL RES, V22, P1203, DOI 10.1038/cr.2012.66; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jamroz M, 2014, NUCLEIC ACIDS RES; Jarmolinska AI, 2016, KNOTTED MEM IN PRESS; Jewett AI, 2004, P NATL ACAD SCI USA, V101, P13192, DOI 10.1073/pnas.0400720101; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; King NP, 2010, P NATL ACAD SCI USA, V107, P20732, DOI 10.1073/pnas.1007602107; Klimov DK, 2002, P NATL ACAD SCI USA, V99, P8019, DOI 10.1073/pnas.072220699; KONIARIS K, 1991, J CHEM PHYS, V95, P2873, DOI 10.1063/1.460889; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Lammert H, 2009, PROTEINS, V77, P881, DOI 10.1002/prot.22511; Li WF, 2012, P NATL ACAD SCI USA, V109, P17789, DOI 10.1073/pnas.1201807109; Lim NCH, 2015, J MOL BIOL, V427, P248, DOI 10.1016/j.jmb.2014.09.007; Lin PK, 2012, MACROMOLECULES, V45, P2920, DOI 10.1021/ma202695e; Lu J, 2009, P NATL ACAD SCI USA, V106, P9643, DOI 10.1073/pnas.0812199106; Mallam AL, 2012, NAT CHEM BIOL, V8, P147, DOI 10.1038/nchembio.742; Mallam AL, 2010, P NATL ACAD SCI USA, V107, P8189, DOI 10.1073/pnas.0912161107; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; Micheletti C, 2014, ACS MACRO LETT, V3, P876, DOI 10.1021/mz500402s; Mittal J, 2008, P NATL ACAD SCI USA, V105, P20233, DOI 10.1073/pnas.0807742105; Najafi S, 2015, J CHEM PHYS, V143, DOI 10.1063/1.4934541; Noel JK, 2013, J PHYS CHEM LETT, V4, P3570, DOI 10.1021/jz401842f; Noel JK, 2010, P NATL ACAD SCI USA, V107, P15403, DOI 10.1073/pnas.1009522107; Noel JK, 2010, NUCLEIC ACIDS RES, V38, pW657, DOI 10.1093/nar/gkq498; Ping G, 2003, J CHEM PHYS, V118, P8042, DOI 10.1063/1.1564053; Przytycki J.H., 1988, KOBE J MATH, V4, P115; Rathore N, 2006, BIOPHYS J, V90, P1767, DOI 10.1529/biophysj.105.071076; Shea JE, 1999, P NATL ACAD SCI USA, V96, P12512, DOI 10.1073/pnas.96.22.12512; Sulkowska JI, 2013, BIOCHEM SOC T, V41, P523, DOI 10.1042/BST20120342; Sulkowska JI, 2012, P NATL ACAD SCI USA, V109, pE1715, DOI 10.1073/pnas.1205918109; Sulkowska JI, 2009, P NATL ACAD SCI USA, V106, P3119, DOI 10.1073/pnas.0811147106; Sulkowska JI, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.058106; Takagi F, 2003, P NATL ACAD SCI USA, V100, P11367, DOI 10.1073/pnas.1831920100; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; VANGIESSEN AE, 1995, J CHEM PHYS, V102, P9069, DOI 10.1063/1.468855; Wallin S, 2007, J MOL BIOL, V368, P884, DOI 10.1016/j.jmb.2007.02.035; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; Whitford PC, 2009, PROTEINS, V75, P430, DOI 10.1002/prot.22253; Wu X, 2015, ADV EXP MED BIOL, V827, P93, DOI 10.1007/978-94-017-9245-5_8; Yang D, 2013, P NATL ACAD SCI USA, V110, pE4298, DOI 10.1073/pnas.1318862110	55	16	16	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176744	10.1371/journal.pone.0176744	http://dx.doi.org/10.1371/journal.pone.0176744			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489858	gold, Green Submitted, Green Published			2022-12-26	WOS:000401314100030
J	Liu, WC; Ren, J; Zhang, JL; Song, XH; Liu, SL; Chi, XY; Chen, Y; Wen, ZH; Li, JM; Chen, W				Liu, Weicen; Ren, Jun; Zhang, Jinlong; Song, Xiaohong; Liu, Shuling; Chi, Xiangyang; Chen, Yi; Wen, Zhonghua; Li, Jianmin; Chen, Wei			Identification and characterization of a neutralizing monoclonal antibody that provides complete protection against Yersinia pestis	PLOS ONE			English	Article							CAPSULAR ANTIGEN; VACCINE; PURIFICATION; EFFICACY; STRAIN; VIRUS	Yersinia pestis (Y. pestis) has caused an alarming number of deaths throughout recorded human history, and novel prophylactics and therapeutics are necessary given its potential as a bioweapon. Only one monoclonal antibody has been identified to date that provides complete protection against Y. pestis. Here, we describe a second novel murine monoclonal antibody (F2H5) that provided complete protection against Y. pestis 141 infection when administered prophylactically to Balb/c mice (100 mu g intravenously). We humanized F2H5, characterized its ability to bind to the Y. pestis F1 protein and further characterized the neutralizing epitope using computational and experimental approaches. While Western blot results suggested a linear epitope, peptide mapping using ELISA failed to identify an epitope, suggesting a conformational epitope instead. We adopted a computational approach based on Residue Contact Frequency to predict the site of antigen-antibody interaction and defined the F2H5/F1 binding site computationally. Based on computational approach, we determined that residues G(104)E(105)N(106) in F1 were critical to F2H5 binding and that CDRH2 and CDRH3 of F2H5 interacted with F1. Our results show that combining computational approach and experimental approach can effectively identify epitopes.	[Liu, Weicen; Ren, Jun; Zhang, Jinlong; Song, Xiaohong; Liu, Shuling; Chi, Xiangyang; Chen, Yi; Wen, Zhonghua; Li, Jianmin; Chen, Wei] Beijing Inst Biotechnol, Lab Vaccine & Antibody Engn, Beijing, Peoples R China		Chen, W (corresponding author), Beijing Inst Biotechnol, Lab Vaccine & Antibody Engn, 20 FengTai Dongdajie St, Beijing, Peoples R China.	lijmqz@126.com; cw0226@foxmail.com	zhang, jin/GXV-9154-2022; LI, JIAN/GRY-2197-2022; li, jian/GSE-0245-2022		National Natural Science Foundation of China [81172980]; State Project For Essential Drug Research and Development [2013ZX09304103]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Project For Essential Drug Research and Development	This work was supported by the National Natural Science Foundation of China (grant no.81172980) to WC and the State Project For Essential Drug Research and Development (grant no. 2013ZX09304103) to JML.	Anderson GW, 1997, AM J TROP MED HYG, V56, P471, DOI 10.4269/ajtmh.1997.56.471; Andrews GP, 1996, INFECT IMMUN, V64, P2180, DOI 10.1128/IAI.64.6.2180-2187.1996; [Anonymous], 2016, Wkly Epidemiol Rec, V91, P89; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Chichester JA, 2009, VACCINE, V27, P3471, DOI 10.1016/j.vaccine.2009.01.050; Chua CL, 2014, J VIROL METHODS, V195, P126, DOI 10.1016/j.jviromet.2013.10.015; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Erova TE, 2013, CLIN VACCINE IMMUNOL, V20, P227, DOI 10.1128/CVI.00597-12; Galimand M, 2006, ANTIMICROB AGENTS CH, V50, P3233, DOI 10.1128/AAC.00306-06; Huang SS, 2014, INT J NANOMED, V9, P813, DOI 10.2147/IJN.S56260; Hwang H, 2014, PROTEINS, V82, P57, DOI 10.1002/prot.24354; Inglesby TV, 2000, JAMA-J AM MED ASSOC, V283, P2281, DOI 10.1001/jama.283.17.2281; Mazumdar S, 2009, MABS-AUSTIN, V1, P531, DOI 10.4161/mabs.1.6.10195; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Qi ZZ, 2012, CLIN VACCINE IMMUNOL, V19, P1746, DOI 10.1128/CVI.00455-12; Quenee LE, 2010, VACCINE, V28, P1870, DOI 10.1016/j.vaccine.2009.11.076; Ren J, 2009, VACCINE, V27, P7436, DOI 10.1016/j.vaccine.2009.07.015; RUSSELL P, 1995, VACCINE, V13, P1551, DOI 10.1016/0264-410X(95)00090-N; Sofer-Podesta C, 2009, INFECT IMMUN, V77, P1561, DOI 10.1128/IAI.00856-08; Subramanian GM, 2005, CLIN INFECT DIS, V41, P12, DOI 10.1086/430708; Tharakaraman K, 2013, P NATL ACAD SCI USA, V110, pE1555, DOI 10.1073/pnas.1303645110; Vorontsov E D, 1990, Biomed Sci, V1, P391; Vreven T, 2015, J MOL BIOL, V427, P3031, DOI 10.1016/j.jmb.2015.07.016; Wang T, 2008, PROTEIN EXPRES PURIF, V61, P7, DOI 10.1016/j.pep.2008.05.003; Xiao XD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013047; Xu Jun-jie, 2005, Weishengwu Xuebao, V45, P947; Zhang J, 2013, PROCEEDINGS OF THE 2013 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE FOR ENGINEERING SOLUTIONS (CIES), P29, DOI 10.1109/CIES.2013.6611725	27	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177012	10.1371/journal.pone.0177012	http://dx.doi.org/10.1371/journal.pone.0177012			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486528	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314000034
J	Thomas, FM; Vesk, PA				Thomas, Freya M.; Vesk, Peter A.			Are trait-growth models transferable? Predicting multi-species growth trajectories between ecosystems using plant functional traits	PLOS ONE			English	Article							SPECIES-AREA CURVES; LEAF TRAITS; TREE GROWTH; DEMOGRAPHIC RATES; BAYESIAN MEASURES; RESPONSES; HEIGHT; DISTRIBUTIONS; RESTORATION; PERFORMANCE	Plant functional traits are increasingly used to generalize across species, however few examples exist of predictions from trait-based models being evaluated in new species or new places. Can we use functional traits to predict growth of unknown species in different areas? We used three independently collected datasets, each containing data on heights of individuals from non-resprouting species over a chronosquence of time-since-fire sites from three ecosystems in south-eastern Australia. We examined the influence of specific leaf area, woody density, seed size and leaf nitrogen content on three aspects of plant growth; maximum relative growth rate, age at maximum growth and asymptotic height. We tested our capacity to perform out-of-sample prediction of growth trajectories between ecosystems using species functional traits. We found strong trait-growth relationships in one of the datasets; whereby species with low SLA achieved the greatest asymptotic heights, species with high leaf-nitrogen content achieved relatively fast growth rates, and species with low seed mass reached their time of maximum growth early. However these same growth-trait relationships did not hold across the two other datasets, making accurate prediction from one dataset to another unachievable. We believe there is evidence to suggest that growth trajectories themselves may be fundamentally different between ecosystems and that trait-height- growth relationships may change over environmental gradients.	[Thomas, Freya M.; Vesk, Peter A.] Univ Melbourne, Sch Biosci, ARC Ctr Excellence Environm Decis, Melbourne, Vic, Australia	University of Melbourne	Thomas, FM (corresponding author), Univ Melbourne, Sch Biosci, ARC Ctr Excellence Environm Decis, Melbourne, Vic, Australia.	freyamthomas@gmail.com	Vesk, Peter/AAG-9970-2020	Vesk, Peter/0000-0003-2008-7062	Australian Postgraduate Award, a Holsworth Wildlife Research Scholarship; Australian Research Council Centre of Excellence in Environmental Decisions (CEED); CEED	Australian Postgraduate Award, a Holsworth Wildlife Research Scholarship; Australian Research Council Centre of Excellence in Environmental Decisions (CEED)(Australian Research Council); CEED	FMT is supported by an Australian Postgraduate Award, a Holsworth Wildlife Research Scholarship and top up from Australian Research Council Centre of Excellence in Environmental Decisions (CEED). PAV is supported by CEED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2014, P NATL ACAD SCI USA, V111, P740, DOI 10.1073/pnas.1315179111; Beven K, 2002, P ROY SOC A-MATH PHY, V458, P2465, DOI 10.1098/rspa.2002.0986; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Cordlandwehr V, 2013, J ECOL, V101, P662, DOI 10.1111/1365-2745.12091; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Cumming G, 2005, AM PSYCHOL, V60, P170, DOI 10.1037/0003-066X.60.2.170; Cunningham SA, 1999, ECOL MONOGR, V69, P569, DOI 10.1890/0012-9615(1999)069[0569:EDILSA]2.0.CO;2; Diaz S, 2007, GLOBAL CHANGE BIOL, V13, P313, DOI 10.1111/j.1365-2486.2006.01288.x; Diaz S, 2016, NATURE, V529, P167, DOI 10.1038/nature16489; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Falster DS, 2008, AM NAT, V172, P299, DOI 10.1086/589889; Falster DS, 2005, OIKOS, V111, P57, DOI 10.1111/j.0030-1299.2005.13383.x; Falster DS, 2005, J ECOL, V93, P521, DOI 10.1111/j.0022-0477.2005.00992.x; Fonseca CR, 2000, J ECOL, V88, P964, DOI 10.1046/j.1365-2745.2000.00506.x; Funk JL, 2013, ECOLOGY, V94, P1893, DOI 10.1890/12-1602.1; Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A; HARRIS GP, 1994, FRESHWATER BIOL, V32, P143, DOI 10.1111/j.1365-2427.1994.tb00874.x; Herault B, 2011, J ECOL, V99, P1431, DOI 10.1111/j.1365-2745.2011.01883.x; Herault B, 2010, J APPL ECOL, V47, P821, DOI 10.1111/j.1365-2664.2010.01826.x; Hooten MB, 2015, ECOL MONOGR, V85, P3, DOI 10.1890/14-0661.1; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; King DA, 2005, FUNCT ECOL, V19, P445, DOI 10.1111/j.1365-2435.2005.00982.x; KITAJIMA K, 1994, OECOLOGIA, V98, P419, DOI 10.1007/BF00324232; Kobayashi K, 2000, AGRON J, V92, P345, DOI 10.1007/s100870050043; Kobe RK, 1999, ECOLOGY, V80, P187, DOI 10.1890/0012-9658(1999)080[0187:LGPATT]2.0.CO;2; Kunstler G, 2016, NATURE, V529, P204, DOI 10.1038/nature16476; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; Martinez-Garza C, 2013, FOREST ECOL MANAG, V303, P35, DOI 10.1016/j.foreco.2013.03.046; Martinez-Vilalta J, 2010, J ECOL, V98, P1462, DOI 10.1111/j.1365-2745.2010.01718.x; May F, 2013, PERSPECT PLANT ECOL, V15, P304, DOI 10.1016/j.ppees.2013.08.002; Mayfield MM, 2013, AM J BOT, V100, P1356, DOI 10.3732/ajb.1200461; Mlambo MC, 2014, BIODIVERS CONSERV, V23, P781, DOI 10.1007/s10531-014-0618-5; Moles AT, 2006, OIKOS, V113, P91, DOI 10.1111/j.0030-1299.2006.14194.x; Muir AM, 2014, AUST J BOT, V62, P369, DOI 10.1071/BT14117; Olden JD, 2000, ECOSCIENCE, V7, P501, DOI 10.1080/11956860.2000.11682622; Paine CET, 2015, J ECOL, V103, P978, DOI 10.1111/1365-2745.12401; Paine CET, 2012, METHODS ECOL EVOL, V3, P245, DOI 10.1111/j.2041-210X.2011.00155.x; Pickering CM, 2013, INCREASING RESILIENC, P94; Plummer M., 2011, JAGS VERSION 3 3 0 U; Poorter L, 2008, ECOLOGY, V89, P1908, DOI 10.1890/07-0207.1; Randin CF, 2006, J BIOGEOGR, V33, P1689, DOI 10.1111/j.1365-2699.2006.01466.x; Reich PB, 2014, J ECOL, V102, P275, DOI 10.1111/1365-2745.12211; Ruger N, 2012, FUNCT ECOL, V26, P759, DOI 10.1111/j.1365-2435.2012.01981.x; Sandel B, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00175.1; Schwilk DW, 2011, J ECOL, V99, P970, DOI 10.1111/j.1365-2745.2011.01828.x; Specht RL., 1970, AUSTR ENV, P44; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Sterck FJ, 2006, AM NAT, V167, P758, DOI 10.1086/503056; Su YS, 2015, SYSTEMREQUIREMENTS; Thomas SC, 1996, AM J BOT, V83, P556, DOI 10.2307/2445913; Thomas SC, 1999, ECOLOGY, V80, P1607; Tjorve E, 2003, J BIOGEOGR, V30, P827, DOI 10.1046/j.1365-2699.2003.00877.x; Tjorve E, 2010, J THEOR BIOL, V267, P417, DOI 10.1016/j.jtbi.2010.09.008; Tjorve E, 2009, J BIOGEOGR, V36, P1435, DOI 10.1111/j.1365-2699.2009.02101.x; Vesk PA, 2001, J APPL ECOL, V38, P897, DOI 10.1046/j.1365-2664.2001.00646.x; Walther BA, 2005, ECOGRAPHY, V28, P815, DOI 10.1111/j.2005.0906-7590.04112.x; Wenger SJ, 2012, METHODS ECOL EVOL, V3, P260, DOI 10.1111/j.2041-210X.2011.00170.x; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; Wilfahrt PA, 2014, FOREST ECOL MANAG, P1; Williams NSG, 2015, PERSPECT PLANT ECOL, V17, P78, DOI 10.1016/j.ppees.2014.10.002; Wright IJ, 2005, NEW PHYTOL, V166, P485, DOI 10.1111/j.1469-8137.2005.01349.x; Wright IJ, 2001, FUNCT ECOL, V15, P423, DOI 10.1046/j.0269-8463.2001.00542.x	63	14	15	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0176959	10.1371/journal.pone.0176959	http://dx.doi.org/10.1371/journal.pone.0176959			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486535	Green Published, gold			2022-12-26	WOS:000401314000031
J	Liu, T; Liang, YC; Chu, GX				Liu, Tao; Liang, Yongchao; Chu, Guixin			Nitrapyrin addition mitigates nitrous oxide emissions and raises nitrogen use efficiency in plastic-film-mulched drip-fertigated cotton field	PLOS ONE			English	Article							NITRIFICATION INHIBITORS; N2O EMISSIONS; NITRIC-OXIDE; SOIL; WHEAT; DENITRIFICATION; CROP; FLUXES; CORN	Nitrification inhibitors (NIs) have been used extensively to reduce nitrogen losses and increase crop nitrogen nutrition. However, information is still scant regarding the influence of NIs on nitrogen transformation, nitrous oxide (N2O) emission and nitrogen utilization in plastic-film-mulched calcareous soil under high frequency drip-fertigated condition. Therefore, a field trial was conducted to evaluate the effect of nitrapyrin (2-chloro-6-(trichloromethyl)-pyridine) on soil mineral nitrogen (N) transformation, N2O emission and nitrogen use efficiency (NUE) in a drip-fertigated cotton-growing calcareous field. Three treatments were established: control (no N fertilizer), urea (225 kg N ha(-1)) and urea+nitrapyrin (225 kg N ha(-1) +2.25 kg nitrapyrin ha(-1)). Compared with urea alone, urea plus nitrapyrin decreased the average N2O emission fluxes by 6.6-21.8% in June, July and August significantly in a drip-fertigation cycle. Urea application increased the seasonal cumulative N2O emission by 2.4 kg N ha(-1) compared with control, and nitrapyrin addition significantly mitigated the seasonal N2O emission by 14.3% compared with urea only. During the main growing season, the average soil ammonium nitrogen (NH4+-N) concentration was 28.0% greater and soil nitrate nitrogen (NO3--N) concentration was 13.8% less in the urea+nitrapyrin treatment than in the urea treatment. Soil NO3--N and water-filled pore space (WFPS) were more closely correlated than soil NH4+-N with soil N2O fluxes under drip-fertigated condition (P<0.001). Compared with urea alone, urea plus nitrapyrin reduced the seasonal N2O emission factor (EF) by 32.4% while increasing nitrogen use efficiency by 10.7%. The results demonstrated that nitrapyrin addition significantly inhibited soil nitrification and maintained more NH4+-N in soil, mitigated N2O losses and improved nitrogen use efficiency in plastic-film-mulched calcareous soil under high frequency drip-fertigated condition.	[Liu, Tao; Chu, Guixin] Shihezi Univ, Coll Agr, Xinjiang Prod & Construct Grp, Key Lab Oasis Ecoagr, Shihezi, Peoples R China; [Liang, Yongchao] Zhejiang Univ, Coll Environm & Resource Sci, Key Lab Environm Remediat & Ecol Hlth, Minist Educ, Hangzhou, Zhejiang, Peoples R China	Shihezi University; Zhejiang University	Chu, GX (corresponding author), Shihezi Univ, Coll Agr, Xinjiang Prod & Construct Grp, Key Lab Oasis Ecoagr, Shihezi, Peoples R China.; Liang, YC (corresponding author), Zhejiang Univ, Coll Environm & Resource Sci, Key Lab Environm Remediat & Ecol Hlth, Minist Educ, Hangzhou, Zhejiang, Peoples R China.	ycliang@zju.edu.cn; chuguixinshzu@163.com	Liang, Yongchao/S-9281-2019; Liang, Yongchao/D-5809-2012	Liang, Yongchao/0000-0002-0501-2823; Liang, Yongchao/0000-0002-0501-2823	Natural Science Foundation of China (NSFC) entitled "The response of N2O emission and soil nitrification-denireification key processing microbial molecular ecological mechanism on nitrapyrin in drip irrigation cropland" P. R. China [41461064]; National Key Basic Research Support Foundation of China (NKBRSF) entitled "Soil Microbial Community Structure in Paddy-upland Crop Rotation System in Relation to Efficient Nitrogen Use in Paddy Field" [2015C6150502]; 12th Five-Year Key Programs for Science and Technology Development of China entitled "Study of Key Technologies for Alleviating Obstacle Factors and Improving Productivity of Low-yield Cropland" [2012BAD05B06]	Natural Science Foundation of China (NSFC) entitled "The response of N2O emission and soil nitrification-denireification key processing microbial molecular ecological mechanism on nitrapyrin in drip irrigation cropland" P. R. China; National Key Basic Research Support Foundation of China (NKBRSF) entitled "Soil Microbial Community Structure in Paddy-upland Crop Rotation System in Relation to Efficient Nitrogen Use in Paddy Field"; 12th Five-Year Key Programs for Science and Technology Development of China entitled "Study of Key Technologies for Alleviating Obstacle Factors and Improving Productivity of Low-yield Cropland"	Our work was supported by three resources of funding; they were: The Natural Science Foundation of China (NSFC) entitled "The response of N2O emission and soil nitrification-denireification key processing microbial molecular ecological mechanism on nitrapyrin in drip irrigation cropland" (approved no. 41461064), P. R. China; The National Key Basic Research Support Foundation of China (NKBRSF) entitled "Soil Microbial Community Structure in Paddy-upland Crop Rotation System in Relation to Efficient Nitrogen Use in Paddy Field" (approved no. 2015C6150502); The 12th Five-Year Key Programs for Science and Technology Development of China entitled "Study of Key Technologies for Alleviating Obstacle Factors and Improving Productivity of Low-yield Cropland" (approved no. 2012BAD05B06).	Abalos D, 2014, SCI TOTAL ENVIRON, V490, P880, DOI 10.1016/j.scitotenv.2014.05.065; AULAKH MS, 1984, SOIL BIOL BIOCHEM, V16, P351, DOI 10.1016/0038-0717(84)90031-2; Bateman EJ, 2005, BIOL FERT SOILS, V41, P379, DOI 10.1007/s00374-005-0858-3; Bhatia A, 2010, AGR ECOSYST ENVIRON, V136, P247, DOI 10.1016/j.agee.2010.01.004; BRONSON KF, 1992, SOIL SCI SOC AM J, V56, P161, DOI 10.2136/sssaj1992.03615995005600010025x; Brown L, 2001, ATMOS ENVIRON, V35, P1439, DOI 10.1016/S1352-2310(00)00361-7; CRAWFORD DM, 1993, PLANT SOIL, V149, P59, DOI 10.1007/BF00010763; DAVIDSON EA, 1986, APPL ENVIRON MICROB, V52, P1287, DOI 10.1128/AEM.52.6.1287-1292.1986; Di HJ, 2012, SOIL USE MANAGE, V28, P54, DOI 10.1111/j.1475-2743.2011.00373.x; Ding WX, 2007, SCI TOTAL ENVIRON, V373, P501, DOI 10.1016/j.scitotenv.2006.12.026; DUXBURY JM, 1982, NATURE, V298, P462, DOI 10.1038/298462a0; FRENEY JR, 1993, FERT RES, V34, P37, DOI 10.1007/BF00749958; HUBER DM, 1977, BIOSCIENCE, V27, P523, DOI 10.2307/1297812; Lin S, 2011, ATMOS ENVIRON, V45, P1775, DOI 10.1016/j.atmosenv.2011.01.003; Liu CY, 2014, ATMOS ENVIRON, V96, P201, DOI 10.1016/j.atmosenv.2014.07.040; Liu CY, 2010, PLANT SOIL, V332, P123, DOI 10.1007/s11104-009-0278-5; [刘涛 Liu Tao], 2011, [土壤, Soils], V43, P758; Lopez NI, 2003, SOIL BIOL BIOCHEM, V35, P1609, DOI 10.1016/j.soilbio.2003.08.005; Lu R.K, 2000, ANAL METHOD SOIL AGR; Majumdar D, 2002, AGR ECOSYST ENVIRON, V91, P283, DOI 10.1016/S0167-8809(01)00223-7; Maljanen M, 2003, SOIL BIOL BIOCHEM, V35, P689, DOI 10.1016/S0038-0717(03)00085-3; Maljanen M, 2007, SOIL BIOL BIOCHEM, V39, P914, DOI 10.1016/j.soilbio.2006.11.001; Merino P, 2005, SOIL USE MANAGE, V21, P53, DOI 10.1079/SUM2005292; Merino P, 2012, SOIL TILL RES, V123, P29, DOI 10.1016/j.still.2012.03.005; Parkin TB, 2010, AGR ECOSYST ENVIRON, V136, P81, DOI 10.1016/j.agee.2009.11.014; Pihlatie M, 2004, NUTR CYCL AGROECOSYS, V70, P135, DOI 10.1023/B:FRES.0000048475.81211.3c; Ravishankara A. R., 2009, Science (Washington), V326, P123, DOI 10.1126/science.1176985; Scheer C, 2009, PLANT SOIL, V314, P273, DOI 10.1007/s11104-008-9728-8; Scheer C, 2008, SOIL BIOL BIOCHEM, V40, P290, DOI 10.1016/j.soilbio.2007.08.007; SKIBA U, 1993, SOIL BIOL BIOCHEM, V25, P1527, DOI 10.1016/0038-0717(93)90007-X; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sun H, 2015, J CHEM-NY, V2015, DOI 10.1155/2015/169680; SWEZEY AW, 1962, AGRON J, V54, P532, DOI 10.2134/agronj1962.00021962005400060020x; Velthof GL, 2002, NUTR CYCL AGROECOSYS, V62, P249, DOI 10.1023/A:1021259107244; Vilain G, 2014, NUTR CYCL AGROECOSYS, V98, P169, DOI 10.1007/s10705-014-9604-2; Weiske A, 2001, BIOL FERT SOILS, V34, P109, DOI 10.1007/s003740100386; Wolt JD, 2004, NUTR CYCL AGROECOSYS, V69, P23, DOI 10.1023/B:FRES.0000025287.52565.99; Xiong Wu, 2013, Acta Pedologica Sinica, V50, P743; Zaman M, 2009, SOIL BIOL BIOCHEM, V41, P1270, DOI 10.1016/j.soilbio.2009.03.011; Zhang M, 2015, AGR ECOSYST ENVIRON, V201, P43, DOI 10.1016/j.agee.2014.12.003; Zhang Q., 2010, CHIN J ECOAGRIC, p[18, 7]; Zheng XH, 2000, CHEMOSPHERE GLOBAL C, V2, P204; Zou JW, 2010, ENVIRON POLLUT, V158, P631, DOI 10.1016/j.envpol.2009.08.026; Zou JW, 2005, ATMOS ENVIRON, V39, P4755, DOI 10.1016/j.atmosenv.2005.04.028	44	17	23	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0176305	10.1371/journal.pone.0176305	http://dx.doi.org/10.1371/journal.pone.0176305			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481923	Green Published, gold, Green Submitted			2022-12-26	WOS:000401313700009
J	Balbaa, M; Abdulmalek, SA; Khalil, S				Balbaa, Mahmoud; Abdulmalek, Shaymaa A.; Khalil, Sofia			Oxidative stress and expression of insulin signaling proteins in the brain of diabetic rats: Role of Nigella sativa oil and antidiabetic drugs	PLOS ONE			English	Article							AMYLOID-BETA PEPTIDE; ALZHEIMERS-DISEASE; MEMORY IMPAIRMENT; BLACK SEED; RESISTANCE; INFLAMMATION; GLUTATHIONE; GLIMEPIRIDE; METABOLISM; PHOSPHORYLATION	Background and objectives Insulin resistance of the brain is a specific form of type2-diabetes mellitus (T2DM) and the active insulin-signaling pathway plays a neuroprotective role against damaging conditions and Alzheimer's progression. The present study identifies the mediated emerging effects of the Nigella sativa oil (NSO) on the memory enhancing process, its anti-oxidative, acetylcho-linestrase (AChE) inhibition, anti-brain insulin resistance and anti-amyloidogenic activities. In addition, the possible role of some anti-diabetic drugs in the neuro-protection processes and their effect in combination with NSO and/or the insulin receptor inhibitor IOMe-AG538 were investigated. Methods T2DM-induced rats were orally and daily administrated 2.0 ml NSO, 100 mg metformin (MT), 0.8 mg glimepiride (GI) and different combinations (100 mg MT & 2.0 ml NSO, 0.8 mg GI & 2.0 ml NSO and 2.0 ml NSO & intraperitoneal injection of 1/100 LD50 of IOMe-AG538) per kg body weight for 21 days. Results A significant increase in the brain lipid peroxidation and decrease in the antioxidant status with peripheral and central production of pro-inflammatory mediators were observed in diabetes- induced rats. The brain AChE was activated and associated with diminished brain glucose level and cholinergic function. In addition, the brain insulin resistance and the attenuated insulin signaling pathway (p-IRS/p-AKT/p-GSK-3 beta) were accompanied by an augmentation in GSK-3 beta level, which in turn may contribute in the extensive alterations of Tau phosphorylation along with changes in PP2A level. Furthermore, neuronal loss and elevation in A beta-42 plaque formation were observed due to a low IDE formation and an increased expression of p53, BACE1 and APP with diminished ADAM10, SIRT1 and BDNF levels. The expression profile of AD-related miRNAs in sera and brain tissues displayed its neuro-protection role. The treatment of diabetes-induced rats with NSO and the anti-diabetic drugs alone and/or in combination have the potential to suppress the oxidative stress, the pro-inflammatory mediators and amyloidogenic pathway. Moreover, it lowers the insulin receptor inhibitory effect of IOMe-AG538 and modifies the insulin-signaling pathway. Therefore, it prevents the neurotoxicity, amyloid plaque formation and Tau hyper-phosphorylation and restores AD-related miRNA normal levels. Conclusion These data suggest that NSO or its combined treatments with anti-diabetic drugs have a possible benefit as disease modifying agents for the insulin resistance in the brain through enhancing brain insulin signaling pathway.	[Balbaa, Mahmoud; Abdulmalek, Shaymaa A.; Khalil, Sofia] Alexandria Univ, Biochem Dept, Fac Sci, Alexandria, Egypt	Egyptian Knowledge Bank (EKB); Alexandria University	Balbaa, M (corresponding author), Alexandria Univ, Biochem Dept, Fac Sci, Alexandria, Egypt.	mahmoud.balbaa@alexu.edu.eg	Balbaa, Mahmoud/H-3572-2019; Abdulmalek, Shaymaa/AAY-7600-2021	Balbaa, Mahmoud/0000-0002-0876-6604; Abdel Monem, Nihad/0000-0002-9539-3614	Alexandria University, Egypt	Alexandria University, Egypt(Alexandria University)	This research work was supported in aid by Alexandria University, Egypt.	Aksoy N, 2003, CELL BIOCHEM FUNCT, V21, P121, DOI 10.1002/cbf.1006; Al-Majed AA, 2006, EUR J PHARMACOL, V543, P40, DOI 10.1016/j.ejphar.2006.05.046; Alhebshi AH, 2013, BIOCHEM BIOPH RES CO, V433, P362, DOI 10.1016/j.bbrc.2012.11.139; Aliev G, 2014, CNS NEUROL DISORD-DR, V13, P467, DOI 10.2174/18715273113126660153; Balbaa M, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2492107; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beheshti F, 2016, AVICENNA J PHYTOMEDI, V6, P124; Beisswenger P, 2003, DIABETES METAB, V29, pS95; Bosco D, 2011, J CELL MOL MED, V15, P1807, DOI 10.1111/j.1582-4934.2011.01318.x; Boura-Halfon S, 2009, AM J PHYSIOL-ENDOC M, V296, pE581, DOI 10.1152/ajpendo.90437.2008; Breteler MMB, 2000, NEUROBIOL AGING, V21, P153, DOI 10.1016/S0197-4580(99)00110-4; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Carvalheira JBC, 2003, DIABETOLOGIA, V46, P1629, DOI 10.1007/s00125-003-1246-x; Chen YM, 2009, P NATL ACAD SCI USA, V106, P3907, DOI 10.1073/pnas.0807991106; Craft S, 2012, NAT REV NEUROL, V8, P360, DOI 10.1038/nrneurol.2012.112; Cunnane S, 2011, NUTRITION, V27, P3, DOI 10.1016/j.nut.2010.07.021; Dinagaran S, 2016, INT J PHARM SCI RES, V7, P4473, DOI 10.13040/IJPSR.0975-8232.7(11).4473-79; DOUMAS BT, 1981, CLIN CHEM, V27, P1642; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hajhashemi V, 2004, PHYTOTHER RES, V18, P195, DOI 10.1002/ptr.1390; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Hosseini M, 2015, CHIN J INTEGR MED, V21, P438, DOI 10.1007/s11655-014-1742-5; Ingham V, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-115; Johnson R, 2012, PROG NEUROBIOL, V99, P293, DOI 10.1016/j.pneurobio.2012.09.006; JOLLOW DJ, 1974, PHARMACOLOGY, V11, P151, DOI 10.1159/000136485; Kalus U, 2003, PHYTOTHER RES, V17, P1209, DOI 10.1002/ptr.1356; Kickstein E, 2010, P NATL ACAD SCI USA, V107, P21830, DOI 10.1073/pnas.0912793107; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Kroner Z, 2009, ALTERN MED REV, V14, P373; Kruszynska YT, 2002, J CLIN ENDOCR METAB, V87, P226, DOI 10.1210/jc.87.1.226; Le PM, 2004, J ETHNOPHARMACOL, V94, P251, DOI 10.1016/j.jep.2004.04.030; LITWACK G, 1953, J BIOL CHEM, V200, P303; Liu FY, 2013, NEUROSCI LETT, V557, P90, DOI 10.1016/j.neulet.2013.10.052; Liu Y, 2011, J PATHOL, V225, P54, DOI 10.1002/path.2912; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; MENDIVIL A, 2005, REV FAC MED, V53, P235; Mitchell K, 2010, METHODS MOL BIOL, V617, P279, DOI 10.1007/978-1-60327-323-7_21; MONTGOMERY H, 1961, ANALYST, V86, P414; Mott JL, 2010, J CELL BIOCHEM, V110, P1155, DOI 10.1002/jcb.22630; Nakamura I, 2014, CARDIOVASC DIABETOL, V13, DOI [10.1186/1475-2840-13-15, 10.1186/s12933-014-0110-2]; Nelson PT, 2010, J ALZHEIMERS DIS, V21, P75, DOI 10.3233/JAD-2010-091603; Padurariu M, 2010, NEUROSCI LETT, V469, P6, DOI 10.1016/j.neulet.2009.11.033; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Qiu WQ, 2006, NEUROBIOL AGING, V27, P190, DOI 10.1016/j.neurobiolaging.2005.01.004; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Rahman AH, 2011, INT J PHARM SCI RES, V2, P1830, DOI 10.13040/IJPSR.0975-8232.2(7).1829-35; Rai S, 2014, PHARMACOL BIOCHEM BE, V117, P104, DOI 10.1016/j.pbb.2013.11.035; Rai S, 2013, J NEUROIMMUNOL, V254, P1, DOI 10.1016/j.jneuroim.2012.08.008; Rosenberg PB, 2006, INT REV PSYCHIATR, V17, P503, DOI 10.1080/02646830500382037; Senn JJ, 2003, J BIOL CHEM, V278, P13740, DOI 10.1074/jbc.M210689200; Sheweita SA, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/5264064; SIMS NR, 1983, J NEUROCHEM, V41, P1329, DOI 10.1111/j.1471-4159.1983.tb00829.x; SORBI S, 1983, ANN NEUROL, V13, P72, DOI 10.1002/ana.410130116; Srinivasan K, 2005, PHARMACOL RES, V52, P313, DOI 10.1016/j.phrs.2005.05.004; Steinberg GR, 2007, CELL CYCLE, V6, P888, DOI 10.4161/cc.6.8.4135; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; TAPPEL A. L., 1959, ARCH BIOCHEM AND BIOPHYS, V80, P326, DOI 10.1016/0003-9861(59)90258-9; Wada A, 2005, J PHARMACOL SCI, V99, P128, DOI 10.1254/jphs.CRJ05006X; Wang KC, 2012, NEUROEPIDEMIOLOGY, V38, P237, DOI 10.1159/000337428; Wang WX, 2011, ACTA NEUROPATHOL, V121, P193, DOI 10.1007/s00401-010-0756-0; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; Yamamoto M, 2008, J IMMUNOL, V181, P3877, DOI 10.4049/jimmunol.181.6.3877; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Zhang XC, 2005, EXP NEUROL, V191, P318, DOI 10.1016/j.expneurol.2004.10.011; Zong YY, 2011, BRAIN RES, V1395, P108, DOI 10.1016/j.brainres.2011.04.035	67	40	43	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0172429	10.1371/journal.pone.0172429	http://dx.doi.org/10.1371/journal.pone.0172429			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505155	Green Submitted, gold, Green Published			2022-12-26	WOS:000401473500002
J	Biwer, C; Rothberg, A; IglayReger, H; Derksen, H; Burant, CF; Najarian, K				Biwer, Craig; Rothberg, Amy; IglayReger, Heidi; Derksen, Harm; Burant, Charles F.; Najarian, Kayvan			Windowed persistent homology: A topological signal processing algorithm applied to clinical obesity data	PLOS ONE			English	Article							WEIGHT-LOSS; TIME-SERIES	Overweight and obesity are highly prevalent in the population of the United States, affecting roughly 2/3 of Americans. These diseases, along with their associated conditions, are a major burden on the healthcare industry in terms of both dollars spent and effort expended. Volitional weight loss is attempted by many, but weight regain is common. The ability to predict which patients will lose weight and successfully maintain the loss versus those prone to regain weight would help ease this burden by allowing clinicians the ability to skip treatments likely to be ineffective. In this paper we introduce a new windowed approach to the persistent homology signal processing algorithm that, when paired with a modified, semimetric version of the Hausdorff distance, can differentiate the two groups where other commonly used methods fail. The novel approach is tested on accelerometer data gathered from an ongoing study at the University of Michigan. While most standard approaches to signal processing show no difference between the two groups, windowed persistent homology and the modified Hausdorff semimetric show a clear separation. This has significant implications for clinical decision making and patient care.	[Biwer, Craig; Najarian, Kayvan] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Rothberg, Amy; IglayReger, Heidi; Burant, Charles F.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Derksen, Harm] Univ Michigan, Dept Math, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Biwer, C (corresponding author), Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA.	cbiwer@umich.edu	Burant, Charles/GPC-5690-2022	Burant, Charles/0000-0001-9189-5003; ROTHBERG, AMY/0000-0002-0243-9135	National Institutes of Health; Nutrition Obesity Research Center [P30DK089503-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089503, P30DK092926, P30DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nutrition Obesity Research Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	CFB received funding from the National Institutes of Health, Nutrition Obesity Research Center, grant number P30DK089503-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendich P, 2016, ARXIV160206245; Carlsson G, 2009, B AM MATH SOC, V46, P255, DOI 10.1090/S0273-0979-09-01249-X; Dubuisson MP, 1994, 1994 C A COMP VIS IM, V1, P1; Edelsbrunner H, 2008, CONTEMP MATH, V453, P257; Edelsbrunner Herbert, 2010, COMPUTATIONAL TOPOLO; Emrani S, 2015, IEEE SIGNAL PROC LET, V22, DOI 10.1109/LSP.2015.2441068; Emrani S, 2014, IEEE SIGNAL PROC LET, V21, P459, DOI 10.1109/LSP.2014.2305700; Fasy BT, 2014, ANN STAT, V42, P2301, DOI 10.1214/14-AOS1252; Ghrist R, 2008, B AM MATH SOC, V45, P61, DOI 10.1090/s0273-0979-07-01191-3; Goodman JE, 2006, SURV DISCR COMP GEOM, V453; Guillemard M, GROUPOID ALGEBRAS PE; Johansson K, 2014, AM J CLIN NUTR, V99, P14, DOI 10.3945/ajcn.113.070052; Kerber M, 2016, 2016 P 18 WORKSH ALG; Khasawneh FA, 2015, ASME INTERNATIONAL MECHANICAL ENGINEERING CONGRESS AND EXPOSITION, 2014, VOL 4B; Khasawneh FA, 2016, MECH SYST SIGNAL PR, V70-71, P527, DOI 10.1016/j.ymssp.2015.09.046; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Ochner CN, 2013, PHYSIOL BEHAV, V120, P106, DOI 10.1016/j.physbeh.2013.07.009; Perea JA, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0645-6; Pereira CMM, 2015, EXPERT SYST APPL, V42, P6026, DOI 10.1016/j.eswa.2015.04.010; Roe J, 2006, NOTICES AM MATH SOC, V53, P668; Rothberg AE, 2013, OBESITY, V21, P2157, DOI 10.1002/oby.20597; Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748; Turner K., 2014, INFORM INFERENCE	23	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177696	10.1371/journal.pone.0177696	http://dx.doi.org/10.1371/journal.pone.0177696			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498844	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314500042
J	Connor, N; Barberan, A; Clauset, A				Connor, Nora; Barberan, Albert; Clauset, Aaron			Using null models to infer microbial co-occurrence networks	PLOS ONE			English	Article							BACTERIAL; COMMUNITY; DIVERSITY; PATTERNS; COMPETITION; PREDICTION	Although microbial communities are ubiquitous in nature, relatively little is known about the structural and functional roles of their constituent organisms' underlying interactions. A common approach to study such questions begins with extracting a network of statistically significant pairwise co-occurrences from a matrix of observed operational taxonomic unit (OTU) abundances across sites. The structure of this network is assumed to encode information about ecological interactions and processes, resistance to perturbation, and the identity of keystone species. However, common methods for identifying these pairwise interactions can contaminate the network with spurious patterns that obscure true ecological signals. Here, we describe this problem in detail and develop a solution that incorporates null models to distinguish ecological signals from statistical noise. We apply these methods to the initial OTU abundance matrix and to the extracted network. We demonstrate this approach by applying it to a large soil microbiome data set and show that many previously reported patterns for these data are statistical artifacts. In contrast, we find the frequency of three-way interactions among microbial OTUs to be highly statistically significant. These results demonstrate the importance of using appropriate null models when studying observational microbiome data, and suggest that extracting and characterizing three-way interactions among OTUs is a promising direction for unraveling the structure and function of microbial ecosystems.	[Connor, Nora; Clauset, Aaron] Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA; [Barberan, Albert] Univ Arizona, Dept Soil Water & Environm Sci, Tucson, AZ USA; [Clauset, Aaron] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA; [Clauset, Aaron] Santa Fe Inst, Santa Fe, NM 87501 USA	University of Colorado System; University of Colorado Boulder; University of Arizona; University of Colorado System; University of Colorado Boulder; The Santa Fe Institute	Connor, N (corresponding author), Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA.	nora.connor@university.edu		CLAUSET, AARON/0000-0002-3529-8746; BARBERAN, ALBERT/0000-0002-3066-7530				Agler MT, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002352; Aicher C, 2015, J COMPLEX NETW, V3, P221, DOI 10.1093/comnet/cnu026; Amerise IL, 2015, J APPL STAT, V42, P2584, DOI 10.1080/02664763.2015.1043870; Ban YG, 2015, BIOINFORMATICS, V31, P3322, DOI 10.1093/bioinformatics/btv364; Barberan A, 2014, ECOL LETT, V17, P794, DOI 10.1111/ele.12282; Barberan A, 2012, ISME J, V6, P343, DOI 10.1038/ismej.2011.119; Bastian M., 2009, INT AAAI C WEBL SOC, V8, P361, DOI DOI 10.13140/2.1.1341.1520; Berry D, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00219; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Chung F., 2002, ANN COMB, V6, P125, DOI [10.1007/PL00012580, 10.1007/PL00012580.pdf, DOI 10.1007/PL00012580.PDF]; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Coyte KZ, 2015, SCIENCE, V350, P663, DOI 10.1126/science.aad2602; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; DeChoudhury M, 2010, P 19 INT C WORLD WID, P301, DOI DOI 10.1145/1772690.1772722; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; ERDOS P, 1960, B INT STATIST INST, V38, P343; Faust K, 2012, NAT REV MICROBIOL, V10, P538, DOI 10.1038/nrmicro2832; Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687; Goberna M, 2014, ECOL LETT, V17, P1191, DOI 10.1111/ele.12341; Goldberg DS, 2003, P NATL ACAD SCI USA, V100, P4372, DOI 10.1073/pnas.0735871100; Guimera R, 2009, P NATL ACAD SCI USA, V106, P22073, DOI 10.1073/pnas.0908366106; Kara EL, 2013, ISME J, V7, P680, DOI 10.1038/ismej.2012.118; Karrer B, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.016107; Kendall MG, 1945, BIOMETRIKA, V33, P239, DOI 10.2307/2332303; Knights D, 2011, FEMS MICROBIOL REV, V35, P343, DOI 10.1111/j.1574-6976.2010.00251.x; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Larremore DB, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.012805; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Levy R, 2013, P NATL ACAD SCI USA, V110, P12804, DOI 10.1073/pnas.1300926110; Liben-Nowell D, 2007, J AM SOC INF SCI TEC, V58, P1019, DOI 10.1002/asi.20591; Lozupone C, 2012, GENOME RES, V22, P1974, DOI 10.1101/gr.138198.112; Martiny AC, 2013, ISME J, V7, P830, DOI 10.1038/ismej.2012.160; MOLLOY M, 1995, RANDOM STRUCT ALGOR, V6, P161, DOI 10.1002/rsa.3240060204; Montoya D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8379; Navarrete AA, 2015, MOL ECOL, V24, P2433, DOI 10.1111/mec.13172; Newman M., 2010, NETWORKS INTRO, DOI [10.1162/artl_r_00062, 10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; O'Dwyer JP, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002832; Peura S, 2015, APPL ENVIRON MICROB, V81, P2090, DOI 10.1128/AEM.03660-14; Philippot L, 2013, ISME J, V7, P1609, DOI 10.1038/ismej.2013.34; Philippot L, 2010, NAT REV MICROBIOL, V8, P523, DOI 10.1038/nrmicro2367; Pholchan MK, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00068; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Steele JA, 2011, ISME J, V5, P1414, DOI 10.1038/ismej.2011.24; Stoeck T, 2010, MOL ECOL, V19, P21, DOI 10.1111/j.1365-294X.2009.04480.x; Thomas AC, 2011, ARXIV11010788; Tucker CM, 2016, OIKOS, V125, P778, DOI 10.1111/oik.02803; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weiss S, 2016, ISME J, V10, P1669, DOI 10.1038/ismej.2015.235; Williams RJ, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00358; Yang Y., 2016, PREPRINT; Yano JM, 2015, CELL, V161, P264, DOI 10.1016/j.cell.2015.02.047	55	40	40	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176751	10.1371/journal.pone.0176751	http://dx.doi.org/10.1371/journal.pone.0176751			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493918	Green Submitted, Green Published, gold			2022-12-26	WOS:000401314300030
J	Iwamoto, T; Nakamura, T; Ishikawa, M; Yoshizaki, K; Sugimoto, A; Ida-Yonemochi, H; Ohshima, H; Saito, M; Yamada, Y; Fukumoto, S				Iwamoto, Tsutomu; Nakamura, Takashi; Ishikawa, Masaki; Yoshizaki, Keigo; Sugimoto, Asuna; Ida-Yonemochi, Hiroko; Ohshima, Hayato; Saito, Masahiro; Yamada, Yoshihiko; Fukumoto, Satoshi			Pannexin 3 regulates proliferation and differentiation of odontoblasts via its hemichannel activities	PLOS ONE			English	Article							GAP-JUNCTION PROTEINS; OSTEOBLAST DIFFERENTIATION; DENTINOGENESIS IMPERFECTA; METABOLIC CHECKPOINT; CELL-PROLIFERATION; MUTATIONS CAUSE; PULP CELLS; TEETH; AMPK; EXPRESSION	Highly coordinated regulation of cell proliferation and differentiation contributes to the formation of functionally shaped and sized teeth; however, the mechanism underlying the switch from cell cycle exit to cell differentiation during odontogenesis is poorly understood. Recently, we identified pannexin 3 (Panx3) as a member of the pannexin gap junction protein family from tooth germs. The expression of Panx3 was predominately localized in preodontoblasts that arise from dental papilla cells and can differentiate into dentin-secreting odontoblasts. Panx3 also co-localized with p21, a cyclin-dependent kinase inhibitor protein, in preodontoblasts. Panx3 was expressed in primary dental mesenchymal cells and in the mDP dental mesenchymal cell line. Both Panx3 and p21 were induced during the differentiation of mDP cells. Overexpression of Panx3 in mDP cells reduced cell proliferation via upregulation of p21, but not of p27, and promoted the Bone morphogenetic protein 2 (BMP2)induced phosphorylation of Smad1/5/8 and the expression of dentin sialophosphoprotein (Dspp), a marker of differentiated odontoblasts. Furthermore, Panx3 released intracellular ATP into the extracellular space through its hemichannel and induced the phosphorylation of AMP-activated protein kinase (AMPK). 5-Aminoimidazole-4-carboxamide-ribonucleoside (AICAR), an activator of AMPK, reduced mDP cell proliferation and induced p21 expression. Conversely, knockdown of endogenous Panx3 by siRNA inhibited AMPK phosphorylation, p21 expression, and the phosphorylation of Smad1/5/8 even in the presence of BMP2. Taken together, our results suggest that Panx3 modulates intracellular ATP levels, resulting in the inhibition of odontoblast proliferation through the AMPK/p21 signaling pathway and promotion of cell differentiation by the BMP/Smad signaling pathway.	[Iwamoto, Tsutomu; Sugimoto, Asuna] Tokushima Univ, Grad Sch, Inst Biomed Sci, Dept Pediat Dent, Kuramoto, Tokushima, Japan; [Nakamura, Takashi; Fukumoto, Satoshi] Tohoku Univ, Grad Sch Dent, Div Pediat Dent, Sendai, Miyagi, Japan; [Ishikawa, Masaki; Saito, Masahiro] Tohoku Univ, Grad Sch Dent, Div Operat Dent, Sendai, Miyagi, Japan; [Ishikawa, Masaki; Yoshizaki, Keigo; Yamada, Yoshihiko] Natl Inst Dent & Craniofacial Res, Lab Cell & Dev Biol, NIH, Bethesda, MD USA; [Yoshizaki, Keigo] Kyushu Univ, Fac Dent Sci, Sect Orthodont & Dentofacial Orthoped, Maidashi, Fukuoka, Japan; [Ida-Yonemochi, Hiroko; Ohshima, Hayato] Niigata Univ, Grad Sch Med & Dent Sci, Div Anat & Cell Biol Hard Tissue, Chuo Ku, Niigata, Japan	Tokushima University; Tohoku University; Tohoku University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Kyushu University; Niigata University	Iwamoto, T (corresponding author), Tokushima Univ, Grad Sch, Inst Biomed Sci, Dept Pediat Dent, Kuramoto, Tokushima, Japan.	iwamoto@tokushima-u.ac.jp	Iwamoto, Tsutomu/AAA-6597-2019; Ohshima, Hayato/AAW-5545-2020; Iwamoto, Tsutomu/AAI-8952-2021; Nakamura, Takashi/A-8931-2012	Iwamoto, Tsutomu/0000-0001-8472-605X; Ohshima, Hayato/0000-0001-8571-9900; Nakamura, Takashi/0000-0001-9904-1037; Fukumoto, Satoshi/0000-0002-5046-6891; Yoshizaki, Keigo/0000-0002-0598-5879	Ministry of Education, Science, and Culture of Japan [22689053, 26293435, 20679006]; NEXT program [LS010]; Research Program of the NIH; NIDCR; Research Fellowship of the Japan Society for the Promotion of Science for Young Scientists; Grants-in-Aid for Scientific Research [15H05688, 17H04414, 17H04415] Funding Source: KAKEN	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NEXT program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Research Fellowship of the Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid (22689053 and 26293435 to T.I., 20679006 to S. F.) from the Ministry of Education, Science, and Culture of Japan and the NEXT program (LS010 to S.F.) and in part by the Research Program of the NIH, NIDCR (Y.Y). T.N., M.I., and K.Y. were supported in part by the Research Fellowship of the Japan Society for the Promotion of Science for Young Scientists.	Akazawa Y, 2015, INT J MOL MED, V36, P442, DOI 10.3892/ijmm.2015.2247; Arakaki M, 2012, J BIOL CHEM; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Baranova A, 2004, GENOMICS, V83, P706, DOI 10.1016/j.ygeno.2003.09.025; Bennett M V, 1992, Semin Cell Biol, V3, P29; Bjorklund MA, 2010, EXP CELL RES, V316, P762, DOI 10.1016/j.yexcr.2009.12.014; Bond SR, 2011, J BONE MINER RES, V26, P2911, DOI 10.1002/jbmr.509; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Bruzzone R, 1996, EUR J BIOCHEM, V238, P1, DOI 10.1111/j.1432-1033.1996.0001q.x; Buhl DL, 2003, J NEUROSCI, V23, P1013; de Vega S, 2007, J BIOL CHEM, V282, P30878, DOI 10.1074/jbc.M705847200; Fried KAJ, 1996, INT J DEV BIOL, V40, P985; Fukumoto E, 2003, J DENT RES, V82, P17, DOI 10.1177/154405910308200105; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Ishikawa M, 2016, J CELL SCI; Ishikawa M, 2014, J BIOL CHEM, V289, P2839, DOI 10.1074/jbc.M113.523241; Ishikawa M, 2011, J CELL BIOL, V193, P1257, DOI 10.1083/jcb.201101050; Iwamoto T, 2010, J BIOL CHEM, V285, P18948, DOI 10.1074/jbc.M110.127027; Joao SMA, 2003, HISTOCHEM CELL BIOL, V119, P21, DOI 10.1007/s00418-002-0482-3; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; Lee DS, 2009, J BIOL CHEM, V284, P17293, DOI 10.1074/jbc.M109.009084; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Lo CW, 1997, COMMUNICATION, V20, P119; McKnight DA, 2008, J DENT RES, V87, P1108, DOI 10.1177/154405910808701217; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Nakamura T, 2004, J BIOL CHEM, V279, P626, DOI 10.1074/jbc.M307502200; Ogasawara T, 2004, MOL CELL BIOL, V24, P6560, DOI 10.1128/mcb.24.15.6560-6568.2004; Oh SK, 2015, FASEB J, V29, P4473, DOI 10.1096/fj.15-273722; Paznekas WA, 2003, AM J HUM GENET, V72, P408, DOI 10.1086/346090; Qin W, 2012, J ENDODONT, V38, P66, DOI 10.1016/j.joen.2011.09.025; REAUME AG, 1995, SCIENCE, V267, P1831, DOI 10.1126/science.7892609; Sasaki T, 1996, ANAT REC, V245, P235, DOI 10.1002/(SICI)1097-0185(199606)245:2<235::AID-AR10>3.0.CO;2-Q; Scemes E, 2007, NEURON GLIA BIOL, V3, P199, DOI 10.1017/S1740925X08000069; Sreenath T, 2003, J BIOL CHEM, V278, P24874, DOI 10.1074/jbc.M303908200; Thesleff I, 2003, J CELL SCI, V116, P1647, DOI 10.1242/jcs.00410; Unger VM, 1999, SCIENCE, V283, P1176, DOI 10.1126/science.283.5405.1176; USHIYAMA J, 1989, CELL TISSUE RES, V258, P611; Vanden Abeele F, 2006, J CELL BIOL, V174, P535, DOI 10.1083/jcb.200601115; Wu BL, 2003, AM J MED GENET A, V121A, P102, DOI 10.1002/ajmg.a.20210; Yuasa K, 2004, J BIOL CHEM, V279, P10286, DOI 10.1074/jbc.M310013200	42	25	26	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177557	10.1371/journal.pone.0177557	http://dx.doi.org/10.1371/journal.pone.0177557			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28494020	Green Submitted, Green Published, gold			2022-12-26	WOS:000401314300135
J	Hiremath, SV; Tyler-Kabara, EC; Wheeler, JJ; Moran, DW; Gaunt, RA; Collinger, JL; Foldes, ST; Weber, DJ; Chen, WD; Boninger, ML; Wang, W				Hiremath, Shivayogi V.; Tyler-Kabara, Elizabeth C.; Wheeler, Jesse J.; Moran, Daniel W.; Gaunt, Robert A.; Collinger, Jennifer L.; Foldes, Stephen T.; Weber, Douglas J.; Chen, Weidong; Boninger, Michael L.; Wang, Wei			Human perception of electrical stimulation on the surface of somatosensory cortex	PLOS ONE			English	Article							MOTOR	Recent advancement in electrocorticography (ECoG)-based brain-computer interface technology has sparked a new interest in providing somatosensory feedback using ECoG electrodes, i.e., cortical surface electrodes. We conducted a 28-day study of cortical surface stimulation in an individual with arm paralysis due to brachial plexus injury to examine the sensation produced by electrical stimulation of the somatosensory cortex. A high-density ECoG grid was implanted over the somatosensory and motor cortices. Stimulation through cortical surface electrodes over the somatosensory cortex successfully elicited arm and hand sensations in our participant with chronic paralysis. There were three key findings. First, the intensity of perceived sensation increased monotonically with both pulse amplitude and pulse frequency. Second, changing pulse width changed the type of sensation based on qualitative description provided by the human participant. Third, the participant could distinguish between stimulation applied to two neighboring cortical surface electrodes, 4.5 mm center-to-center distance, for three out of seven electrode pairs tested. Taken together, we found that it was possible to modulate sensation intensity, sensation type, and evoke sensations across a range of locations from the fingers to the upper arm using different stimulation electrodes even in an individual with chronic impairment of somatosensory function. These three features are essential to provide effective somatosensory feedback for neuroprosthetic applications.	[Hiremath, Shivayogi V.; Tyler-Kabara, Elizabeth C.; Gaunt, Robert A.; Collinger, Jennifer L.; Foldes, Stephen T.; Weber, Douglas J.; Chen, Weidong; Boninger, Michael L.; Wang, Wei] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA USA; [Hiremath, Shivayogi V.; Collinger, Jennifer L.; Foldes, Stephen T.; Weber, Douglas J.; Wang, Wei] Ctr Neural Basis Cognit, Pittsburgh, PA USA; [Hiremath, Shivayogi V.] Temple Univ, Dept Phys Therapy, Philadelphia, PA 19122 USA; [Tyler-Kabara, Elizabeth C.; Gaunt, Robert A.; Collinger, Jennifer L.; Weber, Douglas J.; Boninger, Michael L.; Wang, Wei] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA; [Tyler-Kabara, Elizabeth C.] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA; [Tyler-Kabara, Elizabeth C.; Boninger, Michael L.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA USA; [Wheeler, Jesse J.] Washington Univ, Dept Biomed Engn, St Louis, MO USA; [Collinger, Jennifer L.; Foldes, Stephen T.; Boninger, Michael L.] Dept Vet Affairs Med Ctr, Pittsburgh, PA USA; [Foldes, Stephen T.] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA; [Chen, Weidong] Zhejiang Univ, Qiushi Acad Adv Studies, Hangzhou, Zhejiang, Peoples R China; [Wang, Wei] Univ Pittsburgh, Clin & Translat Sci Inst, Pittsburgh, PA USA; [Wang, Wei] Washington Univ, Mallinckrodt Inst Radiol, Sch Med, St Louis, MO USA; [Wang, Wei] Barnes Jewish Hosp, St Louis, MO 63110 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Washington University (WUSTL); Barrow Neurological Institute; Phoenix Children's Hospital; Zhejiang University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Washington University (WUSTL); Barnes-Jewish Hospital; Washington University (WUSTL)	Wang, W (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA USA.; Wang, W (corresponding author), Ctr Neural Basis Cognit, Pittsburgh, PA USA.; Wang, W (corresponding author), Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA.; Wang, W (corresponding author), Univ Pittsburgh, Clin & Translat Sci Inst, Pittsburgh, PA USA.; Wang, W (corresponding author), Washington Univ, Mallinckrodt Inst Radiol, Sch Med, St Louis, MO USA.; Wang, W (corresponding author), Barnes Jewish Hosp, St Louis, MO 63110 USA.	wei.wang@wustl.edu	Tyler-Kabara, Elizabeth/H-4930-2013; Hiremath, Shivayogi V./X-8758-2019; Foldes, Stephen/Y-4304-2019; Hiremath, Shivayogi/AAV-5752-2020	Tyler-Kabara, Elizabeth/0000-0003-3286-1094; Hiremath, Shivayogi V./0000-0002-9708-1411; Foldes, Stephen/0000-0002-2061-3790; Gaunt, Robert/0000-0001-6202-5818; Boninger, Michael/0000-0001-6966-919X; Collinger, Jennifer/0000-0002-4517-5395	University of Pittsburgh Medical Center (UPMC); UPMC Rehabilitation Institute; National Institutes of Health (NIH) [3R01NS05025605S1, 8KL2TR000146]; Paralyzed Veterans of America Research Foundation (PVA) [3039]	University of Pittsburgh Medical Center (UPMC); UPMC Rehabilitation Institute; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paralyzed Veterans of America Research Foundation (PVA)	This work was supported by the University of Pittsburgh Medical Center (UPMC), UPMC Rehabilitation Institute, the National Institutes of Health (NIH) (Grants 3R01NS05025605S1 and 8KL2TR000146), and Paralyzed Veterans of America Research Foundation (PVA#3039). The funders had no role in the preparation of this article.; We would like to first thank our study participant for the invaluable dedication and effort that made this study possible. We would like to thank Dr. Daniel S. Rizzuto from the University of Pennsylvania for sharing his experience with using Blackrock Stimulator for their research. We would like to thank Dr. Donald Crammond for intra-operative brain mapping and electrode impedance testing. We would also like to thank Ms. Debbie Harrington, our clinical research coordinator, for her great effort in participant recruitment, clinical data management, and study coordination. This work was supported by the University of Pittsburgh Medical Center (UPMC), UPMC Rehabilitation Institute, the National Institutes of Health (NIH) (Grants 3R01NS050256-0551 and 8KL2TR000146), and Paralyzed Veterans of America Research Foundation (PVA#3039). The funders had no role in the preparation of this article.	Bensmaia SJ, 2014, NAT REV NEUROSCI, V15, P313, DOI 10.1038/nrn3724; Borchers S, 2012, NAT REV NEUROSCI, V13, P63, DOI 10.1038/nrn3140; Brodmann K, 1909, VERGLEICHENDE LOKALI; Collinger JL, 2014, CTS-CLIN TRANSL SCI, V7, P52, DOI 10.1111/cts.12086; Cronin J, 2016, IEEE T HAPTICS; Dadarlat MC, 2015, NAT NEUROSCI, V18, P138, DOI 10.1038/nn.3883; DITUNNO JF, 1994, PARAPLEGIA, V32, P70, DOI 10.1038/sc.1994.13; Flesher SN, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf8083; Gardner E.P., 2000, PRINCIPLES NEURAL SC, P411; GODDARD GV, 1969, EXP NEUROL, V25, P295, DOI 10.1016/0014-4886(69)90128-9; GORDON B, 1990, ELECTROEN CLIN NEURO, V75, P371, DOI 10.1016/0013-4694(90)90082-U; Johnson LA, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/3/036021; MacDonald DB, 2015, BRAIN MAPPING ENCY R, P871; MCCREERY DB, 1990, IEEE T BIO-MED ENG, V37, P996, DOI 10.1109/10.102812; Miller KJ, 2007, J NEUROSCI, V27, P2424, DOI 10.1523/JNEUROSCI.3886-06.2007; O'Doherty JE, 2011, NATURE, V479, P228, DOI 10.1038/nature10489; ODOHERTY JE, 2012, SYSTEMS MAN CYBERN A, V20, P85, DOI DOI 10.1109/TNSRE.2011.2166807; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; Penfield W, 1950, CEREBRAL CORTEX MAN; RASMUSSEN T, 1947, FED PROC, V6, P184; Romo R, 1998, NATURE, V392, P387, DOI 10.1038/32891; Romo R, 2000, NEURON, V26, P273, DOI 10.1016/S0896-6273(00)81156-3; Schalk G, 2007, J NEURAL ENG, V4, P264, DOI 10.1088/1741-2560/4/3/012; Tabot GA, 2013, P NATL ACAD SCI USA, V110, P18279, DOI 10.1073/pnas.1221113110; Wang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055344; Wheeler J, 2013, SOC NEUROSCIENCE; Yanagisawa T, 2011, ANN NEUROLOGY	27	50	52	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176020	10.1371/journal.pone.0176020	http://dx.doi.org/10.1371/journal.pone.0176020			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489913	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314100013
J	Kakkanat, A; Phan, MD; Lo, AW; Beatson, SA; Schembri, MA				Kakkanat, Asha; Minh-Duy Phan; Lo, Alvin W.; Beatson, Scott A.; Schembri, Mark A.			Novel genes associated with enhanced motility of Escherichia coli ST131	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; ELONGATION-FACTOR-P; REGULATOR-C QSEBC; FLAGELLAR EXPRESSION; SWARMING MOTILITY; PROTEIN; OPERON; FLHDC; BIOGENESIS; BACTERIA	Uropathogenic Escherichia coli (UPEC) is the cause of similar to 75% of all urinary tract infections (UTIs) and is increasingly associated with multidrug resistance. This includes UPEC strains from the recently emerged and globally disseminated sequence type 131 (ST131), which is now the dominant fluoroquinolone-resistant UPEC clone worldwide. Most ST131 strains are motile and produce H4-type flagella. Here, we applied a combination of saturated Tn5 mutagenesis and transposon directed insertion site sequencing (TraDIS) as a high throughput genetic screen and identified 30 genes associated with enhanced motility of the reference ST131 strain EC958. This included 12 genes that repress motility of E. coli K-12, four of which (lrhA, ihfA, ydiV, lrp) were confirmed in EC958. Other genes represented novel factors that impact motility, and we focused our investigation on characterisation of the mprA, hemK and yjeA genes. Mutation of each of these genes in EC958 led to increased transcription of flagellar genes (flhD and fliC), increased expression of the FliC flagellin, enhanced flagella synthesis and a hyper-motile phenotype. Complementation restored all of these properties to wild-type level. We also identified Tn5 insertions in several intergenic regions (IGRs) on the EC958 chromosome that were associated with enhanced motility; this included flhDC and EC958_1546. In both of these cases, the Tn5 insertions were associated with increased transcription of the downstream gene(s), which resulted in enhanced motility. The EC958_1546 gene encodes a phage protein with similarity to esterase/deacetylase enzymes involved in the hydrolysis of sialic acid derivatives found in human mucus. We showed that over-expression of EC958_1546 led to enhanced motility of EC958 as well as the UPEC strains CFT073 and UTI89, demonstrating its activity affects the motility of different UPEC strains. Overall, this study has identified and characterised a number of novel factors associated with enhanced UPEC motility.	[Kakkanat, Asha; Minh-Duy Phan; Lo, Alvin W.; Beatson, Scott A.; Schembri, Mark A.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Kakkanat, Asha; Minh-Duy Phan; Lo, Alvin W.; Beatson, Scott A.; Schembri, Mark A.] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia; [Beatson, Scott A.] Univ Queensland, Australian Ctr Ecogen, Brisbane, Qld, Australia	University of Queensland; University of Queensland; University of Queensland	Schembri, MA (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia.; Schembri, MA (corresponding author), Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia.	m.schembri@uq.edu.au	Schembri, Mark A/C-7262-2009; Beatson, Scott/B-6985-2013; Phan, Minh-Duy/I-9147-2012	Schembri, Mark A/0000-0003-4863-9260; Beatson, Scott/0000-0002-1806-3283; Kakkanat, Asha/0000-0002-2492-1424; Phan, Minh-Duy/0000-0002-3426-1044	National Health and Medical Research Council (NHMRC) of Australia [GNT1067455]; NHMRC Senior Research Fellowship [GNT1106930]; NHMRC Career Development Fellowship [GNT1090456]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a grant from the National Health and Medical Research Council (NHMRC) of Australia (GNT1067455). MAS is supported by an NHMRC Senior Research Fellowship (GNT1106930) and SAB by an NHMRC Career Development Fellowship (GNT1090456).	Aldridge P, 2002, CURR OPIN MICROBIOL, V5, P160, DOI 10.1016/S1369-5274(02)00302-8; Allsopp LP, 2010, INFECT IMMUN, V78, P1659, DOI 10.1128/IAI.01010-09; AMSLER CD, 1993, J BACTERIOL, V175, P6238, DOI 10.1128/JB.175.19.6238-6244.1993; Arshad M, 2016, J INFECT DIS, V213, P1330, DOI 10.1093/infdis/jiv584; Balestrino D, 2005, J BACTERIOL, V187, P2870, DOI 10.1128/JB.187.8.2870-2880.2005; Barker CS, 2004, J BACTERIOL, V186, P7529, DOI 10.1128/JB.186.22.7529-7537.2004; Bearson SMD, 2011, FOODBORNE PATHOG DIS, V8, P725, DOI 10.1089/fpd.2010.0796; Behshad E, 2006, BIOCHEMISTRY-US, V45, P12639, DOI 10.1021/bi061328t; Bien J, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/681473; Bogomolnaya LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111513; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Chilcott GS, 2000, MICROBIOL MOL BIOL R, V64, P694, DOI 10.1128/MMBR.64.4.694-708.2000; Clarke MB, 2005, MOL MICROBIOL, V58, P441, DOI 10.1111/j.1365-2958.2005.04819.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deditius JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135351; Doerfel LK, 2013, SCIENCE, V339, P85, DOI 10.1126/science.1229017; Duan QD, 2013, J BASIC MICROB, V53, P1, DOI [10.1002/jobm.201100335, 10.1002/jobm.201370001]; Ellison DW, 2006, CURR OPIN MICROBIOL, V9, P153, DOI 10.1016/j.mib.2006.02.003; Fahrner KA, 2015, J BACTERIOL, V197, P3087, DOI 10.1128/JB.00455-15; Flores-Mireles AL, 2015, NAT REV MICROBIOL, V13, P269, DOI 10.1038/nrmicro3432; Foxman B, 2010, NAT REV UROL, V7, P653, DOI 10.1038/nrurol.2010.190; Francez-Charlot A, 2003, MOL MICROBIOL, V49, P823, DOI 10.1046/j.1365-2958.2003.03601.x; Girgis HS, 2007, PLOS GENET, V3, P1644, DOI 10.1371/journal.pgen.0030154; GIVSKOV M, 1995, MOL MICROBIOL, V15, P445, DOI 10.1111/j.1365-2958.1995.tb02258.x; GLICK BR, 1979, EUR J BIOCHEM, V97, P23, DOI 10.1111/j.1432-1033.1979.tb13081.x; GLICK BR, 1975, P NATL ACAD SCI USA, V72, P4257, DOI 10.1073/pnas.72.11.4257; Hadjifrangiskou M, 2012, J BACTERIOL, V194, P6195, DOI 10.1128/JB.01012-12; Hadjifrangiskou M, 2011, MOL MICROBIOL, V80, P1516, DOI 10.1111/j.1365-2958.2011.07660.x; Hancock SJ, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.01740-16; Heurgue-Hamard V, 2002, EMBO J, V21, P769, DOI 10.1093/emboj/21.4.769; Hung CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034220; Inoue T, 2007, J BACTERIOL, V189, P950, DOI 10.1128/JB.01294-06; Kakkanat A, 2015, SCI REP-UK, V5, DOI 10.1038/srep16149; Kalir S, 2001, SCIENCE, V292, P2080, DOI 10.1126/science.1058758; Ko M, 2000, J BACTERIOL, V182, P4670, DOI 10.1128/JB.182.16.4670-4672.2000; Lane MC, 2007, P NATL ACAD SCI USA, V104, P16669, DOI 10.1073/pnas.0607898104; Lehnen D, 2002, MOL MICROBIOL, V45, P521, DOI 10.1046/j.1365-2958.2002.03032.x; Lehti TA, 2012, MICROBIOL-SGM, V158, P1444, DOI 10.1099/mic.0.056499-0; Li BQ, 2012, NUCLEIC ACIDS RES, V40, P11073, DOI 10.1093/nar/gks869; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; LOMOVSKAYA O, 1995, J BACTERIOL, V177, P2328, DOI 10.1128/jb.177.9.2328-2334.1995; LOMOVSKAYA O, 1992, P NATL ACAD SCI USA, V89, P8938, DOI 10.1073/pnas.89.19.8938; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; MACNAB RM, 1992, ANNU REV GENET, V26, P131, DOI 10.1146/annurev.ge.26.120192.001023; MARTINEZ E, 1988, GENE, V68, P159, DOI 10.1016/0378-1119(88)90608-7; Michel E, 1998, FEMS MICROBIOL LETT, V169, P341, DOI 10.1016/S0378-1097(98)00498-4; Phan MD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003834; MOBLEY HLT, 1990, INFECT IMMUN, V58, P1281, DOI 10.1128/IAI.58.5.1281-1289.1990; Mulvey MA, 2001, INFECT IMMUN, V69, P4572, DOI 10.1128/IAI.69.7.4572-4579.2001; Nakahigashi K, 2002, P NATL ACAD SCI USA, V99, P1473, DOI 10.1073/pnas.032488499; Nicolas-Chanoine MH, 2008, J ANTIMICROB CHEMOTH, V61, P273, DOI 10.1093/jac/dkm464; Nielubowicz GR, 2010, NAT REV UROL, V7, P430, DOI 10.1038/nrurol.2010.101; Nubling S, 2014, INT J MED MICROBIOL, V304, P269, DOI 10.1016/j.ijmm.2013.10.008; ORSKOV F, 1992, CAN J MICROBIOL, V38, P699, DOI 10.1139/m92-115; Patrick JE, 2012, MOL MICROBIOL, V83, P14, DOI 10.1111/j.1365-2958.2011.07917.x; Petty NK, 2014, P NATL ACAD SCI USA, V111, P5694, DOI 10.1073/pnas.1322678111; Pichon C, 2009, CELL MICROBIOL, V11, P616, DOI 10.1111/j.1462-5822.2008.01278.x; Reiss DJ, 2011, J BIOL CHEM, V286, P44726, DOI 10.1074/jbc.M111.290684; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rogers BA, 2011, J ANTIMICROB CHEMOTH, V66, P1, DOI 10.1093/jac/dkq415; Roy H, 2011, NAT CHEM BIOL, V7, P667, DOI [10.1038/NCHEMBIO.632, 10.1038/nchembio.632]; Sanchez-Torres V, 2011, APPL MICROBIOL BIOT, V90, P651, DOI 10.1007/s00253-010-3074-5; Schubert HL, 2003, BIOCHEMISTRY-US, V42, P5592, DOI 10.1021/bi034026p; SHIN S, 1995, J BACTERIOL, V177, P4696, DOI 10.1128/jb.177.16.4696-4702.1995; Simms AN, 2008, INFECT IMMUN, V76, P4833, DOI 10.1128/IAI.00630-08; Simms AN, 2008, J BACTERIOL, V190, P3747, DOI 10.1128/JB.01870-07; Sivick KE, 2010, INFECT IMMUN, V78, P568, DOI 10.1128/IAI.01000-09; Smith TG, 2009, ADV APPL MICROBIOL, V67, P257, DOI 10.1016/S0065-2164(08)01008-3; Soutourina O, 1999, J BACTERIOL, V181, P7500, DOI 10.1128/JB.181.24.7500-7508.1999; Soutourina OA, 2003, FEMS MICROBIOL REV, V27, P505, DOI 10.1016/S0168-6445(03)00064-0; Sperandio V, 2002, MOL MICROBIOL, V43, P809, DOI 10.1046/j.1365-2958.2002.02803.x; Steenbergen SM, 2009, J BACTERIOL, V191, P7134, DOI 10.1128/JB.01000-09; STOJILJKOVIC I, 1994, J MOL BIOL, V236, P531, DOI 10.1006/jmbi.1994.1163; Subashchandrabose S, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.UTI-0015-2012; Takaya A, 2012, MOL MICROBIOL, V83, P1268, DOI 10.1111/j.1365-2958.2012.08007.x; Tomoyasu T, 2003, MOL MICROBIOL, V48, P443, DOI 10.1046/j.1365-2958.2003.03437.x; Totsika M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026578; Ude S, 2013, SCIENCE, V339, P82, DOI 10.1126/science.1228985; Ulett GC, 2006, MICROBIOL-SGM, V152, P2101, DOI 10.1099/mic.0.28607-0; Vimr ER, 2004, MICROBIOL MOL BIOL R, V68, P132, DOI 10.1128/MMBR.68.1.132-153.2004; Vimr Eric R, 2013, ISRN Microbiol, V2013, P816713, DOI 10.1155/2013/816713; Wang XX, 2011, ISME J, V5, P1517, DOI 10.1038/ismej.2011.27; Wang XX, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1146; Wiles TJ, 2008, EXP MOL PATHOL, V85, P11, DOI 10.1016/j.yexmp.2008.03.007; Wilkinson SP, 2006, CURR ISSUES MOL BIOL, V8, P51; Wright KJ, 2005, INFECT IMMUN, V73, P7657, DOI 10.1128/IAI.73.11.7657-7668.2005; Xiong A, 2000, ANTIMICROB AGENTS CH, V44, P2905, DOI 10.1128/AAC.44.10.2905-2907.2000; Yanagisawa T, 2010, NAT STRUCT MOL BIOL, V17, P1136, DOI 10.1038/nsmb.1889; Yona-Nadler C, 2003, MICROBIOL-SGM, V149, P877, DOI 10.1099/mic.0.25970-0; Zou SB, 2012, J BACTERIOL, V194, P413, DOI 10.1128/JB.05864-11	94	23	23	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176290	10.1371/journal.pone.0176290j	http://dx.doi.org/10.1371/journal.pone.0176290j			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489862				2022-12-26	WOS:000401314100020
J	Nay, JJ				Nay, John J.			Predicting and understanding law-making with word vectors and an ensemble model	PLOS ONE			English	Article								Out of nearly 70,000 bills introduced in the U.S. Congress from 2001 to 2015, only 2,513 were enacted. We developed a machine learning approach to forecasting the probability that any bill will become law. Starting in 2001 with the 107th Congress, we trained models on data from previous Congresses, predicted all bills in the current Congress, and repeated until the 113th Congress served as the test. For prediction we scored each sentence of a bill with a language model that embeds legislative vocabulary into a high-dimensional, semantic-laden vector space. This language representation enables our investigation into which words increase the probability of enactment for any topic. To test the relative importance of text and context, we compared the text model to a context-only model that uses variables such as whether the bill's sponsor is in the majority party. To test the effect of changes to bills after their introduction on our ability to predict their final outcome, we compared using the bill text and meta-data available at the time of introduction with using the most recent data. At the time of introduction context-only predictions outperform text-only, and with the newest data text-only outperforms context-only. Combining text and context always performs best. We conducted a global sensitivity analysis on the combined model to determine important variables predicting enactment.	[Nay, John J.] Vanderbilt Univ, Sch Engn, 221 Kirkland Hall, Nashville, TN 37235 USA; [Nay, John J.] Vanderbilt Law Sch, Program Law & Innovat, Nashville, TN 37203 USA	Vanderbilt University; Vanderbilt University	Nay, JJ (corresponding author), Vanderbilt Univ, Sch Engn, 221 Kirkland Hall, Nashville, TN 37235 USA.; Nay, JJ (corresponding author), Vanderbilt Law Sch, Program Law & Innovat, Nashville, TN 37203 USA.	john.j.nay@gmail.com						ALTMAN DG, 1994, BRIT MED J, V309, P188, DOI 10.1136/bmj.309.6948.188; [Anonymous], 2012, P 2012 C N AM CHAPT; Bengio Y, 2001, ADV NEUR IN, V13, P932; Breiman L, 1996, MACH LEARN, V24, P49; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Chan K., 2000, SENSITIVITY ANAL; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Gerrish S. M., 2011, P ICML; Martin T, 2016, PROCEEDINGS OF THE 25TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW'16), P683, DOI 10.1145/2872427.2883001; Mikolov T., 2013, ADV NEURAL INF PROCE, P3111; Nay JJ, 2016, P 2016 EMNLP WORKSH, P49; Pujol G., 2014, SENSITIVITY SENSITIV; Rehurek R., 2010, P LREC 2010 WORKSH N; Saltelli A, 2010, ENVIRON MODELL SOFTW, V25, P1508, DOI 10.1016/j.envsoft.2010.04.012; Stewart C, 2011, C COMM ASS 103 112 C; Stewart III C, 2016, C COMM ASS 103 113 C; Taddy M, 2015, PROCEEDINGS OF THE 53RD ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL) AND THE 7TH INTERNATIONAL JOINT CONFERENCE ON NATURAL LANGUAGE PROCESSING (IJCNLP), VOL 2, P45; van dL MJ, 2007, STAT APPL GENETICS M, V6; Wang E, 2010, ADV NEURAL INFORM PR, P2370; Wilkerson J, 2015, AM J POLIT SCI, V59, P943, DOI 10.1111/ajps.12175	21	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176999	10.1371/journal.pone.0176999	http://dx.doi.org/10.1371/journal.pone.0176999			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489868	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314100043
J	Lee, JY; Rahman, A; Azam, H; Kim, HS; Kwon, MJ				Lee, Ju Yeon; Rahman, Arifur; Azam, Hossain; Kim, Hyung Seok; Kwon, Man Jae			Characterizing nutrient uptake kinetics for efficient crop production during Solanum lycopersicum var. cerasiforme Alef. growth in a closed indoor hydroponic system	PLOS ONE			English	Article							FRUIT-QUALITY; TOMATO PLANTS; YIELD; PHOSPHATE; COPPER	A balanced nutrient supply is essential for the healthy growth of plants in hydroponic systems. However, the commonly used electrical conductivity (EC)-based nutrient control for plant cultivation can provide amounts of nutrients that are excessive or inadequate for proper plant growth. In this study, we investigated the kinetics of major and minor nutrient uptake in a nutrient solution during the growth of tomato (Solanum lycopersicum var. cerasiforme Alef.) in a closed hydroponic system. The concentrations of major and minor ions in the nutrient solution were determined by various analytical methods including inductively coupled plasma-optical emission spectroscopy (ICP-OES), ion chromatography (IC), ion specific electrodes, and/or colorimetric methods. The concentrations of the individual nutrient ions were compared with changes in the EC. The EC of the nutrient solution varied according to the different growth stages of tomato plants. Variation in the concentrations of NO3-, SO42-, Mg2+, Ca2+, and K+ was similar to the EC variation. However, in the cases of PO43-, Na+, Cl-, dissolved Fe and Mn, Cu2+, and Zn2+, variation did not correspond with that of EC. These ions were generally depleted (to 0 mg L-1) during tomato growth, suggesting that these specific ions should be monitored individually and their supply increased. Nutrient uptake rates of major ions increased gradually at different growth stages until harvest (from < 3 mg L-1 d(-1) to > 15 mg L-1 d(-1)). Saturation indices determined by MINEQL+ simulation and a mineral precipitation experiment demonstrated the potential for amorphous calcium phosphate precipitation, which may facilitate the abiotic adsorptive removal of dissolved Fe, dissolved Mn, Cu2+, and Zn2+.	[Lee, Ju Yeon; Kim, Hyung Seok; Kwon, Man Jae] Korea Inst Sci & Technol, Kangnung, South Korea; [Lee, Ju Yeon; Kwon, Man Jae] Korea Univ, Seoul, South Korea; [Rahman, Arifur] George Washington Univ, Civil & Environm Engn, Washington, DC USA; [Azam, Hossain] Manhattan Coll, Civil & Environm Engn, Riverdale, NY USA	Korea Institute of Science & Technology (KIST); Korea University; George Washington University; Manhattan College	Kwon, MJ (corresponding author), Korea Inst Sci & Technol, Kangnung, South Korea.; Kwon, MJ (corresponding author), Korea Univ, Seoul, South Korea.	mkwon@kist.re.kr			KIST Open Research Program [2E25701]; National Research Council of Science & Technology (NST) by the Korean Government (MSIP) [CRC-15-01-KIST]; National Research Foundation of Korea - Korean Government (MEST)	KIST Open Research Program; National Research Council of Science & Technology (NST) by the Korean Government (MSIP); National Research Foundation of Korea - Korean Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government)	MJK and HSK were supported by the KIST Open Research Program (grant number, 2E25701)(http://www.kist.re.kr) and a National Research Council of Science & Technology (NST) grant by the Korean Government (MSIP) (grant number, CRC-15-01-KIST)(http://www.nst.re.kr/nst/index.jsp). JYL was partially supported by a National Research Foundation of Korea Grant funded by the Korean Government (MEST) (2015, University-Institute Cooperation Program)(http://www.nrf.re.kr/nrf_eng_cms/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams P., 1986, THE TOMATO CROP, P281, DOI DOI 10.1007/978-94-009-3137-4_7; Albano JP, 2001, HORTSCIENCE, V36, P313, DOI 10.21273/HORTSCI.36.2.313; Arellano-Jimenez MJ, 2009, J PHYS CHEM SOLIDS, V70, P390, DOI 10.1016/j.jpcs.2008.11.001; Bamsey M, 2012, SENSORS-BASEL, V12, P13349, DOI 10.3390/s121013349; Botrini L, 2000, HORTSCIENCE, V35, P1220, DOI 10.21273/HORTSCI.35.7.1220; Bugbee B, 2004, ACTA HORTIC, P99, DOI 10.17660/ActaHortic.2004.648.12; Cao XD, 2004, ENVIRON POLLUT, V131, P435, DOI 10.1016/j.envpol.2004.03.003; Cao XD, 2009, J HAZARD MATER, V164, P555, DOI 10.1016/j.jhazmat.2008.08.034; Caruso G, 2011, SCI HORTIC-AMSTERDAM, V129, P479, DOI 10.1016/j.scienta.2011.04.020; Christie E., 2014, THESIS; Corami A, 2007, J HAZARD MATER, V146, P164, DOI 10.1016/j.jhazmat.2006.12.003; De Borba BM, 2014, J CHROMATOGR A, V1369, P131, DOI 10.1016/j.chroma.2014.10.027; Gales Jr M.E., 1966, J AM WATER WORK ASS, V58, P1363, DOI DOI 10.1002/J.1551-8833.1966.TB01703.X; Girard J.E, 2014, PRINCIPLES ENV CHEM, V3rd; Hartz TK, 1999, J AM SOC HORTIC SCI, V124, P199, DOI 10.21273/JASHS.124.2.199; Kelton N, 2007, AQUAT SCI, V69, P86, DOI 10.1007/s00027-006-0869-7; Komosa A, 2015, J PLANT NUTR, V38, P355, DOI 10.1080/01904167.2014.934466; Lee Seongtae, 2011, [Korean Journal of Soil Science & Fertilizer, 한국토양비료학회지(Korean Journal of Soil Science and Fertilizer)], V44, P767; Nakano Y, 2010, J JPN SOC HORTIC SCI, V79, P47, DOI 10.2503/jjshs1.79.47; Rhine ED, 1998, SOIL SCI SOC AM J, V62, P473, DOI 10.2136/sssaj1998.03615995006200020026x; Satti SME, 1996, J PLANT NUTR, V19, P705, DOI 10.1080/01904169609365154; Savvas D, 2002, SCI HORTIC-AMSTERDAM, V96, P267, DOI 10.1016/S0304-4238(02)00054-7; Schwarz D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00625; Somrani S, 2005, J SOLID STATE CHEM, V178, P1337, DOI 10.1016/j.jssc.2004.11.029; STENSVAND A, 1992, GARTENBAUWISSENSCHAF, V57, P193; Trejo-Tellez L.I., 2012, NUTR SOLUTIONS HYDRO; Turan M., 1999, IMPROVED CROP QUALIT, P229; Zekki H, 1996, J AM SOC HORTIC SCI, V121, P1082, DOI 10.21273/JASHS.121.6.1082	28	18	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177041	10.1371/journal.pone.0177041	http://dx.doi.org/10.1371/journal.pone.0177041			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486501	gold, Green Submitted, Green Published			2022-12-26	WOS:000401314000036
J	Ong, CT; Tsai, CF; Wong, YS; Chen, SCC				Ong, Cheung-Ter; Tsai, Ching-Fang; Wong, Yi-Sin; Chen, Solomon Chih-Cheng			Epidemiology of brain abscess in Taiwan: A 14-year population-based cohort study	PLOS ONE			English	Article							MANAGEMENT	Brain abscess (BA) is a severe neurological emergency, which remains a challenge for physicians despite medical advancements. The purpose of this study is to describe the epidemiology of BA in Taiwan and to investigate potential factors affecting the survival of patients with BA. By using the Taiwan National Health Insurance Research Database, we identified hospitalized patients with a discharge diagnosis of pyogenic BA (324.X) between 2000 and 2013. The incidence and in-hospital mortality of BA were calculated based on both age and sex. A total of 6027 BA cases were identified. The overall incidence of BA was 1.88 (95% CI: 1.83-1.93) per 100,000 person-years and increased with age, from 0.58 per 100,000 person-years in individuals aged 0-14 years to 4.67 per 100,000 person-years in those over 60 years of age. The male-to-female incidence ratio was 2.37 (95% CI: 2.24-2.50), with a mountain-shaped distribution across ages peaking at 40-44 years. The in-hospital mortality also increased with age, from 4.22% (95% CI: 2.54-6.97) at 0-14 years to 17.34% (95% CI: 15.79-19.02) in individuals over 60 years of age, without a gender difference (11.9% for males, 12.5% for females). Age, stroke, septicemia, pneumonia, meningitis, and hepatitis were associated with increased risk of in-hospital mortality. There was a male predominance for BA, and both the incidence and in-hospital mortality rates increased with age. Infection-related disease such as septicemia, pneumonia and meningitis were important factors associated with in-hospital mortality. In addition to the original treatment of BA, we suggest paying close attention to potential infections to improve the outcome of BA patients.	[Ong, Cheung-Ter] Ditmanson Med Fdn, Dept Neurol, Chiayi Christian Hosp, Chiayi, Taiwan; [Ong, Cheung-Ter] Chung Jen Jr Coll Nursing Hlth Sci & Management, Dept Nursing, Chiayi, Taiwan; [Tsai, Ching-Fang; Chen, Solomon Chih-Cheng] Ditmanson Med Fdn, Chiayi Christian Hosp, Dept Med Res, Chiayi, Taiwan; [Wong, Yi-Sin] Ditmanson Med Fdn, Chiayi Christian Hosp, Dept Family Med, Chiayi, Taiwan; [Chen, Solomon Chih-Cheng] Taipei Med Univ, Sch Med, Dept Pediat, Taipei, Taiwan	Chia-Yi Christian Hospital; Chia-Yi Christian Hospital; Chia-Yi Christian Hospital; Taipei Medical University	Ong, CT (corresponding author), Ditmanson Med Fdn, Dept Neurol, Chiayi Christian Hosp, Chiayi, Taiwan.; Ong, CT (corresponding author), Chung Jen Jr Coll Nursing Hlth Sci & Management, Dept Nursing, Chiayi, Taiwan.	ctong98@yahoo.com.tw		Ong, Cheung-Ter/0000-0003-1814-4371				BELLER AJ, 1973, J NEUROL NEUROSUR PS, V36, P757, DOI 10.1136/jnnp.36.5.757; Brouwer MC, 2014, NEW ENGL J MED, V371, P447, DOI 10.1056/NEJMra1301635; Brouwer MC, 2014, NEUROLOGY, V82, P806, DOI 10.1212/WNL.0000000000000172; Carpenter J, 2007, EUR J CLIN MICROBIOL, V26, P1, DOI 10.1007/s10096-006-0236-6; Cartes-Zumelzu FW, 2004, AM J NEURORADIOL, V25, P1310; Datto JP, 2015, NEURAL REGEN RES, V10, P1533, DOI 10.4103/1673-5374.165213; Hakan T, 2006, J INFECTION, V52, P359, DOI 10.1016/j.jinf.2005.07.019; Helweg-Larsen J, BMC INFEC DIS, V12, P332; Kuo CF, 2011, BRIT J DERMATOL, V165, P1273, DOI 10.1111/j.1365-2133.2011.10595.x; Kuo CY, 2015, IRAN J PUBLIC HEALTH, V44, P470; Lai CH, 2010, NEUROEPIDEMIOLOGY, V35, P66, DOI 10.1159/000311012; Landriel F, 2012, ACTA NEUROCHIR, V154, P903, DOI 10.1007/s00701-012-1299-z; Lu CH, 2002, QJM-INT J MED, V95, P501, DOI 10.1093/qjmed/95.8.501; Mathisen GE, 1997, CLIN INFECT DIS, V25, P763, DOI 10.1086/515541; MCCLELLAND CJ, 1978, J NEUROL NEUROSUR PS, V41, P1043, DOI 10.1136/jnnp.41.11.1043; Menon S, 2008, J MED MICROBIOL, V57, P1259, DOI 10.1099/jmm.0.47814-0; Nathoo N, 2011, WORLD NEUROSURG, V75, P716, DOI 10.1016/j.wneu.2010.11.043; NICOLOSI A, 1991, NEUROEPIDEMIOLOGY, V10, P122, DOI 10.1159/000110257; Ong CT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122350; Shachor-Meyouhas Y, 2010, ACTA PAEDIATR, V99, P1163, DOI 10.1111/j.1651-2227.2010.01780.x; Sharma R, 2009, INFECTION, V37, P39, DOI 10.1007/s15010-008-7359-x; Shoko T, 2010, J AM COLL SURGEONS, V211, P338, DOI 10.1016/j.jamcollsurg.2010.04.010; STRANDGAARD S, 1973, BMJ-BRIT MED J, V1, P507, DOI 10.1136/bmj.1.5852.507; Tsou TP, 2009, J MICROBIOL IMMUNOL, V42, P405; Wutzler S, 2009, J AM COLL SURGEONS, V209, P75, DOI 10.1016/j.jamcollsurg.2009.03.015; Zhang C, 2014, BMC INFEC DIS	26	12	12	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0176705	10.1371/journal.pone.0176705	http://dx.doi.org/10.1371/journal.pone.0176705			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486477	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314000023
J	Shiju, S; Sriram, K				Shiju, S.; Sriram, K.			Hypothesis driven single cell dual oscillator mathematical model of circadian rhythms	PLOS ONE			English	Article							SUPRACHIASMATIC-NUCLEUS; GENE-EXPRESSION; MICE LACKING; COUPLED OSCILLATORS; MOLECULAR ANALYSIS; FEEDBACK LOOPS; MUTANT MICE; CLOCK; PACEMAKER; DROSOPHILA	Molecular mechanisms responsible for 24 h circadian oscillations, entrainment to external cues, encoding of day length and the time-of-day effects have been well studied experimentally. However, it is still debated from the molecular network point of view whether each cell in suprachiasmatic nuclei harbors two molecular oscillators, where one tracks dawn and the other tracks dusk activities. A single cell dual morning and evening oscillator was proposed by Daan et al., based on the molecular network that has two sets of similar non-redundant per1/cry1 and per2/cry2 circadian genes and each can independently maintain their endogenous oscillations. Understanding of dual oscillator dynamics in a single cell at molecular level may provide insight about the circadian mechanisms that encodes day length variations and its response to external zeitgebers. We present here a realistic dual oscillator model of circadian rhythms based on the series of hypotheses proposed by Daan et al., in which they conjectured that the circadian genes per1/cry1 track dawn while per2/cry2 tracks dusk and they together constitute the morning and evening oscillators (dual oscillator). Their hypothesis also provides explanations about the encoding of day length in terms of molecular mechanisms of per/cry expression. We frame a minimal mathematical model with the assumption that per1 acts a morning oscillator and per2 acts as an evening oscillator and to support and interpret this assumption we fit the model to the experimental data of per1/per2 circadian temporal dynamics, phase response curves (PRC's), and entrainment phenomena under various light-dark conditions. We also capture different patterns of splitting phenomena by coupling two single cell dual oscillators with neuropeptides vasoactive intestinal polypeptide (VIP) and arginine vasopressin (AVP) as the coupling agents and provide interpretation for the occurrence of splitting in terms of ME oscillators, though they are not required to explain the morning and evening oscillators. The proposed dual oscillator model based on Daan's hypothesis supports per1 and per2 playing the role of morning and evening oscillators respectively and this may be the first step towards the understanding of the core molecular mechanism responsible for encoding the day length.	[Shiju, S.; Sriram, K.] Indraprastha Inst Informat Technol Delhi, Ctr Computat Biol, New Delhi, India	Indraprastha Institute of Information Technology Delhi	Sriram, K (corresponding author), Indraprastha Inst Informat Technol Delhi, Ctr Computat Biol, New Delhi, India.	sriramk@iiitd.ac.in		S, Shiju/0000-0002-9715-1029	Department of Science & Technology, Ministry of Science and Technology, Government of India (DST) cognitive neuroscience [SR/CSI/299/2012]	Department of Science & Technology, Ministry of Science and Technology, Government of India (DST) cognitive neuroscience	This work is supported by the Department of Science & Technology, Ministry of Science and Technology, Government of India (DST) cognitive neuroscience grant,SR/CSI/299/2012. (KS received the funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is supported by the DST cognitive neuroscience grant, SR/CSI/299/2012 from the Department of Science and Technology, INDIA.	Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; Albrecht U, 2001, J BIOL RHYTHM, V16, P100, DOI 10.1177/074873001129001791; ASCHOFF J, 1979, Z TIERPSYCHOL, V49, P225; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Becker-Weimann S, 2004, BIOPHYS J, V87, P3023, DOI 10.1529/biophysj.104.040824; Bodenstein C, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002697; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Carr AJF, 2003, CURR BIOL, V13, P1543, DOI 10.1016/S0960-9822(03)00619-5; Challet E, 2003, J NEUROSCI RES, V72, P629, DOI 10.1002/jnr.10616; DAAN S, 1978, J THEOR BIOL, V70, P297, DOI 10.1016/0022-5193(78)90378-8; Daan S, 2002, J BIOL RHYTHM, V17, P107, DOI 10.1177/074873002129002375; Daan S, 2001, J BIOL RHYTHM, V16, P105, DOI 10.1177/074873001129001809; de la Iglesia HO, 2004, MOL BRAIN RES, V127, P121, DOI 10.1016/j.molbrainres.2004.05.018; DeWoskin D, 2014, INTERFACE FOCUS, V4, DOI 10.1098/rsfs.2013.0076; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Ermentrout, 2002, SIMULATING ANALYZING, Vvol. 14; Forger DB, 2004, J THEOR BIOL, V230, P533, DOI 10.1016/j.jtbi.2004.04.041; Forger DB, 2003, P NATL ACAD SCI USA, V100, P14806, DOI 10.1073/pnas.2036281100; Geier F, 2005, J BIOL RHYTHM, V20, P83, DOI 10.1177/0748730404269309; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Hastings M, 2001, J BIOL RHYTHM, V16, P117, DOI 10.1177/074873001129001818; Helfrich-Forster C, 2009, J BIOL RHYTHM, V24, P259, DOI 10.1177/0748730409339614; Hughes AT, 2004, J NEUROSCI, V24, P3522, DOI 10.1523/JNEUROSCI.5345-03.2004; ILLNEROVA H, 1987, Journal of Biological Rhythms, V2, P95, DOI 10.1177/074873048700200202; Indic P, 2008, J R SOC INTERFACE, V5, P873, DOI 10.1098/rsif.2007.1248; Kalsbeek A, 2012, NEUROBIOLOGY CIRCADI, V199, P5; Kulasiri D, 2008, MATH MODEL NAT PHENO, V3, P1, DOI 10.1051/mmnp:2008053; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Leloup JC, 2003, P NATL ACAD SCI USA, V100, P7051, DOI 10.1073/pnas.1132112100; Leloup JC, 1999, J BIOL RHYTHM, V14, P433, DOI 10.1177/074873099129000948; Loros JJ, 2001, ANNU REV PHYSIOL, V63, P757, DOI 10.1146/annurev.physiol.63.1.757; Maury E, 2010, CIRC RES, V106, P447, DOI 10.1161/CIRCRESAHA.109.208355; Maywood ES, 2003, J NEUROENDOCRINOL, V15, P329, DOI 10.1046/j.1365-2826.2003.00971.x; Mirsky HP, 2009, P NATL ACAD SCI USA, V106, P11107, DOI 10.1073/pnas.0904837106; Nuesslein-Hildesheim B, 2000, EUR J NEUROSCI, V12, P2856, DOI 10.1046/j.1460-9568.2000.00173.x; Oda GA, 2002, J BIOL RHYTHM, V17, P76, DOI 10.1177/074873002129002357; Oda GA, 2000, J BIOL RHYTHM, V15, P246, DOI 10.1177/074873040001500306; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; Oster H, 2002, CHRONOBIOL INT, V19, P507, DOI 10.1081/CBI-120004210; Pendergast JS, 2010, J NEUROSCI, V30, P12179, DOI 10.1523/JNEUROSCI.2607-10.2010; PICKARD GE, 1982, SCIENCE, V215, P1119, DOI 10.1126/science.7063843; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P333, DOI 10.1007/BF01417860; Pittendrigh CS, 1966, LIFE SCI SPACE RES, V5, P122; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Punia S, 2012, AM J PHYSIOL-ENDOC M, V303, pE762, DOI 10.1152/ajpendo.00513.2011; Quintero JE, 2003, J NEUROSCI, V23, P8070; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Romijn HJ, 1997, EUR J NEUROSCI, V9, P2613, DOI 10.1111/j.1460-9568.1997.tb01691.x; Ruby NF, 2008, P NATL ACAD SCI USA, V105, P15593, DOI 10.1073/pnas.0808259105; Ruoff P, 2005, J THEOR BIOL, V237, P41, DOI 10.1016/j.jtbi.2005.03.030; Ruoff P, 2001, J THEOR BIOL, V209, P29, DOI 10.1006/jtbi.2000.2239; Schmutz I, 2010, GENE DEV, V24, P345, DOI 10.1101/gad.564110; Schroder S, 2012, J BIOL RHYTHM, V27, P79, DOI 10.1177/0748730411429659; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; SHINOHARA K, 1993, J NEUROSCI, V13, P793; Steinlechner S, 2002, J BIOL RHYTHM, V17, P202, DOI 10.1177/07430402017003003; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; TOMINAGA K, 1992, NEUROREPORT, V3, P809, DOI 10.1097/00001756-199209000-00022; VANDENPOL AN, 1980, J COMP NEUROL, V191, P661, DOI 10.1002/cne.901910410; Yan L, 2005, J NEUROSCI, V25, P9017, DOI 10.1523/JNEUROSCI.2538-05.2005; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4	65	6	6	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177197	10.1371/journal.pone.0177197	http://dx.doi.org/10.1371/journal.pone.0177197			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486525	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314000056
J	Fan, YY; Jonas, JB; Wang, YX; Chen, CX; Wei, WB				Fan, Yuan Yuan; Jonas, Jost B.; Wang, Ya Xing; Chen, Chang Xi; Wei, Wen Bin			Horizontal and vertical optic disc rotation. The Beijing Eye Study	PLOS ONE			English	Article							PARAPAPILLARY GAMMA ZONE; COHERENCE TOMOGRAPHY; INTRACHOROIDAL CAVITATION; PATHOLOGICAL MYOPIA; NERVE; THICKNESS; TILT; PREVALENCE; GLAUCOMA; FUNDUS	Purpose To measure the optic disc rotation around the vertical and horizontal disc axis and to evaluate associations with general and ocular parameters. Design Population-based study Methods In the Beijing Eye Study, 3468 participants (mean age: 64.6 +/- 9.8 years; range: 50-93 years) underwent an ophthalmological examination which included spectral-domain optical coherence tomography (OCT) with enhanced depth imaging. Using the OCT images, we determined the amount of the rotation of the optic disc (defined as Bruch's membrane opening (BMO)) around the vertical axis and horizontal axis. Results Optic disc rotation measurements were available for 3037 (87.6%) individuals. In multivariate analysis, larger optic disc rotation around the vertical axis (range:-4.90(omicron) to 41.0(omicron)) was associated (regression coefficient r:0.27) with high axial myopia (axial length >= 26.5 mm) (P<0.001;standardized regression coefficient beta beta:0.09), longer disc-fovea distance (P = 0.001;beta: 0.09) and wider parapapillary beta/gamma zone (P<0.001;beta0.12). Larger optic disc rotation around the horizontal axis (range:-7.10(omicron) to 26.4(omicron)) was associated (r:0.32) with high axial myopia (P = 0.001;beta:0.08), larger optic disc-fovea angle (P<0.001; beta:0.13), thinner superior nasal retinal nerve fiber layer (RNFL) thickness (P<0.001;beta:0.19) and thicker inferior nasal RNFL thickness (P<0.001;beta:0.17). Conclusions Vertical optic disc rotation was associated with highly myopic axial elongation, increased disc-fovea distance and development or enlargement of parapapillary, Bruch's membrane free, gamma zone, while macular Bruch's membrane length is not affected. Horizontal optic disc rotation was associated with inferior dislocation of the fovea, in addition to a thinner superior nasal RNFL and thicker inferior nasal RNFL. The latter association may be taken into account in the interpretation of RNFL thickness profiles.	[Fan, Yuan Yuan; Wei, Wen Bin] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing, Peoples R China; [Fan, Yuan Yuan; Wei, Wen Bin] Beijing Ophthalmol & Visual Sci Key Lab, Beijing Key Lab Intraocular Tumor Diag & Treatmen, Beijing, Peoples R China; [Jonas, Jost B.; Wang, Ya Xing; Chen, Chang Xi] Capital Med Univ, Beijing Tongren Hosp, Beijing Key Lab Ophthalmol & Visual Sci, Beijing Inst Ophthalmol,Beijing Tongren Eye Ctr, Beijing, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany	Capital Medical University; Capital Medical University; Ruprecht Karls University Heidelberg	Wei, WB (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing, Peoples R China.; Wei, WB (corresponding author), Beijing Ophthalmol & Visual Sci Key Lab, Beijing Key Lab Intraocular Tumor Diag & Treatmen, Beijing, Peoples R China.	tr_weiwenbin@163.com	wang, YA XING/K-9671-2016; wei, wei/HHR-8613-2022	wang, YA XING/0000-0003-2749-7793; Jonas, Jost/0000-0003-2972-5227; Fan, yuanyuan/0000-0002-4620-0484	State Natural Sciences Fund [81041018]; Natural Sciences Fund of Beijing government [7092021, 7112031]	State Natural Sciences Fund(National Natural Science Foundation of China (NSFC)); Natural Sciences Fund of Beijing government	This study was supported by State Natural Sciences Fund (81041018) and the Natural Sciences Fund of Beijing government (7092021; 7112031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNETT AG, 1994, GRAEF ARCH CLIN EXP, V232, P361, DOI 10.1007/BF00175988; Choi JA, 2014, INVEST OPHTH VIS SCI, V55, P4991, DOI 10.1167/iovs.14-14663; Dai Y, 2015, INVEST OPHTH VIS SCI, V56, P7076, DOI 10.1167/iovs.14-16033; Dai Y, 2015, RETINA-J RET VIT DIS, V35, P655, DOI 10.1097/IAE.0000000000000358; Demer JL, 2016, INVEST OPHTH VIS SCI, V57, P1826, DOI 10.1167/iovs.15-18718; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hosseini H, 2013, AM J OPHTHALMOL, V156, P737, DOI 10.1016/j.ajo.2013.05.036; Jonas J. B., 2017, RETINA; JONAS JB, 1991, INVEST OPHTH VIS SCI, V32, P2942; Jonas JB, 2000, PROG RETIN EYE RES, V19, P1, DOI 10.1016/S1350-9462(99)00002-6; Jonas JB, 1997, OPHTHALMOLOGY, V104, P1934, DOI 10.1016/S0161-6420(97)30004-9; JONAS JB, 1988, GRAEF ARCH CLIN EXP, V226, P531, DOI 10.1007/BF02169200; Jonas JB, 1997, AM J OPHTHALMOL, V124, P488, DOI 10.1016/S0002-9394(14)70864-5; Jonas JB, 2016, INVEST OPHTH VIS SCI, V57, P4373, DOI 10.1167/iovs.16-19885; Jonas JB, 2016, INVEST OPHTH VIS SCI, V57, P1791, DOI 10.1167/iovs.15-18529; Jonas JB, 2016, INVEST OPHTH VIS SCI, V57, P396, DOI 10.1167/iovs.15-18263; Jonas JB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136833; Jonas JB, 2014, ACTA OPHTHALMOL, V92, pE470, DOI 10.1111/aos.12372; Jonas JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047237; Jonas JB, 2011, AM J OPHTHALMOL, V152, P1021, DOI 10.1016/j.ajo.2011.05.006; Jonas RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141771; Jonas RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138701; Law SK, 2010, ARCH OPHTHALMOL-CHIC, V128, P141, DOI 10.1001/archophthalmol.2009.340; LITTMANN H, 1982, KLIN MONATSBL AUGENH, V180, P286, DOI 10.1055/s-2008-1055068; Nangia V, 2010, OPHTHALMOLOGY, V117, P693, DOI 10.1016/j.ophtha.2009.09.037; Ohno-Matsui K, 2012, AM J OPHTHALMOL, V154, P382, DOI 10.1016/j.ajo.2012.02.010; Ohno-Matsui K, 2011, INVEST OPHTH VIS SCI, V52, P9644, DOI 10.1167/iovs.11-8597; Park SC, 2012, OPHTHALMOLOGY, V119, P3, DOI 10.1016/j.ophtha.2011.07.012; Paunescu LA, 2004, INVEST OPHTH VIS SCI, V45, P1716, DOI 10.1167/iovs.03-0514; QUIGLEY HA, 1990, ARCH OPHTHALMOL-CHIC, V108, P51, DOI 10.1001/archopht.1990.01070030057028; Reis ASC, 2012, OPHTHALMOLOGY, V119, P738, DOI 10.1016/j.ophtha.2011.09.054; Reis F., 2015, J GLAUCOMA, V24, P45; Takasaki H, 2013, JPN J OPHTHALMOL, V57, P34, DOI 10.1007/s10384-012-0193-9; Tay E, 2005, AM J OPHTHALMOL, V139, P247, DOI 10.1016/j.ajo.2004.08.076; Vongphanit J, 2002, AM J OPHTHALMOL, V133, P679, DOI 10.1016/S0002-9394(02)01339-9; Wang XF, 2016, INVEST OPHTH VIS SCI, V57, P5825, DOI 10.1167/iovs.16-20560; Wang XF, 2016, INVEST OPHTH VIS SCI, V57, P2452, DOI 10.1167/iovs.15-18986; Wang YZ, 2011, P IEEE INT FREQ CONT, P428; Wei WB, 2013, OPHTHALMOLOGY, V120, P175, DOI 10.1016/j.ophtha.2012.07.048; Wojtkowski M, 2005, OPHTHALMOLOGY, V112, P1734, DOI 10.1016/j.ophtha.2005.05.023; Xu L, 2006, OPHTHALMOLOGY, V113, P747, DOI 10.1016/j.ophtha.2006.01.026; Yan YN, 2015, OPHTHALMOLOGY, V122, P1873, DOI 10.1016/j.ophtha.2015.05.031; Yokoyama Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099138	43	20	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0175749	10.1371/journal.pone.0175749	http://dx.doi.org/10.1371/journal.pone.0175749			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481929	Green Published, gold, Green Submitted			2022-12-26	WOS:000401313700005
J	Wobst, HJ; Delsing, L; Brandon, NJ; Moss, SJ				Wobst, Heike J.; Delsing, Louise; Brandon, Nicholas J.; Moss, Stephen J.			Truncation of the TAR DNA-binding protein 43 is not a prerequisite for cytoplasmic relocalization, and is suppressed by caspase inhibition and by introduction of the A90V sequence variant	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; NUCLEAR FACTOR TDP-43; IN-VITRO; SIGNATURE PROTEIN; RNA TARGETS; CELL-DEATH; MUTATIONS; APOPTOSIS; CLEAVAGE	The RNA-binding and -processing protein TAR DNA-binding protein 43 (TDP-43) is heavily linked to the underlying causes and pathology of neurodegenerative diseases such as amyotrophic lateral sclerosis and frontotemporal lobar degeneration. In these diseases, TDP-43 is mislocalized, hyperphosphorylated, ubiquitinated, aggregated and cleaved. The importance of TDP-43 cleavage in the disease pathogenesis is still poorly understood. Here we detail the use of D-sorbitol as an exogenous stressor that causes TDP-43 cleavage in HeLa cells, resulting in a 35 kDa truncated product that accumulates in the cytoplasm within one hour of treatment. We confirm that the formation of this 35 kDa cleavage product is mediated by the activation of caspases. Inhibition of caspases blocks the cleavage of TDP-43, but does not prevent the accumulation of full-length protein in the cytoplasm. Using D-sorbitol as a stressor and caspase activator, we also demonstrate that the A90V variant of TDP-43, which lies adjacent to the caspase cleavage site within the nuclear localization sequence of TDP-43, confers partial resistance against caspase-mediated generation of the 35 kDa cleavage product.	[Wobst, Heike J.; Delsing, Louise; Brandon, Nicholas J.; Moss, Stephen J.] Tufts Univ, AstraZenecaTufts Lab Basic & Translat Neurosci, Boston, MA 02111 USA; [Delsing, Louise] AstraZeneca, Discovery Sci, Innovat Med & Early Dev Biotech Unit, Molndal, Sweden; [Brandon, Nicholas J.] AstraZeneca, Neurosci, Innovat Med & Early Dev, Waltham, MA USA; [Moss, Stephen J.] Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA	Tufts University; AstraZeneca; AstraZeneca; Tufts University	Moss, SJ (corresponding author), Tufts Univ, AstraZenecaTufts Lab Basic & Translat Neurosci, Boston, MA 02111 USA.; Moss, SJ (corresponding author), Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA.	Stephen.Moss@Tufts.edu	Wobst, Heike/AAA-8276-2020	Delsing, Louise/0000-0003-2899-3801; Brandon, Nicholas/0000-0002-3917-0096	AstraZeneca; National Institutes of Health (NIH)-National Institute of Neurological Disorders and Stroke [NS051195, NS056359, NS081735, R21NS080064, NS087662]; NIH-National Institute of Mental Health [MH097446, MH106954]; DOD [AR140209]	AstraZeneca(AstraZeneca); National Institutes of Health (NIH)-National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH-National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); DOD(United States Department of Defense)	This work was supported by funding from AstraZeneca, National Institutes of Health (NIH)-National Institute of Neurological Disorders and Stroke Grants NS051195, NS056359, NS081735, R21NS080064 and NS087662 (SJM) and NIH-National Institute of Mental Health Grants MH097446, MH106954 and DOD, AR140209 (SJM). AstraZeneca provided support in the form of salaries [NJB, LD]. The specific roles of authors NJB and LD are articulated in the 'author contributions' section.	Abhyankar MM, 2007, J BIOL CHEM, V282, P36143, DOI 10.1074/jbc.M705811200; Acharya KK, 2006, DEV BIOL, V295, P781, DOI 10.1016/j.ydbio.2006.04.443; Alami NH, 2014, NEURON, V81, P536, DOI 10.1016/j.neuron.2013.12.018; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Ariotti N, 2015, DEV CELL, V35, P513, DOI 10.1016/j.devcel.2015.10.016; Ayala YM, 2008, P NATL ACAD SCI USA, V105, P3785, DOI 10.1073/pnas.0800546105; Buendia B, 1999, J CELL SCI, V112, P1743; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Buratti E, 2010, FEBS J, V277, P2268, DOI 10.1111/j.1742-4658.2010.07643.x; Cairns NJ, 2007, AM J PATHOL, V171, P227, DOI 10.2353/ajpath.2007.070182; Chang HY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3757; Chiang CH, 2016, SCI REP-UK, V6, DOI 10.1038/srep21581; Chiang HH, 2012, J HUM GENET, V57, P316, DOI 10.1038/jhg.2012.24; Cohen TJ, 2012, EMBO J, V31, P1241, DOI 10.1038/emboj.2011.471; Colombrita C, 2009, J NEUROCHEM, V111, P1051, DOI 10.1111/j.1471-4159.2009.06383.x; Cushman M, 2010, J CELL SCI, V123, P1191, DOI 10.1242/jcs.051672; D'Alton S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086513; Dewey CM, 2011, MOL CELL BIOL, V31, P1098, DOI 10.1128/MCB.01279-10; Dormann D, 2009, J NEUROCHEM, V110, P1082, DOI 10.1111/j.1471-4159.2009.06211.x; Faleiro L, 2000, J CELL BIOL, V151, P951, DOI 10.1083/jcb.151.5.951; Ferrando-May E, 2001, CELL DEATH DIFFER, V8, P495, DOI 10.1038/sj.cdd.4400837; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; Ghibelli L, 1999, FASEB J, V13, P2031, DOI 10.1096/fasebj.13.14.2031; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Huang CC, 2014, J CELL SCI, V127, P3024, DOI 10.1242/jcs.136150; Igaz LM, 2009, J BIOL CHEM, V284, P8516, DOI 10.1074/jbc.M809462200; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Ilzecka J, 2012, NEUROL SCI, V33, P825, DOI 10.1007/s10072-011-0837-4; Inoue H, 2003, EMBO J, V22, P6665, DOI 10.1093/emboj/cdg634; Ishiguro A, 2016, GENES CELLS, V21, P466, DOI 10.1111/gtc.12352; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kawahara Y, 2012, P NATL ACAD SCI USA, V109, P3347, DOI 10.1073/pnas.1112427109; Kelley JB, 2007, MOL BIOL CELL, V18, P4365, DOI 10.1091/mbc.E07-01-0089; Kodiha M, 2004, CELL DEATH DIFFER, V11, P862, DOI 10.1038/sj.cdd.4401432; Kramer A, 2010, NANOMED-NANOTECHNOL, V6, P605, DOI 10.1016/j.nano.2010.04.006; Li Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7183; Liu-Yesucevitz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013250; Lowe AR, 2015, ELIFE, V4, DOI 10.7554/eLife.04052; Mackenzie IRA, 2007, ANN NEUROL, V61, P427, DOI 10.1002/ana.21147; Martin LJ, 1999, J NEUROPATH EXP NEUR, V58, P459, DOI 10.1097/00005072-199905000-00005; McDonald KK, 2011, HUM MOL GENET, V20, P1400, DOI 10.1093/hmg/ddr021; Narayanan RK, 2013, AMYOTROPH LAT SCL FR, V14, P252, DOI 10.3109/21678421.2012.734520; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nishimoto Y, 2010, J BIOL CHEM, V285, P608, DOI 10.1074/jbc.M109.022012; Nonaka T, 2009, HUM MOL GENET, V18, P3353, DOI 10.1093/hmg/ddp275; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Rutherford NJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000193; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sephton CF, 2011, J BIOL CHEM, V286, P1204, DOI 10.1074/jbc.M110.190884; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Strasser C, 2012, NUCLEUS-PHILA, V3, P540, DOI 10.4161/nucl.21982; Strong MJ, 2007, MOL CELL NEUROSCI, V35, P320, DOI 10.1016/j.mcn.2007.03.007; Su JH, 2000, EXP NEUROL, V163, P9, DOI 10.1006/exnr.2000.7340; Suzuki H, 2011, J BIOL CHEM, V286, P13171, DOI 10.1074/jbc.M110.197483; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Wang IF, 2008, J NEUROCHEM, V105, P797, DOI 10.1111/j.1471-4159.2007.05190.x; Winton MJ, 2008, FEBS LETT, V582, P2252, DOI 10.1016/j.febslet.2008.05.024; Wobst HJ, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00046; Wobst HJ, 2017, FRONTIERS IN MOLECUL, V10; Xiao SX, 2015, ACTA NEUROPATHOL, V130, P49, DOI 10.1007/s00401-015-1412-5; Yang Y, 2004, INT J BIOCHEM CELL B, V36, P223, DOI 10.1016/S1357-2725(03)00215-2; Yang ZH, 2014, J CEREBR BLOOD F MET, V34, P1444, DOI 10.1038/jcbfm.2014.105; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106	66	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177181	10.1371/journal.pone.0177181	http://dx.doi.org/10.1371/journal.pone.0177181			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28510586	Green Published, gold, Green Submitted			2022-12-26	WOS:000401485500016
J	Mondejar, R; Perez, C; Onaindia, A; Martinez, N; Gonzalez-Rincon, J; Pisonero, H; Vague, JP; Cereceda, L; Santibanez, M; Sanchez-Beato, M; Piris, MA				Mondejar, Rufino; Perez, Cristina; Onaindia, Arantza; Martinez, Nerea; Gonzalez-Rincon, Julia; Pisonero, Helena; Vague, Jose Pedro; Cereceda, Laura; Santibanez, Miguel; Sanchez-Beato, Margarita; Piris, Miguel Angel			Molecular basis of targeted therapy in T/NK-cell lymphoma/leukemia: A comprehensive genomic and immunohistochemical analysis of a panel of 33 cell lines	PLOS ONE			English	Article							PERIPHERAL T-CELL; ACTIVATING MUTATIONS; RECURRENT MUTATIONS; UP-REGULATION; LYMPHOMA; BORTEZOMIB; LANDSCAPE; EXPRESSION; PROGNOSIS; SURVIVAL	T and NK-cell lymphoma is a collection of aggressive disorders with unfavorable outcome, in which targeted treatments are still at a preliminary phase. To gain deeper insights into the deregulated mechanisms promoting this disease, we searched a panel of 31 representative T-cell and 2 NK-cell lymphoma/leukemia cell lines for predictive markers of response to targeted therapy. To this end, targeted sequencing was performed alongside the expression of specific biomarkers corresponding to potentially activated survival pathways. The study identified TP53, NOTCH1 and DNMT3A as the most frequently mutated genes. We also found common alterations in JAK/STAT and epigenetic pathways. Immunohistochemical analysis showed nuclear accumulation of MYC (in 85% of the cases), NFKB (62%), p-STAT (44%) and p-MAPK (30%). This panel of cell lines captures the complexity of T/NK-cell lymphoproliferative processes samples, with the partial exception of AITL cases. Integrated mutational and immunohistochemical analysis shows that mutational changes cannot fully explain the activation of key survival pathways and the resulting phenotypes. The combined integration of mutational/expression changes forms a useful tool with which new compounds may be assayed.	[Mondejar, Rufino; Perez, Cristina; Martinez, Nerea; Pisonero, Helena; Vague, Jose Pedro; Cereceda, Laura; Piris, Miguel Angel] IDIVAL, Inst Invest Marques de Valdecilla, Canc Genom Lab, Santander, Spain; [Onaindia, Arantza; Piris, Miguel Angel] Hosp Univ Marques de Valdecilla, Pathol Dept, Santander, Spain; [Gonzalez-Rincon, Julia; Sanchez-Beato, Margarita] Inst Invest Sanitaria Puerta Hierro Majadahonda I, Oncohematol Area, Med Oncol Serv, Lymphoma Res Grp, Madrid, Spain; [Vague, Jose Pedro] Univ Cantabria, Dept Biol Mol, CSIC, IBBTEC,Inst Biomed & Biotecnol Cantabria, Santander, Spain; [Santibanez, Miguel] Univ Cantabria, IDIVAL, Santander, Spain; [Piris, Miguel Angel] Fdn Jimenez Diaz, Pathol Serv, Madrid, Spain	Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario Marques de Valdecilla (HUMV); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); Universidad de Cantabria	Piris, MA (corresponding author), IDIVAL, Inst Invest Marques de Valdecilla, Canc Genom Lab, Santander, Spain.; Piris, MA (corresponding author), Hosp Univ Marques de Valdecilla, Pathol Dept, Santander, Spain.; Piris, MA (corresponding author), Fdn Jimenez Diaz, Pathol Serv, Madrid, Spain.	miguel.piris@quironsalud.es	Sanchez-Beato, Margarita/G-8753-2012; Piris, Miguel A/AAP-1445-2020; Vaqué, José P/H-8413-2015; Magunacelaya, Nerea Martinez/M-5040-2016; Gonzalez-Rincon, Julia/ABE-6664-2021; Santibanez, Miguel/L-3323-2017; CERECEDA, LAURA/K-2608-2017	Sanchez-Beato, Margarita/0000-0002-0058-7599; Piris, Miguel A/0000-0001-5839-3634; Vaqué, José P/0000-0002-3913-2495; Magunacelaya, Nerea Martinez/0000-0002-3983-0867; Santibanez, Miguel/0000-0003-2634-615X; CERECEDA, LAURA/0000-0002-0106-1898; Mondejar, Rufino/0000-0001-6641-2073	Instituto de Salud Carlos III (ISCIII) of the Spanish Ministry of Economy and Competence (MINECO, RTICC ISCIII and CIBER CANCER) [SAF2013-47416-R, RD06/0020/0107- RD012/0036/0060, PI16/ 01294, PIE15/0081]; SCIII-MINECO-AES-FEDER [PI14/00221]; Asociacion Espanola Contra el Cancer (AECC); ISCIII [CD13/00088]; Rio Hortega specialised healthcare post-training contract (ISCIII) [CM15/00186]; ISCIII-MINECO-AES-FEDER [IFI14/00003]; Miguel Servet contract from the ISCIII-MINECO-AES-FEDER [CP11/00018]; Miguel Servet II contract [CPII16/00024]; ISCIII-MINECO-AES-FEDER; Fundacion de Investigacion Biomedica Puerta de Hierro; Ramon y Cajal research program [RYC-2013-14097]	Instituto de Salud Carlos III (ISCIII) of the Spanish Ministry of Economy and Competence (MINECO, RTICC ISCIII and CIBER CANCER); SCIII-MINECO-AES-FEDER; Asociacion Espanola Contra el Cancer (AECC); ISCIII(Instituto de Salud Carlos III); Rio Hortega specialised healthcare post-training contract (ISCIII); ISCIII-MINECO-AES-FEDER; Miguel Servet contract from the ISCIII-MINECO-AES-FEDER; Miguel Servet II contract; ISCIII-MINECO-AES-FEDER; Fundacion de Investigacion Biomedica Puerta de Hierro; Ramon y Cajal research program(Spanish Government)	This work was supported by grants from the Instituto de Salud Carlos III (ISCIII) of the Spanish Ministry of Economy and Competence (MINECO, RTICC ISCIII and CIBER CANCER) to MAP (SAF2013-47416-R, RD06/0020/0107- RD012/0036/0060 and Plan Nacional I+D+I: PI16/ 01294 and PIE15/0081) and from ISCIII-MINECO-AES-FEDER to MSB (Plan Estatal I+D+I 2013-2016: PI14/00221), and the Asociacion Espanola Contra el Cancer (AECC to MAP). CP is a recipient of a Sara Borrel postdoctoral contract from ISCIII (CD13/00088). RM is a recipient of a Rio Hortega specialised healthcare post-training contract (ISCIII, CM15/00186). JG-R is a recipient of an iPFIS predoctoral fellowship (IFI14/00003) from ISCIII-MINECO-AES-FEDER (Plan Estatal I+D+I 2013-2016). MSB was supported by a Miguel Servet contract (CP11/00018) from the ISCIII-MINECO-AES-FEDER (Plan Nacional I+D+I 2008-2011), and currently holds a Miguel Servet II contract (CPII16/00024), supported by ISCIII-MINECO-AES-FEDER (Plan Estatal I+D+I 2013-2016) and Fundacion de Investigacion Biomedica Puerta de Hierro. JPV was supported by a Ramon y Cajal research program (RYC-2013-14097). http://www.rticc.org/, http://www.isciii.es/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abdel-Wahab O, 2009, BLOOD, V114, P144, DOI 10.1182/blood-2009-03-210039; Abouyabis AN, 2011, ISRN HEMATOL, V2011, P623924; Aref S, 2016, CL LYMPH MYELOM LEUK, V16, P43, DOI 10.1016/j.clml.2015.11.003; Atak ZK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038463; Bacher U, 2010, ANN HEMATOL, V89, P643, DOI 10.1007/s00277-010-0920-6; BENE MC, 1995, LEUKEMIA, V9, P1783; Bouchekioua A, 2014, LEUKEMIA, V28, P338, DOI 10.1038/leu.2013.157; Chang TP, 2015, J IMMUNOL, V194, P2942, DOI 10.4049/jimmunol.1402610; Choi J, 2015, NAT GENET, V47, P1011, DOI 10.1038/ng.3356; Cillessen SAGM, 2015, HAEMATOLOGICA, V100, pE365, DOI 10.3324/haematol.2014.118828; Cimmino L, 2011, CELL STEM CELL, V9, P193, DOI 10.1016/j.stem.2011.08.007; d'Amore F, 2015, ANN ONCOL, V26, pV108, DOI 10.1093/annonc/mdv201; Almeida ACD, 2015, NAT GENET, V47, P1465, DOI 10.1038/ng.3442; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Herranz D, 2015, NAT MED, V21, P1182, DOI 10.1038/nm.3955; Hsu FD, 2002, MODERN PATHOL, V15, P1374, DOI 10.1097/01.MP.0000039571.02827.CE; Ishitsuka K, 2015, CANCER SCI, V106, P1219, DOI 10.1111/cas.12735; Jiang L, 2015, NAT GENET, V47, P1061, DOI 10.1038/ng.3358; Kataoka K, 2015, NAT GENET, V47, P1304, DOI 10.1038/ng.3415; Kiel MJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9470; Koss H, 2014, TRENDS BIOCHEM SCI, V39, P603, DOI 10.1016/j.tibs.2014.09.004; Lesokhin AM, 2016, J CLIN ONCOL, V34, P2698, DOI 10.1200/JCO.2015.65.9789; Lindahl LM, 2016, ONCOTARGET, V7, P45730, DOI 10.18632/oncotarget.10160; Losdyck E, 2015, J BIOL CHEM, V290, P29022, DOI 10.1074/jbc.M115.670224; Munoz J, 2014, ONCOLOGIST, V19, P536, DOI 10.1634/theoncologist.2013-0407; Nakagawa M, 2014, J EXP MED, V211, P2497, DOI 10.1084/jem.20140987; Odejide O, 2014, BLOOD, V123, P1293, DOI 10.1182/blood-2013-10-531509; Odqvist L, 2013, CLIN CANCER RES, V19, P2319, DOI 10.1158/1078-0432.CCR-12-3151; Palomero T, 2014, NAT GENET, V46, P166, DOI 10.1038/ng.2873; Perez C, 2015, HAEMATOLOGICA, V100, pE450, DOI 10.3324/haematol.2015.132837; Pro B, 2012, J CLIN ONCOL, V30, P2190, DOI 10.1200/JCO.2011.38.0402; Quivoron C, 2011, CANCER CELL, V20, P25, DOI 10.1016/j.ccr.2011.06.003; Rohr J, 2016, LEUKEMIA, V30, P1062, DOI 10.1038/leu.2015.357; Rubio-Camarillo M, 2013, BIOINFORMATICS, V29, P1687, DOI 10.1093/bioinformatics/btt203; Sakamoto H, 2011, CANCER CELL, V19, P679, DOI 10.1016/j.ccr.2011.04.004; Sakata-Yanagimoto M, 2014, NAT GENET, V46, P171, DOI 10.1038/ng.2872; Schmitz N, 2010, BLOOD, V116, P3418, DOI 10.1182/blood-2010-02-270785; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Talamillo A, 2017, ONCOGENE, V36, P1733, DOI 10.1038/onc.2016.341; Ungewickell A, 2015, NAT GENET, V47, P1056, DOI 10.1038/ng.3370; Vallois D, 2016, BLOOD, V128, P1490, DOI 10.1182/blood-2016-02-698977; van der Wijst MGP, 2015, EPIGENETICS-US, V10, P671, DOI 10.1080/15592294.2015.1062204; Vaque JP, 2014, BLOOD, V123, P2034, DOI 10.1182/blood-2013-05-504308; Vicente C, 2015, HAEMATOLOGICA, V100, P1301, DOI 10.3324/haematol.2015.130179; Vose JM, 2008, J CLIN ONCOL, V26, P4124, DOI 10.1200/JCO.2008.16.4558; Wang C, 2015, BLOOD, V126, P1741, DOI 10.1182/blood-2015-05-644591; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Willemze R, 2013, ANN ONCOL, V24, P149, DOI 10.1093/annonc/mdt242; Yoshida N, 2016, J PATHOL, V238, P621, DOI 10.1002/path.4699; Yuan XQ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003519	50	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177524	10.1371/journal.pone.0177524	http://dx.doi.org/10.1371/journal.pone.0177524			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505169	Green Published, gold			2022-12-26	WOS:000401473500028
J	Sradhanjali, S; Tripathy, D; Rath, S; Mittal, R; Reddy, MM				Sradhanjali, Swatishree; Tripathy, Devjyoti; Rath, Suryasnata; Mittal, Ruchi; Reddy, Mamatha M.			Overexpression of pyruvate dehydrogenase kinase 1 in retinoblastoma: A potential therapeutic opportunity for targeting vitreous seeds and hypoxic regions	PLOS ONE			English	Article							DICHLOROACETATE INDUCES APOPTOSIS; CANCER-CELLS; DRUG-RESISTANCE; COLORECTAL-CANCER; METABOLIC SWITCH; GENE-EXPRESSION; MYCN PROTEIN; IN-VITRO; GROWTH; NEUROBLASTOMA	Pyruvate dehydrogenase kinase 1 (PDK1), a key enzyme implicated in metabolic reprogramming of tumors, is induced in several tumors including glioblastoma, breast cancer and melanoma. However, the role played by PDK1 is not studied in retinoblastoma (RB). In this study, we have evaluated the expression of PDK1 in RB clinical samples, and studied its inhibition as a strategy to decrease cell growth and migration. We show that PDK1 is specifically overexpressed in RB patient samples especially in vitreous seeds and hypoxic regions and cell lines compared to control retina using immunohistochemistry and real-time PCR. Our results further demonstrate that inhibition of PDK1 using small molecule inhibitors dichloroacetic acid (DCA) and dichloroacetophenone (DAP) resulted in reduced cell growth and increased apoptosis. We also confirm that combination treatment of DCA with chemotherapeutic agent carboplatin further enhanced the therapeutic efficacy compared to single drug treatment. In addition, we observed changes in glucose uptake, lactate and reactive oxygen species (ROS) levels as well as decreased cell migration in response to PDK1 inhibition. Additionally, we show that DCA treatment led to inhibition of PI3K/Akt pathway and reduction in PDK1 protein levels. Overall, our data suggest that targeting PDK1 could be a novel therapeutic strategy for RB.	[Sradhanjali, Swatishree; Tripathy, Devjyoti; Rath, Suryasnata; Mittal, Ruchi; Reddy, Mamatha M.] LV Prasad Eye Inst, Operat Eyesight Universal Inst Eye Canc, Bhubaneswar, Orissa, India; [Sradhanjali, Swatishree; Reddy, Mamatha M.] KIIT Univ, Sch Biotechnol, Bhubaneswar, Orissa, India; [Tripathy, Devjyoti; Rath, Suryasnata] LV Prasad Eye Inst, Ophthalm Plast Orbit & Ocular Oncol Serv, Bhubaneswar, Orissa, India; [Mittal, Ruchi] LV Prasad Eye Inst, Dalmia Ophthalm Pathol Serv, Bhubaneswar, Orissa, India	L. V. Prasad Eye Institute; Kalinga Institute of Industrial Technology (KIIT); L. V. Prasad Eye Institute; L. V. Prasad Eye Institute	Reddy, MM (corresponding author), LV Prasad Eye Inst, Operat Eyesight Universal Inst Eye Canc, Bhubaneswar, Orissa, India.; Reddy, MM (corresponding author), KIIT Univ, Sch Biotechnol, Bhubaneswar, Orissa, India.	mamathamuppidi@gmail.com			Department of Biotechnology, Government of India [BT/Bio-CARe/07/9859/2013-14]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	Support was provided by Department of Biotechnology, Government of India, BT/Bio-CARe/07/9859/2013-14 for MR.	Bhanot H, 2015, LEUKEMIA, V29, P1555, DOI 10.1038/leu.2015.46; Boutrid H, 2008, INVEST OPHTH VIS SCI, V49, P2799, DOI 10.1167/iovs.08-1751; Camassei FD, 2003, INVEST OPHTH VIS SCI, V44, P2399, DOI 10.1167/iovs.02-0934; Cao WG, 2008, PROSTATE, V68, P1223, DOI 10.1002/pros.20788; Chakraborty S, 2007, GENOMICS, V90, P344, DOI 10.1016/j.ygeno.2007.05.002; Chesler L, 2006, CANCER RES, V66, P8139, DOI 10.1158/0008-5472.CAN-05-2769; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Chu QSC, 2015, INVEST NEW DRUG, V33, P603, DOI 10.1007/s10637-015-0221-y; Clem BF, 2012, CLIN CANCER RES, V18, P6096, DOI 10.1158/1078-0432.CCR-11-3164; Dimaras H, 2008, HUM MOL GENET, V17, P1363, DOI 10.1093/hmg/ddn024; Dimaras H, 2012, LANCET, V379, P1436, DOI 10.1016/S0140-6736(11)61137-9; DOU QP, 1992, P NATL ACAD SCI USA, V89, P3256, DOI 10.1073/pnas.89.8.3256; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Fry CJ, 1999, J BIOL CHEM, V274, P15883, DOI 10.1074/jbc.274.22.15883; Ganguly A, 2010, MOL VIS, V16, P1292; Gong F, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.438; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Houston SK, 2011, CLIN OPHTHALMOL, V5, P129, DOI 10.2147/OPTH.S15179; Jha Mithilesh Kumar, 2013, Brain Tumor Res Treat, V1, P57, DOI 10.14791/btrt.2013.1.2.57; Johnsen JI, 2008, ONCOGENE, V27, P2910, DOI 10.1038/sj.onc.1210938; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Lu CW, 2008, J BIOL CHEM, V283, P28106, DOI 10.1074/jbc.M803508200; Lu CW, 2011, AM J PATHOL, V179, P1405, DOI 10.1016/j.ajpath.2011.05.050; MacPherson D, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-9; Madhok BM, 2010, BRIT J CANCER, V102, P1746, DOI 10.1038/sj.bjc.6605701; Manjandavida FP, 2015, INDIAN J OPHTHALMOL, V63, P141, DOI 10.4103/0301-4738.154390; McFate T, 2008, J BIOL CHEM, V283, P22700, DOI 10.1074/jbc.M801765200; Michelakis ED, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000677; Olszewski U, 2010, CLIN PHARMACOL-ADV A, V2, P177, DOI 10.2147/CPAA.S11795; Pina Y, 2010, INVEST OPHTH VIS SCI, V51, P6149, DOI 10.1167/iovs.09-5033; Populo H, 2015, EXPERT OPIN THER TAR, V19, P733, DOI 10.1517/14728222.2015.1045416; Qin LJ, 2016, ONCOTARGET, V7, P1395, DOI 10.18632/oncotarget.6366; Reddy MM, 2012, LEUKEMIA, V26, P481, DOI 10.1038/leu.2011.225; Reddy MM, 2011, LEUKEMIA, V25, P281, DOI 10.1038/leu.2010.263; Rushlow DE, 2013, LANCET ONCOL, V14, P327, DOI 10.1016/S1470-2045(13)70045-7; Subramanian N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070422; Sudhakar J, 2013, PEDIATR BLOOD CANCER, V60, P1598, DOI 10.1002/pbc.24599; Sutendra G, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00038; Wigfield SM, 2008, BRIT J CANCER, V98, P1975, DOI 10.1038/sj.bjc.6604356; Wong JYY, 2008, GYNECOL ONCOL, V109, P394, DOI 10.1016/j.ygyno.2008.01.038; Xie Q, 2015, MOL MED REP, V11, P2935, DOI 10.3892/mmr.2014.3080; Zhang JH, 2012, NATURE, V481, P329, DOI 10.1038/nature10733; Zhang Y, 2016, J BIOL CHEM, V291, P17405, DOI 10.1074/jbc.M116.713735	43	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177744	10.1371/journal.pone.0177744	http://dx.doi.org/10.1371/journal.pone.0177744			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505181	gold, Green Published, Green Submitted			2022-12-26	WOS:000401473500039
J	Thirunavukkarasu, S; Plain, KM; Purdie, AC; Whittington, RJ; de Silva, K				Thirunavukkarasu, Shyamala; Plain, Karren M.; Purdie, Auriol C.; Whittington, Richard J.; de Silva, Kumudika			IFN-gamma fails to overcome inhibition of selected macrophage activation events in response to pathogenic mycobacteria	PLOS ONE			English	Article							AVIUM SUBSP PARATUBERCULOSIS; NECROSIS-FACTOR-ALPHA; INFLAMMATORY-BOWEL-DISEASE; TOLL-LIKE RECEPTORS; MHC CLASS-II; NITRIC-OXIDE; CROHNS-DISEASE; TNF-ALPHA; INTERFERON-GAMMA; BOVINE MONOCYTES	According to most models of mycobacterial infection, inhibition of the pro-inflammatory macrophage immune responses contributes to the persistence of bacteria. Mycobacterium avium subsp. paratuberculosis (MAP) is a highly successful pathogen in cattle and sheep and is also implicated as the causative agent of Crohn's disease in humans. Pathogenic mycobacteria such as MAP have developed multiple strategies to evade host defence mechanisms including interfering with the macrophages' capacity to respond to IFN-gamma, a feature which might be lacking in non-pathogenic mycobacteria such as M. smegmatis. We hypothesized that pre-sensitisation of macrophages with the pro-inflammatory cytokine IFN-gamma would help in overcoming the inhibitory effect of MAP or its antigens on macrophage inflammatory responses. Herein we have compared a series of macrophage activation parameters in response to MAP and M. smegmatis as well as mycobacterial antigens. While IFN-gamma did overcome the inhibition in immune suppressive mechanisms in response to MAP antigen as well as M. smegmatis, we could not find a clear role for IFN-gamma in overcoming the inhibition of macrophage inflammatory responses to the pathogenic mycobacterium, MAP. We demonstrate that suppression of macrophage defence mechanisms by pathogenic mycobacteria is unlikely to be overcome by prior sensitization with IFN-gamma alone. This indicates that IFN-gamma signaling pathway-independent mechanisms may exist for overcoming inhibition of macrophage effector functions in response to pathogenic mycobacteria. These findings have important implications in understanding the survival mechanisms of pathogenic mycobacteria directed towards finding better therapeutics and vaccination strategies.	[Thirunavukkarasu, Shyamala; Plain, Karren M.; Purdie, Auriol C.; Whittington, Richard J.; de Silva, Kumudika] Univ Sydney, Sch Vet Sci, Fac Sci, Sydney, NSW, Australia	University of Sydney	de Silva, K (corresponding author), Univ Sydney, Sch Vet Sci, Fac Sci, Sydney, NSW, Australia.	kumi.desilva@sydney.edu.au	Thirunavukkarasu, Shyamala/AAL-5979-2020	Thirunavukkarasu, Shyamala/0000-0001-9888-3304; Purdie, Auriol/0000-0003-1941-6658; de Silva, Kumudika/0000-0001-5973-5077; Plain, Karren/0000-0001-7126-9865				ADAMS JL, 1994, MICROB PATHOGENESIS, V16, P401, DOI 10.1006/mpat.1994.1040; Alzuherri HM, 1996, VET IMMUNOL IMMUNOP, V49, P331, DOI 10.1016/0165-2427(95)05477-4; Bannantine JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128966; Begg DJ, 2010, VET MICROBIOL, V141, P301, DOI 10.1016/j.vetmic.2009.09.007; Berghaus LJ, 2010, COMP IMMUNOL MICROB, V33, P443, DOI 10.1016/j.cimid.2009.07.001; Bhat KH, 2017, SCI REP-UK, V7, DOI 10.1038/srep39706; Bohsali A, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-237; Bosshard C, 2006, J FOOD PROTECT, V69, P1662, DOI 10.4315/0362-028X-69.7.1662; Caulfield AJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004252; CHIODINI RJ, 1986, J CLIN MICROBIOL, V24, P357, DOI 10.1128/JCM.24.3.357-363.1986; CHIODINI RJ, 1984, DIGEST DIS SCI, V29, P1073, DOI 10.1007/BF01317078; CHIODINI RJ, 1984, J CLIN MICROBIOL, V20, P966, DOI 10.1128/JCM.20.5.966-971.1984; Clancy R, 2007, DIGEST LIVER DIS, V39, P445, DOI 10.1016/j.dld.2006.12.006; Cosma CL, 2003, ANNU REV MICROBIOL, V57, P641, DOI 10.1146/annurev.micro.57.030502.091033; Davis AS, 2007, PLOS PATHOG, V3, P1887, DOI 10.1371/journal.ppat.0030186; de Silva K, 2011, VET IMMUNOL IMMUNOP, V139, P10, DOI 10.1016/j.vetimm.2010.07.022; Deretic V, 2009, CURR TOP MICROBIOL, V335, P169, DOI 10.1007/978-3-642-00302-8_8; Dhiman R, 2007, BBA-GEN SUBJECTS, V1770, P649, DOI 10.1016/j.bbagen.2006.11.016; Dow CT, 2011, MED HYPOTHESES, V77, P977, DOI 10.1016/j.mehy.2011.08.024; ENDO Y, 1991, IMMUNOL LETT, V27, P75, DOI 10.1016/0165-2478(91)90248-9; Fu YR, 2015, INT J BIOL SCI, V11, P22, DOI 10.7150/ijbs.10217; Gill CO, 2011, J FOOD PROTECT, V74, P480, DOI 10.4315/0362-028X.JFP-10-301; Gobert AP, 2001, P NATL ACAD SCI USA, V98, P13844, DOI 10.1073/pnas.241443798; Haque MF, 2015, INNATE IMMUN-LONDON, V21, P746, DOI 10.1177/1753425915594245; Hartley JW, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-1; Hasan Z, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-78; Held TK, 1999, INFECT IMMUN, V67, P206, DOI 10.1128/IAI.67.1.206-212.1999; Helguera-Repetto AC, 2014, BIOMED RES INT, V2014, P10; Herbst S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019105; Houben ENG, 2006, CURR OPIN MICROBIOL, V9, P76, DOI 10.1016/j.mib.2005.12.014; JURKOVICH GJ, 1991, J SURG RES, V51, P197, DOI 10.1016/0022-4804(91)90094-3; Kabara E, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00215; Katti MK, 2011, ARCH MED RES, V42, P199, DOI 10.1016/j.arcmed.2011.04.012; Kincaid EZ, 2007, J IMMUNOL, V179, P3187, DOI 10.4049/jimmunol.179.5.3187; Lafuse WP, 2006, J INTERF CYTOK RES, V26, P548, DOI 10.1089/jir.2006.26.548; Lee J, 2006, J IMMUNOL, V176, P4267, DOI 10.4049/jimmunol.176.7.4267; LORSBACH RB, 1993, J BIOL CHEM, V268, P1908; Madan-Lala R, 2011, INFECT IMMUN, V79, P4828, DOI 10.1128/IAI.05574-11; Means TK, 2001, J IMMUNOL, V166, P4074, DOI 10.4049/jimmunol.166.6.4074; Mustafa T, 2001, SCAND J IMMUNOL, V54, P630, DOI 10.1046/j.1365-3083.2001.01020.x; Naser SA, 2000, AM J GASTROENTEROL, V95, P1094, DOI 10.1111/j.1572-0241.2000.01954.x; Naser SA, 2014, WORLD J GASTROENTERO, V20, P7403, DOI 10.3748/wjg.v20.i23.7403; Newell KN, 2006, J IMMUNE BASED THER, V4, P476; Oddo M, 1998, J IMMUNOL, V160, P5448; Okura Hisako, 2011, Vet Med Int, V2011, P152687, DOI 10.4061/2011/152687; Pai RK, 2004, INFECT IMMUN, V72, P6603, DOI 10.1128/IAI.72.11.6603-6614.2004; Park E, 2000, INT J LEPROSY, V68, P444; Periasamy S, 2013, VET MICROBIOL, V165, P392, DOI 10.1016/j.vetmic.2013.03.030; Pine R, 1997, NUCLEIC ACIDS RES, V25, P4346, DOI 10.1093/nar/25.21.4346; Plain KM, 2010, VET IMMUNOL IMMUNOP, V137, P142, DOI 10.1016/j.vetimm.2010.04.002; Purdie AC, 2012, COMP IMMUNOL MICROB, V35, P151, DOI 10.1016/j.cimid.2011.12.007; RASCHKE WC, 1978, CELL, V15, P261, DOI 10.1016/0092-8674(78)90101-0; Roach SK, 2002, INFECT IMMUN, V70, P3040, DOI 10.1128/IAI.70.6.3040-3052.2002; Savi R, 2015, VET MICROBIOL, V177, P403, DOI 10.1016/j.vetmic.2015.03.013; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; SCHULLERLEVIS GB, 1994, INFECT IMMUN, V62, P4671, DOI 10.1128/IAI.62.10.4671-4674.1994; Sechi LA, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00096; Sendide K, 2005, J IMMUNOL, V175, P5324, DOI 10.4049/jimmunol.175.8.5324; Shu DR, 2011, CLIN VACCINE IMMUNOL, V18, P1467, DOI 10.1128/CVI.05201-11; Sibartie S, 2010, INFLAMM BOWEL DIS, V16, P296, DOI 10.1002/ibd.21052; Singh S. V., 2014, Journal of Biological Sciences, V14, P237; Singh SV, 2016, FRONT MED-LAUSANNE, V3, DOI 10.3389/fmed.2016.00049; Smeed Jennifer A, 2007, BMC Vet Res, V3, P18, DOI 10.1186/1746-6148-3-18; STABEL JR, 1995, VET IMMUNOL IMMUNOP, V45, P211, DOI 10.1016/0165-2427(94)05348-V; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Sweet MJ, 1998, J INTERF CYTOK RES, V18, P263, DOI 10.1089/jir.1998.18.263; Thirunavukkarasu S., 2014, CRIT REV MICROBIOL, P1; Thirunavukkarasu S, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftv085; Thirunavukkarasu S, 2013, VET IMMUNOL IMMUNOP, V156, P20, DOI 10.1016/j.vetimm.2013.08.008; Trajkovic V, 2002, INFECT IMMUN, V70, P6558, DOI 10.1128/IAI.70.12.6558-6566.2002; Vadiveloo PK, 2000, CYTOKINE, V12, P1639, DOI 10.1006/cyto.2000.0766; VANKRUININGEN HJ, 1986, DIGEST DIS SCI, V31, P1351, DOI 10.1007/BF01299814; Velmurugan K, 2007, PLOS PATHOG, V3, P972, DOI 10.1371/journal.ppat.0030110; Vila-del Sol V, 2008, J IMMUNOL, V181, P4461, DOI 10.4049/jimmunol.181.7.4461; WADEE AA, 1995, CLIN EXP IMMUNOL, V100, P434; Wang J, 2015, NAT IMMUNOL, V16, P237, DOI 10.1038/ni.3096; Weiss DJ, 2008, AM J VET RES, V69, P804, DOI 10.2460/ajvr.69.6.804; Weiss DJ, 2008, J LEUKOCYTE BIOL, V83, P48, DOI 10.1189/jlb.0707490; Whittington RJ, 2012, VET IMMUNOL IMMUNOP, V148, P29, DOI 10.1016/j.vetimm.2011.03.003; WILLIAMS JG, 1992, J LEUKOCYTE BIOL, V52, P579, DOI 10.1002/jlb.52.6.579; Woo SR, 2006, VET IMMUNOL IMMUNOP, V110, P109, DOI 10.1016/j.vetimm.2005.09.010	81	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0176400	10.1371/journal.pone.0176400	http://dx.doi.org/10.1371/journal.pone.0176400			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505170	Green Published, Green Submitted, gold			2022-12-26	WOS:000401473500007
J	Huipao, N; Borwornpinyo, S; Wiboon-ut, S; Campbell, CR; Lee, IH; Hiranyachattada, S; Sukasem, C; Thitithanyanont, A; Pholpramool, C; Cook, DI; Dinudom, A				Huipao, Nawiya; Borwornpinyo, Suparerk; Wiboon-ut, Suwimon; Campbell, Craig R.; Lee, Il-Ha; Hiranyachattada, Siriphun; Sukasem, Chonlaphat; Thitithanyanont, Arunee; Pholpramool, Chumpol; Cook, David I.; Dinudom, Anuwat			P2Y(6) receptors are involved in mediating the effect of inactivated avian influenza virus H5N1 on IL-6 & CXCL8 mRNA expression in respiratory epithelium	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; PROINFLAMMATORY CYTOKINES; INTERLEUKIN-8 PRODUCTION; CFTR EXPRESSION; CELLS; INFECTION; RESPONSES; RELEASE; HYPERINDUCTION; INFLAMMATION	One of the key pathophysiologies of H5N1 infection is excessive proinflammatory cytokine response (cytokine storm) characterized by increases in IFN-beta, TNF-alpha, IL-6, CXCL10, CCL4, CCL2 and CCL5 in the respiratory tract. H5N1-induced cytokine release can occur via an infection-independent mechanism, however, detail of the cellular signaling involved is poorly understood. To elucidate this mechanism, the effect of inactivated (beta-propiolactonetreated) H5N1 on the cytokine and chemokine mRNA expression in 16HBE14o-human respiratory epithelial cells was investigated. We found that the inactivated-H5N1 increased mRNA for IL-6 and CXCL8 but not TNF-alpha, CCL5 or CXCL10. This effect of the inactivatedH5N1 was inhibited by sialic acid receptor inhibitor (alpha-2,3sialidase), adenosine diphosphatase (apyrase), P2Y receptor (P2YR) inhibitor (suramin), P2Y(6)R antagonist (MRS2578), phospholipase C inhibitor (U73122), protein kinase C inhibitors (BIM and Go E 6976) and cellpermeant Ca2+ chelator (BAPTA-AM). Inhibitors of MAPK signaling, including of ERK1/2 (PD98059), p38 MAPK (SB203580) and JNK (SP600125) significantly suppressed the inactivated-H5N1-induced mRNA expression of CXCL8. On the other hand, the inactivatedH5N1-induced mRNA expression of IL-6 was inhibited by SB203580, but not PD98059 or SP600125, whereas SN-50, an inhibitor of NF-kappa B, inhibited the effect of virus on mRNA expression of both of IL-6 and CXCL8. Taken together, our data suggest that, without infection, inactivated-H5N1 induces mRNA expression of IL-6 and CXCL8 by a mechanism, or mechanisms, requiring interaction between viral hemagglutinin and alpha-2,3 sialic acid receptors at the cell membrane of host cells, and involves activation of P2Y(6) purinergic receptors.	[Huipao, Nawiya; Hiranyachattada, Siriphun] Prince Songkla Univ, Dept Physiol, Fac Sci, Hat Yai, Thailand; [Borwornpinyo, Suparerk] Mahidol Univ, Dept Biotechnol, Fac Sci, Bangkok, Thailand; [Wiboon-ut, Suwimon; Thitithanyanont, Arunee] Mahidol Univ, Dept Microbiol, Fac Sci, Bangkok, Thailand; [Campbell, Craig R.; Lee, Il-Ha; Cook, David I.; Dinudom, Anuwat] Univ Sydney, Bosch Inst, Sch Med Sci, Discipline Physiol, Sydney, NSW, Australia; [Sukasem, Chonlaphat] Mahidol Univ, Ramathibodi Hosp, Div Pharmacogen & Personalized Med, Dept Pathol,Fac Med, Bangkok, Thailand; [Pholpramool, Chumpol] Mahidol Univ, Dept Physiol, Fac Sci, Bangkok, Thailand	Prince of Songkla University; Mahidol University; Mahidol University; University of Sydney; Mahidol University; Mahidol University	Dinudom, A (corresponding author), Univ Sydney, Bosch Inst, Sch Med Sci, Discipline Physiol, Sydney, NSW, Australia.	anuwat@physiol.usyd.edu.au	Thitithanyanont, Arunee/AAN-4383-2021; Campbell, Craig R/B-5983-2012	Thitithanyanont, Arunee/0000-0002-9756-4763; Campbell, Craig R/0000-0002-0843-7579; Manopwisedjaroen, Suwimon/0000-0002-7571-8733; Borwornpinyo, Suparerk/0000-0001-6211-3615	National Health and Medical Research Council of Australia [10027447]; Mahidol University; Science Achievement Scholarship of Thailand (SAST)	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Mahidol University; Science Achievement Scholarship of Thailand (SAST)	This project was supported by the National Health and Medical Research Council of Australia (Project grant number: 10027447) and, in part, by Mahidol University. NH is a recipient of the Science Achievement Scholarship of Thailand (SAST). We thank Olympus Bioimaging Center, Mahidol University, for providing equipment for confocal image studies in this project.; National Health and Medical Research Council of Australia (Project grant number: 10027447), AD & DC, no role in design, data collection, decision to publish or preparation of manuscript. Mahidol University (Seeding Grant), CP, SB & AD, no role in design, data collection, decision to publish or preparation of manuscript. Science Achievement Scholarship of Thailand (SAST), NH, no role in design, data collection, decision to publish or preparation of manuscript.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Bhattacharyya S, 2011, AM J PHYSIOL-LUNG C, V300, pL81, DOI 10.1152/ajplung.00051.2010; Boeynaems JM, 2005, SEMIN THROMB HEMOST, V31, P139, DOI 10.1055/s-2005-869519; Boots AW, 2009, J BIOL CHEM, V284, P17858, DOI 10.1074/jbc.M809761200; Buchholz KR, 2007, INFECT IMMUN, V75, P5924, DOI 10.1128/IAI.01029-07; Burnstock G, 2007, CELL MOL LIFE SCI, V64, P1471, DOI 10.1007/s00018-007-6497-0; Cheng X, 2010, VIROLOGY, V406, P28, DOI 10.1016/j.virol.2010.06.048; Chokephaibulkit K, 2004, PEDIATR INFECT DIS J, V23, P793; Chow AWM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012091; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Cox MA, 2005, BIOCHEM BIOPH RES CO, V330, P467, DOI 10.1016/j.bbrc.2005.03.004; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Fritz RS, 1999, J INFECT DIS, V180, P586, DOI 10.1086/314938; Grbic DM, 2008, J IMMUNOL, V180, P2659, DOI 10.4049/jimmunol.180.4.2659; Hao Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106235; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Hui KPY, 2009, J IMMUNOL, V182, P1088, DOI 10.4049/jimmunol.182.2.1088; Humphries-Waa K, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-549; Khine AA, 2006, BLOOD, V107, P2936, DOI 10.1182/blood-2005-06-2314; Kim B, 2011, J IMMUNOL, V186, P3701, DOI 10.4049/jimmunol.1000212; Koch A, 2004, EUR RESPIR J, V23, P805, DOI 10.1183/09031936.04.00104304; Kujime K, 2000, J IMMUNOL, V164, P3222, DOI 10.4049/jimmunol.164.6.3222; Kunzelmann K, 2000, P NATL ACAD SCI USA, V97, P10282, DOI 10.1073/pnas.160041997; Lam WY, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-344; Lazrak A, 2009, FASEB J, V23, P3829, DOI 10.1096/fj.09-135590; Lee DCW, 2005, J VIROL, V79, P10147, DOI 10.1128/JVI.79.16.10147-10154.2005; Londino JD, 2013, AM J PHYSIOL-LUNG C, V304, pL582, DOI 10.1152/ajplung.00314.2012; Londino JD, 2015, FASEB J, V29, P2712, DOI 10.1096/fj.14-268755; Marcet B, 2007, J CELL PHYSIOL, V211, P716, DOI 10.1002/jcp.20979; Meusel TR, 2003, J IMMUNOL, V171, P3768, DOI 10.4049/jimmunol.171.7.3768; Ohman T, 2009, J IMMUNOL, V182, P5682, DOI 10.4049/jimmunol.0803093; Paulson JC, 2013, VIRUS RES, V178, P99, DOI 10.1016/j.virusres.2013.02.015; Peiris JSM, 2004, LANCET, V363, P617, DOI 10.1016/S0140-6736(04)15595-5; PERRIN P, 1995, BIOLOGICALS, V23, P207, DOI 10.1006/biol.1995.0034; Ramos I, 2011, J VIROL, V85, P4421, DOI 10.1128/JVI.02356-10; Sanders CJ, 2011, CELL TISSUE RES, V343, P13, DOI 10.1007/s00441-010-1043-z; Satrawaha S, 2011, ARCH ORAL BIOL, V56, P1230, DOI 10.1016/j.archoralbio.2011.05.003; Sauer AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089529; Shi L, 2012, AM J RESP CELL MOL, V47, P363, DOI 10.1165/rcmb.2011-0267OC; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Skoner DP, 1999, J INFECT DIS, V180, P10, DOI 10.1086/314823; Sun XJ, 2007, CELL MICROBIOL, V9, P1672, DOI 10.1111/j.1462-5822.2007.00900.x; Thitithanyanont A, 2007, J IMMUNOL, V179, P5220, DOI 10.4049/jimmunol.179.8.5220; Thitithanyanont A, 2010, BIOCHEM BIOPH RES CO, V398, P752, DOI 10.1016/j.bbrc.2010.07.017; To KF, 2001, J MED VIROL, V63, P242, DOI 10.1002/1096-9071(200103)63:3&lt;242::AID-JMV1007&gt;3.0.CO;2-N; Tran TT, 2008, INT J BIOCHEM CELL B, V40, P2671, DOI 10.1016/j.biocel.2008.05.019; Uratsuji H, 2012, J IMMUNOL, V188, P436, DOI 10.4049/jimmunol.1003746; Van Reeth K, 2000, VET MICROBIOL, V74, P109, DOI 10.1016/S0378-1135(00)00171-1; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; Vieira RP, 2011, AM J RESP CRIT CARE, V184, P215, DOI 10.1164/rccm.201011-1762OC; Vogel AJ, 2014, VIRAL IMMUNOL, V27, P214, DOI 10.1089/vim.2013.0095; Wang C, 2014, CLIN INFECT DIS, V58, P1095, DOI 10.1093/cid/ciu053; Warny M, 2001, J BIOL CHEM, V276, P26051, DOI 10.1074/jbc.M102568200; Wolk KE, 2008, AM J RESP CRIT CARE, V178, P969, DOI 10.1164/rccm.200803-455OC; Wong AM, 2009, AM J RESP CELL MOL, V40, P733, DOI 10.1165/rcmb.2008-0020OC; Xing Z, 2010, J GEN VIROL, V91, P343, DOI 10.1099/vir.0.015578-0; Xu WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0022900; Zeng H, 2015, J VIROL, V89, P4655, DOI 10.1128/JVI.03095-14	62	5	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176974	10.1371/journal.pone.0176974	http://dx.doi.org/10.1371/journal.pone.0176974			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28494003	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314300046
J	Li, P; Bian, XY; Chen, Q; Yao, XF; Wang, XD; Zhang, WC; Tao, YJ; Jin, R; Zhang, L				Li, Ping; Bian, Xue-yan; Chen, Qing; Yao, Xiao-feng; Wang, Xu-dong; Zhang, Wen-chao; Tao, Ying-jie; Jin, Rui; Zhang, Lun			Blocking of stromal interaction molecule 1 expression influence cell proliferation and promote cell apoptosis in vitro and inhibit tumor growth in vivo in head and neck squamous cell carcinoma	PLOS ONE			English	Article							EXTRACELLULAR-SUPEROXIDE DISMUTASE; ER STRESS INDUCER; CANCER; CALCIUM; STIM1; THAPSIGARGIN; METASTASIS; ACTIVATION; MIGRATION; PLAYS	Calcium signal plays an important role in a variety of cancer cell metabolism, but knowledge on its role in head and neck squamous cell carcinoma (HNSCC) is limited. Store-operated calcium entry (SOCE) is the principal Ca2+ entry mechanism that maintains calcium concentration and produces calcium signal in non-excitable cells. SOCE is triggered by stromal interaction molecule 1 (STIM1), which is located in endoplasmic reticulum (ER) as Ca2+ sensor. Although, many studies demonstrated that STIM1 and SOCE play important functions in the regulation of many cancer progressions, their clinical relevance in HNSCC remains unclear. In this study, STIM1 expression levels notably increased in 89% HNSCC tissues compared with those in adjacent normal tissues. Meanwhile, this overexpression was close associated with tumor size but not with neck lymph node metastasis. Thus, this study mainly focuses on STIM1 function in HNSCC tumor growth. Three HNSCC cell lines, namely, TSCCA (oral cancer cell line) and Hep2 (laryngeal cell line) with high STIM1 expression levels and Tb3.1 (oral cancer cell line) with STIM1 expression level lower than previous two cell lines, were selected for in vitro study. Downregulated STIM1 expression levels in TSCCA and Hep2 arrested cells in G0/G1 stages, promoted cell apoptosis, and inhibited cell proliferation. By contrast, upregulated STIM1 expression in Tb3.1 inhibited cell apoptosis and promoted cell proliferation. Induced by thapsigargin (TG), ER stress was amplified when STIM1 expression was downregulated but was attenuated as STIM1 expression was upregulated. Furthermore, TSCCA cell xenograft models confirmed that STIM1 could promote HNSCC tumor growth in vivo. The present study provides new insight into HNSCC molecular mechanism and potential therapeutic target through targeting SOCE-dependent process. However, whether STIM1 participates in HNSCC metastasis requires further study.	[Li, Ping; Bian, Xue-yan; Yao, Xiao-feng; Wang, Xu-dong; Zhang, Wen-chao; Tao, Ying-jie; Jin, Rui; Zhang, Lun] Tianjin Med Univ, Canc Inst & Hosp, Dept Maxillofacial Oncol, Tianjin, Peoples R China; [Li, Ping; Bian, Xue-yan; Yao, Xiao-feng; Wang, Xu-dong; Zhang, Wen-chao; Tao, Ying-jie; Jin, Rui; Zhang, Lun] Tianjin Med Univ, Canc Inst & Hosp, Dept Otorhinolaryngol Oncol, Tianjin, Peoples R China; [Li, Ping; Bian, Xue-yan; Chen, Qing; Yao, Xiao-feng; Wang, Xu-dong; Zhang, Wen-chao; Tao, Ying-jie; Jin, Rui; Zhang, Lun] Natl Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China; [Bian, Xue-yan; Chen, Qing] Tianjin Med Univ, Canc Inst & Hosp, Cardiopulm Funct Lab, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Zhang, L (corresponding author), Tianjin Med Univ, Canc Inst & Hosp, Dept Maxillofacial Oncol, Tianjin, Peoples R China.; Zhang, L (corresponding author), Tianjin Med Univ, Canc Inst & Hosp, Dept Otorhinolaryngol Oncol, Tianjin, Peoples R China.; Zhang, L (corresponding author), Natl Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China.	zhanglun16@126.com			National Natural Science Foundation of China [31400801]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Natural Science Foundation of China (grant no: 31400801).	Andruska N, 2015, ONCOGENE, V34, P3760, DOI 10.1038/onc.2014.292; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Birkeland AC, 2015, CANCERS, V7, P2094, DOI 10.3390/cancers7040879; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; Chen YF, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-23; Chen YF, 2011, P NATL ACAD SCI USA, V108, P15225, DOI 10.1073/pnas.1103315108; Cheng HY, 2016, ONCOTARGET, V7, P16866, DOI 10.18632/oncotarget.7619; Flourakis M, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.52; Gandini S, 2008, INT J CANCER, V122, P155, DOI 10.1002/ijc.23033; Hashibe M, 2009, CANCER EPIDEM BIOMAR, V18, P541, DOI 10.1158/1055-9965.EPI-08-0347; Jardin I, 2015, BIOCH BIOPHYS ACTA; Kamiya T, 2013, J CLIN BIOCHEM NUTR, V52, P101, DOI 10.3164/jcbn.12-46; Kamiya T, 2011, FREE RADICAL RES, V45, P692, DOI 10.3109/10715762.2011.567985; Li HY, 2014, INT J CLIN EXP PATHO, V7, P7989; Li P, 2012, ANN BIOMED ENG, V40, P1874, DOI 10.1007/s10439-012-0554-z; Li WD, 2013, SCI WORLD J, DOI 10.1155/2013/587284; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Prevarskaya N, 2011, NAT REV CANCER, V11, P609, DOI 10.1038/nrc3105; Prevarskaya N, 2010, TRENDS MOL MED, V16, P107, DOI 10.1016/j.molmed.2010.01.005; Putney JW, 2005, J CELL BIOL, V169, P381, DOI 10.1083/jcb.200503161; Rizzuto R, 2003, ONCOGENE, V22, P8619, DOI 10.1038/sj.onc.1207105; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; St John MA, 2015, LARYNGOSCOPE, V125, pS1, DOI 10.1002/lary.24998; Sun YH, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0608-9; Wang J. Q., 2015, SCI WORLD J, V2015, P1, DOI [DOI 10.1371/J0URNAL.P0NE.0124261, DOI 10.2118/174392-MS]; Wang JY, 2015, ONCOGENE, V34, P4358, DOI 10.1038/onc.2014.366; Wu JT, 2015, INT J CLIN EXP MED, V8, P13628; Xu S, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.331; Yang N, 2013, CANCER LETT, V330, P163, DOI 10.1016/j.canlet.2012.11.040; Zhang Y, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001838; [张志镇 Zhang Zhizhen], 2015, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V34, P1	33	7	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177484	10.1371/journal.pone.0177484	http://dx.doi.org/10.1371/journal.pone.0177484			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28494008	Green Submitted, gold, Green Published			2022-12-26	WOS:000401314300118
J	Taliercio, E; Eickholt, D; Rouf, R; Carter, T				Taliercio, Earl; Eickholt, David; Rouf, Rakin; Carter, Thomas			Changes in gene expression between a soybean F-1 hybrid and its parents are associated with agronomically valuable traits	PLOS ONE			English	Article							INBRED LINES; REGISTRATION; MAIZE; HETEROSIS; GENOME; YIELD	Soybean [Glycine max (L.) Merr.] genetic diversity is limited because domesticated soybean has undergone multiple genetic bottlenecks. Its progenitor, the wild soybean [Glycine soja Siebold & Zucc], has not undergone the same intense selection and is much more genetically diverse than domesticated soybean. However, the agronomic importance of diversity in wild soybean is unclear, and its weedy nature makes assessment difficult. To address this issue, we chose for study a highly selected, adapted F-4-derived progeny of wild soybean, NMS4-44-329. This breeding line is derived from the hybridization between G. max cultivar N7103 and G. soja PI 366122. Agronomic comparisons were made among N7103, NMS4-44-329 and their F-1 and F-2 progeny in replicated yield trials at two North Carolina locations. Significant F1 mid-parent heterosis was observed at each location for seed yield (189 and 223 kgha(-1), P<0.05 and P<0.10, respectively), seed protein content (1.1g/100g, P<0.01) and protein production per hectare (101 and 100 kgha(-1), P<0.01 and P<0.06, respectively). Increased yield, seed protein content and protein production per hectare in the hybrids suggested that wild soybean has the potential to improve agronomic traits in applied breeding. Comparisons of differentially-expressed genes in the hybrid vs. parents identified genes associated with N metabolism. Non-additive changes in gene expression in the hybrids relative to the parents could reasonably explain the improved protein levels in the F1 hybrids. Changes in gene expression were influenced by environmental effects; however, allele specific bias in the hybrids were well correlated between environments. We propose that changes in gene expression, both additive and non-additive, and changes in allele specific expression bias may explain agronomic traits, and be valuable tools for plant breeders in the assessment of breeding populations.	[Taliercio, Earl; Carter, Thomas] USDA ARS, Raleigh, NC 27695 USA; [Eickholt, David; Rouf, Rakin] North Carolina State Univ, Crop & Soil Sci Dept, Raleigh, NC 27695 USA	United States Department of Agriculture (USDA); University of North Carolina; North Carolina State University	Taliercio, E (corresponding author), USDA ARS, Raleigh, NC 27695 USA.	Earl.Taliercio@ars.usda.gov			USDA research projects [6645-21000-028-00D]	USDA research projects	Funded by USDA research projects # 6645-21000-028-00D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandillo N, 2015, PLANT GENOME-US, V8, DOI 10.3835/plantgenome2015.04.0024; Bernard R. L., 1973, Soybeans: improvement, production and uses., P117; Bi YD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114827; BROWNIE C, 1993, AGRON J, V85, P1244, DOI 10.2134/agronj1993.00021962008500060028x; Burton JW, 2006, CROP SCI, V46, P2643, DOI 10.2135/cropsci2006.03.0156; Burton JW, 2005, CROP SCI, V45, P2654, DOI 10.2135/cropsci2005.0012; Carter T. E, 2004, SOYBEANS IMPROVEMENT, V3rd, DOI DOI 10.2134/AGRONMONOGR16.3ED.C8; Carter TE, 2016, J PLANT REGIST, V10, P238, DOI 10.3198/jpr2015.09.0057crc; Carter TE, 2011, J PLANT REGIST, V5, P309, DOI 10.3198/jpr2010.09.0565crc; CARTER TE, 1995, CROP SCI, V35, P1713, DOI 10.2135/cropsci1995.0011183X003500060042x; CARTER TE, 2003, CROP SCI, V43, P1128; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Delheimer J. C., 2012, THESIS; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Fernandes EH, 2015, GENET MOL RES, V14, P6509, DOI 10.4238/2015.June.12.3; Friedrichs MR, 2016, CROP SCI, V56, P2072, DOI 10.2135/cropsci2015.11.0702; Gaufichon L, 2015, PLANT AND CELL PHYSI; GIZLICE Z, 1994, CROP SCI, V34, P1143, DOI 10.2135/cropsci1994.0011183X003400050001x; Hyten DL, 2006, P NATL ACAD SCI USA, V103, P16666, DOI 10.1073/pnas.0604379103; Munir S, 2016, SCI REP-UK, V6, DOI 10.1038/srep31772; Ndhlela T, 2015, EUPHYTICA, V204, P635, DOI 10.1007/s10681-015-1353-z; Pandurangan S, 2012, J EXP BOT, V63, P3173, DOI 10.1093/jxb/ers039; Song QJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054985; Stupar RM, 2006, GENETICS, V173, P2199, DOI 10.1534/genetics.106.060699; Sun XL, 2016, PLANT J, V86, P514, DOI 10.1111/tpj.13187; Swanson-Wagner RA, 2006, P NATL ACAD SCI USA, V103, P6805, DOI 10.1073/pnas.0510430103; Thomsen HC, 2014, TRENDS PLANT SCI, V19, P656, DOI 10.1016/j.tplants.2014.06.002; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Wegary D, 2013, EUPHYTICA, V191, P205, DOI 10.1007/s10681-012-0757-2; Wilson R. F, 2004, SOYBEANS IMPROV PROD, V16, P621, DOI DOI 10.2134/AGRONMONOGR16.3ED.C13; Yang HA, 2015, THEOR APPL GENET, V128, P779, DOI 10.1007/s00122-015-2499-8; Yang TB, 2003, TRENDS PLANT SCI, V8, P505, DOI 10.1016/j.tplants.2003.09.004; Zhai RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060668	33	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177225	10.1371/journal.pone.0177225	http://dx.doi.org/10.1371/journal.pone.0177225			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493991	Green Submitted, Green Published, gold			2022-12-26	WOS:000401314300075
J	Zheng, YQ; Xu, SJ; Liu, J; Zhao, Y; Liu, JX				Zheng, Yiqi; Xu, Shaojun; Liu, Jing; Zhao, Yan; Liu, Jianxiu			Genetic diversity and population structure of Chinese natural bermudagrass [Cynodon dactylon (L.) Pers.] germplasm based on SRAP markers	PLOS ONE			English	Article							SOUTHWEST CHINA; ACCESSIONS; ISSR; CULTIVARS	Bermudagrass [Cynodon dactylon (L.) Pers.], an important turfgrass used in public parks, home lawns, golf courses and sports fields, is widely distributed in China. In the present study, sequence-related amplified polymorphism (SRAP) markers were used to assess genetic diversity and population structure among 157 indigenous bermudagrass genotypes from 20 provinces in China. The application of 26 SRAP primer pairs produced 340 bands, of which 328 (96.58%) were polymorphic. The polymorphic information content (PIC) ranged from 0.36 to 0.49 with a mean of 0.44. Genetic distance coefficients among accessions ranged from 0.04 to 0.61, with an average of 0.32. The results of STRUCTURE analysis suggested that 157 bermudagrass accessions can be grouped into three subpopulations. Moreover, according to clustering based on the unweighted pair-group method of arithmetic averages (UPGMA), accessions were divided into three major clusters. The UPGMA dendrogram revealed that accessions from identical or adjacent areas were generally, but not entirely, clustered into the same cluster. Comparison of the UPGMA dendrogram and the Bayesian STRUCTURE analysis showed general agreement between the population subdivisions and the genetic relationships among accessions. Principal coordinate analysis (PCoA) with SRAP markers revealed a similar grouping of accessions to the UPGMA dendrogram and STRUCTUE analysis. Analysis of molecular variance (AMOVA) indicated that 18% of total molecular variance was attributed to diversity among subpopulations, while 82% of variance was associated with differences within subpopulations. Our study represents the most comprehensive investigation of the genetic diversity and population structure of bermudagrass in China to date, and provides valuable information for the germplasm collection, genetic improvement, and systematic utilization of bermudagrass.	[Zheng, Yiqi; Xu, Shaojun; Liu, Jing; Zhao, Yan] Henan Univ Sci & Technol, Coll Forestry, Luoyang, Henan, Peoples R China; [Liu, Jianxiu] Jiangsu Prov & Chinese Acad Sci, Inst Bot, Nanjing, Jiangsu, Peoples R China	Henan University of Science & Technology	Zheng, YQ (corresponding author), Henan Univ Sci & Technol, Coll Forestry, Luoyang, Henan, Peoples R China.	yiqi214@163.com			National natural science foundation of Chinese [31101754, 31101567]	National natural science foundation of Chinese(National Natural Science Foundation of China (NSFC))	This work was supported by National natural science foundation of Chinese (Grants No. 31101754 and 31101567) http://www.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1990, CHINESE FLORAL ACTA, V10; Assefa S, 1999, GENOME, V42, P465, DOI 10.1139/gen-42-3-465; Babu BK, 2014, MOL BIOL REP, V41, P4329, DOI 10.1007/s11033-014-3304-5; Beard J. B., 1972, TURFGRASS SCI CULTUR; Belamkar V, 2011, GENETICA, V139, P411, DOI 10.1007/s10709-011-9556-2; Bolibok-Bragoszewska H, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-184; Budak H, 2004, THEOR APPL GENET, V109, P280, DOI 10.1007/s00122-004-1630-z; CAETANOANOLLES G, 1995, THEOR APPL GENET, V91, P228, DOI 10.1007/BF00220882; Chen HL, 2015, GENE, V566, P175, DOI 10.1016/j.gene.2015.04.043; De Riek J, 2001, THEOR APPL GENET, V103, P1254, DOI 10.1007/s001220100710; Etemadi N., 2006, International Journal of Agriculture and Biology, V8, P198; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Farsani TM, 2012, INT J MOL SCI, V13, P383, DOI 10.3390/ijms13010383; Ganesh S. K., 1995, Madras Agricultural Journal, V82, P263; Gulsen O, 2009, THEOR APPL GENET, V118, P1309, DOI 10.1007/s00122-009-0982-9; Hamrick J.L., 1983, GENETICS CONSERVATIO, P335, DOI DOI 10.1111/J.1471-8286.2004.00845.X; HARLAN J R, 1970, East African Agricultural and Forestry Journal, V36, P220; HARLAN J. R., 1970, Herbage Abstracts, V40, P233; HARLAN JR, 1969, CROP SCI, V9, P774, DOI 10.2135/cropsci1969.0011183X000900060031x; HARLAN JR, 1970, CROP SCI, V10, P288, DOI 10.2135/cropsci1970.0011183X001000030023x; HARLAN JR, 1970, EUPHYTICA, V19, P465, DOI 10.1007/BF01902921; Huang CQ, 2010, BIOCHEM SYST ECOL, V38, P993, DOI 10.1016/j.bse.2010.09.013; Huang CQ, 2014, INT J MOL SCI, V15, P19134, DOI 10.3390/ijms151019134; Juyo D, 2015, CROP SCI, V55, P760, DOI 10.2135/cropsci2014.07.0524; Kang SY, 2008, MOL CELLS, V25, P163; KNEEBONE W. R., 1967, Progress in Agriculture, Arizona, V19, P4; Li HY, 2011, SCI HORTIC-AMSTERDAM, V127, P555, DOI 10.1016/j.scienta.2010.12.001; Liang W, 2015, PLANT MOL BIOL REP, V33, P458, DOI 10.1007/s11105-014-0754-9; Ling Y, 2015, GENET MOL RES, V14, P1748, DOI 10.4238/2015.March.13.1; Ling Y, 2012, GENET MOL RES, V11, P4598, DOI 10.4238/2012.October.17.5; Linos A, 2014, SCI HORTIC-AMSTERDAM, V175, P33, DOI 10.1016/j.scienta.2014.05.034; Liu KJ, 2003, GENETICS, V165, P2117; LOVELESS MD, 1984, ANNU REV ECOL SYST, V15, P65, DOI 10.1146/annurev.es.15.110184.000433; MANTEL N, 1967, CANCER RES, V27, P209; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; RICHARDSON WL, 1978, CROP SCI, V18, P332, DOI 10.2135/cropsci1978.0011183X001800020035x; Rohlf F. J., 2000, NTSYS PC NUMERICAL T; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Sneath P.H.A., 1973, NUMERICAL TAXONOMY P; SOKAL RR, 1979, SYST ZOOL, V28, P227, DOI 10.2307/2412528; Tamaki I, 2014, TREE GENET GENOMES, V10, P989, DOI 10.1007/s11295-014-0737-x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tyagi P, 2014, THEOR APPL GENET, V127, P283, DOI 10.1007/s00122-013-2217-3; Wang ZY, 2013, BIOCHEM SYST ECOL, V46, P108, DOI 10.1016/j.bse.2012.09.001; Wang ZY, 2009, SCI HORTIC-AMSTERDAM, V122, P461, DOI 10.1016/j.scienta.2009.05.031; Wu YQ, 2006, CROP SCI, V46, P917, DOI 10.2135/cropsci2005.08.0256; Wu YQ, 2004, GENOME, V47, P689, DOI 10.1139/G04-032; Xie Y, 2015, PLANT SOIL, V390, P307, DOI 10.1007/s11104-015-2391-y; Yerramsetty PN, 2005, CROP SCI, V45, P772, DOI 10.2135/cropsci2005.0772; Zhang CM, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-014-0809-y; Zhang LH, 1999, THEOR APPL GENET, V98, P895, DOI 10.1007/s001220051148; Zong JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137528	54	28	33	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177508	10.1371/journal.pone.0177508	http://dx.doi.org/10.1371/journal.pone.0177508			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493962	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314300124
J	Asli, A; Brouillette, E; Ster, C; Ghinet, MG; Brzezinski, R; Lacasse, P; Jacques, M; Malouin, F				Asli, Abdelhamid; Brouillette, Eric; Ster, Celine; Ghinet, Mariana Gabriela; Brzezinski, Ryszard; Lacasse, Pierre; Jacques, Mario; Malouin, Francois			Antibiofilm and antibacterial effects of specific chitosan molecules on Staphylococcus aureus isolates associated with bovine mastitis	PLOS ONE			English	Article							INTRAMAMMARY INFECTIONS; ESCHERICHIA-COLI; MILK; MODE; OIL; HAMAMELITANNIN; COMBINATION; ANTIBIOTICS; PREVENTION; RESISTANCE	Staphylococcus aureus is one of the major pathogens causing bovine intramammary infections (IMIs) and mastitis. Mastitis is the primary cause for the use of antibiotics in dairy farms but therapeutic failure is often observed. One of the reasons for the lack of effectiveness of antibiotic therapy despite the observed susceptibility of bacterial isolates in vitro are bacterial biofilms. In this study, we used chitosan of well-defined molecular weight (0.4-0.6, 1.3, 2.6 and 4.0 kDa) and investigated their antibiofilm and antibacterial activities in in vitro and in vivo models related to S. aureus IMIs. A chitosan of at least 6 units of glucosamine was necessary for maximum antibacterial activity. The 2.6 and 4.0 kDa forms were able to prevent biofilm production by the biofilm hyperproducer strain S. aureus 2117 and a bovine MRSA (methicillin-resistant S. aureus). The intramammary administration of the 2.6 kDa chitosan showed no adverse effects in mice or in cows, as opposed to the slight inflammatory effect observed in mammary glands with the 4.0 kDa derivative. The 2.6 kDa chitosan killed bacteria embedded in pre-established biofilms in a dose-dependent manner with a > 3 log10 reduction in CFU at 4 mg/ml. Also, the 2.6 kDa chitosan could prevent the persistence of the internalized MRSA into the mammary epithelial cell line MAC-T. An in vitro checkerboard assay showed that the 2.6 kDa chitosan produced a synergy with the macrolide class of antibiotics (e.g., tilmicosin) and reduced the MIC of both molecules by 2-8 times. Finally, the intramammary administration of the 2.6 kDa chitosan alone (P<0.01) or in combination with tilmicosin (P<0.0001) reduced the colonization of mammary glands in a murine IMI model. Our results suggest that the use of chitosan alone or in combination with a low dose of a macrolide could help reduce antibiotic use in dairy farms.	[Asli, Abdelhamid; Brouillette, Eric; Ster, Celine; Ghinet, Mariana Gabriela; Brzezinski, Ryszard; Malouin, Francois] Univ Sherbrooke, Fac Sci, Dept Biol, CEVDM, Sherbrooke, PQ, Canada; [Asli, Abdelhamid; Brouillette, Eric; Ster, Celine; Lacasse, Pierre; Jacques, Mario; Malouin, Francois] Univ Montreal, Canadian Bovine Mastitis & Milk Qual Res Network, Montreal, PQ, Canada; [Asli, Abdelhamid; Brouillette, Eric; Ster, Celine; Lacasse, Pierre; Jacques, Mario; Malouin, Francois] Univ Montreal, Regrp Rech Lait Qualite Optimale Op Lait, Montreal, PQ, Canada; [Lacasse, Pierre] Agr & Agri Food Canada, Sherbrooke Res & Dev Ctr, Sherbrooke, PQ, Canada; [Jacques, Mario] Univ Montreal, Fac Med Vet, Dept Pathol & Microbiol, St Hyacinthe, PQ, Canada	University of Sherbrooke; Universite de Montreal; Universite de Montreal; Agriculture & Agri Food Canada; Universite de Montreal	Malouin, F (corresponding author), Univ Sherbrooke, Fac Sci, Dept Biol, CEVDM, Sherbrooke, PQ, Canada.	francois.malouin@usherbrooke.ca	Lacasse, Pierre/AAS-3143-2020; Ster, Céline/AAT-2620-2020; Lacasse, Pierre/B-5084-2013; Jacques, Mario/D-4901-2015	Malouin, Francois/0000-0001-5031-345X	FRQNT, les Fonds de Recherche du Quebec, Nature et Technologies (St-Hyacinthe, Quebec, Canada)	FRQNT, les Fonds de Recherche du Quebec, Nature et Technologies (St-Hyacinthe, Quebec, Canada)	This research was supported by a contribution from the Dairy Research Cluster initiative [Dairy Farmers of Canada (Ottawa, ON, Canada), Agriculture and AgriFood Canada (Ottawa, ON, Canada), and the Canadian Dairy Commission (Ottawa, ON, Canada)] through the Canadian Bovine Mastitis and Milk Quality Research Network (St-Hyacinthe, QC, Canada). AA received a studentship from Op+Lait, le Regroupement de recherche pour un lait de qualite optimale supported by the FRQNT, les Fonds de Recherche du Quebec, Nature et Technologies (St-Hyacinthe, Quebec, Canada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup FM, 1999, APMIS, V107, P425, DOI 10.1111/j.1699-0463.1999.tb01576.x; Aarestrup FM, 1995, ACTA VET SCAND, V36, P475; Aitken SL, 2011, J MAMMARY GLAND BIOL, V16, P291, DOI 10.1007/s10911-011-9230-4; Anderson KL, 2006, J DAIRY SCI, V89, P4551, DOI 10.3168/jds.S0022-0302(06)72504-8; Barkema HW, 2006, J DAIRY SCI, V89, P1877, DOI 10.3168/jds.S0022-0302(06)72256-1; Bhatnagar A, 2009, ADV COLLOID INTERFAC, V152, P26, DOI 10.1016/j.cis.2009.09.003; Boles BR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000052; BOUCHER I, 1992, APPL MICROBIOL BIOT, V38, P188, DOI 10.1007/BF00174466; Brouillette E, 2004, VET MICROBIOL, V101, P253, DOI 10.1016/j.vetmic.2004.04.008; Cafiso V, 2007, FEMS IMMUNOL MED MIC, V51, P220, DOI 10.1111/j.1574-695X.2007.00298.x; Ceri H, 1999, J CLIN MICROBIOL, V37, P1771, DOI 10.1128/JCM.37.6.1771-1776.1999; Chung YC, 2008, BIORESOURCE TECHNOL, V99, P2806, DOI 10.1016/j.biortech.2007.06.044; Clinical and Laboratory Standards Institute, 2006, M100S16 CLIN LAB STA; Cobrado L, 2013, J ANTIMICROB CHEMOTH, V68, P126, DOI 10.1093/jac/dks376; Cobrado L, 2012, J ANTIMICROB CHEMOTH, V67, P1159, DOI 10.1093/jac/dks007; Costa E, 2014, PATHOGENS, V3, P908, DOI 10.3390/pathogens3040908; Costerton JW, 1999, INT J ANTIMICROB AG, V11, P217, DOI 10.1016/S0924-8579(99)00018-7; Cramton SE, 1999, INFECT IMMUN, V67, P5427, DOI 10.1128/IAI.67.10.5427-5433.1999; Cui HY, 2016, BIOFOULING, V32, P215, DOI 10.1080/08927014.2015.1134516; Cui HY, 2016, FOOD CONTROL, V61, P92, DOI 10.1016/j.foodcont.2015.09.034; Cui HY, 2015, FOOD CONTROL, V56, P128, DOI 10.1016/j.foodcont.2015.03.026; De Vliegher S, 2012, J DAIRY SCI, V95, P1025, DOI 10.3168/jds.2010-4074; Decker EM, 2005, J PERIODONTAL RES, V40, P373, DOI 10.1111/j.1600-0765.2005.00817.x; Dodane V, 1998, PHARM SCI TECHNOL TO, V1, P246, DOI 10.1016/S1461-5347(98)00059-5; Foster TJ, 2004, J CLIN INVEST, V114, P1693, DOI 10.1172/JCI200423825; Fournier C, 2008, RES VET SCI, V85, P439, DOI 10.1016/j.rvsc.2008.01.010; Fox LK, 2005, VET MICROBIOL, V107, P295, DOI 10.1016/j.vetmic.2005.02.005; Geary U, 2012, J DAIRY SCI, V95, P3662, DOI 10.3168/jds.2011-4863; Halasa T, 2007, VET QUART, V29, P18, DOI 10.1080/01652176.2007.9695224; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Islam M.M., 2011, J ADV SCI RES, V2, P63; Kaplan JB, 2010, J DENT RES, V89, P205, DOI 10.1177/0022034509359403; Karatan E, 2009, MICROBIOL MOL BIOL R, V73, P310, DOI 10.1128/MMBR.00041-08; Kim Y, 2009, BIOCHEM BIOPH RES CO, V379, P324, DOI 10.1016/j.bbrc.2008.12.053; Klein RC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120514; Kong M, 2010, INT J FOOD MICROBIOL, V144, P51, DOI 10.1016/j.ijfoodmicro.2010.09.012; Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b; LEVER M, 1972, ANAL BIOCHEM, V47, P273, DOI 10.1016/0003-2697(72)90301-6; Liu XF, 2001, J APPL POLYM SCI, V79, P1324; Ma Y, 2000, J DAIRY SCI, V83, P264, DOI 10.3168/jds.S0022-0302(00)74873-9; MCEWEN SA, 1991, J DAIRY SCI, V74, P2128, DOI 10.3168/jds.S0022-0302(91)78385-9; Melchior MB, 2006, VET J, V171, P398, DOI 10.1016/j.tvjl.2005.01.006; Mitchell G, 2012, J ANTIMICROB CHEMOTH, V67, P559, DOI 10.1093/jac/dkr510; Mu HB, 2014, INT J MOL SCI, V15, P22296, DOI 10.3390/ijms151222296; O'Neill E, 2007, J CLIN MICROBIOL, V45, P1379, DOI 10.1128/JCM.02280-06; Orhan G, 2005, J CLIN MICROBIOL, V43, P140, DOI 10.1128/JCM.43.1.140-143.2005; Osteras O, 2006, J DAIRY SCI, V89, P1010, DOI 10.3168/jds.S0022-0302(06)72167-1; Otto M., 2012, ANNU REV MED, V64, P1; Otto M, 2014, INT J MED MICROBIOL, V304, P164, DOI 10.1016/j.ijmm.2013.11.019; Pitkala A, 2004, J DAIRY SCI, V87, P2433, DOI 10.3168/jds.S0022-0302(04)73366-4; Prashanth KVH, 2007, TRENDS FOOD SCI TECH, V18, P117, DOI 10.1016/j.tifs.2006.10.022; Quintero-Villegas MI, 2013, J AGR FOOD CHEM, V61, P2748, DOI 10.1021/jf400103g; Raafat D, 2008, APPL ENVIRON MICROB, V74, P3764, DOI 10.1128/AEM.00453-08; Raafat D, 2009, MICROB BIOTECHNOL, V2, P186, DOI 10.1111/j.1751-7915.2008.00080.x; Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m; Rainard P, 2003, CLIN DIAGN LAB IMMUN, V10, P272, DOI 10.1128/CDLI.10.2.272-277.2003; Reyher KK, 2011, J DAIRY SCI, V94, P1616, DOI 10.3168/jds.2010-3180; Riekerink RGMO, 2008, J DAIRY SCI, V91, P1366, DOI 10.3168/jds.2007-0757; Saber A, 2010, EUR J PHARM SCI, V39, P110, DOI 10.1016/j.ejps.2009.11.003; Silva-Dias A, 2014, MED MICROBIOL IMMUN, V203, P25, DOI 10.1007/s00430-013-0311-4; Tarsi R, 1997, J DENT RES, V76, P665, DOI 10.1177/00220345970760020701; Tenhagen BA, 2006, J DAIRY SCI, V89, P2542, DOI 10.3168/jds.S0022-0302(06)72330-X; Thompson AK, 2006, J DAIRY SCI, V89, P410, DOI 10.3168/jds.S0022-0302(06)72105-1; Tin S, 2009, INT J BIOL SCI, V5, P153; Tokura S., 1996, NEW MACROMOLECULAR A, P199, DOI DOI 10.1007/978-3-642-80289-8_21; Varum K.M., 2005, VERSATILITY, P625; Veh KA, 2015, J DAIRY SCI, V98, P155, DOI 10.3168/jds.2014-8044; Vergara-Irigaray M, 2009, INFECT IMMUN, V77, P3978, DOI 10.1128/IAI.00616-09; Vinsova J, 2011, CURR PHARM DESIGN, V17, P3596, DOI 10.2174/138161211798194468; Yadav MK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119564; Zheng LY, 2003, CARBOHYD POLYM, V54, P527, DOI 10.1016/j.carbpol.2003.07.009	71	43	45	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0176988	10.1371/journal.pone.0176988	http://dx.doi.org/10.1371/journal.pone.0176988			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486482	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314000033
J	Chao, WC; Lin, CH; Liao, TL; Chen, YM; Chen, DY; Chen, HH				Chao, Wen-Cheng; Lin, Ching-Heng; Liao, Tsai-Ling; Chen, Yi-Ming; Chen, Der-Yuan; Chen, Hsin-Hua			Association between a history of mycobacterial infection and the risk of newly diagnosed Sjogren's syndrome: A nationwide, population-based case-control study	PLOS ONE			English	Article							TUBERCULOSIS; BRONCHIECTASIS; SUSCEPTIBILITY; SIGNATURES; THERAPY; DISEASE; TAIWAN	Objective To address the association between a history of tuberculosis (TB) or nontuberculous mycobacterial (NTM) infection and the risk of newly diagnosed Sjogren's syndrome (SS). Methods Using a nationwide, population-based, claims dataset, and after excluding those who had rheumatoid arthritis or systemic lupus erythematosus, we identified 5,751 newly diagnosed SS cases during 2007-2012, and compared them to 86,265 non-SS controls matched (1: 15) for age, sex, and the year of first SS diagnosis date. The association between the risk of incident SS and a history of mycobacterial infection, including TB and NTM, was quantified by calculating odds ratios (ORs) with 95% confidence intervals (CIs) using conditional logistic regression analysis after adjustment for Charlson comorbidity index (CCI) and bronchiectasis. Results The mean age was 55 +/- 14 years, and the proportion of female gender was 87.8% in both newly diagnosed SS cases andnon-SS controls. An association was observed between NTM infection (OR, 11.24; 95% CI, 2.37-53.24) and incident SS, but not between TB infection and incident SS (OR, 1.29; 95% CI, 0.97-1.71) after adjustment for CCI and bronchiectasis. The association between NTM and SS risk was remarkably strong among those aged between 45 and 65 years (OR, 39.24; 95% CI, 3.97-387.75) and those without bronchiectasis (OR, 39.98; 95% CI, 3.83-376.92). Conclusion The study reveals a significant association of newly diagnosed SS with a history NTM infection, especially among individuals aged 40-65 years or those without bronchiectasis.	[Chao, Wen-Cheng; Lin, Ching-Heng; Liao, Tsai-Ling; Chen, Yi-Ming; Chen, Hsin-Hua] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Chao, Wen-Cheng] Taichung Vet Gen Hosp, Dept Internal Med, Div Chest Med, Taichung, Taiwan; [Chao, Wen-Cheng] Natl Changhua Univ Educ, Dept Business Adm, Changhua, Taiwan; [Liao, Tsai-Ling; Chen, Yi-Ming; Chen, Der-Yuan; Chen, Hsin-Hua] Chung Hsing Univ, Inst Biomed Sci, Taichung, Taiwan; [Liao, Tsai-Ling; Chen, Yi-Ming; Chen, Der-Yuan; Chen, Hsin-Hua] Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung, Taiwan; [Chen, Yi-Ming; Chen, Der-Yuan; Chen, Hsin-Hua] Taichung Vet Gen Hosp, Dept Internal Med, Div Allergy Immunol & Rheumatol, Taichung, Taiwan; [Chen, Yi-Ming; Chen, Der-Yuan; Chen, Hsin-Hua] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Chen, Der-Yuan; Chen, Hsin-Hua] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Chen, Der-Yuan] Taichung Vet Gen Hosp, Dept Med Educ, Taichung, Taiwan; [Chen, Hsin-Hua] Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan; [Chen, Hsin-Hua] Natl Yang Ming Univ, Community Med Res Ctr, Taipei, Taiwan	Taichung Veterans General Hospital; Taichung Veterans General Hospital; National Changhua University of Education; National Chung Hsing University; National Chung Hsing University; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; Chung Shan Medical University; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Chen, HH (corresponding author), Chung Hsing Univ, Inst Biomed Sci, Taichung, Taiwan.	dychen@vghtc.gov.tw; shc5555@hotmail.com	Chen, Yi-Ming/AAV-3806-2021	Chen, Yi-Ming/0000-0001-7593-3065; Chao, Wen-Cheng/0000-0001-9631-8934	Taichung Veterans General Hospital, Taiwan [TCVGH-1057329D, TCVGH-105G213, TCVGH-NHRI10505, TCVGH-1057308C, TCVGH-FCU1058202]	Taichung Veterans General Hospital, Taiwan	This study was supported in part by grants from Taichung Veterans General Hospital, Taiwan (TCVGH-1057329D,TCVGH-105G213, TCVGH-NHRI10505, TCVGH-1057308C, TCVGH-FCU1058202). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Browne SK, 2012, NEW ENGL J MED, V367, P725, DOI 10.1056/NEJMoa1111160; Chan ED, 2013, SEMIN RESP CRIT CARE, V34, P110, DOI 10.1055/s-0033-1333573; Chang YS, 2014, CLIN RHEUMATOL, V33, P377, DOI 10.1007/s10067-013-2408-y; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; Chien JY, 2013, J ANTIMICROB CHEMOTH, V68, P1910, DOI 10.1093/jac/dkt103; Chu HQ, 2014, ARCH MED SCI, V10, P661, DOI 10.5114/aoms.2014.44857; Cronan MR, 2016, IMMUNITY, V45, P861, DOI 10.1016/j.immuni.2016.09.014; Danley Joshua, 2014, Ann Am Thorac Soc, V11, P908, DOI 10.1513/AnnalsATS.201312-422OC; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Elkington P, 2016, TRENDS IMMUNOLOGY; Firestein Gary S., 2013, KELLEYS TXB RHEUMATO, P1169; Friedland JS, 2014, NEW ENGL J MED, V371, P1354, DOI 10.1056/NEJMcibr1408663; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Jordan TS, 2010, RESPIROLOGY, V15, P623, DOI 10.1111/j.1440-1843.2010.01749.x; Jou R, 2009, INT J TUBERC LUNG D, V13, P1142; Kakumanu P, 2008, ARTHRITIS RHEUM-US, V58, P1576, DOI 10.1002/art.23514; Ko JM, 2013, ACTA RADIOL, V54, P412, DOI 10.1177/0284185113475796; Konttinen YT, 2012, J AUTOIMMUN, V39, P49, DOI 10.1016/j.jaut.2012.01.004; Liao TL, 2015, EMERG INFECT DIS, V21, P1387, DOI 10.3201/eid2108.141846; Lo HY, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-915; Maertzdorf J, 2012, P NATL ACAD SCI USA, V109, P7853, DOI 10.1073/pnas.1121072109; Mavragani CP, 2012, J AUTOIMMUN, V39, P354, DOI 10.1016/j.jaut.2012.05.011; Mavragani CP, 2010, J AUTOIMMUN, V35, P225, DOI 10.1016/j.jaut.2010.06.012; Mavragani CP, 2010, AUTOIMMUN REV, V9, pA305, DOI 10.1016/j.autrev.2009.11.004; Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489; Mirsaeidi M, 2015, INT J MYCOBACT, V4, P92, DOI 10.1016/j.ijmyco.2015.05.002; National Health Insurance Administration Ministry of Health and Welfare Taiwan ROC, 2014, NATL HLTH INSURANCE; Nezos A, 2015, J AUTOIMMUN, V63, P47, DOI 10.1016/j.jaut.2015.07.002; Olate S, 2014, INT J CLIN EXP MED, V7, P1140; Peri Y, 2012, BEST PRACT RES CL RH, V26, P105, DOI 10.1016/j.berh.2012.01.012; Root-Bernstein R, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-013-0407-3; Sandhya P, 2016, CURRENT RHEUMATOLOGY; Shoda H, 2016, SCI REP-UK, V6, DOI 10.1038/srep22486; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Wallace RJ, 1997, AM J RESP CRIT CARE, V156, pS1, DOI 10.1164/ajrccm.156.2.atsstatement	35	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0176549	10.1371/journal.pone.0176549	http://dx.doi.org/10.1371/journal.pone.0176549			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486537	Green Submitted, gold, Green Published			2022-12-26	WOS:000401314000015
J	Vejrikova, I; Eloranta, AP; Vejrik, L; Smejkal, M; Cech, M; Sajdlova, Z; Frouzova, J; Kiljunen, M; Peterka, J				Vejrikova, Ivana; Eloranta, Anttl P.; Vejrik, Lukas; Smejkal, Marek; Cech, Martin; sajdlova, Zuzana; Frouzova, Jaroslava; Kiljunen, Mikko; Peterka, Jlri			Macrophytes shape trophic niche variation among generalist fishes	PLOS ONE			English	Article							ROACH RUTILUS-RUTILUS; PERCH PERCA-FLUVIATILIS; SCARDINIUS-ERYTHROPHTHALMUS; STABLE-ISOTOPES; INDIVIDUAL SPECIALIZATION; STRUCTURAL COMPLEXITY; POPULATION-DYNAMICS; COMMUNITY STRUCTURE; PISCIVOROUS PERCH; PREY REFUGES	Generalist species commonly have a fundamental role in ecosystems as they can integrate spatially distinct habitats and food-web compartments, as well as control the composition, abundance and behavior of organisms at different trophic levels. Generalist populations typically consist of specialized individuals, but the potential for and hence degree of individual niche variation can be largely determined by habitat complexity. We compared individual niche variation within three generalist fishes between two comparable lakes in the Czech Republic differing in macrophyte cover, i.e. macrophyte-rich Milada and macrophyte-poor Most. We tested the hypothesis that large individual niche variation among generalist fishes is facilitated by the presence of macrophytes,which provides niches and predation shelter for fish and their prey items. Based on results from stable nitrogen (delta N-15) and carbon (delta C-13) isotopic mixing models, perch (Perca fluviatilis L.) and rudd (Scardinius erythrophthalmus (L.)) showed larger individual variation (i.e., variance) in trophic position in Milada as compared to Most, whereas no significant between-lake differences were observed for roach (Rutilus rutilus (L.)). Contrary to our hypothesis, all the three species showed significantly lower individual variation in the relative reliance on littoral food resources in Milada than in Most. Rudd relied significantly more whereas perch and roach relied less on littoral food resources in Milada than in Most, likely due to prevalent herbivory by rudd and prevalent zooplanktivory by perch and roach in the macrophyte-rich Milada as compared to macrophyte-poor Most. Our study demonstrates how the succession of macrophyte vegetation, via its effects on the physical and biological complexity of the littoral zone and on the availability of small prey fish and zooplankton, can strongly influence individual niche variation among generalist fishes with different ontogenetic trajectories, and hence the overall foodweb structures in lake ecosystems.	[Vejrikova, Ivana; Vejrik, Lukas; Smejkal, Marek; Cech, Martin; sajdlova, Zuzana; Frouzova, Jaroslava; Peterka, Jlri] Czech Acad Sci, Biol Ctr, Inst Hydrobiol, Sadkach 7, Ceske Budejovice, Czech Republic; [Vejrikova, Ivana] Univ South Bohemia Ceske Budejovice, Fac Sci, Branisovska 31, Ceske Budejovice, Czech Republic; [Eloranta, Anttl P.] Norwegian Inst Nat Res, Trondheim, Norway; [Kiljunen, Mikko] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Norwegian Institute Nature Research; University of Jyvaskyla	Peterka, J (corresponding author), Czech Acad Sci, Biol Ctr, Inst Hydrobiol, Sadkach 7, Ceske Budejovice, Czech Republic.	j.peterka@yahoo.com	Frouzova, Jaroslava/F-8518-2014; Peterka, Jiří/C-7218-2014; Vejřík, Lukáš/E-1607-2017; Eloranta, Antti Pekka/AAA-1426-2020; Šmejkal, Marek/E-1269-2017; Sajdlova, Zuzana/R-1383-2018; Vejříková, Ivana/E-1624-2017; Čech, Martin/C-5797-2014	Frouzova, Jaroslava/0000-0003-4876-4985; Vejřík, Lukáš/0000-0001-8911-9128; Šmejkal, Marek/0000-0002-7887-6411; Vejříková, Ivana/0000-0001-9113-2815; Čech, Martin/0000-0003-1350-4286; Eloranta, Antti/0000-0002-8893-0135	(CEKOPOT) of the Ministry of Education, Youth and Sports [CZ.1.07/2.3.00/20.0204]; Norwegian Financial Mechanism [7F14316, MSMT-28477/2014, LM2015075]; (SoWa Research Infrastructure) of the programme "Projects of Large Infrastructure for Research, Development, and Innovations" of the Ministry of Education, Youth and Sports from University of South Bohemia [158/2016/P]	(CEKOPOT) of the Ministry of Education, Youth and Sports; Norwegian Financial Mechanism; (SoWa Research Infrastructure) of the programme "Projects of Large Infrastructure for Research, Development, and Innovations" of the Ministry of Education, Youth and Sports from University of South Bohemia	The study was supported by projects No. CZ.1.07/2.3.00/20.0204 (CEKOPOT) of the Ministry of Education, Youth and Sports, No. 7F14316 of the Norwegian Financial Mechanism 2009-2014 under contract number MSMT-28477/2014, No. LM2015075 (SoWa Research Infrastructure) of the programme "Projects of Large Infrastructure for Research, Development, and Innovations" of the Ministry of Education, Youth and Sports, and No.158/2016/P from University of South Bohemia.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Araujo MS, 2011, ECOL LETT, V14, P948, DOI 10.1111/j.1461-0248.2011.01662.x; Bearhop S, 2002, PHYSIOL BIOCHEM ZOOL, V75, P451, DOI 10.1086/342800; Blabolil P, 2016, FISH RES, V173, P80, DOI 10.1016/j.fishres.2015.05.022; Bode A, 2006, MAR ECOL PROG SER, V318, P89, DOI 10.3354/meps318089; Bolnick DI, 2011, TRENDS ECOL EVOL, V26, P183, DOI 10.1016/j.tree.2011.01.009; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Cabana G, 1996, P NATL ACAD SCI USA, V93, P10844, DOI 10.1073/pnas.93.20.10844; Castanheira MF, PLOS ONE, V8; CEN, 2015, EN14757; Craig FG, 2000, PERCID FISHES SYSTEM; DENNISON WC, 1993, BIOSCIENCE, V43, P86, DOI 10.2307/1311969; DIEHL S, 1988, OIKOS, V53, P207, DOI 10.2307/3566064; DIEHL S, 1992, ECOLOGY, V73, P1646, DOI 10.2307/1940017; Duncan A., 1993, COMP RESERVOIR LIMNO, P153; Estlander S, 2010, J FISH BIOL, V77, P241, DOI 10.1111/j.1095-8649.2010.02682.x; Feyrer F, 2003, ENVIRON BIOL FISH, V67, P277, DOI 10.1023/A:1025839132274; FRANCE R, 1995, CAN J FISH AQUAT SCI, V52, P651, DOI 10.1139/f95-065; Freyhof J., 2007, HDB EUROPEAN FRESHWA; Gerking SD., 2014, FEEDING ECOLOGY FISH; Grenouillet G, 2001, J FISH BIOL, V59, P939; Hargeby A, 2005, FRESHWATER BIOL, V50, P2053, DOI 10.1111/j.1365-2427.2005.01446.x; Hayden B, 2015, FRESHWATER BIOL, V60, P1000, DOI 10.1111/fwb.12564; Horppila J, 2009, J FISH BIOL, V75, P1230, DOI 10.1111/j.1095-8649.2009.02359.x; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Jarolim O, 2010, HYDROBIOLOGIA, V654, P253, DOI 10.1007/s10750-010-0398-1; Jeppesen E, 2000, FRESHWATER BIOL, V45, P201, DOI 10.1046/j.1365-2427.2000.00675.x; Jeppesen E., 1992, STRUCTURING ROLE SUB; Kapuscinski KL, 2012, HYDROBIOLOGIA, V693, P169, DOI 10.1007/s10750-012-1106-0; Kratina P, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00121.1; Lacoul P, 2006, ENVIRON REV, V14, P89, DOI 10.1139/a06-001; Layman CA, 2012, BIOL REV, V87, P545, DOI 10.1111/j.1469-185X.2011.00208.x; LODGE DM, 1991, AQUAT BOT, V41, P195, DOI 10.1016/0304-3770(91)90044-6; Losos JB, 2010, AM NAT, V175, P623, DOI 10.1086/652433; McMeans BC, 2016, ECOL MONOGR, V86, P4, DOI 10.1890/15-0288.1; Mittelbach GG, 2014, CAN J FISH AQUAT SCI, V71, P927, DOI 10.1139/cjfas-2013-0558; NEWMAN RM, 1991, J N AM BENTHOL SOC, V10, P89, DOI 10.2307/1467571; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; Olin M, 2002, J FISH BIOL, V60, P593, DOI 10.1006/jfbi.2002.1876; Persson A, 1999, CAN J FISH AQUAT SCI, V56, P70, DOI 10.1139/cjfas-56-1-70; Persson L, 2000, ECOLOGY, V81, P1058; PERSSON L, 1990, ECOLOGY, V71, P44, DOI 10.2307/1940246; Persson L., 1988, P203; PERSSON L, 1995, ECOLOGY, V76, P70, DOI 10.2307/1940632; PERSSON L, 1991, J FISH BIOL, V38, P281, DOI 10.1111/j.1095-8649.1991.tb03114.x; PERSSON L, 1991, BEHAV ECOL SOCIOBIOL, V28, P101; PERSSON L, 1993, OIKOS, V68, P12, DOI 10.2307/3545304; PERSSON L, 1987, ENVIRON BIOL FISH, V19, P235, DOI 10.1007/BF00005353; PIMM SL, 1978, NATURE, V275, P542, DOI 10.1038/275542a0; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Post DM, 2002, TRENDS ECOL EVOL, V17, P269, DOI 10.1016/S0169-5347(02)02455-2; PREJS A, 1978, EKOL POL-POL J ECOL, V26, P429; Quevedo M, 2009, ECOLOGY, V90, P2263, DOI 10.1890/07-1580.1; Schindler DE, 2002, OIKOS, V98, P177, DOI 10.1034/j.1600-0706.2002.980201.x; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; SCHRIVER P, 1995, FRESHWATER BIOL, V33, P255, DOI 10.1111/j.1365-2427.1995.tb01166.x; Specziar A, 2009, J FISH BIOL, V75, P247, DOI 10.1111/j.1095-8649.2009.02283.x; Svanback R, 2004, J ANIM ECOL, V73, P973, DOI 10.1111/j.0021-8790.2004.00868.x; Takimoto G, 2013, ECOL RES, V28, P675, DOI 10.1007/s11284-012-0943-7; Vasek M, 2004, INT REV HYDROBIOL, V89, P352, DOI 10.1002/iroh.200410734; Vasek M, 2008, FOLIA ZOOL, V57, P324; Vasek M, 2006, INT REV HYDROBIOL, V91, P178, DOI 10.1002/iroh.200510835; Vejrik L, 2016, FRESHWATER BIOL, V61, P899, DOI 10.1111/fwb.12753; Vejrikova I, 2016, SCI REP-UK, V6, DOI 10.1038/srep39600; Warfe DM, 2006, OECOLOGIA, V150, P141, DOI 10.1007/s00442-006-0505-1; WINFIELD IJ, 1986, J FISH BIOL, V29, P37, DOI 10.1111/j.1095-8649.1986.tb04997.x	68	15	17	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177114	10.1371/journal.pone.0177114	http://dx.doi.org/10.1371/journal.pone.0177114			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486550	Green Accepted, Green Published, gold			2022-12-26	WOS:000401314000046
J	Gutierrez-Camino, A; Martin-Guerrero, I; de Andoin, NG; Sastre, A; Baneres, AC; Astigarraga, I; Navajas, A; Garcia-Orad, A				Gutierrez-Camino, Angela; Martin-Guerrero, Idoia; Garcia de Andoin, Nagore; Sastre, Ana; Carbone Baneres, Ana; Astigarraga, Itziar; Navajas, Aurora; Garcia-Orad, Africa			Confirmation of involvement of new variants at CDKN2A/B in pediatric acute lymphoblastic leukemia susceptibility in the Spanish population	PLOS ONE			English	Article							CHILDHOOD; RISK; 10Q21.2; 7P12.2; 14Q11.2; ARID5B; LOCI; CEBPE	The locus CDKN2A/B (9p21.3), which comprises the tumor suppressors genes CDKN2A and CDKN2B and the long noncoding RNA (lncRNA) known as ANRIL (or CDKN2B-AS), was associated with childhood acute lymphoblastic leukemia (ALL) susceptibility in several genome wide association studies (GWAS). However, the variants associated in the diverse studies were different. Recently, new and independent SNPs deregulating the locus function were also identified in association with ALL risk. This diversity in the results may be explained because different variants in each population could alter CDKN2A/B locus function through diverse mechanisms. Therefore, the aim of this study was to determine whether the annotated risk variants in the CDKN2A/B locus affect the susceptibility of B cell precursor ALL (B-ALL) in our Spanish population and explore if other SNPs altering additional regulatory mechanisms could be also involved. We analyzed the four SNPs proposed by GWAs and two additional SNPs in miRNA binding sites in 217 pediatric patients with B-ALL and 330 healthy controls. The SNPs rs2811712, rs3731249, rs3217992 and rs2811709 were associated with B-ALL susceptibility in our Spanish population. ALL subtypes analyses showed that rs2811712 was associated with B-hyperdiploid ALL. These results provide evidence for the influence of genetic variants at CDKN2A/B locus with the risk of developing BALL.	[Gutierrez-Camino, Angela; Martin-Guerrero, Idoia; Garcia-Orad, Africa] Univ Basque Country, Dept Genet Phys Anthropol & Anim Physiol, UPV EHU, Leioa, Spain; [Garcia de Andoin, Nagore] Univ Hosp Donostia, Dept Pediat, San Sebastian, Spain; [Garcia de Andoin, Nagore] BioDonostia Hlth Res Inst, San Sebastian, Spain; [Sastre, Ana] Univ Hosp La Paz, Dept Oncohematol, Madrid, Spain; [Carbone Baneres, Ana] Univ Hosp Miguel Servet, Dept Pediat, Zaragoza, Spain; [Astigarraga, Itziar] Univ Hosp Cruces, Dept Pediat, Baracaldo, Spain; [Astigarraga, Itziar; Navajas, Aurora; Garcia-Orad, Africa] BioCruces Hlth Res Inst, Baracaldo, Spain	University of Basque Country; University Hospital Donostia; Instituto de Investigacion Sanitaria Biodonostia; Hospital Universitario La Paz; Miguel Servet University Hospital; Hospital Universitario Cruces	Garcia-Orad, A (corresponding author), Univ Basque Country, Dept Genet Phys Anthropol & Anim Physiol, UPV EHU, Leioa, Spain.; Garcia-Orad, A (corresponding author), BioCruces Hlth Res Inst, Baracaldo, Spain.	africa.garciaorad@ehu.eus	Gutierrez-Camino, Angela/AAM-2032-2020; Astigarraga, I/I-1215-2014; Martin-Guerrero, Idoia/AAF-3446-2020	Gutierrez-Camino, Angela/0000-0002-8679-6868; Astigarraga, I/0000-0002-5012-0137; Garcia.Orad, Africa/0000-0002-5575-3080; Martin-Guerrero, Idoia/0000-0002-0098-1908	Basque Government [IT661-13, IT989-16]; UPV/EHU [UFI11/35]; pre-doctoral grant from the Basque Government	Basque Government(Basque Government); UPV/EHU; pre-doctoral grant from the Basque Government	This study was funded by the Basque Government (IT661-13, IT989-16), UPV/EHU (UFI11/35). AGC was supported by a pre-doctoral grant from the Basque Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamini Y, 1995, J ROYAL STAT; Boon RA, 2016, J AM COLL CARDIOL, V67, P1214, DOI 10.1016/j.jacc.2015.12.051; Chokkalingam AP, 2013, CANCER CAUSE CONTROL, V24, P1789, DOI 10.1007/s10552-013-0256-3; Gong J, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav029; Gong J, 2012, HUM MUTAT, V33, P254, DOI 10.1002/humu.21641; Greaves M, 2006, NAT REV CANCER, V6, P193, DOI 10.1038/nrc1816; Gutierrez-Camino A, 2013, J CANCER RES CLIN, V139, P1879, DOI 10.1007/s00432-013-1512-3; Hungate EA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10635; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Lopez-Lopez E, 2013, JNCI-J NATL CANCER I, V105, P1512, DOI 10.1093/jnci/djt229; Meseure D, 2016, MOL CANC RES; Migliorini G, 2013, BLOOD, V122, P3298, DOI 10.1182/blood-2013-03-491316; Orsi L, 2012, LEUKEMIA, V26, P2561, DOI 10.1038/leu.2012.148; Papaemmanuil E, 2009, NAT GENET, V41, P1006, DOI 10.1038/ng.430; Pastorczak A, 2011, LEUKEMIA RES, V35, P1534, DOI 10.1016/j.leukres.2011.07.034; Prasad RB, 2010, BLOOD, V115, P1765, DOI 10.1182/blood-2009-09-241513; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Sambrook J, 2001, PREPARATION ANAL EUK, V1, P4; Sherborne AL, 2010, NAT GENET, V42, P492, DOI 10.1038/ng.585; Sullivan KM, 2009, PUBLIC HEALTH REP, V124, P471, DOI 10.1177/003335490912400320; Trevino LR, 2009, NAT GENET, V41, P1001, DOI 10.1038/ng.432; Vijayakrishnan J, 2015, SCI REP-UK, V5, DOI 10.1038/srep15065; Vijayakrishnan J, 2010, LEUKEMIA LYMPHOMA, V51, P1870, DOI 10.3109/10428194.2010.511356; Walsh KM, 2015, CANCER RES, V75, P4884, DOI 10.1158/0008-5472.CAN-15-1105; Xu H, 2013, J NATL CANC I; Xu H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8553	26	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177421	10.1371/journal.pone.0177421	http://dx.doi.org/10.1371/journal.pone.0177421			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481918	gold, Green Published, Green Submitted			2022-12-26	WOS:000401313700061
J	Lei, S; Huang, FJ; Zhao, AH; Chen, TL; Chen, WL; Xie, GX; Zheng, XJ; Zhang, YJ; Yu, HY; Zhang, P; Rajani, C; Bao, YQ; Jia, WP; Jia, W				Lei, Sha; Huang, Fengjie; Zhao, Aihua; Chen, Tianlu; Chen, Wenlian; Xie, Guoxiang; Zheng, Xiaojiao; Zhang, Yunjing; Yu, Haoyong; Zhang, Pin; Rajani, Cynthia; Bao, Yuqian; Jia, Weiping; Jia, Wei			The ratio of dihomo-gamma-linolenic acid to deoxycholic acid species is a potential biomarker for the metabolic abnormalities in obesity	FASEB JOURNAL			English	Article						bile acid; free fatty acid; targeted metabolomics; type 2 diabetes	Y GASTRIC BYPASS; POLYUNSATURATED FATTY-ACIDS; SERUM BILE-ACIDS; GROWTH-FACTOR 19; BODY-MASS INDEX; GLUCOSE-METABOLISM; DIABETES REMISSION; ENERGY-EXPENDITURE; BARIATRIC SURGERY; FOOD-INTAKE	Bile acid (BA) signaling regulates fatty acid metabolism. BA dysregulation plays an important role in the development of metabolic disease. However, BAs in relation to fatty acids have not been fully investigated in obesity-related metabolic disorders. A targeted metabolomic measurement of serum BA and free fatty acid profiles was applied to sera of 381 individuals in 2 independent studies. The results showed that the ratio of dihomo-gamma-linolenic acid (DGLA) to deoxycholic acid (DCA) species (DCAS) was significantly increased in obese individuals with type 2 diabetes (T2DM) from a case-control study and decreased in the remission group of obese subjects with T2DM after metabolic surgery. The changes were closely associated with their metabolic status. These results were consistently confirmed in both serum and liver of mice with diet-induced obesity, implying that such a metabolic alteration in circulation reflects changes occurring in the liver. In vitro studies of human liver L-02 cell lines under BA treatment revealed that DCA and its conjugated form, TDCA, significantly inhibited mRNA expression of fatty acid transport protein 5 in the presence of DGLA, which was involved in hepatocyte DGLA uptake. Thus, the DGLA: DCAS ratio may be a promising biomarker for metabolic abnormalities in obesity.	[Lei, Sha; Huang, Fengjie; Zhao, Aihua; Chen, Tianlu; Zheng, Xiaojiao; Zhang, Yunjing; Jia, Weiping; Jia, Wei] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Key Lab Diabet Mellitus, Shanghai, Peoples R China; [Lei, Sha; Huang, Fengjie; Zhao, Aihua; Chen, Tianlu; Zheng, Xiaojiao; Zhang, Yunjing; Jia, Weiping; Jia, Wei] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Ctr Translat Med, Shanghai, Peoples R China; [Yu, Haoyong; Bao, Yuqian; Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Endocrinol & Metab, Shanghai, Peoples R China; [Yu, Haoyong; Bao, Yuqian; Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Diabet Inst, Shanghai Clin Ctr Diabet, Shanghai, Peoples R China; [Yu, Haoyong; Bao, Yuqian; Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Key Clin Ctr Metab Dis, Shanghai, Peoples R China; [Zhang, Pin] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Gen Surg, Shanghai, Peoples R China; [Chen, Wenlian; Xie, Guoxiang; Rajani, Cynthia; Jia, Wei] Univ Hawaii, Ctr Canc, 701 Ilalo St, Honolulu, HI 96813 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Cancer Research Center of Hawaii; University of Hawaii System	Jia, W (corresponding author), Univ Hawaii, Ctr Canc, 701 Ilalo St, Honolulu, HI 96813 USA.	wjia@cc.hawaii.edu	Jia, Wei/AAN-5102-2020; Xie, Guoxiang/F-3022-2016	Jia, Wei/0000-0002-3739-8994; Xie, Guoxiang/0000-0002-0951-4150	International Science and Technology Cooperation Program of China [2014DFA31870]; NATIONAL CANCER INSTITUTE [P30CA071789] Funding Source: NIH RePORTER	International Science and Technology Cooperation Program of China; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the International Science and Technology Cooperation Program of China (Grant 2014DFA31870). The authors declare no conflicts of interest.	Albaugh VL, 2015, J CLIN ENDOCR METAB, V100, pE1225, DOI 10.1210/jc.2015-2467; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Alhazmi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097001; Boden G, 2011, CURR OPIN ENDOCRINOL, V18, P139, DOI 10.1097/MED.0b013e3283444b09; Buse JB, 2009, DIABETES CARE, V32, P2133, DOI 10.2337/dc09-9036; Chen WL, 2014, BLOOD, V124, P1645, DOI 10.1182/blood-2014-02-554204; Cho JS, 2014, NUTR RES, V34, P733, DOI 10.1016/j.nutres.2014.08.005; Decara J, 2016, BIOFACTORS, V42, P600, DOI 10.1002/biof.1295; Doege H, 2006, GASTROENTEROLOGY, V130, P1245, DOI 10.1053/j.gastro.2006.02.006; Forouhi NG, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002094; Gerhard GS, 2013, DIABETES CARE, V36, P1859, DOI 10.2337/dc12-2255; Guo CS, 2016, IMMUNITY, V45, P802, DOI 10.1016/j.immuni.2016.09.008; Hao Z, 2016, OBES SURG, V26, P2173, DOI 10.1007/s11695-016-2062-y; Hao Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052922; Hubbard B, 2006, GASTROENTEROLOGY, V130, P1259, DOI 10.1053/j.gastro.2006.02.012; Jorgensen NB, 2015, J CLIN ENDOCR METAB, V100, pE396, DOI 10.1210/jc.2014-1658; Jump DB, 2002, J BIOL CHEM, V277, P8755, DOI 10.1074/jbc.R100062200; Kashihara H, 2015, J GASTROEN HEPATOL, V30, P308, DOI 10.1111/jgh.12690; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Kohli R, 2013, J CLIN ENDOCR METAB, V98, pE708, DOI 10.1210/jc.2012-3736; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Li TG, 2014, PHARMACOL REV, V66, P948, DOI 10.1124/pr.113.008201; Ma HJ, 2014, BEST PRACT RES CL GA, V28, P573, DOI 10.1016/j.bpg.2014.07.004; Matsuda M, 2017, OBES RES CLIN PRACT, V11, P34, DOI 10.1016/j.orcp.2016.02.004; Molendi-Coste O, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/364040; Nausheen S, 2013, AM J PHYSIOL-ENDOC M, V305, pE507, DOI 10.1152/ajpendo.00130.2013; Netto BD, 2015, OBES SURG, V25, P1010, DOI 10.1007/s11695-014-1484-7; Ni Y, 2015, EBIOMEDICINE, V2, P1513, DOI 10.1016/j.ebiom.2015.09.004; Nie B, 2012, HEPATOLOGY, V56, P1300, DOI 10.1002/hep.25797; Park WH, 2011, EXP MOL MED, V43, P571, DOI 10.3858/emm.2011.43.10.064; Patti ME, 2009, OBESITY, V17, P1671, DOI 10.1038/oby.2009.102; Penney NC, 2015, INT J OBESITY, V39, P1565, DOI 10.1038/ijo.2015.115; Shao YM, 2015, DRUG DES DEV THER, V9, P1177, DOI 10.2147/DDDT.S79175; Simonen M, 2012, OBES SURG, V22, P1473, DOI 10.1007/s11695-012-0673-5; Steffen BT, 2012, INT J OBESITY, V36, P797, DOI 10.1038/ijo.2011.157; Steinert RE, 2013, OBESITY, V21, pE660, DOI 10.1002/oby.20522; Wall R, 2010, NUTR REV, V68, P280, DOI 10.1111/j.1753-4887.2010.00287.x; Wang XN, 2016, J PROTEOME RES, V15, P1126, DOI 10.1021/acs.jproteome.5b00217; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Xie GX, 2016, INT J CANCER, V139, P1764, DOI 10.1002/ijc.30219; Xie GX, 2015, J PROTEOME RES, V14, P850, DOI 10.1021/pr500920q; Xie GX, 2013, FASEB J, V27, P3583, DOI 10.1096/fj.13-231860; Yabe D, 2011, PROG BIOPHYS MOL BIO, V107, P248, DOI 10.1016/j.pbiomolbio.2011.07.010; Yary T, 2016, AM J CLIN NUTR, V103, P1337, DOI 10.3945/ajcn.115.128629; Yu HY, 2015, SURG OBES RELAT DIS, V11, P6, DOI 10.1016/j.soard.2014.06.019; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P245; Zhou J, 2008, GASTROENTEROLOGY, V134, P556, DOI 10.1053/j.gastro.2007.11.037	47	15	18	3	25	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					3904	3912		10.1096/fj.201700055R	http://dx.doi.org/10.1096/fj.201700055R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28490483	Green Published			2022-12-26	WOS:000408713300017
J	Anderson, DJ; Rojas, LF; Watson, S; Knelson, LP; Pruitt, S; Lewis, SS; Moehring, RW; Bennett, EES; Weber, DJ; Chen, LF; Sexton, DJ				Anderson, Deverick J.; Rojas, Leoncio Flavio; Watson, Shera; Knelson, Lauren P.; Pruitt, Sohayla; Lewis, Sarah S.; Moehring, Rebekah W.; Bennett, Emily E. Sickbert; Weber, David J.; Chen, Luke F.; Sexton, Daniel J.		CDC Prevention Epicenters Program	Identification of novel risk factors for community-acquired Clostridium difficile infection using spatial statistics and geographic information system analyses	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; HOSPITAL-ONSET; PCR RIBOTYPES; SWINE; DENSITY; OPERATIONS; ADMISSION; TIME; AIR		[Anderson, Deverick J.; Lewis, Sarah S.; Moehring, Rebekah W.; Chen, Luke F.; Sexton, Daniel J.] Duke Univ, Dept Med, Durham, NC USA; [Anderson, Deverick J.; Rojas, Leoncio Flavio; Watson, Shera; Knelson, Lauren P.; Lewis, Sarah S.; Moehring, Rebekah W.; Chen, Luke F.; Sexton, Daniel J.] Duke Univ, Duke Ctr Antimicrobial Stewardship & Infect Preve, Durham, NC 27706 USA; [Knelson, Lauren P.] Dana Farber Canc Inst, Breast Oncol Program, Susan F Smith Ctr Womens Canc, Boston, MA 02115 USA; [Pruitt, Sohayla] Duke Hlth Technol Solut, Durham, NC USA; [Pruitt, Sohayla] Forecast Hlth, Durham, NC USA; [Moehring, Rebekah W.] Durham VA Med Ctr, Durham, NC USA; [Bennett, Emily E. Sickbert; Weber, David J.] Univ North Carolina Chapel Hill, Dept Hosp Epidemiol, Chapel Hill, NC USA	Duke University; Duke University; Harvard University; Dana-Farber Cancer Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Anderson, DJ (corresponding author), Duke Univ, Dept Med, Durham, NC USA.; Anderson, DJ (corresponding author), Duke Univ, Duke Ctr Antimicrobial Stewardship & Infect Preve, Durham, NC 27706 USA.	dja@duke.edu		Anderson, Deverick/0000-0001-6882-5496; Sexton, Daniel J/0000-0001-9604-5948	CDC Prevention Epicenters Program [U54CK000164]; National Center for Advancing Translational Sciences (NCATS); National Institutes of Health [UL1TR001111]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS023866] Funding Source: NIH RePORTER	CDC Prevention Epicenters Program(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This work was supported by the CDC Prevention Epicenters Program [U54CK000164] and the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health [UL1TR001111]. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the CDC.	Anderson DJ, 2011, INFECT CONT HOSP EP, V32, P315, DOI 10.1086/658940; Auguet OT, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001944; Bauer MP, 2011, LANCET, V377, P63, DOI 10.1016/S0140-6736(10)61266-4; Bondo KJ, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0563-x; Carrel M, 2014, INFECT CONT HOSP EP, V35, P190, DOI 10.1086/674860; Casey JA, 2013, JAMA INTERN MED, V173, P1980, DOI 10.1001/jamainternmed.2013.10408; Centers for Disease Control and Prevention, ANTIBIOTIC RESISTANC; Centers for Disease Control and Prevention, MULT RES ORG CLOSTR; Chitnis AS, 2013, JAMA INTERN MED, V173, P1359, DOI 10.1001/jamainternmed.2013.7056; Dial S, 2005, JAMA-J AM MED ASSOC, V294, P2989, DOI 10.1001/jama.294.23.2989; Dubberke ER, 2011, INFECT CONT HOSP EP, V32, P360, DOI 10.1086/658944; Eyre DW, 2013, NEW ENGL J MED, V369, P1195, DOI 10.1056/NEJMoa1216064; Feingold BJ, 2012, EMERG INFECT DIS, V18, P1841, DOI 10.3201/eid1811.111850; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; Gibbs SG, 2006, ENVIRON HEALTH PERSP, V114, P1032, DOI 10.1289/ehp.8910; Hall AJ, 2012, CLIN INFECT DIS, V55, P216, DOI 10.1093/cid/cis386; Hopman NEM, 2011, VET MICROBIOL, V149, P186, DOI 10.1016/j.vetmic.2010.10.013; Johnson S, 1998, CLIN INFECT DIS, V26, P1027, DOI 10.1086/520276; Keessen EC, 2013, EMERG INFECT DIS, V19, P1032, DOI 10.3201/eid1906.121645; Khanna S, 2012, AM J GASTROENTEROL, V107, P89, DOI 10.1038/ajg.2011.398; Kuntz JL, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-194; Kutty PK, 2010, EMERG INFECT DIS, V16, P197, DOI 10.3201/eid1602.090953; Kwon JH, 2015, INFECT DIS CLIN N AM, V29, P123, DOI 10.1016/j.idc.2014.11.003; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Love DC, 2011, ENVIRON HEALTH PERSP, V119, P279, DOI 10.1289/ehp.1002625; McDonald L. Clifford, 2012, Morbidity and Mortality Weekly Report, V61, P157; Miller BA, 2011, INFECT CONT HOSP EP, V32, P387, DOI 10.1086/659156; Naggie S, 2011, AM J MED, V124, P276, DOI 10.1016/j.amjmed.2010.10.013; Pelaez T, 2013, ANAEROBE, V22, P45, DOI 10.1016/j.anaerobe.2013.05.009; Pepin J, 2012, J INFECTION, V64, P387, DOI 10.1016/j.jinf.2011.12.011; Rodriguez-Palacios A, 2007, EMERG INFECT DIS, V13, P485, DOI 10.3201/eid1303.060988; Rodriguez-Palacios A, 2006, EMERG INFECT DIS, V12, P1730, DOI 10.3201/eid1211.051581; Schinasi L, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-54; Schneeberg A, 2012, ANAEROBE, V18, P484, DOI 10.1016/j.anaerobe.2012.08.002; Schulz J, 2012, APPL ENVIRON MICROB, V78, P5666, DOI 10.1128/AEM.00550-12; Tabak YP, 2015, INFECT CONT HOSP EP, V36, P695, DOI 10.1017/ice.2015.37; US Census Bureau, US CENS BUR CENS TRA; US Census Bureau, AM COMM SURV 2014; US Census Bureau, DAT WEB DATAFERRETT; Weese JS, 2010, CLIN MICROBIOL INFEC, V16, P3, DOI 10.1111/j.1469-0691.2009.03108.x; Wilcox MH, 2008, J ANTIMICROB CHEMOTH, V62, P388, DOI 10.1093/jac/dkn163; Zidaric V, 2008, ANAEROBE, V14, P325, DOI 10.1016/j.anaerobe.2008.10.001	42	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0176285	10.1371/journal.pone.0176285	http://dx.doi.org/10.1371/journal.pone.0176285			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28510584	Green Published, Green Submitted, gold			2022-12-26	WOS:000401485500005
J	Magnusson, K; Holte, KB; Juel, NG; Brox, JI; Hagen, KB; Haugen, IK; Berg, TJ				Magnusson, Karin; Holte, Kristine Bech; Juel, Niels Gunnar; Brox, Jens Ivar; Hagen, Kare Birger; Haugen, Ida Kristin; Berg, Tore Julsrud			Long term type 1 diabetes is associated with hand pain, disability and stiffness but not with structural hand osteoarthritis features - The Dialong hand study	PLOS ONE			English	Article							METABOLIC FACTORS; DISEASE; PROGRESSION; POPULATION; PREVALENCE; PHENOTYPE; ARTHROSIS; WEIGHT	Objective To explore whether having long-term type 1 diabetes (>45 years) is associated with a higher prevalence of radiographic hand OA, erosive hand OA and increased hand pain, disability and stiffness. Methods In total N = 96 persons with type 1 diabetes diagnosed before 1970 were included (mean [SD] age: 62.2 [7.4], mean [SD] HbA(1c): 7.43 [0.80] and N = 49 [51%] men). Regular measurements of their HbA1c were obtained till 2015. We included N = 69 healthy controls without any diabetes (mean [SD] age: 63.0 [7.0], mean [SD] HbA1c: 5.41 [0.32], N = 29 [42%] men). The groups were compared for radiographic hand OA (Kellgren-Lawrence grade >= 2 in >= 1 joint) and erosive hand OA (central erosions in >= 1 joint), Australian/Canadian index (AUSCAN) for hand pain, disability and stiffness using regression analyses adjusted for age, sex, educational level and waist circumference. Results We found no associations between having long term type 1 diabetes and more prevalent radiographic hand OA (OR = 0.83, 95% CI = 0.38-1.81). We found a trend towards higher prevalence of erosive hand OA in diabetes patients (OR = 2.96, 95% CI = 0.82-10.64). Strong and consistent associations were observed between long term type 1 diabetes and increased hand pain (B = 2.78, 95% CI = 1.65-3.91), disability (B = 5.30, 95% CI = 3.48-7.12) and stiffness (B = 2.00, 95% CI = 1.330-2.67). These associations were particularly strong for women and participants below the median age of 61 years. Conclusion Long-term type 1 diabetes was not associated with radiographic hand OA, but was strongly associated with hand pain, disability and stiffness. The association between diabetes and erosive hand OA warrants further investigation.	[Magnusson, Karin; Hagen, Kare Birger] Diakonhjemmet Hosp, Dept Rheumatol, Natl Advisory Unit Rehabil Rheumatol, Oslo, Norway; [Magnusson, Karin] Lund Univ, Dept Clin Sci Lund, Clin Epidemiol Unit, Orthopaed, Lund, Sweden; [Holte, Kristine Bech; Berg, Tore Julsrud] Oslo Univ Hosp, Dept Endocrinol, Oslo, Norway; [Juel, Niels Gunnar; Brox, Jens Ivar] Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway; [Brox, Jens Ivar; Haugen, Ida Kristin] Diakonhjemmet Hosp, Dept Rheumatol, Oslo, Norway; [Berg, Tore Julsrud] Norwegian Diabet Ctr, Oslo, Norway; [Berg, Tore Julsrud] Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway	Diakonhjemmet Hospital; Lund University; University of Oslo; University of Oslo; Diakonhjemmet Hospital; University of Oslo	Magnusson, K (corresponding author), Diakonhjemmet Hosp, Dept Rheumatol, Natl Advisory Unit Rehabil Rheumatol, Oslo, Norway.; Magnusson, K (corresponding author), Lund Univ, Dept Clin Sci Lund, Clin Epidemiol Unit, Orthopaed, Lund, Sweden.	magnusson_karin@outlook.com	Brox, Jens Ivar/N-1601-2018	Magnusson, Karin/0000-0003-4851-5794; Haugen, Ida Kristin/0000-0001-7810-2216	South-Eastern Norway Regional Health Authority; Oslo Diabetes Research Centre/Oslo University Hospital; Norwegian Diabetics' Centr research fund; Odd Fellow Research Fund; Norwegian Diabetes Association; Blix Family Foundation	South-Eastern Norway Regional Health Authority; Oslo Diabetes Research Centre/Oslo University Hospital; Norwegian Diabetics' Centr research fund; Odd Fellow Research Fund; Norwegian Diabetes Association; Blix Family Foundation	The data collection of the Dialong study has been funded from different sources through the Oslo Diabetes Research Centre/Oslo University Hospital, The Norwegian Diabetics' Centr research fund, the Odd Fellow Research Fund, The Norwegian Diabetes Association, and the Blix Family Foundation. The corresponding author (KM) was funded by the South-Eastern Norway Regional Health Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 1991, PRACTICAL STAT MED R, P440; Altman RD, 2007, OSTEOARTHR CARTILAGE, V15, pA1, DOI 10.1016/j.joca.2006.11.009; Banon S, 2013, Scand J Rheumatol, V42, P1, DOI 10.3109/03009742.2012.713983; BELLAMY N, 2007, INT MED J S2, V37, pA36; Berenbaum F, 2013, OSTEOARTHR CARTILAGE, V21, P16, DOI 10.1016/j.joca.2012.11.012; Berenbaum F, 2011, ANN RHEUM DIS, V70, P1354, DOI 10.1136/ard.2010.146399; Cleary PA, 2013, DIABETES TECHNOL THE, V15, P466, DOI 10.1089/dia.2012.0316; Dahaghin S, 2007, ANN RHEUM DIS, V66, P916, DOI 10.1136/ard.2005.045724; Felson DT, 2013, OSTEOARTHR CARTILAGE, V21, P10, DOI 10.1016/j.joca.2012.09.012; Felson DT, 2004, ARTHRITIS RHEUM, V50, P3904, DOI 10.1002/art.20726; Frey N, 2016, OSTEOARTHRITIS CARTI; Galer BS, 2000, DIABETES RES CLIN PR, V47, P123, DOI 10.1016/S0168-8227(99)00112-6; Haugen IK, 2016, OSTEOARTHR CARTILAGE, V24, P647, DOI 10.1016/j.joca.2015.11.014; Haugen IK, 2015, ANN RHEUM DIS, V74, P74, DOI 10.1136/annrheumdis-2013-203789; Haugen IK, 2011, ANN RHEUM DIS, V70, P1581, DOI 10.1136/ard.2011.150078; Hopstock LA, 2015, HYPERTENSION, V66, P496, DOI 10.1161/HYPERTENSIONAHA.115.05925; JAMES TM, 1981, CLIN BIOCHEM, V14, P25, DOI 10.1016/0009-9120(81)90135-1; Jensen V, 1999, OCCUP MED-OXFORD, V49, P383, DOI 10.1093/occmed/49.6.383; Jungmann PM, 2013, ARTHRIT CARE RES, V65, P1942, DOI 10.1002/acr.22093; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kujala U M, 1999, Twin Res, V2, P196, DOI 10.1375/136905299320565861; Louati K, 2015, RMD OPEN, V1, DOI 10.1136/rmdopen-2015-000077; Magnusson K, 2015, ARTHRIT CARE RES, V67, P187, DOI 10.1002/acr.22460; Marshall M, 2013, OSTEOARTHR CARTILAGE, V21, P1674, DOI 10.1016/j.joca.2013.08.004; NOKLUS, NAT NORW DIAB REG AN; Slatkowsky-Christensen B, 2005, OSTEOARTHR CARTILAGE, V13, P561, DOI 10.1016/j.joca.2005.02.013; Yusuf E, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3894; Yusuf E, 2010, ANN RHEUM DIS, V69, P761, DOI 10.1136/ard.2008.106930	28	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177118	10.1371/journal.pone.0177118	http://dx.doi.org/10.1371/journal.pone.0177118			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28510594	Green Published, Green Submitted, gold			2022-12-26	WOS:000401485500013
J	Qu, XL; Hei, Y; Kang, L; Yang, XJ; Wang, Y; Lu, XZ; Xiao, LH; Yang, G				Qu, Xiao-Li; Hei, Yan; Kang, Li; Yang, Xin-Ji; Wang, Yi; Lu, Xiao-Zhong; Xiao, Li-Hua; Yang, Guang			Establishment of a combination scoring method for diagnosis of ocular adnexal lymphoproliferative disease	PLOS ONE			English	Article							REACTIVE LYMPHOID HYPERPLASIA; FOLLICULAR DENDRITIC CELLS; NON-HODGKIN-LYMPHOMA; MALT LYMPHOMA; HELICOBACTER-PYLORI; CLINICOPATHOLOGICAL FEATURES; MALIGNANT-LYMPHOMA; GERMINAL-CENTERS; DISORDERS; ORBIT	Lymphoproliferative diseases (LPDs) of the ocular adnexa encompass the majority of orbital diseases and include reactive follicular hyperplasia (RFH), atypical lymphoid hyperplasia (ALH), and mucosa-associated lymphoid tissue lymphoma (MALToma). Lymphoid follicles (LFs) are usually observed during the histological examination of LPDs. Currently, because there is a lack of specific clinical signs and diagnostic immunohistochemical biomarkers, it is difficult for pathologists to distinguish MALToma from ocular RFH and ALH, which makes the clinical management of these conditions difficult. Here, we analyzed the clinical features of patients with ocular adnexal LPDs (n = 125) and investigated the structure of LFs in paraffin-embedded tissue samples using anti-CD23 and anti-IgD immunochemistry. We found that some clinical features including age, sex, and laterality were different among RFH, LFH, and MALToma. Additionally, immunohistochemistry revealed that the expression of IgD and CD23 was higher in RFH patients and decreased in patients with ALH and MALToma. Moreover, LFs in RFH were intact, whereas the structures of most LFs were disrupted in ALH. In MALToma specimens, few intact LFs were observed. In a further investigation, we combined the results for CD23/IgD immunohistochemistry and the structure of LFs to establish a scoring method for the differential diagnosis of LPDs. According to the BIOMED-2 protocol, we further detected IgH gene monoclonal rearrangement in 73 cases (35 RFH, 17 ALH, and 21 MALToma cases). The sensitivity of our scoring method, based on a comparison with the results of IgH gene monoclonal rearrangement detection, was 85.7% (18/21) for MALToma and 35.3% (6/17) for ALH. Our study provides a method that may be useful for the differential diagnosis of RFH, ALH, and MALToma.	[Qu, Xiao-Li] Qianfoshan Hosp, Ophthalmol Dept, Jinan, Shandong, Peoples R China; [Hei, Yan; Kang, Li; Yang, Xin-Ji; Wang, Yi; Lu, Xiao-Zhong; Xiao, Li-Hua] Gen Hosp Chinese Peoples Armed Police Forces, Inst Orbital Dis, Beijing, Peoples R China; [Yang, Guang] Beijing Inst Basic Med Sci, Beijing, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Academy of Military Medical Sciences - China	Xiao, LH (corresponding author), Gen Hosp Chinese Peoples Armed Police Forces, Inst Orbital Dis, Beijing, Peoples R China.; Yang, G (corresponding author), Beijing Inst Basic Med Sci, Beijing, Peoples R China.	xiaolihuawj@sina.com; yanggg@hotmail.com			General Hospital of Chinese People's Armed Police Forces [WZ2011001]	General Hospital of Chinese People's Armed Police Forces	The study was supported by the General Hospital of Chinese People's Armed Police Forces (WZ2011001). The funder had no role in study design, data collection an danalysis,decisionto publish,or preparation of the manuscript.	Al-Mujaini A, 2012, MIDDLE EAST AFR J OP, V19, P406, DOI 10.4103/0974-9233.102760; Aljurf MA, 2003, ANN ONCOL, V14, P1595, DOI 10.1093/annonc/mdg442; Allen CDC, 2008, SEMIN IMMUNOL, V20, P14, DOI 10.1016/j.smim.2007.12.001; Bilal JA, 2014, SAUDI MED J, V35, P699; Cahill M, 1999, BRIT J OPHTHALMOL, V83, P742, DOI 10.1136/bjo.83.6.742; Cai JP, 2012, MED SCI MONITOR, V18, pBR84, DOI 10.12659/MSM.882462; Collina F, 2012, INFECT AGENTS CANCER, V7, DOI 10.1186/1750-9378-7-8; Coupland SE, 2011, HISTOPATHOLOGY, V58, P69, DOI 10.1111/j.1365-2559.2010.03706.x; De Silva NS, 2015, NAT REV IMMUNOL, V15, P137, DOI 10.1038/nri3804; Demirci H, 2002, OPHTHALMOLOGY, V109, P243, DOI 10.1016/S0161-6420(01)00932-0; Dong B, 2005, WORLD J GASTROENTERO, V11, P3595, DOI 10.3748/wjg.v11.i23.3595; Fujihara M, 2010, PATHOL INT, V60, P642, DOI 10.1111/j.1440-1827.2010.02574.x; Fukuhara J, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-194; GARNER A, 1983, BRIT J OPHTHALMOL, V67, P561, DOI 10.1136/bjo.67.9.561; GARNER A, 1992, BRIT J OPHTHALMOL, V76, P47, DOI 10.1136/bjo.76.1.47; Gatto D, 2010, J ALLERGY CLIN IMMUN, V126, P898, DOI 10.1016/j.jaci.2010.09.007; Good DJ, 2009, HEMATOL ONCOL CLIN N, V23, P729, DOI 10.1016/j.hoc.2009.04.005; Hamel KM, 2012, AUTOIMMUNITY, V45, P333, DOI 10.3109/08916934.2012.665524; Herwig MC, 2012, ACTA OPHTHALMOL, V90, pE331, DOI 10.1111/j.1755-3768.2011.02285.x; Hoshida Y, 2004, INT J CANCER, V108, P443, DOI 10.1002/ijc.11582; ISAACSON P, 1984, CANCER, V53, P2515, DOI 10.1002/1097-0142(19840601)53:11<2515::AID-CNCR2820531125>3.0.CO;2-C; Isaacson P G, 2003, Verh Dtsch Ges Pathol, V87, P116; Isaacson PG, 2005, BEST PRACT RES CL HA, V18, P57, DOI 10.1016/j.beha.2004.08.003; ISAACSON PG, 1990, HISTOPATHOLOGY, V16, P617, DOI 10.1111/j.1365-2559.1990.tb01173.x; Jin MK, 2011, HISTOPATHOLOGY, V58, P586, DOI 10.1111/j.1365-2559.2011.03779.x; Kasajima-Akatsuka N, 2006, HISTOCHEM CELL BIOL, V126, P261, DOI 10.1007/s00418-006-0157-6; Klein U, 2008, NAT REV IMMUNOL, V8, P22, DOI 10.1038/nri2217; KNOWLES DM, 1990, HUM PATHOL, V21, P959, DOI 10.1016/0046-8177(90)90181-4; Kojima M, 2005, INT J SURG PATHOL, V13, P267, DOI 10.1177/106689690501300306; Langerak AW, 1997, LEUKEMIA, V11, P2192, DOI 10.1038/sj.leu.2400887; Lee Jee-Young, 2005, J Clin Neurol, V1, P8, DOI 10.3988/jcn.2005.1.1.8; Li EY, 2015, ASIA-PAC J OPHTHALMO, V4, P106, DOI 10.1097/APO.0000000000000102; Maeda K, 2002, J HISTOCHEM CYTOCHEM, V50, P1475, DOI 10.1177/002215540205001107; Mannami T, 2001, MODERN PATHOL, V14, P641, DOI 10.1038/modpathol.3880366; MEDEIROS LJ, 1989, AM J SURG PATHOL, V13, P459, DOI 10.1097/00000478-198906000-00002; MURRAY PG, 1991, J PATHOL, V165, P125, DOI 10.1002/path.1711650207; NERI A, 1987, BLOOD, V70, P1519; NGUYEN DT, 1994, HISTOPATHOLOGY, V24, P437, DOI 10.1111/j.1365-2559.1994.tb00552.x; O'Malley DP, 2013, SEMIN DIAGN PATHOL, V30, P137, DOI 10.1053/j.semdp.2012.08.007; Oh DE, 2007, ARCH OPHTHALMOL-CHIC, V125, P1668, DOI 10.1001/archopht.125.12.1668; Pereira MI, 2014, WORLD J GASTROENTERO, V20, P684, DOI 10.3748/wjg.v20.i3.684; Piccaluga PP, 2011, ADV HEMATOL; Ponzoni M, 2013, ONCOLOGIST, V18, P876, DOI 10.1634/theoncologist.2012-0425; Rezk M, 2013, EXPERT REV HEMATOL, V6, P139, DOI [10.1586/ehm.13.4, 10.1586/EHM.13.4]; SCHROER KR, 1979, CANCER, V44, P1155, DOI 10.1002/1097-0142(197909)44:3<1155::AID-CNCR2820440354>3.0.CO;2-C; Shi Yun-fei, 2013, Zhonghua Bing Li Xue Za Zhi, V42, P222, DOI 10.3760/cma.j.issn.0529-5807.2013.04.003; Stefanovic A, 2009, BLOOD, V114, P501, DOI 10.1182/blood-2008-12-195453; Ting DS, 2015, EYE LOND; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; VANDERGAAG R, 1984, BRIT J OPHTHALMOL, V68, P892, DOI 10.1136/bjo.68.12.892; Verma V, 2008, SURV OPHTHALMOL, V53, P312, DOI 10.1016/j.survophthal.2008.04.008; Wang Qian, 2010, Chinese Journal of Pathology, V39, P296, DOI 10.3760/cma.j.issn.0529-5807.2010.05.003; Wilson J B, 1992, Curr Top Microbiol Immunol, V182, P375; Witkowska M, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/523170; Zotos D, 2012, TRENDS IMMUNOL, V33, P281, DOI 10.1016/j.it.2012.04.003; Zucca E, 1998, NEW ENGL J MED, V338, P804, DOI 10.1056/NEJM199803193381205	56	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0160175	10.1371/journal.pone.0160175	http://dx.doi.org/10.1371/journal.pone.0160175			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28510589	Green Published, gold, Green Submitted			2022-12-26	WOS:000401485500001
J	Reardon, C; Tobin, DP; Tierney, P; Delahunt, E				Reardon, Cillian; Tobin, Daniel P.; Tierney, Peter; Delahunt, Eamonn			The worst case scenario: Locomotor and collision demands of the longest periods of gameplay in professional rugby union	PLOS ONE			English	Article							HIGH-INTENSITY EXERCISE; PHYSICAL DEMANDS; ELITE; RELIABILITY; VALIDITY; STRENGTH; PLAYERS; POWER; ACCELERATION; POSITION	A number of studies have used global positioning systems (GPS) to report on positional differences in the physical game demands of rugby union both on an average and singular bout basis. However, the ability of these studies to report quantitative data is limited by a lack of validation of certain aspects of measurement by GPS micro-technology. Furthermore no study has analyzed the positional physical demands of the longest bouts of ball-in-play time in rugby union. The aim of the present study is to compare the demands of the single longest period of ball-in-play, termed "worst case scenario" (WCS) between positional groups, which have previously been reported to have distinguishable game demands. The results of this study indicate that WCS periods follow a similar sporadic pattern as average demands but are played at a far higher pace than previously reported for average game demands with average meters per minute of 116.8 m. The positional differences in running and collision activity previously reported are perpetuated within WCS periods. Backs covered greater total distances than forwards (318 m vs 289 m), carried out more high-speed running (11.1 m.min(-1) vs 5.5 m.min(-1)) and achieved higher maximum velocities (MaxVel). Outside Backs achieved the highest MaxVel values (6.84 m.sec(-1)). Tight Five and Back Row forwards underwent significantly more collisions than Inside Back and Outside Backs (0.73 & 0.89 collisions.min(-1) vs 0.28 & 0.41 collisions.min(-1) respectively). The results of the present study provide information on the positional physical requirements of performance in prolonged periods involving multiple high intensity bursts of effort. Although the current state of GPS micro-technology as a measurement tool does not permit reporting of collision intensity or acceleration data, the combined use of video and GPS provides valuable information to the practitioner. This can be used to match and replicate game demands in training.	[Reardon, Cillian; Tobin, Daniel P.; Tierney, Peter] Leinster Rugby, Dublin, Ireland; [Reardon, Cillian; Delahunt, Eamonn] Univ Coll Dublin, Dublin, Ireland	University College Dublin	Reardon, C (corresponding author), Leinster Rugby, Dublin, Ireland.; Reardon, C (corresponding author), Univ Coll Dublin, Dublin, Ireland.	cillian.reardon@leinsterrugby.ie		Delahunt, Eamonn/0000-0001-5449-5932				Akenhead R, 2014, J SCI MED SPORT, V17, P562, DOI 10.1016/j.jsams.2013.08.005; Argus CK, 2012, J STRENGTH COND RES, V26, P2698, DOI 10.1519/JSC.0b013e318241382a; Austin D, 2011, J SPORT SCI, V29, P1105, DOI 10.1080/02640414.2011.582508; Austin D, 2011, J SCI MED SPORT, V14, P259, DOI 10.1016/j.jsams.2011.01.003; Austin DJ, 2011, J STRENGTH COND RES, V25, P1898, DOI 10.1519/JSC.0b013e3181e83a5b; Baker D, 1999, J STRENGTH COND RES, V13, P230; Black GM, 2014, INT J SPORT PHYSIOL, P556; Cahill N, 2013, J SPORT SCI, V31, P229, DOI 10.1080/02640414.2012.727456; Cronin JB, 2005, J STRENGTH COND RES, V19, P349; Cunniffe B, 2009, J STRENGTH COND RES, V23, P1195, DOI 10.1519/JSC.0b013e3181a3928b; Duthie G, 2005, J SPORT SCI, V23, P523, DOI 10.1080/02640410410001730188; Duthie G, 2003, SPORTS MED, V33, P973, DOI 10.2165/00007256-200333130-00003; Duthie GM, 2006, J STRENGTH COND RES, V20, P208, DOI 10.1519/R-16784.1; Eaton C, 2006, PHYS THER SPORT, V7, P22, DOI 10.1016/j.ptsp.2005.08.006; Fontana FY, 2015, INT J SPORT PHYSIOL, V10, P674, DOI 10.1123/ijspp.2015-0014; Gabbett TJ, 2016, INT J SPORT PHYSIOL, V11, P530, DOI 10.1123/ijspp.2015-0266; Gabbett TJ, 2014, J SCI MED SPORT, V17, P556, DOI 10.1016/j.jsams.2013.08.002; Gabbett TJ, 2013, J STRENGTH COND RES, V27, P1623, DOI 10.1519/JSC.0b013e318274f2af; Quarrie KL, 2013, J SCI MED SPORT, V16, P353, DOI 10.1016/j.jsams.2012.08.005; Quarrie KL, 2000, J SPORT SCI, V18, P237; Reardon C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133410; Reardon CJ, 2016, COLLISION COUNT RUGB, P1; Roberts SP, 2008, J SPORT SCI, V26, P825, DOI 10.1080/02640410801942122; Sirotic AC, 2009, J SPORT SCI, V27, P203, DOI 10.1080/02640410802520802; Smart DJ, 2013, J STRENGTH COND RES, V27, P3033, DOI 10.1519/JSC.0b013e31828c26d3; Varley MC, 2012, J SPORT SCI, V30, P121, DOI 10.1080/02640414.2011.627941; Venter RE, 2010, AFRICAN J PHYS HLTH, V17, P1; Waldron M, 2011, J SPORT SCI, V29, P1223, DOI 10.1080/02640414.2011.587445	28	43	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177072	10.1371/journal.pone.0177072	http://dx.doi.org/10.1371/journal.pone.0177072			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28510582	Green Submitted, Green Published, gold			2022-12-26	WOS:000401485500011
J	de Paula, TG; Zanella, BTT; Fantinatti, BEDA; de Moraes, LN; Duran, BODS; de Oliveira, CB; Salomao, RAS; da Silva, RN; Padovani, CR; dos Santos, VB; Mareco, EA; Carvalho, RF; Dal-Pai-Silva, M				de Paula, Tassiana Gutierrez; Thomazini Zanella, Bruna Tereza; de Almeida Fantinatti, Bruno Evaristo; de Moraes, Leonardo Nazario; da Silva Duran, Bruno Oliveira; de Oliveira, Caroline Bredariol; Simoes Salomao, Rondinelle Artur; da Silva, Rafaela Nunes; Padovani, Carlos Roberto; dos Santos, Vander Bruno; Mareco, Edson Assuncao; Carvalho, Robson Francisco; Dal-Pai-Silva, Maeli			Food restriction increase the expression of mTORC1 complex genes in the skeletal muscle of juvenile pacu (Piaractus mesopotamicus)	PLOS ONE			English	Article							TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; TILAPIA OREOCHROMIS-NILOTICUS; TROUT ONCORHYNCHUS-MYKISS; GROWTH-RELATED GENES; RAINBOW-TROUT; ATLANTIC SALMON; FINE FLOUNDER; PLEURONECTES-PLATESSA; ENDURANCE EXERCISE; NUTRITIONAL-STATUS	Skeletal muscle is capable of phenotypic adaptation to environmental factors, such as nutrient availability, by altering the balance between muscle catabolism and anabolism that in turn coordinates muscle growth. Small noncoding RNAs, known as microRNAs (miRNAs), repress the expression of target mRNAs, and many studies have demonstrated that miRNAs regulate the mRNAs of catabolic and anabolic genes. We evaluated muscle morphology, gene expression of components involved in catabolism, anabolism and energetic metabolism and miRNAs expression in both the fast and slow muscle of juvenile pacu (Piaractus mesopotamicus) during food restriction and refeeding. Our analysis revealed that short periods of food restriction followed by refeeding predominantly affected fast muscle, with changes in muscle fiber diameter and miRNAs expression. There was an increase in the mRNA levels of catabolic pathways components (FBXO25, ATG12, BCL2) and energetic metabolism-related genes (PGC1 alpha and SDHA), together with a decrease in PPAR beta/delta mRNA levels. Interestingly, an increase in mRNA levels of anabolic genes (PI3K and mTORC1 complex: mTOR, mLST8 and RAPTOR) was also observed during food restriction. After refeeding, muscle morphology showed similar patterns of the control group; the majority of genes were slightly up-or down-regulated in fast and slow muscle, respectively; the levels of all miRNAs increased in fast muscle and some of them decreased in slow muscle. Our findings demonstrated that a short period of food restriction in juvenile pacu had a considerable impact on fast muscle, increasing the expression of anabolic (PI3K and mTORC1 complex: mTOR, mLST8 and RAPTOR) and energetic metabolism genes. The miRNAs (miR-1, miR-206, miR-199 and miR-23a) were more expressed during refeeding and while their target genes (IGF-1, mTOR, PGC1 alpha and MAFbx), presented a decreased expression. The alterations in mTORC1 complex observed during fasting may have influenced the rates of protein synthesis by using amino acids from protein degradation as an alternative mechanism to preserve muscle phenotype and metabolic demand maintenance.	[de Paula, Tassiana Gutierrez; Thomazini Zanella, Bruna Tereza; de Almeida Fantinatti, Bruno Evaristo; de Moraes, Leonardo Nazario; da Silva Duran, Bruno Oliveira; de Oliveira, Caroline Bredariol; Simoes Salomao, Rondinelle Artur; da Silva, Rafaela Nunes; Carvalho, Robson Francisco; Dal-Pai-Silva, Maeli] Sao Paulo State Univ, Inst Biosci Botucatu, Dept Morphol, Botucatu, SP, Brazil; [Simoes Salomao, Rondinelle Artur; Dal-Pai-Silva, Maeli] Sao Paulo State Univ, Aquaculture Ctr, Jaboticabal, SP, Brazil; [Padovani, Carlos Roberto] Sao Paulo State Univ, Inst Biosci Botucatu, Dept Biostat, Botucatu, SP, Brazil; [dos Santos, Vander Bruno] Sao Paulo Agcy Agribusiness Technol, Presidente Prudente, SP, Brazil; [Mareco, Edson Assuncao] Univ Western Sao Paulo UNOESTE, Presidente Prudente, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade do Oeste Paulista	Dal-Pai-Silva, M (corresponding author), Sao Paulo State Univ, Inst Biosci Botucatu, Dept Morphol, Botucatu, SP, Brazil.; Dal-Pai-Silva, M (corresponding author), Sao Paulo State Univ, Aquaculture Ctr, Jaboticabal, SP, Brazil.	maeli@ibb.unesp.br	Bredariol de Oliveira, Caroline/D-8721-2019; Duran, Bruno/AAA-9977-2020; de Paula, Tassiana Gutierrez/L-2867-2017; Fantinatti, Bruno/B-2943-2013; de Moraes, Leonardo Nazario/F-8621-2012; Carvalho, Robson Francisco/AAE-4134-2020; Dal-Pai-Silva, Maeli/GLR-1413-2022	Bredariol de Oliveira, Caroline/0000-0002-3130-3907; Duran, Bruno/0000-0002-7920-8175; Carvalho, Robson Francisco/0000-0002-4901-7714; Moraes, Leonardo/0000-0003-4515-4137; Mareco, Edson/0000-0002-3504-6936; Santos, Vander Bruno/0000-0003-1816-169X	Sao Paulo Research Foundation (FAPESP) [2013/25915-1, 2014/16949-2, 2016/00725-3]; National Council for Scientific and Technological Development (CNPq) [447233/2014, 302656/2015-4]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Sao Paulo Research Foundation (FAPESP), http://www.fapesp.br/, Grants 2013/25915-1, 2014/16949-2 and 2016/00725-3; National Council for Scientific and Technological Development (CNPq), http://www.cnpq.br/, Grants 447233/2014 and 302656/2015-4; support to TGP, BTTZ, CBO and MDPS.	de Almeida FLA, 2010, MICRON, V41, P997, DOI 10.1016/j.micron.2010.06.012; Bodine SC, 2001, SCIENCE, P294; Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389; Bower NI, 2010, PHYSIOL GENOMICS, V42A, P114, DOI 10.1152/physiolgenomics.00065.2010; Bower NI, 2008, J EXP BIOL, V211, P3859, DOI 10.1242/jeb.024117; Brett J., 1979, ENV FACTORS GROWTH F; Byfield MP, 2005, J BIOL CHEM, V280, P33076, DOI 10.1074/jbc.M507201200; Castagnolli N, 1986, PISCICULTURA NOS TRO; Chauvigne F, 2003, GEN COMP ENDOCR, V132, P209, DOI 10.1016/S0016-6480(03)00081-9; Chu WY, 2013, CURR MOL MED, V13, P1397, DOI 10.2174/15665240113139990059; Cleveland BM, 2010, COMP BIOCHEM PHYS B, V157, P248, DOI 10.1016/j.cbpb.2010.06.010; Cleveland BM, 2010, AM J PHYSIOL-REG I, V298, pR341, DOI 10.1152/ajpregu.00516.2009; Desgeorges MM, 2014, INT J BIOCHEM CELL B, V54, P208, DOI 10.1016/j.biocel.2014.07.008; Dubowitz V., 1973, MUSCLE BIOPSY MODERN; Elia L, 2009, CIRCULATION, V120, P2377, DOI 10.1161/CIRCULATIONAHA.109.879429; Fonseca R, 2006, NEURON, V52, P239, DOI 10.1016/j.neuron.2006.08.015; Fuentes EN, 2013, GEN COMP ENDOCR, V186, P172, DOI 10.1016/j.ygcen.2013.02.009; Fuentes EN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044256; Fuentes EN, 2012, GEN COMP ENDOCR, V177, P120, DOI 10.1016/j.ygcen.2012.02.019; Fuentes EN, 2012, ENDOCRINOLOGY, V153, P283, DOI 10.1210/en.2011-1313; FUENTES EN, 2011, AM J PHYSIOL-REG I, V300, P1532, DOI DOI 10.1152/AJPREGU.00535.2010; Galluzzi L, 2014, CELL, V159, P1263, DOI 10.1016/j.cell.2014.11.006; Goodman L., 1965, SIMULTANEOUS CONFIDE; He CC, 2012, NATURE, V481, P511, DOI 10.1038/nature10758; Hitachi K, 2014, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00408; Hoppeler H, 2016, J EXP BIOL, V219, P205, DOI 10.1242/jeb.128207; Jamart C, 2013, AM J PHYSIOL-ENDOC M, V305, pE964, DOI 10.1152/ajpendo.00270.2013; Jia L, 2014, INT J MOL SCI, V15, P296, DOI 10.3390/ijms15010296; JOHNSTON IA, 1973, MAR BIOL, V19, P348, DOI 10.1007/BF00348906; JOHNSTON IA, 1981, CELL TISSUE RES, V214, P369; Johnston IA, 2006, J EXP BIOL, V209, P2249, DOI 10.1242/jeb.02153; Johnston IA, 2011, J EXP BIOL, V214, P1617, DOI 10.1242/jeb.038620; Jump DB, 2008, CURR OPIN LIPIDOL, V19, P242, DOI 10.1097/MOL.0b013e3282ffaf6a; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Klionsky DJ, 2005, CURR BIOL, V15, pR282, DOI 10.1016/j.cub.2005.04.013; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Leitao ND, 2011, AQUACULTURE, V315, P78, DOI 10.1016/j.aquaculture.2011.01.006; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mareco EA, 2015, PLOS ONE, V10, P1; Mareco EA, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1423-6; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; NACHLAS MM, 1957, J HISTOCHEM CYTOCHEM, V5, P420, DOI 10.1177/5.4.420; Nakamura MT, 2014, PROG LIPID RES, V53, P124, DOI 10.1016/j.plipres.2013.12.001; Nakamura MT, 2004, ANNU REV NUTR, V24, P345, DOI 10.1146/annurev.nutr.24.121803.063211; Nakamura MT, 2004, LIPIDS, V39, P1077, DOI 10.1007/s11745-004-1333-0; Nakashima H, 2005, ACTA NEUROPATHOL, V110, P547, DOI 10.1007/s00401-005-1087-4; Nebo C, 2013, COMP BIOCHEM PHYS B, V164, P268, DOI 10.1016/j.cbpb.2013.02.003; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Russell AP, 2013, NEUROBIOL DIS, V49, P107, DOI 10.1016/j.nbd.2012.08.015; Safdar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005610; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Seiliez I, 2008, AM J PHYSIOL-REG I, V295, pR329, DOI 10.1152/ajpregu.00146.2008; Shan ZX, 2009, BIOCHEM BIOPH RES CO, V381, P597, DOI 10.1016/j.bbrc.2009.02.097; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Steven A, 1990, THEORY PRACTICE HIST; Suraweera A, 2012, MOL CELL, V48, P242, DOI 10.1016/j.molcel.2012.08.003; Terova G, 2007, J FISH BIOL, V70, P219, DOI 10.1111/j.1095-8649.2007.01402.x; URBINATI E.C., 2005, ESPECIES NATIVAS PIS; Valente LMP, 1999, J FISH BIOL, V55, P675, DOI 10.1111/j.1095-8649.1999.tb00710.x; Valente LMP, 2012, BRIT J NUTR, V108, P2148, DOI 10.1017/S0007114512000396; van Rooij E, 2008, TRENDS GENET, V24, P159, DOI 10.1016/j.tig.2008.01.007; Vechetti IJ, 2016, J GERONTOL A-BIOL, V71, P601, DOI 10.1093/gerona/glv064; Wada S, 2011, J BIOL CHEM, V286, P38456, DOI 10.1074/jbc.M111.271270; Wang XNH, 2013, CURR OPIN CLIN NUTR, V16, P258, DOI 10.1097/MCO.0b013e32835f81b9; Wende AR, 2007, J BIOL CHEM, V282, P36642, DOI 10.1074/jbc.M707006200; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; Wiberg R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142699; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yamano K, 2016, EMBO REP, V17, P300, DOI 10.15252/embr.201541486; Yan BA, 2013, J EXP BIOL, V216, P1265, DOI 10.1242/jeb.079590; Zar J.H., 2009, BIOSTATISTICAL ANAL; Zhang YN, 2014, NATURE, V513, P440, DOI 10.1038/nature13492	84	25	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177679	10.1371/journal.pone.0177679	http://dx.doi.org/10.1371/journal.pone.0177679			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505179	Green Published, gold, Green Submitted			2022-12-26	WOS:000401473500032
J	Fu, Z; Epstein, B; Kelley, JL; Zheng, Q; Bergland, AO; Carrillo, CIC; Jensen, AS; Dahan, J; Karasev, AV; Snyder, WE				Fu, Zhen; Epstein, Brendan; Kelley, Joanna L.; Zheng, Qi; Bergland, Alan O.; Carrillo, Carmen I. Castillo; Jensen, Andrew S.; Dahan, Jennifer; Karasev, Alexander V.; Snyder, William E.			Using NextRAD sequencing to infer movement of herbivores among host plants	PLOS ONE			English	Article							INSECT VECTORS; POPULATIONS; MARKERS; LOCI; DIVERSITY; PATTERNS; DISEASE; ADAPTATION; MIGRATION; SELECTION	Herbivores often move among spatially interspersed host plants, tracking high-quality resources through space and time. This dispersal is of particular interest for vectors of plant pathogens. Existing molecular tools to track such movement have yielded important insights, but often provide insufficient genetic resolution to infer spread at finer spatiotemporal scales. Here, we explore the use of Nextera-tagmented reductively-amplified DNA (Nex-tRAD) sequencing to infer movement of a highly-mobile winged insect, the potato psyllid (Bactericera cockerelli), among host plants. The psyllid vectors the pathogen that causes zebra chip disease in potato (Solanum tuberosum), but understanding and managing the spread of this pathogen is limited by uncertainty about the insect's host plant(s) outside of the growing season. We identified 1,978 polymorphic loci among psyllids separated spatiotemporally on potato or in patches of bittersweet nightshade (S. dulcumara), a weedy plant proposed to be the source of potato-colonizing psyllids. A subset of the psyllids on potato exhibited genetic similarity to insects on nightshade, consistent with regular movement between these two host plants. However, a second subset of potato-collected psyllids was genetically distinct from those collected on bittersweet nightshade; this suggests that a currently unrecognized source, i.e., other nightshade patches or a third host-plant species, could be contributing to psyllid populations in potato. Oftentimes, dispersal of vectors of pathogens must be tracked at a fine scale in order to understand, predict, and manage disease spread. We demonstrate that emerging sequencing technologies that detect genome-wide SNPs of a vector can be used to infer such localized movement.	[Fu, Zhen; Carrillo, Carmen I. Castillo; Snyder, William E.] Washington State Univ, Dept Entomol, Pullman, WA 99164 USA; [Epstein, Brendan; Kelley, Joanna L.] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA; [Zheng, Qi] Univ Louisville, Dept Bioinformat & Biostat, Louisville, KY 40292 USA; [Bergland, Alan O.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Jensen, Andrew S.] Northwest Potato Res Consortium, Lakeview, OR USA; [Dahan, Jennifer; Karasev, Alexander V.] Univ Idaho, Dept Plant Soil & Entomol Sci, Moscow, ID 83843 USA; [Epstein, Brendan] Univ Minnesota, Coll Biol Sci, St Paul, MN 55108 USA; [Bergland, Alan O.] Univ Virginia, Dept Biol, Charlottesville, VA USA; [Carrillo, Carmen I. Castillo] Inst Nacl Invest Agr INIAP, Estn Expt Santa Catalina, Dept Protecc Vegetal, Panamericana Sur Km 1, Quito, Ecuador	Washington State University; Washington State University; University of Louisville; Stanford University; Idaho; University of Idaho; University of Minnesota System; University of Minnesota Twin Cities; University of Virginia	Fu, Z (corresponding author), Washington State Univ, Dept Entomol, Pullman, WA 99164 USA.	zhen.fu@wsu.edu	Kelley, Joanna L/H-1693-2012; Castillo Carrillo, Carmen/I-6752-2016	Kelley, Joanna L/0000-0002-7731-605X; Karasev, Alexander/0000-0001-8197-0639; Snyder, William/0000-0002-2747-3102; Castillo Carrillo, Carmen/0000-0001-7893-5218; Fu, Zhen/0000-0002-8120-590X	National Institute of Food and Agriculture, U.S. Department of Agriculture, Specialty Crop Research Initiative [2015-09273]; Northwest Potato Research Consortium; Washington State Commission on Pesticide Registration	National Institute of Food and Agriculture, U.S. Department of Agriculture, Specialty Crop Research Initiative; Northwest Potato Research Consortium; Washington State Commission on Pesticide Registration	This research was funded by the National Institute of Food and Agriculture, U.S. Department of Agriculture, Specialty Crop Research Initiative (https://nifa.usda.gov/funding-opportunity/specialty-crop-research-initiative-scri) award number 2015-09273, along with grants from the Northwest Potato Research Consortium (http://www.nwpotatoresearch.com/) and the Washington State Commission on Pesticide Registration (http://wscpr.org/), all to WES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Barley AJ, 2015, MOL ECOL, V24, P1696, DOI 10.1111/mec.13151; Behura SK, 2006, MOL ECOL, V15, P3087, DOI 10.1111/j.1365-294X.2006.03014.x; BELOVSKY GE, 1981, ECOLOGY, V62, P1020, DOI 10.2307/1937001; Bischof R, 2012, AM NAT, V180, P407, DOI 10.1086/667590; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Canto T, 2009, GLOBAL CHANGE BIOL, V15, P1884, DOI 10.1111/j.1365-2486.2008.01820.x; Chasen EM, 2014, J INTEGR PEST MANAG, V5, DOI 10.1603/IPM13014; Clement S. L., 2006, Plant Health Progress, P1; Coates BS, 2009, GENOME, V52, P57, DOI 10.1139/G08-104; Crowder DW, 2010, NATURE, V466, P109, DOI 10.1038/nature09183; Despland E, 2004, ECOGRAPHY, V27, P381, DOI 10.1111/j.0906-7590.2004.03779.x; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Ebel ER, 2015, MOL ECOL, V24, P2392, DOI 10.1111/mec.13168; Eigenbrode SD, 2016, J APPL ECOL, V53, P1382, DOI 10.1111/1365-2664.12693; Emerson KJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130773; EXCOFFIER L, 1992, GENETICS, V131, P479; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; FRASER D, 1984, CAN J ZOOL, V62, P80, DOI 10.1139/z84-014; FRYXELL JM, 1988, TRENDS ECOL EVOL, V3, P237, DOI 10.1016/0169-5347(88)90166-8; Greenway G, 2014, AM J POTATO RES, V91, P714, DOI 10.1007/s12230-014-9404-x; Hagler JR, 2001, ANNU REV ENTOMOL, V46, P511, DOI 10.1146/annurev.ento.46.1.511; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Horton D. R., 2015, POTATO PROG, V15, P1; Horton David R., 2015, American Entomologist, V61, P234, DOI 10.1093/ae/tmv047; ILLIUS AW, 1992, J ANIM ECOL, V61, P183, DOI 10.2307/5521; Kamvar ZN, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00208; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; Keller I, 2013, MOL ECOL, V22, P2848, DOI 10.1111/mec.12083; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Koss AM, 2005, ENVIRON ENTOMOL, V34, P87, DOI 10.1603/0046-225X-34.1.87; Larson WA, 2013, CAN J FISH AQUAT SCI, V70, P128, DOI 10.1139/cjfas-2012-0233; Leebens-Mack J, 2004, J HERED, V95, P127, DOI 10.1093/jhered/esh025; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liefting LW, 2009, PLANT DIS, V93, P208, DOI 10.1094/PDIS-93-3-0208; Long EY, 2015, OECOLOGIA, V177, P1067, DOI 10.1007/s00442-014-3194-1; Loxdale HD, 1998, B ENTOMOL RES, V88, P577, DOI 10.1017/S0007485300054250; Loxdale HD, 1999, PHILOS T R SOC B, V354, P1479, DOI 10.1098/rstb.1999.0492; Massonnet B, 2004, HEREDITY, V93, P577, DOI 10.1038/sj.hdy.6800559; MCELHANY P, 1995, ECOLOGY, V76, P444, DOI 10.2307/1941203; Meglecz E, 2007, INSECT MOL BIOL, V16, P175, DOI 10.1111/j.1365-2583.2006.00713.x; Meirmans PG, 2015, MOL ECOL, V24, P3223, DOI 10.1111/mec.13243; Monteith KL, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00096.1; Munyaneza JE, 2012, AM J POTATO RES, V89, P329, DOI 10.1007/s12230-012-9262-3; Nault LR, 1997, ANN ENTOMOL SOC AM, V90, P521, DOI 10.1093/aesa/90.5.521; NEI M, 1977, ANN HUM GENET, V41, P225, DOI 10.1111/j.1469-1809.1977.tb01918.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Peterson MA, 1997, ECOLOGY, V78, P167, DOI 10.1890/0012-9658(1997)078[0167:HPPABD]2.0.CO;2; POWER AG, 1987, ECOLOGY, V68, P1658, DOI 10.2307/1939858; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rasic G, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-275; Redak RA, 2004, ANNU REV ENTOMOL, V49, P243, DOI 10.1146/annurev.ento.49.061802.123403; Reese Justin, 2014, J Genomics, V2, P54; Richards PM, 2013, MOL ECOL, V22, P3077, DOI 10.1111/mec.12262; ROSE DJW, 1979, PHILOS T ROY SOC B, V287, P393, DOI 10.1098/rstb.1979.0071; Russello MA, 2015, PEERJ, V3, DOI 10.7717/peerj.1106; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shariatinajafabadi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108331; Swisher KD, 2012, ENVIRON ENTOMOL, V41, P1019, DOI 10.1603/EN12066; Szulkin M, 2016, MOL ECOL, V25, P542, DOI 10.1111/mec.13486; Takahashi T, 2013, MOL ECOL, V22, P3049, DOI 10.1111/mec.12120; Thomas CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068679; Watt WB, 2003, MOL ECOL, V12, P1265, DOI 10.1046/j.1365-294X.2003.01804.x; Weintraub PG, 2006, ANNU REV ENTOMOL, V51, P91, DOI 10.1146/annurev.ento.51.110104.151039; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whitlock MC, 2015, AM NAT, V186, pS24, DOI 10.1086/682949; Wilmshurst JF, 1999, CAN J ZOOL, V77, P1223, DOI 10.1139/cjz-77-8-1223; Wink M, 2006, J ORNITHOL, V147, P234, DOI 10.1007/s10336-006-0065-5; Zhan S, 2014, NATURE, V514, P317, DOI 10.1038/nature13812; Zhang DX, 2004, TRENDS ECOL EVOL, V19, P507, DOI 10.1016/j.tree.2004.07.020; Zhu M, 2006, AGR FOREST METEOROL, V138, P192, DOI 10.1016/j.agrformet.2006.05.001	75	17	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177742	10.1371/journal.pone.0177742	http://dx.doi.org/10.1371/journal.pone.0177742			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505182	Green Submitted, Green Published, gold			2022-12-26	WOS:000401473500038
J	Zhong, ZJ; Li, W; Deng, L; Song, Y; Wu, KJ; Tian, YN; Huang, XM; Hu, YC; Fu, HL; Geng, Y; Ren, ZH; Peng, GN				Zhong, Zhijun; Li, Wei; Deng, Lei; Song, Yuan; Wu, Kongju; Tian, Yinan; Huang, Xiangming; Hu, Yanchun; Fu, Hualin; Geng, Yi; Ren, Zhihua; Peng, Guangneng			Multilocus genotyping of Enterocytozoon bieneusi derived from nonhuman primates in southwest China	PLOS ONE			English	Article							GIARDIA-DUODENALIS; CAPTIVE WILDLIFE; CRYPTOSPORIDIUM; MICROSPORIDIOSIS; INFECTION; SEQUENCE; HUMANS	Enterocytozoon bieneusi has been increasingly reported in non-human primates (NHPs) in recent years, and this has garnered attention. However, reports of E. bieneusi infections in NHPs are limited worldwide. To appreciate the genetic diversity and assess the zoonotic potential during the transmission of human microsporidiosis, we examined a total of 369 fecal samples from NHPs and performed PCR amplification of the ITS gene of E. bieneusi. An infection rate of 12.5% (46/369) was detected in NHPs, with three known genotypes (D, PigEBITS7, and SC02) and a novel genotype (SCM01) characterized. Phylogenetic analysis indicated that all four genotypes in our study were classified as zoonotic group 1. Multilocus genotyping of positive E. bieneusi strains revealed that 36, 37, 30, and 29 specimens were successfully amplified and sequenced to generate 16, six, four, and five types of MS1, MS3, MS4, and MS7 loci, respectively. Twenty-four specimens were successfully amplified and sequenced at all four loci, forming 13 multilocus genotypes (MLGs). The occurrence of zoonotic genotypes suggests that zoonotic transmission of E. bieneusi between humans and NHPs has probably occurred and NHPs could be a source of human microspordiosis.	[Zhong, Zhijun; Li, Wei; Deng, Lei; Song, Yuan; Tian, Yinan; Hu, Yanchun; Fu, Hualin; Geng, Yi; Ren, Zhihua; Peng, Guangneng] Sichuan Agr Univ, Coll Vet Med, Key Lab Anim Dis & Human Hlth Sichuan Prov, Yaan, Sichuan Provinc, Peoples R China; [Wu, Kongju; Huang, Xiangming] Chengdu Res Base Giant Panda Breeding, Chengdu, Sichuan, Peoples R China	Key Laboratory of Animal Disease & Human Health of Sichuan Province; Sichuan Agricultural University	Peng, GN (corresponding author), Sichuan Agr Univ, Coll Vet Med, Key Lab Anim Dis & Human Hlth Sichuan Prov, Yaan, Sichuan Provinc, Peoples R China.	pgn.sicau@163.com	Deng, Lei/AAB-5622-2020	Deng, Lei/0000-0003-0391-6180	Chengdu Giant Panda Breeding Research Foundation [CPF2014-10, CPF2014-14, CPF2015-4]	Chengdu Giant Panda Breeding Research Foundation	The study was financially supported by the Chengdu Giant Panda Breeding Research Foundation (CPF2014-10; CPF2014-14; CPF2015-4).	Akinbo FO, 2012, AM J TROP MED HYG, V86, P441, DOI 10.4269/ajtmh.2012.11-0548; Anane S, 2010, GASTROEN CLIN BIOL, V34, P450, DOI 10.1016/j.gcb.2010.07.003; Breton J, 2007, J CLIN MICROBIOL, V45, P2580, DOI 10.1128/JCM.02554-06; DESPORTES I, 1985, J PROTOZOOL, V32, P250; Espern A, 2007, J CLIN MICROBIOL, V45, P2999, DOI 10.1128/JCM.00684-07; Feng YY, 2011, APPL ENVIRON MICROB, V77, P4822, DOI 10.1128/AEM.02803-10; Karim MR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117991; Karim MR, 2014, APPL ENVIRON MICROB, V80, P1893, DOI 10.1128/AEM.03845-13; Li J, 2016, CHINA PARASIT VECTOR, V9, P1, DOI DOI 10.1016/J.IJPRT.2015.12.001; Li JQ, 2015, J EUKARYOT MICROBIOL, V62, P833, DOI 10.1111/jeu.12269; Li W, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1668-1; Li W, 2011, J CLIN MICROBIOL, V49, P4326, DOI 10.1128/JCM.05051-11; Liguory O, 2001, J CLIN MICROBIOL, V39, P2672, DOI 10.1128/JCM.39.7.2672-2674.2001; Lobo ML, 2006, J EUKARYOT MICROBIOL, V53, pS61, DOI 10.1111/j.1550-7408.2006.00174.x; Maikai BV, 2012, EXP PARASITOL, V131, P452, DOI 10.1016/j.exppara.2012.05.011; Metge S, 2000, EUR J CLIN MICROBIOL, V19, P221, DOI 10.1007/s100960050463; Mynarova A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152771; Nkinin SW, 2007, J CLIN MICROBIOL, V45, P2841, DOI 10.1128/JCM.00328-07; Sadler F, 2002, J INFECTION, V44, P39, DOI 10.1053/jinf.2001.0934; Sak B, 2013, PLOS ONE, V8; Sak B, 2011, J CLIN MICROBIOL, V49, P1064, DOI 10.1128/JCM.01147-10; Santin M, 2011, RES VET SCI, V90, P363, DOI 10.1016/j.rvsc.2010.07.014; Singh I, 2006, J MED PRIMATOL, V35, P352, DOI 10.1111/j.1600-0684.2006.00181.x; Ten Hove RJ, 2009, J EUKARYOT MICROBIOL, V56, P388, DOI 10.1111/j.1550-7408.2009.00393.x; Wang L, 2013, J CLIN MICROBIOL, V51, P557, DOI 10.1128/JCM.02758-12; Widmer G, 2013, APPL ENVIRON MICROB, V79, P5357, DOI 10.1128/AEM.01260-13; Ye JB, 2014, PARASITOL INT, V63, P132, DOI 10.1016/j.parint.2013.10.007; Ye JB, 2012, EMERG INFECT DIS, V18, P1640, DOI 10.3201/eid1810.120653; Zhang X, 2011, J CLIN MICROBIOL, V49, P2006, DOI 10.1128/JCM.00372-11	29	28	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0176926	10.1371/journal.pone.0176926	http://dx.doi.org/10.1371/journal.pone.0176926			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498867	gold, Green Submitted, Green Published			2022-12-26	WOS:000401314500007
J	Alam, MN; Garg, A; Munia, TTK; Fazel-Rezai, R; Tavakolian, K				Alam, Md Nafiul; Garg, Amanmeet; Munia, Tamanna Tabassum Khan; Fazel-Rezai, Reza; Tavakolian, Kouhyar			Vertical ground reaction force marker for Parkinson's disease	PLOS ONE			English	Article							TREADMILL WALKING; GAIT RHYTHM; CLASSIFICATION; VARIABILITY; PARAMETERS; SENSORS; PEOPLE	Parkinson's disease (PD) patients regularly exhibit abnormal gait patterns. Automated differentiation of abnormal gait from normal gait can serve as a potential tool for early diagnosis as well as monitoring the effect of PD treatment. The aim of current study is to differentiate PD patients from healthy controls, on the basis of features derived from plantar vertical ground reaction force (VGRF) data during walking at normal pace. The current work presents a comprehensive study highlighting the efficacy of different machine learning classifiers towards devising an accurate prediction system. Selection of meaningful feature based on sequential forward feature selection, the swing time, stride time variability, and center of pressure features facilitated successful classification of control and PD gaits. Support Vector Machine (SVM), K-nearest neighbor (KNN), random forest, and decision trees classifiers were used to build the prediction model. We found that SVM with cubic kernel outperformed other classifiers with an accuracy of 93.6%, the sensitivity of 93.1%, and specificity of 94.1%. In comparison to other studies, utilizing same dataset, our designed prediction system improved the classification performance by approximately 10%. The results of the current study underscore the ability of the VGRF data obtained non-invasively from wearable devices, in combination with a SVM classifier trained on meticulously selected features, as a tool for diagnosis of PD and monitoring effectiveness of therapy post pathology.	[Alam, Md Nafiul; Munia, Tamanna Tabassum Khan; Fazel-Rezai, Reza] Univ North Dakota, Dept Elect Engn, Grand Forks, ND 58201 USA; [Garg, Amanmeet; Tavakolian, Kouhyar] Simon Fraser Univ, Sch Engn Sci, Burnaby, BC, Canada	University of North Dakota Grand Forks; Simon Fraser University	Alam, MN (corresponding author), Univ North Dakota, Dept Elect Engn, Grand Forks, ND 58201 USA.; Tavakolian, K (corresponding author), Simon Fraser Univ, Sch Engn Sci, Burnaby, BC, Canada.	mdnafiul.alam@und.edu; kouhyar.tavakolian@engr.und.edu						Abujaber SB, 2015, J ARTHROPLASTY, V30, P2027, DOI 10.1016/j.arth.2015.05.024; Alkhatib R, 2015, IEEE ENG MED BIO, P4186, DOI 10.1109/EMBC.2015.7319317; Alkhatib R, 2015, J COMPUTER COMMUNICA, V3, P13, DOI DOI 10.4236/JCC.2015.33003; Baratin E, 2015, GAIT POSTURE, V41, P634, DOI 10.1016/j.gaitpost.2015.01.012; Begg R, 2005, J BIOMECH, V38, P401, DOI 10.1016/j.jbiomech.2004.05.002; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; del Olmo MF, 2005, PARKINSONISM RELAT D, V11, P25, DOI 10.1016/j.parkreldis.2004.09.002; Dubose DF, 2017, MED SCI SPORT EXER, V49, P167, DOI 10.1249/MSS.0000000000001067; Fernando ME, 2016, CLIN BIOMECH, V37, P98, DOI 10.1016/j.clinbiomech.2016.06.006; Foundation PD, 2016, STAT PARK PARK DIS F; Foundation PD, 2016, PRIM MOT SYMPT PARK; Frenkel-Toledo S, 2005, MOVEMENT DISORD, V20, P1109, DOI 10.1002/mds.20507; Frenkel-Toledo S., 2005, J NEUROENG REHABIL, P2; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Hausdorff JM, 1997, J APPL PHYSIOL, V82, P262; Hausdorff JM, 2003, J GERIATR PSYCH NEUR, V16, P53, DOI 10.1177/0891988702250580; Hausdorff JM, 2000, J APPL PHYSIOL, V88, P2045, DOI 10.1152/jappl.2000.88.6.2045; Hunt E.B., 1966, AM J PSYCHOL; Jolliffe I. T., 1990, Weather, V45, P375, DOI 10.1002/j.1477-8696.1990.tb05558.x; Kalron A, 2016, GAIT POSTURE, V47, P48, DOI 10.1016/j.gaitpost.2016.04.010; Kim HD, 2015, ANN REHABIL MED-ARM, V39, P409, DOI 10.5535/arm.2015.39.3.409; Kononenko I., 1994, EUR C MACH LEARN, V784, P171, DOI DOI 10.1007/3-540-57868-4_57; Kotsiantis SB, 2007, INFORM-J COMPUT INFO, V31, P249; Lozano-Ortiz CA, 2010, IEEE ENG MED BIO, P1413, DOI 10.1109/IEMBS.2010.5626715; Manap HH, 2011, IEEE INT SYMP SIGNAL, P60; Martinez-Manzanera O, 2016, IEEE T BIO-MED ENG, V63, P1016, DOI 10.1109/TBME.2015.2480242; Morris ME, 1999, HUM MOVEMENT SCI, V18, P461, DOI 10.1016/S0167-9457(99)00020-2; Murthy SK, 1998, DATA MIN KNOWL DISC, V2, P345, DOI 10.1023/A:1009744630224; Ota L., 2011, 2011 IEEE/SICE International Symposium on System Integration (SII 2011), P236, DOI 10.1109/SII.2011.6147452; Pamukoff DN, 2016, CLIN BIOMECH, V33, P61, DOI 10.1016/j.clinbiomech.2016.02.007; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Peters J, 2017, ADAPT COMPUT MACH LE; Pietrosimone B, 2016, AM J SPORT MED, V44, P425, DOI 10.1177/0363546515618380; Plotnik M, 2013, GAIT POSTURE, V38, P864, DOI 10.1016/j.gaitpost.2013.04.011; Pohjalainen J, 2015, COMPUT SPEECH LANG, V29, P145, DOI 10.1016/j.csl.2013.11.004; Riley PO, 2007, GAIT POSTURE, V26, P17, DOI 10.1016/j.gaitpost.2006.07.003; Tadano S, 2013, SENSORS-BASEL, V13, P9321, DOI 10.3390/s130709321; Tagliati M, 2008, NEUROLOGY, V71, P76, DOI 10.1212/01.wnl.0000316807.94657.e0; Tao WJ, 2012, SENSORS-BASEL, V12, P2255, DOI 10.3390/s120202255; van der Worp H, 2016, BRIT J SPORT MED, V50, P450, DOI 10.1136/bjsports-2015-094924; Vapnik VN, 1999, IEEE T NEURAL NETWOR, V10, P988, DOI 10.1109/72.788640; Yanci J, 2016, BIOL SPORT, V33, P173, DOI 10.5604/20831862.1198637; Yogev G, 2005, EUR J NEUROSCI, V22, P1248, DOI 10.1111/j.1460-9568.2005.04298.x; Zhang YY, 2013, 2013 INTERNATIONAL CONFERENCE ON DIGITAL IMAGE COMPUTING: TECHNIQUES & APPLICATIONS (DICTA), P328	46	57	57	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0175951	10.1371/journal.pone.0175951	http://dx.doi.org/10.1371/journal.pone.0175951			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493868	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314300009
J	Buechter, M; Kahraman, A; Manka, P; Gerken, G; Dechene, A; Canbay, A; Wetter, A; Umutlu, L; Theysohn, JM				Buechter, Matthias; Kahraman, Alisan; Manka, Paul; Gerken, Guido; Dechene, Alexander; Canbay, Ali; Wetter, Axel; Umutlu, Lale; Theysohn, Jens M.			Partial spleen embolization reduces the risk of portal hypertension-induced upper gastrointestinal bleeding in patients not eligible for TIPS implantation	PLOS ONE			English	Article							PARTIAL SPLENIC EMBOLIZATION; RETROGRADE TRANSVENOUS OBLITERATION; INTRAHEPATIC PORTOSYSTEMIC SHUNT; GASTRIC VARICES; ARTERY EMBOLIZATION; CIRRHOTIC-PATIENTS; LIVER-CIRRHOSIS; SPLENECTOMY; PREVENTION; MANAGEMENT	Introduction Upper gastrointestinal bleeding (UGIB) is a severe and life-threatening complication among patients with portal hypertension (PH). Covered transjugular intrahepatic portosystemic shunt (TIPS) is the treatment of choice for patients with refractory or recurrent UGIB despite pharmacological and endoscopic therapy. In some patients, TIPS implantation is not possible due to co-morbidity or vascular disorders. Spleen embolization (SE) may be a promising alternative in this setting. Materials and methods We retrospectively analyzed 9 patients with PH-induced UGIB who underwent partial SE between 2012 and 2016. All patients met the following criteria: (i) upper gastrointestinal hemorrhage with primary or secondary failure of endoscopic interventions and (ii) TIPS implantation not possible. Each patient was followed for at least 6 months after embolization. Results Five patients (56%) suffered from cirrhotic PH, 4 patients (44%) from non-cirrhotic PH. UGIB occured in terms of refractory hemorrhage from gastric varices (3/9; 33%), hemorrhage from esophageal varices (3/9; 33%), and finally, hemorrhage from portal-hypertensive gastropathy (3/9; 33%). None of the patients treated with partial SE experienced re-bleeding episodes or required blood transfusions during a total follow-up time of 159 months, including both patients with cirrhotic-and non-cirrhotic PH. Discussion Partial SE, as a minimally invasive intervention with low procedure-associated complications, may be a valuable alternative for patients with recurrent PH-induced UGIB refractory to standard therapy.	[Buechter, Matthias; Kahraman, Alisan; Manka, Paul; Gerken, Guido; Dechene, Alexander; Canbay, Ali] Univ Hosp Essen, Dept Gastroenterol & Hepatol, Essen, Germany; [Manka, Paul] Fdn Liver Res, Inst Hepatol London, London, England; [Manka, Paul] Kings Coll London, Fac Life Sci & Med, London, England; [Wetter, Axel; Umutlu, Lale; Theysohn, Jens M.] Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany	University of Duisburg Essen; University of London; University College London; University of London; King's College London; University of Duisburg Essen	Theysohn, JM (corresponding author), Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany.	jens.theysohn@uk-essen.de	Canbay, Ali/AAL-9620-2020; Manka, Paul/ABH-2421-2020; Manka, Paul/AAN-1261-2021	Manka, Paul/0000-0001-8589-7280; Canbay, Ali/0000-0001-6069-7899				Ahuja C, 2015, AM J ROENTGENOL, V205, P720, DOI 10.2214/AJR.15.14637; Akahoshi T, 2008, J GASTROEN HEPATOL, V23, P1702, DOI 10.1111/j.1440-1746.2008.05549.x; Buechter M, 2016, DIGESTION, V94, P138, DOI 10.1159/000450704; Carbonell N, 2004, HEPATOLOGY, V40, P652, DOI 10.1002/hep.20339; Garcia-Pagan JC, 2014, CLIN GASTROENTEROL H, V12, P919, DOI 10.1016/j.cgh.2013.07.015; Garcia-Pagan JC, 2012, SEMIN RESP CRIT CARE, V33, P46, DOI 10.1055/s-0032-1301734; Garcia-Pagan JC, 2010, NEW ENGL J MED, V362, P2370, DOI 10.1056/NEJMoa0910102; Cho H, 2016, HEPATOL RES OFF J JP; Chu HB, 2015, BMC SURG, V15, DOI 10.1186/s12893-015-0077-2; Copelan A, 2014, SEMIN INTERVENT RAD, V31, P235, DOI 10.1055/s-0034-1382790; de Franchis R, 2015, J HEPATOL, V63, P743, DOI 10.1016/j.jhep.2015.05.022; DeLeve LD, 2009, HEPATOLOGY, V49, P1729, DOI 10.1002/hep.22772; Glowka Tim R, 2014, Viszeralmedizin, V30, P409, DOI 10.1159/000369575; Gu JJ, 2012, ACTA RADIOL, V53, P862, DOI 10.1258/ar.2012.110639; Hadduck TA, 2014, WORLD J RADIOL, V6, P160, DOI 10.4329/wjr.v6.i5.160; Holster IL, 2016, HEPATOLOGY, V63, P581, DOI 10.1002/hep.28318; Hong CH, 2009, J GASTROEN HEPATOL, V24, P372, DOI 10.1111/j.1440-1746.2008.05651.x; Jansen C, 2016, LIVER INT OFF J INT; Kanagawa H, 1996, J GASTROEN HEPATOL, V11, P51, DOI 10.1111/j.1440-1746.1996.tb00010.x; Karagul S, 2016, ANN TRANSPL, V21, P317, DOI 10.12659/AOT.898253; Kawanaka H, 2014, BRIT J SURG, V101, P1585, DOI 10.1002/bjs.9622; Kim H, 2012, TRANSPL P, V44, P755, DOI 10.1016/j.transproceed.2012.01.066; Kiyosue H, 2003, RADIOGRAPHICS, V23, P921, DOI 10.1148/rg.234025135; Koconis KG, 2007, J VASC INTERV RADIOL, V18, P463, DOI 10.1016/j.jvir.2006.12.734; Liu CL, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004215; LOFTUS JP, 1993, ANN SURG, V217, P35, DOI 10.1097/00000658-199301000-00007; Luz JHM, 2016, CANCER MED-US, V5, P2715, DOI 10.1002/cam4.856; Ninoi T, 2005, AM J ROENTGENOL, V184, P1340, DOI 10.2214/ajr.184.4.01841340; Ohmoto K, 2003, HEPATO-GASTROENTEROL, V50, P1766; Palsson B, 2003, LANGENBECK ARCH SURG, V387, P421, DOI 10.1007/s00423-002-0342-6; Paramythiotis Daniel, 2010, J Med Case Rep, V4, P139, DOI 10.1186/1752-1947-4-139; Parker R, 2014, CLIN LIVER DIS, V18, P319, DOI 10.1016/j.cld.2013.12.004; Pedersen MR, 2016, ANN HEPATOL, V15, P127, DOI 10.5604/16652681.1184288; Saad Wael E A, 2012, Semin Intervent Radiol, V29, P118, DOI 10.1055/s-0032-1312573; Saad Wael E A, 2011, Semin Intervent Radiol, V28, P339, DOI 10.1055/s-0031-1284461; Saad Wael E A, 2011, Semin Intervent Radiol, V28, P283, DOI 10.1055/s-0031-1284454; Saad Wael E A, 2011, Semin Intervent Radiol, V28, P333, DOI 10.1055/s-0031-1284460; Saif MW, 2016, CUREUS, V8, DOI 10.7759/cureus.689; Sauerbruch T, 2015, GASTROENTEROLOGY, V149, P660, DOI 10.1053/j.gastro.2015.05.011; Schouten JNL, 2011, HEPATOLOGY, V54, P1071, DOI 10.1002/hep.24422; Shimizu T, 2002, HEPATO-GASTROENTEROL, V49, P947; Smith Mitchell, 2012, Semin Intervent Radiol, V29, P135, DOI 10.1055/s-0032-1312575; Sunakawa H, 2015, CLIN J GASTROENTEROL, V8, P138, DOI 10.1007/s12328-015-0563-1; Taniai N, 1999, HEPATO-GASTROENTEROL, V46, P2849; Wang L, 2011, MED PRIN PRACT, V21, P20, DOI 10.1159/000329888; Xu RY, 2004, WORLD J GASTROENTERO, V10, P1072; Yang SC, 2013, HEPATOL INT, V7, P257, DOI 10.1007/s12072-012-9378-z; Yoshida H, 2005, AM J GASTROENTEROL, V100, P43, DOI 10.1111/j.1572-0241.2005.40559.x	48	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177401	10.1371/journal.pone.0177401	http://dx.doi.org/10.1371/journal.pone.0177401			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28494001	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314300103
J	Javidi-Parsijani, P; Niu, GG; Davis, M; Lu, P; Atala, A; Lu, BS				Javidi-Parsijani, Parisa; Niu, Guoguang; Davis, Meghan; Lu, Pin; Atala, Anthony; Lu, Baisong			No evidence of genome editing activity from Natronobacterium gregoryi Argonaute (NgAgo) in human cells	PLOS ONE			English	Article							DNA-BINDING SPECIFICITY; INTRACELLULAR TRAFFICKING; MUSCLE; MODEL	The argonaute protein from the thermophilic bacterium Thermus thermophilus shows DNA-guided DNA interfering activity at high temperatures, complicating its application in mammalian cells. A recent work reported that the argonaute protein from Natronobacterium gregoryi (NgAgo) had DNA-guided genome editing activity in mammalian cells. We compared the genome editing activities of NgAgo and Staphylococcus aureus Cas9 (SaCas9) in human HEK293T cells side by side. EGFP reporter assays and DNA sequencing consistently revealed high genome editing activity from SaCas9. However, these assays did not demonstrate genome editing activity by NgAgo. We confirmed that the conditions allowed simultaneous transfection of the NgAgo expressing plasmid DNA and DNA guides, as well as heterologous expression of NgAgo in the HEK293T cells. Our data show that NgAgo is not a robust genome editing tool, although it may have such activity under other conditions.	[Javidi-Parsijani, Parisa; Niu, Guoguang; Davis, Meghan; Lu, Pin; Atala, Anthony; Lu, Baisong] Wake Forest Univ Hlth Sci, Wake Forest Inst Regenerat Med, Winston Salem, NC 27109 USA	Wake Forest University; Wake Forest University School of Medicine	Lu, BS (corresponding author), Wake Forest Univ Hlth Sci, Wake Forest Inst Regenerat Med, Winston Salem, NC 27109 USA.	blu@wakehealth.edu	Lu, Baisong/B-5837-2013	Lu, Baisong/0000-0001-9240-558X; lyu, pin/0000-0001-6841-1373	NCATS NIH HHS [UL1 TR001420] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001420] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Bhattacharyya D, 2010, METHODS MOL BIOL, V619, P403, DOI 10.1007/978-1-60327-412-8_24; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Burgess S, 2016, PROTEIN CELL, V7, P913, DOI 10.1007/s13238-016-0343-9; Cardarelli F, 2016, SCI REP-UK, V6, DOI 10.1038/srep25879; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cornu TI, 2008, MOL THER, V16, P352, DOI 10.1038/sj.mt.6300357; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Elouahabi A, 2005, MOL THER, V11, P336, DOI 10.1016/j.ymthe.2004.12.006; Gao F, 2016, NAT BIOTECHNOL, V34, P768, DOI 10.1038/nbt.3547; Green M. R., 2012, MOLECULAR CLONING A; Hansel-Hertsch R, 2016, NAT GENET, V48, P1267, DOI 10.1038/ng.3662; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; Lee SH, 2017, NAT BIOTECHNOL, V35, P17, DOI 10.1038/nbt.3753; Li X, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.136630; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Naujok O, 2016, METHODS MOL BIOL, V1341, P67, DOI 10.1007/7651_2015_221; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Qi JL, 2016, CELL RES, V26, P1349, DOI 10.1038/cr.2016.134; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Swarts DC, 2015, NUCLEIC ACIDS RES, V43, P5120, DOI 10.1093/nar/gkv415; Swarts DC, 2014, NATURE, V507, P258, DOI 10.1038/nature12971; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Ye S., 2017, BIORXIV, DOI [10.1101/101923, DOI 10.1101/101923]; Yonezawa M, 1996, INT J CANCER, V66, P347; Zander A, 2014, RNA BIOL, V11, P45, DOI 10.4161/rna.27446	32	21	30	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177444	10.1371/journal.pone.0177444	http://dx.doi.org/10.1371/journal.pone.0177444			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28494027	gold, Green Submitted, Green Published			2022-12-26	WOS:000401314300110
J	Zhao, R; Sun, JB; Zhang, XX; Wu, HJ; Liu, P; Yang, XJ; Qin, W				Zhao, Rui; Sun, Jinbo; Zhang, Xinxin; Wu, Huanju; Liu, Peng; Yang, Xuejuan; Qin, Wei			Sleep spindle detection based on non-experts: A validation study	PLOS ONE			English	Article							EEG; DENSITY; MEMORY; FINGERPRINT; INCREASES; DISORDER; DISEASE	Accurate and efficient detection of sleep spindles is a methodological challenge. The present study describes a method of using non-experts for manual detection of sleep spindles. We recruited five experts and 168 non-experts to manually identify spindles in stage N2 and stage N3 sleep data using a MATLAB interface. Scorers classified each spindle into definite and indefinite spindle (with weights of 1 and 0.5, respectively). First, a method of optimizing the thresholds of the expert/non-expert group consensus according to the results of experts and non-experts themselves is described. Using this method, we established expert and non-expert group standards from expert and non-expert scorers, respectively, and evaluated the performance of the non-expert group standards by compared with the expert group standard (termed EGS). The results indicated that the highest performance was the nonexpert group standard when definite spindles were only considered (termed nEGS-1; F1 score = 0.78 for N2; 0.68 for N3). Second, four automatic spindle detection methods were compared with the EGS. We found that the performance of nEGS-1 versus EGS was higher than that of the four automated methods. Our results also showed positive correlation between the mean F1 score of individual expert in EGS and the F1 score of nEGS-1 versus EGS across 30 segments of stage N2 data (r = 0.61, P < 0.001). Further, we found that six and nine non-experts were needed to manually identify spindles in stages N2 and N3, respectively, while maintaining acceptable performance of nEGS-1 versus EGS (F1 score = 0.79 for N2; 0.64 for N3). In conclusion, this study establishes a detailed process for detection of sleep spindles by non-experts in a crowdsourcing scheme.	[Zhao, Rui; Sun, Jinbo; Zhang, Xinxin; Wu, Huanju; Liu, Peng; Yang, Xuejuan; Qin, Wei] Xidian Univ, Sch Life Sci & Technol, Sleep & Neuroimage Grp, Xian, Shaanxi, Peoples R China	Xidian University	Qin, W (corresponding author), Xidian Univ, Sch Life Sci & Technol, Sleep & Neuroimage Grp, Xian, Shaanxi, Peoples R China.	wqin@xidian.edu.cn	秦, 伟/J-9770-2016; JinBo, Sun/GLT-2082-2022	秦, 伟/0000-0003-4583-0406; 	National Basic Research Program of China [2015CB856403, 2014CB543203, 2012CB518501]; National Natural Science Foundation of China [81271644, 81471811, 81471738, 61401346]; Fundamental Research Funds for the Central Universities	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was financially supported by National Basic Research Program of China under Grant Nos. 2015CB856403, 2014CB543203 and 2012CB518501; the National Natural Science Foundation of China under Grant Nos. 81271644, 81471811, 81471738 and 61401346; and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acir N, 2004, EXPERT SYST APPL, V27, P451, DOI 10.1016/j.eswa.2004.05.007; Bodizs R, 2005, J SLEEP RES, V14, P285, DOI 10.1111/j.1365-2869.2005.00472.x; Bodizs R, 2009, J NEUROSCI METH, V178, P205, DOI 10.1016/j.jneumeth.2008.11.006; CAMPBELL K, 1980, ELECTROEN CLIN NEURO, V48, P602, DOI 10.1016/0013-4694(80)90296-5; Carskadon M.A., 2000, PRINCIPLES PRACTICE, V2, P16; Chen C, 2014, J SURG RES, V187, P65, DOI 10.1016/j.jss.2013.09.024; Christensen JAE, 2014, CLIN NEUROPHYSIOL, V125, P512, DOI 10.1016/j.clinph.2013.08.013; Crowley K, 2002, CLIN NEUROPHYSIOL, V113, P1615, DOI 10.1016/S1388-2457(02)00237-7; De Gennaro L, 2005, NEUROIMAGE, V26, P114, DOI 10.1016/j.neuroimage.2005.01.020; De Gennaro L, 2000, Sleep Res Online, V3, P155; Devuyst S, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P3883; Devuyst S, 2011, ENG MED BIOL SOC EMB; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Ferrarelli F, 2007, AM J PSYCHIAT, V164, P483, DOI 10.1176/appi.ajp.164.3.483; Fogel SM, 2007, BEHAV NEUROSCI, V121, P1, DOI 10.1037/0735-7044.121.1.1; Fogel SM, 2011, NEUROSCI BIOBEHAV R, V35, P1154, DOI 10.1016/j.neubiorev.2010.12.003; GAILLARD JM, 1981, SLEEP, V4, P385, DOI 10.1093/sleep/4.4.385; Gais S, 2002, J NEUROSCI, V22, P6830; Gorurr D., AUTOMATED DETECTION; Hagemann D, 2008, CLIN NEUROPHYSIOL, V119, P1271, DOI 10.1016/j.clinph.2008.02.010; Huupponen E, 2007, ARTIF INTELL MED, V40, P157, DOI 10.1016/j.artmed.2007.04.003; Latreille V, 2015, NEUROBIOL AGING, V36, P1083, DOI 10.1016/j.neurobiolaging.2014.09.009; Limoges E, 2005, BRAIN, V128, P1049, DOI 10.1093/brain/awh425; Martin N, 2013, NEUROBIOL AGING, V34, P468, DOI 10.1016/j.neurobiolaging.2012.05.020; McCormick L, 1997, SLEEP, V20, P939, DOI 10.1093/sleep/20.11.939; Medicine AAoS, 2007, AASM MANUAL SCORING; Mitry D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117401; Molle M, 2002, J NEUROSCI, V22, P10941; Montagna P, 2005, SLEEP MED REV, V9, P339, DOI 10.1016/j.smrv.2005.02.001; Montagna P, 2003, LANCET NEUROL, V2, P167, DOI 10.1016/S1474-4422(03)00323-5; Morin A, 2008, SLEEP, V31, P1149; Nguyen TB, 2012, RADIOLOGY, V262, P824, DOI 10.1148/radiol.11110938; Nicolas A, 2001, CLIN NEUROPHYSIOL, V112, P521, DOI 10.1016/S1388-2457(00)00556-3; Nowak S., 2010, INT C MULT INF RETR; Plante DT, 2013, J AFFECT DISORDERS, V146, P120, DOI 10.1016/j.jad.2012.06.016; Rauchs G, 2008, NEUROREPORT, V19, P1159, DOI 10.1097/WNR.0b013e32830867c4; Ray LB, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00507; Ray LB, 2010, J SLEEP RES, V19, P374, DOI 10.1111/j.1365-2869.2009.00802.x; Rice JK, 2013, NEUROIMAGE, V64, P476, DOI 10.1016/j.neuroimage.2012.09.041; Schabus M, 2007, P NATL ACAD SCI USA, V104, P13164, DOI 10.1073/pnas.0703084104; SCHIMICEK P, 1994, CLIN ELECTROENCEPHAL, V25, P26, DOI 10.1177/155005949402500108; Sitnikova E, 2009, J NEUROSCI METH, V180, P304, DOI 10.1016/j.jneumeth.2009.04.006; Ujma PP, 2014, J NEUROSCI, V34, P16358, DOI 10.1523/JNEUROSCI.1857-14.2014; Ventouras EM, 2005, COMPUT METH PROG BIO, V78, P191, DOI 10.1016/j.cmpb.2005.02.006; Walker MP, 2009, ANN NY ACAD SCI, V1156, P168, DOI 10.1111/j.1749-6632.2009.04416.x; Wamsley EJ, 2012, BIOL PSYCHIAT, V71, P154, DOI 10.1016/j.biopsych.2011.08.008; Warby SC, 2014, NAT METHODS, V11, P385, DOI [10.1038/nmeth.2855, 10.1038/NMETH.2855]; Wendt SL, 2014, CLIN NEUROPHYSIOLOGY; Werth E, 1997, ELECTROEN CLIN NEURO, V103, P535, DOI 10.1016/S0013-4694(97)00070-9; Zeitlhofer J, 1997, J SLEEP RES, V6, P149, DOI 10.1046/j.1365-2869.1997.00046.x; Zygierewicz J, 1999, CLIN NEUROPHYSIOL, V110, P2136, DOI 10.1016/S1388-2457(99)00175-3	51	2	2	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177437	10.1371/journal.pone.0177437	http://dx.doi.org/10.1371/journal.pone.0177437			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493938	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314300108
J	Chen, M; Zhang, Y; Zheng, PS				Chen, Mei; Zhang, Yuan; Zheng, Peng-Sheng			Tafazzin (TAZ) promotes the tumorigenicity of cervical cancer cells and inhibits apoptosis	PLOS ONE			English	Article							CARDIOLIPIN; EXPRESSION; HPV	Tafazzin (TAZ) is often aberrantly expressed in some cancers, including rectal cancer and thyroid neoplasms. However, the function of TAZ in cervical cancer cells remains unknown. This study aims to explore the expression and function of TAZ in cervical cancer cells. Here, we determined the expression of TAZ protein in normal cervical tissue (NC, n = 27), high-grade squamous intraepithelial lesions (HSIL, n = 26) and squamous cervical carcinoma (SCC, n = 41) by immunohistochemistry, the expression of TAZ protein gradually increased from NC to HSIL to SCC. TAZ was overexpressed or down-regulated in cervical cancer cells by stably transfecting a TAZ-expressing plasmid or a shRNA plasmid targeting TAZ. In vitro, the cell growth curves and MTT assays showed that TAZ may promote the growth and viability of cervical cancer cells. In vivo, xenografts experiment showed that TAZ may increase tumor-forming ability. The percentage of apoptosis cells analyzed by FACS and TUNEL assays consistently showed that TAZ inhibits apoptosis in cervical cancer cells. Furthermore, the Cleaved Caspase 9 and Cleaved Caspase 3 were down-regulated by TAZ in cervical cancer cells. Taken together, this study demonstrated that TAZ is overexpressed in cervical cancer and may promote tumorigenicity of cervical cancer cells and inhibit apoptosis.	[Chen, Mei; Zhang, Yuan; Zheng, Peng-Sheng] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Reprod Med, Med Coll, Xian, Peoples R China; [Zheng, Peng-Sheng] Minist Educ Peoples Republ China, Sect Canc Res, Key Lab Environm & Genes Related Dis, Xian, Peoples R China	Xi'an Jiaotong University; Ministry of Education, China	Zheng, PS (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Reprod Med, Med Coll, Xian, Peoples R China.; Zheng, PS (corresponding author), Minist Educ Peoples Republ China, Sect Canc Res, Key Lab Environm & Genes Related Dis, Xian, Peoples R China.	zpsheng@mail.xjtu.edu.cn			National Natural Science Foundation of China [81472728, 81672910]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant to Prof. Peng-Sheng Zheng from the National Natural Science Foundation of China (no. 81472728 and no. 81672910).; This work was supported by a grant to Prof. Peng-Sheng Zheng from the National Natural Science Foundation of China (No. 81472728 and No. 81672910).	Bosch FX, 2008, BRIT J CANCER, V98, P15, DOI 10.1038/sj.bjc.6604146; Brentnall M, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-32; Chevillard S, 2004, CLIN CANCER RES, V10, P6586, DOI 10.1158/1078-0432.CCR-04-0053; Eiben GL, 2003, VIRAL IMMUNOL, V16, P111, DOI 10.1089/088282403322017866; Gonzalvez F, 2007, APOPTOSIS, V12, P877, DOI 10.1007/s10495-007-0718-8; Gonzalvez F, 2013, BBA-MOL BASIS DIS, V1832, P1194, DOI 10.1016/j.bbadis.2013.03.005; Houtkooper RH, 2009, BBA-BIOMEMBRANES, V1788, P2003, DOI 10.1016/j.bbamem.2009.07.009; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Jin MF, 2015, ONCOL LETT, V10, P857, DOI 10.3892/ol.2015.3319; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Kirwin SM, 2014, MOL GENET METAB, V111, P26, DOI 10.1016/j.ymgme.2013.11.006; Liu XY, 2015, CLADISTICS, V31, P18, DOI 10.1111/cla.12071; Pathak S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098317; Saavedra K, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-13; Sigurdsson K., 2007, LAEKNABLADID, V93, P21; Sigurdsson Kristjan, 2007, Laeknabladid, V93, P821; van Loo G, 2002, CELL DEATH DIFFER, V9, P1031, DOI 10.1038/sj.cdd.4401088; Wang HY, 2015, ONCOTARGET, V6, P20711, DOI 10.18632/oncotarget.4133; Wang H, 2015, EURASIP J WIREL COMM, DOI 10.1186/s13638-015-0270-0; Wang T., 2016, INT J DISTRIB SENS N, V2016, P1, DOI DOI 10.1007/S11010-015-2651-4; Wang YD, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.272; Wilson LD, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-25; Wu XL, 2013, CARCINOGENESIS, V34, P1660, DOI 10.1093/carcin/bgt102; Xi RC, 2011, ONKOLOGIE, V34, P428, DOI 10.1159/000331132; Xu Y, 2006, J BIOL CHEM, V281, P39217, DOI 10.1074/jbc.M606100200; Zhang SD, 2016, ONCOL LETT, V11, P1223, DOI 10.3892/ol.2015.3999	27	20	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177171	10.1371/journal.pone.0177171	http://dx.doi.org/10.1371/journal.pone.0177171			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489874	gold, Green Published, Green Submitted			2022-12-26	WOS:000401314100052
J	Hu, WJ; Pan, XL; Abbas, HMK; Li, FF; Dong, WB				Hu, Wenjin; Pan, Xinli; Abbas, Hafiz Muhammad Khalid; Li, Fengfeng; Dong, Wubei			Metabolites contributing to Rhizoctonia solani AG-1-IA maturation and sclerotial differentiation revealed by UPLC-QTOF-MS metabolomics	PLOS ONE			English	Article							CONTAINING AMINO-ACIDS; THIOL REDOX STATE; TENUAZONIC ACID; PROTEOMIC ANALYSIS; SPECTROMETRY DATA; NITRIC-OXIDE; GROWTH; BIOSYNTHESIS; COMPOUND; ROLFSII	Rhizoctonia solani is a causative agent of sheath blight, which results in huge economic losses every year. During its life cycle, the formation of sclerotia helps Rhizoctonia solani withstand a variety of unfavorable factors. Oxidative stress is a key factor that induces sclerotium formation. The differentiated and undifferentiated phenotypes of R. solani AG-1-IA were obtained by controlling aerial conditions. Metabolomics based on the mass spectrometry technique combined with multivariate and univariate analyses was used to investigate the metabolic variation in vegetative, differentiated and undifferentiated mycelia. Our results revealed that during maturation, the metabolic levels of N2-acetyl-L-ornithine,3,1'-( OH)2-Gamma-carotene, (5Z, 7E)-(1S, 3R)-24,24-difluoro-24a-homo-9,10-seco-5,7,10(19)cholestatrien-1,3,25-triol, stoloniferone O, PA(O-18: 0/12: 0), PA(P-16: 0/14: 0), PA(P-16: 0/16:( 19Z)) and PA(P-16: 0/17: 2(9Z, 12Z)) were suppressed in both differentiated and undifferentiated mycelia. The concentrations of PE(20: 1(11Z)/14: 1(9Z)), PE(P-16: 0/20: 4 (5Z, 8Z, 11Z, 13E)(15OH[ S])) and PS(12: 0/18: 1(9Z)) were increased in the differentiated group, while increased levels of N(gamma)-nitro-L-arginine, tenuazonic acid and 9S, 10S, 11R-trihydroxy-12Z, 15Z-octadecadienoic acid were found in the undifferentiated group. Our results suggest that different levels of these metabolites may act as biomarkers for the developmental stages of R. solani AG-1-IA. Moreover, the mechanisms of sclerotium formation and mycelium differentiation were elucidated at the metabolic level.	[Hu, Wenjin; Abbas, Hafiz Muhammad Khalid; Li, Fengfeng; Dong, Wubei] Huazhong Agr Univ, Coll Plant Sci & Technol, Dept Plant Pathol, Wuhan, Hubei Province, Peoples R China; [Hu, Wenjin; Abbas, Hafiz Muhammad Khalid; Li, Fengfeng; Dong, Wubei] Huazhong Agr Univ, Key Lab Crop Dis Monitoring & Safety Control Hube, Wuhan, Hubei Province, Peoples R China; [Pan, Xinli] Tech Univ Dortmund, Dept Biochem & Chem Engn, Dortmund, Germany	Huazhong Agricultural University; Huazhong Agricultural University; Dortmund University of Technology	Dong, WB (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Dept Plant Pathol, Wuhan, Hubei Province, Peoples R China.; Dong, WB (corresponding author), Huazhong Agr Univ, Key Lab Crop Dis Monitoring & Safety Control Hube, Wuhan, Hubei Province, Peoples R China.	dwb@mail.hzau.edu.cn	Abbas, Hafiz Muhammad Khalid/AAD-7630-2019	Abbas, Hafiz Muhammad Khalid/0000-0002-9355-7734; Dong, Wubei/0000-0001-8513-8751	National Major Project for Transgenic Organism Breeding [2011ZX08003-001, 2016ZX08003-001]; Hubei Provincial Technology Innovation Program [2016ABA093]	National Major Project for Transgenic Organism Breeding; Hubei Provincial Technology Innovation Program	This work was supported by the National Major Project for Transgenic Organism Breeding (2011ZX08003-001 and 2016ZX08003-001) and the Hubei Provincial Technology Innovation Program (2016ABA093). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Drs. Guoying Wang and Yunjun Liu for comments and suggestions on the experimental design and data analysis. This work was supported by the National Major Project for Transgenic Organism Breeding (2011ZX08003-001 and 2016ZX08003-001) and the Hubei Provincial Technology Innovation Program (2016ABA093).	Akhtar J., 2009, Asian Journal of Agricultural Sciences, V1, P32; Aliferis KA, 2010, METABOLOMICS, V6, P96, DOI 10.1007/s11306-009-0180-4; Aliferis KA, 2010, J AGR FOOD CHEM, V58, P7604, DOI 10.1021/jf101029a; Anderson JP, 2016, MOL CELL PROTEOMICS, V15, P1188, DOI 10.1074/mcp.M115.054502; Baidya S, 2011, APPL ENVIRON MICROB, V77, P5524, DOI 10.1128/AEM.00638-11; Bernardes-de-Assis J, 2009, PHYTOPATHOLOGY, V99, P1090, DOI 10.1094/PHYTO-99-9-1090; Blunt JW, 2011, NAT PROD REP, V28, P196, DOI 10.1039/c005001f; Calvo AM, 1999, APPL ENVIRON MICROB, V65, P3668; CHET I, 1966, J GEN MICROBIOL, V45, P541, DOI 10.1099/00221287-45-3-541; CHRISTIAS C, 1975, CAN J MICROBIOL, V21, P1541, DOI 10.1139/m75-226; COLEYSMI.JR, 1971, ANNU REV PHYTOPATHOL, V9, P65, DOI 10.1146/annurev.py.09.090171.000433; Edwards PA, 1999, ANNU REV BIOCHEM, V68, P157, DOI 10.1146/annurev.biochem.68.1.157; Fahy E, 2007, NUCLEIC ACIDS RES, V35, pW606, DOI 10.1093/nar/gkm324; Georgiou CD, 2001, PLANT PATHOL, V50, P594, DOI 10.1046/j.1365-3059.2001.00608.x; Georgiou CD, 2000, MYCOL RES, V104, P1191, DOI 10.1017/S0953756200002707; Georgiou CD, 1997, MYCOL RES, V101, P460, DOI 10.1017/S0953756296002882; Georgiou CD, 2006, INTEGR COMP BIOL, V46, P691, DOI 10.1093/icb/icj034; GITTERMA.CO, 1965, J MED CHEM, V8, P483, DOI 10.1021/jm00328a015; HENDRIX JW, 1970, ANNU REV PHYTOPATHOL, V8, P111, DOI 10.1146/annurev.py.08.090170.000551; Huan JJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02303; Kim S, 2016, NUCLEIC ACIDS RES, V44, pD1202, DOI 10.1093/nar/gkv951; KOSENKO E, 1995, NEUROCHEM RES, V20, P451, DOI 10.1007/BF00973101; Kuhl C, 2012, ANAL CHEM, V84, P283, DOI 10.1021/ac202450g; Kwon YS, 2014, FUNGAL BIOL-UK, V118, P433, DOI 10.1016/j.funbio.2014.02.001; LEBRUN MH, 1988, PHYTOCHEMISTRY, V27, P77, DOI 10.1016/0031-9422(88)80594-6; Liang Y, 2010, FUNGAL BIOL-UK, V114, P619, DOI 10.1016/j.funbio.2010.05.003; MILLER FA, 1963, NATURE, V200, P1338, DOI 10.1038/2001338a0; Mooney S, 2009, MOLECULES, V14, P329, DOI 10.3390/molecules14010329; Nes WD, 2009, ARCH BIOCHEM BIOPHYS, V481, P210, DOI 10.1016/j.abb.2008.11.003; OGOSHI A, 1987, ANNU REV PHYTOPATHOL, V25, P125, DOI 10.1146/annurev.py.25.090187.001013; Papapostolou I, 2010, FUNGAL BIOL-UK, V114, P387, DOI 10.1016/j.funbio.2010.01.010; Patsoukis N, 2008, MYCOL RES, V112, P602, DOI 10.1016/j.mycres.2007.10.006; Patsoukis N, 2007, MYCOPATHOLOGIA, V163, P335, DOI 10.1007/s11046-007-9008-9; Priyatmojo A, 2002, J PHYTOPATHOL, V150, P1, DOI 10.1046/j.1439-0434.2002.00707.x; Ritchie F, 2006, MYCOL RES, V110, P725, DOI 10.1016/j.mycres.2006.04.008; ROSETT T, 1957, BIOCHEM J, V67, P390, DOI 10.1042/bj0670390; Ruttkies C, 2016, J CHEMINFORMATICS, V8, DOI 10.1186/s13321-016-0115-9; Samsatly J, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01429; SHAPIRA R, 1989, J GEN MICROBIOL, V135, P1361; SHIGEURA HT, 1963, BIOCHEMISTRY-US, V2, P1132, DOI 10.1021/bi00905a039; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Sonaimuthu V, 2011, MICROBIOL RES-ITALY, V2, DOI 10.4081/mr.2011.e17; STEYN PS, 1976, PHYTOCHEMISTRY, V15, P1977, DOI 10.1016/S0031-9422(00)88860-3; Sumner DR, 1996, RHIZOCTONIA SPECIES: TAXONOMY, MOLECULAR BIOLOGY, ECOLOGY, PATHOLOGY AND DISEASE CONTROL, P207; TOWNSEND B. B., 1954, TRANS BRIT MYCOL SOC, V37, P213; TREVETHICK J, 1971, T BRIT MYCOL SOC, V57, P340, DOI 10.1016/S0007-1536(71)80017-7; UMETSU N, 1972, AGR BIOL CHEM TOKYO, V36, P859, DOI 10.1080/00021369.1972.10860315; Yun CS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9758; Zervoudakis G, 2003, MYCOL RES, V107, P624, DOI 10.1017/S0953756203007822; Zheng AP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2427; Zhu ZJ, 2013, NAT PROTOC, V8, P451, DOI 10.1038/nprot.2013.004	51	14	15	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177464	10.1371/journal.pone.0177464	http://dx.doi.org/10.1371/journal.pone.0177464			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489938	Green Submitted, gold, Green Published			2022-12-26	WOS:000401314100078
J	Okeyo-Owuor, T; Benesh, E; Bibbey, S; Reid, M; Halabi, J; Sutcliffe, S; Moley, K				Okeyo-Owuor, Theresa; Benesh, Emily; Bibbey, Scott; Reid, Michaela; Halabi, Jacques; Sutcliffe, Siobhan; Moley, Kelle			Exposure to maternal obesogenic diet worsens some but not all pre-cancer phenotypes in a murine genetic model of prostate cancer	PLOS ONE			English	Article							NEUROENDOCRINE DIFFERENTIATION; HIGH-FAT; TUMOR-CELLS; PROGRESSION; PHOSPHORYLATION; EXPRESSION; CARCINOMA; OBESITY; RISK; H3	Prostate cancer research has been predominantly focused on adult exposures and risk factors. However, because the prostate develops during gestation and early life, exposure to external factors, such as obesity, during development could affect the prostate cancer progression in adults. Our previous work demonstrated that exposure to a high fat/high sugar (HF/HS) diet during gestation and until weaning stimulated prostate hyperplasia and altered the Pten/Akt pathway in adult mice fed a normal diet after weaning. Here, we asked whether maternal exposure to HF/HS would worsen prostate phenotypes in mice lacking Pten, a widely accepted driver of prostate cancer. We found that, at six weeks of age, both Chow (control)-and HF/HS-exposed Pten knockout mice showed evidence of murine PIN that included ducts with central comedo necrosis but that the HF/HS exposure did not influence murine PIN progression. The Pten knockout mice exposed to HF/HS in utero had significantly more mitotic cells than Pten knockouts exposed to Chow diet. In the Pten null background, the maternal HF/HS diet enhanced proliferation but did not have an additive effect on Akt activation. We observed neuroendocrine differentiation in Pten knockout mice, a phenotype that had not been previously described in this model.	[Okeyo-Owuor, Theresa; Benesh, Emily; Reid, Michaela; Halabi, Jacques; Moley, Kelle] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA; [Bibbey, Scott] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Sutcliffe, Siobhan] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Moley, K (corresponding author), Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA.	moleyk@wudosis.wustl.edu		Sutcliffe, Siobhan/0000-0002-4613-8107	NCI [U54 CA155496]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by the NCI grant U54 CA155496 awarded to KHM. The funders had no role in the study.	ABRAHAMSSON PA, 1987, PATHOL RES PRACT, V182, P298, DOI 10.1016/S0344-0338(87)80065-1; Benesh EC, 2013, SCI REP-UK, V3, DOI 10.1038/srep03466; BOSTWICK DG, 1994, AM J SURG PATHOL, V18, P1240, DOI 10.1097/00000478-199412000-00007; Bostwick DG, 2002, J UROLOGY, V168, P1204, DOI 10.1016/S0022-5347(05)64626-5; Boudoures AL, 2016, REPRODUCTION, V151, P261, DOI 10.1530/REP-15-0419; Cox ME, 1999, CANCER RES, V59, P3821; de Assis S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2058; Ekbom A, 1998, SEMIN CANCER BIOL, V8, P237, DOI 10.1006/scbi.1998.0073; Esakky P, 2013, REPROD SCI, V20, P238, DOI 10.1177/1933719112452939; Freedland SJ, 2007, EPIDEMIOL REV, V29, P88, DOI 10.1093/epirev/mxm006; Grigore AD, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00037; Hans F, 2001, ONCOGENE, V20, P3021, DOI 10.1038/sj.onc.1204326; Hilakivi-Clarke L, 2001, J NUTR, V131, p154S, DOI 10.1093/jn/131.1.154S; HilakiviClarke L, 1997, P NATL ACAD SCI USA, V94, P9372, DOI 10.1073/pnas.94.17.9372; Komiya A, 2009, INT J UROL, V16, P37, DOI 10.1111/j.1442-2042.2008.02175.x; Kwon OJ, 2016, STEM CELL RES, V16, P682, DOI 10.1016/j.scr.2016.04.009; LOEB LA, 1994, CANCER RES, V54, P5059; Lu ZH, 2007, AM J PATHOL, V171, P667, DOI 10.2353/ajpath.2007.061138; Nielsen PS, 2013, MODERN PATHOL, V26, P404, DOI 10.1038/modpathol.2012.188; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Roberts JA, 2013, KOREAN J PATHOL, V47, P307, DOI 10.4132/KoreanJPathol.2013.47.4.307; Saben JL, 2016, CELL REP, V16, P1, DOI 10.1016/j.celrep.2016.05.065; Sagnak L, 2011, CLIN GENITOURIN CANC, V9, P73, DOI 10.1016/j.clgc.2011.07.003; Schiller JS, 2010, VITAL HLTH STAT, V10, P2012; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; SHIBATA K, 1990, EUR J BIOCHEM, V192, P87, DOI 10.1111/j.1432-1033.1990.tb19199.x; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sun Y, 2009, AM J TRANSL RES, V1, P148; Surwit RS, 1998, P NATL ACAD SCI USA, V95, P4061, DOI 10.1073/pnas.95.7.4061; Sutcliffe S, 2013, NAT REV CANCER, V13, P208, DOI 10.1038/nrc3434; Suwa T, 2002, TOXICOL PATHOL, V30, P228, DOI 10.1080/019262302753559560; TRICHOPOULOS D, 1990, LANCET, V335, P939, DOI 10.1016/0140-6736(90)91000-Z; TRICHOPOULOS D, 1995, EPIDEMIOLOGY, V6, P347; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wu CY, 2007, J BIOL CHEM, V282, P3571, DOI 10.1074/jbc.M608487200; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Zhong S, 2016, PROSTATE CANCER P D, V19, P122, DOI 10.1038/pcan.2015.64	37	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0175764	10.1371/journal.pone.0175764	http://dx.doi.org/10.1371/journal.pone.0175764			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489892	Green Submitted, Green Published, gold			2022-12-26	WOS:000401314100009
J	Pennisi, M; Lanza, G; Cantone, M; Ricceri, R; Ferri, R; D'Agate, CC; Pennisi, G; Di Lazzaro, V; Bella, R				Pennisi, Manuela; Lanza, Giuseppe; Cantone, Mariagiovanna; Ricceri, Riccardo; Ferri, Raffaele; D'Agate, Carmela Cinzia; Pennisi, Giovanni; Di Lazzaro, Vincenzo; Bella, Rita			Cortical involvement in celiac disease before and after long-term gluten-free diet: A Transcranial Magnetic Stimulation study	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR CORTEX EXCITABILITY; SLEEP-APNEA SYNDROME; INTRACORTICAL INHIBITION; SILENT PERIOD; DIAGNOSIS; ANTIBODIES; AUTOANTIBODIES; DISTURBANCES; VARIABILITY	Objective Transcranial Magnetic Stimulation in de novo patients with Celiac Disease previously revealed an imbalance in the excitability of cortical facilitatory and inhibitory circuits. After a median period of 16 months of gluten-free diet, a global increase of cortical excitability was reported, suggesting a glutamate-mediated compensation for disease progression. We have now evaluated cross-sectionally the changes of cortical excitability to TMS after a much longer gluten-free diet. Methods Twenty patients on adequate gluten-free diet for a mean period of 8.35 years were enrolled and compared with 20 de novo patients and 20 healthy controls. Transcranial Magnetic Stimulation measures, recorded from the first dorsal interosseous muscle of the dominant hand, consisted of: resting motor threshold, cortical silent period, motor evoked potentials, central motor conduction time, mean short-latency intracortical inhibition and intracortical facilitation. Results The cortical silent period was shorter in de novo patients, whereas in gluten-free diet participants it was similar to controls. The amplitude of motor responses was significantly smaller in all patients than in controls, regardless of the dietary regimen. Notwithstanding the diet, all patients exhibited a statistically significant decrease of mean short-latency intracortical inhibition and enhancement of intracortical facilitation with respect to controls; more intracortical facilitation in gluten-restricted compared to non-restricted patients was also observed. Neurological examination and celiac disease-related antibodies were negative. Conclusions In this new investigation, the length of dietary regimen was able to modulate the electrocortical changes in celiac disease. Nevertheless, an intracortical synaptic dysfunction, mostly involving excitatory and inhibitory interneurons within the motor cortex, may persist. The clinical significance of subtle neurophysiological changes in celiac disease needs to be further investigated.	[Pennisi, Manuela] Emergency Hosp Cannizzaro, Spinal Unit, Catania, Italy; [Lanza, Giuseppe; Cantone, Mariagiovanna; Ferri, Raffaele] IRCCS Oasi Maria SS, Dept Neurol IC, Troina, Enna, Italy; [Ricceri, Riccardo; Bella, Rita] Univ Catania, Dept Med & Surg Sci & Adv Technol, Sect Neurosci, Catania, Italy; [D'Agate, Carmela Cinzia] Univ Catania, Gastroenterol & Endoscopy Unit, Catania, Italy; [Pennisi, Giovanni] Univ Catania, Dept Specialita Med Chirurg, Catania, Italy; [Di Lazzaro, Vincenzo] Campus Biomed Univ, Inst Neurol, Rome, Italy	IRCCS Oasi Maria SS; University of Catania; University of Catania; University of Catania; University Campus Bio-Medico - Rome Italy	Lanza, G (corresponding author), IRCCS Oasi Maria SS, Dept Neurol IC, Troina, Enna, Italy.	glanza@oasi.en.it	Cantone, Mariagiovanna/C-9392-2017; Pennisi, Manuela/AAC-2362-2019; Lanza, Giuseppe/R-3065-2017; Di Lazzaro, Vincenzo/L-3731-2018; Ferri, Raffaele/B-5439-2013	Cantone, Mariagiovanna/0000-0002-9072-4971; Pennisi, Manuela/0000-0003-0776-1411; Lanza, Giuseppe/0000-0002-5659-662X; Di Lazzaro, Vincenzo/0000-0002-9113-5925; Ferri, Raffaele/0000-0001-6937-3065				Alaedini A, 2007, J IMMUNOL, V178, P6590, DOI 10.4049/jimmunol.178.10.6590; Bella R, 2016, BRAIN STIMUL, V9, P225, DOI 10.1016/j.brs.2015.09.013; Bella R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129218; Bella R, 2011, INT J PSYCHOPHYSIOL, V82, P248, DOI 10.1016/j.ijpsycho.2011.09.006; Benwell NM, 2007, EXP BRAIN RES, V179, P255, DOI 10.1007/s00221-006-0790-2; Biagi F, 2012, BRIT J NUTR, V108, P1884, DOI 10.1017/S0007114511007367; Bilgic B, 2013, NEUROL SCI, V34, P2199, DOI 10.1007/s10072-013-1448-z; Brown KJ, 2010, AM J NEURORADIOL, V31, P880, DOI 10.3174/ajnr.A1826; Cantello R, 2002, J CLIN NEUROPHYSIOL, V19, P272, DOI 10.1097/00004691-200208000-00003; Cantone M, 2014, CLIN NEUROPHYSIOL, V125, P1509, DOI 10.1016/j.clinph.2014.04.010; Chin Russell L, 2005, Curr Treat Options Neurol, V7, P43, DOI 10.1007/s11940-005-0005-3; Concerto C, 2015, INT J PSYCHIAT CLIN, V19, P253, DOI 10.3109/13651501.2015.1084329; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Currie S, 2012, J NEUROL NEUROSUR PS, V83, P1216, DOI 10.1136/jnnp-2012-303281; Di Lazzaro V, 2001, EXP BRAIN RES, V141, P121; Di Lazzaro V, 2014, J PHYSIOL-LONDON, V592, P4115, DOI 10.1113/jphysiol.2014.274316; Di Lazzaro V, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00018; Di Lazzaro V, 2010, LANCET, V376, P1798, DOI 10.1016/S0140-6736(10)61163-4; Dube C, 2005, GASTROENTEROLOGY, V128, pS57, DOI 10.1053/j.gastro.2005.02.014; Freeman HJ, 2008, CAN J GASTROENTEROL, V22, P273, DOI 10.1155/2008/905325; Gadoth A, 2015, JAMA NEUROL, V72, P676, DOI 10.1001/jamaneurol.2015.48; Giordano D, 2012, COMPUT METH PROG BIO, V107, P4, DOI 10.1016/j.cmpb.2011.10.008; Green PHR, 2003, LANCET, V362, P383, DOI 10.1016/S0140-6736(03)14027-5; Groppa S, 2012, CLIN NEUROPHYSIOL, V123, P858, DOI 10.1016/j.clinph.2012.01.010; Hadjivassiliou M, 2004, P 11 INT S CEL DIS B; Hadjivassiliou M, 2008, ANN NEUROL, V64, P332, DOI 10.1002/ana.21450; Hadjivassiliou M, 2010, LANCET NEUROL, V9, P318, DOI 10.1016/S1474-4422(09)70290-X; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Humeau Y, 2001, J NEUROSCI, V21, P4195, DOI 10.1523/JNEUROSCI.21-12-04195.2001; Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0; Jackson JR, 2012, PSYCHIAT QUART, V83, P91, DOI 10.1007/s11126-011-9186-y; Kobayashi M, 2003, LANCET NEUROL, V2, P145, DOI 10.1016/S1474-4422(03)00321-1; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Lanza G, 2015, SLEEP MED REV, V19, P39, DOI 10.1016/j.smrv.2014.04.001; Lanza G, 2015, SLEEP MED, V16, P138, DOI 10.1016/j.sleep.2014.08.016; Ludvigsson JF, 2014, EUR J NEUROL, V21, P976, DOI 10.1111/ene.12419; Luostarinen L, 2003, J NEUROL NEUROSUR PS, V74, P490, DOI 10.1136/jnnp.74.4.490; Mavroudi A, 2005, PEDIATR NEUROL, V33, P292, DOI 10.1016/j.pediatrneurol.2005.05.010; Mesrati F, 2004, NEUROPHYSIOL CLIN, V34, P217, DOI 10.1016/j.neucli.2004.09.005; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Orth M, 2004, CLIN NEUROPHYSIOL, V115, P1076, DOI 10.1016/j.clinph.2003.12.025; Orth M, 2003, CLIN NEUROPHYSIOL, V114, P2362, DOI 10.1016/S1388-2457(03)00243-8; Parisi P, 2015, SEIZURE-EUR J EPILEP, V25, P181, DOI 10.1016/j.seizure.2014.09.016; Paulus W, 2008, BRAIN STIMUL, V1, P151, DOI 10.1016/j.brs.2008.06.002; Pennisi G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102790; Pennisi M, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/8154969; Rigamonti A, 2007, MUSCLE NERVE, V35, P675, DOI 10.1002/mus.20727; Roshan L, 2003, EXP BRAIN RES, V151, P330, DOI 10.1007/s00221-003-1502-9; Rossini PM, 2015, CLIN NEUROPHYSIOL, V126, P1071, DOI 10.1016/j.clinph.2015.02.001; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Rubio-Tapia A, 2013, AM J GASTROENTEROL, V108, P656, DOI 10.1038/ajg.2013.79; Sanders DS, 2003, EUR J GASTROEN HEPAT, V15, P407, DOI 10.1097/00042737-200304000-00012; Sanger TD, 2001, J PHYSIOL-LONDON, V530, P307, DOI 10.1111/j.1469-7793.2001.0307l.x; Spampinato C, 2013, IEEE T NEUR SYS REH, V21, P391, DOI 10.1109/TNSRE.2013.2256432; Takenoshita H, 2001, J NEUROL NEUROSUR PS, V70, P386, DOI 10.1136/jnnp.70.3.386; Tijssen MAJ, 2000, NEUROLOGY, V54, P1350, DOI 10.1212/WNL.54.6.1350; Turner MR, 2007, NAT CLIN PRACT NEURO, V3, P581, DOI 10.1038/ncpneuro0631; Turner MR, 2013, NEUROLOGY, V81, P1222, DOI 10.1212/WNL.0b013e3182a6cc13; Tursi A, 2006, DIGEST DIS SCI, V51, P1869, DOI 10.1007/s10620-005-9054-4; Werhahn KJ, 1999, J PHYSIOL-LONDON, V517, P591, DOI 10.1111/j.1469-7793.1999.0591t.x; WILLIAMSON S, 1995, J AUTONOM NERV SYST, V55, P18, DOI 10.1016/0165-1838(95)00028-V; Ziemann U, 1996, J PHYSIOL-LONDON, V496, P873, DOI 10.1113/jphysiol.1996.sp021734; Ziemann U, 1996, ANN NEUROL, V40, P367, DOI 10.1002/ana.410400306; Ziemann U, 1996, EXP BRAIN RES, V109, P127; Ziemann U, 2015, CLIN NEUROPHYSIOL, V126, P1847, DOI 10.1016/j.clinph.2014.08.028	65	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177560	10.1371/journal.pone.0177560	http://dx.doi.org/10.1371/journal.pone.0177560			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489931	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314100079
J	van Boekel, RLM; Vissers, KCP; van der Sande, R; Bronkhorst, E; Lerou, JGC; Steegers, MAH				van Boekel, Regina L. M.; Vissers, Kris C. P.; van der Sande, Rob; Bronkhorst, Ewald; Lerou, Jos G. C.; Steegers, Monique A. H.			Moving beyond pain scores: Multidimensional pain assessment is essential for adequate pain management after surgery	PLOS ONE			English	Article							SEVERE POSTOPERATIVE PAIN; PATIENT SATISFACTION; INTERNATIONAL PAIN; RATING-SCALES; PROFESSIONALS; PERSPECTIVES; PERCEPTIONS; VALIDATION; INPATIENTS; OPIOIDS	Background Clinical experience teaches us that patients are willing to accept postoperative pain, despite high pain intensity scores. Nevertheless, relationships between pain scores and other methods of pain assessment, e.g. acceptability of pain or its interference with physical functioning, are not fully established. Our aims were to examine these relationships. Methods A cross-sectional study was conducted on patients who underwent major surgery between January 2008 and August 2013. Using logistic regression, we quantified the relationships between movement-evoked pain scores on the numerical rating scale (NRS-MEP) and three dichotomous dependent variables: patient's opinion on acceptability of pain (PO: acceptable or unacceptable pain); nurses' observation of patient's performance of necessary activities to expedite recovery (NO: good or bad performance); a compound measure judging the presence of the clinically desirable situation of acceptable pain associated with good patients' performance (PONO: present or not). Using Receiver Operating Characteristics (ROC) analysis, NRS cut-off points were determined such that they best discriminate between patients having one versus the other outcome for PO, NO and PONO. Results 15,394 assessments were obtained in 9,082 patients in the first three postoperative days. Nine percent of the patients had unacceptable pain while having an NRS-MEP of 0-4. An estimated 47% (95% CI = 45%-49%) of patients with an NRS-MEP of 7 described their pain as acceptable on day one. Moreover, 33% (31%-35%) performed all required physical activities, and 22% (21%-24%) combined acceptable pain with appropriate movement. NRS cutoff points for PO, NO and PONO were five, four and four, respectively, but had insufficient discriminatory power. Conclusions Our results suggest pain management should be guided by the many dimensions of the patient's pain experience, not solely by NRS cut-off points. Future research should evaluate the impact of such multidimensional pain assessment on patients' functional outcome.	[van Boekel, Regina L. M.; Vissers, Kris C. P.; Lerou, Jos G. C.; Steegers, Monique A. H.] Radboud Univ Nijmegen, Med Ctr, Dept Anesthesiol Pain & Palliat Med, Nijmegen, Netherlands; [van der Sande, Rob] HAN Univ Appl Sci, Fac Hlth, Nijmegen, Netherlands; [Bronkhorst, Ewald] Radboud Univ Nijmegen, Med Ctr, Dept Med Stat, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	van Boekel, RLM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Anesthesiol Pain & Palliat Med, Nijmegen, Netherlands.	Rianne.vanBoekel@Radboudumc.nl	Vissers, Kris C.P./D-3569-2009; van Boekel, Regina/P-9452-2015; Bronkhorst, Ewald/AAR-2250-2020; Vissers, Kris/H-8110-2014; Steegers, M.A.H./L-4668-2015; Bronkhorst, Ewald/L-4230-2015	Vissers, Kris C.P./0000-0002-2919-6356; van Boekel, Regina/0000-0002-0962-2944; Bronkhorst, Ewald/0000-0003-0953-8053; Vissers, Kris/0000-0002-2919-6356; Lerou, Jos/0000-0003-4006-292X; van der Sande, Rob/0000-0003-1410-900X; Steegers, Monique/0000-0003-0812-5089				Anand KJS, 1996, PAIN, V67, P3, DOI 10.1016/0304-3959(96)03135-1; [Anonymous], ACUTE PAIN MANAGEMEN; Aubrun F, 2003, ANESTHESIOLOGY, V98, P1415, DOI 10.1097/00000542-200306000-00017; Bartlett JW, 2015, AM J EPIDEMIOL, V182, P730, DOI 10.1093/aje/kwv114; Breivik H, 2008, BRIT J ANAESTH, V101, P17, DOI 10.1093/bja/aen103; Carr ECJ, 1997, J CLIN NURS, V6, P191, DOI 10.1111/j.1365-2702.1997.tb00304.x; Clark WC, 2002, PAIN, V98, P241, DOI 10.1016/S0304-3959(01)00474-2; Galley HF, 2004, BRIT J ANAESTH, V93, P623, DOI 10.1093/bja/aeh247; Gan TJ, 2014, CURR MED RES OPIN, V30, P149, DOI 10.1185/03007995.2013.860019; Gerbershagen HJ, 2011, BRIT J ANAESTH, V107, P619, DOI 10.1093/bja/aer195; Gerbershagen HJ, 2014, ANESTHESIOLOGY, V120, P1237, DOI 10.1097/ALN.0000000000000108; Gerbershagen HJ, 2013, ANESTHESIOLOGY, V118, P934, DOI 10.1097/ALN.0b013e31828866b3; Goesling J, 2016, PAIN, V157, P1259, DOI 10.1097/j.pain.0000000000000516; Gordon DB, 2015, CURR OPIN ANESTHESIO, V28, P565, DOI 10.1097/ACO.0000000000000225; Harting B, 2013, QUAL MANAG HEALTH CA, V22, P322, DOI 10.1097/QMH.0000000000000009; Helfand M, 2009, PAIN MED, V10, P1183, DOI 10.1111/j.1526-4637.2009.00718.x; Hosmer DW, 2005, APPL LOGISTIC REGRES, P1; Inspectorate DHC, BAS SET QUAL IND HOS; Ista E, 2013, INT J NURS STUD, V50, P552, DOI 10.1016/j.ijnurstu.2012.11.003; Janssen KJM, 2008, ANESTH ANALG, V107, P1330, DOI 10.1213/ane.0b013e31818227da; Liu SS, 2012, INT ORTHOP, V36, P2261, DOI 10.1007/s00264-012-1623-5; Macintyre P, 2008, CLIN PAIN MANAGEMENT, V1, P148; MacIntyre PE, 2009, COUSINS BRIDENBAUGHS, P1043; Maroney Catherine L, 2004, J Palliat Med, V7, P443, DOI 10.1089/1096621041349563; Massaron S, 2007, Hernia, V11, P517, DOI 10.1007/s10029-007-0267-7; McCaffery M., 1968, U CALIFORNIA PRINT O; MERSKEY H, 1991, European Psychiatry, V6, P153; MERSKEY H, 1994, QUAL LIFE RES, V3, pS69, DOI 10.1007/BF00433379; Oudejans L, 2016, PAIN, V157, P128, DOI 10.1097/j.pain.0000000000000338; RAWAL N, 1994, PAIN, V57, P117, DOI 10.1016/0304-3959(94)90115-5; Rothaug J, 2013, J PAIN, V14, P1361, DOI 10.1016/j.jpain.2013.05.016; Rothaug J, 2013, CLIN J PAIN, V29, P224, DOI 10.1097/AJP.0b013e31824c5d7a; Schiavenato M, 2010, CLIN J PAIN, V26, P667, DOI 10.1097/AJP.0b013e3181e72507; Schug SA, 2016, MED J AUSTRALIA, V204, P315, DOI 10.5694/mja16.00133; Schwenkglenks M, 2014, PAIN, V155, P1401, DOI 10.1016/j.pain.2014.04.021; Sloman R, 2006, PAIN MANAG NURS, V7, P153, DOI 10.1016/j.pmn.2006.09.001; Sommer M, 2008, EUR J ANAESTH, V25, P267, DOI 10.1017/S0265021507003031; Srikandarajah S, 2011, PAIN, V152, P1734, DOI 10.1016/j.pain.2011.02.008; van Boekel RLM, 2016, CLIN J PAIN, V32, P681, DOI 10.1097/AJP.0000000000000315; van Dijk JFM, 2016, INT J NURS STUD, V53, P260, DOI 10.1016/j.ijnurstu.2015.08.007; van Dijk JFM, 2015, PAIN PRACT, V15, P604, DOI 10.1111/papr.12217; van Dijk JFM, 2012, INT J NURS STUD, V49, P65, DOI 10.1016/j.ijnurstu.2011.07.009; White PF, 2010, ANESTHESIOLOGY, V112, P220, DOI 10.1097/ALN.0b013e3181c6316e; Wikstrom L, 2014, APPL NURS RES, V27, P53, DOI 10.1016/j.apnr.2013.11.001; Williamson A, 2005, J CLIN NURS, V14, P798, DOI 10.1111/j.1365-2702.2005.01121.x; Wu CL, 2011, LANCET, V377, P2215, DOI 10.1016/S0140-6736(11)60245-6	46	56	56	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177345	10.1371/journal.pone.0177345	http://dx.doi.org/10.1371/journal.pone.0177345			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UN	28489926	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314100065
J	Cheng, Y; Zheng, SF; Pan, CT; Yuan, MK; Chang, LB; Yao, YU; Zhao, MW; Liang, JH				Cheng, Yong; Zheng, Shufeng; Pan, Chung-Ting; Yuan, Mengke; Chang, Libin; Yao, Yuou; Zhao, Mingwei; Liang, Jianhong			Analysis of aqueous humor concentrations of cytokines in retinoblastoma	PLOS ONE			English	Article							GROWTH-FACTOR; INFLAMMATORY CYTOKINES; PROTEOMIC ANALYSIS; INDUCIBLE PROTEIN; CELL-GROWTH; IN-VIVO; CANCER; VEGF; PHOSPHORYLATION; PATHWAY	To investigate the components of the aqueous humor (AH) in patients with retinoblastoma (RB). We collected 0.1 ml AH of 35 children with RB and 20 patients with congenital cataracts as controls. Multiplex enzyme-linked immunosorbent assays (ELISAs) and Luminex xMAP technology were used to assess 45 cytokines/chemokines, matrix metalloproteinases ( MMPs), and acute-phase proteins in the identification cohort. The concentrations of IL-6, IL-7, IL-8, IFN-gamma, PIGF-1, VEGF-A, beta-NGF, HGF, EGF and FGF-2 were significantly higher in the AH of patients with RB than those in the control group (P<0.05). The study showed that the higher levels of IP-10, IL-6, IL-7, IL-8, IFN-gamma, PIGF-1, VEGF-A, beta-NGF, HGF, EGF and FGF-2 in AH may be associated with RB. Our findings may facilitate a better understanding of the molecular pathways of tumors and solid molecular targets for new strategies for therapy and the earlier diagnosis of RB.	[Cheng, Yong; Yao, Yuou; Zhao, Mingwei; Liang, Jianhong] Peking Univ, Peoples Hosp, Dept Ophthalmol, Beijing, Peoples R China; [Cheng, Yong; Yao, Yuou; Zhao, Mingwei; Liang, Jianhong] Minist Educ, Key Lab Vis Loss & Restorat, Beijing, Peoples R China; [Cheng, Yong; Yao, Yuou; Zhao, Mingwei; Liang, Jianhong] Beijing Key Lab Diag & Therapy Retinal & Choroid, Beijing, Peoples R China; [Zheng, Shufeng] Tradit Chinese Med Hosp Yulin, Eye Hosp, Yulin, Shaanxi, Peoples R China; [Pan, Chung-Ting] Peking Univ, Dept Ophthalmol, Int Hosp, Beijing, Peoples R China; [Yuan, Mengke] Beijing Shunyi Airport Hosp, Dept Ophthalmol, Beijing, Peoples R China; [Chang, Libin] Beijing Jingmei Grp Gen Hosp, Dept Ophthalmol, Beijing, Peoples R China	Peking University; Peking University	Zhao, MW; Liang, JH (corresponding author), Peking Univ, Peoples Hosp, Dept Ophthalmol, Beijing, Peoples R China.; Zhao, MW; Liang, JH (corresponding author), Minist Educ, Key Lab Vis Loss & Restorat, Beijing, Peoples R China.; Zhao, MW; Liang, JH (corresponding author), Beijing Key Lab Diag & Therapy Retinal & Choroid, Beijing, Peoples R China.	zhaomingwei@medmail.com.cn; drjianhongliang@163.com						Alberti L, 2004, INT J CANCER, V111, P653, DOI 10.1002/ijc.20287; Bennett KL, 2011, J PROTEOMICS, V74, P151, DOI 10.1016/j.jprot.2010.10.002; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Cebulla CM, 2008, INVEST OPHTH VIS SCI, V49, P5215, DOI 10.1167/iovs.07-1668; Chen DM, 2009, J VIROL, V83, P722, DOI 10.1128/JVI.01517-08; Chen H, 2016, MOL VIS, V22, P1005; Chiang CW, 2014, J HIGH ENERGY PHYS, DOI [10.1007/JHEP09(2014)006, 10.1186/1750-2187-9-6]; Chintagumpala M, 2007, ONCOLOGIST, V12, P1237, DOI 10.1634/theoncologist.12-10-1237; Chu L, 2015, MOL VIS, P2418; Crawford Y, 2009, CELL TISSUE RES, V335, P261, DOI 10.1007/s00441-008-0675-8; Dong N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125329; El-Gohary A, 2016, J CLIN LAB ANAL, V30, P1135, DOI 10.1002/jcla.21993; Feng J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068149; Fortunato P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-504; Guo J, 2005, J BIOL CHEM, V280, P35992, DOI 10.1074/jbc.M504583200; Hadjistilianou T, 2012, CLIN EXP OPHTHALMOL, V40, pE8, DOI 10.1111/j.1442-9071.2011.02711.x; Jeong YH, 2015, J CLIN MICROBIOL, V53, P504, DOI 10.1128/JCM.02758-14; KRAUSE U, 1970, OPHTHALMOLOGICA, V160, P280, DOI 10.1159/000306003; Kvanta A, 1996, EXP EYE RES, V63, P511, DOI 10.1006/exer.1996.0141; Laveti Durgaprasad, 2013, Inflammation & Allergy Drug Targets, V12, P349; Leshem Y, 2002, J CELL PHYSIOL, V191, P173, DOI 10.1002/jcp.10089; Luo WJ, 2016, INT J OPHTHALMOL-CHI, V9, P937, DOI 10.18240/ijo.2016.07.01; Miao H, 2012, MOL VIS, V18, P574; Niki T, 2015, INT HEART J, V56, P269, DOI 10.1536/ihj.14-300; Ozcan Altan Atakan, 2004, International Ophthalmology, V25, P19, DOI 10.1023/B:INTE.0000018524.48581.79; Pavlakovic Helena, 2001, Angiogenesis, V4, P259, DOI 10.1023/A:1016045012466; Qu H, 2016, INT IMMUNOPHARMACOL, V40, P203, DOI 10.1016/j.intimp.2016.08.017; Richardson MR, 2009, MOL VIS, V15, P2740; Saryeddine L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165876; Sauer A, 2016, GRAEF ARCH CLIN EXP, V254, P1013, DOI 10.1007/s00417-016-3313-2; SCHWEIGERER L, 1995, J MOL MED-JMM, V73, P497; Shields CL, 2006, OPHTHALMOLOGY, V113, P2276, DOI 10.1016/j.ophtha.2006.06.018; SHIELDS JA, 1991, RETINA-J RET VIT DIS, V11, P232, DOI 10.1097/00006982-199111020-00009; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Snoussi K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-283; Sohn HJ, 2011, AM J OPHTHALMOL, V152, P686, DOI 10.1016/j.ajo.2011.03.033; Stacker SA, 2013, CHIN J CANCER, V32, P297, DOI 10.5732/cjc.012.10319; Tai WY, 2010, MOL PHARMACEUT, V7, P543, DOI 10.1021/mp9002514; To Chi-ho, 2002, Clin Exp Optom, V85, P335; Traine PG, 2016, OCUL ONCOL PATHOL, V2, P128, DOI 10.1159/000441528; Urashima M, 1996, BLOOD, V88, P2219, DOI 10.1182/blood.V88.6.2219.bloodjournal8862219; Visciano C, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/705169; Vujosevic S, 2016, ACTA OPHTHALMOL, V94, P56, DOI 10.1111/aos.12812; Wang B, 2014, J OCUL PHARMACOL TH, V30, P587, DOI 10.1089/jop.2013.0241; Wykosky Jill, 2011, Chin J Cancer, V30, P5; Xin GH, 2012, INT J OPHTHALMOL-CHI, V5, P440, DOI 10.3980/j.issn.2222-3959.2012.04.07	46	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177337	10.1371/journal.pone.0177337	http://dx.doi.org/10.1371/journal.pone.0177337			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486560	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314000071
J	McCoy, SI; Fahey, C; Rao, A; Kapologwe, N; Njau, PF; Bautista-Arredondo, S				McCoy, Sandra I.; Fahey, Carolyn; Rao, Aarthi; Kapologwe, Ntuli; Njau, Prosper F.; Bautista-Arredondo, Sergio			Pilot study of a multi-pronged intervention using social norms and priming to improve adherence to antiretroviral therapy and retention in care among adults living with HIV in Tanzania	PLOS ONE			English	Article							INHIBITOR THERAPY; BEHAVIOR; METAANALYSIS	Background Interventions incorporating constructs from behavioral economics and psychology have the potential to enhance HIV 'treatment as prevention' (TasP) strategies. To test this hypothesis, we evaluated an intervention to improve antiretroviral therapy (ART) adherence based on the concepts of social norms and priming. Methods We used tools from marketing research and patient-centered design to develop a combination intervention that included visual feedback about clinic-level retention in care, a self- relevant prime, and useful take-home items with the priming image. The intervention was implemented at two HIV primary clinics in Shinyanga, Tanzania in 2-week intervals for six months. We conducted a quasi-experimental pilot study with a random sample of exposed and unexposed adult patients living with HIV infection (PLHIV) to compare retention and the proportion of patients with medication possession ratio (MPR) >= 95% after six months. Intervention acceptability was determined with a convenience sample of 405 PLHIV at baseline (n = 189) and endline (n = 216). Results Medical records were reviewed for 438 PLHIV (320 intervention, 118 standard of care). In adjusted analyses, PLHIV exposed to the intervention were significantly more likely to be in care after 6 months (87% vs. 79%, adjusted odds ratio (ORa) = 1.73, 95% CI: 1.08, 2.78, p<0.05) and were more likely to achieve MPR >= 95% (70% vs. 59%, OR = 1.51, 95% CI: 0.96, 2.37, p = 0.07). The intervention was associated with increases in staff support of treatment goals (100% vs. 95%, p = 0.01) and life goals (66% vs. 50%, p<0.01), the perceived likelihood of other patients' adherence (54% vs. 32%, p<0.01), support from other patients (71% vs. 60%, p = 0.03), and being very satisfied with care (53% vs. 35%, p<0.01). Conclusions This novel intervention has the potential to improve the clinic experience, short-term retention in care, and ART adherence. Future studies are needed to expand the generalizability of the approach and evaluate effectiveness on clinical outcomes.	[McCoy, Sandra I.; Fahey, Carolyn] Univ Calif Berkeley, Div Epidemiol, Berkeley, CA 94720 USA; [Rao, Aarthi] CVS Hlth, Enterprise Prod Innovat, Woonsocket, RI USA; [Kapologwe, Ntuli] Minist Hlth Community Dev Gender Elderly & Childr, Reg Med Off, Shinyanga, Tanzania; [Njau, Prosper F.] Minist Hlth Community Dev Gender Elderly & Childr, Prevent Mother Child HIV Transmiss Programme, Dar Es Salaam, Tanzania; [Bautista-Arredondo, Sergio] Natl Inst Publ Hlth, Hlth Econ Dept, Cuernavaca, Morelos, Mexico	University of California System; University of California Berkeley; Instituto Nacional de Salud Publica	McCoy, SI (corresponding author), Univ Calif Berkeley, Div Epidemiol, Berkeley, CA 94720 USA.	smccoy@berkeley.edu	Bautista-Arredondo, Sergio/N-7305-2016	Bautista-Arredondo, Sergio/0000-0001-8910-3011; Fahey, Carolyn A./0000-0001-9865-2397; MCCOY, SANDRA/0000-0002-4764-9195	Bill & Melinda Gates Foundation; National Institute of Mental Health [K01MH094246];  [OPP1118511]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD073964] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This publication is based on research funded in part by a Grand Challenges Explorations grant to SIM (Award Number OPP1118511), an initiative of the Bill & Melinda Gates Foundation (http://www.gatesfoundation.org/). The findings and conclusions contained within are those of the authors and do not necessarily reflect positions or policies of the Bill & Melinda Gates Foundation. SIM is supported by Award Number K01MH094246 from the National Institute of Mental Health (www.nimh.nih.gov). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Mental Health or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXELROD R, 1986, AM POLIT SCI REV, V80, P1095, DOI 10.2307/1960858; Bangsberg DR, 2006, CLIN INFECT DIS, V43, P939, DOI 10.1086/507526; Bargh JA, 1996, J PERS SOC PSYCHOL, V71, P230, DOI 10.1037/0022-3514.71.2.230; Bezabhe WM, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003361; Birnbach DJ, 2013, J HOSP INFECT, V85, P79, DOI 10.1016/j.jhin.2013.06.008; Caceres CF, 2010, JAIDS-J ACQ IMM DEF, V54, P204, DOI 10.1097/QAI.0b013e3181d61def; Chaiyachati KH, 2014, AIDS, V28, pS187, DOI 10.1097/QAD.0000000000000252; Codagnone C, 2014, J EPIDEMIOL COMMUN H, V68, P909, DOI 10.1136/jech-2014-203948; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; DELBECQ AL, 1971, J APPL BEHAV SCI, V7, P466, DOI 10.1177/002188637100700404; Dolan P, 2012, J ECON PSYCHOL, V33, P264, DOI 10.1016/j.joep.2011.10.009; Fox MP, 2015, JAIDS-J ACQ IMM DEF, V69, P98, DOI 10.1097/QAI.0000000000000553; Galarraga O, 2013, AIDS BEHAV; Greenland S, 2000, INT J EPIDEMIOL, V29, P1102, DOI 10.1093/oxfordjournals.ije.a019909; Hallsworth M, 2016, LANCET; Hong SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056307; IDEO. org, 2016, FIELD GUID HUM CTR D; Kahana SY, 2013, AIDS BEHAV, V17, P41, DOI 10.1007/s10461-012-0159-4; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Martin S., 2012, HARVARD BUSINESS REV; McMahon JH, 2011, CLIN INFECT DIS, V52, P493, DOI 10.1093/cid/ciq167; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Mugavero MJ, 2010, AIDS PATIENT CARE ST, V24, P607, DOI 10.1089/apc.2010.0086; National Bureau of Statistics (NBS) Office of the Chief Government Statistician (OCGS) CF International, 2013, TANZ HIV AIDS MAL IN; Oyserman D, 2010, COUNS PSYCHOL, V38, P1001, DOI 10.1177/0011000010374775; Oyserman D, 2009, J CONSUM PSYCHOL, V19, P250, DOI 10.1016/j.jcps.2009.05.008; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Pettifor A, 2012, AIDS BEHAV, V16, P1729, DOI 10.1007/s10461-012-0240-z; Rao A, 2016, 21 INT AIDS C AIDS 2; Rao A, 2015, FOSTERING BEHAV CHAN; RAO JNK, 1981, J AM STAT ASSOC, V76, P221, DOI 10.2307/2287815; RICHARDSONKLAVEHN A, 1988, ANNU REV PSYCHOL, V39, P475, DOI 10.1146/annurev.ps.39.020188.002355; Susnstein CR, 2008, NUDGE IMPROVING DECI; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; UNAIDS, 2014, GAP REP; UNAIDS, 2014, 90 90 90 AMB TREATM; Walton GM, 2014, CURR DIR PSYCHOL SCI, V23, P73, DOI 10.1177/0963721413512856	37	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177394	10.1371/journal.pone.0177394	http://dx.doi.org/10.1371/journal.pone.0177394			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UM	28486553	Green Submitted, Green Published, gold			2022-12-26	WOS:000401314000078
J	Zeng, BS; Huang, YP; Xu, J; Shiotsuki, T; Bai, H; Palli, SR; Huang, YP; Tan, AJ				Zeng, Baosheng; Huang, Yuping; Xu, Jun; Shiotsuki, Takahiro; Bai, Hua; Palli, Subba Reddy; Huang, Yongping; Tan, Anjiang			The FOXO transcription factor controls insect growth and development by regulating juvenile hormone degradation in the silkworm, Bombyx mori	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA-MELANOGASTER; INSULIN-RECEPTOR; LIFE-SPAN; FAT-BODY; METAMORPHOSIS; PATHWAY; CELLS; SIZE; BIOSYNTHESIS; ESTERASE	Forkhead box O (FOXO) functions as the terminal transcription factor of the insulin signaling pathway and regulates multiple physiological processes in many organisms, including life-span in insects. However, how FOXO interacts with hormone signaling to modulate insect growth and development is largely unknown. Here, using the transgene-based CRISPR/Cas9 system, we generated and characterized mutants of the silkworm Bombyx mori FOXO (BmFOXO) to elucidate its physiological functions during development of this lepidopteran insect. The BmFOXO mutant (FOXO-M) exhibited growth delays from the first larval stage and showed precocious metamorphosis, pupating at the end of the fourth instar (trimolter) rather than at the end of the fifth instar as in the wild-type (WT) animals. However, different from previous reports on precocious metamorphosis caused by juvenile hormone (JH) deficiency in silkworm mutants, the total developmental time of the larval period in the FOXO-M was comparable with that of the WT. Exogenous application of 20-hydroxyecdysone (20E) or of the JH analog rescued the trimolter phenotype. RNA-seq and gene expression analyses indicated that genes involved in JH degradation but not in JH biosynthesis were up-regulated in the FOXO-M compared with the WT animals. Moreover, we identified several FOXO-binding sites in the promoter of genes coding for JH-degradation enzymes. These results suggest that FOXO regulates JH degradation rather than its biosynthesis, which further modulates hormone homeostasis to control growth and development in B. mori. In conclusion, we have uncovered a pivotal role for FOXO in regulating JH signaling to control insect development.	[Zeng, Baosheng; Huang, Yuping; Xu, Jun; Huang, Yongping; Tan, Anjiang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Insect Dev & Evolutionary Biol, Shanghai 200032, Peoples R China; [Zeng, Baosheng; Xu, Jun] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Shiotsuki, Takahiro] Natl Agr & Food Res Org, Inst Agrobiol Sci, Div Insect Sci, 1-2 Owashi, Tsukuba, Ibaraki 3058634, Japan; [Bai, Hua] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA; [Palli, Subba Reddy] Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; National Agriculture & Food Research Organization - Japan; Iowa State University; University of Kentucky	Tan, AJ (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Insect Dev & Evolutionary Biol, Shanghai 200032, Peoples R China.	ajtan01@sibs.ac.cn	Xu, Jun/ABD-7800-2021; Zeng, Baosheng/AAB-7808-2022; Zeng, Baosheng/X-5191-2019; PALLI, SUBBA REDDY/AAU-8289-2020	Xu, Jun/0000-0002-7963-0253; PALLI, SUBBA REDDY/0000-0002-0873-3247; Shiotsuki, Takahiro/0000-0001-5077-7270	Strategic Priority Research Program of Chinese Academy of Sciences [XDB11010600]; National Basic Research Program of China [2015CB755703]; National Science Foundation of China [31420103918, 31530072]; Chinese Academy of Sciences [KJZD-EW-L12-02]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070559] Funding Source: NIH RePORTER	Strategic Priority Research Program of Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Strategic Priority Research Program of Chinese Academy of Sciences Grant XDB11010600, National Basic Research Program of China Grant 2015CB755703, National Science Foundation of China Grants 31420103918 and 31530072, and Chinese Academy of Sciences Grant KJZD-EW-L12-02. The authors declare that they have no conflicts of interest with the contents of this article.	Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Carter ME, 2007, CURR BIOL, V17, pR113, DOI 10.1016/j.cub.2007.01.008; Colombani J, 2005, SCIENCE, V310, P667, DOI 10.1126/science.1119432; Daimon T, 2015, P NATL ACAD SCI USA, V112, pE4226, DOI 10.1073/pnas.1506645112; Daimon T, 2014, DEV GROWTH DIFFER, V56, P14, DOI 10.1111/dgd.12096; Daimon T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002486; Delanoue R, 2010, DEV CELL, V18, P1012, DOI 10.1016/j.devcel.2010.05.007; Dubrovsky EB, 2005, TRENDS ENDOCRIN MET, V16, P6, DOI 10.1016/j.tem.2004.11.003; Furuta K, 2013, BIOSCI BIOTECH BIOCH, V77, P988, DOI 10.1271/bbb.120883; Gelman DB, 2002, J INSECT PHYSIOL, V48, P63, DOI 10.1016/S0022-1910(01)00146-9; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; Herold MJ, 2013, EMBO REP, V14, P992, DOI 10.1038/embor.2013.152; Hossain MS, 2013, INSECT BIOCHEM MOLEC, V43, P829, DOI 10.1016/j.ibmb.2013.06.007; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Kingan TG, 2000, J EXP BIOL, V203, P3011; Kondo S, 2013, GENETICS, V195, P715, DOI 10.1534/genetics.113.156737; Kramer Jamie M, 2003, BMC Dev Biol, V3, P5, DOI 10.1186/1471-213X-3-5; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Li ZQ, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0513; Li ZQ, 2015, INT J BIOL SCI, V11, P176, DOI 10.7150/ijbs.10235; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Ling L, 2014, INSECT BIOCHEM MOLEC, V53, P13, DOI 10.1016/j.ibmb.2014.06.011; MCCUTCHEN BF, 1995, INSECT BIOCHEM MOLEC, V25, P119, DOI 10.1016/0965-1748(94)00036-H; Mirth C, 2005, CURR BIOL, V15, P1796, DOI 10.1016/j.cub.2005.09.017; Mirth CK, 2014, P NATL ACAD SCI USA, V111, P7018, DOI 10.1073/pnas.1313058111; Niwa R, 2010, DEVELOPMENT, V137, P1991, DOI 10.1242/dev.045641; Puig O, 2005, GENE DEV, V19, P2435, DOI 10.1101/gad.1340505; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Rauschenbach I Yu, 2015, Genetika, V51, P1083; Riddiford LM, 2003, INSECT BIOCHEM MOLEC, V33, P1327, DOI 10.1016/j.ibmb.2003.06.001; Slack C, 2011, AGING CELL, V10, P735, DOI 10.1111/j.1474-9726.2011.00707.x; Suren-Castillo S, 2012, INSECT BIOCHEM MOLEC, V42, P491, DOI 10.1016/j.ibmb.2012.03.006; Tan A, 2005, P NATL ACAD SCI USA, V102, P11751, DOI 10.1073/pnas.0500954102; Tsubota T, 2010, BIOSCI BIOTECH BIOCH, V74, P2259, DOI 10.1271/bbb.100480; Tu MP, 2005, GEN COMP ENDOCR, V142, P347, DOI 10.1016/j.ygcen.2005.02.009; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; Wang YQ, 2013, CELL RES, V23, P1414, DOI 10.1038/cr.2013.146; Xu J, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006576; Zeng BS, 2016, INSECT BIOCHEM MOLEC, V72, P31, DOI 10.1016/j.ibmb.2016.03.006; Zhang L, 2014, J BACTERIOL, V196, P3949, DOI 10.1128/JB.02037-14	43	46	52	8	88	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11659	11669		10.1074/jbc.M117.777797	http://dx.doi.org/10.1074/jbc.M117.777797			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28490635	hybrid, Green Published			2022-12-26	WOS:000405485600007
J	Kogure, A; Uno, M; Ikeda, T; Nishida, E				Kogure, Akiko; Uno, Masaharu; Ikeda, Takako; Nishida, Eisuke			The microRNA machinery regulates fasting-induced changes in gene expression and longevity in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C. ELEGANS; DIETARY-RESTRICTION; LIFE-SPAN; BIOGENESIS; DROSOPHILA; PATHWAY; DISEASE; TARGETS; HEALTH; RNAS	Intermittent fasting (IF) is a dietary restriction regimen that extends the lifespans of Caenorhabditis elegans and mammals by inducing changes in gene expression. However, how IF induces these changes and promotes longevity remains unclear. One proposed mechanism involves gene regulation by microRNAs (miRNAs), small non-coding RNAs (similar to 22 nucleotides) that repress gene expression and whose expression can be altered by fasting. To test this proposition, we examined the role of the miRNA machinery in fasting-induced transcriptional changes and longevity in C. elegans. We revealed that fasting up-regulated the expression of the miRNA-induced silencing complex (miRISC) components, including Argonaute and GW182, and the miRNA-processing enzyme DRSH-1 (the ortholog of the Drosophila Drosha enzyme). Our lifespan measurements demonstrated that IF-induced longevity was suppressed by knock-out or knockdown of miRISC components and was completely inhibited by drsh-1 ablation. Remarkably, drsh-1 ablation inhibited the fasting-induced changes in the expression of the target genes of DAF-16, the insulin/IGF-1 signaling effector in C. elegans. Fasting-induced transcriptome alterations were substantially and modestly suppressed in the drsh-1 null mutant and the null mutant of ain-1, a gene encoding GW182, respectively. Moreover, miRNA array analyses revealed that the expression levels of numerous miRNAs changed after 2 days of fasting. These results indicate that components of the miRNA machinery, especially the miRNA-processing enzyme DRSH-1, play an important role in mediating IF-induced longevity via the regulation of fasting-induced changes in gene expression.	[Kogure, Akiko; Uno, Masaharu; Ikeda, Takako; Nishida, Eisuke] Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan	Kyoto University	Uno, M (corresponding author), Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan.	muno.m06@lif.kyoto-u.ac.jp	Asada, Akiko/ABF-7324-2020	Uno, Masaharu/0000-0001-7770-3941	National Institutes of Health NCRR	National Institutes of Health NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank the members of our laboratory for technical comments and helpful discussion. C. elegans strains were provided by the Caenorhabditis Genetics Center, which is funded by the National Institutes of Health NCRR.	Ahmet I, 2005, CIRCULATION, V112, P3115, DOI 10.1161/CIRCULATIONAHA.105.563817; Bouasker S, 2012, NUCLEIC ACIDS RES, V40, P10452, DOI 10.1093/nar/gks748; BRENNER S, 1974, GENETICS, V77, P71; de Lencastre A, 2010, CURR BIOL, V20, P2159, DOI 10.1016/j.cub.2010.11.015; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Ding XC, 2009, EMBO J, V28, P213, DOI 10.1038/emboj.2008.275; Fontana L, 2015, CELL, V161, P106, DOI 10.1016/j.cell.2015.02.020; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garcia-Segura L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142262; Garg D, 2014, AGEING RES REV, V17, P3, DOI 10.1016/j.arr.2014.04.001; Gill S, 2015, SCIENCE, V347, P1265, DOI 10.1126/science.1256682; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Honjoh S, 2009, NATURE, V457, P726, DOI 10.1038/nature07583; Ibanez-Ventoso C, 2006, AGING CELL, V5, P235, DOI 10.1111/j.1474-9726.2006.00210.x; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kato M, 2011, RNA, V17, P1804, DOI 10.1261/rna.2714411; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kroeger CM, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-98; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lehrbach NJ, 2012, RNA, V18, P2220, DOI 10.1261/rna.035402.112; Liu N, 2012, NATURE, V482, P519, DOI 10.1038/nature10810; Lucas K, 2013, INSECT BIOCHEM MOLEC, V43, P24, DOI 10.1016/j.ibmb.2012.10.009; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; Mattson MP, 2014, P NATL ACAD SCI USA, V111, P16647, DOI 10.1073/pnas.1413965111; Mori MA, 2012, CELL METAB, V16, P336, DOI 10.1016/j.cmet.2012.07.017; Palmer JD, 2014, AGEING RES REV, V17, P16, DOI 10.1016/j.arr.2014.04.005; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Smith-Vikos T, 2014, CURR BIOL, V24, P2238, DOI 10.1016/j.cub.2014.08.013; Smith-Vikos T, 2012, J CELL SCI, V125, P7, DOI 10.1242/jcs.099200; Uno M, 2013, CELL REP, V3, P79, DOI 10.1016/j.celrep.2012.12.018; Vasquez-Rifo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033750; Vora M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003737; WEINDRUCH R, 1986, J NUTR, V116, P641, DOI 10.1093/jn/116.4.641	34	18	18	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11300	11309		10.1074/jbc.M116.765065	http://dx.doi.org/10.1074/jbc.M116.765065			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28507100	Green Published, hybrid			2022-12-26	WOS:000405119600014
J	Buzza, MS; Johnson, TA; Conway, GD; Martin, EW; Mukhopadhyay, S; Shea-Donohue, T; Antalis, TM				Buzza, Marguerite S.; Johnson, Tierra A.; Conway, Gregory D.; Martin, Erik W.; Mukhopadhyay, Subhradip; Shea-Donohue, Terez; Antalis, Toni M.			Inflammatory cytokines down-regulate the barrier-protective prostasin-matriptase proteolytic cascade early in experimental colitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INCREASED INTESTINAL PERMEABILITY; NK T-CELLS; ULCERATIVE-COLITIS; CROHNS-DISEASE; OXAZOLONE COLITIS; TIGHT JUNCTIONS; EXPRESSION; ACTIVATION; CLAUDIN-2; BOWEL	Compromised gastrointestinal barrier function is strongly associated with the progressive and destructive pathologies of the two main forms of irritable bowel disease (IBD), ulcerative colitis (UC), and Crohn's disease (CD). Matriptase is a membrane-anchored serine protease encoded by suppression of tumorigenicity-14 (ST14) gene, which is critical for epithelial barrier development and homeostasis. Matriptase barrier-protective activity is linked with the glycosylphosphatidylinositol (GPI)-anchored serine protease prostasin, which is a co-factor for matriptase zymogen activation. Here we show that mRNA and protein expression of both matriptase and prostasin are rapidly down-regulated in the initiating inflammatory phases of dextran sulfate sodium (DSS)-induced experimental colitis in mice, and, significantly, the loss of these proteases precedes the appearance of clinical symptoms, suggesting their loss may contribute to disease susceptibility. We used heterozygous St14 hypomorphic mice expressing a promoter-linked beta-gal reporter to show that inflammatory colitis suppresses the activity of the St14 gene promoter. Studies in colonic T84 cell monolayers revealed that barrier disruption by the colitis-associated Th2-type cytokines, IL-4 and IL-13, down-regulates matriptase as well as prostasin through phosphorylation of the transcriptional regulator STAT6 and that inhibition of STAT6 with suberoylanilide hydroxamic acid (SAHA) restores protease expression and reverses cytokine-induced barrier dysfunction. Both matriptase and prostasin are significantly down-regulated in colonic tissues from human subjects with active ulcerative colitis or Crohn's disease, implicating the loss of this barrier-protective protease pathway in the pathogenesis of irritable bowel disease.	[Buzza, Marguerite S.; Johnson, Tierra A.; Conway, Gregory D.; Martin, Erik W.; Mukhopadhyay, Subhradip; Antalis, Toni M.] Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Buzza, Marguerite S.; Johnson, Tierra A.; Conway, Gregory D.; Martin, Erik W.; Mukhopadhyay, Subhradip; Antalis, Toni M.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Shea-Donohue, Terez] Univ Maryland, Sch Med, Dept Radiat Oncol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Antalis, TM (corresponding author), 800 West Baltimore St, Baltimore, MD 21201 USA.	tantalis@som.umaryland.edu		Martin, Erik/0000-0003-3979-2378	U.S. Department of Defense [PR110378]; National Institutes of Health [R01 DK081376, R01 HL118390, R01 DK83418]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118390, R01HL084387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083418, R01DK081376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM055036] Funding Source: NIH RePORTER	U.S. Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U.S. Department of Defense Grant PR110378 and National Institutes of Health Grants R01 DK081376 and R01 HL118390 (T. M. A.) and R01 DK83418 (T. S. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amasheh S, 2002, J CELL SCI, V115, P4969, DOI 10.1242/jcs.00165; Behera J, 2015, MINI-REV MED CHEM, V15, P731, DOI 10.2174/1389557515666150521162237; Boirivant M, 1998, J EXP MED, V188, P1929, DOI 10.1084/jem.188.10.1929; Bruewer M, 2003, J IMMUNOL, V171, P6164, DOI 10.4049/jimmunol.171.11.6164; Buzza MS, 2013, J BIOL CHEM, V288, P10328, DOI 10.1074/jbc.M112.443432; Buzza MS, 2010, P NATL ACAD SCI USA, V107, P4200, DOI 10.1073/pnas.0903923107; Chen ML, 2016, INFLAMM BOWEL DIS, V22, P1157, DOI 10.1097/MIB.0000000000000714; Duvic M, 2016, CANCER TREAT REV, V43, P58, DOI 10.1016/j.ctrv.2015.04.003; Felice C, 2015, ALIMENT PHARM THER, V41, P26, DOI 10.1111/apt.13008; Friis S, 2016, J BIOL CHEM, V291, P2577, DOI 10.1074/jbc.C115.706721; Friis S, 2014, J BIOL CHEM, V289, P22319, DOI 10.1074/jbc.M114.574400; Friis S, 2013, J BIOL CHEM, V288, P19028, DOI 10.1074/jbc.M113.469932; Friis S, 2011, J BIOL CHEM, V286, P5793, DOI 10.1074/jbc.M110.186874; Fuss IJ, 2008, MUCOSAL IMMUNOL, V1, pS31, DOI 10.1038/mi.2008.40; Fuss IJ, 2004, J CLIN INVEST, V113, P1490, DOI 10.1172/JCI200419836; Fuss IJ, 1996, J IMMUNOL, V157, P1261; Glauben R, 2008, GUT, V57, P613, DOI 10.1136/gut.2007.134650; Glauben R, 2006, J IMMUNOL, V176, P5015, DOI 10.4049/jimmunol.176.8.5015; Hebenstreit D, 2006, CYTOKINE GROWTH F R, V17, P173, DOI 10.1016/j.cytogfr.2006.01.004; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; Heller F, 2002, IMMUNITY, V17, P629, DOI 10.1016/S1074-7613(02)00453-3; HOLLANDER D, 1986, ANN INTERN MED, V105, P883, DOI 10.7326/0003-4819-105-6-883; Hung RJ, 2004, AM J PHYSIOL-CELL PH, V286, pC1159, DOI 10.1152/ajpcell.00400.2003; Inoue S, 1999, AM J GASTROENTEROL, V94, P2441; Irvine EJ, 2000, GASTROENTEROLOGY, V119, P1740, DOI 10.1053/gast.2000.20231; Ivanov AI, 2005, BIOESSAYS, V27, P356, DOI 10.1002/bies.20203; Ivanov Andrei I, 2004, Novartis Found Symp, V263, P115; JENKINS RT, 1988, CLIN INVEST MED, V11, P151; Kasaian MT, 2014, IMMUNOLOGY, V143, P416, DOI 10.1111/imm.12319; KATZ KD, 1989, GASTROENTEROLOGY, V97, P927, DOI 10.1016/0016-5085(89)91499-6; Keppner A, 2016, INFLAMM BOWEL DIS, V22, P2824, DOI 10.1097/MIB.0000000000000940; Kosa P, 2012, ONCOGENE, V31, P3679, DOI 10.1038/onc.2011.545; Lee MS, 2007, AM J PHYSIOL-CELL PH, V293, pC95, DOI 10.1152/ajpcell.00611.2006; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; List K, 2006, AM J PATHOL, V168, P1513, DOI 10.2353/ajpath.2006.051071; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2007, J BIOL CHEM, V282, P36714, DOI 10.1074/jbc.M705521200; List K, 2007, J CELL PHYSIOL, V213, P237, DOI 10.1002/jcp.21115; List K, 2006, MOL MED, V12, P1, DOI 10.2119/2006-00022.List; List K, 2009, AM J PATHOL, V175, P1453, DOI 10.2353/ajpath.2009.090240; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luettig J, 2015, TISSUE BARRIERS, V3, DOI 10.4161/21688370.2014.977176; Mann ER, 2014, INFLAMM BOWEL DIS, V20, P2299, DOI 10.1097/MIB.0000000000000223; Michielan A, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/628157; Mildner M, 2015, J DTSCH DERMATOL GES, V13, P1165, DOI 10.1111/ddg.12812; MOOLENBEEK C, 1981, LAB ANIM, V15, P57, DOI 10.1258/002367781780958577; Netzel-Arnett S, 2012, INFLAMM BOWEL DIS, V18, P1303, DOI 10.1002/ibd.21930; Oberst MD, 2003, J HISTOCHEM CYTOCHEM, V51, P1017, DOI 10.1177/002215540305100805; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Prasad S, 2005, LAB INVEST, V85, P1139, DOI 10.1038/labinvest.3700316; Ramsay AJ, 2008, J BIOL CHEM, V283, P12293, DOI 10.1074/jbc.M709493200; Randall K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162076; Rosen MJ, 2013, J IMMUNOL, V190, P1849, DOI 10.4049/jimmunol.1201373; Rosen MJ, 2011, INFLAMM BOWEL DIS, V17, P2224, DOI 10.1002/ibd.21628; Rosenthal R, 2010, J CELL SCI, V123, P1913, DOI 10.1242/jcs.060665; Schroder AJ, 2002, J IMMUNOL, V168, P996, DOI 10.4049/jimmunol.168.3.996; Selzer-Plon J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-201; Spacek DV, 2010, EXP DERMATOL, V19, P527, DOI 10.1111/j.1600-0625.2009.01054.x; Stevceva L, 2001, GENES IMMUN, V2, P309, DOI 10.1038/sj.gene.6363782; Szabo R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002937; Tilg H, 2015, GUT, V64, P857, DOI 10.1136/gutjnl-2015-309464; Utech M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/484987; Verghese GM, 2006, AM J PHYSIOL-CELL PH, V291, pC1258, DOI 10.1152/ajpcell.00637.2005; Wang X.D., 2014, J APPL MATH, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0093899; Weber CR, 2010, J BIOL CHEM, V285, P12037, DOI 10.1074/jbc.M109.064808; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Zeissig S, 2007, GUT, V56, P61, DOI 10.1136/gut.2006.094375	67	12	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					10801	10812		10.1074/jbc.M116.771469	http://dx.doi.org/10.1074/jbc.M116.771469			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28490634	hybrid, Green Published			2022-12-26	WOS:000404391000005
J	Biswas, T; Garnett, SP; Pervin, S; Rawal, LB				Biswas, Tuhin; Garnett, Sarah P.; Pervin, Sonia; Rawal, Lal B.			The prevalence of underweight, overweight and obesity in Bangladeshi adults: Data from a national survey	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; POPULATION	Background Over the two last decades Bangladesh, a low-income country, has experienced a rapid demographic and epidemiological transition. The population has increased substantially with rapid urbanization and changing pattern of disease, which at least in part, can be explained by nutritional changes. However, the nutritional status of the adult population has not been previously described. Hence, the objective of this study was to estimate the prevalence and explore socio-demographic determinants of underweight, overweight and obesity among the Bangladeshi adult population. Methods This study is a secondary data analysis of the national 2011 Bangladesh Demographic and Health Survey. We determined the nutritional status of adults aged >= 35 years of age, who had a measured weight and height, using the Asian body mass index (BMI) cut-offs for underweight (BMI < 18.5 kg/m(2)), overweight (BMI 23 to < 27.5 kg/m(2)) and obesity (BMI >= 27.5 kg/m(2)). Logistic regression modeling was used to determine the association between socio-demographic factors and nutritional status. Result Of total sample (n = 5495), 30.4% were underweight, 18.9% were overweight and 4.6% were obese. Underweight was associated with age, education and wealth. The adjusted odd ratios for underweight were higher for older people (>= years) compared to younger, the least educated compared to the most educated and the poorest compared to the wealthiest were 2.51 (95% CI: 1.95-3.23, p < 0.001), 3.59 (95% CI: 2.30-5.61, p < 0.001) and 3.70 (95% CI: 2.76-4.96, p < 0.001), respectively. Younger age (35-44 years), being female, higher education, wealthier and living in urban areas were associated with overweight/obesity with adjusted odds ratios of 1.73 (95% CI: 1.24-2.41, p < 0.001), 2.48 (95% CI: 1.87-3.28, p < 0.001), 3.98 ( 95% CI: 2.96-5.33, p < 0.001), 7.14 ( 95% CI: 5.20-9.81, p < 0.001) 1.27 ( 95% CI: 1.05-1.55, p-0.02), respectively. Conclusion Underweight and overweight/obesity are prevalent in Bangladeshi adults. Both conditions are associated with increased morbidity and mortality and increase the risk of developing non-communicable diseases. Effective public health intervention approaches are necessary to address both these conditions.	[Biswas, Tuhin; Pervin, Sonia; Rawal, Lal B.] Icddr, Hlth Syst & Populat Studies Div, B 68 Shaheed Tajuddin Ahmed Sharani, Dhaka 22, Bangladesh; [Garnett, Sarah P.] Univ Sydney, Westmead Clin Sch, Childrens Hosp, Sydney, NSW, Australia; [Garnett, Sarah P.] Childrens Hosp Westmead Australia, Inst Endocrinol & Diabet, Westmead, NSW, Australia; [Rawal, Lal B.] BRAC Univ, James P Grant Sch Publ Hlth, Dhaka, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR); University of Sydney; Bangladesh Rural Advancement Committee BRAC; BRAC University	Biswas, T (corresponding author), Icddr, Hlth Syst & Populat Studies Div, B 68 Shaheed Tajuddin Ahmed Sharani, Dhaka 22, Bangladesh.	tuhin.biswas@icddrb.org	Garnett, Sarah/D-8067-2012	Garnett, Sarah/0000-0001-7552-0789; Rawal, Lal/0000-0003-1106-0108; Biswas, Tuhin/0000-0002-7837-0306				Akter S, 2014, DIABETES CARE, V37, pE9, DOI 10.2337/dc13-1647; [Anonymous], 2011, PREL REP NIPORT 2013; [Anonymous], 2015, STAT FOOD INS WORLD; [Anonymous], 2000, OB PREV MAN GLOB EP; [Anonymous], 2011, PRELIMINARY REPORT; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Biswas T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167140; Gersh B, 2012, CIRCULATION, V126, pA606; Gortmaker SL, 2011, LANCET, V378, P838, DOI 10.1016/S0140-6736(11)60815-5; Islam A, 2014, CHRONIC NONCOMMUNICA, V1, P6; Kamal SMM, 2015, J HEALTH POPUL NUTR, V33, P92; Karar ZA, 2009, GLOBAL HEALTH ACTION, V2, DOI 10.3402/gha.v2i0.1904; Khan MMH, 2011, B WORLD HEALTH ORGAN, V89, P583, DOI 10.2471/BLT.11.087429; Kolenikov S, 2009, REV INCOME WEALTH, V55, P128, DOI 10.1111/j.1475-4991.2008.00309.x; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nube M, 2003, ANN HUM BIOL, V30, P520, DOI 10.1080/0301446031000119601; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Rahmouni K, 2005, HYPERTENSION, V45, P9, DOI 10.1161/01.HYP.0000151325.83008.b4; Saquib N, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-434; Siddiquee T, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2193-4; Smith LC, 2003, INTL FOOD POLICY RES, V131; Streatfield PK, 2008, J HEALTH POPUL NUTR, V26, P261; Subramanian S, 2010, PEDIATRICS; Sultana T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121456	25	80	82	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177395	10.1371/journal.pone.0177395	http://dx.doi.org/10.1371/journal.pone.0177395			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28510585	Green Published, Green Submitted, gold			2022-12-26	WOS:000401485500025
J	Maffioli, EM				Maffioli, Elisa M.			Is traditional male circumcision effective as an HIV prevention strategy? Evidence from Lesotho	PLOS ONE			English	Article							SOUTH-AFRICA; YOUNG MEN; KISUMU; KENYA	In many developing countries, male circumcision has been promoted as an effective HIV prevention strategy, and medical randomized controlled trials have indeed shown a causal link. However, there is limited empirical evidence to support this conclusion in countries where individuals can voluntary opt for different types of circumcision. The present study considers male circumcision in Lesotho, where HIV prevalence is among the highest in the world (23%). Here, men can opt for one of two types of circumcision: traditional male circumcision in initiation schools, or the medical option in health clinics. This paper investigates whether the former has medical effects on individual HIV status that are as beneficial as those shown for the latter. Controlling for the potential individual behavioral response after the operation, it was found that circumcision performed in initiation schools wholly offset the medical benefits of the surgical procedure. This supports anecdotal evidence that the operation performed by traditional circumcisers does not have the same protective effect against HIV transmission as the medical operation. No evidence of "disinhibition" behavior among circumcised men was found, nor differential risky sexual behavior among men circumcised, traditionally or medically. Considering that, in Lesotho, traditional male circumcision is undertaken by more than 90% of circumcised men, the findings highlight the need for further research into how the operation in initiation schools is performed and its medical benefits.	[Maffioli, Elisa M.] Duke Univ, Dept Econ, Durham, NC 27706 USA; [Maffioli, Elisa M.] Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA	Duke University; Duke University	Maffioli, EM (corresponding author), Duke Univ, Dept Econ, Durham, NC 27706 USA.; Maffioli, EM (corresponding author), Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA.	elisa.maffioli@duke.edu						AKAIKE H, 1974, SELECTED PAPERS HIRO, V19, P716, DOI DOI 10.1007/978-1-4612-1694-0_16; Anderson C, 2011, IMPACT HIV ED UNPUB; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2008, B WORLD HEALTH ORGAN, V86, P669, DOI 10.2471/BLT.08.051482; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Cohen CR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004573; Connolly C, 2008, SAMJ S AFR MED J, V98, P789; Corno L, 2007, POLICY RES WORKING P, V4421; De Paula A, 2014, J APPL ECONOMET, V29, P944, DOI 10.1002/jae.2342; de Walque D, 2009, WORKING PAPER; Delavande A, 2012, DEMOGRAPHY, V49, P1011, DOI 10.1007/s13524-012-0119-7; DHS, 2009, DEM HLTH SURV; Doyle D, 2005, J ROY COLL PHYS EDIN, V35, P279; Godlonton S, 2011, BEHAV RESPONSE UNPUB; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Kling JR, 2007, ECONOMETRICA, V75, P83, DOI 10.1111/j.1468-0262.2007.00733.x; Mattson CL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002443; Peltzer K, 2012, INT J BEHAV MED, V19, P336, DOI 10.1007/s12529-011-9171-8; Peltzer K, 2011, J ASSOC NURSE AIDS C, V22, P397, DOI 10.1016/j.jana.2011.03.003; Quinn TC, 2007, CURR OPIN INFECT DIS, V20, P33, DOI 10.1097/QCO.0b013e328012c5bc; Sarvestani AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045316; Thomas AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027561; UNAIDS, 2015, FACT SHEET 2015 GLOB; USAID, 2003, MAL CIRC CURR EP FIE; Wilcken A, 2010, B WORLD HEALTH ORGAN, V88, P907, DOI 10.2471/BLT.09.072975; Wilson NL, 2014, J DEV ECON, V106, P78, DOI 10.1016/j.jdeveco.2013.08.012; World Health Organization, 2012, VOL MED MAL CIRC HIV; Zungu NP, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3024-y	28	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177076	10.1371/journal.pone.0177076	http://dx.doi.org/10.1371/journal.pone.0177076			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UR	28498835	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314500010
J	Wu, Y; Ma, QH; Sun, HP; Xu, Y; Niu, ME; Pan, CW				Wu, Yin; Ma, Qinghua; Sun, Hong-Peng; Xu, Yong; Niu, Mei-E; Pan, Chen-Wei			Myopia and depressive symptoms among older Chinese adults	PLOS ONE			English	Article							VISUAL IMPAIRMENT; ASSOCIATIONS; DISORDERS; ANXIETY; IMPACT; COST; RISK	Purpose Few population-based data support the hypothesis that refractive errors are associated with depressive symptoms. We aim to assess the impact of myopia on the risk of having depressive symptoms in a community-based cohort of elderly Chinese. Methods A community-based cross-sectional study of 4611 Chinese adults aged 60 years or older was conducted. Depressive symptoms were measured using the 9-item Patient Health Questionnaire (PHQ-9) depression scale in 4597 adults. Refraction was determined by auto-refraction followed by subjective refraction. Myopia was defined as spherical equivalent (SE) < -0.50 diopters (D) and high myopia as SE < -6.00 D. Results After adjusting for age, gender, education, lifestyle-related exposures, presenting visual acuity and age-related cataract, myopic adults were more likely to have any depressive symptoms compared with non-myopic ones (odds ratio = 1.39; 95% confidence interval 1.04, 1.92). There were no significant differences in the risk of having any depressive symptoms between those with and without high myopia. Myopia or high myopia was not associated with having moderate depressive symptoms. The impact of myopia on depressive symptoms was stronger in adults with no formal education compared with those with formal education. Conclusions Myopia was related with the presence of depressive symptoms among older adults.	[Wu, Yin; Niu, Mei-E] Soochow Univ, Affiliated Hosp 1, Dept Nursing, Suzhou, Peoples R China; [Ma, Qinghua] 3rd Peoples Hosp Xiangcheng Dist, Suzhou, Peoples R China; [Sun, Hong-Peng; Xu, Yong; Pan, Chen-Wei] Soochow Univ, Med Coll, Sch Publ Hlth, Suzhou, Peoples R China	Soochow University - China; Soochow University - China	Niu, ME (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Nursing, Suzhou, Peoples R China.; Pan, CW (corresponding author), Soochow Univ, Med Coll, Sch Publ Hlth, Suzhou, Peoples R China.	meniu@suda.edu.cn; pcwonly@gmail.com	Pan, Chen-Wei/L-7174-2019	Pan, Chen-Wei/0000-0003-3362-4613	Science and Technology Board of Xiangcheng District, Suzhou, China [XJ201655, XJ201454]	Science and Technology Board of Xiangcheng District, Suzhou, China	This study was funded by the Science and Technology Board of Xiangcheng District, Suzhou, China (Grant No. XJ201655 and No. XJ201454). The funding organization had no role in the design or conduct of this research.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; Frick KD, 2007, ARCH OPHTHALMOL-CHIC, V125, P544, DOI 10.1001/archopht.125.4.544; Giloyan A, 2015, AGING MENT HEALTH, V19, P175, DOI 10.1080/13607863.2014.920298; Kang Hee-Ju, 2015, Chonnam Med J, V51, P8, DOI 10.4068/cmj.2015.51.1.8; Keeffe JE, 2009, ARCH OPHTHALMOL-CHIC, V127, P1377, DOI 10.1001/archophthalmol.2009.242; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Loprinzi PD, 2014, J AFFECT DISORDERS, V167, P8, DOI 10.1016/j.jad.2014.05.052; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Ong SY, 2013, INVEST OPHTH VIS SCI, V54, P799, DOI 10.1167/iovs.12-10460; Pan C-W, 2015, OPTOM VIS SCI; Pan CW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142516; Pan CW, 2013, OPHTHALMOLOGY, V120, P284, DOI 10.1016/j.ophtha.2012.07.065; Pan CW, 2012, OPHTHAL PHYSL OPT, V32, P3, DOI 10.1111/j.1475-1313.2011.00884.x; Pop-Jordanova Nada, 2014, Pril (Makedon Akad Nauk Umet Odd Med Nauki), V35, P53; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Sun HP, 2015, OPHTHALMIC PHYSL OPT; van der Aa HPA, 2015, INVEST OPHTH VIS SCI, V56, P849, DOI 10.1167/iovs.14-15848; Wong HB, 2009, AM J OPHTHALMOL, V147, P505, DOI 10.1016/j.ajo.2008.09.025; Zheng YF, 2013, INVEST OPHTH VIS SCI, V54, P7532, DOI 10.1167/iovs.13-12795; Zivin K, 2015, J PSYCHOSOM RES, V78, P324, DOI 10.1016/j.jpsychores.2015.01.014	21	12	13	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177613	10.1371/journal.pone.0177613	http://dx.doi.org/10.1371/journal.pone.0177613			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498851	Green Submitted, Green Published, gold			2022-12-26	WOS:000401314500032
J	Yang, FQ; Xu, XP; Wang, W; Ma, JC; Wei, D; He, P; Pampolino, MF; Johnston, AM				Yang, Fuqiang; Xu, Xinpeng; Wang, Wei; Ma, Jinchuan; Wei, Dan; He, Ping; Pampolino, Mirasol F.; Johnston, Adrian M.			Estimating nutrient uptake requirements for soybean using QUEFTS model in China	PLOS ONE			English	Article							IRRIGATED LOWLAND RICE; FERTILIZER REQUIREMENTS; QUANTITATIVE-EVALUATION; YIELD GAPS; MAIZE; MANAGEMENT; WHEAT; EFFICIENCIES; PRODUCTIVITY; CORN	Estimating balanced nutrient requirements for soybean (Glycine max [L.] Merr) in China is essential for identifying optimal fertilizer application regimes to increase soybean yield and nutrient use efficiency. We collected datasets from field experiments in major soybean planting regions of China between 2001 and 2015 to assess the relationship between soybean seed yield and nutrient uptake, and to estimate nitrogen (N), phosphorus (P), and potassium (K) requirements for a target yield of soybean using the quantitative evaluation of the fertility of tropical soils (QUEFTS) model. The QUEFTS model predicted a linear -parabolic-plateau curve for the balanced nutrient uptake with a target yield increased from 3.0 to 6.0 t ha(-1) and the linear part was continuing until the yield reached about 60-70% of the potential yield. To produce 1000 kg seed of soybean in China, 55.4 kg N, 7.9 kg P, and 20.1 kg K (N: P: K = 7: 1: 2.5) were required in the above-ground parts, and the corresponding internal efficiencies (IE, kg seed yield per kg nutrient uptake) were 18.1, 126.6, and 49.8 kg seed per kg N, P, and K, respectively. The QUEFTS model also simulated that a balanced N, P, and K removal by seed which were 48.3, 5.9, and 12.2 kg per 1000 kg seed, respectively, accounting for 87.1%, 74.1%, and 60.8% of the total above-ground parts, respectively. These results were conducive to make fertilizer recommendations that improve the seed yield of soybean and avoid excessive or deficient nutrient supplies. Field validation indicated that the QUEFTS model could be used to estimate nutrient requirements which help develop fertilizer recommendations for soybean.	[Yang, Fuqiang; Xu, Xinpeng; Ma, Jinchuan; He, Ping] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Minist Agr Key Lab Plant Nutr & Fertilizer, Beijing, Peoples R China; [Wang, Wei; Wei, Dan] Heilongjiang Acad Agr Sci, Inst Soil Fertilizer & Environm Resources, Harbin, Peoples R China; [He, Ping] Int Plant Nutr Inst China Program, CAAS IPNI Joint Lab Plant Nutr Innovat Res, Beijing, Peoples R China; [Pampolino, Mirasol F.] Int Plant Nutr Inst Southeast Asia Program, George Town, Malaysia; [Johnston, Adrian M.] Int Plant Nutr Inst, Saskatoon, SK, Canada	Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Heilongjiang Academy of Agricultural Sciences	He, P (corresponding author), Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Minist Agr Key Lab Plant Nutr & Fertilizer, Beijing, Peoples R China.; He, P (corresponding author), Int Plant Nutr Inst China Program, CAAS IPNI Joint Lab Plant Nutr Innovat Res, Beijing, Peoples R China.	phe@ipni.net	He, Ping/HGD-5389-2022		National Key Research and Development Plan [2016YFD0200101]; Central Research Institutes of Basic Research and Public Service Special Operations for CAAS-IPNI Joint Lab for Plant Nutrition Innovation Research [1610132016011, Y2017PT35]	National Key Research and Development Plan; Central Research Institutes of Basic Research and Public Service Special Operations for CAAS-IPNI Joint Lab for Plant Nutrition Innovation Research	This research was supported by the National Key Research and Development Plan (2016YFD0200101) and Central Research Institutes of Basic Research and Public Service Special Operations for CAAS-IPNI Joint Lab for Plant Nutrition Innovation Research (1610132016011, Y2017PT35). The funders had no role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Buresh R. J., 2007, Fertilizer best management practices: general principles, strategy for their adoption and voluntary initiatives vs regulations. Papers presented at the IFA International Workshop on Fertilizer Best Management Practices, Brussels, Belgium, 7-9 March, 2007, P47; Buresh RJ, 2010, PLANT SOIL, V335, P35, DOI 10.1007/s11104-010-0441-z; China National Knowledge Infrastructure, 2001, CHINA NATL KNOWLEDGE; Chinese Society of Soil Science, 2000, METH SOIL PLANT AN; Chuan LM, 2013, FIELD CROP RES, V146, P96, DOI 10.1016/j.fcr.2013.02.015; Chuan LM, 2013, FIELD CROP RES, V140, P1, DOI 10.1016/j.fcr.2012.09.020; Das D, 2009, NUTR CYCL AGROECOSYS, V83, P85, DOI 10.1007/s10705-008-9202-2; Dobermann A, 2004, INCREASING PRODUCTIVITY OF INTENSIVE RICE SYSTEMS THROUGH SITE-SPECIFIC NUTRIENT MANAGEMENT, P75; Dobermann A, 2002, PLANT SOIL, V247, P153, DOI 10.1023/A:1021197525875; FAO. FAOSTAT, 2013, DAT PROD; Fu C.F., 2011, HEILONGJIANG AGR SCI, V10, P33; Grassini P, 2015, FIELD CROP RES, V179, P150, DOI 10.1016/j.fcr.2015.04.015; Haefele SM, 2003, FIELD CROP RES, V80, P19, DOI 10.1016/S0378-4290(02)00152-1; Huang SW, 2006, NUTR CYCL AGROECOSYS, V75, P201, DOI 10.1007/s10705-006-9027-9; Ijgude M. B., 2008, Asian Journal of Soil Science, V3, P142; JANSSEN BH, 1990, GEODERMA, V46, P299, DOI 10.1016/0016-7061(90)90021-Z; Liu HL, 2011, NUTR CYCL AGROECOSYS, V89, P313, DOI 10.1007/s10705-010-9396-y; Liu MQ, 2006, NUTR CYCL AGROECOSYS, V74, P245, DOI 10.1007/s10705-006-9002-5; Liu XY, 2011, AGRON J, V103, P1452, DOI 10.2134/agronj2010.0476; Maiti Debtanu, 2006, Archives of Agronomy and Soil Science, V52, P403, DOI 10.1080/03650340600768706; Mowo JG, 2006, AGR ECOSYST ENVIRON, V116, P47, DOI 10.1016/j.agee.2006.03.021; Ni L., 2004, THESIS; Pampolino MF, 2012, COMPUT ELECTRON AGR, V88, P103, DOI 10.1016/j.compag.2012.07.007; Pathak H, 2003, NUTR CYCL AGROECOSYS, V65, P105, DOI 10.1023/A:1022177231332; Pierce FJ, 1999, ADV AGRON, V67, P1, DOI 10.1016/S0065-2113(08)60513-1; Saidou A, 2003, AGR ECOSYST ENVIRON, V100, P265, DOI 10.1016/S0167-8809(03)00184-1; Salvagiotti F, 2008, FIELD CROP RES, V108, P1, DOI 10.1016/j.fcr.2008.03.001; Setiyono TD, 2010, FIELD CROP RES, V118, P158, DOI 10.1016/j.fcr.2010.05.006; SMALING EMA, 1993, GEODERMA, V59, P21, DOI 10.1016/0016-7061(93)90060-X; Tabi FO, 2008, NUTR CYCL AGROECOSYS, V80, P161, DOI 10.1007/s10705-007-9129-z; Tittonell P, 2008, PLANT SOIL, V313, P19, DOI 10.1007/s11104-008-9676-3; Vitousek PM, 2009, SCIENCE, V324, P1519, DOI 10.1126/science.1170261; Wang HuaiMing, 2011, Jiangsu Journal of Agricultural Sciences, V27, P199; [王寅 Wang Yin], 2016, [植物营养与肥料学报, Journal of Plant Nutrition and Fertitizer], V22, P1441; [魏建军 Wei Jianjun], 2010, [大豆科学, Soybean Science], V29, P413; Witt C., 2006, Better Crops with Plant Food, V90, P28; Witt C, 1999, FIELD CROP RES, V63, P113, DOI 10.1016/S0378-4290(99)00031-3; Witt C., 2002, Better Crops International, V16, P20; Xu XP, 2015, FIELD CROP RES, V180, P37, DOI 10.1016/j.fcr.2015.05.008; Xu XP, 2014, FIELD CROP RES, V157, P27, DOI 10.1016/j.fcr.2013.12.013; Xu XP, 2013, FIELD CROP RES, V150, P115, DOI 10.1016/j.fcr.2013.06.006; Zhang BB, 2016, AGR WATER MANAGE, V177, P440, DOI 10.1016/j.agwat.2016.08.029; Zhang W.F., 2009, PHYTON BUENOS AIRES, VI, P147; Zhang Y, 2012, AGRON J, V104, P1436, DOI 10.2134/agronj2012.0125	44	27	30	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177509	10.1371/journal.pone.0177509	http://dx.doi.org/10.1371/journal.pone.0177509			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498839	Green Submitted, Green Published, gold			2022-12-26	WOS:000401314500023
J	Schneider, T; Kuhne, JF; Bittrich, P; Schroeder, J; Magnus, T; Mohme, M; Grosser, M; Schoen, G; Fiehler, J; Siemonsen, S				Schneider, Tanja; Kuhne, Jan Felix; Bittrich, Paul; Schroeder, Julian; Magnus, Tim; Mohme, Malte; Grosser, Malte; Schoen, Gerhard; Fiehler, Jens; Siemonsen, Susanne			Edema is not a reliable diagnostic sign to exclude small brain metastases	PLOS ONE			English	Article							LUNG-CANCER; BREAST; TUMORS	No prior systematic study on the extent of vasogenic edema (VE) in patients with brain metastases (BM) exists. Here, we aim to determine 1) the general volumetric relationship between BM and VE, 2) a threshold diameter above which a BM shows VE, and 3) the influence of the primary tumor and location of the BM in order to improve diagnostic processes and understanding of edema formation. This single center, retrospective study includes 173 untreated patients with histologically proven BM. Semi-manual segmentation of 1416 BM on contrast-enhanced T1-weighted images and of 865 VE on fluid-attenuated inversion recovery/T2-weighted images was conducted. Statistical analyses were performed using a paired-samples t-test, linear regression/generalized mixed-effects model, and receiver-operating characteristic (ROC) curve controlling for the possible effect of non-uniformly distributed metastases among patients. For BM with non-confluent edema (n = 545), there was a statistically significant positive correlation between the volumes of the BM and the VE (P < 0.001). The optimal threshold for edema formation was a diameter of 9.4 mm for all BM. The primary tumors as interaction term in multivariate analysis had a significant influence on VE formation whereas location had not. Hence VE development is dependent on the volume of the underlying BM and the site of the primary neoplasm, but not from the location of the BM.	[Schneider, Tanja; Kuhne, Jan Felix; Bittrich, Paul; Grosser, Malte; Fiehler, Jens; Siemonsen, Susanne] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Hamburg, Germany; [Schroeder, Julian; Magnus, Tim] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Mohme, Malte] Univ Med Ctr Hamburg Eppendorf, Dept Neurosurg, Hamburg, Germany; [Schoen, Gerhard] Univ Med Ctr Hamburg Eppendorf, Dept Med Biometry & Epidemiol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Schneider, T (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Hamburg, Germany.	tan.schneider@uke.de						Aminoff A, 2014, AMINOFFS NEUROLOGY G; Berghoff AS, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1057388; Bravo-RodroAiguez F, 2012, LEARNING NEUROIMAGIN; CRISCUOLO GR, 1993, YALE J BIOL MED, V66, P277; Drappatz J., UPTODATE; Ewing J, 1928, NEOPLASTIC DIS TREAT; Hengel K, 2013, INT J CLIN ONCOL, V18, P396, DOI 10.1007/s10147-012-0392-x; Kellie G., T MEDICOCHIRURGICAL, P84; Monro A, 1823, OBSERVATIONS STRUCTU; PAGET S, 1989, CANCER METAST REV, V8, P98; Papadopoulos MC, 2004, NEUROSCIENCE, V129, P1011, DOI 10.1016/j.neuroscience.2004.05.044; Papadopoulos MC, 2001, NEUROPATH APPL NEURO, V27, P384, DOI 10.1046/j.0305-1846.2001.00341.x; Quattrocchi CC, 2012, J NEURO-ONCOL, V110, P79, DOI 10.1007/s11060-012-0937-x; Ramalho J, 2016, AM J NEURORADIOL, V37, P1192, DOI 10.3174/ajnr.A4615; Robb RA, 2001, IEEE T MED IMAGING, V20, P854, DOI 10.1109/42.952724; Rogne SG, 2014, ACTA NEUROL SCAND, V130, P1, DOI 10.1111/ane.12206; Roitbak T, 1999, GLIA, V28, P40, DOI 10.1002/(SICI)1098-1136(199910)28:1<40::AID-GLIA5>3.0.CO;2-6; Runge VM, 1997, CONTRAST ENHANCED CL; Schaefer PW, 1996, NEUROSURG CLIN N AM, V7, P393; Sekine A, 2012, LUNG CANCER, V77, P64, DOI 10.1016/j.lungcan.2011.12.017; WALKER AE, 1985, NEUROLOGY, V35, P219, DOI 10.1212/WNL.35.2.219; Wolburg H, 2002, VASC PHARMACOL, V38, P323, DOI 10.1016/S1537-1891(02)00200-8	22	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177217	10.1371/journal.pone.0177217	http://dx.doi.org/10.1371/journal.pone.0177217			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493907	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314300073
J	Baotic, A; Stoeger, AS				Baotic, Anton; Stoeger, Angela S.			Sexual dimorphism in African elephant social rumbles	PLOS ONE			English	Article							SOURCE-FILTER THEORY; LOXODONTA-AFRICANA; VOCAL COMMUNICATION; BODY-SIZE; LARYNX; CALLS; CUES; RECOGNITION; DISTANCE; BEHAVIOR	This study used the source and filter theory approach to analyse sex differences in the acoustic features of African elephant (Loxodonta africana) low-frequency rumbles produced in social contexts ('social rumbles'). Permuted discriminant function analysis revealed that rumbles contain sufficient acoustic information to predict the sex of a vocalizing individual. Features primarily related to the vocalizer's size, i.e. fundamental frequency variables and vocal tract resonant frequencies, differed significantly between the sexes. Yet, controlling for age and size effects, our results indicate that the pronounced sexual size dimorphism in African elephants is partly, but not exclusively, responsible for sexual differences in social rumbles. This provides a scientific foundation for future work investigating the perceptual and functional relevance of specific acoustic characteristics in African elephant vocal sexual communication.	[Baotic, Anton; Stoeger, Angela S.] Univ Vienna, Dept Cognit Biol, Mammal Commun Lab, Vienna, Austria	University of Vienna	Stoeger, AS (corresponding author), Univ Vienna, Dept Cognit Biol, Mammal Commun Lab, Vienna, Austria.	angela.stoeger-horwath@univie.ac.at	Baotic, Anton/AAC-3924-2021	Baotic, Anton/0000-0002-7881-857X; Stoeger, Angela S/0000-0002-6714-8291	FWF Austrian Science Fund [P26448]	FWF Austrian Science Fund(Austrian Science Fund (FWF))	This work was supported by the FWF Austrian Science Fund, grant number P26448, Project description: (http://pf.fwf.ac.at/en/ research-in-practice/project-finder?search% 5Bwhat%5D=P26448&search%5Bpromotion_ category_id%5D%5B%5D=&search%5Bcall%5D= &search%5Bproject_number%5D=&search% 5Bdecision_board_ids%5D=&search%5Bproject_ title%5D=&search%5Blead_frstname%5D= &search%5Blead_lastname%5D=&search% 5Bresearch_place_kind%5D%5B%5D=&search% 5Binstitute_name%5D=&search%5Bstart_date%5D=&search%5Bend_date%5D=&search% 5Bgrant_years%5D%5B%5D=&search% 5Bstatus_id%5D=&search%5Bscience_discipline_ id%5D=&search%5Bper_page%5D=10#search-results.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all participating institutions. We thank Sean Hensman and the Rory Hensman Elephant Research Unit (Adventures with Elephants), Brett Mitchel (Pilanesberg Back Safaris), Andre Kotze (Elephant Whisperers), Dr. Debbie Young (African Elephant Research Unit, Knysna Elephant Park and Addo Elephant Back Safaris), Dr. Harald Schwammer (Vienna Zoo) and Dr. Florian Sicks (Tierpark Berlin) for enabling and supporting our research at their institutions. We further thank our long-term collaborator Matthias Zeppelzauer for developing the annotation and contour analyses tool, and Dr. Michael Stachowitsch for editing the text. We are grateful to Prof. Tecumseh Fitch and Prof. Thomas Bugnyar for strongly supporting our research at the Department of Cognitive Biology. This project was supported by the FWF Austrian Science Fund (P26448).	[Anonymous], 1997, ANIMAL BEHAV, V53, P229; Baotic A, 2014, BIOACOUSTICS, V23, P15, DOI 10.1080/09524622.2013.798744; Barelli C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082748; BECKFORD NS, 1985, ANN OTO RHINOL LARYN, V94, P634, DOI 10.1177/000348948509400622; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Briefer E, 2011, APPL ANIM BEHAV SCI, V133, P175, DOI 10.1016/j.applanim.2011.05.012; Charif RA, 2005, BEHAV ECOL SOCIOBIOL, V57, P327, DOI 10.1007/s00265-004-0867-5; Charlton BD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12739; Charlton BD, 2013, CURR BIOL, V23, pR1035, DOI 10.1016/j.cub.2013.10.069; Charlton BD, 2012, ANIM COGN, V15, P999, DOI 10.1007/s10071-012-0527-5; Charlton BD, 2011, BIOL LETTERS, V7, P71, DOI 10.1098/rsbl.2010.0582; Charlton BD, 2009, ANIM BEHAV, V78, P893, DOI 10.1016/j.anbehav.2009.06.029; Dabbs JM, 1999, PERS INDIV DIFFER, V27, P801, DOI 10.1016/S0191-8869(98)00272-4; Darwin C., 1871, DESCENT MAN SELCTION; Fairbairn DJ., 1997, ANNU REV ECOL SYST, V28, P659; Fitch WT, 2001, P ROY SOC B-BIOL SCI, V268, P1669, DOI 10.1098/rspb.2001.1704; Frey R, 2003, ZOOL ANZ, V242, P33, DOI 10.1078/0044-5231-00086; Frey R, 2007, J ANAT, V210, P131, DOI 10.1111/j.1469-7580.2006.00684.x; Gahr M, 2007, ADV GENET, V59, P67, DOI 10.1016/S0065-2660(07)59003-6; Ganswindt A, 2005, HORM BEHAV, V47, P83, DOI 10.1016/j.yhbeh.2004.09.002; Herbst CT, 2013, J EXP BIOL, V216, P4054, DOI 10.1242/jeb.091009; Kelley D. B., 2002, BEHAV ENDOCRINOLOGY, P289; King LE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010346; LEE PC, 1995, J ZOOL, V236, P29, DOI 10.1111/j.1469-7998.1995.tb01782.x; Lee Phyllis C., 2011, P260; Leighty KA, 2008, ANIM BEHAV, V76, P1601, DOI 10.1016/j.anbehav.2008.06.022; Leong KM, 2003, HORM BEHAV, V43, P433, DOI 10.1016/S0018-506X(03)00025-4; Lueders Imke, 2012, P503; McComb K, 2003, ANIM BEHAV, V65, P317, DOI 10.1006/anbe.2003.2047; McComb K, 2001, SCIENCE, V292, P491, DOI 10.1126/science.1057895; MCCOWAN B, 1995, J COMP PSYCHOL, V109, P242, DOI 10.1037/0735-7036.109.3.242; McPherson FJ, 2012, ANIM REPROD SCI, V131, P109, DOI 10.1016/j.anireprosci.2012.02.007; MITANI JC, 1994, ETHOLOGY, V96, P233, DOI 10.1111/j.1439-0310.1994.tb01012.x; Morisaka T, 2005, J MAMMAL, V86, P541, DOI 10.1644/1545-1542(2005)86[541:EOANOT]2.0.CO;2; Mundry R, 2007, ANIM BEHAV, V74, P965, DOI 10.1016/j.anbehav.2006.12.028; O'Connell-Rodwell CE, 2011, ETHOL ECOL EVOL, V23, P388, DOI 10.1080/03949370.2011.598569; Ortolani A, 2005, ZOO BIOL, V24, P311, DOI 10.1002/zoo.20053; Palacios V, 2015, BEHAVIOUR, V152, P593, DOI 10.1163/1568539X-00003244; Payne KB, 2003, AFR J ECOL, V41, P99, DOI 10.1046/j.1365-2028.2003.00421.x; Pfefferle D, 2006, ANIM BEHAV, V72, P43, DOI 10.1016/j.anbehav.2005.08.021; POOLE JH, 1987, BEHAVIOUR, V102, P283, DOI 10.1163/156853986X00171; POOLE JH, 1988, BEHAV ECOL SOCIOBIOL, V22, P385, DOI 10.1007/BF00294975; Poole Joyce H., 1994, P331; Poole Joyce H., 2011, P125; Reby D, 2005, P ROY SOC B-BIOL SCI, V272, P941, DOI 10.1098/rspb.2004.2954; Rendall D, 2005, J ACOUST SOC AM, V117, P944, DOI 10.1121/1.1848011; Rendall D, 1996, ANIM BEHAV, V51, P1007, DOI 10.1006/anbe.1996.0103; SCHNEIDE.R, 1967, Z WISS ZOOL ABT A, V175, P1; Shannon G, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-62; Shoshani J., TRENDS ECOLOGY EVOLU, V13, P480; Shrader AM, 2006, J ZOOL, V270, P40, DOI 10.1111/j.1469-7998.2006.00108.x; Soltis J, 2005, ANIM BEHAV, V70, P579, DOI 10.1016/j.anbehav.2004.11.015; Soltis J., 2013, EVOLUTION EMOTIONAL, P105, DOI 10.1093/acprof:oso/9780199583560.003.0007; Soltis J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089403; Soltis J, 2011, J ACOUST SOC AM, V129, P1059, DOI 10.1121/1.3531798; Soltis J, 2010, ZOO BIOL, V29, P192, DOI 10.1002/zoo.20251; Stoeger AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048907; Stoeger AS, 2011, J ACOUST SOC AM, V130, P1700, DOI 10.1121/1.3605538; Stoeger-Horwath AS, 2007, J ACOUST SOC AM, V121, P3922, DOI 10.1121/1.2722216; Sukumar R, 2003, STATURAL GROWTH ELEP, P409; Taylor AM, 2010, J ZOOL, V280, P221, DOI 10.1111/j.1469-7998.2009.00661.x; Taylor AM, 2008, J ACOUST SOC AM, V123, P2903, DOI 10.1121/1.2896962; Thompson ME, 2010, AFR J ECOL, V48, P654, DOI 10.1111/j.1365-2028.2009.01161.x; Thompson ME, 2010, AFR J ECOL, V48, P224, DOI 10.1111/j.1365-2028.2009.01106.x; Titze IR, 2011, J SPEECH LANG HEAR R, V54, P520, DOI 10.1044/1092-4388(2010/09-0284); Titze IR, 1994, PRINCIPLES VOICE PRO; Todd NE, 2010, ANAT REC, V293, P62, DOI 10.1002/ar.21011; Townsend SW, 2012, BIOL LETTERS, V8, P179, DOI 10.1098/rsbl.2011.0844; VanDerMerwe NJ, 1995, ONDERSTEPOORT J VET, V62, P245; Venables WN., 2002, MODERN APPL STAT S 4; Youlatos D, 2015, DEV PRIMATOL-PROG PR, P133, DOI 10.1007/978-1-4939-1957-4_6; Zeppelzauer Matthias, 2015, BMC Research Notes, V8, P409, DOI 10.1186/s13104-015-1370-y; Zeppelzauer M, 2015, BIOACOUSTICS, V24, P13, DOI 10.1080/09524622.2014.906321; ZIELINSKI WJ, 1993, ANIM BEHAV, V45, P873, DOI 10.1006/anbe.1993.1108	74	17	17	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177411	10.1371/journal.pone.0177411	http://dx.doi.org/10.1371/journal.pone.0177411			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UN	28489908	gold, Green Published, Green Submitted			2022-12-26	WOS:000401314100073
J	Bethoney, ND; Zhao, LZ; Chen, CS; Stokesbury, KDE				Bethoney, N. David; Zhao, Liuzhi; Chen, Changsheng; Stokesbury, Kevin D. E.			Identification of persistent benthic assemblages in areas with different temperature variability patterns through broad-scale mapping	PLOS ONE			English	Article							SEA SCALLOP; PLACOPECTEN-MAGELLANICUS; GEORGES BANK; FISHERY-MANAGEMENT; CLOSED AREAS; ATLANTIC; USA; RECRUITMENT; MORTALITY; IMPACT	Ecosystem-based management is a place-based approach that considers the relationships between system parts. Due to the complexity of ecosystems in the marine environment it is often difficult to define these relationships in space and time. Maps illustrate spatial concepts. Here we promote ecosystem-based spatial thinking by layering datasets from a larger project that mapped benthic fauna, substrate characteristics, and oceanic conditions on monthly, annual and decadal time scales along the U.S. continental shelf. By combining maps of persistent benthic megafauna and bottom temperature variability over approximately 90,000 km(2), we identified wide spread benthic animal assemblages and regional disparity in temperature variability. From a broad-scale perspective the locations of the assemblage appear to be related to sea scallop population dynamics and indicate potential regional differences in climate change resiliency. These findings offer information on a scale that correlates with marine spatial planning, and could be used as a starting point for further investigation. To spur additional analysis and facilitate their linkage to other datasets, these datasets are available through public, online data portals. Overall, this study demonstrates how the growth of maps from single to multiple elements can help promote and facilitate the multifactor, ecosystem-based thinking needed to support regional ocean planning.	[Bethoney, N. David; Zhao, Liuzhi; Chen, Changsheng; Stokesbury, Kevin D. E.] Univ Massachusetts Dartmouth, Sch Marine Sci & Technol, New Bedford, MA 02740 USA	University of Massachusetts System; University Massachusetts Dartmouth	Bethoney, ND (corresponding author), Univ Massachusetts Dartmouth, Sch Marine Sci & Technol, New Bedford, MA 02740 USA.	nbethoney@umassd.edu			Nature Conservancy from a Gordon and Betty Moore Foundation	Nature Conservancy from a Gordon and Betty Moore Foundation	Funding for this research came through The Nature Conservancy from a Gordon and Betty Moore Foundation(https://www.moore.org/) grant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CF, 2008, ICES J MAR SCI, V65, P995, DOI 10.1093/icesjms/fsn053; Beardsley RC, 2013, J GEOPHYS RES-OCEANS, V118, P6030, DOI 10.1002/2013JC008862; Bethoney ND, 2016, MAR ECOL PROG SER, V547, P137, DOI 10.3354/meps11666; Brown CJ, 2011, ESTUAR COAST SHELF S, V92, P502, DOI 10.1016/j.ecss.2011.02.007; Chen CS, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC007054; Cogan CB, 2009, ICES J MAR SCI, V66, P2033, DOI 10.1093/icesjms/fsp214; Collie JS, 1997, MAR ECOL PROG SER, V155, P159, DOI 10.3354/meps155159; Fogarty MJ, 2014, CAN J FISH AQUAT SCI, V71, P479, DOI 10.1139/cjfas-2013-0203; Hampton RE, 2014, INTRO BIOL STAT, P129; Hare JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146756; Harris BP, 2010, CONT SHELF RES, V30, P1840, DOI 10.1016/j.csr.2010.08.011; Hart D.R., 2004, NMFSNE189 NOAA; Hart DR, 2006, MAR ECOL PROG SER, V306, P209, DOI 10.3354/meps306209; Kleisner KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149220; Levesque MM, 2016, J SHELLFISH RES, V35, P295, DOI 10.2983/035.035.0204; Levin PS, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0275; Li Y, 2015, PROG OCEANOGR, V134, P123, DOI 10.1016/j.pocean.2015.01.003; Link J, 2008, J MARINE SYST, V74, P453, DOI 10.1016/j.jmarsys.2008.03.007; Maggs CA, 2008, ECOLOGY, V89, pS108, DOI 10.1890/08-0257.1; Marino MC, 2009, MAR ECOL PROG SER, V382, P59, DOI 10.3354/meps08011; Mayr E, 1997, THIS IS BIOL SCI LIV, P207; Murawski SA, 2000, B MAR SCI, V66, P775; New England Fisheries Management Council, 2011, OMN ESS FISH HAB EFH; Northeast Regional Planning Body, 2016, NE OC PLAN; O'Leary JK, 2017, BIOSCIENCE, V67, P208, DOI 10.1093/biosci/biw161; Stokesbury KDE, 2006, MAR ECOL PROG SER, V307, P85, DOI 10.3354/meps307085; Stokesbury KDE, 2007, MAR ECOL PROG SER, V349, P151, DOI 10.3354/meps07113; Stokesbury KDE, 2016, DEV AQUAC FISH SCI, V40, P719; Sun YF, 2013, J GEOPHYS RES-OCEANS, V118, P2685, DOI 10.1002/jgrc.20207; Van Wyngaarden M, 2017, EVOL APPL, V10, P102, DOI 10.1111/eva.12432; Young AM, 2002, MAR BIOL, V140, P1059, DOI 10.1007/s00227-002-0780-2	31	3	3	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177333	10.1371/journal.pone.0177333	http://dx.doi.org/10.1371/journal.pone.0177333			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489873	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314100062
J	Zhou, DY; Tang, YC; Jiang, W				Zhou, Deyun; Tang, Yongchuan; Jiang, Wen			A modified belief entropy in Dempster-Shafer framework	PLOS ONE			English	Article							EVIDENTIAL REASONING APPROACH; RELIABILITY-ANALYSIS; CLASSIFICATION RULE; ATTRIBUTE WEIGHTS; HIERARCHY PROCESS; PROBABILITY; UNCERTAINTY; SPECIFICITY; DEPENDENCE; ALGORITHM	How to quantify the uncertain information in the framework of Dempster-Shafer evidence theory is still an open issue. Quite a few uncertainty measures have been proposed in Dempster-Shafer framework, however, the existing studies mainly focus on the mass function itself, the available information represented by the scale of the frame of discernment (FOD) in the body of evidence is ignored. Without taking full advantage of the information in the body of evidence, the existing methods are somehow not that efficient. In this paper, a modified belief entropy is proposed by considering the scale of FOD and the relative scale of a focal element with respect to FOD. Inspired by Deng entropy, the new belief entropy is consistent with Shannon entropy in the sense of probability consistency. What's more, with less information loss, the new measure can overcome the shortage of some other uncertainty measures. A few numerical examples and a case study are presented to show the efficiency and superiority of the proposed method.	[Zhou, Deyun; Tang, Yongchuan; Jiang, Wen] Northwestern Polytech Univ, Sch Elect & Informat, Xian, Shaanxi, Peoples R China	Northwestern Polytechnical University	Tang, YC; Jiang, W (corresponding author), Northwestern Polytech Univ, Sch Elect & Informat, Xian, Shaanxi, Peoples R China.	tangyongchuan@mail.nwpu.edu.cn; jiangwen@nwpu.edu.cn	Tang, Yongchuan/G-8970-2019	Tang, Yongchuan/0000-0003-2568-9628	National Natural Science Foundation of China [61671384]; Natural Science Basic Research Plan in Shaanxi Province of China [2016JM6018]; Fund of SAST [SAST2016083]; Innovation Foundation for Doctor Dissertation of Northwestern Polytechnical University [CX201705]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Basic Research Plan in Shaanxi Province of China; Fund of SAST; Innovation Foundation for Doctor Dissertation of Northwestern Polytechnical University	We declare that the work is partially supported by National Natural Science Foundation of China (Grant No. 61671384), Natural Science Basic Research Plan in Shaanxi Province of China (Grant No. 2016JM6018), the Fund of SAST (Grant No. SAST2016083) and the Innovation Foundation for Doctor Dissertation of Northwestern Polytechnical University (Grant No. CX201705). There was no additional external funding received for this study.	Cao SJ, 2015, APPL MATH COMPUT, V261, P141, DOI 10.1016/j.amc.2015.03.046; Cao SJ, 2014, INFORM SCIENCES, V278, P22, DOI 10.1016/j.ins.2014.03.133; Chen ZQ, 2014, ENTROPY-SWITZ, V16, P5416, DOI 10.3390/e16105416; Chen ZQ, 2014, APPL MATH COMPUT, V242, P462, DOI 10.1016/j.amc.2014.05.105; Chin KS, 2015, COMPUT IND ENG, V87, P150, DOI 10.1016/j.cie.2015.04.016; Conti PL, 2017, COMMUN STAT-THEOR M, V46, P967, DOI 10.1080/03610926.2015.1010005; DEMPSTER AP, 1967, ANN MATH STAT, V38, P325, DOI 10.1214/aoms/1177698950; Deng XY, 2016, INFORM SCIENCES, V340, P250, DOI 10.1016/j.ins.2016.01.033; Deng Y., 2012, J INF COMPUT SCI, V9, P2421; Deng Y, 2016, CHAOS SOLITON FRACT, V91, P549, DOI 10.1016/j.chaos.2016.07.014; Deng Y, 2017, J COMPUT ANAL APPL, V22, P201; Deng Y, 2015, APPL INTELL, V43, P530, DOI 10.1007/s10489-015-0661-2; DENOEUX T, 1995, IEEE T SYST MAN CYB, V25, P804, DOI 10.1109/21.376493; Denoeux T, 2013, IEEE T KNOWL DATA EN, V25, P119, DOI 10.1109/TKDE.2011.201; Du WS, 2016, INFORM SCIENCES, V364, P91, DOI 10.1016/j.ins.2016.05.011; DUBOIS D, 1985, INT J GEN SYST, V10, P279, DOI 10.1080/03081078508934893; Fan XF, 2006, PATTERN RECOGN LETT, V27, P366, DOI 10.1016/j.patrec.2005.08.025; Feller W., 1957, INTRO PROBABILITY TH; Frikha A, 2015, EUR J OPER RES, V241, P133, DOI 10.1016/j.ejor.2014.08.024; Fu C, 2015, EUR J OPER RES, V246, P886, DOI 10.1016/j.ejor.2015.05.042; Fu C, 2015, COMPUT IND ENG, V81, P109, DOI 10.1016/j.cie.2014.12.031; George T, 1996, INT J GEN SYST, V24, P407, DOI 10.1080/03081079608945130; HAN DQ, 2016, KNOWL-BASED SYST, V110, P210, DOI DOI 10.1016/J.KN0SYS.2016.07.029; Hohle U, 1982, P 12 IEEE INT S MULT; Jiang W, 2016, ADV MECH ENG, V8, DOI 10.1177/1687814016641820; Jiang W, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16091509; Jiang W, 2016, MATH PROBL ENG, V2016, DOI 10.1155/2016/5769061; Jiang W, 2016, MATH PROBL ENG, V2016, DOI 10.1155/2016/3878634; Jiang W, 2016, ADV MECH ENG, V8, DOI 10.1177/1687814016644579; Khodabandeh M, 2014, INT J GEN SYST, V43, P610, DOI 10.1080/03081079.2014.896353; Klir G.J., 1992, UNCERTAIN ARTIFICAIA, P138; Klir G. J., 1991, INT J GEN SYST, V18, P155, DOI DOI 10.1080/03081079008935135; Liu WR, 2006, ARTIF INTELL, V170, P909, DOI 10.1016/j.artint.2006.05.002; LIU ZG, 2016, PATTERN RECOGN, V52, P85, DOI DOI 10.1016/J.PATC0G.2015.10.001; Liu ZG, 2014, PATTERN RECOGN, V47, P2532, DOI 10.1016/j.patcog.2014.01.011; Liu ZG, 2013, PATTERN RECOGN, V46, P834, DOI 10.1016/j.patcog.2012.10.001; Ma JB, 2016, INFORM SCIENCES, V333, P10, DOI 10.1016/j.ins.2015.11.011; Ma JB, 2015, INT J APPROX REASON, V59, P20, DOI 10.1016/j.ijar.2015.01.003; PAWLAK Z, 1982, INT J COMPUT INF SCI, V11, P341, DOI 10.1007/BF01001956; Pezzulo G, 2014, P COGN SCI SOC, V26; Sabahi F, 2014, INT J APPROX REASON, V55, P1383, DOI 10.1016/j.ijar.2013.12.003; Sabahi F, 2013, INFORM SCIENCES, V244, P60, DOI 10.1016/j.ins.2013.03.020; Sankaran PG, 2017, COMMUN STAT-THEOR M, V46, P805, DOI 10.1080/03610926.2015.1006779; Schubert J, 2011, INT J APPROX REASON, V52, P449, DOI 10.1016/j.ijar.2010.10.004; Shafer G.A., 1976, MATH THEORY EVIDENCE; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Smets P, 2005, INT J APPROX REASON, V40, P181, DOI 10.1016/j.ijar.2005.04.001; SMETS P, 1994, ARTIF INTELL, V66, P191, DOI 10.1016/0004-3702(94)90026-4; Su XY, 2016, APPL INTELL, V44, P634, DOI 10.1007/s10489-015-0723-5; Su XY, 2015, RISK ANAL, V35, P1296, DOI 10.1111/risa.12347; Su XY, 2015, INT J INTELL SYST, V30, P441, DOI 10.1002/int.21695; Su XY, 2012, ENG FAIL ANAL, V26, P164, DOI 10.1016/j.engfailanal.2012.07.009; Tang YC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160416; Wang YM, 2007, EXPERT SYST APPL, V32, P336, DOI 10.1016/j.eswa.2005.11.029; Wang YM, 2009, EXPERT SYST APPL, V36, P8421, DOI 10.1016/j.eswa.2008.10.052; Wen ML, 2016, FUZZY OPTIM DECIS MA, V15, P491, DOI 10.1007/s10700-016-9235-y; YAGER RR, 1995, IEEE T SYST MAN CYB, V25, P1221, DOI 10.1109/21.398683; YAGER RR, 1983, INT J GEN SYST, V9, P249, DOI 10.1080/03081078308960825; YANG Y, 2016, KNOWL-BASED SYST, V94, P114, DOI DOI 10.1016/J.KN0SYS.2015.11.014; Yang Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147799; Yuan K, 2015, SENSORS, V16, P1; Yuan KJ, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2205-6; Zadeh L.A., 1986, AI MAG, V7, P85, DOI DOI 10.1609/AIMAG.V7I2.542; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X; Zhang MJ, 2017, EUR J OPER RES, V257, P1005, DOI 10.1016/j.ejor.2016.08.028; Zhou DY, 2016, MATH PROBL ENG, V2016, DOI 10.1155/2016/4512383; Zhou K, 2015, KNOWL-BASED SYST, V74, P69, DOI 10.1016/j.knosys.2014.11.010	68	30	31	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0176832	10.1371/journal.pone.0176832	http://dx.doi.org/10.1371/journal.pone.0176832			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481914	gold, Green Submitted, Green Published			2022-12-26	WOS:000401313700018
J	Choi, EJ; Jung, BJ; Lee, SH; Yoo, HS; Shin, EA; Ko, HJ; Chang, S; Kim, SY; Jeon, SM				Choi, E-J; Jung, B-J; Lee, S-H; Yoo, H-S; Shin, E-A; Ko, H-J; Chang, S.; Kim, S-Y; Jeon, S-M			A clinical drug library screen identifies clobetasol propionate as an NRF2 inhibitor with potential therapeutic efficacy in KEAP1 mutant lung cancer	ONCOGENE			English	Article							TRANSCRIPTION FACTOR NRF2; CARDIAC-GLYCOSIDES; OXIDATIVE STRESS; GENE-EXPRESSION; RETINOIC ACID; CELLS; LKB1; PATHWAY; ACTIVATION; ASSAY	The Kelch-like ECH-associated protein 1 (KEAP1)-nuclear factor E2-related factor 2 (NRF2) pathway has a central role in cellular antioxidant defense. NRF2 activation due to KEAP1 or NRF2 mutations occurs frequently in many cancers, suggesting that NRF2 inhibition could be a promising therapeutic strategy. However, no potent NRF2 inhibitors are clinically available to date. To develop potent NRF2 inhibitors for therapeutic purpose, we screened similar to 4000 clinical compounds and determined clobetasol propionate (CP) as the most potent NRF2 inhibitor. Mechanistically, CP prevented nuclear accumulation and promoted beta-TrCP-dependent degradation of NRF2 in a glucocorticoid receptor-and a glycogen synthase kinase 3 (GSK3)-dependent manner. As a result, CP induced oxidative stress and strongly suppressed the anchorage-independent growth of tumors with KEAP1 mutation, but not with the wild-type KEAP1. Further, CP alone or in combination with rapamycin strongly inhibited the in vitro and in vivo growth of tumors harboring mutations in KEAP1 or both KEAP1 and LKB1 that are frequently observed in lung cancer. Thus, CP could be a repurposed therapeutic agent for cancers with high NRF2 activity. We also proposed that the use CP and rapamycin in combination could be a potential therapeutic strategy for tumors harboring both KEAP1 and LKB1 mutations.	[Choi, E-J; Jung, B-J; Yoo, H-S; Shin, E-A; Jeon, S-M] Ajou Univ, Coll Pharm, 206 World Cup Ro,Room 207, Suwon 16499, Gyeonggi Do, South Korea; [Lee, S-H; Kim, S-Y] Natl Canc Ctr, Res Inst, Canc Cell & Mol Biol Branch, Goyang, South Korea; [Ko, H-J] Kangwon Natl Univ, Coll Pharm, Chunchon, South Korea; [Ko, H-J] Adv Inst Convergence Technol, Convergence Res Ctr Funct Plant Prod, Suwon, South Korea; [Chang, S.] Univ Ulsan, Dept Biomed Sci, Asan Med Ctr, Sch Med, Seoul, South Korea; [Jeon, S-M] Ajou Univ, Inst Pharmaceut Sci & Technol, Suwon, South Korea	Ajou University; National Cancer Center - Korea (NCC); Kangwon National University; University of Ulsan; Asan Medical Center; Ajou University	Jeon, SM (corresponding author), Ajou Univ, Coll Pharm, 206 World Cup Ro,Room 207, Suwon 16499, Gyeonggi Do, South Korea.	smjeon@ajou.ac.kr	Jeon, Sang-Min/I-7917-2018	Jeon, Sang-Min/0000-0002-0132-925X; Chang, Suhwan/0000-0002-0282-0120; Ko, Hyun-Jeong/0000-0002-3844-928X	National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea [S2014-A0251-00001]; National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [S2014-A0403-00067]; National Cancer Center of Korea [NCC1410670]	National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning(National Research Foundation of Korea); National Cancer Center of Korea	We thank Y-GL and S-HP for the technical assistance provided. The clinical compound library (with 1887 compounds) was provided by the Korea Chemical Bank (KCB) from the Korea Research Institute of Chemical Technology (KRICT). This work was supported by grants from the National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea (S2014-A0251-00001) and Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (S2014-A0403-00067) to S-MJ and the National Cancer Center of Korea (NCC1410670) to S-YK.	Arlt A, 2013, ONCOGENE, V32, P4825, DOI 10.1038/onc.2012.493; Calderon-Montano JM, 2014, ONCOGENE, V33, P2947, DOI 10.1038/onc.2013.229; Chowdhry S, 2013, ONCOGENE, V32, P3765, DOI 10.1038/onc.2012.388; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Cuadrado A, 2015, FREE RADICAL BIO MED, V88, P147, DOI 10.1016/j.freeradbiomed.2015.04.029; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Faubert B, 2014, P NATL ACAD SCI USA, V111, P2554, DOI 10.1073/pnas.1312570111; Ference JD, 2009, AM FAM PHYSICIAN, V79, P135; Gao YJ, 2010, P NATL ACAD SCI USA, V107, P18892, DOI 10.1073/pnas.1004952107; Gluschnaider U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009060; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Guo Y, 2015, FREE RADICAL BIO MED, V88, P337, DOI 10.1016/j.freeradbiomed.2015.06.013; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hast BE, 2014, CANCER RES, V74, P808, DOI 10.1158/0008-5472.CAN-13-1655; Inami Y, 2011, J CELL BIOL, V193, P275, DOI 10.1083/jcb.201102031; Jacob SE, 2006, J AM ACAD DERMATOL, V54, P723, DOI 10.1016/j.jaad.2005.12.028; Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Kadmiel M, 2013, TRENDS PHARMACOL SCI, V34, P518, DOI 10.1016/j.tips.2013.07.003; Kaufman JM, 2014, J THORAC ONCOL, V9, P794, DOI 10.1097/JTO.0000000000000173; Ki SH, 2005, MOL CELL BIOL, V25, P4150, DOI 10.1128/MCB.25.10.4150-4165.2005; KIM N, 2016, SCI REP UK, V6; Kratschmar DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036774; Leinonen HM, 2015, BIOCHEM SOC T, V43, P645, DOI 10.1042/BST20150048; Lin KT, 2016, STEROIDS, V111, P84, DOI 10.1016/j.steroids.2016.02.019; Lu MC, 2016, MED RES REV, V36, P924, DOI 10.1002/med.21396; Calderon-Montano JM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/794930; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Menegon S, 2016, TRENDS MOL MED, V22, P578, DOI 10.1016/j.molmed.2016.05.002; Moghadam-Kia S, 2010, INT J DERMATOL, V49, P239, DOI 10.1111/j.1365-4632.2009.04322.x; Olayanju A, 2015, FREE RADICAL BIO MED, V78, P202, DOI 10.1016/j.freeradbiomed.2014.11.003; Rada P, 2011, MOL CELL BIOL, V31, P1121, DOI 10.1128/MCB.01204-10; Ramos-Gomez M, 2003, CARCINOGENESIS, V24, P461, DOI 10.1093/carcin/24.3.461; Ren DM, 2011, P NATL ACAD SCI USA, V108, P1433, DOI 10.1073/pnas.1014275108; Salazar M, 2006, J BIOL CHEM, V281, P14841, DOI 10.1074/jbc.M513737200; Sanchez-Cespedes M, 2007, ONCOGENE, V26, P7825, DOI 10.1038/sj.onc.1210594; Scagliotti GV, 2006, EXPERT OPIN THER PAT, V16, P189, DOI 10.1517/13543776.16.2.189; Sharma S, 2006, CARCINOGENESIS, V27, P1721, DOI 10.1093/carcin/bgl052; Shaw RJ, 2009, ACTA PHYSIOL, V196, P65, DOI 10.1111/j.1748-1716.2009.01972.x; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Skoulidis F, 2015, CANCER DISCOV, V5, P860, DOI 10.1158/2159-8290.CD-14-1236; Slingerland M, 2013, INVEST NEW DRUG, V31, P1087, DOI 10.1007/s10637-013-9984-1; Spokoini R, 2010, MOL ENDOCRINOL, V24, P1136, DOI 10.1210/me.2009-0466; Sporn MB, 2012, NAT REV CANCER, V12, P564, DOI 10.1038/nrc3278; Sundahl N, 2015, PHARMACOL THERAPEUT, V152, P28, DOI 10.1016/j.pharmthera.2015.05.001; Suzuki T, 2015, FREE RADICAL BIO MED, V88, P93, DOI 10.1016/j.freeradbiomed.2015.06.006; Tan KP, 2008, FREE RADICAL BIO MED, V45, P1663, DOI 10.1016/j.freeradbiomed.2008.09.010; Tang XW, 2011, FREE RADICAL BIO MED, V50, P1599, DOI 10.1016/j.freeradbiomed.2011.03.008; Tao S, 2014, CANCER RES, V74, P7430, DOI 10.1158/0008-5472.CAN-14-1439; Umemura A, 2016, CANCER CELL, V29, P935, DOI 10.1016/j.ccell.2016.04.006; van Meerloo J, 2011, METHODS MOL BIOL, V731, P237, DOI 10.1007/978-1-61779-080-5_20; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Wang G, 2008, FREE RADICAL RES, V42, P435, DOI 10.1080/10715760802074462; Wang XJ, 2007, P NATL ACAD SCI USA, V104, P19589, DOI 10.1073/pnas.0709483104; Zhang YC, 2013, FOOD CHEM TOXICOL, V59, P272, DOI 10.1016/j.fct.2013.05.058; Zhong D, LUNG CANC, V53, P285	57	64	66	2	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 14	2017	36	37					5285	5295		10.1038/onc.2017.153	http://dx.doi.org/10.1038/onc.2017.153			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FG8HT	28504720				2022-12-26	WOS:000410671700007
J	Xiong, MN; Zhu, ZP; Tian, SW; Zhu, RP; Bai, S; Fu, KQ; Davis, JG; Sun, Z; Baur, JA; Zheng, K; Ye, L				Xiong, Mengneng; Zhu, Zhiping; Tian, Suwen; Zhu, Ruping; Bai, Shun; Fu, Kaiqiang; Davis, James G.; Sun, Zheng; Baur, Joseph A.; Zheng, Ke; Ye, Lan			Conditional ablation of Raptor in the male germline causes infertility due to meiotic arrest and impaired inactivation of sex chromosomes	FASEB JOURNAL			English	Article						germ cells; meiosis; sex chromosome silencing; mTOR	DNA-DAMAGE RESPONSE; SYNAPTONEMAL COMPLEX; MAMMALIAN MEIOSIS; MALE-FERTILITY; MOUSE; RAPAMYCIN; MTOR; SYNAPSIS; CELLS; MICE	Rapamycin is a clinically important drug that is used in transplantation and cancer therapy but which causes a number of side effects, including male infertility. Its canonical target, mammalian target of rapamycin complex 1 (mTORC1), plays a key role in metabolism and binds chromatin; however, its precise role in the male germline has not been elucidated. Here, we inactivate the core component, Raptor, to show that mTORC1 function is critical for male meiosis and the inactivation of sex chromosomes. Disruption of the Raptor gene impairs chromosomal synapsis and prevents the efficient spreading of silencing factors into the XY chromatin. Accordingly, mRNA for XY-linked genes remains inappropriately expressed in Raptor-deficient mice. Molecularly, the failure to suppress gene expression corresponded with deficiencies in 2 repressive chromatin markers, H3K9 dimethylation and H3K9 trimethylation, in the XY body. Together, these results demonstrate that mTORC1 has an essential role in the meiotic progression and silencing of sex chromosomes in the male germline, which may explain the infertility that has been associated with such inhibitors as rapamycin.	[Xiong, Mengneng; Zhu, Zhiping; Tian, Suwen; Zhu, Ruping; Bai, Shun; Fu, Kaiqiang; Zheng, Ke; Ye, Lan] Nanjing Med Univ, State Key Lab Reprod Med, 101 Longmian Ave, Nanjing 211166, Jiangsu, Peoples R China; [Davis, James G.; Baur, Joseph A.] Univ Penn, Dept Physiol, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Sun, Zheng] Baylor Coll Med, Houston, TX 77030 USA	Nanjing Medical University; University of Pennsylvania; Pennsylvania Medicine; Baylor College of Medicine	Ye, L (corresponding author), Nanjing Med Univ, State Key Lab Reprod Med, 101 Longmian Ave, Nanjing 211166, Jiangsu, Peoples R China.	lanye@njmu.edu.cn			National Natural Science Foundation of China [81471502]; Nanjing Medical University Startup Grant [2013RC03]; Innovative and Entrepreneurial Program of Jiangsu Province; Natural Science Foundation of Jiangsu Province [15KJA180006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nanjing Medical University Startup Grant; Innovative and Entrepreneurial Program of Jiangsu Province; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	The authors thank Jeremy Wang (University of Pennsylvania) for critical reading of this manuscript. The authors also thank David M. Sabatini (Massachusetts Institute of Technology, Boston, MA, USA) and Jeremy Wang for providing RaptorFlox/Flox mice and Neurog3-Cre mice, respectively. The authors thank Fang Yang (University of Pennsylvania) for anti-SYCP2 Abs and technique support for chromosome spread. The authors thank Zhenyi Qiao (Shanghai Biotechnology, Shanghai, China) for analyzing RNA-seq data. This work was funded by the National Natural Science Foundation of China (Grant 81471502), a Nanjing Medical University Startup Grant (2013RC03), the Innovative and Entrepreneurial Program of Jiangsu Province, and the Natural Science Foundation of Jiangsu Province (15KJA180006).	Baarends WM, 2005, MOL CELL BIOL, V25, P1041, DOI 10.1128/MCB.25.3.1041-1053.2005; Bailis JM, 1998, GENE DEV, V12, P3551, DOI 10.1101/gad.12.22.3551; Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; Bandhakavi S, 2010, MOL CELL PROTEOMICS, V9, P403, DOI 10.1074/mcp.M900326-MCP200; Barchi M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000076; BELLVE AR, 1993, METHOD ENZYMOL, V225, P84; Beuvink I, 2005, CELL, V120, P747, DOI 10.1016/j.cell.2004.12.040; Blattler SM, 2012, CELL METAB, V15, P505, DOI 10.1016/j.cmet.2012.03.008; Broering TJ, 2014, J CELL BIOL, V205, P663, DOI 10.1083/jcb.201311050; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Burgoyne PS, 2009, NAT REV GENET, V10, P207, DOI 10.1038/nrg2505; Busada Jonathan T, 2015, Dev Biol, V407, P90, DOI 10.1016/j.ydbio.2015.08.004; Chaveroux C, 2013, CELL METAB, V17, P586, DOI 10.1016/j.cmet.2013.03.003; Chow JC, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000604; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; de Vries FAT, 2005, GENE DEV, V19, P1376, DOI 10.1101/gad.329705; Dominick G, 2017, AGING CELL, V16, P52, DOI 10.1111/acel.12525; Edelmann W, 1996, CELL, V85, P1125, DOI 10.1016/S0092-8674(00)81312-4; FAWCETT DW, 1956, J BIOPHYS BIOCHEM CY, V2, P403, DOI 10.1083/jcb.2.4.403; Feng LX, 2000, J BIOL CHEM, V275, P25572, DOI 10.1074/jbc.M002218200; Fernandez-Capetillo O, 2003, DEV CELL, V4, P497, DOI 10.1016/S1534-5807(03)00093-5; Fraenkel M, 2008, DIABETES, V57, P945, DOI 10.2337/db07-0922; Guo F, 2013, LEUKEMIA, V27, P2040, DOI 10.1038/leu.2013.93; Handel MA, 2010, NAT REV GENET, V11, P124, DOI 10.1038/nrg2723; Hobbs RM, 2015, EMBO REP, V16, P467, DOI 10.15252/embr.201439379; Hobbs RM, 2010, CELL, V142, P468, DOI 10.1016/j.cell.2010.06.041; HOLLINGSWORTH NM, 1990, CELL, V61, P73, DOI 10.1016/0092-8674(90)90216-2; Huyghe E, 2007, TRANSPL INT, V20, P305, DOI 10.1111/j.1432-2277.2006.00423.x; Ichijima Y, 2011, GENE DEV, V25, P959, DOI 10.1101/gad.2030811; Khalil AM, 2004, P NATL ACAD SCI USA, V101, P16583, DOI 10.1073/pnas.0406325101; Kofman AE, 2012, AGING-US, V4, P279, DOI 10.18632/aging.100451; Kolas NK, 2005, CHROMOSOMA, V114, P92, DOI 10.1007/s00412-005-0334-8; Korhonen HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024821; Kouznetsova A, 2009, J CELL SCI, V122, P2446, DOI 10.1242/jcs.049353; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Mahadevaiah SK, 2008, J CELL BIOL, V182, P263, DOI 10.1083/jcb.200710195; Mahadevaiah SK, 1998, HUM MOL GENET, V7, P715, DOI 10.1093/hmg/7.4.715; MCKEE BD, 1993, CHROMOSOMA, V102, P71, DOI 10.1007/BF00356023; Modzelewski AJ, 2012, DEV CELL, V23, P251, DOI 10.1016/j.devcel.2012.07.003; MOSES MJ, 1956, J BIOPHYS BIOCHEM CY, V2, P215, DOI 10.1083/jcb.2.2.215; Odorisio T, 1996, DEV BIOL, V180, P336, DOI 10.1006/dbio.1996.0305; Page SL, 2004, ANNU REV CELL DEV BI, V20, P525, DOI 10.1146/annurev.cellbio.19.111301.155141; Pelttari J, 2001, MOL CELL BIOL, V21, P5667, DOI 10.1128/MCB.21.16.5667-5677.2001; Perry J, 2001, GENOME RES, V11, P1826, DOI 10.1101/gr.203001; Peters AHFM, 1997, CHROMOSOME RES, V5, P66, DOI 10.1023/A:1018445520117; Petukhova GV, 2005, NAT STRUCT MOL BIOL, V12, P449, DOI 10.1038/nsmb923; Royo H, 2013, GENE DEV, V27, P1484, DOI 10.1101/gad.219477.113; Royo H, 2010, CURR BIOL, V20, P2117, DOI 10.1016/j.cub.2010.11.010; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Schalk JAC, 1998, CHROMOSOMA, V107, P540, DOI 10.1007/s004120050340; Schell C, 2016, AM J PATHOL, V186, P324, DOI 10.1016/j.ajpath.2015.10.012; Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584; Shiu PKT, 2001, CELL, V107, P905, DOI 10.1016/S0092-8674(01)00609-2; Shor B, 2010, J BIOL CHEM, V285, P15380, DOI 10.1074/jbc.M109.071639; SYM M, 1993, CELL, V72, P365, DOI 10.1016/0092-8674(93)90114-6; Tanwar PS, 2012, HUM MOL GENET, V21, P4394, DOI 10.1093/hmg/dds272; Tsubouchi T, 2008, GENE DEV, V22, P3217, DOI 10.1101/gad.1709408; Turner JMA, 2015, ANNU REV GENET, V49, P395, DOI 10.1146/annurev-genet-112414-055145; Turner JMA, 2005, NAT GENET, V37, P41, DOI 10.1038/ng1484; Turner JMA, 2004, CURR BIOL, V14, P2135, DOI 10.1016/j.cub.2004.11.032; Wang PJ, 2005, HUM MOL GENET, V14, P2911, DOI 10.1093/hmg/ddi322; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yan W, 2009, EPIGENETICS-US, V4, P452, DOI 10.4161/epi.4.7.9923; Yang F, 2008, GENE DEV, V22, P682, DOI 10.1101/gad.1613608; Yang F, 2008, J CELL BIOL, V180, P673, DOI 10.1083/jcb.200709057; Yang F, 2006, J CELL BIOL, V173, P497, DOI 10.1083/jcb.200603063; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9; Zheng K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003038; Zheng K, 2010, P NATL ACAD SCI USA, V107, P11841, DOI 10.1073/pnas.1003953107; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	71	12	12	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					3934	3949		10.1096/fj.201700251R	http://dx.doi.org/10.1096/fj.201700251R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28490482				2022-12-26	WOS:000408713300020
J	Carter, EL; Ramirez, Y; Ragsdale, SW				Carter, Eric L.; Ramirez, Yanil; Ragsdale, Stephen W.			The heme-regulatory motif of nuclear receptor Rev-erb beta is a key mediator of heme and redox signaling in circadian rhythm maintenance and metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT DEGRADATION; TRANSCRIPTION FACTOR; GLUCOSE-METABOLISM; LIGAND-BINDING; ALPHA; PROTEIN; DERIVATIVES; INHIBITION; EXPRESSION; MECHANISM	Rev-erb beta is a heme-responsive transcription factor that regulates genes involved in circadian rhythm maintenance and metabolism, effectively bridging these critical cellular processes. Heme binding to Rev-erb beta indirectly facilitates its interaction with the nuclear receptor co-repressor (NCoR1), resulting in repression of Rev-erb beta target genes. Fe3+-heme binds in a 6-coordinate complex with axial His and Cys ligands, the latter provided by a heme-regulatory motif (HRM). Rev-erb beta was thought to be a heme sensor based on a weak K-d value for the Rev-erb beta heme complex of 2 mu M determined with isothermal titration calorimetry. However, our group demonstrated with UV-visible difference titrations that the Kd value is in the low nanomolar range, and the Fe3+-heme off-rate is on the order of 10(-6) s(-1) making Rev-erb beta ineffective as a sensor of Fe3+-heme. In this study, we dissected the kinetics of heme binding to Rev-erb beta and provided a Kd for Fe3+-heme of similar to 0.1 nM. Loss of the HRM axial thiolate via redox processes, including oxidation to a disulfide with a neighboring cysteine or dissociation upon reduction of Fe3+-to Fe2+-heme, decreased binding affinity by >20-fold. Furthermore, as measured in a co-immunoprecipitation assay, substitution of the His or Cys heme ligands in Rev-erb beta was accompanied by a significant loss of NCoR1 binding. These results demonstrate the importance of the Rev-erb beta HRM in regulating interactions with heme and NCoR1 and advance our understanding of how signaling through HRMs affects the major cellular processes of circadian rhythm maintenance and metabolism.	[Carter, Eric L.; Ramirez, Yanil; Ragsdale, Stephen W.] Univ Michigan, Dept Biol Chem, 1150 W Med Ctr Dr,5220D MSRBIII, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Ragsdale, SW (corresponding author), Univ Michigan, Dept Biol Chem, 1150 W Med Ctr Dr,5220D MSRBIII, Ann Arbor, MI 48109 USA.	sragsdal@umich.edu		Carter, Eric/0000-0003-2877-3411	National Institutes of Health [F32HL114150, R01- GM123513]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL114150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM123513] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants F32HL114150 (to E. L. C.) and R01- GM123513 (to S. W. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Asher C, 2009, INORG CHEM, V48, P7994, DOI 10.1021/ic900647y; Atamna H, 2015, METALLOMICS, V7, P309, DOI 10.1039/c4mt00246f; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bugge A, 2012, GENE DEV, V26, P657, DOI 10.1101/gad.186858.112; Carter EL, 2016, J BIOL CHEM, V291, P2196, DOI 10.1074/jbc.M115.670281; Chandra V, 2013, J BIOL CHEM, V288, P10692, DOI 10.1074/jbc.M113.455915; Chapman SK, 1997, STRUCT BOND, V88, P39; Crumbley C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017290; Dawson R.M., 1969, DATA BIOCH RES, P316; de Villiers KA, 2007, J BIOL INORG CHEM, V12, P101, DOI 10.1007/s00775-006-0170-1; Delezie J, 2012, FASEB J, V26, P3321, DOI 10.1096/fj.12-208751; Dioum EM, 2002, SCIENCE, V298, P2385, DOI 10.1126/science.1078456; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; Fleischhacker AS, 2015, BIOCHEMISTRY-US, V54, P2709, DOI 10.1021/acs.biochem.5b00266; GALLAGHER WA, 1967, BIOCHEM J, V105, P461, DOI 10.1042/bj1050461; Gerhart-Hines Z, 2015, DIABETES OBES METAB, V17, P12, DOI 10.1111/dom.12510; Gibbs JE, 2012, P NATL ACAD SCI USA, V109, P582, DOI 10.1073/pnas.1106750109; GIBSON QH, 1960, BIOCHEM J, V77, P328, DOI 10.1042/bj0770328; Gupta N, 2011, J BIOL CHEM, V286, P4392, DOI 10.1074/jbc.M110.193466; HAMMES GG, 1968, BIOCHEMISTRY-US, V7, P1519, DOI 10.1021/bi00844a039; Hanna DA, 2016, P NATL ACAD SCI USA, V113, P7539, DOI 10.1073/pnas.1523802113; HARGROVE MS, 1994, J BIOL CHEM, V269, P4207; Hargrove MS, 1996, BIOCHEMISTRY-US, V35, P11293, DOI 10.1021/bi960371l; Hayasaka K, 2011, BBA-PROTEINS PROTEOM, V1814, P326, DOI 10.1016/j.bbapap.2010.09.007; Honsa ES, 2011, J BIOL CHEM, V286, P33652, DOI 10.1074/jbc.M111.241687; Hou SW, 2006, ACCOUNTS CHEM RES, V39, P918, DOI 10.1021/ar040020w; Ishikawa H, 2005, MOL CELL, V19, P171, DOI 10.1016/j.molcel.2005.05.027; KAWAMURAKONISHI Y, 1988, EUR J BIOCHEM, V170, P589, DOI 10.1111/j.1432-1033.1988.tb13738.x; KAWAMURAKONISHI Y, 1985, J BIOCHEM-TOKYO, V98, P1181, DOI 10.1093/oxfordjournals.jbchem.a135384; Keilin J, 1943, BIOCHEM J, V37, P281, DOI 10.1042/bj0370281; Kubota Y, 2016, J BIOL CHEM, V291, P20516, DOI 10.1074/jbc.M116.719161; Kumar N, 2010, ENDOCRINOLOGY, V151, P3015, DOI 10.1210/en.2009-0800; Le P, 2014, BIOCHEMISTRY-US, V53, P6863, DOI 10.1021/bi5005975; LIN SX, 1990, J BIOL CHEM, V265, P9670; Liu MY, 2008, J BIOL CHEM, V283, P6668, DOI 10.1074/jbc.M708372200; Malmirchegini GR, 2014, J BIOL CHEM, V289, P34886, DOI 10.1074/jbc.M114.583013; Marvin KA, 2009, BIOCHEMISTRY-US, V48, P7056, DOI 10.1021/bi900697c; MATSUMURA K, 1990, JPN J PHYSIOL, V40, P567, DOI 10.2170/jjphysiol.40.567; Matta-Camacho E, 2014, J BIOL CHEM, V289, P20054, DOI 10.1074/jbc.M113.545111; Mense SM, 2006, CELL RES, V16, P681, DOI 10.1038/sj.cr.7310086; Miksanova M, 2006, BIOCHEMISTRY-US, V45, P9894, DOI 10.1021/bi060556k; Milev NB, 2015, TRENDS ENDOCRIN MET, V26, P430, DOI 10.1016/j.tem.2015.05.012; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Munakata H, 2004, J BIOCHEM, V136, P233, DOI 10.1093/jb/mvh112; Muraki N, 2015, J PORPHYR PHTHALOCYA, V19, P9, DOI 10.1142/S1088424614501090; Nygaard TK, 2006, J BIOL CHEM, V281, P20761, DOI 10.1074/jbc.M601832200; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; Owens CP, 2012, BIOCHEMISTRY-US, V51, P1518, DOI 10.1021/bi2018305; Pardee KI, 2009, PLOS BIOL, V7, P384, DOI 10.1371/journal.pbio.1000043; PASTERNACK RF, 1983, BIOCHEMISTRY-US, V22, P1753, DOI 10.1021/bi00277a002; Qi ZH, 1999, P NATL ACAD SCI USA, V96, P13056, DOI 10.1073/pnas.96.23.13056; Qian JY, 2016, TRENDS ENDOCRIN MET, V27, P282, DOI 10.1016/j.tem.2016.03.005; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Ramakrishnan SN, 2005, J BIOL CHEM, V280, P8651, DOI 10.1074/jbc.M413949200; Raspe E, 2002, J LIPID RES, V43, P2172, DOI 10.1194/jlr.M200386-JLR200; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Shen J, 2014, CELL REP, V7, P180, DOI 10.1016/j.celrep.2014.02.042; Shimizu T, 2015, CHEM REV, V115, P6491, DOI 10.1021/acs.chemrev.5b00018; Simcox JA, 2015, DIABETES, V64, P1108, DOI 10.2337/db14-0646; SPRINGER BA, 1987, P NATL ACAD SCI USA, V84, P8961, DOI 10.1073/pnas.84.24.8961; STRICKLAND S, 1975, J BIOL CHEM, V250, P4048; Takahashi JS, 2015, DIABETES OBES METAB, V17, P6, DOI 10.1111/dom.12514; Tsiftsoglou AS, 2006, PHARMACOL THERAPEUT, V111, P327, DOI 10.1016/j.pharmthera.2005.10.017; Vogt AD, 2013, BIOCHEMISTRY-US, V52, P5723, DOI 10.1021/bi400929b; Wang J, 2006, J BIOL CHEM, V281, P33842, DOI 10.1074/jbc.M607873200; Wang TA, 2012, SCIENCE, V337, P839, DOI 10.1126/science.1222826; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Zenke-Kawasaki Y, 2007, MOL CELL BIOL, V27, P6962, DOI 10.1128/MCB.02415-06; ZHANG L, 1995, EMBO J, V14, P313, DOI 10.1002/j.1460-2075.1995.tb07005.x	71	24	24	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11280	11299		10.1074/jbc.M117.783118	http://dx.doi.org/10.1074/jbc.M117.783118			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28500133	hybrid, Green Published			2022-12-26	WOS:000405119600013
J	Cai, W; Ma, ZX; Yang, CY; Wang, L; Wang, WZ; Zhao, GG; Geng, YP; Yu, DW				Cai, Wang; Ma, Zhuxin; Yang, Chunyan; Wang, Lin; Wang, Wenzhi; Zhao, Guigang; Geng, Yupeng; Yu, Douglas W.			Using eDNA to detect the distribution and density of invasive crayfish in the Honghe-Hani rice terrace World Heritage site	PLOS ONE			English	Article							ENVIRONMENTAL DNA; ORCONECTES-RUSTICUS; WATER; BIODIVERSITY; CAPTURE; SIZE; OCCUPANCY; IMPACT; SAMPLE	The Honghe-Hani landscape in China is a UNESCO World Natural Heritage site due to the beauty of its thousands of rice terraces, but these structures are in danger from the invasive crayfish Procambarus clarkii. Crayfish dig nest holes, which collapse terrace walls and destroy rice production. Under the current control strategy, farmers self-report crayfish and are issued pesticide, but this strategy is not expected to eradicate the crayfish nor to prevent their spread since farmers are not able to detect small numbers of crayfish. Thus, we tested whether environmental DNA (eDNA) from paddy-water samples could provide a sensitive detection method. In an aquarium experiment, Real-time Quantitative polymerase chain reaction (qPCR) successfully detected crayfish, even at a simulated density of one crayfish per average-sized paddy (with one false negative). In a field test, we tested eDNA and bottle traps against direct counts of crayfish. eDNA successfully detected crayfish in all 25 paddies where crayfish were observed and in none of the 7 paddies where crayfish were absent. Bottle-trapping was successful in only 68% of the crayfish-present paddies. eDNA concentrations also correlated positively with crayfish counts. In sum, these results suggest that single samples of eDNA are able to detect small crayfish populations, but not perfectly. Thus, we conclude that a program of repeated eDNA sampling is now feasible and likely reliable for measuring crayfish geographic range and for detecting new invasion fronts in the Honghe Hani landscape, which would inform regional control efforts and help to prevent the further spread of this invasive crayfish.	[Cai, Wang; Yang, Chunyan; Wang, Lin; Wang, Wenzhi; Yu, Douglas W.] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China; [Cai, Wang] Univ Chinese Acad Sci, Kunming Coll Life Sci, Kunming, Yunnan, Peoples R China; [Ma, Zhuxin; Geng, Yupeng] Yunnan Univ, Inst Ecol & Geobot, Sch Ecol & Environm Sci, Kunming, Yunnan, Peoples R China; [Zhao, Guigang] Chinese Acad Sci, Kunming Inst Zool, Publ Tech Serv Ctr, Kunming, Yunnan, Peoples R China; [Zhao, Guigang] Chinese Acad Sci, Kunming Inst Zool, Kunming Biol Divers Reg Ctr Instruments, Kunming, Yunnan, Peoples R China; [Yu, Douglas W.] Univ East Anglia, Sch Biol Sci, Norwich Res Pk, Norwich, Norfolk, England	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Yunnan University; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Kunming Institute of Zoology; University of East Anglia	Yang, CY (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China.; Geng, YP (corresponding author), Yunnan Univ, Inst Ecol & Geobot, Sch Ecol & Environm Sci, Kunming, Yunnan, Peoples R China.	yangyahan@mail.kiz.ac.cn; ypgeng@ynu.edu.cn	Wang, Lin/ABF-8028-2021; Yu, Douglas W./D-2536-2009; Wang, Lin/AAA-2163-2022	Wang, Lin/0000-0001-5645-8991; Yu, Douglas W./0000-0001-8551-5609; 	National Natural Science Foundation of China; Ministry of Science and Technology of the People's Republic of China; Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences)	Support was provided by the National Natural Science Foundation of China [http://www.nsfc.gov.cn] to CYY and DWY; the Ministry of Science and Technology of the People's Republic of China [http://www.most.gov.cn] to DWY and GYP; and the Chinese Academy of Sciences [http://www.cas.cn] to DWY and YPG.	Barnes MA, 2016, CONSERV GENET, V17, P1, DOI 10.1007/s10592-015-0775-4; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Bohmann K, 2014, TRENDS ECOL EVOL, V29, P358, DOI 10.1016/j.tree.2014.04.003; CAPELLI GM, 1983, J CRUSTACEAN BIOL, V3, P548, DOI 10.2307/1547950; Deiner K, 2015, BIOL CONSERV, V183, P53, DOI 10.1016/j.biocon.2014.11.018; Dejean T, 2012, J APPL ECOL, V49, P953, DOI 10.1111/j.1365-2664.2012.02171.x; Doi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122763; Dougherty MM, 2016, J APPL ECOL, V53, P722, DOI 10.1111/1365-2664.12621; Evans NT, 2016, MOL ECOL RESOUR, V16, P29, DOI 10.1111/1755-0998.12433; Geiger W, 2005, BIOL INVASIONS, V7, P49, DOI 10.1007/s10530-004-9635-8; Goldberg CS, 2015, BIOL CONSERV, V183, P1, DOI 10.1016/j.biocon.2014.11.040; Harvey CT, 2009, DIVERS DISTRIB, V15, P429, DOI 10.1111/j.1472-4642.2008.00550.x; Jane SF, 2014, MOL ECOL RESOUR, P216; Klymus KE, 2015, BIOL CONSERV, V183, P77, DOI 10.1016/j.biocon.2014.11.020; Levy-Booth DJ, 2007, SOIL BIOL BIOCHEM, V39, P2977, DOI 10.1016/j.soilbio.2007.06.020; Lodge DM, 2006, ECOL APPL, V16, P2035, DOI 10.1890/1051-0761(2006)016[2035:BIRFUP]2.0.CO;2; Lodge DM, 2012, ANNU REV ECOL EVOL S, V43, P449, DOI 10.1146/annurev-ecolsys-111511-103919; Lucentini L, 2006, MOL ECOL NOTES, V6, P257, DOI 10.1111/j.1471-8286.2005.01142.x; Machler E, 2014, FRESHW SCI, V33, P1174, DOI 10.1086/678128; OLSEN TM, 1991, CAN J FISH AQUAT SCI, V48, P1853, DOI 10.1139/f91-219; Paillisson JM, 2011, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2011015; Pilliod DS, 2014, MOL ECOL RESOUR, V14, P109, DOI 10.1111/1755-0998.12159; Pilliod DS, 2013, CAN J FISH AQUAT SCI, V70, P1123, DOI 10.1139/cjfas-2013-0047; Renshaw M A, 2014, MOL ECOL RESOUR, P168; Schmidt BR, 2013, METHODS ECOL EVOL, V4, P646, DOI 10.1111/2041-210X.12052; Seiler SM, 2004, FRESHWATER BIOL, V49, P870, DOI 10.1111/j.1365-2427.2004.01231.x; Smart AS, 2016, METHODS ECOL EVOL, V7, P1291, DOI 10.1111/2041-210X.12598; Smart AS, 2015, ECOL APPL, V25, P1944, DOI 10.1890/14-1751.1; Takahara T, 2015, BIOL CONSERV, V183, P64, DOI 10.1016/j.biocon.2014.11.014; Takahara T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056584; Takazawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040154; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Treguier A, 2014, J APPL ECOL, V51, P871, DOI 10.1111/1365-2664.12262; Turner CR, 2015, BIOL CONSERV, V183, P93, DOI 10.1016/j.biocon.2014.11.017; Turner CR, 2014, METHODS ECOL EVOL, V5, P676, DOI 10.1111/2041-210X.12206; Twardochleb LA, 2013, FRESHW SCI, V32, P1367, DOI 10.1899/12-203.1; Zhang Gai P, 2015, YUNNAN XINHUA NET, V11, P1	38	27	33	10	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177724	10.1371/journal.pone.0177724	http://dx.doi.org/10.1371/journal.pone.0177724			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505200	Green Submitted, gold, Green Accepted, Green Published			2022-12-26	WOS:000401473500036
J	Kahnert, K; Lucke, T; Huber, RM; Behr, J; Biertz, F; Vogel, A; Watz, H; Alter, P; Fahndrich, S; Bals, R; Holle, R; Karrasch, S; Sohler, S; Wacker, M; Ficker, JH; Parhofer, KG; Vogelmeier, C; Jorres, RA				Kahnert, Kathrin; Lucke, Tanja; Huber, Rudolf M.; Behr, Juergen; Biertz, Frank; Vogt, Anja; Watz, Henrik; Alter, Peter; Faehndrich, Sebastian; Bals, Robert; Holle, Rolf; Karrasch, Stefan; Sohler, Sandra; Wacker, Margarethe; Ficker, Joachim H.; Parhofer, Klaus G.; Vogelmeier, Claus; Joerres, Rudolf A.		COSYCONET Consortium	Relationship of hyperlipidemia to comorbidities and lung function in COPD: Results of the COSYCONET cohort	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; BODY-MASS INDEX; DIFFUSING-CAPACITY; METABOLIC SYNDROME; REFERENCE VALUES; RISK-FACTORS; MORTALITY; HEALTH; AGE	Although hyperlipidemia is common in COPD, its relationship to comorbidities, risk factors and lung function in COPD has not been studied in detail. Using the baseline data of the COSYCONET cohort we addressed this question. Data from 1746 COPD patients (GOLD stage 1-4; mean age 64.6 y, mean FEV1% pred 57%) were evaluated, focusing on the comorbidities hyperlipidemia, diabetes and cardiovascular complex (CVC; including arterial hypertension, cardiac failure, ischemic heart disease). Risk factors comprised age, gender, BMI, and packyears of smoking. The results of linear and logistic regression analyses were implemented into a path analysis model describing the multiple relationships between parameters. Hyperlipidemia (prevalence 42.9%) was associated with lower intrathoracic gas volume (ITGV) and higher forced expiratory volume in 1 second (FEV1) when adjusting for its multiple relationships to risk factors and other comorbidities. These findings were robust in various statistical analyses. The associations between comorbidities and risk factors were in accordance with previous findings, thereby underlining the validity of our data. In conclusion, hyperlipidemia was associated with less hyperinflation and airway obstruction in patients with COPD. This surprising result might be due to different COPD phenotypes in these patients or related to effects of medication.	[Kahnert, Kathrin; Huber, Rudolf M.; Behr, Juergen] Univ Munich, German Ctr Lung Res, Comprehens Pneumol Ctr, Dept Internal Med 5, Munich, Germany; [Lucke, Tanja; Karrasch, Stefan; Joerres, Rudolf A.] Ludwig Maximilians Univ Munchen, Inst & Outpatient Clin Occupat Social & Environm, Munich, Germany; [Biertz, Frank] Hannover Med Sch, Inst Biostat, Hannover, Germany; [Vogt, Anja] Klin & Poliklin Univ Munchen, Stoffwechselambulanz, Munich, Germany; [Watz, Henrik] German Ctr Lung Res, LungenClin Grosshansdorf, Pulm Res Inst, Airway Res Ctr North, Grosshansdorf, Germany; [Alter, Peter; Vogelmeier, Claus] Philipps Univ Marburg, Dept Med Pulm & Crit Care Med, Univ Med Ctr Giessen & Marburg, German Ctr Lung Res DZL, Marburg, Germany; [Faehndrich, Sebastian; Bals, Robert] Saarland Univ Hosp, Dept Internal Med Pulmonol Allergol Resp Intens C, Homburg, Germany; [Holle, Rolf; Wacker, Margarethe] Helmholtz Zentrum Munchen GmbH, German Ctr Lung Res, CPC M, German Res Ctr Environm Hlth,Inst Hlth Econ & Hlt, Neuherberg, Germany; [Karrasch, Stefan] Helmholtz Zentrum Munchen, Inst Epidemiol 1, German Res Ctr Environm Hlth, Neuherberg, Germany; [Sohler, Sandra] Univ Marburg, ASCONET Study Coordinat Off, Marburg, Germany; [Ficker, Joachim H.] Paracelsus Med Univ, Gen Hosp Nuernberg, Dept Resp Med Allergol & Sleep Med, Nurnberg, Germany; [Parhofer, Klaus G.] Univ Munich, Dept Internal Med 4, Munich, Germany	University of Munich; University of Munich; Hannover Medical School; Grosshansdorf Hospital; Philipps University Marburg; University Hospital of Giessen & Marburg; Universitatsklinikum des Saarlandes; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Philipps University Marburg; University of Munich	Kahnert, K (corresponding author), Univ Munich, German Ctr Lung Res, Comprehens Pneumol Ctr, Dept Internal Med 5, Munich, Germany.	kathrin.kahnert@med.uni-muenchen.de	Ficker, Joachim H./A-1153-2015; Huber, Rudolf M./L-2464-2019; Kahnert, Kathrin/AAG-6564-2021; Holle, Rolf/D-9333-2013; Karrasch, Stefan/GQI-2691-2022; Deitsch, Haysha/C-2019-2017	Ficker, Joachim H./0000-0002-7175-5852; Huber, Rudolf M./0000-0001-7041-6368; Holle, Rolf/0000-0001-5395-2695; Deitsch, Haysha/0000-0002-0215-4340	BMBF Competence Network Asthma and COPD (ASCONET); German Federal Ministry of Education and Research (BMBF) [01 GI 0881]; AstraZeneca GmbH; Bayer Schering Pharma AG; Boehringer Ingelheim Pharma GmbH Co. KG; Chiesi GmbH; GlaxoSmithKline; Grifols Deutschland GmbH; MSD Sharp Dohme GmbH; Mundipharma GmbH; Novartis Deutschland GmbH; Pfizer Pharma GmbH; Takeda Pharma Vertrieb GmbH Co. KG	BMBF Competence Network Asthma and COPD (ASCONET)(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); AstraZeneca GmbH(AstraZeneca); Bayer Schering Pharma AG(Bayer AG); Boehringer Ingelheim Pharma GmbH Co. KG(Boehringer Ingelheim); Chiesi GmbH(Chiesi Pharmaceuticals Inc); GlaxoSmithKline(GlaxoSmithKline); Grifols Deutschland GmbH; MSD Sharp Dohme GmbH; Mundipharma GmbH; Novartis Deutschland GmbH; Pfizer Pharma GmbH(Pfizer); Takeda Pharma Vertrieb GmbH Co. KG	This work was supported by BMBF Competence Network Asthma and COPD (ASCONET) and performed in collaboration with the German Center for Lung Research (DZL). The project is funded by the German Federal Ministry of Education and Research (BMBF) with grant number 01 GI 0881; and is funded by unrestricted grants from AstraZeneca GmbH, Bayer Schering Pharma AG, Boehringer Ingelheim Pharma GmbH & Co. KG, Chiesi GmbH, GlaxoSmithKline, Grifols Deutschland GmbH, MSD Sharp & Dohme GmbH, Mundipharma GmbH, Novartis Deutschland GmbH, Pfizer Pharma GmbH, Takeda Pharma Vertrieb GmbH & Co. KG for patient investigations and laboratory measurements.	Akhabue E, 2014, AM J MED SCI, V347, P151, DOI 10.1097/MAJ.0b013e31828aab45; Albert MA, 2001, JAMA-J AM MED ASSOC, V286, P64, DOI 10.1001/jama.286.1.64; AVIRAM M, 1987, POSTGRAD MED J, V63, P91, DOI 10.1136/pgmj.63.736.91; Bando M, 2012, RESPIROLOGY, V17, P493, DOI 10.1111/j.1440-1843.2011.02116.x; Bays HE, 2007, INT J CLIN PRACT, V61, P737, DOI 10.1111/j.1742-1241.2007.01336.x; Chan MC, 2016, INT J CHRONIC OBSTR, V11, P1053, DOI 10.2147/COPD.S102708; Chatila Wissam M, 2008, Proc Am Thorac Soc, V5, P549, DOI 10.1513/pats.200709-148ET; Chen WL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108989; Divo M, 2012, AM J RESP CRIT CARE, V186, P155, DOI 10.1164/rccm.201201-0034OC; Ford ES, 2014, J DIABETES, V6, P603, DOI 10.1111/1753-0407.12136; Grundy SM, 1999, CIRCULATION, V100, P1134, DOI 10.1161/01.CIR.100.10.1134; Guerra S, 2002, CHEST, V122, P1256, DOI 10.1378/chest.122.4.1256; Hersh CP, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-164; Hoyle R.H, 2015, HDB STRUCTURAL EQUAT; Humayun Anjum, 2009, J Ayub Med Coll Abbottabad, V21, P141; Jousilahti P, 1999, CIRCULATION, V99, P1165, DOI 10.1161/01.cir.99.9.1165; Karch A, 2016, RESP MED, V114, P27, DOI 10.1016/j.rmed.2016.03.008; Lee LH, 2005, AM J RESP CRIT CARE, V172, P987, DOI 10.1164/rccm.200501-041OC; Leone N, 2009, AM J RESP CRIT CARE, V179, P509, DOI 10.1164/rccm.200807-1195OC; LOWE GDO, 1982, LANCET, V1, P472; Lucke T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163408; Negewo NA, 2015, RESPIR INVESTIG, V53, P249, DOI 10.1016/j.resinv.2015.02.004; NEWBALL HH, 1975, AM REV RESPIR DIS, V112, P83; PARTRIDGE MR, 1979, THORAX, V34, P265, DOI 10.1136/thx.34.2.265; Pintaric I, 2001, ATHEROSCLEROSIS, V154, P493, DOI 10.1016/S0021-9150(00)00505-0; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Santus P, 2014, RESP PHYSIOL NEUROBI, V197, P36, DOI 10.1016/j.resp.2014.03.012; Silove D, 2015, LANCET PSYCHIAT, V2, P161, DOI 10.1016/S2215-0366(14)00054-6; Soriano JB, 2015, LANCET RESP MED, V3, P443, DOI 10.1016/S2213-2600(15)00157-5; Tawakol A., 2017, LANCET; van der Lee I, 2007, RESP MED, V101, P1579, DOI 10.1016/j.rmed.2006.12.001; Yoshimura C, 2012, INTERNAL MED, V51, P2291, DOI 10.2169/internalmedicine.51.7427	33	26	26	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177501	10.1371/journal.pone.0177501	http://dx.doi.org/10.1371/journal.pone.0177501			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505167	Green Published, Green Submitted, gold			2022-12-26	WOS:000401473500025
J	Murthy, SK; James, PD; Antonova, L; Chalifoux, M; Tanuseputro, P				Murthy, Sanjay K.; James, Paul D.; Antonova, Lilia; Chalifoux, Mathieu; Tanuseputro, Peter			High end of life health care costs and hospitalization burden in inflammatory bowel disease patients: A population-based study	PLOS ONE			English	Article							ADMINISTRATIVE DATA; VALIDATION; PREVALENCE; DATABASES; ONTARIO; ILLNESS; RECORDS; TRENDS	Background End of life (EOL) care is associated with greater costs, particularly for acute care services. In patients with inflammatory bowel disease (IBD), EOL costs may be accentuated due to reliance on hospital-based services and expensive diagnostic tests and treatments. We aimed to compare EOL health care use and costs between IBD and non-IBD decedents. Methods We conducted a retrospective cohort study of all decedents of Ontario, Canada between 2010 and 2013 using linked health administrative data. IBD (N = 2,214) and non-IBD (N = 262,540) decedents were compared on total direct health care costs in the last year of life and hospitalization time during the last 90 days of life. Results During the last 90 days of life, IBD patients spent an average of 16 days in hospital, equal to 2.1 greater adjusted hospital days (95% confidence interval [CI] 1.5-2.8 days) than non-IBD patients. IBD diagnosis was associated with $ 7,210 CAD (95% CI $ 5,005 -$ 9,464) higher adjusted per-patient cost in the last year of life, of which 76% was due to excess hospitalization costs. EOL cost of IBD care was higher than 15 of 16 studied chronic conditions. Health care costs rose sharply in the last 90 days of life, primarily due to escalating hospitalization costs. Conclusions IBD patients spend more time in hospital and incur substantially greater health care costs than other decedents as they approach the EOL. These excess costs could be curtailed through avoidance of unnecessary hospitalizations and expensive treatments in the setting of irreversible deterioration.	[Murthy, Sanjay K.; James, Paul D.; Tanuseputro, Peter] Ottawa Hosp, Dept Med, Div Gastroenterol, Ottawa, ON, Canada; [Murthy, Sanjay K.; James, Paul D.; Tanuseputro, Peter] Univ Ottawa, Ottawa, ON, Canada; [Murthy, Sanjay K.; James, Paul D.; Antonova, Lilia; Chalifoux, Mathieu; Tanuseputro, Peter] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Murthy, Sanjay K.; Chalifoux, Mathieu; Tanuseputro, Peter] Inst Clin Evaluat Sci ICES uOttawa, Ottawa, ON, Canada; [Tanuseputro, Peter] Bruyere Res Inst, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Murthy, SK (corresponding author), Ottawa Hosp, Dept Med, Div Gastroenterol, Ottawa, ON, Canada.; Murthy, SK (corresponding author), Univ Ottawa, Ottawa, ON, Canada.; Murthy, SK (corresponding author), Ottawa Hosp Res Inst, Ottawa, ON, Canada.; Murthy, SK (corresponding author), Inst Clin Evaluat Sci ICES uOttawa, Ottawa, ON, Canada.	smurthy@toh.on.ca		Murthy, Sanjay/0000-0002-0128-7897; Tanuseputro, Peter/0000-0002-4409-0795	Institute for Clinical Evaluative Sciences (ICES); Ontario Ministry of Health and Long-Term Care (MOHLTC); Ontario Ministry of Health and Long-Term Care; Health System Performance Research Network Grant (HSPRN) [06034]	Institute for Clinical Evaluative Sciences (ICES)(University of Toronto); Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario); Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); Health System Performance Research Network Grant (HSPRN)	This research was supported by a research grant from the Ontario Ministry of Health and Long-Term Care to the Health System Performance Research Network Grant [grant number HSPRN #06034]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was made possible with the support of the Institute for Clinical Evaluative Sciences (ICES) which receives funding from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred.	Austin PC, 2011, MED CARE, V49, P932, DOI 10.1097/MLR.0b013e318215d5e2; Bassi A, 2004, GUT, V53, P1471, DOI 10.1136/gut.2004.041616; Benchimol EI, 2009, GUT, V58, P1490, DOI 10.1136/gut.2009.188383; Benchimol EI, 2014, J CLIN EPIDEMIOL, V67, P887, DOI 10.1016/j.jclinepi.2014.02.019; Drummond D, 2012, COMMISSION REFORM ON; Felder S, 2000, J HEALTH ECON, V19, P679, DOI 10.1016/S0167-6296(00)00039-4; Gershon AS, 2009, COPD, V6, P388, DOI 10.1080/15412550903140865; Gershon AS, 2009, CAN RESPIR J, V16, P183, DOI 10.1155/2009/963098; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Jaakkimainen RL, 2016, J ALZHEIMERS DIS, V54, P337, DOI 10.3233/JAD-160105; Johnson SL, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008597; Kappelman MD, 2013, DIGEST DIS SCI, V58, P519, DOI 10.1007/s10620-012-2371-5; Kappelman MD, 2008, GASTROENTEROLOGY, V135, P1907, DOI 10.1053/j.gastro.2008.09.012; Longobardi T, 2006, CLIN GASTROENTEROL H, V4, P731, DOI 10.1016/j.cgh.2006.02.013; LUBITZ JD, 1993, NEW ENGL J MED, V328, P1092, DOI 10.1056/NEJM199304153281506; Mondor L, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002249; Niewiadomski O, 2015, J CROHNS COLITIS; Rocchi A, 2012, CAN J GASTROENTEROL, V26, P811, DOI 10.1155/2012/984575; Schultz SE, 2013, CHRON DIS INJ CAN, V33, P160; Tanuseputro P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121759; Tu Karen, 2007, Open Med, V1, pe18; WEINER JP, 1991, MED CARE, V29, P452, DOI 10.1097/00005650-199105000-00006; Wodchis WP, 2013, GUIDELINES PERSON LE	23	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177211	10.1371/journal.pone.0177211	http://dx.doi.org/10.1371/journal.pone.0177211			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498877	gold, Green Published, Green Submitted			2022-12-26	WOS:000401314500012
J	Barchiesi, F; Orsetti, E; Mazzanti, S; Trave, F; Salvi, A; Nitti, C; Manso, E				Barchiesi, Francesco; Orsetti, Elena; Mazzanti, Sara; Trave, Francesca; Salvi, Aldo; Nitti, Cinzia; Manso, Esther			Candidemia in the elderly: What does it change?	PLOS ONE			English	Article							INVASIVE CANDIDIASIS; SEPTIC SHOCK; EPIDEMIOLOGY; SURVEILLANCE; MULTICENTER; CANDIDAEMIA; INFECTIONS; PREDICTORS; RESISTANCE; MORTALITY	Background Candidemia is a life-threatening fungal infection and it can affect patients of all ages. Characterization of candidemia in the elderly is lacking. Methods We performed a retrospective study of adults (>= 18 years) with candidemia diagnosed in our center in 2010-2015. Demographics, comorbidities, clinical and microbiologic characteristics, antifungal treatment and outcome were compared between older (<= 65 years) and younger (> 65 years) patients. Results Among 302 patients with candidemia identified during the study period, 188 (62%) belonged to the elderly group. Comorbidities were significantly more frequent in older patients and included chronic pulmonary diseases, cardiovascular diseases, diabetes mellitus, and chronic renal failure (p ranging from <0.0001 to 0.017). A significantly higher proportion of older patients had septic shock (p = 0.040) at the time of candidemia. Candida albicans accounted for 53% of isolates and there were no significant differences between patients' age and Candida species. Thirty-day mortality was significantly higher in older (45%) than in younger (28%) patients (p = 0.003). Factors associated with a significant higher proportion of death in the elderly included older age (i.e.: old-old), being hospitalized in ICU rather than in other wards, suffering from chronic pulmonary diseases, the presence of septic shock, multiple organ failure, dialysis and being infected with C. glabrata (p ranging from <0.0001 to 0.034). On multivariate analysis septic shock (HR 1.744 [CI95% 1.049-2.898], p = 0.032) and multiple organ failure (HR 2.242 [CI95% 1.070-4.698], p = 0.032) were independently associated with a higher risk of death. The probability of 30-days survival of older patients was significantly reduced when compared to that of younger patients (p = 0.005) who did not receive any treatment. In the elderly, there was a trend toward higher MICs for fluconazole/C. albicans, fluconazole/C. glabrata, amphotericin B/C. albicans, and caspofungin/C. glabrata. Conclusions In our study, we found that elderly patients with Candida bloodstream infections are characterized by a high mortality rate. In particular, the lack of any antifungal therapy as well as the occurrence of septic shock increased significantly the overall mortality. Additionally, we found that there was a trend of higher MIC for specific drug/Candida combination.	[Barchiesi, Francesco; Orsetti, Elena; Mazzanti, Sara; Trave, Francesca] Univ Politecn Marche, Clin Malattie Infett, Dipartimento Sci Biomed & Sanita Pubbl, Ancona, Italy; [Salvi, Aldo; Nitti, Cinzia] Azienda Osped Univ, Osped Riuniti Umberto IGM Lancisi G Salesi, Med Internist & Subintens, Ancona, Italy; [Manso, Esther] Azienda Osped Univ, Osped Riuniti Umberto IGM Lancisi G Salesi, Lab Microbiol, Ancona, Italy	Marche Polytechnic University	Barchiesi, F (corresponding author), Univ Politecn Marche, Clin Malattie Infett, Dipartimento Sci Biomed & Sanita Pubbl, Ancona, Italy.	f.barchiesi@univpm.it		nitti, cinzia/0000-0003-1655-8263; salvi, aldo/0000-0002-5601-8790				Al-Jasser AM, 2004, SAUDI MED J, V25, P566; Alexander BD, 2013, CLIN INFECT DIS, V56, P1724, DOI 10.1093/cid/cit136; Andes DR, 2012, CLIN INFECT DIS, V54, P1110, DOI 10.1093/cid/cis021; Arendrup MC, 2014, CLIN MICROBIOL INFEC, V20, P42, DOI 10.1111/1469-0691.12513; Arendrup MC, 2013, CLIN MICROBIOL INFEC, V19, pE343, DOI 10.1111/1469-0691.12212; Barchiesi F, 2016, INFECTION, V44, P205, DOI 10.1007/s15010-015-0845-z; Bassetti M, 2014, INTENS CARE MED, V40, P839, DOI 10.1007/s00134-014-3310-z; Bassetti M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024198; Blot S, 2001, J HOSP INFECT, V47, P308, DOI 10.1053/jhin.2000.0918; Chai YAL, 2007, MED MYCOL, V45, P435, DOI 10.1080/13693780701385868; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Cheng Yu-Ren, 2006, Journal of Microbiology Immunology and Infection, V39, P155; Clinical and Laboratory Standards Institute, 2012, M27S4 CLSI, pM27; Diekema DJ, 2002, J CLIN MICROBIOL, V40, P1298, DOI 10.1128/JCM.40.4.1298-1302.2002; Flevari A, 2013, CLIN INTERV AGING, V8, P1199, DOI 10.2147/CIA.S39120; Guimaraes T, 2012, INT J INFECT DIS, V16, pE442, DOI 10.1016/j.ijid.2012.02.005; Hesstvedt L, 2015, CLIN MICROBIOL INFEC, V21, P938, DOI 10.1016/j.cmi.2015.06.008; Kollef M, 2012, CLIN INFECT DIS, V54, P1739, DOI 10.1093/cid/cis305; Luzzati R, 2016, INFECT 1 ONLINE 0711; Luzzati R, 2015, AGING CLIN EXP RES, V27, P131, DOI 10.1007/s40520-014-0251-x; Nucci M, 2010, CLIN INFECT DIS, V51, P887; Nucci M, 2007, DIAGN MICROBIOL INFE, V58, P82, DOI DOI 10.1016/J.DIAGMICR0BI0.2006.11.009; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; Pappas PG, 2003, CLIN INFECT DIS, V37, P634, DOI 10.1086/376906; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pfaller MA, 2012, J CLIN MICROBIOL, V50, P2846, DOI 10.1128/JCM.00937-12; Pfaller MA, 2011, DRUG RESIST UPDATE, V14, P164, DOI 10.1016/j.drup.2011.01.004; Tortorano AM, 2004, EUR J CLIN MICROBIOL, V23, P317, DOI 10.1007/s10096-004-1103-y; Wang H, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0609-x	29	41	46	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176576	10.1371/journal.pone.0176576	http://dx.doi.org/10.1371/journal.pone.0176576			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493896	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314300021
J	Date, SS; Fiori, MC; Altenberg, GA; Jansen, M				Date, Swapneeta S.; Fiori, Mariana C.; Altenberg, Guillermo A.; Jansen, Michaela			Expression in Sf9 insect cells, purification and functional reconstitution of the human proton-coupled folate transporter (PCFT, SLC46A1)	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; MOLECULAR-BASIS; PCFT-SLC46A1; PROTEIN; ACID; GLYCOSYLATION; MALABSORPTION; BIOSYNTHESIS; MECHANISM; RESIDUES	The proton-coupled folate transporter (PCFT) provides an essential uptake route for the vitamin folic acid (B9) in mammals. In addition, it is currently of high interest for targeting chemotherapeutic agents to tumors due to the increased folic acid requirement of rapidly dividing tumor cells as well as the upregulated PCFT expression in several tumors. To understand its function, determination of its atomic structure and molecular mechanism of transport are essential goals that require large amounts of functional PCFT. Here, we present a high-level heterologous expression system for human PCFT using a recombinant baculovirus and Spodoptera frugiperda (Sf9) insect cells. We demonstrate folate transport functionality along the PCFT expression, isolation, and purification process. Importantly, purified PCFT transports folic acid after reconstitution. We thus succeeded in overcoming heterologous expression as a major bottleneck of PCFT research. The availability of an overexpression system for human PCFT provides the basis for future biochemical, biophysical and structural studies.	[Date, Swapneeta S.; Fiori, Mariana C.; Altenberg, Guillermo A.; Jansen, Michaela] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Dept Cell Physiol & Mol Biophys, Lubbock, TX 79430 USA; [Date, Swapneeta S.; Fiori, Mariana C.; Altenberg, Guillermo A.; Jansen, Michaela] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Ctr Membrane Prot Res, Lubbock, TX 79430 USA; [Date, Swapneeta S.] Oak Ridge Natl Lab, Oak Ridge, TN USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; United States Department of Energy (DOE); Oak Ridge National Laboratory	Jansen, M (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Sch Med, Dept Cell Physiol & Mol Biophys, Lubbock, TX 79430 USA.; Jansen, M (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Sch Med, Ctr Membrane Prot Res, Lubbock, TX 79430 USA.	Michaela.jansen@ttuhsc.edu		Jansen, Michaela/0000-0003-1325-9700; Altenberg, Guillermo/0000-0002-8932-740X	seed grants from the Laura W. Bush Institute for Women's Health and University Medical Center in Lubbock; Texas; Center for Membrane Protein Research; School of Medicine; TTUHSC; TTUHSC Office of Research	seed grants from the Laura W. Bush Institute for Women's Health and University Medical Center in Lubbock; Texas; Center for Membrane Protein Research; School of Medicine; TTUHSC; TTUHSC Office of Research	This work was supported in part by seed grants from the Laura W. Bush Institute for Women's Health and University Medical Center in Lubbock, Texas (to MJ and GAA), the Center for Membrane Protein Research, School of Medicine, TTUHSC (to MJ), and the TTUHSC Office of Research (to MJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. A Pandhare, NT Phan, E Pirayesh and A Stuebler from Jansen's laboratory and Drs. MP Blanton, L Guan, and IL Urbatsch for discussion of experimental procedures. This work was supported in part by seed grants from the Laura W. Bush Institute for Women's Health and University Medical Center in Lubbock, Texas (to MJ and GAA), the Center for Membrane Protein Research, School of Medicine, TTUHSC (to MJ), and the TTUHSC Office of Research (to MJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank the TTUHSC Core Facilities: some of the images and data were generated in the Image Analysis Core Facility & Molecular Biology Core Facility supported by TTUHSC. The authors declare that they have no conflicts of interest with the contents of this article.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Achari A, 1997, NAT STRUCT BIOL, V4, P490, DOI 10.1038/nsb0697-490; Alisio A, 2010, PROTEIN EXPRES PURIF, V70, P81, DOI 10.1016/j.pep.2009.10.011; Bermingham A, 2002, BIOESSAYS, V24, P637, DOI 10.1002/bies.10114; Chaptal V, 2017, SCI REP-UK, V7, DOI 10.1038/srep41751; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Crider KS, 2012, ADV NUTR, V3, P21, DOI 10.3945/an.111.000992; Dang SY, 2010, NATURE, V467, P734, DOI 10.1038/nature09406; Date SS, 2016, FEBS OPEN BIO, V6, P216, DOI 10.1002/2211-5463.12041; Deng D, 2014, NATURE, V510, P121, DOI 10.1038/nature13306; Desmoulin SK, 2012, CANCER BIOL THER, V13, P1355, DOI 10.4161/cbt.22020; Desmoulin SK, 2012, MOL PHARMACOL, V82, P591, DOI 10.1124/mol.112.079004; Desmoulin SK, 2011, MOL PHARMACOL, V80, P1096, DOI 10.1124/mol.111.073833; Desmoulin SK, 2010, MOL PHARMACOL, V78, P577, DOI 10.1124/mol.110.065896; Duddempudi PK, 2013, FEBS J, V280, P2900, DOI 10.1111/febs.12293; Duddempudi PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078301; Eichholzer M, 2001, SWISS MED WKLY, V131, P539; Eisses JF, 2002, J BIOL CHEM, V277, P29162, DOI 10.1074/jbc.M203652200; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; Golani LK, 2014, J MED CHEM, V57, P8152, DOI 10.1021/jm501113m; Harrison RL, 2006, ADV VIRUS RES, V68, P159, DOI 10.1016/S0065-3527(06)68005-6; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Holdsworth SR, 2012, BIOCHIMIE, V94, P1334, DOI 10.1016/j.biochi.2012.03.001; Huc-Brandt S, 2011, BBA-BIOMEMBRANES, V1808, P65, DOI 10.1016/j.bbamem.2010.08.013; Jiang DH, 2013, P NATL ACAD SCI USA, V110, P14664, DOI 10.1073/pnas.1308127110; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Lasry I, 2008, BLOOD, V112, P2055, DOI 10.1182/blood-2008-04-150276; Lasry I, 2009, BIOCHEM BIOPH RES CO, V386, P426, DOI 10.1016/j.bbrc.2009.06.007; Lemieux MJ, 2003, PROTEIN SCI, V12, P2748, DOI 10.1110/ps.03276603; Mahadeo K, 2010, AM J PHYSIOL-CELL PH, V299, pC1153, DOI 10.1152/ajpcell.00113.2010; Meyer E, 2010, MOL GENET METAB, V99, P325, DOI 10.1016/j.ymgme.2009.11.004; Morales-Perez CL, 2016, NATURE, V538, P411, DOI 10.1038/nature19785; Nakai Y, 2007, J PHARMACOL EXP THER, V322, P469, DOI 10.1124/jpet.107.122606; Parker JL, 2014, NATURE, V507, P68, DOI 10.1038/nature13116; Pernstich C, 2014, PROTEIN EXPRES PURIF, V101, P68, DOI 10.1016/j.pep.2014.05.011; Qin TT, 2015, SCI REP-UK, V5, DOI 10.1038/srep12044; Qiu A, 2007, AM J PHYSIOL-CELL PH, V293, pC1669, DOI 10.1152/ajpcell.00202.2007; Qiu AD, 2006, CELL, V127, P917, DOI 10.1016/j.cell.2006.09.041; Shin D.S., 2012, AM J PHYSL CELL PHYS; Shin DS, 2012, AM J PHYSIOL-CELL PH, V303, pC834, DOI 10.1152/ajpcell.00171.2012; Shin DS, 2011, MOL GENET METAB, V103, P33, DOI 10.1016/j.ymgme.2011.01.008; Shin DS, 2010, BLOOD, V116, P5162, DOI 10.1182/blood-2010-06-291237; Tao YY, 2015, NATURE, V527, P259, DOI 10.1038/nature15391; Unal ES, 2008, BBA-BIOMEMBRANES, V1778, P1407, DOI 10.1016/j.bbamem.2008.03.009; Vinnicombe HG, 1999, BIOCHEM SOC T, V27, P53, DOI 10.1042/bst0270053; Visentin M, 2014, ANNU REV PHYSIOL, V76, P251, DOI 10.1146/annurev-physiol-020911-153251; Wisedchaisri G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5521; Zhang DD, 2015, NATURE, V520, P317, DOI 10.1038/nature14287; Zhang Z, 2016, CELL, V167, P1586, DOI 10.1016/j.cell.2016.11.014; Zhao RB, 2008, MOL PHARMACOL, V74, P854, DOI 10.1124/mol.108.045443; Zhao RB, 2010, BIOCHEMISTRY-US, V49, P2925, DOI 10.1021/bi9021439	51	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177572	10.1371/journal.pone.0177572	http://dx.doi.org/10.1371/journal.pone.0177572			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493963	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314300138
J	Opoku-Acheampong, AB; Henningson, JN; Beck, AP; Lindshield, BL				Opoku-Acheampong, Alexander B.; Henningson, Jamie N.; Beck, Amanda P.; Lindshield, Brian L.			5 alpha-reductase 1 mRNA levels are positively correlated with TRAMP mouse prostate most severe lesion scores	PLOS ONE			English	Article							ANDROGEN RECEPTOR; TRANSGENIC MOUSE; STEROID 5-ALPHA-REDUCTASE; GENE-EXPRESSION; CANCER; MODEL; PROGRESSION; CARCINOMA; ENZYMES; TYPE-1	Background The contribution of 5 alpha-reductase 1 and 5 alpha-reductase 2 to prostate cancer development and progression is not clearly understood. TRAMP mice are a common prostate cancer model, in which 5 alpha-reductase 1 and 5 alpha-reductase 2 expression levels, along with prostate lesions scores, have not been investigated at different time points to further understand prostate carcinogenesis. Method/Principal findings To this end, 8-, 12-, 16-, and 20-week-old male C57BL/6TRAMP x FVB mice prostate most severe and most common lesion scores, 5 alpha-reductase 1 and 5 alpha-reductase 2 in situ hybridization expression, and Ki-67, androgen receptor, and apoptosis immunohistochemistry levels were measured. Levels of these markers were quantified in prostate epithelium, hyperplasia, and tumors sections. Mice developed low- to high-grade prostatic intraepithelial neoplasia at 8 weeks as the most severe and most common lesions, and moderate-and high-grade prostatic intraepithelial neoplasia at 12 and 16 weeks as the most severe lesion in all lobes. Moderately differentiated adenocarcinoma was observed at 20 weeks in all lobes. Poorly differentiated carcinoma was not observed in any lobe until 12-weeks-old. 5 alpha-reductase 1 and 5 alpha-reductase 2 were not significantly decreased in tumors compared to prostate epithelium and hyperplasia in all groups, while proliferation, apoptosis, and androgen receptor were either notably or significantly decreased in tumors compared with prostate epithelium and hyperplasia in most or all groups. Prostate 5 alpha R1 levels were positively correlated with adjusted prostate most severe lesion scores. Conclusion Downregulation of androgen receptor and 5 alpha-reductase 2, along with upregulation of 5 alpha-reductase 1 in tumors may promote prostatic intraepithelial neoplasia and prostate cancer development in TRAMP mice.	[Opoku-Acheampong, Alexander B.; Lindshield, Brian L.] Kansas State Univ, Dept Food Nutr Dietet & Hlth, Manhattan, KS 66506 USA; [Henningson, Jamie N.] Kansas State Univ, Coll Vet Med, Manhattan, KS 66506 USA; [Beck, Amanda P.] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA	Kansas State University; Kansas State University; Yeshiva University; Albert Einstein College of Medicine	Lindshield, BL (corresponding author), Kansas State Univ, Dept Food Nutr Dietet & Hlth, Manhattan, KS 66506 USA.	blindsh@k-state.edu		Opoku-Acheampong, Alexander/0000-0002-4589-3776	National Institute of Health COBRE Epithelial Function in Health & Disease (NIH from NCRR) [P20-RR017686]; Johnson Center for Basic Cancer Research at Kansas State University	National Institute of Health COBRE Epithelial Function in Health & Disease (NIH from NCRR); Johnson Center for Basic Cancer Research at Kansas State University	This work was supported by National Institute of Health (https://www.nih.gov) COBRE Epithelial Function in Health & Disease (NIH-Grant No: P20-RR017686 from NCRR) and the Johnson Center for Basic Cancer Research at Kansas State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge Nicole M. Fiorentino of the Department of Food, Nutrition, Dietetics and Health, Kansas State University, and staff, especially Jennifer Phinney, of the Kansas State University Histology and Immunohistochemistry laboratory for their support during the immunohistochemistry and in situ hybridization experiments.	Andriole GL, 2004, UROLOGY, V64, P537, DOI 10.1016/j.urology.2004.04.084; BASSALYK LS, 1983, ARK PATOL, V45, P23; Berman-Booty LD, 2012, TOXICOL PATHOL, V40, P5, DOI 10.1177/0192623311425062; Bjelfman C, 1997, J CLIN ENDOCR METAB, V82, P2210, DOI 10.1210/jc.82.7.2210; Chiaverotti T, 2008, AM J PATHOL, V172, P236, DOI 10.2353/ajpath.2008.070602; Conlon LE, 2015, NUTR RES, V35, P882, DOI 10.1016/j.nutres.2015.07.003; derstro TG, 2001, J CLIN ENDOCR METAB, V86, P855; Gingrich JR, 1999, PROSTATE CANCER P D, V2, P70, DOI 10.1038/sj/pcan/4500296; Gingrich JR, 1996, CANCER RES, V56, P4096; Gingrich JR, 1997, CANCER RES, V57, P4687; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Grossmann ME, 2001, JNCI-J NATL CANCER I, V93, P1687, DOI 10.1093/jnci/93.22.1687; Habib FK, 2003, CLIN CANCER RES, V9, P1815; Harris TJ, 2009, PROQUEST; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hurwitz Arthur A, 2001, Curr Protoc Immunol, VChapter 20, DOI 10.1002/0471142735.im2005s45; Iehle C, 1999, J STEROID BIOCHEM, V68, P189, DOI 10.1016/S0960-0760(99)00030-8; Kaplan-Lefko PJ, 2003, PROSTATE, V55, P219, DOI 10.1002/pros.10215; Luo J, 2003, PROSTATE, V57, P134, DOI 10.1002/pros.10284; Murti K, 2010, MED J INDONES, V19, P5; Nakamura Y, 2005, ENDOCR-RELAT CANCER, V12, P101, DOI 10.1677/erc.1.00914; NILSSON S, 1991, ACTA ONCOL, V30, P177, DOI 10.3109/02841869109092346; Opoku-Acheampong AB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077738; Parekh DJ, 2011, RECENT RESULTS CANC, V188, P109, DOI 10.1007/978-3-642-10858-7_9; RUSSELL DW, 1994, ANNU REV BIOCHEM, V63, P25, DOI 10.1146/annurev.bi.63.070194.000325; Shirakawa T, 2004, PROSTATE, V58, P33, DOI 10.1002/pros.10313; So AI, 2003, WORLD J UROL, V21, P325, DOI 10.1007/s00345-003-0373-9; Thomas LN, 2008, EUR UROL, V53, P244, DOI 10.1016/j.eururo.2007.10.052; Thomas LN, 2008, J UROLOGY, V179, P147, DOI 10.1016/j.juro.2007.08.155; Tien A. H., 2013, ANDROGEN RESPONSIVE, P135; Titus MA, 2005, CLIN CANCER RES, V11, P4365, DOI 10.1158/1078-0432.CCR-04-0738; Wako K, 2008, J CLIN PATHOL, V61, P448, DOI 10.1136/jcp.2007.050906; Wang F, 2011, PROG MOL BIOL TRANSL, V100, P1, DOI 10.1016/B978-0-12-384878-9.00001-7; Wikstrom P, 2005, PROSTATE, V62, P148, DOI 10.1002/pros.20123; Xue LX, 1997, CARCINOGENESIS, V18, P995, DOI 10.1093/carcin/18.5.995; Zeng L, 2005, PROSTATE CANCER P D, V8, P7, DOI 10.1038/sj.pcan.4500757	36	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0175874	10.1371/journal.pone.0175874	http://dx.doi.org/10.1371/journal.pone.0175874			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493878	gold, Green Submitted, Green Published			2022-12-26	WOS:000401314300008
J	Takahashi, M; Komine, K; Imai, H; Okada, Y; Saijo, K; Takahashi, M; Shirota, H; Ohori, H; Takahashi, S; Chiba, N; Mori, T; Shimodaira, H; Ishioka, C				Takahashi, Masanobu; Komine, Keigo; Imai, Hiroo; Okada, Yoshinari; Saijo, Ken; Takahashi, Masahiro; Shirota, Hidekazu; Ohori, Hisatsugu; Takahashi, Shin; Chiba, Natsuko; Mori, Takahiro; Shimodaira, Hideki; Ishioka, Chikashi			Efficacy and safety of gemcitabine plus docetaxel in Japanese patients with unresectable or recurrent bone and soft tissue sarcoma: Results from a single-institutional analysis	PLOS ONE			English	Article							RANDOMIZED PHASE-II; COMBINATION CHEMOTHERAPY; REFRACTORY OSTEOSARCOMA; LEIOMYOSARCOMA; TRABECTEDIN; MULTICENTER; DACARBAZINE; DOXORUBICIN; IFOSFAMIDE; STANDARD	Background Combination therapy with gemcitabine and docetaxel has been reported to be a good therapeutic strategy for patients with soft tissue sarcoma. The aim of the present study was to analyze the efficacy and toxicity of gemcitabine with docetaxel in Japanese patients with advanced bone and soft tissue sarcoma. Patients and methods We retrospectively analyzed the effect of gemcitabine and docetaxel therapy on overall response, progression-free survival, overall survival, and toxicity in 42 patients with bone or soft tissue sarcoma who had received the therapy between October 2006 and September 2015, at Tohoku University Hospital. Results The median age was 55 years; 23 patients were men, and 19 were women. Eight had bone sarcoma and 34 had soft tissue sarcoma. Forty patients (95%) had previously been treated with one or more chemotherapeutic regimens. The overall response rate was 6.9% and the disease control rate was 55%. The median progression-free survival was 2.3 months and the median overall survival was 14.3 months. Grade 3 or more neutropenia and febrile neutropenia were observed in 74% and 4.8% of all patients, respectively. Conclusion The response rate was lower and myelosuppression was more frequently observed than in other previous reports. On the other hand, most of toxicities were enough manageable. In addition, some patients had long survival with a good response. Our study supports the notion that gemcitabine and docetaxel therapy is a good therapeutic option for treating patients with advanced soft tissue sarcoma as well as bone sarcoma, also in Asian populations.	[Takahashi, Masanobu; Komine, Keigo; Imai, Hiroo; Okada, Yoshinari; Saijo, Ken; Takahashi, Masahiro; Shirota, Hidekazu; Ohori, Hisatsugu; Takahashi, Shin; Chiba, Natsuko; Mori, Takahiro; Shimodaira, Hideki; Ishioka, Chikashi] Tohoku Univ Hosp, Dept Med Oncol, Aoba Ku, Sendai, Miyagi, Japan; [Takahashi, Masanobu; Komine, Keigo; Imai, Hiroo; Okada, Yoshinari; Saijo, Ken; Takahashi, Masahiro; Shirota, Hidekazu; Takahashi, Shin; Mori, Takahiro; Shimodaira, Hideki; Ishioka, Chikashi] Tohoku Univ, Inst Dev Aging & Canc, Dept Clin Oncol, Aoba Ku, Sendai, Miyagi, Japan; [Chiba, Natsuko] Tohoku Univ, Dept Canc Biol, Inst Dev Aging & Canc, Aoba Ku, Sendai, Miyagi, Japan	Tohoku University; Tohoku University; Tohoku University	Ishioka, C (corresponding author), Tohoku Univ Hosp, Dept Med Oncol, Aoba Ku, Sendai, Miyagi, Japan.; Ishioka, C (corresponding author), Tohoku Univ, Inst Dev Aging & Canc, Dept Clin Oncol, Aoba Ku, Sendai, Miyagi, Japan.	chikashi@tohoku.ac.jp	Imai, Hiroo/AFQ-7814-2022; Takahashi, Shin/AAE-5011-2019	Takahashi, Shin/0000-0001-6695-3099; Masahiro, Takahashi/0000-0001-6820-6011; qi wu, xiao feng/0000-0003-2502-3666; Ishioka, Chikashi/0000-0002-3023-1227; Mori, Takahiro/0000-0001-7324-8574	Ono Pharmaceutical Company; Grants-in-Aid for Scientific Research [16H04690, 15K08962] Funding Source: KAKEN	Ono Pharmaceutical Company; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	M.T. reports receiving research funding from Ono Pharmaceutical Company. C.I. reports receiving lecture fees from Taiho, Chugai, Takeda, Byer, Pfeizer, Mochida, Asahikasei, Bristol-Myers Squibb, Daiichi-Sankyo, Merck Serono, and Novartis, and research funding from Chugai, Taiho, Bristol-Myers Squibb, Daiichi-Sankyo, Merck Serono, Yakult, Ono, and Novartis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTMAN K, 1993, J CLIN ONCOL, V11, P1276, DOI 10.1200/JCO.1993.11.7.1276; Bay JO, 2006, INT J CANCER, V119, P706, DOI 10.1002/ijc.21867; Bramwell V H, 2000, Sarcoma, V4, P103, DOI 10.1080/13577140020008066; Demetri GD, 2016, J CLIN ONCOL, V34, P786, DOI 10.1200/JCO.2015.62.4734; Dickson Mark A., 2015, Sarcoma, V2015, P532478, DOI 10.1155/2015/532478; Dileo P, 2007, CANCER-AM CANCER SOC, V109, P1863, DOI 10.1002/cncr.22609; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fox E, 2012, ONCOLOGIST, V17, P321, DOI 10.1634/theoncologist.2010-0265; Frustaci S, 2001, J CLIN ONCOL, V19, P1238, DOI 10.1200/JCO.2001.19.5.1238; He AN, 2013, INT J CLIN ONCOL, V18, P498, DOI [10.1007/s10147-012-0409-5, 10.1007/s10147-013-0561-6]; Hensley ML, 2002, J CLIN ONCOL, V20, P2824, DOI 10.1200/JCO.2002.11.050; Judson I, 2014, LANCET ONCOL, V15, P415, DOI 10.1016/S1470-2045(14)70063-4; Kawai A, 2015, LANCET ONCOL, V16, P406, DOI 10.1016/S1470-2045(15)70098-7; Linch M, 2014, NAT REV CLIN ONCOL, V11, P187, DOI 10.1038/nrclinonc.2014.26; Maki RG, 2007, J CLIN ONCOL, V25, P2755, DOI 10.1200/JCO.2006.10.4117; MOURIDSEN HT, 1987, EUR J CANCER CLIN ON, V23, P1477, DOI 10.1016/0277-5379(87)90089-7; Navid F, 2008, CANCER, V113, P419, DOI 10.1002/cncr.23586; Palmerini E, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2312-3; Patel SR, 2001, J CLIN ONCOL, V19, P3483, DOI 10.1200/JCO.2001.19.15.3483; Pautier P, 2012, ONCOLOGIST, V17, P1213, DOI 10.1634/theoncologist.2011-0467; Schoffski P, 2016, LANCET, V387, P1629, DOI 10.1016/S0140-6736(15)01283-0; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Song BS, 2014, PEDIATR BLOOD CANCER, V61, P1376, DOI 10.1002/pbc.25035; Takano T, 2014, INT J CLIN ONCOL, V19, P897, DOI 10.1007/s10147-013-0627-5; Talbot SM, 2003, CANCER-AM CANCER SOC, V98, P1942, DOI 10.1002/cncr.11730; Tanaka K, 2016, WORLD J SURG ONCOL, V14, DOI 10.1186/s12957-016-1059-2; van der Graaf WTA, 2012, LANCET, V379, P1879, DOI 10.1016/S0140-6736(12)60651-5; Volkova M, 2011, CURR CARDIOL REV, V7, P214, DOI 10.2174/157340311799960645	28	10	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176972	10.1371/journal.pone.0176972	http://dx.doi.org/10.1371/journal.pone.0176972			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489919	gold, Green Published, Green Submitted			2022-12-26	WOS:000401314100039
J	Ghosh, PK; Debu, DT; French, DA; Herzog, JB				Ghosh, Pijush K.; Debu, Desalegn T.; French, David A.; Herzog, Joseph B.			Calculated thickness dependent plasmonic properties of gold nanobars in the visible to near-infrared light regime	PLOS ONE			English	Article							OPTICAL-PROPERTIES; FIELD ENHANCEMENT; SINGLE; POLARIZATION; SCATTERING; RESONANCE; SHAPE; SIZE; NANOPARTICLES; MORPHOLOGY	Metallic, especially gold, nanostructures exhibit plasmonic behavior in the visible to nearinfrared light range. In this study, we investigate optical enhancement and absorption of gold nanobars with different thicknesses for transverse and longitudinal polarizations using finite element method simulations. This study also reports on the discrepancy in the resonance wavelengths and optical enhancement of the sharp-corner and round-corner nanobars of constant length 100 nm and width 60 nm. The result shows that resonance amplitude and wavelength have strong dependences on the thickness of the nanostructure as well as the sharpness of the corners, which is significant since actual fabricated structure often have rounded corners. Primary resonance mode blue-shifts and broadens as the thickess increases due to decoupling of charge dipoles at the surface for both polarizations. The broadening effect is characterized by measuring the full width at half maximum of the spectra. We also present the surface charge distribution showing dipole mode oscillations at resonance frequency and multimode resonance indicating different oscillation directions of the surface charge based on the polarization direction of the field. Results of this work give insight for precisely tuning nanobar structures for sensing and other enhanced optical applications.	[Ghosh, Pijush K.; Debu, Desalegn T.; French, David A.; Herzog, Joseph B.] Univ Arkansas, Dept Phys, Fayetteville, AR 72701 USA; [Ghosh, Pijush K.] Univ Arkansas, Dept Elect Engn, Fayetteville, AR 72701 USA	University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas System; University of Arkansas Fayetteville	Herzog, JB (corresponding author), Univ Arkansas, Dept Phys, Fayetteville, AR 72701 USA.	jbherzog@uark.edu	Debu, Desalegn T./ABC-2805-2020; Herzog, Joseph/I-5389-2019	Herzog, Joseph/0000-0003-2441-6169	Arkansas Biosciences Institute	Arkansas Biosciences Institute	Support was provided by Arkansas Biosciences Institute, the major research component of the Arkansas Tobacco Settlement Proceeds Act of 2000 [http://arbiosciences.org]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbey GP, 2016, P SOC PHOTO-OPT INS; Catchpole KR, 2008, OPT EXPRESS, V16, P21793, DOI 10.1364/OE.16.021793; Chen HJ, 2013, CHEM SOC REV, V42, P2679, DOI 10.1039/c2cs35367a; Choy T. C., 2015, EFFECTIVE MEDIUM THE, V165; Dai H, 2012, OPT EXPRESS, V20, pA502, DOI 10.1364/OE.20.00A502; Derkacs D, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2336629; Ekinci Y, 2008, J APPL PHYS, V104, DOI 10.1063/1.2999370; Farahani JN, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.017402; Fernandez-Lopez C, 2015, ACS APPL MATER INTER, V7, P12530, DOI 10.1021/am5087209; Ferry VE, 2010, OPT EXPRESS, V18, pA237, DOI 10.1364/OE.18.00A237; Giannini R, 2015, J PHYS CHEM C, V119, P6138, DOI 10.1021/jp509245u; Giannini V, 2010, OPT EXPRESS, V18, P2797, DOI 10.1364/OE.18.002797; Herzog JB, 2014, NANO LETT, V14, P499, DOI 10.1021/nl403510u; Herzog JB, 2013, NANO LETT, V13, P1359, DOI 10.1021/nl400363d; Huang YJ, 2011, NANOSCALE, V3, P3228, DOI 10.1039/c1nr10336a; Huang Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep23159; Jain PK, 2010, CHEM PHYS LETT, V487, P153, DOI 10.1016/j.cplett.2010.01.062; JOHNSON PB, 1972, PHYS REV B, V6, P4370, DOI 10.1103/PhysRevB.6.4370; Kelly KL, 2003, J PHYS CHEM B, V107, P668, DOI 10.1021/jp026731y; Knight MW, 2012, NANO LETT, V12, P6000, DOI 10.1021/nl303517v; Kooij ES, 2006, PHYS CHEM CHEM PHYS, V8, P3349, DOI 10.1039/b518389h; Kreibig U., 2013, OPTICAL PROPERTIES M; Langhammer C, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2734550; Li XF, 2011, OPT EXPRESS, V19, pA888, DOI 10.1364/OE.19.00A888; Macpherson HA, 2012, ACS NANO, V6, P8940, DOI 10.1021/nn3029502; Massa E, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/6/063013; Mokkapati S, 2012, J APPL PHYS, V112, DOI 10.1063/1.4747795; Muhlschlegel P, 2005, SCIENCE, V308, P1607, DOI 10.1126/science.1111886; Muskens OL, 2007, OPT EXPRESS, V15, P17736, DOI 10.1364/OE.15.017736; Ozhikandathil J, 2014, SENSORS-BASEL, V14, P10497, DOI 10.3390/s140610497; Pillai S, 2007, J APPL PHYS, V101, DOI 10.1063/1.2734885; Polavarapu L, 2015, CRYSTENGCOMM, V17, P3727, DOI 10.1039/c5ce00112a; Polavarapu L, 2013, NANOSCALE, V5, P4355, DOI 10.1039/c3nr01244a; Qiu YH, 2016, J PHYS D APPL PHYS, V49, DOI 10.1088/0022-3727/49/18/185107; Raziman TV, 2013, OPT EXPRESS, V21, P21500, DOI 10.1364/OE.21.021500; Saylor C, 2015, J NANOPHOTONICS, V9, DOI 10.1117/1.JNP.9.093053; Schuck PJ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.017402; Shao L, 2015, PHYS CHEM CHEM PHYS, V17, P10861, DOI 10.1039/c5cp00715a; Shiohara A, 2014, NANOSCALE, V6, P9817, DOI 10.1039/c4nr02648a; Song M, 2012, OPT EXPRESS, V20, P22290, DOI 10.1364/OE.20.022290; Sonnichsen C, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.077402; Wang F, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.206806; Wiley BJ, 2007, NANO LETT, V7, P1032, DOI 10.1021/nl070214f; Wissert MD, 2011, OPT EXPRESS, V19, P3686, DOI 10.1364/OE.19.003686; Wu J, 2014, NANO-MICRO LETT, V6, P372, DOI 10.1007/s40820-014-0011-7; Zhang SP, 2011, NANO LETT, V11, P1657, DOI 10.1021/nl200135r	46	16	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177463	10.1371/journal.pone.0177463	http://dx.doi.org/10.1371/journal.pone.0177463			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486554	gold, Green Published			2022-12-26	WOS:000401314000080
J	Tian, HF; Zhang, Y; Shi, Y; Li, XJ; Sun, Q; Liu, L; Zhao, D; Xu, BH				Tian, Huifang; Zhang, Yong; Shi, Yan; Li, Xiujuan; Sun, Qiang; Liu, Li; Zhao, Dong; Xu, Baohong			Epidemiological and aetiological characteristics of hand, foot, and mouth disease in Shijiazhuang City, Hebei province, China, 2009-2012	PLOS ONE			English	Article							ENTEROVIRUS 71 INFECTION; COXSACKIEVIRUS A6; GENETIC-CHARACTERIZATION; CHILDREN; RECOMBINATION; PATTERNS; MALAYSIA; A16; OUTBREAK; JAPAN	Large outbreaks of hand, foot, and mouth disease (HFMD) have repeatedly occurred in mainland of China since 2007. In this study, we investigated the epidemiological and aetiological characteristics of HFMD in Shijiazhuang City, one of the biggest northern cities of China. A total of 57,173 clinical HFMD cases, including 911 severe and 32 fatal cases, were reported in Shijiazhuang City during 2009-2012. The disease incidence peaked during March-July, with a small increase in the number of cases observed in November of each year. Seventeen potential HFMD-causing enterovirus serotypes were detected, with the most frequent serotypes being EV-A71 and CV-A16. CV-A10 was also a frequently detected causative serotype, and was associated with the second largest number of severe HFMD cases, following EV-A71. Phylogenetic analysis revealed that all EV-A71, CV-A16 and CV-A10 strains from Shijiazhuang City had co-evolved and co-circulated with those from other Chinese provinces. Our findings underscore the need for enhanced surveillance and molecular detection for HFMD, and suggest that EV-A71 vaccination may be an effective intervention strategy for HFMD prevention and vaccines against CV-A10 and CV-A16 are also urgently needed.	[Tian, Huifang; Shi, Yan; Li, Xiujuan; Liu, Li; Zhao, Dong; Xu, Baohong] Shijiazhuang Ctr Dis Control & Prevent, Shijiazhuang, Hebei Province, Peoples R China; [Zhang, Yong; Sun, Qiang] Natl Hlth & Family Planning Commiss China, WHO WPRO Reg Polio Reference Lab, Beijing, Peoples R China; [Zhang, Yong; Sun, Qiang] Natl Hlth & Family Planning Commiss China, Key Lab Med Virol, Beijing, Peoples R China; [Zhang, Yong; Sun, Qiang] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Sun, Qiang] Chinese Acad Sci, State Key Lab Mol Dev Biol, Inst Genet & Dev Biol, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Tian, HF (corresponding author), Shijiazhuang Ctr Dis Control & Prevent, Shijiazhuang, Hebei Province, Peoples R China.	fang45530@126.com	li, xiu/GXV-1745-2022	Zhang, Yong/0000-0002-2692-5437	National Natural Science Foundation of China [81672070]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by the National Natural Science Foundation of China (project no. 81672070).	Bian LL, 2015, EXPERT REV ANTI-INFE, V13, P1061, DOI 10.1586/14787210.2015.1058156; Cardosa MJ, 1999, LANCET, V354, P987, DOI 10.1016/S0140-6736(98)11032-2; Chan YF, 2012, TROP BIOMED, V29, P451; Chang L, 2007, NEW ENGL J MED, V356, P1226, DOI 10.1056/NEJMoa065954; Chen L, 2012, MOL MED REP, V5, P1001, DOI 10.3892/mmr.2012.742; Cui AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061451; Deng T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056943; Gaunt E, 2015, J GEN VIROL, V96, P1067, DOI 10.1099/vir.0.000062; Guan HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142733; Gui JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139109; Han JF, 2014, J INFECTION, V69, P303, DOI 10.1016/j.jinf.2014.03.015; He YQ, 2013, J CLIN MICROBIOL, V51, P3560, DOI 10.1128/JCM.01231-13; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hu YF, 2011, J CLIN MICROBIOL, V49, P2426, DOI 10.1128/JCM.00007-11; Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302; Huang XY, 2015, SCI REP-UK, V5, DOI 10.1038/srep08904; Iwai M, 2009, JPN J INFECT DIS, V62, P254; Kroneman A, 2011, J CLIN VIROL, V51, P121, DOI 10.1016/j.jcv.2011.03.006; Laga AC, 2016, J CUTANEOUS PATHOLOG; Letsas Konstantinos P, 2007, J Infect, V54, pe75, DOI 10.1016/j.jinf.2006.04.006; Lim CT, 2015, EPIDEMIOL INFECT, P1; Linsuwanon P, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-16; Liu WY, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0096051, 10.1371/journal.pone.0088077]; Liu WD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131311; Liu XL, 2014, ARCH VIROL, V159, P2497, DOI 10.1007/s00705-014-2067-6; LIU Y, 2011, PLOS GENET, V7, DOI DOI 10.1371/JOURNAL.PONE.0063447; Liu Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117626; Ni H, 2012, J CLIN VIROL, V54, P342, DOI DOI 10.1016/J.JCV; Oberste MS, 2006, J GEN VIROL, V87, P119, DOI 10.1099/vir.0.81179-0; Ooi MH, 2010, LANCET NEUROL, V9, P1097, DOI 10.1016/S1474-4422(10)70209-X; Podin Y, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-180; Qiaoyun F, 2012, ARCH VIROL; Schuffenecker I, 2011, J CLIN VIROL, V50, P50, DOI 10.1016/j.jcv.2010.09.019; Shimizu H, 1999, JPN J INFECT DIS, V52, P12; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Takahashi S, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001958; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teoh HL, 2016, JAMA NEUROL, V73, P300, DOI 10.1001/jamaneurol.2015.4388; Tian HF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084233; Tian XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090379; Urashima M, 2003, JPN J INFECT DIS, V56, P48; van der Sanden S, 2009, J CLIN MICROBIOL, V47, P2826, DOI 10.1128/JCM.00507-09; Wang JF, 2013, GEOSPATIAL HEALTH, V7, P381, DOI 10.4081/gh.2013.95; Wang JF, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-25; Wang Y, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0308-2; Wang Y, 2011, EPIDEMIOLOGY, V22, P781, DOI 10.1097/EDE.0b013e318231d67a; Wu Y, 2010, INT J INFECT DIS, V14, pE1076, DOI 10.1016/j.ijid.2010.07.006; Xing WJ, 2014, LANCET INFECT DIS, V14, P308, DOI 10.1016/S1473-3099(13)70342-6; Yan JJ, 2000, J CLIN VIROL, V17, P13, DOI 10.1016/S1386-6532(00)00067-6; Zeng HR, 2015, SCI REP-UK, V5, DOI 10.1038/srep10550; Zhang Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep17291; Zhang Y, 2013, BIOMED ENVIRON SCI, V26, P875, DOI 10.3967/bes2013.015; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027895; Zhang Y, 2010, J CLIN MICROBIOL, V48, P619, DOI 10.1128/JCM.02338-09; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhuang DF, 2014, INT J ENVIRON HEAL R, V24, P1, DOI 10.1080/09603123.2013.769206	56	14	21	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0176604	10.1371/journal.pone.0176604	http://dx.doi.org/10.1371/journal.pone.0176604			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486500	gold, Green Published, Green Submitted			2022-12-26	WOS:000401314000017
J	D'Amour, S; Harris, LR				D'Amour, Sarah; Harris, Laurence R.			Perceived face size in healthy adults	PLOS ONE			English	Article							IMPLICIT BODY REPRESENTATIONS; ANOREXIA-NERVOSA; IMAGE DISTORTIONS; PERCEPTION; DISTURBANCES; ACCURACY; SELF	Perceptual body size distortions have traditionally been studied using subjective, qualitative measures that assess only one type of body representation-the conscious body image. Previous research on perceived body size has typically focused on measuring distortions of the entire body and has tended to overlook the face. Here, we present a novel psychophysical method for determining perceived body size that taps into implicit body representation. Using a two-alternative forced choice (2AFC), participants were sequentially shown two life-size images of their own face, viewed upright, upside down, or tilted 90 degrees. In one interval, the width or length dimension was varied, while the other interval contained an undistorted image. Participants reported which image most closely matched their own face. An adaptive staircase adjusted the distorted image to hone in on the image that was equally likely to be judged as matching their perceived face as the accurate image. When viewed upright or upside down, face width was overestimated and length underestimated, whereas perception was accurate for the on-side views. These results provide the first psychophysically robust measurements of how accurately healthy participants perceive the size of their face, revealing distortions of the implicit body representation independent of the conscious body image.	[D'Amour, Sarah; Harris, Laurence R.] York Univ, Dept Psychol, Ctr Vis Res, Toronto, ON, Canada	York University - Canada	D'Amour, S (corresponding author), York Univ, Dept Psychol, Ctr Vis Res, Toronto, ON, Canada.	saod16@yorku.ca	Harris, Laurence/AAT-9549-2021	Harris, Laurence/0000-0002-7154-8757	Natural Sciences and Engineering Council of Canada (NSERC); PGS-D3 NSERC graduate scholarship; NSERC CREATE grant	Natural Sciences and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); PGS-D3 NSERC graduate scholarship; NSERC CREATE grant	This work was supported by the Natural Sciences and Engineering Council of Canada (NSERC) grant to LRH. SD was supported by a PGS-D3 NSERC graduate scholarship and an NSERC CREATE grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Natural Sciences and Engineering Council of Canada (NSERC) grant to LRH. SD was supported by a PGS-D3 NSERC graduate scholarship and an NSERC CREATE grant.	Apps MAJ, 2015, CEREB CORTEX, V25, P46, DOI 10.1093/cercor/bht199; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BRODIE DA, 1989, PERCEPT MOTOR SKILL, V69, P723, DOI 10.2466/pms.1989.69.3.723; Brooks KR, 2016, FRONT NEUROSCI, V10, P1; BRUCH H, 1962, PSYCHOSOM MED, V24, P187, DOI 10.1097/00006842-196203000-00009; Cardini F, 2011, J COGNITIVE NEUROSCI, V23, P503, DOI 10.1162/jocn.2010.21484; Cash TF, 1997, INT J EAT DISORDER, V22, P107, DOI 10.1002/(SICI)1098-108X(199709)22:2&lt;107::AID-EAT1&gt;3.0.CO;2-J; Coetzee V, 2009, PERCEPTION, V38, P1700, DOI 10.1068/p6423; Cooper EA, 2012, J VISION, V12, DOI 10.1167/12.5.8; COOPER PJ, 1987, INT J EAT DISORDER, V6, P485, DOI 10.1002/1098-108X(198707)6:4<485::AID-EAT2260060405>3.0.CO;2-O; Eshkevari E, 2012, PSYCHOL MED, V42, P819, DOI 10.1017/S0033291711002091; Farrell C, 2005, EUR EAT DISORD REV, V13, P75, DOI 10.1002/erv.622; Frassinetti F, 2008, J COGNITIVE NEUROSCI, V20, P1507, DOI 10.1162/jocn.2008.20067; Fuentes CT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076805; Fuentes CT, 2013, ACTA PSYCHOL, V144, P344, DOI 10.1016/j.actpsy.2013.06.012; Fuentes CT, 2013, J NEUROL NEUROSUR PS, V84, P201, DOI 10.1136/jnnp-2012-304001; Gardner RM, 2014, PSYCHIAT RES, V219, P407, DOI 10.1016/j.psychres.2014.06.029; Gardner RM, 2010, PERS INDIV DIFFER, V49, P794, DOI 10.1016/j.paid.2010.07.001; Gardner RM, 2010, PERS INDIV DIFFER, V48, P107, DOI 10.1016/j.paid.2009.08.017; Gardner RM, 1996, J CLIN PSYCHOL, V52, P3, DOI 10.1002/(SICI)1097-4679(199601)52:1<3::AID-JCLP1>3.0.CO;2-X; Gardner RM, 2004, BEHAV RES METH INS C, V36, P89, DOI 10.3758/BF03195553; GLEGHORN AA, 1987, J PSYCHOPATHOL BEHAV, V9, P203, DOI 10.1007/BF00960575; Green D., 1966, SOCIETY, V1, P521, DOI [10.1901/jeab.1969.12-475, DOI 10.1901/JEAB.1969.12-475]; Hrabosky JI, 2009, BODY IMAGE, V6, P155, DOI 10.1016/j.bodyim.2009.03.001; KEETON WP, 1990, J PERS ASSESS, V54, P213, DOI 10.1207/s15327752jpa5401&2_21; Keizer A, 2014, NEUROPSYCHOLOGIA, V62, P26, DOI 10.1016/j.neuropsychologia.2014.07.003; Keyes H, 2010, BRAIN COGNITION, V72, P244, DOI 10.1016/j.bandc.2009.09.006; Leopold DA, 2010, J COMP PSYCHOL, V124, P233, DOI 10.1037/a0019460; Linkenauger SA, 2015, J EXP PSYCHOL GEN, V144, P103, DOI 10.1037/xge0000028; Linkenauger SA, 2009, PSYCHOL SCI, V20, P1373, DOI 10.1111/j.1467-9280.2009.02447.x; Longo MR, 2017, Q J EXP PSYCHOL, V70, P378, DOI 10.1080/17470218.2016.1143956; Longo MR, 2015, ACTA PSYCHOL, V160, P77, DOI 10.1016/j.actpsy.2015.07.002; Longo MR, 2015, COGNITION, V142, P230, DOI 10.1016/j.cognition.2015.05.024; Longo MR, 2015, EUR PSYCHOL, V20, P6, DOI 10.1027/1016-9040/a000198; Longo MR, 2012, ACTA PSYCHOL, V141, P164, DOI 10.1016/j.actpsy.2012.07.015; Longo MR, 2012, J EXP PSYCHOL HUMAN, V38, P9, DOI 10.1037/a0025428; Longo MR, 2011, J EXP PSYCHOL HUMAN, V37, P720, DOI 10.1037/a0021921; Longo MR, 2010, P NATL ACAD SCI USA, V107, P11727, DOI 10.1073/pnas.1003483107; Macmillan NA, 2005, DETECTION THEORY USE; Mai S, 2015, BIOL PSYCHOL, V108, P105, DOI 10.1016/j.biopsycho.2015.03.013; Mancini F, 2011, PSYCHOL SCI, V22, P325, DOI 10.1177/0956797611398496; Mancini F, 2011, NEUROPSYCHOLOGIA, V49, P1194, DOI 10.1016/j.neuropsychologia.2010.12.040; McCabe Marita P, 2006, Body Image, V3, P163, DOI 10.1016/j.bodyim.2006.01.004; Mohr HM, 2011, NEUROIMAGE, V56, P1822, DOI 10.1016/j.neuroimage.2011.02.069; MOLINARI E, 1995, PERCEPT MOTOR SKILL, V81, P23, DOI 10.2466/pms.1995.81.1.23; Mussap AJ, 2008, BODY IMAGE, V5, P80, DOI 10.1016/j.bodyim.2007.07.003; NELSON CL, 1993, ADDICT BEHAV, V18, P503, DOI 10.1016/0306-4603(93)90067-J; Pazzaglia M, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/9834340; Peterson M, 2003, AM J HEALTH BEHAV, V27, P355, DOI 10.5993/AJHB.27.4.7; PROBST M, 1995, BEHAV RES THER, V33, P985, DOI 10.1016/0005-7967(95)00037-X; Sand L, 2011, BODY IMAGE, V8, P275, DOI 10.1016/j.bodyim.2011.03.004; Saulton A, 2015, EXP BRAIN RES, V233, P1471, DOI 10.1007/s00221-015-4221-0; SLADE PD, 1973, PSYCHOL MED, V3, P188, DOI 10.1017/S0033291700048510; Smeets MAM, 1997, BRIT J CLIN PSYCHOL, V36, P263, DOI 10.1111/j.2044-8260.1997.tb01412.x; Stephen ID, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01223; Stice E, 2002, J PSYCHOSOM RES, V53, P985, DOI 10.1016/S0022-3999(02)00488-9; Sturman D, 2017, INDEPENDENT AFTEREFF, P1; THOMPSON JK, 1988, INT J EAT DISORDER, V7, P521, DOI 10.1002/1098-108X(198807)7:4<521::AID-EAT2260070410>3.0.CO;2-H; Thompson JK, 1996, BODY IMAGE EATING DI, P49; Thompson P, 2012, I-PERCEPTION, V3, P765, DOI 10.1068/i0554; Urdapilleta I, 2010, PSYCHOL SPORT EXERC, V11, P568, DOI 10.1016/j.psychsport.2010.06.006; VITOUSEK K, 1994, J ABNORM PSYCHOL, V103, P137, DOI 10.1037/0021-843X.103.1.137; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828	64	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177349	10.1371/journal.pone.0177349	http://dx.doi.org/10.1371/journal.pone.0177349			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UJ	28481928	gold, Green Published, Green Submitted			2022-12-26	WOS:000401313700054
J	Weller, SA; Latham, J				Weller, Simon A.; Latham, Jennie			High stringency evaluation of the inactivation / exclusion efficacy of a MALDI-TOF MS chemical extraction method, with filtration of extract through 0.1 mu m filters, on Bacillus anthracis Vollum vegetative cells and spores	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; MASS-SPECTROMETRY; IDENTIFICATION; RESISTANCE	A previous report indicated that a formic acid chemical extraction method for the preparation of protein extracts for matrix-assisted laser desorption time-of-flight mass spectrometry (MALDI-TOF MS) identification, with filtration of extracts through 0.2 mu m regenerated cellulose (RC) filters, would not reliably inactivate or exclude Bacillus anthracis Vollum cells or spores when tested under high stringency conditions. B. anthracis was recovered from 13/36 extracts (3/18 from vegetative cell extracts and 10/18 from bacterial spore extracts). In this paper we report the repetition of this study but with the substitution of the 0.2 mu m, regenerated cellulose, filters with 0.1 mu m polyvinylidene fluoride (PVDF) filters. Experiments were conducted under the same high stringency post-treatment viability test methods (100% of resulting protein content; 7 days Luria (L)-broth and a further 7 days L-agar plate incubation; or 7 days L-agar plate only incubation). B. anthracis was not recovered from any of 18 replicates generated from high concentrations of vegetative cells (10(7) to 10(8) cfu), but a single B. anthracis colony was recovered from one of 18 replicates generated from high concentrations of bacterial spores (10(8) cfu), using a post-treatment viability culture method of 7 days on L-agar plate only. We discuss our results in the context of other similar studies and also a requirement to develop standardised post-treatment viability test methods.	[Weller, Simon A.; Latham, Jennie] Minist Def, Def & Sci Technol Lab, CBR Div, Salisbury, Wilts, England	Defence Science & Technology Laboratory	Weller, SA (corresponding author), Minist Def, Def & Sci Technol Lab, CBR Div, Salisbury, Wilts, England.	sweller@dstl.gov.uk		Weller, Simon/0000-0001-9286-2991	Biological Evaluation & Detection Group (CBR Division, Dstl) Capability Development funding	Biological Evaluation & Detection Group (CBR Division, Dstl) Capability Development funding	This study was funded using Biological Evaluation & Detection Group (CBR Division, Dstl) Capability Development funding. The authorising officer of this funding approved submission of this manuscript but had no role in study design, data collection, or analysis. The views in this paper may not reflect those of the UK Ministry of Defence.	ABSHIRE RL, 1980, APPL ENVIRON MICROB, V39, P695, DOI 10.1128/AEM.39.4.695-701.1980; Carrera M, 2007, J APPL MICROBIOL, V102, P303, DOI 10.1111/j.1365-2672.2006.03111.x; Centers for Disease Control and Prevention, 2014, REP POT EXP ANTHR; Croxatto A, 2012, FEMS MICROBIOL REV, V36, P380, DOI 10.1111/j.1574-6976.2011.00298.x; Daltonics B., 2011, REVISION, V2, P157; Dauphin LA, 2009, J MICROBIOL METH, V76, P212, DOI 10.1016/j.mimet.2008.10.009; Department of Defense, 2015, REV COMM REP IN SHIP; Federal Select Agent Program, 2016, REV FSAP POL STAT IN; Lasch P, 2016, TRENDS ANAL CHEM, V85, P133; Lasch P, 2008, ANAL CHEM, V80, P2026, DOI 10.1021/ac701822j; Millipore Merck, 2014, USER GUIDE ULTRAFREE; Parsons TM., 2013, J BIOTERR BIODEF, VS3, P009, DOI [10.4172/2157-2526.S3-009, DOI 10.4172/2157-2526.S3-009]; Redmond C, 2004, MICROBIOL-SGM, V150, P355, DOI 10.1099/mic.0.26681-0; Russell AD, 1999, J HOSP INFECT, V43, pS57, DOI 10.1016/S0195-6701(99)90066-X; Schulthess B, 2013, J CLIN MICROBIOL, V51, P1834, DOI 10.1128/JCM.02654-12; Thermo Scientific, 2009, TECH TIP 40; Tracz DM, 2016, J CLIN MICROBIOL, V54, P764, DOI 10.1128/JCM.02709-15; Varughese EA, 2007, J MICROBIOL METH, V71, P66, DOI 10.1016/j.mimet.2007.07.011; Weller SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143870; Zeus Industrial Products Inc, 2017, CHEM RES CHART PVDF	20	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177294	10.1371/journal.pone.0177294	http://dx.doi.org/10.1371/journal.pone.0177294			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481931	Green Published, gold, Green Submitted			2022-12-26	WOS:000401313700049
J	Alexander, NS; Katayama, K; Sun, WY; Salom, D; Gulati, S; Zhang, JY; Mogi, M; Palczewski, K; Jastrzebska, B				Alexander, Nathan S.; Katayama, Kota; Sun, Wenyu; Salom, David; Gulati, Sahil; Zhang, Jianye; Mogi, Muneto; Palczewski, Krzysztof; Jastrzebska, Beata			Complex binding pathways determine the regeneration of mammalian green cone opsin with a locked retinal analogue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; COUPLED RECEPTOR RHODOPSIN; VISUAL PIGMENTS; 9-METHYL GROUP; 9-CIS-RETINYL ACETATE; CRYSTAL-STRUCTURE; RPE65 MUTATIONS; COLOR-VISION; MOUSE MODEL; HUMAN RED	Phototransduction is initiated when the absorption of light converts the 11-cis-retinal chromophore to its all-trans configuration in both rod and cone vertebrate photoreceptors. To sustain vision, 11-cis-retinal is continuously regenerated from its all-trans conformation through a series of enzymatic steps comprising the "visual or retinoid" cycle. Abnormalities in this cycle can compromise vision because of the diminished supply of 11-cis-retinal and the accumulation of toxic, constitutively active opsin. As shown previously for rod cells, attenuation of constitutively active opsin can be achieved with the unbleachable analogue, 11-cis-6-membered ring (11-cis-6mr)-retinal, which has therapeutic effects against certain degenerative retinal diseases. However, to discern the molecular mechanisms responsible for this action, pigment regeneration with this locked retinal analogue requires delineation also in cone cells. Here, we compared the regenerative properties of rod and green cone opsins with 11-cis-6mr-retinal and demonstrated that this retinal analogue could regenerate rod pigment but not green cone pigment. Based on structural modeling suggesting that Pro-205 in green cone opsin could prevent entry and binding of 11-cis-6mr-retinal, we initially mutated this residue to Ile, the corresponding residue in rhodopsin. However, this substitution did not enable green cone opsin to regenerate with 11-cis-6mr-retinal. Interestingly, deletion of 16 N-terminal amino acids in green cone opsin partially restored the binding of 11-cis-6mr-retinal. These results and our structural modeling indicate that a more complex binding pathway determines the regeneration of mammalian green cone opsin with chromophore analogues such as 11-cis-6mr-retinal.	[Alexander, Nathan S.; Katayama, Kota; Salom, David; Gulati, Sahil; Zhang, Jianye; Palczewski, Krzysztof; Jastrzebska, Beata] Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA; [Palczewski, Krzysztof; Jastrzebska, Beata] Case Western Reserve Univ, Cleveland Ctr Membrane & Struct Biol, Cleveland, OH 44106 USA; [Sun, Wenyu; Palczewski, Krzysztof] Polgenix Inc, Cleveland, OH 44106 USA; [Mogi, Muneto] Novartis Inst BioMed Res Inc, Cambridge, MA 02139 USA	Case Western Reserve University; Case Western Reserve University; Novartis	Palczewski, K; Jastrzebska, B (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	kxp65@case.edu; bxj27@case.edu		Gulati, Sahil/0000-0002-8255-479X; Salom, David/0000-0002-3208-1509	National Institutes of Health [EY025214, EY009339, EY027283, EY024864, EY025007]; Japan Society for the Promotion of Science; Alcon Research Institute; NATIONAL EYE INSTITUTE [R01EY025214, R24EY027283, R01EY009339, R24EY024864, K99EY025007] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Alcon Research Institute(Novartis); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported National Institutes of Health Grants EY025214 (to B. J.), EY009339 and EY027283 (to K. P.), EY024864 (to T. S. Kern), and EY025007 ( to N. S. A.), Japan Society for the Promotion of Science Overseas Research Fellowship (to K. K.), and an Alcon Research Institute grant (to K. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barth P, 2007, P NATL ACAD SCI USA, V104, P15682, DOI 10.1073/pnas.0702515104; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; BHATTACHARYA S, 1992, J BIOL CHEM, V267, P6763; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Chen Yuanyuan, 2015, Methods Mol Biol, V1271, P369, DOI 10.1007/978-1-4939-2330-4_24; Chun E, 2012, STRUCTURE, V20, P967, DOI 10.1016/j.str.2012.04.010; Das J, 2004, BIOCHEMISTRY-US, V43, P5532, DOI 10.1021/bi036097u; DEGRIP WJ, 1990, EUR J BIOCHEM, V191, P211; Estevez ME, 2009, J GEN PHYSIOL, V134, P137, DOI 10.1085/jgp.200910232; Fan J, 2005, J PHYSIOL-LONDON, V568, P83, DOI 10.1113/jphysiol.2005.091942; FARRENS DL, 1995, J BIOL CHEM, V270, P5073, DOI 10.1074/jbc.270.10.5073; Fotiadis D, 2006, CURR OPIN STRUC BIOL, V16, P252, DOI 10.1016/j.sbi.2006.03.013; Fujimoto K, 2009, B CHEM SOC JPN, V82, P1140, DOI 10.1246/bcsj.82.1140; GANTER UM, 1989, BIOCHEMISTRY-US, V28, P5954, DOI 10.1021/bi00440a036; Garwin GG, 2000, METHOD ENZYMOL, V316, P313; Gulati S, 2017, P NATL ACAD SCI USA, V114, pE2608, DOI 10.1073/pnas.1617446114; HOFMANN KP, 1992, J BIOL CHEM, V267, P15701; Hofmann L, 2015, PROG RETIN EYE RES, V49, P46, DOI 10.1016/j.preteyeres.2015.07.004; HU SH, 1994, BIOCHEMISTRY-US, V33, P408, DOI 10.1021/bi00168a004; Isralewitz B, 1997, BIOPHYS J, V73, P2972, DOI 10.1016/S0006-3495(97)78326-7; Jager S, 1996, BIOCHEMISTRY-US, V35, P2901, DOI 10.1021/bi9524068; Jang GF, 2001, J BIOL CHEM, V276, P26148, DOI 10.1074/jbc.M102212200; Kaufmann KW, 2010, BIOCHEMISTRY-US, V49, P2987, DOI 10.1021/bi902153g; Kelm S, 2010, BIOINFORMATICS, V26, P2833, DOI 10.1093/bioinformatics/btq554; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Kuksa V, 2002, J BIOL CHEM, V277, P42315, DOI 10.1074/jbc.M206014200; Kuwayama S, 2005, BIOCHEMISTRY-US, V44, P2208, DOI 10.1021/bi047994g; Kuwayama S, 2002, BIOCHEMISTRY-US, V41, P15245, DOI 10.1021/bi026444k; Lee J, 2010, PROTEINS, V78, P3428, DOI 10.1002/prot.22849; Lorenz B, 2000, INVEST OPHTH VIS SCI, V41, P2735; MACKENZIE D, 1984, BIOCHEMISTRY-US, V23, P6544, DOI 10.1021/bi00321a041; Maeda T, 2009, INVEST OPHTH VIS SCI, V50, P322, DOI 10.1167/iovs.08-2301; Maeda T, 2009, INVEST OPHTH VIS SCI, V50, P4917, DOI 10.1167/iovs.09-3581; Maeda T, 2009, INVEST OPHTH VIS SCI, V50, P4368, DOI 10.1167/iovs.09-3700; Maeda T, 2009, HUM MOL GENET, V18, P2277, DOI 10.1093/hmg/ddp163; MERBS SL, 1992, NATURE, V356, P433, DOI 10.1038/356433a0; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; OKADA T, 1994, BIOCHEMISTRY-US, V33, P4940, DOI 10.1021/bi00182a024; PALCZEWSKI K, 1994, BIOCHEMISTRY-US, V33, P13741, DOI 10.1021/bi00250a027; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; PAPERMASTER DS, 1982, METHOD ENZYMOL, V81, P48; Perkins BD, 2002, VISUAL NEUROSCI, V19, P257, DOI 10.1017/S0952523802192030; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Salom D, 2006, J STRUCT BIOL, V156, P497, DOI 10.1016/j.jsb.2006.05.003; Senechal A, 2006, AM J OPHTHALMOL, V142, P702, DOI 10.1016/j.ajo.2006.04.057; SHICHIDA Y, 1988, BIOCHEMISTRY-US, V27, P6495, DOI 10.1021/bi00417a044; SHICHIDA Y, 1993, BIOCHEMISTRY-US, V32, P10832, DOI 10.1021/bi00091a039; SPALINK JD, 1983, P NATL ACAD SCI-BIOL, V80, P1887, DOI 10.1073/pnas.80.7.1887; Srinivasan S, 2016, CELL MOL LIFE SCI, V73, P1253, DOI 10.1007/s00018-015-2043-7; Srinivasan S, 2014, CHEM BIOL, V21, P369, DOI 10.1016/j.chembiol.2014.01.006; Thompson DA, 2000, INVEST OPHTH VIS SCI, V41, P4293; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; Van Hooser JP, 2000, METHOD ENZYMOL, V316, P565; Van Hooser JP, 2000, P NATL ACAD SCI USA, V97, P8623, DOI 10.1073/pnas.150236297; Vogel R, 2000, BIOCHEMISTRY-US, V39, P8895, DOI 10.1021/bi000852b; WALD G, 1953, J GEN PHYSIOL, V37, P189, DOI 10.1085/jgp.37.2.189; WALD G, 1955, J GEN PHYSIOL, V38, P623, DOI 10.1085/jgp.38.5.623; Wang T, 2007, J AM CHEM SOC, V129, P6970, DOI 10.1021/ja0691977; Wang T, 2011, J MOL RECOGNIT, V24, P350, DOI 10.1002/jmr.1087; WANG ZY, 1993, BIOCHEMISTRY-US, V32, P2125, DOI 10.1021/bi00060a001	61	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					10983	10997		10.1074/jbc.M117.780478	http://dx.doi.org/10.1074/jbc.M117.780478			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28487362	hybrid, Green Published			2022-12-26	WOS:000404391000020
J	Desmond, PF; Labuza, A; Muriel, J; Markwardt, ML; Mancini, AE; Rizzo, MA; Bloch, RJ				Desmond, Patrick F.; Labuza, Amanda; Muriel, Joaquin; Markwardt, Michele L.; Mancini, Allison E.; Rizzo, Mark A.; Bloch, Robert J.			Interactions between small ankyrin 1 and sarcolipin coordinately regulate activity of the sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM; SKELETAL-MUSCLE; CA2+ TRANSPORT; PHOSPHOLAMBAN; PROTEIN; ISOFORMS; ATPASE; CELLS; FORMS; IDENTIFICATION	SERCA1, the sarco(endo) plasmic reticulum Ca2+-ATPase of skeletal muscle, is essential for muscle relaxation and maintenance of low resting Ca2+ levels in the myoplasm. We recently reported that small ankyrin 1 (sAnk1) interacts with the sarco( endo) plasmic reticulum Ca2+-ATPase in skeletal muscle (SERCA1) to inhibit its activity. We also showed that this interaction is mediated at least in part through sAnk1's transmembrane domain in a manner similar to that of sarcolipin (SLN). Earlier studies have shown that SLN and phospholamban, the other well studied small SERCA-regulatory proteins, oligomerize either alone or together. As sAnk1 is coexpressed with SLN in muscle, we sought to determine whether these two proteins interact with one another when coexpressed exogenously in COS7 cells. Coimmunoprecipitation (coIP) and anisotropy-based FRET (AFRET) assays confirmed this interaction. Our results indicated that sAnk1 and SLN can associate in the sarcoplasmic reticulum membrane and after exogenous expression in COS7 cells in vitro but that their association did not require endogenous SERCA2. Significantly, SLN promoted the interaction between sAnk1 and SERCA1 when the three proteins were coexpressed, and both coIP and AFRET experiments suggested the formation of a complex consisting of all three proteins. Ca2+-ATPase assays showed that sAnk1 ablated SLN's inhibition of SERCA1 activity. These results suggest that sAnk1 interacts with SLN both directly and in complex with SERCA1 and reduces SLN's inhibitory effect on SERCA1 activity.	[Desmond, Patrick F.; Labuza, Amanda; Muriel, Joaquin; Markwardt, Michele L.; Rizzo, Mark A.; Bloch, Robert J.] Univ Maryland, Dept Physiol, Baltimore, MD 21201 USA; [Desmond, Patrick F.; Bloch, Robert J.] Univ Maryland, Program Biochem & Mol Biol, Baltimore, MD 21201 USA; [Labuza, Amanda; Rizzo, Mark A.; Bloch, Robert J.] Univ Maryland, Program Neurosci, Baltimore, MD 21201 USA; [Mancini, Allison E.; Rizzo, Mark A.; Bloch, Robert J.] Univ Maryland, Program Mol Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Bloch, RJ (corresponding author), HSF1 Rm 580C,685 W Baltimore St, Baltimore, MD 21201 USA.	rbloch@som.umaryland.edu		Labuza, Amanda/0000-0002-8298-1521	National Institutes of Health [RO1 DK077140, R01 HL122827A, R01 MH111527A, RO1 AR056330, T32 GM08181, T32 AR 007592]; Kahlert Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056330, T32AR007592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH111527] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kahlert Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by National Institutes of Health Grants RO1 DK077140, R01 HL122827A, and R01 MH111527A (to M. A. R.), National Institutes of Health Grant RO1 AR056330 (to R. J. B.), and The Kahlert Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Training Program in Integrative Membrane Biology Grant T32 GM08181 and Interdisciplinary Training Program in Muscle Biology Grant T32 AR 007592.	Ackermann MA, 2011, J CELL SCI, V124, P3619, DOI 10.1242/jcs.085159; Anderson DM, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaj1460; Anderson DM, 2015, CELL, V160, P595, DOI 10.1016/j.cell.2015.01.009; Armani A, 2006, EXP CELL RES, V312, P3546, DOI 10.1016/j.yexcr.2006.07.027; Asahi M, 1999, J BIOL CHEM, V274, P32855, DOI 10.1074/jbc.274.46.32855; Asahi M, 2003, P NATL ACAD SCI USA, V100, P5040, DOI 10.1073/pnas.0330962100; Asahi M, 2002, J BIOL CHEM, V277, P26725, DOI 10.1074/jbc.C200269200; Autry JM, 2011, J BIOL CHEM, V286, P31697, DOI 10.1074/jbc.M111.246843; Bhupathy P, 2007, J MOL CELL CARDIOL, V42, P903, DOI 10.1016/j.yjmcc.2007.03.738; Birkenmeier CS, 1998, GENOMICS, V50, P79, DOI 10.1006/geno.1998.5305; BIRKENMEIER CS, 1993, J BIOL CHEM, V268, P9533; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bombardier E, 2013, FEBS LETT, V587, P1687, DOI 10.1016/j.febslet.2013.04.019; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; Desmond PF, 2015, J BIOL CHEM, V290, P27854, DOI 10.1074/jbc.M115.676585; Diaz ME, 2005, CELL CALCIUM, V38, P391, DOI 10.1016/j.ceca.2005.06.017; ELETR S, 1972, BIOCHIM BIOPHYS ACTA, V290, P178, DOI 10.1016/0005-2736(72)90062-4; Fajardo VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084304; Fu MH, 2009, AM J PHYSIOL-HEART C, V296, pH1175, DOI 10.1152/ajpheart.01276.2008; Gade P, 2012, P NATL ACAD SCI USA, V109, P10316, DOI 10.1073/pnas.1119273109; Gagelin C, 2002, J BIOL CHEM, V277, P12978, DOI 10.1074/jbc.M111299200; Giacomello E, 2015, AM J PHYSIOL-CELL PH, V308, pC123, DOI 10.1152/ajpcell.00090.2014; Hellstern S, 2001, J BIOL CHEM, V276, P30845, DOI 10.1074/jbc.M102495200; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Kontrogianni-Konstantopoulos A, 2003, MOL BIOL CELL, V14, P1138, DOI 10.1091/mbc.E02-07-0411; Kontrogianni-Konstantopoulos A, 2003, J BIOL CHEM, V278, P3985, DOI 10.1074/jbc.M209012200; Kosk-Kosicka Danuta, 2013, Methods Mol Biol, V937, P343; Lencesova L, 2004, J BIOL CHEM, V279, P2885, DOI 10.1074/jbc.M310365200; MacLennan DH, 2003, ANN NY ACAD SCI, V986, P472, DOI 10.1111/j.1749-6632.2003.tb07231.x; Markwardt ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017896; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; Morita T, 2008, BIOCHEM BIOPH RES CO, V369, P188, DOI 10.1016/j.bbrc.2007.11.098; Nelson BR, 2016, SCIENCE, V351, P271, DOI 10.1126/science.aad4076; Pau G, 2010, BIOINFORMATICS, V26, P979, DOI 10.1093/bioinformatics/btq046; Periasamy M, 2007, MUSCLE NERVE, V35, P430, DOI 10.1002/mus.20745; Piston DW, 2008, METHOD CELL BIOL, V85, P415, DOI 10.1016/S0091-679X(08)85018-2; Porter NC, 2005, MOL MEMBR BIOL, V22, P421, DOI 10.1080/09687860500244262; Rizzo MA, 2005, BIOPHYS J, V88, pL14, DOI 10.1529/biophysj.104.055442; Rizzo MA, 2006, MICROSC MICROANAL, V12, P238, DOI 10.1017/S1431927606060235; Sahoo SK, 2015, J BIOL CHEM, V290, P14057, DOI 10.1074/jbc.M115.636738; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmidt AG, 2002, CARDIOVASC RES, V56, P248, DOI 10.1016/S0008-6363(02)00541-2; Schneider JS, 2013, J MUSCLE RES CELL M, V34, P349, DOI 10.1007/s10974-013-9350-0; Stammers AN, 2015, CAN J PHYSIOL PHARM, V93, P843, DOI 10.1139/cjpp-2014-0463; Toyoshima C, 2003, P NATL ACAD SCI USA, V100, P467, DOI 10.1073/pnas.0237326100; Vangheluwe P, 2006, J MOL CELL CARDIOL, V41, P308, DOI 10.1016/j.yjmcc.2006.05.014; Zhou DX, 1997, J CELL BIOL, V136, P621, DOI 10.1083/jcb.136.3.621	47	14	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					10961	10972		10.1074/jbc.M117.783613	http://dx.doi.org/10.1074/jbc.M117.783613			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28487373	Green Published, hybrid			2022-12-26	WOS:000404391000018
J	Guzy, RD; Li, L; Smith, C; Dorry, SJ; Koo, HY; Chen, L; Ornitz, DM				Guzy, Robert D.; Li, Ling; Smith, Craig; Dorry, Samuel J.; Koo, Hyun Young; Chen, Lin; Ornitz, David M.			Pulmonary fibrosis requires cell-autonomous mesenchymal fibroblast growth factor (FGF) signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						collagen; fibroblast; fibroblast growth factor (FGF); fibroblast growth factor receptor (FGFR); lung injury; myofibroblast; pulmonary fibrosis; bleomycin	HUMAN LUNG FIBROBLASTS; TYROSINE KINASE; ANIMAL-MODELS; MURINE LUNG; BLEOMYCIN; EXPRESSION; PROLIFERATION; RECEPTOR; ADENOCARCINOMA; PIRFENIDONE	Idiopathic pulmonary fibrosis (IPF) is characterized by progressive pulmonary scarring, decline in lung function, and often results in death within 3-5 five years after diagnosis. Fibroblast growth factor (FGF) signaling has been implicated in the pathogenesis of IPF; however, the mechanism through which FGF signaling contributes to pulmonary fibrosis remains unclear. We hypothesized that FGF receptor (FGFR) signaling in fibroblasts is required for the fibrotic response to bleomycin. To test this, mice with mesenchyme-specific tamoxifen-inducible inactivation of FGF receptors 1, 2, and 3 (Col12-CreER; TCKO mice) were lineage labeled and administered intratracheal bleomycin. Lungs were collected for histologic analysis, whole lung RNA and protein, and dissociated for flow cytometry and FACS. Bleomycin-treated Col12-CreER; TCKO mice have decreased pulmonary fibrosis, collagen production, and fewer -smooth muscle actin-positive (SMA+) myofibroblasts compared with controls. Freshly isolated Col12-CreER; TCKO mesenchymal cells from bleomycin-treated mice have decreased collagen expression compared with wild type mesenchymal cells. Furthermore, lineage labeled FGFR-deficient fibroblasts have decreased enrichment in fibrotic areas and decreased proliferation. These data identify a cell autonomous requirement for mesenchymal FGFR signaling in the development of pulmonary fibrosis, and for the enrichment of the Col12-CreER-positive (Col12+) mesenchymal lineage in fibrotic tissue following bleomycin exposure. We conclude that mesenchymal FGF signaling is required for the development of pulmonary fibrosis, and that therapeutic strategies aimed directly at mesenchymal FGF signaling could be beneficial in the treatment of IPF.	[Guzy, Robert D.; Dorry, Samuel J.; Koo, Hyun Young] Univ Chicago, Sect Pulm & Crit Care Med, Dept Med, Chicago, IL 60637 USA; [Guzy, Robert D.; Li, Ling; Smith, Craig; Ornitz, David M.] Washington Univ, Dept Dev Biol, Sch Med, St Louis, MO 63110 USA; [Chen, Lin] Third Mil Med Univ, Daping Hosp, State Key Lab Trauma Burns & Combined Injury, Dept Rehabil Med,Ctr Bone Metab & Repair, Chongqing 400042, Peoples R China	University of Chicago; Washington University (WUSTL); Army Medical University	Guzy, RD (corresponding author), 5841 S Maryland Ave,MC6076, Chicago, IL 60637 USA.	rguzy1@bsd.uchicago.edu		Guzy, Robert/0000-0001-8420-6177; Ornitz, David/0000-0003-1592-7629	National Institutes of Health [HL111190, T32HL007317]; American Heart Association [14FTF19840029]; Washington University Hope Center Alafi Neuroimaging Lab; National Institutes of Health Shared Instrumentation Grant [S10 RR027552]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027552] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111190, T32HL007317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Washington University Hope Center Alafi Neuroimaging Lab; National Institutes of Health Shared Instrumentation Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL111190 and T32HL007317, American Heart Association Grant 14FTF19840029, Washington University Hope Center Alafi Neuroimaging Lab, and a National Institutes of Health Shared Instrumentation Grant S10 RR027552. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arai D, 2015, J PATHOL, V235, P593, DOI 10.1002/path.4486; ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; Blackwell TS, 2014, AM J RESP CRIT CARE, V189, P214, DOI 10.1164/rccm.201306-1141WS; Chaudhary NI, 2007, EUR RESPIR J, V29, P976, DOI 10.1183/09031936.00152106; Coffey E, 2013, J HISTOCHEM CYTOCHEM, V61, P671, DOI 10.1369/0022155413497366; Ding BS, 2014, NATURE, V505, P97, DOI 10.1038/nature12681; Finlay GA, 2000, J BIOL CHEM, V275, P27650; Gupte VV, 2009, AM J RESP CRIT CARE, V180, P424, DOI 10.1164/rccm.200811-1794OC; Guzy RD, 2015, AM J RESP CELL MOL, V52, P116, DOI 10.1165/rcmb.2014-0184OC; Hanumegowda C, 2012, CHEST, V142, P200, DOI 10.1378/chest.11-1962; Hokuto I, 2003, J BIOL CHEM, V278, P415, DOI 10.1074/jbc.M208328200; Hoyles RK, 2011, AM J RESP CRIT CARE, V183, P249, DOI 10.1164/rccm.201002-0279OC; Hu BA, 2015, AM J PATHOL, V185, P3066, DOI 10.1016/j.ajpath.2015.07.014; Hu BA, 2015, AM J RESP CELL MOL, V52, P418, DOI 10.1165/rcmb.2014-0108OC; Hu BA, 2012, AM J PATHOL, V180, P2257, DOI 10.1016/j.ajpath.2012.02.010; Jacob AL, 2006, DEV BIOL, V296, P315, DOI 10.1016/j.ydbio.2006.05.031; Joannes A, 2016, AM J PHYSIOL-LUNG C, V310, pL615, DOI 10.1152/ajplung.00185.2015; Khalil N, 2005, J BIOL CHEM, V280, P43000, DOI 10.1074/jbc.M510441200; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Lin N, 2011, AM J PHYSIOL-CELL PH, V301, pC469, DOI 10.1152/ajpcell.00452.2010; Liu TJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142547; MacKenzie B, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0242-2; MacKenzie B, 2015, AM J PHYSIOL-LUNG C, V308, pL1014, DOI 10.1152/ajplung.00291.2014; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Moeller A, 2008, INT J BIOCHEM CELL B, V40, P362, DOI 10.1016/j.biocel.2007.08.011; Moore BB, 2008, AM J PHYSIOL-LUNG C, V294, pL152, DOI 10.1152/ajplung.00313.2007; Mouratis MA, 2011, CURR OPIN PULM MED, V17, P355, DOI 10.1097/MCP.0b013e328349ac2b; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Oku H, 2008, EUR J PHARMACOL, V590, P400, DOI 10.1016/j.ejphar.2008.06.046; Ornitz DM, 2015, WIRES DEV BIOL, V4, P215, DOI 10.1002/wdev.176; Osaki T, 2001, INT J EXP PATHOL, V82, P231, DOI 10.1046/j.1365-2613.2001.00193.x; Parapuram SK, 2015, MATRIX BIOL, V43, P35, DOI 10.1016/j.matbio.2015.01.017; Ramos C, 2006, AM J PHYSIOL-LUNG C, V291, pL871, DOI 10.1152/ajplung.00019.2006; Rangarajan S, 2016, AM J RESP CELL MOL, V54, P51, DOI 10.1165/rcmb.2014-0445OC; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Schaefer CJ, 2011, EUR RESPIR REV, V20, P85, DOI 10.1183/09059180.00001111; Shimbori C, 2016, J PATHOL, V240, P197, DOI 10.1002/path.4768; Srisuma S, 2010, AM J RESP CRIT CARE, V181, P838, DOI 10.1164/rccm.200904-0544OC; Strutz F, 2001, KIDNEY INT, V59, P579, DOI 10.1046/j.1523-1755.2001.059002579.x; Sugahara K, 1998, J PATHOL, V186, P90; Thannickal VJ, 1998, BIOCHEM BIOPH RES CO, V251, P437, DOI 10.1006/bbrc.1998.9443; Tschumperlin Daniel J, 2015, Ann Am Thorac Soc, V12 Suppl 1, pS24, DOI 10.1513/AnnalsATS.201407-320MG; Tsukui T, 2013, AM J PATHOL, V183, P758, DOI 10.1016/j.ajpath.2013.06.005; Wang J, 2012, MOL MED, V18, P992, DOI 10.2119/molmed.2011.00425; Weinstein M, 1998, DEVELOPMENT, V125, P3615; Wollin L, 2014, J PHARMACOL EXP THER, V349, P209, DOI 10.1124/jpet.113.208223; Xiao L, 2012, FRONT BIOSCI-LANDMRK, V17, P2667, DOI 10.2741/4077; Yin YJ, 2016, DIS MODEL MECH, V9, P563, DOI 10.1242/dmm.024760; Yin YJ, 2013, CANCER RES, V73, P5730, DOI 10.1158/0008-5472.CAN-13-0495; Yu CD, 2003, AM J PATHOL, V163, P1653, DOI 10.1016/S0002-9440(10)63522-5; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491; Yu ZH, 2012, BIOL PHARM BULL, V35, P731, DOI 10.1248/bpb.35.731; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200; Zheng B, 2002, AM J PATHOL, V160, P1609, DOI 10.1016/S0002-9440(10)61108-X	55	38	41	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10364	10378		10.1074/jbc.M117.791764	http://dx.doi.org/10.1074/jbc.M117.791764			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28487375	Green Published, hybrid			2022-12-26	WOS:000404115400004
J	Koga, T; Okada, A; Fukuda, T; Hidaka, T; Ishii, T; Ueki, Y; Kodera, T; Nakashima, M; Takahashi, Y; Honda, S; Horai, Y; Watanabe, R; Okuno, H; Aramaki, T; Izumiyama, T; Takai, O; Miyashita, T; Sato, S; Kawashiri, S; Iwamoto, N; Ichinose, K; Tamai, M; Origuchi, T; Nakamura, H; Aoyagi, K; Eguchi, K; Kawakami, A				Koga, Tomohiro; Okada, Akitomo; Fukuda, Takaaki; Hidaka, Toshihiko; Ishii, Tomonori; Ueki, Yukitaka; Kodera, Takao; Nakashima, Munetoshi; Takahashi, Yuichi; Honda, Seiyo; Horai, Yoshiro; Watanabe, Ryu; Okuno, Hiroshi; Aramaki, Toshiyuki; Izumiyama, Tomomasa; Takai, Osamu; Miyashita, Taiichiro; Sato, Shuntaro; Kawashiri, Shin-ya; Iwamoto, Naoki; Ichinose, Kunihiro; Tamai, Mami; Origuchi, Tomoki; Nakamura, Hideki; Aoyagi, Kiyoshi; Eguchi, Katsumi; Kawakami, Atsushi		Japanese RA Patients RRP Study Grp	Anti-citrullinated peptide antibodies are the strongest predictor of clinically relevant radiographic progression in rheumatoid arthritis patients achieving remission or low disease activity: A post hoc analysis of a nationwide cohort in Japan	PLOS ONE			English	Article							JOINT DAMAGE; RISK MODEL; ULTRASONOGRAPHY; METHOTREXATE; MATRIX; KNEE; RECOMMENDATIONS; THERAPY	Objectives To determine prognostic factors of clinically relevant radiographic progression (CRRP) in patients with rheumatoid arthritis (RA) achieving remission or low disease activity (LDA) in clinical practice. Methods Using data from a nationwide, multicenter, prospective study in Japan, we evaluated 198 biological disease-modifying antirheumatic drug (bDMARD)-naive RA patients who were in remission or had LDA at study entry after being treated with conventional synthetic DMARDs (csDMARDs). CRRP was defined as the yearly progression of modified total Sharp score (mTSS) >3.0 U. We performed a multiple logistic regression analysis to explore the factors to predict CRRP at 1 year. We used receiver operating characteristic (ROC) curve to estimate the performance of relevant variables for predicting CRRP. Results The mean Disease Activity Score in 28 joints-erythrocyte sedimentation rate (DAS28-ESR) was 2.32-0.58 at study entry. During the 1-year observation, remission or LDA persisted in 72% of the patients. CRRP was observed in 7.6% of the patients. The multiple logistic regression analysis revealed that the independent variables to predict the development of CRRP were: anti-citrullinated peptide antibodies (ACPA) positivity at baseline (OR = 15.2, 95% CI 2.64-299), time-integrated DAS28-ESR during the 1 year post-baseline (7.85-unit increase, OR = 1.83, 95% CI 1.03-3.45), and the mTSS at baseline (13-unit increase, OR = 1.22, 95% CI 1.06-1.42). Conclusions ACPA positivity was the strongest independent predictor of CRRP in patients with RA in remission or LDA. Physicians should recognize ACPA as a poor-prognosis factor regarding the radiographic outcome of RA, even among patients showing a clinically favorable response to DMARDs.	[Koga, Tomohiro] Nagasaki Univ, Ctr Bioinformat & Mol Med, Grad Sch Biomed Sci, Sakamoto 1-7-1, Nagasaki, Japan; [Koga, Tomohiro; Horai, Yoshiro; Kawashiri, Shin-ya; Iwamoto, Naoki; Ichinose, Kunihiro; Tamai, Mami; Nakamura, Hideki; Kawakami, Atsushi] Nagasaki Univ, Dept Immunol & Rheumatol, Unit Translat Med, Grad Sch Biomed Sci, Sakamoto 1-7-1, Nagasaki, Japan; [Okada, Akitomo; Nakashima, Munetoshi; Aramaki, Toshiyuki] Japanese Red Cross Nagasaki Genbaku Hosp, Dept Rheumatol, Morimachi 3-15, Nagasaki, Japan; [Fukuda, Takaaki; Nakashima, Munetoshi] Kurume Univ, Med Ctr, Dept Rheumatol, Kokubun 155-1, Kurume, Fukuoka, Japan; [Hidaka, Toshihiko] Zenjinkai Shimin No Mori Hosp, Shioji 2783-37, Miyazaki, Japan; [Ishii, Tomonori; Watanabe, Ryu] Tohoku Univ Hosp, Dept Hematol & Rheumatol, Aoba Ku, Seiryo 1-1, Sendai, Miyagi, Japan; [Ueki, Yukitaka; Aramaki, Toshiyuki] Sasebo Chuo Hosp, Rheumat & Collagen Dis Ctr, Yamato 15, Sasebo, Japan; [Kodera, Takao] Tohoku Med & Pharmaceut Univ Hosp, Aoba Ku, Komatsujima 4-4-1, Sendai, Miyagi, Japan; [Takahashi, Yuichi] Yu Family Clin, Rifu Aza Sinkan 2-5, Rifu, Miyagi, Japan; [Honda, Seiyo] Kurume Univ, Sch Med, Asahi Machi 67, Kurume, Fukuoka, Japan; [Okuno, Hiroshi] Tohoku Univ Hosp, Dept Orthopaed Surg, Hirase 9-3, Sasebo, Japan; [Izumiyama, Tomomasa] East Sendai Rheumatism & Internal Med Clin, Miyagino Ku, Nittahigashi 1-17-5, Sendai, Miyagi, Japan; [Takai, Osamu] Osaki Citizen Hosp, Furukawa Honami 3-8-1, Osaki, Japan; [Miyashita, Taiichiro] NHO Nagasaki Med Ctr, Kubara 2-1001-1, Omura, Nagasaki, Japan; [Sato, Shuntaro] Nagasaki Univ Hosp, Clin Res Ctr, Sakamoto 1-7-1, Nagasaki, Japan; [Kawashiri, Shin-ya; Aoyagi, Kiyoshi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Publ Hlth, Sakamoto 1-12-4, Nagasaki, Japan; [Origuchi, Tomoki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Rehabil Sci, Sakamoto 1-12-4, Nagasaki, Japan; [Eguchi, Katsumi] Sasebo City Gen Hosp, Hirase 9-3, Sasebo, Japan	Nagasaki University; Nagasaki University; Kurume University; Tohoku University; Tohoku Medical & Pharmaceutical University; Kurume University; Tohoku University; Nagasaki University; Nagasaki University; Nagasaki University	Koga, T (corresponding author), Nagasaki Univ, Ctr Bioinformat & Mol Med, Grad Sch Biomed Sci, Sakamoto 1-7-1, Nagasaki, Japan.; Koga, T (corresponding author), Nagasaki Univ, Dept Immunol & Rheumatol, Unit Translat Med, Grad Sch Biomed Sci, Sakamoto 1-7-1, Nagasaki, Japan.	tkoga@nagasaki-u.ac.jp	Koga, Tomohiro/V-9397-2019; Ichinose, Kunihiro/I-2126-2019; Watanabe, Ryu/AAL-2666-2021; Koga, Tomohiro/AAU-9697-2020; Sato, Shuntaro/AAN-8048-2020	Ichinose, Kunihiro/0000-0001-8794-7106; Watanabe, Ryu/0000-0002-1089-5296; Sato, Shuntaro/0000-0002-6055-3649; Koga, Tomohiro/0000-0003-2077-4428				Aletaha D, 2006, ARTHRITIS RHEUM-US, V54, P2784, DOI 10.1002/art.22052; Aletaha D, 2016, RMD OPEN, V2, DOI 10.1136/rmdopen-2014-000009; Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Arend WP, 2012, NAT REV RHEUMATOL, V8, P573, DOI 10.1038/nrrheum.2012.134; Bohler C, 2013, ANN RHEUM DIS, V72, P241, DOI 10.1136/annrheumdis-2012-202297; Brown AK, 2008, ARTHRITIS RHEUM-US, V58, P2958, DOI 10.1002/art.23945; Bruynesteyn K, 2005, ANN RHEUM DIS, V64, P179, DOI 10.1136/ard.2003.018457; Bruynesteyn K, 2002, J RHEUMATOL, V29, P2306; Cohen G, 2007, ANN RHEUM DIS, V66, P358, DOI 10.1136/ard.2006.057497; Colebatch AN, 2013, ANN RHEUM DIS, V72, P804, DOI 10.1136/annrheumdis-2012-203158; Fautrel B, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4092; FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202; Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047; Johnson K, 2002, CLIN RADIOL, V57, P466, DOI 10.1053/crad.2001.0876; Kane D, 2003, J RHEUMATOL, V30, P966; Karim Z, 2004, ARTHRITIS RHEUM-US, V50, P387, DOI 10.1002/art.20054; Koga T, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003476; Lillegraven S, 2013, ARTHRIT CARE RES, V65, P526, DOI 10.1002/acr.21870; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; Meyer O, 2003, ANN RHEUM DIS, V62, P120, DOI 10.1136/ard.62.2.120; Molenaar ETH, 2004, ARTHRITIS RHEUM, V50, P36, DOI 10.1002/art.11481; Salaffi F, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-120; Schett G, 2016, ANN RHEUM DIS, V75, P1428, DOI 10.1136/annrheumdis-2016-209201; Smolen JS, 2009, ANN RHEUM DIS, V68, P159, DOI 10.1136/ard.2008.099382; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Smolen JS, 2010, ANN RHEUM DIS, V69, P631, DOI 10.1136/ard.2009.123919; Smolen JS, 2005, ARTHRITIS RHEUM, V52, P1020, DOI 10.1002/art.20982; Szkudlarek M, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1904; Takahashi C, 2014, ANN RHEUM DIS, V73, P218, DOI 10.1136/annrheumdis-2014-eular.3527; Takeuchi T, 2014, ANN RHEUM DIS, V73, P536, DOI 10.1136/annrheumdis-2012-202433; Vastesaeger N, 2009, RHEUMATOLOGY, V48, P1114, DOI 10.1093/rheumatology/kep155; Visser K, 2010, ANN RHEUM DIS, V69, P1333, DOI 10.1136/ard.2009.121160; Yamanaka H, 2013, MOD RHEUMATOL, V23, P1, DOI [10.1007/s10165-012-0702-1, 10.1007/s10165-011-0510-z]	33	21	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0175281	10.1371/journal.pone.0175281	http://dx.doi.org/10.1371/journal.pone.0175281			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505163	Green Submitted, Green Published, gold			2022-12-26	WOS:000401473500005
J	Wu, HY; Peng, CL; Chen, PC; Chiang, CK; Chang, CJ; Huang, JW; Peng, YS; Tu, YK; Chu, TS; Hung, KY; Chien, KL				Wu, Hon-Yen; Peng, Chiao-Ling; Chen, Pei-Chun; Chiang, Chih-Kang; Chang, Chee-Jen; Huang, Jenq-Wen; Peng, Yu-Sen; Tu, Yu-Kang; Chu, Tzong-Shinn; Hung, Kuan-Yu; Chien, Kuo-Liong			Comparative effectiveness of angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers for major renal outcomes in patients with diabetes: A 15-year cohort study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; ANTIHYPERTENSIVE DRUGS; TAIWAN SOCIETY; MANAGEMENT; NATIONWIDE; RISK; GUIDELINES; MORTALITY; BLOCKADE; HYPERTENSION	Background Angiotensin converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) are considered to have similar renoprotective effects; so far there has been no consensus about their priorities. This study aimed to compare ACEIs and ARBs for major renal outcomes and survival in a 15-year cohort of adults with diabetes. Methods This study utilized Taiwan's medical and pharmacy claims data in the Longitudinal Cohort of Diabetes Patients. The primary outcome was long-term dialysis, and secondary outcomes were hospitalization for acute kidney injury, hospitalization for hyperkalemia, all-cause death, cardiovascular death, and non-cardiovascular death. Cox proportional hazards models were used to estimate the hazard ratios (HRs) and 95% confidence intervals (CIs) for outcomes comparing ACEIs with ARBs. We conducted subgroup analyses and interaction tests among patients with different age and comorbid diseases. Results A total of 34,043 patients received ACEIs and 23,772 patients received ARBs. No differences were found for primary or secondary outcomes in the main analyses. ACEIs showed significantly lower hazard than ARBs for long-term dialysis among patients with cardiovascular disease (HR 0.80, 95% CI 0.66-0.97, interaction P = 0.003) or chronic kidney disease (0.81, 0.71-0.93, interaction P = 0.001). Conclusions Our analyses show similar effects of ACEIs and ARBs in patients with diabetes. However, ACEIs might provide additional renoprotective effects among patients who have cardiovascular disease or chronic kidney disease.	[Wu, Hon-Yen; Peng, Yu-Sen] Far Eastern Mem Hosp, Dept Internal Med, New Taipei, Taiwan; [Wu, Hon-Yen; Chiang, Chih-Kang; Huang, Jenq-Wen; Peng, Yu-Sen; Chu, Tzong-Shinn; Hung, Kuan-Yu; Chien, Kuo-Liong] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Wu, Hon-Yen; Chiang, Chih-Kang; Huang, Jenq-Wen; Peng, Yu-Sen; Chu, Tzong-Shinn; Hung, Kuan-Yu; Chien, Kuo-Liong] Coll Med, Taipei, Taiwan; [Wu, Hon-Yen; Peng, Chiao-Ling; Tu, Yu-Kang; Chien, Kuo-Liong] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei, Taiwan; [Wu, Hon-Yen] Natl Yang Ming Univ, Sch Med, Fac Med, Taipei, Taiwan; [Chen, Pei-Chun; Chang, Chee-Jen] Chang Gung Univ, Clin Informat & Med Stat Res Ctr, Taoyuan, Taiwan; [Hung, Kuan-Yu] Natl Taiwan Univ Hosp, Dept Internal Med, Hsin Chu Branch, Hsinchu, Taiwan	Far Eastern Memorial Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Yang Ming Chiao Tung University; Chang Gung University; National Taiwan University; National Taiwan University Hospital	Hung, KY; Chien, KL (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan.; Hung, KY; Chien, KL (corresponding author), Coll Med, Taipei, Taiwan.; Chien, KL (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei, Taiwan.; Hung, KY (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Hsin Chu Branch, Hsinchu, Taiwan.	kyhung@ntu.edu.tw; kichien@ntu.edu.tw	peng, yu/GXW-2071-2022	CHIANG, CHIH-KANG/0000-0001-9021-4616; Tu, Yu-Kang/0000-0002-2461-474X; CHIEN, KUO-LIONG/0000-0003-4979-8351; Wu, Hon-Yen/0000-0003-3121-3351; Chen, Pei-Chun/0000-0002-8713-8816; HUNG, KUAN-YU/0000-0003-3472-5512; HUANG, JENQ-WEN/0000-0001-8011-2317; Chang, Chee Jen/0000-0002-7725-7555	Ministry of Science and Technology, Taiwan [MOST 103-2314-B-418-003-MY2]; National Health Research Institutes, Taiwan [NHRI-EX105-10510PC, NHRI-EX106-10510PC]; Far Eastern Memorial Hospital, New Taipei City, Taiwan [FEMH-EX105-10510PC, FEMH-EX106-10510PC]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); Far Eastern Memorial Hospital, New Taipei City, Taiwan	This study was supported by research grants to Dr. Hon-Yen Wu from the Ministry of Science and Technology, Taiwan (MOST 103-2314-B-418-003-MY2), the National Health Research Institutes, Taiwan (NHRI-EX105-10510PC, NHRI-EX106-10510PC), and the Far Eastern Memorial Hospital, New Taipei City, Taiwan (FEMH-EX105-10510PC, FEMH-EX106-10510PC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sayed Nasreen A, 2013, Endocr Pract, V19, P579, DOI 10.4158/EP12272.OR; American Diabetes Association, 2017, Diabetes Care, V40, pS75; Barnett AH, 2004, NEW ENGL J MED, V351, P1952, DOI 10.1056/NEJMoa042274; Campbell HM, 2013, DIABETES RES CLIN PR, V102, P233, DOI 10.1016/j.diabres.2013.10.005; Carrero JJ, 2011, CLIN J AM SOC NEPHRO, V6, P1722, DOI 10.2215/CJN.11331210; Chang JW, 2015, KIDNEY INT, V87, P632, DOI 10.1038/ki.2014.299; Chen YC, 2015, KIDNEY INT, V87, P1030, DOI 10.1038/ki.2014.363; Chiang CE, 2015, J CHIN MED ASSOC, V78, P1, DOI 10.1016/j.jcma.2014.11.005; Chiang CE, 2010, J FORMOS MED ASSOC, V109, P740, DOI 10.1016/S0929-6646(10)60120-9; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Fukuma S, CLIN EXP NEPHROL; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Hayashi M, 2015, CLIN EXP NEPHROL, V19, P925, DOI 10.1007/s10157-015-1091-5; Hicks Karen A, 2015, J Nucl Cardiol, V22, P1041, DOI 10.1007/s12350-015-0209-1; Hsing AW, 2015, JAMA INTERN MED, V175, P1527, DOI 10.1001/jamainternmed.2015.3540; Hsu TW, 2014, JAMA INTERN MED, V174, P347, DOI 10.1001/jamainternmed.2013.12700; Hughes DR, 2015, JAMA INTERN MED, V175, P101, DOI 10.1001/jamainternmed.2014.6349; Iseki K, 2013, NEPHROL DIAL TRANSPL, V28, P1579, DOI 10.1093/ndt/gfs590; Izzo JL, 2011, J CLIN HYPERTENS, V13, P667, DOI 10.1111/j.1751-7176.2011.00508.x; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Mann JFE, 2008, LANCET, V372, P547, DOI 10.1016/S0140-6736(08)61236-2; Mauer M, 2009, NEW ENGL J MED, V361, P40, DOI 10.1056/NEJMoa0808400; Palmer SC, 2015, LANCET, V385, P2047, DOI 10.1016/S0140-6736(14)62459-4; Patel Bimal V, 2007, J Clin Hypertens (Greenwich), V9, P692, DOI 10.1111/j.1524-6175.2007.07194.x; Pawluczyk IZA, 2004, KIDNEY INT, V65, P1240, DOI 10.1111/j.1523-1755.2004.00494.x; Seccia TM, 2006, J HYPERTENS, V24, P1419, DOI 10.1097/01.hjh.0000234124.94013.ac; STEINER JF, 1993, J GEN INTERN MED, V8, P306, DOI 10.1007/BF02600143; Tobe SW, 2011, CIRCULATION, V123, P1098, DOI 10.1161/CIRCULATIONAHA.110.964171; Tozawa M, 2003, HYPERTENSION, V41, P1341, DOI 10.1161/01.HYP.0000069699.92349.8C; Tsai WC, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003013; Tsai WC, JAMA INT MED; Tung YC, 2010, STROKE, V41, P504, DOI 10.1161/STROKEAHA.109.568956; Van Wijk BLG, 2006, J CLIN EPIDEMIOL, V59, P11, DOI 10.1016/j.jclinepi.2005.05.005; Wu HY, 2014, JAMA INTERN MED, V174, P1108, DOI 10.1001/jamainternmed.2014.1363; Wu HY, 2014, J COMP EFFECT RES, V3, P213, DOI [10.2217/cer.14.10, 10.2217/CER.14.10]; Wu HY, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6008; Yang DC, 2012, DIABETES CARE, V35, P2279, DOI 10.2337/dc12-0545	40	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177654	10.1371/journal.pone.0177654	http://dx.doi.org/10.1371/journal.pone.0177654			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505194	Green Published, gold, Green Submitted			2022-12-26	WOS:000401473500031
J	Howe, JR; Li, ES; Streeter, SE; Rahme, GJ; Chipumuro, E; Russo, GB; Litzky, JF; Hills, LB; Rodgers, KR; Skelton, PD; Luikart, BW				Howe, James R.; Li, Emily S.; Streeter, Sarah E.; Rahme, Gilbert J.; Chipumuro, Edmond; Russo, Grace B.; Litzky, Julia F.; Hills, L. Benjamin; Rodgers, Kyla R.; Skelton, Patrick D.; Luikart, Bryan W.			MiR-338-3p regulates neuronal maturation and suppresses glioblastoma proliferation	PLOS ONE			English	Article							DENTATE GYRUS; GRANULE CELLS; ADULT NEUROGENESIS; INCREASED FREQUENCY; CANCER-CELL; HIPPOCAMPAL; INTEGRATION; EXPRESSION; SURVIVAL; DIFFERENTIATION	Neurogenesis is a highly-regulated process occurring in the dentate gyrus that has been linked to learning, memory, and antidepressant efficacy. MicroRNAs (miRNAs) have been previously shown to play an important role in the regulation of neuronal development and neurogenesis in the dentate gyrus via modulation of gene expression. However, this mode of regulation is both incompletely described in the literature thus far and highly multifactorial. In this study, we designed sensors and detected relative levels of expression of 10 different miRNAs and found miR-338-3p was most highly expressed in the dentate gyrus. Comparison of miR-338-3p expression with neuronal markers of maturity indicates miR-338-3p is expressed most highly in the mature neuron. We also designed a viral "sponge" to knock down in vivo expression of miR-338-3p. When miR-338-3p is knocked down, neurons sprout multiple primary dendrites that branch off of the soma in a disorganized manner, cellular proliferation is upregulated, and neoplasms form spontaneously in vivo. Additionally, miR-338-3p overexpression in glioblastoma cell lines slows their proliferation in vitro. Further, low miR-338-3p expression is associated with increased mortality and disease progression in patients with glioblastoma. These data identify miR-338-3p as a clinically relevant tumor suppressor in glioblastoma.	[Howe, James R.; Li, Emily S.; Streeter, Sarah E.; Chipumuro, Edmond; Russo, Grace B.; Litzky, Julia F.; Hills, L. Benjamin; Rodgers, Kyla R.; Skelton, Patrick D.; Luikart, Bryan W.] Dartmouth Coll, Geisel Sch Med, Dept Physiol & Neurobiol, Lebanon, NH 03755 USA; [Rahme, Gilbert J.] Dartmouth Coll, Geisel Sch Med, Dept Genet, Lebanon, NH USA	Dartmouth College; Dartmouth College	Luikart, BW (corresponding author), Dartmouth Coll, Geisel Sch Med, Dept Physiol & Neurobiol, Lebanon, NH 03755 USA.	Bryan.W.Luikart@dartmouth.edu	Howe, James R./Q-8170-2018; Rodgers, Kyla/AAR-8045-2021	Howe, James R./0000-0002-7584-3577; Litzky, Julia/0000-0001-6767-5000; Luikart, Bryan/0000-0002-3181-6075; Rahme, Gilbert/0000-0001-6060-1279; Skelton, Patrick/0000-0002-6691-9904; Rodgers, Kyla/0000-0002-5844-1971	Department of Physiology and Neurobiology at the Geisel School of Medicine at Dartmouth (BWL); Optical Cellular Imaging Shared Resource; Norris Cotton Cancer Center at the Geisel School of Medicine at Dartmouth [P30 CA023108]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH097949] Funding Source: NIH RePORTER	Department of Physiology and Neurobiology at the Geisel School of Medicine at Dartmouth (BWL); Optical Cellular Imaging Shared Resource; Norris Cotton Cancer Center at the Geisel School of Medicine at Dartmouth; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by startup funding provided by the Department of Physiology and Neurobiology at the Geisel School of Medicine at Dartmouth (BWL) and the Optical Cellular Imaging Shared Resource and the Norris Cotton Cancer Center at the Geisel School of Medicine at Dartmouth, P30 CA023108. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimone JB, 2014, PHYSIOL REV, V94, P991, DOI 10.1152/physrev.00004.2014; Aldape K, 2015, ACTA NEUROPATHOL, V129, P829, DOI 10.1007/s00401-015-1432-1; Anand S, 2010, NAT MED, V16, P909, DOI 10.1038/nm.2186; Aschrafi A, 2012, CELL MOL LIFE SCI, V69, P4017, DOI 10.1007/s00018-012-1064-8; Brown J, 2003, EUR J NEUROSCI, V17, P2042, DOI 10.1046/j.1460-9568.2003.02647.x; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Campbell NR, 2010, J NEUROSCI, V30, P8734, DOI 10.1523/JNEUROSCI.0931-10.2010; Chen H, 2006, NEUROREPORT, V17, P863, DOI 10.1097/01.wnr.0000221827.03222.70; Chen X, 2013, FEBS LETT, V587, P3729, DOI 10.1016/j.febslet.2013.09.044; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Davis TH, 2008, J NEUROSCI, V28, P4322, DOI 10.1523/JNEUROSCI.4815-07.2008; De Falco M, 2004, J ANAT, V205, P405, DOI 10.1111/j.0021-8782.2004.00347.x; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Dugas JC, 2010, NEURON, V65, P597, DOI 10.1016/j.neuron.2010.01.027; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fu XY, 2012, INT J MOL SCI, V13, P8514, DOI 10.3390/ijms13078514; Gartner A, 2014, J CELL SCI, V127, P4409, DOI 10.1242/jcs.149815; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Ge SY, 2008, J PHYSIOL-LONDON, V586, P3759, DOI 10.1113/jphysiol.2008.155655; Gould E, 1997, J NEUROSCI, V17, P2492; Herrup K, 2007, NAT REV NEUROSCI, V8, P368, DOI 10.1038/nrn2124; Hervey-Jumper S, 2011, CANCER RES, V71, DOI 10.1158/1538-7445.AM2011-134; Huang XH, 2011, J PATHOL, V225, P463, DOI 10.1002/path.2877; Jessberger S, 2008, PLOS BIOL, V6, P2465, DOI 10.1371/journal.pbio.0060272; Johansson A, 2003, NEUROSCI LETT, V340, P69, DOI 10.1016/S0304-3940(03)00051-X; Kaneko N, 2006, GENES CELLS, V11, P1145, DOI 10.1111/j.1365-2443.2006.01010.x; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Konopka W, 2010, J NEUROSCI, V30, P14835, DOI 10.1523/JNEUROSCI.3030-10.2010; Kos A, 2014, MOL NEUROBIOL; Kvajo M, 2008, P NATL ACAD SCI USA, V105, P7076, DOI 10.1073/pnas.0802615105; Lau P, 2010, BRAIN RES, V1338, P14, DOI 10.1016/j.brainres.2010.04.002; Lauer M, 2003, PSYCHIAT RES-NEUROIM, V122, P89, DOI 10.1016/S0925-4927(02)00122-1; Lee Y, 2016, NEUROONCOL S, V18; Li P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066782; Luikart BW, 2012, BEHAV BRAIN RES, V227, P348, DOI 10.1016/j.bbr.2011.03.048; Luikart BW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019077; Moreau MP, 2011, BIOL PSYCHIAT, V69, P188, DOI 10.1016/j.biopsych.2010.09.039; Ninkovic J, 2007, J NEUROSCI, V27, P10906, DOI 10.1523/JNEUROSCI.2572-07.2007; Rahme GJ, 2016, CANC RES; Sainath R, 2015, CELL TISSUE RES, V359, P267, DOI 10.1007/s00441-014-1955-0; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Senitz D, 2003, J NEURAL TRANSM, V110, P317, DOI 10.1007/s00702-002-0776-6; Shang Chao, 2016, Med Sci Monit, V22, P710; Smrt RD, 2010, STEM CELLS, V28, P1060, DOI 10.1002/stem.431; Stone SSD, 2011, J NEUROSCI, V31, P13469, DOI 10.1523/JNEUROSCI.3100-11.2011; Sumrejkanchanakij P, 2003, ONCOGENE, V22, P8723, DOI 10.1038/sj.onc.1206870; Sun K, 2013, WORLD J GASTROENTERO, V19, P2197, DOI 10.3748/wjg.v19.i14.2197; Tsuchiya S, 2009, NUCLEIC ACIDS RES, V37, P3821, DOI 10.1093/nar/gkp255; Wang L, 2012, TRANSL ONCOL, V5, P1, DOI DOI 10.1016/J.FEBSLET.2012.03.035; West AB, 2005, TRENDS NEUROSCI, V28, P348, DOI 10.1016/j.tins.2005.05.002; Williams MR, 2015, J NEUROSCI, V35, P943, DOI 10.1523/JNEUROSCI.3144-14.2015; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; Zhao XH, 2010, NEURON, V65, P612, DOI 10.1016/j.neuron.2010.02.018	54	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177661	10.1371/journal.pone.0177661	http://dx.doi.org/10.1371/journal.pone.0177661			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493990	Green Submitted, Green Published, gold			2022-12-26	WOS:000401314300149
J	Lohner, V; Brookes, RL; Hollocks, MJ; Morris, RG; Markus, HS				Lohner, Valerie; Brookes, Rebecca L.; Hollocks, Matthew J.; Morris, Robin G.; Markus, Hugh S.			Apathy, but not depression, is associated with executive dysfunction in cerebral small vessel disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; QUALITY-OF-LIFE; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; VASCULAR DEPRESSION; BRIEF MEMORY; DEMENTIA; CLASSIFICATION; VALIDATION; MECHANISMS	Objective To determine the prevalence of apathy and depression in cerebral small vessel disease (SVD), and the relationships between both apathy and depression with cognition. To examine whether apathy is specifically related to impairment in executive functioning and processing speed. Methods 196 patients with a clinical lacunar stroke and an anatomically corresponding lacunar infarct on MRI were compared to 300 stroke-free controls. Apathy and depression were measured using the Geriatric Depression Scale, and cognitive functioning was assessed using an SVD cognitive screening tool, the Brief Memory and Executive Test, which measures executive functioning/processing speed and memory/orientation. Path analysis and binary logistic regression were used to assess the relation between apathy, depression and cognitive impairment. Results 31 participants with SVD (15.8%) met criteria for apathy only, 23 (11.8%) for both apathy and depression, and 2 (1.0%) for depression only. In the SVD group the presence of apathy was related to global cognition, and specifically to impaired executive functioning/processing speed, but not memory/orientation. The presence of depression was not related to global cognition, impaired executive functioning/processing speed or memory/orientation. Conclusions Apathy is a common feature of SVD and is associated with impaired executive functioning/processing speed suggesting the two may share biological mechanisms. Screening for apathy should be considered in SVD, and further work is required to develop and evaluate effective apathy treatment or management in SVD.	[Lohner, Valerie; Brookes, Rebecca L.; Hollocks, Matthew J.; Markus, Hugh S.] Univ Cambridge, Dept Clin Neurosci, Stroke Res Grp, Cambridge, England; [Morris, Robin G.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychol, London, England	University of Cambridge; University of London; King's College London	Lohner, V (corresponding author), Univ Cambridge, Dept Clin Neurosci, Stroke Res Grp, Cambridge, England.	valerie.lohner@gmail.com		Lohner, Valerie/0000-0001-5589-9701; Hollocks, Matthew/0000-0002-9513-6917	Priority Program Grant from the Stroke Association [TSA PPA 2015-02]; Stroke Association [TSA2008/10]; Stroke Association/British Heart Foundation Program [TSA BHF 2010/01]; BHF Project [PG/13/30/30005]; English National Institute of Health Research (NIHR) Clinical Stroke Research Network; NIHR Senior Investigator award; Cambridge University Hospital Comprehensive NIHR Biomedical Research Unit; British Heart Foundation [PG/13/30/30005] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10019] Funding Source: researchfish; Stroke Association [TSA2010/08] Funding Source: researchfish	Priority Program Grant from the Stroke Association; Stroke Association; Stroke Association/British Heart Foundation Program; BHF Project; English National Institute of Health Research (NIHR) Clinical Stroke Research Network; NIHR Senior Investigator award; Cambridge University Hospital Comprehensive NIHR Biomedical Research Unit; British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR)); Stroke Association	This work was supported by a Priority Program Grant from the Stroke Association (TSA PPA 2015-02; www.stroke.org.uk). The BMET Study was supported by a grant from the Stroke Association (TSA2008/10). Valerie Lohner is supported by a Stroke Association/British Heart Foundation Program Grant (TSA BHF 2010/01; www.bhf.org.uk). Rebecca Brookes is supported by a BHF Project Grant (PG/13/30/30005). Recruitment to the BMET Study was supported by the English National Institute of Health Research (NIHR) Clinical Stroke Research Network (www. crn.nihr.ac.uk/stroke).Hugh Markus is supported by an NIHR Senior Investigator award (www.nihr.ac.uk) and his work is supported by the Cambridge University Hospital Comprehensive NIHR Biomedical Research Unit (www.cambridge-brc.org.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Aizenstein HJ, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0720-5; Awh E, 2006, NEUROSCIENCE, V139, P201, DOI 10.1016/j.neuroscience.2005.08.023; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Bonnelle V, 2015, J PHYSIOL-PARIS, V109, P16, DOI 10.1016/j.jphysparis.2014.04.002; Brookes RL, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0290-y; Brookes RL, 2014, NEUROPSYCHOLOGY, V28, P247, DOI 10.1037/neu0000015; Brookes RL, 2013, INT J STROKE, V8, P510, DOI 10.1111/j.1747-4949.2011.00763.x; Brookes RL, 2013, J NEUROPSYCHOL, V7, P19, DOI 10.1111/j.1748-6653.2012.02032.x; Brookes RL, 2012, AGE AGEING, V41, P212, DOI 10.1093/ageing/afr172; Charlton RA, 2006, NEUROLOGY, V66, P1523, DOI 10.1212/01.wnl.0000216270.02610.7e; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Herbert V, 2014, J INT NEUROPSYCH SOC, V20, P413, DOI 10.1017/S1355617714000101; Hollocks MJ, 2015, BRAIN, V138, P3803, DOI 10.1093/brain/awv304; Jacova C, 2012, ANN NEUROL, V72, P351, DOI 10.1002/ana.23733; Kline R.B., 2011, PRINCIPLES PRACTICE; Kuzis G, 1999, NEUROLOGY, V52, P1403, DOI 10.1212/WNL.52.7.1403; Lawrence AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135523; Lawrence AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061014; Levy R, 2006, CEREB CORTEX, V16, P916, DOI 10.1093/cercor/bhj043; Makin SDJ, 2013, J NEUROL NEUROSUR PS, V84, P893, DOI 10.1136/jnnp-2012-303645; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; MARIN RS, 1991, J NEUROPSYCH CLIN N, V3, P243; Mitchell AJ, 2010, J AFFECT DISORDERS, V125, P10, DOI 10.1016/j.jad.2009.08.019; Moretti R, 2015, AM J ALZHEIMERS DIS, V30, P390, DOI 10.1177/1533317514550329; Nelson HE., 1991, REVISED NATL ADULT R; Pagonabarraga J, 2015, LANCET NEUROL, V14, P518, DOI 10.1016/S1474-4422(15)00019-8; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Pohjasvaara T, 1998, STROKE, V29, P2311, DOI 10.1161/01.STR.29.11.2311; Prins ND, 2005, BRAIN, V128, P2034, DOI 10.1093/brain/awh553; Robert P, 2009, EUR PSYCHIAT, V24, P98, DOI 10.1016/j.eurpsy.2008.09.001; Roman GC, 2002, LANCET NEUROL, V1, P426, DOI 10.1016/S1474-4422(02)00190-4; Schinka JA, 2010, AM J GERIAT PSYCHIAT, V18, P684, DOI 10.1097/JGP.0b013e3181e56d5a; Sockeel P, 2006, J NEUROL NEUROSUR PS, V77, P579, DOI 10.1136/jnnp.2005.075929; STARKSTEIN SE, 1993, STROKE, V24, P1625, DOI 10.1161/01.STR.24.11.1625; Starkstein SE, 2001, AM J PSYCHIAT, V158, P872, DOI 10.1176/appi.ajp.158.987.872; Taylor WD, 2013, MOL PSYCHIATR, V18, P963, DOI 10.1038/mp.2013.20; Thobois S, 2010, BRAIN, V133, P1111, DOI 10.1093/brain/awq032; Tuladhar AM, 2015, NEUROIMAGE-CLIN, V7, P518, DOI 10.1016/j.nicl.2015.02.003; van Reekum R, 2005, J NEUROPSYCH CLIN N, V17, P7, DOI 10.1176/appi.neuropsych.17.1.7; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	42	30	34	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176943	10.1371/journal.pone.0176943	http://dx.doi.org/10.1371/journal.pone.0176943			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493898	Green Published, gold			2022-12-26	WOS:000401314300042
J	Tomobe, K; Yamamoto, E; Kholmurodov, K; Yasuoka, K				Tomobe, Katsufumi; Yamamoto, Eiji; Kholmurodov, Kholmirzo; Yasuoka, Kenji			Water permeation through the internal water pathway in activated GPCR rhodopsin	PLOS ONE			English	Article							PROTEIN-COUPLED-RECEPTORS; FORCE-FIELD; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; OPSIN; CHANNEL; CONFORMATION; RELEASE; LIGAND; SIMULATIONS	Rhodopsin is a light-driven G-protein-coupled receptor that mediates signal transduction in eyes. Internal water molecules mediate activation of the receptor in a rhodopsin cascade reaction and contribute to conformational stability of the receptor. However, it remains unclear how internal water molecules exchange between the bulk and protein inside, in particular through a putative solvent pore on the cytoplasmic. Using all-atom molecular dynamics simulations, we identified the solvent pore on cytoplasmic side in both the Meta II state and the Opsin. On the other hand, the solvent pore does not exist in the dark-adapted rhodopsin. We revealed two characteristic narrow regions located within the solvent pore in the Meta II state. The narrow regions distinguish bulk and the internal hydration sites, one of which is adjacent to the conserved structural motif "NPxxY". Water molecules in the solvent pore diffuse by pushing or sometimes jumping a preceding water molecule due to the geometry of the solvent pore. These findings revealed a total water flux between the bulk and the protein inside in the Meta II state, and suggested that these pathways provide water molecules to the crucial sites of the activated rhodopsin.	[Tomobe, Katsufumi; Yasuoka, Kenji] Keio Univ, Dept Mech Engn, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan; [Yamamoto, Eiji] Keio Univ, Grad Sch Sci & Technol, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan; [Kholmurodov, Kholmirzo] Joint Inst Nucl Res, Frank Lab Neutron Phys, Dubna 141980, Russia; [Kholmurodov, Kholmirzo] Dubna State Univ, Dubna 141980, Russia	Keio University; Keio University; Joint Institute for Nuclear Research - Russia; Dubna State University	Yasuoka, K (corresponding author), Keio Univ, Dept Mech Engn, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	yasuoka@mech.keio.ac.jp	Yamamoto, Eiji/E-4926-2013	Yamamoto, Eiji/0000-0002-8813-5297; Kholmurodov, Kholmirzo/0000-0002-9415-8276	MEXT (Ministry of Education, Culture, Sports, Science and Technology); JSPS	MEXT (Ministry of Education, Culture, Sports, Science and Technology)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work is supported in part by MEXT (Ministry of Education, Culture, Sports, Science and Technology) Grant-in-Aid for the Program for Leading Graduate Schools, Keio University Doctorate Student Grant-in-Aid Program, and a Bilateral Program JSPS. E.Y. was supported by MEXT Grant-in-Aid for the "Building of Consortia for the Development of Human Resources in Science and Technology".	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Angel TE, 2009, P NATL ACAD SCI USA, V106, P14367, DOI 10.1073/pnas.0901074106; Angel TE, 2009, P NATL ACAD SCI USA, V106, P8555, DOI 10.1073/pnas.0903545106; Aryal P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5377; Ball P, 2008, CHEM REV, V108, P74, DOI 10.1021/cr068037a; Bemporad D, 2004, J PHYS CHEM B, V108, P4875, DOI 10.1021/jp035260s; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; BLAZYNSKI C, 1984, VISION RES, V24, P459, DOI 10.1016/0042-6989(84)90043-9; Bussi G, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3073889; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Dong H, 2013, P NATL ACAD SCI USA, V110, P17332, DOI 10.1073/pnas.1316969110; Espinoza-Fonseca LM, 2015, J AM CHEM SOC, V137, P7055, DOI 10.1021/jacs.5b03814; Fischer G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000130; Frutos LM, 2007, P NATL ACAD SCI USA, V104, P7764, DOI 10.1073/pnas.0701732104; Furutani Y, 2003, BIOCHEMISTRY-US, V42, P9619, DOI 10.1021/bi034592k; Gravelle S, 2013, P NATL ACAD SCI USA, V110, P16367, DOI 10.1073/pnas.1306447110; Grossfield A, 2008, J MOL BIOL, V381, P478, DOI 10.1016/j.jmb.2008.05.036; Hildebrand PW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004382; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jambeck JPM, 2012, J CHEM THEORY COMPUT, V8, P2938, DOI 10.1021/ct300342n; Jastrzebska B, 2011, J BIOL CHEM, V286, P18930, DOI 10.1074/jbc.M111.234583; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kukura P, 2005, SCIENCE, V310, P1006, DOI 10.1126/science.1118379; Lim H, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005135; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mirzadegan T, 2003, BIOCHEMISTRY-US, V42, P2759, DOI 10.1021/bi027224+; Mitchell DC, 2000, J BIOL CHEM, V275, P5355, DOI 10.1074/jbc.275.8.5355; Nakamichi H., 2006, ANGEW CHEM, V118, P4376, DOI DOI 10.1002/ANGE.200600595; Nakamichi H, 2006, P NATL ACAD SCI USA, V103, P12729, DOI 10.1073/pnas.0601765103; Ogata K, 2013, J AM CHEM SOC, V135, P15670, DOI 10.1021/ja404317d; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Pardo L, 2007, CHEMBIOCHEM, V8, P19, DOI 10.1002/cbic.200600429; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Piechnick R, 2012, P NATL ACAD SCI USA, V109, P5247, DOI 10.1073/pnas.1117268109; Piechnick R, 2011, BIOCHEMISTRY-US, V50, P7168, DOI 10.1021/bi200675y; Rohrig UF, 2004, J AM CHEM SOC, V126, P15328, DOI 10.1021/ja048265r; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Smith SO, 2010, ANNU REV BIOPHYS, V39, P309, DOI 10.1146/annurev-biophys-101209-104901; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Sun XQ, 2014, J PHYS CHEM B, V118, P10863, DOI 10.1021/jp505180t; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang T, 2011, J MOL RECOGNIT, V24, P350, DOI 10.1002/jmr.1087; Yamamoto E, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.022718; Yuan SG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5733	50	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176876	10.1371/journal.pone.0176876	http://dx.doi.org/10.1371/journal.pone.0176876			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493967	Green Submitted, Green Published, gold			2022-12-26	WOS:000401314300035
J	Aboalroub, AA; Bachman, AB; Zhang, ZM; Keramisanou, D; Merkler, DJ; Gelis, I				Aboalroub, Adam A.; Bachman, Ashleigh B.; Zhang, Ziming; Keramisanou, Dimitra; Merkler, David J.; Gelis, Ioannis			Acetyl group coordinated progression through the catalytic cycle of an arylalkylamine N-acetyltransferase	PLOS ONE			English	Article							1.8 ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; DROSOPHILA-MELANOGASTER; STRUCTURAL-ANALYSIS; GNAT SUPERFAMILY; BIOCHEMICAL-CHARACTERIZATION; SUBSTRATE-BINDING; PINEAL-GLAND; ENZYME; PROTEIN	The transfer of an acetyl group from acetyl-CoA to an acceptor amine is a ubiquitous biochemical transformation catalyzed by Gcn5-related N-acetyltransferases (GNATs). Although it is established that the reaction proceeds through a sequential ordered mechanism, the role of the acetyl group in driving the ordered formation of binary and ternary complexes remains elusive. Herein, we show that CoA and acetyl-CoA alter the conformation of the substrate binding site of an arylalkylamine N-acetyltransferase (AANAT) to facilitate interaction with acceptor substrates. However, it is the presence of the acetyl group within the catalytic funnel that triggers high affinity binding. Acetyl group occupancy is relayed through a conserved salt bridge between the P-loop and the acceptor binding site, and is manifested as differential dynamics in the CoA and acetyl-CoA-bound states. The capacity of the acetyl group carried by an acceptor to promote its tight binding even in the absence of CoA, but also its mutually exclusive position to the acetyl group of acetyl-CoA underscore its importance in coordinating the progression of the catalytic cycle.	[Aboalroub, Adam A.; Bachman, Ashleigh B.; Zhang, Ziming; Keramisanou, Dimitra; Merkler, David J.; Gelis, Ioannis] Univ S Florida, Dept Chem, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	Gelis, I (corresponding author), Univ S Florida, Dept Chem, Tampa, FL 33620 USA.	igelis@usf.edu	Zhang, ziming/HGA-8604-2022		University of South Florida; National Institute of Health [R15-GM107864]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM107864] Funding Source: NIH RePORTER	University of South Florida; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	I.G. would like to thank the University of South Florida for internal funds. D.J.M. acknowledges the National Institute of Health for support (R15-GM107864). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboalroub AA, 2017, BIOMOL NMR ASSIGN, V11, P105, DOI 10.1007/s12104-017-9729-8; ARENDT J, 1995, NATO ADV SCI INST SE, V277, P165; Battistini MR, BM IAANAT3 EXPRESSIO; Bewley MC, 2006, P NATL ACAD SCI USA, V103, P2063, DOI 10.1073/pnas.0511008103; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Brodbeck D, 1998, DNA CELL BIOL, V17, P621, DOI 10.1089/dna.1998.17.621; Burk DL, 2003, PROTEIN SCI, V12, P426, DOI 10.1110/ps.0233503; Chen JY, 2016, SCI REP-UK, V6, DOI 10.1038/srep31425; Cheng KC, 2012, BIOCHEM J, V446, P395, DOI 10.1042/BJ20120520; COON SL, 1995, SCIENCE, V270, P1681, DOI 10.1126/science.270.5242.1681; Dai FY, 2010, J BIOL CHEM, V285, P19553, DOI 10.1074/jbc.M109.096743; De Angelis J, 1998, J BIOL CHEM, V273, P3045, DOI 10.1074/jbc.273.5.3045; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dempsey DR, 2015, INSECT BIOCHEM MOLEC, V66, P1, DOI 10.1016/j.ibmb.2015.10.003; Dempsey DR, 2015, BIOCHEMISTRY-US, V54, P2644, DOI 10.1021/acs.biochem.5b00113; Dempsey DR, 2014, BIOCHEMISTRY-US, V53, P7777, DOI 10.1021/bi5006078; Dorfmueller HC, 2012, ACTA CRYSTALLOGR D, V68, P1019, DOI 10.1107/S0907444912019592; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; Filippova EV, 2011, PROTEINS, V79, P2566, DOI 10.1002/prot.23062; Freiburger LA, 2011, NAT STRUCT MOL BIOL, V18, P288, DOI 10.1038/nsmb.1978; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Han Q, 2012, P NATL ACAD SCI USA, V109, P11669, DOI 10.1073/pnas.1206828109; Hegde SS, 2007, BIOCHEMISTRY-US, V46, P7187, DOI 10.1021/bi700256z; Hickman AB, 1999, MOL CELL, V3, P23, DOI 10.1016/S1097-2765(00)80171-9; Hickman AB, 1999, CELL, V97, P361, DOI 10.1016/S0092-8674(00)80745-X; Hung MN, 2006, J BACTERIOL, V188, P5606, DOI 10.1128/JB.00306-06; Hurtado-Guerrero R, 2008, BIOCHEM J, V415, P217, DOI 10.1042/BJ20081000; Khalil EM, 1998, J BIOL CHEM, V273, P30321, DOI 10.1074/jbc.273.46.30321; KLEIN DC, 1970, SCIENCE, V169, P1093, DOI 10.1126/science.169.3950.1093; Klein DC, 1997, RECENT PROG HORM RES, V52, P307; Klein DC, 2006, CHRONOBIOL INT, V23, P5, DOI 10.1080/07420520500545839; Klein DC, 1996, TRENDS ENDOCRIN MET, V7, P106, DOI 10.1016/1043-2760(96)00033-1; Kramer KJ, 2001, TETRAHEDRON, V57, P385, DOI 10.1016/S0040-4020(00)00949-2; Liszczak G, 2013, NAT STRUCT MOL BIOL, V20, P1098, DOI 10.1038/nsmb.2636; Majorek KA, 2013, J BIOL CHEM, V288, P30223, DOI 10.1074/jbc.M113.501353; Maksimoska J, 2014, BIOCHEMISTRY-US, V53, P3415, DOI 10.1021/bi500380f; Mun S, 2015, SCI REP-UK, V5, DOI 10.1038/srep10484; Norris AL, 2013, PROTEIN SCI, V22, P916, DOI 10.1002/pro.2273; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; Oda K, 2010, J BIOL CHEM, V285, P1446, DOI 10.1074/jbc.M109.022277; Osanai-Futahashi M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2312; Peneff C, 2001, J BIOL CHEM, V276, P16328, DOI 10.1074/jbc.M009988200; Sloley BD, 2004, NEUROTOXICOLOGY, V25, P175, DOI 10.1016/S0161-813X(03)00096-2; Ud-Din AIMS, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071018; Vetting MW, 2008, PROTEIN SCI, V17, P1781, DOI 10.1110/ps.035899.108; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zilberman-Peled B, 2006, BRAIN RES, V1073, P220, DOI 10.1016/j.brainres.2005.12.028	50	6	6	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177270	10.1371/journal.pone.0177270	http://dx.doi.org/10.1371/journal.pone.0177270			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486510	gold, Green Submitted, Green Published			2022-12-26	WOS:000401314000068
J	Dananche, C; Gustin, MP; Cassier, P; Loeffert, ST; Thibaudon, M; Benet, T; Vanhems, P				Dananche, Cedric; Gustin, Marie-Paule; Cassier, Pierre; Loeffert, Sophie Tiphaine; Thibaudon, Michel; Benet, Thomas; Vanhems, Philippe			Evaluation of hirst-type spore trap to monitor environmental fungal load in hospital	PLOS ONE			English	Article							DEMOLITION; AIR; INFECTION	The main purpose was to validate the use of outdoor-indoor volumetric impaction sampler with Hirst-type spore traps (HTSTs) to continuously monitor fungal load in order to prevent invasive fungal infections during major structural work in hospital settings. For 4 weeks, outdoor fungal loads were quantified continuously by 3 HTSTs. Indoor air was sampled by both HTST and viable impaction sampler. Results were expressed as particles/m(3) (HTST) or colony-forming units (CFU)/m(3) (biocollector). Paired comparisons by day were made with Wilcoxon's paired signed-rank test or paired Student's t-test as appropriate. Paired airborne spore levels were correlated 2 by 2, after log-transformation with Pearson's cross-correlation. Concordance was calculated with kappa coefficient (k). Median total fungal loads (TFLs) sampled by the 3 outdoor HTSTs were 3,025.0, 3,287.5 and 3,625.0 particles/m(3) (P = 0.6, 0.6 and 0.3). -Concordance between Aspergillaceae fungal loads (AFLs, including Aspergillus spp. + Penicillium spp.) was low (k = 0.2). A low positive correlation was found between TFLs sampled with outdoor HTST and indoor HTST with applying a 4-hour time lag, r = 0.30, 95% CI (0.23-0.43), P<0.001. In indoor air, Aspergillus spp. were detected by the viable impaction sampler on 63.1% of the samples, whereas AFLs were found by HTST-I on only 3.6% of the samples. Concordance between Aspergillus spp. loads and AFLs sampled with the 2 methods was very low (k = 0.1). This study showed a 4-hour time lag between increase of outdoor and indoor TFLs, possibly due to insulation and aeraulic flow of the building. Outdoor HTSTs may permit to quickly identify (after 48 hours) time periods with high outdoor fungal loads. An identified drawback is that a too low sample area read did not seem to enable detection of Aspergillaceae spores efficiently. Indoor HTSTs may not be recommended at this time, and outdoor HTSTs need further study. Air sampling by viable impaction sampler remains the reference tool for quantifying fungal contamination of indoor air in hospitals.	[Dananche, Cedric; Loeffert, Sophie Tiphaine; Benet, Thomas; Vanhems, Philippe] Hosp Civils Lyon, Grp Hosp Ctr, Unite Hyg Epidemiol & Prevent, Lyon, France; [Dananche, Cedric; Gustin, Marie-Paule; Loeffert, Sophie Tiphaine; Benet, Thomas; Vanhems, Philippe] ENS Lyon, CNRS, UMR5308, Inserm U1111,CIRI,Lab Pathogenes Emergents,Fdn Me, Lyon, France; [Gustin, Marie-Paule] Univ Claude Bernard Lyon 1, Fac Pharm, ISPB, Dept Sante Publ, Villeurbanne, France; [Cassier, Pierre] Hosp Civils Lyon, Grp Hosp Ctr, Lab Biol Securite Environm, Lyon, France; [Thibaudon, Michel] European Aerobiol Soc, Brussieu, France; [Thibaudon, Michel] Reseau Natl Surveillance Aerobiol, Brussieu, France	CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon	Dananche, C (corresponding author), Hosp Civils Lyon, Grp Hosp Ctr, Unite Hyg Epidemiol & Prevent, Lyon, France.; Dananche, C (corresponding author), ENS Lyon, CNRS, UMR5308, Inserm U1111,CIRI,Lab Pathogenes Emergents,Fdn Me, Lyon, France.	cedric.dananche@chu-lyon.fr		Dananche, Cedric/0000-0002-0791-6391				Araujo Ricardo, 2010, Air Quality, P357; Bouza E, 2002, J HOSP INFECT, V52, P234, DOI 10.1053/jhin.2002.1316; Cabral JPS, 2010, SCI TOTAL ENVIRON, V408, P4285, DOI 10.1016/j.scitotenv.2010.07.005; Chang CC, 2008, INTERN MED J, V38, P538, DOI 10.1111/j.1445-5994.2008.01727.x; Cheng SM, 2001, AM J INFECT CONTROL, V29, P321, DOI 10.1067/mic.2001.118410; European Committee for Standardization, 168682015 CENTS; Fernandez-Rodriguez S, 2014, FUNGAL ECOL, V7, P16, DOI 10.1016/j.funeco.2013.11.004; HIRST JM, 1952, ANN APPL BIOL, V39, P257, DOI 10.1111/j.1744-7348.1952.tb00904.x; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Lacey M.E., 2007, AIR SPORA MANUAL CAT; Levetin E, 2004, CURR ALLERGY ASTHM R, V4, P376, DOI 10.1007/s11882-004-0088-z; Munoz P, 2001, CLIN MICROBIOL INFEC, V7, P38, DOI 10.1111/j.1469-0691.2001.tb00008.x; Nesa D, 2001, J HOSP INFECT, V47, P149, DOI 10.1053/jhin.2000.0883; Sehulster Lynne, 2003, MMWR Recomm Rep, V52, P1; Stern MA, 1999, INDOOR BUILT ENVIRON, V8, P40, DOI 10.1177/1420326X9900800104; STREIFEL AJ, 1983, APPL ENVIRON MICROB, V46, P375, DOI 10.1128/AEM.46.2.375-378.1983	16	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177263	10.1371/journal.pone.0177263	http://dx.doi.org/10.1371/journal.pone.0177263			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486534	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314000066
J	Karadagi, A; Johansson, H; Zemack, H; Salipalli, S; Mork, LM; Kannisto, K; Jorns, C; Gramignoli, R; Strom, S; Stokkeland, K; Ericzon, BG; Jonigk, D; Janciauskiene, S; Nowak, G; Ellis, ECS				Karadagi, Ahmad; Johansson, Helene; Zemack, Helen; Salipalli, Sandeep; Mork, Lisa-Mari; Kannisto, Kristina; Jorns, Carl; Gramignoli, Roberto; Strom, Stephen; Stokkeland, Knut; Ericzon, Bo-Goran; Jonigk, Danny; Janciauskiene, Sabina; Nowak, Greg; Ellis, Ewa C. S.			Exogenous alpha 1-antitrypsin down-regulates SERPINA1 expression	PLOS ONE			English	Article							LIVER-DISEASE; HEPATOCYTE TRANSPLANTATION; DEFICIENCY; ADULTS; MICE; RNA	The main goal of the therapy with purified human plasma alpha1-antitrypsin (A1AT) is to increase A1AT levels and to prevent lungs from elastolytic activity in patients with PiZZ (Glu(342)Lys) A1AT deficiency-related emphysema. Potential hepatic gains of this therapy are unknown. Herein, we investigated the effect of A1AT therapy on SERPINA1 (gene encoding A1AT) expression. The expression of SERPINA1 was determined in A1AT or A1AT plus Oncostatin M (OSM) treated primary human hepatocytes isolated from liver tissues from A1AT deficient patients and control liver tissues. In addition, SERPINA1 mRNA was assessed in lung tissues from PiZZ emphysema patients with and without A1AT therapy, and in adherent human peripheral blood mononuclear cells (PBMC) isolated from healthy PiMM donors. In a dose-dependent manner purified A1AT lowered SERPINA1 expression in hepatocytes. This latter effect was more prominent in hepatocytes stimulated with OSM. Although it did not reach statistical significance (P = 0.0539)-analysis of lung tissues showed lower SERPINA1 expression in PiZZ emphysema patients receiving augmentation therapy relative to those without therapy. Finally, exogenously added purified A1AT (1mg/ml) reduced SERPINA1 expression in naive as well as in lipopolysaccharide (LPS)-stimulated human adherent PBMCs. Exogenous A1AT protein reduces its own endogenous expression. Hence, augmentation with native M-A1AT protein and a parallel reduction in expression of dysfunctional mutant Z-A1AT may be beneficial for PiZZ liver, and this motivates further studies.	[Karadagi, Ahmad; Johansson, Helene; Zemack, Helen; Mork, Lisa-Mari; Jorns, Carl; Ericzon, Bo-Goran; Nowak, Greg; Ellis, Ewa C. S.] Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Clin Sci Intervent & Technol CLINTEC, Div Transplantat Surg, Stockholm, Sweden; [Salipalli, Sandeep; Janciauskiene, Sabina] Hannover Med Sch, German Ctr Lung Res DZL, Dept Resp Med, Res Endstage & Obstruct Lung Dis Hannover BREATH, Hannover, Germany; [Kannisto, Kristina; Gramignoli, Roberto; Strom, Stephen] Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Lab Med, Div Pathol, Stockholm, Sweden; [Stokkeland, Knut] Visby Hosp, Dept Med, Visby, Sweden; [Stokkeland, Knut] Karolinska Inst, Dept Med, Gastroenterol & Hepatol Unit, Stockholm, Sweden; [Jonigk, Danny] Hannover Med Sch, Inst Pathol, Hannover, Germany	Karolinska Institutet; Karolinska University Hospital; Hannover Medical School; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Hannover Medical School	Ellis, ECS (corresponding author), Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Clin Sci Intervent & Technol CLINTEC, Div Transplantat Surg, Stockholm, Sweden.	ewa.ellis@ki.se	Jorns, Carl/AAE-6925-2021; gramignoli, roberto/AAD-8669-2019; Ellis, Ewa C S/D-5370-2014; Johansson, Helene/AGR-5090-2022; Ericzon, Bo-Goran/AAH-5328-2020; Gramignoli, Roberto/AAK-5387-2020	Jorns, Carl/0000-0001-7727-8113; Ellis, Ewa C S/0000-0002-3057-5337; Gramignoli, Roberto/0000-0003-3362-4170; Johansson, Helene/0000-0001-5519-0401; Karadagi, Ahmad/0000-0002-1360-938X	Swedish research council; German Center for Lung Research (DZL); Stockholm county council; ALF; Treatments of the future	Swedish research council(Swedish Research CouncilEuropean Commission); German Center for Lung Research (DZL); Stockholm county council(Stockholm County Council); ALF; Treatments of the future	This work was supported by the Swedish research council (Vetenskapsradet), Project research grant - Treatments of the future, E. Ellis 2013-2015 and by the German Center for Lung Research (DZL), S. Janciauskiene and D. Jonigk. It was also supported by Stockholm county council (Stockholms Lans Landsting), ALF 2015, E. Ellis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal N, 2016, AM J RESP CRIT CARE, V193, P1065, DOI 10.1164/rccm.201510-2062LE; Amer Thoracic Soc European Respir, 2003, AM J RESP CRIT CARE, V168, P818, DOI 10.1164/rccm.168.7.818; Bartels CL, 2009, AM J TRANSL RES, V1, P406; BERG NO, 1972, NEW ENGL J MED, V287, P1264, DOI 10.1056/NEJM197212212872502; Carey EJ, 2013, LIVER TRANSPLANT, V19, P1370, DOI 10.1002/lt.23744; CRYSTAL RG, 1990, J CLIN INVEST, V85, P1343, DOI 10.1172/JCI114578; ERIKSSON S, 1987, ACTA MED SCAND, V221, P461; Frenzel E, 2014, J IMMUNOL, V192, P5354, DOI 10.4049/jimmunol.1400378; Gramignoli R, 2012, CELL TRANSPLANT, V21, P1245, DOI 10.3727/096368911X600939; Izykowski N, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0933-6; Jedicke N, 2014, HEPATOLOGY, V59, P2299, DOI 10.1002/hep.27024; Jonigk D, 2011, METHODS MOL BIOL, V755, P67, DOI 10.1007/978-1-61779-163-5_5; Jonigk D, 2011, AM J PATHOL, V178, P599, DOI 10.1016/j.ajpath.2010.10.032; Jorns C, 2012, J INTERN MED, V272, P201, DOI 10.1111/j.1365-2796.2012.02574.x; Kleinman H K, 2001, Curr Protoc Cell Biol, VChapter 10, DOI 10.1002/0471143030.cb1002s00; LARSSON C, 1978, ACTA MED SCAND, V204, P345, DOI 10.1111/j.0954-6820.1978.tb08452.x; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; Nguyen TM, 2012, J LIPID RES, V53, P1598, DOI 10.1194/jlr.M026823; Petrache I, 2006, AM J PATHOL, V169, P1155, DOI 10.2353/ajpath.2006.060058; Piitulainen E, 2003, EUR J CLIN PHARMACOL, V59, P151, DOI 10.1007/s00228-003-0589-z; Rudnick DA, 2004, HEPATOLOGY, V39, P1048, DOI 10.1002/hep.20118; Stoller JK, 2005, LANCET, V365, P2225, DOI 10.1016/S0140-6736(05)66781-5; Strom SC, 1997, TRANSPLANTATION, V63, P559, DOI 10.1097/00007890-199702270-00014; Sveger T., 1976, N ENGL J MED; Teckman JH, 2015, EXPERT REV GASTROENT, V9, P261, DOI 10.1586/17474124.2014.943187; Theophile K, 2008, DIAGN MOL PATHOL, V17, P101, DOI 10.1097/PDM.0b013e318163f26e	26	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177279	10.1371/journal.pone.0177279	http://dx.doi.org/10.1371/journal.pone.0177279			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486562	Green Submitted, gold, Green Published			2022-12-26	WOS:000401314000070
J	Liu, W; Wang, HL; Zhu, B; Yin, CQ; Chen, SY; Li, J; Yu, XA; Azietaku, JT; An, MR; Gao, XM; Chang, YX				Liu, Wei; Wang, Huilin; Zhu, Bo; Yin, Chengqian; Chen, Shuyang; Li, Jin; Yu, Xie-an; Azietaku, John Teye; An, Mingrui; Gao, Xiu-mei; Chang, Yan-xu			An activity-integrated strategy of the identification, screening and determination of potential neuraminidase inhibitors from Radix Scutellariae	PLOS ONE			English	Article							BAICALENSIS GEORGI; MASS-SPECTROMETRY; INFLUENZA; VIRUS; FLAVONOIDS; RHABDOMYOSARCOMA; INFECTION; BARBATA	Small molecules isolated from herbal medicines (HMs) were identified as the potential neuraminidase inhibitors which are effective in influenza prevention and treatment. Unfortunately, current available screen methods of small molecules isolated from HMs are inefficient and insensitive. Here a novel Ultra Performance Liquid Chromatography coupled with diode-array detectors and auto-fraction collector / time-of-flight mass spectrometry (UPLC-DAD-FC/Q-TOF-MS) screening method with high efficiency was developed and validated to separate, collect, enrich, identify and quantify potential neuraminidase inhibitors from Radix Scutellariae. The results showed that 26 components with neuraminidase inhibitory activity were identified from Radix Scutellariae extracts. It was also found that the influence of origins on the quality of RS was more than that of cultivated time on the basis of the concentration of the effective components. These results brought novel insights into quality evaluation of Radix Scutellariae. It was demonstrated that new activity-integrated strategy was a suitable technique for the identification, screening and determination of potential neuraminidase inhibitors in herbal medicine and will provide novel potential strategies in other drug screening from herbal medicine.	[Liu, Wei; Wang, Huilin; Li, Jin; Yu, Xie-an; Azietaku, John Teye; Gao, Xiu-mei; Chang, Yan-xu] Tianjin Univ Tradit Chinese Med, Tianjin State Key Lab Modern Chinese Med, Tianjin, Peoples R China; [Liu, Wei; Wang, Huilin; Li, Jin; Yu, Xie-an; Azietaku, John Teye; Gao, Xiu-mei; Chang, Yan-xu] Tianjin Univ Tradit Chinese Med, Tianjin Key Lab Phytochem & Pharmaceut Anal, Tianjin, Peoples R China; [Zhu, Bo; Yin, Chengqian; Chen, Shuyang] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA; [An, Mingrui] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA	Tianjin University of Traditional Chinese Medicine; Tianjin University of Traditional Chinese Medicine; Boston University; University of Michigan System; University of Michigan	Gao, XM; Chang, YX (corresponding author), Tianjin Univ Tradit Chinese Med, Tianjin State Key Lab Modern Chinese Med, Tianjin, Peoples R China.; Gao, XM; Chang, YX (corresponding author), Tianjin Univ Tradit Chinese Med, Tianjin Key Lab Phytochem & Pharmaceut Anal, Tianjin, Peoples R China.	gaoxiumei@tjutcm.edu.cn; Tcmcyx@126.com	Liu, Wei/E-8826-2018	Liu, Wei/0000-0003-1792-6048; Yin, Chengqian/0000-0003-4247-6245; Yu, Xie-an/0000-0003-2918-7369; Li, Jin/0000-0003-3094-4777	National Natural Science Foundation of China [81374050]; National Science and Technology Support Program Projects [2014BA105B01]; PCSIRT [IRT-14R41]; State the Science & Technology Commission of MOST of China [2014ZX09304307001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Support Program Projects; PCSIRT(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); State the Science & Technology Commission of MOST of China	This research was supported by National Natural Science Foundation of China (81374050), National Science and Technology Support Program Projects (2014BA105B01), and PCSIRT (IRT-14R41) and State the Science & Technology Commission of MOST of China (2014ZX09304307001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed Y, 2015, ANTIVIR RES, V114, P57, DOI 10.1016/j.antiviral.2014.12.006; Apea-Bah FB, 2009, J MED PLANTS RES, V3, P736; Cuong TD, 2015, BIOORG MED CHEM LETT, V25, P1129, DOI 10.1016/j.bmcl.2014.12.055; Dai ZJ, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-150; Guo Shan-shan, 2009, Yaoxue Xuebao, V44, P1348; Han J, 2007, J CHROMATOGR B, V848, P355, DOI 10.1016/j.jchromb.2006.10.061; He HZ, 2012, J PHARMACEUT BIOMED, V62, P196, DOI 10.1016/j.jpba.2011.12.025; Hour MJ, 2013, ALTERN MED, V2013, P1; Huang S. H., 2015, J MICROBIOL IMMUNOL; Liu GZ, 2009, J CHROMATOGR A, V1216, P4809, DOI 10.1016/j.chroma.2009.04.021; Lohani M, 2013, NAT PROD COMMUN, V8, P1415; Lu XH, 2014, VIROLOGY, V454, P169, DOI 10.1016/j.virol.2014.02.011; Nakano T, 2014, J INFECT CHEMOTHER, V20, P401, DOI 10.1016/j.jiac.2014.01.012; Patel M, 2013, J GENE MED, V15, P51, DOI 10.1002/jgm.2695; Rakers C, 2014, BIOORG MED CHEM LETT, V24, P4312, DOI 10.1016/j.bmcl.2014.07.010; Samson M, 2013, ANTIVIR RES, V98, P174, DOI 10.1016/j.antiviral.2013.03.014; Seo ON, 2013, J FUNCT FOODS, V5, P1741, DOI 10.1016/j.jff.2013.07.020; Tian L, 2011, J ETHNOPHARMACOL, V137, P534, DOI 10.1016/j.jep.2011.06.002; von Itzstein M, 2007, NAT REV DRUG DISCOV, V6, P967, DOI 10.1038/nrd2400; Wang HL, 2013, J CHROMATOGR A, V1315, P107, DOI 10.1016/j.chroma.2013.09.052; Yi T, 2015, LWT-FOOD SCI TECHNOL, V62, P194, DOI 10.1016/j.lwt.2015.01.003; Zhang ML, 2015, J BIOL CHEM, V290, P310, DOI 10.1074/jbc.M114.606277; Zhu B, 2016, ONCOGENE, V35, P4212, DOI 10.1038/onc.2015.486; Zhu B, 2015, BRIT J CANCER, V112, P227, DOI 10.1038/bjc.2014.471; Zhu HY, 2015, ANTIVIR RES, V113, P62, DOI 10.1016/j.antiviral.2014.11.003	25	4	5	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0175751	10.1371/journal.pone.0175751	http://dx.doi.org/10.1371/journal.pone.0175751			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486473	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314000005
J	Powers, AK; Davis, EM; Kaplan, SA; Gross, JB				Powers, Amanda K.; Davis, Erin M.; Kaplan, Shane A.; Gross, Joshua B.			Cranial asymmetry arises later in the life history of the blind Mexican cavefish, Astyanax mexicanus	PLOS ONE			English	Article							FLUCTUATING ASYMMETRY; GEOMETRIC MORPHOMETRICS; FACIAL ATTRACTIVENESS; SEXUAL SELECTION; MICRO-CT; EVOLUTION; FISH; HANDEDNESS; ZEBRAFISH; SYMMETRY	As a consequence of adaptation to the cave environment, the blind Mexican cavefish, Astyanax mexicanus, has evolved several cranial aberrations including changes to bone sizes, shapes and presence of numerous lateral asymmetries. Prior studies of cranial asymmetry in cavefish focused strictly on adult specimens. Thus, the extent to which these asymmetries emerge in adulthood, or earlier in the life history of cavefish, was unknown. We performed a geometric morphometric analysis of shape variation in the chondrocranium and osteocranium across life history in two distinct cavefish populations and surface-dwelling fish. The cartilaginous skull in juveniles was bilaterally symmetric and chondrocranial shape was conserved in all three populations. In contrast, bony skull shapes segregated into significantly distinct groups in adults. Cavefish demonstrated significant asymmetry for the bones surrounding the collapsed eye orbit, and the opercle bone posterior to the eye orbit. Interestingly, we discovered that cavefish also exhibit directional "bends" in skull shape, almost always biased to the left. In sum, this work reveals that asymmetric craniofacial aberrations emerge later in the cavefish life history. These abnormalities may mirror asymmetries in the lateral line sensory system, reflect a 'handedness' in cavefish swimming behavior, or evolve through neutral processes.	[Powers, Amanda K.; Davis, Erin M.; Kaplan, Shane A.; Gross, Joshua B.] Univ Cincinnati, Dept Biol Sci, Cincinnati, OH 45220 USA	University System of Ohio; University of Cincinnati	Gross, JB (corresponding author), Univ Cincinnati, Dept Biol Sci, Cincinnati, OH 45220 USA.	grossja@ucmail.uc.edu		Gross, Joshua/0000-0002-0032-1053	US National Institute of Health [NIDCR R01-DE025033]; US National Science Foundation [DEB-1457630]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE025033] Funding Source: NIH RePORTER	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was funded by the US National Institute of Health (NIDCR R01-DE025033) and the US National Science Foundation (DEB-1457630) awarded to JG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abzhanov A, 2007, DEVELOPMENT, V134, P3133, DOI 10.1242/dev.002709; Alvarez J., 1947, SLP Rev Soc Mexicana Hist nat, V8, P215; Alvarez J., 1946, AN ESCUELA NATION CIENC BIOL MEXICO, V4, P263; Atukorala ADS, 2015, BIOL MEXICAN CAVEFIS, P208; Bandyopadhyay PR, 2013, SCI REP-UK, V3, DOI 10.1038/srep01128; Cardini A, 2007, ZOOMORPHOLOGY, V126, P121, DOI 10.1007/s00435-007-0036-2; Cashmore L, 2008, J ANTHROPOL SCI, V86, P7; Coombs S., 1989, MECHANOSENSORY LATER, P3, DOI DOI 10.1007/978-1-4612-3560-6_1; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Dufton M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050308; Finnerty JR, 2003, INT J DEV BIOL, V47, P523; GRAMMER K, 1994, J COMP PSYCHOL, V108, P233, DOI 10.1037/0735-7036.108.3.233; Griscom L., 1937, MONOGRAPHIC STUDY RE; Gross JB, 2016, SYMMETRY-BASEL, V8, DOI 10.3390/sym8110118; Gross JB, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0716-y; Gross JB, 2016, BIOLOGY AND EVOLUTION OF THE MEXICAN CAVEFISH, P193, DOI 10.1016/B978-0-12-802148-4.00010-4; Gross JB, 2014, GENETICS, V196, P1303, DOI 10.1534/genetics.114.161661; Gross JB, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-105; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; Hernandez LP, 2002, INTEGR COMP BIOL, V42, P222, DOI 10.1093/icb/42.2.222; Hinaux H, 2011, ZEBRAFISH, V8, P155, DOI 10.1089/zeb.2011.0713; Holdsworth DW, 2002, TRENDS BIOTECHNOL, V20, pS34, DOI 10.1016/S0167-7799(02)02004-8; HORI M, 1993, SCIENCE, V260, P216, DOI 10.1126/science.260.5105.216; Jamniczky HA, 2015, EVOL BIOL, V42, P260, DOI 10.1007/s11692-015-9318-7; Jeffery WR, 2009, ANNU REV GENET, V43, P25, DOI 10.1146/annurev-genet-102108-134216; Jeffery WR, 2001, DEV BIOL, V231, P1, DOI 10.1006/dbio.2000.0121; JOLLIE M, 1975, J MORPHOL, V147, P61, DOI 10.1002/jmor.1051470106; Kimmel CB, 1998, DEV BIOL, V203, P245, DOI 10.1006/dbio.1998.9016; Kimmel CB, 2003, DEVELOPMENT, V130, P1339, DOI 10.1242/dev.00338; Klingenberg CP, 2015, SYMMETRY-BASEL, V7, P843, DOI 10.3390/sym7020843; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg CP, 2002, EVOLUTION, V56, P1909; Klingenberg CP, 1998, EVOLUTION, V52, P1363, DOI 10.1111/j.1558-5646.1998.tb02018.x; Kowalko JE, 2013, P NATL ACAD SCI USA, V110, P16933, DOI 10.1073/pnas.1317192110; Levy J, 1977, Ann N Y Acad Sci, V299, P264, DOI 10.1111/j.1749-6632.1977.tb41913.x; Mitchell R.W., 1977, MEXICAN EYELESS CHAR; MOLLER AP, 1994, EVOLUTION, V48, P658, DOI 10.2307/2410476; Morgan TH, 1923, AM NAT, V57, P269, DOI 10.1086/279921; NORBERG RA, 1978, PHILOS T R SOC B, V282, P325, DOI 10.1098/rstb.1978.0014; Oest ME, 2008, BIRTH DEFECTS RES B, V83, P582, DOI 10.1002/bdrb.20177; Piotrowski T, 1996, DEVELOPMENT, V123, P345; Potthoff T., 1984, American Society of Ichthyologists and Herpetologists Special Publication, P35; Pouilly M, 2003, J FISH BIOL, V63, P490, DOI 10.1046/j.1095-8649.2003.00171.x; Powder KE, 2015, EVODEVO, V6, DOI 10.1186/s13227-015-0020-8; Reboleira ASPS, 2012, ZOOTAXA, P33; Retaux S, 2016, BIOLOGY AND EVOLUTION OF THE MEXICAN CAVEFISH, P227, DOI 10.1016/B978-0-12-802148-4.00012-8; Savriama Y, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-280; Scheib JE, 1999, P ROY SOC B-BIOL SCI, V266, P1913, DOI 10.1098/rspb.1999.0866; Schemmel C., 1980, ETHOLOGY, V53, P9; SCHEMMEL CHRISTIAN, 1967, Z MORPHOL TIERE, V61, P255, DOI 10.1007/BF00400988; SCHILLING TF, 1994, DEVELOPMENT, V120, P483; Sharma S, 2009, J COMP PHYSIOL A, V195, P225, DOI 10.1007/s00359-008-0400-9; Smith DR, 1997, J EVOLUTION BIOL, V10, P551; Speder P, 2007, CURR OPIN GENET DEV, V17, P351, DOI 10.1016/j.gde.2007.05.008; Stewart TA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-8; TEYKE T, 1990, BRAIN BEHAV EVOLUT, V35, P23, DOI 10.1159/000115853; Thomas F, 1998, CAN J ZOOL, V76, P931, DOI 10.1139/cjz-76-5-931; Tokita M, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2015.0481; Tomkins JL, 2002, ELS; Valdez-Moreno ME, 2003, P BIOL SOC WASH, V116, P341; Wilkens H, 2001, ENVIRON BIOL FISH, V62, P251, DOI 10.1023/A:1011897805681; Windsor SP., 2014, FLOW SENSING AIR WAT, P103, DOI 10.1007/978-3-642-41446-6_4; XIA Y, 1994, MAGNET RESON MED, V31, P273, DOI 10.1002/mrm.1910310306; Yamamato Y., 2015, BIOL MEXICAN CAVEFIS, P175; Yamamoto Y, 2003, EVOL DEV, V5, P435, DOI 10.1046/j.1525-142X.2003.03050.x; Yoshizawa M, 2010, CURR BIOL, V20, P1631, DOI 10.1016/j.cub.2010.07.017; Zelditch ML, 2012, GEOMETRIC MORPHOMETRICS FOR BIOLOGISTS: A PRIMER, 2ND EDITION, P1	67	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177419	10.1371/journal.pone.0177419	http://dx.doi.org/10.1371/journal.pone.0177419			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486546	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314000079
J	Corby, MJ; Stoneman, MR; Biener, G; Paprocki, JD; Kolli, R; Raicu, V; Frick, DN				Corby, M. J.; Stoneman, Michael R.; Biener, Gabriel; Paprocki, Joel D.; Kolli, Rajesh; Raicu, Valerica; Frick, David N.			Quantitative microspectroscopic imaging reveals viral and cellular RNA helicase interactions in live cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATITIS-C VIRUS; ANTIVIRAL SIGNAL-TRANSDUCTION; INNATE IMMUNE SENSOR; I-LIKE RECEPTORS; NF-KAPPA-B; RIG-I; NS3 HELICASE; LIVING CELLS; QUATERNARY STRUCTURE; PATTERN-RECOGNITION	Human cells detect RNA viruses through a set of helicases called RIG-I-like receptors (RLRs) that initiate the interferon response via a mitochondrial signaling complex. Many RNA viruses also encode helicases, which are sometimes covalently linked to proteases that cleave signaling proteins. One unresolved question is how RLRs interact with each other and with viral proteins in cells. This study examined the interactions among the hepatitis C virus (HCV) helicase and RLR helicases in live cells with quantitative microspectroscopic imaging (Q-MSI), a technique that determines FRET efficiency and subcellular donor and acceptor concentrations. HEK293T cells were transfected with various vector combinations to express cyan fluorescent protein (CFP) or YFP fused to either biologically active HCV helicase or one RLR (i. e. RIG-I, MDA5, or LGP2), expressed in the presence or absence of polyinosinicpolycytidylic acid (poly(I: C)), which elicits RLR accumulation at mitochondria. Q-MSI confirmed previously reported RLR interactions and revealed an interaction between HCV helicase and LGP2. Mitochondria in CFP-RIG-I: YFP-RIG-I cells, CFPMDA5: YFP-MDA5 cells, and CFP-MDA5: YFP-LGP2 cells had higher FRET efficiencies in the presence of poly(I: C), indicating that RNA causes these proteins to accumulate at mitochondria in higher-order complexes than those formed in the absence of poly(I: C). However, mitochondria in CFP-LGP2: YFP-LGP2 cells had lower FRET signal in the presence of poly(I: C), suggesting that LGP2 oligomers disperse so that LGP2 can bind MDA5. Data support a new model where an LGP2-MDA5 oligomer shuttles NS3 to the mitochondria to block antiviral signaling.	[Corby, M. J.; Kolli, Rajesh; Frick, David N.] Univ Wisconsin, Dept Chem & Biochem, Milwaukee, WI 53201 USA; [Stoneman, Michael R.; Biener, Gabriel; Paprocki, Joel D.; Raicu, Valerica] Univ Wisconsin, Dept Phys, Milwaukee, WI 53201 USA; [Raicu, Valerica] Univ Wisconsin, Dept Biol Sci, POB 413, Milwaukee, WI 53201 USA	University of Wisconsin System; University of Wisconsin Milwaukee; University of Wisconsin System; University of Wisconsin Milwaukee; University of Wisconsin System; University of Wisconsin Milwaukee	Frick, DN (corresponding author), Univ Wisconsin, Dept Chem & Biochem, Milwaukee, WI 53201 USA.; Raicu, V (corresponding author), Univ Wisconsin, Dept Phys, Milwaukee, WI 53201 USA.; Raicu, V (corresponding author), Univ Wisconsin, Dept Biol Sci, POB 413, Milwaukee, WI 53201 USA.	vraicu@uwm.edu; frickd@uwm.edu		Frick, David/0000-0002-2434-7223	National Institutes of Health [RO1AI088001]; University of Wisconsin-Milwaukee Research Growth Innitiative [101X333]; National Science Foundation Major Research Instrumentation Program Grant [PHY-1126386]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Wisconsin-Milwaukee Research Growth Innitiative; National Science Foundation Major Research Instrumentation Program Grant(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant RO1AI088001 (to D. N. F.), University of Wisconsin-Milwaukee Research Growth Innitiative Grant 101X333 (to D. N. F. and V. R.), and National Science Foundation Major Research Instrumentation Program Grant PHY-1126386 (to V. R.). Dr. Raicu is a co-founder of Aurora Spectral Technologies LLC (AST), which commercializes OptiMiS technology used in this work. Dr. Stoneman was employed by AST in the past and occasionally consults for them. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABDELMONEM M, 1976, EUR J BIOCHEM, V65, P431, DOI 10.1111/j.1432-1033.1976.tb10358.x; Baril M, 2009, J VIROL, V83, P1299, DOI 10.1128/JVI.01659-08; Belon CA, 2009, J MOL BIOL, V388, P851, DOI 10.1016/j.jmb.2009.03.059; Berke IC, 2012, EMBO J, V31, P1714, DOI 10.1038/emboj.2012.19; Biener G, 2014, INT J MOL SCI, V15, P261, DOI 10.3390/ijms15010261; Bruns AM, 2015, CYTOKINE, V74, P198, DOI 10.1016/j.cyto.2015.02.010; Bruns AM, 2014, CYTOKINE GROWTH F R, V25, P507, DOI 10.1016/j.cytogfr.2014.07.006; Bruns AM, 2014, MOL CELL, V55, P771, DOI 10.1016/j.molcel.2014.07.003; Bruns AM, 2013, J BIOL CHEM, V288, P938, DOI 10.1074/jbc.M112.424416; Bruns AM, 2012, CRIT REV BIOCHEM MOL, V47, P194, DOI 10.3109/10409238.2011.630974; Byrd AK, 2012, FRONT BIOSCI-LANDMRK, V17, P2070, DOI 10.2741/4038; CUBITT AB, 1995, TRENDS BIOCHEM SCI, V20, P448, DOI 10.1016/S0968-0004(00)89099-4; David RYS, 2016, ELIFE, V5, DOI 10.7554/eLife.11275; Day RN, 2009, CHEM SOC REV, V38, P2887, DOI 10.1039/b901966a; Deddouche S, 2014, ELIFE, V3, DOI 10.7554/eLife.01535; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Errett JS, 2015, VIROL SIN, V30, P163, DOI 10.1007/s12250-015-3604-5; Fitzgerald ME, 2014, CURR OPIN MICROBIOL, V20, P76, DOI 10.1016/j.mib.2014.05.004; Foy E, 2005, P NATL ACAD SCI USA, V102, P2986, DOI 10.1073/pnas.0408707102; Foy E, 2003, SCIENCE, V300, P1145, DOI 10.1126/science.1082604; Frick DN, 2007, CURR ISSUES MOL BIOL, V9, P1; Frick DN, 2010, METHODS MOL BIOL, V587, P223, DOI 10.1007/978-1-60327-355-8_16; Frick DN, 2004, J BIOL CHEM, V279, P1269, DOI 10.1074/jbc.M310630200; Gu MG, 2010, P NATL ACAD SCI USA, V107, P521, DOI 10.1073/pnas.0913380107; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; Horner SM, 2013, NAT MED, V19, P879, DOI 10.1038/nm.3253; Horner SM, 2012, J VIROL, V86, P3112, DOI 10.1128/JVI.06727-11; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Itsathitphaisarn O, 2012, CELL, V151, P267, DOI 10.1016/j.cell.2012.09.014; Jennings TA, 2009, J BIOL CHEM, V284, P4806, DOI 10.1074/jbc.M805540200; Jones CT, 2010, NAT BIOTECHNOL, V28, P167, DOI 10.1038/nbt.1604; King C, 2016, INTEGR BIOL-UK, V8, P216, DOI 10.1039/c5ib00202h; Levin MK, 1999, J BIOL CHEM, V274, P31839, DOI 10.1074/jbc.274.45.31839; Lin RT, 2006, J VIROL, V80, P6072, DOI 10.1128/JVI.02495-05; Louber J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108770; Mackintosh SG, 2006, J BIOL CHEM, V281, P3528, DOI 10.1074/jbc.M512100200; Martin BR, 2005, NAT BIOTECHNOL, V23, P1308, DOI 10.1038/nbt1136; Mishra AK, 2016, BIOCHEM J, V473, P3819, DOI 10.1042/BCJ20160422; Mishra AK, 2015, BIOCHEM J, V466, P263, DOI 10.1042/BJ20141321; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Murali A, 2008, J BIOL CHEM, V283, P15825, DOI 10.1074/jbc.M800542200; Neumann-Haefelin C, 2008, J VIROL, V82, P3438, DOI 10.1128/JVI.01700-07; Patel JR, 2013, EMBO REP, V14, P780, DOI 10.1038/embor.2013.102; Patowary S, 2015, BIOPHYS J, V108, P1613, DOI 10.1016/j.bpj.2015.02.021; Patowary S, 2013, BIOCHEM J, V452, P303, DOI 10.1042/BJ20121902; Peisley A, 2013, MOL CELL, V51, P573, DOI 10.1016/j.molcel.2013.07.024; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Raicu V, 2005, BIOCHEM J, V385, P265, DOI 10.1042/BJ20040226; Raicu V, 2013, BIOPHYS J, V105, P1937, DOI 10.1016/j.bpj.2013.09.015; Raicu V, 2009, NAT PHOTONICS, V3, P107, DOI 10.1038/NPHOTON.2008.291; Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020; Reikine S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00342; Rodriguez KR, 2014, J VIROL, V88, P8194, DOI 10.1128/JVI.00640-14; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sikora B, 2008, J BIOL CHEM, V283, P11516, DOI 10.1074/jbc.M708125200; Singh DR, 2013, INTEGR BIOL-UK, V5, P312, DOI 10.1039/c2ib20218b; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Skordalakes E, 2006, CELL, V127, P553, DOI 10.1016/j.cell.2006.08.051; Stoneman M, 2011, JOVE-J VIS EXP, DOI 10.3791/2247; Stoneman MR, 2017, BBA-BIOMEMBRANES, V1859, P1456, DOI 10.1016/j.bbamem.2016.12.008; Sumpter R, 2004, J VIROL, V78, P11591, DOI 10.1128/JVI.78.21.11591-11604.2004; Uchikawa E, 2016, MOL CELL, V62, P586, DOI 10.1016/j.molcel.2016.04.021; Vazquez C, 2015, J VIROL, V89, P6974, DOI 10.1128/JVI.01918-14; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wu B, 2014, MOL CELL, V55, P511, DOI 10.1016/j.molcel.2014.06.010; Zhang HX, 2013, P NATL ACAD SCI USA, V110, P6459, DOI 10.1073/pnas.1304432110; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899	67	7	7	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11165	11177		10.1074/jbc.M117.777045	http://dx.doi.org/10.1074/jbc.M117.777045			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28483922	hybrid, Green Published			2022-12-26	WOS:000405119600004
J	Sato, O; Komatsu, S; Sakai, T; Tsukasaki, Y; Tanaka, R; Mizutani, T; Watanabe, TM; Ikebe, R; Ikebe, M				Sato, Osamu; Komatsu, Satoshi; Sakai, Tsuyoshi; Tsukasaki, Yoshikazu; Tanaka, Ryosuke; Mizutani, Takeomi; Watanabe, Tomonobu M.; Ikebe, Reiko; Ikebe, Mitsuo			Human myosin VIIa is a very slow processive motor protein on various cellular actin structures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							USHER 1B SYNDROME; GLOBULAR TAIL DOMAIN; ATPASE ACTIVITY; ARP2/3 COMPLEX; F-ACTIN; MUTATIONS; SHAKER-1; GENE; CONFORMATION; ORGANIZATION	Human myosin VIIa (MYO7A) is an actin-linked motor protein associated with human Usher syndrome (USH) type 1B, which causes human congenital hearing and visual loss. Although it has been thought that the role of human myosin VIIa is critical for USH1 protein tethering with actin and transportation along actin bundles in inner-ear hair cells, myosin VIIa's motor function remains unclear. Here, we studied the motor function of the tail-truncated human myosin VIIa dimer (HM7A Delta Tail/LZ) at the single-molecule level. We found that the HM7A Delta Tail/LZ moves processively on single actin filaments with a step size of 35 nm. Dwell-time distribution analysis indicated an average waiting time of 3.4 s, yielding similar to 0.3 s(-1) for the mechanical turnover rate; hence, the velocity of HM7A Delta Tail/LZ was extremely slow, at 11 nm.s(-1). We also examined HM7A Delta Tail/LZ movement on various actin structures in demembranated cells. HM7A Delta Tail/LZ showed unidirectional movement on actin structures at cell edges, such as lamellipodia and filopodia. However, HM7A Delta Tail/LZ frequently missed steps on actin tracks and exhibited bidirectional movement at stress fibers, which was not observed with tail-truncated myosin Va. These results suggest that the movement of the human myosin VIIa motor protein is more efficient on lamellipodial and filopodial actin tracks than on stress fibers, which are composed of actin filaments with different polarity, and that the actin structures influence the characteristics of cargo transportation by human myosin VIIa. In conclusion, myosin VIIa movement appears to be suitable for translocating USH1 proteins on stereocilia actin bundles in inner-ear hair cells.	[Sato, Osamu; Komatsu, Satoshi; Sakai, Tsuyoshi; Tsukasaki, Yoshikazu; Ikebe, Reiko; Ikebe, Mitsuo] Univ Texas Hlth Sci Ctr Tyler, Dept Cellular & Mol Biol, 11937 US Hwy 271, Tyler, TX 75708 USA; [Tsukasaki, Yoshikazu] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA; [Tanaka, Ryosuke] Hokkaido Univ, Grad Sch Informat Sci & Technol, Sapporo, Hokkaido 0600814, Japan; [Mizutani, Takeomi] Hokkaido Univ, Fac Adv Life Sci, Dept Adv Transdisciplinary Sci, Sapporo, Hokkaido 0600810, Japan; [Watanabe, Tomonobu M.] RIKEN Quantitat Biol Ctr, Lab Comprehens Bioimaging, Suita, Osaka 5650874, Japan	University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Hokkaido University; Hokkaido University; RIKEN	Ikebe, M (corresponding author), Univ Texas Hlth Sci Ctr Tyler, Dept Cellular & Mol Biol, 11937 US Hwy 271, Tyler, TX 75708 USA.	Mitsuo.Ikebe@uthct.edu		Sato, Osamu/0000-0001-9913-1745; Watanabe, Tomonobu/0000-0002-2420-4230	National Institutes of Health [R01 DC006103]; University of Texas System TEXAS STARS PLUS award; Grants-in-Aid for Scientific Research [25287106] Funding Source: KAKEN; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006103] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas System TEXAS STARS PLUS award; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health Grant R01 DC006103 and by the University of Texas System TEXAS STARS PLUS award (to M. I.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ali MY, 2013, TRAFFIC, V14, P70, DOI 10.1111/tra.12017; Brawley CM, 2009, P NATL ACAD SCI USA, V106, P9685, DOI 10.1073/pnas.0810451106; BRETSCHER A, 1980, CELL, V20, P839, DOI 10.1016/0092-8674(80)90330-X; Brown JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009406; BRYAN J, 1982, METHOD CELL BIOL, V25, P175, DOI 10.1016/S0091-679X(08)61425-9; Coluccio L.M., 2008, MYOS SUP MOL MOT, P95; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Cramer LP, 1997, J CELL BIOL, V136, P1287, DOI 10.1083/jcb.136.6.1287; El-Amraoui A, 2002, EMBO REP, V3, P463, DOI 10.1093/embo-reports/kvf090; El-Amraoui A., 2008, MYOS SUP MOL MOT, V7, P353; ElAmraoui A, 1996, HUM MOL GENET, V5, P1171, DOI 10.1093/hmg/5.8.1171; Gibbs D, 2003, P NATL ACAD SCI USA, V100, P6481, DOI 10.1073/pnas.1130432100; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Grati M, 2011, P NATL ACAD SCI USA, V108, P11476, DOI 10.1073/pnas.1104161108; Hasson T, 1997, CELL MOTIL CYTOSKEL, V37, P127, DOI 10.1002/(SICI)1097-0169(1997)37:2<127::AID-CM5>3.0.CO;2-5; HASSON T, 1995, P NATL ACAD SCI USA, V92, P9815, DOI 10.1073/pnas.92.21.9815; Hasson T, 1997, J CELL BIOL, V137, P1287, DOI 10.1083/jcb.137.6.1287; HINNEBUSCH AG, 1984, P NATL ACAD SCI-BIOL, V81, P6442, DOI 10.1073/pnas.81.20.6442; Hodges AR, 2007, J BIOL CHEM, V282, P27192, DOI 10.1074/jbc.M703968200; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; KLEE CB, 1977, BIOCHEMISTRY-US, V16, P1017, DOI 10.1021/bi00624a033; Knight PJ, 2005, J BIOL CHEM, V280, P34702, DOI 10.1074/jbc.M504887200; Krementsov DN, 2004, J CELL BIOL, V164, P877, DOI 10.1083/jcb.200310065; LEWIS AK, 1992, J CELL BIOL, V119, P1219, DOI 10.1083/jcb.119.5.1219; Li XD, 2004, BIOCHEM BIOPH RES CO, V315, P538, DOI 10.1016/j.bbrc.2004.01.084; Li XD, 2008, P NATL ACAD SCI USA, V105, P1140, DOI 10.1073/pnas.0709741105; Li XD, 2006, J BIOL CHEM, V281, P21789, DOI 10.1074/jbc.M602957200; Liu XR, 1999, J NEUROSCI, V19, P6267; Liu XR, 1997, CELL MOTIL CYTOSKEL, V37, P240, DOI 10.1002/(SICI)1097-0169(1997)37:3<240::AID-CM6>3.3.CO;2-2; Liu XR, 1998, NAT GENET, V19, P117, DOI 10.1038/470; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; MEYER RK, 1990, J CELL BIOL, V110, P2013, DOI 10.1083/jcb.110.6.2013; Morgan CP, 2016, ELIFE, V5, DOI 10.7554/eLife.18312; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Olney JJ, 1996, J BIOL CHEM, V271, P20375, DOI 10.1074/jbc.271.34.20375; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Ricca BL, 2010, BIOPHYS J, V99, P1818, DOI 10.1016/j.bpj.2010.06.066; Sakai T, 2015, J BIOL CHEM, V290, P17587, DOI 10.1074/jbc.M114.599365; Sakai T, 2011, P NATL ACAD SCI USA, V108, P7028, DOI 10.1073/pnas.1009188108; Sivaramakrishnan S, 2009, J CELL BIOL, V187, P53, DOI 10.1083/jcb.200906133; Spink BJ, 2008, NAT STRUCT MOL BIOL, V15, P591, DOI 10.1038/nsmb.1429; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Tamagawa Y, 2002, ADV OTO-RHINO-LARYNG, V61, P79; TAYLOR KA, 1994, BIOPHYS J, V67, P1976, DOI 10.1016/S0006-3495(94)80680-0; Tojkander S, 2012, J CELL SCI, V125, P1855, DOI 10.1242/jcs.098087; Umeki N, 2011, NAT STRUCT MOL BIOL, V18, P783, DOI 10.1038/nsmb.2065; Umeki N, 2009, P NATL ACAD SCI USA, V106, P8483, DOI 10.1073/pnas.0812930106; Wang F, 2004, J BIOL CHEM, V279, P2333, DOI 10.1074/jbc.C300488200; Watanabe S, 2006, J BIOL CHEM, V281, P7151, DOI 10.1074/jbc.M511592200; Watanabe S, 2008, BIOCHEMISTRY-US, V47, P9505, DOI 10.1021/bi8007142; Watanabe TM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012224; Weil D, 1997, NAT GENET, V16, P191, DOI 10.1038/ng0697-191; Weil D, 1996, P NATL ACAD SCI USA, V93, P3232, DOI 10.1073/pnas.93.8.3232; WEINER MP, 1994, GENE, V151, P119, DOI 10.1016/0378-1119(94)90641-6; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Yang Y, 2006, P NATL ACAD SCI USA, V103, P5746, DOI 10.1073/pnas.0509935103; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	61	13	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					10950	10960		10.1074/jbc.M116.765966	http://dx.doi.org/10.1074/jbc.M116.765966			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28507101	hybrid, Green Published			2022-12-26	WOS:000404391000017
J	He, DM; Ren, BG; Liu, S; Tan, LZ; Cieply, K; Tseng, G; Yu, YP; Luo, JH				He, D-M; Ren, B-G; Liu, S.; Tan, L-Z; Cieply, K.; Tseng, G.; Yu, Y. P.; Luo, J-H			Oncogenic activity of amplified miniature chromosome maintenance 8 in human malignancies	ONCOGENE			English	Article							GENE-EXPRESSION ALTERATIONS; PROSTATE-CANCER; DNA-REPLICATION; PROTEIN MCM7; HEPATOCELLULAR-CARCINOMA; CELL-CYCLE; CDK4; INHIBITOR; CHROMATIN; KINASES	Miniature chromosome maintenance (MCM) proteins play critical roles in DNA replication licensing, initiation and elongation. MCM8, one of the MCM proteins playing a critical role in DNA repairing and recombination, was found to have overexpression and increased DNA copy number in a variety of human malignancies. The gain of MCM8 is associated with aggressive clinical features of several human cancers. Increased expression of MCM8 in prostate cancer is associated with cancer recurrence. Forced expression of MCM8 in RWPE1 cells, the immortalized but non-transformed prostate epithelial cell line, exhibited fast cell growth and transformation, while knock down of MCM8 in PC3, DU145 and LNCaP cells induced cell growth arrest, and decreased tumour volumes and mortality of severe combined immunodeficiency mice xenografted with PC3 and DU145 cells. MCM8 bound cyclin D1 and activated Rb protein phosphorylation by cyclin-dependent kinase 4 in vitro and in vivo. The cyclin D1/MCM8 interaction is required for Rb phosphorylation and S-phase entry in cancer cells. As a result, our study showed that copy number increase and overexpression of MCM8 may play critical roles in human cancer development.	[He, D-M; Ren, B-G; Tan, L-Z; Cieply, K.; Yu, Y. P.; Luo, J-H] Univ Pittsburgh, Sch Med, Dept Pathol, 3550 Terrace St,Scaife S-728, Pittsburgh, PA 15261 USA; [Liu, S.; Tseng, G.] Univ Pittsburgh, Dept Biostat, Sch Med, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Luo, JH (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, 3550 Terrace St,Scaife S-728, Pittsburgh, PA 15261 USA.	luoj@msx.upmc.edu			National Cancer Institute [RO1 CA098249]; University of Pittsburgh Cancer Institute; NATIONAL CANCER INSTITUTE [R01CA098249] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Pittsburgh Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from National Cancer Institute (RO1 CA098249) to JHL and a grant from University of Pittsburgh Cancer Institute.	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; AlAsiri S, 2015, J CLIN INVEST, V125, P258, DOI 10.1172/JCI78473; Blow JJ, 2002, TRENDS CELL BIOL, V12, P72, DOI 10.1016/S0962-8924(01)02203-6; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; Dai K, 1996, J BIOL CHEM, V271, P22030, DOI 10.1074/jbc.271.36.22030; Edwards MC, 2002, J BIOL CHEM, V277, P33049, DOI 10.1074/jbc.M204438200; Facoetti A, 2006, ANTICANCER RES, V26, P1071; Feber A, 2011, GENOME RES, V21, P515, DOI 10.1101/gr.109678.110; Feng CJ, 2008, ANTICANCER RES, V28, P3763; Freeman A, 1999, CLIN CANCER RES, V5, P2121; Fristrup N, 2013, AM J PATHOL, V182, P339, DOI 10.1016/j.ajpath.2012.10.017; Fujioka S, 2009, LUNG CANCER, V65, P223, DOI 10.1016/j.lungcan.2008.11.007; Gozuacik D, 2003, NUCLEIC ACIDS RES, V31, P570, DOI 10.1093/nar/gkg136; Han YC, 2010, CANCER RES, V70, P4375, DOI 10.1158/0008-5472.CAN-09-4403; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Honeycutt KA, 2006, ONCOGENE, V25, P4027, DOI 10.1038/sj.onc.1209435; Iizuka N, 2006, J CANCER RES CLIN, V132, P473, DOI 10.1007/s00432-006-0094-8; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jing L, 2004, AM J PATHOL, V164, P1799, DOI 10.1016/S0002-9440(10)63738-8; Kang W, 2014, ONCOL REP, V31, P2071, DOI 10.3892/or.2014.3094; KATO J, 1993, GENE DEV, V7, P331; KATO JY, 1994, CELL, V79, P487, DOI 10.1016/0092-8674(94)90257-7; Kearsey SE, 1996, BIOESSAYS, V18, P183, DOI 10.1002/bies.950180305; Labib K, 2001, MOL BIOL CELL, V12, P3658, DOI 10.1091/mbc.12.11.3658; Laitinen S, 2008, INT J CANCER, V122, P595, DOI 10.1002/ijc.23145; Lee KY, NAT COMMUN, V6, P7744; Lu ZH, 1999, MOL BIOL CELL, V10, P4091, DOI 10.1091/mbc.10.12.4091; Luo JH, 2002, DRUG TODAY, V38, P713, DOI 10.1358/dot.2002.38.10.704653; Luo JH, 2002, MOL CARCINOGEN, V33, P25, DOI 10.1002/mc.10018; Luo JH, 2013, AM J PATHOL, V182, P2028, DOI 10.1016/j.ajpath.2013.02.040; Luo JH, 2011, WORLD J CLIN ONCOL, V2, P120, DOI 10.5306/wjco.v2.i2.120; Lutzmann M, 2012, MOL CELL, V47, P523, DOI 10.1016/j.molcel.2012.05.048; Maiorano D, 2005, CELL, V120, P315, DOI 10.1016/j.cell.2004.12.010; MATSUSHIME H, 1992, CELL, V71, P323, DOI 10.1016/0092-8674(92)90360-O; Nishihara K, 2008, INT J ONCOL, V33, P245, DOI 10.3892/ijo_00000003; Ota T, 2011, MODERN PATHOL, V24, P277, DOI 10.1038/modpathol.2010.202; Padmanabhan V, 2004, J CLIN PATHOL, V57, P1057, DOI 10.1136/jcp.2004.016436; Park J, 2013, MOL CELL BIOL, V33, P1632, DOI 10.1128/MCB.01503-12; Ren B, 2006, ONCOGENE, V25, P1090, DOI 10.1038/sj.onc.1209134; Ren BG, 2007, J NATL CANCER I, V99, P868, DOI 10.1093/jnci/djk199; Shi YK, 2008, AM J PATHOL, V173, P1758, DOI 10.2353/ajpath.2008.080363; Shohet JM, 2002, CANCER RES, V62, P1123; Siegel RL, 2017, CA CANC J CLIN 2017; Stepanova L, 1996, GENE DEV, V10, P1491, DOI 10.1101/gad.10.12.1491; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Vallot C, 2011, JNCI-J NATL CANCER I, V103, P47, DOI 10.1093/jnci/djq470; van Dekken H, 2009, CANCER GENET CYTOGEN, V189, P37, DOI 10.1016/j.cancergencyto.2008.08.018; Volkening M, 2005, MOL CELL BIOL, V25, P1560, DOI 10.1128/MCB.25.4.1560-1568.2005; Wang H, 2012, J BIOL CHEM, V287, P16890, DOI 10.1074/jbc.M111.322636; Wang LQ, 2013, J NANOMATER, V2013, DOI 10.1155/2013/321459; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; XIONG Y, 1993, GENE DEV, V7, P1572, DOI 10.1101/gad.7.8.1572; XIONG Y, 1992, CELL, V71, P505, DOI 10.1016/0092-8674(92)90518-H; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Yu YP, 2013, AM J PATHOL, V183, P1960, DOI 10.1016/j.ajpath.2013.08.018; Yu YP, 2012, AM J PATHOL, V180, P2240, DOI 10.1016/j.ajpath.2012.03.008; Yu YP, 2006, UROLOGY, V68, P578, DOI 10.1016/j.urology.2006.03.027; Yu YP, 2006, CANCER RES, V66, P7414, DOI 10.1158/0008-5472.CAN-06-0227; Yu YP, 2005, CARCINOGENESIS, V26, P471, DOI 10.1093/carcin/bgh310; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zhang JM, 1999, EMBO J, V18, P926, DOI 10.1093/emboj/18.4.926; Zhou YM, 2012, LIVER INT, V32, P1505, DOI 10.1111/j.1478-3231.2012.02846.x	64	17	18	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 22	2017	36	25					3629	3639		10.1038/onc.2017.123	http://dx.doi.org/10.1038/onc.2017.123			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EY3NL	28481876	Green Accepted			2022-12-26	WOS:000403878600012
J	Karathedath, S; Rajamani, BM; Aalam, SMM; Abraham, A; Varatharajan, S; Krishnamurthy, P; Mathews, V; Velayudhan, SR; Balasubramanian, P				Karathedath, Sreeja; Rajamani, Bharathi M.; Aalam, Syed Mohammed Musheer; Abraham, Ajay; Varatharajan, Savitha; Krishnamurthy, Partha; Mathews, Vikram; Velayudhan, Shaji Ramachandran; Balasubramanian, Poonkuzhali			Role of NF-E2 related factor 2 (Nrf2) on chemotherapy resistance in acute myeloid leukemia (AML) and the effect of pharmacological inhibition of Nrf2	PLOS ONE			English	Article							OXIDATIVE STRESS; CANCER-CELLS; LUNG-CANCER; STEM-CELLS; ACTIVATION; EXPRESSION; PATHWAY; KEAP1; PROLIFERATION; APOPTOSIS	Cytarabine (Ara-C) and Daunorubicin (Dnr) forms the backbone of acute myeloid leukemia (AML) therapy. Drug resistance and toxic side effects pose a major threat to treatment success and hence alternate less toxic therapies are warranted. NF-E2 related factor-2 (Nrf2), a master regulator of antioxidant response is implicated in chemoresistance in solid tumors. However, little is known about the role of Nrf2 in AML chemoresistance and the effect of pharmacological inhibitor brusatol in modulating this resistance. Primary AML samples with high ex-vivo IC50 to Ara-C, ATO, Dnr had significantly high NRF2 RNA expression. Gene-specific knockdown of NRF2 improved sensitivity to these drugs in resistant AML cell lines by decreasing the expression of downstream antioxidant targets of Nrf2 by compromising the cell's ability to scavenge the ROS. Treatment with brusatol, a pharmacological inhibitor of Nrf2, improved sensitivity to Ara-C, ATO, and Dnr and reduced colony formation capacity. AML cell lines stably overexpressing NRF2 showed increased resistance to ATO, Dnr and Ara-C and increased expression of downstream targets. This study demonstrates that Nrf2 could be an ideal druggable target in AML, more so to the drugs that function through ROS, suggesting the possibility of using Nrf2 inhibitors in combination with chemotherapeutic agents to modulate drug resistance in AML.	[Karathedath, Sreeja; Rajamani, Bharathi M.; Abraham, Ajay; Varatharajan, Savitha; Mathews, Vikram; Velayudhan, Shaji Ramachandran; Balasubramanian, Poonkuzhali] Christian Med Coll & Hosp, Dept Haematol, Vellore, Tamil Nadu, India; [Aalam, Syed Mohammed Musheer; Velayudhan, Shaji Ramachandran] Christian Med Coll & Hosp, Ctr Stem Cell Res, Vellore, Tamil Nadu, India; [Krishnamurthy, Partha] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA	Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore; University of Kansas; University of Kansas Medical Center	Balasubramanian, P (corresponding author), Christian Med Coll & Hosp, Dept Haematol, Vellore, Tamil Nadu, India.	bpoonkuzhali@cmcvellore.ac.in	Abraham, Ajay/AAK-8454-2020; Aalam, Syed Mohammed Musheer/AAR-2902-2021	Abraham, Ajay/0000-0003-4094-2476; Aalam, Syed Mohammed Musheer/0000-0002-8566-197X; Balasubramanian, Poonkuzhali/0000-0002-9443-439X; R Velayudhan, Shaji/0000-0002-8600-2933; Mathews, Vikram/0000-0001-9417-2353	Centre of Excellence grant from Department of Biotechnology India [BT/COE/34/SP13432/2015, BT/PR8742/AGR/36/773/2013]; University Grants Commission, Government of India; Indian Council of Medical Research; Wellcome DBT India Alliance, New Delhi, India [IN 5/11/2500267, IA/S/15/1/501842]	Centre of Excellence grant from Department of Biotechnology India; University Grants Commission, Government of India(University Grants Commission, India); Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Wellcome DBT India Alliance, New Delhi, India(Wellcome Trust DBT India Alliance)	This study is supported by Centre of Excellence grant from Department of Biotechnology India: BT/COE/34/SP13432/2015 to Dr. Poonkuzhali Balasubramanian and BT/PR8742/AGR/36/773/2013 to Dr. Shaji R.V. SK and AA are supported by University Grants Commission, Government of India. SV is a recipient of a senior research fellowship from Indian Council of Medical Research. VM and PB are supported by Senior Fellowship from Wellcome DBT India Alliance (IN 5/11/2500267 and IA/S/15/1/501842), New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlt A, 2013, ONCOGENE, V32, P4825, DOI 10.1038/onc.2012.493; Bhullar J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071266; Biswas C, 2014, J BIOL CHEM, V289, P26882, DOI 10.1074/jbc.M114.567685; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Furukawa Y, 1998, Hum Cell, V11, P81; Gao AM, 2013, CARCINOGENESIS, V34, P1806, DOI 10.1093/carcin/bgt108; Hanada N, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-66; Hole PS, 2013, BLOOD, V122, P3322, DOI 10.1182/blood-2013-04-491944; Hu XF, 2013, ASIAN PAC J CANCER P, V14, P5231, DOI 10.7314/APJCP.2013.14.9.5231; Kang KA, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.149; Lagadinou ED, 2013, CELL STEM CELL, V12, P329, DOI 10.1016/j.stem.2012.12.013; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Li MH, 2006, FREE RADICAL BIO MED, V41, P1079, DOI 10.1016/j.freeradbiomed.2006.06.010; Lien EC, 2016, NAT CELL BIOL, V18, P572, DOI 10.1038/ncb3341; Lister A, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-37; Liu QA, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-37; Liu Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.467; Minocherhomji S, 2015, NATURE, V528, P286, DOI 10.1038/nature16139; Mitsuishi Y, 2012, CANCER CELL, V22, P66, DOI 10.1016/j.ccr.2012.05.016; No Jae Hong, 2014, J Cancer Prev, V19, P111, DOI 10.15430/JCP.2014.19.2.111; Ofran Y, 2016, BLOOD, V128, P488, DOI 10.1182/blood-2016-01-635060; Ohta T, 2008, CANCER RES, V68, P1303, DOI 10.1158/0008-5472.CAN-07-5003; Olayanju A, 2015, FREE RADICAL BIO MED, V78, P202, DOI 10.1016/j.freeradbiomed.2014.11.003; Peng HG, 2011, PROCED EARTH PLAN SC, V2, P7, DOI 10.1016/j.proeps.2011.09.002; Pulte D, 2010, ANN ONCOL, V21, P335, DOI 10.1093/annonc/mdp309; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; Rushworth SA, 2012, BLOOD, V120, P5188, DOI 10.1182/blood-2012-04-422121; Rushworth Stuart A, 2011, Cancers (Basel), V3, P1605, DOI 10.3390/cancers3021605; Takahashi T, 2010, J SURG ONCOL, V101, P500, DOI 10.1002/jso.21520; Tang XW, 2011, FREE RADICAL BIO MED, V50, P1599, DOI 10.1016/j.freeradbiomed.2011.03.008; Tao S, 2014, CANCER RES, V74, P7430, DOI 10.1158/0008-5472.CAN-14-1439; Townsend DM, 2005, METHOD ENZYMOL, V401, P287, DOI 10.1016/S0076-6879(05)01019-0; Uras IZ, 2016, BLOOD; Walter RB, 2011, J CLIN ONCOL, V29, P4417, DOI 10.1200/JCO.2011.35.7525; Wang XJ, 2008, CARCINOGENESIS, V29, P1235, DOI 10.1093/carcin/bgn095; Yoon DS, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.3	36	49	51	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177227	10.1371/journal.pone.0177227	http://dx.doi.org/10.1371/journal.pone.0177227			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505160	Green Submitted, gold, Green Published			2022-12-26	WOS:000401473500015
J	Heo, JY; Seo, YB; Choi, WS; Lee, J; Noh, JY; Jeong, HW; Kim, WJ; Kim, MJ; Lee, HY; Song, JY				Heo, Jung Yeon; Seo, Yu Bin; Choi, Won Suk; Lee, Jacob; Noh, Ji Yun; Jeong, Hye Won; Kim, Woo Joo; Kim, Min Ja; Lee, Hee Young; Song, Joon Young			Cost-effectiveness of pneumococcal vaccination strategies for the elderly in Korea	PLOS ONE			English	Article							AT-RISK ADULTS; CONJUGATE VACCINE; POLYSACCHARIDE VACCINE; ECONOMIC BURDEN; PUBLIC-HEALTH; DISEASE; PNEUMONIA; INFLUENZA; OLDER; POPULATION	Background Although the 13-valent pneumococcal conjugate vaccine (PCV13) showed good efficacy against pneumococcal disease in the the CAPiTA trial, the 23-valent pneumococcal polysaccharide vaccination (PPSV23) program has been ongoing for older adults aged >= 65 years in Korea since May of 2013. This study aimed to evaluate the cost-effectiveness of the current vaccination strategy (a single-dose PPSV23 vaccination) compared to a single-dose PCV13 vaccination and sequential PCV13-PPSV23 vaccinations in the elderly population aged >= 65 years. Methods Using a Markov model, the incremental cost-effectiveness ratios (ICERs) of three vaccination strategies were assessed in a societal context. The transition probabilities, utility weights to estimate quality adjusted life year (QALY), and disease treatment costs were either calculated or cited from published data and the Health Insurance Review and Assessment Service. Simulations were performed in hypothetical cohorts of Korean adults aged >= 19 years. The vaccine effectiveness of PPSV23 was cited from a Cochrane Review report, while PCV13 effectiveness data were gathered from the CAPiTA trial. Results Current PPSV23 vaccination strategies were cost-effective (ICER, $ 25,786 per QALY). However, the administration of PCV13 as a substitute for PPSV23 was shown to be more cost-effective than PPSV23 vaccination (ICER, $ 797 per QALY). Sequential PCV13PPSV23 vaccination was also more cost-effective than PPSV23 for elderly people aged >= 65 years. In sensitivity analysis assuming significant PPSV23 effectiveness (50%) against non-bacteremic pneumococcal pneumonia, the PCV13 vaccination strategy was superior to the PPSV23 vaccination strategy in terms of cost-effectiveness. Conclusion The results suggest that PCV13 vaccination is more cost-effective in elderly subjects aged >= 65 years compared to the current PPSV23 vaccination strategy. When complete data is obtained in 2018 on the maximal herd effects of childhood PCV13 immunization, the incidence of pneumococcal pneumonia and the cost-effectiveness of vaccination strategies need to be reassessed.	[Heo, Jung Yeon; Jeong, Hye Won] Chungbuk Natl Univ, Coll Med, Dept Internal Med, Div Infect Dis, Cheongju, South Korea; [Heo, Jung Yeon; Jeong, Hye Won] Chungbuk Natl Univ Hosp, Dept Internal Med, Div Infect Dis, Cheongju, South Korea; [Seo, Yu Bin; Lee, Jacob] Hallym Univ, Coll Med, Dept Internal Med, Div Infect Dis, Chunchon, South Korea; [Choi, Won Suk; Noh, Ji Yun; Kim, Woo Joo; Kim, Min Ja; Song, Joon Young] Korea Univ, Coll Med, Dept Internal Med, Div Infect Dis, Seoul, South Korea; [Lee, Hee Young] Seoul Natl Univ, Bundang Hosp, Ctr Prevent Med & Publ Hlth, Seongnam, South Korea	Chungbuk National University; Chungbuk National University; Chungbuk National University Hospital; Hallym University; Korea University; Korea University Medicine (KU Medicine); Seoul National University (SNU)	Song, JY (corresponding author), Korea Univ, Coll Med, Dept Internal Med, Div Infect Dis, Seoul, South Korea.; Lee, HY (corresponding author), Seoul Natl Univ, Bundang Hosp, Ctr Prevent Med & Publ Hlth, Seongnam, South Korea.	wanderingstone@gmail.com; infection@korea.ac.kr	lee, hy/GRS-0797-2022; Choi, Won Suk/V-2730-2017	Choi, Won Suk/0000-0001-5874-4764; Song, Joon Young/0000-0002-0148-7194; KIM, MIN JA/0000-0002-2125-7521; Heo, Jung Yeon/0000-0002-6548-1939	Korea Centers for Disease Control and Prevention [2015-E32009-00]	Korea Centers for Disease Control and Prevention	This research was supported by funding (No. 2015-E32009-00) from the Korea Centers for Disease Control and Prevention.	[Anonymous], 2005, MMWR-MORBID MORTAL W, V54, P893; Boccalini S, 2013, HUM VACC IMMUNOTHER, V9, P699, DOI 10.4161/hv.23268; Bonten MJM, 2015, NEW ENGL J MED, V372, P1114, DOI 10.1056/NEJMoa1408544; Castiglia P, 2014, ADV THER, V31, P1011, DOI 10.1007/s12325-014-0157-1; Choi MJ, 2016, IDWEEK 2016; Christenson B, 2001, LANCET, V357, P1008, DOI 10.1016/S0140-6736(00)04237-9; Christenson B, 2004, EUR RESPIR J, V23, P363, DOI 10.1183/09031936.04.00063504; Department of Health and Human Services Centers for Disease Control and Prevention, 2012, 20091202 ACIP CDCP D; Diao WQ, 2016, VACCINE, V34, P1496, DOI 10.1016/j.vaccine.2016.02.023; Elston JWT, 2012, EPIDEMIOL INFECT, V140, P1252, DOI 10.1017/S0950268811001907; Feikin DR, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001517; French N, 2000, LANCET, V355, P2106, DOI 10.1016/S0140-6736(00)02377-1; Guevara M, 2009, CLIN MICROBIOL INFEC, V15, P1013, DOI 10.1111/j.1469-0691.2009.02904.x; Health Insurance Review and Assessment Service (HIRA), 2006, GUID EC EV PHARM KOR; Heo JY, 2016, 10 INT S PNEUM PNEUM; Hoshi SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139140; Huss A, 2009, CAN MED ASSOC J, V180, P48, DOI 10.1503/cmaj.080734; Hutton J, 2002, ISPOR 5 ANN EUR C, P47; Jackson LA, 2013, VACCINE, V31, P3577, DOI 10.1016/j.vaccine.2013.04.085; Jackson LA, 2013, VACCINE, V31, P3585, DOI 10.1016/j.vaccine.2013.05.010; Jiang Y, 2014, EXPERT REV PHARM OUT, V14, P913, DOI 10.1586/14737167.2014.950232; Jiang YL, 2014, EXPERT REV PHARM OUT, V14, P901, DOI 10.1586/14737167.2014.953932; Jiang YL, 2012, EXPERT REV PHARM OUT, V12, P645, DOI [10.1586/erp.12.54, 10.1586/ERP.12.54]; Kee SY, 2007, J INFECTION, V55, P273, DOI 10.1016/j.jinf.2007.04.354; Kim MJ, 2015, PNEUMOCOCCAL DIS SER; Klugman KP, 2014, LANCET GLOB HEALTH, V2, pE365, DOI 10.1016/S2214-109X(14)70241-4; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Korean Centers for Disease Control and Prevention(KCDC), 2016, GUID NAT PNEUM IMM P, P83; Kraicer-Melamed H, 2016, VACCINE, V34, P1540, DOI 10.1016/j.vaccine.2016.02.024; Kuhlmann A, 2012, HEALTH ECON REV, V2, DOI 10.1186/2191-1991-2-4; Lee SG., 2013, 2013E320010 KOR CTR; Mangen MJJ, 2015, EUR RESPIR J, V46, P1407, DOI 10.1183/13993003.00325-2015; McCullers JA, 2002, J INFECT DIS, V186, P341, DOI 10.1086/341462; Moberley SA, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000422.pub2; Moberley S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000422.pub3; Moore MR, 2015, LANCET INFECT DIS, V15, P301, DOI 10.1016/S1473-3099(14)71081-3; National Evidence- based Healthcare Collaborating Agency (NECA), 2015, HDB CLIN PRACT GUID; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Smith KJ, 2012, JAMA-J AM MED ASSOC, V307, P804, DOI 10.1001/jama.2012.169; Song JY, 2013, INFECT CHEMOTHER, V45, P351, DOI 10.3947/ic.2013.45.4.351; Song JY, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-202; Stoecker C, 2016, J GEN INTERN MED, V31, P901, DOI 10.1007/s11606-016-3651-0; The Statistics Korea, 2016, KEY NAT IND KOR; Tomczyk S, 2014, MMWR-MORBID MORTAL W, V63, P822; van Hoek AJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149540; Vila-Corcoles A, 2006, CLIN INFECT DIS, V43, P860, DOI 10.1086/507340; Waight PA, 2015, LANCET INFECT DIS, V15, P535, DOI 10.1016/S1473-3099(15)70044-7; Walter ND, 2010, CLIN INFECT DIS, V50, P175, DOI 10.1086/649208; Weycker D, 2012, VACCINE, V30, P5437, DOI 10.1016/j.vaccine.2012.05.076; Yoo KH, 2013, J KOREAN MED SCI, V28, P888, DOI 10.3346/jkms.2013.28.6.888	50	21	22	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177342	10.1371/journal.pone.0177342	http://dx.doi.org/10.1371/journal.pone.0177342			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498857	Green Submitted, Green Published, gold			2022-12-26	WOS:000401314500016
J	Kische, H; Gross, S; Wallaschofski, H; Grabe, HJ; Volzke, H; Nauck, M; Haring, R				Kische, Hanna; Gross, Stefan; Wallaschofski, Henri; Grabe, Hans Joergen; Voelzke, Henry; Nauck, Matthias; Haring, Robin			Associations of androgens with depressive symptoms and cognitive status in the general population	PLOS ONE			English	Article							FREE TESTOSTERONE LEVELS; OLDER MEN; SERUM TESTOSTERONE; DEHYDROEPIANDROSTERONE-SULFATE; REPRODUCTIVE HORMONES; RECEPTOR POLYMORPHISM; REFERENCE RANGES; WOMEN; MOOD; HEALTH	Objectives Associations between androgens and depressive symptoms were mostly reported from cross-sectional and patient-based studies. Study design/main outcome measures Longitudinal data from 4,110 participants of the Study of Health in Pomerania were used to assess sex-specific associations of baseline total and free testosterone, androstenedione and sex hormone-binding globulin with incident depressive symptoms and cognitive status at 5-and 10-year follow-up. Results Despite sex-specific differences in depressive symptoms prevalence at baseline (women: 17.4%, men: 8.1%), cross-sectional analyses showed no associations between sex hormones and depressive symptoms. In age-adjusted longitudinal analyses, total testosterone was associated with incident depressive symptoms (relative risk at 5-year follow-up: 0.73, 95% confidence interval: 0.58-0.92). Similarly, age-adjusted analyses showed a positive association between sex hormone-binding globulin and cognitive status in men (beta-coefficient per standard deviation: 0.44, 95% confidence interval: 0.13-0.74). In women, age-adjusted associations of androstenedione with baseline depressive symptoms (relative risk: 0.88, 95% confidence interval: 0.77-0.99) were found. None of the observed associations remained after multivariable adjustment. Conclusions The present population-based, longitudinal study revealed inverse associations between sex hormones and depressive symptoms. However, the null finding after multivariable adjustment suggests, that the observed associations were not independent of relevant confounders including body mass index, smoking and physical inactivity. Furthermore, the low number of incident endpoints in our non-clinical population-based sample limited the statistical power and reduced the chance to detect a statistically significant effect.	[Kische, Hanna; Wallaschofski, Henri; Nauck, Matthias; Haring, Robin] Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany; [Gross, Stefan; Voelzke, Henry; Nauck, Matthias] German Ctr Cardiovasc Res DZHK, Partner Site Greifswald, Greifswald, Germany; [Gross, Stefan] Univ Med Greifswald, Dept Cardiol, Greifswald, Germany; [Grabe, Hans Joergen] Univ Med Greifswald, Dept Psychiat & Psychotherapy, Greifswald, Germany; [Voelzke, Henry] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Haring, Robin] European Univ Appl Sci, Fac Appl Publ Hlth, Rostock, Germany; [Haring, Robin] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Australia	Greifswald Medical School; German Centre for Cardiovascular Research; Greifswald Medical School; Greifswald Medical School; Greifswald Medical School; Monash University	Kische, H (corresponding author), Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany.	kischeh@uni-greifswald.de	Wilkening, Robin/J-5535-2018	Wilkening, Robin/0000-0002-8332-5016	Federal Ministry of Education and Research [01ZZ9603, 01ZZ0103, 01ZZ0403]; Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania	SHIP is part of the Community Medicine Research net of the University Greifswald, Germany, which is funded by the Federal Ministry of Education and Research (grants no. 01ZZ9603, 01ZZ0103, and 01ZZ0403), the Ministry of Cultural Affairs, as well as the Social Ministry of the Federal State of Mecklenburg-West Pomerania. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida OP, 2008, ARCH GEN PSYCHIAT, V65, P283, DOI 10.1001/archgenpsychiatry.2007.33; Amiaz R, 2008, CURR OPIN ENDOCRINOL, V15, P278, DOI 10.1097/MED.0b013e3282fc27eb; Barrett-Connor E, 1999, J AM GERIATR SOC, V47, P685, DOI 10.1111/j.1532-5415.1999.tb01590.x; Barrett-Connor E, 1999, J CLIN ENDOCR METAB, V84, P573, DOI 10.1210/jc.84.2.573; Barrett-Connor E, 1999, BIOAVAILABLE TESTOST, P573; Booth A, 1999, J HEALTH SOC BEHAV, V40, P130, DOI 10.2307/2676369; Bove RM, 2016, OBESITY, V24, P954, DOI 10.1002/oby.21415; Bromberger JT, 2010, ARCH GEN PSYCHIAT, V67, P598, DOI 10.1001/archgenpsychiatry.2010.55; Ebner Natalie C, 2014, Front Psychol, V5, P1595, DOI 10.3389/fpsyg.2014.01595; Ford AH, 2016, PSYCHONEUROENDOCRINO, V64, P57, DOI 10.1016/j.psyneuen.2015.11.012; Friedrich N, 2008, J ANDROL, V29, P610, DOI 10.2164/jandrol.108.005561; Grabe HJ, 2009, SOC PSYCH PSYCH EPID, V44, P835, DOI 10.1007/s00127-009-0005-9; Haring R, 2012, J CLIN ENDOCR METAB, V97, P408, DOI 10.1210/jc.2011-2134; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; Heinemann L A, 2000, Aging Male, V3, P124, DOI 10.1080/13685530008500334; Hohlagschwandtner M, 2001, ACTA OBSTET GYN SCAN, V80, P326, DOI 10.1034/j.1600-0412.2001.080004326.x; Holland J, 2011, MATURITAS, V69, P322, DOI 10.1016/j.maturitas.2011.05.012; Hsu B, 2015, J CLIN ENDOCR METAB, V100, P2223, DOI 10.1210/jc.2015-1016; Huang G, 2016, LANCET DIABETES ENDO; Ibrahim AK, 2013, J PSYCHIATR RES, V47, P391, DOI 10.1016/j.jpsychires.2012.11.015; Joshi D, 2010, CLIN ENDOCRINOL, V72, P232, DOI 10.1111/j.1365-2265.2009.03641.x; Luppa M, 2012, J AFFECT DISORDERS, V136, P212, DOI 10.1016/j.jad.2010.11.033; Margolese HC, 2000, J GERIATR PSYCH NEUR, V13, P93, DOI 10.1177/089198870001300208; Miller KK, 2004, J CLIN ENDOCR METAB, V89, P525, DOI 10.1210/jc.2003-030680; Resnick SM, 2006, J CLIN ENDOCR METAB, V91, P1802, DOI 10.1210/jc.2005-2097; Rohr UD, 2002, MATURITAS, V41, pS25; Schule C, 2007, NERVENARZT, V78, P531, DOI 10.1007/s00115-007-2370-5; Schwarz S, 2007, MENOPAUSE, V14, P123, DOI 10.1097/01.gme.0000227860.58097.e9; Seidman SN, 2001, BIOL PSYCHIAT, V50, P371, DOI 10.1016/S0006-3223(01)01148-9; SHERWIN BB, 1988, PSYCHONEUROENDOCRINO, V13, P345, DOI 10.1016/0306-4530(88)90060-1; Shores MM, 2005, J CLIN PSYCHIAT, V66, P7, DOI 10.4088/JCP.v66n0102; T'Sjoen GG, 2005, J AM GERIATR SOC, V53, P636, DOI 10.1111/j.1532-5415.2005.53212.x; Takayanagi Y, 2015, AM J GERIAT PSYCHIAT, V23, P253, DOI 10.1016/j.jagp.2013.02.003; Thienpont LM, 2008, CLIN CHEM, V54, P1290, DOI 10.1373/clinchem.2008.105841; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Volzke H, 2010, INT J EPIDEMIOL; Wang C, 2004, LONG TERM TESTOSTERO, P2085; Zarrour FA, 2009, J PSYCHIATR PRACT, V15, P289, DOI 10.1097/01.pra.0000358315.88931.fc	38	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177272	10.1371/journal.pone.0177272	http://dx.doi.org/10.1371/journal.pone.0177272			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UR	28498873	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314500014
J	Fayon, M; Lacoste-Rodrigues, A; Barat, P; Helbling, JC; Nacka, F; Berger, P; Moisan, MP; Corcuff, JB				Fayon, Michael; Lacoste-Rodrigues, Aurelie; Barat, Pascal; Helbling, Jean-Christophe; Nacka, Fabienne; Berger, Patrick; Moisan, Marie-Pierre; Corcuff, Jean-Benoit			Nasal airway epithelial cell IL-6 and FKBP51 gene expression and steroid sensitivity in asthmatic children	PLOS ONE			English	Article							LEUKEMIA INHIBITORY FACTOR; SMOOTH-MUSCLE-CELLS; INFLAMMATION; BIOMARKERS; CYTOKINE; FUTURE	Background Many asthmatic patients exhibit uncontrolled asthma despite high-dose inhaled corticosteroids (ICS). Airway epithelial cells (AEC) have distinct activation profiles that can influence ICS response. Objectives A pilot study to identify gene expression markers of AEC dysfunction and markers of corticosteroid sensitivity in asthmatic and non-asthmatic control children, for comparison with published reports in adults. Methods AEC were obtained by nasal brushings and primary submerged cultures, and incubated in control conditions or in the presence of 10 ng/ml TNFalpha, 10(-8) M dexamethasone, or both. RT-PCR-based expression of FKBP51 (a steroid hormone receptor signalling regulator), NF-kB, IL-6, LIF (an IL-6 family neurotrophic cytokine), serpinB2 (which inhibits plasminogen activation and promotes fibrin deposition) and porin (a marker of mitochondrial mass) were determined. Results 6 patients without asthma (median age 11yr; min-max: 7-13), 8 with controlled asthma (11yr, 7-13; median daily fluticasone dose = 100 mu g), and 4 with uncontrolled asthma (12yr, 7-14; 1000 mu g fluticasone daily) were included. Baseline expression of LIF mRNA was significantly increased in uncontrolled vs controlled asthmatic children. TNFalpha significantly increased LIF expression in uncontrolled asthma. A similar trend was observed regarding IL-6. Dexamethasone significantly upregulated FKBP51 expression in all groups but the response was blunted in asthmatic children. No significant upregulation was identified regarding NF-kB, serpinB2 and porin. Conclusion LIF and FKBP51 expression in epithelial cells were the most interesting markers of AEC dysfunction/response to corticosteroid treatment.	[Fayon, Michael; Lacoste-Rodrigues, Aurelie; Berger, Patrick] Univ Bordeaux, Ctr Rech Cardiothorac Bordeaux, U1045, Bordeaux, France; [Fayon, Michael; Lacoste-Rodrigues, Aurelie; Barat, Pascal; Nacka, Fabienne; Berger, Patrick] CHU Bordeaux, Ctr Invest Clin CIC 1401, Bordeaux, France; [Barat, Pascal; Helbling, Jean-Christophe; Moisan, Marie-Pierre; Corcuff, Jean-Benoit] Univ Bordeaux, Nutr & Integrat Neurobiol, Bordeaux, France; [Helbling, Jean-Christophe; Moisan, Marie-Pierre; Corcuff, Jean-Benoit] INRA, UMR1286, Nutr & Integrat Neurobiol, Bordeaux, France	UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; INRAE; UDICE-French Research Universities; Universite de Bordeaux	Fayon, M (corresponding author), Univ Bordeaux, Ctr Rech Cardiothorac Bordeaux, U1045, Bordeaux, France.; Fayon, M (corresponding author), CHU Bordeaux, Ctr Invest Clin CIC 1401, Bordeaux, France.	michael.fayon@chu-bordeaux.fr	Moisan, Marie-Pierre/AAO-9971-2021; BARAT, Pascal/AAC-8948-2019; Berger, Patrick/D-8779-2012; Fayon, Michael/HDN-7887-2022; Corcuff, jb/GWM-4201-2022	Moisan, Marie-Pierre/0000-0001-7315-5319; BARAT, Pascal/0000-0001-5029-0200; Berger, Patrick/0000-0003-4702-0343; Fayon, Michael/0000-0002-1238-2128; Helbling, Jean-Christophe/0000-0001-7407-0114				Aguilera-Aguirre L, 2009, J IMMUNOL, V183, P5379, DOI 10.4049/jimmunol.0900228; [Anonymous], 2000, Am J Respir Crit Care Med, V162, P2341; Bhandari V, 2006, FREE RADICAL BIO MED, V41, P4, DOI 10.1016/j.freeradbiomed.2006.01.027; Bucchieri F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120510; Bush Andrew, 2004, Paediatr Respir Rev, V5 Suppl A, pS93, DOI 10.1016/S1526-0542(04)90018-8; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carayol N, 2002, AM J RESP CELL MOL, V26, P341, DOI 10.1165/ajrcmb.26.3.4684; Chaker AM, 2017, ORL J OTO-RHINO-LARY, V79, P72, DOI 10.1159/000455725; Chanez P, 2014, EUR RESPIR REV, V23, P405, DOI 10.1183/09059180.00009614; Desai D, 2010, RECENT PATENTS INFLA, V4, P193, DOI 10.2174/187221310793564218; Dietz K, 2016, J ALLERGY CLIN IMMUN; Fayon M, 2006, AM J PHYSIOL-LUNG C, V291, pL244, DOI 10.1152/ajplung.00474.2005; Fayon M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122446; Ferreira MAR, 2011, LANCET, V378, P1006, DOI 10.1016/S0140-6736(11)60874-X; Giovannini-Chami L, 2012, EUR RESPIR J, V39, P1197, DOI 10.1183/09031936.00070511; Girodet PO, 2011, PHARMACOL THERAPEUT, V130, P325, DOI 10.1016/j.pharmthera.2011.02.001; Hawkins GA, 2012, J ALLERGY CLIN IMMUN, V130, P510; Holgate ST, 2013, ALLERGY ASTHMA IMMUN, V5, P343, DOI 10.4168/aair.2013.5.6.343; Iosifidis T, 2016, RESPIROLOGY, V21, P438, DOI 10.1111/resp.12731; Kicic A, 2016, CLIN EXP ALLERGY; Kicic A, 2006, AM J RESP CRIT CARE, V174, P1110, DOI 10.1164/rccm.200603-392OC; Knight D, 2001, PULM PHARMACOL THER, V14, P169, DOI 10.1006/pupt.2001.0282; Konradova V, 1985, Pediatr Pulmonol, V1, P182, DOI 10.1002/ppul.1950010403; Le Souef PN, 2004, PEDIATR PULM, P34, DOI 10.1002/ppul.70040; Li MA, 2014, PATHOL RES PRACT, V210, P1038, DOI 10.1016/j.prp.2014.03.010; Lin Min-juan, 2005, Zhonghua Jiehe He Huxi Zazhi, V28, P820; Ling KM, 2016, RESPIROLOGY; Lopez-Guisa JM, 2012, J ALLERGY CLIN IMMUN, V129, P990, DOI 10.1016/j.jaci.2011.11.035; Martinez-Nunez RT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111659; Matsumura Yasuhiro, 2010, Int J Biomed Sci, V6, P158; McDougall CM, 2015, RESP MED, V109, P689, DOI 10.1016/j.rmed.2015.04.001; McLellan K, 2015, PEDIAT PULMONOL; Muller GC, 2011, NEUROIMMUNOMODULAT, V18, P98, DOI 10.1159/000320343; Payne DNR, 1998, PEDIATR PULM, V25, P59, DOI 10.1002/(SICI)1099-0496(199801)25:1<59::AID-PPUL7>3.3.CO;2-9; Petrovic N, 2006, PROSTAG OTH LIPID M, V81, P126, DOI 10.1016/j.prostaglandins.2006.08.006; Poole A, 2014, J ALLERGY CLIN IMMUN, V133, P670, DOI 10.1016/j.jaci.2013.11.025; Pringle EJ, 2012, PEDIATR PULM, V47, P1215, DOI 10.1002/ppul.22672; Ranganathan SC, 2001, PEDIATR PULM, V31, P114, DOI 10.1002/1099-0496(200102)31:2<114::AID-PPUL1018>3.0.CO;2-O; Sabbagh JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107241; Sebag SC, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.88297; Singhania A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168680; Trian T, 2007, J EXP MED, V204, P3173, DOI 10.1084/jem.20070956; Trian T, 2015, AM J RESP CRIT CARE, V191, P538, DOI 10.1164/rccm.201409-1582OC; Woodruff PG, 2007, P NATL ACAD SCI USA, V104, P15858, DOI 10.1073/pnas.0707413104; Xiong WN, 2007, J HUAZHONG U SCI-MED, V27, P372, DOI 10.1007/s11596-007-0406-5; Yim RP, 2012, PAEDIATR RESPIR REV, V13, P172, DOI 10.1016/j.prrv.2011.05.002; Zissler UM, 2016, ALLERGY, V71, P475, DOI 10.1111/all.12828	47	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177051	10.1371/journal.pone.0177051	http://dx.doi.org/10.1371/journal.pone.0177051			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493984	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314300054
J	Rafacho, BPM; dos Santos, PP; Goncalves, AD; Fernandes, AAH; Okoshi, K; Chiuso-Minicucci, F; Azevedo, PS; Zornoff, LAM; Minicucci, MF; Wang, XD; de Paiva, SAR				Murino Rafacho, Bruna Paola; dos Santos, Priscila Portugal; Goncalves, Andrea de Freitas; Henrique Fernandes, Ana Angelica; Okoshi, Katashi; Chiuso-Minicucci, Fernanda; Azevedo, Paula S.; Mamede Zornoff, Leonardo Antonio; Minicucci, Marcos Ferreira; Wang, Xiang-Dong; Rupp de Paiva, Sergio Alberto			Rosemary supplementation (Rosmarinus oficinallis L.) attenuates cardiac remodeling after myocardial infarction in rats	PLOS ONE			English	Article							OXIDATIVE STRESS; DIASTOLIC DYSFUNCTION; HEART-FAILURE; ANTIOXIDANT; ACID; SIZE; RECOMMENDATIONS; OFFICINALIS; ASSOCIATION; INHIBITION	Background Myocardial infarction (MI) is one of the leading causes of morbidity and mortality worldwide. Dietary intervention on adverse cardiac remodeling after MI has significant clinical relevance. Rosemary leaves are a natural product with antioxidant/anti-inflammatory properties, but its effect on morphology and ventricular function after MI is unknown. Methods and results To determine the effect of the dietary supplementation of rosemary leaves on cardiac remodeling after MI, male Wistar rats were divided into 6 groups after sham procedure or experimental induced MI: 1) Sham group fed standard chow (SR0, n = 23); 2) Sham group fed standard chow supplemented with 0.02% rosemary (R002) (SR002, n = 23); 3) Sham group fed standard chow supplemented with 0.2% rosemary (R02) (SR02, n = 22); 4) group submitted to MI and fed standard chow (IR0, n = 13); 5) group submitted to MI and fed standard chow supplemented with R002 (IR002, n = 8); and 6) group submitted to MI and fed standard chow supplemented with R02 (IR02, n = 9). After 3 months of the treatment, systolic pressure evaluation, echocardiography and euthanasia were performed. Left ventricular samples were evaluated for: fibrosis, cytokine levels, apoptosis, energy metabolism enzymes, and oxidative stress. Rosemary dietary supplementation attenuated cardiac remodeling by improving energy metabolism and decreasing oxidative stress. Rosemary supplementation of 0.02% improved diastolic function and reduced hypertrophy after MI. Regarding rosemary dose, 0.02% and 0.2% for rats are equivalent to 11 mg and 110 mg for humans, respectively. Conclusion Our findings support further investigations of the rosemary use as adjuvant therapy in adverse cardiac remodeling.	[Murino Rafacho, Bruna Paola; dos Santos, Priscila Portugal; Goncalves, Andrea de Freitas; Okoshi, Katashi; Chiuso-Minicucci, Fernanda; Azevedo, Paula S.; Mamede Zornoff, Leonardo Antonio; Minicucci, Marcos Ferreira; Rupp de Paiva, Sergio Alberto] UNESP, Internal Med Dept, Botucatu Med Sch, Botucatu, SP, Brazil; [Henrique Fernandes, Ana Angelica] UNESP, Dept Biochem, Botucatu Biosci Inst, Botucatu, SP, Brazil; [Chiuso-Minicucci, Fernanda] UNESP, Dept Microbiol & Immunol, Botucatu Biosci Inst, Botucatu, SP, Brazil; [Wang, Xiang-Dong] Tufts Univ, Nutr & Canc Biol Lab, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista; Tufts University; United States Department of Agriculture (USDA)	Rafacho, BPM (corresponding author), UNESP, Internal Med Dept, Botucatu Med Sch, Botucatu, SP, Brazil.	bpmrafacho@alunos.fmb.unesp.br	Rafacho, Bruna Paola Murino/AGW-5794-2022; Minicucci, Fernanda C/A-9220-2015; Okoshi, Katashi/A-3955-2011; Zornoff, Leonardo/A-5612-2008; Rafacho, Bruna Paola Murino/B-5460-2013; Azevedo, Paula Schmidt/S-1597-2019; Paiva, Sergio AR/A-5101-2008; Fernandes, Ana Angelica Henrique/D-5291-2012; Minicucci, Marcos F/A-9094-2008; wang, xiao/HGB-7081-2022; dos Santos, Priscila Portugal/U-5345-2018	Rafacho, Bruna Paola Murino/0000-0001-8825-6980; Minicucci, Fernanda C/0000-0002-4155-6414; Okoshi, Katashi/0000-0001-8980-8839; Zornoff, Leonardo/0000-0002-9831-8820; Rafacho, Bruna Paola Murino/0000-0001-8825-6980; Azevedo, Paula Schmidt/0000-0002-5843-6232; Paiva, Sergio AR/0000-0003-4412-1990; Minicucci, Marcos F/0000-0002-5980-4367; wang, xiao/0000-0002-4088-3341; dos Santos, Priscila Portugal/0000-0003-1159-5030	National Council of Technological and Scientific Development [CNPq 140262/2011-3]; Sao Paulo Research Foundation [FAPESP 2011/08956-0, 2011/15059-5]	National Council of Technological and Scientific Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was funded by National Council of Technological and Scientific Development (CNPq 140262/2011-3) and Sao Paulo Research Foundation (FAPESP 2011/08956-0 and 2011/15059-5), Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, GUIDE CARE USE LAB A; Assalin HB, 2013, CIRC-HEART FAIL, V6, P809, DOI 10.1161/CIRCHEARTFAILURE.112.000298; Baba K, 2013, J BIOL CHEM, V288, P18393, DOI 10.1074/jbc.M112.438762; Bai NS, 2010, J AGR FOOD CHEM, V58, P5363, DOI 10.1021/jf100332w; Botsoglou N, 2010, FOOD CHEM TOXICOL, V48, P944, DOI 10.1016/j.fct.2010.01.004; Burneiko RCM, 2006, FOOD CHEM TOXICOL, V44, P1167, DOI 10.1016/j.fct.2006.01.004; Buttros JB, 2009, PHARMACOLOGY, V84, P29, DOI 10.1159/000222245; Cheung S, 2007, ONCOL REP, V17, P1525; Chohan M, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-578; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; Csonka C, 2010, J PHARMACOL TOX MET, V61, P163, DOI 10.1016/j.vascn.2010.02.014; de Paiva SAR, 2003, AM J PHYSIOL-HEART C, V284, pH2242, DOI 10.1152/ajpheart.00646.2002; dos Santos PP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098895; Eilat-Adar S, 2013, NUTRIENTS, V5, P3646, DOI 10.3390/nu5093646; Ewing JF, 1995, ANAL BIOCHEM, V232, P243, DOI 10.1006/abio.1995.0014; Forman HJ, 2014, FREE RADICAL BIO MED, V66, P24, DOI 10.1016/j.freeradbiomed.2013.05.045; Genena AK, 2008, CIENCIA TECNOL ALIME, V28, P463, DOI 10.1590/S0101-20612008000200030; Gilbert B, 2003, CURR MED CHEM, V10, P13, DOI 10.2174/0929867033368583; Goncalves AF, 2015, CELL PHYSIOL BIOCHEM, V35, P259, DOI 10.1159/000369693; HARAGUCHI H, 1995, PLANTA MED, V61, P333, DOI 10.1055/s-2006-958094; Hori M, 2009, CARDIOVASC RES, V81, P457, DOI 10.1093/cvr/cvn335; Idikio HA, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/836806; Jeong EM, 2015, CIRC J, V79, P470, DOI 10.1253/circj.CJ-15-0064; Karthik D, 2011, J CARDIOVASC PHARM, V58, P514, DOI 10.1097/FJC.0b013e31822c265d; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lian KC, 2010, TOXICOL APPL PHARM, V245, P21, DOI 10.1016/j.taap.2010.01.003; Liu QF, 2016, J AGR FOOD CHEM, V64, P6716, DOI 10.1021/acs.jafc.6b03001; Liu TT, 2014, LIFE SCI, V101, P27, DOI 10.1016/j.lfs.2014.02.004; Lustosa BB, 2016, INT J CARDIOL, V225, P147, DOI 10.1016/j.ijcard.2016.09.092; Madamanchi NR, 2013, FREE RADICAL BIO MED, V61, P473, DOI 10.1016/j.freeradbiomed.2013.04.001; Minicucci MF, 2014, ARQ BRAS CARDIOL, V102, P549, DOI 10.5935/abc.20140051; Minicucci MF, 2011, INT J CARDIOL, V151, P242, DOI 10.1016/j.ijcard.2011.06.068; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Mozaffarian D, 2011, CIRCULATION, V123, P2870, DOI 10.1161/CIRCULATIONAHA.110.968735; NEELY JR, 1974, ANNU REV PHYSIOL, V36, P413, DOI 10.1146/annurev.ph.36.030174.002213; Paiva SAR, 2005, J NUTR, V135, P2109, DOI 10.1093/jn/135.9.2109; Peng CH, 2007, BIOSCI BIOTECH BIOCH, V71, P2223, DOI 10.1271/bbb.70199; Perez-Fons L, 2010, J AGR FOOD CHEM, V58, P161, DOI 10.1021/jf9026487; Pfeffer JM, 2000, CARDIOVASC DRUG THER, V14, P579, DOI 10.1023/A:1007890126061; PFEFFER MA, 1979, CIRC RES, V44, P503, DOI 10.1161/01.RES.44.4.503; Polegato BF, 2016, ARQ BRAS CARDIOL, V106, P105, DOI 10.5935/abc.20160015; Posadas SJ, 2009, EXP GERONTOL, V44, P383, DOI 10.1016/j.exger.2009.02.015; Punithavathi VR, 2010, LIFE SCI, V86, P178, DOI 10.1016/j.lfs.2009.11.021; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Retelny VS, 2008, NUTR CLIN PRACT, V23, P468, DOI 10.1177/0884533608323425; Ristow M, 2014, DOSE-RESPONSE, V12, P288, DOI 10.2203/dose-response.13-035.Ristow; Rustin P, 2002, EUR J HUM GENET, V10, P289, DOI 10.1038/sj.ejhg.5200793; Sadzuka Y, 1997, TOXICOL LETT, V92, P1, DOI 10.1016/S0378-4274(97)00028-3; Sahu BD, 2014, MOL CELL BIOCHEM, V394, P163, DOI 10.1007/s11010-014-2092-5; Saks V, 2006, J PHYSIOL-LONDON, V577, P769, DOI 10.1113/jphysiol.2006.120584; Scheckel KA, 2008, J NUTR, V138, P2098, DOI 10.3945/jn.108.090431; SPADARO J, 1980, ARCH PATHOL LAB MED, V104, P179; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Sun DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033491; Sun GB, 2012, TOXICOL APPL PHARM, V265, P229, DOI 10.1016/j.taap.2012.10.002; Sun Y, 2009, CARDIOVASC RES, V81, P482, DOI 10.1093/cvr/cvn333; Tamaki Y, 2010, PLANTA MED, V76, P683, DOI 10.1055/s-0029-1240622; van Deel ED, 2008, FREE RADICAL BIO MED, V44, P1305, DOI 10.1016/j.freeradbiomed.2007.12.007; WEBER KT, 1994, J MOL CELL CARDIOL, V26, P279, DOI 10.1006/jmcc.1994.1036; WOLFE CL, 1993, CIRCULATION, V87, P881, DOI 10.1161/01.CIR.87.3.881; Zhou SS, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/260429; Zhu YZ, 2004, NAT PROD REP, V21, P478, DOI 10.1039/b304821g; Zornoff LAM, 2006, NUTRITION, V22, P146, DOI 10.1016/j.nut.2005.05.008; Zornoff LAM, 2009, ARQ BRAS CARDIOL, V93, P434, DOI 10.1590/S0066-782X2009001000018; Zornoff LAM, 2009, ARQ BRAS CARDIOL, V92, P157, DOI 10.1590/S0066-782X2009000200013	65	15	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177521	10.1371/journal.pone.0177521	http://dx.doi.org/10.1371/journal.pone.0177521			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28494028	gold, Green Submitted, Green Published			2022-12-26	WOS:000401314300128
J	St-Jean, M; Boudreau, F; Carpentier, AC; Hivert, MF				St-Jean, Matthieu; Boudreau, Francois; Carpentier, Andre C.; Hivert, Marie-France			HNF1 alpha defect influences post-prandial lipid regulation	PLOS ONE			English	Article							HEPATOCYTE NUCLEAR FACTOR-1-ALPHA; HUMAN LIPOPROTEIN-LIPASE; GLUCAGON-LIKE PEPTIDE-1; INSULIN-SECRETION; BILE-ACID; GLUCOSE; GHRELIN; HUMANS; SENSITIVITY; RESISTANCE	Purpose Hepatocyte nuclear factor 1 alpha (HNF1 alpha) defects cause Mature Onset Diabetes of the Young type 3 (MODY3), characterized by defects in beta-cell insulin secretion. However, HNF1a is involved in many other metabolic pathways with relevance for monogenic or polygenic type 2 diabetes. We aimed to investigate gut hormones, lipids, and insulin regulation in response to a meal test in HNF1a defect carriers (MODY3) compared to non-diabetic subjects (controls) and type 2 diabetes (T2D). Methods We administered a standardized liquid meal to each participant. Over 6 hours, we measured post-meal responses of insulin regulation (blood glucose, c-peptide, insulin), gut hormones (ghrelin, glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1) and lipids (non-esterified fatty acids [NEFA] and triglycerides). Results We found that MODY3 participants had lower insulin secretion indices than controls and T2D participants, showing the expected beta-cell defect. MODY3 had similar glycated hemoglobin levels (HbA1c median [IQR]: 6.5 [5.6-7.6]%) compared to T2D (median: 6.6 [6.2- 6.9]%; P<0.05). MODY3 had greater insulin sensitivity (Matsuda index: 71.9 [29.6; 125.5]) than T2D (3.2 [4.0; 6.0]; P<0.05). MODY3 experienced a larger decrease in the ratio of NEFA to insulin (NEFA 30-0/insulin 3-0: -39 [-78; -30] x10(4)) in the early post-prandial period (0-30 minutes) compared to controls and to T2D (-2.0 [-0.6; -6.4] x10(4); P<0.05). MODY3 had lower fasting (0.66 [0.46; 1.2] mM) and post-meal triglycerides levels compared to T2D (fasting: 2.3 [1.7; 2.7] mM; P<0.05). We did not detect significant post-meal differences in ghrelin and incretins between MODY3 and other groups. Conclusion In response to a standard meal test, MODY3 showed greater early post-prandial NEFA diminution in response to relatively low early insulin secretion, and they maintained very low post-prandial triglycerides levels.	[St-Jean, Matthieu; Carpentier, Andre C.; Hivert, Marie-France] Univ Sherbrooke, Dept Med, Sherbrooke, PQ, Canada; [Boudreau, Francois] Univ Sherbrooke, Dept Anat & Cellular Biol, Sherbrooke, PQ, Canada; [Hivert, Marie-France] Harvard Med Sch, Harvard Pilgrim Hlth Care Inst, Dept Populat Med, Boston, MA 02115 USA; [Hivert, Marie-France] Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA	University of Sherbrooke; University of Sherbrooke; Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Hivert, MF (corresponding author), Univ Sherbrooke, Dept Med, Sherbrooke, PQ, Canada.; Hivert, MF (corresponding author), Harvard Med Sch, Harvard Pilgrim Hlth Care Inst, Dept Populat Med, Boston, MA 02115 USA.; Hivert, MF (corresponding author), Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA.	mhivert@partners.org	St-Jean, Matthieu/AAR-9352-2021; Hivert, Marie-France/GWN-0455-2022	Hivert, Marie-France/0000-0001-7752-2585				Adamska E, 2014, GASTROENTEROL REV, V2, P69; Alssema M, 2013, EUR J ENDOCRINOL, V169, P421, DOI 10.1530/EJE-13-0487; Amer Diabet Assoc, 2005, DIABETES CARE, V28, pS37; Babaya N, 2003, J CLIN ENDOCR METAB, V88, P2548, DOI 10.1210/jc.2002-021891; Bergman RN, 2002, DIABETES, V51, pS212, DOI 10.2337/diabetes.51.2007.S212; Brassard P, 2008, J CLIN ENDOCR METAB, V93, P837, DOI 10.1210/jc.2007-1670; Brial F, 2015, DIABETES, V64, P3314, DOI 10.2337/db15-0124; Broglio F, 2001, J CLIN ENDOCR METAB, V86, P5083, DOI 10.1210/jc.86.10.5083; Calanna S, 2013, DIABETOLOGIA, V56, P965, DOI 10.1007/s00125-013-2841-0; Calanna S, 2013, DIABETES CARE, V36, P3346, DOI 10.2337/dc13-0465; Carpentier A, 1999, AM J PHYSIOL-ENDOC M, V276, pE1055, DOI 10.1152/ajpendo.1999.276.6.E1055; Carpentier AC, 2010, J CLIN ENDOCR METAB, V95, P1256, DOI 10.1210/jc.2009-1932; Cusi K, 2012, GASTROENTEROLOGY, V142, P711, DOI 10.1053/j.gastro.2012.02.003; Dukes ID, 1998, J BIOL CHEM, V273, P24457, DOI 10.1074/jbc.273.38.24457; Ekholm E, 2013, J INTERN MED, V274, P263, DOI 10.1111/joim.12082; Ferreira LDMCB, 2001, DIABETES, V50, P1064, DOI 10.2337/diabetes.50.5.1064; Gardner DSL, 2012, DIABETES METAB SYNDR, V5, P101, DOI 10.2147/DMSO.S23353; Gnanapavan S, 2002, J CLIN ENDOCR METAB, V87, P2988, DOI 10.1210/jc.87.6.2988; Green BD, 2004, CURR PHARM DESIGN, V10, P3651, DOI 10.2174/1381612043382774; Grenier-Larouche T, 2012, Int J Obes Suppl, V2, pS37, DOI 10.1038/ijosup.2012.21; Hanson RL, 2000, AM J EPIDEMIOL, V151, P190; Hegele RA, 2000, ARTERIOSCL THROM VAS, V20, P217, DOI 10.1161/01.ATV.20.1.217; Kong M, 2013, INT J IMMUNOGENET, V40, P120, DOI 10.1111/j.1744-313X.2012.01141.x; Kunach M, 2015, DIABETES, V64, P2432, DOI 10.2337/db14-1166; Labbe SM, 2012, DIABETES, V61, P2701, DOI 10.2337/db11-1805; Labbe SM, 2011, AM J PHYSIOL-ENDOC M, V300, pE445, DOI 10.1152/ajpendo.00579.2010; Lehto M, 1997, J CLIN INVEST, V99, P582, DOI 10.1172/JCI119199; Lussier CR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012378; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Menke A, 2015, JAMA-J AM MED ASSOC, V314, P1021, DOI 10.1001/jama.2015.10029; Nowak N, 2015, ENDOCRINE, V50, P643, DOI 10.1007/s12020-015-0627-5; Odom DT, 2010, TRANSCRIPTION FACTOR, V303, P1378; Ostoft SH, 2014, DIABETES, V63, P2838, DOI 10.2337/db13-1878; Pirro M, 2002, ATHEROSCLEROSIS, V160, P377, DOI 10.1016/S0021-9150(01)00588-3; Pontoglio M, 2000, J AM SOC NEPHROL, V11, pS140; Pontoglio M, 1996, CELL, V84, P575, DOI 10.1016/S0092-8674(00)81033-8; Pramfalk C, 2005, J LIPID RES, V46, P1868, DOI 10.1194/jlr.M400450-JLR200; Rodriguez A, 2009, INT J OBESITY, V33, P541, DOI 10.1038/ijo.2009.40; Rufibach LE, 2006, J LIPID RES, V47, P1463, DOI 10.1194/jlr.M600082-JLR200; Sharifi F, 2013, ACYLATED GHRELIN LEP, P8; Shih DQ, 2001, NAT GENET, V27, P375, DOI 10.1038/86871; SHIMADA M, 1993, J BIOL CHEM, V268, P17924; Tchernof A, PLASMA FREE FATTY AC; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Toft-Nielsen MB, 2001, J CLIN ENDOCR METAB, V86, P3717, DOI 10.1210/jc.86.8.3717; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Yada T, 2014, OBES METAB, V16, P111; Yoh J, 2011, REGUL PEPTIDES, V167, P140, DOI 10.1016/j.regpep.2010.12.010	49	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177110	10.1371/journal.pone.0177110	http://dx.doi.org/10.1371/journal.pone.0177110			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493909	gold, Green Published, Green Submitted			2022-12-26	WOS:000401314300061
J	Wang, MM; Xin, LH; Cai, GQ; Zhang, X; Yang, X; Li, XN; Xia, Q; Wang, L; Xu, SQ; Xu, JH; Shuai, ZW; Ding, CH; Pan, FM				Wang, Mengmeng; Xin, Lihong; Cai, Guoqi; Zhang, Xu; Yang, Xiao; Li, Xiaona; Xia, Qing; Wang, Li; Xu, Shengqian; Xu, Jianhua; Shuai, Zongwen; Ding, Changhai; Pan, Faming			Pathogenic variants screening in seventeen candidate genes on 2p15 for association with ankylosing spondylitis in a Han Chinese population	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISM; SUSCEPTIBILITY; HLA-B27; USP34; ERAP1	Objectives Previous studies have found the association between rs10865331 in 2p15 area and ankylosing spondylitis (AS). This study aimed to identify additional functional genetic variants in 2p15 region associated with AS susceptibility. Methods We used next generation sequencing (NGS) in 100 AS cases and 100 healthy controls to screen AS susceptible genetic variants, and validated these variants in 620 cases and 620 controls by using imLDR (TM) technique for single nucleotide polymorphism (SNP) genotyping. Results Totally, we identified 12 SNPs that might confer susceptibility to AS. Of those SNPs, three (rs14170, rs2123111 and rs1729674) were nominally associated (P<0.05) with AS, but were no longer statistically significant after Bonferroni correction. After stratified by gender, another two SNPs (rs11428092 and rs10208769 in USP34) were associated with AS in males but not females, though this was not statistically significant after Bonferroni correction. In addition, rs1729674, rs14170, rs2123111 and rs10208769 were in strong linkage disequilibrium (LD) and were further enrolled in haplotype analysis. A novel haplotype TAGA was found to be associated with a decreased risk of AS (odds ratio (OR) (95% confidence interval (CI)) = 0.832 (0.705-0.982)). Beyond that, we also demonstrated a strong relationship between rs10865331 and AS susceptibility (OR (95% CI) = 1.303(1.111-1.526)). Conclusions rs14170 and rs2123111 inUSP34 and rs1729674 in C2orf74 may be associated with AS susceptibility in Han Chinese population. USP34 and C2orf74 in 2p15 region may be AS novel susceptibility genes.	[Wang, Mengmeng; Xin, Lihong; Cai, Guoqi; Zhang, Xu; Yang, Xiao; Li, Xiaona; Xia, Qing; Wang, Li; Pan, Faming] Anhui Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hefei, Anhui, Peoples R China; [Xu, Shengqian; Xu, Jianhua; Shuai, Zongwen; Ding, Changhai] Anhui Med Univ, Dept Rheumatism & Immun, Affiliated Hosp 1, Hefei, Anhui, Peoples R China; [Ding, Changhai; Pan, Faming] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia	Anhui Medical University; Anhui Medical University; University of Tasmania; Menzies Institute for Medical Research	Pan, FM (corresponding author), Anhui Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hefei, Anhui, Peoples R China.; Pan, FM (corresponding author), Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia.	famingpan@ahmu.edu.cn	zhang, xu/AAR-6231-2021; Cai, Guoqi/HGE-7097-2022; Xia, Qing/AAX-7441-2021; Ding, Changhai/J-7730-2014	Xia, Qing/0000-0002-8556-3456; Zhang, Xu/0000-0002-6217-6824; Ding, Changhai/0000-0002-9479-730X	National Natural Science Foundation of China [30771849, 30972530, 81273169, 81573218]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the grants from the National Natural Science Foundation of China (30771849, 30972530, 81273169 and 81573218). Faming Pan is supported by National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang SY, 2011, J RHEUMATOL, V38, P322, DOI 10.3899/jrheum.100652; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Braun J, 2007, LANCET, V369, P1379, DOI 10.1016/S0140-6736(07)60635-7; Brown MA, 2011, BRIEF FUNCT GENOMICS, V10, P249, DOI 10.1093/bfgp/elr023; Cheng S, 2007, SEMIN ARTHRITIS RHEU, V37, P39, DOI 10.1016/j.semarthrit.2007.01.003; Davidson SI, 2013, ARTHRITIS RHEUM-US, V65, P1747, DOI 10.1002/art.37976; Davidson SI, 2011, ANN RHEUM DIS, V70, P289, DOI 10.1136/ard.2010.133322; Duan ZH, 2012, SCAND J RHEUMATOL, V41, P219, DOI 10.3109/03009742.2011.625972; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Fan D, 2014, SCAND J RHEUMATOL, V43, P374, DOI 10.3109/03009742.2014.882408; Feldtkeller E, 2003, RHEUMATOL INT, V23, P61, DOI 10.1007/s00296-002-0237-4; Gao XY, 2011, GENET EPIDEMIOL, V35, P154, DOI 10.1002/gepi.20563; Khan MA, 2002, BEST PRACT RES CL RH, V16, P675, DOI 10.1053/BERH.2002.0243; Lin ZM, 2012, NAT GENET, V44, P73, DOI 10.1038/ng.1005; LIU Y, 2015, RHEUMATOL INT; Lui TTH, 2011, MOL CELL BIOL, V31, P2053, DOI 10.1128/MCB.01094-10; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Poalas K, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-25; Reveille JD, 2010, NAT GENET, V42, P123, DOI 10.1038/ng.513; Sanchez A, 2010, J RHEUMATOL, V37, P2345, DOI 10.3899/jrheum.100211; Slobodin G, 2012, ISR MED ASSOC J, V14, P763; Smith JA, 2015, CURR ALLERGY ASTHM R, V15, DOI 10.1007/s11882-014-0489-6; Sy SMH, 2013, NUCLEIC ACIDS RES, V41, P8572, DOI 10.1093/nar/gkt622; Thomas GP, 2010, DISCOV MED, V10, P263; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Wen Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103618; Yang T, 2014, MOD RHEUMATOL, V24, P150, DOI 10.3109/14397595.2013.852856; Zeng Z, 2012, CLIN RHEUMATOL, V31, P1449, DOI 10.1007/s10067-012-2028-y; Zhang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130982; Zhao SG, 2015, J OVARIAN RES, V8, DOI 10.1186/s13048-015-0158-y	31	5	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177080	10.1371/journal.pone.0177080	http://dx.doi.org/10.1371/journal.pone.0177080			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493913	gold, Green Published, Green Accepted			2022-12-26	WOS:000401314300057
J	Yuan, Y; Liu, ZQ; Jin, H; Sun, S; Liu, TJ; Wang, X; Fan, HJ; Hou, SK; Ding, H				Yuan, Yao; Liu, Zi-Quan; Jin, Heng; Sun, Shi; Liu, Tian-Jun; Wang, Xue; Fan, Hao-Jun; Hou, Shi-Ke; Ding, Hui			Photodynamic antimicrobial chemotherapy with the novel amino acid-porphyrin conjugate 4I: In vitro and in vivo studies	PLOS ONE			English	Article							RESISTANT ACINETOBACTER-BAUMANNII; PHOTOINDUCED ANTIBACTERIAL ACTIVITY; STAPHYLOCOCCUS-AUREUS INFECTION; METHICILLIN-RESISTANT; MULTIDRUG-RESISTANCE; WOUND INFECTIONS; RESCUES MICE; THERAPY; PHOTOSENSITIZERS; INACTIVATION	Photodynamic antimicrobial chemotherapy (PACT), as a novel and effective therapeutic modality to eradicate drug resistant bacteria without provoking multidrug resistance, has attracted increasing attention. This study examined the antimicrobial efficacy of the novel cationic amino acid-porphyrin conjugate 4I with four lysine groups against two different clinical isolated strains (drug sensitive and multidrug resistant) of the Acinetobacter baumannii species and its toxicity on murine dermal fibroblasts in vitro, as well as the therapeutic effect of PACT on acute, potentially lethal multidrug resistant strain excisional wound infections in vivo. The PACT protocol exposed 4I to illumination, exhibiting high antimicrobial efficacy on two different strains due to a high yield of reactive oxygen species (ROS) and non-selectivity to microorganisms. The photoinactivation effects of 4I against two different strains were dose-dependent. At 3.9 mu M and 7.8 mu M, PACT induced 6 log units of inactivation of sensitive and multidrug resistant strains. In contrast, 4I alone and illumination alone treatments had no visibly antimicrobial effect. Moreover, cytotoxicity tests revealed the great safety of the photosensitizer 4I in mice. In the in vivo study, we found 4I-mediated PACT was not only able to kill bacteria but also accelerated wound recovery. Compared with non-treated mice, over 2.89 log reduction of multidrug resistant Acinetobacter baumannii strain was reached in PACT treat mice at 24 h post-treatment. These results imply that 4I-mediated PACT therapy is an effective and safe alternative to conventional antibiotic therapy and has clinical potential for superficial drug-resistant bacterial infections.	[Yuan, Yao; Liu, Zi-Quan; Wang, Xue; Fan, Hao-Jun; Hou, Shi-Ke; Ding, Hui] Logist Univ Chinese Peoples Armed Police Force PA, Affiliated Hosp, Inst Disaster Med & Publ Hlth, Tianjin, Peoples R China; [Jin, Heng; Sun, Shi] Tianjin Med Univ, Dept Emergency Med, Gen Hosp, Tianjin, Peoples R China; [Liu, Tian-Jun] Chinese Acad Med Sci, Peking Union Med Coll, Tianjin Key Lab Biomed Mat, Inst Biomed Engn, Tianjin, Peoples R China	Tianjin Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of BioMedical Engineering - CAMS; Peking Union Medical College	Ding, H (corresponding author), Logist Univ Chinese Peoples Armed Police Force PA, Affiliated Hosp, Inst Disaster Med & Publ Hlth, Tianjin, Peoples R China.	huidingah@163.com	Jin, Heng/S-7674-2019	Jin, Heng/0000-0001-9264-1187; YUAN, YAO/0000-0003-0351-2645	Major Projects of the National Health and Family Planning Commission of China [201302003]; Tianjin Natural Science Foundation of China [15JCYBJC28500, 15ZXLCSY00040]; Tianjin Health bureau science and technology Foundation of China [2015KZ123]; Basic Research Program of Logistics University of PAP [WHJ2016025]	Major Projects of the National Health and Family Planning Commission of China; Tianjin Natural Science Foundation of China; Tianjin Health bureau science and technology Foundation of China; Basic Research Program of Logistics University of PAP	This study was supported by the Major Projects of the National Health and Family Planning Commission of China (201302003 to ShikeHou), Tianjin Natural Science Foundation of China (15JCYBJC28500 to HuiDing, 15ZXLCSY00040 to ShikeHou), Tianjin Health bureau science and technology Foundation of China (2015KZ123 to ZiquanLiu), Basic Research Program of Logistics University of PAP (WHJ2016025 to ZiquanLiu). The funders provided support in study design.	Abrahamse H, 2016, BIOCHEM J, V473, P347, DOI 10.1042/BJ20150942; Alves E, 2014, FUTURE MED CHEM, V6, P141, DOI 10.4155/fmc.13.211; Cheon S, 2016, KOREAN J INTERN MED, V31, P367, DOI 10.3904/kjim.2015.178; Coyne S, 2011, ANTIMICROB AGENTS CH, V55, P947, DOI 10.1128/AAC.01388-10; Dai TH, 2013, ANTIMICROB AGENTS CH, V57, P1238, DOI 10.1128/AAC.01652-12; Dai TH, 2010, LASER SURG MED, V42, P38, DOI 10.1002/lsm.20887; Dai TH, 2009, ANTIMICROB AGENTS CH, V53, P3929, DOI 10.1128/AAC.00027-09; Dosselli R, 2014, J MED CHEM, V57, P1403, DOI 10.1021/jm401653r; Dosselli R, 2013, J MED CHEM, V56, P1052, DOI 10.1021/jm301509n; Feng Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep24342; Fu XJ, 2014, J PHOTOCH PHOTOBIO B, V136, P72, DOI 10.1016/j.jphotobiol.2014.04.016; Garland MJ, 2009, FUTURE MED CHEM, V1, P667, DOI 10.4155/FMC.09.55; Grinholc M, 2015, APPL MICROBIOL BIOT, V99, P4031, DOI 10.1007/s00253-015-6539-8; Grinholc M, 2014, PHOTOMED LASER SURG, V32, P121, DOI 10.1089/pho.2013.3663; Hamblin MR, 2003, J INFECT DIS, V187, P1717, DOI 10.1086/375244; Hamblin MR, 2002, PHOTOCHEM PHOTOBIOL, V75, P51, DOI 10.1562/0031-8655(2002)075<0051:RCOWIB>2.0.CO;2; Hanakova A, 2014, MICROBIOL RES, V169, P163, DOI 10.1016/j.micres.2013.07.005; Huang LY, 2014, NANOMEDICINE-UK, V9, P253, DOI 10.2217/nnm.13.22; Lai MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153361; Lee H, 2016, CLIN EC EVALUATION M, V48, P174; Li K, 2014, LANGMUIR, V30, P14573, DOI 10.1021/la5028724; Lu ZS, 2010, NANOMEDICINE-UK, V5, P1525, DOI 10.2217/NNM.10.98; Luan YY, 2014, J INTERF CYTOK RES, V34, P2, DOI 10.1089/jir.2013.0042; Maisch T, 2011, J DTSCH DERMATOL GES, V9, P360, DOI 10.1111/j.1610-0387.2010.07577.x; Maisch T, 2009, MINI-REV MED CHEM, V9, P974, DOI 10.2174/138955709788681582; Maraki S, 2016, 5 YEAR SURVEILLANCE, V48, P190; Meng S, 2015, EUR J MED CHEM, V92, P35, DOI 10.1016/j.ejmech.2014.12.029; Nakamizo S, 2013, SKIN PHARMACOL PHYS, V26, P22, DOI 10.1159/000343208; Orenstein A, 1997, FEMS IMMUNOL MED MIC, V19, P307, DOI 10.1016/S0928-8244(97)00097-7; Orlandi VT, 2013, J PHOTOCH PHOTOBIO B, V127, P123, DOI 10.1016/j.jphotobiol.2013.08.011; Pan T, 2016, EXP THER MED, V11, P1345, DOI 10.3892/etm.2016.3051; Prasanth CS, 2014, PHOTOCHEM PHOTOBIOL, V90, P628, DOI 10.1111/php.12198; Reginato Eleonora, 2014, World J Immunol, V4, P1; Sahu K, 2013, LASER MED SCI, V28, P465, DOI 10.1007/s10103-012-1083-6; Santajit S, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2475067; Sarmiento D, 2015, MICROVASC RES, V98, P187, DOI 10.1016/j.mvr.2014.02.001; Scrivens WA, 1994, SYNTHESIS C 14 LABEL; Sharma SK, 2011, CURR PHARM DESIGN, V17, P1303, DOI 10.2174/138161211795703735; Sharman WM, 2000, METHOD ENZYMOL, V319, P376; Sperandio Felipe F, 2013, Recent Pat Antiinfect Drug Discov, V8, P108; Stojiljkovic I, 2001, EXPERT OPIN INV DRUG, V10, P309, DOI 10.1517/13543784.10.2.309; Tanaka T, 2016, IMMUNOTHERAPY-UK, V8, P959, DOI 10.2217/imt-2016-0020; Tavares A, 2010, MAR DRUGS, V8, P91, DOI 10.3390/md8010091; Tegos GP, 2006, ANTIMICROB AGENTS CH, V50, P196, DOI 10.1128/AAC.50.1.196-203.2006; Tsioutis C, 2016, INT J ANTIMICROB AG, V48, P492, DOI 10.1016/j.ijantimicag.2016.07.007; Vandepitte Warunee Punpanich, 2014, Journal of the Medical Association of Thailand, V97, pS129; Vecchio D, 2013, J BIOPHOTONICS, V6, P733, DOI 10.1002/jbio.201200121; Xu ZP, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00242; Zhang YS, 2015, NANOMEDICINE-UK, V10, P603, DOI 10.2217/nnm.14.131; Zilberberg MD, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1392-4	50	28	28	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176529	10.1371/journal.pone.0176529	http://dx.doi.org/10.1371/journal.pone.0176529			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493985	Green Submitted, Green Published, gold			2022-12-26	WOS:000401314300020
J	Zmora, P; Molau-Blazejewska, P; Bertram, S; Walendy-Gnirss, K; Nehlmeier, I; Hartleib, A; Moldenhauer, AS; Konzok, S; Dehmel, S; Sewald, K; Brinkmann, C; Curths, C; Knauf, S; Gruber, J; Matz-Rensing, K; Dahlmann, F; Braun, A; Pohlmann, S				Zmora, Pawel; Molau-Blazejewska, Paulina; Bertram, Stephanie; Walendy-Gnirss, Kerstin; Nehlmeier, Inga; Hartleib, Anika; Moldenhauer, Anna-Sophie; Konzok, Sebastian; Dehmel, Susann; Sewald, Katherina; Brinkmann, Constantin; Curths, Christoph; Knauf, Sascha; Gruber, Jens; Maetz-Rensing, Kerstin; Dahlmann, Franziska; Braun, Armin; Poehlmann, Stefan			Non-human primate orthologues of TMPRSS2 cleave and activate the influenza virus hemagglutinin	PLOS ONE			English	Article							ANCHORED SERINE PROTEASES; HUMAN AIRWAY EPITHELIUM; A VIRUSES; PROTEOLYTIC ACTIVATION; CELLS; REPLICATION; MATRIPTASE; TRYPSIN; ENTRY; MICE	The cellular serine protease TMPRSS2, a member of the type II transmembrane serine protease (TTSP) family, cleaves and activates the hemagglutinin of influenza A viruses (FLUAV) in cell culture and is essential for spread of diverse FLUAV in mice. Non-human primates (NHP), in particular rhesus and cynomolgus macaques, serve as animal models for influenza and experimental FLUAV infection of common marmosets has recently also been reported. However, it is currently unknown whether the NHP orthologues of human TMPRSS2 cleave and activate FLUAV hemagglutinin and contribute to viral spread in respiratory tissue. Here, we cloned and functionally analyzed the macaque and marmoset orthologues of human TMPRSS2. In addition, we analyzed the macaque orthologues of human TMPRSS4 and HAT, which also belong to the TTSP family. We found that all NHP orthologues of human TMPRSS2, TMPRSS4 and HAT cleave and activate HA upon directed expression and provide evidence that endogenous TMPRSS2 is expressed in the respiratory epithelium of rhesus macaques. Finally, we demonstrate that a serine protease inhibitor active against TMPRSS2 suppresses FLUAV spread in precision-cut lung slices of human, macaque and marmoset origin. These results indicate that FLUAV depends on serine protease activity for spread in diverse NHP and in humans. Moreover, our findings suggest that macaques and marmosets may serve as models to study FLUAV activation by TMPRSS2 in human patients.	[Zmora, Pawel; Molau-Blazejewska, Paulina; Bertram, Stephanie; Walendy-Gnirss, Kerstin; Nehlmeier, Inga; Hartleib, Anika; Moldenhauer, Anna-Sophie; Brinkmann, Constantin; Poehlmann, Stefan] Leibniz Inst, German Primate Ctr, Infect Biol Unit, Kellnerweg 4, Gottingen, Germany; [Konzok, Sebastian; Dehmel, Susann; Sewald, Katherina; Curths, Christoph; Dahlmann, Franziska; Braun, Armin] Fraunhofer Inst Toxicol & Expt Med, Div Preclin Pharmacol & In Vitro Toxicol, Nikolai Fuchs Str 1, Hannover, Germany; [Konzok, Sebastian; Dehmel, Susann; Sewald, Katherina; Curths, Christoph; Dahlmann, Franziska; Braun, Armin] German Ctr Lung Res, Biomed Res Endstage & Obstruct Lung Dis Hannover, Nikolai Fuchs Str 1, Hannover, Germany; [Curths, Christoph; Knauf, Sascha; Maetz-Rensing, Kerstin; Dahlmann, Franziska] Leibniz Inst, Pathol Unit, German Primate Ctr, Kellnerweg 4, Gottingen, Germany; [Knauf, Sascha] Leibniz Inst, Workgrp Neglected Trop Dis, German Primate Ctr, Kellnerweg 4, Gottingen, Germany; [Gruber, Jens] Leibniz Inst, German Primate Ctr, Jr Res Grp Med RNA Biol, Primate Genet Lab, Gottingen, Germany; [Zmora, Pawel] Max Planck Inst Dynam Complex Tech Syst, Dept Bioproc Engn, Sandtorstr 1, Magdeburg, Germany; [Bertram, Stephanie] Leibniz Inst Expt Virol, Heinrich Pette Inst, Viral Zoonosis & Adaptat, Martinistr 52, Hamburg, Germany	Deutsches Primatenzentrum (DPZ); Fraunhofer Gesellschaft; Deutsches Primatenzentrum (DPZ); Deutsches Primatenzentrum (DPZ); Deutsches Primatenzentrum (DPZ); Max Planck Society; Heinrich Pette Institute	Pohlmann, S (corresponding author), Leibniz Inst, German Primate Ctr, Infect Biol Unit, Kellnerweg 4, Gottingen, Germany.	spoehlmann@dpz.eu	Zmora, Pawel/V-3843-2019; Braun, Armin/B-8750-2009; Pöhlmann, Stefan/H-2395-2011; Knauf, Sascha/F-1661-2017	Zmora, Pawel/0000-0002-2012-7223; Braun, Armin/0000-0002-1142-1463; Pöhlmann, Stefan/0000-0001-6086-9136; Knauf, Sascha/0000-0001-5744-4946	DFG [PO 716/6-1]; Leibniz Foundation (Graduate School Emerging Infectious Diseases)	DFG(German Research Foundation (DFG)); Leibniz Foundation (Graduate School Emerging Infectious Diseases)	This work was supported by DFG (PO 716/6-1 to SP) and Leibniz Foundation (Graduate School Emerging Infectious Diseases).	Antalis TM, 2011, PROG MOL BIOL TRANSL, V99, P1, DOI 10.1016/S1877-1173(11)99001-2; Baron J, 2013, J VIROL, V87, P1811, DOI 10.1128/JVI.02320-12; Beaulieu A, 2013, J VIROL, V87, P4237, DOI 10.1128/JVI.03005-12; Bertram S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035876; Bertram S, 2010, J VIROL, V84, P10016, DOI 10.1128/JVI.00239-10; Bertram S, 2010, REV MED VIROL, V20, P298, DOI 10.1002/rmv.657; Bottcher E, 2009, VACCINE, V27, P6324, DOI 10.1016/j.vaccine.2009.03.029; Bottcher-Friebertshauser E, 2013, PATHOG DIS, V69, P87, DOI 10.1111/2049-632X.12053; Bottcher-Friebertshauser E, 2011, J VIROL, V85, P1554, DOI 10.1128/JVI.01294-10; Bottcher E, 2006, J VIROL, V80, P9896, DOI 10.1128/JVI.01118-06; Chaipan C, 2009, J VIROL, V83, P3200, DOI 10.1128/JVI.02205-08; Cheng Z, 2015, J INFECT DIS; Davis AS, 2015, ANTIVIR RES, V117, P75, DOI 10.1016/j.antiviral.2015.02.011; Hamilton BS, 2012, J VIROL, V86, P10579, DOI 10.1128/JVI.00306-12; Hatesuer B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003774; Hurt AC, 2014, CURR OPIN VIROL, V8, P22, DOI 10.1016/j.coviro.2014.04.009; Kawase M, 2012, J VIROL, V86, P6537, DOI 10.1128/JVI.00094-12; Kido H, 2007, CURR PHARM DESIGN, V13, P405, DOI 10.2174/138161207780162971; Kim TS, 2006, MOL CELL BIOL, V26, P965, DOI 10.1128/MCB.26.3.965-975.2006; KLENK HD, 1973, J VIROL, V11, P823, DOI 10.1128/JVI.11.6.823-831.1973; KLENK HD, 1975, VIROLOGY, V68, P426, DOI 10.1016/0042-6822(75)90284-6; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Kuhn N, 2016, J VIROL, V90, P4298, DOI 10.1128/JVI.02693-15; LAZAROWI.SG, 1973, VIROLOGY, V52, P199, DOI 10.1016/0042-6822(73)90409-1; Marriott AC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157887; Matsuyama S, 2010, J VIROL, V84, P12658, DOI 10.1128/JVI.01542-10; Moncla LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078750; Mooij P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126132; O'Donnell CD, 2011, MICROBES INFECT, V13, P502, DOI 10.1016/j.micinf.2011.01.014; Rimmelzwaan GF, 2001, J VIROL, V75, P6687, DOI 10.1128/JVI.75.14.6687-6691.2001; Russell CJ, 2005, CELL, V123, P368, DOI 10.1016/j.cell.2005.10.019; Sakai K, 2015, J VIROL, V89, P5154, DOI 10.1128/JVI.00124-15; Sakai K, 2014, J VIROL, V88, P5608, DOI 10.1128/JVI.03677-13; Seehase S, 2011, J APPL PHYSIOL, V111, P791, DOI 10.1152/japplphysiol.00162.2011; Switalla S, 2010, TOXICOL APPL PHARM, V246, P107, DOI 10.1016/j.taap.2010.04.010; Szabo R, 2011, ANNU REV CELL DEV BI, V27, P213, DOI 10.1146/annurev-cellbio-092910-154247; Tarnow C, 2014, J VIROL, V88, P4744, DOI 10.1128/JVI.03799-13; Trombetta C, 2015, VACCINES-BASEL, V3, P172, DOI 10.3390/vaccines3010172; Watanabe T, 2015, CURR OPIN VIROL, V14, P71, DOI 10.1016/j.coviro.2015.08.008; Winkler M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043337; Yamada H, 2012, ANTIVIR RES, V96, P344, DOI 10.1016/j.antiviral.2012.09.012; Zmora P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138380; Zmora P, 2014, J VIROL, V88, P12087, DOI 10.1128/JVI.01427-14	43	11	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176597	10.1371/journal.pone.0176597	http://dx.doi.org/10.1371/journal.pone.0176597			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493964	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314300022
J	Doubleday, ZA; Jones, AR; Deveney, MR; Ward, TM; Gillanders, BM				Doubleday, Zoe A.; Jones, Alice R.; Deveney, Marty R.; Ward, Tim M.; Gillanders, Bronwyn M.			Eight habitats, 38 threats and 55 experts: Assessing ecological risk in a multi-use marine region	PLOS ONE			English	Article							VULNERABILITY; ECOSYSTEM; STRESSORS; IMPACTS; MAP	Identifying the relative risk human activities pose to a habitat, and the ecosystem services they provide, can guide management prioritisation and resource allocation. Using a combination of expert elicitation to assess the probable effect of a threat and existing data to assess the level of threat exposure, we conducted a risk assessment for 38 human-mediated threats to eight marine habitats (totalling 304 threat-habitat combinations) in Spencer Gulf, Australia. We developed a score-based survey to collate expert opinion and assess the relative effect of each threat to each habitat, as well as a novel and independent measure of knowledge-based uncertainty. Fifty-five experts representing multiple sectors and institutions participated in the study, with 6 to 15 survey responses per habitat (n = 81 surveys). We identified key threats specific to each habitat; overall, climate change threats received the highest risk rankings, with nutrient discharge identified as a key local-scale stressor. Invasive species and most fishing-related threats, which are commonly identified as major threats to the marine environment, were ranked as low-tier threats to Spencer Gulf, emphasising the importance of regionally-relevant assessments. Further, we identified critical knowledge gaps and quantified uncertainty scores for each risk. Our approach will facilitate prioritisation of resource allocation in a region of increasing social, economic and environmental importance, and can be applied to marine regions where empirical data are lacking.	[Doubleday, Zoe A.; Jones, Alice R.; Gillanders, Bronwyn M.] Univ Adelaide, Sch Biol Sci, Adelaide, SA, Australia; [Doubleday, Zoe A.; Jones, Alice R.; Gillanders, Bronwyn M.] Univ Adelaide, Environm Inst, Adelaide, SA, Australia; [Deveney, Marty R.; Ward, Tim M.] South Australian Res & Dev Inst & Marine Innovat, West Beach, SA, Australia	University of Adelaide; University of Adelaide	Doubleday, ZA; Gillanders, BM (corresponding author), Univ Adelaide, Sch Biol Sci, Adelaide, SA, Australia.; Doubleday, ZA; Gillanders, BM (corresponding author), Univ Adelaide, Environm Inst, Adelaide, SA, Australia.	zoe.doubleday@adelaide.edu.au; bronwyn.gillanders@adelaide.edu.au	Doubleday, Zoe/N-9955-2013; Doubleday, Zoe/AAU-6278-2020; Gillanders, Bronwyn/B-4218-2013	Doubleday, Zoe/0000-0003-0045-6377; Jones, Alice/0000-0002-6157-2024; Gillanders, Bronwyn/0000-0002-7680-2240; Ward, Timothy Mark/0000-0002-9003-2772	Environment Institute; University of Adelaide; Spencer Gulf Ecosystem Development Initiative (SGEDI)	Environment Institute; University of Adelaide; Spencer Gulf Ecosystem Development Initiative (SGEDI)	Funding was provided by the Environment Institute, University of Adelaide and the consortia comprising the Spencer Gulf Ecosystem Development Initiative (SGEDI). https://www.adelaide.edu.au/environment/water/spencer-gulf/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Thomas Prowse, Phillip Casey, Sally Scrivens, Alice Mackay, Simon Goldsworthy, Fred Bailleul, Charlie Huveneers, Will Robbins, and Kathryn Wiltshire for their advice and input regarding method development and survey design. Funding was provided by the Environment Institute, University of Adelaide and the consortia comprising the Spencer Gulf Ecosystem Development Initiative (SGEDI). This project forms part of the SGEDI integrated marine management series of projects. The Spencer Gulf Ecosystem Development Initiative (SGEDI) is a collaboration between a broad range of industry investors, and the University of Adelaide, South Australian Research and Development Institute, a division of Primary Industries and Regions SA, and Flinders University. The program aims to reduce costs, aid development and answer environmental challenges for one of South Australia's leading economic development zones.	[Anonymous], 2013, PLOS ONE, DOI DOI 10.1371/JOURNAL.PONE.0079889; Ascough JC, 2008, ECOL MODEL, V219, P383, DOI 10.1016/j.ecolmodel.2008.07.015; Auguie B, 2017, GRIDEXTRA MISCELLANE; Batista MI, 2014, OCEAN COAST MANAGE, V102, P248, DOI 10.1016/j.ocecoaman.2014.09.020; Brown CJ, 2014, DIVERS DISTRIB, V20, P538, DOI 10.1111/ddi.12159; Brown CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065765; Burgman M., 2005, RISKS DECISIONS CONS; Burgman MA., 2016, TRUSTING JUDGEMENTS; Chin A, 2010, GLOBAL CHANGE BIOL, V16, P1936, DOI 10.1111/j.1365-2486.2009.02128.x; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; de Chazal J, 2008, GLOBAL ENVIRON CHANG, V18, P508, DOI 10.1016/j.gloenvcha.2008.04.005; De Lange HJ, 2010, SCI TOTAL ENVIRON, V408, P3871, DOI 10.1016/j.scitotenv.2009.11.009; Doubleday ZA, 2013, AQUACULT ENV INTERAC, V3, P163, DOI 10.3354/aei00058; FAO, 2012, STAT WORLD FISH AQ 2; Gillanders B., 2016, SPENCER GULF ECOSYST; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2007, CONSERV BIOL, V21, P1301, DOI 10.1111/j.1523-1739.2007.00752.x; Hijmans R. J., 2014, R PACKAGE VERSION; Hobday AJ, 2011, FISH RES, V108, P372, DOI 10.1016/j.fishres.2011.01.013; ISO, 2018, 310002018 ISO; Metcalf SJ, 2015, ECOL SOC, V20, DOI 10.5751/ES-07509-200235; Molnar JL, 2008, FRONT ECOL ENVIRON, V6, P485, DOI 10.1890/070064; Murray CC, 2015, MAR POLICY, V58, P71, DOI 10.1016/j.marpol.2015.04.003; Pecl GT, 2014, CLIMATIC CHANGE, V127, P505, DOI 10.1007/s10584-014-1284-z; Richardson AJ, 2008, SCIENCE, V320, P1294, DOI 10.1126/science.1156129; Selkoe KA, 2009, CORAL REEFS, V28, P635, DOI 10.1007/s00338-009-0490-z; Shepherd SA, 2014, NATURAL HIST SPENCER; Smith SDP, 2015, ECOL APPL, V25, P717, DOI 10.1890/14-0366.1; Teck SJ, 2010, ECOL APPL, V20, P1402, DOI 10.1890/09-1173.1; Wiltshire KH, SARDI PUBLICATION, V468; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Zhou SJ, 2008, FISH RES, V91, P56, DOI 10.1016/j.fishres.2007.11.007	33	13	13	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177393	10.1371/journal.pone.0177393	http://dx.doi.org/10.1371/journal.pone.0177393			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489912	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314100069
J	Mattouk, M; Talhouk, SN				Mattouk, Miriam; Talhouk, Salma N.			A content analysis of nature photographs taken by Lebanese rural youth	PLOS ONE			English	Article							PHOTOVOICE; FAMILY; BIODIVERSITY	'Living in Harmony with Nature' is a 2050 vision put forth by the Convention on Biological Diversity (CBD) which takes into consideration culture and locality of perceptions of nature and aspirations for its use. Considering that 54% of the world population lives in cities, where nature has been decimated, the role of rural communities, living within or in proximity of natural and semi natural areas, will effectively influence the fate of the 'remaining' nature while they engage in local development. Reconciling between growth and development on the one hand, and nature conservation on the other, necessitates an understanding of how rural communities, especially the youth, imprint their own ideas on landscapes and develop ownership over natural spaces. In order to extend the understanding of how harmony with nature is perceived in different parts of the world, this paper presents the findings of primary research involving a group of young people who live in rural areas in Lebanon, a country in the Arab Middle East. Participatory research based on photovoice methodology was conducted with 77 young people aged 7-16 and residing in five rural villages located in different parts of Lebanon. Photographs taken by participants indicated that for many, nature was not perceived literally i.e. woodlands, forests, plants, animals, etc.... Instead, the participants saw nature as part of agriculture and local culture. Nature was also seen as symbolic expression of the participants' inner state of mind. Narratives written to explain the photographs shed light on the perception of harmony with nature which focused on positive family experiences and relayed personal emotions, abstract, and holistic yet functional view of nature. Another recurring theme that emerged from photographs and narratives was the role of family members, in particular grandparents, as having a strong influence on the positive perceptions of nature.	[Mattouk, Miriam; Talhouk, Salma N.] Amer Univ Beirut, Nat Conservat Ctr, Beirut, Lebanon; [Talhouk, Salma N.] Amer Univ Beirut, Dept Landscape Design & Ecosyst Management, Fac Agr & Food Sci, Beirut, Lebanon	American University of Beirut; American University of Beirut	Talhouk, SN (corresponding author), Amer Univ Beirut, Nat Conservat Ctr, Beirut, Lebanon.; Talhouk, SN (corresponding author), Amer Univ Beirut, Dept Landscape Design & Ecosyst Management, Fac Agr & Food Sci, Beirut, Lebanon.	ntsalma@aub.edu.lb			Coca Cola Foundation	Coca Cola Foundation	The study was partially funded by Coca Cola Foundation (SNT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, RUR TOUR STRAT LEB; Ballouard JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023152; BARRANTI CCR, 1985, FAM RELAT, V34, P343, DOI 10.2307/583572; Bellin R., 2006, VISUAL STUD, V20, P56; Bengtson VL, 2001, J MARRIAGE FAM, V63, P1, DOI 10.1111/j.1741-3737.2001.00001.x; Blondel J., 1999, Biology and wildlife of the Mediterranean region.; Blondel J, 2006, HUM ECOL, V34, P713, DOI 10.1007/s10745-006-9030-4; Carlson ED, 2006, QUAL HEALTH RES, V16, P836, DOI 10.1177/1049732306287525; Castleden H, 2008, SOC SCI MED, V66, P1393, DOI 10.1016/j.socscimed.2007.11.030; Chawla L., 1998, J ENVIRON EDUC, V4, P369, DOI DOI 10.1080/00958969809599114; Dakin EK, 2014, QUALITATIVE SOCIAL W, P1; DENHAM TE, 1989, FAM RELAT, V38, P345, DOI 10.2307/585064; Djoundourian Salpie, 2009, Environment Development and Sustainability, V11, P427, DOI 10.1007/s10668-007-9122-3; Farina A, 2003, ECOL ECON, V45, P11, DOI 10.1016/S0921-8009(02)00255-0; King K, 2013, J RURAL STUD, V31, P67, DOI 10.1016/j.jrurstud.2013.02.004; MATTHEWS H, 1995, GEOGR J, V161, P285, DOI 10.2307/3059833; Merzel C, 2003, AM J PUBLIC HEALTH, V93, P557, DOI 10.2105/AJPH.93.4.557; Mutamba E, 2004, ENVIRON MONIT ASSESS, V99, P105, DOI 10.1007/s10661-004-4010-x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nabhan G., 1994, GEOGRAPHY CHILDHOOD; Palmberg I.E., 2000, J ENVIRON EDUC, V31, P32, DOI [DOI 10.1080/00958960009598649, 10.1080/00958960009598649]; Payne PG, 2010, ENVIRON EDUC RES, V16, P209, DOI 10.1080/13504620903580545; Phenice L., 2003, CONT ISSUES EARLY CH, V4, P167, DOI [10.2304/ciec.2003.4.2.6, DOI 10.2304/CIEC.2003.4.2.6]; Potts SG, 2006, BIOL CONSERV, V129, P519, DOI 10.1016/j.biocon.2005.11.019; Sobel D., 1996, ECOPHOBIA RECLAIMING; State of the Environment Report (SOER), 2010, LEB ENV DEV OBS; Strack Robert W, 2004, Health Promot Pract, V5, P49, DOI 10.1177/1524839903258015; Tawk LY, 2014, THESIS; Wang C, 1996, SOC SCI MED, V42, P1391, DOI 10.1016/0277-9536(95)00287-1; Wang C, 1997, HEALTH EDUC BEHAV, V24, P369, DOI 10.1177/109019819702400309; Wang CC, 2006, J COMMUNITY PRACT, V14, P147, DOI 10.1300/J125v14n01_09; Wang CC, 2004, MATERN CHILD HLTH J, V8, P95, DOI 10.1023/B:MACI.0000025732.32293.4f; Wesley A., 2011, DO YOU SEE WHAT I SE	33	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177079	10.1371/journal.pone.0177079	http://dx.doi.org/10.1371/journal.pone.0177079			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UN	28489929	Green Submitted, Green Published, gold			2022-12-26	WOS:000401314100047
J	Montana, L; Caniglia, R; Galaverni, M; Fabbri, E; Ahmed, A; Bolfikova, BC; Czarnomska, SD; Galov, A; Godinho, R; Hindrikson, M; Hulva, P; Jedrzejewska, B; Jelencic, M; Kutal, M; Saarma, U; Skrbinsek, T; Randi, E				Montana, Luca; Caniglia, Romolo; Galaverni, Marco; Fabbri, Elena; Ahmed, Atidje; Bolfikova, Barbora Cerna; Czarnomska, Sylwia D.; Galov, Ana; Godinho, Raquel; Hindrikson, Maris; Hulva, Pavel; Jedrzejewska, Bogumila; Jelencic, Maja; Kutal, Miroslav; Saarma, Urmas; Skrbinsek, Tomaz; Randi, Ettore			Combining phylogenetic and demographic inferences to assess the origin of the genetic diversity in an isolated wolf population	PLOS ONE			English	Article							APPROXIMATE BAYESIAN COMPUTATION; CANIS-LUPUS; EVOLUTIONARY TREES; LARGE CARNIVORES; VARIABILITY; SOFTWARE; HISTORY; WOLVES; SIZE; POLYMORPHISM	The survival of isolated small populations is threatened by both demographic and genetic factors. Large carnivores declined for centuries in most of Europe due to habitat changes, overhunting of their natural prey and direct persecution. However, the current rewilding trends are driving many carnivore populations to expand again, possibly reverting the erosion of their genetic diversity. In this study we reassessed the extent and origin of the genetic variation of the Italian wolf population, which is expanding after centuries of decline and isolation. We genotyped wolves from Italy and other nine populations at four mtDNA regions (control-region, ATP6, COIII and ND4) and 39 autosomal microsatellites. Results of phylogenetic analyses and assignment procedures confirmed in the Italian wolves a second private mtDNA haplotype, which belongs to a haplogroup distributed mostly in southern Europe. Coalescent analyses showed that the unique mtDNA haplotypes in the Italian wolves likely originated during the late Pleistocene. ABC simulations concordantly showed that the extant wolf populations in Italy and in south-western Europe started to be isolated and declined right after the last glacial maximum. Thus, the standing genetic variation in the Italian wolves principally results from the historical isolation south of the Alps.	[Montana, Luca; Caniglia, Romolo; Galaverni, Marco; Fabbri, Elena; Randi, Ettore] ISPRA, Lab Genet, Bologna, Italy; [Ahmed, Atidje] Bulgarian Acad Sci, Inst Biodivers & Ecosyst Res, Sofia, Bulgaria; [Bolfikova, Barbora Cerna] Czech Univ Life Sci Prague, Fac Trop AgriSci, Prague, Czech Republic; [Czarnomska, Sylwia D.; Jedrzejewska, Bogumila] Polish Acad Sci, Mammal Res Inst, Bialowieza, Poland; [Galov, Ana] Univ Zagreb, Dept Biol, Fac Sci, Zagreb, Croatia; [Godinho, Raquel] Univ Porto, CIBIO InBIO Ctr Invest Biodiversidade & Recursos, Campus Vairao, Vairao, Portugal; [Godinho, Raquel] Univ Porto, Fac Ciencias, Dept Biol, Oporto, Portugal; [Hindrikson, Maris] Univ Tartu, Inst Ecol & Earth Sci, Dept Zool, Tartu, Estonia; [Hulva, Pavel] Charles Univ Prague, Dept Zool, Prague, Czech Republic; [Hulva, Pavel] Univ Ostrava, Dept Biol & Ecol, Ostrava, Czech Republic; [Jelencic, Maja] Univ Ljubljana, Biotech Fac, Dept Biol, Ljubljana, Slovenia; [Kutal, Miroslav; Skrbinsek, Tomaz] Mendel Univ Brno, Fac Forestry & Wood Technol, Dept Forest Ecol, Brno, Czech Republic; [Kutal, Miroslav] Friends Earth Czech Republ, Olomouc Branch, Olomouc, Czech Republic; [Randi, Ettore] Aalborg Univ, Dept 18, Sect Environm Engn, Aalborg, Denmark	Italian Institute for Environmental Protection & Research (ISPRA); Bulgarian Academy of Sciences; Czech University of Life Sciences Prague; Polish Academy of Sciences; Mammal Research Institute of the Polish Academy of Sciences; University of Zagreb; Universidade do Porto; Universidade do Porto; University of Tartu; Tartu University Institute of Ecology & Earth Sciences; Charles University Prague; University of Ostrava; University of Ljubljana; Mendel University in Brno; Aalborg University	Montana, L (corresponding author), ISPRA, Lab Genet, Bologna, Italy.	luca.montana@usherbrooke.ca	Saarma, Urmas/AAC-9813-2019; Kutal, Miroslav/B-9612-2014; Galov, Ana/AAC-4557-2020; Bolfikova, Barbora Cerna/I-6620-2019; Godinho, Raquel/L-6804-2013; Hindrikson, Maris/G-4573-2017	Saarma, Urmas/0000-0002-3222-571X; Kutal, Miroslav/0000-0003-3857-5419; Galov, Ana/0000-0002-3709-7286; Bolfikova, Barbora Cerna/0000-0001-8059-4889; Godinho, Raquel/0000-0002-4260-4799; Czarnomska, Sylwia/0000-0002-8081-0956; CANIGLIA, Romolo/0000-0002-3641-9490; Jedrzejewska, Bogumila/0000-0002-9652-0953; Montana, Luca/0000-0002-8869-6916; Skrbinsek, Tomaz/0000-0003-4435-7477; Hindrikson, Maris/0000-0001-8094-1860; Galaverni, Marco/0000-0002-2648-1506	Italian Ministry of Environment (MATTM); Italian Institute for Environmental Protection and Research (ISPRA); European Economic Area (EEA) and Norway; Estonian Ministry of Education and Research [IUT20-32]; Portuguese Foundation for Science and Technology [IF/564/2012]; BIOGEAST Biodiversity of East-European; Siberian large mammals on the level of genetic variation of populations, 7th Framework Programme [247652, 2096/7, UE/2011/2]	Italian Ministry of Environment (MATTM); Italian Institute for Environmental Protection and Research (ISPRA); European Economic Area (EEA) and Norway; Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); BIOGEAST Biodiversity of East-European; Siberian large mammals on the level of genetic variation of populations, 7th Framework Programme	This project was supported by grants from Italian Ministry of Environment (MATTM) and the Italian Institute for Environmental Protection and Research (ISPRA). A grant from European Economic Area (EEA) and Norway was assigned for monitoring carnivore species of European importance in selected Natura 2000 sites. MH and US were supported by institutional research funding (IUT20-32) from the Estonian Ministry of Education and Research. RG was supported by the Portuguese Foundation for Science and Technology (IF/564/2012). US was supported by BIOGEAST Biodiversity of East-European and Siberian large mammals on the level of genetic variation of populations, 7th Framework Programme (contract nos. 247652 and no. 2096/7. PR UE/2011/2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H, 1973, INFORM THEORY EXTENS, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bartlett LJ, 2016, ECOGRAPHY, V39, P152, DOI 10.1111/ecog.01566; Beaumont MA, 2002, GENETICS, V162, P2025; Belkhir K, 2004, GENETIX 4 05 POPULAT, P2004; Bertorelle G, 2010, MOL ECOL, V19, P2609, DOI 10.1111/j.1365-294X.2010.04690.x; Bjornerfeldt S, 2006, GENOME RES, V16, P990, DOI 10.1101/gr.5117706; Boggiano F, 2013, MAMM BIOL, V78, P374, DOI 10.1016/j.mambio.2013.06.001; BOITANI L, 1992, BIOL CONSERV, V61, P125, DOI 10.1016/0006-3207(92)91102-X; Boitani Luigi, 2003, P317; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Caniglia R, 2014, J MAMMAL, V95, P41, DOI 10.1644/13-MAMM-A-039; Chapman JR, 2009, MOL ECOL, V18, P2746, DOI 10.1111/j.1365-294X.2009.04247.x; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; Cornuet JM, 2014, BIOINFORMATICS, V30, P1187, DOI 10.1093/bioinformatics/btt763; Cornuet JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-401; Crooks KR, 2011, PHILOS T R SOC B, V366, P2642, DOI 10.1098/rstb.2011.0120; de Groot GA, 2015, MAMMAL REV, P1; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fabbri E, 2014, MAMM BIOL, V79, P138, DOI 10.1016/j.mambio.2013.10.002; Fan ZX, 2016, GENOME RES, V26, P163, DOI 10.1101/gr.197517.115; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Flower LOH, 2014, QUATERNARY SCI REV, V96, P188, DOI 10.1016/j.quascirev.2014.04.015; Freedman AH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004016; Galaverni M, 2016, MAMMAL RES, V61, P13, DOI 10.1007/s13364-015-0247-8; Heled J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-289; Hindrikson M, 2016, BIOL REV; Hindrikson M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075765; Hindrikson M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046465; Hoban S, 2012, NAT REV GENET, V13, P110, DOI 10.1038/nrg3130; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Koblmu Eller S, 2016, J BIO GEOGR, P1; LACY R C, 1987, Conservation Biology, V1, P143, DOI 10.1111/j.1523-1739.1987.tb00023.x; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Larget B, 1999, MOL BIOL EVOL, V16, P750, DOI 10.1093/oxfordjournals.molbev.a026160; Leonard JA, 2005, MOL ECOL, V14, P9, DOI 10.1111/j.1365-294X.2004.02389.x; Leonard JA, 2007, CURR BIOL, V17, P1146, DOI 10.1016/j.cub.2007.05.072; Leonard JA, 2014, EVOL ECOL RES, V16, P461; Leonard JA, 2014, FREE-RANGING DOGS AND WILDLIFE CONSERVATION, P170; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Linnell JDC, 2001, ANIM CONSERV, V4, P345, DOI 10.1017/S1367943001001408; Lohmueller KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002326; LONGMIRE JL, 1997, USE LYSIS BUFFER DNA; Lucchini V, 2004, MOL ECOL, V13, P523, DOI 10.1046/j.1365-294X.2004.02077.x; MECH LD, 1987, J MAMMAL, V68, P871, DOI 10.2307/1381570; Montana L, 2017, MAMM BIOL, V84, P30, DOI 10.1016/j.mambio.2017.01.005; Morey DF, 2014, J ARCHAEOL SCI, V52, P300, DOI 10.1016/j.jas.2014.08.015; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Palstra FP, 2012, ECOL EVOL, V2, P2357, DOI 10.1002/ece3.329; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pereira H.M., 2015, REWILDING EUROPEAN L; Perri A, 2016, J ARCHAEOL SCI, V68, P1, DOI 10.1016/j.jas.2016.02.003; Pilot M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093828; Pilot M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-104; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard JK, 2000, GENETICS, V155, P945; Randi E, 2000, CONSERV BIOL, V14, P464, DOI 10.1046/j.1523-1739.2000.98280.x; Randi E, 2014, PLOS ONE, V9; Randi E, 2011, MAMMAL REV, V41, P99, DOI 10.1111/j.1365-2907.2010.00176.x; Rannala B, 1996, J MOL EVOL, V43, P304, DOI 10.1007/PL00006090; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sandom C, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3254; Sastre N, 2011, CONSERV GENET, V12, P701, DOI 10.1007/s10592-010-0177-6; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Silva PM., 2016, HIST DEMOGRAPHY DIFF; Skoglund P, 2011, MOL BIOL EVOL, V28, P1505, DOI 10.1093/molbev/msq342; Thalmann O, 2013, SCIENCE, V342, P871, DOI 10.1126/science.1243650; Vila C, 1999, MOL ECOL, V8, P2089, DOI 10.1046/j.1365-294x.1999.00825.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x	73	20	20	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176560	10.1371/journal.pone.0176560	http://dx.doi.org/10.1371/journal.pone.0176560			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UN	28489863	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314100025
J	Cardoso, JMS; Guerreiro, SI; Lourenco, A; Alves, MM; Montemor, MF; Mira, NP; Leitao, JH; Carvalho, MFNN				Cardoso, Joao M. S.; Guerreiro, Soraia I.; Lourenco, Andreia; Alves, Marta M.; Fatima Montemor, M.; Mira, Nuno P.; Leitao, Jorge H.; Carvalho, M. Fernanda N. N.			Ag(I) camphorimine complexes with antimicrobial activity towards clinically important bacteria and species of the Candida genus	PLOS ONE			English	Article							SILVER NANOPARTICLES; RESISTANCE; TOXICITY; BIOFILMS; ALBICANS	The present work follows a previous report describing the antibacterial activity of silver camphorimine complexes of general formula [Ag(NO3)L]. The synthesis and demonstration of the antifungal and antibacterial activity of three novel [Ag(NO3) L] complexes (named 1, 2 and 3) is herein demonstrated. This work also shows for the first time that the previously studied complexes (named 4 to 8) also exert antifungal activity. The antibacterial activity of complexes was evaluated against Staphylococcus aureus, Pseudomonas aeruginosa, Burkholderia contaminans and Escherichia coli strains, while antifungal activity was tested against the Candida species C. albicans, C. glabrata, C. parapsilosis and C. tropicalis. The antimicrobial activity of the complexes ranged from very high (complex 4) to moderate (complex 6) or low (complex 8), depending on the structural and electronic characteristics of the camphorimine ligands. Notably, the highest antibacterial and anti-Candida activities do not coincide in the same complex and in some cases they were even opposite, as is the case of complex 4 which exhibits a high anti-bacterial and low antifungal activity. These distinct results suggest that the complexes may have different mechanisms against prokaryotic and eukaryotic cells. The antifungal activity of the Ag(I) camphorimine complexes (in particular of complex 1) was found to be very high (MIC = 2 mu g/mL) against C. parapsilosis, being also registered a prominent activity against C. tropicalis and C. glabrata. None of the tested compounds inhibited C. albicans growth, being this attributed to the ability of these yeast cells to mediate the formation of less toxic Ag nanoparticles, as confirmed by Scanning Electron Microscopy images. The high antibacterial and anti-Candida activities of the here studied camphorimine complexes, especially of complexes 1 and 7, suggests a potential therapeutic application for these compounds.	[Cardoso, Joao M. S.; Alves, Marta M.; Fatima Montemor, M.; Carvalho, M. Fernanda N. N.] Univ Lisbon, Ctr Quim Estrutural, Inst Super Tecn, Av Rovisco Pais, Lisbon, Portugal; [Guerreiro, Soraia I.; Lourenco, Andreia; Mira, Nuno P.; Leitao, Jorge H.] Univ Lisbon, iBB Inst Bioengn & Biosci, Inst Super Tecn, Av Rovisco Pais, Lisbon, Portugal; [Guerreiro, Soraia I.; Lourenco, Andreia; Mira, Nuno P.; Leitao, Jorge H.] Univ Lisbon, Dept Bioengn, Inst Super Tecn, Av Rovisco Pais, Lisbon, Portugal	Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Lisboa; Instituto Superior Tecnico	Carvalho, MFNN (corresponding author), Univ Lisbon, Ctr Quim Estrutural, Inst Super Tecn, Av Rovisco Pais, Lisbon, Portugal.; Mira, NP; Leitao, JH (corresponding author), Univ Lisbon, iBB Inst Bioengn & Biosci, Inst Super Tecn, Av Rovisco Pais, Lisbon, Portugal.; Mira, NP; Leitao, JH (corresponding author), Univ Lisbon, Dept Bioengn, Inst Super Tecn, Av Rovisco Pais, Lisbon, Portugal.	nuno.mira@tecnico.ulisboa.pt; jorgeleitao@tecnico.ulisboa.pt; fcarvalho@ist.utl.pt	MONTEMOR, FATIMA/D-8976-2012; Mira, Nuno Pereira/E-2965-2012; Alves, Marta M./E-9716-2015; Leitão, Jorge H./A-5122-2012; Carvalho, MFNN/H-8162-2012	MONTEMOR, FATIMA/0000-0001-7835-6814; Mira, Nuno Pereira/0000-0001-7556-0385; Alves, Marta M./0000-0002-9679-4022; Leitão, Jorge H./0000-0001-8850-274X; Carvalho, MFNN/0000-0002-6825-1696	FCT-Fundacao para a Ciencia e Tecnologia [UID/QUI/00100/2013, UID/BIO/04565/2013, RECI/QEQ-QIN/0189/2012, PTDC/BIA-MIC/1615/2014]; Programa Operacional Regional de Lisboa [007317]; NMR Network (IST-UTL Node)	FCT-Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and Technology); Programa Operacional Regional de Lisboa; NMR Network (IST-UTL Node)	Financial support by FCT-Fundacao para a Ciencia e Tecnologia through projects UID/QUI/00100/2013, UID/BIO/04565/2013, RECI/QEQ-QIN/0189/2012 and partial contracts PTDC/BIA-MIC/1615/2014); Programa Operacional Regional de Lisboa 2020 (Project N. 007317) and the NMR Network (IST-UTL Node) for facilities are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Financial support by FCT-Fundacao para a Ciencia e Tecnologia through projects UID/QUI/00100/2013, UID/BIO/04565/2013, RECI/QEQ-QIN/0189/2012 and partial contracts PTDC/BIA-MIC/1615/2014); Programa Operacional Regional de Lisboa 2020 (Project N. 007317) and the NMR Network (IST-UTL Node) for facilities are gratefully acknowledged.	Ahmed S, 2016, J ADV RES, V7, P17, DOI 10.1016/j.jare.2015.02.007; [Anonymous], M26A CLSI; Arendrup MC, 2012, CLIN MICROBIOL INFEC, V18, pE246, DOI 10.1111/j.1469-0691.2012.03880.x; Armarego WLF, 2009, PURIFICATION OF LABORATORY CHEMICALS, 6TH EDITION, P1; Atiyeh BS, 2007, BURNS, V33, P139, DOI 10.1016/j.burns.2006.06.010; Brunetto PS, 2011, MATERIALS, V4, P355, DOI 10.3390/ma4020355; Cardoso JMS, 2017, J INORG BIOCHEM, V166, P55, DOI 10.1016/j.jinorgbio.2016.11.003; Cardoso JMS, 2016, DALTON T, V45, P7114, DOI 10.1039/c6dt00099a; Chai LYA, 2010, CRIT REV MICROBIOL, V36, P282, DOI 10.3109/1040841X.2010.489506; Chen WY, 2013, MOLECULES, V18, P5434, DOI 10.3390/molecules18055434; Coutinho CP, 2015, J MED MICROBIOL, V64, P927, DOI 10.1099/jmm.0.000094; Dorobantu LS, 2015, J NANOPART RES, V17, DOI 10.1007/s11051-015-2984-7; Drake PL, 2005, ANN OCCUP HYG, V49, P575, DOI 10.1093/annhyg/mei019; Fernandes TA, 2015, POLYHEDRON, V87, P215, DOI 10.1016/j.poly.2014.11.020; Fernandes TA, 2014, J ORGANOMET CHEM, V760, P186, DOI 10.1016/j.jorganchem.2013.10.040; Fewtrell L., 2014, SILVER WATER DISINFE; Fromm KM, 2013, APPL ORGANOMET CHEM, V27, P683, DOI 10.1002/aoc.3047; Justino GC, 2016, RSC ADV, V6, P56249, DOI 10.1039/c6ra09627a; Klasen HJ, 2000, BURNS, V26, P117, DOI 10.1016/S0305-4179(99)00108-4; Lara HH, 2015, J NANOBIOTECHNOL, V13, DOI 10.1186/s12951-015-0147-8; Maillard JY, 2013, CRIT REV MICROBIOL, V39, P373, DOI 10.3109/1040841X.2012.713323; McRee AE, 2015, J EXOT PET MED, V24, P240, DOI 10.1053/j.jepm.2015.04.015; Medici S, 2016, COORDIN CHEM REV, V327, P349, DOI 10.1016/j.ccr.2016.05.015; Mujahid M, 2016, J INORG BIOCHEM, V163, P53, DOI 10.1016/j.jinorgbio.2016.07.010; Obeng-Ofori D, 1998, INT J PEST MANAGE, V44, P203, DOI 10.1080/096708798228112; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Rauwel P, 2015, ADV MATER SCI ENG, V2015, DOI 10.1155/2015/682749; Rendosova M, 2017, J INORG BIOCHEM, V168, P1, DOI 10.1016/j.jinorgbio.2016.12.003; Rice LB, 2008, J INFECT DIS, V197, P1079, DOI 10.1086/533452; Richau JA, 2000, J CLIN MICROBIOL, V38, P1651, DOI 10.1128/JCM.38.4.1651-1655.2000; Sanguinetti M, 2015, MYCOSES, V58, P2, DOI 10.1111/myc.12330; Silva S, 2013, MED MYCOL, V51, P178, DOI 10.3109/13693786.2012.700492; Silva S, 2012, FEMS MICROBIOL REV, V36, P288, DOI 10.1111/j.1574-6976.2011.00278.x; Silvestry-Rodriguez N, 2008, APPL ENVIRON MICROB, V74, P1639, DOI 10.1128/AEM.02237-07; Sokolova AS, 2015, EUR J MED CHEM, V105, P263, DOI 10.1016/j.ejmech.2015.10.010; Trofa D, 2008, CLIN MICROBIOL REV, V21, P606, DOI 10.1128/CMR.00013-08; Vazquez-Munoz R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108876; Waghmare SR, 2015, 3 BIOTECH, V5, P33, DOI 10.1007/s13205-014-0196-y; Xu HX, 2005, J NEUROSCI, V25, P8924, DOI 10.1523/JNEUROSCI.2574-05.2005; 2008, EUR J CLIN MICROBIOL, V27, P1101, DOI DOI 10.1007/S10096-008-0552-0	40	15	15	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177355	10.1371/journal.pone.0177355	http://dx.doi.org/10.1371/journal.pone.0177355			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486529	Green Submitted, Green Published, gold			2022-12-26	WOS:000401314000075
J	Zhao, Y; Wu, KJ; Nguyen, C; Smbatyan, G; Melendez, E; Higuchi, Y; Chen, YB; Kahn, M				Zhao, Yi; Wu, Kaijin; Nguyen, Cu; Smbatyan, Goar; Melendez, Elisabeth; Higuchi, Yusuke; Chen, Yibu; Kahn, Michael			Small molecule p300/catenin antagonist enhances hematopoietic recovery after radiation	PLOS ONE			English	Article							CREB-BINDING PROTEIN; BETA-CATENIN; STEM-CELLS; SELF-RENEWAL; GAMMA-CATENIN; LONG-TERM; CBP; P300; DIFFERENTIATION; INHIBITION	There is currently no FDA approved therapeutic agent for ARS mitigation post radiation exposure. Here we report that the small molecule YH250, which specifically antagonizes p300/catenin interaction, stimulates hematopoiesis in lethally or sublethally irradiated mice. A single administration of YH250 24 hours post irradiation can significantly stimulate HSC proliferation, improve survival and accelerate peripheral blood count recovery. Our studies suggest that promotion of the expansion of the remaining HSC population via stimulation of symmetric non-differentiative proliferation is at least part of the mechanism of action.	[Zhao, Yi] Univ Southern Calif, Keck Sch Med, Dept Med, Los Angeles, CA USA; [Zhao, Yi; Higuchi, Yusuke; Kahn, Michael] Univ Southern Calif, Keck Sch Med, Ctr Mol Pathways & Drug Discovery, Los Angeles, CA 90007 USA; [Zhao, Yi; Higuchi, Yusuke; Kahn, Michael] Univ Southern Calif, Norris Comprehens Canc Ctr, Los Angeles, CA 90007 USA; [Wu, Kaijin; Nguyen, Cu; Smbatyan, Goar; Melendez, Elisabeth; Higuchi, Yusuke; Kahn, Michael] Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Res Ctr, Dept Biochem & Mol Biol, Los Angeles, CA 90007 USA; [Higuchi, Yusuke] Osaka Univ, Inst Sci & Ind Res, Dept Organ Fine Chem, Ibaraki, Osaka, Japan; [Chen, Yibu] Univ Southern Calif, Norris Med Lib, Bioinformat Serv Program, Los Angeles, CA USA; [Kahn, Michael] Univ Southern Calif, Keck Sch Med, Dept Mol Pharmacol & Toxicol, Los Angeles, CA 90007 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; Osaka University; University of Southern California; University of Southern California	Kahn, M (corresponding author), Univ Southern Calif, Keck Sch Med, Ctr Mol Pathways & Drug Discovery, Los Angeles, CA 90007 USA.	kahnm@usc.edu	Higuchi, Yusuke/I-1991-2018	Higuchi, Yusuke/0000-0002-5982-9660	USC Norris Comprehensive Cancer Center [P30 CA014089, NIH 1R01CM66161-01A1, 1R21N5074392-01, 1R21A1105057-01, NIH 1R01 HL112638-01]; USC Office of Research; Norris Medical Library; NATIONAL CANCER INSTITUTE [P30CA014089] Funding Source: NIH RePORTER	USC Norris Comprehensive Cancer Center; USC Office of Research; Norris Medical Library; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support from USC Norris Comprehensive Cancer Center Support Grant P30 CA014089 (MK), NIH 1R01CM66161-01A1, 1R21N5074392-01, 1R21A1105057-01 and NIH 1R01 HL112638-01 (MK) is gratefully acknowledged. The bioinformatics software and computing resources used in the analysis are funded by the USC Office of Research and the Norris Medical Library. The funders had no role in study design, data collection; Support from USC Norris Comprehensive Cancer Center Support Grant P30 CA014089 (MK), NIH 1R01CA166161-01A1, 1R21N5074392-01, 1R21A1105057-01 and NIH 1R01 HL112638-01 (MK) is gratefully acknowledged. The bioinformatics software and computing resources used in the analysis are funded by the USC Office of Research and the Norris Medical Library.and analysis, decision to publish, or preparation of the manuscript.	Baba Y, 2005, IMMUNITY, V23, P599, DOI 10.1016/j.immuni.2005.10.009; Baba Y, 2006, J IMMUNOL, V177, P2294, DOI 10.4049/jimmunol.177.4.2294; Beckmann J, 2007, BLOOD, V109, P5494, DOI 10.1182/blood-2006-11-055921; Blobel GA, 2000, BLOOD, V95, P745, DOI 10.1182/blood.V95.3.745.003k05_745_755; Chan WI, 2011, MOL CELL BIOL, V31, P5046, DOI 10.1128/MCB.05830-11; Chen TC, 2007, EXP HEMATOL, V35, P203, DOI 10.1016/j.exphem.2006.10.002; Dainiak N, 2011, DISASTER MED PUBLIC, V5, P183, DOI 10.1001/dmp.2011.73; Dainiak N, 2011, DISASTER MED PUBLIC, V5, P202, DOI 10.1001/dmp.2011.68; Descalzo S, 2015, SEMIN CELL DEV BIOL, V47-48, P101; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; Fang F, 2014, STEM CELLS, V32, P1805, DOI 10.1002/stem.1705; Fukunaga Y, 2005, CELL STRUCT FUNCT, V30, P25, DOI 10.1247/csf.30.25; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; Hao S, 2011, J AM SOC NEPHROL, V22, P1642, DOI 10.1681/ASN.2010101079; Henderson WR, 2010, P NATL ACAD SCI USA, V107, P14309, DOI 10.1073/pnas.1001520107; Higuchi Y, 2016, CURR MOL PHARMACOL, V9, P272, DOI 10.2174/1874467208666150526155146; Ito K, 2012, NAT MED, V18, P1350, DOI 10.1038/nm.2882; Ito K, 2016, SCIENCE, V354, P1156, DOI 10.1126/science.aaf5530; Jeannet G, 2008, BLOOD, V111, P142, DOI 10.1182/blood-2007-07-102558; Kahn M, 2014, NAT REV DRUG DISCOV, V13, P513, DOI 10.1038/nrd4233; Kahn M, 2011, FUTURE MED CHEM, V3, P1745, DOI [10.4155/FMC.11.126, 10.4155/fmc.11.126]; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim YM, CURR CANC DRUG TARGE; Koch U, 2008, BLOOD, V111, P160, DOI 10.1182/blood-2007-07-099754; Lei S., 2015, BLOOD, V126, P117; Ma H, 2005, ONCOGENE, V24, P3619, DOI 10.1038/sj.onc.1208433; Miyoshi H, 2017, J BIOCHEM, V161, P19, DOI 10.1093/jb/mvw070; Morisot S, 2006, MOL THER, V13, pS131, DOI 10.1016/j.ymthe.2006.08.403; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; Oguro H, 2013, CELL STEM CELL, V13, P102, DOI 10.1016/j.stem.2013.05.014; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Rebel VI, 2002, P NATL ACAD SCI USA, V99, P14789, DOI 10.1073/pnas.232568499; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Rockman SP, 2001, J BIOL CHEM, V276, P45113, DOI 10.1074/jbc.M107742200; Schreck C, 2014, ANN NY ACAD SCI, V1310, P32, DOI 10.1111/nyas.12384; Staal FJT, 2005, NAT REV IMMUNOL, V5, P21, DOI 10.1038/nri1529; Takemaru KI, 2000, J CELL BIOL, V149, P249, DOI 10.1083/jcb.149.2.249; Teo JL, 2005, P NATL ACAD SCI USA, V102, P12171, DOI 10.1073/pnas.0504600102; Thomas PD, 2016, CELL BIOL TOXICOL, V32, P61, DOI 10.1007/s10565-016-9318-0; Trowbridge JJ, 2006, NAT MED, V12, P89, DOI 10.1038/nm1339; Van Camp J, 2014, STEM CELL REV REP, V10, P207, DOI 10.1007/s12015-013-9486-8; van Galen P, 2014, CELL STEM CELL, V14, P94, DOI 10.1016/j.stem.2013.11.021; Weissman IL, 2008, BLOOD, V112, P3543, DOI 10.1182/blood-2008-08-078220; Wickline ED, 2011, J HEPATOL, V55, P1256, DOI 10.1016/j.jhep.2011.03.014; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yan D, 2011, P NATL ACAD SCI USA, V98, P14973; Zhang T, 2001, CANCER RES, V61, P8664; Zhao Y, 2016, ONCOGENE, V35, P3705, DOI 10.1038/onc.2015.438; Zhou BY, 2012, J BIOL CHEM, V287, P7026, DOI 10.1074/jbc.M111.276311; Zhou JB, 2007, AM J PHYSIOL-HEART C, V292, pH270, DOI 10.1152/ajpheart.00576.2006	50	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177245	10.1371/journal.pone.0177245	http://dx.doi.org/10.1371/journal.pone.0177245			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486541	Green Submitted, Green Published, gold			2022-12-26	WOS:000401314000063
J	Verma, K; Ogonek, J; Varanasi, PR; Luther, S; Bunting, I; Thomay, K; Behrens, YL; Mischak-Weissinger, E; Hambach, L				Verma, Kriti; Ogonek, Justyna; Varanasi, Pavankumar Reddy; Luther, Susanne; Buenting, Ivonne; Thomay, Katrin; Behrens, Yvonne Lisa; Mischak-Weissinger, Eva; Hambach, Lothar			Human CD8+CD57-T-EMRA cells: Too young to be called "old"	PLOS ONE			English	Article							CD8(+) T-CELLS; EFFECTOR FUNCTIONS; TELOMERE LENGTH; MEMORY; DIFFERENTIATION; SUBSETS; LYMPHOCYTES; EXPRESSION; IDENTIFICATION; INFECTIONS	End-stage differentiation of antigen-specific T-cells may precede loss of immune responses against e.g. viral infections after allogeneic stem cell transplantation (SCT). Antigen-specific CD8+ T-cells detected by HLA/peptide multimers largely comprise CD45RA-/CCR7-effector memory (T-EM) and CD45RA+/CCR7-T-EMRA subsets. A majority of terminally differentiated T-cells is considered to be part of the heterogeneous T-EMRA subset. The senescence marker CD57 has been functionally described in memory T-cells mainly composed of central memory (T-CM) and T-EM cells. However, its role specifically in T-EMRA cells remained undefined. Here, we investigated the relevance of CD57 to separate human CD8+ T-EMRA cells into functionally distinct subsets. CD57-CD8+ T-EMRA cells isolated from healthy donors had considerably longer telomeres and showed significantly more BrdU uptake and IFN-gamma release upon stimulation compared to the CD57+ counterpart. Cytomegalovirus (CMV) specific T-cells isolated from patients after allogeneic SCT were purified into CD57+ and CD57-T-EMRA subsets. CMV specific CD57-T-EMRA cells had longer telomeres and a considerably higher CMV peptide sensitivity in BrdU uptake and IFN-gamma release assays compared to CD57 + T-EMRA cells. In contrast, CD57+ and CD57-T-EMRA cells showed comparable peptide specific cytotoxicity. Finally, CD57-CD8+ T-EMRA cells partially changed phenotypically into T-EM cells and gained CD57 expression, while CD57+ CD8+ T-EMRA cells hardly changed phenotypically and showed considerable cell death after in vitro stimulation. To the best of our knowledge, these data show for the first time that CD57 separates CD8+ T-EMRA cells into a terminally differentiated CD57+ population and a so far functionally undescribed "young" CD57-T-EMRA subset with high proliferative capacity and differentiation plasticity.	[Verma, Kriti; Ogonek, Justyna; Varanasi, Pavankumar Reddy; Luther, Susanne; Buenting, Ivonne; Mischak-Weissinger, Eva; Hambach, Lothar] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany; [Verma, Kriti] Integrated Res & Treatment Ctr Transplantat IFB T, Hannover, Germany; [Thomay, Katrin; Behrens, Yvonne Lisa] Hannover Med Sch, Inst Human Genet, Hannover, Germany	Hannover Medical School; Hannover Medical School	Hambach, L (corresponding author), Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany.	hambach.lothar@mh-hannover.de	Varanasi, Pavankumar/AGP-6339-2022	Varanasi, Pavankumar/0000-0003-4658-0453; Verma, Kriti/0000-0002-7368-8171	German Federal Ministry of Education and Research [01EO1302]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by the German Federal Ministry of Education and Research (reference number: 01EO1302). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Bondanza A, 2011, BLOOD, V117, P6469, DOI 10.1182/blood-2010-11-320366; Borchers S, 2011, TRANSPL INFECT DIS, V13, P222, DOI 10.1111/j.1399-3062.2011.00626.x; Breckpot K, 2004, J IMMUNOL, V172, P2232, DOI 10.4049/jimmunol.172.4.2232; Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103; Calarota Sandra A, 2013, Clin Dev Immunol, V2013, P637649, DOI 10.1155/2013/637649; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; Chattopadhyay PK, 2009, J LEUKOCYTE BIOL, V85, P88, DOI 10.1189/jlb.0208107; Geginat J, 2003, BLOOD, V101, P4260, DOI 10.1182/blood-2002-11-3577; Gerritsen B, 2016, IMMUNOL CELL BIOL, V94, P236, DOI 10.1038/icb.2015.118; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; Hombrink P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022523; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Lugli E, 2013, NAT PROTOC, V8, P33, DOI 10.1038/nprot.2012.143; Macchia I, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/726239; Mahnke YD, 2013, EUR J IMMUNOL, V43, P2797, DOI 10.1002/eji.201343751; Mattis AE, 1997, J IMMUNOL METHODS, V204, P135, DOI 10.1016/S0022-1759(97)00047-1; O'Callaghan NJ, 2011, BIOL PROCED ONLINE, V13, DOI 10.1186/1480-9222-13-3; Romero P, 2007, J IMMUNOL, V178, P4112, DOI 10.4049/jimmunol.178.7.4112; Rufer N, 2003, BLOOD, V102, P1779, DOI 10.1182/blood-2003-02-0420; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Scheinberg P, 2009, BLOOD, V114, P5071, DOI 10.1182/blood-2009-04-214684; van der Torren CR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119595; Voehringer D, 2001, J IMMUNOL, V167, P4838, DOI 10.4049/jimmunol.167.9.4838; Wang F, 2013, P NATL ACAD SCI USA, V110, pE1906, DOI 10.1073/pnas.1306639110	26	38	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177405	10.1371/journal.pone.0177405	http://dx.doi.org/10.1371/journal.pone.0177405			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481945	Green Submitted, Green Published, gold			2022-12-26	WOS:000401313700058
J	Xiang, Z; Zhou, ZJ; Xia, GK; Zhang, XH; Wei, ZW; Zhu, JT; Yu, J; Chen, W; He, Y; Schwarz, RE; Brekken, RA; Awasthi, N; Zhang, CH				Xiang, Z.; Zhou, Z-J; Xia, G-K; Zhang, X-H; Wei, Z-W; Zhu, J-T; Yu, J.; Chen, W.; He, Y.; Schwarz, R. E.; Brekken, R. A.; Awasthi, N.; Zhang, C-H			A positive crosstalk between CXCR4 and CXCR2 promotes gastric cancer metastasis	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; RECEPTOR 4 AXIS; BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; CELL-MIGRATION; TUMOR HETEROGENEITY; COLORECTAL-CANCER; UP-REGULATION; EXPRESSION; INVASION	The molecular mechanism underlying gastric cancer (GC) invasion and metastasis is still poorly understood. In this study, we tried to investigate the roles of CXCR4 and CXCR2 signalings in gastric cancer metastasis. A highly invasive gastric cancer cell model was established. Chemokines receptors were profiled to search for the accountable ones. Then the underlying molecular mechanism was investigated using both in vitro and in vivo techniques, and the clinical relevance of CXCR4 and CXCR2 expression was studied in gastric cancer samples. CXCR4 and CXCR2 were highly expressed in a high invasive gastric cancer cell model and in gastric cancer tissues. Overexpression of CXCR4 and CXCR2 was associated with more advanced tumor stage and poorer survival for GC patients. CXCR4 and CXCR2 expression strongly correlated with each other in the way that CXCR2 expression changed accordingly with the activity of CXCR4 signaling and CXCR4 expression also changed in agreement with CXCR2 activity. Further studies demonstrated CXCR4 and CXCR2 can both activated NF-kappa B and STAT3 signaling, while NF-kappa Bp65 can then transcriptionally activate CXCR4 and STAT3 can activate CXCR2 expression. This crosstalk between CXCR4 and CXCR2 contributed to EMT, migration and invasion of gastric cancer. Finally, Co-inhibition of CXCR4 and CXCR2 is more effective in reducing gastric cancer metastasis. Our results demonstrated that CXCR4 and CXCR2 cross-activate each other to promote the metastasis of gastric cancer.	[Xiang, Z.; Zhou, Z-J; Xia, G-K; Zhang, X-H; Wei, Z-W; Zhu, J-T; Yu, J.; Chen, W.; He, Y.; Zhang, C-H] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Gastrointestinal Surg, 58 Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China; [Xiang, Z.; Zhou, Z-J; Xia, G-K; Zhang, X-H; Wei, Z-W; Zhu, J-T; Yu, J.; Chen, W.; Zhang, C-H] Sun Yat Sen Univ, Gastr Canc Ctr, Guangzhou, Guangdong, Peoples R China; [He, Y.] Sun Yat Sen Univ, Affiliated Hosp 1, Gastrointestinal Ctr, Guangzhou, Guangdong, Peoples R China; [Schwarz, R. E.; Awasthi, N.] Indiana Univ Sch Med, South Bend, IN USA; [Schwarz, R. E.; Awasthi, N.] IU Hlth Goshen Ctr Canc Care, Goshen, IN USA; [Brekken, R. A.] Univ Texas Southwestern Med Ctr Dallas, Dept Surg, Div Surg Oncol, Dallas, TX 75390 USA; [Brekken, R. A.] Univ Texas Southwestern Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Indiana University System; Indiana University South Bend; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zhang, CH (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Gastrointestinal Surg, 58 Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China.; Zhang, CH (corresponding author), Sun Yat Sen Univ, Gastr Canc Ctr, Guangzhou, Guangdong, Peoples R China.	zhchangh@mail.sysu.edu.cn	Zhou, Zhijun/AAU-9428-2021	Zhou, Zhijun/0000-0003-2226-2223	National Natural Science Foundation of China [81272643, 81272637]; '3 & 3' project of The First Affiliated Hospital of Sun Yat-sen University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); '3 & 3' project of The First Affiliated Hospital of Sun Yat-sen University	We acknowledge the use of NCBI GEO database, such as GSE29272, GSE15459 and GSE62254. This study was supported by the National Natural Science Foundation of China (No. 81272643 and No. 81272637) and '3 & 3' project of The First Affiliated Hospital of Sun Yat-sen University.	Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; An HM, 2015, EUR J CANCER, V51, P1953, DOI 10.1016/j.ejca.2015.06.125; Becker P.S., 2014, BLOOD, V124, P386, DOI [10.1182, DOI 10.1182/blood.V124.21.386.386]; Bertran E, 2013, HEPATOLOGY, V58, P2032, DOI 10.1002/hep.26597; Bertran E, 2009, CELL SIGNAL, V21, P1595, DOI 10.1016/j.cellsig.2009.06.006; Bicocca VT, 2012, CANCER CELL, V22, P656, DOI 10.1016/j.ccr.2012.08.027; Borsig L, 2014, ONCOGENE, V33, P3217, DOI 10.1038/onc.2013.272; Borthakur G, 2014, BLOOD, V124, P950, DOI DOI 10.1182/blood.V124.21.950.950; Cambien B, 2009, BRIT J CANCER, V100, P1755, DOI 10.1038/sj.bjc.6605078; Chen G, 2012, J BIOL CHEM, V287, P12132, DOI 10.1074/jbc.M111.302299; Cheng WL, 2011, ANN ONCOL, V22, P2267, DOI 10.1093/annonc/mdq739; Domanska UM, 2013, EUR J CANCER, V49, P219, DOI 10.1016/j.ejca.2012.05.005; Feng YF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136175; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; FIDLER IJ, 1978, CANCER RES, V38, P2651; Fontanella R, 2016, CANCER LETT, V370, P100, DOI 10.1016/j.canlet.2015.10.018; Fujita T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130808; Galsky MD, 2014, CLIN CANCER RES, V20, P3581, DOI 10.1158/1078-0432.CCR-13-2686; Garcia-Irigoyen O, 2015, HEPATOLOGY, V62, P166, DOI 10.1002/hep.27798; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Guo F, 2016, ONCOGENE, V35, P816, DOI 10.1038/onc.2015.139; Hayashi H, 2015, CANCER RES, V75, P4985, DOI 10.1158/0008-5472.CAN-15-0291; Heinrich EL, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-68; Helbig G, 2003, J BIOL CHEM, V278, P21631, DOI 10.1074/jbc.M300609200; Highfill SL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007974; Hu JJ, 2011, P NATL ACAD SCI USA, V108, P15984, DOI 10.1073/pnas.1113416108; Hu TH, 2014, CANCER LETT, V354, P417, DOI 10.1016/j.canlet.2014.08.012; Kawada K, 2007, ONCOGENE, V26, P4679, DOI 10.1038/sj.onc.1210267; Ko YS, 2015, BRIT J CANCER, V113, P1186, DOI 10.1038/bjc.2015.273; Li Z, 2014, CYTOKINE, V69, P6, DOI 10.1016/j.cyto.2014.05.004; Liu H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9494; Liu LP, 2015, GUT, V64, P26, DOI 10.1136/gutjnl-2013-306388; Manu KA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-107; Maxwell PJ, 2007, ONCOGENE, V26, P7333, DOI 10.1038/sj.onc.1210536; Maxwell PJ, 2014, ONCOTARGET, V5, P4895, DOI 10.18632/oncotarget.2052; Mukherjee S, 2016, ONCOGENE, V35, P4937, DOI 10.1038/onc.2016.26; Murakami T, 2013, INT J CANCER, V132, P276, DOI 10.1002/ijc.27670; Naschberger E, 2008, INT J CANCER, V123, P2120, DOI 10.1002/ijc.23764; Nguyen-Jackson H, 2010, BLOOD, V115, P3354, DOI 10.1182/blood-2009-08-240317; Pozzobon T, 2016, IMMUNOL LETT, V177, P6, DOI 10.1016/j.imlet.2016.06.006; Pradelli E, 2009, INT J CANCER, V125, P2586, DOI 10.1002/ijc.24665; Roussos ET, 2011, NAT REV CANCER, V11, P573, DOI 10.1038/nrc3078; Saintigny P, 2013, CANCER RES, V73, P571, DOI 10.1158/0008-5472.CAN-12-0263; Sarvaiya PJ, 2013, ONCOTARGET, V4, P2171, DOI 10.18632/oncotarget.1426; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Siewert JR, 1998, ANN SURG, V228, P449, DOI 10.1097/00000658-199810000-00002; Singh AK, 2013, CYTOKINE GROWTH F R, V24, P41, DOI 10.1016/j.cytogfr.2012.08.007; Sobolik T, 2014, MOL BIOL CELL, V25, P566, DOI 10.1091/mbc.E13-07-0360; Steele CW, 2016, CANCER CELL, V29, P832, DOI 10.1016/j.ccell.2016.04.014; Sun XQ, 2010, CANCER METAST REV, V29, P709, DOI 10.1007/s10555-010-9256-x; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Tie J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000879; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Walser TC, 2006, CANCER RES, V66, P7701, DOI 10.1158/0008-5472.CAN-06-0709; Wang HY, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0169-y; Wang SM, 2016, GUT, V65, P1427, DOI 10.1136/gutjnl-2014-308932; Wang YW, 2015, ONCOTARGET, V6, P10646, DOI 10.18632/oncotarget.3392; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Wei ZW, 2015, CANCER LETT, V359, P335, DOI 10.1016/j.canlet.2015.01.033; Xiang JY, 2014, CANCER RES, V74, DOI 10.1158/1538-7445.AM2014-1114; Yang G, 2010, CLIN CANCER RES, V16, P3875, DOI 10.1158/1078-0432.CCR-10-0483; Yang JM, 2004, MOL THER, V9, P846, DOI 10.1016/j.ymthe.2004.01.010; YANG K, 2015, MEDICINE, V94; Yao CJ, 2016, MOL NEUROBIOL, V53, P3948, DOI 10.1007/s12035-015-9340-x; Yasumoto K, 2006, CANCER RES, V66, P2181, DOI 10.1158/0008-5472.CAN-05-3393; Zhou SL, 2015, CANCER LETT, V358, P124, DOI 10.1016/j.canlet.2014.11.044	66	59	61	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 7	2017	36	36					5122	5133		10.1038/onc.2017.108	http://dx.doi.org/10.1038/onc.2017.108			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FF9XD	28481874				2022-12-26	WOS:000409371100004
J	Chen, XW; Yu, TJ; Zhang, J; Li, Y; Chen, HL; Yang, GF; Yu, W; Liu, YZ; Liu, XX; Duan, CF; Tang, HL; Qiu, M; Wang, CL; Zheng, H; Yue, J; Guo, AM; Yang, J				Chen, X. W.; Yu, T. J.; Zhang, J.; Li, Y.; Chen, H. L.; Yang, G. F.; Yu, W.; Liu, Y. Z.; Liu, X. X.; Duan, C. F.; Tang, H. L.; Qiu, M.; Wang, C. L.; Zheng, H.; Yue, J.; Guo, A. M.; Yang, J.			CYP4A in tumor-associated macrophages promotes pre-metastatic niche formation and metastasis	ONCOGENE			English	Article							MARROW-DERIVED CELLS; PREMETASTATIC NICHE; CANCER METASTASIS; LUNG METASTASIS; POLARIZATION; RECRUITMENT; GROWTH; ACTIVATION; ENZYMES; MATRIX-METALLOPROTEINASE-9	Tumor-associated macrophages (TAMs) play an essential role in metastasis. However, what enables TAMs to have a superior capacity to establish pre-metastatic microenvironment in distant organs is unclear. Here we have begun to uncover the effects of cytochrome P450 (CYP) 4A in TAMs on lung pre-metastatic niche formation and metastasis. CYP4A(+) TAM infiltration was positively associated with metastasis, pre-metastatic niche formation and poor prognosis in breast cancer patients. The pharmacological inhibition of CYP4A reduced lung pre-metastatic niche formation (evidenced by a decrease in vascular endothelial growth factor receptor 1 positive (VEGFR1(+)) myeloid cell recruitment and pro-metastatic protein expression) and metastatic burden, accompanied with TAM polarization away from the M2 phenotype in spontaneous metastasis models of 4T1 breast cancer and B16F10 melanoma. Co-implantation of 4T1 cells with CYP4A10(high) macrophages promoted lung pre-metastatic niche formation and metastasis. Depletion of TAMs disrupted lung pre-metastatic niches and thereby prevented metastasis. Treatment with the CM from CYP4A10(high) M2 macrophages (M2) increased pre-metastatic niche formation and metastatic burden in the lungs, whereas CYP4A inhibition attenuated these effects. In vitro TAM polarization away from the M2 phenotype induced by CYP4A inhibition decreased VEGFR1(+) myeloid cell migration and fibronectin expression, accompanied with downregulation of STAT3 signaling. Conversely, overexpression of CYP4A or exogenous addition of 2'-hydroxyeicosatetraenoic acid promoted M2 polarization and cytokine production of macrophages and thereby enhanced migration of VEGFR1(+) myeloid cells, which were reversed by siRNA or pharmacological inhibition of STAT3. Importantly, a combined blocking M2 macrophage-derived factors TGF-beta, VEGF and SDF-1 abolished VEGFR1(+) myeloid cell migration and fibroblast activation induced by CYP4A. In summary, CYP4A in TAMs is crucial for lung pre-metastatic niche formation and metastasis, and may serve as a potential therapeutic target in human cancer.	[Chen, X. W.; Yu, T. J.; Li, Y.; Liu, Y. Z.; Liu, X. X.; Duan, C. F.; Tang, H. L.; Qiu, M.; Wang, C. L.; Zheng, H.; Yue, J.; Yang, J.] Wuhan Univ, Sch Basic Med Sci, Dept Pharmacol, Donghu Rd, Wuhan 430071, Hubei, Peoples R China; [Zhang, J.] Wuhan Univ, Anim Expt Ctr, Wuhan, Hubei, Peoples R China; [Chen, H. L.] Wuhan Univ, Sch Basic Med Sci, Dept Pathol & Pathophysiol, Wuhan, Hubei, Peoples R China; [Yang, G. F.] Wuhan Univ, Zhongnan Hosp, Dept Pathol, Wuhan, Hubei, Peoples R China; [Yu, W.] China Three Gorges Univ, Dept Oncol, Coll Clin Med 1, Yichang, Peoples R China; [Guo, A. M.] New York Med Coll, Dept Pharmacol, Valhalla, NY 10595 USA	Wuhan University; Wuhan University; Wuhan University; Wuhan University; China Three Gorges University; New York Medical College	Yang, J (corresponding author), Wuhan Univ, Sch Basic Med Sci, Dept Pharmacol, Donghu Rd, Wuhan 430071, Hubei, Peoples R China.	yangjingliu2013@163.com		yang, jing/0000-0003-2733-8629	National Natural Science Foundation of China [30973552, 81272464, 81173089, 81402958, 81201261]; Fundamental Research Funds for the Central Universities [2014301020201]; Hubei Key Laboratory of Medical Information Analysis & Tumor Diagnosis and Treatment [PJS140011508]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Hubei Key Laboratory of Medical Information Analysis & Tumor Diagnosis and Treatment	This work was supported by the National Natural Science Foundation of China (grant nos 30973552, 81272464, 81173089 (to JY), 81402958 (to WY) and 81201261 (to JZ)), the Fundamental Research Funds for the Central Universities (grant no. 2014301020201) (to XC) and Hubei Key Laboratory of Medical Information Analysis & Tumor Diagnosis and Treatment (PJS140011508) (to CW).	Acuff HB, 2006, CANCER RES, V66, P259, DOI 10.1158/0008-5472.CAN-05-2502; Alexanian A, 2013, ONCOTARGETS THER, V6, P243, DOI 10.2147/OTT.S31586; Alexanian A, 2012, CANCER GENOM PROTEOM, V9, P163; Borin TF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116247; Chen PW, 2013, INT REV CEL MOL BIO, V301, P1, DOI 10.1016/B978-0-12-407704-1.00001-4; Chen YK, 2015, ONCOTARGET, V6, P32575, DOI 10.18632/oncotarget.5331; Cirri P, 2011, AM J CANCER RES, V1, P482; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; Dayer C, 2015, J BIOL CHEM, V290, P13763, DOI 10.1074/jbc.M114.622274; Deng JH, 2012, CANCER CELL, V21, P642, DOI 10.1016/j.ccr.2012.03.039; Ding L, 2015, ONCOTARGET, V6, P36441, DOI 10.18632/oncotarget.5541; Edson KZ, 2013, CURR TOP MED CHEM, V13, P1429; Fang WY, 2014, CARCINOGENESIS, V35, P1780, DOI 10.1093/carcin/bgu060; Gil-Bernabe AM, 2012, BLOOD, V119, P3164, DOI 10.1182/blood-2011-08-376426; Giles AJ, 2016, CANCER RES, V76, P1335, DOI 10.1158/0008-5472.CAN-15-0204; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Jia XM, 2014, BREAST CANCER RES TR, V148, P291, DOI 10.1007/s10549-014-3164-7; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kitamura T, 2015, NAT REV IMMUNOL, V15, P73, DOI 10.1038/nri3789; Kortylewski M, 2005, NAT MED, V11, P1314, DOI 10.1038/nm1325; Kowanetz M, 2010, P NATL ACAD SCI USA, V107, P21248, DOI 10.1073/pnas.1015855107; Kroetz DL, 2005, ANNU REV PHARMACOL, V45, P413, DOI 10.1146/annurev.pharmtox.45.120403.100045; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Liu YF, 2016, CANCER CELL, V30, P243, DOI 10.1016/j.ccell.2016.06.021; Liu Y, 2016, CANCER CELL, V30, P668, DOI 10.1016/j.ccell.2016.09.011; Pal SK, 2015, MOL CANCER THER, V14, P2896, DOI 10.1158/1535-7163.MCT-15-0367; Rolny C, 2011, CANCER CELL, V19, P31, DOI 10.1016/j.ccr.2010.11.009; Sceneay J, 2013, CANCER METAST REV, V32, P449, DOI 10.1007/s10555-013-9420-1; Sharma SK, 2015, J IMMUNOL, V194, P5529, DOI 10.4049/jimmunol.1403215; Sun QZ, 2016, CELL SIGNAL, V28, P307, DOI 10.1016/j.cellsig.2016.01.004; Wculek SK, 2015, NATURE, V528, P413, DOI 10.1038/nature16140; Wei J, 2015, J SURG RES, V197, P126, DOI 10.1016/j.jss.2015.03.023; Wu CF, 2015, INT J CANCER, V137, P837, DOI 10.1002/ijc.29444; Yu W, 2011, CANCER CHEMOTH PHARM, V68, P619, DOI 10.1007/s00280-010-1521-8; Zhang W, 2010, CLIN CANCER RES, V16, P3420, DOI 10.1158/1078-0432.CCR-09-2904; Zhao HX, 2014, TOXICOL APPL PHARM, V279, P311, DOI 10.1016/j.taap.2014.07.001; Zheng H, 2014, TOXICOL APPL PHARM, V280, P10, DOI 10.1016/j.taap.2014.07.018	39	77	80	4	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 31	2017	36	35					5045	5057		10.1038/onc.2017.118	http://dx.doi.org/10.1038/onc.2017.118			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FF3AV	28481877	hybrid, Green Published			2022-12-26	WOS:000408768800009
J	Wang, HY; Guo, J; Lin, ZL; Namgoong, S; Oh, JS; Kim, NH				Wang, HaiYang; Guo, Jing; Lin, ZiLi; Namgoong, Suk; Oh, Jeong Su; Kim, Nam-Hyung			Filamin A is required for spindle migration and asymmetric division in mouse oocytes	FASEB JOURNAL			English	Article						FLNA; actin; cofilin; ROCK	ACTIN-BINDING PROTEIN; MEIOTIC SPINDLE; LIM-KINASE; COFILIN PHOSPHORYLATION; CYTOKINESIS; MATURATION; MEIOSIS; ROCK; FILAMENTS; RHO	Dynamic changes in the actin network are crucial for the cortical migration of spindles and establishment of polarity, to ensure asymmetric division during meiotic maturation. In this study, filamin A (FLNA) was found to be an essential actin regulator that controlled spindle migration and asymmetric division during oocyte meiosis. FLNA was localized in the cytoplasm and enriched at the cortex and near the chromosomes. Knockdown of FLNA impaired meiotic asymmetric division and spindle migration with a decrease in the amount of cytoplasmic actin mesh and cortical actin levels. Moreover, FLNA knockdown reduced the phosphorylation of cofilin and Rho kinase (ROCK) near the spindle. Similar phenotypes, such as decreased filament actin levels, impaired spindle migration and polar body extrusion, were observed when active cofilin (S3A) was overexpressed or ROCK was inhibited. Notably, we found that FLNA and ROCK interacted directly in mouse oocytes. Taken together, our results show that FLNA plays crucial roles in asymmetric division during meiotic maturation by regulating ROCK-cofilin-mediated actin reorganization.	[Wang, HaiYang; Guo, Jing; Namgoong, Suk; Kim, Nam-Hyung] Chungbuk Natl Univ, Dept Anim Sci, Cheongju, South Korea; [Lin, ZiLi] Tsinghua Univ, Sch Life Sci, Beijing, Peoples R China; [Oh, Jeong Su] Sungkyunkwan Univ, Dept Genet Engn, Coll Biotechnol & Bioengn, Suwon, Gyeonggi Do, South Korea	Chungbuk National University; Tsinghua University; Sungkyunkwan University (SKKU)	Kim, NH (corresponding author), Chungbuk Natl Univ, Dept Anim Sci, Cheongju, South Korea.; Oh, JS (corresponding author), Sungkyunkwan Univ, Dept Genet Engn, Coll Biotechnol & Bioengn, Suwon, Gyeonggi Do, South Korea.	ohjs@skku.edu; nhkim@chungbuk.ac.kr		WANG, HAIYANG/0000-0002-6362-6022	Next-Generation BioGreen 21 Program (Republic of Korea Rural Development Administration) [PJ011126]	Next-Generation BioGreen 21 Program (Republic of Korea Rural Development Administration)	This study was supported by Next-Generation BioGreen 21 Program PJ011126 (Republic of Korea Rural Development Administration). The authors declare no conflicts of interest.	Almonacid M, 2014, J CELL SCI, V127, P477, DOI 10.1242/jcs.142711; Azoury J, 2008, CURR BIOL, V18, P1514, DOI 10.1016/j.cub.2008.08.044; Azoury J, 2009, BIOL CELL, V101, P69, DOI 10.1042/BC20080003; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Brunet S, 2011, HUM REPROD UPDATE, V17, P68, DOI 10.1093/humupd/dmq044; Chaigne A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7027; Chaigne A, 2013, NAT CELL BIOL, V15, P958, DOI 10.1038/ncb2799; Clift D, 2013, NAT REV MOL CELL BIO, V14, P549, DOI 10.1038/nrm3643; Conti M, 2012, MOL CELL ENDOCRINOL, V356, P65, DOI 10.1016/j.mce.2011.11.002; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; Dehapiot B, 2013, DEV BIOL, V377, P202, DOI 10.1016/j.ydbio.2013.01.029; Deng MQ, 2007, DEV CELL, V12, P301, DOI 10.1016/j.devcel.2006.11.008; Duan X, 2016, CELL CYCLE, V15, P471, DOI 10.1080/15384101.2015.1128590; Duan X, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.113522; Dumont J, 2007, DEV BIOL, V301, P254, DOI 10.1016/j.ydbio.2006.08.044; Feng YY, 2006, P NATL ACAD SCI USA, V103, P19836, DOI 10.1073/pnas.0609628104; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Halet G, 2007, DEV CELL, V12, P309, DOI 10.1016/j.devcel.2006.12.010; HARTWIG JH, 1986, J CELL BIOL, V103, P1007, DOI 10.1083/jcb.103.3.1007; HARTWIG JH, 1989, J CELL BIOL, V108, P467, DOI 10.1083/jcb.108.2.467; Jang WI, 2014, CELL CYCLE, V13, P2359, DOI 10.4161/cc.29333; Jay D, 2000, ARCH BIOCHEM BIOPHYS, V377, P80, DOI 10.1006/abbi.2000.1762; Jo YJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep29204; Jo YJ, 2015, J CELL SCI, V128, P160, DOI 10.1242/jcs.163576; Kaji N, 2008, J BIOL CHEM, V283, P4983, DOI 10.1074/jbc.M708644200; Leader B, 2002, NAT CELL BIOL, V4, P921, DOI 10.1038/ncb880; Lee SR, 2015, MOL REPROD DEV, V82, P849, DOI 10.1002/mrd.22524; Liu M, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-149; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Namgoong S, 2016, CELL CYCLE, V15, P1830, DOI 10.1080/15384101.2016.1181239; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; Ono S, 2002, J CELL BIOL, V156, P1065, DOI 10.1083/jcb.200110013; Pfender S, 2011, CURR BIOL, V21, P955, DOI 10.1016/j.cub.2011.04.029; Savoy RM, 2013, ENDOCR-RELAT CANCER, V20, pR341, DOI 10.1530/ERC-13-0364; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Sun SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018392; Thomas JAI, 2008, CELL MOTIL CYTOSKEL, V65, P979, DOI 10.1002/cm.20320; Tigges U, 2003, J BIOL CHEM, V278, P23561, DOI 10.1074/jbc.M302302200; Van Troys M, 2008, EUR J CELL BIOL, V87, P649, DOI 10.1016/j.ejcb.2008.04.001; WALLACH D, 1978, J BIOL CHEM, V253, P4739; Wang F, 2015, CELL CYCLE, V14, P2835, DOI 10.1080/15384101.2015.1031438; Wang ZB, 2013, MOL BIOL CELL, V24, P3832, DOI 10.1091/mbc.E13-03-0123; Xu YJ, 2010, J EXP MED, V207, P2421, DOI 10.1084/jem.20100433; YASUTAKA O, 1995, BIOCHEMISTRY-US, V34, P6745, DOI 10.1021/bi00020a020; Yi K, 2011, NAT CELL BIOL, V13, P1252, DOI 10.1038/ncb2320; Zhang Y, 2014, THERIOGENOLOGY, V82, P49, DOI 10.1016/j.theriogenology.2014.02.020; Zhou AX, 2010, TRENDS CELL BIOL, V20, P113, DOI 10.1016/j.tcb.2009.12.001	47	9	9	3	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3677	3688		10.1096/fj.201700056R	http://dx.doi.org/10.1096/fj.201700056R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28487281				2022-12-26	WOS:000405932400038
J	Gu, JL; Chen, F; Iqbal, K; Gong, CX; Wang, XL; Liu, F				Gu, Jianlan; Chen, Feng; Iqbal, Khalid; Gong, Cheng-Xin; Wang, Xinglong; Liu, Fei			Transactive response DNA-binding protein 43 (TDP-43) regulates alternative splicing of tau exon 10: Implications for the pathogenesis of tauopathies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alternative splicing; Alzheimer disease; TAR DNA-binding protein 43 (TDP-43) (TARDBP); tau protein (tau); tauopathy	FRONTOTEMPORAL LOBAR DEGENERATION; AMYOTROPHIC-LATERAL-SCLEROSIS; ALZHEIMERS-DISEASE; PICKS-DISEASE; SR PROTEINS; MUTATIONS; PATHOLOGY; GENE; PHOSPHORYLATION; NEURODEGENERATION	Hyperphosphorylation and aggregation of the neuronal protein tau are responsible for neurodegenerative diseases called tauopathies. Dysregulation of the alternative splicing of tau exon 10 results in alterations of the ratio of two tau isoforms, 3R-tau and 4R-tau, which have been seen in several tauopathies. Transactive response DNA-binding protein of 43 kDa (TDP-43) is involved in the regulation of RNA processing, including splicing. Cytoplasmic aggregation of TDP-43 has been observed in the brains of individuals with chronic traumatic encephalopathy or Alzheimer's disease, diseases in which neurofibrillary tangles of hyperphosphorylated tau are hallmarks. Here, we investigated the role of TDP-43 in tau exon 10 splicing. We found that TDP-43 promoted tau exon 10 inclusion, which increased production of the 4R-tau isoform. Moreover, TDP-43 could bind to intron 9 of tau pre-mRNA. Deletion of the TDP-43 N or C terminus promoted its cytoplasmic aggregation and abolished or diminished TDP-43-promoted tau exon 10 inclusion. Several TDP-43 mutations associated with amyotrophic lateral sclerosis or frontotemporal lobar degeneration with ubiquitin inclusions promoted tau exon 10 inclusion more effectively than wild-type TDP-43 but did not affect TDP-43 cytoplasmic aggregation in cultured cells. The ratio of 3R-tau/4R-tau was decreased in transgenic mouse brains expressing human TDP-43 and increased in the brains expressing the disease-causing mutation TDP-43(M337V), in which cytoplasmic TDP-43 was increased. These findings suggest that TDP-43 promotes tau exon 10 inclusion and 4R-tau expression and that disease-related changes of TDP-43, truncations and mutations, affect its function in tau exon 10 splicing, possibly because of TDP-43 mislocalization to the cytoplasm.	[Gu, Jianlan; Chen, Feng; Gong, Cheng-Xin; Liu, Fei] Nantong Univ, Key Lab Neuroregenerat Jiangsu, Coinnovat Ctr Neuroregenerat, Sch Med, Nantong 226001, Jiangsu, Peoples R China; [Gu, Jianlan; Chen, Feng; Gong, Cheng-Xin; Liu, Fei] Nantong Univ, Minist Educ, Coinnovat Ctr Neuroregenerat, Sch Med, Nantong 226001, Jiangsu, Peoples R China; [Gu, Jianlan] Nantong Univ, Sch Med, Dept Biochem & Mol Biol, Nantong 226001, Jiangsu, Peoples R China; [Gu, Jianlan; Chen, Feng; Iqbal, Khalid; Gong, Cheng-Xin; Liu, Fei] New York State Inst Basic Res Dev Disabil, Dept Neurochem, 1050 Forest Hill Rd, Staten Isl, NY 10314 USA; [Wang, Xinglong] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA	Nantong University; Nantong University; Nantong University; Institute for Basic Research in Developmental Disabilities; Case Western Reserve University	Liu, F (corresponding author), New York State Inst Basic Res Dev Disabil, Dept Neurochem, Inge Grundke Iqbal Res Floor, Staten Isl, NY 10314 USA.	feiliu63@hotmail.com			Nantong University; New York State Office for People With Developmental Disabilities; National Natural Science Foundation of China [81030059, 31671046]; Natural Science Foundation from Jiangsu Education Department [16KJB310013]; Priority Academic Program Development of Jiangsu Higher Education Institution (PAPD); United States Alzheimer's Association Grant [DSAD-15-363172]	Nantong University; New York State Office for People With Developmental Disabilities; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation from Jiangsu Education Department; Priority Academic Program Development of Jiangsu Higher Education Institution (PAPD); United States Alzheimer's Association Grant	This work was supported by Nantong University, the New York State Office for People With Developmental Disabilities, National Natural Science Foundation of China Grants 81030059 and 31671046, Natural Science Foundation from Jiangsu Education Department Grant 16KJB310013, a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institution (PAPD), and United States Alzheimer's Association Grant DSAD-15-363172. The authors declare that they have no conflicts of interest with the contents of this article.	Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; ANDREADIS A, 1992, BIOCHEMISTRY-US, V31, P10626, DOI 10.1021/bi00158a027; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Arnold ES, 2013, P NATL ACAD SCI USA, V110, pE736, DOI 10.1073/pnas.1222809110; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Borroni B, 2010, REJUV RES, V13, P509, DOI 10.1089/rej.2010.1017; Bronner IF, 2005, BRAIN, V128, P2645, DOI 10.1093/brain/awh591; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Buratti E, 2008, FRONT BIOSCI-LANDMRK, V13, P867, DOI 10.2741/2727; Buratti E, 2012, TRENDS BIOCHEM SCI, V37, P237, DOI 10.1016/j.tibs.2012.03.003; Cairns NJ, 2007, AM J PATHOL, V171, P227, DOI 10.2353/ajpath.2007.070182; CHOI DW, 1987, J NEUROSCI, V7, P357; Cohen TJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6845; Cohen TJ, 2012, EMBO J, V31, P1241, DOI 10.1038/emboj.2011.471; D'Souza I, 2006, J BIOL CHEM, V281, P2460, DOI 10.1074/jbc.M505809200; DEGARCINI EM, 1986, BIOCHIM BIOPHYS ACTA, V881, P456, DOI 10.1016/0304-4165(86)90039-5; Ding SH, 2012, NEUROBIOL AGING, V33, P1389, DOI 10.1016/j.neurobiolaging.2010.11.021; Fiesel FC, 2012, NUCLEIC ACIDS RES, V40, P2668, DOI 10.1093/nar/gkr1082; Gao L, 2007, MOL CELL NEUROSCI, V34, P48, DOI 10.1016/j.mcn.2006.10.004; Gendron TF, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-13; Ghoshal N, 1999, AM J PATHOL, V155, P1163, DOI 10.1016/S0002-9440(10)65219-4; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Gregory JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031899; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Gu JL, 2017, NUCLEIC ACIDS RES, V45, P6177, DOI 10.1093/nar/gkx175; Gu JL, 2012, FEBS LETT, V586, P2239, DOI 10.1016/j.febslet.2012.05.046; Hartmann AM, 2001, MOL CELL NEUROSCI, V18, P80, DOI 10.1006/mcne.2001.1000; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; Higashi S, 2007, BRAIN RES, V1184, P284, DOI 10.1016/j.brainres.2007.09.048; Ingram EM, 2002, TRENDS MOL MED, V8, P555, DOI 10.1016/S1471-4914(02)02440-1; Josephs KA, 2014, ACTA NEUROPATHOL, V127, P441, DOI 10.1007/s00401-013-1211-9; Kametani F, 2009, BIOCHEM BIOPH RES CO, V382, P405, DOI 10.1016/j.bbrc.2009.03.038; Kirby J, 2010, NEUROGENETICS, V11, P217, DOI 10.1007/s10048-009-0218-9; KOSIK KS, 1989, ANN MED, V21, P109, DOI 10.3109/07853898909149195; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Manley JL, 2010, GENE DEV, V24, P1073, DOI 10.1101/gad.1934910; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mercado PA, 2005, NUCLEIC ACIDS RES, V33, P6000, DOI 10.1093/nar/gki897; Neumann M, 2001, ANN NEUROL, V50, P503, DOI 10.1002/ana.1223; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, ACTA NEUROPATHOL, V117, P137, DOI 10.1007/s00401-008-0477-9; Niblock M, 2016, NEUROBIOL AGING, V37, P45, DOI 10.1016/j.neurobiolaging.2015.09.022; Nonaka T, 2009, HUM MOL GENET, V18, P3353, DOI 10.1093/hmg/ddp275; Panda D, 2003, P NATL ACAD SCI USA, V100, P9548, DOI 10.1073/pnas.1633508100; Passoni M, 2012, J MOL BIOL, V415, P46, DOI 10.1016/j.jmb.2011.11.003; Pickering-Brown S, 2000, ANN NEUROL, V48, P859, DOI 10.1002/1531-8249(200012)48:6<859::AID-ANA6>3.0.CO;2-1; Qian W, 2014, NEUROSCI BULL, V30, P367, DOI 10.1007/s12264-013-1411-2; Qian W, 2011, NUCLEIC ACIDS RES, V39, P6161, DOI 10.1093/nar/gkr195; Shi JH, 2011, J BIOL CHEM, V286, P14639, DOI 10.1074/jbc.M110.204453; Umeda T, 2013, AM J PATHOL, V183, P211, DOI 10.1016/j.ajpath.2013.03.015; Uryu K, 2008, J NEUROPATH EXP NEUR, V67, P555, DOI 10.1097/NEN.0b013e31817713b5; Wang JN, 2004, J NEUROCHEM, V88, P1078, DOI 10.1046/j.1471-4159.2003.02232.x; Wang YZ, 2005, J BIOL CHEM, V280, P14230, DOI 10.1074/jbc.M413846200; Yen SH, 1999, BRAIN PATHOL, V9, P695; Yin XM, 2012, J BIOL CHEM, V287, P30497, DOI 10.1074/jbc.M112.355412; Yoshida M, 2006, NEUROPATHOLOGY, V26, P457, DOI 10.1111/j.1440-1789.2006.00743.x; Yu QM, 2004, J NEUROCHEM, V90, P164, DOI 10.1111/j.1471-4159.2004.02477.x; Zhang YJ, 2013, HUM MOL GENET, V22, P3112, DOI 10.1093/hmg/ddt166	58	47	48	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10600	10612		10.1074/jbc.M117.783498	http://dx.doi.org/10.1074/jbc.M117.783498			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28487370	Green Published, hybrid			2022-12-26	WOS:000404115400020
J	Einaga, N; Yoshida, A; Noda, H; Suemitsu, M; Nakayama, Y; Sakurada, A; Kawaji, Y; Yamaguchi, H; Sasaki, Y; Tokino, T; Esumi, M				Einaga, Naoki; Yoshida, Akio; Noda, Hiroko; Suemitsu, Masaaki; Nakayama, Yuki; Sakurada, Akihisa; Kawaji, Yoshiko; Yamaguchi, Hiromi; Sasaki, Yasushi; Tokino, Takashi; Esumi, Mariko			Assessment of the quality of DNA from various formalin-fixed paraffin-embedded (FFPE) tissues and the use of this DNA for next-generation sequencing (NGS) with no artifactual mutation	PLOS ONE			English	Article							CROSS-LINKS; FORMALDEHYDE; EXTRACTION; EVOLUTION; URACIL; PROBE	Formalin-fixed, paraffin-embedded (FFPE) tissues used for pathological diagnosis are valuable for studying cancer genomics. In particular, laser-capture microdissection of target cells determined by histopathology combined with FFPE tissue section immunohistochemistry (IHC) enables precise analysis by next-generation sequencing (NGS) of the genetic events occurring in cancer. The result is a new strategy for a pathological tool for cancer diagnosis: 'microgenomics'. To more conveniently and precisely perform microgenomics, we revealed by systematic analysis the following three details regarding FFPE DNA compared with paired frozen tissue DNA. 1) The best quality of FFPE DNA is obtained by tissue fixation with 10% neutral buffered formalin for 1 day and heat treatment of tissue lysates at 95 degrees C for 30 minutes. 2) IHC staining of FFPE tissues decreases the quantity and quality of FFPE DNA to one-fourth, and antigen retrieval (at 120 degrees C for 15 minutes, pH 6.0) is the major reason for this decrease. 3) FFPE DNA prepared as described herein is sufficient for NGS. For non-mutated tissue specimens, no artifactual mutation occurs during FFPE preparation, as shown by precise comparison of NGS of FFPE DNA and paired frozen tissue DNA followed by validation. These results demonstrate that even FFPE tissues used for routine clinical diagnosis can be utilized to obtain reliable NGS data if appropriate conditions of fixation and validation are applied.	[Einaga, Naoki; Yoshida, Akio; Noda, Hiroko; Suemitsu, Masaaki; Nakayama, Yuki; Sakurada, Akihisa; Kawaji, Yoshiko; Yamaguchi, Hiromi; Esumi, Mariko] Nihon Univ, Sch Med, Dept Pathol, Itabashi Ku, Tokyo, Japan; [Yoshida, Akio] Nihon Univ, Sch Med, Dept Orthopaed Surg, Itabashi Ku, Tokyo, Japan; [Suemitsu, Masaaki] Nihon Univ, Sch Dent Matsudo, Dept Oral Pathol, Matsudo, Chiba, Japan; [Sasaki, Yasushi; Tokino, Takashi] Sapporo Med Univ, Dept Med Genome Sci, Sapporo, Hokkaido, Japan	Nihon University; Nihon University; Nihon University; Sapporo Medical University	Esumi, M (corresponding author), Nihon Univ, Sch Med, Dept Pathol, Itabashi Ku, Tokyo, Japan.	esumi.mariko@nihon-u.ac.jp	Tokino, Takashi/AAI-9887-2021; Sasaki, Yasushi/AAA-3079-2019	Sasaki, Yasushi/0000-0002-3500-8059	Ministry of Education, Culture, Sports, Science and Technology of Japan [25430142]; Scientific Support Programs for Cancer Research; Nihon University Multidisciplinary Research Grant [M14-012]; Grants-in-Aid for Scientific Research [17K09354] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Scientific Support Programs for Cancer Research; Nihon University Multidisciplinary Research Grant; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-Aid for Scientific Research (C) 25430142 from the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www.mext.go.jp/) received by ME, Scientific Support Programs for Cancer Research Grant-in-Aid Scientific Research on Innovative Areas MEXT (http://ganshien.umin.jp/) received by TT, and Nihon University Multidisciplinary Research Grant (M14-012) from Nihon University (http://www.nihon-u.ac.jp/) received by ME. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astolfi A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1982-6; Avesson L, 2014, BBA-REV CANCER, V1845, P308, DOI 10.1016/j.bbcan.2014.03.001; Betge J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127146; CHAW YFM, 1980, BIOCHEMISTRY-US, V19, P5525, DOI 10.1021/bi00565a010; Do HD, 2015, CLIN CHEM, V61, P64, DOI 10.1373/clinchem.2014.223040; Do HD, 2013, CLIN CHEM, V59, P1376, DOI 10.1373/clinchem.2012.202390; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Kavli B, 2007, DNA REPAIR, V6, P505, DOI 10.1016/j.dnarep.2006.10.014; Kennedy-Darling J, 2014, ANAL CHEM, V86, P5678, DOI 10.1021/ac501354y; Kuong KJ, 2013, NAT GENET, V45, P964, DOI 10.1038/ng.2736; Lamy A, 2011, MODERN PATHOL, V24, P1090, DOI 10.1038/modpathol.2011.60; Lu K, 2010, J AM CHEM SOC, V132, P3388, DOI 10.1021/ja908282f; MCGHEE JD, 1977, BIOCHEMISTRY-US, V16, P3276, DOI 10.1021/bi00634a002; Munchel S, 2015, ONCOTARGET, V6, P25943, DOI 10.18632/oncotarget.4671; Nakayama Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150528; Oh E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144162; OHBA Y, 1979, EUR J BIOCHEM, V100, P285, DOI 10.1111/j.1432-1033.1979.tb02059.x; RYCHLIK W, 1990, NUCLEIC ACIDS RES, V18, P6409, DOI 10.1093/nar/18.21.6409; SEPP R, 1994, J CLIN PATHOL, V47, P318, DOI 10.1136/jcp.47.4.318; Shi SR, 2002, J HISTOCHEM CYTOCHEM, V50, P1005, DOI 10.1177/002215540205000802; SOLOMON MJ, 1985, P NATL ACAD SCI USA, V82, P6470, DOI 10.1073/pnas.82.19.6470; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wong SQ, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-23; Wong SQ, 2013, SCI REP-UK, V3, DOI 10.1038/srep03494; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515	26	60	63	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0176280	10.1371/journal.pone.0176280	http://dx.doi.org/10.1371/journal.pone.0176280			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498833	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314500002
J	Gilbert, BM; Avenant-Oldewage, A				Gilbert, Beric M.; Avenant-Oldewage, Annemarie			Trace element and metal sequestration in vitellaria and sclerites, and reactive oxygen intermediates in a freshwater monogenean, Paradiplozoon ichthyoxanthon	PLOS ONE			English	Article							CHUB LEUCISCUS-CEPHALUS; LABEOBARBUS-KIMBERLEYENSIS GILCHRIST; POMPHORHYNCHUS-LAEVIS; AQUEOUS ALUMINUM; SOUTH-AFRICA; BOTHRIOCEPHALUS-ACHEILOGNATHI; LARGEMOUTH YELLOWFISH; GYRODACTYLUS NORDMANN; TRANSITION-METALS; CHEMICAL NATURE	Exposure to metals and other trace elements negatively affects infection dynamics of monogeneans, including diplozoids, but, physiological mechanisms linked to exposure have yet to be documented. In this study sequestration of trace elements and reactive oxygen intermediate production in the monogenean, Paradiplozoon ichthyoxanthon, was demonstrated. During dissection of host fish, Labeobarbus aeneus, the gills were excised and assessed for P. ichthyoxanthon, which were removed and frozen for fluorescence microscopy or fixed for transmission electron microscopy. Trace elements were sequestered in the vitellaria and sclerites in P. ichthyoxanthon, and the presence of reactive oxygen intermediates was observed predominantly in the tegument of the parasite. Trace elements and metals identified and ranked according to weight percentages (wt%) in the vitellaria were Cu > C > Au > O > Cr > Fe > Si while for the sclerites C > Cu > O > Au > Fe > Cr > Si were identified. For most element detected, readings were higher in the vitellaria than the sclerites, except for C and O which were higher in sclerites. Specifically for metals, all levels detected in the vitellaria were greater than in sclerites. Based on the proportion of trace elements present in the vitellaria and sclerites it appears that most trace elements including metals were sequestered in the vitellaria. The results of reactive oxygen intermediate production in the tegument of the parasite suggests either trace element accumulation takes place across the tegument or results from the action of the host's immune response on the parasite. The results serve as the first demonstration of trace element sequestration and reactive oxygen intermediates in a freshwater monogenean parasite.	[Gilbert, Beric M.; Avenant-Oldewage, Annemarie] Univ Johannesburg, Dept Zool, Johannesburg, Gauteng, South Africa	University of Johannesburg	Avenant-Oldewage, A (corresponding author), Univ Johannesburg, Dept Zool, Johannesburg, Gauteng, South Africa.	aoldewage@uj.ac.za	Avenant-Oldewage, Annemarie/A-7778-2011; Gilbert, Beric Michael/ABB-7255-2021	Avenant-Oldewage, Annemarie/0000-0001-8820-7679; Gilbert, Beric Michael/0000-0002-5681-8528	National Research Foundation South Africa [80789]; University of Johannesburg Faculty Research Committee [SASOLD-0107]	National Research Foundation South Africa(National Research Foundation - South AfricaSouth African Medical Research Council); University of Johannesburg Faculty Research Committee	Funding for this work was provided by the National Research Foundation South Africa (80789) and University of Johannesburg Faculty Research Committee (SASOLD-0107) to A-O. In both instances the funding was provided after proposal submission to the granting body. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Gaber R, 2016, J HELMINTHOL, V90, P742, DOI 10.1017/S0022149X15001054; Abdel-Ghaffar F, 2015, PARASITOL RES, V114, P513, DOI 10.1007/s00436-014-4213-1; Ahearn GA, 2004, J COMP PHYSIOL B, V174, P439, DOI 10.1007/s00360-004-0438-0; Baptista-Farias MDD, 1998, MEM I OSWALDO CRUZ, V93, P543, DOI 10.1590/S0074-02761998000400023; Barus V, 2007, PARASITOL RES, V100, P929, DOI 10.1007/s00436-006-0384-8; Brabec J, 2015, INT J PARASITOL, V45, P761, DOI 10.1016/j.ijpara.2015.05.006; Broomell CC, 2008, ACTA BIOMATER, V4, P2045, DOI 10.1016/j.actbio.2008.06.017; Cohen M, 2012, JOVE-J VIS EXP, DOI 10.3791/3928; Cribb BW, 2010, ACTA BIOMATER, V6, P3152, DOI 10.1016/j.actbio.2010.02.009; Degger N, 2009, AFR ZOOL, V44, P204, DOI 10.3377/004.044.0208; Dusek L, 1998, INT J PARASITOL, V28, P1555, DOI 10.1016/S0020-7519(98)00130-1; ERASMUS DA, 1975, EXP PARASITOL, V38, P240, DOI 10.1016/0014-4894(75)90027-2; Gagne F, 2004, COMP BIOCHEM PHYS C, V138, P33, DOI 10.1016/j.cca.2004.04.006; Gagne F, 2005, ENVIRON RES, V98, P89; Gheorghiu C, 2007, INT J PARASITOL, V37, P375, DOI 10.1016/j.ijpara.2006.09.004; Gilbert BM, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1706-z; Gilbert BM, 2016, ACTA PARASITOL, V61, P52, DOI 10.1515/ap-2016-0005; HALTON DW, 1974, Z PARASITENKD, V45, P45, DOI 10.1007/BF00636526; Hauglund RP, 2005, HDB GUIDE FLUORESCEN; Hook SE, 2001, MAR BIOL, V138, P1131, DOI 10.1007/s002270000533; Hwang DS, 2010, COMP BIOCHEM PHYS C, V151, P360, DOI 10.1016/j.cbpc.2009.12.010; Jeffree RA, 2008, ARCH ENVIRON CON TOX, V55, P451, DOI 10.1007/s00244-007-9103-4; Jirsa F, 2008, ARCH ENVIRON CON TOX, V55, P619, DOI 10.1007/s00244-008-9154-1; Khalil M, 2009, INT J PARASITOL, V39, P1093, DOI 10.1016/j.ijpara.2009.02.023; Khan FR, 2010, AQUAT TOXICOL, V96, P124, DOI 10.1016/j.aquatox.2009.10.010; Khan R. A., 1991, Advances in Parasitology, V30, P201, DOI 10.1016/S0065-308X(08)60309-7; Knight DP, 1996, BIOL REV, V71, P81, DOI 10.1111/j.1469-185X.1996.tb00742.x; KRITSKY DC, 1978, J PARASITOL, V64, P172, DOI 10.2307/3279642; LYONS KM, 1966, PARASITOLOGY, V56, P63, DOI 10.1017/S0031182000071109; Mehta A, 2006, FREE RADICAL BIO MED, V40, P1857, DOI 10.1016/j.freeradbiomed.2006.01.024; Milne SJ, 2006, ONDERSTEPOORT J VET, V73, P149; Monserrat JM., 2003, COMMENTS TOXICOL, V9, P255, DOI [DOI 10.1080/08865140390450359, 10.1080/08865140390450359]; MONTORZI M, 1995, BIOCHEMISTRY-US, V34, P10851, DOI 10.1021/bi00034a018; Nachev M, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-21; Ohashi H, 2007, PARASITOLOGY, V134, P229, DOI 10.1017/S0031182006001430; Oliva M, 2012, ECOTOX ENVIRON SAFE, V75, P151, DOI 10.1016/j.ecoenv.2011.08.017; Otachi EO, 2014, ENVIRON SCI POLLUT R, V21, P7339, DOI 10.1007/s11356-014-2602-8; Pettersen RA, 2006, SCI TOTAL ENVIRON, V369, P129, DOI 10.1016/j.scitotenv.2006.05.024; Poleo ABS, 2004, PARASITOLOGY, V128, P169, DOI 10.1017/S0031182003004396; RAMALING.K, 1973, EXP PARASITOL, V34, P115, DOI 10.1016/0014-4894(73)90069-6; Retief NR, 2006, PHYS CHEM EARTH, V31, P840, DOI 10.1016/j.pce.2006.08.004; Retief NR, 2007, PHYS CHEM EARTH, V32, P1384, DOI 10.1016/j.pce.2007.07.044; Rico D, 2009, COMP BIOCHEM PHYS C, V149, P90, DOI 10.1016/j.cbpc.2008.07.016; RIGGS MR, 1987, J PARASITOL, V73, P893, DOI 10.2307/3282507; SAKAI H, 1995, MAR POLLUT BULL, V30, P347, DOI 10.1016/0025-326X(94)00185-C; Scheef G, 2000, PARASITOL RES, V86, P688, DOI 10.1007/PL00008553; Schofield RMS, 2002, NATURWISSENSCHAFTEN, V89, P579, DOI 10.1007/s00114-002-0381-4; Schofield RMS, 2003, J INSECT PHYSIOL, V49, P31, DOI 10.1016/S0022-1910(02)00224-X; SHINN AP, 1995, INT J PARASITOL, V25, P797, DOI 10.1016/0020-7519(95)00008-P; SHINN AP, 1993, SYST PARASITOL, V25, P135, DOI 10.1007/BF00009983; Smyth J.D., 1989, PHYSL BIOCH CESTODES; Soleng A, 2005, AQUACULTURE, V250, P616, DOI 10.1016/j.aquaculture.2005.05.006; SUNDERMAN FW, 1995, MOL REPROD DEV, V42, P180, DOI 10.1002/mrd.1080420207; Sures B, 2007, J HELMINTHOL, V81, P191, DOI 10.1017/S0022149X07751465; Sures B, 1997, PARASITOL RES, V83, P618, DOI 10.1007/s004360050307; Sures B, 1997, B ENVIRON CONTAM TOX, V59, P14, DOI 10.1007/s001289900437; Sures B, 1999, EXP PARASITOL, V93, P66, DOI 10.1006/expr.1999.4437; Sures B, 2003, INT J PARASITOL, V33, P1617, DOI 10.1016/S0020-7519(03)00251-0; Sures B, 2003, INT J PARASITOL, V33, P65, DOI 10.1016/S0020-7519(02)00249-7; Sures B, 2002, ECOTOXICOLOGY, V11, P365, DOI 10.1023/A:1020561406624; SURES B, 1994, DIS AQUAT ORGAN, V19, P105, DOI 10.3354/dao019105; Sures Bernd, 2001, Aquatic Ecology, V35, P245, DOI 10.1023/A:1011422310314; Szefer P, 1998, SCI TOTAL ENVIRON, V220, P19, DOI 10.1016/S0048-9697(98)00221-6; Torres J, 2014, ACTA PARASITOL, V59, P580, DOI 10.2478/s11686-014-0293-4; Valtonen ET, 2003, PARASITOLOGY, V126, pS43, DOI 10.1017/S0031182003003494; Vijver MG, 2004, ENVIRON SCI TECHNOL, V38, P4705, DOI 10.1021/es040354g; Wallace WG, 2003, MAR ECOL PROG SER, V249, P183, DOI 10.3354/meps249183; Wang WY, 2005, AGR WATER MANAGE, V75, P1, DOI 10.1016/j.agwat.2004.12.009; WHARTON DA, 1983, PARASITOLOGY, V86, P85, DOI 10.1017/S003118200005085X; Wong WL, 1963, PARASITOLOGY, V2012, P1; Wu XY, 2011, J FOOD COMPOS ANAL, V24, P62, DOI 10.1016/j.jfca.2010.03.030	71	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177558	10.1371/journal.pone.0177558	http://dx.doi.org/10.1371/journal.pone.0177558			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498876	Green Submitted, gold, Green Published			2022-12-26	WOS:000401314500027
J	Billingsley, MM; Riley, RS; Day, ES				Billingsley, Margaret M.; Riley, Rachel S.; Day, Emily S.			Antibody-nanoparticle conjugates to enhance the sensitivity of ELISA-based detection methods	PLOS ONE			English	Article							FACTOR RECEPTOR EGFR; THERAPY	Accurate antigen detection is imperative for clinicians to diagnose disease, assess treatment success, and predict patient prognosis. The most common technique used for the detection of disease-associated biomarkers is the enzyme linked immunosorbent assay (ELISA). In an ELISA, primary antibodies are incubated with biological samples containing the biomarker of interest. Then, detectible secondary antibodies conjugated with horseradish peroxidase (HRP) bind the primary antibodies. Upon addition of a color-changing substrate, the samples provide a colorimetric signal that directly correlates to the targeted biomarker concentration. While ELISAs are effective for analyzing samples with high biomarker content, they lack the sensitivity required to analyze samples with low antigen levels. We hypothesized that the sensitivity of ELISAs could be enhanced by replacing freely delivered primary antibodies with antibody-nanoparticle conjugates that provide excess binding sites for detectible secondary antibodies, ultimately leading to increased signal. Here, we investigated the use of nanoshells (NS) decorated with antibodies specific to epidermal growth factor receptor (EGFR) as a model system (EGFR-NS). We incubated one healthy and two breast cancer cell lines, each expressing different levels of EGFR, with EGFR-NS, untargeted NS, or unconjugated EGFR antibodies, as well as detectable secondary antibodies. We found that EGFR-NS consistently increased signal intensity relative to unconjugated EGFR antibodies, with a substantial 13-fold enhancement from cells expressing high levels of EGFR. Additionally, 40x more unconjugated antibodies were required to detect EGFR compared to those conjugated to NS. Our results demonstrate that antibody-nanoparticle conjugates lower the detection limit of traditional ELISAs and support further investigation of this strategy with other antibodies and nanoparticles. Owing to their enhanced sensitivity, we anticipate that nanoparticle-modified ELISAs can be used to detect low levels of biomarkers found in various diseases, such as cancers, tuberculosis, and rheumatoid arthritis, and may ultimately enable earlier diagnosis, better prognostication, and improved treatment monitoring.	[Billingsley, Margaret M.; Riley, Rachel S.; Day, Emily S.] Univ Delaware, Dept Biomed Engn, Newark, DE 19716 USA; [Day, Emily S.] Univ Delaware, Dept Mat Sci & Engn, Newark, DE 19716 USA; [Day, Emily S.] Helen F Graham Canc Ctr & Res Inst, Newark, DC 19713 USA	University of Delaware; University of Delaware; Helen F. Graham Cancer Center & Research Institute	Day, ES (corresponding author), Univ Delaware, Dept Biomed Engn, Newark, DE 19716 USA.; Day, ES (corresponding author), Univ Delaware, Dept Mat Sci & Engn, Newark, DE 19716 USA.; Day, ES (corresponding author), Helen F Graham Canc Ctr & Res Inst, Newark, DC 19713 USA.	emilyday@udel.edu	Day, Emily/A-9026-2012	Day, Emily/0000-0002-8707-826X; Billingsley, Margaret/0000-0003-4499-9066	University of Delaware Research Foundation; American Cancer Society [IRG14-251-07-IRG]; National Institute of Health - National Institute of General Medical Sciences [R35GM119659, P20-GM103446]; state of Delaware; University of Delaware Summer Scholars program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103446, R35GM119659] Funding Source: NIH RePORTER	University of Delaware Research Foundation; American Cancer Society(American Cancer Society); National Institute of Health - National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); state of Delaware; University of Delaware Summer Scholars program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The University of Delaware Research Foundation provided funding for this project (https://www1.udel.edu/research/about/udrf.html). Research reported in this publication and funding for RSR was supported by Grant #IRG14-251-07-IRG from the American Cancer Society (http://www.cancer.org/index?_ga=1.211377937.58737158.1483112836) and by the National Institute of Health - National Institute of General Medical Sciences under Award Number R35GM119659 (hops://www.nigms.nih.gov/ Pages/default.aspx). Scanning electron microscopy was made possible by the Delaware IDeA Network of Biomedical Research Excellence program, supported by a grant from National Institute of Health - National Institute of General Medical Sciences (P20-GM103446) and the state of Delaware (http://de-inbre.org/ and https:/www.nigms.nih.gov/Pages/default.aspx). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. MMB received support from the University of Delaware Summer Scholars program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Ambrosi A, 2010, ANAL CHEM; Bidard F, 2010, SINGLE CIRCULATING T, P729; Bode GH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126136; Buchholz TA, 2005, CORRELATES POOR SURV, P676; Chan WCW, 2016, PATIENTS HERE COMES; Chen H, 2013, SENSITIVE DETECTION, P431; Chen H, 2012, ANALYST, V137; Chung HH, 2013, ONE STEP DETECTION C, P2247; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Day ES, 2012, NANOMEDICINE-UK, V7, P1133, DOI [10.2217/NNM.11.189, 10.2217/nnm.11.189]; Day ES, 2010, INT J NANOMED, V5, P445; DUFF DG, 1993, LANGMUIR, V9, P2301, DOI 10.1021/la00033a010; Giljohann DA, 2009, NATURE, V462, P461, DOI 10.1038/nature08605; Hossain M, 2012, BIOSENS BIOELECTRON; Jiang W, 2008, NAT NANOTECHNOL, V3, P145, DOI 10.1038/nnano.2008.30; Jo H, 2015, BIOSENS BIOELECTRON, V71, P129, DOI 10.1016/j.bios.2015.04.030; Kallergi G, 2008, BREAST CANCER RES, V10, P1; Kelley SO, ADV SPEED SENSITIVIT; Lautrette A, 2005, NAT MED, V11, P867, DOI 10.1038/nm1275; LEBEAU J, 1987, INT J CANCER, V40, P189, DOI 10.1002/ijc.2910400210; Lee HWAY, 2010, BILE ACID REGULATES, P941; Li C, 2014, SCI REP-UK, V4, DOI 10.1038/srep04893; Lowery AR, 2006, INT J NANOMED, V1, P149, DOI 10.2147/nano.2006.1.2.149; Ma HM, 2016, BIOSENS BIOELECTRON, V79, P379, DOI 10.1016/j.bios.2015.12.080; McKay JA, 2002, EUR J CANCER, V38, P2258, DOI 10.1016/S0959-8049(02)00234-4; Mehlen P, METASTASIS QUESTION; Miller MC, 2010, J ONCOL, V2010, DOI 10.1155/2010/617421; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Normanno N, 2006, EPIDERMAL GROWTH FAC; Oldenburg SJ, 1998, CHEM PHYS LETT, V288, P243, DOI 10.1016/S0009-2614(98)00277-2; Shen N, 2016, ONCOTARGET, P7; Wang L, 2013, NANOSTRUCTURED SUBST, V8, P1; Wang X, 2011, CANC RES; Wu X, IMPROVED SERS NANOPA; Yoon HJ, 2014, ACS NANO, V8, P1995, DOI 10.1021/nn5004277; Zhan L, 2014, NEW J CHEM, V38, P2935, DOI 10.1039/c4nj00253a; Zhang L, 2016, THERANOSTICS, P6	38	32	32	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177592	10.1371/journal.pone.0177592	http://dx.doi.org/10.1371/journal.pone.0177592			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28494030	Green Submitted, Green Published, gold			2022-12-26	WOS:000401314300142
J	Kindvall, SSI; Diaz, S; Svensson, J; Wollmer, P; Olsson, LE				Kindvall, Simon Sven Ivan; Diaz, Sandra; Svensson, Jonas; Wollmer, Per; Olsson, Lars E.			The change of longitudinal relaxation rate in oxygen enhanced pulmonary MRI depends on age and BMI but not diffusing capacity of carbon monoxide in healthy never-smokers	PLOS ONE			English	Article							LUNG-FUNCTION; PHYSICAL-ACTIVITY; TIME; BLOOD; T-1; IMPACT; LEVEL; T1	Objective Oxygen enhanced pulmonary MRI is a promising modality for functional lung studies and has been applied to a wide range of pulmonary conditions. The purpose of this study was to characterize the oxygen enhancement effect in the lungs of healthy, never-smokers, in light of a previously established relationship between oxygen enhancement and diffusing capacity of carbon monoxide in the lung (D-L,D-CO) in patients with lung disease. Methods In 30 healthy never-smoking volunteers, an inversion recovery with gradient echo read-out (Snapshot-FLASH) was used to quantify the difference in longitudinal relaxation rate, while breathing air and 100% oxygen Delta R1, at 1.5 Tesla. Measurements were performed under multiple tidal inspiration breath-holds. Results In single parameter linear models,Delta R1 exhibit a significant correlation with age (p = 0.003) and BMI (p = 0.0004), but not D-L,D-CO (p = 0.33). Stepwise linear regression of Delta R1 yields an optimized model including an age-BMI interaction term. Conclusion In this healthy, never-smoking cohort, age and BMI are both predictors of the change in MRI longitudinal relaxation rate when breathing oxygen. However, D-L,D-CO does not show a significant correlation with the oxygen enhancement. This is possibly because oxygen transfer in the lung is not diffusion limited at rest in healthy individuals. This work stresses the importance of using a physiological model to understand results from oxygen enhanced MRI.	[Kindvall, Simon Sven Ivan; Olsson, Lars E.] Lund Univ, Med Radiat Phys Translat Med, Malmo, Sweden; [Diaz, Sandra] Lund Univ, Med Radiol Translat Med, Malmo, Sweden; [Svensson, Jonas] Skane Univ Hosp, Med Imaging & Physiol, Lund, Sweden; [Wollmer, Per] Lund Univ, Clin Physiol Translat Med, Malmo, Sweden	Lund University; Lund University; Lund University; Skane University Hospital; Lund University	Kindvall, SSI (corresponding author), Lund Univ, Med Radiat Phys Translat Med, Malmo, Sweden.	Simon.kindvall@med.lu.se	Wollmer, Per/S-5895-2019; Svensson, Jonas PO/B-8807-2013	Svensson, Jonas PO/0000-0003-1945-9594; Kindvall, Simon/0000-0003-2176-7529; Olsson, Lars E./0000-0001-6090-6697; Diaz Ruiz, Sandra/0000-0003-2016-4195	Allmanna Sjukhusets i Malmo stiftelse for bekampande av cancer; Stiftelsen for cancerforskning vid onkologiska kliniken vid Universitetsjukhuset MAS	Allmanna Sjukhusets i Malmo stiftelse for bekampande av cancer; Stiftelsen for cancerforskning vid onkologiska kliniken vid Universitetsjukhuset MAS	This work was supported by Allmanna Sjukhusets i Malmo stiftelse for bekampande av cancer and Stiftelsen for cancerforskning vid onkologiska kliniken vid Universitetsjukhuset MAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamidi FD, 2015, J CHRONIC OBSTRUCTIV, V2555, P1, DOI DOI 10.3109/15412555.2015.10488; Arnold JFT, 2004, MAGN RESON MATER PHY, V16, P246, DOI 10.1007/s10334-004-0034-z; Blockley NP, 2008, MAGN RESON MED, V60, P1313, DOI 10.1002/mrm.21792; COTES JE, 1993, EUR RESPIR J, V6, P41, DOI 10.1183/09041950.041s1693; Edelman RR, 1996, NAT MED, V2, P1236, DOI 10.1038/nm1196-1236; Hernan MA, 2011, INT J EPIDEMIOL, V40, P780, DOI 10.1093/ije/dyr041; Hueckel P., 2000, P INT SOC MAGNETIC R, V8, P1586; Jakob PM, 2001, J MAGN RESON IMAGING, V14, P795, DOI 10.1002/jmri.10024; JENKINS SC, 1991, RESP MED, V85, P309, DOI 10.1016/S0954-6111(06)80102-2; Jensen RL, 1996, J INVEST MED, P44; Jobst BJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121520; Kershaw LE, 2010, MAGN RESON MED, V64, P1838, DOI 10.1002/mrm.22571; Kindvall SSI, 2016, J MAGN RESON IMAGING, V43, P1250, DOI 10.1002/jmri.25085; Kruger SJ, 2014, NMR BIOMED, V27, P1535, DOI 10.1002/nbm.3158; Ley S, 2007, INVEST RADIOL, V42, P283, DOI 10.1097/01.rli.0000258655.58753.5d; Li W, 2015, MAGN RESON MED; Look D. C., 1970, Review of Scientific Instruments, V41, P250, DOI 10.1063/1.1684482; Meinel FG, 2013, EUR J RADIOL, V82, P1565, DOI 10.1016/j.ejrad.2013.04.019; Morgan AR, 2014, EUR J RADIOL, V83, P2093, DOI 10.1016/j.ejrad.2014.08.004; Muller CJ, 2002, RADIOLOGY, V222, P499, DOI 10.1148/radiol.2222000869; Nystad W, 2006, INT J TUBERC LUNG D, V10, P1399; Ohno Y, 2002, MAGN RESON MED, V47, P1139, DOI 10.1002/mrm.10168; Ohno Y, 2007, EUR J RADIOL, V64, P320, DOI 10.1016/j.ejrad.2007.08.006; Ohno Y, 2014, EUR J RADIOL, V83, P391, DOI 10.1016/j.ejrad.2013.11.001; Parsons TJ, 2005, INT J OBESITY, V29, P1212, DOI 10.1038/sj.ijo.0802932; Preisser AM, 2015, ADV EXP MED BIOL, V849, P65, DOI 10.1007/5584_2014_90; Renne J, 2015, RADIOLOGY, V276, P266, DOI 10.1148/radiol.15141486; Silvennoinen MJ, 2003, MAGNET RESON MED, V49, P568, DOI 10.1002/mrm.10370; Stadler A, 2005, J MAGN RESON IMAGING, V21, P759, DOI 10.1002/jmri.20319; Stanisz GJ, 2000, MAGNET RESON MED, V44, P665, DOI 10.1002/1522-2594(200011)44:5<665::AID-MRM1>3.0.CO;2-M; Triphan SMF, 2015, J MAGN RESON IMAGING, V42, P610, DOI 10.1002/jmri.24840; Triphan SMF, 2015, J MAGN RESON IMAGING, V41, P1708, DOI 10.1002/jmri.24692; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; West J.B., 2012, RESP PHYSL ESSENTIAL; Zaharchuk G, 2006, ACAD RADIOL, V13, P1016, DOI 10.1016/j.acra.2006.04.016; Zhang WJ, 2015, EUR J RADIOL, V84, P318, DOI 10.1016/j.ejrad.2014.10.021; Zheng SK, 2010, MAGN RESON MED, V63, P25, DOI 10.1002/mrm.22169; Zurek M, 2014, MAGN RESON MED, V71, P2180, DOI 10.1002/mrm.24876; Zurek M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151211	39	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177670	10.1371/journal.pone.0177670	http://dx.doi.org/10.1371/journal.pone.0177670			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28494006	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314300151
J	Liu, X; Shen, Y; Xie, JY; Bao, HH; Cao, Q; Wan, R; Xu, XM; Zhou, H; Huang, L; Xu, ZY; Zhu, WG; Hu, JZ; Cheng, XS; Hong, K				Liu, Xin; Shen, Yang; Xie, Jinyan; Bao, Huihui; Cao, Qing; Wan, Rong; Xu, Xiaoming; Zhou, Hui; Huang, Lin; Xu, Zhenyan; Zhu, Wengen; Hu, Jinzhu; Cheng, Xiaoshu; Hong, Kui			9 A mutation in the CACNA1C gene leads to early repolarization syndrome with incomplete penetrance: A Chinese family study	PLOS ONE			English	Article							IDIOPATHIC VENTRICULAR-FIBRILLATION; CHANNEL BLOCKADE; SCN5A MUTATIONS; SODIUM-CHANNEL; BRUGADA; ASSOCIATION; GUIDELINES; DEATH	Background Early repolarization syndrome (ERS) may be a near-Mendelian or an oligogenic disease; however, no direct evidence has been provided to support this theory. Methods and results We described a large Chinese family with nocturnal sudden cardiac death induced by ERS in most of the young male adults. One missense mutation (p.Q1916R) was found in the major subunit of the L-type calcium channel gene CACNA1C by the direct sequencing of candidate genes. A concomitant gain-of-function variant in the sodium channel gene SCN5A (p.R1193Q) was found to rescue the phenotype of the female CACNA1C-Q1916R mutation carriers, which led to the incomplete penetrance. The functional studies, via the exogenous expression approach, revealed that the CACNA1C-Q1916R mutation led to a decreasing L-type calcium current and the protein expression defect. The decreased calcium current produced by the mutant channel was improved by isoproterenol but exacerbated by testosterone. The effects of CACNA1C-Q1916R mutation and testosterone on cellular electrophysiology were further confirmed by the human ventricular action potential simulation. Conclusions Our results demonstrated that the loss-of-function CACNA1C-Q1916R mutation contributed to ERS-related sudden cardiac death, and the phenotypic incomplete penetrance was modified by the SCN5A-R1193Q variant and sex. These findings suggest that phenotypes of ERS are modified by multiple genetic factors, which supports the theory that ERS may be an oligogenic disease.	[Liu, Xin; Bao, Huihui; Zhou, Hui; Huang, Lin; Xu, Zhenyan; Zhu, Wengen; Hu, Jinzhu; Cheng, Xiaoshu; Hong, Kui] Nanchang Univ, Dept Cardiovasc Med, Affiliated Hosp 2, Nanchang, Jiangxi, Peoples R China; [Shen, Yang; Xie, Jinyan; Cao, Qing; Wan, Rong; Hong, Kui] Jiangxi Prov Key Lab Mol Med, Nanchang, Jiangxi, Peoples R China; [Xu, Xiaoming] Nanchang Univ, Dept Forens Med, Med Coll, Nanchang, Jiangxi, Peoples R China	Nanchang University; Nanchang University	Hong, K (corresponding author), Nanchang Univ, Dept Cardiovasc Med, Affiliated Hosp 2, Nanchang, Jiangxi, Peoples R China.; Hong, K (corresponding author), Jiangxi Prov Key Lab Mol Med, Nanchang, Jiangxi, Peoples R China.	hongkui88@163.com		Zhu, Wengen/0000-0002-1280-0158	National Natural Science Foundation of China [81530013]; Graduate Innovation Fund Project of Jiangxi Province [YC2012-B013, YC2013-001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Graduate Innovation Fund Project of Jiangxi Province	The study design, data collection and analysis, decision to publish, or preparation of the manuscript were supported by grants from the National Natural Science Foundation of China (81530013), and Graduate Innovation Fund Project of Jiangxi Province (YC2012-B013 and YC2013-001).	Aizawa Y, 2013, J AM COLL CARDIOL, V62, P1015, DOI 10.1016/j.jacc.2013.05.030; Bezzina CR, 2015, CIRC RES, V116, P1919, DOI 10.1161/CIRCRESAHA.116.304030; Binkowski BF, 2011, ACS CHEM BIOL, V6, P1193, DOI 10.1021/cb200248h; Burashnikov E, 2010, HEART RHYTHM, V7, P1872, DOI 10.1016/j.hrthm.2010.08.026; Derval N, 2011, J AM COLL CARDIOL, V58, P722, DOI 10.1016/j.jacc.2011.04.022; Fukuyama M, 2013, CIRC J, V77, P1799, DOI 10.1253/circj.CJ-12-1457; Gao TY, 1997, NEURON, V19, P185, DOI 10.1016/S0896-6273(00)80358-X; Giudicessi JR, 2012, NAT REV CARDIOL, V9, P319, DOI 10.1038/nrcardio.2012.3; Guo Q, 2016, INT J MOL MED, V37, P727, DOI 10.3892/ijmm.2016.2468; Haissaguerre M, 2008, NEW ENGL J MED, V358, P2016, DOI 10.1056/NEJMoa071968; Haissaguerre M, 2009, J CARDIOVASC ELECTR, V20, P93, DOI 10.1111/j.1540-8167.2008.01326.x; Hata Y, 2016, HEART RHYTHM, V13, P1544, DOI 10.1016/j.hrthm.2016.03.038; Hu D, 2014, INT J CARDIOL, V171, P431, DOI 10.1016/j.ijcard.2013.12.084; Hu ST, 2011, PHYSIOL RES, V60, P27, DOI 10.33549/physiolres.931948; Kawata H, 2012, HEART RHYTHM, V9, P77, DOI 10.1016/j.hrthm.2011.08.017; Koncz I, 2014, J MOL CELL CARDIOL, V68, P20, DOI 10.1016/j.yjmcc.2013.12.012; Kramer DB, 2011, CARDIOL REV, V19, P217, DOI 10.1097/CRD.0b013e3182203504; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li N, 2013, INT J MOL MED, V32, P661, DOI 10.3892/ijmm.2013.1422; Macfarlane PW, 2015, J AM COLL CARDIOL, V66, P470, DOI 10.1016/j.jacc.2015.05.033; Medeiros-Domingo A, 2010, HEART RHYTHM, V7, P1466, DOI 10.1016/j.hrthm.2010.06.016; Patton KK, 2016, CIRCULATION, V133, P1520, DOI 10.1161/CIR.0000000000000388; Priori SG, 2015, EUR HEART J, V36, P2793, DOI 10.1093/eurheartj/ehv316; Priori SG, 2013, HEART RHYTHM, V10, P1932, DOI 10.1016/j.hrthm.2013.05.014; Probst V, 2009, CIRC-CARDIOVASC GENE, V2, P552, DOI 10.1161/CIRCGENETICS.109.853374; Reinhard W, 2011, CIRC-CARDIOVASC GENE, V4, P134, DOI 10.1161/CIRCGENETICS.110.958298; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rosso R, 2011, HEART RHYTHM, V8, P923, DOI 10.1016/j.hrthm.2011.01.037; Sager SJ, 2013, AM J CARDIOL, V112, P444, DOI 10.1016/j.amjcard.2013.03.052; Scragg JL, 2007, CELL CALCIUM, V42, P11, DOI 10.1016/j.ceca.2006.11.003; Shimizu W, 2005, NAT CLIN PRACT CARD, V2, P408, DOI 10.1038/ncpcardio0268; ten Tusscher KHWJ, 2006, AM J PHYSIOL-HEART C, V291, pH1088, DOI 10.1152/ajpheart.00109.2006; Wang Q, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013300; Watanabe H, 2011, CIRC-ARRHYTHMIA ELEC, V4, P874, DOI 10.1161/CIRCEP.111.963983; Weiss S, 2013, CIRC RES, V113, P617, DOI 10.1161/CIRCRESAHA.113.301781; Xiong QM, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001526	36	13	16	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177532	10.1371/journal.pone.0177532	http://dx.doi.org/10.1371/journal.pone.0177532			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493952	Green Submitted, gold, Green Published			2022-12-26	WOS:000401314300130
J	Tao, T; Zhou, CJ; Wang, Q; Chen, XR; Sun, Q; Zhao, TY; Ye, JC; Wang, Y; Zhang, ZY; Zhang, YL; Guo, ZJ; Wang, XB; Li, DW; Yu, JL; Han, CG				Tao, Tao; Zhou, Cui-Ji; Wang, Qian; Chen, Xiang-Ru; Sun, Qian; Zhao, Tian-Yu; Ye, Jian-Chun; Wang, Ying; Zhang, Zong-Ying; Zhang, Yong-Liang; Guo, Ze-Jian; Wang, Xian-Bing; Li, Da-Wei; Yu, Jia-Lin; Han, Cheng-Gui			Rice black streaked dwarf virus P7-2 forms a SCF complex through binding to Oryza sativa SKP1-like proteins, and interacts with GID2 involved in the gibberellin pathway	PLOS ONE			English	Article							UBIQUITIN-LIGASE COMPLEX; F-BOX SUBUNIT; FUNCTIONAL-ANALYSIS; ANALYSIS REVEALS; COMPLETE GENOME; IN-VIVO; ARABIDOPSIS; GENES; DEGRADATION; EXPRESSION	As a core subunit of the SCF complex that promotes protein degradation through the 26S proteasome, S-phase kinase-associated protein 1 (SKP1) plays important roles in multiple cellular processes in eukaryotes, including gibberellin (GA), jasmonate, ethylene, auxin and light responses. P7-2 encoded by Rice black streaked dwarf virus (RBSDV), a devastating viral pathogen that causes severe symptoms in infected plants, interacts with SKP1 from different plants. However, whether RBSDV P7-2 forms a SCF complex and targets host proteins is poorly understood. In this study, we conducted yeast two-hybrid assays to further explore the interactions between P7-2 and 25 type I Oryza sativa SKP1-like (OSK) proteins, and found that P7-2 interacted with eight OSK members with different binding affinity. Co-immunoprecipitation assay further confirmed the interaction of P7-2 with OSK1, OSK5 and OSK20. It was also shown that P7-2, together with OSK1 and O. sativa Cullin-1, was able to form the SCF complex. Moreover, yeast two-hybrid assays revealed that P7-2 interacted with gibberellin insensitive dwarf2 (GID2) from rice and maize plants, which is essential for regulating the GA signaling pathway. It was further demonstrated that the N-terminal region of P7-2 was necessary for the interaction with GID2. Overall, these results indicated that P7-2 functioned as a component of the SCF complex in rice, and interaction of P7-2 with GID2 implied possible roles of the GA signaling pathway during RBSDV infection.	[Tao, Tao; Zhou, Cui-Ji; Chen, Xiang-Ru; Sun, Qian; Zhao, Tian-Yu; Ye, Jian-Chun; Wang, Ying; Zhang, Zong-Ying; Zhang, Yong-Liang; Guo, Ze-Jian; Wang, Xian-Bing; Li, Da-Wei; Yu, Jia-Lin; Han, Cheng-Gui] China Agr Univ, State Key Lab Agrobiotechnol, Beijing, Peoples R China; [Tao, Tao; Zhou, Cui-Ji; Chen, Xiang-Ru; Sun, Qian; Zhao, Tian-Yu; Ye, Jian-Chun; Wang, Ying; Zhang, Zong-Ying; Zhang, Yong-Liang; Guo, Ze-Jian; Wang, Xian-Bing; Li, Da-Wei; Yu, Jia-Lin; Han, Cheng-Gui] China Agr Univ, Minist Agr, Key Lab Plant Pathol, Beijing, Peoples R China; [Wang, Qian] Chinese Acad Agr Sci, Tobacco Res Inst, Key Lab Tobacco Gene Resources, Qingdao, Shandong, Peoples R China	China Agricultural University; China Agricultural University; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Tobacco Research Institute, CAAS	Han, CG (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing, Peoples R China.; Han, CG (corresponding author), China Agr Univ, Minist Agr, Key Lab Plant Pathol, Beijing, Peoples R China.	hanchenggui@cau.edu.cn	Wang, Xianbing/E-4831-2013; Li, Dawei/I-8751-2016; Zhang, Yongliang/AAE-7639-2021	Li, Dawei/0000-0003-4133-1263; Zhang, Yongliang/0000-0002-6790-1044; Wang, Xian-Bing/0000-0003-3082-2462; Sun, Qian/0000-0003-4650-0257	National Natural Science Foundation of China [31201489]; National Department Public Benefit Research Funds [201303021]; 111 Project [613006]; Project of State Key Laboratory for Agrobiotechnology [2016SKLAB-6]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Department Public Benefit Research Funds; 111 Project(Ministry of Education, China - 111 Project); Project of State Key Laboratory for Agrobiotechnology	This research was supported by the National Natural Science Foundation of China (31201489, http://www.nsfc.gov.cn, QW received the funding), the National Department Public Benefit Research Funds (201303021, JLY received the funding), the 111 Project (613006, CGH received the funding), and The Project of State Key Laboratory for Agrobiotechnology (2016SKLAB-6, CGH received the funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2009, J EXP BOT, V60, P1085, DOI 10.1093/jxb/ern301; Akita F, 2012, J VIROL, V86, P746, DOI 10.1128/JVI.00826-11; Alcaide-Loridan C, 2012, PLANT PHYSIOL, V160, P72, DOI 10.1104/pp.112.201905; Aronson MN, 2000, J VIROL, V74, P2967, DOI 10.1128/JVI.74.7.2967-2972.2000; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Bai FW, 2002, VIRUS GENES, V25, P201, DOI 10.1023/A:1020170020581; Baumberger N, 2007, CURR BIOL, V17, P1609, DOI 10.1016/j.cub.2007.08.039; Bortolamiol D, 2007, CURR BIOL, V17, P1615, DOI 10.1016/j.cub.2007.07.061; Bragg JN, 2004, MOL PLANT PATHOL, V5, P465, DOI [10.1111/j.1364-3703.2004.00246.x, 10.1111/J.1364-3703.2004.00246.X]; CHIANG HH, 1995, PLANT CELL, V7, P195, DOI 10.1105/tpc.7.2.195; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Dantu SC, 2016, PROTEINS, V84, P159, DOI 10.1002/prot.24963; Daviere JM, 2013, DEVELOPMENT, V140, P1147, DOI 10.1242/dev.087650; De V D, 2014, FRONT PLANT SCI, V5, P611; De Vleesschauwer D, 2013, TRENDS PLANT SCI, V18, P555, DOI 10.1016/j.tplants.2013.07.002; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Dill A, 2004, PLANT CELL, V16, P1392, DOI 10.1105/tpc.020958; Eltahir YM, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-145; Fang S, 2001, ARCH VIROL, V146, P167, DOI 10.1007/s007050170200; Gomi K, 2004, PLANT J, V37, P626, DOI 10.1111/j.1365-313X.2003.01990.x; Goodin MM, 2002, PLANT J, V31, P375, DOI 10.1046/j.1365-313X.2002.01360.x; Gray WM, 1999, GENE DEV, V13, P1678, DOI 10.1101/gad.13.13.1678; Griffiths J, 2006, PLANT CELL, V18, P3399, DOI 10.1105/tpc.106.047415; Guo HW, 2003, CELL, V115, P667, DOI 10.1016/S0092-8674(03)00969-3; Hao Q, 2017, PLANT CELL REP, V36, P151, DOI 10.1007/s00299-016-2066-z; He P, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-136; He Y, 2016, NEW PHYTOL; Hellmann H, 2002, SCIENCE, V297, P793, DOI 10.1126/science.1072831; Hibino H, 1996, ANNU REV PHYTOPATHOL, V34, P249, DOI 10.1146/annurev.phyto.34.1.249; Isogai M, 1998, J GEN VIROL, V79, P1487, DOI 10.1099/0022-1317-79-6-1487; Kahloul S, 2013, DNA RES, V20, P67, DOI 10.1093/dnares/dss034; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; KAUFMAN RJ, 1987, EMBO J, V6, P187, DOI 10.1002/j.1460-2075.1987.tb04737.x; Kong H, 2007, PLANT J, V50, P873, DOI 10.1111/j.1365-313X.2007.03097.x; Kunkel BN, 2002, CURR OPIN PLANT BIOL, V5, P325, DOI 10.1016/S1369-5266(02)00275-3; Kuroda H, 2002, PLANT CELL PHYSIOL, V43, P1073, DOI 10.1093/pcp/pcf151; Liu HJ, 2007, VIRUS RES, V127, P34, DOI 10.1016/j.virusres.2007.03.017; Liu HJ, 2007, FEBS LETT, V581, P2534, DOI 10.1016/j.febslet.2007.04.071; Liu YJ, 2011, IEEE SYS MAN CYBERN, P2011, DOI 10.1109/ICSMC.2011.6083967; McGinnis KM, 2003, PLANT CELL, V15, P1120, DOI 10.1105/tpc.010827; Olszewski N, 2002, PLANT CELL, V14, pS61, DOI 10.1105/tpc.010476; Pazhouhandeh M, 2006, P NATL ACAD SCI USA, V103, P1994, DOI 10.1073/pnas.0510784103; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Qian W, 2013, VIROL J, V10, P1; Risseeuw EP, 2003, PLANT J, V34, P753, DOI 10.1046/j.1365-313X.2003.01768.x; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P317, DOI 10.1146/annurev-phyto-073009-114447; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; SHIKATA E, 1977, VIROLOGY, V77, P826, DOI 10.1016/0042-6822(77)90502-5; SHINKAI A., 1962, Bull. natn. Inst. agric. Sci., Tokyo, V14, P1; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Takahashi N, 2004, PLANT CELL PHYSIOL, V45, P83, DOI 10.1093/pcp/pch009; Ueguchi-Tanaka M, 2005, NATURE, V437, P693, DOI 10.1038/nature04028; Ueguchi-Tanaka M, 2007, PLANT CELL, V19, P2140, DOI 10.1105/tpc.106.043729; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; Wang ZH, 2003, VIRUS GENES, V27, P163, DOI 10.1023/A:1025776527286; Wei TY, 2016, ANNU REV PHYTOPATHOL, V54, P99, DOI 10.1146/annurev-phyto-080615-095900; Willige BC, 2007, PLANT CELL, V19, P1209, DOI 10.1105/tpc.107.051441; Win J, 2011, METHODS MOL BIOL, V712, P181, DOI 10.1007/978-1-61737-998-7_15; Wu Z.Z., 2013, THESIS; Xu LH, 2002, PLANT CELL, V14, P1919, DOI 10.1105/tpc.003368; Yang J, 2014, ARCH VIROL, V159, P307, DOI 10.1007/s00705-013-1832-2; [张爱红 Zhang Aihong], 2011, [华北农学报, Acta Agriculturae Boreali-Sinica], V26, P217; Zhang CZ, 2008, J GEN VIROL, V89, P1770, DOI 10.1099/vir.0.2008/000109-0; Zhang HM, 2001, ARCH VIROL, V146, P2331, DOI 10.1007/s007050170006; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhou YC, 2002, PLANT PHYSIOL, V128, P1098, DOI 10.1104/pp.010811; Zhu SF, 2005, PLANT PHYSIOL, V139, P1935, DOI 10.1104/pp.105.072306; Zhuo T, 2014, MOL PLANT MICROBE IN, V27, P515, DOI 10.1094/MPMI-08-13-0231-R	69	25	33	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177518	10.1371/journal.pone.0177518	http://dx.doi.org/10.1371/journal.pone.0177518			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28494021	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314300127
J	He, C; Chen, YC; Yang, KX; Zhai, ZX; Zhao, WJ; Liu, SY; Ding, JM; Dai, RH; Yang, LY; Xu, K; Zhou, ZX; Gu, CJ; Huang, QZ; Meng, H				He, Chuan; Chen, Yongcan; Yang, Kaixuan; Zhai, Zhengxiao; Zhao, Wenjing; Liu, Shuyun; Ding, Jinmei; Dai, Ronghua; Yang, Lingyu; Xu, Ke; Zhou, Zhenxiang; Gu, Caiju; Huang, Qizhong; Meng, He			Genetic pattern and gene localization of polydactyly in Beijing fatty chicken	PLOS ONE			English	Article							RANGE SHH ENHANCER; SONIC HEDGEHOG; SNP DISCOVERY; EXPRESSION; LIMB; ASSOCIATION; LINKAGE; INHERITANCE; MUTATION; MOUSE	Polydactyly, a common heritable limb malformation in vertebrates, is characterized by supernumerary digits. In chickens, basic characteristics and rough dominant genes have been explored in past decades; however, the elaborate pattern of inheritance and the determinant gene remain obscure. In this study, different types of polydactylism were classified by the numbers and the shapes of toes, including the newly defined subtypes of B' and G, for the Beijing fatty chicken, a native breed of chicken from China. Through experiments on hybridization, we demonstrated a complete dominant inheritance of polydactyly instead of an incomplete penetrance or genetic modification of the previous conjecture. In particular, by using the F2 population of the five-digit purebred line of Beijing fatty chicken backcrossed to Shiqiza chicken and by using restriction-site associated DNA based markers, we performed a genome-wide association study on the trait of polydactyly. Furthermore, whole genome resequencing strategy was applied to sweep SNPs across the whole genome. An outlier-based F-st approach was employed to search for signatures of selection, and results indicated that the determinant mutation was found in the region ranging from 8.3 Mb to 8.7 Mb, where the polydactyly candidate gene LMBR1 was located. The G/T mutation of rs80659072 was identified to be highly associated with polydactyly in our resequencing and was validated in random samples from an expanded population. Thus, we confirmed that LMBR1 was the causative gene of polydactyly in the Beijing fatty chicken by using GWAS with restriction-site associated DNA based markers and resequencing.	[He, Chuan; Chen, Yongcan; Zhai, Zhengxiao; Zhao, Wenjing; Liu, Shuyun; Ding, Jinmei; Dai, Ronghua; Yang, Lingyu; Xu, Ke; Meng, He] Shanghai Jiao Tong Univ, Sch Agr & Biol, Dept Anim Sci, Shanghai, Peoples R China; [He, Chuan; Chen, Yongcan; Zhai, Zhengxiao; Zhao, Wenjing; Liu, Shuyun; Ding, Jinmei; Dai, Ronghua; Yang, Lingyu; Xu, Ke; Meng, He] Shanghai Key Lab Vet Biotechnol, Shanghai, Peoples R China; [Yang, Kaixuan; Zhou, Zhenxiang; Gu, Caiju; Huang, Qizhong] Shanghai Acad Agr Sci, Anim Husb & Vet Res Inst, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Academy of Agricultural Sciences	Meng, H (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, Dept Anim Sci, Shanghai, Peoples R China.; Meng, H (corresponding author), Shanghai Key Lab Vet Biotechnol, Shanghai, Peoples R China.; Huang, QZ (corresponding author), Shanghai Acad Agr Sci, Anim Husb & Vet Res Inst, Shanghai, Peoples R China.	huangqizh@163.com; menghe@sjtu.edu.cn	ding, jin/GVT-5062-2022; He, Chuan/AAN-4356-2020	He, Chuan/0000-0002-8532-2898	National Science Foundation of China [31272430]; Agriculture Development through Science and Technology Key Project of Shanghai [2012, 2-3]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agriculture Development through Science and Technology Key Project of Shanghai	This work was supported by National Science Foundation of China (grant no. 31272430) and the Agriculture Development through Science and Technology Key Project of Shanghai (grant no. 2012, 2-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054454; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; BERRY AJ, 1991, GENETICS, V129, P1111; Bond CJ, 1920, J GENET, V10, P87, DOI 10.1007/BF02983525; Bond CJ, 1926, J GENET, V16, P253, DOI 10.1007/BF02983001; Clark RM, 2000, GENOMICS, V67, P19, DOI 10.1006/geno.2000.6225; Dorshorst B, 2010, J HERED, V101, P339, DOI 10.1093/jhered/esp120; Dundar M, 2001, J MED GENET, V38, P304, DOI 10.1136/jmg.38.5.304; Dunn IC, 2011, DEV DYNAM, V240, P1163, DOI 10.1002/dvdy.22623; Ebnet K, 2003, J CELL SCI, V116, P3879, DOI 10.1242/jcs.00704; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Etter PD, 2011, METHODS MOL BIOL, V772, P157, DOI 10.1007/978-1-61779-228-1_9; Gurnett CA, 2007, AM J MED GENET A, V143A, P27, DOI 10.1002/ajmg.a.31563; Harman MT, 1938, AM NAT, V72, P59, DOI 10.1086/280765; Hermisson J, 2005, GENETICS, V169, P2335, DOI 10.1534/genetics.104.036947; Hill RE, 2003, J ANAT, V202, P13, DOI 10.1046/j.1469-7580.2003.00148.x; Hohenlohe Paul A, 2012, Methods Mol Biol, V888, P235, DOI 10.1007/978-1-61779-870-2_14; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Huang YQ, 2006, GENE, V374, P10, DOI 10.1016/j.gene.2005.07.047; Hutchinson JB, 1931, AM NAT, V65, P376, DOI 10.1086/280381; Hutt FB, 1943, AM NAT, V77, P70, DOI 10.1086/281099; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Masuya H, 2007, GENOMICS, V89, P207, DOI 10.1016/j.ygeno.2006.09.005; Pitel F, 2000, GENET SEL EVOL, V32, P73, DOI 10.1051/gse:2000107; Punnett RC, 1929, J GENET, V21, P341, DOI 10.1007/BF02984212; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; SESGIN MZ, 1961, PLAST RECONSTR SURG, V27, P261, DOI 10.1097/00006534-196103000-00003; Sheng XH, 2015, GENE, V568, P176, DOI 10.1016/j.gene.2015.05.049; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Somes RG, 1990, POULTRY BREEDING GEN, P209; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Sturkie PD, 1942, J GENET, V27, P172; Sun YF, 2014, G3-GENES GENOM GENET, V4, P1167, DOI 10.1534/g3.114.011338; Warren DC, 1944, GENETICS, V29, P217; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang K, 2013, ANIM GENET, V44, P118, DOI 10.1111/j.1365-2052.2012.02369.x; Zhai ZX, 2015, ANIM GENET, V46, P216, DOI 10.1111/age.12250; Zhang ZB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149010; Zhao G., 2005, CHINA POULTRY, V27, P49	42	3	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176113	10.1371/journal.pone.0176113	http://dx.doi.org/10.1371/journal.pone.0176113			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489934	Green Submitted, gold, Green Published			2022-12-26	WOS:000401314100014
J	Sekhar, DL; Murray-Kolb, LE; Kunselman, AR; Weisman, CS; Paul, IM				Sekhar, Deepa L.; Murray-Kolb, Laura E.; Kunselman, Allen R.; Weisman, Carol S.; Paul, Ian M.			Association between menarche and iron deficiency in non-anemic young women	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; US PRESCHOOL-CHILDREN; NATIONAL-HEALTH; CHILDBEARING AGE; ADOLESCENT; PREVALENCE; ANEMIA; SUPPLEMENTATION; FEMALES; RATIOS	Background The prevalence of iron deficiency (ID) among non-pregnant, reproductive-age US women significantly exceeds rates among males. In clinical practice ID screening relies on hemoglobin, a late-stage indicator of ID. As a single, low-cost laboratory test to diagnose ID before anemia develops is lacking, the study objective was to improve ID screening by identifying risk factors among non-anemic, iron-deficient reproductive age women. Methods Cross-sectional data were from the National Health and Nutrition Examination Survey (NHANES) 2003-2010. Hemoglobin identified non-anemic women. ID was defined using the body iron formula, requiring ferritin and transferrin receptor values. Logistic regression assessed the association of sociodemographic, behavioral, and reproductive risk factors in an anemia-based conceptual framework with non-anemic reproductive age women (12-49 years) with ID, as well as subsets of younger (12-21 years) and older (22-49 years) women, recognizing that risks may differ by age. Results Among 6216 women, 494 had ID (prevalence was 8.0%, 95% CI 7.3%, 8.6%). Among nonanemic younger women, 250 (8.7%, 95% CI 7.7%, 9.8%) had ID, compared to 244 (7.3%, 95% CI 6.4%, 8.2%) older women. Among younger women, menstruation for over 3 years was the only variable significantly associated with non-anemic ID (risk ratio 3.18, 95% CI 2.03, 4.96). No other significant risk factors were identified. Conclusion Menstrual years was the only risk factor significantly associated with ID among non-anemic younger women. The negative results suggest ID risk factors among non-anemic women may need to be considered separately from those associated with ID anemia.	[Sekhar, Deepa L.; Paul, Ian M.] Penn State Coll Med, Dept Pediat, Hershey, PA 17033 USA; [Murray-Kolb, Laura E.] Penn State Univ, Dept Nutr Sci, University Pk, PA 16802 USA; [Kunselman, Allen R.; Weisman, Carol S.; Paul, Ian M.] Penn State Coll Med, Dept Publ Hlth Sci, Hershey, PA USA; [Weisman, Carol S.] Penn State Coll Med, Dept Obstet & Gynecol, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Sekhar, DL (corresponding author), Penn State Coll Med, Dept Pediat, Hershey, PA 17033 USA.	dsekhar@hmc.psu.edu	Paul, Ian/AAD-9813-2020	Paul, Ian/0000-0002-6344-8609	Eunice Kennedy Shriver National Institute of Child Health; Human Development of the National Institutes of Health under BIRCWH [K12HD055882]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD055882] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Human Development of the National Institutes of Health under BIRCWH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Dr. Sekhar's research is supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health under BIRCWH award number K12HD055882, "Career Development Program in Women's Health Research at Penn State." The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	[Anonymous], 1998, MMWR Recomm Rep, V47, P1; Bastos LS, 2015, CAD SAUDE PUBLICA, V31, P487, DOI [10.1590/0102-311X00175413, 10.1590/0102-311x00175413]; Beard J, 2004, ASSESSING IRON STATU, P77; Beck KL, 2014, NUTRIENTS, V6, P3747, DOI 10.3390/nu6093747; Bieler GS, 2010, AM J EPIDEMIOL, V171, P618, DOI 10.1093/aje/kwp440; Blanton CA, 2013, BRIT J NUTR, V109, P906, DOI 10.1017/S0007114512002620; Bruinvels G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149881; Bruner AB, 1996, LANCET, V348, P992, DOI 10.1016/S0140-6736(96)02341-0; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P897; Cogswell ME, 2009, AM J CLIN NUTR, V89, P1334, DOI 10.3945/ajcn.2008.27151; Cook JD, 2003, BLOOD, V101, P3359, DOI 10.1182/blood-2002-10-3071; FISHER KD, 1985, AM J CLIN NUTR, V42, P1318; Friedman AJ, 2012, J WOMENS HEALTH, V21, P1282, DOI 10.1089/jwh.2012.3713; Frith-Terhune AL, 2000, AM J CLIN NUTR, V72, P963; Graubard BI, 1999, BIOMETRICS, V55, P652, DOI 10.1111/j.0006-341X.1999.00652.x; GRONER JA, 1986, J ADOLESCENT HEALTH, V7, P44, DOI 10.1016/S0197-0070(86)80094-8; Hagan JF, 2008, BRIGHT FUTURES GUIDE; Halterman JS, 2001, PEDIATRICS, V107, P1381, DOI 10.1542/peds.107.6.1381; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Killip S, 2007, AM FAM PHYSICIAN, V75, P671; Konofal E, 2008, PEDIATR NEUROL, V38, P20, DOI 10.1016/j.pediatrneurol.2007.08.014; Korn E. L., 1999, ANAL HLTH SURVEYS; Looker AC, 1997, JAMA-J AM MED ASSOC, V277, P973, DOI 10.1001/jama.277.12.973; Lopez MAV, 2006, HAEMATOL-HEMATOL J, V91, P264; Lynch SR, 2011, J NUTR, V141, p763S, DOI 10.3945/jn.110.130609; Mei ZG, 2012, CLIN CHIM ACTA, V413, P1479, DOI 10.1016/j.cca.2012.05.022; Murray-Kolb LE, 2007, AM J CLIN NUTR, V85, P778, DOI 10.1093/ajcn/85.3.778; Murray-Kolb LE, 2011, J NUTR, V141, p747S, DOI 10.3945/jn.110.130658; Nead KG, 2004, PEDIATRICS, V114, P104, DOI 10.1542/peds.114.1.104; Nestel P., 2002, ADJUSTING HEMOGLOBIN; Peyrin-Biroulet L, 2015, AM J CLIN NUTR, V102, P1585, DOI 10.3945/ajcn.114.103366; Picchietti D, 2007, SLEEP MED, V8, P693, DOI 10.1016/j.sleep.2007.06.007; Sekhar DL, 2016, J WOMENS HEALTH, V25, P505, DOI 10.1089/jwh.2015.5449; Takala TI, 2003, CLIN CHEM LAB MED, V41, P203, DOI 10.1515/CCLM.2003.033; Wu Ann Chen, 2002, Pediatr Rev, V23, P171, DOI 10.1542/pir.23-5-171	35	13	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177183	10.1371/journal.pone.0177183	http://dx.doi.org/10.1371/journal.pone.0177183			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486542	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314000053
J	Kumari, A; Ray, K; Sadhna, S; Pandey, AK; Sreelakshmi, Y; Sharma, R				Kumari, Alka; Ray, Kamalika; Sadhna, Sadhna; Pandey, Arun Kumar; Sreelakshmi, Yellamaraju; Sharma, Rameshwar			Metabolomic homeostasis shifts after callus formation and shoot regeneration in tomato	PLOS ONE			English	Article							PLANT-GROWTH; NITRIC-OXIDE; ARABIDOPSIS-THALIANA; LIGNIN BIOSYNTHESIS; ROOT DEVELOPMENT; TOR PATHWAY; COMPLEX; TARGET; AUXIN; METABOLITES	Plants can regenerate from a variety of tissues on culturing in appropriate media. However, the metabolic shifts involved in callus formation and shoot regeneration are largely unknown. The metabolic profiles of callus generated from tomato (Solanum lycopersicum) cotyledons and that of shoot regenerated from callus were compared with the pct1-2 mutant that exhibits enhanced polar auxin transport and the shr mutant that exhibits elevated nitric oxide levels. The transformation from cotyledon to callus involved a major shift in metabolite profiles with denser metabolic networks in the callus. In contrast, the transformation from callus to shoot involved minor changes in the networks. The metabolic networks in pct1-2 and shr mutants were distinct from wild type and were rewired with shifts in endogenous hormones and metabolite interactions. The callus formation was accompanied by a reduction in the levels of metabolites involved in cell wall lignification and cellular immunity. On the contrary, the levels of monoamines were upregulated in the callus and regenerated shoot. The callus formation and shoot regeneration were accompanied by an increase in salicylic acid in wild type and mutants. The transformation to the callus and also to the shoot downregulated LST8 and upregulated TOR transcript levels indicating a putative linkage between metabolic shift and TOR signalling pathway. The network analysis indicates that shift in metabolite profiles during callus formation and shoot regeneration is governed by a complex interaction between metabolites and endogenous hormones.	[Kumari, Alka; Ray, Kamalika; Sadhna, Sadhna; Pandey, Arun Kumar; Sreelakshmi, Yellamaraju; Sharma, Rameshwar] Univ Hyderabad, Dept Plant Sci, Repository Tomato Genom Resources, Hyderabad, Andhra Prades, India	University of Hyderabad	Sharma, R (corresponding author), Univ Hyderabad, Dept Plant Sci, Repository Tomato Genom Resources, Hyderabad, Andhra Prades, India.	rameshwar.sharma@gmail.com	Pandey, Arun K/ABB-2179-2020	Sreelakshmi, Yellamaraju/0000-0003-3468-9136	Department of Biotechnology, Government of India, New Delhi [BT/PR11671/PBD/16/828/2008]	Department of Biotechnology, Government of India, New Delhi(Department of Biotechnology (DBT) India)	This work was supported by the Department of Biotechnology, Government of India, New Delhi (Grant no. BT/PR11671/PBD/16/828/2008 to RS and YS.).	Al-Hammadi ASA, 2003, PLANT PHYSIOL, V133, P113, DOI 10.1104/pp.103.025478; Anzola JM, 2010, P NATL ACAD SCI USA, V107, P10308, DOI 10.1073/pnas.0913918107; Atta R, 2009, PLANT J, V57, P626, DOI 10.1111/j.1365-313X.2008.03715.x; BACKSHUSEMANN D, 1970, PROTOPLASMA, V70, P49, DOI 10.1007/BF01276841; Bahman F. N., 2012, International Journal of Agriculture and Crop Sciences (IJACS), V4, P17; Barrada A, 2015, INT J MOL SCI, V16, P19671, DOI 10.3390/ijms160819671; Berckmans RJ, 2011, BLOOD, V117, P3172, DOI 10.1182/blood-2010-06-290460; Caldana C, 2013, PLANT J, V73, P897, DOI 10.1111/tpj.12080; Capitani F, 2005, PLANTA, V220, P507, DOI 10.1007/s00425-004-1362-y; Cheng ZJ, 2013, PLANT PHYSIOL, V161, P240, DOI 10.1104/pp.112.203166; Correa-Aragunde N, 2006, J EXP BOT, V57, P581, DOI 10.1093/jxb/erj045; Correa-Aragunde N, 2004, PLANTA, V218, P900, DOI 10.1007/s00425-003-1172-7; De Bruyne L, 2014, MOL PLANT, V7, P943, DOI 10.1093/mp/ssu050; Deprost D, 2007, EMBO REP, V8, P864, DOI 10.1038/sj.embor.7401043; Fan MZ, 2012, CELL RES, V22, P1169, DOI 10.1038/cr.2012.63; Fares MA, 2015, TRENDS GENET, V31, P373, DOI 10.1016/j.tig.2015.04.008; Felix MA, 2015, NAT REV GENET, V16, P483, DOI 10.1038/nrg3949; Freschi L, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00398; GAUTHERET R., 1939, COMPT REND ACAD SCI [PARIS], V208, P118; Gomes AP, 2015, CURR OPIN BIOTECH, V34, P110, DOI 10.1016/j.copbio.2014.12.007; Gordon SP, 2007, DEVELOPMENT, V134, P3539, DOI 10.1242/dev.010298; Gupta SK, 2014, PLANT CELL ENVIRON, V37, P1688, DOI 10.1111/pce.12279; Haberlandt G., 1902, BER MAT NAT KI KAIS, V111, P69; Henriques R, 2014, J EXP BOT, V65, P2691, DOI 10.1093/jxb/eru049; Huang WL, 2012, PLANT CELL TISS ORG, V108, P257, DOI 10.1007/s11240-011-0038-0; Ikeda Y, 2006, PLANT CELL PHYSIOL, V47, P1443, DOI 10.1093/pcp/pcl023; Ikeuchi M, 2013, PLANT CELL, V25, P3159, DOI 10.1105/tpc.113.116053; Kareem A, 2015, CURR BIOL, V25, P1017, DOI 10.1016/j.cub.2015.02.022; Kharshiing EV, 2010, PLANT BIOLOGY, V12, P224, DOI 10.1111/j.1438-8677.2009.00267.x; Laplante M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011593; Leiber RM, 2010, PLANT CELL, V22, P1898, DOI 10.1105/tpc.109.073007; Li X, 2010, PLANT CELL, V22, P1620, DOI 10.1105/tpc.110.074161; Lommen A, 2012, METABOLOMICS, V8, P719, DOI 10.1007/s11306-011-0369-1; Mahmud I, 2014, ANAL BIOANAL CHEM, V406, P5997, DOI 10.1007/s00216-014-8002-6; Moreau M, 2012, PLANT CELL, V24, P463, DOI 10.1105/tpc.111.091306; Moreau M, 2010, ENZYMES, V27, P285, DOI 10.1016/S1874-6047(10)27015-4; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Navarova H, 2012, PLANT CELL, V24, P5123, DOI 10.1105/tpc.112.103564; Negi S, 2010, MOL PLANT, V3, P854, DOI 10.1093/mp/ssq033; Pacifici E, 2015, J EXP BOT, V66, P1113, DOI 10.1093/jxb/eru534; Pan XQ, 2010, NAT PROTOC, V5, P986, DOI 10.1038/nprot.2010.37; Lopez-Gresa MP, 2011, ENVIRON EXP BOT, V74, P216, DOI 10.1016/j.envexpbot.2011.06.003; PROTACIO CM, 1992, PLANT PHYSIOL, V98, P89, DOI 10.1104/pp.98.1.89; Pulianmackal AJ, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00142; Qiao M, 2012, PLANT J, V71, P14, DOI 10.1111/j.1365-313X.2012.04944.x; Radus I, 2001, ACTA PHYSIOL PLANT, V23, P103, DOI 10.1007/s11738-001-0029-6; Ramesh SA, 2015, NATURE COMMUNICATION, P6; Ren MZ, 2011, PLANT PHYSIOL, V155, P1367, DOI 10.1104/pp.110.169045; Renault H, 2011, PLANT CELL PHYSIOL, V52, P894, DOI 10.1093/pcp/pcr041; Rexin D, 2015, BIOCHEM J, V470, P1, DOI 10.1042/BJ20150505; Robaglia C, 2012, CURR OPIN PLANT BIOL, V15, P301, DOI 10.1016/j.pbi.2012.01.012; Roessner U, 2000, PLANT J, V23, P131, DOI 10.1046/j.1365-313x.2000.00774.x; Sanz L, 2015, J EXP BOT, V66, P2857, DOI 10.1093/jxb/erv213; Schepetilnikov M, 2013, EMBO J, V32, P1087, DOI 10.1038/emboj.2013.61; Sebanek J, 2012, EXPT MORPHOGENESIS I, V18; SKOOG F, 1957, Symp Soc Exp Biol, V11, P118; Sugimoto K, 2010, DEV CELL, V18, P463, DOI 10.1016/j.devcel.2010.02.004; Sugiyama M, 2015, J PLANT RES, V128, P349, DOI 10.1007/s10265-015-0706-y; Takahashi H, 2006, ANN BOT-LONDON, V98, P819, DOI 10.1093/aob/mcl162; Thimann KV, 1935, NATURE, V135, P101, DOI 10.1038/135101a0; Tikunov YM, 2012, METABOLOMICS, V8, P714, DOI 10.1007/s11306-011-0368-2; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Toubiana D, 2013, TRENDS BIOTECHNOL, V31, P29, DOI 10.1016/j.tibtech.2012.10.011; Tsugawa H, 2015, NAT METHODS, V12, P523, DOI 10.1038/nmeth.3393; Vanholme R, 2010, PLANT PHYSIOL, V153, P895, DOI 10.1104/pp.110.155119; Vogel-Adghough D, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.26366; Wagner A, 2007, BIOSYSTEMS, V88, P163, DOI 10.1016/j.biosystems.2006.06.002; Wang WF, 2014, CELL HOST MICROBE, V15, P401, DOI 10.1016/j.chom.2014.03.014; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Xiong Y, 2014, PLANT PHYSIOL, V164, P499, DOI 10.1104/pp.113.229948; Zacares L, 2007, MOL PLANT MICROBE IN, V20, P1439, DOI 10.1094/MPMI-20-11-1439; Zhang YF, 2008, PLANT CELL TISS ORG, V93, P323, DOI 10.1007/s11240-008-9380-2	72	11	11	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0176978	10.1371/journal.pone.0176978	http://dx.doi.org/10.1371/journal.pone.0176978			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481937	gold, Green Submitted, Green Published			2022-12-26	WOS:000401313700026
J	Ratnayake, M; Tselepi, M; Bloxham, R; Ploger, F; Reynard, LN; Loughlin, J				Ratnayake, Madhushika; Tselepi, Maria; Bloxham, Robert; Ploeger, Frank; Reynard, Louise N.; Loughlin, John			A consistent and potentially exploitable response during chondrogenesis of mesenchymal stem cells from osteoarthritis patients to the protein encoded by the susceptibility gene GDF5	PLOS ONE			English	Article							ALLELIC EXPRESSION; HUMAN CHONDROCYTES; CARTILAGE; DIFFERENTIATION; RECEPTORS; MUTATION; FACTOR-5; GROWTH; CDMP1; SNP	Osteoarthritis (OA) is a common joint disease characterised by the focal loss of the protective cartilage layer at the ends of the bones. It is painful, disabling, multifactorial and polygenic. The growth differentiation factor 5 gene GDF5 was one of the first reported OA susceptibility signals that showed consistent association to OA, with the transcript single nucleotide polymorphism (SNP) rs143383 demonstrating association in Asians and Europeans. The functional effect of the signal is reduced expression of the gene. The GDF5 protein is an extracellular matrix signalling molecule that is active during chondrogenesis and in mature chondrocytes. Due to the functional impact of the susceptibility, we previously assessed the effect of supplementing chondrocytes from OA patients with exogenous GDF5. Their response was highly discordant, precluding the application of GDF5 as a simple means of attenuating the genetic deficit. Since GDF5 is also active during development, we have now assessed the effect of exogenous GDF5 on bone marrow derived mesenchymal stem cells (MSCs) that are undergoing chondrogenesis during cartilage disc formation. MSCs from healthy donors and OA patients were studied and the effect of GDF5 was assessed by measuring the wet mass of the discs, by histological staining, and by monitoring the change in expression of anabolic, catabolic and hypertrophic protein-coding genes. The MSCs expressed the three principal GDF5 receptor genes and responded in a significantly anabolic manner (increase in wet mass, p = 0.0022; Bonferroni corrected p = 0.018) to a variant form of GDF5 that targets the most abundantly expressed receptor, BMPR-IA. GDF5 elicited significant (p < 0.05) changes in the expression of anabolic, catabolic and hypertrophic genes with several consistent effects in healthy donors and in OA patients. Our data implies that, unlike OA chondrocytes, OA MSCs do respond in a predictable, anabolic manner to GDF5, which could therefore provide a route to modulate the genetic deficit mediated by the rs143383 association signal.	[Ratnayake, Madhushika; Tselepi, Maria; Bloxham, Robert; Reynard, Louise N.; Loughlin, John] Newcastle Univ, Inst Cellular Med, Musculoskeletal Res Grp, Newcastle Upon Tyne, Tyne & Wear, England; [Ploeger, Frank] BioPharm GmbH, Heidelberg, Germany; [Ratnayake, Madhushika; Tselepi, Maria; Bloxham, Robert; Reynard, Louise N.; Loughlin, John] Newcastle Univ, Inst Genet Med, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Tselepi, M (corresponding author), Newcastle Univ, Inst Cellular Med, Musculoskeletal Res Grp, Newcastle Upon Tyne, Tyne & Wear, England.; Tselepi, M (corresponding author), Newcastle Univ, Inst Genet Med, Newcastle Upon Tyne, Tyne & Wear, England.	maria.tselepi@ncl.ac.uk		Loughlin, John/0000-0003-2018-3361; Reynard, Louise/0000-0002-6613-1797	Arthritis Research UK [19824, 20231]; Medical Research Council; Arthritis Research UK as part of the MRCArthritis Research UK Centre for Integrated Research into Musculoskeletal Ageing (CIMA) [JXR 10641]; European Unions Seventh Framework Program for research, technological development and demonstration [305815]; NIHR Newcastle Biomedical Research Centre; MRC [MR/K006312/1] Funding Source: UKRI; Medical Research Council [MR/K006312/1] Funding Source: researchfish; Versus Arthritis [20771, 20231, 19824] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research UK as part of the MRCArthritis Research UK Centre for Integrated Research into Musculoskeletal Ageing (CIMA)(Versus Arthritis); European Unions Seventh Framework Program for research, technological development and demonstration; NIHR Newcastle Biomedical Research Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis)	This research was funded by Arthritis Research UK (http://www.arthritisresearchuk.org/; grant codes 19824 and 20231), by the Medical Research Council and Arthritis Research UK as part of the MRCArthritis Research UK Centre for Integrated Research into Musculoskeletal Ageing (CIMA; http://www.cimauk.org/; grant code JXR 10641), and by the European Unions Seventh Framework Program for research, technological development and demonstration under grant agreement No. 305815 (D-BOARD; http://cordis.europa.eu/project/rcn/105314_en.html). FP is an employee of the company Biopharm GmbH, which provided support in the form of salary for FP. None of the funders, including Biopharm, had any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of FP and all authors are articulated in the author contributions section.; Patient tissue was provided by the Newcastle Bone and Joint Biobank supported by the NIHR Newcastle Biomedical Research Centre awarded to the Newcastle upon Tyne NHS Foundation Trust and Newcastle University. We thank the surgeons and research nurses at the Trust for providing us with access to these samples. We thank Sharon Watson for carrying out histological staining of our samples. We thank Lucy Gentles for her assistance with hip joint collection. We are grateful for Simon Partridge and Sotiria Toumpaniari for their assistance with MSC isolation from the femoral head of OA hips. We thank Fabio D'Agostino for his help with healthy donor MSC culture. We thank the patients for donating their tissue samples.	Bucher C, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/326828; Coleman CM, 2013, STEM CELLS DEV, V22, P1968, DOI 10.1089/scd.2012.0282; Enochson L, 2014, OSTEOARTHR CARTILAGE, V22, P566, DOI 10.1016/j.joca.2014.02.004; Francis-West PH, 1999, DEVELOPMENT, V126, P1305; Kasten P, 2010, BIOMATERIALS, V31, P3878, DOI 10.1016/j.biomaterials.2010.01.109; Miyamoto Y, 2007, NAT GENET, V39, P529, DOI 10.1038/2005; Murdoch AD, 2007, STEM CELLS, V25, P2786, DOI 10.1634/stemcells.2007-0374; Murphy MK, 2015, STEM CELLS, V33, P762, DOI 10.1002/stem.1890; Neagu M, 2005, ROMANIAN J BIOPHYS, V15, P1; Nishitoh H, 1996, J BIOL CHEM, V271, P21345, DOI 10.1074/jbc.271.35.21345; Oda T, 2016, BIOCHEM BIOPH RES CO, V479, P469, DOI 10.1016/j.bbrc.2016.09.085; Polinkovsky A, 1997, NAT GENET, V17, P18, DOI 10.1038/ng0997-18; Ratnayake M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086590; Reynard LN, 2014, HUM GENET, V133, P1059, DOI 10.1007/s00439-014-1447-z; Somoza RA, 2014, TISSUE ENG PART B-RE, V20, P596, DOI [10.1089/ten.teb.2013.0771, 10.1089/ten.TEB.2013.0771]; Southam L, 2007, HUM MOL GENET, V16, P2226, DOI 10.1093/hmg/ddm174; Tew SR, 2008, METHODS, V45, P2, DOI 10.1016/j.ymeth.2008.01.006; Thomas JT, 1997, NAT GENET, V17, P58, DOI 10.1038/ng0997-58; Thomas JT, 1996, NAT GENET, V12, P315, DOI 10.1038/ng0396-315; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704; Zou HY, 1997, GENE DEV, V11, P2191, DOI 10.1101/gad.11.17.2191	21	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0176523	10.1371/journal.pone.0176523	http://dx.doi.org/10.1371/journal.pone.0176523			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481944	Green Submitted, Green Published, gold			2022-12-26	WOS:000401313700012
J	Wald, JH; Hatakeyama, J; Printsev, I; Cuevas, A; Fry, WHD; Saldana, MJ; VanderVorst, K; Rowson-Hodel, A; Angelastro, JM; Sweeney, C; Carraway, KL				Wald, J. H.; Hatakeyama, J.; Printsev, I.; Cuevas, A.; Fry, W. H. D.; Saldana, M. J.; VanderVorst, K.; Rowson-Hodel, A.; Angelastro, J. M.; Sweeney, C.; Carraway, K. L., III			Suppression of planar cell polarity signaling and migration in glioblastoma by Nrdp1-mediated Dvl polyubiquitination	ONCOGENE			English	Article							E3 UBIQUITIN LIGASE; DISHEVELLED DEP DOMAIN; NEURAL-TUBE DEFECTS; CANCER CELLS; NRDP1; PROTEIN; MECHANISMS; INVASION; RECEPTOR; CATENIN	The lethality of the aggressive brain tumor glioblastoma multiforme (GBM) results in part from its strong propensity to invade surrounding normal brain tissue. Although oncogenic drivers such as epidermal growth factor receptor activation and Phosphatase and Tensin homolog inactivation are thought to promote the motility and invasiveness of GBM cells via phosphatidylinostitol 3-kinase activation, other unexplored mechanisms may also contribute to malignancy. Here we demonstrate that several components of the planar cell polarity (PCP) arm of non-canonical Wnt signaling including VANGL1, VANGL2 and FZD7 are transcriptionally upregulated in glioma and correlate with poorer patient outcome. Knockdown of the core PCP pathway component VANGL1 suppresses the motility of GBM cell lines, pointing to an important mechanistic role for this pathway in glioblastoma malignancy. We further observe that restoration of Nrdp1, a RING finger type E3 ubiquitin ligase whose suppression in GBM also correlates with poor prognosis, reduces GBM cell migration and invasiveness by suppressing PCP signaling. Our observations indicate that Nrdp1 physically interacts with the Vangl1 and Vangl2 proteins to mediate the K63-linked polyubiquitination of the Dishevelled, Egl-10 and Pleckstrin (DEP) domain of the Wnt pathway protein Dishevelled (Dvl). Ubiquitination hinders Dvl binding to phosphatidic acid, an interaction necessary for efficient Dvl recruitment to the plasma membrane upon Wnt stimulation of Fzd receptor and for the propagation of downstream signals. We conclude that the PCP pathway contributes significantly to the motility and hence the invasiveness of GBM cells, and that Nrdp1 acts as a negative regulator of PCP signaling by inhibiting Dvl through a novel polyubiquitination mechanism. We propose that the upregulation of core PCP components, together with the loss of the key negative regulator Nrdp1, act coordinately to promote GBM invasiveness and malignancy.	[Wald, J. H.; Hatakeyama, J.; Printsev, I.; Cuevas, A.; Fry, W. H. D.; Saldana, M. J.; VanderVorst, K.; Rowson-Hodel, A.; Sweeney, C.; Carraway, K. L., III] Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Sacramento, CA 95817 USA; [Wald, J. H.; Hatakeyama, J.; Printsev, I.; Cuevas, A.; Fry, W. H. D.; Saldana, M. J.; VanderVorst, K.; Rowson-Hodel, A.; Sweeney, C.; Carraway, K. L., III] Univ Calif Davis, Sch Med, UC Davis Comprehens Canc Ctr, Sacramento, CA 95817 USA; [Angelastro, J. M.] Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Carraway, KL (corresponding author), Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Res Bldg 3,Room 1100B,4645 2nd Ave, Sacramento, CA 95817 USA.	klcarraway@ucdavis.edu	Rowson-Hodel, Ashley/AAE-2619-2022	Rowson-Hodel, Ashley/0000-0003-0531-9929; Hatakeyama, Jason/0000-0001-8690-5107; Cuevas-Navarro, Antonio/0000-0001-6208-6944	NIH [CA123541, CA166412, CA118384, CA165758, CA165546]; DoD BCRP fellowship [W81XWH-10-1-0069]; NCI [P30CA093373]; NATIONAL CANCER INSTITUTE [F31CA165546, R01CA166412, R01CA118384, P30CA093373, R01CA123541, F31CA165758] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DoD BCRP fellowship; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	These studies were supported by NIH grants CA123541 (KLC), CA166412 (KLC) and CA118384 (CS), NIH fellowships CA165758 (JH) and CA165546 (IP), DoD BCRP fellowship W81XWH-10-1-0069 (JHW), and NCI P30CA093373 (Cancer Center Support Grant-FACS core). We thank Drs Paul Knoepfler, Madelon Maurice and Hiroaki Miki for kindly providing reagents and cell lines.	Anastas JN, 2012, ONCOGENE, V31, P3696, DOI 10.1038/onc.2011.528; Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Andersson U, 2004, ACTA NEUROPATHOL, V108, P135, DOI 10.1007/s00401-004-0875-6; Cao ZW, 2007, MOL CELL BIOL, V27, P2180, DOI 10.1128/MCB.01245-06; Chen LQ, 2010, CANCER RES, V70, P5994, DOI 10.1158/0008-5472.CAN-09-4440; Courbard JR, 2009, DEV BIOL, V333, P67, DOI 10.1016/j.ydbio.2009.06.024; de Groot REA, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004985; Diamonti AJ, 2002, P NATL ACAD SCI USA, V99, P2866, DOI 10.1073/pnas.052709799; Eke I, 2012, INT J RADIAT ONCOL, V84, pE515, DOI 10.1016/j.ijrobp.2012.06.012; Fry WHD, 2011, MOL CELL BIOL, V31, P3009, DOI 10.1128/MCB.05105-11; Funato Y, 2010, CURR BIOL, V20, P1945, DOI 10.1016/j.cub.2010.09.065; Gao B, 2011, DEV CELL, V20, P163, DOI 10.1016/j.devcel.2011.01.001; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Gonzalez-Sancho JM, 2004, MOL CELL BIOL, V24, P4757, DOI 10.1128/MCB.24.11.4757-4768.2004; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Hatakeyama J, 2014, ENDOCR-RELAT CANCER, V21, pR345, DOI 10.1530/ERC-14-0141; Huang Z, 2010, PROTEIN CELL, V1, P638, DOI 10.1007/s13238-010-0078-y; Huse JT, 2013, ANNU REV MED, V64, P59, DOI 10.1146/annurev-med-100711-143028; Ingalla EQ, 2010, J BIOL CHEM, V285, P28691, DOI 10.1074/jbc.M110.127977; Jiang YS, 2015, TUMOR BIOL, V36, P1129, DOI 10.1007/s13277-014-2726-y; Kamino M, 2011, CANCER SCI, V102, P540, DOI 10.1111/j.1349-7006.2010.01815.x; Lee KH, 2015, ONCOTARGET, V6, P3240, DOI 10.18632/oncotarget.3087; Lewandowski KT, 2014, J CELL SCI, V127, P315, DOI 10.1242/jcs.129148; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Luk SK, 2012, EUR J CANCER, V48, P149, DOI 10.1016/j.ejca.2011.09.006; Montcouquiol M, 2006, J NEUROSCI, V26, P5265, DOI 10.1523/JNEUROSCI.4680-05.2006; Murdoch JN, 2001, HUM MOL GENET, V10, P2593, DOI 10.1093/hmg/10.22.2593; Ostrom QT, 2013, NEURO-ONCOLOGY, V15, P1, DOI 10.1093/neuonc/not151; Paw I, 2015, CANCER LETT, V362, P1, DOI 10.1016/j.canlet.2015.03.015; Pellegrin S, 2008, CURR PROTOC CELL BIO, V38, DOI DOI 10.1002/0471143030.CB1408S38; Peng Y, 2012, CURR TOP DEV BIOL, V101, P33, DOI 10.1016/B978-0-12-394592-1.00002-8; Printsev I, 2014, J BIOL CHEM, V289, P8570, DOI 10.1074/jbc.M113.527036; Qiu XB, 2004, EMBO J, V23, P800, DOI 10.1038/sj.emboj.7600075; Sewduth RN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5832; Shi HL, 2015, J NEURO-ONCOL, V124, P357, DOI 10.1007/s11060-015-1851-9; Shi HL, 2014, IUBMB LIFE, V66, P704, DOI 10.1002/iub.1320; Simons M, 2009, NAT CELL BIOL, V11, P286, DOI 10.1038/ncb1836; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Tauriello DVF, 2012, P NATL ACAD SCI USA, V109, pE812, DOI 10.1073/pnas.1114802109; Tauriello DVF, 2010, CELL CYCLE, V9, P3700, DOI 10.4161/cc.9.18.13204; Tauriello DVF, 2010, MOL CELL, V37, P607, DOI 10.1016/j.molcel.2010.01.035; Thakkar JP, 2014, CANCER EPIDEM BIOMAR, V23, P1985, DOI 10.1158/1055-9965.EPI-14-0275; Torban E, 2008, P NATL ACAD SCI USA, V105, P3449, DOI 10.1073/pnas.0712126105; Torban E, 2012, CURR TOP DEV BIOL, V101, P237, DOI 10.1016/B978-0-12-394592-1.00005-3; Trinh J., 2009, THESIS; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wong HC, 2000, NAT STRUCT BIOL, V7, P1178; Wu XL, 2004, MOL CELL BIOL, V24, P7748, DOI 10.1128/MCB.24.17.7748-7757.2004; Yen L, 2006, CANCER RES, V66, P11279, DOI 10.1158/0008-5472.CAN-06-2319	49	26	26	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 7	2017	36	36					5158	5167		10.1038/onc.2017.126	http://dx.doi.org/10.1038/onc.2017.126			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FF9XD	28481871	Green Submitted, Green Accepted			2022-12-26	WOS:000409371100007
J	Nishimoto, Y; Nakajima, S; Tateya, S; Saito, M; Ogawa, W; Tamori, Y				Nishimoto, Yuki; Nakajima, Shinsuke; Tateya, Sanshiro; Saito, Masayuki; Ogawa, Wataru; Tamori, Yoshikazu			Cell death-inducing DNA fragmentation factor A-like effector A and fat-specific protein 27 beta coordinately control lipid droplet size in brown adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN; TRANSCRIPTION FACTOR; INSULIN SENSITIVITY; DEFICIENT MICE; ACID OXIDATION; FSP27; PROMOTES; STORAGE; CIDEA; CREBH	Adipose tissue stores neutral lipids and is a major metabolic organ involved in regulating whole-body energy homeostasis. Triacylglycerol is stored as unilocular large lipid droplets (LDs) in white adipocytes and as multilocular small LDs in brown adipocytes. Proteins of the cell death-inducing DNA fragmentation factor A-like effector (Cide) family include CideA, CideB, and fat-specific protein of 27 (FSP27). Of these, FSP27 has been shown to play a crucial role in the formation of unilocular large LDs in white adipocytes. However, the mechanisms by which brown adipocytes store small and multilocular LDs remain unclear. An FSP27 isoform, FSP27 beta, was recently identified. We herein report that CideA and FSP27 beta are mainly expressed in brown adipose tissue and that FSP27 beta overexpression inhibits CideA-induced LD enlargements in a dose-dependent manner in COS cells. Furthermore, RNAi-mediated FSP27 beta depletion resulted in enlarged LDs in HB2 adipocytes, which possess the characteristics of brown adipocytes. Brown adipocytes in FSP27-knock-out mice that express CideA, but not FSP27 beta, had larger and fewer LDs. Moreover, we confirmed that FSP27 beta and CideA form a complex in brown adipose tissue. Our results suggest that FSP27 beta negatively regulates CideA-promoted enlargement of LD size in brown adipocytes. FSP27 beta appears to be responsible for the formation of small and multilocular LDs in brown adipose tissue, a morphology facilitating free fatty acid transport to mitochondria adjacent to LDs for oxidation in brown adipocytes.	[Nishimoto, Yuki; Nakajima, Shinsuke; Tateya, Sanshiro; Ogawa, Wataru; Tamori, Yoshikazu] Kobe Univ, Grad Sch Med, Div Diabet & Endocrinol, Dept Internal Med, Kobe, Hyogo 6500017, Japan; [Tateya, Sanshiro] Kakogawa Cent City Hosp, Div Diabet, Dept Internal Med, Kakogawa, Hyogo 6758611, Japan; [Saito, Masayuki] Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci, Sapporo, Hokkaido 0600818, Japan; [Tamori, Yoshikazu] Chibune Gen Hosp, Div Diabet & Endocrinol, Dept Internal Med, Osaka 5550001, Japan	Kobe University; Hokkaido University	Tamori, Y (corresponding author), Kobe Univ, Grad Sch Med, Div Diabet & Endocrinol, Dept Internal Med, Kobe, Hyogo 6500017, Japan.; Tamori, Y (corresponding author), Chibune Gen Hosp, Div Diabet & Endocrinol, Dept Internal Med, Osaka 5550001, Japan.	tamori@med.kobe-u.ac.jp	OGAWA, Wataru/AAQ-9586-2020		Japan Society for the Promotion of Science KAKENHI [16K09748]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science KAKENHI Grant 16K09748 (to Y. T.) The authors declare that they have no conflicts of interest with the contents of this manuscript.	Barneda D, 2015, ELIFE, V4, DOI 10.7554/eLife.07485; Christianson JL, 2010, J LIPID RES, V51, P3455, DOI 10.1194/jlr.M009498; Cohen P, 2016, MOL BIOL CELL, V27, P2523, DOI 10.1091/mbc.E15-10-0749; Gong JY, 2011, J CELL BIOL, V195, P953, DOI 10.1083/jcb.201104142; Grahn THM, 2014, J BIOL CHEM, V289, P12029, DOI 10.1074/jbc.M113.539890; Grahn THM, 2013, BIOCHEM BIOPH RES CO, V432, P296, DOI 10.1016/j.bbrc.2013.01.113; Irie Y, 1999, BIOCHEM BIOPH RES CO, V255, P221, DOI 10.1006/bbrc.1998.9999; Jambunathan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028614; Keller P, 2008, J BIOL CHEM, V283, P14355, DOI 10.1074/jbc.M708323200; Lee JH, 2011, NAT MED, V17, P812, DOI 10.1038/nm.2347; Lee MW, 2010, CELL METAB, V11, P331, DOI 10.1016/j.cmet.2010.02.016; Lee SM, 2013, BIOCHEM BIOPH RES CO, V439, P564, DOI 10.1016/j.bbrc.2013.09.018; Li JZ, 2007, DIABETES, V56, P2523, DOI 10.2337/db07-0040; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Puri V, 2008, P NATL ACAD SCI USA, V105, P7833, DOI 10.1073/pnas.0802063105; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; Sun ZQ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2581; Tamori Y, 2016, FEBS LETT, V590, P750, DOI 10.1002/1873-3468.12114; Toh SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002890; Xu L, 2012, ARTERIOSCL THROM VAS, V32, P1094, DOI 10.1161/ATVBAHA.111.241489; Xu X, 2015, HEPATOLOGY, V61, P857, DOI 10.1002/hep.27371; Zhang CB, 2012, HEPATOLOGY, V55, P1070, DOI 10.1002/hep.24783; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225	24	12	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					10824	10834		10.1074/jbc.M116.768820	http://dx.doi.org/10.1074/jbc.M116.768820			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28490632	hybrid, Green Published			2022-12-26	WOS:000404391000007
J	Shibata, T; Hadano, J; Kawasaki, D; Dong, XQ; Kawabata, S				Shibata, Toshio; Hadano, Jinki; Kawasaki, Daichi; Dong, Xiaoqing; Kawabata, Shun-ichiro			Drosophila TG-A transglutaminase is secreted via an unconventional Golgi-independent mechanism involving exosomes and two types of fatty acylations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Drosophila; exosome (vesicle); protein myristoylation; protein palmitoylation; protein secretion; transglutaminase	TERMINAL N-MYRISTOYLATION; PROTEIN CROSS-LINKING; CLOTTING PROTEIN; PLASMA-MEMBRANE; TRANSFERRIN RECEPTOR; ALPHA-SUBUNIT; PALMITOYLATION; IDENTIFICATION; LOCALIZATION; SYSTEM	Transglutaminases (TGs) play essential intracellular and extracellular roles by covalently cross-linking many proteins. Drosophila TG is encoded by one gene and has two alternative splicing-derived isoforms, TG-A and TG-B, which contain distinct N-terminal 46- and 38-amino acid sequences, respectively. The TGs identified to date do not have a typical endoplasmic reticulum (ER)-signal peptide, and the molecular mechanisms of their secretion under physiologic conditions are unclear. Immunocytochemistry revealed that TG-A localizes to multivesicular-like structures, whereas TG-B localizes to the cytosol. We also found that TG-A, but not TG-B, was modified concomitantly by N-myristoylation and S-palmitoylation, and N-myristoylation was a pre-requisite for S-palmitoylation. Moreover, TG-A, but not TG-B, was secreted in response to calcium signaling induced by Ca2+ ionophores and uracil, a pathogenic bacteria-derived substance. Brefeldin A and monensin, inhibitors of the ER/Golgi-mediated conventional pathway, did not suppress TG-A secretion, whereas inhibition of S-palmitoylation by 2-bromopalmitate blocked TG-A secretion. Ultracentrifugation, electron microscopy analyses, and treatments with inhibitors of multivesicular body formation revealed that TG-A was secreted via exosomes together with co-transfected mammalian CD63, an exosomal marker, and the secreted TG-A was taken up by other cells. The 8-residue N-terminal fragment of TG-A containing the fatty acylation sites was both necessary and sufficient for the exosome-dependent secretion of TG-A. In conclusion, TG-A is secreted through an unconventional ER/Golgi-independent pathway involving two types of fatty acylations and exosomes.	[Shibata, Toshio; Kawabata, Shun-ichiro] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 8190395, Japan; [Shibata, Toshio] Kyushu Univ, Inst Adv Study, Fukuoka 8190395, Japan; [Hadano, Jinki; Kawasaki, Daichi; Dong, Xiaoqing; Kawabata, Shun-ichiro] Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 8190395, Japan	Kyushu University; Kyushu University; Kyushu University	Kawabata, S (corresponding author), Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 8190395, Japan.; Kawabata, S (corresponding author), Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 8190395, Japan.	skawascb@kyudai.jp			Qdai-jump Research Program (TT type) Grant [26701];  [15H04353];  [26860333]	Qdai-jump Research Program (TT type) Grant; ; 	This work was supported by Grant-in-Aid for Scientific Research (B) 15H04353 (to S. K.), Grant-in-Aid for Young Scientists (B) 26860333 (to T. S.), and the Qdai-jump Research Program (TT type) Grant 26701 (to T. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Aicart-Ramos C, 2011, BBA-BIOMEMBRANES, V1808, P2981, DOI 10.1016/j.bbamem.2011.07.009; ALLAND L, 1994, J BIOL CHEM, V269, P16701; Bannan Barbra A, 2008, Fly (Austin), V2, P198; Bartels DJ, 1999, MOL CELL BIOL, V19, P6775, DOI 10.1128/mcb.19.10.6775; Bastos-Amador P, 2012, J LEUKOCYTE BIOL, V91, P751, DOI 10.1189/jlb.0111054; Beckett K, 2013, TRAFFIC, V14, P82, DOI 10.1111/tra.12016; BERTHIAUME L, 1995, J BIOL CHEM, V270, P22399, DOI 10.1074/jbc.270.38.22399; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; Conibear E, 2010, J CELL SCI, V123, P4007, DOI 10.1242/jcs.059287; Demuny M.A., 2015, TRANSGLUTAMINASES MU, P1, DOI [10.1007/978-4-431-55825-5_1, DOI 10.1007/978-4-431-55825-5_1]; Denny PW, 2000, J BIOL CHEM, V275, P11017, DOI 10.1074/jbc.275.15.11017; Diaz-Hidalgo L, 2016, BBA-MOL CELL RES, V1863, P2084, DOI 10.1016/j.bbamcr.2016.05.005; Eckert RL, 2014, PHYSIOL REV, V94, P383, DOI 10.1152/physrev.00019.2013; Ezure T, 2007, PROTEOMICS, V7, P4424, DOI 10.1002/pmic.200700774; Farazi TA, 2001, J BIOL CHEM, V276, P39501, DOI 10.1074/jbc.R100042200; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Furutani Y., 2015, TRANSGLUTAMINASES, P43, DOI DOI 10.1007/978-4-431-55825-5_2; Greaves J, 2007, J CELL BIOL, V176, P249, DOI 10.1083/jcb.200610151; Hall M, 1999, P NATL ACAD SCI USA, V96, P1965, DOI 10.1073/pnas.96.5.1965; HALLAK H, 1994, J BIOL CHEM, V269, P4571; HARDING C, 1983, J CELL BIOL, V97, P329, DOI 10.1083/jcb.97.2.329; Ichikawa A, 2010, BIOSCI BIOTECH BIOCH, V74, P2494, DOI 10.1271/bbb.100449; Johnstone RM, 2006, BLOOD CELL MOL DIS, V36, P315, DOI 10.1016/j.bcmd.2005.12.001; Kalinin A, 2001, J CELL SCI, V114, P3069; KOPACEK P, 1993, EUR J BIOCHEM, V213, P591, DOI 10.1111/j.1432-1033.1993.tb17798.x; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Lee KA, 2013, CELL, V153, P797, DOI 10.1016/j.cell.2013.04.009; Lindgren M, 2008, J INSECT PHYSIOL, V54, P586, DOI 10.1016/j.jinsphys.2007.12.008; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Maurer-Stroh S, 2002, J MOL BIOL, V317, P541, DOI 10.1006/jmbi.2002.5426; Maurer-Stroh S, 2002, J MOL BIOL, V317, P523, DOI 10.1006/jmbi.2002.5425; MERESSE S, 1995, J CELL SCI, V108, P3349; Moriya K, 2010, INSECT MOL BIOL, V19, P291, DOI 10.1111/j.1365-2583.2009.00982.x; NASSARGENTINA V, 1994, CELL CALCIUM, V16, P475, DOI 10.1016/0143-4160(94)90077-9; Nickel W, 2005, TRAFFIC, V6, P607, DOI 10.1111/j.1600-0854.2005.00302.x; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; Osaki T, 2002, J BIOL CHEM, V277, P40084, DOI 10.1074/jbc.M206773200; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; PAN BT, 1983, CELL, V33, P967, DOI 10.1016/0092-8674(83)90040-5; Phan HP, 2008, BIOSCI BIOTECH BIOCH, V72, P1847, DOI 10.1271/bbb.80108; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; Shen BY, 2011, J BIOL CHEM, V286, P14383, DOI 10.1074/jbc.M110.208660; Shibata T, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005244; Shibata T, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003970; Shibata T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013477; Silverman JM, 2010, J IMMUNOL, V185, P5011, DOI 10.4049/jimmunol.1000541; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Stegmayer C, 2005, J CELL SCI, V118, P517, DOI 10.1242/jcs.01645; Steinert PM, 1996, J BIOL CHEM, V271, P26242, DOI 10.1074/jbc.271.42.26242; Suzuki T, 2007, PROTEOMICS, V7, P1942, DOI 10.1002/pmic.200700237; Suzuki T, 2010, PROTEOMICS, V10, P1780, DOI 10.1002/pmic.200900783; Swarthout JT, 2005, J BIOL CHEM, V280, P31141, DOI 10.1074/jbc.M504113200; Theopold U, 2014, DEV COMP IMMUNOL, V42, P42, DOI 10.1016/j.dci.2013.03.014; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tsutsumi R, 2009, MOL CELL BIOL, V29, P435, DOI 10.1128/MCB.01144-08; vantHof W, 1997, J CELL BIOL, V136, P1023, DOI 10.1083/jcb.136.5.1023; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; Wang Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000763; Zemskov EA, 2006, FRONT BIOSCI-LANDMRK, V11, P1057, DOI 10.2741/1863; Zemskov EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019414; Zlatkine P, 1997, J CELL SCI, V110, P673	68	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10723	10734		10.1074/jbc.M117.779710	http://dx.doi.org/10.1074/jbc.M117.779710			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28476891	Green Published, hybrid			2022-12-26	WOS:000404115400030
J	Al-Aama, JY; Shaik, NA; Banaganapalli, B; Salama, MA; Rashidi, O; Sahly, AN; Mohsen, MO; Shawoosh, HA; Shalabi, HA; Al Edreesi, M; Alharthi, SE; Wang, J; Elango, R; Saadah, OI				Al-Aama, Jumana Yousuf; Shaik, Noor Ahmad; Banaganapalli, Babajan; Salama, Mohammed A.; Rashidi, Omran; Sahly, Ahmed N.; Mohsen, Mohammed O.; Shawoosh, Harbi A.; Shalabi, Hebah Ahmad; Al Edreesi, Mohammad; Alharthi, Sameer E.; Wang, Jun; Elango, Ramu; Saadah, Omar I.			Whole exome sequencing of a consanguineous family identifies the possible modifying effect of a globally rare AK5 allelic variant in celiac disease development among Saudi patients	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ADENYLATE KINASE-5; GENETIC-VARIATION; PROTEIN; DATABASE; REPLICATION; EXPRESSION; PROJECT; ARABIA; RISK	Celiac disease (CD), a multi-factorial auto-inflammatory disease of the small intestine, is known to occur in both sporadic and familial forms. Together HLA and Non-HLA genes can explain up to 50% of CD's heritability. In order to discover the missing heritability due to rare variants, we have exome sequenced a consanguineous Saudi family presenting CD in an autosomal recessive (AR) pattern. We have identified a rare homozygous insertion c. 1683_1684insATT, in the conserved coding region of AK5 gene that showed classical AR model segregation in this family. Sequence validation of 200 chromosomes each of sporadic CD cases and controls, revealed that this extremely rare (EXac MAF 0.000008) mutation is highly penetrant among general Saudi populations (MAF is 0.62). Genotype and allelic distribution analysis have indicated that this AK5 (c. 1683_1684insATT) mutation is negatively selected among patient groups and positively selected in the control group, in whom it may modify the risk against CD development [p<0.002]. Our observation gains additional support from computational analysis which predicted that Iso561 insertion shifts the existing H-bonds between 400th and 556th amino acid residues lying near the functional domain of adenylate kinase. This shuffling of amino acids and their H-bond interactions is likely to disturb the secondary structure orientation of the polypeptide and induces the gain-of-function in nucleoside phosphate kinase activity of AK5, which may eventually down-regulates the reactivity potential of CD4(+) T-cells against gluten antigens. Our study underlines the need to have population-specific genome databases to avoid false leads and to identify true candidate causal genes for the familial form of celiac disease.	[Al-Aama, Jumana Yousuf; Shaik, Noor Ahmad; Banaganapalli, Babajan; Elango, Ramu] King Abdulaziz Univ, Dept Genet Med, Fac Med, Jeddah, Saudi Arabia; [Al-Aama, Jumana Yousuf; Shaik, Noor Ahmad; Banaganapalli, Babajan; Salama, Mohammed A.; Rashidi, Omran; Sahly, Ahmed N.; Mohsen, Mohammed O.; Alharthi, Sameer E.; Wang, Jun; Elango, Ramu; Saadah, Omar I.] King Abdulaziz Univ, Princess Al Jawhara Al Brahim Ctr Excellence Res, Jeddah, Saudi Arabia; [Salama, Mohammed A.] King Abdulaziz Univ, Dept Biol Sci, Fac Sci, Jeddah, Saudi Arabia; [Shawoosh, Harbi A.] King Fand Armed Forces Hosp, Dept Pediat, Jeddah, Saudi Arabia; [Shalabi, Hebah Ahmad] Minist Hlth, Primary Healthcare Ctr, Jeddah, Saudi Arabia; [Al Edreesi, Mohammad] Saudi Aramco Med Serv Org, Dhahran Hlth Ctr, Div Gastroenterol, Dept Pediat, Dhahran, Saudi Arabia; [Saadah, Omar I.] King Abdulaziz Univ, Div Pediat Gastroenterol, Dept Pediat, Fac Med, Jeddah, Saudi Arabia	King Abdulaziz University; King Abdulaziz University; King Abdulaziz University; Ministry of Health - Saudi Arabia; Saudi Aramco; King Abdulaziz University	Elango, R (corresponding author), King Abdulaziz Univ, Dept Genet Med, Fac Med, Jeddah, Saudi Arabia.; Elango, R; Saadah, OI (corresponding author), King Abdulaziz Univ, Princess Al Jawhara Al Brahim Ctr Excellence Res, Jeddah, Saudi Arabia.; Saadah, OI (corresponding author), King Abdulaziz Univ, Div Pediat Gastroenterol, Dept Pediat, Fac Med, Jeddah, Saudi Arabia.	relango@ntlworld.com; osaddah@kau.edu.sa	Banaganapalli, Babajan/A-6282-2013; Saadah, Omar I/G-2068-2011; Elango, Ramu/C-7684-2014; Shaik, Noor ahmad/ABE-4084-2020; Al-aama, Jumana/AAA-8653-2021	Banaganapalli, Babajan/0000-0001-8089-2210; Saadah, Omar I/0000-0002-3744-9907; Elango, Ramu/0000-0003-4264-2135; Shaik, Noor ahmad/0000-0002-7133-656X; Al-Harthi, Sameer/0000-0003-4293-3215	Deanship of Scientific Research (DSR), King Abdulaziz University [HiCi-1434-140-1: OS]; Princess Al-Jawhara Al-Brahim Center of Excellence in Research of Hereditary Disorders (PACER-HD)	Deanship of Scientific Research (DSR), King Abdulaziz University; Princess Al-Jawhara Al-Brahim Center of Excellence in Research of Hereditary Disorders (PACER-HD)	This work was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, under Grant no. HiCi-1434-140-1: OS Received the funding.; All authors sincerely extend their thanks to Princess Al-Jawhara Al-Brahim Center of Excellence in Research of Hereditary Disorders (PACER-HD) for its support in laboratory logistics required for this study. The authors sincerely appreciate Ms. Sana Khadir for her good effort in coordinating with patients and healthy volunteers for sampling and clinical data collection.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Al-Owain M, 2012, AM J MED GENET A, V158A, P2629, DOI 10.1002/ajmg.a.35551; Alkhiary YM, SAUDI J BIOL SCI; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Annette K, 2008, CELIAC DIS; Ashurst JL, 2005, NUCLEIC ACIDS RES, V33, pD459, DOI 10.1093/nar/gki135; Balasopoulou A, 2016, HUM GENOMICS, V10, DOI 10.1186/s40246-016-0091-1; BEUTLER E, 1983, J CLIN INVEST, V72, P648, DOI 10.1172/JCI111014; Candi E, 2004, BIOCHEM J, V381, P313, DOI 10.1042/BJ20031474; Di Sabatino A, 2009, LANCET, V373, P1480, DOI 10.1016/S0140-6736(09)60254-3; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Erzurumluoglu AM, 2016, ANN HUM GENET, V80, P187, DOI 10.1111/ahg.12150; Festen EAM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001283; Garcia-Etxebarria K, 2016, EUR J HUM GENET, V24, P1831, DOI 10.1038/ejhg.2016.120; Garner CP, 2009, HUM MOL GENET, V18, P4219, DOI 10.1093/hmg/ddp364; Gottenberg JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059868; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Gutierrez-Achury J, 2015, NAT GENET, V47, P577, DOI 10.1038/ng.3268; Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767; Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0; Kuja-Halkola R., 2016, GUT; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kumar V, 2012, SEMIN IMMUNOPATHOL, V34, P567, DOI 10.1007/s00281-012-0312-1; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lindahl E, 2006, NUCLEIC ACIDS RES, V34, pW52, DOI 10.1093/nar/gkl082; Lundin KEA, 2015, NAT REV GASTRO HEPAT, V12, P507, DOI 10.1038/nrgastro.2015.136; Makinen N, 2011, SCIENCE, V334, P252, DOI 10.1126/science.1208930; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mistry V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116845; Mustalahti K, 2010, ANN MED, V42, P587, DOI 10.3109/07853890.2010.505931; Ng ASL, 2015, J NEUROIMMUNOL, V287, P31, DOI 10.1016/j.jneuroim.2015.08.009; Ott J, 2015, NAT REV GENET, V16, P275, DOI 10.1038/nrg3908; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Romanos J, 2014, GUT, V63, P415, DOI 10.1136/gutjnl-2012-304110; Saadah OI, 2015, DIS MARKERS, V2015, P1, DOI 10.1155/2015/351673; Saadah OI, 2011, ANN SAUDI MED, V31, P51, DOI 10.4103/0256-4947.75779; Samasca G, 2013, IMMUNOL INVEST, V42, P273, DOI 10.3109/08820139.2013.777074; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Solaroli N, 2009, FEBS LETT, V583, P2872, DOI 10.1016/j.febslet.2009.07.047; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Szperl AM, 2011, CLIN GENET, V80, P138, DOI 10.1111/j.1399-0004.2011.01714.x; Torinsson Naluai A., 2016, GUT; Trynka G, 2010, TRENDS MOL MED, V16, P537, DOI 10.1016/j.molmed.2010.09.003; Van Rompay AR, 1999, EUR J BIOCHEM, V261, P509, DOI 10.1046/j.1432-1327.1999.00294.x; Withoff S, 2016, TRENDS GENET, V32, P295, DOI 10.1016/j.tig.2016.02.003	48	14	14	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0176664	10.1371/journal.pone.0176664	http://dx.doi.org/10.1371/journal.pone.0176664			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505210	Green Published, gold, Green Submitted			2022-12-26	WOS:000401473500008
J	Kim, YK; Kim, SH; Yi, JM; Kang, CK; Short, F; Lee, KS				Kim, Young Kyun; Kim, Seung Hyeon; Yi, Joo Mi; Kang, Chang-Keun; Short, Frederick; Lee, Kun-Seop			Genetic identification and evolutionary trends of the seagrass Halophila nipponica in temperate coastal waters of Korea	PLOS ONE			English	Article							HYDROCHARITACEAE; DNA; ANGIOSPERMS; DIVERSITY; INSIGHTS; THOUARS; OVALIS; RATES	Although seagrass species in the genus Halophila are generally distributed in tropical or subtropical regions, H. nipponica has been reported to occur in temperate coastal waters of the northwestern Pacific. Because H. nipponica occurs only in the warm temperate areas influenced by the Kuroshio Current and shows a tropical seasonal growth pattern, such as severely restricted growth in low water temperatures, it was hypothesized that this temperate Halophila species diverged from tropical species in the relatively recent evolutionary past. We used a phylogenetic analysis of internal transcribed spacer (ITS) regions to examine the genetic variability and evolutionary trend of H. nipponica. ITS sequences of H. nipponica from various locations in Korea and Japan were identical or showed very low sequence divergence (less than 3-base pair, bp, difference), confirming that H. nipponica from Japan and Korea are the same species. Halophila species in the section Halophila, which have simple phyllotaxy (a pair of petiolate leaves at the rhizome node), were separated into five well-supported clades by maximum parsimony analysis. H. nipponica grouped with H. okinawensis and H. gaudichaudii from the subtropical regions in the same clade, the latter two species having quite low ITS sequence divergence from H. nipponica (7-15-bp). H. nipponica in Clade I diverged 2.95 +/- 1.08 million years ago from species in Clade II, which includes H. ovalis. According to geographical distribution and genetic similarity, H. nipponica appears to have diverged from a tropical species like H. ovalis and adapted to warm temperate environments. The results of divergence time estimates suggest that the temperate H. nipponica is an older species than the subtropical H. okinawensis and H. gaudichaudii and they may have different evolutionary histories.	[Kim, Young Kyun; Kim, Seung Hyeon; Lee, Kun-Seop] Pusan Natl Univ, Dept Biol Sci, Busan, South Korea; [Kim, Young Kyun; Kang, Chang-Keun] Gwangju Inst Sci & Technol, Sch Earth Sci & Environm Engn, Gwangju, South Korea; [Yi, Joo Mi] Dongnam Inst Radiol & Med Sci DIRAMS, Res Ctr, Busan, South Korea; [Short, Frederick] Univ New Hampshire, Jackson Estuarine Lab, Durham, NH 03824 USA	Pusan National University; Gwangju Institute of Science & Technology (GIST); Korea Institute of Radiological & Medical Sciences; University System Of New Hampshire; University of New Hampshire	Lee, KS (corresponding author), Pusan Natl Univ, Dept Biol Sci, Busan, South Korea.	klee@pusan.ac.kr	Kang, Chang-Keun/GLR-8512-2022		Ministry of Oceans and Fisheries, Korea; Pusan National University; National Research Foundation of Korea (NRF) - Korean government (MEST) [NRF-2015R1A2A2A01004850]	Ministry of Oceans and Fisheries, Korea; Pusan National University(Pusan National University); National Research Foundation of Korea (NRF) - Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government)	This study was supported by the Ministry of Oceans and Fisheries, Korea (Project title: Longterm changes in structure and function in the marine ecosystems of Korea) to KSL and CKK, Pusan National University to KSL, and a National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST; NRF-2015R1A2A2A01004850) to KSL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDWIN BG, 1995, ANN MO BOT GARD, V82, P247, DOI 10.2307/2399880; den Hartog C, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P1; DenHartog C, 1970, SEA GRASSES WORLD; Dubouzet JG, 1999, THEOR APPL GENET, V98, P422, DOI 10.1007/s001220051088; Gillanders BM, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P503; Hershkovitz MA, 1999, SYST ASSOC SPEC VOL, V57, P268; Kay KM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-36; Kim JB, 2009, AQUAT BOT, V90, P269, DOI 10.1016/j.aquabot.2008.10.007; Kim SH, 2012, MAR BIOL, V159, P255, DOI 10.1007/s00227-011-1804-6; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KROPF M., 2002, VERGLEICHENDE BIOGEO; Kuo John, 2006, Acta Phytotaxonomica et Geobotanica, V57, P129; Les DH, 1997, SYST BOT, V22, P443, DOI 10.2307/2419820; Makino T., 1912, BOT MAG TOKYO, V26, P208, DOI 10.15281/jplantres1887.26.307_208; McRoy C.P., 1997, SEAGRASS ECOSYSTEMS, P53; Miki S., 1934, BOT MAG TOKYO, V48, P131, DOI DOI 10.15281/JPLANTRES1887.48.131; MUKAI H, 1993, AUST J MAR FRESH RES, V44, P1; Nei M., 2000, MOL EVOLUTION PHYLOG; Nguyen VX, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-92; Vy NX, 2013, AQUAT BOT, V110, P6, DOI 10.1016/j.aquabot.2013.04.003; Osathanunkul M, 2015, AFR J BIOTECHNOL, V14, P649, DOI DOI 10.5897/AJB204.13855; Setchell WA, 1920, B TORREY BOT CLUB, V47, P563; SHIMADA S., 2012, COASTAL MARINE SCI, V35, P85; Short F, 2007, J EXP MAR BIOL ECOL, V350, P3, DOI 10.1016/j.jembe.2007.06.012; Short FT, 2011, BIOL CONSERV, V144, P1961, DOI 10.1016/j.biocon.2011.04.010; Short FT, 2010, AQUAT BOT, V93, P141, DOI 10.1016/j.aquabot.2010.05.001; Short FT, 2001, GLOBAL SEAGRASS RESEARCH METHODS, P5, DOI 10.1016/B978-044450891-1/50002-5; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Uchimura M, 2006, BOT MAR, V49, P111, DOI 10.1515/BOT.2006.015; Uchimura Masayuki, 2006, Bulletin of the National Science Museum Series B (Botany), V32, P129; Uchimura M, 2008, BOT MAR, V51, P258, DOI 10.1515/BOT.2008.036; Waycott M, 2002, B MAR SCI, V71, P1299; Waycott M, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P25; WEST RJ, 1990, MAR POLLUT BULL, V21, P197, DOI 10.1016/0025-326X(90)90502-Y; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wissler L, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-8; Nguyen XV, 2015, SYST BIODIVERS, V13, P496, DOI 10.1080/14772000.2015.1046408	37	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177772	10.1371/journal.pone.0177772	http://dx.doi.org/10.1371/journal.pone.0177772			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505209	Green Published, gold, Green Submitted			2022-12-26	WOS:000401473500043
J	Smith, CA; Board, TN; Rooney, P; Eagle, MJ; Richardson, SM; Hoyland, JA				Smith, Christopher A.; Board, Tim N.; Rooney, Paul; Eagle, Mark J.; Richardson, Stephen M.; Hoyland, Judith A.			Human decellularized bone scaffolds from aged donors show improved osteoinductive capacity compared to young donor bone	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; GROWTH-FACTOR-I; OSTEOGENIC DIFFERENTIATION; POTENTIAL IMPLICATIONS; CORTICAL BONE; ALLOGRAFT; MATRIX; ARCHITECTURE; WOMEN; SITE	To improve the safe use of allograft bone, decellularization techniques may be utilized to produce acellular scaffolds. Such scaffolds should retain their innate biological and biomechanical capacity and support mesenchymal stem cell (MSC) osteogenic differentiation. However, as allograft bone is derived from a wide age-range, this study aimed to determine whether donor age impacts on the ability an osteoinductive, acellular scaffold produced from human bone to promote the osteogenic differentiation of bone marrow MSCs (BM-MSC). BM-MSCs from young and old donors were seeded on acellular bone cubes from young and old donors undergoing osteoarthritis related hip surgery. All combinations resulted in increased osteogenic gene expression, and alkaline phosphatase (ALP) enzyme activity, however BM-MSCs cultured on old donor bone displayed the largest increases. BM-MSCs cultured in old donor bone conditioned media also displayed higher osteogenic gene expression and ALP activity than those exposed to young donor bone conditioned media. ELISA and Luminex analysis of conditioned media demonstrated similar levels of bioactive factors between age groups; however, IGF binding protein 1 (IGFBP1) concentration was significantly higher in young donor samples. Additionally, structural analysis of old donor bone indicated an increased porosity compared to young donor bone. These results demonstrate the ability of a decellularized scaffold produced from young and old donors to support osteogenic differentiation of cells from young and old donors. Significantly, the older donor bone produced greater osteogenic differentiation which may be related to reduced IGFBP1 bioavailability and increased porosity, potentially explaining the excellent clinical results seen with the use of allograft from aged donors.	[Smith, Christopher A.; Richardson, Stephen M.; Hoyland, Judith A.] Univ Manchester, Fac Biol Med & Hlth, Sch Biol Sci, Div Cell Matrix Biol & Regenerat Med, Manchester, Lancs, England; [Board, Tim N.] Wrightington Hosp, Wigan, England; [Rooney, Paul; Eagle, Mark J.] NHS Blood & Tissue Transplant Serv, Liverpool, Merseyside, England; [Hoyland, Judith A.] Manchester Acad Hlth Sci Ctr, Cent Manchester Fdn Trust, NIHR Manchester Musculoskeletal Biomed Res Unit, Manchester, Lancs, England	University of Manchester; University of Manchester	Hoyland, JA (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Sch Biol Sci, Div Cell Matrix Biol & Regenerat Med, Manchester, Lancs, England.; Hoyland, JA (corresponding author), Manchester Acad Hlth Sci Ctr, Cent Manchester Fdn Trust, NIHR Manchester Musculoskeletal Biomed Res Unit, Manchester, Lancs, England.	Judith.a.hoyland@manchester.ac.uk	Richardson, Stephen/A-4124-2009; Board, Tim/I-9296-2019; Smith, Christopher Andrew/A-7229-2015	Richardson, Stephen/0000-0002-7637-4135; Board, Tim/0000-0002-3295-2087; Smith, Christopher Andrew/0000-0001-6478-2310	John Charnley Trust; Joint Action; MRC CIC; NHSBT; Wrightington Hospital; National Institute for Health Research Manchester Musculoskeletal Biomedical Research Unit	John Charnley Trust; Joint Action; MRC CIC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHSBT; Wrightington Hospital; National Institute for Health Research Manchester Musculoskeletal Biomedical Research Unit	This work was funded by the John Charnley Trust, Joint Action, MRC CIC (http://www.johncharnleytrust.org/trust/index.html) to TB and JAH, the NHSBT, and Wrightington Hospital. Technical support for this project was funded by the National Institute for Health Research Manchester Musculoskeletal Biomedical Research Unit. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkisson HD, 2000, J ORTHOPAED RES, V18, P503, DOI 10.1002/jor.1100180326; Aerssens J, 1997, J ENDOCRINOL, V155, P411, DOI 10.1677/joe.0.1550411; Boonen S, 1997, CALCIFIED TISSUE INT, V61, P173; Boskey A, 2003, OSTEOPOROSIS INT, V14, pS16, DOI 10.1007/s00198-003-1468-2; CAMPBELL PG, 1991, J CELL PHYSIOL, V149, P293, DOI 10.1002/jcp.1041490216; CHALMERS J, 1959, J BONE JOINT SURG BR, V41, P160, DOI 10.1302/0301-620X.41B1.160; Chaudhary LR, 2004, BONE, V34, P402, DOI 10.1016/j.bone.2003.11.014; Chen H, 2010, OSTEOPOROSIS INT, V21, P627, DOI 10.1007/s00198-009-0993-z; Chen L, 2015, BMB REPORTS; Chen LA, 2010, J BONE MINER RES, V25, P2447, DOI 10.1002/jbmr.133; Chen PY, 2011, J MECH BEHAV BIOMED, V4, P961, DOI 10.1016/j.jmbbm.2011.02.006; Clough BH, 2015, J BONE MINER RES, V30, P83, DOI 10.1002/jbmr.2320; Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057; da Costa LC, 1999, J PERIODONTOL, V70, P562; daCosta FL, 1998, J PERIODONTOL, V69, P470; Delloye C, 2014, ACTA ORTHOP BELG, V80, P196; Dutra TF, 2010, EXP MOL PATHOL, V88, P58, DOI 10.1016/j.yexmp.2009.09.007; Ebraheim N A, 2001, J Am Acad Orthop Surg, V9, P210; Hashimoto Y, 2011, BIOMATERIALS, V32, P7060, DOI 10.1016/j.biomaterials.2011.06.008; JERGESEN HE, 1991, CLIN ORTHOP RELAT R, P253; Kurtz SM, 2014, J BONE JOINT SURG AM, V96A, P624, DOI 10.2106/JBJS.M.00285; Lochmuller EM, 2008, J BONE MINER RES, V23, P1964, DOI [10.1359/jbmr.080709, 10.1359/JBMR.080709]; Luu HH, 2007, J ORTHOP RES, V25, P665, DOI 10.1002/jor.20359; Marcos-Campos I, 2012, BIOMATERIALS, V33, P8329, DOI 10.1016/j.biomaterials.2012.08.013; Mathieu PS, 2012, TISSUE ENG PART B-RE, V18, P436, DOI [10.1089/ten.teb.2012.0014, 10.1089/ten.TEB.2012.0014]; NICOLAS V, 1994, J CLIN ENDOCR METAB, V78, P1011, DOI 10.1210/jc.78.5.1011; NyssenBehets C, 1996, ARCH ORTHOP TRAUM SU, V115, P303, DOI 10.1007/BF00420320; Pietrzak WS, 2006, J CRANIOFAC SURG, V17, P84, DOI 10.1097/01.scs.0000179745.91165.73; Pinholt EM, 1998, J CRANIOFAC SURG, V9, P142, DOI 10.1097/00001665-199803000-00011; Schwartz Z, 1998, J PERIODONTOL, V69, P470, DOI 10.1902/jop.1998.69.4.470; Sicchieri LG, 2012, J TISSUE ENG REGEN M, V6, P155, DOI 10.1002/term.422; Smith CA, 2015, J TISSUE ENG REGEN M, V9, P595, DOI 10.1002/term.1934; Stauber M, 2006, OSTEOPOROSIS INT, V17, P616, DOI 10.1007/s00198-005-0025-6; Traianedes K, 2004, J BIOMED MATER RES B, V70B, P21, DOI 10.1002/jbm.b.30015; Turunen MJ, 2013, BONE, V54, P118, DOI 10.1016/j.bone.2013.01.045; Ueland T, 2003, J CLIN ENDOCR METAB, V88, P1014, DOI 10.1210/jc.2002-020977; Varettas K, 2011, CELL TISSUE BANK, V12, P37, DOI 10.1007/s10561-009-9154-z; Wagner W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005846; Wilkinson A, 2011, ACTA BIOMATER, V7, P2919, DOI 10.1016/j.actbio.2011.03.026; Zhou S, 2008, AGING CELL, V7, P335, DOI 10.1111/j.1474-9726.2008.00377.x; Zimmermann G, 2011, INJURY, V42, pS16, DOI 10.1016/j.injury.2011.06.199	41	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177416	10.1371/journal.pone.0177416	http://dx.doi.org/10.1371/journal.pone.0177416			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505164	Green Published, Green Submitted, gold			2022-12-26	WOS:000401473500020
J	Andersson, K; Dahllof, G; Lindahl, K; Kindmark, A; Grigelioniene, G; Astrom, E; Malmgren, B				Andersson, Kristofer; Dahllof, Goran; Lindahl, Katarina; Kindmark, Andreas; Grigelioniene, Giedre; Astrom, Eva; Malmgren, Barbro			Mutations in COL1A1 and COL1A2 and dental aberrations in children and adolescents with osteogenesis imperfecta - A retrospective cohort study	PLOS ONE			English	Article							GENOTYPE-PHENOTYPE CORRELATIONS; COLLAGEN STRUCTURAL GENES; I COLLAGEN; PAMIDRONATE THERAPY; SWEDISH POPULATION; HELICAL DOMAIN; 2ND MOLAR; BONE MASS; EXPRESSION; TEETH	Osteogenesis imperfecta (OI) is a heterogeneous group of disorders of connective tissue, caused mainly by mutations in the collagen I genes (COL1A1 and COL1A2). Dentinogenesis imperfecta (DGI) and other dental aberrations are common features of OI. We investigated the association between collagen I mutations and DGI, taurodontism, and retention of permanent second molars in a retrospective cohort of 152 unrelated children and adolescents with OI. The clinical examination included radiographic evaluations. Teeth from 81 individuals were available for histopathological evaluation. COL1A1/2 mutations were found in 104 individuals by nucleotide sequencing. DGI was diagnosed clinically and radiographically in 29% of the individuals (44/152) and through isolated histological findings in another 19% (29/152). In the individuals with a COL1A1 mutation, 70% (7/10) of those with a glycine substitution located C-terminal of p. Gly305 exhibited DGI in both dentitions while no individual (0/7) with a mutation N-terminal of this point exhibited DGI in either dentition (p = 0.01). In the individuals with a COL1A2 mutation, 80% (8/10) of those with a glycine substitution located C terminal of p. Gly211 exhibited DGI in both dentitions while no individual (0/5) with a mutation N-terminal of this point (p = 0.007) exhibited DGI in either dentition. DGI was restricted to the deciduous dentition in 20 individuals. Seventeen had missense mutations where glycine to serine was the most prevalent substitution (53%). Taurodontism occurred in 18% and retention of permanent second molars in 31% of the adolescents. Dental aberrations are strongly associated with qualitatively changed collagen I. The varying expressivity of DGI is related to the location of the collagen I mutation. Genotype information may be helpful in identifying individuals with OI who have an increased risk of dental aberrations.	[Andersson, Kristofer; Dahllof, Goran; Malmgren, Barbro] Karolinska Inst, Dept Dent Med, Div Pediat Dent, Huddinge, Sweden; [Dahllof, Goran] Ctr Pediat Oral Hlth Res, Stockholm, Sweden; [Lindahl, Katarina; Kindmark, Andreas] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Grigelioniene, Giedre] Karolinska Univ Hosp, Dept Clin Genet, Stockholm, Sweden; [Grigelioniene, Giedre] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Astrom, Eva] Karolinska Inst, Dept Woman & Child Hlth, Stockholm, Sweden; [Astrom, Eva] Karolinska Univ Hosp, Astrid Lindgren Childrens Hosp, Pediat Neurol & Musculoskeletal Disorders & Home, Stockholm, Sweden	Karolinska Institutet; Uppsala University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Andersson, K (corresponding author), Karolinska Inst, Dept Dent Med, Div Pediat Dent, Huddinge, Sweden.	kristofer.andersson@ki.se	Grigelioniene, Giedre/N-6599-2013; Grigelioniene, Giedre/AAH-8408-2020	Grigelioniene, Giedre/0000-0001-9601-3137; Grigelioniene, Giedre/0000-0001-9601-3137; Dahllof, Goran/0000-0001-8536-5292	American Dental Society of Sweden (ADSS); Swedish Endocrine Society; Uppsala County Council; Stiftelsen Promobilia and Stockholm County Council; Stockholm County Council	American Dental Society of Sweden (ADSS); Swedish Endocrine Society; Uppsala County Council; Stiftelsen Promobilia and Stockholm County Council; Stockholm County Council(Stockholm County Council)	KA has been supported by grants from the American Dental Society of Sweden (ADSS) (http://www.adss.se/) and Svenska Tandlakare-Sallskapet (https://tandlakarforbundet.setforskning/svenska-tandlakare-sallskapet/); and KL was supported by the Swedish Endocrine Society (http://endokrinelogforeningen.se/). AK received grants from Uppsala County Council (ALF project). GG has been supported by Stiftelsen Promobilia (http://www.promobilia.se) and Stockholm County Council (ALF project). EA has been supported by Stockholm County Council (ALF project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDUJAR MB, 1991, DEVELOPMENT, V111, P691; Astrom E, 1998, ACTA PAEDIATR, V87, P64; Axelsson Stefan, 2005, Swed Dent J Suppl, P3; Backman B, 2001, Int J Paediatr Dent, V11, P11, DOI 10.1046/j.1365-263x.2001.00205.x; Bardai G, 2016, OSTEOPOROS INT; Bondernark L, 2007, ANGLE ORTHOD, V77, P773, DOI 10.2319/072506-306.1; Chang PC, 2007, EUR J ORTHODONT, V29, P232, DOI 10.1093/ejo/cjl035; da Fontoura CSG, 2015, J DENT RES, V94, P913, DOI 10.1177/0022034515581643; Dalgleish R, 1998, NUCLEIC ACIDS RES, V26, P253, DOI 10.1093/nar/26.1.253; Dalgleish R, 1997, NUCLEIC ACIDS RES, V25, P181, DOI 10.1093/nar/25.1.181; Farman A G, 1978, Br J Orthod, V5, P93; Forlino A, 2000, MOL GENET METAB, V71, P225, DOI 10.1006/mgme.2000.3039; Glorieux FH, 1998, NEW ENGL J MED, V339, P947, DOI 10.1056/NEJM199810013391402; Gupta Saurabh K, 2011, J Oral Sci, V53, P231; Islam M, 2005, ORAL SURG ORAL MED O, V100, P736, DOI 10.1016/j.tripleo.2005.04.017; JASPERS MT, 1981, ORAL SURG ORAL MED O, V51, P632, DOI 10.1016/S0030-4220(81)80014-X; Jensen BL, 1997, J CRAN GENET DEV BIO, V17, P121; Joseph M, 2008, ORAL SURG ORAL MED O, V105, P670, DOI 10.1016/j.tripleo.2007.11.015; Lindahl K, 2015, EUR J HUM GENET, V23, P1042, DOI 10.1038/ejhg.2015.81; Lindahl K, 2011, HUM MUTAT, V32, P598, DOI 10.1002/humu.21475; Luder HU, 1996, J CRAN GENET DEV BIO, V16, P156; LUKINMAA PL, 1987, J CRAN GENET DEV BIO, V7, P115; LUKINMAA PL, 1987, J CRAN GENET DEV BIO, V7, P127; LUKINMAA PL, 1992, J DENT RES, V71, P36, DOI 10.1177/00220345920710010601; Lund AM, 1998, J CRAN GENET DEV BIO, V18, P30; Lund AM, 1996, CLIN GENET, V50, P304; Magnusson C, 2009, ANGLE ORTHOD, V79, P422, DOI 10.2319/021908-97.1; Malmgren B, 2017, ORAL DIS, V23, P42, DOI 10.1111/odi.12568; Malmgren B, 2002, ACTA ODONTOL SCAND, V60, P65, DOI 10.1080/000163502753509446; Malmgren Barbro, 2003, Acta Odontologica Scandinavica, V61, P72, DOI 10.1080/00016350310001398; Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429; O'Connell AC, 1999, ORAL SURG ORAL MED O, V87, P189, DOI 10.1016/S1079-2104(99)70272-6; ORMISTON IW, 1995, J CRANIO MAXILL SURG, V23, P261, DOI 10.1016/S1010-5182(05)80219-7; Rauch F, 2003, J BONE MINER RES, V18, P610, DOI 10.1359/jbmr.2003.18.4.610; Rauch F, 2003, J CLIN ENDOCR METAB, V88, P986, DOI 10.1210/jc.2002-021371; Rauch F, 2010, J BONE MINER RES, V25, P1367, DOI 10.1359/jbmr.091109; Rauch F, 2010, EUR J HUM GENET, V18, P642, DOI 10.1038/ejhg.2009.242; SCHWARTZ S, 1984, ORAL SURG ORAL MED O, V57, P161, DOI 10.1016/0030-4220(84)90206-8; Shaw JCM, 1928, J ANAT, V62, P476; SILLENCE DO, 1979, J MED GENET, V16, P101, DOI 10.1136/jmg.16.2.101; STENVIK A, 1985, SCAND J DENT RES, V93, P56; SYKES B, 1986, LANCET, V2, P69; Thilander B, 2005, EUR J ORTHODONT, V27, P370, DOI 10.1093/ejo/cji033; VARPIO M, 1988, J DENT CHILD, V55, P114; WALLIS GA, 1993, J MED GENET, V30, P492, DOI 10.1136/jmg.30.6.492; Waltimo-Siren J, 2005, AM J MED GENET A, V133A, P142, DOI 10.1002/ajmg.a.30523; WENSTRUP RJ, 1990, AM J HUM GENET, V46, P975; WILLING MC, 1992, AM J HUM GENET, V51, P508; Willing MC, 1996, AM J HUM GENET, V59, P799; WITKOP CJ, 1971, ORAL SURG ORAL MED O, V32, P278, DOI 10.1016/0030-4220(71)90232-5	50	44	46	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0176466	10.1371/journal.pone.0176466	http://dx.doi.org/10.1371/journal.pone.0176466			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498836	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314500005
J	Birger, RB; Le, T; Kouyos, RD; Grenfell, BT; Hallett, TB				Birger, Ruthie B.; Thuy Le; Kouyos, Roger D.; Grenfell, Bryan T.; Hallett, Timothy B.			The impact of HCV therapy in a high HIV-HCV prevalence population: A modeling study on people who inject drugs in Ho Chi Minh City, Vietnam	PLOS ONE			English	Article							HEPATITIS-C VIRUS; HIGH-RISK; INFECTION; USERS; COINFECTION; EPIDEMIOLOGY; MEN; TRANSMISSION; REINFECTION; CLEARANCE	Background Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) coinfection is a major global health problem especially among people who inject drugs (PWID), with significant clinical implications. Mathematical models have been used to great effect to shape HIV care, but few have been proposed for HIV/HCV. Methods We constructed a deterministic compartmental ODE model that incorporated layers for HIV disease progression, HCV disease progression and PWID demography. Antiretroviral therapy (ART) and Methadone Maintenance Therapy (MMT) scale-ups were modeled as from 2016 and projected forward 10 years. HCV treatment roll-out was modeled beginning in 2026, after a variety of MMT scale-up scenarios, and projected forward 10 years. Results Our results indicate that scale-up of ART has a major impact on HIV though not on HCV burden. MMT scale-up has an impact on incidence of both infections. HCV treatment roll-out has a measurable impact on reductions of deaths, increasing multifold the mortality reductions afforded by just ART/MMT scale-ups. Conclusion HCV treatment roll-out can have major and long-lasting effects on averting PWID deaths on top of those averted by ART/MMT scale-up. Efficient intervention scale-up of HCV alongside HIV interventions is critical in Vietnam.	[Birger, Ruthie B.; Grenfell, Bryan T.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Birger, Ruthie B.] Columbia Univ, Dept Environm Hlth Sci, Mailman Sch Publ Hlth, New York, NY 10027 USA; [Thuy Le] Univ Oxford, Clin Res Unit, Ho Chi Minh City, Vietnam; [Kouyos, Roger D.] Univ Zurich, Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland; [Grenfell, Bryan T.] NIH, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA; [Hallett, Timothy B.] Imperial Coll London, Dept Infect Dis Epidemiol, London, England	Princeton University; Columbia University; University of Oxford; University of Zurich; University Zurich Hospital; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Imperial College London	Birger, RB (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.; Birger, RB (corresponding author), Columbia Univ, Dept Environm Hlth Sci, Mailman Sch Publ Hlth, New York, NY 10027 USA.	ruthie.birger@gmail.com	Birger, Ruthie/F-2416-2014; Kouyos, Roger/ABB-2291-2021; Kouyos, Roger/G-6226-2014	Birger, Ruthie/0000-0002-2960-5084; Kouyos, Roger/0000-0002-9220-8348; Kouyos, Roger/0000-0002-9220-8348; Hallett, Timothy/0000-0002-9681-0424	Princeton University Department of Ecology and Evolutionary Biology; Princeton University Center for Health and Well-Being; Wellcome Trust; Hawaii Center for AIDS; Bill and Melinda Gates Foundation; RAPIDD program of the Science and Technology Directorate, NIH; U.S. Department of Homeland Security, NIH; Fogarty International Center, NIH; Family Health International; Medical Research Council [G1100682, MR/K010174/1B] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD047879] Funding Source: NIH RePORTER; MRC [G1100682] Funding Source: UKRI	Princeton University Department of Ecology and Evolutionary Biology(Princeton University); Princeton University Center for Health and Well-Being; Wellcome Trust(Wellcome TrustEuropean Commission); Hawaii Center for AIDS; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); RAPIDD program of the Science and Technology Directorate, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Homeland Security, NIH; Fogarty International Center, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Family Health International; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	RBB was supported by the Princeton University Department of Ecology and Evolutionary Biology and the Princeton University Center for Health and Well-Being. TL is supported by the Wellcome Trust and the Hawaii Center for AIDS. BTG is supported by the Bill and Melinda Gates Foundation and the RAPIDD program of the Science and Technology Directorate, U.S. Department of Homeland Security, and the Fogarty International Center, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Masaya Kato, Nguyen To Nhu, and Family Health International for their support, and in particular their help with data acquisition. We also thank Maciej Boni, Jon Zelner, Jonathan Dushoff, David Wilson, Pejman Rohani, Andrea Graham, C. Jessica E. Metcalf, Simon Levin and the HIV Modelling Consortium for valuable insight and discussions.	Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; Andreoni M, 2012, EUR REV MED PHARMACO, V16, P1473; [Anonymous], 2010, RES PROGR EV PAT IN; [Anonymous], 2014, NATURE MED, V20, P319, DOI 10.1038/nm.3538; Badri M, 2006, ANTIVIR THER, P63; Barth H, 2011, HEPATOLOGY, V54, P1135, DOI 10.1002/hep.24489; Birger R, 2015, EPIDEMICS-NETH, V12, P1, DOI 10.1016/j.epidem.2015.04.001; Birger RB, 2014, CLIN INFECT DIS, V58, P274, DOI 10.1093/cid/cit687; Chinh NT, 2010, CROI; Clatts MC, 2010, J URBAN HEALTH, V87, P278, DOI 10.1007/s11524-009-9417-9; Collins S., 2013, PIPELINE ORAL HCV DR; Cremin I, 2013, AIDS, V27, P447, DOI 10.1097/QAD.0b013e32835ca2dd; Cunningham EB, 2015, NAT REV GASTRO HEPAT, V12, P218, DOI 10.1038/nrgastro.2015.36; Danta M, 2007, AIDS, V21, P983, DOI 10.1097/QAD.0b013e3281053a0c; de Vos AS, 2012, EPIDEMICS-NETH, V4, P57, DOI 10.1016/j.epidem.2012.01.001; Di Martino V, 2001, HEPATOLOGY, V34, P1193, DOI 10.1053/jhep.2001.29201; Do TN, 2013, INT AIDS SOC C KUAL; Durier N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034548; Fernandez-Montero J. V., 2013, Current Hepatitis Reports, V12, P269, DOI 10.1007/s11901-013-0179-1; FHI360 USAID, 2011, EFF EV PIOL PROGR OP; Foster GR, 2016, J HEPATOL, V64, P1224, DOI 10.1016/j.jhep.2016.01.029; Grebely J, 2012, LANCET INFECT DIS, V12, P408, DOI 10.1016/S1473-3099(12)70010-5; Hill A, 2014, CLIN INFECT DIS, V58, P928, DOI 10.1093/cid/ciu012; Hirschler B, 2014, GILEAD OFFERS EGYPT; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Kamarulzaman A, 2015, INT J DRUG POLICY, V26, pS33, DOI 10.1016/j.drugpo.2014.11.011; Kato M, 1999, J ACQUIRED IMMUNE DE; Keating GM, 2014, DRUGS, V74, P273, DOI 10.1007/s40265-014-0179-7; Kwon JA, 2009, JAIDS-J ACQ IMM DEF, V51, P462, DOI 10.1097/QAI.0b013e3181a2539a; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Martin NK, 2011, J HEPATOL, V54, P1137, DOI 10.1016/j.jhep.2010.08.029; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Mehta SJ, 2014, CLEV CLIN J MED, V81, P173, DOI 10.3949/ccjm.81a.14010; Mudecins du Monde and Treatment Action Group, 2016, MAPCROWD ONL GLOB DA; Nadol P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118304; NAKATA S, 1994, J GASTROEN HEPATOL, V9, P416, DOI 10.1111/j.1440-1746.1994.tb01265.x; National Committee for Aids Drugs Control and Prostitution Prevention UNAIDS, 2012, VIET NAM AIDS RESP P; [National Institute of Hygiene and Epidemiology Family Health International Viet Nam Administration of HIV/AIDS Control United States Agency for International Development], 2006, RES HIV STI INT BIOL; National Institute of Hygiene and Epidemiology and Family Health International Vietnam, 2009, RES HIV STI INT BIOL; Nguyen VT, 2008, ADDICTION, V103, P535, DOI 10.1111/j.1360-0443.2007.02122.x; Phan HTT, 2009, HEPATITIS C HUMAN IM; Price JC, 2010, CLIN GASTROENTEROL H, V8, P1002, DOI 10.1016/j.cgh.2010.08.024; Quan VM, 2010, ADDICTION, V106, P583, DOI DOI 10.1111/J.1360-0443.2010.03175.X; Quan VM, 2008, PUBLIC HLTH ASPECTS, P457; Quan VM, 2009, AIDS CARE, V21, P7, DOI 10.1080/09540120802017610; Rangarajan S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108939; Rangsin R, 2004, JAIDS-J ACQ IMM DEF, V36, P622, DOI 10.1097/00126334-200405010-00011; Rotman Y, 2009, J VIROL, V83, P7366, DOI 10.1128/JVI.00191-09; Sereno L, 2012, J INT ASS PHYS AIDS; Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375; Khuat TH, 2012, HARM REDUCT J, V9, DOI 10.1186/1477-7517-9-25; Vuong T, 2012, INT J DRUG POLICY, V23, P319, DOI 10.1016/j.drugpo.2011.11.005; Hoang TV, 2015, HARM REDUCT J, V12, DOI 10.1186/s12954-015-0075-9; VAAC UNAIDS World Bank University of New South Wales Partnership for Epidemic Analysis, 2011, PARTN EP AN EV EP IM; van de Laar TJW, 2010, AIDS, V24, P1799, DOI 10.1097/QAD.0b013e32833c11a5; Vickerman P, 2009, SEX TRANSM INFECT, V85, P23, DOI 10.1136/sti.2008.034660; Vietnam Authority of HIV/AIDS Control, 2012, VIETN HIV AIDS DAT; Vietnam Ministry of Health, 2012, VIET NAM HIV AIDS ES; Vietnam Ministry of Health, 2016, ISS TECHN GUID HCV D; Vogel M, 2011, CURR OPIN INFECT DIS, V24, P1, DOI 10.1097/QCO.0b013e3283422e09; Wilson DP, 2011, EVALUATION EPIDEMIOL; World Health Organization, 2015, HEP C FACT SHEET	63	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177195	10.1371/journal.pone.0177195	http://dx.doi.org/10.1371/journal.pone.0177195			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493917	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000401314300070
J	Blair, DP; Blanchard, W; Banks, SC; Lindenmayer, DB				Blair, David P.; Blanchard, Wade; Banks, Sam C.; Lindenmayer, David B.			Non-linear growth in tree ferns, Dicksonia antarctica and Cyathea australis	PLOS ONE			English	Article							EUCALYPT FOREST; EPIPHYTIC FERNS; FIRE; ECOLOGY; AGE; PERSISTENCE; DISTURBANCE; DEMOGRAPHY; VICTORIA; HABITAT	Tree ferns are an important structural component of forests in many countries. However, because their regeneration is often unrelated to major disturbances, their age is often difficult to determine. In addition, rates of growth may not be uniform, which further complicates attempts to determine their age. In this study, we measured 5 years of growth of Cyathea australis and Dicksonia antarctica after a large wildfire in 2009 in south-eastern Australia. We found growth rates of these two species were unaffected by aspect and elevation but slope had a minor effect with D. antarctica growing 0.3mm faster for each additional degree of slope. Geographic location influenced growth in both species by up to 12 14mm/yr. The most consistent factor influencing growth rate, however, was initial height at the time of the 2009 fire; a finding consistent in both species and all geographic locations. For both tree fern species, individuals that were taller at the commencement of the study had greater overall growth for the duration of the study. This effect did not decrease even among the tallest tree ferns in our study (up to 6 metres tall). Overall, Cyathea australis averaged 73 (+/- 22) mm/year of growth (+/- 1SD), with the rate increasing 5mm/yr per metre of additional height. Dicksonia antarctica averaged 33 (+/- 13) mm/year, increasing by 6mm/yr/m. Growth rates dependent on initial height were unexpected and we discuss possible reasons for this finding. Variable growth rates also suggest that common age estimation methods of dividing height by average growth rate are likely to underestimate the age of short tree ferns, while overestimating the age of tall tree ferns, particularly if they have been subject to a fire.	[Blair, David P.; Blanchard, Wade; Banks, Sam C.; Lindenmayer, David B.] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia; [Blair, David P.; Blanchard, Wade; Banks, Sam C.; Lindenmayer, David B.] Australian Natl Univ, Fenner Sch Environm & Soc, Long Term Ecol Res Network, Canberra, ACT, Australia	Australian National University; Australian National University	Blair, DP (corresponding author), Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia.; Blair, DP (corresponding author), Australian Natl Univ, Fenner Sch Environm & Soc, Long Term Ecol Res Network, Canberra, ACT, Australia.	david.blair@anu.edu.au	Lindenmayer, David B/P-7183-2017; /K-4907-2012	Lindenmayer, David B/0000-0002-4766-4088; /0000-0003-2415-0057	Australian Research Council; Victorian Government (Department of Environment, Land, Water and Planning); Victorian Government (Parks Victoria); Wood Foundation; Long Term Ecological Research Network (LTERN); Terrestrial Ecosystem Research Network (TERN)	Australian Research Council(Australian Research Council); Victorian Government (Department of Environment, Land, Water and Planning); Victorian Government (Parks Victoria); Wood Foundation; Long Term Ecological Research Network (LTERN); Terrestrial Ecosystem Research Network (TERN)	This work was funded by the Australian Research Council, Victorian Government (Department of Environment, Land, Water and Planning and Parks Victoria), Wood Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Academic Editor of PLOS ONE, Sergio Rossi and the four anonymous reviewers for their thoughtful comments which improved the manuscript. We also thank the Long Term Ecological Research Network (LTERN) and the Terrestrial Ecosystem Research Network (TERN) for their support of our research.	Arens NC, 2000, AM FERN J, V90, P1, DOI 10.2307/1547257; Arens NC, 2001, AM J BOT, V88, P545, DOI 10.2307/2657118; ASH J, 1987, AUST J BOT, V35, P331, DOI 10.1071/BT9870331; Ashton D, 1982, SPECIAL PUBLICATION; ASHTON DH, 1986, AUST J BOT, V34, P107, DOI 10.1071/BT9860107; ATTIWILL PM, 1987, FOREST SOILS NUTR CY; Australian Bureau of Meteorology, 2017, ANN AV SEAS MONTHL R; Australian Bureau of Meteorology, 2017, ANN AV MONTL DAYS RA; Australian Bureau of Meteorology, 2016, CLIM WEATH; Benyon RG, 2013, FOREST ECOL MANAG, V294, P197, DOI 10.1016/j.foreco.2012.04.003; Berry LE, 2015, ECOL APPL, V25, P2337, DOI [10.1890/14-1699.1.sm, 10.1890/14-1699.1]; BITTNER J, 1995, AM FERN J, V85, P37, DOI 10.2307/1547463; Blair D, 2016, UNPUB; Blair DP, 2016, ECOL APPL, V26, P2280, DOI 10.1002/eap.1369; Brock JMR, 2016, FOREST ECOL MANAG, V375, P112, DOI 10.1016/j.foreco.2016.05.030; Bystriakova N, 2011, J VEG SCI, V22, P72, DOI 10.1111/j.1654-1103.2010.01227.x; Conant DS, 1995, AM FERN J, V85, P328, DOI 10.2307/1547813; Coomes DA, 2005, J ECOL, V93, P918, DOI 10.1111/j.1365-2745.2005.01012.x; Dignan P, 2003, FOREST ECOL MANAG, V172, P161, DOI 10.1016/S0378-1127(01)00810-6; Fedrigo M, 2014, FOREST ECOL MANAG, V334, P129, DOI 10.1016/j.foreco.2014.08.025; FERWERDA F, 1981, Proceedings of the Royal Society of Victoria, V93, P1; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hunt MA, 2002, AUSTRAL ECOL, V27, P360, DOI 10.1046/j.1442-9993.2002.01190.x; Jemison M., 2012, ASSESSING IMPACT 200; Jones MM, 2007, J VEG SCI, V18, P13, DOI 10.1111/j.1654-1103.2007.tb02511.x; Korall P, 2014, J BIOGEOGR, V41, P402, DOI 10.1111/jbi.12222; Large MF., 2004, TREE FERNS; Lee PH, 2009, J PLANT RES, V122, P61, DOI 10.1007/s10265-008-0191-7; Lindenmayer D, 2015, MOUNTAIN ASH: FIRE, LOGGING AND THE FUTURE OF VICTORIA'S GIANT FORESTS, P1; Lindenmayer DB, 2006, CONSERV BIOL, V20, P1005, DOI 10.1111/j.1523-1739.2006.00501.x; LINDENMAYER DB, 1994, BIOL CONSERV, V68, P43, DOI 10.1016/0006-3207(94)90545-2; Lindenmayer DB, 2000, FOREST ECOL MANAG, V134, P189, DOI 10.1016/S0378-1127(99)00257-1; McCarthy MA, 1999, FOREST ECOL MANAG, V124, P193, DOI 10.1016/S0378-1127(99)00066-3; Moran RC, 2003, BIOTROPICA, V35, P48, DOI 10.1111/j.1744-7429.2003.tb00261.x; Mueck SG, 1996, AUST J ECOL, V21, P345, DOI 10.1111/j.1442-9993.1996.tb00619.x; Nagano T, 2007, TROPICS, V16, P47, DOI 10.3759/tropics.16.47; Neyland M.G., 1986, CONSERVATION MANAGEM; Ough K, 2004, FOREST ECOL MANAG, V199, P153, DOI 10.1016/j.foreco.2004.05.030; Page C, 1981, ECOLOGICAL BIOGEOGRA; Peacock R, 1995, DIVISION SILVICULTUR; Pharo EJ, 2013, FOREST ECOL MANAG, V296, P24, DOI 10.1016/j.foreco.2013.01.018; POPE AIRINI, 1926, NEW ZEALAND JOUR SCI & TECH, V8, P85; R Core Team, 2013, R LANG ENV STAT COMP; Roberts NR, 2005, AUSTRAL ECOL, V30, P146, DOI 10.1111/j.1442-9993.2005.01440.x; Schmitt JL, 2006, AM FERN J, V96, P103, DOI 10.1640/0002-8444(2006)96[103:GRAAEO]2.0.CO;2; Seebeck J.H., 1984, P145; TANNER EVJ, 1983, BOT J LINN SOC, V87, P213, DOI 10.1111/j.1095-8339.1983.tb00991.x; Volkova L, 2011, ENVIRON EXP BOT, V70, P11, DOI 10.1016/j.envexpbot.2010.06.001; Volkova L, 2009, AUST J BOT, V57, P562, DOI 10.1071/BT09153; Volkova L, 2009, FUNCT PLANT BIOL, V36, P1046, DOI 10.1071/FP09098; Walsh N.G., 1994, FLORA VICTORIA	51	11	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176908	10.1371/journal.pone.0176908	http://dx.doi.org/10.1371/journal.pone.0176908			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493884	gold, Green Published, Green Submitted			2022-12-26	WOS:000401314300041
J	Gargallo-Garriga, A; Wright, SJ; Sardans, J; Perez-Trujillo, M; Oravec, M; Vecerova, K; Urban, O; Fernandez-Martinez, M; Parella, T; Penuelas, J				Gargallo-Garriga, Albert; Wright, S. Joseph; Sardans, Jordi; Perez-Trujillo, Miriam; Oravec, Michal; Vecerova, Kristyna; Urban, Otmar; Fernandez-Martinez, Marcos; Parella, Teodor; Penuelas, Josep			Long-term fertilization determines different metabolomic profiles and responses in saplings of three rainforest tree species with different adult canopy position	PLOS ONE			English	Article							PHOSPHORUS FERTILIZATION; ELEMENTAL COMPOSITION; NUTRIENT LIMITATION; LITTER PRODUCTION; YOUNG LEAVES; NITROGEN; LOWLAND; GROWTH; FOLIAR; LIGHT	Background Tropical rainforests are frequently limited by soil nutrient availability. However, the response of the metabolic phenotypic plasticity of trees to an increase of soil nutrient availabilities is poorly understood. We expected that increases in the ability of a nutrient that limits some plant processes should be detected by corresponding changes in plant metabolome profile related to such processes. Methodology/Principal findings We studied the foliar metabolome of saplings of three abundant tree species in a 15 year field NPK fertilization experiment in a Panamanian rainforest. The largest differences were among species and explained 75% of overall metabolome variation. The saplings of the large canopy species, Tetragastris panamensis, had the lowest concentrations of all identified amino acids and the highest concentrations of most identified secondary compounds. The saplings of the "mid canopy" species, Alseis blackiana, had the highest concentrations of amino acids coming from the biosynthesis pathways of glycerate-3P, oxaloacetate and alpha-ketoglutarate, and the saplings of the low canopy species, Heisteria concinna, had the highest concentrations of amino acids coming from the pyruvate synthesis pathways. Conclusions/Significance The changes in metabolome provided strong evidence that different nutrients limit different species in different ways. With increasing P availability, the two canopy species shifted their metabolome towards larger investment in protection mechanisms, whereas with increasing N availability, the sub-canopy species increased its primary metabolism. The results highlighted the proportional distinct use of different nutrients by different species and the resulting different metabolome profiles in this high diversity community are consistent with the ecological niche theory.	[Gargallo-Garriga, Albert; Sardans, Jordi; Fernandez-Martinez, Marcos; Penuelas, Josep] Global Ecol Unit CREAF CEAB CSIC UAB, CSIC, Cerdanyola Del Valles, Catalonia, Spain; [Gargallo-Garriga, Albert; Sardans, Jordi; Fernandez-Martinez, Marcos; Penuelas, Josep] CREAF, Cerdanyola Del Valles, Catalonia, Spain; [Gargallo-Garriga, Albert; Perez-Trujillo, Miriam; Parella, Teodor] Univ Autonoma Barcelona, Fac Sci & Biosci, Serv Ressonancia Magnet Nucl, Barcelona, Catalonia, Spain; [Wright, S. Joseph] Smithsonian Trop Res Inst, Balboa, Panama; [Oravec, Michal; Vecerova, Kristyna; Urban, Otmar] Czech Acad Sci, Global Change Res Inst, Brno, Czech Republic	Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Autonomous University of Barcelona; Smithsonian Institution; Smithsonian Tropical Research Institute; Czech Academy of Sciences; Global Change Research Centre of the Czech Academy of Sciences	Gargallo-Garriga, A (corresponding author), Global Ecol Unit CREAF CEAB CSIC UAB, CSIC, Cerdanyola Del Valles, Catalonia, Spain.; Gargallo-Garriga, A (corresponding author), CREAF, Cerdanyola Del Valles, Catalonia, Spain.; Gargallo-Garriga, A (corresponding author), Univ Autonoma Barcelona, Fac Sci & Biosci, Serv Ressonancia Magnet Nucl, Barcelona, Catalonia, Spain.	albert.gargallo@mail.com	Martínez, Marcos Fernández/I-7240-2012; Wright, Stuart Joseph/M-3311-2013; Penuelas, Josep/D-9704-2011; Oravec, Michal/G-9681-2014; PEREZ-TRUJILLO, MIRIAM/I-6349-2012; Urban, Otmar/J-7432-2012; Coll, Teodor Parella/A-5371-2008; Sardans, Jordi/AEM-0228-2022	Martínez, Marcos Fernández/0000-0002-5661-3610; Wright, Stuart Joseph/0000-0003-4260-5676; Penuelas, Josep/0000-0002-7215-0150; Oravec, Michal/0000-0002-2506-5826; PEREZ-TRUJILLO, MIRIAM/0000-0002-6919-7417; Urban, Otmar/0000-0002-1716-8876; Coll, Teodor Parella/0000-0002-1914-2709; Sardans, Jordi/0000-0003-2478-0219	European Research Council Synergy [ERC-2013SyG-610028 IMBALANCE-P]; Spanish Government [CGL2013-48074-P, CTQ2012-32436]; Catalan Government [SGR 2014-274]; Scholarly Studies program of the Smithsonian Institution; Academy of Sciences of the Czech Republic [M200871201]; Ministry of Education, Youth and Sports of the Czech Republic [LO1415]	European Research Council Synergy; Spanish Government(Spanish GovernmentEuropean Commission); Catalan Government; Scholarly Studies program of the Smithsonian Institution; Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	This research was supported by the European Research Council Synergy grant ERC-2013-SyG-610028 IMBALANCE-P, the Spanish Government grants CGL2013-48074-P, CTQ2012-32436, and the Catalan Government grant SGR 2014-274, the Scholarly Studies program of the Smithsonian Institution, the projects M200871201 (Academy of Sciences of the Czech Republic) and LO1415 (Ministry of Education, Youth and Sports of the Czech Republic).	Ameh SJ, 2012, ANEMIA, V2012, DOI 10.1155/2012/607436; BEGGS CJ, 1985, PLANT PHYSIOL, V79, P630, DOI 10.1104/pp.79.3.630; Beggs JJ, 1986, J IND RELAT, V2, P137; Bernhardsson C, 2013, ECOL LETT, V16, P791, DOI 10.1111/ele.12114; Binkley D, 2000, FOREST ECOL MANAG, V128, P241, DOI 10.1016/S0378-1127(99)00138-3; Carreno-Quintero N, 2013, TRENDS GENET, V29, P41, DOI 10.1016/j.tig.2012.09.006; Cheynier V, 2013, PLANT PHYSIOL BIOCH, V72, P1, DOI 10.1016/j.plaphy.2013.05.009; Coelho GC, 2007, BIOCHEM SYST ECOL, V35, P75, DOI 10.1016/j.bse.2006.09.001; Corre MD, 2010, ECOLOGY, V91, P1715, DOI 10.1890/09-0274.1; Eckert AJ, 2012, NEW PHYTOL, V193, P890, DOI 10.1111/j.1469-8137.2011.03976.x; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Estiarte M., 1999, ORSIS, V14, P159; Fernandez-Martinez M, 2014, NAT CLIM CHANGE, V4, P471, DOI [10.1038/nclimate2177, 10.1038/NCLIMATE2177]; Fiehn O, 2000, NAT BIOTECHNOL, V18, P1157, DOI 10.1038/81137; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Gargallo-Garriga A, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0767-7; Gargallo-Garriga A, 2015, NEW PHYTOL, V207, P591, DOI 10.1111/nph.13377; Gargallo-Garriga A, 2014, SCI REP-UK, V4, DOI 10.1038/srep06829; Ghasemzadeh A, 2011, J MED PLANTS RES, V5, P6697, DOI 10.5897/JMPR11.1404; Gianoli E, 2013, OECOLOGIA, V173, P13, DOI 10.1007/s00442-013-2590-2; Gil M, 2012, PHYTOCHEMISTRY, V77, P89, DOI 10.1016/j.phytochem.2011.12.011; Grassi G, 2000, TREE PHYSIOL, V20, P645; Gyimah R, 2007, NEW FOREST, V33, P217, DOI 10.1007/s11056-006-9028-1; HAHLBROCK K, 1981, PLANT PHYSIOL, V67, P768, DOI 10.1104/pp.67.4.768; Hedin LO, 2003, ECOLOGY, V84, P2231, DOI 10.1890/02-4066; Kitajima K, 2002, FUNCT ECOL, V16, P433, DOI 10.1046/j.1365-2435.2002.00641.x; Klem K, 2015, PLANT PHYSIOL BIOCH, V93, P74, DOI 10.1016/j.plaphy.2015.01.001; Lambers H, 2008, TRENDS ECOL EVOL, V23, P95, DOI 10.1016/j.tree.2007.10.008; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; Leiss KA, 2011, PHYTOCHEM REV, V10, P205, DOI 10.1007/s11101-010-9175-z; LI JY, 1993, PLANT CELL, V5, P171, DOI 10.1105/tpc.5.2.171; LOIS R, 1994, PLANTA, V194, P498, DOI 10.1007/BF00714462; Lokvam J, 2005, J CHEM ECOL, V31, P2563, DOI 10.1007/s10886-005-7614-x; Lokvam J, 2004, PHYTOCHEMISTRY, V65, P351, DOI 10.1016/j.phytochem.2003.11.012; Marino G, 2010, FUNCT ECOL, V24, P263, DOI 10.1111/j.1365-2435.2009.01630.x; Martz F, 2010, J CHEM ECOL, V36, P1017, DOI 10.1007/s10886-010-9836-9; Mayor JR, 2014, J ECOL, V102, P36, DOI 10.1111/1365-2745.12190; Montero-Vargas JM, 2013, MOL BIOSYST, V9, P693, DOI 10.1039/c3mb25509c; Mirmanto E, 1999, PHILOS T ROY SOC B, V354, P1825, DOI 10.1098/rstb.1999.0524; Nguyen HTM, 2013, PLANT PHYSIOL BIOCH, V73, P23, DOI 10.1016/j.plaphy.2013.07.018; Niinemets U, 1997, FUNCT ECOL, V11, P518, DOI 10.1046/j.1365-2435.1997.00109.x; Paoli GD, 2007, ECOSYSTEMS, V10, P503, DOI 10.1007/s10021-007-9042-y; Pasquini SC, 2012, OECOLOGIA, V168, P311, DOI 10.1007/s00442-011-2099-5; Pasquini SC, 2014, ECOLOGY, V96; Penuelas J, 2010, GLOBAL CHANGE BIOL, V16, P2171, DOI 10.1111/j.1365-2486.2009.02054.x; Penuelas J, 2009, CHEM ECOL, V25, P305, DOI 10.1080/02757540903062517; Penuelas J, 2009, NATURE, V460, P803, DOI 10.1038/460803a; Randi AM, 2014, PHOTOSYNTHETICA, V52, P50, DOI 10.1007/s11099-014-0006-0; Rivas-Ubach A, 2012, P NATL ACAD SCI USA, V109, P4181, DOI 10.1073/pnas.1116092109; Robinson AR, 2005, J EXP BOT, V56, P2807, DOI 10.1093/jxb/eri273; Santiago LS, 2015, TREES-STRUCT FUNCT, V29, P1291, DOI 10.1007/s00468-015-1260-x; Santiago LS, 2012, J ECOL, V100, P309, DOI 10.1111/j.1365-2745.2011.01904.x; Sardans J, 2014, PLANT ECOL, V215, P441, DOI 10.1007/s11258-014-0314-2; Sardans J, 2015, GLOBAL ECOL BIOGEOGR, V24, P261, DOI 10.1111/geb.12259; Sardans J, 2015, GLOBAL ECOL BIOGEOGR, V24, P240, DOI 10.1111/geb.12253; Sardans J, 2014, ECOHYDROLOGY, V7, P1, DOI 10.1002/eco.1459; Sardans J, 2013, GLOBAL ECOL BIOGEOGR, V22, P494, DOI 10.1111/geb.12015; Schweiger R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4886; Skillman JB, 2005, AM J BOT, V92, P1811, DOI 10.3732/ajb.92.11.1811; Stamp N, 2003, Q REV BIOL, V78, P23, DOI 10.1086/367580; Tang JW, 2005, GLOBAL CHANGE BIOL, V11, P1298, DOI 10.1111/j.1365-2486.2005.00978.x; TANNER EVJ, 1992, ECOLOGY, V73, P78, DOI 10.2307/1938722; Tohge T, 2014, J CHROMATOGR B, V966, P7, DOI 10.1016/j.jchromb.2014.04.003; Tripler CE, 2006, ECOL LETT, V9, P451, DOI 10.1111/j.1461-0248.2006.00891.x; Turner BL, 2005, SCI TOTAL ENVIRON, V344, P27, DOI 10.1016/j.scitotenv.2005.02.003; Urbina I, 2015, ENVIRON EXP BOT, V111, P63, DOI 10.1016/j.envexpbot.2014.10.005; Vitousek, 2004, NUTR CYCLING LIMITAT; Vitousek PM, 2010, ECOL APPL, V20, P5, DOI 10.1890/08-0127.1; WALKER TW, 1976, GEODERMA, V15, P1, DOI 10.1016/0016-7061(76)90066-5; Wang WQ, 2015, PLANT ECOL, V216, P809, DOI 10.1007/s11258-015-0469-5; WILSON M, 1994, APPL ENVIRON MICROB, V60, P4468, DOI 10.1128/AEM.60.12.4468-4477.1994; Wright SJ, 2011, ECOLOGY, V92, P1616, DOI 10.1890/10-1558.1; Wurzburger N, 2015, ECOLOGY, V96, P2137, DOI 10.1890/14-1362.1; Yavitt JB, 2009, AUST J SOIL RES, V47, P674, DOI 10.1071/SR08258; Yavitt JB, 2011, AUSTRAL ECOL, V36, P433, DOI 10.1111/j.1442-9993.2010.02157.x; Yu Q, 2010, ECOL LETT, V13, P1390, DOI 10.1111/j.1461-0248.2010.01532.x; Zavala JA, 2001, FIELD CROP RES, V69, P143, DOI 10.1016/S0378-4290(00)00136-2; Zhao HJ, 2002, PHOTOSYNTHETICA, V40, P523, DOI 10.1023/A:1024339716382	78	7	7	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177030	10.1371/journal.pone.0177030	http://dx.doi.org/10.1371/journal.pone.0177030			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493911	Green Published, gold			2022-12-26	WOS:000401314300051
J	Morales, G; Llorente, I; Montesinos, E; Moragrega, C				Morales, Gerard; Llorente, Isidre; Montesinos, Emilio; Moragrega, Concepcio			A model for predicting Xanthomonas arboricola pv. pruni growth as a function of temperature	PLOS ONE			English	Article							VIABLE COUNT DATA; BACTERIAL-GROWTH; OPTICAL-DENSITY; LISTERIA-MONOCYTOGENES; 1ST REPORT; LAG PHASE; SPOT; PEACH; TIMES; FIREBLIGHT	A two-step modeling approach was used for predicting the effect of temperature on the growth of Xanthomonas arboricola pv. pruni, causal agent of bacterial spot disease of stone fruit. The in vitro growth of seven strains was monitored at temperatures from 5 to 35 degrees C with a Bioscreen C system, and a calibrating equation was generated for converting optical densities to viable counts. In primary modeling, Baranyi, Buchanan, and modified Gompertz equations were fitted to viable count growth curves over the entire temperature range. The modified Gompertz model showed the best fit to the data, and it was selected to estimate the bacterial growth parameters at each temperature. Secondary modeling of maximum specific growth rate as a function of temperature was performed by using the Ratkowsky model and its variations. The modified Ratkowsky model showed the best goodness of fit to maximum specific growth rate estimates, and it was validated successfully for the seven strains at four additional temperatures. The model generated in this work will be used for predicting temperature-based Xanthomonas arboricola pv. pruni growth rate and derived potential daily doublings, and included as the inoculum potential component of a bacterial spot of stone fruit disease forecaster.	[Morales, Gerard; Llorente, Isidre; Montesinos, Emilio; Moragrega, Concepcio] Univ Girona, CIDSAV, XaRTA, Inst Food & Agr Technol, Girona, Spain	Universitat de Girona	Moragrega, C (corresponding author), Univ Girona, CIDSAV, XaRTA, Inst Food & Agr Technol, Girona, Spain.	concepcio.moragrega@udg.edu	Llorente, Isidre/L-7211-2017; MORAGREGA, CONCEPCIÓ/H-4441-2017; MONTESINOS, EMILIO/H-5246-2015; Morales, Gerard/O-1522-2015	Llorente, Isidre/0000-0003-1893-8649; MORAGREGA, CONCEPCIÓ/0000-0001-6270-9611; MONTESINOS, EMILIO/0000-0003-4455-8332; Morales, Gerard/0000-0002-4535-3438	Ministerio de Educacion, Ciencia y Deporte [AGL2013-41405-R]; University of Girona [SING12/13, MPCUdG2016/085, BR 2013/31]; MECD from Spain [FPU13/04123]	Ministerio de Educacion, Ciencia y Deporte(Spanish Government); University of Girona; MECD from Spain	This research was supported, in part, by grants from the Ministerio de Educacion, Ciencia y Deporte (AGL2013-41405-R; https.//sede.rnteinn.gob.es) and from the University of Girona (SING12/13 and MPCUdG2016/085; http://www.udg.edu/).Gerard Morales was the recipient of predocotoral fellowships from the University of Girona (BR 2013/31; http://www.udg.edu) and from MECD (FPU13/04123; http://www.mecd.gob.es) from Spain.	Augustin JC, 1999, J MICROBIOL METH, V38, P137, DOI 10.1016/S0167-7012(99)00089-5; BARANYI J, 1994, INT J FOOD MICROBIOL, V23, P277, DOI 10.1016/0168-1605(94)90157-0; Battilani P., 1999, Journal of Plant Pathology, V81, P161; Baty F, 2015, J STAT SOFTW, V66, P1; Begot C, 1997, FOOD MICROBIOL, V14, P403, DOI 10.1006/fmic.1997.0097; Begot C, 1996, J MICROBIOL METH, V25, P225, DOI 10.1016/0167-7012(95)00090-9; Biesta-Peters EG, 2010, APPL ENVIRON MICROB, V76, P1399, DOI 10.1128/AEM.02336-09; BILLING E, 1976, ANN APPL BIOL, V82, P259, DOI 10.1111/j.1744-7348.1976.tb00561.x; Billing E, 1999, ACTA HORTIC, V489, P399; BILLING E, 1974, J APPL BACTERIOL, V37, P643, DOI 10.1111/j.1365-2672.1974.tb00488.x; Boudon S, 2005, PHYTOPATHOLOGY, V95, P1081, DOI 10.1094/PHYTO-95-1081; Buchanan RL, 1997, FOOD MICROBIOL, V14, P313, DOI 10.1006/fmic.1997.0125; Bugiani R, 2008, IOBC WPRS B, V54, P565; Chorin E, 1997, INT J FOOD MICROBIOL, V38, P229, DOI 10.1016/S0168-1605(97)00110-4; DALGAARD P, 1994, INT J FOOD MICROBIOL, V23, P391, DOI 10.1016/0168-1605(94)90165-1; Dalgaard P, 2001, J MICROBIOL METH, V43, P183, DOI 10.1016/S0167-7012(00)00219-0; de Bernonville TD, 2014, FEMS MICROBIOL ECOL, V89, P527, DOI 10.1111/1574-6941.12345; EPPO, 2016, EPPO GLOB DAT; EPPO, 2006, EPPO B, V36, P129, DOI DOI 10.1111/J.1365-2338.2006.00925.X; Garcin A., 2011, INFOS CTIFL, V268, P26; HUDSON JA, 1994, J FOOD SAFETY, V14, P329, DOI 10.1111/j.1745-4565.1994.tb00604.x; Janse JD, 2012, J PLANT PATHOL, V94, pS5; Kim JH, 2014, PLANT PATHOLOGY J, V30, P125, DOI 10.5423/PPJ.OA.09.2013.0090; Kim J, 2013, FOODS, V2, P364, DOI 10.3390/foods2030364; Lalancette N, 2007, PLANT DIS, V91, P1122, DOI 10.1094/PDIS-91-9-1122; Lightner Gary W., 1992, Computers and Electronics in Agriculture, V7, P249, DOI 10.1016/S0168-1699(05)80023-7; Maniatis T., 1982, MOL CLONING; Marchi G, 2011, PLANT DIS, V95, P74, DOI 10.1094/PDIS-07-10-0529; MCCLURE PJ, 1993, J IND MICROBIOL, V12, P277, DOI 10.1007/BF01584203; McKellar RC, 1997, INT J FOOD MICROBIOL, V36, P179, DOI 10.1016/S0168-1605(97)01266-X; Morales G, 2016, ACTA HORTIC, V1149, P1, DOI [10.17660/ActaHortic.2016.1149.1, 10.1109/PESGM.2016.7741838]; Oscar TP, 2005, J FOOD PROTECT, V68, P2606, DOI 10.4315/0362-028X-68.12.2606; Palacio-Bielsa A, 2010, PLANT DIS, V94, P786, DOI 10.1094/PDIS-94-6-0786B; RATKOWSKY DA, 1983, J BACTERIOL, V154, P1222, DOI 10.1128/JB.154.3.1222-1226.1983; RATKOWSKY DA, 1982, J BACTERIOL, V149, P1; Ritchie D., 1999, FUNGICIDE NEMATICIDE, V54, P63; Ritchie D., 2005, SE PEACH GROWERS HDB; Ritchie D., 1995, COMPENDIUM STONE FRU, P50; Rolfe MD, 2012, J BACTERIOL, V194, P686, DOI 10.1128/JB.06112-11; Ross T, 1996, J APPL BACTERIOL, V81, P501, DOI 10.1111/j.1365-2672.1996.tb03539.x; Ross T, 2000, INT J FOOD MICROBIOL, V62, P231, DOI 10.1016/S0168-1605(00)00340-8; Sant'Ana AS, 2012, FOOD MICROBIOL, V30, P267, DOI 10.1016/j.fm.2011.11.003; Scortichini M., 2010, J PLANT PATHOLOGY S1, V92; Sezonov G, 2007, J BACTERIOL, V189, P8746, DOI 10.1128/JB.01368-07; SHEPARD DP, 1994, PLANT DIS, V78, P627, DOI 10.1094/PD-78-0627; Smith E., 1903, SCIENCE, V17, P456, DOI DOI 10.1126/SCIENCE.17.420.114-A; Smith IM, 1997, QUAR PESTS EUR, P1096; Smith T. J., 1993, ACTA HORTIC, V338, P153, DOI DOI 10.17660/ACTAHORTIC.1993.338.21; Socquet-Juglard D, 2012, J PLANT PATHOL, V94, DOI 10.4454/jpp.v94i1sup.015; Stefani E, 2010, J PLANT PATHOL, V92, pS99; Stephens PJ, 1997, J APPL MICROBIOL, V83, P445, DOI 10.1046/j.1365-2672.1997.00255.x; Swinnen IAM, 2004, INT J FOOD MICROBIOL, V94, P137, DOI 10.1016/j.ijfoodmicro.2004.01.006; Tjou-Tam-Sin NNA, 2012, PLANT DIS, V96, P759, DOI 10.1094/PDIS-04-11-0265-PDN; VAUTERIN L, 1995, INT J SYST BACTERIOL, V45, P472, DOI 10.1099/00207713-45-3-472; YOUNG JM, 1977, J APPL BACTERIOL, V42, P345, DOI 10.1111/j.1365-2672.1977.tb00702.x; Zehr EI, 1996, PLANT DIS, V80, P339, DOI 10.1094/PD-80-0339; ZWIETERING MH, 1991, APPL ENVIRON MICROB, V57, P1094, DOI 10.1128/AEM.57.4.1094-1101.1991; ZWIETERING MH, 1994, APPL ENVIRON MICROB, V60, P204, DOI 10.1128/AEM.60.1.204-213.1994; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	59	8	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							0177583	10.1371/journal.pone.0177583	http://dx.doi.org/10.1371/journal.pone.0177583			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493954	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314300141
J	Castley, A; Sawleshwarkar, S; Varma, R; Herring, B; Thapa, K; Dwyer, D; Chibo, D; Nguyen, N; Hawke, K; Ratcliff, R; Garsia, R; Kelleher, A; Nolan, D				Castley, Alison; Sawleshwarkar, Shailendra; Varma, Rick; Herring, Belinda; Thapa, Kiran; Dwyer, Dominic; Chibo, Doris; Nam Nguyen; Hawke, Karen; Ratcliff, Rodney; Garsia, Roger; Kelleher, Anthony; Nolan, David		Australian Mol Epidemiology Networ	A national study of the molecular epidemiology of HIV-1 in Australia 2005-2012	PLOS ONE			English	Article							VIRUS TYPE-1 SUBTYPES; DISEASE PROGRESSION; GENETIC DIVERSITY; IMMUNE-RESPONSES; TRANSMISSION; INFECTIONS; RISK; INDIVIDUALS; RESISTANCE; CRF01-AE	Introduction Rates of new HIV-1 diagnoses are increasing in Australia, with evidence of an increasing proportion of non-B HIV-1 subtypes reflecting a growing impact of migration and travel. The present study aims to define HIV-1 subtype diversity patterns and investigate possible HIV-1 transmission networks within Australia. Methods The Australian Molecular Epidemiology Network (AMEN) HIV collaborating sites in Western Australia, South Australia, Victoria, Queensland and western Sydney (New South Wales), provided baseline HIV-1 partial pol sequence, age and gender information for 4,873 patients who had genotypes performed during 2005-2012. HIV-1 phylogenetic analyses utilised MEGA V6, with a stringent classification of transmission pairs or clusters (bootstrap >= 98%, genetic distance <= 1.5% from at least one other sequence in the cluster). Results HIV-1 subtype B represented 74.5% of the 4,873 sequences (WA 59%, SA 68.4%, w-Syd 73.8%, Vic 75.6%, Qld 82.1%), with similar proportion of transmission pairs and clusters found in the B and non-B cohorts (23% vs 24.5% of sequences, p = 0.3). Significantly more subtype B clusters were comprised of =3 sequences compared with non-B clusters (45.0% vs 24.0%, p = 0.021) and significantly more subtype B pairs and clusters were male-only (88% compared to 53% CRF01_AE and 17% subtype C clusters). Factors associated with being in a cluster of any size included; being sequenced in a more recent time period (p<0.001), being younger (p<0.001), being male (p = 0.023) and having a B subtype (p = 0.02). Being in a larger cluster (>3) was associated with being sequenced in a more recent time period (p = 0.05) and being male (p = 0.008). Conclusion This nationwide HIV-1 study of 4,873 patient sequences highlights the increased diversity of HIV-1 subtypes within the Australian epidemic, as well as differences in transmission networks associated with these HIV-1 subtypes. These findings provide epidemiological insights not readily available using standard surveillance methods and can inform the development of effective public health strategies in the current paradigm of HIV prevention in Australia.	[Castley, Alison; Nolan, David] Royal Perth Hosp, Dept Clin Immunol, Perth, WA, Australia; [Sawleshwarkar, Shailendra; Varma, Rick] Western Sydney Local Hlth Dist, Western Sydney Sexual Hlth Ctr, Parramatta, NSW, Australia; [Sawleshwarkar, Shailendra; Varma, Rick] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW, Australia; [Herring, Belinda; Thapa, Kiran; Dwyer, Dominic] Westmead Hosp, Ctr Infect Dis & Microbiol Lab Serv, ICPMR Pathol West NSW Hlth Pathol, Westmead, NSW, Australia; [Herring, Belinda; Thapa, Kiran; Dwyer, Dominic] Univ Sydney, Westmead, NSW, Australia; [Chibo, Doris] Doherty Inst, HIV Characterisat Lab, Victorian Infect Dis Reference Lab, Melbourne, Vic, Australia; [Nam Nguyen] RBWH Herston, Div Immunol, HSQ Pathol Queensland Cent Lab, Herston, Qld, Australia; [Hawke, Karen] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia; [Hawke, Karen] Flinders Univ S Australia, Sch Med, Adelaide, SA, Australia; [Ratcliff, Rodney] Royal Adelaide Hosp, Clin 275, Adelaide, SA, Australia; [Ratcliff, Rodney] SA Pathol, Dept Microbiol & Infect Dis, Adelaide, SA, Australia; [Garsia, Roger] Royal Prince Alfred Hosp, Clin Immunol Dept, Sydney, NSW, Australia; [Kelleher, Anthony] Univ New South Wales, Kirby Inst Infect & Immun Soc, Sydney, NSW, Australia	Royal Perth Hospital; University of Western Australia; University of Sydney; University of Sydney; University of Sydney; Victorian Infectious Diseases Reference Laboratory; Royal Brisbane & Women's Hospital; South Australian Health & Medical Research Institute (SAHMRI); Flinders University South Australia; Royal Adelaide Hospital; SA Pathology; University of Sydney; University of New South Wales Sydney; Kirby Institute	Castley, A (corresponding author), Royal Perth Hosp, Dept Clin Immunol, Perth, WA, Australia.	allison.castley@health.wa.gov.au	Hawke, Karen/AAD-6172-2022; Sawleshwarkar, Shailendra/AAB-3628-2020	Hawke, Karen/0000-0003-4118-0995; Sawleshwarkar, Shailendra/0000-0002-9399-0490; /0000-0001-8284-1505; Kelleher, Anthony/0000-0002-0009-3337; Chibo, Doris/0000-0002-6950-6910	Royal Perth Hospital (RPH)-Medical Research Foundation (MRF)	Royal Perth Hospital (RPH)-Medical Research Foundation (MRF)	Alison Castley gratefully acknowledges the Royal Perth Hospital (RPH)-Medical Research Foundation (MRF) for providing funding to complete this study.	Aldous JL, 2012, CLIN INFECT DIS, V55, P1135, DOI 10.1093/cid/cis612; Angelis K, 2015, J INFECT DIS, V211, P1735, DOI 10.1093/infdis/jiu666; [Anonymous], 2013, GLOBAL REPORT UNAIDS; [Anonymous], 2014, 34010 AUSTR BUR STAT; Baeten JM, 2007, J INFECT DIS, V195, P1177, DOI 10.1086/512682; Brenner B, 2013, AIDS, V27, P1045, DOI 10.1097/QAD.0b013e32835cffd9; Brenner BG, 2006, AIDS, V20, pF9, DOI 10.1097/01.aids.0000232228.88511.0b; Brenner BG, 2011, J MED VIROL, V83, P751, DOI 10.1002/jmv.22047; Buonaguro L, 2007, J VIROL, V81, P10209, DOI 10.1128/JVI.00872-07; Carlson JM, 2016, NAT MED, V22, P606, DOI 10.1038/nm.4100; Castley ASL, 2016, AIDS RES HUM RETROV, V32, P211, DOI [10.1089/aid.2015.0206, 10.1089/AID.2015.0206]; Castro-Nallar E, 2012, FUTURE VIROL, V7, P239, DOI 10.2217/FVL.12.4; Chalmet K, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-262; Chibo D, 2012, AIDS RES HUM RETROV, V28, P578, DOI [10.1089/aid.2011.0200, 10.1089/AID.2011.0200]; Combs BC, 2009, SEX HEALTH, V6, P35, DOI 10.1071/SH08010; Dunn D, 2014, AIDS, V28, P773, DOI 10.1097/QAD.0000000000000119; Easterbrook PJ, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-4; Frentz D, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-36; Gisselquist D, 2003, INT J STD AIDS, V14, P162, DOI 10.1258/095646203762869160; Graf T, 2011, J CLIN VIROL, V51, P186, DOI 10.1016/j.jcv.2011.04.011; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hawke KG, 2013, AIDS RES HUM RETROV, V29, P311, DOI 10.1089/aid.2012.0082; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Herbeck JT, 2012, AIDS, V26, P193, DOI 10.1097/QAD.0b013e32834db418; Herring BL, 2003, J CLIN MICROBIOL, V41, P4600, DOI 10.1128/JCM.41.10.4600-4604.2003; Hocking J, 2004, AUST NZ J PUBL HEAL, V28, P217, DOI 10.1111/j.1467-842X.2004.tb00698.x; Hughes GJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000590; Ivanov IA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059666; Kirby Institute, HIV VIR HEP SEX TRAN; Kouri V, 2015, EBIOMEDICINE, V2, P244, DOI 10.1016/j.ebiom.2015.01.015; Lau KA, 2013, INFECT DIS REP, V5, P15, DOI 10.4081/idr.2013.s1.e4; Li X., 2015, 2015 IEEE 58 INT MID, P1, DOI DOI 10.1109/IJCNN.2015.7280320; Li Xiao-He, 2007, Virologica Sinica, V22, P426, DOI 10.1007/s12250-007-0043-y; Lihana RW, 2012, AIDS REV, V14, P83; Longosz AF, 2014, JAIDS-J ACQ IMM DEF, V65, P390, DOI 10.1097/QAI.0000000000000006; Luft LM, 2011, INT J INFECT DIS, V15, pE661, DOI 10.1016/j.ijid.2011.05.013; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Ng KY, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-90; Oelrichs RB, 2000, J BIOMED SCI, V7, P128, DOI 10.1007/BF02256619; Palm AA, 2014, J INFECT DIS, V209, P721, DOI 10.1093/infdis/jit416; Paraskevis D, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-49; Phanuphak N, 2015, AIDS RES HUM RETROV, V31, P1060, DOI 10.1089/aid.2015.0049; Phuphuakrat A, 2014, HIV MED, V15, P269, DOI 10.1111/hiv.12108; Renjifo B, 2004, AIDS, V18, P1629, DOI 10.1097/01.aids.0000131392.68597.34; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; Sacktor N, 2009, CLIN INFECT DIS, V49, P780, DOI 10.1086/605284; Santoro M, 2013, ISRN MICROBIOL; Siemieniuk RAC, 2013, CAN J INFECT DIS MED, V24, P69, DOI 10.1155/2013/230380; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tebit DM, 2011, LANCET INFECT DIS, V11, P45, DOI 10.1016/S1473-3099(10)70186-9; Vidal N, 2003, JAIDS-J ACQ IMM DEF, V33, P239, DOI 10.1097/00126334-200306010-00020; von Wyl V, 2011, J INFECT DIS, V204, P1095, DOI 10.1093/infdis/jir491; Wertheim JO, 2014, J INFECT DIS, V209, P304, DOI 10.1093/infdis/jit524	53	17	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0170601	10.1371/journal.pone.0170601	http://dx.doi.org/10.1371/journal.pone.0170601			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489920	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314100001
J	James, AW; Zhang, XL; Crisan, M; Hardy, WR; Liang, P; Meyers, CA; Lobo, S; Lagishetty, V; Childers, MK; Asatrian, G; Ding, C; Yen, YH; Zou, E; Ting, K; Peault, B; Soo, C				James, Aaron W.; Zhang, Xinli; Crisan, Mihaela; Hardy, Winters R.; Liang, Pei; Meyers, Carolyn A.; Lobo, Sonja; Lagishetty, Venu; Childers, Martin K.; Asatrian, Greg; Ding, Catherine; Yen, Yu-Hsin; Zou, Erin; Ting, Kang; Peault, Bruno; Soo, Chia			Isolation and characterization of canine perivascular stem/stromal cells for bone tissue engineering	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; RAT SPINAL-FUSION; ADIPOSE-TISSUE; STROMAL CELLS; ADIPOGENIC DIFFERENTIATION; CHRONIC OSTEOARTHRITIS; SONIC HEDGEHOG; IN-VITRO; NELL-1; MODEL	For over 15 years, human subcutaneous adipose tissue has been recognized as a rich source of tissue resident mesenchymal stem/stromal cells (MSC). The isolation of perivascular progenitor cells from human adipose tissue by a cell sorting strategy was first published in 2008. Since this time, the interest in using pericytes and related perivascular stem/stromal cell (PSC) populations for tissue engineering has significantly increased. Here, we describe a set of experiments identifying, isolating and characterizing PSC from canine tissue (N = 12 canine adipose tissue samples). Results showed that the same antibodies used for human PSC identification and isolation are cross-reactive with canine tissue (CD45, CD146, CD34). Like their human correlate, canine PSC demonstrate characteristics of MSC including cell surface marker expression, colony forming unit-fibroblast (CFU-F) inclusion, and osteogenic differentiation potential. As well, canine PSC respond to osteoinductive signals in a similar fashion as do human PSC, such as the secreted differentiation factor NEL-Like Molecule-1 (NELL-1). Nevertheless, important differences exist between human and canine PSC, including differences in baseline osteogenic potential. In summary, canine PSC represent a multipotent mesenchymogenic cell source for future translational efforts in tissue engineering.	[James, Aaron W.; Meyers, Carolyn A.; Yen, Yu-Hsin; Zou, Erin] Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21218 USA; [James, Aaron W.; Hardy, Winters R.; Liang, Pei; Lobo, Sonja; Lagishetty, Venu; Peault, Bruno; Soo, Chia] Univ Calif Los Angeles, Los Angeles, CA 90095 USA; [James, Aaron W.; Hardy, Winters R.; Liang, Pei; Lobo, Sonja; Lagishetty, Venu; Peault, Bruno; Soo, Chia] Orthoped Hosp, Dept Orthopaed Surg, Los Angeles, CA 90007 USA; [James, Aaron W.; Hardy, Winters R.; Liang, Pei; Lobo, Sonja; Lagishetty, Venu; Peault, Bruno; Soo, Chia] Orthoped Hosp, Res Ctr, Los Angeles, CA 90007 USA; [Zhang, Xinli; Asatrian, Greg; Ding, Catherine; Ting, Kang] Univ Calif Los Angeles, Sch Dent, Div Growth & Dev, Los Angeles, CA 90024 USA; [Zhang, Xinli; Asatrian, Greg; Ding, Catherine; Ting, Kang] Univ Calif Los Angeles, Sch Dent, Sect Orthodont, Los Angeles, CA 90024 USA; [Crisan, Mihaela; Peault, Bruno] Univ Edinburgh, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland; [Crisan, Mihaela; Peault, Bruno] Univ Edinburgh, MRC Ctr Regenerat Med, Edinburgh, Midlothian, Scotland; [Childers, Martin K.] UWMC, Rehabil Med Clin, Seattle, WA USA; [Soo, Chia] Univ Calif Los Angeles, David Geffen Sch Med, Div Plast & Reconstruct Surg, Dept Surg, Los Angeles, CA 90095 USA	Johns Hopkins University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Edinburgh; University of Edinburgh; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	James, AW (corresponding author), Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21218 USA.; James, AW (corresponding author), Univ Calif Los Angeles, Los Angeles, CA 90095 USA.; James, AW (corresponding author), Orthoped Hosp, Dept Orthopaed Surg, Los Angeles, CA 90007 USA.; James, AW (corresponding author), Orthoped Hosp, Res Ctr, Los Angeles, CA 90007 USA.	awjames@jhmi.edu	Lobo, Sonja/G-5151-2015; Lagishetty, Venu/C-8251-2009	Lobo, Sonja/0000-0002-5697-9858; Lagishetty, Venu/0000-0001-6500-8255; Zou, Erin/0000-0001-8614-1178; James, Aaron/0000-0002-2002-622X; Meyers, Carolyn/0000-0002-0734-029X	NIH/NIAMS [R01 AR061399, R01 AR066782, K08 AR068316]; California Institute of Regenerative Medicine (CIRM); Orthopaedic Research and Education Foundation; Musculoskeletal Transplant Foundation; The Catherine and Constantinos J. Limas Research Award; MRC [G1000816] Funding Source: UKRI; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR070773] Funding Source: NIH RePORTER; Medical Research Council [G1000816] Funding Source: researchfish	NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); California Institute of Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); Orthopaedic Research and Education Foundation; Musculoskeletal Transplant Foundation; The Catherine and Constantinos J. Limas Research Award; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The present work was supported by the NIH/NIAMS (grants R01 AR061399, R01 AR066782, K08 AR068316), California Institute of Regenerative Medicine (CIRM), and Orthopaedic Research and Education Foundation with funding provided by the Musculoskeletal Transplant Foundation, as well as The Catherine and Constantinos J. Limas Research Award.	Aerssens J, 1998, ENDOCRINOLOGY, V139, P663, DOI 10.1210/en.139.2.663; Askarinam A, 2013, TISSUE ENG PT A, V19, P1386, DOI [10.1089/ten.tea.2012.0367, 10.1089/ten.TEA.2012.0367]; Black LL, 2007, VET THER, V8, P272; Caplan AI, 2008, CELL STEM CELL, V3, P229, DOI 10.1016/j.stem.2008.08.008; Chen CW, 2009, CYTOKINE GROWTH F R, V20, P429, DOI 10.1016/j.cytogfr.2009.10.014; Chen F, 2012, INT ORTHOP, V36, P2181, DOI 10.1007/s00264-012-1590-x; Cheung WK, 2010, CYTOTHERAPY, V12, P554, DOI 10.3109/14653241003709694; Chung CG, 2014, STEM CELL TRANSL MED, V3, P1231, DOI 10.5966/sctm.2014-0027; Corselli M, 2012, STEM CELLS DEV, V21, P1299, DOI 10.1089/scd.2011.0200; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Csaki C, 2007, HISTOCHEM CELL BIOL, V128, P507, DOI 10.1007/s00418-007-0337-z; D'Alimonte I, 2013, STEM CELL REV REP, V9, P642, DOI 10.1007/s12015-013-9436-5; De Boer J, 2004, TISSUE ENG, V10, P393, DOI 10.1089/107632704323061753; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Fontaine C, 2008, STEM CELLS, V26, P1037, DOI 10.1634/stemcells.2007-0974; Freeman FE, 2016, TISSUE ENG A; FRODEL JL, 1993, ARCH OTOLARYNGOL, V119, P17; GIBSON GJ, 1991, BIOCHEM J, V277, P513, DOI 10.1042/bj2770513; Guercio A, 2012, CELL BIOL INT, V36, P189, DOI 10.1042/CBI20110304; Harman R, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00081; Hass R, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-12; Hindle P, 2016, STEM CELLS DEV; Hindle P., 2016, STEM CELLS TRANSL ME; Jackson WM, 2012, STEM CELL TRANSL MED, V1, P44, DOI 10.5966/sctm.2011-0024; James AW, 2016, TISSUE ENG PT A, V22, P840, DOI [10.1089/ten.tea.2015.0230, 10.1089/ten.TEA.2015.0230]; James AW, 2010, TISSUE ENG PT A, V16, P2605, DOI [10.1089/ten.tea.2010.0048, 10.1089/ten.TEA.2010.0048]; James AW, 2012, STEM CELL TRANSL MED, V1, P673, DOI 10.5966/sctm.2012-0053; James AW, 2012, STEM CELL TRANSL MED, V1, P510, DOI 10.5966/sctm.2012-0002; James AW, 2012, STEM CELLS DEV, V21, P2170, DOI 10.1089/scd.2011.0461; James AW, 2011, BIOCHEM BIOPH RES CO, V411, P126, DOI 10.1016/j.bbrc.2011.06.111; James AW, 2016, PHARM THER; Kang BJ, 2012, J VET SCI, V13, P299, DOI 10.4142/jvs.2012.13.3.299; Kang JW, 2008, STEM CELLS DEV, V17, P681, DOI 10.1089/scd.2007.0153; Kisiel AH, 2012, AM J VET RES, V73, P1305, DOI 10.2460/ajvr.73.8.1305; KLOTCH DW, 1995, OTOLARYNG HEAD NECK, V112, P291, DOI 10.1016/S0194-5998(95)70252-0; Konigshoff M, 2009, J CLIN INVEST, V119, P772, DOI 10.1172/JCI33950; Kramann R., 2016, CELL STEM CELL; LARUE SM, 1989, J AM VET MED ASSOC, V195, P1734; Lee H, 2009, VET MED, P198; Levi B, 2011, PLAST RECONSTR SURG, V128, P373, DOI 10.1097/PRS.0b013e31821e6e49; Levi B, 2011, STEM CELLS, V29, P576, DOI 10.1002/stem.612; Li WM, 2010, TISSUE ENG PT A, V16, P2861, DOI 10.1089/ten.tea.2009.0550; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Liu GP, 2013, BIOMATERIALS, V34, P2655, DOI 10.1016/j.biomaterials.2013.01.004; Lu SS, 2007, SPINE J, V7, P50, DOI 10.1016/j.spinee.2006.04.020; Majesky MW, 2012, CELLS TISSUES ORGANS, V195, P73, DOI 10.1159/000331413; Mizuno H, 2012, STEM CELLS, V30, P804, DOI 10.1002/stem.1076; Muller AM, 2010, EUR CELLS MATER, V19, P127; Murray IR, 2014, CELL MOL LIFE SCI, V71, P1353, DOI 10.1007/s00018-013-1462-6; Ostrander EA, 2000, TRENDS GENET, V16, P117, DOI 10.1016/S0168-9525(99)01958-7; Patterson DF, 2000, J VET INTERN MED, V14, P1, DOI 10.1892/0891-6640(2000)14[1:CAMITA]2.0.CO;2; Pham D, 2016, INT J ORTHOPAEDICS, P549; REHMAN I, 1995, J BIOMED MATER RES, V29, P1287, DOI 10.1002/jbm.820291016; Rowell JL, 2011, TRENDS MOL MED, V17, P380, DOI 10.1016/j.molmed.2011.02.004; Russell KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167442; Shen J, 2016, AM J PATHOL, V186, P419, DOI 10.1016/j.ajpath.2015.10.011; Shen J, 2012, J CELL BIOCHEM, V113, P3620, DOI 10.1002/jcb.24253; Takemitsu H, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-150; Tawonsawatruk T, 2016, SCI REP-UK, V6, DOI 10.1038/srep22779; Vieira NM, 2010, CELL TRANSPLANT, V19, P279, DOI 10.3727/096368909X481764; West CC, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0302-7; Wilke HJ, 1997, ANAT RECORD, V247, P542, DOI 10.1002/(SICI)1097-0185(199704)247:4<542::AID-AR13>3.0.CO;2-P; Yoon D, 2015, J VET SCI, V16, P397, DOI 10.4142/jvs.2015.16.4.397; Zhang X, 2011, EURASIP J WIREL COMM, DOI 10.1155/2011/765143; Zhao H, 2014, CELL STEM CELL, V14, P160, DOI 10.1016/j.stem.2013.12.013	65	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177308	10.1371/journal.pone.0177308	http://dx.doi.org/10.1371/journal.pone.0177308			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489940	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314100059
J	Lee, JS; Zakeri, IF; Butte, NF				Lee, Jong Soo; Zakeri, Issa F.; Butte, Nancy F.			Functional data analysis of sleeping energy expenditure	PLOS ONE			English	Article							METABOLIC-RATE; BODY-MASS; OBESITY; CHILDREN; DURATION; REGULARIZATION; CALORIMETER; OVERWEIGHT; PREDICTION; MODELS	Adequate sleep is crucial during childhood for metabolic health, and physical and cognitive development. Inadequate sleep can disrupt metabolic homeostasis and alter sleeping energy expenditure (SEE). Functional data analysis methods were applied to SEE data to elucidate the population structure of SEE and to discriminate SEE between obese and nonobese children. Minute-by-minute SEE in 109 children, ages 5-18, was measured in room respiration calorimeters. A smoothing spline method was applied to the calorimetric data to extract the true smoothing function for each subject. Functional principal component analysis was used to capture the important modes of variation of the functional data and to identify differences in SEE patterns. Combinations of functional principal component analysis and classifier algorithm were used to classify SEE. Smoothing effectively removed instrumentation noise inherent in the room calorimeter data, providing more accurate data for analysis of the dynamics of SEE. SEE exhibited declining but subtly undulating patterns throughout the night. Mean SEE was markedly higher in obese than non-obese children, as expected due to their greater body mass. SEE was higher among the obese than non-obese children (p<0.01); however, the weight-adjusted mean SEE was not statistically different (p>0.1, after post hoc testing). Functional principal component scores for the first two components explained 77.8% of the variance in SEE and also differed between groups (p = 0.037). Logistic regression, support vector machine or random forest classification methods were able to distinguish weight-adjusted SEE between obese and non-obese participants with good classification rates (62-64%). Our results implicate other factors, yet to be uncovered, that affect the weight-adjusted SEE of obese and non-obese children. Functional data analysis revealed differences in the structure of SEE between obese and non-obese children that may contribute to disruption of metabolic homeostasis.	[Lee, Jong Soo] Univ Massachusetts Lowell, Dept Math Sci, Lowell, MA 01854 USA; [Zakeri, Issa F.] Drexel Univ, Dept Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Butte, Nancy F.] Baylor Coll Med, Dept Pediat, USDA ARS, Childrens Nutr Res Ctr, Houston, TX 77030 USA	University of Massachusetts System; University of Massachusetts Lowell; Drexel University; Baylor College of Medicine; United States Department of Agriculture (USDA)	Lee, JS (corresponding author), Univ Massachusetts Lowell, Dept Math Sci, Lowell, MA 01854 USA.	jongsoo_lee@uml.edu			US Department of Agriculture/Agricultural Research Service [58-6250-0-008]; National Institutes of Health [R01 DK085163]	US Department of Agriculture/Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Support was provided by the US Department of Agriculture/Agricultural Research Service (https://www.ars.usda.gov). Cooperative Agreement No. 58-6250-0-008. NB received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Support was also provided by the National Institutes of Health (https://www.nih.gov), grant number R01 DK085163. NB received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barati Z, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.11.117007; BREBBIA DR, 1965, SCIENCE, V150, P1621, DOI 10.1126/science.150.3703.1621; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; BROWN D, 1984, MED BIOL ENG COMPUT, V22, P333, DOI 10.1007/BF02442102; Butte NF, 2007, J NUTR, V137, P2660, DOI 10.1093/jn/137.12.2660; Butte NF, 2015, OBESITY, V23, P591, DOI 10.1002/oby.20994; Cappuccio FP, 2008, SLEEP, V31, P619, DOI 10.1093/sleep/31.5.619; Chaput JP, 2016, EAT WEIGHT DISORD-ST, V21, P5, DOI 10.1007/s40519-015-0233-9; Chen XL, 2008, OBESITY, V16, P265, DOI 10.1038/oby.2007.63; CHILDS C, 1993, ARCH DIS CHILD, V68, P658, DOI 10.1136/adc.68.5.658; Cox DD, 2008, BIOMETRIKA, V95, P621, DOI 10.1093/biomet/asn021; CRAVEN P, 1979, NUMER MATH, V31, P377, DOI 10.1007/BF01437407; Dashti HS, 2015, ADV NUTR, V6, P648, DOI 10.3945/an.115.008623; DAUNCEY MJ, 1978, BRIT J NUTR, V39, P557, DOI 10.1079/BJN19780071; De Boor C, 2000, PRACTICAL GUIDE SPLI; Di CZ, 2009, ANN APPL STAT, V3, P458, DOI 10.1214/08-AOAS206; Efron B, 1993, INTRO BOOTSTRAP, DOI [DOI 10.1007/978-1-4899-4541-9, 10.1007/978-1-4899-4541-9]; Eggermont PPB, 2009, SPRINGER SER STAT, P1, DOI 10.1007/b12285_1; Eubank R. L., 1999, NONPARAMETRIC REGRES; Fan JQ, 1998, J AM STAT ASSOC, V93, P1007, DOI 10.2307/2669845; Fatima Y, 2015, OBES REV, V16, P137, DOI 10.1111/obr.12245; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Hirotsu C, 2015, SLEEP SCI, V8, P143, DOI 10.1016/j.slsci.2015.09.002; Hitchcock DB, 2006, J AM STAT ASSOC, V101, P211, DOI 10.1198/016214505000000673; Katayose Y, 2009, METABOLISM, V58, P920, DOI 10.1016/j.metabol.2009.02.025; Kuczmarski RJ, 2000, ADV DATA, V314, P1; Li A. M., 2003, Hong Kong Medical Journal, V9, P353; Magee L, 2012, SLEEP MED REV, V16, P231, DOI 10.1016/j.smrv.2011.05.005; MOON JK, 1995, J NUTR, V125, P220; MURGATROYD PR, 1987, BRIT J NUTR, V58, P347, DOI 10.1079/BJN19870104; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Quist JS, 2016, SLEEP MED REV, V29, P76, DOI 10.1016/j.smrv.2015.09.001; Ramsay JO, 2009, USE R, P1, DOI 10.1007/978-0-387-98185-7_1; Ramsay J.O., 2005, FUNCTIONAL DATA ANAL; Rencher AC, 2002, METHODS MULTIVARIATE; RUMPLER WV, 1990, AM J CLIN NUTR, V51, P147, DOI 10.1093/ajcn/51.2.147; Ruppert D, 2002, J COMPUT GRAPH STAT, V11, P735, DOI 10.1198/106186002853; Shang HL, 2014, ASTA-ADV STAT ANAL, V98, P121, DOI 10.1007/s10182-013-0213-1; Shen Q, 2004, STAT SINICA, V14, P1239; Shimizu I, 2016, HYPERTENS RES; Spaeth AM, 2015, OBESITY, V23, P2349, DOI 10.1002/oby.21198; Tokuyama K, 2009, J APPL PHYSIOL, V106, P640, DOI 10.1152/japplphysiol.90718.2008; Treuth MS, 1998, AM J PHYSIOL-ENDOC M, V275, pE12, DOI 10.1152/ajpendo.1998.275.1.E12; Treuth MS, 2000, AM J CLIN NUTR, V71, P893; Vapnik V., 1998, STAT LEARNING THEORY, V3, DOI DOI 10.1007/978-1-4419-1428-6_5864; Viviani R, 2005, HUM BRAIN MAPP, V24, P109, DOI 10.1002/hbm.20074; Vsevolozhskaya OA, 2015, ENVIRON ECOL STAT, V22, P45, DOI 10.1007/s10651-014-0282-7; WAHBA G, 1985, ANN STAT, V13, P1378, DOI 10.1214/aos/1176349743; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; Wong WW, 1999, J CLIN ENDOCR METAB, V84, P906, DOI 10.1210/jc.84.3.906; Zakeri I, 2006, J NUTR, V136, P1371, DOI 10.1093/jn/136.5.1371; Zakeri I, 2008, J APPL PHYSIOL, V104, P1665, DOI 10.1152/japplphysiol.01163.2007; Zakeri IF, 2010, J APPL PHYSIOL, V108, P128, DOI 10.1152/japplphysiol.00729.2009; Zhang K, 2002, INT J OBESITY, V26, P376, DOI 10.1038/sj.ijo.0801922; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	57	1	1	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177286	10.1371/journal.pone.0177286	http://dx.doi.org/10.1371/journal.pone.0177286			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489875	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314100057
J	Maierhofer, A; Flunkert, J; Dittrich, M; Muller, T; Schindler, D; Nanda, I; Haaf, T				Maierhofer, Anna; Flunkert, Julia; Dittrich, Marcus; Mueller, Tobias; Schindler, Detlev; Nanda, Indrajit; Haaf, Thomas			Analysis of global DNA methylation changes in primary human fibroblasts in the early phase following X-ray irradiation	PLOS ONE			English	Article							IONIZING-RADIATION; 5-HYDROXYMETHYLCYTOSINE; TISSUE; 5-METHYLCYTOSINE; SEQUENCES; PROTEINS; DAMAGE; SITES	Epigenetic alterations may contribute to the generation of cancer cells in a multi-step process of tumorigenesis following irradiation of normal body cells. Primary human fibroblasts with intact cell cycle checkpoints were used as a model to test whether X-ray irradiation with 2 and 4 Gray induces direct epigenetic effects (within the first cell cycle) in the exposed cells. ELISA-based fluorometric assays were consistent with slightly reduced global DNA methylation and hydroxymethylation, however the observed between-group differences were usually not significant. Similarly, bisulfite pyrosequencing of interspersed LINE-1 repeats and centromeric alpha-satellite DNA did not detect significant methylation differences between irradiated and non-irradiated cultures. Methylation of interspersed ALU repeats appeared to be slightly increased (one percentage point; p = 0.01) at 6 h after irradiation with 4 Gy. Single-cell analysis showed comparable variations in repeat methylation among individual cells in both irradiated and control cultures. Radiation-induced changes in global repeat methylation, if any, were much smaller than methylation variation between different fibroblast strains. Interestingly, alpha-satellite DNA methylation positively correlated with gestational age. Finally, 450K methylation arrays mainly targeting genes and CpG islands were used for global DNA methylation analysis. There were no detectable methylation differences in genic (promoter, 5' UTR, first exon, gene body, 3' UTR) and intergenic regions between irradiated and control fibroblast cultures. Although we cannot exclude minor effects, i.e. on individual CpG sites, collectively our data suggest that global DNA methylation remains rather stable in irradiated normal body cells in the early phase of DNA damage response.	[Maierhofer, Anna; Flunkert, Julia; Schindler, Detlev; Nanda, Indrajit; Haaf, Thomas] Julius Maximilians Univ, Inst Human Genet, Wurzburg, Germany; [Dittrich, Marcus; Mueller, Tobias] Julius Maximilians Univ, Dept Bioinformat, Wurzburg, Germany	University of Wurzburg; University of Wurzburg	Haaf, T (corresponding author), Julius Maximilians Univ, Inst Human Genet, Wurzburg, Germany.	thomas.haaf@uni-wuerzburg.de	Müller, Tobias/A-8952-2008		German Cancer Foundation [110805]	German Cancer Foundation	This work was supported by research grant 110805 from the German Cancer Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antwih DA, 2013, EPIGENETICS-US, V8, P839, DOI 10.4161/epi.25498; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Aypar U, 2011, MUTAT RES-FUND MOL M, V707, P24, DOI 10.1016/j.mrfmmm.2010.12.003; Bae JH, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1229-6; BERNHARD EJ, 1995, RADIAT ENVIRON BIOPH, V34, P79, DOI 10.1007/BF01275210; Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Chaudhry MA, 2012, DNA CELL BIOL, V31, P908, DOI 10.1089/dna.2011.1509; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Deckbar D, 2011, CRIT REV BIOCHEM MOL, V46, P271, DOI 10.3109/10409238.2011.575764; FRANKENBERGSCHWAGER M, 1990, RADIAT ENVIRON BIOPH, V29, P273, DOI 10.1007/BF01210408; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Goetz W, 2011, RADIAT RES, V175, P575, DOI 10.1667/RR2390.1; HAAF T, 1995, PHARMACOL THERAPEUT, V65, P19, DOI 10.1016/0163-7258(94)00053-6; Haffner MC, 2011, ONCOTARGET, V2, P627; Hayden KE, 2013, MOL CELL BIOL, V33, P763, DOI 10.1128/MCB.01198-12; Holliday R, 2005, BIOCHEMISTRY-MOSCOW+, V70, P500, DOI 10.1007/s10541-005-0144-x; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kaup S, 2006, MUTAT RES-FUND MOL M, V597, P87, DOI 10.1016/j.mrfmmm.2005.06.032; Kinney SM, 2011, J BIOL CHEM, V286, P24685, DOI 10.1074/jbc.M110.217083; KOCHANEK S, 1993, EMBO J, V12, P1141, DOI 10.1002/j.1460-2075.1993.tb05755.x; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Koturbash I, 2005, BIOCHEM BIOPH RES CO, V337, P526, DOI 10.1016/j.bbrc.2005.09.084; Kovalchuk O, 2004, MUTAT RES-FUND MOL M, V548, P75, DOI 10.1016/j.mrfmmm.2003.12.016; Kulis M, 2010, ADV GENET, V70, P27, DOI [10.1016/S0065-2660(10)70002-X, 10.1016/B978-0-12-380866-0.60002-2]; Lahtz Christoph, 2013, F1000Res, V2, P45, DOI 10.12688/f1000research.2-45.v1; Lahtz C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044858; Lee Y, 2015, INT J RADIAT BIOL, V91, P142, DOI 10.3109/09553002.2015.969847; Liang HQ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5048; MAITY A, 1994, RADIOTHER ONCOL, V31, P1, DOI 10.1016/0167-8140(94)90408-1; Pfeifer GP, 2014, CELL TISSUE RES, V356, P631, DOI 10.1007/s00441-014-1896-7; Pidsley R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-293; Pogribny I, 2004, BIOCHEM BIOPH RES CO, V320, P1253, DOI 10.1016/j.bbrc.2004.06.081; Pogrlbny I, 2005, MOL CANCER RES, V3, P553, DOI 10.1158/1541-7786.MCR-05-0074; REIS RJS, 1982, P NATL ACAD SCI-BIOL, V79, P3949, DOI 10.1073/pnas.79.13.3949; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Schneider E, 2016, GENE, V592, P110, DOI 10.1016/j.gene.2016.07.058; SEYSCHAB H, 1993, HUM GENET, V92, P61, DOI 10.1007/BF00216146; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Spiers H, 2015, GENOME RES, V25, P338, DOI 10.1101/gr.180273.114; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tan L, 2012, DEVELOPMENT, V139, P1895, DOI 10.1242/dev.070771; Tawa R, 1998, J RADIAT RES, V39, P271, DOI 10.1269/jrr.39.271; Wagner JR, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r37; Wang X.D., 2014, J APPL MATH, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0090804; WARD JF, 1988, PROG NUCLEIC ACID RE, V35, P95, DOI 10.1016/S0079-6603(08)60611-X; WEVRICK R, 1989, P NATL ACAD SCI USA, V86, P9394, DOI 10.1073/pnas.86.23.9394; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032; Yang H, 2013, ONCOGENE, V32, P663, DOI 10.1038/onc.2012.67; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	52	13	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177442	10.1371/journal.pone.0177442	http://dx.doi.org/10.1371/journal.pone.0177442			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489894	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314100076
J	Marcella, TK; Gende, SM; Roby, DD; Allignol, A				Marcella, Timothy K.; Gende, Scott M.; Roby, Daniel D.; Allignol, Arthur			Disturbance of a rare seabird by ship-based tourism in a marine protected area	PLOS ONE			English	Article							MURRELET BRACHYRAMPHUS-BREVIROSTRIS; BAY NATIONAL-PARK; GLACIER BAY; KITTLITZS MURRELET; COMPETING RISKS; INFORMATION; CONSERVATION; DISTANCES; IMPACTS; PATTERN	Managers of marine protected areas (MPAs) must often seek ways to allow for visitation while minimizing impacts to the resources they are intended to protect. Using shipboard observers, we quantified the "zone of disturbance" for Kittlitz's and marbled murrelets (Brachyramphus brevirostris and B. marmoratus) exposed to large cruise ships traveling through Glacier Bay National Park, one of the largest MPAs in North America. In the upper reaches of Glacier Bay, where Kittlitz's murrelets predominated, binary logistic regression models predicted that 61% of all murrelets within 850 m perpendicular distance of a cruise ship were disturbed (defined as flushing or diving), whereas in the lower reaches, where marbled murrelets predominated, this percentage increased to 72%. Using survival analysis, murrelets in both reaches were found to react at greater distances when ships approached indirectly, presumably because of the ship's larger profile, suggesting murrelets responded to visual rather than audio cues. No management-relevant covariates (e.g., ship velocity, route distance from shore) were found to be important predictors of disturbance, as distance from ship to murrelet accounted for > 90% of the explained variation in murrelet response. Utilizing previously published murrelet density estimates from Glacier Bay, and applying an average empirical disturbance probability (68%) out to 850 m from a cruise ship's typical route, we estimated that a minimum of 9.8-19.6% of all murrelets in Glacier Bay are disturbed per ship entry. Whether these disturbance levels are inconsistent with Park management objectives, which include conserving wildlife as well as providing opportunities for visitation, depends in large part on whether disturbance events caused by cruise ships have impacts on murrelet fitness, which remains uncertain.	[Marcella, Timothy K.] Oregon State Univ, Dept Fisheries & Wildlife, Oregon Cooperat Fish & Wildlife Res Unit, Corvallis, OR 97331 USA; [Gende, Scott M.] Natl Pk Serv, Glacier Bay Field Stn, Juneau, AK USA; [Roby, Daniel D.] Oregon State Univ, US Geol Survey, Oregon Cooperat Fish & Wildlife Res Unit, Corvallis, OR 97331 USA; [Allignol, Arthur] Ulm Univ, Inst Stat, Ulm, Germany; [Marcella, Timothy K.] Quantum Spatial Inc, Corvallis, OR USA	Oregon State University; United States Department of the Interior; Oregon State University; United States Department of the Interior; United States Geological Survey; Ulm University	Gende, SM (corresponding author), Natl Pk Serv, Glacier Bay Field Stn, Juneau, AK USA.	scott_gende@nps.gov			National Park Service (NPS); Pacific Northwest Cooperative Ecosystems Studies Unit Task [J8W07100046]; USGS Oregon Cooperative Fish and Wildlife Research Unit; Oregon State University	National Park Service (NPS); Pacific Northwest Cooperative Ecosystems Studies Unit Task; USGS Oregon Cooperative Fish and Wildlife Research Unit; Oregon State University	Funding and logistical support was provided by the National Park Service (NPS), as part of the Pacific Northwest Cooperative Ecosystems Studies Unit Task Agreement No: J8W07100046 in cooperation with Oregon State University and the USGS Oregon Cooperative Fish and Wildlife Research Unit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding and logistical support was provided by the National Park Service (NPS), as part of the Pacific Northwest Cooperative Ecosystems Studies Unit Task Agreement No: J8W07100046, in cooperation with Oregon State University and the USGS-Oregon Cooperative Fish and Wildlife Research Unit. Additional logistical support was provided by the Holland America Line and Princess Cruises. We would like to acknowledge Dr. Michelle Antolos, Michelle Kissling, Kelsey Brasseur, Leslie Skora, Alishia Zyer, and Melissa Etheridge for their hard work in helping to collect, organize, analyze, and inspire this work. We are particularly grateful to the staff of Glacier Bay National Park and the residents of Gustavus, Alaska, who helped us work and live safely within the Park while completing this study.	Agness AM, 2008, AUK, V125, P346, DOI 10.1525/auk.2008.06203; Agness Alison M., 2013, Marine Ornithology, V41, P13; Allignol A, 2011, J STAT SOFTW, V38, P1; Arimitsu ML, 2007, P 4 GLAC BAY SCI S O, P102; Bejder L, 2006, CONSERV BIOL, V20, P1791, DOI 10.1111/j.1523-1739.2006.00540.x; Bellefleur D, 2009, J ENVIRON MANAGE, V90, P531, DOI 10.1016/j.jenvman.2007.12.002; Bennett NJ, 2014, MAR POLICY, V44, P107, DOI 10.1016/j.marpol.2013.08.017; Beyersmann J., 2012, COMPETING RISKS MULT, DOI DOI 10.7326/0003-4819-153-6-201009210-00005; BirdLife International, 2014, SPEC FACTSH BRACH BR; Breslow NE, 1980, BIRDS N AM; Chatwin TA, 2013, WATERBIRDS, V36, P43, DOI 10.1675/063.036.0108; Christiansen F, 2015, J WILDLIFE MANAGE, V79, P1; Christiansen F, 2013, MAR ECOL PROG SER, V478, P239, DOI 10.3354/meps10163; COX DR, 1972, J R STAT SOC B, V34, P187; Cresswell W, 2000, P ROY SOC B-BIOL SCI, V267, P733, DOI 10.1098/rspb.2000.1064; de Wreede LC, 2011, J STAT SOFTW, V38, P1; Drew GS, 2008, AUK, V125, P178, DOI 10.1525/auk.2008.125.1.178; Fernandez-Juricic E, 2011, BEHAV ECOL, V22, P1304, DOI 10.1093/beheco/arr132; French SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017686; Gende SM, 2011, ECOL APPL, V21, P2232, DOI 10.1890/10-1965.1; Gerrodette T, 2011, MAR MAMMAL SCI, V27, pE101, DOI 10.1111/j.1748-7692.2010.00449.x; Harris K, 2012, ENVIRON MANAGE, V49, P44, DOI 10.1007/s00267-011-9754-9; Hoekman ST, 2013, NPSSEANNRR2013735; Hoyt E., 2011, MARINE PROTECTED ARE; Jansen JK, 2010, J WILDLIFE MANAGE, V74, P1186, DOI 10.2193/2008-192; Jones PJS, 2001, REV FISH BIOL FISHER, V11, P197, DOI 10.1023/A:1020327007975; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kirchhoff MD, 2014, CONDOR, V116, P24, DOI 10.1650/CONDOR-13-123.1; LIMA SL, 1994, J AVIAN BIOL, V25, P319, DOI 10.2307/3677279; Lukacs PM, 2010, CONDOR, V112, P455, DOI 10.1525/cond.2010.090204; Lusseau D, 2005, MAR ECOL PROG SER, V295, P265, DOI 10.3354/meps295265; Mathews EA, 2006, MAR MAMMAL SCI, V22, P167, DOI 10.1111/j.1748-7692.2006.00011.x; National Audubon Society, 2006, AM TOP 10 MOST END R; [National Park Service United States Department of the Interior], 2003, GLAC BAY NAT PARK PR; National Park Service, 2006, MAN POL 2006 GUID MA; NCH Software, 2014, WAVEPAD AUD ED V 4 5; Pennycuik C.J., 1987, P43; Piatt John F., 2011, Marine Ornithology, V39, P65; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Reisdorph SC, 2014, BIOGEOSCIENCES DISCU, V11, P13029; Reyes-Arriagada R, 2013, AVIAN CONSERV ECOL, V8, DOI 10.5751/ACE-00617-080213; Rodgers JA, 2002, CONSERV BIOL, V16, P216, DOI 10.1046/j.1523-1739.2002.00316.x; Ronconi RA, 2002, BIOL CONSERV, V108, P265, DOI 10.1016/S0006-3207(02)00126-X; Rosciano NG, 2013, REV BIOL MAR OCEANOG, V48, P165, DOI 10.4067/S0718-19572013000100014; Rossiter JS, 2014, MAR POLICY, V44, P196, DOI 10.1016/j.marpol.2013.08.022; Saracco James F., 2013, Northwestern Naturalist, V94, P187; Schwemmer P, 2011, ECOL APPL, V21, P1851, DOI 10.1890/10-0615.1; Sergeant CJ, 2017, NPSSEANNRTR20171375; Sergeant CJ, 2015, NPSSEANNRR20151076; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Sirot E, 2006, ANIM BEHAV, V72, P373, DOI 10.1016/j.anbehav.2005.10.028; Venables WN., 2002, MODERN APPL STAT S 4; Webb KR, 2015, COAST MANAGE, V43, P67, DOI 10.1080/08920753.2014.989148; Williams ID, 2009, BIOL CONSERV, V142, P1066, DOI 10.1016/j.biocon.2008.12.029; Young C., 2014, Tourism in Marine Environments, V10, P5, DOI 10.3727/154427314X14056884441626; YOUNG IT, 1977, J HISTOCHEM CYTOCHEM, V25, P935, DOI 10.1177/25.7.894009	56	8	8	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176176	10.1371/journal.pone.0176176	http://dx.doi.org/10.1371/journal.pone.0176176			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489902	gold, Green Published			2022-12-26	WOS:000401314100017
J	Hanoudi, S; Donato, M; Draghici, S				Hanoudi, Samer; Donato, Michele; Draghici, Sorin			Identifying biologically relevant putative mechanisms in a given phenotype comparison	PLOS ONE			English	Article							GENE SET ENRICHMENT; DIFFERENTIAL EXPRESSION; RNA-SEQ; R PACKAGE; PATHWAY; KEGG; RECONSTRUCTION; NETWORKS	A major challenge in life science research is understanding the mechanism involved in a given phenotype. The ability to identify the correct mechanisms is needed in order to understand fundamental and very important phenomena such as mechanisms of disease, immune systems responses to various challenges, and mechanisms of drug action. The current data analysis methods focus on the identification of the differentially expressed (DE) genes using their fold change and/or p-values. Major shortcomings of this approach are that: i) it does not consider the interactions between genes; ii) its results are sensitive to the selection of the threshold(s) used, and iii) the set of genes produced by this approach is not always conducive to formulating mechanistic hypotheses. Here we present a method that can construct networks of genes that can be considered putative mechanisms. The putative mechanisms constructed by this approach are not limited to the set of DE genes, but also considers all known and relevant gene-gene interactions. We analyzed three real datasets for which both the causes of the phenotype, as well as the true mechanisms were known. We show that the method identified the correct mechanisms when applied on microarray datasets from mouse. We compared the results of our method with the results of the classical approach, showing that our method produces more meaningful biological insights.	[Hanoudi, Samer; Donato, Michele; Draghici, Sorin] Wayne State Univ, Dept Comp Sci, Detroit, MI 48202 USA; [Draghici, Sorin] Dept Obstet & Gynecol, Detroit, MI 48202 USA	Wayne State University	Draghici, S (corresponding author), Wayne State Univ, Dept Comp Sci, Detroit, MI 48202 USA.; Draghici, S (corresponding author), Dept Obstet & Gynecol, Detroit, MI 48202 USA.	sorin@wayne.edu	Draghici, Sorin/B-3074-2013	Draghici, Sorin/0000-0002-0786-8377	National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [RO1 DK089167]; National Institutes of Health, National Institute Of General Medical Sciences [STTR R42GM087013]; National Science Foundation [DBI-0965741]; Robert J. Sokol Endowment in Systems Biology; NIH [RO1 DK089167, STTR R42GM087013]; NSF [DBI-0965741]	National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health, National Institute Of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); Robert J. Sokol Endowment in Systems Biology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF))	This work has been partially supported by the following grants: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), RO1 DK089167, (https://www.nih.gov/), National Institutes of Health, National Institute Of General Medical Sciences STTR R42GM087013, (https://www.nih.gov/), National Science Foundation DBI-0965741 (to Sorin Draghici), (https://www.nsf.gov/index.jsp), and by the Robert J. Sokol Endowment in Systems Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.r This work has been partially supported by the following grants: NIH RO1 DK089167, NIH STTR R42GM087013, NSF DBI-0965741 (to Sorin Draghici, and by the Robert J. Sokol Endowment in Systems Biology. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of any of the funding agencies. We would like to thank Rebeca Tagett for her help in the preprocessing of the data.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ansari Sahar, 2017, Proc IEEE Inst Electr Electron Eng, V105, P482, DOI 10.1109/JPROC.2016.2531000; Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562; Bokanizad B, 2016, NUCLEIC ACIDS RES, V44, P5034, DOI 10.1093/nar/gkw429; Butte A J, 2000, Pac Symp Biocomput, P418; Cerami EG, 2011, NUCLEIC ACIDS RES, V39, pD685, DOI 10.1093/nar/gkq1039; Chen C, 2012, AM J PHYSIOL-GASTR L, V302, pG407, DOI 10.1152/ajpgi.00314.2011; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Donato M, 2013, GENOME RES, V23, P1885, DOI 10.1101/gr.153551.112; Dong XR, 2016, SCI REP-UK, V6, DOI 10.1038/srep18871; Draghici S, 2003, GENOMICS, V81, P98, DOI 10.1016/S0888-7543(02)00021-6; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Efron B, 1993, INTRO BOOTSTRAP, P578; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; Ein-Dor L, 2006, P NATL ACAD SCI USA, V103, P5923, DOI 10.1073/pnas.0601231103; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Glaab E, 2012, BIOINFORMATICS, V28, pI451, DOI 10.1093/bioinformatics/bts389; Ha E, 2006, J PINEAL RES, V41, P67, DOI 10.1111/j.1600-079X.2006.00334.x; Hardcastle TJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-422; Hartemink Alexander J, 2002, Pac Symp Biocomput, P437; Jiang CH, 2001, P NATL ACAD SCI USA, V98, P1930, DOI 10.1073/pnas.98.4.1930; Jin Lv, 2014, Genomics Proteomics & Bioinformatics, V12, P210, DOI 10.1016/j.gpb.2014.10.002; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Khatri P, 2002, GENOMICS, V79, P266, DOI 10.1006/geno.2002.6698; Khatri PS, 2005, ENCY GENETICS GENOMI; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Killick R, 2014, J STAT SOFTW, V58, P1; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087; Li J, 2011, BIOSTATISTICS; Li J, 2013, STAT METHODS MED RES, V22, P519, DOI 10.1177/0962280211428386; Liu M, 2007, PLOS GENET, V3, P958, DOI 10.1371/journal.pgen.0030096; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Mitrea C, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00278; Munoz EM, 2007, J NEUROCHEM, V102, P887, DOI 10.1111/j.1471-4159.2007.04605.x; Nguyen T, 2016, P IEEE, VPP, P1; Nicholson DJ, 2012, STUD HIST PHI PART C, V43, P152, DOI 10.1016/j.shpsc.2011.05.014; Pan KH, 2005, P NATL ACAD SCI USA, V102, P8961, DOI 10.1073/pnas.0502674102; Peliciari-Garcia RA, 2010, LIFE SCI, V87, P169, DOI 10.1016/j.lfs.2010.06.005; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Sandberg R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-48; Schurch NJ, 2016, RNA, V22, P839, DOI 10.1261/rna.053959.115; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; ter Linde JJM, 1999, J BACTERIOL, V181, P7409, DOI 10.1128/JB.181.24.7409-7413.1999; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Werhli AV, 2007, STAT APPL GENET MOL, V6; Zeng S, 2012, FASEB J, V26, P882, DOI 10.1096/fj.11-192997; Zhu J, 2004, CYTOGENET GENOME RES, V105, P363, DOI 10.1159/000078209; Zhu J, 2008, NAT GENET, V40, P854, DOI 10.1038/ng.167	58	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0176950	10.1371/journal.pone.0176950	http://dx.doi.org/10.1371/journal.pone.0176950			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486531	Green Submitted, gold, Green Published			2022-12-26	WOS:000401314000029
J	Li, JL; Chen, TS; Yuan, CC; Zhao, GQ; Xu, M; Li, XY; Cao, J; Xing, LH				Li, Junlu; Chen, Tingsang; Yuan, Congcong; Zhao, Guoqiang; Xu, Min; Li, Xiaoyan; Cao, Jie; Xing, Lihua			Effect of intravenous immunoglobulin on the function of Treg cells derived from immunosuppressed mice with Pseudomonas aeruginosa pneumonia	PLOS ONE			English	Article							REGULATORY T-CELLS; IMMUNOLOGICAL SELF-TOLERANCE; SEVERE SEPSIS; SEPTIC SHOCK; CYCLOPHOSPHAMIDE; PATHOGENESIS; INDUCTION; ARTHRITIS; RESPONSES; SURVIVAL	Aim The present study aimed to investigate the effect of intravenous immunoglobulin (IVIG) on regulatory T (Treg) cells derived from immunosuppressed mice with Pseudomonas aeruginosa (PA) pneumonia. Methods A total of 108 BALB/c mice were randomly divided into the following groups: control group (Control), immunosuppressed group (IS), PA pneumonia group (PA), PA pneumonia in immunosuppressed group (IS + PA), PA pneumonia with IVIG treatment in immunocompetent group (PA + IVIG) and PA pneumonia with IVIG treatment in immunosuppressed group (IS + PA + IVIG). Each group comprised 18 mice. The combined PA pneumonia in immunosuppressed model and the treatment models were established. The mice in each group were sacrificed at 4, 8, and 24 h time points. The general condition and pathological changes in the lung tissues of the mice were monitored. Reverse transcription-polymerase chain reaction was used to detect the forkhead box P3 (FOXP3) mRNA relative expression level in the lung tissues. The enzyme-linked immunosorbent assay was used to detect the serum concentration of active transforming growth factor beta (TGF-beta). Results No inflammatory response were exhibited in the lung tissues of the mice in Control group and IS group, while varying degrees of acute lung injury were revealed in the mice in PA group, IS + PA group, PA + IVIG group and IS + PA + IVIG group. Lung tissue injury was most apparent at the 8 h time point, and it indicated the greatest effect in IS + PA group. Whereas tissue damages were alleviated in PA + IVIG group and IS + PA + IVIG group compared with IS + PA group. In addition, tissue damage lessened in PA + IVIG group compared with PA group and IS + PA + IVIG group. FOXP3 mRNA expression levels in the lung tissues and the serum concentration of TGF-beta were lower in IS group, PA group, IS + PA group and IS + PA + IVIG group at the 4, 8 and 24 h time points, respectively compared with Control group. FOXP3 mRNA expression levels decreased in PA + IVIG group at the 4h time point and TGF-beta serum concentrations decreased at the 4 and 8h time points compared with Control group, and subsequently increased. Conclusions In the immunosuppred model with PA pneumonia, the immune system was greatly compromised. IVIG partially restored the immunosuppressed functions of Treg cells, suppressed the overactivated immune system and ameliorated the development of the disease.	[Li, Junlu; Chen, Tingsang; Yuan, Congcong; Li, Xiaoyan; Cao, Jie; Xing, Lihua] Zhengzhou Univ, Affiliated Hosp 1, Dept Resp Intens Care Unit RICU, Zhengzhou, Henan, Peoples R China; [Zhao, Guoqiang] Zhengzhou Univ, Sch Basic Med Sci, Zhengzhou, Henan, Peoples R China; [Xu, Min] Zhengzhou Univ, Affiliated Hosp 1, Dept Lab, Zhengzhou, Henan, Peoples R China	Zhengzhou University; Zhengzhou University; Zhengzhou University	Xing, LH (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Resp Intens Care Unit RICU, Zhengzhou, Henan, Peoples R China.	Lihuaxingricu@163.com			Basic and advanced technology research of Henan Province Science and Technology Department [142 300 410 327]; Medical science and technology research project of Henan Provience [201403060]	Basic and advanced technology research of Henan Province Science and Technology Department; Medical science and technology research project of Henan Provience	Support was provided by Basic and advanced technology research of Henan Province Science and Technology Department, Number: 142 300 410 327; [http://xm.hnkjt.gov.cn/]; and Medical science and technology research project of Henan Provience 201403060. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basta M, 2014, CLIN EXP IMMUNOL, V178, P111, DOI 10.1111/cei.12532; Cattepoel S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161826; Chen Tingsang, 2016, INT J RESP, V36, P445; Eibl MM, 2008, IMMUNOL ALLERGY CLIN, V28, P737, DOI 10.1016/j.iac.2008.06.004; Hill NS, 2001, NEW ENGL J MED, V344, P522, DOI 10.1056/NEJM200102153440711; Jing Gao, 2016, J HUAZHONG UNI SCI T, V36, P653; Kashima H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156643; Katz-Agranov N, 2015, AUTOIMMUN REV, V14, P651, DOI 10.1016/j.autrev.2015.04.003; Kaufman GN, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00469; Laupland KB, 2007, CRIT CARE MED, V35, P2686, DOI 10.1097/01.CCM.0000295312.13466.1C; Le DT, 2012, CANCER RES, V72, P3439, DOI 10.1158/0008-5472.CAN-11-3912; Lee SY, 2014, ARTHRITIS RHEUMATOL, V66, P1768, DOI 10.1002/art.38627; Lu PX, 2016, CENT EUR J IMMUNOL, V41, P143, DOI 10.5114/ceji.2016.60987; Manepalli S, 2013, J MED MICROBIOL, V62, P1747, DOI 10.1099/jmm.0.060004-0; Massoud AH, 2012, J ALLERGY CLIN IMMUN, V129, P1656, DOI 10.1016/j.jaci.2012.02.050; Odeh AN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155648; Radojcic V, 2010, CANCER IMMUNOL IMMUN, V59, P137, DOI 10.1007/s00262-009-0734-3; Restagno D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162109; Rodriguez A, 2005, SHOCK, V23, P298, DOI 10.1097/01.shk.0000157302.69125.f8; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; SCHEDEL I, 1991, CRIT CARE MED, V19, P1104, DOI 10.1097/00003246-199109000-00003; Schmidt A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148474; Schwab I, 2013, NAT REV IMMUNOL, V13, P176, DOI 10.1038/nri3401; Su ZQ, 2014, INT IMMUNOPHARMACOL, V22, P371, DOI 10.1016/j.intimp.2014.06.043; Tai X, 2013, IMMUNITY, V38, P1116, DOI 10.1016/j.immuni.2013.02.022; Travis MA, 2014, ANNU REV IMMUNOL, V32, P51, DOI 10.1146/annurev-immunol-032713-120257; Yayan J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139836; Zuercher AW, 2016, AUTOIMMUN REV, V15, P781, DOI 10.1016/j.autrev.2016.03.018	29	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0176843	10.1371/journal.pone.0176843	http://dx.doi.org/10.1371/journal.pone.0176843			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481908	Green Submitted, Green Published, gold			2022-12-26	WOS:000401313700019
J	Park, HS; Lee, MK; Kim, SC; Yu, JH				Park, Hee-Soo; Lee, Mi-Kyung; Kim, Sun Chang; Yu, Jae-Hyuk			0000 The role of VosA/VelB-activated developmental gene vadA in Aspergillus nidulans	PLOS ONE			English	Article							SECONDARY METABOLISM; ASEXUAL SPORULATION; FILAMENTOUS FUNGI; CONIDIOPHORE DEVELOPMENT; SEXUAL DEVELOPMENT; VEA; EXPRESSION; STERIGMATOCYSTIN; CONIDIATION; FUMIGATUS	The filamentous fungus Aspergillus nidulans primarily reproduces by forming asexual spores called conidia, the integrity of which is governed by the NF-kappa B type velvet regulators VosA and VelB. The VosA-VelB hetero-complex regulates the expression of spore-specific structural and regulatory genes during conidiogenesis. Here, we characterize one of the VosA/VelB-activated developmental genes, called vadA, the expression of which in conidia requires activity of both VosA and VelB. VadA (AN5709) is predicted to be a 532-amino acid length fungal-specific protein with a highly conserved domain of unknown function (DUF) at the N-terminus. This DUF was found to be conserved in many Ascomycota and some Glomeromycota species, suggesting a potential evolutionarily conserved function of this domain in fungi. Deletion studies of vadA indicate that VadA is required for proper downregulation of brlA, fksA, and rodA, and for proper expression of tpsA and orlA during sporogenesis. Moreover, vadA null mutant conidia exhibit decreased trehalose content, but increased beta(1,3)-glucan levels, lower viability, and reduced tolerance to oxidative stress. We further demonstrate that the vadA null mutant shows increased production of the mycotoxin sterigmatocystin. In summary, VadA is a dual-function novel regulator that controls development and secondary metabolism, and participates in bridging differentiation and viability of newly formed conidia in A. nidulans.	[Park, Hee-Soo] Kyungpook Natl Univ, Inst Agr Sci & Technol, Sch Food Sci & Biotechnol, Daegu, South Korea; [Lee, Mi-Kyung; Yu, Jae-Hyuk] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Lee, Mi-Kyung; Yu, Jae-Hyuk] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Kim, Sun Chang] Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon, South Korea	Kyungpook National University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Korea Advanced Institute of Science & Technology (KAIST)	Yu, JH (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.; Yu, JH (corresponding author), Univ Wisconsin, Dept Genet, Madison, WI 53706 USA.	jyu1@wisc.edu	Kim, Sun Chang/C-2026-2011; Yu, Jae-Hyuk/A-2343-2008; Park, Hee-Soo/AAC-6422-2019; Kim, Sun/GSN-4867-2022	Yu, Jae-Hyuk/0000-0002-6530-8407	Research Foundation of Korea (NRF) - Korea government (MSIP) [2016010945]; Intelligent Synthetic Biology Center of Global Frontier Project [2011-0031955]; National Research Foundation of Korea (NRF) grant [2016010945]; Intelligent Synthetic Biology Center of Global Frontier Project - Ministry of Education, Science and Technology [2011-0031955]	Research Foundation of Korea (NRF) - Korea government (MSIP); Intelligent Synthetic Biology Center of Global Frontier Project; National Research Foundation of Korea (NRF) grant; Intelligent Synthetic Biology Center of Global Frontier Project - Ministry of Education, Science and Technology	The work by HSP was supported by the National Research Foundation of Korea (NRF) grant to HSP founded by the Korea government (MSIP: No. 2016010945). This work was in part supported by the Intelligent Synthetic Biology Center of Global Frontier Project (2011-0031955) funded by the Ministry of Education, Science and Technology grants to SCK and JHY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Wendy Bedale of our institute for critically reviewing the manuscript. The work by HSP was supported by the National Research Foundation of Korea (NRF) grant to HSP founded by the Korea government (MSIP: No. 2016010945). This work was in part supported by the Intelligent Synthetic Biology Center of Global Frontier Project (2011-0031955) funded by the Ministry of Education, Science and Technology grants to SCK and JHY.	ADAMS TH, 1988, CELL, V54, P353, DOI 10.1016/0092-8674(88)90198-5; ADAMS TH, 1990, MOL CELL BIOL, V10, P1815, DOI 10.1128/MCB.10.4.1815; Adams TH, 1998, MICROBIOL MOL BIOL R, V62, P35, DOI 10.1128/MMBR.62.1.35-54.1998; ADRIANOPOULOS A, 1991, PLANT CELL, V3, P747, DOI 10.1105/tpc.3.8.747; Ahmed YL, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001750; ANDRIANOPOULOS A, 1994, MOL CELL BIOL, V14, P2503, DOI 10.1128/MCB.14.4.2503; Bayram O, 2008, SCIENCE, V320, P1504, DOI 10.1126/science.1155888; Bayram O, 2012, FEMS MICROBIOL REV, V36, P1, DOI 10.1111/j.1574-6976.2011.00285.x; Bayram OS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001226; Bennett JW, 2010, ASPERGILLUS: MOLECULAR BIOLOGY AND GENOMICS, P1; Beyhan S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001614; BOYLAN MT, 1987, MOL CELL BIOL, V7, P3113, DOI 10.1128/MCB.7.9.3113; Calvo AM, 2004, APPL ENVIRON MICROB, V70, P4733, DOI 10.1128/AEM.70.8.4733-4739.2004; Casselton L, 2002, NAT REV GENET, V3, P683, DOI 10.1038/nrg889; de Vries RP, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1151-0; Dhingra S, 2012, EUKARYOT CELL, V11, P1531, DOI 10.1128/EC.00222-12; Ebbole DJ, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P577; Gugnani HC, 2003, FRONT BIOSCI-LANDMRK, V8, pS346, DOI 10.2741/1002; Kafer E, 1977, Adv Genet, V19, P33, DOI 10.1016/S0065-2660(08)60245-X; Kato N, 2003, EUKARYOT CELL, V2, P1178, DOI 10.1128/EC.2.6.1178-1186.2003; Kim HS, 2002, FUNGAL GENET BIOL, V37, P72, DOI 10.1016/S1087-1845(02)00029-4; Kwon NJ, 2010, FUNGAL GENET BIOL, V47, P981, DOI 10.1016/j.fgb.2010.08.009; MARSHALL MA, 1991, MOL CELL BIOL, V11, P55, DOI 10.1128/MCB.11.1.55; Martinelli S D, 1994, Prog Ind Microbiol, V29, P33; MCKNIGHT GL, 1985, EMBO J, V4, P2093, DOI 10.1002/j.1460-2075.1985.tb03897.x; MIMS CW, 1988, PROTOPLASMA, V144, P132, DOI 10.1007/BF01637246; MIRABITO PM, 1989, CELL, V57, P859, DOI 10.1016/0092-8674(89)90800-3; Ni M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000970; Ni M, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P559; Park HK, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032847, 10.1371/journal.pone.0039921]; Park Hee Soo, 2012, Methods Mol Biol, V944, P183, DOI 10.1007/978-1-62703-122-6_13; Park Hee-Soo, 2016, Microbiology and Biotechnology Letters, V44, P409, DOI 10.4014/mbl.1607.07007; Park HS, 2015, SCI REP-UK, V5, DOI 10.1038/srep10199; Park HS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089883; Park HS, 2012, CURR OPIN MICROBIOL, V15, P669, DOI 10.1016/j.mib.2012.09.006; Park HS, 2012, MOL MICROBIOL, V86, P937, DOI 10.1111/mmi.12032; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Roberts RG, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001751; Samson R A, 1992, Biotechnology, V23, P355; Seo JA, 2003, GENETICS, V165, P1083; SEWALL TC, 1990, DEV BIOL, V138, P499, DOI 10.1016/0012-1606(90)90215-5; Shaaban MI, 2010, EUKARYOT CELL, V9, P1816, DOI 10.1128/EC.00189-10; TIMBERLAKE WE, 1990, ANNU REV GENET, V24, P5, DOI 10.1146/annurev.ge.24.120190.000253; WARING RB, 1989, GENE, V79, P119, DOI 10.1016/0378-1119(89)90097-8; Yu Jae-Hyuk, 2010, Mycobiology, V38, P229, DOI 10.4489/MYCO.2010.38.4.229; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001	46	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177099	10.1371/journal.pone.0177099	http://dx.doi.org/10.1371/journal.pone.0177099			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481894	gold, Green Submitted, Green Published			2022-12-26	WOS:000401313700033
J	Chi, HC; Chen, SL; Lin, SL; Tsai, CY; Chuang, WY; Lin, YH; Huang, YH; Tsai, MM; Yeh, CT; Lin, KH				Chi, H-C; Chen, S-L; Lin, S-L; Tsai, C-Y; Chuang, W-Y; Lin, Y-H; Huang, Y-H; Tsai, M-M; Yeh, C-T; Lin, K-H			Thyroid hormone protects hepatocytes from HBx-induced carcinogenesis by enhancing mitochondrial turnover	ONCOGENE			English	Article							VIRUS-X-PROTEIN; HEPATITIS-B; HEPATOCELLULAR-CARCINOMA; CELL-PROLIFERATION; REDUCTIVE STRESS; LIVER; METASTASIS; ACTIVATION; DEATH; HYPOTHYROIDISM	Infection by hepatitis B virus (HBV) accounts for 50-80% of hepatocellular carcinoma (HCC) development worldwide, in which the HBV-encoded X protein (HBx) has critical role in the induction of carcinogenesis. Several studies have shown that thyroid hormone (TH) suppresses HCC development and protects hepatocytes from HBx-induced damage, thus it is of interest to examine whether TH can protect hepatocytes from HBx-induced carcinogenesis. By treating HBx-transgenic mice with or without TH, we confirmed the protective effects of TH on HBx-induced hepatocarcinogenesis, which was achieved via reduction of reactive oxygen species (ROS) inflicted DNA damage. We further found that TH induced biogenesis of mitochondria (MITO) and autophagy of HBx-targeted MITO simultaneously, consequently leading to suppression of HBx-promoted ROS and carcinogenesis. Using microarray data analysis, this protective effect of TH was found to be mediated via activation of PTEN-induced kinase 1 (PINK1) in hepatocytes. PINK1, in turn, activated and recruited Parkin, an E3 ligase, to ubiquitinate MITO-associated HBx protein and trigger selective mitophagy. The pathological significance of the TH/PINK1 pathway in liver protection was confirmed by the concomitant decrease in expression of both TR and PINK1 in matched HCC tumor tissues and negatively correlated with aggressive progression of cancer and poor prognosis. Our data indicate that TH/PINK1/Parkin pathway has a critical role in protecting hepatocytes from HBx-induced carcinogenesis. Notably, several liver-targeting therapeutic derivatives of TH facilitating prevention or therapy of steatosis have been identified. Furthermore, our proof-of-concept experiments suggest that application of T3 constitutes an effective novel therapeutic or preventive option for HCC. Thus, the utilization of the agonists of TRs could be the meaningful strategy in liver relative diseases, ranging from simple hepatic steatosis to HCC.	[Chi, H-C; Lin, S-L; Lin, Y-H; Lin, K-H] Chang Gung Univ, Dept Biochem, Coll Med, Taoyuan, Taiwan; [Chen, S-L] Natl Cent Univ, Dept Life Sci, Jhongli, Taiwan; [Tsai, C-Y] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Kidney Res Ctr, Taoyuan, Taiwan; [Tsai, C-Y] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Nephrol,Chang Gung Immunol Consortium, Taoyuan, Taiwan; [Chuang, W-Y] Chang Gung Mem Hosp, Dept Pathol, Taoyuan, Taiwan; [Chuang, W-Y] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Huang, Y-H; Yeh, C-T; Lin, K-H] Chang Gung Mem Hosp, Dept Hepatogastroenterol, Liver Res Ctr, Taoyuan, Taiwan; [Tsai, M-M] Chang Gung Univ Sci & Technol, Dept Nursing, Taoyuan, Taiwan; [Tsai, M-M] Chang Gung Mem Hosp, Dept Gen Surg, Chiayi, Taiwan; [Lin, K-H] Chang Gung Univ Sci & Technol, Coll Human Ecol, Res Ctr Chinese Herbal Med, Taoyuan, Taiwan	Chang Gung University; National Central University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University of Science & Technology; Chang Gung Memorial Hospital; Chang Gung University of Science & Technology	Lin, KH (corresponding author), Chang Gung Univ, Dept Biochem, 259 Wen Hwa 1 Rd, Taoyuan, Taiwan.	khlin@mail.cgu.edu.tw	Chuang, Wen-Yu/I-8013-2019	Chuang, Wen-Yu/0000-0002-3729-073X	Chang Gung Memorial Hospital, Taoyuan, Taiwan [CRRPD1F0011, CRRPD1F0012]; Ministry of Science and Technology of the Republic of China [MOST 103-2320-B-182-018-MY3, 103-2320-B-182-017-MY3, 105-2811-B-182-018, 105-2321-B-182-002-MY3]	Chang Gung Memorial Hospital, Taoyuan, Taiwan(Chang Gung Memorial Hospital); Ministry of Science and Technology of the Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by grants from Chang Gung Memorial Hospital, Taoyuan, Taiwan (CRRPD1F0011, CRRPD1F0012) and from the Ministry of Science and Technology of the Republic of China (MOST 103-2320-B-182-018-MY3, 103-2320-B-182-017-MY3, 105-2811-B-182-018, 105-2321-B-182-002-MY3). Accession number of transcript profiling: GEO accession: GSE14520.	BARLOW C, 1994, EMBO J, V13, P4241, DOI 10.1002/j.1460-2075.1994.tb06744.x; Calvisi DF, 2006, GASTROENTEROLOGY, V130, P1117, DOI 10.1053/j.gastro.2006.01.006; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; Chi HC, 2012, CELL DEATH DIFFER, V19, P1802, DOI 10.1038/cdd.2012.58; Chi HC, 2016, AUTOPHAGY, V12, P2271, DOI 10.1080/15548627.2016.1230583; Clippinger AJ, 2008, J VIROL, V82, P6798, DOI 10.1128/JVI.00154-08; Columbano A, 1996, FASEB J, V10, P1118, DOI 10.1096/fasebj.10.10.8751714; DAWSON TL, 1993, AM J PHYSIOL, V264, pC961, DOI 10.1152/ajpcell.1993.264.4.C961; Dias V, 2013, J PARKINSON DIS, V3, P461, DOI 10.3233/JPD-130230; FARBER E, 1991, DIGEST DIS SCI, V36, P973, DOI 10.1007/BF01297150; Frau C, 2015, HEPATOLOGY, V61, P249, DOI 10.1002/hep.27399; Gentric G, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/282430; GORES GJ, 1989, AM J PHYSIOL, V257, pC347, DOI 10.1152/ajpcell.1989.257.2.C347; GROSS NJ, 1971, J CELL BIOL, V48, P29, DOI 10.1083/jcb.48.1.29; Harper ME, 2008, THYROID, V18, P145, DOI 10.1089/thy.2007.0250; Hassan MM, 2009, HEPATOLOGY, V49, P1563, DOI 10.1002/hep.22793; Hunter J, 1996, MOL CELL ENDOCRINOL, V116, P213, DOI 10.1016/0303-7207(95)03717-9; Jiang TY, 2016, P NATL ACAD SCI USA, V113, P2074, DOI 10.1073/pnas.1525616113; KEKULE AS, 1993, NATURE, V361, P742, DOI 10.1038/361742a0; Kim HJ, 2008, IUBMB LIFE, V60, P473, DOI 10.1002/iub.68; Kim SJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003722; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Kremsdorf D, 2006, ONCOGENE, V25, P3823, DOI 10.1038/sj.onc.1209559; Ledda-Columbano GM, 2000, CANCER RES, V60, P603; Ledda-Columbano GM, 1999, CARCINOGENESIS, V20, P2299, DOI 10.1093/carcin/20.12.2299; Lee S, 2014, TOX RESEARCH, V30, P243, DOI 10.5487/TR.2014.30.4.243; Lee YI, 2004, J BIOL CHEM, V279, P15460, DOI 10.1074/jbc.M309280200; Lin YH, 2013, ONCOGENE, V32, P3904, DOI 10.1038/onc.2013.5; Ma NF, 2008, CLIN CANCER RES, V14, P5061, DOI 10.1158/1078-0432.CCR-07-5082; Malhi H, 2008, GASTROENTEROLOGY, V134, P1641, DOI 10.1053/j.gastro.2008.03.002; Mansour-Ghanaei F, 2012, ANN HEPATOL, V11, P667, DOI 10.1016/S1665-2681(19)31440-1; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Nguyen VTT, 2009, J VIRAL HEPATITIS, V16, P453, DOI 10.1111/j.1365-2893.2009.01117.x; Perra A, 2008, FASEB J, V22, P2981, DOI 10.1096/fj.08-108464; Perra A, 2009, HEPATOLOGY, V49, P1287, DOI 10.1002/hep.22750; PRESTONMARTIN S, 1990, CANCER RES, V50, P7415; Rahmani Z, 2000, J VIROL, V74, P2840, DOI 10.1128/JVI.74.6.2840-2846.2000; Roessler S, 2010, CANCER RES, V70, P10202, DOI 10.1158/0008-5472.CAN-10-2607; SAP J, 1986, NATURE, V324, P635, DOI 10.1038/324635a0; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490; Shirakata Y, 2003, J BIOL CHEM, V278, P22071, DOI 10.1074/jbc.M301606200; Sinha RA, 2015, AUTOPHAGY, V11, P1341, DOI 10.1080/15548627.2015.1061849; Sinha RA, 2012, J CLIN INVEST, V122, P2428, DOI 10.1172/JCI60580; Sullivan LB, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-17; Sze KMF, 2013, HEPATOLOGY, V57, P131, DOI 10.1002/hep.25979; Takada S, 1999, ONCOGENE, V18, P6965, DOI 10.1038/sj.onc.1203188; Terradillos O, 2002, ONCOGENE, V21, P377, DOI 10.1038/sj.onc.1205110; Tseng YH, 2014, AUTOPHAGY, V10, P20, DOI 10.4161/auto.26126; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Waris G, 2001, MOL CELL BIOL, V21, P7721, DOI 10.1128/MCB.21.22.7721-7730.2001; Weitzel JM, 2011, MOL CELL ENDOCRINOL, V342, P1, DOI 10.1016/j.mce.2011.05.009; Wu BK, 2006, BIOCHEM BIOPH RES CO, V340, P916, DOI 10.1016/j.bbrc.2005.12.089; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028	56	34	36	3	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 14	2017	36	37					5274	5284		10.1038/onc.2017.136	http://dx.doi.org/10.1038/onc.2017.136			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FG8HT	28504722				2022-12-26	WOS:000410671700006
J	Goto, H; Kariya, R; Kudo, E; Okuno, Y; Ueda, K; Katano, H; Okada, S				Goto, H.; Kariya, R.; Kudo, E.; Okuno, Y.; Ueda, K.; Katano, H.; Okada, S.			Restoring PU.1 induces apoptosis and modulates viral transactivation via interferon-stimulated genes in primary effusion lymphoma	ONCOGENE			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; ACUTE MYELOID-LEUKEMIA; KAPOSIS-SARCOMA; CELL-LINE; TRANSCRIPTION FACTOR; REGULATED GENES; EXPRESSION; GROWTH; AIDS; ELEMENTS	Primary effusion lymphoma (PEL), which is an aggressive subgroup of B-cell lymphoma associated with Kaposi sarcoma-associated herpes virus/human herpes virus-8, is refractory to the standard treatment, and exhibits a poor survival. Although PU.1 is downregulated in PEL, the potential role of its reduction remains to be elucidated. In this investigation, we analyzed the DNA methylation of PU.1 cis-regulatory elements in PEL and the effect of restoring PU.1 on PEL cells. The mRNA level of PU.1 was downregulated in PEL cells. The methylated promoter and enhancer regions of the PU.1 gene were detected in PEL cells. Suppression of cell growth and apoptosis were caused by the restoration of PU.1 in PEL cells. A microarray analysis revealed that interferon-stimulated genes (ISGs) including pro-apoptotic ISGs were strongly increased in BCBL-1 cells after the induction of PU.1. Reporter assays showed that PU.1 transactivated pro-apoptotic ISG promoters, such as the XAF1, OAS1 and TRAIL promoters. Mutations at the PU.1 binding sequences suppressed its transactivation. We confirmed the binding of PU.1 to the XAF1, OAS1 and TRAIL promoters in a chromatin immunoprecipitation assay. PU.1 suppressed ORF57 activation by inducing IRF7. The reinduction of PU.1 reduced formation of ascites and lymphoma cell infiltration of distant organs in PEL xenograft model mice. Collectively, PU.1 has a role in tumor suppression in PEL and its down-regulation is associated with PEL development. Restoring PU.1 with demethylation agents may be a novel therapeutic approach for PEL.	[Goto, H.; Kariya, R.; Kudo, E.; Okada, S.] Kumamoto Univ, Div Hematopoiesis, Ctr AIDS Res, Honjo, Kumamoto, Japan; [Okuno, Y.] Kumamoto Univ, Grad Sch Med, Dept Hematol, Honjo, Kumamoto, Japan; [Okuno, Y.] Kumamoto Univ, Grad Sch Med, Dept Rheumatol, Honjo, Kumamoto, Japan; [Okuno, Y.] Kumamoto Univ, Grad Sch Med, Dept Infect Dis, Honjo, Kumamoto, Japan; [Ueda, K.] Osaka Univ, Grad Sch Med, Dept Microbiol & Immunol, Div Virol, Suita, Osaka, Japan; [Katano, H.] Natl Inst Infect Dis, Dept Pathol, Shinjuku Ku, Toyama, Tokyo, Japan	Kumamoto University; Kumamoto University; Kumamoto University; Kumamoto University; Osaka University; National Institute of Infectious Diseases (NIID)	Okada, S (corresponding author), Kumamoto Univ, Ctr AIDS Res, Div Hematopoiesis, Chuo Ku, 2-2-1 Honjo, Kumamoto 8600811, Japan.	okadas@kumamoto-u.ac.jp		Okada, Seiji/0000-0003-3124-5206	Japan Agency for Medical Research and Development, AMED [17fk0410208h0002]; Ministry of Education, Science, Sports, and Culture of Japan [16K08742]; Grants-in-Aid for Scientific Research [16H07080] Funding Source: KAKEN	Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Research program on HIV/AIDS (No. 17fk0410208h0002) from the Japan Agency for Medical Research and Development, AMED, and Grants-in-Aid for Science Research (No. 16K08742) from the Ministry of Education, Science, Sports, and Culture of Japan.	Ansari MQ, 1996, AM J CLIN PATHOL, V105, P221; Arguello M, 2003, ONCOGENE, V22, P964, DOI 10.1038/sj.onc.1206270; Boulanger E, 2005, J CLIN ONCOL, V23, P4372, DOI 10.1200/JCO.2005.07.084; Castelli JC, 1998, CELL DEATH DIFFER, V5, P313, DOI 10.1038/sj.cdd.4400352; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; Chawla-Sarkar M, 2003, APOPTOSIS, V8, P237, DOI 10.1023/A:1023668705040; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Deng H, 2007, CURR TOP MICROBIOL, V312, P157; Domingo-Gil E, 2006, APOPTOSIS, V11, P725, DOI 10.1007/s10495-006-5541-0; DONG BH, 1995, J BIOL CHEM, V270, P4133, DOI 10.1074/jbc.270.8.4133; EISENBEIS CF, 1993, MOL CELL BIOL, V13, P6452, DOI 10.1128/MCB.13.10.6452; Fan W, 2005, J VIROL, V79, P1244, DOI 10.1128/JVI.79.2.1244-1251.2005; Goto H, 2015, J CANCER RES CLIN, V141, P465, DOI 10.1007/s00432-014-1842-9; Goto H, 2014, EUR J CANCER, V50, P1836, DOI 10.1016/j.ejca.2014.03.004; Goto H, 2013, INT J HEMATOL, V97, P624, DOI 10.1007/s12185-013-1339-3; Goto H, 2012, CANCER SCI, V103, P775, DOI 10.1111/j.1349-7006.2012.02212.x; Gradoville L, 2000, J VIROL, V74, P6207, DOI 10.1128/JVI.74.13.6207-6212.2000; Hussain AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039945; Iwasaki H, 2005, BLOOD, V106, P1590, DOI 10.1182/blood-2005-03-0860; Katano H, 1999, J MED VIROL, V58, P394, DOI 10.1002/(SICI)1096-9071(199908)58:4&lt;394::AID-JMV12&gt;3.0.CO;2-H; Katano H, 1999, AM J PATHOL, V155, P47, DOI 10.1016/S0002-9440(10)65097-3; Leaman DW, 2002, J BIOL CHEM, V277, P28504, DOI 10.1074/jbc.M204851200; Li YL, 2001, BLOOD, V98, P2958, DOI 10.1182/blood.V98.10.2958; Liston P, 2001, NAT CELL BIOL, V3, P128, DOI 10.1038/35055027; Majerciak V, 2009, FRONT BIOSCI-LANDMRK, V14, P1516, DOI 10.2741/3322; Miyagi J, 2002, INT J HEMATOL, V76, P165, DOI 10.1007/BF02982580; Moore PS, 2001, PHILOS T R SOC B, V356, P499, DOI 10.1098/rstb.2000.0777; MOREAUGACHELIN F, 1994, BBA-REV CANCER, V1198, P149, DOI 10.1016/0304-419X(94)90011-6; Nador RG, 1996, BLOOD, V88, P645, DOI 10.1182/blood.V88.2.645.bloodjournal882645; NELSEN B, 1993, SCIENCE, V261, P82, DOI 10.1126/science.8316859; Nishiyama C, 2002, J IMMUNOL, V168, P4546, DOI 10.4049/jimmunol.168.9.4546; Nutt SL, 2005, J EXP MED, V201, P221, DOI 10.1084/jem.20041535; Okada S, 2014, INTRACTABLE RARE DIS, V3, P65, DOI 10.5582/irdr.2014.01010; Palmeri D, 2007, J VIROL, V81, P13299, DOI 10.1128/JVI.00732-07; Pang SHM, 2016, LEUKEMIA, V30, P1375, DOI 10.1038/leu.2016.27; PONGUBALA JMR, 1992, MOL CELL BIOL, V12, P368, DOI 10.1128/MCB.12.1.368; Rosenbauer F, 2006, NAT GENET, V38, P27, DOI 10.1038/ng1679; Rosenbauer F, 2004, NAT GENET, V36, P624, DOI 10.1038/ng1361; Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215; Samarajiwa SA, 2009, NUCLEIC ACIDS RES, V37, pD852, DOI 10.1093/nar/gkn732; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Solomon LA, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1303-0; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Tatetsu H, 2007, CANCER RES, V67, P5328, DOI 10.1158/0008-5472.CAN-06-4265; Uddin S, 2005, ONCOGENE, V24, P7022, DOI 10.1038/sj.onc.1208864; Uddin S, 2005, CLIN CANCER RES, V11, P3102, DOI 10.1158/1078-0432.CCR-04-1857; Ueda K, 2002, J VIROL, V76, P12044, DOI 10.1128/JVI.76.23.12044-12054.2002; Ueno S, 2009, ONCOGENE, V28, P4116, DOI 10.1038/onc.2009.263; Wang JZ, 2005, J VIROL, V79, P2420, DOI 10.1128/JVI.79.4.2420-2431.2005; Wang S, 2001, ARCH VIROL, V146, P1415, DOI 10.1007/s007050170102; Will B, 2015, NAT MED, V21, P1172, DOI 10.1038/nm.3936; Yuki H, 2013, BLOOD, V121, P962, DOI 10.1182/blood-2012-05-431429; Zou B, 2012, MOL CARCINOGEN, V51, P422, DOI 10.1002/mc.20807	54	4	4	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 14	2017	36	37					5252	5262		10.1038/onc.2017.138	http://dx.doi.org/10.1038/onc.2017.138			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FG8HT	28481873				2022-12-26	WOS:000410671700004
J	Shi, JX; Wang, YF; He, J; Li, PP; Jin, R; Wang, K; Xu, X; Hao, J; Zhang, Y; Liu, HJ; Chen, XP; Wu, HN; Ge, Q				Shi, Junxiu; Wang, Yifan; He, Jian; Li, Pingping; Jin, Rong; Wang, Ke; Xu, Xi; Hao, Jie; Zhang, Yan; Liu, Hongju; Chen, Xiaoping; Wu, Hounan; Ge, Qing			Intestinal microbiota contributes to colonic epithelial changes in simulated microgravity mouse model	FASEB JOURNAL			English	Article						intestinal epithelial cells; homeostasis; colitis	SEGMENTED FILAMENTOUS BACTERIA; GERM-FREE; BARRIER FUNCTION; GUT MICROBIOTA; CELL-DEATH; VIRULENCE; MUCOSAL; MUCUS; HOMEOSTASIS; MICE	Exposure to microgravity leads to alterations in multiple systems, but microgravity-related changes in the gastrointestinal tract and its clinical significance have not been well studied. We used the hindlimb unloading (HU) mouse model to simulate a microgravity condition and investigated the changes in intestinal microbiota and colonic epithelial cells. Compared with ground-based controls (Ctrls), HU affected fecal microbiota composition with a profile that was characterized by the expansion of Firmicutes and decrease of Bacteroidetes. The colon epithelium of HU mice showed decreased goblet cell numbers, reduced epithelial cell turnover, and decreased expression of genes that are involved in defense and inflammatory responses. As a result, increased susceptibility to dextran sulfate sodium-induced epithelial injury was observed in HU mice. Cohousing of Ctrl mice with HU mice resulted in HU like epithelial changes in Ctrl mice. Transplantation of feces from Ctrl to HU mice alleviated these epithelial changes in HU mice. Results indicate that HU changes intestinal microbiota, which leads to altered colonic epithelial cell homeostasis, impaired barrier function, and increased susceptibility to colitis. We further demonstrate that alteration in gastrointestinal motility may contribute to HU-associated dysbiosis. These animal results emphasize the necessity of evaluating astronauts' intestinal homeostasis during distant space travel.	[Shi, Junxiu; Wang, Yifan; Jin, Rong; Wang, Ke; Hao, Jie; Zhang, Yan; Ge, Qing] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Key Lab Med Immunol,Minist Hlth,Dept Immunol, Beijing, Peoples R China; [Wu, Hounan] Peking Univ, Hlth Sci Ctr, Med & Hlth Analyt Ctr, Beijing, Peoples R China; [He, Jian] Chinese Astronaut Res & Training Ctr, State Key Lab Space Med Fundamentals & Applicat, Beijing, Peoples R China; [Li, Pingping; Liu, Hongju; Chen, Xiaoping] China Med Univ, Shengjing Hosp, Shenyang, Peoples R China; [Xu, Xi] Nanjing Univ Sci & Technol, Ctr Mol Metab, Nanjing, Jiangsu, Peoples R China	Peking University; Peking University; China Medical University; Nanjing University of Science & Technology	Wu, HN; Ge, Q (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Immunol, 38 Xue Yuan Rd, Beijing 100191, Peoples R China.	wuhounan@bjmu.edu.cn; qingge@bjmu.edu.cn	Shi, Junxiu/M-1393-2019; Li, Ping/GYV-4914-2022; Shi, Junxiu/GXH-8588-2022	he, jian/0000-0002-8632-4924	National Natural Science Foundation of China [31671244, 81471525, 31270935]; Foundation for Innovative Research Groups of the National Natural Science Foundation of China [81621001]; Beijing Natural Science Foundation [5152010]; Natural Basic Research Program of China [2011CB711000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for Innovative Research Groups of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Natural Basic Research Program of China(National Basic Research Program of China)	This work was supported by grants from the National Natural Science Foundation of China (31671244, 81471525, and 31270935 to Q.G.), the Foundation for Innovative Research Groups of the National Natural Science Foundation of China (81621001 to Q.G.), Beijing Natural Science Foundation (5152010 to Q.G.), and the Natural Basic Research Program of China (2011CB711000 to Q.G.). The authors thank Professors Xiaohuan Guo (Qinghua University, Beijing, China), Zhihua Liu (Institute of Biophysics, Chinese Academy of Sciences, Beijing, China), Kunshan Zhang (Tongji University, Shanghai, China), Xiaoyan Qiu, and Pingzhang Wang (Peking University Health Science Center) for data analysis and helpful discussions. The authors declare no conflicts of interest.	ABRAMS GD, 1963, LAB INVEST, V12, P355; Al-Asmakh M, 2015, J MICROBIOL BIOTECHN, V25, P1583, DOI 10.4014/jmb.1501.01039; Allen CA, 2008, ENVIRON MICROBIOL, V10, P1512, DOI 10.1111/j.1462-2920.2008.01567.x; AMIDON GL, 1991, J CLIN PHARMACOL, V31, P968, DOI 10.1002/j.1552-4604.1991.tb03658.x; Atiakshin D A, 2011, Aviakosm Ekolog Med, V45, P25; Backhed F, 2007, P NATL ACAD SCI USA, V104, P606, DOI 10.1073/pnas.0605957104; Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07; Barzegari A, 2012, FUTURE MICROBIOL, V7, P571, DOI [10.2217/FMB.12.37, 10.2217/fmb.12.37]; Bergstrom KSB, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005108; Birchenough GMH, 2016, SCIENCE, V352, P1535, DOI 10.1126/science.aaf7419; BROWN LR, 1976, J AM DENT ASSOC, V93, P357, DOI 10.14219/jada.archive.1976.0502; Cervantes JL, 2016, INT REV IMMUNOL, V35, P67, DOI 10.3109/08830185.2015.1027821; CHAPES SK, 1993, J LEUKOCYTE BIOL, V54, P227, DOI 10.1002/jlb.54.3.227; Chopra V, 2006, J TOXICOL ENV HEAL A, V69, P1345, DOI 10.1080/15287390500361792; Coskun M, 2013, PHARMACOL RES, V76, P1, DOI 10.1016/j.phrs.2013.06.007; Crawford PA, 2005, P NATL ACAD SCI USA, V102, P13254, DOI 10.1073/pnas.0504830102; DECELLE JG, 1976, APPL ENVIRON MICROB, V32, P659, DOI 10.1128/AEM.32.5.659-665.1976; Delgado ME, 2016, FEBS J, V283, P2701, DOI 10.1111/febs.13575; Drossman DA, 2016, GASTROENTEROLOGY, V150, P1262, DOI 10.1053/j.gastro.2016.02.032; Giogha C, 2014, CYTOKINE GROWTH F R, V25, P235, DOI 10.1016/j.cytogfr.2013.12.012; Hansen CHF, 2013, GUT MICROBES, V4, P241, DOI 10.4161/gmic.23999; Harm DL, 2002, DIGEST DIS SCI, V47, P1737, DOI 10.1023/A:1016480109272; Higginson EE, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw095; Hudson LE, 2017, CLIN MICROBIOL REV, V30, P191, DOI 10.1128/CMR.00049-16; Ilyin VK, 2005, ACTA ASTRONAUT, V56, P839, DOI 10.1016/j.actaastro.2005.01.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Iwai H, 2007, CELL, V130, P611, DOI 10.1016/j.cell.2007.06.043; Johansson MEV, 2013, DIGEST DIS, V31, P305, DOI 10.1159/000354683; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kabat AM, 2014, TRENDS IMMUNOL, V35, P507, DOI 10.1016/j.it.2014.07.010; Klaus DM, 2006, TRENDS BIOTECHNOL, V24, P131, DOI 10.1016/j.tibtech.2006.01.008; Kriegel MA, 2011, P NATL ACAD SCI USA, V108, P11548, DOI 10.1073/pnas.1108924108; Kubinak JL, 2015, CELL HOST MICROBE, V17, P153, DOI 10.1016/j.chom.2014.12.009; Kuwahara T, 2011, DNA RES, V18, P291, DOI 10.1093/dnares/dsr022; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Li PP, 2015, FASEB J, V29, P3263, DOI 10.1096/fj.15-271700; LIZKO NN, 1991, ACTA ASTRONAUT, V23, P163, DOI 10.1016/0094-5765(91)90115-L; Lopez-Posadas R, 2017, CELL MOL LIFE SCI, V74, P803, DOI 10.1007/s00018-016-2363-2; Lung TWF, 2014, CELL MICROBIOL, V16, P1736, DOI 10.1111/cmi.12371; McCarville JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068961; McCauley HA, 2015, TRENDS MOL MED, V21, P492, DOI 10.1016/j.molmed.2015.06.003; Mori T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076941; Nefedov Y G, 1971, Life Sci Space Res, V9, P11; Negroni A, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/250762; Nickerson CA, 2004, MICROBIOL MOL BIOL R, V68, P345, DOI 10.1128/MMBR.68.2.345-361.2004; Nickerson CA, 2000, INFECT IMMUN, V68, P3147, DOI 10.1128/IAI.68.6.3147-3152.2000; Nowarski R, 2015, CELL, V163, P1444, DOI 10.1016/j.cell.2015.10.072; Pearson JS, 2013, NATURE, V501, P247, DOI 10.1038/nature12524; Pelaseyed T, 2014, IMMUNOL REV, V260, P8, DOI 10.1111/imr.12182; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Reading NC, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00148; Ritchie LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125792; SAVAGE DC, 1981, APPL ENVIRON MICROB, V42, P996, DOI 10.1128/AEM.42.6.996-1001.1981; SAWYER HR, 1992, J APPL PHYSIOL, V73, pS148, DOI 10.1152/jappl.1992.73.2.S148; Seedorf H, 2014, CELL, V159, P253, DOI 10.1016/j.cell.2014.09.008; Shan MM, 2013, SCIENCE, V342, P447, DOI 10.1126/science.1237910; Shih VFS, 2014, P NATL ACAD SCI USA, V111, P13942, DOI 10.1073/pnas.1323852111; SHUBICH MG, 1977, KOSM BIOL AVIAK MED+, V11, P40; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Somova LA, 2005, ADV SPACE RES-SERIES, V35, P1621, DOI 10.1016/j.asr.2004.12.046; Stepankova R, 2007, INFLAMM BOWEL DIS, V13, P1202, DOI 10.1002/ibd.20221; Stowe RP, 1999, J LEUKOCYTE BIOL, V65, P179, DOI 10.1002/jlb.65.2.179; Tanoue T, 2012, SEMIN IMMUNOL, V24, P50, DOI 10.1016/j.smim.2011.11.009; Thelemann C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086844; Tomas J, 2016, P NATL ACAD SCI USA, V113, pE5934, DOI 10.1073/pnas.1612559113; Vandeputte D, 2016, GUT, V65, P57, DOI 10.1136/gutjnl-2015-309618; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Versari S, 2013, FASEB J, V27, P4466, DOI 10.1096/fj.13-229195; Wallace KL, 2014, WORLD J GASTROENTERO, V20, P6, DOI 10.3748/wjg.v20.i1.6; Weigmann B, 2007, NAT PROTOC, V2, P2307, DOI 10.1038/nprot.2007.315; Wilson JW, 2007, P NATL ACAD SCI USA, V104, P16299, DOI 10.1073/pnas.0707155104; Wilson JW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003923; Zhang KY, 2015, CELL MICROBIOL, V17, P1561, DOI 10.1111/cmi.12501; Zhou Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044329; Zigmond E, 2012, IMMUNITY, V37, P1076, DOI 10.1016/j.immuni.2012.08.026	75	33	36	2	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3695	3709		10.1096/fj.201700034R	http://dx.doi.org/10.1096/fj.201700034R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28495755				2022-12-26	WOS:000405932400040
J	Ricciardi, A; Gentilotti, E; Coppola, L; Maffongelli, G; Cerva, C; Malagnino, V; Mari, A; Di Veroli, A; Berrilli, F; Apice, F; Toschi, N; Di Cave, D; Parisi, SG; Andreoni, M; Sarmati, L				Ricciardi, Alessandra; Gentilotti, Elisa; Coppola, Luigi; Maffongelli, Gaetano; Cerva, Carlotta; Malagnino, Vincenzo; Mari, Alessia; Di Veroli, Ambra; Berrilli, Federica; Apice, Fabiana; Toschi, Nicola; Di Cave, David; Parisi, Saverio Giuseppe; Andreoni, Massimo; Sarmati, Loredana			Infectious disease ward admission positively influences P.jiroveci pneumonia (PjP) outcome: A retrospective analysis of 116 HIV-positive and HIV-negative immunocompromised patients	PLOS ONE			English	Article							PNEUMOCYSTIS-JIROVECII PNEUMONIA; HUMAN-IMMUNODEFICIENCY-VIRUS; CELL TRANSPLANT RECIPIENTS; POLYMERASE-CHAIN-REACTION; REAL-TIME PCR; HEMATOLOGICAL MALIGNANCIES; RESPIRATORY SPECIMENS; CARINII; DNA; EPIDEMIOLOGY	P. jiroveci (Pj) causes a potentially fatal pneumonia in immunocompromised patients and the factors associated with a bad outcome are poorly understood. A retrospective analysis on Pj pneumonia (PjP) cases occurring in Tor Vergata University Hospital, Italy, during the period 2011-2015. The patients' demographic, clinical and radiological characteristics and the Pj genotypes were considered. The study population included 116 patients, 37.9% of whom had haematological malignancy or underwent haematological stem cell transplantation (HSCT), 22.4% had HIV infection, 16.4% had chronic lung diseases (CLD), 7.8% had a solid cancer, and 3.4% underwent a solid organ transplant (SOT). The remaining 12.1% had a miscellaneous other condition. At univariate analysis, being older than 60 years was significantly correlated with a severe PjP (OR [95% CI] 2.52 [0.10-5.76]; p = 0.031) and death (OR [95% CI] 2.44 [1.05-5.70]; p = 0.036), while a previous trimethoprim/sulfamethoxazole (TMP/SMX) prophylaxis were significantly associated with a less severe pneumonia (OR [95% CI] 0.35 [0.15-0.84], p = 0.023); moreover, death due to PjP was significantly more frequent in patients with CLD (OR[95% CI] 3.26 [1.17-9.05]; p = 0.019) while, admission to the Infectious Diseases Unit was significantly associated with fewer deaths (OR[95% CI] 0.10 [0.03-0.36], p = 0.002). At multivariate analysis, a better PjP outcome was observed in patients taking TMP/ SMX prophylaxis and that were admitted to the Infectious Diseases Unit (OR[95% CI] 0.27 [0.07-1.03], p = 0.055, OR[95% CI] 0.16 [0.05-0.55]; p = 0.004, respectively).	[Ricciardi, Alessandra; Gentilotti, Elisa; Coppola, Luigi; Maffongelli, Gaetano; Cerva, Carlotta; Malagnino, Vincenzo; Andreoni, Massimo; Sarmati, Loredana] Tor Vergata Univ, Infect Dis, Rome, Italy; [Mari, Alessia] Tor Vergata Univ, Resp Dis Unit, Rome, Italy; [Di Veroli, Ambra] Tor Vergata Univ, Dept Haematol, Rome, Italy; [Berrilli, Federica; Apice, Fabiana; Di Cave, David] Tor Vergata Univ, Dept Clin Sci & Translat Med, Rome, Italy; [Toschi, Nicola] Tor Vergata Univ, Dept Biomed & Prevent, Rome, Italy; [Toschi, Nicola] Athinoula A Martinos Ctr Biomed Imaging, Dept Radiol, Boston, MA USA; [Toschi, Nicola] Harvard Med Sch, Boston, MA USA; [Parisi, Saverio Giuseppe] Univ Padua, Dept Mol Med, Padua, Italy; [Parisi, Saverio Giuseppe] Padua Univ Hosp, Clin Microbiol & Virol Unit, Padua, Italy	University of Rome Tor Vergata; University of Rome Tor Vergata; University of Rome Tor Vergata; University of Rome Tor Vergata; University of Rome Tor Vergata; Harvard University; Harvard Medical School; University of Padua; University of Padua; Azienda Ospedaliera - Universita di Padova	Sarmati, L (corresponding author), Tor Vergata Univ, Infect Dis, Rome, Italy.	sarmati@med.uniroma2.it	Toschi, Nicola/J-2555-2012; Andreoni, Masimo/AAL-2214-2020; Maffongelli, Gaetano/AAB-8651-2022	Toschi, Nicola/0000-0003-1929-5833; MAFFONGELLI, GAETANO/0000-0001-7784-2511; Malagnino, Vincenzo/0000-0002-6561-5298; Gentilotti, Elisa/0000-0001-6018-5295; Cerva, Carlotta/0000-0001-9060-7313; sarmati, loredana/0000-0003-1452-0333	Abbvie; Bristol-Myers Squibb; Gilead Sciences; Merck Sharp Dohme; ViiV Healthcare; Janssen-Cilag; Gilead	Abbvie(AbbVie); Bristol-Myers Squibb(Bristol-Myers Squibb); Gilead Sciences(Gilead Sciences); Merck Sharp Dohme(Merck & Company); ViiV Healthcare; Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Gilead(Gilead Sciences)	MA and SGP have received speaker fees, travel grants, and consulting fees from Abbvie, Bristol-Myers Squibb, Gilead Sciences, Merck Sharp & Dohme, ViiV Healthcare, and Janssen-Cilag. LS has received travel grants from Gilead Sciences and Merck Sharp & Dohme, payment for lectures from Gilead Sciences, Merck Sharp & Dohme and Abbvie and researcher funding from Gilead. This does not alter our adherence to PLOS ONE policies on sharing data and materials. All the other authors have no disclosures.	Alanio A, 2016, J ANTIMICROB CHEMOTH, V71, P2075, DOI 10.1093/jac/dkw036; Beard CB, 2000, EMERG INFECT DIS, V6, P265, DOI 10.3201/eid0603.000306; Bitar D, 2014, EMERG INFECT DIS, V20, P1149, DOI 10.3201/eid2007.140087; Catherinot E, 2010, INFECT DIS CLIN N AM, V24, P107, DOI 10.1016/j.idc.2009.10.010; Cordonnier C, 2016, J ANTIMICROB CHEMOTH, V71, P2379, DOI 10.1093/jac/dkw155; Crothers K, 2005, AIDS, V19, P801, DOI 10.1097/01.aids.0000168974.67090.70; Curtis JR, 2000, AM J RESP CRIT CARE, V162, P393, DOI 10.1164/ajrccm.162.2.9909014; Esteves F, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.03.013; Fei MW, 2009, THORAX, V64, P1070, DOI 10.1136/thx.2009.117846; Flori P, 2004, J MED MICROBIOL, V53, P603, DOI 10.1099/jmm.0.45528-0; Gupta R, 2009, DIAGN MICR INFEC DIS, V64, P381, DOI 10.1016/j.diagmicrobio.2009.04.008; Hardak E, 2012, RESPIROLOGY, V17, P681, DOI 10.1111/j.1440-1843.2012.02158.x; Hauser PM, 2011, J CLIN MICROBIOL, V49, P1872, DOI 10.1128/JCM.02390-10; Huggett JF, 2008, THORAX, V63, P154, DOI 10.1136/thx.2007.081687; Kanne JP, 2012, AM J ROENTGENOL, V198, pW555, DOI 10.2214/AJR.11.7329; LEIBOVITZ E, 1995, J CLIN MICROBIOL, V33, P3004, DOI 10.1128/JCM.33.11.3004-3007.1995; Li MC, 2014, J MICROBIOL IMMUNOL, V47, P42, DOI 10.1016/j.jmii.2012.08.024; Lopez-Sanchez C, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000681; Maini R, 2013, EMERG INFECT DIS, V19, P386, DOI 10.3201/eid1903.121151; Matos O, 2010, FUTURE MICROBIOL, V5, P1257, DOI [10.2217/fmb.10.75, 10.2217/FMB.10.75]; McQuillen DP, 2008, CLIN INFECT DIS, V47, P1051, DOI 10.1086/592067; Morris A, 2004, EMERG INFECT DIS, V10, P1713, DOI 10.3201/eid1010.030985; Morris A, 2008, COPD, V5, P43, DOI 10.1080/15412550701817656; Morris A, 2012, CLIN MICROBIOL REV, V25, P297, DOI 10.1128/CMR.00013-12; Procop GW, 2004, J CLIN MICROBIOL, V42, P3333, DOI 10.1128/JCM.42.7.3333-3335.2004; Roux A, 2014, EMERG INFECT DIS, V20, P1490, DOI 10.3201/eid2009.131668; Schmitt S, 2014, CLIN INFECT DIS, V58, P22, DOI 10.1093/cid/cit610; Sing A, 2000, J CLIN MICROBIOL, V38, P1461, DOI 10.1128/JCM.38.4.1461-1467.2000; Stern A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005590.pub3; Thomas CF, 2004, NEW ENGL J MED, V350, P2487, DOI 10.1056/NEJMra032588; WAKEFIELD AE, 1990, LANCET, V336, P451, DOI 10.1016/0140-6736(90)92008-6; Wakefield AE, 1996, J CLIN MICROBIOL, V34, P1754, DOI 10.1128/JCM.34.7.1754-1759.1996; Walzer PD, 2008, CLIN INFECT DIS, V46, P625, DOI 10.1086/526778	33	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0176881	10.1371/journal.pone.0176881	http://dx.doi.org/10.1371/journal.pone.0176881			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505159	Green Published, gold, Green Submitted			2022-12-26	WOS:000401473500010
J	Cors, JF; Kashyap, A; Khartchenko, AF; Schraml, P; Kaigala, GV				Cors, Julien F.; Kashyap, Aditya; Khartchenko, Anna Fomitcheva; Schraml, Peter; Kaigala, Govind V.			Tissue lithography: Microscale dewaxing to enable retrospective studies on formalin-fixed paraffin-embedded (FFPE) tissue sections	PLOS ONE			English	Article							MICROFLUIDIC PROBE; IMMUNOHISTOCHEMISTRY; BIOMARKERS; BIOBANKING	We present a new concept, termed tissue lithography (TL), and its implementation which enables retrospective studies on formalin-fixed paraffin-embedded tissue sections. Tissue lithography uses a microfluidic probe to remove microscale areas of the paraffin layer on formalin-fixed paraffin-embedded biopsy samples. Current practices in sample utilization for research and diagnostics require complete deparaffinization of the sample prior to molecular testing. This imposes strong limitations in terms of the number of tests as well as the time when they can be performed on a single sample. Microscale dewaxing lifts these constraints by permitting deprotection of a fraction of a tissue for testing while keeping the remaining of the sample intact for future analysis. After testing, the sample can be sent back to storage instead of being discarded, as is done in standard workflows. We achieve this microscale dewaxing by hydrodynamically confining nanoliter volumes of xylene on top of the sample with a probe head. We demonstrate micrometer-scale, chromogenic and fluorescencebased immunohistochemistry against multiple biomarkers ( p53, CD45, HER2 and beta-actin) on tonsil and breast tissue sections and microarrays. We achieve stain patterns as small as 100 mu m x 50 mu m as well as multiplexed immunostaining within a single tissue microarray core with a 20-fold time reduction for local dewaxing as compared to standard protocols. We also demonstrate a 10-fold reduction in the rehydration time, leading to lower processing times between different stains. We further show the potential of TL for retrospective studies by sequentially dewaxing and staining four individual cores within the same tissue microarray over four consecutive days. By combining tissue lithography with the concept of microimmunohistochemistry, we implement each step of the IHC protocol D dewaxing, rehydration and staining D with the same microfluidic probe head. Tissue lithography brings a new level of versatility and flexibility in sample processing and budgeting in biobanks, which may alleviate current sample limitations for retrospective studies in biomarker discovery and drug screening.	[Cors, Julien F.; Kashyap, Aditya; Khartchenko, Anna Fomitcheva; Kaigala, Govind V.] IBM Res Zurich, Ruschlikon, Switzerland; [Schraml, Peter] Univ Hosp Zurich, Inst Pathol & Mol Pathol, Zurich, Switzerland	International Business Machines (IBM); University of Zurich; University Zurich Hospital	Kaigala, GV (corresponding author), IBM Res Zurich, Ruschlikon, Switzerland.	gov@zurich.ibm.com	Fomitcheva-Khartchenko, Anna/AAS-8458-2021	Fomitcheva-Khartchenko, Anna/0000-0002-4846-3923; Kashyap, Aditya/0000-0002-5033-2826	European Research Council (ERC) Starting Grant, under the 7th Framework Program [311122]; IBM Research Zurich	European Research Council (ERC) Starting Grant, under the 7th Framework Program(European Research Council (ERC)); IBM Research Zurich(International Business Machines (IBM))	This work was supported by the European Research Council (ERC) Starting Grant, under the 7th Framework Program (Project No. 311122, BioProbe) (URL: http://www.bioprobe.eu/). IBM Research Zurich provided support in the form of salaries for authors JFC, AK, AFK, and GVK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Baker M, 2012, NATURE, V486, P141, DOI 10.1038/486141a; Ciftlik AT, 2013, P NATL ACAD SCI USA, V110, P5363, DOI 10.1073/pnas.1211273110; Cors JF, 2016, CHEM COMMUN, V52, P13035, DOI 10.1039/c6cc08018a; Cors JF, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4866976; Economou M, 2014, CLIN TRANSL MED, V3, DOI 10.1186/2001-1326-3-4; Espina V, 2006, NAT PROTOC, V1, P586, DOI 10.1038/nprot.2006.85; Gannot G, 2005, J MOL DIAGN, V7, P427, DOI 10.1016/S1525-1578(10)60573-9; Haga SB, 2008, ADV GENET, V60, P505, DOI 10.1016/S0065-2660(07)00418-X; Hewitt RE, 2011, CURR OPIN ONCOL, V23, P112, DOI 10.1097/CCO.0b013e32834161b8; Huber D, 2016, BIOMED MICRODEVICES, V18, DOI 10.1007/s10544-016-0064-0; Kaigala GV, 2011, LANGMUIR, V27, P5686, DOI 10.1021/la2003639; Kashyap A, 2016, SCI REP-UK, V6, DOI 10.1038/srep29579; Kim MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010441; Lovchik RD, 2012, LAB CHIP, V12, P1040, DOI 10.1039/c2lc21016a; Massett Holly A., 2011, Journal of the National Cancer Institute Monographs, P8, DOI 10.1093/jncimonographs/lgr007; Poste G, 2011, NATURE, V469, P156, DOI 10.1038/469156a; Taylor DP, 2016, LANGMUIR, V32, P10537, DOI 10.1021/acs.langmuir.6b02983; Wolf SM, 2012, GENET MED, V14, P361, DOI 10.1038/gim.2012.23; Womack C, 2014, METHODS, V70, P3, DOI 10.1016/j.ymeth.2014.01.014	19	10	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176691	10.1371/journal.pone.0176691	http://dx.doi.org/10.1371/journal.pone.0176691			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493979	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000401314300026
J	Kobatake, E; Nakagawa, H; Seki, T; Miyazaki, T				Kobatake, Eiji; Nakagawa, Hisako; Seki, Takahiro; Miyazaki, Tadaaki			Protective effects and functional mechanisms of Lactobacillus gasseri SBT2055 against oxidative stress	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; SIGNALING PATHWAY; HEME OXYGENASE-1; GENE-EXPRESSION; DEFENSE PATHWAY; NRF2; INHIBITION; INDUCTION; INFLUENZA	Lactobacillus gasseri SBT2055 (LG2055) is one of the probiotic lactic acid bacteria. Recently, we demonstrated that feeding with LG2055 extended the lifespan of Caenorhabditis elegans and that the prolongevity effect was dependent upon the regulation of oxidative stress response. In this study, we assessed whether LG2055 regulated the oxidative stress response of mammalian cells. In NIH-3T3 cells and primary mouse embryonic fibroblast cells, low cell proliferation rates and high reactive oxygen species levels were observed following paraquat treatment. LG2055 treatment suppressed these responses in paraquat-treated cells, indicating that LG2055 protected against oxidative stress in mammalian cells. The mRNA expression of oxidative stress-related genes, total nuclear factor-erythroid-2related factor 2 (Nrf2) protein levels, and the nuclear translocation of Nrf2 were increased by LG2055 treatment. These results suggested that the Nrf2-antioxidant response element (ARE) signaling pathway was activated by LG2055. Furthermore, c-Jun NH2-terminal kinase (JNK) was activated by LG2055 treatment and the inhibition of JNK suppressed the activation of the Nrf2-ARE signaling pathway in LG2055-treated cells. Together, these findings suggest that LG2055 activated the Nrf2-ARE signaling pathway by JNK activation, thus strengthening the defense system against oxidative stress in mammalian cells.	[Kobatake, Eiji; Seki, Takahiro] Megmilk Snow Brand Co Ltd, Milk Sci Res Inst, Saitama, Japan; [Nakagawa, Hisako; Miyazaki, Tadaaki] Hokkaido Univ, Inst Genet Med, Dept Probiot Immunol, Sapporo, Hokkaido, Japan	Hokkaido University	Miyazaki, T (corresponding author), Hokkaido Univ, Inst Genet Med, Dept Probiot Immunol, Sapporo, Hokkaido, Japan.	miyazaki@pop.med.hokudai.ac.jp		Kobatake, Eiji/0000-0001-6599-6097	Megmilk Snow Brand Co., Ltd.	Megmilk Snow Brand Co., Ltd.	This study was funded by Megmilk Snow Brand Co., Ltd. The funder provided support in the form of salaries for Eiji Kobatake and Takahiro Seki, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Aleksunes LM, 2007, TOXICOL PATHOL, V35, P459, DOI 10.1080/01926230701311344; Atia A, 2014, INT J MED RES HEALTH, V3, P428, DOI 10.5958/j.2319-5886.3.2.087; Blanco-Ayala T, 2014, FREE RADICAL RES, V48, P623, DOI 10.3109/10715762.2014.899694; Bonomini F, 2008, HISTOL HISTOPATHOL, V23, P381, DOI 10.14670/HH-23.381; Bryan HK, 2013, BIOCHEM PHARMACOL, V85, P705, DOI 10.1016/j.bcp.2012.11.016; Calkins MJ, 2009, ANTIOXID REDOX SIGN, V11, P497, DOI [10.1089/ars.2008.2242, 10.1089/ARS.2008.2242]; Choi SS, 2006, LETT APPL MICROBIOL, V42, P452, DOI 10.1111/j.1472-765X.2006.01913.x; FICHERA GA, 1994, CANCER LETT, V85, P93, DOI 10.1016/0304-3835(94)90244-5; Gao DW, 2013, FOOD FUNCT, V4, P982, DOI 10.1039/c3fo30316k; Haeusgen W, 2011, EUR J CELL BIOL, V90, P536, DOI 10.1016/j.ejcb.2010.11.008; Halliwell B, 2007, BIOCHEM J, V401, P1, DOI 10.1042/BJ20061131; Harata G, 2010, LETT APPL MICROBIOL, V50, P597, DOI 10.1111/j.1472-765X.2010.02844.x; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Harrison D, 2003, AM J CARDIOL, V91, p7A; Hosono A, 1997, BIOSCI BIOTECH BIOCH, V61, P312, DOI 10.1271/bbb.61.312; Hosoya T, 2014, PLOS ONE, V9; Howden R., 2013, OXID MED CELL LONGEV, V2013; Hwang Onyou, 2013, Exp Neurobiol, V22, P11, DOI 10.5607/en.2013.22.1.11; Jeong JH, 2015, IMMUNOBIOLOGY, V220, P460, DOI 10.1016/j.imbio.2014.11.002; Jones RM, 2015, CELL REP, V12, P1217, DOI 10.1016/j.celrep.2015.07.042; Kadooka Y, 2010, EUR J CLIN NUTR, V64, P636, DOI 10.1038/ejcn.2010.19; Kawashima T, 2013, IMMUNITY, V38, P1187, DOI 10.1016/j.immuni.2013.02.024; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Keum YS, 2006, CANCER RES, V66, P8804, DOI 10.1158/0008-5472.CAN-05-3513; Li N, 2009, PEDIATR RES, V66, P203, DOI 10.1203/PDR.0b013e3181aabd4f; Liu CC, 2015, MOL CARCINOGEN, V54, P889, DOI 10.1002/mc.22161; Lu T, 2008, EXP CELL RES, V314, P1918, DOI 10.1016/j.yexcr.2008.01.011; Mann GE, 2009, CURR OPIN PHARMACOL, V9, P139, DOI 10.1016/j.coph.2008.12.012; Miyoshi M, 2014, EUR J NUTR, V53, P599, DOI 10.1007/s00394-013-0568-9; Naidu S, 2009, J IMMUNOL, V182, P7048, DOI 10.4049/jimmunol.0900006; Nakagawa H, 2016, AGING CELL, V15, P227, DOI 10.1111/acel.12431; Nakayama Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep04638; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Sakai F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105370; Sashihara T, 2006, J DAIRY SCI, V89, P2846, DOI 10.3168/jds.S0022-0302(06)72557-7; Singh S, 2010, FREE RADICAL RES, V44, P1267, DOI 10.3109/10715762.2010.507670; Surh YJ, 2008, PLANTA MED, V74, P1526, DOI 10.1055/s-0028-1088302; Tsutsui H, 2011, AM J PHYSIOL-HEART C, V301, pH2181, DOI 10.1152/ajpheart.00554.2011; Volonte D, 2013, MOL BIOL CELL, V24, P1852, DOI 10.1091/mbc.E12-09-0666; von Schillde MA, 2012, CELL HOST MICROBE, V11, P387, DOI 10.1016/j.chom.2012.02.006; Yang Y, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-48; You GE, 2013, J MICROBIOL BIOTECHN, V23, P1357, DOI 10.4014/jmb.1306.06026; Zhao Y, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/316523	43	36	38	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177106	10.1371/journal.pone.0177106	http://dx.doi.org/10.1371/journal.pone.0177106			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493927	gold, Green Published, Green Submitted			2022-12-26	WOS:000401314300060
J	Molina-Jijon, E; Rodriguez-Munoz, R; Gonzalez-Ramirez, R; Namorado-Tonix, C; Pedraza-Chaverri, J; Reyes, JL				Molina-Jijon, Eduardo; Rodriguez-Munoz, Rafael; Gonzalez-Ramirez, Ricardo; Namorado-Tonix, Carmen; Pedraza-Chaverri, Jose; Reyes, Jose L.			Aldosterone signaling regulates the overexpression of claudin-4 and-8 at the distal nephron from type 1 diabetic rats	PLOS ONE			English	Article							TIGHT JUNCTION PROTEINS; PARACELLULAR CHLORIDE PERMEABILITY; INDUCED PODOCYTE INJURY; OXIDATIVE STRESS; MINERALOCORTICOID RECEPTOR; EPITHELIAL-CELLS; CL-PERMEABILITY; EXPRESSION; KIDNEY; SPIRONOLACTONE	Hyperglycemia in diabetes alters tight junction (TJ) proteins in the kidney. We evaluated the participation of aldosterone (ALD), and the effect of spironolactone (SPL), a mineralocorticoid receptor antagonist, on the expressions of claudin-2, -4, -5 and -8, and occludin in glomeruli, proximal and distal tubules isolated from diabetic rats. Type 1 diabetes was induced in female Wistar rats by a single tail vein injection of streptozotocin (STZ), and SPL was administrated daily by gavage, from days 3 - 21. Twenty-one days after STZ injection the rats were sacrificed. In diabetic rats, the serum ALD levels were increased, and SPLtreatment did not have effect on these levels or in hyperglycemia, however, proteinuria decreased in SPL-treated diabetic rats. Glomerular damage, evaluated by nephrin and Wilm's tumor 1 (WT1) protein expressions, and proximal tubular damage, evaluated by kidney injury molecule 1 (Kim-1) and heat shock protein 72 kDa (Hsp72) expressions, were ameliorated by SPL. Also, SPL prevented decrement in claudin-5 in glomeruli, and claudin2 and occludin in proximal tubules by decreasing oxidative stress, evaluated by superoxide anion (O-2(center dot-)) production, and oxidative stress markers. In distal tubules, SPL ameliorated increase in mRNA, protein expression, and phosphorylation in threonine residues of claudin- 4 and -8, through a serum and glucocorticoid-induced kinase 1 (SGK1), and with-nolysine kinase 4 (WNK4) signaling pathway. In conclusion, this is the first study that demonstrates that ALD modulates the expression of renal TJ proteins in diabetes, and that the blockade of its actions with SPL, may be a promising therapeutic strategy to prevent alterations of TJ proteins in diabetic nephropathy.	[Molina-Jijon, Eduardo; Rodriguez-Munoz, Rafael; Namorado-Tonix, Carmen; Reyes, Jose L.] CINVESTAV IPN, Ctr Res & Adv Studies, Dept Physiol Biophys & Neurosci, Natl Polytech Inst, Mexico City, DF, Mexico; [Molina-Jijon, Eduardo] IPN, Dept Biociencias & Ingn, CIIEMAD, Mexico City, DF, Mexico; [Gonzalez-Ramirez, Ricardo] Dr Manuel Gea Gonzalez Gen Hosp, Dept Mol Biol & Histocompatibil, Mexico City, DF, Mexico; [Pedraza-Chaverri, Jose] Natl Autonomous Univ Mexico UNAM, Dept Biol, Fac Chem, Mexico City, DF, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Instituto Politecnico Nacional - Mexico; Universidad Nacional Autonoma de Mexico	Reyes, JL (corresponding author), CINVESTAV IPN, Ctr Res & Adv Studies, Dept Physiol Biophys & Neurosci, Natl Polytech Inst, Mexico City, DF, Mexico.	jreyes@fisio.cinvestav.mx	González-Ramírez, Ricardo/O-1792-2014; Molina-Jijon, Eduardo/AAY-2192-2021	González-Ramírez, Ricardo/0000-0003-1399-8036; Rodriguez-Munoz, Rafael/0000-0001-9668-052X; Reyes, Jose L./0000-0001-5830-2691	Consejo Nacional de Ciencia y Tecnologia (CONACyT) [0179870, 220046, 252008, PAPIIT IN201316]; CONACyT [255413]	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by Consejo Nacional de Ciencia y Tecnologia (CONACyT) grants 0179870 to JLR and 220046 and 252008 and PAPIIT IN201316 to JPCh. EMJ thanks support by CONACyT (255413).	Amasheh S, 2002, J CELL SCI, V115, P4969, DOI 10.1242/jcs.00165; Amasheh S, 2009, BIOCHEM BIOPH RES CO, V378, P45, DOI 10.1016/j.bbrc.2008.10.164; Angelow S, 2006, J PHYSIOL-LONDON, V571, P15, DOI 10.1113/jphysiol.2005.099135; Arreola-Mendoza L, 2006, TOXICOLOGY, V218, P237, DOI 10.1016/j.tox.2005.11.010; Arreola-Mendoza L, 2009, TOXICOL LETT, V191, P279, DOI 10.1016/j.toxlet.2009.09.011; Beesley AH, 1998, J PHYSIOL-LONDON, V509, P629, DOI 10.1111/j.1469-7793.1998.629bm.x; Blasi ER, 2003, KIDNEY INT, V63, P1791, DOI 10.1046/j.1523-1755.2003.00929.x; Chen SY, 1999, P NATL ACAD SCI USA, V96, P2514, DOI 10.1073/pnas.96.5.2514; Edelman I S, 1968, Recent Prog Horm Res, V24, P1; FROMTER E, 1972, NATURE-NEW BIOL, V235, P9, DOI 10.1038/newbio235009a0; Fujisawa G, 2004, KIDNEY INT, V66, P1493, DOI 10.1111/j.1523-1755.2004.00913.x; Gilbert KC, 2010, CURR OPIN ENDOCRINOL, V17, P199, DOI 10.1097/MED.0b013e3283391989; Gonzalez-Mariscal L, 2000, KIDNEY INT, V57, P2386, DOI 10.1046/j.1523-1755.2000.00098.x; Gonzalez-Mariscal L, 2008, BBA-BIOMEMBRANES, V1778, P729, DOI 10.1016/j.bbamem.2007.08.018; Gonzalez-Mariscal L, 2006, NEPHROL DIAL TRANSPL, V21, P2391, DOI 10.1093/ndt/gfl255; Guo C, 2008, CIRCULATION, V117, P2253, DOI 10.1161/CIRCULATIONAHA.107.748640; Hofni A, 2014, EUR J PHARMACOL, V744, P173, DOI 10.1016/j.ejphar.2014.10.021; Hollenberg NK, 2004, KIDNEY INT, V65, P1435, DOI 10.1111/j.1523-1755.2004.00524.x; Hou JH, 2013, ANNU REV PHYSIOL, V75, P479, DOI 10.1146/annurev-physiol-030212-183705; Hou JH, 2010, P NATL ACAD SCI USA, V107, P18010, DOI 10.1073/pnas.1009399107; Kahle KT, 2004, P NATL ACAD SCI USA, V101, P14877, DOI 10.1073/pnas.0406172101; Kiuchi-Saishin Y, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134875; Ko B, 2013, AM J PHYSIOL-RENAL, V305, pF645, DOI 10.1152/ajprenal.00053.2013; Koda R, 2011, CELL TISSUE RES, V343, P637, DOI 10.1007/s00441-010-1117-y; Kolla V, 2000, MOL CELL BIOCHEM, V204, P35, DOI 10.1023/A:1007009700377; Le Moellic C, 2005, AM J PHYSIOL-CELL PH, V289, pC1513, DOI 10.1152/ajpcell.00314.2005; Matavelli LC, 2013, J CARDIOVASC PHARM, V61, P17, DOI 10.1097/FJC.0b013e318274d2ef; Molina-Jijon E, 2015, J NUTR BIOCHEM, V26, P441, DOI 10.1016/j.jnutbio.2014.11.018; Molina-Jijon E, 2014, FREE RADICAL BIO MED, V72, P162, DOI 10.1016/j.freeradbiomed.2014.03.040; Morita K, 1999, J CELL BIOL, V147, P185, DOI 10.1083/jcb.147.1.185; Muzzarelli S, 2012, AM J CARDIOL, V109, P693, DOI 10.1016/j.amjcard.2011.10.027; Ohse T, 2008, J AM SOC NEPHROL, V19, P1879, DOI 10.1681/ASN.2007101087; Ohta A, 2006, BIOCHEM BIOPH RES CO, V349, P804, DOI 10.1016/j.bbrc.2006.08.101; Patni H, 2007, AM J PHYSIOL-RENAL, V293, pF1065, DOI 10.1152/ajprenal.00147.2007; Reyes JL, 2002, KIDNEY INT, V62, P476, DOI 10.1046/j.1523-1755.2002.00479.x; Ring AM, 2007, P NATL ACAD SCI USA, V104, P4025, DOI 10.1073/pnas.0611728104; Siragy HM, 2003, ENDOCRINOLOGY, V144, P2229, DOI 10.1210/en.2003-0010; Taira M, 2008, EUR J PHARMACOL, V589, P264, DOI 10.1016/j.ejphar.2008.06.019; Tatum R, 2007, FEBS LETT, V581, P3887, DOI 10.1016/j.febslet.2007.07.014; Toyonaga J, 2011, NEPHROL DIAL TRANSPL, V26, P2475, DOI 10.1093/ndt/gfq750; Trujillo J, 2015, J BIOCHEM MOL TOXIC, V29, P149, DOI 10.1002/jbt.21679; Van Itallie C, 2001, J CLIN INVEST, V107, P1319, DOI 10.1172/JCI12464; WHITTEMBURY G, 1971, PFLUG ARCH EUR J PHY, V330, P302, DOI 10.1007/BF00588582; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Xue C, 2005, HYPERTENSION, V46, P584, DOI 10.1161/01.HYP.0000175814.18550.c0; Yamauchi K, 2004, P NATL ACAD SCI USA, V101, P4690, DOI 10.1073/pnas.0306924101; Yu ASL, 2015, J AM SOC NEPHROL, V26, P11, DOI 10.1681/ASN.2014030284; Yu ASL, 2003, J BIOL CHEM, V278, P17350, DOI 10.1074/jbc.M213286200; Yuan J, 2007, J RENIN-ANGIO-ALDO S, V8, P118, DOI 10.3317/jraas.2007.014; Yuan YG, 2015, LAB INVEST, V95, P1374, DOI 10.1038/labinvest.2015.118; Zhao LN, 2008, AM J PHYSIOL-REG I, V294, pR1856, DOI 10.1152/ajpregu.00862.2007; Zhou QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047360; Zhu D, 2013, MOL CELL BIOCHEM, V380, P185, DOI 10.1007/s11010-013-1672-0	53	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177362	10.1371/journal.pone.0177362	http://dx.doi.org/10.1371/journal.pone.0177362			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493961	gold, Green Published, Green Submitted			2022-12-26	WOS:000401314300094
J	Sarabhai, T; Peter, C; Bar, AK; Windolf, J; Relja, B; Wesselborg, S; Wahlers, T; Paunel-Gorgulu, A				Sarabhai, Theresia; Peter, Christoph; Baer, Anne-Kathrin; Windolf, Joachim; Relja, Borna; Wesselborg, Sebastian; Wahlers, Thorsten; Paunel-Goerguelue, Adnana			Serum alpha-1 Antitrypsin (AAT) antagonizes intrinsic apoptosis induction in neutrophils from patients with systemic inflammatory response syndrome	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; TRAUMA; ACTIVATION; INHIBITOR; SEPSIS; ALPHA; LEADS; GENE	Excessive neutrophil activation accompanied by delayed apoptotic cell death in inflammatory conditions causes progressive damage of cells and tissues, leading to life-threatening multiple organ dysfunction syndrome. Previous work suggested that circulating serum factors during inflammation are critically involved in the suppression of neutrophil cell death although the identity of these antiapoptotic mediators remained elusive. In this study, we identified the acute phase protein alpha-1 Antitrypsin (AAT) as a potent suppressor of stauros-porine (STS)-induced apoptosis in human neutrophils through a mechanism implicating cas-pases-independent pathways. We show here that serum levels of AAT, potentially in part released by stimulated neutrophils, are markedly elevated in major trauma patients suffering from systemic inflammatory response syndrome (SIRS). Notably, AAT depletion from serum increased sensitivity of human neutrophils for STS-induced cell death. In fact, AAT was demonstrated to confer intrinsic apoptosis resistance by preventing PKC/Akt inactivation and subsequent proteasomal degradation of antiapoptotic Mcl-1 protein in response to STS treatment. Neither MAP kinase ERK1/2 nor caspases were found to be involved in AAT-triggered antiapoptotic pathways in neutrophils. In summary, these results establish a novel pivotal role of circulating AAT in mediating survival by antagonizing the proapoptotic action of the PKC inhibitor STS and should be considered for AAT augmentation therapies in future.	[Sarabhai, Theresia; Windolf, Joachim] Univ Hosp Dusseldorf, Dept Trauma & Hand Surg, Dusseldorf, Germany; [Peter, Christoph; Wesselborg, Sebastian] Heinrich Heine Univ Dusseldorf, Inst Mol Med 1, Dusseldorf, Germany; [Baer, Anne-Kathrin; Wahlers, Thorsten; Paunel-Goerguelue, Adnana] Univ Cologne, Dept Cardiothorac Surg, Heart Ctr, Cologne, Germany; [Relja, Borna] Goethe Univ, Univ Hosp Frankfurt, Dept Trauma Hand & Reconstruct Surg, Frankfurt, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Heinrich Heine University Dusseldorf; University of Cologne; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Paunel-Gorgulu, A (corresponding author), Univ Cologne, Dept Cardiothorac Surg, Heart Ctr, Cologne, Germany.	adnana.paunel-goerguelue@uk-koeln.de	Relja, Borna/B-6642-2016; Peter, Christoph/ABB-4684-2020	Relja, Borna/0000-0002-5625-8823; Peter, Christoph/0000-0002-0048-2279; Wesselborg, Sebastian/0000-0002-5236-942X	German Research Foundation [PA2029/1-1]; Koein Fortune Program / Faculty of Medicine, University of Cologne [229/2016]	German Research Foundation(German Research Foundation (DFG)); Koein Fortune Program / Faculty of Medicine, University of Cologne	This study was supported in part by the German Research Foundation (PA2029/1-1, http://www.dfg.de, to APG) and by the Koein Fortune Program / Faculty of Medicine, University of Cologne (229/2016, www.uni-koeln.de/med-fak/dekanat/forschung/fortune, to APG and AKB). The funders had no role in study design, data collection and Analysis, decision to publish, or preparation of the manuscript.	BIRCHALL AM, 1994, J PHARMACOL EXP THER, V268, P922; Braun F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023577; Charles I, 2005, INVEST OPHTH VIS SCI, V46, P1330, DOI 10.1167/iovs.04-0363; Clemmensen SN, 2011, EUR J HAEMATOL, V86, P517, DOI 10.1111/j.1600-0609.2011.01601.x; COLOTTA F, 1992, BLOOD, V80, P2012; Di Martino M., 1995, Inflammation Research, V44, pS123; DUBOIS RM, 1991, BLOOD, V77, P2724; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Fialkow L, 2006, CRIT CARE, V10, DOI 10.1186/cc5090; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Gray RD, 2013, J INFLAMM-LOND, V10, DOI 10.1186/1476-9255-10-12; GREENE CM, 2010, THE EUROPEAN, V35, P1155, DOI DOI 10.1183/09031936.00191908; Hornstein T, 2016, J LEUKOCYTE BIOL, V99, P163, DOI 10.1189/jlb.3A1114-537RR; Hurley K, 2014, J IMMUNOL, V193, P3978, DOI 10.4049/jimmunol.1400132; JACOBSON PB, 1995, J PHARMACOL EXP THER, V275, P995; Janciauskiene S, 2001, BBA-MOL BASIS DIS, V1535, P221, DOI 10.1016/S0925-4439(01)00025-4; Jimenez MF, 1997, ARCH SURG-CHICAGO, V132, P1263; Kannan S, 2002, MED HYPOTHESES, V59, P266, DOI 10.1016/S0306-9877(02)00214-1; Kim C, 2001, J IMMUNOL, V166, P1223, DOI 10.4049/jimmunol.166.2.1223; Knoell DL, 1998, AM J RESP CRIT CARE, V157, P246, DOI 10.1164/ajrccm.157.1.9702033; Kumar V, 2010, INT IMMUNOPHARMACOL, V10, P1325, DOI 10.1016/j.intimp.2010.08.012; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucas CD, 2014, MUCOSAL IMMUNOL, V7, P857, DOI 10.1038/mi.2013.102; Matamala N, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0585-y; MatuteBello G, 1997, AM J RESP CRIT CARE, V156, P1969, DOI 10.1164/ajrccm.156.6.96-12081; Milot E, 2011, THESCIENTIFICWORLDJO, V11, P1948, DOI 10.1100/2011/131539; Nifoussi SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047060; Paunel-Gorgulu A, 2012, MOL MED, V18, P325, DOI 10.2119/molmed.2011.00380; Paunel-Gorgulu A, 2011, CRIT CARE, V15, DOI 10.1186/cc9965; Paunel-Gorgulu A, 2009, J IMMUNOL, V183, P6198, DOI 10.4049/jimmunol.0901264; Petrache I, 2006, AM J PATHOL, V169, P1155, DOI 10.2353/ajpath.2006.060058; SAVILL JS, 1989, J CLIN INVEST, V83, P865, DOI 10.1172/JCI113970; Schamberger CJ, 2005, EXP CELL RES, V302, P115, DOI 10.1016/j.yexcr.2004.08.026; Stoller JK, 2005, LANCET, V365, P2225, DOI 10.1016/S0140-6736(05)66781-5; Taneja R, 2004, CRIT CARE MED, V32, P1460, DOI 10.1097/01.CCM.0000129975.26905.77; Toldo S, 2011, J MOL CELL CARDIOL, V51, P244, DOI 10.1016/j.yjmcc.2011.05.003; Trager Karl, 2016, Case Rep Crit Care, V2016, P9852073, DOI 10.1155/2016/9852073; van 't Wout EFA, 2012, AM J RESP CELL MOL, V46, P607, DOI 10.1165/rcmb.2011-0231OC; Weir S, 2010, EXPERT REV PHARM OUT, V10, P187, DOI [10.1586/erp.10.8, 10.1586/ERP.10.8]; Zhang Y, 2013, IMMUNOLOGY, V140, P143, DOI 10.1111/imm.12123	40	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177450	10.1371/journal.pone.0177450	http://dx.doi.org/10.1371/journal.pone.0177450			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493974	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314300111
J	Ji, F; Mokoena, MP; Zhao, HY; Olaniran, AO; Shi, JR				Ji, Fang; Mokoena, Mduduzi P.; Zhao, Hongyan; Olaniran, Ademola O.; Shi, Jianrong			Development of an immunochromatographic strip test for the rapid detection of zearalenone in wheat from Jiangsu province, China	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; TANDEM MASS-SPECTROMETRY; MONOCLONAL-ANTIBODY; FOOD SAMPLES; AFLATOXIN B-1; OCHRATOXIN-A; T-2 TOXIN; DEOXYNIVALENOL; MYCOTOXINS; IMMUNOASSAY	A colloidal gold (ICS) test was developed for rapid detection of zearalenone (ZEN) in wheat samples. The mAb against ZEN was prepared in our laboratory and labelled with colloidal gold as a probe for the ICS test. The conditions were optimized and 30 nm colloidal gold nanoparticles were chosen for optimal performance. Millipore 135 was chosen as the NC membrane for its level of sensitivity. The optimum amount of coated antigen ZEN-OVA and anti-ZEN mAb was 0.5 mg/mL and 8 mu g/mL, respectively. The ICS test, which has a detection limit of 15 ng/mL for ZEN, could be completed in 5 min. Analysis of ZEN in 202 wheat samples over three consecutive years revealed that data obtained from the ICS test were in a good agreement with LC-MS/MS data. This result demonstrated that the ICS test could be used as a qualitative tool to screen on-site for ZEN.	[Ji, Fang; Zhao, Hongyan; Shi, Jianrong] Jiangsu Acad Agr Sci, Key Lab Control Technol & Standard Agroprod Safet, Key Lab Agroprod Safety Risk Evaluat Nanjing, Minist Agr,Inst Food Qual & Safety,Key Lab Food Q, Nanjing, Jiangsu, Peoples R China; [Ji, Fang; Mokoena, Mduduzi P.; Olaniran, Ademola O.] Univ KwaZulu Natal, Discipline Microbiol, Sch Life Sci, Westville Campus,Private Bag X54001, Durban, South Africa; [Ji, Fang; Shi, Jianrong] Collaborat Innovat Ctr Modern Grain Circulat & Sa, Nanjing, Jiangsu, Peoples R China	Jiangsu Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs; University of Kwazulu Natal	Shi, JR (corresponding author), Jiangsu Acad Agr Sci, Key Lab Control Technol & Standard Agroprod Safet, Key Lab Agroprod Safety Risk Evaluat Nanjing, Minist Agr,Inst Food Qual & Safety,Key Lab Food Q, Nanjing, Jiangsu, Peoples R China.; Shi, JR (corresponding author), Collaborat Innovat Ctr Modern Grain Circulat & Sa, Nanjing, Jiangsu, Peoples R China.	jianrong63@126.com	Shi, Jianrong/AAQ-1805-2020; Olaniran, Ademola Olufolahan/AAU-6836-2021; Shi, Jianrong/AAQ-3456-2020	Shi, Jianrong/0000-0003-3818-5074; Mokoena, Mduduzi/0000-0003-4620-0502; shi, jianrong/0000-0001-8650-248X	Special Fund for Agro-scientific Research in the Public Interest [201303088]; Natural Science Foundation of China [31271988]; Science and Technology Planning Project of Jiangsu Province [BE2014738]; Special Fund for Risk Assessment of China [GJFP201500702]; Jiangsu Agriculture Science and Technology [CX(14)2126]	Special Fund for Agro-scientific Research in the Public Interest; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Jiangsu Province; Special Fund for Risk Assessment of China; Jiangsu Agriculture Science and Technology	This work was supported by the Special Fund for Agro-scientific Research in the Public Interest (201303088), Natural Science Foundation of China (31271988), Science and Technology Planning Project of Jiangsu Province (BE2014738), Special Fund for Risk Assessment of China (GJFP201500702), Jiangsu Agriculture Science and Technology CX(14)2126.	Brenn-Struckhofova Z, 2007, ANAL CHEM, V79, P710, DOI 10.1021/ac061672w; Bucheli TD, 2008, J AGR FOOD CHEM, V56, P1029, DOI 10.1021/jf073082k; Cho YJ, 2005, J AGR FOOD CHEM, V53, P8447, DOI 10.1021/jf051681q; Cui L, 2013, FOOD CONTROL, V30, P469, DOI 10.1016/j.foodcont.2012.08.011; Delmulle BS, 2005, J AGR FOOD CHEM, V53, P3364, DOI 10.1021/jf0404804; GB/T, 2011, CHIN NCO MAX LEV MYC; Guo YC, 2010, ANAL CHEM, V82, P7550, DOI 10.1021/ac101020y; Huang ZB, 2012, FOOD CONTROL, V28, P7, DOI 10.1016/j.foodcont.2012.04.035; IARC, 1993, WHO IARC MONOGRAPHS, Va, P56; Ji F, 2014, FOOD CHEM, V157, P393, DOI 10.1016/j.foodchem.2014.02.058; Kharbikar LL, 2015, FOOD ADDIT CONTAM A, V32, P2075, DOI 10.1080/19440049.2015.1084652; KIESSLING KH, 1978, ACTA PHARMACOL TOX, V43, P285; Klotzel M, 2005, J AGR FOOD CHEM, V53, P8904, DOI 10.1021/jf051501c; Li PW, 2013, MASS SPECTROM REV, V32, P420, DOI 10.1002/mas.21377; Liu BH, 2008, ANAL CHEM, V80, P7029, DOI 10.1021/ac800951p; Liu J, 2012, FOOD CONTROL, V26, P88, DOI 10.1016/j.foodcont.2012.01.005; Minervini F, 2005, TOXICOLOGY, V210, P81, DOI 10.1016/j.tox.2005.01.007; Molinelli A, 2008, J AGR FOOD CHEM, V56, P2589, DOI 10.1021/jf800393j; Paek SH, 2000, METHODS, V22, P53, DOI 10.1006/meth.2000.1036; PALYUSIK M, 1980, ACTA VET ACAD SCI H, V28, P159; Romanazzo D, 2010, BIOSENS BIOELECTRON, V25, P2615, DOI 10.1016/j.bios.2010.04.029; Shephard GS, 2008, CHEM SOC REV, V37, P2468, DOI 10.1039/b713084h; Shim WB, 2006, J AGR FOOD CHEM, V54, P9728, DOI 10.1021/jf0620057; Shim WB, 2009, J AGR FOOD CHEM, V57, P4035, DOI 10.1021/jf900075h; Soleimany F, 2012, FOOD CHEM, V130, P1055, DOI 10.1016/j.foodchem.2011.07.131; Spanjer MC, 2008, FOOD ADDIT CONTAM A, V25, P472, DOI 10.1080/02652030701552964; Sulyok M, 2007, ANAL BIOANAL CHEM, V389, P1505, DOI 10.1007/s00216-007-1542-2; Sulyok M, 2006, RAPID COMMUN MASS SP, V20, P2649, DOI 10.1002/rcm.2640; Wang S, 2006, J AGR FOOD CHEM, V54, P2491, DOI 10.1021/jf0530401; Wang YK, 2013, FOOD CONTROL, V31, P180, DOI 10.1016/j.foodcont.2012.09.048; Xu Y, 2010, FOOD CHEM, V119, P834, DOI 10.1016/j.foodchem.2009.08.049; Zhang ZW, 2014, FOOD CHEM, V146, P314, DOI 10.1016/j.foodchem.2013.09.048; Zinedine A, 2007, FOOD CHEM TOXICOL, V45, P1, DOI 10.1016/j.fct.2006.07.030	33	11	12	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0175282	10.1371/journal.pone.0175282	http://dx.doi.org/10.1371/journal.pone.0175282			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489899	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314100005
J	Meyer, L; Causse, R; Pernin, F; Scalone, R; Bailly, G; Chauvel, B; Delye, C; Le Corre, V				Meyer, Lucie; Causse, Romain; Pernin, Fanny; Scalone, Romain; Bailly, Geraldine; Chauvel, Bruno; Delye, Christophe; Le Corre, Valerie			New gSSR and EST-SSR markers reveal high genetic diversity in the invasive plant Ambrosia artemisiifolia L. and can be transferred to other invasive Ambrosia species	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; COMMON RAGWEED; POPULATION-STRUCTURE; CLIMATE-CHANGE; NULL ALLELES; R-PACKAGE; ASTERACEAE; LOCI; EUROPE; TESTS	Ambrosia artemisiifolia L., (common ragweed), is an annual invasive and highly troublesome plant species originating from North America that has become widespread across Europe. New sets of genomic and expressed sequence tag (EST) based simple sequence repeats (SSRs) markers were developed in this species using three approaches. After validation, 13 genomic SSRs and 13 EST-SSRs were retained and used to characterize the genetic diversity and population genetic structure of Ambrosia artemisiifolia populations from the native (North America) and invasive (Europe) ranges of the species. Analysing the mating system based on maternal families did not reveal any departure from complete allogamy and excess homozygosity was mostly due the presence of null alleles. High genetic diversity and patterns of genetic structure in Europe suggest two main introduction events followed by secondary colonization events. Cross-species transferability of the newly developed markers to other invasive species of the Ambrosia genus was assessed. Sixty-five percent and 75% of markers, respectively, were transferable from A. artemisiifolia to Ambrosia psilostachya and Ambrosia tenuifolia. 40% were transferable to Ambrosia trifida, this latter species being seemingly more phylogenetically distantly related to A. artemisiifolia than the former two.	[Meyer, Lucie; Causse, Romain; Pernin, Fanny; Chauvel, Bruno; Delye, Christophe; Le Corre, Valerie] Univ Bourgogne Franche Comte, INRA, AgroSup Dijon, Agroecol, Dijon, France; [Bailly, Geraldine] BASF France SAS, Sustainable Agr Dept, Ecully, France; [Scalone, Romain] Swedish Univ Agr Sci, Dept Crop Prod Ecol, Uppsala, Sweden	INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; BASF; Swedish University of Agricultural Sciences	Le Corre, V (corresponding author), Univ Bourgogne Franche Comte, INRA, AgroSup Dijon, Agroecol, Dijon, France.	valerie.le-corre@dijon.inra.fr		Le Corre, Valerie/0000-0001-6515-7795	BASF France SAS; EU COST Action FM203; Carl Trygger Foundation for Scientific Research (CTS); Short Term Scientific Mission [COST-STSM-FA1203-21009, CTS 14.425]	BASF France SAS(BASF); EU COST Action FM203; Carl Trygger Foundation for Scientific Research (CTS); Short Term Scientific Mission	This work was funded by BASF France SAS. BASF France SAS provided support in the form of a research grant and of salaries for LM and GB. We also acknowledge support from EU COST Action FM203 "Sustainable management of Ambrosia artemisiifolia in Europe (SMARTER)" and from the Carl Trygger Foundation for Scientific Research (CTS). Part of the work was achieved thanks to the Short Term Scientific Mission COST-STSM-FA1203-21009 and the grant CTS 14.425 attributed to RS. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors supported by funders are articulated in the 'author contributions' section.	Abercrombie LG, 2009, MOL ECOL RESOUR, V9, P1375, DOI 10.1111/j.1755-0998.2009.02746.x; Alberto F, 2009, J HERED, V100, P394, DOI 10.1093/jhered/esn110; Baltisberger M, 2016, WILLDENOWIA, V46, P121, DOI 10.3372/wi.46.46110; BASSETT IJ, 1982, CAN J PLANT SCI, V62, P1003, DOI 10.4141/cjps82-148; BASSETT IJ, 1975, CAN J PLANT SCI, V55, P463, DOI 10.4141/cjps75-072; Castoe TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030953; Chapman DS, 2016, GLOBAL CHANGE BIOL, V22, P3067, DOI 10.1111/gcb.13220; Chauvel B, 2006, J BIOGEOGR, V33, P665, DOI 10.1111/j.1365-2699.2005.01401.x; Chun YJ, 2010, NEW PHYTOL, V185, P1100, DOI 10.1111/j.1469-8137.2009.03129.x; Chybicki IJ, 2009, J HERED, V100, P106, DOI 10.1093/jhered/esn088; Ciappetta S, 2016, FLORA, V223, P106, DOI 10.1016/j.flora.2016.05.002; Cornuet JM, 1996, GENETICS, V144, P2001; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; DeFaveri J, 2013, MOL ECOL RESOUR, V13, P377, DOI 10.1111/1755-0998.12071; Delye C, 2002, PEST MANAG SCI, V58, P474, DOI 10.1002/ps.485; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Ellis JR, 2007, HEREDITY, V99, P125, DOI 10.1038/sj.hdy.6801001; Essl F, 2015, J ECOL, V103, P1069, DOI 10.1111/1365-2745.12424; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Facon B, 2006, TRENDS ECOL EVOL, V21, P130, DOI 10.1016/j.tree.2005.10.012; Falush D, 2003, GENETICS, V164, P1567; Falush D, PREPRINT; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Foll M, 2006, GENETICS, V174, P875, DOI 10.1534/genetics.106.059451; Follak S, 2013, PRESLIA, V85, P41; Gaggiotti OE, 2010, MOL ECOL RESOUR, V10, P821, DOI 10.1111/j.1755-0998.2010.02873.x; Gaudeul M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017658; Genton BJ, 2005, MOL ECOL, V14, P4275, DOI 10.1111/j.1365-294X.2005.02750.x; Genton BJ, 2005, MOL ECOL NOTES, V5, P381, DOI 10.1111/j.1471-8286.2005.00934.x; Gladieux P, 2011, BIOL INVASIONS, V13, P933, DOI 10.1007/s10530-010-9880-y; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Guichoux E, 2011, MOL ECOL RESOUR, V11, P591, DOI 10.1111/j.1755-0998.2011.03014.x; Haasl RJ, 2011, HEREDITY, V106, P158, DOI 10.1038/hdy.2010.21; Hodel RDGJ, 2016, APPL PLANT SCI, V4, DOI 10.3732/apps.1600025; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; INSAUSTI P, 1995, OECOLOGIA, V103, P127, DOI 10.1007/BF00328433; Insausti P, 2006, AUSTRAL ECOL, V31, P828, DOI 10.1111/j.1442-9993.2006.01641.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kocis Tubic N, 2014, GENETIKA-BELGRADE, V46, P255, DOI 10.2298/GENSR1401255K; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Li XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031935; Lotterhos KE, 2014, MOL ECOL, V23, P2178, DOI 10.1111/mec.12725; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Malausa T, 2011, MOL ECOL RESOUR, V11, P638, DOI 10.1111/j.1755-0998.2011.02992.x; Martin MD, 2014, MOL ECOL, V23, P1701, DOI 10.1111/mec.12675; Meglecz E, 2014, MOL ECOL RESOUR, V14, P1302, DOI 10.1111/1755-0998.12271; MIAO B, 1995, PLANT SYST EVOL, V194, P241, DOI 10.1007/BF00982858; MULLIGAN GERALD A., 1957, CANADIAN JOUR BOT, V35, P779, DOI 10.1139/b57-064; Narum SR, 2013, MOL ECOL, V22, P2841, DOI 10.1111/mec.12350; Ortmans W, 2016, FLORA, V220, P134, DOI 10.1016/j.flora.2016.03.003; PAYNE WILLARD W., 1964, J ARNOLD ARBORETUM HARVARD UNIV, V45, P401; Peery MZ, 2012, MOL ECOL, V21, P3403, DOI 10.1111/j.1365-294X.2012.05635.x; Postolache D, 2014, PLANT MOL BIOL REP, V32, P750, DOI 10.1007/s11105-013-0688-7; Pritchard JK, 2000, GENETICS, V155, P945; Putman AI, 2014, ECOL EVOL, V4, P4399, DOI 10.1002/ece3.1305; Ritland K, 2002, HEREDITY, V88, P221, DOI 10.1038/sj.hdy.6800029; Rodriguez A., 2015, J BOT SOC BOT FRANCE, V71, P25; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Smith M, 2013, ENVIRON INT, V61, P115, DOI 10.1016/j.envint.2013.08.005; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WAGNER W. H., 1958, RHODORA, V60, P177; Ziska LH, 2003, J ALLERGY CLIN IMMUN, V111, P290, DOI 10.1067/mai.2003.53	63	15	18	4	148	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176197	10.1371/journal.pone.0176197	http://dx.doi.org/10.1371/journal.pone.0176197			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489870	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314100018
J	Shrestha, SK; Cochran, A; Mengistu, A; Lamour, K; Castro-Rocha, A; Young-Kelly, H				Shrestha, Sandesh Kumar; Cochran, Alicia; Mengistu, Alemu; Lamour, Kurt; Castro-Rocha, Arturo; Young-Kelly, Heather			Genetic diversity, QoI fungicide resistance, and mating type distribution of Cercospora sojina-Implications for the disease dynamics of frogeye leaf spot on soybean	PLOS ONE			English	Article							POPULATIONS; YIELD; RACE	Frogeye leaf spot (FLS), caused by Cercospora sojina, causes significant damage to soybean in the U.S. One control strategy is the use of quinone outside inhibitor (QoI) fungicides. QoI resistant isolates were first reported in Tennessee (TN) in 2010. To investigate the disease dynamics of C. sojina, we collected 437 C. sojina isolates in 2015 from Jackson and Milan, TN and used 40 historical isolates collected from 2006-2009 from TN and ten additional states for comparison. A subset of 186 isolates, including historical isolates, were genotyped for 49 single nucleotide polymorphism (SNP) markers and the QoI resistance locus, revealing 35 unique genotypes. The genotypes clustered into three groups with two groups containing only sensitive isolates and the remaining group containing all resistant isolates and a dominant clonal lineage of 130 isolates. All 477 C. sojina isolates were genotyped for the QoI locus revealing 344 resistant and 133 sensitive isolates. All isolates collected prior to 2015 were QoI sensitive. Both mating type alleles (MAT1-1-1 and MAT1-2) were found in Jackson and Milan, TN and recovered from single lesions suggesting sexual recombination may play a role in the epidemiology of field populations. Analysis of C. sojina isolates using SNP markers proved useful to investigate population diversity and to elaborate on diversity as it relates to QoI resistance and mating type.	[Shrestha, Sandesh Kumar; Lamour, Kurt] Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37901 USA; [Cochran, Alicia; Young-Kelly, Heather] Univ Tennessee, Dept Entomol & Plant Pathol, Jackson, TN USA; [Mengistu, Alemu] ARS, USDA, Jackson, TN USA; [Castro-Rocha, Arturo] Univ Autonoma Cd Juarez, Dept Ciencias Quim Biol, Chihuahua, Mexico	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; United States Department of Agriculture (USDA); Universidad Autonoma de Ciudad Juarez	Young-Kelly, H (corresponding author), Univ Tennessee, Dept Entomol & Plant Pathol, Jackson, TN USA.	youngkelly@utk.edu		Lamour, Kurt/0000-0001-6407-8825				ATHOW K, 1952, PHYTOPATHOLOGY, V42, P660; ATHOW KL, 1962, PHYTOPATHOLOGY, V52, P712; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bradley CA, 2012, CAN J PLANT PATHOL, V34, P410, DOI 10.1080/07060661.2012.711775; Cruz C, 2009, PLANT HLTH PROGR, V10; DASHIELL KE, 1991, CROP PROT, V10, P465, DOI 10.1016/S0261-2194(91)80134-2; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Grau CR, 2004, FUNGAL DIS SOYBEANS, P679; Groenewald M, 2008, PLANT PATHOL, V57, P25, DOI 10.1111/j.1365-3059.2007.01697.x; Hartwig E, 1990, UNIFORM SOYBEAN TEST; Kim H, 2013, PHYTOPATHOLOGY, V103, P1045, DOI 10.1094/PHYTO-09-12-0229-R; LAVIOLETTE FA, 1970, CROP SCI, V10, P418, DOI 10.2135/cropsci1970.0011183X001000040031x; Lehman SG, 1928, J AGRIC RES, V36, P0811; Mengistu A, 2012, PLANT HLTH PROGR, V10; Mengistu Alemu, 2002, Plant Disease, V86, P1272, DOI 10.1094/PDIS.2002.86.11.1272B; Mian MAR, 2008, CROP SCI, V48, P14, DOI 10.2135/cropsci2007.08.0432; Mian MAR, 1998, PLANT DIS, V82, P1017, DOI 10.1094/PDIS.1998.82.9.1017; Muller MF, 2016, PHYTOPATHOLOGY, V106, P1194, DOI 10.1094/PHYTO-02-16-0084-FI; Nei M., 2000, MOL EVOLUTION PHYLOG; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Phillips D, 1999, FROGEYE LEAF SPOT CO, P20; PHILLIPS DV, 1982, PHYTOPATHOLOGY, V72, P764, DOI 10.1094/Phyto-72-764; Pritchard JK, 2000, GENETICS, V155, P945; Sanogo S, 2001, PLANT DIS, V85, P773, DOI 10.1094/PDIS.2001.85.4.443A; Tamura K., 2013, MOL BIOL EVOL, P197, DOI DOI 10.1093/M0LBEV/MST197; Tu ND, 2013, BIOTECHNIQUES, V55, P69, DOI 10.2144/000114052; USDA, 2016, CROP PROD 2015 SUMM; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wrather JA, 2006, J NEMATOL, V38, P173; Yeh F.C., 1997, MOL BIOL BIOTECHNOL, V10, P295; Zeng F, 2015, PLANT DIS, V99, P544, DOI 10.1094/PDIS-05-14-0460-RE; Zhang G, 2014, PLANT HLTH PROG, V10; Zhang G, 2014, PHYTOPATHOLOGY; Zhang GR, 2012, PLANT DIS, V96, P767, DOI 10.1094/PDIS-10-11-0915-PDN	35	10	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177220	10.1371/journal.pone.0177220	http://dx.doi.org/10.1371/journal.pone.0177220			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486517	Green Submitted, Green Published, gold			2022-12-26	WOS:000401314000059
J	Cao, JM; Zhou, J; Zhang, YF; Zou, YZ; Liu, XW				Cao, Jiamu; Zhou, Jing; Zhang, Yufeng; Zou, Yuezhang; Liu, Xiaowei			MoS2 nanosheets direct supported on reduced graphene oxide: An advanced electrocatalyst for hydrogen evolution reaction	PLOS ONE			English	Article							EFFICIENCY; ELECTRODES; REDUCTION; CATALYST; SITES	Molybdenum disulfide nanosheets/reduced graphene oxide (MoS2 NSs/rGO) nanohybrid as a highly effective catalyst for hydrogen evolution reaction (HER) have been successfully synthesized by a facile microwave-assisted method. The results clearly reveal that direct grown of MoS2 NSs on rGO have been achieved. Electrochemical tests show that the asprepared hybrid material exhibited excellent HER activity, with a small Tafel slope of 57 mV dec(-1), an overpotential of 130 mV and remarkable cycling stability. After analysis, the observed outstanding catalytic performance can be attributed to the uniform distribution of the MoS2 NSs, which are characterized by the presence of multiple active sites as well as the effective electron transport route provided by the conductive rGO substrate. Moreover, according to the classic theory, the mechanism governing of the catalytic HER on the MoS2 NSs/ rGO nanohybrid has been clarified.	[Cao, Jiamu; Zhou, Jing; Zhang, Yufeng; Zou, Yuezhang; Liu, Xiaowei] Harbin Inst Technol, Sch Astronaut, MEMS Ctr, Harbin, Peoples R China; [Zhang, Yufeng; Liu, Xiaowei] Minist Educ, Key Lab Microsyst & Microstruct Mfg, Harbin, Peoples R China	Harbin Institute of Technology	Zhang, YF (corresponding author), Harbin Inst Technol, Sch Astronaut, MEMS Ctr, Harbin, Peoples R China.; Zhang, YF (corresponding author), Minist Educ, Key Lab Microsyst & Microstruct Mfg, Harbin, Peoples R China.	yufeng_zhang@hit.edu.cn	Zhang, Yufeng/GZL-1973-2022		National Natural Science Foundation of China [61404037]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work described in this paper was financially supported by the National Natural Science Foundation of China (No.61404037).	Bonde J, 2008, FARADAY DISCUSS, V140, P219, DOI 10.1039/b803857k; Cao JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161374; Chen C, 2014, SCIENCE, V343, P1339, DOI 10.1126/science.1249061; Chen WF, 2010, CARBON, V48, P1146, DOI 10.1016/j.carbon.2009.11.037; Du GD, 2010, CHEM COMMUN, V46, P1106, DOI 10.1039/b920277c; Hinnemann B, 2005, J AM CHEM SOC, V127, P5308, DOI 10.1021/ja0504690; Jaramillo TF, 2007, SCIENCE, V317, P100, DOI 10.1126/science.1141483; Jin BW, 2016, ANGEW CHEM INT EDIT, V55, P12252, DOI 10.1002/anie.201605551; Karunadasa HI, 2010, NATURE, V464, P1329, DOI 10.1038/nature08969; Li F, 2015, J POWER SOURCES, V292, P15, DOI 10.1016/j.jpowsour.2015.04.173; Liang X, 2016, CERAM INT, V42, P12888, DOI 10.1016/j.ceramint.2016.05.055; Luo JS, 2014, SCIENCE, V345, P1593, DOI 10.1126/science.1258307; Ma CB, 2014, NANOSCALE, V6, P5624, DOI 10.1039/c3nr04975b; Ma FK, 2016, NANO ENERGY, V27, P466, DOI 10.1016/j.nanoen.2016.07.014; Ma LB, 2016, NANO ENERGY, V24, P139, DOI 10.1016/j.nanoen.2016.04.024; Shi Y, 2015, J AM CHEM SOC, V137, P7365, DOI 10.1021/jacs.5b01732; Suresh C, 2016, MATER LETT, V164, P417, DOI 10.1016/j.matlet.2015.11.052; Tang YJ, 2016, ADV ENERGY MATER, V6, DOI 10.1002/aenm.201600116; THOMAS JG, 1961, T FARADAY SOC, V57, P1603, DOI 10.1039/tf9615701603; Tiwari AP, 2016, NANO ENERGY, V28, P366, DOI 10.1016/j.nanoen.2016.08.065; Turner JA, 2004, SCIENCE, V305, P972, DOI 10.1126/science.1103197; Walter MG, 2010, CHEM REV, V110, P6446, DOI 10.1021/cr1002326; Wang M, 2012, ENERG ENVIRON SCI, V5, P6763, DOI 10.1039/c2ee03309g; Wang QH, 2012, NAT NANOTECHNOL, V7, P699, DOI [10.1038/NNANO.2012.193, 10.1038/nnano.2012.193]; Wu WZ, 2014, NATURE, V514, P470, DOI 10.1038/nature13792; Xu SJ, 2015, J MATER CHEM A, V3, P16337, DOI 10.1039/c5ta02637g; Yan HH, 2016, CERAM INT, V42, P9327, DOI 10.1016/j.ceramint.2016.02.160; Yan SM, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4905656; Ye TN, 2015, NANO ENERGY, V15, P335, DOI 10.1016/j.nanoen.2015.04.033; Yu XL, 2016, APPL CATAL B-ENVIRON, V182, P504, DOI 10.1016/j.apcatb.2015.09.003; Zhang ZY, 2015, NANO ENERGY, V18, P196, DOI 10.1016/j.nanoen.2015.10.014; Zhou WJ, 2016, NANO ENERGY, V28, P29, DOI 10.1016/j.nanoen.2016.08.027; Zhou YC, 2015, NANO ENERGY, V16, P357, DOI 10.1016/j.nanoen.2015.07.008	33	15	15	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177258	10.1371/journal.pone.0177258	http://dx.doi.org/10.1371/journal.pone.0177258			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481951	Green Published, gold, Green Submitted			2022-12-26	WOS:000401313700044
J	Dong, CX; Gao, MX; Guo, CW; Lin, L; Wu, DH; Zhang, LM				Dong, Chengxu; Gao, Meixiang; Guo, Chuanwei; Lin, Lin; Wu, Donghui; Zhang, Limin			The underlying processes of a soil mite metacommunity on a small scale	PLOS ONE			English	Article							TRADE-OFFS; BIODIVERSITY; DISPERSAL; ROLES; COLONIZATION; PATTERNS; FOREST	Metacommunity theory provides an understanding of how ecological processes regulate local community assemblies. However, few field studies have evaluated the underlying mechanisms of a metacommunity on a small scale through revealing the relative roles of spatial and environmental filtering in structuring local community composition. Based on a spatially explicit sampling design in 2012 and 2013, this study aims to evaluate the underlying processes of a soil mite metacommunity on a small spatial scale (50 m) in a temperate deciduous forest located at the Maoershan Ecosystem Research Station, Northeast China. Moran's eigenvector maps (MEMs) were used to model independent spatial variables. The relative importance of spatial (including trend variables, i.e., geographical coordinates, and broad-and fine-scale spatial variables) and environmental factors in driving the soil mite metacommunity was determined by variation partitioning. Mantel and partial Mantel tests and a redundancy analysis (RDA) were also used to identify the relative contributions of spatial and environmental variables. The results of variation partitioning suggested that the relatively large and significant variance was a result of spatial variables (including broad-and fine-scale spatial variables and trend), indicating the importance of dispersal limitation and autocorrelation processes. The significant contribution of environmental variables was detected in 2012 based on a partial Mantel test, and soil moisture and soil organic matter were especially important for the soil mite metacommunity composition in both years. The study suggested that the soil mite metacommunity was primarily regulated by dispersal limitation due to broad-scale and neutral biotic processes at a fine-scale and that environmental filtering might be of subordinate importance. In conclusion, a combination of metacommunity perspectives between neutral and species sorting theories was suggested to be important in the observed structure of the soil mite metacommunity at the studied small scale.	[Dong, Chengxu; Gao, Meixiang; Guo, Chuanwei; Lin, Lin; Zhang, Limin] Harbin Normal Univ, Coll Geog Sci, 1 Limin Econ Dev Dist, Harbin, Peoples R China; [Dong, Chengxu; Gao, Meixiang; Guo, Chuanwei; Lin, Lin; Zhang, Limin] Harbin Normal Univ, Coll Heilongjiang Prov, Key Lab Remote Sensing Monitoring Geog Environm, Harbin, Peoples R China; [Wu, Donghui] Chinese Acad Sci, Northeast Inst Geog & Agroecol, Key Lab Wetland Ecol & Environm, Changchun, Peoples R China	Harbin Normal University; Harbin Normal University; Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS	Gao, MX (corresponding author), Harbin Normal Univ, Coll Geog Sci, 1 Limin Econ Dev Dist, Harbin, Peoples R China.; Gao, MX (corresponding author), Harbin Normal Univ, Coll Heilongjiang Prov, Key Lab Remote Sensing Monitoring Geog Environm, Harbin, Peoples R China.	gmx102@hotmail.com		Meixiang, Gao/0000-0002-5841-9918	National Natural Sciences Foundation of China [41471037, 41101049, 41371072, 41430857]; University Nursing Program for Young Scholars with Creative Talents in Heilongjiang Province [UNPYSCT-2015054]; Excellent Youth Scholars of Harbin Normal University, Chinese Academy of Sciences [DLSYQ2012004]; Excellent Youth Scholars of Northeast Institute of Geography and Agroecology, Chinese Academy of Sciences [DLSYQ2012004]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); University Nursing Program for Young Scholars with Creative Talents in Heilongjiang Province; Excellent Youth Scholars of Harbin Normal University, Chinese Academy of Sciences; Excellent Youth Scholars of Northeast Institute of Geography and Agroecology, Chinese Academy of Sciences	This study was supported by the National Natural Sciences Foundation of China (Nos. 41471037, 41101049, 41371072, 41430857), University Nursing Program for Young Scholars with Creative Talents in Heilongjiang Province (No. UNPYSCT-2015054), Excellent Youth Scholars of Harbin Normal University and Excellent Youth Scholars of Northeast Institute of Geography and Agroecology, Chinese Academy of Sciences (No. DLSYQ2012004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Ping He for her assistances with the experimental performing. We thank managers of the Maoershan Ecosystem Research Station for the convenience they provided. We also thank the anonymous reviewers. This study was supported by the National Natural Sciences Foundation of China (Nos. 41471037, 41101049, 41371072, 41430857), University Nursing Program for Young Scholars with Creative Talents in Heilongjiang Province (No. UNPYSCT-2015054), Excellent Youth Scholars of Harbin Normal University and Excellent Youth Scholars of Northeast Institute of Geography and Agroecology, Chinese Academy of Sciences (No. DLSYQ2012004).	Astrom J, 2011, OECOLOGIA, V167, P747, DOI 10.1007/s00442-011-2024-y; Balogh J., 1992, ORIBATID MITES GENER, V1; Behan-Pelletier VM, 1999, AGR ECOSYST ENVIRON, V74, P411, DOI 10.1016/S0167-8809(99)00046-8; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; Bonthoux S, 2015, ECOL COMPLEX, V21, P39, DOI 10.1016/j.ecocom.2014.12.002; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Brown JH, 2001, EVOLUTION, V55, P2137; Cadotte MW, 2007, ECOLOGY, V88, P823, DOI 10.1890/06-1117; Chalmandrier L, 2015, ECOLOGY, V96, P143, DOI 10.1890/13-2153.1; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; Crawley MJ, 2001, SCIENCE, V291, P864, DOI 10.1126/science.291.5505.864; dos Santos AS, 2015, PERSPECT PLANT ECOL, V17, P96, DOI 10.1016/j.ppees.2015.01.002; Downing AS, 2014, ECOL LETT, V17, P1219, DOI 10.1111/ele.12327; Dray S., 2011, PACKFOR FORWARD SELE; Gan H., 2013, ORIBATID MITE COMMUN; Gao MX, 2014, SOIL BIOL BIOCHEM, V79, P68, DOI 10.1016/j.soilbio.2014.09.003; Gao MX, 2012, CHINESE GEOGR SCI, V22, P647, DOI 10.1007/s11769-012-0573-6; GHILAROV MS, 1984, PEDOBIOLOGIA, V27, P107; Gilpin M.E., 1991, METAPOPULATION DYNAM; Gong Z.T., 1999, SOIL-GERMANY, V31, P57, DOI [10.13758/j.cnki.tr.1999.02.001, DOI 10.13758/J.CNKI.TR.1999.02.001]; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Griffith DA, 2006, ECOLOGY, V87, P2603, DOI 10.1890/0012-9658(2006)87[2603:SMIETF]2.0.CO;2; Gronroos M, 2013, ECOL EVOL, V3, P4473, DOI 10.1002/ece3.834; Heino J, 2015, FRESHWATER BIOL, V60, P845, DOI 10.1111/fwb.12533; Hortal J, 2010, ECOGRAPHY, V33, P51, DOI 10.1111/j.1600-0587.2009.06428.x; Hubbell Stephen P., 2001, V32, pi; Ingimarsdottir M, 2012, OECOLOGIA, V170, P745, DOI 10.1007/s00442-012-2334-8; Jiang XJ, 2015, SOIL BIOL BIOCHEM, V81, P9, DOI 10.1016/j.soilbio.2014.10.025; Jimenez JJ, 2012, OIKOS, V121, P915, DOI 10.1111/j.1600-0706.2012.20428.x; Jocque M, 2010, GLOBAL ECOL BIOGEOGR, V19, P244, DOI 10.1111/j.1466-8238.2009.00510.x; Krantz G., 2009, MANUAL ACAROLOGY; Lao JC, 1998, HDB SOIL AGROCHEMIST; Legendre P. D., 2012, PCNM MEM SPATIAL EIG; Legendre P, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2728; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Leibold MA, 2002, OIKOS, V97, P237, DOI 10.1034/j.1600-0706.2002.970210.x; Lindstrom ES, 2012, ENV MICROBIOL REP, V4, P1, DOI 10.1111/j.1758-2229.2011.00257.x; Logue JB, 2011, TRENDS ECOL EVOL, V26, P482, DOI 10.1016/j.tree.2011.04.009; MARINISSEN JCY, 1992, OECOLOGIA, V91, P371, DOI 10.1007/BF00317626; Mouquet N., 2005, METACOMMUNITIES SPAT, P237; Norton R.A., 1980, International Journal of Acarology, V6, P121; Ojala R, 2001, PEDOBIOLOGIA, V45, P443, DOI 10.1078/0031-4056-00098; Oksanen J., 2019, VEGAN COMMUNITY ECOL; Pachepsky E, 2001, NATURE, V410, P923, DOI 10.1038/35073563; Sharma S, 2011, ECOGRAPHY, V34, P762, DOI 10.1111/j.1600-0587.2010.06811.x; Soininen J, 2012, ENV MICROBIOL REP, V4, P10, DOI 10.1111/j.1758-2229.2011.00308.x; Soininen J, 2007, ECOGRAPHY, V30, P3, DOI 10.1111/j.2006.0906-7590.04817.x; Virtanen L, 2012, EUR J PHYCOL, V47, P160, DOI 10.1080/09670262.2012.682610; Walter DE, 2001, MITES IN SOIL; WILSON DS, 1992, ECOLOGY, V73, P1984, DOI 10.2307/1941449; Winegardner AK, 2012, TRENDS ECOL EVOL, V27, P253, DOI 10.1016/j.tree.2012.01.007; Yin W., 1998, PICTORICAL KEYS SOIL; Yu DW, 2001, AM NAT, V158, P49, DOI 10.1086/320865	55	5	6	5	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0176828	10.1371/journal.pone.0176828	http://dx.doi.org/10.1371/journal.pone.0176828			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481906	Green Published, gold, Green Submitted			2022-12-26	WOS:000401313700017
J	Kee, JY; Han, YH; Kim, DS; Mun, JG; Park, SH; So, HS; Park, SJ; Park, R; Um, JY; Hong, SH				Kee, Ji-Ye; Han, Yo-Han; Kim, Dae-Seung; Mun, Jeong-Geon; Park, Seong-Hwan; So, Hong-Seob; Park, Sung-Joo; Park, Raekil; Um, Jae-Young; Hong, Seung-Heon			beta-Lapachone suppresses the lung metastasis of melanoma via the MAPK signaling pathway	PLOS ONE			English	Article							CELL-CYCLE; MATRIX METALLOPROTEINASES; INDUCED APOPTOSIS; CANCER; INDUCTION; ACTIVATION; INHIBITOR; PROLIFERATION; EXPRESSION; SELECTION	beta-Lapachone is a natural quinone compound from Lapacho trees, which has various pharmacological effects such as anti-bacterial, anti-fungal, anti-viral, and anti-inflammatory activities. However, the effect of beta-lapachone on metastasis of melanoma cells is unclear. In this study, beta-lapachone reduced cell viability of metastatic melanoma cancer cell lines B16F10 and B16BL6 through induction of apoptosis via the mitogen-activated protein kinase (MAPK) pathway. Additionally, flow cytometry results showed that beta-lapachone increased DNA content in the G0/G1 phase of the cell cycle. Analysis of the mechanisms of these events indicated that beta-lapachone regulated the expression of Bcl-2, Bcl-xL, and Bax, resulting in the activation of caspase-3, -8, -9, and poly-ADP-ribose polymerase (PARP). Moreover, the beta-lapachone-administered group showed significantly decreased lung metastasis in the experimental mouse model. In conclusion, our study demonstrates the inhibitory effect of beta-lapachone on lung metastasis of melanoma cells and provides a new insight into the role of beta-lapachone as a potential antitumor agent.	[Kee, Ji-Ye; Han, Yo-Han; Kim, Dae-Seung; Mun, Jeong-Geon; Park, Seong-Hwan; Hong, Seung-Heon] Wonkwang Univ, Wonkwang Oriental Med Res Inst, Dept Oriental Pharm, Coll Pharm, Iksan, Jeonbuk, South Korea; [Kee, Ji-Ye; So, Hong-Seob] Wonkwang Univ, Ctr Metab Funct Regulat, Iksan, South Korea; [Park, Sung-Joo] Wonkwang Univ, Dept Herbol, Coll Oriental Med, Iksan, Jeonbuk, South Korea; [Park, Raekil] Gwangju Inst Sci & Technol, Dept Biomed Sci & Engn, Gwangu, South Korea; [Um, Jae-Young] Kyung Hee Univ, Inst Korean Med, Dept Pharmacol, Coll Korean Med, Seoul, South Korea	Wonkwang University; Wonkwang University; Wonkwang University; Gwangju Institute of Science & Technology (GIST); Kyung Hee University	Hong, SH (corresponding author), Wonkwang Univ, Wonkwang Oriental Med Res Inst, Dept Oriental Pharm, Coll Pharm, Iksan, Jeonbuk, South Korea.	jooklim@wonkwang.ac.kr	Kee, Ji-Ye/V-5687-2019	Kee, Ji-Ye/0000-0002-9836-2127	National Research Foundation of Korea (NRF) [2015R1C1A1A02036733, 2011-0030130]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	This study was supported by the National Research Foundation of Korea (NRF); Grant numbers: 2011-0030130, 2015R1C1A1A02036733.	Gomez-Sarosi LA, 2009, CANCER BIOL THER, V8, P1173, DOI 10.4161/cbt.8.12.8561; Banerji A, 2004, CANCER LETT, V211, P235, DOI 10.1016/j.canlet.2004.02.007; Bhatia S, 2009, ONCOLOGY-NY, V23, P488; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Bold RJ, 1997, SURG ONCOL, V6, P133, DOI 10.1016/S0960-7404(97)00015-7; Chi ZH, BMC CANC, P85; Choi YH, 2003, J BIOCHEM MOL BIOL, V36, P223; Cummins DL, 2006, MAYO CLIN PROC, V81, P500, DOI 10.4065/81.4.500; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; FIDLER IJ, 1973, NATURE-NEW BIOL, V242, P148, DOI 10.1038/newbio242148a0; Fidler IJ, 2002, DIFFERENTIATION, V70, P498, DOI 10.1046/j.1432-0436.2002.700904.x; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Hofmann UB, 1999, BRIT J CANCER, V81, P774, DOI 10.1038/sj.bjc.6690763; Huang LL, 1999, MOL MED, V5, P711, DOI 10.1007/BF03402095; Ishiguro T, 1996, CANCER RES, V56, P875; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Khanna C, 2005, CARCINOGENESIS, V26, P513, DOI 10.1093/carcin/bgh261; Khasigov PZ, 2003, BIOCHEMISTRY-MOSCOW+, V68, P711, DOI 10.1023/A:1025051214001; Kim SO, 2007, BIOSCI BIOTECH BIOCH, V71, P2169, DOI 10.1271/bbb.70103; LI CJ, 1993, J BIOL CHEM, V268, P22463; LI CJ, 1995, CANCER RES, V55, P3712; Li JZ, 2014, TOXICOL APPL PHARM, V281, P285, DOI 10.1016/j.taap.2014.10.012; Lien YC, 2008, HISTOL HISTOPATHOL, V23, P1299, DOI 10.14670/HH-23.1299; Lim SH, 2013, DEVELOPMENT, V140, P3079, DOI 10.1242/dev.091744; Macedo L, 2013, PHYTOMEDICINE, V21, P25, DOI 10.1016/j.phymed.2013.08.010; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; POSTE G, 1980, CANCER RES, V40, P1636; Serrone L, 2000, J EXP CLIN CANC RES, V19, P21; Sitonio MM, 2013, INFLAMM RES, V62, P107, DOI 10.1007/s00011-012-0557-0; Stadheim TA, 2002, LEUKEMIA RES, V26, P55, DOI 10.1016/S0145-2126(01)00099-6; Sun HP, 2012, PHYSIOLOGY, V27, P43, DOI 10.1152/physiol.00034.2011; TALMADGE JE, 1982, NATURE, V297, P593, DOI 10.1038/297593a0; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tsuchiya T, 2008, HEPATO-GASTROENTEROL, V55, P930; Wells JM, 2015, MATRIX BIOL, V44-46, P122, DOI 10.1016/j.matbio.2015.01.016; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Wheelock MJ, 2003, ANNU REV CELL DEV BI, V19, P207, DOI 10.1146/annurev.cellbio.19.011102.111135; Wong RSY, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-87; Woo HJ, 2006, J MED FOOD, V9, P161, DOI 10.1089/jmf.2006.9.161; Wuerzberger SM, 1998, CANCER RES, V58, P1876; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105; Zhang XM, 2001, CLIN EXP METASTAS, V18, P415, DOI 10.1023/A:1010960615370	43	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e01 76937	10.1371/journal.pone.0176937	http://dx.doi.org/10.1371/journal.pone.0176937			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481901	Green Published, gold, Green Submitted			2022-12-26	WOS:000401313700024
J	Goetzl, EJ; Schwartz, JB; Mustapic, M; Lobach, IV; Daneman, R; Abner, EL; Jicha, GA				Goetzl, Edward J.; Schwartz, Janice B.; Mustapic, Maja; Lobach, Iryna V.; Daneman, Richard; Abner, Erin L.; Jicha, Gregory A.			Altered cargo proteins of human plasma endothelial cell-derived exosomes in atherosclerotic cerebrovascular disease	FASEB JOURNAL			English	Article						blood biomarkers; stroke; platelets; cellular adhesion; angiogenesis	BLOOD-BRAIN-BARRIER; ALZHEIMERS-DISEASE	Plasma endothelial cell-derived exosomes (EDEs) and platelet-derived exosomes (PDEs) were precipitated and enriched separately by immunospecific absorption procedures for analyses of cargo proteins relevant to atherosclerosis. EDEs had usual exosome size and marker protein content, and significantly higher levels than PDEs of the endothelial proteins vascular cell adhesion molecule-1 (VCAM-1) and endothelial nitric oxide synthase, whereas PDEs had significantly higher levels of platelet glycoprotein VI. EDE levels of VCAM-1, von Willebrand factor, platelet-derived growth factor (PDGF)-BB, angiopoietin-1, and lysyl oxidase-2 and the cerebrovascular-selective proteins glucose transporter 1, permeability-glycoprotein, and large neutral amino acid transporter 1 were significantly higher for 18 patients with cerebrovascular disease (CeVD) than for 18 age-and gender-matched control subjects. PDE levels of PDGF-AA, platelet glycoprotein VI, integrin-linked kinase-1, high mobility group box-1 protein, chemokine CXCL4, and thrombospondin-1 were significantly higher in patients with CeVD than in control subjects, but differences were less with greater overlaps than for EDE proteins. EDE levels of Yes-associated protein (YAP) were higher and of P(S127)-YAP lower in patients with CeVD than in control subjects, consistent with heightened activity of this mechanical force-sensitive system in atherosclerosis. Elevated EDE and PDE levels of atherosclerosis-promoting proteins in CeVD justify clinical studies of their potential value as biomarkers.	[Goetzl, Edward J.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Schwartz, Janice B.] Univ Calif San Francisco, Dept Bioengn, San Francisco, CA 94143 USA; [Lobach, Iryna V.] Univ Calif San Francisco, Clin Translat Sci Inst, San Francisco, CA 94143 USA; [Goetzl, Edward J.; Schwartz, Janice B.] Jewish Home San Francisco, San Francisco, CA USA; [Mustapic, Maja] NIA, Neurosci Lab, Baltimore, MD 21224 USA; [Daneman, Richard] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Daneman, Richard] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Abner, Erin L.; Jicha, Gregory A.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of California System; University of California San Diego; University of California System; University of California San Diego; University of Kentucky	Goetzl, EJ (corresponding author), Geriatr Res Ctr, 1719 Broderick St, San Francisco, CA 94115 USA.	edward.goetzl@ucsf.edu	Schwartz, Janice/K-6354-2019; Mustapic, Maja/AAV-3212-2020	Mustapic, Maja/0000-0003-0511-2047	Biomarkers Across Neurodegenerative Diseases 2 (BAND2) Program of the Michael J. Fox Foundation for Parkinson's Research; Alzheimer's Association; Alzheimer's Research UK; Weston Brain Institute; U.S. National Institutes of Health (NIH) National Institute for Nursing Research [R01 NR014189]; Intramural Research Program of the NIH National Institute on Aging; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR014189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028383] Funding Source: NIH RePORTER	Biomarkers Across Neurodegenerative Diseases 2 (BAND2) Program of the Michael J. Fox Foundation for Parkinson's Research; Alzheimer's Association(Alzheimer's Association); Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Weston Brain Institute; U.S. National Institutes of Health (NIH) National Institute for Nursing Research; Intramural Research Program of the NIH National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a grant from the Biomarkers Across Neurodegenerative Diseases 2 (BAND2) Program of the Michael J. Fox Foundation for Parkinson's Research, Alzheimer's Association, Alzheimer's Research UK and the Weston Brain Institute (to E.J.G.), and by Grant R01 NR014189 from the U.S. National Institutes of Health (NIH) National Institute for Nursing Research (to G.A.J.). M.M. was supported by the Intramural Research Program of the NIH National Institute on Aging. The authors thank Judith H. Goetzl (Jewish Home of San Francisco) for expert preparation of the illustrations. E.J.G. has filed an application with the U.S. Patent Office for the platform and methodologies described in this report. All remaining authors declare no conflicts of interest.	Boado RJ, 1999, P NATL ACAD SCI USA, V96, P12079, DOI 10.1073/pnas.96.21.12079; Chakraborty S, 2017, J BIOL CHEM, V292, P6600, DOI 10.1074/jbc.M116.742627; Chironi GN, 2009, CELL TISSUE RES, V335, P143, DOI 10.1007/s00441-008-0710-9; de Jong OG, 2016, J CELL MOL MED, V20, P342, DOI 10.1111/jcmm.12730; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; Gimbrone MA, 2016, CIRC RES, V118, P620, DOI 10.1161/CIRCRESAHA.115.306301; Goetzl EJ, 2016, FASEB J, V30, P4141, DOI 10.1096/fj.201600816R; Goetzl EJ, 2016, FASEB J, V30, P3853, DOI 10.1096/fj.201600756R; Goetzl EJ, 2016, FASEB J, V30, P2058, DOI 10.1096/fj.201500150R; Haqqani AS, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-4; Jakobi AJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1385; Ju R, 2014, J BIOL CHEM, V289, P510, DOI 10.1074/jbc.M113.506899; Pircher A, 2016, ATHEROSCLEROSIS, V253, P247, DOI 10.1016/j.atherosclerosis.2016.08.011; Rautou PE, 2011, CIRC RES, V109, P593, DOI 10.1161/CIRCRESAHA.110.233163; Rautou PE, 2011, CIRC RES, V108, P335, DOI 10.1161/CIRCRESAHA.110.237420; Schinkel AH, 1999, ADV DRUG DELIVER REV, V36, P179, DOI 10.1016/S0169-409X(98)00085-4; Seidner G, 1998, NAT GENET, V18, P188, DOI 10.1038/ng0298-188; Tabas I, 2015, J CELL BIOL, V209, P13, DOI 10.1083/jcb.201412052; Wang J, 2016, STEM CELLS INT, V2016; Wang L, 2016, NATURE, V540, P579, DOI 10.1038/nature20602; Winston Charisse N, 2016, Alzheimers Dement (Amst), V3, P63, DOI 10.1016/j.dadm.2016.04.001	21	56	58	2	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3689	3694		10.1096/fj.201700149	http://dx.doi.org/10.1096/fj.201700149			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28476896	Green Submitted, Green Published			2022-12-26	WOS:000405932400039
J	Bergqvist, N; Nyman, E; Cedersund, G; Stenkula, KG				Bergqvist, Niclas; Nyman, Elin; Cedersund, Gunnar; Stenkula, Karin G.			A systems biology analysis connects insulin receptor signaling with glucose transporter translocation in rat adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING-PROTEIN; PLASMA-MEMBRANE; ADIPOSE-CELLS; SUBCELLULAR TRAFFICKING; GLUT4 TRANSLOCATION; PHOSPHORYLATION; FUSION; EXOCYTOSIS; RESISTANCE; MUSCLE	Type 2 diabetes is characterized by insulin resistance, which arises from malfunctions in the intracellular insulin signaling network. Knowledge of the insulin signaling network is fragmented, and because of the complexity of this network, little consensus has emerged for the structure and importance of the different branches of the network. To help overcome this complexity, systems biology mathematical models have been generated for predicting both the activation of the insulin receptor (IR) and the redistribution of glucose transporter 4 (GLUT4) to the plasma membrane. Although the insulin signal transduction between IR and GLUT4 has been thoroughly studied with modeling and time-resolved data in human cells, comparable analyses in cells from commonly used model organisms such as rats and mice are lacking. Here, we combined existing data and models for rat adipocytes with new data collected for the signaling network between IR and GLUT4 to create a model also for their interconnections. To describe all data (>140 data points), the model needed three distinct pathways from IR to GLUT4: (i) via protein kinase B (PKB) and Akt substrate of 160 kDa (AS160), (ii) via an AS160-independent pathway from PKB, and (iii) via an additional pathway from IR, e.g. affecting the membrane constitution. The developed combined model could describe data not used for training the model and was used to generate predictions of the relative contributions of the pathways from IR to translocation of GLUT4. The combined model provides a systems-level understanding of insulin signaling in rat adipocytes, which, when combined with corresponding models for human adipocytes, may contribute to model-based drug development for diabetes.	[Bergqvist, Niclas; Nyman, Elin; Cedersund, Gunnar] Linkoping Univ, Dept Biomed Engn, SE-58185 Linkoping, Sweden; [Cedersund, Gunnar] Linkoping Univ, Dept Clin & Expt Med & Biomed Engn, SE-58185 Linkoping, Sweden; [Nyman, Elin] AstraZeneca R&D, Cardiovasc & Metab Dis Innovat Med & Early Dev Bi, SE-43183 Gothenburg, Sweden; [Stenkula, Karin G.] Lund Univ, Biomed Ctr, Dept Expt Med Sci, Glucose Transport & Prot Trafficking, SE-22184 Lund, Sweden	Linkoping University; Linkoping University; AstraZeneca; Lund University	Cedersund, G (corresponding author), Linkoping Univ, Dept Biomed Engn, SE-58185 Linkoping, Sweden.; Stenkula, KG (corresponding author), Lund Univ, Dept Expt Med Sci, BMC C11, S-22384 Lund, Sweden.	gunnar.cedersund@liu.se; karin.stenkula@med.lu.se	Nyman, Elin/I-3363-2019	Nyman, Elin/0000-0002-4261-0291; Stenkula, Karin/0000-0002-0739-1150	Swedish Research Council [2013-3542]; AstraZeneca; Diabetes Foundation; Craaford Foundation; Royal Physiographic Society in Lund	Swedish Research Council(Swedish Research CouncilEuropean Commission); AstraZeneca(AstraZeneca); Diabetes Foundation; Craaford Foundation; Royal Physiographic Society in Lund	This work was supported by Swedish Research Council Grant 2013-3542 (to K. G. S.), AstraZeneca, the Diabetes Foundation, the Craaford Foundation, and the Royal Physiographic Society in Lund. The salary for E. N. was paid through a grant from AstraZeneca.	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brannmark C, 2013, J BIOL CHEM, V288, P9867, DOI 10.1074/jbc.M112.432062; Brannmark C, 2010, J BIOL CHEM, V285, P20171, DOI 10.1074/jbc.M110.106849; Brewer PD, 2014, J BIOL CHEM, V289, P17280, DOI 10.1074/jbc.M114.555714; Brewer PD, 2011, J BIOL CHEM, V286, P26287, DOI 10.1074/jbc.M111.253880; Bryant NJ, 2011, TRAFFIC, V12, P657, DOI 10.1111/j.1600-0854.2011.01163.x; Buren J, 2008, ARCH BIOCHEM BIOPHYS, V474, P91, DOI 10.1016/j.abb.2008.02.034; Cedersund G, 2016, STUD MECHANOBIOL TIS, V17, P449, DOI 10.1007/978-3-319-21296-8_17; Cedersund G, 2012, FEBS J, V279, P3513, DOI 10.1111/j.1742-4658.2012.08725.x; Cedersund G, 2009, FEBS J, V276, P903, DOI 10.1111/j.1742-4658.2008.06845.x; CLARK AE, 1991, BIOCHEM J, V278, P235, DOI 10.1042/bj2780235; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; CUSHMAN SW, 1980, J BIOL CHEM, V255, P4758; Dietze D, 2002, DIABETES, V51, P2369, DOI 10.2337/diabetes.51.8.2369; Eguez L, 2005, CELL METAB, V2, P263, DOI 10.1016/j.cmet.2005.09.005; Frayn KN, 2001, P NUTR SOC, V60, P375, DOI 10.1079/PNS200195; Gandasi NR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4914; Govers R, 2014, DIABETES METAB, V40, P400, DOI 10.1016/j.diabet.2014.01.005; Hauner H, 1998, INT J OBESITY, V22, P448, DOI 10.1038/sj.ijo.0800606; HOLMAN GD, 1994, J BIOL CHEM, V269, P17516; Jewell JL, 2011, J CELL BIOL, V193, P185, DOI 10.1083/jcb.201007176; Kiselyov VV, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.78; Kondapaka SB, 2004, CLIN CANCER RES, V10, P7192, DOI 10.1158/1078-0432.CCR-04-0772; Koumanov F, 2005, CELL METAB, V2, P179, DOI 10.1016/j.cmet.2005.08.007; Lizunov VA, 2013, DIABETES, V62, P3114, DOI 10.2337/db12-1741; Lizunov VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057559; Muretta JM, 2009, VITAM HORM, V80, P245, DOI 10.1016/S0083-6729(08)00610-9; Nyman E, 2014, J BIOL CHEM, V289, P33215, DOI 10.1074/jbc.M114.608927; Nyman E, 2012, FEBS J, V279, P987, DOI 10.1111/j.1742-4658.2012.08488.x; Nyman E, 2011, J BIOL CHEM, V286, P26028, DOI 10.1074/jbc.M110.188987; Rajan MR, 2016, J BIOL CHEM, V291, P15806, DOI 10.1074/jbc.M116.715763; RODBELL M, 1964, J BIOL CHEM, V239, P375; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; SATOH S, 1993, J BIOL CHEM, V268, P17820; Schmidt H, 2006, BIOINFORMATICS, V22, P514, DOI 10.1093/bioinformatics/bti799; Schmidt H, 2007, BIOINFORMATICS, V23, P646, DOI 10.1093/bioinformatics/btl668; Stenkula KG, 2010, CELL METAB, V12, P250, DOI 10.1016/j.cmet.2010.08.005; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; SUZUKI K, 1980, P NATL ACAD SCI-BIOL, V77, P2542, DOI 10.1073/pnas.77.5.2542; [No title captured]	44	4	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11206	11217		10.1074/jbc.M117.787515	http://dx.doi.org/10.1074/jbc.M117.787515			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28495883	hybrid, Green Published			2022-12-26	WOS:000405119600007
J	Fantini, M; Pandolfini, L; Lisi, S; Chirichella, M; Arisi, I; Terrigno, M; Goracci, M; Cremisi, F; Cattaneo, A				Fantini, Marco; Pandolfini, Luca; Lisi, Simonetta; Chirichella, Michele; Arisi, Ivan; Terrigno, Marco; Goracci, Martina; Cremisi, Federico; Cattaneo, Antonino			Assessment of antibody library diversity through next generation sequencing and technical error compensation	PLOS ONE			English	Article							INTRACELLULAR ANTIBODIES; IMMUNOGLOBULIN GENES; ALLELIC EXCLUSION; IMMUNIZED MICE; SELECTION; REPERTOIRE; PHAGE; DISPLAY; HEAVY; LIGHT	Antibody libraries are important resources to derive antibodies to be used for a wide range of applications, from structural and functional studies to intracellular protein interference studies to developing new diagnostics and therapeutics. Whatever the goal, the key parameter for an antibody library is its complexity (also known as diversity), i.e. the number of distinct elements in the collection, which directly reflects the probability of finding in the library an antibody against a given antigen, of sufficiently high affinity. Quantitative evaluation of antibody library complexity and quality has been for a long time inadequately addressed, due to the high similarity and length of the sequences of the library. Complexity was usually inferred by the transformation efficiency and tested either by fingerprinting and/or sequencing of a few hundred random library elements. Inferring complexity from such a small sampling is, however, very rudimental and gives limited information about the real diversity, because complexity does not scale linearly with sample size. Next-generation sequencing (NGS) has opened new ways to tackle the antibody library complexity quality assessment. However, much remains to be done to fully exploit the potential of NGS for the quantitative analysis of antibody repertoires and to overcome current limitations. To obtain a more reliable antibody library complexity estimate here we show a new, PCR-free, NGS approach to sequence antibody libraries on Illumina platform, coupled to a new bioinformatic analysis and software (Diversity Estimator of Antibody Library, DEAL) that allows to reliably estimate the complexity, taking in consideration the sequencing error.	[Fantini, Marco; Pandolfini, Luca; Lisi, Simonetta; Chirichella, Michele; Terrigno, Marco; Goracci, Martina; Cremisi, Federico; Cattaneo, Antonino] Scuola Normale Super Pisa, Bio SNS Lab, Pisa, Italy; [Arisi, Ivan; Cattaneo, Antonino] European Brain Res Inst, Rome, Italy; [Pandolfini, Luca] Univ Cambridge, Wellcome Trust, CRUK Gurdon Inst, Cambridge, England	Scuola Normale Superiore di Pisa; University of Cambridge; Wellcome Trust Sanger Institute	Cattaneo, A (corresponding author), Scuola Normale Super Pisa, Bio SNS Lab, Pisa, Italy.; Cattaneo, A (corresponding author), European Brain Res Inst, Rome, Italy.	antonino.cattaneo@sns.it	Cattaneo, Antonino/AAA-7252-2019; Pandolfini, Luca/AAK-4213-2021; cremisi, federico/AAI-2183-2020; Arisi, Ivan/AAM-1152-2021	Arisi, Ivan/0000-0002-0536-2508; Cremisi, Federico/0000-0003-4925-2703; Fantini, Marco/0000-0002-2195-3957; TERRIGNO, MARCO/0000-0001-8967-7269; Pandolfini, Luca/0000-0003-1444-8167; Goracci, Martina/0000-0002-2350-0724	European Union [604102]	European Union(European Commission)	Funded by European Union Seventh Framework Program [grant No. 604102 A.C.] (Human Brain Project). https://www.humanbrainproject.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andris-Widhopf J, 2011, COLD SPRING HARB PRO, V2011; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cai XH, 1996, P NATL ACAD SCI USA, V93, P6280, DOI 10.1073/pnas.93.13.6280; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; Chirichella M, 2017, NAT METHODS, V14, P279, DOI [10.1038/NMETH.4144, 10.1038/nmeth.4144]; Daly J, 2007, EMBO J, V26, P4273, DOI 10.1038/sj.emboj.7601846; DAVIES EL, 1995, J IMMUNOL METHODS, V186, P125, DOI 10.1016/0022-1759(95)00143-X; DeKosky BJ, 2015, NAT MED, V21, P86, DOI 10.1038/nm.3743; DeKosky BJ, 2013, NAT BIOTECHNOL, V31, P166, DOI 10.1038/nbt.2492; Fischer N, 2011, MABS-AUSTIN, V3, P17, DOI 10.4161/mabs.3.1.14169; Georgiou G, 2014, NAT BIOTECHNOL, V32, P158, DOI 10.1038/nbt.2782; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; Glanville J, 2015, CURR OPIN STRUC BIOL, V33, P146, DOI 10.1016/j.sbi.2015.09.001; Glanville J, 2009, P NATL ACAD SCI USA, V106, P20216, DOI 10.1073/pnas.0909775106; Greiff V, 2014, BMC IMMUNOL, V15, DOI 10.1186/s12865-014-0040-5; Hanes J, 1997, P NATL ACAD SCI USA, V94, P4937, DOI 10.1073/pnas.94.10.4937; He MY, 1997, NUCLEIC ACIDS RES, V25, P5132, DOI 10.1093/nar/25.24.5132; Hoogenboom HR, 1998, IMMUNOTECHNOLOGY, V4, P1, DOI 10.1016/S1380-2933(98)00007-4; KETTLEBOROUGH CA, 1994, EUR J IMMUNOL, V24, P952, DOI 10.1002/eji.1830240426; Koohapitagtam M, 2010, MOL BIOL REP, V37, P1677, DOI 10.1007/s11033-009-9583-6; Lang IM, 1996, GENE, V172, P295, DOI 10.1016/0378-1119(96)00021-2; Logan AC, 2011, P NATL ACAD SCI USA, V108, P21194, DOI 10.1073/pnas.1118357109; Luo CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030087; Marks James D, 2004, Methods Mol Biol, V248, P117; MARKS JD, 1991, J MOL BIOL, V222, P581, DOI 10.1016/0022-2836(91)90498-U; Meli G, 2009, J MOL BIOL, V387, P584, DOI 10.1016/j.jmb.2009.01.061; Milstein C., 1990, P R SOC LONDON B, V239; Nordgard O, 2006, ANAL BIOCHEM, V356, P182, DOI 10.1016/j.ab.2006.06.020; PERELSON AS, 1979, J THEOR BIOL, V81, P645, DOI 10.1016/0022-5193(79)90275-3; Rhoads A, 2015, GENOM PROTEOM BIOINF, V13, P278, DOI 10.1016/j.gpb.2015.08.002; Shugay M, 2014, NAT METHODS, V11, P653, DOI [10.1038/NMETH.2960, 10.1038/nmeth.2960]; Tanaka T, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng023; Tanaka T, 2003, J MOL BIOL, V331, P1109, DOI 10.1016/S0022-2836(03)00836-2; Tanaka T, 2010, NAT PROTOC, V5, P67, DOI 10.1038/nprot.2009.199; Vettermann C, 2010, IMMUNOL REV, V237, P22, DOI 10.1111/j.1600-065X.2010.00935.x; Visintin M, 1999, P NATL ACAD SCI USA, V96, P11723, DOI 10.1073/pnas.96.21.11723; Visintin M, 2004, METHODS, V34, P200, DOI 10.1016/j.ymeth.2004.04.008; Visintin M, 2004, J IMMUNOL METHODS, V290, P135, DOI 10.1016/j.jim.2004.04.014; Vollmers C, 2013, P NATL ACAD SCI USA, V110, P13463, DOI 10.1073/pnas.1312146110; Weinstein JA, 2009, SCIENCE, V324, P807, DOI 10.1126/science.1170020; WINTER G, 1991, NATURE, V349, P293, DOI 10.1038/349293a0; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	44	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177574	10.1371/journal.pone.0177574	http://dx.doi.org/10.1371/journal.pone.0177574			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505201	Green Published, gold, Green Submitted			2022-12-26	WOS:000401473500030
J	Kan, HJ; Verrijp, FW; Hovius, SER; van Nieuwenhoven, CA; Selles, RW				Kan, Hester J.; Verrijp, Frank W.; Hovius, Steven E. R.; van Nieuwenhoven, Christianne A.; Selles, Ruud W.		Dupuytren Delphi Grp	Recurrence of Dupuytren's contracture: A consensus-based definition	PLOS ONE			English	Article							FOLLOW-UP; NONSURGICAL TREATMENT; DISEASE; DERMOFASCIECTOMY; MOTION; RANGE; HAND	Purpose One of the major determinants of Dupyutren disease (DD) treatment efficacy is recurrence of the contracture. Unfortunately, lack of agreement in the literature on what constitutes recurrence makes it nearly impossible to compare the multiple treatments alternatives available today. The aim of this study is to bring an unbiased pool of experts to agree upon what would be considered a recurrence of DD after treatment; and from that consensus establish a much-needed definition for DD recurrence. Methods To reach an expert consensus on the definition of recurrence we used the Delphi method and invited 43 Dupuytren's research and treatment experts from 10 countries to participate by answering a series of questionnaire rounds. After each round the answers were analyzed and the experts received a feedback report with another questionnaire round to further hone in of the definition. We defined consensus when at least 70% of the experts agreed on a topic. Results Twenty-one experts agreed to participate in this study. After four consensus rounds, we agreed that DD recurrence should be defined as "more than 20 degrees of contracture recurrence in any treated joint at one year post-treatment compared to six weeks post-treatment". In addition, "recurrence should be reported individually for every treated joint" and afterwards measurements should be repeated and reported yearly. Conclusion This study provides the most comprehensive to date definition of what should be considered recurrence of DD. These standardized criteria should allow us to better evaluate the many treatment alternatives.	[Kan, Hester J.; Verrijp, Frank W.; Hovius, Steven E. R.; van Nieuwenhoven, Christianne A.; Selles, Ruud W.] Erasmus MC, Dept Plast & Reconstruct Surg & Hand Surg, Rotterdam, Netherlands; [Selles, Ruud W.] Erasmus MC, Dept Rehabil Med & Physiotherapy, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Kan, HJ (corresponding author), Erasmus MC, Dept Plast & Reconstruct Surg & Hand Surg, Rotterdam, Netherlands.	h.kan@erasmusmc.nl	Selles, Ruud/N-9665-2019; Eaton, Charles/H-4666-2015; Zyluk, Andrzej/G-8377-2014	Selles, Ruud/0000-0002-2432-6756; Eaton, Charles/0000-0002-8186-3611; Degreef, Ilse/0000-0003-2464-2641; Jerosch-Herold, Christina/0000-0003-0525-1282; Zyluk, Andrzej/0000-0002-8299-4525				Abe Y, 2004, J HAND SURG-BRIT EUR, V29B, P427, DOI 10.1016/j.jhsb.2004.06.004; Becker GW, 2010, J HAND SURG-EUR VOL, V35E, P623, DOI 10.1177/1753193410376286; BROTHERSTON TM, 1994, BRIT J PLAST SURG, V47, P440, DOI 10.1016/0007-1226(94)90075-2; Cheng H S, 2008, J Orthop Surg (Hong Kong), V16, P88; Ellis B, 2002, CLIN REHABIL, V16, P562, DOI 10.1191/0269215502cr513oa; Gilpin D, 2010, J HAND SURG-AM, V35A, P2027, DOI 10.1016/j.jhsa.2010.08.007; Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x; Hovius SER, 2011, PLAST RECONSTR SURG, V128, P221, DOI 10.1097/PRS.0b013e31821741ba; HUESTON JT, 1976, MED J AUSTRALIA, V2, P189, DOI 10.5694/j.1326-5377.1976.tb134472.x; Kan HJ, 2013, J PLAST RECONSTR AES, V66, P95, DOI 10.1016/j.bjps.2012.08.019; KETCHUM LD, 1987, J HAND SURG-AM, V12A, P659, DOI 10.1016/S0363-5023(87)80043-6; LEA RD, 1995, J BONE JOINT SURG AM, V77A, P784, DOI 10.2106/00004623-199505000-00017; Pratt AL, 2009, J CLIN NURS, V18, P1793, DOI 10.1111/j.1365-2702.2008.02692.x; Skoff HD, 2004, PLAST RECONSTR SURG, V113, P540, DOI 10.1097/01.PRS.0000101054.80392.88; van Rijssen AL, 2006, J HAND SURG-AM, V31A, P717, DOI 10.1016/j.jhsa.2006.02.021; Watt AJ, 2010, J HAND SURG-AM, V35A, P534, DOI 10.1016/j.jhsa.2010.01.003; Werker PM, 2011, PLASTIC RECONSTRUCTI	17	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0164849	10.1371/journal.pone.0164849	http://dx.doi.org/10.1371/journal.pone.0164849			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505187	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000401473500001
J	Myrick, DA; Christopher, MA; Scott, AM; Simon, AK; Donlin-Asp, PG; Kelly, WG; Katz, DJ				Myrick, Dexter A.; Christopher, Michael A.; Scott, Alyssa M.; Simon, Ashley K.; Donlin-Asp, Paul G.; Kelly, William G.; Katz, David J.			KDM1A/LSD1 regulates the differentiation and maintenance of spermatogonia in mice	PLOS ONE			English	Article							RETINOIC ACID; LSD1; METHYLATION; EXPRESSION; REPRESSION; COMPONENT; COREST; CELLS; CRE	The proper regulation of spermatogenesis is crucial to ensure the continued production of sperm and fertility. Here, we investigated the function of the H3K4me2 demethylase KDM1A/LSD1 during spermatogenesis in developing and adult mice. Conditional deletion of Kdm1a in the testis just prior to birth leads to fewer spermatogonia and germ cell loss before 3 weeks of age. These results demonstrate that KDM1A is required for spermatogonial differentiation, as well as germ cell survival, in the developing testis. In addition, inducible deletion of Kdm1a in the adult testis results in the abnormal accumulation of meiotic spermatocytes, as well as apoptosis and progressive germ cell loss. These results demonstrate that KDM1A is also required during adult spermatogenesis. Furthermore, without KDM1A, the stem cell factor OCT4 is ectopically maintained in differentiating germ cells. This requirement for KDM1A is similar to what has been observed in other stem cell populations, suggesting a common function. Taken together, we propose that KDM1A is a key regulator of spermatogenesis and germ cell maintenance in the mouse.	[Myrick, Dexter A.; Christopher, Michael A.; Scott, Alyssa M.; Simon, Ashley K.; Donlin-Asp, Paul G.; Katz, David J.] Emory Univ, Dept Cell Biol, Atlanta, GA 30322 USA; [Myrick, Dexter A.; Christopher, Michael A.; Scott, Alyssa M.; Donlin-Asp, Paul G.] Emory Univ, Grad Div Biol & Biomed Sci, Atlanta, GA 30322 USA; [Kelly, William G.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Katz, DJ (corresponding author), Emory Univ, Dept Cell Biol, Atlanta, GA 30322 USA.	djkatz@emory.edu			PREP post-baccalaureate program [5R25GM089615-04]; GMB [T32GM008490-21]; National Science Foundation [10S1354998]; BCDB [5T32GM008367]	PREP post-baccalaureate program; GMB; National Science Foundation(National Science Foundation (NSF)); BCDB	D. Myrick was a member of the PREP post-baccalaureate program (5R25GM089615-04). M. Christopher is supported by the GMB training grant (T32GM008490-21). P. Donlin-Asp was supported by the BCDB training grant (5T32GM008367). The work was supported by a grant to D.J.K from the National Science Foundation (10S1354998).	Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Bowles J, 2007, DEVELOPMENT, V134, P3401, DOI 10.1242/dev.001107; Brown JP, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-18; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Choi J, 2010, BIOCHEM BIOPH RES CO, V401, P327, DOI 10.1016/j.bbrc.2010.09.014; Dann CT, 2008, STEM CELLS, V26, P2928, DOI 10.1634/stemcells.2008-0134; de Rooij DG, 2001, REPRODUCTION, V121, P347, DOI 10.1530/rep.0.1210347; Gallardo T, 2007, GENESIS, V45, P413, DOI 10.1002/dvg.20310; Godmann M, 2007, BIOL REPROD, V77, P754, DOI 10.1095/biolreprod.107.062265; Godmann M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012727; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Jan SZ, 2012, BBA-MOL BASIS DIS, V1822, P1838, DOI 10.1016/j.bbadis.2012.02.008; Kerenyi MA, 2013, ELIFE, V2, DOI 10.7554/eLife.00633; Lambrot R, 2015, FASEB J; Macfarlan TS, 2011, GENE DEV, V25, P594, DOI 10.1101/gad.2008511; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Muramoto T, 2010, CURR BIOL, V20, P397, DOI 10.1016/j.cub.2010.01.017; Musri MM, 2010, J BIOL CHEM, V285, P30034, DOI 10.1074/jbc.M110.151209; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; RUSSELL LD, 1990, AM J ANAT, V188, P21, DOI 10.1002/aja.1001880104; Sada A, 2009, SCIENCE, V325, P1394, DOI 10.1126/science.1172645; Saleque S, 2007, MOL CELL, V27, P562, DOI 10.1016/j.molcel.2007.06.039; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Soper SFC, 2008, DEV CELL, V15, P285, DOI 10.1016/j.devcel.2008.05.015; Su ST, 2009, MOL CELL BIOL, V29, P1421, DOI 10.1128/MCB.01158-08; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; You A, 2001, P NATL ACAD SCI USA, V98, P1454, DOI 10.1073/pnas.98.4.1454; Zhang J, 2013, GENE DEV, V27, P749, DOI 10.1101/gad.210963.112; Zhu DM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4174	36	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177473	10.1371/journal.pone.0177473	http://dx.doi.org/10.1371/journal.pone.0177473			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498828	gold, Green Submitted, Green Published			2022-12-26	WOS:000401314500018
J	Chen, Q; Hu, CY; Liu, Y; Liu, Y; Wang, W; Zheng, HC; Rong, LC; Jia, JY; Sun, SX; Yu, C; Liu, YM				Chen, Qian; Hu, Chaoying; Liu, Ye; Liu, Yun; Wang, Wei; Zheng, Hongchao; Rong, Lianchen; Jia, Jingying; Sun, Shixuan; Yu, Chen; Liu, Yan Mei			Safety and tolerability of high-dose ulinastatin after 2-hour intravenous infusion in adult healthy Chinese volunteers: A randomized, double-blind, placebo-controlled, ascending-dose study	PLOS ONE			English	Article							URINARY TRYPSIN-INHIBITOR; PROTEASE INHIBITOR; STRESS; INJURY; RATS	Ulinastatin, is a broad-spectrum protease inhibitor purified from human urine, inhibits endogenous proteases such as trypsin, a-chymotrypsin, hyaluronidase, and plasmin. It is widely being used at increasingly higher doses for the treatment of acute or chronic pancreatitis, severe infection, and acute organ failure. We aimed to evaluate the safety and tolerability of high-dose ulinastatin in healthy volunteers in our single center, randomized, double-blind, placebo-controlled, single-dose escalation study. Fifty-one healthy Chinese subjects were enrolled in 9 dose cohorts (3x10(5) U, 6x10(5) U, 12x10(5) U, 20x10(5) U, 30x10(5) U, 45x10(5) U, 60x10(5) U, 70x10(5) U, or 80x10(5) U of ulinastatin) and randomized to UTI or matching placebo (n = 1). Each dose cohort was composed of 3-7 subjects. All subjects were required to have 2 h of intravenous infusion. Safety and tolerability were assessed throughout the study via monitoring of vital signs, physical examinations, clinical laboratory tests, 12-lead electrocardiograms, and interviews with the subjects about adverse events. Fifty-one subjects (35 men and 16 women) completed the study. A total of 13 AEs were reported by 10 subjects: 11 adverse events in the ulinastatin groups and 2 adverse events in the placebo group. Twelve of the adverse events were possibly related to the study drug. The most common drug-related adverse events included dizziness, pain at injection site, and a decrease in white blood cell count. All adverse events were of mild severity; none were serious. In conclusion, 2 hours of intravenous infusion of ulinastatin (3x10(5) to 80x10(5) U) was well tolerated by healthy Chinese subjects.	[Chen, Qian; Hu, Chaoying; Liu, Ye; Liu, Yun; Jia, Jingying; Sun, Shixuan; Yu, Chen; Liu, Yan Mei] Fudan Univ, Shanghai Xuhui Cent Hosp, Cent Lab, Shanghai, Peoples R China; [Chen, Qian; Hu, Chaoying; Liu, Ye; Liu, Yun; Wang, Wei; Zheng, Hongchao; Jia, Jingying; Sun, Shixuan; Yu, Chen; Liu, Yan Mei] Fudan Univ, Zhongshan Xuhui Hosp, Shanghai, Peoples R China; [Wang, Wei] Fudan Univ, Shanghai Xuhui Cent Hosp, Dept Emergency, Shanghai, Peoples R China; [Zheng, Hongchao] Fudan Univ, Shanghai Xuhui Cent Hosp, Dept Cardiol, Shanghai, Peoples R China; [Rong, Lianchen] Techpool Biopharma Co Ltd, Clin Dev Dept, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University	Liu, YM (corresponding author), Fudan Univ, Shanghai Xuhui Cent Hosp, Cent Lab, Shanghai, Peoples R China.; Liu, YM (corresponding author), Fudan Univ, Zhongshan Xuhui Hosp, Shanghai, Peoples R China.	ymliu@shxh-centerlab.com		Jia, Jingying/0000-0002-2492-3219	Guangdong Techpool Bio-pharma Co., Ltd.; Techpool Bio-pharma Company, Limited	Guangdong Techpool Bio-pharma Co., Ltd.; Techpool Bio-pharma Company, Limited	This study was funded by Guangdong Techpool Bio-pharma Co., Ltd., who provided the study drug and financial support for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Lianchen Rong is employed by Techpool Bio-pharma Company, Limited, Shanghai, China. Techpool Bio-pharma Company, Limited provided support in the form of salary for author LR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.; All authors are grateful to the sponsor, Guangdong Techpool Bio-pharma Co., Ltd., who provided the study drug and financial support for this study. We would also like to thank Shanghai Clinical Research Center for performing the data analysis.	Bao PT, 2009, EUR J PHARMACOL, V603, P114, DOI 10.1016/j.ejphar.2008.12.007; [冯国辉 FENG Guo-hui], 2009, [中华麻醉学杂志, Chinese Journal of Anesthesiology], V29, P296; Fries E, 2000, INT J BIOCHEM CELL B, V32, P125, DOI 10.1016/S1357-2725(99)00125-9; Jeong CW, 2012, KOREAN J ANESTHESIOL, V63, P120, DOI 10.4097/kjae.2012.63.2.120; Koga Y, 2010, NEUROL RES, V32, P925, DOI 10.1179/016164110X12645013515133; Pugia MJ, 2005, CLIN CHEM LAB MED, V43, P1, DOI 10.1515/CCLM.2005.001; Sato N, 2002, DIGEST SURG, V19, P300, DOI 10.1159/000064578; Song J, 2013, KOREAN J ANESTHESIOL, V64, P334, DOI 10.4097/kjae.2013.64.4.334; State Food and Drug Administration of China, GUID GOOD CLIN PRINC; Umeadi C, 2008, TRANSPL P, V40, P387, DOI 10.1016/j.transproceed.2008.01.034; WMA, 1964, WMA DECL HELS ETH PR; Wu CY, 2007, CHIN J CLIN PHARM, V12, P103; Yang HY, 2011, AM J SURG, V202, P151, DOI 10.1016/j.amjsurg.2010.07.044; [张安 ZHANG An], 2008, [中国临床药理学杂志, The Chinese Journal of Clinical Pharmacology], V24, P104; [张献全 ZHANG Xianquan], 2008, [中国急救医学, Chinese Journal of Critical Care Medicine], V28, P1060; Zhong DF, 2011, CHIN J CLIN RATIONAL, V4, P41	16	16	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177425	10.1371/journal.pone.0177425	http://dx.doi.org/10.1371/journal.pone.0177425			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493932	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314300105
J	Choi, YH; Cho, SS; Simkhada, JR; Rahman, MS; Choi, YS; Kim, CS; Yoo, JC				Choi, Yun Hee; Cho, Seung Sik; Simkhada, Jaya Ram; Rahman, Md. Saifur; Choi, Yoon Seok; Kim, Chun Sung; Yoo, Jin Cheol			A novel multifunctional peptide oligomer of bacitracin with possible bioindustrial and therapeutic applications from a Korean food-source Bacillus strain	PLOS ONE			English	Article							NITRIC-OXIDE; RAW 264.7; BACTERIOCIN; PURIFICATION; THERMOTOLERANT; DEFENSE	Investigating the effects of a multifunctional microbial peptide possessing strong anti-inflammatory activity against pathogenic bacteria. The antimicrobial activity of the purified peptide (CSP32) against various multidrug-resistant as well as anaerobic pathogens was determined. Anti-inflammatory activity was determined by an enzyme-linked immunosorbent assay, western blotting, and RT-PCR in RAW 264.7 macrophages. Molecular weight and structural elucidation were performed by several analytical methods such as mass spectrometry and chemoinformatic analysis. CSP32, purified from newly isolated Bacillus sp. CS32, was active against methicillin-resistant Staphylococcus aureus, vancomycin-resistant S. aureus, vancomycin-resistant enterococci, and anaerobic pathogens Propionibacterium acne and Clostridium difficile. Furthermore, CSP32 showed strong inhibitory effects on lipopolysaccharide (LPS)-induced nitric oxide (NO) production and nitric oxide synthase (iNOS) and cyclooxygenase 2 (COX-2) expression in RAW 264.7 macrophages. At concentrations of 10, 50, and 100 mu g/mL, CSP32 treatment attenuated LPS-induced expression of nuclear factor kappa B (NF-kappa B)and mitogen-activated protein kinases (MAPKs) as well as other proinflammatory mediators such as tumor necrosis factor alpha (TNF-alpha), interleukin 6 (IL6), and IL-1 beta. CSP32 potently inhibited translocation of NF-kappa B into the nucleus by suppressing degradation of I.B kinase (I kappa Ba) and its phosphorylation, thereby causing NF-.B to remain inactive. CSP32 may be the first oligomer of bacitracin with anti-inflammatory properties. Conclusion CSP32 has stable characteristics and may find bio-industrial and therapeutic applications.	[Choi, Yun Hee; Simkhada, Jaya Ram; Rahman, Md. Saifur; Choi, Yoon Seok; Yoo, Jin Cheol] Chosun Univ, Dept Pharm, Coll Pharm, Gwangju, South Korea; [Cho, Seung Sik] Mokpo Natl Univ, Dept Pharm, Coll Pharm, Muan 5, Jeonnam, South Korea; [Kim, Chun Sung] Chosun Univ Gwangju, Dept Oral Biochem, Coll Dent, Gwangju, South Korea	Chosun University; Mokpo National University; Chosun University	Yoo, JC (corresponding author), Chosun Univ, Dept Pharm, Coll Pharm, Gwangju, South Korea.	jcyu@chosun.ac.kr	Rahman, Mohammad Sohelur/AAJ-7376-2020; SIMKHADA, JAYA RAM/AAK-1014-2020; Rahman, Mohammad Saifur/GZM-5483-2022; RAHMAN, MD SAIFUR/ABG-5140-2021	Rahman, Mohammad Sohelur/0000-0002-4489-2202; Rahman, Mohammad Saifur/0000-0002-9887-4456; 	National Research Foundation of Korea (NRF) - Korean government (MEST) [NRF- 2015R1A2A1A15056120, NRF- 2015R1D1A1A01059483]; Bio-industry Technology Development Program, Ministry of Agriculture, Food and Rural Affairs [115073-2]	National Research Foundation of Korea (NRF) - Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government); Bio-industry Technology Development Program, Ministry of Agriculture, Food and Rural Affairs	Support was provided by: The National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (NRF- 2015R1A2A1A15056120, NRF- 2015R1D1A1A01059483); and Bio-industry Technology Development Program, Ministry of Agriculture, Food and Rural Affairs (115073-2).	Ahern M, 2003, FEMS MICROBIOL LETT, V220, P127, DOI 10.1016/S0378-1097(03)00086-7; Bizani D, 2002, J APPL MICROBIOL, V93, P512, DOI 10.1046/j.1365-2672.2002.01720.x; Chapman HD, 2010, POULTRY SCI, V89, P1788, DOI 10.3382/ps.2010-00931; Cherif A, 2001, LETT APPL MICROBIOL, V32, P243, DOI 10.1046/j.1472-765X.2001.00898.x; Cho SS, 2012, BIOPROC BIOSYST ENG, V35, P247, DOI 10.1007/s00449-011-0599-7; Choi YH, 2016, ARCH PHARM RES, V39, P429, DOI 10.1007/s12272-015-0679-3; Choi YH, 2012, INT J ANTIMICROB AG, V40, P80, DOI 10.1016/j.ijantimicag.2012.03.019; COOK RJ, 1995, P NATL ACAD SCI USA, V92, P4197, DOI 10.1073/pnas.92.10.4197; Dischinger J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006788; Jorgensen J. H., 2015, MANUAL CLIN MICROBIO, P1253, DOI [DOI 10.1128/9781555817381.CH71, 10.1128/9781555817381]; Kayalvizhi N, 2008, LETT APPL MICROBIOL, V47, P600, DOI 10.1111/j.1472-765X.2008.02473.x; Khalil R, 2009, PAK J NUTR, V8, P242, DOI DOI 10.3923/PJN.2009.242.250; Kim HK, 1999, BIOCHEM PHARMACOL, V58, P759, DOI 10.1016/S0006-2952(99)00160-4; Lee HJ, 1999, J BIOSCI BIOENG, V88, P153, DOI 10.1016/S1389-1723(99)80194-7; Lee HJ, 2009, ARCH PHARM RES, V32, P437, DOI 10.1007/s12272-009-1318-7; Mendo S, 2004, BIOTECHNOL LETT, V26, P115, DOI 10.1023/B:BILE.0000012888.72489.3f; NCCLS, 2004, METH ANT SUSC TEST A; Oscariz JC, 1999, FEMS MICROBIOL LETT, V178, P337, DOI 10.1111/j.1574-6968.1999.tb08696.x; Pattnaik P, 2001, J APPL MICROBIOL, V91, P636, DOI 10.1046/j.1365-2672.2001.01429.x; Rana M., 2006, Journal of Endocrinology and Reproduction, V10, P88; Rosenfeld Y, 2006, BBA-BIOMEMBRANES, V1758, P1513, DOI 10.1016/j.bbamem.2006.05.017; Sarkar D, 2008, INT IMMUNOPHARMACOL, V8, P1264, DOI 10.1016/j.intimp.2008.05.003; Sumi CD, 2015, CAN J MICROBIOL, V61, P93, DOI 10.1139/cjm-2014-0613; Tamang J. P., 2016, FRONTIERS MICROBIOLO, V7; Wu SM, 2005, CURR MICROBIOL, V51, P292, DOI 10.1007/s00284-005-0004-3; Yoon WJ, 2012, ARCH PHARM RES, V35, P1421, DOI 10.1007/s12272-012-0812-5; Yoon WJ, 2009, POL J MICROBIOL, V58, P61; Yu HY, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/637512	28	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176971	10.1371/journal.pone.0176971	http://dx.doi.org/10.1371/journal.pone.0176971			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493903	Green Submitted, gold, Green Published			2022-12-26	WOS:000401314300045
J	Eriksson, S; Elbing, K; Soderman, O; Lindkvist-Petersson, K; Topgaard, D; Lasic, S				Eriksson, Stefanie; Elbing, Karin; Soderman, Olle; Lindkvist-Petersson, Karin; Topgaard, Daniel; Lasic, Samo			NMR quantification of diffusional exchange in cell suspensions with relaxation rate differences between intra and extracellular compartments	PLOS ONE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; FIELD GRADIENT NMR; RED-BLOOD-CELLS; WATER DIFFUSION; SELF-DIFFUSION; POROUS-MEDIA; TRANSPORT; PERMEABILITY; MEMBRANE; ECHO	Water transport across cell membranes can be measured non-invasively with diffusion NMR. We present a method to quantify the intracellular lifetime of water in cell suspensions with short transverse relaxation times, T-2, and also circumvent the confounding effect of different T-2 values in the intra- and extracellular compartments. Filter exchange spectroscopy (FEXSY) is specifically sensitive to exchange between compartments with different apparent diffusivities. Our investigation shows that FEXSY could yield significantly biased results if differences in T-2 are not accounted for. To mitigate this problem, we propose combining FEXSY with diffusion-relaxation correlation experiment, which can quantify differences in T-2 values in compartments with different diffusivities. Our analysis uses a joint constrained fitting of the two datasets and considers the effects of diffusion, relaxation and exchange in both experiments. The method is demonstrated on yeast cells with and without human aquaporins.	[Eriksson, Stefanie; Soderman, Olle; Topgaard, Daniel] Lund Univ, Div Phys Chem, Dept Chem, Lund, Sweden; [Elbing, Karin; Lindkvist-Petersson, Karin] Lund Univ, Dept Expt Med Sci, Lund, Sweden; [Lasic, Samo] CR Dev AB, Lund, Sweden	Lund University; Lund University	Lasic, S (corresponding author), CR Dev AB, Lund, Sweden.	samo@crdev.se	Lasic, Samo/AAR-7539-2021	Lasic, Samo/0000-0002-9284-7182; Lindkvist, Karin/0000-0002-5209-3160; Topgaard, Daniel/0000-0001-9373-6348	Swedish Foundation for Strategic Research (SSF) [AM13-0090]; Cancer foundation [2010/1171, 2014/575]; Swedish Research Council (VR) [2011-2891, 2014-3910]; Organizing Molecular Matter (OMM) center of excellence and CR Development AB (Lund, Sweden)	Swedish Foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research); Cancer foundation; Swedish Research Council (VR)(Swedish Research Council); Organizing Molecular Matter (OMM) center of excellence and CR Development AB (Lund, Sweden)	The work was financially supported by the Swedish Foundation for Strategic Research (SSF) (AM13-0090), the Cancer foundation (2010/1171 and 2014/575), the Swedish Research Council (VR) (2011-2891, 2014-3910 and the Linnaeus grant), the Organizing Molecular Matter (OMM) center of excellence and CR Development AB (Lund, Sweden). The funder provided support in the form of salaries for authors [SL], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agre P, 2004, ANGEW CHEM INT EDIT, V43, P4278, DOI 10.1002/anie.200460804; Allan EA, 1972, PURE APPL CHEM, V32; ANDRASKO J, 1976, BIOCHIM BIOPHYS ACTA, V428, P304, DOI 10.1016/0304-4165(76)90038-6; Aslund I, 2009, J MAGN RESON, V200, P291, DOI 10.1016/j.jmr.2009.07.015; BENGA G, 1988, PROG BIOPHYS MOL BIO, V51, P193, DOI 10.1016/0079-6107(88)90002-8; Benga G., 1989, WATER TRANSPORT BIOL; Benga G, 2013, EUR BIOPHYS J BIOPHY, V42, P33, DOI 10.1007/s00249-012-0868-7; Bernin D, 2013, CURR OPIN COLLOID IN, V18, P166, DOI 10.1016/j.cocis.2013.03.007; Callaghan P. T., 2011, TRANSLATIONAL DYNAMI; Callaghan PT, 2004, J CHEM PHYS, V120, P4032, DOI 10.1063/1.1642604; Callaghan PT, 2003, J MAGN RESON, V162, P320, DOI 10.1016/S1090-7807(03)00056-9; Chakraborty D, 2010, LANGMUIR, V26, P12940, DOI 10.1021/la101836a; Choudhury RP, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2807239; CONLON T, 1972, BIOCHIM BIOPHYS ACTA, V288, P354, DOI 10.1016/0005-2736(72)90256-8; Dyrby TB, 2014, MAGN RESON MED, V72, P756; Eden M, 2003, CONCEPTS MAGN RESO A, V18A, P24, DOI 10.1002/cmr.a.10065; EFRON B, 1981, BIOMETRIKA, V68, P589, DOI 10.1093/biomet/68.3.589; Fischer G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000130; Fras-Zemljic L, 2015, REACT FUNCT POLYM, V97, p56 ; Gianolio E, 2016, BBA-BIOMEMBRANES, V1858, P627, DOI 10.1016/j.bbamem.2015.12.029; Godefroy S, 2003, MAGN RESON IMAGING, V21, P381, DOI 10.1016/S0730-725X(03)00144-9; HAINES TH, 1994, FEBS LETT, V346, P115, DOI 10.1016/0014-5793(94)00470-6; HERBST MD, 1989, AM J PHYSIOL, V256, pC1097, DOI 10.1152/ajpcell.1989.256.5.C1097; Hurlimann MD, 2002, J MAGN RESON, V157, P31, DOI 10.1006/jmre.2002.2567; Hurlimann MD, 2002, J CHEM PHYS, V117, P10223, DOI 10.1063/1.1518959; KARGER J, 1985, ADV COLLOID INTERFAC, V23, P129, DOI 10.1016/0001-8686(85)80018-X; Khrapitchev AA, 2001, J MAGN RESON, V152, P259, DOI 10.1006/jmre.2001.2402; Kuchel PW, 2006, CELL MOL BIOL, V52, P2, DOI 10.1170/T741; LABADIE C, 1994, J MAGN RESON SER B, V105, P99, DOI 10.1006/jmrb.1994.1109; Lampinen B, 2017, MAGN RESON MED, V77, P1104, DOI 10.1002/mrm.26195; Lasic S, 2016, NMR BIOMED, V29, P631, DOI 10.1002/nbm.3504; Lasic S, 2011, MAGN RESON MED, V66, P356, DOI 10.1002/mrm.22782; Maler L, 2018, NUCL SPIN RELAXATION, V2nd; Nilsson M, 2013, MAGN RESON MED, V69, P1572, DOI 10.1002/mrm.24395; Nyblom M, 2007, PROTEIN EXPRES PURIF, V56, P110, DOI 10.1016/j.pep.2007.07.007; Peled S, 1999, MAGNET RESON MED, V42, P911, DOI 10.1002/(SICI)1522-2594(199911)42:5<911::AID-MRM11>3.0.CO;2-J; Pfeuffer J, 1998, NMR BIOMED, V11, P19, DOI 10.1002/(SICI)1099-1492(199802)11:1<19::AID-NBM499>3.0.CO;2-O; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; PRESTON GM, 1991, P NATL ACAD SCI USA, V88, P11110, DOI 10.1073/pnas.88.24.11110; PRICE HD, 1969, J MOL BIOL, V41, P443, DOI 10.1016/0022-2836(69)90287-3; Price W.S., 2009, NMR STUDIES TRANSLAT; Price WS, 1998, BIOPHYS J, V74, P2259, DOI 10.1016/S0006-3495(98)77935-4; REEVES LW, 1970, CAN J CHEMISTRY, V48, P3641, DOI 10.1139/v70-612; Roth Y, 2008, MAGN RESON IMAGING, V26, P88, DOI 10.1016/j.mri.2007.04.013; Schilling F, 2017, NAT BIOTECHNOL, V35, P75, DOI 10.1038/nbt.3714; Schonhoff M, 1997, J PHYS CHEM B, V101, P8237, DOI 10.1021/jp9711611; Shemesh N, 2016, MAGN RESON MED, V75, P82, DOI 10.1002/mrm.25901; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; TANNER JE, 1968, J CHEM PHYS, V49, P1768, DOI 10.1063/1.1670306; TANNER JE, 1970, J CHEM PHYS, V52, P2523, DOI 10.1063/1.1673336; Van Landeghem M, 2010, CONCEPT MAGN RESON A, V36A, P153, DOI 10.1002/cmr.a.20157; VANDUSSCHOTEN D, 1995, J MAGN RESON SER A, V116, P22, DOI 10.1006/jmra.1995.1185; vanDusschoten D, 1996, MAGN RESON MED, V36, P907, DOI 10.1002/mrm.1910360613; Waldeck AR, 1997, PROG NUCL MAG RES SP, V30, P39, DOI 10.1016/S0079-6565(96)01034-5; ZEIDEL ML, 1992, BIOCHEMISTRY-US, V31, P7436, DOI 10.1021/bi00148a002; Zhang YJ, 2011, BIOPHYS J, V101, P2833, DOI 10.1016/j.bpj.2011.10.035; ZIMMERMAN JR, 1957, J PHYS CHEM-US, V61, P1328, DOI 10.1021/j150556a015	58	33	33	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177273	10.1371/journal.pone.0177273	http://dx.doi.org/10.1371/journal.pone.0177273			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493928	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314300080
J	Sepulveda-Torres, LD; Rishishwar, L; Rogers, ML; Rios-Olivares, E; Boukli, N; Jordan, IK; Cubano, LA				Sepulveda-Torres, Lycely del C.; Rishishwar, Lavanya; Rogers, Maria Luisa; Rios-Olivares, Eddy; Boukli, Nawal; Jordan, I. King; Cubano, Luis A.			A decade of viral mutations and associated drug resistance in a population of HIV-1(+) Puerto Ricans: 2002-2011	PLOS ONE			English	Article							DNA-SEQUENCING SYSTEM; ANTIRETROVIRAL TREATMENT; GENOTYPING KIT; UNITED-STATES; HIV; IMPACT; PERFORMANCE; INFECTION; PROTEASE; THERAPY	Puerto Rico has one of the highest rates of HIV/AIDS seen for any US state or territory, and antiretroviral therapy has been a mainstay of efforts to mitigate the HIV/AIDS public health burden on the island. We studied the evolutionary dynamics of HIV-1 mutation and antiretroviral drug resistance in Puerto Rico by monitoring the population frequency of resistance-associated mutations from 2002 to 2011. Whole blood samples from 4,475 patients were analyzed using the TRUGENE HIV-1 Genotyping Kit and OpenGene DNA Sequencing System in the Immunoretrovirus Research Laboratory at Universidad Central del Caribe. Results show that 64.0% of female and 62.9% of male patients had HIV-1 mutations that confer resistance to at least one antiretroviral medication. L63P and M184V were the dominant mutations observed for the protease ( PRO) and reverse transcriptase ( RT) encoding genes, respectively. Specific resistance mutations, along with their associated drug resistance profiles, can be seen to form temporal clusters that reveal a steadily changing landscape of resistance trends over time. Both women and men showed resistance mutations for an average of 4.8 drugs over the 10-year period, further underscoring the strong selective pressure exerted by antiretrovirals along with the rapid adaptive response of HIV. Nevertheless, both female and male patients showed a precipitous decrease for overall drug resistance, and for PRO mutations in particular, over the entire course of the study, with the most rapid decrease in frequency seen after 2006. The reduced HIV-1 mutation and drug resistance trends that we observed are consistent with previous reports from multi-year studies conducted around the world. Reduced resistance can be attributed to the use of more efficacious antiretroviral drug therapy, including the introduction of multi-drug combination therapies, which limited the ability of the virus to mount rapid adaptive responses to antiretroviral selection pressure.	[Sepulveda-Torres, Lycely del C.; Rios-Olivares, Eddy; Boukli, Nawal; Cubano, Luis A.] Univ Cent Caribe, Dept Microbiol & Immunol, Bayamon, PR 00960 USA; [Rishishwar, Lavanya; Jordan, I. King] Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA; [Rishishwar, Lavanya; Jordan, I. King] PanAmer Bioinformat Inst, Cali, Valle Del Cauca, Colombia; [Rishishwar, Lavanya; Jordan, I. King] Appl Bioinformat Lab, Atlanta, GA USA; [Rogers, Maria Luisa] Sacred Heart Univ, Nat Sci Dept, San Juan, PR USA	University System of Georgia; Georgia Institute of Technology	Sepulveda-Torres, LD (corresponding author), Univ Cent Caribe, Dept Microbiol & Immunol, Bayamon, PR 00960 USA.	lycely.sepulveda@uccaribe.edu	Rishishwar, Lavanya/H-5587-2013	Rishishwar, Lavanya/0000-0002-2055-9392	Research Center in Minority Institution (RCMI) from the National Institutes of Health National Center for Research Resources [G12RR003035]; National Institute on Minority Health and Health Disparities [G12MD007583] Funding Source: NIH RePORTER	Research Center in Minority Institution (RCMI) from the National Institutes of Health National Center for Research Resources; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This research was supported by a Research Center in Minority Institution (RCMI) grant number G12RR003035 from the National Institutes of Health National Center for Research Resources, https://www.nimhd.nih.gov/programs/extramural/coe/rcmi.html. The funders had no role in study design, data collection and analysis decision to publish, or preparation of the manuscript.	Alteri C, 2013, J ANTIMICROB CHEMOTH, V68, P2205, DOI 10.1093/jac/dkt173; Ammaranond P, 2012, FUND CLIN PHARMACOL, V26, P146, DOI 10.1111/j.1472-8206.2011.01009.x; Avila-Rios S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158560; Boyer PL, 2015, ANTIMICROB AGENTS CH, V59, P7184, DOI 10.1128/AAC.05069-14; *CDCP, 2002, HIV AIDS SURV REP 20; Centers for Disease Control and Prevention, 2012, HIV AIDS SURV REP 20; Centers for Disease Control and Prevention (CDC), 2014, EP HIV INF 2014; Charest H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109420; Chen NE, 2012, J IMMIGR MINOR HEALT, V14, P65, DOI 10.1007/s10903-011-9497-y; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Costa MGS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S7-S5; Cubano Luis A, 2010, Bol Asoc Med P R, V102, P13; Cubano Luis A, 2008, Ethn Dis, V18, pS2; D'Aquila Richard T, 2003, Top HIV Med, V11, P92; D'Aquila Richard T., 2002, Top HIV Med, V10, P21; DAQUILA RT, 2001, TOP HIV MED, V9, P21; De Luca A, 2013, J INFECT DIS, V207, P1216, DOI 10.1093/infdis/jit017; Duani H, 2016, BRAZ J INFECT DIS; FDA, 2012, TRUGENE R HIV 1 GENO; Feder AF, 2016, ELIFE, V5, DOI 10.7554/eLife.10670; Franzetti M, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-398; Gale HB, 2006, CLIN VACCINE IMMUNOL, V13, P235, DOI 10.1128/CVI.13.2.235-238.2006; Garcia D., 2015, STATE HIV AIDS HISPA; Grant RM, 2003, J CLIN MICROBIOL, V41, P1586, DOI 10.1128/JCM.41.4.1586-1593.2003; Gunthard HF, 2014, JAMA-J AM MED ASSOC, V312, P410, DOI 10.1001/jama.2014.8722; Gupta A, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/1471-2105-16-S19-S10; Heron M., 2012, DEATHS LEADING CAUSE; Johnson Victoria A, 2008, Top HIV Med, V16, P62; Johnson Victoria A, 2007, Top HIV Med, V15, P119; Johnson Victoria A, 2006, Top HIV Med, V14, P125; Johnson Victoria A, 2011, Top Antivir Med, V19, P156; Johnson Victoria A, 2010, Top HIV Med, V18, P156; Johnson Victoria A, 2005, Top HIV Med, V13, P51; Johnson Victoria A, 2009, Top HIV Med, V17, P138; Johnson Victoria A, 2004, Top HIV Med, V12, P119; Kuritzkes DR, 2003, J CLIN MICROBIOL, V41, P1594, DOI 10.1128/JCM.41.4.1594-1599.2003; Langs-Barlow A, 2014, VIRUSES-BASEL, V6, P3855, DOI 10.3390/v6103855; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; O'Brien William A 3rd, 2006, AIDS Read, V16, P38; Office of Epidemiological Research, 2016, PUERT RIC HIV AIDS S; Pennings PS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004000; Puerto Rico Department of Health, 2012, INT EP PROF HIV PREV; Richman DD, 2016, CLIN INFECT DIS, V62, P1318, DOI 10.1093/cid/ciw130; Scherrer AU, 2016, CLIN INFECT DIS, V62, P1310, DOI 10.1093/cid/ciw128; Sepulveda-Torres Ldel C, 2012, AIDS RES TREAT, V2012; Sheehan DM, 2015, INT J STD AIDS, V26, P1, DOI 10.1177/0956462414532242; Siliciano JD, 2013, CURR OPIN VIROL, V3, P487, DOI 10.1016/j.coviro.2013.08.007; Statistics N. C. F. H., 2013, HLTH US 2012 SPEC FE; Tang MW, 2012, DRUGS, V72, pE1, DOI 10.2165/11633630-000000000-00000; Tossas-Milligan KY, 2016, P R HEALTH SCI J, V35, P113; U. S. Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents, 2016, GUIDELINES USE ANTIR; Ulett KB, 2009, AIDS PATIENT CARE ST, V23, P41, DOI 10.1089/apc.2008.0132; US Department of Health Human Services, 2006, GUIDELINES USE ANTIR; Wensing AM, 2017, TOPICS ANTIVIRAL MED, V24	54	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177452	10.1371/journal.pone.0177452	http://dx.doi.org/10.1371/journal.pone.0177452			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493944	gold, Green Published, Green Submitted			2022-12-26	WOS:000401314300112
J	Soleiman, AA; Thameem, F; Khan, I				Soleiman, Amal Ali; Thameem, Farook; Khan, Islam			Mechanism of down regulation of Na-H exchanger-2 in experimental colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; NA+/H+ EXCHANGER; ELECTROLYTE TRANSPORT; COLONIC CRYPTS; EXPRESSION; NHE2; ISOFORM; RAT; LOCALIZATION; PROTEINS	Background The Na-H exchanger [NHE] performs an electroneutral uptake of NaCl and water from the lumen of the gastrointestinal tract. There are several distinct NHE isoforms, some of which show an altered expression in the inflammatory bowel diseases (IBD). In this study, we examined a role of NHE-2 in experimental colitis. Methods Colitis was induced in male Sprague-Dawley rats by intra-rectal administration of trinitroben-zenesulphonic acid (TNBS). On day 6 post-TNBS, the animals were sacrificed, colonic and ileal segments were taken out, cleaned with phosphate buffered saline and used in this study. Results There was a significant decrease in the level of NHE-2 protein as measured by ECL western blot analysis and confocal immunofluorescence microscopy. The levels of NHE-2 mRNA and heteronuclear RNA measured by an end-point RT-PCR and a real time PCR were also decreased significantly in the inflamed colon. However, there was no change in the level of NHE-2 protein in response to in vitro TNF-alpha treatment of uninflamed rat colonic segment. These changes were selective and localized to the colon as actin, an internal control, remained unchanged. Confocal immunofluorescence microscopy revealed co-localization of NHE-2 and NHE-3 in the brush borders of colonic epithelial cells. Inflamed colon showed a significant increase in myeloperoxidase activity and colon hypertrophy. In addition, there was a significant decrease in body weight and goblet cells' mucin staining in the TNBS treated colon. These changes were not conspicuous in the non-inflamed ileum. Conclusions These findings demonstrate suppression of NHE-2 expression on the brush borders in the colonic epithelial cells which is regulated transcriptionally. However a role of TNF-alpha in the regulation of NHE-2 is discounted in the present model of colitis. This decrease in the NHE-2 expression will lead to a loss of electrolyte and water uptake thus contributing to the symptoms associated with IBD.	[Soleiman, Amal Ali; Thameem, Farook; Khan, Islam] Kuwait Univ, Dept Biochem, Fac Med, Jabriya, Kuwait	Kuwait University	Khan, I (corresponding author), Kuwait Univ, Dept Biochem, Fac Med, Jabriya, Kuwait.	islam@hsc.edu.kw			Kuwait University Research Grant [YM 12/15]	Kuwait University Research Grant	This work was supported by the Kuwait University Research Administration through a grant (YM 12/15).; This work was supported by Kuwait University Research Grant No. [YM 12/15]. Dr James Craik for editing the manuscript. Prof Khan, Anatomy Department for allowing use of his laboratory for tissue block preparation and Histochemistry. Research Core Facility, Health Sciences Center, Kuwait University for providing technical support (Ms Gabriel J) and equipment for confocal immunofluorescence microscopy.	Al-Shamali A, 2011, SCAND J GASTROENTERO, V46, P20, DOI 10.3109/00365521.2010.521890; Amin MR, 2011, INFLAMM BOWEL DIS, V17, P720, DOI 10.1002/ibd.21419; Bachmann O, 2004, AM J PHYSIOL-GASTR L, V287, pG125, DOI 10.1152/ajpgi.00332.2003; Bou-Fersen AM, 2008, MED PRIN PRACT, V17, P190, DOI 10.1159/000117791; Chow CW, 1999, CLIN INVEST MED, V22, P195; COLLINS JF, 1993, P NATL ACAD SCI USA, V90, P3938, DOI 10.1073/pnas.90.9.3938; Donowitz M, 2013, MOL ASPECTS MED, V34, P236, DOI 10.1016/j.mam.2012.05.001; Dudeja PK, 1996, AM J PHYSIOL-GASTR L, V271, pG483, DOI 10.1152/ajpgi.1996.271.3.G483; Fliegel L, 2009, EXPERT OPIN THER TAR, V13, P55, DOI [10.1517/14728220802600707, 10.1517/14728220802600707 ]; Gawenis LR, 2002, AM J PHYSIOL-GASTR L, V282, pG776, DOI 10.1152/ajpgi.00297.2001; Goyal S, 2005, AM J PHYSIOL-RENAL, V288, pF530, DOI 10.1152/ajprenal.00229.2004; Guan YF, 2006, AM J PHYSIOL-GASTR L, V291, pG689, DOI 10.1152/ajpgi.00342.2005; HAWKER PC, 1980, GASTROENTEROLOGY, V79, P508; Hoogerwerf WA, 1996, AM J PHYSIOL-GASTR L, V270, pG29, DOI 10.1152/ajpgi.1996.270.1.G29; Khan I, 1998, J PHARMACOL EXP THER, V285, P869; Khan I., 2006, NOVASCIENCE, P191; Kong JP, 2015, ONCOTARGET, V6, P32980, DOI 10.18632/oncotarget.5431; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Martinez-Augustin O, 2009, INFLAMM BOWEL DIS, V15, P114, DOI 10.1002/ibd.20579; Nakamura N, 2005, J BIOL CHEM, V280, P1561, DOI 10.1074/jbc.M410041200; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Orlowski J, 1997, J BIOL CHEM, V272, P22373, DOI 10.1074/jbc.272.36.22373; Rajendran VM, 2015, J BIOL CHEM, V290, P25487, DOI 10.1074/jbc.M115.654277; Rocha F, 2001, AM J PHYSIOL-CELL PH, V280, pC1224, DOI 10.1152/ajpcell.2001.280.5.C1224; SANDLE GI, 1990, GASTROENTEROLOGY, V99, P97, DOI 10.1016/0016-5085(90)91235-X; Schultheis PJ, 1998, J CLIN INVEST, V101, P1243, DOI 10.1172/JCI1249; Siddique I, 2011, DIGEST DIS SCI, V56, P1656, DOI 10.1007/s10620-010-1524-7; Strober W, 2011, GASTROENTEROLOGY, V140, P1756, DOI 10.1053/j.gastro.2011.02.016; Sullivan S, 2009, INFLAMM BOWEL DIS, V15, P261, DOI 10.1002/ibd.20743; TSE CM, 1994, BIOCHEMISTRY-US, V33, P12954, DOI 10.1021/bi00248a003; TSE CM, 1993, J BIOL CHEM, V268, P11917; Wakabayashi S, 1997, PHYSIOL REV, V77, P51, DOI 10.1152/physrev.1997.77.1.51; WALLACE JL, 1995, J PHARMACOL TOXICOL, V33, P237, DOI 10.1016/1056-8719(95)00001-X; Xu H, 2005, AM J PHYSIOL-GASTR L, V289, pG36, DOI 10.1152/ajpgi.00552.2004; Yeruva S, 2010, INFLAMM BOWEL DIS, V16, P1149, DOI 10.1002/ibd.21183	35	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5								10.1371/journal.pone.0176767	http://dx.doi.org/10.1371/journal.pone.0176767			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493993	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314300032
J	Chen, YZ				Chen, Yuzhong			Scanning double-sided documents without incurring show-through by learning to fuse two complementary images using multilayer perceptron	PLOS ONE			English	Article								This paper presents a novel method for scanning duplex-printed documents without incurring the unwanted show-through artifact. The proposed method achieves the goal of eliminating the leaked-out reverse-side content by fusing a white backed scan image with a black backed scan image of the document. The fusion is accomplished using a multilayer perceptron having learned a fusion mapping from manually corrected document images. The main novel contributions of this work include (1) being the first to propose to accomplish the goal of show through free scanning by fusing a white backed scan image with a black backed scan image of the document; (2) proposing a learning approach using a multilayer perceptron to learn the fusion mapping from manually corrected scan images; and (3) proposing to use the pixel value histogram of reverse-side-printed area as well as the pixel value histogram of duplex-printed area to quantitatively indicate show through severity to facilitate objective comparison of the methods in consideration. The experiment results show that the proposed method is remarkably more powerful in eliminating show through than the two state-of-the-art methods in comparison.	[Chen, Yuzhong] Shandong Univ, Sch Mat Sci & Engn, Jinan, Peoples R China	Shandong University	Chen, YZ (corresponding author), Shandong Univ, Sch Mat Sci & Engn, Jinan, Peoples R China.	chenyz_sdu@163.com			Science and Technological Innovation Foundation of Shandong University	Science and Technological Innovation Foundation of Shandong University	The author would like to gratefully acknowledge the financial support of the Science and Technological Innovation Foundation of Shandong University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fan Z, 2011, United States Patent, Patent No. [7,965,421, 7965421]; FISCHLER MA, 1981, COMMUN ACM, V24, P381, DOI 10.1145/358669.358692; Knox K, 1998, U.S. Patent, Patent No. [5,832,137, 5832137]; Liu Q, 2013, IEEE CHIN SUMM INT C; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Merrikh-Bayat F, 2011, INT J DOC ANAL RECOG, V14, P319, DOI 10.1007/s10032-010-0131-7; Merrikh-Bayat F, 2010, LECT NOTES COMPUT SC, V6365, P482, DOI 10.1007/978-3-642-15995-4_60; MOLLER MF, 1993, NEURAL NETWORKS, V6, P525, DOI 10.1016/S0893-6080(05)80056-5; Raguram R, 2008, LECT NOTES COMPUT SC, V5303, P500, DOI 10.1007/978-3-540-88688-4_37; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Sharma G, 2001, IEEE T IMAGE PROCESS, V10, P736, DOI 10.1109/83.918567; Sharma G., 1998, U. S. Patent Application, Patent No. [09/200984, 09200984]; Smith SM, 1997, INT J COMPUT VISION, V23, P45, DOI 10.1023/A:1007963824710; Tonazzini A, 2009, 10 INT C DOC AN REC; Tonazzini A, 2007, INT J DOC ANAL RECOG, V10, P17, DOI 10.1007/s10032-006-0015-z; Tuytelaars T., 2006, EUR C COMP VIS, V1, P404, DOI DOI 10.1007/11744023_32; Wu J, 2013, MEAS SCI REV, V13, P122, DOI 10.2478/msr-2013-0021	17	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176969	10.1371/journal.pone.0176969	http://dx.doi.org/10.1371/journal.pone.0176969			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489900	gold, Green Published, Green Submitted			2022-12-26	WOS:000401314100038
J	Farris, DW; Cardona, A; Montes, C; Foster, D; Jaramillo, C				Farris, David W.; Cardona, Agustin; Montes, Camilo; Foster, David; Jaramillo, Carlos			Magmatic evolution of Panama Canal volcanic rocks: A record of arc processes and tectonic change	PLOS ONE			English	Article							AMERICAN LAND-BRIDGE; GEOCHEMICAL EVOLUTION; EARLY MIOCENE; COLLISION; COMPLEX; ORIGIN; SOUTH; CONSEQUENCES; TRANSITION; SUBDUCTION	Volcanic rocks along the Panama Canal present a world-class opportunity to examine the relationship between arc magmatism, tectonic forcing, wet and dry magmas, and volcanic structures. Major and trace element geochemistry of Canal volcanic rocks indicate a significant petrologic transition at 21-25 Ma. Oligocene Bas Obispo Fm. rocks have large negative Nb-Ta anomalies, low HREE, fluid mobile element enrichments, a THI of 0.88, and a H2Ocalc of >3 wt. %. In contrast, the Miocene Pedro Miguel and Late Basalt Fm. exhibit reduced Nb-Ta anomalies, flattened REE curves, depleted fluid mobile elements, a THI of 1.45, a H2Ocalc of < 1 wt. %, and plot in mid-ocean ridge/back-arc basin fields. Geochemical modeling of Miocene rocks indicates 0.5-0.1 kbar crystallization depths of hot (1100- 1190 degrees C) magmas in which most compositional diversity can be explained by fractional crystallization (F = 0.5). However, the most silicic lavas (Las Cascadas Fm.) require an additional mechanism, and assimilation-fractional-crystallization can reproduce observed compositions at reasonable melt fractions. The Canal volcanic rocks, therefore, change from hydrous basaltic pyroclastic deposits typical of mantle-wedge-derived magmas, to hot, dry bi-modal magmatism at the Oligocene-Miocene boundary. We suggest the primary reason for the change is onset of arc perpendicular extension localized to central Panama. High-resolution mapping along the Panama Canal has revealed a sequence of inward dipping maar-diatreme pyroclastic pipes, large basaltic sills, and bedded silicic ignimbrites and tuff deposits. These volcanic bodies intrude into the sedimentary Canal Basin and are cut by normal and subsequently strike-slip faults. Such pyroclastic pipes and basaltic sills are most common in extensional arc and large igneous province environments. Overall, the change in volcanic edifice form and geochemistry are related to onset of arc perpendicular extension, and are consistent with the idea that Panama arc crust fractured during collision with South America forming the observed Canal extensional zone.	[Farris, David W.] Florida State Univ, Dept Earth Ocean & Atmospher Sci, Tallahassee, FL 32306 USA; [Cardona, Agustin] Univ Nacl Colombia, Medellin, Colombia; [Montes, Camilo] Yachay Tech Univ, Dept Geol Sci, San Jose De Urcuqui, Ecuador; [Foster, David] Univ Florida, Dept Geol Sci, Gainesville, FL USA; [Jaramillo, Carlos] Smithsonian Trop Res Inst, Unit 0948, APO, AA USA	State University System of Florida; Florida State University; Universidad Nacional de Colombia; State University System of Florida; University of Florida; Smithsonian Institution; Smithsonian Tropical Research Institute	Farris, DW (corresponding author), Florida State Univ, Dept Earth Ocean & Atmospher Sci, Tallahassee, FL 32306 USA.	dwfarris@fsu.edu	Farris, David/AAK-5570-2020	Farris, David/0000-0002-8728-2746; jaramillo, carlos/0000-0002-2616-5079; Foster, David/0000-0002-5603-9372	National Science Foundation (NSF) PIRE [0966884]; NSF [DEB 0733725]; Smithsonian Institution; Panama Canal Authority; National Geographic; SENACYT; Ricardo Perez SA	National Science Foundation (NSF) PIRE; NSF(National Science Foundation (NSF)); Smithsonian Institution(Smithsonian Institution); Panama Canal Authority; National Geographic(National Geographic Society); SENACYT; Ricardo Perez SA	This contribution to the Panama Canal Project (PCP) was supported by National Science Foundation (NSF) PIRE grant 0966884 (OISE, EAR, DRL). Funding also came from NSF grant DEB 0733725, the Smithsonian Institution, the Panama Canal Authority, Mr. Mark Tupper, the National Geographic, SENACYT, and Ricardo Perez SA. Thanks go to the Panama Canal Authority, Ministerio de lndustria y Comercio, Odebretch for access and logistical help. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This contribution to the Panama Canal Project (PCP) was supported by National Science Foundation (NSF) PIRE grant 0966884 (OISE, EAR, DRL). Funding also came from NSF grant DEB-0733725, the Smithsonian Institution, the Panama Canal Authority, Mr. Mark Tupper, the National Geographic, SENACYT, and Ricardo Perez SA. Thanks go to the Panama Canal Authority, Ministerio de Industria y Comercio, Odebretch for access and logistical help.	Abratis M, 2001, GEOLOGY, V29, P127, DOI 10.1130/0091-7613(2001)029<0127:RCSWFA>2.0.CO;2; Arculus R.J., 1995, GEOPHYS MONOGR SER, P45; ARZI AA, 1978, TECTONOPHYSICS, V44, P173, DOI 10.1016/0040-1951(78)90069-0; Asimow PD, 1998, AM MINERAL, V83, P1127; Barat F, 2014, TECTONOPHYSICS, V622, P145, DOI 10.1016/j.tecto.2014.03.008; Bloch JI, 2016, NATURE, V533, P243, DOI 10.1038/nature17415; Buchs DM, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2009GC002901; Cassidy J, 2007, J VOLCANOL GEOTH RES, V159, P153, DOI 10.1016/j.jvolgeores.2006.06.007; DEFANT MJ, 1991, CONTRIB MINERAL PETR, V106, P309, DOI 10.1007/BF00324560; DEFANT MJ, 1992, J GEOL SOC LONDON, V149, P569, DOI 10.1144/gsjgs.149.4.0569; England P, 2004, GEOPHYS J INT, V156, P377, DOI 10.1111/j.1365-246X.2003.02132.x; Farris DW, 2011, GEOLOGY, V39, P1007, DOI 10.1130/G32237.1; Farris DW., GEOLOGICAL SOC AM AB, V45, P290; Fowler G. D., 2015, THESIS; Gazel E, 2015, NAT GEOSCI, V8, P321, DOI 10.1038/NGEO2392; Gazel E, 2011, LITHOS, V121, P117, DOI 10.1016/j.lithos.2010.10.008; GHIORSO MS, 1995, CONTRIB MINERAL PETR, V119, P197, DOI 10.1007/BF00307281; Gill J., 1981, OROGENIC ANDESITES P; Giordano D., 2008, VISCOSITY MAGMATIC L, V271; Goss AR, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001163; GROVE TL, 1982, CONTRIB MINERAL PETR, V80, P160, DOI 10.1007/BF00374893; GROVE TL, 1984, J GEOPHYS RES, V89, P3253, DOI 10.1029/JB089iB05p03253; Hidalgo P. J., 2011, CONTRIBUTIONS MINERA; Hochstaedter AG, 2000, J GEOPHYS RES-SOL EA, V105, P495, DOI 10.1029/1999JB900125; Houghton BF, 1999, J VOLCANOL GEOTH RES, V91, P97, DOI 10.1016/S0377-0273(99)00058-X; Jamtveit B, 2004, GEOL SOC SPEC PUBL, V234, P233, DOI 10.1144/GSL.SP.2004.234.01.15; Kelemen P.B., 2007, TREATISE GEOCHEMISTR, V3, P1, DOI [10.1016/B0-08-043751-6/03035-8, DOI 10.1016/B0-08-043751-6/03035-8]; Kirby MX, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002791; LEE JM, 1995, J GEOPHYS RES-SOL EA, V100, P17671, DOI 10.1029/95JB01685; Lorenz V., 1985, T GEOL SOC S AFR, V88, P459; Lorenz V, 2007, J VOLCANOL GEOTH RES, V159, P4, DOI 10.1016/j.jvolgeores.2006.06.019; Lutton R. J., 1970, 1 US ARM ENG WAT EXP; MacDonald D. F., 1915, SOME ENG PROBLEMS PA; MacFadden BJ, 2014, J GEOL, V122, P113, DOI 10.1086/675244; MacFadden BJ, 2010, J PALEONTOL, V84, P288, DOI 10.1666/09-064R.1; Molloy C, 2009, GEOL SOC AM BULL, V121, P1666, DOI 10.1130/B26447.1; Montes C., 2012, GEOLOGICAL SOC AM B; Mynhier K. N., 2015, THESIS; Peacock SM, 2001, GEOLOGY, V29, P299, DOI 10.1130/0091-7613(2001)029<0299:ATLPOD>2.0.CO;2; PEARCE JA, 1995, ANNU REV EARTH PL SC, V23, P251, DOI 10.1146/annurev.ea.23.050195.001343; PEARCE JA, 1984, J PETROL, V25, P956, DOI 10.1093/petrology/25.4.956; Perfit M. R., 1980, CHEM GEOL, V30, P1; Pratt TL, 2003, TECTONOPHYSICS, V368, P211, DOI 10.1016/S0040-1951(03)00159-8; Ramirez DA, 2016, GEOCHEM GEOPHY GEOSY, V17, P1758, DOI 10.1002/2016GC006289; Rockwell TK, 2010, TECTONICS, V29, DOI 10.1029/2009TC002571; Rollinson H.R, 1993, USING GEOCHEMICAL DA, P306; Rooney T. O., 2010, CONTRIBUTIONS MINERA; Rooney TO, 2015, GEOCHEM GEOPHY GEOSY, V16, P4178, DOI 10.1002/2015GC006150; RUDNICK RL, 1995, NATURE, V378, P571, DOI 10.1038/378571a0; Saginor I, 2013, GEOCHEM GEOPHY GEOSY, V14, P4504, DOI 10.1002/ggge.20259; SHERVAIS JW, 1982, EARTH PLANET SC LETT, V59, P101, DOI 10.1016/0012-821X(82)90120-0; Sisson TW, 1996, CONTRIB MINERAL PETR, V126, P81, DOI 10.1007/s004100050237; Smith IEM, 2006, J VOLCANOL GEOTH RES, V156, P315, DOI 10.1016/j.jvolgeores.2006.03.006; Stewart R. H., 1980, MISCELLANEOUS INVEST; Svensen H, 2004, NATURE, V429, P542, DOI 10.1038/nature02566; Svensen H, 2006, J GEOL SOC LONDON, V163, P671, DOI 10.1144/1144-764905-037; Svensen H, 2009, EARTH PLANET SC LETT, V277, P490, DOI 10.1016/j.epsl.2008.11.015; Syracuse EM, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001045; Tatsumi Y., 2005, GSA TODAY, V15; TAYLOR SR, 1995, REV GEOPHYS, V33, P241, DOI 10.1029/95RG00262; Wegner W, 2011, GEOL SOC AM BULL, V123, P703, DOI 10.1130/B30109.1; Whattam SA, 2012, LITHOS, V142, P226, DOI 10.1016/j.lithos.2012.02.017; White JDL, 2001, GEOLOGY, V29, P935, DOI 10.1130/0091-7613(2001)029<0935:IVCMFB>2.0.CO;2; Worner G, 2009, GEOL SOC AM MEM, V204, P183, DOI 10.1130/2009.1204(08); WOOD DA, 1980, EARTH PLANET SC LETT, V50, P11, DOI 10.1016/0012-821X(80)90116-8; Zimmer MM, 2010, J PETROL, V51, P2411, DOI 10.1093/petrology/egq062	66	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176010	10.1371/journal.pone.0176010	http://dx.doi.org/10.1371/journal.pone.0176010			44	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489866	gold, Green Submitted, Green Published			2022-12-26	WOS:000401314100012
J	Lin, XL; Xu, Q; Tang, L; Sun, L; Han, T; Wang, LW; Xiao, XY				Lin, Xiao-Lin; Xu, Qi; Tang, Lei; Sun, Li; Han, Ting; Wang, Li-Wei; Xiao, Xiu-Ying			Regorafenib inhibited gastric cancer cells growth and invasion via CXCR4 activated Wnt pathway	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR4; CATENIN SIGNALING PATHWAY; DOUBLE-BLIND; DRUG-RESISTANCE; PLACEBO PLUS; CHEMOTHERAPY; ADENOCARCINOMA; OSTEOSARCOMA; ANGIOGENESIS; PROGRESSION	Aim Regorafenib is an oral small-molecule multi kinase inhibitor. Recently, several clinical trials have revealed that regorafenib has an anti-tumor activity in gastric cancer. However, only part of patients benefit from regorafenib, and the mechanisms of regorafenib's anti-tumor effect need further demonstrating. In this study, we would assess the potential anti-tumor effects and the underlying mechanisms of regorafenib in gastric cancer cells, and explore novel biomarkers for patients selecting of regorafenib. Methods The anti-tumor effects of regorafenib on gastric cancer cells were analyzed via cell proliferation and invasion. The underlying mechanisms were demonstrated using molecular biology techniques. Results We found that regorafenib inhibited cell proliferation and invasion at the concentration of 20 mu mol/L and in a dose dependent manner. The anti-tumor effects of regorafenib related to the decreased expression of CXCR4, and elevated expression and activation of CXCR4 could reverse the inhibition effect of regorafenib on gastric cancer cells. Further studies revealed that regorafenib reduced the transcriptional activity of Wnt/beta-Catenin pathway and led to decreased expression of Wnt pathway target genes, while overexpression and activation of CXCR4 could attenuate the inhibition effect of regorafenib on Wnt/beta-Catenin pathway. Conclusions Our findings demonstrated that regorafenib effectively inhibited cell proliferation and invasion of gastric cancer cells via decreasing the expression of CXCR4 and further reducing the transcriptional activity of Wnt/beta-Catenin pathway.	[Lin, Xiao-Lin; Xu, Qi; Tang, Lei; Sun, Li; Han, Ting; Wang, Li-Wei; Xiao, Xiu-Ying] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Oncol, Shanghai, Peoples R China	Shanghai Jiao Tong University	Xiao, XY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Oncol, Shanghai, Peoples R China.	xiaoxiuying2002@163.com	HAN, TINGTING/GQZ-8692-2022	xiao, xiuying/0000-0002-9873-0380	National Natural Science Foundation of China [81101648]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (No. 81101648)	Bao W, 2011, GASTROENTEROLOGY, V141, P2076, DOI 10.1053/j.gastro.2011.08.050; Brenner B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157548; Burki TK, 2016, LANCET ONCOL, V17, pE323, DOI 10.1016/S1470-2045(16)30284-4; Calinescu AA, 2016, CLIN CANC RES; Chen DS, 2014, CLIN CANCER RES, V20, P3472, DOI 10.1158/1078-0432.CCR-13-2944; Chen L.T., 2017, CANC RES TREAT; Cristescu R, 2015, NAT MED, V21, P449, DOI 10.1038/nm.3850; Davis SL, 2013, DRUG TODAY, V49, P105, DOI 10.1358/dot.2013.49.2.1930525; Domanska UM, 2013, EUR J CANCER, V49, P219, DOI 10.1016/j.ejca.2012.05.005; Fan DM, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0432-x; Fontanella R, 2016, CANCER LETT, V370, P100, DOI 10.1016/j.canlet.2015.10.018; Fuchs CS, 2014, LANCET, V383, P31, DOI 10.1016/S0140-6736(13)61719-5; Gao DY, 2015, BIOMATERIALS, V67, P194, DOI 10.1016/j.biomaterials.2015.07.035; Garrido M, 2014, EXPERT REV ANTICANC, V14, P887, DOI 10.1586/14737140.2014.915194; Grothey A, 2013, LANCET, V381, P303, DOI 10.1016/S0140-6736(12)61900-X; Guo ZJ, 2016, ONCOTARGET, V7, P20999, DOI 10.18632/oncotarget.8236; He HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071864; Ilson DH, 2014, LANCET, V383, P4, DOI 10.1016/S0140-6736(13)61892-9; Iwasa S, 2009, ANTICANCER RES, V29, P4751; Izumi D, 2016, INT J CANCER, V138, P1207, DOI 10.1002/ijc.29864; JANJIGIAN YY, 2015, J CLIN ONCOL S, V33; Jiang CM, 2017, BIOMED PHARMACOTHER, V86, P677, DOI 10.1016/j.biopha.2016.12.055; Jiang YY, 2016, ONCOGENE; Lee HJ, 2014, WORLD J GASTROENTERO, V20, P1681, DOI 10.3748/wjg.v20.i7.1681; Lee HJ, 2009, INT J ONCOL, V34, P473, DOI 10.3892/ijo_00000172; Li J, 2016, J CLIN ONCOL, V34, P1448, DOI 10.1200/JCO.2015.63.5995; Li J, 2015, LANCET ONCOL, V16, P619, DOI 10.1016/S1470-2045(15)70156-7; Lombardi L, 2013, CRIT REV ONCOL HEMAT, V88, P696, DOI 10.1016/j.critrevonc.2013.08.005; Nakamura T, 2015, ONCOTARGET, V6, P1008, DOI 10.18632/oncotarget.2826; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; Ohtsu A, 2011, J CLIN ONCOL, V29, P3968, DOI 10.1200/JCO.2011.36.2236; Pavlakis N, 2016, J CLIN ONCOL, V34, P2728, DOI 10.1200/JCO.2015.65.1901; Peng Y, 2017, CANCER LETT, V385, P117, DOI 10.1016/j.canlet.2016.10.035; Qiao JL, 2016, ONCOTARGET, V7, P46088, DOI 10.18632/oncotarget.10024; Riquelme I, 2015, ONCOTARGET, V6, P24750, DOI 10.18632/oncotarget.4990; Santos JC, 2016, CANC RES; Shah MA, 2010, JAMA-J AM MED ASSOC, V303, P1753, DOI 10.1001/jama.2010.553; Shirley M, 2015, DRUGS, V75, P1009, DOI 10.1007/s40265-015-0406-x; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Wilhelm SM, 2011, INT J CANCER, V129, P245, DOI 10.1002/ijc.25864; Wilke H, 2014, LANCET ONCOL, V15, P1224, DOI 10.1016/S1470-2045(14)70420-6; Yi JH, 2012, BRIT J CANCER, V106, P1469, DOI 10.1038/bjc.2012.100; Yu J, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0340-8; Zhao SQ, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0103-8	46	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177335	10.1371/journal.pone.0177335	http://dx.doi.org/10.1371/journal.pone.0177335			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489887	gold, Green Published, Green Submitted			2022-12-26	WOS:000401314100063
J	Tenan, MS; Tweedell, AJ; Haynes, CA				Tenan, Matthew S.; Tweedell, Andrew J.; Haynes, Courtney A.			Analysis of statistical and standard algorithms for detecting muscle onset with surface electromyography	PLOS ONE			English	Article							BAYESIAN-ANALYSIS; R-PACKAGE; RECTIFICATION; EMG; ENTROPY; INPUT	The timing of muscle activity is a commonly applied analytic method to understand how the nervous system controls movement. This study systematically evaluates six classes of standard and statistical algorithms to determine muscle onset in both experimental surface electromyography (EMG) and simulated EMG with a known onset time. Eighteen participants had EMG collected from the biceps brachii and vastus lateralis while performing a biceps curl or knee extension, respectively. Three established methods and three statistical methods for EMG onset were evaluated. Linear envelope, Teager-Kaiser energy operator + linear envelope and sample entropy were the established methods evaluated while general time series mean/variance, sequential and batch processing of parametric and nonparametric tools, and Bayesian changepoint analysis were the statistical techniques used. Visual EMG onset (experimental data) and objective EMG onset (simulated data) were compared with algorithmic EMG onset via root mean square error and linear regression models for stepwise elimination of inferior algorithms. The top algorithms for both data types were analyzed for their mean agreement with the gold standard onset and evaluation of 95% confidence intervals. The top algorithms were all Bayesian changepoint analysis iterations where the parameter of the prior (p(0)) was zero. The best performing Bayesian algorithms were p(0) = 0 and a posterior probability for onset determination at 60-90%. While existing algorithms performed reasonably, the Bayesian changepoint analysis methodology provides greater reliability and accuracy when determining the singular onset of EMG activity in a time series. Further research is needed to determine if this class of algorithms perform equally well when the time series has multiple bursts of muscle activity.	[Tenan, Matthew S.; Tweedell, Andrew J.; Haynes, Courtney A.] US Army Res Lab, Human Res & Engn Directorate, Integrated Capabil Enhancement Branch, Aberdeen Proving Ground, MD 21010 USA	United States Department of Defense; United States Army; US Army Research, Development & Engineering Command (RDECOM); US Army Research Laboratory (ARL)	Tenan, MS (corresponding author), US Army Res Lab, Human Res & Engn Directorate, Integrated Capabil Enhancement Branch, Aberdeen Proving Ground, MD 21010 USA.	matthew.s.tenan.civ@mail.mil		Tenan, Matthew/0000-0003-2215-0846				Addona V, 2010, JQAS, V6, P17; Almog M, 2016, J NEUROPHYSIOL, V116, P2180, DOI 10.1152/jn.00360.2016; BARRY D, 1993, J AM STAT ASSOC, V88, P309, DOI 10.1080/01621459.1993.10594323; Bennell K, 2010, MED SCI SPORT EXER, V42, P856, DOI 10.1249/MSS.0b013e3181c12771; Boonstra TW, 2010, J NEUROPHYSIOL, V104, P576, DOI 10.1152/jn.00258.2010; Box George E. P., 1979, ROBUSTNESS STAT, P201, DOI 10.1016/B978-0-12-438150-6.50018-2; Dakin CJ, 2014, J NEUROPHYSIOL, V112, P1685, DOI 10.1152/jn.00296.2014; Donges JF, 2015, CHAOS, V25, DOI 10.1063/1.4934554; Erdman C, 2007, J STAT SOFTW, V23, P1; Erdman C, 2008, BIOINFORMATICS, V24, P2143, DOI 10.1093/bioinformatics/btn404; Gao ZK, 2016, EPL-EUROPHYS LETT, V116, DOI 10.1209/0295-5075/116/50001; Gao ZK, 2016, SCI REP-UK, V6, DOI 10.1038/srep35622; Halliday DM, 2010, J NEUROPHYSIOL, V103, P3547, DOI 10.1152/jn.00222.2010; Hodges PW, 1996, ELECTROMYOGR MOTOR C, V101, P511, DOI 10.1016/S0013-4694(96)95190-5; Kaiser J. F., 1990, INT C AC SPEECH SIGN; Kaiser JF, 1993, INT C AC SPEECH SIGN; Killick R, 2014, J STAT SOFTW, V58, P1; Kortsch S, 2012, P NATL ACAD SCI USA, V109, P14052, DOI 10.1073/pnas.1207509109; Li XY, 2007, ANN BIOMED ENG, V35, P1532, DOI 10.1007/s10439-007-9320-z; LYONS K, 1983, PHYS THER, V63, P1597, DOI 10.1093/ptj/63.10.1597; PINCUS SM, 1991, J CLIN MONITOR, V7, P335, DOI 10.1007/BF01619355; Neto OP, 2010, J NEUROPHYSIOL, V103, P1093, DOI 10.1152/jn.00792.2009; R Core Team, 2013, R LANG ENV STAT COMP; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; ROSS GJ, 2015, J STAT SOFTW, V66, P1, DOI [DOI 10.18637/JSS.V066.I03, 10.18637/jss.v066.i03]; Socher R, 2011, P 28 INT C MACH LEAR; Solnik S, 2010, EUR J APPL PHYSIOL, V110, P489, DOI 10.1007/s00421-010-1521-8; Sutherland DH, 2001, GAIT POSTURE, V14, P61, DOI 10.1016/S0966-6362(01)00100-X; VANBOXTEL GJM, 1993, PSYCHOPHYSIOLOGY, V30, P405; Winter D, 2005, BIOMECHANICS MOTOR C; YAO YC, 1984, ANN STAT, V12, P1434, DOI 10.1214/aos/1176346802; Zhang X, 2012, J ELECTROMYOGR KINES, V22, P901, DOI 10.1016/j.jelekin.2012.06.005	33	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177312	10.1371/journal.pone.0177312	http://dx.doi.org/10.1371/journal.pone.0177312			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489897	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314100060
J	Thiesen, HJ; Steinbeck, F; Maruschke, M; Koczan, D; Ziems, B; Hakenberg, OW				Thiesen, H. -J.; Steinbeck, F.; Maruschke, M.; Koczan, D.; Ziems, B.; Hakenberg, O. W.			Stratification of clear cell renal cell carcinoma (ccRCC) genomes by gene-directed copy number alteration (CNA) analysis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; VHL GENE; TUMOR AGGRESSIVENESS; POOR SURVIVAL; WHOLE-EXOME; CANCER; EXPRESSION; MUTATIONS; DISEASE; PATTERNS	Tumorigenic processes are understood to be driven by epi-/genetic and genomic alterations from single point mutations to chromosomal alterations such as insertions and deletions of nucleotides up to gains and losses of large chromosomal fragments including products of chromosomal rearrangements e.g. fusion genes and proteins. Overall comparisons of copy number alterations (CNAs) presented in 48 clear cell renal cell carcinoma (ccRCC) genomes resulted in ratios of gene losses versus gene gains between 26 ccRCC Fuhrman malignancy grades G1 (ratio 1.25) and 20 G3 (ratio 0.58). Gene losses and gains of 15762 CNA genes were mapped to 795 chromosomal cytoband loci including 280 KEGG path-ways. CNAs were classified according to their contribution to Fuhrman tumour gradings G1 and G3. Gene gains and losses turned out to be highly structured processes in ccRCC genomes enabling the subclassification and stratification of ccRCC tumours in a genome-wide manner. CNAs of ccRCC seem to start with common tumour related gene losses flanked by CNAs specifying Fuhrman grade G1 losses and CNA gains favouring grade G3 tumours. The appearance of recurrent CNA signatures implies the presence of causal mechanisms most likely implicated in the pathogenesis and disease-outcome of ccRCC tumours distinguishing lower from higher malignant tumours. The diagnostic quality of initial 201 genes (108 genes supporting G1 and 93 genes G3 phenotypes) has been successfully validated on published Swiss data (GSE19949) leading to a restricted CNA gene set of 171 CNA genes of which 85 genes favour Fuhrman grade G1 and 86 genes Fuhrman grade G3. Regarding these gene sets overall survival decreased with the number of G3 related gene losses plus G3 related gene gains. CNA gene sets presented define an entry to a gene-directed and pathway-related functional understanding of ongoing copy number alterations within and between individual ccRCC tumours leading to CNA genes of prognostic and predictive value.	[Thiesen, H. -J.; Steinbeck, F.; Koczan, D.] Univ Rostock, Inst Immunol, Rostock, Germany; [Maruschke, M.; Hakenberg, O. W.] Univ Rostock, Dept Urol, Rostock, Germany; [Maruschke, M.] HELIOS Hanseklinikum Stralsund, Dept Urol, Stralsund, Germany; [Ziems, B.] Steinbeis Ctr Proteome Anal, Rostock, Germany	University of Rostock; University of Rostock	Thiesen, HJ (corresponding author), Univ Rostock, Inst Immunol, Rostock, Germany.	hans-juergen.thiesen@med.uni-rostock.de			Research Executive Agency (IRSES grant) [269186]; German Federal Ministry of Education and Research (BMBF grant BioChancePLUS-2) [0313692A]	Research Executive Agency (IRSES grant); German Federal Ministry of Education and Research (BMBF grant BioChancePLUS-2)(Federal Ministry of Education & Research (BMBF))	The work has been supported by the Research Executive Agency (IRSES grant: 269186) and the German Federal Ministry of Education and Research (BMBF grant BioChancePLUS-2: 0313692A).	Adibi M, 2015, UROL ONCOL-SEMIN ORI, V33, P528, DOI 10.1016/j.urolonc.2015.10.003; Arai E, 2014, INT J CANCER, V135, P1330, DOI 10.1002/ijc.28768; Aron M, 2008, EUR UROL, V54, P133, DOI 10.1016/j.eururo.2007.12.001; Banks RE, 2006, CANCER RES, V66, P2000, DOI 10.1158/0008-5472.CAN-05-3074; Beleut M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161514; Beleut M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-310; Beroukhim R, 2009, CANCER RES, V69, P4674, DOI 10.1158/0008-5472.CAN-09-0146; Bhatt JR, 2014, NAT REV UROL, V11, P517, DOI 10.1038/nrurol.2014.194; Brugarolas J, 2014, J CLIN ONCOL, V32, P1968, DOI 10.1200/JCO.2012.45.2003; Chen FJ, 2016, CELL REP, V14, P2476, DOI 10.1016/j.celrep.2016.02.024; Chen M, 2009, INT J CANCER, V125, P2342, DOI 10.1002/ijc.24642; Choueiri TK, 2008, J UROLOGY, V180, P860, DOI 10.1016/j.juro.2008.05.015; Chow WH, 1999, JAMA-J AM MED ASSOC, V281, P1628, DOI 10.1001/jama.281.17.1628; Cifola I, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-6; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Dituri F, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/947858; Dondeti VR, 2012, CANCER RES, V72, P112, DOI 10.1158/0008-5472.CAN-11-1698; Essletzbichler P, 2014, GENOME RES, V24, P2059, DOI 10.1101/gr.177220.114; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655, DOI 10.1097/00000478-198210000-00007; Gandolfi G, 2015, PIGMENT CELL MELANOM; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gerstung M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1814; Girgis AH, 2012, CANCER RES, V72, P5273, DOI 10.1158/0008-5472.CAN-12-0656; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Gomez-Rueda H, 2015, BIODATA MIN, V8, DOI 10.1186/s13040-015-0065-1; Gonzalez-Perez A, 2013, NAT METHODS, V10, P1081, DOI [10.1038/NMETH.2642, 10.1038/nmeth.2642]; Guinan P, 1997, CANCER, V80, P992, DOI 10.1002/(SICI)1097-0142(19970901)80:5<992::AID-CNCR26>3.0.CO;2-Q; Gunawan B, 2001, CANCER RES, V61, P7731; Guo GW, 2012, NAT GENET, V44, P17, DOI 10.1038/ng.1014; Haddad AQ, 2015, NAT REV UROL, V12, P253, DOI 10.1038/nrurol.2015.71; Hakimi AA, 2013, CLIN CANCER RES, V19, P3259, DOI 10.1158/1078-0432.CCR-12-3886; Higgins JPT, 2006, THESCIENTIFICWORLDJO, V6, P502, DOI 10.1100/tsw.2006.109; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Hofree M, 2013, NAT METHODS, V10, P1108, DOI [10.1038/NMETH.2651, 10.1038/nmeth.2651]; Hoglund M, 2004, CANCER GENET CYTOGEN, V153, P1, DOI 10.1016/j.cancergencyto.2003.12.019; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kapur P, 2013, LANCET ONCOL, V14, P159, DOI 10.1016/S1470-2045(12)70584-3; Klatte T, 2009, J CLIN ONCOL, V27, P746, DOI 10.1200/JCO.2007.15.8345; Kondo K, 2002, GENE CHROMOSOME CANC, V34, P58, DOI 10.1002/gcc.10054; Kovacs G, 1997, J PATHOL, V183, P131, DOI 10.1002/(SICI)1096-9896(199710)183:2<131::AID-PATH931>3.0.CO;2-G; Krill-Burger JM, 2012, AM J PATHOL, V180, P2427, DOI 10.1016/j.ajpath.2012.01.044; Kroeger N, 2013, CANCER-AM CANCER SOC, V119, P1547, DOI 10.1002/cncr.27947; Kwiatkowski DJ, 2016, CLIN CANCER RES, V22, P2445, DOI 10.1158/1078-0432.CCR-15-2631; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lee E, 2015, HUM PATHOL, V46, P1111, DOI 10.1016/j.humpath.2015.04.009; Maher ER, 2013, SEMIN CANCER BIOL, V23, P10, DOI 10.1016/j.semcancer.2012.06.003; Mandriota SJ, 2002, CANCER CELL, V1, P459, DOI 10.1016/S1535-6108(02)00071-5; Maruschke M, 2011, UROL INT, V87, P205, DOI 10.1159/000328196; Maruschke M, 2011, BJU INT, V108, pE29, DOI 10.1111/j.1464-410X.2010.09794.x; Matsuda D, 2008, CANCER LETT, V272, P260, DOI 10.1016/j.canlet.2008.06.015; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Moore LE, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.14; Neumann HPH, 1998, J UROLOGY, V160, P1248, DOI 10.1016/S0022-5347(01)62509-6; Nguyen MM, 2006, J UROLOGY, V176, P2397, DOI 10.1016/j.juro.2006.07.144; Parker AS, 2005, UROLOGY, V65, P1090, DOI 10.1016/j.urology.2004.12.040; Patard JJ, 2009, BRIT J CANCER, V101, P1417, DOI 10.1038/sj.bjc.6605298; Patard JJ, 2008, INT J CANCER, V123, P395, DOI 10.1002/ijc.23496; Riazalhosseini Y, 2016, NAT REV NEPHROL, V12, P655, DOI 10.1038/nrneph.2016.133; Rini BI, 2006, BJU INT, V98, P756, DOI 10.1111/j.1464-410X.2006.06376.x; Rydzanicz M, 2013, CANCER LETT, V341, P111, DOI 10.1016/j.canlet.2013.08.006; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Scelo G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6135; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Slomovitz BM, 2012, CLIN CANCER RES, V18, P5856, DOI 10.1158/1078-0432.CCR-12-0662; Soares MJ, 2009, MODERN PATHOL, V22, P744, DOI 10.1038/modpathol.2009.43; Thoma CR, 2009, NAT CELL BIOL, V11, P994, DOI 10.1038/ncb1912; Toma MI, 2008, NEOPLASIA, V10, P634, DOI 10.1593/neo.08160; Van Poppel H, 2011, EUR UROL, V60, P662, DOI 10.1016/j.eururo.2011.06.040; vandenBerg A, 1997, GENE CHROMOSOME CANC, V19, P228, DOI 10.1002/(SICI)1098-2264(199708)19:4<228::AID-GCC4>3.0.CO;2-Z; Wang XY, 2015, HUM GENOMICS, V9, DOI 10.1186/s40246-015-0044-0; Wei EY, 2015, NAT REV UROL, V12, P706, DOI 10.1038/nrurol.2015.260; Yao M, 2002, JNCI-J NATL CANCER I, V94, P1569; Yap TA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003854; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217; Zhao M, 2013, NUCLEIC ACIDS RES, V41, pD970, DOI 10.1093/nar/gks937	81	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0176659	10.1371/journal.pone.0176659	http://dx.doi.org/10.1371/journal.pone.0176659			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486536	gold, Green Published, Green Submitted			2022-12-26	WOS:000401314000021
J	Ivanova, AA; Caspary, T; Seyfried, NT; Duong, DM; West, AB; Liu, ZY; Kahn, RA				Ivanova, Anna A.; Caspary, Tamara; Seyfried, Nicholas T.; Duong, Duc M.; West, Andrew B.; Liu, Zhiyong; Kahn, Richard A.			Biochemical characterization of purified mammalian ARL13B protein indicates that it is an atypical GTPase and ARL3 guanine nucleotide exchange factor (GEF)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION FACTOR; ARF FAMILY GTPASES; BINDING PROTEINS; JOUBERT-SYNDROME; ACTIVATING PROTEIN; FACTOR-I; ACID PHOSPHOLIPIDS; P-LOOP; RAS; HYDROLYSIS	Primary cilia play central roles in signaling during metazoan development. Several key regulators of ciliogenesis and ciliary signaling are mutated in humans, resulting in a number of ciliopathies, including Joubert syndrome (JS). ARL13B is a ciliary GTPase with at least three missense mutations identified in JS patients. ARL13B is a member of the ADP ribosylation factor family of regulatory GTPases, but is atypical in having a non-homologous, C-terminal domain of similar to 20 kDa and at least one key residue difference in the consensus GTP-binding motifs. For these reasons, and to establish a solid biochemical basis on which to begin to model its actions in cells and animals, we developed preparations of purified, recombinant, murine Arl13b protein. We report results from assays for solution-based nucleotide binding, intrinsic and GTPase-activating protein-stimulated GTPase, and ARL3 guanine nucleotide exchange factor activities. Biochemical analyses of three human missense mutations found in JS and of two consensus GTPase motifs reinforce the atypical properties of this regulatory GTPase. We also discovered that murine Arl13b is a substrate for casein kinase 2, a contaminant in our preparation from human embryonic kidney cells. This activity, and the ability of casein kinase 2 to use GTP as a phosphate donor, may be a source of differences between our data and previously published results. These results provide a solid framework for further research into ARL13B on which to develop models for the actions of this clinically important cell regulator.	[Ivanova, Anna A.; Seyfried, Nicholas T.; Duong, Duc M.; Kahn, Richard A.] Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd, Atlanta, GA 30322 USA; [Caspary, Tamara] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [West, Andrew B.; Liu, Zhiyong] Univ Alabama Birmingham, Ctr Neurodegenerat & Expt Therapeut, Birmingham, AL 35294 USA	Emory University; Emory University; University of Alabama System; University of Alabama Birmingham	Kahn, RA (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd, Atlanta, GA 30322 USA.	rkahn@emory.edu	Ivanova, Anna/GZK-6458-2022; Kahn, Richard/ABD-2666-2020; Caspary, Tamara/AAH-5625-2020	Kahn, Richard/0000-0002-0259-0601; Caspary, Tamara/0000-0002-6579-7589; Duong, Duc/0000-0001-5880-1888	National Institutes of Health [R01 GM110663, R01 NS064934]; Proteomics Core of the Emory Neuroscience NINDS Core Facilities Grant [P30NS055077]; Emory Integrated Proteomics Core (EIPC) - Emory University School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110663, R35GM122568, R01GM090158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064934, P30NS055077] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Proteomics Core of the Emory Neuroscience NINDS Core Facilities Grant; Emory Integrated Proteomics Core (EIPC) - Emory University School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R01 GM110663 (to A. A. I., R. A. K., and T. C.) and R01 NS064934 (to A. B. W. and Z. L.), Proteomics Core of the Emory Neuroscience NINDS Core Facilities Grant P30NS055077 (to R. A. K., N. T. S., and D. M. D.), and in part by the Emory Integrated Proteomics Core (EIPC), which is subsidized by the Emory University School of Medicine and is one of the Emory Integrated Core Facilities. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AMOR JC, 1994, NATURE, V372, P704, DOI 10.1038/372704a0; Amor JC, 2001, J BIOL CHEM, V276, P42477, DOI 10.1074/jbc.M106660200; Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Bale AE, 2001, HUM MOL GENET, V10, P757, DOI 10.1093/hmg/10.7.757; Bichet P, 2000, PROTEIN EXPRES PURIF, V19, P197, DOI 10.1006/prep.2000.1239; Bodle JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062554; Boman AL, 1999, CELL MOTIL CYTOSKEL, V44, P119, DOI 10.1002/(SICI)1097-0169(199910)44:2<119::AID-CM4>3.3.CO;2-3; Bostrom SL, 2009, BIOCHEM BIOPH RES CO, V390, P1154, DOI 10.1016/j.bbrc.2009.10.107; Bowzard JB, 2007, J BIOL CHEM, V282, P17568, DOI 10.1074/jbc.M701347200; Bowzard JB, 2005, METHOD ENZYMOL, V404, P453, DOI 10.1016/S0076-6879(05)04040-1; BROWNBRIDGE GG, 1993, J BIOL CHEM, V268, P10914; Buhrman G, 2010, P NATL ACAD SCI USA, V107, P4931, DOI 10.1073/pnas.0912226107; Cantagrel V, 2008, AM J HUM GENET, V83, P170, DOI 10.1016/j.ajhg.2008.06.023; Cardenas-Rodriguez M, 2009, AM J MED GENET C, V151C, P263, DOI 10.1002/ajmg.c.30227; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; CAVENAGH MM, 1994, J BIOL CHEM, V269, P18937; Cevik S, 2010, J CELL BIOL, V188, P953, DOI 10.1083/jcb.200908133; Chidiac P, 1999, BIOCHEM PHARMACOL, V58, P39, DOI 10.1016/S0006-2952(99)00080-5; CLARK J, 1993, P NATL ACAD SCI USA, V90, P8952, DOI 10.1073/pnas.90.19.8952; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; Cuvillier A, 2000, J CELL SCI, V113, P2065; Daumke O, 2004, NATURE, V429, P197, DOI 10.1038/nature02505; DER CJ, 1986, CELL, V44, P167, DOI 10.1016/0092-8674(86)90495-2; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Duldulao NA, 2009, DEVELOPMENT, V136, P4033, DOI 10.1242/dev.036350; East MP, 2011, SEMIN CELL DEV BIOL, V22, P3, DOI 10.1016/j.semcdb.2010.07.002; Elias M, 2012, J CELL SCI, V125, P2500, DOI 10.1242/jcs.101378; Fan YL, 2004, NAT GENET, V36, P989, DOI 10.1038/ng1414; FERGUSON KM, 1986, J BIOL CHEM, V261, P7393; Francis JW, 2017, J BIOL CHEM, V292, P4336, DOI 10.1074/jbc.M116.770909; Garcia-Garcia MJ, 2005, P NATL ACAD SCI USA, V102, P5913, DOI 10.1073/pnas.0501071102; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Gotthardt K, 2015, ELIFE, V4, DOI 10.7554/eLife.11859; GSCHWENDT M, 1995, BIOCHEM BIOPH RES CO, V206, P614, DOI 10.1006/bbrc.1995.1087; Hall BE, 2001, J BIOL CHEM, V276, P27629, DOI 10.1074/jbc.M101727200; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Hori Y, 2008, BIOCHEM BIOPH RES CO, V373, P119, DOI 10.1016/j.bbrc.2008.06.001; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Inoue H, 2007, TRAFFIC, V8, P1465, DOI 10.1111/j.1600-0854.2007.00624.x; Ismail SA, 2010, CELL, V141, P812, DOI 10.1016/j.cell.2010.03.051; Ivanova AA, 2014, J BIOL CHEM, V289, P11111, DOI 10.1074/jbc.M114.548529; Iyer GH, 2005, J BIOL CHEM, V280, P8800, DOI 10.1074/jbc.M407586200; Joneson T, 1996, SCIENCE, V271, P810, DOI 10.1126/science.271.5250.810; KAHN RA, 1991, J BIOL CHEM, V266, P2606; KAHN RA, 1986, J BIOL CHEM, V261, P7906; Kahn RA, 2008, J CELL BIOL, V182, P1039, DOI 10.1083/jcb.200806041; Kuai J, 2000, J BIOL CHEM, V275, P4022, DOI 10.1074/jbc.275.6.4022; Kuai J, 2002, METHOD ENZYMOL, V345, P359; Larkins CE, 2011, MOL BIOL CELL, V22, P4694, DOI 10.1091/mbc.E10-12-0994; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Menetrey J, 2000, NAT STRUCT BIOL, V7, P466; Miertzschke M, 2014, BIOCHEM J, V457, P301, DOI 10.1042/BJ20131097; Newman LE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099270; Nomanbhoy TK, 1996, J BIOL CHEM, V271, P10004, DOI 10.1074/jbc.271.17.10004; NORTHUP JK, 1982, J BIOL CHEM, V257, P1416; Paoli P, 2000, BIOCHEM J, V349, P43, DOI 10.1042/0264-6021:3490043; PAPAGEORGE A, 1982, J VIROL, V44, P509, DOI 10.1128/JVI.44.2.509-519.1982; Parisi M., 1993, GENEREVIEWS, P1993; RANDAZZO PA, 1994, J BIOL CHEM, V269, P10758; RANDAZZO PA, 1995, METHOD ENZYMOL, V257, P128; Randazzo PA, 2004, CELL SIGNAL, V16, P401, DOI 10.1016/j.cellsig.2003.09.012; RANDAZZO PA, 1995, J BIOL CHEM, V270, P14809, DOI 10.1074/jbc.270.24.14809; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Scrima A, 2008, EMBO J, V27, P1145, DOI 10.1038/emboj.2008.30; Seewald MJ, 2002, NATURE, V415, P662, DOI 10.1038/415662a; Shern JF, 2003, J BIOL CHEM, V278, P40829, DOI 10.1074/jbc.M308678200; SIGAL IS, 1986, P NATL ACAD SCI USA, V83, P4725, DOI 10.1073/pnas.83.13.4725; SIGAL IS, 1986, P NATL ACAD SCI USA, V83, P952, DOI 10.1073/pnas.83.4.952; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; TERUI T, 1994, J BIOL CHEM, V269, P28130; Thomas S, 2015, EUR J HUM GENET, V23, P621, DOI 10.1038/ejhg.2014.156; TIAN G, 1990, BIOCHEMISTRY-US, V29, P4296, DOI 10.1021/bi00470a006; Tropea Joseph E., 2009, V498, P297, DOI 10.1007/978-1-59745-196-3_19; TUAZON PT, 1991, ADV SEC MESS PHOSPH, V23, P123; Van Valkenburgh H, 2001, J BIOL CHEM, V276, P22826, DOI 10.1074/jbc.M102359200; VanAelst L, 1996, EMBO J, V15, P3778, DOI 10.1002/j.1460-2075.1996.tb00751.x; WEISS O, 1989, J BIOL CHEM, V264, P21066; ZHANG CJ, 1994, J CELL BIOL, V124, P289, DOI 10.1083/jcb.124.3.289; Zhang Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep24534; Zhou CJ, 2006, MOL BIOL CELL, V17, P2476, DOI 10.1091/mbc.E05-10-0929	86	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					11091	11108		10.1074/jbc.M117.784025	http://dx.doi.org/10.1074/jbc.M117.784025			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28487361	hybrid, Green Published			2022-12-26	WOS:000404391000029
J	Palich, R; Irenge, LM; Sainte Fare, EBD; Augier, A; Malvy, D; Gala, JL				Palich, Romain; Irenge, Leonid M.; Fare, Eric Barte de Sainte; Augier, Augustin; Malvy, Denis; Gala, Jean-Luc			Ebola virus RNA detection on fomites in close proximity to confirmed Ebola patients; N'Zerekore, Guinea, 2015	PLOS ONE			English	Article							TRANSMISSION; FLUIDS; RISK	Objective Health care workers (HCWs) in contact with patients with Ebola virus disease (EVD) are exposed to a risk of viral contamination. Fomites contaminated with the patient's blood or body fluids represents this risk. Our study aims to detect Ebola virus (EBOV) RNA within the high-and low-risk areas of an Ebola treatment unit (ETU) located in inland Guinea during the 2014 - 2015 West African Ebola epidemics. For samples from patients' immediate vicinity, we aim to seek an association between viral RNA detectability and level of plasma viral load of patients (intermediate to high, or very high). Methods Swabbing was performed on immediate vicinity of Ebola patients, on surfaces of an ETU, and on personal protective equipment (PPE) of HCWs after patient care and prior to doffing. All samples were assessed by quantitative reverse-transcribed PCR (RT-qPCR). Results 32% (22/68) of swabs from high-risk areas were tested positive for EBOV RNA, including 42% (18/43) from patients' immediate vicinity, and 16% (4/25) from HCWs PPE. None of specimens from low-risk areas were tested positive (0/19). Swabs were much more often viral RNA positive in the vicinity of patients with a very high plasma viral load (OR 6.7, 95% CI [1.7 - 23.4]). Conclusion Our findings show the persistence of EBOV RNA in the environment of Ebola patients and of HCWs, in a Guinean ETU, despite strict infection prevention and control measures. This detection raises the possibility that patients' environment could be a potential source of contamination with the virus.	[Palich, Romain; Fare, Eric Barte de Sainte; Augier, Augustin] Alliance Int Med Act, Dakar, Senegal; [Irenge, Leonid M.; Gala, Jean-Luc] Louvain Catholic Univ, Ctr Appl Mol Technol, Brussels, Belgium; [Malvy, Denis] Univ Hosp Bordeaux, Dept Trop Med & Clin Int Hlth, Div Infect & Trop Dis, Bordeaux, France; [Malvy, Denis] Univ Bordeaux, INSERM1219, Bordeaux, France	Universite Catholique Louvain; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Palich, R (corresponding author), Alliance Int Med Act, Dakar, Senegal.	romain.palich@alima-ngo.org	MALVY, Denis/T-7930-2019; Palich, Romain/ABZ-1131-2022	Palich, Romain/0000-0003-0047-0101				Bausch DG, 2007, J INFECT DIS, V196, pS142, DOI 10.1086/520545; Centers for Disease Control and Prevention (CDC), GEN HEALTHC SETT W A; Dowell SF, 1995, TRANSMISSION EBOLA H, V179, pS87; Fischer R, 2015, EMERG INFECT DIS, V21, P1243, DOI 10.3201/eid2107.150253; Francesconi P, 2003, EMERG INFECT DIS, V9, P1430, DOI 10.3201/eid0911.030339; Poliquin PG, 2016, J INFECT DIS, V214, pS145, DOI 10.1093/infdis/jiw198; Roels TH, 1999, J INFECT DIS, V179, pS92, DOI 10.1086/514286; Schuit M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148476; Sissoko D, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001967; Spengler JR, 2015, J INFECT DIS, V212, pS346, DOI 10.1093/infdis/jiv187; Wamala JF, 2010, EMERG INFECT DIS, V16, P1087, DOI 10.3201/eid1607.091525; WHO, 2015, EB SIT REP; Youkee D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145167	13	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177350	10.1371/journal.pone.0177350	http://dx.doi.org/10.1371/journal.pone.0177350			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493945	Green Submitted, Green Published, gold			2022-12-26	WOS:000401314300091
J	Cerri, CEP; You, X; Cherubin, MR; Moreira, CS; Raucci, GS; Castigioni, BD; Alves, PA; Cerri, DGP; Mello, FFD; Cerri, CC				Pellegrino Cerri, Carlos Eduardo; You, Xin; Cherubin, Mauricio Roberto; Moreira, Cindy Silva; Raucci, Guilherme Silva; Castigioni, Bruno de Almeida; Alves, Priscila Aparecida; Pellegrino Cerri, Domingos Guilherme; de Castro Mello, Francisco Fujita; Cerri, Carlos Clemente			Assessing the greenhouse gas emissions of Brazilian soybean biodiesel production	PLOS ONE			English	Article							SOIL CARBON STOCKS; FOOTPRINT; BIOFUEL; AGRICULTURE; BIOENERGY; CERRADO	Soybean biodiesel (B100) has been playing an important role in Brazilian energy matrix towards the national bio-based economy. Greenhouse gas (GHG) emissions is the most widely used indicator for assessing the environmental sustainability of biodiesels and received particular attention among decision makers in business and politics, as well as consumers. Former studies have been mainly focused on the GHG emissions from the soybean cultivation, excluding other stages of the biodiesel production. Here, we present a holistic view of the total GHG emissions in four life cycle stages for soybean biodiesel. The aim of this study was to assess the GHG emissions of Brazilian soybean biodiesel production system with an integrated life cycle approach of four stages: agriculture, extraction, production and distribution. Allocation of mass and energy was applied and special attention was paid to the integrated and non-integrated industrial production chain. The results indicated that the largest source of GHG emissions, among four life cycle stages, is the agricultural stage (42-51%) for B100 produced in integrated systems and the production stage (46-52%) for B100 produced in non-integrated systems. Integration of industrial units resulted in significant reduction in life cycle GHG emissions. Without the consideration of LUC and assuming biogenic CO2 emissions is carbon neutral in our study, the calculated life cycle GHG emissions for domestic soybean biodiesel varied from 23.1 to 25.8 gCO(2)eq. MJ(-1) B100 and those for soybean biodiesel exported to EU ranged from 26.5 to 29.2 gCO(2)eq. MJ(-1) B100, which represent reductions by 65% up to 72% (depending on the delivery route) of GHG emissions compared with the EU benchmark for diesel fuel. Our findings from a life cycle perspective contributed to identify the major GHG sources in Brazilian soybean biodiesel production system and they can be used to guide mitigation priority for policy and decisionmaking. Projected scenarios in this study would be taken as references for accounting the environmental sustainability of soybean biodiesel within a domestic and global level.	[Pellegrino Cerri, Carlos Eduardo; You, Xin] Univ Sao Paulo, Luiz de Queiroz Coll Agr, Dept Soil Sci, 11 Padua Dias Ave, Piracicaba, SP, Brazil; [You, Xin] Univ Hohenheim, Fac Agr Sci, Inst Soil Sci & Land Evaluat 310, Stuttgart, Germany; [Cherubin, Mauricio Roberto; Cerri, Carlos Clemente] Univ Sao Paulo, Ctr Nucl Energy Agr, 303 Centenario Ave, Piracicaba, SP, Brazil; [Moreira, Cindy Silva] Brazilian Vegetable Oil Ind Assoc, 3707 Vereador Jose Diniz Ave, Sao Paulo, SP, Brazil; [Raucci, Guilherme Silva] Espaco Eco Fdn, 230 Ribeirao do Soldado Rd, Sao Bernardo Do Campo, SP, Brazil; [Castigioni, Bruno de Almeida; Alves, Priscila Aparecida; Pellegrino Cerri, Domingos Guilherme] DeltaCO2 Sustentabilidade Ambiental, 600 Cezira Giovanoni Moretti St, Piracicaba, SP, Brazil; [de Castro Mello, Francisco Fujita] Minist Agr Livestock & Food Supply, Dept Dev Prod Chains & Sustainable Prod, Bl D Anexo 1 Aandar Ala B Sl 137, Brasilia, DF, Brazil	Universidade de Sao Paulo; University Hohenheim; Universidade de Sao Paulo	Cerri, CEP (corresponding author), Univ Sao Paulo, Luiz de Queiroz Coll Agr, Dept Soil Sci, 11 Padua Dias Ave, Piracicaba, SP, Brazil.	cepcerri@usp.br	Cherubin, Mauricio/A-6896-2016; Cerri, Carlos Eduardo p/C-5039-2012	Cherubin, Mauricio/0000-0001-7920-8362; Cerri, Carlos Eduardo p/0000-0002-4374-4056	National Council for Scientific and Technological Development (CNPq) Brazil; DAAD; BMBF; CSM (Brazilian Vegetable Oil Industries Association); GSR (Espaco Eco Foundation); BAC; PM; DGPC (DeltaCO2 - Sustentabilidade Ambiental)	National Council for Scientific and Technological Development (CNPq) Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); BMBF(Federal Ministry of Education & Research (BMBF)); CSM (Brazilian Vegetable Oil Industries Association); GSR (Espaco Eco Foundation); BAC; PM; DGPC (DeltaCO2 - Sustentabilidade Ambiental)	CEPC and CCC thank the National Council for Scientific and Technological Development (CNPq) Brazil for their productivity grants. XY thanks the Strategic Network Bio-based Economy (BECY) supported by DAAD and BMBF for providing his mobility research fellowship. The authors CSM (Brazilian Vegetable Oil Industries Association), GSR (Espaco Eco Foundation), BAC, PM and DGPC (DeltaCO2 - Sustentabilidade Ambiental) thank their respective companies for providing support in form of salaries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Almeida MC, 2008, EXTEMALIDADES ANALIS, P160; [Anonymous], 2016, BIOD STAT; ANP-Agencia Nacional de Petroleo Gas Natural e Biocombustiveis, 2016, AN DAD EST; Bjorklund AE, 2002, INT J LIFE CYCLE ASS, V7, P64, DOI 10.1065/lca2001.12/071; Brazil, 2015, FEDERATIVE REPUBLIC; Castanheira EG, 2013, J CLEAN PROD, V54, P49, DOI 10.1016/j.jclepro.2013.05.026; Cavalett O, 2010, J CLEAN PROD, V18, P55, DOI 10.1016/j.jclepro.2009.09.008; Cerri CEP, 2014, AGR ECOSYST ENVIRON, V183, P167; Cleary J, 2009, ENVIRON INT, V35, P1256, DOI 10.1016/j.envint.2009.07.009; Conab-Companhia Brasileira de Agricultura e Abastecimento, 2016, COMP BRAS AGR AB AC, V10; da Silva VP, 2010, J ENVIRON MANAGE, V91, P1831, DOI 10.1016/j.jenvman.2010.04.001; Davis SC, 2013, GCB BIOENERGY, V5, P623, DOI 10.1111/gcbb.12042; Davis SC, 2012, FRONT ECOL ENVIRON, V10, P69, DOI 10.1890/110003; Ecoinvent, 2010, LIF CYCL INV DAT BAS; European Commission, 2009, OFF J EUR UNION, V5, P16; Fargione J, 2008, SCIENCE, V319, P1235, DOI 10.1126/science.1152747; Fearnside PM, 2007, ENVIRON MANAGE, V39, P601, DOI 10.1007/s00267-006-0149-2; Finkbeiner M, 2009, INT J LIFE CYCLE ASS, V14, P91, DOI 10.1007/s11367-009-0064-x; Flach B, 2012, EU 27 OILSEEDS PRODU; de Alvarenga RAF, 2012, J CLEAN PROD, V28, P25, DOI 10.1016/j.jclepro.2011.06.023; Goldemberg J, 2014, ENERG POLICY, V69, P14, DOI 10.1016/j.enpol.2014.02.008; Grisoli R, 2015, J CLEAN PROD; Heijungs R., 1996, J CLEAN PROD, V4, P159, DOI [10.1016/S0959-6526(96)00042-X, DOI 10.1016/S0959-6526(96)00042-X]; IPCC, 2007, CLIMATE CHANGE 2007; ISO, 2006, 14044 ISO; Karp A, 2008, NEW PHYTOL, V179, P15, DOI 10.1111/j.1469-8137.2008.02432.x; Kim S, 2009, INT J LIFE CYCLE ASS, V14, P540, DOI 10.1007/s11367-009-0106-4; Lapola DM, 2014, NAT CLIM CHANGE, V4, P27, DOI 10.1038/NCLIMATE2056; Laurent A, 2010, CIRP ANN-MANUF TECHN, V59, P37, DOI 10.1016/j.cirp.2010.03.008; Lehuger S, 2009, J CLEAN PROD, V17, P616, DOI 10.1016/j.jclepro.2008.10.005; Macedo IC, 2008, BIOMASS BIOENERG, V32, P582, DOI 10.1016/j.biombioe.2007.12.006; Macedo MN, 2012, P NATL ACAD SCI USA, V109, P1341, DOI 10.1073/pnas.1111374109; Maciel VG, 2016, J CLEAN PROD, V131, P747, DOI 10.1016/j.jclepro.2016.04.100; Miranda E, 2016, LAND DEGRAD DEV, V27, P1586, DOI 10.1002/ldr.2473; Neto MS, 2010, SOIL TILL RES, V110, P187, DOI 10.1016/j.still.2010.07.010; Ozturk I., 2015, GCB BIOENERGY, V8, P826; Ozturk I, 2016, BIOFUEL BIOPROD BIOR, V10, P150, DOI 10.1002/bbb.1628; Panichelli L, 2009, INT J LIFE CYCLE ASS, V14, P144, DOI 10.1007/s11367-008-0050-8; Esteves VPP, 2016, CLEAN TECHNOL ENVIR, V18, P1655, DOI 10.1007/s10098-016-1161-8; Persson UM, 2014, GLOBAL CHANGE BIOL, V20, P3482, DOI 10.1111/gcb.12635; Pradhan A, 2012, T ASABE, V55, P2257; Raucci GS, 2015, J CLEAN PROD, V96, P418, DOI 10.1016/j.jclepro.2014.02.064; Solomon BD, 2015, ENVIRON MANAGE, V56, P1276, DOI 10.1007/s00267-014-0424-6; United Soybean Board, 2009, APPL RECENT US SOYBE; US EPA-Environmental Protection Agency, 2010, FIN REG NAT REN FUEL; USDA, 2014, BRAZ BIOF ANN USDA F; Uusitalo V, 2014, RENEW ENERG, V69, P103, DOI 10.1016/j.renene.2014.03.020; Vigon B.W., 1993, LIFE CYCLE ASSESSMEN; Weidema BP, 2008, J IND ECOL, V12, P3, DOI 10.1111/j.1530-9290.2008.00005.x; West TO, 2002, AGR ECOSYST ENVIRON, V91, P217, DOI 10.1016/S0167-8809(01)00233-X; Wolfram P, 2016, J CLEAN PROD, V124, P236, DOI 10.1016/j.jclepro.2016.02.080; WRI, 2001, GREENH GAS PROT CORP; Zamagni A, 2008, MAIN R D LINES IMPRO, P5	53	13	13	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176948	10.1371/journal.pone.0176948	http://dx.doi.org/10.1371/journal.pone.0176948			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493965	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314300043
J	Sanchez-Mendoza, EH; Bellver-Landete, V; Arce, C; Doeppner, TR; Hermann, DM; Oset-Gasque, MJ				Sanchez-Mendoza, Eduardo H.; Bellver-Landete, Victor; Arce, Carmen; Doeppner, Thorsten R.; Hermann, Dirk M.; Jesus Oset-Gasque, Maria			Vesicular glutamate transporters play a role in neuronal differentiation of cultured SVZ-derived neural precursor cells	PLOS ONE			English	Article							MURINE SUBVENTRICULAR ZONE; CEREBRAL-ISCHEMIA; NEUROPATHIC PAIN; STEM-CELLS; RAT-BRAIN; NEUROGENESIS; EXPRESSION; RECEPTORS; PROMOTES; PROLIFERATION	The role of glutamate in the regulation of neurogenesis is well-established, but the role of vesicular glutamate transporters (VGLUTs) and excitatory amino acid transporters (EAATs) in controlling adult neurogenesis is unknown. Here we investigated the implication of VGLUTs in the differentiation of subventricular zone (SVZ)-derived neural precursor cells (NPCs). Our results show that NPCs express VGLUT1-3 and EAAT1-3 both at the mRNA and protein level. Their expression increases during differentiation closely associated with the expression of marker genes. In expression analyses we show that VGLUT1 and VGLUT2 are preferentially expressed by cultured SVZ-derived doublecortin+ neuroblasts, while VGLUT3 is found on GFAP+ glial cells. In cultured NPCs, inhibition of VGLUT by Evans Blue increased the mRNA level of neuronal markers doublecortin, B3T and MAP2, elevated the number of NPCs expressing doublecortin protein and promoted the number of cells with morphological appearance of branched neurons, suggesting that VGLUT function prevents neuronal differentiation of NPCs. This survival-and differentiation-promoting effect of Evans blue was corroborated by increased AKT phosphorylation and reduced MAPK phosphorylation. Thus, under physiological conditions, VGLUT1-3 inhibition, and thus decreased glutamate exocytosis, may promote neuronal differentiation of NPCs.	[Sanchez-Mendoza, Eduardo H.; Bellver-Landete, Victor; Arce, Carmen; Jesus Oset-Gasque, Maria] Univ Complutense Madrid, Dept Biochem & Mol Biol, Fac Pharm, Madrid, Spain; [Sanchez-Mendoza, Eduardo H.; Hermann, Dirk M.] Univ Duisburg Essen, Dept Neurol, Essen, Germany; [Doeppner, Thorsten R.] Univ Gottingen, Dept Neurol, Med Sch, Gottingen, Germany; [Jesus Oset-Gasque, Maria] Univ Complutense Madrid, Inst Univ Invest Neuroquim, Madrid, Spain	Complutense University of Madrid; University of Duisburg Essen; University of Gottingen; Complutense University of Madrid	Oset-Gasque, MJ (corresponding author), Univ Complutense Madrid, Dept Biochem & Mol Biol, Fac Pharm, Madrid, Spain.; Oset-Gasque, MJ (corresponding author), Univ Complutense Madrid, Inst Univ Invest Neuroquim, Madrid, Spain.	mjoset@ucm.es	Hermann, Dirk M./AAT-3652-2021; Hermann, Dirk M/AAP-5538-2020; Hermann, Dirk/GZB-9350-2022; Oset Gasque, Maria Jesus/I-1072-2015	Hermann, Dirk M./0000-0003-0198-3152; Oset Gasque, Maria Jesus/0000-0002-7223-0222	Ministry of Economy and Competitiveness (MINECO, Spain) [SAF2010-20337, BFU-2013-43163-R]; Complutense University of Madrid-Santander Bank [GR35/10-B and GR3/14]; Institute of Health Carlos III, ISCIII [RD06/0026/0012]	Ministry of Economy and Competitiveness (MINECO, Spain); Complutense University of Madrid-Santander Bank; Institute of Health Carlos III, ISCIII	This study was supported by the grants SAF2010-20337 and BFU-2013-43163-R from Ministry of Economy and Competitiveness (MINECO, Spain), GR35/10-B and GR3/14 (Complutense University of Madrid-Santander Bank) and RD06/0026/0012 (Institute of Health Carlos III, ISCIII). E. Sanchez-Mendoza has contract from RD06/0026/0012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the grants SAF2010-20337 from Ministry of Economy and Competitiveness (MINECO, Spain), GR35/10-B and GR3/14 (Complutense University of Madrid-Santander Bank) and RD06/0026/0012 (Institute of Health Carlos III, ISCIII) to MJ. Oset-Gasque. E. Sanchez-Mendoza has a contract from RD06/0026/0012.	Agasse F, 2008, STEM CELLS, V26, P1636, DOI 10.1634/stemcells.2008-0056; Arranz AM, 2010, NEUROBIOL DIS, V37, P156, DOI 10.1016/j.nbd.2009.09.019; Banasr M, 2004, NEUROPSYCHOPHARMACOL, V29, P450, DOI 10.1038/sj.npp.1300320; Bath KG, 2010, DEV NEUROBIOL, V70, P339, DOI 10.1002/dneu.20781; Castillo J, 2003, NEUROLOGIA, V18, P368; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Coronas V, 2004, J NEUROCHEM, V91, P1292, DOI 10.1111/j.1471-4159.2004.02823.x; Di Giorgi-Gerevini V, 2005, CELL DEATH DIFFER, V12, P1124, DOI 10.1038/sj.cdd.4401639; Fujiyama F, 2001, J COMP NEUROL, V435, P379, DOI 10.1002/cne.1037; Garcia-Verdugo J, 1998, J NEUROBIOL, V36, P234, DOI 10.1002/(SICI)1097-4695(199808)36:2<234::AID-NEU10>3.0.CO;2-E; Gu WG, 2010, STEM CELL RES, V4, P148, DOI 10.1016/j.scr.2009.12.001; Gundersen V, 2015, PHYSIOL REV, V95, P695, DOI 10.1152/physrev.00024.2014; Hermann DM, 2012, LANCET NEUROL, V11, P369, DOI 10.1016/S1474-4422(12)70039-X; Herzog E, 2004, NEUROSCIENCE, V123, P983, DOI 10.1016/j.neuroscience.2003.10.039; Hossmann KA, 2006, CELL MOL NEUROBIOL, V26, P1057, DOI 10.1007/s10571-006-9008-1; Islam MM, 2015, BBA-GENE REGUL MECH, V1849, P210, DOI 10.1016/j.bbagrm.2014.06.001; Juge N, 2006, J BIOL CHEM, V281, P39499, DOI 10.1074/jbc.M607670200; Kashani A, 2007, NEUROBIOL AGING, V28, P568, DOI 10.1016/j.neurobiolaging.2006.02.010; Katsetos CD, 2003, J CHILD NEUROL, V18, P851, DOI 10.1177/088307380301801205; Kim Y, 2010, J NEUROCHEM, V114, P750, DOI 10.1111/j.1471-4159.2010.06799.x; Li L, 2006, J ENG FIBER FABR, V1, P1; Martinez-Lozada Z, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/787396; Montana V, 2004, J NEUROSCI, V24, P2633, DOI 10.1523/JNEUROSCI.3770-03.2004; Nakamichi N, 2009, J PHARMACOL SCI, V110, P133, DOI 10.1254/jphs.08R03CR; Perez-Rodriguez R, 2009, J NEUROCHEM, V108, P1083, DOI 10.1111/j.1471-4159.2008.05862.x; Platel JC, 2008, J PHYSIOL-LONDON, V586, P3783, DOI 10.1113/jphysiol.2008.155879; Platel JC, 2008, J PHYSIOL-LONDON, V586, P3739, DOI 10.1113/jphysiol.2008.155325; Platel JC, 2007, J MOL HISTOL, V38, P601, DOI 10.1007/s10735-007-9153-y; Platel JC, 2010, BRAIN RES REV, V63, P60, DOI 10.1016/j.brainresrev.2010.02.004; Platel JC, 2010, NEURON, V65, P859, DOI 10.1016/j.neuron.2010.03.009; Preobraschenski J, 2014, NEURON, V84, P1287, DOI 10.1016/j.neuron.2014.11.008; Quinones-Hinojosa A, 2006, J COMP NEUROL, V494, P415, DOI 10.1002/cne.20798; Ransome MI, 2008, MOL CELL NEUROSCI, V38, P537, DOI 10.1016/j.mcn.2008.05.002; ROSETH S, 1995, J NEUROCHEM, V65, P96; Sanchez-Mendoza E, 2013, NEUROPATH APPL NEURO, V39, P722, DOI 10.1111/nan.12082; Sanchez-Mendoza E, 2010, J NEUROCHEM, V113, P1343, DOI 10.1111/j.1471-4159.2010.06707.x; Santos MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109824; Schramm J, 2014, NEUROSCI LETT, V562, P69, DOI 10.1016/j.neulet.2014.01.003; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Takamori S, 2006, NEUROSCI RES, V55, P343, DOI 10.1016/j.neures.2006.04.016; Tzingounis AV, 2007, NAT REV NEUROSCI, V8, P935, DOI 10.1038/nrn2274; Uda Y, 2016, STEM CELL REP, V6, P474, DOI 10.1016/j.stemcr.2016.02.007; Wallen-Mackenzie A, 2010, UPSALA J MED SCI, V115, P11, DOI 10.3109/03009730903572073; Wang ZT, 2015, BRAIN RES, V1624, P515, DOI 10.1016/j.brainres.2015.08.010; Weng HR, 2014, EXP NEUROL, V252, P18, DOI 10.1016/j.expneurol.2013.11.018; Whitney NP, 2008, FASEB J, V22, P2888, DOI 10.1096/fj.07-104661; Wojcik SM, 2004, P NATL ACAD SCI USA, V101, P7158, DOI 10.1073/pnas.0401764101; Xia WL, 2015, STEM CELL REP, V4, P795, DOI 10.1016/j.stemcr.2015.03.004; Yoshimura T, 2006, J NEUROSCI, V26, P10626, DOI 10.1523/JNEUROSCI.3824-06.2006; Zhu GZ, 2015, EXP MOL PATHOL, V99, P474, DOI 10.1016/j.yexmp.2015.09.002	50	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177069	10.1371/journal.pone.0177069	http://dx.doi.org/10.1371/journal.pone.0177069			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493916	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314300056
J	Tilley, SK; Joseph, RM; Kuban, KCK; Dammann, OU; O'Shea, TM; Fry, RC				Tilley, Sloane K.; Joseph, Robert M.; Kuban, Karl C. K.; Dammann, Olaf U.; O'Shea, T. Michael; Fry, Rebecca C.			Genomic biomarkers of prenatal intrauterine inflammation in umbilical cord tissue predict later life neurological outcomes	PLOS ONE			English	Article							EXTREMELY PRETERM INFANTS; SYSTEMIC INFLAMMATION; CEREBRAL-PALSY; 28TH WEEK; GESTATION; RISK; AGE; PROTEINS; NEWBORNS; NEUROGENESIS	Background Preterm birth is a major risk factor for neurodevelopmental delays and disorders. This study aimed to identify genomic biomarkers of intrauterine inflammation in umbilical cord tissue in preterm neonates that predict cognitive impairment at 10 years of age. Study design Genome-wide messenger RNA (mRNA) levels from umbilical cord tissue were obtained from 43 neonates born before 28 weeks of gestation. Genes that were differentially expressed across four indicators of intrauterine inflammation were identified and their functions examined. Exact logistic regression was used to test whether expression levels in umbilical cord tissue predicted neurocognitive function at 10 years of age. Results Placental indicators of inflammation were associated with changes in the mRNA expression of 445 genes in umbilical cord tissue. Transcripts with decreased expression showed significant enrichment for biological signaling processes related to neuronal development and growth. The altered expression of six genes was found to predict neurocognitive impairment when children were 10 years old These genes include two that encode for proteins involved in neuronal development. Conclusion Prenatal intrauterine inflammation is associated with altered gene expression in umbilical cord tissue. A set of six of the differentially expressed genes predict cognitive impairment later in life, suggesting that the fetal environment is associated with significant adverse effects on neurodevelopment that persist into later childhood.	[Tilley, Sloane K.; Fry, Rebecca C.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Environm Sci & Engn, Chapel Hill, NC 27599 USA; [Joseph, Robert M.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Kuban, Karl C. K.] Boston Univ, Sch Med, Dept Pediat, Boston, MA 02118 USA; [Dammann, Olaf U.] Tufts Univ, Sch Med, Dept Publ Hlth & Community Med, Boston, MA 02111 USA; [O'Shea, T. Michael] Univ N Carolina, Dept Pediat, Chapel Hill, NC USA; [Fry, Rebecca C.] Univ N Carolina, Sch Med, Curriculum Toxicol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; Boston University; Boston University; Massachusetts Department of Public Health; Tufts University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Fry, RC (corresponding author), Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Environm Sci & Engn, Chapel Hill, NC 27599 USA.; Fry, RC (corresponding author), Univ N Carolina, Sch Med, Curriculum Toxicol, Chapel Hill, NC 27599 USA.	rfry@unc.edu		Fry, Rebecca/0000-0003-0899-9018; Joseph, Robert/0000-0001-6879-0254	National Institutes of Health [R01 ES019315, P42 ES005948, 5U01NS040069-05, 5U01NS040069-09, 1UG3OD023348-01]; National Institute for Occupational Safety and Health [T42/OH-008673]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES005948, P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS040069] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [UG3OD023348] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute for Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by grants from the National Institutes of Health (http://www.nih.gov < http://www.nih.gov/>): R01 ES019315 (RF), P42 ES005948 (RF), 5U01NS040069-05 (KK), and 5U01NS040069-09 (KK), 1UG3OD023348-01 (TS) and from the National Institute for Occupational Safety and Health: T42/OH-008673. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by grants from the National Institutes of Health (http://www.nih.gov): R01 ES019315, P42 ES005948, 5U01NS040069-05, 2R01NS040069-09, and 1UG3OD023348-01, and from the National Institute for Occupational Safety and Health: T42/OH-008673. The funders of this study had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Chapman I, 2006, CURR OPIN INFECT DIS, V19, P290, DOI 10.1097/01.qco.0000224825.57976.87; Beran TN, 2007, CAN J SCH PSYCHOL, V22, P128, DOI 10.1177/0829573507302967; Bizzoca A, 2012, DEV BIOL, V365, P133, DOI 10.1016/j.ydbio.2012.02.011; Blencowe H, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S2; Blencowe H, 2013, PEDIATR RES, V74, P17, DOI 10.1038/pr.2013.204; Chiquet BT, 2011, BIRTH DEFECTS RES A, V91, P44, DOI 10.1002/bdra.20737; Cohen J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r210; Costa D., 2015, PEDIATR RES, VXVI, P1; Dammann O, 2008, CLIN PERINATOL, V35, P643, DOI 10.1016/j.clp.2008.07.011; Dellett M, 2012, DEV GROWTH DIFFER, V54, P327, DOI 10.1111/j.1440-169X.2012.01339.x; Derr RE, 2000, ASYMPTOTIC ANAL, V254, P1; Elias LAB, 2008, TRENDS NEUROSCI, V31, P243, DOI 10.1016/j.tins.2008.02.007; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Goldenberg RL, 2005, ARCH PEDIAT ADOL MED, V159, P89, DOI 10.1001/archpedi.159.1.89; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Guralnick M, 2004, J INTELL DISABIL RES, V48, P283; Hecht JL, 2008, PATHOLOGY, V40, P372, DOI 10.1080/00313020802035865; Helderman JB, 2012, PEDIATRICS, V129, P494, DOI 10.1542/peds.2011-1796; Ibrahim S.A., 2015, AM J OBSTET GYNECOL; Joseph RM, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-4343; Kilinc D, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00282; Korkman M., 2007, NEPSY II CLIN INTERP; Kristman V, 2004, EUR J EPIDEMIOL, V19, P751, DOI 10.1023/B:EJEP.0000036568.02655.f8; Kuban KCK, 2016, J PEDIATR-US, V173, P69, DOI 10.1016/j.jpeds.2016.02.048; Kuban KCK, 2015, PEDIATR NEUROL, V52, P42, DOI 10.1016/j.pediatrneurol.2014.10.005; Kuban KCK, 2014, J CHILD NEUROL, V29, P1692, DOI 10.1177/0883073813513335; Lee AWS, 2012, PLOS ONE, P7; Leviton A, 2011, EARLY HUM DEV, V87, P325, DOI 10.1016/j.earlhumdev.2011.01.043; Leviton A, 2010, EARLY HUM DEV, V86, P515, DOI 10.1016/j.earlhumdev.2010.07.001; Leviton A, 2010, PEDIATR RES, V67, P95, DOI 10.1203/PDR.0b013e3181bf5fab; Mathews TJ, 2013, NATL VITAL STAT REPO, V54, P0; McElrath TF, 2008, AM J EPIDEMIOL, V168, P980, DOI 10.1093/aje/kwn202; Mehren E., 2012, J PERINATOL, V13, P393; Money KM, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00260; Nair RR, 2013, PLACENTA, V34, P824, DOI 10.1016/j.placenta.2013.06.307; O'Shea TM, 2009, EARLY HUM DEV, V85, P719, DOI 10.1016/j.earlhumdev.2009.08.060; O'Shea TM, 2014, PEDIATR RES, V75, P781, DOI 10.1038/pr.2014.41; O'Shea TM, 2012, J PEDIATR MOSBY, V160, P395; Paganoni S, 2005, J CELL SCI, V118, P433, DOI 10.1242/jcs.01622; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P17, DOI 10.1111/j.1471-0528.2006.01120.x; Swayne LA, 2016, BMC CELL BIOL, V17, DOI 10.1186/s12860-016-0089-5; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tauszig-Delamasure S, 2007, P NATL ACAD SCI USA, V104, P13361, DOI 10.1073/pnas.0701243104; Teichmann SA, 2000, J MOL BIOL, V296, P1367, DOI 10.1006/jmbi.1999.3497; Tita ATN, 2010, CLIN PERINATOL, V37, P339, DOI 10.1016/j.clp.2010.02.003; Yoon BH, 2000, AM J OBSTET GYNECOL, V182, P675, DOI 10.1067/mob.2000.104207; Zhang Qiang, 2015, Zhongguo Dang Dai Er Ke Za Zhi, V17, P217	47	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176953	10.1371/journal.pone.0176953	http://dx.doi.org/10.1371/journal.pone.0176953			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493900	gold, Green Published, Green Submitted			2022-12-26	WOS:000401314300044
J	Chiu, HT; Li, TC; Li, CI; Liu, CS; Lin, WY; Lin, CC				Chiu, Hsien-Tsai; Li, Tsai-Chung; Li, Chia-Ing; Liu, Chiu-Shong; Lin, Wen-Yuan; Lin, Cheng-Chieh			Visit-to-visit glycemic variability is a strong predictor of chronic obstructive pulmonary disease in patients with type 2 diabetes mellitus: Competing risk analysis using a national cohort from the Taiwan diabetes study	PLOS ONE			English	Article							LUNG-FUNCTION; STRESS HYPERGLYCEMIA; OXIDATIVE STRESS; ENDOTHELIAL-CELL; GLUCOSE; ASSOCIATION; OUTCOMES; HYPOGLYCEMIA; MANAGEMENT; APOPTOSIS	Background This study aims to examine the association between visit-to-visit glucose variability, which was measured by coefficient of variation (CV) of fasting plasma glucose (FPG) and hemoglobin A1c (HbA1c), and risk of chronic obstructive pulmonary disease (COPD) in a large number of patients with type 2 diabetes with an average follow-up of 7.58 years. Methods We conducted a retrospective cohort study on 27,257 patients with type 2 diabetes who participated in the National Diabetes Case Management Program in Taiwan. Visit-to-visit variability in HbA1c and FPG at baseline and the incidence of COPD were analyzed using a modified Cox proportional hazards model considering competing risks. Results A total of 2,346 incident cases of COPD. Patients were grouped into tertiles of FPG-CV and HbA1c-CV. The incidence rates in the first, second, and third tertiles were 9.87, 11.06, and 13.19, respectively, for FPG-CV and 10.2, 11.81, and 12.07, for HbA1c-CV per 1000 person-years. After adjusting for age, gender, diabetes duration, treatment type, smoking, hypertension, hyperlipidemia, baseline FPG and HbA1c levels, and complications, both FPG-CV and HbA1c-CV were independently associated with COPD. The hazard ratios of COPD for the third terile compared with the first tertile of FPG-CV were 1.26 (95% confidence interval [CI]: 1.13-1.40). Moreover, the hazard ratios of COPD for the third and second tertiles compared with the first tertile of HbA1c-CV were 1.13 (1.02-1.25) and 1.13 (1.02-1.26), respectively. Conclusions Patients with FPG-CV higher than 34.6% or HbA1c-CV higher than 8.4% exhibited an increased risk of COPD. This finding confirmed the linear relationship of FPG-CV and HbA1c-CV to COPD. Visit-to-visit variability in FPG and HbA1c levels are strong predictors of COPD in patients with type 2 diabetes. Future studies should focus on lung dysfunction in diabetes, and adequate glucose control strategy in regular clinical practices must be established for COPD prevention.	[Chiu, Hsien-Tsai] China Med Univ, Dept Publ Hlth, Coll Publ Hlth, Taichung, Taiwan; [Chiu, Hsien-Tsai] China Med Univ Hosp, Big Data Ctr, Clin Res Outcome & Training Ctr, Taichung, Taiwan; [Li, Tsai-Chung] China Med Univ, Grad Inst Biostat, Coll Publ Hlth, Taichung, Taiwan; [Li, Tsai-Chung] Asia Univ, Dept Healthcare Adm, Coll Med & Hlth Sci, Taichung, Taiwan; [Li, Chia-Ing; Liu, Chiu-Shong; Lin, Wen-Yuan; Lin, Cheng-Chieh] China Med Univ, Sch Med, Coll Med, Taichung, Taiwan; [Li, Chia-Ing; Liu, Chiu-Shong; Lin, Cheng-Chieh] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Liu, Chiu-Shong; Lin, Wen-Yuan; Lin, Cheng-Chieh] China Med Univ Hosp, Dept Family Med, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Asia University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Lin, CC (corresponding author), China Med Univ, Sch Med, Coll Med, Taichung, Taiwan.; Lin, CC (corresponding author), China Med Univ Hosp, Dept Med Res, Taichung, Taiwan.; Lin, CC (corresponding author), China Med Univ Hosp, Dept Family Med, Taichung, Taiwan.	cclin@mail.cmuh.org.tw	Lin, Cheng-Chieh/P-2564-2015	Lin, Cheng-Chieh/0000-0002-9625-6216	Bureau of National Health Insurance [D0H94-NH-1007]; Ministry of Science and Technology of Taiwan [NSC 101-2314-B-039 -017-MY3, NSC 102-2314-B-039-005-MY2, MOST 104-2314-B-039-016]; Taiwan Ministry of Health and Welfare Clinical Trial Center [MOHW-106-TDU-B-212-113004]; China Medical University Hospital [DMR-105-088]	Bureau of National Health Insurance; Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Taiwan Ministry of Health and Welfare Clinical Trial Center; China Medical University Hospital	This study was funded primarily by the Bureau of National Health Insurance (D0H94-NH-1007), the Ministry of Science and Technology of Taiwan (NSC 101-2314-B-039 -017-MY3 & NSC 102-2314-B-039-005-MY2 & MOST 104-2314-B-039-016), the Taiwan Ministry of Health and Welfare Clinical Trial Center (MOHW-106-TDU-B-212-113004), and China Medical University Hospital (DMR-105-088). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Baker EH, 2006, THORAX, V61, P284, DOI 10.1136/thx.2005.051029; BUNN HF, 1976, J CLIN INVEST, V57, P1652, DOI 10.1172/JCI108436; Buscemi S, 2010, DIABETIC MED, V27, P872, DOI 10.1111/j.1464-5491.2010.03059.x; Capes SE, 2000, LANCET, V355, P773, DOI 10.1016/S0140-6736(99)08415-9; Capes SE, 2001, STROKE, V32, P2426, DOI 10.1161/hs1001.096194; Ceriello A, 2010, DIABETIC MED, V27, P862, DOI 10.1111/j.1464-5491.2010.02967.x; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Chang CH, 2010, DIABETIC MED, V27, P636, DOI 10.1111/j.1464-5491.2010.03007.x; Davis TME, 2000, DIABETES RES CLIN PR, V50, P153, DOI 10.1016/S0168-8227(00)00166-2; Di Flaviani A, 2011, DIABETES CARE, V34, P1605, DOI 10.2337/dc11-0034; Ehrlich SF, 2010, DIABETES CARE, V33, P55, DOI 10.2337/dc09-0880; Esposito K, 2002, CIRCULATION, V106, P2067, DOI 10.1161/01.CIR.0000034509.14906.AE; Forgiarini LA, 2009, J BRAS PNEUMOL, V35, P788, DOI 10.1590/S1806-37132009000800011; Glaser S, 2015, RESPIRATION, V89, P253, DOI 10.1159/000369863; Goldman MD, 2003, DIABETES CARE, V26, P1915, DOI 10.2337/diacare.26.6.1915; Hsu PF, 2013, DIABETES CARE, V36, P894, DOI 10.2337/dc12-0916; IHNAT MA, 2007, AM J BIOCH BIOTECH, V3, P16; International Diabetes Federation, 2014, IDF DIAB ATL UPD POS; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Jiang YD, 2012, J FORMOS MED ASSOC, V111, P599, DOI 10.1016/j.jfma.2012.09.014; Kovatchev BP, 2006, DIABETES CARE, V29, P2433, DOI 10.2337/dc06-1085; LANGE P, 1989, EUR RESPIR J, V2, P14; Lawlor DA, 2004, DIABETOLOGIA, V47, P195, DOI 10.1007/s00125-003-1310-6; Li CI, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000367; Lin CH, 2013, J INTERN MED, V273, P102, DOI 10.1111/joim.12000; Mamdani M, 2005, BMJ-BRIT MED J, V330, P960, DOI 10.1136/bmj.330.7497.960; Maurizi AR, 2013, DIABETES METAB RES R; McAlister FA, 2005, DIABETES CARE, V28, P810, DOI 10.2337/diacare.28.4.810; Mirrakhimov AE, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-132; Monnier L, 2008, DIABETES CARE, V31, pS150, DOI 10.2337/dc08-s241; Nalysnyk L, 2010, DIABETES OBES METAB, V12, P288, DOI 10.1111/j.1463-1326.2009.01160.x; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Piconi L, 2006, DIABETES-METAB RES, V22, P198, DOI 10.1002/dmrr.613; Quagliaro L, 2003, DIABETES, V52, P2795, DOI 10.2337/diabetes.52.11.2795; Rogliani P, 2014, ACTA DIABETOL, V51, P933, DOI 10.1007/s00592-014-0584-0; Shih CJ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000771; Tay J, 2015, ANNU REV NUTR, V35, P389, DOI 10.1146/annurev-nutr-121214-104422; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; VRACKO R, 1979, AM REV RESPIR DIS, V120, P973; Walter RE, 2003, AM J RESP CRIT CARE, V167, P911, DOI 10.1164/rccm.2203022	42	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177184	10.1371/journal.pone.0177184	http://dx.doi.org/10.1371/journal.pone.0177184			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489885	Green Submitted, Green Published, gold			2022-12-26	WOS:000401314100053
J	Seher, A; Lagler, C; Stuhmer, T; Muller-Richter, UDA; Kubler, AC; Sebald, W; Muller, TD; Nickel, J				Seher, Axel; Lagler, Charlotte; Stuehmer, Thorsten; Mueller-Richter, Urs Dietmar Achim; Kuebler, Alexander Christian; Sebald, Walter; Mueller, Thomas Dieter; Nickel, Joachim			Utilizing BMP-2 muteins for treatment of multiple myeloma	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEINS; SMAD SIGNALING PATHWAY; ACTIVIN-A; INDUCE APOPTOSIS; RECEPTOR; CELLS; ANTAGONISTS; DIFFERENTIATION; EXPRESSION; DISEASE	Multiple myeloma (MM) represents a haematological cancer characterized by the pathological hyper proliferation of antibody-producing B-lymphocytes. Patients typically suffer from kidney malfunction and skeletal disorders. In the context of MM, the transforming growth factor beta (TGF beta) member Activin A was recently identified as a promoter of both accompanying symptoms. Because studies have shown that (b) under bar one (m) under bar orphogenetic (p) under bar rotein (BMP)2-mediated activities are counteracted by Activin A, we analysed whether BMP2, which also binds to the Activin A receptors ActRII and ActRIIB but activates the alternative SMAD-1/5/8 pathway, can be used to antagonize Activin A activities, such as in the context of MM. Therefore three BMP2 derivatives were generated with modified binding activities for the type II (ActRIIB) and/or type I receptor (BMPRIA) showing either increased or decreased BMP2 activity. In the context of MM these BMP2 muteins show two functionalities since they act as a) an anti-proliferative/apoptotic agent against neoplastic B-cells, b) as a bone-formation promoting growth factor. The molecular basis of both activities was shown in two different cellular models to clearly rely on the properties of the investigated BMP2 muteins to compete for the binding of Activin A to the Activin type II receptors. The experimental outcome suggests new therapeutic strategies using BMP2 variants in the treatment of MMrelated pathologies.	[Seher, Axel; Lagler, Charlotte; Mueller-Richter, Urs Dietmar Achim; Kuebler, Alexander Christian] Univ Hosp Wurzburg, Dept Oral & Maxillofacial Plast Surg, Wurzburg, Germany; [Stuehmer, Thorsten] Univ Hosp Wurzburg, Dept Internal Med 2, Wurzburg, Germany; [Sebald, Walter] Univ Wurzburg, Dept Physiol Chem 2, Theodor Boveri Inst, Bioctr, Wurzburg, Germany; [Mueller, Thomas Dieter] Univ Wurzburg, Dept Mol Plant Physiol & Biophys, Julius von Sachs Inst, Wurzburg, Germany; [Nickel, Joachim] Univ Hosp Wurzburg, Chair Tissue Engn & Regenerat Med, Wurzburg, Germany; [Nickel, Joachim] Fraunhofer IGB, Translat Ctr Wurzburg Regenerat Therapies Oncol &, Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg	Muller, TD (corresponding author), Univ Wurzburg, Dept Mol Plant Physiol & Biophys, Julius von Sachs Inst, Wurzburg, Germany.; Nickel, J (corresponding author), Univ Hosp Wurzburg, Chair Tissue Engn & Regenerat Med, Wurzburg, Germany.; Nickel, J (corresponding author), Fraunhofer IGB, Translat Ctr Wurzburg Regenerat Therapies Oncol &, Wurzburg, Germany.	mueller@botanik.uni-wuerzburg.de; joachim.nickel@uni-wuerzburg.de	DA Müller-Richter, Urs/P-5864-2014; Kübler, Alexander/ABA-9297-2021	DA Müller-Richter, Urs/0000-0001-7869-7686; Mueller, Thomas/0000-0003-1862-7357	Deutsche Forschungsgemeinschaft [KFO 216]; University of Wuerzburg (funding program Open Access Publishing)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Wuerzburg (funding program Open Access Publishing)	This work was supported by the Deutsche Forschungsgemeinschaft (KFO 216) and the University of Wuerzburg (funding program Open Access Publishing).	Albers CE, 2012, BONE, V51, P401, DOI 10.1016/j.bone.2012.06.020; Anguiano A, 2009, J CLIN ONCOL, V27, P4197, DOI 10.1200/JCO.2008.19.1916; Aykul S, 2016, J BIOL CHEM, V291, P10792, DOI 10.1074/jbc.M115.713487; Bergsagel PL, 2001, ONCOGENE, V20, P5611, DOI 10.1038/sj.onc.1204641; Chantry AD, 2010, J BONE MINER RES, V25, P2357, DOI 10.1002/jbmr.142; Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929; Choi YJ, 2012, MED ONCOL, V29, P582, DOI 10.1007/s12032-011-9852-9; DeLisi C, 1979, Cell Biophys, V1, P117; DELISI C, 1981, MOL IMMUNOL, V18, P507, DOI 10.1016/0161-5890(81)90128-0; DELISI C, 1981, NATURE, V289, P322, DOI 10.1038/289322a0; Dudaric L, 2013, COLLEGIUM ANTROPOL, V37, P1291; Fields SZ, 2013, EXPERT OPIN INV DRUG, V22, P87, DOI 10.1517/13543784.2013.738666; Fukuda N, 2006, ONCOGENE, V25, P3509, DOI 10.1038/sj.onc.1209393; Harousseau JL, 2009, NEW ENGL J MED, V360, P2645, DOI 10.1056/NEJMct0805626; Heinecke K, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-59; Holien T, 2012, LEUKEMIA, V26, P1073, DOI 10.1038/leu.2011.263; Katagiri T, 2013, BIOL CHEM, V394, P703, DOI 10.1515/hsz-2012-0310; Kawamura C, 2000, BLOOD, V96, P2005, DOI 10.1182/blood.V96.6.2005.h8002005a_2005_2011; Kawamura C, 2002, LEUKEMIA LYMPHOMA, V43, P635, DOI 10.1080/10428190290012182; Keller S, 2004, NAT STRUCT MOL BIOL, V11, P481, DOI 10.1038/nsmb756; Kirsch T, 2000, EMBO J, V19, P3314, DOI 10.1093/emboj/19.13.3314; Knight MN, 2013, ADV WOUND CARE, V2, P306, DOI 10.1089/wound.2012.0420; Longo V, 2012, CANCER TREAT REV, V38, P787, DOI 10.1016/j.ctrv.2012.03.004; McCormack N, 2013, CELL SIGNAL, V25, P2856, DOI 10.1016/j.cellsig.2013.09.012; Mueller TD, 2012, FEBS LETT, V586, P1846, DOI 10.1016/j.febslet.2012.02.043; Nickel J, 2009, CYTOKINE GROWTH F R, V20, P367, DOI 10.1016/j.cytogfr.2009.10.022; NISHIHARA T, 1993, BIOCHEM BIOPH RES CO, V197, P985, DOI 10.1006/bbrc.1993.2576; Olsen OE, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2014.16; Olsen OE, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0104-z; Park Y, 2010, MED ONCOL, V27, P1192, DOI 10.1007/s12032-009-9358-x; Piek E, 1999, J CELL PHYSIOL, V180, P141, DOI 10.1002/(SICI)1097-4652(199908)180:2<141::AID-JCP1>3.0.CO;2-I; Raje N, 2010, CURR OPIN MOL THER, V12, P586; Rajkumar SV, 2011, AM J HEMATOL, V86, P57, DOI 10.1002/ajh.21913; Ro TB, 2004, ONCOGENE, V23, P3024, DOI 10.1038/sj.onc.1207386; Ryoo HM, 2006, GENE, V366, P51, DOI 10.1016/j.gene.2005.10.011; Scullen T, 2013, LEUKEMIA, V27, P1715, DOI 10.1038/leu.2013.50; Sebald HJ, 2012, ACTA BIOMATER, V8, P3816, DOI 10.1016/j.actbio.2012.06.036; Seckinger A, 2009, ONCOGENE, V28, P3866, DOI 10.1038/onc.2009.257; Stuhmer T, 2010, BRIT J HAEMATOL, V149, P529, DOI 10.1111/j.1365-2141.2010.08126.x; Sugatani T, 2003, J CELL BIOCHEM, V90, P59, DOI 10.1002/jcb.10613; Terpos E, 2012, ANN ONCOL, V23, P2681, DOI 10.1093/annonc/mds068; URIST MR, 1979, P NATL ACAD SCI USA, V76, P1828, DOI 10.1073/pnas.76.4.1828; Vallet S, 2010, P NATL ACAD SCI USA, V107, P5124, DOI 10.1073/pnas.0911929107; Weber D, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-6; WIEGEL FW, 1982, AM J PHYSIOL, V243, pR475, DOI 10.1152/ajpregu.1982.243.5.R475; You LT, 2002, INVEST OPHTH VIS SCI, V43, P72; Yu Nicole Y C, 2012, Front Biosci (Elite Ed), V4, P2647; Zipori D, 2001, J LEUKOCYTE BIOL, V69, P867	48	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0174884	10.1371/journal.pone.0174884	http://dx.doi.org/10.1371/journal.pone.0174884			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489849	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314100004
J	Hagiwara, D; Sakai, K; Suzuki, S; Umemura, M; Nogawa, T; Kato, N; Osada, H; Watanabe, A; Kawamoto, S; Gonoi, T; Kamei, K				Hagiwara, Daisuke; Sakai, Kanae; Suzuki, Satoshi; Umemura, Myco; Nogawa, Toshihiko; Kato, Naoki; Osada, Hiroyuki; Watanabe, Akira; Kawamoto, Susumu; Gonoi, Tohru; Kamei, Katsuhiko			Temperature during conidiation affects stress tolerance, pigmentation, and trypacidin accumulation in the conidia of the airborne pathogen Aspergillus fumigatus	PLOS ONE			English	Article							BIOSYNTHESIS; MORPHOLOGY; VIRULENCE; PATHWAY; MELANIN; FUNGI; GENE	Asexual spores (conidia) are reproductive structures that play a crucial role in fungal distribution and survival. As fungal conidia are, in most cases, etiological agents of plant diseases and fungal lung disease, their stress resistance and interaction with their hosts have drawn increasing attention. In the present study, we investigated whether environmental temperature during conidiation affects the stress tolerance of the conidia of the human pathogenic fungus Aspergillus fumigatus. Conidia from a 25 degrees C culture showed a lower tolerance to heat (60 degrees C) and oxidative (H2O2) stresses and a marked resistance to ultraviolet radiation exposure, compared with those produced at 37 and 45 degrees C. The accumulation of trehalose was lower in the conidia from the 25 degrees C culture. Furthermore, the conidia from the 25 degrees C culture showed darker pigmentation and increased transcripts of dihydroxynaphthalene (DHN)melanin biosynthesis-related genes (i.e., pksP, arp1, and arp2). An RNA-sequencing analysis revealed that the transcription level of the trypacidin (tpc) gene cluster, which contains 13 genes, was sharply and coordinately activated in the conidia from the 25 degrees C culture. Accordingly, trypacidin was abundant in the conidia from the 25 degrees C culture, whereas there was little trypacidin in the conidia from the 37 degrees C culture. Taken together, these data show that the environmental temperature during conidiation affects conidial properties such as stress tolerance, pigmentation, and mycotoxin accumulation. To enhance our knowledge, we further explored the temperature-dependent production of DHN-melanin and trypacidin in clinical A. fumigatus isolates. Some of the isolates showed temperature-independent production of DHN-melanin and/or trypacidin, indicating that the conidia-associated secondary metabolisms differed among the isolates.	[Hagiwara, Daisuke; Sakai, Kanae; Watanabe, Akira; Kawamoto, Susumu; Gonoi, Tohru; Kamei, Katsuhiko] Chiba Univ, MMRC, Chuo Ku, 1-8-1 Inohana, Chiba, Japan; [Suzuki, Satoshi] Natl Food Res Inst, 2-1-12 Kan Nondai, Tsukuba, Ibaraki, Japan; [Umemura, Myco] Natl Inst Adv Ind Sci & Technol, Toyohira Ku, 17-2-1 Higashi Nijo, Sapporo, Hokkaido, Japan; [Nogawa, Toshihiko; Kato, Naoki; Osada, Hiroyuki] RIKEN, Ctr Sustainable Resource Sci, Wako, Saitama, Japan	Chiba University; National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan; National Institute of Advanced Industrial Science & Technology (AIST); RIKEN	Hagiwara, D (corresponding author), Chiba Univ, MMRC, Chuo Ku, 1-8-1 Inohana, Chiba, Japan.	dhagi@chiba-u.jp	Osada, Hiroyuki/AAY-6254-2020; Osada, Hiroyuki/N-4305-2014; Umemura, Maiko/M-4092-2018; gonoi, tohru/AAC-5181-2021; Hagiwara, Daisuke/A-3488-2016; Kato, Naoki/D-4018-2017; Nogawa, Toshihiko/ABG-2652-2020; , gonoi/GRS-0648-2022; Nogawa, Toshihiko/C-4095-2017	Umemura, Maiko/0000-0001-8730-1380; gonoi, tohru/0000-0003-3655-7911; Hagiwara, Daisuke/0000-0003-1382-3914; Kato, Naoki/0000-0003-4410-4090; , gonoi/0000-0003-3655-7911; Nogawa, Toshihiko/0000-0003-1270-5270	Noda Institute for Science Research; Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT) - MEXT, Japan; Agricultural chemical research foundation [1-328]; MEXT	Noda Institute for Science Research(Noda Institute for Scientific ResearchUemura Fund); Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT) - MEXT, Japan; Agricultural chemical research foundation(Agricultural Chemical Research Foundation, Japan); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the Noda Institute for Science Research to DH. This work was also supported in part by the Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT) Special Budget for Research Project: The Project on Controlling Aspergillosis and the Related Emerging Mycoses, a Cooperative Research Grant of NEKKEN (2013), the National Bio Resource project for Pathogenic Microbes funded by the MEXT, Japan (http://www.nbrp.jp/), the Agricultural chemical research foundation (1-328 to DH), and a Grant-in-Aid for Scientific Research from MEXT (to DH).	ABBAS HK, 1995, PHYTOPATHOLOGY, V85, P677, DOI 10.1094/Phyto-85-677; Al-Bader N, 2010, INFECT IMMUN, V78, P3007, DOI 10.1128/IAI.00813-09; BALAN J, 1963, J ANTIBIOT, V16, P157; Bertolini P, 1997, PLANT PATHOL, V46, P432, DOI 10.1046/j.1365-3059.1997.d01-24.x; Braga G, 2015, CURR GENET, V61, P405, DOI 10.1007/s00294-015-0483-0; d'Enfert C, 1999, MOL MICROBIOL, V32, P471, DOI 10.1046/j.1365-2958.1999.01327.x; Eisenman HC, 2012, APPL MICROBIOL BIOT, V93, P931, DOI 10.1007/s00253-011-3777-2; Fillinger S, 2001, MOL MICROBIOL, V39, P145, DOI 10.1046/j.1365-2958.2001.02223.x; Fuller KK, 2016, MBIO, V7, DOI [10.1128/mBio.01517-16, 10.1128/mbio.01517-16]; Gauthier T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029906; Geib E, 2016, CELL CHEM BIOL, V23, P587, DOI 10.1016/j.chembiol.2016.03.014; Hagiwara D, 2016, BIOSCI BIOTECH BIOCH, V80, P1667, DOI 10.1080/09168451.2016.1162085; Hagiwara D, 2014, FUNGAL GENET BIOL, V73, P138, DOI 10.1016/j.fgb.2014.10.011; Hagiwara D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080881; Heinekamp T, 2013, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00440; Hillmann F, 2015, ENVIRON MICROBIOL, V17, P2858, DOI 10.1111/1462-2920.12808; Jorgensen TR, 2011, FUNGAL GENET BIOL, V48, P544, DOI 10.1016/j.fgb.2011.01.005; Kowalski CH, 2016, MBIO, V7, DOI [10.1128/mBio.01515-16, 10.1128/mbio.01515-16]; Kwon-Chung KJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003743; Low SY, 2011, FUNGAL BIOL-UK, V115, P625, DOI 10.1016/j.funbio.2011.03.006; Mattern DJ, 2015, APPL MICROBIOL BIOT, V99, P10151, DOI 10.1007/s00253-015-6898-1; MISAGHI IJ, 1978, PHYTOPATHOLOGY, V68, P29, DOI 10.1094/Phyto-68-29; Osherov N, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00346; PHILLIPS DJ, 1982, PHYTOPATHOLOGY, V72, P1281, DOI 10.1094/Phyto-77-1281; Pihet M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-177; Rangel DEN, 2015, CURR GENET, V61, P383, DOI 10.1007/s00294-015-0477-y; Ruijter GJG, 2003, EUKARYOT CELL, V2, P690, DOI 10.1128/EC.2.4.690-698.2003; Sakamoto K, 2009, FUNGAL GENET BIOL, V46, P887, DOI 10.1016/j.fgb.2009.09.004; Sanchez JF, 2012, NAT PROD REP, V29, P351, DOI 10.1039/c2np00084a; Takahashi-Nakaguchi A, 2015, MED MYCOL, V53, P353, DOI 10.1093/mmy/myv003; Throckmorton K, 2016, ENVIRON MICROBIOL, V18, P246, DOI 10.1111/1462-2920.13007; Thywissen A, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00096; Tsai HF, 1998, J BACTERIOL, V180, P3031, DOI 10.1128/JB.180.12.3031-3038.1998; Umemura M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084028; Van Waeyenberghe L, 2013, ENV MICROBIOL REP, V5, P819, DOI 10.1111/1758-2229.12082; Volling K, 2011, CELL MICROBIOL, V13, P1130, DOI 10.1111/j.1462-5822.2011.01605.x; Wyatt TT, 2013, ADV APPL MICROBIOL, V85, P43, DOI 10.1016/B978-0-12-407672-3.00002-2	37	36	38	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177050	10.1371/journal.pone.0177050	http://dx.doi.org/10.1371/journal.pone.0177050			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486558	gold, Green Submitted, Green Published			2022-12-26	WOS:000401314000039
J	Verwaaijen, B; Wibberg, D; Krobber, M; Winkler, A; Zrenner, R; Bednarz, H; Niehaus, K; Grosch, R; Puhler, A; Schluter, A				Verwaaijen, Bart; Wibberg, Daniel; Kroebber, Magdalena; Winkler, Anika; Zrenner, Rita; Bednarz, Hanna; Niehaus, Karsten; Grosch, Rita; Puehler, Alfred; Schlueter, Andreas			The Rhizoctonia solani AG1-IB (isolate 7/3/14) transcriptome during interaction with the host plant lettuce (Lactuca sativa L.)	PLOS ONE			English	Article							CYANOVIRIN-N; SEQUENCE; PROTEIN; PATHOGEN; LECTIN; VISUALIZATION; ESTABLISHMENT; INFECTION; ALIGNMENT; TOXINS	The necrotrophic pathogen Rhizoctonia solani is one of the most economically important soil-borne pathogens of crop plants. Isolates of R. solani AG1-IB are the major pathogens responsible for bottom-rot of lettuce (Lactuca sativa L.) and are also responsible for diseases in other plant species. Currently, there is lack of information regarding the molecular responses in R. solani during the pathogenic interaction between the necrotrophic soilborne pathogen and its host plant. The genome of R. solani AG1-IB (isolate 7/3/14) was recently established to obtain insights into its putative pathogenicity determinants. In this study, the transcriptional activity of R. solani AG1-IB was followed during the course of its pathogenic interaction with the host plant lettuce under controlled conditions. Based on visual observations, three distinct pathogen-host interaction zones on lettuce leaves were defined which covered different phases of disease progression on tissue inoculated with the AG1-IB (isolate 7/3/14). The zones were defined as: Zone 1-symptomless, Zone 2-light brown discoloration, and Zone 3-dark brown, necrotic lesions. Differences in R. solani hyphae structure in these three zones were investigated by microscopic observation. Transcriptional activity within these three interaction zones was used to represent the course of R. solani disease progression applying high-throughput RNA sequencing (RNA-Seq) analysis of samples collected from each Zone. The resulting three transcriptome data sets were analyzed for their highest expressed genes and for differentially transcribed genes between the respective interaction zones. Among the highest expressed genes was a group of not previously described genes which were transcribed exclusively during early stages of interaction, in Zones 1 and 2. Previously described importance of up-regulation in R. solani agglutinin genes during disease progression could be further confirmed; here, the corresponding genes exhibited extremely high transcription levels. Most differentially higher expressed transcripts were found within Zone 2. In Zone 3, the zone with the strongest degree of interaction, gene transcripts indicative of apoptotic activity were highly abundant. The transcriptome data presented in this work support previous models of the disease and interaction cycle of R. solani and lettuce and may influence effective techniques for control of this pathogen.	[Verwaaijen, Bart; Wibberg, Daniel; Kroebber, Magdalena; Winkler, Anika; Bednarz, Hanna; Niehaus, Karsten; Puehler, Alfred; Schlueter, Andreas] Bielefeld Univ, Ctr Biotechnol, Bielefeld, Germany; [Verwaaijen, Bart; Zrenner, Rita; Grosch, Rita] Leibniz Inst Vegetable & Ornamental Crops IGZ, Grossbeeren, Germany	University of Bielefeld; Leibniz Institut fur Gemuse- und Zierpflanzenbau (IGZ)	Schluter, A (corresponding author), Bielefeld Univ, Ctr Biotechnol, Bielefeld, Germany.	aschluet@cebitec.uni-bielefeld.de	Zrenner, Rita/A-1593-2012; Grosch, Rita/HHM-5490-2022	Zrenner, Rita/0000-0002-1563-8942; Schluter, Andreas/0000-0003-4830-310X; Puhler, Alfred/0000-0003-4723-2960; Grosch, Rita/0000-0002-7179-5715	CUB Graduate Cluster 'Industrial Biotechnology'; Ministry of Innovation of North Rhine-Westphalia, Germany; Federal Ministry of Education and Research (BMBF) of the BonaRes program [FKZ 031A560D]; Resource Center for Microbial Bioinformatics BiGi within the German Network for Bioinformatics Infrastructure (de.NBI) [031A533]	CUB Graduate Cluster 'Industrial Biotechnology'; Ministry of Innovation of North Rhine-Westphalia, Germany; Federal Ministry of Education and Research (BMBF) of the BonaRes program(Federal Ministry of Education & Research (BMBF)); Resource Center for Microbial Bioinformatics BiGi within the German Network for Bioinformatics Infrastructure (de.NBI)	B.V. and D.W. acknowledge the receipt of a scholarship from the CUB Graduate Cluster 'Industrial Biotechnology', cofinanced by the Ministry of Innovation of North Rhine-Westphalia, Germany. A.S. acknowledges funding by the Federal Ministry of Education and Research (BMBF) in the frame of the BonaRes program (DiControl project: FKZ 031A560D). A.P. gratefully acknowledges funding by the Resource Center for Microbial Bioinformatics BiGi (Grant number 031A533) within the German Network for Bioinformatics Infrastructure (de.NBI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akileswaran L, 1999, APPL ENVIRON MICROB, V65, P415; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; ARMSTRONG JL, 1985, J BACTERIOL, V161, P39, DOI 10.1128/JB.161.1.39-46.1985; Bannwarth M, 2004, BIOCHEMISTRY-US, V43, P11683, DOI 10.1021/bi048609q; Blancard D, 2006, COLOR ATLAS DIS LETT; Boenisch MJ, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-110; Boyd MR, 1997, ANTIMICROB AGENTS CH, V41, P1521, DOI 10.1128/AAC.41.7.1521; Candy L, 2001, BIOCHEM BIOPH RES CO, V282, P655, DOI 10.1006/bbrc.2001.4626; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Davis R.M., 1997, STEMPHYLIUM LEAF SPO; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Friesen TL, 2008, CELL MICROBIOL, V10, P1421, DOI 10.1111/j.1462-5822.2008.01153.x; Garcia VG, 2006, SPAN J AGRIC RES, V4, P55; GOODWIN DC, 1995, BIOCHEMISTRY-US, V34, P5060, DOI 10.1021/bi00015a017; Grosch R, 2004, EUR J PLANT PATHOL, V110, P53, DOI 10.1023/B:EJPP.0000010137.69498.10; Hamshou M, 2010, FUNGAL BIOL-UK, V114, P34, DOI 10.1016/j.mycres.2009.10.002; Hamshou M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033680; Hilker R, 2016, BIOINFORMATICS; Hilker R, 2014, BIOINFORMATICS, V30, P2247, DOI 10.1093/bioinformatics/btu205; Justesen A, 1996, GENE, V170, P131, DOI 10.1016/0378-1119(95)00875-6; Kadow KJ, 1937, DAMPING CONTROL EVAL; KELLENS JTC, 1990, J GEN MICROBIOL, V136, P2489, DOI 10.1099/00221287-136-12-2489; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Koharudin LMI, 2008, STRUCTURE, V16, P570, DOI 10.1016/j.str.2008.01.015; Konopka JB, 2012, SCIENTIFICA, V2012, P631, DOI DOI 10.6064/2012/489208; Kwon SJ, 2009, PLANT J, V58, P235, DOI 10.1111/j.1365-313X.2008.03772.x; Lakshman DK, 2008, MYCOLOGIA, V100, P867, DOI 10.3852/08-065; Laluk Kristin, 2010, Arabidopsis Book, V8, pe0136, DOI 10.1199/tab.0136; Lazzari B, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S1-S13; Liu TB, 2009, J ZHEJIANG UNIV-SC B, V10, P434, DOI 10.1631/jzus.B0920017; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Oh IS, 2005, PLANT CELL, V17, P2832, DOI 10.1105/tpc.105.034819; Paulsrud P, 2002, APPL ENVIRON MICROB, V68, P2036, DOI 10.1128/AEM.68.4.2036-2039.2002; Pearson WR, 1997, GENOMICS, V46, P24, DOI 10.1006/geno.1997.4995; Podobnik B, 2008, J MED CHEM, V51, P3480, DOI 10.1021/jm800030e; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Stodart BJ, 2007, MYCOL RES, V111, P891, DOI 10.1016/j.mycres.2007.05.008; Studier J, 1988, MOL BIOL EVOL; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Urban M, 2015, NUCLEIC ACIDS RES, V43, pD645, DOI 10.1093/nar/gku1165; van Driel KGA, 2008, EUKARYOT CELL, V7, P1865, DOI 10.1128/EC.00125-08; Veneault-Fourrey C, 2006, SCIENCE, V312, P580, DOI 10.1126/science.1124550; Walton JD, 1996, PLANT CELL, V8, P1723, DOI 10.1105/tpc.8.10.1723; Westermann AJ, 2012, NAT REV MICROBIOL, V10, P618, DOI 10.1038/nrmicro2852; Wibberg D, 2015, PLOS ONE, P1, DOI DOI 10.1371/JOURNAL.PONE.0144769; Wibberg D, 2014, FUNGAL BIOL-UK, V118, P800, DOI 10.1016/j.funbio.2014.06.007; Wibberg D, 2013, J BIOTECHNOL, V167, P142, DOI 10.1016/j.jbiotec.2012.12.010; Wu J, 2009, AUSTRALAS PLANT PATH, V38, P79, DOI 10.1071/AP08081; Wu ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-444; Xue CY, 2002, PLANT CELL, V14, P2107, DOI 10.1105/tpc.003426; Yang YQ, 2011, RICE SCI, V18, P297, DOI 10.1016/S1672-6308(12)60008-0; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479; Yoshimoto K, 2010, FEBS LETT, V584, P1350, DOI 10.1016/j.febslet.2010.01.007; Zheng AP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2427; Zhuang XF, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-668	55	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177278	10.1371/journal.pone.0177278	http://dx.doi.org/10.1371/journal.pone.0177278			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486484	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314000069
J	Watanabe, Y; Wakayoshi, K; Nomura, T				Watanabe, Yasunori; Wakayoshi, Kohji; Nomura, Teruo			New evaluation index for the retainability of a swimmer's horizontal posture	PLOS ONE			English	Article							COMPETITIVE SWIMMERS; WET SUIT; BUOYANCY; VOLUME; DRAG	This study aims to investigate the effect of changes in buoyancy when a swimmer respires in a horizontal posture. We attempted to evaluate the levelness of swimmers' streamline posture by simultaneously measuring the lung capacity and buoyancy under water. The buoyancy was measured based on the changes in the vertical loads of the upper and lower limbs on the subjects' streamline posture under water. The horizontal x-axis as lung ventilation and the vertical y-axis as buoyancy forms a linear equation y = ax + b. The relation between hand (upper-limb) buoyancy and lung ventilation is defined as y = a1x + b1 and that between foot (lower-limb) buoyancy and lung ventilation as y = a2x + b2. Horizontal levelness was calculated as a ratio by dividing a2 by a1 using the inclination (a) values from these formulas for an underwater streamline posture. We defined this ratio as the breathing-balance (BB) ratio. Although the performance levels in the present study did not show any difference in the absolute quantity of air that humans can inhale in a streamline posture, the BB ratio was higher in a statistically significant manner in junior swimmers competing at international levels compared with the other groups of subjects (P < 0.001). This statistical difference in horizontal levelness, despite the absence of a noticeable difference in the absolute quantity of inhaled air, may be attributable to the way in which each person inhales and exhales air. Top-level junior swimmers that exhibited a high BB ratio might have inhaled in a way that would counteract the sinking of the lower limbs, for example, through abdominal respiration. When exhaling, on the other hand, they might have let out air gradually to mitigate the acceleration force involved in submerging the lower limbs.	[Watanabe, Yasunori] Sendai Univ, Fac Sports Sci, Sendai, Miyagi, Japan; [Wakayoshi, Kohji] Osaka Univ Econ, Fac Human Sci, Osaka, Japan; [Nomura, Teruo] Kyoto Inst Technol, Grad Sch Sci & Technol, Kyoto, Japan	Kyoto Institute of Technology	Watanabe, Y (corresponding author), Sendai Univ, Fac Sports Sci, Sendai, Miyagi, Japan.	ysn-watanabe@sendai-u.ac.jp			JSPS [JP23500761]; KOZUKI FOUNDATION	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); KOZUKI FOUNDATION	This work was supported by JSPS Grant-in-Aid for Scientific Research C Grant Number JP23500761 (http://www.jsps.go.jp/english/e-grants/index.html) and KOZUKI FOUNDATION (http://www.kozuki-foundation.or.jp/jigyou/index-e.html).; We would like to thank Dr. Hideki Takagi, Professor of University of Tsukuba, for detailed comments, suggestions, and constant support. This work was supported by JSPS Grant-in-Aid for Scientific Research C Grant Number JP23500761 and KOZUKI FOUNDATION.	CAPELLI C, 1995, J APPL PHYSIOL, V78, P674, DOI 10.1152/jappl.1995.78.2.674; Carmody JF, 1965, NZ J PHYSICAL ED, V37, P15; Carter JEL, 1955, NZ J PHYS ED, V6, P14; Carter JEL, 1956, NZ J PHYSICAL ED, V8, P9; CHATARD JC, 1995, MED SCI SPORT EXER, V27, P580; Cordain L, 1991, Br J Sports Med, V25, P31; Cureton TK, 1933, BEACH POOL, V7, P282; GAGNON M, 1981, J BIOMECH, V14, P235, DOI 10.1016/0021-9290(81)90068-3; Hay JG, 1993, BIOMECHANICS SPORTS, V4th; Konin JG, 2005, ATHLETIC THERAPY TOD, V10, P30; Lynch SS, 2010, BRIT J SPORT MED, V44, P376, DOI 10.1136/bjsm.2009.066837; McLean SP, 1998, J SPORT SCI, V16, P373, DOI 10.1080/02640419808559365; McLean SP, 2000, RES Q EXERCISE SPORT, V71, P182, DOI 10.1080/02701367.2000.10608896; Nakashima M., 2007, J FLUID SCI TECHNOL, V2, P290, DOI [10.1299/jfst.2.290, DOI 10.1299/JFST.2.290, DOI 10.1299/jfst.2.290]; Rork R, 1937, RES QUART, V8, P19, DOI 10.1080/23267402.1937.10761845; TOUSSAINT HM, 1989, MED SCI SPORT EXER, V21, P325; Watanabe Y, 2014, SPORT MONT, V12, P98; Yanai T, 2004, J BIOMECH, V37, P605, DOI 10.1016/j.jbiomech.2003.10.004; Yanai T, 2001, J BIOMECH, V34, P235, DOI 10.1016/S0021-9290(00)00186-X; Zamparo P, 1996, EUR J APPL PHYSIOL O, V73, P195, DOI 10.1007/BF02425476	20	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177368	10.1371/journal.pone.0177368	http://dx.doi.org/10.1371/journal.pone.0177368			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486565	Green Submitted, Green Published, gold			2022-12-26	WOS:000401314000076
J	Chen, YH; Lee, YC; Tsai, YS; Guo, YC; Hsiao, CT; Tsai, PC; Huang, JA; Liao, YC; Soong, BW				Chen, Ying-Hao; Lee, Yi-Chung; Tsai, Yu-Shuen; Guo, Yuh-Cherng; Hsiao, Cheng-Tsung; Tsai, Pei-Chien; Huang, Jin-An; Liao, Yi-Chu; Soong, Bing-Wen			Unmasking adrenoleukodystrophy in a cohort of cerebellar ataxia	PLOS ONE			English	Article							X-LINKED ADRENOLEUKODYSTROPHY; LATE-ONSET CEREBELLAR; ABCD1 GENE MUTATION; SPINOCEREBELLAR DEGENERATION; MISSENSE MUTATIONS; VARIANT; MRI; PROGRESSION; DIAGNOSIS; FORM	Adrenoleukodystrophy (ALD) is a rare and progressive neurogenetic disease that may manifest disparate symptoms. The present study aims at investigating the role of ataxic variant of ALD (AVALD) in patients with adult-onset cerebellar ataxia, as well as characterizing their clinical features that distinguish AVALD from other cerebellar ataxias. Mutations in the ATP binding cassette subfamily D member 1 gene (ABCD1) were ascertained in 516 unrelated patients with ataxia. The patients were categorized into three groups: molecularly unassigned hereditary ataxia (n = 118), sporadic ataxia with autonomic dysfunctions (n = 296), and sporadic ataxia without autonomic dysfunctions (n = 102). Brain MRIs were scrutinized for white matter hyperintensity (WMH) in the parieto-occipital lobes, frontal lobes, corticospinal tracts, pons, middle cerebellar peduncles and cerebellar hemispheres. Two ABCD1 mutations (p.S108L and p.P623fs) previously linked to cerebral ALD and adrenomyelo-neuropathy but not AVALD were identified. ALD accounts for 0.85% (1/118) of the patients with molecularly unassigned hereditary ataxia and 0.34% (1/296) of the patients with sporadic ataxia with autonomic dysfunctions. WMH in the corticospinal tracts and WMH in the cerebellar hemispheres were strongly associated with AVALD rather than other ataxias. To conclude, ALD accounts for approximately 0.39% (2/516) of adult-onset cerebellar ataxias. This study expands the mutational spectrum of AVALD and underscores the importance of considering ALD as a potential etiology of cerebellar ataxia.	[Chen, Ying-Hao; Lee, Yi-Chung; Liao, Yi-Chu; Soong, Bing-Wen] Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan; [Chen, Ying-Hao; Lee, Yi-Chung; Hsiao, Cheng-Tsung; Tsai, Pei-Chien; Liao, Yi-Chu; Soong, Bing-Wen] Natl Yang Ming Univ, Sch Med, Dept Neurol, Taipei, Taiwan; [Lee, Yi-Chung; Tsai, Pei-Chien; Soong, Bing-Wen] Natl Yang Ming Univ, Brain Res Ctr, Taipei, Taiwan; [Tsai, Yu-Shuen] Natl Yang Ming Univ, Ctr Syst & Synthet Biol, Taipei, Taiwan; [Guo, Yuh-Cherng] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan; [Guo, Yuh-Cherng] China Med Univ Hosp, Dept Neurol, Taichung, Taiwan; [Guo, Yuh-Cherng] China Med Univ, Sch Med, Coll Med, Taichung, Taiwan; [Hsiao, Cheng-Tsung] Taipei Vet Gen Hosp, Div Neurol, Dept Internal Med, Taoyuan Branch, Taoyuan, Taiwan; [Hsiao, Cheng-Tsung] Natl Taiwan Univ, Grad Inst Physiol, Coll Med, Taipei, Taiwan; [Huang, Jin-An] Taichung Vet Gen Hosp, Neurol Inst, Taichung, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Taipei Veterans General Hospital; National Taiwan University; Taichung Veterans General Hospital	Liao, YC; Soong, BW (corresponding author), Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan.; Liao, YC; Soong, BW (corresponding author), Natl Yang Ming Univ, Sch Med, Dept Neurol, Taipei, Taiwan.; Soong, BW (corresponding author), Natl Yang Ming Univ, Brain Res Ctr, Taipei, Taiwan.	ycliao5@vghtpe.gov.tw; bwsoong@ym.edu.tw	Lee, Yi-Chung/GZK-7162-2022	Tsai, Pei-Chien/0000-0001-7303-0516; Liao, Yi-Chu/0000-0002-9644-2086; Lee, Yi-Chung/0000-0003-0102-164X; Huang, Jin-An/0000-0003-1275-059X	Ministry of Science & Technology, Taiwan, ROC [NSC102-2628-B-075-006-MY3, NSC103-2314-B-75-076-MY3, MOST 103-2314-B-010-049-MY3, MOST 104-2314-B-075-045-MY4]; Brain Research Center, National Yang-Ming University [104AC-B19]; High-Throughput Genome Analysis Core Facility and Bioinformatics Consortium of Taiwan of the National Core Facility Program for Biotechnology, Taiwan [NSC 101-2319-B-010-001]; Taipei Veterans General Hospital [V103C-109, V104C-061, V104C-079, V104E9-006, V105C-118, V105C-048]; Taiwan Ataxia Association; Hsu Tsung Pei Medical Research Fund	Ministry of Science & Technology, Taiwan, ROC; Brain Research Center, National Yang-Ming University; High-Throughput Genome Analysis Core Facility and Bioinformatics Consortium of Taiwan of the National Core Facility Program for Biotechnology, Taiwan; Taipei Veterans General Hospital(Taipei Veterans General Hospital); Taiwan Ataxia Association; Hsu Tsung Pei Medical Research Fund	The research was supported by grants from the Ministry of Science & Technology, Taiwan, ROC (NSC102-2628-B-075-006-MY3, NSC103-2314-B-75-076-MY3 and MOST 103-2314-B-010-049-MY3, MOST 104-2314-B-075-045-MY4), the Brain Research Center, National Yang-Ming University (104AC-B19), the High-Throughput Genome Analysis Core Facility and Bioinformatics Consortium of Taiwan of the National Core Facility Program for Biotechnology, Taiwan (NSC 101-2319-B-010-001), and Taipei Veterans General Hospital (V103C-109, V104C-061, V104C-079, V104E9-006, V105C-118 and V105C-048), as well as research funds supported by the Taiwan Ataxia Association and the Hsu Tsung Pei Medical Research Fund.	Abele M, 2002, BRAIN, V125, P961, DOI 10.1093/brain/awf107; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Asheuer M, 2005, HUM MOL GENET, V14, P1293, DOI 10.1093/hmg/ddi140; Brusse E, 2007, CLIN GENET, V71, P12, DOI 10.1111/j.1399-0004.2006.00722.x; Burk K, 2005, ARCH NEUROL-CHICAGO, V62, P981, DOI 10.1001/archneur.62.6.981; Dunne E, 1999, ANN NEUROL, V45, P652, DOI 10.1002/1531-8249(199905)45:5<652::AID-ANA14>3.0.CO;2-M; Elenein RA, 2013, NEUROLOGY, V80, pE69, DOI 10.1212/WNL.0b013e3182815416; Fogel BL, 2006, NAT CLIN PRACT NEURO, V2, P629, DOI 10.1038/ncpneuro0319; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Guo YC, 2014, NEUROLOGY, V83, P1554, DOI 10.1212/WNL.0000000000000909; Jayadev S, 2013, GENET MED, V15, P673, DOI 10.1038/gim.2013.28; Jung S, 2009, J MOV DISORD, V2, P91, DOI 10.14802/jmd.09025; Kang JW, 2014, YONSEI MED J, V55, P1157, DOI 10.3349/ymj.2014.55.4.1157; Kano S, 1998, J NEUROL SCI, V158, P187, DOI 10.1016/S0022-510X(98)00120-8; Kemp S, 2001, HUM MUTAT, V18, P499, DOI 10.1002/humu.1227; Kim JE, 2012, PARKINSONISM RELAT D, V18, P210, DOI 10.1016/j.parkreldis.2011.06.005; Klockgether T, 2010, LANCET NEUROL, V9, P94, DOI 10.1016/S1474-4422(09)70305-9; Ko CY, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.09.017; Kumar N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025094; KUSAKA H, 1992, J NEUROL, V239, P307, DOI 10.1007/BF00867585; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee YC, 2009, EUR J NEUROL, V16, P513, DOI 10.1111/j.1468-1331.2008.02524.x; Lee YC, 2016, NEUROL-GENET, V2, DOI 10.1212/NXG.0000000000000068; Li JY, 2010, J NEUROL SCI, V290, P163, DOI 10.1016/j.jns.2009.12.002; Loes DJ, 2003, NEUROLOGY, V61, P369, DOI 10.1212/01.WNL.0000079050.91337.83; Manto M, 2009, CURR OPIN NEUROL, V22, P419, DOI 10.1097/WCO.0b013e32832b9897; MARSDEN CD, 1982, NEUROLOGY, V32, P1031, DOI 10.1212/WNL.32.9.1031; Matsukawa T, 2011, NEUROGENETICS, V12, P41, DOI 10.1007/s10048-010-0253-6; Mishra S, 2006, NEUROL INDIA, V54, P195; MIYAI I, 1990, J NEUROL NEUROSUR PS, V53, P623, DOI 10.1136/jnnp.53.7.623-a; Moseley ML, 1998, NEUROLOGY, V51, P1666, DOI 10.1212/WNL.51.6.1666; Moser HW, 2007, NAT CLIN PRACT NEURO, V3, P140, DOI 10.1038/ncpneuro0421; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; Ochi H, 1996, Rinsho Shinkeigaku, V36, P1229; Ochi K, 1998, AM J NEURORADIOL, V19, P1904; Ogaki K, 2016, NEUROPATHOLOGY, V36, P64, DOI 10.1111/neup.12230; Park HJ, 2014, YONSEI MED J, V55, P676, DOI 10.3349/ymj.2014.55.3.676; Patel K, 2008, INT J INFECT DIS, V12, pE111, DOI 10.1016/j.ijid.2008.03.006; Perusi C, 1999, MOL CELL PROBE, V13, P179, DOI 10.1006/mcpr.1999.0232; Ramirez-Zamora A, 2015, MOVEMENT DISORD, V30, P614, DOI 10.1002/mds.26158; Ruano L, 2014, NEUROEPIDEMIOLOGY, V42, P174, DOI 10.1159/000358801; Schiffmann R, 2009, NEUROLOGY, V72, P750, DOI 10.1212/01.wnl.0000343049.00540.c8; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Soong BW, 2001, ARCH NEUROL-CHICAGO, V58, P1105, DOI 10.1001/archneur.58.7.1105; Suda S, 2006, NEUROLOGY, V66, P144, DOI 10.1212/01.wnl.0000191329.34585.15; Suzuki Y, 2005, BRAIN DEV-JPN, V27, P353, DOI 10.1016/j.braindev.2004.09.008; Tan EK, 1999, CLIN NEUROL NEUROSUR, V101, P137, DOI 10.1016/S0303-8467(99)00028-1; Vianello M, 2005, EUR J NEUROL, V12, P912, DOI 10.1111/j.1468-1331.2005.01134.x; Watanabe H, 2002, BRAIN, V125, P1070, DOI 10.1093/brain/awf117; Wiesinger C, 2015, APPL CLIN GENET, V8, P109, DOI 10.2147/TACG.S49590; Yabe I, 2006, J NEUROL SCI, V249, P115, DOI 10.1016/j.jns.2006.05.064	51	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177296	10.1371/journal.pone.0177296	http://dx.doi.org/10.1371/journal.pone.0177296			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481932	Green Published, gold, Green Submitted			2022-12-26	WOS:000401313700051
J	Lokhandwala, S; Waghela, SD; Bray, J; Sangewar, N; Charendoff, C; Martin, CL; Hassan, WS; Koynarski, T; Gabbert, L; Burrage, TG; Brake, D; Neilan, J; Mwangi, W				Lokhandwala, Shehnaz; Waghela, Suryakant D.; Bray, Jocelyn; Sangewar, Neha; Charendoff, Chloe; Martin, Cameron L.; Hassan, Wisam S.; Koynarski, Tsvetoslav; Gabbert, Lindsay; Burrage, Thomas G.; Brake, David; Neilan, John; Mwangi, Waithaka			Adenovirus-vectored novel African Swine Fever Virus antigens elicit robust immune responses in swine	PLOS ONE			English	Article							PROTEIN; ANTIBODY; CHALLENGE; IMMUNIZATION; REPLICATION; HOMOLOG; P-30; CD2V; PIGS; P54	African Swine Fever Virus (ASFV) is a high-consequence transboundary animal pathogen that often causes hemorrhagic disease in swine with a case fatality rate close to 100%. Lack of treatment or vaccine for the disease makes it imperative that safe and efficacious vaccines are developed to safeguard the swine industry. In this study, we evaluated the immunogenicity of seven adenovirus-vectored novel ASFV antigens, namely A151R, B119L, B602L, EP402R.PRR, B438L, K205R and A104R. Immunization of commercial swine with a cocktail of the recombinant adenoviruses formulated in adjuvant primed strong ASFV antigen-specific IgG responses that underwent rapid recall upon boost. Notably, most vaccinees mounted robust IgG responses against all the antigens in the cocktail. Most importantly and relevant to vaccine development, the induced antibodies recognized viral proteins from Georgia 2007/1 ASFV-infected cells by IFA and by western blot analysis. The recombinant adenovirus cocktail also induced ASFV-specific IFN-Y-secreting cells that were recalled upon boosting. Evaluation of local and systemic effects of the recombinant adenovirus cocktail post-priming and post-boosting in the immunized animals showed that the immunogen was well tolerated and no serious negative effects were observed. Taken together, these outcomes showed that the adenovirus-vectored novel ASFV antigen cocktail was capable of safely inducing strong antibody and IFN-Y+ cell responses in commercial swine. The data will be used for selection of antigens for inclusion in a multi-antigen prototype vaccine to be evaluated for protective efficacy.	[Lokhandwala, Shehnaz; Waghela, Suryakant D.; Bray, Jocelyn; Sangewar, Neha; Charendoff, Chloe; Martin, Cameron L.; Hassan, Wisam S.; Mwangi, Waithaka] Texas A&M Univ, Dept Vet Pathobiol, College Stn, TX 77843 USA; [Koynarski, Tsvetoslav] Trakia Univ, Dept Anim Genet, Stara Zagora, Bulgaria; [Gabbert, Lindsay; Burrage, Thomas G.; Brake, David; Neilan, John] US Dept Homeland Secur, Plum Isl Anim Dis Ctr, Sci & Technol Directorate, Greenport, NY USA; [Lokhandwala, Shehnaz; Mwangi, Waithaka] Kansas State Univ, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA	Texas A&M University System; Texas A&M University College Station; Trakia University; Kansas State University	Lokhandwala, S; Mwangi, W (corresponding author), Texas A&M Univ, Dept Vet Pathobiol, College Stn, TX 77843 USA.; Lokhandwala, S; Mwangi, W (corresponding author), Kansas State Univ, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA.	shehnaz@vet.k-state.edu; wmwangi@vet.k-state.edu	Hassan, Wisam Salim/AFV-0948-2022; Koynarski, Tsvetoslav V/E-4800-2012	Hassan, Wisam Salim/0000-0001-8120-5224; Lokhandwala, Shehnaz/0000-0002-0873-8611	U. S. National Pork Board Award [13-176]	U. S. National Pork Board Award	This work was funded by U. S. National Pork Board Award # 13-176. Recipients: WM, SW, SL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argilaguet JM, 2013, ANTIVIR RES, V98, P61, DOI 10.1016/j.antiviral.2013.02.005; Argilaguet JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040942; Borca MV, 1996, ARCH VIROL, V141, P301, DOI 10.1007/BF01718401; Cobbold C, 2001, J VIROL, V75, P7221, DOI 10.1128/JVI.75.16.7221-7229.2001; Costard S, 2009, PHILOS T R SOC B, V364, P2683, DOI 10.1098/rstb.2009.0098; Epifano C, 2006, J VIROL, V80, P11456, DOI 10.1128/JVI.01468-06; Epifano C, 2006, J VIROL, V80, P12260, DOI 10.1128/JVI.01323-06; Escribano JM, 2013, VIRUS RES, V173, P101, DOI 10.1016/j.virusres.2012.10.012; Gomez-Puertas P, 1998, VIROLOGY, V243, P461, DOI 10.1006/viro.1998.9068; Grubman MJ, 2012, FUTURE VIROL, V7, P767, DOI 10.2217/FVL.12.65; Gutierrez-Castaneda B, 2008, ARCH VIROL, V153, P2303, DOI 10.1007/s00705-008-0246-z; Kamen A, 2004, J GENE MED, V6, pS184, DOI 10.1002/jgm.503; Kay-Jackson PC, 2004, J GEN VIROL, V85, P119, DOI 10.1099/vir.0.19435-0; Keita D, 2010, ANTIVIR THER, V15, P727, DOI 10.3851/IMP1593; Lacasta A, 2014, J VIROL, V88, P13322, DOI 10.1128/JVI.01893-14; Lewis T, 2000, J VIROL, V74, P1275, DOI 10.1128/JVI.74.3.1275-1285.2000; Lokhandwala S, 2016, CLIN VACCINE IMMUNOL; Malogolovkin A, 2015, J GEN VIROL, V96, P866, DOI [10.1099/jgv.0.000490, 10.1099/jgv.0.000024]; Mulumba-Mfumu LK, 2015, TRANSBOUND EMERG DIS; Mwangi W, 2007, CLIN VACCINE IMMUNOL, V14, P304, DOI 10.1128/CVI.00363-06; Neilan JG, 2004, VIROLOGY, V319, P337, DOI 10.1016/j.virol.2003.11.011; O'Donnell V, 2015, J VIROL; ONISK DV, 1994, VIROLOGY, V198, P350, DOI 10.1006/viro.1994.1040; Patch JR, 2011, CLIN VACCINE IMMUNOL, V18, P280, DOI 10.1128/CVI.00417-10; Reis AL, 2007, J GEN VIROL, V88, P2426, DOI 10.1099/vir.0.82857-0; Rodriguez I, 2006, J VIROL, V80, P3157, DOI 10.1128/JVI.80.7.3157-3166.2006; RODRIGUEZ JM, 1993, J VIROL, V67, P5312; SCHLAFER DH, 1984, AM J VET RES, V45, P1361; SCOTT G.R, 1957, EAST AFRICAN AGRIC JOUR, V22, P168; Tatsis N, 2004, MOL THER, V10, P616, DOI 10.1016/j.ymthe.2004.07.013	30	32	43	6	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e177007	10.1371/journal.pone.0177007	http://dx.doi.org/10.1371/journal.pone.0177007			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481911	Green Submitted, gold, Green Published			2022-12-26	WOS:000401313700028
J	Lubitz, C; Ali, A; Zhan, TN; Heberle, C; White, C; Ito, Y; Miyauchi, A; Gazelle, GS; Kong, CY; Hur, C				Lubitz, Carrie; Ali, Ayman; Zhan, Tiannan; Heberle, Curtis; White, Craig; Ito, Yasuhiro; Miyauchi, Akira; Gazelle, G. Scott; Kong, Chung Yin; Hur, Chin			The thyroid cancer policy model: A mathematical simulation model of papillary thyroid carcinoma in The US population	PLOS ONE			English	Article							SONOGRAPHIC FEATURES; ACTIVE SURVEILLANCE; TUMOR SIZE; MICROCARCINOMA; RISK; NODULES; SURGERY	Background Thyroid cancer affects over 1/2 million people in the U.S. and the incidence of thyroid cancer has increased worldwide at a rate higher than any other cancer, while survival has remained largely unchanged. The aim of this research was to develop, calibrate and verify a mathematical disease model to simulate the natural history of papillary thyroid cancer, which will serve as a platform to assess the effectiveness of clinical and cancer control interventions. Methods Herein, we modeled the natural pre-clinical course of both benign and malignant thyroid nodules with biologically relevant health states from normal to detected nodule. Using established calibration techniques, optimal parameter sets for tumor growth characteristics, development rate, and detection rate were used to fit Surveillance Epidemiology and End Results (SEER) incidence data and other calibration targets. Results Model outputs compared to calibration targets demonstrating sufficient calibration fit and model validation are presented including primary targets of SEER incidence data and size distribution at detection of malignancy. Additionally, we show the predicted underlying benign and malignant prevalence of nodules in the population, the probability of detection based on size of nodule, and estimates of growth over time in both benign and malignant nodules. Conclusions This comprehensive model provides a dynamic platform employable for future comparative effectiveness research. Future model analyses will test and assess various clinical management strategies to improve patient outcomes related to thyroid cancer and optimize resource utilization for patients with thyroid nodules.	[Lubitz, Carrie; Ali, Ayman; Zhan, Tiannan; Heberle, Curtis; Kong, Chung Yin; Hur, Chin] Massachusetts Gen Hosp, Inst Technol Assessment, Boston, MA 02114 USA; [Lubitz, Carrie; Gazelle, G. Scott; Kong, Chung Yin; Hur, Chin] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Lubitz, Carrie] Massachusetts Gen Hosp, Dept Surg, Div Surg Oncol, Boston, MA 02114 USA; [White, Craig; Gazelle, G. Scott] Harvard Univ, PhD Program Hlth Policy, Grad Sch Arts & Sci, Cambridge, MA 02138 USA; [Ito, Yasuhiro; Miyauchi, Akira] Kuma Hosp, Dept Surg, Kobe, Hyogo, Japan; [Gazelle, G. Scott] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Hur, Chin] Massachusetts Gen Hosp, Dept Med, Div Gastroenterol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Kuma Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Lubitz, C (corresponding author), Massachusetts Gen Hosp, Inst Technol Assessment, Boston, MA 02114 USA.; Lubitz, C (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA.; Lubitz, C (corresponding author), Massachusetts Gen Hosp, Dept Surg, Div Surg Oncol, Boston, MA 02114 USA.	clubitz@mgh.harvard.edu		Zhan, Tiannan/0000-0003-4691-5284; Ali, Ayman/0000-0002-2791-2793; Miyauchi, Akira/0000-0003-0041-197X; Hur, Chin/0000-0002-2819-7576	National Institutes of Health/National Cancer Institute [K07-CA177900]; The Claflin Foundation at Massachusetts General Hospital; American Thyroid Association/ThyCa Research; NATIONAL CANCER INSTITUTE [K07CA177900] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); The Claflin Foundation at Massachusetts General Hospital; American Thyroid Association/ThyCa Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by the National Institutes of Health/National Cancer Institute Grant (K07-CA177900, www.nihms.nih..gov/), The Claflin Foundation at Massachusetts General Hospital (www.ecor.mgh.harvard.edu), and the American Thyroid Association/ThyCa Research Grant (www. thyroid.org/professionals/research-grants/) for Dr. Carrie Lubitr. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HS, 2016, THYROID; Alexander EK, 2012, NEW ENGL J MED, V367, P705, DOI 10.1056/NEJMoa1203208; [Anonymous], 2016, NAT CANC I NAT I HLT; Applewhite MK, 2016, WORLD J SURG, V40, P551, DOI 10.1007/s00268-015-3300-5; Aschebrook-Kilfoy B, 2013, CANCER EPIDEM BIOMAR, V22, P1252, DOI 10.1158/1055-9965.EPI-13-0242; Benzekry S, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003800; BONDESON L, 1984, CANCER-AM CANCER SOC, V53, P1790, DOI 10.1002/1097-0142(19840415)53:8<1790::AID-CNCR2820530831>3.0.CO;2-9; Brito JP, 2016, THYROID, V26, P144, DOI 10.1089/thy.2015.0178; Chignola R, 2005, IEEE T BIO-MED ENG, V52, P808, DOI 10.1109/TBME.2005.845219; Control CfD, 2012, US LIF TABL 2012, P65; Davies L, 2014, JAMA OTOLARYNGOL, V140, P317, DOI 10.1001/jamaoto.2014.1; Durante C, 2015, JAMA-J AM MED ASSOC, V313, P926, DOI 10.1001/jama.2015.0956; FURMANCHUK AW, 1993, HISTOPATHOLOGY, V23, P319, DOI 10.1111/j.1365-2559.1993.tb01214.x; FURUYAKANAMORI L, 2016, J CLIN ONCOL; Giordano TJ, 2016, CURR OPIN ONCOL, V28, P1, DOI 10.1097/CCO.0000000000000248; Grogan RH, 2013, SURGERY, V154, P1436, DOI 10.1016/j.surg.2013.07.008; Gu WJ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000841; HARACH HR, 1985, CANCER-AM CANCER SOC, V56, P531, DOI 10.1002/1097-0142(19850801)56:3<531::AID-CNCR2820560321>3.0.CO;2-3; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; Hay ID, 2002, WORLD J SURG, V26, P879, DOI 10.1007/s00268-002-6612-1; Ito Y, 2003, THYROID, V13, P381, DOI 10.1089/105072503321669875; Ito Y, 2010, WORLD J SURG, V34, P2333, DOI 10.1007/s00268-010-0712-0; Kamran SC, 2013, J CLIN ENDOCR METAB, V98, P564, DOI 10.1210/jc.2012-2968; Lai XJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148567; Leboulleux S, 2016, LANCET DIABETES ENDO, V4, P933, DOI 10.1016/S2213-8587(16)30180-2; Lubitz CC, 2016, J MOL DIAGN, V18, P100, DOI 10.1016/j.jmoldx.2015.08.003; Lubitz CC, 2014, CANCER-AM CANCER SOC, V120, P1345, DOI 10.1002/cncr.28562; Mandel Susan J, 2004, Endocr Pract, V10, P246; Miyauchi A, 2016, WORLD J SURG, V40, P516, DOI 10.1007/s00268-015-3392-y; Pellegriti G, 2013, J CANCER EPIDEMIOL, V2013, DOI 10.1155/2013/965212; Popoveniuc G, 2012, MED CLIN N AM, V96, P329, DOI 10.1016/j.mcna.2012.02.002; Ramsey S, 2013, HEALTH AFFAIR, V32, P1143, DOI 10.1377/hlthaff.2012.1263; Reiners C, 2004, THYROID, V14, P926, DOI 10.1089/thy.2004.14.926; Society AC, 2016, AM CANC SOC CANC FAC; Stout NK, 2009, PHARMACOECONOMICS, V27, P533, DOI 10.2165/11314830-000000000-00000; Sugitani I, 2010, WORLD J SURG, V34, P1222, DOI 10.1007/s00268-009-0359-x; Wang LY, 2015, CANCER-AM CANCER SOC, V121, P4132, DOI 10.1002/cncr.29633; Wang TS, 2014, WORLD J SURG, V38, P2297, DOI 10.1007/s00268-014-2602-3; Wylie D, 2016, J PATHOL CLIN RES, V2, P93, DOI 10.1002/cjp2.38; Zhou LG, 2015, J ULTRAS MED, V34, P1003, DOI 10.7863/ultra.34.6.1003	40	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177068	10.1371/journal.pone.0177068	http://dx.doi.org/10.1371/journal.pone.0177068			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481909	Green Submitted, Green Published, gold			2022-12-26	WOS:000401313700031
J	Wang, Y; Dai, W				Wang, Yan; Dai, Wu			Fine structure of mouthparts and feeding performance of Pyrrhocoris sibiricus Kuschakevich with remarks on the specialization of sensilla and stylets for seed feeding	PLOS ONE			English	Article							LABIAL TIP SENSILLA; STINK BUG; HETEROPTERA-PENTATOMIDAE; HEMIPTERA FULGOROMORPHA; ANTENNAL SENSILLA; SENSORY SYSTEMS; ULTRASTRUCTURE; MORPHOLOGY; BEHAVIOR; FOOD	Mouthpart structure and feeding behavior in the temperate firebug, Pyrrhocoris sibiricus Kuschakevich, an important pest that feeds on seeds of leguminous and gramineous plants, are described for the first time. Mouthparts were observed using scanning electron microscopy to examine the external morphology, distribution and abundance of sensilla on mouthparts. Feeding performance by adults on both seeds and shoots were observed using a binocular microscope. The four-segmented labium contains 3 types of sensilla trichodea, 3 types of sensilla basiconica, 1 type of sensilla placodea and 1 type of sensilla campaniformia. Among them, sensilla trichodea are most abundant. The tripartite apex of the labium consists of two lateral lobes and an apical plate. Each lateral lobe possesses a field of 12 thick-walled uniporous peg sensilla and long non-porous hair sensilla. The mandibular stylet tips have three central teeth and two pairs of lateral teeth, which may help in penetrating hard seed coats. A series of scale-like projections are present on the inner surface of the mandibular stylets. The externally smooth maxillary stylets interlock to form a larger food canal and a smaller salivary canal, and there are five tubercles near the tip of the right stylet. Cross-sections of the stylet fascicle show that each mandibular stylet has a dendritic canal. The adult feeding process involves several steps, including exploring and puncturing of the host epidermis, a probing phase, an engorgement phase, and removal of the mouthparts from the host tissue. The structure and function of the mouthparts are adapted for the seed feeding habits.	[Wang, Yan] Northwest A&F Univ, Coll Plant Protect, State Key Lab Crop Stress Biol Arid Areas, Yangling, Peoples R China; [Dai, Wu] Northwest A&F Univ, Key Lab Plant Protect Resources & Pest Integrated, Minist Educ, Coll Plant Protect, Yangling, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Dai, W (corresponding author), Northwest A&F Univ, Key Lab Plant Protect Resources & Pest Integrated, Minist Educ, Coll Plant Protect, Yangling, Peoples R China.	daiwu@nwsuaf.edu.cn			National Natural Science Foundation of China [31572306, 31272343]; Chinese Universities Scientific Fund [YQ2013010]; West Light Foundation of the Chinese Academy of Sciences [2012DF06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Universities Scientific Fund; West Light Foundation of the Chinese Academy of Sciences(Chinese Academy of Sciences)	Funding was provided by the National Natural Science Foundation of China (Nos. 31572306, 31272343), the Chinese Universities Scientific Fund (YQ2013010) and the West Light Foundation of the Chinese Academy of Sciences (2012DF06) to Wu Dai.	Ahmad I., 1987, Phytophaga, V1, P75; Altner H., 1980, International Review of Cytology, V67, P69, DOI 10.1016/S0074-7696(08)62427-4; Anderson WG, 2006, J ECON ENTOMOL, V99, P212, DOI 10.1603/0022-0493(2006)099[0212:CBHBMM]2.0.CO;2; Ave D, 1978, ENTOMOL EXP APPL, V24, P217; Backus E.A., 1985, P163; BACKUS EA, 1988, J INSECT PHYSIOL, V34, P151, DOI 10.1016/0022-1910(88)90045-5; Backus EA, 2005, ANNU REV ENTOMOL, V50, P125, DOI 10.1146/annurev.ento.49.061802.123310; BACKUS EA, 1983, J MORPHOL, V176, P3, DOI 10.1002/jmor.1051760102; Baker GT, 2008, INSECT SCI, V15, P271, DOI 10.1111/j.1744-7917.2008.00210.x; Bernays E. A., 1994, Host-plant selection by phytophagous insects.; Borjek J, 2006, POL J ENTOMOL, V75, P255; Boyd DW, 2003, ANN ENTOMOL SOC AM, V96, P667, DOI 10.1603/0013-8746(2003)096[0667:DEASMO]2.0.CO;2; BROMLEY AK, 1980, CELL TISSUE RES, V205, P493; Brozek Jolanta, 2006, Polskie Pismo Entomologiczne, V75, P239; Brozek J, 2014, EUR J ENTOMOL, V111, P275, DOI 10.14411/eje.2014.033; Brozek J, 2013, ZOOMORPHOLOGY, V132, P403, DOI 10.1007/s00435-013-0195-2; Brozek J, 2013, ZOOMORPHOLOGY, V132, P33, DOI 10.1007/s00435-012-0174-z; Chen HH, 2003, J BIOSCIENCES, V28, P743, DOI 10.1007/BF02708435; Chlond D., 2010, ZOOTAXA, V2476, P39; Cobben RH, 1978, EVOLUTIONARY TRENDS, P65; COHEN AC, 1990, ANN ENTOMOL SOC AM, V83, P1215, DOI 10.1093/aesa/83.6.1215; Depieri RA, 2010, REV BRAS ENTOMOL, V54, P584, DOI 10.1590/S0085-56262010000400008; Depieri RA, 2010, NEOTROP ENTOMOL, V39, P952, DOI 10.1590/S1519-566X2010000600017; Esquivel JF, 2011, ENTOMOL EXP APPL, V140, P163, DOI 10.1111/j.1570-7458.2011.01148.x; FAUCHEUX MJ, 1975, CR ACAD SCI D NAT, V281, P41; FEIR DOROTHY, 1963, ANN ENTOMOL SOC AMER, V56, P224; FOSTER S, 1983, CELL TISSUE RES, V230, P353; GAFFAL KP, 1981, INT J INSECT MORPHOL, V10, P1, DOI 10.1016/0020-7322(81)90008-8; Ge FR, 2016, ARTHROPOD STRUCT DEV, V45, P230, DOI 10.1016/j.asd.2016.01.005; Gullan PJ, 2005, INSECTS OUTLINE ENTO, P86; Hao YN, 2016, SCI REP-UK, V6, DOI 10.1038/srep38151; Hao YA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156640; HATFIELD LD, 1980, INT J INSECT MORPHOL, V9, P59, DOI 10.1016/0020-7322(80)90036-7; Henry Thomas J., 2009, P223, DOI 10.1002/9781444308211.ch10; Krenn Harald W., 2007, Arthropod Systematics & Phylogeny, V65, P7; Labandeira CC, 1997, ANNU REV ECOL SYST, V28, P153, DOI 10.1146/annurev.ecolsys.28.1.153; Liang XM, 2013, ARTHROPOD STRUCT DEV, V42, P495, DOI 10.1016/j.asd.2013.08.002; Lucini T, 2016, ANN ENTOMOL SOC AM, V109, P198, DOI 10.1093/aesa/sav156; MATOLIN S, 1987, ACTA ENTOMOL BOHEMOS, V84, P246; MCIVER S, 1984, J MORPHOL, V180, P19, DOI 10.1002/jmor.1051800104; Parveen S, 2015, ZOOTAXA, V4039, P359, DOI 10.11646/zootaxa.4039.2.9; Pei HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064290; Peregrine D.J., 1972, International J Insect Morph Embryol, V1, P241, DOI 10.1016/0020-7322(72)90032-3; Rani Pathipati Usha, 2005, International Journal of Tropical Insect Science, V25, P198, DOI 10.1079/IJT200577; Rani PU, 2009, ACTA ZOOL-STOCKHOLM, V90, P246, DOI 10.1111/j.1463-6395.2008.00346.x; RANI PU, 1995, INT J INSECT MORPHOL, V24, P119, DOI 10.1016/0020-7322(94)00020-Q; RATHORE Y. K., 1961, INDIAN JOUR ENTOMOL, V23, P163; Roitberg BD, 2005, NATURWISSENSCHAFTEN, V92, P431, DOI 10.1007/s00114-005-0013-x; SAXENA KN, 1963, J INSECT PHYSIOL, V9, P47, DOI 10.1016/0022-1910(63)90084-2; Schaefer CW, 2000, HETEROPTERA OF ECONOMIC IMPORTANCE, P3; Schaefer CW, 2000, HETEROPTERA OF ECONOMIC IMPORTANCE, P271; SCHNEIDER D, 1964, ANNU REV ENTOMOL, V9, P103, DOI 10.1146/annurev.en.09.010164.000535; SCHOONHOVEN L M, 1972, Netherlands Journal of Zoology, V22, P343, DOI 10.1163/002829672X00149; Wang RR, 2013, MICRON, V44, P261, DOI 10.1016/j.micron.2012.07.003; Weirauch C, 2011, ANNU REV ENTOMOL, V56, P487, DOI 10.1146/annurev-ento-120709-144833; Zhang CN, 2016, ZOOL ANZ, V262, P20, DOI 10.1016/j.jcz.2016.03.011; Zhang SM, 1985, EC INSECT FAUNA CHIN, V50; Zhao LQ, 2010, MICRON, V41, P754, DOI 10.1016/j.micron.2010.06.001	58	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177209	10.1371/journal.pone.0177209	http://dx.doi.org/10.1371/journal.pone.0177209			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481941	Green Submitted, Green Published, gold			2022-12-26	WOS:000401313700041
J	Will, SE; Neumann-Schaal, M; Heydorn, RL; Bartling, P; Petersen, J; Schomburg, D				Will, Sabine Eva; Neumann-Schaal, Meina; Heydorn, Raymond Leopold; Bartling, Pascal; Petersen, Joern; Schomburg, Dietmar			The limits to growth - energetic burden of the endogenous antibiotic tropodithietic acid in Phaeobacter inhibens DSM 17395	PLOS ONE			English	Article							GALLAECIENSIS; BIOSYNTHESIS; ANGUILLARUM; ADAPTATION; CATABOLISM; PLASMIDS; PATHWAYS; STRAINS; REVEAL; MEMBER	Phaeobacter inhibens DSM 17395, a model organism for marine Roseobacter group, was studied for its response to its own antimicrobial compound tropodithietic acid (TDA). TDA biosynthesis is encoded on the largest extrachromosomal element of P. inhibens, the 262 kb plasmid, whose curation leads to an increased growth and biomass yield. In this study, the plasmid-cured strain was compared to the wild-type strain and to transposon mutants lacking single genes of the TDA biosynthesis. The data show that the growth inhibition of the wild-type strain can be mainly attributed to the TDA produced by P. inhibens itself. Oxygen uptake rates remained constant in all strains but the growth rate dropped in the wild-type which supports the recently proposed mode of TDA action. Metabolome analysis showed no metabolic alterations that could be attributed directly to TDA. Taken together, the growth of P. inhibens is limited by its own antibacterial compound due to a partial destruction of the proton gradient which leads to a higher energetic demand. The universal presence of TDA biosynthesis in genome-sequenced isolates of the genus Phaeobacter shows that there must be a high benefit of TDA for P. inhibens in its ecological niche despite the drawback on its metabolism.	[Will, Sabine Eva; Neumann-Schaal, Meina; Heydorn, Raymond Leopold; Schomburg, Dietmar] Tech Univ Carolo Wilhelmina Braunschweig, Dept Bioinformat & Biochem, Braunschweig, Germany; [Will, Sabine Eva; Neumann-Schaal, Meina; Heydorn, Raymond Leopold; Schomburg, Dietmar] Tech Univ Carolo Wilhelmina Braunschweig, Braunschweig Integrated Ctr Syst Biol BRICS, Braunschweig, Germany; [Bartling, Pascal; Petersen, Joern] Leibniz Inst DSMZ German Collect Microorganisms &, Braunschweig, Germany	Braunschweig University of Technology; Braunschweig University of Technology; Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ)	Schomburg, D (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Dept Bioinformat & Biochem, Braunschweig, Germany.; Schomburg, D (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Braunschweig Integrated Ctr Syst Biol BRICS, Braunschweig, Germany.	d.schomburg@tu-braunschweig.de	Neumann-Schaal, Meina/AAM-6389-2021	Heydorn, Raymond Leopold/0000-0002-2247-208X; Schomburg, Dietmar/0000-0002-3354-822X	Deutsche Forschungsgemeinschaft [SFB TRR 51]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft, SFB TRR 51 (www.dfg.de). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger M, 2011, J BACTERIOL, V193, P6576, DOI 10.1128/JB.05818-11; Brock NL, 2014, CHEM COMMUN, V50, P5487, DOI 10.1039/c4cc01924e; Buddruhs N, 2013, INT J SYST EVOL MICR, V63, P4340, DOI 10.1099/ijs.0.053900-0; D'Alvise PW, 2016, APPL ENVIRON MICROB, V82, P502, DOI 10.1128/AEM.02992-15; D'Alvise PW, 2010, APPL ENVIRON MICROB, V76, P2366, DOI 10.1128/AEM.02717-09; Dannheim H, 2017, FEBS OPEN BIO; Druppel K, 2014, ENVIRON MICROBIOL, V16, P218, DOI 10.1111/1462-2920.12276; Frank O, 2014, STAND GENOMIC SCI, V9, DOI 10.4056/sigs.5179110; Grotkjaer T, 2016, SYST APPL MICROBIOL, V39, P180, DOI 10.1016/j.syapm.2016.01.005; Hensler M., 2015, THESIS; Michael V, 2016, ISME J, V10, P2498, DOI 10.1038/ismej.2016.30; Petersen J, 2013, APPL MICROBIOL BIOT, V97, P2805, DOI 10.1007/s00253-013-4746-8; Planas M, 2006, AQUACULTURE, V255, P323, DOI 10.1016/j.aquaculture.2005.11.039; Porsby CH, 2011, ANTIMICROB AGENTS CH, V55, P1332, DOI 10.1128/AAC.01222-10; Prado S, 2009, INT MICROBIOL, V12, P107, DOI 10.2436/20.1501.01.87; REUBER TL, 1993, CELL, V74, P269, DOI 10.1016/0092-8674(93)90418-P; Revelles O, 2005, J BACTERIOL, V187, P7500, DOI 10.1128/JB.187.21.7500-7510.2005; Ruiz-Ponte C, 1998, INT J SYST BACTERIOL, V48, P537, DOI 10.1099/00207713-48-2-537; Schneider K, 2010, BIOPROC BIOSYST ENG, V33, P541, DOI 10.1007/s00449-009-0367-0; Thole S, 2012, ISME J, V6, P2229, DOI 10.1038/ismej.2012.62; Trautwein K, 2016, ENVIRON MICROBIOL, V18, P4817, DOI 10.1111/1462-2920.13381; Wiegmann K, 2014, APPL ENVIRON MICROB, V80, P4725, DOI 10.1128/AEM.00719-14; Wilson MZ, 2016, P NATL ACAD SCI USA, V113, P1630, DOI 10.1073/pnas.1518034113; Zech H, 2013, PROTEOMICS, V13, P2869, DOI 10.1002/pmic.201200560; Zech H, 2013, PROTEOMICS, V13, P2851, DOI 10.1002/pmic.201200513; Zech H, 2009, PROTEOMICS, V9, P3677, DOI 10.1002/pmic.200900120; Zhao WJ, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-015-0617-z	27	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177295	10.1371/journal.pone.0177295	http://dx.doi.org/10.1371/journal.pone.0177295			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481933	gold, Green Published, Green Submitted			2022-12-26	WOS:000401313700050
J	Varnum, MM; Clayton, KA; Yoshii-Kitahara, A; Yonemoto, G; Koro, L; Ikezu, S; Ikezu, T				Varnum, Megan M.; Clayton, Kevin A.; Yoshii-Kitahara, Asuka; Yonemoto, Grant; Koro, Lacin; Ikezu, Seiko; Ikezu, Tsuneya			A split-luciferase complementation, real-time reporting assay enables monitoring of the disease-associated transmembrane protein TREM2 in live cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; cell culture; genetic polymorphism; microglia; phagocytosis; plasmid; Alzheimer's disease	FLUID SOLUBLE TREM2; NASU-HAKOLA-DISEASE; ALZHEIMERS-DISEASE; MYELOID CELLS-2; SCLEROSING LEUKOENCEPHALOPATHY; FRONTOTEMPORAL DEMENTIA; APOPTOTIC NEURONS; RECEPTOR FAMILY; CUTTING EDGE; MICROGLIA	Triggering receptor expressed on myeloid cells 2 (TREM2) is a single transmembrane molecule uniquely expressed in microglia. TREM2 mutations are genetically linked to Nasu-Hakola disease and associated with multiple neurodegenerative disorders, including Alzheimer's disease. TREM2 may regulate microglial inflammation and phagocytosis through coupling to the adaptor protein TYRO protein-tyrosine kinase-binding protein (TYROBP). However, there is no functional system for monitoring this protein-protein interaction. We developed a luciferase-based modality for real-time monitoring of TREM2-TYROBP coupling in live cells that utilizes split-luciferase complementation technology based on TREM2 and TYROBP fusion to the C- or N-terminal portion of the Renilla luciferase gene. Transient transfection of human embryonic kidney 293 cells with this reporter vector increased luciferase activity upon stimulation with an anti-TREM2 antibody, which induces their homodimerization. This was confirmed by ELISA-based analysis of the TREM2-TYROBP interaction. Antibody-mediated TREM2 stimulation enhanced spleen tyrosine kinase (SYK) activity and uptake of Staphylococcus aureus in microglial cell line BV-2 in a kinase-dependent manner. Interestingly, the TREM2 T66M mutation significantly enhanced luciferase activity without stimulation, indicating constitutive coupling to TYROBP. Finally, flow cytometry analyses indicated significantly lower surface expression of T66M TREM2 variant than wild type or other TREM2 variants. These results demonstrate that our TREM2 reporter vector is a novel tool for monitoring the TREM2-TYROBP interaction in real time.	[Varnum, Megan M.; Clayton, Kevin A.; Yoshii-Kitahara, Asuka; Yonemoto, Grant; Koro, Lacin; Ikezu, Seiko; Ikezu, Tsuneya] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, 72 East Concord St,L-606B, Boston, MA 02118 USA; [Ikezu, Tsuneya] Boston Univ, Sch Med, Dept Neurol, 72 East Concord St,L-606B, Boston, MA 02118 USA	Boston University; Boston University	Ikezu, T (corresponding author), Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, 72 East Concord St,L-606B, Boston, MA 02118 USA.; Ikezu, T (corresponding author), Boston Univ, Sch Med, Dept Neurol, 72 East Concord St,L-606B, Boston, MA 02118 USA.	tikezu@bu.edu		Ikezu, Tsuneya/0000-0002-3979-8596	National Institutes of Health [5T32 GM008541, RF1 AG054199-01]; Henry I. Russek Award; Boston University Undergraduate Research Opportunities Program Awards; Alzheimer's Association; BrightFocus Foundation; Massachusetts Neuroscience Consortium; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RF1AG054199] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Henry I. Russek Award; Boston University Undergraduate Research Opportunities Program Awards; Alzheimer's Association(Alzheimer's Association); BrightFocus Foundation(BrightFocus Foundation); Massachusetts Neuroscience Consortium; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Predoctoral Training Grant 5T32 GM008541 (to M. M. V. and K. A. C.) and Grant RF1 AG054199-01 (to T. I.), a Henry I. Russek Award (to M. M. V.), Boston University Undergraduate Research Opportunities Program Awards (to G. Y. and L. K.), the Alzheimer's Association (to T. I.), the BrightFocus Foundation (to T. I.), and the Massachusetts Neuroscience Consortium (to T. I.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Atagi Y, 2015, J BIOL CHEM, V290, P26043, DOI 10.1074/jbc.M115.679043; Bianchin MM, 2004, CELL MOL NEUROBIOL, V24, P1, DOI 10.1023/B:CEMN.0000012721.08168.ee; Borroni B, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.09.017; Bouchon A, 2001, J EXP MED, V194, P1111, DOI 10.1084/jem.194.8.1111; Cady J, 2014, JAMA NEUROL, V71, P449, DOI 10.1001/jamaneurol.2013.6237; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; Cuyvers E, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.09.009; Daws MR, 2001, EUR J IMMUNOL, V31, P783, DOI 10.1002/1521-4141(200103)31:3<783::AID-IMMU783>3.0.CO;2-U; Deng QJ, 2011, J VIROL METHODS, V176, P108, DOI 10.1016/j.jviromet.2011.04.028; Frank S, 2008, GLIA, V56, P1438, DOI 10.1002/glia.20710; Fujikawa Y, 2007, PLANT J, V52, P185, DOI 10.1111/j.1365-313X.2007.03214.x; Fuller AD, 2008, J NEUROIMMUNE PHARM, V3, P246, DOI 10.1007/s11481-008-9118-2; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Guerreiro RJ, 2013, JAMA NEUROL, V70, P78, DOI 10.1001/jamaneurol.2013.579; Hamerman JA, 2005, NAT IMMUNOL, V6, P579, DOI 10.1038/ni1204; Hamerman JA, 2006, J IMMUNOL, V177, P2051, DOI 10.4049/jimmunol.177.4.2051; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Heslegrave A, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0071-x; Hsieh CL, 2009, J NEUROCHEM, V109, P1144, DOI 10.1111/j.1471-4159.2009.06042.x; Iqbal K, 1998, J NEURAL TRANSM-SUPP, P169; Ivashkiv LB, 2008, NAT REV IMMUNOL, V8, P816, DOI 10.1038/nri2396; Jay TR, 2015, J EXP MED, V212, P287, DOI 10.1084/jem.20142322; Jiang T, 2014, NEUROPSYCHOPHARMACOL, V39, P2949, DOI 10.1038/npp.2014.164; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kleinberger G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009093; Klesney-Tait J, 2006, NAT IMMUNOL, V7, P1266, DOI 10.1038/ni1411; Kondo T, 2002, NEUROLOGY, V59, P1105, DOI 10.1212/WNL.59.7.1105; Lew ED, 2014, ELIFE, V3, DOI 10.7554/eLife.03385; Liu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055754; MATTHEWS JC, 1977, BIOCHEMISTRY-US, V16, P85, DOI 10.1021/bi00620a014; Melchior B, 2010, ASN NEURO, V2, P157, DOI 10.1042/AN20100010; Mizuno N, 1975, Nihon Hifuka Gakkai Zasshi, V85, P587; N'Diaye EN, 2009, J CELL BIOL, V184, P215, DOI 10.1083/jcb.200808080; Paloneva J, 2002, AM J HUM GENET, V71, P656, DOI 10.1086/342259; Paulmurugan R, 2003, ANAL CHEM, V75, P1584, DOI 10.1021/ac020731c; Peng QS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000500; Piccio L, 2016, ACTA NEUROPATHOL, V131, P925, DOI 10.1007/s00401-016-1533-5; Rayaprolu S, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-19; Rizvi SM, 2010, TRAFFIC, V11, P332, DOI 10.1111/j.1600-0854.2009.01025.x; Schmid CD, 2002, J NEUROCHEM, V83, P1309, DOI 10.1046/j.1471-4159.2002.01243.x; Sessa G, 2004, EUR J NEUROSCI, V20, P2617, DOI 10.1111/j.1460-9568.2004.03729.x; Song W, 2017, ALZHEIMERS DEMENT, V13, P381, DOI 10.1016/j.jalz.2016.07.004; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Takahashi K, 2007, PLOS MED, V4, P675, DOI 10.1371/journal.pmed.0040124; Tsou WI, 2014, J BIOL CHEM, V289, P25750, DOI 10.1074/jbc.M114.569020; Turnbull IR, 2006, J IMMUNOL, V177, P3520, DOI 10.4049/jimmunol.177.6.3520; van der Meer JHM, 2014, BLOOD, V123, P2460, DOI 10.1182/blood-2013-09-528752; Vicente-Manzanares M, 2004, NAT REV IMMUNOL, V4, P110, DOI 10.1038/nri1268; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Yeh FL, 2016, NEURON, V91, P328, DOI 10.1016/j.neuron.2016.06.015; Yuan P, 2016, NEURON, V90, P724, DOI 10.1016/j.neuron.2016.05.003; Zhong L, 2015, J BIOL CHEM, V290, P15866, DOI 10.1074/jbc.M115.645986	52	13	13	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10651	10663		10.1074/jbc.M116.759159	http://dx.doi.org/10.1074/jbc.M116.759159			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28490631	hybrid, Green Published			2022-12-26	WOS:000404115400024
J	Liu, PF; Liu, QH; Wu, Y; Huang, J				Liu, Peng-fei; Liu, Qing-hui; Wu, Yin; Huang, Jie			Increased nucleoside diphosphate kinase activity induces white spot syndrome virus infection in Litopenaeus vannamei	PLOS ONE			English	Article							PENAEUS-MONODON; RNA INTERFERENCE; SHRIMP; HEMOCYTES; GENES; THIOREDOXIN	Nucleoside diphosphate kinase (NDK), which has the same sequence as oncoprotein (OP) in humans, can induce nucleoside triphosphates in DNA replication by maintenance of the deoxynucleotide triphosphate (dNTP's) and is known to be regulated by viral infection in the shrimp Litopenaeus vannamei. This paper describes the relationship between NDK and white spot syndrome virus (WSSV) infection. The recombinant NDK was produced by a prokaryotic expression system. WSSV copy numbers and mRNA levels of IE1 and VP28 were significantly increased in shrimp injected with recombinant NDK at 72 h after WSSV infection. After synthesizing dsRNA-NDK and confirming the efficacy of NDK silencing, we recorded the cumulative mortality of WSSV-infected shrimp injected with NDK and dsRNA-NDK. A comparison between the results demonstrated that silencing NDK delayed the death of shrimps. These findings indicate that NDK has an important role influencing the replication of WSSV replication in shrimp. Furthermore, NDK may have potential target as a new therapeutic strategy against WSSV infection in shrimp.	[Liu, Peng-fei; Liu, Qing-hui; Huang, Jie] Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Key Lab Sustainable Dev Marine Fisheries, Minist Agr, Qingdao, Peoples R China; [Liu, Peng-fei; Wu, Yin] Dalian Ocean Univ, Dalian, Peoples R China; [Liu, Qing-hui; Huang, Jie] Natl Lab Marine Sci & Technol, Qingdao, Peoples R China	Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs; Dalian Ocean University; Qingdao National Laboratory for Marine Science & Technology	Liu, QH (corresponding author), Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Key Lab Sustainable Dev Marine Fisheries, Minist Agr, Qingdao, Peoples R China.; Liu, QH (corresponding author), Natl Lab Marine Sci & Technol, Qingdao, Peoples R China.	liuqh@ysfri.ac.cn	Huang, Jie/GWQ-5005-2022	Huang, Jie/0000-0002-0348-6590	National Science Foundation of China [31672679]; National Basic Research Program (973 program) of China [2012CB114401]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program (973 program) of China(National Basic Research Program of China)	This study was supported by the National Science Foundation of China (Grant: 31672679) and the National Basic Research Program (973 program) of China (Grant No: 2012CB114401).	Alday-Sanz V, 2002, DIS AQUAT ORGAN, V48, P91, DOI 10.3354/dao048091; Boissan M, 2009, MOL CELL BIOCHEM, V329, P51, DOI 10.1007/s11010-009-0120-7; Chakrabarty AM, 1998, MOL MICROBIOL, V28, P875, DOI 10.1046/j.1365-2958.1998.00846.x; Chen X.Y., 2010, AQUACULT SCI ANHUI, V26, P14265; Chou HY, 1995, DIS AQUAT ORGAN, V23, P165, DOI 10.3354/dao023165; Clavero-Salas A, 2007, FISH SHELLFISH IMMUN, V23, P459, DOI 10.1016/j.fsi.2007.01.010; de Lorgeril J, 2005, PHYSIOL GENOMICS, V21, P174, DOI 10.1152/physiolgenomics.00281.2004; Desvignes T, 2009, BMC EVOL BIOL, P249; Durand SV, 2002, J FISH DIS, V25, P381, DOI 10.1046/j.1365-2761.2002.00367.x; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Gross PS, 2001, DEV COMP IMMUNOL, V25, P565, DOI 10.1016/S0145-305X(01)00018-0; He NH, 2005, ANTIVIR RES, V66, P39, DOI 10.1016/j.antiviral.2004.12.010; Hsu T, 2011, N-S ARCH PHARMACOL, V384, P363, DOI 10.1007/s00210-011-0607-0; Huang JY, 2012, ANTIOXID REDOX SIGN, V17, P914, DOI 10.1089/ars.2011.4264; Johansson MW, 2000, AQUACULTURE, V191, P45, DOI 10.1016/S0044-8486(00)00418-X; Leu JH, 2011, MAR BIOTECHNOL, V13, P608, DOI 10.1007/s10126-010-9286-y; Liu PF, 2015, J INVERTEBR PATHOL, V129, P57, DOI 10.1016/j.jip.2015.05.009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marino N, 2012, CANCER METAST REV, V31, P593, DOI 10.1007/s10555-012-9374-8; Parks R.E., 1973, ENZYMES, V8, P307, DOI [10.1016/S1874-6047(08)60069-4, DOI 10.1016/S1874-6047(08)60069-4]; Quintero-Reyes IE, 2012, J BIOENERG BIOMEMBR, V44, P325, DOI 10.1007/s10863-012-9436-1; Sambrook J., 2001, MOL CLONING LAB MANU; Sharp PA, 2001, GENE DEV, V15, P485, DOI 10.1101/gad.880001; Takacs-Vellai K, J MOL SIGNAL, V9, P42014; Van De Braak CB, 2002, FISH SHELLFISH IMMUN, V13, P293, DOI 10.1006/fsim.2002.0409; Xie XX, 2005, VIROLOGY, V336, P93, DOI 10.1016/j.virol.2005.03.011; Zamore PD, 2002, SCIENCE, V296, P1265, DOI 10.1126/science.1072457; Zhou Q, 2007, J VIROL METHODS, V146, P288, DOI 10.1016/j.jviromet.2007.07.007	28	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0175741	10.1371/journal.pone.0175741	http://dx.doi.org/10.1371/journal.pone.0175741			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505172	Green Submitted, gold, Green Published			2022-12-26	WOS:000401473500006
J	Mau-Moeller, A; Jacksteit, R; Jackszis, M; Feldhege, F; Weippert, M; Mittelmeier, W; Bader, R; Skripitz, R; Behrens, M				Mau-Moeller, Anett; Jacksteit, Robert; Jackszis, Mario; Feldhege, Frank; Weippert, Matthias; Mittelmeier, Wolfram; Bader, Rainer; Skripitz, Ralf; Behrens, Martin			Neuromuscular function of the quadriceps muscle during isometric maximal, submaximal and submaximal fatiguing voluntary contractions in knee osteoarthrosis patients	PLOS ONE			English	Article							FORCE STEADINESS; OLDER-ADULTS; STRENGTH; ACTIVATION; MECHANISMS; PERFORMANCE; WEAKNESS; ATROPHY; FEMORIS; HIP	Introduction Knee osteoarthrosis (KOA) is commonly associated with a dysfunction of the quadriceps muscle which contributes to alterations in motor performance. The underlying neuromuscular mechanisms of muscle dysfunction are not fully understood. The main objective of this study was to analyze how KOA affects neuromuscular function of the quadriceps muscle during different contraction intensities. Materials and methods The following parameters were assessed in 20 patients and 20 healthy controls: (i) joint position sense, i.e. position control (mean absolute error, MAE) at 30 degrees and 50 degrees of knee flexion, (ii) simple reaction time task performance, (iii) isometric maximal voluntary torque (IMVT) and root mean square of the EMG signal (RMS-EMG), (iv) torque control, i.e. accuracy (MAE), absolute fluctuation (standard deviation, SD), relative fluctuation (coefficient of variation, CV) and periodicity (mean frequency, MNF) of the torque signal at 20%, 40% and 60% IMVT, (v) EMG-torque relationship at 20%, 40% and 60% IMVT and (vi) performance fatigability, i.e. time to task failure (TTF) at 40% IMVT. Results Compared to the control group, the KOA group displayed: (i) significantly higher MAE of the angle signal at 30 degrees (99.3%; P = 0.027) and 50 degrees (147.9%; P < 0.001), (ii) no significant differences in reaction time, (iii) significantly lower IMVT (-41.6%; P = 0.001) and tendentially lower RMS-EMG of the rectus femoris (-33.7%; P = 0.054), (iv) tendentially higher MAE of the torque signal at 20% IMVT (65.9%; P = 0.068), significantly lower SD of the torque signal at all three torque levels and greater MNF at 60% IMVT (44.8%; P = 0.018), (v) significantly increased RMS-EMG of the vastus lateralis at 20% (70.8%; P = 0.003) and 40% IMVT (33.3%; P = 0.034), significantly lower RMS-EMG of the biceps femoris at 20% (-63.6%; P = 0.044) and 40% IMVT (-41.3%; P = 0.028) and tendentially lower at 60% IMVT (-24.3%; P = 0.075) and (vi) significantly shorter TTF (-51.1%; P = 0.049). Conclusion KOA is not only associated with a deterioration of IMVT and neuromuscular activation, but also with an impaired position and torque control at submaximal torque levels, an altered EMG-torque relationship and a higher performance fatigability of the quadriceps muscle. It is recommended that the rehabilitation includes strengthening and fatiguing exercises at maximal and submaximal force levels.	[Mau-Moeller, Anett; Jacksteit, Robert; Jackszis, Mario; Feldhege, Frank; Mittelmeier, Wolfram; Bader, Rainer; Skripitz, Ralf] Univ Med Rostock, Dept Orthopaed, Rostock, Germany; [Weippert, Matthias; Behrens, Martin] Univ Rostock, Inst Sports Sci, Rostock, Germany	University of Rostock; University of Rostock	Mau-Moeller, A (corresponding author), Univ Med Rostock, Dept Orthopaed, Rostock, Germany.	anett.mau-moeller@uni-rostock.de	Behrens, Martin/H-8443-2019; Weippert, Matthias/AAE-4048-2021	Behrens, Martin/0000-0003-1980-3260; Weippert, Matthias/0000-0003-2323-0047; Mau-Moeller, Anett/0000-0002-3097-1700	Deutsche Athrose-Hilfe e.V.	Deutsche Athrose-Hilfe e.V.	This study was supported by the Deutsche Athrose-Hilfe e.V. (http://www.arthrose.de/). The study sponsor was not involved in the study design, collection, analysis and interpretation of data as well as in the writing of the manuscript.	Alkner BA, 2000, MED SCI SPORT EXER, V32, P459, DOI 10.1097/00005768-200002000-00030; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Bade MJ, 2010, J ORTHOP SPORT PHYS, V40, P559, DOI 10.2519/jospt.2010.3317; BARRETT DS, 1991, J BONE JOINT SURG BR, V73, P53, DOI 10.1302/0301-620X.73B1.1991775; Behrens M, 2016, J SCI MED SPORT, V19, P170, DOI 10.1016/j.jsams.2015.01.011; Behrens M, 2015, SCI REP-UK, V5, DOI 10.1038/srep10209; Behrens M, 2015, EUR J APPL PHYSIOL, V115, P1075, DOI 10.1007/s00421-014-3089-1; Bennell KL, 2013, RHEUM DIS CLIN N AM, V39, P145, DOI 10.1016/j.rdc.2012.11.003; Berger MJ, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-199; Bijur PE, 2001, ACAD EMERG MED, V8, P1153, DOI 10.1111/j.1553-2712.2001.tb01132.x; BOTWINICK J, 1966, J EXP PSYCHOL, V71, P9, DOI 10.1037/h0022634; Cohen J.E., 1988, STAT POWER ANAL BEHA; Elboim-Gabyzon M, 2013, CLIN INTERV AGING, V8, P1071, DOI 10.2147/CIA.S42094; Enoka RM, 2003, J ELECTROMYOGR KINES, V13, P1, DOI 10.1016/S1050-6411(02)00084-6; Enoka RM, 2016, MED SCI SPORT EXER, V48, P2228, DOI 10.1249/MSS.0000000000000929; Enoka RM, 2011, J ELECTROMYOGR KINES, V21, P208, DOI 10.1016/j.jelekin.2010.10.006; Fink B, 2007, ARTHRITIS RHEUM, V56, P3626, DOI 10.1002/art.22960; Fisher NM, 1997, DISABIL REHABIL, V19, P47, DOI 10.3109/09638289709166827; Fransen M, 2016, COCHRANE DB SYST REV, V1; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Gapeyeva H, 2007, KNEE SURG SPORT TR A, V15, P202, DOI 10.1007/s00167-006-0166-y; GLASBERG M R, 1986, Henry Ford Hospital Medical Journal, V34, P37; Hiranaka T, 1995, Nihon Seikeigeka Gakkai Zasshi, V69, P675; Hopkins WG, 2011, NEW VIEW STAT; Hortobagyi T, 2001, J GERONTOL A-BIOL, V56, pB38, DOI 10.1093/gerona/56.1.B38; Hortobagyi T, 2004, ARTHRIT RHEUM-ARTHR, V51, P562, DOI 10.1002/art.20545; Hurley MV, 1999, RHEUM DIS CLIN N AM, V25, P283, DOI 10.1016/S0889-857X(05)70068-5; Hurley MV, 1997, ANN RHEUM DIS, V56, P641, DOI 10.1136/ard.56.11.641; Ikeda S, 2005, J ORTHOP SCI, V10, P121, DOI 10.1007/s00776-004-0876-2; Jerosch J, 1995, Sportverletz Sportschaden, V9, P72, DOI 10.1055/s-2007-993428; Knoop J, 2011, OSTEOARTHR CARTILAGE, V19, P381, DOI 10.1016/j.joca.2011.01.003; Lajoie Y, 2004, ARCH GERONTOL GERIAT, V38, P11, DOI 10.1016/S0167-4943(03)00082-7; Levinger P, 2011, KNEE SURG SPORT TR A, V19, P1082, DOI 10.1007/s00167-010-1325-8; Lewek MD, 2006, MUSCLE NERVE, V34, P767, DOI 10.1002/mus.20663; Lin DH, 2009, J ORTHOP SPORT PHYS, V39, P450, DOI 10.2519/jospt.2009.2923; Ling SM, 2007, OSTEOARTHR CARTILAGE, V15, P1134, DOI 10.1016/j.joca.2007.03.024; MARKS R, 1994, CLIN EXP RHEUMATOL, V12, P11; Mizner RL, 2005, J RHEUMATOL, V32, P1533; Mizner RL, 2005, J ORTHOP SPORT PHYS, V35, P424, DOI 10.2519/jospt.2005.35.7.424; Mizner RL, 2005, J BONE JOINT SURG AM, V87A, P1047, DOI 10.2106/JBJS.D.01992; Nakamura T, 1992, Nihon Seikeigeka Gakkai Zasshi, V66, P467; Nelson AE, 2014, SEMIN ARTHRITIS RHEU, V43, P701, DOI 10.1016/j.semarthrit.2013.11.012; Petterson SC, 2008, MED SCI SPORT EXER, V40, P422, DOI [10.1249/mss.0b013e31815ef285, 10.1249/MSS.0b013e31815ef285]; Pietrosimone BG, 2011, PM&R, V3, P153, DOI 10.1016/j.pmrj.2010.07.485; Ploutz-Snyder LL, 2002, J GERONTOL A-BIOL, V57, pB144, DOI 10.1093/gerona/57.4.B144; Rice DA, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3467; Rice DA, 2010, SEMIN ARTHRITIS RHEU, V40, P250, DOI 10.1016/j.semarthrit.2009.10.001; Roos EM, 2011, NAT REV RHEUMATOL, V7, P57, DOI 10.1038/nrrheum.2010.195; SCHENAU GJV, 1994, HUM MOVEMENT SCI, V13, P495; Seynnes O, 2005, J AGING PHYS ACTIV, V13, P395, DOI 10.1123/japa.13.4.395; Singh NB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082791; Singh NB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048449; Singh NB, 2010, PHILOS T R SOC A, V368, P2783, DOI 10.1098/rsta.2010.0091; Smith JW, 2014, J ARTHROPLASTY, V29, P1143, DOI 10.1016/j.arth.2013.11.023; Stevens-Lapsley JE, 2010, CLIN ORTHOP RELAT R, V468, P2460, DOI 10.1007/s11999-009-1219-6; STOKES M, 1985, Physiotherapy Practice, V1, P71; Suelto MD, 1999, ANESTHESIOLOGY; Suetta C, 2007, J APPL PHYSIOL, V102, P942, DOI 10.1152/japplphysiol.00067.2006; Takacs J, 2013, AGING DIS, V4, P84; Tanaka R, 2016, CLIN REHABIL, V30, P36, DOI 10.1177/0269215515570098; Tanaka S, 1998, AM J PHYS MED REHAB, V77, P122, DOI 10.1097/00002060-199803000-00007; Taylor JL, 2008, J APPL PHYSIOL, V104, P542, DOI 10.1152/japplphysiol.01053.2007; Tracy BL, 2002, J APPL PHYSIOL, V92, P1004, DOI 10.1152/japplphysiol.00954.2001; Watanbe K, 2014, MUSCLE NERVE, V50; Winter SL, 2010, J APPL BIOMECH, V26, P45, DOI 10.1123/jab.26.1.45; WORRINGHAM CJ, 1985, EXP BRAIN RES, V61, P38; Zacharias A, 2014, OSTEOARTHR CARTILAGE, V22, P1752, DOI 10.1016/j.joca.2014.07.005	67	16	17	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0176976	10.1371/journal.pone.0176976	http://dx.doi.org/10.1371/journal.pone.0176976			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV0YN	28505208	Green Submitted, gold, Green Published			2022-12-26	WOS:000401473500011
J	Zhan, ZX; Nwafor, CC; Hou, ZK; Gong, JF; Zhu, B; Jiang, YF; Zhou, YM; Wu, JS; Piao, ZY; Tong, Y; Liu, C; Zhang, CY				Zhan, Zongxiang; Nwafor, Chinedu Charles; Hou, Zhaoke; Gong, Jianfang; Zhu, Bin; Jiang, Yingfen; Zhou, Yongming; Wu, Jiangsheng; Piao, Zhongyun; Tong, Yue; Liu, Chao; Zhang, Chunyu			Cytological and morphological analysis of hybrids between Brassicoraphanus, and Brassica napus for introgression of clubroot resistant trait into Brassica napus L	PLOS ONE			English	Article							CYTOPLASMIC MALE-STERILITY; RAPHANUS-SATIVUS; PLASMODIOPHORA-BRASSICAE; SOMATIC HYBRIDS; INTERSPECIFIC HYBRIDS; DURUM-WHEAT; GENE RFO; RAPA; RADISH; RECOMBINATION	Interspecific hybridization is a powerful tool for improvement of crop species, it has the potential to broaden the genetic base and create new plant forms for breeding programs. Synthetic allopolyploid is a widely-used model for the study of genetic recombination and fixed heterosis in Brassica. In Brassica napus breeding, identification and introgression of new sources of clubroot resistance trait from wild or related species into it by hybridization is a long-term crop management strategy for clubroot disease. Radish (Raphanus sativus L.) is a close relative of the Brassica and most radish accessions are immune to the clubroot disease. A synthesized allotetraploid Brassicoraphanus (RRCC, 2n = 36) between R. sativus cv. HQ-04 (2n = 18, RR) and Brassica oleracea var. alboglabra (L.H Bailey) (2n = 18, CC) proved resistant of multiple clubroot disease pathogen P. brassicae. To predict the possibility to transfer the clubroot resistance trait from the RR subgenome of allotetraploid Brassicoraphanus (RRCC, 2n = 36) into Brassica napus (AACC, 2n = 38), we analyzed the frequency of chromosome pairings in the F-1 hybrids produced from a cross between B. napus cv. HS5 and the allotetraploid, characterize the genomic composition of some back-crossed progeny (BC1) using GISH, BAC-FISH and AFLP techniques. The level of intergenomic pairing between A and R genomes in the F-1 hybrid was high, allosyndetic bivalents formed in 73.53% PMCs indicative of significant level of homeologous recombination between two genomes and high probability of incorporating chromosomal segments/genes from R-genome into A/C-genomes. The BC1 plants inherited variant extra R chromosomes or fragments from allotetraploid as revealed by GISH and AFLP analysis. 13.51% BC2 individuals were resistant to clubroot disease, and several resistance lines had high pollen fertility, Overall, the genetic material presented in this work represents a potential new genetic resource for practical use in breeding B. napus clubroot resistant cultivars.	[Zhan, Zongxiang; Nwafor, Chinedu Charles; Hou, Zhaoke; Gong, Jianfang; Zhou, Yongming; Wu, Jiangsheng; Liu, Chao; Zhang, Chunyu] Huazhong Agr Univ, Natl Res Ctr Rapeseed Engn & Technol, Wuhan, Peoples R China; [Zhan, Zongxiang; Nwafor, Chinedu Charles; Hou, Zhaoke; Gong, Jianfang; Zhou, Yongming; Wu, Jiangsheng; Liu, Chao; Zhang, Chunyu] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China; [Zhu, Bin] Guizhou Normal Univ, Coll Life Sci, Guiyang, Peoples R China; [Jiang, Yingfen] Anhui Acad Agr Sci, Crop Res Inst, Hefei, Peoples R China; [Piao, Zhongyun] Shenyang Agr Univ, Dept Hort, Shenyang, Peoples R China; [Tong, Yue] Yichang Acad Agr Sci, Yichang, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Guizhou Normal University; Anhui Academy of Agricultural Sciences; Shenyang Agricultural University	Zhang, CY (corresponding author), Huazhong Agr Univ, Natl Res Ctr Rapeseed Engn & Technol, Wuhan, Peoples R China.; Zhang, CY (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China.	zhchy@mail.hzau.edu.cn	Zhu, Bin/ABC-6740-2021; Zhang, Chun-yu/HDP-5776-2022		National Key Research and Development Program of China [2016YFD0101300]; Special Fund for Agroscientific Research in the Public Interest [201203026-6]; Technological innovation project of HuBei [2016ABA084]; China Agriculture Research System [nycytx00503]	National Key Research and Development Program of China; Special Fund for Agroscientific Research in the Public Interest; Technological innovation project of HuBei; China Agriculture Research System	This work was supported by the grants from the National Key Research and Development Program of China (no. 2016YFD0101300), Special Fund for Agroscientific Research in the Public Interest (201203026-6), Technological innovation project of HuBei (2016ABA084), and China Agriculture Research System (nycytx00503).	Arumugam N, 2002, PLANT BREEDING, V121, P168, DOI 10.1046/j.1439-0523.2002.00681.x; Chai AL, 2014, CAN J PLANT PATHOL, V36, P142, DOI 10.1080/07060661.2013.868829; Chandra A, 2004, THEOR APPL GENET, V108, P1620, DOI 10.1007/s00122-004-1592-1; Chen HG, 2008, GENET RESOUR CROP EV, V55, P143, DOI 10.1007/s10722-007-9223-8; Chen JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085307; Cifuentes M, 2010, CYTOGENET GENOME RES, V129, P124, DOI 10.1159/000313593; Cronn R, 2003, EVOLUTION, V57, P2475, DOI 10.1111/j.0014-3820.2003.tb01493.x; Cui C, 2012, GENETICS, V191, P725, DOI 10.1534/genetics.112.140780; Diederichsen E, 2009, J PLANT GROWTH REGUL, V28, P265, DOI 10.1007/s00344-009-9100-0; Doyle JJ, 1993, AUSTR SYSTEMATIC BOT, V3, P125; Feng JH, 2009, GENOME, V52, P401, DOI [10.1139/G09-016, 10.1139/g09-016]; Grandont L, 2014, PLANT CELL, V26, P1448, DOI 10.1105/tpc.114.122788; Guttman B., 2001, ENCY GENETICS, V49, P663; HAGIMORI M, 1992, THEOR APPL GENET, V84, P819, DOI 10.1007/BF00227390; Han HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091066; He QY, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0480-y; Heneen WK, 1995, HEREDITAS, V123, P251, DOI 10.1111/j.1601-5223.1995.00251.x; Hirai M, 2006, BREEDING SCI, V56, P223, DOI 10.1270/jsbbs.56.223; Hu XY, 2008, MOL BREEDING, V22, P663, DOI 10.1007/s11032-008-9207-1; Jauhar PP, 2009, J CROP IMPROV, V23, P319, DOI 10.1080/15427520902838648; Jenczewski E, 2003, GENETICS, V164, P645; Johnston TD, 2007, PLANT PATHOL, V17, P184; Kamei A, 2010, THEOR APPL GENET, V120, P1021, DOI 10.1007/s00122-009-1230-z; Kaneko Y, 2001, PLANT BREEDING, V120, P163, DOI 10.1046/j.1439-0523.2001.00576.x; Kato T, 2012, BREEDING SCI, V62, P282, DOI 10.1270/jsbbs.62.282; Ky CL, 2000, THEOR APPL GENET, V101, P669, DOI 10.1007/s001220051529; Lee YP, 2008, THEOR APPL GENET, V117, P905, DOI 10.1007/s00122-008-0830-3; Levin DA, 2012, NEW PHYTOL, V196, P666, DOI 10.1111/j.1469-8137.2012.04309.x; Li G, 2001, THEOR APPL GENET, V103, P455, DOI 10.1007/s001220100570; Li MT, 2004, CHROMOSOME RES, V12, P417, DOI 10.1023/B:CHRO.0000034722.66981.94; LI Z, 1995, THEOR APPL GENET, V91, P131, DOI 10.1007/BF00220869; Mason AS, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-103; MCNAUGHTON IH, 1973, NATURE, V243, P547, DOI 10.1038/243547a0; Navabi ZK, 2011, GENETICS, V187, P659, DOI 10.1534/genetics.110.124925; PAULMANN W, 1988, PLANT BREEDING, V100, P299, DOI 10.1111/j.1439-0523.1988.tb00256.x; PELLANDELOURME R, 1987, PLANT BREEDING, V99, P89, DOI 10.1111/j.1439-0523.1987.tb01157.x; Qi LL, 2007, CHROMOSOME RES, V15, P3, DOI 10.1007/s10577-006-1108-8; Rahman H, 2017, CAN J PLANT SCI, V91, P447; Rahman H, 2013, CAN J PLANT SCI, V93, P363, DOI [10.4141/CJPS2012-074, 10.4141/cjps2012-074]; Rieseberg LH, 2007, SCIENCE, V317, P910, DOI 10.1126/science.1137729; Rohlf FJ., 1988, NTSYS PC NUMERICAL T; Sakamoto K, 2008, THEOR APPL GENET, V117, P759, DOI 10.1007/s00122-008-0817-0; Schelfhout CJ, 2006, GENOME, V49, P1490, DOI 10.1139/G06-103; Suwabe K, 2003, THEOR APPL GENET, V107, P997, DOI 10.1007/s00122-003-1309-x; Tu YQ, 2008, PLANT CELL REP, V27, P873, DOI 10.1007/s00299-008-0513-1; VOORRIPS RE, 1995, EUPHYTICA, V83, P139, DOI 10.1007/BF01678041; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Yamagishi H, 2014, BREEDING SCI, V64, P38, DOI 10.1270/jsbbs.64.38	48	22	25	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177470	10.1371/journal.pone.0177470	http://dx.doi.org/10.1371/journal.pone.0177470			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505203	gold, Green Submitted, Green Published			2022-12-26	WOS:000401473500022
J	Zhang, BB; Peng, B; Zhang, CH; Song, ZZ; Ma, RJ				Zhang, Binbin; Peng, Bin; Zhang, Chunhua; Song, Zhizhong; Ma, Ruijuan			Determination of fruit maturity and its prediction model based on the pericarp index of absorbance difference (I-AD) for peaches	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; TOTAL SOLUBLE SOLIDS; ON-TREE; HARVEST; ETHYLENE; FLESH; COLOR; NECTARINES; FIRMNESS; QUALITY	Harvest maturity is closely related to peach fruit quality and has a very important effect on the fresh fruit market. Unfortunately, at present, it is difficult to determine the maturity level of peach fruits by artificial methods. The objectives of this study were to develop quadratic polynomial regression models using near-infrared spectroscopy that could determine the peel color difference, fruit firmness, soluble solids content (SSC), soluble sugar, organic acid components, and their relationships with the absorbance of chlorophyll (index of absorbance difference, I-AD) in late maturing 'Xiahui 8' peach and 'Xiaguang' nectarine fruits. The analysis was based on data for fruits at veraison, fruits at harvesting maturity, and all fruits. The results showed that firmness has the highest correlation coefficient with I-AD. Prediction models for fruit maturity were established between firmness and the I-AD of the two cultivars using the quadratic polynomial regression method. Further variance analysis on the one degree term and quadratic term of each equation showed that every partial regression coefficient reached a significant or extremely significant level. No significant difference was observed between estimated and observed values after regression prediction. The regression equations seem to fit well. Other peach and nectarine varieties were used to test the feasibility of maturity prediction by this method, and it was found that maturity was successfully predicted in all the samples. The result indicated that the I-AD can be used as an index to predict peach fruit maturity.	[Zhang, Binbin; Peng, Bin; Zhang, Chunhua; Song, Zhizhong; Ma, Ruijuan] Jiangsu Acad Agr Sci, Inst Pomol, Jiangsu Key Lab Hort Crop Genet Improvement, Nanjing, Jiangsu, Peoples R China	Jiangsu Academy of Agricultural Sciences	Ma, RJ (corresponding author), Jiangsu Acad Agr Sci, Inst Pomol, Jiangsu Key Lab Hort Crop Genet Improvement, Nanjing, Jiangsu, Peoples R China.	marj311@163.com			China Agriculture Research System [CARS-31]; Jiangsu Agriculture Science and Technology Innovation Fund [CX(15)1020]	China Agriculture Research System; Jiangsu Agriculture Science and Technology Innovation Fund	This work was supported by the earmarked fund of China Agriculture Research System (No.CARS-31), Ruijuan Ma (http//119.253.58.231/), and Jiangsu Agriculture Science and Technology Innovation Fund [No. CX(15)1020], Ruijuan Ma (http://www.jsnyzzcx.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonora E, 2013, SCI HORTIC-AMSTERDAM, V159, P166, DOI 10.1016/j.scienta.2013.05.011; Cantin CM, 2009, J SCI FOOD AGR, V89, P1909, DOI 10.1002/jsfa.3672; Crisosto C.H., 1994, POSTHARVEST NEWS INF, V5, P65; Dabbou S, 2016, PLANT PHYSIOL BIOCH, V100, P1, DOI 10.1016/j.plaphy.2015.12.015; Farneti B, 2015, SCI HORTIC-AMSTERDAM, V190, P110, DOI 10.1016/j.scienta.2015.04.023; Golding JB, 2006, ACTA HORTIC, P461, DOI 10.17660/ActaHortic.2006.713.69; Golic M, 2006, ANAL CHIM ACTA, V555, P286, DOI 10.1016/j.aca.2005.09.014; Goncalves RG, 2016, SCI HORTIC-AMSTERDAM, V209, P293, DOI 10.1016/j.scienta.2016.06.040; Herrero-Langreo A, 2012, J FOOD ENG, V108, P150, DOI 10.1016/j.jfoodeng.2011.07.004; Infante R, 2012, NEW ZEAL J CROP HORT, V40, P103, DOI 10.1080/01140671.2011.611149; Infante R, 2011, POSTHARVEST BIOL TEC, V61, P35, DOI 10.1016/j.postharvbio.2011.01.003; Infante R, 2011, CHIL J AGR RES, V71, P445, DOI 10.4067/S0718-58392011000300016; Koukounaras A, 2009, POSTHARVEST BIOL TEC, V54, P172, DOI 10.1016/j.postharvbio.2009.07.002; Lewallen KS, 2003, J AM SOC HORTIC SCI, V128, P163, DOI 10.21273/JASHS.128.2.0163; Liu MH, 2007, NEW ZEAL J AGR RES, V50, P601; Louw ED, 2010, POSTHARVEST BIOL TEC, V58, P176, DOI 10.1016/j.postharvbio.2010.07.001; Lurie S, 2013, POSTHARVEST BIOL TEC, V76, P10, DOI 10.1016/j.postharvbio.2012.08.007; Nascimento PAM, 2016, POSTHARVEST BIOL TEC, V111, P345, DOI 10.1016/j.postharvbio.2015.08.006; Matteoli S, 2015, IEEE SENS J, V15, P5455, DOI 10.1109/JSEN.2015.2442337; MITCHELL FG, 1974, CALIF AGR, V28, P12; Onelli E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145341; Pinto C, 2015, SCI HORTIC-AMSTERDAM, V192, P231, DOI 10.1016/j.scienta.2015.05.033; Rodrigo MJ, 2007, POSTHARVEST BIOL TEC, V43, P14, DOI 10.1016/j.postharvbio.2006.07.008; Shao YN, 2011, FOOD BIOPROCESS TECH, V4, P1376, DOI 10.1007/s11947-009-0227-6; Shinya P, 2013, POSTHARVEST BIOL TEC, V86, P472, DOI 10.1016/j.postharvbio.2013.07.038; Spadoni A, 2016, SCI HORTIC-AMSTERDAM, V201, P140, DOI 10.1016/j.scienta.2016.01.041; STEWART I, 1972, J AGR FOOD CHEM, V20, P448, DOI 10.1021/jf60180a024; Tiwari G, 2013, POSTHARVEST BIOL TEC, V86, P221, DOI 10.1016/j.postharvbio.2013.07.009; TONUTTI P, 1991, J AM SOC HORTIC SCI, V116, P274, DOI 10.21273/JASHS.116.2.274; Trainotti L, 2007, J EXP BOT, V58, P3299, DOI 10.1093/jxb/erm178; VOSS DH, 1992, HORTSCIENCE, V27, P1256, DOI 10.21273/HORTSCI.27.12.1256; Ying YB, 2005, T ASAE, V48, P229, DOI 10.13031/2013.17922; Zerbini PE, 2006, POSTHARVEST BIOL TEC, V39, P223, DOI 10.1016/j.postharvbio.2005.10.011; Zhang BB, 2015, J HORTIC SCI BIOTECH, V90, P303, DOI 10.1080/14620316.2015.11513187; [张斌斌 Zhang Binbin], 2014, [食品科学, Food Science], V35, P68; Ziosi V, 2008, POSTHARVEST BIOL TEC, V49, P319, DOI 10.1016/j.postharvbio.2008.01.017	36	19	21	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177511	10.1371/journal.pone.0177511	http://dx.doi.org/10.1371/journal.pone.0177511			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505165	Green Submitted, Green Published, gold			2022-12-26	WOS:000401473500026
J	Atassi, N; Xu, MS; Triantafyllou, C; Keil, B; Lawson, R; Cernasov, P; Ratti, E; Long, CJ; Paganoni, S; Murphy, A; Salibi, N; Seethamraju, R; Rosen, B; Ratai, EM				Atassi, Nazem; Xu, Maosheng; Triantafyllou, Christina; Keil, Boris; Lawson, Robert; Cernasov, Paul; Ratti, Elena; Long, Christopher J.; Paganoni, Sabrina; Murphy, Alyssa; Salibi, Nouha; Seethamraju, Ravi; Rosen, Bruce; Ratai, Eva-Maria			Ultra high-field (7tesla) magnetic resonance spectroscopy in Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							VIVO H-1-NMR SPECTROSCOPY; MOTOR-NEURON INVOLVEMENT; IN-VIVO; MR SPECTROSCOPY; CEREBRAL DEGENERATION; PREDICTS SURVIVAL; DIFFUSION-TENSOR; HUMAN BRAIN; ALSFRS-R; GLUTAMATE	The main objective of this study was to utilize high field (7T) in vivo proton magnetic resonance imaging to increase the ability to detect metabolite changes in people with ALS, specifically, to quantify levels of glutamine and glutamine separately. The second objective of this study was to correlate metabolic markers with clinical outcomes of disease progression. 13 ALS participants and 12 age-matched healthy controls (HC) underwent 7 Tesla MRI and MRS. Single voxel MR spectra were acquired from the left precentral gyrus using a very short echo time (TE = 5 ms) STEAM sequence. MRS data was quantified using LCModel and correlated to clinical outcome markers. N-acetylaspartate (NAA) and total NAA (tNA, NAA + NAAG) were decreased by 17% in people with ALS compared to HC (P = 0.004 and P = 0.005, respectively) indicating neuronal injury and/or loss in the precentral gyrus. tNA correlated with disease progression as measured by forced vital capacity (FVC) (P = 0.014; R rho = 0.66) and tNA/tCr correlated with overall functional decline as measured by worsening of the ALS Functional Rating Scale-Revised (ALSFRS-R) (P = 0.004; R rho = -0.74). These findings underscore the importance of NAA as a reliable biomarker for neuronal injury and disease progression in ALS. Glutamate (Glu) was 15% decreased in people with ALS compared to HC (P = 0.02) while glutamine (Gln) concentrations were similar between the two groups. Furthermore, the decrease in Glu correlated with the decrease in FVC (P = 0.013; R rho = 0.66), a clinical marker of disease progression. The decrease in Glu is most likely driven by intracellular Glu loss due to neuronal loss and degeneration. Neither choline containing components (Cho), a marker for cell membrane turnover, nor myo-Inositol (ml), a suspected marker for neuroinflammation, showed significant differences between the two groups. However, ml/tNA was correlated with upper motor neuron burden (P = 0.004, R rho = 0.74), which may reflect a relative increase of activated microglia around motor neurons. In summary, 7T(1) H MRS is a powerful non-invasive imaging technique to study molecular changes related to neuronal injury and/or loss in people with ALS.	[Atassi, Nazem; Lawson, Robert; Cernasov, Paul; Ratti, Elena] Massachusetts Gen Hosp, NCRI, Dept Neurol, Boston, MA 02114 USA; [Atassi, Nazem; Lawson, Robert; Cernasov, Paul; Ratti, Elena; Murphy, Alyssa] Harvard Med Sch, Boston, MA 02114 USA; [Xu, Maosheng] Zhejiang Chinese Med Univ, Affiliated Hosp 1, Dept Radiol, Hangzhou, Zhejiang, Peoples R China; [Triantafyllou, Christina; Keil, Boris; Rosen, Bruce; Ratai, Eva-Maria] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Dept Radiol, Charlestown, MA USA; [Triantafyllou, Christina; Keil, Boris; Rosen, Bruce; Ratai, Eva-Maria] Harvard Med Sch, Charlestown, MA USA; [Long, Christopher J.] MIT, Sloan Sch Management, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Paganoni, Sabrina] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Charlestown, MA USA; [Salibi, Nouha] Siemens, Siemens Healthineers MR R&D, Auburn, AL USA; [Seethamraju, Ravi] Siemens, Siemens Healthineers MR R&D, Charlestown, MA USA; [Triantafyllou, Christina] Siemens Healthineers, Erlangen, Germany; [Keil, Boris] Mittelhessen Univ Appl Sci, Inst Med Phys & Radiat Safety, Dept Life Sci Engn, Giessen, Germany; [Ratti, Elena] Biogen, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Zhejiang Chinese Medical University; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Harvard University; Spaulding Rehabilitation Hospital; Siemens AG; Siemens AG; Siemens AG; Biogen	Ratai, EM (corresponding author), Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Dept Radiol, Charlestown, MA USA.; Ratai, EM (corresponding author), Harvard Med Sch, Charlestown, MA USA.	ratai@nmr.mgh.harvard.edu	Keil, Boris/AAX-9557-2020; Keil, Boris/P-1411-2014	Keil, Boris/0000-0003-0805-8330; Seethamraju, Ravi Teja/0000-0002-2719-6854	Harvard NeuroDiscovery Center; Muscular Dystrophy Association Clinical Research Training Grant; Research fellowship from the American Academy of Neurology; Anne B. Young neuroscience translational medicine fellowship; Siemens Healtheneers	Harvard NeuroDiscovery Center; Muscular Dystrophy Association Clinical Research Training Grant(Muscular Dystrophy Association); Research fellowship from the American Academy of Neurology; Anne B. Young neuroscience translational medicine fellowship; Siemens Healtheneers	This work was conducted with support from the Harvard NeuroDiscovery Center, Muscular Dystrophy Association Clinical Research Training Grant, Research fellowship from the American Academy of Neurology, and the Anne B. Young neuroscience translational medicine fellowship. Siemens Healtheneers provided support in the form of salaries for authors CT, NS and RS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was conducted with support from the Harvard NeuroDiscovery Center, Muscular Dystrophy Association Clinical Research Training Grant, Research fellowship from the American Academy of Neurology, and the Anne B. Young neuroscience translational medicine fellowship. We like to thank Drs. Dinesh Deelchand and Gulin Oz from the Center for Magnetic Resonance Research at the University of Minnesota for providing us with the 7T-LCModel basis-set. In addition, we like to thank Dr. Merit Cudkowicz for insightful discussion on the study design. Lastly, we like to thank all participating patients and their families.	Abe K, 2001, NEURORADIOLOGY, V43, P537, DOI 10.1007/s002340000521; Block W, 1998, ARCH NEUROL-CHICAGO, V55, P931, DOI 10.1001/archneur.55.7.931; Bowen BC, 2000, AM J NEURORADIOL, V21, P647; Bradley WG, 1999, J NEUROL SCI, V169, P84, DOI 10.1016/S0022-510X(99)00221-X; Brettschneider J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039216; Brown AM, 2007, GLIA, V55, P1263, DOI 10.1002/glia.20557; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; da Rocha AJ, 2012, ARQ NEURO-PSIQUIAT, V70, P532, DOI 10.1590/S0004-282X2012000700012; Daikhin Y, 2000, J NUTR, V130, p1026S, DOI 10.1093/jn/130.4.1026S; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dangond F, 2004, PHYSIOL GENOMICS, V16, P229, DOI 10.1152/physiolgenomics.00087.2001; Deelchand DK, 2012, MAGN RESON MED, V67, P891, DOI 10.1002/mrm.23080; Duarte JMN, 2012, NEUROIMAGE, V61, P342, DOI 10.1016/j.neuroimage.2011.12.038; Evans MC, 2013, MOL CELL NEUROSCI, V53, P34, DOI 10.1016/j.mcn.2012.10.008; Foerster BR, 2013, NAT REV NEUROL, V9, P513, DOI 10.1038/nrneurol.2013.153; Foerster BR, 2013, JAMA NEUROL, V70, P1009, DOI 10.1001/jamaneurol.2013.234; Govind V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035607; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; Griffith HR, 2008, NMR BIOMED, V21, P381, DOI 10.1002/nbm.1203; Han J, 2010, J MAGN RESON IMAGING, V31, P305, DOI 10.1002/jmri.22053; Henkel JS, 2004, ANN NEUROL, V55, P221, DOI 10.1002/ana.10805; Kalra S, 2006, J NEUROL NEUROSUR PS, V77, P1253, DOI 10.1136/jnnp.2006.090696; Kalra S, 2006, ARCH NEUROL-CHICAGO, V63, P1144, DOI 10.1001/archneur.63.8.1144; Kaufmann P, 2004, NEUROLOGY, V62, P1753, DOI 10.1212/01.WNL.0000125182.17874.59; Kaufmann Petra, 2002, Curr Neurol Neurosci Rep, V2, P55, DOI 10.1007/s11910-002-0054-x; KAWAMATA T, 1992, AM J PATHOL, V140, P691; Kimura F, 2006, NEUROLOGY, V66, P265, DOI 10.1212/01.wnl.0000194316.91908.8a; Liu CJ, 2015, INT J ANTENN PROPAG, V2015, DOI [10.1155/2015/252717, 10.1155/2015/256536]; Lombardo F, 2009, ARCH ITAL BIOL, V147, P69; Mitsumoto H, 2007, NEUROLOGY, V68, P1402, DOI 10.1212/01.wnl.0000260065.57832.87; Pioro EP, 1999, NEUROLOGY, V53, P71, DOI 10.1212/WNL.53.1.71; Pioro EP, 1997, J NEUROL SCI, V152, pS49, DOI 10.1016/S0022-510X(97)00244-X; Pohl C, 2001, ARCH NEUROL-CHICAGO, V58, P729, DOI 10.1001/archneur.58.5.729; ROTHSTEIN JD, 1990, ANN NEUROL, V28, P18, DOI 10.1002/ana.410280106; ROTHSTEIN JD, 1995, J NEUROCHEM, V65, P643; Rule RR, 2004, AMYOTROPH LATERAL SC, V5, P141, DOI 10.1080/14660820410017109; Sargsyan SA, 2005, GLIA, V51, P241, DOI 10.1002/glia.20210; Schuff N, 2001, MAGN RESON MED, V45, P513, DOI 10.1002/1522-2594(200103)45:3<513::AID-MRM1067>3.0.CO;2-D; Shiino A, 2012, J CEREBR BLOOD F MET, V32, P805, DOI 10.1038/jcbfm.2012.9; Sivak S, 2010, NEURORADIOLOGY, V52, P1079, DOI 10.1007/s00234-010-0685-6; Sudharshan N, 2011, AM J NEURORADIOL, V32, P403, DOI 10.3174/ajnr.A2289; Tiret B, 2015, NEUROCHEM RES, V40, P2482, DOI 10.1007/s11064-015-1748-1; Tkac I, 1999, MAGNET RESON MED, V41, P649, DOI 10.1002/(SICI)1522-2594(199904)41:4<649::AID-MRM2>3.0.CO;2-G; Tkac I, 2001, MAGNET RESON MED, V46, P451, DOI 10.1002/mrm.1213; Tkac I, 2009, MAGN RESON MED, V62, P868, DOI 10.1002/mrm.22086; Turner MR, 2013, AMYOTROPH LAT SCL FR, V14, P19, DOI 10.3109/21678421.2013.778554; Turner MR, 2013, LANCET NEUROL, V12, P310, DOI 10.1016/S1474-4422(13)70036-X; Turner Martin R, 2010, Expert Opin Med Diagn, V4, P483, DOI 10.1517/17530059.2010.536836; Unrath A, 2007, J NEUROL, V254, P1099, DOI 10.1007/s00415-006-0495-2; URENJAK J, 1993, J NEUROSCI, V13, P981, DOI 10.1523/jneurosci.13-03-00981.1993; van der Graaff MM, 2010, AM J NEURORADIOL, V31, P1799, DOI 10.3174/ajnr.A2217; Verma G, 2013, RADIOLOGY, V267, P851, DOI 10.1148/radiol.13121148; Wang SM, 2006, RADIOLOGY, V239, P831, DOI 10.1148/radiol.2393050573; Wang SM, 2011, NEUROTHERAPEUTICS, V8, P63, DOI 10.1007/s13311-010-0011-3; Weiduschat N, 2014, NEUROSCI LETT, V570, P102, DOI 10.1016/j.neulet.2014.04.020; Zurcher NR, 2015, NEUROIMAGE-CLIN, V7, P409, DOI 10.1016/j.nicl.2015.01.009	58	36	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177680	10.1371/journal.pone.0177680	http://dx.doi.org/10.1371/journal.pone.0177680			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498852	Green Submitted, Green Published, gold			2022-12-26	WOS:000401314500041
J	Wu, L; Feng, XQ; He, AX; Ding, Y; Zhou, XW; Xu, ZC				Wu, Lei; Feng, Xueqin; He, Axin; Ding, Yi; Zhou, Xiuwen; Xu, Zhice			Prenatal exposure to the Great Chinese Famine and mid-age hypertension	PLOS ONE			English	Article							DUTCH-HUNGER-WINTER; BLOOD-PRESSURE; RISK; DISEASE; HEALTH; PREVALENCE; ORIGIN; ADULTS; LIFE	Background One of the most terrible famines last century was Great Chinese Famine (GCF) in 1959-1961 when millions of people died from starving. Under-nutrition during famine between the Western and Eastern (Dutch Hungry vs. GCF) was similar, while cardiovascular consequences might not be the same. Addressing such questions may gain new insight into prevention of cardiovascular diseases. Methods A retrospective cohort of 18,593 participants aged 43-49 years of old, was from Suzhou, China. Logistic regression model was used to calculate the relative risk (RR) of hypertension and corresponding 95% confidence interval (CI). The multivariate RRs were adjusted for age, plasma glucose, triglyceride, and cholesterol. Results The multivariate RRs of systolic and diastolic pressure were not significantly elevated in the rural subgroups, but was higher in the urban population born in the famine (systolic pressure adjust RR 1.382, 95% CI 1.235-1.545, diastolic pressure adjust RR 1.569, 95% CI 1.415-1.740). The risks of hypertension were significantly higher among the urban subjects than that in the rural subgroups (systolic hypertension adjust RR 2.915, 95% CI 2.616-3.249, diastolic hypertension adjust RR 4.568, 95% CI 4.079-5.116). Percentile of optimal diastolic pressure at mid-age was significantly lower in the urban population prenatally exposed to the famine regardless of sexes. However, a similar reduction of percentage of optimal systolic pressure was only seen in the female, not the male population in the urban region. Conclusion The data suggest Asian genetic basis was not able to block famine-programmed vascular diseases as that happened in Europe, and the programmed problems due to under-nutrition could be reversed after birth. Protective mechanisms may be related to diet habits before age of 30 years old, which is important contribution to early prevention of hypertension.	[Wu, Lei; Feng, Xueqin; He, Axin; Zhou, Xiuwen; Xu, Zhice] Soochow Univ, Hosp 1, Inst Fetol, Suzhou, Jiangsu, Peoples R China; [Wu, Lei; Feng, Xueqin; He, Axin; Zhou, Xiuwen; Xu, Zhice] Soochow Univ, Hosp 1, Reprod Med Ctr, Suzhou, Jiangsu, Peoples R China; [Wu, Lei; Ding, Yi] Suzhou Ind Pk Ctr Dis Control & Prevent, Suzhou, Jiangsu, Peoples R China; [Xu, Zhice] Loma Linda Univ, Ctr Perinatal Biol, Loma Linda, CA 92350 USA	Soochow University - China; Soochow University - China; Loma Linda University	Zhou, XW; Xu, ZC (corresponding author), Soochow Univ, Hosp 1, Inst Fetol, Suzhou, Jiangsu, Peoples R China.; Zhou, XW; Xu, ZC (corresponding author), Soochow Univ, Hosp 1, Reprod Med Ctr, Suzhou, Jiangsu, Peoples R China.; Xu, ZC (corresponding author), Loma Linda Univ, Ctr Perinatal Biol, Loma Linda, CA 92350 USA.	xiuwen-z@163.com; xuzhice@suda.edu.cn			Ministry of Science and Technology of the People's Republic of China [81320108006]; Science and Technology Department of Jiangsu Province [BK20160297]; Bureau of Science and Technology of Suzhou Municipality [SYS201405]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); Science and Technology Department of Jiangsu Province; Bureau of Science and Technology of Suzhou Municipality	This work was supported by the Ministry of Science and Technology of the People's Republic of China, 81320108006, (http://www.nsfc.gov.cn/) to ZX; Science and Technology Department of Jiangsu Province, BK20160297, (http://www.jstd.gov.cn/) to XZ and the Bureau of Science and Technology of Suzhou Municipality, SYS201405, (http://www.szkj.gov.cn/) to LW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker D, 1999, PUBLIC HLTH, V113; Barker DJP, 2004, J AM COLL NUTR, V23, p588S, DOI 10.1080/07315724.2004.10719428; Barker DJP, 2001, MONATSSCHR KINDERH, V149, pS2, DOI 10.1007/s001120170002; Barker DJP, 1998, MOTHERS BABIES HLTH; Baskar V, 2006, DIABETES OBES METAB, V8, P214, DOI 10.1111/j.1463-1326.2005.00485.x; BROWN AS, 1995, BRIT J PSYCHIAT, V166, P601, DOI 10.1192/bjp.166.5.601; Brown AS, 1997, EPIDEMIOLOGY, V8, P55, DOI 10.1097/00001648-199701000-00009; Brown AS, 2000, AM J PSYCHIAT, V157, P190, DOI 10.1176/appi.ajp.157.2.190; Cappuccio FP, 1997, J HUM HYPERTENS, V11, P571, DOI 10.1038/sj.jhh.1000516; Daliao X, 2009, HYPERTENSION, V53, P937; de Rooij SR, 2006, DIABETES CARE, V29, P1897, DOI 10.2337/dc06-0460; Edwards LJ, 2001, CLIN EXP PHARMACOL P, V28, P938, DOI 10.1046/j.1440-1681.2001.03553.x; Forman JP, 2009, JAMA-J AM MED ASSOC, V302, P401, DOI 10.1001/jama.2009.1060; Franzek EJ, 2008, ADDICTION, V103, P433, DOI 10.1111/j.1360-0443.2007.02084.x; Howard BV, 2006, JAMA-J AM MED ASSOC, V295, P655, DOI 10.1001/jama.295.6.655; Irwin B, 2014, PEDIATR ANN, V67, P738; Krupp D, 2015, EUR J NUTR, V54, P1269, DOI 10.1007/s00394-014-0804-y; Liu L.S., 2010, ZHONGHUA XIN XUE GUA, V39, P579; Lohmueller KE, 2006, ANN HUM GENET, V70, P27, DOI 10.1111/j.1529-8817.2005.00197.x; Painter RC, 2006, J HYPERTENS, V24, P1771, DOI 10.1097/01.hjh.0000242401.45591.e7; Patrick B, 2004, NATURE, V430, P419; Roseboom T, 2006, EARLY HUM DEV, V82, P485, DOI 10.1016/j.earlhumdev.2006.07.001; Roseboom TJ, 2003, PAEDIATR PERINAT EP, V17, P391, DOI 10.1046/j.1365-3016.2003.00516.x; Sethi AA, 2003, ARTERIOSCL THROM VAS, V23, P1269, DOI 10.1161/01.ATV.0000079007.40884.5C; Smil V, 1999, BMJ-BRIT MED J, V319, P1619, DOI 10.1136/bmj.319.7225.1619; Somm E, 2009, MOL CELL ENDOCRINOL, V304, P69, DOI 10.1016/j.mce.2009.02.026; Stein AD, 2006, EUR J EPIDEMIOL, V21, P759, DOI 10.1007/s10654-006-9065-2; TRUSWELL AS, 1985, BRIT MED J, V291, P125, DOI 10.1136/bmj.291.6488.125; Vitale C, 2009, NAT REV CARDIOL, V6, P532, DOI 10.1038/nrcardio.2009.105; Wu XG, 1995, INT J CARDIOL, V52, P39, DOI 10.1016/0167-5273(95)02443-Z	30	16	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0176413	10.1371/journal.pone.0176413	http://dx.doi.org/10.1371/journal.pone.0176413			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498832	Green Submitted, Green Published, gold			2022-12-26	WOS:000401314500004
J	Agbadi, P; Urke, HB; Mittelmark, MB				Agbadi, Pascal; Urke, Helga Bjornoy; Mittelmark, Maurice B.			Household food security and adequacy of child diet in the food insecure region north in Ghana	PLOS ONE			English	Article							COMPLEMENTARY FEEDING PRACTICES; AGED 6-23 MONTHS; NUTRITIONAL-STATUS; ASSOCIATIONS; DETERMINANTS; INDICATORS; DIVERSITY; INFANT; INDEX	Background and objectives Adequate diet is of crucial importance for healthy child development. In food insecure areas of the world, the provision of adequate child diet is threatened in the many households that sometimes experience having no food at all to eat (household food insecurity). In the context of food insecure northern Ghana, this study investigated the relationship between level of household food security and achievement of recommended child diet as measured by WHO Infant and Young Child Feeding Indicators. Methods Using data from households and 6-23 month old children in the 2012 Feed the Future baseline survey (n = 871), descriptive analyses assessed the prevalence of minimum meal frequency; minimum dietary diversity, and minimum acceptable diet. Logistic regression analysis was used to examine the association of minimum acceptable diet with household food security, while accounting for the effects of child sex and age, maternal-age,-dietary diversity,-literacy and-education, household size, region, and urban-rural setting. Household food security was assessed with the Household Hunger Scale developed by USAID's Food and Nutrition Technical Assistance Project. Results Forty-nine percent of children received minimum recommended meal frequency, 31% received minimum dietary diversity, and 17% of the children received minimum acceptable diet. Sixty-four percent of the children lived in food secure households, and they were significantly more likely than children in food insecure households to receive recommended minimum acceptable diet [O.R = 0.53; 95% CI: 0.35, 0.82]. However, in 80% of food secure households, children did not receive a minimal acceptable diet by WHO standards. Conclusions Children living in food secure households were more likely than others to receive a minimum acceptable diet. Yet living in a food secure household was no guarantee of child dietary adequacy, since eight of 10 children in food secure households received less than a minimum acceptable diet. The results call for research into factors besides household food security in the search for determinants of child diet adequacy. In this study at least, household food security was a very weak marker of child diet adequacy. This finding is of significance to public health practice, since it calls into question any assumption that having enough food in a household necessarily results in adequately fed children.	[Agbadi, Pascal; Urke, Helga Bjornoy; Mittelmark, Maurice B.] Univ Bergen, Fac Psychol, Dept Hlth Promot & Dev, Bergen, Norway	University of Bergen	Urke, HB (corresponding author), Univ Bergen, Fac Psychol, Dept Hlth Promot & Dev, Bergen, Norway.	helga.urke@uib.no	Agbadi, Pascal/AAS-6842-2020	Agbadi, Pascal/0000-0001-5297-2512				Abafita J, 2013, J RURAL DEVELOP, V37, P129; Amanor-Boadu V., 2013, DISTRICT LEVEL ANAL; Amugsi D. A., 2014, British Journal of Medicine and Medical Research, V4, P4310, DOI 10.9734/BJMMR/2014/10014; Amugsi DA., 2015, CHILD CARE PRACTICES; Amugsi DA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-960; Amugsi DA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136748; [Anonymous], 2011, HOUSEHOLD HUNGER SCA; Arimond M, 2004, J NUTR, V134, P2579, DOI 10.1093/jn/134.10.2579; Beyene A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1804-4; Bond T., 2001, APPL RASCH MODEL FUN; Deitchler M., 2010, VALIDATION MEASURE H; Dewey KG., 2003, GUIDING PRINCIPLES C; Disha A. D., 2012, African Journal of Food, Agriculture, Nutrition and Development, V12, P5895; Du Plessis LM, 2013, S AFR J CLIN NUTR, pS129; Faber M., 2009, International Journal of Food Safety, Nutrition and Public Health, V2, P1, DOI 10.1504/IJFSNPH.2009.026915; FAO, 2009, DECL WORLD SUMM FOOD; FAO, 1996, WORLD FOOD SUMMIT; FTF, 2010, FEED FUT GUID; GFSI, 2014, FOOD SEC FOC SUB SAH; Ghana Statistical Service (GSS) Ghana Health Service (GHS) ICF Macro., 2009, GHAN DEM HLTH SURV 2; Humphries DL, 2015, J NUTR, V145, P1924, DOI 10.3945/jn.115.210229; Issaka AI, 2015, MATERN CHILD NUTR, V11, P14, DOI 10.1111/mcn.12194; Issaka AI, 2015, MATERN CHILD NUTR, V11, P31, DOI 10.1111/mcn.12193; Joshi N, 2012, MATERN CHILD NUTR, V8, P45, DOI 10.1111/j.1740-8709.2011.00384.x; Kennedy G., 2011, GUID MEAS HOUS IND D; Lutter CK, 2011, PEDIATRICS, V128, pE1418, DOI 10.1542/peds.2011-1392; Marriott BP, 2012, MATERN CHILD NUTR, V8, P354, DOI 10.1111/j.1740-8709.2011.00380.x; Matanda DJ, 2015, CHILD PHYS GROWTH CA; Maxwell D, 2013, DIFFERENT INDICATORS; Mensah O., 2013, GLOBAL ADV RES J AGR, V2; METSS-Ghana, 2012, FTF GHANA POP BAS SU; Ng CS, 2012, PUBLIC HEALTH NUTR, V15, P827, DOI 10.1017/S1368980011002485; Nguyen PH, 2013, J NUTR, V143, P1176, DOI 10.3945/jn.112.172247; Nord M, 2007, J NUTR, V137, P533, DOI 10.1093/jn/137.3.533; Osei A, 2010, FOOD NUTR BULL, V31, P483, DOI 10.1177/156482651003100402; Reinbott A, 2015, PAEDIATR INT CHILD H, V35, P124, DOI 10.1179/2046905514Y.0000000155; Renzaho AMN, 2010, NUTRITION, V26, P1, DOI 10.1016/j.nut.2009.05.001; Rosas LG, 2009, J AM DIET ASSOC, V109, P2001, DOI 10.1016/j.jada.2009.09.004; Saaka M, 2015, BMC PUBLIC HEALTH, V15, P1; Sasson A, 2012, AGR FOOD SECURITY, V1, P1, DOI [10.1186/2048-7010-1-2, DOI 10.1186/2048-7010-1-2]; Sawadogo PS, 2006, J NUTR, V136, P656, DOI 10.1093/jn/136.3.656; Stanturf J. A., 2011, GHANA CLIMATE CHANGE; Stewart CP, 2013, MATERN CHILD NUTR, V9, P27, DOI 10.1111/mcn.12088; Tefera T., 2014, J FOOD SECURITY, V2, P92, DOI [10.12691/jfs-2-3-4, DOI 10.12691/JFS-2-3-4]; The Economist Group, 2017, GLOB FOOD SECUR-AGR; USAID, 2012, MAT DIET DIV IMPL CH; Victor R, 2014, MATERN CHILD NUTR, V10, P545, DOI 10.1111/j.1740-8709.2012.00435.x; WHO, 2009, INF YOUNG CHILD FEED; Zeitlin M, 1996, PARENTS CULTURAL BEL, P408; Zereyesus YA, 2014, BASELINE FEED FUTURE	51	26	26	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177377	10.1371/journal.pone.0177377	http://dx.doi.org/10.1371/journal.pone.0177377			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28494024	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314300096
J	Armero, VES; Tremblay, MP; Allaire, A; Boudreault, S; Martenon-Brodeur, C; Duval, C; Durand, M; Lapointe, E; Thibault, P; Tremblay-Letourneau, M; Perreault, JP; Scott, MS; Bisaillon, M				Armero, Victoria E. S.; Tremblay, Marie-Pier; Allaire, Andrea; Boudreault, Simon; Martenon-Brodeur, Camille; Duval, Cyntia; Durand, Mathieu; Lapointe, Elvy; Thibault, Philippe; Tremblay-Letourneau, Maude; Perreault, Jean-Pierre; Scott, Michelle S.; Bisaillon, Martin			Transcriptome-wide analysis of alternative RNA splicing events in Epstein-Barr virus-associated gastric carcinomas	PLOS ONE			English	Article							MESSENGER-RNA; RIBONUCLEOPROTEIN-K; NUCLEAR EXPORT; PROTEIN; CANCER; EXPRESSION; MULTIPLE; IDENTIFICATION; PROLIFERATION; INHIBITION	Multiple human diseases including cancer have been associated with a dysregulation in RNA splicing patterns. In the current study, modifications to the global RNA splicing landscape of cellular genes were investigated in the context of Epstein-Barr virus-associated gastric cancer. Global alterations to the RNA splicing landscape of cellular genes was examined in a large-scale screen from 295 primary gastric adenocarcinomas using high-throughput RNA sequencing data. RT-PCR analysis, mass spectrometry, and co-immuno-precipitation studies were also used to experimentally validate and investigate the differential alternative splicing (AS) events that were observed through RNA-seq studies. Our study identifies alterations in the AS patterns of approximately 900 genes such as tumor suppressor genes, transcription factors, splicing factors, and kinases. These findings allowed the identification of unique gene signatures for which AS is misregulated in both Epstein-Barr virus-associated gastric cancer and EBV-negative gastric cancer. Moreover, we show that the expression of Epstein-Barr nuclear antigen 1 (EBNA1) leads to modifications in the AS profile of cellular genes and that the EBNA1 protein interacts with cellular splicing factors. These findings provide insights into the molecular differences between various types of gastric cancer and suggest a role for the EBNA1 protein in the dysregulation of cellular AS.	[Armero, Victoria E. S.; Tremblay, Marie-Pier; Allaire, Andrea; Boudreault, Simon; Martenon-Brodeur, Camille; Duval, Cyntia; Tremblay-Letourneau, Maude; Perreault, Jean-Pierre; Scott, Michelle S.; Bisaillon, Martin] Univ Sherbrooke, Fac Med & Sci Sante, Dept Med, Sherbrooke, PQ, Canada; [Durand, Mathieu; Lapointe, Elvy; Thibault, Philippe] Univ Sherbrooke, Plateforme RNom, Sherbrooke, PQ, Canada	University of Sherbrooke; University of Sherbrooke	Bisaillon, M (corresponding author), Univ Sherbrooke, Fac Med & Sci Sante, Dept Med, Sherbrooke, PQ, Canada.	Martin.Bisaillon@USherbrooke.ca	Duval, Cyntia/AAF-7468-2021		Centre de recherche du Centre hospitalier universitaire de Sherbrooke; Faculte de medecine et des sciences de la sante de l'Universite de Sherbrooke; Universite de Sherbrooke Research Chair in Structure and Genomic RNA; Fonds de recherche du Quebec-Sante (FRQ-S)	Centre de recherche du Centre hospitalier universitaire de Sherbrooke; Faculte de medecine et des sciences de la sante de l'Universite de Sherbrooke; Universite de Sherbrooke Research Chair in Structure and Genomic RNA; Fonds de recherche du Quebec-Sante (FRQ-S)	This work was supported by grants from the Centre de recherche du Centre hospitalier universitaire de Sherbrooke (M.B. and J.P.P.) and the Faculte de medecine et des sciences de la sante de l'Universite de Sherbrooke (M.B., M.S.S. and J. P.P.). J.P.P. holds the Universite de Sherbrooke Research Chair in Structure and Genomic RNA. M. B. is a Chercheur-boursier Senior from the Fonds de recherche du Quebec-Sante (FRQ-S).	Anczukow O, 2012, NAT STRUCT MOL BIOL, V19, P220, DOI 10.1038/nsmb.2207; Artimo Panu, 2012, Nucleic Acids Res, V40, pW597, DOI 10.1093/nar/gks400; Barboro P, 2009, BRIT J CANCER, V100, P1608, DOI 10.1038/sj.bjc.6605057; Barnhart MD, 2013, CELL REP, V5, P909, DOI 10.1016/j.celrep.2013.10.012; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bechara EG, 2013, MOL CELL, V52, P720, DOI 10.1016/j.molcel.2013.11.010; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Boisvert FM, 2010, MOL CELL PROTEOMICS, V9, P457, DOI 10.1074/mcp.M900429-MCP200; Bonomi S, 2013, INT J CELL BIOL; Borsi L, 1996, INT J CANCER, V66, P632, DOI 10.1002/(SICI)1097-0215(19960529)66:5<632::AID-IJC9>3.0.CO;2-U; Bozzetti F, 1999, ANN SURG, V230, P170, DOI 10.1097/00000658-199908000-00006; Brosseau JP, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1287; Bryant HE, 2001, J VIROL, V75, P4376, DOI 10.1128/JVI.75.9.4376-4385.2001; Chen LC, 2008, CLIN CANCER RES, V14, P3807, DOI 10.1158/1078-0432.CCR-08-0155; Cidon Esther Una, 2011, J Gastrointest Cancer, V42, P127, DOI 10.1007/s12029-010-9161-0; Convertini P, 2014, NUCLEIC ACIDS RES, V42, P4947, DOI 10.1093/nar/gku151; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; da Cunha CB, 2010, LAB INVEST, V90, P1604, DOI 10.1038/labinvest.2010.155; Danan-Gotthold M, 2015, NUCLEIC ACIDS RES, V43, P5130, DOI 10.1093/nar/gkv210; de Noronha CMC, 2001, SCIENCE, V294, P1105, DOI 10.1126/science.1063957; Dicken BJ, 2005, ANN SURG, V241, P27, DOI 10.1097/01.sla.0000149300.28588.23; Drissi R, 2015, MOL CELL PROTEOMICS, V14, P2002, DOI 10.1074/mcp.M115.048991; Enninga J, 2002, SCIENCE, V295, P1523, DOI 10.1126/science.1067861; Fackenthal JD, 2008, DIS MODEL MECH, V1, P37, DOI 10.1242/dmm.000331; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; FORTES P, 1994, EMBO J, V13, P704, DOI 10.1002/j.1460-2075.1994.tb06310.x; Geiser V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022929; Ghigna C, 2005, MOL CELL, V20, P881, DOI 10.1016/j.molcel.2005.10.026; Goswami CP, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-970; Grosso AR, 2008, EMBO REP, V9, P1087, DOI 10.1038/embor.2008.189; Gruhne B, 2009, P NATL ACAD SCI USA, V106, P2313, DOI 10.1073/pnas.0810619106; Gustin KE, 2002, J VIROL, V76, P8787, DOI 10.1128/JVI.76.17.8787-8796.2002; Gustin KE, 2001, EMBO J, V20, P240, DOI 10.1093/emboj/20.1.240; Ivarez E, 2013, PLOS ONE, V8; Jiao XL, 2012, BIOINFORMATICS, V28, P1805, DOI 10.1093/bioinformatics/bts251; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Kieff E, 2001, FIELDS VIROLOGY; Klinck R, 2008, CANCER RES, V68, P657, DOI 10.1158/0008-5472.CAN-07-2580; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kumar M, 2015, J TRANSL MED, V13, P1; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; LeFave CV, 2011, EMBO J, V30, P4084, DOI 10.1038/emboj.2011.259; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li Y, 2008, 2008 PROCEEDINGS OF INFORMATION TECHNOLOGY AND ENVIRONMENTAL SYSTEM SCIENCES: ITESS 2008, VOL 4, P1; Lindberg A, 2002, VIROLOGY, V294, P189, DOI 10.1006/viro.2001.1301; Line A, 2002, CANCER GENET CYTOGEN, V139, P78, DOI 10.1016/S0165-4608(02)00607-6; Liu XY, 2013, J NAT PROD, V76, P685, DOI 10.1021/np300913h; Lu J., 2011, J WIREL COMMUN NETWO, V1, P1, DOI DOI 10.1128/JVI.01531-10; Luo B, 2005, WORLD J GASTROENTERO, V11, P629, DOI 10.3748/wjg.v11.i5.629; Mehta Sunali, 2010, Ther Adv Med Oncol, V2, P125, DOI 10.1177/1758834009360519; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Muranyi W, 2002, SCIENCE, V297, P854, DOI 10.1126/science.1071506; Pawellek A, 2014, J BIOL CHEM, V289, P34683, DOI 10.1074/jbc.M114.590976; Petersen JM, 2000, MOL CELL BIOL, V20, P8590, DOI 10.1128/MCB.20.22.8590-8601.2000; Petersen JM, 2001, P NATL ACAD SCI USA, V98, P8590, DOI 10.1073/pnas.151240998; Pimienta G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124638; Rutkowski AJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8126; SANDRIGOLDIN RM, 1995, J VIROL, V69, P6063, DOI 10.1128/JVI.69.10.6063-6076.1995; Schwerk C, 2005, MOL CELL, V19, P1, DOI 10.1016/j.molcel.2005.05.026; Sciabica KS, 2003, EMBO J, V22, P1608, DOI 10.1093/emboj/cdg166; Scott ES, 2001, J VIROL, V75, P8818, DOI 10.1128/JVI.75.18.8818-8830.2001; Shinozaki-Ushiku A, 2015, INT J ONCOL, V46, P1421, DOI 10.3892/ijo.2015.2856; Siewert JR, 1998, ANN SURG, V228, P449, DOI 10.1097/00000658-199810000-00002; Sivachandran N, 2011, J VIROL, V85, P10425, DOI 10.1128/JVI.05293-11; Smyth EC, 2014, ONCOTARGETS THER, V7, P1001, DOI 10.2147/OTT.S44941; Stamm S, 2012, ALTERNATIVE PREMRNA; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sturgeon CM, 2010, USE TUMOR MARKERS LI; Uozaki H, 2008, INT J CLIN EXP PATHO, V1, P198; Venables JP, 2008, MOL CELL BIOL, V28, P6033, DOI 10.1128/MCB.00726-08; Wang Y, 2014, CANCER CELL, V26, P374, DOI 10.1016/j.ccr.2014.07.010; Wilson JB, 1996, EMBO J, V15, P3117, DOI 10.1002/j.1460-2075.1996.tb00674.x; Wu HH, 2014, EXPERT REV MOL MED, V16, DOI 10.1017/erm.2013.16; Xiao YF, 2016, INT J NANOMED, V11, P3023, DOI 10.2147/IJN.S103648; Xu Jin-Heng, 2008, Ai Zheng, V27, P1271	76	18	20	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176880	10.1371/journal.pone.0176880	http://dx.doi.org/10.1371/journal.pone.0176880			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493890	Green Submitted, Green Published, gold			2022-12-26	WOS:000401314300036
J	Biri-Kovacs, B; Kiss, B; Vadaszi, H; Gogl, G; Palfy, G; Torok, G; Homolya, L; Bodor, A; Nyitray, L				Biri-Kovacs, Beata; Kiss, Bence; Vadaszi, Henrietta; Gogl, Gergo; Palfy, Gyula; Torok, Gyorgy; Homolya, Laszlo; Bodor, Andrea; Nyitray, Laszlo			Ezrin interacts with S100A4 via both its N- and C-terminal domains	PLOS ONE			English	Article							NONMUSCLE MYOSIN-IIA; METASTASIS-ASSOCIATED PROTEIN; TUMOR-SUPPRESSOR P53; ACTIN-BINDING-SITE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; ERM PROTEINS; FERM DOMAIN; ANNEXIN-II; CELL-MIGRATION	Ezrin belongs to the ERM (ezrin, radixin, moesin) protein family that has a role in cell morphology changes, adhesion and migration as an organizer of the cortical cytoskeleton by linking actin filaments to the apical membrane of epithelial cells. It is highly expressed in a variety of human cancers and promotes metastasis. Members of the Ca2+-binding EF-hand containing S100 proteins have similar pathological properties; they are overexpressed in cancer cells and involved in metastatic processes. In this study, using tryptophan fluorescence and stopped-flow kinetics, we show that S100A4 binds to the N-terminal ERM domain (N-ERMAD) of ezrin with a micromolar affinity. The binding involves the F2 lobe of the N-ERMAD and follows an induced fit kinetic mechanism. Interestingly, S100A4 binds also to the unstructured C-terminal actin binding domain (C-ERMAD) with similar affinity. Using NMR spectroscopy, we characterized the complex of S100A4 with the C-ERMAD and demonstrate that no ternary complex is simultaneously formed with the two ezrin domains. Furthermore, we show that S100A4 co-localizes with ezrin in HEK-293T cells. However, S100A4 very weakly binds to full-length ezrin in vitro indicating that the interaction of S100A4 with ezrin requires other regulatory events such as protein phosphorylation and/or membrane binding, shifting the conformational equilibrium of ezrin towards the open state. As both proteins play an important role in promoting metastasis, the characterization of their interaction could shed more light on the molecular events contributing to this pathological process.	[Biri-Kovacs, Beata; Kiss, Bence; Vadaszi, Henrietta; Gogl, Gergo; Nyitray, Laszlo] Eotvos Lorand Univ, Dept Biochem, Budapest, Hungary; [Palfy, Gyula; Bodor, Andrea] Eotvos Lorand Univ, Inst Chem, Lab Struct Chem & Biol, Budapest, Hungary; [Torok, Gyorgy; Homolya, Laszlo] Res Ctr Nat Sci, Mol Cell Biol Res Grp, Inst Enzymol, Budapest, Hungary	Eotvos Lorand University; Eotvos Lorand University; Hungarian Academy of Sciences; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Nyitray, L (corresponding author), Eotvos Lorand Univ, Dept Biochem, Budapest, Hungary.	nyitray@elte.hu	Gogl, Gergo/ABH-4309-2020; Biri-Kovács, Beáta/A-8844-2016; Nyitray, László/AAE-5910-2020; Bodor, Andrea/G-1797-2018; Kiss, Bence/AAF-1808-2020; Homolya, Laszlo/N-1154-2016; Bodor, Andrea/AAL-7854-2020	Gogl, Gergo/0000-0002-8597-3711; Biri-Kovács, Beáta/0000-0001-5803-9969; Nyitray, László/0000-0003-4717-5994; Bodor, Andrea/0000-0002-7422-298X; Homolya, Laszlo/0000-0003-1639-8140; Bodor, Andrea/0000-0002-7422-298X; Palfy, Gyula/0000-0003-1590-5331; Kiss, Bence/0000-0001-5810-5858	National Research, Development and Innovation Office [K108437, K119359]; Momentum Program of the Hungarian Academy of Sciences [LP 2012-025]; MedlnProt program of the Hungarian Academy of Sciences; National Development Agency Grant [KMOP-4.2.1/B-10-2011]; New National Excellence Program of the Ministry of Human Capacities	National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary); Momentum Program of the Hungarian Academy of Sciences; MedlnProt program of the Hungarian Academy of Sciences; National Development Agency Grant; New National Excellence Program of the Ministry of Human Capacities	This work was supported by the National Research, Development and Innovation Office K108437 and K119359 to Laszlo Nyitray and the Momentum Program of the Hungarian Academy of Sciences LP 2012-025 to Laszlo Homolya. We also acknowledge the support of the MedlnProt program of the Hungarian Academy of Sciences and the National Development Agency Grant (KMOP-4.2.1/B-10-2011). Beata Biri-Kovacs was supported through the New National Excellence Program of the Ministry of Human Capacities.	Arpin M, 2011, CELL ADHES MIGR, V5, P199, DOI 10.4161/cam.5.2.15081; Austermann J, 2008, J BIOL CHEM, V283, P29331, DOI 10.1074/jbc.M806145200; Barreiro O, 2002, J CELL BIOL, V157, P1233, DOI 10.1083/jcb.200112126; Barret C, 2000, J CELL BIOL, V151, P1067, DOI 10.1083/jcb.151.5.1067; Biri B, 2016, BIOCHEM J, V473, P31, DOI 10.1042/BJ20150843; Bosk S, 2011, BIOPHYS J, V100, P1708, DOI 10.1016/j.bpj.2011.02.039; Bresnick AR, 2015, NAT REV CANCER, V15, P96, DOI 10.1038/nrc3893; BRETSCHER A, 1989, J CELL BIOL, V108, P921, DOI 10.1083/jcb.108.3.921; Cant SH, 2005, MOL BIOL CELL, V16, P3088, DOI 10.1091/mbc.E04-10-0877; Clucas J, 2015, J CELL SCI, V128, P1253, DOI 10.1242/jcs.170027; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Du M, 2012, J BIOL CHEM, V287, P15330, DOI 10.1074/jbc.M112.349787; Elliott PR, 2012, STRUCTURE, V20, P654, DOI 10.1016/j.str.2012.02.002; Fernandez-Fernandez MR, 2005, P NATL ACAD SCI USA, V102, P4735, DOI 10.1073/pnas.0501459102; Ford HL, 1997, BIOCHEMISTRY-US, V36, P16321, DOI 10.1021/bi971182l; GARY R, 1995, MOL BIOL CELL, V6, P1061, DOI 10.1091/mbc.6.8.1061; Gingras AR, 2008, FEBS LETT, V582, P1651, DOI 10.1016/j.febslet.2008.04.017; Goddard TD, SPARKY 32000; Gogl G, 2016, J BIOL CHEM, V291, P11, DOI 10.1074/jbc.M115.684928; Granes F, 2000, J CELL SCI, V113, P1267; Grigorian M, 2001, J BIOL CHEM, V276, P22699, DOI 10.1074/jbc.M010231200; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; Hamada K, 2003, EMBO J, V22, P502, DOI 10.1093/emboj/cdg039; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Jia J, 2014, CELL, V159, P623, DOI 10.1016/j.cell.2014.09.032; Kang BS, 2002, ACTA CRYSTALLOGR D, V58, P381, DOI 10.1107/S0907444901021175; Keller R., 2004, COMPUTER AIDED RESON, V1; Kiss B, 2016, FEBS J, V283, P2164, DOI 10.1111/febs.13728; Kiss B, 2012, P NATL ACAD SCI USA, V109, P6048, DOI 10.1073/pnas.1114732109; Koltzscher M, 2003, MOL BIOL CELL, V14, P2372, DOI 10.1091/mbc.E02-09-0553; KRIAJEVSKA MV, 1994, J BIOL CHEM, V269, P19679; Lee YT, 2008, BIOCHEMISTRY-US, V47, P10921, DOI 10.1021/bi801233z; Liu YD, 2015, BRIT J PHARMACOL, V172, P1664, DOI 10.1111/bph.12978; Lukanidin E, 2012, SEMIN CANCER BIOL, V22, P216, DOI 10.1016/j.semcancer.2012.02.006; Malashkevich VN, 2008, BIOCHEMISTRY-US, V47, P5111, DOI 10.1021/bi702537s; Martin TA, 2003, CRIT REV ONCOL HEMAT, V46, P165, DOI 10.1016/S1040-8428(02)00172-5; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Mohan SK, 2013, BIOCHEM BIOPH RES CO, V434, P328, DOI 10.1016/j.bbrc.2013.03.049; Neisch AL, 2011, CURR OPIN CELL BIOL, V23, P377, DOI 10.1016/j.ceb.2011.04.011; Ng T, 2001, EMBO J, V20, P2723, DOI 10.1093/emboj/20.11.2723; Palfy G, 2016, CHEMBIOCHEM, V17, P1829, DOI 10.1002/cbic.201600280; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; Penumutchu SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103947; Phang JM, 2016, BIOCHEM J, V473, P2763, DOI 10.1042/BCJ20160541; Quang CT, 2000, EMBO J, V19, P4565, DOI 10.1093/emboj/19.17.4565; Rety S, 1999, NAT STRUCT BIOL, V6, P89; Rezvanpour A, 2011, J BIOL CHEM, V286, P40174, DOI 10.1074/jbc.M111.244038; Rustandi RR, 2000, NAT STRUCT BIOL, V7, P570; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Semov A, 2005, J BIOL CHEM, V280, P20833, DOI 10.1074/jbc.M412653200; Shiue H, 2005, J BIOL CHEM, V280, P1688, DOI 10.1074/jbc.M409471200; Simons PC, 1998, BIOCHEM BIOPH RES CO, V253, P561, DOI 10.1006/bbrc.1998.9823; Smith WJ, 2003, J BIOL CHEM, V278, P4949, DOI 10.1074/jbc.M210601200; Streicher WW, 2009, BIOCHEMISTRY-US, V48, P2788, DOI 10.1021/bi8019959; TURUNEN O, 1994, J CELL BIOL, V126, P1445, DOI 10.1083/jcb.126.6.1445; van Dieck J, 2010, ONCOGENE, V29, P2024, DOI 10.1038/onc.2009.490; van Dieck J, 2009, J MOL BIOL, V394, P922, DOI 10.1016/j.jmb.2009.10.002; van Dieck J, 2009, J BIOL CHEM, V284, P13804, DOI 10.1074/jbc.M901351200; Vogt AD, 2012, BIOCHEMISTRY-US, V51, P5894, DOI 10.1021/bi3006913; YOUNG RM, 1994, BIOPHYS J, V67, P881, DOI 10.1016/S0006-3495(94)80549-1; Zar J.H., 2009, BIOSTATISTICAL ANAL; Zimmer D.B., 2010, CARDIOVASC PSYCHIAT, V2010	62	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177489	10.1371/journal.pone.0177489	http://dx.doi.org/10.1371/journal.pone.0177489			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493957	Green Accepted, Green Submitted, gold, Green Published			2022-12-26	WOS:000401314300120
J	Garcia-Jimenez, A; Teruel-Puche, JA; Berna, J; Rodriguez-Lopez, JN; Tudela, J; Garcia-Canovas, F				Garcia-Jimenez, Antonio; Antonio Teruel-Puche, Jose; Berna, Jose; Neptuno Rodriguez-Lopez, Jose; Tudela, Jose; Garcia-Canovas, Francisco			Action of tyrosinase on alpha and beta-arbutin: A kinetic study	PLOS ONE			English	Article							MUSHROOM TYROSINASE; DEPIGMENTING AGENT; CATALYZED HYDROXYLATION; MELANIN BIOSYNTHESIS; MICHAELIS CONSTANTS; HUMAN MELANOCYTES; ELLAGIC ACID; HYDROQUINONE; MECHANISM; INHIBITORS	The known derivatives from hydroquinone, a and beta-arbutin, are used as depigmenting agents. In this work, we demonstrate that the oxy form of tyrosinase (oxytyrosinase) hydroxylates a and beta-arbutin in ortho position of the phenolic hydroxyl group, giving rise to a complex formed by met-tyrosinase with the hydroxylated a or beta-arbutin. This complex could evolve in two ways: by oxidizing the originated o-diphenol to o-quinone and deoxy-tyrosinase, or by delivering the o-diphenol and met-tyrosinase to the medium, which would produce the self-activation of the system. Note that the quinones generated in both cases are unstable, so the catalysis cannot be studied quantitatively. However, if 3-methyl-2-benzothiazolinone hydrazone hydrochloride hydrate is used, the o-quinone is attacked, so that it becomes an adduct, which can be oxidized by another molecule of o-quinone, generating o-diphenol in the medium. In this way, the system reaches the steady state and originates a chromophore, which, in turn, has a high absorptivity in the visible spectrum. This reaction allowed us to characterize a and beta-arbutin kinetically as substrates of tyrosinase for the first time, obtaining a Michaelis constant values of 6.5 +/- 0.58 mM and 3 +/- 0.19 mM, respectively. The data agree with those from docking studies that showed that the enzyme has a higher affinity for beta-arbutin. Moreover, the catalytic constants obtained by the kinetic studies (catalytic constant = 4.43 +/- 0.33 s(-1) and 3.7 +/- 0.29 s(-1) for a and beta-arbutin respectively) agree with our forecast based on 13 C NMR considerations. This kinetic characterization of alpha and beta-arbutin as substrates of tyrosinase should be taken into account to explain possible adverse effects of these compounds.	[Garcia-Jimenez, Antonio; Neptuno Rodriguez-Lopez, Jose; Tudela, Jose; Garcia-Canovas, Francisco] Univ Murcia, GENZ Grp Res Enzymol, Dept Biochem & Mol Biol A, Reg Campus Int Excellence Campus Mare Nostrum, Murcia, Spain; [Antonio Teruel-Puche, Jose] Univ Murcia, Dept Biochem & Mol Biol A, Grp Mol Interact Membranes, Murcia, Spain; [Berna, Jose] Univ Murcia, Dept Organ Chem, Grp Synthet Organ Chem, Fac Chem, Murcia, Spain	University of Murcia; University of Murcia; University of Murcia	Garcia-Canovas, F (corresponding author), Univ Murcia, GENZ Grp Res Enzymol, Dept Biochem & Mol Biol A, Reg Campus Int Excellence Campus Mare Nostrum, Murcia, Spain.	canovasf@um.es	Puche, José Antonio Teruel/R-4137-2018; Tudela, Jose/M-1278-2014; Berna, Jose/C-9334-2011; Garcia-Canovas, Francisco/M-1290-2014	Puche, José Antonio Teruel/0000-0003-2256-3368; Tudela, Jose/0000-0002-5528-4296; Berna, Jose/0000-0001-7775-3703; Garcia-Canovas, Francisco/0000-0002-8869-067X; Rodriguez-Lopez, Jose Neptuno/0000-0001-6863-1173	Fundacion Seneca (CARM, Murcia, Spain) [19545/PI/14, 19304/PI/14, 19240/PI/ 14]; MINECO (Fondos FEDER) [SAF2016-77241-R, CTQ2014-56887-P]; University of Murcia, Murcia [UMU15452, UMU17766]; University of Murci	Fundacion Seneca (CARM, Murcia, Spain)(Fundacion Seneca); MINECO (Fondos FEDER); University of Murcia, Murcia; University of Murci	This work was supported by the Fundacion Seneca (CARM, Murcia, Spain) under Projects 19545/PI/14, 19304/PI/14 and 19240/PI/ 14; MINECO under Projects SAF2016-77241-R and CTQ2014-56887-P (Co-financing with Fondos FEDER); and University of Murcia, Murcia under Projects UMU15452 and UMU17766. A. Garcia Jimenez has a FPU fellowship from the University of Murcia.	Alvarez-Parrilla E, 2007, FOOD CHEM, V101, P1346, DOI 10.1016/j.foodchem.2006.03.040; Maria-Solano MA, 2016, J MOL CATAL B-ENZYM, V125, P6, DOI 10.1016/j.molcatb.2015.12.008; Avonto C, 2016, INT J COSMETIC SCI, V38, P187, DOI 10.1111/ics.12275; Boissy RE, 2005, EXP DERMATOL, V14, P601, DOI 10.1111/j.0906-6705.2005.00337.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chakraborty AK, 1998, PIGM CELL RES, V11, P206, DOI 10.1111/j.1600-0749.1998.tb00731.x; CHAVIN W, 1980, SCIENCE, V208, P408, DOI 10.1126/science.7367868; Chen WC, 2015, SCI REP-UK, V5, DOI 10.1038/srep07995; Couteau C., 2016, COSMETICS-BASEL, V3, P27, DOI [10.3390/cosmetics3030027, DOI 10.3390/COSMETICS3030027]; Degen GH, 2015, REGUL TOXICOL PHARM, V73, P866, DOI 10.1016/j.yrtph.2015.10.008; Garcia-Molina MD, 2014, REACT KINET MECH CAT, V112, P305, DOI 10.1007/s11144-014-0723-1; Garcia-Molina MD, 2014, BIOORGAN MED CHEM, V22, P3360, DOI 10.1016/j.bmc.2014.04.048; Deri B, 2016, SCI REP-UK, V6, DOI 10.1038/srep34993; Espin JC, 1998, J AGR FOOD CHEM, V46, P2968, DOI 10.1021/jf971045v; Espin JC, 2000, EUR J BIOCHEM, V267, P1270, DOI 10.1046/j.1432-1327.2000.01013.x; Espin JC, 1996, J FOOD SCI, V61, P1177, DOI 10.1111/j.1365-2621.1996.tb10955.x; Fenoll LG, 2002, INT J BIOCHEM CELL B, V34, P332, DOI 10.1016/S1357-2725(01)00133-9; Fenoll LG, 2001, BBA-PROTEIN STRUCT M, V1548, P1, DOI 10.1016/S0167-4838(01)00207-2; FUNAYAMA M, 1995, BIOSCI BIOTECH BIOCH, V59, P143, DOI 10.1271/bbb.59.143; Garcia-Jimenez A, 2017, REACT KINET MECH CAT, V120, P1, DOI 10.1007/s11144-016-1106-6; Garcia-Jimenez A, 2016, BIOORGAN MED CHEM, V24, P4434, DOI 10.1016/j.bmc.2016.07.048; Garcia-Jimenez A, 2016, IUBMB LIFE, V68, P663, DOI 10.1002/iub.1528; Garcia-Molina F, 2007, J AGR FOOD CHEM, V55, P9739, DOI 10.1021/jf0712301; Garcia-Molina F, 2005, J AGR FOOD CHEM, V53, P3702, DOI 10.1021/jf048340h; Hamed SH, 2006, J COSMET SCI, V57, P291; Hori I, 2004, PHYTOTHER RES, V18, P475, DOI 10.1002/ptr.1456; Hsiao NW, 2014, J CHEM INF MODEL, V54, P3099, DOI 10.1021/ci500370x; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Ismaya WT, 2011, BIOCHEMISTRY-US, V50, P5477, DOI 10.1021/bi200395t; Kim S, 2016, NUCLEIC ACIDS RES, V44, pD1202, DOI 10.1093/nar/gkv951; Kolbe L, 2013, J EUR ACAD DERMATOL, V27, P19, DOI 10.1111/jdv.12051; Lim YJ, 2009, ARCH PHARM RES, V32, P367, DOI 10.1007/s12272-009-1309-8; Liu C-Q, 2013, J MICROBIOL BIOTECHN, V29, P1391; Maeda K, 1996, J PHARMACOL EXP THER, V276, P765; Makino ET, 2013, J DRUGS DERMATOL, V12, pS16; Mary Sea Garcia-Molina, 2013, BIOSCI BIOTECH BIOCH, V77, P2383, DOI 10.1271/bbb.130500; Migas P, 2015, PHYTOCHEM LETT, V13, P35, DOI 10.1016/j.phytol.2015.05.015; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Munoz JL, 2006, ANAL BIOCHEM, V351, P128, DOI 10.1016/j.ab.2006.01.011; Nakajima M, 1998, PIGM CELL RES, V11, P12, DOI 10.1111/j.1600-0749.1998.tb00705.x; Nihei KI, 2003, BIOORG MED CHEM LETT, V13, P2409, DOI 10.1016/S0960-894X(03)00395-0; PENNEY KB, 1984, J INVEST DERMATOL, V82, P308, DOI 10.1111/1523-1747.ep12260588; Pillaiyar T, 2015, EXPERT OPIN THER PAT, V25, P775, DOI 10.1517/13543776.2015.1039985; Qin L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109398; Qiu L, 2009, FOOD CHEM, V112, P609, DOI 10.1016/j.foodchem.2008.06.021; Rodriguez-Lopez JN, 2000, BIOCHEMISTRY-US, V39, P10497, DOI 10.1021/bi000539+; RODRIGUEZLOPEZ JN, 1993, BIOCHEM J, V293, P859, DOI 10.1042/bj2930859; RODRIGUEZLOPEZ JN, 1994, ANAL BIOCHEM, V216, P205, DOI 10.1006/abio.1994.1026; SANCHEZFERRER A, 1995, BBA-PROTEIN STRUCT M, V1247, P1; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; SCCS Degen GH, 2016, REGUL TOXICOL PHARM, V74, P75; Scientific J., 2006, SIGMA PLOT 9 0 WINDO; Seo DH, 2012, APPL MICROBIOL BIOT, V95, P1417, DOI 10.1007/s00253-012-4297-4; Stratford MRL, 2012, BIOORGAN MED CHEM, V20, P4364, DOI 10.1016/j.bmc.2012.05.041; Sugimoto K, 2003, CHEM PHARM BULL, V51, P798; Tokiwa Y, 2007, BIOTECHNOL LETT, V29, P481, DOI 10.1007/s10529-006-9267-4; Ortiz-Ruiz CV, 2016, J DERMATOL SCI, V82, P115, DOI 10.1016/j.jdermsci.2016.02.004; Ortiz-Ruiz CV, 2015, IUBMB LIFE, V67, P828, DOI 10.1002/iub.1439; Ortiz-Ruiz CV, 2015, IUBMB LIFE, V67, P757, DOI 10.1002/iub.1432; Ortiz-Ruiz CV, 2015, J AGR FOOD CHEM, V63, P7032, DOI 10.1021/acs.jafc.5b02523; Ortiz-Ruiz CV, 2015, J AGR FOOD CHEM, V63, P2162, DOI 10.1021/jf5051816; Yoshikawa M, 2016, J DERMATOL IN PRESS; Yoshimura M, 2005, BIOSCI BIOTECH BIOCH, V69, P2368, DOI 10.1271/bbb.69.2368; Zheng ZP, 2011, FOOD FUNCT, V2, P259, DOI 10.1039/c1fo10033e	64	37	39	7	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177330	10.1371/journal.pone.0177330	http://dx.doi.org/10.1371/journal.pone.0177330			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493937	gold, Green Published, Green Submitted			2022-12-26	WOS:000401314300088
J	Luo, L; Kim, SW; Lee, HK; Kim, ID; Lee, H; Lee, JK				Luo, Lidan; Kim, Seung-Woo; Lee, Hye-Kyung; Kim, Il-Doo; Lee, Hahnbie; Lee, Ja-Kyeong			Anti-oxidative effects of 4-hydroxybenzyl alcohol in astrocytes confer protective effects in autocrine and paracrine manners	PLOS ONE			English	Article							HEME OXYGENASE-1; GENE-EXPRESSION; REGULATORY MECHANISMS; NRF2; NEURONS; OVEREXPRESSION; STABILIZATION; HIF-1-ALPHA; ACTIVATION; TARGET	4-Hydroxybenzyl alcohol (4-HBA) is an important phenolic constituent of Gastrodia elata Blume (GEB), a traditional herbal medicine used in East Asia. Many activities have been reported to underlie the beneficial effects of 4-HBA in the brain, and in particular, its anti-inflammatory, anti-oxidative, and anti-zinc-toxic effects have been implicated in the postischemic brain. Here, the authors investigated the anti-oxidative effect of 4-HBA on astrocytes and sought to identify the underlying molecular mechanisms involved. 4-HBA dose-dependently suppressed H2O2-induced astrocyte cell death. More specifically, pre-incubation of C6 cells (an astrocyte cell line) with 100 mu M 4-HBA for 6 hrs increased survival when cells were treated with H2O2 (100 mu M, 1 hr) from 54.2 +/- 0.7% to 85.9 +/- 1.5%. In addition, 4-HBA was found to up-regulate and activate Nrf2, and subsequently, to induce the expressions of several anti-oxidative genes, such as, HO-1, NQO1, and GCLM. Notably, HO-1 was induced by 3.4-fold in 4-HBA-treated C6 cells, and siRNA-mediated HO-1 knockdown demonstrated that Nrf2 activation and HO-1 induction were responsible for the observed cytoprotective effect of 4-HBA. ERK and Akt signaling pathways were activated by 4-HBA in C6 cells, suggesting their involvements in protective effect of 4-HBA. In addition, 4-HBA-conditioned astrocyte culture medium was found to have neuroprotective effects on primary neuronal cultures or fresh C6 cells exposed to oxidative stress, and these effects seemed to be mediated by glial cell line-derived neurotrophic factor (GDNF) and vascular endothelial growth factor (VEGF), which both accumulated in 4-HBA-treated astrocyte culture media. Thus, the 4-HBA-mediated activation of Nrf2 and induction of HO-1 in astrocytes were found to act via autocrine and paracrine mechanisms to confer protective effects. Furthermore, given the pleiotropic effects of 4-HBA with respect to its targeting of various brain cell types and functions, it would appear that 4-HBA has therapeutic potential for the prevention and amelioration of various brain diseases.	[Luo, Lidan; Lee, Hye-Kyung; Kim, Il-Doo; Lee, Hahnbie; Lee, Ja-Kyeong] Inha Univ, Dept Anat, Sch Med, Inchon, South Korea; [Luo, Lidan; Kim, Seung-Woo; Lee, Hye-Kyung; Kim, Il-Doo; Lee, Hahnbie; Lee, Ja-Kyeong] Inha Univ, Sch Med, Med Res Ctr, Inchon, South Korea; [Kim, Seung-Woo] Inha Univ, Sch Med, Dept Biomed Sci, Inchon, South Korea	Inha University; Inha University; Inha University	Lee, JK (corresponding author), Inha Univ, Dept Anat, Sch Med, Inchon, South Korea.; Lee, JK (corresponding author), Inha Univ, Sch Med, Med Res Ctr, Inchon, South Korea.	jklee@inha.ac.kr	ja-kyeong, lee/GZL-0409-2022		Mid-career Research Grant from the Korean National Research Foundation [2015R1A2A2A01003395]; Medical Research Center Grant from the Korean National Research Foundation [2014R1A5A2009392]	Mid-career Research Grant from the Korean National Research Foundation; Medical Research Center Grant from the Korean National Research Foundation(National Research Foundation of Korea)	This work was supported by a Mid-career Research Grant (#2015R1A2A2A01003395) from the Korean National Research Foundation (to J.-K.L.) and by a Medical Research Center Grant (#2014R1A5A2009392) from the Korean National Research Foundation (to J.-K.L.).	[Anonymous], ACTA BOT YUNNAN; Chio IIC, 2016, CELL, V166, P963, DOI 10.1016/j.cell.2016.06.056; Cho BR, 2015, BIOMATERIALS, V53, P679, DOI 10.1016/j.biomaterials.2015.02.107; Choi YK, 2010, J BIOL CHEM, V285, P32116, DOI 10.1074/jbc.M110.131284; Cuadrado A, 2008, CURR PHARM DESIGN, V14, P429, DOI 10.2174/138161208783597407; Descamps E, 2009, NEUROSCI RES, V64, P137, DOI 10.1016/j.neures.2009.02.005; Dhiman SB, 2009, CHEM-BIOL INTERACT, V182, P119, DOI 10.1016/j.cbi.2009.07.025; Hung SY, 2008, MOL PHARMACOL, V74, P1564, DOI 10.1124/mol.108.048611; Hus HY, 1986, ORIENTAL MAT MED CON, P662; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jaiswal AK, 2000, FREE RADICAL BIO MED, V29, P254, DOI 10.1016/S0891-5849(00)00306-3; Jeyapaul J, 2000, BIOCHEM PHARMACOL, V59, P1433, DOI 10.1016/S0006-2952(00)00256-2; Kam KY, 2011, MOL CELLS, V31, P209, DOI 10.1007/s10059-011-0028-4; Kim HJ, 2007, BRAIN RES, V1181, P130, DOI 10.1016/j.brainres.2007.08.066; Kim SW, 2011, MOL PHARMACOL, V79, P220, DOI 10.1124/mol.110.067520; Kim SW, 2013, IEEE ICCE, P65, DOI 10.1109/ICCE.2013.6486797; Lakkisto P, 2010, EUR J PHARMACOL, V635, P156, DOI 10.1016/j.ejphar.2010.02.050; Lau A, 2008, PHARMACOL RES, V58, P262, DOI 10.1016/j.phrs.2008.09.003; Lee H, 2016, ANIM CELLS SYST, V20, P246, DOI 10.1080/19768354.2016.1223169; Lee PJ, 1996, P NATL ACAD SCI USA, V93, P10393, DOI 10.1073/pnas.93.19.10393; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Li WG, 2006, J BIOL CHEM, V281, P27251, DOI 10.1074/jbc.M602746200; Lim EJ, 2007, J PHARM PHARMACOL, V59, P1235, DOI 10.1211/jpp.59.9.0007; MAINES MD, 1988, FASEB J, V2, P2557, DOI 10.1096/fasebj.2.10.3290025; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Ryter SW, 2002, ANTIOXID REDOX SIGN, V4, P625, DOI 10.1089/15230860260220120; Sandhu JK, 2009, NEUROBIOL DIS, V33, P405, DOI 10.1016/j.nbd.2008.11.016; Shih AY, 2003, J NEUROSCI, V23, P3394, DOI 10.1523/jneurosci.23-08-03394.2003; Shin JH, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/919650; Wan YQ, 2007, J NEUROSCI RES, V85, P73, DOI 10.1002/jnr.21091; Wang H., 2012, WAP C SERIES ED SOCI, V2012, P1, DOI DOI 10.1093/IJICT/CTS043; Wild AC, 1999, J BIOL CHEM, V274, P33627, DOI 10.1074/jbc.274.47.33627; Willis D, 1996, NAT MED, V2, P87, DOI 10.1038/nm0196-87; Wu KW, 2015, NEUROSCIENCE, V298, P94, DOI 10.1016/j.neuroscience.2015.04.015; Yang CH, 2009, BRAIN RES, V1282, P133, DOI 10.1016/j.brainres.2009.05.009; Yu SS, 2011, NEUROCHEM RES, V36, P339, DOI 10.1007/s11064-010-0335-8; Yu SS, 2010, BRAIN RES, V1308, P167, DOI 10.1016/j.brainres.2009.10.037; Yu SS, 2013, NEUROCHEM RES, V38, P1501, DOI 10.1007/s11064-013-1052-x; Yu SJ, 2005, BIOL PHARM BULL, V28, P1016, DOI 10.1248/bpb.28.1016; Yue P, 2017, NEUROCHEM RES; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003	42	16	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177322	10.1371/journal.pone.0177322	http://dx.doi.org/10.1371/journal.pone.0177322			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489907	Green Submitted, Green Published, gold			2022-12-26	WOS:000401314100061
J	Eppinga, H; Thio, HB; Schreurs, MWJ; Blakaj, B; Tahitu, RI; Konstantinov, SR; Peppelenbosch, MP; Fuhler, GM				Eppinga, Hester; Thio, H. Bing; Schreurs, Marco W. J.; Blakaj, Blerdi; Tahitu, Ruena I.; Konstantinov, Sergey R.; Peppelenbosch, Maikel P.; Fuhler, Gwenny M.			Depletion of Saccharomyces cerevisiae in psoriasis patients, restored by Dimethylfumarate therapy (DMF)	PLOS ONE			English	Article							CONTACT-DERMATITIS; DISEASE; PATHWAYS; SURGERY; RISK	Background Psoriasis and inflammatory bowel disease (IBD) are chronic inflammatory diseases sharing similar pathogenic pathways. Intestinal microbial changes such as a decrease of bakers' yeast Saccharomyces cerevisiae have been reported in IBD, suggesting the presence of a gut-skin axis. Objective To investigate whether the S. cerevisiae abundance was altered in psoriasis patients versus healthy controls, and whether dimethylfumarate (DMF) interacted with this yeast. Methods Using qPCR, faecal samples were compared between psoriasis patients without DMF (n = 30), psoriasis patients with DMF (n = 28), and healthy controls (n = 32). Results Faecal S. cerevisiae abundance was decreased in psoriasis compared to healthy controls (p<0.001). Interestingly, DMF use raised S. cerevisiae levels (p<0.001). Gastrointestinal adverse-effects of DMF were correlated with a higher S. cerevisiae abundance (p = 0.010). In vitro, a direct effect of DMF on S. cerevisiae growth was observed. In addition, anti-Saccharomyces cerevisiae antibodies were not elevated in psoriasis. Conclusion The abundance of baker's yeast S. cerevisiae is decreased in psoriasis patients, but appears to be restored upon DMF use. S. cerevisiae is generally classified as a yeast with beneficial immunomodulatory properties, but may also be involved in the occurrence of DMF's gastrointestinal adverse-effects. Potentially, DMF might be a new therapy for IBD.	[Eppinga, Hester; Thio, H. Bing; Tahitu, Ruena I.] Erasmus MC Univ Med Ctr, Dept Dermatol, Rotterdam, Netherlands; [Eppinga, Hester; Blakaj, Blerdi; Konstantinov, Sergey R.; Peppelenbosch, Maikel P.; Fuhler, Gwenny M.] Erasmus MC Univ Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [Schreurs, Marco W. J.] Erasmus MC Univ Med Ctr, Dept Immunol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Fuhler, GM (corresponding author), Erasmus MC Univ Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands.	g.fuhler@erasmusmc.nl	Fuhler, Gwenny/AAC-7122-2019; Peppelenbosch, Maikel P./U-5304-2019	Fuhler, Gwenny/0000-0001-9221-4855; Peppelenbosch, Maikel/0000-0001-9112-6028				Aterido A, 2016, J INVEST DERMATOL, V136, P593, DOI 10.1016/j.jid.2015.11.026; Atwan A, 2016, BR J DERMATOL; Casili G, 2016, J CROHNS COLITIS, V10, P472, DOI 10.1093/ecco-jcc/jjv231; D'Erme AM, 2012, INT J DERMATOL, V51, P42, DOI 10.1111/j.1365-4632.2011.04916.x; Ellinghaus D, 2016, NAT GENET, V48, P510, DOI 10.1038/ng.3528; Ellinghaus D, 2012, AM J HUM GENET, V90, P636, DOI 10.1016/j.ajhg.2012.02.020; Eppinga H, 2016, J CROHNS COLITIS; Forcione DG, 2004, GUT, V53, P1117, DOI 10.1136/gut.2003.030734; Gaspar LR, 2008, FOOD CHEM TOXICOL, V46, P3493, DOI 10.1016/j.fct.2008.08.028; Gimenez-Arnau A, 2009, CONTACT DERMATITIS, V61, P249, DOI 10.1111/j.1600-0536.2009.01628.x; Jawhara S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040648; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kostic AD, 2014, GASTROENTEROLOGY, V146, P1489, DOI 10.1053/j.gastro.2014.02.009; Lees CW, 2011, GUT, V60, P1739, DOI 10.1136/gut.2009.199679; Maillet J, 2016, ANTISACCHAROMYCES CE; Mrowietz U, 2005, TRENDS MOL MED, V11, P43, DOI 10.1016/j.molmed.2004.11.003; Palma ML, 2015, APPL MICROBIOL BIOT, V99, P6563, DOI 10.1007/s00253-015-6776-x; Perez-Torrado R, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01522; Skroza N, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/983902; Sokol H, 2016, FUNGAL MIROBIOTA DYS; Takada Y, 2014, FEMS YEAST RES, V14, P261, DOI 10.1111/1567-1364.12098; Xu Z, 2015, COCHRANE DB SYST REV, V4; Zhang ZX, 2012, DIGEST DIS SCI, V57, P2944, DOI 10.1007/s10620-012-2244-y	23	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0176955	10.1371/journal.pone.0176955	http://dx.doi.org/10.1371/journal.pone.0176955			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486503	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314000030
J	Horvath, D; Tamas, I; Sipos, A; Darula, Z; Becsi, B; Nagy, D; Ivan, J; Erdodi, F; Lontay, B				Horvath, Daniel; Tamas, Istvan; Sipos, Adrienn; Darula, Zsuzsanna; Becsi, Balint; Nagy, Denes; Ivan, Judit; Erdodi, Ferenc; Lontay, Beata			Myosin phosphatase and RhoA-activated kinase modulate neurotransmitter release by regulating SNAP-25 of SNARE complex	PLOS ONE			English	Article							SYNAPTOSOME-ASSOCIATED PROTEIN; DEPENDENT PHOSPHORYLATION; DIFFERENTIAL PHOSPHORYLATION; MEDIATED REGULATION; LEUKEMIC-CELLS; RAT-BRAIN; VESICLE; EXOCYTOSIS; SYNTAXIN; LOCALIZATION	Reversible phosphorylation of neuronal proteins plays an important role in the regulation of neurotransmitter release. Myosin phosphatase holoenzyme (MP) consists of a protein phosphatase-1 (PP1) catalytic subunit (PP1c) and a regulatory subunit, termed myosin phosphatase targeting subunit (MYPT1). The primary function of MP is to regulate the phosphorylation level of contractile proteins; however, recent studies have shown that MP is localized to neurons, and is also involved in the mediation of neuronal processes. Our goal was to investigate the effect of RhoA-activated kinase (ROK) and MP on the phosphorylation of one potential neuronal substrate, the synaptosomal-associated protein of 25 kDa (SNAP-25). SNAP-25 is a member of the SNARE (soluble N-ethylmaleimide sensitive factor attachment protein receptor) complex, along with synaptobrevin and syntaxin, and the primary role of SNAP25 is to mediate vesicle fusion. We showed that MYPT1 interacts with SNAP-25, as revealed by immunoprecipitation and surface plasmon resonance based binding studies. Mass spectrometry analysis and in vitro phosphorylation/dephosphorylation assays demonstrated that ROK phosphorylates, while MP dephosphorylates, SNAP-25 at Thr138. Silencing MYPT1 in B50 neuroblastoma cells increased phosphorylation of SNAP25 at Thr138. Inhibition of PP1 with tautomycetin increased, whereas inhibition of ROK by H1152, decreased the phosphorylation of SNAP-25 at Thr138 in B50 cells, in cortical synaptosomes, and in brain slices. In response to the transduction of the MP inhibitor, kinaseenhanced PP1 inhibitor (KEPI), into synaptosomes, an increase in phosphorylation of SNAP-25 and a decrease in the extent of neurotransmitter release were detected. The interaction between SNAP-25 and syntaxin increased with decreasing phosphorylation of SNAP-25 at Thr138, upon inhibition of ROK. Our data suggest that ROK/MP play a crucial role in vesicle trafficking, fusion, and neurotransmitter release by oppositely regulating the phosphorylation of SNAP-25 at Thr138.	[Horvath, Daniel; Tamas, Istvan; Sipos, Adrienn; Becsi, Balint; Nagy, Denes; Ivan, Judit; Erdodi, Ferenc; Lontay, Beata] Univ Debrecen, Dept Med Chem, Fac Med, Debrecen, Hungary; [Darula, Zsuzsanna] Hungarian Acad Sci, Prote Res Grp, Biol Res Ctr, Szeged, Hungary; [Becsi, Balint; Ivan, Judit; Erdodi, Ferenc] Univ Debrecen, MTA DE Cell Biol & Signaling Res Grp, Fac Med, Debrecen, Hungary	University of Debrecen; Hungarian Academy of Sciences; Hungarian Biological Research Center; University of Debrecen	Lontay, B (corresponding author), Univ Debrecen, Dept Med Chem, Fac Med, Debrecen, Hungary.	lontay@med.unideb.hu						Baker PR, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008078; Baldwin ML, 2003, J NEUROCHEM, V85, P1190, DOI 10.1046/j.1471-4159.2003.01779.x; BIEMANN K, 1990, METHOD ENZYMOL, V193, P886, DOI 10.1016/0076-6879(90)93460-3; Chen YA, 2001, NEURON, V30, P161, DOI 10.1016/S0896-6273(01)00270-7; Cousin MA, 2000, J NEUROCHEM, V75, P1645, DOI 10.1046/j.1471-4159.2000.0751645.x; Cousin MA, 1999, J NEUROCHEM, V73, P2227, DOI 10.1046/j.1471-4159.1999.0732227.x; Dedinszki D, 2015, CELL SIGNAL, V27, P363, DOI 10.1016/j.cellsig.2014.11.021; Dedinszki D, 2015, BBA-MOL BASIS DIS, V1852, P22, DOI 10.1016/j.bbadis.2014.11.005; Erdodi F, 2003, BIOCHEM BIOPH RES CO, V306, P382, DOI 10.1016/S0006-291X(03)00976-8; Eto M, 2013, BIOCHEM BIOPH RES CO, V434, P137, DOI 10.1016/j.bbrc.2013.03.055; Feng JH, 1999, J BIOL CHEM, V274, P37385, DOI 10.1074/jbc.274.52.37385; Fu J, 2005, J BIOL CHEM, V280, P3178, DOI 10.1074/jbc.M410044200; Gao J, 2016, CELL SIGNAL, V28, P425, DOI 10.1016/j.cellsig.2015.12.014; Gao J, 2012, J BIOL CHEM, V287, P10565, DOI 10.1074/jbc.M111.294645; Genoud S, 1999, J NEUROCHEM, V72, P1699, DOI 10.1046/j.1471-4159.1999.721699.x; Gerst JE, 2003, BBA-MOL CELL RES, V1641, P99, DOI 10.1016/S0167-4889(03)00096-X; Gladycheva SE, 2007, J BIOL CHEM, V282, P22887, DOI 10.1074/jbc.M701787200; Guan SH, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010728; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Hartshorne DJ, 2004, J BIOL CHEM, V279, P37211, DOI 10.1074/jbc.R400018200; Hepp R, 2002, FEBS LETT, V532, P52, DOI 10.1016/S0014-5793(02)03629-3; Kiss A, 2008, CELL SIGNAL, V20, P2059, DOI 10.1016/j.cellsig.2008.07.018; Klenchin VA, 2000, BIOCHIMIE, V82, P399, DOI 10.1016/S0300-9084(00)00208-X; Koszeghy A, 2012, PFLUG ARCH EUR J PHY, V463, P829, DOI 10.1007/s00424-012-1103-1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; Lee HK, 2006, PHARMACOL THERAPEUT, V112, P810, DOI 10.1016/j.pharmthera.2006.06.003; Lontay B, 2004, J COMP NEUROL, V478, P72, DOI 10.1002/cne.20273; Lontay B, 2012, J NEUROCHEM, V123, P84, DOI 10.1111/j.1471-4159.2012.07882.x; Mansuy IM, 2006, TRENDS NEUROSCI, V29, P679, DOI 10.1016/j.tins.2006.10.004; Mathe C, 2009, AQUAT TOXICOL, V92, P122, DOI 10.1016/j.aquatox.2009.02.005; Morgan A, 2005, BIOCHEM SOC T, V33, P1341, DOI 10.1042/BST0331341; Muranyi A, 2005, FEBS LETT, V579, P6611, DOI 10.1016/j.febslet.2005.10.055; Nagy G, 2004, NEURON, V41, P417, DOI 10.1016/S0896-6273(04)00038-8; Nakata Y, 2012, J NEUROSCI, V32, P17186, DOI 10.1523/JNEUROSCI.2220-12.2012; NICHOLS RA, 1989, J NEUROCHEM, V52, P521, DOI 10.1111/j.1471-4159.1989.tb09151.x; Pfeffer SR, 1999, NAT CELL BIOL, V1, pE17, DOI 10.1038/8967; Richards DA, 2003, NEURON, V39, P529, DOI 10.1016/S0896-6273(03)00405-7; Risinger C, 1999, J NEUROCHEM, V72, P614, DOI 10.1046/j.1471-4159.1999.0720614.x; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Sakisaka T, 2004, J CELL BIOL, V166, P17, DOI 10.1083/jcb.200405002; Schiavo G, 1997, P NATL ACAD SCI USA, V94, P997, DOI 10.1073/pnas.94.3.997; Shimazaki Y, 1996, J BIOL CHEM, V271, P14548, DOI 10.1074/jbc.271.24.14548; Shu YL, 2008, J NEUROSCI, V28, P21, DOI 10.1523/JNEUROSCI.2352-07.2008; Sim ATR, 2003, BIOCHEM J, V373, P641, DOI 10.1042/BJ20030484; Snyder DA, 2006, CELL BIOCHEM BIOPHYS, V45, P111, DOI 10.1385/CBB:45:1:111; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Tian JH, 2003, J BIOL CHEM, V278, P26265, DOI 10.1074/jbc.M300492200; Tolar LA, 1998, J NEUROSCI, V18, P10250; Turner KM, 1999, TRENDS NEUROSCI, V22, P459, DOI 10.1016/S0166-2236(99)01436-8; Yang Y, 2007, J GEN PHYSIOL, V129, P233, DOI 10.1085/jgp.200609685	51	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177046	10.1371/journal.pone.0177046	http://dx.doi.org/10.1371/journal.pone.0177046			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486561	gold, Green Published			2022-12-26	WOS:000401314000038
J	Wong, CKM; Kung, K; Au-Doung, PLW; Ip, M; Lee, N; Fung, A; Wong, SYS				Wong, Carmen Ka Man; Kung, Kenny; Au-Doung, Philip Lung Wai; Ip, Margaret; Lee, Nelson; Fung, Alice; Wong, Samuel Yeung Shan			Antibiotic resistance rates and physician antibiotic prescription patterns of uncomplicated urinary tract infections in southern Chinese primary care	PLOS ONE			English	Article							ESCHERICHIA-COLI; ANTIMICROBIAL RESISTANCE; EPIDEMIOLOGY; WOMEN	Uncomplicated urinary tract infections (UTI) are common in primary care. Whilst primary care physicians are called to be antimicrobial stewards, there is limited primary care antibiotic resistance surveillance and physician antibiotic prescription data available in southern Chinese primary care. The study aimed to investigate the antibiotic resistance rate and antibiotic prescription patterns in female patients with uncomplicated UTI. Factors associated with antibiotic resistance and prescription was explored. A prospective cohort study was conducted in 12 primary care group clinics in Hong Kong of patients presenting with symptoms of uncomplicated UTI from January 2012 to December 2013. Patients' characteristics such as age, comorbidity, presenting symptoms and prior antibiotic use were recorded by physicians, as well as any empirical antibiotic prescription given at presentation. Urine samples were collected to test for antibiotic resistance of uropathogens. Univariate analysis was conducted to identify factors associated with antibiotic resistance and prescription. A total of 298 patients were included in the study. E. coli was detected in 107 (76%) out of the 141 positive urine samples. Antibiotic resistance rates of E. coli isolates for ampicillin, co-trimoxazole, ciprofloxacin, amoxicillin and nitrofurantoin were 59.8%, 31.8%, 23.4%, 1.9% and 0.9% respectively. E. coli isolates were sensitive to nitrofurantoin (98.1%) followed by amoxicillin (78.5%). The overall physician antibiotic prescription rate was 82.2%. Amoxicillin (39.6%) and nitrofurantoin (28.6%) were the most common prescribed antibiotics. Meanwhile, whilst physicians in public primary care prescribed more amoxicillin (OR: 2.84, 95% CI: 1.67 to 4.85, P<0.001) and nitrofurantoin (OR: 2.01, 95% CI: 1.14 to 3.55, P = 0.015), physicians in private clinics prescribed more cefuroxime and ciprofloxacin (P<0.05). Matching of antibiotic prescription and antibiotic sensitivity of E. coli isolates occurred in public than private primary care prescriptions (OR: 6.72, 95% CI: 2.07 to 21.80 P = 0.001) and for other uropathogens (OR: 6.19, 95% CI: 1.04 to 36.78 P = 0.034). Mismatching differences of antibiotic prescription and resistance were not evident. In conclusion, nitrofurantoin and amoxicillin should be used as first line antibiotic treatment for uncomplicated UTI. There were significant differences in antibiotic prescription patterns between public and private primary care. Public primary care practitioners were more likely to prescribe first line antibiotic treatment which match antibiotic sensitivity of E. coli isolates and other uropathogens. Further exploration of physician prescribing behaviour and educational interventions, particularly in private primary care may helpful. Meanwhile, development and dissemination of guidelines for primary care management of uncomplicated UTI as well as continued surveillance of antibiotic resistance and physician antibiotic prescription is recommended.	[Wong, Carmen Ka Man; Kung, Kenny; Au-Doung, Philip Lung Wai; Fung, Alice; Wong, Samuel Yeung Shan] Chinese Univ Hong Kong, Fac Med, JC Sch Publ Hlth & Primary Care, Div Family Med & Primary Hlth Care, Hong Kong, Hong Kong, Peoples R China; [Ip, Margaret] Chinese Univ Hong Kong, Fac Med, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Lee, Nelson] Chinese Univ Hong Kong, Fac Med, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Wong, CKM (corresponding author), Chinese Univ Hong Kong, Fac Med, JC Sch Publ Hlth & Primary Care, Div Family Med & Primary Hlth Care, Hong Kong, Hong Kong, Peoples R China.	carmenwong@cuhk.edu.hk	Ip, Margaret/K-1096-2013; WONG, Samuel Yeung Shan/D-7311-2013; Lee, Nelson/B-6418-2008	Ip, Margaret/0000-0003-1291-6537; WONG, Samuel Yeung Shan/0000-0003-0934-6385; Lee, Nelson/0000-0002-0783-6607	Research Fund for the Control of Infectious Disease [CU-10-01-03]	Research Fund for the Control of Infectious Disease	The study was funded by Research Fund for the Control of Infectious Disease (Reference no: CU-10-01-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alos JI, 2005, CLIN MICROBIOL INFEC, V11, P199, DOI 10.1111/j.1469-0691.2004.01057.x; Butler CC, 2006, BRIT J GEN PRACT, V56, P686; Centre of Health Protection. Department of Health, RED BACT RES IMPACT; Centre of Health Protection Hong Kong, BACT PATH IS PERC AN; Flores-Mireles AL, 2015, NAT REV MICROBIOL, V13, P269, DOI 10.1038/nrmicro3432; Foxman B, 2010, NAT REV UROL, V7, P653, DOI 10.1038/nrurol.2010.190; Grude N, 2005, SCAND J PRIM HEALTH, V23, P115, DOI 10.1080/02813430510015287; Gupta K, 2011, CLIN INFECT DIS, V52, pE103, DOI [10.1093/cid/ciq257, 10.1093/cid/cir102]; Ho PL, 2007, DIAGN MICR INFEC DIS, V59, P439, DOI 10.1016/j.diagmicrobio.2007.06.012; Ho PL, 2010, DIAGN MICR INFEC DIS, V66, P87, DOI 10.1016/j.diagmicrobio.2009.03.027; Hooton TM, 2012, NEW ENGL J MED, V366, P1028, DOI 10.1056/NEJMcp1104429; Kahlmeter G, 2003, J ANTIMICROB CHEMOTH, V51, P69, DOI 10.1093/jac/dkg028; Karlowsky JA, 2002, ANTIMICROB AGENTS CH, V46, P2540, DOI 10.1128/AAC.46.8.2540-2545.2002; Li Y, 2005, HONG KONG J EMERG ME, V12, P77; Little P, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5633; Manka W, 2000, DRUG SAFETY, V22, P83, DOI 10.2165/00002018-200022010-00007; Ong DSY, 2008, J ANTIMICROB CHEMOTH, V62, P587, DOI 10.1093/jac/dkn230; Oplinger M, 2013, ANN PHARMACOTHER, V47, P106, DOI 10.1345/aph.1R352; Public Health England, MAN COMM INF GUID PR; RAZ R, 1988, J ANTIMICROB CHEMOTH, V22, P945, DOI 10.1093/jac/22.6.945; Ronald A, 2003, DM-DIS MON, V49, P71, DOI 10.1067/mda.2003.8; Schito GC, 2009, INT J ANTIMICROB AG, V34, P407, DOI 10.1016/j.ijantimicag.2009.04.012; Sotto A, 2001, J CLIN MICROBIOL, V39, P438, DOI 10.1128/JCM.39.2.438-444.2001; Wei XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121269; Zhanel GG, 2005, INT J ANTIMICROB AG, V26, P380, DOI 10.1016/j.ijantimicag.2005.08.003	25	24	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177266	10.1371/journal.pone.0177266	http://dx.doi.org/10.1371/journal.pone.0177266			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486532	Green Submitted, Green Published, gold			2022-12-26	WOS:000401314000067
J	Kang, M; Cha, SY; Jang, HK				Kang, Min; Cha, Se-Yeoun; Jang, Hyung-Kwan			Tropism and infectivity of duck-derived egg drop syndrome virus in chickens	PLOS ONE			English	Article							DNA-REPLICATION; BINDING DOMAIN; EARLY REGION-4; ADENOVIRUS; PROTEIN; EXPRESSION; INHIBITION; ANTIBODIES; SEQUENCE; FIBER	Egg drop syndrome virus (EDSV) can markedly decrease egg production in laying hens. Duck is the natural host of EDSV. EDSV derived from ducks abrogate egg drop in laying hens. We have previously confirmed that duck-derived EDSVs have a variety of replication activities in chick embryo liver (CEL) cells. However, it is currently unclear whether duck-derived EDSV could display tropism and adaptation in laying hens. This study assessed whether duck-derived EDSV can adapt to laying hens, and estimated the inducing factors. Complete genome sequences of duck-derived EDSVs (D11-JW-012, D11-JW-017, and D11-JW-032 isolates) with various replication efficiency in CEL cells and C10-GY-001 isolate causing disease in laying hens were analyzed to find their differences. Phylogenetic analysis of complete genome sequence revealed that C10-GY-001, D11-JW-032, and strain 127 virus as vaccine were clustered into the same group, with D11-JW-012 and D11-JW-017 clustered in another group. Comparison between D11-JW-012 isolate that poorly replicated and D11-JW-017 isolate that replicated well in CEL cells in same cluster revealed six amino acid differences on IVa2, DNA polymerase, endopeptidase, and DNA-binding protein. These amino acids might be key candidates enhancing cellular tropism in chicken. When the pathogenicities of these isolates in laying hens were compared, D11-JW-032 showed severe signs similar to 127 virus, D11-JW-017 showed intermediate signs, while D11-JW-012 showed almost no sign. Eleven amino acids differed between D11-JW-032 and D11-JW-017, and 17 amino acids were different between D11-JW-032 and D11-JW-012. These results suggest that EDSVs derived from ducks have various pathogenicities in laying hens. Key amino acid candidates might have altered their affinity to tropism of laying hens, causing difference pathogenicities.	[Jang, Hyung-Kwan] Chonbuk Natl Univ, Dept Vet Infect Dis & Avian Dis, Coll Vet Med, Iksan, South Korea; Chonbuk Natl Univ, Ctr Poultry Dis Control, Iksan, South Korea	Jeonbuk National University; Jeonbuk National University	Jang, HK (corresponding author), Chonbuk Natl Univ, Dept Vet Infect Dis & Avian Dis, Coll Vet Med, Iksan, South Korea.	hkjang@jbnu.ac.kr			Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries [314023-3, 316039-3, 314004-3, 716002-7]; Research of Animal and Plant Quarantine Agency, South Korea	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries; Research of Animal and Plant Quarantine Agency, South Korea	This work was supported by Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (314023-3, 316039-3, 314004-3, 716002-7) and Research of Animal and Plant Quarantine Agency, South Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair B, 2008, GROUP 1 ADENOVIRUS I, V12, P251; BARTHA A, 1985, ACTA VET HUNG, V33, P125; BRUGH M, 1984, AVIAN DIS, V28, P168, DOI 10.2307/1590139; CALNEK BW, 1978, AVIAN DIS, V22, P798, DOI 10.2307/1589660; Cha SY, 2013, POULTRY SCI, V92, P1783, DOI 10.3382/ps.2013-03067; Christensen JB, 2012, VIROLOGY, V433, P124, DOI 10.1016/j.virol.2012.07.013; Cuesta R, 2004, J VIROL, V78, P7707, DOI 10.1128/JVI.78.14.7707-7716.2004; CUILLEL M, 1987, GENE, V55, P295, DOI 10.1016/0378-1119(87)90289-7; Fu G, 2013, GENOME ANNOUNC; GREEN NM, 1983, EMBO J, V2, P1357, DOI 10.1002/j.1460-2075.1983.tb01592.x; Hess M, 1997, VIROLOGY, V238, P145, DOI 10.1006/viro.1997.8815; Hong SS, 2005, J MOL BIOL, V352, P125, DOI 10.1016/j.jmb.2005.06.070; HUANG MM, 1989, J VIROL, V63, P2605, DOI 10.1128/JVI.63.6.2605-2615.1989; King A.M.Q., 2011, VIRUS TAXONOMY, V1st ed; Liu H, 2003, CURR TOP MICROBIOL, V272, P131; LOUIS N, 1994, J VIROL, V68, P4104, DOI 10.1128/JVI.68.6.4104-4106.1994; MALKINSON M, 1980, AVIAN PATHOL, V9, P421, DOI 10.1080/03079458008418425; MCFERRAN JB, 1978, AVIAN PATHOL, V7, P35, DOI 10.1080/03079457808418258; Raj GD, 2001, AVIAN PATHOL, V30, P21, DOI 10.1080/03079450020023159; Raue R, 1998, J VIROL METHODS, V73, P211, DOI 10.1016/S0166-0934(98)00065-2; Reddy PS, 2006, VIRUS RES, V116, P119, DOI 10.1016/j.virusres.2005.09.005; RICHARDSON WD, 1981, CELL, V27, P133, DOI 10.1016/0092-8674(81)90367-6; SCHLOER GM, 1980, AVIAN DIS, V24, P91, DOI 10.2307/1589769; Thomas NJ, 2008, INFECT DIS WILD BIRD, P182; VANDERVLIET PC, 1973, NATURE-NEW BIOL, V246, P170, DOI 10.1038/newbio246170a0; VILLEGAS P, 1979, AVIAN DIS, V23, P507, DOI 10.2307/1589581; Weber J M, 1995, Curr Top Microbiol Immunol, V199 ( Pt 1), P227; WEINBERG DH, 1986, J VIROL, V57, P833, DOI 10.1128/JVI.57.3.833-838.1986	28	2	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177236	10.1371/journal.pone.0177236	http://dx.doi.org/10.1371/journal.pone.0177236			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481913	gold, Green Published, Green Submitted			2022-12-26	WOS:000401313700042
J	Tascone, LD; Payne, ME; MacFall, J; Azevedo, D; de Castro, CC; Steffens, DC; Busatto, GF; Bottino, CMC				Tascone, Lyssandra dos Santos; Payne, Martha E.; MacFall, James; Azevedo, Dionisio; de Castro, Claudio Campi; Steffens, David C.; Busatto, Geraldo F.; Bottino, Cassio M. C.			Cortical brain volume abnormalities associated with few or multiple neuropsychiatric symptoms in Alzheimer's disease	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; SUPERIOR TEMPORAL GYRUS; COGNITIVE IMPAIRMENT; TALAIRACH ATLAS; CACHE COUNTY; GRAY-MATTER; DEMENTIA; PREVALENCE; INVENTORY; SCHIZOPHRENIA	New research on assessing neuropsychiatric manifestations of Alzheimer's Disease (AD) involves grouping neuropsychiatric symptoms into syndromes. Yet this approach is limited by high inter-subject variability in neuropsychiatric symptoms and a relatively low degree of concordance across studies attempting to cluster neuropsychiatric symptoms into syndromes. An alternative strategy that involves dichotomizing AD subjects into those with few versus multiple neuropsychiatric symptoms is both consonant with real-world clinical practice and can contribute to understanding neurobiological underpinnings of neuropsychiatric symptoms in AD patients. The aim of this study was to address whether the number of neuropsychiatric symptoms (i.e., presence of few [<= 2] versus multiple [<= 3] symptoms) in AD would be associated with degree of significant gray matter (GM) volume loss. Of particular interest was volume loss in brain regions involved in memory, emotional processing and salience brain networks, including the prefrontal, lateral temporal and parietal cortices, anterior cingulate gyrus, temporo-limbic structures and insula. We recruited 19 AD patients and 13 healthy controls, which underwent an MRI and neuropsychiatric assessment. Regional brain volumes were determined using voxel-based morphometry and other advanced imaging processing methods. Our results indicated the presence of different patterns of GM atrophy in the two AD subgroups relative to healthy controls. AD patients with multiple neuropsychiatric manifestations showed more evident GM atrophy in the left superior temporal gyrus and insula as compared with healthy controls. In contrast, AD subjects with few neuropsychiatric symptoms displayed more GM atrophy in prefrontal regions, as well as in the dorsal anterior cingulate ad post-central gyri, as compared with healthy controls. Our findings suggest that the presence of multiple neuropsychiatric symptoms is more related to the degree of atrophy in specific brain networks rather than dependent on the global severity of widespread neurodegenerative brain changes.	[Tascone, Lyssandra dos Santos; Azevedo, Dionisio; Bottino, Cassio M. C.] Univ Sao Paulo, Old Age Res Grp PROTER, Inst Psychiat, Sao Paulo, Brazil; [Tascone, Lyssandra dos Santos; Azevedo, Dionisio; Bottino, Cassio M. C.] Univ Sao Paulo, Old Age Res Grp PROTER, Dept Psychiat, Sao Paulo, Brazil; [Tascone, Lyssandra dos Santos] Minist Educ Brazil, CAPES Fdn, Brasilia, DF, Brazil; [Payne, Martha E.] Duke Univ, Sch Med, Off Res Dev, Durham, NC USA; [MacFall, James] Duke Univ, Dept Radiol, Sch Med, Durham, NC 27710 USA; [de Castro, Claudio Campi] Univ Sao Paulo, Hosp Clin, Dept Diagnost Imaging, Heart Inst nCor, Sao Paulo, Brazil; [Steffens, David C.] Univ Connecticut, Ctr Hlth, Dept Psychiat, Psychiat, Farmington, CT 06032 USA; [Busatto, Geraldo F.] Univ Sao Paulo, Fac Med, Dept Psychiat, Lab Psychiat Neuroimaging, Sao Paulo, Brazil; [Busatto, Geraldo F.] Univ Sao Paulo, Fac Med, Inst Psychiat, Lab Psychiat Neuroimaging, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Duke University; Duke University; Universidade de Sao Paulo; University of Connecticut; Universidade de Sao Paulo; Universidade de Sao Paulo	Tascone, LD (corresponding author), Univ Sao Paulo, Old Age Res Grp PROTER, Inst Psychiat, Sao Paulo, Brazil.; Tascone, LD (corresponding author), Univ Sao Paulo, Old Age Res Grp PROTER, Dept Psychiat, Sao Paulo, Brazil.; Tascone, LD (corresponding author), Minist Educ Brazil, CAPES Fdn, Brasilia, DF, Brazil.	lyss.tascone@gmail.com	Busatto, Geraldo F/D-4431-2009	Busatto, Geraldo F/0000-0003-4749-4602	FAPESP [2012/50329-6]; CNPQ-Brazil	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPQ-Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The first author was grantee of Brazilian Federal Agency for Support and Evaluation of Graduate Education CAPES, Brasilia, DF, Brazil. GFB was supported by FAPESP (2012/50329-6) and CNPQ-Brazil during the development of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalten P, 2005, INT J GERIATR PSYCH, V20, P531, DOI 10.1002/gps.1317; Aalten P, 2003, DEMENT GERIATR COGN, V15, P99, DOI 10.1159/000067972; Aalten P, 2007, DEMENT GERIATR COGN, V24, P457, DOI 10.1159/000110738; Aalten P, 2008, DEMENT GERIATR COGN, V25, P1, DOI 10.1159/000111082; American Psychiatric Association DSM-IV, 1994, DSM 4 DIAGN STAT MAN; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Benoit M, 2005, J NUTR HEALTH AGING, V9, P95; Blanc F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114774; Bottino C. M. C., 1999, ENTREVISTA ESTRUTURA; Bottino CMC, 2008, DEMENT GERIATR COGN, V26, P291, DOI 10.1159/000161053; Bottino CMC, 2001, ARQ NEURO-PSIQUIAT, V59, pS20; Brettschneider J, 2015, NAT REV NEUROSCI, V16, P109, DOI 10.1038/nrn3887; Bruen PD, 2008, BRAIN, V131, P2455, DOI 10.1093/brain/awn151; Camozzato AL, 2008, INT PSYCHOGERIATR, V20, P383, DOI 10.1017/S1041610207006254; Canevelli M, 2013, INT J GERIATR PSYCH, V28, P795, DOI 10.1002/gps.3904; Canu E, 2010, J ALZHEIMERS DIS, V19, P963, DOI 10.3233/JAD-2010-1295; Ceunen E, 2016, FRONT PSYCHOL, P7; Chaves MLF, 2007, ALZ DIS ASSOC DIS, V21, P210; Craig A. D., 2008, HDB EMOTIONS, P272; Craig D, 2005, AM J GERIAT PSYCHIAT, V13, P460, DOI 10.1176/appi.ajgp.13.6.460; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; EBLY EM, 1995, ARCH NEUROL-CHICAGO, V52, P612, DOI 10.1001/archneur.1995.00540300086018; Farber NB, 2000, ARCH GEN PSYCHIAT, V57, P1165, DOI 10.1001/archpsyc.57.12.1165; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Geda YE, 2013, ALZHEIMERS DEMENT, V9, P602, DOI 10.1016/j.jalz.2012.12.001; Grupe DW, 2013, NAT REV NEUROSCI, V14, P488, DOI 10.1038/nrn3524; HACHINSKI VC, 1975, ARCH NEUROL-CHICAGO, V32, P632, DOI 10.1001/archneur.1975.00490510088009; Hu XC, 2015, CURR ALZHEIMER RES, V12, P266, DOI 10.2174/1567205012666150302154914; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Koppel J, 2014, NEUROPSYCH DIS TREAT, V10, P2253, DOI 10.2147/NDT.S60837; Koppel J, 2014, NEUROBIOL AGING, V35, P2021, DOI 10.1016/j.neurobiolaging.2014.03.003; Kragel PA, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0090-15.2016; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lehmann M, 2013, BRAIN, V136, P844, DOI 10.1093/brain/aws327; Levy R, 2006, CEREB CORTEX, V16, P916, DOI 10.1093/cercor/bhj043; Lyketsos CG, 2002, JAMA-J AM MED ASSOC, V288, P1475, DOI 10.1001/jama.288.12.1475; Lyketsos CG, 2001, INT J GERIATR PSYCH, V16, P1037, DOI 10.1002/gps.440; Lyketsos CG, 2001, INT J GERIATR PSYCH, V16, P1043, DOI 10.1002/gps.448; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maldjian JA, 2004, NEUROIMAGE, V21, P450, DOI 10.1016/j.neuroimage.2003.09.032; Mamah D, 2013, J AFFECT DISORDERS, V150, P601, DOI 10.1016/j.jad.2013.01.051; Manoliu A., 2013, SCHIZOPHR B; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McLaren DG, 2010, METHODS, V50, P157, DOI 10.1016/j.ymeth.2009.10.003; Mega MS, 2000, J NEUROL NEUROSUR PS, V69, P167, DOI 10.1136/jnnp.69.2.167; Menon V, 2011, TRENDS COGN SCI, V15, P483, DOI 10.1016/j.tics.2011.08.003; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Mirakhur A, 2004, INT J GERIATR PSYCH, V19, P1035, DOI 10.1002/gps.1203; Moroney J T, 1997, Ann N Y Acad Sci, V826, P490, DOI 10.1111/j.1749-6632.1997.tb48510.x; Nakaaki S, 2013, NEUROPSYCH DIS TREAT, V9, P1, DOI 10.2147/NDT.S38939; Okura T, 2011, J AM GERIATR SOC, V59, P473, DOI 10.1111/j.1532-5415.2011.03314.x; Paulus MP, 2010, BRAIN STRUCT FUNCT, V214, P451, DOI 10.1007/s00429-010-0258-9; Peters KR, 2006, NEUROLOGY, V66, P523, DOI 10.1212/01.wnl.0000198255.84842.06; Ridgway G, 2011, ALZHEIMERS DEMENT, V7, pS62, DOI [10.1016/j.jalz.2011.05.099, DOI 10.1016/J.JALZ.2011.05.099]; Ridgway GR, 2009, NEUROIMAGE, V44, P99, DOI 10.1016/j.neuroimage.2008.08.045; Robert PH, 2005, EUR PSYCHIAT, V20, P490, DOI 10.1016/j.eurpsy.2004.09.031; Rosen HJ, 2005, BRAIN, V128, P2612, DOI 10.1093/brain/awh628; Rosenberg PB, 2015, MOL ASPECTS MED, V43-44, P25, DOI 10.1016/j.mam.2015.05.005; ROTH M, 1986, BRIT J PSYCHIAT, V149, P698, DOI 10.1192/bjp.149.6.698; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Serra L, 2010, J ALZHEIMERS DIS, V21, P627, DOI 10.3233/JAD-2010-100048; Shin IS, 2005, AM J GERIAT PSYCHIAT, V13, P469, DOI 10.1176/appi.ajgp.13.6.469; Spalletta G, 2004, J NEUROL, V251, P688, DOI 10.1007/s00415-004-0403-6; Steinberg M, 2008, INT J GERIATR PSYCH, V23, P170, DOI 10.1002/gps.1858; Summerlin JL., 1997, NEUROIMAGE, V5, pS633, DOI DOI 10.1002/(SICI)1097-0193(1997)5:4<238:AID-HBM6>3.0.C0;2-4; Takahashi T, 2009, ARCH GEN PSYCHIAT, V66, P366, DOI 10.1001/archgenpsychiatry.2009.12; Tatsch MF, 2006, AM J GERIAT PSYCHIAT, V14, P438, DOI 10.1097/01.JGP.0000218218.47279.db; Tekin S, 2001, ANN NEUROL, V49, P355, DOI 10.1002/ana.72; Ting WKC, 2015, CURR ALZHEIMER RES, V12, P165, DOI 10.2174/1567205012666150204130456; Trzepacz Paula T, 2013, Alzheimers Dement, V9, pS95, DOI 10.1016/j.jalz.2012.10.005; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uddin LQ, 2015, NAT REV NEUROSCI, V16, P55, DOI 10.1038/nrn3857; van der Linde RM, 2014, INT J GERIATR PSYCH, V29, P562, DOI 10.1002/gps.4037; van Tol MJ, 2014, NEUROIMAGE-CLIN, V4, P249, DOI 10.1016/j.nicl.2013.12.008; Vermeiren Y, 2014, NEUROBIOL AGING, V35, P2691, DOI 10.1016/j.neurobiolaging.2014.05.031; Vita A, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.116; Wang HD, 2008, NEUROPSYCHOPHARMACOL, V33, P1276, DOI 10.1038/sj.npp.1301521; Warren JD, 2013, TRENDS NEUROSCI, V36, P561, DOI 10.1016/j.tins.2013.06.007; Woodward ND, 2009, NEUROIMAGE, V46, P31, DOI 10.1016/j.neuroimage.2009.01.049	81	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177169	10.1371/journal.pone.0177169	http://dx.doi.org/10.1371/journal.pone.0177169			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UJ	28481904	gold, Green Submitted, Green Published			2022-12-26	WOS:000401313700038
J	Hu, X; Dong, SH; Chen, J; Zhou, XZ; Chen, R; Nair, S; Lu, KP; Chen, LF				Hu, X.; Dong, S-H; Chen, J.; Zhou, X. Z.; Chen, R.; Nair, S.; Lu, K. P.; Chen, L-F			Prolyl isomerase PIN1 regulates the stability, transcriptional activity and oncogenic potential of BRD4	ONCOGENE			English	Article							RNA-POLYMERASE-II; NF-KAPPA-B; BET BROMODOMAIN PROTEINS; BREAST-CANCER; CELL-PROLIFERATION; PROSTATE-CANCER; GASTRIC-CANCER; P-TEFB; INHIBITION; EXPRESSION	BRD4 has emerged as an important factor in tumorigenesis by promoting the transcription of genes involved in cancer development. However, how BRD4 is regulated in cancer cells remains largely unknown. Here, we report that the stability and functions of BRD4 are positively regulated by prolyl isomerase PIN1 in gastric cancer cells. PIN1 directly binds to phosphorylated threonine (T) 204 of BRD4 as revealed by peptide binding and crystallographic studies and enhances BRD4's stability by inhibiting its ubiquitination. PIN1 also catalyses the isomerization of proline 205 of BRD4 and induces its conformational change, which promotes its interaction with CDK9 and increases BRD4's transcriptional activity. Substitution of BRD4 with PIN1-binding-defective BRD4-T204A mutant in gastric cancer cells reduces BRD4's stability, attenuates BRD4-mediated gene expression by impairing its interaction with CDK9 and suppresses gastric cancer cell proliferation, migration and invasion, and tumor formation. Our results identify BRD4 as a new target of PIN1 and suggest that interfering with their interaction could be a potential therapeutic approach for cancer treatment.	[Hu, X.; Dong, S-H; Chen, J.; Nair, S.; Chen, L-F] Univ Illinois, Dept Biochem, Urbana, IL USA; [Zhou, X. Z.; Lu, K. P.] Harvard Med Sch, BIDMC, Dept Med, Div Translat Therapeut, Boston, MA USA; [Chen, R.] Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Peoples R China; [Lu, K. P.] Fujian Med Univ, Inst Translat Med, Fuzhou, Fujian, Peoples R China; [Chen, L-F] Univ Illinois, Coll Med, Dept Med Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Xiamen University; Fujian Medical University; University of Illinois System; University of Illinois Urbana-Champaign	Chen, LF (corresponding author), Univ Illinois, Dept Biochem, 506 S Mathews Ave,MC-714, Urbana, IL 61801 USA.	lfchen@life.illinois.edu	Dong, Shihui/T-4864-2017; Nair, Satish/AAY-2510-2021		UIUC; NIH [DK085158, CA179511]; Natural Science Foundation of China [81361120386]; NATIONAL CANCER INSTITUTE [R01CA167677, R01CA179511] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI117080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085158] Funding Source: NIH RePORTER	UIUC; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members in the Chen lab for discussion. This work is supported in part by fund provided by UIUC (to LFC) and NIH grants DK085158 and CA179511 (to LFC) and Natural Science Foundation of China Grants 81361120386 (to RC).	Ai NP, 2011, NUCLEIC ACIDS RES, V39, P9592, DOI 10.1093/nar/gkr698; Alsarraj J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080746; Alsarraj J, 2011, CANCER RES, V71, P3121, DOI 10.1158/0008-5472.CAN-10-4417; Asangani IA, 2014, NATURE, V510, P278, DOI 10.1038/nature13229; Atkinson GP, 2009, ONCOGENE, V28, P3735, DOI 10.1038/onc.2009.232; Ayala G, 2003, CANCER RES, V63, P6244; Bao L, 2004, AM J PATHOL, V164, P1727, DOI 10.1016/S0002-9440(10)63731-5; Basheer F, 2015, EXP HEMATOL, V43, P718, DOI 10.1016/j.exphem.2015.06.004; Belkina AC, 2012, NAT REV CANCER, V12, P465, DOI 10.1038/nrc3256; Chiang CM, 2009, BIOL REP, V1, P98, DOI DOI 10.3410/B1-98; Chung CW, 2012, PROGR MED CHEM, V51, P1, DOI 10.1016/B978-0-12-396493-9.00001-7; Feng Q, 2014, CELL RES, V24, P809, DOI 10.1038/cr.2014.71; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; FISCHER G, 1984, BIOCHIM BIOPHYS ACTA, V791, P87, DOI 10.1016/0167-4838(84)90285-1; French CA, 2012, ANNU REV PATHOL-MECH, V7, P247, DOI 10.1146/annurev-pathol-011811-132438; Gallagher SJ, 2014, PIGM CELL MELANOMA R, V27, P1126, DOI 10.1111/pcmr.12282; Hsu TI, 2015, ONCOGENE, V34, P826, DOI 10.1038/onc.2014.22; Hu Y, 2015, INT J MOL SCI, V16, P1928, DOI 10.3390/ijms16011928; Huang B, 2009, MOL CELL BIOL, V29, P1375, DOI 10.1128/MCB.01365-08; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jeanmougin F, 1997, TRENDS BIOCHEM SCI, V22, P151, DOI 10.1016/S0968-0004(97)01042-6; Jin J, 2013, NEOPLASMA, V60, P92, DOI 10.4149/neo_2013_013; Jung M, 2015, EPIGENOMICS-UK, V7, P487, DOI 10.2217/epi.14.91; Knoechel B, 2014, NAT GENET, V46, P364, DOI 10.1038/ng.2913; Liou YC, 2011, TRENDS BIOCHEM SCI, V36, P501, DOI 10.1016/j.tibs.2011.07.001; Lockwood WW, 2012, P NATL ACAD SCI USA, V109, P19408, DOI 10.1073/pnas.1216363109; Lu KP, 1996, NATURE, V380, P544; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu ZM, 2014, CELL RES, V24, P1033, DOI 10.1038/cr.2014.109; Ma T, 2014, BIOMED RES INT; Morishita A, 2014, WORLD J GASTROENTERO, V20, P4536, DOI 10.3748/wjg.v20.i16.4536; Muller S, 2011, EXPERT REV MOL MED, V13, P1, DOI 10.1017/S1462399411001992; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Pastori C, 2014, EPIGENETICS-US, V9, P611, DOI 10.4161/epi.27906; Proserpio V, 2013, GENE DEV, V27, P1299, DOI 10.1101/gad.217240.113; Ryo A, 2002, MOL CELL BIOL, V22, P5281, DOI 10.1128/MCB.22.15.5281-5295.2002; Segura MF, 2013, CANCER RES, V73, P6264, DOI 10.1158/0008-5472.CAN-13-0122-T; Shi M, 2015, CELL BIOCHEM BIOPHYS, V71, P857, DOI 10.1007/s12013-014-0274-0; Stukenberg PT, 2001, MOL CELL, V7, P1071, DOI 10.1016/S1097-2765(01)00245-3; Suizu F, 2006, MOL CELL BIOL, V26, P1463, DOI 10.1128/MCB.26.4.1463-1479.2006; Takahashi K, 2007, ONCOGENE, V26, P3835, DOI 10.1038/sj.onc.1210153; Tsang YHN, 2013, ONCOGENE, V32, P1488, DOI 10.1038/onc.2012.178; Uchida T, 2003, CHEM BIOL, V10, P15, DOI 10.1016/S1074-5521(02)00310-1; Wu SY, 2007, J BIOL CHEM, V282, P13141, DOI 10.1074/jbc.R700001200; Wu SY, 2016, CELL REP, V16, P1733, DOI 10.1016/j.celrep.2016.07.001; Wu SY, 2013, MOL CELL, V49, P843, DOI 10.1016/j.molcel.2012.12.006; Wu XW, 2013, J BIOL CHEM, V288, P36094, DOI 10.1074/jbc.M113.485029; Wulf G, 2004, EMBO J, V23, P3397, DOI 10.1038/sj.emboj.7600323; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; Xu YX, 2003, GENE DEV, V17, P2765, DOI 10.1101/gad.1135503; Yang S, 2011, J INT MED RES, V39, P2076, DOI 10.1177/147323001103900603; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Yogesha SD, 2014, MOLECULES, V19, P1481, DOI 10.3390/molecules19021481; Zhang Y, 2007, ACS CHEM BIOL, V2, P320, DOI 10.1021/cb7000044; Zou Z, 2014, ONCOGENE, V33, P2395, DOI 10.1038/onc.2013.179; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	56	27	27	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 7	2017	36	36					5177	5188		10.1038/onc.2017.137	http://dx.doi.org/10.1038/onc.2017.137			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FF9XD	28481868	Green Submitted, Green Accepted			2022-12-26	WOS:000409371100009
J	Calles-Garcia, D; Yang, M; Soya, N; Melero, R; Menade, M; Ito, Y; Vargas, J; Lukacs, GL; Kollman, JM; Kozlov, G; Gehring, K				Calles-Garcia, Daniel; Yang, Meng; Soya, Naoto; Melero, Roberto; Menade, Marie; Ito, Yukishige; Vargas, Javier; Lukacs, Gergely L.; Kollman, Justin M.; Kozlov, Guennadi; Gehring, Kalle			Single-particle electron microscopy structure of UDP-glucose: glycoprotein glucosyltransferase suggests a selectivity mechanism for misfolded proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOLDING-SENSOR ENZYME; GLUCOSEGLYCOPROTEIN GLUCOSYLTRANSFERASE; ENDOPLASMIC-RETICULUM; CRYSTAL-STRUCTURE; QUALITY-CONTROL; RECOGNITION; DOMAIN; ER; BINDING; CALRETICULIN	The enzyme UDP-glucose: glycoprotein glucosyltransferase (UGGT) mediates quality control of glycoproteins in the endoplasmic reticulum by attaching glucose to N-linked glycan of misfolded proteins. As a sensor, UGGT ensures that misfolded proteins are recognized by the lectin chaperones and do not leave the secretory pathway. The structure of UGGT and the mechanism of its selectivity for misfolded proteins have been unknown for 25 years. Here, we used negative-stain electron microscopy and small-angle X-ray scattering to determine the structure of UGGT from Drosophila melanogaster at 18-angstrom resolution. Three-dimensional reconstructions revealed a cagelike structure with a large central cavity. Particle classification revealed flexibility that precluded determination of a high-resolution structure. Introduction of biotinylation sites into a fungal UGGT expressed in Escherichia coli allowed identification of the catalytic and first thioredoxin-like domains. We also used hydrogen-deuterium exchange mass spectrometry to map the binding site of an accessory protein, Sep15, to the first thioredoxin-like domain. The UGGT structural features identified suggest that the central cavity contains the catalytic site and is lined with hydrophobic surfaces. This enhances the binding of misfolded substrates with exposed hydrophobic residues and excludes folded proteins with hydrophilic surfaces. In conclusion, we have determined the UGGT structure, which enabled us to develop a plausible functional model of the mechanism for UGGT's selectivity for misfolded glycoproteins.	[Calles-Garcia, Daniel; Yang, Meng; Menade, Marie; Kozlov, Guennadi; Gehring, Kalle] McGill Univ, Dept Biochem, Montreal, PQ H3G 0B1, Canada; [Soya, Naoto; Lukacs, Gergely L.] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada; [Melero, Roberto; Vargas, Javier] Ctr Nacl Biotectnol, Biocomp Unit, Madrid 28049, Spain; [Ito, Yukishige] RIKEN, Synthet Cellular Chem Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan; [Vargas, Javier] Univ San Pablo CEU, Escuela Politecn Super, Bioengn Lab, Madrid 28668, Spain; [Kollman, Justin M.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	McGill University; McGill University; RIKEN; San Pablo CEU University; University of Washington; University of Washington Seattle	Gehring, K (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ H3G 0B1, Canada.	kalle.gehring@mcgill.ca	Gehring, Kalle/N-2945-2019; Vargas, Javier/L-5546-2015; Ito, Yukishige/ACL-6203-2022; Ito, Yukishige/M-5119-2014; Gehring, Kalle/I-4403-2013; Soya, Naoto/B-2821-2011; Melero, Roberto/J-8780-2014	Gehring, Kalle/0000-0001-6500-1184; Vargas, Javier/0000-0001-7519-6106; Ito, Yukishige/0000-0001-6251-7249; Ito, Yukishige/0000-0001-6251-7249; Gehring, Kalle/0000-0001-6500-1184; Soya, Naoto/0000-0003-0086-4389; Melero, Roberto/0000-0001-9467-9381; Yang, Meng/0000-0002-1371-5844; Lukacs, Gergely/0000-0003-0900-0675	Natural Sciences and Engineering Research Council of Canada [RPGIN 2014-04686]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Natural Sciences and Engineering Research Council of Canada Grant RPGIN 2014-04686 (to K.G.). The authors declare that they have no conflicts of interest with the contents of this article.	Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Arnold SM, 2000, BIOCHEMISTRY-US, V39, P2149, DOI 10.1021/bi9916473; Arnold SM, 2003, J BIOL CHEM, V278, P43320, DOI 10.1074/jbc.M305800200; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Baldwin PR, 2007, J STRUCT BIOL, V157, P250, DOI 10.1016/j.jsb.2006.06.002; Caramelo JJ, 2004, J BIOL CHEM, V279, P46280, DOI 10.1074/jbc.M408404200; Choudhury P, 1997, J BIOL CHEM, V272, P13446, DOI 10.1074/jbc.272.20.13446; D'Alessio C, 2010, SEMIN CELL DEV BIOL, V21, P491, DOI 10.1016/j.semcdb.2009.12.014; de la Rosa-Trevin JM, 2016, J STRUCT BIOL, V195, P93, DOI 10.1016/j.jsb.2016.04.010; Dedola S, 2014, ANGEW CHEM INT EDIT, V53, P2883, DOI 10.1002/anie.201309665; Elmlund D, 2012, J STRUCT BIOL, V180, P420, DOI 10.1016/j.jsb.2012.07.010; Elmlund H, 2013, STRUCTURE, V21, P1299, DOI 10.1016/j.str.2013.07.002; Ferguson AD, 2006, J BIOL CHEM, V281, P3536, DOI 10.1074/jbc.M511386200; Guerin M, 2003, J BIOL CHEM, V278, P20540, DOI 10.1074/jbc.M300891200; Herrero AB, 2004, EUKARYOT CELL, V3, P1423, DOI 10.1128/EC.3.6.1423-1432.2004; Howarth M, 2006, NAT METHODS, V3, P267, DOI 10.1038/NMETH861; Izumi M, 2012, J AM CHEM SOC, V134, P7238, DOI 10.1021/ja3013177; Korotkov KV, 2001, J BIOL CHEM, V276, P15330, DOI 10.1074/jbc.M009861200; Kozlov G, 2006, STRUCTURE, V14, P1331, DOI 10.1016/j.str.2006.06.019; Kozlov G, 2010, J BIOL CHEM, V285, P38612, DOI 10.1074/jbc.M110.168294; Kozlov G, 2010, J BIOL CHEM, V285, P35551, DOI 10.1074/jbc.M110.160101; Labunskyy VM, 2005, J BIOL CHEM, V280, P37839, DOI 10.1074/jbc.M508685200; Lau PW, 2012, STRUCTURE, V20, P1995, DOI 10.1016/j.str.2012.10.019; Ohara K, 2015, BIOCHEMISTRY-US, V54, P4909, DOI 10.1021/acs.biochem.5b00785; Okiyoneda T, 2013, NAT CHEM BIOL, V9, P444, DOI [10.1038/NCHEMBIO.1253, 10.1038/nchembio.1253]; PARKER CG, 1995, EMBO J, V14, P1294, DOI 10.1002/j.1460-2075.1995.tb07115.x; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Ritter C, 2005, EMBO J, V24, P1730, DOI 10.1038/sj.emboj.7600645; Ritter C, 2000, NAT STRUCT BIOL, V7, P278; Sakono M, 2012, BIOCHEM BIOPH RES CO, V426, P504, DOI 10.1016/j.bbrc.2012.08.112; Sorzano COS, 2010, J STRUCT BIOL, V171, P197, DOI 10.1016/j.jsb.2010.03.011; SOUSA MC, 1992, BIOCHEMISTRY-US, V31, P97, DOI 10.1021/bi00116a015; Takeda Y, 2014, GLYCOBIOLOGY, V24, P344, DOI 10.1093/glycob/cwt163; Takeda Y, 2009, CURR OPIN CHEM BIOL, V13, P582, DOI 10.1016/j.cbpa.2009.09.011; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tannous A, 2015, MOL BIOL CELL, V26, P390, DOI 10.1091/mbc.E14-08-1254; Taylor SC, 2004, NAT STRUCT MOL BIOL, V11, P128, DOI 10.1038/nsmb715; Taylor SC, 2003, EMBO REP, V4, P405, DOI 10.1038/sj.embor.embor797; Tessier DC, 2000, GLYCOBIOLOGY, V10, P403, DOI 10.1093/glycob/10.4.403; Totani K, 2005, ANGEW CHEM INT EDIT, V44, P7950, DOI 10.1002/anie.200502723; Totani K, 2009, BIOCHEMISTRY-US, V48, P2933, DOI 10.1021/bi8020586; TRATHNIGG B, 1995, PROG POLYM SCI, V20, P615, DOI 10.1016/0079-6700(95)00005-Z; TROMBETTA S E, 1991, Glycobiology, V1, P155, DOI 10.1093/glycob/1.2.155; Vargas J, 2014, BIOINFORMATICS, V30, P2891, DOI 10.1093/bioinformatics/btu404; Wearsch PA, 2011, P NATL ACAD SCI USA, V108, P4950, DOI 10.1073/pnas.1102524108; Zapun A, 1998, J BIOL CHEM, V273, P6009, DOI 10.1074/jbc.273.11.6009; Zhang W, 2011, P NATL ACAD SCI USA, V108, P4956, DOI 10.1073/pnas.1102527108; Zhu T, 2014, SCI REP-UK, V4, DOI 10.1038/srep07322	49	19	19	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11499	11507		10.1074/jbc.M117.789495	http://dx.doi.org/10.1074/jbc.M117.789495			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28490633	Green Published, hybrid			2022-12-26	WOS:000405119600031
J	Hong, WC; Yano, H; Hiranita, T; Chin, FT; McCurdy, CR; Su, TP; Amara, SG; Katz, JL				Hong, Weimin Conrad; Yano, Hideaki; Hiranita, Takato; Chin, Frederick T.; McCurdy, Christopher R.; Su, Tsung-Ping; Amara, Susan G.; Katz, Jonathan L.			The sigma-1 receptor modulates dopamine transporter conformation and cocaine binding and may thereby potentiate cocaine self-administration in rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN-LIKE-I; NEUROTRANSMITTER TRANSPORTERS; MEMBRANE-PROTEINS; UPTAKE INHIBITORS; LIVING CELLS; OLIGOMERIZATION; CHANNEL; DISEASE; LIGAND; SITE	The dopamine transporter (DAT) regulates dopamine (DA) neurotransmission by recapturing DA into the presynaptic terminals and is a principal target of the psychostimulant cocaine. The sigma-1 receptor (sigma R-1) is a molecular chaperone, and its ligands have been shown to modulate DA neuronal signaling, although their effects on DAT activity are unclear. Here, we report that the prototypical sigma R-1 agonist (+)-pentazocine potentiated the dose response of cocaine self-administration in rats, consistent with the effects of the sigma R agonists PRE-084 and DTG (1,3-di-o-tolylguanidine) reported previously. These behavioral effects appeared to be correlated with functional changes of DAT. Preincubation with (+)-pentazocine or PRE084 increased the B-max values of [ 3H] WIN35428 binding toDAT in rat striatal synaptosomes and transfected cells. A specific interaction between sigma R-1 andDATwas detected by co-immunoprecipitation and bioluminescence resonance energy transfer assays. Mutational analyses indicated that the transmembrane domain of sigma R-1 likely mediated this interaction. Furthermore, cysteine accessibility assays showed that sigma R-1 agonist preincubation potentiated cocaine-induced changes in DAT conformation, which were blocked by the specific sigma R-1 antagonist CM304. Moreover, sigma R-1 ligands had distinct effects on sigma R-1 multimerization. CM304 increased the proportion of multimeric sigma(1)Rs, whereas (+)-pentazocine increased monomeric sigma(1)Rs. Together these results support the hypothesis that sigma R-1 agonists promote dissociation of sigma R-1 multimers into monomers, which then interact with DAT to stabilize an outward-facing DAT conformation and enhance cocaine binding. We propose that this novel molecular mechanism underlies the behavioral potentiation of cocaine self-administration by sigma R-1 agonists in animal models.	[Hong, Weimin Conrad] Butler Univ, Dept Pharmaceut Sci, PB351,4600 Sunset Ave, Indianapolis, IN 46208 USA; [Yano, Hideaki; Hiranita, Takato; Su, Tsung-Ping; Katz, Jonathan L.] NIDA, Intramural Res Program, Baltimore, MD 21224 USA; [Chin, Frederick T.] Stanford Univ, Dept Radiol, MIPS, Stanford, CA 94305 USA; [McCurdy, Christopher R.] Univ Florida, Coll Pharm, Dept Med Chem, Gainesville, FL 32610 USA; [Amara, Susan G.] NIMH, Lab Mol & Cellular Neurobiol, Bethesda, MD 20892 USA	Butler University; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); Stanford University; State University System of Florida; University of Florida; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Hong, WC (corresponding author), Butler Univ, Dept Pharmaceut Sci, PB351,4600 Sunset Ave, Indianapolis, IN 46208 USA.	chong@butler.edu		Amara, Susan/0000-0001-8914-1106; McCurdy, Christopher Robert/0000-0001-8695-2915; Yano, Hideaki/0000-0001-9242-3884	Butler University; Butler University Faculty Startup Fund; Butler University Holcomb Research Award; National Institutes of Health Intramural Research Programs [R37 DA007595, R01 DA023205, P20 GM104932]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA023205, R37DA007595, ZIADA000206] Funding Source: NIH RePORTER	Butler University; Butler University Faculty Startup Fund; Butler University Holcomb Research Award; National Institutes of Health Intramural Research Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by Butler University Faculty Startup Fund and Holcomb Research Award (to W. C. H.), National Institutes of Health Intramural Research Programs (to H. Y., T. H., T. P. S., S. G. A., and J. L. K.), Grant R37 DA007595 (to S. G. A.), and in part by Grants R01 DA023205 (to C. R. M.) and P20 GM104932 (to C. R. M.). C. R. M. and F. T. C. are co-inventors and patent holders of CM304. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; Aydar E, 2002, NEURON, V34, P399, DOI 10.1016/S0896-6273(02)00677-3; Balasuriya D, 2012, J BIOL CHEM, V287, P37021, DOI 10.1074/jbc.M112.382077; Bermingham DP, 2016, PHARMACOL REV, V68, P888, DOI 10.1124/pr.115.012260; Carnally SM, 2010, BIOPHYS J, V98, P1182, DOI 10.1016/j.bpj.2009.12.4293; Chae PS, 2012, CHEM-EUR J, V18, P9485, DOI 10.1002/chem.201200069; Fontanilla D, 2008, BIOCHEMISTRY-US, V47, P7205, DOI 10.1021/bi800564j; German CL, 2015, PHARMACOL REV, V67, P1005, DOI 10.1124/pr.114.010397; GONZALEZALVEAR GM, 1994, J PHARMACOL EXP THER, V271, P212; Gromek KA, 2014, J BIOL CHEM, V289, P20333, DOI 10.1074/jbc.M113.537993; Hanner M, 1996, P NATL ACAD SCI USA, V93, P8072, DOI 10.1073/pnas.93.15.8072; Hastrup H, 2001, P NATL ACAD SCI USA, V98, P10055, DOI 10.1073/pnas.181344298; Hayashi T, 2001, P NATL ACAD SCI USA, V98, P491, DOI 10.1073/pnas.021413698; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Hiranita T, 2013, NEUROPSYCHOPHARMACOL, V38, P605, DOI 10.1038/npp.2012.224; Hiranita T, 2010, J PHARMACOL EXP THER, V332, P515, DOI 10.1124/jpet.109.159236; Hiranita T, 2009, J PHARMACOL EXP THER, V329, P677, DOI 10.1124/jpet.108.145813; Hong WC, 2010, J BIOL CHEM, V285, P32616, DOI 10.1074/jbc.M110.150565; James ML, 2012, J MED CHEM, V55, P8272, DOI 10.1021/jm300371c; Katz JL, 2016, J PHARMACOL EXP THER, V358, P109, DOI 10.1124/jpet.116.232728; Katz JL, 2016, BEHAV PHARMACOL, V27, P100, DOI 10.1097/FBP.0000000000000209; KAVANAUGH MP, 1988, P NATL ACAD SCI USA, V85, P2844, DOI 10.1073/pnas.85.8.2844; Kedei N, 2001, J BIOL CHEM, V276, P28613, DOI 10.1074/jbc.M103272200; Kim FJ, 2010, MOL PHARMACOL, V77, P695, DOI 10.1124/mol.109.057083; Kourrich S, 2013, CELL, V152, P236, DOI 10.1016/j.cell.2012.12.004; Kourrich S, 2012, TRENDS NEUROSCI, V35, P762, DOI 10.1016/j.tins.2012.09.007; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; MARTIN WR, 1976, J PHARMACOL EXP THER, V197, P517; MCCANN DJ, 1991, J PHARMACOL EXP THER, V257, P547; Mishra AK, 2015, BIOCHEM J, V466, P263, DOI 10.1042/BJ20141321; Narayanan S, 2011, CURR TOP MED CHEM, V11, P1128, DOI 10.2174/156802611795371323; Navarro G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061245; Navarro G, 2010, P NATL ACAD SCI USA, V107, P18676, DOI 10.1073/pnas.1008911107; Pal A, 2008, J BIOL CHEM, V283, P19646, DOI 10.1074/jbc.M802192200; Palmer CP, 2007, CANCER RES, V67, P11166, DOI 10.1158/0008-5472.CAN-07-1771; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Ramjeesingh M, 1999, BIOCHEM J, V342, P119, DOI 10.1042/0264-6021:3420119; Reith MEA, 2001, J BIOL CHEM, V276, P29012, DOI 10.1074/jbc.M011785200; Robson MJ, 2012, CURR PHARM DESIGN, V18, P902; Schmidt HR, 2016, NATURE, V532, P527, DOI 10.1038/nature17391; SCHUSTER DI, 1995, BRAIN RES, V670, P14, DOI 10.1016/0006-8993(94)01123-Y; Sitte HH, 2003, EUR J PHARMACOL, V479, P229, DOI 10.1016/j.ejphar.2003.08.072; Sohy D, 2009, J BIOL CHEM, V284, P31270, DOI 10.1074/jbc.M109.054809; Sorkina T, 2003, J BIOL CHEM, V278, P28274, DOI 10.1074/jbc.M210652200; Sulzer D, 2016, BASAL GANGLIA, V6, P123, DOI 10.1016/j.baga.2016.02.001; Torres GE, 2003, J BIOL CHEM, V278, P2731, DOI 10.1074/jbc.M201926200; Vaughan RA, 2013, TRENDS PHARMACOL SCI, V34, P489, DOI 10.1016/j.tips.2013.07.005; WALKER JM, 1990, PHARMACOL REV, V42, P355; Wang KH, 2015, NATURE, V521, P322, DOI 10.1038/nature14431; Xu JK, 2004, J BIOL CHEM, V279, P19781, DOI 10.1074/jbc.M310785200; Zhen J, 2015, J NEUROCHEM, V133, P167, DOI 10.1111/jnc.13025	52	47	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11250	11261		10.1074/jbc.M116.774075	http://dx.doi.org/10.1074/jbc.M116.774075			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28495886	Green Published, hybrid			2022-12-26	WOS:000405119600011
J	Shrestha, R; Lockless, SW; Sorg, JA				Shrestha, Ritu; Lockless, Steve W.; Sorg, Joseph A.			A Clostridium difficile alanine racemase affects spore germination and accommodates serine as a substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacteria; bacterial genetics; bacterial pathogenesis; bacterial signal transduction; microbiology; physiology; clostridium difficile; germination; racemase; spore	BACILLUS-ANTHRACIS; ACID; RECEPTORS; INITIATION; INHIBITOR; ANALOGS	Clostridium difficile has become one of the most common bacterial pathogens in hospital-acquired infections in the United States. Although C. difficile is strictly anaerobic, it survives in aerobic environments and transmits between hosts via spores. C. difficile spore germination is triggered in response to certain bile acids and glycine. Although glycine is the most effective co-germinant, other amino acids can substitute with varying efficiencies. Of these, l-alanine is an effective co-germinant and is also a germinant for most bacterial spores. Many endospore-forming bacteria embed alanine racemases into their spore coats, and these enzymes are thought to convert the l-alanine germinant into d-alanine, a spore germination inhibitor. Although the C. difficile Alr2 racemase is the sixth most highly expressed gene during C. difficile spore formation, a previous study reported that Alr2 has little to no role in germination of C. difficile spores in rich medium. Here, we hypothesized that Alr2 could affect C. difficilel-alanine-induced spore germination in a defined medium. We found that alr2 mutant spores more readily germinate in response to l-alanine as a co-germinant. Surprisingly, d-alanine also functioned as a co-germinant. Moreover, we found that Alr2 could interconvert l- and d-serine and that Alr2 bound to l- and d-serine with approximate to 2-fold weaker affinity to that of l- and d-alanine. Finally, we demonstrate that l- and d-serine are also co-germinants for C. difficile spores. These results suggest that C. difficile spores can respond to a diverse set of amino acid co-germinants and reveal that Alr2 can accommodate serine as a substrate.	[Shrestha, Ritu; Lockless, Steve W.; Sorg, Joseph A.] Texas A&M Univ, Dept Biol, 3258 TAMU, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Sorg, JA (corresponding author), Texas A&M Univ, Dept Biol, 3258 TAMU, College Stn, TX 77843 USA.	jsorg@bio.tamu.edu		Sorg, Joseph/0000-0001-7822-2656	NIAID, National Institutes of Health [5R01AI116895, 1U01AI124290]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI116895, U01AI124290] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by awards 5R01AI116895 and 1U01AI124290 from the NIAID, National Institutes of Health (to J. A. S.) The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams CM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003165; Akoachere M, 2007, J BIOL CHEM, V282, P12112, DOI 10.1074/jbc.M611432200; Asojo OA, 2014, ACTA CRYSTALLOGR D, V70, P1922, DOI 10.1107/S1399004714009419; Bhattacharjee D, 2016, J BACTERIOL, V198, P2767, DOI 10.1128/JB.00405-16; Bhattacharjee D, 2016, J BACTERIOL, V198, P777, DOI 10.1128/JB.00908-15; Bhushan R, 2004, AMINO ACIDS, V27, P231, DOI 10.1007/s00726-004-0118-0; Bouillaut L, 2013, J BACTERIOL, V195, P844, DOI 10.1128/JB.01492-12; Centers for Disease Control and Prevention, 2013, ANT ANT RES BIGG THR; Chesnokova ON, 2009, J BACTERIOL, V191, P1303, DOI 10.1128/JB.01098-08; Deakin LJ, 2012, INFECT IMMUN, V80, P2704, DOI 10.1128/IAI.00147-12; Dodatko T, 2010, MICROBIOL-SGM, V156, P1244, DOI 10.1099/mic.0.030270-0; Donnelly ML, 2017, MBIO, V8, DOI 10.1128/mBio.02085-16; Fimlaid KA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005239; Fimlaid KA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003660; Francis MB, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00306-16; Francis MB, 2015, J BACTERIOL, V197, P2276, DOI 10.1128/JB.02575-14; Francis MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073653; Francis MB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003356; GEORGE WL, 1979, J CLIN MICROBIOL, V9, P214; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Girinathan BP, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00383-16; Gutelius D, 2014, MICROBIOL-SGM, V160, P209, DOI 10.1099/mic.0.072454-0; Howerton A, 2011, J BACTERIOL, V193, P274, DOI 10.1128/JB.00980-10; Lawley TD, 2009, J BACTERIOL, V191, P5377, DOI 10.1128/JB.00597-09; McKevitt MT, 2007, INFECT IMMUN, V75, P5726, DOI 10.1128/IAI.00727-07; Paredes-Sabja D, 2011, TRENDS MICROBIOL, V19, P85, DOI 10.1016/j.tim.2010.10.004; Radkov AD, 2014, APPL MICROBIOL BIOT, V98, P5363, DOI 10.1007/s00253-014-5726-3; Ramirez N, 2010, J BACTERIOL, V192, P4215, DOI 10.1128/JB.00488-10; Ramirez N, 2010, J BACTERIOL, V192, P418, DOI 10.1128/JB.01226-09; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Setlow P, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.TBS-0003-2012; Setlow P, 2014, J BACTERIOL, V196, P1297, DOI 10.1128/JB.01455-13; Shields K, 2015, ANAEROBE, V34, P59, DOI 10.1016/j.anaerobe.2015.04.012; Sorg JA, 2008, J BACTERIOL, V190, P2505, DOI 10.1128/JB.01765-07; Sorg JA, 2010, J BACTERIOL, V192, P4983, DOI 10.1128/JB.00610-10; Sorg JA, 2009, J BACTERIOL, V191, P1115, DOI 10.1128/JB.01260-08; STEDMAN RL, 1956, SCIENCE, V124, P403, DOI 10.1126/science.124.3218.403; Stoltz KL, 2017, J MED CHEM, V60, P3451, DOI 10.1021/acs.jmedchem.7b00295; Theriot CM, 2015, ANNU REV MICROBIOL, V69, P445, DOI 10.1146/annurev-micro-091014-104115; TITBALL RW, 1987, J APPL BACTERIOL, V62, P269, DOI 10.1111/j.1365-2672.1987.tb02408.x; YASUDA Y, 1984, MICROBIOL IMMUNOL, V28, P197, DOI 10.1111/j.1348-0421.1984.tb00671.x	41	26	31	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10735	10742		10.1074/jbc.M117.791749	http://dx.doi.org/10.1074/jbc.M117.791749			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28487371	hybrid, Green Published			2022-12-26	WOS:000404115400031
J	Garcia-Martin, E; Pablo, LE; Bambo, MP; Alarcia, R; Polo, V; Larrosa, JM; Vilades, E; Cameo, B; Orduna, E; Ramirez, T; Satue, M				Garcia-Martin, Elena; Pablo, Luis E.; Bambo, Maria P.; Alarcia, Raquel; Polo, Vicente; Larrosa, Jose M.; Vilades, Elisa; Cameo, Beatriz; Orduna, Elvira; Ramirez, Teresa; Satue, Maria			Comparison of peripapillary choroidal thickness between healthy subjects and patients with Parkinson's disease	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; LINEAR DISCRIMINANT FUNCTION; NORMAL-TENSION GLAUCOMA; LAYER ATROPHY; EYES; IMPAIRMENT; DISABILITY; DIAGNOSIS; SEVERITY; ABILITY	Purpose To study peripapillary choroidal thickness (PPCT) in healthy subjects using swept-source optical coherence tomography (SS-OCT), and to evaluate PPCT differences between Parkinson's disease (PD) patients, and age-and sex-matched healthy controls. Design Case-control study Methods 80 healthy subjects and 40 PD patients were consecutively recruited in this single institution study. The healthy subjects were divided into two populations: a teaching population (n = 40, used to establish choroidal zones) and a validating population (n = 40, used to compare measurements with PD patients). An optic disc 6.0x6.0 mm three-dimensional scan was obtained using Deep Range Imaging (DRI) OCT Triton. A 26x26 cube-grid centered on the optic disc was generated to automatically measure choroidal thickness. Five concentric choroidal zones were established and used to compare PPCT between healthy and PD patients. Results PPCT was significantly thicker in PD patients compared with controls in all four concentric zones evaluated (p <= 0.0001). PPCT followed a similar pattern in controls and PD; it was thicker in the temporosuperior region, followed by the superior, temporal, nasal, and inferior regions. Conclusion PD patients presented with an increased PPCT in all zones surrounding the optic disc compared with healthy subjects. The peripapillary choroidal tissue showed a concentric pattern, with the thickness increasing with increasing distance from the optic nerve. SS-OCT could be useful for evaluating choroidal thinning in clinical practice.	[Garcia-Martin, Elena; Pablo, Luis E.; Bambo, Maria P.; Polo, Vicente; Larrosa, Jose M.; Vilades, Elisa; Cameo, Beatriz; Orduna, Elvira; Satue, Maria] Miguel Servet Univ Hosp, Ophthalmol Dept, Zaragoza, Spain; [Garcia-Martin, Elena; Pablo, Luis E.; Bambo, Maria P.; Alarcia, Raquel; Polo, Vicente; Larrosa, Jose M.; Vilades, Elisa; Cameo, Beatriz; Orduna, Elvira; Ramirez, Teresa; Satue, Maria] Univ Zaragoza, Aragon Inst Hlth Res IIS Aragon, Zaragoza, Spain; [Alarcia, Raquel] Miguel Servet Univ Hosp, Neurol Dept, Zaragoza, Spain; [Ramirez, Teresa] Lozano Blesa Univ Hosp, Anat Pathol Dept, Zaragoza, Spain	Miguel Servet University Hospital; University of Zaragoza; Miguel Servet University Hospital; Lozano Blesa University Clinical Hospital	Garcia-Martin, E (corresponding author), Miguel Servet Univ Hosp, Ophthalmol Dept, Zaragoza, Spain.; Garcia-Martin, E (corresponding author), Univ Zaragoza, Aragon Inst Hlth Res IIS Aragon, Zaragoza, Spain.	egmvivax@yahoo.com		Pablo, Luis/0000-0003-2389-8282; GARCIA-MARTIN, ELENA/0000-0001-6258-2489; Larrosa Poves, Jose Manuel/0000-0002-6745-7668; Satue, Maria/0000-0002-1609-5994; Bambo, Maria Pilar/0000-0001-5320-7839; Polo Llorens, Vicente/0000-0002-1402-3129; Perez-Olivan, Susana/0000-0003-3513-4714; Larrosa, Jose Manuel/0000-0003-4403-4854				Arora KS, 2012, INVEST OPHTH VIS SCI, V53, P7813, DOI 10.1167/iovs.12-10483; Banitt M, 2013, CURR OPIN OPHTHALMOL, V24, P125, DOI 10.1097/ICU.0b013e32835d9245; Bodis-Wollner I, 2009, J NEURAL TRANSM, V116, P1493, DOI 10.1007/s00702-009-0292-z; Braak H, 2002, J NEUROL, V249, DOI [1007/s00415-002-1301-4, 10.1007/s00415-002-1301-4, DOI 10.1007/S00415-002-1301-4]; Chakraborty R, 2011, INVEST OPHTH VIS SCI, V52, P5121, DOI 10.1167/iovs.11-7364; Chen FK, 2012, INVEST OPHTH VIS SCI, V53, P975, DOI 10.1167/iovs.11-8771; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; Cubo E, 2010, MOVEMENT DISORD, V25, P2461, DOI 10.1002/mds.23215; Edwards ME, 2001, BIOTECHNOL PROGR, V17, P760, DOI 10.1021/bp010040m; Ehrlich JR, 2011, EXP EYE RES, V92, P189, DOI 10.1016/j.exer.2011.01.002; Eraslan M, 2016, ACTA OPHTHALMOL, V94, pE68, DOI 10.1111/aos.12809; Fujiwara T, 2009, AM J OPHTHALMOL, V148, P445, DOI 10.1016/j.ajo.2009.04.029; Garcia-Martin E, 2014, INVEST OPHTH VIS SCI, V55, P696, DOI 10.1167/iovs.13-13062; Garcia-Martin E, 2014, AM J OPHTHALMOL, V157, P470, DOI 10.1016/j.ajo.2013.09.028; Garcia-Martin E, 2012, OPHTHALMOLOGY, V119, P2161, DOI 10.1016/j.ophtha.2012.05.003; Garcia-Martin E, 2012, OPHTHALMOLOGY, V119, P1705, DOI 10.1016/j.ophtha.2012.01.046; Hirata M, 2011, INVEST OPHTH VIS SCI, V52, P4971, DOI 10.1167/iovs.11-7729; Hirooka K, 2012, BMC OPHTHALMOL, V12, DOI 10.1186/1471-2415-12-29; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Ikuno Y, 2009, INVEST OPHTH VIS SCI, V50, P3876, DOI 10.1167/iovs.08-3325; Jiang R, 2015, INVEST OPHTH VIS SCI, V56, P4045, DOI 10.1167/iovs.15-16521; Larrosa JM, 2014, INVEST OPHTH VIS SCI, V55, P3043, DOI 10.1167/iovs.13-13629; Margolis R, 2009, AM J OPHTHALMOL, V147, P811, DOI 10.1016/j.ajo.2008.12.008; Maul EA, 2011, OPHTHALMOLOGY, V118, P1571, DOI 10.1016/j.ophtha.2011.01.016; Moschos MM, 2011, EUR J OPHTHALMOL, V21, P24, DOI 10.5301/EJO.2010.1318; Park A, 2009, J NEUROL, V256, pS293, DOI 10.1007/s00415-009-5240-1; Park HYL, 2014, AM J OPHTHALMOL, V157, P550, DOI 10.1016/j.ajo.2013.11.008; Pedersen JA, 2005, ANN BIOMED ENG, V33, P1469, DOI 10.1007/s10439-005-8159-4; Pinto LA, 2016, ACTA OPHTHALMOL, V94, P592, DOI 10.1111/aos.12962; Polo V, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009658; Ramaker C, 2002, MOVEMENT DISORD, V17, P867, DOI 10.1002/mds.10248; RAMRATTAN RS, 1994, INVEST OPHTH VIS SCI, V35, P2857; Reichmann H, 2010, NEURODEGENER DIS, V7, P284, DOI 10.1159/000314478; Roberts KF, 2012, ARCH OPHTHALMOL-CHIC, V130, P980, DOI 10.1001/archophthalmol.2012.371; Satue M, 2014, BRIT J OPHTHALMOL, V98, P350, DOI 10.1136/bjophthalmol-2013-304152; Satue M, 2013, EYE, V27, P507, DOI 10.1038/eye.2013.4; Schwartz RS, 2012, MOVEMENT DISORD, V27, P1506, DOI 10.1002/mds.25112; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Tan CS, 2012, INVEST OPHTH VIS SCI, V53, P261, DOI 10.1167/iovs.11-8782; Usui S, 2012, AM J OPHTHALMOL, V153, P10, DOI 10.1016/j.ajo.2011.05.037; Vale TC, 2015, J NEUROL NEUROSUR PS, V86, P547, DOI 10.1136/jnnp-2014-307867; Yang P, 2015, J PARKINSON DIS, V5, P821, DOI 10.3233/JPD-140454; Zhang X, SURV OPHTHALMOL, V60, P547	43	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177163	10.1371/journal.pone.0177163	http://dx.doi.org/10.1371/journal.pone.0177163			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28510576	Green Published, gold, Green Submitted			2022-12-26	WOS:000401485500015
J	Tavares, WC; Seuanez, HN				Tavares, William Correa; Seuanez, Hector N.			Disease-associated mitochondrial mutations and the evolution of primate mitogenomes	PLOS ONE			English	Article							DNA MUTATIONS; PURIFYING SELECTION; POSITIVE SELECTION; SEQUENCE ALIGNMENT; GENE; GENOME; DIVERSIFICATION; INFERENCE; VARIANTS; SUBUNITS	Several human diseases have been associated with mutations in mitochondrial genes comprising a set of confirmed and reported mutations according to the MITOMAP database. An analysis of complete mitogenomes across 139 primate species showed that most confirmed disease-associated mutations occurred in aligned codon positions and gene regions under strong purifying selection resulting in a strong evolutionary conservation. Only two confirmed variants (7.1%), coding for the same amino acids accounting for severe human diseases, were identified without apparent pathogenicity in non-human primates, like the closely related Bornean orangutan. Conversely, reported disease-associated mutations were not especially concentrated in conserved codon positions, and a large fraction of them occurred in highly variable ones. Additionally, 88 (45.8%) of reported mutations showed similar variants in several non-human primates and some of them have been present in extinct species of the genus Homo. Considering that recurrent mutations leading to persistent variants throughout the evolutionary diversification of primates are less likely to be severely damaging to fitness, we suggest that these 88 mutations are less likely to be pathogenic. Conversely, 69 (35.9%) of reported disease-associated mutations occurred in extremely conserved aligned codon positions which makes them more likely to damage the primate mitochondrial physiology.	[Tavares, William Correa; Seuanez, Hector N.] Inst Nacl Canc, Programa Genet, Rio De Janeiro, RJ, Brazil; [Tavares, William Correa; Seuanez, Hector N.] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, RJ, Brazil; [Tavares, William Correa] Univ Fed Rio de Janeiro, Inst Biol, Dept Zool, Rio De Janeiro, RJ, Brazil	National Cancer Institute (Inca); Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Seuanez, HN (corresponding author), Inst Nacl Canc, Programa Genet, Rio De Janeiro, RJ, Brazil.; Seuanez, HN (corresponding author), Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, RJ, Brazil.	hseuanez@inca.gov.br	Tavares, William Corrêa/AAM-3362-2021	Tavares, William Corrêa/0000-0003-3385-7265; Seuanez, Hector/0000-0003-3355-8003	Conselho Nacional de Desenvolvimento, CNPq-Brazil [303306/2010-6]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES-Brazil; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro-Brazil-FAPERJ; William Tavares with post-doctoral grant [209101/E_44/2014]	Conselho Nacional de Desenvolvimento, CNPq-Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES-Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro-Brazil-FAPERJ; William Tavares with post-doctoral grant	Conselho Nacional de Desenvolvimento, CNPq-Brazil (www.npq.r) provided funding for computing facilities (grant 303306/2010-6). Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES-Brazil (www.capes.gov.br) and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro-Brazil-FAPERJ (www.faperj.br) supported William Tavares with post-doctoral grant 209101/E_44/2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Work supported by Conselho Nacional de Desenvolvimento, CNPq-Brazil, grant 303306/2010-6. WCT was supported by a post-doctoral fellowship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-Brazil) and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, Brazil (FAPERJ; 209101/E_44/2014).	Achilli A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042242; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Aristide L, 2015, MOL PHYLOGENET EVOL, V82, P375, DOI 10.1016/j.ympev.2013.11.008; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Bairoch A, 2007, NUCLEIC ACIDS RES, V35, pD193, DOI 10.1093/nar/gkl929; Bazinet AL, 2014, SYST BIOL, V63, P812, DOI 10.1093/sysbio/syu031; Bi R, 2012, MOL VIS, V18, P3087; Bridges HR, 2011, BIOCHEM SOC T, V39, P799, DOI 10.1042/BST0390799; Cai W, 2008, J GENET GENOMICS, V35, P649, DOI 10.1016/S1673-8527(08)60086-7; Celniker G, 2013, ISR J CHEM, V53, P199, DOI 10.1002/ijch.201200096; Crimi M, 2004, PEDIATR RES, V55, P842, DOI 10.1203/01.PDR.0000117844.73436.68; da Fonseca RR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-119; de Magalhaes JP, 2005, J MOL EVOL, V61, P491, DOI 10.1007/s00239-004-0258-6; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Dubot A, 2004, BIOCHEM BIOPH RES CO, V313, P687, DOI 10.1016/j.bbrc.2003.12.013; Echave J, 2016, NAT REV GENET, V17, P109, DOI 10.1038/nrg.2015.18; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eo SH, 2010, P ROY SOC B-BIOL SCI, V277, P3587, DOI 10.1098/rspb.2010.0965; Fabre PH, 2009, MOL PHYLOGENET EVOL, V53, P808, DOI 10.1016/j.ympev.2009.08.004; Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786; Finstermeier K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069504; Fleming MA, 2003, P NATL ACAD SCI USA, V100, P1151, DOI 10.1073/pnas.0237285100; Ghelli A, 2013, HUM MOL GENET, V22, P2141, DOI 10.1093/hmg/ddt067; Gissi C, 2008, HEREDITY, V101, P301, DOI 10.1038/hdy.2008.62; Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hashimoto T, 2001, ANN NEUROL, V50, P528, DOI 10.1002/ana.1229; Hassanin A, 2009, J MOL EVOL, V68, P293, DOI 10.1007/s00239-009-9208-7; Jonckheere AI, 2012, J INHERIT METAB DIS, V35, P211, DOI 10.1007/s10545-011-9382-9; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Kistler L, 2015, J HUM EVOL, V79, P45, DOI 10.1016/j.jhevol.2014.06.016; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lemos B, 2005, MOL BIOL EVOL, V22, P1345, DOI 10.1093/molbev/msi122; Levin L, 2013, GENOME BIOL EVOL, V5, P876, DOI 10.1093/gbe/evt058; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; Liao BY, 2006, MOL BIOL EVOL, V23, P2072, DOI 10.1093/molbev/msl076; Liedigk R, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0176-1; Lipman DJ, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-20; Lloyd RE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069003; Lott M. T., 2013, CURR PROTOC BIOINFOR, V123, P1, DOI [10.1002/0471250953.bi0123s44, DOI 10.1002/0471250953.BI0123S44]; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Matsumoto M, 1999, Ophthalmic Genet, V20, P153, DOI 10.1076/opge.20.3.153.2281; Mayrose I, 2004, MOL BIOL EVOL, V21, P1781, DOI 10.1093/molbev/msh194; McClellan David A, 2010, Int J Bioinform Res Appl, V6, P120, DOI 10.1504/IJBRA.2010.032116; Meiklejohn CD, 2007, TRENDS GENET, V23, P259, DOI 10.1016/j.tig.2007.03.008; Menezes AN, 2013, MITOCHONDRION, V13, P846, DOI 10.1016/j.mito.2013.06.001; Mitchell AL, 2006, J MED GENET, V43, P175, DOI 10.1136/jmg.2005.032474; Nabholz B, 2013, MOL BIOL EVOL, V30, P272, DOI 10.1093/molbev/mss238; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Niroula A, 2017, HUM MUTAT, P1; Paradis E., 2014, MODERN PHYLOGENETIC, P3; Pecon-Slattery J, 2014, ANNU REV ANIM BIOSCI, V2, P41, DOI 10.1146/annurev-animal-022513-114217; Pereira L, 2011, AM J HUM GENET, V88, P433, DOI 10.1016/j.ajhg.2011.03.006; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pontzer H, 2010, P NATL ACAD SCI USA, V107, P14048, DOI 10.1073/pnas.1001031107; Popadin KY, 2013, MOL BIOL EVOL, V30, P347, DOI 10.1093/molbev/mss219; Pozzi L, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-72; Pozzi L, 2014, MOL PHYLOGENET EVOL, V75, P165, DOI 10.1016/j.ympev.2014.02.023; Pupko T, 2002, BIOINFORMATICS, V18, P1116, DOI 10.1093/bioinformatics/18.8.1116; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Rogers J, 2014, NAT REV GENET, V15, P347, DOI 10.1038/nrg3707; Ruhoy LS, 2014, APPL CLIN GENET, V7, P221, DOI 10.2147/TACG.S46176; Scally A, 2012, NATURE, V483, P169, DOI 10.1038/nature10842; Schon EA, 2000, TRENDS BIOCHEM SCI, V25, P555, DOI 10.1016/S0968-0004(00)01688-1; Schrago CG, 2014, GENOME BIOL EVOL, V6, P3105, DOI 10.1093/gbe/evu244; Shin SH, 2015, GENES GENOM, V37, P365, DOI 10.1007/s13258-015-0265-6; Sinha PK, 2009, J BIOL CHEM, V284, P9814, DOI 10.1074/jbc.M809468200; Springer MS, 2012, PLOS ONE, P7; Stewart JB, 2008, NAT REV GENET, V9, P657, DOI 10.1038/nrg2396; Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor RW, 2001, ANN NEUROL, V50, P104, DOI 10.1002/ana.1084; Thusberg J, 2011, HUM MUTAT, V32, P358, DOI 10.1002/humu.21445; Tomasco IH, 2014, GENE, V534, P371, DOI 10.1016/j.gene.2013.09.097; Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586; Wang XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040084, 10.1371/journal.pone.0040711, 10.1371/journal.pone.0038932, 10.1371/journal.pone.0052707, 10.1371/journal.pone.0036663, 10.1371/journal.pone.0045380, 10.1371/journal.pone.0052082, 10.1371/journal.pone.0040857, 10.1371/journal.pone.0047429, 10.1371/journal.pone.0045939, 10.1371/journal.pone.0045036]; Woolley S, 2003, BIOINFORMATICS, V19, P671, DOI 10.1093/bioinformatics/btg043; Xia Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-691; Zeng S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-455; Zuo L, 2016, MITOCHONDRIAL MECH D, P49	85	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177403	10.1371/journal.pone.0177403	http://dx.doi.org/10.1371/journal.pone.0177403			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28510580	Green Submitted, gold, Green Published			2022-12-26	WOS:000401485500026
J	Li, SP; Peng, Q; Liao, SY; Li, WR; Ma, Q; Lu, XM				Li, Siping; Peng, Qi; Liao, Shengyun; Li, Wenrui; Ma, Qiang; Lu, Xiaomei			A reverse dot blot assay for the screening of twenty mutations in four genes associated with NSHL in a Chinese population	PLOS ONE			English	Article							NONSYNDROMIC HEARING-LOSS; MOLECULAR ETIOLOGY; DEAFNESS; IMPAIRMENT; SLC26A4; GJB2; CHILDHOOD; MONGOLIA	Background Congenital deafness is one of the most distressing disorders affecting humanity and exhibits a high incidence worldwide. Most cases of congenital deafness in the Chinese population are caused by defects in a limited number of genes. A convenient and reliable method for detecting common deafness-related gene mutations in the Chinese population is required. Methods We developed a PCR-reverse dot blot (RDB) assay for screening 20 hotspot mutations of GJB2, GJB3, SLC26A4, and MT-RNR1, which are common non-syndromic hearing loss (NSHL)-associated genes in the Chinese population. The PCR-RDB assay consists of multiplex PCR amplifications of 10 fragments in the target sequence of the four above-mentioned genes in wild-type and mutant genomic DNA samples followed by hybridization to a test strip containing allele-specific oligonucleotide probes. We applied our method to a set of 225 neonates with deafness gene mutations and 30 normal neonates. Results The test was validated through direct sequencing in a blinded study with 100% concordance. Conclusions The results demonstrated that our reverse dot blot assay is a reliable and effective genetic screening method for identifying carriers and individuals with NSHL among the Chinese population.	[Li, Siping; Li, Wenrui; Lu, Xiaomei] Dongguan Childrens Hosp, Dept Lab, Dongguan, Guangdong, Peoples R China; [Peng, Qi; Ma, Qiang; Lu, Xiaomei] Dongguan Inst Pediat, Dept Med & Mol Genet, Dongguan, Guangdong, Peoples R China; [Liao, Shengyun] Shenzhen Yilifang Biotech CO LTD, Shenzhen, Peoples R China		Lu, XM (corresponding author), Dongguan Childrens Hosp, Dept Lab, Dongguan, Guangdong, Peoples R China.; Lu, XM (corresponding author), Dongguan Inst Pediat, Dept Med & Mol Genet, Dongguan, Guangdong, Peoples R China.	lxm020@126.com			Dongguan Bureau of Science and Technology for the City Key Program of Science and Technology [2013108101018]; Science and Technology Planning Project of Guangdong Province [2014A020213001]	Dongguan Bureau of Science and Technology for the City Key Program of Science and Technology; Science and Technology Planning Project of Guangdong Province	This work was supported by the Dongguan Bureau of Science and Technology for the City Key Program of Science and Technology (Project Number: 2013108101018) and the Science and Technology Planning Project of Guangdong Province (Project Number: 2014A020213001). We also thank all the neonates and their parents for their cooperation during this work.	Alves RM, 2016, BMC MED GENET, V17, DOI 10.1186/s12881-016-0303-5; Dai P, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-26; Dai P, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-74; Du W, 2014, GENOMICS, V104, P264, DOI 10.1016/j.ygeno.2014.07.009; Gasparini P, 2000, EUR J HUM GENET, V8, P19, DOI 10.1038/sj.ejhg.5200406; Huang SW, 2016, GENE, V591, P119, DOI 10.1016/j.gene.2016.07.019; Kral A, 2010, NEW ENGL J MED, V363, P1438, DOI 10.1056/NEJMra0911225; Kudo T, 2000, AM J MED GENET, V90, P141, DOI 10.1002/(SICI)1096-8628(20000117)90:2<141::AID-AJMG10>3.0.CO;2-G; Lappin S, 2001, J MOL DIAGN, V3, P178, DOI 10.1016/S1525-1578(10)60670-8; Lerer I, 2000, AM J MED GENET, V95, P53, DOI 10.1002/1096-8628(20001106)95:1<53::AID-AJMG11>3.0.CO;2-2; Lin D, 2001, HUM MUTAT, V18, P42, DOI 10.1002/humu.1148; Lu YJ, 2011, J BIOMED RES, V25, P309, DOI 10.1016/S1674-8301(11)60042-0; Ma YL, 2016, ACTA OTO-LARYNGOL, V136, P800, DOI 10.3109/00016489.2016.1164893; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Pandya A, 1997, J MED GENET, V34, P169, DOI 10.1136/jmg.34.2.169; Peng Q, 2016, GENET TEST MOL BIOMA, V20, P603, DOI 10.1089/gtmb.2016.0055; Petit C, 1996, NAT GENET, V14, P385, DOI 10.1038/ng1296-385; Wang QJ, 2007, CLIN GENET, V72, P245, DOI 10.1111/j.1399-0004.2007.00862.x; Willems PJ, 2000, NEW ENGL J MED, V342, P1101, DOI 10.1056/NEJM200004133421506; Wu H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151909; Xia JH, 1998, NAT GENET, V20, P370, DOI 10.1038/3845; Xin F, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-312; Yao GD, 2014, EXP THER MED, V7, P218, DOI 10.3892/etm.2013.1406; Yao GD, 2013, ACTA OTO-LARYNGOL, V133, P833, DOI 10.3109/00016489.2013.777160; Yuan Y, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-79; Zhang J, INT J PEDIAT OTORHIN, V77, P1929; Zhang JQ, 2013, INT J PEDIATR OTORHI, V77, P1929, DOI 10.1016/j.ijporl.2013.08.038	27	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177196	10.1371/journal.pone.0177196	http://dx.doi.org/10.1371/journal.pone.0177196			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505178	Green Published, gold, Green Submitted			2022-12-26	WOS:000401473500013
J	Pava, Z; Noviyanti, R; Handayuni, I; Trimarsanto, H; Trianty, L; Burdam, FH; Kenangalem, E; Utami, RAS; Tirta, YK; Coutrier, F; Poespoprodjo, JR; Price, RN; Marfurt, J; Auburn, S				Pava, Zuleima; Noviyanti, Rintis; Handayuni, Irene; Trimarsanto, Hidayat; Trianty, Leily; Burdam, Faustina H.; Kenangalem, Enny; Utami, Retno A. S.; Tirta, Yusrifar K.; Coutrier, Farah; Poespoprodjo, Jeanne R.; Price, Ric N.; Marfurt, Jutta; Auburn, Sarah			Genetic micro-epidemiology of malaria in Papua Indonesia: Extensive P-vivax diversity and a distinct subpopulation of asymptomatic P-falciparum infections	PLOS ONE			English	Article							POPULATION-STRUCTURE; MICROSATELLITE DIVERSITY; TRANSMISSION DYNAMICS; P.-VIVAX; CHLOROQUINE; PREVALENCE; RESISTANCE; MARKERS	Background Genetic analyses of Plasmodium have potential to inform on transmission dynamics, but few studies have evaluated this on a local spatial scale. We used microsatellite genotyping to characterise the micro-epidemiology of P. vivax and P. falciparum diversity to inform malaria control strategies in Timika, Papua Indonesia. Methods Genotyping was undertaken on 713 sympatric P. falciparum and P. vivax isolates from a cross-sectional household survey and clinical studies conducted in Timika. Standard population genetic measures were applied, and the data was compared to published data from Kalimantan, Bangka, Sumba and West Timor. Results Higher diversity (H-E = 0.847 vs 0.625; p = 0.017) and polyclonality (46.2% vs 16.5%, p<0.001) were observed in P. vivax versus P. falciparum. Distinct P. falciparum substructure was observed, with two subpopulations, K1 and K2. K1 was comprised solely of asymptomatic infections and displayed greater relatedness to isolates from Sumba than to K2, possibly reflecting imported infections. Conclusions The results demonstrate the greater refractoriness of P. vivax versus P. falciparum to control measures, and risk of distinct parasite subpopulations persisting in the community undetected by passive surveillance. These findings highlight the need for complimentary new surveillance strategies to identify transmission patterns that cannot be detected with traditional malariometric methods.	[Pava, Zuleima; Handayuni, Irene; Price, Ric N.; Marfurt, Jutta; Auburn, Sarah] Charles Darwin Univ, Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT, Australia; [Noviyanti, Rintis; Trianty, Leily; Utami, Retno A. S.; Tirta, Yusrifar K.; Coutrier, Farah] Eijkman Inst Mol Biol, Malaria Pathogenesis Unit, Jakarta, Indonesia; [Trimarsanto, Hidayat] Eijkman Inst Mol Biol, Bioinformat Lab, Jakarta, Indonesia; [Trimarsanto, Hidayat] Agcy Assessment & Applicat Technol, Jakarta, Indonesia; [Burdam, Faustina H.; Kenangalem, Enny; Poespoprodjo, Jeanne R.] Mimika Dist Hlth Author, Timika, Papua, Indonesia; [Burdam, Faustina H.; Kenangalem, Enny; Poespoprodjo, Jeanne R.] Papuan Hlth & Community Dev Fdn, Timika Malaria Res Programme, Timika, Papua, Indonesia; [Burdam, Faustina H.; Poespoprodjo, Jeanne R.] Univ Gadjah Mada, Fac Med, Dept Child, Pediat Res Off, Yogyakarta, Indonesia; [Price, Ric N.] Univ Oxford, Ctr Trop Med, Nuffield Dept Clin Med, Oxford, England	Charles Darwin University; Menzies School of Health Research; Eijkman Institute; Eijkman Institute; Agency for the Assessment & Application of Technology (BPPT); Gadjah Mada University; University of Oxford	Auburn, S (corresponding author), Charles Darwin Univ, Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT, Australia.	sarah.auburn@menzies.edu.au	Poespoprodjo, Jeanne/AAF-1698-2020; Auburn, Sarah/N-2266-2013	Poespoprodjo, Jeanne/0000-0003-1573-734X; Pava, Zuleima/0000-0002-4802-0647; Price, Richard/0000-0003-2000-2874; Noviyanti, Rintis/0000-0003-1383-3274; Tirta, Yusrifar Kharisma/0000-0001-7592-9445; Auburn, Sarah/0000-0002-4638-536X; Trimarsanto, Hidayat/0000-0003-2436-8283	Wellcome Trust [200909, 099875, 512-2010]; DFAT (Australian Department of Foreign Affairs and Trade); NHMRC [1037304]	Wellcome Trust(Wellcome TrustEuropean Commission); DFAT (Australian Department of Foreign Affairs and Trade); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	The study was supported by the Wellcome Trust (a Senior Fellowship in Clinical Science awarded to RNP - 200909) and Fellowships to: JRP (Wellcome Trust - 099875) and ZP (Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnologia Francisco Jose de Caldas, Colciencias - 512-2010). The Timika Research Facility and Papuan Health and Community Development Foundation were supported by DFAT (Australian Department of Foreign Affairs and Trade) and the NHMRC (Program Grant 1037304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TJC, 1999, PARASITOLOGY, V119, P113, DOI 10.1017/S0031182099004552; [Anonymous], 2015, WORLD MALARIA REPORT; Auburn S, 2016, INT J PARASITOL; Barry AE, 2015, PATHOG GLOB HEALTH, V109, P142, DOI 10.1179/2047773215Y.0000000012; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Cheng Q, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003413; Elyazar IRF, 2011, ADV PARASIT, V74, P41, DOI 10.1016/B978-0-12-385897-9.00002-1; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Ferreira MU, 2007, J INFECT DIS, V195, P1218, DOI 10.1086/512685; Ferreira MU, 2014, TRENDS PARASITOL, V30, P465, DOI 10.1016/j.pt.2014.08.003; Gray KA, 2013, SOLOMON ISLANDS MALA, V12, P429, DOI DOI 10.1186/1475-2875-12-429; Hamedi Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166124; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Jennison C, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003634; Karunaweera ND, 2008, GENE, V410, P105, DOI 10.1016/j.gene.2007.11.022; Koepfli Cristian, 2014, P N G Med J, V57, P75; Koepfli C, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003872; Koepfli C, 2009, J INFECT DIS, V199, P1074, DOI 10.1086/597303; Laufer MK, 2004, DRUG RESIST UPDATE, V7, P279, DOI 10.1016/j.drup.2004.08.003; Miotto O, 2013, NAT GENET, V45, P648, DOI 10.1038/ng.2624; Noviyanti R, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003739; Orjuela-Sanchez P, 2013, EXP PARASITOL, V134, P318, DOI 10.1016/j.exppara.2013.03.029; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pava Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165340; Preston MD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5052; Pritchard JK, 2000, GENETICS, V155, P945; Pumpaibool T, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-155; Ratcliff A, 2007, T ROY SOC TROP MED H, V101, P351, DOI 10.1016/j.trstmh.2006.06.008; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Singh B, 1999, AM J TROP MED HYG, V60, P687, DOI 10.4269/ajtmh.1999.60.687; Sumawinata IW, 2003, AM J TROP MED HYG, V68, P416, DOI 10.4269/ajtmh.2003.68.416; Sutton PL, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-447; WHO, 2016, EL MAL, V24	36	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177445	10.1371/journal.pone.0177445	http://dx.doi.org/10.1371/journal.pone.0177445			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498860	gold, Green Published, Green Submitted			2022-12-26	WOS:000401314500017
J	Sakai, H; Fukuda, S; Nakamura, M; Uezumi, A; Noguchi, Y; Sato, T; Morita, M; Yamada, H; Tsuchida, K; Tajbakhsh, S; Fukada, S				Sakai, Hiroshi; Fukuda, Sumiaki; Nakamura, Miki; Uezumi, Akiyoshi; Noguchi, Yu-taro; Sato, Takahiko; Morita, Mitsuhiro; Yamada, Harumoto; Tsuchida, Kunihiro; Tajbakhsh, Shahragim; Fukada, So-ichiro			Notch ligands regulate the muscle stem-like state ex vivo but are not sufficient for retaining regenerative capacity	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; HUMAN SKELETAL-MUSCLE; SATELLITE CELL NICHE; SELF-RENEWAL; PROGENITOR CELLS; MESENCHYMAL PROGENITORS; EXPANSION; GENE; MYOD; TRANSPLANTATION	Myogenic stem cells are a promising avenue for the treatment of muscular disorders. Freshly isolated muscle stem cells have a remarkable engraftment ability in vivo, but their cell number is limited. Current conventional culture conditions do not allow muscle stem cells to expand in vitro with their bona fide engraftment efficiency, requiring the improvement of culture procedures for achieving successful cell-therapy for muscle disorders. Here we expanded mouse muscle stem cells and human myoblasts with Notch ligands, DLL1, DLL4, and JAG1 to activate Notch signaling in vitro and to investigate whether these cells could retain their engraftment efficiency. Notch signaling promotes the expansion of Pax7+MyoD-mouse muscle stem-like cells and inhibits differentiation even after passage in vitro. Treatment with Notch ligands induced the Notch target genes and generated PAX7+MYOD-stem-like cells from human myoblasts previously cultured on conventional culture plates. However, cells treated with Notch ligands exhibit a stem cell-like state in culture, yet their regenerative ability was less than that of freshly isolated cells in vivo and was comparable to that of the control. These unexpected findings suggest that artificial maintenance of Notch signaling alone is insufficient for improving regenerative capacity of mouse and human donor-muscle cells and suggest that combinatorial events are critical to achieve muscle stem cell and myoblast engraftment potential.	[Sakai, Hiroshi; Tajbakhsh, Shahragim] CNRS, Inst Pasteur, Dept Dev & Stem Cell Biol, Stem Cells & Dev,UMR 3738, Paris, France; [Fukuda, Sumiaki; Nakamura, Miki; Noguchi, Yu-taro; Fukada, So-ichiro] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Mol & Cellular Physiol Grad, Osaka, Japan; [Uezumi, Akiyoshi; Tsuchida, Kunihiro] Fujita Hlth Univ, Inst Comprehens Med Sci, Div Therapies Intractable Dis, Aichi, Japan; [Sato, Takahiko] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan; [Yamada, Harumoto] Fujita Hlth Univ, Dept Orthopaed Surg, Aichi, Japan	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Osaka University; Fujita Health University; Kyoto Prefectural University of Medicine; Fujita Health University	Tajbakhsh, S (corresponding author), CNRS, Inst Pasteur, Dept Dev & Stem Cell Biol, Stem Cells & Dev,UMR 3738, Paris, France.; Fukada, S (corresponding author), Osaka Univ, Grad Sch Pharmaceut Sci, Lab Mol & Cellular Physiol Grad, Osaka, Japan.	shahragim.tajbakhsh@pasteur.fr; fukada@phs.osaka-u.ac.jp	Uezumi, Akiyoshi/ABF-7359-2020; Hiroshi, SAKAI/B-1450-2016; Tsuchida, Kunihiro/A-4501-2012; Fukada, So-ichiro/AAI-9151-2020	Uezumi, Akiyoshi/0000-0003-4294-0116; Hiroshi, SAKAI/0000-0001-9456-0911; Tsuchida, Kunihiro/0000-0002-3983-5756; Fukada, So-ichiro/0000-0003-4051-5108	Japan Agency for Medical Research and Development; Institut Pasteur; Centre National pour la Recherche Scientific; Agence Nationale de la Recherche (Laboratoire d'Excellence Revive, Investissement d'Avenir) [ANR-10-LABX-73]; European Research Council [332893]; Grants-in-Aid for Scientific Research [16K08599] Funding Source: KAKEN	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Institut Pasteur(European Commission); Centre National pour la Recherche Scientific; Agence Nationale de la Recherche (Laboratoire d'Excellence Revive, Investissement d'Avenir)(French National Research Agency (ANR)); European Research Council(European Research Council (ERC)European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	So-ichiro F. and A.U. were supported by Japan Agency for Medical Research and Development. S.T. was funded by Institut Pasteur, Centre National pour la Recherche Scientific, the Agence Nationale de la Recherche (Laboratoire d'Excellence Revive, Investissement d'Avenir; ANR-10-LABX-73) and the European Research Council (Advanced Research Grant 332893).	Asakura A, 2007, P NATL ACAD SCI USA, V104, P16552, DOI 10.1073/pnas.0708145104; Besseyrias V, 2007, J EXP MED, V204, P331, DOI 10.1084/jem.20061442; Bjornson CRR, 2012, STEM CELLS, V30, P232, DOI 10.1002/stem.773; Brohl D, 2012, DEV CELL, V23, P469, DOI 10.1016/j.devcel.2012.07.014; Buas MF, 2010, J BIOL CHEM, V285, P1249, DOI 10.1074/jbc.M109.046441; Castel D, 2013, GENE DEV, V27, P1059, DOI 10.1101/gad.211912.112; Charville GW, 2015, STEM CELL REP, V5, P621, DOI 10.1016/j.stemcr.2015.08.004; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Fukada S, 2011, DEVELOPMENT, V138, P4609, DOI 10.1242/dev.067165; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Hicks C, 2002, J NEUROSCI RES, V68, P655, DOI 10.1002/jnr.10263; Ikemoto M, 2007, MOL THER, V15, P2178, DOI 10.1038/sj.mt.6300295; Kanisicak O, 2009, DEV BIOL, V332, P131, DOI 10.1016/j.ydbio.2009.05.554; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kuroda K, 1999, J BIOL CHEM, V274, P7238, DOI 10.1074/jbc.274.11.7238; Law P K, 1992, Cell Transplant, V1, P235; Le Roux I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9528; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; MENDELL JR, 1995, NEW ENGL J MED, V333, P832, DOI 10.1056/NEJM199509283331303; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Motohashi N, 2008, AM J PATHOL, V173, P781, DOI 10.2353/ajpath.2008.070902; Mourikis P, 2012, STEM CELLS, V30, P243, DOI 10.1002/stem.775; Parker MH, 2012, STEM CELLS, V30, P2212, DOI 10.1002/stem.1181; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Sakai H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063016; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Sambasivan R, 2009, DEV CELL, V16, P810, DOI 10.1016/j.devcel.2009.05.008; Sun DQ, 2008, J CELL SCI, V121, P3815, DOI 10.1242/jcs.035493; TREMBLAY JP, 1993, CELL TRANSPLANT, V2, P99, DOI 10.1177/096368979300200203; Uezumi A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.161; Uezumi A, 2016, STEM CELL REP, V7, P263, DOI 10.1016/j.stemcr.2016.07.004; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Vasyutina E, 2007, P NATL ACAD SCI USA, V104, P4443, DOI 10.1073/pnas.0610647104; Vieira NM, 2015, CELL, V163, P1204, DOI 10.1016/j.cell.2015.10.049; Wertz K, 1998, DEV DYNAM, V212, P229, DOI 10.1002/(SICI)1097-0177(199806)212:2<229::AID-AJA7>3.0.CO;2-J; Yamamoto S, 2012, SCIENCE, V338, P1229, DOI 10.1126/science.1228745; Zheng W, 2011, BLOOD, V118, P1154, DOI 10.1182/blood-2010-11-317800; Zucconi E, 2010, NEUROMUSCULAR DISORD, V20, P64, DOI 10.1016/j.nmd.2009.10.011	39	14	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177516	10.1371/journal.pone.0177516	http://dx.doi.org/10.1371/journal.pone.0177516			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498863	Green Submitted, Green Published, gold			2022-12-26	WOS:000401314500024
J	Durda, K; Kaklewski, K; Gupta, S; Szydlowski, M; Baszuk, P; Jaworska-Bieniek, K; Sukiennicki, G; Kaczmarek, K; Waloszczyk, P; Narod, S; Lubinski, J; Jakubowska, A				Durda, Katarzyna; Kaklewski, Krzysztof; Gupta, Satish; Szydlowski, Michal; Baszuk, Piotr; Jaworska-Bieniek, Katarzyna; Sukiennicki, Grzegorz; Kaczmarek, Katarzyna; Waloszczyk, Piotr; Narod, Steven; Lubinski, Jan; Jakubowska, Anna			Serum folate concentration and the incidence of lung cancer	PLOS ONE			English	Article							ALCOHOL-CONSUMPTION; B-VITAMINS; RISK; POLYMORPHISMS; REDUCTASE; ASSOCIATION; SMOKING; MTHFR; MTR	Background Lung cancer is a leading cause of cancer-related mortality globally. Folate helps to maintain DNA integrity and to regulate gene expression. Serum folate levels may affect the risk of several cancers, including lung cancer. In this study we evaluated the association between serum folate concentration and variations in genes involved in folate metabolism with lung cancer incidence in Poland. Methods The study included 366 lung cancer patients and 366 control subjects. We measured serum folate concentration and genotyped six variants in MTHFR, MTR and MTRR genes. The odds ratios of being diagnosed with lung cancer were calculated using conditional univariable and multivariable logistic regression with respect to folate level and genotypes. Results The mean serum folate level was lower in lung cancer cases than in control group (20.07 nmol/l vs. 22.52 nmol/l, p = 0.002). The odds ratio for lung cancer declined with increasing serum content of the folate. The folate concentration of >25.71 nmol/l (IVth quartile) in comparison to < 15.92 nmol/l (Ist quartile) was associated with an odds ratio of 0.61 (95% CI 0.40-0.95, p = 0.03). The analysis of variations in MTHFR, MTR and MTRR genes did not reveal any significant difference between lung cancer cases and controls in univariable and multivariable analyses. Conclusion In this case-control study, lower serum folate concentrations were associated with a higher risk of lung cancer diagnosis. Although previous findings have been somewhat mixed, our results add to the evidence that circulating folate levels may be an indicator of lung cancer risk.	[Durda, Katarzyna; Kaklewski, Krzysztof; Gupta, Satish; Baszuk, Piotr; Jaworska-Bieniek, Katarzyna; Sukiennicki, Grzegorz; Kaczmarek, Katarzyna; Lubinski, Jan; Jakubowska, Anna] Pomeranian Med Univ, Dept Genet & Pathol, Int Hereditary Canc Ctr, Polabska 4, Szczecin, Poland; [Szydlowski, Michal] West Pomeranian Univ Technol, Fac Mech Engn & Mechatron, Al Piastow 19, Szczecin, Poland; [Waloszczyk, Piotr] Zdunomed, Independent Lab Pathol, Szczecin, Poland; [Narod, Steven] Womens Coll Res Inst, Toronto, ON, Canada	Pomeranian Medical University; West Pomeranian University of Technology; University of Toronto; University Toronto Affiliates; Womens College Hospital	Durda, K (corresponding author), Pomeranian Med Univ, Dept Genet & Pathol, Int Hereditary Canc Ctr, Polabska 4, Szczecin, Poland.	k.durda@onet.pl	Jakubowska, Anna/O-8050-2014; Szydlowski, Michal/ABI-1376-2020; Szydlowski, Michal J./AAZ-3809-2020; Narod, Steven A/AAA-6112-2022; Szydłowski, Michał J/B-4472-2017	Jakubowska, Anna/0000-0002-5650-0501; Szydłowski, Michał J/0000-0003-4723-6726; Kaklewski, Krzysztof/0000-0002-0846-2619; Bialkowska, Katarzyna/0000-0001-8489-6665; Lubinski, Jan/0000-0003-2931-3003	National Science Centre [DEC-2013/09/N/NZ4/02225]	National Science Centre(National Science Centre, Poland)	This work was supported by National Science Centre (https://www.ncn.gov.pl/) grant DEC-2013/09/N/NZ4/02225 (KD). The funder (National Science Center; NCN) provided support in the form of research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey LB, 2015, J NUTR, V145, P1636, DOI 10.3945/jn.114.206599; Bandera EV, 1997, CANCER CAUSE CONTROL, V8, P828, DOI 10.1023/A:1018456127018; Choi SW, 2000, J NUTR, V130, P129, DOI 10.1093/jn/130.2.129; Cui LH, 2011, PHARMACOGENOMICS, V12, P797, DOI [10.2217/pgs.11.27, 10.2217/PGS.11.27]; Dai WM, 2013, CHINESE MED J-PEKING, V126, P1957, DOI 10.3760/cma.j.issn.0366-6999.20130391; Drammeh BS, 2008, CLIN CHEM, V54, P1883, DOI 10.1373/clinchem.2008.108761; Dutkowska A, 2013, MOLBIOL REP, V40; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Hartman TJ, 2001, AM J EPIDEMIOL, V153, P688, DOI 10.1093/aje/153.7.688; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Jansen EHJM, 2012, CLIN CHEM LAB MED, V50, P1761, DOI 10.1515/cclm-2012-0108; Jatoi A, 2001, J SURG ONCOL, V77, P247, DOI 10.1002/jso.1104; Johansson M, 2010, JAMA-J AM MED ASSOC, V303, P2377, DOI 10.1001/jama.2010.808; Kabat GC, 2008, BRIT J CANCER, V99, P816, DOI 10.1038/sj.bjc.6604540; Kiyohara C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-459; LAHIRI DK, 1993, BIOCHEM GENET, V31, P321, DOI 10.1007/BF00553174; Langevin SM, 2015, TRANSL RES, V165, P74, DOI 10.1016/j.trsl.2014.03.001; Larsen JE, 2011, CLIN CHEST MED, V32, P703, DOI 10.1016/j.ccm.2011.08.003; LEMARCHAND L, 1989, JNCI-J NATL CANCER I, V81, P1158, DOI 10.1093/jnci/81.15.1158; Li H, 2015, NUTRIENTS, V7; Liu Chiu-Shong, 2009, Cancer Genomics & Proteomics, V6, P325; Pfeiffer CM, 2010, FOLATE HLTH DIS, P179; Roswall N, 2010, LUNG CANCER, V67, P275, DOI 10.1016/j.lungcan.2009.11.010; Shen HB, 2003, CANCER EPIDEM BIOMAR, V12, P980; Shi QL, 2005, CANCER EPIDEM BIOMAR, V14, P1477, DOI 10.1158/1055-9965.EPI-04-0905; Shi QL, 2005, PHARMACOGENET GENOM, V15, P547, DOI 10.1097/01.fpc.0000170916.96650.70; Slatore CG, 2008, AM J RESP CRIT CARE, V177, P524, DOI 10.1164/rccm.200709-1398OC; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Suzuki T, 2007, CARCINOGENESIS, V28, P1718, DOI 10.1093/carcin/bgm104; Takata Y, 2013, NUTR CANCER, V65, P51, DOI 10.1080/01635581.2013.741757; Tastekin D., 2015, Experimental Oncology, V37, P218; Wettergren Y, 2010, MOL MED, V16, P425, DOI 10.2119/molmed.2009.00156	32	21	23	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177441	10.1371/journal.pone.0177441	http://dx.doi.org/10.1371/journal.pone.0177441			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493936	gold, Green Published, Green Submitted			2022-12-26	WOS:000401314300109
J	Hopkins, JB; Ferguson, JM; Tyers, DB; Kurle, CM				Hopkins, John B., III; Ferguson, Jake M.; Tyers, Daniel B.; Kurle, Carolyn M.			Selecting the best stable isotope mixing model to estimate grizzly bear diets in the Greater Yellowstone Ecosystem	PLOS ONE			English	Article							AMERICAN BLACK BEARS; MOUNTAIN PINE-BEETLE; DELTA-N-15; DELTA-C-13; NITROGEN; SULFUR; CONSUMPTION; COMPONENTS; BROWN; SEX	Past research indicates that whitebark pine seeds are a critical food source for Threatened grizzly bears (Ursus arctos) in the Greater Yellowstone Ecosystem (GYE). In recent decades, whitebark pine forests have declined markedly due to pine beetle infestation, invasive blister rust, and landscape-level fires. To date, no study has reliably estimated the contribution of whitebark pine seeds to the diets of grizzlies through time. We used stable isotope ratios (expressed as delta C-13, delta(15) N, and delta(34) S values) measured in grizzly bear hair and their major food sources to estimate the diets of grizzlies sampled in Cooke City Basin, Montana. We found that stable isotope mixing models that included different combinations of stable isotope values for bears and their foods generated similar proportional dietary contributions. Estimates generated by our top model suggest that whitebark pine seeds (35 +/- 10%) and other plant foods (56 +/- 10%) were more important than meat (9 +/- 8%) to grizzly bears sampled in the study area. Stable isotope values measured in bear hair collected elsewhere in the GYE and North America support our conclusions about plant-based foraging. We recommend that researchers consider model selection when estimating the diets of animals using stable isotope mixing models. We also urge researchers to use the new statistical framework described here to estimate the dietary responses of grizzlies to declines in whitebark pine seeds and other important food sources through time in the GYE (e.g., cutthroat trout), as such information could be useful in predicting how the population will adapt to future environmental change.	[Hopkins, John B., III] Unity Coll, Sch Biodivers Conservat, Unity, ME 04988 USA; [Hopkins, John B., III; Kurle, Carolyn M.] Univ Calif San Diego, Ecol Behav & Evolut Sect, Div Biol Sci, La Jolla, CA 92093 USA; [Ferguson, Jake M.] Univ Idaho, Ctr Modeling Complex Interact, Moscow, ID 83843 USA; [Tyers, Daniel B.] US Forest Serv, Northern Rocky Mt Sci Ctr, Bozeman, MT USA	University of California System; University of California San Diego; Idaho; University of Idaho; United States Department of Agriculture (USDA); United States Forest Service	Hopkins, JB (corresponding author), Unity Coll, Sch Biodivers Conservat, Unity, ME 04988 USA.; Hopkins, JB (corresponding author), Univ Calif San Diego, Ecol Behav & Evolut Sect, Div Biol Sci, La Jolla, CA 92093 USA.	jhopkins@unity.edu		Ferguson, Jake/0000-0002-5034-9089	National Institute for Mathematical and Biological Synthesis at University of Tennessee Knoxville (NSF Award) [DBI-130042,6]; Center for Modeling Complex Interactions (NIH Award) [GM104420]; D. Ohman; G. Bennett; Direct For Biological Sciences [1300426] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104420] Funding Source: NIH RePORTER	National Institute for Mathematical and Biological Synthesis at University of Tennessee Knoxville (NSF Award); Center for Modeling Complex Interactions (NIH Award); D. Ohman; G. Bennett; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to the U.S. Forest Service, Federal Highway Administration-Western Federal Lands, University of California San Diego, the National Institute for Mathematical and Biological Synthesis at University of Tennessee Knoxville (NSF Award \#DBI-130042,6), the Center for Modeling Complex Interactions (NIH Award \#GM104420), D. Ohman, and G. Bennett.	[Anonymous], 2021, LANG ENV STAT COMP; Ben-David M, 2004, OECOLOGIA, V138, P465, DOI 10.1007/s00442-003-1442-x; Bockino NK, 2012, NAT AREA J, V32, P31, DOI 10.3375/043.032.0105; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Costello CM, 2014, ECOL EVOL, V4, P2004, DOI 10.1002/ece3.1082; Day NE, 1969, BIOMETRIKA; ENNIS S, 1994, ANIM GENET, V25, P425, DOI 10.1111/j.1365-2052.1994.tb00533.x; Felicetti LA, 2003, CAN J ZOOL, V81, P763, DOI [10.1139/z03-054, 10.1139/Z03-054]; Ferguson J., 2016, ISOTOPER STABLE ISOT; Florin ST, 2011, FUNCT ECOL, V25, P519, DOI 10.1111/j.1365-2435.2010.01799.x; Fortin JK, 2013, J WILDLIFE MANAGE, V77, P270, DOI 10.1002/jwmg.483; FRENCH S.P., 1994, INT C BEAR RES MANAG, V9, P389; Goossens B, 1998, MOL ECOL, V7, P1237, DOI 10.1046/j.1365-294x.1998.00407.x; Gunther KA, 2014, URSUS, V25, P61, DOI 10.2192/URSUS-D-13-00008.1; Haroldson M. A., 2006, WILDLIFE MONOGR, V161, P33; Haroldson MA, 2013, YELLOWSTONE GRIZZLY, P48; Haroldson MA, 2010, URSUS, V21, P1, DOI 10.2192/09GR022.1; Hobson KA, 2000, CAN J ZOOL, V78, P1332, DOI 10.1139/cjz-78-8-1332; Hopkins JB, 2016, METHODS ECOL EVOL, V7, P210, DOI 10.1111/2041-210X.12446; Hopkins JB, 2014, FRONT ECOL ENVIRON, V12, P107, DOI 10.1890/130276; Hopkins JB, 2012, J WILDLIFE MANAGE, V76, P703, DOI 10.1002/jwmg.318; Hopkins JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028478; Jacoby ME, 1999, J WILDLIFE MANAGE, V63, P921, DOI 10.2307/3802806; Kendall KC, 2009, J WILDLIFE MANAGE, V73, P3, DOI 10.2193/2008-330; Koch PL, 2002, OECOLOGIA, V133, P14, DOI 10.1007/s00442-002-0977-6; Kurle CM, 2014, ISOT ENVIRON HEALT S, V50, P307, DOI 10.1080/10256016.2014.908872; Lopez-Alfaro C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128088; Mahalovich MF, 2016, FOREST ECOL MANAG, V359, P174, DOI 10.1016/j.foreco.2015.09.047; Mattson D.J., 2000, THESIS; MATTSON DJ, 1991, CAN J ZOOL, V69, P1619, DOI 10.1139/z91-226; Mattson DJ, 1998, URSUS-SERIES, V10, P129; MATTSON DJ, 1992, J WILDLIFE MANAGE, V56, P432, DOI 10.2307/3808855; Middleton AD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0870; Mitton JB, 2012, AM NAT, V179, pE163, DOI 10.1086/665007; Mowat G, 2006, CAN J ZOOL, V84, P473, DOI 10.1139/z06-016; Paetkau D, 2003, MOL ECOL, V12, P1375, DOI 10.1046/j.1365-294X.2003.01820.x; Phillips DL, 2014, CAN J ZOOL, V92, P823, DOI 10.1139/cjz-2014-0127; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; Plummer M, 2008, BIOSTATISTICS, V9, P523, DOI 10.1093/biostatistics/kxm049; Ripple WJ, 2014, J ANIM ECOL, V83, P223, DOI 10.1111/1365-2656.12123; Rossi J. L, 2016, THESIS; Schwartz CC, 2006, WILDLIFE MONOGR, P1; Schwartz CC, 2014, WILDLIFE SOC B, V38, P664, DOI 10.1002/wsb.426; Schwartz CC, 2014, J WILDLIFE MANAGE, V78, P68, DOI 10.1002/jwmg.633; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Teisberg JE, 2014, J WILDLIFE MANAGE, V78, P369, DOI 10.1002/jwmg.667; van Manen FT, 2013, RESPONSE YELLOWSTONE, P1; Wolf N, 2009, FUNCT ECOL, V23, P17, DOI 10.1111/j.1365-2435.2009.01529.x; Woods JG, 1999, WILDLIFE SOC B, V27, P616	49	11	12	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0174903	10.1371/journal.pone.0174903	http://dx.doi.org/10.1371/journal.pone.0174903			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493929	gold, Green Submitted, Green Published			2022-12-26	WOS:000401314300005
J	Pols, TWH; Puchner, T; Korkmaz, HI; Vos, M; Soeters, MR; de Vries, CJM				Pols, Thijs W. H.; Puchner, Teresa; Korkmaz, H. Inci; Vos, Mariska; Soeters, Maarten R.; de Vries, Carlie J. M.			Lithocholic acid controls adaptive immune responses by inhibition of Th1 activation through the Vitamin D receptor	PLOS ONE			English	Article							BILE-ACIDS; TGR5; CELLS; ATHEROSCLEROSIS; EXPRESSION; INDUCE; ERK; DIFFERENTIATION; INFLAMMATION; MECHANISMS	Bile acids are established signaling molecules next to their role in the intestinal emulsification and uptake of lipids. We here aimed to identify a potential interaction between bile acids and CD4(+) Th cells, which are central in adaptive immune responses. We screened distinct bile acid species for their potency to affect T cell function. Primary human and mouse CD4+ Th cells as well as Jurkat T cells were used to gain insight into the mechanism underlying these effects. We found that unconjugated lithocholic acid (LCA) impedes Th1 activation as measured by i) decreased production of the Th1 cytokines IFN gamma. and TNF alpha alpha, ii) decreased expression of the Th1 genes T-box protein expressed in T cells (T-bet), Stat-1 and Stat4, and iii) decreased STAT1 alpha/beta phosphorylation. Importantly, we observed that LCA impairs Th1 activation at physiological relevant concentrations. Profiling of MAPK signaling pathways in Jurkat T cells uncovered an inhibition of ERK-1/2 phosphorylation upon LCA exposure, which could provide an explanation for the impaired Th1 activation. LCA induces these effects via Vitamin D receptor (VDR) signaling since VDR RNA silencing abrogated these effects. These data reveal for the first time that LCA controls adaptive immunity via inhibition of Th1 activation. Many factors influence LCA levels, including bile acid-based drugs and gut microbiota. Our data may suggest that these factors also impact on adaptive immunity via a yet unrecognized LCA-Th cell axis.	[Pols, Thijs W. H.; Puchner, Teresa; Korkmaz, H. Inci; Vos, Mariska; de Vries, Carlie J. M.] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Amsterdam, Netherlands; [Soeters, Maarten R.] Univ Amsterdam, Acad Med Ctr, Dept Endocrinol & Metab, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Pols, TWH (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Amsterdam, Netherlands.	Thijs.pols@amc.uva.nl			Netherlands Organization of Scientific Research [NWO VENI] [016.136.083]; Federation of European Biochemical Societies (FEBS); Dutch Diabetes Research Foundation	Netherlands Organization of Scientific Research [NWO VENI]; Federation of European Biochemical Societies (FEBS); Dutch Diabetes Research Foundation	TWHP was supported by a personal grant from the Netherlands Organization of Scientific Research [NWO VENI grant number 016.136.083] as well as by a Follow-up Research Fund from the Federation of European Biochemical Societies (FEBS). MRS was funded by the Dutch Diabetes Research Foundation.	ATTILI AF, 1986, MED HYPOTHESES, V19, P57, DOI 10.1016/0306-9877(86)90137-4; Cantorna MT, 2015, NUTRIENTS, V7, P3011, DOI 10.3390/nu7043011; Chang CF, 2012, J IMMUNOL, V189, P721, DOI 10.4049/jimmunol.1103015; Cipriani S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025637; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Duboc H, 2012, HEPATOLOGY, V56, P2426, DOI 10.1002/hep.25839; Fang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070667; Glicksman C, 2010, ANN CLIN BIOCHEM, V47, P482, DOI 10.1258/acb.2010.010040; Goodwin B, 2003, P NATL ACAD SCI USA, V100, P223, DOI 10.1073/pnas.0237082100; Gringhuis SI, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4898; Haselow K, 2013, J LEUKOCYTE BIOL, V94, P1253, DOI 10.1189/jlb.0812396; Hashimoto S, 1996, LIPIDS, V31, P601, DOI 10.1007/BF02523830; Hayes CE, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00100; Hogenauer K, 2014, J MED CHEM, V57, P10343, DOI 10.1021/jm501052c; Ichikawa R, 2012, IMMUNOLOGY, V136, P153, DOI 10.1111/j.1365-2567.2012.03554.x; Katsuma S, 2005, BIOCHEM BIOPH RES CO, V329, P386, DOI 10.1016/j.bbrc.2005.01.139; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Keitel V, 2008, BIOCHEM BIOPH RES CO, V372, P78, DOI 10.1016/j.bbrc.2008.04.171; Kongsbak M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00148; Lahoute C, 2011, NAT REV CARDIOL, V8, P348, DOI 10.1038/nrcardio.2011.62; Lanna A, 2014, NAT IMMUNOL, V15, P965, DOI 10.1038/ni.2981; Li N, 2010, J IMMUNOL, V185, P3041, DOI 10.4049/jimmunol.1000993; Lou GY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093567; Ma HJ, 2014, BEST PRACT RES CL GA, V28, P573, DOI 10.1016/j.bpg.2014.07.004; Makishima M, 2002, SCIENCE, V296, P1313, DOI 10.1126/science.1070477; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; McMahan RH, 2013, J BIOL CHEM, V288, P11761, DOI 10.1074/jbc.M112.446575; Mobraten K, 2015, J RECEPT SIG TRANSD, V35, P402, DOI 10.3109/10799893.2014.986744; O'Kelly J, 2002, J CLIN INVEST, V109, P1091, DOI 10.1172/JCI200212392; Pepper C, 2003, BLOOD, V101, P2454, DOI 10.1182/blood-2002-07-1984; Perino A, 2014, J CLIN INVEST, V124, P5424, DOI 10.1172/JCI76289; Pols TWH, 2014, BIOCHEM SOC T, V42, P244, DOI 10.1042/BST20130279; Pols TWH, 2011, CELL METAB, V14, P747, DOI 10.1016/j.cmet.2011.11.006; Pols TWH, 2011, J HEPATOL, V54, P1263, DOI 10.1016/j.jhep.2010.12.004; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Russell DW, 2009, J LIPID RES, V50, pS120, DOI 10.1194/jlr.R800026-JLR200; Sell H, 2012, NAT REV ENDOCRINOL, V8, P709, DOI 10.1038/nrendo.2012.114; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Steiner C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025006; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Takeda A, 2003, J IMMUNOL, V170, P4886, DOI 10.4049/jimmunol.170.10.4886; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Wang YD, 2011, HEPATOLOGY, V54, P1421, DOI 10.1002/hep.24525; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Yoneno K, 2013, IMMUNOLOGY, V139, P19, DOI 10.1111/imm.12045; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	47	58	58	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176715	10.1371/journal.pone.0176715	http://dx.doi.org/10.1371/journal.pone.0176715			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493883	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314300027
J	Rivera-Millot, A; Lesne, E; Solans, L; Coutte, L; Bertrand-Michel, J; Froguel, P; Dhennin, V; Hot, D; Locht, C; Antoine, R; Jacob-Dubuisson, F				Rivera-Millot, Alex; Lesne, Elodie; Solans, Luis; Coutte, Loic; Bertrand-Michel, Justine; Froguel, Philippe; Dhennin, Veronique; Hot, David; Locht, Camille; Antoine, Rudy; Jacob-Dubuisson, Francoise			Characterization of a Bvg-regulated fatty acid methyl-transferase in Bordetella pertussis	PLOS ONE			English	Article							FILAMENTOUS HEMAGGLUTININ; CRYSTAL-STRUCTURE; ADHESIN; REGULON; PROTEIN; METHYLTRANSFERASE; PHAGOCYTOSIS; PATHOGENESIS; PALMITATE; SEQUENCE	The whooping cough agent Bordetella pertussis controls the expression of its large virulence regulon in a coordinated manner through the two-component signal transduction system BvgAS. In addition to the genes coding for bona fide virulence factors, the Bvg regulon comprises genes of unknown function. In this work, we characterized a new Bvg-activated gene called BP2936. Homologs of BP2936 are found in other pathogenic Bordetellae and in several other species, including plant pathogens and environmental bacteria. We showed that the gene product of BP2936 is a membrane-associated methyl-transferase of free fatty acids. We thus propose to name it FmtB, for (f) under bar atty acid (m) under bar ethyl-(t) under bar ransferase of (B) under bar ordetella. The role of this protein was tested in cellular and animal models of infection, but the loss of BP2936 did not appear to affect host-pathogen interactions in those assays. The high level of conservation of BP2936 among B. pertussis isolates nevertheless argues that it probably plays a role in the life cycle of this pathogen.	[Rivera-Millot, Alex; Lesne, Elodie; Solans, Luis; Coutte, Loic; Hot, David; Locht, Camille; Antoine, Rudy; Jacob-Dubuisson, Francoise] Univ Lille, CNRS, INSERM, CHU Lille,Inst Pasteur Lille,U1019,UMR 8204,CIIL, Lille, France; [Bertrand-Michel, Justine] INSERM, U1048, MetaboHUB MetaToul Lipid Core Facil, Toulouse, France; [Froguel, Philippe; Dhennin, Veronique] Univ Lille, CNRS, Inst Pasteur Lille, UMR 8199,European Genom Inst Diabet, Lille, France; [Froguel, Philippe] Imperial Coll London, Dept Genom Common Dis, Sch Publ Hlth, Hammersmith Hosp, London, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Imperial College London	Antoine, R; Jacob-Dubuisson, F (corresponding author), Univ Lille, CNRS, INSERM, CHU Lille,Inst Pasteur Lille,U1019,UMR 8204,CIIL, Lille, France.	rudy.antoine@pasteur-lille.fr; francoise.jacob@ibl.cnrs.fr	Antoine, Rudy/CAH-6653-2022; Rivera-Millot, Alex/P-6776-2019; coutte, loic/B-2566-2019; Jacob-Dubuisson, Françoise/F-1610-2018; Locht, Camille/L-3516-2018; FROGUEL, Philippe/O-6799-2017; Antoine, Rudy/L-1630-2018; Coutte, Loïc/G-4379-2012; Rivera-Millot, Alex/AAA-9668-2021; Hot, David/M-6775-2016	Antoine, Rudy/0000-0002-7369-0626; Rivera-Millot, Alex/0000-0001-8431-5509; coutte, loic/0000-0002-8626-8109; Jacob-Dubuisson, Françoise/0000-0002-5102-1704; FROGUEL, Philippe/0000-0003-2972-0784; Antoine, Rudy/0000-0002-7369-0626; Coutte, Loïc/0000-0002-8626-8109; Solans, Luis/0000-0002-5841-4754; Hot, David/0000-0002-2361-0616; Locht, Camille/0000-0001-7295-7336	laboratory (INSERM, Lille University); LIGAN-PM Genomics platform (Lille, France) [UMR 8199]; European Genomics Institute for Diabetes [ANR-10-LABX-46]; ANR Equipex session [ANR-10-EQPX-07-01]; FEDER; Region Nord-Pas-de-Calais-Picardie	laboratory (INSERM, Lille University); LIGAN-PM Genomics platform (Lille, France); European Genomics Institute for Diabetes; ANR Equipex session(French National Research Agency (ANR)); FEDER(European Commission); Region Nord-Pas-de-Calais-Picardie(Region Hauts-de-France)	This work was supported by the recurrent funding of our laboratory (INSERM, Lille University). We also acknowledge the participation of the UMR 8199 LIGAN-PM Genomics platform (Lille, France), which belongs to the 'Federation de Recherche' 3508 Labex EGID (European Genomics Institute for Diabetes; ANR-10-LABX-46) and was supported by the ANR Equipex 2010 session (ANR-10-EQPX-07-01; 'LIGAN-PM'). The LIGAN-PM Genomics platform (Lille, France) is also supported by the FEDER and the Region Nord-Pas-de-Calais-Picardie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas M, 2011, J BACTERIOL, V193, P3473, DOI 10.1128/JB.01539-10; Alonso S, 2001, INFECT IMMUN, V69, P6038, DOI 10.1128/IAI.69.10.6038-6043.2001; ANTOINE R, 1990, INFECT IMMUN, V58, P1518, DOI 10.1128/IAI.58.6.1518-1526.1990; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cai P, 2005, TOXICOLOGY, V210, P197, DOI 10.1016/j.tox.2005.02.001; Chatterjee T, 2015, ARCH BIOCHEM BIOPHYS, V583, P140, DOI 10.1016/j.abb.2015.08.001; Coote JG, 2001, ADV MICROB PHYSIOL, V44, P141, DOI 10.1016/S0065-2911(01)44013-6; Cotter PA, 2003, TRENDS MICROBIOL, V11, P367, DOI 10.1016/S0966-842X(03)00156-2; Coutte L, 2003, J EXP MED, V197, P735, DOI 10.1084/jem.20021153; Coutte L, 2016, SCI REP-UK, V6, DOI 10.1038/srep32774; Cummings CA, 2006, J BACTERIOL, V188, P1775, DOI 10.1128/JB.188.5.1775-1785.2006; Cummings CA, 2004, J BACTERIOL, V186, P1484, DOI 10.1128/JB.186.5.1484-1492.2004; Danne L, 2015, MOL MICROBIOL, V95, P313, DOI 10.1111/mmi.12870; de Gouw D, 2011, FEMS MICROBIOL REV, V35, P441, DOI 10.1111/j.1574-6976.2010.00257.x; Deora R, 2001, MOL MICROBIOL, V40, P669, DOI 10.1046/j.1365-2958.2001.02415.x; Diavatopoulos DA, 2005, PLOS PATHOG, V1, P373, DOI 10.1371/journal.ooat.0010045; EFTIMIADI C, 1990, J INFECT DIS, V161, P138, DOI 10.1093/infdis/161.1.138; Frohlich BT, 1996, J BIOTECHNOL, V45, P137, DOI 10.1016/0168-1656(95)00155-7; Herrou J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006996; Im HN, 2016, J STRUCT BIOL, V193, P172, DOI 10.1016/j.jsb.2016.01.002; Jacob-Dubuisson F, 2012, TWO-COMPONENT SYSTEMS IN BACTERIA, P57; KAWAI Y, 1982, J BACTERIOL, V151, P996, DOI 10.1128/JB.151.2.996-1005.1982; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Kozbial PZ, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-19; Kumar V, 2011, J STRUCT BIOL, V176, P409, DOI 10.1016/j.jsb.2011.08.007; Lamberti Y, 2016, J PROTEOMICS, V136, P55, DOI 10.1016/j.jprot.2016.02.002; Lamberti YA, 2010, INFECT IMMUN, V78, P907, DOI 10.1128/IAI.01031-09; Lavine JS, 2011, P NATL ACAD SCI USA, V108, P7259, DOI 10.1073/pnas.1014394108; LOCHT C, 1992, EMBO J, V11, P3175, DOI 10.1002/j.1460-2075.1992.tb05394.x; Locht C, 2001, CURR OPIN MICROBIOL, V4, P82, DOI 10.1016/S1369-5274(00)00169-7; MELTON AR, 1993, INFECT IMMUN, V61, P807, DOI 10.1128/IAI.61.3.807-815.1993; Melvin JA, 2014, NAT REV MICROBIOL, V12, P274, DOI 10.1038/nrmicro3235; MENOZZI FD, 1994, INFECT IMMUN, V62, P769, DOI 10.1128/IAI.62.3.769-778.1994; Nakamura MM, 2006, INFECT IMMUN, V74, P5537, DOI 10.1128/IAI.00781-06; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; PORTER JF, 1991, APPL ENVIRON MICROB, V57, P1202, DOI 10.1128/AEM.57.4.1202-1206.1991; Preston A, 2004, NAT REV MICROBIOL, V2, P379, DOI 10.1038/nrmicro886; Rohani P, 2010, SCIENCE, V330, P982, DOI 10.1126/science.1194134; Sarkar S, 2006, J BIOCHEM MOL TOXIC, V20, P302, DOI 10.1002/jbt.20150; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Shields DJ, 2003, J BIOL CHEM, V278, P35826, DOI 10.1074/jbc.M306308200; STIBITZ S, 1994, METHOD ENZYMOL, V235, P458; Stibitz S, 2007, BORDETELLA MOL MICRO, P47; Thalen M, 1999, J BIOTECHNOL, V75, P147, DOI 10.1016/S0168-1656(99)00155-8; THIELE O W, 1973, European Journal of Biochemistry, V34, P333, DOI 10.1111/j.1432-1033.1973.tb02764.x; Uhl MA, 1996, EMBO J, V15, P1028, DOI 10.1002/j.1460-2075.1996.tb00440.x; Vandebriel RJ, 2003, MICROB PATHOGENESIS, V35, P19, DOI 10.1016/S0882-4010(03)00087-1; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6, P32, DOI [10.1002/0471250953.bi0506s47, DOI 10.1002/0471250953.BI0506S47]; Williamson YM, 2012, J MICROBIOL METH, V90, P119, DOI 10.1016/j.mimet.2012.04.007	50	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176396	10.1371/journal.pone.0176396	http://dx.doi.org/10.1371/journal.pone.0176396			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493897	gold, Green Submitted, Green Published			2022-12-26	WOS:000401314300014
J	Rojas, SV; Kensah, G; Rotaermel, A; Baraki, H; Kutschka, I; Zweigerdt, R; Martin, U; Haverich, A; Gruh, I; Martens, A				Rojas, Sebastian V.; Kensah, George; Rotaermel, Alexander; Baraki, Hassina; Kutschka, Ingo; Zweigerdt, Robert; Martin, Ulrich; Haverich, Axel; Gruh, Ina; Martens, Andreas			Transplantation of purified iPSC-derived cardiomyocytes in myocardial infarction	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; VENTRICULAR ASSIST DEVICE; MOUSE MODEL; HEART; DIFFERENTIATION; GENERATION; THERAPY; SURVIVAL; MURINE; REPAIR	Background Induced pluripotent stem cells (iPSC) can be differentiated into cardiomyocytes and represent a possible autologous cell source for myocardial repair. We analyzed the engraftment and functional effects of murine iPSC-derived cardiomyocytes (iPSC-CMs) in a murine model of myocardial infarction. Methods and results To maximize cardiomyocyte yield and purity a genetic purification protocol was applied. Murine iPSCs were genetically modified to express a Zeocin T resistance gene under control of the cardiac-specific a-myosin heavy chain (alpha-MHC, MYH6) promoter. Thus, CM selection was performed during in vitro differentiation. iPSC-CM aggregates ("cardiac bodies ", CBs) were transplanted on day 14 after LAD ligation into the hearts of previously LADligated mice (800 CBs/animal; 2-3x10(6) CMs). Animals were treated with placebo (PBS, n = 14) or iPSC-CMs (n = 35). Myocardial remodeling and function were evaluated by magnetic resonance imaging (MRI), conductance catheter (CC) analysis and histological morphometry. In vitro and in vivo differentiation was investigated. Follow up was 28 days (including histological assessment and functional analysis). iPSC-CM purity was >99%. Transplanted iPSC-CMs formed mature grafts within the myocardium, expressed cardiac markers and exhibited sarcomeric structures. Intramyocardial transplantation of iPSC-CMs significantly improved myocardial remodeling and left ventricular function 28 days after LAD-ligation. Conclusions We conclude that iPSCs can effectively be differentiated into cardiomyocytes and genetically enriched to high purity. iPSC derived cardiomyocytes engraft within the myocardium of LAD-ligated mice and contribute to improve left ventricular function.	[Rojas, Sebastian V.; Kensah, George; Rotaermel, Alexander; Baraki, Hassina; Kutschka, Ingo; Zweigerdt, Robert; Martin, Ulrich; Haverich, Axel; Gruh, Ina; Martens, Andreas] Hannover Med Sch, Leibniz Res Labs Biotechnol & Artificial Organs L, Hannover, Germany; [Rojas, Sebastian V.; Kensah, George; Rotaermel, Alexander; Baraki, Hassina; Kutschka, Ingo; Zweigerdt, Robert; Martin, Ulrich; Haverich, Axel; Gruh, Ina; Martens, Andreas] Hannover Med Sch, Dept Cardiothorac Transplantat & Vasc Surg, Hannover, Germany; [Rojas, Sebastian V.; Kensah, George; Rotaermel, Alexander; Baraki, Hassina; Kutschka, Ingo; Zweigerdt, Robert; Martin, Ulrich; Haverich, Axel; Gruh, Ina; Martens, Andreas] Hannover Med Sch, REBIRTH Cluster Excellence, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School	Rojas, SV (corresponding author), Hannover Med Sch, Leibniz Res Labs Biotechnol & Artificial Organs L, Hannover, Germany.; Rojas, SV (corresponding author), Hannover Med Sch, Dept Cardiothorac Transplantat & Vasc Surg, Hannover, Germany.; Rojas, SV (corresponding author), Hannover Med Sch, REBIRTH Cluster Excellence, Hannover, Germany.	Rojas.Sebastian@mh-hannover.de	Haverich, Axel/AAC-7552-2022; Martin, Ulrich/F-4888-2017; Rojas, Sebastian V/AFR-1536-2022; Martens, Andreas/AAG-2746-2020	Martin, Ulrich/0000-0003-1058-4540; Rojas, Sebastian V/0000-0002-9505-1358; Martens, Andreas/0000-0002-7953-2645	German Research Foundation [KU 2752/2-1]; Federal Ministry of Education and Research [RTC, University of Rostock, Germany] [01GN0958, 01E00802]; CORTISS Foundation (Heinz and lngeburg Wille Trust); REBIRTH Cluster of Excellence [DFG EXC 62/1, DFG EXC 62/2]	German Research Foundation(German Research Foundation (DFG)); Federal Ministry of Education and Research [RTC, University of Rostock, Germany]; CORTISS Foundation (Heinz and lngeburg Wille Trust); REBIRTH Cluster of Excellence	This work was supported by the German Research Foundation [KU 2752/2-1; grant to AM, RZ, UM, IK], the Federal Ministry of Education and Research [RTC, University of Rostock, Germany, 01GN0958, grant to AM, IK, AH; IFB-TX, 01E00802, grant to AM, IK, IG], the CORTISS Foundation (Heinz and lngeburg Wille Trust, grant to IG) and the REBIRTH Cluster of Excellence (DFG EXC 62/1, 62/2).	Braunwald E, 2013, JACC-HEART FAIL, V1, P1, DOI 10.1016/j.jchf.2012.10.002; Burridge PW, 2012, CELL STEM CELL, V10, P16, DOI 10.1016/j.stem.2011.12.013; Carpenter L, 2012, STEM CELLS DEV, V21, P977, DOI 10.1089/scd.2011.0075; Cheng YT, 2015, INT J CARDIOL, V201, P441, DOI 10.1016/j.ijcard.2015.08.118; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hong KU, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0346-0; Huber I, 2007, FASEB J, V21, P2551, DOI 10.1096/fj.05-5711com; Kensah G, 2013, EUR HEART J, V34, P1134, DOI 10.1093/eurheartj/ehs349; Klug MG, 1996, J CLIN INVEST, V98, P216, DOI 10.1172/JCI118769; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109; Logan SJ, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0471-z; Ma J, 2011, AM J PHYSIOL-HEART C, pH2006; Marban E, 2010, CIRCULATION, V121, P1981, DOI 10.1161/CIRCULATIONAHA.110.952580; Martens A, 2014, ARTIF ORGANS, V38, P978, DOI 10.1111/aor.12268; Martens A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101775; Martens A, 2011, CYTOTHERAPY, V13, P864, DOI 10.3109/14653249.2011.571247; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mauritz C, 2008, CIRCULATION, V118, P507, DOI 10.1161/CIRCULATIONAHA.108.778795; Mauritz C, 2011, EUR HEART J, V32, P2634, DOI 10.1093/eurheartj/ehr166; Mollmann H, 2009, HEART, V95, P508, DOI 10.1136/hrt.2007.125054; Moon SH, 2013, INT J CARDIOL, V168, P41, DOI 10.1016/j.ijcard.2012.09.077; Nelson TJ, 2009, CIRCULATION, V120, P408, DOI 10.1161/CIRCULATIONAHA.109.865154; Nsair A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045603; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Olmer R, 2012, TISSUE ENG PART C-ME, V18, P772, DOI 10.1089/ten.tec.2011.0717; Passier R, 2008, NATURE, V453, P322, DOI 10.1038/nature07040; Rojas SV, 2015, MINERVA CHIR, V70, P63; Rojas SV, 2015, TISSUE ENG PT A, V21, P1991, DOI [10.1089/ten.tea.2014.0537, 10.1089/ten.TEA.2014.0537]; Rojas SV, 2015, ARTIF ORGANS, V39, P473, DOI 10.1111/aor.12422; Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175; Slaughter MS, 2009, NEW ENGL J MED, V361, P2241, DOI 10.1056/NEJMoa0909938; So KH, 2011, INT J CARDIOL, V153, P277, DOI 10.1016/j.ijcard.2010.08.052; Strauer BE, 2011, J AM COLL CARDIOL, V58, P1095, DOI 10.1016/j.jacc.2011.06.016; Strueber M, 2011, J AM COLL CARDIOL, V57, P1375, DOI 10.1016/j.jacc.2010.10.040; Szabo PE, 2002, MECH DEVELOP, V115, P157, DOI 10.1016/S0925-4773(02)00087-4; Uribarri A, 2015, INT J CARDIOL, V197, P128, DOI 10.1016/j.ijcard.2015.04.046; van Laake LW, 2007, STEM CELL RES, V1, P9, DOI 10.1016/j.scr.2007.06.001; van Laake LW, 2007, NAT PROTOC, V2, P2551, DOI 10.1038/nprot.2007.371; van Laake LW, 2010, CIRC RES, V107, P340, DOI 10.1161/CIRCRESAHA.109.215434; Wollert KC, 2010, NAT REV CARDIOL, V7, P204, DOI 10.1038/nrcardio.2010.1; Xu XQ, 2009, STEM CELLS, V27, P2163, DOI 10.1002/stem.166; Zhang M, 2001, J MOL CELL CARDIOL, V33, P907, DOI 10.1006/jmcc.2001.1367; Zweigerdt R, 2007, SEMIN CELL DEV BIOL, V18, P794, DOI 10.1016/j.semcdb.2007.09.014; Zweigerdt R, 2011, NAT PROTOC, V6, P689, DOI 10.1038/nprot.2011.318; Zwi-Dantsis L, 2012, CELL MOL LIFE SCI, V69, P3285, DOI 10.1007/s00018-012-1078-2	47	36	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0173222	10.1371/journal.pone.0173222	http://dx.doi.org/10.1371/journal.pone.0173222			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493867	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314300003
J	Lakatos, E; Salehi-Reyhani, A; Barclay, M; Stumpf, MPH; Klug, DR				Lakatos, Eszter; Salehi-Reyhani, Ali; Barclay, Michael; Stumpf, Michael P. H.; Klug, David R.			Protein degradation rate is the dominant mechanism accounting for the differences in protein abundance of basal p53 in a human breast and colorectal cancer cell line	PLOS ONE			English	Article							APPROXIMATE BAYESIAN COMPUTATION; PHOSPHORYLATION; EXPRESSION; MDM2; QUANTIFICATION	We determine p53 protein abundances and cell to cell variation in two human cancer cell lines with single cell resolution, and show that the fractional width of the distributions is the same in both cases despite a large difference in average protein copy number. We developed a computational framework to identify dominant mechanisms controlling the variation of protein abundance in a simple model of gene expression from the summary statistics of single cell steady state protein expression distributions. Our results, based on single cell data analysed in a Bayesian framework, lends strong support to a model in which variation in the basal p53 protein abundance may be best explained by variations in the rate of p53 protein degradation. This is supported by measurements of the relative average levels of mRNA which are very similar despite large variation in the level of protein.	[Lakatos, Eszter; Stumpf, Michael P. H.] Imperial Coll London, Dept Life Sci, Ctr Integrat Syst Biol & Bioinformat, London, England; [Salehi-Reyhani, Ali; Barclay, Michael; Klug, David R.] Imperial Coll London, Dept Chem, Inst Chem Biol, London, England	Imperial College London; Imperial College London	Salehi-Reyhani, A (corresponding author), Imperial Coll London, Dept Chem, Inst Chem Biol, London, England.	ali.salehi-reyhani@imperial.ac.uk	Klug, David R/F-3357-2011	Klug, David R/0000-0001-9301-1654; Salehi-Reyhani, Ali/0000-0002-1084-2012; Lakatos, Eszter/0000-0002-7221-6850	UK Engineering and Physical Sciences Research Council [EP/1017887/1]; Imperial College London Junior Research Fellowship; Schrodinger Scholarship; Imperial College London; Engineering and Physical Sciences Research Council [1232251, EP/I017887/1] Funding Source: researchfish; EPSRC [EP/I017887/1] Funding Source: UKRI	UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Imperial College London Junior Research Fellowship; Schrodinger Scholarship; Imperial College London(General Electric); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the UK Engineering and Physical Sciences Research Council [grant number EP/1017887/1]; Imperial College London Junior Research Fellowship to ASR; and the Schrodinger Scholarship to EL. Funding for open access charge: Imperial College London.	Ananiev J., 2011, Acta Medica Bulgarica, V38, P72; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Battle A, 2015, SCIENCE, V347, P664, DOI 10.1126/science.1260793; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Burgin E, 2014, ANALYST, V139, P3235, DOI 10.1039/c4an00091a; Candeias MM, 2008, NAT CELL BIOL, V10, P1098, DOI 10.1038/ncb1770; Fox JG, 2002, CANCER RES, V62, P696; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Ghazalpour A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001393; Gilkes DM, 2007, CELL CYCLE, V6, P151, DOI 10.4161/cc.6.2.3719; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Jingyi JL, 2015, AM ASSOC ADV SCI PUB, V347, P1066; Jovanovic M, 2015, SCIENCE, V347, DOI 10.1126/science.1259038; Khosravi R, 1999, P NATL ACAD SCI USA, V96, P14973, DOI 10.1073/pnas.96.26.14973; Khoury MP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000927; Kristensen AR, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.47; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Lenive O, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0324-x; Li JJ, 2014, PEERJ, V2, DOI 10.7717/peerj.270; Li XL, 2015, WORLD J GASTROENTERO, V21, P84, DOI 10.3748/wjg.v21.i1.84; Liepe J, 2010, BIOINFORMATICS, V26, P1797, DOI 10.1093/bioinformatics/btq278; Loewer A, 2010, CELL, V142, P89, DOI 10.1016/j.cell.2010.05.031; Moll UM, 2003, MOL CANCER RES, V1, P1001; Pestov DG, 2001, MOL CELL BIOL, V21, P4246, DOI 10.1128/MCB.21.13.4246-4255.2001; Poyurovsky MV, 2006, GENE DEV, V20, P125, DOI 10.1101/gad.1397506; Salehi-Reyhani A, 2011, LAB CHIP, V11, P1256, DOI [10.1039/c0lc00613k, 10.1039/c01c00613k]; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shahrezaei V, 2008, P NATL ACAD SCI USA, V105, P17256, DOI 10.1073/pnas.0803850105; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; Stadler C, 2010, J PROTEOMICS, V73, P1067, DOI 10.1016/j.jprot.2009.10.012; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Toni T, 2009, J R SOC INTERFACE, V6, P187, DOI 10.1098/rsif.2008.0172; Wilkinson D.J., 2012, STOCHASTIC MODELLING; Zhang B, 2014, NATURE, V513, P382, DOI 10.1038/nature13438; Zhou YX, 2011, BIOINFORMATICS, V27, P874, DOI 10.1093/bioinformatics/btr015	38	4	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177336	10.1371/journal.pone.0177336	http://dx.doi.org/10.1371/journal.pone.0177336			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489927	Green Submitted, Green Published, gold			2022-12-26	WOS:000401314100064
J	Qiong, L; Zhang, WJ; Wang, H; Zeng, LY; Birks, HJB; Zhong, Y				Qiong, La; Zhang, Wenju; Wang, Hao; Zeng, Liyan; Birks, H. John B.; Zhong, Yang			Testing the effect of the Himalayan mountains as a physical barrier to gene flow in Hippophae tibetana Schlect. (Elaeagnaceae)	PLOS ONE			English	Article							MATING-SYSTEM; POPULATION; DIVERSITY; DIFFERENTIATION; SOFTWARE; PATTERNS; L.; MARKERS; CHINA; SHRUB	Hippophae tibetana is a small, dioecious wind-pollinated shrub endemic to the Tibetan-Qinghai Plateau. It is one of the shrubs that occur at very high elevations (5250 m a.s.l.). The Himalayan mountains provides a significant geographical barrier to the Qinghai-Tibetan Plateau, dividing the Himalayan area into two regions with Nepal to the south and Tibet to the north. There is no information on how the Himalayan mountains influence gene flow and population differentiation of alpine plants. In this study, we analyzed eight nuclear microsatellite markers and cpDNA trnT-trnF regions to test the role of the Himalayan mountains as a barrier to gene flow between populations of H. tibetana. We also examined the fine-scale genetic structure within a population of H. tibetana on the north slope of Mount (Mt.) Everest. For microsatellite analyses, a total of 241 individuals were sampled from seven populations in our study area (4 from Nepal, 3 from Tibet), including 121 individuals that were spatially mapped within a 100 m x 100 m plot. To test for seed flow, the cpDNA trnT-trnF regions of 100 individuals from 6 populations (4 from Nepal, 2 from Tibet) were also sequenced. Significant genetic differentiation was detected between the two regions by both microsatellite and cpDNA data analyses. These two datasets agree about southern and northern population differentiation, indicating that the Himalayan mountains represent a barrier to H. tibetana limiting gene flow between these two areas. At a fine scale, spatial autocorrelation analysis suggests significant genetic structure within a distance of less than 45 m, which may be attributed mainly to vegetative reproduction and habitat fragmentation, as well as limited gene flow.	[Qiong, La; Zhang, Wenju; Wang, Hao; Zeng, Liyan; Zhong, Yang] Fudan Univ, Inst Biodivers Sci, Sch Life Sci, Shanghai, Peoples R China; [Qiong, La; Zhong, Yang] Tibet Univ, Dept Biol, Lhasa, Peoples R China; [Birks, H. John B.] Univ Bergen, Dept Biol, Bergen, Norway; [Birks, H. John B.] UCL, Environm Change Res Ctr, London, England	Fudan University; Tibet University; University of Bergen; University of London; University College London	Zhong, Y (corresponding author), Fudan Univ, Inst Biodivers Sci, Sch Life Sci, Shanghai, Peoples R China.; Zhong, Y (corresponding author), Tibet Univ, Dept Biol, Lhasa, Peoples R China.	yangzhong@fudan.edu.cn			National Natural Science Foundation of China [41061007, 91131901]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Grant Number 41061007 and Grant Number 91131901).; We thank Ning Zhao and Wei-dong Zhu for their help in sample collection, and Miao An and Ting Xu for their help in the data analysis. H. John B. Birks is grateful to Cathy Jenks for invaluable editorial help. This study was supported by the National Natural Science Foundation of China (Grant Number 41061007 and Grant Number 91131901).	Alberto F, MOL ECOLOGY, V14, P2669; ALLARD RW, 1975, GENETICS, V79, P115; Avise John C., 2004, P1; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bartish IV, 1999, MOL ECOL, V8, P791, DOI 10.1046/j.1365-294X.1999.00631.x; Bartish IV, 2000, PLANT SYST EVOL, V225, P85, DOI 10.1007/BF00985460; Bauert MR, 1998, MOL ECOL, V7, P1519, DOI 10.1046/j.1365-294x.1998.00470.x; Berge G, 1998, OIKOS, V81, P17, DOI 10.2307/3546463; Chen SY, 2008, BOT J LINN SOC, V157, P125, DOI 10.1111/j.1095-8339.2008.00785.x; Chen SF, 2014, BIOCHEM SYST ECOL, V55, P66, DOI 10.1016/j.bse.2014.02.029; [陈学林 Chen Xuelin], 2003, [西北植物学报, Acta Botanica Boreali-Occidentalla Sinica], V23, P451; Comes HP, 1998, TRENDS PLANT SCI, V3, P432, DOI 10.1016/S1360-1385(98)01327-2; Cortes AJ, 2014, HEREDITY, V113, P233, DOI 10.1038/hdy.2014.19; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; ERIKSSON O, 1989, OIKOS, V55, P231, DOI 10.2307/3565427; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fisher PJ, 1996, NUCLEIC ACIDS RES, V24, P4369, DOI 10.1093/nar/24.21.4369; Gao LM, 2007, MOL ECOL, V16, P4684, DOI 10.1111/j.1365-294X.2007.03537.x; Gayden T, 2007, AM J HUM GENET, V80, P884, DOI 10.1086/516757; Gehring JL, 1999, HEREDITY, V82, P628, DOI 10.1046/j.1365-2540.1999.00524.x; Geng YP, 2009, GENETICA, V135, P419, DOI 10.1007/s10709-008-9290-6; Hamilton MB, 1999, NATURE, V401, P129, DOI 10.1038/43597; Hamrick J. L., 1992, New Forests, V6, P95, DOI 10.1007/BF00120641; Hawkes LA, 2011, P NATL ACAD SCI USA, V108, P9516, DOI 10.1073/pnas.1017295108; Hoffmann Robert S., 2001, Acta Zoologica Sinica, V47, P121; Hutsemekers V, 2013, AQUAT BOT, V108, P1, DOI 10.1016/j.aquabot.2013.02.001; Ikeda H, 2006, MOL ECOL, V15, P3731, DOI 10.1111/j.1365-294X.2006.03054.x; Jacquemyn H, 2005, MOL ECOL, V14, P4479, DOI 10.1111/j.1365-294X.2005.02741.x; Kang SC, 2001, EPISODES, V24, P176; Kittel TGF, 2000, GLOBAL CHANGE BIOL, V6, P1, DOI 10.1046/j.1365-2486.2000.06011.x; Lesica P, 2004, J VEG SCI, V15, P679, DOI 10.1111/j.1654-1103.2004.tb02310.x; Lian YS., 1998, SEABUCKTHORN RES, V1, P13; Lian YS, 2001, BIOL CHEM GENUS HIPP, P151; LIU Z, 1993, THEOR APPL GENET, V87, P97, DOI 10.1007/BF00223752; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; MANTEL N, 1967, CANCER RES, V27, P209; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nei M., 1987, MOL EVOLUTIONARY GEN; Nesbo CL, 1998, HEREDITAS, V129, P241, DOI 10.1111/j.1601-5223.1998.00241.x; Ness RW, 2010, GENETICS, V184, P381, DOI 10.1534/genetics.109.110130; Nie Y, 2010, J GEOGR SCI, V20, P667, DOI 10.1007/s11442-010-0803-8; Ohsawa T, 2008, GLOBAL ECOL BIOGEOGR, V17, P152, DOI 10.1111/j.1466-8238.2007.00357.x; Owen LA, 2009, QUATERNARY SCI REV, V28, P1412, DOI 10.1016/j.quascirev.2009.02.010; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pluess AR, 2004, AM J BOT, V91, P2013, DOI 10.3732/ajb.91.12.2013; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard JK, 2000, GENETICS, V155, P945; Pulido F, 2004, ADV ECOL RES, V35, P151, DOI 10.1016/S0065-2504(04)35008-7; RITLAND K, 1989, CAN J BOT, V67, P2017, DOI 10.1139/b89-255; Rousset F, 1997, GENETICS, V145, P1219; ROUSSET F, 1995, GENETICS, V140, P1413; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sebbenn AM, 2011, HEREDITY, V106, P134, DOI 10.1038/hdy.2010.33; Sharma SS, 2000, COLD REG SCI TECHNOL, V31, P95, DOI 10.1016/S0165-232X(99)00034-8; Sheng HM, 2006, PLANT SYST EVOL, V260, P25, DOI 10.1007/s00606-006-0413-1; Smith JM, 1999, EVOLUTIONARY GENETIC; Smouse PE, 2008, MOL ECOL, V17, P3389, DOI 10.1111/j.1365-294X.2008.03839.x; SOKAL RR, 1983, GENETICS, V105, P219; Streiff R, 1998, MOL ECOL, V7, P317, DOI 10.1046/j.1365-294X.1998.00360.x; Su H, 2003, HEREDITY, V90, P212, DOI 10.1038/sj.hdy.6800237; Sun K, 2002, PLANT SYST EVOL, V235, P121, DOI 10.1007/s00606-002-0206-0; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Teixeira H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088996; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tian CJ, 2004, BIOCHEM GENET, V42, P259, DOI 10.1023/B:BIGI.0000034430.93055.ff; Vekemans X, 2004, MOL ECOL, V13, P921, DOI 10.1046/j.1365-294X.2004.02076.x; Von Oheimb PV, 2013, BIOL J LINN SOC, V109, P526, DOI 10.1111/bij.12068; Vornam B, 2004, CONSERV GENET, V5, P561, DOI 10.1023/B:COGE.0000041025.82917.ac; Wang H, 2010, MOL ECOL, V19, P2964, DOI 10.1111/j.1365-294X.2010.04729.x; Wang YH, 2011, PLANT SYST EVOL, V295, P97, DOI 10.1007/s00606-011-0466-7; Wolff K, 1997, MOL ECOL, V6, P365, DOI 10.1046/j.1365-294X.1997.00201.x; Yokozeki Y, 1997, THEOR APPL GENET, V94, P61, DOI 10.1007/s001220050382; YOUNG AG, 1993, HEREDITY, V71, P277, DOI 10.1038/hdy.1993.136; Yuan JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034955; Zeng LY, 2012, AM J BOT, V99, pE326, DOI 10.3732/ajb.1200019	81	12	12	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0172948	10.1371/journal.pone.0172948	http://dx.doi.org/10.1371/journal.pone.0172948			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489850	Green Published, gold			2022-12-26	WOS:000401314100002
J	van Aalst, S; Ludwig, IS; van der Zee, R; van Eden, W; Broere, F				van Aalst, Susan; Ludwig, Irene S.; van der Zee, Ruurd; van Eden, Willem; Broere, Femke			Bystander activation of irrelevant CD4(+) T cells following antigen-specific vaccination occurs in the presence and absence of adjuvant	PLOS ONE			English	Article							IN-VIVO; AUTOIMMUNITY; PROLIFERATION; INFECTION; ARTHRITIS; VACCINES; VIRUS; STIMULATION; RECRUITMENT; PHENOTYPE	Autoimmune and other chronic inflammatory diseases (AID) are prevalent diseases which can severely impact the quality of life of those that suffer from the disease. In most cases, the etiology of these conditions have remained unclear. Immune responses that take place e.g. during natural infection or after vaccination are often linked with the development or exacerbation of AID. It is highly debated if vaccines induce or aggravate AID and in particular adjuvants are mentioned as potential cause. Since vaccines are given on a large scale to healthy individuals but also to elderly and immunocompromised individuals, more research is warranted. Non-specific induction of naive or memory autoreactive T cells via bystander activation is one of the proposed mechanisms of how vaccination might be involved in AID. During bystander activation, T cells unrelated to the antigen presented can be activated without (strong) T cell receptor (TCR) ligation, but via signals derived from the ongoing response directed against the vaccine-antigen or adjuvant at hand. In this study we have set up a TCR transgenic T cell transfer mouse model by which we were able to measure local bystander activation of transferred and labeled CD4(+) T cells. Intramuscular injection with the highly immunogenic Complete Freund's Adjuvant (CFA) led to local in vivo proliferation and activation of intravenously transferred CD4(+) T cells in the iliac lymph node. This local bystander activation was also observed after CFA prime and Incomplete Freund's Adjuvant (IFA) boost injection. Furthermore, we showed that an antigen specific response is sufficient for the induction of a bystander activation response and the general, immune stimulating effect of CFA or IFA does not appear to increase this effect. In other words, no evidence was obtained that adjuvation of antigen specific responses is essential for bystander activation.	[van Aalst, Susan; Ludwig, Irene S.; van der Zee, Ruurd; van Eden, Willem; Broere, Femke] Univ Utrecht, Dept Infect Dis & Immunol, Utrecht, Netherlands	Utrecht University	Broere, F (corresponding author), Univ Utrecht, Dept Infect Dis & Immunol, Utrecht, Netherlands.	f.broere@uu.nl		Broere, Femke/0000-0001-9343-0111; van Eden, Willem/0000-0003-1272-704X	Innovative Medicines Initiative Joint Undertaking [115308]; European Union's Seventh Framework Programme (FP7); EFPIA	Innovative Medicines Initiative Joint Undertaking; European Union's Seventh Framework Programme (FP7); EFPIA	This work was part of the BioVacSafe project. The BioVacSafe project has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement no 115308, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies' in kind contribution.	Ahmed S.S., 2014, AUTOIMMUN DIS, V5th ed., P275, DOI [10.1016/B978-0-12-384929-8.00020-4, DOI 10.1016/B978-0-12-384929-8.00020-4]; AHMED SS, 2015, SCI TRANSL MED, V7; Bangs SC, 2006, TRENDS IMMUNOL, V27, P518, DOI 10.1016/j.it.2006.09.006; Barker CIS, 2014, LANCET INFECT DIS, V14, P227, DOI 10.1016/S1473-3099(13)70238-X; Batista-Duharte A, 2014, INT IMMUNOPHARMACOL, V20, P170, DOI 10.1016/j.intimp.2014.02.033; Benn CS, 2013, TRENDS IMMUNOL, V34, P431, DOI 10.1016/j.it.2013.04.004; Berlo SE, 2005, J AUTOIMMUN, V25, P172, DOI 10.1016/j.jaut.2005.09.017; Billiau A, 2001, J LEUKOCYTE BIOL, V70, P849; Boyman O, 2010, EUR J IMMUNOL, V40, P936, DOI 10.1002/eji.201040466; Broere F, 2008, J IMMUNOL, V181, P899, DOI 10.4049/jimmunol.181.2.899; Chapman TJ, 2005, VIROLOGY, V340, P296, DOI 10.1016/j.virol.2005.06.023; Chen RT, 2001, J AUTOIMMUN, V16, P309, DOI 10.1006/jaut.2000.0491; Chillingworth NL, 2003, J NEUROSCI METH, V128, P45, DOI 10.1016/S0165-0270(03)00147-X; Darabi K, 2004, J IMMUNOL, V173, P92, DOI 10.4049/jimmunol.173.1.92; Di Genova G, 2006, BLOOD, V107, P2806, DOI 10.1182/blood-2005-08-3255; Di Genova G, 2010, EUR J IMMUNOL, V40, P976, DOI 10.1002/eji.200940017; Doisne JM, 2004, J IMMUNOL, V173, P2410, DOI 10.4049/jimmunol.173.4.2410; Eberl G, 2000, J IMMUNOL, V165, P4305, DOI 10.4049/jimmunol.165.8.4305; Ehl S, 1997, J EXP MED, V185, P1241, DOI 10.1084/jem.185.7.1241; Floreani A., 2015, CLIN REV ALLERGY IMM; Getts DR, 2013, IMMUNOL REV, V255, P197, DOI 10.1111/imr.12091; Goodridge HS, 2016, NAT REV IMMUNOL, V16, P392, DOI 10.1038/nri.2016.43; Hawkes D, 2015, J AUTOIMMUN, V59, P77, DOI 10.1016/j.jaut.2015.02.005; Holmdahl R, 2001, IMMUNOL REV, V184, P184, DOI 10.1034/j.1600-065x.2001.1840117.x; Jansen MAA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00090; Kamath AT, 2005, J IMMUNOL, V174, P767, DOI 10.4049/jimmunol.174.2.767; Lambert P., 2002, STATUS NONCLINICAL M, VI, P237; Letourneau S, 2009, J ALLERGY CLIN IMMUN, V123, P758, DOI 10.1016/j.jaci.2009.02.011; Li Causi E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136717; McLachlan JB, 2009, IMMUNITY, V30, P277, DOI 10.1016/j.immuni.2008.11.013; Munz C, 2009, NAT REV IMMUNOL, V9, P246, DOI 10.1038/nri2527; O'Donnell H, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00621; Pellegrino P, 2015, AUTOIMMUN REV, V14, P880, DOI 10.1016/j.autrev.2015.05.014; Polley R, 2005, EUR J IMMUNOL, V35, P498, DOI 10.1002/eji.200425436; Regner M, 2001, NAT IMMUNOL, V2, P185, DOI 10.1038/85228; Root-Bernstein R, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-013-0407-3; Salemi S, 2010, INT REV IMMUNOL, V29, P247, DOI 10.3109/08830181003746304; Sandalova E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001051; Sckisel GD, 2014, CLIN EXP IMMUNOL, V175, P79, DOI 10.1111/cei.12186; Sfriso P, 2010, J LEUKOCYTE BIOL, V87, P385, DOI 10.1189/jlb.0709517; Sharma S, 2014, J LEUKOCYTE BIOL, V95, P405, DOI 10.1189/jlb.0713386; Shoenfeld Y, 2011, J AUTOIMMUN, V36, P4, DOI 10.1016/j.jaut.2010.07.003; Soriano A, 2015, PHARMACOL RES, V92, P18, DOI 10.1016/j.phrs.2014.08.002; Su LF, 2013, IMMUNITY, V38, P373, DOI 10.1016/j.immuni.2012.10.021; Tough DF, 1996, SCIENCE, V272, P1947, DOI 10.1126/science.272.5270.1947; Tough DF, 1998, VET IMMUNOL IMMUNOP, V63, P123, DOI 10.1016/S0165-2427(98)00088-9; van Aalst S, 2017, VACCINE, V35, P1622, DOI 10.1016/j.vaccine.2017.02.005; van der Laan JW, 2015, VACCINE, V33, P1507, DOI 10.1016/j.vaccine.2015.01.073; van Eden W, 2001, ANONYMOUS CURRENT PR; Walker LSK, 2002, NAT REV IMMUNOL, V2, P11, DOI 10.1038/nri701; Wraith DC, 2003, LANCET, V362, P1659, DOI 10.1016/S0140-6736(03)14802-7	51	21	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177365	10.1371/journal.pone.0177365	http://dx.doi.org/10.1371/journal.pone.0177365			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489886	Green Submitted, Green Published, gold			2022-12-26	WOS:000401314100067
J	Anderson, BA				Anderson, Brian A.			On the feature specificity of value-driven attention	PLOS ONE			English	Article							OCULOMOTOR CAPTURE; VISUAL-CORTEX; REWARD; PRIORITY; SIGNALS; CONTINGENCIES; SALIENCE; COLOR	When an otherwise inconspicuous stimulus is learned to predict a reward, this stimulus will automatically capture visual attention. This learned attentional bias is not specific to the precise object previously associated with reward, but can be observed for different stimuli that share a defining feature with the reward cue. Under certain circumstances, value-driven attentional biases can even transfer to new contexts in which the reward cues were not previously experienced, and can also be evident for different exemplars of a stimulus category, suggesting some degree of tolerance in the scope of the underlying bias. Whether a match to a reward-predictive feature is necessary to support value-driven attention, or whether similar-looking features also receive some degree of elevated priority following associative reward learning, remains an open question. Here, I examine the impact of learned associations between reward and red-and green-colored stimuli on the processing of other colors. The findings show that even though other colors experienced during training were non-predictive with respect to reward, the speed with which targets possessing these colors were identified in a subsequent test phase was affected by their similarity to the high-value color. Thus, value-driven attentional biases for stimulus features are imprecise, as would be predicted by a sensory gain model of value-driven attention.	[Anderson, Brian A.] Texas A&M Univ, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Anderson, BA (corresponding author), Texas A&M Univ, College Stn, TX 77843 USA.	brian.anderson@tamu.edu			University Libraries; Office of the Vice President for Research	University Libraries; Office of the Vice President for Research	The open access publishing fees for this article have been covered by the Texas A&M University Open Access to Knowledge Fund (OAKFund), supported by the University Libraries and the Office of the Vice President for Research.	Anderson BA, ATTN PERCEP IN PRESS; Anderson BA, 2017, SOC COGN AFFECT NEUR, V12, P461, DOI 10.1093/scan/nsw141; Anderson BA, 2016, ANN NY ACAD SCI, V1369, P24, DOI 10.1111/nyas.12957; Anderson BA, 2016, CURR BIOL, V26, P550, DOI 10.1016/j.cub.2015.12.062; Anderson BA, 2015, PSYCHON B REV, V22, P750, DOI 10.3758/s13423-014-0724-0; Anderson BA, 2015, VIS COGN, V23, P67, DOI 10.1080/13506285.2014.956851; Anderson BA, 2014, BRAIN RES, V1587, P88, DOI 10.1016/j.brainres.2014.08.062; Anderson BA, 2014, COGN AFFECT BEHAV NE, V14, P1221, DOI 10.3758/s13415-014-0301-z; Anderson BA, 2014, J EXP PSYCHOL HUMAN, V40, P1755, DOI 10.1037/a0037685; Anderson BA, 2013, J VISION, V13, DOI 10.1167/13.3.7; Anderson BA, 2012, ATTEN PERCEPT PSYCHO, V74, P1183, DOI 10.3758/s13414-012-0325-9; Anderson BA, 2012, VIS COGN, V20, P647, DOI 10.1080/13506285.2012.679711; Anderson BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027926; Anderson BA, 2011, P NATL ACAD SCI USA, V108, P10367, DOI 10.1073/pnas.1104047108; Anderson BA, 2010, ATTEN PERCEPT PSYCHO, V72, P342, DOI 10.3758/APP.72.2.342; [Anonymous], 2001, B WORLD HEALTH ORGAN, V79, P373; Ansorge U, 2003, J EXP PSYCHOL HUMAN, V29, P937, DOI 10.1037/0096-1523.29.5.937; Arsenault JT, 2013, NEURON, V77, P1174, DOI 10.1016/j.neuron.2013.01.008; Della Libera C, 2009, PSYCHOL SCI, V20, P778, DOI 10.1111/j.1467-9280.2009.02360.x; Donohue SE, 2016, J COGNITIVE NEUROSCI, V28, P529, DOI 10.1162/jocn_a_00917; DUNCAN J, 1994, NATURE, V369, P313, DOI 10.1038/369313a0; Engelmann JB, 2007, EMOTION, V7, P668, DOI 10.1037/1528-3542.7.3.668; Failing MF, 2014, J VISION, V14, DOI 10.1167/14.5.6; Failing MF, 2015, VIS COGN, V23, P82, DOI 10.1080/13506285.2014.990546; Folk CL, 1998, J EXP PSYCHOL HUMAN, V24, P847, DOI 10.1037/0096-1523.24.3.847; Hickey C, 2015, NEURON, V85, P512, DOI 10.1016/j.neuron.2014.12.049; Hickey C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103372; Hickey C, 2010, J NEUROSCI, V30, P11096, DOI 10.1523/JNEUROSCI.1026-10.2010; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Itthipuripat S, 2015, J NEUROPHYSIOL, V114, P560, DOI 10.1152/jn.00343.2015; Johnson EN, 2008, J NEUROSCI, V28, P8096, DOI 10.1523/JNEUROSCI.1404-08.2008; Kiss M, 2009, PSYCHOL SCI, V20, P245, DOI 10.1111/j.1467-9280.2009.02281.x; Krebs RM, 2012, CEREB CORTEX, V22, P607, DOI 10.1093/cercor/bhr134; Kristjansson A, 2010, ATTEN PERCEPT PSYCHO, V72, P1229, DOI 10.3758/APP.72.5.1229; Le Pelley ME, 2015, J EXP PSYCHOL GEN, V144, P158, DOI 10.1037/xge0000037; MacLean MH, 2015, BRAIN RES, V1606, P86, DOI 10.1016/j.brainres.2015.02.016; Navalpakkam V, 2010, P NATL ACAD SCI USA, V107, P5232, DOI 10.1073/pnas.0911972107; Navalpakkam V, 2009, J VISION, V9, DOI 10.1167/9.1.31; Pessoa L, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00017; Pool E, 2014, COGNITION, V130, P348, DOI 10.1016/j.cognition.2013.12.002; Qi SQ, 2013, BRAIN RES, V1532, P32, DOI 10.1016/j.brainres.2013.07.044; Roelfsema PR, 2005, NEURAL COMPUT, V17, P2176, DOI 10.1162/0899766054615699; Rombouts JO, 2015, VIS COGN, V23, P179, DOI 10.1080/13506285.2015.1010462; Serences JT, 2010, J NEUROPHYSIOL, V104, P76, DOI 10.1152/jn.01090.2009; Serences JT, 2008, NEURON, V60, P1169, DOI 10.1016/j.neuron.2008.10.051; Sharma G, 2005, COLOR RES APPL, V30, P21, DOI 10.1002/col.20070; Shuler MG, 2006, SCIENCE, V311, P1606, DOI 10.1126/science.1123513; Stormer VS, 2014, CURR BIOL, V24, P1985, DOI 10.1016/j.cub.2014.07.030; Theeuwes J, 2012, VISION RES, V74, P80, DOI 10.1016/j.visres.2012.07.024; TREISMAN A, 1983, PERCEPT PSYCHOPHYS, V33, P527, DOI 10.3758/BF03202934; van Koningsbruggen MG, 2016, SOC COGN AFFECT NEUR, V11, P1481, DOI 10.1093/scan/nsw056; Yamamoto S, 2013, J NEUROSCI, V33, P11227, DOI 10.1523/JNEUROSCI.0318-13.2013	52	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177491	10.1371/journal.pone.0177491	http://dx.doi.org/10.1371/journal.pone.0177491			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UM	28486526	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314000082
J	Chen, L; Liu, X; Gao, LG; Wang, R; Gao, DW; Bai, DY				Chen, Lei; Liu, Xi; Gao, Linggen; Wang, Rong; Gao, Dewei; Bai, Dongyu			The clinicopathological features and prognosis of signet ring cell carcinoma of the esophagus: A 10-year retrospective study in China	PLOS ONE			English	Article							PREOPERATIVE CHEMORADIATION; ADENOCARCINOMA; CANCER; EPITHELIUM; HISTOLOGY; SURVIVAL	Objectives The aim of this study was to analyze the clinicopathological features and prognosis of esophageal signet ring cell (SRC) carcinoma in China. Methods Patients with poorly differentiated adenocarcinoma were identified in two hospitals from January 2006 to June 2016. The patients were divided into three groups according to component of SRCs: SRC >= 50% group, SRC < 50% group and non-SRC poorly differentiated adenocarcinoma group. Results Fifty-seven patients had carcinoma (SRC >= 50%), and 79 patients had tumors containing < 50% SRCs, and 535 patients was in non-SRC poorly differentiated adenocarcinoma group. There were no significant differences among the three groups in clinicopathological characteristics. Patients in SRC >= 50% group had a lower overall survival rate (at 3-year 37.6% versus71.1%; at 5-year 0% versus 43.3%; p<0.001) compared with the control group. Even survival outcome of patients in SRC < 50% was inferior to that of in control group (at 3-year 53.0% versus71.1%; at 5-year 25.9% versus 43.3%; p<0.001). Female sex, large tumor size and increasing TNM stage were independent prognostic factors for SRC >= 50% esophageal carcinoma patients. Conclusions The incidence of esophageal SRC carcinoma is relatively rare and the worst outcome is observed in the SRC >= 50% group. It is necessary to explore new therapeutic modalities to achieve further improvements in the clinical outcome of these patients.	[Chen, Lei; Liu, Xi] Chinese Peoples Liberat Army, Gen Hosp, Dept Thorac Surg, Beijing, Peoples R China; [Gao, Linggen; Wang, Rong; Gao, Dewei] Chinese Peoples Liberat Army, Gen Hosp, Dept Comprehens Surg, Beijing, Peoples R China; [Bai, Dongyu] Xiamen Univ, Affiliated Hosp 1, Dept Pathol, Xiamen, Province Fujian, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Xiamen University	Gao, DW (corresponding author), Chinese Peoples Liberat Army, Gen Hosp, Dept Comprehens Surg, Beijing, Peoples R China.; Bai, DY (corresponding author), Xiamen Univ, Affiliated Hosp 1, Dept Pathol, Xiamen, Province Fujian, Peoples R China.	gaodeweigdw@163.com; baidongyu@163.com			China Postdoctoral Science Foundation [2012T50865]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by a general financial grant from the China Postdoctoral Science Foundation (2012T50865, to L. Gao.).	Cen P, 2012, ANN SURG ONCOL, V19, P1685, DOI 10.1245/s10434-011-2141-1; Chirieac LR, 2005, CLIN CANCER RES, V11, P2229, DOI 10.1158/1078-0432.CCR-04-1840; Chon HJ, 2017, ANN SURG, V265, P946, DOI 10.1097/SLA.0000000000001793; Enlow JM, 2013, ANN THORAC SURG, V96, P1927, DOI 10.1016/j.athoracsur.2013.06.047; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; FROST AR, 1995, ARCH PATHOL LAB MED, V119, P64; Hornick JL, 2006, AM J SURG PATHOL, V30, P28, DOI 10.1097/01.pas.0000174011.29816.fa; KITAMURA H, 1985, ACTA PATHOL JAPON, V35, P675; Kwon KJ, 2014, GASTRIC CANCER, V17, P43, DOI 10.1007/s10120-013-0234-1; Kwon WA, 2013, CUAJ-CAN UROL ASSOC, V7, pE768, DOI 10.5489/cuaj.630; Liu XW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144420; Maezato K, 2007, SURG TODAY, V37, P1096, DOI 10.1007/s00595-007-3533-5; Merchant SH, 2001, AM J SURG PATHOL, V25, P1515, DOI 10.1097/00000478-200112000-00007; Nafteux PR, 2014, ANN SURG, V260, P1023, DOI 10.1097/SLA.0000000000000689; Patel VR, 2014, ANN THORAC SURG, V98, P1064, DOI 10.1016/j.athoracsur.2014.04.099; Piessen G, 2014, EJSO-EUR J SURG ONC, V40, P1746, DOI 10.1016/j.ejso.2014.04.019; Sobin LH, 2010, CANCER-AM CANCER SOC, V116, P5336, DOI 10.1002/cncr.25537; Taghavi S, 2012, J CLIN ONCOL, V30, P3493, DOI 10.1200/JCO.2012.42.6635; TAKUBO K, 1987, ACTA PATHOL JAPON, V37, P989; Tan YN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121944; Wei Q, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156659; YAMASHINA M, 1986, CANCER, V58, P1333, DOI 10.1002/1097-0142(19860915)58:6<1333::AID-CNCR2820580625>3.0.CO;2-B; Yendamuri S, 2013, CANCER-AM CANCER SOC, V119, P3156, DOI 10.1002/cncr.28099	23	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0176637	10.1371/journal.pone.0176637	http://dx.doi.org/10.1371/journal.pone.0176637			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486494	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314000020
J	Kenney, A; Cusick, A; Payne, J; Gaughenbaugh, A; Renshaw, A; Wright, J; Seeber, R; Barnes, R; Florjanczyk, A; Horzempa, J				Kenney, Adam; Cusick, Austin; Payne, Jessica; Gaughenbaugh, Anna; Renshaw, Andrea; Wright, Jenna; Seeber, Roger; Barnes, Rebecca; Florjanczyk, Aleksandr; Horzempa, Joseph			The potential for flower nectar to allow mosquito to mosquito transmission of Francisella tularensis	PLOS ONE			English	Article							DERMACENTOR-RETICULATUS TICKS; DIPTERA-CULICIDAE; TULAREMIA; SWEDEN; TEMPERATURE; TURKEY; OUTBREAK; GROWTH; FOCUS; PILIN	Francisella tularensis is disseminated in nature by biting arthropods such as mosquitoes. The relationship between mosquitoes and F. tularensis in nature is highly ambiguous, due in part to the fact that mosquitoes have caused significant tularemia outbreaks despite being classified as a mechanical vector of F. tularensis. One possible explanation for mosquitoes being a prominent, yet mechanical vector is that these insects feed on flower nectar between blood meals, allowing for transmission of F. tularensis between mosquitoes. Here, we aimed to assess whether F. tularensis could survive in flower nectar. Moreover, we examined if mosquitoes could interact with or ingest and transmit F. tularensis from one source of nectar to another. F. tularensis exhibited robust survivability in flower nectar with concentrations of viable bacteria remaining consistent with the rich growth medium. Furthermore, F. tularensis was able to survive (albeit to a lesser extent) in 30% sucrose (a nectar surrogate) over a period of time consistent with that of a typical flower bloom. Although we observed diminished bacterial survival in the nectar surrogate, mosquitoes that fed on this material became colonized with F. tularensis. Finally, colonized mosquitoes were capable of transferring F. tularensis to a sterile nectar surrogate. These data suggest that flower nectar may be capable of serving as a temporary source of F. tularensis that could contribute to the amplification of outbreaks. Mosquitoes that feed on an infected mammalian host and subsequently feed on flower nectar could deposit some F. tularensis bacteria into the nectar in the process. Mosquitoes subsequently feeding on this nectar source could potentially become colonized by F. tularensis. Thus, the possibility exists that flower nectar may allow for vector-vector transmission of F. tularensis.	[Kenney, Adam; Cusick, Austin; Payne, Jessica; Gaughenbaugh, Anna; Renshaw, Andrea; Wright, Jenna; Seeber, Roger; Barnes, Rebecca; Florjanczyk, Aleksandr; Horzempa, Joseph] West Liberty Univ, Dept Nat Sci & Math, West Liberty, WV USA		Horzempa, J (corresponding author), West Liberty Univ, Dept Nat Sci & Math, West Liberty, WV USA.	joseph.horzempa@westliberty.edu			NASA WV Space Grant Consortium [NNX10AK62H]; National Institute of General Medical Sciences of the National Institutes of Health [P20GM103434]; National Institutes of Health, National Institute of Allergy and Infectious Diseases [5K22AI087703]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI087703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103434] Funding Source: NIH RePORTER	NASA WV Space Grant Consortium; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by a grant through the NASA WV Space Grant Consortium (NNX10AK62H), an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health (P20GM103434), and a grant from the National Institutes of Health, National Institute of Allergy and Infectious Diseases (5K22AI087703).; The authors thank Deanna Schmitt and Tricia Gilson for technical contributions and helpful insight. This work was funded by a grant through the NASA WV Space Grant Consortium (NNX10AK62H), an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health (P20GM103434), and a grant from the National Institutes of Health, National Institute of Allergy and Infectious Diseases (5K22AI087703).	Abd H, 2003, APPL ENVIRON MICROB, V69, P600, DOI 10.1128/AEM.69.1.600-606.2003; Akimana C, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00034; Andrews FM, 1929, PLANT PHYSIOL, V4, P281, DOI 10.1104/pp.4.2.281; Asare R, 2010, ENVIRON MICROBIOL, V12, P2587, DOI 10.1111/j.1462-2920.2010.02230.x; Baron GS, 1998, MOL MICROBIOL, V29, P247, DOI 10.1046/j.1365-2958.1998.00926.x; CASTRIC PA, 1989, MOL GEN GENET, V216, P75, DOI 10.1007/BF00332233; Chadee DD, 2014, ACTA TROP, V132, pS86, DOI 10.1016/j.actatropica.2013.09.019; Chalcoff VR, 2006, ANN BOT-LONDON, V97, P413, DOI 10.1093/aob/mcj043; CHRISTENSON B, 1984, SCAND J INFECT DIS, V16, P285, DOI 10.3109/00365548409070402; Clemons A, 2010, COLD SPRING HARB PRO, V2010; Desvars A, 2015, EMERG INFECT DIS, V21, P32, DOI 10.3201/eid2101.140916; Duzlu O, 2016, VECTOR-BORNE ZOONOT, V16, P26, DOI 10.1089/vbz.2015.1818; Eliasson H, 2002, EMERG INFECT DIS, V8, P956, DOI 10.3201/eid0809.020051; Eliasson H, 2007, SCAND J INFECT DIS, V39, P880, DOI 10.1080/00365540701402970; GUERRANT RL, 1976, ARCH INTERN MED, V136, P811, DOI 10.1001/archinte.136.7.811; Hanke CA, 2009, EUR J PEDIATR, V168, P937, DOI 10.1007/s00431-008-0862-3; Horzempa J, 2006, J BIOL CHEM, V281, P1128, DOI 10.1074/jbc.M510975200; Horzempa J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-172; Hubalek Z, 1998, WIEN KLIN WOCHENSCHR, V110, P909; Hubalek Z, 1997, J MED ENTOMOL, V34, P660, DOI 10.1093/jmedent/34.6.660; Hubalek Z, 1996, MED VET ENTOMOL, V10, P241, DOI 10.1111/j.1365-2915.1996.tb00737.x; Karolyi F, 2014, ARTHROPOD STRUCT DEV, V43, P403, DOI 10.1016/j.asd.2014.07.003; Kilic S, 2015, EMERG INFECT DIS, V21, P2213, DOI 10.3201/eid2112.150634; Lindh JM, 2006, ACTA TROP, V99, P173, DOI 10.1016/j.actatropica.2006.07.008; Lundstrom JO, 2011, EMERG INFECT DIS, V17, P794, DOI 10.3201/eid1705.100426; Mohammed A, 2011, ACTA TROP, V119, P38, DOI 10.1016/j.actatropica.2011.04.004; Mostowy WM, 2004, J VECTOR ECOL, V29, P84; Olin Gunnar, 1942, ACTA PATH ET MICROBIOL SCAND, V19, P220; Payne L, 2005, EMERG INFECT DIS, V11, P1440, DOI 10.3201/eid1109.041189; Petersen JM, 2009, VET RES, V40, DOI 10.1051/vetres:2008045; Ryden P, 2012, J INFECT DIS, V205, P297, DOI 10.1093/infdis/jir732; Santic M, 2009, ENVIRON MICROBIOL, V11, P1473, DOI 10.1111/j.1462-2920.2009.01875.x; SASLAW S, 1961, AM J MED SCI, V241, P689, DOI 10.1097/00000441-196106000-00001; SMITH SM, 1994, MED VET ENTOMOL, V8, P201, DOI 10.1111/j.1365-2915.1994.tb00499.x; Svensson K, 2009, EMERG INFECT DIS, V15, P1937, DOI 10.3201/eid1512.090487; Tarnvik A, 1996, FEMS IMMUNOL MED MIC, V13, P201, DOI 10.1016/0928-8244(95)00104-2; Thelaus J, 2014, MICROB ECOL, V67, P96, DOI 10.1007/s00248-013-0285-1; Triebenbach AN, 2010, J MED ENTOMOL, V47, P639, DOI 10.1603/ME09192; Yanik K, 2015, MIKROBIYOL BUL, V49, P139, DOI 10.5578/mb.8632	39	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0175157	10.1371/journal.pone.0175157	http://dx.doi.org/10.1371/journal.pone.0175157			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486521	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314000003
J	Nguyen-McCarty, M; Klein, PS				Nguyen-McCarty, Michelle; Klein, Peter S.			Autophagy is a signature of a signaling network that maintains hematopoietic stem cells	PLOS ONE			English	Article							PROTEIN-SYNTHESIS; MITOCHONDRIAL BIOGENESIS; MAMMALIAN TARGET; BONE-MARROW; MTOR; DIFFERENTIATION; INHIBITION; RENEWAL; GSK3; PHOSPHORYLATION	Hematopoietic stem cells (HSCs) are able to self-renew and to differentiate into all blood cells. HSCs reside in a low-perfusion niche and depend on local signals to survive and to maintain the capacity for self-renewal. HSCs removed from the niche are unable to survive without addition of hematopoietic cytokines and rapidly lose their ability to self-renew. We reported previously that inhibition of both GSK-3 and mTORC1 is essential to maintain long-term HSCs ex vivo. Although Wnt/beta-catenin signaling downstream of GSK-3 is required for this response, the downstream effectors of mTORC1 remain undefined. We now report that HSCs express a pro-autophagic gene signature and accumulate LC3 puncta only when both mTORC1 and GSK-3 are inhibited, identifying autophagy as a signature for a signaling network that maintains HSCs ex vivo. In addition, these conditions sustain HSC repopulating function despite an increased rate of global translation. Together, these findings provide new insight into the relative contributions of various mTORC1 outputs toward the maintenance of HSC function and build upon the growing body of literature implicating autophagy and tightly controlled protein synthesis as important modulators of diverse stem cell populations.	[Nguyen-McCarty, Michelle; Klein, Peter S.] Univ Penn, Perelman Sch Med, Cell & Mol Biol Grad Grp, Philadelphia, PA 19104 USA; [Klein, Peter S.] Univ Penn, Perelman Sch Med, Dept Med Hematol Oncol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Klein, PS (corresponding author), Univ Penn, Perelman Sch Med, Cell & Mol Biol Grad Grp, Philadelphia, PA 19104 USA.	pklein@mail.med.upenn.edu			Hematopoiesis Training Grant at the University of Pennsylvania [T32-DK07780]; Penn-CHOP Blood Center for Patient Care and Discovery; United States National Institutes of Health [1R21HL107968, 1R01HL110806, 1R01GM115517]; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110806, R21HL107968] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK103001, T32DK007780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115517] Funding Source: NIH RePORTER	Hematopoiesis Training Grant at the University of Pennsylvania; Penn-CHOP Blood Center for Patient Care and Discovery; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	MN was supported by the Hematopoiesis Training Grant at the University of Pennsylvania (T32-DK07780). This study was supported by grants to PSK from The Penn-CHOP Blood Center for Patient Care and Discovery and the United States National Institutes of Health (1R21HL107968, 1R01HL110806, and 1R01GM115517).; We thank Zhixun Dou, Caiyue Xu, and Jian Huang for technical advice and insightful discussion. We also thank all members of the Klein laboratory for support and discussions. We are grateful to Hank Pletcher, Richard Schretzenmair, and the University of Pennsylvania Flow Cytometry and Cell Sorting Facility. M.N. was supported by the Hematopoiesis Training Grant at the University of Pennsylvania (T32-DK07780). This study was supported by grants to P.S.K. from The Penn-CHOP Blood Center for Patient Care and Discovery and the United States National Institutes of Health (1R21HL107968, 1R01HL110806, and 1R01GM115517).	Azoulay-Alfaguter I, 2015, ONCOGENE, V34, P4613, DOI 10.1038/onc.2014.390; Blattler SM, 2012, MOL CELL BIOL, V32, P3333, DOI 10.1128/MCB.00337-12; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Cook M, 2007, CURR OPIN BIOTECH, V18, P341, DOI 10.1016/j.copbio.2007.07.006; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Gan B, 2008, P NATL ACAD SCI USA, V105, P19384, DOI 10.1073/pnas.0810584105; Garcia-Prat L, 2016, AUTOPHAGY, V12, P612, DOI 10.1080/15548627.2016.1143211; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Guan JL, 2013, AUTOPHAGY, V9, P830, DOI 10.4161/auto.24132; Guezguez B, 2016, CANCER CELL, V29, P61, DOI 10.1016/j.ccell.2015.11.012; Ho TT, 2017, NATURE; Huang J, 2012, NAT MED, V18, P1778, DOI 10.1038/nm.2984; Huang J, 2009, J CLIN INVEST, V119, P3519, DOI 10.1172/JCI40572; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Isotani S, 1999, J BIOL CHEM, V274, P34493, DOI 10.1074/jbc.274.48.34493; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kalaitzidis D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003776; Kharas MG, 2010, BLOOD, V115, P1406, DOI 10.1182/blood-2009-06-229443; Liu J, 2012, P NATL ACAD SCI USA, V109, P413, DOI 10.1073/pnas.1111561108; Lloyd AC, 2013, CELL, V154, P1194, DOI 10.1016/j.cell.2013.08.053; Lymperi S, 2010, ANN NY ACAD SCI, V1192, P12, DOI 10.1111/j.1749-6632.2009.05223.x; Mantel C, 2010, CELL CYCLE, V9, P2008, DOI 10.4161/cc.9.10.11733; Marchand B, 2015, J BIOL CHEM, V290, P5592, DOI 10.1074/jbc.M114.616714; Moerke NJ, 2007, CELL, V128, P257, DOI 10.1016/j.cell.2006.11.046; Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001; Mortensen M, 2011, J EXP MED, V208, P455, DOI 10.1084/jem.20101145; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Parr C, 2012, MOL CELL BIOL, V32, P4410, DOI 10.1128/MCB.00930-12; Phadwal K, 2013, CELL MOL LIFE SCI, V70, P89, DOI 10.1007/s00018-012-1032-3; Purton LE, 2007, CELL STEM CELL, V1, P263, DOI 10.1016/j.stem.2007.08.016; REERS M, 1991, BIOCHEMISTRY-US, V30, P4480, DOI 10.1021/bi00232a015; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; Salemi S, 2012, CELL RES, V22, P432, DOI 10.1038/cr.2011.200; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; Schultz MB, 2016, DEVELOPMENT, V143, P3, DOI 10.1242/dev.130633; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Signer RAJ, 2016, GENE DEV, V30, P1698, DOI 10.1101/gad.282756.116; Signer RAJ, 2014, NATURE, V509, P49, DOI 10.1038/nature13035; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Spencer JA, 2014, NATURE, V508, P269, DOI 10.1038/nature13034; Sukumar M, 2016, CELL METAB, V23, P63, DOI 10.1016/j.cmet.2015.11.002; Tang AH, 2014, EMBO J, V33, P2782, DOI 10.15252/embj.201488278; Vazquez P, 2012, AUTOPHAGY, V8, P187, DOI 10.4161/auto.8.2.18535; Warr MR, 2013, NATURE, V494, P323, DOI 10.1038/nature11895; Watson AS, 2015, CELL DEATH DISCOV, V1, DOI 10.1038/cddiscovery.2015.8; Wu XT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10533; Xiao LJ, 2009, CURR GENOMICS, V10, P198, DOI 10.2174/138920209788185261; Yang ZF, 2006, MOL BIOL CELL, V17, P5094, DOI 10.1091/mbc.E06-06-0479; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703	49	16	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177054	10.1371/journal.pone.0177054	http://dx.doi.org/10.1371/journal.pone.0177054			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486555	Green Submitted, gold, Green Published			2022-12-26	WOS:000401314000040
J	Han, B; Kpark, H; Ching, T; Panneerselvam, J; Wang, H; Shen, Y; Zhang, J; Li, L; Che, R; Garmire, L; Fei, P				Han, B.; KPark, H.; Ching, T.; Panneerselvam, J.; Wang, H.; Shen, Y.; Zhang, J.; Li, L.; Che, R.; Garmire, L.; Fei, P.			Human DBR1 modulates the recycling of snRNPs to affect alternative RNA splicing and contributes to the suppression of cancer development	ONCOGENE			English	Article							DISTINCT METABOLIC SIGNATURE; HUMAN BLADDER-CANCER; TUMOR-SUPPRESSOR; BRANCH POINT; DEBRANCHING ENZYME; DNA-DAMAGE; SPLICEOSOME; PATHWAY; FANCD2; COMPLEX	The contribution of RNA processing to tumorigenesis is understudied. Here, we report that the human RNA debranching enzyme (hDBR1), when inappropriately regulated, induces oncogenesis by causing RNA processing defects, for example, splicing defects. We found that wild-type p53 and hypoxia-inducible factor 1 co-regulate hDBR1 expression, and insufficient hDBR1 leads to a higher rate of exon skipping. Transcriptomic sequencing confirmed the effect of hDBR1 on RNA splicing, and metabolite profiling supported the observation that neoplasm is triggered by a decrease in hDBR1 expression both in vitro and in vivo. Most importantly, when modulating the expression of hDBR1, which was found to be generally low in malignant human tissues, higher expression of hDBR1 only affected exon-skipping activity in malignant cells. Together, our findings demonstrate previously unrecognized regulation and functions of hDBR1, with immediate clinical implications regarding the regulation of hDBR1 as an effective strategy for combating human cancer.	[Han, B.; Panneerselvam, J.; Shen, Y.; Li, L.; Che, R.; Fei, P.] Univ Hawaii, Canc Ctr, Div Canc Biol, 701 Ilalo St, Honolulu, HI 96813 USA; [KPark, H.; Wang, H.; Zhang, J.] Mayo Clin, Coll Med, Dept Lab Med & Pathol, Rochester, MN USA; [Ching, T.; Garmire, L.; Fei, P.] Univ Hawaii, Canc Ctr, Div Epidemiol, Honolulu, HI 96813 USA; [Li, L.] Xuzhou Med Coll, Canc Inst, Xuzhou, Peoples R China	Cancer Research Center of Hawaii; University of Hawaii System; Mayo Clinic; Cancer Research Center of Hawaii; University of Hawaii System; Xuzhou Medical University	Fei, P (corresponding author), Univ Hawaii, Canc Ctr, Div Canc Biol, 701 Ilalo St, Honolulu, HI 96813 USA.	Pfei@cc.hawaii.edu		Ching, Travers/0000-0002-5577-3516; HAN, BING/0000-0002-0818-409X; li, liantao/0000-0002-8788-2880	NIH [R01CA136532, R01CA188251]; Chinese National Science Foundation (CNSF) [81372171]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD084633] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA188251, P30CA071789, R01CA136532] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K01ES025434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103457] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM012373] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese National Science Foundation (CNSF)(National Natural Science Foundation of China (NSFC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This study was supported in part by NIH grants (R01CA136532 and R01CA188251) to PF and Chinese National Science Foundation (CNSF#81372171) to PF. We thank Dr Alberto R Kornblihtt (Universidad de Buenos Aires, Argentina) for providing the FN-EDI reporter construct.	Azubel M, 2004, MOL CELL, V15, P833, DOI 10.1016/j.molcel.2004.07.022; Barrett SP, 2015, ELIFE, V4, DOI 10.7554/eLife.07540; Bischof O, 2015, IUBMB LIFE, V67, P255, DOI 10.1002/iub.1373; Bitton DA, 2014, GENOME RES, V24, P1169, DOI 10.1101/gr.166819.113; Carstens RP, 2014, MOL CELL, V54, P903, DOI 10.1016/j.molcel.2014.06.014; Chan SP, 2003, SCIENCE, V302, P279, DOI 10.1126/science.1086602; CHAPMAN KB, 1991, CELL, V65, P483, DOI 10.1016/0092-8674(91)90466-C; Clark NE, 2016, P NATL ACAD SCI USA, V113, P14727, DOI 10.1073/pnas.1612729114; Clerte C, 2009, BIOCHEMISTRY-US, V48, P2063, DOI 10.1021/bi8016872; Fei PW, 2004, CANCER CELL, V6, P597, DOI 10.1016/j.ccr.2004.10.012; Fourmann JB, 2013, GENE DEV, V27, P413, DOI 10.1101/gad.207779.112; Frye M, 2016, DEVELOPMENT, V143, P3871, DOI 10.1242/dev.136556; Fu DC, 2013, CELL CYCLE, V12, P803, DOI 10.4161/cc.23755; Gao KP, 2008, NUCLEIC ACIDS RES, V36, P2257, DOI 10.1093/nar/gkn073; Han B, 2017, ONCOTARGET, V8, P22490, DOI 10.18632/oncotarget.14989; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Hube F, 2017, NUCLEIC ACIDS RES, V45, P4768, DOI 10.1093/nar/gkw1341; Ilagan JO, 2013, RNA, V19, P400, DOI 10.1261/rna.034223.112; Kataoka N, 2013, SCI REP-UK, V3, DOI 10.1038/srep01090; Kataoka N, 2009, MOL CELL BIOL, V29, P3243, DOI 10.1128/MCB.00360-09; Kock KH, 2015, NUCLEIC ACIDS RES, V43, P6568, DOI 10.1093/nar/gkv617; Kol G, 2005, HUM MOL GENET, V14, P1559, DOI 10.1093/hmg/ddi164; Kornblihtt AR, 1996, FASEB J, V10, P248, DOI 10.1096/fasebj.10.2.8641558; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Lee Y, 2015, ANNU REV BIOCHEM, V84, P291, DOI 10.1146/annurev-biochem-060614-034316; Li ZL, 2016, OXID MED CELL LONGEV, V2016, P12, DOI DOI 10.1007/S10529-016-2066-7; Matera AG, 2014, NAT REV MOL CELL BIO, V15, P108, DOI 10.1038/nrm3742; Moore MJ, 2010, CELL, V142, P625, DOI 10.1016/j.cell.2010.07.019; Munoz MJ, 2009, CELL, V137, P708, DOI 10.1016/j.cell.2009.03.010; Nam K, 1997, MOL CELL BIOL, V17, P809, DOI 10.1128/MCB.17.2.809; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Ohi MD, 2007, P NATL ACAD SCI USA, V104, P3195, DOI 10.1073/pnas.0611591104; Panneerselvam J, 2016, J PROTEOME RES, V15, P1333, DOI 10.1021/acs.jproteome.6b00076; Panneerselvam J, 2014, ONCOTARGET, V5, P1326, DOI 10.18632/oncotarget.1796; Panneerselvam J, 2013, ONCOTARGET, V4, P1416, DOI 10.18632/oncotarget.1217; Panneerselvam J, 2012, CELL CYCLE, V11, P2947, DOI 10.4161/cc.21400; Park HK, 2011, CELL CYCLE, V10, P2574, DOI 10.4161/cc.10.15.15923; Park HK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013313; Pastuszak AW, 2011, NUCLEIC ACIDS RES, V39, P2344, DOI 10.1093/nar/gkq1046; Qiu YP, 2014, CLIN CANCER RES, V20, P2136, DOI 10.1158/1078-0432.CCR-13-1939; Qiu YP, 2013, INT J MOL SCI, V14, P8047, DOI 10.3390/ijms14048047; RUSKIN B, 1985, SCIENCE, V229, P135, DOI 10.1126/science.2990042; Schmitt AM, 2016, CANCER CELL, V29, P452, DOI 10.1016/j.ccell.2016.03.010; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; SHARP PA, 1987, SCIENCE, V238, P729, DOI 10.1126/science.2445035; Sullenger BA, 2016, SCIENCE, V352, P1417, DOI 10.1126/science.aad8709; Svoronos AA, 2016, CANCER RES, V76, P3666, DOI 10.1158/0008-5472.CAN-16-0359; Wahl MC, 2015, CELL, V161, P1474, DOI 10.1016/j.cell.2015.05.050; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Ward AJ, 2010, J PATHOL, V220, P152, DOI 10.1002/path.2649; Yoshimoto R, 2009, NUCLEIC ACIDS RES, V37, P891, DOI 10.1093/nar/gkn1002; Zheng SM, 2015, CELL, V161, P762, DOI 10.1016/j.cell.2015.03.020	52	22	22	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 21	2017	36	38					5382	5391		10.1038/onc.2017.150	http://dx.doi.org/10.1038/onc.2017.150			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FH7PJ	28504715	hybrid, Green Accepted, Green Published			2022-12-26	WOS:000411382100005
J	Read, ML; Fong, JC; Modasia, B; Fletcher, A; Imruetaicharoenchoke, W; Thompson, RJ; Nieto, H; Reynolds, JJ; Bacon, A; Mallick, U; Hackshaw, A; Watkinson, JC; Boelaert, K; Turnell, AS; Smith, VE; McCabe, CJ				Read, M. L.; Fong, J. C.; Modasia, B.; Fletcher, A.; Imruetaicharoenchoke, W.; Thompson, R. J.; Nieto, H.; Reynolds, J. J.; Bacon, A.; Mallick, U.; Hackshaw, A.; Watkinson, J. C.; Boelaert, K.; Turnell, A. S.; Smith, V. E.; McCabe, C. J.			Elevated PTTG and PBF predicts poor patient outcome and modulates DNA damage response genes in thyroid cancer	ONCOGENE			English	Article							TUMOR-TRANSFORMING-GENE; HUMAN BREAST-CANCER; BINDING-FACTOR; MICROSATELLITE INSTABILITY; GENOMIC INSTABILITY; COLORECTAL-CANCER; CELLS; EXPRESSION; TUMORIGENESIS; GROWTH	The proto-oncogene PTTG and its binding partner PBF have been widely studied in multiple cancer types, particularly thyroid and colorectal, but their combined role in tumourigenesis is uncharacterised. Here, we show for the first time that together PTTG and PBF significantly modulate DNA damage response (DDR) genes, including p53 target genes, required to maintain genomic integrity in thyroid cells. Critically, DDR genes were extensively repressed in primary thyrocytes from a bitransgenic murine model (Bi-Tg) of thyroid-specific PBF and PTTG overexpression. Irradiation exposure to amplify p53 levels further induced significant repression of DDR genes in Bi-Tg thyrocytes (P = 2.4 x 10(-4)) compared with either PBF-(P = 1.5 x 10(-3)) or PTTG-expressing thyrocytes (P = NS). Consistent with this, genetic instability was greatest in Bi-Tg thyrocytes with a mean genetic instability (GI) index of 35.8 +/- 2.6%, as well as significant induction of gross chromosomal aberrations in thyroidal TPC-1 cells following overexpression of PBF and PTTG. We extended our findings to human thyroid cancer using TCGA data sets (n = 322) and found striking correlations with PBF and PTTG expression in well-characterised DDR gene panel RNA-seq data. In addition, genetic associations and transient transfection identified PBF as a downstream target of the receptor tyrosine kinase-BRAF signalling pathway, emphasising a role for PBF as a novel component in a pathway well described to drive neoplastic growth. We also showed that overall survival (P = 1.91 x 10(-5)) and disease-free survival (P = 4.9 x 10(-5)) was poorer for TCGA patients with elevated tumoural PBF/PTTG expression and mutationally activated BRAF. Together our findings indicate that PBF and PTTG have a critical role in promoting thyroid cancer that is predictive of poorer patient outcome.	[Read, M. L.; Fong, J. C.; Modasia, B.; Fletcher, A.; Imruetaicharoenchoke, W.; Thompson, R. J.; Nieto, H.; Bacon, A.; Boelaert, K.; Smith, V. E.; McCabe, C. J.] Univ Birmingham, Inst Metab & Syst Res, Birmingham, W Midlands, England; [Reynolds, J. J.; Turnell, A. S.] Univ Birmingham, Inst Canc & Genom Sci, Birmingham, W Midlands, England; [Mallick, U.] Freeman Rd Hosp, Northern Ctr Canc Care, Newcastle Upon Tyne, Tyne & Wear, England; [Hackshaw, A.] UCL, Canc Res UK, London, England; [Hackshaw, A.] UCL, UCL Canc Trials Ctr, London, England; [Watkinson, J. C.] Univ Hosp Birmingham NHS Fdn Trust, Dept Otolaryngol Head & Neck Surg, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham; Newcastle Freeman Hospital; Newcastle University - UK; Cancer Research UK; University of London; University College London; University of London; University College London; University of Birmingham	McCabe, CJ (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Inst Metab & Syst Res, Birmingham B15 2TH, W Midlands, England.	mccabcjz@bham.ac.uk	Read, Martin/A-3505-2012; Smith, Vicki E/F-6972-2010	Read, Martin/0000-0001-8918-4333; Smith, Vicki E/0000-0003-0757-7198; Reynolds, John Joseph/0000-0001-8690-5828; Fletcher, Anne/0000-0003-1534-1142	Medical Research Council [MR/J001414/1]; Wellcome Trust; Cancer Research UK; Get Ahead Charitable Trust; AMEND; Medical Research Council [G0601811, 1367609, MR/P000509/1] Funding Source: researchfish; MRC [G0601811, MR/J001414/1, MR/P000509/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Cancer Research UK(Cancer Research UK); Get Ahead Charitable Trust; AMEND; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (MR/J001414/1), Wellcome Trust, Cancer Research UK, Get Ahead Charitable Trust and AMEND. Results are in part based upon data generated by the TCGA Research Network: http://cancergenome.nih.gov/.	Agrawal N, 2014, CELL, V159, P676, DOI 10.1016/j.cell.2014.09.050; Basik M, 1997, GENE CHROMOSOME CANC, V18, P19, DOI 10.1002/(SICI)1098-2264(199701)18:1<19::AID-GCC3>3.0.CO;2-4; Bernal JA, 2002, NAT GENET, V32, P306, DOI 10.1038/ng997; Bieging KT, 2014, NAT REV CANCER, V14, P359, DOI 10.1038/nrc3711; Boelaert K, 2003, J CLIN ENDOCR METAB, V88, P2341, DOI 10.1210/jc.2002-021113; Byrne M, 2014, ANN NY ACAD SCI, V1310, P89, DOI 10.1111/nyas.12370; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chesnokova V, 2009, ENDOCRINOLOGY, V150, P2603, DOI 10.1210/en.2008-0972; Chien WW, 2000, J BIOL CHEM, V275, P19422, DOI 10.1074/jbc.M910105199; Fong MY, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-532; Gao H, 2016, AM J CANCER RES, V6, P425; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Grogan RH, 2013, SURGERY, V154, P1436, DOI 10.1016/j.surg.2013.07.008; Gurvits N, 2016, CELL ONCOL, V39, P319, DOI 10.1007/s13402-016-0277-5; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hamid T, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-18; Haymart MR, 2009, ONCOLOGIST, V14, P216, DOI 10.1634/theoncologist.2008-0194; Heaney AP, 2001, J CLIN ENDOCR METAB, V86, P5025, DOI 10.1210/jc.86.10.5025; Higgs MR, 2015, MOL CELL, V59, P462, DOI 10.1016/j.molcel.2015.06.007; Hsu YH, 2010, J BIOL CHEM, V285, P22630, DOI 10.1074/jbc.M109.096255; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kim D, 2005, ONCOGENE, V24, P4861, DOI 10.1038/sj.onc.1208659; Kim DS, 2007, CARCINOGENESIS, V28, P749, DOI 10.1093/carcin/bgl202; Knauf JA, 2005, CANCER RES, V65, P4238, DOI 10.1158/0008-5472.CAN-05-0047; La Vecchia C, 2015, INT J CANCER, V136, P2187, DOI 10.1002/ijc.29251; Lancia I, 2016, J CLIN INVEST, V126, P1052, DOI 10.1172/JCI85271; Leeman-Neill RJ, 2014, CANCER-AM CANCER SOC, V120, P799, DOI 10.1002/cncr.28484; Lewy GD, 2013, ENDOCRINOLOGY, V154, P4408, DOI 10.1210/en.2012-2156; Liang HQ, 2015, ONCOTARGET; McCabe CJ, 2003, CLIN ENDOCRINOL, V58, P141, DOI 10.1046/j.1365-2265.2003.01598.x; Melloni GEM, 2014, GENOME MED, V6, DOI 10.1186/gm563; Mitmaker E, 2008, J SURG RES, V150, P40, DOI 10.1016/j.jss.2007.12.760; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; Pellegriti G, 2013, J CANCER EPIDEMIOL, V2013, DOI 10.1155/2013/965212; Read ML, 2016, MOL CARCINOGEN, V55, P15, DOI 10.1002/mc.22254; Read ML, 2014, ENDOCRINOLOGY, V155, P1222, DOI 10.1210/en.2013-1646; Read ML, 2011, CANCER RES, V71, P6153, DOI 10.1158/0008-5472.CAN-11-0720; Ruan JW, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3226; Rubinek T, 2007, AM J PHYSIOL-CELL PH, V293, pC1082, DOI 10.1152/ajpcell.00145.2007; Salehi F, 2008, ENDOCR-RELAT CANCER, V15, P721, DOI 10.1677/ERC-08-0012; Santos JC, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-79; Smith VE, 2009, J CELL SCI, V122, P3393, DOI 10.1242/jcs.045427; Stratford AL, 2005, J CLIN ENDOCR METAB, V90, P4341, DOI 10.1210/jc.2005-0523; Vaish M, 2004, EXP MOL MED, V36, P122, DOI 10.1038/emm.2004.18; Wang H, 2016, MOL CELL, V63, P277, DOI 10.1016/j.molcel.2016.05.038; Wang X, 2015, ONCOTARGET, V6, P40959, DOI 10.18632/oncotarget.5726; Watkins RJ, 2010, CANCER RES, V70, P3739, DOI 10.1158/0008-5472.CAN-09-3531; Yoon CH, 2012, J BIOL CHEM, V287, P19516, DOI 10.1074/jbc.M111.337428; Zheng Y, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0126-9; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	53	14	15	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 14	2017	36	37					5296	5308		10.1038/onc.2017.154	http://dx.doi.org/10.1038/onc.2017.154			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FG8HT	28504713	Green Submitted, Green Accepted			2022-12-26	WOS:000410671700008
J	Brocklehurst, P; Ni, HB; Zhang, HG; Ye, JQ				Brocklehurst, Paul; Ni, Haibo; Zhang, Henggui; Ye, Jianqiao			Electro-mechanical dynamics of spiral waves in a discrete 2D model of human atrial tissue	PLOS ONE			English	Article							MECHANOELECTRIC FEEDBACK; CONTRACTILE DYSFUNCTION; POTASSIUM CURRENT; IONIC MECHANISMS; CARDIAC-MUSCLE; ACTIVATION; INSIGHTS; CURRENTS; CALCIUM; LENGTH	We investigate the effect of mechano-electrical feedback and atrial fibrillation induced electrical remodelling (AFER) of cellular ion channel properties on the dynamics of spiral waves in a discrete 2D model of human atrial tissue. The tissue electro-mechanics are modelled using the discrete element method (DEM). Millions of bonded DEM particles form a network of coupled atrial cells representing 2D cardiac tissue, allowing simulations of the dynamic behaviour of electrical excitation waves and mechanical contraction in the tissue. In the tissue model, each cell is modelled by nine particles, accounting for the features of individual cellular geometry; and discrete inter-cellular spatial arrangement of cells is also considered. The electro-mechanical model of a human atrial single-cell was constructed by strongly coupling the electrophysiological model of Colman et al. to the mechanical myofilament model of Rice et al., with parameters modified based on experimental data. A stretch-activated channel was incorporated into the model to simulate the mechano-electrical feedback. In order to investigate the effect of mechano-electrical feedback on the dynamics of spiral waves, simulations of spiral waves were conducted in both the electromechanical model and the electrical-only model in normal and AFER conditions, to allow direct comparison of the results between the models. Dynamics of spiral waves were characterized by tracing their tip trajectories, stability, excitation frequencies and meandering range of tip trajectories. It was shown that the developed DEM method provides a stable and efficient model of human atrial tissue with considerations of the intrinsically discrete and anisotropic properties of the atrial tissue, which are challenges to handle in traditional continuum mechanics models. This study provides mechanistic insights into the complex behaviours of spiral waves and the genesis of atrial fibrillation by showing an important role of the mechano-electrical feedback in facilitating and promoting atrial fibrillation.	[Brocklehurst, Paul; Ye, Jianqiao] Univ Lancaster, Engn Dept, Lancaster, England; [Ni, Haibo; Zhang, Henggui] Univ Manchester, Sch Phys & Astron, Biol Phys Grp, Manchester, Lancs, England	Lancaster University; University of Manchester	Ye, JQ (corresponding author), Univ Lancaster, Engn Dept, Lancaster, England.; Zhang, HG (corresponding author), Univ Manchester, Sch Phys & Astron, Biol Phys Grp, Manchester, Lancs, England.	henggui.zhang@manchester.ac.uk; j.ye2@lancaster.ac.uk	Zhang, Henggui/D-6712-2011; Ye, Jianqiao/D-1521-2013; Zhang, Henggui/AAM-1043-2020	Ye, Jianqiao/0000-0002-1039-1944; Ni, Haibo/0000-0003-0083-4286	Engineering and Physical Sciences Research Council [EP/J009482/1, EP/J00958X/1]; EPSRC [EP/J009482/1, EP/J00958X/1]; University of Manchester; British Heart Foundation [FS/14/5/30533] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); University of Manchester; British Heart Foundation(British Heart Foundation)	JY was funded by EP/J009482/1; Engineering and Physical Sciences Research Council, https://www.epsrc.ac.uk/; HZ was funded by EP/J00958X/1; Engineering and Physical Sciences Research Council, https://www.epsrc.ac.uk/.; The authors are grateful for financial support provided to the project by EPSRC (EP/J009482/1; EP/J00958X/1). HN would like to thank the University of Manchester for financial support of his study.	Adeniran I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142397; Adeniran I, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00166; Andrade J, 2014, CIRC RES, V114, P1453, DOI 10.1161/CIRCRESAHA.114.303211; Aslanidi OV, 2011, PROG BIOPHYS MOL BIO, V107, P156, DOI 10.1016/j.pbiomolbio.2011.06.011; Bosch RF, 1999, CARDIOVASC RES, V44, P121, DOI 10.1016/S0008-6363(99)00178-9; Brocklehurst P, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/854953; Cave DM, 2010, CIRCULATION, V122, pS720, DOI 10.1161/CIRCULATIONAHA.110.970970; Clayton RH, 2011, PROG BIOPHYS MOL BIO, V104, P22, DOI 10.1016/j.pbiomolbio.2010.05.008; Colman MA, 2013, J PHYSIOL-LONDON, V591, P4249, DOI 10.1113/jphysiol.2013.254987; Courtemanche M, 1998, AM J PHYSIOL-HEART C, V275, pH301, DOI 10.1152/ajpheart.1998.275.1.H301; DANIELS M, 1984, J PHYSIOL-LONDON, V355, P367, DOI 10.1113/jphysiol.1984.sp015424; Dobrev D, 2002, CARDIOVASC RES, V54, P397, DOI 10.1016/S0008-6363(01)00555-7; Dorn A, 2012, BIOMED TECH BERL S, V57, P1; Fenton FH, 2002, CHAOS, V12, P852, DOI 10.1063/1.1504242; Franz MR, 2003, PROG BIOPHYS MOL BIO, V82, P163, DOI 10.1016/S0079-6107(03)00013-0; Harada M, 2015, J AM COLL CARDIOL, V66, P47, DOI 10.1016/j.jacc.2015.04.056; HOFMANN PA, 1987, AM J PHYSIOL, V253, pC90; Huikuri HV, 2001, NEW ENGL J MED, V345, P1473, DOI 10.1056/NEJMra000650; Inc. ICG, 2014, PART FLOW COD VERS 5; Kamkin A, 2003, PFLUG ARCH EUR J PHY, V446, P339, DOI 10.1007/s00424-002-0948-0; Keldermann RH, 2010, AM J PHYSIOL-HEART C, V299, pH134, DOI 10.1152/ajpheart.00862.2009; Khan IA, 2003, AM HEART J, V145, P787, DOI 10.1016/S0002-8703(03)00086-3; Kohl P, 2001, CARDIOVASC RES, V50, P280, DOI 10.1016/S0008-6363(01)00194-8; Kohl P, 1999, PROG BIOPHYS MOL BIO, V71, P91, DOI 10.1016/S0079-6107(98)00038-8; Kohl P, 2001, PHILOS T R SOC A, V359, P1173, DOI 10.1098/rsta.2001.0824; Koo SH, 2010, EUROPACE, V12, P1490, DOI 10.1093/europace/euq280; Kuijpers NHL, 2007, AM J PHYSIOL-HEART C, V292, pH2832, DOI 10.1152/ajpheart.00923.2006; Lunze K, 2010, IFMBE PROC, V25, P740; Narolska NA, 2005, J MUSCLE RES CELL M, V26, P39, DOI 10.1007/s10974-005-9005-x; Nash MP, 2004, PROG BIOPHYS MOL BIO, V85, P501, DOI 10.1016/j.pbiomolbio.2004.01.016; Nattel S, 2014, J AM COLL CARDIOL, V63, P2335, DOI 10.1016/j.jacc.2014.02.555; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Nobile F, 2012, INT J NUMER METH BIO, V28, P52, DOI 10.1002/cnm.1468; Qi XY, 2015, CIRC RES, V116, P836, DOI 10.1161/CIRCRESAHA.116.305326; Rice JJ, 2008, BIOPHYS J, V95, P2368, DOI 10.1529/biophysj.107.119487; RUDY Y, 1987, CIRC RES, V61, P815, DOI 10.1161/01.RES.61.6.815; RUSH S, 1978, IEEE T BIO-MED ENG, V25, P389, DOI 10.1109/TBME.1978.326270; SANO T, 1970, CIRC RES, V26, P201, DOI 10.1161/01.RES.26.2.201; Schotten U, 2001, CIRCULATION, V103, P691; Schotten U, 2007, CARDIOVASC RES, V73, P37, DOI 10.1016/j.cardiores.2006.11.024; Seemann G, 2006, PHILOS T R SOC A, V364, P1465, DOI 10.1098/rsta.2006.1781; Severs NJ, 2004, CARDIOVASC RES, V62, P368, DOI 10.1016/j.cardiores.2003.12.007; Voigt N, 2012, CIRCULATION, V125, P2059, DOI 10.1161/CIRCULATIONAHA.111.067306; Wakili R, 2010, CIRC-ARRHYTHMIA ELEC, V3, P530, DOI 10.1161/CIRCEP.109.933036; Weise LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059317; Youm J.B., 2005, MECHANOSENSITIVITY C; Zhang DL, 2014, CIRCULATION, V129, P346, DOI 10.1161/CIRCULATIONAHA.113.005300; Zhang HG, 2009, PHYSICA D, V238, P976, DOI 10.1016/j.physd.2008.06.012	48	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0176607	10.1371/journal.pone.0176607	http://dx.doi.org/10.1371/journal.pone.0176607			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28510575	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000401485500007
J	Yang, C; Yang, SJ; Xu, WW; Zhang, JH; Fu, WG; Feng, CH				Yang, Chao; Yang, Shujuan; Xu, Weiwei; Zhang, Junhui; Fu, Wenguang; Feng, Chunhong			Association between the hyperuricemia and nonalcoholic fatty liver disease risk in a Chinese population: A retrospective cohort study	PLOS ONE			English	Article							SERUM URIC-ACID; METABOLIC SYNDROME; INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; POSTMENOPAUSAL WOMEN; HEPATIC STEATOSIS; URATE TRANSPORT; NATURAL-HISTORY; OBESE CHILDREN; UNITED-STATES	Nonalcoholic fatty liver disease (NAFLD) is a common chronic disease associated with high levels of serum uric acid (SUA). However, whether this relationship applies in obese subjects has been unclear, and no cohort study has previously been conducted in non-obese subjects. We therefore performed a retrospective cohort study among employees of seven companies in China to investigate whether hyperuricemia was independently associated with NAFLD in obese and non-obese subjects, respectively. A total of 2383 initially NAFLD-free subjects were followed up for four years, and 15.2% (363/2383) developed NAFLD. Hyperuricemia subjects had a higher cumulative incidence than did those with normouricemia (29.0% vs. 12.9%, P<0.001). Cox proportional hazard regression analyses showed that baseline hyperuricemia was significantly associated with risk of developing NAFLD in nonobese subjects. This relationship was significantly independent of baseline age, gender, metabolic syndrome components, and other clinical variables (RR = 1.389, 95% CI: 1.051-2.099). However, this association did not exist in obese subjects (RR = 1.010, 95% CI: 0.649-1.571). The independent effect of hyperuricemia on NAFLD was stronger in females (RR = 2.138, 95% CI: 1.050-4.355) than in males (RR = 1.435, 95% CI: 1.021-2.018). In conclusion, further studies are needed to explore the different mechanisms between obese and non-obese subjects, and the reason hyperuricemia raises NAFLD risk in females more than in males.	[Yang, Chao; Zhang, Junhui] Southwest Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Luzhou, Peoples R China; [Yang, Shujuan] Sichuan Univ, West China Sch Publ Hlth, Dept Hlth Related Social & Behav Sci, Chengdu, Peoples R China; [Xu, Weiwei; Feng, Chunhong] Southwest Med Univ, Affiliated Hosp 1, Hlth Management Dept, Coll Med, Luzhou, Peoples R China; [Fu, Wenguang] Southwest Med Univ, Affiliated Hosp 1, Coll Med, Dept Hepatobiliary Surg, Luzhou, Peoples R China	Southwest Medical University; Sichuan University; Southwest Medical University; Southwest Medical University	Feng, CH (corresponding author), Southwest Med Univ, Affiliated Hosp 1, Hlth Management Dept, Coll Med, Luzhou, Peoples R China.	chunhongf@tom.com	fu, wenguang/ABI-7883-2020; WENGUANG, FU/AAI-1142-2019					Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Argo CK, 2017, AM J GASTROENTEROL, V112, P111, DOI 10.1038/ajg.2016.527; Bellentani S, 2009, ANN HEPATOL, V8, pS4, DOI 10.1016/S1665-2681(19)31820-4; Cai W, 2014, SCI WORLD J, DOI 10.1155/2014/393628; Cardoso AS, 2013, J PEDIAT-BRAZIL, V89, P412, DOI 10.1016/j.jped.2012.12.008; Chen CH, 2006, J CLIN GASTROENTEROL, V40, P745, DOI 10.1097/00004836-200609000-00016; Cho HC, 2016, GUT LIVER, V10, P117, DOI 10.5009/gnl14444; Choi YJ, 2014, LAB INVEST, V94, P1114, DOI 10.1038/labinvest.2014.98; Das K, 2010, HEPATOLOGY, V51, P1593, DOI 10.1002/hep.23567; de Alwis NMW, 2008, J HEPATOL, V48, pS104, DOI 10.1016/j.jhep.2008.01.009; Ekstedt M, 2015, HEPATOLOGY, V61, P1547, DOI 10.1002/hep.27368; Fang J, 2000, JAMA-J AM MED ASSOC, V283, P2404, DOI 10.1001/jama.283.18.2404; Farrell GC, 2007, J GASTROEN HEPATOL, V22, P775, DOI 10.1111/j.1440-1746.2007.05002.x; Feldman A, 2017, AM J GASTROENTEROL, V112, P102, DOI 10.1038/ajg.2016.318; Feng RN, 2014, WORLD J GASTROENTERO, V20, P17932, DOI 10.3748/wjg.v20.i47.17932; Gong SL, 2016, EUR J GASTROEN HEPAT, V28, P132, DOI 10.1097/MEG.0000000000000507; Hediger MA, 2005, PHYSIOLOGY, V20, P125, DOI 10.1152/physiol.00039.2004; Hwang IC, 2011, J KOREAN MED SCI, V26, P386, DOI 10.3346/jkms.2011.26.3.386; Jaruvongvanich V, 2017, EUR J GASTROENTEROL; Jian-gao Fan, 2010, Zhonghua Gan Zang Bing Za Zhi, V18, P163; Kojima S, 2003, J GASTROENTEROL, V38, P954, DOI 10.1007/s00535-003-1178-8; Kuo CF, 2010, SCAND J RHEUMATOL, V39, P466, DOI 10.3109/03009741003742797; Lanaspa MA, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047948, 10.1371/journal.pone.0048801]; Lee JW, 2010, GUT LIVER, V4, P378, DOI 10.5009/gnl.2010.4.3.378; Li CG, 2013, CURR OPIN RHEUMATOL, V25, P210, DOI 10.1097/BOR.0b013e32835d951e; Liu CQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep38605; Liu J, 2016, HEPATOLOGY RES OFFIC; Liu PJ, 2014, CLIMACTERIC, V17, P692, DOI 10.3109/13697137.2014.926323; Liu Pengju, 2014, Zhonghua Gan Zang Bing Za Zhi, V22, P53, DOI 10.3760/cma.j.issn.1007-3418.2014.01.012; Lombardi R, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040548; Lonardo A, 2002, DIGEST LIVER DIS, V34, P204, DOI 10.1016/S1590-8658(02)80194-3; Lonardo A, 2000, J GASTROEN HEPATOL, V15, P775, DOI 10.1046/j.1440-1746.2000.02226.x; Lonardo A, 2017, DIGESTIVE LIVER DIS; Lonardo A, 2015, DIGEST LIVER DIS, V47, P181, DOI 10.1016/j.dld.2014.09.020; Miyake T, 2013, J GASTROENTEROL, V48, P413, DOI 10.1007/s00535-012-0650-8; Moon SS, 2013, ANN NUTR METAB, V62, P158, DOI 10.1159/000346202; Mosca A, 2017, J HEPATOLOGY; Mount DB, 2006, RHEUM DIS CLIN N AM, V32, P313, DOI 10.1016/j.rdc.2006.02.006; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; Ozcelik F, 2016, LIVER INT, V36, P768, DOI 10.1111/liv.13063; Petta S, 2011, ALIMENT PHARM THER, V34, P757, DOI 10.1111/j.1365-2036.2011.04788.x; Richette P, 2010, LANCET, V375, P318, DOI 10.1016/S0140-6736(09)60883-7; Ryu S, 2011, METABOLISM, V60, P860, DOI 10.1016/j.metabol.2010.08.005; Sartorio A, 2007, EUR J CLIN NUTR, V61, P877, DOI 10.1038/sj.ejcn.1602588; Serfaty L, 2008, DIABETES METAB, V34, P634, DOI 10.1016/S1262-3636(08)74597-X; Shen HC, 2014, CLIN INTERV AGING, V9, P501, DOI 10.2147/CIA.S59538; Sirota JC, 2013, METABOLISM, V62, P392, DOI 10.1016/j.metabol.2012.08.013; Suzuki A, 2009, WOMENS HEALTH, V5, P191, DOI 10.2217/17455057.5.2.191; Targher G, 2005, DIABETES, V54, P3541, DOI 10.2337/diabetes.54.12.3541; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Vos MB, 2012, J PEDIATR GASTR NUTR, V54, P90, DOI 10.1097/MPG.0b013e318229da1a; Wan XY, 2016, J HEPATOL, V64, P925, DOI 10.1016/j.jhep.2015.11.022; Wijarnpreecha K, 2016, LIVER INT OFFICIAL J; Wu SJ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000802; Xie YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067152; Xu CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011578; Younossi ZM, 2012, MEDICINE, V91, P319, DOI 10.1097/MD.0b013e3182779d49; Zhang SJ, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006381; Zhao CC, 2016, J DIABETES COMPLICAT, V30, P1074, DOI 10.1016/j.jdiacomp.2016.04.017; Zhou YL, 2016, ACTA ASTRONAUT, V127, P209, DOI 10.1016/j.actaastro.2016.05.027; Zhu YZ, 2014, BIOCHEM BIOPH RES CO, V447, P707, DOI 10.1016/j.bbrc.2014.04.080; Zoppini G, 2014, AM J GASTROENTEROL, V109, P1020, DOI 10.1038/ajg.2014.132	64	16	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177249	10.1371/journal.pone.0177249	http://dx.doi.org/10.1371/journal.pone.0177249			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28510581	Green Published, Green Submitted, gold			2022-12-26	WOS:000401485500017
J	Berruezo, F; de Souza, FSJ; Picca, PI; Nemirovsky, SI; Tosar, LM; Rivero, M; Mentaberry, AN; Zelada, AM				Berruezo, Florencia; de Souza, Flavio S. J.; Picca, Pablo I.; Nemirovsky, Sergio I.; Martinez Tosar, Leandro; Rivero, Mercedes; Mentaberry, Alejandro N.; Zelada, Alicia M.			Sequencing of small RNAs of the fern Pleopeltis minima (Polypodiaceae) offers insight into the evolution of the microrna repertoire in land plants	PLOS ONE			English	Article							MARCHANTIA-POLYMORPHA; GENOME; TARGETS; IDENTIFICATION; EXPRESSION; LIVERWORT; ORIGIN; MIRNAS; ALGAE; SIRNA	MicroRNAs (miRNAs) are short, single stranded RNA molecules that regulate the stability and translation of messenger RNAs in diverse eukaryotic groups. Several miRNA genes are of ancient origin and have been maintained in the genomes of animal and plant taxa for hundreds of millions of years, playing key roles in development and physiology. In the last decade, genome and small RNA (sRNA) sequencing of several plant species have helped unveil the evolutionary history of land plants. Among these, the fern group (monilophytes) occupies a key phylogenetic position, as it represents the closest extant cousin taxon of seed plants, i.e. gymno- and angiosperms. However, in spite of their evolutionary, economic and ecological importance, no fern genome has been sequenced yet and few genomic resources are available for this group. Here, we sequenced the small RNA fraction of an epiphytic South American fern, Pleopeltis minima (Polypodiaceae), and compared it to plant miRNA databases, allowing for the identification of miRNA families that are shared by all land plants, shared by all vascular plants (tracheophytes) or shared by euphyllophytes (ferns and seed plants) only. Using the recently described transcriptome of another fern, Lygodium japonicum, we also estimated the degree of conservation of fern miRNA targets in relation to other plant groups. Our results pinpoint the origin of several miRNA families in the land plant evolutionary tree with more precision and are a resource for future genomic and functional studies of fern miRNAs.	[Berruezo, Florencia; Martinez Tosar, Leandro; Mentaberry, Alejandro N.; Zelada, Alicia M.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fisiol Biol Mol & Celular, Lab Agrobiotecnol, Buenos Aires, DF, Argentina; [de Souza, Flavio S. J.] Consejo Nacl Invest Cient & Tecn, Inst Invest Ingn Genet Biol Mol Dr Hector N Torre, Buenos Aires, DF, Argentina; [de Souza, Flavio S. J.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fisiol Biol Mol & Celular, Buenos Aires, DF, Argentina; [Picca, Pablo I.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Biodiversidad & Biol Expt, Buenos Aires, DF, Argentina; [Nemirovsky, Sergio I.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, CONICET, Inst Quim Biol,IQUIBICEN, Buenos Aires, DF, Argentina; [Martinez Tosar, Leandro; Mentaberry, Alejandro N.; Zelada, Alicia M.] Univ Buenos Aires, CONICET, IBBEA, Buenos Aires, DF, Argentina; [Rivero, Mercedes] Inst Agrobiotecnol Rosario INDEAR, Rosario, Santa Fe, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Zelada, AM (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fisiol Biol Mol & Celular, Lab Agrobiotecnol, Buenos Aires, DF, Argentina.; Zelada, AM (corresponding author), Univ Buenos Aires, CONICET, IBBEA, Buenos Aires, DF, Argentina.	azelada@fbmc.fcen.uba.ar	de Souza, Flavio S J/H-7974-2013	de Souza, Flavio S J/0000-0002-6725-2873; Nemirovsky, Sergio I./0000-0003-4501-7052	National Agency for the Promotion of Science and Technology [ANPCyT-PICT 08-1481]; National Council for Scientific and Technological Research of Argentina [CONICET-PIP 11220110100715/12]	National Agency for the Promotion of Science and Technology(ANPCyT); National Council for Scientific and Technological Research of Argentina	This study was supported by the National Agency for the Promotion of Science and Technology (ANPCyT-PICT 08-1481) and the National Council for Scientific and Technological Research (CONICET-PIP 11220110100715/12) of Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; Addo-Quaye C, 2009, RNA, V15, P2112, DOI 10.1261/rna.1774909; Alaba S, 2015, NEW PHYTOL, V206, P352, DOI 10.1111/nph.13220; Arazi T, 2012, PLANT MOL BIOL, V80, P55, DOI 10.1007/s11103-011-9761-5; Axtell MJ, 2007, PLANT CELL, V19, P1750, DOI 10.1105/tpc.107.051706; Axtell MJ, 2006, CELL, V127, P565, DOI 10.1016/j.cell.2006.09.032; Axtell MJ, 2013, ANNU REV PLANT BIOL, V64, P137, DOI 10.1146/annurev-arplant-050312-120043; Axtell MJ, 2005, PLANT CELL, V17, P1658, DOI 10.1105/tpc.105.032185; Aya K, 2015, PLANT CELL PHYSIOL, V56, DOI 10.1093/pcp/pcu184; Banks JA, 2011, SCIENCE, V332, P960, DOI 10.1126/science.1203810; Becker B, 2009, ANN BOT-LONDON, V103, P999, DOI 10.1093/aob/mcp044; Birol I, 2013, BIOINFORMATICS, V29, P1492, DOI 10.1093/bioinformatics/btt178; Montes RAC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4722; Coruh C, 2015, PLANT CELL, V27, P2148, DOI 10.1105/tpc.15.00228; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Hao DC, 2012, PHYSIOL PLANTARUM, V146, P388, DOI 10.1111/j.1399-3054.2012.01668.x; Jagtap S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1049; Jones-Rhoades MW, 2012, PLANT MOL BIOL, V80, P3, DOI 10.1007/s11103-011-9829-2; Juarez MT, 2004, NATURE, V428, P84, DOI 10.1038/nature02363; Kenrick P, 1997, NATURE, V389, P33, DOI 10.1038/37918; Kidner CA, 2004, NATURE, V428, P81, DOI 10.1038/nature02366; Koi S, 2016, CURR BIOL, V26, P1775, DOI 10.1016/j.cub.2016.05.013; Koszegi D, 2011, PLANT J, V67, P280, DOI 10.1111/j.1365-313X.2011.04592.x; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Krasnikova MS, 2013, SCI WORLD J, DOI 10.1155/2013/924153; Li Y, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-122; Lin PC, 2016, PLANT CELL PHYSIOL, V57, P339, DOI 10.1093/pcp/pcw020; Llorente B, 2016, SCI REP-UK, V6, DOI 10.1038/srep19036; Mai Morente P., 2014, THESIS U REPUBLICA U; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Neale DB, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r59; Nystedt B, 2013, NATURE, V497, P579, DOI 10.1038/nature12211; Morea EGO, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0716-5; Palatnik JF, 2007, DEV CELL, V13, P115, DOI 10.1016/j.devcel.2007.04.012; Pires ND, 2012, PHILOS T R SOC B, V367, P508, DOI 10.1098/rstb.2011.0252; Plavskin Y, 2012, Cold Spring Harb Symp Quant Biol, V77, P221, DOI 10.1101/sqb.2013.77.014878; Prado J, 2010, AM FERN J, V100, P189, DOI 10.1640/0002-8444-100.4.189; Proctor MCF, 2002, NEW PHYTOL, V156, P327, DOI 10.1046/j.1469-8137.2002.00526.x; Pryer KM, 2004, AM J BOT, V91, P1582, DOI 10.3732/ajb.91.10.1582; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Rodriguez RE, 2014, WIRES DEV BIOL, V3, P41, DOI 10.1002/wdev.115; Rovekamp M, 2016, CURR BIOL, V26, P1782, DOI 10.1016/j.cub.2016.05.028; Ruhfel BR, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-23; Schneider H, 2004, NATURE, V428, P553, DOI 10.1038/nature02361; Sessa EB, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-15; Sun GL, 2012, PLANT MOL BIOL, V80, P17, DOI 10.1007/s11103-011-9817-6; Taylor RS, 2014, TRENDS PLANT SCI, V19, P175, DOI 10.1016/j.tplants.2013.11.008; Tsuzuki M, 2016, PLANT CELL PHYSIOL, V57, P359, DOI 10.1093/pcp/pcv182; Vanneste K, 2015, PLANT CELL, V27, P1567, DOI 10.1105/tpc.15.00157; Vasco A, 2016, NEW PHYTOL, V212, P745, DOI 10.1111/nph.14075; Vasco A, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00345; Vazquez F, 2004, CURR BIOL, V14, P346, DOI 10.1016/j.cub.2004.01.035; Wan LC, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-146; Wickett NJ, 2014, P NATL ACAD SCI USA, V111, pE4859, DOI 10.1073/pnas.1323926111; Wolf PG, 2015, GENOME BIOL EVOL, V7, P2533, DOI 10.1093/gbe/evv163; Wu G, 2013, J GENET GENOMICS, V40, P217, DOI 10.1016/j.jgg.2013.04.002; Xia R, 2015, MOL BIOL EVOL, V32, P2905, DOI 10.1093/molbev/msv164; Zhang Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127184; Zhang S, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/275435; Zimin A, 2014, GENETICS, V196, P875, DOI 10.1534/genetics.113.159715	60	9	9	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							0177573	10.1371/journal.pone.0177573	http://dx.doi.org/10.1371/journal.pone.0177573			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28494025	gold, Green Published, Green Submitted			2022-12-26	WOS:000401314300139
J	Rusterholz, PM; Hansen, PJ; Daugbjerg, N				Rusterholz, Pernille Moller; Hansen, Per Juel; Daugbjerg, Niels			Evolutionary transition towards permanent chloroplasts? - Division of kleptochloroplasts in starved cells of two species of Dinophysis (Dinophyceae)	PLOS ONE			English	Article							MIXOTROPHIC DINOFLAGELLATE; FOOD AVAILABILITY; CILIATE PREY; ACUMINATA; GROWTH; KLEPTOPLASTIDY; PHOTOSYNTHESIS; MESODINIUM; SURVIVAL; CAUDATA	Species within the marine toxic dinoflagellate genus Dinophysis are phagotrophic organisms that exploit chloroplasts (kleptochloroplasts) from other protists to perform photosynthesis. Dinophysis spp. acquire the kleptochloroplasts from the ciliate Mesodinium rubrum, which in turn acquires the chloroplasts from a unique clade of cryptophytes. Dinophysis spp. digest the prey nuclei and all other cell organelles upon ingestion (except the kleptochloroplasts) and they are therefore believed to constantly acquire new chloroplasts as the populations grow. Previous studies have, however, indicated that Dinophysis can keep the kleptochloroplasts active during long term starvation and are able to produce photosynthetic pigments when exposed to prey starvation. This indicates a considerable control over the kleptochloroplasts and the ability of Dinophysis to replicate its kleptochloroplasts was therefore re- investigated in detail in this study. The kleptochloroplasts of Dinophysis acuta and Dinophysis acuminata were analyzed using confocal microscopy and 3D bioimaging software during long term starvation experiments. The cell concentrations were monitored to confirm cell divisions and samples were withdrawn each time a doubling had occurred. The results show direct evidence of kleptochloroplastidic division and that the decreases in total kleptochloroplast volume, number of kleptochloroplasts and number of kleptochloroplast centers were not caused by dilution due to cell divisions. This is the first report of division of kleptochloroplasts in any protist without the associated prey nuclei. This indicates that Dinophysis spp. may be in a transitional phase towards possessing permanent chloroplasts, which thereby potentially makes it a key organism to understand the evolution of phototrophic protists.	[Rusterholz, Pernille Moller; Hansen, Per Juel; Daugbjerg, Niels] Univ Copenhagen, Marine Biol Sect, Dept Biol, Copenhagen, Denmark	University of Copenhagen	Daugbjerg, N (corresponding author), Univ Copenhagen, Marine Biol Sect, Dept Biol, Copenhagen, Denmark.	n.daugbjerg@bio.ku.dk	Hansen, Per Juel/AAX-6193-2020; Hansen, Per J/E-9969-2011; Daugbjerg, Niels/D-3521-2014	Hansen, Per Juel/0000-0003-0228-9621; Hansen, Per J/0000-0003-0228-9621; Daugbjerg, Niels/0000-0002-0397-3073	Danish Council for Independent Research, grant [4181-00484]	Danish Council for Independent Research, grant	This study was partly supported by the Danish Council for Independent Research, grant number 4181-00484 to PJH. ND thanks the Villum Kann Rasmussen Foundation for an equipment grant.	Archibald JM, 2009, CURR BIOL, V19, pR81, DOI 10.1016/j.cub.2008.11.067; Bhattacharya D, 2008, J PHYCOL, V44, P7, DOI 10.1111/j.1529-8817.2007.00433.x; FALKOWSKI PG, 1991, J PHYCOL, V27, P8, DOI 10.1111/j.0022-3646.1991.00008.x; Garcia-Cuetos L, 2010, HARMFUL ALGAE, V9, P25, DOI 10.1016/j.hal.2009.07.002; Guillard RRL, 1983, CULTURE MARINE INVER, P123; Hansen PJ, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00785; Hansen PJ, 2013, HARMFUL ALGAE, V28, P126, DOI 10.1016/j.hal.2013.06.004; Hattenrath-Lehmann T, 2015, LIMNOL OCEANOGR, V60, P1588, DOI 10.1002/lno.10119; Kim M, 2012, J PHYCOL, V48, P569, DOI 10.1111/j.1529-8817.2012.01150.x; Koike K, 2005, PROTIST, V156, P225, DOI 10.1016/j.protis.2005.04.002; LUCAS IAN, 1990, J PHYCOL, V26, P345, DOI 10.1111/j.0022-3646.1990.00345.x; Minnhagen S, 2008, ENVIRON MICROBIOL, V10, P2411, DOI 10.1111/j.1462-2920.2008.01666.x; Minnhagen S, 2011, AQUAT MICROB ECOL, V62, P99, DOI 10.3354/ame01459; Nielsen LT, 2013, HARMFUL ALGAE, V23, P34, DOI 10.1016/j.hal.2012.12.004; Nielsen LT, 2012, MAR ECOL PROG SER, V471, P37, DOI 10.3354/meps10027; Park MG, 2008, J PHYCOL, V44, P1154, DOI 10.1111/j.1529-8817.2008.00579.x; Riisgaard K, 2009, MAR ECOL PROG SER, V381, P51, DOI 10.3354/meps07953; Sanchez-Puerta MV, 2007, PROTIST, V158, P105, DOI 10.1016/j.protis.2006.09.004; Slamovits CH, 2008, MOL BIOL EVOL, V25, P1297, DOI 10.1093/molbev/msn075; Stoecker DK, 2009, AQUAT MICROB ECOL, V57, P279, DOI 10.3354/ame01340; Stoecker DK, 2016, ANNU REV MAR SCI, V9, P1; Takishita K, 2002, PROTIST, V153, P293, DOI 10.1078/1434-4610-00106; Tong MM, 2015, AQUAT MICROB ECOL, V75, P169, DOI 10.3354/ame01757; Wisecaver JH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-366	24	9	9	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177512	10.1371/journal.pone.0177512	http://dx.doi.org/10.1371/journal.pone.0177512			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493958	Green Published, gold			2022-12-26	WOS:000401314300125
J	Ohno, Y; Koizumi, M; Nakayama, H; Watanabe, T; Hirooka, M; Tokumoto, Y; Kuroda, T; Abe, M; Fukuda, S; Higashiyama, S; Kumagi, T; Hiasa, Y				Ohno, Yoshinori; Koizumi, Mitsuhito; Nakayama, Hironao; Watanabe, Takao; Hirooka, Masashi; Tokumoto, Yoshio; Kuroda, Taira; Abe, Masanori; Fukuda, Shinji; Higashiyama, Shigeki; Kumagi, Teru; Hiasa, Yoichi			Downregulation of ANP32B exerts anti-apoptotic effects in hepatocellular carcinoma	PLOS ONE			English	Article							HEPATOPOIETIN CN; SET COMPLEX; FAMILY; PROTEINS; BAD; SORAFENIB; INHIBITOR; GROWTH; CANCER; MEMBER	The acidic (leucine-rich) nuclear phosphoprotein 32 family member B (ANP32B), a highly conserved member of the acidic nuclear phosphoprotein 32 (ANP32) family, is critical for the development of normal tissue. However, its role in the development of hepatocellular carcinoma (HCC) is controversial. In this study, we elucidated the role of ANP32B in HCC cell lines and tissues. ANP32B expression in HCC cell lines was modulated using siRNA and ANP32B expression plasmids and lentiviruses. The levels of apoptosis-related proteins were analyzed by real-time RT-PCR and Western blotting. The expression of ANP32B in tissues from patients with HCC was investigated using real-time RT-PCR and immunohistochemistry. ANP32B knockdown by siRNA altered the expression of apoptosis-related proteins in HCC cell lines and reduced the expression of cleaved forms of caspase 3 and caspase 9, but not that of caspase 8, in HCC cells cultured with the pro-apoptotic agent staurosporine. Phosphorylated Bad was upregulated, whereas Bak was downregulated. Moreover, ABT-737, which binds to and inhibits anti-apoptotic proteins of the Bcl-2 family, rendered HCC cells resistant to apoptosis induced by ANP32B silencing. Conversely, ANP32B overexpression decreased Bad phosphorylation and upregulated Bak, but did not induce apoptosis because Bax expression was downregulated. In tissues from patients with HCC, a low tumor/non-tumor ratio of ANP32B mRNA expression was related to advanced UICC stage (p = 0.032). TUNEL-positive cells were observed in parallel with ANP32B expression in HCC tissues. ANP32B modulates Bad phosphorylation as well as Bak and Bax expression, resulting in regulation of apoptosis in HCC. These findings indicate the potential value of ANP32B as a therapeutic target for HCC.	[Ohno, Yoshinori; Koizumi, Mitsuhito; Watanabe, Takao; Hirooka, Masashi; Tokumoto, Yoshio; Kuroda, Taira; Abe, Masanori; Kumagi, Teru; Hiasa, Yoichi] Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Toon, Ehime, Japan; [Nakayama, Hironao; Fukuda, Shinji; Higashiyama, Shigeki] Ehime Univ, Dept Biochem & Mol Genet, Grad Sch Med, Toon, Ehime, Japan; [Nakayama, Hironao; Fukuda, Shinji; Higashiyama, Shigeki] Ehime Univ, Grad Sch Med, Div Cell Growth & Tumor Regulat, Proteosci Ctr PROS, Toon, Ehime, Japan	Ehime University; Ehime University; Ehime University	Hiasa, Y (corresponding author), Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Toon, Ehime, Japan.	hiasa@m.ehime-u.ac.jp	Hiasa, Yoichi/ABD-2759-2021; Kumagi, Teru/AAS-7427-2021	Hiasa, Yoichi/0000-0003-4117-339X; Kumagi, Teru/0000-0002-2292-7750	Japan Society for the Promotion of Science, KAKENHI [15K19334, 26461034, 15K09006]; Program for Enhancing Systematic Education in Graduate School from the Japanese Ministry of Education, Culture, Sports, Science and Technology; Japanese Ministry of Health, Labor, and Welfare	Japan Society for the Promotion of Science, KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Program for Enhancing Systematic Education in Graduate School from the Japanese Ministry of Education, Culture, Sports, Science and Technology; Japanese Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Grant-in-Aid for Scientific Research (Japan Society for the Promotion of Science, KAKENHI 15K19334 to MK, 26461034 to T. Kumagi, and 15K09006 to YH), by the Program for Enhancing Systematic Education in Graduate School from the Japanese Ministry of Education, Culture, Sports, Science and Technology (to YO), and by a Grant-in-Aid for Scientific Research and Development from the Japanese Ministry of Health, Labor, and Welfare (to YH).	Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Chang J, 2010, WORLD J GASTROENTERO, V16, P193, DOI 10.3748/wjg.v16.i2.193; Chiang CW, 2003, MOL CELL BIOL, V23, P6350, DOI 10.1128/MCB.23.18.6350-6362.2003; Cui CP, 2008, HEPATOLOGY, V47, P986, DOI 10.1002/hep.22126; Cui CP, 2009, HEPATOL RES, V39, P200, DOI 10.1111/j.1872-034X.2008.00447.x; Fabregat I, 2009, WORLD J GASTROENTERO, V15, P513, DOI 10.3748/wjg.15.513; Galmiche A, 2010, MOL CANCER RES, V8, P1116, DOI 10.1158/1541-7786.MCR-10-0029; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hikita H, 2012, J HEPATOL, V57, P92, DOI 10.1016/j.jhep.2012.01.027; Hikita H, 2010, HEPATOLOGY, V52, P1310, DOI 10.1002/hep.23836; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Kadkol SS, 1998, PROSTATE, V34, P231, DOI 10.1002/(SICI)1097-0045(19980215)34:3<231::AID-PROS11>3.0.CO;2-F; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Li CX, 2015, MOL MED REP, V11, P2813, DOI 10.3892/mmr.2014.3035; Li C, 2012, J PROTEOME RES, V11, P871, DOI 10.1021/pr2006999; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Liu Y, 2013, J PATHOL, V230, P365, DOI 10.1002/path.4194; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Matilla A, 2005, CEREBELLUM, V4, P7, DOI 10.1080/14734220410019020; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Ouellet V, 2006, INT J CANCER, V119, P2119, DOI 10.1002/ijc.22054; Reilly PT, 2014, BIOESSAYS, V36, P1062, DOI 10.1002/bies.201400058; Reilly PT, 2011, P NATL ACAD SCI USA, V108, P10243, DOI 10.1073/pnas.1106211108; Saraswat VA, 2014, J CLIN EXP HEPATOL, V4, pS80, DOI 10.1016/j.jceh.2014.05.004; Shen SM, 2010, CARCINOGENESIS, V31, P419, DOI 10.1093/carcin/bgp320; Shi HJ, 2011, J PROTEOMICS, V75, P339, DOI 10.1016/j.jprot.2011.07.025; Siegel AB, 2010, HEPATOLOGY, V52, P360, DOI 10.1002/hep.23633; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; VAESEN M, 1994, BIOL CHEM H-S, V375, P113, DOI 10.1515/bchm3.1994.375.2.113; Weber A, 2010, HEPATOLOGY, V51, P1226, DOI 10.1002/hep.23479; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Yang S, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.8; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yu Y, 2012, BIOCHEM BIOPH RES CO, V423, P721, DOI 10.1016/j.bbrc.2012.06.025; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhu BD, 2010, CLIN EXP METASTAS, V27, P571, DOI 10.1007/s10585-010-9346-8	39	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177343	10.1371/journal.pone.0177343	http://dx.doi.org/10.1371/journal.pone.0177343			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486557	Green Submitted, Green Published, gold			2022-12-26	WOS:000401314000072
J	Entin-Meer, M; Cohen, L; Hertzberg-Bigelman, E; Levy, R; Ben-Shoshan, J; Keren, G				Entin-Meer, Michal; Cohen, Lena; Hertzberg-Bigelman, Einat; Levy, Ran; Ben-Shoshan, Jeremy; Keren, Gad			TRPV2 knockout mice demonstrate an improved cardiac performance following myocardial infarction due to attenuated activity of peri-infarct macrophages	PLOS ONE			English	Article							POTENTIAL VANILLOID 2; CHANNEL; TRANSLOCATION; PHAGOCYTOSIS; INNATE	Background We have recently shown that the expression of the transient receptor potential vanilloid 2 channel, TRPV2, is upregulated in the peri-infarct zone 3-5 days following an acute myocardial infarction (AMI). Further analysis has demonstrated that invading monocytes maturing to macrophages merely harbor the documented elevated expression of this channel. Purpose Assess cardiac function in TRPV2-KO mice compared to TRPV2-WT following AMI and analyze the potential involvement of TRPV2-expressing macrophages in the recovery process. Methods TRPV2-KO or WT mice were induced with AMI by ligation of the left anterior descending artery (LAD). In another set of experiments, TRPV2-KO mice induced with AMI, were intravenously (IV) injected with WT or TRPV2-KO peritoneal macrophages in order to directly assess the potential contribution of TRPV2-expressing macrophages to cardiac healing. Cardiac parameters were obtained by echocardiography 1 day and 30 days post infarction. The relative changes in the ejection fraction (EF) and additional cardiac parameters between baseline (day 1) and day 30 were calculated and statistical significance was determined (SPSS). Results The in vivo study showed that while EF was significantly decreased in the WT animals between baseline and day 30, EF was only slightly and insignificantly reduced in the KO animals. Likewise LVESD and LVESA were significantly modified exclusively in the WT animals. Moreover, intravenous administration of peritoneal WT macrophages, but not KO macrophages, significantly reduced survival of post-MI TRPV2-KO mice. Conclusion The data suggest that knockout of the TRPV2 channel may attenuate macrophage-dependent pro-inflammatory processes and result in better cardiac recovery. TRPV2 may thus represent a novel therapeutic target for treatment of patients undergoing an acute MI.	[Entin-Meer, Michal; Cohen, Lena; Hertzberg-Bigelman, Einat; Levy, Ran; Ben-Shoshan, Jeremy; Keren, Gad] Tel Aviv Sourasky Med Ctr, Dept Cardiol, Lab Cardiovasc Res, Tel Aviv, Israel; [Entin-Meer, Michal; Cohen, Lena; Hertzberg-Bigelman, Einat; Ben-Shoshan, Jeremy; Keren, Gad] Tel Aviv Sourasky Med Ctr, Dept Cardiol, Sackler Fac Med, Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Entin-Meer, M (corresponding author), Tel Aviv Sourasky Med Ctr, Dept Cardiol, Lab Cardiovasc Res, Tel Aviv, Israel.; Entin-Meer, M (corresponding author), Tel Aviv Sourasky Med Ctr, Dept Cardiol, Sackler Fac Med, Tel Aviv, Israel.	michale@tlvmc.gov.il			Israel Science Foundation [400/15]; Tel-Aviv University Research [0601243392]	Israel Science Foundation(Israel Science Foundation); Tel-Aviv University Research	This work was supported by the Israel Science Foundation NO. 400/15 and Tel-Aviv University Research grant No. 0601243392. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Entin-Meer M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105055; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Frantz S, 2013, FASEB J, V27, P871, DOI 10.1096/fj.12-214049; Gao Shumin, 2011, Curr Protoc Mouse Biol, V1, P71; Hassan S, 2014, BRIT J PHARMACOL, V171, P2426, DOI 10.1111/bph.12615; Huynh KW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11130; Issa CM, 2014, SCAND J IMMUNOL, V80, P307, DOI 10.1111/sji.12206; Kanzaki M, 1999, NAT CELL BIOL, V1, P165, DOI 10.1038/11086; Katanosaka Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4932; Leuschner F, 2012, J EXP MED, V209, P123, DOI 10.1084/jem.20111009; Link TM, 2010, NAT IMMUNOL, V11, P232, DOI 10.1038/ni.1842; Nagasawa M, 2007, J CELL PHYSIOL, V210, P692, DOI 10.1002/jcp.20883; Nagasawa M, 2012, CELL CALCIUM, V51, P186, DOI 10.1016/j.ceca.2011.12.012; Nahrendorf M, 2016, EUR HEART J, V37, P868, DOI 10.1093/eurheartj/ehv453; Naticchioni M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136901; Park U, 2011, J NEUROSCI, V31, P11425, DOI 10.1523/JNEUROSCI.1384-09.2011; Penna A, 2006, CELL CALCIUM, V39, P495, DOI 10.1016/j.ceca.2006.01.009; Peralvarez-Marin A, 2013, FEBS J, V280, P5471, DOI 10.1111/febs.12302; Roberts E, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h910; Rubinstein J, 2014, AM J PHYSIOL-HEART C, V306, pH574, DOI 10.1152/ajpheart.00854.2013; Santoni G, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00034; Schwarz E. C., 2007, V179, P445; Sharir R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113653; Sopel M, 2010, J INVEST SURG, V23, P79, DOI 10.3109/08941930903469425; Tang MS, 2012, GROWTH HORM IGF RES, V22, P206, DOI 10.1016/j.ghir.2012.09.002; van Amerongen MJ, 2007, AM J PATHOL, V170, P818, DOI 10.2353/ajpath.2007.060547; van der Laan AM, 2014, EUR HEART J, V35, P376, DOI 10.1093/eurheartj/eht331; Weinberger T, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00107; Yamashiro K, 2010, BIOCHEM BIOPH RES CO, V398, P284, DOI 10.1016/j.bbrc.2010.06.082	30	26	26	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177132	10.1371/journal.pone.0177132	http://dx.doi.org/10.1371/journal.pone.0177132			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481959	Green Published, Green Submitted, gold			2022-12-26	WOS:000401313700036
J	Sidney, J; Becart, S; Zhou, M; Duffy, K; Lindvall, M; Moore, EC; Moore, EL; Rao, T; Rao, N; Nielsen, M; Peters, B; Sette, A				Sidney, John; Becart, Stephane; Zhou, Mimi; Duffy, Karen; Lindvall, Mikaela; Moore, Erin C.; Moore, Eugene L.; Rao, Tadimeti; Rao, Navin; Nielsen, Morten; Peters, Bjoern; Sette, Alessandro			Citrullination only infrequently impacts peptide binding to HLA class II MHC	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; SHARED EPITOPE; HLA-DRB1 ALLELES; AUTOANTIBODIES; AFFINITY; SUSCEPTIBILITY; ASSOCIATION; ANTIBODIES; MOLECULES; SEVERITY	It has been hypothesized that HLA class II alleles associated with rheumatoid arthritis (RA) preferentially present self-antigens altered by post-translational modification, such as citrullination. To understand the role of citrullination we tested four RA-associated citrullinated epitopes and their corresponding wild-type version for binding to 28 common HLA class II. Binding patterns were variable, and no consistent impact of citrullination was identified. Indeed, in one case citrullination significantly increased binding compared to the WT peptide, in another citrullination was associated with a reduction in promiscuity by 40%. For a more comprehensive analysis, we tested over 200 citrullinated peptides derived from vimentin and collagen II for their capacity to bind the RA-associated shared epitope alleles DRB1*01:01 and DRB1*04:01. The overall effect of citrullination on binding was found to be relatively minor, and only rarely associated with 3-fold increases or decreases in affinity. Previous studies have suggested that citrullination of MHC anchor residues, in particular P4, is associated with generation of novel RA-associated epitopes. However, analysis of the predicted MHC-binding cores of all peptides tested found that in modified peptides with increased binding affinity the citrullinated residue was predicted to occupy an anchor position in only a minority of cases. Finally, we also show that identification of citrullinated peptide binders could be facilitated by using the NetMHCIIpan 3.1 algorithm, representing citrullination as a wildcard. Our studies identify a total of 117 citrullinated peptides that bound RA-associated alleles with an affinity of 1000 nM or better.	[Sidney, John; Lindvall, Mikaela; Moore, Erin C.; Moore, Eugene L.; Peters, Bjoern; Sette, Alessandro] La Jolla Inst Allergy & Immunol, La Jolla, CA USA; [Becart, Stephane; Zhou, Mimi; Duffy, Karen; Rao, Tadimeti; Rao, Navin] Janssen Res & Dev, San Diego, CA USA; [Nielsen, Morten] Tech Univ Denmark, Dept Bio & Hlth Informat, Ctr Biol Sequence Anal, Lyngby, Denmark; [Nielsen, Morten] Univ Nacl San Martin, Inst Invest Biotecnol, Buenos Aires, DF, Argentina	La Jolla Institute for Immunology; Technical University of Denmark	Sidney, J (corresponding author), La Jolla Inst Allergy & Immunol, La Jolla, CA USA.	jsidney@lji.org	Sette, Alessandro/AFO-8916-2022; Nielsen, Morten/AAL-8700-2020	Nielsen, Morten/0000-0001-7885-4311; Lindvall, Mikaela/0000-0002-0042-1353; Rao, Tadimeti/0000-0001-5332-7304	Janssen Research and Development; NIH-NIAID Immune Epitope Database and Analysis Project [HHSN272201200010C]	Janssen Research and Development; NIH-NIAID Immune Epitope Database and Analysis Project	These collaborative studies have been supported by funding from Janssen Research and Development. Janssen Research and Development provided financial support in the form of authors' salaries (SB, KD, NR, TR, MZ), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.Additional support has been provided from the NIH-NIAID Immune Epitope Database and Analysis Project [contract HHSN272201200010C] (AS).	ALEXANDER J, 1994, IMMUNITY, V1, P751, DOI 10.1016/S1074-7613(94)80017-0; Andreatta M, 2015, IMMUNOGENETICS, V67, P641, DOI 10.1007/s00251-015-0873-y; Arkema EV, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4342; Avouac J, 2006, ANN RHEUM DIS, V65, P845, DOI 10.1136/ard.2006.051391; Balandraud N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064108; Benham H, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa9301; Calvo-Calle JM, 2007, PLOS PATHOG, V3, P1511, DOI 10.1371/journal.ppat.0030144; Chemin K, 2016, ARTHRITIS RHEUMATOL, V68, P1124, DOI 10.1002/art.39553; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; DEIGHTON CM, 1989, CLIN GENET, V36, P178; Ding B, 2009, ARTHRITIS RHEUM, V60, P30, DOI 10.1002/art.24135; Fries JF, 2002, ARTHRITIS RHEUM, V46, P2320, DOI 10.1002/art.10485; Gerstner C, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00494; Gonzalez-Gay MA, 2002, SEMIN ARTHRITIS RHEU, V31, P355, DOI 10.1053/sarh.2002.32552; Gourraud PA, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2131; Greenbaum J, 2011, IMMUNOGENETICS, V63, P325, DOI 10.1007/s00251-011-0513-0; Griffiths B, 2000, RHEUMATOLOGY, V39, P857, DOI 10.1093/rheumatology/39.8.857; Gulukota K, 1997, J MOL BIOL, V267, P1258, DOI 10.1006/jmbi.1997.0937; Harre U, 2012, J CLIN INVEST, V122, P1791, DOI 10.1172/JCI60975; Hill JA, 2003, J IMMUNOL, V171, P538, DOI 10.4049/jimmunol.171.2.538; Hill JA, 2008, J EXP MED, V205, P967, DOI 10.1084/jem.20072051; James EA, 2014, ARTHRITIS RHEUMATOL, V66, P1712, DOI 10.1002/art.38637; James EA, 2010, ARTHRITIS RHEUM-US, V62, P2909, DOI 10.1002/art.27594; Kampstra ASB, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1153-4; Klareskog L, 2009, LANCET, V373, P659, DOI 10.1016/S0140-6736(09)60008-8; Kotturi Maya F, 2010, Immunome Res, V6, P4, DOI 10.1186/1745-7580-6-4; Kuhn KA, 2006, J CLIN INVEST, V116, P961, DOI 10.1172/JCI25422; Law SC, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3848; Lundstrom E, 2009, ARTHRITIS RHEUM-US, V60, P924, DOI 10.1002/art.24410; Meyer D, 2007, P 13 INT HIST WORKSH, V1, P653; Meyer O, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1896; Moreno I, 1996, J RHEUMATOL, V23, P6; Nielen MMJ, 2004, ARTHRITIS RHEUM-US, V50, P380, DOI 10.1002/art.20018; Nishimura K, 2007, ANN INTERN MED, V146, P797, DOI 10.7326/0003-4819-146-11-200706050-00008; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Reviron D, 2001, ARTHRITIS RHEUM, V44, P535, DOI 10.1002/1529-0131(200103)44:3<535::AID-ANR101>3.0.CO;2-Z; Roark CL, 2016, J AUTOIMMUN, V72, P25, DOI 10.1016/j.jaut.2016.04.006; ROCHE PA, 1990, J IMMUNOL, V144, P1849; Sakkas LI, 2014, AUTOIMMUN REV, V13, P1114, DOI 10.1016/j.autrev.2014.08.012; Scally SW, 2013, J EXP MED, V210, P2569, DOI 10.1084/jem.20131241; Schellekens GA, 1998, J CLIN INVEST, V101, P273, DOI 10.1172/JCI1316; Schellekens GA, 2000, ARTHRITIS RHEUM-US, V43, P155, DOI 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3; Scholz E, 2016, ARTHRITIS RHEUMATOL, V68, P2412, DOI 10.1002/art.39736; Sidney J, 1996, HUM IMMUNOL, V45, P79, DOI 10.1016/0198-8859(95)00173-5; Sidney J., 2013, CURR PROTOC IMMUNOL, V100, p18.3.1, DOI [DOI 10.1002/0471142735.IM1803S100, 10.1002/0471142735.im1803s100]; Sidney J, 2010, J IMMUNOL, V185, P4189, DOI 10.4049/jimmunol.1001006; Sidney J, 2010, J IMMUNOL, V184, P2492, DOI 10.4049/jimmunol.0903655; SMILEK DE, 1991, P NATL ACAD SCI USA, V88, P9633, DOI 10.1073/pnas.88.21.9633; Snir O, 2011, ARTHRITIS RHEUM-US, V63, P2873, DOI 10.1002/art.30445; Southwood S, 1998, J IMMUNOL, V160, P3363; Turesson C, 2005, ARTHRITIS RES THER, V7, pR1386, DOI 10.1186/ar1837; Valesini G, 2015, AUTOIMMUN REV, V14, P490, DOI 10.1016/j.autrev.2015.01.013; van der Helm-van Mil AHM, 2005, ARTHRITIS RES THER, V7, pR949, DOI 10.1186/ar1767; van der Woude D, 2009, ARTHRITIS RHEUM-US, V60, P916, DOI 10.1002/art.24385; van Gaalen FA, 2004, ARTHRITIS RHEUM, V50, P2113, DOI 10.1002/art.20316; van Gaalen FA, 2004, ARTHRITIS RHEUM, V50, P709, DOI 10.1002/art.20044; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004; von Delwig A, 2010, ARTHRITIS RHEUM-US, V62, P143, DOI 10.1002/art.25064; WORDSWORTH BP, 1991, BRIT J RHEUMATOL, V30, P178; Zou J, 2005, ANN RHEUM DIS, V64, P722, DOI 10.1136/ard.2004.024455; Zou J, 2003, RHEUMATOLOGY, V42, P846, DOI 10.1093/rheumatology/keg230	62	31	32	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177140	10.1371/journal.pone.0177140	http://dx.doi.org/10.1371/journal.pone.0177140			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481943	Green Published, Green Submitted, gold			2022-12-26	WOS:000401313700037
J	Liu, Y; Xu, J; Xu, LL; Wu, TY; Sun, YX; Lee, YW; Wang, B; Chan, HC; Jiang, XH; Zhang, JF; Li, G				Liu, Yang; Xu, Jia; Xu, Liangliang; Wu, Tianyi; Sun, Yuxin; Lee, Yuk-Wai; Wang, Bin; Chan, Hsiao-Chang; Jiang, Xiaohua; Zhang, Jinfang; Li, Gang			Cystic fibrosis transmembrane conductance regulator mediates tenogenic differentiation of tendon-derived stem cells and tendon repair: accelerating tendon injury healing by intervening in its downstream signaling	FASEB JOURNAL			English	Article						CFTR; beta-catenin; ERK1/2	INHIBITOR U0126; GROWTH-FACTORS; CFTR; INFLAMMATION; TENDINOPATHY; BIOLOGY; INVOLVEMENT; ACTIVATION; DECORIN; TISSUE	Tendons are a mechanosensitive tissue, which enables them to transmit to bone forces that are derived from muscle. Patients with tendon injuries, such as tendinopathy or tendon rupture, were often observed with matrix degeneration, and the healing of tendon injuries remains a challenge as a result of the limited understanding of tendon biology. Our study demonstrates that the stretch-mediated activation channel, cystic fibrosis transmembrane conductance regulator (CFTR), was up-regulated intendon-derived stem cells (TDSCs) during tenogenic differentiation under mechanical stretching. Tendon tissues in CFTR-dysfunctional DF508 mice exhibited irregular cell arrangement, uneven fibril diameter distribution, weak mechanical properties, and less matrix formation in a tendon defect model. Moreover, both tendon tissues and TDSCs isolated from DF508 mice showed significantly decreased levels of tendon markers, such as scleraxis, tenomodulin, Col1A1 (collagen type I a 1 chain), and decorin. Furthermore, by RNA sequencing analysis, we demonstrated that Wnt/beta-catenin signaling was abnormally activated in TDSCs from DF508 mice, thereby further activating the pERK1/2 signaling pathway. Of most importance, we found that intervention in pERK1/2 signaling could promote tenogenic differentiation and tendon regeneration both in vitro and in vivo. Taken together, our study demonstrates that CFTR plays an important role in tenogenic differentiation and tendon regeneration by inhibiting the beta-catinin/pERK1/2 signaling pathway. The therapeutic strategy of intervening in the CFTR/beta-catenin/pERK1/2 regulatory axis may be helpful for accelerating tendon injury healing, which has implications for tendon injury management.	[Liu, Yang; Xu, Liangliang; Wu, Tianyi; Sun, Yuxin; Lee, Yuk-Wai; Wang, Bin; Zhang, Jinfang; Li, Gang] Chinese Univ Hong Kong, Prince Wales Hosp, Fac Med, Dept Orthopaed & Traumatol, Shatin, Hong Kong, Peoples R China; [Zhang, Jinfang; Li, Gang] Chinese Univ Hong Kong, Lui Che Woo Inst Innovat Med, Stem Cells & Regenerat Med Lab, Li Ka Shing Inst Hlth Sci,Prince Wales Hosp, Shatin, Hong Kong, Peoples R China; [Xu, Jia; Wu, Tianyi] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Orthopaed Surg, Shanghai, Peoples R China; [Xu, Liangliang] Guangzhou Univ Chinese Med, Key Lab Orthopaed & Traumatol, Affiliated Hosp 1, Clin Med Coll 1, Guangzhou, Guangdong, Peoples R China; [Chan, Hsiao-Chang; Jiang, Xiaohua] Chinese Univ Hong Kong, Sch Biomed Sci, Fac Med, Hong Kong, Hong Kong, Peoples R China; [Li, Gang] Chinese Univ Hong Kong, Minist Educ, Key Lab Regenerat Med, Sch Biomed Sci,Fac Med, Hong Kong, Hong Kong, Peoples R China; [Li, Gang] Chinese Univ Hong Kong, Shenzhen Res Inst, Chinese Univ Hong Kong China Astronaut Res & Trai, Shenzhen, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Shanghai Jiao Tong University; Guangzhou University of Chinese Medicine; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong, Shenzhen	Zhang, JF; Li, G (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Orthopaed & Traumatol, Shatin, Hong Kong, Peoples R China.; Li, G (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China.	zhangjf06@gmail.com; gangli@cuhk.edu.hk	Li, Gang/J-7830-2018; jiang, cynthia xiaohua/F-7580-2017; Chan, Hsiao Chang/E-1507-2016; WANG, BIN/O-2346-2019; Liangliang, XU/K-9185-2019; Lee, Wayne YW/H-8298-2013	Li, Gang/0000-0002-3981-2239; jiang, cynthia xiaohua/0000-0002-7372-4961; WANG, BIN/0000-0002-1348-1494; Liangliang, XU/0000-0002-5249-7480; Lee, Wayne YW/0000-0002-0486-360X	National Natural Science Foundation of China [81371946, 81374568]; Hong Kong Government Research Grant Council, General Research Fund [470813, 14119115, 9054014]; China Shenzhen City Science and Technology Bureau [GJHZ20140419120051680, JCYJ20150630165236960]; Sports Medicine And Regenerative Technology (SMART; Chinese University of Hong Kong) program; Lui Che Woo Institute of Innovation Medicine, The Chinese University of Hong Kong	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hong Kong Government Research Grant Council, General Research Fund; China Shenzhen City Science and Technology Bureau; Sports Medicine And Regenerative Technology (SMART; Chinese University of Hong Kong) program; Lui Che Woo Institute of Innovation Medicine, The Chinese University of Hong Kong	This work was supported, in part, by grants from National Natural Science Foundation of China (81371946 and 81374568); the Hong Kong Government Research Grant Council, General Research Fund (470813, 14119115 and 9054014); and the China Shenzhen City Science and Technology Bureau (GJHZ20140419120051680 and JCYJ20150630165236960) to G. L.; as well as by a grant from Sports Medicine And Regenerative Technology (SMART; Chinese University of Hong Kong) program and Lui Che Woo Institute of Innovation Medicine, The Chinese University of Hong Kong. The authors thank Dr. Xiaohu Zhang for the breeding of DF508 and WT mice and Josie Lai and Jean Kung for help with the transmembrane electron microscope at The Chinese University of Hong Kong. The authors also thank Yuk-Wa Lee for the technique support of tendon mechanical testing at The Chinese University of Hong Kong. The authors thank Prof. Dong Sun and Dr. Ran Wang for help with the examination with confocal laser scanning microscopy at The City University of Hong Kong. The authors declare no conflicts of interest.	Andres BM, 2008, CLIN ORTHOP RELAT R, V466, P1539, DOI 10.1007/s11999-008-0260-1; Berger AL, 2005, J BIOL CHEM, V280, P5221, DOI 10.1074/jbc.M412972200; Bestwick CS, 2004, BRIT J SPORT MED, V38, P672, DOI 10.1136/bjsm.2004.012351; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Bikkavilli Rama Kamesh, 2009, Commun Integr Biol, V2, P46; Bonvin E, 2008, J PHYSIOL-LONDON, V586, P3231, DOI 10.1113/jphysiol.2008.150763; Buhrmann C, 2011, J BIOL CHEM, V286, P28556, DOI 10.1074/jbc.M111.256180; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Chiodo CP, 2006, FOOT ANKLE INT, V27, P305, DOI 10.1177/107110070602700415; Cohen JC, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-70; Cutting GR, 2015, NAT REV GENET, V16, P45, DOI 10.1038/nrg3849; Dakin SG, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4269; de Jong JP, 2014, CLIN ORTHOP SURG, V6, P196, DOI 10.4055/cios.2014.6.2.196; Divangahi M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000586; Dong ZW, 2015, SCI REP-UK, V5, DOI 10.1038/srep15946; Duan W, 2004, J IMMUNOL, V172, P7053, DOI 10.4049/jimmunol.172.11.7053; Dunkman AA, 2014, ANN BIOMED ENG, V42, P619, DOI 10.1007/s10439-013-0915-2; Guardavaccaro D, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002921; Havis E, 2014, DEVELOPMENT, V141, P3683, DOI 10.1242/dev.108654; Heijerman Harry, 2005, J Cyst Fibros, V4 Suppl 2, P3, DOI 10.1016/j.jcf.2005.05.005; Ito Y, 2010, P NATL ACAD SCI USA, V107, P10538, DOI 10.1073/pnas.1000525107; James R, 2008, J HAND SURG-AM, V33A, P102, DOI 10.1016/j.jhsa.2007.09.007; Jiang DP, 2016, CONNECT TISSUE RES, V57, P20, DOI 10.3109/03008207.2015.1087517; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liu HH, 2015, STEM CELLS, V33, P443, DOI 10.1002/stem.1866; Longo UG, 2008, DISABIL REHABIL, V30, P1563, DOI 10.1080/09638280701785643; Luciani A, 2010, NAT CELL BIOL, V12, P863, DOI 10.1038/ncb2090; Lui PPY, 2013, RHEUMATOLOGY, V52, P1609, DOI 10.1093/rheumatology/ket214; Mohammad G, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/658548; Moyer BD, 1999, J CLIN INVEST, V104, P1353, DOI 10.1172/JCI7453; Ni M, 2013, BIOMATERIALS, V34, P2024, DOI 10.1016/j.biomaterials.2012.11.046; Ni M, 2012, J ORTHOP RES, V30, P613, DOI 10.1002/jor.21559; Nourissat G, 2015, NAT REV RHEUMATOL, V11, P223, DOI 10.1038/nrrheum.2015.26; Pouzaud F, 2004, J PHARMACOL EXP THER, V308, P394, DOI 10.1124/jpet.103.057984; Prasadam I, 2013, J MOL MED, V91, P369, DOI 10.1007/s00109-012-0953-5; Ruan YC, 2014, J CELL SCI, V127, P4396, DOI 10.1242/jcs.148098; Rui YF, 2010, TISSUE ENG PT A, V16, P1549, DOI 10.1089/ten.TEA.2009.0529; Sharma P., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P181; Shead EF, 2007, THORAX, V62, P650, DOI 10.1136/thx.2006.075887; Skutek M, 2001, EUR J APPL PHYSIOL, V86, P48, DOI 10.1007/s004210100502; Stalvey MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080098; Wang JHC, 2005, ANN BIOMED ENG, V33, P337, DOI 10.1007/s10439-005-1736-8; Yuan J, 2003, BBA-MOL CELL RES, V1641, P35, DOI 10.1016/S0167-4889(03)00047-8; Zhang GY, 2006, J CELL BIOCHEM, V98, P1436, DOI 10.1002/jcb.20776; Zhang WK, 2010, NAT CELL BIOL, V12, P507, DOI 10.1038/ncb2053	45	26	27	0	28	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					3800	3815		10.1096/fj.201601181R	http://dx.doi.org/10.1096/fj.201601181R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28495756				2022-12-26	WOS:000408713300009
J	Yan, L; Li, Y; Shi, ZX; Lu, XY; Ma, J; Hu, BY; Jiao, JW; Wang, HM				Yan, Long; Li, Yue; Shi, Zixiao; Lu, Xiaoyin; Ma, Jiao; Hu, Baoyang; Jiao, Jianwei; Wang, Hongmei			The zinc finger E-box-binding homeobox 1 (Zeb1) promotes the conversion of mouse fibroblasts into functional neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell biology; cell therapy; fibroblasts; neurons; reprogramming; transcription factor; Zeb1; transdifferentiation	EPITHELIAL-MESENCHYMAL TRANSITION; KEY DETERMINANT; INDUCTION; CELLS; CROSSROADS; METASTASIS; EXPRESSION; GENERATION; PHENOTYPE; PROTEIN	The zinc finger E-box-binding transcription factor Zeb1 plays a pivotal role in the epithelial-mesenchymal transition. Numerous studies have focused on the molecular mechanisms by which Zeb1 contributes to this process. However, the functions of Zeb1 beyond the epithelial-mesenchymal transition remain largely elusive. Using a transdifferentiation system to convert mouse embryonic fibroblasts (MEFs) into functional neurons via the neuronal transcription factors achaete-scute family bHLH (basic helix-loop-helix) transcription factor1 (Ascl1), POU class 3 homeobox 2 (POU3F2/Brn2), and neurogenin 2 (Neurog2, Ngn2) (ABN), we found that Zeb1 was up-regulated during the early stages of transdifferentiation. Knocking down Zeb1 dramatically attenuated the transdifferentiation efficiency, whereas Zeb1 overexpression obviously increased the efficiency of transdifferentiation from MEFs to neurons. Interestingly, Zeb1 improved the transdifferentiation efficiency induced by even a single transcription factor (e.g. Asc1 or Ngn2). Zeb1 also rapidly promoted the maturation of induced neuron cells to functional neurons and improved the formation of neuronal patterns and electrophysiological characteristics. Induced neuron cells could form functional synapse in vivo after transplantation. Genome-wide RNA arrays showed that Zeb1 overexpression up-regulated the expression of neuron-specific genes and down-regulated the expression of epithelial-specific genes during conversion. Taken together, our results reveal a new role for Zeb1 in the transdifferentiation of MEFs into neurons.	[Yan, Long; Shi, Zixiao; Lu, Xiaoyin; Ma, Jiao; Hu, Baoyang; Jiao, Jianwei; Wang, Hongmei] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China; [Shi, Zixiao; Lu, Xiaoyin; Ma, Jiao] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Li, Yue] Peking Univ, Hosp 3, Dept Obstet & Gynecol, Ctr Reprod Med, Beijing 100191, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Peking University	Jiao, JW; Wang, HM (corresponding author), 1 Beichen West Rd, Beijing 100101, Peoples R China.	jwjiao@ioz.ac.cn; wanghm@ioz.ac.cn	Hu, Baoyang/R-8374-2016; Lu, Xiaoyin/AAO-5561-2021; Jiao, Jianwei/I-1452-2013; Jiao, Jianwei/AAA-7902-2020	Hu, Baoyang/0000-0003-3993-4014; Lu, Xiaoyin/0000-0002-9244-325X; Jiao, Jianwei/0000-0002-7893-0721; Jiao, Jianwei/0000-0002-7893-0721	Strategic Priority Research Program of the Chinese Academy of Sciences [XDA01020102]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA01020102). The authors declare that they have no conflicts of interest with the contents of this article.	Ali FR, 2014, DEVELOPMENT, V141, P2216, DOI 10.1242/dev.106377; Ambasudhan R, 2011, CELL STEM CELL, V9, P113, DOI 10.1016/j.stem.2011.07.002; Arima Y, 2012, J BIOL CHEM, V287, P7896, DOI 10.1074/jbc.M111.313759; Bellon E, 2009, J CELL BIOL, V187, P685, DOI 10.1083/jcb.200904034; Berx G, 2007, CLIN EXP METASTAS, V24, P587, DOI 10.1007/s10585-007-9114-6; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Chanda S, 2014, STEM CELL REP, V3, P282, DOI 10.1016/j.stemcr.2014.05.020; Chanda S, 2013, P NATL ACAD SCI USA, V110, P16622, DOI 10.1073/pnas.1316240110; Chang YC, 2014, J CELL MOL MED, V18, P698, DOI 10.1111/jcmm.12219; Darling DS, 2003, GENE EXPR PATTERNS, V3, P709, DOI 10.1016/S1567-133X(03)00147-9; Fu JJ, 2010, J BIOL CHEM, V285, P10870, DOI 10.1074/jbc.M109.004200; Gheldof A, 2012, CELL MOL LIFE SCI, V69, P2527, DOI 10.1007/s00018-012-0935-3; Gubelmann C, 2014, ELIFE, V3, DOI 10.7554/eLife.03346; Hu WX, 2015, CELL STEM CELL, V17, P204, DOI 10.1016/j.stem.2015.07.006; Jiang HB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10100; Kim T, 2011, J EXP MED, V208, P875, DOI 10.1084/jem.20110235; Ladewig J, 2012, NAT METHODS, V9, P575, DOI [10.1038/NMETH.1972, 10.1038/nmeth.1972]; Li X, 2015, CELL STEM CELL, V17, P195, DOI 10.1016/j.stem.2015.06.003; Liu YQ, 2008, DEVELOPMENT, V135, P579, DOI 10.1242/dev.007047; Meng FX, 2012, CELL RES, V22, P436, DOI 10.1038/cr.2011.185; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Pirinen E, 2014, APMIS, V122, P530, DOI 10.1111/apm.12187; Ren J, 2013, J CELL BIOCHEM, V114, P1395, DOI 10.1002/jcb.24481; Sabourin JC, 2009, STEM CELLS, V27, P2722, DOI 10.1002/stem.226; Sanchez-Tillo E, 2011, P NATL ACAD SCI USA, V108, P19204, DOI 10.1073/pnas.1108977108; Shenoy Archana, 2012, F1000 Biol Rep, V4, P3, DOI 10.3410/B4-3; Shi ZX, 2014, J BIOL CHEM, V289, P6415, DOI 10.1074/jbc.M113.515601; Shin JO, 2012, HISTOCHEM CELL BIOL, V137, P459, DOI 10.1007/s00418-012-0915-6; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Thoma EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038651; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wapinski OL, 2013, CELL, V155, P621, DOI 10.1016/j.cell.2013.09.028; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Zhang PJ, 2015, CELL CYCLE, V14, P481, DOI 10.1080/15384101.2015.1006048; Zhang P, 2014, NAT CELL BIOL, V16, P864, DOI 10.1038/ncb3013; Zhang YS, 2013, NEURON, V78, P785, DOI 10.1016/j.neuron.2013.05.029	38	11	11	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 4	2017	292	31					12959	12970		10.1074/jbc.M116.771493	http://dx.doi.org/10.1074/jbc.M116.771493			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD0HJ	28500132	Green Published, hybrid			2022-12-26	WOS:000407220100024
J	Lee, JY; Steinfeld, JB; Qi, Z; Kwon, Y; Sung, P; Greene, EC				Lee, Ja Yil; Steinfeld, Justin B.; Qi, Zhi; Kwon, YoungHo; Sung, Patrick; Greene, Eric C.			Sequence imperfections and base triplet recognition by the Rad51/RecA family of recombinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA STRAND EXCHANGE; RECA PROTEIN; HOMOLOGOUS RECOMBINATION; BRANCH MIGRATION; ATP HYDROLYSIS; EVOLUTION; POLARITY; REPAIR; DMC1; REPLICATION	Homologous recombination plays key roles in double-strand break repair, rescue, and repair of stalled replication forks and meiosis. The broadly conserved Rad51/RecA family of recombinases catalyzes the DNA strand invasion reaction that takes place during homologous recombination. We have established single-stranded (ss) DNA curtain assays for measuring individual base triplet steps during the early stages of strand invasion. Here, we examined how base triplet stepping by RecA, Rad51, and Dmc1 is affected by DNA sequence imperfections, such as single and multiple mismatches, abasic sites, and single nucleotide insertions. Our work reveals features of base triplet stepping that are conserved among these three phylogenetic lineages of the Rad51/RecA family and also reveals lineage-specific behaviors reflecting properties that are unique to each recombinase. These findings suggest that Dmc1 is tolerant of single mismatches, multiple mismatches, and even abasic sites, whereas RecA and Rad51 are not. Interestingly, the presence of single nucleotide insertion abolishes recognition of an adjacent base triplet by all three recombinases. On the basis of these findings, we describe models for how sequence imperfections may affect base triplet recognition by Rad51/RecA family members, and we discuss how these models and our results may relate to the different biological roles of RecA, Rad51, and Dmc1.	[Lee, Ja Yil; Steinfeld, Justin B.; Qi, Zhi; Greene, Eric C.] Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA; [Kwon, YoungHo; Sung, Patrick] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA; [Lee, Ja Yil] UNIST, Sch Life Sci, Ulsan 689798, South Korea; [Qi, Zhi] Peking Univ, Acad Adv Interdisciplinary Studies, Ctr Quantitat Biol, Beijing 100871, Peoples R China; [Qi, Zhi] Peking Univ, Acad Adv Interdisciplinary Studies, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China	Columbia University; Yale University; Ulsan National Institute of Science & Technology (UNIST); Peking University; Peking University	Greene, EC (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA.	ecg2108@cumc.columbia.edu	Classen, Scott/AAY-8176-2020		National Institutes of Health [R35GM118026, R01ES007061, P01CA92584, F31CA210663]; NATIONAL CANCER INSTITUTE [P01CA092584, F31CA210663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118026] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant R35GM118026 (to E. C. G.) and Grants R01ES007061 and P01CA92584 (to P. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Training Grant F31CA210663. Present address: School of Life Science, Ulsan National Institute of Science and Technology (UNIST), Ulsan 689-798, Republic of Korea.	Anand R, 2017, NATURE, V544, P377, DOI 10.1038/nature22046; Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1223, DOI 10.1093/nar/27.5.1223; Bianco P R, 1998, Front Biosci, V3, pD570; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Brown MS, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016659; CameriniOtero RD, 1995, ANNU REV GENET, V29, P509, DOI 10.1146/annurev.genet.29.1.509; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; CLARK AJ, 1965, P NATL ACAD SCI USA, V53, P451, DOI 10.1073/pnas.53.2.451; Coop G, 2007, NAT REV GENET, V8, P23, DOI 10.1038/nrg1947; Cox MM, 2007, NAT REV MOL CELL BIO, V8, P127, DOI 10.1038/nrm2099; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; COX MM, 1981, P NATL ACAD SCI-BIOL, V78, P6018, DOI 10.1073/pnas.78.10.6018; Danilowicz C, 2015, NUCLEIC ACIDS RES, V43, P6473, DOI 10.1093/nar/gkv610; EGELMAN EH, 1986, J MOL BIOL, V191, P677, DOI 10.1016/0022-2836(86)90453-5; Flores-Rozas H, 2000, TRENDS BIOCHEM SCI, V25, P196, DOI 10.1016/S0968-0004(00)01568-1; Gibb B, 2012, ANAL CHEM, V84, P7607, DOI 10.1021/ac302117z; Greene EC, 2010, METHOD ENZYMOL, V472, P293, DOI 10.1016/S0076-6879(10)72006-1; Hunter N, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016618; KIM JI, 1992, J BIOL CHEM, V267, P16438; Kolodner RD, 2002, SCIENCE, V297, P552, DOI 10.1126/science.1075277; Kowalczykowski SC, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016410; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Lee JY, 2016, J BIOL CHEM, V291, P22218, DOI 10.1074/jbc.M116.740563; Lee JY, 2015, SCIENCE, V349, P977, DOI 10.1126/science.aab2666; Lin ZG, 2006, P NATL ACAD SCI USA, V103, P10328, DOI 10.1073/pnas.0604232103; Malkova A, 2012, ANNU REV GENET, V46, P455, DOI 10.1146/annurev-genet-110711-155547; Mehta A, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016428; Morrical SW, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016444; Murayama Y, 2011, GENE DEV, V25, P516, DOI 10.1101/gad.1997511; Namsaraev EA, 1998, P NATL ACAD SCI USA, V95, P10477, DOI 10.1073/pnas.95.18.10477; Namsaraev EA, 2000, J BIOL CHEM, V275, P3970, DOI 10.1074/jbc.275.6.3970; Neale MJ, 2006, NATURE, V442, P153, DOI 10.1038/nature04885; OGAWA T, 1993, SCIENCE, V259, P1896, DOI 10.1126/science.8456314; Ortiz-Barrientos D, 2016, TRENDS ECOL EVOL, V31, P226, DOI 10.1016/j.tree.2015.12.016; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Persky NS, 2008, CRIT REV BIOCHEM MOL, V43, P347, DOI [10.1080/10409230802485358, 10.1080/10409230802485358 ]; Prentiss M, 2015, CRIT REV BIOCHEM MOL, V50, P453, DOI 10.3109/10409238.2015.1092943; Qi Z, 2016, METHODS, V105, P62, DOI 10.1016/j.ymeth.2016.03.027; Qi Z, 2015, CELL, V160, P856, DOI 10.1016/j.cell.2015.01.029; ROSSELLI W, 1991, EMBO J, V10, P4391, DOI 10.1002/j.1460-2075.1991.tb05017.x; Sheridan SD, 2008, NUCLEIC ACIDS RES, V36, P4057, DOI 10.1093/nar/gkn352; Soucy SM, 2015, NAT REV GENET, V16, P472, DOI 10.1038/nrg3962; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; SUNG P, 1995, CELL, V82, P453, DOI 10.1016/0092-8674(95)90434-4; Symington LS, 2014, GENETICS, V198, P795, DOI 10.1534/genetics.114.166140; WEST SC, 1981, P NATL ACAD SCI-BIOL, V78, P6149, DOI 10.1073/pnas.78.10.6149; Yu X, 2001, P NATL ACAD SCI USA, V98, P8419, DOI 10.1073/pnas.111005398	47	18	19	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					11125	11135		10.1074/jbc.M117.787614	http://dx.doi.org/10.1074/jbc.M117.787614			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28476890	Green Published, hybrid			2022-12-26	WOS:000404391000031
J	Pinto, APA; Pereira, HM; Zeraik, AE; Ciol, H; Ferreira, FM; Brandao-Neto, J; DeMarco, R; Navarro, MVAS; Risi, C; Galkin, VE; Garratt, RC; Araujo, APU				Pinto, Andressa P. A.; Pereira, Humberto M.; Zeraik, Ana E.; Ciol, Heloisa; Ferreira, Frederico M.; Brandao-Neto, Jose; DeMarco, Ricardo; Navarro, Marcos V. A. S.; Risi, Cristina; Galkin, Vitold E.; Garratt, Richard C.; Araujo, Ana P. U.			Filaments and fingers: Novel structural aspects of the single septin from Chlamydomonas reinhardtii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING; SCHISTOSOMA-MANSONI; NUCLEOTIDE-BINDING; CRYSTAL-STRUCTURE; G-PROTEINS; FORCHLORFENURON; ORGANIZATION; INSIGHTS; YEAST; LOCALIZATION	Septins are filament-forming GTP-binding proteins involved in many essential cellular events related to cytoskeletal dynamics and maintenance. Septins can self-assemble into heterocomplexes, which polymerize into highly organized, cell membrane-interacting filaments. The number of septin genes varies among organisms, and although their structure and function have been thoroughly studied in opisthokonts (including animals and fungi), no structural studies have been reported for other organisms. This makes the single septin from Chlamydomonas (CrSEPT) a particularly attractive model for investigating whether functional homopolymeric septin filaments also exist. CrSEPT was detected at the base of the flagella in Chlamydomonas, suggesting that CrSEPT is involved in the formation of a membrane-diffusion barrier. Using transmission electron microscopy, we observed that recombinant CrSEPT forms long filaments with dimensions comparable with those of the canonical structure described for opisthokonts. The GTP-binding domain of CrSEPT purified as a nucleotide-free monomer that hydrolyzes GTP and readily binds its analog guanosine 5'-3-O-(thio) triphosphate. We also found that upon nucleotide binding, CrSEPT formed dimers that were stabilized by an interface involving the ligand (G-interface). Across this interface, one monomer supplied a catalytic arginine to the opposing subunit, greatly accelerating the rate of GTP hydrolysis. This is the first report of an arginine finger observed in a septin and suggests that CrSEPT may act as its own GTP-activating protein. The finger is conserved in all algal septin sequences, suggesting a possible correlation between the ability to form homopolymeric filaments and the accelerated rate of hydrolysis that it provides.	[Pinto, Andressa P. A.; Pereira, Humberto M.; Zeraik, Ana E.; Ciol, Heloisa; DeMarco, Ricardo; Navarro, Marcos V. A. S.; Garratt, Richard C.; Araujo, Ana P. U.] Univ Sao Paulo, Inst Fis Sao Carlos, BR-13563120 Sao Carlos, SP, Brazil; [Pinto, Andressa P. A.; Araujo, Ana P. U.] Univ Fed Sao Carlos, Programa Posgrad Genet Evolut & Biol Mol, BR-13565905 Sao Carlos, SP, Brazil; [Ferreira, Frederico M.] Univ Santo Amaro, BR-04829300 Sao Paulo, SP, Brazil; [Brandao-Neto, Jose] Diamond Light Source, Harwell Sci & Innovat Campus, Didcot OX11 0DE, Oxon, England; [Risi, Cristina; Galkin, Vitold E.] Eastern Virginia Med Sch, Dept Physiol Sci, Norfolk, VA 23501 USA	Universidade de Sao Paulo; Universidade Federal de Sao Carlos; Universidade de Santo Amaro (UNISA); Diamond Light Source; Eastern Virginia Medical School	Garratt, RC; Araujo, APU (corresponding author), Univ Sao Paulo, Inst Fis Sao Carlos, Dept Fis & Ciencia Interdisciplinar, Ave Joao Dagnone 1100,POB 369, BR-13563120 Sao Carlos, SP, Brazil.	richard@ifsc.usp.br; anapaula@ifsc.usp.br	Navarro, Marcos VAS/C-9141-2013; garratt, richard c/F-6921-2011; DeMarco, Ricardo/A-7773-2008; Araujo, Ana Paula U/I-6664-2012; Galkin, Vitold/AAD-2844-2019; Ferreira, Frederico/A-4622-2013	DeMarco, Ricardo/0000-0001-8944-1301; Araujo, Ana Paula U/0000-0001-5455-084X; Ferreira, Frederico/0000-0002-7403-9165; Zeraik, Ana Eliza/0000-0001-9508-4283; garratt, richard/0000-0002-2016-3179; Brandao-Neto, Jose/0000-0001-6015-320X; Ciol, Heloisa/0000-0002-7539-023X; Navarro, Marcos/0000-0002-2461-0431	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/10152-7, 2014/15546-1, 2012/14223-9, 12/21259-0, 2013/20715-4]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) under Grants 2011/10152-7 (to A. P. U. A.), 2014/15546-1 (to R. C. G. and A. P. U. A.), and 2012/14223-9 (to H. M. P.) and Fellowships 12/21259-0 and 2013/20715-4 (to H. C. and A. E. Z., respectively). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Serrao VHB, 2011, FEBS LETT, V585, P3868, DOI 10.1016/j.febslet.2011.10.043; Bertin A, 2008, P NATL ACAD SCI USA, V105, P8274, DOI 10.1073/pnas.0803330105; Bourne HR, 1997, NATURE, V389, P673, DOI 10.1038/39470; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Bridges AA, 2014, P NATL ACAD SCI USA, V111, P2146, DOI 10.1073/pnas.1314138111; Caudron F, 2009, DEV CELL, V16, P493, DOI 10.1016/j.devcel.2009.04.003; Clark AM, 2007, J CHEM INF MODEL, V47, P1933, DOI 10.1021/ci7001473; Demay BS, 2010, CYTOSKELETON, V67, P383, DOI 10.1002/cm.20452; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Farkasovsky M, 2005, BIOL CHEM, V386, P643, DOI 10.1515/BC.2005.075; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Graham DL, 2002, CHEM BIOL, V9, P375, DOI 10.1016/S1074-5521(02)00112-6; GRAZIANO MP, 1989, J BIOL CHEM, V264, P15475; HARTWELL LH, 1971, EXP CELL RES, V69, P265, DOI 10.1016/0014-4827(71)90223-0; Helliwell KE, 2011, MOL BIOL EVOL, V28, P2921, DOI 10.1093/molbev/msr124; Hoober J. K., 1989, CHLAMYDOMONAS SOURCE, P241; Hu QC, 2008, J BIOL CHEM, V283, P29563, DOI 10.1074/jbc.M804962200; Hu QC, 2010, SCIENCE, V329, P436, DOI 10.1126/science.1191054; Huang YW, 2006, FEBS J, V273, P3248, DOI 10.1111/j.1742-4658.2006.05333.x; John CM, 2007, EMBO J, V26, P3296, DOI 10.1038/sj.emboj.7601775; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KEEFE LJ, 1993, P NATL ACAD SCI USA, V90, P3275, DOI 10.1073/pnas.90.8.3275; Keller LC, 2010, CYTOSKELETON, V67, P504, DOI 10.1002/cm.20462; Kim SK, 2010, SCIENCE, V329, P1337, DOI 10.1126/science.1191184; Kinoshita M, 2006, CURR OPIN CELL BIOL, V18, P54, DOI 10.1016/j.ceb.2005.12.005; Kinoshita M, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-236; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; Lindsey R, 2006, CURR OPIN MICROBIOL, V9, P559, DOI 10.1016/j.mib.2006.10.009; Longtine MS, 1996, CURR OPIN CELL BIOL, V8, P106, DOI 10.1016/S0955-0674(96)80054-8; Macedo JNA, 2013, BIOCHEM J, V450, P95, DOI 10.1042/BJ20120851; Mendoza M, 2002, CURR BIOL, V12, P1858, DOI 10.1016/S0960-9822(02)01258-7; Miao WY, 1996, J BIOL CHEM, V271, P15322, DOI 10.1074/jbc.271.26.15322; Nishihama R, 2011, BIOL CHEM, V392, P681, DOI 10.1515/BC.2011.086; Ong K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6698; Pan FF, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-103; Quarmby L.M., 2009, CHLAMYDOMONAS SOURCE, VSecond Edition, P43, DOI [10.1016/b978-0-12-370873-1.00040-x, DOI 10.1016/B978-0-12-370873-1.00040-X]; Rittinger K, 1997, NATURE, V388, P693, DOI 10.1038/41805; Schwefel D, 2013, STRUCTURE, V21, P550, DOI 10.1016/j.str.2013.01.014; Schwefel D, 2010, P NATL ACAD SCI USA, V107, P20299, DOI 10.1073/pnas.1010322107; SECKLER R, 1990, J BIOL CHEM, V265, P7655; Sellin ME, 2011, MOL BIOL CELL, V22, P3152, DOI 10.1091/mbc.E11-03-0253; Sheffield PJ, 2003, J BIOL CHEM, V278, P3483, DOI 10.1074/jbc.M209701200; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sirajuddin M, 2007, NATURE, V449, P311, DOI 10.1038/nature06052; Sirajuddin M, 2009, P NATL ACAD SCI USA, V106, P16592, DOI 10.1073/pnas.0902858106; Valadares NF, 2016, METHOD CELL BIOL, V136, P321, DOI 10.1016/bs.mcb.2016.03.017; Versele M, 2005, TRENDS CELL BIOL, V15, P414, DOI 10.1016/j.tcb.2005.06.007; Versele M, 2004, MOL BIOL CELL, V15, P4568, DOI 10.1091/mbc.E04-04-0330; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; WEISS RL, 1977, J CELL BIOL, V72, P133, DOI 10.1083/jcb.72.1.133; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Wloga D, 2008, EUKARYOT CELL, V7, P1373, DOI 10.1128/EC.00085-08; Yamazaki T, 2013, PLANT J, V74, P605, DOI 10.1111/tpj.12147; Zent E, 2014, BIOL CHEM, V395, P169, DOI 10.1515/hsz-2013-0268; Zent E, 2011, BIOL CHEM, V392, P791, DOI 10.1515/BC.2011.082; Zeraik AE, 2014, INT J PARASITOL, V44, P523, DOI 10.1016/j.ijpara.2014.03.010; Zeraik AE, 2014, J BIOL CHEM, V289, P7799, DOI 10.1074/jbc.M113.525352; Zhang BL, 1999, J BIOL CHEM, V274, P2609, DOI 10.1074/jbc.274.5.2609	61	8	8	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					10899	10911		10.1074/jbc.M116.762229	http://dx.doi.org/10.1074/jbc.M116.762229			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28476887	Green Published, hybrid			2022-12-26	WOS:000404391000013
J	Irimia, JM; Meyer, CM; Segvich, DM; Surendran, S; DePaoli-Roach, AA; Morral, N; Roach, PJ				Irimia, Jose M.; Meyer, Catalina M.; Segvich, Dyann M.; Surendran, Sneha; DePaoli-Roach, Anna A.; Morral, Nuria; Roach, Peter J.			Lack of liver glycogen causes hepatic insulin resistance and steatosis in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fatty acid metabolism; glycogen; glycogen storage disease; insulin resistance; lipogenesis; fatty liver	DE-NOVO LIPOGENESIS; MUSCLE GLYCOGEN; FATTY LIVER; METABOLIC SYNDROME; GLUCOSE-TRANSPORT; DISEASE; SYNTHASE; SENSITIVITY; PROTEINS; PHOSPHORYLATION	Disruption of the Gys2 gene encoding the liver isoform of glycogen synthase generates a mouse strain (LGSKO) that almost completely lacks hepatic glycogen, has impaired glucose disposal, and is pre-disposed to entering the fasted state. This study investigated how the lack of liver glycogen increases fat accumulation and the development of liver insulin resistance. Insulin signaling in LGSKO mice was reduced in liver, but not muscle, suggesting an organ-specific defect. Phosphorylation of components of the hepatic insulin-signaling pathway, namely IRS1, Akt, and GSK3, was decreased in LGSKO mice. Moreover, insulin stimulation of their phosphorylation was significantly suppressed, both temporally and in an insulin dose response. Phosphorylation of the insulin-regulated transcription factor FoxO1 was somewhat reduced and insulin treatment did not elicit normal translocation of FoxO1 out of the nucleus. Fat overaccumulated in LGSKO livers, showing an aberrant distribution in the acinus, an increase not explained by a reduction in hepatic triglyceride export. Rather, when administered orally to fasted mice, glucose was directed toward hepatic lipogenesis as judged by the activity, protein levels, and expression of several fatty acid synthesis genes, namely, acetyl-CoA carboxylase, fatty acid synthase, SREBP1c, chREBP, glucokinase, and pyruvate kinase. Furthermore, using cultured primary hepatocytes, we found that lipogenesis was increased by 40% in LGSKO cells compared with controls. Of note, the hepatic insulin resistance was not associated with increased levels of pro-inflammatory markers. Our results suggest that loss of liver glycogen synthesis diverts glucose toward fat synthesis, correlating with impaired hepatic insulin signaling and glucose disposal.	[Irimia, Jose M.; Meyer, Catalina M.; Segvich, Dyann M.; DePaoli-Roach, Anna A.; Roach, Peter J.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Surendran, Sneha; Morral, Nuria] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Irimia, Jose M.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Diabet Endocrinol & Metab, Duarte, CA 91010 USA; [Meyer, Catalina M.] Lilly Res Labs, Indianapolis, IN 46225 USA; [Surendran, Sneha] IUPUI, Dept Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; City of Hope; Beckman Research Institute of City of Hope; Eli Lilly; Indiana University System; Indiana University-Purdue University Indianapolis	Roach, PJ (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.	proach@iupui.edu	Morral, Nuria/AAC-7149-2020		National Institutes of Health [DK 27221, NS 056454]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK027221, P30DK097512, R37DK027221, R01DK027221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056454] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK 27221 and NS 056454. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Accili D, 2004, DIABETES, V53, P1633, DOI 10.2337/diabetes.53.7.1633; Bandsma RHJ, 2008, PEDIATR RES, V63, P702, DOI 10.1203/PDR.0b013e31816c9013; Biddinger SB, 2008, CELL METAB, V7, P125, DOI 10.1016/j.cmet.2007.11.013; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Choi CS, 2007, P NATL ACAD SCI USA, V104, P16480, DOI 10.1073/pnas.0706794104; Cook JR, 2015, J BIOL CHEM, V290, P13972, DOI 10.1074/jbc.M115.638197; DAVIDSON AL, 1987, ARCH BIOCHEM BIOPHYS, V253, P156, DOI 10.1016/0003-9861(87)90648-5; Dentin R, 2004, J BIOL CHEM, V279, P20314, DOI 10.1074/jbc.M312475200; Derave W, 2000, AM J PHYSIOL-ENDOC M, V279, pE947, DOI 10.1152/ajpendo.2000.279.5.E947; Derave W, 1999, AM J PHYSIOL-ENDOC M, V277, pE1103, DOI 10.1152/ajpendo.1999.277.6.E1103; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; Ferre P, 2010, DIABETES OBES METAB, V12, P83, DOI 10.1111/j.1463-1326.2010.01275.x; Graham TE, 2010, ACTA PHYSIOL, V199, P489, DOI 10.1111/j.1748-1716.2010.02131.x; Grefhorst A, 2005, AM J PHYSIOL-GASTR L, V289, pG592, DOI 10.1152/ajpgi.00063.2005; Guo SD, 2014, J ENDOCRINOL, V220, pT1, DOI 10.1530/JOE-13-0327; Hijmans BS, 2014, BIOCHIMIE, V96, P121, DOI 10.1016/j.biochi.2013.06.007; Hoehn KL, 2008, CELL METAB, V7, P421, DOI 10.1016/j.cmet.2008.04.005; Hojlund K, 2003, DIABETES, V52, P1393, DOI 10.2337/diabetes.52.6.1393; Hojlund K, 2009, J CLIN ENDOCR METAB, V94, P4547, DOI 10.1210/jc.2009-0897; Hung MC, 2011, J CELL SCI, V124, P3381, DOI 10.1242/jcs.089110; Irimia JM, 2010, J BIOL CHEM, V285, P12851, DOI 10.1074/jbc.M110.106534; Jensen J, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00112; LUDVIK B, 1995, J CLIN INVEST, V95, P2232, DOI 10.1172/JCI117913; Mao J, 2006, P NATL ACAD SCI USA, V103, P8552, DOI 10.1073/pnas.0603115103; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Nagy TR, 2000, OBES RES, V8, P392, DOI 10.1038/oby.2000.47; Park Jae-Seung, 2011, BMC Res Notes, V4, P8, DOI 10.1186/1756-0500-4-8; Pederson BA, 2005, DIABETES, V54, P3466, DOI 10.2337/diabetes.54.12.3466; Pederson BA, 2005, J BIOL CHEM, V280, P17260, DOI 10.1074/jbc.M410448200; Petersen KF, 2007, P NATL ACAD SCI USA, V104, P12587, DOI 10.1073/pnas.0705408104; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Roach PJ, 2012, BIOCHEM J, V441, P763, DOI 10.1042/BJ20111416; Roach Peter J., 1998, Journal of Basic and Clinical Physiology and Pharmacology, V9, P139; Ros S, 2011, DIABETOLOGIA, V54, P2639, DOI 10.1007/s00125-011-2238-x; Ros S, 2010, J BIOL CHEM, V285, P37170, DOI 10.1074/jbc.M110.157396; Sakiyama H, 2008, J BIOL CHEM, V283, P24899, DOI 10.1074/jbc.M804308200; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Schwarz JM, 2003, AM J CLIN NUTR, V77, P43, DOI 10.1093/ajcn/77.1.43; Stapleton D, 2010, PROTEOMICS, V10, P2320, DOI 10.1002/pmic.200900628; Sun Z, 2013, TRENDS ENDOCRIN MET, V24, P4, DOI 10.1016/j.tem.2012.09.005; Suzuki Y, 2001, MOL CELL BIOL, V21, P2683, DOI 10.1128/MCB.21.8.2683-2694.2001; Tilg H, 2008, TRENDS ENDOCRIN MET, V19, P371, DOI 10.1016/j.tem.2008.08.005; Titchenell PM, 2016, CELL METAB, V23, P1154, DOI 10.1016/j.cmet.2016.04.022; Weinstein DA, 2006, MOL GENET METAB, V87, P284, DOI 10.1016/j.ymgme.2005.10.006; Williams KH, 2013, ENDOCR REV, V34, P84, DOI 10.1210/er.2012-1009	47	46	46	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10455	10464		10.1074/jbc.M117.786525	http://dx.doi.org/10.1074/jbc.M117.786525			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28483921	Green Published, hybrid			2022-12-26	WOS:000404115400011
J	Popinako, A; Antonov, M; Tikhonov, A; Tikhonova, T; Popov, V				Popinako, Anna; Antonov, Mikhail; Tikhonov, Alexey; Tikhonova, Tamara; Popov, Vladimir			Structural adaptations of octaheme nitrite reductases from haloalkaliphilic Thioalkalivibrio bacteria to alkaline pH and high salinity	PLOS ONE			English	Article							SP NOV.; PROTEIN; DEHYDROGENASE; STABILITY; INSIGHTS; TOOL	Bacteria Tv. nitratireducens and Tv. paradoxus from soda lakes grow optimally in sodium carbonate/NaCl brines at pH range from 9.5 to 10 and salinity from 0.5 to 1.5 M Na+. Octaheme nitrite reductases (ONRs) from haloalkaliphilic bacteria of genus Thioalkalivibrio are stable and active in a wide range of pH (up to 11) and salinity (up to 1 M NaCl). To establish adaptation mechanisms of ONRs from haloalkaliphilic bacteria a comparative analysis of amino acid sequences and structures of ONRs from haloalkaliphilic bacteria and their homologues from non-halophilic neutrophilic bacteria was performed. The following adaptation strategies were observed: (1) strategies specific for halophilic and alkaliphilic proteins (an increase in the number of aspartate and glutamate residues and a decrease in the number of lysine residues on the protein surface), (2) strategies specific for halophilic proteins (an increase in the arginine content and a decrease in the number of hydrophobic residues on the solvent-accessible protein surface), (3) strategies specific for alkaliphilic proteins (an increase in the area of intersubunit hydrophobic contacts). Unique adaptation mechanism inherent in the ONRs from bacteria of genus Thioalkalivibrio was revealed (an increase in the core in the number of tryptophan and phenylalanine residues, and an increase in the number of small side chain residues, such as alanine and valine, in the core).	[Popinako, Anna; Tikhonov, Alexey; Tikhonova, Tamara; Popov, Vladimir] Russian Acad Sci, Res Ctr Biotechnol, Bach Inst Biochem, Leninsky Prospekt 33,Bld 2, Moscow, Russia; [Antonov, Mikhail] MK Ammosov North Eastern Fed Univ, Suite 312, Yakutsk, Yakutia, Russia; [Popov, Vladimir] Natl Res Ctr, Kurchatov Inst, Akad Kurchatova Sqr 1, Moscow, Russia	Research Center of Biotechnology RAS; Russian Academy of Sciences; North-Eastern Federal University in Yakutsk; National Research Centre - Kurchatov Institute	Popinako, A (corresponding author), Russian Acad Sci, Res Ctr Biotechnol, Bach Inst Biochem, Leninsky Prospekt 33,Bld 2, Moscow, Russia.	popinakoav@gmail.com	Antonov, Mikhail/B-4703-2014	Antonov, Mikhail/0000-0003-3674-0863; Popov, Vladimir/0000-0002-0133-7962; Tikhonova, Tamara/0000-0003-4264-8676	Russian Science Foundation [14-24-00172]; Russian Foundation for Basic Research [16-34-60252]; Russian Science Foundation [17-24-00022] Funding Source: Russian Science Foundation	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF))	The bioinformatics analysis was supported by the Russian Science Foundation (grant 14-24-00172) (http://www.rscf.ru/en/enprjcard?rid=17-24-00022). The improvement of the protocol for the structural analysis of proteins from poliextremophiles was supported by the Russian Foundation for Basic Research (grant 16-34-60252)(http://www.rfbr.ru/rffi/ru/project_search/o_2038468)	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bezsudnova EY, 2015, BIOCHIMIE, V118, P82, DOI 10.1016/j.biochi.2015.08.010; Bieger B, 2003, STRUCTURE, V11, P375, DOI 10.1016/S0969-2126(03)00048-0; Dubnovitsky AP, 2005, ENZYME ADAPTATION AL, P97; DYM O, 1995, SCIENCE, V267, P1344, DOI 10.1126/science.267.5202.1344; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Filimonenkov AA, 2010, BIOCHEMISTRY-MOSCOW+, V75, P744, DOI 10.1134/S000629791006009X; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Fukuchi S, 2003, J MOL BIOL, V327, P347, DOI 10.1016/S0022-2836(03)00150-5; Graziano G, 2014, BBA-PROTEINS PROTEOM, V1844, P850, DOI 10.1016/j.bbapap.2014.02.018; Hekkelman ML, 2010, NUCLEIC ACIDS RES, V38, pW719, DOI 10.1093/nar/gkq453; Karyagina Anna, 2006, Journal of Bioinformatics and Computational Biology, V4, P357, DOI 10.1142/S0219720006001837; Kassner BRJ, 1973, BIOCHEM J, P283; Kastritis PL, 2007, INT J BIOL MACROMOL, V41, P447, DOI 10.1016/j.ijbiomac.2007.06.005; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Madern D, 2004, EXTREMOPHILES, V8, P377, DOI 10.1007/s00792-004-0398-z; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; McGaughey GB, 1998, J BIOL CHEM, V273, P15458, DOI 10.1074/jbc.273.25.15458; Mevarech M, 2000, BIOPHYS CHEM, V86, P155, DOI 10.1016/S0301-4622(00)00126-5; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Oguchi Y, 2006, BIOTECHNOL LETT, V28, P1383, DOI 10.1007/s10529-006-9100-0; Paul S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r70; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pica A, 2013, BBA-PROTEINS PROTEOM, V1834, P149, DOI 10.1016/j.bbapap.2012.09.014; Poidevin L, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-44; Polyakov KM, 2009, J MOL BIOL, V389, P846, DOI 10.1016/j.jmb.2009.04.037; Pyrkov TV, 2009, BIOINFORMATICS, V25, P1201, DOI 10.1093/bioinformatics/btp111; Reed C. J., 2013, ARCHAEA, V2013, DOI DOI 10.1155/2013/373275; REID KSC, 1985, FEBS LETT, V190, P209, DOI 10.1016/0014-5793(85)81285-0; Sadovnichy V., 2013, LOMONOSOV SUPERCOMPU, P283; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Selivanov VA, 2008, J BIOL CHEM, V283, P29292, DOI 10.1074/jbc.M801019200; Shifman JM, 2000, BIOCHEMISTRY-US, V39, P14813, DOI 10.1021/bi000927b; Siddiqui K.S., 2008, PROTEIN ADAPTATIONS, P250; Siglioccolo A, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-50; Sorokin DY, 2012, INT J SYST EVOL MICR, V62, P1884, DOI 10.1099/ijs.0.034504-0; Sorokin DY, 2003, INT J SYST EVOL MICR, V53, P1779, DOI 10.1099/ijs.0.02615-0; Suplatov D, 2014, J BIOMOL STRUCT DYN, V32, P1752, DOI 10.1080/07391102.2013.834514; Tadeo X, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000257; Tamura K, MEGA5 MOL EVOLUTIONA; Tikhonova T, COMP STRUCTURAL FUNC; Tikhonova T, 2012, FEBS J, V279, P4052, DOI 10.1111/j.1742-4658.2012.08811.x; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Warden AC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10278; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang GS, 2016, ACTA CRYSTALLOGR B, V72, P20, DOI 10.1107/S2052520615018582; ZWEIG MH, 1993, CLIN CHEM, V39, P561	51	10	11	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177392	10.1371/journal.pone.0177392	http://dx.doi.org/10.1371/journal.pone.0177392			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28510595	Green Published, Green Submitted, gold			2022-12-26	WOS:000401485500024
J	Schunter, S; Villa, R; Flynn, V; Heidelberger, JB; Classen, AK; Beli, P; Becker, PB				Schunter, Sarah; Villa, Raffaella; Flynn, Victoria; Heidelberger, Jan B.; Classen, Anne-Kathrin; Beli, Petra; Becker, Peter B.			Ubiquitylation of the acetyltransferase MOF in Drosophila melanogaster	PLOS ONE			English	Article							DOSAGE COMPENSATION COMPLEX; X-CHROMOSOME; ACETYL TRANSFERASE; MSL COMPLEX; LETHAL; PHOSPHORYLATION; UBIQUITINATION; IDENTIFICATION; REVEALS; DOMAIN	The nuclear acetyltransferase MOF (KAT8 in mammals) is a subunit of at least two multicomponent complexes involved in transcription regulation. In the context of complexes of the 'Non-Specific-Lethal' (NSL) type it controls transcription initiation of many nuclear housekeeping genes and of mitochondrial genes. While this function is conserved in metazoans, MOF has an additional, specific function in Drosophila in the context of dosage compensation. As a subunit of the male-specific-lethal dosage compensation complex (MSLDCC) it contributes to the doubling of transcription output from the single male X chromosome by acetylating histone H4. Proper dosage compensation requires finely tuned levels of MSL-DCC and an appropriate distribution of MOF between the regulatory complexes. The amounts of DCC formed depends directly on the levels of the male-specific MSL2, which orchestrates the assembly of the DCC, including MOF recruitment. We found earlier that MSL2 is an E3 ligase that ubiquitylates most MSL proteins, including MOF, suggesting that ubiquitylation may contribute to a quality control of MOF's overall levels and folding state as well as its partitioning between the complex entities. We now used mass spectrometry to map the lysines in MOF that are ubiquitylated by MSL2 in vitro and identified in vivo ubiquitylation sites of MOF in male and female cells. MSL2-specific ubiquitylation in vivo could not be traced due to the dominance of other, sex-independent ubiquitylation events and conceivably may be rare or transient. Expressing appropriately mutated MOF derivatives we assessed the importance of the ubiquitylated lysines for dosage compensation by monitoring DCC formation and X chromosome targeting in cultured cells, and by genetic complementation of the male-specific-lethal mof 2 allele in flies. Our study provides a comprehensive analysis of MOF ubiquitylation as a reference for future studies.	[Schunter, Sarah; Villa, Raffaella; Flynn, Victoria; Becker, Peter B.] Ludwig Maximilians Univ Munchen, Mol Biol Div, Biomed Ctr, Munich, Germany; [Schunter, Sarah; Villa, Raffaella; Flynn, Victoria; Becker, Peter B.] Ludwig Maximilians Univ Munchen, Ctr Integrated Prot Sci, Munich, Germany; [Heidelberger, Jan B.; Beli, Petra] IMB, Mainz, Germany; [Classen, Anne-Kathrin] Ctr Biol Syst Anal ZSBA, Freiburg, Germany	University of Munich; University of Munich; Institute of Molecular Biology (IMB)	Becker, PB (corresponding author), Ludwig Maximilians Univ Munchen, Mol Biol Div, Biomed Ctr, Munich, Germany.; Becker, PB (corresponding author), Ludwig Maximilians Univ Munchen, Ctr Integrated Prot Sci, Munich, Germany.	pbecker@bmc.med.lmu.de	Classen, Anne-Kathrin/L-6164-2018; Villa, Raffaella/D-5223-2018	Classen, Anne-Kathrin/0000-0001-5157-0749; Becker, Peter/0000-0001-7186-0372	European Research Council under the European Union's Seventh Framework Programme/ERC [293948]; European Commission [630763]	European Research Council under the European Union's Seventh Framework Programme/ERC(European Research Council (ERC)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no 293948 (P.B. B.),https://erc.europa.eu/. P.B. is supported by the Emmy Noether Program (BE 5342/1-1) from the German Research Foundation, http://www.dgr.de/foerderung/programme/einzelfoerderung/emmy_noether/ and the Marie Curie Career Integration Grant from the European Commission (630763), http://ec.europa.eu/research/mariecurieactions/ funded-projects/career-integration-grants_en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseyenko AA, 2008, CELL, V134, P599, DOI 10.1016/j.cell.2008.06.033; Azevedo Cristina, 2015, Advances in Biological Regulation, V60, P144, DOI 10.1016/j.jbior.2015.09.008; Bashaw GJ, 1997, CELL, V89, P789, DOI 10.1016/S0092-8674(00)80262-7; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Cai Y, 2010, J BIOL CHEM, V285, P4268, DOI 10.1074/jbc.C109.087981; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chatterjee A, 2016, CELL, V167, P722, DOI 10.1016/j.cell.2016.09.052; Chatterjee RN, 2012, NUCLEUS CALCUTTA, V55, P3, DOI 10.1007/s13237-012-0054-4; Conrad T, 2012, DEV CELL, V22, P610, DOI 10.1016/j.devcel.2011.12.016; Corn JE, 2014, NAT STRUCT MOL BIOL, V21, P297, DOI 10.1038/nsmb.2808; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Du J., 2011, PLOS ONE, V6; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Fauth T, 2010, NUCLEIC ACIDS RES, V38, P3209, DOI 10.1093/nar/gkq026; Feller C, 2012, NUCLEIC ACIDS RES, V40, P1509, DOI 10.1093/nar/gkr869; Fiil BK, 2013, MOL CELL, V50, P818, DOI 10.1016/j.molcel.2013.06.004; Gelbart ME, 2009, NAT STRUCT MOL BIOL, V16, P825, DOI 10.1038/nsmb.1644; Gilfillan GD, 2006, GENE DEV, V20, P858, DOI 10.1101/gad.1399406; Gu WG, 1998, DEV GENET, V22, P56, DOI 10.1002/(SICI)1520-6408(1998)22:1<56::AID-DVG6>3.0.CO;2-6; Izzo A, 2008, NUCLEIC ACIDS RES, V36, P950, DOI 10.1093/nar/gkm1108; Jaffrey X, 2013, BIOTECHNOL GENET ENG, V29, P73; Johansson AM, 2011, NUCLEIC ACIDS RES, V39, P6428, DOI 10.1093/nar/gkr236; Kadlec J, 2011, NAT STRUCT MOL BIOL, V18, P142, DOI 10.1038/nsmb.1960; Keusekotten K, 2013, CELL, V153, P1312, DOI 10.1016/j.cell.2013.05.014; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kosik I, 2015, PLOS ONE, V10; Kuroda MI, 2016, GENETICS, V204, P435, DOI 10.1534/genetics.115.185108; Lam KC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002736; Marchal C, 1998, MOL CELL BIOL, V18, P314, DOI 10.1128/MCB.18.1.314; Matic I, 2010, MOL CELL, V39, P641, DOI 10.1016/j.molcel.2010.07.026; Mendjan S, 2006, MOL CELL, V21, P811, DOI 10.1016/j.molcel.2006.02.007; Michalski A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.011015; Morales V, 2004, EMBO J, V23, P2258, DOI 10.1038/sj.emboj.7600235; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Prestel M, 2010, MOL CELL, V38, P815, DOI 10.1016/j.molcel.2010.05.022; Raja SJ, 2010, MOL CELL, V38, P827, DOI 10.1016/j.molcel.2010.05.021; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Ristic M, 2016, METHODS MOL BIOL, V1449, P279, DOI 10.1007/978-1-4939-3756-1_17; Straub T, 2005, STABLE CHROMOSOMAL A, P352; Straub T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000302; Thomae AW, 2013, DEV CELL, V27, P412, DOI 10.1016/j.devcel.2013.10.001; Vaughan L, 2015, CELL REP, V10, P88, DOI 10.1016/j.celrep.2014.12.012; Villa R, 2016, NATURE, V537, P244, DOI 10.1038/nature19338; Villa R, 2012, MOL CELL, V48, P647, DOI 10.1016/j.molcel.2012.09.012; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Zheng S, 2014, STRUCTURAL BASIS X C, P2652	47	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177408	10.1371/journal.pone.0177408	http://dx.doi.org/10.1371/journal.pone.0177408			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28510597	Green Submitted, gold, Green Published			2022-12-26	WOS:000401485500027
J	Benavente, ED; Ward, Z; Chan, W; Mohareb, FR; Sutherland, CJ; Roper, C; Campino, S; Clark, TG				Benavente, Ernest Diez; Ward, Zoe; Chan, Wilson; Mohareb, Fady R.; Sutherland, Colin J.; Roper, Cally; Campino, Susana; Clark, Taane G.			Genomic variation in Plasmodium vivax malaria reveals regions under selective pressure	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; RESISTANCE-CONFERRING MUTATIONS; GENETIC DIVERSITY; DRUG-RESISTANCE; POPULATIONS; EVOLUTION; CHLOROQUINE; ORIGINS; PVMDR1; ASIA	Background Although Plasmodium vivax contributes to almost half of all malaria cases outside Africa, it has been relatively neglected compared to the more deadly P. falciparum. It is known that P. vivax populations possess high genetic diversity, differing geographically potentially due to different vector species, host genetics and environmental factors. Results We analysed the high-quality genomic data for 46 P. vivax isolates spanning 10 countries across 4 continents. Using population genetic methods we identified hotspots of selection pressure, including the previously reported MRP1 and DHPS genes, both putative drug resistance loci. Extra copies and deletions in the promoter region of another drug resistance candidate, MDR1 gene, and duplications in the Duffy binding protein gene (PvDBP) potentially involved in erythrocyte invasion, were also identified. For surveillance applications, continental-informative markers were found in putative drug resistance loci, and we show that organellar polymorphisms could classify P. vivax populations across continents and differentiate between Plasmodia spp. Conclusions This study has shown that genomic diversity that lies within and between P. vivax populations can be used to elucidate potential drug resistance and invasion mechanisms, as well as facilitate the molecular barcoding of the parasite for surveillance applications.	[Benavente, Ernest Diez; Ward, Zoe; Chan, Wilson; Sutherland, Colin J.; Roper, Cally; Campino, Susana; Clark, Taane G.] London Sch Hyg & Trop Med, Keppel St, London, England; [Ward, Zoe] Cranfield Univ, Sch Water Energy & Environm, Bioinformat Grp, Cranfield, Beds, England; [Chan, Wilson; Mohareb, Fady R.] Univ Calgary, Dept Pathol & Lab Med, Diagnost & Sci Ctr, Fac Med, Calgary, AB, Canada	University of London; London School of Hygiene & Tropical Medicine; Cranfield University; University of Calgary	Clark, TG (corresponding author), London Sch Hyg & Trop Med, Keppel St, London, England.	taane.clark@lshtm.ac.uk	Mohareb, Fady/O-1952-2019; Sutherland, Colin/AAN-3939-2020; Campino, Susana/AAM-2577-2020; Clark, Taane G./AAM-2570-2020; Roper, Cally/K-2989-2013	Mohareb, Fady/0000-0002-7880-2519; Sutherland, Colin/0000-0003-1592-6407; Campino, Susana/0000-0003-1403-6138; Clark, Taane G./0000-0001-8985-9265; Diez Benavente, Ernest/0000-0002-4313-4290; Ward, Zoe/0000-0003-0334-6659; Roper, Cally/0000-0002-6545-309X	Medical Research Council UK [MR/K000551/1, MR/M01360X/1, MR/N010469/1, MC_PC_15103]; MRC UK; MRC [MR/M01360X/1] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	TGC receives funding from the Medical Research Council UK (grant numbers MR/K000551/1, MR/M01360X/1, MR/N010469/1, MC_PC_15103). CR and SC are funded by the Medical Research Council UK (grant no. MR/M01360X/1). The funding body had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.; We thank Samuel Assefa, Francesc Coll, and Mark Preston for providing computing support. Sequence data were analysed using the MRC UK funded eMedlab computing resource.	Arnott A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-14; Assefa SA, 2014, BIOINFORMATICS, V30, P1292, DOI 10.1093/bioinformatics/btu005; Auburn S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053160; Baniecki ML, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003539; Barnadas C, 2008, ANTIMICROB AGENTS CH, V52, P4233, DOI 10.1128/AAC.00578-08; Brega S, 2005, J INFECT DIS, V191, P272, DOI 10.1086/426830; Bright AT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-262; Campino S, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1254-1; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cornejo OE, 2015, GENOME BIOL EVOL, V7, P106, DOI 10.1093/gbe/evu267; Dharia NV, 2010, P NATL ACAD SCI USA, V107, P20045, DOI 10.1073/pnas.1003776107; Flannery EL, 2015, ACS INFECT DIS, V1, P367, DOI 10.1021/acsinfecdis.5b00049; Franca CT, 2016, PLOS NEGLECT TROP D, V10, DOI [10.1371/journal.pntd.0004639, 10.1371/journal.pntd.0005091]; Gunawardena S, 2010, AM J TROP MED HYG, V82, P235, DOI 10.4269/ajtmh.2010.09-0588; Hawkins VN, 2007, TRENDS PARASITOL, V23, P213, DOI 10.1016/j.pt.2007.03.002; Hawkins VN, 2009, AM J TROP MED HYG, V81, P348, DOI 10.4269/ajtmh.2009.81.348; Hawkins VN, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-72; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Holsinger KE, 2009, NAT REV GENET, V10, P639, DOI 10.1038/nrg2611; Hupalo DN, 2016, NAT GENET, V48, P953, DOI 10.1038/ng.3588; Imwong M, 2006, MOL BIOL EVOL, V23, P1016, DOI 10.1093/molbev/msj116; Imwong M, 2008, ANTIMICROB AGENTS CH, V52, P2657, DOI 10.1128/AAC.01459-07; Imwong M, 2007, INT J PARASITOL, V37, P1013, DOI 10.1016/j.ijpara.2007.02.010; Kim JY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151514; Koepfli C, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003872; Kryazhimskiy S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000304; Lu F, 2010, AM J TROP MED HYG, P83; Lu F, 2011, ACTA TROP, V117, P69, DOI 10.1016/j.actatropica.2010.08.011; Menard D, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002489; Molina-Cruz A, 2013, SCIENCE, V340, P984, DOI 10.1126/science.1235264; Neafsey DE, 2012, NAT GENET, V44, P1046, DOI 10.1038/ng.2373; Ocholla H, 2014, J INFECT DIS, V210, P1991, DOI 10.1093/infdis/jiu349; Ord R, 2005, MOL BIOCHEM PARASIT, V144, P86, DOI 10.1016/j.molbiopara.2005.08.005; Pain A, 2008, NATURE, V455, P799, DOI 10.1038/nature07306; Parobek CM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002796; Pearson RD, 2016, NAT GENET, V48, P959, DOI 10.1038/ng.3599; Preston MD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5052; Rungsihirunrat K, 2007, AM J TROP MED HYG, V76, P1057, DOI 10.4269/ajtmh.2007.76.1057; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Samad H, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005131; Saralamba N, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1543-8; Schousboe ML, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004196; Shen HX, 2015, MATER RES-IBERO-AM J, V18, P66, DOI 10.1590/1516-1439.325514; Sinka ME, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-89; Suwanarusk R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001089; Tachibana M, 2015, VACCINE, V33, P1901, DOI 10.1016/j.vaccine.2015.03.008; TAJIMA F, 1989, GENETICS, V123, P585; TRIGLIA T, 1994, P NATL ACAD SCI USA, V91, P7149, DOI 10.1073/pnas.91.15.7149; Vallejo AF, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1263-0; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; WHO, WORLD MAL REP 2013; Winter DJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004252	53	16	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177134	10.1371/journal.pone.0177134	http://dx.doi.org/10.1371/journal.pone.0177134			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493919	Green Published, Green Accepted, gold			2022-12-26	WOS:000401314300063
J	Canizares, M; Hogg-Johnson, S; Gignac, MAM; Glazier, RH; Badley, EM				Canizares, Mayilee; Hogg-Johnson, Sheilah; Gignac, Monique A. M.; Glazier, Richard H.; Badley, Elizabeth M.			Changes in the use practitioner-based complementary and alternative medicine over time in Canada: Cohort and period effects	PLOS ONE			English	Article							HEALTH-CARE; CAM USE; UNITED-STATES; AGE; ADULTS; PAIN; THERAPIES; TRENDS; SELF; PREVALENCE	Background The use of complementary and alternative medicine (CAM) is growing. However the factors contributing to changes over time and to birth cohort differences in CAM use are not well understood. Setting We used data from 10186 participants, who were aged 20-69 years at the first cycle of data collection in the longitudinal component of the Canadian National Population Health Survey (1994/95-2010/11). We examined chiropractic and other practitioner-based CAM use with a focus on five birth cohorts: pre-World War II (born 1925-1934); World War II (born 1935-1944); older baby boomers (born 1945-1954); younger baby boomers (born 1955-1964); and Gen Xers (born 1965-1974). The survey collected data every two years on predisposing (e.g., sex, education), enabling (e.g., income), behavior-related factors (e.g., obesity), need (e.g., chronic conditions), and use of conventional care (primary care and specialists). Results The findings suggest that, at corresponding ages, more recent cohorts reported greater CAM (OR = 25.9, 95% CI: 20.0; 33.6 for Gen Xers vs. pre-World War) and chiropractic use than their predecessors (OR = 2.2, 95% CI: 1.7; 2.8 for Gen Xers vs. pre-World War). There was also a secular trend of increasing CAM use, but not chiropractic use, over time (period effect) across all ages. Factors associated with cohort differences were different for CAM and chiropractic use. Cohort differences in CAM use were partially related to a period effect of increasing CAM use over time across all ages while cohort differences in chiropractic use were related to the higher prevalence of chronic conditions among recent cohorts. The use of conventional care was positively related to greater CAM use (OR = 1.8, 95% CI: 1.6; 2.0)	[Canizares, Mayilee] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Canizares, Mayilee; Gignac, Monique A. M.; Badley, Elizabeth M.] Univ Hlth Network, Krembil Res Inst, Toronto, ON, Canada; [Hogg-Johnson, Sheilah; Gignac, Monique A. M.; Glazier, Richard H.; Badley, Elizabeth M.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Hogg-Johnson, Sheilah; Gignac, Monique A. M.] Inst Work & Hlth, Toronto, ON, Canada; [Glazier, Richard H.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Glazier, Richard H.] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada; [Glazier, Richard H.] St Michaels Hosp, Dept Family & Community Med, Toronto, ON, Canada	University of Toronto; Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Institute for Work & Health; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Canizares, M (corresponding author), Univ Toronto, Inst Med Sci, Toronto, ON, Canada.; Canizares, M (corresponding author), Univ Hlth Network, Krembil Res Inst, Toronto, ON, Canada.	mcanizar@uhnres.utoronto.ca		Badley, Elizabeth/0000-0002-6045-2549	CIHR Operating Grant Secondary Analysis of Databases [SEC 117113]	CIHR Operating Grant Secondary Analysis of Databases	Access to the data is through the Statistics Canada Research Data Centres (RDC) Program. RDCs are operated under the provisions of the Statistics Act in accordance with all the confidentiality rules. The findings and conclusions of this paper are those of the authors and do not represent the official position of Statistics Canada. This study was partially supported by a CIHR Operating Grant Secondary Analysis of Databases (SEC 117113). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshar S, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2008-7; Ahn AC, 2006, AM J PUBLIC HEALTH, V96, P647, DOI 10.2105/AJPH.2004.048496; Astin JA, 1998, ARCH INTERN MED, V158, P2303, DOI 10.1001/archinte.158.21.2303; Ayers SL, 2012, HEALTH SERV RES, V47, P2081, DOI 10.1111/j.1475-6773.2012.01406.x; Ayers SL, 2010, HEALTH-LONDON, V14, P234, DOI 10.1177/1363459309347491; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bell A, 2014, SOC SCI MED, V120, P21, DOI 10.1016/j.socscimed.2014.09.008; Bell A, 2013, SOC SCI MED, V93, P163, DOI 10.1016/j.socscimed.2013.04.029; Bishop FL, 2010, EVID-BASED COMPL ALT, V7, P11, DOI 10.1093/ecam/nen023; Brown C, 2009, J ALTERN COMPLEM MED, V15, P911, DOI 10.1089/acm.2008.0561; Busse JW, 2005, MAYO CLIN P, P80; Canadian Institute for Health Information, CANADAS HEALTH CARE; Canizares M, 2017, J GERONTOL B-PSYCHOL; Carle AC, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-49; Clarke TC, 2015, NATL HLTH STAT REPOR, P1; Coulter ID, 2004, MED J AUSTRALIA, V180, P587, DOI 10.5694/j.1326-5377.2004.tb06099.x; Davis MA, 2011, HEALTH SERV RES, V46, P1402, DOI 10.1111/j.1475-6773.2011.01270.x; Deloitte Center for Health Solutions, THE QUEST FOR VALUE; Eisenberg DM, 2001, ANN INTERN MED, V135, P344, DOI 10.7326/0003-4819-135-5-200109040-00011; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Esmail N, 2007, COMPLEMENTARY AND AL; Faith J, 2015, ALTERN THER HEALTH M, V21, P30; Feinglass J, 2007, CLIN J PAIN, V23, P744, DOI 10.1097/AJP.0b013e31815349d4; Foster MM, 2010, HEALTH POLICY, V97, P105, DOI 10.1016/j.healthpol.2010.04.005; Fries C. J., 2012, Issues in health and health care related to race/ethnicity, immigration, SES and gender, P113; Fries CJ, 2013, HEALTH SOCIOL REV, V22, P37, DOI 10.5172/hesr.2013.22.1.37; Grzywacz JG, 2008, AM J HEALTH BEHAV, V32, P650, DOI 10.5555/ajhb.2008.32.6.650; Grzywacz JG, 2007, J HEALTH SOC BEHAV, V48, P84, DOI 10.1177/002214650704800106; Harris PE, 2012, INT J CLIN PRACT, V66, P924, DOI 10.1111/j.1742-1241.2012.02945.x; Hirschkorn KA, 2009, CAN REV SOCIOL, V46, P143, DOI 10.1111/j.1755-618X.2009.01208.x; Ho TF, 2014, J AM BOARD FAM MED, V27, P465, DOI 10.3122/jabfm.2014.04.130238; Kelner M, 1997, SOC SCI MED, V45, P203, DOI 10.1016/S0277-9536(96)00334-6; Kessler RC, 2001, ANN INTERN MED, V135, P262, DOI 10.7326/0003-4819-135-4-200108210-00011; Lapane KL, 2012, OSTEOARTHR CARTILAGE, V20, P22, DOI 10.1016/j.joca.2011.10.005; Lawrence Dana J, 2007, Chiropr Osteopat, V15, P2, DOI 10.1186/1746-1340-15-2; Lind BK, 2010, J ALTERN COMPLEM MED, V16, P411, DOI 10.1089/acm.2009.0261; McFarland B, 2002, AM J PUBLIC HEALTH, V92, P1616, DOI 10.2105/AJPH.92.10.1616; Metcalfe A, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-58; Mior SA, 2008, J MANIP PHYSIOL THER, V31, P104, DOI 10.1016/j.jmpt.2007.12.007; Moffatt S, 2012, AGEING SOC, V32, P725, DOI 10.1017/S0144686X11000602; Murthy V, 2014, CLIN RHEUMATOL, V33, P253, DOI 10.1007/s10067-013-2357-5; Nahin RL, 2010, BMC HEALTH SERV RES, P10; Neiberg RH, 2011, J ALTERN COMPLEM MED, V17, P363, DOI 10.1089/acm.2009.0157; Pagan JA, 2005, HEALTH AFFAIR, V24, P255, DOI 10.1377/hlthaff.24.1.255; Rabe-Hesketh S, 2006, J R STAT SOC A STAT, V169, P805, DOI 10.1111/j.1467-985X.2006.00426.x; Redwood D, 2008, J ALTERN COMPLEM MED, V14, P361, DOI 10.1089/acm.2007.0766; Reither EN, 2015, SOC SCI MED, V128, P356, DOI 10.1016/j.socscimed.2015.01.011; Rochelle TL, 2010, BRIT J HEALTH PSYCH, V15, P715, DOI 10.1348/135910709X479195; Rosenthal M, 2002, MILBANK Q, V80, P41, DOI 10.1111/1468-0009.00003; SAS Institute Inc, 2013, SAS STAT 9 3 US GUID; Sirois FM, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-16; Statistics Canada, 2011, INFORMATION ABOUT TH; Sulik GA, 2008, NO LONGER PATIENT SO, P3; Suzuki E, 2012, SOC SCI MED, V75, P452, DOI 10.1016/j.socscimed.2012.03.036; Tindle HA, 2005, ALTERN THER HEALTH M, V11, P42; Vallerand AH, 2003, AM J PUBLIC HEALTH, V93, P923, DOI 10.2105/AJPH.93.6.923; Ventola C Lee, 2010, P T, V35, P461; Villanueva-Russell Y, 2011, SOC SCI MED, V72, P1826, DOI 10.1016/j.socscimed.2011.03.038; Votova K, 2010, J ALTERN COMPLEM MED, V16, P995, DOI 10.1089/acm.2009.0628; Weigel P, 2010, CHIROPR OSTEO, V18, P1; Yang SB, 2013, CLIN THER, V35, P1690, DOI 10.1016/j.clinthera.2013.09.022; Yang Y, 2013, AGE PERIOD COHORT AN, Vxiii	62	21	21	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177307	10.1371/journal.pone.0177307	http://dx.doi.org/10.1371/journal.pone.0177307			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UP	28494011	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314300084
J	D'Aquila, PS; Galistu, A				D'Aquila, Paolo S.; Galistu, Adriana			Within-session decrement of the emission of licking bursts following reward devaluation in rats licking for sucrose	PLOS ONE			English	Article							MEDIATED BEHAVIORAL ACTIVATION; NUCLEUS-ACCUMBENS DOPAMINE; D2-LIKE RECEPTORS; DEPRIVED RATS; MICROSTRUCTURAL ANALYSIS; INCENTIVE SALIENCE; INGESTIVE BEHAVIOR; NACL SOLUTIONS; D1-LIKE; PIMOZIDE	We previously observed that dopamine D2-like receptor blockade in rats licking for sucrose produced a within-session decrement of the emission of licking bursts similar to the effect of either reward devaluation, or neuroleptics, on operant responding for different rewards, which, accordingly, we interpreted as an extinction-like effect. This implies that exposing animals to reward devaluation would result in a drop of burst number taking place only after the contact with the devalued reward. To test this prediction, we compared the difference in the within-session time course of burst number in response to high (10%) versus low (2%) concentration sucrose solutions, either in a condition of reward devaluation (exposure to 2% after daily 10%), or in a condition which does not involve changes in the reward value (two groups of subjects each repeatedly exposed to only one of the two concentrations). Reward devaluation resulted in a within-session decrement of the burst number, with the response rate dropping only after the contact with the devalued reward, as predicted. This response pattern was reliably observed only in subjects at their first devaluation experience. In contrast, exposure of separate groups of animals to the two different concentrations yielded lower levels of burst number in the low concentration group apparent since the beginning of the session, as previously observed with dopamine D1-like receptor blockade. These results show that the analysis of burst number, but not of burst size, reveals a specific activation pattern in response to reward devaluation, which differs from the pattern observed comparing the response to two different sucrose concentrations in separate groups of subjects, i.e. in a condition not involving reward devaluation. Finally, the characterisation of the experimental measures of the analysis of licking microstructure in behaviourally (and psychologically) meaningful functional terms, might be relevant for the investigation of the mechanisms underlying behavioural activation and the related evaluation processes.	[D'Aquila, Paolo S.; Galistu, Adriana] Univ Sassari, Dipartimento Sci Biomed, Sassari, Italy	University of Sassari	D'Aquila, PS (corresponding author), Univ Sassari, Dipartimento Sci Biomed, Sassari, Italy.	dsfpaolo@uniss.it	D'Aquila, Paolo S./H-5389-2011	D'Aquila, Paolo S./0000-0002-7885-9988	Fondazione Banco di Sardegna, Italy [U5002013/A.I.424MGB]	Fondazione Banco di Sardegna, Italy(Fondazione Banco di Sardegna)	This work was funded by Fondazione Banco di Sardegna, Italy (www.fondazionedisardegna.it, Grant N. U5002013/A.I.424MGB to PSD). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austen JM, 2016, PHYSIOL BEHAV, V167, P92, DOI 10.1016/j.physbeh.2016.09.001; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Berridge KC, 2012, EUR J NEUROSCI, V35, P1124, DOI 10.1111/j.1460-9568.2012.07990.x; Canu ME, 2010, PHARMACOL BIOCHEM BE, V96, P194, DOI 10.1016/j.pbb.2010.05.004; D'Aquila PS, 2012, PHARMACOL BIOCHEM BE, V101, P99, DOI 10.1016/j.pbb.2011.12.004; D'Aquila PS, 2012, NEUROPHARMACOLOGY, V62, P1717, DOI 10.1016/j.neuropharm.2011.11.018; D'Aquila PS, 2010, NEUROPHARMACOLOGY, V58, P1085, DOI 10.1016/j.neuropharm.2010.01.017; DAVIS JD, 1989, ANN NY ACAD SCI, V575, P106; DAVIS JD, 1992, BEHAV NEUROSCI, V106, P217, DOI 10.1037/0735-7044.106.1.217; Frisina PG, 2002, PHARMACOL BIOCHEM BE, V74, P163, DOI 10.1016/S0091-3057(02)00995-4; Galistu A, 2013, PSYCHOPHARMACOLOGY, V229, P357, DOI 10.1007/s00213-013-3110-0; Galistu A, 2012, PHYSIOL BEHAV, V105, P230, DOI 10.1016/j.physbeh.2011.08.006; Galistu A, 2011, PSYCHOPHARMACOLOGY, V216, P411, DOI 10.1007/s00213-011-2237-0; GEARY N, 1985, PHARMACOL BIOCHEM BE, V22, P787, DOI 10.1016/0091-3057(85)90528-3; Genn RF, 2003, BEHAV PHARMACOL, V14, P609, DOI 10.1097/00008877-200312000-00005; GRAMLING SE, 1986, PHARMACOL BIOCHEM BE, V25, P219, DOI 10.1016/0091-3057(86)90256-X; GRAMLING SE, 1984, PHARMACOL BIOCHEM BE, V21, P617, DOI 10.1016/S0091-3057(84)80047-7; GRIGSON PS, 1993, PHYSIOL BEHAV, V54, P909, DOI 10.1016/0031-9384(93)90301-U; Higgs S, 1998, PSYCHOPHARMACOLOGY, V139, P342, DOI 10.1007/s002130050725; Jimenez-Garcia AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164331; Liao R M, 1995, Chin J Physiol, V38, P65; Lin JY, 2012, PHYSIOL BEHAV, V106, P515, DOI 10.1016/j.physbeh.2012.03.029; Moore JD, 2014, TRENDS NEUROSCI, V37, P370, DOI 10.1016/j.tins.2014.05.001; Robles CF, 2017, BEHAV BRAIN RES, V320, P431, DOI 10.1016/j.bbr.2016.10.043; Salamone JD, 2005, CURR OPIN PHARMACOL, V5, P34, DOI 10.1016/j.coph.2004.09.004; Salamone JD, 1997, NEUROSCI BIOBEHAV R, V21, P341, DOI 10.1016/S0149-7634(96)00017-6; Salamone JD, 2016, BRAIN, V139, P1325, DOI 10.1093/brain/aww050; Salamone JD, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.013.2009; SANGER DJ, 1986, PSYCHOPHARMACOLOGY, V89, P98; SCHNEIDER LH, 1990, EUR J PHARMACOL, V186, P61, DOI 10.1016/0014-2999(90)94060-B; Schneider LH, 1989, APPETITE, V12, P236; Sclafani A, 2004, PHYSIOL BEHAV, V82, P89, DOI 10.1016/j.physbeh.2004.04.045; SCLAFANI A, 1987, NEUROSCI BIOBEHAV R, V11, P169, DOI 10.1016/S0149-7634(87)80022-2; Smith GP, 2004, APPETITE, V43, P11, DOI 10.1016/j.appet.2004.02.006; Smith GP, 2001, APPETITE, V36, P84, DOI 10.1006/appe.2000.0371; Spector AC, 1998, BEHAV NEUROSCI, V112, P678, DOI 10.1037/0735-7044.112.3.678; WEINGARTEN HP, 1982, PHYSIOL BEHAV, V28, P401, DOI 10.1016/0031-9384(82)90131-7; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; WISE RA, 1978, SCIENCE, V201, P262, DOI 10.1126/science.566469	39	10	10	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177705	10.1371/journal.pone.0177705	http://dx.doi.org/10.1371/journal.pone.0177705			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493981	Green Published, gold			2022-12-26	WOS:000401314300152
J	Douglas, SM; Chubiz, LM; Harcombe, WR; Marx, CJ				Douglas, Sarah M.; Chubiz, Lon M.; Harcombe, William R.; Marx, Christopher J.			Identification of the potentiating mutations and synergistic epistasis that enabled the evolution of inter-species cooperation	PLOS ONE			English	Article							S-ADENOSYLMETHIONINE SYNTHETASE; ESCHERICHIA-COLI POPULATION; METHIONINE BIOSYNTHESIS; SALMONELLA-TYPHIMURIUM; BENEFICIAL MUTATIONS; MICROBIAL MUTUALISM; KEY INNOVATION; ADAPTATION; MUTANTS; DYNAMICS	Microbes often engage in cooperation through releasing biosynthetic compounds required by other species to grow. Given that production of costly biosynthetic metabolites is generally subjected to multiple layers of negative feedback, single mutations may frequently be insufficient to generate cooperative phenotypes. Synergistic epistatic interactions between multiple coordinated changes may thus often underlie the evolution of cooperation through overproduction of metabolites. To test the importance of synergistic mutations in cooperation we used an engineered bacterial consortium of an Escherichia coli methionine auxotroph and Salmonella enterica. S. enterica relies on carbon by-products from E. coli if lactose is the only carbon source. Directly selecting wild-type S. enterica in an environment that favored cooperation through secretion of methionine only once led to a methionine producer, and this producer both took a long time to emerge and was not very effective at cooperating. On the other hand, when an initial selection for resistance of S. enterica to a toxic methionine analog, ethionine, was used, subsequent selection for cooperation with E. coli was rapid, and the resulting double mutants were much more effective at cooperation. We found that potentiating mutations in metJ increase expression of metA, which encodes the first step of methionine biosynthesis. This increase in expression is required for the previously identified actualizing mutations in metA to generate cooperation. This work highlights that where biosynthesis of metabolites involves multiple layers of regulation, significant secretion of those metabolites may require multiple mutations, thereby constraining the evolution of cooperation.	[Douglas, Sarah M.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Douglas, Sarah M.; Chubiz, Lon M.; Harcombe, William R.; Marx, Christopher J.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Chubiz, Lon M.] Univ Missouri, Dept Biol, St Louis, MO 63121 USA; [Harcombe, William R.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Marx, Christopher J.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; [Marx, Christopher J.] Univ Idaho, Inst Bioinformat & Evolutionary Studies, Moscow, ID 83843 USA; [Marx, Christopher J.] Univ Idaho, Ctr Modeling Complex Interact, Moscow, ID 83843 USA	Harvard University; Harvard University; University of Missouri System; University of Missouri Saint Louis; University of Minnesota System; University of Minnesota Twin Cities; Idaho; University of Idaho; Idaho; University of Idaho; Idaho; University of Idaho	Marx, CJ (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.; Marx, CJ (corresponding author), Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA.; Marx, CJ (corresponding author), Univ Idaho, Inst Bioinformat & Evolutionary Studies, Moscow, ID 83843 USA.; Marx, CJ (corresponding author), Univ Idaho, Ctr Modeling Complex Interact, Moscow, ID 83843 USA.	cmarx@uidaho.edu			US Department of Energy [DE-SC0006731]	US Department of Energy(United States Department of Energy (DOE))	CJM recognizes funding from the US Department of Energy (DE-SC0006731). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Blount ZD, 2008, P NATL ACAD SCI USA, V105, P7899, DOI 10.1073/pnas.0803151105; Blount ZD, 2012, NATURE, V489, P513, DOI 10.1038/nature11514; Brown KM, 2009, MOL BIOL EVOL, V26, P2455, DOI 10.1093/molbev/msp151; Bull JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004115; Burch CL, 2000, NATURE, V406, P625, DOI 10.1038/35020564; CAIRNS J, 1988, NATURE, V335, P142, DOI 10.1038/335142a0; Chou HH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004149; Chou HH, 2011, SCIENCE, V332, P1190, DOI 10.1126/science.1203799; Chou HH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000652; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Douglas SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161837; Ellermeier CD, 2002, GENE, V290, P153, DOI 10.1016/S0378-1119(02)00551-6; Finkel SE, 2006, NAT REV MICROBIOL, V4, P113, DOI 10.1038/nrmicro1340; Fischbach MA, 2011, CELL HOST MICROBE, V10, P336, DOI 10.1016/j.chom.2011.10.002; GREENE RC, 1970, BIOCHEM BIOPH RES CO, V38, P1120, DOI 10.1016/0006-291X(70)90355-4; HALL BG, 1993, METHOD ENZYMOL, V224, P603, DOI 10.1016/0076-6879(93)24045-V; Harcombe W, 2010, EVOLUTION, V64, P2166, DOI 10.1111/j.1558-5646.2010.00959.x; Harcombe WR, 2014, CELL REP, V7, P1104, DOI 10.1016/j.celrep.2014.03.070; HEGEMAN GD, 1970, ANNU REV MICROBIOL, V24, P429, DOI 10.1146/annurev.mi.24.100170.002241; Hillesland KL, 2014, P NATL ACAD SCI USA, V111, P14822, DOI 10.1073/pnas.1407986111; Hillesland KL, 2010, P NATL ACAD SCI USA, V107, P2124, DOI 10.1073/pnas.0908456107; HOBSON AC, 1973, MOL GEN GENET, V126, P7, DOI 10.1007/BF00333477; Jarvik T, 2010, J BACTERIOL, V192, P560, DOI 10.1128/JB.01233-09; Khan AI, 2011, SCIENCE, V332, P1193, DOI 10.1126/science.1203801; Kiers ET, 2011, SCIENCE, V333, P880, DOI 10.1126/science.1208473; Kryazhimskiy S, 2014, SCIENCE, V344, P1519, DOI 10.1126/science.1250939; Kryazhimskiy S, 2009, P NATL ACAD SCI USA, V106, P18638, DOI 10.1073/pnas.0905497106; Kvitek DJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002056; LaMonte BL, 2006, MICROBIOL-SGM, V152, P1451, DOI 10.1099/mic.0.28489-0; LAWRENCE DA, 1968, GENETICS, V58, P473; LAWRENCE DA, 1972, J BACTERIOL, V109, P8, DOI 10.1128/JB.109.1.8-11.1972; McCutcheon JP, 2012, NAT REV MICROBIOL, V10, P13, DOI 10.1038/nrmicro2670; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Na D, 2011, J BIOTECHNOL, V153, P35, DOI 10.1016/j.jbiotec.2011.03.004; OLD IG, 1991, PROG BIOPHYS MOL BIO, V56, P145, DOI 10.1016/0079-6107(91)90012-H; Pande S, 2016, ISME J, V10, P1413, DOI 10.1038/ismej.2015.212; Pande S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7238; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Plucain J, 2014, SCIENCE, V343, P1366, DOI 10.1126/science.1248688; Quandt EM, 2015, ELIFE, V4, DOI 10.7554/eLife.09696; Quandt EM, 2014, P NATL ACAD SCI USA, V111, P2217, DOI 10.1073/pnas.1314561111; Rakoff-Nahoum S, 2016, NATURE, V533, P255, DOI 10.1038/nature17626; Rokyta DR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002075; Shimoyama T, 2009, SCIENCE, V323, P1574, DOI 10.1126/science.1170086; Stolyar S, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100131; SU CH, 1971, P NATL ACAD SCI USA, V68, P367, DOI 10.1073/pnas.68.2.367; UMBARGER HE, 1969, ANNU REV BIOCHEM, V38, P323, DOI 10.1146/annurev.bi.38.070169.001543; URBANOWSKI ML, 1985, NUCLEIC ACIDS RES, V13, P673, DOI 10.1093/nar/13.3.673; Usuda Y, 2005, APPL ENVIRON MICROB, V71, P3228, DOI 10.1128/AEM.71.6.3228-3234.2005; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Wilson K., 2001, CURRENT PROTOCOLS MO, P241; Wiser MJ, 2013, SCIENCE, V342, P1364, DOI 10.1126/science.1243357; Woods RJ, 2011, SCIENCE, V331, P1433, DOI 10.1126/science.1198914; Zamboni N, 2009, NAT PROTOC, V4, P878, DOI 10.1038/nprot.2009.58; Zelezniak A, 2015, P NATL ACAD SCI USA, V112, P6449, DOI 10.1073/pnas.1421834112	57	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0174345	10.1371/journal.pone.0174345	http://dx.doi.org/10.1371/journal.pone.0174345			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493869	Green Published, gold			2022-12-26	WOS:000401314300004
J	Khalid, M; Hassani, D; Bilal, M; Liao, JL; Huang, DF				Khalid, Muhammad; Hassani, Danial; Bilal, Muhammad; Liao, Jianli; Huang, Danfeng			Elevation of secondary metabolites synthesis in Brassica campestris ssp chinensis L. via exogenous inoculation of Piriformospora indica with appropriate fertilizer	PLOS ONE			English	Article							LETTUCE LACTUCA-SATIVA; ANTIOXIDANT ACTIVITY; PLANT-GROWTH; MEDICINAL-PLANT; ARABIDOPSIS; LEAVES; POLYPHENOLS; EXPRESSION; PHENOLICS; IMPACT	This work evaluated the impact of exogenous soil inoculation of beneficial fungal strain Piriformospora indica on phytochemical changes and the related genes expression of Chinese cabbage (Brassica campestris ssp. chinensis L.) by greenhouse pot experiments. High performance liquid chromatography (HPLC) affirmed that among the different combinations of fungal and organic fertilizer treatments, the phenolic acids and flavonoids were considerably enriched in organic fertilizer and fungi (OP) followed by organic fertilizer, biochar, fungi (OBP) treated plants. The antiradical activity was higher in OP (61.29%) followed by P (60%) and organic fertilizer (OF) (53.84%) inoculated plants which positively correlated with chlorophyll, carotenoids and flavonoids level (P<0.05). Furthermore, results showed that the exogenous application of P. indica significantly (P<0.05) enhanced plant growth, as well as stimulating the activation of chlorophyll, carotenoids and other antioxidant related pathways. The RT-qPCR analysis indicated that key FLS gene triggering the synthesis of kaemferol was up-regulated by the inoculation of P. indica. In conclusion, the results revealed that organic fertilizer and P. indica (OP) is the most appropriate combination for improving phytochemical and antiradical properties in Pakchoi.	[Khalid, Muhammad; Hassani, Danial; Liao, Jianli; Huang, Danfeng] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai, Peoples R China; [Bilal, Muhammad] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Microbial Metab, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Huang, DF (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai, Peoples R China.	hdf@sjtu.edu.cn	Khalid, Muhammad/AAU-4383-2021; Hassani, Danial/AGZ-8246-2022; Bilal, Muhammad/AAH-6461-2020	Hassani, Danial/0000-0001-8024-0837; Bilal, Muhammad/0000-0001-5388-3183	National High-tech R&D Program of China (863 Program) [2013AA103000]; Shanghai Agriculture Applied Technology Development Program, China [T20140502]	National High-tech R&D Program of China (863 Program)(National High Technology Research and Development Program of China); Shanghai Agriculture Applied Technology Development Program, China	This research was supported in part by the National High-tech R&D Program of China (863 Program) (Grant No. 2013AA103000) and Shanghai Agriculture Applied Technology Development Program, China (Grant No. T20140502).	Abadi VAJM, 2016, SYMBIOSIS, V69, P9, DOI 10.1007/s13199-015-0361-z; Achatz B, 2010, PLANT SOIL, V333, P59, DOI 10.1007/s11104-010-0319-0; Ackland ML, 2005, IN VIVO, V19, P69; Aron PM, 2008, MOL NUTR FOOD RES, V52, P79, DOI 10.1002/mnfr.200700137; Bagchi DB, 2003, MUTAT RES-FUND MOL M, V523, P87, DOI 10.1016/S0027-5107(02)00324-X; Bagheri A. A., 2013, International Journal of Advanced Biological and Biomedical Research, V1, P1337; Baishya D, 2015, SYMBIOSIS, V66, P37, DOI 10.1007/s13199-015-0331-5; Baltruschat H, 2008, NEW PHYTOL, V180, P501, DOI 10.1111/j.1469-8137.2008.02583.x; Baslam M, 2011, J AGR FOOD CHEM, V59, P5504, DOI 10.1021/jf200501c; Bravo L, 1998, NUTR REV, V56, P317, DOI 10.1111/j.1753-4887.1998.tb01670.x; Caldwell CR, 2006, J FOOD COMPOS ANAL, V19, P637, DOI 10.1016/j.jfca.2005.12.016; Camehl I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002051; Cartea ME, 2011, MOLECULES, V16, P251, DOI 10.3390/molecules16010251; Ceccarelli N, 2010, PLANT SOIL, V335, P311, DOI 10.1007/s11104-010-0417-z; Chu YH, 2000, J SCI FOOD AGR, V80, P561, DOI 10.1002/(SICI)1097-0010(200004)80:5&lt;561::AID-JSFA574&gt;3.0.CO;2-#; Das A, 2012, PLANT SIGNAL BEHAV, V7, P103, DOI 10.4161/psb.7.1.18472; Duthie GG, 2000, NUTR RES REV, V13, P79, DOI 10.1079/095442200108729016; Francisco M, 2010, FOOD RES INT, V43, P1455, DOI 10.1016/j.foodres.2010.04.024; Fresco P, 2010, CURR PHARM DESIGN, V16, P114, DOI 10.2174/138161210789941856; Gawlik-Dziki U, 2011, ACTA SCI POL-HORTORU, V10, P15; GianinazziPearson V, 1996, PLANT CELL, V8, P1871, DOI 10.1105/tpc.8.10.1871; Gil MI, 1999, J AGR FOOD CHEM, V47, P2213, DOI 10.1021/jf981200l; GIOVANNETTI M, 1980, NEW PHYTOL, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; Gould W. D., 1990, Biotechnology of plant-microbe interactions., P287; Harbaum B, 2008, FOOD CHEM, V110, P838, DOI 10.1016/j.foodchem.2008.02.069; Hassani D, 2015, GENET MOL RES, V14, P13425, DOI 10.4238/2015.October.28.4; Hause B, 2005, PLANTA, V221, P184, DOI 10.1007/s00425-004-1436-x; Hegde DM, 1999, INDIAN J AGR SCI, V69, P73; Holm G., 1954, Acta Agriculturae Scandinavica, V4, P457; Jogawat A, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.26891; Johnson J.M., 2011, ENDOCYT CELL RES, V21, P101; Jugran AK, 2015, J SOIL SCI PLANT NUT, V15, P1035; Khan AG, 2000, CHEMOSPHERE, V41, P197, DOI 10.1016/S0045-6535(99)00412-9; Kilam D, 2015, SYMBIOSIS, V66, P149, DOI 10.1007/s13199-015-0347-x; Kim HJ, 2006, J AGR FOOD CHEM, V54, P7263, DOI 10.1021/jf060568c; Kim JD, 2006, J NUTR BIOCHEM, V17, P165, DOI 10.1016/j.jnutbio.2005.06.006; Krishna K, 1991, CURRENT RES, V20, P173; Kumar M, 2011, PLANT SIGNAL BEHAV, V6, P723, DOI 10.4161/psb.6.5.15106; LAMAISON JL, 1990, PHARM ACTA HELV, V65, P315; Lee YC, 2011, MOL PLANT MICROBE IN, V24, P421, DOI 10.1094/MPMI-05-10-0110; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Middleton Jr E, 1994, IMPACT PLANT FLAVONO; Mulabagal V, 2010, FOOD CHEM, V118, P300, DOI 10.1016/j.foodchem.2009.04.119; Oelmuller R, 2009, SYMBIOSIS, V49, P1, DOI 10.1007/s13199-009-0009-y; Pant AP, 2009, J SCI FOOD AGR, V89, P2383, DOI 10.1002/jsfa.3732; Podsedek A, 2007, LWT-FOOD SCI TECHNOL, V40, P1, DOI 10.1016/j.lwt.2005.07.023; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Prasad R, 2013, J BASIC MICROB, V53, P1016, DOI 10.1002/jobm.201200367; Rochfort SJ, 2006, J AGR FOOD CHEM, V54, P4855, DOI 10.1021/jf060154j; Sarwat M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00869; Schliemann W, 2008, PHYTOCHEMISTRY, V69, P112, DOI 10.1016/j.phytochem.2007.06.032; Seeram NP, 2008, J AGR FOOD CHEM, V56, P627, DOI 10.1021/jf071988k; Shen DZ, 1997, AGR ECOSYST ENVIRON, V62, P237, DOI 10.1016/S0167-8809(96)01132-2; Sherameti I, 2005, J BIOL CHEM, V280, P26241, DOI 10.1074/jbc.M500447200; Sherameti I, 2008, MOL PLANT MICROBE IN, V21, P799, DOI 10.1094/MPMI-21-6-0799; SHETTY KG, 1994, ENVIRON POLLUT, V86, P181, DOI 10.1016/0269-7491(94)90189-9; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Smith SE., 1996, MYCORRHIZAL SYMBIOSI; Strasser R. J., 2007, V11, P319; Sun CA, 2010, J PLANT PHYSIOL, V167, P1009, DOI 10.1016/j.jplph.2010.02.013; Swieca M, 2012, SCI HORTIC-AMSTERDAM, V140, P87, DOI 10.1016/j.scienta.2012.04.005; Szaufer-Hajdrych M., 2004, Herba Polonica, V50, P50; Unnikumar KR, 2013, SYMBIOSIS, V60, P107, DOI 10.1007/s13199-013-0246-y; Vadassery J, 2008, MOL PLANT MICROBE IN, V21, P1371, DOI 10.1094/MPMI-21-10-1371; Vadassery J, 2009, J PLANT PHYSIOL, V166, P1263, DOI 10.1016/j.jplph.2008.12.016; Vahabi K, 2016, PLANT SIGNAL BEHAV, V11, DOI 10.1080/15592324.2015.1136763; VARMA A, 1994, ANGEW BOT, V68, P108; Varma A, 1999, APPL ENVIRON MICROB, V65, P2741; Varma A, 2001, PIRIFORMOSPORA INDIC, P125; Vessey JK, 2003, PLANT SOIL, V255, P571, DOI 10.1023/A:1026037216893; Waller F, 2008, J PLANT PHYSIOL, V165, P60, DOI 10.1016/j.jplph.2007.05.017; Wei YZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019455; Wu SC, 2005, GEODERMA, V125, P155, DOI 10.1016/j.geoderma.2004.07.003; Yadav V, 2010, J BIOL CHEM, V285, P26532, DOI 10.1074/jbc.M110.111021; Yochum L, 1999, AM J EPIDEMIOL, V149, P943, DOI 10.1093/oxfordjournals.aje.a009738; Zlotek U, 2014, FOOD CHEM, V148, P253, DOI 10.1016/j.foodchem.2013.10.031	76	23	23	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177185	10.1371/journal.pone.0177185	http://dx.doi.org/10.1371/journal.pone.0177185			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493970	Green Submitted, Green Published, gold			2022-12-26	WOS:000401314300069
J	Wang, Y; Yin, Y; Lan, X; Ye, F; Tian, K; Zhao, XL; Yin, HD; Li, DY; Xu, HY; Liu, YP; Zhu, Q				Wang, Yan; Yin, Yue; Lan, Xi; Ye, Fei; Tian, Kai; Zhao, Xiaoling; Yin, Huadong; Li, Diyan; Xu, Hengyong; Liu, Yiping; Zhu, Qing			Molecular characterization, expression of chicken TBK1 gene and its effect on IRF3 signaling pathway	PLOS ONE			English	Article							KAPPA-B KINASE; TANK-BINDING KINASE-1; VIRUS-INFECTION; IKK-EPSILON; INNATE IMMUNITY; RIG-I; INTERFERON; ACTIVATION; PHOSPHORYLATION; RECOGNITION	TRAF family member-associated NF-kappa B activator (TANK)-binding kinase1 (TBK1) is a serine- threonine kinase at the crossroads of multiple interferon (IFN)-inducing signaling pathways in innate immunity. The importance of TBK1 in antiviral immunity is well established in mammal models, but in chicken, the molecular characterization and potential function of TBK1 remain unclear. In the present study, the open-reading frame (ORF) of chicken TBK1 (chTBK1) was cloned and characterized. The sequencing results revealed that the chTBK1 ORF consists of 2190 base pairs (bp) encoding a deduced protein of 729 amino acid residues. Multiple sequence alignment analysis demonstrated chTBK1 similarity to other birds and mammals, which indicates that it is evolutionarily conserved. Quantitative real-time PCR (qRT-PCR) results showed that chTBK1 was ubiquitously expressed in chicken tissues and expression was especially high in immune tissues. In addition, the expression of chTBK1 was significantly up-regulated by infection with avian leukosis virus subgroup J (ALV-J) both in vivo and in chicken embryo fibroblasts (CEFs) challenged with ALV-J or stimulated with poly I:C in vitro. Consistent with the activation of chTBK1, the interferon regulatory factor 3 (IRF3) and IFN beta gene in CEFs were also up-regulated after challenge with ALV-J or polyI:C. In contrast, the expression of IRF3 and IFN beta in CEFs was significantly reduced by siRNA targeting the chTBK1 gene compared with a negative control (NC) during ALV-J infection or polyI:C transfection. In conclusion, our results demonstrated that chTBK1 may be an important immunoregulator for IRF3 and IFN beta induction in response to viral stimulation in chicken.	[Wang, Yan; Lan, Xi; Ye, Fei; Tian, Kai; Zhao, Xiaoling; Yin, Huadong; Li, Diyan; Xu, Hengyong; Liu, Yiping; Zhu, Qing] Sichuan Agr Univ, Farm Anim Genet Resources Explorat & Innovat Key, Chengdu, Peoples R China; [Yin, Yue] Sichuan Acad Med Sci, Inst Lab Anim, Chengdu, Peoples R China; [Yin, Yue] Sichuan Prov Peoples Hosp, Chengdu, Peoples R China	Sichuan Agricultural University; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital	Zhu, Q (corresponding author), Sichuan Agr Univ, Farm Anim Genet Resources Explorat & Innovat Key, Chengdu, Peoples R China.	zhuqing5959@163.com		Li, Diyan/0000-0001-7490-3550	Twelfth Five Year Plan for Breeding Program in Sichuan [2011NZ0099-7]; thirteenth Five Year Plan for Breeding Program in Sichuan [2016NYZ0050]; China Agriculture Research System [CARS-41]; National Natural Science Foundation of China [31601936]	Twelfth Five Year Plan for Breeding Program in Sichuan; thirteenth Five Year Plan for Breeding Program in Sichuan; China Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the Twelfth Five Year Plan for Breeding Program in Sichuan (No. 2011NZ0099-7), the thirteenth Five Year Plan for Breeding Program in Sichuan (No. 2016NYZ0050), the China Agriculture Research System (No. CARS-41) and National Natural Science Foundation of China (No. 31601936).	Bonnard M, 2000, EMBO J, V19, P4976, DOI 10.1093/emboj/19.18.4976; Brown CC, 1999, J COMP PATHOL, V120, P383, DOI 10.1053/jcpa.1998.0286; Chau TL, 2008, TRENDS BIOCHEM SCI, P33171; Chi H, 2011, FISH SHELLFISH IMMUN, V30, P1055, DOI 10.1016/j.fsi.2011.02.002; Clark K, 2011, BIOCHEM J, V434, P93, DOI 10.1042/BJ20101701; Cysique LA, 2004, J NEUROVIROL, V10, P350, DOI 10.1080/13550280490521078; Feng ZQ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/419256; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; GRANT CE, 1995, NUCLEIC ACIDS RES, V23, P2137, DOI 10.1093/nar/23.12.2137; Hang BL, 2014, VIRUS RES, V188, P8, DOI 10.1016/j.virusres.2014.03.009; Huang B, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-22; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Koop A, 2011, EUR J IMMUNOL, V41, P224, DOI 10.1002/eji.201040814; Larabi A, 2013, CELL REPORTS, P3734; Lee MN, 2013, NAT IMMUNOL, V14, P179, DOI 10.1038/ni.2509; Li XJ, 2009, ARCH BIOCHEM BIOPHYS, V488, P23, DOI 10.1016/j.abb.2009.06.008; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Liniger M, 2012, J VIROL, V86, P705, DOI 10.1128/JVI.00742-11; Liu HX, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-196; Matsui K, 2006, J IMMUNOL, V177, P5785, DOI 10.4049/jimmunol.177.9.5785; May DL, 2000, DNA CELL BIOL, V19, P555, DOI 10.1089/104454900439782; McWhirter SM, 2004, P NATL ACAD SCI USA, V101, P233, DOI 10.1073/pnas.2237236100; Ng SL, 2011, P NATL ACAD SCI USA, V108, P21170, DOI 10.1073/pnas.1119137109; Nociari M, 2009, J VIROL, V83, P4081, DOI 10.1128/JVI.02591-08; Otsuka M, 2005, HEPATOLOGY, V41, P1004, DOI 10.1002/hep.20666; Perry AK, 2004, J EXP MED, V199, P1651, DOI 10.1084/jem.20040528; Rue CA, 2011, J GEN VIROL, V92, P931, DOI 10.1099/vir.0.025486-0; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shu C, 2013, STRUCTURE, V21, P1137, DOI 10.1016/j.str.2013.04.025; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; TBK1, 1999, EMBO J, V18, P6694; Tenoever BR, 2007, SCIENCE, V315, P1274, DOI 10.1126/science.1136567; Tojima Y, 2000, NATURE, V404, P778, DOI 10.1038/35008109; Tu DQ, 2013, CELL REP, V3, P747, DOI 10.1016/j.celrep.2013.01.033; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087	40	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177608	10.1371/journal.pone.0177608	http://dx.doi.org/10.1371/journal.pone.0177608			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493975	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314300144
J	Zhang, P; Li, XM; Zhao, XK; Song, X; Yuan, L; Shen, FF; Fan, ZM; Wang, LD				Zhang, Peng; Li, Xin-Min; Zhao, Xue-Ke; Song, Xin; Yuan, Ling; Shen, Fang-Fang; Fan, Zong-Min; Wang, Li-Dong			Novel genetic locus at MHC region for esophageal squamous cell carcinoma in Chinese populations	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY; RISK; EXPRESSION; CANCER	Background Our previous genome-wide association study (GWAS) identified three independent single nucleotide polymorphisms (SNPs) in human major histocompatibility complex (MHC) region showing association with esophageal squamous cell carcinoma (ESCC). In this study, we increased GWAS sample size on MHC region and performed validation in an independent ESCC cases and normal controls with aim to find additional loci at MHC region showing association with an increased risk to ESCC. Methods The 1,077 ESCC cases and 1,733 controls were genotyped using Illumina Human 610-Quad Bead Chip, and 451 cases and 374 controls were genotyped using Illumina Human 660W-Quad Bead Chip. After quality control, the selected SNPs were replicated by TaqMan genotyping assay on another 2,026 ESCC cases and 2,384 normal controls. Results By excluding low quality SNPs in primary GWAS screening, we selected 2,533 SNPs in MHC region for association analysis, and identified 5 SNPs with p < 10(-4). Further validation analysis in an independent case-control cohort confirmed one of the 5 SNPs (rs911178) that showed significant association with ESCC. rs911178 (P-GWAS = 6.125E-04, OR = 0.644 and P-replication = 1.406E-22, OR = 0.489) was located at upstream of SCAND3. Conclusion The rs911178 (SCAND3 gene) in MHC region is significantly associated with high risk of ESCC. This study not only reveal the potential role of MHC region for the pathogenesis of ESCC, but also provides important clues for the establishment of tools and methods for screening high risk population of ESCC.	[Zhang, Peng; Li, Xin-Min; Zhao, Xue-Ke; Song, Xin; Fan, Zong-Min; Wang, Li-Dong] Zhengzhou Univ, Henan Key Lab Esophageal Canc Res, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China; [Li, Xin-Min] Maternal & Child Hlth Care Hosp Zhengzhou, Dept Pathol, Zhengzhou, Henan, Peoples R China; [Yuan, Ling] Zhengzhou Univ, Henan Canc Hosp, Dept Radiotherapy, Affiliated Canc Hosp, Zhengzhou, Henan, Peoples R China; [Shen, Fang-Fang] Xinxiang Med Univ, Key Lab Tumor Translat Med, Affiliated Hosp 3, Xinxiang, Henan, Peoples R China	Zhengzhou University; Zhengzhou University; Xinxiang Medical University	Wang, LD (corresponding author), Zhengzhou Univ, Henan Key Lab Esophageal Canc Res, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China.	ldwang2007@126.com			National Natural Science Foundation of China [81472323]; NSFC-Guangdong Joint Fund [U1301227]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSFC-Guangdong Joint Fund	This study was funded by the National Natural Science Foundation of China (No. 81472323, http://www.nsfc.gov.cn/) and the NSFC-Guangdong Joint Fund (No. U1301227, http://www.nsfc.gov.cn/) for LDW.	Abnet CC, 2012, HUM MOL GENET, V21, P2132, DOI 10.1093/hmg/dds029; Chen J, 2015, DIS ESOPHAGUS, V28, P84, DOI 10.1111/dote.12088; Chen W, 2011, CHIN J CANCER, V34, P502, DOI DOI 10.1186/S40880-015-0042-6; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hongo M, 2009, J GASTROEN HEPATOL, V24, P729, DOI 10.1111/j.1440-1746.2009.05824.x; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Ko JM, 2014, ONCOL REP, V32, P860, DOI 10.3892/or.2014.3222; Lin J, 2003, WORLD J GASTROENTERO, V9, P412, DOI 10.3748/wjg.v9.i3.412; Llorens Carlos, 2012, Mob Genet Elements, V2, P205; Makeyev AV, 2009, BIOCHEM BIOPH RES CO, V386, P554, DOI 10.1016/j.bbrc.2009.06.045; Matejcic M, 2015, CRIT REV CL LAB SCI, V52, P211, DOI 10.3109/10408363.2015.1020358; Mizuki N, 1997, GENOMICS, V42, P55, DOI 10.1006/geno.1997.4708; Nie Y, 2001, CARCINOGENESIS, V22, P1615, DOI 10.1093/carcin/22.10.1615; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; ROCKETT JC, 1995, J CLIN PATHOL, V48, P539, DOI 10.1136/jcp.48.6.539; Schwartz M, 2016, J IMMUNOTHER CANCER, V4, DOI 10.1186/s40425-016-0145-x; Shen FF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090438; Tran GD, 2005, INT J CANCER, V113, P456, DOI 10.1002/ijc.20616; Urayama KY, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00300; Urayama KY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072557; Wang LD, 2010, NAT GENET, V42, P759, DOI 10.1038/ng.648; Wu C, 2014, NAT GENET, V46, P1001, DOI 10.1038/ng.3064; Wu M, 2009, INT J CANCER, V124, P1907, DOI 10.1002/ijc.24142; Yang Y, 2008, TISSUE ANTIGENS, V72, P105, DOI 10.1111/j.1399-0039.2008.01078.x; Zhao X., 2011, SINGAPORE MANAGEMENT, V10, P2011	27	4	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e177494	10.1371/journal.pone.0177494	http://dx.doi.org/10.1371/journal.pone.0177494			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493959	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314300123
J	Carreras-Planella, L; Soler-Majoral, J; Rubio-Esteve, C; Lozano-Ramos, SI; Franquesa, M; Bonet, J; Troya-Saborido, MI; Borras, FE				Carreras-Planella, Laura; Soler-Majoral, Jordi; Rubio-Esteve, Cristina; Ines Lozano-Ramos, Sara; Franquesa, Marcella; Bonet, Josep; Isabel Troya-Saborido, Maria; Enric Borras, Francesc			Characterization and proteomic profile of extracellular vesicles from peritoneal dialysis efflux	PLOS ONE			English	Article							HEMODIALYSIS; BIOMARKERS; FLUID; MODEL	Peritoneal Dialysis (PD) is considered the best option for a cost-effective mid-term dialysis in patients with Chronic Renal Failure. However, functional failure of the peritoneal membrane (PM) force many patients to stop PD treatment and start haemodialysis. Currently, PM functionality is monitored by the peritoneal equilibration test, a tedious technique that often show changes when the membrane damage is advanced. As in other pathologies, the identification and characterization of extracellular vesicles (EVs) in the peritoneal dialysis efflux (PDE) may represent a non-invasive alternative to identify biomarkers of membrane failure. Using size-exclusion chromatography, we isolated EVs from PDE in a group of patients. Vesicles were characterized by the presence of tetraspanin markers, nanoparticle tracking analysis profile, cryo-electron microscopy and mass spectrometry. Here, we report the isolation and characterization of PDE-EVs. Based on mass spectrometry, we have found a set of well-conserved proteins among patients. Interestingly, the peptide profile also revealed remarkable changes between newly enrolled and longer-treated PD patients. These results are the first step to the identification of PDE-EVs based new markers of PM damage, which could support clinicians in their decision-making in a non-invasive manner.	[Carreras-Planella, Laura; Soler-Majoral, Jordi; Rubio-Esteve, Cristina; Ines Lozano-Ramos, Sara; Franquesa, Marcella; Bonet, Josep; Isabel Troya-Saborido, Maria; Enric Borras, Francesc] Germans Trias & Pujol Hlth Sci Res Inst, REMAR IVECAT Grp, Can Ruti Campus, Badalona, Spain; [Carreras-Planella, Laura; Ines Lozano-Ramos, Sara; Enric Borras, Francesc] Autonomous Univ Barcelona, Dept Cell Biol Physiol & Immunol, Barcelona, Spain; [Soler-Majoral, Jordi; Rubio-Esteve, Cristina; Franquesa, Marcella; Bonet, Josep; Isabel Troya-Saborido, Maria; Enric Borras, Francesc] Germans Trias & Pujol Univ Hosp, Nephrol Dept, Can Ruti Campus, Badalona, Spain; [Soler-Majoral, Jordi] Autonomous Univ Barcelona, Dept Med, Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona	Troya-Saborido, MI; Borras, FE (corresponding author), Germans Trias & Pujol Hlth Sci Res Inst, REMAR IVECAT Grp, Can Ruti Campus, Badalona, Spain.; Borras, FE (corresponding author), Autonomous Univ Barcelona, Dept Cell Biol Physiol & Immunol, Barcelona, Spain.; Troya-Saborido, MI; Borras, FE (corresponding author), Germans Trias & Pujol Univ Hosp, Nephrol Dept, Can Ruti Campus, Badalona, Spain.	mitroya.germanstrias@gencat.cat; feborras@igtp.cat	Franquesa, Marcella/A-7231-2017; Borràs, Francesc E/P-2287-2017	Franquesa, Marcella/0000-0002-1287-8908; Borràs, Francesc E/0000-0003-4038-1912; Carreras-Planella, Laura/0000-0003-3512-0849; Soler, Jordi/0000-0001-6693-4859; Franquesa/0000-0001-6251-8575	National R+D+I [PI16/00072]; ISCIII; European Regional Development Fund [2014SGR804]; Instituto de Salud Carlos III-Red de Investigacion Renal (REDinREN) [RD16/0009]; Fundacio Cellex; Beatriu de Pinos-B contract from Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR)-Generalitat de Catalunya [2014BPB00118]; Spanish "Sistema Nacionalde Salud" (SNS-ISCIII); "Direccio d'Estrategia i Coordinacio" Catalan Health Department [CES07/015]	National R+D+I; ISCIII(Instituto de Salud Carlos III); European Regional Development Fund(European Commission); Instituto de Salud Carlos III-Red de Investigacion Renal (REDinREN)(Instituto de Salud Carlos III); Fundacio Cellex(Foundation CELLEX); Beatriu de Pinos-B contract from Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR)-Generalitat de Catalunya; Spanish "Sistema Nacionalde Salud" (SNS-ISCIII); "Direccio d'Estrategia i Coordinacio" Catalan Health Department	This work was supported by the PI16/00072 project, integrated in the National R+D+I and funded by the ISCIII and the European Regional Development Fund http://www.isciii.es), "Suport Grups de Recerca" programme of Generalitat de Catalunya (2014SGR804, Group REMAR, http://agaur.gencat.cat), Instituto de Salud Carlos III-Red de Investigacion Renal (REDinREN) (RD16/0009 Feder Funds, http://www.isciii.es, http://redinren.org), and Fundacio Cellex. MF is sponsored by the Beatriu de Pinos-B contract (2014BPB00118, http://agaur.gencat.cat) from Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR)-Generalitat de Catalunya. FEB is sponsored by the "Researchers Stabilization Program" from the Spanish "Sistema Nacionalde Salud" (SNS-ISCIII, http://www.isciii.es) and "Direccio d'Estrategia i Coordinacio" Catalan Health Department (CES07/015, http://salutweb.gencat.cat). The funders had no role in study design,data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera Abelardo, 2005, Curr Opin Investig Drugs, V6, P262; Aroeira L, 2008, PERIT DIAL, V28, P29; Atapour A, 2015, SAUDI J KIDNEY DIS T, V26, P962, DOI 10.4103/1319-2442.164578; Barreto DL, 2013, AM J KIDNEY DIS, V62, P823, DOI 10.1053/j.ajkd.2013.01.031; Boukouris S, 2015, PROTEOM CLIN APPL, V9, P358, DOI 10.1002/prca.201400114; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Erdbrugger U, 2015, J AM SOC NEPHROL, P1; Fais S, 2016, ACS NANO, V10, P3886, DOI 10.1021/acsnano.5b08015; Gamez-Valero A, 2016, SCI REP-UK, V6, DOI 10.1038/srep33641; Gamez-Valero A, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00006; Heaf JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090119; Heberle H, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0611-3; Kalra H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001450; Kim DK, 2015, BIOINFORMATICS, V31, P933, DOI 10.1093/bioinformatics/btu741; Lechner M, 2010, J PROTEOME RES, V9, P2472, DOI 10.1021/pr9011574; Lener T, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.30087; Lin F, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0039-z; Lozano-Ramos I, 2015, J EXTRACELL VESICLES, P1; Lozano-Ramos I, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27369; Lukowsky LR, 2013, CLIN J AM SOC NEPHRO, V8, P619, DOI 10.2215/CJN.04810512; LYNOE N, 1991, BRIT MED J, V303, P610, DOI 10.1136/bmj.303.6803.610; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; Mujais S, 2000, PERITON DIALYSIS INT, V20, pS5; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Sritippayawain S, 2007, J PROTEOME RES, V6, P4356, DOI 10.1021/pr0702969; Treharne C, 2014, APPL HEALTH ECON HEA, V12, P409, DOI 10.1007/s40258-014-0108-7; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Wang HY, 2010, NEPHROL DIAL TRANSPL, V25, P1955, DOI 10.1093/ndt/gfp696; WANIEWSKI J, 1991, BLOOD PURIFICAT, V9, P129, DOI 10.1159/000170009; Yanez-Mo M, 2003, NEW ENGL J MED, V348, P403, DOI 10.1056/NEJMoa020809; Yanez-Mo M, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27066	31	16	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176987	10.1371/journal.pone.0176987	http://dx.doi.org/10.1371/journal.pone.0176987			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489901	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314100041
J	Chen, FP; Zhou, GQ; Qi, ZY; Lin, L; Hu, J; Wang, XJ; Sun, Y				Chen, Fo-Ping; Zhou, Guan-Qun; Qi, Zhen-Yu; Lin, Li; Hu, Jiang; Wang, Xiao-Ju; Sun, Ying			Prognostic value of cervical nodal tumor volume in nasopharyngeal carcinoma: Analysis of 1230 patients with positive cervical nodal metastasis	PLOS ONE			English	Article							STAGING SYSTEM; PATTERNS; NECROSIS	Purpose To investigate the variability and prognostic value of nodal tumor volume (NTV) in nasopharyngeal carcinoma (NPC). Methods and materials Data on 1230 patients with newly diagnosed stage T1-4N1-3M0 NPC treated with definitive radiation therapy with or without chemotherapy at a single cancer center were reviewed. NTV was determined from dose volume histogram (DVH) data. X-tile analysis was applied to identify the optimal cut-off points for the NTV with respect to regional recurrence-free survival (RRFS). Correlations between the TNM classification system, NTV and RRFS were assessed using a Cox regression model. Cross-validation based on receiver operating characteristic (ROC) curve analysis was applied to compare the prognostic predictive validity of NTV and N categories. Results Within a median follow-up of 49.9 (range, 1.27-76.40) months, 61/1230 (5%) patients developed regional recurrence and 154 (12.5%) developed distant metastasis. NTV values of 7.2 cc and 35.7 cc were identified as the optimal cut-off points. Patients with larger NTV had poorer prognosis. Compared with the N category, NTV was better at determining RRFS for patients with NPC. Hazard ratios increased with NTV, ranging from 1.86 (95% confidence interval [95% CI], 0.92-3.78) for NTV between 7.2 cc to 35.7 cc, and 3.67 (95% CI, 1.58-8.50) for NTV > 35.7 cc. With both NTV and N category in the same Cox regression model, only NTV remained statistically significant in the RRFS of NPC. The validation results with ROC curves also revealed that, NTV was superior to N category for predicting RRFS with significantly larger area under the ROC curve. Conclusions NTV offers important prognostic value for treatment outcomes in NPC, especially regional control. Volumetric analysis of nodal involvement may assist selection of patients with poor prognosis.	[Chen, Fo-Ping; Zhou, Guan-Qun; Qi, Zhen-Yu; Lin, Li; Hu, Jiang; Wang, Xiao-Ju; Sun, Ying] Sun Yat Sen Univ, Dept Radiat Oncol, Canc Ctr, Collaborat Innovat Ctr Canc Med,State Key Lab Onc, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University	Sun, Y (corresponding author), Sun Yat Sen Univ, Dept Radiat Oncol, Canc Ctr, Collaborat Innovat Ctr Canc Med,State Key Lab Onc, Guangzhou, Guangdong, Peoples R China.	sunying@sysucc.org.cn						[Anonymous], 2010, ICRU REP, V83; [Anonymous], 1999, ICRU REP, V62; Camp RL., 2004, CLIN CANCER RES, V10, P7252, DOI [DOI 10.1158/1078-0432.CCR-04-0713, 10.1158/1078-0432.CCR-04-0713]; Chen MK, 2004, CANCER-AM CANCER SOC, V100, P2160, DOI 10.1002/cncr.20210; Chua DTT, 2004, INT J RADIAT ONCOL, V58, P1437, DOI 10.1016/j.ijrobp.2003.09.075; Chua DTT, 1997, INT J RADIAT ONCOL, V39, P711, DOI 10.1016/S0360-3016(97)00374-X; Cooper JS, 1998, CANCER-AM CANCER SOC, V83, P213, DOI 10.1002/(SICI)1097-0142(19980715)83:2<213::AID-CNCR3>3.0.CO;2-R; GATENBY RA, 1988, INT J RADIAT ONCOL, V14, P831, DOI 10.1016/0360-3016(88)90002-8; Groebe K, 1996, INT J RADIAT ONCOL, V34, P395, DOI 10.1016/0360-3016(95)02065-9; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Ho FCH, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-98; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; King AD, 2004, RADIOLOGY, V230, P720, DOI 10.1148/radiol.2303030157; Lan M, 2015, RADIOLOGY, V276, P536, DOI 10.1148/radiol.15141251; Liu LZ, 2006, INT J RADIAT ONCOL, V66, P721, DOI 10.1016/j.ijrobp.2006.05.054; Loong HH, 2008, HEMATOL ONCOL CLIN N, V22, P1267, DOI 10.1016/j.hoc.2008.08.012; Ma J, 2001, INT J RADIAT ONCOL, V50, P1181, DOI 10.1016/S0360-3016(01)01537-1; Mao YP, 2008, CLIN CANCER RES, V14, P7497, DOI 10.1158/1078-0432.CCR-08-0271; Ng SH, 2004, EUR J NUCL MED MOL I, V31, P1073, DOI 10.1007/s00259-004-1498-9; SHAM JST, 1990, INT J RADIAT ONCOL, V19, P929, DOI 10.1016/0360-3016(90)90014-B; Sobin LHGM., 2009, TNM CLASSIFICATION M, V7th; Su SF, 2012, INT J RADIAT ONCOL, V82, P327, DOI 10.1016/j.ijrobp.2010.09.011; Tang LL, 2009, CANCER-AM CANCER SOC, V115, P680, DOI 10.1002/cncr.24049	23	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176995	10.1371/journal.pone.0176995	http://dx.doi.org/10.1371/journal.pone.0176995			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489930	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314100042
J	Fegraeus, KJ; Lawrence, C; Petajisto, K; Johansson, MK; Wiklund, M; Olsson, C; Andersson, L; Andersson, LS; Roed, KH; Ihler, CF; Strand, E; Lindgren, G; Velie, BD				Fegraeus, Kim Jaderkvist; Lawrence, Chameli; Petajisto, Katrine; Johansson, Maria K.; Wiklund, Maja; Olsson, Christina; Andersson, Leif; Andersson, Lisa S.; Roed, Knut H.; Ihler, Carl-Fredrik; Strand, Eric; Lindgren, Gabriella; Velie, Brandon D.			Lack of significant associations with early career performance suggest no link between the DMRT3 "Gait Keeper" mutation and precocity in Coldblooded trotters	PLOS ONE			English	Article							STANDARD-BRED TROTTERS; HORSES; ABILITY; GENE	The Swedish-Norwegian Coldblooded trotter (CBT) is a local breed in Sweden and Norway mainly used for harness racing. Previous studies have shown that a mutation from cytosine (C) to adenine (A) in the doublesex and mab-3 related transcription factor 3 (DMRT3) gene has a major impact on harness racing performance of different breeds. An association of the DMRT3 mutation with early career performance has also been suggested. The aim of the current study was to investigate this proposed association in a randomly selected group of CBTs. 769 CBTs (485 raced, 284 unraced) were genotyped for the DMRT3 mutation. The association with racing performance was investigated for 13 performance traits and three different age intervals: 3 years, 3 to 6 years, and 7 to 10 years of age, using the statistical software R. Each performance trait was analyzed for association with DMRT3 using linear models. The results suggest no association of the DMRT3 mutation with precocity (i.e. performance at 3 years of age). Only two traits (race time and number of disqualifications) were significantly different between the genotypes, with AA horses having the fastest times and CC horses having the highest number of disqualifications at 3 years of age. The frequency of the AA genotype was significantly lower in the raced CBT sample compared with the unraced sample and less than 50% of the AA horses participated in a race. For the age intervals 3 to 6 and 7 to 10 years the AA horses also failed to demonstrate significantly better performance than the other genotypes. Although suggested as the most favorable genotype for racing performance in Standardbreds and Finnhorses across all ages, the AA genotype does not appear to be associated with superior performance, early or late, in the racing career of CBTs.	[Fegraeus, Kim Jaderkvist; Lawrence, Chameli; Petajisto, Katrine; Johansson, Maria K.; Andersson, Leif; Lindgren, Gabriella; Velie, Brandon D.] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden; [Wiklund, Maja] Swedish Univ Agr Sci, Dept Clin Sci, Uppsala, Sweden; [Olsson, Christina] Swedish Trotting Assoc, Bromma, Sweden; [Andersson, Leif] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Andersson, Leif] Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX USA; [Andersson, Lisa S.] Capilet Genet AB, Vasteras, Sweden; [Roed, Knut H.] Norwegian Univ Life Sci, Dept Basic Sci & Aquat Med, Fac Vet Med, Oslo, Norway; [Ihler, Carl-Fredrik; Strand, Eric] Norwegian Univ Life Sci, Dept Compan Anim Clin Sci, Fac Vet Med, Oslo, Norway	Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Uppsala University; Texas A&M University System; Texas A&M University College Station; Norwegian University of Life Sciences; Norwegian University of Life Sciences	Fegraeus, KJ (corresponding author), Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden.	kim.jaderkvist@slu.se	Strand, Eric/J-4452-2019	Wiklund, Maja/0000-0002-4196-2498; Lindgren, Gabriella/0000-0001-6046-9669; Rosengren, Maria/0000-0003-0144-7034	Swedish Norwegian Foundation for Equine Research [H-15-47-075]; Swedish Research Council [621-2012-4666]; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning [221-2013-1661]; Capilet Genetics AB; Swedish Trotting Association	Swedish Norwegian Foundation for Equine Research; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); Capilet Genetics AB; Swedish Trotting Association	This work was supported by: Swedish Norwegian Foundation for Equine Research, H-15-47-075, http://hastforskning.se (GL, ES); The Swedish Research Council (VR), 621-2012-4666, www.ur.se (GL); The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas), 221-2013-1661, www.formas.se (GL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Capilet Genetics AB and The Swedish Trotting Association provided support in the form of salaries for authors LSA and CO, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of these authors is articulated in the 'author contributions' section.	Abdi H., 2010, ENCY RES DESIGN; Andersson LS, 2012, NATURE, V488, P642, DOI 10.1038/nature11399; Arnason T., 1994, Genetics and breeding of dairy and beef cattle, swine and horses, Volume 17. Proceedings of the 5th World Congress on Genetics applied to Livestock Production, University of Guelph, Guelph, Ontario, Canada, 7-12 August, 1994., P462; Arnason T, 1999, J ANIM BREED GENET, V116, P387, DOI 10.1046/j.1439-0388.1999.00202.x; Fegraeus KJ, 2015, J HERED, V106, P734, DOI 10.1093/jhered/esv062; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Hill EW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008645; Jaderkvist K, 2014, J ANIM SCI, V92, P4279, DOI [10.2527/jas2014-7803, 10.2527/jas.2014-7803]; Kristjansson T, 2016, LIVEST SCI, V189, P91, DOI 10.1016/j.livsci.2016.05.010; Promerova M, 2014, ANIM GENET, V45, P274, DOI 10.1111/age.12120; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ricard A, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0095-7; Thiruvenkadan AK, 2009, LIVEST SCI, V124, P163, DOI 10.1016/j.livsci.2009.01.010	13	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							0177351	10.1371/journal.pone.0177351	http://dx.doi.org/10.1371/journal.pone.0177351			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489879	Green Submitted, Green Published, gold			2022-12-26	WOS:000401314100066
J	Kim, JS; Cho, MS; Nam, JH; Kim, HJ; Choi, KW; Ryu, JS				Kim, Jung Soo; Cho, Min Seong; Nam, Jong Hyeon; Kim, Hyun-Jung; Choi, Kyeng-Won; Ryu, Jeong-Seon			Prognostic impact of EGFR mutation in non-small-cell lung cancer patients with family history of lung cancer	PLOS ONE			English	Article							FACTOR RECEPTOR MUTATIONS; T790M MUTATION; NEVER SMOKERS; ASSOCIATION; TUMORS; RISK; GENE	Background A family history can be a valuable tool in the era of precision medicine. Although a few studies have described an association of family history of lung cancer with EGFR activating mutation, their impact on survival of lung cancer patients is unclear. Methods The study included consecutive 829 non-small-cell lung cancer patients who received analysis of EGFR mutation in a prospective lung cancer cohort. Family history of lung cancer was obtained by face-to-face interviews at the time of diagnosis. An association of EGFR activating mutation with a family history of lung cancer in first-degree relatives was evaluated with multivariate logistic regression analysis, and its association with survival was estimated with Cox's proportional hazards model. Results Seventy five (9.0%) patients had family history of lung cancer. The EGFR mutation was commonly observed in patients with positive family history compared to those with no family history (46.7% v 31.3%, x(2) p = 0.007). The family history was significantly associated with the EGFR mutation (aOR and 95% CI: 2.01 and 1.18-3.60, p = 0.011). Patients with the positive family history survived longer compared to those without (MST, 17.9 v 13.0 months, log-rank p = 0.037). The presence of the EGFR mutation was associated with better survival in patients without the family history (aHR and 95% CI: 0.72 and 0.57-0.90, p = 0.005). However, this prognostic impact was not observed in patients with the positive family history (aHR and 95% CI: 1.01 and 0.50-2.36, p = 0.832). Conclusions In comparison to patients without the family history, EGFR activating mutation was common, and it did not affect prognosis in patients with positive family history.	[Kim, Jung Soo; Cho, Min Seong; Nam, Jong Hyeon; Kim, Hyun-Jung; Choi, Kyeng-Won; Ryu, Jeong-Seon] Inha Univ Hosp, Dept Internal Med, 27 Inhang Ro, Incheon, South Korea	Inha University; Inha University Hospital	Ryu, JS (corresponding author), Inha Univ Hosp, Dept Internal Med, 27 Inhang Ro, Incheon, South Korea.	jsryu@inha.ac.kr		Kim, Jung Soo/0000-0001-6603-6768	Korea government (MSIP) (Medical Research Center (MRC) [2014009392]	Korea government (MSIP) (Medical Research Center (MRC)	This work was supported by the Korea government (MSIP) (Medical Research Center (MRC) No. 2014009392). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anagnostou VK, 2015, CLIN CANCER RES, V21, P976, DOI 10.1158/1078-0432.CCR-14-1187; Bell DW, 2005, NAT GENET, V37, P1315, DOI 10.1038/ng1671; Cassidy A, 2009, EUR J CANCER, V45, P3047, DOI 10.1016/j.ejca.2009.05.006; Cheng PC, 2015, J THORAC DIS, V7, P281, DOI 10.3978/j.issn.2072-1439.2015.02.03; Ganti AK, 2009, LUNG CANCER, V63, P136, DOI 10.1016/j.lungcan.2008.04.008; Gaughan EM, 2013, LUNG CANCER, V79, P193, DOI 10.1016/j.lungcan.2012.12.002; Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Han SW, 2005, J CLIN ONCOL, V23, P2493, DOI 10.1200/JCO.2005.01.388; Haraguchi S, 2012, INT J MED SCI, V9, P68, DOI 10.7150/ijms.9.68; He YY, 2013, LUNG CANCER, V81, P162, DOI 10.1016/j.lungcan.2013.05.004; Inukai M, 2006, CANCER RES, V66, P7854, DOI 10.1158/0008-5472.CAN-06-1951; Jonsson S, 2004, JAMA-J AM MED ASSOC, V292, P2977, DOI 10.1001/jama.292.24.2977; Li N, 2011, FAM CANCER, V10, P331, DOI 10.1007/s10689-010-9403-0; Liu PY, 2008, JNCI-J NATL CANCER I, V100, P1326, DOI 10.1093/jnci/djn268; Matakidou A, 2005, BRIT J CANCER, V93, P825, DOI 10.1038/sj.bjc.6602769; Ohtsuka K, 2011, J CLIN ONCOL, V29, pE191, DOI 10.1200/JCO.2010.31.4492; Oxnard GR, 2012, J THORAC ONCOL, V7, P1049, DOI 10.1097/JTO.0b013e318250ed9d; Rachtan J, 2009, LUNG CANCER, V65, P138, DOI 10.1016/j.lungcan.2008.10.029; Ryu JS, 2014, J CLIN ONCOL, V32, P960, DOI 10.1200/JCO.2013.50.5453; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Su KY, 2012, J CLIN ONCOL, V30, P433, DOI 10.1200/JCO.2011.38.3224; Wu JY, 2011, CLIN CANCER RES, V17, P3812, DOI 10.1158/1078-0432.CCR-10-3408; Yu HA, 2014, ANN ONCOL, V25, P423, DOI 10.1093/annonc/mdt573; Yu HA, 2014, J THORAC ONCOL, V9, P554, DOI 10.1097/JTO.0000000000000052	24	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177015	10.1371/journal.pone.0177015	http://dx.doi.org/10.1371/journal.pone.0177015			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486527	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314000035
J	Li, K; Yu, N; Li, PF; Song, SM; Wu, YL; Li, Y; Liu, M				Li, Ke; Yu, Nan; Li, Pengfei; Song, Shimin; Wu, Yalei; Li, Yang; Liu, Meng			Multi-label spacecraft electrical signal classification method based on DBN and random forest	PLOS ONE			English	Article								In spacecraft electrical signal characteristic data, there exists a large amount of data with high-dimensional features, a high computational complexity degree, and a low rate of identification problems, which causes great difficulty in fault diagnosis of spacecraft electronic load systems. This paper proposes a feature extraction method that is based on deep belief networks (DBN) and a classification method that is based on the random forest (RF) algorithm; The proposed algorithm mainly employs a multi-layer neural network to reduce the dimension of the original data, and then, classification is applied. Firstly, we use the method of wavelet denoising, which was used to pre-process the data. Secondly, the deep belief network is used to reduce the feature dimension and improve the rate of classification for the electrical characteristics data. Finally, we used the random forest algorithm to classify the data and comparing it with other algorithms. The experimental results show that compared with other algorithms, the proposed method shows excellent performance in terms of accuracy, computational efficiency, and stability in addressing spacecraft electrical signal data.	[Li, Ke; Yu, Nan; Li, Pengfei; Wu, Yalei; Liu, Meng] Beihang Univ, Ergon & Environm Control Lab, Beijing, Peoples R China; [Song, Shimin] China Acad Space Technol, Beijing, Peoples R China; [Li, Yang] Beihang Univ, Sch Automat Sci & Elect Engn, Beijing, Peoples R China	Beihang University; Beihang University	Liu, M (corresponding author), Beihang Univ, Ergon & Environm Control Lab, Beijing, Peoples R China.	like@buaa.edu.cn			Aeronautical Science Foundation of China [2012ZD51043]; Fanzhou Youth Scientific Funds [20100504]; Chinese Government Fundamental Research Funds for the Central Universities [YWF-14-HKXY-017, YWF-13-HKXY-033]; National Natural Science Foundation of China [61403016]	Aeronautical Science Foundation of China; Fanzhou Youth Scientific Funds; Chinese Government Fundamental Research Funds for the Central Universities; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors are supported by the Aeronautical Science Foundation of China (No. 2012ZD51043), Fanzhou Youth Scientific Funds (No. 20100504), Chinese Government Fundamental Research Funds for the Central Universities (No. YWF-14-HKXY-017, YWF-13-HKXY-033), and the National Natural Science Foundation of China (61403016).	Batzel TD, 2009, IEEE T AERO ELEC SYS, V45, P473, DOI 10.1109/TAES.2009.5089535; Deng HT, 2013, PATTERN RECOGN, V46, P3483, DOI 10.1016/j.patcog.2013.05.018; Goadrich M., 2010, P 23 INT C MACH LEAR, P233; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; Hu Qing, 2010, High Voltage Engineering, V36, P1725; Khaing H K.T., 2013, INT J ADV RES COMPUT, V2; Kulkarni V. Y., 2015, J I ENG, V23, P1; Li K., 2015, PLOS ONE, V10; Li K, 2014, CHINESE J AERONAUT, V27, P1390, DOI 10.1016/j.cja.2014.10.005; Li K, 2013, CHINESE J AERONAUT, V26, P1360, DOI 10.1016/j.cja.2013.07.006; Liu Yang, 2014, ScientificWorldJournal, V2014, P476219, DOI 10.1155/2014/476219; Liu Y, 2014, INT CONF SIGN PROCES, P1413, DOI 10.1109/ICOSP.2014.7015232; Luo R., 2013, ANAL PHM TECHNOLOGY; Pal M, 2005, INT J REMOTE SENS, V26, P217, DOI 10.1080/01431160412331269698; Quiroga RQ, 2003, CLIN NEUROPHYSIOL, V114, P376, DOI 10.1016/S1388-2457(02)00365-6; Shaw S R., 2005, SYSTEM IDENTIFICATIO; Toth N, 2008, INT J INTELL COMPUT, V1, P169, DOI 10.1108/17563780810874708; Vidakovic B, 1998, IEEE T SIGNAL PROCES, V46, P2549, DOI 10.1109/78.709544; Xi Chen, 2011, 2011 International Conference on Intelligent Computation Technology and Automation (ICICTA), P132, DOI 10.1109/ICICTA.2011.40; Xiang Gao, 2013, Advanced Materials Research, V760-762, P1062, DOI 10.4028/www.scientific.net/AMR.760-762.1062; Yan WZ, 2006, 2006 IMACS: MULTICONFERENCE ON COMPUTATIONAL ENGINEERING IN SYSTEMS APPLICATIONS, VOLS 1 AND 2, P468; Yi WG, 2011, INT J MACH LEARN CYB, V2, P67, DOI 10.1007/s13042-011-0015-2; Zhao L, 2016, NEUROCOMPUTING, V171, P230, DOI 10.1016/j.neucom.2015.06.063; Zhuang Jin-fa, 2009, Computer Integrated Manufacturing Systems, V15, P777	25	11	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0176614	10.1371/journal.pone.0176614	http://dx.doi.org/10.1371/journal.pone.0176614			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486479	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314000018
J	Linhart, P; Salek, M				Linhart, Pavel; Salek, Martin			The assessment of biases in the acoustic discrimination of individuals	PLOS ONE			English	Article							OWL ATHENE-NOCTUA; POPULATION DECLINE; RECOGNITION; CALLS; CLASSIFICATION; ANIMALS; SIGNALS; SONG; DISTINCTIVENESS; IDENTIFICATION	Animal vocalizations contain information about individual identity that could potentially be used for the monitoring of individuals. However, the performance of individual discrimination is subjected to many biases depending on factors such as the amount of identity information, or methods used. These factors need to be taken into account when comparing results of different studies or selecting the most cost-effective solution for a particular species. In this study, we evaluate several biases associated with the discrimination of individuals. On a large sample of little owl male individuals, we assess how discrimination performance changes with methods of call description, an increasing number of individuals, and number of calls per male. Also, we test whether the discrimination performance within the whole population can be reliably estimated from a subsample of individuals in a pre-screening study. Assessment of discrimination performance at the level of the individual and at the level of call led to different conclusions. Hence, studies interested in individual discrimination should optimize methods at the level of individuals. The description of calls by their frequency modulation leads to the best discrimination performance. In agreement with our expectations, discrimination performance decreased with population size. Increasing the number of calls per individual linearly increased the discrimination of individuals (but not the discrimination of calls), likely because it allows distinction between individuals with very similar calls. The available pre-screening index does not allow precise estimation of the population size that could be reliably monitored. Overall, projects applying acoustic monitoring at the individual level in population need to consider limitations regarding the population size that can be reliably monitored and fine-tune their methods according to their needs and limitations.	[Linhart, Pavel] Inst Anim Sci, Ethol Dept, Prague, Czech Republic; [Linhart, Pavel] Adam Mickiewicz Univ, Dept Behav Ecol, Fac Biol, Poznan, Poland; [Salek, Martin] Acad Sci Czech Republ, Inst Vertebrate Biol, Brno, Czech Republic; [Salek, Martin] Czech Univ Life Sci Prague, Fac Environm Sci, Prague, Czech Republic	Czech Research Institute of Animal Science; Adam Mickiewicz University; Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech Academy of Sciences; Czech University of Life Sciences Prague	Linhart, P (corresponding author), Inst Anim Sci, Ethol Dept, Prague, Czech Republic.; Linhart, P (corresponding author), Adam Mickiewicz Univ, Dept Behav Ecol, Fac Biol, Poznan, Poland.	pavel.linhart83@gmail.com	Salek, Martin/H-6253-2011; Salek, Martin/AAE-9233-2019; Linhart, Pavel/AAZ-7474-2021	Linhart, Pavel/0000-0002-6097-5892; Salek, Martin/0000-0003-2639-9745	Czech Science Foundation [GA14-279255]; Ministry of Agriculture of Czech Republic [MZER00716]; National Science Centre, Poland [2015/19/P/NZ8/02507]; Academy of Sciences of the Czech Republic [RV068081766]	Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Agriculture of Czech Republic(Ministry of Agriculture, Czech Republic); National Science Centre, Poland(National Science Centre, Poland); Academy of Sciences of the Czech Republic(Czech Academy of Sciences)	PL was supported by the Czech Science Foundation (GA14-279255), Ministry of Agriculture of Czech Republic (MZER00716), and National Science Centre, Poland (2015/19/P/NZ8/02507); MS was funded by the Academy of Sciences of the Czech Republic (RV068081766). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adi K, 2010, J ACOUST SOC AM, V127, P874, DOI 10.1121/1.3273887; Amorim MCP, 2011, BEHAV ECOL SOCIOBIOL, V65, P707, DOI 10.1007/s00265-010-1072-3; Antunes R, 2011, ANIM BEHAV, V81, P723, DOI 10.1016/j.anbehav.2010.12.019; Arriaga JG, 2014, LECT NOTES COMPUT SC, V8495, P291, DOI 10.1007/978-3-319-07491-7_30; BEECHER MD, 1982, AM ZOOL, V22, P477; BEECHER MD, 1989, ANIM BEHAV, V38, P248, DOI 10.1016/S0003-3472(89)80087-9; Blumstein DT, 2011, J APPL ECOL, V48, P758, DOI 10.1111/j.1365-2664.2011.01993.x; Budka M, 2015, J ORNITHOL, V156, P481, DOI 10.1007/s10336-014-1149-2; Budka M, 2013, ETHOLOGY, V119, P960, DOI 10.1111/eth.12141; Cheng JK, 2010, PATTERN RECOGN, V43, P3846, DOI 10.1016/j.patcog.2010.04.026; Cinkova I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098475; Delport W, 2002, IBIS, V144, P30, DOI 10.1046/j.0019-1019.2001.00019.x; Exo K. M., 1989, VOGELWARTE, V35, P99; Exo K. M., 1989, ECOLOGY BIRDS, V11, P149; Feng AS, 2009, ETHOLOGY, V115, P1015, DOI 10.1111/j.1439-0310.2009.01692.x; Feng JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096317; Fernandez-Juricic E, 2009, AUK, V126, P89, DOI 10.1525/auk.2009.07090; Fox EJS, 2008, ANIM BEHAV, V75, P1187, DOI 10.1016/j.anbehav.2007.11.003; Grava T, 2008, IBIS, V150, P279, DOI 10.1111/j.1474-919X.2007.00776.x; Hardouin LA, 2006, ANIM BEHAV, V72, P105, DOI 10.1016/j.anbehav.2005.09.020; Jacobsen LB, 2013, ORNIS FENNICA, V90, P41; Janik VM, 2013, J COMP PHYSIOL A, V199, P479, DOI 10.1007/s00359-013-0817-7; Janik VM, 1999, ANIM BEHAV, V57, P133, DOI 10.1006/anbe.1998.0923; Kennedy RAW, 2009, J AVIAN BIOL, V40, P481, DOI 10.1111/j.1600-048X.2008.04682.x; Kirschel ANG, 2009, BIOACOUSTICS, V19, P1; Klenova AV, 2009, J ETHOL, V27, P401, DOI 10.1007/s10164-008-0133-9; Laiolo P, 2007, J AVIAN BIOL, V38, P672, DOI 10.1111/j.2007.0908-8857.04006.x; Lein MR, 2008, WILSON J ORNITHOL, V120, P256, DOI 10.1676/07-067.1; Lengagne T, 2001, BEHAVIOUR, V138, P1407, DOI 10.1163/156853901317367663; Lengagne T, 1997, CR ACAD SCI III-VIE, V320, P885, DOI 10.1016/S0764-4469(97)80873-6; MEDVIN MB, 1993, ANIM BEHAV, V45, P841, DOI 10.1006/anbe.1993.1105; Merchant ND, 2015, METHODS ECOL EVOL, V6, P257, DOI 10.1111/2041-210X.12330; Milligan JL, 2003, J FIELD ORNITHOL, V74, P111, DOI 10.1648/0273-8570-74.2.111; Nieuwenhuyse DV, 2008, LITTLE OWL CONSERVAT; Odom KJ, 2013, J RAPTOR RES, V47, P21, DOI 10.3356/JRR-12-11.1; Peake TM, 1998, IBIS, V140, P120, DOI 10.1111/j.1474-919X.1998.tb04548.x; Petruskova T, 2016, METHODS ECOL EVOL, V7, P274, DOI 10.1111/2041-210X.12496; Pollard KA, 2010, J APPL ECOL, V47, P1103, DOI 10.1111/j.1365-2664.2010.01851.x; Ptacek L, 2016, BIOACOUSTICS, V25, P55, DOI 10.1080/09524622.2015.1089524; Robertson BC, 1996, ANIM BEHAV, V51, P303, DOI 10.1006/anbe.1996.0030; Rognan CB, 2009, J WILDLIFE MANAGE, V73, P755, DOI 10.2193/2008-124; Salek M, 2008, POL J ECOL, V56, P527; Salek M, 2016, AGR ECOSYST ENVIRON, V224, P56, DOI 10.1016/j.agee.2016.03.031; Salek Martin, 2014, Sylvia, V50, P2; Salek M, 2013, POL J ECOL, V61, P165; Salmi R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101940; Schneiderova I, 2010, BIOACOUSTICS, V20, P29; Taylor AM, 2010, J ZOOL, V280, P221, DOI 10.1111/j.1469-7998.2009.00661.x; Terry AMR, 2002, ANIM CONSERV, V5, P103, DOI 10.1017/S1367943002002147; Terry AMR, 2005, FRONT ZOOL, V2, P10, DOI DOI 10.1186/1742-9994-2-10; Tibbetts EA, 2007, TRENDS ECOL EVOL, V22, P529, DOI 10.1016/j.tree.2007.09.001; WEARY DM, 1990, AUK, V107, P623; Wiley RH, 2013, BIOL REV, V88, P179, DOI 10.1111/j.1469-185X.2012.00246.x; Wilson DR, 2014, BIOACOUSTICS, V23, P99, DOI 10.1080/09524622.2013.827588; Xia CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042528; Xia Canwei, 2011, Chinese Birds, V2, P132; Zmihorski M, 2006, POL J ECOL, V54, P321	57	11	12	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177206	10.1371/journal.pone.0177206	http://dx.doi.org/10.1371/journal.pone.0177206			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486488	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314000057
J	Schwarz, NG; Mertens, E; Winter, D; Maiga-Ascofare, O; Dekker, D; Jansen, S; Tappe, D; Randriamampionona, N; May, J; Rakotozandrindrainy, R; Schmidt-Chanasit, J				Schwarz, Norbert Georg; Mertens, Eva; Winter, Doris; Maiga-Ascofare, Oumou; Dekker, Denise; Jansen, Stephanie; Tappe, Dennis; Randriamampionona, Njary; May, Juergen; Rakotozandrindrainy, Raphael; Schmidt-Chanasit, Jonas			No serological evidence for Zika virus infection and low specificity for anti-Zika virus ELISA in malaria positive individuals among pregnant women from Madagascar in 2010	PLOS ONE			English	Article							SEROPREVALENCE; OUTBREAK; DENGUE; CHIKUNGUNYA; ANTIBODIES	It was previously reported that a malaria infection may interfere with the specificity of a commercial ELISA test against Zika virus (ZIKV). We analyzed 1,216 plasma samples from healthy, pregnant women collected in two sites in Madagascar in 2010 for ZIKV antibodies using a commercial ELISA and for Plasmodium infection by PCR. This screen revealed six putative ZIKV-positive samples by ELISA. These results could not be confirmed by indirect immunofluorescence assays or virus neutralization tests. Four of these six samples were also positive for P. falciparum. We noted that the frequency of malaria positivity was higher in ZIKV-ELISA positive samples (50% and 100% in the two study sites) than ZIKV-negative samples (17% and 10%, respectively), suggesting that malaria may have led to false ZIKV-ELISA positives.	[Schwarz, Norbert Georg; Mertens, Eva; Winter, Doris; Maiga-Ascofare, Oumou; Dekker, Denise; May, Juergen] Bernhard Nocht Inst Trop Med, Res Grp Infect Dis Epidemiol, Hamburg, Germany; [Mertens, Eva; Winter, Doris; Maiga-Ascofare, Oumou; Dekker, Denise; May, Juergen] German Ctr Infect Res, Hamburg Borstel Lubeck, Germany; [Maiga-Ascofare, Oumou] Kumasi Ctr Collaborat Res, Res Grp Med Trop, Kumasi, Ghana; [Jansen, Stephanie; Schmidt-Chanasit, Jonas] Bernhard Nocht Inst Trop Med, WHO Collaborating Ctr Arbovirus & Haemorrhag Feve, Hamburg, Germany; [Tappe, Dennis] Bernhard Nocht Inst Trop Med, Res Grp Zoonoses, Hamburg, Germany; [Randriamampionona, Njary; Rakotozandrindrainy, Raphael] Univ Antananarivo, Dept Microbiol & Parasitol, Antananarivo, Madagascar	Bernhard Nocht Institut fur Tropenmedizin; German Center for Infection Research; Kumasi Center for Collaborative Research; Bernhard Nocht Institut fur Tropenmedizin; Bernhard Nocht Institut fur Tropenmedizin; University Antananarivo	Mertens, E (corresponding author), Bernhard Nocht Inst Trop Med, Res Grp Infect Dis Epidemiol, Hamburg, Germany.; Mertens, E (corresponding author), German Ctr Infect Res, Hamburg Borstel Lubeck, Germany.	mertens@bnitm.de	Schwarz, Norbert G/C-8797-2012; amsalu, ribka/G-8780-2019	Schwarz, Norbert G/0000-0002-8387-2837; Maiga Ascofare, Oumou/0000-0003-2947-5651; May, Jurgen/0000-0001-7831-8420	Bernhard Nocht Institute for Tropical Medicine	Bernhard Nocht Institute for Tropical Medicine	This study was financed by in house resources of the Bernhard Nocht Institute for Tropical Medicine. The funders had no role in study design, data collection and analysis, decision to publish,or preparation of the manuscript.	Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847; Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036; FONTENILLE D, 1989, J AM MOSQUITO CONTR, V5, P219; Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477; Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442; Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203; Maiga-Ascofare O, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0704-5; Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272; Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707; Pan American Health Organization WHO, 2016, ZIK EP UPD; Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Ratsitorahina M, 2008, EMERG INFECT DIS, V14, P1135, DOI 10.3201/eid1407.071521; ROGAN WJ, 1978, AM J EPIDEMIOL, V107, P71, DOI 10.1093/oxfordjournals.aje.a112510; Schwarz NG, 2012, EMERG INFECT DIS, V18, P1780, DOI 10.3201/eid1811.111036; Steinhagen K, 2016, EUROSURVEILLANCE; Tappe D, 2010, J CLIN VIROL, V49, P148, DOI 10.1016/j.jcv.2010.05.012; Tappe D, 2009, MED MICROBIOL IMMUN, V198, P271, DOI 10.1007/s00430-009-0122-9; Van Esbroeck M, 2016, EUROSURVEILLANCE, V21; Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010	25	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0176708	10.1371/journal.pone.0176708	http://dx.doi.org/10.1371/journal.pone.0176708			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28510593	Green Published, gold, Green Submitted			2022-12-26	WOS:000401485500008
J	Chanda, A; Chan, A; Deng, LL; Kornaga, EN; Enwere, EK; Morris, DG; Bonni, S				Chanda, Ayan; Chan, Angela; Deng, Lili; Kornaga, Elizabeth N.; Enwere, Emeka K.; Morris, Donald G.; Bonni, Shirin			Identification of the SUMO E3 ligase PIAS1 as a potential survival biomarker in breast cancer	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TGF-BETA; SNON; SUMOYLATION; TIF1-GAMMA; TUMOR; EXPRESSION; PROTEINS	Metastasis is the ultimate cause of breast cancer related mortality. Epithelial-mesenchymal transition (EMT) is thought to play a crucial role in the metastatic potential of breast cancer. Growing evidence has implicated the SUMO E3 ligase PIAS1 in the regulation of EMT in mammary epithelial cells and breast cancer metastasis. However, the relevance of PIAS1 in human cancer and mechanisms by which PIAS1 might regulate breast cancer metastasis remain to be elucidated. Using tissue-microarray analysis (TMA), we report that the protein abundance and subcellular localization of PIAS1 correlate with disease specific overall survival of a cohort of breast cancer patients. In mechanistic studies, we find that PIAS1 acts via sumoylation of the transcriptional regulator SnoN to suppress invasive growth of MDA-MB-231 human breast cancer cell-derived organoids. Our studies thus identify the SUMO E3 ligase PIAS1 as a prognostic biomarker in breast cancer, and suggest a potential role for the PIAS1-SnoN sumoylation pathway in controlling breast cancer metastasis.	[Chanda, Ayan; Deng, Lili; Bonni, Shirin] Univ Calgary, Arnie Charbonneau Canc Inst, Calgary, AB, Canada; [Chanda, Ayan; Deng, Lili; Bonni, Shirin] Univ Calgary, Biochem & Mol Biol, Calgary, AB, Canada; [Chan, Angela; Kornaga, Elizabeth N.; Enwere, Emeka K.; Morris, Donald G.] Alberta Hlth Serv, Tom Baker Canc Ctr, Translat Labs, Calgary, AB, Canada; [Morris, Donald G.] Alberta Hlth Serv, Dept Oncol, Calgary, AB, Canada	University of Calgary; University of Calgary; Alberta Health Services (AHS); Tom Baker Cancer Clinic; University of Calgary; Alberta Health Services (AHS); University of Calgary	Bonni, S (corresponding author), Univ Calgary, Arnie Charbonneau Canc Inst, Calgary, AB, Canada.; Bonni, S (corresponding author), Univ Calgary, Biochem & Mol Biol, Calgary, AB, Canada.	sbonni@ucalgary.ca		Chanda, Ayan/0000-0002-2692-8558	University of Calgary, Achievers in Medical Sciences Recruitment Award; Eyes High Recruitment Award; Breast Cancer Society of Canada Grant; Canadian Institutes of Health Research; Alberta Innovates Health Solutions; Canadian Breast Cancer Foundation Prairies/NWT	University of Calgary, Achievers in Medical Sciences Recruitment Award; Eyes High Recruitment Award; Breast Cancer Society of Canada Grant; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions; Canadian Breast Cancer Foundation Prairies/NWT	This work was supported by the University of Calgary, Achievers in Medical Sciences Recruitment Award and Eyes High Recruitment Award; the Breast Cancer Society of Canada Grant; the Canadian Institutes of Health Research; Alberta Innovates Health Solutions and the Canadian Breast Cancer Foundation Prairies/NWT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshareeda AT, 2014, BREAST CANCER RES TR, V144, P519, DOI 10.1007/s10549-014-2897-7; Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; Bonni S, 2001, NAT CELL BIOL, V3, P587, DOI 10.1038/35078562; Bonni S, 2012, FEBS LETT, V586, P1977, DOI 10.1016/j.febslet.2012.02.048; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chandhoke AS, 2016, CELL DEATH DIFFER, V23, P876, DOI 10.1038/cdd.2015.152; Coppola D, 2009, J CANCER RES CLIN, V135, P1287, DOI 10.1007/s00432-009-0570-z; Creighton Chad J, 2013, Cancer Manag Res, V5, P187, DOI 10.2147/CMAR.S35171; Dadakhujaev Shorafidinkhuja, 2014, Oncoscience, V1, P229; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Feng XL, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0575-2; Gonzalez-Prieto R, 2015, CELL CYCLE, V14, P1859, DOI 10.1080/15384101.2015.1040965; Gur I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099503; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hsu YHR, 2006, J BIOL CHEM, V281, P33008, DOI 10.1074/jbc.M604380200; Ikeuchi Y, 2014, J BIOL CHEM, V289, P25067, DOI 10.1074/jbc.M114.575878; Jahchan NS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055794; Jain S, 2011, WORLD J GASTROENTERO, V17, P3994, DOI 10.3748/wjg.v17.i35.3994; Ji S., 2012, ADV DIFFER EQU, V2012, P1, DOI DOI 10.1016/J.CAGE0.2012.01.004; Kahyo T, 2001, MOL CELL, V8, P713, DOI 10.1016/S1097-2765(01)00349-5; Kassem L, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1471-y; Kornaga EN, 2016, MOD PATHOL; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Ling Y, 2004, NUCLEIC ACIDS RES, V32, P598, DOI 10.1093/nar/gkh195; Liu B, 2014, PLOS ONE, V9; Malinen M, 2015, MOL CELL ENDOCRINOL, V414, P91, DOI 10.1016/j.mce.2015.07.024; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Miyauchi Y, 2002, J BIOL CHEM, V277, P50131, DOI 10.1074/jbc.M208319200; Netherton SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013971; Palvimo JJ, 2007, BIOCHEM SOC T, V35, P1405, DOI 10.1042/BST0351405; Pot I, 2008, CURR MOL MED, V8, P319, DOI 10.2174/156652408784533797; Puhr M, 2016, ONCOGENE, V35, P2322, DOI 10.1038/onc.2015.292; Remotti Helen, 2013, Methods Mol Biol, V980, P13, DOI 10.1007/978-1-62703-287-2_2; Rytinki MM, 2009, CELL MOL LIFE SCI, V66, P3029, DOI 10.1007/s00018-009-0061-z; Sarker KP, 2005, J BIOL CHEM, V280, P13037, DOI 10.1074/jbc.M409367200; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Vinci M, 2015, JOVE-J VIS EXP, DOI 10.3791/52686; Weber S, 2009, GENE DEV, V23, P118, DOI 10.1101/gad.489409; Wei J, 2011, J NATL CANCER I, V103, P1552, DOI 10.1093/jnci/djr326; Yin X, 2016, ONCOL REP; Zhang F, 2003, CANCER RES, V63, P5005	43	30	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177639	10.1371/journal.pone.0177639	http://dx.doi.org/10.1371/journal.pone.0177639			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493978	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314300146
J	Hussein, AA; Leow, CY; Rahman, TA				Hussein, Ahmed Abdulqader; Leow, Chee Yen; Rahman, Tharek A.			Robust multiple frequency multiple power localization schemes in the presence of multiple jamming attacks	PLOS ONE			English	Article							WIRELESS SENSOR NETWORKS; CLOCK SYNCHRONIZATION; CHANNEL; ACCURACY; SECURITY; PROTOCOL; NODE	Localization of the wireless sensor network is a vital area acquiring an impressive research concern and called upon to expand more with the rising of its applications. As localization is gaining prominence in wireless sensor network, it is vulnerable to jamming attacks. Jamming attacks disrupt communication opportunity among the sender and receiver and deeply impact the localization process, leading to a huge error of the estimated sensor node position. Therefore, detection and elimination of jamming influence are absolutely indispensable. Range-based techniques especially Received Signal Strength (RSS) is facing severe impact of these attacks. This paper proposes algorithms based on Combination Multiple Frequency Multiple Power Localization (C-MFMPL) and Step Function Multiple Frequency Multiple Power Localization (SF-MFMPL). The algorithms have been tested in the presence of multiple types of jamming attacks including capture and replay, random and constant jammers over a log normal shadow fading propagation model. In order to overcome the impact of random and constant jammers, the proposed method uses two sets of frequencies shared by the implemented anchor nodes to obtain the averaged RSS readings all over the transmitted frequencies successfully. In addition, three stages of filters have been used to cope with the replayed beacons caused by the capture and replay jammers. In this paper the localization performance of the proposed algorithms for the ideal case which is defined by without the existence of the jamming attack are compared with the case of jamming attacks. The main contribution of this paper is to achieve robust localization performance in the presence of multiple jamming attacks under log normal shadow fading environment with a different simulation conditions and scenarios.	[Hussein, Ahmed Abdulqader; Leow, Chee Yen; Rahman, Tharek A.] Univ Teknol Malaysia, WCC, Fac Elect Engn, Utm Skudai 81310, Johor, Malaysia; [Hussein, Ahmed Abdulqader] Univ Technol Baghdad, Baghdad 10066, Iraq	Universiti Teknologi Malaysia; University of Technology- Iraq	Hussein, AA (corresponding author), Univ Teknol Malaysia, WCC, Fac Elect Engn, Utm Skudai 81310, Johor, Malaysia.; Hussein, AA (corresponding author), Univ Technol Baghdad, Baghdad 10066, Iraq.	ahmedabdulqaderhussein@gmail.com	LEOW, CHEE YEN/J-9206-2018; HUSSEIN, AHMED ABDULQADER/O-8158-2019	LEOW, CHEE YEN/0000-0001-6418-0184; HUSSEIN, AHMED ABDULQADER/0000-0002-7929-8668	Ministry of Higher Education Malaysia and Universiti Teknologi Malaysia [4F818, 4J210, 12H35]	Ministry of Higher Education Malaysia and Universiti Teknologi Malaysia	The work of C.Y. Leow is jointly supported by the Ministry of Higher Education Malaysia and Universiti Teknologi Malaysia under vote number 4F818, 4J210 and 12H35. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; "The work of C.Y. Leow is jointly supported by the Ministry of Higher Education Malaysia and Universiti Teknologi Malaysia under vote number 4F818, 4J210 and 12H35."	Aalsalem MY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158072; Acs G, 2006, P 4 ACM WORKSH SEC A, P49; Ahsan Faraz, 2011, Journal of Theoretical and Applied Information Technology, V30, P55; Akyildiz IF, 2002, IEEE COMMUN MAG, V40, P102, DOI 10.1109/MCOM.2002.1024422; Ashraf QM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160311; Bao Hua Liu, 2008, International Journal of Sensor Networks, V3, P211, DOI 10.1504/IJSNET.2008.019006; Bao QR, 2016, INT CONF INFO SCI, P443, DOI 10.1109/ICIST.2016.7483455; Chen Y, 2011, P 9 ACM C EMB NETW S, P26; Chen YY, 2010, IEEE T VEH TECHNOL, V59, P2418, DOI 10.1109/TVT.2010.2044904; Chen YY, 2009, ACM T SENSOR NETWORK, V5, DOI 10.1145/1464420.1464422; Chuku N., 2013, P IEEE SOUTHEASTCON, P1; Do Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138449; Donlan BM, 2006, IEEE T WIREL COMMUN, V5, P2863, DOI 10.1109/TWC.2006.04482; Gao Y, 2014, 2014 TENTH INTERNATIONAL CONFERENCE ON COMPUTATIONAL INTELLIGENCE AND SECURITY (CIS), P633, DOI 10.1109/CIS.2014.147; Ge MM, 2014, LECT NOTES COMPUT SC, V8792, P462, DOI 10.1007/978-3-319-11698-3_35; Huang Y, 2015, INT J DISTRIB SENS N, DOI 10.1155/2015/587318; Hussein Ahmed Abdulqader, 2015, Journal of Theoretical and Applied Information Technology, V78, P53; HUSSEIN AA, 2015, JOURNAL OF THEORETIC, V71; Hussein AA, 2015, SENSORS-BASEL, V15, P30545, DOI 10.3390/s151229817; Jiang X, 2010, LECT NOTES COMPUT SC, V6476, P140, DOI 10.1007/978-3-642-17650-0_11; Jiuqiang Xu, 2010, Wireless Sensor Network, V2, P606, DOI 10.4236/wsn.2010.28072; Kim YY, 1999, IEEE J SEL AREA COMM, V17, P888, DOI 10.1109/49.768203; Kumari S, 2016, CONCURRENCY AND COMP; Li HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049141; Li MY, 2007, IEEE INFOCOM SER, P1307, DOI 10.1109/INFCOM.2007.155; Lin L, 2014, SENSORS-BASEL, V14, P14744, DOI 10.3390/s140814744; Liu H, 2009, EURASIP J ADV SIG PR, DOI 10.1155/2009/263540; Ma D, 2009, IEEE NETWORK, V23, P43, DOI 10.1109/MNET.2009.4804335; Mao G., 2009, LOCALIZATION ALGORIT, DOI [10.4018/978-1-60566-396-8, DOI 10.4018/978]; Mao GQ, 2007, COMPUT NETW, V51, P2467, DOI 10.1016/j.comnet.2006.11.007; Mpitziopoulos A, 2009, SECUR COMMUN NETW, V2, P145, DOI 10.1002/sec.81; Nam J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116709; Obaidat M, 2014, PRINCIPLES OF WIRELE; Pu C. C., 2014, P INT C FRONT COMM N, P1; Rhee IK, 2009, SENSORS-BASEL, V9, P56, DOI 10.3390/s90100056; Sen J, 2010, ARXIV PREPRINT ARXIV; Shim KA, 2016, IEEE COMMUN SURV TUT, V18, P577, DOI 10.1109/COMST.2015.2459691; Sookhak M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115324; Tague P, 2008, ANN ALLERTON CONF, P1221, DOI 10.1109/ALLERTON.2008.4797699; Tian F, 2008, WIRELESS COMMUNICATI, P1; Xing K, 2010, NETWORK SECURITY, P251, DOI 10.1007/978-0-387-73821-5_11; Xu W., 2005, P INT S MOBILE AD HO, P46, DOI [10.1145/1062689.1062697, DOI 10.1145/1062689.1062697]; Xu W., 2004, P 2004 ACM WORKSHOP, P80, DOI DOI 10.1145/1023646.1023661; Xu W., 2007, P 2007 8 INT C EL ME, DOI [10.1109/ICEMI.2007.4350524, DOI 10.1109/ICEMI.2007.4350524]; Xu WY, 2006, IEEE NETWORK, V20, P41, DOI 10.1109/MNET.2006.1637931; Xu WY, 2008, ACM T SENSOR NETWORK, V4, DOI 10.1145/1387663.1387664; Yu Seung Kim, 2012, IEEE International Conference on Communications (ICC 2012), P949, DOI 10.1109/ICC.2012.6364441; Zeng P, 2010, IEEE T CONSUM ELECTR, V56, P566, DOI 10.1109/TCE.2010.5505971; Zhang H, 2016, IEEE T CONTR SYST T, V24, P843, DOI 10.1109/TCST.2015.2462741; Zhang H, 2015, IEEE T AUTOMAT CONTR, V60, P3023, DOI 10.1109/TAC.2015.2409905; Zheng XY, 2014, IEEE T PARALL DISTR, V25, P1955, DOI 10.1109/TPDS.2013.281; Zhu Y, 2012, INTERNATIONAL JOURNA, V2012	52	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177326	10.1371/journal.pone.0177326	http://dx.doi.org/10.1371/journal.pone.0177326			43	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493977	Green Submitted, Green Published, gold			2022-12-26	WOS:000401314300087
J	Morrison, JM; Baker, KD; Zamor, RM; Nikolai, S; Elshahed, MS; Youssef, NH				Morrison, Jessica M.; Baker, Kristina D.; Zamor, Richard M.; Nikolai, Steve; Elshahed, Mostafa S.; Youssef, Noha H.			Spatiotemporal analysis of microbial community dynamics during seasonal stratification events in a freshwater lake (Grand Lake, OK, USA)	PLOS ONE			English	Article							GROWTH-PROMOTING BACTERIUM; SP-NOV.; POLYNUCLEOBACTER-NECESSARIUS; ORGANIC-MATTER; GEN.-NOV.; BACTERIOPLANKTON COMMUNITY; MARINE BACTERIOPLANKTON; EUTROPHIC LAKE; DIVERSITY; SEDIMENT	Many freshwater lakes undergo seasonal stratification, where the formation of phototrophic blooms in the epilimnion and subsequent sedimentation induces hypoxia/anoxia in the thermocline and hypolimnion. This autochthonously produced biomass represents a major seasonal organic input that impacts the entire ecosystem. While the limnological aspects of this process are fairly well documented, relatively little is known regarding the microbial community response to such events, especially in the deeper anoxic layers of the water column. Here, we conducted a spatiotemporal survey of the particle-associated and free-living microbial communities in a warm monomictic freshwater reservoir (Grand Lake O' the Cherokees) in northeastern Oklahoma, USA. Pre-stratification samples (March) harbored a homogeneous community throughout the oxygenated water column dominated by typical oligotrophic aquatic lineages (acl clade within Actinobacteria, and Flavobacterium within the Bacteroidetes). The onset of phototrophic blooming in June induced the progression of this baseline community into two distinct trajectories. Within the oxic epilimnion, samples were characterized by the propagation of phototrophic (Prochlorococcus), and heterotrophic (Planctomycetes, Verrucomicrobia, and Beta-Proteobacteria) lineages. Within the oxygen-deficient thermocline and hypolimnion, the sedimentation of surface biomass induced the development of a highly diverse community, with the enrichment of Chloroflexi, "Latescibacteria", Armatimonadetes, and Delta-Proteobacteria in the particle-associated fraction, and Gemmatimonadetes and "Omnitrophica" in the free-living fraction. Our work documents the development of multiple spatially and temporally distinct niches during lake stratification, and supports the enrichment of multiple yet-uncultured and poorly characterized lineages in the lake's deeper oxygen-deficient layers, an ecologically relevant microbial niche that is often overlooked in lakes diversity surveys.	[Morrison, Jessica M.; Baker, Kristina D.; Elshahed, Mostafa S.; Youssef, Noha H.] Oklahoma State Univ, Dept Microbiol & Mol Genet, Stillwater, OK 74078 USA; [Zamor, Richard M.; Nikolai, Steve] Grand River Dam Author, Vinita, OK USA	Oklahoma State University System; Oklahoma State University - Stillwater	Youssef, NH (corresponding author), Oklahoma State Univ, Dept Microbiol & Mol Genet, Stillwater, OK 74078 USA.	Noha@Okstate.edu	Youssef, Noha H./T-5198-2019; M.Zamor, Richard/AAG-7504-2019	Youssef, Noha H./0000-0001-9159-3785; M.Zamor, Richard/0000-0003-3512-2940; Baker, Kristina/0000-0003-2812-5502	Oklahoma State University	Oklahoma State University	This work was funded by Oklahoma State University startup-funds to N. H. Youssef.	Bahr M, 1996, AQUAT MICROB ECOL, V11, P271, DOI 10.3354/ame011271; Baltar F, 2012, MICROBIOLOGYOPEN, V1, P214, DOI 10.1002/mbo3.25; Beck DAC, 2013, PEERJ, V1, DOI 10.7717/peerj.23; Bendall ML, 2016, ISME J, V10, P1589, DOI 10.1038/ismej.2015.241; Bowman J, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P266, DOI 10.1007/0-387-30745-1_15; Bresciani M, 2013, EUR J REMOTE SENS, V46, P445, DOI 10.5721/EuJRS20134626; Buchan A, 2014, NAT REV MICROBIOL, V12, P686, DOI 10.1038/nrmicro3326; Cai HY, 2013, MICROB ECOL, V66, P73, DOI 10.1007/s00248-013-0224-1; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Carpenter SR, 2011, ANNU REV ENV RESOUR, V36, P75, DOI 10.1146/annurev-environ-021810-094524; Cebron A, 2004, APPL ENVIRON MICROB, V70, P6726, DOI 10.1128/AEM.70.11.6726-6737.2004; Chauhan A, 2006, APPL ENVIRON MICROB, V72, P2400, DOI 10.1128/AEM.72.4.2400-2406.2006; Chen YW, 2003, J PLANKTON RES, V25, P445, DOI 10.1093/plankt/25.4.445; Chistoserdova L, 2011, APPL ENVIRON MICROB, V77, P4705, DOI 10.1128/AEM.00314-11; Cho DH, 2015, BIORESOURCE TECHNOL, V175, P578, DOI 10.1016/j.biortech.2014.10.159; DIAPOULIS A, 1987, Acta Adriatica, V28, P85; Eiler A, 2004, ENVIRON MICROBIOL, V6, P1228, DOI 10.1111/j.1462-2920.2004.00657.x; Eiler A, 2014, ENVIRON MICROBIOL, V16, P2682, DOI 10.1111/1462-2920.12301; Flombaum P, 2013, P NATL ACAD SCI USA, V110, P9824, DOI 10.1073/pnas.1307701110; Fukunaga Y., 2014, PROKARYOTES OTHER MA, V4, P683; Fukunaga Y, 2009, J GEN APPL MICROBIOL, V55, P267, DOI 10.2323/jgam.55.267; Gallina N, 2011, J LIMNOL, V70, P186, DOI 10.4081/jlimnol.2011.186; Garcia SL, 2014, ENV MICROBIOL REP, V6, P21, DOI 10.1111/1758-2229.12104; Garcia SL, 2013, ISME J, V7, P137, DOI 10.1038/ismej.2012.86; Ghai R, 2012, SCI REP-UK, V2, DOI 10.1038/srep00490; Ghai R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023785; Ghylin TW, 2014, ISME J, V8, P2503, DOI 10.1038/ismej.2014.135; Glockner FO, 1999, APPL ENVIRON MICROB, V65, P3721; Glockner FO, 2000, APPL ENVIRON MICROB, V66, P5053, DOI 10.1128/AEM.66.11.5053-5065.2000; Glockner J, 2010, ENVIRON MICROBIOL, V12, P1218, DOI 10.1111/j.1462-2920.2010.02164.x; Gonzalez LE, 2000, APPL ENVIRON MICROB, V66, P1527, DOI 10.1128/AEM.66.4.1527-1531.2000; Gregoire P, 2011, INT J SYST EVOL MICR, V61, P1436, DOI 10.1099/ijs.0.025676-0; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hahn MW, 2007, INT J SYST EVOL MICR, V57, P936, DOI 10.1099/ijs.0.64807-0; Hahn MW, 2016, ISME J, V10, P1642, DOI 10.1038/ismej.2015.237; Hahn MW, 2009, INT J SYST EVOL MICR, V59, P2002, DOI 10.1099/ijs.0.005801-0; Hahn MW, 2004, J MICROBIOL METH, V57, P379, DOI 10.1016/j.mimet.2004.02.004; Hanert HH., 2006, PROKARYOTES, P990, DOI [DOI 10.1007/0-387-30747-8_46, 10.1007/0-387-30747-8_46]; Hedlund B. P., 2015, PROSTHECOBACTER BERG; Herren CM, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00013-16; Hiller KA, 2015, APPL ENVIRON MICROB, V81, P7114, DOI 10.1128/AEM.01986-15; Hugerth LW, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0834-7; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Imazaki I, 2010, CAN J MICROBIOL, V56, P333, DOI [10.1139/W10-019, 10.1139/w10-019]; Jackson CR, 2014, APPL ENVIRON MICROB, V80, P7186, DOI 10.1128/AEM.01844-14; Jezberova J, 2010, ENVIRON MICROBIOL, V12, P658, DOI 10.1111/j.1462-2920.2009.02106.x; Kalyuhznaya MG, 2009, ENV MICROBIOL REP, V1, P385, DOI 10.1111/j.1758-2229.2009.00046.x; Kalyuzhnaya MG, 2006, INT J SYST EVOL MICR, V56, P2819, DOI 10.1099/ijs.0.64191-0; Kan JJ, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00210; Kant R, 2011, J BACTERIOL, V193, P2900, DOI 10.1128/JB.00299-11; Kent AD, 2004, MICROB ECOL, V48, P550, DOI 10.1007/s00248-004-0244-y; Kent AD, 2006, ENVIRON MICROBIOL, V8, P1448, DOI 10.1111/j.1462-2920.2006.01039.x; Kim BH, 2014, BIOMASS BIOENERG, V69, P95, DOI 10.1016/j.biombioe.2014.07.015; Kirchman DL, 2002, FEMS MICROBIOL ECOL, V39, P91, DOI 10.1111/j.1574-6941.2002.tb00910.x; Klindworth A, 2014, MAR GENOM, V18, P185, DOI 10.1016/j.margen.2014.08.007; Kojima H, 2014, SCI REP-UK, V4, DOI 10.1038/srep05728; Kormas KA, 2001, MAR ECOL-P S Z N I, V22, P201, DOI 10.1046/j.1439-0485.2001.01720.x; Kuever J., 2014, PROKARYOTES DELTAPRO, P45, DOI DOI 10.1007/978-3-642-39044-9_266; Lage OM, 2011, FEMS MICROBIOL ECOL, V78, P366, DOI 10.1111/j.1574-6941.2011.01168.x; Lage OM, FRONT MICROBIOL, V5, P1; Lee J, 2013, BIORESOURCE TECHNOL, V131, P195, DOI 10.1016/j.biortech.2012.11.130; Lee KCY, 2011, INT J SYST EVOL MICR, V61, P2482, DOI 10.1099/ijs.0.027235-0; Li N, 2015, ANTON LEEUW INT J G, V107, P305, DOI 10.1007/s10482-014-0327-9; Logue JB, 2004, LIMNOL OCEANOGR, V49, P2001, DOI 10.4319/lo.2004.49.6.2001; Logue JB, 2008, BIOSCIENCE, V58, P103, DOI 10.1641/B580205; Louati I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140614; Lovley DR, 2011, ADV MICROB PHYSIOL, V59, P1, DOI 10.1016/B978-0-12-387661-4.00004-5; Martinez-Garcia M, 2012, ISME J, V6, P113, DOI 10.1038/ismej.2011.84; Methe BA, 1998, LIMNOL OCEANOGR, V43, P368, DOI 10.4319/lo.1998.43.2.0368; MEYERS PA, 1993, ORG GEOCHEM, V20, P867, DOI 10.1016/0146-6380(93)90100-P; MEYERS PA, 1994, CHEM GEOL, V114, P289, DOI 10.1016/0009-2541(94)90059-0; Miller TR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074933; Mulamattathil S. G., 2014, J PATHOGENS, V2014, P11; Newton RJ, 2007, APPL ENVIRON MICROB, V73, P7169, DOI 10.1128/AEM.00794-07; Newton RJ, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01028; Nunez M, 2003, BIOPHYS J, V84, P3379, DOI 10.1016/S0006-3495(03)70061-7; Oestreicher Z, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00406; Oh S, 2011, APPL ENVIRON MICROB, V77, P6000, DOI 10.1128/AEM.00107-11; Okazaki Y, 2016, ENV MICROBIOL REP, V8, P780, DOI 10.1111/1758-2229.12439; Oksanen J., 2017, VEGAN INTRO ORDINATI; OWRB, 2009, STAT OKL WAT RES BOA; OWRB, STAT OKL WAT RES BOA; Page KA, 2004, APPL ENVIRON MICROB, V70, P6542, DOI 10.1128/AEM.70.11.6542-6550.2004; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Parveen B, 2013, ENV MICROBIOL REP, V5, P716, DOI 10.1111/1758-2229.12071; Perry KA, 1990, CHEM LIMNOLOGY 2 MER; Ramanan R, 2016, BIOTECHNOL ADV, V34, P14, DOI 10.1016/j.biotechadv.2015.12.003; Ramanan R, 2015, ALGAL RES, V8, P140, DOI 10.1016/j.algal.2015.02.003; Reichenbach H., 2015, MYXOCOCCALES BERGEYS; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Rinta-Kanto JM, 2012, ENVIRON MICROBIOL, V14, P228, DOI 10.1111/j.1462-2920.2011.02602.x; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Schiaffino MR, 2016, J PLANKTON RES, V38, P64, DOI 10.1093/plankt/fbv105; Sack ELW, 2011, APPL ENVIRON MICROB, V77, P6931, DOI 10.1128/AEM.00372-11; SALEEM S., 2011, JES, V2, P185; Sapp M, 2007, MICROB ECOL, V53, P683, DOI 10.1007/s00248-006-9162-5; Schauer M, 2006, APPL ENVIRON MICROB, V72, P4704, DOI 10.1128/AEM.02935-05; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schwarz JIK, 2007, SYST APPL MICROBIOL, V30, P239, DOI 10.1016/j.syapm.2006.05.004; Sekiguchi Y, 2003, INT J SYST EVOL MICR, V53, P1843, DOI 10.1099/ijs.0.02699-0; Shade A, 2011, ENVIRON MICROBIOL, V13, P2752, DOI 10.1111/j.1462-2920.2011.02546.x; Shi LM, 2012, ENV MICROBIOL REP, V4, P669, DOI 10.1111/1758-2229.12001; Sison-Mangus MP, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01433; Smalley NE, 2015, INT J SYST EVOL MICR, V65, P2227, DOI 10.1099/ijs.0.000190; Spring S, 2000, FEMS MICROBIOL REV, V24, P573, DOI 10.1016/S0168-6445(00)00046-2; Steffen MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044002; Stoecker K, 2006, P NATL ACAD SCI USA, V103, P2363, DOI 10.1073/pnas.0506361103; Tamaki H, 2005, APPL ENVIRON MICROB, V71, P2162, DOI 10.1128/AEM.71.4.2162-2169.2005; Tamaki H, 2011, INT J SYST EVOL MICR, V61, P1442, DOI 10.1099/ijs.0.025643-0; Taylor CB, 1942, J HYG-CAMBRIDGE, V42, P284, DOI 10.1017/S0022172400035488; Teeling H, 2012, SCIENCE, V336, P608, DOI 10.1126/science.1218344; Tseng CH, 2013, ISME J, V7, P2374, DOI 10.1038/ismej.2013.118; Uyaguari-Diaz MI, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0166-1; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007401; Watanabe K, 2009, FEMS MICROBIOL ECOL, V67, P57, DOI 10.1111/j.1574-6941.2008.00606.x; Wells ML, 2015, HARMFUL ALGAE, V49, P68, DOI 10.1016/j.hal.2015.07.009; White RA, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01531; Williams TJ, 2013, ENVIRON MICROBIOL, V15, P1302, DOI 10.1111/1462-2920.12017; Woodhouse JN, 2013, J APPL PHYCOL, V25, P1039, DOI 10.1007/s10811-012-9909-y; Wu LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101837; Xie CH, 2005, INT J SYST EVOL MICR, V55, P2419, DOI 10.1099/ijs.0.63733-0; Yannarell AC, 2005, APPL ENVIRON MICROB, V71, P227, DOI 10.1128/AEM.71.1.227-239.2005; Yannarell AC, 2004, APPL ENVIRON MICROB, V70, P214, DOI 10.1128/AEM.70.1.214-223.2004; Yannarell AC, 2003, MICROB ECOL, V46, P391, DOI 10.1007/s00248-003-1008-9; Ye WJ, 2011, HARMFUL ALGAE, V10, P472, DOI 10.1016/j.hal.2011.03.002; Youssef NH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127499; Zaremba-Niedzwiedzka K, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-11-r130; Zwart G, 2002, AQUAT MICROB ECOL, V28, P141, DOI 10.3354/ame028141	131	28	31	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177488	10.1371/journal.pone.0177488	http://dx.doi.org/10.1371/journal.pone.0177488			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493994	gold, Green Published, Green Submitted			2022-12-26	WOS:000401314300119
J	Provencio, M; Sabin, P; Gomez-Codina, J; Torrente, M; Calvo, V; Llanos, M; Guma, J; Quero, C; Blasco, A; Cruz, MA; Aguiar, D; Garcia-Arroyo, F; Lavernia, J; Martinez, N; Morales, M; Saez-Cusi, A; Rodriguez, D; de la Cruz, L; Sanchez, JJ; Rueda, A				Provencio, Mariano; Sabin, Pilar; Gomez-Codina, Jose; Torrente, Maria; Calvo, Virginia; Llanos, Marta; Guma, Josep; Quero, Cristina; Blasco, Ana; Angel Cruz, Miguel; Aguiar, David; Garcia-Arroyo, Francisco; Lavernia, Javier; Martinez, Natividad; Morales, Manuel; Saez-Cusi, Alvaro; Rodriguez, Delvys; de la Cruz, Luis; Javier Sanchez, Jose; Rueda, Antonio		GOTEL Spanish Lymphoma Oncology Gr	Impact of treatment in long-term survival patients with follicular lymphoma: A Spanish Lymphoma Oncology Group registry	PLOS ONE			English	Article							NON-HODGKINS-LYMPHOMAS; PROGNOSTIC-FACTORS; TRANSFORMATION; OUTCOMES; TIME	Background Follicular lymphoma is the second most common non-Hodgkin lymphoma in the United States and Europe. However, most of the prospective randomized studies have very little follow-up compared to the long natural history of the disease. The primary aim of this study was to investigate the long-term survival of our series of patients with follicular lymphoma. Patients and methods A total of 1074 patients with newly diagnosed FL were enrolled. Patients diagnosed were prospectively enrolled from 1980 to 2013. Results Median follow-up was 54.9 months and median overall survival is over 20 years in our series. We analyzed the patients who are still alive beyond 10 years from diagnosis in order to fully assess the prognostic factors that condition this group. Out of 166 patients who are still alive after more than 10 years of follow-up, 118 of them (73%) are free of evident clinical disease. Variables significantly associated with survival at 10 years were stage < II (p <0.03), age < 60 years (p <0.0001), low FLIPI (p <0.002), normal beta 2 microglobulin (p <0.005), no B symptoms upon diagnosis (p <0.02), Performance Status 0-1 (p <0.03) and treatment with anthra-cyclines and rituximab (p <0.001), or rituximab (p <0.0001). Conclusions A longer follow-up and a large series demonstrated a substantial population of patients with follicular lymphoma free of disease for more than 10 years.	[Provencio, Mariano; Torrente, Maria; Calvo, Virginia] Hosp Univ Puerta de Hierro Majadahonda, Dept Med Oncol, Madrid, Spain; [Sabin, Pilar] Hosp Univ Gregorio Maranon, Dept Med Oncol, Madrid, Spain; [Gomez-Codina, Jose] Hosp Univ La Fe, Dept Med Oncol, Valencia, Spain; [Llanos, Marta] Hosp Univ Canarias, Dept Med Oncol, Tenerife, Spain; [Guma, Josep] Hosp Univ San Joan de Reus, Dept Med Oncol, Tarragona, Spain; [Quero, Cristina] Hosp Univ Virgen de la Victoria, Dept Med Oncol, Malaga, Spain; [Blasco, Ana] Hosp Gen Univ, Dept Med Oncol, Valencia, Spain; [Angel Cruz, Miguel] Hosp Virgen de la Salud, Dept Med Oncol, Toledo, Spain; [Aguiar, David] Hosp Univ Gran Canaria Doctor Negrin, Dept Med Oncol, Las Palmas Gran Canaria, Spain; [Garcia-Arroyo, Francisco] Complejo Hosp Pontevedra, Dept Med Oncol, Pontevedra, Spain; [Lavernia, Javier] Inst Valenciano Oncol, Dept Oncol, Valencia, Spain; [Martinez, Natividad] Hosp Gen Univ Elche, Dept Med Oncol, Alicante, Spain; [Morales, Manuel] Hosp Univ Nuestra Senora de Candelaria, Dept Med Oncol, Santa Cruz De Tenerife, Spain; [Saez-Cusi, Alvaro] Hosp Clin Univ Lozano Blesa, Dept Med Oncol, Zaragoza, Spain; [Rodriguez, Delvys] Hosp Univ Insular Gran Canaria, Dept Med Oncol, Las Palmas Gran Canaria, Spain; [de la Cruz, Luis] Hosp Univ Virgen de la Macarena, Dept Med Oncol, Seville, Spain; [Javier Sanchez, Jose] Univ Autonoma Nuevo Leon, Monterrey, Mexico; [Rueda, Antonio] Hosp Costa Sol, Dept Med Oncol, Marbella, Spain	Hospital Puerta de Hierro-Majadahonda; General University Gregorio Maranon Hospital; Hospital Universitari i Politecnic La Fe; Universidad de la Laguna; Hospital Virgen de la Victoria; Universidad de Malaga; Hospital Clinic Universitari de Valencia; Complejo Hospitalario de Toledo; Complexo Hospitalario Universitario de Pontevedra; Instituto Valenciano De Oncologia; Lozano Blesa University Clinical Hospital; Universidad Autonoma de Nuevo Leon	Provencio, M (corresponding author), Hosp Univ Puerta de Hierro Majadahonda, Dept Med Oncol, Madrid, Spain.	mariano.provencio@salud.madrid.org	Provencio, Mariano/ABE-8586-2020; de Juan, Virginia Calvo/AAD-4505-2021; Blasco, Ana/D-7970-2018; Morales, Manuel/ABG-4659-2021; Martínez Madrid, Natividad/Y-2636-2018	Provencio, Mariano/0000-0001-9053-9197; Blasco, Ana/0000-0002-5625-235X; Martínez Madrid, Natividad/0000-0003-1965-9481; Blasco Cordellat, Ana/0000-0001-5889-0382; Martinez-Banaclocha, Natividad/0000-0002-7515-5037; Calvo de Juan, Virginia/0000-0002-3503-4847; Provencio Pulla, Mariano/0000-0001-6315-7919; TORRENTE, MARIA/0000-0001-8791-7660				Armitage JO, 1998, J CLIN ONCOL, V16, P2780, DOI 10.1200/JCO.1998.16.8.2780; Chan WC, 1997, BLOOD, V89, P3909; Chau I, 2003, BRIT J CANCER, V89, P36, DOI 10.1038/sj.bjc.6601006; COIFFIER B, 1993, SEMIN ONCOL, V20, P89; Conconi A, 2015, ANN ONCOL, V26, P2317, DOI 10.1093/annonc/mdv376; Conconi A, 2010, LEUKEMIA LYMPHOMA, V51, P1028, DOI 10.3109/10428191003743460; CULLEN MH, 1979, CANCER, V44, P645, DOI 10.1002/1097-0142(197908)44:2<645::AID-CNCR2820440234>3.0.CO;2-Y; Curado M., 2009, CANC INCIDENCE 5 CON, VIX; De Sanjose S., 2008, MED CLIN BARC S1, V131, p72 ; Denham JW, 1996, EUR J CANCER, V32A, P480, DOI 10.1016/0959-8049(95)00635-4; Dreyling M, 2014, ANN ONCOL, V25, P76, DOI [10.1093/annonc/mdu200, 10.1093/annonc/mdx020]; Federico M, 2013, J CLIN ONCOL, V31, P1506, DOI 10.1200/JCO.2012.45.0866; Federico M, 2009, J CLIN ONCOL, V27, P4555, DOI 10.1200/JCO.2008.21.3991; Fisher RI, 2005, J CLIN ONCOL, V23, P8447, DOI 10.1200/JCO.2005.03.1674; Gangatharan SA, 2015, BRIT J HAEMATOL, V170, P384, DOI 10.1111/bjh.13451; GARVIN AJ, 1983, CANCER-AM CANCER SOC, V52, P393, DOI 10.1002/1097-0142(19830801)52:3<393::AID-CNCR2820520302>3.0.CO;2-M; HORNING SJ, 1984, NEW ENGL J MED, V311, P1471, DOI 10.1056/NEJM198412063112303; Nabhan C, 2014, AM J HEMATOL, V89, P633, DOI 10.1002/ajh.23708; Nastoupil LJ, 2014, CANCER-AM CANCER SOC, V120, P1830, DOI 10.1002/cncr.28659; Provencio M, 2012, CLIN TRANSL ONCOL, V14, P386, DOI 10.1007/s12094-012-0813-3; Relander T, 2010, J CLIN ONCOL, V28, P2902, DOI 10.1200/JCO.2009.26.1693; Sarkozy C, 2016, J CLIN ONCOL, V34, P2575, DOI 10.1200/JCO.2015.65.7163; Sebban C, 2008, J CLIN ONCOL, V26, P3614, DOI 10.1200/JCO.2007.15.5358; Solal-Celigny P, 2012, J CLIN ONCOL, V30, P3848, DOI 10.1200/JCO.2010.33.4474; SOUBEYRAN P, 1991, EUR J CANCER, V27, P1606, DOI 10.1016/0277-5379(91)90425-D; Swenson WT, 2005, J CLIN ONCOL, V23, P5019, DOI 10.1200/JCO.2005.04.503; Swerdlow SH, 2008, WHO CLASSIFICATION T, P200; van de Schans SAM, 2009, ANN ONCOL, V20, P1697, DOI 10.1093/annonc/mdp053; YOUNG RC, 1988, SEMIN HEMATOL, V25, P11	29	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177204	10.1371/journal.pone.0177204	http://dx.doi.org/10.1371/journal.pone.0177204			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493986	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314300071
J	Ha, TMH; Yong, D; Lee, EMY; Kumar, P; Lee, YK; Zhou, WBA				Thi Mai Hoa Ha; Yong, Derrick; Lee, Elizabeth Mei Yin; Kumar, Prathab; Lee, Yuan Kun; Zhou, Weibiao			Activation and inactivation of Bacillus pumilus spores by kiloelectron volt X-ray irradiation	PLOS ONE			English	Article							RELATIVE BIOLOGICAL EFFECTIVENESS; PHASE-CONTRAST MICROSCOPY; ESCHERICHIA-COLI O157H7; DNA-REPAIR; IONIZING-RADIATION; RAMAN-SPECTROSCOPY; HEAT ACTIVATION; HIGH-PRESSURE; GERMINATION; RESISTANCE	In this study, we investigated the inactivation efficacy of endospore-forming bacteria, Bacillus pumilus, irradiated by low-energy X-rays of different beam qualities. The different low-energy X-rays studied had cut-off energies of 50, 100 and 150 keV. Bacillus pumilus spores (in biological indicator strips) were irradiated at step doses between 6.5 to 390 Gy. The resulting bacteria populations were then quantified by a pour plate method. Results showed that X-rays of lower energies were more effective in inactivating bacterial spores. In addition, an increment in bacterial population was observed at doses below 13Gy. We attributed this increase to a radiation-induced activation of bacterial spores. Four kinetic models were then evaluated for their prediction of bacterial spore behavior under irradiation. This included: (i) first-order kinetics model; (ii) Shull model; (iii) Sapru model; and (iv) probabilistic model. From R-2 and AIC analyses, we noted that the probabilistic model performed the best, followed by the Sapru model. We highlighted that for simplicity in curve fitting the Sapru model should be used instead of the probabilistic model. A 12-log reduction in bacterial population (corresponding to a sterility assurance level of 10-6 as required in the sterilization of medical devices) was computed to be achievable at doses of 1000, 1600 and 2300 Gy for the three different X-ray cut-off energies respectively. These doses are an order in magnitude lesser than that required in gamma irradiation. This highlights the applicability of cheaper and safer table-top X-ray sources for sterilization application.	[Thi Mai Hoa Ha; Yong, Derrick; Lee, Elizabeth Mei Yin] Singapore Inst Mfg Technol, Singapore, Singapore; [Lee, Elizabeth Mei Yin] Nanyang Technol Univ, Sch Elect & Elect Engn, Singapore, Singapore; [Kumar, Prathab; Zhou, Weibiao] Natl Univ Singapore, Dept Chem, Food Sci & Technol Programme, Singapore, Singapore; [Lee, Yuan Kun] Natl Univ Singapore, Dept Microbiol, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute of Manufacturing Technology (SIMTech); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; National University of Singapore	Ha, TMH (corresponding author), Singapore Inst Mfg Technol, Singapore, Singapore.	tmhha@simtech.a-star.edu.sg	Zhou, Weibiao/AAG-8840-2020; Lee, Elizabeth/Q-9074-2019	Zhou, Weibiao/0000-0002-4990-9835; Yong, Derrick/0000-0001-6806-8472	Agency of Science Technology and Research (A*STAR), as well as its Graduate Scholarship	Agency of Science Technology and Research (A*STAR), as well as its Graduate Scholarship(Agency for Science Technology & Research (A*STAR))	This work was supported by the Agency of Science Technology and Research (A*STAR), as well as its Graduate Scholarship.; This work was supported by the Agency of Science Technology and Research (A*STAR) as well as its Graduate Scholarship. The authors also wish to thank NGUYEN Thi Quynh Ngoc at Singapore Center for Environmental Life Sciences Engineering (SCELSE), Nanyang Technological University for her help on phase-contrast microscopy of spores.	AGENCY IAE, 2008, TRENDS RAD STERILIZA; AKAIKE H, 1981, J ECONOMETRICS, V16, P3, DOI 10.1016/0304-4076(81)90071-3; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Aleid SM, 2013, INT J FOOD SCI TECH, V48, P1453, DOI 10.1111/ijfs.12112; Alpen EL, 1998, RAD BIOPHYSICS, P365; Bacq ZM, 1961, PERGAMON, P239; Brenner DJ, 1999, PHYS MED BIOL, V44, P323, DOI 10.1088/0031-9155/44/2/002; Cavanaugh JE, 1997, STAT PROBABIL LETT, V33, P201, DOI 10.1016/S0167-7152(96)00128-9; Eijlander RT, 2011, CURR OPIN BIOTECH, V22, P180, DOI 10.1016/j.copbio.2010.11.009; ESTAR PSTAR and ASTAR, 2005, COMP PROGR CALC STOP; Ghosh S, 2012, J BACTERIOL, V194, P2221, DOI 10.1128/JB.00151-12; GOODHEAD DT, 1994, INT J RADIAT BIOL, V65, P7, DOI 10.1080/09553009414550021; Hada M, 2006, RADIAT RES, V165, P223, DOI 10.1667/RR3498.1; Hill MA, 2004, RADIAT PROT DOSIM, V112, P471, DOI 10.1093/rpd/nch091; Horneck G, 1989, Adv Space Res, V9, P105, DOI 10.1016/0273-1177(89)90428-6; Hornstra LM, 2009, INT J FOOD MICROBIOL, V134, P9, DOI 10.1016/j.ijfoodmicro.2009.02.011; Horowitz J, 2010, APPL ENVIRON MICROB, V76, P230, DOI 10.1128/AEM.01527-09; Hunter N, 2009, J RADIOL PROT, V29, P5, DOI 10.1088/0952-4746/29/1/R01; Jeong S, 2012, INT J FOOD MICROBIOL, V153, P365, DOI 10.1016/j.ijfoodmicro.2011.11.028; Jeong S, 2010, J FOOD PROTECT, V73, P547, DOI 10.4315/0362-028X-73.3.547; Kong LB, 2014, APPL ENVIRON MICROB, V80, P345, DOI 10.1128/AEM.03043-13; Kong LB, 2011, NAT PROTOC, V6, P625, DOI 10.1038/nprot.2011.307; Kong LB, 2010, ANAL CHEM, V82, P3840, DOI 10.1021/ac1003322; Leuschner RGK, 1999, LETT APPL MICROBIOL, V29, P228, DOI 10.1046/j.1365-2672.1999.00604.x; LING CC, 1995, INT J RADIAT ONCOL, V32, P373, DOI 10.1016/0360-3016(95)00530-C; Mahmoud BSM, 2010, FOOD MICROBIOL, V27, P24, DOI 10.1016/j.fm.2009.07.004; Mahmoud BSM, 2009, FOOD MICROBIOL, V26, P860, DOI 10.1016/j.fm.2009.05.013; Mahmoud BSM, 2009, INT J FOOD MICROBIOL, V130, P135, DOI 10.1016/j.ijfoodmicro.2009.01.023; Moeller R, 2005, FEMS MICROBIOL ECOL, V51, P231, DOI 10.1016/j.femsec.2004.08.008; Moeller R, 2008, J BACTERIOL, V190, P1134, DOI 10.1128/JB.01644-07; Moeller R, 2014, APPL ENVIRON MICROB, V80, P104, DOI 10.1128/AEM.03136-13; Moosekian SR, 2014, FOOD CONTROL, V36, P243, DOI 10.1016/j.foodcont.2013.08.024; Motulsky Harvey J., 2004, P1; Nagler K, 2014, APPL ENVIRON MICROB, V80, P1314, DOI 10.1128/AEM.03293-13; Nicholson WL, 2000, MICROBIOL MOL BIOL R, V64, P548, DOI 10.1128/MMBR.64.3.548-572.2000; Pandey R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058972; SAPRU V, 1992, J FOOD SCI, V57, P1248, DOI 10.1111/j.1365-2621.1992.tb11310.x; Setlow B, 1996, J BACTERIOL, V178, P3486, DOI 10.1128/jb.178.12.3486-3495.1996; Setlow P, 2006, J APPL MICROBIOL, V101, P514, DOI 10.1111/j.1365-2672.2005.02736.x; Setlow P, 2013, J APPL MICROBIOL, V115, P1251, DOI 10.1111/jam.12343; Setlow P, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.TBS-0003-2012; SHULL JJ, 1963, APPL MICROBIOL, V11, P485, DOI 10.1128/AEM.11.6.485-487.1963; SYMONS MCR, 1994, RADIAT PHYS CHEM, V43, P403, DOI 10.1016/0969-806X(94)90035-3; Tirumalai RS, 2006, PHARMACOPEIAL FORUM, V27; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Wei J, 2010, J BACTERIOL, V192, P1455, DOI 10.1128/JB.01497-09	46	12	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177571	10.1371/journal.pone.0177571	http://dx.doi.org/10.1371/journal.pone.0177571			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493969	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314300137
J	Bollum, LK; Huse, K; Oksvold, MP; Bai, BY; Hilden, VI; Forfang, L; Yoon, SO; Walchli, S; Smeland, EB; Myklebust, JH				Bollum, Lise K.; Huse, Kanutte; Oksvold, Morten P.; Bai, Baoyan; Hilden, Vera I.; Forfang, Lise; Yoon, Sun Ok; Walchli, Sebastien; Smeland, Erlend B.; Myklebust, June H.			BMP-7 induces apoptosis in human germinal center B cells and is influenced by TGF-beta receptor type I ALK5	PLOS ONE			English	Article							UP-REGULATION; HEMATOPOIETIC STEM; SMAD; DIFFERENTIATION; ACTIVATION; GROWTH; IL-21; PROLIFERATION; INHIBITION; INDUCTION	Selection and maturation of B cells into plasma cells producing high-affinity antibodies occur in germinal centers (GC). GCs form transiently in secondary lymphoid organs upon antigen challenge, and the GC reaction is a highly regulated process. TGF-beta is a potent negative regulator, but the influence of other family members including bone morphogenetic proteins (BMPs) is less known. Studies of human peripheral blood B lymphocytes showed that BMP-6 suppressed plasmablast differentiation, whereas BMP-7 induced apoptosis. Here, we show that human naive and GC B cells had a strikingly different receptor expression pattern. GC B cells expressed high levels of BMP type I receptor but low levels of type II receptors, whereas naive B cells had the opposite pattern. Furthermore, GC B cells had elevated levels of downstream signaling components SMAD1 and SMAD5, but reduced levels of the inhibitory SMAD7. Functional assays of GC B cells revealed that BMP-7 suppressed the viability-promoting effect of CD40L and IL-21, but had no effect on CD40L- and IL-21-induced differentiation into plasmablasts. BMP-7-induced apoptosis was counteracted by a selective TGF-beta type I receptor (ALK4/5/7) inhibitor, but not by a selective BMP receptor type I inhibitor. Furthermore, overexpression of truncated ALK5 in a B-cell line counteracted BMP-7-induced apoptosis, whereas overexpression of truncated ALK4 had no effect. BMP-7 mRNA and protein was readily detected in tonsillar B cells, indicating a physiological relevance of the study. Altogether, we identified BMP-7 as a negative regulator of GC B-cell survival. The effect was counteracted by truncated ALK5, suggesting greater complexity in regulating BMP-7 signaling than previously believed.	[Bollum, Lise K.; Huse, Kanutte; Oksvold, Morten P.; Bai, Baoyan; Hilden, Vera I.; Forfang, Lise; Walchli, Sebastien; Smeland, Erlend B.; Myklebust, June H.] Norwegian Radium Hosp, Inst Canc Res, Dept Canc Immunol, Oslo, Norway; [Bollum, Lise K.; Huse, Kanutte; Oksvold, Morten P.; Bai, Baoyan; Hilden, Vera I.; Forfang, Lise; Walchli, Sebastien; Smeland, Erlend B.; Myklebust, June H.] Univ Oslo, Ctr Canc Biomed, Oslo, Norway; [Bollum, Lise K.] Univ Oslo, Fac Med, Oslo, Norway; [Yoon, Sun Ok] Ochsner Clin Fdn, Lab Cellular Immunol, New Orleans, LA USA; [Yoon, Sun Ok] Seoul Natl Univ, Transplantat Res Inst, Coll Med, Seoul, South Korea; [Walchli, Sebastien] Norwegian Radium Hosp, Dept Cellular Therapy, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; Ochsner Health System; Seoul National University (SNU); University of Oslo	Myklebust, JH (corresponding author), Norwegian Radium Hosp, Inst Canc Res, Dept Canc Immunol, Oslo, Norway.; Myklebust, JH (corresponding author), Univ Oslo, Ctr Canc Biomed, Oslo, Norway.	junehm@rr-research.no	Myklebust, June Helen/ABH-6494-2020; Smeland, Erlend/AAO-3214-2020	Myklebust, June Helen/0000-0003-0394-9986; Huse, Kanutte/0000-0001-9128-670X; Walchli, Sebastien/0000-0001-5869-1746				Bakkebo M, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-57; Bhatia M, 1999, J EXP MED, V189, P1139, DOI 10.1084/jem.189.7.1139; Borggrete I, 2016, BIOCHIM BIOPHYS ACTA, V1863, P303; Bragdon B, 2011, CELL SIGNAL, V23, P609, DOI 10.1016/j.cellsig.2010.10.003; Bryant VL, 2007, J IMMUNOL, V179, P8180, DOI 10.4049/jimmunol.179.12.8180; Camara-Clayette V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073993; CASAMAYORPALLEJA M, 1995, J EXP MED, V181, P1293, DOI 10.1084/jem.181.4.1293; Cazac BB, 2000, IMMUNITY, V13, P443, DOI 10.1016/S1074-7613(00)00044-3; Chadwick K, 2003, BLOOD, V102, P906, DOI 10.1182/blood-2003-03-0832; Chen WJ, 2016, NAT REV IMMUNOL, V16, P723, DOI 10.1038/nri.2016.112; Ding BB, 2013, J IMMUNOL, V190, P1827, DOI 10.4049/jimmunol.1201678; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Fuchs O, 2002, BLOOD CELL MOL DIS, V28, P221, DOI 10.1006/bcmd.2002.0487; Ginkel FWv, 1999, J IMMUNOL, V163, P1951; Goldman DC, 2009, BLOOD, V114, P4393, DOI 10.1182/blood-2009-02-206433; Greenwald J, 2004, MOL CELL, V15, P485, DOI 10.1016/j.molcel.2004.07.011; Hildebrand L, 2017, CELL SIGNAL, V29, P23, DOI 10.1016/j.cellsig.2016.10.001; Holien T, 2012, LEUKEMIA, V26, P1073, DOI 10.1038/leu.2011.263; Holtzhausen A, 2014, FASEB J, V28, P1248, DOI 10.1096/fj.13-239178; Huse K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046117; Huse K, 2011, EUR J IMMUNOL, V41, P3135, DOI 10.1002/eji.201141558; Itoh S, 2003, J BIOL CHEM, V278, P3751, DOI 10.1074/jbc.M208258200; Kersten C, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-9; Kersten C, 2006, EXP HEMATOL, V34, P72, DOI 10.1016/j.exphem.2005.09.010; Khurana S, 2013, BLOOD, V121, P781, DOI 10.1182/blood-2012-07-446443; KIM HS, 1995, J IMMUNOL, V155, P1101; KIM HS, 1994, J IMMUNOL, V153, P2951; Klein U, 2008, NAT REV IMMUNOL, V8, P22, DOI 10.1038/nri2217; Lagna G, 2006, AM J PHYSIOL-LUNG C, V291, pL1059, DOI 10.1152/ajplung.00180.2006; Lu Q, 2009, AM J PHYSIOL-LUNG C, V296, pL825, DOI 10.1152/ajplung.90307.2008; MartinezValdez H, 1996, J EXP MED, V183, P971, DOI 10.1084/jem.183.3.971; Miyazono K., 2002, SCI SIGNAL TRANSDUCT, V2002, pE40, DOI DOI 10.1126/3114E.2002.151.0E40; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Mueller TD, 2012, FEBS LETT, V586, P1846, DOI 10.1016/j.febslet.2012.02.043; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Pene J, 2004, J IMMUNOL, V172, P5154, DOI 10.4049/jimmunol.172.9.5154; Pi WF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035283; Piek E, 1999, J CELL SCI, V112, P4557; Recher M, 2011, BLOOD, V118, P6824, DOI 10.1182/blood-2011-06-362533; Ro TB, 2004, ONCOGENE, V23, P3024, DOI 10.1038/sj.onc.1207386; Seckinger A, 2009, ONCOGENE, V28, P3866, DOI 10.1038/onc.2009.257; Shimizu T, 2012, BIOCHEM BIOPH RES CO, V417, P869, DOI 10.1016/j.bbrc.2011.12.064; SHOKAT KM, 1995, NATURE, V375, P334, DOI 10.1038/375334a0; Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007; SMELAND EB, 1987, EXP CELL RES, V171, P213, DOI 10.1016/0014-4827(87)90264-3; Spender LC, 2009, CELL DEATH DIFFER, V16, P593, DOI 10.1038/cdd.2008.183; TENDIJKE P, 1994, J BIOL CHEM, V269, P16985; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Wakefield LM, 2013, NAT REV CANCER, V13, P328, DOI 10.1038/nrc3500; Walchli S, 2011, PLOS ONE, V6; Weber D, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-6; Yang SX, 2006, CANCER RES, V66, P4285, DOI 10.1158/0008-5472.CAN-05-4456; Yang Y, 2009, MIDWEST SYMP CIRCUIT, P5, DOI 10.1109/MWSCAS.2009.5236167; Yoon SO, 2009, J IMMUNOL, V183, P352, DOI 10.4049/jimmunol.0803183; Zhang S, 2003, AM J PHYSIOL-LUNG C, V285, pL740, DOI 10.1152/ajplung.00284.2002	55	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177188	10.1371/journal.pone.0177188	http://dx.doi.org/10.1371/journal.pone.0177188			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489883	gold, Green Submitted, Green Published			2022-12-26	WOS:000401314100054
J	McDonald, AT; Gates, TA; Zanno, LE; Makovicky, PJ				McDonald, Andrew T.; Gates, Terry A.; Zanno, Lindsay E.; Makovicky, Peter J.			Anatomy, taphonomy, and phylogenetic implications of a new specimen of Eolambia caroljonesa (Dinosauria: Ornithopoda) from the Cedar Mountain Formation, Utah, USA	PLOS ONE			English	Article							CRETACEOUS KITADANI FORMATION; HADROSAUROID DINOSAUR; ORNITHISCHIA ORNITHOPODA; GROWTH DYNAMICS; DELAPPARENTIA-TUROLENSIS; JINZHOUSAURUS-YANGI; YIXIAN FORMATION; NORTH-AMERICA; CHINA; SPAIN	Background Eolambia caroljonesa is the most abundant dinosaur in the lower Cenomanian Mussentuchit Member of the Cedar Mountain Formation of Utah, and one of the most completely known non-hadrosaurid iguanodontians from North America. In addition to the large holotype and paratype partial skulls, copious remains of skeletally immature individuals, including three bonebeds, have been referred to E. caroljonesa. Nevertheless, aspects of the postcranial anatomy of this taxon, particularly the pelvic girdle, have remained ambiguous due to the lack of associated postcranial material of larger, more mature individuals. Methodology/Principal findings Here we describe a recently discovered associated partial postcranial skeleton of a large Eolambia caroljonesa. This specimen, FMNH PR 3847, provides new anatomical data regarding the vertebral column and pelvic girdle, supplementing previous diagnoses and descriptions of E. caroljonesa. A new phylogenetic analysis incorporating information from FMNH PR 3847 places E. caroljonesa as a basal hadrosauromorph closely related to Protohadros byrdi from the Cenomanian Woodbine Formation of Texas. Histological analysis of FMNH PR 3847 reveals that it represents a subadult individual eight to nine years of age. Taphonomic analysis indicates that FMNH PR 3847 was preserved in a crevasse splay deposit, along with an unusual abundance of small crocodylomorph material. Conclusions/Significance FMNH PR 3847 provides a wealth of new morphological data, adding to the anatomical and systematic characterization of Eolambia caroljonesa, and histological data, revealing new information on growth history in a basal hadrosauromorph. Taphonomic characterization of FMNH PR 3847 and associated vertebrate material will allow comparison with other vertebrate localities in the Mussentuchit Member of the Cedar Mountain Formation.	[McDonald, Andrew T.] St Louis Sci Ctr, St Louis, MO 63110 USA; [Gates, Terry A.; Zanno, Lindsay E.] North Carolina State Univ, Dept Biol Sci, Raleigh, NC USA; [Gates, Terry A.; Zanno, Lindsay E.] North Carolina Museum Nat Sci, Raleigh, NC USA; [Makovicky, Peter J.] Field Museum Nat Hist, Sect Earth Sci, Chicago, IL 60605 USA	Saint Louis University; University of North Carolina; North Carolina State University; Field Museum of Natural History (Chicago)	McDonald, AT (corresponding author), St Louis Sci Ctr, St Louis, MO 63110 USA.	andrew.mcdonald@slsc.org		Zanno, Lindsay/0000-0002-1654-1990	Jurassic Foundation; Evolving Earth Foundation; Utah Friends of Paleontology; University of Pennsylvania Paleobiology Summer Stipend; John Caldwell Meeker postdoctoral fellowship at The Field Museum [FMNH PR 3847]	Jurassic Foundation; Evolving Earth Foundation; Utah Friends of Paleontology; University of Pennsylvania Paleobiology Summer Stipend; John Caldwell Meeker postdoctoral fellowship at The Field Museum	TNT is provided free by the Willi Hennig Society. We thank Jim Kirkland and Martha Hayden of the Utah Geological Survey and Randall Irmis and Janaki Krishna of the Natural History Museum of Utah for assistance with permits. We are grateful to Akiko Shinya, Bill Simpson, Connie van Beek, Lisa Herzog, James Holstein, Debbie Wagner, Josh Ostergaard, Erin Fitzgerald, Christian Kammerer, Michael Eklund, Will Adams, Allie Weil, and Odin for excavation and fieldwork. Akiko Shinya, Kurt Zahnle, Tim Nelson, Lis Meeker, Eric Ahlgren, Steve Clawson, Debbie Wagner, Jim Holstein, Joanne Kluger, Bill Zandrew, Magdalena Garczynska, and Janice Kelly ably prepared the material described herein. ATM thanks the following people for access to specimens under their care: Carl Mehling (AMNH); Ted Daeschler (ANSP); Jeff Bartlett and John Bird (CEUM); Amy Henrici and Matt Lamanna (CM); Ken Carpenter (DMNS); Annelise Folie and Hugo du Potter (IRSNB); Steve Hutt (MIWG); Ronan Allain (MNHN); Robert McCord (MSM); Paul Barrett, Sandra Chapman, and Lorna Steel (NHMUK); Sally Shelton (SDSM); Louis Jacobs (SMU); Don DeBlieux, Jim Kirkland, and Scott Madsen (Utah Geological Survey); Michael Brett-Surman and Matt Carrano (USNM); Douglas Wolfe (White Mountain Dinosaur Exploration Center); and Dan Brinkman (YPM). ATM is grateful to Paul Barrett, Ken Carpenter, Matt Lamanna, Chloe Marquart, David Norman, and Christopher Noto for discussions and correspondence on iguanodontian taxonomy. ATM also thanks Hailu You for providing additional images of Xuwulong and Luis Alcala for providing additional images of Proa. ATMs research on iguanodontians was supported by grants from the Jurassic Foundation, Evolving Earth Foundation, Utah Friends of Paleontology, and University of Pennsylvania Paleobiology Summer Stipend. PJM thanks The Field Museum Women's Board for their generous support to acquire equipment used in the excavation of FMNH PR 3847. LEZ was supported by the John Caldwell Meeker postdoctoral fellowship at The Field Museum over the span of the fieldwork that resulted in collection of FMNH PR 3847. Finally, we thank Mark Spigelman, the Academic Editor, and Glenn Storrs for reviewing the manuscript.	Ramirez-Velasco AA, 2012, CAN J EARTH SCI, V49, P379, DOI 10.1139/E11-062; Allain R, 2012, NATURWISSENSCHAFTEN, V99, P369, DOI 10.1007/s00114-012-0911-7; Apesteguia S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157793; Barrett PM, 2011, SPEC PAP PALAEONTOL, P131, DOI 10.1111/j.1475-4983.2011.01076.x; Barrett PM, 2009, ACTA PALAEONTOL POL, V54, P35, DOI 10.4202/app.2009.0105; Benson RBJ, 2010, NATURWISSENSCHAFTEN, V97, P71, DOI 10.1007/s00114-009-0614-x; Boyd CA, 2015, PEERJ, V3, DOI 10.7717/peerj.1263; BRILL K, 2006, HORNS BEAKS CERATOPS, P49; Brinkman Donald B., 2013, P195; Brochu CA, 1996, J VERTEBR PALEONTOL, V16, P49, DOI 10.1080/02724634.1996.10011283; Brusatte SL, 2012, ACTA PALAEONTOL POL, V57, P65, DOI 10.4202/app.2010.0125; Brusatte SL, 2009, NATURWISSENSCHAFTEN, V96, P1051, DOI 10.1007/s00114-009-0565-2; Buffetaut E, 2011, ANN PALEONTOL, V97, P51, DOI 10.1016/j.annpal.2011.08.001; Campione Nicolas E., 2014, P208; CARPENTER K, 1995, J VERTEBR PALEONTOL, V15, P275, DOI 10.1080/02724634.1995.10011230; Carpenter K, 2008, ANN CARNEGIE MUS, V76, P227, DOI 10.2992/0097-4463(2008)76[227:ANSOCO]2.0.CO;2; Cifelli R.I., 1999, VERTEBRATE PALEONTOL, V99, P219; Cifelli RL, 1997, P NATL ACAD SCI USA, V94, P11163, DOI 10.1073/pnas.94.21.11163; Cohen KM, 2013, EPISODES, V36, P199, DOI 10.18814/epiiugs/2013/v36i3/002; Cooper LN, 2008, P ROY SOC B-BIOL SCI, V275, P2609, DOI 10.1098/rspb.2008.0912; Cope E.D., 1869, T AM PHIL SOC, V14, P1; Dalla Vecchia FM, 2009, J VERTEBR PALEONTOL, V29, P1100, DOI 10.1671/039.029.0428; DiCroce Tony, 2001, P183; DOLLO L, 1888, CR HEBD ACAD SCI, V106, P775; Erickson GM, 2004, NATURE, V430, P772, DOI 10.1038/nature02699; Escaso F, 2014, J VERTEBR PALEONTOL, V34, P1102, DOI 10.1080/02724634.2014.849715; Garrison JR, 2007, CRETACEOUS RES, V28, P461, DOI 10.1016/j.cretres.2006.07.007; Gasca JM, 2015, J IBER GEOL, V41, P57, DOI 10.5209/rev_JIGE.2015.v41.n1.48655; Gilmore C. W., 1909, P US NATIONAL MUSEUM, V36, P197, DOI DOI 10.5479/SI.00963801.36-1666.197; Gilpen D., 2006, HORNS BEAKS CERATOPS, P79; Godefroit P, 2005, CR PALEVOL, V4, P697, DOI 10.1016/j.crpv.2005.07.004; Godefroit P., 1998, B I ROYAL SCI NAT S, V68, P3; Godefroit Pascal, 2012, P334; Goloboff P, 2008, CLADISTICS, V24, P91; Grande L, 2010, COPEIA, P1; Head JJ, 1998, J VERTEBR PALEONTOL, V18, P718, DOI 10.1080/02724634.1998.10011101; Head JJ, 2001, J VERTEBR PALEONTOL, V21, P392, DOI 10.1671/0272-4634(2001)021[0392:AROTPP]2.0.CO;2; Horner JR, 2004, DINOSAURIA, 2ND EDITION, P438; Horner JR, 2004, P ROY SOC B-BIOL SCI, V271, P1875, DOI 10.1098/rspb.2004.2829; Horner JR, 2000, J VERTEBR PALEONTOL, V20, P115, DOI 10.1671/0272-4634(2000)020[0115:LBHOTH]2.0.CO;2; Horner JR, 1999, PALEOBIOLOGY, V25, P295, DOI 10.1017/S0094837300021308; Hunt G.J., 2011, SEVIER THRUST BELT N, VVolume 40, P193; Irmis Randall B., 2013, P424; Jiang BY, 2006, J ASIAN EARTH SCI, V28, P205, DOI 10.1016/j.jseaes.2005.07.006; Kirkland J. I., 1999, VERTEBRATE PALEONTOL, V99, P243; Kirkland J.I., 1999, UTAH GEOLOGICAL SURV, V99-1, P201; Kirkland James I., 1998, Bulletin of the New Mexico Museum of Natural History and Science, V14, P283; Kirkland James I., 1997, Brigham Young University Geology Studies, V42, P69; Kobayashi Y, 2003, J VERTEBR PALEONTOL, V23, P166, DOI 10.1671/0272-4634(2003)23[166:ANIDOF]2.0.CO;2; Lu Junchang, 1997, P27; Main Derek J., 2014, P77; Makovicky PJ, 2014, MIDMESOZOIC AGE DINO, P70; Marsh O.C., 1881, AM J SCI, V21, P417, DOI DOI 10.2475/AJS.S3-21.125.417; McDonald Andrew T., 2014, P44; Mcdonald AT, 2011, ZOOTAXA, P52, DOI 10.11646/zootaxa.2783.1.4; Mcdonald AT, 2010, ZOOTAXA, P1; Mcdonald AT, 2012, ZOOTAXA, P61; McDonald AT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045712; McDonald AT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036745; McDonald AT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014075; Mcdonald AT, 2010, J VERTEBR PALEONTOL, V30, P799, DOI 10.1080/02724631003763516; Gasulla JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144167; Mo JY, 2007, ACTA GEOL SIN-ENGL, V81, P550; Norman D.B., 1986, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V56, P281; Norman DB, 2004, DINOSAURIA, 2ND EDITION, P413; Norman DB, 2015, ZOOL J LINN SOC-LOND, V173, P92, DOI 10.1111/zoj.12193; Norman David B., 2012, P174; Norman DB, 2011, SPEC PAP PALAEONTOL, P165, DOI 10.1111/j.1475-4983.2011.01082.x; Norman DB, 2002, ZOOL J LINN SOC-LOND, V136, P113, DOI 10.1046/j.1096-3642.2002.00027.x; Norman DB, 1998, ZOOL J LINN SOC-LOND, V122, P291; Norman DB., 1980, MEMOIRES I ROYAL SCI, V178, P1; Ortega F, 2010, NATURE, V467, P203, DOI 10.1038/nature09181; Owen R., 1842, REPORTS BRIT ASS ADV, V11, P60; Prieto-Marquez A, 2010, AM MUS NOVIT, P1, DOI 10.1206/3694.2; Prieto-Marquez A, 2010, ZOOL J LINN SOC-LOND, V159, P435, DOI 10.1111/j.1096-3642.2009.00617.x; Ruiz-Omenaca JI, 2011, ESTUD GEOL-MADRID, V67, P83, DOI 10.3989/egeol.40276.124; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Sereno P. C, 2005, STEM ARCHOSAURIA VER; Sereno Paul C., 1998, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V210, P41; SERENO PC, 1986, NATL GEOGR RES, V2, P234; Sereno PC, 1997, ANNU REV EARTH PL SC, V25, P435, DOI 10.1146/annurev.earth.25.1.435; Shibata M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145904; Shibata M, 2015, ZOOTAXA, V3914, P421, DOI 10.11646/zootaxa.3914.4.3; Sues HD, 2009, P R SOC B, V276, P2549, DOI 10.1098/rspb.2009.0229; Taquet P., 1976, GEOLOGIE PALEONTOLOG, P57; Taquet Philippe, 2012, P282; Taquet Philippe, 1999, Annales de Paleontologie, V85, P85, DOI 10.1016/S0753-3969(99)80009-3; Tsogtbaatar Khishigjav, 2014, P108; Verdu FJ, 2017, HIST BIOL; Verdu FJ, 2015, CRETACEOUS RES, V56, P250, DOI 10.1016/j.cretres.2015.05.010; Wang Deyou, 2013, Dizhi Xuebao, V87, P1049; Wang RF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077058; Wang XL, 2010, EARTH ENV SCI T R SO, V101, P135, DOI 10.1017/S1755691010009266; Waskow K, 2014, J VERTEBR PALEONTOL, V34, P852, DOI 10.1080/02724634.2014.840645; WEISHAMPEL DB, 1993, PALAEONTOLOGY, V36, P361; Wiman C., 1929, Palaeontologia Sinica C vi, V1, P1; Woodward HN, 2015, PALEOBIOLOGY, V41, P503, DOI 10.1017/pab.2015.19; Wu Wenhao, 2012, P292; Xing H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098821; Xu Xing, 2000, Vertebrata Palasiatica, V38, P176; You Hai-lu, 2014, P73; [You Hailu 尤海鲁], 2005, [地质通报, Geological Bulletin of China], V24, P785; You H, 2011, ACTA GEOL SIN-ENGL, V85, P51, DOI 10.1111/j.1755-6724.2011.00377.x; You HL, 2003, CRETACEOUS RES, V24, P347, DOI 10.1016/S0195-6671(03)00048-X; You HL, 2003, ACTA GEOL SIN-ENGL, V77, P148; Zanno L.E., 2016, SOC VERT PAL 76 ANN, V2016, P256; Zanno LE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3827; Zheng WJ, 2014, HIST BIOL, V26, P236, DOI 10.1080/08912963.2013.809347	108	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176896	10.1371/journal.pone.0176896	http://dx.doi.org/10.1371/journal.pone.0176896			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489871	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314100035
J	Sosa-Calvo, J; Jesovnik, A; Vasconcelos, HL; Bacci, M; Schultz, TR				Sosa-Calvo, Jeffrey; Jesovnik, Ana; Vasconcelos, Heraldo L.; Bacci, Mauricio, Jr.; Schultz, Ted R.			Rediscovery of the enigmatic fungus-farming ant "Mycetosoritis" asper Mayr (Hymenoptera: Formicidae): Implications for taxonomy, phylogeny, and the evolution of agriculture in ants	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; GROWING ANTS; MYRMICINAE ATTINI; SPECIES COMPLEX; SOCIAL PARASITE; INSECT ORDER; TRIBE ATTINI; COSTA-RICA; MANTOPHASMATODEA; MITOCHONDRIAL	We report the rediscovery of the exceedingly rarely collected and enigmatic fungus-farming ant species Mycetosoritis asper. Since the description of the type specimen in 1887, only four additional specimens are known to have been added to the world's insect collections. Its biology is entirely unknown and its phylogenetic position within the fungus-farming ants has remained puzzling due to its aberrant morphology. In 2014 we excavated and collected twenty-one colonies of M. asper in the Floresta Nacional de Chapeco A in Santa Catarina, Brazil. We describe here for the first time the male and larva of the species and complement the previous descriptions of both the queen and the worker. We describe, also for the first time, M. asper biology, nest architecture, and colony demographics, and identify its fungal cultivar. Molecular phylogenetic analyses indicate that both M. asper and M. clorindae are members of the genus Cyphomyrmex, which we show to be paraphyletic as currently defined. More precisely, M. asper is a member of the Cyphomyrmex strigatus group, which we also show to be paraphyletic with respect to the genus Mycetophylax. Based on these results, and in the interest of taxonomic stability, we transfer the species M. asper, M. clorindae, and all members of the C. strigatus group to the genus Mycetophylax, the oldest available name for this clade. Based on ITS sequence data, Mycetophylax asper practices lower agriculture, cultivating a fungal species that belongs to lower-attine fungal Clade 2, subclade F.	[Sosa-Calvo, Jeffrey] Univ Rochester, Dept Biol, Rochester, NY 14627 USA; [Sosa-Calvo, Jeffrey; Jesovnik, Ana; Schultz, Ted R.] Smithsonian Inst, Natl Museum Nat Hist, Dept Entomol, Washington, DC 20560 USA; [Sosa-Calvo, Jeffrey; Jesovnik, Ana] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Vasconcelos, Heraldo L.] Univ Fed Uberlandia, Inst Biol, Uberlandia, MG, Brazil; [Bacci, Mauricio, Jr.] Univ Estadual Paulista, Ctr Estudos Insetos Sociais, Rio Claro, SP, Brazil	University of Rochester; Smithsonian Institution; Smithsonian National Museum of Natural History; University System of Maryland; University of Maryland College Park; Universidade Federal de Uberlandia; Universidade Estadual Paulista	Sosa-Calvo, J (corresponding author), Univ Rochester, Dept Biol, Rochester, NY 14627 USA.; Sosa-Calvo, J; Schultz, TR (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept Entomol, Washington, DC 20560 USA.; Sosa-Calvo, J (corresponding author), Univ Maryland, Dept Entomol, College Pk, MD 20742 USA.	jsosacalvo@gmail.com; schultzt@si.edu	Vasconcelos, Heraldo L/C-3353-2013; Bacci, Mauricio/C-4960-2013	Vasconcelos, Heraldo L/0000-0001-6969-7131; Bacci, Mauricio/0000-0002-5619-1411	National Science Foundation (NSF) [DEB-1456964, DEB-0949689]; National Museum of Natural History (NMNH) Small Grants program; Smithsonian Institution Scholarly Studies Program; NMNH Peter Buck Predoctoral Fellowships; Max and Vera Britton Environmental Science Awards (Cosmos Club Foundation); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP [2011/50226-0]; CNPq [311562/2012-4, 487639/2012-0]; Brazilian Council of Research and Scientific Development (CNPq) [302588/2015-9]	National Science Foundation (NSF)(National Science Foundation (NSF)); National Museum of Natural History (NMNH) Small Grants program; Smithsonian Institution Scholarly Studies Program; NMNH Peter Buck Predoctoral Fellowships; Max and Vera Britton Environmental Science Awards (Cosmos Club Foundation); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Council of Research and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	T.R.S., and J.S.-C, were partially supported by National Science Foundation (NSF) grants DEB-1456964 and DEB-0949689 and the National Museum of Natural History (NMNH) Small Grants program; T.R.S. by the Smithsonian Institution Scholarly Studies Program; J.S.-C. and A.J. by NMNH Peter Buck Predoctoral Fellowships and Max and Vera Britton Environmental Science Awards (Cosmos Club Foundation); M.B. by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; 2011/50226-0) and CNPq (311562/2012-4 and 487639/2012-0), and H.L.V. by the Brazilian Council of Research and Scientific Development (CNPq grant 302588/2015-9).; We are exceedingly grateful to Maria Tavano (MSNG) for facilitating access to the worker described by Emery (1906), for further investigating F. Silvestri's travels in South America, and especially for suggesting that the Chubut locality in Emery (1906) may have been erroneous. We are equally grateful to Rogerio da Silva for invaluable locality information and for directing us onto the right path for locating colonies of Mycetophylax asper. We are additionally indebted to Bonnie Blaimer (USNM) for help with translation of Mayr's publication; to ICMbio for granting us permission to collect at Floresta Nacional de Chapeco; to Eugenia Okonski (NMNH) for collections and research support; to Eugenia Okonski and Nick Silverson (NMNH) for help maintaining the live colonies and for helping with the census; and to Scott Whittaker (NMNH) for help with the preparation of the larvae. J.S.-C. is exceedingly grateful to Christian Rabeling for support. T.R.S., and J.S.-C, were partially supported by National Science Foundation (NSF) grants DEB-1456964 and DEB-0949689 and the National Museum of Natural History (NMNH) Small Grants program; T.R.S. by the Smithsonian Institution Scholarly Studies Program; J.S.-C. and A.J. by NMNH Peter Buck Predoctoral Fellowships and Max and Vera Britton Environmental Science Awards (Cosmos Club Foundation); M.B. by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; 2011/50226-0) and CNPq (311562/2012-4 and 487639/2012-0); and H.L.V. by the Brazilian Council of Research and Scientific Development (CNPq grant 302588/2015-9). Fabio S. Nascimento, Rodrigo M. Feitosa, and Lars Vilhelmsen provided many helpful comments that greatly improved the manuscript.	[Anonymous], 2012, OXFORD LATIN DICT; Boudinot BE, 2015, EUR J TAXON, V120, P1, DOI 10.5852/ejt.2015.120; Branstetter MG, 2017, P ROYAL SOC B, V284; Brown JM, 2010, SYST BIOL, V59, P145, DOI 10.1093/sysbio/syp081; Cameron SL, 2006, MOL PHYLOGENET EVOL, V38, P274, DOI 10.1016/j.ympev.2005.09.020; CHAPELA IH, 1994, SCIENCE, V266, P1691, DOI 10.1126/science.266.5191.1691; CREIGHTON W. S., 1950, BULL MUS COMP ZOOL HARVARD UNIV, V104, P1; Currie CR, 2006, SCIENCE, V311, P81, DOI 10.1126/science.1119744; Emery C., 1894, Bollettino della Societa Entomologica Italiana, Vxxvi, P137; Emery C., 1922, Genera Insectorum Fasc Bruxelles, V174, P207; Emery C., 1888, BOLLETTINO SOCIET EN, V19, P352; Emery C, 1913, ANN SOC ENTOMOLOGIQU, V57, P250; Emery C, 1906, B SOC ENTOMOLOGICA I, V37, P107; Forel A., 1893, Annales de la Societe Entomologique de Belgique, Vxxxvii, P586; FOREL A, 1911, DTSCH ENTOMOLOGISCHE, P285; Frandsen PB, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0283-7; Gallardo A., 1916, Anales del Museo Nacional Buenos Aires, V28; Heath TA, 2008, J SYST EVOL, V46, P239, DOI 10.3724/SP.J.1002.2008.08016; ICMBio, 2013, SUMR EX PLAN AO NAC; ICZN [International Commission of Zoological Nomenclature], 1999, INT COD ZOOL NOM AD; Jesovnik A, 2013, INSECT SOC, V60, P531, DOI 10.1007/s00040-013-0320-8; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kempf W. W., 1962, Studia Entomologica Petropolis (NS), V5, P1; Kempf W. W., 1964, Studia Entomologica Petropolis (NS), V7, P1; Kempf W.W., 1968, STUDIA ENTOMOLOGICA, V11, P369; Klass KD, 2002, SCIENCE, V296, P1456, DOI 10.1126/science.1069397; Klass Klaus-Dieter, 2003, Entomologische Abhandlungen (Dresden), V61, P3; Klingenberg C, 2009, ZOOTAXA, P1; Kusnezov N., 1957, Revista de la Sociedad Uruguaya de Entomologia, V2, P7; KUSNEZOV NICOLAS, 1949, ACTA ZOOL LILLOANA, V8, P427; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Little AEF, 2003, NATURWISSENSCHAFTEN, V90, P558, DOI 10.1007/s00114-003-0480-x; Lucas Elaine Maria, 2008, Biota Neotrop., V8, P0, DOI 10.1590/S1676-06032008000300004; Lutinski JA, 2008, CIENC RURAL, V38, P1810, DOI 10.1590/S0103-84782008000700002; Mackay WP, 2010, J HYMENOPT RES, V19, P44; Mackay WP, 1998, REV BIOL TROP, V46, P421; Maddison WP, 2015, MESQUITE 3 0 MOD SYS; Marshall DC, 2006, SYST BIOL, V55, P993, DOI 10.1080/10635150601087641; Marshall DC, 2010, SYST BIOL, V59, P108, DOI 10.1093/sysbio/syp080; Mayr G., 1884, T RUSSKAGO ENTOMOLOG, V18, P31; MAYR G, 1887, VERHANDLUNGEN KAISER, V37, P511; Mehdiabadi NJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1844; Mehdiabadi NJ, 2010, MYRMECOL NEWS, V13, P37; Mueller UG, 1998, SCIENCE, V281, P2034, DOI 10.1126/science.281.5385.2034; NEWTON MA, 1994, J R STAT SOC B, V56, P3; Oxford University Press, 1996, GREEK ENGLISH LEXICO; Picker MD, 2002, SCIENCE, V297, P1475; Rabeling C, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.4001; Rabeling C, 2015, INSECT SOC, V62, P335, DOI 10.1007/s00040-015-0406-6; Rabeling C, 2008, P NATL ACAD SCI USA, V105, P14913, DOI 10.1073/pnas.0806187105; Rabeling C, 2007, ZOOTAXA, P1; Rabeling C, 2016, ZOOKEYS, P79, DOI 10.3897/zookeys.618.9692; Rabeling C, 2011, P NATL ACAD SCI USA, V108, P12366, DOI 10.1073/pnas.1105467108; Rabeling C, 2010, SYST ENTOMOL, V35, P379, DOI 10.1111/j.1365-3113.2010.00533.x; Rambaut A, TRACER 1 5 0 U EDINB; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; SANTSCHI F., 1933, ANALES SOC CIENT ARGENTINA, V116, P105; Santschi F, 1917, ANALES SOC CIENTIFIC, V84, P277; Schultz TR, 2008, P NATL ACAD SCI USA, V105, P5435, DOI 10.1073/pnas.0711024105; Schultz TR, 2015, AM NAT, V185, P693, DOI 10.1086/680501; Schultz TR, 1998, INSECT SOC, V45, P457, DOI 10.1007/s000400050101; Schultz TR, 1995, SYST ENTOMOL, V20, P337, DOI 10.1111/j.1365-3113.1995.tb00100.x; Schultz TR, 1993, NOTES UNDERGROUND, V8, P7; SILVESTRI F., 1959, RICORDI ITINERARI SC; Soares AER, 2012, BIOINFORM BIOL INSIG, V6, P129, DOI 10.4137/BBI.S9677; Solomon SE, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.0112; Sosa-Calvo J, 2015, SOCIOBIOLOGY, V62, P300; Sosa-Calvo J, 2010, ANN ENTOMOL SOC AM, V103, P181, DOI 10.1603/AN09108; Sosa-Calvo J., 2015, THESIS; Sosa-Calvo J, 2017, INSECTES SOCIAUX; Sosa-Calvo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080498; Sosa-Calvo J, 2009, J HYMENOPT RES, V18, P113; Spinks PQ, 2009, SYST BIOL, V58, P1, DOI 10.1093/sysbio/syp005; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Ward PS, 2015, SYST ENTOMOL, V40, P61, DOI 10.1111/syen.12090; Ward PS, 2010, SYST BIOL, V59, P342, DOI 10.1093/sysbio/syq012; WHEELER GC, 1974, P ENTOMOL SOC WASH, V76, P76; WHEELER GC, 1948, AM MIDL NAT, V40, P664, DOI 10.2307/2421490; Wheeler GC., 1956, MYRMECOLOGICAL ORTHO; Wheeler WM, 1907, B AM MUS NAT HIST, V23, P669; Wheeler WM, 1922, B AM MUSEUM NATURAL, V1139; Wheeler WM., 1925, ARK ZOOL, V17A, P1; Yoshimura M, 2007, ZOOTAXA, P21, DOI 10.11646/zootaxa.1654.1.2; Zompro Oliver, 2001, Mitteilungen aus dem Geologisch-Palaeontologischen Institut der Universitaet Hamburg, V85, P229	88	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176498	10.1371/journal.pone.0176498	http://dx.doi.org/10.1371/journal.pone.0176498			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489860	gold, Green Published			2022-12-26	WOS:000401314100024
J	Byberg, KK; Oymar, K; Eide, GE; Forman, MR; Juliusson, PB				Byberg, Kristine Kjer; Oymar, Knut; Eide, Geir Egil; Forman, Michele R.; Juliusson, Petur Benedikt			Exposure to preeclampsia in utero affects growth from birth to late childhood dependent on child's sex and severity of exposure: Follow-up of a nested case-control study	PLOS ONE			English	Article							NORWEGIAN CHILDREN; POSTNATAL-GROWTH; PRETERM INFANTS; BLOOD-PRESSURE; WEIGHT; AGE; PREGNANCY; FETAL; REFERENCES; CYTOKINES	Background and objective An adverse intrauterine environment may affect offspring growth and development. Our aim was to explore whether preeclampsia (PE) exposure in utero influences growth from birth to 13 years. Methods In a nested case-control study, 229 children were exposed to PE (mild/moderate: n = 164, severe: n = 54) and 385 were unexposed. Length/height and weight were abstracted from records at birth, 3 and 6 months, 1 and 4 years, and measured along with waist circumference and skinfolds at follow-up at 11/12 (girls/boys) and 13 years (both sexes). Associations between PE and z-scores for growth were analyzed by multiple linear and fractional polynomial regression with adjustment for potential confounders. Results In boys, exposure to mild/moderate PE was positively associated with linear growth after 0.5 years, but severe PE was negatively associated with linear growth in all ages. In girls, both exposure to mild/moderate and severe PE were negatively associated with linear growth. Exposure to PE was negatively associated with weight and body mass index (BMI) during infancy, but positively associated with weight and BMI thereafter, except that boys exposed to severe PE consistently had a lower weight and BMI compared to the unexposed. Exposure to severe PE only was positively associated with waist-to-height ratio at 11/12 (girls/boys) and 13 years (both sexes). Conclusions From birth to adolescence, linear growth, weight and BMI trajectories differed between the sexes by severity of exposure to PE. In general, PE exposure was negatively associated with linear growth, while in girls; positive associations with weight and BMI were observed. This underlines fetal life as a particularly sensitive period affecting subsequent growth and this may have implications for targeted approaches for healthy growth and development.	[Byberg, Kristine Kjer; Oymar, Knut] Stavanger Univ Hosp, Dept Pediat, Stavanger, Norway; [Oymar, Knut; Juliusson, Petur Benedikt] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Eide, Geir Egil] Haukeland Hosp, Ctr Clin Res, Bergen, Norway; [Eide, Geir Egil] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Forman, Michele R.] Univ Texas Austin, Sch Human Ecol, Dept Nutr Sci, Austin, TX 78712 USA; [Juliusson, Petur Benedikt] Haukeland Hosp, Dept Pediat, Bergen, Norway; [Forman, Michele R.] Purdue Univ, Dept Nutr Sci, W Lafayette, IN 47907 USA	Stavanger University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; University of Texas System; University of Texas Austin; University of Bergen; Haukeland University Hospital; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Byberg, KK (corresponding author), Stavanger Univ Hosp, Dept Pediat, Stavanger, Norway.	kristine.kjer.byberg@sus.no			National Cancer Institute, National Institute of Health, R03 [1R03CA137754]; MD Anderson Global Programme; Western Norway Regional Health Authority [911835]	National Cancer Institute, National Institute of Health, R03; MD Anderson Global Programme; Western Norway Regional Health Authority	"The Stavanger Study was funded by an internal grant from the National Cancer Institute, National Institute of Health, R03 (grant number: 1R03CA137754) and is a part of the MD Anderson Global Programme. The present study was funded by a PhD grant for the first author, from the Western Norway Regional Health Authority, grant number: 911835. URL: http://www.helse-vest.no/ en/FagOgSamarbeid/forsking/retringslinjer-skiema/Sider/dektorgrad.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aibar L, 2012, J PERINAT MED, V40, P271, DOI 10.1515/jpm-2011-0137; Alsnes IV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167714; Alsnes IV, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.06.026; Beardsall K, 2014, J PEDIATR-US, V164, P1038, DOI 10.1016/j.jpeds.2013.12.046; BEROYZ G, 1994, LANCET, V343, P619; Brannsether B, 2013, EUR J CLIN NUTR, V67, P928, DOI 10.1038/ejcn.2013.91; Brannsether B, 2011, ACTA PAEDIATR, V100, P1576, DOI 10.1111/j.1651-2227.2011.02370.x; Byberg KK, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-101; Davidovici BB, 2010, J INVEST DERMATOL, V130, P1785, DOI 10.1038/jid.2010.103; De Boo HA, 2006, AUST NZ J OBSTET GYN, V46, P4, DOI 10.1111/j.1479-828X.2006.00506.x; Druet C, 2008, BEST PRACT RES CL EN, V22, P489, DOI 10.1016/j.beem.2008.02.002; Dubova EA, 2014, B EXP BIOL MED+, V157, P103, DOI 10.1007/s10517-014-2502-4; Gillman MW, 2008, AM J CLIN NUTR, V87, P1587, DOI 10.1093/ajcn/87.6.1587; Guasti L, 2014, J CLIN ENDOCR METAB, V99, pE2198, DOI 10.1210/jc.2014-1566; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Hellstrom A, 2016, ACTA PAEDIATR, V105, P576, DOI 10.1111/apa.13350; Herberth G, 2011, ALLERGY, V66, P1065, DOI 10.1111/j.1398-9995.2011.02587.x; Huppertz B, 2008, HYPERTENSION, V51, P970, DOI 10.1161/HYPERTENSIONAHA.107.107607; Jain V, 2012, REV ENDOCR METAB DIS, V13, P141, DOI 10.1007/s11154-012-9216-6; Jensen RB, 2015, J CLIN ENDOCR METAB, V100, pE503, DOI 10.1210/jc.2014-3469; Jim B, 2010, CARDIOL REV, V18, P178, DOI 10.1097/CRD.0b013e3181c60ca6; Juliusson PB, 2011, ARCH DIS CHILD, V96, P916, DOI 10.1136/adc.2009.166157; Juliusson PB, 2013, ANN HUM BIOL, V40, P220, DOI 10.3109/03014460.2012.759276; LANES R, 1989, BIOL NEONATE, V56, P252; Mansson J, 2015, ACTA PAEDIATR, V104, P514, DOI 10.1111/apa.12937; Odegard RA, 2000, OBSTET GYNECOL, V96, P950, DOI 10.1016/S0029-7844(00)01040-1; Ogland B, 2009, ARCH DIS CHILD, V94, P855, DOI 10.1136/adc.2008.150870; Ogland B, 2011, ARCH DIS CHILD, V96, P740, DOI 10.1136/adc.2009.178434; Ong KK, 2015, ACTA PAEDIATR, V104, P974, DOI 10.1111/apa.13128; Ong KKL, 2002, PEDIATR RES, V52, P863, DOI 10.1203/00006450-200212000-00009; Orak U, 2016, J MATERN-FETAL NEO M, V29, P270, DOI 10.3109/14767058.2014.998191; Pizzi C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090291; Royston P., 2008, MULTIVARIABLE MODEL, V1st ed., P115, DOI DOI 10.1002/9780470770771.CH6; Sederquist B, 2014, J MOL ENDOCRINOL, V53, pT35, DOI 10.1530/JME-14-0006; SEIDMAN DS, 1991, BRIT J OBSTET GYNAEC, V98, P1009, DOI 10.1111/j.1471-0528.1991.tb15339.x; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Simchen MJ, 2014, J MATERN-FETAL NEO M, V27, P839, DOI 10.3109/14767058.2013.845658; Szarka A, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-59; Taveras EM, 2009, PEDIATRICS, V123, P1177, DOI 10.1542/peds.2008-1149; Turner JA, 2010, INT J WOMENS HEALTH, V2, P327, DOI 10.2147/IJWH.S8550; Valensise H, 2008, HYPERTENSION, V52, P873, DOI 10.1161/HYPERTENSIONAHA.108.117358; van der Steen M, 2016, ENDOCRIN METAB CLIN, V45, P283, DOI 10.1016/j.ecl.2016.01.008; Vatten LJ, 2003, OBSTET GYNECOL, V101, P529, DOI 10.1016/S0029-7844(02)02718-7; Vatten LJ, 2002, OBSTET GYNECOL, V99, P85, DOI 10.1016/S0029-7844(01)01651-9; Westerberg AC, 2010, ACTA PAEDIATR, V99, P556, DOI 10.1111/j.1651-2227.2009.01667.x; Yadav S, 2015, INDIAN PEDIATR, V52, P135, DOI 10.1007/s13312-015-0588-z	46	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0176627	10.1371/journal.pone.0176627	http://dx.doi.org/10.1371/journal.pone.0176627			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486480	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000401314000019
J	Li, QF; Deng, C; Xia, Y; Kong, LS; Zhang, HG; Zhang, SG; Wang, JH				Li, Qingfen; Deng, Cheng; Xia, Yan; Kong, Lisheng; Zhang, Hanguo; Zhang, Shougong; Wang, Junhui			Identification of novel miRNAs and miRNA expression profiling in embryogenic tissues of Picea balfouriana treated by 6-benzylaminopurine	PLOS ONE			English	Article							SUITABLE REFERENCE GENES; WHEAT TRITICUM-AESTIVUM; PROGRAMMED CELL-DEATH; QUANTITATIVE RT-PCR; SOMATIC EMBRYOGENESIS; CONSERVED MICRORNAS; TARGET GENES; SMALL RNAS; CALCIUM; NORMALIZATION	Here, we compared miRNA expression profiles in embryonic cell cultures of the conifer Picea balfouriana following application of the synthetic cytokinin 6-benzylaminopurine (6-BAP). We used next-generation sequencing to analyze three libraries of small RNAs from the treated embryogenic cell cultures and generated 24,000,000 raw reads from each of the libraries. Over 70 differentially regulated micro RNA (miRNA) families (>= 2 fold change in expression) were identified between pairs of treatments. A quantitative analysis showed that miR3633 and miR1026 were upregulated in tissues with the highest embryogenic ability. These two miRNAs were predicted to target genes encoding receptor-like protein kinase and GAMYB transcription factors, respectively. In one library, miR1160, miR5638, miR1315, and miR5225 were downregulated. These four miRNAs were predicted to target genes encoding APETALA2, calmodulin-binding protein, and calciumdependent protein kinase transcription factors. The expression patterns of the miRNAs and their targets were negatively correlated. Approximately 181 potentially novel P. balfouriana miRNAs were predicted from the three libraries, and seven were validated during the quantitative analysis. This study is the first report of differential miRNA regulation in tissues treated with 6-BAP during somatic embryogenesis. The differentially expressed miRNAs will be of value for investigating the mechanisms of embryogenic processes that are responsive to 6-BAP in P. balfouriana.	[Li, Qingfen; Deng, Cheng] South China Agr Univ, Coll Forestry & Landscape Architecture, Guangdong Key Lab Innovat Dev & Utilizat Forest P, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China; [Li, Qingfen; Xia, Yan; Zhang, Shougong; Wang, Junhui] Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Key Lab Tree Breeding & Cultivat,State Forestry A, Beijing, Peoples R China; [Kong, Lisheng] Univ Victoria, Dept Biol, Ctr Forest Biol, Victoria, BC, Canada; [Zhang, Hanguo] Northeast Forestry Univ, State Key Lab Tree Genet & Breeding, Harbin, Peoples R China	South China Agricultural University; Chinese Academy of Forestry; Research Institute of Forestry, CAF; State Key Laboratory of Tree Genetics & Breeding, CAF; University of Victoria; Northeast Forestry University - China	Wang, JH (corresponding author), Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Key Lab Tree Breeding & Cultivat,State Forestry A, Beijing, Peoples R China.	wangjh@caf.ac.cn			Fundamental Research Funds for the Central Non-profit Research Institution of CAF, China [TGB2013011]	Fundamental Research Funds for the Central Non-profit Research Institution of CAF, China	Financial support for this study was provided by the Fundamental Research Funds for the Central Non-profit Research Institution of CAF, China (TGB2013011).	Alonso-Peral MM, 2010, PLANT PHYSIOL, V154, P757, DOI 10.1104/pp.110.160630; Anil VS, 2000, PLANT PHYSIOL, V122, P1035, DOI 10.1104/pp.122.4.1035; Anil VS, 2000, PLANT PHYSIOL, V123, P1301, DOI 10.1104/pp.123.4.1301; Barakat Abdelali, 2007, BMC Genomics, V8, P481, DOI 10.1186/1471-2164-8-481; Boutilier K, 2002, PLANT CELL, V14, P1737, DOI 10.1105/tpc.001941; Che P, 2006, PLANT MOL BIOL, V62, P1, DOI 10.1007/s11103-006-9013-2; Dai XB, 2011, BRIEF BIOINFORM, V12, P115, DOI 10.1093/bib/bbq065; Davoren PA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-76; Duan CF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-30; El Ouakfaoui S, 2010, PLANT MOL BIOL, V74, P313, DOI 10.1007/s11103-010-9674-8; Ge XX, 2012, PLANTA, V236, P1107, DOI 10.1007/s00425-012-1661-7; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gimenez MJ, 2011, PLANTA, V233, P163, DOI 10.1007/s00425-010-1290-y; Guo WJ, 2008, PLANT PHYSIOL, V147, P1710, DOI 10.1104/pp.108.120238; He Z., 1993, LAB GUIDE CHEM CONTR; Hecht V, 2001, PLANT PHYSIOL, V127, P803, DOI 10.1104/pp.010324; JANSEN MAK, 1990, PLANT CELL REP, V9, P221, DOI 10.1007/BF00232184; Jeyaraj A, 2014, PLANT CELL REP, V33, P1053, DOI 10.1007/s00299-014-1589-4; Jia BX, 2012, J NANOMATER, V2012, DOI 10.1155/2012/796815; Jime Anez VM, 2000, VITIS, V39, P151; Jimenez V. M, 2001, PLANT CELL TISS ORG, V67, P37; Jimenez VM, 2001, PHYSIOL PLANTARUM, V111, P389, DOI 10.1034/j.1399-3054.2001.1110317.x; Jimenez VM, 2001, PLANT SCI, V160, P247, DOI 10.1016/S0168-9452(00)00382-4; Joshi T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S14; Kou SJ, 2012, PLANT CELL REP, V31, P2151, DOI 10.1007/s00299-012-1325-x; Lau S, 2012, ANNU REV PLANT BIOL, V63, P483, DOI 10.1146/annurev-arplant-042811-105507; Li QF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141841; Li QF, 2015, PHYSIOL PLANTARUM, V154, P95, DOI 10.1111/ppl.12276; Li QF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-553; Li TT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043451; Li WF, 2013, PLANT CELL TISS ORG, V113, P131, DOI [10.1007/s11240-012-0233-7, 10.1007/s11240-012-0221-y]; Li ZX, 2016, PLANT CELL TISS ORG, V127, P461, DOI 10.1007/s11240-016-1071-9; Liang CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010698; Lin YC, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054466, 10.1371/journal.pone.0069722]; LITVAY JD, 1981, I PAPER CHEM TECH PA, V115, P1; Luo YC, 2006, FEBS LETT, V580, P5111, DOI 10.1016/j.febslet.2006.08.046; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Maroufi A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-15; Morcillo F, 2007, PLANTA, V226, P1353, DOI 10.1007/s00425-007-0574-3; Moxon S, 2008, GENOME RES, V18, P1602, DOI 10.1101/gr.080127.108; Nolan KE, 2009, J EXP BOT, V60, P1759, DOI 10.1093/jxb/erp046; NOMA M, 1982, PLANTA, V155, P369, DOI 10.1007/BF00394464; Oh TJ, 2008, NEW PHYTOL, V179, P67, DOI 10.1111/j.1469-8137.2008.02448.x; OVERVOORDE PJ, 1994, PLANT CELL PHYSIOL, V35, P135; Piyatrakul P, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-244; Prabu G. R., 2010, Genomics Proteomics & Bioinformatics, V8, P113, DOI 10.1016/S1672-0229(10)60012-5; Qiu DY, 2009, GENE, V436, P37, DOI 10.1016/j.gene.2009.01.006; Sharma SK, 2008, PLANT MOL BIOL, V68, P185, DOI 10.1007/s11103-008-9360-2; Singla B, 2007, PLANT MOL BIOL, V65, P677, DOI 10.1007/s11103-007-9234-z; Song CNA, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-431, 10.1186/1471-2164-11-261]; Stasolla C, 2003, PLANT PHYSIOL, V131, P49, DOI 10.1104/pp.015214; Su YH, 2016, PLANT CELL TISS ORG, V124, P405, DOI 10.1007/s11240-015-0903-3; Szittya G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-593; Thibaud-Nissen FO, 2003, PLANT PHYSIOL, V132, P118, DOI 10.1104/pp.103.019968; Tsuji H, 2006, PLANT J, V47, P427, DOI 10.1111/j.1365-313X.2006.02795.x; Tsuwamoto R, 2010, PLANT MOL BIOL, V73, P481, DOI 10.1007/s11103-010-9634-3; van Zyl L, 2003, GENE EXPR PATTERNS, V3, P83, DOI 10.1016/S1567-133X(02)00068-6; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vernoux T, 2005, CURR OPIN GENET DEV, V15, P388, DOI 10.1016/j.gde.2005.06.008; WEILER EW, 1981, PLANTA, V153, P561, DOI 10.1007/BF00385542; Williams L, 2005, DEVELOPMENT, V132, P3657, DOI 10.1242/dev.01942; Woodger FJ, 2003, J PLANT GROWTH REGUL, V22, P176, DOI 10.1007/s00344-003-0025-8; Wu L, 2010, MOL CELL, V38, P465, DOI 10.1016/j.molcel.2010.03.008; Wu XM, 2015, PLANT BIOTECHNOL J, V13, P383, DOI 10.1111/pbi.12317; Wu XM, 2011, PLANTA, V233, P495, DOI 10.1007/s00425-010-1312-9; Yang XY, 2013, J EXP BOT, V64, P1521, DOI 10.1093/jxb/ert013; Yang XY, 2010, CRIT REV PLANT SCI, V29, P36, DOI 10.1080/07352680903436291; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96; Zeng FC, 2006, PLANT MOL BIOL, V60, P167, DOI 10.1007/s11103-005-3381-x; Zhang JH, 2012, PLANTA, V236, P647, DOI 10.1007/s00425-012-1643-9; Zhang SG, 2010, BIOCHEM BIOPH RES CO, V398, P355, DOI 10.1016/j.bbrc.2010.06.056; Zhang SZ, 2011, PLANT CELL TISS ORG, V105, P29, DOI 10.1007/s11240-010-9834-1; Zhao CZ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-3	73	22	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0176112	10.1371/journal.pone.0176112	http://dx.doi.org/10.1371/journal.pone.0176112			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486552	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314000008
J	Moonen, AJH; Weiss, PH; Wiesing, M; Weidner, R; Fink, GR; Reijnders, JSAM; Weber, WM; Leentjens, AFG				Moonen, Anja J. H.; Weiss, Peter H.; Wiesing, Michael; Weidner, Ralph; Fink, Gereon R.; Reijnders, Jennifer S. A. M.; Weber, Wim M.; Leentjens, Albert F. G.			An fMRI study into emotional processing in Parkinson's disease: Does increased medial prefrontal activation compensate for striatal dysfunction?	PLOS ONE			English	Article							QUALITY-OF-LIFE; DIAGNOSTIC-CRITERIA; LIMBIC SYSTEM; RATING-SCALE; DEPRESSION; AMYGDALA; RECOGNITION; AROUSAL; CORTEX; APATHY	Background Apart from a progressive decline of motor functions, Parkinson's disease (PD) is also characterized by non-motor symptoms, including disturbed processing of emotions. This study aims at assessing emotional processing and its neurobiological correlates in PD with the focus on how medicated Parkinson patients may achieve normal emotional responsiveness despite basal ganglia dysfunction. Methods Nineteen medicated patients with mild to moderate PD (without dementia or depression) and 19 matched healthy controls passively viewed positive, negative, and neutral pictures in an event-related blood oxygen level-dependent functional magnetic resonance imaging study (BOLD-fMRI). Individual subjective ratings of valence and arousal levels for these pictures were obtained right after the scanning. Results Parkinson patients showed similar valence and arousal ratings as controls, denoting intact emotional processing at the behavioral level. Yet, Parkinson patients showed decreased bilateral putaminal activation and increased activation in the right dorsomedial prefrontal cortex (PFC), compared to controls, both most pronounced for highly arousing emotional stimuli. Conclusions Our findings revealed for the first time a possible compensatory neural mechanism in Parkinson patients during emotional processing. The increased medial PFC activity may have modulated emotional responsiveness in patients via top-down cognitive control, therewith restoring emotional processing at the behavioral level, despite striatal dysfunction. These results may impact upon current treatment strategies of affective disorders in PD as patients may benefit from this intact or even compensatory influence of prefrontal areas when therapeutic strategies are applied that rely on cognitive control to modulate disturbed processing of emotions.	[Moonen, Anja J. H.; Leentjens, Albert F. G.] Maastricht Univ, Med Ctr, Dept Psychiat, Maastricht, Netherlands; [Moonen, Anja J. H.; Weiss, Peter H.; Wiesing, Michael; Weidner, Ralph; Fink, Gereon R.] Res Ctr Julich, Inst Neurosci & Med INM3, Julich, Germany; [Weiss, Peter H.; Fink, Gereon R.] Univ Hosp Cologne, Dept Neurol, Cologne, Germany; [Reijnders, Jennifer S. A. M.] Open Univ, Dept Lifespan Psychol, Heerlen, Netherlands; [Weber, Wim M.] Maastricht Univ, Med Ctr, Dept Neurol, Maastricht, Netherlands	Maastricht University; Helmholtz Association; Research Center Julich; University of Cologne; Open University Netherlands; Maastricht University	Moonen, AJH (corresponding author), Maastricht Univ, Med Ctr, Dept Psychiat, Maastricht, Netherlands.; Moonen, AJH (corresponding author), Res Ctr Julich, Inst Neurosci & Med INM3, Julich, Germany.	anja.moonen@maastrichtuniversity.nl	Fink, Gereon R./AFW-9377-2022; Weidner, Ralph/H-3796-2013; Fink, Gereon R./E-1616-2012; Weiss, Peter H./H-8983-2013	Fink, Gereon R./0000-0002-8230-1856; Weidner, Ralph/0000-0002-4502-0166; Fink, Gereon R./0000-0002-8230-1856; Weiss, Peter H./0000-0002-5230-9080; Wiesing, Michael/0000-0001-8287-127X	Stichting ParkinsonFonds, Hoofddorp, the Netherlands	Stichting ParkinsonFonds, Hoofddorp, the Netherlands	This study was funded by the Stichting ParkinsonFonds, Hoofddorp, the Netherlands. The research grant was awarded to A.F.G. Leentjens and does not have a grant number.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Association AP, 1994, DIAGN STAT MAN MENT, P143; Baggio HC, 2012, NEUROPSYCHOLOGIA, V50, P2121, DOI 10.1016/j.neuropsychologia.2012.05.020; Barbas H, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-25; Barbas H., 2006, ORBITOFRONTAL CORTEX, P57, DOI [DOI 10.1093/ACPROF:OSO/9780198565741.003.0004, 10.1093/acprof:oso/9780198565741.003.0004]; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Brucke C, 2007, EUR J NEUROSCI, V26, P767, DOI 10.1111/j.1460-9568.2007.05683.x; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; Delaveau P, 2010, EUR NEUROPSYCHOPHARM, V20, P784, DOI 10.1016/j.euroneuro.2010.07.001; Delaveau P, 2009, J CLIN PSYCHOPHARM, V29, P548, DOI 10.1097/JCP.0b013e3181bf1c5f; deRijk MC, 1997, NEUROLOGY, V48, P1277, DOI 10.1212/WNL.48.5.1277; Dietz J, 2013, NEUROPSYCHOLOGIA, V51, P960, DOI 10.1016/j.neuropsychologia.2013.01.001; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Folstein MF, 1975, MINIMENTAL STATE PRA; Garrido-Vasquez P, 2012, SOC COGN AFFECT NEUR; Geng DY, 2006, NEUROSURGERY, V58, P256, DOI 10.1227/01.NEU.0000194845.19462.7B; Gross J.J., 2008, HDB EMOTIONS, P497; Gross JJ, 1998, J PERS SOC PSYCHOL, V74, P224, DOI 10.1037/0022-3514.74.1.224; Hacker C, 2012, BRAIN AWS, V281; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Hariri AR, 2000, NEUROREPORT, V11, P43, DOI 10.1097/00001756-200001170-00009; Ibarretxe-Bilbao N, 2009, EUR J NEUROSCI, V30, P1162, DOI 10.1111/j.1460-9568.2009.06892.x; Kehoe EG, 2012, SOC COGN AFFECT NEUR, V7, P858, DOI 10.1093/scan/nsr059; Lang PJ, 2008, INT AFFECTIVE PICTUR; Leentjens AFG, 2014, MOVEMENT DISORD, V29, P1035, DOI 10.1002/mds.25919; Lisanby SH, 1992, J NEURAL TRANSM-SUPP, V40, P13; Lotze M, 2009, J COGNITIVE NEUROSCI, V21, P1321, DOI 10.1162/jocn.2009.21087; Mansson KNT, 2013, PSYCHIAT RES-NEUROIM, V214, P229, DOI 10.1016/j.pscychresns.2013.08.012; Martinez-Martin P, 2011, MOVEMENT DISORD, V26, P399, DOI 10.1002/mds.23462; Miller KM, 2009, NEUROPSYCHOLOGIA, V47, P1917, DOI 10.1016/j.neuropsychologia.2009.03.002; O'Callaghan C, 2014, J NEUROL NEUROSUR PS, V85, P371, DOI 10.1136/jnnp-2012-304558; Paquette V, 2003, NEUROIMAGE, V18, P401, DOI 10.1016/S1053-8119(02)00030-7; Phan KL, 2003, BIOL PSYCHIAT, V53, P211, DOI 10.1016/S0006-3223(02)01485-3; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Price J. L., 2006, ORBITOFRONTAL CORTEX, P39; Ray RD, 2012, NEUROSCI BIOBEHAV R, V36, P479, DOI 10.1016/j.neubiorev.2011.08.005; Reijnders JSAM, 2008, MOVEMENT DISORD, V23, P183, DOI 10.1002/mds.21803; Remy P, 2005, BRAIN, V128, P1314, DOI 10.1093/brain/awh445; Reuter-Lorenz PA, 2008, CURR DIR PSYCHOL SCI, V17, P177, DOI 10.1111/j.1467-8721.2008.00570.x; Robert P, 2009, EUR PSYCHIAT, V24, P98, DOI 10.1016/j.eurpsy.2008.09.001; Rottenberg J, 2003, CLIN PSYCHOL-SCI PR, V10, P227, DOI 10.1093/clipsy/bpg012; Schrag A, 2006, J NEUROL SCI, V248, P151, DOI 10.1016/j.jns.2006.05.030; Schroder C, 2006, MOVEMENT DISORD, V21, P1774, DOI 10.1002/mds.21038; Slawek J, 2005, PARKINSONISM RELAT D, V11, P465, DOI 10.1016/j.parkreldis.2005.04.006; Sockeel P, 2006, J NEUROL NEUROSUR PS, V77, P579, DOI 10.1136/jnnp.2005.075929; Taylor SF, 2003, NEUROIMAGE, V18, P650, DOI 10.1016/S1053-8119(02)00051-4; Tessitore A, 2002, J NEUROSCI, V22, P9099, DOI 10.1523/jneurosci.22-20-09099.2002; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Wieser MJ, 2012, CORTEX, V48, P1207, DOI 10.1016/j.cortex.2011.06.006; Wieser MJ, 2006, CLIN NEUROPHYSIOL, V117, P94, DOI 10.1016/j.clinph.2005.09.009; Yoshimura N, 2005, NEUROSCIENCE, V131, P523, DOI 10.1016/j.neuroscience.2004.09.054; Yuvaraj R, 2014, BEHAV BRAIN FUNCT, V10, DOI 10.1186/1744-9081-10-12	54	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177085	10.1371/journal.pone.0177085	http://dx.doi.org/10.1371/journal.pone.0177085			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486506	Green Submitted, Green Published, gold			2022-12-26	WOS:000401314000042
J	Belteky, J; Agnvall, B; Jensen, P				Belteky, Johan; Agnvall, Beatrix; Jensen, Per			Gene expression of behaviorally relevant genes in the cerebral hemisphere changes after selection for tameness in Red Junglefowl	PLOS ONE			English	Article							LONG-TERM POTENTIATION; DOMESTICATION; PROTEIN; EVOLUTION; MAMMALS; WILD; FEAR	The process of domestication in animals has led to alterations in behavior, physiology and phenotypic traits, changes that may be driven by correlations with reduced fear of humans. We used Red Junglefowl, ancestors of all domesticated chickens selected for either high or low fear of humans for five generations to study the effects of selection on gene transcription in the cerebral hemisphere, which is heavily involved in behaviour control. A total of 24 individuals from the parental generation as well as from the fifth selected generation were used. Twenty-two genes were significantly differentially expressed at p < 0.05 after false discovery rate (FDR) correction. Those genes that were upregulated in the low fearful animals were found to be involved in neural functions. Gene ontology and pathway analysis revealed enrichment for terms associated with behavioural processes. We conclude that five generations of divergent selection for high or low tameness has significantly changed gene expression patterns in the cerebral hemisphere in the Red Junglefowl population used here, which could underlie a range of changes in the domestic phenotype.	[Belteky, Johan; Agnvall, Beatrix; Jensen, Per] Linkoping Univ, IFM Biol, AVIAN Behav Physiol & Genom Grp, Linkoping, Sweden	Linkoping University	Jensen, P (corresponding author), Linkoping Univ, IFM Biol, AVIAN Behav Physiol & Genom Grp, Linkoping, Sweden.	perje@ifm.liu.se			research council Formas [221-2010-35]; Swedish Research Council VR [621-2011-4731]; European Research Council, ERC [322206 GENEWELL]; ERC [322206 GENEWELL]	research council Formas(Swedish Research Council Formas); Swedish Research Council VR(Swedish Research Council); European Research Council, ERC(European Research Council (ERC)European Commission); ERC(European Research Council (ERC)European Commission)	The project was supported by grants from the research council Formas (Grant no: 221-2010-35) (http://www.formas.se/), the Swedish Research Council VR (Grant no: 621-2011-4731) (http://www.vr.se/) and the European Research Council, ERC (Grant no: 322206 GENEWELL) (https://erc.europa.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The project was supported by grants from the research council Formas, and ERC (grant no. 322206 GENEWELL). We thank Lejla Bektic for technical assistance and for supervising the animals, Markus Jongren for help in developing the breeding programme, and also Petros Batakis for sample preparations.	Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Agnvall B, 2014, ANIMAL, V8, P1498, DOI 10.1017/S1751731114001426; Agnvall B, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0509; Agnvall B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035162; Albert FW, 2008, HORM BEHAV, V53, P413, DOI 10.1016/j.yhbeh.2007.11.010; Albert FW, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002962; Albert FW, 2009, GENETICS, V182, P541, DOI 10.1534/genetics.109.102186; Andersson L, 2004, NAT REV GENET, V5, P202, DOI 10.1038/nrg1294; Belteky J, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160033; BELYAEV DK, 1979, J HERED, V70, P301, DOI 10.1093/oxfordjournals.jhered.a109263; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Burdette AJ, 2010, CELL STRESS CHAPERON, V15, P605, DOI 10.1007/s12192-010-0173-2; Cao SS, 2005, J NEUROSCI, V25, P3801, DOI 10.1523/JNEUROSCI.5157-04.2005; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; EBINGER P, 1995, J BRAIN RES, V36, P219; Fu J, 2015, BBA-MOL CELL RES, V1853, P1, DOI 10.1016/j.bbamcr.2014.09.022; Heyne HO, 2014, GENETICS, V198, P1277, DOI 10.1534/genetics.114.168948; Jensen P, 2006, APPL ANIM BEHAV SCI, V97, P3, DOI 10.1016/j.applanim.2005.11.015; Kruska DCT, 2005, BRAIN BEHAV EVOLUT, V65, P73, DOI 10.1159/000082979; Levenson J, 2002, NAT NEUROSCI, V5, P155, DOI 10.1038/nn791; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Natt D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-59; NAUMENKO EV, 1989, PHARMACOL BIOCHEM BE, V33, P85, DOI 10.1016/0091-3057(89)90434-6; Patterson Marc C, 2005, Semin Pediatr Neurol, V12, P144, DOI 10.1016/j.spen.2005.10.002; Price E.O., 2002, ANIMAL DOMESTICATION; Rehkamper G, 2008, BRAIN BEHAV EVOLUT, V71, P115, DOI 10.1159/000111458; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rodriguez AR, 2014, J COMP NEUROL, V522, P1411, DOI 10.1002/cne.23521; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Sanchez-Villagra MR, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160107; Shao XP, 1999, DEV BIOL, V211, P109, DOI 10.1006/dbio.1999.9297; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Suh YH, 2010, NAT NEUROSCI, V13, P338, DOI 10.1038/nn.2488; Tixier-Boichard M, 2011, CR BIOL, V334, P197, DOI 10.1016/j.crvi.2010.12.012; Trut L, 2009, BIOESSAYS, V31, P349, DOI 10.1002/bies.200800070; Vigne JD, 2011, CR BIOL, V334, P171, DOI 10.1016/j.crvi.2010.12.009; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; WEST B, 1988, J ARCHAEOL SCI, V15, P515, DOI 10.1016/0305-4403(88)90080-5; Wilkins AS, 2014, GENETICS, V197, P795, DOI 10.1534/genetics.114.165423; Yassine S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118698; Zeder MA, 2012, BIODIVERSITY IN AGRICULTURE: DOMESTICATION, EVOLUTION, AND SUSTAINABILITY, P227; Zhang XC, 2009, NEURON, V64, P173, DOI 10.1016/j.neuron.2009.08.018	42	8	8	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177004	10.1371/journal.pone.0177004	http://dx.doi.org/10.1371/journal.pone.0177004			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481924	Green Submitted, Green Published, gold			2022-12-26	WOS:000401313700027
J	Kawauchi, D; Ogg, RJ; Liu, L; Shih, DJH; Finkelstein, D; Murphy, BL; Rehg, JE; Korshunov, A; Calabrese, C; Zindy, F; Phoenix, T; Kawaguchi, Y; Gronych, J; Gilbertson, RJ; Lichter, P; Gajjar, A; Kool, M; Northcott, PA; Pfister, SM; Roussel, MF				Kawauchi, D.; Ogg, R. J.; Liu, L.; Shih, D. J. H.; Finkelstein, D.; Murphy, B. L.; Rehg, J. E.; Korshunov, A.; Calabrese, C.; Zindy, F.; Phoenix, T.; Kawaguchi, Y.; Gronych, J.; Gilbertson, R. J.; Lichter, P.; Gajjar, A.; Kool, M.; Northcott, P. A.; Pfister, S. M.; Roussel, M. F.			Novel MYC-driven medulloblastoma models from multiple embryonic cerebellar cells	ONCOGENE			English	Article							GRANULE NEURON PRECURSORS; CENTRAL-NERVOUS-SYSTEM; CONSTITUTIVE ACTIVATION; GENE-EXPRESSION; BETA-CATENIN; MOUSE MODEL; STEM-CELLS; TUMORS; P53; PROGENITORS	Group3 medulloblastoma (MBG3) that predominantly occur in young children are usually associated with MYC amplification and/or overexpression, frequent metastasis and a dismal prognosis. Physiologically relevant MBG3 models are currently lacking, making inferences related to their cellular origin thus far limited. Using in utero electroporation, we here report that MBG3 mouse models can be developed in situ from different multipotent embryonic cerebellar progenitor cells via conditional expression of Myc and loss of Trp53 function in several Cre driver mouse lines. The Blbp-Cre driver that targets embryonic neural progenitors induced tumors exhibiting a large-cell/anaplastic histopathology adjacent to the fourth ventricle, recapitulating human MBG3. Enforced co-expression of luciferase together with Myc and a dominant-negative form of Trp53 revealed that GABAergic neuronal progenitors as well as cerebellar granule cells give rise to MBG3 with their distinct growth kinetics. Cross-species gene expression analysis revealed that these novel MBG3 models shared molecular characteristics with human MBG3, irrespective of their cellular origin. We here developed MBG3 mouse models in their physiological environment and we show that oncogenic insults drive this MB subgroup in different cerebellar lineages rather than in a specific cell of origin.	[Kawauchi, D.; Liu, L.; Murphy, B. L.; Zindy, F.; Roussel, M. F.] St Jude Childrens Res Hosp SJCRH, Dept Tumor Cell Biol, 262 Danny Thomas Pl, Memphis, TN 38105 USA; [Kawauchi, D.; Kool, M.; Pfister, S. M.] German Canc Res Ctr, Div Pediat Neurooncol, Neuenheimer Feld 280, D-69120 Heidelberg, Germany; [Ogg, R. J.] St Jude Childrens Res Hosp SJCRH, Dept Radiol Sci, 262 Danny Thomas Pl, Memphis, TN 38105 USA; [Shih, D. J. H.] Hosp Sick Children, Peter Gilgan Ctr Res & Learning, Toronto, ON, Canada; [Finkelstein, D.] St Jude Childrens Res Hosp SJCRH, Dept Computat Biol, 262 Danny Thomas Pl, Memphis, TN 38105 USA; [Rehg, J. E.] St Jude Childrens Res Hosp SJCRH, Dept Vet Pathol Core, 262 Danny Thomas Pl, Memphis, TN 38105 USA; [Korshunov, A.] Heidelberg Univ, Dept Neuropathol, German Canc Res Ctr DKFZ, Clin Cooperat Unit Neuropathol, Heidelberg, Germany; [Calabrese, C.] St Jude Childrens Res Hosp SJCRH, Dept Small Anim Imaging Core, 262 Danny Thomas Pl, Memphis, TN 38105 USA; [Phoenix, T.; Gilbertson, R. J.; Northcott, P. A.] St Jude Childrens Res Hosp SJCRH, Dept Dev Neurobiol, 262 Danny Thomas Pl, Memphis, TN 38105 USA; [Kawaguchi, Y.] Kyoto Univ, Ctr iPS Cell Res & Applicat, Dept Clin Applicat, Kyoto, Japan; [Gronych, J.; Lichter, P.] German Canc Res Ctr, Dept Mol Genet, Heidelberg, Germany; [Gajjar, A.] St Jude Childrens Res Hosp SJCRH, Dept Oncol, 262 Danny Thomas Pl, Memphis, TN 38105 USA; [Pfister, S. M.] Heidelberg Univ Hosp, Dept Pediat Hematol & Oncol, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Kyoto University; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Kawauchi, D; Roussel, MF (corresponding author), St Jude Childrens Res Hosp SJCRH, Dept Tumor Cell Biol, 262 Danny Thomas Pl, Memphis, TN 38105 USA.; Kawauchi, D (corresponding author), German Canc Res Ctr, Div Pediat Neurooncol, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	d.kawauchi@dkfz.de; martine.roussel@stjude.org	Northcott, Paul A/N-4022-2018; Rehg, Jerold E/N-8111-2018; Pfister, Stefan M/F-6860-2013; Gilbertson, Richard James/ABE-1346-2021; Gajjar, Amar/N-8059-2018; Shih, David J. H./AAE-8726-2019; Roussel, Martine F/F-1469-2016	Northcott, Paul A/0000-0002-1220-5252; Pfister, Stefan M/0000-0002-5447-5322; Gilbertson, Richard James/0000-0001-7539-9472; Shih, David J. H./0000-0002-9802-4937; Roussel, Martine F/0000-0002-1740-8139; Korshunov, Andrey/0000-0002-5257-3623	National Institute of Health [CA-096832, CA-21765, HD-049888, RR-029005]; Anderson fellowship; Deutsche Forschungsgemeinschaft [KA 4472/1-1]; Helmholtz Alliance 'Preclinical Comprehensive Cancer Center' [HA-305]; American Lebanese Syrian Associated Charities of SJCRH; Cancer Research UK [22492] Funding Source: researchfish; The Brain Tumour Charity [GN-000356] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD049888] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA096832] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029005] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Anderson fellowship; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Helmholtz Alliance 'Preclinical Comprehensive Cancer Center'; American Lebanese Syrian Associated Charities of SJCRH(American Lebanese Syrian Associated Charities (ALSAC)); Cancer Research UK(Cancer Research UK); The Brain Tumour Charity; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank Drs Y Takahashi (Kyoto University) and K Kawakami (National Institute of Genetics, Japan) for generously providing Tol2 transposon related vectors; L Linke and N Mack (DKFZ), J Grenet, D Farmer, S Wilkerson, S Smith and S Robinson for excellent technical assistance, J Morris and M Loyd for Affymetrix microarray analysis; Drs R Ashmun and A-M Hamilton Easton for fluorescence-activated cell sorting analysis; M Payton and C Winter for in vivo imaging of tumor growth; M Johnson and S Brown for orthotopic transplants; Dr MA Scoggins, L Stokes and A Owens for processing and analysis of human images; Drs O Witt, K Reifenberg, N Denk and K Dell for helpful assistance with animal experiments at DKFZ; Dr C Wright (Vanderbilt University), Y Nakano and M Horiguchi (Kyoto University) for mice; Drs H Liu and W Feng (DKFZ) for sharing R26-LSL-tdTomato mice and helpful discussions; Drs Y Ouyang (SJCRH) and F Bestvater (DKFZ) for Light Microscopy. This work was funded in part by the National Institute of Health Grants CA-096832, CA-21765 (to MFR), HD-049888, RR-029005 (to RJO), the Anderson fellowship and the Deutsche Forschungsgemeinschaft, KA 4472/1-1 (to DK), the Helmholtz Alliance 'Preclinical Comprehensive Cancer Center' Grant HA-305 (to PL, JG and SMP) and the American Lebanese Syrian Associated Charities of SJCRH.	Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Birks DK, 2013, PEDIATR BLOOD CANCER, V60, P1095, DOI 10.1002/pbc.24481; Bowman T, 1996, GENE DEV, V10, P826, DOI 10.1101/gad.10.7.826; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brett M., 2005, MNI BRAIN TALAIRACH; Cheng FY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035541; Cho KH, 2011, SURG RADIOL ANAT, V33, P523, DOI 10.1007/s00276-011-0796-8; Dastjerdi FV, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00010; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Fattet S, 2009, J PATHOL, V218, P86, DOI 10.1002/path.2514; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Gajjar AJ, 2014, NAT REV CLIN ONCOL, V11, P714, DOI 10.1038/nrclinonc.2014.181; Gibson P, 2010, NATURE, V468, P1095, DOI 10.1038/nature09587; Gilbertson RJ, 2008, ANNU REV PATHOL-MECH, V3, P341, DOI 10.1146/annurev.pathmechdis.3.121806.151518; Hanaford AR, 2016, CLIN CANCER RES, V22, P3903, DOI 10.1158/1078-0432.CCR-15-3011; Hevner RF, 2006, NEUROSCI RES, V55, P223, DOI 10.1016/j.neures.2006.03.004; Hill RM, 2015, CANCER CELL, V27, P72, DOI 10.1016/j.ccell.2014.11.002; Hoshino M, 2005, NEURON, V47, P201, DOI 10.1016/j.neuron.2005.06.007; Hunter NL, 2007, DEVELOPMENT, V134, P3449, DOI 10.1242/dev.003095; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kawauchi D, 2008, DEV BIOL, V322, P345, DOI 10.1016/j.ydbio.2008.08.005; Kawauchi D, 2012, CANCER CELL, V21, P168, DOI 10.1016/j.ccr.2011.12.023; Khandanpour C, 2013, CANCER CELL, V23, P200, DOI 10.1016/j.ccr.2013.01.011; Kool M, 2014, CANCER CELL, V25, P393, DOI 10.1016/j.ccr.2014.02.004; Kool M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003088; Li P, 2013, NAT NEUROSCI, V16, P1737, DOI 10.1038/nn.3553; Lorenz A, 2011, MOL CELL BIOL, V31, P3326, DOI 10.1128/MCB.05718-11; McCall MN, 2014, NUCLEIC ACIDS RES, V42, pD938, DOI 10.1093/nar/gkt1204; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; Murphy BL, 2013, CANCER RES, V73, P7068, DOI 10.1158/0008-5472.CAN-13-0927; Northcott PA, 2014, NATURE, V511, P428, DOI 10.1038/nature13379; Northcott PA, 2012, NAT REV NEUROL, V8, P340, DOI 10.1038/nrneurol.2012.78; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Paxinos G., 2008, MOUSE BRAIN STEREOTA; Pei YX, 2012, CANCER CELL, V21, P155, DOI 10.1016/j.ccr.2011.12.021; Perreault S, 2014, AM J NEURORADIOL, V35, P1263, DOI 10.3174/ajnr.A3990; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Poschl J, 2013, DEV BIOL, V374, P319, DOI 10.1016/j.ydbio.2012.12.001; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Rogers HA, 2013, BRIT J CANCER, V108, P2130, DOI 10.1038/bjc.2013.170; Roussel MF, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014308; Roussel MF, 2011, CURR TOP DEV BIOL, V94, P235, DOI 10.1016/B978-0-12-380916-2.00008-5; Sato Y, 2007, DEV BIOL, V305, P616, DOI 10.1016/j.ydbio.2007.01.043; Schmahmann J.D., 2000, MRI ATLAS HUMAN CERE; Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005; Sgaier SK, 2005, NEURON, V45, P27, DOI 10.1016/S0896-6273(04)00802-5; Swartling FJ, 2012, CANCER CELL, V21, P601, DOI 10.1016/j.ccr.2012.04.012; Talairach J., 1988, COPLANAR STEREOTAXIC; Uziel T, 2005, GENE DEV, V19, P2656, DOI 10.1101/gad.1368605; Wefers AK, 2014, ACTA NEUROPATHOL, V127, P931, DOI 10.1007/s00401-014-1271-5; Wu Xiaochong, 2011, Chin J Cancer, V30, P442, DOI 10.5732/cjc.011.10040; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003; Yokota Y, 2011, DEV BIOL, V353, P382, DOI 10.1016/j.ydbio.2011.02.001; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589; Zindy F, 2007, CANCER RES, V67, P2676, DOI 10.1158/0008-5472.CAN-06-3418; Zuckermann M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8391	57	24	25	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 14	2017	36	37					5231	5242		10.1038/onc.2017.110	http://dx.doi.org/10.1038/onc.2017.110			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FG8HT	28504719	Green Published, hybrid			2022-12-26	WOS:000410671700002
J	West, AC; Tang, K; Tye, H; Yu, L; Deng, N; Najdovska, M; Lin, SJ; Balic, JJ; Okochi-Takada, E; McGuirk, P; Keogh, B; McCormack, W; Bhathal, PS; Reilly, M; Oshima, M; Ushijima, T; Tan, P; Jenkins, BJ				West, A. C.; Tang, K.; Tye, H.; Yu, L.; Deng, N.; Najdovska, M.; Lin, S. J.; Balic, J. J.; Okochi-Takada, E.; McGuirk, P.; Keogh, B.; McCormack, W.; Bhathal, P. S.; Reilly, M.; Oshima, M.; Ushijima, T.; Tan, P.; Jenkins, B. J.			Identification of a TLR2-regulated gene signature associated with tumor cell growth in gastric cancer	ONCOGENE			English	Article							TOLL-LIKE RECEPTORS; HELICOBACTER-PYLORI; INNATE IMMUNITY; TUMORIGENESIS; EXPRESSION; PROGRESSION; CARCINOMA; PROTEIN; TLR2; TOLL-LIKE-RECEPTOR-2	Toll-like receptors (TLRs) are key regulators of innate immune responses, and their dysregulation is observed in numerous inflammation-associated malignancies, including gastric cancer (GC). However, the identity of specific TLRs and their molecular targets which promote the pathogenesis of human GC is ill-defined. Here, we sought to determine the clinical utility of TLR2 in human GC. TLR2 mRNA and protein expression levels were elevated in >50% of GC patient tumors across multiple ethnicities. TLR2 was also widely expressed among human GC cell lines, and DNA microarray-based expression profiling demonstrated that the TLR2-induced growth responsiveness of human GC cells corresponded with the up-regulation of six anti-apoptotic (BCL2A1, BCL2, BIRC3, CFLAR, IER3, TNFAIP3) and down-regulation of two tumor suppressor (PDCD4, TP53INP1) genes. The TLR2-mediated regulation of these anti-apoptotic and tumor suppressor genes was also supported by their increased and reduced expression, respectively, in two independent genetic GC mouse models (gp130(F/F) and Gan) characterized by high tumor TLR2 expression. Notably, enrichment of this TLR2-regulated gene signature also positively correlated with augmented TLR2 expression in human GC tumors, and served as an indicator of poor patient survival. Furthermore, treatment of gp130(F/F) and cell line-derived xenograft (MKN1) GC mouse models with a humanized anti-TLR2 antibody suppressed gastric tumor growth, which was coincident with alterations to the TLR2-driven gene signature. Collectively, our study demonstrates that in the majority of GC patients, elevated TLR2 expression is associated with a growth-potentiating gene signature which predicts poor patient outcomes, thus supporting TLR2 as a promising therapeutic target in GC.	[West, A. C.; Tang, K.; Tye, H.; Yu, L.; Najdovska, M.; Balic, J. J.; Jenkins, B. J.] Hudson Inst Med Res, Ctr Innate Immun & Infect Dis, 27-31 Wright St, Clayton, Vic 3168, Australia; [West, A. C.; Tang, K.; Yu, L.; Balic, J. J.; Bhathal, P. S.; Jenkins, B. J.] Monash Univ, Fac Med Nursing & Hlth Sci, Dept Mol Translat Sci, Clayton, Vic, Australia; [Deng, N.; Lin, S. J.; Tan, P.] Genome Inst Singapore, Singapore, Singapore; [Okochi-Takada, E.; Ushijima, T.] Natl Canc Ctr, Div Epigen, Tokyo, Japan; [McGuirk, P.; Keogh, B.; McCormack, W.; Reilly, M.] Opsona Therapeut Ltd, Dublin, Ireland; [Oshima, M.] Kanazawa Univ, Canc Res Inst, Div Genet, Kanazawa, Ishikawa, Japan; [Tan, P.] Duke NUS Med Sch, Canc & Stem Cell Biol, Singapore, Singapore; [Tan, P.] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore, Singapore	Hudson Institute of Medical Research; Monash University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National Cancer Center - Japan; Kanazawa University; National University of Singapore; National University of Singapore	Jenkins, BJ (corresponding author), Hudson Inst Med Res, Ctr Innate Immun & Infect Dis, 27-31 Wright St, Clayton, Vic 3168, Australia.	Brendan.Jenkins@hudson.org.au	Oshima, Masanobu/F-9958-2014; Ushijima, Toshikazu/AAP-5742-2021	Oshima, Masanobu/0000-0002-3304-0004; Ushijima, Toshikazu/0000-0003-3405-7817; Deng, Niantao/0000-0001-9717-2236; Jenkins, Brendan/0000-0002-7552-4656; Balic, Jesse/0000-0002-9681-6834	National Health and Medical Research Council (NHMRC) of Australia; Cancer Council Victoria; Victorian Government of Australia; NHMRC; Monash Graduate Scholarship; Monash International Postgraduate Research Scholarship	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Victorian Government of Australia; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Monash Graduate Scholarship(Monash University); Monash International Postgraduate Research Scholarship(Monash University)	This work was supported by research grants awarded by the National Health and Medical Research Council (NHMRC) of Australia and Cancer Council Victoria, as well as the Operational Infrastructure Support Program by the Victorian Government of Australia. AW is supported by an NHMRC Early Career Fellowship, KT is supported by Monash Graduate and Monash International Postgraduate Research Scholarships and BJJ is supported by an NHMRC Senior Medical Research Fellowship.	[Anonymous], 2012, TUMORI, V98, P663; Asprodites N, 2008, FASEB J, V22, P3628, DOI 10.1096/fj.08-108274; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Castano-Rodriguez N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060327; Chen SY, 2015, LEUKEMIA RES, V39, P976, DOI 10.1016/j.leukres.2015.06.004; Choi HJ, 2010, BIOCHEM BIOPH RES CO, V400, P396, DOI 10.1016/j.bbrc.2010.08.084; Conti L, 2013, FASEB J, V27, P4731, DOI 10.1096/fj.13-230201; Correa Pelayo, 2011, US Gastroenterol Hepatol Rev, V7, P59; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; de Oliveira JG, 2012, WORLD J GASTROENTERO, V18, P1235, DOI 10.3748/wjg.v18.i11.1235; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Fox JG, 2007, J CLIN INVEST, V117, P60, DOI 10.1172/JCI30111; Itadani H, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-615; Jiang PH, 2006, WORLD J GASTROENTERO, V12, P691, DOI 10.3748/wjg.v12.i5.691; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kennedy CL, 2014, ONCOGENE, V33, P2540, DOI 10.1038/onc.2013.205; Kennedy CL, 2011, J PATHOL, V225, P255, DOI 10.1002/path.2933; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Li ZS, 2011, CANCER LETT, V313, P192, DOI 10.1016/j.canlet.2011.09.007; Lordick F, 2014, CANCER TREAT REV, V40, P692, DOI 10.1016/j.ctrv.2014.03.002; Ma G, 2013, TUMOR BIOL, V34, P3879, DOI 10.1007/s13277-013-0975-9; Maeda Y, 2016, CANCER PREV RES, V9, P253, DOI 10.1158/1940-6207.CAPR-15-0315; Mandell L, 2004, INFECT IMMUN, V72, P6446, DOI 10.1128/IAI.72.11.6446-6454.2004; Meng GX, 2004, J CLIN INVEST, V113, P1473, DOI 10.1172/JCI200420762; Niccolai E, 2015, WORLD J GASTROENTERO, V21, P5778, DOI 10.3748/wjg.v21.i19.5778; Nihon-Yanagi Y, 2012, CANCER IMMUNOL IMMUN, V61, P71, DOI 10.1007/s00262-011-1085-4; Ooi CH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000676; Oshima H, 2006, GASTROENTEROLOGY, V131, P1086, DOI 10.1053/j.gastro.2006.07.014; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Pimentel-Nunes P, 2013, HELICOBACTER, V18, P22, DOI 10.1111/hel.12008; Pimentel-Nunes P, 2011, PATHOL ONCOL RES, V17, P677, DOI 10.1007/s12253-011-9368-9; Piva R, 2006, J CLIN INVEST, V116, P3171, DOI 10.1172/JCI29401; Reilly M, 2013, CLIN PHARMACOL THER, V94, P593, DOI 10.1038/clpt.2013.150; Savva A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00387; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seya T, 2015, CANCER SCI, V106, P1659, DOI 10.1111/cas.12824; Shi WN, 2014, TUMOR BIOL, V35, P9627, DOI 10.1007/s13277-014-2268-3; Tahara T, 2007, CANCER SCI, V98, P1790, DOI 10.1111/j.1349-7006.2007.00590.x; Tebbutt NC, 2002, NAT MED, V8, P1089, DOI 10.1038/nm763; Tye H, 2012, CANCER CELL, V22, P466, DOI 10.1016/j.ccr.2012.08.010; Uno K, 2007, AM J PHYSIOL-GASTR L, V293, pG1004, DOI 10.1152/ajpgi.00096.2007; Wei Q, 2012, IUBMB LIFE, V64, P697, DOI 10.1002/iub.1051; Wu MX, 2003, APOPTOSIS, V8, P11, DOI 10.1023/A:1021688600370; Wu YH, 2013, GUT, V62, P1100, DOI 10.1136/gutjnl-2011-301373; Yang HZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006520; Yang H, 2014, ANN CLIN LAB SCI, V44, P158; Zeng HM, 2011, CANCER EPIDEM BIOMAR, V20, P2594, DOI 10.1158/1055-9965.EPI-11-0702; Zhen Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.376; Zhou XD, 2004, CLIN SCI, V106, P397, DOI 10.1042/CS20030238	50	40	45	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 7	2017	36	36					5134	5144		10.1038/onc.2017.121	http://dx.doi.org/10.1038/onc.2017.121			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FF9XD	28481875				2022-12-26	WOS:000409371100005
J	Hu, XY; Binns, D; Reese, ML				Hu, Xiaoyu; Binns, Derk; Reese, Michael L.			The coccidian parasites Toxoplasma and Neospora dysregulate mammalian lipid droplet biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATITIS-C VIRUS; BINDING PROTEIN 5; FATTY-ACID UPTAKE; CORE PROTEIN; HOST; METABOLISM; CELLS; TRANSCRIPTION; EXPRESSION; INFECTION	Upon infection, the intracellular parasite Toxoplasma gondii co-opts critical functions of its host cell to avoid immune clearance and gain access to nutritional resources. One route by which Toxoplasma co-opts its host cell is through hijacking host organelles, many of which have roles in immunomodulation. Here we demonstrate that Toxoplasma infection results in increased biogenesis of host lipid droplets through rewiring of multiple components of host neutral lipid metabolism. These metabolic changes cause increased responsiveness of host cells to free fatty acid, leading to a radical increase in the esterification of free fatty acids into triacylglycerol. We identified c-Jun kinase and mammalian target of rapamycin (mTOR) as components of two distinct host signaling pathways that modulate the parasite-induced lipid droplet accumulation. We also found that, unlike many host processes dysregulated during Toxoplasma infection, the induction of lipid droplet generation is conserved not only during infection with genetically diverse Toxoplasma strains but also with Neospora caninum, which is closely related to Toxoplasma but has a restricted host range and uses different effector proteins to alter host signaling. Finally, by showing that a Toxoplasma strain deficient in exporting a specific class of effectors is unable to induce lipid droplet accumulation, we demonstrate that the parasite plays an active role in this process. These results indicate that, despite their different host ranges, Toxoplasma and Neospora use a conserved mechanism to co-opt these host organelles, which suggests that lipid droplets play a critical role at the coccidian host-pathogen interface.	[Hu, Xiaoyu; Binns, Derk; Reese, Michael L.] Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Reese, ML (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	michael.reese@UTSouthwestern.edu		Reese, Michael/0000-0001-9401-9594; Hu, Xiaoyu/0000-0002-6030-0019	National Institutes of Health [1K22AI097345]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI097345] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded in part by National Institutes of Health Grant 1K22AI097345 (to M. L. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adeyo O, 2011, J CELL BIOL, V192, P1043, DOI 10.1083/jcb.201010111; Aflaki E, 2011, J BIOL CHEM, V286, P7418, DOI 10.1074/jbc.M110.175703; Anand P, 2012, ELIFE, V1, DOI 10.7554/eLife.00003; Araujo-Santos T, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000873; Barbosa AD, 2015, CURR OPIN CELL BIOL, V35, P91, DOI 10.1016/j.ceb.2015.04.017; Bensaad K, 2014, CELL REP, V9, P349, DOI 10.1016/j.celrep.2014.08.056; Blader IJ, 2001, J BIOL CHEM, V276, P24223, DOI 10.1074/jbc.M100951200; Boothroyd JC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003296; Boyle JP, 2006, P NATL ACAD SCI USA, V103, P10514, DOI 10.1073/pnas.0510319103; Braun L, 2013, J EXP MED, V210, P2071, DOI 10.1084/jem.20130103; Brown KM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004180; Cartwright BR, 2015, MOL BIOL CELL, V26, P726, DOI 10.1091/mbc.E14-08-1303; Chandak PG, 2010, J BIOL CHEM, V285, P20192, DOI 10.1074/jbc.M110.107854; Charron AJ, 2002, J CELL SCI, V115, P3049; Cheng B, 2014, MICROB PATHOGENESIS, V69-70, P1, DOI 10.1016/j.micpath.2014.03.001; Cocchiaro JL, 2008, P NATL ACAD SCI USA, V105, P9379, DOI 10.1073/pnas.0712241105; Coppens I, 2006, CELL, V125, P261, DOI 10.1016/j.cell.2006.01.056; Coppens I, 2000, J CELL BIOL, V149, P167, DOI 10.1083/jcb.149.1.167; Crawford SE, 2016, CURR OPIN VIROL, V19, P11, DOI 10.1016/j.coviro.2016.05.008; D'Andrea S, 2016, BIOCHIMIE, V120, P17, DOI 10.1016/j.biochi.2015.07.010; Dansako H, 2014, VIROLOGY, V462, P166, DOI 10.1016/j.virol.2014.05.017; Dubikovskaya E, 2014, METHOD ENZYMOL, V538, P107, DOI 10.1016/B978-0-12-800280-3.00007-4; Franco M, 2016, MBIO, V7, DOI 10.1128/mBio.02231-15; Franco M, 2014, EUKARYOT CELL, V13, P483, DOI 10.1128/EC.00316-13; Fujimoto T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004838; Gay G, 2016, J EXP MED, V213, P1779, DOI 10.1084/jem.20160340; Gilk SD, 2012, ADV EXP MED BIOL, V984, P199, DOI 10.1007/978-94-007-4315-1_10; Gomes AF, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-47; Harris C, 2011, J BIOL CHEM, V286, P42615, DOI 10.1074/jbc.M111.285148; Hashemi HF, 2015, CURR OPIN CELL BIOL, V33, P119, DOI 10.1016/j.ceb.2015.02.002; Hunter CA, 2012, NAT REV MICROBIOL, V10, P766, DOI 10.1038/nrmicro2858; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Kannan-Thulasiraman P, 2010, J BIOL CHEM, V285, P19106, DOI 10.1074/jbc.M109.099770; Kawaguchi K, 2016, BIOCHEM J, V473, P449, DOI 10.1042/BJ20150926; Krahmer N, 2013, EMBO MOL MED, V5, P973, DOI 10.1002/emmm.201100671; Kumar Y, 2006, CURR BIOL, V16, P1646, DOI 10.1016/j.cub.2006.06.060; Lecoeur H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002276; Levi L, 2013, CANCER RES, V73, P4770, DOI 10.1158/0008-5472.CAN-13-0384; Liu K, 2013, CELL DEATH DIFFER, V20, P3, DOI 10.1038/cdd.2012.63; Liu L, 2015, CELL, V160, P177, DOI 10.1016/j.cell.2014.12.019; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Markgraf DF, 2014, CELL REP, V6, P44, DOI 10.1016/j.celrep.2013.11.046; Mattos KA, 2011, J IMMUNOL, V187, P2548, DOI 10.4049/jimmunol.1101344; Morgado P, 2011, INFECT IMMUN, V79, P4401, DOI 10.1128/IAI.05562-11; Mota LAM, 2014, MEM I OSWALDO CRUZ, V109, P767, DOI 10.1590/0074-0276140119; Muniz-Feliciano L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003809; Olias P, 2016, CELL HOST MICROBE, V20, P72, DOI 10.1016/j.chom.2016.06.006; Pernas L, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001845; Romano JD, 2013, MOL BIOL CELL, V24, P1974, DOI 10.1091/mbc.E12-11-0827; Rosowski EE, 2011, J EXP MED, V208, P195, DOI 10.1084/jem.20100717; Saeij JPJ, 2007, NATURE, V445, P324, DOI 10.1038/nature05395; Saeij JPJ, 2006, SCIENCE, V314, P1780, DOI 10.1126/science.1133690; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sinai AP, 1997, J CELL SCI, V110, P2117; Sonda S, 2001, J BIOL CHEM, V276, P34434, DOI 10.1074/jbc.M105025200; Toledo DAM, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00174; Wiley M, 2010, J BIOL CHEM, V285, P26852, DOI 10.1074/jbc.M110.147041; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Yu Jinhai, 2015, Biophys Rep, V1, P41; Zhang T, 2012, CHEM BIOL, V19, P140, DOI 10.1016/j.chembiol.2011.11.010; Zhang YW, 2015, IMMUNITY, V42, P953, DOI 10.1016/j.immuni.2015.04.016; Zirath H, 2013, P NATL ACAD SCI USA, V110, P10258, DOI 10.1073/pnas.1222404110	63	31	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					11009	11020		10.1074/jbc.M116.768176	http://dx.doi.org/10.1074/jbc.M116.768176			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28487365	hybrid, Green Published			2022-12-26	WOS:000404391000022
J	Zyszka, B; Aniol, M; Lipok, J				Zyszka, Beata; Aniol, Miroslaw; Lipok, Jacek			Modulation of the growth and metabolic response of cyanobacteria by the multifaceted activity of naringenin	PLOS ONE			English	Article							NATURAL FLAVONOIDS; SUBSTANCES; MICROALGAE; GENE	The interactions between the plant-derived bioflavonoid, naringenin, and prokaryotic microalgae representatives (cyanobacteria), were investigated with respect to its influence on the growth and metabolic response of these microorganisms. To achieve reliable results, the growth of cyanobacteria was determined based on measurements of chlorophyll content, morphological changes were assessed through microscopic observations, and the chemical response of cells was determined using liquid and gas chromatography (HPLC; GC-FID). The results show that micromolar levels of naringenin stimulated the growth of cyanobacteria. Increased growth was observed for halophilic strains at naringenin concentrations below 40 mg L-1, and in freshwater strains at concentrations below 20 mg L-1. The most remarkable stimulation was observed for the freshwater species Nostoc muscorum, which had a growth rate that was up to 60% higher than in the control. When naringenin was examined at concentrations above 40 mg L-1, the growth of the tested microorganisms was inhibited. Simultaneously, an intensive excretion of exopolysaccharides was observed. Microscopic observations strongly suggest that these effects resulted from a structural disturbance of cyanobacterial cell walls that was exerted by naringenin. This phenomenon, in combination with the absorption of naringenin into cell wall structures, influenced cell permeability and thus the growth of bacteria. Fortunately, almost all the naringenin added to the culture was incorporated into to cell substructures and could be recovered through extraction, raising the possibility that this modulator could be recycled.	[Zyszka, Beata; Lipok, Jacek] Univ Opole, Fac Chem, Dept Analyt & Ecol Chem, Opole, Poland; [Aniol, Miroslaw] Wroclaw Univ Environm & Life Sci, Fac Food Sci, Dept Chem, Wroclaw, Poland	University of Opole; Wroclaw University of Environmental & Life Sciences	Lipok, J (corresponding author), Univ Opole, Fac Chem, Dept Analyt & Ecol Chem, Opole, Poland.	jacek.lipok@uni.opole.pl		Zyszka-Haberecht, Beata/0000-0002-3232-8815; Lipok, Jacek/0000-0002-8567-5351	National Centre for Research and Development in Poland [PBS3/B8/25/2015]	National Centre for Research and Development in Poland(National Centre for Research & Development, Poland)	This work was financially supported in the frame of the project PBS3/B8/25/2015, granted by the National Centre for Research and Development in Poland.	Ahmad A, 2015, FOOD RES INT, V77, P221, DOI 10.1016/j.foodres.2015.06.021; Ahmad A, 2013, J AGR FOOD CHEM, V61, P8039, DOI 10.1021/jf402145u; Andersen O. M., 2006, FLAVONOIDS CHEM BIOC; Babic O, 2016, J APPL PHYCOL, V28, P2333, DOI 10.1007/s10811-015-0773-4; Becker-Ritt AB, 2007, TOXICON, V50, P971, DOI 10.1016/j.toxicon.2007.07.008; Bugianesi R, 2002, J NUTR, V132, P3349, DOI 10.1093/jn/132.11.3349; Cohen MF, 2002, MOL PLANT MICROBE IN, V15, P875, DOI 10.1094/MPMI.2002.15.9.875; Cohen MF, 2000, J BACTERIOL, V182, P4644, DOI 10.1128/JB.182.16.4644-4646.2000; Cushnie TPT, 2005, INT J ANTIMICROB AG, V26, P343, DOI 10.1016/j.ijantimicag.2005.09.002; Forlani G, 2011, ENZYME MICROB TECH, V48, P299, DOI 10.1016/j.enzmictec.2010.12.005; Goiris K, 2014, J PHYCOL, V50, P483, DOI 10.1111/jpy.12180; Goldstein J., 1981, SCANNING ELECT MICRO; Hossain MF, 2016, FOOD SCI NUTR, V4, P753, DOI 10.1002/fsn3.340; Huang HM, 2015, TOXINS, V7, P66, DOI 10.3390/toxins7010066; Jain V, 1999, FOLIA MICROBIOL, V44, P311, DOI 10.1007/BF02818553; Lee KA, 2010, FOOD SCI BIOTECHNOL, V19, P257, DOI 10.1007/s10068-010-0037-7; Lin CC, 1999, BIOL FERT SOILS, V30, P83, DOI 10.1007/s003740050591; Martinia S, 2009, INT J ANTIMICROB AG, V34, P50, DOI 10.1016/j.ijantimicag.2009.01.010; McSwain BS, 2005, APPL ENVIRON MICROB, V71, P1051, DOI 10.1128/AEM.71.2.1051-1057.2005; Mirzoeva OK, 1997, MICROBIOL RES, V152, P239, DOI 10.1016/S0944-5013(97)80034-1; Moon SH, 2013, INT J ENV RES PUB HE, V10, P5459, DOI 10.3390/ijerph10115459; Nychas G., 1995, NEW METHODS FOOD PRE, P58, DOI [DOI 10.1007/978-1-4615-2105-1_4, 10.1007/978-1-4615-2105-1_4]; Plaper A, 2003, BIOCHEM BIOPH RES CO, V306, P530, DOI 10.1016/S0006-291X(03)01006-4; Porra RJ, 2002, PHOTOSYNTH RES, V73, P149, DOI 10.1023/A:1020470224740; RECOURT K, 1989, J BACTERIOL, V171, P4370, DOI 10.1128/JB.171.8.4370-4377.1989; Scholz B, 2006, PHARM BIOL, V44, P544, DOI 10.1080/13880200600883114; Sharathchandra K., 2013, INT J PHARM BIO SCI, V4, P275; Sheng GP, 2006, WATER RES, V40, P1233, DOI 10.1016/j.watres.2006.01.023; Shin SY, 2007, LWT-FOOD SCI TECHNOL, V40, P1515, DOI 10.1016/j.lwt.2006.12.005; Singh D. P., 2014, American Journal of Plant Sciences, V5, P726; Snedecor G.W., 1989, AMES IOWA STATE U PR; Ultee A, 2000, ARCH MICROBIOL, V174, P233, DOI 10.1007/s002030000199; Wang MJ, 2006, J FOOD DRUG ANAL, V14, P247; WANG YC, 1995, J CHEM TECHNOL BIOT, V63, P215, DOI 10.1002/jctb.280630304; Wenig P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-405; Yan R, 2011, FRESEN ENVIRON BULL, V20, P18	36	16	16	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177631	10.1371/journal.pone.0177631	http://dx.doi.org/10.1371/journal.pone.0177631			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498848	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314500037
J	Arai, KY; Hara, T; Nagatsuka, T; Kudo, C; Tsuchiya, S; Nomura, Y; Nishiyama, T				Arai, Koji Y.; Hara, Takuya; Nagatsuka, Toyofumi; Kudo, Chikako; Tsuchiya, Sho; Nomura, Yoshihiro; Nishiyama, Toshio			Postnatal changes and sexual dimorphism in collagen expression in mouse skin	PLOS ONE			English	Article							ANDROGEN RECEPTOR; III COLLAGENS; TISSUE-REPAIR; GROWTH; AGE; FIBRILLOGENESIS; ACTIVIN; MICE; IDENTIFICATION; FIBROBLASTS	To investigate sexual dimorphism and postnatal changes in skin collagen expression, mRNA levels of collagens and their regulatory factors in male and female skin were examined during the first 120 days of age by quantitative realtime PCR. Levels of mRNAs encoding extracellular matrices did not show any differences between male and female mice until day 15. Col1a1 and Col1a2 mRNAs noticeably increased at day 30 and remained at high levels until day 120 in male mice, while those in female mice remained at low levels during the period. Consistent with the mRNA expression, pepsin-soluble type I collagen contents in skin was very high in mature male as compared to female. Col3a1 mRNA in male mice also showed significantly high level at day 120 as compared to female. On the other hand, expression of mRNAs encoding TGF-beta s and their receptors did not show apparent sexual dimorphism although small significant differences were observed at some points. Castration at 60 days of age resulted in a significant decrease in type I collagen mRNA expression within 3 days, and noticeably decreased expression of all fibril collagen mRNAs examined within 14 days, while administration of testosterone tube maintained the mRNA expression at high levels. Despite the in vivo effect of testosterone, administration of physiological concentrations of testosterone did not affect fibril collagen mRNA expression in either human or mouse skin fibroblasts in vitro, suggesting that testosterone does not directly affect collagen expression in fibroblasts. In summary, present study demonstrated dynamic postnatal changes in expression of collagens and their regulatory factors, and suggest that testosterone and its effects on collagen expression are responsible for the skin sexual dimorphism but the effects of testosterone is not due to direct action on dermal fibroblasts.	[Arai, Koji Y.; Hara, Takuya; Nagatsuka, Toyofumi; Kudo, Chikako; Tsuchiya, Sho; Nomura, Yoshihiro; Nishiyama, Toshio] Tokyo Univ Agr & Technol, Fac Agr, Scleroprotein Res Inst, Fuchu, Tokyo, Japan	Tokyo University of Agriculture & Technology	Arai, KY (corresponding author), Tokyo Univ Agr & Technol, Fac Agr, Scleroprotein Res Inst, Fuchu, Tokyo, Japan.	kojiarai@cc.tuat.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [19580336]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (grant No. 19580336). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Dr. Satoshi Amano (Shiseido Ltd.) for providing CGS27023A. This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (grant No. 19580336).	Arai KY, 2011, ENDOCRINOLOGY, V152, P3779, DOI 10.1210/en.2011-0255; Ashcroft GS, 1997, NAT MED, V3, P1209, DOI 10.1038/nm1197-1209; Azzi L, 2005, J INVEST DERMATOL, V124, P22, DOI 10.1111/j.0022-202X.2004.23545.x; BIRK DE, 1990, J CELL SCI, V95, P649; BLAUER M, 1991, J INVEST DERMATOL, V97, P264, DOI 10.1111/1523-1747.ep12480373; DUMAS M, 1994, MECH AGEING DEV, V73, P179, DOI 10.1016/0047-6374(94)90050-7; EPSTEIN EH, 1974, J BIOL CHEM, V249, P3225; Foley CJ, 2014, J CELL PHYSIOL, V229, P1875, DOI 10.1002/jcp.24650; HAYASHI T, 1979, J BIOCHEM-TOKYO, V86, P453, DOI 10.1093/oxfordjournals.jbchem.a132544; Hibino T, 2004, J DERMATOL SCI, V35, P9, DOI 10.1016/j.jdermsci.2003.12.003; Inui S, 2003, J INVEST DERM SYMP P, V8, P69, DOI 10.1046/j.1523-1747.2003.12174.x; JEANFAUCHER C, 1978, ACTA ENDOCRINOL-COP, V89, P780, DOI 10.1530/acta.0.0890780; KLEIN L, 1977, P NATL ACAD SCI USA, V74, P1436, DOI 10.1073/pnas.74.4.1436; Liu X, 1997, P NATL ACAD SCI USA, V94, P1852, DOI 10.1073/pnas.94.5.1852; LONGAKER MT, 1990, J PEDIATR SURG, V25, P63, DOI 10.1016/S0022-3468(05)80165-4; Markiewicz M, 2007, J DERMATOL SCI, V47, P217, DOI 10.1016/j.jdermsci.2007.05.008; Markova MS, 2004, J INVEST DERMATOL, V123, P1052, DOI 10.1111/j.0022-202X.2004.23494.x; MAYS PK, 1988, MECH AGEING DEV, V45, P203, DOI 10.1016/0047-6374(88)90002-4; Saito M, 2010, OSTEOPOROSIS INT, V21, P195, DOI 10.1007/s00198-009-1066-z; SEIDENARI S, 1994, SKIN PHARMACOL, V7, P201; Shi-Wen X, 2008, CYTOKINE GROWTH F R, V19, P133, DOI 10.1016/j.cytogfr.2008.01.002; SHUSTER S, 1975, BRIT J DERMATOL, V93, P639, DOI 10.1111/j.1365-2133.1975.tb05113.x; SMITH LT, 1986, AM J ANAT, V175, P507, DOI 10.1002/aja.1001750409; Son ED, 2005, J INVEST DERMATOL, V124, P1149, DOI 10.1111/j.0022-202X.2005.23736.x; Tsuchida K, 2004, MOL CELL ENDOCRINOL, V225, P1, DOI 10.1016/j.mce.2004.02.006; Tsuchida K, 2000, J BIOL CHEM, V275, P40788, DOI 10.1074/jbc.M006114200; Tur E, 1997, CLIN DERMATOL, V15, P5, DOI 10.1016/S0738-081X(96)00105-8; VANDERREST M, 1991, FASEB J, V5, P2814, DOI 10.1096/fasebj.5.13.1916105; Vazquez F, 1996, MATURITAS, V25, P209, DOI 10.1016/S0378-5122(96)01066-3; Verrecchia F, 2002, J INVEST DERMATOL, V118, P211, DOI 10.1046/j.1523-1747.2002.01641.x; Wenstrup RJ, 2004, J BIOL CHEM, V279, P53331, DOI 10.1074/jbc.M409622200; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Werner S, 2007, J INVEST DERMATOL, V127, P998, DOI 10.1038/sj.jid.5700786; Werner S, 2006, CYTOKINE GROWTH F R, V17, P157, DOI 10.1016/j.cytogfr.2006.01.001; Wu XF, 2010, REPRODUCTION, V140, P113, DOI 10.1530/REP-09-0349	35	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177534	10.1371/journal.pone.0177534	http://dx.doi.org/10.1371/journal.pone.0177534			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28494009	gold, Green Published, Green Submitted			2022-12-26	WOS:000401314300131
J	Caulley, L; Sawada, M; Hinther, K; Ko, YTI; Crowther, JA; Kontorinis, G				Caulley, Lisa; Sawada, Michael; Hinther, Kelsey; Ko, Ya-tung Iris; Crowther, John A.; Kontorinis, Georgios			Geographic distribution of vestibular schwannomas in West Scotland between 2000-2015	PLOS ONE			English	Article							ENVIRONMENTAL RISK-FACTORS; QUALITY-OF-LIFE; ACOUSTIC NEUROMA; EPIDEMIOLOGY; ASSOCIATION; INDICATORS; HISTORY; TRENDS	Background Although the natural history of vestibular schwannomas (VS) has been previously studied, few studies have investigated associated epidemiological factors, primarily because of the lack of large available cohorts. Objective The objective of this study was to perform a multi-scale geographical analysis of the period prevalence of VS in West Scotland from 2000 to 2015. Methods Adults diagnosed with sporadic VS were identified through the National Health Services of West Scotland database and geocoded to the unit postcode. To assess whether the cohort of VS cases could be pooled into a period prevalence measure, the locations of VS cases were analyzed by sex using Cross-L and Difference-K functions. VS period prevalence was examined at two aggregate spatial scales: the postcode district and a coarser scale of NHS Health Boards. The spatial structure of period prevalence within each level of spatial aggregation was measured using univariate global and local Moran's I. Bivariate local Moran's I was used to examine the between-scale variability in period prevalence from the postcode district level to the NHS Health Boards levels. Prior to spatial autocorrelation analyses, the period prevalence at the postcode district was tested for stratified spatial heterogeneity within the NHS Health Boards using Wang's q-Statistic. Results A total of 512 sporadic VS were identified in a population of over 3.1 million. Between 2000 and 2015, VS period prevalence was highest within the NHS Health Boards of Greater Glasgow and Clyde, Ayrshire and Arran and the Western Isles. However, at the NHS scale, period prevalence exhibited no spatial autocorrelation globally or locally. At the district scale, Highland exhibited the most unusual local spatial autocorrelation. Bivariate local Moran's I results indicated general stability of period prevalence across the postcode district to Health Boards scales. However, locally, some postcode districts in Greater Glasgow and Clyde, Ayrshire and Arran exhibited unusually low district to zone spatial autocorrelation in period prevalence, as did the southern parts of the Western Isles. Some unusually high period prevalence values between the postcode district to Health Board scale were found in Tayside, Forth Valley and Dumfries and Galloway. Conclusion Geographic variability in VS in West Scotland was identified in this patient population, showing that there are areas, even remote, with unusually high or low period prevalence. This can be partially attributed to links between primary and tertiary care. Potential genetic or environmental risk factors that may contribute to geographic variation in this disease within Scotland are also a possibility but require further investigation.	[Caulley, Lisa] Univ Ottawa, Dept Otolaryngol Head & Neck Surg, Ottawa, ON, Canada; [Caulley, Lisa] Ottawa Hosp, Ottawa, ON, Canada; [Sawada, Michael] Univ Ottawa, Dept Geog Environm & Geomat, LAGGISS, Ottawa, ON, Canada; [Hinther, Kelsey] Univ Saskatchewan, Undergrad Med Program, Saskatoon, SK, Canada; [Ko, Ya-tung Iris; Crowther, John A.; Kontorinis, Georgios] Queen Elizabeth Univ Hosp, Dept Otolaryngol Head & Neck Surg, Glasgow, Lanark, Scotland	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Saskatchewan; Queen Elizabeth University Hospital (QEUH)	Kontorinis, G (corresponding author), Queen Elizabeth Univ Hosp, Dept Otolaryngol Head & Neck Surg, Glasgow, Lanark, Scotland.	gkontorinis@gmail.com	Sawada, Michael/O-8457-2019	Sawada, Michael/0000-0001-5180-5325; Caulley, Lisa/0000-0002-9661-4634				Andersen JF, 2015, OTOL NEUROTOL, V36, P647, DOI 10.1097/MAO.0000000000000668; Anselin L, 2006, GEOGR ANAL, V38, P5, DOI 10.1111/j.0016-7363.2005.00671.x; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Babu R, 2013, J NEUROSURG, V119, P121, DOI 10.3171/2013.1.JNS121370; Baddeley A, 2016, CHAP HALL CRC INTERD, P1; Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Baddeley A, 2014, ECOL MONOGR, V84, P477, DOI 10.1890/13-2042.1; Berkowitz O, 2015, WORLD NEUROSURG, V84, P1674, DOI 10.1016/j.wneu.2015.07.007; Bivand R, 2015, J STAT SOFTW, V63, P1; Bivand R, 2013, GEOGR ANAL, V45, P150, DOI 10.1111/gean.12008; Brenner AV, 2002, INT J CANCER, V99, P252, DOI 10.1002/ijc.10320; Carlson ML, 2016, J NEURO-ONCOL, V129, P269, DOI 10.1007/s11060-016-2170-5; Carlson ML, 2015, OTOLARYNG HEAD NECK, V153, P202, DOI 10.1177/0194599815585508; Carlson ML, 2015, J NEUROSURG, V122, P833, DOI 10.3171/2014.11.JNS14594; Carlson ML, 2014, OTOLARYNGOL HEAD NEC, V151, P1028; Census Ss, 2011, CENS RES SCOTL CENS; Del Pero MM, 2009, SKULL BASE-INTERD AP, V19, P159, DOI 10.1055/s-0028-1096203; ESRI, 2016, INVENTORARCGIS DESKT; Grubesic T.H., 2008, SOCIOECON PLAN SCI, V42, P129, DOI [DOI 10.1016/j.seps.2006.09.001, 10.1016/j.seps.2006.09.001, DOI 10.1016/J.SEPS.2006.09.001]; Inskip PD, 2003, INT J EPIDEMIOL, V32, P225, DOI 10.1093/ije/dyg051; Jeyakumar A, 2007, ACTA OTO-LARYNGOL, V127, P1051, DOI 10.1080/00016480701200210; Klenke C, 2013, HEAD NECK ONCOLOGY, V16; Kontorinis G, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3601; Kshettry VR, 2015, J NEURO-ONCOL, V124, P223, DOI 10.1007/s11060-015-1827-9; Larjavaara S, 2011, BRIT J CANCER, V105, P1069, DOI 10.1038/bjc.2011.344; Lee JW, 2012, EURASIP J IMAGE VIDE, DOI 10.1186/1687-5281-2012-7; Loosmore NB, 2006, ECOLOGY, V87, P1925, DOI 10.1890/0012-9658(2006)87[1925:SIUTGO]2.0.CO;2; Matisziw TC, 2008, COMPUT ENVIRON URBAN, V32, P81, DOI 10.1016/j.compenvurbsys.2007.06.002; Neff BA, 2006, OTOL NEUROTOL, V27, P197, DOI 10.1097/01.mao.0000180484.24242.54; Nelson JK, 2017, CARTOGR GEOGR INF SC, V44, P35, DOI 10.1080/15230406.2015.1093431; Nieters A, 2004, CLIN EXP ALLERGY, V34, P346, DOI 10.1111/j.1365-2222.2004.01889.x; Parenteau MP, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-58; R Core Team, 2021, R LANGUAGE ENV STAT; Rey SJ, 2010, PYSAL A PYTHON LIBRA; RIPLEY BD, 1977, J ROY STAT SOC B MET, V39, P172; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; Saman Y, 2009, LARYNGOSCOPE, V119, P2085, DOI 10.1002/lary.20648; Schlehofer B, 2007, EUR J CANCER, V43, P1741, DOI 10.1016/j.ejca.2007.05.008; Schoemaker MJ, 2007, INT J CANCER, V120, P103, DOI 10.1002/ijc.22272; Scottish Government MS, 2013, SCOTL NAT MAR PLAN C; Statistics OfN, POST GEOGR; Stepanidis K, 2014, ACTA OTO-LARYNGOL, V134, P551, DOI 10.3109/00016489.2014.890293; Streiner D, 2009, PDQ EPIDEMIOLOGY; Torres-Martin M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065868; TROFATTER JA, 1993, CELL, V72, P791, DOI 10.1016/0092-8674(93)90406-G; Wang JF, 2016, ECOL INDIC, V67, P250, DOI 10.1016/j.ecolind.2016.02.052; [王婧宇 Wang Jingyu], 2010, [华东师范大学学报. 自然科学版, Journal of East China Normal University. Natural Science], P101; Wong BYW, 2012, J LARYNGOL OTOL, V126, P658, DOI 10.1017/S0022215112000680; Zygourakis CC, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.8.FOCUS14435	49	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0175489	10.1371/journal.pone.0175489	http://dx.doi.org/10.1371/journal.pone.0175489			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493872	gold, Green Submitted, Green Published			2022-12-26	WOS:000401314300007
J	Parikh, JD; Hollingsworth, KG; Wallace, D; Blamire, AM; MacGowan, GA				Parikh, Jehill D.; Hollingsworth, Kieren G.; Wallace, Dorothy; Blamire, Andrew M.; MacGowan, Guy A.			Left ventricular functional, structural and energetic effects of normal aging: Comparison with hypertension	PLOS ONE			English	Article							PRESERVED EJECTION FRACTION; HEART-FAILURE; DIASTOLIC FUNCTION; FIBER; AGE; DEFORMATION; HYPERTROPHY; RELAXATION; COMMUNITY; STIFFNESS	Objectives Both aging and hypertension are significant risk factors for heart failure in the elderly. The purpose of this study was to determine how aging, with and without hypertension, affects left ventricular function. Methods Cross-sectional study of magnetic resonance imaging and P-31 spectroscopy-based measurements of left ventricular structure, global function, strains, pulse wave velocity, high energy phosphate metabolism in 48 normal subjects and 40 treated hypertensive patients (though no other cardiovascular disease or diabetes) stratified into 3 age deciles from 50-79 years. Results Normal aging was associated with significant increases in systolic blood pressure, vascular stiffness, torsion, and impaired diastolic function (all P<0.05). Age-matched hypertension exacerbated the effects of aging on systolic pressure, and diastolic function. Hypertension alone, and not aging, was associated with increased left ventricular mass index, reduced energetic reserve, reduced longitudinal shortening and increased endocardial circumferential shortening (all P<0.05). Multiple linear regression analysis showed that these unique hypertensive features were significantly related to systolic blood pressure (P<0.05). Conclusions 1) Hypertension adds to the age-related changes in systolic blood pressure and diastolic function; 2) hypertension is uniquely associated with changes in several aspects of left ventricular structure, function, systolic strains, and energetics; and 3) these uniquely hypertensive-associated parameters are related to the level of systolic blood pressure and so are potentially modifiable.	[Parikh, Jehill D.; Hollingsworth, Kieren G.; Wallace, Dorothy; Blamire, Andrew M.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England; [Parikh, Jehill D.; Hollingsworth, Kieren G.; Wallace, Dorothy; Blamire, Andrew M.] Newcastle Univ, Newcastle Magnet Resonance Ctr, Newcastle Upon Tyne, Tyne & Wear, England; [Parikh, Jehill D.; Hollingsworth, Kieren G.; Wallace, Dorothy; Blamire, Andrew M.; MacGowan, Guy A.] Newcastle Univ, Ctr In Vivo Imaging, Newcastle Upon Tyne, Tyne & Wear, England; [MacGowan, Guy A.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne, Tyne & Wear, England; [MacGowan, Guy A.] Freeman Rd Hosp, Dept Cardiol, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle Freeman Hospital; Newcastle University - UK	MacGowan, GA (corresponding author), Newcastle Univ, Ctr In Vivo Imaging, Newcastle Upon Tyne, Tyne & Wear, England.; MacGowan, GA (corresponding author), Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne, Tyne & Wear, England.; MacGowan, GA (corresponding author), Freeman Rd Hosp, Dept Cardiol, Newcastle Upon Tyne, Tyne & Wear, England.	guy.macgowan@nuth.nhs.uk	Blamire, Andrew/AAU-6100-2021; Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; Blamire, Andrew/0000-0002-8749-1257	British Heart Foundation, Clinical Leave Research Fellowship [FS/11/89/29162]; British Heart Foundation [FS/11/89/29162] Funding Source: researchfish	British Heart Foundation, Clinical Leave Research Fellowship; British Heart Foundation(British Heart Foundation)	British Heart Foundation, Clinical Leave Research Fellowship to GMG (FS/11/89/29162) (https://www.bhf.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MI, 2012, JACC-CARDIOVASC IMAG, V5, P273, DOI 10.1016/j.jcmg.2011.11.013; AVOLIO AP, 1983, CIRCULATION, V68, P50, DOI 10.1161/01.CIR.68.1.50; Bauer R, 2008, CARDIOVASC RES, V79, P652, DOI 10.1093/cvr/cvn131; BRUTSAERT DL, 1978, J PHYSIOL-LONDON, V283, P469, DOI 10.1113/jphysiol.1978.sp012513; BUCHALTER MB, 1990, CIRCULATION, V81, P1236, DOI 10.1161/01.CIR.81.4.1236; Chantler PD, 2008, J APPL PHYSIOL, V105, P1342, DOI 10.1152/japplphysiol.90600.2008; Chantler PD, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00090; Cheng SS, 2014, J HYPERTENS, V32, P174, DOI 10.1097/HJH.0b013e32836586da; Cheng S, 2009, CIRC-CARDIOVASC IMAG, V2, P191, DOI 10.1161/CIRCIMAGING.108.819938; de Santi D, 2005, EUR J HEART FAIL, V7, P829, DOI 10.1016/j.ejheart.2004.09.008; Hollingsworth KG, 2013, EUR J HEART FAIL, V15, P986, DOI 10.1093/eurjhf/hft057; Hollingsworth KG, 2012, AM J PHYSIOL-HEART C, V302, pH885, DOI 10.1152/ajpheart.00985.2011; Ibrahim ESH, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-26; Jones DEJ, 2010, AM J PHYSIOL-GASTR L, V298, pG764, DOI 10.1152/ajpgi.00501.2009; Kannel W B, 1987, J Cardiovasc Pharmacol, V10 Suppl 6, pS135, DOI 10.1097/00005344-198706106-00018; Kawaguchi M, 2003, CIRCULATION, V107, P714, DOI 10.1161/01.CIR.0000048123.22359.A0; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Lee WH, 2016, J HYPERTENS, V34, P1195, DOI 10.1097/HJH.0000000000000903; LEVY D, 1990, NEW ENGL J MED, V0322; Lumens J, 2006, AM J PHYSIOL-HEART C, V291, pH1573, DOI 10.1152/ajpheart.00074.2006; MacGowan GA, 1997, CIRCULATION, V96, P535; Melenovsky V, 2007, J AM COLL CARDIOL, V49, P198, DOI 10.1016/j.jacc.2006.08.050; Mitchell GF, 2007, CIRCULATION, V115, P2628, DOI 10.1161/CIRCULATIONAHA.106.667733; Narayanan A, 2009, CIRC-CARDIOVASC IMAG, V2, P382, DOI 10.1161/CIRCIMAGING.108.811620; Neubauer S, 1997, CIRCULATION, V96, P2190; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; PALMON LC, 1994, CIRCULATION, V89, P122, DOI 10.1161/01.CIR.89.1.122; Parikh JD, 2016, INT J CARDIOL, V223, P306, DOI 10.1016/j.ijcard.2016.07.252; Parikh JD, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0224-4; Pavlopoulos H, 2008, EUR J ECHOCARDIOGR, V9, P741, DOI 10.1093/ejechocard/jen133; PEARLMAN ES, 1982, LAB INVEST, V46, P158; RADEMAKERS FE, 1994, CIRCULATION, V89, P1174, DOI 10.1161/01.CIR.89.3.1174; Solomon SD, 2010, HYPERTENSION, V55, P241, DOI 10.1161/HYPERTENSIONAHA.109.138529; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Van der Toorn A, 2002, AM J PHYSIOL-HEART C, V283, pH1609, DOI 10.1152/ajpheart.00239.2002; WEISS RG, 1990, NEW ENGL J MED, V323, P1593, DOI 10.1056/NEJM199012063232304	36	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177404	10.1371/journal.pone.0177404	http://dx.doi.org/10.1371/journal.pone.0177404			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493996	gold, Green Published, Green Submitted			2022-12-26	WOS:000401314300104
J	Rosa, DF; Sarandy, MM; Novaes, RD; da Matta, SLP; Goncalves, RV				Rosa, Daiane Figueiredo; Sarandy, Mariaurea Matias; Novaes, Romulo Dias; Pinto da Matta, Sergio Luis; Goncalves, Reggiani Vilela			Effect of a high-fat diet and alcohol on cutaneous repair: A systematic review of murine experimental models	PLOS ONE			English	Review							ACUTE ETHANOL EXPOSURE; INFLAMMATORY RESPONSE; EXTRACELLULAR-MATRIX; FIBROBLAST FUNCTION; OXIDATIVE STRESS; WOUND REPAIR; TISSUE; ANGIOGENESIS; RAT; ASSOCIATION	Background and purpose Chronic alcohol intake associated with an inappropriate diet can cause lesions in multiple organs and tissues and complicate the tissue repair process. In a systematic review, we analyzed the relevance of alcohol and high fat consumption to cutaneous and repair, compared the main methodologies used and the most important parameters tested. Preclinical investigations with murine models were assessed to analyze whether the current evidence support clinical trials. Methods The studies were selected from MEDLINE/PubMed and Scopus databases, according to Fig 1. All 15 identified articles had their data extracted. The reporting bias was investigated according to the ARRIVE (Animal Research: Reporting of in Vivo Experiments) strategy. Results In general, animals offered a high-fat diet and alcohol showed decreased cutaneous wound closure, delayed skin contraction, chronic inflammation and incomplete re-epithelialization. Conclusion In further studies, standardized experimental design is needed to establish comparable study groups and advance the overall knowledge background, facilitating data translatability from animal models to human clinical conditions.	[Rosa, Daiane Figueiredo; Sarandy, Mariaurea Matias; Pinto da Matta, Sergio Luis] Univ Fed Vicosa, Dept Gen Biol, Vicosa, MG, Brazil; [Novaes, Romulo Dias] Univ Fed Alfenas, Dept Cell Tissue & Dev Biol, Alfenas, MG, Brazil; [Goncalves, Reggiani Vilela] Univ Fed Vicosa, Dept Anim Biol, Vicosa, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Alfenas; Universidade Federal de Vicosa	Goncalves, RV (corresponding author), Univ Fed Vicosa, Dept Anim Biol, Vicosa, MG, Brazil.	reggiani.goncalves@ufv.br	Novaes, Romulo D/F-1210-2015; SOUZA, MARIAUREA/GQP-7833-2022; Gonçalves, Reggiani V/J-1550-2016	Novaes, Romulo D/0000-0002-3186-5328; Gonçalves, Reggiani V/0000-0002-5831-3590	Fundagao de Amparo a Pesquisa do estado de Minas Gerais (Fapemig)	Fundagao de Amparo a Pesquisa do estado de Minas Gerais (Fapemig)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	The authors received funding of the Fundagao de Amparo a Pesquisa do estado de Minas Gerais (Fapemig).	Aghdam SY, 2012, BIOCHEM BIOPH RES CO, V421, P197, DOI 10.1016/j.bbrc.2012.03.134; Altman DG, 2010, J ANTIMICROB CHEMOTH, V65, P1, DOI 10.1093/jac/dkp410; Amar MB, 2014, ROY SOC INTERFACE, V11, P1; Blum KS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094713; Bogl LH, 2013, NUTR METAB CARDIOVAS, V23, P1071, DOI 10.1016/j.numecd.2012.11.007; Campbell L, 2010, J EXP MED, V207, P1825, DOI 10.1084/jem.20100500; Chang WJ, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008540; Choudhry MA, 2000, ALCOHOL, V21, P239, DOI 10.1016/S0741-8329(00)00093-8; Das SK, 2010, OXID MED CELL LONGEV, V3, P414, DOI 10.4161/oxim.3.6.14417; Ding J, 2015, ADV WOUND CARE, V4, P673, DOI 10.1089/wound.2014.0550; do Nascimento AP, 2011, BRIT J NUTR, V106, P603, DOI [10.1017/80007114511000468, 10.1017/S0007114511000468]; Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701; Emmerson E, 2013, MOL CELL ENDOCRINOL, V375, P149, DOI 10.1016/j.mce.2013.05.015; Faunce DE, 2003, ALCOHOL CLIN EXP RES, V27, P1199, DOI 10.1097/01.ALC.0000075833.92139.35; Fitzgerald DJ, 2007, ALCOHOL CLIN EXP RES, V31, P317, DOI 10.1111/j.1530-0277.2006.00307.x; Flegg JA, 2015, FRONT PHYSIOL, V6, P1; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Gallardo CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041161; Gantwerker EA, 2011, FACIAL PLAST SURG CL, V19, P441, DOI 10.1016/j.fsc.2011.06.009; GENTILELLO LM, 1993, J TRAUMA, V34, P669, DOI 10.1097/00005373-199305000-00009; Gupta M, 2015, J DIABETES, V7, P573, DOI 10.1111/1753-0407.12223; Halici M, 2010, EKLEM HAST CERRAHISI, V21, P172; Hiebert PR, 2013, CELL DEATH DIFFER, V20, P1404, DOI 10.1038/cdd.2013.96; Holcomb VB, 2009, VIVO, V23, P15; Hooijmans CR, 2010, LAB ANIM-UK, V44, P170, DOI 10.1258/la.2010.009117; Jakobsdottir G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080476; Jung MK, 2011, ALCOHOL CLIN EXP RES, V35, P392, DOI 10.1111/j.1530-0277.2010.01356.x; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Leite SN, 2015, LASER MED SCI, V30, P1481, DOI 10.1007/s10103-015-1745-2; Masuda R, 2009, WOUND REPAIR REGEN, V17, P127, DOI 10.1111/j.1524-475X.2008.00450.x; McCutcheon JE, 2009, EUR J NEUROSCI, V29, P997, DOI 10.1111/j.1460-9568.2009.06648.x; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Moraes JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005045; Nascimento AP, 2006, BRIT J NUTR, V96, P1069, DOI 10.1017/BJN20061955; Nassar D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037084; Olczyk Pawel, 2014, Biomed Res Int, V2014, P747584, DOI 10.1155/2014/747584; Otranto M, 2013, WOUND REPAIR REGEN, V21, P464, DOI 10.1111/wrr.12042; Panigrahy D, 2013, P NATL ACAD SCI USA, V110, P13528, DOI 10.1073/pnas.1311565110; Pence BD, 2012, MED SCI SPORT EXER, V44, P1846, DOI 10.1249/MSS.0b013e31825a5971; Potz BA, 2016, J SURG RES, V203, P154, DOI 10.1016/j.jss.2016.03.009; Radek KA, 2005, AM J PHYSIOL-HEART C, V289, pH1084, DOI 10.1152/ajpheart.00080.2005; Radek KA, 2009, J LEUKOCYTE BIOL, V86, P1125, DOI 10.1189/jlb.0209103; Ram M, 2015, EUR J PHARMACOL, V764, P9, DOI 10.1016/j.ejphar.2015.06.029; Randi AM, 2017, J THROMB HAEMOST, V15, P13, DOI 10.1111/jth.13551; Ranzer MJ, 2011, ALCOHOL CLIN EXP RES, V35, P83, DOI 10.1111/j.1530-0277.2010.01324.x; Renaud HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088584; Sampey BP, 2011, OBESITY, V19, P1109, DOI 10.1038/oby.2011.18; Seitz O, 2010, EXP DIABETES RES, DOI 10.1155/2010/476969; Silva MLS, 2016, ACTA TROP, V154, P133, DOI 10.1016/j.actatropica.2015.11.010; Slavkovsky R, 2011, WOUND REPAIR REGEN, V19, P515, DOI 10.1111/j.1524-475X.2011.00703.x; Stephens P, 1996, INT J ORAL MAX SURG, V25, P161, DOI 10.1016/S0901-5027(96)80065-8; Su YJ, 2015, ADV WOUND CARE, V4, P631, DOI 10.1089/wound.2014.0559; Szabo G, 2009, ALCOHOL CLIN EXP RES, V33, P220, DOI 10.1111/j.1530-0277.2008.00842.x; Tang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092082; Tepole AB, 2013, PEDIATR RES, V73, P553, DOI 10.1038/pr.2013.3; Tonnesen MG, 2000, J INVEST DERM SYMP P, V5, P40, DOI 10.1046/j.1087-0024.2000.00014.x; Tracy LE, 2016, ADV WOUND CARE, V5, P119, DOI 10.1089/wound.2014.0561; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Wang H, 2015, EURASIP J WIREL COMM, DOI 10.1186/s13638-015-0270-0; Wang JH, 2014, INTERNATIONAL CONFERENCE ON MECHANISM SCIENCE AND CONTROL ENGINEERING (MSCE 2014), P1; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yonehiro L, 2013, WOUNDS, V25, P340	62	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176240	10.1371/journal.pone.0176240	http://dx.doi.org/10.1371/journal.pone.0176240			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493875	Green Submitted, gold, Green Published			2022-12-26	WOS:000401314300010
J	Lee, JH; Shin, MS; Kim, EJ; Ahn, YB; Kim, HD				Lee, Jung-Hoo; Shin, Myung-Seop; Kim, Eun-Jeong; Ahn, Yoo-Been; Kim, Hyun-Duck			The association of dietary vitamin C intake with periodontitis among Korean adults: Results from KNHANES IV	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; ASCORBIC-ACID; NATIONAL-HEALTH; DISEASE; INFECTION; SMOKING; PLASMA; STROKE; NHANES; RISK	Backgrounds The association of dietary vitamin C (vit C) on periodontitis requires more valid evidence from large representative samples to enable sufficient adjustments. This study aimed to evaluate the association between dietary vit C intake and periodontitis after controlling for various confounders in the representative Korean adult population Method A total of 10,930 Korean adults (>= 19 years) from the fourth Korean National Health and Nutrition Examination Survey data set were included in this cross-sectional study. Periodontitis was defined as community periodontal index score of 3 or 4. Dietary vit C intake was estimated from a 24-hour dietary record, and categorized into adequate and inadequate according to the Korean Estimated Average Requirement value. Potential confounders included age, sex, income, frequency of tooth brushing, use of floss, dental visit, drinking, smoking, diabetes, hypercholesterolemia, hypertension, and obesity. A multivariable logistic regression analysis and stratified analysis were applied. Results Those with inadequate dietary vit C intake were more likely by 1.16 times to have periodontitis than those with adequate dietary vit C intake (adjusted odds ratio [aOR] = 1.16, 95% confidence interval = 1.04-1.29). Lowest and middle-low quartile of dietary vit C intake, compared to highest quartile of dietary vit C intake, showed significant association (aOR = 1.28 and 1.22 respectively), which was in a biological-gradient relationship (trendp < 0.05). Conclusions Our data showed that inadequate dietary vit C intake was independently associated with periodontitis among Korean adults. Hence, adequate intake of dietary vitamin C could be substantially important on the promotion of periodontal health among Korean adults.	[Lee, Jung-Hoo; Shin, Myung-Seop; Kim, Eun-Jeong; Ahn, Yoo-Been; Kim, Hyun-Duck] Seoul Natl Univ, Sch Dent, Dept Prevent & Social Dent, 101 Daehak Ro, Seoul, South Korea; [Kim, Hyun-Duck] Seoul Natl Univ, Dent Res Inst, Sch Dent, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Kim, HD (corresponding author), Seoul Natl Univ, Sch Dent, Dept Prevent & Social Dent, 101 Daehak Ro, Seoul, South Korea.; Kim, HD (corresponding author), Seoul Natl Univ, Dent Res Inst, Sch Dent, Seoul, South Korea.	hyundkim@snu.ac.kr			National Research Foundation of Korea through the Oromaxillofacial Dysfunction Research Center for the Elderly at Seoul National University, Korea [2015-048003]	National Research Foundation of Korea through the Oromaxillofacial Dysfunction Research Center for the Elderly at Seoul National University, Korea	This work was supported by a grant from the National Research Foundation of Korea through the Oromaxillofacial Dysfunction Research Center for the Elderly (No. 2015-048003) at Seoul National University, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a grant from the National Research Foundation of Korea through the Oromaxillofacial Dysfunction Research Center for the Elderly (No. 2015-048003) at Seoul National University, Korea.	Abou Sulaiman AE, 2010, J PERIODONTOL, V81, P1547, DOI 10.1902/jop.2010.100173; Ahn YB, 2015, J CLIN PERIODONTOL, V42, P998, DOI 10.1111/jcpe.12471; AINAMO J, 1982, INT DENT J, V32, P281; Amaliya, 2007, J CLIN PERIODONTOL, V34, P299, DOI 10.1111/j.1600-051X.2007.01053.x; Amaliya A, 2014, JAVA PROJECT PERIODO; Amarasena N, 2005, J CLIN PERIODONTOL, V32, P93, DOI 10.1111/j.1600-051X.2004.00643.x; [Anonymous], 1997, Nutr Rev, V55, P319; Balwant Rai, 2008, Advances in Medical and Dental Sciences, V2, P26; Bartold PM, 2010, PERIODONTOL 2000, V53, P55, DOI 10.1111/j.1600-0757.2010.00347.x; Chapple ILC, 2007, J NUTR, V137, P657, DOI 10.1093/jn/137.3.657; Chapple ILC, 2007, PERIODONTOL 2000, V43, P160, DOI 10.1111/j.1600-0757.2006.00178.x; Ciol MA, 2006, ARCH PHYS MED REHAB, V87, P299, DOI 10.1016/j.apmr.2005.09.021; CLARK DE, 1990, J DENT RES, V69, P890, DOI 10.1177/00220345900690031201; Dodd KW, 2006, J AM DIET ASSOC, V106, P1640, DOI 10.1016/j.jada.2006.07.011; Dwyer J, 2003, J NUTR, V133, p609S; Eke PI, 2010, J DENT RES, V89, P1208, DOI 10.1177/0022034510377793; Falagas ME, 2006, LANCET INFECT DIS, V6, P438, DOI 10.1016/S1473-3099(06)70523-0; Gelskey SC, 1999, COMMUNITY DENT ORAL, V27, P16, DOI 10.1111/j.1600-0528.1999.tb01987.x; Genco RJ, 2013, PERIODONTOL 2000, V62, P59, DOI 10.1111/j.1600-0757.2012.00457.x; Han DH, 2013, J PERIODONTOL, V84, P776, DOI 10.1902/jop.2012.120237; Han DH, 2012, J CLIN PERIODONTOL, V39, P30, DOI 10.1111/j.1600-051X.2011.01806.x; Haytac MC, 2013, PERIODONTOL 2000, V61, P252, DOI 10.1111/j.1600-0757.2011.00410.x; ISMAIL AI, 1983, J AM DENT ASSOC, V107, P927, DOI 10.14219/jada.archive.1983.0365; Iwasaki M, 2012, J DENT RES, V91, P167, DOI 10.1177/0022034511431702; Jang AY, 2016, KOREAN J FAM MED, V37, P117, DOI 10.4082/kjfm.2016.37.2.117; Johansen JS, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-5; Kaye EK, 2012, PERIODONTOL 2000, V58, P93, DOI 10.1111/j.1600-0757.2011.00418.x; Kim DW, 2014, ORAL DIS, V20, P551, DOI 10.1111/odi.12168; Kim HD, 2010, J PERIODONTOL, V81, P658, DOI 10.1902/jop.2010.090614; Korea Health Industry Development Institute (KHIDI), 2019, KOR NAT HLTH NUTR EX; Kuzmanova D, 2012, J CLIN PERIODONTOL, V39, P905, DOI 10.1111/j.1600-051X.2012.01927.x; LEGGOTT PJ, 1991, J DENT RES, V70, P1531, DOI 10.1177/00220345910700121101; Llambes F, 2015, WORLD J DIABETES, V6, P927, DOI 10.4239/wjd.v6.i7.927; Merchant Anwar T, 2008, J Evid Based Dent Pract, V8, P103, DOI 10.1016/j.jebdp.2008.03.005; Ministry of Health and Welfare Korea Centers for Disease Control and Prevention, 2014, KOR HLTH STAT 2013 K; Murphy SP, 2002, PUBLIC HEALTH NUTR, V5, P843, DOI 10.1079/PHN2002389; Nishida M, 2000, J PERIODONTOL, V71, P1215, DOI 10.1902/jop.2000.71.8.1215; Park JB, 2014, J PERIODONTOL, V85, P1521, DOI 10.1902/jop.2014.130782; Petersen PE, 2005, J PERIODONTOL, V76, P2187, DOI 10.1902/jop.2005.76.12.2187; Pfeiffer CM, 2013, J NUTR, V143, p957S, DOI 10.3945/jn.112.173021; Pussinen PJ, 2003, CLIN DIAGN LAB IMMUN, V10, P897, DOI 10.1128/CDLI.10.5.897-902.2003; Castell GS, 2015, NUTR HOSP, V31, P46, DOI 10.3305/nh.2015.31.sup3.8750; Sim SJ, 2008, J PERIODONTOL, V79, P1652, DOI [10.1902/jop.2008.080015, 10.1902/jop.2008.080015 ]; The Korean Nutrition Society, 2010, DIET REF INT KOR 201; Van der Velden U, 2011, J CLIN PERIODONTOL, V38, P142, DOI 10.1111/j.1600-051X.2010.01663.x; VOGEL RI, 1986, J PERIODONTOL, V57, P472, DOI 10.1902/jop.1986.57.8.472; Yan Y, 2013, PROTEIN CELL, V4, P620, DOI 10.1007/s13238-013-3030-0	47	19	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177074	10.1371/journal.pone.0177074	http://dx.doi.org/10.1371/journal.pone.0177074			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489936	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314100046
J	Mashauri, FM; Manjurano, A; Kinung'hi, S; Martine, J; Lyimo, E; Kishamawe, C; Ndege, C; Ramsan, MM; Chan, A; Mwalimu, CD; Changalucha, J; Magesa, S				Mashauri, Fabian M.; Manjurano, Alphaxard; Kinung'hi, Safari; Martine, Jackline; Lyimo, Eric; Kishamawe, Coleman; Ndege, Chacha; Ramsan, Mahdi M.; Chan, Adeline; Mwalimu, Charles D.; Changalucha, John; Magesa, Stephen			Indoor residual spraying with micro-encapsulated pirimiphos-methyl (Actellic (R) 300CS) against malaria vectors in the Lake Victoria basin, Tanzania	PLOS ONE			English	Article							INSECTICIDE-TREATED NETS; ANOPHELES-GAMBIAE COMPLEX; BED NETS; TRANSMISSION; RESISTANCE; COMMUNITY; MOSQUITOS; AREA; SUSCEPTIBILITY; PREVALENCE	Background The indoor residual spraying programme for malaria vectors control was implemented in four districts of the Lake Victoria basin of Tanzania namely Ukerewe, Sengerema, Rorya andSerengeti. Entomological monitoring activities were implemented in one sentinel village in each district to evaluate the efficacy of pirimiphos-methyl 300 CS sprayed on different wall surfaces and its impact against malaria vectors post-IRS intervention. Methods The residual decay rate of p-methyl 300 CS applied at a target dosage of 1g a.i./m(2) on the-sprayed wall surfaces was monitored for a period of 43 weeks post-IRSusing the WHO cone wall bioassay method. The bioassays were performed by exposing 2-5 days old unfed susceptible female Anopheles gambiae s.s. (Kisumu strain) to sprayed wall surfaces for a period of 30 minutes. In each sentinel village, mosquito collection was carried out by trained community mosquito collectors. Monthly mosquito collections were carried out from 6.00pm to 6.00am using CDC light traps and clay pot methods for indoors host seekingand outdoors resting mosquitoes respectively. Six traps (2 CDC light traps and 4 clay pots) were set per sentinel village per night for28 consecutive days in a moon. PCR and ELISA were used for mosquito species identification and sporozoite detection, respectively. Results Based on the WHOPES recommendation, insecticides should have a minimum efficacy of >= 80% mosquito mortality at 24 hours post exposure on the sprayed wall surfaces to be considered effective. In this study, p-methyl 300 CS was demonstrated to have a long residual efficacy of 21-43 weeks post-IRS on mud, cement, painted and wood wall surfaces. Number of anopheline mosquitoes decreased post-IRS interventions in all sentinel villages. The highest numbers ofanopheline mosquitoes were collected in November-December, 38-43 weeks post-IRS. A total of 270 female anopheline mosquitoes were analyzed by PCR; out of which 236 (87.4%) were An. gambiae s.l. and 34 (12.6%) were An. funestus group. Of the 236 An. gambiae s.l. identified 12.6% (n = 34) were An. gambiae s. s. and 68.6% (n = 162) were An. arabiensis. Ofthe 34 An. funestus group indentified 91.2% (n = 31) were An. parensis and 8.8% (n = 3) were An. rivulorum. The overall Plasmodium falciparum sporozoite rate was 0.7% (n = 2,098). Conclusions Pirimiphos-methyl 300 CS was found to be effective for IRS in the Lake Victoria basin, Tanzania. P-methyl 300 CShas a long residual efficacy on sprayed wall surfaces and therefore it is effective in controlling principal malaria vectors of An. gambiae s.l and An. funestus which rest on wall surfaces after and before feeding.	[Mashauri, Fabian M.; Manjurano, Alphaxard; Kinung'hi, Safari; Martine, Jackline; Lyimo, Eric; Kishamawe, Coleman; Ndege, Chacha; Changalucha, John] Mwanza Ctr, Natl Inst Med Res, Mwanza, Tanzania; [Ramsan, Mahdi M.; Magesa, Stephen] Res Triangle Inst RTI Int, Dar Es Salaam, Tanzania; [Chan, Adeline] Ctr Dis Control & Prevent, Atlanta, GA USA; [Mwalimu, Charles D.] Minist Hlth Community Dev Gender Elderly & Childr, Natl Malaria Control Program, Dar Es Salaam, Tanzania	National Institute of Medical Research; Research Triangle Institute; Centers for Disease Control & Prevention - USA	Mashauri, FM (corresponding author), Mwanza Ctr, Natl Inst Med Res, Mwanza, Tanzania.	mashauri@hotmail.com		Lyimo, Eric/0000-0002-1904-7410	US President's Malaria Initiative (PMI) through Research Triangle Institute (RTI) International [6-330-0212555]; US President's Malaria Initiative (PMI) through Research Triangle Institute (RTI) International; Ministry of Health, Community Development, Gender, Elderly and Children of the United Republic of Tanzania	US President's Malaria Initiative (PMI) through Research Triangle Institute (RTI) International; US President's Malaria Initiative (PMI) through Research Triangle Institute (RTI) International; Ministry of Health, Community Development, Gender, Elderly and Children of the United Republic of Tanzania	This research was funded by the US President's Malaria Initiative (PMI) through Research Triangle Institute (RTI) International, Grant number 6-330-0212555.; We are grateful to Michael Sadataley and Epiphany Michael for assistance to conductcone wall bioassay, rearing and maintaining a colony of susceptible Anopheles gambiae (Kisumu strain). We are thankful for the financial support extended to the project by the US President's Malaria Initiative (PMI) through Research Triangle Institute (RTI) International and the Ministry of Health, Community Development, Gender, Elderly and Children of the United Republic of Tanzania. We also acknowledge the logistic support provided to the project by the management of NIMR-Mwanza Centre. We thank the District Medical team in particular District Vector Control Officers (DVCOs) from all selected districts for field support and supervision of entomological monitoring activities. Last but not least we extend our sincere appreciation to the community mosquito collectors and communities from all selected sentinel villages for the support and cooperation during fieldwork implementation.	Abbott F F, 1925, Cal West Med, V23, P758; Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Abilio AP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-110; Ajayi IO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-190; [Anonymous], 2004, COCHRANE DB SYST REV; [Anonymous], 1987, SUPPLEMENT ANOPHELIN; BEIER JC, 1990, J MED ENTOMOL, V27, P377, DOI 10.1093/jmedent/27.3.377; BURKOT TR, 1984, AM J TROP MED HYG, V33, P783, DOI 10.4269/ajtmh.1984.33.783; Chanda E, 2013, J MED ENTOMOL, V50, P1275, DOI 10.1603/ME13041; Chiu Chen, 2008, Proc Natl Acad Sci U S A, V105, P13116, DOI 10.1073/pnas.0804408105; Damien GB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-380; DAS M, 1987, MED VET ENTOMOL, V1, P289, DOI 10.1111/j.1365-2915.1987.tb00357.x; Eze IC, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-196; Frohlich F., 1966, BRIT J AESTHET, V6, P17; Fuseini G, 2011, J MED ENTOMOL, V48, P437, DOI 10.1603/ME09286; Gaiger J, 2001, BRIT J AESTHET, V41, P455, DOI 10.1093/bjaesthetics/41.4.455; Haji KA, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1239-x; Hamusse SD, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.11619; Hawley WA, 2003, AM J TROP MED HYG, V68, P121, DOI 10.4269/ajtmh.2003.68.121; Holland RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001676; Ishengoma DS, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-338; Ishengoma DS, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-176; Kabula B, 2014, MED VET ENTOMOL, V28, P244, DOI 10.1111/mve.12036; Kabula B, 2012, TROP MED INT HEALTH, V17, P742, DOI 10.1111/j.1365-3156.2012.02986.x; Kawada H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022574; Kim MJ, 2015, KOREAN J PARASITOL, V53, P571, DOI 10.3347/kjp.2015.53.5.571; Kleinschmidt I, 2009, AM J TROP MED HYG, V81, P519, DOI 10.4269/ajtmh.2009.81.519; Knox TB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-76; Kolaczinski K, 2007, T ROY SOC TROP MED H, V101, P852, DOI 10.1016/j.trstmh.2007.04.003; Mashauri FM, 2013, AM J TROP MED HYG, V88, P841, DOI 10.4269/ajtmh.12-0412; Mathias DK, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-10; Matowo J, 2015, MED VET ENTOMOL, V29, P51, DOI 10.1111/mve.12090; Meyrowitsch DW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-188; Mmbando AS, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1013-8; Motherwell R, 1952, MODERN ARTISTS AM; Muturi EJ, 2006, J VECTOR ECOL, V31, P129, DOI 10.3376/1081-1710(2006)31[129:MSDAAI]2.0.CO;2; Mwangangi JM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-228; N'Guessan R, 2012, LANCET INFECT DIS, V12, P581, DOI 10.1016/S1473-3099(12)70139-1; Najera JA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000412; NASIR SM, 1982, J TROP MED HYG, V85, P239; Ngufor C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-343; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; Okiro EA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-285; OSBORNE H, 1976, BRIT J AESTHET, V16, P291, DOI 10.1093/bjaesthetics/16.4.291; Oxborough RM, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-37; Porter JI, 2009, BRIT J AESTHET, V49, P1, DOI 10.1093/aesthj/ayn054; Protopopoff N, 2008, AM J TROP MED HYG, V79, P12, DOI 10.4269/ajtmh.2008.79.12; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Rowland M, 1997, B WORLD HEALTH ORGAN, V75, P23; Rowland M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069516; Russell TL, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1195-8; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Seyoum A, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-101; Sirima SB, 2003, TROP MED INT HEALTH, V8, P133, DOI 10.1046/j.1365-3156.2003.00997.x; Tangena JAA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074351; Tia E, 2006, Bull Soc Pathol Exot, V99, P278; Trigg PI, 1998, B WORLD HEALTH ORGAN, V76, P11; Wakabi W, 2007, LANCET, V370, P1895, DOI 10.1016/S0140-6736(07)61796-6; West PA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115661; West PA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001630; WHITE GB, 1974, T ROY SOC TROP MED H, V68, P278, DOI 10.1016/0035-9203(74)90035-2; Whitney JR, 1997, NEW DIRECTIONS PALEO, P24; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2006, IND RES SPRAYING US; WHOPES, 2013, REP 16 WHOPES WORK G; WIRTZ RA, 1987, B WORLD HEALTH ORGAN, V65, P39; Wort UU, 2004, INT J EPIDEMIOL, V33, P1311, DOI 10.1093/ije/dyh256; Zhou GF, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-67	68	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176982	10.1371/journal.pone.0176982	http://dx.doi.org/10.1371/journal.pone.0176982			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489935	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314100040
J	Hung, PS; Chen, CY; Chen, WT; Kuo, CY; Fang, WL; Huang, KH; Chiu, PC; Lo, SS				Hung, Pei-Shih; Chen, Chin-Yau; Chen, Wei-Ting; Kuo, Chen-Yu; Fang, Wen-Liang; Huang, Kuo-Hung; Chiu, Peng-Chih; Lo, Su-Shun			miR-376c promotes carcinogenesis and serves as a plasma marker for gastric carcinoma	PLOS ONE			English	Article							CIRCULATING MICRORNAS; ENDOGENOUS CONTROL; CANCER; DNA; EXPRESSION; ARID1A; IDENTIFICATION; PROLIFERATION; PATHOGENESIS; BIOMARKERS	Gastric carcinoma is highly prevalent throughout the world. Understanding the pathogenesis of this disease will benefit diagnosis and resolution. Studies show that miRNAs are involved in the tumorigenesis of gastric carcinoma. An initial screening followed by subsequent validation identified that miR-376c is up-regulated in gastric carcinoma tissue and the plasma of patients with the disease. In addition, the urinary level of miR-376c is also significantly increased in gastric carcinoma patients. The plasma miR-376c level was validated as a biomarker for gastric carcinoma, including early stage tumors. The induction of miR-376c was found to enrich the proliferation, migration and anchorage-independent growth of carcinoma cells and, furthermore, the repression of the expression of endogenous miR-376c was able to reduce such oncogenic phenotypes. ARID4A gene is a direct target of miR-376c. Knockdown of endogenous ARID4A increased the oncogenicity of carcinoma cells, while ARID4A was found to be drastically down-regulated in tumor tissue. Thus, expression levels of miR-376c and ARID4A mRNA tended to be opposing in tumor tissue. Our results demonstrate that miR-376c functions by suppressing ARID4A expression, which in turn enhances the oncogenicity of gastric carcinoma cells. It seems likely that the level of miR-376c in plasma and urine could act as invaluable markers for the detection of gastric carcinoma.	[Hung, Pei-Shih] Natl Yang Ming Univ Hosp, Dept Educ & Med Res, Yilan, Taiwan; [Chen, Chin-Yau; Chen, Wei-Ting; Lo, Su-Shun] Natl Yang Ming Univ Hosp, Dept Surg, Yilan, Taiwan; [Kuo, Chen-Yu] Natl Yang Ming Univ Hosp, Dept Med, Yilan, Taiwan; [Fang, Wen-Liang; Huang, Kuo-Hung] Vet Gen Hosp Taipei, Div Gen Surg, Taipei, Taiwan; [Fang, Wen-Liang; Huang, Kuo-Hung; Chiu, Peng-Chih] Natl Yang Ming Univ Hosp, Dept Dent, Yilan, Taiwan; [Lo, Su-Shun] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan	National Yang Ming Chiao Tung University	Lo, SS (corresponding author), Natl Yang Ming Univ Hosp, Dept Surg, Yilan, Taiwan.; Lo, SS (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.	sslo@ymuh.ym.edu.tw			Ministry of Science and Technology [MOST-102-2314-B-010-043-MY3]; National Yang-Ming University Hospital [RD2014001, RD2015-001]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Yang-Ming University Hospital	This study was supported by grant MOST-102-2314-B-010-043-MY3 from Ministry of Science and Technology, and National Yang-Ming University Hospital grants RD2014001 and RD2015-001.; We acknowledge the technical services provided by Clinical Medicine Research Laboratory of National Yang-Ming University Hospital. This study was supported by grant MOST-102-2314-B-010-043-MY3 from Ministry of Science and Technology, and National Yang-Ming University Hospital grants RD2014-001 and RD2015-001.	Ahn SM, 2012, ONCOGENE, V31, P3051, DOI 10.1038/onc.2011.484; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Cajuso T, 2014, INT J CANCER, V135, P611, DOI 10.1002/ijc.28705; Calcagno DQ, 2013, WORLD J GASTROENTERO, V19, P1182, DOI 10.3748/wjg.v19.i8.1182; Chen X, 2012, TRENDS CELL BIOL, V22, P125, DOI 10.1016/j.tcb.2011.12.001; Chin LT, 1987, J SURG ASS ROC, V19, P27; CHITTENDEN T, 1991, CELL, V65, P1073, DOI 10.1016/0092-8674(91)90559-H; Conteduca V, 2013, INT J ONCOL, V42, P5, DOI 10.3892/ijo.2012.1701; Creemers EE, 2012, CIRC RES, V110, P483, DOI 10.1161/CIRCRESAHA.111.247452; Cuk K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076729; Cuk K, 2013, INT J CANCER, V132, P1602, DOI 10.1002/ijc.27799; Davoren PA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-76; Figueiredo C, 2013, HELICOBACTER, V18, P28, DOI 10.1111/hel.12083; Formosa A, 2014, ONCOGENE, V33, P5173, DOI 10.1038/onc.2013.451; Gao X, 2016, ONCOTARGET, DOI 10.18632/oncotarget.11198; Gonzalez CA, 2012, INT J CANCER, V130, P745, DOI 10.1002/ijc.26430; Gonzalez-Perez A, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r106; Hanke M, 2010, UROL ONCOL-SEMIN ORI, V28, P655, DOI 10.1016/j.urolonc.2009.01.027; Hu J, 2014, INT J CANCER, V135, P1187, DOI 10.1002/ijc.28757; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kim SH, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003563; Kuroda A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022313; Lo SS, 2012, ONCOGENE, V31, P226, DOI 10.1038/onc.2011.226; Lo SS, 2007, ANN SURG ONCOL, V14, P340, DOI 10.1245/s10434-006-9077-x; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Pang ALY, 2014, ONCOL LETT, V7, P1819, DOI 10.3892/ol.2014.2034; Qiu X, 2016, J GASTROENTEROL HEPA; Rodrigues-Lisoni FC, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-14; Sassen S, 2008, VIRCHOWS ARCH, V452, P1, DOI 10.1007/s00428-007-0532-2; Sheng JP, 2013, CANCER BIOTHER RADIO, V28, P523, DOI 10.1089/cbr.2012.1446; Singchat W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160901; Song MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033608; Stuopelyte K, 2016, BR J CANC; Tsai MM, 2016, EUR J CANCER, V64, P137, DOI 10.1016/j.ejca.2016.05.007; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wilsker D, 2002, CELL GROWTH DIFFER, V13, P95; Wu CW, 2006, LANCET ONCOL, V7, P309, DOI 10.1016/S1470-2045(06)70623-4; Wu MY, 2008, JNCI-J NATL CANCER I, V100, P1247, DOI 10.1093/jnci/djn253; Wu Q, 2010, BIOCHEM BIOPH RES CO, V392, P340, DOI 10.1016/j.bbrc.2009.12.182; Xiao B, 2012, ONCOL REP, V27, P559, DOI 10.3892/or.2011.1514; Yabushita S, 2012, PANCREAS, V41, P1013, DOI 10.1097/MPA.0b013e31824ac3a5; Yang L, 2016, SCI REP-UK, V6, DOI 10.1038/srep28919; Ye G, 2011, J CELL SCI, V124, P359, DOI 10.1242/jcs.072223; Zehavi L, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-44; Zeng ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073278; Zhang Y, 2013, NEOPLASMA, V60, P247, DOI 10.4149/neo_2013_033; Zhang ZY, 2008, LAB INVEST, V88, P1358, DOI 10.1038/labinvest.2008.94; Zhou J, 2015, ONCOL REP, V33, P2915, DOI 10.3892/or.2015.3937	51	28	28	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177346	10.1371/journal.pone.0177346	http://dx.doi.org/10.1371/journal.pone.0177346			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486502	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314000073
J	Thomazelli, LM; de Araujo, J; Fabrizio, T; Walker, D; Reischak, D; Ometto, T; Barbosa, CM; Petry, MV; Webby, RJ; Durigon, EL				Thomazelli, Luciano Matsumiya; de Araujo, Jansen; Fabrizio, Thomas; Walker, David; Reischak, Dilmara; Ometto, Tatiana; Barbosa, Carla Meneguin; Petry, Maria Virginia; Webby, Richard J.; Durigon, Edison Luiz			Novel avian paramyxovirus (APMV-15) isolated from a migratory bird in South America	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; PENGUINS; SEROTYPE; VIRUS	A novel avian paramyxovirus (APMV) isolated from a migratory bird cloacal swab obtained during active surveillance in April 2012 in the Lagoa do Peixe National Park, Rio Grande do Sul state, South of Brazil was biologically and genetically characterized. The nucleotide sequence of the full viral genome was completed using a next-generation sequencing approach. The genome was 14,952 nucleotides (nt) long, with six genes (3'-NP-P-M-F-HNL-5') encoding 7 different proteins, typical of APMV. The fusion (F) protein gene of isolate RS-1177 contained 1,707 nucleotides in a single open reading frame encoding a protein of 569 amino acids. The F protein cleavage site contained two basic amino acids (VPKER down arrow L), typical of avirulent strains. Phylogenetic analysis of the whole genome indicated that the virus is related to APMV-10, -2 and -8, with 60.1% nucleotide sequence identity to the closest APMV-10 virus, 58.7% and 58.5% identity to the closest APMV-8 and APMV-2 genome, respectively, and less than 52% identity to representatives of the other APMVs groups. Such distances are comparable to the distances observed among other previously identified APMVs serotypes. These results suggest that unclassified/calidris_fuscicollis/Brazil/RS1177/2012 is the prototype strain of a new APMV serotype, APMV-15.	[Thomazelli, Luciano Matsumiya; de Araujo, Jansen; Ometto, Tatiana; Barbosa, Carla Meneguin; Durigon, Edison Luiz] Univ Sao Paulo, Lab Virol Clin & Mol, Inst Ciencias Biomed, Sao Paulo, Brazil; [Fabrizio, Thomas; Walker, David; Webby, Richard J.] St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA; [Reischak, Dilmara] Lab Nacl Agropecuario, Campinas, SP, Brazil; [Petry, Maria Virginia] Univ Vale Rio dos Sinos, Sao Leopoldo, Rio Grande Do S, Brazil	Universidade de Sao Paulo; St Jude Children's Research Hospital; Universidade do Vale do Rio dos Sinos (Unisinos)	Thomazelli, LM (corresponding author), Univ Sao Paulo, Lab Virol Clin & Mol, Inst Ciencias Biomed, Sao Paulo, Brazil.	lucmt@usp.br	Petry, Maria Virginia/AAG-5333-2021; Webby, Richard J/N-5657-2018; Thomazelli, Luciano/Q-6119-2017; Fabrizio, Thomas/J-9935-2013; Barbosa, Carla Meneguin/AAA-8413-2019; Petry, Maria Virginia/K-8410-2013	Thomazelli, Luciano/0000-0002-9157-6122; Fabrizio, Thomas/0000-0002-8960-0728; Barbosa, Carla Meneguin/0000-0002-7329-202X; Petry, Maria Virginia/0000-0002-7870-7394; Araujo, Jansen/0000-0002-7250-3024	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/05485-2]; Conselho Nacional de Desenvolvimento a Pesquisa (CNPq); National Institute of Allergy and Infectious Diseases of the National Institutes of Health [HHSN266200700005C]; ALSAC; The British Council [172710323] Funding Source: researchfish	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento a Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ALSAC(American Lebanese Syrian Associated Charities (ALSAC)); The British Council	This work has been funded in part by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP 2013/05485-2), Conselho Nacional de Desenvolvimento a Pesquisa (CNPq) and the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, under contract number HHSN266200700005C and ALSAC. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.; Field logistic support by Centro Nacional de Pesquisa e Conservacao das Ayes Silvestres (CEMAVE-ICMBio), Universidade Vale do Rio do Sinos (UNISINOS), field team of University of Sao Paulo and Secretaria de Estado da Agricultura, Pecuaria e Abastecimento SEAPA-RS, MAPA. We thank Dr. Andre de Oliveira Mendonca and Dra. Maria Angela Orsi from LANAGRO for the institutional support and Monique Guardieiro, Rodrigo Labello and Soraya C. A. Camillo for the technical support.	Briand FX, 2012, J VIROL, V86, P7710, DOI 10.1128/JVI.00946-12; Costa Erli Schneider, 2011, Oecologia Australis, V15, P59; Djikeng A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-5; Fornells LAMG, 2012, VET MICROBIOL, V156, P429, DOI 10.1016/j.vetmic.2011.11.026; Goraichuk I, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00729-16; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hayman P, 1986, SHOREBIRDS IDENTIFIC; Karamendin K, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00167-16; Kolakofsky D, 2005, J GEN VIROL, V86, P1869, DOI 10.1099/vir.0.80986-0; Maximino C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103943; Miller PJ, 2010, J VIROL, V84, P11496, DOI 10.1128/JVI.00822-10; OIE (Office International des Epizooties) Newcastle disease, 2004, OIE MAN STAND DIAGN; Rosseel T, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-463; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Terregino C, 2013, ARCH VIROL, V158, P2233, DOI 10.1007/s00705-013-1735-2; Thampaisarn R, 2017, VIRUS RES, V228, P46, DOI 10.1016/j.virusres.2016.11.018; Thomazelli LM, 2012, BRAZ J POULTRY SCI, V14, P1, DOI 10.1590/S1516-635X2012000100001; Tong S, 2008, J CLIN MICROBIOL, V46, P2652, DOI 10.1128/JCM.00192-08; White DJ, 2016, VIRUS GENES, V52, P727, DOI 10.1007/s11262-016-1342-x; Yamamo E, 2015, J VET MED SCI, V77, P1079, DOI 10.1292/jvms.14-0529	21	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177214	10.1371/journal.pone.0177214	http://dx.doi.org/10.1371/journal.pone.0177214			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486490	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314000058
J	Wang, SY; Yang, YF; Zhi, H				Wang, Shiyu; Yang, Yunfei; Zhi, Heng			Water-soluble carbohydrates of root components and activity rhythms at vegetative growth stage of Artemisia scoparia in northeastern grassland of China	PLOS ONE			English	Article							DACTYLIS-GLOMERATA L.; NONSTRUCTURAL CARBOHYDRATE; LEYMUS-CHINENSIS; STORAGE ORGANS; SONGNEN PLAINS; PERENNIAL HERB; LOESS PLATEAU; GRASSES; POPULATIONS; RESERVES	The root system of perennials is composed of the roots of different growth years. The nutrient storage capacities and activities of roots are an important basis for judging root components and plant senescence. In this research, changes in the contents of water-soluble carbohydrate (WSC) were used as indicators of the nutrient storage and activity of roots of different life years. From the early resprouting stage to the rapid growth stage, Artemisia scoparia L. plants of 1-3 age classes were sampled and measured once every 18 days. The nutrient storage capacities and activity rhythms of plant root components of the three age classes were analysed quantitatively. Among the A. scoparia population in northeast China, the nutrient storage capacities of 1a/2a plant root collars and 2-year old roots were generally large, whereas those of 3a plant root collars and 3-year old roots were significantly reduced. As for changes in the WSC content in the root system at the 18 day resprouting stage, the decline rates in the root collars of the 1a and 2a plants were 102 and 109 times those of the 3a plants, respectively. The decline rate in the 2-year old roots of the 1a plants was 1.8 times that of the 2a plants and 29.6 times that of the 3a plants. When nutrients were most active, all root components of the 1a plants entered into the resprouting stage, but the 2/3-year old roots of the 2a plants lagged behind. All the root components of the 3a plants generally lagged. At the vegetative growth stage, the WSC contents in all root components of the 1a plants declined logarithmically. For the 3a plants, the content in the root collars decreased linearly with that in the 3-year old roots. The older root components (3-year old roots) of the 2a plants and all root components of the 3a plants exhibited signs of aging.	[Wang, Shiyu; Yang, Yunfei; Zhi, Heng] Northeast Normal Univ, Inst Grassland Sci, Key Lab Vegetat Ecol, Minist Educ, Changchun, Jilin Province, Peoples R China	Northeast Normal University - China	Yang, YF (corresponding author), Northeast Normal Univ, Inst Grassland Sci, Key Lab Vegetat Ecol, Minist Educ, Changchun, Jilin Province, Peoples R China.	yunfeiyangcncn@sina.com			National Natural Science Foundation of China [31672471, 31170504, 31670427]; National Key Research and Development Program of China [2016YFC0500602]; Natural Science and Technology Commission of Jilin Province, China [20170101150JC]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Natural Science and Technology Commission of Jilin Province, China	This work was funded by the National Natural Science Foundation of China (Grant numbers: 31672471, 31170504, 31670427), the National Key Research and Development Program of China (2016YFC0500602), and the Natural Science and Technology Commission of Jilin Province, China (20170101150JC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai YF, 1995, GRASSLAND CHINA, V1, P7; Bai ZJ, 2015, J VEG SCI, V26, P686, DOI 10.1111/jvs.12282; Ding XM, 2007, J INTEGR PLANT BIOL, V49, P576, DOI 10.1111/j.1744-7909.2007.00487.x; Du Feng, 2006, Zhiwu Shengtai Xuebao, V30, P601; Fulkerson WJ, 2001, AUST J EXP AGR, V41, P261, DOI 10.1071/EA00062; Gao Y, 2014, PLANT BIOLOGY, V16, P774, DOI 10.1111/plb.12122; Hedhly A, 2016, PLANT PHYSIOL, V172, P2388, DOI 10.1104/pp.16.00916; Huang Gang, 2007, Zhiwu Shengtai Xuebao, V31, P1161; Johnson MP, 2016, ESSAYS BIOCHEM, V60, P255, DOI 10.1042/EBC20160016; Kabeya D, 2003, ANN BOT-LONDON, V92, P537, DOI 10.1093/aob/mcg165; Li XH, 2012, J ARID LAND, V4, P36, DOI 10.3724/SP.J.1227.2012.00036; Lin R, 1991, FLORA CHINA, V76; Liu LX, 2008, NEW ZEAL J BOT, V46, P119, DOI 10.1080/00288250809509759; Masuko T, 2005, ANAL BIOCHEM, V339, P69, DOI 10.1016/j.ab.2004.12.001; McGrath S, 2014, PLANT GENET RESOUR-C, V12, P236, DOI 10.1017/S1479262113000567; Newell EA, 2002, OECOLOGIA, V131, P333, DOI 10.1007/s00442-002-0888-6; [潘庆民 Pan Qingmin], 2002, [植物学通报, Chinese Bulletin of Botany], V19, P30; Phillips N, 2015, HORTTECHNOLOGY, V25, P536, DOI 10.21273/HORTTECH.25.4.536; Ranjbar M, 2015, IND CROP PROD, V76, P836, DOI 10.1016/j.indcrop.2015.07.077; Ranwala AP, 2008, NEW PHYTOL, V180, P421, DOI 10.1111/j.1469-8137.2008.02585.x; Roberto GG, 2015, BRAGANTIA, V74, P379, DOI 10.1590/1678-4499.0062; Robins JG, 2015, EUPHYTICA, V204, P503, DOI 10.1007/s10681-014-1326-7; Sanada Y, 2007, EUPHYTICA, V153, P267, DOI 10.1007/s10681-006-9262-9; Sharma I, 2014, NATL ACAD SCI LETT, V37, P285, DOI 10.1007/s40009-014-0233-8; Shi LX, 2006, PHOTOSYNTHETICA, V44, P542, DOI 10.1007/s11099-006-0068-8; Singh HP, 2009, J CHEM ECOL, V35, P154, DOI 10.1007/s10886-009-9595-7; Su Yuan, 2014, Chinese Journal of Plant Ecology, V38, P694, DOI 10.3724/SP.J.1258.2014.00065; Suzuki Jun-ichirou, 1999, Plant Species Biology, V14, P11, DOI 10.1046/j.1442-1984.1999.00002.x; Tamura Y, 2001, PLANT PROD SCI, V4, P56, DOI 10.1626/pps.4.56; Volaire F, 1997, AUST J AGR RES, V48, P933, DOI 10.1071/A97004; Wang J, 2002, ACTA ECOLOGICA SINIC, V23, P908; [王勇 Wang Yong], 2014, [生态学报, Acta Ecologica Sinica], V34, P4535; Wang Zheng-Wen, 2007, Zhiwu Shengtai Xuebao, V31, P673; WHITE LM, 1973, J RANGE MANAGE, V26, P13, DOI 10.2307/3896873; Wulfes R, 1999, AGR SYST, V61, P1, DOI 10.1016/S0308-521X(99)00028-1; Wyka T, 1999, OECOLOGIA, V120, P198, DOI 10.1007/s004420050849; Xu ZX, 1994, ACTA PRATACULTURAL S, V4, P27; Yan Q, 2003, ACTA ECOLOGICA SINIC, V24, P2422; [杨超 YANG Chao], 2008, [生态学报, Acta Ecologica Sinica], V28, P4732; Yang YF, 2003, ACTA BOT SIN, V45, P158; Yang YunFei, 2003, Acta Prataculturae Sinica, V12, P8; Ye XiaoQi, 2013, Acta Hydrobiologica Sinica, V37, P450; Zhang BaoTian, 2002, Grassland of China, V24, P13; Zhang ZL, 2003, GUIDE PLANT PHYSL EX, P127; [周天 ZHOU Tian], 2008, [草业科学, Pratacultural Science], V25, P41; Zhou Yong-Bin, 2009, Zhiwu Shengtai Xuebao, V33, P118, DOI 10.3773/j.issn.1005-264x.2009.01.013	46	1	2	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0176667	10.1371/journal.pone.0176667	http://dx.doi.org/10.1371/journal.pone.0176667			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486507	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314000022
J	Benz, C; Stribrna, E; Hashimi, H; Lukes, J				Benz, Corinna; Stribrna, Eva; Hashimi, Hassan; Lukes, Julius			Dynamin-like proteins in Trypanosoma brucei: A division of labour between two paralogs?	PLOS ONE			English	Article							BLOOD-STREAM FORMS; MITOCHONDRIAL FISSION; SEQUENCE ALIGNMENT; GTPASE ACTIVITY; SINGLE DYNAMIN; LIFE-CYCLE; ENDOCYTOSIS; FIS1; EXPRESSION; SURFACE	Dynamins and dynamin-like proteins (DLPs) belong to a family of large GTPases involved in membrane remodelling events. These include both fusion and fission processes with different dynamin proteins often having a specialised function within the same organism. Trypanosoma brucei is thought to have only one multifunctional DLP (TbDLP). While this was initially reported to function in mitochondrial division only, an additional role in endocytosis and cytokinesis was later also proposed. Since there are two copies of TbDLP present in the trypanosome genome, we investigated potential functional differences between these two paralogs by re-expressing either protein in a TbDLP RNAi background. These paralogs, called TbDLP1 and TbDLP2, are almost identical bar a few amino acid substitutions. Our results, based on cell lines carrying tagged and RNAi-resistant versions of each protein, show that overexpression of TbDLP1 alone is able to rescue the observed endocytosis and growth defects in the mammalian bloodstream form (BSF) of the parasite. While TbDLP2 shows no rescue in our experiments in BSF, this might also be due to lower expression levels of the protein in this life stage. In contrast, both TbDLP proteins apparently play more complementary roles in the insect procyclic form (PCF) since neither TbDLP1 nor TbDLP2 alone can fully restore wildtype growth and morphology in TbDLP-depleted parasites.	[Benz, Corinna; Hashimi, Hassan; Lukes, Julius] Univ South Bohemia, Fac Sci, Ceske Budejovice, Budweis, Czech Republic; [Stribrna, Eva; Hashimi, Hassan; Lukes, Julius] Czech Acad Sci, Biol Ctr, Inst Parasitol, Ceske Budejovice, Budweis, Czech Republic; [Lukes, Julius] Canadian Inst Adv Res, Toronto, ON, Canada; [Benz, Corinna] Univ Lancaster, Fac Hlth & Med, Div Biomed & Life Sci, Lancaster, England	University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Canadian Institute for Advanced Research (CIFAR); Lancaster University	Lukes, J (corresponding author), Univ South Bohemia, Fac Sci, Ceske Budejovice, Budweis, Czech Republic.; Lukes, J (corresponding author), Czech Acad Sci, Biol Ctr, Inst Parasitol, Ceske Budejovice, Budweis, Czech Republic.; Lukes, J (corresponding author), Canadian Inst Adv Res, Toronto, ON, Canada.	jula@paru.cas.cz	Lukes, Julius/H-6760-2012; Benz, Corinna/AAD-8702-2021; Hashimi, Hassan/H-6740-2012	Lukes, Julius/0000-0002-0578-6618; Benz, Corinna/0000-0003-4367-2758; Hashimi, Hassan/0000-0002-6678-1618	Grant Agency of the Czech Republic [15-21974S, 17-24036S]; Bioglobe [CZ.1.07/2.3.00/30.0006]; European Research Council [CZ LL1601]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Bioglobe; European Research Council(European Research Council (ERC)European Commission)	This work was supported by the Grant Agency of the Czech Republic (grant number: 15-21974S; https.//gacr.cz/en/) to JL and (grant number: 17-24036S; https://gacr.cz/en/) to HH, Bioglobe grant CZ.1.07/2.3.00/30.0006 (http://alfa. bc.cas.czlen/Postdok-BIOGLOBE/) to JL and CB and the European Research Council (grant number: CZ LL1601; https.//erc.europa.eu/) to JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CL, 2003, EMBO J, V22, P4991, DOI 10.1093/emboj/cdg481; Benz C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030367; BIENEN EJ, 1991, MOL BIOCHEM PARASIT, V45, P185, DOI 10.1016/0166-6851(91)90085-K; Bramkamp M, 2012, BIOL CHEM, V393, P1203, DOI 10.1515/hsz-2012-0185; BRUN R, 1979, ACTA TROP, V36, P289; Burmann F, 2011, MOL MICROBIOL, V79, P1294, DOI 10.1111/j.1365-2958.2011.07523.x; Bui HT, 2013, CURR BIOL, V23, pR891, DOI 10.1016/j.cub.2013.08.040; Butter F, 2013, MOL CELL PROTEOMICS, V12, P172, DOI 10.1074/mcp.M112.019224; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; Chanez AL, 2006, J CELL SCI, V119, P2968, DOI 10.1242/jcs.03023; Changmai P, 2013, MOL MICROBIOL, V89, P135, DOI 10.1111/mmi.12264; Coustou V, 2008, J BIOL CHEM, V283, P16342, DOI 10.1074/jbc.M709592200; Cross GAM, 2014, MOL BIOCHEM PARASIT, V195, P59, DOI 10.1016/j.molbiopara.2014.06.004; Dejung M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005439; Detmer SA, 2007, J CELL BIOL, V176, P405, DOI 10.1083/jcb.200611080; Engstler M, 2007, CELL, V131, P505, DOI 10.1016/j.cell.2007.08.046; Field MC, 2009, NAT REV MICROBIOL, V7, P775, DOI 10.1038/nrmicro2221; Figueroa-Romero C, 2009, FASEB J, V23, P3917, DOI 10.1096/fj.09-136630; Garcia-Salcedo JA, 2004, EMBO J, V23, P780, DOI 10.1038/sj.emboj.7600094; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Gunasekera K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-556; Guo Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053523; Hammarton TC, 2007, MOL BIOCHEM PARASIT, V153, P1, DOI 10.1016/j.molbiopara.2007.01.017; Kashatus DF, 2011, NAT CELL BIOL, V13, P1108, DOI 10.1038/ncb2310; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kelly S, 2007, MOL BIOCHEM PARASIT, V154, P103, DOI 10.1016/j.molbiopara.2007.03.012; Koirala S, 2013, P NATL ACAD SCI USA, V110, pE1342, DOI 10.1073/pnas.1300855110; Kumar S, 2007, EUKARYOT CELL, V6, P2029, DOI 10.1128/EC.00213-07; Loson OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721; Macdonald PJ, 2016, J BIOL CHEM, V291, P493, DOI 10.1074/jbc.M115.680181; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; Matthews KR, 2005, J CELL SCI, V118, P283, DOI 10.1242/jcs.01649; Morgan GW, 2004, J BIOL CHEM, V279, P10692, DOI 10.1074/jbc.M312178200; Morrison LJ, 2014, MICROBIOLOGY SPECTRU, P409; Nett IRE, 2009, MOL CELL PROTEOMICS, V8, P1527, DOI 10.1074/mcp.M800556-MCP200; Osellame L. D., 2016, J CELL SCI; Purkanti R, 2015, P NATL ACAD SCI USA, V112, P2800, DOI 10.1073/pnas.1407163112; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Surve S, 2012, EUKARYOT CELL, V11, P183, DOI 10.1128/EC.05282-11; Tan TC, 2003, NAT CELL BIOL, V5, P701, DOI 10.1038/ncb1020; Tielens AGM, 1998, PARASITOL TODAY, V14, P265, DOI 10.1016/S0169-4758(98)01263-0; Tielens AGM, 2009, TRENDS PARASITOL, V25, P482, DOI 10.1016/j.pt.2009.07.007; Urbaniak MD, 2013, J PROTEOME RES, V12, P2233, DOI 10.1021/pr400086y; Urbaniak MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036619; Vanwalleghem G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9078; Verner Z, 2015, INT REV CEL MOL BIO, V315, P73, DOI 10.1016/bs.ircmb.2014.11.001; Wang B, 2011, EMBO J, V30, P451, DOI 10.1038/emboj.2010.352; Wang JY, 2012, MOL MICROBIOL, V83, P471, DOI 10.1111/j.1365-2958.2011.07938.x; Wickstead B, MOL BIOCH PARASITOL, V125, P211; Williams M, 2014, EUR J CELL BIOL, V93, P267, DOI 10.1016/j.ejcb.2014.05.002; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Zhang ZZ, 2016, FASEB J, V30, P466, DOI 10.1096/fj.15-274258	55	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177200	10.1371/journal.pone.0177200	http://dx.doi.org/10.1371/journal.pone.0177200			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481934	gold, Green Published, Green Submitted			2022-12-26	WOS:000401313700040
J	Parent, L				Parent, Lucie			A helical segment makes potassium channels go-go	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							TRAFFICKING; MECHANISM	More than 500 variants in the KCNH2 gene, which encodes the cardiac human ether-a-go-go (hERG) ion channel, have been associated with sudden cardiac death, but only a subset of these variants have been investigated. Matthew D. Perry and colleagues now combine NMR spectroscopy and electrophysiological experiments to explore the functional properties of mutations within an overlooked hERG helix, finding important contributions to channel function.	[Parent, Lucie] Univ Montreal, Inst Cardiol Montreal, Ctr Rech, Dept Pharmacol & Physiol,Fac Med, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Institut de Cardiologie de Montreal	Parent, L (corresponding author), Univ Montreal, Inst Cardiol Montreal, Ctr Rech, Dept Pharmacol & Physiol,Fac Med, Montreal, PQ H3C 3J7, Canada.	lucie.parent@umontreal.ca			Canadian Institutes of Health Research; Canadian Heart and Stroke Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Heart and Stroke Foundation(Heart & Stroke Foundation of Canada)	Supported by the Canadian Institutes of Health Research and the Canadian Heart and Stroke Foundation. To whom correspondence should be addressed. E-mail: lucie.parent@umontreal.ca.	Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; Giudicessi JR, 2013, TRANSL RES, V161, P1, DOI 10.1016/j.trsl.2012.08.005; Phan K, 2017, J BIOL CHEM, V292, P7688, DOI 10.1074/jbc.M117.779298; Pintacuda G, 2002, J AM CHEM SOC, V124, P372, DOI 10.1021/ja016985h; Robertson GA, 2006, HANDB EXP PHARMACOL, V171, P349; Tester David J, 2014, Methodist Debakey Cardiovasc J, V10, P29; Vandenberg JI, 2012, PHYSIOL REV, V92, P1393, DOI 10.1152/physrev.00036.2011; Whicher JR, 2016, SCIENCE, V353, P664, DOI 10.1126/science.aaf8070; Wilde AAM, 2005, HEART, V91, P1352, DOI 10.1136/hrt.2004.046334	9	0	0	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7706	7707		10.1074/jbc.H117.779298	http://dx.doi.org/10.1074/jbc.H117.779298			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28476926	Green Published, hybrid			2022-12-26	WOS:000400761300035
J	Takeda, T; Komiya, Y; Koga, T; Ishida, T; Ishii, Y; Kikuta, Y; Nakaya, M; Kurose, H; Yokomizo, T; Shimizu, T; Uchi, H; Furue, M; Yamada, H				Takeda, Tomoki; Komiya, Yukiko; Koga, Takayuki; Ishida, Takumi; Ishii, Yuji; Kikuta, Yasushi; Nakaya, Michio; Kurose, Hitoshi; Yokomizo, Takehiko; Shimizu, Takao; Uchi, Hiroshi; Furue, Masutaka; Yamada, Hideyuki			Dioxin-induced increase in leukotriene B4 biosynthesis through the aryl hydrocarbon receptor and its relevance to hepatotoxicity owing to neutrophil infiltration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aryl hydrocarbon receptor (AHR); dioxin; leukotriene; liver injury; metabolomics	2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD; B-4 RECEPTOR; MICE LACKING; AH RECEPTOR; FATTY-ACIDS; INFLAMMATION; INDUCTION; TOXICITY; MOUSE; LIVER	Dioxin and related chemicals alter the expression of a number of genes by activating the aryl hydrocarbon receptors (AHR) to produce a variety of disorders including hepatotoxicity. However, it remains largely unknown how these changes in gene expression are linked to toxicity. To address this issue, we initially examined the effect of 2,3,7,8-tetrachrolodibenzo-p-dioxin (TCDD), a most toxic dioxin, on the hepatic and serum metabolome in male pubertal rats and found that TCDD causes many changes in the level of fatty acids, bile acids, amino acids, and their metabolites. Among these findings was the discovery that TCDD increases the content of leukotriene B4 (LTB4), an inducer of inflammation due to the activation of leukocytes, in the liver of rats and mice. Further analyses suggested that an increase in LTB4 comes from a dual mechanism consisting of an induction of arachidonate lipoxygenase-5, a rate-limiting enzyme in LTB4 synthesis, and the down-regulation of LTC4 synthase, an enzyme that converts LTA4 to LTC4. The above changes required AHR activation, because the same was not observed in AHR knock-out rats. In agreement with LTB4 accumulation, TCDD caused the marked infiltration of neutrophils into the liver. However, deleting LTB4 receptors (BLT1) blocked this effect. A TCDD-produced increase in the mRNA expression of inflammatory markers, including tumor-necrosis factor and hepatic damage, was also suppressed in BLT1-null mice. The above observations focusing on metabolomic changes provide novel evidence that TCDD accumulates LTB4 in the liver by an AHR-dependent induction of LTB4 biosynthesis to cause hepatotoxicity through neutrophil activation.	[Takeda, Tomoki; Komiya, Yukiko; Koga, Takayuki; Ishida, Takumi; Ishii, Yuji; Yamada, Hideyuki] Kyushu Univ, Grad Sch Pharmaceut Sci, Lab Mol Life Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan; [Nakaya, Michio; Kurose, Hitoshi] Kyushu Univ, Grad Sch Pharmaceut Sci, Lab Pharmacol & Toxicol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan; [Uchi, Hiroshi; Furue, Masutaka] Kyushu Univ, Grad Sch Med Sci, Dept Dermatol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan; [Kikuta, Yasushi] Fukuyama Univ, Dept Appl Biol Sci, Hiroshima 7290292, Japan; [Yokomizo, Takehiko] Juntendo Univ, Dept Biochem, Sch Med, Tokyo 1138421, Japan; [Shimizu, Takao] Natl Ctr Global Hlth & Med, Dept Lipid Signaling, Res Inst, Tokyo 1628655, Japan; [Shimizu, Takao] Univ Tokyo, Grad Sch Med, Dept Lipid, Tokyo 1130033, Japan; [Furue, Masutaka] Kyushu Univ Hosp, Res & Clin Ctr Yusho & Dioxin, Fukuoka 8128582, Japan; [Koga, Takayuki] Daiichi Univ Pharm, Fac Pharmaceut Sci, Fukuoka 8158511, Japan; [Ishida, Takumi] Sojo Univ, Fac Pharmaceut Sci, Kumamoto 8600082, Japan	Kyushu University; Kyushu University; Kyushu University; Fukuyama University; Juntendo University; National Center for Global Health & Medicine - Japan; University of Tokyo; Kyushu University; Sojo University	Takeda, T (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	takeda@phar.kyushu-u.ac.jp	Yokomizo, Takehiko/P-5673-2016; Ishii, Yuji/AAU-3300-2021; Shimizu, Takao/AAV-7052-2021	Yokomizo, Takehiko/0000-0002-5219-1553; Koga, Takayuki/0000-0001-9782-6746	ONO Pharmaceutical Co.; Shimadzu Corp.; Grants-in-Aid for Scientific Research [15H05897] Funding Source: KAKEN	ONO Pharmaceutical Co.; Shimadzu Corp.; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The Lipidomics Department of the University of Tokyo is funded by ONO Pharmaceutical Co. and Shimadzu Corp.	Arita M, 2007, J IMMUNOL, V178, P3912, DOI 10.4049/jimmunol.178.6.3912; AUGUSTINE PC, 1979, AVIAN DIS, V23, P854, DOI 10.2307/1589601; BAILIE MB, 1995, TOXICOLOGY, V100, P139, DOI 10.1016/0300-483X(95)03060-S; BRUNGS M, 1995, P NATL ACAD SCI USA, V92, P107, DOI 10.1073/pnas.92.1.107; Chiba N, 1999, BIOL PHARM BULL, V22, P1047; Cho KJ, 2011, MOL CELLS, V32, P1, DOI 10.1007/s10059-011-1021-7; Crooks SW, 1998, INT J BIOCHEM CELL B, V30, P173, DOI 10.1016/S1357-2725(97)00123-4; Falck JR, 2011, J MED CHEM, V54, P4109, DOI 10.1021/jm200132q; Feldstein AE, 2004, HEPATOLOGY, V40, P185, DOI 10.1002/hep.20283; FernandezSalguero PM, 1996, TOXICOL APPL PHARM, V140, P173, DOI 10.1006/taap.1996.0210; Forgacs AL, 2012, TOXICOL SCI, V125, P41, DOI 10.1093/toxsci/kfr262; FUJISAWASEHARA A, 1987, NUCLEIC ACIDS RES, V15, P4179, DOI 10.1093/nar/15.10.4179; Gasiewicz TA., 1991, HDB PESTICIDE TOXICO, V3, P1217; GERMOLEC DR, 1995, BIOCHEM PHARMACOL, V50, P1495, DOI 10.1016/0006-2952(95)02062-4; Harrill JA, 2013, TOXICOL APPL PHARM, V272, P503, DOI 10.1016/j.taap.2013.06.024; HARRIS M W, 1973, Environmental Health Perspectives, V5, P101, DOI 10.2307/3428118; Ishida T, 2005, TOXICOL APPL PHARM, V205, P89, DOI 10.1016/j.taap.2004.09.014; Kakizuka S, 2015, BIOL PHARM BULL, V38, P1484, DOI 10.1248/bpb.b15-00235; Kanaoka Y, 2001, J BIOL CHEM, V276, P22608, DOI 10.1074/jbc.M103562200; Kaplanski G, 2003, TRENDS IMMUNOL, V24, P25, DOI 10.1016/S1471-4906(02)00013-3; Kennedy GD, 2014, TOXICOL SCI, V140, P135, DOI 10.1093/toxsci/kfu065; Kim ND, 2006, J EXP MED, V203, P829, DOI 10.1084/jem.20052349; Koga T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040322; Konkel A, 2011, BBA-PROTEINS PROTEOM, V1814, P210, DOI 10.1016/j.bbapap.2010.09.009; Lin SH, 2011, MOL BIOSYST, V7, P1956, DOI 10.1039/c1mb05057e; Linden J, 2010, FRONT NEUROENDOCRIN, V31, P452, DOI 10.1016/j.yfrne.2010.07.002; Matsubara T, 2012, CELL METAB, V16, P634, DOI 10.1016/j.cmet.2012.10.006; Matsumura F, 2009, BIOCHEM PHARMACOL, V77, P608, DOI 10.1016/j.bcp.2008.10.013; Mimura J, 1997, GENES CELLS, V2, P645, DOI 10.1046/j.1365-2443.1997.1490345.x; Mitoma C, 2015, ENVIRON INT, V82, P41, DOI 10.1016/j.envint.2015.05.004; Morin C, 2010, AM J RESP CELL MOL, V43, P564, DOI 10.1165/rcmb.2009-0155OC; Morin C, 2009, AM J PHYSIOL-LUNG C, V296, pL130, DOI 10.1152/ajplung.90436.2008; Nebert DW, 2008, J BIOL CHEM, V283, P36061, DOI 10.1074/jbc.R800053200; NEBERT DW, 1972, NATURE-NEW BIOL, V236, P107, DOI 10.1038/newbio236107a0; Nishimura N, 2009, TOXICOL APPL PHARM, V236, P301, DOI 10.1016/j.taap.2009.01.025; Oyoshi MK, 2012, IMMUNITY, V37, P747, DOI 10.1016/j.immuni.2012.06.018; Pande K, 2005, MOL PHARMACOL, V67, P1393, DOI 10.1124/mol.105.010983; Pierre S, 2014, TOXICOL SCI, V137, P114, DOI 10.1093/toxsci/kft236; Platzer B, 2009, J IMMUNOL, V183, P66, DOI 10.4049/jimmunol.0802997; POLAND A, 1976, J BIOL CHEM, V251, P4936; Puga A, 1997, BIOCHEM PHARMACOL, V54, P1287, DOI 10.1016/S0006-2952(97)00417-6; Saiwai H, 2010, AM J PATHOL, V176, P2352, DOI 10.2353/ajpath.2010.090839; Schmidt JV, 1996, P NATL ACAD SCI USA, V93, P6731, DOI 10.1073/pnas.93.13.6731; Schwarz D, 2004, BIOCHEM PHARMACOL, V67, P1445, DOI 10.1016/j.bcp.2003.12.023; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Serezani CH, 2011, J CLIN INVEST, V121, P671, DOI 10.1172/JCI43302; SHIMIZU T, 1984, P NATL ACAD SCI-BIOL, V81, P689, DOI 10.1073/pnas.81.3.689; STOHS SJ, 1990, FREE RADICAL BIO MED, V9, P79, DOI 10.1016/0891-5849(90)90052-K; Strassburg K., 2015, WATERS APPL NOTES, V147, P20; Subbarao K, 2004, ARTERIOSCL THROM VAS, V24, P369, DOI 10.1161/01.ATV.0000110503.16605.15; Tajima Y, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-68; Takeda T, 2014, MOL PHARMACOL, V85, P74, DOI 10.1124/mol.113.088575; Terawaki K, 2005, J IMMUNOL, V175, P4217, DOI 10.4049/jimmunol.175.7.4217; Tsujimoto S, 2013, BBA-GEN SUBJECTS, V1830, P3616, DOI 10.1016/j.bbagen.2013.03.008; VANDENBERG M, 1994, CRIT REV TOXICOL, V24, P1; Warner M, 2011, ENVIRON HEALTH PERSP, V119, P1700, DOI 10.1289/ehp.1103720; Wu KK, 2005, PROSTAG LEUKOTR ESS, V72, P89, DOI 10.1016/j.plefa.2004.11.001; Yi SW, 2014, ENVIRON RES, V133, P56, DOI 10.1016/j.envres.2014.04.027; Yokomizo T, 2000, J EXP MED, V192, P421, DOI 10.1084/jem.192.3.421; Yokomizo T, 2001, ARCH BIOCHEM BIOPHYS, V385, P231, DOI 10.1006/abbi.2000.2168; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506	61	17	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10586	10599		10.1074/jbc.M116.764332	http://dx.doi.org/10.1074/jbc.M116.764332			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28487374	Green Published, hybrid			2022-12-26	WOS:000404115400019
J	Bussiere, R; Lacampagne, A; Reiken, S; Liu, XP; Scheuerman, V; Zalk, R; Martin, C; Checler, F; Marks, AR; Chami, M				Bussiere, Renaud; Lacampagne, Alain; Reiken, Steven; Liu, Xiaoping; Scheuerman, Valerie; Zalk, Ran; Martin, Cecile; Checler, Frederic; Marks, Andrew R.; Chami, Mounia			Amyloid beta production is regulated by beta 2-adrenergic signaling-mediated post-translational modifications of the ryanodine receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR CALCIUM LEAK; ALZHEIMERS-DISEASE; A-BETA; MOUSE MODEL; TAU PATHOLOGY; MITOCHONDRIAL DYSFUNCTION; ADRENERGIC-RECEPTOR; COGNITIVE DEFICITS; PRECURSOR PROTEIN; CORTICAL-NEURONS	Alteration of ryanodine receptor (RyR)-mediated calcium (Ca2+) signaling has been reported in Alzheimer disease (AD) models. However, the molecular mechanisms underlying altered RyR-mediated intracellular Ca2+ release in AD remain to be fully elucidated. We report here that RyR2 undergoes post-translational modifications (phosphorylation, oxidation, and nitrosylation) in SH-SY5Y neuroblastoma cells expressing the beta-amyloid precursor protein (beta APP) harboring the familial double Swedish mutations (APPswe). RyR2 macromolecular complex remodeling, characterized by depletion of the regulatory protein calstabin2, resulted in increased cytosolic Ca2+ levels and mitochondrial oxidative stress. We also report a functional interplay between amyloid beta (A beta), beta-adrenergic signaling, and altered Ca2+ signaling via leaky RyR2 channels. Thus, post-translational modifications of RyR occur downstream of A beta through a beta 2-adrenergic signaling cascade that activates PKA. RyR2 remodeling in turn enhances beta APP processing. Importantly, pharmacological stabilization of the binding of calstabin2 to RyR2 channels, which prevents Ca2+ leakage, or blocking the beta 2-adrenergic signaling cascade reduced beta APP processing and the production of A beta in APPswe-expressing SH-SY5Y cells. We conclude that targeting RyR-mediated Ca2+ leakage may be a therapeutic approach to treat AD.	[Bussiere, Renaud; Martin, Cecile; Checler, Frederic; Chami, Mounia] Univ Cote Azur, CNRS, IPMC, 660 Route Lucioles, F-06560 Valbonne, France; [Lacampagne, Alain; Scheuerman, Valerie] Univ Montpellier, CHRU Montpellier, CNRS LIA1185, INSERM U1046,CNRS UMR9214, F-34295 Montpellier, France; [Reiken, Steven; Liu, Xiaoping; Zalk, Ran; Marks, Andrew R.] Columbia Univ, Coll Phys & Surg, Clyde & Helen Wu Ctr Mol Cardiol, Dept Physiol & Cellular Biophys, New York, NY 10032 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Columbia University	Chami, M (corresponding author), Univ Cote Azur, CNRS, IPMC, 660 Route Lucioles, F-06560 Valbonne, France.; Marks, AR (corresponding author), Columbia Univ, Coll Phys & Surg, Clyde & Helen Wu Ctr Mol Cardiol, Dept Physiol & Cellular Biophys, New York, NY 10032 USA.	arm42@columbia.edu; mchami@ipmc.cnrs.fr	Chami, Mounia/S-6471-2019; Lacampagne, Alain/S-3719-2016; Bussiere, Renaud/O-3856-2018; Checler, Frederic/C-1241-2009	Chami, Mounia/0000-0003-1498-7187; Lacampagne, Alain/0000-0003-0264-1787; Bussiere, Renaud/0000-0002-2202-8536; Checler, Frederic/0000-0003-2098-1750	National Institutes of Health [R01HL061503, R01HL102040, R01AR060037, NIH T32 HL120826, R25NS076445]; Fondation Leducq; INSERM; Philippe Foundation; Columbia University; LECMA (Ligue Europe enne Contre la Maladie d'Alzheimer); LABEX (Laboratory of excellence, program investment for the future); DISTALZ (Development of Innovative Strategies for a Transdisciplinary approach to Alzheimer's disease); Hospital University Federation (FHU OncoAge); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061503, T32HL120826, R01HL102040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R25NS076445] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Leducq(Leducq Foundation); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Philippe Foundation; Columbia University; LECMA (Ligue Europe enne Contre la Maladie d'Alzheimer); LABEX (Laboratory of excellence, program investment for the future); DISTALZ (Development of Innovative Strategies for a Transdisciplinary approach to Alzheimer's disease); Hospital University Federation (FHU OncoAge); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R01HL061503 (NHLBI; to A. R. M.), R01HL102040 (NHLBI; to A. R. M.), R01AR060037 (NIAMS; to A. R. M.), NIH T32 HL120826 (to A. R. M.), and R25NS076445 (NINDS; to A. R. M). This work was also supported by Fondation Leducq and a generous donation from Carol Stix (A. R. M.) and grants from INSERM, the Philippe Foundation, and a Schaefer Award from Columbia University (to A. L.), LECMA (Ligue Europe enne Contre la Maladie d'Alzheimer) (to M. C.), LABEX (Laboratory of excellence, program investment for the future), DISTALZ (Development of Innovative Strategies for a Transdisciplinary approach to Alzheimer's disease) (to F. C.), and Hospital University Federation (FHU OncoAge) (to F. C.). A. R. M. is a board member and owns shares in ARMGO Pharma Inc., which is targeting RyR channels for therapeutic purposes. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ADUNSKY A, 1995, J GERONTOL A-BIOL, V50, pB201, DOI 10.1093/gerona/50A.4.B201; Agostinho P, 2003, EUR J NEUROSCI, V17, P1189, DOI 10.1046/j.1460-9568.2003.02546.x; Andersson DC, 2011, CELL METAB, V14, P196, DOI 10.1016/j.cmet.2011.05.014; Barage SH, 2015, NEUROPEPTIDES, V52, P1, DOI 10.1016/j.npep.2015.06.008; Bellinger AM, 2008, P NATL ACAD SCI USA, V105, P2198, DOI 10.1073/pnas.0711074105; Bezprozvanny I, 2012, J BIOL CHEM, V287, P20469, DOI 10.1074/jbc.L112.356790; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bootman Martin D, 2013, Cold Spring Harb Protoc, V2013, P83, DOI 10.1101/pdb.top066050; Bootman Martin D, 2013, Cold Spring Harb Protoc, V2013, P126, DOI 10.1101/pdb.prot072827; Branca C, 2014, NEUROBIOL AGING, V35, P2726, DOI 10.1016/j.neurobiolaging.2014.06.011; BRINI M, 1995, J BIOL CHEM, V270, P9896, DOI 10.1074/jbc.270.17.9896; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Brunello L, 2009, J CELL MOL MED, V13, P3358, DOI 10.1111/j.1582-4934.2009.00755.x; Bull R, 2008, J NEUROSCI, V28, P9463, DOI 10.1523/JNEUROSCI.2286-08.2008; Chakroborty S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052056; Chakroborty S, 2009, J NEUROSCI, V29, P9458, DOI 10.1523/JNEUROSCI.2047-09.2009; Chan SL, 2000, J BIOL CHEM, V275, P18195, DOI 10.1074/jbc.M000040200; Christensen RA, 2004, J BIOL CHEM, V279, P53524, DOI 10.1074/jbc.M408473200; Dang V, 2014, BIOL PSYCHIAT, V75, P179, DOI 10.1016/j.biopsych.2013.05.024; De Strooper B, 2016, CELL, V164, P603, DOI 10.1016/j.cell.2015.12.056; Del Prete D, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-21; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Dobarro M, 2013, INT J NEUROPSYCHOPH, V16, P2245, DOI 10.1017/S1461145713000631; Echeverria V, 2005, NEUROSCIENCE, V135, P1193, DOI 10.1016/j.neuroscience.2005.06.057; Eftekharzadeh B, 2012, BEHAV BRAIN RES, V226, P301, DOI 10.1016/j.bbr.2011.08.015; Ferreiro E, 2004, J NEUROSCI RES, V76, P872, DOI 10.1002/jnr.20135; FINCH EA, 1991, SCIENCE, V252, P443, DOI 10.1126/science.2017683; Flammang B, 2012, J ALZHEIMERS DIS, V30, P145, DOI 10.3233/JAD-2012-112186; Ghosh D, 2012, J NEUROSCI, V32, P5821, DOI 10.1523/JNEUROSCI.6192-11.2012; GOLDE TE, 1993, ANN NY ACAD SCI, V695, P103, DOI 10.1111/j.1749-6632.1993.tb23036.x; Guillot-Sestier MV, 2012, J BIOL CHEM, V287, P5021, DOI 10.1074/jbc.M111.323626; Hayley M, 2009, BBA-BIOMEMBRANES, V1788, P1933, DOI 10.1016/j.bbamem.2009.05.015; Hayrapetyan V, 2008, CELL CALCIUM, V44, P507, DOI 10.1016/j.ceca.2008.03.004; Heneka MT, 2010, P NATL ACAD SCI USA, V107, P6058, DOI 10.1073/pnas.0909586107; Hidalgo C, 2011, ANTIOXID REDOX SIGN, V14, P1203, DOI 10.1089/ars.2010.3711; Ho Michael, 2010, Int J Alzheimers Dis, V2011, P950932, DOI 10.4061/2011/950932; Igbavboa U, 2006, NEUROSCIENCE, V142, P655, DOI 10.1016/j.neuroscience.2006.06.056; IVERSEN LL, 1983, NEUROSCI LETT, V39, P95, DOI 10.1016/0304-3940(83)90171-4; Jardanhazi-Kurutz D, 2010, NEUROCHEM INT, V57, P375, DOI 10.1016/j.neuint.2010.02.001; Jensen LE, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00036; KALARIA RN, 1989, J NEUROCHEM, V53, P1772, DOI 10.1111/j.1471-4159.1989.tb09242.x; Lanner JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003996; Lauritzen I, 2012, J NEUROSCI, V32, P16243, DOI 10.1523/JNEUROSCI.2775-12.2012; Lee Sun Young, 2006, FASEB J, V20, P151, DOI 10.1096/fj.05-4017fje;1; Lehnart SE, 2006, P NATL ACAD SCI USA, V103, P7906, DOI 10.1073/pnas.0602133103; Li SM, 2013, NEURON, V77, P929, DOI 10.1016/j.neuron.2012.12.040; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liu XP, 2012, CELL, V150, P1055, DOI 10.1016/j.cell.2012.06.052; Lochner A, 2006, CARDIOVASC DRUG REV, V24, P261, DOI 10.1111/j.1527-3466.2006.00261.x; Marambaud P, 1999, BRIT J PHARMACOL, V126, P1186, DOI 10.1038/sj.bjp.0702406; Marambaud P, 1998, MOL MED, V4, P715, DOI 10.1007/BF03401766; Marks Andrew R, 2006, Novartis Found Symp, V274, P132; Martinez M, 1999, BRAIN RES, V846, P265, DOI 10.1016/S0006-8993(99)01981-2; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Marx SO, 2001, J CELL BIOL, V153, P699, DOI 10.1083/jcb.153.4.699; Mattson MP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3114pe10; MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992; May PC, 2011, J NEUROSCI, V31, P16507, DOI 10.1523/JNEUROSCI.3647-11.2011; Mbaya E, 2010, CELL DEATH DIFFER, V17, P1855, DOI 10.1038/cdd.2010.51; Mikami M, 2008, EUR J PHARMACOL, V589, P14, DOI 10.1016/j.ejphar.2008.04.045; Muresan Z, 2007, MOL BIOL CELL, V18, P3835, DOI 10.1091/mbc.E06-07-0625; Ni YX, 2006, NAT MED, V12, P1390, DOI 10.1038/nm1485; Oules B, 2012, J NEUROSCI, V32, P11820, DOI 10.1523/JNEUROSCI.0875-12.2012; Pack-Chung E, 2000, J BIOL CHEM, V275, P14440, DOI 10.1074/jbc.M909882199; Palavicini JP, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.183; Pardossi-Piquard R, 2012, J NEUROCHEM, V120, P109, DOI 10.1111/j.1471-4159.2011.07475.x; Paula-Lima AC, 2011, ANTIOXID REDOX SIGN, V14, P1209, DOI 10.1089/ars.2010.3287; Peng J, 2012, NEUROSCI LETT, V516, P274, DOI 10.1016/j.neulet.2012.04.008; Prapong T, 2001, EXP NEUROL, V167, P59, DOI 10.1006/exnr.2000.7519; Probst G, 2013, J MED CHEM, V56, P5261, DOI 10.1021/jm301741t; Resende R, 2007, BRAIN RES, V1143, P11, DOI 10.1016/j.brainres.2007.01.071; Robinson KM, 2008, NAT PROTOC, V3, P941, DOI 10.1038/nprot.2008.56; Rosenberg PB, 2008, AM J GERIAT PSYCHIAT, V16, P883, DOI 10.1097/JGP.0b013e318181276a; Ross JA, 2015, NEUROBIOL STRESS, V2, P73, DOI 10.1016/j.ynstr.2015.09.002; Rybalchenko V, 2008, INT J BIOCHEM CELL B, V40, P84, DOI 10.1016/j.biocel.2007.06.023; SanMartin CD, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00013; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Sevalle J, 2009, J NEUROCHEM, V109, P248, DOI 10.1111/j.1471-4159.2009.05950.x; Shilling D, 2014, J NEUROSCI, V34, P6910, DOI 10.1523/JNEUROSCI.5441-13.2014; Shilling D, 2012, J BIOL CHEM, V287, P10933, DOI 10.1074/jbc.M111.300491; Stieren E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011992; Stutzmann GE, 2004, J NEUROSCI, V24, P508, DOI 10.1523/JNEUROSCI.4386-03.2004; Stutzmann GE, 2007, ANN NY ACAD SCI, V1097, P265, DOI 10.1196/annals.1379.025; Stutzmann GE, 2006, J NEUROSCI, V26, P5180, DOI 10.1523/JNEUROSCI.0739-06.2006; Su Y, 2003, FEBS LETT, V546, P407, DOI 10.1016/S0014-5793(03)00645-8; Takeda T, 2005, FASEB J, V19, P2069, DOI 10.1096/fj.05-3744fje; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Ueda K, 1996, NEUROSCI LETT, V203, P175, DOI 10.1016/0304-3940(95)12288-5; Van Cauwenberghe C, 2016, GENET MED, V18, P421, DOI 10.1038/gim.2015.117; von Bernhardi R, 2012, ANTIOXID REDOX SIGN, V16, P974, DOI 10.1089/ars.2011.4082; Wang DY, 2013, J BIOL CHEM, V288, P10298, DOI 10.1074/jbc.M112.415141; Wang DY, 2010, FASEB J, V24, P3511, DOI 10.1096/fj.10-156661; Wehrens XHT, 2004, SCIENCE, V304, P292, DOI 10.1126/science.1094301; Wisely EV, 2014, HUM MOL GENET, V23, P4024, DOI 10.1093/hmg/ddu116; Yu JT, 2008, BRAIN RES, V1210, P216, DOI 10.1016/j.brainres.2008.03.019; Yu NN, 2010, BRAIN RES, V1317, P305, DOI 10.1016/j.brainres.2009.12.087; Zhang YW, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-3	97	36	36	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					10153	10168		10.1074/jbc.M116.743070	http://dx.doi.org/10.1074/jbc.M116.743070			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28476886	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000403580600026
J	Ye, F; Yang, C; Kim, J; MacNevin, CJ; Hahn, KM; Park, D; Ginsberg, MH; Kim, C				Ye, Feng; Yang, Chansik; Kim, Jiyoon; MacNevin, Christopher J.; Hahn, Klaus M.; Park, Dongeun; Ginsberg, Mark H.; Kim, Chungho			Epigallocatechin gallate has pleiotropic effects on transmembrane signaling by altering the embedding of transmembrane domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEN TEA CATECHINS; (-)-EPIGALLOCATECHIN GALLATE; INTEGRIN ACTIVATION; EGF RECEPTOR; MEMBRANE; EGCG; COMPLEX; TALIN; MECHANISMS; PROTEINS	Epigallocatechin gallate (EGCG) is the principal bioactive ingredient in green tea and has been reported to have many health benefits. EGCG influences multiple signal transduction pathways related to human diseases, including redox, inflammation, cell cycle, and cell adhesion pathways. However, the molecular mechanisms of these varying effects are unclear, limiting further development and utilization of EGCG as a pharmaceutical compound. Here, we examined the effect of EGCG on two representative transmembrane signaling receptors, integrin alpha IIb beta 3 and epidermal growth factor receptor (EGFR). We report that EGCG inhibits talin-induced integrin alpha IIb beta 3 activation, but it activates alpha IIb beta 3 in the absence of talin both in a purified system and in cells. This apparent paradox was explained by the fact that the activation state of alpha IIb beta 3 is tightly regulated by the topology of beta 3 transmembrane domain (TMD); increases or decreases in TMD embedding can activate integrins. Talin increases the embedding of integrin beta 3 TMD, resulting in integrin activation, whereas we observed here that EGCG decreases the embedding, thus opposing talin-induced integrin activation. In the absence of talin, EGCG decreases the TMD embedding, which can also disrupt the integrin alpha-beta TMD interaction, leading to integrin activation. EGCG exhibited similar paradoxical behavior in EGFR signaling. EGCG alters the topology of EGFR TMD and activates the receptor in the absence of EGF, but inhibits EGF-induced EGFR activation. Thus, this widely ingested polyphenol exhibits pleiotropic effects on transmembrane signaling by modifying the topology of TMDs.	[Ye, Feng; Ginsberg, Mark H.] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; [Yang, Chansik; Kim, Jiyoon; Kim, Chungho] Korea Univ, Dept Life Sci, Seoul 136701, South Korea; [Yang, Chansik; Park, Dongeun] Seoul Natl Univ, Sch Biol Sci, Seoul 151747, South Korea; [MacNevin, Christopher J.; Hahn, Klaus M.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [MacNevin, Christopher J.; Hahn, Klaus M.] Univ N Carolina, Lineberger Canc Ctr, Chapel Hill, NC 27599 USA	University of California System; University of California San Diego; Korea University; Seoul National University (SNU); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Ginsberg, MH (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA.; Kim, C (corresponding author), Korea Univ, Dept Life Sci, Seoul 136701, South Korea.	mhginsberg@ucsd.edu; chungho@korea.ac.kr		Hahn, Klaus/0000-0002-1970-7562	National Research Foundation of Korea [NRF-2016R1A2B4009755]; Korea Health Industry Development Institute [HI14C0209]; National Institutes of Health [CA-142833, P41-EB002025, HL 078784, HL 117807]; NATIONAL CANCER INSTITUTE [R01CA142833] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117807, P01HL078784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS092521] Funding Source: NIH RePORTER	National Research Foundation of Korea(National Research Foundation of Korea); Korea Health Industry Development Institute(Korea Health Industry Development Institute (KHIDI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (Grant NRF-2016R1A2B4009755) (to C.K.), by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (Grant HI14C0209) (to C. K.), and by National Institutes of Health Grants CA-142833 and P41-EB002025 (to K. M. H.) and HL 078784 and HL 117807 (to M. H. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adachi S, 2007, CANCER RES, V67, P6493, DOI 10.1158/0008-5472.CAN-07-0411; Arkhipov A, 2013, CELL, V152, P557, DOI 10.1016/j.cell.2012.12.030; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Endres NF, 2013, CELL, V152, P543, DOI 10.1016/j.cell.2012.12.032; Escriba PV, 2008, J CELL MOL MED, V12, P829, DOI 10.1111/j.1582-4934.2008.00281.x; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Iwamoto DV, 2015, CURR OPIN CELL BIOL, V36, P41, DOI 10.1016/j.ceb.2015.06.009; Kalli AC, 2011, P NATL ACAD SCI USA, V108, P11890, DOI 10.1073/pnas.1104505108; Kang WS, 1999, THROMB RES, V96, P229, DOI 10.1016/S0049-3848(99)00104-8; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; Kim CH, 2012, J CELL BIOL, V197, P605, DOI 10.1083/jcb.201112141; Kim C, 2012, NATURE, V481, P209, DOI 10.1038/nature10697; Kuriyama S, 2008, J NUTR, V138, P1548; Lau TL, 2009, EMBO J, V28, P1351, DOI 10.1038/emboj.2009.63; Lee AG, 2003, BBA-BIOMEMBRANES, V1612, P1, DOI 10.1016/S0005-2736(03)00056-7; Lee WJ, 2005, MOL PHARMACOL, V68, P1018, DOI 10.1124/mol.104.008367; Liang YC, 1997, J CELL BIOCHEM, V67, P55, DOI 10.1002/(SICI)1097-4644(19971001)67:1<55::AID-JCB6>3.0.CO;2-V; Lill G, 2003, FEBS LETT, V546, P265, DOI 10.1016/S0014-5793(03)00599-4; MacNevin CJ, 2013, BIOCONJUGATE CHEM, V24, P215, DOI 10.1021/bc3005073; Moriki T, 2001, J MOL BIOL, V311, P1011, DOI 10.1006/jmbi.2001.4923; Nieves B, 2010, J CELL SCI, V123, P1216, DOI 10.1242/jcs.056549; Palhano FL, 2013, J AM CHEM SOC, V135, P7503, DOI 10.1021/ja3115696; Partridge AW, 2005, J BIOL CHEM, V280, P7294, DOI 10.1074/jbc.M412701200; Patra SK, 2008, J PHYSIOL PHARMACOL, V59, P217; Scheidt HA, 2004, BBA-BIOMEMBRANES, V1663, P97, DOI 10.1016/j.bbamem.2004.02.004; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; SHATTIL SJ, 1985, J BIOL CHEM, V260, P1107; Shimizu M, 2011, MOL NUTR FOOD RES, V55, P832, DOI 10.1002/mnfr.201000622; Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093; Sirk TW, 2009, J AGR FOOD CHEM, V57, P6720, DOI 10.1021/jf900951w; Sun Y, 2009, BIOPHYS J, V96, P1026, DOI 10.1016/j.bpj.2008.11.007; Tachibana H, 2004, NAT STRUCT MOL BIOL, V11, P380, DOI 10.1038/nsmb743; Tamba Y, 2007, BIOPHYS J, V92, P3178, DOI 10.1529/biophysj.106.097105; Uekusa Y, 2011, BBA-BIOMEMBRANES, V1808, P1654, DOI 10.1016/j.bbamem.2011.02.014; Velayutham P, 2008, CURR MED CHEM, V15, P1840; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Ye F, 2010, J CELL BIOL, V188, P157, DOI 10.1083/jcb.200908045	38	6	6	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					9858	9864		10.1074/jbc.C117.787309	http://dx.doi.org/10.1074/jbc.C117.787309			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28487468	hybrid, Green Published			2022-12-26	WOS:000403580600001
J	Murray, DL; Peers, MJL; Majchrzak, YN; Wehtje, M; Ferreira, C; Pickles, RSA; Row, JR; Thornton, DH				Murray, Dennis L.; Peers, Michael J. L.; Majchrzak, Yasmine N.; Wehtje, Morgan; Ferreira, Catarina; Pickles, Rob S. A.; Row, Jeffrey R.; Thornton, Daniel H.			Continental divide: Predicting climate-mediated fragmentation and biodiversity loss in the boreal forest	PLOS ONE			English	Article							SPECIES DISTRIBUTIONS; HABITAT LOSS; RANGE SHIFTS; PHENOTYPIC PLASTICITY; RELATIVE INFLUENCE; GENETIC-STRUCTURE; CHANGE IMPACTS; SAMPLING BIAS; MODELS; NORTH	Climate change threatens natural landscapes through shifting distribution and abundance of species and attendant change in the structure and function of ecosystems. However, it remains unclear how climate-mediated variation in species' environmental niche space may lead to large-scale fragmentation of species distributions, altered meta-population dynamics and gene flow, and disrupted ecosystem integrity. Such change may be especially relevant when species distributions are restricted either spatially or to a narrow environmental niche, or when environments are rapidly changing. Here, we use range-wide environmental niche models to posit that climate-mediated range fragmentation aggravates the direct effects of climate change on species in the boreal forest of North America. We show that climate change will directly alter environmental niche suitability for boreal-obligate species of trees, birds and mammals (n = 12), with most species ranges becoming smaller and shifting northward through time. Importantly, species distributions will become increasingly fragmented, as characterized by smaller mean size and greater isolation of environmentally-suitable landscape patches. This loss is especially pronounced along the Ontario-Quebec border, where the boreal forest is narrowest and roughly 78% of suitable niche space could disappear by 2080. Despite the diversity of taxa surveyed, patterns of range fragmentation are remarkably consistent, with our models predicting that spruce grouse (Dendragapus canadensis), boreal chickadee (Poecile hudsonicus), moose (Alces americanus) and caribou (Rangifer tarandus) could have entirely disjunct east-west population segments in North America. These findings reveal potentially dire consequences of climate change on population continuity and species diversity in the boreal forest, highlighting the need to better understand: 1) extent and primary drivers of anticipated climate-mediated range loss and fragmentation; 2) diversity of species to be affected by such change; 3) potential for rapid adaptation in the most strongly-affected areas; and 4) potential for invasion by replacement species.	[Murray, Dennis L.; Wehtje, Morgan; Ferreira, Catarina; Pickles, Rob S. A.] Trent Univ, Dept Biol, Peterborough, ON, Canada; [Peers, Michael J. L.; Majchrzak, Yasmine N.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Ferreira, Catarina] UFZ Helmholtz Ctr Environm Res, Dept Conservat Biol, Leipzig, Germany; [Pickles, Rob S. A.] Panthera, New York, NY USA; [Row, Jeffrey R.] Univ Waterloo, Environm & Resource Studies, Waterloo, ON, Canada; [Thornton, Daniel H.] Washington State Univ, Sch Environm, Pullman, WA 99164 USA	Trent University; University of Alberta; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Waterloo; Washington State University	Murray, DL (corresponding author), Trent Univ, Dept Biol, Peterborough, ON, Canada.	dennismurray@trentu.ca	Ferreira, Catarina Campos/A-3898-2011	Ferreira, Catarina Campos/0000-0002-5093-0789	Natural Sciences and Engineering Research Council (Canada); Canada Research Chairs program; European Union [PIOF-GA-2013-621571]	Natural Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs program(Canada Research Chairs); European Union(European Commission)	This work was supported by grants from the Natural Sciences and Engineering Research Council (Canada) and the Canada Research Chairs program. C.F. is supported by a Marie Curie Outgoing International Fellowship for Career Development (PIOF-GA-2013-621571) within the 7th Framework Programme of the European Union.; We are grateful to the various organizations and museums that provided presence records and digitized maps used in our analyses. We also thank the Integrative Wildlife Conservation lab for discussions on previous versions of this manuscript, and anonymous reviewers for helpful comments. This work was supported by grants from the Natural Sciences and Engineering Research Council (Canada) and the Canada Research Chairs program. C.F. is supported by a Marie Curie Outgoing International Fellowship from the European Union.	Anderson RP, 2012, ANN NY ACAD SCI, V1260, P66, DOI 10.1111/j.1749-6632.2011.06440.x; Anderson RP, 2011, ECOL MODEL, V222, P2796, DOI 10.1016/j.ecolmodel.2011.04.011; Andrello M, 2015, DIVERS DISTRIB, V21, P139, DOI 10.1111/ddi.12250; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Araujo MB, 2014, ECOGRAPHY, V37, P406, DOI 10.1111/j.1600-0587.2013.00643.x; Barber VA, 2000, NATURE, V405, P668, DOI 10.1038/35015049; Beaumont LJ, 2008, ECOL LETT, V11, P1135, DOI 10.1111/j.1461-0248.2008.01231.x; Berger KM, 2007, J ANIM ECOL, V76, P1075, DOI 10.1111/j.1365-2656.2007.01287.x; Boria RA, 2014, ECOL MODEL, V275, P73, DOI 10.1016/j.ecolmodel.2013.12.012; Brandt JP, 2009, ENVIRON REV, V17, P101, DOI 10.1139/A09-004; Cannone N, 2008, ECOL APPL, V18, P637, DOI 10.1890/07-1188.1; Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Cushman SA, 2012, LANDSCAPE ECOL, V27, P369, DOI 10.1007/s10980-011-9693-0; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Fahrig L, 1997, J WILDLIFE MANAGE, V61, P603, DOI 10.2307/3802168; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Feldman RE, 2017, GLOB ECOL CONSERV, V9, P1, DOI 10.1016/j.gecco.2016.10.001; Franco AMA, 2006, GLOBAL CHANGE BIOL, V12, P1545, DOI 10.1111/j.1365-2486.2006.01180.x; Gagnon AS, 2005, CLIMATIC CHANGE, V69, P269, DOI 10.1007/s10584-005-1815-8; Gamache I, 2005, J BIOGEOGR, V32, P849, DOI 10.1111/j.1365-2699.2004.01182.x; Gauthier S, 2015, SCIENCE, V349, P819, DOI 10.1126/science.aaa9092; GROISMAN PY, 1994, J CLIMATE, V7, P184, DOI 10.1175/1520-0442(1994)007<0184:VATOTP>2.0.CO;2; Haddad NM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500052; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hitch AT, 2007, CONSERV BIOL, V21, P534, DOI 10.1111/j.1523-1739.2006.00609.x; Ipcc, 2014, INT PAN CLIM CHANG 5; Jump AS, 2006, MOL ECOL, V15, P3469, DOI 10.1111/j.1365-294X.2006.03027.x; Krebs CJ, 2011, P ROY SOC B-BIOL SCI, V278, P481, DOI 10.1098/rspb.2010.1992; Kupfer JA, 2012, PROG PHYS GEOG, V36, P400, DOI 10.1177/0309133312439594; Lee-Yaw JA, 2016, ECOL LETT, V19, P710, DOI 10.1111/ele.12604; Logan JA, 2003, FRONT ECOL ENVIRON, V1, P130, DOI 10.2307/3867985; McGarigal K., 2012, TECH REP; McGuire JL, 2016, P NATL ACAD SCI USA, V113, P7195, DOI 10.1073/pnas.1602817113; Mckenney DW, 2007, BIOSCIENCE, V57, P939, DOI 10.1641/B571106; Milanovich JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012189; Millette KL, 2015, ECOL EVOL, V5, P73, DOI 10.1002/ece3.1325; Murray DL, 2006, WILDLIFE MONOGR, P1, DOI 10.2193/0084-0173(2006)166[1:PNDACI]2.0.CO;2; Murray DL, 2015, BIOL CONSERV, V192, P174, DOI 10.1016/j.biocon.2015.09.017; Muscarella R, 2014, METHODS ECOL EVOL, V5, P1198, DOI 10.1111/2041-210X.12261; Normand S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0479; Otis JA, 2017, DIVERS DISTRIB; Ovaskainen O, 2002, J THEOR BIOL, V215, P95, DOI 10.1006/jtbi.2001.2502; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pearce JL, 2006, J APPL ECOL, V43, P405, DOI 10.1111/j.1365-2664.2005.01112.x; Peers MJL, 2014, GLOBAL CHANGE BIOL, V20, P1126, DOI 10.1111/gcb.12469; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Pilliod DS, 2015, ECOL EVOL, V5, P3979, DOI 10.1002/ece3.1634; Price DT, 2013, ENVIRON REV, V21, P322, DOI 10.1139/er-2013-0042; Pyke CR, 2004, FRONT ECOL ENVIRON, V2, P178, DOI 10.1890/1540-9295(2004)002[0178:HLCCCI]2.0.CO;2; Radosavljevic A, 2014, J BIOGEOGR, V41, P629, DOI 10.1111/jbi.12227; Ralston J, 2013, CONSERV GENET, V14, P543, DOI 10.1007/s10592-012-0418-y; Raupach MR, 2007, P NATL ACAD SCI USA, V104, P10288, DOI 10.1073/pnas.0700609104; Row JR, 2014, GLOBAL CHANGE BIOL, V20, P2076, DOI 10.1111/gcb.12526; Ruhland KM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1887; Ruffell J, 2016, OIKOS, V125, P117, DOI 10.1111/oik.01948; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schloss CA, 2012, P NATL ACAD SCI USA, V109, P8606, DOI 10.1073/pnas.1116791109; Searcy CA, 2016, AM NAT, V187, P423, DOI 10.1086/685387; Smith AC, 2009, LANDSCAPE ECOL, V24, P1271, DOI 10.1007/s10980-009-9383-3; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Soja AJ, 2007, GLOBAL PLANET CHANGE, V56, P274, DOI 10.1016/j.gloplacha.2006.07.028; Stachowicz JJ, 2002, P NATL ACAD SCI USA, V99, P15497, DOI 10.1073/pnas.242437499; Stenseth NC, 2004, P NATL ACAD SCI USA, V101, P10632, DOI 10.1073/pnas.0308674101; Stocks BJ, 1998, CLIMATIC CHANGE, V38, P1, DOI 10.1023/A:1005306001055; Stralberg D, 2015, ECOL APPL, V25, P52, DOI 10.1890/13-2289.1; Stralberg D, 2017, ECOGRAPHY; Strickland D, 2011, OECOLOGIA, V167, P943, DOI 10.1007/s00442-011-2040-y; Sultaire SM, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.3104; Tape KD, 2016, GLOBAL CHANGE BIOL, V22, P208, DOI 10.1111/gcb.13058; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thornton DH, 2011, ECOL APPL, V21, P2324, DOI 10.1890/10-2124.1; Travis JMJ, 2003, P ROY SOC B-BIOL SCI, V270, P467, DOI 10.1098/rspb.2002.2246; Trzcinski MK, 1999, ECOL APPL, V9, P586, DOI 10.1890/1051-0761(1999)009[0586:IEOFCA]2.0.CO;2; Valladares F, 2014, ECOL LETT, V17, P1351, DOI 10.1111/ele.12348; Venier LA, 2014, ENVIRON REV, V22, P457, DOI 10.1139/er-2013-0075; Villard MA, 2014, J APPL ECOL, V51, P309, DOI 10.1111/1365-2664.12190; Virkkala R, 2008, BIOL CONSERV, V141, P1343, DOI 10.1016/j.biocon.2008.03.007; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wisz MS, 2013, BIOL REV, V88, P15, DOI 10.1111/j.1469-185X.2012.00235.x; With KA, 1999, CONSERV BIOL, V13, P314, DOI 10.1046/j.1523-1739.1999.013002314.x; Wright AN, 2016, CLIMATIC CHANGE, V134, P579, DOI 10.1007/s10584-015-1552-6; Zhang X, 2011, 5 CAN COUNC RES MIN; Zimova M, 2016, ECOL LETT, V19, P299, DOI 10.1111/ele.12568	91	19	19	2	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0176706	10.1371/journal.pone.0176706	http://dx.doi.org/10.1371/journal.pone.0176706			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505173	Green Submitted, Green Published, gold			2022-12-26	WOS:000401473500009
J	Al-Jarallah, A; Oriowo, M				Al-Jarallah, Aishah; Oriowo, Mabayoje			The effect of sphingosine-1-phosphate on colonic smooth muscle contractility: Modulation by TNBS-induced colitis	PLOS ONE			English	Article							PROTEIN-KINASE-C; INFLAMMATORY-BOWEL-DISEASE; SPHINGOSINE 1-PHOSPHATE; ULCERATIVE-COLITIS; CEREBRAL-ARTERIES; DOWN-REGULATION; MOTOR-ACTIVITY; CA2+ CHANNELS; RAT MODEL; MOTILITY	Aim Increased levels of circulating sphingosine-1-phosphate (S1P) have been reported in ulcerative colitis. The objective of this study was to examine the effect of S1P on colonic smooth muscle contractility and how is it affected by colitis. Methods Colonic inflammation was induced by intrarectal administration of trinitrobenzene sulfonic acid. Five days later colon segments were isolated and used for contractility experiments and immunoblotting. Results S1P contracted control and inflamed colon segments and the contraction was significantly greater in inflamed colon segments. S1P-induced contraction was mediated by S1PR1 and S1PR2 in control and S1PR2 in inflamed colon segments. S1PR3 did not play a significant role in S1P-induced contractions in control or inflamed colon. S1PR1, S1PR2 and S1PR3 proteins were expressed in colon segments from both groups. The expression of S1PR1 and S1PR2 was significantly enhanced in control and inflamed colon segments, respectively. S1PR3 levels however were not significantly different between the two groups. Nifedipine significantly reduced S1P-induced contraction in control but not inflamed colon segments. Thapsigargin significantly reduced S1P-induced contraction of the inflamed colon. GF 109203X and Y-27632, alone abolished S1P-induced contraction of the control but not inflamed colon segments. Combination of GF 109203X, Y-27632 and thapsigargin abolished S1P-induced contraction of inflamed colon segments. Conclusion S1P contracted control colon via S1PR1 and S1PR2 and inflamed colon exclusively via S1PR2. Calcium influx (control) or release (inflamed) and calcium sensitization are involved in S1P-induced contraction. Exacerbated response to S1P in colitic colon segments may explain altered colonic motility reported in patients and experimental models of inflammatory bowel disease.	[Al-Jarallah, Aishah] Kuwait Univ, Dept Biochem, Hlth Sci Ctr, Fac Med, Jabreya, Kuwait; [Oriowo, Mabayoje] Kuwait Univ, Dept Pharmacol & Toxicol, Hlth Sci Ctr, Fac Med, Jabreya, Kuwait	Kuwait University; Kuwait University	Al-Jarallah, A (corresponding author), Kuwait Univ, Dept Biochem, Hlth Sci Ctr, Fac Med, Jabreya, Kuwait.	a.jarallah@hsc.edu.kw			Kuwait University [MB01/12]	Kuwait University	This work was supported by the Research Sector, Kuwait University, Grant No. MB01/12. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Jarallah A, 2007, MOL CELL BIOCHEM, V298, P169, DOI 10.1007/s11010-006-9363-8; Al-Jarallah A, 2008, EUR J PHARMACOL, V579, P365, DOI 10.1016/j.ejphar.2007.10.069; Al-Saffar A, 2001, SCAND J GASTROENTERO, V36, P485; Auli M, 2008, AUTON NEUROSCI-BASIC, V141, P10, DOI 10.1016/j.autneu.2008.04.005; Aydin M, 2010, BJU INT, V106, P562, DOI 10.1111/j.1464-410X.2009.09156.x; Bassotti G, 2004, INT J COLORECTAL DIS, V19, P493, DOI 10.1007/s00384-004-0604-6; Bianca RDD, 2006, J PHARMACOL EXP THER, V316, P703, DOI 10.1124/jpet.105.093419; Cao WB, 2004, AM J PHYSIOL-GASTR L, V286, pG833, DOI 10.1152/ajpgi.00414.2003; Cheon GJ, 2012, KOREAN J PHYSIOL PHA, V16, P437, DOI 10.4196/kjpp.2012.16.6.437; Chiba Y, 2010, PHARMACOL RES, V62, P357, DOI 10.1016/j.phrs.2010.05.005; Choi SK, 2009, CARDIOVASC RES, V82, P324, DOI 10.1093/cvr/cvp054; Coulie B, 2001, ALIMENT PHARM THERAP, V15, P653, DOI 10.1046/j.1365-2036.2001.00959.x; Coussin F, 2002, CIRC RES, V91, P151, DOI 10.1161/01.RES.0000028150.51130.36; Hu W, 2006, BIOCHEM BIOPH RES CO, V343, P1038, DOI 10.1016/j.bbrc.2006.03.079; Hu WH, 2006, AM J PHYSIOL-GASTR L, V291, pG605, DOI 10.1152/ajpgi.00147.2006; Ikeda H, 2004, BIOCHEM BIOPH RES CO, V320, P754, DOI 10.1016/j.bbrc.2004.04.207; Jolly PS, 2002, MOL IMMUNOL, V38, P1239, DOI 10.1016/S0161-5890(02)00070-6; Jouet P, 1995, AM J PHYSIOL-GASTR L, V269, pG913, DOI 10.1152/ajpgi.1995.269.6.G913; Kamiya T, 2014, EXP EYE RES, V121, P94, DOI 10.1016/j.exer.2014.01.011; Kandabashi T, 2003, ARTERIOSCL THROM VAS, V23, P2209, DOI 10.1161/01.ATV.0000104010.87348.26; Kegeyama Y, 2012, HEPATOLOGY; Kendig DM, 2013, EUR J PHARMACOL, V720, P355, DOI 10.1016/j.ejphar.2013.10.004; Khan I, 1999, DIGEST DIS SCI, V44, P1525, DOI 10.1023/A:1026694406446; Kim YS, 2007, ARCH PHARM RES, V30, P1608, DOI 10.1007/BF02977331; Kinoshita K, 2003, AM J PHYSIOL-GASTR L, V285, pG483, DOI 10.1152/ajpgi.00038.2003; Kume H, 2007, J PHARMACOL EXP THER, V320, P766, DOI 10.1124/jpet.106.110718; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leiber D, 2007, AM J PHYSIOL-CELL PH, V292, pC240, DOI 10.1152/ajpcell.00023.2006; Liu XR, 2001, GASTROENTEROLOGY, V120, P480, DOI 10.1053/gast.2001.21167; LOENINGBAUCKE V, 1989, AM J GASTROENTEROL, V84, P892; Lundberg S, 2006, ACTA PHYSIOL, V187, P489, DOI 10.1111/j.1748-1716.2006.01576.x; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Mair KM, 2010, BRIT J PHARMACOL, V161, P176, DOI 10.1111/j.1476-5381.2010.00878.x; Makino Y, 2012, ALLERGOL INT, V61, P311, DOI 10.2332/allergolint.11-OA-0350; Murakami A, 2010, MOL PHARMACOL, V77, P704, DOI 10.1124/mol.109.061481; Nakayama K, 2003, BIORHEOLOGY, V40, P307; Ohama T, 2008, J GASTROENTEROL, V43, P858, DOI 10.1007/s00535-008-2241-2; Ohama Takashi, 2007, Journal of Smooth Muscle Research, V43, P43, DOI 10.1540/jsmr.43.43; Ohama T, 2007, AM J PHYSIOL-GASTR L, V292, pG1429, DOI 10.1152/ajpgi.00315.2006; Oriowo MA, 2004, EUR J PHARMACOL, V506, P157, DOI 10.1016/j.ejphar.2004.11.008; Pfaff M, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-48; Rosen H, 2009, ANNU REV BIOCHEM, V78, P743, DOI 10.1146/annurev.biochem.78.072407.103733; Rosenfeldt HM, 2003, FASEB J, V17, P1789, DOI 10.1096/fj.02-0836com; Ross GR, 2007, J PHARMACOL EXP THER, V322, P948, DOI 10.1124/jpet.107.123075; Roviezzo F, 2007, AM J RESP CELL MOL, V36, P757, DOI 10.1165/rcmb.2006-0383OC; Salomone S, 2008, BRIT J PHARMACOL, V153, P140, DOI 10.1038/sj.bjp.0707581; Salomone S, 2003, EUR J PHARMACOL, V469, P125, DOI 10.1016/S0014-2999(03)01731-X; Salomone S, 2010, PHARMACOL RES, V62, P465, DOI 10.1016/j.phrs.2010.09.002; SETHI AK, 1991, GASTROENTEROLOGY, V100, P954, DOI 10.1016/0016-5085(91)90269-Q; Shi XZ, 2000, AM J PHYSIOL-GASTR L, V278, pG234, DOI 10.1152/ajpgi.2000.278.2.G234; SNAPE W J JR, 1991, Keio Journal of Medicine, V40, P6; Snider AJ, 2009, FASEB J, V23, P143, DOI 10.1096/fj.08-118109; Song HJ, 2006, MOL CELLS, V21, P42; Spijkers LJA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021817; Van Doorn R, 2010, GLIA, V58, P1465, DOI 10.1002/glia.21021; Wang TC, 2012, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00083; Wang TC, 2009, AM J PHYSIOL-RENAL, V297, pF1534, DOI 10.1152/ajprenal.00095.2009; Watterson KR, 2007, FASEB J, V21, P2818, DOI 10.1096/fj.06-7326com; Zhang YZ, 2014, WORLD J GASTROENTERO, V20, P91, DOI 10.3748/wjg.v20.i1.91; Zhou HP, 2004, AM J PHYSIOL-CELL PH, V286, pC1130, DOI 10.1152/ajpcell.00429.2003	60	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0170792	10.1371/journal.pone.0170792	http://dx.doi.org/10.1371/journal.pone.0170792			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493876	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314300002
J	Niskanen, J; Dillard, K; Arumilli, M; Salmela, E; Anttila, M; Lohi, H; Hytonen, MK				Niskanen, Julia; Dillard, Kati; Arumilli, Meharji; Salmela, Elina; Anttila, Marjukka; Lohi, Hannes; Hytonen, Marjo K.			Nonsense variant in COL7A1 causes recessive dystrophic epidermolysis bullosa in Central Asian Shepherd dogs	PLOS ONE			English	Article							VII COLLAGEN; GENE-THERAPY; ANIMAL-MODEL; SKIN; TRANSPLANTATION; MUTATIONS	A rare hereditary mechanobullous disorder called epidermolysis bullosa (EB) causes blistering in the skin and the mucosal membranes. To date, nineteen EB-related genes have been discovered in human and other species. We describe here a novel EB variant in dogs. Two newborn littermates of Central Asian Shepherd dogs with severe signs of skin blistering were brought to a veterinary clinic and euthanized due to poor prognosis. In post-mortem examination, the puppies were shown to have findings in the skin and the mucosal membranes characteristic of EB. A whole-genome sequencing of one of the affected puppies was performed to identify the genetic cause. The resequencing data were filtered under a recessive model against variants from 31 other dog genomes, revealing a homozygous case-specific nonsense variant in one of the known EB-causing genes, COL7A1 (c.4579C> T, p.R1527*). The variant results in a premature stop codon and likely absence of the functional protein in the basement membrane of the skin in the affected dogs. This was confirmed by immunohistochemistry using a COL7A1 antibody. Additional screening of the variant indicated full penetrance and breed specificity at similar to 28% carrier frequency. In summary, this study reveals a novel COL7A1 variant causing recessive dystrophic EB and provides a genetic test for the eradication of the disease from the breed.	[Niskanen, Julia; Arumilli, Meharji; Salmela, Elina; Lohi, Hannes; Hytonen, Marjo K.] Univ Helsinki, Dept Vet Biosci, Helsinki, Finland; [Niskanen, Julia; Arumilli, Meharji; Salmela, Elina; Lohi, Hannes; Hytonen, Marjo K.] Univ Helsinki, Res Programs Unit, Mol Neurol, Helsinki, Finland; [Niskanen, Julia; Arumilli, Meharji; Salmela, Elina; Lohi, Hannes; Hytonen, Marjo K.] Folkhalsan Inst Genet, Helsinki, Finland; [Dillard, Kati; Anttila, Marjukka] Finnish Food Safety Author, Pathol Unit, Helsinki, Finland; [Salmela, Elina] Univ Helsinki, Dept Biosci, Helsinki, Finland	University of Helsinki; University of Helsinki; Finnish Food Authority; University of Helsinki	Lohi, H (corresponding author), Univ Helsinki, Dept Vet Biosci, Helsinki, Finland.; Lohi, H (corresponding author), Univ Helsinki, Res Programs Unit, Mol Neurol, Helsinki, Finland.; Lohi, H (corresponding author), Folkhalsan Inst Genet, Helsinki, Finland.	Hannes.lohi@helsinki.fi	Lohi, Hannes/F-4596-2011; Niskanen, Julia/AAH-7917-2020; Niskanen, Julia/U-7837-2017	Lohi, Hannes/0000-0003-1087-5532; Niskanen, Julia/0000-0002-2871-6890; Niskanen, Julia/0000-0002-2871-6890; Salmela, Elina/0000-0003-1326-4462; Arumilli, Meharji/0000-0003-4072-0996; Hytonen, Marjo/0000-0003-1976-5874	Academy of Finland [1268091]; Jane and Aatos Erkko Foundation; Biocentrum Helsinki; Orion Research Foundation; Morris Animal Foundation [D13CA-403]; Jenny and Antti Wihuri Foundation	Academy of Finland(Academy of Finland); Jane and Aatos Erkko Foundation; Biocentrum Helsinki; Orion Research Foundation; Morris Animal Foundation; Jenny and Antti Wihuri Foundation	This work was supported by the Academy of Finland, grant number 1268091 (http://www.aka.fi/) (HL); the Jane and Aatos Erkko Foundation (http://jaes.fi/) (HL); Biocentrum Helsinki (http://www.helsinki.fi/biocentrum/) (HL); the Orion Research Foundation (http://www.orion.fi/en/rd) (HL); the Morris Animal Foundation-D13CA-403 (http://www.morrisanimalfoundation.org) (MKH); and the Jenny and Antti Wihuri Foundation (http://wihurinrahasto.fi/) (ES)	Baldeschi C, 2003, HUM MOL GENET, V12, P1897, DOI 10.1093/hmg/ddg200; Capt A, 2005, J INVEST DERMATOL, V124, P530, DOI 10.1111/j.0022-202X.2004.23584.x; Conget P, 2010, CYTOTHERAPY, V12, P429, DOI 10.3109/14653241003587637; Dang NN, 2008, EXP DERMATOL, V17, P553, DOI 10.1111/j.1600-0625.2008.00723.x; Fine JD, 2008, J PEDIATR GASTR NUTR, V46, P147, DOI 10.1097/MPG.0b013e31812f5667; Fine JD, 2014, J AM ACAD DERMATOL, V70, P1103, DOI 10.1016/j.jaad.2014.01.903; Fine JD, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-12; Gache Y, 2011, J INVEST DERMATOL, V131, P2069, DOI 10.1038/jid.2011.172; Hytonen MK, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006037; KEENE DR, 1987, J CELL BIOL, V104, P611, DOI 10.1083/jcb.104.3.611; Lin ZM, 2016, NAT GENET, V48, P1508, DOI 10.1038/ng.3701; Magnol JP, 2005, B ACAD NAT MED PARIS, V189, P107, DOI 10.1016/S0001-4079(19)33609-X; Mauldin EA, 2017, VET DERMATOL, V28, P10, DOI 10.1111/vde.12394; Medeiros GX, 2015, VET DERMATOL, V26, P3, DOI 10.1111/vde.12176; Niskanen J, 2017, J OPEN SOURCE SOFTW, V2; Olivry T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032072; Osborn MJ, 2013, MOL THER, V21, P1151, DOI 10.1038/mt.2013.56; Palazzi X, 2000, J INVEST DERMATOL, V115, P135, DOI 10.1046/j.1523-1747.2000.00031-5.x; Siprashvili Z, 2010, HUM GENE THER, V21, P1299, DOI 10.1089/hum.2010.023; Uitto J, 2017, MATRIX BIOL; Wagner JE, 2010, NEW ENGL J MED, V363, P629, DOI 10.1056/NEJMoa0910501; Wong T, 2008, J INVEST DERMATOL, V128, P2179, DOI 10.1038/jid.2008.78; Woodley DT, 2013, J INVEST DERMATOL, V133, P1910, DOI 10.1038/jid.2013.10; Woodley DT, 2004, NAT MED, V10, P693, DOI 10.1038/nm1063	24	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177527	10.1371/journal.pone.0177527	http://dx.doi.org/10.1371/journal.pone.0177527			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493971	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314300129
J	Petushkova, NA; Zgoda, VG; Pyatnitskiy, MA; Larina, OV; Teryaeva, NB; Potapov, AA; Lisitsa, AV				Petushkova, Natalia A.; Zgoda, Victor G.; Pyatnitskiy, Mikhail A.; Larina, Olesya V.; Teryaeva, Nadezhda B.; Potapov, Alexander A.; Lisitsa, Andrey V.			Post-translational modifications of FDA-approved plasma biomarkers in glioblastoma samples	PLOS ONE			English	Article							MASS-SPECTROMETRY; PROTEIN-PHOSPHORYLATION; DATABASE SEARCH; STRATEGY; IDENTIFICATION; ACETYLATION; CANCER; CELLS; SERUM	Liquid chromatography-tandem mass spectrometry was used to analyze plasma proteins of volunteers (control) and patients with glioblastoma multiform (GBM). A database search was pre-set with a variable post-translational modification (PTM): phosphorylation, acetylation or ubiquitination. There were no significant differences between the control and the GBM groups regarding the number of protein identifications, sequence coverage or number of PTMs. However, in GBM plasma, we unambiguously observed a decreased fraction in post-translationally modified peptides identified with high quality. The disease-specific PTM patterns were extracted and mapped to the set of FDA-approved plasma protein markers. Decreases of 46% and 24% in the number of acetylated and ubiquitinated peptides, respectively, were observed in the GBM samples. Significance of capturing disease-associated patterns of protein modifications was envisaged.	[Petushkova, Natalia A.; Zgoda, Victor G.; Pyatnitskiy, Mikhail A.; Larina, Olesya V.; Lisitsa, Andrey V.] VN Orekhovich Res Inst Biomed Chem, Moscow, Russia; [Teryaeva, Nadezhda B.; Potapov, Alexander A.] NN Burdenko Res Inst Neurosurg, Moscow, Russia	Russian Academy of Medical Sciences; Institute of Biomedical Chemistry; Russian Academy of Medical Sciences; N.N.Burdenko National Medical Research Center of Neurosurgery	Petushkova, NA (corresponding author), VN Orekhovich Res Inst Biomed Chem, Moscow, Russia.	cyp450@mail.ru	Лисица, Андрей/ABD-2934-2020; Zgoda, Victor G/F-1791-2017; Petushkova, Natalia/E-9951-2017	Zgoda, Victor G/0000-0002-4532-4274; Petushkova, Natalia/0000-0002-4101-4607; Potapov, Alexander/0000-0001-8343-3511	RSF [16-44-03007]	RSF(Russian Science Foundation (RSF))	Mass spectrometric measurements and bioinformatics processing of the results were supported by the RSF grant No. 16-44-03007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Pavel Pogodin for his contribution to the statistical analysis. Mass spectrometric measurements and bioinformatics processing of the results were supported by the RSF grant No. 16-44-03007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NL, 2010, CLIN CHEM, V56, P177, DOI 10.1373/clinchem.2009.126706; Bonilla LE, 2008, BIOTECHNIQUES, V44, P671, DOI 10.2144/000112800; Cappadona S, 2012, AMINO ACIDS, V43, P1087, DOI 10.1007/s00726-012-1289-8; Cesnik AJ, 2016, J PROTEOME RES, V15, P800, DOI 10.1021/acs.jproteome.5b00817; Chick JM, 2015, NAT BIOTECHNOL, V33, P743, DOI 10.1038/nbt.3267; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Froelich JM, 2008, PROTEOMICS, V8, P1334, DOI 10.1002/pmic.200700792; Geyer PE, 2016, CELL SYST, V2, P185, DOI 10.1016/j.cels.2016.02.015; Han S, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1125-0; Hintze JL, 1998, AM STAT, V52, P181, DOI 10.2307/2685478; Kalvik TV, 2013, ONCOGENE, V32, P269, DOI 10.1038/onc.2012.82; Kampstra P., 2008, J STAT SOFTW, V28, P1, DOI [10.18637/jss.v028.c01, DOI 10.18637/JSS.V028.C01]; Langton SD, 2002, INT J FOOD MICROBIOL, V79, P175, DOI 10.1016/S0168-1605(02)00107-1; Lee P, 2015, ANTICANCER RES, V35, P615; Matsuura H, 1985, NEUROL NEUROSURG PSY, V48, P835; Mauri P, 2005, FASEB J, V19, P1125, DOI 10.1096/fj.04-3000fje; Melo-Braga MN, 2015, METHODS MOL BIOL, V1295, P275, DOI 10.1007/978-1-4939-2550-6_21; Mughal AA, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0432-z; Narushima Y, 2016, MOL CELL PROTEOMICS, V15, P1017, DOI 10.1074/mcp.M115.049999; Pan SJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11066; Rodchenkova M., 2013, ANALITIKA, V3, P40; Ryslava H, 2013, J PROTEOMICS, V92, P80, DOI 10.1016/j.jprot.2013.03.025; Seo J, 2008, J PROTEOME RES, V7, P587, DOI 10.1021/pr700657y; Seto E, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018713; Shortreed MR, 2015, J PROTEOME RES, V14, P4714, DOI 10.1021/acs.jproteome.5b00599; Sims RJ, 2008, NAT REV MOL CELL BIO, V9, P815, DOI 10.1038/nrm2502; Tabb DL, 2010, J PROTEOME RES, V9, P761, DOI 10.1021/pr9006365; Takebe N, 2011, NAT REV CLIN ONCOL, V8, P97, DOI 10.1038/nrclinonc.2010.196; Walker J M, 1994, Methods Mol Biol, V32, P5; Wu SL, 2007, J PROTEOME RES, V6, P4230, DOI 10.1021/pr070313u; Zhao YM, 2009, PROTEOMICS, V9, P4632, DOI 10.1002/pmic.200900398	33	17	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177427	10.1371/journal.pone.0177427	http://dx.doi.org/10.1371/journal.pone.0177427			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493947	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314300106
J	Raviv, B; Granot, G; Chalifa-Caspi, V; Grafi, G				Raviv, Buzi; Granot, Gila; Chalifa-Caspi, Vered; Grafi, Gideon			The dead, hardened floral bracts of dispersal units of wild wheat function as storage for active hydrolases and in enhancing seedling vigor	PLOS ONE			English	Article							POLYACRYLAMIDE-GEL ELECTROPHORESIS; LATERAL ROOT DEVELOPMENT; EMMER WHEAT; DNA; DOMESTICATION; ENDONUCLEASES; EVOLUTION; NITRATE; PLANT; DEFICIENCY	It is commonly assumed that the dead, hardened floral bracts of the dispersal unit of grasses have been evolved to protect seeds from predation and / or assist in fruit/caryopsis dispersal. While these structures have important agronomical and economical implications, their adaptive value has not been fully explored. We investigated the hypothesis that the maternally derived hardened floral bracts have been evolved not just as a means for caryopsis protection and dispersal, but also as storage for substances that might affect seed germination and seedling vigor. Dead glumes as well as lemmas and paleas of wild emmer wheat (Triticum turgidum var dicoccoides) were found to store and release upon hydration active hydrolases including nucleases and chitinases. High nuclease activity was released upon hydration from glumes derived from wild strains of wheat including Triticum urartu and wild emmer wheat, while very low nuclease activity was detected in glumes derived from domesticated, free- threshing wheat cultivars (e.g., durum wheat). Germination from the intact dispersal unit of wild emmer wheat was delayed, but post germination growth was better than those of separated caryopses. Most notable was a significant increase in lateral root production on seedlings germinated from the intact dispersal unit. Proteome analysis of wild emmer wheat glumes revealed many proteins stored and released upon hydration including S1-type nucleases, peptidases, antifungal hydrolases such as chitinases and beta-1,3-glucanase as well as pectin acetylesterase, a protein involved in cell wall degradation and remodeling. Also, reactive oxygen species (ROS)-detoxifying enzymes such as superoxide dismutase and ascorbate peroxidase were overrepresented in dead glumes of wild emmer wheat. Thus our study highlighted previously unknown features of the dispersal unit in wild wheat in which the dead, hardened floral bracts enclosing the caryopsis store active hydrolases and nutritional elements and probably growth promoting substances that facilitate seed longevity and germination and increase seedling vigor.	[Raviv, Buzi; Granot, Gila; Grafi, Gideon] Ben Gurion Univ Negev, Inst Desert Res, French Associates Inst Agr & Biotechnol Drylands, Midreshet Ben Gurion, Israel; [Chalifa-Caspi, Vered] Ben Gurion Univ Negev, Natl Inst Biotechnol, Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Grafi, G (corresponding author), Ben Gurion Univ Negev, Inst Desert Res, French Associates Inst Agr & Biotechnol Drylands, Midreshet Ben Gurion, Israel.	ggrafi@bgu.ac.il		Chalifa-Caspi, Vered/0000-0001-6030-5816	Harbour Foundation; Margolin foundation	Harbour Foundation; Margolin foundation	This work was supported by the Harbour Foundation to B.R., and the Margolin foundation to G. Grafi.; We thank Z. Peleg for providing dispersal units of wild and domesticated wheat lines. We thank the Harbour Foundation for supporting B.R. research. The work was supported in part by the Margolin foundation to G. Grafi.	Bailly C, 2004, SEED SCI RES, V14, P93, DOI 10.1079/SSR2004159; Balakrishnan L, 2013, ANNU REV BIOCHEM, V82, P119, DOI 10.1146/annurev-biochem-072511-122603; Balasubramanian V, 2012, BIOTECHNOL LETT, V34, P1983, DOI 10.1007/s10529-012-1012-6; BEARD P, 1973, J VIROL, V12, P1303, DOI 10.1128/JVI.12.6.1303-1313.1973; BENHAM CJ, 1979, P NATL ACAD SCI USA, V76, P3870, DOI 10.1073/pnas.76.8.3870; Bertini L, 2009, FEBS LETT, V583, P2865, DOI 10.1016/j.febslet.2009.07.045; Bhatt I, 2011, BIOTECHNOL ADV, V29, P850, DOI 10.1016/j.biotechadv.2011.07.002; BLANK A, 1982, ANAL BIOCHEM, V120, P267, DOI 10.1016/0003-2697(82)90347-5; Booth D. T., 1990, Journal of Seed Technology, V14, P61; BOOTH DT, 1983, J RANGE MANAGE, V36, P387, DOI 10.2307/3898495; BOOTH DT, 1984, J RANGE MANAGE, V37, P222, DOI 10.2307/3899141; Buchanan-Wollaston V, 2003, PLANT BIOTECHNOL J, V1, P3, DOI 10.1046/j.1467-7652.2003.00004.x; Cao J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046944; Casimiro I, 2003, TRENDS PLANT SCI, V8, P165, DOI 10.1016/S1360-1385(03)00051-7; Ceasar SA, 2012, BIOTECHNOL LETT, V34, P995, DOI 10.1007/s10529-012-0871-1; DREW MC, 1975, NEW PHYTOL, V75, P479, DOI 10.1111/j.1469-8137.1975.tb01409.x; Dubcovsky J, 2007, SCIENCE, V316, P1862, DOI 10.1126/science.1143986; Dvorak J, 2012, J HERED, V103, P426, DOI 10.1093/jhered/esr152; Elbaum R, 2008, J STRUCT BIOL, V164, P101, DOI 10.1016/j.jsb.2008.06.008; Elbaum R, 2007, SCIENCE, V316, P884, DOI 10.1126/science.1140097; Eriksson O, 2008, INT J PLANT SCI, V169, P863, DOI 10.1086/589888; Feldman M, 2007, ISR J PLANT SCI, V55, P207, DOI 10.1560/IJPS.55.3-4.207; Fukaki H, 2009, PLANT MOL BIOL, V69, P437, DOI 10.1007/s11103-008-9417-2; Galiana E, 1997, PLANT PHYSIOL, V115, P1557, DOI 10.1104/pp.115.4.1557; Gartemann KH, 2003, J BIOTECHNOL, V106, P179, DOI 10.1016/j.jbiotec.2003.07.011; Grafi G, 1995, PLANT MOL BIOL, V29, P703, DOI 10.1007/BF00041161; Granot G, 2015, BBA-GENE REGUL MECH, V1849, P239, DOI 10.1016/j.bbagrm.2014.12.003; Hugot K, 2002, MOL PLANT MICROBE IN, V15, P243, DOI 10.1094/MPMI.2002.15.3.243; Ko CY, 2012, J AGR FOOD CHEM, V60, P5169, DOI 10.1021/jf300945c; Kohli P., 2015, J BIOPROCESSING BIOT, V5, P1, DOI DOI 10.4172/2155-9821.1000227; Kumar SPJ, 2015, ANN BOT-LONDON, V116, P663, DOI 10.1093/aob/mcv098; Lu JJ, 2015, SEED SCI RES, V25, P276, DOI 10.1017/S0960258515000215; Peleg Z, 2011, J EXP BOT, V62, P5051, DOI 10.1093/jxb/err206; Peret B, 2009, TRENDS PLANT SCI, V14, P399, DOI 10.1016/j.tplants.2009.05.002; Pulido P, 2009, PLANT J, V57, P132, DOI 10.1111/j.1365-313X.2008.03675.x; Remans T, 2006, P NATL ACAD SCI USA, V103, P19206, DOI 10.1073/pnas.0605275103; RUDALL PJ, 2005, ECDEIOCOLEACEAE AM J, V92, P1432, DOI DOI 10.3732/AJB.92.9.1432; Sharma N., 2011, Asian Journal of Biochemistry, V6, P29, DOI 10.3923/ajb.2011.29.37; Simpson DJ, 2003, J CEREAL SCI, V37, P111, DOI 10.1006/jcrs.2002.0488; Song WJ, 2015, PLANT SOIL, V396, P163, DOI 10.1007/s11104-015-2579-1; Sugiyama M, 2000, PLANT MOL BIOL, V44, P387, DOI 10.1023/A:1026504911786; TRETTER V, 1991, EUR J BIOCHEM, V199, P647, DOI 10.1111/j.1432-1033.1991.tb16166.x; TRUDEL J, 1989, ANAL BIOCHEM, V178, P362, DOI 10.1016/0003-2697(89)90653-2; Vercauteren I, 2002, MOL PLANT MICROBE IN, V15, P404, DOI 10.1094/MPMI.2002.15.4.404; Wilkes H.G., 1967, TEOSINTE CLOSEST REL; Wurzburger J., 1969, BIOSS NEW PHYTOL, V68, P337, DOI DOI 10.1111/J.1469-8137.1969.TB06445.X; Zhang HM, 2000, J EXP BOT, V51, P51, DOI 10.1093/jexbot/51.342.51; Zhu JM, 2005, PLANT SOIL, V270, P299, DOI 10.1007/s11104-004-1697-y	48	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177537	10.1371/journal.pone.0177537	http://dx.doi.org/10.1371/journal.pone.0177537			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493968	Green Submitted, Green Published, gold			2022-12-26	WOS:000401314300132
J	Simion, V; Sobilo, J; Clemoncon, R; Natkunarajah, S; Ezzine, S; Abdallah, F; Lerondel, S; Pichon, C; Baril, P				Simion, Viorel; Sobilo, Julien; Clemoncon, Rudy; Natkunarajah, Sharuja; Ezzine, Safia; Abdallah, Florence; Lerondel, Stephanie; Pichon, Chantal; Baril, Patrick			Positive radionuclide imaging of miRNA expression using RILES and the human sodium iodide symporter as reporter gene is feasible and supports a protective role of miRNA-23a in response to muscular atrophy	PLOS ONE			English	Article							SKELETAL-MUSCLE; THYROID-CANCER; NA+/I-SYMPORTER; PROTEIN; THERAPY; SYSTEM; INVOLVEMENT; TRANSPORT; MICRORNAS; MECHANISM	MicroRNAs (miRNAs) are key players in many biological processes and are considered as an emerging class of pharmacology drugs for diagnosis and therapy. However to fully exploit the therapeutic potential of miRNAs, it is becoming crucial to monitor their expression pattern using medical imaging modalities. Recently, we developed a method called RILES, for RNAi-Inducible Luciferase Expression System that relies on an engineered regulatable expression system to switch-ON the expression of the luciferase gene when a miRNA of interest is expressed in cells. Here we investigated whether replacing the luciferase reporter gene with the human sodium iodide symporter (hNIS) reporter gene will be also suited to monitor the expression of miRNAs in a clinical setting context. We provide evidence that radionuclide imaging of miRNA expression using hNIS is feasible although it is not as robust as when the luciferase reporter gene is used. However, under appropriate conditions, we monitored the expression of several miRNAs in cells, in the liver and in the tibialis anterior muscle of mice undergoing muscular atrophy. We demonstrated that radiotracer accumulation in transfected cells correlated with the induction of hNIS and with the expression of miRNAs detected by real time PCR. We established the kinetic of miRNA-23a expression in mice and demonstrated that this miRNA follows a biphasic expression pattern characterized by a loss of expression at a late time point of muscular atrophy. At autopsy, we found an opposite expression pattern between miRNA-23a and one of the main transcriptional target of this miRNA, APAF-1, and as downstream target, Caspase 9. Our results report the first positive monitoring of endogenously expressed miRNAs in a nuclear medicine imaging context and support the development of additional work to establish the potential therapeutic value of miRNA-23 to prevent the damaging effects of muscular atrophy.	[Simion, Viorel; Clemoncon, Rudy; Ezzine, Safia; Abdallah, Florence; Pichon, Chantal; Baril, Patrick] CNRS, UPR4301, Ctr Biophys Mol, Orleans, France; [Sobilo, Julien; Natkunarajah, Sharuja; Lerondel, Stephanie] CNRS Orleans, PHENOMIN TAAM UPS44, CIPA, Orleans, France; [Pichon, Chantal; Baril, Patrick] Univ Orleans, Coll Sci & Tech, Orleans, France; [Ezzine, Safia] Synthelis, Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Orleans	Baril, P (corresponding author), CNRS, UPR4301, Ctr Biophys Mol, Orleans, France.; Baril, P (corresponding author), Univ Orleans, Coll Sci & Tech, Orleans, France.	patrick.baril@cnrs.fr	Simion, Viorel/M-3355-2019	Simion, Viorel/0000-0002-2683-2871; PICHON, Chantal/0000-0003-3161-3937; BARIL, Patrick/0000-0001-8290-9899	French National Cancer Institute (INCA) [2014-168]; Marengo INCA funding	French National Cancer Institute (INCA)(Institut National du Cancer (INCA) France); Marengo INCA funding	This work was supported by the French National Cancer Institute (INCA, No 2014-168, MARENGO project). Viorel Simion is supported by a postdoctoral fellowship from the Marengo INCA funding.	Adhihetty PJ, 2007, J APPL PHYSIOL, V102, P1143, DOI 10.1152/japplphysiol.00768.2006; Ahn BC, 2012, THERANOSTICS, V2, P392, DOI 10.7150/thno.3722; Arano Y, 2002, ANN NUCL MED, V16, P79, DOI 10.1007/BF02993710; Aumiller JJ, 2012, GLYCOBIOLOGY, V22, P417, DOI 10.1093/glycob/cwr160; Baril P, 2016, METHODS MOL BIOL, V1372, P193, DOI 10.1007/978-1-4939-3148-4_15; Baril P, 2010, BRIT J PHARMACOL, V159, P761, DOI 10.1111/j.1476-5381.2009.00412.x; Barton KN, 2008, MOL THER, V16, P1761, DOI 10.1038/mt.2008.172; Billiet L, 2012, BIOMATERIALS, V33, P2980, DOI 10.1016/j.biomaterials.2011.12.027; Brader P, 2013, J NUCL MED, V54, P167, DOI 10.2967/jnumed.111.099788; Castro MR, 2001, J CLIN ENDOCR METAB, V86, P5627, DOI 10.1210/jc.86.11.5627; Chen Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.92; Chisholm EJ, 2009, CANCER RES, V69, P2655, DOI 10.1158/0008-5472.CAN-08-2657; Christopher Ajay Francis, 2016, Perspect Clin Res, V7, P68, DOI 10.4103/2229-3485.179431; Chung T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142984; Dayem M, 2008, J ENDOCRINOL, V197, P95, DOI 10.1677/JOE-07-0455; DEUTSCH E, 1987, J NUCL MED, V28, P1491; Dobrowolny G, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-3; Dohan O, 2006, MOL ENDOCRINOL, V20, P1121, DOI 10.1210/me.2005-0376; Ezzine S, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt797; Galanis E, 2015, CANCER RES, V75, P22, DOI 10.1158/0008-5472.CAN-14-2533; Grohmann M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-301; Guller I, 2010, J PHYSIOL-LONDON, V588, P4075, DOI 10.1113/jphysiol.2010.194175; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hudson MB, 2014, AM J PHYSIOL-CELL PH, V306, pC551, DOI 10.1152/ajpcell.00266.2013; Jo MH, 2013, BIOMATERIALS, V34, P4803, DOI 10.1016/j.biomaterials.2013.03.032; Jung KH, 2008, J NUCL MED, V49, P1966, DOI 10.2967/jnumed.108.055764; Kim YH, 2015, THERANOSTICS, V5, P86, DOI 10.7150/thno.10062; Ko HY, 2009, NAT PROTOC, V4, P1663, DOI 10.1038/nprot.2009.119; Kole R, 2012, NAT REV DRUG DISCOV, V11, P125, DOI 10.1038/nrd3625; Le Guiner C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102538; Liu N, 2015, DIGEST DIS SCI, V60, P2000, DOI 10.1007/s10620-015-3588-x; Ma GD, 2015, INT J BIOL SCI, V11, P345, DOI 10.7150/ijbs.10921; Merron A, 2010, EUR J NUCL MED MOL I, V37, P1377, DOI 10.1007/s00259-009-1379-3; Miller A, 2016, EXPERT OPIN BIOL TH, V16, P15, DOI 10.1517/14712598.2016.1100162; Mitrofanova E, 2006, GENE THER, V13, P1052, DOI 10.1038/sj.gt.3302758; Mullick A, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-43; Neumann S, 2004, THYROID, V14, P99, DOI 10.1089/105072504322880337; Nicola JP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4948; Peerlinck I, 2009, CLIN CANCER RES, V15, P6595, DOI 10.1158/1078-0432.CCR-09-0262; Portulano C, 2014, ENDOCR REV, V35, P106, DOI 10.1210/er.2012-1036; Pugliese M, 2013, THYROID, V23, P838, DOI 10.1089/thy.2012.0359; Rajecki M, 2011, MOL THER, V19, P629, DOI 10.1038/mt.2011.31; Russell SJ, 2014, MAYO CLIN PROC, V89, P926, DOI 10.1016/j.mayocp.2014.04.003; Sekar TV, 2013, THERANOSTICS, V3, P953, DOI 10.7150/thno.4928; Singh TD, 2015, J NUCL MED, V56, P1690, DOI 10.2967/jnumed.115.160366; Soares RJ, 2014, J BIOL CHEM, V289, P21909, DOI 10.1074/jbc.M114.561845; Stieger K, 2009, ADV DRUG DELIVER REV, V61, P527, DOI 10.1016/j.addr.2008.12.016; Tonacchera M, 2002, J CLIN ENDOCR METAB, V87, P352, DOI 10.1210/jc.87.1.352; Vadysirisack DD, 2006, J NUCL MED, V47, P182; Wada S, 2011, J BIOL CHEM, V286, P38456, DOI 10.1074/jbc.M111.271270; Wang FQ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0062988, 10.1371/journal.pone.0061792, 10.1371/journal.pone.0069284, 10.1371/journal.pone.0064373, 10.1371/journal.pone.0080480, 10.1371/journal.pone.0078025]; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046; Yong FL, 2014, INT J MOL SCI, V15, P11713, DOI 10.3390/ijms150711713; ZHANG XF, 2015, J INEQUAL APPL, V2015, P1, DOI DOI 10.3892/0L.2015.3238	54	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177492	10.1371/journal.pone.0177492	http://dx.doi.org/10.1371/journal.pone.0177492			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493972	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314300121
J	Wang, B; Guo, X; Zhao, PJ; Ruan, MB; Yu, XL; Zou, LP; Yang, YL; Li, X; Deng, DL; Xiao, JX; Xiao, YW; Hu, CJ; Wang, X; Wang, XL; Wang, WQ; Peng, M				Wang, Bin; Guo, Xin; Zhao, Pingjuan; Ruan, Mengbin; Yu, Xiaoling; Zou, Liangping; Yang, Yiling; Li, Xiao; Deng, Deli; Xiao, Jixiang; Xiao, Yiwei; Hu, Chunji; Wang, Xue; Wang, Xiaolin; Wang, Wenquan; Peng, Ming			Molecular diversity analysis, drought related marker-traits association mapping and discovery of excellent alleles for 100-day old plants by EST-SSRs in cassava germplasms (Manihot esculenta Cranz)	PLOS ONE			English	Article							FIBER QUALITY; STRESS TOLERANCE; LINKAGE MAP; GENE; ARABIDOPSIS; DEHYDRATION; RESISTANCE; LANDRACES; LOCI; HEAT	Cassava is the third largest food crop of the world and has strong ability of drought tolerance. In order to evaluate the molecular diversity and to discover novel alleles for drought tolerance in cassava germplasms, we examined a total of 107 abiotic stress related expressed sequence tags-simple sequence repeat (EST-SSR) markers in 134 cassava genotypes coming from planting regions worldwide and performed drought related marker-traits association mapping. As results, we successfully amplified 98 of 107 markers in 97 polymorphic loci and 279 alleles, with 2.87 alleles per locus, gene diversity of 0.48 and polymorphic information content (PIC) of 0.41 on average. The genetic coefficient between every two lines was 0.37 on average, ranging from 0.21 to 0.82. According to our population structure analysis, these samples could be divided into three sub-populations showing obvious gene flow between them. We also performed water stress experiments using 100-day old cassava plants in two years and calculated the drought tolerance coefficients (DTCs) and used them as phenotypes for marker-trait association mapping. We found that 53 markers were significantly associated with these drought-related traits, with a contribution rate for trait variation of 8.60% on average, ranging between 2.66 and 28.09%. Twenty-four of these 53 associated genes showed differential transcription or protein levels which were confirmed by qRT-PCR under drought stress when compared to the control conditions in cassava. Twelve of twenty-four genes were the same differential expression patterns in omics data and results of qRT-PCR. Out of 33 marker-traits combinations on 24 loci, 34 were positive and 53 negative alleles according to their phenotypic effects and we also obtained the typical materials which carried these elite alleles. We also found 23 positive average allele effects while 10 loci were negative according to their allele effects (AAEs). Our results on molecular diversity, locus association and differential expression under drought can prove beneficial to select excellent materials through marker assisted selection and for functional genes research in the future.	[Wang, Bin; Guo, Xin; Yang, Yiling] Huazhong Agricultrural Univ, Coll Plant Sci & Technol, Wuhan, Hubei, Peoples R China; [Wang, Bin; Guo, Xin; Zhao, Pingjuan; Ruan, Mengbin; Yu, Xiaoling; Zou, Liangping; Yang, Yiling; Li, Xiao; Deng, Deli; Xiao, Jixiang; Xiao, Yiwei; Hu, Chunji; Wang, Xue; Wang, Xiaolin; Wang, Wenquan; Peng, Ming] Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Haikou, Peoples R China; [Wang, Bin; Guo, Xin; Zhao, Pingjuan; Ruan, Mengbin; Yu, Xiaoling; Zou, Liangping; Yang, Yiling; Li, Xiao; Deng, Deli; Xiao, Jixiang; Xiao, Yiwei; Hu, Chunji; Wang, Xue; Wang, Xiaolin; Wang, Wenquan; Peng, Ming] Minist Agr, Key Lab Biol & Genet Resources Trop Crops, Haikou, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Peng, M (corresponding author), Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Haikou, Peoples R China.; Peng, M (corresponding author), Minist Agr, Key Lab Biol & Genet Resources Trop Crops, Haikou, Peoples R China.	pengming@itbb.org.cn	wang, xiao/HGB-7081-2022	wang, xiao/0000-0002-4088-3341; Wang, Wenquan/0000-0002-7603-3437	National Natural Science Foundation of China NSFC-CGIAR Project [31561143012]; National Science Foundation of China [31501378]; national key technology RAMP;D program of China [2015BAD15B01]; Hainan province innovative research team foundation [2016CXTD013]	National Natural Science Foundation of China NSFC-CGIAR Project(CGIAR); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); national key technology RAMP;D program of China; Hainan province innovative research team foundation	This work was financially supported by National Natural Science Foundation of China NSFC-CGIAR Project (grant no. 31561143012), the National Science Foundation of China (grant No. 31501378), the national key technology R&D program of China (grant no. 2015BAD15B01) and the Hainan province innovative research team foundation (grant no. 2016CXTD013).	Adams DC, 2000, P NATL ACAD SCI USA, V97, P4106, DOI 10.1073/pnas.97.8.4106; Akano AO, 2002, THEOR APPL GENET, V105, P521, DOI 10.1007/s00122-002-0891-7; [Anonymous], 2009, BMC PLANT BIOL, DOI DOI 10.1186/1471-2229-9-118; Ashraf M, 2008, ADV AGRON, V97, P45, DOI 10.1016/S0065-2113(07)00002-8; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonaldo MDF, 1996, GENOME RES, V6, P791, DOI 10.1101/gr.6.9.791; BOUSLAMA M, 1984, CROP SCI, V24, P933, DOI 10.2135/cropsci1984.0011183X002400050026x; Bredeson JV, 2016, NAT BIOTECHNOL, V34, P562, DOI 10.1038/nbt.3535; Soto JC, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1397-4; Chen X, 2012, EUPHYTICA, V187, P227, DOI 10.1007/s10681-012-0662-8; [邓德力 Deng Deli], 2015, [热带作物学报, Chinese Journal of Tropical Crops], V36, P1986; Ding Y, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-229; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Ferguson ME, 2012, THEOR APPL GENET, V124, P685, DOI 10.1007/s00122-011-1739-9; Fregene MA, 2003, THEOR APPL GENET, V107, P1083, DOI 10.1007/s00122-003-1348-3; Gaviria J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143955; Guerinier T, 2013, PLANT J, V75, P515, DOI 10.1111/tpj.12218; Gupta PK, 2008, HEREDITY, V101, P5, DOI 10.1038/hdy.2008.35; Haq SU, 2016, GENET RES INT; Hernandez A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00085; Howeler RN, 2013, SAVA GROW CASSAVA; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Khadilkar AS, 2016, PLANT PHYSIOL, V170, P401, DOI 10.1104/pp.15.01409; Kim DH, 2013, PLANT CELL REP, V32, P1953, DOI 10.1007/s00299-013-1506-2; Kizito EB, 2007, HEREDITAS, V144, P129, DOI 10.1111/j.2007.0018-0661.01975.x; Kunkeaw S, 2011, MOL BREEDING, V27, P67, DOI 10.1007/s11032-010-9414-4; Lin Z, 2005, PLANT BREEDING, V124, P180, DOI 10.1111/j.1439-0523.2004.01039.x; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Liu ML, 2013, PLANT PHYSIOL BIOCH, V73, P161, DOI 10.1016/j.plaphy.2013.09.016; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lokko Y, 2007, PLANT CELL REP, V26, P1605, DOI 10.1007/s00299-007-0378-8; Lopez CE, 2007, GENOME, V50, P1078, DOI 10.1139/G07-087; Min HW, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01080; Nie XH, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2662-x; Nie XH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141064; Okogbenin E, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00093; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pootakham W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116028; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 2000, GENETICS, V155, P945; Qie LF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101868; Rabbi I, 2012, THEOR APPL GENET, V125, P329, DOI 10.1007/s00122-012-1836-4; Raji AAJ, 2009, ANN APPL BIOL, V155, P187, DOI 10.1111/j.1744-7348.2009.00329.x; Rodriguez PL, 1998, PLANT MOL BIOL, V38, P919, DOI 10.1023/A:1006054607850; Rosti J, 2007, PLANT CELL, V19, P1565, DOI 10.1105/tpc.106.049619; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sakurai T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074056; Sakurai T, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-66; Sautron E, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150065; Schweighofer A, 2004, TRENDS PLANT SCI, V9, P236, DOI 10.1016/j.tplants.2004.03.007; Siqueira MVBM, 2009, GENET MOL BIOL, V32, P104, DOI 10.1590/S1415-47572009005000010; Sun WN, 2002, BBA-GENE STRUCT EXPR, V1577, P1, DOI 10.1016/S0167-4781(02)00417-7; Thanyasiriwat T, 2014, PLANT BIOLOGY, V16, P197, DOI 10.1111/plb.12022; Tomar RSS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156528; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang B, 2012, THEOR APPL GENET, V125, P1263, DOI 10.1007/s00122-012-1911-x; Wang XL, 2016, NAT GENET, V48, P1233, DOI 10.1038/ng.3636; Wang XB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165733; Wang XC, 2016, SCI REP-UK, V6, DOI 10.1038/srep19643; Wang Y, 2003, DEV BIOL, V264, P228, DOI 10.1016/j.ydbio.2003.07.017; Wei YX, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00025; Wen ZiXiang, 2008, Acta Agronomica Sinica, V34, P1339, DOI 10.3724/SP.J.1006.2008.01339; Whankaew S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-266; Xu J, 2012, EMBO J, V31, P1975, DOI 10.1038/emboj.2012.56; Yang XH, 2011, MOL BREEDING, V28, P511, DOI 10.1007/s11032-010-9500-7; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhao PJ, 2015, J EXP BOT; Zhong LL, 2013, PLANT CELL, V25, P2925, DOI 10.1105/tpc.113.111229; Zhou Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146242	69	24	26	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177456	10.1371/journal.pone.0177456	http://dx.doi.org/10.1371/journal.pone.0177456			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493955	Green Submitted, Green Published, gold			2022-12-26	WOS:000401314300115
J	Wang, X; Xue, JY; Wang, XY; Liu, XH				Wang, Xin; Xue, Jianyue; Wang, Xinyun; Liu, Xiaoheng			Heterogeneous Ag-TiO2-SiO2 composite materials as novel catalytic systems for selective epoxidation of cyclohexene by H2O2	PLOS ONE			English	Article							LEAF EXTRACT; OXIDATION; NANOCOMPOSITE; TS-1; AG; REDUCTION; COMPLEXES; STYRENE; OXIDE	TiO2-SiO2 composites were synthesized using cetyl trimethyl ammonium bromide (CTAB) as the structure directing template. Self-assembly hexadecyltrimethyl-ammonium bromide TiO2-SiO2/(CTAB) were soaked into silver nitrate (AgNO3) aqueous solution. The Ag-TiO2-SiO2(Ag-TS) composite were prepared via a precipitation of AgBr in soaking process and its decomposition at calcination stage. Structural characterization of the materials was carried out by various techniques including X-ray diffraction (XRD), scanning electron microscopy (SEM), transmission electron microscopy (TEM), N-2 adsorption-desorption and ultraviolet visible spectroscopy (UV-Vis). Characterization results revealed that Ag particles were incorporated into hierarchical TiO2-SiO2 without significantly affecting the structures of the supports. Further heating-treatment at 723 K was more favorable for enhancing the stability of the Ag-TS composite. The cyclohexene oxide was the major product in the epoxidation using H2O2 as the oxidant over the Ag-TS catalysts. Besides, the optimum catalytic activity and stability of Ag-TS catalysts were obtained under operational conditions of calcined at 723 K for 2 h, reaction time of 120 min, reaction temperature of 353 K, catalyst amount of 80 mg, aqueous H2O2 (30 wt.%) as oxidant and chloroform as solvent. High catalytic activity with conversion rate up to 99.2% of cyclohexene oxide could be obtainable in water-bathing. The catalyst was found to be stable and could be reused three times without significant loss of catalytic activity under the optimized reaction conditions.	[Wang, Xin; Xue, Jianyue; Wang, Xinyun] Chaohu Univ, Coll Chem & Mat Engn, Chaohu, Anhui, Peoples R China; [Wang, Xin; Xue, Jianyue; Wang, Xinyun] Chaohu Univ, Inst Novel Funct Mat & Fine Chem, Chaohu, Anhui, Peoples R China; [Liu, Xiaoheng] Nanjing Univ Sci & Technol, Key Lab Soft Chem & Funct Mat, Minist Educ, Nanjing, Jiangsu, Peoples R China	Chaohu University; Chaohu University; Nanjing University of Science & Technology	Wang, X (corresponding author), Chaohu Univ, Coll Chem & Mat Engn, Chaohu, Anhui, Peoples R China.; Wang, X (corresponding author), Chaohu Univ, Inst Novel Funct Mat & Fine Chem, Chaohu, Anhui, Peoples R China.	wangxin@chu.edu.cn	Xiaoheng, LIU/GNP-3359-2022		Natural Science Foundation of Anhui Province [KJ2013B161]; Special Project of the Scientific Research Institute Foundation [XLY-201319]; Dr. Scientific Research Foundation of Chaohu University	Natural Science Foundation of Anhui Province(Natural Science Foundation of Anhui Province); Special Project of the Scientific Research Institute Foundation; Dr. Scientific Research Foundation of Chaohu University	This work was supported by the Natural Science Foundation of Anhui Province (No. KJ2013B161) to XW, the Special Project of the Scientific Research Institute Foundation (No. XLY-201319) to XW and the Dr. Scientific Research Foundation of Chaohu University to XW. The funders had no role in study, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hardan NH, 2016, SENSOR ACTUAT A-PHYS, V242, P50, DOI 10.1016/j.sna.2016.02.036; Behera GC, 2013, APPL CATAL A-GEN, V464, P364, DOI 10.1016/j.apcata.2013.06.012; Belaidi N, 2015, APPL CLAY SCI, V107, P14, DOI 10.1016/j.clay.2015.01.026; Berube F, 2010, CHEM MATER, V22, P1988, DOI 10.1021/cm9030667; Bet-Moushoul E, 2016, RENEW ENERG, V92, P12, DOI 10.1016/j.renene.2016.01.070; Bradley CA, 2007, J PHYS CHEM C, V111, P17570, DOI 10.1021/jp074512c; Cao D, 2016, CHEMOSPHERE, V159, P23, DOI 10.1016/j.chemosphere.2016.05.080; Cao YH, 2014, ACS CATAL, V4, P1617, DOI 10.1021/cs500187q; Chen JJ, 2016, INT J HYDROGEN ENERG, V41, P11441, DOI 10.1016/j.ijhydene.2016.05.022; Doi Y, 2014, J MOL CATAL A-CHEM, V383, P70, DOI 10.1016/j.molcata.2013.11.033; Garcia AM, 2016, J MOL CATAL A-CHEM, V416, P10, DOI 10.1016/j.molcata.2016.01.034; He W, 2016, IND ENG CHEM RES, V55, P1373, DOI 10.1021/acs.iecr.5b04187; Hereijgers BPC, 2011, ACS CATAL, V1, P1183, DOI 10.1021/cs200354c; Hosseini-Sarvari M, 2015, MATER RES BULL, V72, P98, DOI 10.1016/j.materresbull.2015.07.019; Kwon S, 2015, J CATAL, V326, P107, DOI 10.1016/j.jcat.2015.04.005; Liu JH, 2009, CATAL COMMUN, V10, P868, DOI 10.1016/j.catcom.2008.12.013; Liu S, 2016, J CATAL, V337, P188, DOI 10.1016/j.jcat.2016.01.019; Mantri Y, 2007, J AM CHEM SOC, V129, P5023, DOI 10.1021/ja067631z; Moosavifar M, 2015, CHINESE J CATAL, V36, P1719, DOI 10.1016/s1872-2067(15)60908-1; Muratsugu S, 2013, ACS CATAL, V3, P2020, DOI 10.1021/cs400053f; Notari B, 1996, ADV CATAL, V41, P253, DOI 10.1016/S0360-0564(08)60042-5; Peng C, 2016, J MOL CATAL A-CHEM, V423, P393, DOI 10.1016/j.molcata.2016.07.038; Qiu CJ, 2009, J ORGANOMET CHEM, V694, P3418, DOI 10.1016/j.jorganchem.2009.06.034; Rayati S, 2016, J MOL CATAL A-CHEM, V423, P105, DOI 10.1016/j.molcata.2016.06.012; Reddy AS, 2010, J MOL CATAL A-CHEM, V318, P60, DOI 10.1016/j.molcata.2009.11.008; SING KSW, 1982, PURE APPL CHEM, V54, P2201, DOI 10.1351/pac198254112201; Sun DL, 2015, APPL CATAL A-GEN, V505, P422, DOI 10.1016/j.apcata.2015.03.047; Tajbakhsh M, 2016, J ALLOY COMPD, V685, P258, DOI 10.1016/j.jallcom.2016.05.278; Tekla J, 2016, MICROPOR MESOPOR MAT, V233, P16, DOI 10.1016/j.micromeso.2016.06.031; Wang AL, 2010, APPL SURF SCI, V256, P2611, DOI 10.1016/j.apsusc.2009.11.003; Williams FJ, 2004, J AM CHEM SOC, V126, P8509, DOI 10.1021/ja039378y; Yan YB, 2016, CATAL TODAY, V259, P292, DOI 10.1016/j.cattod.2015.07.021; Yang Q, 2016, APPL CATAL A-GEN, V518, P213, DOI 10.1016/j.apcata.2015.10.023; Zhan WC, 2009, J PHYS CHEM C, V113, P7181, DOI 10.1021/jp8101095; Zhuang JQ, 2004, ANGEW CHEM INT EDIT, V43, P6377, DOI 10.1002/anie.200461113	35	3	3	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176332	10.1371/journal.pone.0176332	http://dx.doi.org/10.1371/journal.pone.0176332			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493879	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314300012
J	Horn, S; de la Vega, C; Asmus, R; Schwemmer, P; Enners, L; Garthe, S; Binder, K; Asmus, H				Horn, Sabine; de la Vega, Camille; Asmus, Ragnhild; Schwemmer, Philipp; Enners, Leonie; Garthe, Stefan; Binder, Kirsten; Asmus, Harald			Interaction between birds and macrofauna within food webs of six intertidal habitats of the Wadden Sea	PLOS ONE			English	Article							SYLT-ROMO BIGHT; ECOLOGICAL NETWORK ANALYSIS; ESTUARINE NITROGEN-CYCLE; ECOSYSTEM STRUCTURE; MARINE ECOSYSTEMS; TROPHIC STRUCTURE; BROUAGE MUDFLAT; AIGUILLON COVE; FEEDING BIRDS; NORTH-SEA	The determination of food web structures using Ecological Network Analysis (ENA) is a helpful tool to get insight into complex ecosystem processes. The intertidal area of the Wadden Sea is structured into diverse habitat types which differ in their ecological functioning. In the present study, six different intertidal habitats (i.e. cockle field, razor clam field, mud flat, mussel bank, sand flat and seagrass meadow) were analyzed using ENA to determine similarities and characteristic differences in the food web structure of the systems. All six systems were well balanced between their degree of organization and their robustness. However, they differed in their detailed features. The cockle field and the mussel bank exhibited a strong dependency on external imports. The razor clam field appeared to be a rather small system with low energy transfer. In the mud flat microphytobenthos was used as a main food source and the system appeared to be sensitive to perturbations. Bird predation was the most pronounced in the sand flat and the seagrass meadow and led to an increase in energy transfer and parallel trophic cycles in these habitats. Habitat diversity appears to be an important trait for the Wadden Sea as each subsystem seems to have a specific role in the overall functioning of the entire ecosystem.	[Horn, Sabine; de la Vega, Camille; Asmus, Ragnhild; Asmus, Harald] Helmholtz Zentrum Polar & Meeresforsch, Alfred Wegener Inst, WaddenSea Stn Sylt, List Auf Sylt, Germany; [Schwemmer, Philipp; Enners, Leonie; Garthe, Stefan] Univ Kiel, Res & Technol Ctr FTZ, Busum, Germany; [Binder, Kirsten] State Agcy Agr Environm & Rural Areas Schleswig H, Flintbek, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Kiel	Horn, S (corresponding author), Helmholtz Zentrum Polar & Meeresforsch, Alfred Wegener Inst, WaddenSea Stn Sylt, List Auf Sylt, Germany.	sabine.horn@awi.de	Asmus, Ragnhild/O-2397-2017; Asmus, Harald/O-2417-2017; Horn, Sabine/L-2689-2017	Asmus, Ragnhild/0000-0003-3300-6065; Asmus, Harald/0000-0002-7772-1303; Horn, Sabine/0000-0003-1637-1191	Federal Ministry of Education and Research [FKZ 03F672B]	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by the Federal Ministry of Education and Research (DE) FKZ 03F672B.	Abarca-Arenas LG, 2002, ECOL MODEL, V149, P285, DOI 10.1016/S0304-3800(01)00474-4; [Anonymous], WADDEN SEA ECOSYSTEM; ASMUS H, 1987, MAR ECOL PROG SER, V39, P251, DOI 10.3354/meps039251; Asmus H, 2000, HELGOLAND MAR RES, V54, P137, DOI 10.1007/s101520050012; Asmus R., 1998, BEDEUTUNG ORGANISMEN, P257; BAIRD D, 1985, OCEANOGR MAR BIOL, V23, P573; BAIRD D, 1993, MAR ECOL PROG SER, V99, P221, DOI 10.3354/meps099221; Baird D, 2004, MAR ECOL PROG SER, V279, P45, DOI 10.3354/meps279045; BAIRD D, 1989, ECOL MONOGR, V59, P329, DOI 10.2307/1943071; BAIRD D, 1991, PHILOS T R SOC B, V333, P15, DOI 10.1098/rstb.1991.0058; Baird D, 2011, COASTAL SHELF SCI, V91, P51; Baird D, 2008, ESTUAR COAST SHELF S, V80, P339, DOI 10.1016/j.ecss.2008.08.012; Baird D, 2007, MAR ECOL PROG SER, V351, P25, DOI 10.3354/meps07137; Baird D, 2012, MAR ECOL PROG SER, V462, P143, DOI 10.3354/meps09837; Baird D, 2009, ECOL MODEL, V220, P3465, DOI 10.1016/j.ecolmodel.2009.09.008; BALDWIN JR, 1994, MAR BIOL, V120, P627, DOI 10.1007/BF00350084; Beukema JJ, 2015, MAR ECOL PROG SER, V538, P157, DOI 10.3354/meps11485; Bezzel E., 1985, KOMPENDIUM VOGEL MIT; Blew J., 2015, TRENDS MIGRATORY WIN; Borrett SR, 2014, METHODS ECOL EVOL, V5, P1206, DOI 10.1111/2041-210X.12282; Buttger H, 2008, HELGOLAND MAR RES, V62, P23, DOI 10.1007/s10152-007-0099-y; BUXTON NE, 1981, BIRD STUDY, V28, P41, DOI 10.1080/00063658109476697; CHRISTENSEN V, 1995, ECOL MODEL, V77, P3, DOI 10.1016/0304-3800(93)E0073-C; COSTANZA R, 1992, ENVIRON MANAGE, V16, P121, DOI 10.1007/BF02393914; Costanza R., 1992, ECOLOGICAL EC SCI MA; Dannheim J, 2012, HELGOLAND MAR RES, V66, P307, DOI 10.1007/s10152-011-0271-2; Degre D, 2006, ESTUAR COAST SHELF S, V69, P107, DOI 10.1016/j.ecss.2006.04.001; Dolch T, 2013, J SEA RES; Edler L., 1979, PHYTOPLANKTON CHLORO; Fath BD, 2007, ECOL MODEL, V208, P49, DOI 10.1016/j.ecolmodel.2007.04.029; Fath BD, 2015, OCEAN COAST MANAGE, V108, P13, DOI 10.1016/j.ocecoaman.2014.06.020; Fath BD, 2013, ECOL MODEL, V252, P214, DOI 10.1016/j.ecolmodel.2012.06.010; FINN JT, 1980, ECOLOGY, V61, P562, DOI 10.2307/1937422; FINN JT, 1976, J THEOR BIOL, V56, P363, DOI 10.1016/S0022-5193(76)80080-X; Goerner SJ, 2009, ECOL ECON, V69, P76, DOI 10.1016/j.ecolecon.2009.07.018; Gollasch Stephan, 2015, ICES Cooperative Research Report, V323, P1; Goss-Custard J, 1977, J ANIM ECOL, P1; HARRIS PR, 1979, BIRD STUDY, V26, P258; Heymans JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095845; Hines DE, 2016, ECOL ENG, V89, P70, DOI 10.1016/j.ecoleng.2016.01.009; Hines DE, 2015, MAR ECOL PROG SER, V524, P137, DOI 10.3354/meps11187; Hines DE, 2012, ESTUAR COAST SHELF S, V106, P45, DOI 10.1016/j.ecss.2012.04.018; Horn S, 2016, J EXP MAR BIOL ECOL, V481, P41, DOI 10.1016/j.jembe.2016.04.010; Jeffrey S. W., 1975, BIOCH PHYSL PFLANZ B; Kabat P, 2012, OCEAN COAST MANAGE, V68, P4, DOI 10.1016/j.ocecoaman.2012.05.022; Kaufman AG, 2010, ECOL MODEL, V221, P1230, DOI 10.1016/j.ecolmodel.2009.12.018; Kay J. J., 1989, NETWORK ANAL MARINE, P15, DOI DOI 10.1007/978-3-642-75017-5_2; Kones JK, 2009, ECOL MODEL, V220, P370, DOI 10.1016/j.ecolmodel.2008.10.012; Kubetzki U, 2003, MAR BIOL, V143, P199, DOI 10.1007/s00227-003-1036-5; Lau M. K., 2015, ECOSYSTEM NETWORK AN; Leguerrier D, 2003, MAR ECOL PROG SER, V246, P17, DOI 10.3354/meps246017; Leguerrier D, 2007, ESTUAR COAST SHELF S, V74, P403, DOI 10.1016/j.ecss.2007.04.014; Mann KH, 1989, NETWORK ANAL MARINE; Mathers R.G., 1998, OCEANOGRAPHIC LIT RE, V1, P126; MELTOFTE H, 1994, IWRB PUBLICATION, V34; Mendel B., 2008, PROFILES SEABIRDS WA; Merkel C., 2015, THESIS; Monaco ME, 1986, MARINE ECOLOGY PROGR, V1, P9; NEHLS G, 1989, HELGOLANDER MEERESUN, V43, P385, DOI 10.1007/BF02365898; NEHLS G, 1993, NETH J SEA RES, V31, P375, DOI 10.1016/0077-7579(93)90054-V; Nienhuis P, 1986, MARINE ECOLOGY PROGR, V29, P1; Nithart M, 1999, J MAR BIOL ASSOC UK, V79, P1029, DOI 10.1017/S0025315499001265; Odum E.P., 1969, SUSTAINABILITY SUSTA, V164, P58; Parsons T. R., 1973, BIOL OCEANOGRAPHIC P; Pienkowski KW., 1980, ASPECTS ECOLOGY BEHA; PIERSMA T, 1993, NETH J SEA RES, V31, P331, DOI 10.1016/0077-7579(93)90052-T; Pockberger M., 2014, EMPFEHLUNGEN ANWENDU; Reise K., 2010, WADDEN SEA UNIVERSAL, V29, P7; Reise K, 2008, HELGOLAND MAR RES, V62, P77, DOI 10.1007/s10152-007-0088-1; RIEMANN B, 1989, J PLANKTON RES, V11, P1037, DOI 10.1093/plankt/11.5.1037; Saint-Beat B, 2015, ECOL INDIC, V52, P458, DOI 10.1016/j.ecolind.2014.12.017; Saint-Beat B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076739; Scharler UM, 2005, J MARINE SYST, V56, P283, DOI 10.1016/j.jmarsys.2004.12.003; Scheiffarth G, 2001, ARDEA, V89, P481; Schuckel U, 2015, MAR ECOL PROG SER, V536, P25, DOI 10.3354/meps11391; Schwemmer P, 2016, J AVIAN BIOL; Schwemmer P, 2016, ECOL MODEL, V320, P322, DOI 10.1016/j.ecolmodel.2015.10.023; Schwemmer Philipp, 2012, Vogelwarte, V50, P141; Schwemmer P, 2011, MAR BIOL, V158, P541, DOI 10.1007/s00227-010-1579-1; Soetaert K., 2009, LIM LINEAR INVERSE M; Soetaert K, 2013, PACKAGE LIMSOLVE; SWENNEN C, 1985, HELGOLANDER MEERESUN, V39, P255, DOI 10.1007/BF01992773; Tiedemann R, 1997, J ORNITHOL, V138, P183, DOI 10.1007/BF01651622; Tulp I, 2010, ESTUAR COAST SHELF S, V90, P116, DOI 10.1016/j.ecss.2010.07.008; ULANOWICZ RE, 1980, J THEOR BIOL, V85, P223, DOI 10.1016/0022-5193(80)90019-3; Ulanowicz RE, 2004, COMPUT BIOL CHEM, V28, P321, DOI 10.1016/j.compbiolchem.2004.09.001; Ulanowicz RE, 2014, ECOL LETT, V17, P127, DOI 10.1111/ele.12216; Ulanowicz RE, 2009, ECOL COMPLEX, V6, P27, DOI 10.1016/j.ecocom.2008.10.005; Van den Meersche K., 2009, J STAT SOFTW, V30, P1, DOI [DOI 10.18637/JSS.V030.C01, 10.1002/wics.10., DOI 10.18637/jss.v030.c01]; van Roomen M, 2012, OCEAN COAST MANAGE, V68, P79, DOI 10.1016/j.ocecoaman.2012.04.004; Vasconcellos M, 1997, ECOL MODEL, V100, P125, DOI 10.1016/S0304-3800(97)00150-6; Wulff F., 1989, NETWORK ANAL MARINE; [No title captured]	93	12	13	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176381	10.1371/journal.pone.0176381	http://dx.doi.org/10.1371/journal.pone.0176381			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489869	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314100021
J	Dong, XL; Lytle, DA; Olden, JD; Schriever, TA; Muneepeerakul, R				Dong, Xiaoli; Lytle, David A.; Olden, Julian D.; Schriever, Tiffany A.; Muneepeerakul, Rachata			Importance of neutral processes varies in time and space: Evidence from dryland stream ecosystems	PLOS ONE			English	Article							COMMUNITY STRUCTURE; PATTERNS; DISTURBANCE; DISPERSAL; DIVERSITY; SIMILARITY; ABUNDANCE; NICHES	Many ecosystems experience strong temporal variability in environmental conditions; yet, a clear picture of how niche and neutral processes operate to determine community assembly in temporally variable systems remains elusive. In this study, we constructed neutral metacommunity models to assess the relative importance of neutral processes in a spatially and temporally variable ecosystem. We analyzed macroinvertebrate community data spanning multiple seasons and years from 20 sites in a Sonoran Desert river network in Arizona. The model goodness-of-fit was used to infer the importance of neutral processes. Averaging over eight stream flow conditions across three years, we found that neutral processes were more important in perennial streams than in non-perennial streams (intermittent and ephemeral streams). Averaging across perennial and non-perennial streams, we found that neutral processes were more important during very high flow and in low flow periods; whereas, at very low flows, the relative importance of neutral processes varied greatly. These findings were robust to the choice of model parameter values. Our study suggested that the net effect of disturbance on the relative importance of niche and neutral processes in community assembly varies non-monotonically with the severity of disturbance. In contrast to the prevailing view that disturbance promotes niche processes, we found that neutral processes could become more important when the severity of disturbance is beyond a certain threshold such that all organisms are adversely affected regardless of their biological traits and strategies.	[Dong, Xiaoli] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Dong, Xiaoli] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Lytle, David A.] Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA; [Olden, Julian D.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Schriever, Tiffany A.] Western Michigan Univ, Dept Biol Sci, Kalamazoo, MI 49008 USA; [Schriever, Tiffany A.] Western Michigan Univ, Inst Environm & Sustainabil, Kalamazoo, MI 49008 USA; [Muneepeerakul, Rachata] Univ Florida, Dept Agr & Biol Engn, Gainesville, FL USA	Arizona State University; Arizona State University-Tempe; Duke University; Oregon State University; University of Washington; University of Washington Seattle; Western Michigan University; Western Michigan University; State University System of Florida; University of Florida	Dong, XL (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.; Dong, XL (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.	xiaoli.dong@duke.edu	Olden, Julian D/A-8535-2010	Olden, Julian/0000-0003-2143-1187	U.S. Department of Defense Strategic Environmental Research and Development Program [RC-2203]	U.S. Department of Defense Strategic Environmental Research and Development Program(United States Department of Defense)	Funding support by the U.S. Department of Defense Strategic Environmental Research and Development Program (RC-2203). URL (https://www.serdp-estcp.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge funding support by the U.S. Department of Defense Strategic Environmental Research and Development Program (RC-2203). We thank Michael Bogan, Kate Boersma, Miguel Canedo-Arguelles, and Richard Van Driesche for help with sample collection and identification, and Kristin Jaeger and Meryl Mims for assisting with the electrical resistance sensors. The manuscript benefited from comments by Nancy B. Grimm, Stuart G. Fisher and 4 anonymous reviewers.	Adler PB, 2007, ECOL LETT, V10, P95, DOI 10.1111/j.1461-0248.2006.00996.x; Bogan MT, 2013, FRESHWATER BIOL, V58, P1016, DOI 10.1111/fwb.12105; Bogan MT, 2011, FRESHWATER BIOL, V56, P2070, DOI 10.1111/j.1365-2427.2011.02638.x; Bohonak AJ, 2003, ECOL LETT, V6, P783, DOI 10.1046/j.1461-0248.2003.00486.x; BOULTON AJ, 1992, FRESHWATER BIOL, V27, P123, DOI 10.1111/j.1365-2427.1992.tb00528.x; Canedo-Arguelles M, 2015, ECOGRAPHY, V42, P778; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Chase JM, 2003, OECOLOGIA, V136, P489, DOI 10.1007/s00442-003-1311-7; Chase JM, 2007, P NATL ACAD SCI USA, V104, P17430, DOI 10.1073/pnas.0704350104; Chase JM, 2011, PHILOS T R SOC B, V366, P2351, DOI 10.1098/rstb.2011.0063; Clark JS, 1999, ECOLOGY, V80, P1475, DOI 10.1890/0012-9658(1999)080[1475:SDNAFP]2.0.CO;2; Datry T, 2016, OIKOS, V125, P149, DOI 10.1111/oik.02922; Dong X, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00497.1; Ferrenberg S, 2016, PEERJ, V4, DOI 10.7717/peerj.2545; Ferrenberg S, 2013, ISME J, V7, P1102, DOI 10.1038/ismej.2013.11; Fritz KM, 2004, HYDROBIOLOGIA, V527, P99, DOI 10.1023/B:HYDR.0000043188.53497.9b; Gause G. F., 1934, STRUGGLE EXISTENCE; Gouhier TC, 2010, AM NAT, V175, pE16, DOI 10.1086/649579; Gravel D, 2006, ECOL LETT, V9, P399, DOI 10.1111/j.1461-0248.2006.00884.x; Harpole WS, 2006, ECOL LETT, V9, P15, DOI 10.1111/j.1461-0248.2005.00836.x; Hubbell Stephen P., 2001, V32, pi; INOUYE RS, 1995, ECOLOGY, V76, P1872, DOI 10.2307/1940720; Jaeger KL, 2012, RIVER RES APPL, V28, P1843, DOI 10.1002/rra.1554; Jaeger KL, 2014, P NATL ACAD SCI USA, V111, P13894, DOI 10.1073/pnas.1320890111; Jiang L, 2008, ECOLOGY, V89, P1931, DOI 10.1890/07-1263.1; Leigh C, 2016, ECOGRAPHY, V39, P1; Lepori F, 2009, OIKOS, V118, P471, DOI 10.1111/j.1600-0706.2008.16989.x; Lytle DA, 2004, TRENDS ECOL EVOL, V19, P94, DOI 10.1016/j.tree.2003.10.002; McGill BJ, 2006, ECOLOGY, V87, P1411, DOI 10.1890/0012-9658(2006)87[1411:EEONT]2.0.CO;2; Moriasi DN, 2007, T ASABE, V50, P885, DOI 10.13031/2013.23153; Muneepeerakul R, 2008, NATURE, V453, P220, DOI 10.1038/nature06813; Muneepeerakul R, 2011, J THEOR BIOL, V269, P256, DOI 10.1016/j.jtbi.2010.11.003; POFF NL, 1989, CAN J FISH AQUAT SCI, V46, P1805, DOI 10.1139/f89-228; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Scheffer M, 2006, P NATL ACAD SCI USA, V103, P6230, DOI 10.1073/pnas.0508024103; Schriever TA, 2015, FRESHW SCI, V34, P399, DOI 10.1086/680518; Stokes CJ, 2010, ECOLOGY, V91, P1152, DOI 10.1890/08-1105.1; Trexler JC, 2005, OECOLOGIA, V145, P140, DOI 10.1007/s00442-005-0094-4; Tucker CM, 2016, OIKOS, V125, P778, DOI 10.1111/oik.02803; Urban MC, 2004, ECOLOGY, V85, P2971, DOI 10.1890/03-0631; Vergnon R, 2009, ECOL LETT, V12, P1079, DOI 10.1111/j.1461-0248.2009.01364.x; Vinson MR, 2003, ECOGRAPHY, V26, P751, DOI 10.1111/j.0906-7590.2003.03397.x	42	1	1	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0176949	10.1371/journal.pone.0176949	http://dx.doi.org/10.1371/journal.pone.0176949			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486499	Green Published, gold			2022-12-26	WOS:000401314000028
J	Ma, JN; Du, C; Zhou, C; Sheng, YM; Fan, ZX; Yue, BS; Zhang, XY				Ma, Jinnan; Du, Chao; Zhou, Chuang; Sheng, Yongmei; Fan, Zhenxin; Yue, Bisong; Zhang, Xiuyue			Complete mitochondrial genomes of two blattid cockroaches, Periplaneta australasiae and Neostylopyga rhombifolia, and phylogenetic relationships within the Blattaria	PLOS ONE			English	Article							CONTROL REGION; STRUCTURAL CONSERVATION; MOLECULAR PHYLOGENY; MAXIMUM-LIKELIHOOD; GENE-SEQUENCES; WEB SERVER; EVOLUTION; DNA; DICTYOPTERA; TERMITES	Complete mitochondrial genomes (mitogenomes) of two cockroach species, Periplaneta australasiae and Neostylopyga rhombifolia, 15,605 bp and 15,711 bp in length, respectively, were determined. As reported for other cockroach mitogenomes, the two mitogenomes possessed typical ancestral insect mitogenome gene composition and arrangement. Only several small intergenic spacers were found: one, which was common in all sequenced cockroach mitogenomes except for the genus Cryptocercus, was between tRNA-Ser (UCN) and ND1 and contained a 7bp highly conserved motif (WACTTAA). Three different types of short tandem repeats in the N. rhombifolia control region (CR) were observed. The homologous alignments of these tandem repeats with other six cockroach mitogenome CRs revealed a low similarity. Three conserved sequence blocks (CSB) were detected in both cockroach mitochondrial CRs. CSB1 was specific for blattinine mitogenomes and was highly conserved with 95% similarity, speculating that this block was a possible molecular synapomorphy for this subfamily. CSB3 located nearby downstream of CSB1 and has more variations within blattinine mitogenomes compared with CSB1. The CSB3 was capable of forming stable stem-loop structure with a small T-stretch in the loop portion. We assessed the influence of four datasets and two inference methods on topology within Orthopteroidea. All genes excluding the third codon positions of PCGs could generate more stable topology, and higher posterior probabilities than bootstrap values were presented at some branch nodes. The phylogenetic analysis with different datasets and analytical methods supported the monophyly of Dictyoptera and supported strongly the proposal that Isoptera should be classified as a family (Termitidae) of the Blattaria. Specifically, Shelfordella lateralis was inserted in the clade Periplaneta. Considering the K2P genetic distance, morphological characters, and the phylogenetic trees, we suggested that S. lateralis should be placed in the genus Periplaneta.	[Ma, Jinnan; Du, Chao; Fan, Zhenxin; Yue, Bisong; Zhang, Xiuyue] Sichuan Univ, Key Lab Bioresources & Ecoenvironm, Minist Educ, Coll Life Sci, Chengdu, Peoples R China; [Zhou, Chuang; Fan, Zhenxin; Yue, Bisong; Zhang, Xiuyue] Sichuan Univ, Sichuan Key Lab Conservat Biol Endangered Wildlif, Coll Life Sci, Chengdu, Peoples R China; [Sheng, Yongmei] Sichuan Key Lab Med Amer Cockroach, Chengdu, Peoples R China	Sichuan University; Sichuan University	Zhang, XY (corresponding author), Sichuan Univ, Key Lab Bioresources & Ecoenvironm, Minist Educ, Coll Life Sci, Chengdu, Peoples R China.; Zhang, XY (corresponding author), Sichuan Univ, Sichuan Key Lab Conservat Biol Endangered Wildlif, Coll Life Sci, Chengdu, Peoples R China.	zhangxy317@126.com			Science and Technology Project of Sichuan Province [2015SZ0036]	Science and Technology Project of Sichuan Province	The research was funded by the Science and Technology Project of Sichuan Province, 2015SZ0036 (Department of Science and Technology of Sichuan Province http://www.scst.gov.cn/). Prof. Xiuyue Zhang received the funding.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We sincerely appreciate Shilin He and Wujiao Li at Sichuan University for the sample collection. We also thank professor Timothy Moermond (University of Wisconsin-Madison) and Alexa C Privratsky (University of North Dakota) for editing the manuscript and thank the anonymous reviewers for insightful comments. The research was funded by the Science and Technology Project of Sichuan Province, 2015SZ0036.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anisyutkin LN, 2010, ENTOMOLOGICAL REV, V90, P871, DOI DOI 10.1134/S0013873810070055; Appel AG, 2002, ANNU REV ENTOMOL, V47, P33, DOI 10.1146/annurev.ento.47.091201.145106; Avise John C., 1994, pi; Ballard JWO, 2005, ANNU REV ECOL EVOL S, V36, P621, DOI 10.1146/annurev.ecolsys.36.091704.175513; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Cameron SL, 2007, GENOME, V50, P188, DOI 10.1139/G06-148; Cameron SL, 2014, ANNU REV ENTOMOL, V59, P95, DOI 10.1146/annurev-ento-011613-162007; Cameron SL, 2012, MOL PHYLOGENET EVOL, V65, P163, DOI 10.1016/j.ympev.2012.05.034; Chandra SBC, 2006, AFR J BIOTECHNOL, V5, P1308; Cheng XF, 2016, GENE, V586, P115, DOI 10.1016/j.gene.2016.03.057; CLAYTON DA, 1991, ANNU REV CELL BIOL, V7, P453, DOI 10.1146/annurev.cb.07.110191.002321; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; Djernaes M, 2015, MOL PHYLOGENET EVOL, V84, P284, DOI 10.1016/j.ympev.2014.08.019; Djernaes M, 2012, SYST ENTOMOL, V37, P65, DOI 10.1111/j.1365-3113.2011.00598.x; Dotson EM, 2001, INSECT MOL BIOL, V10, P205, DOI 10.1046/j.1365-2583.2001.00258.x; Du C, 2016, GENE, V578, P274, DOI 10.1016/j.gene.2015.12.036; Fenn JD, 2008, MOL PHYLOGENET EVOL, V49, P59, DOI 10.1016/j.ympev.2008.07.004; Grandcolas P, 1996, CAN J ZOOL, V74, P508, DOI 10.1139/z96-059; Grandcolas P, 2001, CLADISTICS, V17, P48, DOI 10.1111/j.1096-0031.2001.tb00110.x; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guthrie D., 1968, BIOL COCKROACH; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Inward D, 2007, BIOL LETTERS, V3, P331, DOI 10.1098/rsbl.2007.0102; Jeon MG, 2015, ANIM CELLS SYST, V19, P432, DOI 10.1080/19768354.2015.1105866; Kambhampati S, 1996, SYST ENTOMOL, V21, P89; KAMBHAMPATI S, 1995, P NATL ACAD SCI USA, V92, P2017, DOI 10.1073/pnas.92.6.2017; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Klass Klaus-Dieter, 2006, Entomologische Abhandlungen (Dresden), V63, P3; Kuzmenko A, 2014, BIOCHIMIE, V100, P132, DOI 10.1016/j.biochi.2013.07.024; Legendre F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130127; Lo N, 2003, MOL BIOL EVOL, V20, P907, DOI 10.1093/molbev/msg097; Lo N, 2000, CURR BIOL, V10, P801, DOI 10.1016/S0960-9822(00)00561-3; Lo N, 2007, BIOL LETTERS, V3, P327, DOI 10.1098/rsbl.2006.0614; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Maekawa K, 1999, ZOOL SCI, V16, P175, DOI 10.2108/zsj.16.175; Maekawa K, 2000, SYST ENTOMOL, V25, P511, DOI 10.1046/j.1365-3113.2000.00128.x; Mancini E, 2008, GENOME, V51, P196, DOI 10.1139/G07-116; Mao M, 2015, MOL PHYLOGENET EVOL, V84, P34, DOI 10.1016/j.ympev.2014.12.009; Nelson LA, 2012, GENE, V511, P131, DOI 10.1016/j.gene.2012.09.103; Pellens R, 2007, MOL PHYLOGENET EVOL, V43, P616, DOI 10.1016/j.ympev.2006.12.017; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rambaut A., 2009, FIGTREE; Robinson William H., 2005, P147; Roth LM, 2003, ORIENT INSECTS, V37, P1, DOI 10.1080/00305316.2003.10417344; Roth S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-50; Saito S, 2005, GENETICS, V171, P1695, DOI 10.1534/genetics.105.046243; Schultheis AS, 2002, INSECT MOL BIOL, V11, P605, DOI 10.1046/j.1365-2583.2002.00371.x; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Simon C, 2006, ANNU REV ECOL EVOL S, V37, P545, DOI 10.1146/annurev.ecolsys.37.091305.110018; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TAYLOR MFJ, 1993, MOL BIOL EVOL, V10, P1259; Tian X, 2015, MITOCHONDR DNA, V28, P1; Timmermans MJTN, 2016, GENOME BIOL EVOL, V8, P161, DOI 10.1093/gbe/evv241; Tokuda G, 2012, INSECT SOC, V59, P17, DOI 10.1007/s00040-011-0182-x; Walker FLS, 1868, CATALOGUE SPECIMENS; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064; Xiao B, 2012, CURR GENET, V58, P65, DOI 10.1007/s00294-012-0365-7; Yamauchi MM, 2004, INSECT MOL BIOL, V13, P435, DOI 10.1111/j.0962-1075.2004.00505.x; Ye F, 2016, SCI REP-UK, V6, DOI 10.1038/srep25634; Yin H, 2012, GENE, V494, P214, DOI 10.1016/j.gene.2011.12.020; Yue H, 2015, BIOCHEM SYST ECOL, V60, P123, DOI 10.1016/j.bse.2015.04.013; Zhang DX, 1997, BIOCHEM SYST ECOL, V25, P99, DOI 10.1016/S0305-1978(96)00042-7; ZHANG DX, 1995, J MOL EVOL, V40, P382, DOI 10.1007/BF00164024; Zhang YY, 2010, MOL BIOL REP, V37, P3509, DOI 10.1007/s11033-009-9944-1; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	69	6	7	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177162	10.1371/journal.pone.0177162	http://dx.doi.org/10.1371/journal.pone.0177162			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486518	gold, Green Published, Green Submitted			2022-12-26	WOS:000401314000050
J	Rico, JE; Samii, SS; Mathews, AT; Lovett, J; Haughey, NJ; McFadden, JW				Rico, J. Eduardo; Samii, Sina Saed; Mathews, Alice T.; Lovett, Jacqueline; Haughey, Norman J.; McFadden, Joseph W.			Temporal changes in sphingolipids and systemic insulin sensitivity during the transition from gestation to lactation	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; INTRAMYOCELLULAR CERAMIDE ACCUMULATION; BODY CONDITION SCORE; DAIRY-COWS; FATTY LIVER; SKELETAL-MUSCLE; LATE PREGNANCY; GLUCOSE-TOLERANCE; PLASMA CERAMIDES; MILK-PRODUCTION	Reduced insulin action develops naturally during the peripartum to ensure maternal nutrient delivery to the fetus and neonate. However, increased insulin resistance can facilitate excessive lipolysis which in turn promotes metabolic disease in overweight dairy cattle. Increased fatty acid availability favors the accumulation of the sphingolipid ceramide and is implicated in the pathogenesis of insulin resistance, however, the relationship between sphingolipid metabolism and insulin resistance during the peripartum remains largely unknown. Our objectives were to characterize temporal responses in plasma and tissue sphingolipids in lean and overweight peripartal cows and to establish the relationships between sphingolipid supply and lipolysis, hepatic lipid deposition, and systemic insulin action. Twenty-one multiparous lean and overweight Holstein cows were enrolled in a longitudinal study spanning the transition from gestation to lactation (d -21 to 21, relative to parturition). Plasma, liver, and skeletal muscle samples were obtained, and sphingolipids were profiled using LC/MS/MS. Insulin sensitivity was assessed utilizing intravenous insulin and glucose challenges. Our results demonstrated the following: first, insulin resistance develops postpartum concurrently with increased lipolysis and hepatic lipid accumulation; second, ceramides and glycosylated ceramides accumulate during the transition from gestation to lactation and are further elevated in overweight cows; third, ceramide accrual is associated with lipolysis and liver lipid accumulation, and C16: 0- and C24: 0-ceramide are inversely associated with systemic insulin sensitivity postpartum; fourth, plasma sphingomyelin, a potential source of ceramides reaches a nadir at parturition and is closely associated with feed intake; fifth, select sphingomyelins are lower in the plasma of overweight cows during the peripartal period. Our results demonstrate that dynamic changes occur in peripartal sphingolipids that are influenced by adiposity, and are associated with the onset of peripartal insulin resistance. These observations are in agreement with a putative potential role for sphingolipids in facilitating the physiological adaptations of peripartum.	[Rico, J. Eduardo; Samii, Sina Saed; Mathews, Alice T.; McFadden, Joseph W.] West Virginia Univ, Div Anim & Nutr Sci, Morgantown, WV 26506 USA; [Lovett, Jacqueline; Haughey, Norman J.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA	West Virginia University; Johns Hopkins University	McFadden, JW (corresponding author), West Virginia Univ, Div Anim & Nutr Sci, Morgantown, WV 26506 USA.	JWMcFadden@mail.wvu.edu	Samii, Sina Saed/AAO-3223-2020; Rico, Eduardo/M-6779-2019	Samii, Sina Saed/0000-0002-4218-3146; Rico, Eduardo/0000-0003-0286-1747	United States Department of Agriculture, National Institute of Food and Agriculture, Agriculture and Food Research Initiative [2014-67016-21611]	United States Department of Agriculture, National Institute of Food and Agriculture, Agriculture and Food Research Initiative(United States Department of Agriculture (USDA))	This work was supported by the United States Department of Agriculture, National Institute of Food and Agriculture, Agriculture and Food Research Initiative 2014-67016-21611, http://portal.nifa.usda.gov/web/crisprojectpages/1001895-mechanisms-mediating-insulin-resistance-in-overconditioned-dairy-cows-transitioning-from-gestation-to-lactation.html (JWM). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2004, DIABETES, V53, P25, DOI 10.2337/diabetes.53.1.25; Aerts JM, 2007, DIABETES, V56, P1341, DOI 10.2337/db06-1619; AOAC, 2000, AOAC INT OFF METH AN, V17; AOAC International, 2012, AOAC OFFICIAL METHOD; BAUMAN DE, 1980, J DAIRY SCI, V63, P1514, DOI 10.3168/jds.S0022-0302(80)83111-0; Bell AW, 1997, J MAMMARY GLAND BIOL, V2, P265, DOI 10.1023/A:1026336505343; BELL AW, 1995, J DAIRY SCI, V78, P1954, DOI 10.3168/jds.S0022-0302(95)76821-7; BELL AW, 1995, J ANIM SCI, V73, P2804, DOI 10.2527/1995.7392804x; Blouin CM, 2010, DIABETES, V59, P600, DOI 10.2337/db09-0897; Bobe G, 2004, J DAIRY SCI, V87, P3105, DOI 10.3168/jds.S0022-0302(04)73446-3; Boon J, 2013, DIABETES, V62, P401, DOI 10.2337/db12-0686; Canals D, 2011, BRIT J PHARMACOL, V163, P694, DOI 10.1111/j.1476-5381.2011.01279.x; Chapinal N, 2012, J DAIRY SCI, V95, P5676, DOI 10.3168/jds.2011-5132; Chavez JA, 2014, J BIOL CHEM, V289, P723, DOI 10.1074/jbc.M113.522847; Contreras GA, 2015, J DAIRY SCI, V98, P6176, DOI 10.3168/jds.2015-9370; Cooke RF, 2007, J DAIRY SCI, V90, P2413, DOI 10.3168/jds.2006-028; Drackley JK, 2005, ITAL J ANIM SCI, V4, P323, DOI 10.4081/ijas.2005.323; Drackley JK, 1999, J DAIRY SCI, V82, P2259, DOI 10.3168/jds.S0022-0302(99)75474-3; ELEY RM, 1978, J DAIRY SCI, V61, P467, DOI 10.3168/jds.S0022-0302(78)83622-4; Ghafourifar P, 1999, J BIOL CHEM, V274, P6080, DOI 10.1074/jbc.274.10.6080; Hall MB, 2009, J AOAC INT, V92, P42; Hanamatsu H, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.38; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Haughey NJ, 2004, ANN NEUROL, V55, P257, DOI 10.1002/ana.10828; Haus JM, 2009, DIABETES, V58, P337, DOI 10.2337/db08-1228; Hla T, 2014, CELL METAB, V20, P703, DOI 10.1016/j.cmet.2014.10.017; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; HUGHES JP, 1962, AM J VET RES, V23, P1111; Kabayama K, 2005, GLYCOBIOLOGY, V15, P21, DOI 10.1093/glycob/cwh135; Kabayama K, 2007, P NATL ACAD SCI USA, V104, P13678, DOI 10.1073/pnas.0703650104; Kasumov T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126910; Kerestes M, 2009, DOMEST ANIM ENDOCRIN, V37, P250, DOI 10.1016/j.domaniend.2009.07.003; KOLESNICK R, 1994, CELL, V77, P325, DOI 10.1016/0092-8674(94)90147-3; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Mann S, 2016, J DAIRY SCI, V99, P701, DOI 10.3168/jds.2015-9908; Mathews AT, 2016, J DAIRY SCI, V99, P8802, DOI 10.3168/jds.2016-11295; Merrill AH, 2002, J BIOL CHEM, V277, P25843, DOI 10.1074/jbc.R200009200; MORROW DA, 1976, J DAIRY SCI, V59, P1625, DOI 10.3168/jds.S0022-0302(76)84415-3; NRC (National Research Council), 2001, NUTRIENT REQUIREMENT; O'Boyle N, 2006, VET IMMUNOL IMMUNOP, V113, P297, DOI 10.1016/j.vetimm.2006.05.013; Ohtsuka H, 2001, J VET MED SCI, V63, P1021, DOI 10.1292/jvms.63.1021; Oikawa S, 2006, J DAIRY SCI, V89, P2999, DOI 10.3168/jds.S0022-0302(06)72572-3; Pagadala M, 2012, TRENDS ENDOCRIN MET, V23, P365, DOI 10.1016/j.tem.2012.04.005; Park M, 2016, J BIOL CHEM, V291, P23978, DOI 10.1074/jbc.M116.737684; Peraldi P, 1996, J BIOL CHEM, V271, P13018, DOI 10.1074/jbc.271.22.13018; Petersen MC, 2016, J PHYSIOL-LONDON, V594, P3171, DOI 10.1113/JP271677; Pires JAA, 2007, J DAIRY SCI, V90, P2735, DOI 10.3168/jds.2006-759; Powell DJ, 2003, MOL CELL BIOL, V23, P7794, DOI 10.1128/MCB.23.21.7794-7808.2003; Raichur S, 2014, CELL METAB, V20, P687, DOI 10.1016/j.cmet.2014.09.015; Rico JE, 2016, J DAIRY SCI, V99, P8817, DOI 10.3168/jds.2016-11296; Rico JE, 2015, J DAIRY SCI, V98, P7757, DOI 10.3168/jds.2015-9519; Roche JR, 2009, J DAIRY SCI, V92, P5769, DOI 10.3168/jds.2009-2431; Sordillo LM, 2013, VET CLIN N AM-FOOD A, V29, P267, DOI 10.1016/j.cvfa.2013.03.002; Starke A, 2010, J ANIM SCI, V88, P2741, DOI 10.2527/jas.2009-2599; Straczkowski M, 2007, DIABETOLOGIA, V50, P2366, DOI 10.1007/s00125-007-0781-2; Stratford S, 2004, J BIOL CHEM, V279, P36608, DOI 10.1074/jbc.M406499200; Summers SA, 2006, PROG LIPID RES, V45, P42, DOI 10.1016/j.plipres.2005.11.002; Summers SA, 1998, MOL CELL BIOL, V18, P5457, DOI 10.1128/MCB.18.9.5457; Summers SA, 2016, J PHYSIOL-LONDON, V594, P3167, DOI 10.1113/JP271676; Turpin SM, 2014, CELL METAB, V20, P678, DOI 10.1016/j.cmet.2014.08.002; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Watt MJ, 2012, DIABETOLOGIA, V55, P2741, DOI 10.1007/s00125-012-2649-3; WILDMAN EE, 1982, J DAIRY SCI, V65, P495, DOI 10.3168/jds.S0022-0302(82)82223-6; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Xia JY, 2015, CELL METAB, V22, P266, DOI 10.1016/j.cmet.2015.06.007; Zachut M, 2013, J DAIRY SCI, V96, P5656, DOI 10.3168/jds.2012-6142	66	27	27	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0176787	10.1371/journal.pone.0176787	http://dx.doi.org/10.1371/journal.pone.0176787			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486481	Green Submitted, Green Published, gold			2022-12-26	WOS:000401314000025
J	Wang, C; Dang, YL; Waxman, S; Xia, XB; Weinreb, RN; Loewen, NA				Wang, Chao; Dang, Yalong; Waxman, Susannah; Xia, Xiaobo; Weinreb, Robert N.; Loewen, Nils A.			Angle stability and outflow in dual blade ab interno trabeculectomy with active versus passive chamber management	PLOS ONE			English	Article							DIFFERENTIAL CANALOGRAMS; ANTERIOR-SEGMENT; GLAUCOMA; GONIOTOMY; OUTCOMES	Purpose To compare intraoperative angle stability and postoperative outflow of two ab interno trabeculectomy devices that excise the trabecular meshwork with or without active aspiration and irrigation. We hypothesized that anterior segment optical coherence tomography (AS-OCT) allows for a quantitative comparison of intraoperative angle stability in a microincisional glaucoma surgery (MIGS) pig eye training model. Methods Twelve freshly enucleated porcine eyes were measured with AS-OCT at baseline, at the beginning of the procedure and at its conclusion to determine the anterior chamber depth (ACD) and the nasal angle a in degrees. The right and left eye of pairs were randomly assigned to an active dual blade goniectome (aDBG) and a passive dual blade goniectome (pDBG) group, respectively. The aDBG had irrigation and aspiration ports while the pDBG required surgery under viscoelastic. We performed the procedures using our MIGS training system with a standard, motorized ophthalmic operating microscope. We estimated outflow by obtaining canalograms with fluorescent spheres. Results In aDBG, the nasal angle remained wide open during the procedure at above 90 degrees and did not change towards the end (100 +/- 10%, p = 0.9). In contrast, in pDBG, ACD decreased by 51 +/- 19% to 21% below baseline (p<0.01) while the angle progressively narrowed by 40 +/- 12% (p< 0.001). Canalograms showed a similar extent of access to the outflow tract with the aDBG and the pDBG (p = 0.513). The average increase for the aDBG in the superonasal and inferonasal quadrants was between 27 to 31% and for the pDBG between 15 to 18%. Conclusion AS-OCT demonstrated that active irrigation and aspiration improved anterior chamber maintenance and ease of handling with the aDBG in this MIGS training model. The immediate postoperative outflow was equally good with both devices.	[Wang, Chao; Dang, Yalong; Waxman, Susannah; Loewen, Nils A.] Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15261 USA; [Wang, Chao; Xia, Xiaobo] Cent S Univ, Xiangya Hosp, Dept Ophthalmol, Changsha, Hunan, Peoples R China; [Weinreb, Robert N.] Univ Calif San Diego, Shiley Eye Inst, Hamilton Glaucoma Ctr, La Jolla, CA 92093 USA; [Weinreb, Robert N.] Univ Calif San Diego, Dept Ophthalmol, La Jolla, CA 92093 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Central South University; University of California System; University of California San Diego; University of California System; University of California San Diego	Loewen, NA (corresponding author), Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15261 USA.	loewen.nils@gmail.com	Loewen, Nils/E-9946-2014; Waxman, Susannah/AAM-4636-2020; Dang, Yalong/Q-4156-2017	Loewen, Nils/0000-0001-7167-1213; Dang, Yalong/0000-0003-2194-6375; Xia, Xiaobo/0000-0002-2785-3391; Waxman, Susannah/0000-0001-6708-3187	The Initiative to Cure Glaucoma; Eye and Ear Foundation of Pittsburgh [R44 - EY 015037-02]; SBIR; Wiegand Fellowship; Eye and Ear Foundation of Pittsburgh; Third Xiangya Hospital of Central South University for studying in University of Pittsburgh School of Medicine; NATIONAL EYE INSTITUTE [K08EY022737, P30EY008098] Funding Source: NIH RePORTER	The Initiative to Cure Glaucoma; Eye and Ear Foundation of Pittsburgh; SBIR; Wiegand Fellowship; Eye and Ear Foundation of Pittsburgh; Third Xiangya Hospital of Central South University for studying in University of Pittsburgh School of Medicine; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by The Initiative to Cure Glaucoma by the Eye and Ear Foundation of Pittsburgh, R44 - EY 015037-02, SBIR grant, the Wiegand Fellowship, Eye and Ear Foundation of Pittsburgh, and an unrestricted grant from the Third Xiangya Hospital of Central South University for studying in University of Pittsburgh School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DR, 1983, OPHTHALMOLOGY, V90, P805; Arshinoff SA, 2005, J CATARACT REFR SURG, V31, P2167, DOI 10.1016/j.jcrs.2005.08.056; Baerveldt G, 2005, US Patent, Patent No. [6979328, 6979328 B2]; Bussel II, 2015, BRIT J OPHTHALMOL, V99, P914, DOI 10.1136/bjophthalmol-2014-305577; Carreon T., 2016, PROG RETIN EYE RES; Dang Y, 2017, SCI REPORTS IN PRESS; Dang Y, 2017, PEER J PREPRINTS; DRAEGER J, 1982, KLIN MONATSBL AUGENH, V180, P264, DOI 10.1055/s-2008-1055063; Duker JS, 2013, OPHTHALMOLOGY EXPERT, P1133; Fallano K, 2017, TRAINING STRATEGIES; Kaplowitz K, 2016, EXPERT REV OPHTHALMO, P1; Kaplowitz K, 2016, BRIT J OPHTHALMOL, V100, P594, DOI 10.1136/bjophthalmol-2015-307131; Kaplowitz K, 2014, BRIT J OPHTHALMOL, V98, P579, DOI 10.1136/bjophthalmol-2013-304256; Lewis RA, 2014, J CATARACT REFR SURG, V40, P1301, DOI 10.1016/j.jcrs.2014.01.032; LISTER A, 1965, BRIT J OPHTHALMOL, V49, P594, DOI 10.1136/bjo.49.11.594; Loewen RT, 2016, INVEST OPHTH VIS SCI, V57, P2831, DOI 10.1167/iovs.16-19541; Loewen RT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151754; LUNTZ MH, 1977, AM J OPHTHALMOL, V83, P174, DOI 10.1016/0002-9394(77)90612-2; Narayanaswamy A, 2010, ARCH OPHTHALMOL-CHIC, V128, P1321, DOI 10.1001/archophthalmol.2010.231; Neiweem AE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153585; Oatts JT, 2013, INVEST OPHTH VIS SCI, V54, P5416, DOI 10.1167/iovs.13-11853; Parikh HA, 2016, SCI REP-UK, V6, DOI 10.1038/srep34705; Parikh HA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149384; Pfeiffer N, 2015, OPHTHALMOLOGY, V122, P1283, DOI 10.1016/j.ophtha.2015.03.031; Quintana M, 1985, 2 EUR GLAUC S HELS M, P265; Radhakrishnan S, 2001, ARCH OPHTHALMOL-CHIC, V119, P1179, DOI 10.1001/archopht.119.8.1179; Samuelson TW, 2011, OPHTHALMOLOGY, V118, P459, DOI 10.1016/j.ophtha.2010.07.007; SooHoo JR, 2015, MIDDLE EAST AFR J OP, V22, P25, DOI 10.4103/0974-9233.148345; Sorensen JT, 2015, US Patent, Patent No. [20150297400A1, 20150297400]; Vold S, 2016, OPHTHALMOLOGY; Yeung HH, 2016, PEARLS GLAUCOMA MANA, P487	31	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177238	10.1371/journal.pone.0177238	http://dx.doi.org/10.1371/journal.pone.0177238			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486513	gold, Green Submitted, Green Published			2022-12-26	WOS:000401314000062
J	Chang, CC; Hsu, HJ; Yen, JH; Lo, SY; Liou, JW				Chang, Chun-Chun; Hsu, Hao-Jen; Yen, Jui-Hung; Lo, Shih-Yen; Liou, Je-Wen			A Sequence in the loop domain of hepatitis C virus E2 protein identified in silico as crucial for the selective binding to human CD81	PLOS ONE			English	Article							LARGE EXTRACELLULAR LOOP; ENVELOPE GLYCOPROTEIN; VIRAL ENTRY; NEUTRALIZING ANTIBODIES; STRUCTURE PREDICTION; ANTIVIRAL THERAPY; INFECTION; RECEPTOR; ESCAPE; HCV	Hepatitis C virus (HCV) is a species-specific pathogenic virus that infects only humans and chimpanzees. Previous studies have indicated that interactions between the HCV E2 protein and CD81 on host cells are required for HCV infection. To determine the crucial factors for species-specific interactions at the molecular level, this study employed in silico molecular docking involving molecular dynamic simulations of the binding of HCV E2 onto human and rat CD81s. In vitro experiments including surface plasmon resonance measurements and cellular binding assays were applied for simple validations of the in silico results. The in silico studies identified two binding regions on the HCV E2 loop domain, namely E2-site1 and E2-site2, as being crucial for the interactions with CD81s, with the E2-site2 as the determinant factor for human-specific binding. Free energy calculations indicated that the E2/CD81 binding process might follow a two-step model involving (i) the electrostatic interaction-driven initial binding of human-specific E2-site2, followed by (ii) changes in the E2 orientation to facilitate the hydrophobic and van der Waals interaction-driven binding of E2-site1. The sequence of the human-specific, stronger-binding E2-site2 could serve as a candidate template for the future development of HCV-inhibiting peptide drugs.	[Chang, Chun-Chun; Liou, Je-Wen] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan; [Chang, Chun-Chun] Dept Lab Med, Tzu Chi Med Ctr, Hualien, Taiwan; [Hsu, Hao-Jen] Tzu Chi Univ, Dept Life Sci, Hualien, Taiwan; [Yen, Jui-Hung] Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan; [Lo, Shih-Yen] Tzu Chi Univ, Dept Lab Med & Biotechnol, Hualien, Taiwan; [Liou, Je-Wen] Tzu Chi Univ, Dept Biochem, Sch Med, Hualien, Taiwan	Tzu Chi University; Buddhist Tzu Chi General Hospital; Tzu Chi University; Tzu Chi University; Tzu Chi University; Tzu Chi University	Liou, JW (corresponding author), Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan.; Liou, JW (corresponding author), Tzu Chi Univ, Dept Biochem, Sch Med, Hualien, Taiwan.	jwliou@mail.tcu.edu.tw	Hsu, Hao-Jen/ABE-3718-2020; Liou, Je-Wen/ABB-2157-2020	Liou, Je-Wen/0000-0002-6181-7263	Tzu Chi University [TCIRP 103002-01]; Tzu Chi Medical Center, Hualien, Taiwan [TCRD 105-34]	Tzu Chi University; Tzu Chi Medical Center, Hualien, Taiwan	This work is supported by Tzu Chi University (TCIRP 103002-01, http://www.tcu.edu.tw/) and Tzu Chi Medical Center, Hualien, Taiwan (TCRD 105-34, http://hlm.tzuchi.com.tw/).	Al Olaby RR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111333; Alhammad YMO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126397; Au JS, 2014, CLIN PHARMACOL THER, V95, P78, DOI 10.1038/clpt.2013.206; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; Bertaux C, 2006, J VIROL, V80, P4940, DOI 10.1128/JVI.80.10.4940-4948.2006; Bitzegeio J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000978; Chen R, 2003, PROTEINS, V51, P397, DOI 10.1002/prot.10334; Colpitts CC, 2016, HEPATOL INT, V10, P741, DOI 10.1007/s12072-016-9724-7; Dorner M, 2013, NATURE, V501, P237, DOI 10.1038/nature12427; Dorner M, 2011, NATURE, V474, P208, DOI 10.1038/nature10168; Drummer HE, 2002, J VIROL, V76, P11143, DOI 10.1128/JVI.76.21.11143-11147.2002; Drummer HE, 2006, J VIROL, V80, P7844, DOI 10.1128/JVI.00029-06; Fafi-Kremer S, 2010, J EXP MED, V207, P2019, DOI 10.1084/jem.20090766; Fauvelle C, 2013, MICROB PATHOGENESIS, V58, P66, DOI 10.1016/j.micpath.2013.02.005; Feneant L, 2014, VIRUSES-BASEL, V6, P535, DOI 10.3390/v6020535; Flint M, 1999, J VIROL, V73, P6235, DOI 10.1128/JVI.73.8.6235-6244.1999; Flint M, 2006, J VIROL, V80, P11331, DOI 10.1128/JVI.00104-06; Forns X, 2000, VIROLOGY, V274, P75, DOI 10.1006/viro.2000.0419; Ginalski K, 2006, CURR OPIN STRUC BIOL, V16, P172, DOI 10.1016/j.sbi.2006.02.003; Higginbottom A, 2000, J VIROL, V74, P3642, DOI 10.1128/JVI.74.8.3642-3649.2000; Houldsworth A, 2014, J MED VIROL, V86, P162, DOI 10.1002/jmv.23726; Jiang SJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep18638; Keck ZY, 2008, J VIROL, V82, P6067, DOI 10.1128/JVI.00252-08; Keck ZY, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004297; Keck ZY, 2011, J VIROL, V85, P10451, DOI 10.1128/JVI.05259-11; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Khan AG, 2014, NATURE, V509, P381, DOI 10.1038/nature13117; Kitadokoro K, 2002, BIOL CHEM, V383, P1447, DOI 10.1515/BC.2002.164; Kitadokoro K, 2001, EMBO J, V20, P12, DOI 10.1093/emboj/20.1.12; Kong L, 2013, SCIENCE, V342, P1090, DOI 10.1126/science.1243876; Krey T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003364; Kumari R, 2014, J CHEM INF MODEL, V54, P1951, DOI 10.1021/ci500020m; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698; Lindenbach BD, 2013, NAT REV MICROBIOL, V11, P688, DOI 10.1038/nrmicro3098; Liou JC, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-1; Meyer K, 2015, SCI REP-UK, V5, DOI 10.1038/srep09012; Owsianka A, 2001, J GEN VIROL, V82, P1877, DOI 10.1099/0022-1317-82-8-1877; Owsianka AM, 2008, J GEN VIROL, V89, P653, DOI 10.1099/vir.0.83386-0; Owsianka AM, 2006, J VIROL, V80, P8695, DOI 10.1128/JVI.00271-06; Pawlotsky JM, 2014, ANTIVIR RES, V105, P22, DOI 10.1016/j.antiviral.2014.02.008; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Rocha-Perugini V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001866; Rothwang KB, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-46; Rupp D, 2014, SEMIN LIVER DIS, V34, P9, DOI 10.1055/s-0034-1371006; Schneider MD, 2014, ANTIVIR RES, V105, P64, DOI 10.1016/j.antiviral.2014.02.011; von Hahn T, 2008, J BIOL CHEM, V283, P3689, DOI 10.1074/jbc.R700024200; Wasitthankasem R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149362; Wunschmann S, 2000, J VIROL, V74, P10055, DOI 10.1128/JVI.74.21.10055-10062.2000; Xiao F, 2015, GUT, V64, P483, DOI 10.1136/gutjnl-2013-306155; Zeisel MB, 2007, HEPATOLOGY, V46, P1722, DOI 10.1002/hep.21994; Zhao Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084346; Zhu YZ, 2014, WORLD J GASTROENTERO, V20, P3457, DOI 10.3748/wjg.v20.i13.3457; Zona L, 2014, VIRUSES-BASEL, V6, P875, DOI 10.3390/v6020875	54	9	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177383	10.1371/journal.pone.0177383	http://dx.doi.org/10.1371/journal.pone.0177383			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481946	gold, Green Published, Green Submitted			2022-12-26	WOS:000401313700057
J	Jaffe, A; Giveon, S; Wulffhart, L; Oberman, B; Baidousi, M; Ziv, A; Kalter-Leibovici, O				Jaffe, Anat; Giveon, Shmuel; Wulffhart, Liat; Oberman, Bernice; Baidousi, Maslama; Ziv, Arnona; Kalter-Leibovici, Ofra			Adult Arabs have higher risk for diabetes mellitus than Jews in Israel	PLOS ONE			English	Article							POPULATION; PREVALENCE	Objective Diabetes mellitus is an emerging epidemic in the Arab world. Although high diabetes prevalence is documented in Israeli Arabs, information from cohort studies is scant. Methods This is a population study, based on information derived between 2007-2011, from the electronic database of the largest health fund in Israel, among Arabs and Jews. Prevalence, 4-year- incidence and diabetes hazard ratios [HRs], adjusted for sex and the metabolic-syndrome [MetS]-components, were determined in 3 age groups (<50 years, 50-59 years, and >= 60 years). Results The study cohort included 17,044 Arabs (males: 49%, age: 39.4 +/- 17.3) and 16,012 Jews (males: 50%, age: 40.5 +/- 17.6). The overall age and sex-adjusted diabetes prevalence rates were much higher among Arabs 18.4% (95% CI: 17.6-19.1); and 10.3% (95% CI: 9.7-10.9) among Jews. Arab females had higher prevalence rates 20.0% (95% CI: 19-21) than Arab males 16.7% (95% CI: 15.7-17.8). Annual incidence rates were also significantly higher among Arabs 2.9% (95% CI: 2.7-3.1) than among Jews 1.7% (95% CI: 1.6-1.8). This held true across all age and sex subgroups. Adjustment for body mass index [BMI] attenuated HR estimates associated with Arab ethnicity across all age subgroups, mainly in the <50yrs age group from HR 2.04 (95% CI: 1.74-2.40) to 1.64 (95% CI: 1.40-1.92). BMI at incident diabetes among females was higher in Arabs than Jews. Males, however, did not differ by ethnicity. Conclusion Arabs, mainly female, have high incidence and prevalence of diabetes. This excess risk is only partially explained by the high prevalence of obesity. Effective culturally-congruent diabetes prevention and treatment and an effective engagement partnership with the Arab community are of paramount need.	[Jaffe, Anat; Baidousi, Maslama] Hillel Yaffe Med Ctr, Endocrinol & Diabet Unit, Hadera, Israel; [Giveon, Shmuel] Clalit Hlth Serv, Tel Aviv, Israel; [Giveon, Shmuel] Tel Aviv Univ, Dept Family Med, Tel Aviv, Israel; [Wulffhart, Liat; Oberman, Bernice] Sheba Med Ctr, Gertner Inst Epidemiol & Hlth Policy Res, Unit Biostat, Ramat Gan, Israel; [Ziv, Arnona] Sheba Med Ctr, Gertner Inst Epidemiol & Hlth Policy Res, Informat & Comp Unit, Ramat Gan, Israel; [Kalter-Leibovici, Ofra] Sheba Med Ctr, Gertner Inst Epidemiol & Hlth Policy Res, Unit Cardiovasc Epidemiol, Ramat Gan, Israel; [Kalter-Leibovici, Ofra] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel	Clalit Health Services; Tel Aviv University; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Jaffe, A (corresponding author), Hillel Yaffe Med Ctr, Endocrinol & Diabet Unit, Hadera, Israel.	anatjaffe@gmail.com		Jaffe, Anat/0000-0003-3976-0923				Abu-Rmeileh NME, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001061; Abu-Saad K, 2012, J NUTR, V142, P2175, DOI 10.3945/jn.112.166611; Ajlouni K, 2008, J DIABETES COMPLICAT, V22, P317, DOI 10.1016/j.jdiacomp.2007.01.004; Al-Mahroos F, 1998, DIABETES CARE, V21, P936, DOI 10.2337/diacare.21.6.936; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Badran M, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/902873; Baron-Epel O, 2009, SOC SCI MED, V69, P1460, DOI 10.1016/j.socscimed.2009.08.028; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Daoud N, 2008, WOMEN HEALTH, V48, P145, DOI 10.1080/03630240802313530; Di Cesare M, 2013, LANCET, V381, P585, DOI 10.1016/S0140-6736(12)61851-0; Israel Central Bureau of Statistics, 65 IND DAY; Israeli Center of Disease Control, 2003, MABAT 1 ISR NAT HLTH; Jaber LA, 2003, DIABETES CARE, V26, P2010, DOI 10.2337/diacare.26.7.2010; Kalter-Leibovici O, 2012, DIABETIC MED, V29, P748, DOI 10.1111/j.1464-5491.2011.03516.x; Kalter-Leibovici O, 2007, ISR MED ASSOC J, V9, P525; Lysy Z, 2013, DIABETES RES CLIN PR, V99, P372, DOI 10.1016/j.diabres.2012.12.005; Ma YS, 2012, DIABETES CARE, V35, P2226, DOI 10.2337/dc12-0412; Malik M, 2005, DIABETES RES CLIN PR, V69, P188, DOI 10.1016/j.diabres.2004.12.005; Motlagh B, 2009, EUR J CARDIOV PREV R, V16, P268, DOI 10.1097/HJR.0b013e328322ca1b; Pinelli NR, 2011, ETHNIC DIS, V21, P480; Saabneh AM, 2016, EUR J PUBLIC HEALTH, V26, P433, DOI 10.1093/eurpub/ckv211; Shalaby S, 2015, WORLD J DIABETES, V6, P304, DOI 10.4239/wjd.v6.i2.304; Yitzhaki S., 2010, ISRAEL FIGURES 2010	23	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0176661	10.1371/journal.pone.0176661	http://dx.doi.org/10.1371/journal.pone.0176661			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UJ	28481942	Green Submitted, Green Published, gold			2022-12-26	WOS:000401313700013
J	Pantin-Jackwood, MJ; Stephens, CB; Bertran, K; Swayne, DE; Spackman, E				Pantin-Jackwood, Mary J.; Stephens, Christopher B.; Bertran, Kateri; Swayne, David E.; Spackman, Erica			The pathogenesis of H7N8 low and highly pathogenic avian influenza viruses from the United States 2016 outbreak in chickens, turkeys and mallards	PLOS ONE			English	Article							DUCKS; INFECTIONS; ADAPTATION; SUBTYPE; POULTRY; US	In January 2016, a combined outbreak of highly pathogenic (HP) avian influenza virus (AIV) and low pathogenicity (LP) AIV occurred in commercial turkeys in the state of Indiana, United States. Genetically, the viruses were highly similar, belonged to the North American wild bird lineage, and had not been previously detected in poultry. In order to understand the pathobiology of the H7N8 LPAIV and HPAIV, infectivity, transmission and pathogenicity studies were conducted in chickens, turkeys, and mallards. Among the three species the lowest mean infectious dose for both the LP and HP phenotype was for turkeys, and also disease from the LPAIV was only observed with turkeys. Furthermore, although the HPAIV was lethal for both chickens and turkeys, clinical signs caused by the HPAIV isolate differed between the two species; neurological signs were only observed in turkeys. Mallards could be infected with and transmit both viruses to contacts, but neither caused clinical disease. Interestingly, with all three species, the mean infectious dose of the HP isolate was at least ten times lower than that of the LP isolate. This study corroborates the high susceptibility of turkeys to AIV as well as a pathobiology that is different from chickens. Further, this study demonstrates that mallards can be asymptomatically infected with HP and LP AIV from gallinaceous poultry and may not just be involved in transmitting AIV to them.	[Pantin-Jackwood, Mary J.; Stephens, Christopher B.; Bertran, Kateri; Swayne, David E.; Spackman, Erica] ARS, Exot & Emerging Avian Viral Dis Unit, Southeast Poultry Res Lab, US Natl Poultry Res Ctr,USDA, Athens, GA 30602 USA	United States Department of Agriculture (USDA)	Spackman, E (corresponding author), ARS, Exot & Emerging Avian Viral Dis Unit, Southeast Poultry Res Lab, US Natl Poultry Res Ctr,USDA, Athens, GA 30602 USA.	Erica.Spackman@ARS.USDA.gov	Bertran, Kateri/H-3458-2019; Swayne, David/AAP-7166-2020	Bertran, Kateri/0000-0002-6920-4154; Spackman, Erica/0000-0002-4935-2360; Swayne, David/0000-0001-7472-1992; Pantin-Jackwood, Mary J./0000-0003-0414-213X				ALEXANDER DJ, 1986, AVIAN PATHOL, V15, P647, DOI 10.1080/03079458608436328; Bardakcioglu D., 2013, DIS POULTRY, V13, P181, DOI DOI 10.1002/9781119421481; Bertran K, 2016, VIROLOGY, V494, P190, DOI 10.1016/j.virol.2016.04.019; Bonfanti L, 2014, VET REC, V174, DOI 10.1136/vr.102202corr1; Bowes VA, 2004, AVIAN DIS, V48, P928, DOI 10.1637/7218-060304R; Dargatz D, 2016, AVIAN DIS, V60, P467, DOI 10.1637/11350-121715-Reg; Das A, 2009, J VET DIAGN INVEST, V21, P771, DOI 10.1177/104063870902100603; DeJesus E, 2016, VIROLOGY, V499, P52, DOI 10.1016/j.virol.2016.08.036; Donatelli I, 2001, J GEN VIROL, V82, P623, DOI 10.1099/0022-1317-82-3-623; HOMME PJ, 1970, AVIAN DIS, V14, P240, DOI 10.2307/1588468; KARUNAKARAN D, 1988, AVIAN DIS, V32, P319, DOI 10.2307/1590820; Killian ML, 2016, GENOME ANNOUNC, V4; KLEVEN S H, 1970, Avian Diseases, V14, P153, DOI 10.2307/1588566; Morales Jr AC, AVIAN DIS; OIE, 2016, MAN DIAGN TESTS VACC; Pantin-Jackwood MJ, 2007, AVIAN DIS, V51, P250, DOI 10.1637/7710-090606R.1; Pantin-Jackwood MJ, 2016, J VIROL, V90, P9967, DOI 10.1128/JVI.01165-16; Pantin-Jackwood MJ, 2014, METHODS MOL BIOL, V1161, P51, DOI 10.1007/978-1-4939-0758-8_5; Pantin-Jackwood MJ, 2016, J VIROL; Pedersen JC, 2014, METHODS MOL BIOL, V1161, P11, DOI 10.1007/978-1-4939-0758-8_2; Pillai SPS, 2010, ARCH VIROL, V155, P1439, DOI 10.1007/s00705-010-0727-8; RANCK F M JR, 1970, Avian Diseases, V14, P54, DOI 10.2307/1588556; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reid SM, 2016, AVIAN DIS, V60, P126, DOI 10.1637/11356-122315-Case.1; Spackman E, 2016, BMC VET RES, P12; Spackman E, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0890-6; Spackman E, 2015, VIROLOGY, V477, P72, DOI 10.1016/j.virol.2015.01.013; Spackman E, 2014, METHODS MOL BIOL, V1161, P125, DOI 10.1007/978-1-4939-0758-8_12; Spackman E, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-331; Swayne DE, 2008, AVIAN DIS, V52, P455, DOI 10.1637/8229-012508-Reg.1; Swayne DE, 2008, AVIAN DIS; Swayne DE., 2008, AVIAN INFLUENZA, V1, P87, DOI 10.1002/9780813818634.ch5; USDA APHIS, 2015, EP OTH AN HPAI AFF P; Van der Goot JA, 2003, EPIDEMIOL INFECT, V131, P1003, DOI 10.1017/S0950268803001067; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Xu Y, 2017, J VIROL, V91, DOI [10.1128/JVI.02208-16, 10.1128/jvi.02208-16]; Zanella A, 2001, AVIAN DIS, V45, P257, DOI 10.2307/1593038; Ziegler AF, 1999, AVIAN DIS, V43, P142, DOI 10.2307/1592774	38	35	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177265	10.1371/journal.pone.0177265	http://dx.doi.org/10.1371/journal.pone.0177265			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481948	Green Published, Green Submitted, gold			2022-12-26	WOS:000401313700045
J	Ramke, J; Palagyi, A; Jordan, V; Petkovic, J; Gilbert, CE				Ramke, Jacqueline; Palagyi, Anna; Jordan, Vanessa; Petkovic, Jennifer; Gilbert, Clare E.			Using the STROBE statement to assess reporting in blindness prevalence surveys in low and middle income countries	PLOS ONE			English	Article							COMPLETENESS; EPIDEMIOLOGY; GUIDELINES; JOURNALS; QUALITY; TRIALS	Objective Cross-sectional blindness prevalence surveys are essential to plan and monitor eye care services. Incomplete or inaccurate reporting can prevent effective translation of research findings. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement is a 32 item checklist developed to improve reporting of observational studies. The aim of this study was to assess the completeness of reporting in blindness prevalence surveys in low and middle income countries (LMICs) using STROBE. Methods MEDLINE, EMBASE and Web of Science databases were searched on April 8 2016 to identify cross-sectional blindness prevalence surveys undertaken in LMICs and published after STROBE was published in December 2007. The STROBE tool was applied to all included studies, and each STROBE item was categorized as 'yes' (met criteria), 'no' (did not meet criteria) or 'not applicable'. The 'Completeness of reporting (COR) score' for each manuscript was calculated: COR score = yes / [yes + no]. In journals with included studies the instructions to authors and reviewers were checked for reference to STROBE. Results The 89 included studies were undertaken in 32 countries and published in 37 journals. The mean COR score was 60.9% (95% confidence interval [CI] 58.1-63.7%; range 30.8-88.9%). The mean COR score did not differ between surveys published in journals with author instructions referring to STROBE (10/37 journals; 61.1%, 95% CI 56.4-65.8%) or in journals where STROBE was not mentioned (60.9%, 95% CI 57.4-64.3%; p = 0.93). Conclusion While reporting in blindness prevalence surveys is strong in some areas, others need improvement. We recommend that more journals adopt the STROBE checklist and ensure it is used by authors and reviewers.	[Ramke, Jacqueline] Univ Auckland, Sch Populat Hlth, Fac Med & Hlth Sci, Auckland, New Zealand; [Palagyi, Anna] Univ Sydney, George Inst Global Hlth, Sydney Med Sch, Sydney, NSW, Australia; [Jordan, Vanessa] Univ Auckland, Dept Obstet & Gynaecol, Fac Med & Hlth Sci, Auckland, New Zealand; [Petkovic, Jennifer] Univ Ottawa, Bruyere Res Inst, Ottawa, ON, Canada; [Gilbert, Clare E.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Int Ctr Eye Hlth, Clin Res Unit, London, England	University of Auckland; George Institute for Global Health; University of Sydney; University of Auckland; University of Ottawa; University of London; London School of Hygiene & Tropical Medicine	Ramke, J (corresponding author), Univ Auckland, Sch Populat Hlth, Fac Med & Hlth Sci, Auckland, New Zealand.	jramke@gmail.com	Ramke, Jacqueline/I-8844-2019; Palagyi, Anna/AAB-5634-2022	Ramke, Jacqueline/0000-0002-5764-1306; Palagyi, Anna/0000-0002-8127-9351				Bastuji-Garin S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064733; Bourne R, 2013, OPHTHAL EPIDEMIOL, V20, P33, DOI 10.3109/09286586.2012.741279; Cobo E, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6783; da Costa BR, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2010-000048; Ebrahim S, 2007, INT J EPIDEMIOL, V36, P946, DOI 10.1093/ije/dym185; Furtado JM, 2012, SURV OPHTHALMOL, V57, P149, DOI 10.1016/j.survophthal.2011.07.002; Hoy D, 2012, J CLIN EPIDEMIOL, V65, P934, DOI 10.1016/j.jclinepi.2011.11.014; Institute of Social and Preventive Medicine, 2009, TRANSL STROBE STAT 2; International Centre for Eye Health, RAP ASS AV BLINDN 20; Kuper Hannah, 2006, Community Eye Health, V19, P68; Morissette K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000025.pub2; Murthy GV, 2012, EPIDEMIOLOGY EYE DIS; Parsons NR, 2011, J BONE JOINT SURG BR, V93B, P1154, DOI 10.1302/0301-620X.93B9.27193; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; Sorensen AA, 2013, J HAND SURG-AM, V38A, P1584, DOI 10.1016/j.jhsa.2013.05.008; Stevens A, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3804; Stevens GA, 2013, OPHTHALMOLOGY, V120, P2377, DOI 10.1016/j.ophtha.2013.05.025; The PLOS Medicine Editors, 2014, PLOS MED, V11; Turner L, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-60; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; World Bank, 2014, COUNTR EC 2014; World Health Organization, 2012, WHO STRAT RES HLTH; World Health Organization, 2013, UN EYE HLTH GLOB ACT	23	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0176178	10.1371/journal.pone.0176178	http://dx.doi.org/10.1371/journal.pone.0176178			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481888	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000401313700007
J	Schutte, I; Slagter, HA; Collins, AGE; Frank, MJ; Kenemans, JL				Schutte, Iris; Slagter, Heleen A.; Collins, Anne G. E.; Frank, Michael J.; Kenemans, J. Leon			Stimulus discriminability may bias value-based probabilistic learning	PLOS ONE			English	Article							DECISION-MAKING; PARKINSONS-DISEASE; DOPAMINE; REWARD; NEUROBIOLOGY; SIGNALS; DISSOCIATION; DYSFUNCTION; MEDICATION; DISORDERS	Reinforcement learning tasks are often used to assess participants' tendency to learn more from the positive or more from the negative consequences of one's action. However, this assessment often requires comparison in learning performance across different task conditions, which may differ in the relative salience or discriminability of the stimuli associated with more and less rewarding outcomes, respectively. To address this issue, in a first set of studies, participants were subjected to two versions of a common probabilistic learning task. The two versions differed with respect to the stimulus (Hiragana) characters associated with reward probability. The assignment of character to reward probability was fixed within version but reversed between versions. We found that performance was highly influenced by task version, which could be explained by the relative perceptual discriminability of characters assigned to high or low reward probabilities, as assessed by a separate discrimination experiment. Participants were more reliable in selecting rewarding characters that were more discriminable, leading to differences in learning curves and their sensitivity to reward probability. This difference in experienced reinforcement history was accompanied by performance biases in a test phase assessing ability to learn from positive vs. negative outcomes. In a subsequent large-scale web-based experiment, this impact of task version on learning and test measures was replicated and extended. Collectively, these findings imply a key role for perceptual factors in guiding reward learning and underscore the need to control stimulus discriminability when making inferences about individual differences in reinforcement learning.	[Schutte, Iris; Kenemans, J. Leon] Univ Utrecht, Helmholtz Inst, Dept Expt Psychol & Psychopharmacol, Utrecht, Netherlands; [Slagter, Heleen A.] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Slagter, Heleen A.] Univ Amsterdam, ABC, Amsterdam, Netherlands; [Collins, Anne G. E.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Dept Psychol, Berkeley, CA 94720 USA; [Frank, Michael J.] Brown Univ, Brown Inst Brain Sci, Dept Cognit Linguist & Psychol Sci, Providence, RI 02912 USA	Utrecht University; University of Amsterdam; University of Amsterdam; University of California System; University of California Berkeley; Brown University	Schutte, I (corresponding author), Univ Utrecht, Helmholtz Inst, Dept Expt Psychol & Psychopharmacol, Utrecht, Netherlands.	i.schutte@uu.nl	Slagter, Heleen/ABF-1338-2020; Schutte, Iris/AAN-8455-2020	Slagter, Heleen/0000-0002-4180-1483; 	Netherlands Organization for Scientific Research [404-10-318]; National Science Foundation (NSF) [1460604]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); National Science Foundation (NSF)(National Science Foundation (NSF))	Experiment 1 and 2 were supported by a grant from the Netherlands Organization for Scientific Research awarded to LK (grant nr: 404-10-318). Experiment 3 was supported by a grant from the National Science Foundation awarded to MF (NSF grant, nr 1460604). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Bodi N, 2009, BRAIN, V132, P2385, DOI 10.1093/brain/awp094; Cavanagh JF, 2014, J EXP PSYCHOL GEN, V143, P1476, DOI 10.1037/a0035813; Cavanagh JF, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00331; Cockburn J, 2014, NEURON, V83, P551, DOI 10.1016/j.neuron.2014.06.035; Cools R, 2006, NEUROPSYCHOLOGIA, V44, P1663, DOI 10.1016/j.neuropsychologia.2006.03.030; Cools R, 2009, J NEUROSCI, V29, P1538, DOI 10.1523/JNEUROSCI.4467-08.2009; Cox SML, 2015, NEUROIMAGE, V109, P95, DOI 10.1016/j.neuroimage.2014.12.070; Crump MJC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057410; Doll BB, 2011, J NEUROSCI, V31, P6188, DOI 10.1523/JNEUROSCI.6486-10.2011; Ernst M, 2006, PSYCHOL MED, V36, P299, DOI 10.1017/S0033291705005891; FABIANI M, 1986, PSYCHOPHYSIOLOGY, V23, P298, DOI 10.1111/j.1469-8986.1986.tb00636.x; Frank MJ, 2007, SCIENCE, V318, P1309, DOI 10.1126/science.1146157; Frank MJ, 2007, P NATL ACAD SCI USA, V104, P16311, DOI 10.1073/pnas.0706111104; Frank MJ, 2005, NEURON, V47, P495, DOI 10.1016/j.neuron.2005.06.020; Gillan CM, 2016, NEURON, V91, P19, DOI 10.1016/j.neuron.2016.06.002; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Grillon C, 2002, BIOL PSYCHIAT, V52, P958, DOI 10.1016/S0006-3223(02)01665-7; Grundler TOJ, 2009, NEUROPSYCHOLOGIA, V47, P1978, DOI 10.1016/j.neuropsychologia.2009.03.010; HUNT RR, 1995, PSYCHON B REV, V2, P105, DOI 10.3758/BF03214414; IMAI S, 1965, J EXP PSYCHOL, V69, P596, DOI 10.1037/h0021980; Jocham G, 2011, J NEUROSCI, V31, P1606, DOI 10.1523/JNEUROSCI.3904-10.2011; Kiss M, 2007, J COGNITIVE NEUROSCI, V19, P1316, DOI 10.1162/jocn.2007.19.8.1316; Klein TA, 2007, SCIENCE, V318, P1642, DOI 10.1126/science.1145044; Lou B, 2015, J NEUROSCI, V35, P13064, DOI 10.1523/JNEUROSCI.1601-15.2015; LUBOW RE, 1973, PSYCHOL BULL, V79, P398, DOI 10.1037/h0034425; Maltzman I., 1979, ORIENTING REFLEX HUM, P323; Manil S, 2013, NEUROPSYCHOLOGIA, V51, P818, DOI 10.1016/j.neuropsychologia.2013.02.003; Navalpakkam V, 2010, P NATL ACAD SCI USA, V107, P5232, DOI 10.1073/pnas.0911972107; Palminteri S, 2009, P NATL ACAD SCI USA, V106, P19179, DOI 10.1073/pnas.0904035106; Piray P, 2014, J NEUROSCI, V34, P7814, DOI 10.1523/JNEUROSCI.4063-13.2014; Polania R, 2014, NEURON, V82, P709, DOI 10.1016/j.neuron.2014.03.014; SCHMAJUK NA, 1992, PSYCHOL REV, V99, P268, DOI 10.1037/0033-295X.99.2.268; Schonberg T, 2007, J NEUROSCI, V27, P12860, DOI 10.1523/JNEUROSCI.2496-07.2007; Smith PL, 2004, TRENDS NEUROSCI, V27, P161, DOI 10.1016/j.tins.2004.01.006; Thorndike EL, 1927, AM J PSYCHOL, V39, P212, DOI 10.2307/1415413; Waltz JA, 2007, BIOL PSYCHIAT, V62, P756, DOI 10.1016/j.biopsych.2006.09.042	36	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0176205	10.1371/journal.pone.0176205	http://dx.doi.org/10.1371/journal.pone.0176205			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UJ	28481915	gold, Green Published, Green Submitted			2022-12-26	WOS:000401313700008
J	Xin, B; Yamamoto, M; Fujii, K; Ooshio, T; Chen, X; Okada, Y; Watanabe, K; Miyokawa, N; Furukawa, H; Nishikawa, Y				Xin, B.; Yamamoto, M.; Fujii, K.; Ooshio, T.; Chen, X.; Okada, Y.; Watanabe, K.; Miyokawa, N.; Furukawa, H.; Nishikawa, Y.			Critical role of Myc activation in mouse hepatocarcinogenesis induced by the activation of AKT and RAS pathways	ONCOGENE			English	Article							C-MYC; HEPATOCELLULAR-CARCINOMA; SLEEPING-BEAUTY; IN-VIVO; SOMATIC INTEGRATION; TRANSPOSON SYSTEM; N-RAS; CANCER; CELLS; MICE	MYC activation at modest levels has been frequently found in hepatocellular carcinoma. However, its significance in hepatocarcinogenesis has remained obscure. Here we examined the role of Myc activation in mouse liver tumours induced by hepatocytic expression of myristoylated AKT (AKT) and/or mutant HRAS(V12) (HRAS) via transposon-mediated gene integration. AKT or HRAS alone required 5 months to induce liver tumours, whereas their combination generated hepatocellular carcinoma within 8 weeks. Co-introduction of AKT and HRAS induced lipid-laden preneoplastic cells that grew into nodules composed of tumour cells with or without intracytoplasmic lipid, with the latter being more proliferative and associated with spontaneous Myc expression. AKT/HRAS-induced tumorigenesis was almost completely abolished when MadMyc, a competitive Myc inhibitor, was expressed simultaneously. The Tet-On induction of MadMyc in preneoplastic cells significantly inhibited the progression of AKT/HRAS-induced tumours; its induction in transformed cells suppressed their proliferative activity with alterations in lipid metabolism and protein translation. Transposon-mediated Myc overexpression facilitated tumorigenesis by AKT or HRAS, and when it was co-introduced with AKT and HRAS, diffusely infiltrating tumours without lipid accumulation developed as early as 2 weeks. Examination of the dose-responses of Myc in the enhancement of AKT/HRAS-induced tumorigenesis revealed that a reduction to one-third retained enhancing effect but three-times greater introduction damped the process with increased apoptosis. Myc overexpression suppressed the mRNA expression of proteins involved in the synthesis of fatty acids, and when combined with HRAS introduction, it also suppressed the mRNA expression of proteins involved in their degradation. Finally, the MYC-positive human hepatocellular carcinoma was characterized by the cytoplasm devoid of lipid accumulation, prominent nucleoli and a higher proliferative activity. Our results demonstrate that in hepatocarcinogenesis induced by both activated AKT and HRAS, activation of endogenous Myc is an enhancing factor and adequate levels of Myc deregulation further facilitate the process with alterations in cellular metabolism.	[Xin, B.; Yamamoto, M.; Fujii, K.; Ooshio, T.; Chen, X.; Okada, Y.; Watanabe, K.; Nishikawa, Y.] Asahikawa Med Univ, Dept Pathol, Div Tumor Pathol, Higashi 2-1-1-1, Asahikawa, Hokkaido 0788510, Japan; [Watanabe, K.; Furukawa, H.] Asahikawa Med Univ, Dept Surg, Div Gastroenterol & Gen Surg, Asahikawa, Hokkaido, Japan; [Miyokawa, N.] Asahikawa Med Univ, Dept Surg Pathol, Asahikawa, Hokkaido, Japan	Asahikawa Medical College; Asahikawa Medical College; Asahikawa Medical College	Nishikawa, Y (corresponding author), Asahikawa Med Univ, Dept Pathol, Div Tumor Pathol, Higashi 2-1-1-1, Asahikawa, Hokkaido 0788510, Japan.	nishikwa@asahikawa-med.ac.jp		Xin, Bing/0000-0002-8644-2429	Ministry of Education, Culture, Sports, Science, and Technology of Japan [26870025, 18590362, 21590426, 24390092]; Grants-in-Aid for Scientific Research [15K15107] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (#26870025 to MY; #18590362, #21590426 and #24390092 to YN). We thank Mr Yoshiyasu Satake for animal care and Ms Ema Yamatomi, Ms Hiroko Chiba, and Ms Aya Kitano for secretarial assistance. We are also grateful to the staff of the Department of Pathology, Asahikawa Medical University Hospital for generous help.	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Akita H, 2014, CANCER RES, V74, P5903, DOI 10.1158/0008-5472.CAN-14-0527; Antonov A, 2014, ONCOTARGET, V5, P11004, DOI 10.18632/oncotarget.2668; Bell JB, 2007, NAT PROTOC, V2, P3153, DOI 10.1038/nprot.2007.471; Berns K, 1997, ONCOGENE, V15, P1347, DOI 10.1038/sj.onc.1201280; Calvisi DF, 2011, GASTROENTEROLOGY, V140, P1071, DOI 10.1053/j.gastro.2010.12.006; Carlson CM, 2005, P NATL ACAD SCI USA, V102, P17059, DOI 10.1073/pnas.0502974102; Carroll M, 2013, J INTERF CYTOK RES, V33, P227, DOI 10.1089/jir.2012.0142; Castellano E, 2007, ONCOGENE, V26, P917, DOI 10.1038/sj.onc.1209845; Castellano E, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r123; Chen X, 2015, CANCER SCI, V106, P972, DOI 10.1111/cas.12700; Chow EKH, 2012, HEPATOLOGY, V56, P1331, DOI 10.1002/hep.25776; Coulouarn C, 2006, HEPATOLOGY, V44, P1003, DOI 10.1002/hep.21293; De Ponti A, 2015, CANCER LETT, V369, P396, DOI 10.1016/j.canlet.2015.09.005; Diersch S, 2016, ONCOGENE, V35, P3880, DOI 10.1038/onc.2015.437; Factor VM, 1998, J BIOL CHEM, V273, P15846, DOI 10.1074/jbc.273.25.15846; FUJIWARA Y, 1993, CANCER RES, V53, P857; Hermeking H, 2000, P NATL ACAD SCI USA, V97, P2229, DOI 10.1073/pnas.050586197; Ho C, 2012, HEPATOLOGY, V55, P833, DOI 10.1002/hep.24736; Hoffman B, 2002, ONCOGENE, V21, P3414, DOI 10.1038/sj.onc.1205400; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599; Kaposi-Novak P, 2009, CANCER RES, V69, P2775, DOI 10.1158/0008-5472.CAN-08-3357; KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0; Kawate S, 1999, ONCOLOGY-BASEL, V57, P157, DOI 10.1159/000012024; Kim S, 2000, P NATL ACAD SCI USA, V97, P11198, DOI 10.1073/pnas.200372597; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Lutz W, 2002, BBA-REV CANCER, V1602, P61, DOI 10.1016/S0304-419X(02)00036-7; Murphy DJ, 2008, CANCER CELL, V14, P447, DOI 10.1016/j.ccr.2008.10.018; Poortinga G, 2015, ONCOGENE, V34, P403, DOI 10.1038/onc.2014.13; Qu AJ, 2014, J HEPATOL, V60, P331, DOI 10.1016/j.jhep.2013.09.024; Ren JW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153863; SANDGREN EP, 1989, ONCOGENE, V4, P715; Schlosser I, 2003, NUCLEIC ACIDS RES, V31, P6148, DOI 10.1093/nar/gkg794; Sears RC, 2004, CELL CYCLE, V3, P1133, DOI 10.4161/cc.3.9.1145; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Soucek L, 2013, GENE DEV, V27, P504, DOI 10.1101/gad.205542.112; Stein TJ, 2011, LIVER INT, V31, P1298, DOI 10.1111/j.1478-3231.2011.02596.x; Stine ZE, 2015, CANCER DISCOV, V5, P1024, DOI 10.1158/2159-8290.CD-15-0507; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Wahlstrom T, 2015, BBA-GENE REGUL MECH, V1849, P563, DOI 10.1016/j.bbagrm.2014.07.004; Wang XY, 2011, CANCER RES, V71, P925, DOI 10.1158/0008-5472.CAN-10-1032; Yant SR, 2000, NAT GENET, V25, P35, DOI 10.1038/75568; Zhang YX, 2014, MOL ENDOCRINOL, V28, P116, DOI 10.1210/me.2013-1268; Zhu JD, 2008, P NATL ACAD SCI USA, V105, P6584, DOI 10.1073/pnas.0802785105; Zirath H, 2013, P NATL ACAD SCI USA, V110, P10258, DOI 10.1073/pnas.1222404110; Zucman-Rossi J, 2015, GASTROENTEROLOGY, V149, P1226, DOI 10.1053/j.gastro.2015.05.061	48	21	21	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 7	2017	36	36					5087	5097		10.1038/onc.2017.114	http://dx.doi.org/10.1038/onc.2017.114			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FF9XD	28481866	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000409371100001
J	Chen, HQ; Mruk, DD; Lee, WM; Cheng, CY				Chen, Haiqi; Mruk, Dolores D.; Lee, Will M.; Cheng, C. Yan			Regulation of spermatogenesis by a local functional axis in the testis: role of the basement membrane-derived noncollagenous 1 domain peptide	FASEB JOURNAL			English	Article						Sertoli cell; collagen; NC1 domain; ectoplasmic specialization; blood-testis barrier	EXTRACELLULAR-MATRIX COMPONENTS; TESTICULAR PERITUBULAR CELLS; RAT SERTOLI-CELLS; ECTOPLASMIC SPECIALIZATION DYNAMICS; NECROSIS-FACTOR-ALPHA; F-ACTIN ORGANIZATION; IV COLLAGEN CHAINS; IN-VITRO; BARRIER DYNAMICS; TUMOR-GROWTH	Spermatogenesis takes place in the epithelium of the seminiferous tubules of the testes, producing millions of spermatozoa per day in an adult male in rodents and humans. Thus, multiple cellular events that are regulated by an array of signaling molecules and pathways are tightly coordinated to support spermatogenesis. Here, we report findings of a local regulatory axis between the basement membrane (BM), the blood-testis barrier (BTB), and the apical ectoplasmic specialization (apical ES; a testis-specific, actin-rich adherens junction at the Sertoli cell-spermatid interface) to coordinate cellular events across the seminiferous epithelium during the epithelial cycle. In short, a biologically active fragment, noncollagenous 1 (NC1) domain that is derived from collagen chains in the BM, was found to modulate cell junction dynamics at the BTB and apical ES. NC1 domain from the collagen alpha 3(IV) chain was cloned into a mammalian expression vector, pCI-neo, with and without a collagen signal peptide. We also prepared a specific Ab against the purified recombinant NC1 domain peptide. These reagents were used to examine whether overexpression of NC1 domain with high transfection efficacy would perturb spermatogenesis, in particular, spermatid adhesion (i.e., inducing apical ES degeneration) and BTB function (i.e., basal ES and tight junction disruption, making the barrier leaky), in the testis in vivo. We report our findings that NC1 domain derived from collagen a3(IV) chain-a major structural component of the BM-was capable of inducing BTB remodeling, making the BTB leaky in studies in vivo. Furthermore, NC1 domain peptide was transported across the epithelium via a microtubule-dependent mechanism and is capable of inducing apical ES degeneration, which leads to germ cell exfoliation from the seminiferous epithelium. Of more importance, we show that NC1 domain peptide exerted its regulatory effect by disorganizing actin microfilaments and microtubules in Sertoli cells so that they failed to support cell adhesion and transport of germ cells and organelles (e.g., residual bodies, phagosomes) across the seminiferous epithelium. This local regulatory axis between the BM, BTB, and the apical ES thus coordinates cellular events that take place across the seminiferous epithelium during the epithelial cycle of spermatogenesis.	[Chen, Haiqi; Mruk, Dolores D.; Cheng, C. Yan] Populat Council, Ctr Biomed Res, Mary M Wohlford Lab Male Contracept Res, 1230 York Ave, New York, NY 10065 USA; [Lee, Will M.; Cheng, C. Yan] Univ Hong Kong, Sch Biol Sci, Pokfulam, Hong Kong, Peoples R China	Population Council; University of Hong Kong	Cheng, CY (corresponding author), Populat Council, Ctr Biomed Res, Mary M Wohlford Lab Male Contracept Res, 1230 York Ave, New York, NY 10065 USA.	y-cheng@popcbr.rockefeller.edu	Chen, Haiqi/J-7468-2019	Chen, Haiqi/0000-0001-7179-3229; Cheng, C Yan/0000-0003-3117-3791	U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01-HD056034, U54-HD029990]; Hong Kong Research Grants Council (RGC) General Research Fund (GRF) [771513]; National Natural Science Foundation of China (NSFC)/RGC [N_HKU 717/12]; University of Hong Kong CRCG; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD029990, R01HD056034] Funding Source: NIH RePORTER	U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Hong Kong Research Grants Council (RGC) General Research Fund (GRF)(Hong Kong Research Grants Council); National Natural Science Foundation of China (NSFC)/RGC(Hong Kong Research Grants CouncilNational Natural Science Foundation of China (NSFC)); University of Hong Kong CRCG(University of Hong Kong); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development Grants R01-HD056034 (to C.Y.C.), U54-HD029990 Project 5 (to C.Y.C.), Hong Kong Research Grants Council (RGC) General Research Fund (GRF) 771513 (to W.M.L.), National Natural Science Foundation of China (NSFC)/RGC Joint Research Scheme N_HKU 717/12 (to W.M.L.), and University of Hong Kong CRCG Seed Funding (to W.M.L.). The authors declare no conflicts of interest.	Ahmed S, 2010, SEMIN CELL DEV BIOL, V21, P350, DOI 10.1016/j.semcdb.2009.11.008; Aikio M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051044; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Chen HQ, 2016, ENDOCRINOLOGY, V157, P2140, DOI 10.1210/en.2015-1987; Chen YH, 1997, J CELL BIOL, V138, P891, DOI 10.1083/jcb.138.4.891; Cheng CY, 2012, PHARMACOL REV, V64, P16, DOI 10.1124/pr.110.002790; Cheng CY, 2011, BIOCHEM J, V435, P553, DOI 10.1042/BJ20102121; Cheng CY, 2010, NAT REV ENDOCRINOL, V6, P380, DOI 10.1038/nrendo.2010.71; Cheng CY, 2009, CRIT REV BIOCHEM MOL, V44, P245, DOI 10.1080/10409230903061207; Cooke VG, 2008, METHOD ENZYMOL, V444, P1, DOI 10.1016/S0076-6879(08)02801-2; DAVIS CM, 1990, BIOL REPROD, V43, P860, DOI 10.1095/biolreprod43.5.860; DENDUCHIS B, 1985, J REPROD IMMUNOL, V7, P59, DOI 10.1016/0165-0378(85)90021-X; DYM M, 1994, ENDOCR REV, V15, P102, DOI 10.1210/er.15.1.102; Frojdman K, 1998, DIFFERENTIATION, V63, P125, DOI 10.1046/j.1432-0436.1998.6330125.x; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Gao Y, 2017, FASEB J, V31, P584, DOI 10.1096/fj.201600870R; Gao Y, 2016, ONCOTARGET, V7, P64203, DOI 10.18632/oncotarget.11887; GELLY JL, 1989, HISTOCHEMISTRY, V93, P31, DOI 10.1007/BF00266844; HADLEY MA, 1985, J CELL BIOL, V101, P1511, DOI 10.1083/jcb.101.4.1511; Hager M, 2005, AM J PATHOL, V167, P823, DOI 10.1016/S0002-9440(10)62054-8; Hamano Y, 2005, BIOCHEM BIOPH RES CO, V333, P292, DOI 10.1016/j.bbrc.2005.05.130; Hamano Y, 2003, CANCER CELL, V3, P589, DOI 10.1016/S1535-6108(03)00133-8; HEW KW, 1993, BIOL REPROD, V49, P840, DOI 10.1095/biolreprod49.4.840; Hu P, 2013, J CELL PHYSIOL, V228, P306, DOI 10.1002/jcp.24154; Ip CKM, 2011, ONCOGENE, V30, P2420, DOI 10.1038/onc.2010.615; Kahsai TZ, 1997, J BIOL CHEM, V272, P17023, DOI 10.1074/jbc.272.27.17023; Kamphaus GD, 2000, J BIOL CHEM, V275, P1209, DOI 10.1074/jbc.275.2.1209; Lee NPY, 2003, BIOL REPROD, V68, P489, DOI 10.1095/biolreprod.102.005793; LEMAGUERESSEBATTISTONI B, 1995, J ENDOCRINOL, V146, P501, DOI 10.1677/joe.0.1460501; Li MWM, 2009, INT J BIOCHEM CELL B, V41, P2302, DOI 10.1016/j.biocel.2009.05.016; Li N, 2016, ENDOCRINOLOGY, V157, P2894, DOI 10.1210/en.2016-1133; LUSTIG L, 1978, ARCH ANDROLOGY, V1, P333, DOI 10.3109/01485017808988354; Lustig L, 2000, BIOL REPROD, V62, P1505, DOI 10.1095/biolreprod62.6.1505; Ma Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08894; Maeshima Y, 2000, J BIOL CHEM, V275, P21340, DOI 10.1074/jbc.M001956200; Maeshima Y, 2001, J BIOL CHEM, V276, P31959, DOI 10.1074/jbc.M103024200; Maeshima Y, 2001, J BIOL CHEM, V276, P15240, DOI 10.1074/jbc.M007764200; Marneros AG, 2001, MATRIX BIOL, V20, P337, DOI 10.1016/S0945-053X(01)00151-2; McLachlan RI, 2002, J ANDROL, V23, P149; Mok KW, 2015, ENDOCRINOLOGY, V156, P1900, DOI 10.1210/en.2014-1791; Mruk DD, 2011, METHODS MOL BIOL, V763, P237, DOI 10.1007/978-1-61779-191-8_16; Mundel TM, 2008, INT J CANCER, V122, P1738, DOI 10.1002/ijc.23269; O'Donnell Liza, 2011, Spermatogenesis, V1, P14; Ortega N, 2002, J CELL SCI, V115, P4201, DOI 10.1242/jcs.00106; Ozaki-Kuroda K, 2002, CURR BIOL, V12, P1145, DOI 10.1016/S0960-9822(02)00922-3; PALOMBI F, 1992, BIOL REPROD, V47, P1173, DOI 10.1095/biolreprod47.6.1173; Pasco S, 2000, J BIOL CHEM, V275, P32999, DOI 10.1074/jbc.M005235200; Pelletier RM, 2011, PROG HISTOCHEM CYTO, V46, P49, DOI 10.1016/j.proghi.2011.05.001; Pizarro-Cerda J, 2017, TRENDS CELL BIOL, V27, P93, DOI 10.1016/j.tcb.2016.08.001; Poluzzi C, 2016, ADV DRUG DELIVER REV, V97, P156, DOI 10.1016/j.addr.2015.10.012; Rehn M, 2001, P NATL ACAD SCI USA, V98, P1024, DOI 10.1073/pnas.031564998; RUSSELL LD, 1989, TISSUE CELL, V21, P361, DOI 10.1016/0040-8166(89)90051-7; Schlatt S, 2014, SEMIN CELL DEV BIOL, V29, P2, DOI 10.1016/j.semcdb.2014.03.007; Shen B, 2012, CURR OPIN CELL BIOL, V24, P600, DOI 10.1016/j.ceb.2012.08.011; Siu MKY, 2005, J BIOL CHEM, V280, P25029, DOI 10.1074/jbc.M501049200; Siu MKY, 2004, BIOESSAYS, V26, P978, DOI 10.1002/bies.20099; Siu MKY, 2004, BIOL REPROD, V70, P945, DOI 10.1095/biolreprod.103.023606; Siu MKY, 2003, ENDOCRINOLOGY, V144, P371, DOI 10.1210/en.2002-220786; SKINNER MK, 1985, J CELL BIOL, V100, P1941, DOI 10.1083/jcb.100.6.1941; SKINNER MK, 1985, J BIOL CHEM, V260, P1874; Su LL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2171; Sudhakar A, 2007, GENE REGUL SYST BIO, V1, P217; Sudhakar A, 2008, PHARM RES-DORD, V25, P2731, DOI 10.1007/s11095-008-9634-z; Tang EI, 2016, ENDOCRINOLOGY, V157, P1644, DOI 10.1210/en.2015-1962; TUNG PS, 1986, DEV BIOL, V113, P119, DOI 10.1016/0012-1606(86)90114-4; TUNG PS, 1993, J CELL PHYSIOL, V156, P1, DOI 10.1002/jcp.1041560102; Vogl AW, 2008, ADV EXP MED BIOL, V636, P186, DOI 10.1007/978-0-387-09597-4_11; Walia A, 2015, BBA-GEN SUBJECTS, V1850, P2422, DOI 10.1016/j.bbagen.2015.09.007; Wan HT, 2013, AM J PHYSIOL-ENDOC M, V305, pE687, DOI 10.1152/ajpendo.00254.2013; WEBER JE, 1983, AM J ANAT, V167, P163, DOI 10.1002/aja.1001670203; Winters SJ, 2004, REPRODUCTION, V128, P13, DOI 10.1530/rep.1.00195; Wong CH, 2004, J CELL SCI, V117, P783, DOI 10.1242/jcs.00900; Wong EW, 2013, SPERMATOGENESIS, V3, DOI DOI 10.4161/SPMG.25465; Xiao X, 2014, AM J PHYSIOL-ENDOC M, V307, pE553, DOI 10.1152/ajpendo.00176.2014; Xiao X, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004447; Xiao X, 2014, METHOD ENZYMOL, V534, P181, DOI 10.1016/B978-0-12-397926-1.00010-X; Yan HHN, 2008, P NATL ACAD SCI USA, V105, P8950, DOI 10.1073/pnas.0711264105; Yan HHN, 2006, J BIOL CHEM, V281, P17286, DOI 10.1074/jbc.M513218200; ZWAIN IH, 1994, MOL CELL ENDOCRINOL, V104, P213, DOI 10.1016/0303-7207(94)90124-4	79	32	32	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3587	3607		10.1096/fj.201700052R	http://dx.doi.org/10.1096/fj.201700052R			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28487282	Green Published			2022-12-26	WOS:000405932400032
J	Tabaja, N; Yuan, ZY; Oswald, F; Kovall, RA				Tabaja, Nassif; Yuan, Zhenyu; Oswald, Franz; Kovall, Rhett A.			Structure-function analysis of RBP-J-interacting and tubulin-associated (RITA) reveals regions critical for repression of Notch target genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene regulation; isothermal titration calorimetry (ITC); Notch pathway; protein-protein interaction; signal transduction; transcription corepressor; transcription factor; X-ray crystallography	SECONDARY STRUCTURE ANALYSES; TRANSCRIPTION; BINDING; PROTEIN; DOMAIN; SUPPRESSOR; INSIGHTS; COMPLEX	The Notch pathway is a cell-to-cell signaling mechanism that is essential for tissue development and maintenance, and aberrant Notch signaling has been implicated in various cancers, congenital defects, and cardiovascular diseases. Notch signaling activates the expression of target genes, which are regulated by the transcription factor CSL (CBF1/RBP-J, Su(H), Lag-1). CSL interacts with both transcriptional corepressor and coactivator proteins, functioning as both a repressor and activator, respectively. Although Notch activation complexes are relatively well understood at the structural level, less is known about how CSL interacts with corepressors. Recently, a new RBP-J (mammalian CSL ortholog)-interacting protein termed RITA has been identified and shown to export RBP-J out of the nucleus, thereby leading to the down-regulation of Notch target gene expression. However, the molecular details of RBP-J/RITA interactions are unclear. Here, using a combination of biochemical/cellular, structural, and biophysical techniques, we demonstrate that endogenous RBP-J and RITA proteins interact in cells, map the binding regions necessary for RBP-JRITA complex formation, and determine the X-ray structure of the RBP-JRITA complex bound to DNA. To validate the structure and glean more insights into function, we tested structure-based RBP-J and RITA mutants with biochemical/cellular assays and isothermal titration calorimetry. Whereas our structural and biophysical studies demonstrate that RITA binds RBP-J similarly to the RAM (RBP-J-associated molecule) domain of Notch, our biochemical and cellular assays suggest that RITA interacts with additional regions in RBP-J. Taken together, these results provide molecular insights into the mechanism of RITA-mediated regulation of Notch signaling, contributing to our understanding of how CSL functions as a transcriptional repressor of Notch target genes.	[Tabaja, Nassif; Yuan, Zhenyu; Kovall, Rhett A.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; [Oswald, Franz] Univ Med Ctr Ulm, Ctr Internal Med, Dept Internal Med 1, D-89081 Ulm, Germany	University System of Ohio; University of Cincinnati; Ulm University	Kovall, RA (corresponding author), Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA.	kovallra@ucmail.uc.edu	Oswald, Franz/AAO-9584-2020		DOE Office of Science [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [T32CA117846, R01CA178974] Funding Source: NIH RePORTER	DOE Office of Science(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the Kovall and Oswald laboratories for technical assistance. This research used resources of the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Borggrefe T, 2009, CELL MOL LIFE SCI, V66, P1631, DOI 10.1007/s00018-009-8668-7; Bray SJ, 2016, NAT REV MOL CELL BIO, V17, P722, DOI 10.1038/nrm.2016.94; Brockmann B, 2014, HEREDITAS, V151, P209, DOI 10.1111/hrd2.00074; Castel D, 2013, GENE DEV, V27, P1059, DOI 10.1101/gad.211912.112; Choi SH, 2012, STRUCTURE, V20, P340, DOI 10.1016/j.str.2011.12.011; Collins KJ, 2014, STRUCTURE, V22, P70, DOI 10.1016/j.str.2013.10.010; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Friedmann DR, 2008, J BIOL CHEM, V283, P14781, DOI 10.1074/jbc.M709501200; Friedmann DR, 2010, PROTEIN SCI, V19, P34, DOI 10.1002/pro.280; Gridley T, 2003, HUM MOL GENET, V12, pR9, DOI 10.1093/hmg/ddg052; HSIEH JJD, 1995, SCIENCE, V268, P560, DOI 10.1126/science.7725102; Johnson SE, 2010, J BIOL CHEM, V285, P6681, DOI 10.1074/jbc.M109.019968; Kettenbach AN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001497; Koch U, 2010, CURR TOP DEV BIOL, V92, P411, DOI 10.1016/S0070-2153(10)92013-9; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kovall RA, 2010, CURR TOP DEV BIOL, V92, P31, DOI 10.1016/S0070-2153(10)92002-4; Krejci A, 2007, GENE DEV, V21, P1322, DOI 10.1101/gad.424607; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuroda K, 2003, IMMUNITY, V18, P301, DOI 10.1016/S1074-7613(03)00029-3; Li X, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145504; LING PD, 1995, J VIROL, V69, P1944, DOI 10.1128/JVI.69.3.1944-1950.1995; Maier D, 2006, HEREDITAS, V143, P212, DOI 10.1111/j.2007.0018-0661.01971.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Nam Y, 2003, J BIOL CHEM, V278, P21232, DOI 10.1074/jbc.M301567200; Ntziachristos P, 2014, CANCER CELL, V25, P318, DOI 10.1016/j.ccr.2014.02.018; Oswald F, 2002, EMBO J, V21, P5417, DOI 10.1093/emboj/cdf549; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; STURTEVANT JM, 1977, P NATL ACAD SCI USA, V74, P2236, DOI 10.1073/pnas.74.6.2236; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X; Taniguchi Y, 1998, MOL CELL BIOL, V18, P644, DOI 10.1128/MCB.18.1.644; VanderWielen BD, 2011, J BIOL CHEM, V286, P14892, DOI 10.1074/jbc.M110.181156; Wacker SA, 2011, EMBO J, V30, P43, DOI 10.1038/emboj.2010.289; Wang HH, 2012, ONCOL RES, V20, P437, DOI 10.3727/096504013X13685487925059; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wilson JJ, 2006, CELL, V124, P985, DOI 10.1016/j.cell.2006.01.035; Yuan ZY, 2012, J BIOL CHEM, V287, P34904, DOI 10.1074/jbc.M112.403287	43	24	24	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10549	10563		10.1074/jbc.M117.791707	http://dx.doi.org/10.1074/jbc.M117.791707			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28487372	hybrid, Green Published			2022-12-26	WOS:000404115400016
J	Lam, HV; Nguyen, DT; Nguyen, CD				Lam, Hoang V.; Nguyen, Dat T.; Nguyen, Cao D.			Sibling method increases risk assessment estimates for type 1 diabetes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BETA-CELL; PATHOGENESIS; NEPHROPATHY; CONCORDANCE; PREVENTION; MELLITUS; LINKAGE; COHORT	We presented a risk assessment model to distinguish between type 1 diabetes (T1D) affected and unaffected siblings using only three single nucleotide polymorphism (SNP) genotypes. In addition we calculated the heritability from genome-wide identity-by-descent (IBD) sharing between full siblings. We analyzed 1,253 pairs of affected individuals and their unaffected siblings (750 pairs from a discovery set and 503 pairs from a validation set) from the T1D Genetics Consortium (T1DGC), applying a logistic regression to analyze the area under the receiver operator characteristic (ROC) curve (AUC). To calculate the heritability of T1D we used the Haseman-Elston regression analysis of the squared difference between the phenotypes of the pairs of siblings on the estimate of their genome-wide IBD proportion. The model with only 3 SNPs achieving an AUC of 0.75 in both datasets outperformed the model using the presence of the high-risk DR3/4 HLA genotype, namely AUC of 0.60. The heritability on the liability scale of T1D was approximately from 0.53 to 0.92, close to the results obtained from twin studies, ranging from 0.4 to 0.88.	[Lam, Hoang V.] Cho Ray Hosp, Dept Endocrinol, Ho Chi Minh City, Vietnam; [Nguyen, Dat T.] Hoa Sen Univ, Dept Sci & Technol, Ho Chi Minh City, Vietnam; [Nguyen, Cao D.] Econ Univ, Dept Business & Informat Syst, Ho Chi Minh City, Vietnam; [Nguyen, Cao D.] Clin Anal & Modelling Dept Hlth, Perth, WA, Australia	Hoa Sen University; Vietnam National University Hochiminh City	Nguyen, CD (corresponding author), Econ Univ, Dept Business & Informat Syst, Ho Chi Minh City, Vietnam.; Nguyen, CD (corresponding author), Clin Anal & Modelling Dept Hlth, Perth, WA, Australia.	cao.nguyen@health.wa.gov.au						Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; Atkinson MA, 2014, LANCET, V383, P69, DOI 10.1016/S0140-6736(13)60591-7; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bates D., 2014, IME4 LINEAR MIXED EF; Bjornstad P, 2014, CURR OPIN ENDOCRINOL, V21, P279, DOI 10.1097/MED.0000000000000074; Bjornstad P, 2013, DIABETES CARE, V36, P3678, DOI 10.2337/dc13-0631; Bresson D, 2009, DIABETES CARE, V32, P1753, DOI 10.2337/dc09-0373; Cameron FJ, 2014, DIABETES CARE, V37, P1554, DOI 10.2337/dc13-1904; Efron B., 1992, BREAKTHROUGHS STAT, P569, DOI DOI 10.1007/978-1-4612-4380-9_41; Epstein CJ, 2006, AM J HUM GENET, V79, P434, DOI 10.1086/507610; Falconer D. S., 1996, INTRO QUANTITATIVE G; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Gillespie KM, 2006, CAN MED ASSOC J, V175, P165, DOI 10.1503/cmaj.060244; Hagopian WA, 2006, ANN NY ACAD SCI, V1079, P320, DOI 10.1196/annals.1375.049; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Hyttinen V., 2003, DIABETES, V52, P1052; Jakobsdottir J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000337; Jostins L, 2011, HUM MOL GENET, V20, pR182, DOI 10.1093/hmg/ddr378; KAPRIO J, 1992, DIABETOLOGIA, V35, P1060, DOI 10.1007/BF02221682; Krischer J, 2007, PEDIATR DIABETES, V8, P117, DOI 10.1111/j.1399-5448.2007.00239.x; KYVIK KO, 1995, BRIT MED J, V311, P913; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Lu Q, 2010, BIOMETRICS, V66, P586, DOI 10.1111/j.1541-0420.2009.01278.x; Manolio TA, 2013, NAT REV GENET, V14, P549, DOI 10.1038/nrg3523; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Morahan G, 2010, HLA COMPLEX BIOL MED, P205; Morahan G, 2012, CURR OPIN ENDOCRINOL, V19, P263, DOI 10.1097/MED.0b013e328355b7fe; Nathan DM, 2014, DIABETES CARE, V37, P9, DOI 10.2337/dc13-2112; Nguyen C, 2013, DIABETES, V62, P2135; Parikka V, 2012, DIABETOLOGIA, V55, P1926, DOI 10.1007/s00125-012-2523-3; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; REICH T, 1972, ANN HUM GENET, V36, P163, DOI 10.1111/j.1469-1809.1972.tb00767.x; Skyler JS, 2008, ANN NY ACAD SCI, V1150, P14, DOI 10.1196/annals.1447.054; Van Belle TL, 2011, PHYSIOL REV, V91, P79, DOI 10.1152/physrev.00003.2010; Vetere A, 2014, NAT REV DRUG DISCOV, V13, P278, DOI 10.1038/nrd4231; Virtanen SM, 2006, DIABETOLOGIA, V49, P1512, DOI 10.1007/s00125-006-0236-1; Wei Z, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000678; Ziegler AG, 2016, DIABETES, V65, P3233, DOI 10.2337/db16-0687	39	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0176341	10.1371/journal.pone.0176341	http://dx.doi.org/10.1371/journal.pone.0176341			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28510587	Green Submitted, Green Published, gold			2022-12-26	WOS:000401485500006
J	Hammond, NE; Taylor, C; Finfer, S; Machado, FR; An, YZ; Billot, L; Bloos, F; Bozza, F; Cavalcanti, AB; Correa, M; Du, B; Hjortrup, PB; Li, Y; McIntryre, L; Saxena, M; Schortgen, F; Watts, NR; Myburgh, J				Hammond, Naomi E.; Taylor, Colman; Finfer, Simon; Machado, Flavia R.; An, YouZhong; Billot, Laurent; Bloos, Frank; Bozza, Fernando; Cavalcanti, Alexandre Biasi; Correa, Maryam; Du, Bin; Hjortrup, Peter B.; Li, Yang; McIntryre, Lauralyn; Saxena, Manoj; Schortgen, Frederique; Watts, Nicola R.; Myburgh, John		Fluid-TRIPS Fluidos Investigators; George Inst Global Hlth; ANZICS Clinical Trials Grp; BRICNet; REVA Res Network	Patterns of intravenous fluid resuscitation use in adult intensive care patients between 2007 and 2014: An international cross-sectional study	PLOS ONE			English	Article							IN-HOSPITAL MORTALITY; HYDROXYETHYL STARCH 130/0.4; CRITICALLY-ILL ADULTS; KIDNEY INJURY; ASSOCIATION; SEPSIS; SALINE; CHOICE; SCORE; SHOCK	Background In 2007, the Saline versus Albumin Fluid Evaluation D Translation of Research Into Practice Study (SAFE-TRIPS) reported that 0.9% sodium chloride (saline) and hydroxyethyl starch (HES) were the most commonly used resuscitation fluids in intensive care unit (ICU) patients. Evidence has emerged since 2007 that these fluids are associated with adverse patient-centred outcomes. Based on the published evidence since 2007, we sought to determine the current type of fluid resuscitation used in clinical practice and the predictors of fluid choice and determine whether these have changed between 2007 and 2014. Methods In 2014, an international, cross-sectional study was conducted (Fluid-TRIPS) to document current patterns of intravenous resuscitation fluid use and determine factors associated with fluid choice. We examined univariate and multivariate associations between patients and prescriber characteristics, geographical region and fluid type. Additionally, we report secular trends of resuscitation fluid use in a cohort of ICUs that participated in both the 2007 and 2014 studies. Regression analysis were conducted to determine changes in the administration of crystalloid or colloid between 2007 and 2014. Findings In 2014, a total of 426 ICUs in 27 countries participated. Over the 24 hour study day, 1456/ 6707 (21.7%) patients received resuscitation fluid during 2716 resuscitation episodes. Crystalloids were administered to 1227/1456 (84.3%) patients during 2208/2716 (81.3%) episodes and colloids to 394/1456 (27.1%) patients during 581/2716 (21.4%) episodes. In multivariate analyses, practice significantly varied between geographical regions. Additionally, patients with a traumatic brain injury were less likely to receive colloid when compared to patients with no trauma (adjusted OR 0.24; 95% CI 0.1 to 0.62; p = 0.003). Patients in the ICU for one or more days where more likely to receive colloid compared to patients in the ICU on their admission date (adjusted OR 1.75; 95% CI 1.27 to 2.41; p = < 0.001). For secular trends in fluid resuscitation, 84 ICUs in 17 countries contributed data. In 2007, 527/1663 (31.7%) patients received fluid resuscitation during 1167 episodes compared to 491/1763 (27.9%) patients during 960 episodes in 2014. The use of crystalloids increased from 498/1167 (42.7%) in 2007 to 694/960 (72.3%) in 2014 (odds ratio (OR) 3.75, 95% confidence interval (CI) 2.95 to 4.77; p = < 0.001), primarily due to a significant increase in the use of buffered salt solutions. The use of colloids decreased from 724/1167 (62.0%) in 2007 to 297/960 (30.9%) in 2014 (OR 0.29, 95% CI 0.19 to 0.43; p = < 0.001), primarily due to a decrease in the use of HES, but an overall increase in the use of albumin. Conclusions Clinical practices of intravenous fluid resuscitation have changed between 2007 and 2014. Geographical location remains a strong predictor of the type of fluid administered for fluid resuscitation. Overall, there is a preferential use of crystalloids, specifically buffered salt solutions, over colloids. There is now an imperative to conduct a trial determining the safety and efficacy of these fluids on patient-centred outcomes.	[Hammond, Naomi E.; Taylor, Colman; Finfer, Simon; Correa, Maryam; Li, Yang; Saxena, Manoj; Watts, Nicola R.; Myburgh, John] George Inst Global Hlth, Crit Care & Trauma Div, Sydney, NSW, Australia; [Hammond, Naomi E.; Finfer, Simon] Royal North Shore Hosp, Malcolm Fisher Dept Intens Care Med, Sydney, NSW, Australia; [Hammond, Naomi E.; Taylor, Colman; Finfer, Simon; Billot, Laurent] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia; [Hammond, Naomi E.; Saxena, Manoj; Myburgh, John] Univ New South Wales, Fac Med, St George Clin Sch, Sydney, NSW, Australia; [Machado, Flavia R.] Univ Fed Sao Paulo, Pain & Intens Care Dept, Anesthesiol, Sao Paulo, Brazil; Peking Univ, Peoples Hosp, Dept Crit Care Med, Beijing, Peoples R China; George Inst Global Hlth, Stat Div, Sydney, NSW, Australia; Jena Univ Hosp, Dept Anesthesiol & Intens Care Med, Jena, Germany; DOr Inst Res & Educ, Rio De Janeiro, Brazil; Hosp Coracao, Res Inst, Sao Paulo, Brazil; Peking Union Med Coll Hosp, Med Intens Care Unit, Beijing, Peoples R China; Copenhagen Univ Hosp, Rigshosp, Dept Intens Care, Copenhagen, Denmark; Ottawa Hosp, Res Inst, Dept Med Crit Care, Ottawa, ON, Canada; St George Hosp, Dept Intens Care Med, Sydney, NSW, Australia; Reanimat Med Grp Hosp Henri Mondor, Assistance Publ Hop Paris, Creteil, France	George Institute for Global Health; University of Sydney; Royal North Shore Hospital; University of Sydney; University of New South Wales Sydney; Universidade Federal de Sao Paulo (UNIFESP); Peking University; George Institute for Global Health; University of Sydney; Friedrich Schiller University of Jena; IDOR - Instituto D'Or de Ensino e Pesquisa; Hospital do Coracao - HCor; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Rigshospitalet; University of Copenhagen; University of Ottawa; Ottawa Hospital Research Institute; St George Hospital; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Hammond, NE (corresponding author), George Inst Global Hlth, Crit Care & Trauma Div, Sydney, NSW, Australia.; Hammond, NE (corresponding author), Royal North Shore Hosp, Malcolm Fisher Dept Intens Care Med, Sydney, NSW, Australia.; Hammond, NE (corresponding author), Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia.; Hammond, NE (corresponding author), Univ New South Wales, Fac Med, St George Clin Sch, Sydney, NSW, Australia.	nhammond@georgeinstitute.org.au	Bozza, Fernando A/A-2618-2013; Colombo, Riccardo/AAK-9081-2020; Billot, Laurent/Y-1241-2019; Biondi, Rodrigo S/H-5212-2016; Christian, Michael/AAZ-4452-2020; Bloos, Frank/AAY-8265-2020; Christian, Mike/AAO-6338-2020; Cavalcanti, Alexandre/K-5529-2013; Du, Bin/K-4283-2013	Bozza, Fernando A/0000-0003-4878-0256; Colombo, Riccardo/0000-0002-9616-803X; Billot, Laurent/0000-0002-4975-9793; Biondi, Rodrigo S/0000-0002-9242-6062; Christian, Michael/0000-0001-9644-9950; Bloos, Frank/0000-0002-0767-7941; Christian, Mike/0000-0001-9644-9950; Cavalcanti, Alexandre/0000-0003-2798-6263; da Costa Nunes Bosso, Carlos Eduardo/0000-0001-8216-4372; Micallef, Sharon/0000-0002-8496-2324; Hammond, Naomi/0000-0002-6559-7747; Saxena, Manoj/0000-0002-0385-6731; Finfer, Simon/0000-0002-2785-5864; Banner-Goodspeed, Valerie/0000-0002-7644-2521; Schortgen, Frederique/0000-0003-1756-7508; Deeb, Ahmad/0000-0002-3680-7338; Du, Bin/0000-0001-6237-2895; Myburgh, John/0000-0003-4088-7016	Baxter Healthcare; CSL Behring; National Health and Medical Research Council of Australia [APP1039312]	Baxter Healthcare; CSL Behring; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was partially supported by unrestricted fluid grants from Baxter Healthcare and CSL Behring paid to The George Institute for Global Health. NH received a National Health and Medical Research Council of Australia Postgraduate Scholarship (2012-2014) that has supported part of this work [APP1039312]. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation of the manuscript; or decision to submit the manuscript for publication.	Annane D, 2013, JAMA-J AM MED ASSOC, V310, P1809, DOI 10.1001/jama.2013.280502; Caironi P, 2014, NEW ENGL J MED, V370, P1412, DOI 10.1056/NEJMoa1305727; Cecconi M, 2015, INTENS CARE MED, V41, P1529, DOI 10.1007/s00134-015-3850-x; EMA, 2013, PRAC REC SUSP MARK A; FDA, 2013, HYDR STARCH SOL FDA; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Finfer S, 2011, INTENS CARE MED, V37, P86, DOI 10.1007/s00134-010-2039-6; Finfer S, 2010, CRIT CARE, V14, DOI 10.1186/cc9293; Gattas DJ, 2012, ANESTH ANALG, V114, P159, DOI 10.1213/ANE.0b013e318236b4d6; Guidet B, 2012, CRIT CARE, V16, DOI 10.1186/cc11358; Hammond NE, 2015, INTENS CARE MED, V41, P1611, DOI 10.1007/s00134-015-3878-y; Hammond Naomi, 2015, Rev. bras. ter. intensiva, V27, P309, DOI 10.5935/0103-507X.20150053; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Krajewski ML, 2015, BRIT J SURG, V102, P24, DOI 10.1002/bjs.9651; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; MHRA, 2013, HYDR STARCH HES PROD; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Myburgh JA, 2012, NEW ENGL J MED, V367, P1901, DOI 10.1056/NEJMoa1209759; Perner A, 2012, NEW ENGL J MED, V367, P124, DOI 10.1056/NEJMoa1204242; R Core Team, 2013, R LANG ENV STAT COMP; Raghunathan K, 2015, ANESTHESIOLOGY, V123, P1385, DOI 10.1097/ALN.0000000000000861; Raghunathan K, 2014, CRIT CARE MED, V42, P1585, DOI 10.1097/CCM.0000000000000305; Shaw AD, 2014, INTENS CARE MED, V40, P1897, DOI 10.1007/s00134-014-3505-3; Shaw AD, 2012, ANN SURG, V255, P821, DOI 10.1097/SLA.0b013e31825074f5; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; TGA, 2014, HYDR STRACH VOL VOL; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Young P, 2015, JAMA-J AM MED ASSOC, V314, P1701, DOI 10.1001/jama.2015.12334; Yunos NM, 2012, JAMA-J AM MED ASSOC, V308, P1566, DOI 10.1001/jama.2012.13356	30	64	67	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0176292	10.1371/journal.pone.0176292	http://dx.doi.org/10.1371/journal.pone.0176292			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498856	gold, Green Submitted, Green Published			2022-12-26	WOS:000401314500003
J	Sadeh, D; Nitzan, N; Shachter, A; Chaimovitsh, D; Dudai, N; Ghanim, M				Sadeh, Dganit; Nitzan, Nadav; Shachter, Alona; Chaimovitsh, David; Dudai, Nativ; Ghanim, Murad			Whitefly attraction to rosemary (Rosmarinus officinialis L.) is associated with volatile composition and quantity	PLOS ONE			English	Article							BEMISIA-TABACI; INSECTICIDES; OFFICINALIS; BIOTYPES	Whitefly (Bemisia tabaci) is an important insect pest, causing severe damage to agricultural crops. The pest was recorded in a commercial rosemary (Rosmarinus officinalis, Lamiaceae) field, colonizing rosemary variety (var.) '2', but not '11'. A series of field and controlled laboratory choice bioassays confirmed the observed phenomenon. Mature potted plants of the two varieties were randomly organized in a lemon verbena (Lippia citrodora) and lemon grass (Cymbopogon spp.) fields. Seven days later var. '2'was significantly more colonized by whiteflies than var. '11'. Under lab conditions, whiteflies were significantly more attracted to var. '2'plantlets than to var. '11'following choice bioassays. Furthermore, cotton plants dipped in an essential oil emulsion of var. '2'had significantly greater colonization than cotton plants dipped in the essential oil emulsion of var. '11'. Similar results were obtained in 'plant-plant', 'plant-no plant'as well as, 'essential oil D essential oil'choice bioassay designs. Analyses of the essential oils of the two varieties identified a set of common and unique volatiles in each variety. Among these volatiles were beta-caryophyllene and limonene, two compounds known to be associated with plantinsect interactions. The attraction of B. tabaci to pure (> 95%) beta-caryophyllene and limonene using a range of concentrations was examined in vitro by choice bioassays. The compounds were attractive to the insect at moderate concentration, but not at the lowest or highest concentrations used, where the insect was not attracted or repelled, respectively. Limonene attracted the insects at rates that were 10-fold lower than beta-caryophyllene. The results emphasized the role of host plant volatiles in shaping the structure of B. tabaci populations in nature and in agricultural systems, and provided insights into the factors that contribute to the development of insect populations with unique characteristics. The results could also serve for future development of bio-pesticides and in breeding programs.	[Sadeh, Dganit; Nitzan, Nadav; Shachter, Alona; Chaimovitsh, David; Dudai, Nativ] ARO, Newe Yaar Res Ctr, Unit Aromat & Med plants, Ramat Yishay, Israel; [Sadeh, Dganit; Ghanim, Murad] ARO, Volcani Ctr, Dept Entomol, Bet Dagan, Israel; [Sadeh, Dganit; Dudai, Nativ; Ghanim, Murad] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Rehovot, Israel	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Hebrew University of Jerusalem	Dudai, N (corresponding author), ARO, Newe Yaar Res Ctr, Unit Aromat & Med plants, Ramat Yishay, Israel.; Ghanim, M (corresponding author), ARO, Volcani Ctr, Dept Entomol, Bet Dagan, Israel.; Dudai, N; Ghanim, M (corresponding author), Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Rehovot, Israel.	ghanim@agri.gov.il; nativdud@agri.gov.il						Ahn YJ, 2006, ADV PHYTOMED, V3, P269; Alvarez A, 2012, FOOD CHEM, V132, P1395, DOI 10.1016/j.foodchem.2011.11.127; Apel MA, 2009, PARASITOL RES, V105, P863, DOI 10.1007/s00436-009-1455-4; Baldin ELL, 2013, J PEST SCI, V86, P301, DOI 10.1007/s10340-012-0462-x; Bleeker PM, 2009, PLANT PHYSIOL, V151, P925, DOI 10.1104/pp.109.142661; Boykin LM, 2007, MOL PHYLOGENET EVOL, V44, P1306, DOI 10.1016/j.ympev.2007.04.020; BROWN JK, 1995, ANNU REV ENTOMOL, V40, P511, DOI 10.1146/annurev.en.40.010195.002455; Brown JK, 1994, FAO PLANT PROTECT B, V42, P2; Bruce TJA, 2005, TRENDS PLANT SCI, V10, P269, DOI 10.1016/j.tplants.2005.04.003; Caspi-Fluger A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021096; Chiel E, 2007, B ENTOMOL RES, V97, P407, DOI 10.1017/S0007485307005159; Crowder DW, 2010, J ANIM ECOL, V79, P563, DOI 10.1111/j.1365-2656.2010.01666.x; Czosnek H, 2002, ANN APPL BIOL, V140, P215, DOI 10.1111/j.1744-7348.2002.tb00175.x; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Delatte H, 2009, BIOL INVASIONS, V11, P1059, DOI 10.1007/s10530-008-9328-9; Deletre E, 2016, PEST MANAG SCI, V72, P179, DOI 10.1002/ps.3987; Dudai N, 2012, ACTA HORTIC, V955, P175, DOI 10.17660/ActaHortic.2012.955.25; Dudai N, 2007, ISRAEL PLANT BREEDER, V69, P23; El Omari A, 2012, J ETHNOPHARMACOL, V131, P451; Firdaus S, 2013, INSECT SCI, V20, P723, DOI 10.1111/1744-7917.12001; Horowitz AR, 2014, PEST MANAG SCI, V70, P1568, DOI 10.1002/ps.3752; Hu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016061; Huang M, 2012, NEW PHYTOL, V193, P997, DOI 10.1111/j.1469-8137.2011.04001.x; Inbar M, 2008, ANNU REV ENTOMOL, V53, P431, DOI 10.1146/annurev.ento.53.032107.122456; Isman MB, 2006, ANNU REV ENTOMOL, V51, P45, DOI 10.1146/annurev.ento.51.110104.151146; Jiu M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000182; Kaloshian I, 2005, ANNU REV PHYTOPATHOL, V43, P491, DOI 10.1146/annurev.phyto.43.040204.135944; Li YF, 2014, ARTHROPOD-PLANT INTE, V8, P183, DOI 10.1007/s11829-014-9302-7; Liu SS, 2012, J INTEGR AGR, V11, P176, DOI 10.1016/S2095-3119(12)60002-1; Mahmoodi Leila, 2014, Journal of Plant Protection Research, V54, P294, DOI 10.2478/jppr-2014-0044; McCormick AC, 2014, PLANT CELL ENVIRON, V37, P1836, DOI 10.1111/pce.12357; Mena P, 2016, MOLECULES, V21, DOI 10.3390/molecules21111576; Navarrete A, 2011, J FOOD ENG, V104, P196, DOI 10.1016/j.jfoodeng.2010.10.033; Ngo SNT, 2011, CRIT REV FOOD SCI, V51, P946, DOI 10.1080/10408398.2010.490883; Pengelly A, 2012, J MED FOOD, V15, P10, DOI 10.1089/jmf.2011.0005; Raiciu AD, 2010, FARMACIA, V58, P735; Ravid U, 1994, ISRAEL AGRESEARCH, V7, P85; Regnault-Roger C, 2012, ANNU REV ENTOMOL, V57, P405, DOI 10.1146/annurev-ento-120710-100554; Reymond P, 2004, PLANT CELL, V16, P3132, DOI 10.1105/tpc.104.026120; Soliman MM, 2007, ARCH PHYTOPATHOL PLA, V40, P128; Sun DB, 2013, B ENTOMOL RES, V103, P344, DOI 10.1017/S0007485312000788; Tan XL, 2014, ENTOMOL EXP APPL, V151, P259, DOI 10.1111/eea.12190; Tosh CR, 2015, AGRON SUSTAIN DEV, V35, P183, DOI 10.1007/s13593-014-0219-4; Walling LL, 2000, J PLANT GROWTH REGUL, V19, P195; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Yanishlieva NV, 2006, EUR J LIPID SCI TECH, V108, P776, DOI 10.1002/ejlt.200600127; Zavala Jorge A., 2004, BMC Ecology, V4, P11, DOI 10.1186/1472-6785-4-11; Zoubiri S, 2014, J SAUDI CHEM SOC, V18, P925, DOI 10.1016/j.jscs.2011.11.015	48	22	23	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177483	10.1371/journal.pone.0177483	http://dx.doi.org/10.1371/journal.pone.0177483			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498837	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314500021
J	Kshettry, A; Vaidyanathan, S; Athreya, V				Kshettry, Aritra; Vaidyanathan, Srinivas; Athreya, Vidya			Leopard in a tea-cup: A study of leopard habitat-use and human-leopard interactions in north-eastern India	PLOS ONE			English	Article							PANTHERA-PARDUS; LARGE CARNIVORES; NATIONAL-PARK; CONSERVATION; SELECTION; CONFLICT; TIGER; MODEL; RECOVERY; ATTACKS	There is increasing evidence of the importance of multi-use landscapes for the conservation of large carnivores. However, when carnivore ranges overlap with high density of humans, there are often serious conservation challenges. This is especially true in countries like India where loss of peoples' lives and property to large wildlife are not uncommon. The leopard (Panthera pardus) is a large felid that is widespread in India, often sharing landscapes with high human densities. In order to understand the ecology of leopards in a human use landscape and the nature of human-leopard interactions, we studied (i) the spatial and temporal distribution and the characteristics of leopard attacks on people, (ii) the spatial variability in the pattern of habitat use by the leopard, and (iii) the spatial relationship between attack locations and habitat use by leopards. The study site, located in northern West Bengal, India, is a densely populated mixed-use landscape of 630 km 2, comprising of forests, tea plantations, agriculture fields, and human settlements. A total of 171 leopard attacks on humans were reported between January 2009 and March 2016, most of which occurred within the tea-gardens. None of the attacks was fatal. We found significant spatial clustering of locations of leopard attacks on humans. However, most of the attacks were restricted to certain tea estates and occurred mostly between January and May. Analysis of habitat use by leopards showed that the probability of use of areas with more ground vegetation cover was high while that of areas with high density of buildings was low. However, locations of leopard attacks on people did not coincide with areas that showed a higher probability of use by leopards. This indicates that an increased use of an area by leopards, by itself, does not necessarily imply an increase in attacks on people. The spatial and temporal clustering of attack locations allowed us to use this information to prioritize areas to focus mitigation activities in order reduce negative encounters between people and leopards in this landscape which has had a long history of conflict.	[Kshettry, Aritra] GKVK, Natl Ctr Biol Sci, Wildlife Conservat Soc India, Post Grad Program Wildlife Biol & Conservat, Bangalore, Karnataka, India; [Vaidyanathan, Srinivas] Fdn Ecol Res Advocacy & Learning, Villupuram, Tamil Nadu, India; [Athreya, Vidya] Wildlife Conservat Soc India, Bangalore, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Kshettry, A (corresponding author), GKVK, Natl Ctr Biol Sci, Wildlife Conservat Soc India, Post Grad Program Wildlife Biol & Conservat, Bangalore, Karnataka, India.	aritra.kshettry@gmail.com		Vaidyanathan, Srinivas/0000-0003-3642-0309	Department of Science and Technology, Government of India; Science and Engineering Research Board [SERB/F/2235/2012-2013]; Rufford Foundation [168271]; IdeaWild	Department of Science and Technology, Government of India(Department of Science & Technology (India)); Science and Engineering Research Board; Rufford Foundation; IdeaWild	This work was supported by Department of Science and Technology, Government of India, Science and Engineering Research Board grant number SERB/F/2235/2012-2013, the Rufford Foundation grant number 168271 (http://www.rufford.org/projects/aritra_kshettry) and IdeaWild. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, LEOPARD INDIA NATURA; Athreya V, 2016, ORYX, V50, P156, DOI 10.1017/S0030605314000106; Athreya V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142647; Athreya V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057872; Athreya V, 2011, CONSERV BIOL, V25, P133, DOI 10.1111/j.1523-1739.2010.01599.x; Baddeley A, 2014, ECOL MONOGR, V84, P477, DOI 10.1890/13-2042.1; Balme G, 2007, ANIM BEHAV, V74, P589, DOI 10.1016/j.anbehav.2006.12.014; Banerjee K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049457; Bhattacharjee Anushree, 2013, Human Dimensions of Wildlife, V18, P20, DOI 10.1080/10871209.2012.698403; Boyce MS, 2006, DIVERS DISTRIB, V12, P269, DOI 10.1111/j.1366-9516.2006.00243.x; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Champion S.H., 1968, REVISED SURVEY FORES; Chape S, 2005, PHILOS T R SOC B, V360, P443, DOI 10.1098/rstb.2004.1592; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; Chatterjee Piya, 2001, TIME TEA WOMEN LABOR; Corbett J, 1946, MAN EATERS OF KUMAON; Dellinger JA, 2013, BIOL CONSERV, V157, P324, DOI 10.1016/j.biocon.2012.09.004; Dhanwatey HS, 2013, ORYX, V47, P221, DOI 10.1017/S0030605311001803; Doherty PF, 2012, J ORNITHOL, V152, pS317, DOI 10.1007/s10336-010-0598-5; Gavashelishvili A, 2008, J APPL ECOL, V45, P579, DOI 10.1111/j.1365-2664.2007.01432.x; Ghosal S, 2013, BIODIVERS CONSERV, V22, P2665, DOI 10.1007/s10531-013-0549-6; Gurung B, 2008, BIOL CONSERV, V141, P3069, DOI 10.1016/j.biocon.2008.09.013; Harihar A, 2011, J APPL ECOL, V48, P806, DOI 10.1111/j.1365-2664.2011.01981.x; Hayward MW, 2006, J ZOOL, V270, P298, DOI 10.1111/j.1469-7998.2006.00139.x; Hines JE, 2010, ECOL APPL, V20, P1456, DOI 10.1890/09-0321.1; Hines J. E., 2006, PROGRAM PRESENCE; Inskip C, 2013, HUM ECOL, V41, P169, DOI 10.1007/s10745-012-9556-6; Johnsingh AT, 2003, BIOL CONSERV, V111, P385, DOI 10.1016/S0006-3207(02)00307-5; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; JONES MC, 1993, STAT COMPUT, V3, P135, DOI 10.1007/BF00147776; Joshi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077980; Karanth KU, 2004, TIGERS THEIR PREY PR; Kshettry A, 2014, THESIS; Lele SR, 2013, J ANIM ECOL, V82, P1183, DOI 10.1111/1365-2656.12141; MacKenzie DI, 2006, J WILDLIFE MANAGE, V70, P367, DOI 10.2193/0022-541X(2006)70[367:MTPORU]2.0.CO;2; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Maiorano L, 2008, P ROY SOC B-BIOL SCI, V275, P1297, DOI 10.1098/rspb.2007.1756; Mondal K, 2013, ACTA THERIOL, V58, P179, DOI 10.1007/s13364-012-0109-6; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Navya R, 2014, CURR SCI INDIA, V107, P1381; Ngoprasert D, 2007, ORYX, V41, P343, DOI 10.1017/S0030605307001102; Odden M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112044; Packer C, 2005, NATURE, V436, P927, DOI 10.1038/436927a; Packer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022285; R Core Team, 2021, R LANGUAGE ENV STAT; Redpath SM, 2013, TRENDS ECOL EVOL, V28, P100, DOI 10.1016/j.tree.2012.08.021; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Royle JA, 2006, BIOMETRICS, V62, P97, DOI 10.1111/j.1541-0420.2005.00439.x; SABERWAL VK, 1994, CONSERV BIOL, V8, P501, DOI 10.1046/j.1523-1739.1994.08020501.x; Shehzad W, 2015, ORYX, V49, P248, DOI 10.1017/S0030605313001026; Srivathsa A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098803; Sunarto S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030859; Suryawanshi KR, 2014, CONSERV BIOL, V28, P1657, DOI 10.1111/cobi.12320; Takahata C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086181; Teichman KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074663; Terborgh J, 2002, PROBLEM PEOPLE PARKS, P307; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Vijayan S, 2002, POPUL ENVIRON, V23, P541, DOI 10.1023/A:1016317819552; Wickham H, 2014, GGPLOT2 IMPLEMENTATI; Woodroffe R, 2000, ANIM CONSERV, V3, P165, DOI 10.1111/j.1469-1795.2000.tb00241.x; Zarco-Gonzalez MM, 2013, BIOL CONSERV, V159, P80, DOI 10.1016/j.biocon.2012.11.007	62	38	38	4	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177013	10.1371/journal.pone.0177013	http://dx.doi.org/10.1371/journal.pone.0177013			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493999	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314300049
J	Seo, MG; Ouh, IO; Lee, SH; Kim, JW; Rhee, MH; Kwon, OD; Kim, TH; Kwak, D				Seo, Min-Goo; Ouh, In-Ohk; Lee, Seung-Hun; Kim, Jong Wan; Rhee, Man Hee; Kwon, Oh-Deog; Kim, Tae-Hwan; Kwak, Dongmi			Prevalence of Coxiella burnetii in cattle at South Korean national breeding stock farms	PLOS ONE			English	Article							Q-FEVER; DAIRY-CATTLE; INFECTION; TICKS	This is the first study to evaluate the serologic and molecular prevalence of Coxiella burnetii in cattle at national breeding stock farms in South Korea. These government farms have well-organized biosecurity and management systems to prevent livestock diseases. Of the 736 cattle in this study, 77 tested positive for antibodies against C. burnetii antigens (10.5%, 95% CI: 8.3-12.7) and 11 were positive for a C. burnetti infection on PCR analysis (1.5%, 95% CI: 0.6-2.4). Since the 16S rRNA sequences of C. burnetii from all 11 PCR-positive samples were identical, three representative samples (C-CN-3 from the southern region, C-JJ-9 from Jeju Island, and C-CB-37 from the central region) are described in this paper. These three sequences had 99.3-100% identity to those of C. burnetii deposited in GenBank. These sequences clustered with those from USA, Japan, and Greenland, underscoring the sequence similarity among C. burnetii isolates in these countries. Because C. burnetii was detected in cattle at well-managed national breeding stock farms, cattle at non-government operated farms may be more likely to be exposed to C. burnetii in South Korea. Thus, continuous surveillance and control strategies in animals and humans are required to prevent the transmission of C. burnetii to humans.	[Seo, Min-Goo; Lee, Seung-Hun; Rhee, Man Hee; Kwon, Oh-Deog; Kim, Tae-Hwan; Kwak, Dongmi] Kyungpook Natl Univ, Coll Vet Med, Daegu, South Korea; [Seo, Min-Goo; Ouh, In-Ohk; Lee, Seung-Hun; Kim, Jong Wan] Anim & Plant Quarantine Agcy, Gimcheon, South Korea; [Kwak, Dongmi] Kyungpook Natl Univ, Cardiovasc Res Inst, Daegu, South Korea	Kyungpook National University; Animal & Plant Quarantine Agency; Kyungpook National University	Kwak, D (corresponding author), Kyungpook Natl Univ, Coll Vet Med, Daegu, South Korea.; Kwak, D (corresponding author), Kyungpook Natl Univ, Cardiovasc Res Inst, Daegu, South Korea.	dmkwak@knu.ac.kr	Rhee, Man Hee/O-5705-2016	Rhee, Man Hee/0000-0002-3088-1318; Kwak, Dongmi/0000-0003-0876-3179; Seo, Min-Goo/0000-0003-1752-5105	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2013R1A1A2013102]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by a grant from the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (Grant No. NRF-2013R1A1A2013102). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Duron O, 2015, TRENDS PARASITOL, V31, P536, DOI 10.1016/j.pt.2015.06.014; Duron O, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004892; Duron O, 2014, TICKS TICK-BORNE DIS, V5, P557, DOI 10.1016/j.ttbdis.2014.04.003; Eldin C, 2017, CLIN MICROBIOL REV, V30, P115, DOI 10.1128/CMR.00045-16; Guatteo R, 2011, VET MICROBIOL, V149, P1, DOI 10.1016/j.vetmic.2010.10.007; Hirai K, 1998, J VET MED SCI, V60, P781, DOI 10.1292/jvms.60.781; Jung BY, 2014, VET MICROBIOL, V173, P152, DOI 10.1016/j.vetmic.2014.06.029; Keyvanirad N, 2013, IRAN J VET RES, V15, P1; Khalili M, 2011, ASIAN PAC J TROP MED, V4, P58, DOI 10.1016/S1995-7645(11)60033-3; Kim JiYeon, 2014, Korean Journal of Veterinary Research, V54, P147, DOI 10.14405/kjvr.2014.54.3.147; Kim WJ, 2006, J KOREAN MED SCI, V21, P823, DOI 10.3346/jkms.2006.21.5.823; Korean Statistical Information Service, 2014, NUMB FARMS HOUS AN H; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; Muskens J, 2011, Vet Rec, V168, P79, DOI 10.1136/vr.c6106; Ouh IO, 2014, KOREAN J VET SERV, V36, P243; Rahimi E, 2010, AFR J MICROBIOL RES, V4, P2324; Seo MG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165784; Seo MG, 2016, EMERG INFECT DIS, V22, P2192, DOI 10.3201/eid2212.161236; Seo MG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156710; Smith TA, 2015, GENOME BIOL EVOL, V7, P831, DOI 10.1093/gbe/evv016; Thrusfield M, 2005, VET EPIDEMIOLOGY, VThird, P228; Woldehiwet Z, 2004, RES VET SCI, V77, P93, DOI 10.1016/j.rvsc.2003.09.001	22	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177478	10.1371/journal.pone.0177478	http://dx.doi.org/10.1371/journal.pone.0177478			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493973	gold, Green Submitted, Green Published			2022-12-26	WOS:000401314300117
J	Twining, JP; Bernard, H; Ewers, RM				Twining, Joshua P.; Bernard, Henry; Ewers, Robert M.			Increasing land-use intensity reverses the relative occupancy of two quadrupedal scavengers	PLOS ONE			English	Article							FOREST FRAGMENTATION; VARANUS-SALVATOR; OIL; MESOPREDATORS; CONSERVATION; CARCASSES; ISLAND	Human land use is continuously altering the natural environment, yet the greater ecological implications of this change for many groups that are key to healthy ecosystem functioning remains uncharacterised in the tropics. Terrestrial scavenging vertebrates are one such group, providing integral ecosystem services through the removal of carrion which is a crucial component of both nutrient cycling and disease dynamics. To explore how anthropogenic processes may affect forest scavengers, we investigated the changes in the relative occupancy of two important terrestrial scavengers along a gradient of land use intensity, ranging from protected forest to oil palm plantation in Borneo. We found the Malay civet (Viverra tangalunga) had highest, albeit variable, occupancy in areas of low land use intensity and the Southeast Asian water monitor (Varanus salvator macromaculatus) had highest occupancy in areas of high land use intensity. Land use had no effect on the combined occupancy of the two species. In high land use intensity sites, individual water monitors were larger and had better body condition, but at population level had a highly biased sex ratio with more males than females and increased signs of intraspecific conflict. We did not assess scavenging rate or efficiency as a process, but the high occupancy rates and apparent health of the scavengers in high land use intensity landscapes suggests this ecological process is robust to land use change.	[Twining, Joshua P.; Ewers, Robert M.] Imperial Coll London, Dept Life Sci, London, England; [Bernard, Henry] Univ Malaysia Sabah, Inst Trop Biol & Conservat, Kota Kinabalu, Malaysia	Imperial College London; Universiti Malaysia Sabah	Twining, JP (corresponding author), Imperial Coll London, Dept Life Sci, London, England.	joshuaptwining@gmail.com	Twining, Joshua/GXF-8474-2022	Twining, Joshua/0000-0002-0881-9665	Sime Darby Foundation; Sabah Foundation; Benta Wawasan; Sabah Forestry Department; South East Asia Rainforest Research Partnership	Sime Darby Foundation; Sabah Foundation; Benta Wawasan; Sabah Forestry Department; South East Asia Rainforest Research Partnership	Funding came from the Sime Darby Foundation, (http://www.yayasansimedarby.com) who provide financial support to the Sustainability of Altered Forest Ecosystems Project (SAFE). Sime Darby had no input into study design, data collection, analysis or preparation of manuscript. This work was also financially supported by the Sabah Foundation, Benta Wawasan, the Sabah Forestry Department and the South East Asia Rainforest Research Partnership. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Sabah Biodiversity Centre for providing research permits, the Sabah Foundation, Benta Wawasan, the Sabah Forestry Department and the South East Asia Rainforest Research Partnership for providing financial support. Ryan Gray, Denny Benasip and the SAFE Project team of Research Assistants provided field assistance, and Marion Pfeifer and Igor Lysenko helped with data analysis. The SAFE Project is funded by the Sime Darby Foundation.	[Anonymous], 2014, R LANG ENV STAT COMP; Ariefiandy A, 2014, BIODIVERS CONSERV, V23, P2473, DOI 10.1007/s10531-014-0733-3; Auliya M., 2003, TAXONOMY LIFE HIST C; Banks-Leite C, 2014, J APPL ECOL, V51, P849, DOI 10.1111/1365-2664.12272; Battin J, 2004, CONSERV BIOL, V18, P1482, DOI 10.1111/j.1523-1739.2004.00417.x; Beasley JC, 2011, LANDSCAPE ECOL, V26, P937, DOI 10.1007/s10980-011-9619-x; Bohme W., ZOOLOGICAL SYSTEMATI, V33, P129; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Brashares Justin S., 2010, P221; Brown Danny, 2009, Biawak, V3, P26; DeVault T. L., 2003, SCAVENGING VERTEBRAT, P269; DeVault TL, 2002, ACTA THERIOL, V47, P185, DOI 10.1007/BF03192458; DeVault TL, 2011, BASIC APPL ECOL, V12, P268, DOI 10.1016/j.baae.2011.02.008; Eagan TS, 2011, CAN J ZOOL, V89, P724, DOI 10.1139/Z11-045; Ewers RM, 2011, PHILOS T R SOC B, V366, P3292, DOI 10.1098/rstb.2011.0049; Gaveau DLA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101654; Houston D.C., 1979, SERENGETI DYNAMICS E, P263; HOUSTON DC, 1986, CONDOR, V88, P318, DOI 10.2307/1368878; Jennings AP, 2015, MAMMAL RES, V60, P181, DOI 10.1007/s13364-015-0217-1; Jessop Tim, 2010, Biawak, V4, P59; Jessop TS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034069; King D., 1999, MONITORS BIOL VARANI; Koch A., 2007, ADV MONITOR RES, V16, P109; Koch Andre, 2010, Russian Journal of Herpetology, V17, P299; Koh LP, 2007, NATURE, V448, P993, DOI 10.1038/448993a; Kvarnemo C, 1996, TRENDS ECOL EVOL, V11, P404, DOI 10.1016/0169-5347(96)10056-2; Mateo-Tomas P, 2015, DIVERS DISTRIB, V21, P913, DOI 10.1111/ddi.12330; Moleon M, 2015, BIOSCIENCE, V65, P1003, DOI 10.1093/biosci/biv101; Moleon M, 2014, BIOL REV, V89, P1042, DOI 10.1111/brv.12097; Olson ZH, 2012, OIKOS, V121, P77, DOI 10.1111/j.1600-0706.2011.19771.x; PAYNE J, 1985, FIELD GUIDE MAMMALS; Peterson CA, 2001, J FIELD ORNITHOL, V72, P150, DOI 10.1648/0273-8570-72.1.150; Pfeifer M., REMOTE SENSING ENV, V176, P84; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; Putman R. J., 1976, THESIS; Reynolds G, 2011, PHILOS T R SOC B, V366, P3168, DOI 10.1098/rstb.2011.0154; ROBINSON SK, 1995, SCIENCE, V267, P1987, DOI 10.1126/science.267.5206.1987; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Sebastian-Gonzalez E, 2016, ECOLOGY, V97, P95, DOI 10.1890/15-0212.1; Sebastian-Gonzalez E, 2013, IBIS, V155, P881, DOI 10.1111/ibi.12079; Selva N, 2007, P ROY SOC B-BIOL SCI, V274, P1101, DOI 10.1098/rspb.2006.0232; Seymour A. S., J ZOOLOGY, V268, P63; Sha JCM, 2011, NATURAL HIST PROBOSC; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Shukor M. N., 1996, FIELDIANA ZOOLOGY, V83; Somaweera R., 2009, LIZARDS SRI LANKA CO, P304; Struebig MJ, 2013, ADV ECOL RES, V48, P183, DOI 10.1016/B978-0-12-417199-2.00003-3; Sweet Samuel S., 2007, Mertensiella, V16, P79; Traeholt Carl, 1994, Malayan Nature Journal, V47, P345; Traeholt Carl, 1993, Malayan Nature Journal, V46, P229; Traeholt Carl, 1997, Malayan Nature Journal, V50, P317; Traeholt Carl, 1997, Malayan Nature Journal, V50, P301; Turner EC, 2011, ENV IMPACT BIOFUELS, P19, DOI DOI 10.5772/20263; Turner EC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001572; Uyeda Linda, 2009, Biawak, V3, P9; Uyeda LT, 2015, HERPETOL CONSERV BIO, V10, P753; Wearn O. R., 2015, COMMUNICATION; West G, 2007, ZOO ANIMAL WILDLIFE; Wilson EE, 2011, TRENDS ECOL EVOL, V26, P129, DOI 10.1016/j.tree.2010.12.011; Yue S, 2015, ECOL APPL, V25, P2285, DOI 10.1890/14-1928.1	60	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177143	10.1371/journal.pone.0177143	http://dx.doi.org/10.1371/journal.pone.0177143			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28494004	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314300064
J	Zhang, W; Xu, J; Li, YY; Zou, XF				Zhang, Wei; Xu, Jia; Li, Yuanyuan; Zou, Xiufen			A new two-stage method for revealing missing parts of edges in protein-protein interaction networks	PLOS ONE			English	Article							RANDOM-WALK; PREDICTION; COMPLEXES; DATABASE; RESTART	With the increasing availability of high-throughput data, various computational methods have recently been developed for understanding the cell through protein-protein interaction (PPI) networks at a systems level. However, due to the incompleteness of the original PPI networks those efforts have been significantly hindered. In this paper, we propose a two stage method to predict underlying links between two originally unlinked protein pairs. First, we measure gene expression and gene functional similarly between unlinked protein pairs on Saccharomyces cerevisiae benchmark network and obtain new constructed networks. Then, we select the significant part of the new predicted links by analyzing the difference between essential proteins that have been identified based on the new constructed networks and the original network. Furthermore, we validate the performance of the new method by using the reliable and comprehensive PPI dataset obtained from the STRING database and compare the new proposed method with four other random walk-based methods. Comparing the results indicates that the new proposed strategy performs well in predicting underlying links. This study provides a general paradigm for predicting new interactions between protein pairs and offers new insights into identifying essential proteins.	[Zhang, Wei] East China Jiaotong Univ, Sch Sci, Nanchang 330013, Jiangxi, Peoples R China; [Xu, Jia] East China Jiaotong Univ, Sch Mechatron Engn, Nanchang 330013, Jiangxi, Peoples R China; [Li, Yuanyuan] Wuhan Inst Technol Wuhan, Sch Math & Stat, Wuhan 430072, Peoples R China; [Zou, Xiufen] Wuhan Univ, Sch Math & Stat, Wuhan 430072, Peoples R China	East China Jiaotong University; East China Jiaotong University; Wuhan University	Zhang, W (corresponding author), East China Jiaotong Univ, Sch Sci, Nanchang 330013, Jiangxi, Peoples R China.; Zou, XF (corresponding author), Wuhan Univ, Sch Math & Stat, Wuhan 430072, Peoples R China.	wzhang_math@whu.edu.cn; xfzou@whu.edu.cn			National Natural Science Foundation of China [11626102, 61672388]; Major Research Plan of the National Natural Science 359 Foundation of China [91530320]; Natural Science Foundation of Jiangxi Province [20161BAB211022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Research Plan of the National Natural Science 359 Foundation of China; Natural Science Foundation of Jiangxi Province(Natural Science Foundation of Jiangxi Province)	This work was partly supported by NO. 11626102 and NO. 61672388, National Natural Science Foundation of China (CN), www.nsfc.gov, WZ XFZ; and NO. 91530320, Major Research Plan of the National Natural Science 359 Foundation of China, XFZ; NO.20161BAB211022, Natural Science Foundation of Jiangxi Province (CN), WZ.	Alanis-Lobato G, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00296; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Backstrom L, 2011, P 4 ACM INT C WEB SE, V11, P635; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; Chua HN, 2006, BIOINFORMATICS, V22, P1623, DOI 10.1093/bioinformatics/btl145; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Hart GT, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-120; Hulovatyy Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090073; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Lei CW, 2013, BIOINFORMATICS, V29, P355, DOI 10.1093/bioinformatics/bts688; Li M, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-15; Li YY, 2015, SCI REP-UK, V5, DOI 10.1038/srep09283; Liu WP, 2010, EPL-EUROPHYS LETT, V89, DOI 10.1209/0295-5075/89/58007; Lu L, 2009, PHYS REV E, V80; Mewes HW, 2006, NUCLEIC ACIDS RES, V34, pD169, DOI 10.1093/nar/gkj148; Nepusz T, 2012, NAT METHODS, V9, P471, DOI [10.1038/nmeth.1938, 10.1038/NMETH.1938]; Przulj N, 2011, BIOESSAYS, V33, P115, DOI 10.1002/bies.201000044; Shoemaker BA, 2007, PLOS COMPUT BIOL, V3, P595, DOI 10.1371/journal.pcbi.0030043; Tong HH, 2008, KNOWL INF SYST, V14, P327, DOI 10.1007/s10115-007-0094-2; Tong HH, 2006, IEEE DATA MINING, P613; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Wang JZ, 2007, BIOINFORMATICS, V23, P1274, DOI 10.1093/bioinformatics/btm087; Wang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108716; Wong DLK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S5-S15; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Zhang QC, 2012, NATURE, V490, P556, DOI 10.1038/nature11503; Zhang R, 2009, NUCLEIC ACIDS RES, V37, pD455, DOI 10.1093/nar/gkn858; Zhang W, 2015, IEEE ACM T COMPUT BI, V12, P879, DOI 10.1109/TCBB.2014.2386314; Zhang WJS., 2015, SELFORGANIZOLOGY, V2, P91; Zhao J, 2015, SCI REP-UK, V5, DOI 10.1038/srep12261	33	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177029	10.1371/journal.pone.0177029	http://dx.doi.org/10.1371/journal.pone.0177029			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493910	gold, Green Submitted, Green Published			2022-12-26	WOS:000401314300050
J	Crane, NL; Nelson, P; Abelson, A; Precoda, K; Rulmal, J; Bernardi, G; Paddack, M				Crane, Nicole L.; Nelson, Peter; Abelson, Avigdor; Precoda, Kristin; Rulmal, John, Jr.; Bernardi, Giacomo; Paddack, Michelle			Atoll-scale patterns in coral reef community structure: Human signatures on Ulithi Atoll, Micronesia	PLOS ONE			English	Article							MARINE RESERVES; FISH; HABITAT; BIODIVERSITY; DEGRADATION; RESILIENCE; MANAGEMENT; SPILLOVER; RICHNESS; IMPACTS	The dynamic relationship between reefs and the people who utilize them at a subsistence level is poorly understood. This paper characterizes atoll-scale patterns in shallow coral reef habitat and fish community structure, and correlates these with environmental characteristics and anthropogenic factors, critical to conservation efforts for the reefs and the people who depend on them. Hierarchical clustering analyses by site for benthic composition and fish community resulted in the same 3 major clusters: cluster 1-oceanic (close proximity to deep water) and uninhabited (low human impact); cluster 2-oceanic and inhabited (high human impact); and cluster 3-lagoonal (facing the inside of the lagoon) and inhabited (highest human impact). Distance from village, reef exposure to deep water and human population size had the greatest effect in predicting the fish and benthic community structure. Our study demonstrates a strong association between benthic and fish community structure and human use across the Ulithi Atoll (Yap State, Federated States of Micronesia) and confirms a pattern observed by local people that an 'opportunistic' scleractinian coral (Montipora sp.) is associated with more highly impacted reefs. Our findings suggest that small human populations (subsistence fishing) can nevertheless have considerable ecological impacts on reefs due, in part, to changes in fishing practices rather than overfishing per se, as well as larger global trends. Findings from this work can assist in building local capacity to manage reef resources across an atoll-wide scale, and illustrates the importance of anthropogenic impact even in small communities.	[Crane, Nicole L.] Cabrillo Coll, Dept Biol, Aptos, CA 95003 USA; [Crane, Nicole L.] Ocean Soc, Ross, CA 94957 USA; [Crane, Nicole L.; Nelson, Peter; Abelson, Avigdor; Precoda, Kristin; Rulmal, John, Jr.; Bernardi, Giacomo; Paddack, Michelle] One People One Reef, Santa Cruz, CA 95062 USA; [Nelson, Peter] HT Harvey & Associates, Bldg D, Los Gatos, CA USA; [Abelson, Avigdor] Tel Aviv Univ, Dept Zool, Ramat Aviv, Israel; [Precoda, Kristin] Univ Sydney, Marine Studies Inst, Sydney, NSW, Australia; [Rulmal, John, Jr.] Ulithi Falalop Community Act Program, Yap, Micronesia; [Bernardi, Giacomo] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Paddack, Michelle] Santa Barbara City Coll, Santa Barbara, CA USA	Tel Aviv University; University of Sydney; University of California System; University of California Santa Cruz	Crane, NL (corresponding author), Cabrillo Coll, Dept Biol, Aptos, CA 95003 USA.; Crane, NL (corresponding author), Ocean Soc, Ross, CA 94957 USA.; Crane, NL (corresponding author), One People One Reef, Santa Cruz, CA 95062 USA.	nicrane@cabrillo.edu	Bernardi, Giacomo/F-6346-2011	Bernardi, Giacomo/0000-0002-8249-4678	University of California Santa Cruz Pacific Rim award; David and Lucile Packard Foundation; The Nature Conservancy; Department of the Interior/Office of Insular Affairs [CRI-Ulithi1-2]; NOAA [NA15NMF4270336]; National Science Foundation [OCE 1546374]	University of California Santa Cruz Pacific Rim award; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); The Nature Conservancy; Department of the Interior/Office of Insular Affairs; NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); National Science Foundation(National Science Foundation (NSF))	This work was funded by a University of California Santa Cruz Pacific Rim award, the David and Lucile Packard Foundation, The Nature Conservancy, Department of the Interior/Office of Insular Affairs (CRI-Ulithi1-2), NOAA (Award # NA15NMF4270336), the National Science Foundation (OCE 1546374) and the many contributors to our Indiegogo crowd-funding campaign.	Abesamis RA, 2005, ECOL APPL, V15, P1798, DOI 10.1890/05-0174; Adam TC, 2015, MAR ECOL PROG SER, V520, P1, DOI 10.3354/meps11170; Adam TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023717; ALCALA AC, 1988, AMBIO, V17, P194; Allen GR, 2007, CONSERV INT REP, P1; Alvarez-Filip L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126004; Beldade R, 2015, PEERJ, V3, DOI 10.7717/peerj.745; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bellwood DR, 2001, SCIENCE, V292, P1532, DOI 10.1126/science.1058635; Bruno JF, 2016, SCI REP-UK, V6, DOI 10.1038/srep29778; Burgi M, 2013, FOREST ECOL MANAG, V289, P115, DOI 10.1016/j.foreco.2012.10.012; Burkepile DE, 2008, P NATL ACAD SCI USA, V105, P16201, DOI 10.1073/pnas.0801946105; Cinner JE, 2016, NATURE, V535, P416, DOI 10.1038/nature18607; Crane Nicole L., 2016, Journal of the Ocean Science Foundation, V21, P10; Cudney-Bueno R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004140; D'Angelo C, 2014, CURR OPIN ENV SUST, V7, P82, DOI 10.1016/j.cosust.2013.11.029; Darling ES, 2008, ECOL LETT, V11, P1278, DOI 10.1111/j.1461-0248.2008.01243.x; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; DeMartini EE, 2008, MAR ECOL PROG SER, V365, P199, DOI 10.3354/meps07501; Dulvy NK, 2015, NATURE, V520, P304, DOI 10.1038/nature14384; Dulvy NK, 2004, CAN J FISH AQUAT SCI, V61, P466, DOI 10.1139/F03-169; Espinoza-Tenorio A, 2013, ECOL SOC, V18, DOI 10.5751/ES-05369-180206; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Food and Agriculture Organization (FAO), 2009, CLIM CHANG FOOD SEC; FROESE R, 2000, FISHBASE 2000 CONCEP; Fujita R, 2013, MAR POLICY, V38, P538, DOI 10.1016/j.marpol.2012.05.025; Fukami H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003222; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Graham NAJ, 2007, CONSERV BIOL, V21, P1291, DOI 10.1111/j.1523-1739.2007.00754.x; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Harrison HB, 2012, CURR BIOL, V22, P1023, DOI 10.1016/j.cub.2012.04.008; Holbrook SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124054; Houk P, 2007, CONSERV INT REP, V43; Houk P, 2008, QUANTITATIVE ASSESSM; Hughes TP, 2002, ECOL LETT, V5, P775, DOI 10.1046/j.1461-0248.2002.00383.x; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Johnson AE, 2013, FISH FISH, V14, P281, DOI 10.1111/j.1467-2979.2012.00468.x; JOKIEL PL, 1990, CORAL REEFS, V8, P155, DOI 10.1007/BF00265006; Jouffray JB, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0268; Kittinger JN, 2013, CURR OPIN ENV SUST, V5, P352, DOI 10.1016/j.cosust.2013.06.008; Kittinger JN, 2012, ECOL SOC, V17, DOI 10.5751/ES-05115-170417; Kulbicki M, 2005, CYBIUM, V29, P235; Lessa William A, 1966, ULITHI MICRONESIAN D; Levis C, 2017, SCIENCE, V355, P925, DOI 10.1126/science.aal0157; Lilley I., 2010, EARLY HUMAN EXPANSIO; McClanahan TR, 2014, CURR OPIN ENV SUST, V7, P59, DOI 10.1016/j.cosust.2013.11.028; McClanahan TR, 2000, ECOL APPL, V10, P1792, DOI 10.2307/2641239; McCune B., 2002, ANAL ECOLOGICAL COMM, P1; Messmer V, 2011, ECOLOGY, V92, P2285, DOI 10.1890/11-0037.1; Mora C, 2008, P R SOC B, V275, P767, DOI 10.1098/rspb.2007.1472; Nystrom M, 2001, ECOSYSTEMS, V4, P406, DOI 10.1007/s10021-001-0019-y; Nystrom M, 2000, TRENDS ECOL EVOL, V15, P413, DOI 10.1016/S0169-5347(00)01948-0; Oksanen J, 2016, COMMUNITY ECOLOGY PA; Paddack MJ, 2009, CURR BIOL, V19, P590, DOI 10.1016/j.cub.2009.02.041; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Plass-Johnson JG, 2015, LIMNOL OCEANOGR, V60, P1382, DOI 10.1002/lno.10105; Poepoe KK., 2003, PUTTING FISHERSKNOWL, V11, P328; Quimbayo JP, 2017, ENVIRON BIOL FISH, V100, P149, DOI 10.1007/s10641-016-0557-y; Randall CJ, 2009, BIOL BULL-US, V217, P269, DOI 10.1086/BBLv217n3p269; ROBERTS CM, 1995, CONSERV BIOL, V9, P988, DOI 10.1046/j.1523-1739.1995.9051332.x-i1; ROY P, 1991, J COASTAL RES, V7, P1057; Russ GR, 2015, CORAL REEFS, V34, P773, DOI 10.1007/s00338-015-1296-9; Russ GR, 2015, MAR ECOL PROG SER, V529, P233, DOI 10.3354/meps11246; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Sheppard CRC, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198566359.001.0001; Smith JE, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.1985; Spalding MD, 2015, SCIENCE, V350, P769, DOI 10.1126/science.aad0349; Team RDC, 2016, R LANG ENV STAT COMP; Vroom PS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009733; Ward-Paige C, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011722, 10.1371/journal.pone.0011968]; Williams GJ, 2013, PEERJ, V1, DOI 10.7717/peerj.81; Williams ID, 2006, MAR ECOL PROG SER, V310, P139, DOI 10.3354/meps310139; Williams ID, PLOS ONE, V10; Wilson SK, 2008, GLOBAL CHANGE BIOL, V14, P2796, DOI 10.1111/j.1365-2486.2008.01696.x	74	7	7	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177083	10.1371/journal.pone.0177083	http://dx.doi.org/10.1371/journal.pone.0177083			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489903	gold, Green Published			2022-12-26	WOS:000401314100048
J	Dong, YT; Liu, H; Zhang, Y; Hu, JH; Feng, JY; Li, C; Li, C; Chen, JH; Zhu, SJ				Dong, Yating; Liu, Hui; Zhang, Yi; Hu, Jiahui; Feng, Jiyu; Li, Cong; Li, Cheng; Chen, Jinhong; Zhu, Shuijin			Comparative genomic study of ALDH gene superfamily in Gossypium: A focus on Gossypium hirsutum under salt stress	PLOS ONE			English	Article							ALDEHYDE DEHYDROGENASE GENE; SUBCELLULAR-LOCALIZATION; ARABIDOPSIS; EVOLUTIONARY; DUPLICATION; SEQUENCE; PLANTS; POLYPLOIDY; EXPRESSION; TOLERANCE	Aldehyde dehydrogenases (ALDHs) are a superfamily of enzymes which play important role in the scavenging of active aldehydes molecules. In present work, a comprehensive whole-genomic study of ALDH gene superfamily was carried out for an allotetraploid cultivated cotton species, G. hirsutum, as well as in parallel relative to their diploid progenitors, G. arboreum and G. raimondii. Totally, 30 and 58 ALDH gene sequences belong to 10 families were identified from diploid and allotetraploid cotton species, respectively. The gene structures among the members from same families were highly conserved. Whole-genome duplication and segmental duplication might be the major driver for the expansion of ALDH gene superfamily in G. hirsutum. In addition, the expression patterns of GhALDH genes were diverse across tissues. Most GhALDH genes were induced or repressed by salt stress in upland cotton. Our observation shed lights on the molecular evolutionary properties of ALDH genes in diploid cottons and their alloallotetraploid derivatives. It may be useful to mine key genes for improvement of cotton response to salt stress.	[Dong, Yating; Liu, Hui; Zhang, Yi; Hu, Jiahui; Feng, Jiyu; Li, Cong; Li, Cheng; Chen, Jinhong; Zhu, Shuijin] Zhejiang Univ, Dept Agron, Zhejiang Key Lab Crop Germplasm, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Chen, JH; Zhu, SJ (corresponding author), Zhejiang Univ, Dept Agron, Zhejiang Key Lab Crop Germplasm, Hangzhou, Zhejiang, Peoples R China.	jinhongchen@zju.edu.cn; shjzhu@zju.edu.cn	Dong, Yating/AAR-2051-2021	Dong, Yating/0000-0002-0268-2995; Li, Cheng/0000-0003-4366-6139	National High Technology Research and Development Program of China [2013AA102601]; China Agriculture Research System [CARS-18-25]; Jiangsu Collaborative Innovation Center for Modern Crop Production; Zhejiang Provincial Top Key Discipline of Biology Open Foundation [2016D06]; National Natural Science Foundation of China [31371667]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); China Agriculture Research System; Jiangsu Collaborative Innovation Center for Modern Crop Production; Zhejiang Provincial Top Key Discipline of Biology Open Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was funded by the National High Technology Research and Development Program of China (2013AA102601), China Agriculture Research System (CARS-18-25), Jiangsu Collaborative Innovation Center for Modern Crop Production, Zhejiang Provincial Top Key Discipline of Biology Open Foundation (2016D06), and National Natural Science Foundation of China (31371667).	Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BJELLQVIST B, 1994, ELECTROPHORESIS, V15, P529, DOI 10.1002/elps.1150150171; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Brocker C, 2010, J BIOL CHEM, V285, P18452, DOI 10.1074/jbc.M109.077925; Chen JM, 2015, PLANTA, V242, P137, DOI 10.1007/s00425-015-2290-8; Cong J, 2015, SCI REP-UK, V5, DOI [10.1038/srep10007, 10.1038/srep14139]; Dong YT, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00139; Flagel LE, 2009, NEW PHYTOL, V183, P557, DOI 10.1111/j.1469-8137.2009.02923.x; Force A, 1999, GENETICS, V151, P1531; Gao CX, 2009, GENE, V431, P86, DOI 10.1016/j.gene.2008.11.010; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guo Y, 2001, PLANT CELL, V13, P1383, DOI 10.1105/tpc.13.6.1383; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; He DH, 2014, GENE, V549, P123, DOI 10.1016/j.gene.2014.07.054; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Jimenez-Lopez JC, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-43; Kirch HH, 2005, PLANT MOL BIOL, V57, P315, DOI 10.1007/s11103-004-7796-6; Kirch HH, 2004, TRENDS PLANT SCI, V9, P371, DOI 10.1016/j.tplants.2004.06.004; Kotchoni SO, 2012, GENE, V495, P128, DOI 10.1016/j.gene.2011.12.035; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lan T, 2009, PLANT CELL, V21, P3749, DOI 10.1105/tpc.109.070219; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li FG, 2015, NAT BIOTECHNOL, V33, P524, DOI 10.1038/nbt.3208; Li FG, 2014, NAT GENET, V46, P567, DOI 10.1038/ng.2987; LINDAHL R, 1992, CRIT REV BIOCHEM MOL, V27, P283, DOI 10.3109/10409239209082565; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maher C, 2006, GENOME RES, V16, P510, DOI 10.1101/gr.4680506; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Missihoun TD, 2011, PLANTA, V233, P369, DOI 10.1007/s00425-010-1297-4; opdenCamp RGL, 1997, PLANT MOL BIOL, V35, P355, DOI 10.1023/A:1005889129491; Ouyang YD, 2009, PLANT MOL BIOL, V70, P341, DOI 10.1007/s11103-009-9477-y; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Rodrigues SM, 2006, J EXP BOT, V57, P1909, DOI 10.1093/jxb/erj132; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Skibbe David S., 2002, Plant Molecular Biology, V48, P751, DOI 10.1023/A:1014870429630; Sophos NA, 2003, CHEM-BIOL INTERACT, V143, P5, DOI 10.1016/S0009-2797(02)00163-1; Stiti N, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00065; Sunkar R, 2003, PLANT J, V35, P452, DOI 10.1046/j.1365-313X.2003.01819.x; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanaka KM, GENET RES CAMB; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Tian FX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124669; Vasiliou V, 1999, PHARMACOGENETICS, V9, P421, DOI 10.1097/00008571-199910000-00004; Vasiliou V, 2000, CHEM-BIOL INTERACT, V129, P1, DOI 10.1016/S0009-2797(00)00211-8; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wei YL, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-7; Wendel JF, 2003, ADV AGRON, V78, P139, DOI 10.1016/S0065-2113(02)78004-8; Wood AJ, 2009, BRYOLOGIST, V112, P1, DOI 10.1639/0007-2745-112.1.1; Yu CS, 2004, PROTEIN SCI, V13, P1402, DOI 10.1110/ps.03479604; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhang TZ, 2015, NAT BIOTECHNOL, V33, P531, DOI 10.1038/nbt.3207; Zhang YA, 2012, J NANOMATER, V2012, DOI 10.1155/2012/375496	56	8	8	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176733	10.1371/journal.pone.0176733	http://dx.doi.org/10.1371/journal.pone.0176733			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489898	gold, Green Submitted, Green Published			2022-12-26	WOS:000401314100029
J	Githaiga, MN; Kairo, JG; Gilpin, L; Huxham, M				Githaiga, Michael N.; Kairo, James G.; Gilpin, Linda; Huxham, Mark			Carbon storage in the seagrass meadows of Gazi Bay, Kenya	PLOS ONE			English	Article							THALASSODENDRON-CILIATUM; POSIDONIA-OCEANICA; MANGROVE FOREST; LEAF PRODUCTION; BLUE CARBON; IMPACT; SEQUESTRATION	Vegetated marine habitats are globally important carbon sinks, making a significant contribution towards mitigating climate change, and they provide a wide range of other ecosystem services. However, large gaps in knowledge remain, particularly for seagrass meadows in Africa. The present study estimated biomass and sediment organic carbon (C-org) stocks of four dominant seagrass species in Gazi Bay, Kenya. It compared sediment Corg between seagrass areas in vegetated and un-vegetated 'controls', using the naturally patchy occurence of seagrass at this site to test the impacts of seagrass growth on sediment C-org. It also explored relationships between the sediment and above-ground C-org, as well as between the total biomass and above-ground parameters. Sediment Corg was significantly different between species, range: 160.7-233.8 Mg C ha(-1) (compared to the global range of 115.3 to 829.2 Mg C ha(-1)). Vegetated areas in all species had significantly higher sediment C-org compared with un-vegetated controls; the presence of seagrass increased C-org by 4-6 times. Biomass carbon differed significantly between species with means ranging between 4.8-7.1 Mg C ha(-1) compared to the global range of 2.5-7.3 Mg C ha(-1). To our knowledge, these are among the first results on seagrass sediment Corg to be reported from African seagrass beds; and contribute towards our understanding of the role of seagrass in global carbon dynamics.	[Githaiga, Michael N.; Kairo, James G.] Kenya Marine & Fisheries Res Inst, Mombasa, Kenya; [Githaiga, Michael N.; Gilpin, Linda; Huxham, Mark] Edinburgh Napier Univ, Sch Appl Sci, Edinburgh, Midlothian, Scotland	Edinburgh Napier University	Githaiga, MN (corresponding author), Kenya Marine & Fisheries Res Inst, Mombasa, Kenya.; Githaiga, MN (corresponding author), Edinburgh Napier Univ, Sch Appl Sci, Edinburgh, Midlothian, Scotland.	njoroge.michael04@gmail.com	Githaiga, Michael/AAB-4442-2021; Huxham, Mark/D-4427-2015	James, Kairo/0000-0001-8325-2550; Huxham, Mark/0000-0001-7877-6675	Coastal Ecosystem Services in East Africa (CESEA) [NE/L001535/1]; Ecosystem Services for Poverty Alleviation (ESPA) programme; Department for International Development (DFID); Economic and Social Research Council (ESRC); Natural Environment Research Council (NERC); Edinburgh Napier University; Kenya Marine and Fisheries Research Institute (KMFRI); Natural Environment Research Council [NE/L001535/1] Funding Source: researchfish; NERC [NE/L001535/1] Funding Source: UKRI	Coastal Ecosystem Services in East Africa (CESEA); Ecosystem Services for Poverty Alleviation (ESPA) programme; Department for International Development (DFID); Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Edinburgh Napier University; Kenya Marine and Fisheries Research Institute (KMFRI); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This article is based on research undertaken for Coastal Ecosystem Services in East Africa (CESEA) NE/L001535/1 research project and was funded with support from the Ecosystem Services for Poverty Alleviation (ESPA) programme. The ESPA programme is funded by the Department for International Development (DFID), the Economic and Social Research Council (ESRC) and the Natural Environment Research Council (NERC). Additional support was made through Edinburgh Napier University and Kenya Marine and Fisheries Research Institute (KMFRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandeira SO, 2002, AQUAT BOT, V72, P13, DOI 10.1016/S0304-3770(01)00192-9; Bouillon S, 2004, BIOGEOSCIENCES, V1, P71, DOI 10.5194/bg-1-71-2004; Bouillon S, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000325; Chmura GL, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001917; COPPEJANS E, 1992, HYDROBIOLOGIA, V247, P59, DOI 10.1007/BF00008205; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Dahdouh E, 1999, HYDROBIOLOGIA, V400, P63; Dahl M, 2016, J ECOL, V104, P654, DOI 10.1111/1365-2745.12564; de la Torre-Castro M, 2004, OCEAN COAST MANAGE, V47, P361, DOI 10.1016/j.ocecoaman.2004.07.005; Duarte C.M., 2005, BIOGEOSCIENCES, V2, P2005; Duarte CM, 2013, NAT CLIM CHANGE, V3, P961, DOI [10.1038/nclimate1970, 10.1038/NCLIMATE1970]; Duarte CM, 1996, LIMNOL OCEANOGR, V41, P1758, DOI 10.4319/lo.1996.41.8.1758; Duarte CM, 1999, AQUAT BOT, V65, P159, DOI 10.1016/S0304-3770(99)00038-8; Duarte CM, 1996, AQUAT BOT, V55, P1, DOI 10.1016/0304-3770(96)01066-2; Erftemeier P., 1993, THESIS; Fourqurean JW, 2012, NAT GEOSCI, V5, P505, DOI 10.1038/ngeo1477; Gacia E, 2001, ESTUAR COAST SHELF S, V52, P505, DOI 10.1006/ecss.2000.0753; Githaiga MN, 2016, BOT MAR, V59, P173, DOI 10.1515/bot-2015-0075; Greiner JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072469; HAAS LW, 1977, ESTUAR COAST MAR SCI, V5, P485, DOI 10.1016/0302-3524(77)90096-2; HEMMINGA MA, 1995, AQUAT BOT, V50, P159, DOI 10.1016/0304-3770(95)00450-E; HEMMINGA MA, 1994, MAR ECOL PROG SER, V106, P291, DOI 10.3354/meps106291; Howard J., 2014, COASTAL BLUE CARBON, P99; IPCC, 2014, 2013 SUPPL 2006 IPCC, V2; Irving AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018311; ISAAC W E, 1968, Journal of the East Africa Natural History Society and National Museum, V27, P7; Kennedy H, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2010GB003848; Kitheka JU, 1996, LIMNOL OCEANOGR, V41, P169, DOI 10.4319/lo.1996.41.1.0169; Lavery PS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073748; Macreadie PI, 2014, MAR BIOL, V161, P2939, DOI 10.1007/s00227-014-2558-8; Marba N, 2002, MAR ECOL PROG SER, V226, P287, DOI 10.3354/meps226287; Marba N, 2015, J ECOL, V103, P296, DOI 10.1111/1365-2745.12370; McGlathery KJ, 2007, MAR ECOL PROG SER, V348, P1, DOI 10.3354/meps07132; Mcleod E, 2011, FRONT ECOL ENVIRON, V9, P552, DOI 10.1890/110004; MPRUT-KWS, 2016, PROP MAR TRANSB CONS; Nellemann C., 2009, BLUE CARBON RAPID RE; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Pendleton L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043542; Prrezllorrns JL, 1993, SEASONAL DYNAMICS BI, P46; Richmond Matthew, 1997, GUIDE SEASHORES E AF; ROMERO J, 1994, AQUAT BOT, V47, P13, DOI 10.1016/0304-3770(94)90044-2; Schott FA, 2009, REV GEOPHYS, V47, DOI 10.1029/2007RG000245; Serrano O, 2016, SCI REP-UK, V6, DOI 10.1038/srep23193; Serrano O, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00042; WATSON RA, 1993, AUST J MAR FRESH RES, V44, P211; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106	46	32	33	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177001	10.1371/journal.pone.0177001	http://dx.doi.org/10.1371/journal.pone.0177001			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489880	gold, Green Published, Green Submitted			2022-12-26	WOS:000401314100044
J	Kim, TN				Kim, Tania N.			How plant neighborhood composition influences herbivory: Testing four mechanisms of associational resistance and susceptibility	PLOS ONE			English	Article							INSECT HERBIVORES; INTERSPECIFIC COMPETITION; SOLIDAGO-ALTISSIMA; BRASSICA-NAPUS; SOIL-MOISTURE; DAMAGE; COMMUNITY; DENSITY; DEFENSE; GROWTH	Neighboring plants can decrease or increase each other's likelihood of damage from herbivores through associational resistance or susceptibility, respectively. Associational effects (AE) can transpire through changes in herbivore or plant traits that affect herbivore movement, densities, and feeding behaviors to ultimately affect plant damage. While much work has focused on understanding the mechanisms that underlie associational effects, we know little about how these mechanisms are influenced by neighborhood composition, i.e., plant density or relative frequency which is necessary to make predictions about when AE should occur in nature. Using a series of field and greenhouse experiments, I examined how plant density and relative frequency affected plant damage to Solanum carolinense and four mechanisms that underlie AE; (i) accumulation of insect herbivores and arthropod predators, (ii) microclimate conditions, (iii) plant resistance, and (iv) specialist herbivore preference. I found a positive relationship between S. carolinense damage and the relative frequency of a non-focal neighbor (Solidago altissima) and all four AE mechanisms were influenced by one or multiple neighborhood components. Frequency-dependence in S. carolinense damage is most likely due to greater generalist herbivore load on S. carolinense (through spillover from S. altissima) with microclimate variables, herbivore preference, predation pressures, and plant resistance having relatively weaker effects. Associational effects may have long-term consequences for these two plant species during plant succession and understanding context-dependent herbivory has insect pest management implication for other plant species in agriculture and forestry.	[Kim, Tania N.] Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA; [Kim, Tania N.] Univ Wisconsin, Great Lakes Bioenergy Res Ctr, Madison, WI 53706 USA	State University System of Florida; Florida State University; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison	Kim, TN (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.; Kim, TN (corresponding author), Univ Wisconsin, Great Lakes Bioenergy Res Ctr, Madison, WI 53706 USA.	tania.kim@wisc.edu			National Science Foundation Division of Environmental Biology [1110460]	National Science Foundation Division of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by the National Science Foundation Division of Environmental Biology #1110460. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2004, ECOLOGY, V85, P2118, DOI 10.1890/03-4084; Agrawal AA, 2006, Q REV BIOL, V81, P349, DOI 10.1086/511529; BACH CE, 1984, ECOLOGY, V65, P175; BACH CE, 1993, AM MIDL NAT, V130, P193, DOI 10.2307/2426287; Barbosa P, 2009, ANNU REV ECOL EVOL S, V40, P1, DOI 10.1146/annurev.ecolsys.110308.120242; BOSIO CF, 1990, ENVIRON ENTOMOL, V19, P465, DOI 10.1093/ee/19.3.465; Castagneyrol B, 2013, J ECOL, V101, P418, DOI 10.1111/1365-2745.12055; Chown S.L., 2004, INSECT PHYSL ECOLOGY, DOI DOI 10.1002/joc.5086; Cipollini DF, 2002, PLANT ECOL, V162, P227, DOI 10.1023/A:1020377627529; Cipollini DF, 2001, J CHEM ECOL, V27, P593, DOI 10.1023/A:1010384805014; EDWARDS RL, 1965, CAN ENTOMOL, V97, P401, DOI 10.4039/Ent97401-4; Feeny P., 1976, BIOCHEMICAL INTERACT, V10, P1, DOI [10.1007/978-1-4684-2646-5_1, DOI 10.1007/978-1-4684-2646-5_1]; Gelman A., 2007, DATA ANAL USING REGR; Hahn PG, 2016, ECOLOGY, V97, P2103, DOI 10.1002/ecy.1430; Hamback PA, 2005, ECOL LETT, V8, P1057, DOI 10.1111/j.1461-0248.2005.00811.x; Hamback PA, 2000, ECOLOGY, V81, P1784, DOI 10.1890/0012-9658(2000)081[1784:ARIDTP]2.0.CO;2; Hamback PA, 2014, ECOLOGY, V95, P1370, DOI 10.1890/13-0793.1; Himanen SJ, 2010, NEW PHYTOL, V186, P722, DOI 10.1111/j.1469-8137.2010.03220.x; HOLM S, 1979, SCAND J STAT, V6, P65; Hughes AR, 2012, ECOLOGY, V93, P1411, DOI 10.1890/11-1555.1; Inouye BD, 2001, ECOLOGY, V82, P2696, DOI 10.2307/2679954; Jactel H, 2007, ECOL LETT, V10, P835, DOI 10.1111/j.1461-0248.2007.01073.x; Karban R, 2001, BIOCHEM SYST ECOL, V29, P995, DOI 10.1016/S0305-1978(01)00046-1; Kim TN, 2015, ECOLOGY, V96, P1431, DOI 10.1890/14-1097.1; Kim TN, 2014, OIKOS, V123, P886, DOI 10.1111/j.1600-0706.2013.00946.x; Kim TN, 2013, ECOLOGY, V94, P1753, DOI 10.1890/12-1261.1; Kos M, 2015, ECOLOGY, V96, P164, DOI 10.1890/14-0563.1; Kost C, 2006, J ECOL, V94, P619, DOI 10.1111/j.1365-2745.2006.01120.x; Lapointe SL, 1999, FLA ENTOMOL, V82, P291, DOI 10.2307/3496582; Letourneau DK, 2011, ECOL APPL, V21, P9, DOI 10.1890/09-2026.1; LETOURNEAU DK, 1995, ECOL APPL, V5, P823, DOI 10.2307/1941990; Marquis RJ, 2002, OIKOS, V99, P531, DOI 10.1034/j.1600-0706.2002.11897.x; McNutt DW, 2012, OECOLOGIA, V170, P1033, DOI 10.1007/s00442-012-2377-x; Morrison S, 2004, CAN J ZOOL, V82, P533, DOI 10.1139/Z04-024; Orians CM, 2009, J TROP ECOL, V25, P551, DOI 10.1017/S0266467409990071; Orrock JL, 2010, ECOL LETT, V13, P11, DOI 10.1111/j.1461-0248.2009.01412.x; Plath M, 2012, OECOLOGIA, V169, P477, DOI 10.1007/s00442-011-2215-6; R Development Core Team, 2014, R LANG ENV STAT COMP; Rand TA, 1999, OECOLOGIA, V121, P39, DOI 10.1007/s004420050905; Root RB, 1996, ECOLOGY, V77, P1074, DOI 10.2307/2265577; Sato Y, 2016, EVOL ECOL, V30, P137, DOI 10.1007/s10682-015-9809-0; Schroeder R, 2008, BIOSCIENCE, V58, P308, DOI 10.1641/B580406; Shiojiri K, 2006, OECOLOGIA, V149, P214, DOI 10.1007/s00442-006-0441-0; SILANDER JA, 1985, OECOLOGIA, V66, P256, DOI 10.1007/BF00379863; Stastny M, 2014, ECOLOGY, V95, P2904, DOI 10.1890/13-1115.1; Strong D., 1984, INSECTS PLANTS COMMU; TAHVANAINEN JO, 1972, OECOLOGIA, V10, P321, DOI 10.1007/BF00345736; Turchin P, 2003, ECOLOGY, V84, P1207, DOI 10.1890/0012-9658(2003)084[1207:DEOPQA]2.0.CO;2; Underwood N, 2014, Q REV BIOL, V89, P1, DOI 10.1086/674991; Verschut TA, 2016, FUNCT ECOL, V30, P1826, DOI 10.1111/1365-2435.12670; WERNER PA, 1980, CAN J PLANT SCI, V60, P1393, DOI 10.4141/cjps80-194; Wise MJ, 2008, EVOL ECOL, V22, P19, DOI 10.1007/s10682-007-9156-x; Wise MJ, 2010, AM J BOT, V97, P525, DOI 10.3732/ajb.0900227; Wise MJ, 1996, OECOLOGIA, V108, P328, DOI 10.1007/BF00334658; Yamawo A, 2012, J PLANT RES, V125, P71, DOI 10.1007/s10265-011-0407-0	55	20	21	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0176499	10.1371/journal.pone.0176499	http://dx.doi.org/10.1371/journal.pone.0176499			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486538	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314000013
J	Lee, JY; Kim, TW; Kim, HT; Lee, MY; Min, HW; Won, YS; Kwon, HS; Park, KH; Kim, JM				Lee, Jae Yeun; Kim, Tae-Woo; Kim, Hyun Tae; Lee, Mi Yeon; Min, Hye Won; Won, Yu Sam; Kwon, Hyun Seok; Park, Ki Ho; Kim, Joon Mo		Korean Ophthalmological Soc	Relationship between anthropometric parameters and open angle glaucoma: The Korea National Health and Nutrition Examination Survey	PLOS ONE			English	Article							BODY-MASS INDEX; CEREBROSPINAL-FLUID PRESSURE; NORMAL-TENSION GLAUCOMA; HUMAN TRABECULAR MESHWORK; RISK-FACTORS; INTRAOCULAR-PRESSURE; OCULAR HYPERTENSION; METABOLIC SYNDROME; ALZHEIMER-DISEASE; PHYSICAL-ACTIVITY	Aims To evaluate the relationships between open-angle glaucoma (OAG) and various anthropometric measurements. Design Korea National Health and Nutrition Examination Survey (KNHANES), a population-based cross-sectional study using a complex, stratified, multistage, probability-cluster survey. Methods A total of 5,255 participants including 247 glaucoma patients, aged >= 19 years were included from the KNHANES V database. Glaucoma diagnosis was based on International Society of Geographical and Epidemiological Ophthalmology criteria. Various anthropometric data regarding obesity were analyzed including body mass index (BMI), total body fat mass, total body muscle mass (lean body mass, non-bone lean body mass, and appendicular skeletal muscle (ASM) mass), and waist circumference (WC). The differences in OAG prevalence with respect to anthropometric parameter quartiles were examined. Results In males, the multivariate general linear model adjusted for age, alcohol, smoking, exercise, systemic hypertension, diabetes, and intraocular pressure (IOP) showed the quartiles for the anthropometric parameters BMI, fat mass/weight ratio and fat mass/muscle mass ratio were negatively associated with OAG. However, muscle mass parameter/BMI ratio was significantly positively associated with OAG (P for trend< 0.05). In females, height and fat mass/ BMI showed a significant relationship with the risk of OAG. (P value< 0.05) Conclusions In the present study, high fat mass was associated with low OAG risk. Body composition seemed to affect the prevalence of OAG, but further evaluation is needed.	[Lee, Jae Yeun; Kim, Hyun Tae; Kim, Joon Mo] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Ophthalmol, Sch Med, Seoul, South Korea; [Kim, Tae-Woo] Seoul Natl Univ, Dept Ophthalmol, Bundang Hosp, Coll Med, Gyeonggi Do, South Korea; [Lee, Mi Yeon] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Sch Med, Dept R&D Management,Div Biostat, Seoul, South Korea; [Min, Hye Won] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Sch Med, Div Med Informat,Dept Phys Educ & Training, Seoul, South Korea; [Won, Yu Sam] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Sch Med, Dept Neurosurg, Seoul, South Korea; [Kwon, Hyun Seok] SU Yonsei Eye Clin, Seoul, South Korea; [Park, Ki Ho] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Ophthalmol, Coll Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul National University (SNU); Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul National University (SNU); Seoul National University Hospital	Kim, JM (corresponding author), Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Ophthalmol, Sch Med, Seoul, South Korea.	kjoonmo1@gmail.com		Kim, Tae-Woo/0000-0002-5180-0978				Anderson DR, 2003, AM J OPHTHALMOL, V136, P820, DOI 10.1016/S0002-9394(03)00478-1; Berdahl JP, 2008, INVEST OPHTH VIS SCI, V49, P5412, DOI 10.1167/iovs.08-2228; Bouloumie A, 1999, FASEB J, V13, P1231, DOI 10.1096/fasebj.13.10.1231; Caballero M, 2003, BIOCHEM BIOPH RES CO, V308, P346, DOI 10.1016/S0006-291X(03)01385-8; Cepeda-Valery B, 2011, NAT REV CARDIOL, V8, P233, DOI 10.1038/nrcardio.2010.209; Chon B, 2013, INVEST OPHTH VIS SCI, V54, P6570, DOI 10.1167/iovs.13-12173; Climie RED, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142589; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Fitzpatrick AL, 2009, ARCH NEUROL-CHICAGO, V66, P336, DOI 10.1001/archneurol.2008.582; Fleischman D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052664; Fleischman D, 2011, OPHTHALMOLOGY, V118, P1225, DOI 10.1016/j.ophtha.2011.01.025; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Gasser P, 1999, J GLAUCOMA, V8, P8; Gustafson DR, 2009, NEUROLOGY, V73, P1559, DOI 10.1212/WNL.0b013e3181c0d4b6; Hagstromer M, 2006, PUBLIC HEALTH NUTR, V9, P755, DOI 10.1079/PHN2005898; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; HEYMSFIELD SB, 1990, AM J CLIN NUTR, V52, P214, DOI 10.1093/ajcn/52.2.214; Howard KP, 2014, INVEST OPHTH VIS SCI, V55, P2592, DOI 10.1167/iovs.13-13763; Izzotti A, 2003, AM J MED, V114, P638, DOI 10.1016/S0002-9343(03)00114-1; Kim HT, 2017, AM J OPHTHALMOL, V173, P23, DOI 10.1016/j.ajo.2016.09.031; Kim M, 2014, ACTA OPHTHALMOL, V92, pe637, DOI 10.1111/aos.12434; Kim MJ, 2014, CLIN EXP OPHTHALMOL, V42, P825, DOI 10.1111/ceo.12347; Kim S.H., 2015, EUR HEART J; Kim Yang Jae, 2015, Korean J Ophthalmol, V29, P336, DOI 10.3341/kjo.2015.29.5.336; Kivipelto M, 2005, ARCH NEUROL-CHICAGO, V62, P1556, DOI 10.1001/archneur.62.10.1556; Kolovou GD, 2007, AM J MED SCI, V333, P362, DOI 10.1097/MAJ.0b013e318065c3a1; LESKE MC, 1995, ARCH OPHTHALMOL-CHIC, V113, P918, DOI 10.1001/archopht.1995.01100070092031; Lin SC, 2014, JAMA OPHTHALMOL, V132, P1414, DOI 10.1001/jamaophthalmol.2014.2876; Man REK, 2016, JAMA OPHTHALMOL, V134, P251, DOI 10.1001/jamaophthalmol.2015.5103; McMonnies CW, 2016, J OPTOM; Newman-Casey PA, 2011, OPHTHALMOLOGY, V118, P1318, DOI 10.1016/j.ophtha.2010.11.022; Pasquale LR, 2010, OPHTHALMOLOGY, V117, P1521, DOI 10.1016/j.ophtha.2009.12.017; Prior BM, 1997, J APPL PHYSIOL, V83, P623, DOI 10.1152/jappl.1997.83.2.623; Ren RJ, 2012, GRAEF ARCH CLIN EXP, V250, P445, DOI 10.1007/s00417-011-1746-1; Ren RJ, 2011, ACTA OPHTHALMOL, V89, pE142, DOI 10.1111/j.1755-3768.2010.02015.x; Ren RJ, 2010, OPHTHALMOLOGY, V117, P259, DOI 10.1016/j.ophtha.2009.06.058; Sacca SC, 2005, ARCH OPHTHALMOL-CHIC, V123, P458, DOI 10.1001/archopht.123.4.458; Shah P, 2001, EYE, V15, P616, DOI 10.1038/eye.2001.196; Suzuki Y, 2006, OPHTHALMOLOGY, V113, P1613, DOI 10.1016/j.ophtha.2006.03.059; Vohra R, 2013, SURV OPHTHALMOL, V58, P311, DOI 10.1016/j.survophthal.2012.08.010; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Whitmer RA, 2008, NEUROLOGY, V71, P1057, DOI 10.1212/01.wnl.0000306313.89165.ef; Whitmer RA, 2007, CURR ALZHEIMER RES, V4, P103, DOI 10.2174/156720507780362047; Williams PT, 2009, MED SCI SPORT EXER, V41, P1566, DOI 10.1249/MSS.0b013e31819e420f; Wong SL, 2004, J CLIN ENDOCR METAB, V89, P2672, DOI 10.1210/jc.2003-031931; World Health Organization, 2015, CONTR GLOB OB EP; Yoon Kyung-Chul, 2011, Korean J Ophthalmol, V25, P421, DOI 10.3341/kjo.2011.25.6.421; ZANG EA, 1994, NUTR CANCER, V21, P247, DOI 10.1080/01635589409514323; Zhao D, 2015, OPHTHALMOLOGY, V122, P72, DOI 10.1016/j.ophtha.2014.07.051	50	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0176894	10.1371/journal.pone.0176894	http://dx.doi.org/10.1371/journal.pone.0176894			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481907	Green Published, gold, Green Submitted			2022-12-26	WOS:000401313700022
J	Yang, L; Ruan, X; Jiang, DA; Zhang, JH; Pan, CD; Wang, Q				Yang, Li; Ruan, Xiao; Jiang, Dean; Zhang, Jianhong; Pan, Cunde; Wang, Qiang			Physiological effects of autotoxicity due to DHAP stress on Picea schrenkiana regeneration	PLOS ONE			English	Article							INDUCED CELL-DEATH; ANTIOXIDANT ENZYMES; LYCOPERSICON-ESCULENTUM; SUPEROXIDE DISMUTASES; GLUTATHIONE-REDUCTASE; HYDROGEN-PEROXIDE; SEED-GERMINATION; PROPIDIUM IODIDE; GIBBERELLIC-ACID; HIGHER-PLANTS	Picea Schrenkiana as one of the most important zonal vegetation was an endemic species in Middle Asia. Natural regeneration of P. Schrenkiana is a long existing problem troubling scientists. The autotoxicity of 3,4-dihydroxy-acetophenone (DHAP) was found to be a causative factor causing the failure of P. Schrenkiana natural regeneration. The effects of concentrations of DHAP treatment on the viability of root cell, activities of antioxidant enzymes and levels of P. Schrenkiana phytohormones were performed to disclose the physiological mechanism of DHAP autotoxicity. It was observed that high concentration of DHAP could inhibit the seed germination and seedling growth, but had a hormesis at low concentrations. Analyses showed that the root cells significantly lost their viability treated with high DHAP. The enzymes activities of seedlings were significantly stimulated by the treatment of 0.5 mM DHAP to give a transient increase and then decrease as DHAP concentration increased to 1.0 mM except for GR (glutathione reductase) in which DHAP treatment had little effect on its activity. Comparing with the control, an increase in the levels of phytohormones ZT (zeatin), GA3 (gibberellic acid) and IAA (indole acetic acid) was induced by the treatment of DHAP at low concentrations (0.1-0.25 mM), but the significant deficiency was found treated by high concentrations (0.5-1.0 mM). In addition, the ABA (abscisic acid) level increased in all experimental observations. These results suggested that DHAP significantly affected indices of growth and physiology, and provided some new information about different effect in P. Schrenkiana treated with DHAP.	[Yang, Li; Ruan, Xiao; Wang, Qiang] Zhejiang Univ, Ningbo Inst Technol, Ningbo, Zhejiang, Peoples R China; [Yang, Li; Jiang, Dean] Zhejiang Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Zhang, Jianhong] Ningbo Acad Agr Sci, Ningbo, Zhejiang, Peoples R China; [Pan, Cunde] Xinjiang Agr Univ, Coll Forestry & Hort, Urumqi, Peoples R China	Zhejiang University; Zhejiang University; Xinjiang Agricultural University	Wang, Q (corresponding author), Zhejiang Univ, Ningbo Inst Technol, Ningbo, Zhejiang, Peoples R China.	wangqiangsky@263.net			Natural Science Foundation of China (NSFC) [31670631]; Preferential Foundation for Postdoctoral Research Project of Zhejiang [20300586201]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Preferential Foundation for Postdoctoral Research Project of Zhejiang	This work was supported by Natural Science Foundation of China (NSFC, 31670631) and Preferential Foundation for Postdoctoral Research Project of Zhejiang (20300586201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2004, BIOL PLANTARUM, V48, P555, DOI 10.1023/B:BIOP.0000047152.07878.e7; Alrababah MA, 2009, NEW FOREST, V38, P261, DOI 10.1007/s11056-009-9145-8; Batish DR, 2008, J PLANT PHYSIOL, V165, P297, DOI 10.1016/j.jplph.2007.05.003; BOWLER C, 1992, ANNU REV PLANT PHYS, V43, P83, DOI 10.1146/annurev.pp.43.060192.000503; Broncano MJ, 1998, PLANT ECOL, V138, P17, DOI 10.1023/A:1009784215900; CAKMAK I, 1992, PLANT PHYSIOL, V98, P1222, DOI 10.1104/pp.98.4.1222; Callaway RM, 2000, SCIENCE, V290, P521, DOI 10.1126/science.290.5491.521; Devi SR, 1996, BIOL PLANTARUM, V38, P387, DOI 10.1007/BF02896668; Duke SO, 2010, ALLELOPATHY J, V25, P17; Falik O, 2003, J ECOL, V91, P525, DOI 10.1046/j.1365-2745.2003.00795.x; Fernandez C, 2008, FOREST ECOL MANAG, V255, P2928, DOI 10.1016/j.foreco.2008.01.072; Fernandez C, 2009, J CHEM ECOL, V35, P970, DOI 10.1007/s10886-009-9667-8; GALLET C, 1994, J CHEM ECOL, V20, P1009, DOI 10.1007/BF02059738; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P309, DOI 10.1104/pp.59.2.309; Gossett DR, 1996, PLANT PHYSIOL, V112, P803, DOI 10.1104/pp.112.2.803; Ha S, 2012, TRENDS PLANT SCI, V17, P172, DOI 10.1016/j.tplants.2011.12.005; HALLIWELL B, 1978, PLANTA, V139, P9, DOI 10.1007/BF00390803; Hao ZP, 2007, SCI HORTIC-AMSTERDAM, V112, P315, DOI 10.1016/j.scienta.2006.12.030; Harrison Marcia A, 2012, PHYTOHORMONES ABIOTI, P49, DOI [10.1007/978-981-10-7479-0_12, DOI 10.1007/978-981-10-7479-0_12]; Inderjit, 2006, TRENDS PLANT SCI, V11, P574, DOI 10.1016/j.tplants.2006.10.004; JONES KH, 1985, J HISTOCHEM CYTOCHEM, V33, P77, DOI 10.1177/33.1.2578146; Kamal J, 2008, AFR J BIOTECHNOL, V7; Kato-Noguchi H, 2010, J PLANT PHYSIOL, V167, P468, DOI 10.1016/j.jplph.2009.10.018; Kaya Y, 2015, TOXICOL IND HEALTH, V31, P247, DOI 10.1177/0748233712471702; Kazan K, 2013, ANN BOT-LONDON, V112, P1655, DOI 10.1093/aob/mct229; KEFU Z, 1991, AUST J PLANT PHYSIOL, V18, P17, DOI 10.1071/PP9910017; KOCHBA J, 1977, PLANT CELL PHYSIOL, V18, P463, DOI 10.1093/oxfordjournals.pcp.a075455; Lara-Nunez A, 2006, PLANT CELL ENVIRON, V29, P2009, DOI 10.1111/j.1365-3040.2006.01575.x; Lara-Nunez A, 2009, PHYSIOL PLANTARUM, V136, P180, DOI 10.1111/j.1399-3054.2009.01228.x; Lee DH, 2001, J PLANT PHYSIOL, V158, P737, DOI 10.1078/0176-1617-00174; Li ZH, 2009, CHINESE J ANAL CHEM, V37, P888; LINCOLN C, 1990, PLANT CELL, V2, P1071, DOI 10.1105/tpc.2.11.1071; Maffei M, 1999, PLANT SCI, V141, P139, DOI 10.1016/S0168-9452(98)00235-0; Mallik AU, 2003, CRIT REV PLANT SCI, V22, P341, DOI 10.1080/713610860; MALLIK AU, 1988, FOREST ECOL MANAG, V23, P273, DOI 10.1016/0378-1127(88)90058-8; Matsukura C, 1998, PLANTA, V205, P145, DOI 10.1007/s004250050306; Mazhoudi S, 1997, PLANT SCI, V127, P129, DOI 10.1016/S0168-9452(97)00116-7; Mushtaq MN, 2013, PLANT PHYSIOL BIOCH, V70, P374, DOI 10.1016/j.plaphy.2013.06.003; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Nathan R, 2004, PLANT ECOL, V171, P123, DOI 10.1023/B:VEGE.0000029379.32705.0f; O'Brien MJ, 2007, FOREST ECOL MANAG, V240, P178, DOI 10.1016/j.foreco.2006.12.025; Pan JW, 2001, ENVIRON EXP BOT, V46, P71, DOI 10.1016/S0098-8472(01)00083-1; Qin F, 2011, PLANT PHYSIOL, V157, P1900, DOI 10.1104/pp.111.187302; Reddy AR, 2004, J PLANT PHYSIOL, V161, P1189, DOI 10.1016/j.jplph.2004.01.013; Romero-Romero T, 2002, J CHEM ECOL, V28, P617, DOI 10.1023/A:1014504531418; Ruan X, 2011, MOLECULES, V16, P8874, DOI 10.3390/molecules16108874; SCANDALIOS JG, 1993, PLANT PHYSIOL, V101, P7, DOI 10.1104/pp.101.1.7; Schenk HJ, 1999, ADV ECOL RES, V28, P145, DOI 10.1016/S0065-2504(08)60032-X; Sunohara Y, 2008, PHYTOCHEMISTRY, V69, P2312, DOI 10.1016/j.phytochem.2008.06.012; Tamas L, 2004, ENVIRON EXP BOT, V51, P281, DOI 10.1016/j.envexpbot.2003.11.007; THIBAULT JR, 1982, AM J BOT, V69, P676, DOI 10.2307/2442957; Turker M, 2008, ALLELOPATHY J, V21, P273; Ullah N, 2015, TOXICOL IND HEALTH, V31, P931, DOI 10.1177/0748233713483205; Umebayashi Y, 2003, J BIOCHEM, V134, P219, DOI 10.1093/jb/mvg132; Utsugi E, 2006, FOREST ECOL MANAG, V237, P15, DOI 10.1016/j.foreco.2006.09.011; Wang Q, 2006, FOREST CHRON, V82, P31, DOI 10.5558/tfc82031-1; WEIDENHAMER JD, 1989, J APPL ECOL, V26, P613, DOI 10.2307/2404086; Weir TL, 2004, CURR OPIN PLANT BIOL, V7, P472, DOI 10.1016/j.pbi.2004.05.007; Wu T, 2008, SCI HORTIC-AMSTERDAM, V116, P27, DOI 10.1016/j.scienta.2007.11.003; Yang GQ, 2006, ALLELOPATHY J, V18, P237; Yang L, 2016, MOLECULES, V21, DOI 10.3390/molecules21040528; Ye SF, 2006, ENVIRON EXP BOT, V56, P255, DOI 10.1016/j.envexpbot.2005.02.010; Yokoyama H, 1997, J FISH DIS, V20, P281, DOI 10.1046/j.1365-2761.1997.00293.x; Yu JQ, 2003, BIOCHEM SYST ECOL, V31, P129, DOI 10.1016/S0305-1978(02)00150-3; Yu JQ, 2000, PLANT SOIL, V223, P149, DOI 10.1023/A:1004829512147; Zeevaart JAD, 2003, ANNU REV PLANT BIOL, V39, P439; Zhang AH, 2011, J MED PLANTS RES, V5, P3217; Zhang J, 1990, ACTA AGR BOREALI S S, V5, P19; ZHANG QS, 1993, PLANT SOIL, V151, P205, DOI 10.1007/BF00016285	69	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177047	10.1371/journal.pone.0177047	http://dx.doi.org/10.1371/journal.pone.0177047			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481896	Green Published, Green Submitted, gold			2022-12-26	WOS:000401313700029
J	Maurus, K; Hufnagel, A; Geiger, F; Graf, S; Berking, C; Heinemann, A; Paschen, A; Kneitz, S; Stigloher, C; Geissinger, E; Otto, C; Bosserhoff, A; Schartl, M; Meierjohann, S				Maurus, K.; Hufnagel, A.; Geiger, F.; Graf, S.; Berking, C.; Heinemann, A.; Paschen, A.; Kneitz, S.; Stigloher, C.; Geissinger, E.; Otto, C.; Bosserhoff, A.; Schartl, M.; Meierjohann, S.			The AP-1 transcription factor FOSL1 causes melanocyte reprogramming and transformation	ONCOGENE			English	Article							C-JUN; METASTATIC MELANOMA; CANCER METASTASIS; CELLS; ACTIVATION; FRA-1; MITF; GENE; DEDIFFERENTIATION; PHOSPHORYLATION	The MAPK pathway is activated in the majority of melanomas and is the target of therapeutic approaches. Under normal conditions, it initiates the so-called immediate early response, which encompasses the transient transcription of several genes belonging to the AP-1 transcription factor family. Under pathological conditions, such as continuous MAPK pathway overactivation due to oncogenic alterations occurring in melanoma, these genes are constitutively expressed. The consequences of a permanent expression of these genes are largely unknown. Here, we show that FOSL1 is the main immediate early AP-1 member induced by melanoma oncogenes. We first examined its role in established melanoma cells. We found that FOSL1 is involved in melanoma cell migration as well as cell proliferation and anoikis-independent growth, which is mediated by the gene product of its target gene HMGA1, encoding a multipotent chromatin modifier. As FOSL1 expression is increased in patient melanoma samples compared to nevi, we investigated the effect of enhanced FOSL1 expression on melanocytes. Intriguingly, we found that FOSL1 acts oncogenic and transforms melanocytes, enabling subcutaneous tumor growth in vivo. During the process of transformation, FOSL1 reprogrammed the melanocytes and downregulated MITF in a HMGA1-dependent manner. At the same time, AXL was upregulated, leading to a shift in the MITF/AXL balance. Furthermore, FOSL1 re-enforced pro-tumorigenic transcription factors MYC, E2F3 and AP-1. Together, this led to the enhancement of several growth-promoting processes, such as ribosome biogenesis, cellular detachment and pyrimidine metabolism. Overall, we demonstrate that FOSL1 is a novel reprogramming factor for melanocytes with potent tumor transformation potential.	[Maurus, K.; Hufnagel, A.; Geiger, F.; Kneitz, S.; Schartl, M.; Meierjohann, S.] Univ Wurzburg, Dept Phys Chem, Wurzburg, Germany; [Maurus, K.; Geissinger, E.] Univ Wurzburg, Inst Pathol, Wurzburg, Germany; [Graf, S.; Berking, C.] Munich Univ Hosp LMU, Dept Dermatol & Allergy, Munich, Germany; [Heinemann, A.] Paul Ehrlich Inst, Div Immunol, Langen, Germany; [Paschen, A.] Univ Duisburg Essen, Univ Hosp Essen, Dept Dermatol, Partner Site Essen, Essen, Germany; [Paschen, A.] German Canc Consortium DKTK, Partner Site Essen Dusseldorf, Essen, Germany; [Stigloher, C.] Univ Wurzburg, Div Elect Microscopy, Dept Cell & Dev Biol, Wurzburg, Germany; [Otto, C.] Univ Hosp Wurzburg, Dept Gen Visceral Vasc & Pediat Surg, Expt Surg, Wurzburg, Germany; [Bosserhoff, A.] Friedrich Alexander Univ Erlangen Nurnberg, Emil Fischer Ctr, Inst Biochem, Nurnberg, Germany; [Bosserhoff, A.] Univ Erlangen Nurnberg, Comprehens Canc Ctr Erlangen EMN, Erlangen, Germany; [Schartl, M.; Meierjohann, S.] Univ Hosp Wurzburg, Comprehens Canc Ctr Mainfranken, Wurzburg, Germany; [Schartl, M.] Texas A&M Univ, Texas A&M Inst Adv Studies, College Stn, TX USA; [Schartl, M.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA	University of Wurzburg; University of Wurzburg; University of Munich; Paul Ehrlich Institute; University of Duisburg Essen; Helmholtz Association; German Cancer Research Center (DKFZ); University of Wurzburg; University of Wurzburg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Wurzburg; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Meierjohann, S (corresponding author), Univ Wurzburg, Dept Physiol Chem, Bioctr, D-97074 Wurzburg, Bavaria, Germany.	svenja.meierjohann@biozentrum.uni-wuerzburg.de	Bosserhoff, Anja/GNH-4801-2022	Geiger, Fabienne/0000-0002-7550-9739; Bosserhoff, Anja/0000-0001-8147-394X	Melanoma Research Network of the Deutsche Krebshilfe eV (German Cancer Aid); research unit FOR2314, German Research Foundation	Melanoma Research Network of the Deutsche Krebshilfe eV (German Cancer Aid)(Deutsche Krebshilfe); research unit FOR2314, German Research Foundation	This work was supported by the Melanoma Research Network of the Deutsche Krebshilfe eV (German Cancer Aid) and by the research unit FOR2314, project 5 (German Research Foundation). We are furthermore grateful to Manfred Gessler (Dept of Developmental Biochemistry, University of Wurzburg) for providing us with the pSB-ET-iE vector and to Stefan Gaubatz (Dept. of Physiological Chemistry, University of Wurzburg) for the E2F3 antibody. We would also like to thank Marie-Christine Dabauvalle (Dept of Zoology and Developmental Biology, University of Wurzburg) for sharing the fibrillarin antibody with us.	Basbous J, 2007, MOL CELL BIOL, V27, P3936, DOI 10.1128/MCB.01776-06; Belton A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030034; Bianchi-Smiraglia A, 2017, ONCOGENE, V36, P84, DOI 10.1038/onc.2016.178; Chinenov Y, 2001, ONCOGENE, V20, P2438, DOI 10.1038/sj.onc.1204385; COHEN DR, 1988, MOL CELL BIOL, V8, P2063, DOI 10.1128/MCB.8.5.2063; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Das KC, 2010, MOL CELL BIOCHEM, V337, P53, DOI 10.1007/s11010-009-0285-0; Desmet CJ, 2013, P NATL ACAD SCI USA, V110, P5139, DOI 10.1073/pnas.1222085110; Elkon R, 2015, EMBO REP, V16, P1723, DOI 10.15252/embr.201540717; Gentilella A, 2015, BBA-GENE REGUL MECH, V1849, P812, DOI 10.1016/j.bbagrm.2015.02.005; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iskit S, 2015, ONCOTARGET, V6, P43146, DOI 10.18632/oncotarget.6454; Kapoor A, 2014, CELL, V158, P185, DOI 10.1016/j.cell.2014.06.003; Kappelmann M, 2013, ONCOGENE, V32, P2984, DOI 10.1038/onc.2012.307; Landsberg J, 2012, NATURE, V490, P412, DOI 10.1038/nature11538; Leikam C, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.71; Lister JA, 2014, J INVEST DERMATOL, V134, P133, DOI 10.1038/jid.2013.293; Lopez-Bergami P, 2010, J BIOL CHEM, V285, P903, DOI 10.1074/jbc.M109.075630; Mandal R, 2016, ONCOGENE, V35, P2547, DOI 10.1038/onc.2015.329; Martin RM, 2007, HISTOCHEM CELL BIOL, V127, P243, DOI 10.1007/s00418-006-0256-4; Muller J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6712; NAKABEPPU Y, 1993, MOL CELL BIOL, V13, P4157, DOI 10.1128/MCB.13.7.4157; NISHINA H, 1990, P NATL ACAD SCI USA, V87, P3619, DOI 10.1073/pnas.87.9.3619; Ploper D, 2015, P NATL ACAD SCI USA, V112, pE420, DOI 10.1073/pnas.1424576112; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Renaud SJ, 2014, J BIOL CHEM, V289, P5025, DOI 10.1074/jbc.M113.523746; Riesenberg S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9755; SAEZ E, 1995, CELL, V82, P721, DOI 10.1016/0092-8674(95)90469-7; Sensi M, 2011, J INVEST DERMATOL, V131, P2448, DOI 10.1038/jid.2011.218; Shah SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048533; Shain AH, 2015, NEW ENGL J MED, V373, P1926, DOI 10.1056/NEJMoa1502583; Shaulian E, 2000, CELL, V103, P897, DOI 10.1016/S0092-8674(00)00193-8; Spangler B, 2011, PIGM CELL MELANOMA R, V24, P148, DOI 10.1111/j.1755-148X.2010.00787.x; Spangler B, 2012, INT J CANCER, V130, P2801, DOI 10.1002/ijc.26277; Thomas S, 2008, HUM MOL GENET, V17, P3411, DOI 10.1093/hmg/ddn235; Tice DA, 2002, J BIOL CHEM, V277, P6118, DOI 10.1074/jbc.M111255200; Ting CH, 2016, ONCOTARGET, V7, P40329, DOI 10.18632/oncotarget.9612; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Vincek V, 2010, J CUTAN PATHOL, V37, P3, DOI 10.1111/j.1600-0560.2009.01299.x; Vogt PK, 2002, NAT REV CANCER, V2, P465, DOI 10.1038/nrc818; Vredeveld LCW, 2012, GENE DEV, V26, P1055, DOI 10.1101/gad.187252.112; Wellbrock C, 2015, PIGM CELL MELANOMA R, V28, P390, DOI 10.1111/pcmr.12370; Widmer DS, 2012, PIGM CELL MELANOMA R, V25, P343, DOI 10.1111/j.1755-148X.2012.00986.x; Yang S, 2013, ONCOGENE, V32, P4294, DOI 10.1038/onc.2012.432; Zanconato F, 2015, NAT CELL BIOL, V17, P1218, DOI 10.1038/ncb3216	45	41	43	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 7	2017	36	36					5110	5121		10.1038/onc.2017.135	http://dx.doi.org/10.1038/onc.2017.135			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FF9XD	28481878				2022-12-26	WOS:000409371100003
J	Gupta, D; Jetton, TL; LaRock, K; Monga, N; Satish, B; Lausier, J; Peshavaria, M; Leahy, JL				Gupta, Dhananjay; Jetton, Thomas L.; LaRock, Kyla; Monga, Navjot; Satish, Basanthi; Lausier, James; Peshavaria, Mina; Leahy, Jack L.			Temporal characterization of cell-adaptive and -maladaptive mechanisms during chronic high-fat feeding in C57BL/6NTac mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell; gene expression; insulin secretion; peroxisome proliferator-activated receptor (PPAR); unfolded protein response (UPR); adaptation; high-fat diet	ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; TYPE-2 DIABETES-MELLITUS; DIET-INDUCED OBESE; BETA-CELLS; INSULIN-RESISTANCE; ER STRESS; RECEPTOR EXPRESSION; INDUCED APOPTOSIS; MASS	The onset of type 2 diabetes is characterized by transition from successful to failed insulin secretory compensation to obesity-related insulin resistance and dysmetabolism. Energy-rich diets in rodents are commonly studied models of compensatory increases in both insulin secretion and cell mass. However, the mechanisms of these adaptive responses are incompletely understood, and it is also unclear why these responses eventually fail. We measured the temporal trends of glucose homeostasis, insulin secretion, cell morphometry, and islet gene expression in C57BL/6NTac mice fed a 60% high-fat diet (HFD) or control diet for up to 16 weeks. A 2-fold increased hyperinsulinemia was maintained for the first 4 weeks of HFD feeding and then further increased through 16 weeks. cell mass increased progressively starting at 4 weeks, principally through nonproliferative growth. Insulin sensitivity was not significantly perturbed until 11 weeks of HFD feeding. Over the first 8 weeks, we observed two distinct waves of increased expression of cell functional and prodifferentiation genes. This was followed by activation of the unfolded protein response at 8 weeks and overt cell endoplasmic reticulum stress at 12-16 weeks. In summary, cell adaptation to an HFD in C57BL/6NTac mice entails early insulin hypersecretion and a robust growth phase along with hyperexpression of related genes that begin well before the onset of observed insulin resistance. However, continued HFD exposure results in cessation of gene hyperexpression, cell functional failure, and endoplasmic reticulum stress. These data point to a complex but not sustainable integration of cell-adaptive responses to nutrient overabundance, obesity development, and insulin resistance.	[Gupta, Dhananjay; Jetton, Thomas L.; LaRock, Kyla; Monga, Navjot; Satish, Basanthi; Lausier, James; Peshavaria, Mina; Leahy, Jack L.] Univ Vermont, Div Endocrinol Diabet & Metab, Burlington, VT 05446 USA	University of Vermont	Leahy, JL (corresponding author), Univ Vermont, Larner Coll Med, Colchester Res Facil, 360 South Pk Dr, Colchester, VT 05446 USA.	jleahy@uvm.edu			American Diabetes Association; National Institutes of Health [DK56818]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056818, R56DK056818] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by research grants from the American Diabetes Association (to J. L. L.) and National Institutes of Health Grant DK56818 (to J. L. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahren J, 2010, ISLETS, V2, P353, DOI 10.4161.islets.2.6.13619; Alejandro EU, 2015, MOL ASPECTS MED, V42, P19, DOI 10.1016/j.mam.2014.12.002; Alonso LC, 2012, OBESITY, V20, P1403, DOI 10.1038/oby.2012.36; Bonner-Weir S, 2010, DIABETES, V59, P2340, DOI 10.2337/db10-0084; Butler AE, 2010, DIABETOLOGIA, V53, P2167, DOI 10.1007/s00125-010-1809-6; Cantley J, 2010, DIABETES OBES METAB, V12, P159, DOI 10.1111/j.1463-1326.2010.01276.x; El Ouaamari A, 2016, CELL METAB, V23, P194, DOI 10.1016/j.cmet.2015.12.001; Evans-Molina C, 2013, DIABETES OBES METAB, V15, P159, DOI 10.1111/dom.12163; Evans-Molina C, 2009, MOL CELL BIOL, V29, P2053, DOI 10.1128/MCB.01179-08; Gonzalez A, 2013, ENDOCRINOLOGY, V154, P3515, DOI 10.1210/en.2013-1424; Gupta D, 2008, J BIOL CHEM, V283, P32462, DOI 10.1074/jbc.M801813200; Gupta D, 2013, J BIOL CHEM, V288, P25440, DOI 10.1074/jbc.M113.486852; Gupta D, 2010, DIABETES, V59, P1445, DOI 10.2337/db09-1655; Halban PA, 2014, DIABETES CARE, V37, P1751, DOI 10.2337/dc14-0396; Imai J, 2008, SCIENCE, V322, P1250, DOI 10.1126/science.1163971; Jalali S, 2008, BBA-MOL CELL RES, V1783, P2344, DOI 10.1016/j.bbamcr.2008.08.014; Jetton TL, 2008, AM J PHYSIOL-ENDOC M, V294, pE679, DOI 10.1152/ajpendo.00569.2007; Jetton TL, 2005, DIABETES, V54, P2294, DOI 10.2337/diabetes.54.8.2294; Jetton TL, 2001, DIABETOLOGIA, V44, P2056, DOI 10.1007/s001250100011; Jitrapakdee S, 2010, DIABETOLOGIA, V53, P1019, DOI 10.1007/s00125-010-1685-0; Kahn SE, 2014, LANCET, V383, P1068, DOI 10.1016/S0140-6736(13)62154-6; Kim H, 2000, DIABETES, V49, P1517, DOI 10.2337/diabetes.49.9.1517; Kim HI, 2002, DIABETES, V51, P676, DOI 10.2337/diabetes.51.3.676; Kim HS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050128; Leahy J. L., 2014, THERAPY DIABETES MEL, V6th, P92; Leahy JL, 2005, ARCH MED RES, V36, P197, DOI 10.1016/j.arcmed.2005.01.003; Lin YQ, 2001, DIABETOLOGIA, V44, P1026, DOI 10.1007/s001250100597; Liu YQ, 2002, J BIOL CHEM, V277, P39163, DOI 10.1074/jbc.M207157200; Mahmazi S, 2013, INT J DIABETES DEV C, V33, P219, DOI 10.1007/s13410-013-0152-0; Mathijs I, 2014, MOL NUTR FOOD RES, V58, P1980, DOI 10.1002/mnfr.201400211; Michalak M, 1999, BIOCHEM J, V344, P281, DOI 10.1042/0264-6021:3440281; Moibi JA, 2007, DIABETES, V56, P88, DOI 10.2337/db06-0948; Montgomery MK, 2013, DIABETOLOGIA, V56, P1129, DOI 10.1007/s00125-013-2846-8; Mosser RE, 2015, AM J PHYSIOL-ENDOC M, V308, pE573, DOI 10.1152/ajpendo.00460.2014; Papa FR, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007666; Park SY, 2005, DIABETES, V54, P3530, DOI 10.2337/diabetes.54.12.3530; Paulsen SJ, 2010, OBESITY, V18, P266, DOI 10.1038/oby.2009.245; Peshavaria M, 2006, DIABETES, V55, P3289, DOI 10.2337/db06-0017; Peyot ML, 2010, DIABETES, V59, P2178, DOI 10.2337/db09-1452; Porat S, 2011, CELL METAB, V13, P440, DOI 10.1016/j.cmet.2011.02.012; Puri S, 2009, DIABETES, V58, P433, DOI 10.2337/db08-0749; Ramos RR, 2007, P NATL ACAD SCI USA, V104, P10470, DOI 10.1073/pnas.0701114104; Rivera JF, 2014, J CLIN INVEST, V124, P3489, DOI 10.1172/JCI71981; Sachdeva MM, 2009, P NATL ACAD SCI USA, V106, P19090, DOI 10.1073/pnas.0904849106; Saisho Y, 2013, DIABETES CARE, V36, P111, DOI 10.2337/dc12-0421; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Sharma RB, 2015, J CLIN INVEST, V125, P3831, DOI 10.1172/JCI79264; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Stamateris RE, 2013, AM J PHYSIOL-ENDOC M, V305, pE149, DOI 10.1152/ajpendo.00040.2013; Stewart AF, 2015, DIABETES, V64, P1872, DOI 10.2337/db14-1843; Takatani T, 2016, SCI REP-UK, V6, DOI 10.1038/srep28177; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660; Wagner R, 2014, MOL METAB, V3, P676, DOI 10.1016/j.molmet.2014.07.001; Weir GC, 2013, ANN NY ACAD SCI, V1281, P92, DOI 10.1111/nyas.12031; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215	56	38	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12449	12459		10.1074/jbc.M117.781047	http://dx.doi.org/10.1074/jbc.M117.781047			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28487366	Green Published, hybrid			2022-12-26	WOS:000406636900010
J	Pathak, P; Liu, HL; Boehme, S; Xie, C; Krausz, KW; Gonzalez, F; Chiang, JYL				Pathak, Preeti; Liu, Hailiang; Boehme, Shannon; Xie, Cen; Krausz, Kristopher W.; Gonzalez, Frank; Chiang, John Y. L.			Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTEROENDOCRINE CELL-LINE; FATTY LIVER-DISEASE; CHOLESTEROL 7-ALPHA-HYDROXYLASE; OBETICHOLIC ACID; GENE-EXPRESSION; GASTRIC BYPASS; MICE; ACTIVATION; SECRETION; GLUCOSE	The bile acid-activated receptors, nuclear farnesoid X receptor (FXR) and the membrane Takeda G-protein receptor 5(TGR5), are known to improve glucose and insulin sensitivity in obese and diabetic mice. However, the metabolic roles of these two receptors and the underlying mechanisms are incompletely understood. Here, we studied the effects of the dual FXR and TGR5 agonist INT-767 on hepatic bile acid synthesis and intestinal secretion of glucagon-like peptide-1 (GLP-1) in wild-type, Fxr(-/-), and Tgr5(-/-) mice. INT-767 efficaciously stimulated intracellular Ca2+ levels, cAMP activity, and GLP-1 secretion and improved glucose and lipid metabolism more than did the FXR-selective obeticholic acid and TGR5-selective INT-777 agonists. Interestingly, INT-767 reduced expression of the genes in the classic bile acid synthesis pathway but induced those in the alternative pathway, which is consistent with decreased taurocholic acid and increased tauromuricholic acids in bile. Furthermore, FXR activation induced expression of FXR target genes, including fibroblast growth factor 15, and unexpectedly Tgr5 and prohormone convertase 1/3 gene expression in the ileum. We identified an FXR-responsive element on the Tgr5 gene promoter. Fxr(-/-) and Tgr5(-/-) mice exhibited reduced GLP-1 secretion, which was stimulated by INT-767 in the Tgr5(-/-) mice but not in the Fxr(-/-) mice. Our findings uncovered a novel mechanism in which INT-767 activation of FXR induces Tgr5 gene expression and increases Ca2+ levels and cAMP activity to stimulate GLP-1 secretion and improve hepatic glucose and lipid metabolism in high-fat diet-induced obese mice. Activation of both FXR and TGR5 may therefore represent an effective therapy for managing hepatic steatosis, obesity, and diabetes.	[Pathak, Preeti; Liu, Hailiang; Boehme, Shannon; Chiang, John Y. L.] Northeast Ohio Med Univ, Dept Integrat Med Sci, Coll Med, 4209 SR 44, Rootstown, OH 44272 USA; [Xie, Cen; Krausz, Kristopher W.; Gonzalez, Frank] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	Northeast Ohio Medical University (NEOMED); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Chiang, JYL (corresponding author), Northeast Ohio Med Univ, Dept Integrat Med Sci, Coll Med, 4209 SR 44, Rootstown, OH 44272 USA.	jchiang@neomed.edu		Chiang, John/0000-0001-9360-7650	National Institutes of Health from NIDDK [DK58379, DK44442]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK058379, R01DK044442, R56DK044442, R01DK058379] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK58379 and DK44442 from NIDDK (to J. Y. L. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baghdasaryan A, 2011, HEPATOLOGY, V54, P1303, DOI 10.1002/hep.24537; Brubaker PL, 1998, ENDOCRINOLOGY, V139, P4108, DOI 10.1210/en.139.10.4108; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Donepudi AC, 2017, HEPATOLOGY, V65, P813, DOI 10.1002/hep.28707; Dufer M, 2012, DIABETES, V61, P1479, DOI 10.2337/db11-0815; Fang S, 2015, NAT MED, V21, P159, DOI 10.1038/nm.3760; FEHMANN HC, 1992, ENDOCRINOLOGY, V130, P159, DOI 10.1210/en.130.1.159; Haeusler RA, 2013, DIABETES, V62, P4184, DOI 10.2337/db13-0639; Harach T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00430; Hirschfield GM, 2015, GASTROENTEROLOGY, V148, P751, DOI 10.1053/j.gastro.2014.12.005; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Jiang CT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10166; Jiang CT, 2015, J CLIN INVEST, V125, P386, DOI 10.1172/JCI76738; Katsuma S, 2005, BIOCHEM BIOPH RES CO, V329, P386, DOI 10.1016/j.bbrc.2005.01.139; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Keitel V, 2008, BIOCHEM BIOPH RES CO, V372, P78, DOI 10.1016/j.bbrc.2008.04.171; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Li F, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3384; Li TG, 2007, GASTROENTEROLOGY, V133, P1660, DOI 10.1053/j.gastro.2007.08.042; Li TG, 2014, PHARMACOL REV, V66, P948, DOI 10.1124/pr.113.008201; Li TG, 2012, J BIOL CHEM, V287, P1861, DOI 10.1074/jbc.M111.305789; Li TG, 2010, HEPATOLOGY, V52, P678, DOI 10.1002/hep.23721; Maruyama T, 2002, BIOCHEM BIOPH RES CO, V298, P714, DOI 10.1016/S0006-291X(02)02550-0; McGavigan AK, 2017, GUT, V66, P226, DOI 10.1136/gutjnl-2015-309871; McMahan RH, 2013, J BIOL CHEM, V288, P11761, DOI 10.1074/jbc.M112.446575; Miyazaki-Anzai S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108270; MOJSOV S, 1986, J BIOL CHEM, V261, P1880; Neuschwander-Tetri BA, 2015, LANCET, V385, P956, DOI 10.1016/S0140-6736(14)61933-4; Parker HE, 2012, BRIT J PHARMACOL, V165, P414, DOI 10.1111/j.1476-5381.2011.01561.x; Patti ME, 2009, OBESITY, V17, P1671, DOI 10.1038/oby.2009.102; Renga B, 2010, BBA-MOL BASIS DIS, V1802, P363, DOI 10.1016/j.bbadis.2010.01.002; Rizzo G, 2010, MOL PHARMACOL, V78, P617, DOI 10.1124/mol.110.064501; Ryan KK, 2014, NATURE, V509, P183, DOI 10.1038/nature13135; Simonen M, 2012, OBES SURG, V22, P1473, DOI 10.1007/s11695-012-0673-5; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Takahashi S, 2016, J LIPID RES, V57, P2130, DOI 10.1194/jlr.M071183; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Trabelsi MS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8629; Vassileva G, 2006, BIOCHEM J, V398, P423, DOI 10.1042/BJ20060537; Wagner M, 2011, HEPATOLOGY, V53, P1023, DOI 10.1002/hep.24148; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Xu Y, 2016, HEPATOLOGY, V64, P1072, DOI 10.1002/hep.28712	43	130	142	5	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					11055	11069		10.1074/jbc.M117.784322	http://dx.doi.org/10.1074/jbc.M117.784322			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28478385	hybrid, Green Published			2022-12-26	WOS:000404391000026
J	Taniguchi, T; Woodward, AM; Magnelli, P; McColgan, NM; Lehoux, S; Jacobo, SMP; Mauris, J; Argueso, P				Taniguchi, Takazumi; Woodward, Ashley M.; Magnelli, Paula; McColgan, Nicole M.; Lehoux, Sylvain; Jacobo, Sarah Melissa P.; Mauris, Jerome; Argueso, Pablo			N-Glycosylation affects the stability and barrier function of the MUC16 mucin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; OVARIAN-CANCER ANTIGEN; CELL-SURFACE; CONJUNCTIVAL EPITHELIA; HUMAN CORNEAL; GALECTIN-3; EXPRESSION; DISEASE; IDENTIFICATION; RECOGNITION	Transmembrane mucins are highly O-glycosylated glycoproteins that coat the apical glycocalyx on mucosal surfaces and represent the first line of cellular defense against infection and injury. Relatively low levels of N-glycans are found on transmembrane mucins, and their structure and function remain poorly characterized. We previously reported that carbohydrate-dependent interactions of transmembrane mucins with galectin-3 contribute to maintenance of the epithelial barrier at the ocular surface. Now, using MALDI-TOF mass spectrometry, we report that transmembrane mucin N-glycans in differentiated human corneal epithelial cells contain primarily complex-type structures with N-acetyllactosamine, a preferred galectin ligand. In N-glycosylation inhibition experiments, we find that treatment with tunicamycin and siRNA-mediated knockdown of the Golgi N-acetylglucosaminyl transferase I gene (MGAT1) induce partial loss of both total and cell-surface levels of the largest mucin, MUC16, and a concomitant reduction in glycocalyx barrier function. Moreover, we identified a distinct role for N-glycans in promoting MUC16's binding affinity toward galectin-3 and in causing retention of the lectin on the epithelial cell surface. Taken together, these studies define a role for N-linked oligosaccharides in supporting the stability and function of transmembrane mucins on mucosal surfaces.	[Taniguchi, Takazumi; Woodward, Ashley M.; McColgan, Nicole M.; Jacobo, Sarah Melissa P.; Mauris, Jerome; Argueso, Pablo] Harvard Med Sch, Schepens Eye Res Inst, 20 Staniford St, Boston, MA 02114 USA; [Taniguchi, Takazumi; Woodward, Ashley M.; McColgan, Nicole M.; Jacobo, Sarah Melissa P.; Mauris, Jerome; Argueso, Pablo] Harvard Med Sch, Dept Ophthalmol, Massachusetts Eye & Ear, 20 Staniford St, Boston, MA 02114 USA; [Magnelli, Paula] New England Biolabs Inc, Ipswich, MA 01938 USA; [Lehoux, Sylvain] Harvard Med Sch, Dept Surg, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Schepens Eye Research Institute; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; New England Biolabs; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Argueso, P (corresponding author), Harvard Med Sch, Schepens Eye Res Inst, 20 Staniford St, Boston, MA 02114 USA.; Argueso, P (corresponding author), Harvard Med Sch, Dept Ophthalmol, Massachusetts Eye & Ear, 20 Staniford St, Boston, MA 02114 USA.	pablo_argueso@meei.harvard.edu		Argueso, Pablo/0000-0001-7321-9503	National Institutes of Health (NEI) [R01EY014847, R01EY026147]; NEI [P30EY003790]; National Center for Functional Glycomics (NIGMS) [P41GM103694]; NATIONAL EYE INSTITUTE [R01EY014847, R01EY026147, P30EY003790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103694] Funding Source: NIH RePORTER	National Institutes of Health (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Center for Functional Glycomics (NIGMS); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Grants R01EY014847 and R01EY026147 (NEI; to P. A.), NEI Core Grant P30EY003790, and the National Center for Functional Glycomics Grant P41GM103694 (NIGMS; to S. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Argueso Pablo, 2006, V347, P277; Arguso P, 2012, METHODS MOL BIOL, V842, P313, DOI 10.1007/978-1-61779-513-8_19; Argueso P, 2009, J BIOL CHEM, V284, P23037, DOI 10.1074/jbc.M109.033332; Bafna S, 2010, ONCOGENE, V29, P2893, DOI 10.1038/onc.2010.87; Blalock TD, 2007, INVEST OPHTH VIS SCI, V48, P4509, DOI 10.1167/iovs.07-0430; Bravo-Osuna I, 2012, PHARM RES-DORDR, V29, P2329, DOI 10.1007/s11095-012-0761-1; Chachadi VB, 2015, GLYCOBIOLOGY, V25, P963, DOI 10.1093/glycob/cwv030; Corfield AP, 2015, BBA-GEN SUBJECTS, V1850, P236, DOI 10.1016/j.bbagen.2014.05.003; Cummings RD., 2009, ESSENTIALS GLYCOBIOL, P513; Dam TK, 2010, GLYCOBIOLOGY, V20, P270, DOI 10.1093/glycob/cwp186; Das S, 2015, SCI REP-UK, V5, DOI 10.1038/srep09759; Dharmaraj N, 2014, HUM REPROD, V29, P1730, DOI 10.1093/humrep/deu146; Dogru M, 2008, ALLERGY, V63, P1324, DOI 10.1111/j.1398-9995.2008.01781.x; Einerhand AWC, 2002, EUR J GASTROEN HEPAT, V14, P757, DOI 10.1097/00042737-200207000-00008; Fang H, 2006, CELL RES, V16, P82, DOI 10.1038/sj.cr.7310011; Gipson IK, 2003, INVEST OPHTH VIS SCI, V44, P2496, DOI 10.1167/iovs.02-0851; Gipson IK, 2003, INT REV CYTOL, V231, P1, DOI 10.1016/S0074-7696(03)31001-0; Gipson IK, 2013, INVEST OPHTH VIS SCI, V54, DOI 10.1167/iovs.13-12840; Haridas D, 2014, FASEB J, V28, P4183, DOI 10.1096/fj.14-257352; Hattrup CL, 2008, ANNU REV PHYSIOL, V70, P431, DOI 10.1146/annurev.physiol.70.113006.100659; HILKENS J, 1992, TRENDS BIOCHEM SCI, V17, P359, DOI 10.1016/0968-0004(92)90315-Z; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Ishida H, 2005, FEBS LETT, V579, P71, DOI 10.1016/j.febslet.2004.11.037; KUI WN, 2003, J BIOL CHEM, V278, P28619, DOI DOI 10.1074/JBC.M302741200; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Lloyd KO, 1997, INT J CANCER, V71, P842, DOI 10.1002/(SICI)1097-0215(19970529)71:5<842::AID-IJC24>3.0.CO;2-8; Mantelli F, 2008, CURR OPIN ALLERGY CL, V8, P477, DOI 10.1097/ACI.0b013e32830e6b04; Mauris J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072304; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Merlin J, 2011, ONCOGENE, V30, P2514, DOI 10.1038/onc.2010.631; Miwa HE, 2012, GLYCOCONJUGATE J, V29, P609, DOI 10.1007/s10719-012-9373-6; Mori Y, 2015, J BIOL CHEM, V290, P26125, DOI 10.1074/jbc.M115.651489; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Patnaik SK, 2006, GLYCOBIOLOGY, V16, P305, DOI 10.1093/glycob/cwj063; Saldova R, 2013, INT J MOL SCI, V14, P15636, DOI 10.3390/ijms140815636; Seelenmeyer C, 2003, J CELL SCI, V116, P1305, DOI 10.1242/jcs.00312; Sindrewicz P, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00079; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Strohalm M, 2010, ANAL CHEM, V82, P4648, DOI 10.1021/ac100818g; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; Uchino Y, 2015, AM J OPHTHALMOL, V159, P1027, DOI 10.1016/j.ajo.2015.02.008; Ujita M, 1999, J BIOL CHEM, V274, P16717, DOI 10.1074/jbc.274.24.16717; WESSELING J, 1995, J CELL BIOL, V129, P255, DOI 10.1083/jcb.129.1.255; Woodward AM, 2014, INVEST OPHTH VIS SCI, V55, P6132, DOI 10.1167/iovs.14-15269; Yin BWT, 2001, J BIOL CHEM, V276, P27371, DOI 10.1074/jbc.M103554200; Zhang ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065218	46	44	45	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					11079	11090		10.1074/jbc.M116.770123	http://dx.doi.org/10.1074/jbc.M116.770123			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28487369	hybrid, Green Published			2022-12-26	WOS:000404391000028
J	Fields, MA; Bowrey, HE; Gong, J; Moreira, EF; Cai, H; Del Priore, LV				Fields, Mark A.; Bowrey, Hannah E.; Gong, Jie; Moreira, Ernesto F.; Cai, Hui; Del Priore, Lucian V.			Extracellular matrix nitration alters growth factor release and activates bioactive complement in human retinal pigment epithelial cells	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; AGE-RELATED MACULOPATHY; MACULAR DEGENERATION; BRUCHS MEMBRANE; NATURAL COURSE; DRUSEN; VEGF; RPE; EXPRESSION; PROTEINS	Purpose We have shown previously that non-enzymatic nitration (NEN) of the extracellular matrix (ECM), which serves as a model of Bruch's membrane (BM) aging, has a profound effect on the behavior of the overlying retinal pigment epithelial (RPE) cells, including altered phagocytic ability, reduced cell adhesion, and inhibition of proliferation. We know that transplanted RPE monolayers will encounter a hostile sub-RPE environment, including age-related alterations in BM that may compromise cell function and survival. Here we use our previous NEN model of BM aging to determine the effects of NEN of the ECM on growth factor release and complement activation in RPE cells. Methods Human induced-pluripotent stem cells (iPSCs) were differentiated into RPE cells, and confirmed by immunohistochemistry, confocal microscopy, and polymerase chain reaction. IPSC-derived RPE cells were plated onto RPE-derived ECM under untreated or nitrite-modified conditions. Cells were cultured for 7 days and barrier function measured by transepithelial resistance (TER). Vascular endothelial growth factor (VEGF), pigment epithelium-derived factor (PEDF), and complement component C3a were measured using enzyme-linked immunosorbent assay (ELISA). Results On average nitrite-modified ECM increased VEGF release both apically and basally by 0.15 +/- 0.014 ng/mL (p < 0.0001) and 0.21 +/- 0.022 ng/mL (p < 0.0001), respectively, in iPSC-derived RPE cells. Nitrite-modified ECM increased PEDF release in iPSC-derived RPE cells apically by 0.16 +/- 0.031 ng/mL (p < 0.0001), but not basally (0.27 +/- 0.015 vs. 0.32 +/- 0.029 ng/mL, (p > 0.05)). Nitrite-modified ECM increased production of C3a in iPSC-derived RPE cells by 0.52 +/- 0.123 ng/mL (p < 0.05). Conclusion Nitrite-modified ECM increased VEGF, PEDF release, and C3a production in human iPSC-derived RPE cells. This model demonstrates changes seen in the basement membrane can lead to alterations in the cell biology of the RPE cells that may be related to the development of age-related macular degeneration.	[Fields, Mark A.; Gong, Jie; Cai, Hui; Del Priore, Lucian V.] Yale Sch Med, Dept Ophthalmol & Visual Sci, New Haven, CT 06510 USA; [Bowrey, Hannah E.] Rutgers State Univ, Brain Hlth Inst, Piscataway, NJ USA; [Bowrey, Hannah E.] Univ Sydney, Save Sight Inst, Sydney, NSW, Australia; [Moreira, Ernesto F.] Med Univ South Carolina, Dept Ophthalmol, Storm Eye Inst, Charleston, SC USA	Yale University; Rutgers State University New Brunswick; University of Sydney; Medical University of South Carolina	Fields, MA (corresponding author), Yale Sch Med, Dept Ophthalmol & Visual Sci, New Haven, CT 06510 USA.	mark.fields@yale.edu		Bowrey, Hannah/0000-0002-3774-4201	Research to Prevent Blindness; Greater New York Center for Retinal Degenerative Disease Foundation Fighting Blindness; BrightFocus Foundation; Lions International Foundation Research Program	Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Greater New York Center for Retinal Degenerative Disease Foundation Fighting Blindness; BrightFocus Foundation(BrightFocus Foundation); Lions International Foundation Research Program	Research to Prevent Blindness, www.rpbusa.org. Greater New York Center for Retinal Degenerative Disease Foundation Fighting Blindness, www.blindness.org. BrightFocus Foundation, www.brightfocus.org. The Lions International Foundation Research Program. "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."	Abdelsalam A, 1999, SURV OPHTHALMOL, V44, P1, DOI 10.1016/S0039-6257(99)00072-7; Ablonczy Z, 2014, FASEB J, V28, P2369, DOI 10.1096/fj.13-248021; Ablonczy Z, 2011, INVEST OPHTH VIS SCI, V52, P8614, DOI 10.1167/iovs.11-8021; Amano S, 2005, MICROVASC RES, V69, P45, DOI 10.1016/j.mvr.2004.11.001; Anderson DH, 2002, AM J OPHTHALMOL, V134, P411, DOI 10.1016/S0002-9394(02)01624-0; Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; Bhutto IA, 2006, EXP EYE RES, V82, P99, DOI 10.1016/j.exer.2005.05.007; Blaauwgeers HGT, 1999, AM J PATHOL, V155, P421, DOI 10.1016/S0002-9440(10)65138-3; BORLAND C, 1987, INT J EPIDEMIOL, V16, P31, DOI 10.1093/ije/16.1.31; Brandl C, 2015, J CLIN MED, V4, P282, DOI 10.3390/jcm4020282; Buecker C, 2010, CELL STEM CELL, V6, P535, DOI 10.1016/j.stem.2010.05.003; Capuron L, 2011, BIOL PSYCHIAT, V70, P175, DOI 10.1016/j.biopsych.2010.12.006; Chen M, 2008, EXP EYE RES, V87, P543, DOI 10.1016/j.exer.2008.09.005; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Crow JP, 1996, METHOD ENZYMOL, V269, P185; Curcio CA, 2011, BRIT J OPHTHALMOL, V95, P1638, DOI 10.1136/bjophthalmol-2011-300344; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; Donoso LA, 2006, SURV OPHTHALMOL, V51, P137, DOI 10.1016/j.survophthal.2005.12.001; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Fett AL, 2012, HISTOL HISTOPATHOL, V27, P357, DOI 10.14670/HH-27.357; Fields MA, 2015, INVEST OPHTH VIS SCI, V56, P4231, DOI 10.1167/iovs.15-16438; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Gamm DM, 2013, EXPERT REV OPHTHALMO, V8, P213, DOI 10.1586/EOP.13.14; Gong J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143272; Grskovic M, 2011, NAT REV DRUG DISCOV, V10, P915, DOI 10.1038/nrd3577; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Johnson LV, 2002, P NATL ACAD SCI USA, V99, P11830, DOI 10.1073/pnas.192203399; KARWATOWSKI WSS, 1995, BRIT J OPHTHALMOL, V79, P944, DOI 10.1136/bjo.79.10.944; Kawa MP, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/483960; Kerr CL, 2010, CELL STEM CELL, V6, P497, DOI 10.1016/j.stem.2010.05.014; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; Klettner A, 2009, GRAEF ARCH CLIN EXP, V247, P1487, DOI 10.1007/s00417-009-1139-x; Kunchithapautham K., 2014, J BIOL CHEM, P7; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Marneros AG, 2013, CELL REP, V4, P945, DOI 10.1016/j.celrep.2013.08.002; MARSHALL GE, 1992, BRIT J OPHTHALMOL, V76, P607, DOI 10.1136/bjo.76.10.607; Meyer JS, 2009, P NATL ACAD SCI USA, V106, P16698, DOI 10.1073/pnas.0905245106; Moreira EF, 2015, TRANSL VIS SCI TECHN, V4, DOI 10.1167/tvst.4.5.10; Mullins RF, 2001, EYE, V15, P390, DOI 10.1038/eye.2001.142; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Murdaugh LS, 2010, EXP EYE RES, V90, P564, DOI 10.1016/j.exer.2010.01.014; Nguyen HV, 2015, J CLIN MED, V4, P567, DOI 10.3390/jcm4040567; Nozaki M, 2006, P NATL ACAD SCI USA, V103, P2328, DOI 10.1073/pnas.0408835103; Nystrom A, 2016, MATRIX BIOL; Ogata N, 2002, INVEST OPHTH VIS SCI, V43, P1168; Ohno-Matsui K, 2003, BIOCHEM BIOPH RES CO, V303, P962, DOI 10.1016/S0006-291X(03)00446-7; Paik DC, 2001, CONNECT TISSUE RES, V42, P111, DOI 10.3109/03008200109014253; Parmeggiani F, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/546786; PAULEIKHOFF D, 1990, OPHTHALMOLOGY, V97, P171; Pons M, 2011, INVEST OPHTH VIS SCI, V52, P3842, DOI 10.1167/iovs.10-6254; QUINN RH, 1992, INVEST OPHTH VIS SCI, V33, P3513; Sarks SH, 1999, BRIT J OPHTHALMOL, V83, P358, DOI 10.1136/bjo.83.3.358; Singh R, 2013, INVEST OPHTH VIS SCI, V54, P6767, DOI 10.1167/iovs.13-11943; Smith W, 2001, OPHTHALMOLOGY, V108, P697, DOI 10.1016/S0161-6420(00)00580-7; Solberg Y, 1998, SURV OPHTHALMOL, V42, P535, DOI 10.1016/S0039-6257(98)00002-2; Sonoda S, 2009, NAT PROTOC, V4, P662, DOI 10.1038/nprot.2009.33; Spraul CW, 1999, SURV OPHTHALMOL, V44, pS10, DOI 10.1016/S0039-6257(99)00086-7; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Sun K, 2007, MOL VIS, V13, P2310; Sunness JS, 1999, OPHTHALMOLOGY, V106, P910, DOI 10.1016/S0161-6420(99)00509-6; Tabar V, 2014, NAT REV GENET, V15, P82, DOI 10.1038/nrg3563; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Taylor H R, 1990, Trans Am Ophthalmol Soc, V88, P163; TAYLOR HR, 1992, ARCH OPHTHALMOL-CHIC, V110, P99, DOI 10.1001/archopht.1992.01080130101035; Tezel TH, 2004, INVEST OPHTH VIS SCI, V45, P3337, DOI 10.1167/iovs.04-0193; TOMBRANTINK J, 1991, EXP EYE RES, V53, P411, DOI 10.1016/0014-4835(91)90248-D; Tong HP, 2006, CLIN BIOCHEM, V39, P267, DOI 10.1016/j.clinbiochem.2005.11.013; Tsao YP, 2006, LIFE SCI, V79, P545, DOI 10.1016/j.lfs.2006.01.041; van Leeuwen R, 2003, ARCH OPHTHALMOL-CHIC, V121, P519, DOI 10.1001/archopht.121.4.519; Wang AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005304; Wang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010329; Wang Z, 2005, CURR EYE RES, V30, P691, DOI 10.1080/02713680590968259; Wiradjaja F, 2010, BIRTH DEFECTS RES C, V90, P8, DOI 10.1002/bdrc.20172; Witmer AN, 2003, PROG RETIN EYE RES, V22, P1, DOI 10.1016/S1350-9462(02)00043-5; Wong T, 2008, OPHTHALMOLOGY, V115, P116, DOI 10.1016/j.ophtha.2007.03.008; Yamanaka Shinya, 2006, Tanpakushitsu Kakusan Koso, V51, P2346; Yu Y, 2011, HUM MOL GENET, V20, P3699, DOI 10.1093/hmg/ddr270	79	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177763	10.1371/journal.pone.0177763	http://dx.doi.org/10.1371/journal.pone.0177763			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505174	gold, Green Published, Green Submitted			2022-12-26	WOS:000401473500042
J	Lin, S; Sterling, NA; Junker, IP; Helm, CT; Smith, GM				Lin, Shen; Sterling, Noelle A.; Junker, Ian P.; Helm, Courtney T.; Smith, George M.			Effects of alpha TAT1 and HDAC5 on axonal regeneration in adult neurons	PLOS ONE			English	Article							TUBULIN ACETYLTRANSFERASE; MICROTUBULE DYNAMICS; NERVOUS-SYSTEM; ACETYLATION; GROWTH; INJURY; INHIBITION; OUTGROWTH; MEC-17; MICE	The role of posttranslational modifications in axonal injury and regeneration has been widely studied but there has been little consensus over the mechanism by which each modification affects adult axonal growth. Acetylation is known to play an important role in a variety of neuronal functions and its homeostasis is controlled by two enzyme families: the Histone Deacetylases (HDACs) and Histone Acetyl Transferases (HATs). Recent studies show that HDAC5 deacetylates microtubules in the axonal cytoplasm as part of an injury-induced regeneration response, but little is known about how acetylation of microtubules plays a role. Alpha-tubulin acetyl transferase (alpha TAT1) is a microtubule specific acetyl transferase that binds to microtubules and directly affects microtubule stability in cells. We hypothesize that increasing tubulin acetylation may play an important role in increasing the rate of axonal growth. In this study, we infected cultured adult DRG neurons with alpha TAT1 and alpha TAT1-D157N, a catalytically inactive mutant, and HDAC5, using lentiviruses. We found that alpha TAT1 significantly increases tubulin acetylation in 293T cells and DRG neurons but alpha TAT1-D157N does not. Furthermore, in neurons infected with alpha TAT1, a significant increase in acetylated tubulin was detected towards the distal portion of the axon but this increase was not detected in neurons infected with alpha TAT1-D157N. However, we found a significant increase in axon lengths of DRG neurons after alpha TAT1 and alpha TAT1-D157N infection, but no effect on axon lengths after infection with HDAC5. Our results suggest that while alpha TAT1 may play a role in axon growth in vitro, the increase is not directly due to acetylation of axonal microtubules. Our results also show that HDAC5 overexpression in the axonal cytoplasm does not play a crucial role in axonal regeneration of cultured DRG neurons. We expressed these genes in DRG neurons in adult rats and performed a sciatic nerve crush. We found that axons did not regenerate any better when infected with any of the constructs compared with control animals. Thus, while alpha TAT1 may be important for axonal growth in vitro, neither alpha TAT1 nor HDAC5 had an effect in vivo on the regeneration of sciatic nerves.	[Lin, Shen; Sterling, Noelle A.; Junker, Ian P.; Helm, Courtney T.; Smith, George M.] Temple Univ, Sch Med, Shriners Hosp Pediat Res Ctr, Ctr Neural Repair & Rehabil,Dept Neurosci, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Shriners Hospitals Children Philadelphia	Lin, S (corresponding author), Temple Univ, Sch Med, Shriners Hosp Pediat Res Ctr, Ctr Neural Repair & Rehabil,Dept Neurosci, Philadelphia, PA 19122 USA.	sher.lin@temple.edu			National Institute of Neurological Disorders and Stroke (NINDS) [N5060784]; Shriners Hospital for Pediatric Research grants [84050, 85200, 84294]	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Shriners Hospital for Pediatric Research grants	Support was provided by the National Institute of Neurological Disorders and Stroke (NINDS), contract grant number: N5060784; and by the Shriners Hospital for Pediatric Research grants, contract grant numbers: 84050, 85200 (GMS) and 84294 (SL).	Aguilar A, 2014, MOL BIOL CELL, V25, P1854, DOI 10.1091/mbc.E13-10-0609; AHMAD FJ, 1993, J NEUROSCI, V13, P856; Akella JS, 2010, NATURE, V467, P218, DOI 10.1038/nature09324; Baas P.W., 2016, CYTOSKELETON; BAAS PW, 1991, J NEUROSCI RES, V30, P134, DOI 10.1002/jnr.490300115; BAAS PW, 1990, J CELL BIOL, V111, P495, DOI 10.1083/jcb.111.2.495; Cho Y, 2014, CURR OPIN NEUROBIOL, V27, P118, DOI 10.1016/j.conb.2014.03.008; Cho Y, 2013, CELL, V155, P894, DOI 10.1016/j.cell.2013.10.004; Cho Y, 2012, EMBO J, V31, P3063, DOI 10.1038/emboj.2012.160; Choudhary C, 2014, NAT REV MOL CELL BIO, V15, P536, DOI 10.1038/nrm3841; Coombes C, 2016, P NATL ACAD SCI USA, V113, pE7176, DOI 10.1073/pnas.1605397113; Creppe C, 2009, CELL, V136, P551, DOI 10.1016/j.cell.2008.11.043; Davenport AM, 2014, J MOL BIOL, V426, P2605, DOI 10.1016/j.jmb.2014.05.009; Gaub P, 2010, CELL DEATH DIFFER, V17, P1392, DOI 10.1038/cdd.2009.216; Gaub P, 2011, BRAIN, V134, P2134, DOI 10.1093/brain/awr142; Graff J, 2013, NAT REV NEUROSCI, V14, P97, DOI 10.1038/nrn3427; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Janke C, 2010, TRENDS NEUROSCI, V33, P362, DOI 10.1016/j.tins.2010.05.001; Kalebic N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2962; Kalebic N, 2013, MOL CELL BIOL, V33, P1114, DOI 10.1128/MCB.01044-12; Kedei N, 2004, CANCER RES, V64, P3243, DOI 10.1158/0008-5472.CAN-03-3403; Kim GW, 2013, J BIOL CHEM, V288, P20334, DOI 10.1074/jbc.M113.464792; Li L, 2015, CELL MOL LIFE SCI, V72, P4237, DOI 10.1007/s00018-015-2000-5; Lin S, 2015, J NEUROSCIENCE RES; Morley SJ, 2016, ELIFE, V5, DOI 10.7554/eLife.20813; Perdiz D, 2011, CELL SIGNAL, V23, P763, DOI 10.1016/j.cellsig.2010.10.014; Puttagunta R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4527; Rivieccio MA, 2009, P NATL ACAD SCI USA, V106, P19599, DOI 10.1073/pnas.0907935106; Shida T, 2010, P NATL ACAD SCI USA, V107, P21517, DOI 10.1073/pnas.1013728107; Shin JE, 2014, EXP NEUROL, V252, P1, DOI 10.1016/j.expneurol.2013.11.007; Smith GM, 2013, METHODS MOL BIOL, V1078, P153, DOI 10.1007/978-1-62703-640-5_14; Song Y., 2014, TRENDS CELL BIOL; Steczkiewicz K, 2006, CELL CYCLE, V5, P2927, DOI 10.4161/cc.5.24.3572; Tapia M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012908; Trakhtenberg EF, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00024; Zhang YJ, 2010, J NEUROSCI RES, V88, P2374, DOI 10.1002/jnr.22394	36	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177496	10.1371/journal.pone.0177496	http://dx.doi.org/10.1371/journal.pone.0177496			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505206	Green Published, Green Submitted, gold			2022-12-26	WOS:000401473500024
J	Ichikawa, Y; Zemljic-Harpf, AE; Zhang, Z; McKirnan, MD; Manso, AM; Ross, RS; Hammond, HK; Patel, HH; Roth, DM				Ichikawa, Yasuhiro; Zemljic-Harpf, Alice E.; Zhang, Zheng; McKirnan, M. Dan; Manso, Ana Maria; Ross, Robert S.; Hammond, H. Kirk; Patel, Hemal H.; Roth, David M.			Modulation of caveolins, integrins and plasma membrane repair proteins in anthracycline-induced heart failure in rabbits	PLOS ONE			English	Article							CARDIAC-SPECIFIC OVEREXPRESSION; NITRIC-OXIDE; MULTIDRUG-RESISTANCE; DOXORUBICIN; EXPRESSION; DAUNORUBICIN; MG53; CARDIOTOXICITY; HYPERTROPHY; PREVENTION	Anthracyclines are chemotherapeutic drugs known to induce heart failure in a dose-dependent manner. Mechanisms involved in anthracycline cardiotoxicity are an area of relevant investigation. Caveolins bind, organize and regulate receptors and signaling molecules within cell membranes. Caveolin-3 (Cav-3), integrins and related membrane repair proteins can function as cardioprotective proteins. Expression of these proteins in anthracyclineinduced heart failure has not been evaluated. We tested the hypothesis that daunorubicin alters cardioprotective protein expression in the heart. Rabbits were administered daunorubicin (3 mg/kg, IV) weekly, for three weeks or nine weeks. Nine weeks but not three weeks of daunorubicin resulted in progressive reduced left ventricular function. Cav-3 expression in the heart was unchanged at three weeks of daunorubicin and increased in nine week treated rabbits when compared to control hearts. Electron microscopy showed caveolae in the heart were increased and mitochondrial number and size were decreased after nine weeks of daunorubicin. Activated beta-1 (beta 1) integrin and the membrane repair protein MG53 were increased after nine weeks of daunorubicin vs. controls with no change at the three week time point. The results suggest a potential pathophysiological role for Cav3, integrins and membrane repair in daunorubicin-induced heart failure.	[Ichikawa, Yasuhiro; Zemljic-Harpf, Alice E.; Zhang, Zheng; McKirnan, M. Dan; Manso, Ana Maria; Ross, Robert S.; Hammond, H. Kirk; Patel, Hemal H.; Roth, David M.] Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA; [Ichikawa, Yasuhiro; Zemljic-Harpf, Alice E.; McKirnan, M. Dan; Patel, Hemal H.; Roth, David M.] Univ Calif San Diego, Dept Anesthesiol, San Diego, CA 92103 USA; [Zhang, Zheng; Manso, Ana Maria; Ross, Robert S.; Hammond, H. Kirk] Univ Calif San Diego, Dept Med, Div Cardiovasc Med, La Jolla, CA 92093 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; University of California System; University of California San Diego	Roth, DM (corresponding author), Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA.; Roth, DM (corresponding author), Univ Calif San Diego, Dept Anesthesiol, San Diego, CA 92103 USA.	droth@ucsd.edu	Ross, Robert/ABE-1109-2020; Patel, Hemal/C-7325-2019	Ross, Robert/0000-0003-2195-8982; Patel, Hemal/0000-0001-6722-9625	Veteran Affairs Merit Awards from the Department of Veterans Affairs [BX000783, BX003260, BX003774, BX001963]; National Institutes of Health [HL091071, HL107200, HL066941, HL115933, HL127806]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091071, R42HL122038, R01HL115933, R01HL127806] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000783, I01BX003774, I01BX001963] Funding Source: NIH RePORTER	Veteran Affairs Merit Awards from the Department of Veterans Affairs; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	The work was supported by Veteran Affairs Merit Awards from the Department of Veterans Affairs (http://www.sandiego.va.gov) BX000783 (DMR), BX003260 (RSR), BX003774 (HKH) and BX001963 (HHP), National Institutes of Health (https://www.nih.gov) HL091071 (HHP), HL107200 (HHP, DMR), HL066941 (HKH, DMR, HHP, RSR), HL115933 (RSR, DMR, HHP), and HL127806 (RSR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbagallo F, 2016, CIRC RES, V119, P931, DOI 10.1161/CIRCRESAHA.116.308964; Belanger MM, 2003, ANTI-CANCER DRUG, V14, P281, DOI 10.1097/00001813-200304000-00005; Bendall JK, 2004, CIRCULATION, V110, P2368, DOI 10.1161/01.CIR.0000145160.04084.AC; Blazek AD, 2015, PHYSIOLOGY, V30, P438, DOI 10.1152/physiol.00019.2015; Cao CM, 2010, CIRCULATION, V121, P2565, DOI 10.1161/CIRCULATIONAHA.110.954628; Fanous I, 2016, MED ONCOL, V33, DOI 10.1007/s12032-016-0801-5; Feijen EAM, 2015, J CLIN ONCOL, V33, P3774, DOI 10.1200/JCO.2015.61.5187; Feiner EC, 2011, J CARD FAIL, V17, P253, DOI 10.1016/j.cardfail.2010.10.008; Fridolfsson HN, 2012, FASEB J, V26, P4637, DOI 10.1096/fj.12-215798; Hare JM, 2000, CIRC RES, V86, P1085, DOI 10.1161/01.RES.86.10.1085; Horikawa YT, 2011, J AM COLL CARDIOL, V57, P2273, DOI 10.1016/j.jacc.2010.12.032; Ichikawa Y, 2012, CIRC J, V76, P2456, DOI 10.1253/circj.CJ-12-0215; Israeli-Rosenberg S, 2015, FASEB J, V29, P374, DOI 10.1096/fj.13-243139; Jasmin JF, 2011, AM J PHYSIOL-HEART C, V300, pH1274, DOI 10.1152/ajpheart.01173.2010; Jirkovsky E, 2012, J PHARMACOL EXP THER, V343, P468, DOI 10.1124/jpet.112.198358; Kassan A, 2016, AM J PHYSIOL-CELL PH, V311, pC854, DOI 10.1152/ajpcell.00147.2016; Keefe DL, 2001, SEMIN ONCOL, V28, P2, DOI 10.1053/sonc.2001.26431; Klimtova I, 2002, HUM EXP TOXICOL, V21, P649, DOI 10.1191/0960327102ht311oa; Lemckert FA, 2016, CARDIOVASC RES, V110, P178, DOI 10.1093/cvr/cvw017; Lenneman CG, 2016, CIRC RES, V118, P1008, DOI 10.1161/CIRCRESAHA.115.303633; Li DL, 2016, CIRCULATION; Makarewich CA, 2012, CIRC RES, V110, P669, DOI 10.1161/CIRCRESAHA.111.264028; Markandeya YS, 2015, J BIOL CHEM, V290, P22085, DOI 10.1074/jbc.M115.674945; MOMPARLER RL, 1976, CANCER RES, V36, P2891; Moslehi JJ, 2016, NEW ENGL J MED, V375, P1457, DOI 10.1056/NEJMra1100265; Moulin M, 2015, CIRC-HEART FAIL, V8, P98, DOI 10.1161/CIRCHEARTFAILURE.114.001180; Oka N, 1997, AM J PHYSIOL-CELL PH, V273, pC1957, DOI 10.1152/ajpcell.1997.273.6.C1957; Oliveira GH, 2015, BLOOD REV; Patel HH, 2008, ANNU REV PHARMACOL, V48, P359, DOI 10.1146/annurev.pharmtox.48.121506.124841; PAUL C, 1989, THER DRUG MONIT, V11, P140, DOI 10.1097/00007691-198903000-00004; Pham CG, 2000, AM J PHYSIOL-HEART C, V279, pH2916, DOI 10.1152/ajpheart.2000.279.6.H2916; Piech A, 2002, AM J PHYSIOL-HEART C, V282, pH219, DOI 10.1152/ajpheart.2002.282.1.H219; Ruiz-Hurtado G, 2007, HYPERTENSION, V50, P1049, DOI 10.1161/HYPERTENSIONAHA.107.093666; Schilling JM, 2016, BASIC RES CARDIOL, V111, DOI 10.1007/s00395-016-0542-9; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Song KS, 1996, J BIOL CHEM, V271, P15160, DOI 10.1074/jbc.271.25.15160; Sterba M, 2011, J MOL CELL CARDIOL, V50, P849, DOI 10.1016/j.yjmcc.2011.01.018; Sun JH, 2015, CARDIOVASC RES, V106, P227, DOI 10.1093/cvr/cvv044; TEICHHOLZ LE, 1976, AM J CARDIOL, V37, P7, DOI 10.1016/0002-9149(76)90491-4; Tsutsumi YM, 2008, CIRCULATION, V118, P1979, DOI 10.1161/CIRCULATIONAHA.108.788331; Tsutsumi YM, 2010, ANESTHESIOLOGY, V112, P1136, DOI 10.1097/ALN.0b013e3181d3d624; van der Pal HJ, 2010, ARCH INTERN MED, V170, P1247, DOI 10.1001/archinternmed.2010.233; Vejpongsa P, 2014, J AM COLL CARDIOL, V64, P938, DOI 10.1016/j.jacc.2014.06.1167; Volonte D, 2008, AM J PHYSIOL-HEART C, V294, pH392, DOI 10.1152/ajpheart.01039.2007; Yi JS, 2013, J PROTEOME RES, V12, P605, DOI 10.1021/pr300651m; Zhang S, 2012, NAT MED, V18, P1639, DOI 10.1038/nm.2919; Zhang Y, 2011, CARDIOVASC RES, V91, P108, DOI 10.1093/cvr/cvr029; Zhang Y, 2015, TUMOR BIOL, V36, P2277, DOI 10.1007/s13277-014-2835-7; Zhao JL, 2013, CIRCULATION, V128, pS121, DOI 10.1161/CIRCULATIONAHA.112.000045	49	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177660	10.1371/journal.pone.0177660	http://dx.doi.org/10.1371/journal.pone.0177660			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498861	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314500040
J	Pio, GM; Xia, Y; Piaseczny, MM; Chu, JE; Allan, AL				Pio, Graciella M.; Xia, Ying; Piaseczny, Matthew M.; Chu, Jenny E.; Allan, Alison L.			Soluble bone-derived osteopontin promotes migration and stem-like behavior of breast cancer cells	PLOS ONE			English	Article							HEMATOPOIETIC PROGENITOR CELLS; MAMMARY EPITHELIAL-CELLS; PLASMA OSTEOPONTIN; ALDEHYDE DEHYDROGENASE; METASTATIC PATTERNS; NICHE; EXPRESSION; INHIBITION; RECEPTOR; SURVIVAL	Breast cancer is a leading cause of cancer death in women, with the majority of these deaths caused by metastasis to distant organs. The most common site of breast cancer metastasis is the bone, which has been shown to provide a rich microenvironment that supports the migration and growth of breast cancer cells. Additionally, growing evidence suggests that breast cancer cells that do successfully metastasize have a stem-like phenotype including high activity of aldehyde dehydrogenase (ALDH) and/or a CD44(+)CD24(-)phenotype. In the current study, we tested the hypothesis that these ALDH (hi) CD44 (+) CD24(-)breast cancer cells interact with factors in the bone secondary organ microenvironment to facilitate metastasis. Specifically, we focused on bone-derived osteopontin and its ability to promote the migration and stem-like phenotype of breast cancer cells. Our results indicate that bone-derived osteopontin promotes the migration, tumorsphere-forming ability and colony-forming ability of whole population and ALDH hi CD44(+)CD24-breast cancer cells in bone marrow-conditioned media (an ex vivo representation of the bone microenvironment) (p <= 0.05). We also demonstrate that CD44 and RGD-dependent cell surface integrins facilitate this functional response to bone-derived osteopontin (p <= 0.05), potentially through activation of WNK-1 and PRAS40-related pathways. Our findings suggest that soluble bone-derived osteopontin enhances the ability of breast cancer cells to migrate to the bone and maintain a stem-like phenotype within the bone microenvironment, and this may contribute to the establishment and growth of bone metastases.	[Pio, Graciella M.; Piaseczny, Matthew M.; Chu, Jenny E.; Allan, Alison L.] Univ Western Univ, Schulich Sch Med & Dent, Dept Anat & Cell Biol, London, ON, Canada; [Xia, Ying; Allan, Alison L.] London Hlth Sci Ctr, London Reg Canc Program, London, ON, Canada; [Allan, Alison L.] Univ Western Univ, Schulich Sch Med & Dent, Dept Oncol, London, ON, Canada; [Allan, Alison L.] Lawson Hlth Res Inst, Canc Res Labs, London, ON, Canada	London Health Sciences Centre; Western University (University of Western Ontario); Western University (University of Western Ontario)	Allan, AL (corresponding author), Univ Western Univ, Schulich Sch Med & Dent, Dept Anat & Cell Biol, London, ON, Canada.; Allan, AL (corresponding author), London Hlth Sci Ctr, London Reg Canc Program, London, ON, Canada.; Allan, AL (corresponding author), Univ Western Univ, Schulich Sch Med & Dent, Dept Oncol, London, ON, Canada.; Allan, AL (corresponding author), Lawson Hlth Res Inst, Canc Res Labs, London, ON, Canada.	alison.allan@lhsc.on.ca		Chu, Jenny/0000-0002-1841-3175	Canadian Breast Cancer Foundation-Ontario Region; Canada Foundation for Innovation [13199]; Ontario Graduate Scholarship program (Province of Ontario); Canada Graduate Scholarship-Master's program; Canadian Institutes of Health Research (CIHR)-Strategic Training Program; Pamela Greenaway-Kohlmeier Translational Breast Cancer Research Unit at the London Regional Cancer Program; Ontario Ministry of Research and Innovation	Canadian Breast Cancer Foundation-Ontario Region; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Graduate Scholarship program (Province of Ontario); Canada Graduate Scholarship-Master's program; Canadian Institutes of Health Research (CIHR)-Strategic Training Program(Canadian Institutes of Health Research (CIHR)); Pamela Greenaway-Kohlmeier Translational Breast Cancer Research Unit at the London Regional Cancer Program; Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario)	This work was supported by grants from the Canadian Breast Cancer Foundation-Ontario Region, the Canada Foundation for Innovation (No. 13199), and donor support from John and Donna Bristol through the London Health Sciences Foundation (to A.L.A.). Studentship and fellowship support were provided by the Ontario Graduate Scholarship program (Province of Ontario, to G.M.P. and J.E.C.), the Canada Graduate Scholarship-Master's program (to M.M.P), the Canadian Institutes of Health Research (CIHR)-Strategic Training Program (to M.M.P., G.M.P and J.E.C.) and the Pamela Greenaway-Kohlmeier Translational Breast Cancer Research Unit at the London Regional Cancer Program (to M.M.P., G.M.P., J.E.C. and Y.X.). A.L.A. was supported by a CIHR New Investigator Award and an Early Researcher Award from the Ontario Ministry of Research and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Allan AL, 2006, AM J PATHOL, V169, P233, DOI 10.2353/ajpath.2006.051152; Anborgh PH, 2015, AM J TRANSL RES, V7, P723; Andersen JN, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001065; Balic M, 2006, CLIN CANCER RES, V12, P5615, DOI 10.1158/1078-0432.CCR-06-0169; Benoit Yannick D, 2012, J Signal Transduct, V2012, P248759, DOI 10.1155/2012/248759; Bramwell VHC, 2006, CLIN CANCER RES, V12, P3337, DOI 10.1158/1078-0432.CCR-05-2354; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; Calvi LM, 2015, BLOOD, V126, P2443, DOI 10.1182/blood-2015-07-533588; Campbell LL, 2007, CELL CYCLE, V6, P2332, DOI 10.4161/cc.6.19.4914; Canadian Cancer Society's Advisory Committee on Cancer Statistics, 2016, CAN CANC STAT; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Chu JE, 2014, NEOPLASIA, V16, P180, DOI 10.1593/neo.132076; COLEMAN RE, 1987, BRIT J CANCER, V55, P61, DOI 10.1038/bjc.1987.13; Croker AK, 2008, J CELL MOL MED, V12, P374, DOI 10.1111/j.1582-4934.2007.00211.x; Croker AK, 2012, BREAST CANCER RES TR, V133, P75, DOI 10.1007/s10549-011-1692-y; Croker AK, 2009, J CELL MOL MED, V13, P2236, DOI 10.1111/j.1582-4934.2008.00455.x; Forozan F, 1999, BRIT J CANCER, V81, P1328, DOI 10.1038/sj.bjc.6695007; Furger KA, 2003, MOL CANCER RES, V1, P810; Gillespie MT, 1997, INT J CANCER, V73, P812; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Guise T, 2010, SEMIN ONCOL, V37, pS2, DOI 10.1053/j.seminoncol.2010.10.007; Haylock DN, 2005, CELL CYCLE, V4, P1353, DOI 10.4161/cc.4.10.2056; Hess KR, 2006, CANCER, V106, P1624, DOI 10.1002/cncr.21778; Khan SA, 2005, CLIN EXP METASTAS, V22, P663, DOI 10.1007/s10585-006-9007-0; Kim JH, 2002, JAMA-J AM MED ASSOC, V287, P1671, DOI 10.1001/jama.287.13.1671; Lee BH, 2007, J BIOL CHEM, V282, P17985, DOI 10.1074/jbc.M702664200; Levesque JP, 2010, LEUKEMIA, V24, P1979, DOI 10.1038/leu.2010.214; Ling LJ, 2008, CHINESE MED J-PEKING, V121, P1980, DOI 10.1097/00029330-200810020-00006; Lipton A, 2009, J NATL COMPR CANC NE, V7, pS1; Louderbough JMV, 2011, MOL CANCER RES, V9, P1573, DOI 10.1158/1541-7786.MCR-11-0156; Luzzi KJ, 1998, AM J PATHOL, V153, P865, DOI 10.1016/S0002-9440(10)65628-3; Miller KD, 2016, CA-CANCER J CLIN, V66, P271, DOI 10.3322/caac.21349; Moniz S, 2010, CELL MOL LIFE SCI, V67, P1265, DOI 10.1007/s00018-010-0261-6; Nanni P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039626; Nemoto H, 2001, J BONE MINER RES, V16, P652, DOI 10.1359/jbmr.2001.16.4.652; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Olechnowicz SWZ, 2014, CANCER RES, V74, P1625, DOI 10.1158/0008-5472.CAN-13-2645; PAGET S, 1989, CANCER METAST REV, V8, P98; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Pietras A, 2014, CELL STEM CELL, V14, P357, DOI 10.1016/j.stem.2014.01.005; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rota LM, 2012, J MAMMARY GLAND BIOL, V17, P119, DOI 10.1007/s10911-012-9258-0; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Shevde LA, 2010, CURR MOL MED, V10, P71, DOI 10.2174/156652410791065381; Singhal H, 1997, CLIN CANCER RES, V3, P605; Standal T, 2004, EXP ONCOL, V26, P179; Standal T, 2004, HAEMATOLOGICA, V89, P174; Sterling JA, 2011, BONE, V48, P6, DOI 10.1016/j.bone.2010.07.015; Sun XT, 2006, J NEUROCHEM, V99, P1114, DOI 10.1111/j.1471-4159.2006.04159.x; Taichman RS, 1996, BLOOD, V87, P518, DOI 10.1182/blood.V87.2.518.bloodjournal872518; Tuck AB, 2003, ONCOGENE, V22, P1198, DOI 10.1038/sj.onc.1206209; Tuck AB, 2000, J CELL BIOCHEM, V78, P465, DOI 10.1002/1097-4644(20000901)78:3<465::AID-JCB11>3.0.CO;2-C; Tuck AB, 1998, INT J CANCER, V79, P502, DOI 10.1002/(SICI)1097-0215(19981023)79:5<502::AID-IJC10>3.0.CO;2-3; Tuck AB, 2001, J MAMMARY GLAND BIOL, V6, P419, DOI 10.1023/A:1014734930781; Tuck AB, 2001, BREAST CANCER RES TR, V70, P197, DOI 10.1023/A:1013095329825; Tuck AB, 2007, J CELL BIOCHEM, V102, P859, DOI 10.1002/jcb.21520; Ue T, 1998, INT J CANCER, V79, P127, DOI 10.1002/(SICI)1097-0215(19980417)79:2<127::AID-IJC5>3.0.CO;2-V; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wander SA, 2013, BREAST CANCER RES TR, V138, P369, DOI 10.1007/s10549-012-2389-6; WEISS L, 1992, CLIN EXP METASTAS, V10, P191, DOI 10.1007/BF00132751; XUAN JW, 1994, J CELL BIOCHEM, V54, P247, DOI 10.1002/jcb.240540213; Zhang H, 2014, CELL PHYSIOL BIOCHEM, V33, P991, DOI 10.1159/000358670; Zhang ZH, 2009, J BIOL CHEM, V284, P15717, DOI 10.1074/jbc.M808751200	64	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177640	10.1371/journal.pone.0177640	http://dx.doi.org/10.1371/journal.pone.0177640			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498874	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314500038
J	Takeuchi, Y; Saito, A; Ojima, Y; Kagaya, S; Fukami, H; Sato, H; Matsuda, K; Nagasawa, T				Takeuchi, Yoichi; Saito, Ayako; Ojima, Yoshie; Kagaya, Saeko; Fukami, Hirotaka; Sato, Hiroyuki; Matsuda, Ken; Nagasawa, Tasuku			The influence of the Great East Japan earthquake on microscopic polyangiitis: A retrospective observational study	PLOS ONE			English	Article							ANTIBODY-ASSOCIATED VASCULITIS; SMALL-VESSEL VASCULITIS; SILICA EXPOSURE; ANTINEUTROPHIL; ASSOCIATION; TSUNAMI; GLOMERULONEPHRITIS; ACTIVATION	Background Antineutrophil cytoplasmic antibody-associated vasculitis is triggered by environmental factors, including silica dust exposure. Repeated tsunami waves brought a large volume of silica-containing sludge inland after the Great East Japan earthquake in 2011. We aimed to determine if the serious disaster influenced the clinical features of the microscopic polyangiitis. Methods This is an observational retrospective study conducted in a single institute. A total of 43 patients were included based on the CHCC2012 criteria for microscopic polyangiitis from 2007 to 2015. We used the Poisson regression model to determine the incidence of microscopic polyangiitis within the annual population of the medical district. The participants were selected during a 3-year period from before (N = 13) to after the disaster (N = 20). The differences of parameters and the overall survival between the groups were analyzed. Results The incidence of microscopic polyangiitis increased after the disaster (lambda= 17.4/million/year [ 95% CI: 7.66-39.6] before the disaster and lambda = 33.1/million/year [17.7-61.7] after the disaster, P = 0.044). A high Birmingham Activity Score was associated with a high incidence of microscopic polyangiitis after the disaster. The overall survival of the patients with microscopic polyangiitis declined significantly after the disaster. Conclusions The Great East Japan earthquake influenced the development of the microscopic polyangiitis in our restricted area. The patients who developed after the disaster had severe symptoms and a high mortality rate.	[Takeuchi, Yoichi; Saito, Ayako; Ojima, Yoshie; Kagaya, Saeko; Fukami, Hirotaka; Sato, Hiroyuki; Matsuda, Ken; Nagasawa, Tasuku] Japanese Red Cross Ishinomaki Hosp, Dept Med, Div Nephrol, Ishinomaki, Miyagi, Japan		Takeuchi, Y (corresponding author), Japanese Red Cross Ishinomaki Hosp, Dept Med, Div Nephrol, Ishinomaki, Miyagi, Japan.	muu_tko@yahoo.co.jp		Sato, Hiroyuki/0000-0002-7820-0219; Nagasawa, Tasuku/0000-0002-2012-1171; Fukami, Hirotaka/0000-0002-7375-0748				Arimura Y, 2016, CLIN EXP NEPHROL, V20, P322, DOI 10.1007/s10157-015-1218-8; Bomback AS, 2011, KIDNEY INT, V79, P757, DOI 10.1038/ki.2010.489; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Ebisawa K, 2013, RESPIR INVESTIG, V51, P2, DOI 10.1016/j.resinv.2012.10.002; Ellard DR, 2001, INT J PSYCHOPHYSIOL, V41, P93, DOI 10.1016/S0167-8760(00)00180-X; Farquhar HJ, 2017, INTERN MED J, V47, P57, DOI 10.1111/imj.13246; Fujimoto S, 2011, RHEUMATOLOGY, V50, P1916, DOI 10.1093/rheumatology/ker205; Fukuhara N, 2016, ALLERGOL INT, V65, P117, DOI 10.1016/j.alit.2015.09.005; Hogan SL, 2001, J AM SOC NEPHROL, V12, P134, DOI 10.1681/ASN.V121134; Hogan SL, 2007, CLIN J AM SOC NEPHRO, V2, P290, DOI 10.2215/CJN.03501006; Inui T, 2012, SOILS FOUND, V52, P856, DOI 10.1016/j.sandf.2012.11.008; Jagiello P, 2004, HUM GENET, V114, P468, DOI 10.1007/s00439-004-1092-z; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kawasaki A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154393; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Kuroda H, 2011, W PAC SURVEILL RESPO, V2, P14; Lane SE, 2003, ARTHRITIS RHEUM-US, V48, P814, DOI 10.1002/art.10830; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; McCullagh P., 1999, GEN LINEAR MODELS; Nagasawa T, 2016, CLIN EXP NEPHROL, V20, P411, DOI 10.1007/s10157-015-1168-1; Nakahara S, 2013, J EPIDEMIOL, V23, P70, DOI 10.2188/jea.JE20120114; Nakazawa D, 2014, J AM SOC NEPHROL, V25, P990, DOI 10.1681/ASN.2013060606; Takahashi S, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001958; Tervaert JWC, 2012, CLIN REV ALLERG IMMU, V43, P211, DOI 10.1007/s12016-012-8320-4; Tsuchiya N, 2003, J RHEUMATOL, V30, P1534; Ueda Shinsaku, 2014, Ann Vasc Dis, V7, P365, DOI 10.3400/avd.oa.14-00106; van Wijngaarden RAFDL, 2008, CLIN J AM SOC NEPHRO, V3, P237, DOI 10.2215/CJN.03550807; Yamagata K, 2012, CLIN EXP NEPHROL, V16, P580, DOI 10.1007/s10157-012-0598-2; Yamanda S, 2016, INTERNAL MED, V55, P3645, DOI 10.2169/internalmedicine.55.6952; Yamanda S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-000865; Yamanouchi S, 2015, PREHOSP DISASTER MED, V30, P145, DOI 10.1017/S1049023X15000114; Yashiro M, 2000, AM J KIDNEY DIS, V35, P889, DOI 10.1016/S0272-6386(00)70260-5; Yuzawa Y, EVIDENCE BASED CLIN	34	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177482	10.1371/journal.pone.0177482	http://dx.doi.org/10.1371/journal.pone.0177482			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498830	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314500020
J	Velazquez-Ulloa, NA				Velazquez-Ulloa, Norma Andrea			A Drosophila model for developmental nicotine exposure	PLOS ONE			English	Article							ACETYLCHOLINE-RECEPTOR; PRENATAL NICOTINE; CHOLINERGIC SYSTEM; MATERNAL SMOKING; TOBACCO USE; ETHANOL; MELANOGASTER; DOPAMINE; BODY; PREGNANCY	Despite the known health risks of tobacco smoking, many people including pregnant women continue smoking. The effects of developmental nicotine exposure are known, but the underlying mechanisms are not well understood. Drosophila melanogaster is a model organism that can be used for uncovering genetic and molecular mechanisms for drugs of abuse. Here I show that Drosophila can be a model to elucidate the mechanisms for nicotine's effects on a developing organism. Drosophila reared on nicotine food display developmental and behavioral effects similar to those in mammals including decreased survival and weight, increased developmental time, and decreased sensitivity to acute nicotine and ethanol. The Drosophila nicotinic acetylcholine receptor subunit alpha 7 (D alpha 7) mediates some of these effects. A novel role for D alpha 7 on ethanol sedation in Drosophila is also shown. Future research taking advantage of the genetic and molecular tools for Drosophila will allow additional discovery of the mechanisms behind the effects of nicotine during development.	[Velazquez-Ulloa, Norma Andrea] Lewis & Clark Coll, Dept Biol, Portland, OR 97219 USA		Velazquez-Ulloa, NA (corresponding author), Lewis & Clark Coll, Dept Biol, Portland, OR 97219 USA.	nvelazquezulloa@lclark.edu		Velazquez-Ulloa, Norma/0000-0001-5616-2103	Consejo Nacional de Ciencia y Tecnologia (CONACyT, Mexico) [141799, 160227]	Consejo Nacional de Ciencia y Tecnologia (CONACyT, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by Consejo Nacional de Ciencia y Tecnologia (CONACyT, Mexico), (http://www.conacyt.mx/), scholarships no. 141799 and 160227 to NAVU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abburi C, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0112-15.2016; Abreu-Villaca Y, 2011, BEHAV BRAIN RES, V221, P367, DOI 10.1016/j.bbr.2009.12.049; [Anonymous], 2014, RES 2013 NAT SURV DR; Azanchi R, 2013, P NATL ACAD SCI USA, V110, P21153, DOI 10.1073/pnas.1320208110; Bainton RJ, 2000, CURR BIOL, V10, P187, DOI 10.1016/S0960-9822(00)00336-5; Benowitz Neal L, 2009, Handb Exp Pharmacol, P29, DOI 10.1007/978-3-540-69248-5_2; Bruel-Jungerman E, 2011, BEHAV BRAIN RES, V221, P379, DOI 10.1016/j.bbr.2011.01.021; Burke CJ, 2012, NATURE, V492, P433, DOI 10.1038/nature11614; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Changeux JP, 2010, NAT REV NEUROSCI, V11, P389, DOI 10.1038/nrn2849; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Christiansen F, 2011, J NEUROSCI, V31, P9696, DOI 10.1523/JNEUROSCI.6542-10.2011; Colomb J, 2014, F1000RESEARCH; Corl AB, 2009, CELL, V137, P949, DOI 10.1016/j.cell.2009.03.020; Cornelius MD, 2009, CURR OPIN NEUROL, V22, P121, DOI 10.1097/WCO.0b013e328326f6dc; Cornelius MD, 2000, ALCOHOL RES HEALTH, V24, P242; Dani JA, 2011, TRENDS NEUROSCI, V34, P383, DOI 10.1016/j.tins.2011.05.001; DAR MS, 1994, BRAIN RES, V644, P117; Drenan RM, 2012, PHARMACOL REV, V64, P869, DOI 10.1124/pr.111.004671; du Rand EE, 2015, SCI REP-UK, V5, DOI 10.1038/srep11779; Dupuis J, 2012, NEUROSCI BIOBEHAV R, V36, P1553, DOI 10.1016/j.neubiorev.2012.04.003; Faville R, 2015, SCI REP-UK, V5, DOI 10.1038/srep08454; Fayyazuddin A, 2006, PLOS BIOL, V4, P420, DOI 10.1371/journal.pbio.0040063; Fergusson DM, 1998, ARCH GEN PSYCHIAT, V55, P721, DOI 10.1001/archpsyc.55.8.721; Franke RM, 2008, EUR J NEUROSCI, V27, P2952, DOI 10.1111/j.1460-9568.2008.06253.x; Fuenzalida-Uribe N, 2013, J NEUROCHEM, V125, P281, DOI 10.1111/jnc.12161; Gelbart WM, FBRF0221009 FLYBASE; Govind AP, 2009, BIOCHEM PHARMACOL, V78, P756, DOI 10.1016/j.bcp.2009.06.011; Gramates LS, 2017, NUCLEIC ACIDS RES, V45, pD663, DOI 10.1093/nar/gkw1016; Grauso M, 2002, GENETICS, V160, P1519; GUNDELFINGER ED, 1992, BIOCHIM BIOPHYS ACTA, V1137, P299, DOI 10.1016/0167-4889(92)90150-A; Harrod SB, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00116; Hou JM, 2004, J NEUROBIOL, V60, P249, DOI 10.1002/neu.20021; Huizink AC, 2006, NEUROSCI BIOBEHAV R, V30, P24, DOI 10.1016/j.neubiorev.2005.04.005; Jones Andrew K., 2007, Invertebrate Neuroscience, V7, P67, DOI 10.1007/s10158-006-0039-6; Kaun KR, 2012, HUM GENET, V131, P959, DOI 10.1007/s00439-012-1146-6; Kaun KR, 2011, NAT NEUROSCI, V14, P612, DOI 10.1038/nn.2805; King I, 2011, J NEUROSCI, V31, P1139, DOI 10.1523/JNEUROSCI.4416-10.2011; Kremer MC, 2010, CURR BIOL, V20, P1938, DOI 10.1016/j.cub.2010.09.060; Lansdell SJ, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-73; Laudenbach V., 2002, FASEB J; Lester HA, 2009, AAPS J, V11, P167, DOI 10.1208/s12248-009-9090-7; Levin ED, 2006, PHARMACOL BIOCHEM BE, V85, P669, DOI 10.1016/j.pbb.2006.11.006; Li MD, 2003, ADDICTION, V98, P23, DOI 10.1046/j.1360-0443.2003.00295.x; Liu Z, 2007, BIOCHEM PHARMACOL, V74, P1112, DOI 10.1016/j.bcp.2007.05.022; Lozada AF, 2012, J NEUROSCI, V32, P7651, DOI 10.1523/JNEUROSCI.6246-11.2012; McClure KD, 2011, DIS MODEL MECH, V4, P335, DOI 10.1242/dmm.006411; Morean ME, 2010, ALCOHOL CLIN EXP RES, V34, P385, DOI 10.1111/j.1530-0277.2009.01103.x; Nakayama M, 2016, J NEUROSCI, V36, P590, DOI 10.1523/JNEUROSCI.2300-15.2016; Nunes-Freitas AL, 2011, TOXICOL SCI, V123, P144, DOI 10.1093/toxsci/kfr147; Oliff Heather S., 1999, Frontiers in Bioscience, V4, pd883, DOI 10.2741/Oliff; Omelchenko N, 2016, BRAIN STRUCT FUNCT, V221, P1939, DOI 10.1007/s00429-015-1014-y; Parker B, 2007, ZEBRAFISH, V4, P59, DOI 10.1089/zeb.2006.9994; Poon K, 2016, FRONT NUTR, V3, DOI 10.3389/fnut.2016.00011; Ren J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052521; Rothenfluh A, 2006, CELL, V127, P199, DOI 10.1016/j.cell.2006.09.010; Salas R, 2007, NEUROPHARMACOLOGY, V53, P863, DOI 10.1016/j.neuropharm.2007.08.017; Samet JM, 2010, NATURE, V463, P1020, DOI 10.1038/4631020a; Sanchez-Diaz I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133956; SCHELLING TC, 1992, SCIENCE, V255, P430, DOI 10.1126/science.1734519; Shopland DR, SMOKING TOBACCO CONT, V10; Slotkin TA, 2005, NEUROPSYCHOPHARMACOL, V30, P129, DOI 10.1038/sj.npp.1300544; Slotkin TA, 2004, BRAIN RES BULL, V64, P227, DOI 10.1016/j.brainresbull.2004.07.005; Smith AM, 2010, J PEDIATR BIOCHEM, V1, P125, DOI 10.3233/JPB-2010-0012; SNYDER MJ, 1995, ARCH BIOCHEM BIOPHYS, V321, P13, DOI 10.1006/abbi.1995.1362; STOLERMAN IP, 1995, PSYCHOPHARMACOLOGY, V117, P2, DOI 10.1007/BF02245088; Svoboda KR, 2002, J NEUROSCI, V22, P10731; Taslim N, 2011, ALCOHOL CLIN EXP RES, V35, P540, DOI 10.1111/j.1530-0277.2010.01371.x; Tizabi Y, 1997, PHARMACOL BIOCHEM BE, V58, P141, DOI 10.1016/S0091-3057(96)00461-3; Wolf FW, 2003, J NEUROBIOL, V54, P161, DOI 10.1002/neu.10166; World Health Organization, 2016, TOB FACT SHEET; Wu PP, 2005, J BIOL CHEM, V280, P20987, DOI 10.1074/jbc.M409639200; Xian H, 2003, NICOTINE TOB RES, V5, P245, DOI 10.1080/1462220031000073667; Yu DH, 1996, MOL PHARMACOL, V50, P1010; Zalucki O, 2015, FLY, V9, P7, DOI 10.1080/19336934.2015.1072663; Zhang Y, 2016, ACTA BIOMATER, V40, P243, DOI 10.1016/j.actbio.2016.04.007	76	17	17	5	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177710	10.1371/journal.pone.0177710	http://dx.doi.org/10.1371/journal.pone.0177710			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498868	Green Submitted, Green Published, gold			2022-12-26	WOS:000401314500043
J	Alberich, R; Castro, JA; Llabres, M; Palmer-Rodriguez, P				Alberich, Ricardo; Castro, Jose A.; Llabres, Merce; Palmer-Rodriguez, Pere			Metabolomics analysis: Finding out metabolic building blocks	PLOS ONE			English	Article							PATHWAY ANALYSIS; NETWORK; EVOLUTION	In this paper we propose a new methodology for the analysis of metabolic networks. We use the notion of strongly connected components of a graph, called in this context metabolic building blocks. Every strongly connected component is contracted to a single node in such a way that the resulting graph is a directed acyclic graph, called a metabolic DAG, with a considerably reduced number of nodes. The property of being a directed acyclic graph brings out a background graph topology that reveals the connectivity of the metabolic network, as well as bridges, isolated nodes and cut nodes. Altogether, it becomes a key information for the discovery of functional metabolic relations. Our methodology has been applied to the glycolysis and the purine metabolic pathways for all organisms in the KEGG database, although it is general enough to work on any database. As expected, using the metabolic DAGs formalism, a considerable reduction on the size of the metabolic networks has been obtained, specially in the case of the purine pathway due to its relative larger size. As a proof of concept, from the information captured by a metabolic DAG and its corresponding metabolic building blocks, we obtain the core of the glycolysis pathway and the core of the purine metabolism pathway and detect some essential metabolic building blocks that reveal the key reactions in both pathways. Finally, the application of our methodology to the glycolysis pathway and the purine metabolism pathway reproduce the tree of life for the whole set of the organisms represented in the KEGG database which supports the utility of this research.	[Alberich, Ricardo; Llabres, Merce; Palmer-Rodriguez, Pere] Univ Balearic Isl, Dept Math & Comp Sci, Palma De Mallorca, Balearic Island, Spain; [Castro, Jose A.] Univ Balearic Isl, Dept Biol, Palma De Mallorca, Balearic Island, Spain	Universitat de les Illes Balears; Universitat de les Illes Balears	Llabres, M (corresponding author), Univ Balearic Isl, Dept Math & Comp Sci, Palma De Mallorca, Balearic Island, Spain.	merce.llabres@uib.es	Llabrés, Mercè/R-1954-2019; Rodriguez, Pere A Palmer/G-3098-2015; Llabrés Segura, Maria de la Mercè/K-8725-2014; Castro, Jose A./J-9192-2014	Llabrés, Mercè/0000-0002-5358-6768; Rodriguez, Pere A Palmer/0000-0001-5794-6858; Llabrés Segura, Maria de la Mercè/0000-0002-5358-6768; Castro, Jose A./0000-0001-8262-560X	Spanish Government [DPI2015-67082-P]; Programa Pont La Caixa per a grups de recerca de la UIB	Spanish Government(Spanish GovernmentEuropean Commission); Programa Pont La Caixa per a grups de recerca de la UIB	This work was partially supported by the Spanish Government, through project DPI2015-67082-P, and the Programa Pont La Caixa per a grups de recerca de la UIB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research reported in this paper has been partially supported by the Spanish Government, through project DPI2015-67082-P, and the "Programa Pont La Caixa per a grups de recerca de la UIB". We thank F. Rossello A and G. Valiente for several comments on previous versions of this work.	Abaka G, 2013, BIOINFORMATICS, V29, P145, DOI 10.1093/bioinformatics/btt235; Alberich R, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-58; Ay F, 2011, J COMPUT BIOL, V18, P219, DOI 10.1089/cmb.2010.0280; Chartrand G., 2015, GRAPHS DIGRAPHS, V6th; Ebenhoh Oliver, 2004, Genome Inform, V15, P35; Fani R, 2009, PHYS LIFE REV, V6, P23, DOI 10.1016/j.plrev.2008.12.003; Garrity G., 2007, BERGEYS MANUAL SYSTE, V2; Hattori M, 2003, J AM CHEM SOC, V125, P11853, DOI 10.1021/ja036030u; International Union of Biochemistry and Molecular Biology. Nomenclature committee Webb EC, 1992, ENZ NOM 1992 REC NOM; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kauffman KJ, 2003, CURR OPIN BIOTECH, V14, P491, DOI 10.1016/j.copbio.2003.08.001; Klamt S, 2002, MOL BIOL REP, V29, P233, DOI 10.1023/A:1020390132244; Lazcano A, 1996, CELL, V85, P793, DOI 10.1016/S0092-8674(00)81263-5; Lingam M, 2016, ASTROBIOLOGY, V16, P418, DOI 10.1089/ast.2015.1411; Price ND, 2003, J THEOR BIOL, V225, P185, DOI 10.1016/S0022-5193(03)00237-6; Rison SCG, 2002, CURR OPIN STRUC BIOL, V12, P374, DOI 10.1016/S0959-440X(02)00331-7; Ruggiero MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119248; Steinway SN, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004338; Sweetlove LJ, 2008, BIOCHEM J, V409, P27, DOI 10.1042/BJ20071115; Tarjan R., 1972, SIAM Journal on Computing, V1, P146, DOI 10.1137/0201010; Tomar N, 2013, GENE, V521, P1, DOI 10.1016/j.gene.2013.03.017; Trinh CT, 2009, APPL MICROBIOL BIOT, V81, P813, DOI 10.1007/s00253-008-1770-1; Ver Eecke HC, 2009, APPL ENVIRON MICROB, V75, P242, DOI 10.1128/AEM.01462-08; Wiechert W, 2001, METAB ENG, V3, P195, DOI 10.1006/mben.2001.0187; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088	25	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177031	10.1371/journal.pone.0177031	http://dx.doi.org/10.1371/journal.pone.0177031			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493998	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314300052
J	Domingues, RR; Trugilho, PF; Silva, CA; de Melo, ICNA; Melo, LCA; Magriotis, ZM; Sanchez-Monedero, MA				Domingues, Rimena R.; Trugilho, Paulo F.; Silva, Carlos A.; de Melo, Isabel Cristina N. A.; Melo, Leonidas C. A.; Magriotis, Zuy M.; Sanchez-Monedero, Miguel A.			Properties of biochar derived from wood and high-nutrient biomasses with the aim of agronomic and environmental benefits	PLOS ONE			English	Article							PYROLYSIS TEMPERATURE; CHEMICAL-CHARACTERIZATION; SOIL; CARBON; CADMIUM; SHELL; ZINC; BIOAVAILABILITY; CONTAMINANTS; ADSORPTION	Biochar production and use are part of the modern agenda to recycle wastes, and to retain nutrients, pollutants, and heavy metals in the soil and to offset some greenhouse gas emissions. Biochars from wood (eucalyptus sawdust, pine bark), sugarcane bagasse, and substances rich in nutrients (coffee husk, chicken manure) produced at 350, 450 and 750 degrees C were characterized to identify agronomic and environmental benefits, which may enhance soil quality. Biochars derived from wood and sugarcane have greater potential for improving C storage in tropical soils due to a higher aromatic character, high C concentration, low H/C ratio, and FTIR spectra features as compared to nutrient-rich biochars. The high ash content associated with alkaline chemical species such as KHCO3 and CaCO3, verified by XRD analysis, made chicken manure and coffee husk biochars potential liming agents for remediating acidic soils. High Ca and K contents in chicken manure and coffee husk biomass can significantly replace conventional sources of K (mostly imported in Brazil) and Ca, suggesting a high agronomic value for these biochars. High-ash biochars, such as chicken manure and coffee husk, produced at low-temperatures (350 and 450 degrees C) exhibited high CEC values, which can be considered as a potential applicable material to increase nutrient retention in soil. Therefore, the agronomic value of the biochars in this study is predominantly regulated by the nutrient richness of the biomass, but an increase in pyrolysis temperature to 750 degrees C can strongly decrease the adsorptive capacities of chicken manure and coffee husk biochars. A diagram of the agronomic potential and environmental benefits is presented, along with some guidelines to relate biochar properties with potential agronomic and environmental uses. Based on biochar properties, research needs are identified and directions for future trials are delineated.	[Domingues, Rimena R.; Silva, Carlos A.; Melo, Leonidas C. A.] Univ Fed Lavras, UFLA, Dept Soil Sci, Lavras, MG, Brazil; [Trugilho, Paulo F.; de Melo, Isabel Cristina N. A.] Univ Fed Lavras, UFLA, Forest Sci Dept, Lavras, MG, Brazil; [Magriotis, Zuy M.] Univ Fed Lavras, UFLA, Chem Dept, Lavras, MG, Brazil; [Sanchez-Monedero, Miguel A.] Ctr Edafol & Biol Aplicada Segura CEBAS CSIC, Dept Conservac Suelos & Agua & Manejo Residuos Or, Campus Univ Espinardo, Murcia, Spain	Universidade Federal de Lavras; Universidade Federal de Lavras; Universidade Federal de Lavras; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Edafologia y Biologia Aplicada del Segura (CEBAS); University of Murcia	Domingues, RR (corresponding author), Univ Fed Lavras, UFLA, Dept Soil Sci, Lavras, MG, Brazil.	rimena_r@yahoo.com.br	Trugilho, Paulo F/I-5613-2013; Melo, L.C.A./C-1839-2014; Sanchez-Monedero, Miguel A./B-7298-2011; Magriotis, Zuy Maria/AAW-3982-2020	Trugilho, Paulo F/0000-0002-6230-5462; Melo, L.C.A./0000-0002-4034-4209; Sanchez-Monedero, Miguel A./0000-0002-2233-7144; Magriotis, Zuy Maria/0000-0002-1996-3961	Brazilian Ministry of Science, Technology, Innovations and Communications (MCTIC); National Council for Technological and Scientific Development - CNPq [3038592/2011-5, 303899/2015-8]; Coordination for the Improvement of Higher Level Education Personnel [CAPESPROEX AUXPE 590/2014]; CAPES; CNPq	Brazilian Ministry of Science, Technology, Innovations and Communications (MCTIC); National Council for Technological and Scientific Development - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Level Education Personnel; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	XDR analyses were performed at XRD1 beam-line of the Brazilian Synchrotron Light Laboratory (LNLS), which is supported by the Brazilian Ministry of Science, Technology, Innovations and Communications (MCTIC). This study was funded by the National Council for Technological and Scientific Development - CNPq,grants 3038592/2011-5 and 303899/2015-8 and Coordination for the Improvement of Higher Level Education Personnel (CAPES-PROEX AUXPE 590/2014). A PhD scholarship for RRD was provided by CAPES and research scholarships for PFT and CAS were provided by CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors are grateful to Claudineia Olimpia de Assis, PhD, for producing some of the biochar samples. XDR analyses were performed at XRD1 beam-line of the Brazilian Synchrotron Light Laboratory (LNLS), which is supported by the Brazilian Ministry of Science, Technology, Innovations and Communications (MCTIC). This study was funded by the National Council for Technological and Scientific Development - CNPq, grants 3038592/2011-5 and 303899/2015-8 and Coordination for the Improvement of Higher Level Education Personnel (CAPESPROEX AUXPE 590/2014). A PhD scholarship for RRD was provided by CAPES and research scholarships for PFT and CAS were provided by CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adinata D, 2007, BIORESOURCE TECHNOL, V98, P145, DOI 10.1016/j.biortech.2005.11.006; Ahmad M, 2012, BIORESOURCE TECHNOL, V118, P536, DOI 10.1016/j.biortech.2012.05.042; ASTM, 1990, STANDARD METHOD FOR; Beesley L, 2011, ENVIRON POLLUT, V159, P474, DOI 10.1016/j.envpol.2010.10.016; Beesley L, 2010, ENVIRON POLLUT, V158, P2282, DOI 10.1016/j.envpol.2010.02.003; Bruun EW, 2011, BIOMASS BIOENERG, V35, P1182, DOI 10.1016/j.biombioe.2010.12.008; Cantrell KB, 2012, BIORESOURCE TECHNOL, V107, P419, DOI 10.1016/j.biortech.2011.11.084; Cao XD, 2009, ENVIRON SCI TECHNOL, V43, P3285, DOI 10.1021/es803092k; Cayuela ML, 2015, AGR ECOSYST ENVIRON, V202, P135, DOI 10.1016/j.agee.2014.12.015; Cayuela ML, 2014, AGR ECOSYST ENVIRON, V191, P5, DOI 10.1016/j.agee.2013.10.009; Chen BL, 2008, ENVIRON SCI TECHNOL, V42, P5137, DOI 10.1021/es8002684; Cheng CH, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000642; Chintala R, 2014, CLEAN-SOIL AIR WATER, V42, P626, DOI 10.1002/clen.201300089; CONAB Companhia Nacional de Abastecimento, 2016, AC SAFR BRAS GRAOS; Dominghetti TFD, 2015, REV BRAS PARASITOL V, V24, P387, DOI 10.1590/S1984-29612015079; Deenik JL, 2011, SOIL SCI, V176, P336, DOI 10.1097/SS.0b013e31821fbfea; Domene X, 2015, SCI TOTAL ENVIRON, V512, P552, DOI 10.1016/j.scitotenv.2014.12.035; Enders A, 2012, BIORESOURCE TECHNOL, V114, P644, DOI 10.1016/j.biortech.2012.03.022; Fellet G, 2011, CHEMOSPHERE, V83, P1262, DOI 10.1016/j.chemosphere.2011.03.053; Fernandes AHBM, 2011, B PESQUISA DESENVOLV, V111, P1; Fidel RB, 2017, CHEMOSPHERE, V167, P367, DOI 10.1016/j.chemosphere.2016.09.151; GAI XP, 2014, PLOS ONE, V9, DOI DOI 10.1371/journal.pone.0113888; Gaskin JW, 2008, T ASABE, V51, P2061, DOI 10.13031/2013.25409; Higashikawa FS, 2010, REV BRAS CIENC SOLO, V34, P1743, DOI 10.1590/S0100-06832010000500026; Hossain MK, 2011, J ENVIRON MANAGE, V92, P223, DOI 10.1016/j.jenvman.2010.09.008; Houben D, 2013, CHEMOSPHERE, V92, P1450, DOI 10.1016/j.chemosphere.2013.03.055; Ipea-Instituto de Pesquisa, 2012, RELATORIO PESQUISA; Jindo K, 2014, BIOGEOSCIENCES, V11, P6613, DOI 10.5194/bg-11-6613-2014; Keiluweit M, 2010, ENVIRON SCI TECHNOL, V44, P1247, DOI 10.1021/es9031419; Kuzyakov Y, 2014, SOIL BIOL BIOCHEM, V70, P229, DOI 10.1016/j.soilbio.2013.12.021; Lehmann J., 2009, SCI TECHNOL HUM VAL, DOI 10.4324/9781849770552; Li XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065949; Lin Y, 2012, CHEMOSPHERE, V87, P151, DOI 10.1016/j.chemosphere.2011.12.007; Melo LCA, 2013, BIORESOURCES, V8, P4992; Mukherjee A, 2011, GEODERMA, V163, P247, DOI 10.1016/j.geoderma.2011.04.021; Namgay T, 2010, AUST J SOIL RES, V48, P638, DOI 10.1071/SR10049; Novak JM, 2010, GEODERMA, V154, P281, DOI 10.1016/j.geoderma.2009.10.014; Novak J. M., 2009, Annals of Environmental Science, V3, P195; Paz-Ferreiro J, 2014, SOLID EARTH, V5, P65, DOI 10.5194/se-5-65-2014; Pradhan BK, 1999, CARBON, V37, P1323, DOI 10.1016/S0008-6223(98)00328-5; Prakongkep N, 2014, J MET MATER MINER, V24, P7, DOI 10.14456/jmmm.2014.2; Qian LB, 2014, J AGR FOOD CHEM, V62, P373, DOI 10.1021/jf404624h; Rondon MA, 2007, BIOL FERT SOILS, V43, P699, DOI 10.1007/s00374-006-0152-z; Sagrilo E., 2015, GEODERMA REG, V6, P1, DOI DOI 10.1016/j.geodrs.2015.08.006; Santos J. R. A. dos, 2009, Revista Brasileira de Produtos Agroindustriais, V11, P27; Schulz H, 2012, J PLANT NUTR SOIL SC, V175, P410, DOI 10.1002/jpln.201100143; Shenbagavalli S., 2012, INT J ADV RES, V2, P249, DOI DOI 10.2134/JEQ2011.0133; Sigua GC, 2016, CHEMOSPHERE, V142, P168, DOI 10.1016/j.chemosphere.2015.06.016; Singh B, 2010, AUST J SOIL RES, V48, P516, DOI 10.1071/SR10058; Singla A, 2014, AGR ECOSYST ENVIRON, V197, P278, DOI 10.1016/j.agee.2014.08.010; Smider B, 2014, AGR ECOSYST ENVIRON, V191, P99, DOI 10.1016/j.agee.2014.01.024; Song WP, 2012, J ANAL APPL PYROL, V94, P138, DOI 10.1016/j.jaap.2011.11.018; Spokas KA, 2012, J ENVIRON QUAL, V41, P973, DOI 10.2134/jeq2011.0069; Steinbeiss S, 2009, SOIL BIOL BIOCHEM, V41, P1301, DOI 10.1016/j.soilbio.2009.03.016; Uchimiya M, 2011, J AGR FOOD CHEM, V59, P2501, DOI 10.1021/jf104206c; Wan Q, 2014, ENVIRON SCI POLLUT R, V21, P2486, DOI 10.1007/s11356-013-2183-y; Wang JY, 2012, PLANT SOIL, V360, P287, DOI 10.1007/s11104-012-1250-3; Xu G, 2014, ECOL ENG, V62, P54, DOI 10.1016/j.ecoleng.2013.10.027; Xu MZ, 2012, ENERG FUEL, V26, P209, DOI 10.1021/ef2011657; Yang HP, 2007, FUEL, V86, P1781, DOI 10.1016/j.fuel.2006.12.013; Yargicoglu EN, 2015, WASTE MANAGE, V36, P256, DOI 10.1016/j.wasman.2014.10.029; Yuan JH, 2011, BIORESOURCE TECHNOL, V102, P3488, DOI 10.1016/j.biortech.2010.11.018; Zhang JN, 2015, SCI REP-UK, V5, DOI 10.1038/srep09406; Zhao L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115373; Zimmerman AR, 2010, ENVIRON SCI TECHNOL, V44, P1295, DOI 10.1021/es903140c	65	251	255	26	165	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176884	10.1371/journal.pone.0176884	http://dx.doi.org/10.1371/journal.pone.0176884			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493951	Green Submitted, Green Published, gold			2022-12-26	WOS:000401314300037
J	Douglas, SJ; Li, BH; Kliebenstein, DJ; Nambara, E; Riggs, CD				Douglas, Scott J.; Li, Baohua; Kliebenstein, Daniel J.; Nambara, Eiji; Riggs, C. Daniel			A novel Filamentous Flower mutant suppresses brevipedicellus developmental defects and modulates glucosinolate and auxin levels	PLOS ONE			English	Article							ADAXIAL-ABAXIAL POLARITY; MAIZE HOMEOBOX GENE; ARABIDOPSIS-THALIANA; ECTOPIC EXPRESSION; INFLORESCENCE ARCHITECTURE; ORGAN DEVELOPMENT; DEFENSE COMPOUNDS; MERISTEM ACTIVITY; LEAF DEVELOPMENT; CELL FATE	BREVIPEDICELLUS (BP) encodes a class-I KNOTTED1-like homeobox (KNOX) transcription factor that plays a critical role in conditioning a replication competent state in the apical meristem, and it also governs growth and cellular differentiation in internodes and pedicels. To search for factors that modify BP signaling, we conducted a suppressor screen on bp er (erecta) plants and identified a mutant that ameliorates many of the pleiotropic defects of the parent line. Map based cloning and complementation studies revealed that the defect lies in the FILAMENTOUS FLOWER (FIL) gene, a member of the YABBY family of transcriptional regulators that contribute to meristem organization and function, phyllotaxy, leaf and floral organ growth and polarity, and are also known to repress KNOX gene expression. Genetic and cytological analyses of the fil-10 suppressor line indicate that the role of FIL in promoting growth is independent of its previously characterized influences on meristem identity and lateral organ polarity, and likely occurs non-cell-autonomously from superior floral organs. Transcription profiling of inflorescences revealed that FIL downregulates numerous transcription factors which in turn may subordinately regulate inflorescence architecture. In addition, FIL, directly or indirectly, activates over a dozen genes involved in glucosinolate production in part by activating MYB28, a known activator of many aliphatic glucosinolate biosynthesis genes. In the bp er fil-10 suppressor mutant background, enhanced expression of CYP71A13, AMIDASE1 (AMI) and NITRILASE genes suggest that auxin levels can be modulated by shunting glucosinolate metabolites into the IAA biosynthetic pathway, and increased IAA levels in the bp er fil-10 suppressor accompany enhanced internode and pedicel elongation. We propose that FIL acts to oppose KNOX1 gene function through a complex regulatory network that involves changes in secondary metabolites and auxin.	[Douglas, Scott J.; Riggs, C. Daniel] Univ Toronto, Dept Biol Sci, Scarborough, ON, Canada; [Li, Baohua; Kliebenstein, Daniel J.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Kliebenstein, Daniel J.] Univ Copenhagen, Copenhagen Plant Sci Ctr, DynaMo Ctr Excellence, Copenhagen, Denmark; [Nambara, Eiji; Riggs, C. Daniel] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada; [Nambara, Eiji; Riggs, C. Daniel] Univ Toronto, Ctr Anal Gene Evolut & Funct, Toronto, ON, Canada	University of Toronto; University Toronto Scarborough; University of California System; University of California Davis; University of Copenhagen; University of Toronto; University of Toronto	Riggs, CD (corresponding author), Univ Toronto, Dept Biol Sci, Scarborough, ON, Canada.; Riggs, CD (corresponding author), Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada.; Riggs, CD (corresponding author), Univ Toronto, Ctr Anal Gene Evolut & Funct, Toronto, ON, Canada.	riggs@utsc.utoronto.ca	Nambara, Eiji/E-5533-2012; Riggs, Dan/I-1718-2012	Riggs, Dan/0000-0002-3751-6129	Natural Sciences and Engineering Research Council of Canada [RGPIN 90057-06, RGPIN-2014-03621]; National Science Foundation [IOS 1339125, MCB 1330337]; United States Department of Agriculture [CA-D-PLS-7033-H]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture(United States Department of Agriculture (USDA))	This research was supported by grants from the Natural Sciences and Engineering Research Council of Canada (RGPIN 90057-06 to CDR and RGPIN-2014-03621 to EN), by grants from the National Science Foundation (IOS 1339125 and MCB 1330337 to DJK) and by a grant from the United States Department of Agriculture (Hatch project CA-D-PLS-7033-H to DJK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloni R, 2003, PLANTA, V216, P841, DOI 10.1007/s00425-002-0937-8; Bak S, 2001, PLANT CELL, V13, P101, DOI 10.1105/tpc.13.1.101; Bak S, 2001, PLANT PHYSIOL, V127, P108, DOI 10.1104/pp.127.1.108; Bao F, 2010, PLANT PHYSIOL, V152, P821, DOI 10.1104/pp.109.146183; Bar M, 2015, CURR OPIN PLANT BIOL, V23, P61, DOI 10.1016/j.pbi.2014.10.007; Barton MK, 2010, DEV BIOL, V341, P95, DOI 10.1016/j.ydbio.2009.11.029; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Belles-Boix E, 2006, PLANT CELL, V18, P1900, DOI 10.1105/tpc.106.041988; BOERJAN W, 1995, PLANT CELL, V7, P1405, DOI 10.1105/tpc.7.9.1405; Bolduc N, 2012, GENE DEV, V26, P1685, DOI 10.1101/gad.193433.112; Bolduc N, 2009, PLANT CELL, V21, P1647, DOI 10.1105/tpc.109.068221; Bonaccorso O, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-176; Bundy MGR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046262; Byrne ME, 2002, DEVELOPMENT, V129, P1957; Chen QY, 1999, DEVELOPMENT, V126, P2715; Chen SX, 2001, PLANT PHYSIOL, V127, P194, DOI 10.1104/pp.127.1.194; Chuck G, 1996, PLANT CELL, V8, P1277, DOI 10.1105/tpc.8.8.1277; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Delarue M, 1998, PLANT J, V14, P603, DOI 10.1046/j.1365-313X.1998.00163.x; Dinneny JR, 2005, DEVELOPMENT, V132, P4687, DOI 10.1242/dev.02062; Douglas SJ, 2005, DEV BIOL, V284, P451, DOI 10.1016/j.ydbio.2005.06.011; Douglas SJ, 2002, PLANT CELL, V14, P547, DOI 10.1105/tpc.010391; Emery JF, 2003, CURR BIOL, V13, P1768, DOI 10.1016/j.cub.2003.09.035; Eshed Y, 2004, DEVELOPMENT, V131, P2997, DOI 10.1242/dev.01186; Eshed Y, 1999, CELL, V99, P199, DOI 10.1016/S0092-8674(00)81651-7; Eshed Y, 2001, CURR BIOL, V11, P1251, DOI 10.1016/S0960-9822(01)00392-X; Franks RG, 2002, DEVELOPMENT, V129, P253; Gallagher TL, 2008, PLANT PHYSIOL, V147, P306, DOI 10.1104/pp.107.114603; Gigolashvili T, 2007, PLANT J, V51, P247, DOI 10.1111/j.1365-313X.2007.03133.x; Gil P, 2001, GENE DEV, V15, P1985, DOI 10.1101/gad.905201; Goldshmidt A, 2008, PLANT CELL, V20, P1217, DOI 10.1105/tpc.107.057877; Gonzalez-Reig S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003020; Greb T, 2003, GENE DEV, V17, P1175, DOI 10.1101/gad.260703; Grigorova B, 2011, DEVELOPMENT, V138, P2451, DOI 10.1242/dev.058362; Grubb CD, 2004, PLANT J, V40, P893, DOI 10.1111/j.1365-313X.2004.02261.x; Guo XL, 2013, PLANTA, V237, P1135, DOI 10.1007/s00425-012-1834-4; Hamant O, 2010, CR BIOL, V333, P371, DOI 10.1016/j.crvi.2010.01.015; Hareven D, 1996, CELL, V84, P735, DOI 10.1016/S0092-8674(00)81051-X; Hasegawa T, 2000, PHYTOCHEMISTRY, V54, P275, DOI 10.1016/S0031-9422(00)00080-7; Hay A, 2002, CURR BIOL, V12, P1557, DOI 10.1016/S0960-9822(02)01125-9; Hay A, 2006, DEVELOPMENT, V133, P3955, DOI 10.1242/dev.02545; Hay A, 2010, DEVELOPMENT, V137, P3153, DOI 10.1242/dev.030049; Hepworth SR, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01052; Ikezaki M, 2010, PLANT J, V61, P70, DOI 10.1111/j.1365-313X.2009.04033.x; Jasinski S, 2005, CURR BIOL, V15, P1560, DOI 10.1016/j.cub.2005.07.023; Jensen LM, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00697; Jorgensen ME, 2015, TRENDS PLANT SCI, V20, P508, DOI 10.1016/j.tplants.2015.04.006; Katz E, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2015.1062200; Katz E, 2015, PLANT J, V82, P547, DOI 10.1111/tpj.12824; Kerstetter RA, 2001, NATURE, V411, P706, DOI 10.1038/35079629; Kerwin R, 2015, ELIFE, V4, DOI 10.7554/eLife.05604; Kerwin RE, 2011, PLANT CELL, V23, P471, DOI 10.1105/tpc.110.082065; Kliebenstein DJ, 2001, PLANT PHYSIOL, V126, P811, DOI 10.1104/pp.126.2.811; Kong WW, 2015, PLANT CELL PHYSIOL, V56, P715, DOI 10.1093/pcp/pcu216; KONIECZNY A, 1993, PLANT J, V4, P403, DOI 10.1046/j.1365-313X.1993.04020403.x; Kumaran MK, 1999, SEX PLANT REPROD, V12, P118, DOI 10.1007/s004970050180; Kumaran MK, 2002, PLANT CELL, V14, P2761, DOI 10.1105/tpc.004911; Lee JE, 2014, PLANT J, V80, P122, DOI 10.1111/tpj.12625; Li BH, 2014, PLANT PHYSIOL, V166, P1803, DOI 10.1104/pp.114.248716; Lin WC, 2003, PLANT CELL, V15, P2241, DOI 10.1105/tpc.014969; LINCOLN C, 1994, PLANT CELL, V6, P1859, DOI 10.1105/tpc.6.12.1859; Liu N, 2014, J EXP BOT, V65, P2507, DOI 10.1093/jxb/eru141; LIU ZC, 1995, DEVELOPMENT, V121, P975; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ljung K, 2013, DEVELOPMENT, V140, P943, DOI 10.1242/dev.086363; Long JA, 1998, DEVELOPMENT, V125, P3027; Lugassi N, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-131; Machida C, 2015, WIRES DEV BIOL, V4, P655, DOI 10.1002/wdev.196; Maharjan PM, 2014, PLANT J, V80, P797, DOI 10.1111/tpj.12678; Malitsky S, 2008, PLANT PHYSIOL, V148, P2021, DOI 10.1104/pp.108.124784; McHale NA, 2004, PLANT CELL, V16, P1251, DOI 10.1105/tpc.019307; Meister RJ, 2005, PLANT PHYSIOL, V137, P651, DOI 10.1104/pp.104.055368; Mikkelsen MD, 2004, PLANT J, V37, P770, DOI 10.1111/j.1365-313X.2004.02002.x; Muller A, 1998, PLANTA, V206, P362, DOI 10.1007/s004250050411; Nafisi M, 2007, PLANT CELL, V19, P2039, DOI 10.1105/tpc.107.051383; Nakajima E, 2001, PLANT GROWTH REGUL, V35, P11, DOI 10.1023/A:1013856400351; Navarro C, 2004, DEVELOPMENT, V131, P3649, DOI 10.1242/dev.01205; NORMANLY J, 1993, P NATL ACAD SCI USA, V90, P10355, DOI 10.1073/pnas.90.21.10355; Nour-Eldin HH, 2012, NATURE, V488, P531, DOI 10.1038/nature11285; Pekker I, 2005, PLANT CELL, V17, P2899, DOI 10.1105/tpc.105.034876; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pfluger J, 2004, DEVELOPMENT, V131, P4697, DOI 10.1242/dev.01306; Pollmann S, 2003, PHYTOCHEMISTRY, V62, P293, DOI 10.1016/S0031-9422(02)00563-0; Prasad K, 2011, CURR BIOL, V21, P1123, DOI 10.1016/j.cub.2011.05.009; Ragni L, 2008, PLANT CELL, V20, P888, DOI 10.1105/tpc.108.058230; Reintanz B, 2001, PLANT CELL, V13, P351, DOI 10.1105/tpc.13.2.351; Ruegger M, 1997, PLANT CELL, V9, P745, DOI 10.1105/tpc.9.5.745; Sakamoto T, 2001, GENE DEV, V15, P581, DOI 10.1101/gad.867901; Sarojam R, 2010, PLANT CELL, V22, P2113, DOI 10.1105/tpc.110.075853; Sato Y, 1999, EMBO J, V18, P992, DOI 10.1093/emboj/18.4.992; Sawa S, 1999, PLANT CELL, V11, P69, DOI 10.1105/tpc.11.1.69; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schneeberger R, 1998, DEVELOPMENT, V125, P2857; SCHNEEBERGER RG, 1995, GENE DEV, V9, P2292, DOI 10.1101/gad.9.18.2292; Scofield S, 2006, PLANT MOL BIOL, V60, P929, DOI 10.1007/s11103-005-4478-y; Sentoku N, 2000, DEV BIOL, V220, P358, DOI 10.1006/dbio.2000.9624; Shani E, 2009, PLANT CELL, V21, P3078, DOI 10.1105/tpc.109.068148; Siegfried KR, 1999, DEVELOPMENT, V126, P4117; SMITH LG, 1992, DEVELOPMENT, V116, P21; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Sonderby IE, 2010, TRENDS PLANT SCI, V15, P283, DOI 10.1016/j.tplants.2010.02.005; Sonderby IE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001322; Sridhar VV, 2006, DEVELOPMENT, V133, P3159, DOI 10.1242/dev.02498; Stahl Y, 2010, CURR OPIN PLANT BIOL, V13, P53, DOI 10.1016/j.pbi.2009.09.008; Stahle MI, 2009, PLANT CELL, V21, P3105, DOI 10.1105/tpc.109.070458; Staldal V, 2008, NEW PHYTOL, V180, P798, DOI 10.1111/j.1469-8137.2008.02625.x; Stokes ME, 2013, PLANT PHYSIOL, V162, P1552, DOI 10.1104/pp.113.215095; Sugawara S, 2009, P NATL ACAD SCI USA, V106, P5430, DOI 10.1073/pnas.0811226106; Tabata R, 2010, PLANT CELL PHYSIOL, V51, P164, DOI 10.1093/pcp/pcp176; Tantikanjana T, 2001, GENE DEV, V15, P1577, DOI 10.1101/gad.887301; Tattersall AD, 2005, PLANT CELL, V17, P1046, DOI 10.1105/tpc.104.029447; Timmermans MCP, 1999, SCIENCE, V284, P151, DOI 10.1126/science.284.5411.151; Tivendale ND, 2014, TRENDS PLANT SCI, V19, P44, DOI 10.1016/j.tplants.2013.09.012; Venglat SP, 2002, P NATL ACAD SCI USA, V99, P4730, DOI 10.1073/pnas.072626099; Vollbrecht E, 2000, DEVELOPMENT, V127, P3161; Wentzell AM, 2007, PLOS GENET, V3, P1687, DOI 10.1371/journal.pgen.0030162; WilliamsCarrier RE, 1997, DEVELOPMENT, V124, P3737; Wu G, 2008, P NATL ACAD SCI USA, V105, P16392, DOI 10.1073/pnas.0803997105; Xu L, 2003, DEVELOPMENT, V130, P4097, DOI 10.1242/dev.00622; Yamada K, 2003, J PLANT PHYSIOL, V160, P255, DOI 10.1078/0176-1617-00950; Yamaguchi N, 2007, PLANT CELL PHYSIOL, V48, P1275, DOI 10.1093/pcp/pcm094; Yamaguchi N, 2013, PLANT SCI, V209, P64, DOI 10.1016/j.plantsci.2013.04.009; Yanai O, 2005, CURR BIOL, V15, P1566, DOI 10.1016/j.cub.2005.07.060; Zhao ML, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005125; Zhao YD, 2002, GENE DEV, V16, P3100, DOI 10.1101/gad.1035402	125	5	6	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177045	10.1371/journal.pone.0177045	http://dx.doi.org/10.1371/journal.pone.0177045			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493925	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314300053
J	Kang, JH; Park, JS; Yu, JS; Chung, JJ; Kim, JH; Cho, ES; Yoon, DS				Kang, Jung-Hyun; Park, Joon Seong; Yu, Jeong-Sik; Chung, Jae-Joon; Kim, Joo Hee; Cho, Eun-Suk; Yoon, Dong Sup			Prediction of pancreatic fistula after pancreatoduodenectomy by preoperative dynamic CT and fecal elastase-1 levels	PLOS ONE			English	Article							PROSPECTIVE RANDOMIZED-TRIAL; INTERNATIONAL STUDY-GROUP; PLACEBO-CONTROLLED TRIAL; AUTOIMMUNE PANCREATITIS; CLINICAL-EVALUATION; HEAD RESECTION; RISK-FACTORS; DUCT SIZE; COMPLICATIONS; PANCREATICOJEJUNOSTOMY	Objective To validate preoperative dynamic CT and fecal elastase-1 level in predicting the development of pancreatic fistulae after pancreatoduodenectomy. Materials and methods For 146 consecutive patients, CT attenuation values of the nontumorous pancreatic parenchyma were retrospectively measured on precontrast, arterial and equilibrium phase images for calculation of enhancement ratios. CT enhancement ratios and preoperative fecal elastase-1 levels were correlated with the development of pancreatic fistulae using independent t-test, logistic regression models, ROC analysis, Youden method and tree analysis. Results The mean value of enhancement ratio on equilibrium phase was significantly higher (p = 0.001) in the patients without pancreatic fistula (n = 107; 2.26 +/- 3.63) than in the patients with pancreatic fistula (n = 39; 1.04 +/- 0.51); in the logistic regression analyses, it was significant predictor for the development of pancreatic fistulae (odds ratio = 0.243, p = 0.002). The mean preoperative fecal elastase-1 levels were higher (odds ratio = 1.003, p = 0.034) in the pancreatic fistula patients than other patients, but there were no significant differences in the areas under the curve between the prediction values of CT enhancement ratios and fecal elastase-1 combined and those of CT enhancement ratios alone (P = 0.897, p = 0.917) on ROC curve analysis. Tree analysis revealed that the CT enhancement ratio was more powerful predictor of pancreatic fistula than fecal elastase-1 levels. Conclusion The preoperative CT enhancement ratio of pancreas acquired at equilibrium phase regardless of combination with fecal elastase-1 levels might be a useful predictor of the risk of developing a pancreatic fistula following pancreatoduodenectomy.	[Kang, Jung-Hyun; Yu, Jeong-Sik; Chung, Jae-Joon; Kim, Joo Hee; Cho, Eun-Suk] Yonsei Univ, Gangnam Severance Hosp, Dept Radiol, Coll Med, Seoul, South Korea; [Park, Joon Seong; Yoon, Dong Sup] Yonsei Univ, Gangnam Severance Hosp, Dept Surg, Coll Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Yu, JS (corresponding author), Yonsei Univ, Gangnam Severance Hosp, Dept Radiol, Coll Med, Seoul, South Korea.	yjsrad97@yuhs.ac		Yoon, Dong Sup/0000-0001-6444-9606; Park, Joon Seong/0000-0001-8048-9990; Chung, Jae-Joon/0000-0002-7447-1193; Yu, Jeong-Sik/0000-0002-8171-5838; KIM, JOO HEE/0000-0001-5383-3602				Adam U, 2004, AM J SURG, V187, P201, DOI 10.1016/j.amjsurg.2003.11.004; Allen PJ, 2014, NEW ENGL J MED, V370, P2014, DOI 10.1056/NEJMoa1313688; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; CAMERON JL, 1993, ANN SURG, V217, P430, DOI 10.1097/00000658-199305010-00002; DeOliveira ML, 2006, ANN SURG, V244, P931, DOI 10.1097/01.sla.0000246856.03918.9a; Dinter DJ, 2009, J GASTROINTEST SURG, V13, P735, DOI 10.1007/s11605-008-0765-7; Dong Z, 2016, REVIEW; Farnell MB, 2005, SURGERY, V138, P618, DOI 10.1016/j.surg.2005.06.044; Fletcher JG, 2003, RADIOLOGY, V229, P81, DOI 10.1148/radiol.2291020582; Friess H, 1996, PANCREAS, V13, P202; Glasbrenner B, 1996, EUR J GASTROEN HEPAT, V8, P1117, DOI 10.1097/00042737-199611000-00016; Hamanaka Y, 1996, SURGERY, V119, P281, DOI 10.1016/S0039-6060(96)80114-0; Hashimoto Y, 2011, J GASTROINTEST SURG, V15, P2193, DOI 10.1007/s11605-011-1687-3; Hashimoto Y, 2010, J AM COLL SURGEONS, V211, P510, DOI 10.1016/j.jamcollsurg.2010.06.018; Hashimoto Y, 2010, SURGERY, V147, P503, DOI 10.1016/j.surg.2009.10.034; Irie H, 1998, AM J ROENTGENOL, V170, P1323, DOI 10.2214/ajr.170.5.9574610; Katschinski M, 1997, PANCREAS, V15, P191, DOI 10.1097/00006676-199708000-00012; Kawamoto S, 2004, AM J ROENTGENOL, V183, P915, DOI 10.2214/ajr.183.4.1830915; Kim T, 2001, AM J ROENTGENOL, V177, P367, DOI 10.2214/ajr.177.2.1770367; Lee SE, 2010, ANN SURG, V251, P932, DOI 10.1097/SLA.0b013e3181d65483; Lillemoe KD, 2004, J GASTROINTEST SURG, V8, P766, DOI 10.1016/j.gassur.2004.06.011; Lin JW, 2004, J GASTROINTEST SURG, V8, P951, DOI 10.1016/j.gassur.2004.09.044; Loser C, 1996, GUT, V39, P580, DOI 10.1136/gut.39.4.580; Lowy AM, 1997, ANN SURG, V226, P632, DOI 10.1097/00000658-199711000-00008; Lu DSK, 1996, RADIOLOGY, V199, P697, DOI 10.1148/radiology.199.3.8637990; Ma LW, 2016, ANN SURG; MARCUS SG, 1995, ANN SURG, V221, P635, DOI 10.1097/00000658-199506000-00003; Murakami H, 2002, ANN SURG, V235, P240, DOI 10.1097/00000658-200202000-00012; Murakami Y, 2008, J SURG ONCOL, V97, P205, DOI 10.1002/jso.20903; Nakamura H, 2009, J GASTROINTEST SURG, V13, P1321, DOI 10.1007/s11605-009-0896-5; Niedergethmann M, 2004, Minerva Chir, V59, P175; Pedrazzoli S, 2009, ANN SURG, V249, P97, DOI 10.1097/SLA.0b013e31819274fe; Poon RTP, 2007, ANN SURG, V246, P425, DOI 10.1097/SLA.0b013e3181492c28; Pratt WB, 2007, ANN SURG, V245, P443, DOI 10.1097/01.sla.0000251708.70219.d2; Richter A, 2003, WORLD J SURG, V27, P324, DOI 10.1007/s00268-002-6659-z; Roder JD, 1999, ANN SURG, V229, P41, DOI 10.1097/00000658-199901000-00005; Sarr MG, 2003, J AM COLL SURGEONS, V196, P556, DOI 10.1016/S1072-7515(03)00104-2; Sato N, 1998, ARCH SURG-CHICAGO, V133, P1094, DOI 10.1001/archsurg.133.10.1094; Stein J, 1996, CLIN CHEM, V42, P222; Suzuki Y, 2002, ARCH SURG-CHICAGO, V137, P1044, DOI 10.1001/archsurg.137.9.1044; SZIEGOLEIT A, 1991, GASTROENTEROLOGY, V100, P768, DOI 10.1016/0016-5085(91)80024-4; Tajima Y, 2004, BRIT J SURG, V91, P595, DOI 10.1002/bjs.4461; Takahashi N, 2009, AM J ROENTGENOL, V193, P479, DOI 10.2214/AJR.08.1883; TREDE M, 1990, ANN SURG, V211, P447, DOI 10.1097/00000658-199004000-00011; YEO CJ, 1995, ANN SURG, V222, P580; Yeo CJ, 2000, ANN SURG, V232, P419, DOI 10.1097/00000658-200009000-00014	46	13	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177052	10.1371/journal.pone.0177052	http://dx.doi.org/10.1371/journal.pone.0177052			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493949	gold, Green Published, Green Submitted			2022-12-26	WOS:000401314300055
J	Mazanderani, AH; Moyo, F; Sherman, GG				Mazanderani, Ahmad Haeri; Moyo, Faith; Sherman, Gayle G.			Missed diagnostic opportunities within South Africa's early infant diagnosis program, 2010-2015	PLOS ONE			English	Article							HIV-INFECTION; MORTALITY; PREVENTION; BLOOD	Background Samples submitted for HIV PCR testing that fail to yield a positive or negative result represent missed diagnostic opportunities. We describe HIV PCR test rejections and indeterminate results, and the associated delay in diagnosis, within South Africa's early infant diagnosis (EID) program from 2010 to 2015. Methods HIV PCR test data from January 2010 to December 2015 were extracted from the National Health Laboratory Service Corporate Data Warehouse, a central data repository of all registered test-sets within the public health sector in South Africa, by laboratory number, result, date, facility, and testing laboratory. Samples that failed to yield either a positive or negative result were categorized according to the rejection code on the laboratory information system, and descriptive analysis performed using Microsoft Excel. Delay in diagnosis was calculated for patients who had a missed diagnostic opportunity registered between January 2013 and December 2015 by means of a patient linking-algorithm employing demographic details. Results Between 2010 and 2015, 2 178 582 samples were registered for HIV PCR testing of which 6.2% (n = 134 339) failed to yield either a positive or negative result, decreasing proportionally from 7.0% (n = 20 556) in 2010 to 4.4% (n = 21 388) in 2015 (p<0.001). Amongst 76 972 coded missed diagnostic opportunities, 49 585 (64.4%) were a result of pre-analytical error and 27 387 (35.6%) analytical error. Amongst 49 694 patients searched for follow-up results, 16 895 (34.0%) had at least one subsequent HIV PCR test registered after a median of 29 days (IQR: 13-57), of which 8.4% tested positive compared with 3.6% of all samples submitted for the same period. Conclusions Routine laboratory data provides the opportunity for near real-time surveillance and quality improvement within the EID program. Delay in diagnosis and wastage of resources associated with missed diagnostic opportunities must be addressed and infants actively followed-up as South Africa works towards elimination of mother-to-child transmission.	[Mazanderani, Ahmad Haeri; Moyo, Faith; Sherman, Gayle G.] Natl Inst Communicable Dis, Ctr HIV & STIs, Johannesburg, South Africa; [Mazanderani, Ahmad Haeri] Univ Pretoria, Dept Med Virol, Pretoria, South Africa; [Moyo, Faith; Sherman, Gayle G.] Wits Hlth Consortium, Paediat HIV Diagnost Syndicate, Johannesburg, South Africa; [Sherman, Gayle G.] Univ Witwatersrand, Fac Hlth Sci, Dept Paediat & Child Hlth, Johannesburg, South Africa	National Institute for Communicable Diseases (NICD); University of Pretoria; University of Witwatersrand; University of Witwatersrand	Mazanderani, AH (corresponding author), Natl Inst Communicable Dis, Ctr HIV & STIs, Johannesburg, South Africa.; Mazanderani, AH (corresponding author), Univ Pretoria, Dept Med Virol, Pretoria, South Africa.	ahmadh@nicd.ac.za		Haeri Mazanderani, Ahmad/0000-0001-7644-153X	Discovery Foundation; United Nations Children's Fund; UNICEF	Discovery Foundation; United Nations Children's Fund; UNICEF	This work was supported by Discovery Foundation www.tshikululu.org.za), AHM, and United Nations Children's Fund (www.unicef.org), GGS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors gratefully acknowledge the National Health Laboratory Service Corporate Data Warehouse manager, Mrs Sue Candy, and the National Health Laboratory Services for provision of laboratory test data and thank UNICEF for partially funding this work.	[Anonymous], 2015, 2013 NAT ANT SENT HI; Barker Pierre, 2015, AIDS, V29 Suppl 2, pS137, DOI 10.1097/QAD.0000000000000718; Bourne DE, 2009, AIDS, V23, P101, DOI 10.1097/QAD.0b013e32831c54bd; Feucht U, 2012, SAMJ S AFR MED J, V102, P149, DOI 10.7196/SAMJ.4951; Innes S, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18914; Lilian RR, 2013, PEDIATR INFECT DIS J, V32, P1080, DOI 10.1097/INF.0b013e318290622e; Lippi G, 2006, CLIN CHEM LAB MED, V44, P358, DOI 10.1515/CCLM.2006.073; Lippi G, 2011, CLIN CHEM LAB MED, V49, P1113, DOI 10.1515/CCLM.2011.600; MacLeod W, 2014, ANALYSIS OF BIG DATA; Marinda E, 2007, PEDIATR INFECT DIS J, V26, P519, DOI 10.1097/01.inf.0000264527.69954.4c; Maritz J, 2014, J MED VIROL, V86, P82, DOI 10.1002/jmv.23811; Maritz J, 2012, J CLIN VIROL, V53, P106, DOI 10.1016/j.jcv.2011.12.002; Massyn N., 2014, DURBAN HLTH SYSTEMS; Mazanderani AFH, 2014, SAMJ S AFR MED J, V104, P574, DOI [10.7196/SAMJ.8322, 10.7196/samj.8322]; Mazanderani AH, 2016, S AFR J HIV MED, V17, DOI 10.4102/sajhivmed.v17i1.451; National Department of Health, 2015, NAT CONS GUILD PREV; National Department of Health, 2004, NAT ANT TREATM GUID; National Department of Health, 2013, S AFR ANT TREATM GUI; National Department of Health, 2010, GUID MAN HIV CHILDR; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Penazzato M, 2014, LANCET INFECT DIS, V14, P650, DOI 10.1016/S1473-3099(13)70262-7; Plebani M, 2010, ANN CLIN BIOCHEM, V47, P101, DOI 10.1258/acb.2009.009222; Roche&REG;, 2013, COBAS AMPLIPREP COBA; Sherman GG, 2014, SAMJ S AFR MED J, V104, P235, DOI [10.7196/SAMJ.7598, 10.7196/samj.7598]; Sherman GG, 2017, J GLOB HEALTH, V7, DOI 10.7189/jogh.07.010701; Sherman GG, 2016, 8 HIV PED WORKSH 15; Stevens W, 2008, J CLIN MICROBIOL, V46, P3941, DOI 10.1128/JCM.00754-08; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; WHO, 2016, CONGUID UANT DRU; Woldesenbet SA, 2015, JAIDS-J ACQ IMM DEF, V68, pe26, DOI 10.1097/QAI.0000000000000460; World Health Organization, 2014, GLOB GUID CRIT PROC	31	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177173	10.1371/journal.pone.0177173	http://dx.doi.org/10.1371/journal.pone.0177173			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493908	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314300066
J	Shao, Q; Casin, KM; Mackowski, N; Murphy, E; Steenbergen, C; Kohr, MJ				Shao, Qin; Casin, Kevin M.; Mackowski, Nathan; Murphy, Elizabeth; Steenbergen, Charles; Kohr, Mark J.			Adenosine A1 receptor activation increases myocardial protein S-nitrosothiols and elicits protection from ischemia-reperfusion injury in male and female hearts	PLOS ONE			English	Article							ALPHA-KETOGLUTARATE DEHYDROGENASE; ESTROGEN-RECEPTOR; INFARCT SIZE; MITOCHONDRIAL PROTEINS; GENDER-DIFFERENCES; CONTROLLED-TRIAL; SEX-DIFFERENCES; RABBIT HEART; NITRIC-OXIDE; NITROSYLATION	Nitric oxide (NO) plays an important role in cardioprotection, and recent work from our group and others has implicated protein S-nitrosylation (SNO) as a critical component of NO-mediated protection in different models, including ischemic pre-and post-conditioning and sexdependent cardioprotection. However, studies have yet to examine whether protein SNO levels are similarly increased with pharmacologic preconditioning in male and female hearts, and whether an increase in protein SNO levels, which is protective in male hearts, is sufficient to increase baseline protection in female hearts. Therefore, we pharmacologically preconditioned male and female hearts with the adenosine A1 receptor agonist N6-cyclohexyl adenosine (CHA). CHA administration prior to ischemia significantly improved functional recovery in both male and female hearts compared to baseline in a Langendorff-perfused heart model of ischemia-reperfusion injury (% of preischemic function +/- SE: male baseline: 37.5 +/- 3.4% vs. male CHA: 55.3 +/- 3.2%; female baseline: 61.4 +/- 5.7% vs. female CHA: 76.0 +/- 6.2%). In a separate set of hearts, we found that CHA increased p-Akt and p-eNOS levels. We also used SNO-resin-assisted capture with LC-MS/MS to identify SNO proteins in male and female hearts, and determined that CHA perfusion induced a modest increase in protein SNO levels in both male (11.4%) and female (12.3%) hearts compared to baseline. These findings support a potential role for protein SNO in a model of pharmacologic preconditioning, and provide evidence to suggest that a modest increase in protein SNO levels is sufficient to protect both male and female hearts from ischemic injury. In addition, a number of the SNO proteins identified with CHA treatment were also observed with other forms of cardioprotective stimuli in prior studies, further supporting a role for protein SNO in cardioprotection.	[Shao, Qin] Shanghai Jiao Tong Univ, Renji Hosp, Dept Cardiol, Sch Med, Shanghai, Peoples R China; [Shao, Qin; Steenbergen, Charles; Kohr, Mark J.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Casin, Kevin M.; Mackowski, Nathan; Kohr, Mark J.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Whiting Sch Engn, Dept Environm Hlth & Engn, Baltimore, MD 21218 USA; [Murphy, Elizabeth] NHLBI, Syst Biol Ctr, Bldg 10, Bethesda, MD 20892 USA	Shanghai Jiao Tong University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Kohr, MJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.; Kohr, MJ (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Whiting Sch Engn, Dept Environm Hlth & Engn, Baltimore, MD 21218 USA.	mkohr1@jhu.edu		Casin, Kevin/0000-0003-3734-6075	National Natural Science Foundation of China [81270374, 81570390]; China Scholarship Council (QS); NHLBI/NIH Intramural Program [ZIAHL002065]; National Institutes of Health [T32ES0741, KC, R01HL039752, R00HL114721]; American Heart Association [16GRNT30420019]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL096142, K99HL114721, ZIAHL002065, R00HL114721, ZIAHL006059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007141] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council (QS)(China Scholarship Council); NHLBI/NIH Intramural Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Natural Science Foundation of China (81270374, 81570390, QS), the China Scholarship Council (QS), the NHLBI/NIH Intramural Program (ZIAHL002065, EM), the National Institutes of Health (T32ES0741, KC; R01HL039752, CS; R00HL114721, MK), and the American Heart Association (16GRNT30420019, MK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosio G, 2010, EUR HEART J, V31, P430, DOI 10.1093/eurheartj/ehp457; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Azhar G, 1999, EXP GERONTOL, V34, P699, DOI 10.1016/S0531-5565(99)00031-5; Bae SC, 2005, J PHARMACOL EXP THER, V315, P1125, DOI 10.1124/jpet.105.090803; BarrettConnor E, 1997, CIRCULATION, V95, P252, DOI 10.1161/01.CIR.95.1.252; Benhar M, 2008, SCIENCE, V320, P1050, DOI 10.1126/science.1158265; Bibli SI, 2014, J PHARM PHARMACOL, V66, P1140, DOI 10.1111/jphp.12238; Booth EA, 2005, AM J PHYSIOL-HEART C, V289, pH2039, DOI 10.1152/ajpheart.00479.2005; Brown-Steinke K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014007; Camper-Kirby D, 2001, CIRC RES, V88, P1020, DOI 10.1161/hh1001.090858; Chen C, 2013, LIFE SCI, V93, P265, DOI 10.1016/j.lfs.2013.06.019; Chouchani ET, 2013, NAT MED, V19, P753, DOI 10.1038/nm.3212; Chouchani ET, 2010, BIOCHEM J, V430, P49, DOI 10.1042/BJ20100633; Cohen MV, 2010, AM J PHYSIOL-HEART C, V299, pH2028, DOI 10.1152/ajpheart.00527.2010; Crabbe DL, 2003, J AM COLL CARDIOL, V41, P300, DOI 10.1016/S0735-1097(02)02710-9; Cross HR, 2002, AM J PHYSIOL-HEART C, V283, pH481, DOI 10.1152/ajpheart.00790.2001; Deschamps AM, 2009, AM J PHYSIOL-HEART C, V297, pH1806, DOI 10.1152/ajpheart.00283.2009; Evangelista AM, 2012, ANTIOXID REDOX SIGN, V17, P1099, DOI 10.1089/ars.2011.4022; Fredette N, 2014, FASEB J, V28; Hale SL, 1996, AM HEART J, V132, P258, DOI 10.1016/S0002-8703(96)90419-6; Hatzistergos KE, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001974; Hausenloy DJ, 2007, HEART FAIL REV, V12, P217, DOI 10.1007/s10741-007-9026-1; Hayward CS, 2000, CARDIOVASC RES, V46, P28, DOI 10.1016/S0008-6363(00)00005-5; Heusch G, 2016, CIRC RES, V119, P676, DOI 10.1161/CIRCRESAHA.116.308736; HILDEBRANDT P, 1992, AM HEART J, V124, P1139, DOI 10.1016/0002-8703(92)90392-9; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Johnson MS, 2006, AM J PHYSIOL-HEART C, V290, pH2644, DOI 10.1152/ajpheart.01291.2005; Jones DA, 2015, CIRC RES, V116, P437, DOI 10.1161/CIRCRESAHA.116.305082; Kis A, 2003, CARDIOVASC DRUG THER, V17, P415, DOI 10.1023/B:CARD.0000015856.02691.fa; Kloner RA, 2006, EUR HEART J, V27, P2400, DOI 10.1093/eurheartj/ehl094; Kohr MJ, 2014, J MOL CELL CARDIOL, V69, P67, DOI 10.1016/j.yjmcc.2014.01.010; Kohr MJ, 2012, CIRC RES, V111, P1308, DOI 10.1161/CIRCRESAHA.112.271320; Kohr MJ, 2011, AM J PHYSIOL-HEART C, V300, pH1327, DOI 10.1152/ajpheart.00997.2010; Kohr MJ, 2011, CIRC RES, V108, P418, DOI 10.1161/CIRCRESAHA.110.232173; Lagranha CJ, 2010, CIRC RES, V106, P1681, DOI 10.1161/CIRCRESAHA.109.213645; Leesar MA, 2001, CIRCULATION, V103, P2935, DOI 10.1161/01.CIR.103.24.2935; Lejay A, 2016, J MOL CELL CARDIOL, V91, P11, DOI 10.1016/j.yjmcc.2015.12.020; Li, 1995, J Thromb Thrombolysis, V2, P221; Lima B, 2009, P NATL ACAD SCI USA, V106, P6297, DOI 10.1073/pnas.0901043106; Lin J, 2009, CIRCULATION, V120, P245, DOI 10.1161/CIRCULATIONAHA.109.868729; Liu L, 2004, CELL, V116, P617, DOI 10.1016/S0092-8674(04)00131-X; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; Mahaffey KW, 1999, J AM COLL CARDIOL, V34, P1711, DOI 10.1016/S0735-1097(99)00418-0; Mariani J, 2000, J THORAC CARDIOV SUR, V120, P660, DOI 10.1067/mtc.2000.106528; McStay GP, 2002, BIOCHEM J, V367, P541, DOI 10.1042/BJ20011672; Menazza S, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002251; Methner C, 2014, EUR J HEART FAIL, V16, P712, DOI 10.1002/ejhf.100; Montagna C, 2014, ANTIOXID REDOX SIGN, V21, P570, DOI 10.1089/ars.2013.5696; MORRIS JL, 1995, BRIT HEART J, V73, P310; Murphy E, 2011, PEDIATR CARDIOL, V32, P354, DOI 10.1007/s00246-010-9877-4; Murray CI, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004721; Nadtochiy SM, 2007, J MOL CELL CARDIOL, V42, P812, DOI 10.1016/j.yjmcc.2007.01.010; Nakamura T, 2015, NEUROBIOL DIS, V84, P99, DOI 10.1016/j.nbd.2015.03.017; Nguyen TT, 2011, J BIOL CHEM, V286, P40184, DOI 10.1074/jbc.M111.243469; Penna C, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0371-z; Penna C, 2011, PFLUG ARCH EUR J PHY, V462, P219, DOI 10.1007/s00424-011-0970-1; Prime TA, 2009, P NATL ACAD SCI USA, V106, P10764, DOI 10.1073/pnas.0903250106; PRZYKLENK K, 1995, AM HEART J, V129, P1108, DOI 10.1016/0002-8703(95)90390-9; Ross AM, 2005, J AM COLL CARDIOL, V45, P1775, DOI 10.1016/j.jacc.2005.02.061; Ross JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038425; Ruiz-Holst C, 2010, CAN J PHYSIOL PHARM, V88, P121, DOI 10.1139/Y09-115; Shao Q, 2015, AM J PHYSL HEART CIR; Shao Q, 2016, AM J PHYSIOL-HEART C, V310, pH505, DOI 10.1152/ajpheart.00681.2015; Siddiqi N, 2014, EUR HEART J, V35, P1255, DOI 10.1093/eurheartj/ehu096; Sips PY, 2013, AM J PHYSIOL-HEART C, V304, pH1134, DOI 10.1152/ajpheart.00887.2012; Soetkamp D, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0433-x; Starkov AA, 2004, J NEUROSCI, V24, P7779, DOI 10.1523/JNEUROSCI.1899-04.2004; Sun JH, 2006, CIRC RES, V98, P403, DOI 10.1161/01.RES.0000202707.79018.0a; Sun JH, 2007, CIRC RES, V101, P1155, DOI 10.1161/CIRCRESAHA.107.155879; Sun JH, 2016, CARDIOVASC RES, V110, P96, DOI 10.1093/cvr/cvw037; Sun JH, 2013, FREE RADICAL BIO MED, V54, P105, DOI 10.1016/j.freeradbiomed.2012.09.005; Sun JH, 2012, ANTIOXID REDOX SIGN, V16, P45, DOI 10.1089/ars.2010.3844; Tahara EB, 2007, FASEB J, V21, P274, DOI 10.1096/fj.06-6686com; Tong G, 2014, AM J PHYSIOL-HEART C, V306, pH825, DOI 10.1152/ajpheart.00660.2013; Tretter L, 2005, PHILOS T R SOC B, V360, P2335, DOI 10.1098/rstb.2005.1764; Vander Heide RS, 2013, CIRC RES, V113, P464, DOI 10.1161/CIRCRESAHA.113.300765; Wang MJ, 2006, AM J PHYSIOL-HEART C, V290, pH2204, DOI 10.1152/ajpheart.01219.2005; Willems L, 2005, CARDIOVASC RES, V66, P245, DOI 10.1016/j.cardiores.2004.11.008; Willems Laura, 2005, J Mol Cell Cardiol, V38, P245, DOI 10.1016/j.yjmcc.2004.09.014; Zhan EB, 2011, AM J PHYSIOL-HEART C, V301, pH1183, DOI 10.1152/ajpheart.00264.2011	80	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177315	10.1371/journal.pone.0177315	http://dx.doi.org/10.1371/journal.pone.0177315			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493997	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314300086
J	Yu, Y; Chen, JM; Yang, XG; Fan, WY; Li, MZ; He, LM				Yu, Ying; Chen, Jing M.; Yang, Xiguang; Fan, Wenyi; Li, Mingze; He, Liming			Influence of site index on the relationship between forest net primary productivity and stand age	PLOS ONE			English	Article							CARBON SEQUESTRATION; BOREAL FORESTS; JACK PINE; GROWTH; BIOMASS; DECLINE; STORAGE; CANADA; PHOTOSYNTHESIS; DISTURBANCE	Previous studies show that forest net primary productivity (NPP) varies pronouncedly with stand age, and these variations play a crucial role in determining forest carbon sinks or sources at regional scales. Some forest carbon cycling models, eg. InTEC (The integrated terrestrial ecosystem C-budget model), calculates annual forest NPP in the long term according to normalized NPP-age relationships and the reference forest NPP at a given age. Therefore, the accurate NPP-age relationship is important for forest NPP estimation. In this study, NPP at various stand ages for twelve major forest stand types in Heilongjiang Province in northeast China is derived from yield tables with consideration of the total biomass increment and foliage and fine-root turnovers. Similar to previous studies, our results also show that forest NPP increases quickly at young ages, reaches the maximum value at middle age (10-40 years old), and then decreases to a relative stable level at old ages. However, we additionally found that forests under better site conditions have faster growth rates in young ages and steeper declines after reaching the maximum. Therefore, when the NPP-age curves for different site indices are normalized against the maximum value of each curve, there are significant differences among them. These differences have implications on the methodology for estimating the spatial distribution of forest carbon sources and sinks.	[Yu, Ying; Fan, Wenyi; Li, Mingze] Northeast Forestry Univ, Sch Forestry, Harbin, Heilongjiang, Peoples R China; [Chen, Jing M.; He, Liming] Univ Toronto, Dept Geog, Toronto, ON, Canada; [Chen, Jing M.; He, Liming] Univ Toronto, Program Planning, Toronto, ON, Canada; [Yang, Xiguang] Northeast Forestry Univ, Key Lab Saline Alkali Vegetat Ecol Restorat SAVER, Minist Educ, Alkali Soil Nat Environm Sci Ctr, Harbin, Heilongjiang, Peoples R China	Northeast Forestry University - China; University of Toronto; University of Toronto; Northeast Forestry University - China	Fan, WY (corresponding author), Northeast Forestry Univ, Sch Forestry, Harbin, Heilongjiang, Peoples R China.	fanwy5384@163.com	Chen, Jing/AAD-4768-2020; Yang, Xiguang/AAI-2136-2020	Chen, Jing/0000-0002-8682-1293; He, Liming/0000-0003-4010-6814	National Natural Science Foundation of China [31500519, 31500518, 31470640, 31300533]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research is supported by the National Natural Science Foundation of China (No. 31500519, 31500518, 31470640, 31300533), https://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list#.	[Anonymous], 2000, EARTH INTERACT, DOI DOI 10.1175/1087-3562(2000)004%3C0003:PASAOT%3E2.0.CO;2; Bradford JB, 2008, GLOBAL CHANGE BIOL, V14, P2882, DOI 10.1111/j.1365-2486.2008.01686.x; BREWER JA, 1985, FOREST SCI, V31, P414; Carmean WH, 1989, NC128 US DEP AGR FOR; Chapin F.S., 2002, PRINCIPLES TERRESTRI, DOI 10.1007/978-1-4419-9504-9; Chen J, 2000, GLOBAL BIOGEOCHEM CY, V14, P839, DOI 10.1029/1999GB001207; Chen JM, 1999, ECOL MODEL, V124, P99, DOI 10.1016/S0304-3800(99)00156-8; Chen JM, 2003, TELLUS B, V55, P622, DOI 10.1034/j.1600-0889.2003.00036.x; Chen WJ, 2002, CAN J FOREST RES, V32, P833, DOI [10.1139/x01-165, 10.1139/X01-165]; Dean C, 2004, FOREST ECOL MANAG, V194, P109, DOI 10.1016/j.foreco.2004.02.013; DesRochers A, 2001, CAN J FOREST RES, V31, P1012, DOI 10.1139/cjfr-31-6-1012; Dong Li-hu, 2011, Yingyong Shengtai Xuebao, V22, P2653; Euskirchen ES, 2002, ECOL MODEL, V154, P75, DOI 10.1016/S0304-3800(02)00052-2; Fan W, P 2011 INT C MAT REN; Fang J., 2001, CHIN J PLANT ECOL, V25, P414; Gao L, 2012, J GEOPHYS RES-BIOGEO, V117, DOI [10.1029/2011JG001930, 10.1029/2012JG001952]; GOELZ JCG, 1992, CAN J FOREST RES, V22, P776, DOI 10.1139/x92-106; Gough CM, 2007, GLOBAL CHANGE BIOL, V13, P1935, DOI 10.1111/j.1365-2486.2007.01406.x; Gower ST, 1996, TRENDS ECOL EVOL, V11, P378, DOI 10.1016/0169-5347(96)10042-2; Harmon ME, 2001, J FOREST, V99, P24; He LM, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2010GB003942; Houghton Richard A., 2001, TERRESTRIAL GLOBAL P, P499; Hudiburg T, 2009, ECOL APPL, V19, P163, DOI 10.1890/07-2006.1; Jin S, 2003, FOREST ECOL MANAG, V184, P125, DOI 10.1016/S0378-1127(03)00205-6; Kurz WA, 2009, ECOL MODEL, V220, P480, DOI 10.1016/j.ecolmodel.2008.10.018; Kurz WA, 1999, ECOL APPL, V9, P526, DOI 10.1890/1051-0761(1999)009[0526:AYRAOC]2.0.CO;2; Liu J, 2002, GLOBAL ECOL BIOGEOGR, V11, P115, DOI 10.1046/j.1466-822X.2002.00278.x; Liu X, 2011, SCAND J FOREST RES, V26, P30, DOI 10.1080/02827581.2010.533692; Luo L, 2010, ESTIMATION INFLUENCI; Mei L., 2006, FIN ROOT TURN CARB A; Mei Li, 2009, Yingyong Shengtai Xuebao, V20, P1791; MURTAUGH PA, 1988, ECOL MODEL, V43, P225, DOI 10.1016/0304-3800(88)90005-1; Pregitzer KS, 2004, GLOBAL CHANGE BIOL, V10, P2052, DOI 10.1111/j.1365-2486.2004.00866.x; Reich PB., 1995, ECOPHYSIOLOGY CONIFE, P225; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; RICKLEFS RE, 1979, AUK, V96, P10; Ryan MG, 1997, ADV ECOL RES, V27, P213, DOI 10.1016/S0065-2504(08)60009-4; Schroeder TA, 2011, REMOTE SENS ENVIRON, V115, P1421, DOI 10.1016/j.rse.2011.01.022; Skovsgaard JP, 2008, FORESTRY, V81, P13, DOI 10.1093/forestry/cpm041; Smith FW, 2001, FOREST ECOL MANAG, V144, P175, DOI 10.1016/S0378-1127(00)00369-8; Ter-Mikaelian MT, 2014, MITIG ADAPT STRAT GL, V19, P1063, DOI 10.1007/s11027-013-9460-4; Thomas SC, 2007, J ENVIRON MANAGE, V85, P663, DOI 10.1016/j.jenvman.2006.04.027; Thornley JHM, 2004, TREE PHYSIOL, V24, P765, DOI 10.1093/treephys/24.7.765; Wang P, 2007, J ENVIRON MANAGE, V85, P607, DOI 10.1016/j.jenvman.2006.08.017; Wang SQ, 2011, J ENVIRON MANAGE, V92, P1651, DOI 10.1016/j.jenvman.2011.01.024; Wang Xiao-ke, 1991, HYDRAULIC IND, V2, P32; Xia C, 2004, IEEE INT GEOSC REM S; Yu Ying, 2012, Yingyong Shengtai Xuebao, V23, P341; Zha TS, 2013, AGR FOREST METEOROL, V174, P54, DOI 10.1016/j.agrformet.2013.02.004; Zha T, 2009, GLOBAL CHANGE BIOL, V15, P1475, DOI 10.1111/j.1365-2486.2008.01817.x; Zhao M, 2005, FOREST ECOL MANAG, V207, P295, DOI 10.1016/j.foreco.2004.10.049; Zhou GS, 2002, FOREST ECOL MANAG, V169, P149, DOI 10.1016/S0378-1127(02)00305-5; Zhou L, 2011, ANN FOREST SCI, V68, P953, DOI 10.1007/s13595-011-0101-3; ZULLINGER EM, 1984, J MAMMAL, V65, P607, DOI 10.2307/1380844; ZWEIFEL JR, 1976, FISH B-NOAA, V74, P609	55	12	14	7	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177084	10.1371/journal.pone.0177084	http://dx.doi.org/10.1371/journal.pone.0177084			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493995	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314300058
J	Amarasekera, AT; Assadi-Khansari, B; Liu, SF; Black, M; Dymmott, G; Rogers, NM; Sverdlov, AL; Horowitz, JD; Ngo, DTM				Amarasekera, Anjalee T.; Assadi-Khansari, Bahador; Liu, Saifei; Black, Marilyn; Dymmott, Greer; Rogers, Natasha M.; Sverdlov, Aaron L.; Horowitz, John D.; Ngo, Doan T. M.			Vitamin D supplementation lowers thrombospondin-1 levels and blood pressure in healthy adults	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; 3RD NATIONAL-HEALTH; CARDIOVASCULAR-DISEASE; NITRIC-OXIDE; D DEFICIENCY; ACTIVIN-A; SERUM 25-HYDROXYVITAMIN-D; RISK; RESPONSES; IMPACT	Introduction Vitamin D insufficiency, defined as 25-hydroxyvitamin D (25(OH)D) levels < 75nmol/L is associated with cardio-metabolic dysfunction. Vitamin D insufficiency is associated with inflammation and fibrosis, but it remains uncertain whether these anomalies are readily reversible. Therefore, we aimed to determine the effects of vitamin D supplementation on markers of: 1) nitric oxide (NO) signaling, 2) inflammation, and 3) fibrosis, in healthy volunteers with mild hypovitaminosis. Methods Healthy volunteers (n = 35) (mean age: 45 +/- 11 years) with 25(OH)D levels <75nmol/L, received vitamin D supplementation (Ostelin (R) capsules 2000IU) for 12 weeks. Resting systolic and diastolic blood pressures (BP) were assessed. Routine biochemistry was examined. Plasma concentrations of asymmetric dimethylarginine (ADMA), thrombospondin-1 (TSP-1), plasminogen activator inhibitor-1 (PAI-1), hs-CRP, activin-A, and follistatin-like 3 (FSTL3) were quantitated. Results Vitamin D administration for 12 weeks significantly increased 25-(OH)D levels (48.8 +/- 16 nmol/L to 100.8 +/- 23.7 nmol/L, p<0.001). There was significant lowering of systolic and diastolic BP, while there was no significant change in lipid profiles, or fasting insulin. Plasma concentrations of ADMA, hs-CRP, PAI-1, activin A, and FSTL-3 did not change with vitamin D supplementation. However, there was a marked reduction of TSP-1 (522.7 +/- 379.8 ng/mL vs 206.7 +/- 204.5 ng/mL, p<0.001). Conclusions Vitamin D supplementation in vitamin D insufficient, but otherwise healthy individuals markedly decreased TSP-1 levels and blood pressure. Since TSP-1 suppresses signaling of NO, it is possible that the fall in BP is engendered by restoration of NO effect.	[Amarasekera, Anjalee T.; Assadi-Khansari, Bahador; Liu, Saifei; Black, Marilyn; Dymmott, Greer; Sverdlov, Aaron L.; Horowitz, John D.; Ngo, Doan T. M.] Univ Adelaide, Queen Elizabeth Hosp, Dept Med, Cardiol Unit,Basil Hetzel Inst, Adelaide, SA, Australia; [Amarasekera, Anjalee T.; Ngo, Doan T. M.] Univ South Australia, Sch Pharm & Med Sci, Adelaide, SA, Australia; [Rogers, Natasha M.] Westmead Inst Med Res, Ctr Transplant & Renal Res, Sydney, NSW, Australia	University of Adelaide; University of South Australia; University of Sydney; Westmead Institute for Medical Research	Ngo, DTM (corresponding author), Univ Adelaide, Queen Elizabeth Hosp, Dept Med, Cardiol Unit,Basil Hetzel Inst, Adelaide, SA, Australia.; Ngo, DTM (corresponding author), Univ South Australia, Sch Pharm & Med Sci, Adelaide, SA, Australia.	doan.ngo@adelaide.edu.au	Liu, Saifei/AAH-9701-2020; Rogers, Natasha/ABC-2546-2020; Amarasekera, Anjalee Thanuja/N-7258-2017; Sverdlov, Aaron/G-1384-2010	Liu, Saifei/0000-0003-4200-431X; Amarasekera, Anjalee Thanuja/0000-0003-3922-2914; Horowitz, John/0000-0001-6883-0703; Sverdlov, Aaron/0000-0003-2539-8038	Rebecca L. Cooper Medical Research Foundation; Tom Simpson Trust Fund Award; Hospital Research Foundation; Lyn Huddleston Award, University of Adelaide	Rebecca L. Cooper Medical Research Foundation; Tom Simpson Trust Fund Award; Hospital Research Foundation; Lyn Huddleston Award, University of Adelaide	This work was supported by the Rebecca L. Cooper Medical Research Foundation (AU) (Dr Doan TM Ngo); Tom Simpson Trust Fund Award (Dr Doan TM Ngo); Hospital Research Foundation (Dr Doan TM Ngo); and Lyn Huddleston Award, University of Adelaide (Dr Aaron L Sverdlov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara K, 2004, J BIOL CHEM, V279, P35798, DOI 10.1074/jbc.M404865200; Anderson JL, 2010, AM J CARDIOL, V106, P963, DOI 10.1016/j.amjcard.2010.05.027; Assalin HB, 2013, CIRC-HEART FAIL, V6, P809, DOI 10.1161/CIRCHEARTFAILURE.112.000298; Bauer EM, 2010, CARDIOVASC RES, V88, P471, DOI 10.1093/cvr/cvq218; Beveridge LA, 2015, JAMA INTERN MED, V175, P745, DOI 10.1001/jamainternmed.2015.0237; Blondon M, 2016, J CLIN ENDOCR METAB, V101, P2348, DOI 10.1210/jc.2016-1368; Bornstein P, 2001, J CLIN INVEST, V107, P929, DOI 10.1172/JCI12749; Calton EK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141770; Carvalho LSF, 2015, ATHEROSCLEROSIS, V241, P729, DOI 10.1016/j.atherosclerosis.2015.06.034; Choi KY, 2012, KOREAN CIRC J, V42, P100, DOI 10.4070/kcj.2012.42.2.100; Dobnig H, 2008, ARCH INTERN MED, V168, P1340, DOI 10.1001/archinte.168.12.1340; Forman JP, 2010, HYPERTENSION, V55, P1283, DOI 10.1161/HYPERTENSIONAHA.109.148619; Fraser A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013882; Gao JB, 2015, CLIN CHIM ACTA, V450, P176, DOI 10.1016/j.cca.2015.08.014; Harris RA, 2011, AM J HYPERTENS, V24, P557, DOI 10.1038/ajh.2011.12; Hobson SR, 2016, PREGNANCY HYPERTENS, V6, P130, DOI 10.1016/j.preghy.2016.03.001; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Isenberg JS, 2006, CARDIOVASC RES, V71, P785, DOI 10.1016/j.cardiores.2006.05.024; Kaur S, 2010, J BIOL CHEM, V285, P38923, DOI 10.1074/jbc.M110.172304; Krishna SM, 2013, INT J CARDIOL, V168, P692, DOI 10.1016/j.ijcard.2013.04.139; Lee JH, 2008, J AM COLL CARDIOL, V52, P1949, DOI 10.1016/j.jacc.2008.08.050; Li Y, 2005, IEEE COMMUN LETT, V9, P1, DOI 10.1109/LCOMM.200501010; Looker AC, 2002, BONE, V30, P771, DOI 10.1016/S8756-3282(02)00692-0; Martins D, 2007, ARCH INTERN MED, V167, P1159, DOI 10.1001/archinte.167.11.1159; Ngo DTM, 2011, NITRIC OXIDE-BIOL CH, V25, P326, DOI 10.1016/j.niox.2011.06.005; Ngo DT, 2010, AM J MED, V123, P335, DOI 10.1016/j.amjmed.2009.09.024; OKABEKADO J, 1991, ANTICANCER RES, V11, P181; Roberts DD, 2012, MATRIX BIOL, V31, P162, DOI 10.1016/j.matbio.2012.01.005; Rochette L, 2013, PHARMACOL THERAPEUT, V140, P239, DOI 10.1016/j.pharmthera.2013.07.004; Rogers NM, 2014, MATRIX BIOL, V37, P92, DOI 10.1016/j.matbio.2014.01.002; Scragg R, 2007, AM J HYPERTENS, V20, P713, DOI 10.1016/j.amjhyper.2007.01.017; Smadja DM, 2011, ARTERIOSCL THROM VAS, V31, P551, DOI 10.1161/ATVBAHA.110.220624; Sugden JA, 2008, DIABETIC MED, V25, P320, DOI 10.1111/j.1464-5491.2007.02360.x; Sverdlov AL, 2012, EUR HEART J, V33, P2419, DOI 10.1093/eurheartj/ehs171; Szeto FL, 2012, MOL ENDOCRINOL, V26, P1091, DOI 10.1210/me.2011-1329; Talmor Y, 2008, AM J PHYSIOL-RENAL, V294, pF1059, DOI 10.1152/ajprenal.00051.2008; Temmerman JC, 2011, J AM COLL NUTR, V30, P167, DOI 10.1080/07315724.2011.10719956; Wang L, 2012, CIRC-CARDIOVASC QUAL, V5, P819, DOI 10.1161/CIRCOUTCOMES.112.967604; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Wang TT, 2005, MOL ENDOCRINOL, V19, P2685, DOI 10.1210/me.2005-0106; Woeckel VJ, 2013, J CELL PHYSIOL, V228, P2167, DOI 10.1002/jcp.24388; Wong MSK, 2010, AM J PHYSIOL-HEART C, V299, pH1226, DOI 10.1152/ajpheart.00288.2010; Wu-Wong JR, 2007, J VASC RES, V44, P11, DOI 10.1159/000097812; Wu-Wong JR, 2006, ATHEROSCLEROSIS, V186, P20, DOI 10.1016/j.atherosclerosis.2005.06.046; Yndestad A, 2009, J APPL PHYSIOL, V106, P1356, DOI 10.1152/japplphysiol.90719.2008; Zittermann A, 2008, CURR OPIN CLIN NUTR, V11, P752, DOI 10.1097/MCO.0b013e328312c33f	46	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0174435	10.1371/journal.pone.0174435	http://dx.doi.org/10.1371/journal.pone.0174435			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489857	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000401314100003
J	Machida, T; Takata, F; Matsumoto, J; Miyamura, T; Hirata, R; Kimura, I; Kataoka, Y; Dohgu, S; Yamauchi, A				Machida, Takashi; Takata, Fuyuko; Matsumoto, Junichi; Miyamura, Tomoyuki; Hirata, Ryosuke; Kimura, Ikuya; Kataoka, Yasufumi; Dohgu, Shinya; Yamauchi, Atsushi			Contribution of thrombin-reactive brain pericytes to blood-brain barrier dysfunction in an in vivo mouse model of obesity-associated diabetes and an in vitro rat model	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; PERMEABILITY; RETINOPATHY; APOPTOSIS; RELEASE; CELLS; INFLAMMATION; NEPHROPATHY	Diabetic complications are characterized by the dysfunction of pericytes located around microvascular endothelial cells. The blood-brain barrier (BBB) exhibits hyperpermeability with progression of diabetes. Therefore, brain pericytes at the BBB may be involved in diabetic complications of the central nervous system (CNS). We hypothesized that brain pericytes respond to increased brain thrombin levels in diabetes, leading to BBB dysfunction and diabetic CNS complications. Mice were fed a high-fat diet (HFD) for 2 or 8 weeks to induce obesity. Transport of i.v.-administered sodium fluorescein and I-125-thrombin across the BBB were measured. We evaluated brain endothelial permeability and expression of tight junction proteins in the presence of thrombin-treated brain pericytes using a BBB model of co-cultured rat brain endothelial cells and pericytes. Mice fed a HFD for 8 weeks showed both increased weight gain and impaired glucose tolerance. In parallel, the brain influx rate of sodium fluorescein was significantly greater than that in mice fed a normal diet. HFD feeding inhibited the decline in brain thrombin levels occurring during 6 weeks of feeding. In the HFD fed mice, plasma thrombin levels were significantly increased, by up to 22%. I-125-thrombin was transported across the BBB in normal mice after i.v.injection, with uptake further enhanced by co-injection of unlabeled thrombin. Thrombin-treated brain pericytes increased brain endothelial permeability and caused decreased expression of zona occludens-1 (ZO-1) and occludin and morphological disorganization of ZO-1. Thrombin also increased mRNA expression of interleukin-1 beta and 6 and tumor necrosis factor-alpha in brain pericytes. Thrombin can be transported from circulating blood through the BBB, maintaining constant levels in the brain, where it can stimulate pericytes to induce BBB dysfunction. Thus, the brain pericyte-thrombin interaction may play a key role in causing BBB dysfunction in obesity-associated diabetes and represent a therapeutic target for its CNS complications.	[Machida, Takashi; Takata, Fuyuko; Matsumoto, Junichi; Miyamura, Tomoyuki; Hirata, Ryosuke; Kimura, Ikuya; Kataoka, Yasufumi; Dohgu, Shinya; Yamauchi, Atsushi] Fukuoka Univ, Fac Pharmaceut Sci, Dept Pharmaceut Care & Hlth Sci, Fukuoka, Japan; [Takata, Fuyuko; Kataoka, Yasufumi] PharmaCo Cell Co Ltd, BBB Lab, Nagasaki, Japan	Fukuoka University	Yamauchi, A (corresponding author), Fukuoka Univ, Fac Pharmaceut Sci, Dept Pharmaceut Care & Hlth Sci, Fukuoka, Japan.	atyama@fukuoka-u.ac.jp	Dohgu, Shinya/AAK-9992-2020		Japan Society for the Promotion of Science, funds [25460236, 26460113, 24790102, 26860177]; Central Research Institute of Fukuoka University [141104, 136005]; Takeda Science Foundation	Japan Society for the Promotion of Science, funds; Central Research Institute of Fukuoka University; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by Grants-in-Aid for Scientific Research [(to YK) (C) 25460236 and (to FT) (C) 26460113], Grants-in-id for Young Scientists [(to T. Machida) (B) 24790102 and (to SD) (B) 26860177] from the Japan Society for the Promotion of Science, funds [(to JM) no. 141104, and (to SD) no. 136005] from the Central Research Institute of Fukuoka University, and funds (to SD) from the Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. BBB Laboratory PharmaCo-Cell Co., Ltd. provided no support in the form of salaries for all authors, and did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal NK, 2014, WORLD J DIABETES, V5, P697, DOI 10.4239/wjd.v5.i5.697; Alabanza LM, 2012, J NEUROIMMUNOL, V245, P48, DOI 10.1016/j.jneuroim.2012.02.004; Argaw AT, 2006, J IMMUNOL, V177, P5574, DOI 10.4049/jimmunol.177.8.5574; Bauer AT, 2010, J CEREBR BLOOD F MET, V30, P837, DOI 10.1038/jcbfm.2009.248; Bell RD, 2009, ACTA NEUROPATHOL, V118, P103, DOI 10.1007/s00401-009-0522-3; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Boden G, 2007, J CLIN ENDOCR METAB, V92, P4352, DOI 10.1210/jc.2007-0933; Chang HC, 2014, J AGR FOOD CHEM, V62, P3466, DOI 10.1021/jf403286w; Cukierman T, 2005, DIABETOLOGIA, V48, P2460, DOI 10.1007/s00125-005-0023-4; DEHOUCK MP, 1992, J NEUROCHEM, V58, P1790, DOI 10.1111/j.1471-4159.1992.tb10055.x; deVries HE, 1996, J NEUROIMMUNOL, V64, P37, DOI 10.1016/0165-5728(95)00148-4; Dohgu S, 2005, BRAIN RES, V1038, P208, DOI 10.1016/j.brainres.2005.01.027; Dominguez RO, 2013, NEUROLOGIA, V28, P57, DOI 10.1016/j.nrl.2011.04.009; Fujita T, 2013, DIABETES-METAB RES, V29, P220, DOI 10.1002/dmrr.2380; Gasche Y, 2001, J CEREBR BLOOD F MET, V21, P1393, DOI 10.1097/00004647-200112000-00003; Geraldes P, 2009, NAT MED, V15, P1298, DOI 10.1038/nm.2052; Grammas P, 2004, J ALZHEIMERS DIS, V6, P275; Hammes HP, 2002, DIABETES, V51, P3107, DOI 10.2337/diabetes.51.10.3107; Hasegawa K, 2013, NAT MED, V19, P1496, DOI 10.1038/nm.3363; Hawkins BT, 2007, DIABETOLOGIA, V50, P202, DOI 10.1007/s00125-006-0485-z; Hawkins BT, 2015, J CEREBR BLOOD F MET, V35, P985, DOI 10.1038/jcbfm.2015.9; Humpel C, 2011, EXP GERONTOL, V46, P225, DOI 10.1016/j.exger.2010.11.032; Isermann B, 2007, NAT MED, V13, P1349, DOI 10.1038/nm1667; Jayashree B, 2014, MOL CELL BIOCHEM, V388, P203, DOI 10.1007/s11010-013-1911-4; Jongen C, 2007, DIABETOLOGIA, V50, P1509, DOI 10.1007/s00125-007-0688-y; King GL, 2008, J PERIODONTOL, V79, P1527, DOI 10.1902/jop.2008.080246; Lee JH, 2015, BRAIN RES, V1613, P73, DOI 10.1016/j.brainres.2015.04.002; Luchsinger JA, 2007, ARCH NEUROL-CHICAGO, V64, P570, DOI 10.1001/archneur.64.4.570; Machida T, 2015, NEUROSCI LETT, V599, P109, DOI 10.1016/j.neulet.2015.05.028; MARUO N, 1992, ENDOCRINOLOGY, V131, P710, DOI 10.1210/en.131.2.710; Matsumoto J, 2014, NEUROSCI LETT, V578, P133, DOI 10.1016/j.neulet.2014.06.052; Mizutani M, 1996, J CLIN INVEST, V97, P2883, DOI 10.1172/JCI118746; Montagne A, 2015, NEURON, V85, P296, DOI 10.1016/j.neuron.2014.12.032; Nishioku T, 2009, CELL MOL NEUROBIOL, V29, P309, DOI 10.1007/s10571-008-9322-x; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Price TO, 2012, ENDOCRINOLOGY, V153, P362, DOI 10.1210/en.2011-1638; Roberts RO, 2014, NEUROLOGY, V82, P1132, DOI 10.1212/WNL.0000000000000269; Rosenberg GA, 1995, BRAIN RES, V703, P151, DOI 10.1016/0006-8993(95)01089-0; Rosenberg GA, 2012, J CEREBR BLOOD F MET, V32, P1139, DOI 10.1038/jcbfm.2011.197; Samad F, 2013, BLOOD, V122, P3415, DOI 10.1182/blood-2013-05-427708; Shimizu F, 2013, NEUROBIOL AGING, V34, P1902, DOI 10.1016/j.neurobiolaging.2013.01.012; Starr JM, 2003, J NEUROL NEUROSUR PS, V74, P70, DOI 10.1136/jnnp.74.1.70; Stranahan AM, 2016, J CEREB BLOOD FLOW M; Takata F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055166; Takata F, 2009, NEUROSCI LETT, V449, P71, DOI 10.1016/j.neulet.2008.10.082; Verzola D, 2007, KIDNEY INT, V72, P1262, DOI 10.1038/sj.ki.5002531; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Yemisci M, 2009, NAT MED, V15, P1031, DOI 10.1038/nm.2022; Yin XL, 2010, AM J PATHOL, V176, P1600, DOI 10.2353/ajpath.2010.090406; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	50	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177447	10.1371/journal.pone.0177447	http://dx.doi.org/10.1371/journal.pone.0177447			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489922	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314100077
J	Brouwer, MJ; Kersbergen, KJ; van Kooij, BJM; Benders, MJNL; van Haastert, IC; Koopman-Esseboom, C; Neil, JJ; de Vries, LS; Kidokoro, H; Inder, TE; Groenendaal, F				Brouwer, Margaretha J.; Kersbergen, Karina J.; van Kooij, Britt J. M.; Benders, Manon J. N. L.; van Haastert, Ingrid C.; Koopman-Esseboom, Corine; Neil, Jeffrey J.; de Vries, Linda S.; Kidokoro, Hiroyuki; Inder, Terrie E.; Groenendaal, Floris			Preterm brain injury on term-equivalent age MRI in relation to perinatal factors and neurodevelopmental outcome at two years	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; MAGNETIC-RESONANCE; WHITE-MATTER; PREMATURE-INFANTS; CEREBRAL-PALSY; MOTOR FUNCTION; GROWTH; BORN; ABNORMALITIES; CEREBELLUM	Objectives First, to apply a recently extended scoring system for preterm brain injury at term-equivalent age (TEA-)MRI in a regional extremely preterm cohort; second, to identify independent perinatal factors associated with this score; and third, to assess the prognostic value of this TEA-MRI score with respect to early neurodevelopmental outcome. Study design 239 extremely preterm infants (median gestational age [range] in weeks: 26.6 [24.3-27.9]), admitted to the Wilhelmina Children's Hospital between 2006 and 2012 were included. Brain abnormalities in white matter, cortical and deep grey matter and cerebellum and brain growth were scored on T1-and T2-weighted TEA-MRI using the Kidokoro scoring system. Neurodevelopmental outcome was assessed at two years corrected age using the Bayley Scales of Infant and Toddler Development, third edition. The association between TEA-MRI and perinatal factors as well as neurodevelopmental outcome was evaluated using multivariable regression analysis. Results The distribution of brain abnormalities and brain metrics in the Utrecht cohort differed from the original St. Louis cohort (p < .05). Mechanical ventilation > 7 days ( [95% confidence interval, CI]: 1.3 [. 5; 2.0]) and parenteral nutrition > 21 days (2.2 [1.2; 3.2]) were independently associated with higher global brain abnormality scores (p < .001). Global brain abnormality scores were inversely associated with cognitive (a in composite scores [95% CI]: -.7 [-1.2; -.2], p = .004), fine motor (a in scaled scores [95% CI]: -.1 [-.3; -.0], p = .007) and gross motor outcome (beta in scaled scores [ 95% CI]: -.2 [-.3; -.1], p < .001) at two years corrected age, although the explained variances were low (R-2 <=.219). Conclusion Patterns of brain injury differed between cohorts. Prolonged mechanical ventilation and parenteral nutrition were identified as independent perinatal risk factors. The prognostic value of the TEA-MRI score was rather limited in this well-performing cohort.	[Brouwer, Margaretha J.; Kersbergen, Karina J.; van Kooij, Britt J. M.; Benders, Manon J. N. L.; van Haastert, Ingrid C.; Koopman-Esseboom, Corine; de Vries, Linda S.; Groenendaal, Floris] Wilhelmina Childrens Hosp, Dept Perinatol, Utrecht, Netherlands; [Brouwer, Margaretha J.; Kersbergen, Karina J.; van Kooij, Britt J. M.; Benders, Manon J. N. L.; van Haastert, Ingrid C.; Koopman-Esseboom, Corine; de Vries, Linda S.; Groenendaal, Floris] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [Neil, Jeffrey J.] Boston Childrens Hosp, Dept Neurol, Boston, MA USA; [Kidokoro, Hiroyuki] Nagoya Univ, Grad Sch Med, Dept Pediat, Nagoya, Aichi, Japan; [Kidokoro, Hiroyuki] Nagoya Univ, Brain & Mind Res Ctr, Nagoya, Aichi, Japan; [Inder, Terrie E.] Brigham & Womens Hosp, Dept Pediat Newborn Med, Boston, MA 02115 USA	Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; Harvard University; Boston Children's Hospital; Nagoya University; Nagoya University; Harvard University; Brigham & Women's Hospital	Groenendaal, F (corresponding author), Wilhelmina Childrens Hosp, Dept Perinatol, Utrecht, Netherlands.	f.groenendaal@umcutrecht.nl	Kidokoro, Hiroyuki/AGN-1205-2022; de Vries, Linda S/AAB-6454-2021; Groenendaal, Floris/P-6872-2019	Kidokoro, Hiroyuki/0000-0002-7991-8580; Groenendaal, Floris/0000-0002-9284-1637	ZonMW [LSHM-CT-2006-036534]; The Netherlands Organization for Health Research and Development [94527022]; Wilhelmina Research Fund [10-427]; Alexander Suerman MD/ PhD Stipendium of the University Medical Center Utrecht	ZonMW(Netherlands Organization for Health Research and Development); The Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Wilhelmina Research Fund; Alexander Suerman MD/ PhD Stipendium of the University Medical Center Utrecht	This study includes infants participating in the Neobrain study (LSHM-CT-2006-036534) as well as infants participating in two studies funded by, respectively, the ZonMW, The Netherlands Organization for Health Research and Development, project 94527022, and Wilhelmina Research Fund (10-427). Margaretha J. Brouwer received a grant from the Alexander Suerman MD/ PhD Stipendium of the University Medical Center Utrecht. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alders M, 2001, CLASSIFICATION POPUL; Allin M, 2001, BRAIN, V124, P60, DOI 10.1093/brain/124.1.60; Aylward GP, 2002, MENT RETARD DEV D R, V8, P234, DOI 10.1002/mrdd.10043; Ball G, 2010, NEUROIMAGE, V53, P94, DOI 10.1016/j.neuroimage.2010.05.055; Bayley N., 2019, BAYLEY SCALES INFANT; Boardman JP, 2010, NEUROIMAGE, V52, P409, DOI 10.1016/j.neuroimage.2010.04.261; Boardman JP, 2007, ANN NEUROL, V62, P185, DOI 10.1002/ana.21171; Brouwer AJ, 2012, NEONATOLOGY, V101, P210, DOI 10.1159/000331797; Brouwer A, 2008, J PEDIATR-US, V152, P648, DOI 10.1016/j.jpeds.2007.10.005; Brouwer MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109556; Childs AM, 2001, CLIN RADIOL, V56, P647, DOI 10.1053/crad.2001.0754; de Bruine FT, 2011, RADIOLOGY, V261, P899, DOI 10.1148/radiol.11110797; de Vries LS, 2011, SEMIN FETAL NEONAT M, V16, P279, DOI 10.1016/j.siny.2011.04.004; DEVRIES LS, 1992, BEHAV BRAIN RES, V49, P1, DOI 10.1016/S0166-4328(05)80189-5; Ehrenkranz RA, 1999, PEDIATRICS, V104, P280, DOI 10.1542/peds.104.2.280; Hay Jr WW, 2013, CURR PEDIAT REP, V1; Inder TE, 2003, J PEDIATR-US, V143, P171, DOI 10.1067/S0022-3476(03)00357-3; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Kaukola T, 2009, ACTA PAEDIATR, V98, P990, DOI 10.1111/j.1651-2227.2009.01268.x; Keunen K, 2015, PEDIATR RES, V77, P148, DOI 10.1038/pr.2014.171; Kidokoro H, 2013, AM J NEURORADIOL, V34, P2208, DOI 10.3174/ajnr.A3521; Latal B, 2009, PEDIATR NEUROL, V40, P413, DOI 10.1016/j.pediatrneurol.2009.01.008; LEVENE MI, 1981, ARCH DIS CHILD, V56, P900, DOI 10.1136/adc.56.12.900; Limperopoulos C, 2007, PEDIATRICS, V120, P584, DOI 10.1542/peds.2007-1041; Miller SP, 2005, J PEDIATR-US, V147, P609, DOI 10.1016/j.jpeds.2005.06.033; Omizzolo C, 2014, MEMORY, V22, P605, DOI 10.1080/09658211.2013.809765; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Parikh NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062804; Rosenbaum PL, 2008, DEV MED CHILD NEUROL, V50, P249, DOI 10.1111/j.1469-8749.2008.02045.x; Short EJ, 2003, PEDIATRICS, V112, pE359, DOI 10.1542/peds.112.5.e359; Spittle AJ, 2011, DEV MED CHILD NEUROL, V53, P1000, DOI 10.1111/j.1469-8749.2011.04095.x; Thompson DK, 2007, BRAIN, V130, P667, DOI 10.1093/brain/awl277; van Haastert IC, 2011, J PEDIATR-US, V159, P86, DOI 10.1016/j.jpeds.2010.12.053; Van Kooij BJM, 2012, DEV MED CHILD NEUROL, V54, P260, DOI 10.1111/j.1469-8749.2011.04168.x; van't Hooft J, 2015, SYST REV-LONDON, V4, DOI 10.1186/s13643-015-0058-7; Vinall J, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004666; Visser GHA, 2009, EARLY HUM DEV, V85, P737, DOI 10.1016/j.earlhumdev.2009.09.008; Volpe JJ, 2009, J CHILD NEUROL, V24, P1085, DOI 10.1177/0883073809338067; Woodward LJ, 2006, NEW ENGL J MED, V355, P685, DOI 10.1056/NEJMoa053792	39	39	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177128	10.1371/journal.pone.0177128	http://dx.doi.org/10.1371/journal.pone.0177128			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486543	Green Submitted, Green Published, gold			2022-12-26	WOS:000401314000047
J	Brusco, M; Stolze, HJ; Hoffman, M; Steinley, D				Brusco, Michael; Stolze, Hannah J.; Hoffman, Michaela; Steinley, Douglas			A simulated annealing heuristic for maximum correlation core/periphery partitioning of binary networks	PLOS ONE			English	Article							MODELS; OPTIMIZATION	A popular objective criterion for partitioning a set of actors into core and periphery subsets is the maximization of the correlation between an ideal and observed structure associated with intra-core and intra-periphery ties. The resulting optimization problem has commonly been tackled using heuristic procedures such as relocation algorithms, genetic algorithms, and simulated annealing. In this paper, we present a computationally efficient simulated annealing algorithm for maximum correlation core/periphery partitioning of binary networks. The algorithm is evaluated using simulated networks consisting of up to 2000 actors and spanning a variety of densities for the intra-core, intra-periphery, and inter-core-periphery components of the network. Core/periphery analyses of problem solving, trust, and information sharing networks for the frontline employees and managers of a consumer packaged goods manufacturer are provided to illustrate the use of the model.	[Brusco, Michael] Florida State Univ, Dept Mkt, Tallahassee, FL 32306 USA; [Stolze, Hannah J.] Wheaton Coll, Dept Econ & Business, Wheaton, IL 60187 USA; [Hoffman, Michaela; Steinley, Douglas] Univ Missouri, Dept Psychol Sci, Columbia, MO USA	State University System of Florida; Florida State University; Wheaton College; University of Missouri System; University of Missouri Columbia	Brusco, M (corresponding author), Florida State Univ, Dept Mkt, Tallahassee, FL 32306 USA.	steinleyd@missouri.edu			NIH [R21AA022074]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The only funding to support this work was the NIH grant mentioned - R21AA022074, awarded to Douglas Steinley. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts E., 2005, SEARCH METHODOLOGIES, P187, DOI 10.1007/0-387-28356-0_7; [Anonymous], [No title captured]; [Anonymous], 1981, MANAGING MULTIORGANI; [Anonymous], 2005, MODELS METHODS SOCIA, DOI [10.1017/cbo9780511811395.004, DOI 10.1017/CBO9780511811395.004]; Baker D. R., 1992, J SOCIAL SERVICE RES, V15, P153, DOI [DOI 10.1300/J079V15N03_09, DOI 10.1300/J079V15N03_]; BATAGELJ V, 1992, SOC NETWORKS, V14, P63, DOI 10.1016/0378-8733(92)90014-X; Borgatti S. P., 2002, UCINET WINDOWS VERSI; Borgatti SP, 1999, SOC NETWORKS, V21, P375; Boyd JP, 2010, SOC NETWORKS, V32, P125, DOI 10.1016/j.socnet.2009.09.003; Boyd JP, 2006, SOC NETWORKS, V28, P165, DOI 10.1016/j.socnet.2005.06.003; Brewer DD, 2000, SOC NETWORKS, V22, P29, DOI 10.1016/S0378-8733(99)00017-9; Brusco M, 2011, SOC NETWORKS, V33, P201, DOI 10.1016/j.socnet.2011.05.001; Brusco M, 2011, SOC NETWORKS, V33, P12, DOI 10.1016/j.socnet.2010.08.002; Brusco MJ, 2014, COMPUT STAT DATA AN, V77, P38, DOI 10.1016/j.csda.2014.03.001; CERNY V, 1985, J OPTIMIZ THEORY APP, V45, P41, DOI 10.1007/BF00940812; Csermely P, 2013, J COMPLEX NETW, V1, P93, DOI 10.1093/comnet/cnt016; Everett MG, 1999, SOC NETWORKS, V21, P397; Glover F., 1993, MODERN HEURISTIC TEC, P70; Goldberg D.E., 1989, GENETIC ALGORITHMS; Groenen PJF, 1996, PSYCHOMETRIKA, V61, P529, DOI 10.1007/BF02294553; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; KERNIGHAN BW, 1970, BELL SYST TECH J, V49, P221; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Lee JS, 2012, HDB OPTIMIZATION CLA, P395; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Mladenovic N, 1997, COMPUT OPER RES, V24, P1097, DOI 10.1016/S0305-0548(97)00031-2; Muniz ASG, 2006, SOC NETWORKS, V28, P442, DOI 10.1016/j.socnet.2005.11.001; Nourani Y, 1998, J PHYS A-MATH GEN, V31, P8373, DOI 10.1088/0305-4470/31/41/011; van der Ark LA, 2008, PSYCHOMETRIKA, V73, P183, DOI 10.1007/s11336-007-9034-z; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478	31	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0170448	10.1371/journal.pone.0170448	http://dx.doi.org/10.1371/journal.pone.0170448			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486475	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314000001
J	Goodwin, JM; Rana, H; Ndungu, J; Chakrabarti, G; Moomaw, EW				Goodwin, John M.; Rana, Hassan; Ndungu, Joan; Chakrabarti, Gaurab; Moomaw, Ellen W.			Hydrogen peroxide inhibition of bicupin oxalate oxidase	PLOS ONE			English	Article							SEED STORAGE PROTEINS; BACILLUS-SUBTILIS; MICROBIAL RELATIVES; SPECIFICITY SWITCH; PANCREATIC-CANCER; CUPIN SUPERFAMILY; MEMBRANE INLET; NITRIC-OXIDE; DECARBOXYLASE; OXIDATION	Oxalate oxidase is a manganese containing enzyme that catalyzes the oxidation of oxalate to carbon dioxide in a reaction that is coupled with the reduction of oxygen to hydrogen peroxide. Oxalate oxidase from Ceriporiopsis subvermispora (CsOxOx) is the first fungal and bicupin enzyme identified that catalyzes this reaction. Potential applications of oxalate oxidase for use in pancreatic cancer treatment, to prevent scaling in paper pulping, and in bio-fuel cells have highlighted the need to understand the extent of the hydrogen peroxide inhibition of the CsOxOx catalyzed oxidation of oxalate. We apply a membrane inlet mass spectrometry (MIMS) assay to directly measure initial rates of carbon dioxide formation and oxygen consumption in the presence and absence of hydrogen peroxide. This work demonstrates that hydrogen peroxide is both a reversible noncompetitive inhibitor of the CsOxOx catalyzed oxidation of oxalate and an irreversible inactivator. The build-up of the turnover-generated hydrogen peroxide product leads to the inactivation of the enzyme. The introduction of catalase to reaction mixtures protects the enzyme from inactivation allowing reactions to proceed to completion. Circular dichroism spectra indicate that no changes in global protein structure take place in the presence of hydrogen peroxide. Additionally, we show that the CsOxOx catalyzed reaction with the three carbon substrate mesoxalate consumes oxygen which is in contrast to previous proposals that it catalyzed a non-oxidative decarboxylation with this substrate.	[Goodwin, John M.; Rana, Hassan; Ndungu, Joan; Moomaw, Ellen W.] Kennesaw State Univ, Dept Chem & Biochem, Kennesaw, GA 30144 USA; [Chakrabarti, Gaurab] Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol Oncol & Radiat Oncol, Dallas, TX 75390 USA; [Chakrabarti, Gaurab] Univ Texas Southwestern Med Ctr Dallas, Lab Mol Stress Responses, Dallas, TX 75390 USA; [Chakrabarti, Gaurab] Univ Texas Southwestern Med Ctr Dallas, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA	University System of Georgia; Kennesaw State University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Moomaw, EW (corresponding author), Kennesaw State Univ, Dept Chem & Biochem, Kennesaw, GA 30144 USA.	emoomaw@kennesaw.edu			National Science Foundation [MRI- 1337781, MCB1041912]; Kennesaw State University Office of the Vice President of Research; Kennesaw State University College of Science and Mathematics	National Science Foundation(National Science Foundation (NSF)); Kennesaw State University Office of the Vice President of Research; Kennesaw State University College of Science and Mathematics	This work was supported by National Science Foundation (MRI- 1337781 and MCB1041912), the Kennesaw State University Office of the Vice President of Research, and the Kennesaw State University College of Science and Mathematics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge helpful discussions with Kennesaw State University colleagues Chris Dockery, John Haseltine, Chris Alexander, Daniela Tapu, and Marina Koether. We gratefully acknowledge the support provided by the National Science Foundation (MRI-1337781 and MCB-1041912), the Kennesaw State University Office of the Vice President of Research, and the Kennesaw State University College of Science and Mathematics. We are also grateful for the support and collaboration that we have received from Hiden Analytical.	Baid R, 2013, J BIOL CHEM, V288, P17372, DOI 10.1074/jbc.M112.441618; Burrell MR, 2007, BIOCHEMISTRY-US, V46, P12327, DOI 10.1021/bi700947s; Carrillo MC, 2008, PHYTOPATHOLOGY, V98, pS31; Chakrabarti G, 2015, THESIS; Chakrabarti G, 2015, CANCER METAB, V3, DOI 10.1186/s40170-015-0137-1; CHIRIBOGA J, 1963, BIOCHEM BIOPH RES CO, V11, P277, DOI 10.1016/0006-291X(63)90557-6; CHIRIBOGA J, 1966, ARCH BIOCHEM BIOPHYS, V116, P516, DOI 10.1016/0003-9861(66)90057-9; Ciriminna R, 2003, ADV SYNTH CATAL, V345, P383, DOI 10.1002/adsc.200390043; Cleland W. W., 1979, METHOD ENZYMOL, V62, P151; Cook P. F., 2007, ENZYME KINETICS MECH; Du JA, 2010, CLIN CANCER RES, V16, P509, DOI 10.1158/1078-0432.CCR-09-1713; Dunwell JM, 2004, PHYTOCHEMISTRY, V65, P7, DOI 10.1016/j.phytochem.2003.08.016; Dunwell JM, 2001, TRENDS BIOCHEM SCI, V26, P740, DOI 10.1016/S0968-0004(01)01981-8; Dunwell JM, 2000, MICROBIOL MOL BIOL R, V64, P153, DOI 10.1128/MMBR.64.1.153-179.2000; Dunwell JM, 1998, BIOTECHNOL GENET ENG, V15, P1; Dunwell JM, 1998, J MOL EVOL, V46, P147, DOI 10.1007/PL00006289; Escutia MR, 2005, APPL ENVIRON MICROB, V71, P3608, DOI 10.1128/AEM.71.7.3608-3616.2005; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Hickey DP, 2014, J AM CHEM SOC, V136, P15917, DOI 10.1021/ja5098379; Imaram W, 2011, FREE RADICAL BIO MED, V50, P1009, DOI 10.1016/j.freeradbiomed.2011.01.023; Kotsira VP, 1997, ARCH BIOCHEM BIOPHYS, V340, P239, DOI 10.1006/abbi.1997.9896; Lane BG, 2000, BIOCHEM J, V349, P309, DOI 10.1042/0264-6021:3490309; Lardinois OM, 1996, BBA-PROTEIN STRUCT M, V1295, P222, DOI 10.1016/0167-4838(96)00043-X; Larsson S, 2003, ACS SYM SER, V855, P81, DOI 10.1021/bk-2003-0855.ch005; LEEK AE, 1972, BIOCHEM J, V128, pP87; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Moomaw EW, 2014, BIOCHEM BIOPH RES CO, V450, P750, DOI 10.1016/j.bbrc.2014.06.040; Moomaw EW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057933; Moral MEG, 2011, CHEM COMMUN, V47, P3111, DOI 10.1039/c0cc04946h; Moussatche P, 2011, ARCH BIOCHEM BIOPHYS, V509, P100, DOI 10.1016/j.abb.2011.02.022; Nilvebrant NO, 2002, ABSTR PAP AM CHEM S, V223, pU125; PUNDIR CS, 1993, INDIAN J BIOCHEM BIO, V30, P54; Rana Hassan, 2016, Biochem Biophys Rep, V5, P396, DOI 10.1016/j.bbrep.2016.01.016; Requena L, 1999, BIOCHEM J, V343, P185, DOI 10.1042/0264-6021:3430185; SATYAPAL, 1993, BIOCHIM BIOPHYS ACTA, V1161, P1, DOI 10.1016/0167-4838(93)90188-W; SCHIMERLIK MI, 1973, J BIOL CHEM, V248, P8418; Segel IH, 1975, ENZYME KINETICS BEHA; SELWYN MJ, 1965, BIOCHIM BIOPHYS ACTA, V105, P193, DOI 10.1016/S0926-6593(65)80190-4; SHIMAZONO H, 1955, J BIOCHEM-TOKYO, V42, P321, DOI 10.1093/oxfordjournals.jbchem.a126533; SILVERMAN DN, 1982, METHOD ENZYMOL, V87, P732; Svedruzic D, 2005, ARCH BIOCHEM BIOPHYS, V433, P176, DOI 10.1016/j.abb.2004.08.032; Svedruzic D, 2007, ARCH BIOCHEM BIOPHYS, V464, P36, DOI 10.1016/j.abb.2007.03.016; Tu C, 2007, FREE RADICAL BIO MED, V43, P1453, DOI 10.1016/j.freeradbiomed.2007.07.026; Twahir UT, 2015, FREE RADICAL BIO MED, V80, P59, DOI 10.1016/j.freeradbiomed.2014.12.012; Twahir UT, 2016, BIOCHEMISTRY; Urbansky ET, 2000, J CHROMATOGR A, V867, P143, DOI 10.1016/S0021-9673(99)01158-9; VAISEY EB, 1961, ARCH BIOCHEM BIOPHYS, V95, P66, DOI 10.1016/0003-9861(61)90109-6; VARALAKSHMI P, 1992, BIOCHEM INT, V26, P153; Whittaker MM, 2007, J BIOL CHEM, V282, P7011, DOI 10.1074/jbc.M609374200; Whittaker MM, 2002, J BIOL INORG CHEM, V7, P136, DOI 10.1007/s007750100281; Xu S, 2012, ACS CATAL, V2, P91, DOI 10.1021/cs200523s; Zhu W, 2016, BIOCHEMISTRY-US, V55, P2163, DOI 10.1021/acs.biochem.6b00043; Zhu W, 2016, BIOCHEMISTRY-US, V55, P429, DOI 10.1021/acs.biochem.5b01340	53	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177164	10.1371/journal.pone.0177164	http://dx.doi.org/10.1371/journal.pone.0177164			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486485	Green Submitted, Green Published, gold			2022-12-26	WOS:000401314000051
J	Valera, MC; Noirrit-Esclassan, E; Dupuis, M; Buscato, M; Vinel, A; Guillaume, M; Briaux, A; Garcia, C; Benoit, T; Lairez, O; Fontaine, C; Payrastre, B; Arnal, JF				Valera, Marie-Cecile; Noirrit-Esclassan, Emmanuelle; Dupuis, Marion; Buscato, Melissa; Vinel, Alexia; Guillaume, Maeva; Briaux, Anne; Garcia, Cedric; Benoit, Thibaut; Lairez, Olivier; Fontaine, Coralie; Payrastre, Bernard; Arnal, Jean-Francois			Effect of chronic estradiol plus progesterone treatment on experimental arterial and venous thrombosis in mouse	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; POSTMENOPAUSAL HORMONE-THERAPY; MEDROXYPROGESTERONE ACETATE; REPLACEMENT THERAPY; THROMBOEMBOLISM; RISKS; WOMEN; HRT	Postmenopausal hormone replacement therapy (HRT) with estrogen plus progestogens is the first line therapy to treat menopausal symptoms. The progestogen is added to estrogen to reduce or eliminate the excess risk of endometrial cancer due to the unopposed effect of estrogen. Whereas progestin clearly opposes the proliferative and deleterious long-term actions of estrogen on the endometrium, the interference of progestin on the other estrogen action remains unclear. We previously reported that chronic subcutaneous 17 alpha-estradiol (E2) in mice decreases platelet responsiveness, prolongs the tail-bleeding time and protects against acute thromboembolism. Here, we report the tissue-specific interference of progesterone (P4) on the action of E2 in ovariectomized mice. We first confirm that, in our experimental conditions, P4 attenuates the proliferative action of E2 on the uterus and the effects of E2 on vagina weight and lubrication. We then studied the effect of E2 combined with P4 on hemostasis and thrombosis in vivo in mice and found that P4 did not interfere with the main actions of E2 on platelets, bleeding time and arterial and venous thrombosis. Thus, whereas activation of progesterone receptor interferes with the action of E2 on its classic sex targets, P4 appears to have minimal effect on the hemostasis and thrombosis actions of E2, supporting the prominent role of estrogens and the accessory role of natural progestin on the extra-reproductive cells and tissues involved in thrombosis.	[Valera, Marie-Cecile; Noirrit-Esclassan, Emmanuelle; Dupuis, Marion; Buscato, Melissa; Vinel, Alexia; Guillaume, Maeva; Briaux, Anne; Benoit, Thibaut; Lairez, Olivier; Fontaine, Coralie; Payrastre, Bernard; Arnal, Jean-Francois] INSERM, U1048, Toulouse, France; [Valera, Marie-Cecile; Noirrit-Esclassan, Emmanuelle; Dupuis, Marion; Buscato, Melissa; Vinel, Alexia; Guillaume, Maeva; Briaux, Anne; Benoit, Thibaut; Lairez, Olivier; Fontaine, Coralie; Payrastre, Bernard; Arnal, Jean-Francois] Univ Toulouse III, I2MC, Toulouse, France; [Valera, Marie-Cecile; Noirrit-Esclassan, Emmanuelle; Vinel, Alexia] Univ Toulouse III, Fac Chirurg Dent, Toulouse, France; [Garcia, Cedric; Payrastre, Bernard] CHU Toulouse, Lab Hematol, Toulouse, France; [Benoit, Thibaut] CHU Toulouse, Serv Urol, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; CHU de Toulouse	Valera, MC (corresponding author), INSERM, U1048, Toulouse, France.	marie.valera@inserm.fr	Fontaine, Coralie/N-3814-2017; Noirrit, Emmanuelle/ADK-4568-2022; Cédric, GARCIA/AAG-8785-2020; O, Lairez/B-7152-2016	Noirrit, Emmanuelle/0000-0002-7039-6405; Cédric, GARCIA/0000-0003-1566-3846; O, Lairez/0000-0001-8141-6582; ARNAL, Jean Francois/0000-0003-2229-6300; Fontaine, Coralie/0000-0002-7253-922X; , Bernard/0000-0002-8693-0190; Guillaume, Maeva/0000-0002-2782-7556; briaux, anne/0000-0001-8278-4256				Abot A, 2013, ENDOCRINOLOGY, V154, P2222, DOI 10.1210/en.2012-2059; Adlanmerini M, 2014, P NATL ACAD SCI USA, V111, pE283, DOI 10.1073/pnas.1322057111; Canonico M, 2007, CIRCULATION, V115, P840, DOI 10.1161/CIRCULATIONAHA.106.642280; Canonico M, 2015, MATURITAS, V82, P304, DOI 10.1016/j.maturitas.2015.06.040; Canonico M, 2010, ARTERIOSCL THROM VAS, V30, P340, DOI 10.1161/ATVBAHA.109.196022; Cooke PS, 1997, P NATL ACAD SCI USA, V94, P6535, DOI 10.1073/pnas.94.12.6535; DONALDSO.LE, 1970, J ENDOCRINOL, V48, P599, DOI 10.1677/joe.0.0480599; Douin-Echinard V, 2008, J IMMUNOL, V180, P3661, DOI 10.4049/jimmunol.180.6.3661; Freudenberger T, 2014, BRIT J PHARMACOL, V171, P5032, DOI 10.1111/bph.12814; Freudenberger T, 2009, BRIT J PHARMACOL, V158, P1951, DOI 10.1111/j.1476-5381.2009.00470.x; Furness S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000402.pub4; Game X, 2013, J SEX MED, V10, P1452, DOI 10.1111/jsm.12127; Geddings J, 2014, J THROMB HAEMOST, V12, P571, DOI 10.1111/jth.12510; Hoibraaten E, 2001, BRIT J HAEMATOL, V115, P415, DOI 10.1046/j.1365-2141.2001.03111.x; Karas RH, 2001, J CLIN INVEST, V108, P611; L'Hermite M, 2013, CLIMACTERIC, V16, P44, DOI 10.3109/13697137.2013.808563; L'Hermite M, 2008, MATURITAS, V60, P185, DOI 10.1016/j.maturitas.2008.07.007; Liu AL, 2012, ENDOCRINOLOGY, V153, P3747, DOI 10.1210/en.2012-1138; Miyagawa K, 1997, NAT MED, V3, P324, DOI 10.1038/nm0397-324; Modena MG, 2005, MATURITAS, V52, P1, DOI 10.1016/j.maturitas.2005.05.003; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Salerni S, 2015, EUR J CLIN INVEST, V45, P634, DOI 10.1111/eci.12447; Scarabin PY, 2014, CLIMACTERIC, V17, P34, DOI 10.3109/13697137.2014.956717; Scarabin PY, 2014, FRONT HORM RES, V43, P21, DOI 10.1159/000360554; Scarabin PY, 2003, LANCET, V362, P428, DOI 10.1016/S0140-6736(03)14066-4; Schnoes KK, 2008, MOL ENDOCRINOL, V22, P2544, DOI 10.1210/me.2008-0044; Shultz JM, 2004, FERTIL STERIL, V82, P1133, DOI 10.1016/j.fertnstert.2004.05.069; Stanczyk FZ, 2013, ENDOCR REV, V34, P171, DOI 10.1210/er.2012-1008; Subramaniam Saravanan, 2014, Curr Protoc Mouse Biol, V4, P151, DOI 10.1002/9780470942390.mo140140; Valera MC, 2012, BLOOD, V120, P1703, DOI 10.1182/blood-2012-01-405498; Wrobleski SK, 2011, JOVE-J VIS EXP, DOI 10.3791/2738; Zaragoza C, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/497841	32	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177043	10.1371/journal.pone.0177043	http://dx.doi.org/10.1371/journal.pone.0177043			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486478	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314000037
J	Blanco, M; Ospina-Alvarez, A; Gonzalez, C; Fernandez, M				Blanco, Marta; Ospina-Alvarez, Andres; Gonzalez, Catherine; Fernandez, Miriam			Egg production patterns of two invertebrate species in rocky subtidal areas under different fishing regimes along the coast of central Chile	PLOS ONE			English	Article							MARINE PROTECTED AREAS; SNAPPER PAGRUS-AURATUS; BENTHIC INVERTEBRATES; RESERVES; FISHERIES; CONSERVATION; COMMUNITIES; ECOSYSTEMS; MANAGEMENT; POPULATIONS	Fishing is a major source of human impact, reducing density and size of a wide range of exploited species in comparison to areas exhibiting strong regulations (no-take and partially protected areas, including Territorial Use Rights for Fisheries, TURFs). Since size and density might have important consequences on reproduction, and therefore natural re-seeding, we monitored adult size, density and potential fecundity of the keyhole limpet (Fissurella latimarginata) and the red sea urchin (Loxechinus albus) in areas under two fishing regimes (TURFs and Open Access Areas, OAAs). Analyzing the distribution of suitable habitats, we predict spatial patterns of potential egg production, to identify reproductive hotspots along the central coast of Chile. The current system of TURFs in central Chile showed higher potential egg production of F. latimarginata and of L. albus than expected under a complete OAAs scenario (67 and 52% respectively). Potential egg production showed more than a twofold reduction when the complete TURFs scenario was compared against complete OAAs condition in both species. Individual size and density explained between 60% and 100% of the variability in potential egg production, suggesting the importance of the enhancement of both biological variables in TURFs in Chile. Potential egg production for both species in the northern part of the studied domain was higher due to the combined effect of (a) suitable habitat and (b) concentration of TURFs. Our results suggest that partially protected areas, such as TURFs can significantly enhance the production of propagules that could seed exploited areas.	[Blanco, Marta; Ospina-Alvarez, Andres; Gonzalez, Catherine; Fernandez, Miriam] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Ecol, Nucleo Milenio,CCM,ECIM, Santiago, Chile; [Fernandez, Miriam] Pontificia Univ Catolica Chile, Dept Ecol, Santiago, Chile	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile	Blanco, M (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Ecol, Nucleo Milenio,CCM,ECIM, Santiago, Chile.	marblasa@gmail.com	Ospina-Alvarez, Andres/M-2556-2014	Ospina-Alvarez, Andres/0000-0003-2454-7169; Blanco, Marta/0000-0002-8172-7628	Fundacion Mutua Madrilena; Fondecyt [3150425, 1130976]; Iniciativa Cientifica Milenio from the Ministerio de Economia, Fomento y Turismo de Chile [CCM RC 1300004]	Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Iniciativa Cientifica Milenio from the Ministerio de Economia, Fomento y Turismo de Chile	We thank Fundacion Mutua Madrilena (MB), Fondecyt 3150425 (AO), Fondecyt 1130976 (MF) and the Iniciativa Cientifica Milenio CCM RC 1300004 from the Ministerio de Economia, Fomento y Turismo de Chile.	Aburto-Oropeza O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023601; Afflerbach JC, 2014, GLOB ECOL CONSERV; Anger K, 1998, J CRUSTACEAN BIOL, V18, P823, DOI 10.2307/1549156; Brown G. DI, 1997, INFORM FINAL PROYECT, P196; CASTILLA JC, 1985, OIKOS, V45, P391, DOI 10.2307/3565575; Castilla JC, 1999, TRENDS ECOL EVOL, V14, P280, DOI 10.1016/S0169-5347(99)01602-X; Castilla JC, 1998, ECOL APPL, V8, pS124, DOI 10.1890/1051-0761(1998)8[S124:SBFICO]2.0.CO;2; Castilla JC, 2000, J EXP MAR BIOL ECOL, V250, P3, DOI 10.1016/S0022-0981(00)00177-5; Costello C, 2013, SCIENCE, P517; de Juan S, 2015, SCI TOTAL ENVIRON, V533, P122, DOI 10.1016/j.scitotenv.2015.06.094; Denny CM, 2004, MAR ECOL PROG SER, V272, P183, DOI 10.3354/meps272183; Edgar GJ, 1999, J EXP MAR BIOL ECOL, V242, P107, DOI 10.1016/S0022-0981(99)00098-2; FAO, 2014, COUNTR REC VIT ROL S; Fernandez M, 2005, CONSERV BIOL, V19, P1752, DOI 10.1111/j.1523-1739.2005.00277.x; Fogarty MJ, 2007, OCEANOGRAPHY, V20, P112, DOI 10.5670/oceanog.2007.34; Freire J, 2000, MAR POLICY, V24, P375, DOI 10.1016/S0308-597X(00)00013-0; Gelcich S, 2012, CONSERV BIOL, V26, P1005, DOI 10.1111/j.1523-1739.2012.01928.x; Gelcich S, 2010, P NATL ACAD SCI USA, V107, P16794, DOI 10.1073/pnas.1012021107; Gell FR, 2003, TRENDS ECOL EVOL, V18, P448, DOI 10.1016/S0169-5347(03)00189-7; Gonza A, 1782, J SHELLFISH RES, V6, P109; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2003, ECOL APPL, V13, pS117; Halpern BS, 2003, P ROY SOC B-BIOL SCI, V270, P1871, DOI 10.1098/rspb.2003.2405; Jennings S, 1996, BIOL CONSERV, V75, P201, DOI 10.1016/0006-3207(95)00081-X; Kaiser MJ, 2009, EVIDENCE GREATER REP; Kelly S, 2000, BIOL CONSERV, V92, P359, DOI 10.1016/S0006-3207(99)00109-3; Lester SE, 2008, MAR ECOL PROG SER, V367, P49, DOI 10.3354/meps07599; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Levin PS, 2009, PLOS BIOL, V7, P23, DOI 10.1371/journal.pbio.1000014; LEVITAN DR, 1991, BIOL BULL-US, V181, P261, DOI 10.2307/1542097; LOWERREBARBIERI SK, 1993, FISH B-NOAA, V91, P165; Manriquez PH, 2001, MAR ECOL PROG SER, V215, P201, DOI 10.3354/meps215201; Metaxas A, 2009, BIOL BULL-US, V216, P257, DOI 10.1086/BBLv216n3p257; Murray SN, 1999, FISHERIES, V24, P11, DOI 10.1577/1548-8446(1999)024&lt;0011:NRN&gt;2.0.CO;2; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pelc RA, 2009, MAR ECOL PROG SER, V394, P65, DOI 10.3354/meps08326; Prado P, 2009, ESTUAR COAST SHELF S, V85, P472, DOI 10.1016/j.ecss.2009.09.012; R DCT, 2013, R LANG ENV STAT COMP; Roberts CM, 2001, SCIENCE, V294, P1920, DOI 10.1126/science.294.5548.1920; Rogers-Bennett L, 2002, CONSERV BIOL, V16, P1308, DOI 10.1046/j.1523-1739.2002.01002.x; Russ GR, 2004, ECOL APPL, V14, P597, DOI 10.1890/03-5076; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Shears NT, 2006, BIOL CONSERV, V132, P222, DOI 10.1016/j.biocon.2006.04.001; Tognelli MF, 2009, BIOL CONSERV, V142, P3147, DOI 10.1016/j.biocon.2009.08.016; Walters CJ, 2007, CAN J FISH AQUAT SCI, V64, P1009, DOI 10.1139/F07-072; Willis TJ, 2003, J APPL ECOL, V40, P214, DOI 10.1046/j.1365-2664.2003.00775.x; Wood CL, 2013, J ANIM ECOL, V82, P1276, DOI 10.1111/1365-2656.12104; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146	49	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0176758	10.1371/journal.pone.0176758	http://dx.doi.org/10.1371/journal.pone.0176758			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481886	Green Submitted, Green Published, gold			2022-12-26	WOS:000401313700015
J	Zhang, F; Tang, H; Jiang, Y; Mao, Z				Zhang, F.; Tang, H.; Jiang, Y.; Mao, Z.			The transcription factor GATA3 is required for homologous recombination repair by regulating CtIP expression	ONCOGENE			English	Article							DNA-END RESECTION; DOUBLE-STRAND BREAKS; GENOMIC INSTABILITY; CHECKPOINT CONTROL; CANCER; PATHWAY; BRCA1; TUMORIGENESIS; GENES; CELLS	GATA3, a critical transcription factor involved in the development of the mammary gland, also plays important roles in mammary tumorigenesis by regulating transcription in coordination with two essential DNA repair factors, PARP1 and BRCA1. However, whether and how GATA3 participates in the process of DNA repair, which is often associated with tumorigenesis, has not been investigated. Here we demonstrate that GATA3 is required for the repair of DNA double-strand breaks (DSBs) by homologous recominbation (HR). Mechanistic studies indicate that at both the protein and the mRNA level, depleting GATA3 leads to reduced expression of CtIP, an essential HR factor involved in end resection, thereby suppressing the repair of DSBs by HR and sensitizing cells to etoposide induced DNA DSBs. Further studies indicate that upon the occurrence of DNA DSBs GATA3 directly binds to the CtIP promoter at the region of -2119 to -2130 and -2274 to -2285, and promotes the transcription of CtIP. Overexpression of CtIP in GATA3 depleted cells rescues the decline of HR, and cell survival in the presence of etoposide. In addition, through data mining analysis, we observed an extremely strong correlation between the expression levels of GATA3 and CtIP in paratumors, but the correlation turned insignificant in mammary tumors. Using vectors encoding GATA3 with mutations frequently occurring in mammary tumors, we found that several mutations on GATA3 led to a dysregulation of CtIP, and therefore HR repair. In summary, our data delineates the regulatory mechanisms of GATA3 in DNA DSB repair and strongly suggests that it might act as a tumor suppressor by promoting CtIP expression and HR to stabilize genomes.	[Zhang, F.; Tang, H.; Jiang, Y.; Mao, Z.] Tongji Univ, Shanghai Matern & Infant Hosp 1, Shanghai Key Lab Signaling & Dis Res, Clin & Translat Res Ctr,Sch Life Sci & Technol, Shanghai, Peoples R China	Tongji University	Jiang, Y; Mao, Z (corresponding author), Tongji Univ, Sch Life Sci & Technol, 1239 Siping Rd, Shanghai 200092, Peoples R China.	ying_jiang@tongji.edu.cn; zhiyong_mao@tongji.edu.cn		Mao, Zhiyong/0000-0002-5298-1918	Chinese National Program on Key Basic Research Project [2013CB967600, 2015CB964800]; National Science Foundation of China [81502385, 81622019, 31371396, 31570813, 81402543, 81601212]; 1000 Youth Talents Program; Shanghai Municipal Natural Science Foundation [15ZR1442600]; Fundamental Research Funds for the Central Universities	Chinese National Program on Key Basic Research Project; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); 1000 Youth Talents Program; Shanghai Municipal Natural Science Foundation; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	We thank Dr Michael Van Meter for critically reading the manuscript. We thank Yang Yu for helping with the clonogenic assay. We thank Lu Chen for helping create the vector encoding GATA3. We thank TCGA for providing high quality high-throughput data for public analysis. The work was supported by grants from Chinese National Program on Key Basic Research Project (Grant No. 2013CB967600, 2015CB964800), the National Science Foundation of China (Grant No. 81502385, 81622019, 31371396, 31570813, 81402543, 81601212), the 1000 Youth Talents Program, Shanghai Municipal Natural Science Foundation (Grant No. 15ZR1442600), and the Fundamental Research Funds for the Central Universities.	Aqeilan RI, 2007, J CELL PHYSIOL, V212, P307, DOI 10.1002/jcp.21099; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Chen HY, 2011, CANCER PREV RES, V4, P973, DOI 10.1158/1940-6207.CAPR-10-0387; Chen PL, 2005, MOL CELL BIOL, V25, P3535, DOI 10.1128/MCB.25.9.3535-3542.2005; Chou J, 2010, J CELL PHYSIOL, V222, P42, DOI 10.1002/jcp.21943; Ciocca V, 2009, HUM PATHOL, V40, P489, DOI 10.1016/j.humpath.2008.09.010; Davis AJ, 2014, DNA REPAIR, V17, P21, DOI 10.1016/j.dnarep.2014.02.020; DEFROMENTEL CC, 1992, GENE CHROMOSOME CANC, V4, P1; Eeckhoute J, 2007, CANCER RES, V67, P6477, DOI 10.1158/0008-5472.CAN-07-0746; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Guo MZ, 2004, CLIN CANCER RES, V10, P7917, DOI 10.1158/1078-0432.CCR-04-1140; Haveri H, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-9; Hsu HM, 2007, CANCER EPIDEM BIOMAR, V16, P2024, DOI 10.1158/1055-9965.EPI-07-0116; Huhn D, 2015, ONCOGENE, V34, P3977, DOI 10.1038/onc.2014.329; Jimeno S, 2015, NUCLEIC ACIDS RES, V43, P987, DOI 10.1093/nar/gku1384; Kaidi A, 2010, SCIENCE, V329, P1348, DOI 10.1126/science.1192049; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Li Z, 2016, CELL DEATH DIFFER, V23, P1765, DOI 10.1038/cdd.2016.65; Liu F, 2006, MOL CELL BIOL, V26, P3124, DOI 10.1128/MCB.26.8.3124-3134.2006; Mao ZY, 2007, P NATL ACAD SCI USA, V104, P13068, DOI 10.1073/pnas.0702410104; Mao ZY, 2009, NEOPLASIA, V11, P683, DOI 10.1593/neo.09312; Minchenko DO, 2012, AM J MOL BIOL, V2, P21; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; NIE ZR, 1995, CANCER RES, V55, P4760; Patient RK, 2002, CURR OPIN GENET DEV, V12, P416, DOI 10.1016/S0959-437X(02)00319-2; Pikkarainen S, 2004, CARDIOVASC RES, V63, P196, DOI 10.1016/j.cardiores.2004.03.025; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Shan L, 2014, ONCOGENE, V33, P3205, DOI 10.1038/onc.2013.270; Soria-Bretones I, 2013, CANCER MED-US, V2, P774, DOI 10.1002/cam4.141; Takaku M, 2015, GENE EXPRESSION, V16, P163, DOI 10.3727/105221615X14399878166113; Tkocz D, 2012, ONCOGENE, V31, P3667, DOI 10.1038/onc.2011.531; Wu GK, 2006, CELL CYCLE, V5, P1592, DOI 10.4161/cc.5.15.3127; Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004; Yu XC, 2006, GENE DEV, V20, P1721, DOI 10.1101/gad.1431006; Zhang L, 2015, CANCER BIOL THER, V16, P1585, DOI 10.1080/15384047.2015.1078021	37	7	7	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 7	2017	36	36					5168	5176		10.1038/onc.2017.127	http://dx.doi.org/10.1038/onc.2017.127			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FF9XD	28481869				2022-12-26	WOS:000409371100008
J	Logeman, BL; Wood, LK; Lee, J; Thiele, DJ				Logeman, Brandon L.; Wood, L. Kent; Lee, Jaekwon; Thiele, Dennis J.			Gene duplication and neo-functionalization in the evolutionary and functional divergence of the metazoan copper transporters Ctr1 and Ctr2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONVERGENT EVOLUTION; BINDING-SITES; SACCHAROMYCES-CEREVISIAE; STIMULATED ENDOCYTOSIS; WILSON DISEASE; METAL-BINDING; N-TERMINUS; IDENTIFICATION; PROTEIN; YEAST	Copper is an essential element for proper organismal development and is involved in a range of processes, including oxidative phosphorylation, neuropeptide biogenesis, and connective tissue maturation. The copper transporter (Ctr) family of integral membrane proteins is ubiquitously found in eukaryotes and mediates the high-affinity transport of Cu+ across both the plasma membrane and endomembranes. Although mammalian Ctr1 functions as a Cu+ transporter for Cu acquisition and is essential for embryonic development, a homologous protein, Ctr2, has been proposed to function as a low-affinity Cu transporter, a lysosomal Cu exporter, or a regulator of Ctr1 activity, but its functional and evolutionary relationship to Ctr1 is unclear. Here we report a biochemical, genetic, and phylogenetic comparison of metazoan Ctr1 and Ctr2, suggesting that Ctr2 arose over 550 million years ago as a result of a gene duplication event followed by loss of Cu+ transport activity. Using a random mutagenesis and growth selection approach, we identified amino acid substitutions inhumanand mouse Ctr2 proteins that support copper-dependent growth in yeast and enhance copper accumulation in Ctr1(-/-) mouse embryonic fibroblasts. These mutations revert Ctr2 to a more ancestral Ctr1-like state while maintaining endogenous functions, such as stimulating Ctr1 cleavage. We suggest key structural aspects of metazoan Ctr1 and Ctr2 that discriminate between their biological roles, providing mechanistic insights into the evolutionary, biochemical, and functional relationships between these two related proteins.	[Logeman, Brandon L.; Thiele, Dennis J.] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Box 3813, Durham, NC 27710 USA; [Thiele, Dennis J.] Duke Univ, Sch Med, Dept Biochem, Durham, NC 27710 USA; [Wood, L. Kent; Thiele, Dennis J.] Duke Univ, Sch Med, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Lee, Jaekwon] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Lee, Jaekwon] Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA	Duke University; Duke University; Duke University; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Thiele, DJ (corresponding author), Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Box 3813, Durham, NC 27710 USA.	dennis.thiele@duke.edu		Logeman, Brandon/0000-0002-9975-3541	National Institutes of Health [DK074192, DK079209, P30GM103335]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079209, R01DK074192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants DK074192 (to D. J. T.), DK079209 (to J. L.), and P30GM103335 (to the Nebraska Redox Biology Center). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aller SG, 2006, P NATL ACAD SCI USA, V103, P3627, DOI 10.1073/pnas.0509929103; Aller SG, 2004, J BIOL CHEM, V279, P53435, DOI 10.1074/jbc.M409421200; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Assis R, 2013, P NATL ACAD SCI USA, V110, P17409, DOI 10.1073/pnas.1313759110; Beaudoin J, 2013, BIOCHEM SOC T, V41, P1679, DOI 10.1042/BST2013089; Bellemare DR, 2002, J BIOL CHEM, V277, P46676, DOI 10.1074/jbc.M206444200; Bertinato J, 2008, BIOCHEM J, V409, P731, DOI 10.1042/BJ20071025; Bertinato J, 2010, J TRACE ELEM MED BIO, V24, P178, DOI 10.1016/j.jtemb.2010.01.009; Blaby-Haas CE, 2014, J BIOL CHEM, V289, P28129, DOI 10.1074/jbc.R114.592618; Blair BG, 2011, MOL PHARMACOL, V79, P157, DOI 10.1124/mol.110.068411; Brust A, 2013, MOL CELL PROTEOMICS, V12, P1488, DOI [10.1074/mcp.A112.023135, 10.1074/mcp.M112.023135]; Castoe TA, 2009, P NATL ACAD SCI USA, V106, P8986, DOI 10.1073/pnas.0900233106; Chavez-Crooker P, 2001, J EXP BIOL, V204, P1433; Cobine PA, 2006, BBA-MOL CELL RES, V1763, P759, DOI 10.1016/j.bbamcr.2006.03.002; DANCIS A, 1994, CELL, V76, P393, DOI 10.1016/0092-8674(94)90345-X; de Bie P, 2007, J MED GENET, V44, P673, DOI 10.1136/jmg.2007.052746; De Feo CJ, 2010, J MEMBRANE BIOL, V234, P113, DOI 10.1007/s00232-010-9239-4; De Feo CJ, 2009, P NATL ACAD SCI USA, V106, P4237, DOI 10.1073/pnas.0810286106; Deng C, 2010, P NATL ACAD SCI USA, V107, P21593, DOI 10.1073/pnas.1007883107; Ding C, 2011, MOL MICROBIOL, V81, P1560, DOI 10.1111/j.1365-2958.2011.07794.x; Du XB, 2013, CHEM COMMUN, V49, P9134, DOI 10.1039/c3cc45360j; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eisses JF, 2005, J BIOL CHEM, V280, P37159, DOI 10.1074/jbc.M508822200; Fedonkin MA, 1997, NATURE, V388, P868, DOI 10.1038/42242; Foote AD, 2015, NAT GENET, V47, P272, DOI 10.1038/ng.3198; Force A, 1999, GENETICS, V151, P1531; Gallant JR, 2014, SCIENCE, V344, P1522, DOI 10.1126/science.1254432; Georgatsou E, 1997, J BIOL CHEM, V272, P13786, DOI 10.1074/jbc.272.21.13786; Gomes FM, 2012, J INSECT PHYSIOL, V58, P211, DOI 10.1016/j.jinsphys.2011.09.008; Guo Y, 2004, J BIOL CHEM, V279, P17428, DOI 10.1074/jbc.M401493200; Gupta A, 2012, CURR GENOMICS, V13, P124, DOI 10.2174/138920212799860661; Haas KL, 2011, J AM CHEM SOC, V133, P4427, DOI 10.1021/ja108890c; HASSETT R, 1995, J BIOL CHEM, V270, P128, DOI 10.1074/jbc.270.1.128; Hong-Hermesdorf A, 2014, NAT CHEM BIOL, V10, P1034, DOI 10.1038/nchembio.1662; Hooghe B, 2008, NUCLEIC ACIDS RES, V36, pW128, DOI 10.1093/nar/gkn195; HOPKIN SP, 1982, TISSUE CELL, V14, P703, DOI 10.1016/0040-8166(82)90060-X; Kaessmann H, 2010, GENOME RES, V20, P1313, DOI 10.1101/gr.101386.109; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Klevay LM, 2000, J NUTR, V130, p489S, DOI 10.1093/jn/130.2.489S; Klomp AEM, 2002, BIOCHEM J, V364, P497, DOI 10.1042/BJ20011803; Kuo YM, 2001, P NATL ACAD SCI USA, V98, P6836, DOI 10.1073/pnas.111057298; Lee LW, 2001, P NATL ACAD SCI USA, V98, P6842, DOI 10.1073/pnas.111058698; LUKASEWYCZ OA, 1990, ANN NY ACAD SCI, V587, P147, DOI 10.1111/j.1749-6632.1990.tb00142.x; Lutsenko S, 2008, ARCH BIOCHEM BIOPHYS, V476, P22, DOI 10.1016/j.abb.2008.05.005; Luza Sandra C., 1996, American Journal of Clinical Nutrition, V63, p812S; Madsen E, 2007, ANNU REV NEUROSCI, V30, P317, DOI 10.1146/annurev.neuro.30.051606.094232; Maryon EB, 2013, J BIOL CHEM, V288, P18035, DOI 10.1074/jbc.M112.442426; Maryon EB, 2009, J BIOL CHEM, V284, P28104, DOI 10.1074/jbc.M109.044925; MEDEIROS DM, 1993, P SOC EXP BIOL MED, V203, P262, DOI 10.3181/00379727-203-43599; Mirceta S, 2013, SCIENCE, V340, DOI 10.1126/science.1234192; Molloy SA, 2009, J BIOL CHEM, V284, P29704, DOI 10.1074/jbc.M109.000166; Nevitt T, 2012, BBA-MOL CELL RES, V1823, P1580, DOI 10.1016/j.bbamcr.2012.02.011; Ohrvik H, 2015, J TRACE ELEM MED BIO, V31, P178, DOI 10.1016/j.jtemb.2014.03.006; Ohrvik H, 2014, ANN NY ACAD SCI, V1314, P32, DOI 10.1111/nyas.12371; Ohrvika H, 2013, P NATL ACAD SCI USA, V110, pE4279, DOI 10.1073/pnas.1311749110; Ohrvik H, 2016, J BIOL CHEM, V291, P13905, DOI 10.1074/jbc.M116.731281; Parker J, 2013, NATURE, V502, P228, DOI 10.1038/nature12511; Pascale MC, 2003, EXP CELL RES, V291, P377, DOI 10.1016/j.yexcr.2003.07.001; Pena MMO, 2000, J BIOL CHEM, V275, P33244, DOI 10.1074/jbc.M005392200; Petris MJ, 2003, J BIOL CHEM, V278, P9639, DOI 10.1074/jbc.M209455200; Polishchuk EV, 2014, DEV CELL, V29, P686, DOI 10.1016/j.devcel.2014.04.033; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Projecto-Garcia J, 2013, P NATL ACAD SCI USA, V110, P20669, DOI 10.1073/pnas.1315456110; Puig S, 2002, J BIOL CHEM, V277, P26021, DOI 10.1074/jbc.M202547200; Pushie MJ, 2015, INORG CHEM, V54, P8544, DOI 10.1021/acs.inorgchem.5b01162; Ralle M, 2010, J BIOL CHEM, V285, P30875, DOI 10.1074/jbc.M110.114447; Ramos I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027276; Rees EM, 2004, J BIOL CHEM, V279, P54221, DOI 10.1074/jbc.M411669200; Rees EM, 2007, J BIOL CHEM, V282, P21629, DOI 10.1074/jbc.M703397200; Riggio M, 2002, BBA-GENE STRUCT EXPR, V1576, P127, DOI 10.1016/S0167-4781(02)00337-8; Rubino JT, 2011, METALLOMICS, V3, P61, DOI 10.1039/c0mt00044b; Rubino JT, 2012, J INORG BIOCHEM, V107, P129, DOI 10.1016/j.jinorgbio.2011.11.024; Rubino JT, 2010, J BIOL INORG CHEM, V15, P1033, DOI 10.1007/s00775-010-0663-9; Sancenon V, 2003, PLANT MOL BIOL, V51, P577, DOI 10.1023/A:1022345507112; Schwab S, 2016, J INORG BIOCHEM, V158, P70, DOI 10.1016/j.jinorgbio.2015.12.021; Steiger D, 2010, J BIOL CHEM, V285, P17089, DOI 10.1074/jbc.M109.090282; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tapia L, 2004, BIOCHEM J, V378, P617, DOI 10.1042/BJ20031174; Turski ML, 2007, J BIOL CHEM, V282, P24017, DOI 10.1074/jbc.M703792200; Van den Berghe PVE, 2007, BIOCHEM J, V407, P49, DOI 10.1042/BJ20070705; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; WEST AK, 1990, GENOMICS, V8, P513, DOI 10.1016/0888-7543(90)90038-V; Yang ZH, 2012, NAT REV GENET, V13, P303, DOI 10.1038/nrg3186; Zhou B, 1997, P NATL ACAD SCI USA, V94, P7481, DOI 10.1073/pnas.94.14.7481; Zhou H, 2003, J BIOL CHEM, V278, P48210, DOI 10.1074/jbc.M309820200; Zhou H, 2001, J BIOL CHEM, V276, P20529, DOI 10.1074/jbc.M102004200	86	19	19	1	19	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11531	11546		10.1074/jbc.M117.793356	http://dx.doi.org/10.1074/jbc.M117.793356			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28507097	hybrid, Green Published			2022-12-26	WOS:000405119600033
J	Zhu, W; He, XY; Hua, Y; Li, Q; Wang, JY; Gan, XQ				Zhu, Wei; He, Xinyu; Hua, Yue; Li, Qian; Wang, Jiyong; Gan, Xiaoqing			The E3 ubiquitin ligase WWP2 facilitates RUNX2 protein transactivation in a mono-ubiquitination manner during osteogenic differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOBLAST DIFFERENTIATION; CLEIDOCRANIAL DYSPLASIA; SKELETAL DEVELOPMENT; TRANSCRIPTION FACTORS; ANGSTROM RESOLUTION; BONE-DEVELOPMENT; BETA INTERACTS; IMPORTIN BETA; UP-REGULATION; STEM-CELLS	Poly-ubiquitination-mediated RUNX2 degradation is an important cause of age- and inflammation-related bone loss. NEDD4 family E3 ubiquitin protein ligases are thought to be the major regulators of RUNX2 poly-ubiquitination. However, we observed a mono-ubiquitination of RUNX2 that was catalyzed by WWP2, a member of the NEDD4 family of E3 ubiquitin ligases. WWP2 has been reported to catalyze the mono-ubiquitination of Goosecoid in chondrocytes, facilitating craniofacial skeleton development. In this study, we found that osteogenic differentiation of mesenchymal stem cells promoted WWP2 expression and nuclear accumulation. Knockdown of Wwp2 in mesenchymal stem cells and osteoblasts led to significant deficiencies of osteogenesis, including decreased mineral deposition and down-regulation of osteogenic marker genes. Co-immunoprecipitation experiments showed the interaction of WWP2 with RUNX2 in vitro and in vivo. Mono-ubiquitination by WWP2 leads to RUNX2 transactivation, as evidenced by the wild type of WWP2, but not its ubiquitin ligase-dead mutant, augmenting RUNX2-reponsive reporter activity. Moreover, deletion of WWP2-dependent mono-ubiquitination resulted in striking defects of RUNX2 osteoblastic activity. In addition, ectopic expression of the constitutively active type 1A bone morphogenetic protein receptor enhanced WWP2-dependent RUNX2 ubiquitination and transactivation, demonstrating a regulatory role of bone morphogenetic protein signaling in the WWP2-RUNX2 axis. Taken together, our results provide evidence that WWP2 serves as a positive regulator of osteogenesis by augmenting RUNX2 transactivation in a nonproteolytic mono-ubiquitination manner.	[Zhu, Wei; He, Xinyu; Hua, Yue; Li, Qian; Wang, Jiyong; Gan, Xiaoqing] Fudan Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Key Lab Metab & Mol Med,Minist Educ, POB 240, Shanghai 200032, Peoples R China	Fudan University	Wang, JY; Gan, XQ (corresponding author), Fudan Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Key Lab Metab & Mol Med,Minist Educ, POB 240, Shanghai 200032, Peoples R China.	jiyongwang73@gmail.com; xiaoqinggan@fudan.edu.cn			National Natural Science Foundation of China [31471317, 31671466]; Shanghai Pujiang Program [14PJ1400600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program)	This work was sponsored by National Natural Science Foundation of China Grants 31471317 and 31671466 and Shanghai Pujiang Program Grant 14PJ1400600. The authors declare that they have no conflicts of interest with the contents of this article.	Ali SA, 2010, P NATL ACAD SCI USA, V107, P4165, DOI 10.1073/pnas.1000620107; Avis JM, 1996, J CELL SCI, V109, P2423; Backstrom S, 2002, J MOL BIOL, V322, P259, DOI 10.1016/S0022-2836(02)00702-7; Bethel M, 2013, CURR OSTEOPOROS REP, V11, P99, DOI 10.1007/s11914-013-0135-6; Bidwell JP, 2013, CURR OSTEOPOROS REP, V11, P117, DOI 10.1007/s11914-013-0139-2; Calo E, 2010, NATURE, V466, P1110, DOI 10.1038/nature09264; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Cingolani G, 2002, MOL CELL, V10, P1345, DOI 10.1016/S1097-2765(02)00727-X; Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012; Gan XQ, 2008, J CELL BIOL, V180, P1087, DOI 10.1083/jcb.200710050; Gan XQ, 2012, NAT CELL BIOL, V14, P686, DOI 10.1038/ncb2507; Gibon E, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0300-9; Gu GL, 2006, CELL TISSUE RES, V323, P263, DOI 10.1007/s00441-005-0066-3; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Jeon EJ, 2006, J BIOL CHEM, V281, P16502, DOI 10.1074/jbc.M512494200; Jung JG, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004751; Kaneki H, 2006, J BIOL CHEM, V281, P4326, DOI 10.1074/jbc.M509430200; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Komori T, 2005, J CELL BIOCHEM, V95, P445, DOI 10.1002/jcb.20420; Krings A, 2012, BONE, V50, P546, DOI 10.1016/j.bone.2011.06.016; Kundu M, 2002, NAT GENET, V32, P639, DOI 10.1038/ng1050; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Li XN, 2008, J CELL BIOL, V181, P959, DOI 10.1083/jcb.200711044; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Macias MJ, 1996, NATURE, V382, P646, DOI 10.1038/382646a0; Makkerh JPS, 1996, CURR BIOL, V6, P1025, DOI 10.1016/S0960-9822(02)00648-6; Nakamura Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1242; Nishimura R, 2012, J BIOCHEM, V151, P247, DOI 10.1093/jb/mvs004; Ott CE, 2010, HUM MUTAT, V31, pE1587, DOI 10.1002/humu.21298; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Paredes R, 2004, J STEROID BIOCHEM, V89-90, P269, DOI 10.1016/j.jsbmb.2004.03.076; Petosa C, 2004, MOL CELL, V16, P761, DOI 10.1016/j.molcel.2004.11.018; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Shrivats AR, 2015, ACS BIOMATER SCI ENG, V1, P1139, DOI 10.1021/acsbiomaterials.5b00294; Shu L, 2013, J BONE MINER RES, V28, P1925, DOI 10.1002/jbmr.1938; Sierra J, 2003, MOL CELL BIOL, V23, P3339, DOI 10.1128/MCB.23.9.3339-3351.2003; Sinha KM, 2013, J CELL BIOCHEM, V114, P975, DOI 10.1002/jcb.24439; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; Weng JJ, 2013, BBA-GEN SUBJECTS, V1830, P2839, DOI 10.1016/j.bbagen.2012.12.021; Xu HM, 2009, CELL RES, V19, P561, DOI 10.1038/cr.2009.31; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Yoshida CA, 2002, NAT GENET, V32, P633, DOI 10.1038/ng1015; Yoshida T, 2002, AM J HUM GENET, V71, P724, DOI 10.1086/342717; Zhao L, 2010, J BONE MINER RES, V25, P1246, DOI 10.1002/jbmr.28; Zhao M, 2003, J BIOL CHEM, V278, P27939, DOI 10.1074/jbc.M304132200; Zou WG, 2011, NAT CELL BIOL, V13, P59, DOI 10.1038/ncb2134	48	26	26	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11178	11188		10.1074/jbc.M116.772277	http://dx.doi.org/10.1074/jbc.M116.772277			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28500134	hybrid, Green Published			2022-12-26	WOS:000405119600005
J	Garcia-Villegas, R; Camacho-Villasana, Y; Shingu-Vazquez, MA; Cabrera-Orefice, A; Uribe-Carvajal, S; Fox, TD; Perez-Martinez, X				Garcia-Villegas, Rodolfo; Camacho-Villasana, Yolanda; Shingu-Vazquez, Miguel Angel; Cabrera-Orefice, Alfredo; Uribe-Carvajal, Salvador; Fox, Thomas D.; Perez-Martinez, Xochitl			The Cox1 C-terminal domain is a central regulator of cytochrome c oxidase biogenesis in yeast mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; MESSENGER-RNA; IN-VIVO; TRANSLATION; GENE; STABILITY; SUBUNIT; HEME; SUPERCOMPLEXES; IDENTIFICATION	Cytochrome c oxidase (CcO) is the last electron acceptor in the respiratory chain. The CcO core is formed by mitochondrial DNA-encoded Cox1, Cox2, and Cox3 subunits. Cox1 synthesis is highly regulated; for example, if CcO assembly is blocked, Cox1 synthesis decreases. Mss51 activates translation of COX1 mRNA and interacts with Cox1 protein in high-molecular weight complexes (COA complexes) to form the Cox1 intermediary assembly module. Thus, Mss51 coordinates both Cox1 synthesis and assembly. We previously reported that the last 15 residues of the Cox1 C terminus regulate Cox1 synthesis by modulating an interaction of Mss51 with Cox14, another component of the COA complexes. Here, using site-directed mutagenesis of the mitochondrial COX1 gene from Saccharomyces cerevisiae, we demonstrate that mutations P521A/P522A and V524E disrupt the regulatory role of the Cox1 C terminus. These mutations, as well as C terminus deletion (Cox1 Delta C15), reduced binding of Mss51 and Cox14 to COA complexes. Mss51 was enriched in a translationally active form that maintains full Cox1 synthesis even if CcO assembly is blocked in these mutants. Moreover, Cox1 Delta C15, but not Cox1-P521A/P522A and Cox1-V524E, promoted formation of aberrant super-complexes in CcO assembly mutants lacking Cox2 or Cox4 subunits. The aberrant supercomplex formation depended on the presence of cytochrome b and Cox3, supporting the idea that supercomplex assembly factors associate with Cox3 and demonstrating that supercomplexes can be formed even if CcO is inactive and not fully assembled. Our results indicate that the Cox1 C-terminal end is a key regulator of CcO iogenesis and that it is important for supercomplex formation/stability.	[Garcia-Villegas, Rodolfo; Camacho-Villasana, Yolanda; Uribe-Carvajal, Salvador; Perez-Martinez, Xochitl] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Genet Mol, Mexico City 04510, DF, Mexico; [Shingu-Vazquez, Miguel Angel] Monash Univ, Australian Res Council Ctr Excellence Adv Mol Ima, Clayton, Vic 3800, Australia; [Cabrera-Orefice, Alfredo] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Mitochondrial Med, NL-6500 HB Nijmegen, Netherlands; [Fox, Thomas D.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Universidad Nacional Autonoma de Mexico; Monash University; Radboud University Nijmegen; Cornell University	Perez-Martinez, X (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Genet Mol, Mexico City 04510, DF, Mexico.	xperez@ifc.unam.mx	Cabrera-Orefice, Alfredo/H-3464-2016	Cabrera-Orefice, Alfredo/0000-0002-2042-3794; Fox, Thomas/0000-0001-7629-3661; Uribe-Carvajal, Salvador/0000-0002-7028-8121	Consejo Nacional de Ciencia y Tecnologia [47514, 250726, 289024]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) UNAM [IN204414, IN209217]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico)	This work was supported by Consejo Nacional de Ciencia y Tecnologia Research Grant 47514 (to X. P.-M.) and Fellowships 250726 (to R. G.-V.) and 289024 (to A. C.-O.) and Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) UNAM Grants IN204414 and IN209217 (to X. P.-M.). This work is part of the Ph.D. thesis of R. G.-V. from the Programa de Doctorado en Ciencias Biomedicas, Universidad Nacional Autonoma de Mexico. The authors declare that they have no conflicts of interest with the contents of this article.	Bareth B, 2013, MOL CELL BIOL, V33, P4128, DOI 10.1128/MCB.00747-13; Barrientos A, 2004, EMBO J, V23, P3472, DOI 10.1038/sj.emboj.7600358; Barrientos Antoni, 2009, Curr Protoc Hum Genet, VChapter 19, DOI 10.1002/0471142905.hg1903s63; Barros MH, 2001, FEBS LETT, V492, P133, DOI 10.1016/S0014-5793(01)02249-9; Bonnefoy N, 2007, METHOD CELL BIOL, V80, P525, DOI 10.1016/S0091-679X(06)80026-9; BROWN NG, 1994, MOL CELL BIOL, V14, P1045, DOI 10.1128/MCB.14.2.1045; Burke D., 2000, METHODS YEAST GENETI; Chaban Y, 2014, BBA-BIOENERGETICS, V1837, P418, DOI 10.1016/j.bbabio.2013.10.004; Chen YC, 2012, CELL METAB, V15, P348, DOI 10.1016/j.cmet.2012.02.006; Cruciat CM, 2000, J BIOL CHEM, V275, P18093, DOI 10.1074/jbc.M001901200; Cui TZ, 2014, J BIOL CHEM, V289, P6133, DOI 10.1074/jbc.M113.523688; DECOSTER E, 1990, MOL GEN GENET, V224, P111, DOI 10.1007/BF00259457; Diekert K, 2001, METHOD CELL BIOL, V65, P37, DOI 10.1016/S0091-679X(01)65003-9; Dunstan HM, 1997, GENETICS, V147, P87; Fontanesi F, 2008, IUBMB LIFE, V60, P557, DOI 10.1002/iub.86; Fontanesi F, 2011, J BIOL CHEM, V286, P555, DOI 10.1074/jbc.M110.188805; Fontanesi F, 2010, MOL CELL BIOL, V30, P245, DOI 10.1128/MCB.00983-09; Glerum DM, 1997, J BIOL CHEM, V272, P19088, DOI 10.1074/jbc.272.30.19088; Guthrie C., 2002, GUIDE YEAST GENETICS, V350, P3; Hornig-Do HT, 2012, EMBO J, V31, P1293, DOI 10.1038/emboj.2011.477; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Khalimonchuk O, 2007, J BIOL CHEM, V282, P17442, DOI 10.1074/jbc.M702379200; Khalimonchuk O, 2012, J BIOL CHEM, V287, P26715, DOI 10.1074/jbc.M112.377200; Khalimonchuk O, 2010, MOL CELL BIOL, V30, P1004, DOI 10.1128/MCB.00640-09; KLOECKENERGRUISSEM B, 1988, J BACTERIOL, V170, P1399, DOI 10.1128/jb.170.3.1399-1402.1988; Levchenko M, 2016, BBA-MOL CELL RES, V1863, P1624, DOI 10.1016/j.bbamcr.2016.04.007; MANTHEY GM, 1995, EMBO J, V14, P4031, DOI 10.1002/j.1460-2075.1995.tb00074.x; McStay GP, 2013, J BIOL CHEM, V288, P26546, DOI 10.1074/jbc.M113.498592; McStay GP, 2013, FEBS LETT, V587, P943, DOI 10.1016/j.febslet.2013.02.022; McStay GP, 2013, MOL BIOL CELL, V24, P440, DOI 10.1091/mbc.E12-10-0749; MEUNIER B, 1993, EUR J BIOCHEM, V213, P129, DOI 10.1111/j.1432-1033.1993.tb17742.x; Mick DU, 2007, EMBO J, V26, P4347, DOI 10.1038/sj.emboj.7601862; Mick DU, 2011, NAT REV MOL CELL BIO, V12, P14, DOI 10.1038/nrm3029; Mick DU, 2010, J CELL BIOL, V191, P141, DOI 10.1083/jcb.201007026; Ott M, 2016, ANNU REV BIOCHEM, V85, P77, DOI 10.1146/annurev-biochem-060815-014334; Mayorga JP, 2016, J BIOL CHEM, V291, P9343, DOI 10.1074/jbc.M116.721985; Perez-Martinez X, 2003, EMBO J, V22, P5951, DOI 10.1093/emboj/cdg566; Perez-Martinez X, 2009, MOL BIOL CELL, V20, P4371, DOI 10.1091/mbc.E09-06-0522; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Pierrel F, 2007, EMBO J, V26, P4335, DOI 10.1038/sj.emboj.7601861; POUTRE CG, 1987, GENETICS, V115, P637; RODEL G, 1986, CURR GENET, V11, P41, DOI 10.1007/BF00389424; Rompler K, 2016, J BIOL CHEM, V291, P23769, DOI 10.1074/jbc.M116.734665; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shingu-Vazquez M, 2010, J BIOL CHEM, V285, P34382, DOI 10.1074/jbc.M110.161976; Soto IC, 2012, BBA-BIOENERGETICS, V1817, P883, DOI 10.1016/j.bbabio.2011.09.005; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Strecker V, 2016, BBA-MOL CELL RES, V1863, P1643, DOI 10.1016/j.bbamcr.2016.04.012; Strogolova V, 2012, MOL CELL BIOL, V32, P1363, DOI 10.1128/MCB.06369-11; Su CH, 2014, MOL BIOL CELL, V25, P965, DOI [10.1091/mbc.E13-0-0575, 10.1091/mbc.E13-10-0575]; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Vukotic M, 2012, CELL METAB, V15, P336, DOI 10.1016/j.cmet.2012.01.016; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Westermann B, 2001, METHOD CELL BIOL, V65, P429, DOI 10.1016/S0091-679X(01)65025-8; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Zamudio-Ochoa A, 2014, RNA BIOL, V11, P953, DOI 10.4161/rna.29780	58	16	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					10912	10925		10.1074/jbc.M116.773077	http://dx.doi.org/10.1074/jbc.M116.773077			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28490636	Green Published, hybrid			2022-12-26	WOS:000404391000014
J	Bischoff, AR; Pokhvisneva, I; Leger, E; Gaudreau, H; Steiner, M; Kennedy, JL; O'Donnell, KJ; Diorio, J; Meaney, MJ; Silveira, PP				Bischoff, Adrianne R.; Pokhvisneva, Irina; Leger, Etienne; Gaudreau, Helene; Steiner, Meir; Kennedy, James L.; O'Donnell, Kieran J.; Diorio, Josie; Meaney, Michael J.; Silveira, Patricia P.		MAVAN Res Teaall	Dynamic interaction between fetal adversity and a genetic score reflecting dopamine function on developmental outcomes at 36 months	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; RECEPTOR GENE; RISK-FACTORS; GROWTH; NEURODEVELOPMENT; AGE; ASSOCIATION; DEPRESSION; ATTENTION; CHILDREN	Background Fetal adversity, evidenced by poor fetal growth for instance, is associated with increased risk for several diseases later in life. Classical cut-offs to characterize small (SGA) and large for gestational age (LGA) newborns are used to define long term vulnerability. We aimed at exploring the possible dynamism of different birth weight cut-offs in defining vulnerability in developmental outcomes (through the Bayley Scales of Infant and Toddler Development), using the example of a gene vs. fetal adversity interaction considering gene choices based on functional relevance to the studied outcome. Methods 36-month-old children from an established prospective birth cohort (Maternal Adversity, Vulnerability, and Neurodevelopment) were classified according to birth weight ratio (BWR) (SGA <= 0.85, LGA > 1.15, exploring a wide range of other cut-offs) and genotyped for polymorphisms associated with dopamine signaling (TaqIA-A1 allele, DRD2-141C Ins/Ins, DRD4 7-repeat, DAT1-10-repeat, Met/Met-COMT), composing a score based on the described function, in which hypofunctional variants received lower scores. Results There were 251 children (123 girls and 128 boys). Using the classic cut-offs (0.85 and 1.15), there were no statistically significant interactions between the neonatal groups and the dopamine genetic score. However, when changing the cut-offs, it is possible to see ranges of BWR that could be associated with vulnerability to poorer development according to the variation in the dopamine function. Conclusion The classic birth weight cut-offs to define SGA and LGA newborns should be seen with caution, as depending on the outcome in question, the protocols for long-term follow up could be either too inclusive-therefore most costly, or unable to screen true vulnerabilities-and therefore ineffective to establish early interventions and primary prevention.	[Pokhvisneva, Irina; Gaudreau, Helene; O'Donnell, Kieran J.] Univ Toronto, Div Neonatol, Dept Pediat, Toronto, ON, Canada; [O'Donnell, Kieran J.; Meaney, Michael J.; MAVAN Res Teaall] Hosp Sick Children, Toronto, ON, Canada; [Leger, Etienne; Gaudreau, Helene; O'Donnell, Kieran J.; Meaney, Michael J.] Douglas Mental Hlth Univ Inst, McGill Univ, Ludmer Ctr Neuroinformat & Mental Hlth, Montreal, PQ, Canada; [Bischoff, Adrianne R.; Gaudreau, Helene; Steiner, Meir; Silveira, Patricia P.] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada; [Steiner, Meir] Univ Toronto & Ctr Addict & Mental Hlth, Dept Psychiat, Toronto, ON, Canada; [Gaudreau, Helene; Kennedy, James L.; Silveira, Patricia P.] Canadian Inst Adv Res CI FAR, Child & Brain Dev Program, Toronto, ON, Canada; [Gaudreau, Helene; Kennedy, James L.; Silveira, Patricia P.] McGill Univ, Dept Psychiat, Montreal, PQ, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McGill University; McMaster University; Canadian Institute for Advanced Research (CIFAR); McGill University	Silveira, PP (corresponding author), Univ Toronto, Div Neonatol, Dept Pediat, Toronto, ON, Canada.	patricia.pelufosilverira@douglas.mcgill.ca	Kennedy, James Lowery/AAZ-6947-2020; O'Donnell, Kieran/ABC-5593-2020; Silveira, Patricia/K-2364-2019; Meaney, Michael/N-5931-2019	Kennedy, James Lowery/0000-0002-8733-3806; Silveira, Patricia/0000-0001-8626-2519; Bischoff, Adrianne R/0000-0001-9218-1301; Leger, Etienne/0000-0001-5452-9266	Canadian Institutes of Health Research (CIHR); JPB Foundation; Sackler Institute	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); JPB Foundation; Sackler Institute	This work was funded by the Canadian Institutes of Health Research (CIHR), the JPB Foundation and the Sackler Institute. These sponsors had no influence on the study design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. Bischoff AR wrote the first draft of the manuscript, and although we had financial support from these granting agencies for the project no honorarium, grant, or other form of payment was given to anyone to produce specifically this manuscript.	Abulseoud OA, 2015, PLOS ONE, V10; Altink ME, 2012, WORLD J BIOL PSYCHIA, V13, P293, DOI 10.3109/15622975.2011.595822; Alves MB, 2015, BEHAV BRAIN RES; [Anonymous], 2006, STAT CAN 2006; ASGHARI V, 1995, J NEUROCHEM, V65, P1157, DOI 10.1046/j.1471-4159.1995.65031157.x; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Bayley N, 1993, BAYLEY SCALES INFANT; Belsky J, 2009, MOL PSYCHIATR, V14, P746, DOI 10.1038/mp.2009.44; BENINGER RJ, 1983, BRAIN RES REV, V6, P173, DOI 10.1016/0165-0173(83)90038-3; Bersani G, 2007, J PERINAT MED, V35, P159, DOI 10.1515/JPM.2007.021; Brookes KJ, 2013, GENOMICS, V101, P273, DOI 10.1016/j.ygeno.2013.03.003; Bruder GE, 2005, BIOL PSYCHIAT, V58, P901, DOI 10.1016/j.biopsych.2005.05.010; Buschgens CJM, 2009, EUR CHILD ADOLES PSY, V18, P65, DOI 10.1007/s00787-008-0704-x; Cardinal RN, 2004, ANN NY ACAD SCI, V1021, P33, DOI 10.1196/annals.1308.004; Chiavaroli V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104278; Colman I, 2007, BIOL PSYCHIAT, V62, P1265, DOI 10.1016/j.biopsych.2007.05.012; Costello EJ, 2007, ARCH GEN PSYCHIAT, V64, P338, DOI 10.1001/archpsyc.64.3.338; Daraki V, 2017, EUR CHILD ADOLESC PS; Davids E, 2003, BRAIN RES REV, V42, P1, DOI 10.1016/S0165-0173(02)00274-6; Davis C, 2013, PHYSIOL BEHAV, V118, P63, DOI 10.1016/j.physbeh.2013.05.014; ElBaz Mohamed F, 2016, J CHILD NEUROL; Eriksson JG, 2014, ACTA PHYSIOL, V210, P154, DOI 10.1111/apha.12142; Eriksson JG, 2002, DIABETOLOGIA, V45, P342, DOI 10.1007/s00125-001-0757-6; Esteban FJ, 2010, NEUROIMAGE, V53, P1225, DOI 10.1016/j.neuroimage.2010.07.019; Garcia-Garcia M, 2010, EUR J NEUROSCI, V31, P754, DOI 10.1111/j.1460-9568.2010.07102.x; Gasso P, 2015, J AFFECT DISORDERS, V186, P284, DOI 10.1016/j.jad.2015.07.035; Genro JP, 2010, EXPERT REV NEUROTHER, V10, P587, DOI [10.1586/ern.10.17, 10.1586/ERN.10.17]; Gizer IR, 2009, HUM GENET, V126, P51, DOI 10.1007/s00439-009-0694-x; Goel N, 2012, PLOS ONE, V7; Grissom NM, 2013, INT J DEV NEUROSCI, V31, P406, DOI 10.1016/j.ijdevneu.2012.11.006; Hack M, 2004, PEDIATRICS, V114, P932, DOI 10.1542/peds.2003-1017-L; Herva A, 2008, PSYCHIAT RES, V160, P263, DOI 10.1016/j.psychres.2007.07.020; Hosp JA, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00145; Hultman CM, 1997, BRIT J PSYCHIAT, V170, P128, DOI 10.1192/bjp.170.2.128; Jonsson EG, 1999, MOL PSYCHIATR, V4, P290, DOI 10.1038/sj.mp.4000532; Kadesjo B, 1999, J AM ACAD CHILD PSY, V38, P820, DOI 10.1097/00004583-199907000-00011; Kordas K, 2011, J PEDIATR-US, V159, P638, DOI 10.1016/j.jpeds.2011.03.043; Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35; Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007; Lahti M, 2015, PSYCHOL MED, V45, P985, DOI 10.1017/S0033291714001998; Leitner Y, 2000, J CHILD NEUROL, V15, P781, DOI 10.1177/088307380001501202; Levine TA, 2015, PEDIATRICS, V135, P126, DOI 10.1542/peds.2014-1143; Maitra S, 2014, CELL MOL NEUROBIOL, V34, P549, DOI 10.1007/s10571-014-0038-9; Mill J, 2002, AM J MED GENET, V114, P975, DOI 10.1002/ajmg.b.10948; Molle RD, 2017, NEUROSCI BIOBEHAV R, V73, P326, DOI 10.1016/j.neubiorev.2016.12.028; Molle RD, 2015, BRAIN RES, V1618, P41, DOI 10.1016/j.brainres.2015.05.019; Moore GS, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.01.044; NOBLE EP, 1991, ARCH GEN PSYCHIAT, V48, P648; O'Donnell KA, 2014, CAN J PSYCHIAT, V59, P497, DOI 10.1177/070674371405900906; Padilla N, 2011, BRAIN RES, V1382, P98, DOI 10.1016/j.brainres.2011.01.032; Qian Y, 2013, GENES BRAIN BEHAV, V12, P604, DOI 10.1111/gbb.12062; R CT, 2014, R LANG ENV STAT COMP; Reuter M, 2006, BRAIN RES, V1069, P190, DOI 10.1016/j.brainres.2005.11.046; Rowe DC, 1997, PERS INDIV DIFFER, V23, P105, DOI 10.1016/S0191-8869(97)00005-6; Sheldrick AJ, 2008, EUR PSYCHIAT, V23, P385, DOI 10.1016/j.eurpsy.2008.05.002; Silveira P. P., 2016, JAMA PEDIAT; Silveira PP, 2007, J PEDIAT, V83, P494, DOI [10.2223/JPED.1728, 10.1590/S0021-75572007000800004]; Stice E, 2012, J NEUROSCI, V32, P10093, DOI 10.1523/JNEUROSCI.1506-12.2012; Szekely A, 2011, GENES BRAIN BEHAV, V10, P129, DOI 10.1111/j.1601-183X.2010.00645.x; Tovo-Rodrigues L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085164; vanderReijdenLakeman IEA, 1997, J CLIN EXP NEUROPSYC, V19, P101, DOI 10.1080/01688639708403840; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Vucetic Z, 2010, NEUROSCIENCE, V168, P359, DOI 10.1016/j.neuroscience.2010.04.010; WISE RA, 1989, ANNU REV PSYCHOL, V40, P191, DOI 10.1146/annurev.ps.40.020189.001203; YOUNG AB, 1984, NEUROL CLIN, V2, P417, DOI 10.1016/S0733-8619(18)31082-X; Yue JK, 2016, NEUROGENETICS; Zhang S, 2014, CREATIVITY RES J, V26, P115, DOI 10.1080/10400419.2014.874267	68	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177344	10.1371/journal.pone.0177344	http://dx.doi.org/10.1371/journal.pone.0177344			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV0YN	28505190	Green Submitted, Green Published, gold			2022-12-26	WOS:000401473500018
J	Ho, YR; Wang, P; Lu, MC; Tseng, ST; Yang, CP; Yan, YH				Ho, Yi-Ran; Wang, Panchalli; Lu, Mei-Chun; Tseng, Shih-Ting; Yang, Chun-Pai; Yan, Yuan-Horng			Associations of mid-pregnancy HbA1c with gestational diabetes and risk of adverse pregnancy outcomes in high-risk Taiwanese women	PLOS ONE			English	Article							SCREENING-TEST; GLYCATED HEMOGLOBIN; GLYCOSYLATED HEMOGLOBIN; CARDIOVASCULAR-DISEASE; NONDIABETIC ADULTS; MELLITUS; DIAGNOSIS; A1C; PREDICTION; HBA(1C)	Background The objective of this study was to investigate the associations among the mid-pregnancy glycated hemoglobin A1c (HbA1c) level, gestational diabetes (GDM), and risk of adverse pregnancy outcomes in women without overt diabetes and with positive 50-g, 1-h glucose challenge test (GCT) results (140 mg/dL or greater). Methods This prospective study enrolled 1,989 pregnant Taiwanese women. A two-step approach, including a 50-g, 1-h GCT and 100-g, 3-h oral glucose tolerance test (OGTT), was employed for the diagnosis of GDM at weeks 23-32. The mid-pregnancy HbA1c level was measured at the time the OGTT was performed. A receiver operating characteristic (ROC) curve was used to determine the relationship between the mid-pregnancy HbA1c level and GDM. Multiple logistic regression models were implemented to assess the relationships between the mid-pregnancy HbA1c level and adverse pregnancy outcomes. Results An ROC curve demonstrated that the optimal mid-pregnancy HbA1c cut-off point to predict GDM, as diagnosed by the Carpenter-Coustan criteria using a two-step approach, was 5.7%. The area under the ROC curve of the mid-pregnancy HbA1c level for GDM was 0.70. Compared with the levels of 4.5-4.9%, higher mid-pregnancy HbA1c levels (5.0-5.4, 5.5-5.9, 6.0-6.4, 6.5-6.9, and > 7.0%) were significantly associated with increased risks of gestational hypertension or preeclampsia, preterm delivery, admission to the neonatal intensive care unit, low birth weight, and macrosomia (the odds ratio [OR] ranges were 1.20-9.98, 1.31-5.16, 0.88-3.15, 0.89-4.10, and 2.22-27.86, respectively). Conclusions The mid-pregnancy HbA1c level was associated with various adverse pregnancy outcomes in high-risk Taiwanese women. However, it lacked adequate sensitivity and specificity to replace the two-step approach in the diagnosis of GDM. The current study comprised a single-center prospective study; thus, additional, randomized control design studies are required.	[Ho, Yi-Ran; Tseng, Shih-Ting] Kuang Tien Gen Hosp, Dept Endocrinol & Metab, Taichung, Taiwan; [Wang, Panchalli] Ditmanson Med Fdn, Chia Yi Christian Hosp, Dept Obstet & Gynecol, Chiayi, Taiwan; [Lu, Mei-Chun; Yang, Chun-Pai; Yan, Yuan-Horng] Kuang Tien Gen Hosp, Dept Med Res, Taichung, Taiwan; [Tseng, Shih-Ting] Providence Univ, Dept Food & Nutr, Taichung, Taiwan; [Yang, Chun-Pai] Kuang Tien Gen Hosp, Dept Neurol, Taichung, Taiwan; [Yang, Chun-Pai; Yan, Yuan-Horng] Hung Kuang Univ, Dept Nutr, Taichung, Taiwan; [Yang, Chun-Pai; Yan, Yuan-Horng] Hung Kuang Univ, Inst Biomed Nutr, Taichung, Taiwan; [Yan, Yuan-Horng] Natl Taiwan Univ, Inst Occupat Med & Ind Hyg, Coll Publ Hlth, Taipei, Taiwan	Providence University - Taiwan; Hungkuang University; Hungkuang University; National Taiwan University	Yang, CP; Yan, YH (corresponding author), Kuang Tien Gen Hosp, Dept Med Res, Taichung, Taiwan.; Yang, CP (corresponding author), Kuang Tien Gen Hosp, Dept Neurol, Taichung, Taiwan.; Yang, CP; Yan, YH (corresponding author), Hung Kuang Univ, Dept Nutr, Taichung, Taiwan.; Yang, CP; Yan, YH (corresponding author), Hung Kuang Univ, Inst Biomed Nutr, Taichung, Taiwan.; Yan, YH (corresponding author), Natl Taiwan Univ, Inst Occupat Med & Ind Hyg, Coll Publ Hlth, Taipei, Taiwan.	neuralyung@gmail.com; d97841006@ntu.edu.tw						Agarwal MM, 2005, ACTA OBSTET GYN SCAN, V84, P1159, DOI 10.1111/j.0001-6349.2005.00650.x; Aggarwal V, 2012, DIABETES CARE, V35, P2055, DOI 10.2337/dc11-2531; Anaka O, 2014, OBSTET GYNECOL, V123, p38S, DOI 10.1097/01.AOG.0000447315.90086.64; ARTAL R, 1984, AM J OBSTET GYNECOL, V148, P412, DOI 10.1016/0002-9378(84)90717-8; Brewer N, 2008, DIABETES CARE, V31, P1144, DOI 10.2337/dc07-2374; CARPENTER MW, 1982, AM J OBSTET GYNECOL, V144, P768, DOI 10.1016/0002-9378(82)90349-0; Chamnan P, 2013, DIABETOLOGIA, V56, P1004, DOI 10.1007/s00125-013-2854-8; Claesson R, 2017, PRIM CARE DIABETES, V11, P46, DOI 10.1016/j.pcd.2016.09.002; COUSINS L, 1984, AM J OBSTET GYNECOL, V150, P455, DOI 10.1016/S0002-9378(84)90420-4; Di Angelantonio E, 2014, JAMA-J AM MED ASSOC, V311, P1225, DOI 10.1001/jama.2014.1873; Garner LA, 2014, OBSTET GYNECOL, V123, p52S, DOI 10.1097/01.AOG.0000447343.89639.52; Hughes RCE, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-015-0698-y; Hughes RCE, 2014, DIABETES CARE, V37, P2953, DOI 10.2337/dc14-1312; Kwon SS, 2015, DIABETES RES CLIN PR, V110, P38, DOI 10.1016/j.diabres.2015.07.014; Lowe LP, 2012, DIABETES CARE, V35, P574, DOI 10.2337/dc11-1687; MCFARLAND KF, 1984, OBSTET GYNECOL, V64, P516; Moses RG, 2012, DIABETES RES CLIN PR, V98, P3, DOI 10.1016/j.diabres.2012.05.016; Odsaeter IH, 2016, DIABETOL METAB SYNDR, V8, DOI 10.1186/s13098-016-0168-y; Odsaeter IH, 2015, BMC ENDOCR DISORD, V15, DOI 10.1186/s12902-015-0039-9; Osmundson SS, 2016, AM J PERINAT, V33, P977, DOI 10.1055/s-0036-1581055; PHELPS RL, 1983, AM J OBSTET GYNECOL, V147, P651, DOI 10.1016/0002-9378(83)90443-X; Rajput R, 2012, DIABETES RES CLIN PR, V98, P104, DOI 10.1016/j.diabres.2012.02.018; Renz PB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135989; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; Silbernagel G, 2011, DIABETES CARE, V34, P1355, DOI 10.2337/dc10-2010; Soumya S, 2015, DIABETES TECHNOL THE, V17, P899, DOI 10.1089/dia.2015.0041; Ye M, 2016, DIABETES RES CLIN PR, V114, P43, DOI 10.1016/j.diabres.2016.02.007	27	25	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177563	10.1371/journal.pone.0177563	http://dx.doi.org/10.1371/journal.pone.0177563			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505205	Green Published, Green Submitted, gold			2022-12-26	WOS:000401473500029
J	Smith-Strom, H; Iversen, MM; Igland, J; Ostbye, T; Graue, M; Skeie, S; Wu, B; Rokne, B				Smith-Strom, Hilde; Iversen, Marjolein M.; Igland, Jannicke; Ostbye, Truls; Graue, Marit; Skeie, Svein; Wu, Bei; Rokne, Berit			Severity and duration of diabetic foot ulcer (DFU) before seeking care as predictors of healing time: A retrospective cohort study	PLOS ONE			English	Article							AMPUTATION; DISEASE; CLASSIFICATION; EURODIALE; RISK; ASSOCIATION; INFECTION; ISCHEMIA; EUROPE; RATES	Objectives To investigate whether A) duration of ulcer before start of treatment in specialist health care, and B) severity of ulcer according to University of Texas classification system (UT) at start of treatment (baseline), are independent predictors of healing time. Methods This retrospective cohort study, based on electronic medical record data, included 105 patients from two outpatient clinics in Western Norway with a new diabetic foot ulcer during 2009-2011. The associations of duration of ulcer and ulcer severity with healing time were assessed using cumulative incidence curves and subdistribution hazard ratio estimated using competing risk regression with adjustment for potential confounders. Results Of the 105 participants, 45.7% achieved ulcer healing, 36.2% underwent amputations, 9.5% died before ulcer healing and 8.5% were lost to follow-up. Patients who were referred to specialist health care by a general practitioner >= 52 days after ulcer onset had a 58% (SHR 0.42, CI 0.18-0.98) decreased healing rate compared to patients who were referred earlier, in the adjusted model. High severity (grade 2/3, stage C/D) according to the UT classification system was associated with a decreased healing rate compared to low severity (grade1, stage A/B or grade 2, stage A) with SHR (95% CI) equal to 0.14 (0.05-0.43) after adjustment for referral time and other potential confounders. Conclusion Early detection and referral by both the patient and general practitioner are crucial for optimal foot ulcer healing. Ulcer grade and severity are also important predictors for healing time, and early screening to assess the severity and initiation of prompt treatment is important.	[Smith-Strom, Hilde; Iversen, Marjolein M.; Igland, Jannicke; Graue, Marit; Rokne, Berit] Western Norway Univ Appl Sci, Ctr Evidence Based Practice, Dept Hlth & Social Sci, Bergen, Norway; [Smith-Strom, Hilde; Igland, Jannicke] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Iversen, Marjolein M.] Stavanger Univ Hosp, Dept Med, Sect Endocrinol, Stavanger, Norway; [Ostbye, Truls] Duke Univ, Duke Global Hlth Inst, Durham, NC USA; [Skeie, Svein] Stavanger Univ Hosp, Dept Res, Stavanger, Norway; [Wu, Bei] Duke Univ, Duke Sch Nursing, Durham, NC USA; [Wu, Bei] NYU, Rory Meyers Coll Nursing, New York, NY USA	Western Norway University of Applied Sciences; University of Bergen; Stavanger University Hospital; Duke University; Stavanger University Hospital; Duke University; New York University	Smith-Strom, H (corresponding author), Western Norway Univ Appl Sci, Ctr Evidence Based Practice, Dept Hlth & Social Sci, Bergen, Norway.; Smith-Strom, H (corresponding author), Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway.	hss@hvl.no	Wu, Bei/X-2404-2019	Wu, Bei/0000-0002-6891-244X; Iversen, Marjolein Memelink/0000-0001-9954-171X	Norwegian Research Council [221065]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported from the Norwegian Research Council, project number 221065. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong DG, 1998, DIABETES CARE, V21, P855, DOI 10.2337/diacare.21.5.855; Bakker K, 2012, DIABETES-METAB RES, V28, P225, DOI 10.1002/dmrr.2253; Boulton AJM, 2005, LANCET, V366, P1719, DOI 10.1016/S0140-6736(05)67698-2; Boulton AJM, 2008, DIABETES CARE, V31, P1679, DOI 10.2337/dc08-9021; Brownrigg JRW, 2013, EUR J VASC ENDOVASC, V45, P673, DOI 10.1016/j.ejvs.2013.02.014; Bus S, 2015, DIABETES METABOLISM; Clincal Audit and Registries Management Service, 2016, NAT DIAB FOOT CAR AU; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Game F, 2016, DIABETES-METAB RES, V32, P186, DOI 10.1002/dmrr.2746; Graue M, 2013, SCAND J PRIM HEALTH, V31, P241, DOI 10.3109/02813432.2013.854445; Ince P, 2007, DIABETES CARE, V30, P660, DOI 10.2337/dc06-2043; Lau B., 2009, AM J EPIDEMIOL; Lavery LA, 1997, DIABETIC MED, V14, P46, DOI 10.1002/(SICI)1096-9136(199701)14:1<46::AID-DIA291>3.0.CO;2-T; Margolis DJ, 2002, DIABETES CARE, V25, P1835, DOI 10.2337/diacare.25.10.1835; Ministry of Health and Care Services, 2015, PRIM HLTH CAR SERV T; Monteiro-Soares M, 2012, DIABETES-METAB RES, V28, P574, DOI 10.1002/dmrr.2319; Monteiro-Soares M, 2011, DIABETOLOGIA, V54, P1190, DOI 10.1007/s00125-010-2030-3; National Institute for Health and Care Excellence (NICE), 2019, DIABETIC FOOT PROBLE; Orneholm H, 2015, WOUND REPAIR REGEN, V23, P922, DOI 10.1111/wrr.12328; Oyibo SO, 2001, DIABETES CARE, V24, P84, DOI 10.2337/diacare.24.1.84; Prompers L, 2008, DIABETIC MED, V25, P700, DOI 10.1111/j.1464-5491.2008.02445.x; Prompers L, 2008, DIABETOLOGIA, V51, P747, DOI 10.1007/s00125-008-0940-0; Prompers L, 2007, DIABETOLOGIA, V50, P18, DOI 10.1007/s00125-006-0491-1; Rayman G, 2004, DIABETES CARE, V27, P1892, DOI 10.2337/diacare.27.8.1892; Sanders AP, 2013, DIABETES RES CLIN PR, V102, P105, DOI 10.1016/j.diabres.2013.09.016; van Battum P, 2011, DIABETIC MED, V28, P199, DOI 10.1111/j.1464-5491.2010.03192.x	26	54	55	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177176	10.1371/journal.pone.0177176	http://dx.doi.org/10.1371/journal.pone.0177176			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498862	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314500011
J	Kobayashi, M; Usui-Kawanishi, F; Karasawa, T; Kimura, H; Watanabe, S; Mise, N; Kayama, F; Kasahara, T; Hasebe, N; Takahashi, M				Kobayashi, Motoi; Usui-Kawanishi, Fumitake; Karasawa, Tadayoshi; Kimura, Hiroaki; Watanabe, Sachiko; Mise, Nathan; Kayama, Fujio; Kasahara, Tadashi; Hasebe, Naoyuki; Takahashi, Masafumi			The cardiac glycoside ouabain activates NLRP3 inflammasomes and promotes cardiac inflammation and dysfunction	PLOS ONE			English	Article							MICE DEFICIENT; DIGOXIN; INJURY; INHIBITION; MORTALITY; APOPTOSIS; PROTEIN; ATPASE	Cardiac glycosides such as digoxin are Na+/K+ -ATPase inhibitors that are widely used for the treatment of chronic heart failure and cardiac arrhythmias; however, recent epidemiological studies have suggested a relationship between digoxin treatment and increased mortality. We previously showed that nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing 3 (NLRP3) inflammasomes, which regulate caspase-1-dependent interleukin (IL)-1 beta release, mediate the sterile cardiovascular inflammation. Because the Na+/K+ -ATPase is involved in inflammatory responses, we investigated the role of NLRP3 inflammasomes in the pathophysiology of cardiac glycoside-induced cardiac inflammation and dysfunction. The cardiac glycoside ouabain induced cardiac dysfunction and injury in wild-type mice primed with a low dose of lipopolysaccharide (LPS), although no cardiac dysfunction was observed in mice treated with either ouabain or LPS alone. Ouabain also induced cardiac inflammatory responses, such as macrophage infiltration and IL-d1 beta release, when mice were primed with LPS. These cardiac manifestations were all significantly attenuated in mice deficient in IL-1 beta. Furthermore, deficiency of NLRP3 inflammasome components, NLRP3 and caspase-1, also attenuated ouabain-induced cardiac dysfunction and inflammation. In vitro experiments revealed that ouabain induced NLRP3 inflammasome activation as well as subsequent IL-1 beta release from macrophages, and this activation was mediated by K+ efflux. Our findings demonstrate that cardiac glycosides promote cardiac inflammation and dysfunction through NLRP3 inflammasomes and provide new insights into the mechanisms underlying the adverse effects of cardiac glycosides.	[Kobayashi, Motoi; Usui-Kawanishi, Fumitake; Karasawa, Tadayoshi; Kimura, Hiroaki; Watanabe, Sachiko; Kasahara, Tadashi; Takahashi, Masafumi] Jichi Med Univ, Ctr Mol Med, Div Inflammat Res, Shimotsuke, Tochigi, Japan; [Mise, Nathan; Kayama, Fujio] Jichi Med Univ, Dept Environm & Prevent Med, Shimotsuke, Tochigi, Japan; [Hasebe, Naoyuki] Asahikawa Med Univ, Dept Med, Div Cardiovasc Resp & Neurol, Asahikawa, Hokkaido, Japan	Jichi Medical University; Jichi Medical University; Asahikawa Medical College	Takahashi, M (corresponding author), Jichi Med Univ, Ctr Mol Med, Div Inflammat Res, Shimotsuke, Tochigi, Japan.	masafumi2@jichi.ac.jp	Watanabe, Sachiko/GRE-6723-2022; 名丹, 三瀬/AAD-1036-2021; sachiko, watanabe/AAM-8862-2021; Kimura, Hiroaki/E-3224-2010	Watanabe, Sachiko/0000-0002-6110-9603; sachiko, watanabe/0000-0002-6110-9603; Kimura, Hiroaki/0000-0002-7441-0382; Takahashi, Masafumi/0000-0003-2716-7532; Karasawa, Tadayoshi/0000-0002-6738-2360	Japan Society for the Promotion of Science (JSPS) [15K09146]; MEXT-supported program for the Strategic Foundation at Private Universities [S1311029]; Agency for Medical Research and Development-Core Research for Evolutional Science and Technology (AMED-CREST) [16gm0610012h0103]; Salt Science Research Foundation [1541]; Grants-in-Aid for Scientific Research [16K19544] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT-supported program for the Strategic Foundation at Private Universities; Agency for Medical Research and Development-Core Research for Evolutional Science and Technology (AMED-CREST)(Japan Agency for Medical Research and Development (AMED)); Salt Science Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants from the Japan Society for the Promotion of Science (JSPS) through the Grant-in-Aid for Scientific Research (MT:15K09146), MEXT-supported program for the Strategic Foundation at Private Universities (MT:S1311029), Agency for Medical Research and Development-Core Research for Evolutional Science and Technology (AMED-CREST) (MT:16gm0610012h0103), and the Salt Science Research Foundation (MT:No.1541).; We are grateful to Masako Sakurai, Naoko Sugaya, and Namiko Nakada for technical assistance, Dr. Yoichiro Iwakura (Tokyo University of Science), Dr. Hiroko Tsutui (Hyogo College of Medicine), and Dr. Vishava M. Dixit (Genentech) for providing the IL -1 beta<SUP>-/-</SUP>, NLRP3<SUP>-/-</SUP>, and Casp1<SUP>-/-</SUP> mice, respectively. This study was supported by grants from the Japan Society for the Promotion of Science (JSPS) through the Grant-in-Aid for Scientific Research (MT:15K09146), MEXT-supported program for the Strategic Foundation at Private Universities (MT:S1311029), Agency for Medical Research and Development-Core Research for Evolutional Science and Technology (AMED-CREST) (MT:16gm0610012h0103), and the Salt Science Research Foundation (MT:No.1541).	Ahmed A, 2006, CIRCULATION, V114, P397, DOI 10.1161/CIRCULATIONAHA.106.628347; Horai R, 1998, J EXP MED, V187, P1463, DOI 10.1084/jem.187.9.1463; Kawaguchi M, 2011, CIRCULATION, V123, P594, DOI 10.1161/CIRCULATIONAHA.110.982777; Kobayashi M, 2016, SCI REP-UK, V6, DOI 10.1038/srep26489; Komada T, 2015, SCI REP-UK, V5, DOI 10.1038/srep10901; Komada T, 2014, AM J PATHOL, V184, P1287, DOI 10.1016/j.ajpath.2014.01.014; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Liu LJ, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00382; Mezzaroma E, 2011, P NATL ACAD SCI USA, V108, P19725, DOI 10.1073/pnas.1108586108; Orellana AM, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00010; Takahashi M, 2014, INT HEART J, V55, P101, DOI 10.1536/ihj.13-388; Tsutsui H, 1999, IMMUNITY, V11, P359, DOI 10.1016/S1074-7613(00)80111-9; Usui F, 2015, ARTERIOSCL THROM VAS, V35, P127, DOI 10.1161/ATVBAHA.114.303763; Usui F, 2012, BIOCHEM BIOPH RES CO, V425, P162, DOI 10.1016/j.bbrc.2012.07.058; Washam JB, 2015, LANCET, V385, P2363, DOI 10.1016/S0140-6736(14)61836-5; Whitbeck MG, 2013, EUR HEART J, V34, P1481, DOI 10.1093/eurheartj/ehs348; Xie ZJ, 2002, EUR J BIOCHEM, V269, P2434, DOI 10.1046/j.1432-1033.2002.02910.x; Yajima N, 2008, CIRCULATION, V117, P3079, DOI 10.1161/CIRCULATIONAHA.107.746453; Zhang T, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0254-8; Ziff OJ, 2016, TRENDS CARDIOVAS MED, V26, P585, DOI 10.1016/j.tcm.2016.03.011	22	26	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176676	10.1371/journal.pone.0176676	http://dx.doi.org/10.1371/journal.pone.0176676			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493895	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314300024
J	Madariaga-Venegas, F; Fernandez-Soto, R; Duarte, LF; Suarez, N; Delgadillo, D; Jara, JA; Fernandez-Ramires, R; Urzua, B; Molina-Berrios, A				Madariaga-Venegas, Francisco; Fernandez-Soto, Roberto; Fernanda Duarte, Luisa; Suarez, Nicole; Delgadillo, Daniela; Jara, Jose A.; Fernandez-Ramires, Ricardo; Urzua, Blanca; Molina-Berrios, Alfredo			Characterization of a novel antibiofilm effect of nitric oxide-releasing aspirin (NCX-4040) on Candida albicans isolates from denture stomatitis patients	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; BIOFILM FORMATION; ANTIFUNGAL SUSCEPTIBILITY; FLUCONAZOLE; EPIDEMIOLOGY; INHIBITORS; EFFICACY	Candida albicans biofilms play a key role in denture stomatitis, one of the most common oral pathologies in elderly people. Because biofilms are highly resistant to antifungals, new pharmacological strategies are needed. Aspirin and nitric oxide-donor molecules have both shown antibiofilm effects on C. albicans, making them promising candidates for treatment. In this study, we evaluated the antifungal/antibiofilm effect of a nitric-oxide releasing aspirin (NO-ASA) on C. albicans isolates from denture stomatitis patients in vitro. Disk diffusion assays showed that while NO-ASA had no antifungal effect, the drug potentiated fluconazole inhibition zone diameters, increasing the effect of fluconazole by 20-30% (p<0.05). The effect of NO-ASA on the morphogenesis of C. albicans was evaluated using light microscopy after inducing hyphae formation. For all clinical strains assayed, 125 mu M NO-ASA significantly decreased the number of filamentous cells present (p<0.01). Adhesion to abiotic surfaces, a critical event for biofilm formation, was evaluated in 96-well polystyrene plates using crystal violet assay; 125 mu M NO-ASA significantly inhibited adhesion. Biofilms were observed with scanning electron microscopy (SEM) and quantified using XTT reduction assay. NO-ASA decreased biofilm formation (IC50 ranging from 300 mu M to 700 mu M), consistent with SEM findings of altered biofilm microarchitecture. PGE(2) and carboxy-PTIO ( an NO scavenger) both blocked the antibiofilm effects of NO-ASA, suggesting that the efficacy of NO-ASA may be associated with both inhibition of PGE(2) synthesis and release of NO. NO-ASA is a promising novel antibiofilm agent for treating fluconazole-resistant strains of C. albicans.	[Madariaga-Venegas, Francisco; Fernandez-Soto, Roberto; Fernanda Duarte, Luisa; Suarez, Nicole; Delgadillo, Daniela; Jara, Jose A.; Urzua, Blanca; Molina-Berrios, Alfredo] Univ Chile, Inst Res Dent Sci, Fac Dent, Santiago, Chile; [Fernandez-Ramires, Ricardo] Univ Chile, Dept Pathol & Oral Med, Fac Dent, Santiago, Chile	Universidad de Chile; Universidad de Chile	Molina-Berrios, A (corresponding author), Univ Chile, Inst Res Dent Sci, Fac Dent, Santiago, Chile.	aemolina@u.uchile.cl	Jara, Jose/GQB-5331-2022; Fernández-Ramires, Ricardo/H-3707-2014; Orellana, Blanca Urzúa/K-1856-2014	Orellana, Blanca Urzúa/0000-0003-2443-2580; Duarte Penaloza, Luisa Fernanda/0000-0003-1828-1800; Fernandez-Ramires, Ricardo/0000-0002-6974-2593; Molina-Berrios, Alfredo/0000-0001-8351-3239	Fondo Nacional de Desarrollo Cientffico y Tecnologico, proyecto FONDECYT [11140227]; Vicerrectoria de Investigacion y Desarrollo (VID); Universidad de Chile; project U-INICIA [2014-82383]; project U-redes [URED-2014-007]	Fondo Nacional de Desarrollo Cientffico y Tecnologico, proyecto FONDECYT; Vicerrectoria de Investigacion y Desarrollo (VID); Universidad de Chile; project U-INICIA; project U-redes	This work was supported by Fondo Nacional de Desarrollo Cientffico y Tecnologico, proyecto FONDECYT (grant number 11140227, AMB) (http://www.conicyt.cl/fondecyt/); Vicerrectoria de Investigacion y Desarrollo (VID), Universidad de Chile, project U-INICIA (grant number 2014-82383, AMB) (http://www.uchile.cl/porta/investgacion/5077/presentaci or); and Vicerrectoria de Investigacion y Desarrollo (VID), Universidad de Chile, project U-redes (grant number URED-2014-007, AMB, RFR, JAJ, BU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abdelmegeed E, 2013, J MICROBIOL, V51, P598, DOI 10.1007/s12275-013-3052-6; Al-Bakri AG, 2009, J APPL MICROBIOL, V107, P280, DOI 10.1111/j.1365-2672.2009.04205.x; Alem MAS, 2005, J MED MICROBIOL, V54, P1001, DOI 10.1099/jmm.0.46172-0; Alem MAS, 2004, ANTIMICROB AGENTS CH, V48, P41, DOI 10.1128/AAC.48.1.41-47.2004; Blankenship JR, 2006, CURR OPIN MICROBIOL, V9, P588, DOI 10.1016/j.mib.2006.10.003; Bonilla Rodriguez Y., 2012, REV ODONTOL MEX, V16, P40; Coleman JW, 2001, INT IMMUNOPHARMACOL, V1, P1397, DOI 10.1016/S1567-5769(01)00086-8; Dar-Odeh N.S., 2012, INT ARABIC J ANTIMIC, V2, DOI DOI 10.3823/705; de Quadros AU, 2011, FOLIA MICROBIOL, V56, P349, DOI 10.1007/s12223-011-0049-6; Ells R, 2011, MED MICROBIOL IMMUN, V200, P23, DOI 10.1007/s00430-010-0169-7; Figueiral MH, 2015, OPEN DENT J, V9, P46, DOI 10.2174/1874210601509010046; Finkel J.S., 2011, MICROBIOLOGY, V9, P109, DOI DOI 10.1038/NRMICR02475; Gendreau L, 2011, J PROSTHODONT, V20, P251, DOI 10.1111/j.1532-849X.2011.00698.x; Gleiznys Alvydas, 2015, Stomatologija, V17, P54; Heilman BJ, 2013, J INORG BIOCHEM, V123, P18, DOI 10.1016/j.jinorgbio.2013.02.003; Jardeleza C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092117; Konopka K, 2010, ANTON LEEUW INT J G, V97, P413, DOI 10.1007/s10482-010-9417-5; Lee X, 2013, INT J ODONTOSTOMATOL, V7, P279; Macherla C, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00193; Mishra NN, 2014, BRAZ J INFECT DIS, V18, P287, DOI 10.1016/j.bjid.2013.09.006; Mitchell KF, 2013, ANTIMICROB AGENTS CH, V57, P1918, DOI 10.1128/AAC.02378-12; National Comittee for Clinical Laboratory Standards, 2009, M44A2 NCCLS; Neidrauer M, 2014, J MED MICROBIOL, V63, P203, DOI 10.1099/jmm.0.067322-0; Nett JE, 2014, EXPERT REV ANTI-INFE, V12, P375, DOI 10.1586/14787210.2014.885838; Oliveira MT, 2010, MICRON, V41, P604, DOI 10.1016/j.micron.2010.03.011; Sardi JDO, 2014, REV IBEROAM MICOL, V31, P22, DOI 10.1016/j.riam.2013.09.014; Pereira CA, 2016, DIAGN MICR INFEC DIS, V85, P66, DOI 10.1016/j.diagmicrobio.2016.01.014; Pierce CG, 2008, NAT PROTOC, V3, P1494, DOI 10.1038/nprot.2008.141; Privett BJ, 2010, BIOFOULING, V26, P973, DOI 10.1080/08927014.2010.534552; Redding S, 2009, ORAL SURG ORAL MED O, V107, P669, DOI 10.1016/j.tripleo.2009.01.021; Rosato A, 2016, BIOORGAN MED CHEM, V24, P1002, DOI 10.1016/j.bmc.2016.01.026; Sanchez-Vargas LO, 2013, ARCH ORAL BIOL, V58, P1318, DOI 10.1016/j.archoralbio.2013.06.006; Sanita PV, 2013, OR SURG OR MED OR PA, V116, P562, DOI 10.1016/j.oooo.2013.07.002; Sardi JCO, 2013, J MED MICROBIOL, V62, P10, DOI 10.1099/jmm.0.045054-0; Staniszewska M, 2013, BRAZ J MICROBIOL, V44, P813, DOI 10.1590/S1517-83822013005000056; Tobudic S, 2012, MYCOSES, V55, P199, DOI 10.1111/j.1439-0507.2011.02076.x; Turnbull CM, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-12; Wallace JL, 2002, NAT REV DRUG DISCOV, V1, P375, DOI 10.1038/nrd794; Walraven CJ, 2014, MED MYCOL, V52, P131, DOI 10.1093/mmy/myt007; Yarborough A, 2016, J PROSTHODONT, V25, P288, DOI 10.1111/jopr.12454	40	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176755	10.1371/journal.pone.0176755	http://dx.doi.org/10.1371/journal.pone.0176755			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493889	gold, Green Submitted, Green Published			2022-12-26	WOS:000401314300031
J	Jud, NA; Gandolfo, MA; Iglesias, A; Wilf, P				Jud, Nathan A.; Gandolfo, Maria A.; Iglesias, Ari; Wilf, Peter			Flowering after disaster: Early Danian buckthorn (Rhamnaceae) flowers and leaves from Patagonia	PLOS ONE			English	Article							SP-NOV RHAMNACEAE; LAGUNA DEL HUNCO; SAN JORGE BASIN; EARLY PALEOCENE; SOUTH-AMERICA; SALAMANCA FORMATION; MIDTERTIARY AMBER; PLANT DIVERSITY; FOSSIL FRUITS; RAIN-FOREST	Southern-Hemisphere terrestrial communities from the early Paleocene are poorly known, but recent work on Danian plant fossils from the Salamanca Formation in Chubut Province, Argentina are providing critical data on earliest Paleocene floras. The fossils described here come from a site in the Salamanca Formation dating to ca. 1 million years or less after the end-Cretaceous extinction event; they are the first fossil flowers reported from the Danian of South America, and possible the entire Southern Hemisphere. They are compressions and impressions in flat-laminated light gray shale, and they belong to the family Rhamnaceae (buckthorns). Flowers of Notiantha grandensis gen. et sp. nov. are pentamerous, with distinctly keeled calyx lobes projecting from the hypanthium, clawed and cucullate emarginate petals, antepetalous stamens, and a pentagonal floral disk that fills the hypanthium. Their phylogenetic position was evaluated using a molecular scaffold approach combined with morphological data. Results indicate that the flowers are most like those of extant ziziphoid Rhamnaceae. The associated leaves, assigned to Suessenia grandensis gen. et sp. nov. are simple and ovate, with serrate margins and three acrodromous basal veins. They conform to the distinctive leaves of some extant Rhamnaceae in the ziziphoid and ampelozizyphoid clades. These fossils provide the first unequivocal megafossil evidence of Rhamnaceae in the Southern Hemisphere, demonstrating that Rhamnaceae expanded beyond the tropics by the earliest Paleocene. Given previous reports of rhamnaceous pollen in the late Paleogene and Neogene of Antarctica and southern Australia, this new occurrence increases the possibility of high-latitude dispersal of this family between South America and Australia via Antarctica during the Cenozoic.	[Jud, Nathan A.; Gandolfo, Maria A.] Cornell Univ, Plant Biol Sect, LH Bailey Hortorium, Sch Integrat Plant Sci, Ithaca, NY 14853 USA; [Iglesias, Ari] Univ Nacl Comahue, Inst Invest Biodiversidad & Ambiente INIBIO, CONICET, San Carlos De Bariloche, Rio Negro, Argentina; [Wilf, Peter] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA	Cornell University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional del Comahue; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Jud, NA (corresponding author), Cornell Univ, Plant Biol Sect, LH Bailey Hortorium, Sch Integrat Plant Sci, Ithaca, NY 14853 USA.	nathan.jud@cornell.edu	Jud, Nathan/AAI-2384-2020	Jud, Nathan/0000-0001-6100-9779; Iglesias, Ari/0000-0002-9098-8758	National Science Foundation [DEB-1556136, DEB-0918932, DEB-1556666, DEB-0919071, DEB-0345750]; David and Lucile Packard Foundation; Fulbright Foundation; Direct For Biological Sciences [1556136] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Fulbright Foundation; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funded by National Science Foundation DEB-1556136 to MAG www.nsf.gov, National Science Foundation DEB-0918932 to MAG www.nsf.gov, National Science Foundation DEB-1556666 to NRC and PW www.nsf.gov, National Science Foundation DEB-0919071 to NRC and PW www.nsf.gov, National Science Foundation DEB-0345750 to NRC, PW and MAG www.nsf.gov, David and Lucile Packard Foundation to PW, Fulbright Foundation to MAG.; The authors thank M. Caffa, L. Canessa, K. Johnson, P. Puerta, A. Reznicek, J. Svitko, and many others for assistance in the field and laboratory work. We also thank the Secretaria de Cultura de la Provincia de Chubut, and E. Thomas for facilitating land access. Funding supporting this work came from the National Science Foundation (grants DEB -1556136, DEB-0918932, DEB-1556666, DEB-0919071, and DEB-0345750) and the Fulbright Foundation (MAG).	Aagesen L, 1999, BOT J LINN SOC, V131, P1; Akkiraz MS, 2008, TURK J EARTH SCI, V17, P317; Andreis R.R., 1977, OBRA CENTENARIO MUSE, V4, P77; Andreis RR, 1975, REV ASOCIACION GEOL, V30, P85; [Anonymous], 1992, B MUSEO NACL HIST NA; [Anonymous], 1971, ROZPRAVY USTREDNIHO; [Anonymous], 1925, J HOPKINS U STUD GEO; ARCHANGELSKY S, 1973, Ameghiniana, V10, P339; Archangelsky S., 1986, AMEGHINIANA, V23, P35; AVERDIECK F-R, 1971, Meyniana, V21, P1; Axelrod D.I., 1995, U CALIFORNIA PUBLICA, V139; Axelrod DI, 1985, U CALIFORNIA PUBLICA, V129; Barreda VD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052455; BASINGER JF, 1984, SCIENCE, V224, P511, DOI 10.1126/science.224.4648.511; Bentham G, 1862, GENERA PLANTARUM AD; Berry E.W., 1931, GEOL SURV PROF PAPER, P31; BERRY EDWARD W., 1929, JOHNS HOPKINS UNIV STUD GEOL, V10, P79; Berry EW, 1928, AM J SCI, V16, P39; Berry EW, 1930, REVISION LOWER EOCEN; Berry EW, 1937, J HOPKINS U STUDIES, V12, P33; Berry EW, 1916, LOWER EOCENE FLORAS; Bertels A., 1975, Revista Esp Micropaleont, V7, P429; Blackburn DT, 1994, HIST AUSTR VEGETATIO, P328; Bona P, 2005, J VERTEBR PALEONTOL, V25, P569, DOI 10.1671/0272-4634(2005)025[0569:PAPIOY]2.0.CO;2; Bona P., 2012, AMEGHINIANA, V44, P435; Bonaparte J. F., 1997, Estudios Geologicos (Madrid), V53, P263; Bonaparte JF, 1993, EVOLUTIONARY MONOGRA, V14, P161; BRABENEC B, 1904, ROZPRAVY CESKE AKAD, V2, P1; Brea M, 2005, AMEGHINIANA, V42, P407; Brea M, 2008, ALCHERINGA, V32, P427, DOI 10.1080/03115510802417695; BROWN R, 1814, GEN REMARKS GEOGRAPH; Brown R. W., 1939, J PALEONTOL, V13, P485; BROWN RW, 1962, PALEOCENE FLORA ROCK; Burge DO, 2008, INT J PLANT SCI, V169, P1066, DOI 10.1086/590453; Burge DO, 2011, INT J PLANT SCI, V172, P1137, DOI 10.1086/662028; Buzek C., 1992, J MINERALOGY GEOLOGY, V37, P117; Callmander MW, 2008, ADANSONIA, V30, P151; Calvillo-Canadell L., 2000, THESIS; Calvillo-Canadell L, 2007, AM J BOT, V94, P1658, DOI 10.3732/ajb.94.10.1658; Camacho H., 1967, REV ASOC GEOL ARGENT, V22, P253; CAMACHO H. H., 1954, CONTR CUSHMAN FOUND FORAMINIFERAL RES, V5, P31; Campbell JD, 2002, J ROY SOC NEW ZEAL, V32, P149, DOI 10.1080/03014223.2002.9517687; Carvalho MR, 2013, AM J BOT, V100, P1831, DOI 10.3732/ajb.1200637; Chambers Kenton L., 2015, Journal of the Botanical Research Institute of Texas, V9, P361; Chambers Kenton L., 2014, Journal of the Botanical Research Institute of Texas, V8, P551; Chebli G., 1974, REV ASOC GEOL ARGENT, V29, P311; Chesters K.I.M., 1957, PALAEONTOGR ABT B, V101, P30; CHITALEY S D, 1972, Botanique (Nagpur), V3, P41; Clyde WC, 2014, GEOL SOC AM BULL, V126, P289, DOI 10.1130/B30915.1; Collinson Margaret E., 2012, Abhandlungen der Senckenberg Gesellschaft fur Naturforschung, V570, P1; Collinson ME, 2009, J HUM EVOL, V57, P149, DOI 10.1016/j.jhevol.2009.02.010; Comer EE, 2015, PALAIOS, V30, P553, DOI 10.2110/palo.2014.064; Correa E, 2010, AM J BOT, V97, P71, DOI 10.3732/ajb.0900093; Crepet WL, 2004, AM J BOT, V91, P1666, DOI 10.3732/ajb.91.10.1666; Cronquist A., 1981, INTEGRATED SYSTEM CL; Cuneo NR, 2013, INT J PLANT SCI, V174, P340, DOI 10.1086/668811; CUNNINGHAM WD, 1995, J GEOPHYS RES-SOL EA, V100, P8257, DOI 10.1029/95JB00033; Dong JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140653; Donovan MP, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0012; Dorofeev P.I., 1963, TERTIARY FLORAS W SI; Ettingshausen C., 1869, DENKSCHR K AKAD W MN, V29, P1; Feldmann RM, 1997, J PALEONTOL, V71, P125, DOI 10.1017/S0022336000039019; FERUGLIO E, 1949, YACIMIENTOS PETROLIF, V2, P1; Forasiepi AM, 2003, AMEGHINIANA, V40, P625; Frenguelli J., 1936, BANCO VERDE PASO NIE; Futey MK, 2012, BOT REV, V78, P205, DOI 10.1007/s12229-012-9100-9; Gandolfo MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021084; Gelfo JN, 2007, EARTH ENV SCI T R SO, V98, P127, DOI 10.1017/SI755691007006081; Gelfo JN, 2008, J PALEONTOL, V82, P329, DOI 10.1666/06-099.1; Gelfo JN, 2007, J VERTEBR PALEONTOL, V27, P651, DOI 10.1671/0272-4634(2007)27[651:TCRPMD]2.0.CO;2; Gelfo Javier N., 2001, Geodiversitas, V23, P369; GENTRY AH, 1982, ANN MO BOT GARD, V69, P557, DOI 10.2307/2399084; Goloboff PA, 1998, CLADISTICS, V14, P229, DOI 10.1111/j.1096-0031.1998.tb00336.x; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1; Gregor H. -J., 1978, PALAEONTOGRAPHICA B, V167, P8; Grote PJ, 2007, STUDIES FLORA PLEIST; GULERIA J.S., 1992, PALEOBOTANIST, V39, P303; Gurovich Y, 2008, PALAEONTOLOGY, V51, P1069, DOI 10.1111/j.1475-4983.2008.00805.x; Han M, 2016, SCI CHINA EARTH SCI, V59, P824, DOI 10.1007/s11430-015-5245-9; Hauenschild F, 2016, TAXON, V65, P65, DOI 10.12705/651.5; Hauenschild F, 2016, TAXON, V65, P47, DOI 10.12705/651.4; Henrickson J., 2003, LONDELLIA, V6, P138; Hermsen EJ, 2016, SYST BOT, V41, P316, DOI 10.1600/036364416X691830; Herrera F, 2011, AM J BOT, V98, P2004, DOI 10.3732/ajb.1000461; Hinojosa LF, 2011, GLOBAL ECOL BIOGEOGR, V20, P380, DOI 10.1111/j.1466-8238.2010.00595.x; Iglesias A, 2007, GEOLOGY, V35, P947, DOI 10.1130/G23889A.1; Iglesias A, 2011, BIOL J LINN SOC, V103, P409, DOI 10.1111/j.1095-8312.2011.01657.x; Islam MB, 2006, SYST BOT, V31, P826, DOI 10.1600/036364406779695997; JACCARD A, 1858, B SOC NEUCHATEL SCI, V4, P55; Jansen RK, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-32; JOHNSTON MC, 1974, B TORREY BOT CLUB, V101, P64, DOI 10.2307/2484536; JONES JH, 1980, AM J BOT, V67, P959, DOI 10.2307/2442438; KERSHAW AP, 1976, NEW PHYTOL, V77, P469, DOI 10.1111/j.1469-8137.1976.tb01534.x; Knobloch E, 1976, MIOZANE BLATTERFLORE; Kooyman RM, 2014, AM J BOT, V101, P2121, DOI 10.3732/ajb.1400340; Kovar-Eder J, 2004, EVOLUTION W EURASIAN, P399; KRYSHTOFOVICH A, 1918, J GEOL SOC TOKYO, V25, P25; Kvacek Zlatko, 2000, Sbornik Narodniho Muzea v Praze Rada B Prirodni Vedy, V56, P1; LACROIX C, 1988, AM J BOT, V75, P906, DOI 10.2307/2444011; LANGERON M, 2002, B TRIMEST SOC HIST N, V15, P35; Lawver LA, 2003, PALAEOGEOGR PALAEOCL, V198, P11, DOI 10.1016/S0031-0182(03)00392-4; Le Houerou HN, 1997, J ARID ENVIRON, V37, P619, DOI 10.1006/jare.1997.0315; Legarreta Leonardo, 1994, Ameghiniana, V31, P257; Leon Rolando J. C., 1998, Ecologia Austral, V8, P125; Li XC, 2014, ACTA GEOL SIN-ENGL, V88, P1364, DOI 10.1111/1755-6724.12304; Liu KN, 2015, J SYST EVOL, V53, P252, DOI 10.1111/jse.12136; MacGinitie HD, 1953, CARNEGIE I WASHINGTO, V599; Mai DH, 2000, FUNDSTELLEN EOZANER; Mai Dieter Hans, 2001, Palaeontographica Abteilung B Palaeophytologie, V257, P35; Manchester S. R., 2001, PROC DENVER MUS NAT, V4, P137; Manchester SR, 1999, ANN MO BOT GARD, V86, P472, DOI 10.2307/2666183; Manchester Steven R., 2014, Sbornik Narodniho Muzea v Praze Rada B Prirodni Vedy, V70, P153, DOI 10.14446/AMNP.2014.153; Masiuk V., 1967, REV MUSEO PLATA NUEV, V5, P197; Mason HL, 1942, DISTRIBUTIONAL HIST; Matheos S.D., 2001, REV ASOCIACION ARGEN, V8, P93; Matheos SD, 2005, ACT 16 C GEOL ARG LA, P83; Medan D, 2004, FA GE VAS P, V6, P320; Meier W, 2008, BRITTONIA, V60, P131, DOI 10.1007/s12228-008-9011-6; Mendez I. A., 1966, Revista Soc geol argent, V21, P127; Menke, 1976, GEOLOGISCHES JB, V32; MEYER H., 1997, U CALIFORNIA PUBLICA, V141; Miki S., 1933, YAMASHIRO JPN KYOTO, V14, P1; MIKI SHIGERU, 1937, JAP JOUR BOT, V8, P303; Millan M, 2014, BOT REV, V80, P73, DOI 10.1007/s12229-014-9134-2; Mohr B.A.R., 1990, Proceedings of the Ocean Drilling Program Scientific Results, V113, P595, DOI 10.2973/odp.proc.sr.113.140.1990; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; Nobs M. A., 1963, CARNEGIE I WASHINGTO, P623; Nowicke JW, 1971, NNALS MO BOT GARD, V58, P267; Onstein RE, 2016, J ECOL, V104, P665, DOI 10.1111/1365-2745.12538; Onstein RE, 2015, EVOLUTION, V69, P756, DOI 10.1111/evo.12605; OZAKI K, 1991, B KANAGAWA PREFECTUR; Palazzesi L, 2007, FLORA, V202, P328, DOI 10.1016/j.flora.2006.07.006; Parma SG, 2005, J PALEONTOL, V79, P1072; Pascual R, 2002, ACTA PALAEONTOL POL, V47, P487; PASCUAL R, 1992, NATURE, V356, P704, DOI 10.1038/356704a0; Pascual Rosendo, 2007, Journal of Mammalian Evolution, V14, P75, DOI 10.1007/s10914-007-9039-5; Pennington RT, 2004, PHILOS T R SOC B, V359, P1611, DOI 10.1098/rstb.2004.1532; Peppe DJ, 2011, NEW PHYTOL, V190, P724, DOI 10.1111/j.1469-8137.2010.03615.x; PETRIELLA B.T.P., 1975, ACT 1 C ARG PAL BIOE, V2, P257; Prakash U., 1974, ASPECTS APPRAISAL IN, P306; Pusalkar PK, 2010, NORD J BOT, V28, P49, DOI 10.1111/j.1756-1051.2009.00520.x; Raigemborn María Sol, 2010, Rev. Asoc. Geol. Argent., V67, P239; Ramrez-Arriaga E, PALAEONTOL ELECT, V18, P1; Raniecka-Bobrowska J., 1959, I GEOL BIUL, V130, P159; RAVEN PH, 1974, ANN MO BOT GARD, V61, P539, DOI 10.2307/2395021; RETALLACK GJ, 1992, PALEOBIOLOGY, V18, P383, DOI 10.1017/S0094837300010964; Richardson J. E., 2000, Kew Bulletin, V55, P311, DOI 10.2307/4115645; Richardson JE, 2004, PHILOS T R SOC B, V359, P1495, DOI 10.1098/rstb.2004.1537; Richardson JE, 2000, AM J BOT, V87, P1309, DOI 10.2307/2656724; Servicio Meteorologico Nacional, ATL CLIM, P658; Singh H, 2010, CURR SCI, V001, P98; Smiley C., 1985, LATE CENOZOIC HIST P, V95, P112; SMILEY CHARLES J., 1963, UNIV CALIFORNIA PUBL GEOL SCI, V35, P159; SMITH N, 2004, FLOWERING PLANTS NEO; Springer MS, 2001, P NATL ACAD SCI USA, V98, P6241, DOI 10.1073/pnas.111551998; Sterli J, 2013, J SYST PALAEONTOL, V11, P835, DOI 10.1080/14772019.2012.708674; STUCHLIK L, 1981, Studia Geologica Polonica, V72, P109; Suessenguth K, 1953, NATURLICHEN PFLANZEN, V20d; SUZUKI M, 1982, BOT MAG TOKYO, V95, P281, DOI 10.1007/BF02488539; TIFFNEY BH, 1994, REV PALAEOBOT PALYNO, V82, P299, DOI 10.1016/0034-6667(94)90081-7; Tortosa Roberto D., 1992, Darwiniana (San Isidro), V31, P223; Traverse A, 1955, REPORT INVESTIGATION; Trivedi BS, 1982, J INDIAN BOT SOC, V61, P212; Tsukagoshi M., 1990, JAPAN B MISUNAMI FOS, V17, P71; Udhoji S. G, 1990, CRETACEOUS EVENT STR, P99; Udhoji SG, 1989, REC GEOL SURV INDIA, V122, P214; Watari S1952Dicotyledonous, J FAC SCI U TOKYO SE, V6, P97; *WGCPC, 1978, CHIN MES PLANTS CLAS; Wheeler EA, 2012, IAWA J, V33, P309, DOI 10.1163/22941932-90000096; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Wilf P, 2005, AM NAT, V165, P634, DOI 10.1086/430055; Wilf P, 2003, SCIENCE, V300, P122, DOI 10.1126/science.1080475; Wilf P, 2013, ANNU REV EARTH PL SC, V41, P561, DOI 10.1146/annurev-earth-050212-124217; Wilford G.E., 1994, HIST AUSTR VEGETATIO, P5; ZHILIN SG, 1989, BOT REV, V55, P205, DOI 10.1007/BF02858522; Zuccarini J.G, 1832, ABH MATH PHYS KGL, V1, P287; Zucol AF, 2008, FITOLITOS ESTADO ACT, P149; Zuloaga Fernando O., 2015, Rodriguésia, V66, P989, DOI 10.1590/2175-7860201566405; Zuloaga FO., 1999, MONOGRAPHS SYSTEMATI, V74	180	21	21	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176164	10.1371/journal.pone.0176164	http://dx.doi.org/10.1371/journal.pone.0176164			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489895	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314100016
J	Iqbal, M; Rehan, M; Hong, KS				Iqbal, Muhammad; Rehan, Muhammad; Hong, Keum-Shik			Modeling of inter-neuronal coupling medium and its impact on neuronal synchronization	PLOS ONE			English	Article							PARTICLE SWARM OPTIMIZATION; FITZHUGH-NAGUMO NEURONS; EXTERNAL ELECTRICAL-STIMULATION; PID CONTROLLER; GAP-JUNCTIONS; SYSTEMS; BRAIN; NETWORK; INPUT; COMMUNICATION	In this paper, modeling of the coupling medium between two neurons, the effects of the model parameters on the synchronization of those neurons, and compensation of coupling strength deficiency in synchronization are studied. Our study exploits the inter-neuronal coupling medium and investigates its intrinsic properties in order to get insight into neuronal-information transmittance and, there from, brain-information processing. A novel electrical model of the coupling medium that represents a well-known RLC circuit attributable to the coupling medium's intrinsic resistive, inductive, and capacitive properties is derived. Surprisingly, the integration of such properties reveals the existence of a natural three-term control strategy, referred to in the literature as the proportional integral derivative (PID) controller, which can be responsible for synchronization between two neurons. Consequently, brain-information processing can rely on a large number of PID controllers based on the coupling medium properties responsible for the coherent behavior of neurons in a neural network. Herein, the effects of the coupling model (or natural PID controller) parameters are studied and, further, a supervisory mechanism is proposed that follows a learning and adaptation policy based on the particle swarm optimization algorithm for compensation of the coupling strength deficiency.	[Iqbal, Muhammad] Pakistan Inst Engn & Appl Sci, Dept Comp & Informat Sci, Islamabad, Pakistan; [Rehan, Muhammad] Pakistan Inst Engn & Appl Sci, Dept Elect Engn, Islamabad, Pakistan; [Hong, Keum-Shik] Pusan Natl Univ, Dept Cognomechatron Engn, Busan, South Korea; [Hong, Keum-Shik] Pusan Natl Univ, Sch Mech Engn, Busan, South Korea	Pakistan Institute of Engineering & Applied Science; Pakistan Institute of Engineering & Applied Science; Pusan National University; Pusan National University	Rehan, M (corresponding author), Pakistan Inst Engn & Appl Sci, Dept Elect Engn, Islamabad, Pakistan.	rehanqau@gmail.com	Hong, Keum-Shik/B-9911-2013; Rehan, Muhammad/ABG-5590-2020	Hong, Keum-Shik/0000-0002-8528-4457; Rehan, Muhammad/0000-0002-9908-3971	Higher Education Commission (HEC) of Pakistan; National Research Foundation of Korea under Ministry of Science, ICT and Future Planning, Korea [NRF-2014-R1A2A1A10049727]	Higher Education Commission (HEC) of Pakistan(Higher Education Commission of Pakistan); National Research Foundation of Korea under Ministry of Science, ICT and Future Planning, Korea	This work was supported by Higher Education Commission (HEC) of Pakistan (to MR) and the National Research Foundation of Korea under the auspices of the Ministry of Science, ICT and Future Planning, Korea (grant no. NRF-2014-R1A2A1A10049727 to KSH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarbanel H. D. I., 1996, Physics-Uspekhi, V39, P337, DOI 10.1070/PU1996v039n04ABEH000141; Aqil M, 2012, NEUROIMAGE, V63, P553, DOI 10.1016/j.neuroimage.2012.07.006; Aqil M, 2012, COMMUN NONLINEAR SCI, V17, P1615, DOI 10.1016/j.cnsns.2011.09.028; Bedard C, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.022709; Chang WD, 2010, COMMUN NONLINEAR SCI, V15, P3632, DOI 10.1016/j.cnsns.2010.01.005; Chang WD, 2009, CHAOS SOLITON FRACT, V39, P910, DOI 10.1016/j.chaos.2007.01.064; Deak GO, 2007, NEUROCOMPUTING, V70, P2139, DOI 10.1016/j.neucom.2006.06.008; Dehghani N, 2010, J COMPUT NEUROSCI, V29, P405, DOI 10.1007/s10827-010-0263-2; Di Garbo A, 2007, BIOSYSTEMS, V88, P216, DOI 10.1016/j.biosystems.2006.08.011; Dunin-Barkowski WL, 2002, NEUROCOMPUTING, V44, P381, DOI 10.1016/S0925-2312(02)00385-5; Eberhart RC, 2004, IEEE T EVOLUT COMPUT, V8, P201, DOI 10.1109/tevc.2004.830335; Gaing ZL, 2004, IEEE T ENERGY CONVER, V19, P384, DOI 10.1109/TEC.2003.821821; Gharghory SM, 2012, INT J COMPUT COMMUN, V7, P101, DOI 10.15837/ijccc.2012.1.1426; Gray C M, 1994, J Comput Neurosci, V1, P11, DOI 10.1007/BF00962716; Iqbal M, 2015, CHAOS SOLITON FRACT, V77, P158, DOI 10.1016/j.chaos.2015.05.021; Iqbal M, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/367173; Jobst B, 2010, EPILEPSY RES, V89, P154, DOI 10.1016/j.eplepsyres.2009.08.017; Kassimali A., 2011, STRUCTURAL ANAL, V4th; Knoblauch A, 2005, BIOSYSTEMS, V79, P83, DOI 10.1016/j.biosystems.2004.09.007; Kopell N, 2004, P NATL ACAD SCI USA, V101, P15482, DOI 10.1073/pnas.0406343101; Nguyen LH, 2013, APPL MATH MODEL, V37, P2460, DOI 10.1016/j.apm.2012.06.003; Nguyen LH, 2011, MATH COMPUT SIMULAT, V82, P590, DOI 10.1016/j.matcom.2011.10.005; Limousin P, 2008, NEUROTHERAPEUTICS, V5, P309, DOI 10.1016/j.nurt.2008.01.006; Lv M, 2016, NONLINEAR DYNAM, V85, P1479, DOI 10.1007/s11071-016-2773-6; Lv M, 2016, NEUROCOMPUTING, V205, P375, DOI 10.1016/j.neucom.2016.05.004; Marrazzi AS, 1944, J NEUROPHYSIOL, V7, P83, DOI 10.1152/jn.1944.7.2.83; Mejias JF, 2007, NEUROCOMPUTING, V70, P2026, DOI 10.1016/j.neucom.2006.10.097; Nowotny T, 2008, CHAOS, V18, DOI 10.1063/1.2949925; Pikovsky A., 2003, SYNCHRONIZATION UNIV, V12; Rabinovich MI, 2006, REV MOD PHYS, V78, P1213, DOI 10.1103/RevModPhys.78.1213; Raffone A, 2003, CHAOS, V13, P1090, DOI 10.1063/1.1602211; Rehan M, 2016, CHAOS SOLITON FRACT, V87, P197, DOI 10.1016/j.chaos.2016.04.001; Rehan M, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/230980; Rehan M, 2011, NEUROCOMPUTING, V74, P3296, DOI 10.1016/j.neucom.2011.05.015; Rehan M, 2011, PHYS LETT A, V375, P1666, DOI 10.1016/j.physleta.2011.03.012; Sadiku MN., 2007, ELEMENTS ELECTROMAGN; Schnitzler A, 2005, NAT REV NEUROSCI, V6, P285, DOI 10.1038/nrn1650; Schoppa NE, 2001, NEURON, V31, P639, DOI 10.1016/S0896-6273(01)00389-0; Shin JH, 2010, IEEE T NEURAL NETWOR, V21, P1697, DOI 10.1109/TNN.2010.2050600; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Stephens GJ, 2010, P NATL ACAD SCI USA, V107, P14425, DOI 10.1073/pnas.1008662107; Suykens JAK, 2008, CHAOS, V18, DOI 10.1063/1.2985139; Thompson CJ, 1999, CHAOS SOLITON FRACT, V10, P1825, DOI 10.1016/S0960-0779(98)00131-3; Tsumoto K, 2003, INT J BIFURCAT CHAOS, V13, P653, DOI 10.1142/S0218127403006832; Wang J, 2007, CHAOS SOLITON FRACT, V31, P30, DOI 10.1016/j.chaos.2005.09.006; Wang QY, 2006, PHYS LETT A, V356, P17, DOI 10.1016/j.physleta.2006.03.017; Wang QY, 2008, PHYSICA A, V387, P4404, DOI 10.1016/j.physa.2008.02.067; Wang Y, 2010, NEUROCOMPUTING, V73, P2532, DOI 10.1016/j.neucom.2010.06.006; Xu Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep43452; Zhang T, 2007, CHAOS SOLITON FRACT, V33, P194, DOI 10.1016/j.chaos.2006.01.037	50	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0176986	10.1371/journal.pone.0176986	http://dx.doi.org/10.1371/journal.pone.0176986			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486505	Green Submitted, Green Published, gold			2022-12-26	WOS:000401314000032
J	Kumar, S; Jung, JK; Kim, Y				Kumar, Sunil; Jung, Jin-Kyo; Kim, Yonggyun			Characterization of joining sites of a viral histone H4 on host insect chromosomes	PLOS ONE			English	Article							COTESIA-PLUTELLAE BRACOVIRUS; DIAMONDBACK MOTH; TRANSCRIPTOME ANALYSIS; TRANSIENT EXPRESSION; GENE-EXPRESSION; WASP; POLYDNAVIRUS; PARASITISM; SUPPRESSES; PROTEIN	A viral histone H4 (CpBV-H4) is encoded in a polydnavirus, Cotesia plutellae bracovirus (CpBV). It plays a crucial role in parasitism of an endoparasitoid wasp, C. plutellae, against diamondback moth, Plutella xylostella, by altering host gene expression in an epigenetic mode by its N-terminal tail after joining host nucleosomes. Comparative transcriptomic analysis between parasitized and nonparasitized P. xylostella by RNA-Seq indicated that 1,858 genes were altered at more than two folds in expression levels at late parasitic stage, including 877 up-regulated genes and 981 down-regulated genes. Among parasitic factors altering host gene expression, CpBV-H4 alone explained 16.3% of these expressional changes. To characterize the joining sites of CpBV-H4 on host chromosomes, ChIP-Seq (chromatin immunoprecipitation followed by deep sequencing) was applied to chromatins extracted from parasitized larvae. It identified specific 538 ChIP targets. Joining sites were rich (60.2%) in AT sequence. Almost 40% of ChIP targets included short nucleotide repeat sequences presumably recognizable by transcriptional factors and chromatin remodeling factors. To further validate these CpBV-H4 targets, CpBV-H4 was transiently expressed in nonparasitized host at late larval stage and subjected to ChIP-Seq.Two kinds of ChIP-Seqs shared 51 core joining sites. Common targets were close (within 1 kb) to genes regulated at expression levels by CpBV-H4. However, other host genes not close to CpBV-H4 joining sites were also regulated by CpBV-H4. These results indicate that CpBV-H4 joins specific chromatin regions of P. xylostella and controls about one sixth of the total host genes that were regulated by C. plutellae parasitism in an epigenetic mode.	[Kumar, Sunil; Kim, Yonggyun] Andong Natl Univ, Dept Plant Med, Andong, South Korea; [Jung, Jin-Kyo] Rural Dev Adm, Natl Inst Crop Sci, Dept Cent Area Crop Sci, Div Crop Cultivat & Environm Res, Suwon, South Korea	Andong National University; Rural Development Administration (RDA), Republic of Korea; National Institute of Crop Science	Kim, Y (corresponding author), Andong Natl Univ, Dept Plant Med, Andong, South Korea.	hosanna@anu.ac.kr		Jung, Jin Kyo/0000-0003-3809-1836; Kim, Yonggyun/0000-0002-6840-2167	Agenda Research Grant - Rural Administration Development, Republic of Korea [PJ01182003]	Agenda Research Grant - Rural Administration Development, Republic of Korea	This study was supported by an Agenda Research Grant (Project number: PJ01182003) funded by Rural Administration Development, Republic of Korea.	Ali MR, 2013, COMP BIOCHEM PHYS A, V166, P251, DOI 10.1016/j.cbpa.2013.06.028; Andrew N, 2006, PHYSIOL ENTOMOL, V31, P341, DOI 10.1111/j.1365-3032.2006.00524.x; Armstrong JA, 2002, EMBO J, V21, P5245, DOI 10.1093/emboj/cdf517; Asgari S, 2006, ARCH INSECT BIOCHEM, V61, P146, DOI 10.1002/arch.20109; Bae S, 2004, COMP BIOCHEM PHYS A, V138, P39, DOI 10.1016/j.cbpb.2004.02.018; Bae S, 2009, J INVERTEBR PATHOL, V102, P79, DOI 10.1016/j.jip.2009.06.007; Baxter SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019315; Bezier A, 2009, J INVERTEBR PATHOL, V101, P194, DOI 10.1016/j.jip.2009.04.006; Black JC, 2010, MOL CELL, V40, P736, DOI 10.1016/j.molcel.2010.11.008; Burke GR, 2014, MOL ECOL, V23, P890, DOI 10.1111/mec.12648; Etebari K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-446; Gad W, 2009, INSECT MOL BIOL, V18, P111, DOI 10.1111/j.1365-2583.2009.00860.x; Gad W, 2008, J GEN VIROL, V89, P931, DOI 10.1099/vir.0.83585-0; Hepat R, 2013, J VIROL, V87, P11223, DOI 10.1128/JVI.01759-13; Hepat R, 2013, J INVERTEBR PATHOL, V114, P34, DOI 10.1016/j.jip.2013.05.004; Hepat R, 2012, J INVERTEBR PATHOL, V111, P152, DOI 10.1016/j.jip.2012.07.025; Hepat R, 2011, BIOCHEM BIOPH RES CO, V415, P279, DOI 10.1016/j.bbrc.2011.10.040; Ibrahim AMA, 2006, J INSECT PHYSIOL, V52, P943, DOI 10.1016/j.jinsphys.2006.06.001; Kim E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161661; Kim GS, 2010, J INSECT PHYSIOL, V56, P559, DOI 10.1016/j.jinsphys.2009.11.022; Kim J, 2013, COMP BIOCHEM PHYS A, V166, P60, DOI 10.1016/j.cbpa.2013.04.025; Kim Y, INSECT SCI UNPUB; Kim Yonggyun, 2007, Journal of Asia-Pacific Entomology, V10, P181, DOI 10.1016/S1226-8615(08)60351-9; Kumar S, 2016, J GEN VIROL, V97, P2780, DOI 10.1099/jgv.0.000560; Kwon B, 2010, J INSECT PHYSIOL, V56, P650, DOI 10.1016/j.jinsphys.2010.01.013; Luckhart S, 1996, DEV COMP IMMUNOL, V20, P1, DOI 10.1016/0145-305X(95)00040-Z; Provost B, 2011, INSECT BIOCHEM MOLEC, V41, P582, DOI 10.1016/j.ibmb.2011.03.010; Qi YX, 2015, ARCH INSECT BIOCHEM, V88, P203, DOI 10.1002/arch.21214; Shi M, 2016, INSECT MOL BIOL, V25, P679, DOI 10.1111/imb.12252; Song KH, 2008, J INSECT PHYSIOL, V54, P1271, DOI 10.1016/j.jinsphys.2008.06.010; Strand MR, 2015, VIROLOGY, V479, P393, DOI 10.1016/j.virol.2015.01.018; Strand MR, 2013, CURR OPIN VIROL, V3, P587, DOI 10.1016/j.coviro.2013.06.004; Surakasi VP, 2011, INSECT MOL BIOL, V20, P609, DOI 10.1111/j.1365-2583.2011.01091.x; Webb B.A., 2000, VIRUS TAXONOMY, P253; Webb BA, 1996, ARCH INSECT BIOCH PH, V26, P147	35	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177066	10.1371/journal.pone.0177066	http://dx.doi.org/10.1371/journal.pone.0177066			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486493	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314000041
J	Santra, T; Roche, S; Conlon, N; O'Donovan, N; Crown, J; O'Connor, R; Kolch, W				Santra, Tapesh; Roche, Sandra; Conlon, Neil; O'Donovan, Norma; Crown, John; O'Connor, Robert; Kolch, Walter			Identification of potential new treatment response markers and therapeutic targets using a Gaussian process-based method in lapatinib insensitive breast cancer models	PLOS ONE			English	Article							CELL-LINES; VITAMIN-D; DIFFERENTIAL EXPRESSION; NETWORK RECONSTRUCTION; KINASE INHIBITOR; TIME-SERIES; IN-VITRO; RESISTANCE; CALCITRIOL; RECEPTOR	Molecularly targeted therapeutics hold promise of revolutionizing treatments of advanced malignancies. However, a large number of patients do not respond to these treatments. Here, we take a systems biology approach to understand the molecular mechanisms that prevent breast cancer (BC) cells from responding to lapatinib, a dual kinase inhibitor that targets human epidermal growth factor receptor 2 (HER2) and epidermal growth factor receptor (EGFR). To this end, we analysed temporal gene expression profiles of four BC cell lines, two of which respond and the remaining two do not respond to lapatinib. For this analysis, we developed a Gaussian process based algorithm which can accurately find differentially expressed genes by analysing time course gene expression profiles at a fraction of the computational cost of other state-of-the-art algorithms. Our analysis identified 519 potential genes which are characteristic of lapatinib non-responsiveness in the tested cell lines. Data from the Genomics of Drug Sensitivity in Cancer (GDSC) database suggested that the basal expressions 120 of the above genes correlate with the response of BC cells to HER2 and/or EGFR targeted therapies. We selected 27 genes from the larger panel of 519 genes for experimental verification and 16 of these were successfully validated. Further bioinformatics analysis identified vitamin D receptor (VDR) as a potential target of interest for lapatinib non-responsive BC cells. Experimentally, calcitriol, a commonly used reagent for VDR targeted therapy, in combination with lapatinib additively inhibited proliferation in two HER2 positive cell lines, lapatinib insensitive MDA-MB-453 and lapatinib resistant HCC 1954-L cells.	[Santra, Tapesh; Kolch, Walter] Univ Coll Dublin, Syst Biol Ireland, Dublin, Ireland; [Roche, Sandra; Conlon, Neil; O'Donovan, Norma; Crown, John; O'Connor, Robert] Dublin City Univ, Natl Inst Cellular Biotechnol, Dublin, Ireland; [Crown, John] St Vincents Univ Hosp, Dept Med Oncol, Dublin, Elm Park, Ireland; [Kolch, Walter] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin, Ireland; [Kolch, Walter] Univ Coll Dublin, Sch Med, Dublin, Ireland	University College Dublin; Dublin City University; University College Dublin; Saint Vincent's University Hospital; University College Dublin; University College Dublin	Santra, T (corresponding author), Univ Coll Dublin, Syst Biol Ireland, Dublin, Ireland.	tapesh.santra@ucd.ie	Kolch, Walter/ABF-2102-2021; Admin, SBI/HGB-2738-2022; Roche, Sandra/AAM-9800-2021; Crown, John/AAL-3367-2020	Roche, Sandra/0000-0002-4363-4607; Conlon, Neil/0000-0001-5921-7114; Santra, Tapesh/0000-0003-2242-3189; Crown, John/0000-0002-3125-7613	Science Foundation Ireland [06/CE/B1129]; Irish Cancer Society Collaborative Cancer Research Centre BREAST-PREDICT [CCRC13GAL]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Irish Cancer Society Collaborative Cancer Research Centre BREAST-PREDICT	This work was supported by the Science Foundation Ireland under Grant No. 06/CE/B1129 (CSET) and the Irish Cancer Society Collaborative Cancer Research Centre BREAST-PREDICT (CCRC13GAL).	Batut P, 2013, GENOME RES, V23, P169, DOI 10.1101/gr.139618.112; Beer TM, 2004, CANCER EPIDEM BIOMAR, V13, P2225; Beer TM, 2004, MOL CANCER THER, V3, P373; Blackwell KL, 2010, J CLIN ONCOL, V28, P1124, DOI 10.1200/JCO.2008.21.4437; Bovolenta LA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-405; Brawer Michael K, 2007, Rev Urol, V9, P1; Bryan EJ, 2002, INT J CANCER, V102, P137, DOI 10.1002/ijc.10682; Burris HA, 2005, J CLIN ONCOL, V23, P5305, DOI 10.1200/JCO.2005.16.584; Charlebois DA, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.022713; Creighton CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071158; D'Amato V, 2015, CANCER TREAT REV, V41, P877, DOI 10.1016/j.ctrv.2015.08.001; Docquier F, 2005, CANCER RES, V65, P5112, DOI 10.1158/0008-5472.CAN-03-3498; Donders ART, J CLIN EPIDEMIOLOGY, V59, P1087; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Feldman D, 2014, NAT REV CANCER, V14, P342, DOI 10.1038/nrc3691; Fiorito E, 2013, CHROMOSOMA, V122, P1, DOI 10.1007/s00412-012-0392-7; Pons DG, 2015, FREE RADICAL BIO MED, V86, P67, DOI 10.1016/j.freeradbiomed.2015.04.032; Gajria D, 2011, EXPERT REV ANTICANC, V11, P263, DOI 10.1586/ERA.10.226; Ganesh SK, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-20; Gee JMW, 2009, J PATHOL, V217, P32, DOI 10.1002/path.2430; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Gomez HL, 2008, J CLIN ONCOL, V26, P2999, DOI 10.1200/JCO.2007.14.0590; Grigorov MG, 2011, METHODS MOL BIOL, V719, P153, DOI 10.1007/978-1-61779-027-0_7; Hajian-Tilaki K, 2013, CASP J INTERN MED, V4, P627; Halasz M, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aae0535; Hannesdottir L, 2013, EUR J IMMUNOL, V43, P2718, DOI 10.1002/eji.201242505; Hegde PS, 2007, MOL CANCER THER, V6, P1629, DOI 10.1158/1535-7163.MCT-05-0399; Hejblum BP, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004310; Henjes F, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.16; Hensman J, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-252; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094226; Iglesias-Martinez LF, 2016, SCI REP-UK, V6, DOI 10.1038/srep37140; Kalaitzis AA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-180; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kayano M, 2015, BIOSTATISTICS; Kim J, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-310; Kim S, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-299; Konecny GE, 2006, CANCER RES, V66, P1630, DOI 10.1158/0008-5472.CAN-05-1182; Kurozumi S, 2016, J HUM GENET; Lambert N, 2014, MOL CELL, V54, P887, DOI 10.1016/j.molcel.2014.04.016; Lee YY, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.115; Liang YL, 2005, BIOINFORMATICS, V21, P3009, DOI 10.1093/bioinformatics/bti465; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maheshri N, 2007, ANNU REV BIOPH BIOM, V36, P413, DOI 10.1146/annurev.biophys.36.040306.132705; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; MARTIN A, 1991, IN VITRO CELL DEV B, V27, P183; Mayer IA, 2010, CLIN CANCER RES, V16, P1355, DOI 10.1158/1078-0432.CCR-09-3223; McDermott M, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00040; McDermott MSJ, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-157; Mckay JD, 2009, CANCER EPIDEM BIOMAR, V18, P297, DOI 10.1158/1055-9965.EPI-08-0539; Mi HY, 2009, METHODS MOL BIOL, V563, P123, DOI 10.1007/978-1-60761-175-2_7; Muindi JR, 2002, CLIN PHARMACOL THER, V72, P648, DOI 10.1067/mcp.2002.129305; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; O'Brien NA, 2010, MOL CANCER THER, V9, P1489, DOI 10.1158/1535-7163.MCT-09-1171; O'Neill F, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-41; Okolicsanyi RK, 2015, TUMOR BIOL, V36, P1731, DOI 10.1007/s13277-014-2774-3; Park SH, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0594-z; PATEL SR, 1994, KIDNEY INT, V45, P1020, DOI 10.1038/ki.1994.138; Petralia F, 2015, BIOINFORMATICS, V31, P197, DOI 10.1093/bioinformatics/btv268; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Rohlfs RV, 2014, MOL BIOL EVOL, V31, P201, DOI 10.1093/molbev/mst190; Rosenfeldt MT, 2014, ONCOGENE, V33, P4164, DOI 10.1038/onc.2013.470; Rusnak DW, 2001, MOL CANCER THER, V1, P85; Santos-Martinez N, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-230; Santra T., 2014, FRONTIERS BIOENGINEE, P2; Santra T, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-57; Santra T, 2012, ADV EXP MED BIOL, V736, P59, DOI 10.1007/978-1-4419-7210-1_3; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Segovia-Mendoza M, 2015, J STEROID BIOCHEM, V148, P122, DOI 10.1016/j.jsbmb.2014.12.006; Shapiro IM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002218; Singh JC, 2014, BRIT J CANCER, V111, P1888, DOI 10.1038/bjc.2014.388; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Stewart B, 2014, WORLD CANC REPORT 20; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Szasz A.M., 2016, CROSS VALIDATION SUR; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Thill M, 2012, ANTICANCER RES, V32, P359; Topa H, 2015, BIOINFORMATICS, V31, P1762, DOI 10.1093/bioinformatics/btv014; Uhlenbeck GE, 1930, PHYS REV, V36, P0823, DOI 10.1103/PhysRev.36.823; van der Watt PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027723; Wang YXR, 2014, J THEOR BIOL, V362, P53, DOI 10.1016/j.jtbi.2014.03.040; Yan LH, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-904; Yang WJ, 2013, NUCLEIC ACIDS RES, V41, pD955, DOI 10.1093/nar/gks1111; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhao P, 2012, J BIOL CHEM, V287, P25230, DOI 10.1074/jbc.M112.339465; Zur Hausen H., 2008, INT J CANCER, V122, P15004, DOI [10. 1002/ijc. 23348, DOI 10.1002/IJC.23348, 10.1002/ijc.23348]	89	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177058	10.1371/journal.pone.0177058	http://dx.doi.org/10.1371/journal.pone.0177058			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481952	Green Published, gold, Green Submitted			2022-12-26	WOS:000401313700030
J	Grechowa, I; Horke, S; Wallrath, A; Vahl, CF; Dorweiler, B				Grechowa, Irina; Horke, Sven; Wallrath, Anja; Vahl, Christian-Friedrich; Dorweiler, Bernhard			Human neutrophil elastase induces endothelial cell apoptosis by activating the PERK-CHOP branch of the unfolded protein response	FASEB JOURNAL			English	Article						atherosclerosis; human plaque; endoplasmic reticulum stress	ENDOPLASMIC-RETICULUM STRESS; ACUTE CORONARY SYNDROME; ACUTE MYOCARDIAL-INFARCTION; ATHEROSCLEROTIC PLAQUES; POLYMORPHONUCLEAR NEUTROPHILS; THERAPEUTIC TARGET; OXIDATIVE STRESS; ANGINA-PECTORIS; MECHANISMS; DISEASE	Human neutrophil elastase impacts on atherosclerotic plaque stability by inducing apoptosis in endothelial cells. Our aim was to investigate the proapoptotic mechanism of elastase on endothelial cells and to evaluate the presence of elastase in human plaque material. Human endothelial cells were treated with purified human neutrophil elastase. Apoptosis was assayed by capsase-3/7 activation, TUNEL, and sub-G(1) assay. Activation of unfolded protein response (UPR) effector molecules binding Ig protein, soluble X-binding protein-1, protein kinase RNA-like ER kinase (PERK), and C/EBP-homologous protein (CHOP) was analyzed by RT-PCR, immunocytochemistry, and Western blot. Genetic silencing of CHOP was achieved by small interfering RNA. Elastase induces autophagic-apoptotic forms of endothelial cell death in a time-and dose-dependent manner, in conjunction with a significant increase in phosphorylation/expression of the canonical UPR-activation markers PERK and CHOP. By using CHOP knockdown, we identified CHOP as a key mediator of elastase-induced endothelial cell death. Immunohistochemical analysis of human rupture-prone plaque specimens confirmed the presence of elastase and colocalization with apoptosis. We have demonstrated for the first time that the PERK-CHOP branch of the UPR is causally involved in elastase-induced apoptosis of endothelial cells. Ex vivo analysis of human rupture-prone plaques confirmed the presence of elastase and its colocalization with markers of apoptosis. This novel role of elastase underlines the potential of combined targeting of elastase and endoplasmic reticulum stress in the prevention of plaque progression and cardiovascular events.	[Grechowa, Irina; Wallrath, Anja; Vahl, Christian-Friedrich; Dorweiler, Bernhard] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Div Vasc Surg, Dept Cardiothorac & Vasc Surg, Langenbeckstr 1, D-55131 Mainz, Germany; [Grechowa, Irina; Horke, Sven] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Pharmacol, Mainz, Germany; [Horke, Sven] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Ctr Thrombosis & Hemostasis, Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Dorweiler, B (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Div Vasc Surg, Dept Cardiothorac & Vasc Surg, Langenbeckstr 1, D-55131 Mainz, Germany.	bernhard.dorweiler@unimedizin-mainz.de			Deutsche Forschungsgemeinschaft (DFG) [DO1289/6-1]; German Federal Ministry for Education and Research [BMBF 01EO1003]; University Medical Center, University of Mainz	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); University Medical Center, University of Mainz	The authors thank Wolfram Ruf (Center of Thrombosis Research, University Medical Center Mainz) for providing the PAR-2 blocking antibody. This work contains parts of the doctoral thesis of I.G. This research was supported by Deutsche Forschungsgemeinschaft (DFG) Grant DO1289/6-1, German Federal Ministry for Education and Research Grant BMBF 01EO1003, and intramural funds from the University Medical Center, University of Mainz. The authors declare no conflicts of interest.	Ahamed J, 2006, P NATL ACAD SCI USA, V103, P13932, DOI 10.1073/pnas.0606411103; Alberelli MA, 2014, VASC PHARMACOL, V62, P72, DOI 10.1016/j.vph.2014.06.001; Baetta R, 2010, ATHEROSCLEROSIS, V210, P1, DOI 10.1016/j.atherosclerosis.2009.10.028; Barnes JA, 2004, MOL CELL BIOCHEM, V263, P227, DOI 10.1023/B:MCBI.0000041864.14092.5b; Bentzon JF, 2014, CIRC RES, V114, P1852, DOI 10.1161/CIRCRESAHA.114.302721; Carbone F, 2015, CURR DRUG TARGETS, V16, P321, DOI 10.2174/1389450115666141110093013; Carbone F, 2013, THROMB HAEMOSTASIS, V110, P501, DOI 10.1160/TH13-03-0211; Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI [10.1056/NEJMra1205406, 10.1056/NEJMc1303158]; De Meyer GRY, 2015, CIRC RES, V116, P468, DOI 10.1161/CIRCRESAHA.116.303804; Della Bona R, 2013, INFLAMM RES, V62, P537, DOI 10.1007/s00011-013-0617-0; Dickhout JG, 2007, CIRCULATION, V116, P1214, DOI 10.1161/CIRCULATIONAHA.107.728378; DINERMAN JL, 1990, J AM COLL CARDIOL, V15, P1559, DOI 10.1016/0735-1097(90)92826-N; Dollery CM, 2003, CIRCULATION, V107, P2829, DOI 10.1161/01.CIR.0000072792.65250.4A; Dollery CM, 2006, CARDIOVASC RES, V69, P625, DOI 10.1016/j.cardiores.2005.11.003; Dorweiler B, 2006, THROMB HAEMOSTASIS, V95, P182, DOI 10.1160/TH05-05-0357; Dorweiler B, 2014, EUR J VASC ENDOVASC, V48, P248, DOI 10.1016/j.ejvs.2014.06.038; Dorweiler B, 2008, THROMB HAEMOSTASIS, V99, P373, DOI 10.1160/TH07-06-0387; Durand E, 2004, CIRCULATION, V109, P2503, DOI 10.1161/01.CIR.0000130172.62481.90; Engin F, 2010, DIABETES OBES METAB, V12, P108, DOI 10.1111/j.1463-1326.2010.01282.x; Garcia-Touchard A, 2005, ARTERIOSCL THROM VAS, V25, P1119, DOI 10.1161/01.ATV.0000164311.48592.da; Guasti L, 2011, THROMB HAEMOSTASIS, V106, P591, DOI 10.1160/TH11-02-0096; Henriksen PA, 2008, INT J BIOCHEM CELL B, V40, P1095, DOI 10.1016/j.biocel.2008.01.004; Horke S, 2007, CIRCULATION, V115, P2055, DOI 10.1161/CIRCULATIONAHA.106.681700; Hotamisligil GS, 2010, NAT MED, V16, P396, DOI 10.1038/nm0410-396; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; Intermountain Heart Collaborative Study Group, 2005, J AM COLL CARDIOL, V45, P1638; Ionita MG, 2010, ARTERIOSCL THROM VAS, V30, P1842, DOI 10.1161/ATVBAHA.110.209296; Jacobi J, 2006, AM J PHYSIOL-HEART C, V290, pH2051, DOI 10.1152/ajpheart.01040.2005; Jerke U, 2015, KIDNEY INT, V88, P764, DOI 10.1038/ki.2015.159; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kolattukudy PE, 2012, CIRC RES, V110, P174, DOI 10.1161/CIRCRESAHA.111.243212; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Leger AJ, 2006, CIRCULATION, V114, P1070, DOI 10.1161/CIRCULATIONAHA.105.574830; Lindstedt KA, 2004, ARTERIOSCL THROM VAS, V24, P2205, DOI 10.1161/01.ATV.0000149753.74793.88; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Mangold A, 2015, CIRC RES, V116, P1182, DOI 10.1161/CIRCRESAHA.116.304944; Marino F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124565; Mattart L, 2012, CELL SIGNAL, V24, P199, DOI 10.1016/j.cellsig.2011.09.002; McAlpine CS, 2012, ARTERIOSCL THROM VAS, V32, P82, DOI 10.1161/ATVBAHA.111.237941; Mihara K, 2013, J BIOL CHEM, V288, P32979, DOI 10.1074/jbc.M113.483123; Minamino T, 2010, CIRC RES, V107, P1071, DOI 10.1161/CIRCRESAHA.110.227819; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Muller C, 2011, CELL DEATH DIFFER, V18, P817, DOI 10.1038/cdd.2010.149; Myoishi M, 2007, CIRCULATION, V116, P1226, DOI 10.1161/CIRCULATIONAHA.106.682054; Naruko T, 2002, CIRCULATION, V106, P2894, DOI 10.1161/01.CIR.0000042674.89762.20; Preston GA, 2002, J AM SOC NEPHROL, V13, P2840, DOI 10.1097/01.ASN.0000034911.03334.C3; Ramachandran R, 2008, BRIT J PHARMACOL, V153, pS263, DOI 10.1038/sj.bjp.0707507; Ramachandran R, 2011, J BIOL CHEM, V286, P24638, DOI 10.1074/jbc.M110.201988; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Rotzius P, 2010, AM J PATHOL, V177, P493, DOI 10.2353/ajpath.2010.090480; Roy A, 2012, CELL SIGNAL, V24, P2123, DOI 10.1016/j.cellsig.2012.07.014; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Scull CM, 2011, ARTERIOSCL THROM VAS, V31, P2792, DOI 10.1161/ATVBAHA.111.224881; Smith FB, 2000, EUR HEART J, V21, P1607, DOI 10.1053/euhj.2000.2127; Soehnlein O, 2012, CIRC RES, V110, P875, DOI 10.1161/CIRCRESAHA.111.257535; Suzuki T, 2005, AM J RESP CELL MOL, V33, P231, DOI 10.1165/rcmb.2005-0109OC; Suzuki T, 2009, AM J RESP CELL MOL, V41, P742, DOI 10.1165/rcmb.2008-0157OC; Tabas I, 2015, J CELL BIOL, V209, P13, DOI 10.1083/jcb.201412052; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tabas I, 2010, CIRC RES, V107, P839, DOI 10.1161/CIRCRESAHA.110.224766; Thorp E, 2009, CELL METAB, V9, P474, DOI 10.1016/j.cmet.2009.03.003; Tsukano H, 2010, ARTERIOSCL THROM VAS, V30, P1925, DOI 10.1161/ATVBAHA.110.206094; Tull SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043916; Weber C, 2008, NAT REV IMMUNOL, V8, P802, DOI 10.1038/nri2415; Witte I, 2011, METHOD ENZYMOL, V489, P127, DOI 10.1016/B978-0-12-385116-1.00008-X; Yang JJ, 1996, AM J PATHOL, V149, P1617; Yvan-Charvet L, 2008, CIRCULATION, V118, P1837, DOI 10.1161/CIRCULATIONAHA.108.793869; Zernecke A, 2008, CIRC RES, V102, P209, DOI 10.1161/CIRCRESAHA.107.160697	70	31	32	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					3868	3881		10.1096/fj.201700012R	http://dx.doi.org/10.1096/fj.201700012R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28507169				2022-12-26	WOS:000408713300014
J	Lajczak, NK; Saint-Criq, V; O'Dwyer, AM; Perino, A; Adorini, L; Schoonjans, K; Keely, SJ				Lajczak, Natalia K.; Saint-Criq, Vinciane; O'Dwyer, Aoife M.; Perino, Alessia; Adorini, Luciano; Schoonjans, Kristina; Keely, Stephen J.			Bile acids deoxycholic acid and ursodeoxycholic acid differentially regulate human beta-defensin-1 and-2 secretion by colonic epithelial cells	FASEB JOURNAL			English	Article						HbD; UDCA; epithelium; innate immunity	NF-KAPPA-B; INFLAMMATORY-BOWEL-DISEASE; HUMAN BETA-DEFENSINS; INTESTINAL EPITHELIUM; EXPERIMENTAL COLITIS; ADAPTIVE IMMUNITY; GENE-EXPRESSION; GUT MICROBIOTA; CANCER CELLS; IN-VITRO	Bile acids and epithelial-derived human beta-defensins (H beta Ds) are known to be important factors in the regulation of colonic mucosal barrier function and inflammation. We hypothesized that bile acids regulate colonic H beta D expression and aimed to test this by investigating the effects of deoxycholic acid (DCA) and ursodeoxycholic acid on the expression and release of H beta D1 and H beta D2 from colonic epithelial cells and mucosal tissues. DCA (10-150 mu M) stimulated the release of both H beta D1 and H beta D2 from epithelial cell monolayers and human colonic mucosal tissue in vitro. In contrast, ursodeoxycholic acid (50-200 mu M) inhibited both basal and DCA-induced defensin release. Effects of DCA were mimicked by the Takeda GPCR 5 agonist, INT-777 (50 mu M), but not by the farnesoid X receptor agonist, GW4064 (10 mu M). INT-777 also stimulated colonic H beta D1 and H beta D2 release from wild-type, but not Takeda GPCR 5(-/-), mice. DCA stimulated phosphorylation of the p65 subunit of NF-kappa B, an effect that was attenuated by ursodeoxycholic acid, whereas an NF-kappa B inhibitor, BMS-345541 (25 mu M), inhibited DCA-induced H beta D2, but not H beta D1, release. We conclude that bile acids can differentially regulate colonic epithelial H beta D expression and secretion and discuss the implications of our findings for intestinal health and disease.	[Lajczak, Natalia K.; Saint-Criq, Vinciane; O'Dwyer, Aoife M.; Keely, Stephen J.] Beaumont Hosp, Educ & Res Ctr, Royal Coll Surg Ireland, Dept Mol Med, Dublin, Ireland; [Perino, Alessia; Schoonjans, Kristina] Ecole Polytech Fed Lausanne, Lausanne, Switzerland; [Adorini, Luciano] Intercept Pharmaceut, San Diego, CA USA	Royal College of Surgeons - Ireland; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Intercept Pharmaceuticals	Keely, SJ (corresponding author), Beaumont Hosp, Royal Coll Surg Ireland, Dept Mol Med, Smurfit Bldg, Dublin 9, Ireland.	skeely@rcsi.ie	Adorini, Luciano/AAE-5149-2020; Saint-Criq, Vinciane/A-6602-2010	Saint-Criq, Vinciane/0000-0003-0042-3735; Lajczak-Mc Ginley, Natalia/0000-0002-1277-0761; Schoonjans, Kristina/0000-0003-1247-4265	Science Foundation Ireland Principal Investigator Award [10/IN.1/B2983]; Crohn's and Colitis Foundation of America Senior Researcher Award [354322]	Science Foundation Ireland Principal Investigator Award(Science Foundation Ireland); Crohn's and Colitis Foundation of America Senior Researcher Award	This work was supported by a Science Foundation Ireland Principal Investigator Award (10/IN.1/B2983) and a Crohn's and Colitis Foundation of America Senior Researcher Award (354322; to S.J.K.).	Antoni Lena, 2013, J Crohns Colitis, V7, pe652, DOI 10.1016/j.crohns.2013.05.006; Bajaj JS, 2016, ALIMENT PHARM THER, V43, P11, DOI 10.1111/apt.13435; Barrasa JI, 2013, TOXICOL IN VITRO, V27, P964, DOI 10.1016/j.tiv.2012.12.020; Bevins CL, 2013, DIGEST DIS, V31, P299, DOI 10.1159/000354681; Boniotto M, 2006, ANTIMICROB AGENTS CH, V50, P1433, DOI 10.1128/AAC.50.4.1433-1441.2006; Burke JR, 2003, J BIOL CHEM, V278, P1450, DOI 10.1074/jbc.M209677200; Cobo ER, 2013, PATHOGENS, V2, P177, DOI 10.3390/pathogens2010177; Feng YB, 2009, J ETHNOBIOL ETHNOMED, V5, DOI 10.1186/1746-4269-5-2; Gersemann M, 2012, J INTERN MED, V271, P421, DOI 10.1111/j.1365-2796.2012.02515.x; Ghosh SK, 2011, INFECT IMMUN, V79, P4578, DOI 10.1128/IAI.05586-11; Guo CL, 2015, INT J ANAL CHEM, V2015, DOI 10.1155/2015/912631; Hamilton JP, 2007, AM J PHYSIOL-GASTR L, V293, pG256, DOI 10.1152/ajpgi.00027.2007; Harder Juergen, 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P75, DOI 10.2174/187153007780832091; Hazlett L, 2011, CELL TISSUE RES, V343, P175, DOI 10.1007/s00441-010-1022-4; Hofmann AF, 2009, FRONT BIOSCI-LANDMRK, V14, P2584, DOI 10.2741/3399; Joyce SA, 2016, ANNU REV FOOD SCI T, V7, P313, DOI 10.1146/annurev-food-041715-033159; Kanda N, 2011, J LEUKOCYTE BIOL, V89, P935, DOI 10.1189/jlb.0111004; Keating Niamh, 2009, Curr Gastroenterol Rep, V11, P375; Kelly CJ, 2013, MUCOSAL IMMUNOL, V6, P1110, DOI 10.1038/mi.2013.6; Kiilerich P, 2016, AM J PHYSIOL-ENDOC M, V310, pE886, DOI 10.1152/ajpendo.00363.2015; Kim YS, 2010, J ENDODONT, V36, P64, DOI 10.1016/j.joen.2009.09.022; Klag T, 2013, DIGEST DIS, V31, P310, DOI 10.1159/000354858; Kliewer SA, 2015, DIGEST DIS, V33, P327, DOI 10.1159/000371670; Laukens D, 2014, LAB INVEST, V94, P1419, DOI 10.1038/labinvest.2014.117; Lee HY, 2010, INT J ONCOL, V36, P941, DOI 10.3892/ijo_00000573; Lewis SB, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00068; Martinez-Moya P, 2013, INT IMMUNOPHARMACOL, V15, P372, DOI 10.1016/j.intimp.2012.11.017; Muhlbauer M, 2004, AM J PHYSIOL-GASTR L, V286, pG1000, DOI 10.1152/ajpgi.00338.2003; Nehra V, 2016, PHYSIOLOGY, V31, P327, DOI 10.1152/physiol.00005.2016; Niyonsaba F, 2016, CLIN EXP ALLERGY, V46, P1522, DOI 10.1111/cea.12843; O'Neil DA, 1999, J IMMUNOL, V163, P6718; Oliver KM, 2009, ANTIOXID REDOX SIGN, V11, P2057, DOI [10.1089/ars.2008.2400, 10.1089/ARS.2008.2400]; Otte JM, 2008, J CELL BIOCHEM, V104, P2286, DOI 10.1002/jcb.21787; Perino A, 2015, TRENDS PHARMACOL SCI, V36, P847, DOI 10.1016/j.tips.2015.08.002; Poupon R, 2012, CLIN RES HEPATOL GAS, V36, pS3, DOI 10.1016/S2210-7401(12)70015-3; Ridlon JM, 2014, CURR OPIN GASTROEN, V30, P332, DOI 10.1097/MOG.0000000000000057; Salzman NH, 2010, GUT MICROBES, V1, P401, DOI 10.4161/gmic.1.6.14076; Schroeder BO, 2012, Z GASTROENTEROL, V50, P1171, DOI 10.1055/s-0032-1312865; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Shant J, 2009, EXP CELL RES, V315, P432, DOI 10.1016/j.yexcr.2008.11.003; Stenman LK, 2013, AM J PHYSIOL-GASTR L, V304, pG227, DOI 10.1152/ajpgi.00267.2012; Subramanian H, 2013, J IMMUNOL, V191, P345, DOI 10.4049/jimmunol.1300023; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Vang Sheila, 2014, Glob Adv Health Med, V3, P58, DOI 10.7453/gahmj.2014.017; Vavassori P, 2009, J IMMUNOL, V183, P6251, DOI 10.4049/jimmunol.0803978; Vongsa RA, 2009, J BIOL CHEM, V284, P10034, DOI 10.1074/jbc.M805289200; Wang YD, 2011, HEPATOLOGY, V54, P1421, DOI 10.1002/hep.24525; Ward JBJ, 2017, AM J PHYSIOL-GASTR L, V312, pG550, DOI 10.1152/ajpgi.00256.2016; WEBER K, 1969, J BIOL CHEM, V244, P4406; Wehkamp J, 2002, EUR J GASTROEN HEPAT, V14, P745, DOI 10.1097/00042737-200207000-00006; Wehkamp J, 2009, GASTROEN CLIN BIOL, V33, pS137, DOI 10.1016/S0399-8320(09)73149-5; Weiss GA, 2017, CELL MOL LIFE SCI, V74, P2959, DOI 10.1007/s00018-017-2509-x; Wilson SS, 2013, J MOL BIOL, V425, P4965, DOI 10.1016/j.jmb.2013.09.038; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yang D, 2007, CURR PHARM DESIGN, V13, P3131, DOI 10.2174/138161207782110453; Yoneno K, 2013, IMMUNOLOGY, V139, P19, DOI 10.1111/imm.12045; Zhang KY, 2015, CELL MICROBIOL, V17, P1561, DOI 10.1111/cmi.12501; Zilbauer M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015389	58	16	16	3	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					3848	3857		10.1096/fj.201601365R	http://dx.doi.org/10.1096/fj.201601365R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28487283				2022-12-26	WOS:000408713300012
J	Schoepflin, ZR; Silagi, ES; Shapiro, IM; Risbud, MV				Schoepflin, Zachary R.; Silagi, Elizabeth S.; Shapiro, Irving M.; Risbud, Makarand V.			PHD3 is a transcriptional coactivator of HIF-1 alpha in nucleus pulposus cells independent of the PKM2-JMJD5 axis	FASEB JOURNAL			English	Article						intervertebral disc; hypoxia; skeletal tissue; transcription factor	PYRUVATE-KINASE M2; NF-KAPPA-B; FACTOR-I; GENE-EXPRESSION; HYPOXIA; CANCER; HYDROXYLATION; PROMOTES; PKM2; INHIBITION	The role of prolyl hydroxylase (PHD)-3 as a hypoxia inducible factor (HIF)-1 alpha cofactor is controversial and remains unknown in skeletal tissues. We investigated whether PHD3 controls HIF-1 transcriptional activity in nucleus pulposus (NP) cells through the pyruvate kinase muscle (PKM)-2-Jumonji domain-containing protein (JMJD5) axis. PHD3(-/-) mice (12.5 mo old) showed increased incidence of intervertebral disc degeneration with a concomitant decrease in expression of the HIF-1 alpha targets VEGF-A, glucose transporter-1, and lactate dehydrogenase A. PHD3 silencing decreased hypoxic activation of HIF-1 alpha C-terminal transactivation domain (C-TAD), but not HIF1 alpha-N-terminal-(N)-TAD or HIF-2 alpha-TAD. Moreover, PHD3 suppression in NP cells resulted in decreased HIF-1 alpha enrichment on target promoters and lower expression of select HIF-1 targets. Contrary to other cell types, manipulation of PKM2 and JMJD5 levels had no effect on HIF-1 activity in NP cells. Likewise, stabilization of tetrameric PKM2 by a chemical approach had no effect on PHD3-dependent HIF-1 activity. Coimmunoprecipitation assays showed lack of association between HIF-1 alpha and PKM2 in NP cells. Results support the role of the PHD3 as a cofactor for HIF-1, independent of PKM2-JMJD5.	[Schoepflin, Zachary R.; Silagi, Elizabeth S.; Shapiro, Irving M.; Risbud, Makarand V.] Thomas Jefferson Univ, Dept Orthopaed Surg, Coll Bldg,Suite 511,1025 Walnut St, Philadelphia, PA 19107 USA	Jefferson University	Risbud, MV (corresponding author), Thomas Jefferson Univ, Dept Orthopaed Surg, Coll Bldg,Suite 511,1025 Walnut St, Philadelphia, PA 19107 USA.	makarand.risbud@jefferson.edu			U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01AR05565, R01AR064733, F30AR066506, T32AR052273]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064733, R01AR055655, F30AR066506, T32AR052273] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases Grants R01AR05565, R01AR064733, F30AR066506 (to Z.R.S.), and T32AR052273 (to E.S.S.). The authors declare no conflicts of interest.	Agrawal A, 2007, AM J PHYSIOL-CELL PH, V293, pC621, DOI 10.1152/ajpcell.00538.2006; Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; Azoitei N, 2016, MOL CANCER, V15, DOI 10.1186/s12943-015-0490-2; Bedore J, 2013, ARTHRITIS RHEUM-US, V65, P2634, DOI 10.1002/art.38075; Bishop T, 2008, MOL CELL BIOL, V28, P3386, DOI 10.1128/MCB.02041-07; Chen S, 2016, LAB INVEST, V96, P561, DOI 10.1038/labinvest.2016.32; Chen Y, 2015, J BIOL CHEM, V290, P20580, DOI 10.1074/jbc.M115.653584; Coimbra IB, 2004, OSTEOARTHR CARTILAGE, V12, P336, DOI 10.1016/j.joca.2003.12.005; Dayan F, 2006, CANCER RES, V66, P3688, DOI 10.1158/0008-5472.CAN-05-4564; de Wit RH, 2016, ONCOTARGET, V7, P67966, DOI 10.18632/oncotarget.11817; Fu J, 2013, MOL CELL BIOL, V33, P3050, DOI 10.1128/MCB.00273-13; Fujita N, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.375964; Fujita N, 2012, J BIOL CHEM, V287, P16975, DOI 10.1074/jbc.M111.334466; Fujita N, 2012, J BONE MINER RES, V27, P401, DOI 10.1002/jbmr.538; Giannoni E, 2015, ONCOTARGET, V6, P24061, DOI 10.18632/oncotarget.4448; GOLDRING MB, 1994, J CLIN INVEST, V94, P2307, DOI 10.1172/JCI117595; Greer SN, 2012, EMBO J, V31, P2448, DOI 10.1038/emboj.2012.125; Hassett G, 2003, ARTHRITIS RHEUM, V48, P3112, DOI 10.1002/art.11321; Henze AT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6582; Hirose Y, 2014, J BIOL CHEM, V289, P20594, DOI 10.1074/jbc.M114.565101; Hosios AM, 2015, MOL CELL, V59, P850, DOI 10.1016/j.molcel.2015.07.013; Iqbal MA, 2014, FEBS LETT, V588, P2685, DOI 10.1016/j.febslet.2014.04.011; Israelsen WJ, 2015, SEMIN CELL DEV BIOL, V43, P43, DOI 10.1016/j.semcdb.2015.08.004; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang BH, 1997, J BIOL CHEM, V272, P19253, DOI 10.1074/jbc.272.31.19253; Johansen JL, 2010, J NEUROCHEM, V115, P209, DOI 10.1111/j.1471-4159.2010.06917.x; Kim DJ, 2015, MOL CELLS, V38, P373, DOI 10.14348/molcells.2015.2314; Li J, 2015, J BIOL CHEM, V290, P7195, DOI 10.1074/jbc.M114.611483; Lincet H, 2015, ONCOGENE, V34, P3751, DOI 10.1038/onc.2014.320; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Merceron C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110768; Moser SC, 2013, DEV CELL, V26, P381, DOI 10.1016/j.devcel.2013.06.014; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Nunez-O'Mara A, 2015, J CELL SCI, V128, P40, DOI 10.1242/jcs.151514; Palsson-McDermott EM, 2015, CELL METAB, V21, P65, DOI [10.1016/j.cmet.2014.12.005, 10.1016/j.cmet.2015.01.017]; Provot S, 2007, J CELL BIOL, V177, P451, DOI 10.1083/jcb.200612023; Rajpurohit R, 2002, CELL TISSUE RES, V308, P401, DOI 10.1007/s00441-002-0563-6; Risbud MV, 2015, J ORTHOP RES, V33, P283, DOI 10.1002/jor.22789; Risbud MV, 2010, AM J PATHOL, V176, P1577, DOI 10.2353/ajpath.2010.090734; Risbud MV, 2006, J CELL BIOCHEM, V98, P152, DOI 10.1002/jcb.20765; Rodriguez J, 2016, CELL REP, V14, P2745, DOI 10.1016/j.celrep.2016.02.043; Scaal M, 2016, SEMIN CELL DEV BIOL, V49, P83, DOI 10.1016/j.semcdb.2015.11.003; Schipani E, 2001, GENE DEV, V15, P2865; Schoepflin ZR, 2016, J BONE MINER RES, V31, P1287, DOI 10.1002/jbmr.2787; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Swain L, 2014, J LEUKOCYTE BIOL, V96, P365, DOI 10.1189/jlb.2HI1013-533R; THOMPSON JP, 1990, SPINE, V15, P411, DOI 10.1097/00007632-199005000-00012; Wang HJ, 2014, P NATL ACAD SCI USA, V111, P279, DOI 10.1073/pnas.1311249111; Xie L, 2015, J CLIN INVEST, V125, P2759, DOI 10.1172/JCI80369; Xie L, 2012, J CLIN INVEST, V122, P2827, DOI 10.1172/JCI62374; Yang LC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5436; Yu ZH, 2013, J BIOL CHEM, V288, P35406, DOI 10.1074/jbc.M113.508226; Zheng XN, 2014, GENE DEV, V28, P1429, DOI 10.1101/gad.242131.114	53	16	17	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					3831	3847		10.1096/fj.201601291R	http://dx.doi.org/10.1096/fj.201601291R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28495754	Green Published			2022-12-26	WOS:000408713300011
J	Marulanda, J; Eimar, H; Mckee, MD; Berkvens, M; Nelea, V; Roman, H; Borras, T; Tamimi, F; Ferron, M; Murshed, M				Marulanda, Juliana; Eimar, Hazem; Mckee, Marc D.; Berkvens, Michelle; Nelea, Valentin; Roman, Hassem; Borras, Teresa; Tamimi, Faleh; Ferron, Mathieu; Murshed, Monzur			Matrix Gla protein deficiency impairs nasal septum growth, causing midface hypoplasia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPHENO-OCCIPITAL SYNCHONDROSIS; KEUTEL-SYNDROME; MOUSE MODEL; PFEIFFER SYNDROME; MUENKE SYNDROME; CRANIAL BASE; MUTATIONS; CARTILAGE; CALCIFICATION; GENE	Genetic and environmental factors may lead to abnormal growth of the orofacial skeleton, affecting the overall structure of the face. In this study, we investigated the craniofacial abnormalities in a mouse model for Keutel syndrome, a rare genetic disease caused by loss-of-function mutations in the matrix Gla protein (MGP) gene. Keutel syndrome patients show diffuse ectopic calcification of cartilaginous tissues and impaired midface development. Our comparative cephalometric analyses of micro-computed tomography images revealed a severe midface hypoplasia in Mgp(-/-) mice. In vivo reporter studies demonstrated that the Mgp promoter is highly active at the cranial sutures, cranial base synchondroses, and nasal septum. Interestingly, the cranial sutures of the mutant mice showed normal anatomical features. Although we observed a mild increase in mineralization of the spheno-occipital synchondrosis, it did not reduce the relative length of the cranial base in comparison with total skull length. Contrary to this, we found the nasal septum to be abnormally mineralized and shortened in Mgp(-/-) mice. Transgenic restoration of Mgp expression in chondrocytes fully corrected the craniofacial anomalies caused byMGPdeficiency, suggesting a local role for MGP in the developing nasal septum. Although there was no up-regulation of markers for hypertrophic chondrocytes, aTUNELassay showed a marked increase in apoptotic chondrocytes in the calcified nasal septum. Transmission electron microscopy confirmed unusual mineral deposits in the septal extracellular matrix of the mutant mice. Of note, the systemic reduction of the inorganic phosphate level was sufficient to prevent abnormal mineralization of the nasal septum in Mgp(-/-); Hyp compound mutants. Our work provides evidence that modulation of local and systemic factors regulating extracellular matrix mineralization can be possible therapeutic strategies to prevent ectopic cartilage calcification and some forms of congenital craniofacial anomalies in humans.	[Marulanda, Juliana; Eimar, Hazem; Mckee, Marc D.; Berkvens, Michelle; Nelea, Valentin; Tamimi, Faleh; Murshed, Monzur] McGill Univ, Fac Dent, Montreal, PQ H3A 1G1, Canada; [Mckee, Marc D.; Roman, Hassem] McGill Univ, Fac Med, Dept Anat & Cell Biol, Montreal, PQ H3A 0C7, Canada; [Roman, Hassem; Murshed, Monzur] McGill Univ, Dept Med, Div Expt Med, Montreal, PQ H4A 3J1, Canada; [Borras, Teresa] Univ N Carolina, Sch Med, Dept Ophthalmol, Chapel Hill, NC 27516 USA; [Ferron, Mathieu] Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Murshed, Monzur] Shriners Hosp Children, 1003 Blvd Decarie, Montreal, PQ H4A 0A9, Canada	McGill University; McGill University; McGill University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; McGill University	Murshed, M (corresponding author), Shriners Hosp Children, 1003 Blvd Decarie, Montreal, PQ H4A 0A9, Canada.	monzur.murshed@mcgill.ca	McKee, Marc D/E-2187-2011	McKee, Marc D/0000-0001-8349-965X; Tamimi, Faleh/0000-0002-4618-8374	Le Reseau de Recherche en Sante Buccodentaire et Osseuse; NATIONAL EYE INSTITUTE [R01EY026220, R01EY013126] Funding Source: NIH RePORTER	Le Reseau de Recherche en Sante Buccodentaire et Osseuse; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Dr. Gerard Karsenty for critical reading of the manuscript. We also thank Mia Esser, Louise Marineau, and Maude Danis Ladouceur for animal husbandry. The core facility for skeletal phenotyping was supported by Le Reseau de Recherche en Sante Buccodentaire et Osseuse.	Al Dayeh AA, 2013, AM J ORTHOD DENTOFAC, V143, P773, DOI 10.1016/j.ajodo.2013.01.012; Anderson H Clarke, 2003, Curr Rheumatol Rep, V5, P222, DOI 10.1007/s11926-003-0071-z; Ayyildiz P., 2012, Firat Tip Dergisi, V17, P167; Borras T, 2015, INVEST OPHTH VIS SCI, V56, P2203, DOI 10.1167/iovs.15-16460; Chokdeemboon C, 2013, J CRANIOFAC SURG, V24, P150, DOI 10.1097/SCS.0b013e3182646454; Cielo CM, 2015, PAEDIATR RESPIR REV, V16, P189, DOI 10.1016/j.prrv.2014.11.003; COPRAY JCVM, 1986, J ANAT, V144, P99; DELAIRE J, 1986, CLEFT PALATE J, V23, P270; Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0; EICHER EM, 1976, P NATL ACAD SCI USA, V73, P4667, DOI 10.1073/pnas.73.12.4667; Eimar H, 2016, J DENT RES, V95, P761, DOI 10.1177/0022034516637045; Forte AJ, 2014, PLAST RECONSTR SURG, V134, P285, DOI 10.1097/PRS.0000000000000360; Goldstein JA, 2014, PLAST RECONSTR SURG, V134, P504, DOI 10.1097/PRS.0000000000000419; Golub EE, 2009, BBA-GEN SUBJECTS, V1790, P1592, DOI 10.1016/j.bbagen.2009.09.006; Hall BK, 2013, OR SURG OR MED OR PA, V115, P442, DOI 10.1016/j.oooo.2012.05.005; Hayano S, 2015, DEVELOPMENT, V142, P1357, DOI 10.1242/dev.118802; Ho AM, 2000, SCIENCE, V289, P265, DOI 10.1126/science.289.5477.265; Hur DJ, 2005, AM J MED GENET A, V135A, P36, DOI 10.1002/ajmg.a.30680; Khavandgar Z, 2014, J BONE MINER RES, V29, P327, DOI 10.1002/jbmr.2039; KVINNSLAND S, 1974, ANGLE ORTHOD, V44, P135; Laurita J, 2011, DEV DYNAM, V240, P2584, DOI 10.1002/dvdy.22752; Lee ER, 2009, DEV DYNAM, V238, P1547, DOI 10.1002/dvdy.21960; Lefebvre M, 2015, PRENATAL DIAG, V35, P675, DOI 10.1002/pd.4591; LUO GB, 1995, J BONE MINER RES, V10, P325; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Mansfield K, 1999, J CELL PHYSIOL, V179, P276, DOI 10.1002/(SICI)1097-4652(199906)179:3<276::AID-JCP5>3.0.CO;2-#; Martelli H, 2008, PEDIATR DENT, V30, P464; Marulanda J, 2014, CURR PHARM DESIGN, V20, P5801, DOI 10.2174/1381612820666140212205848; Mehndiratta S, 2010, ARCH GYNECOL OBSTET, V282, P335, DOI 10.1007/s00404-010-1369-5; Meier M, 2001, EUR RESPIR J, V17, P566, DOI 10.1183/09031936.01.17305660; MOSS ML, 1968, PLAST RECONSTR SURG, V41, P536, DOI 10.1097/00006534-196806000-00004; Munroe PB, 1999, NAT GENET, V21, P142, DOI 10.1038/5102; Murshed M, 2004, J CELL BIOL, V165, P625, DOI 10.1083/jcb.200402046; Murshed M, 2005, GENE DEV, V19, P1093, DOI 10.1101/gad.1276205; Nah HD, 2012, CHILD NERV SYST, V28, P1483, DOI 10.1007/s00381-012-1778-9; O'Young J, 2011, J AM CHEM SOC, V133, P18406, DOI 10.1021/ja207628k; Okawa A, 1998, NAT GENET, V19, P271, DOI 10.1038/956; Palhazi P, 2015, AESTHET SURG J, V35, P242, DOI 10.1093/asj/sju079; Paliga JT, 2014, J CRANIOFAC SURG, V25, P202, DOI 10.1097/SCS.0000000000000386; Patel N, 2015, PLAST RECONSTR SURG, V135, p731E, DOI 10.1097/PRS.0000000000001062; Rosenberg P, 1997, PLAST RECONSTR SURG, V99, P1396, DOI 10.1097/00006534-199704001-00030; Sarnat B. G., 1967, ACTA OTO-LARYNGOL, V63, P467; SCOTT J. H., 1956, AMER JOUR ORTHODONT, V42, P381, DOI 10.1016/0002-9416(56)90165-8; Starling LD, 2012, BMJ CASE REP, V2012; Tie JK, 2016, J THROMB HAEMOST, V14, P236, DOI 10.1111/jth.13217; Tie JK, 2016, BLOOD, V127, P1847, DOI 10.1182/blood-2015-10-677633; Wang Y, 2015, J PEDIATR-US, V166, P819, DOI 10.1016/j.jpeds.2014.12.025; Watzka M, 2014, THROMB RES, V134, P856, DOI 10.1016/j.thromres.2014.07.004; Weaver KN, 2014, AM J MED GENET A, V164, P1062, DOI 10.1002/ajmg.a.36390; WHO RMo C. A, 2000, GLOB REG DAT CRAN AN; Wong KK, 2010, LARYNGOSCOPE, V120, P450, DOI 10.1002/lary.20769; Zebboudj AF, 2002, J BIOL CHEM, V277, P4388, DOI 10.1074/jbc.M109683200	52	20	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11400	11412		10.1074/jbc.M116.769802	http://dx.doi.org/10.1074/jbc.M116.769802			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28487368	Green Published, hybrid			2022-12-26	WOS:000405119600023
J	Joshi, KK; Sutherland, M; Chien, P				Joshi, Kamal Kishore; Sutherland, Madeleine; Chien, Peter			Cargo engagement protects protease adaptors from degradation in a substrate-specific manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL-CELL CYCLE; AAA PLUS PROTEASE; REGULATED PROTEOLYSIS; BACILLUS-SUBTILIS; CAULOBACTER-CRESCENTUS; PROTEINS; CLPXP; PHOSPHORYLATION; PROGRESSION; DELIVERY	Protein degradation in bacteria is a highly controlled process involving proteolytic adaptors that regulate protein degradation during cell cycle progression or during stress responses. Many adaptors work as scaffolds that selectively bind cargo and tether substrates to their cognate proteases to promote substrate destruction, whereas others primarily activate the target protease. Because adaptors must bind their cognate protease, all adaptors run the risk of being recognized by the protease as substrates themselves, a process that could limit their effectiveness. Here we use purified proteins in a reconstituted system and in vivo studies to show that adaptors of the ClpXP protease are readily degraded but that cargo binding inhibits this degradation. We found that this principle extends across several adaptor systems, including the hierarchical adaptors that drive the Caulobacter bacterial cell cycle and the quality control adaptor SspB. We also found that the ability of a cargo to protect its adaptor is adaptor substrate-specific, as adaptors with artificial degradation tags were not protected even though cargo binding is unaffected. Our work points to an optimization of inherent adaptor degradation and cargo binding that ensures that robust adaptor activity is maintained when high amounts of substrate must be delivered and that adaptors can be eliminated when their tasks have been completed.	[Joshi, Kamal Kishore; Sutherland, Madeleine; Chien, Peter] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Joshi, Kamal Kishore; Chien, Peter] Univ Massachusetts, Mol & Cellular Biol Grad Program, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Chien, P (corresponding author), Univ Massachusetts, Mol & Cellular Biol Grad Program, Dept Biochem & Mol Biol, 240 Thatcher Rd,N325, Amherst, MA 01003 USA.	pchien@biochem.umass.edu	Joshi, Kamal/AFF-8135-2022	Sutherland, Madeleine/0000-0003-4099-9085; Joshi, Kamal Kishore/0000-0001-5816-6888	National Institutes of Health [R01GM111706]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111706] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported in part by National Institutes of Health Grant R01GM111706 (to P. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abel S, 2011, MOL CELL, V43, P550, DOI 10.1016/j.molcel.2011.07.018; Ades SE, 2004, CURR BIOL, V14, pR924, DOI 10.1016/j.cub.2004.10.015; Battesti A, 2013, CURR OPIN MICROBIOL, V16, P140, DOI 10.1016/j.mib.2013.01.002; Bhat NH, 2013, MOL MICROBIOL, V88, P1083, DOI 10.1111/mmi.12241; Bougdour A, 2006, GENE DEV, V20, P884, DOI 10.1101/gad.1400306; Chan CM, 2014, MOL MICROBIOL, V93, P426, DOI 10.1111/mmi.12671; Chien P, 2007, STRUCTURE, V15, P1296, DOI 10.1016/j.str.2007.08.008; Chien P, 2007, P NATL ACAD SCI USA, V104, P6590, DOI 10.1073/pnas.0701776104; Collier J, 2016, CURR OPIN MICROBIOL, V30, P107, DOI 10.1016/j.mib.2016.01.010; Curtis PD, 2010, MICROBIOL MOL BIOL R, V74, P13, DOI 10.1128/MMBR.00040-09; Davis J. J., 2010, THESIS; Domian IJ, 1997, CELL, V90, P415, DOI 10.1016/S0092-8674(00)80502-4; Dougan DA, 2003, MOL CELL, V12, P373, DOI 10.1016/j.molcel.2003.08.012; Duerig A, 2009, GENE DEV, V23, P93, DOI 10.1101/gad.502409; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Griffith KL, 2008, MOL MICROBIOL, V70, P1012, DOI 10.1111/j.1365-2958.2008.06467.x; Iniesta AA, 2008, P NATL ACAD SCI USA, V105, P16602, DOI 10.1073/pnas.0808807105; Iniesta AA, 2006, P NATL ACAD SCI USA, V103, P10935, DOI 10.1073/pnas.0604554103; Joshi KK, 2016, ANNU REV GENET, V50, P423, DOI 10.1146/annurev-genet-120215-035235; Joshi KK, 2015, CELL, V163, P419, DOI 10.1016/j.cell.2015.09.030; Karradt A, 2008, J BIOL CHEM, V283, P32394, DOI 10.1074/jbc.M805823200; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Kirstein J, 2009, NAT REV MICROBIOL, V7, P589, DOI 10.1038/nrmicro2185; Lau J, 2015, MOL CELL, V59, P104, DOI 10.1016/j.molcel.2015.05.014; Levchenko I, 2003, MOL CELL, V12, P365, DOI 10.1016/j.molcel.2003.08.014; Mei ZQ, 2009, J BIOL CHEM, V284, P34366, DOI 10.1074/jbc.M109.053017; Roman-Hernandez G, 2011, MOL CELL, V43, P217, DOI 10.1016/j.molcel.2011.06.009; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Sendersky E, 2014, PLANT J, V79, P118, DOI 10.1111/tpj.12543; Skerker JM, 2005, PLOS BIOL, V3, P1770, DOI 10.1371/journal.pbio.0030334; Smith SC, 2014, P NATL ACAD SCI USA, V111, P14229, DOI 10.1073/pnas.1407862111; Turgay K, 1998, EMBO J, V17, P6730; Zhou YN, 2001, GENE DEV, V15, P627, DOI 10.1101/gad.864401	34	3	3	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					10973	10982		10.1074/jbc.M117.786392	http://dx.doi.org/10.1074/jbc.M117.786392			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28507098	hybrid, Green Published			2022-12-26	WOS:000404391000019
J	Gupta, S; Kesarla, R; Chotai, N; Omri, A				Gupta, Shweta; Kesarla, Rajesh; Chotai, Narendra; Omri, Abdelwahab			Development and validation of reversed-phase HPLC gradient method for the estimation of efavirenz in plasma	PLOS ONE			English	Article							LIQUID-CHROMATOGRAPHY; TRANSCRIPTASE; INHIBITOR	Efavirenz is an anti-viral agent of non-nucleoside reverse transcriptase inhibitor category used as a part of highly active retroviral therapy for the treatment of infections of human immune deficiency virus type-1. A simple, sensitive and rapid reversed D phase high performance liquid chromatographic gradient method was developed and validated for the determination of efavirenz in plasma. The method was developed with high performance liquid chromatography using Waters X-Terra Shield, RP18 50 x 4.6 mm, 3.5 mu m column and a mobile phase consisting of phosphate buffer pH 3.5 and Acetonitrile. The elute was monitored with the UV-Visible detector at 260 nm with a flow rate of 1.5 mL/min. Tenofovir disoproxil fumarate was used as internal standard. The method was validated for linearity, precision, accuracy, specificity, robustness and data obtained were statistically analyzed. Calibration curve was found to be linear over the concentration range of 1-300 mu g/mL. The retention times of efavirenz and tenofovir disoproxil fumarate (internal standard) were 5.941 min and 4.356 min respectively. The regression coefficient value was found to be 0.999. The limit of detection and the limit of quantification obtained were 0.03 and 0.1 mu g/mL respectively. The developed HPLC method can be useful for quantitative pharmacokinetic parameters determination of efavirenz in plasma.	[Gupta, Shweta] Parul Univ, Dept Pharmaceut Technol, Vadodara, Gujarat, India; [Kesarla, Rajesh] ISF Coll Pharm, Dept Pharmaceut, Moga, Punjab, India; [Chotai, Narendra] AR Coll Pharm, Dept Pharmaceut, Anand, Gujarat, India; [Omri, Abdelwahab] Laurentian Univ, Dept Chem & Biochem, Sudbury, ON, Canada	Parul University; ISF College of Pharmacy; Laurentian University	Omri, A (corresponding author), Laurentian Univ, Dept Chem & Biochem, Sudbury, ON, Canada.	aomri@laurentian.ca	Omri, Abdelwahab/G-3172-2010; Gupta, Shweta/AGK-3210-2022	Omri, Abdelwahab/0000-0002-4093-5762; Gupta, Shweta/0000-0001-9519-6744	M/s Sun Pharma Ltd.	M/s Sun Pharma Ltd.	This study was materially supported by M/s Sun Pharma Ltd. Sikkim and Paradise Healthcare, Vadodara, India, which provided samples of EFV and TDF, respectively. The infrastructural facilities required for carrying out the experiments were provided by Parul University, India. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors received no other specific funding for this study.	Cundy KC, 1997, ANTIVIR RES, V35, P113, DOI 10.1016/S0166-3542(97)00022-3; Guideline ICH, 2005, GUIDELINE ICH VALIDA, V1, P5; Gunthard HF, 2016, J AM MED ASS, V316; Gupta S, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/5984014; Hamrapurkar P, 2009, J YOUNG PHARM, V1, P359, DOI 10.4103/0975-1483.59328; Heydari R, 2014, CURR ANAL CHEM, V10, P280, DOI 10.2174/15734110113099990003; Kadam AA, 2012, AM J PHARMTECH RES, V2, P324; Kamble RN, 2015, INT J PHARM PHARM SC, V7, P153; Kappelhoff BS, 2003, J CHROMATOGR B, V792, P353, DOI 10.1016/S1570-0232(03)00325-8; Langmann P, 2001, J CHROMATOGR B, V755, P151, DOI 10.1016/S0378-4347(01)00059-7; Marzolini C, 2001, AIDS, V15, P71, DOI 10.1097/00002030-200101050-00011; Ramachandran G, 2006, J CHROMATOGR B, V835, P131, DOI 10.1016/j.jchromb.2006.03.014; Ramaswamy A., 2014, ARAB J CHEM; Ravikumar K, 2009, MOL CRYST LIQ CRYST, V515, P190, DOI 10.1080/15421400903291434; Reddy N.P., 2015, INT, V4, P390, DOI [10.3329/icpj.v4i6.23290, DOI 10.3329/ICPJ.V4I6.23290]; Sailaja AL, 2007, CHROMATOGRAPHIA, V65, P359, DOI 10.1365/s10337-006-0170-x; Sarasa-Nacenta M, 2001, J CHROMATOGR B, V763, P53, DOI 10.1016/S0378-4347(01)00357-7; Veldkamp AI, 1999, J CHROMATOGR B, V734, P55, DOI 10.1016/S0378-4347(99)00336-9	18	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0174777	10.1371/journal.pone.0174777	http://dx.doi.org/10.1371/journal.pone.0174777			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505168	Green Published, Green Submitted, gold			2022-12-26	WOS:000401473500003
J	Lin, SH; Chung, PH; Wu, YY; Fung, CP; Hsu, CM; Chen, LW				Lin, Shu-Han; Chung, Pei-Hsuan; Wu, Ying-Ying; Fung, Chang-Phone; Hsu, Ching-Mei; Chen, Lee-Wei			Inhibition of nitric oxide production reverses diabetes-induced Kupffer cell activation and Klebsiella pneumonia liver translocation	PLOS ONE			English	Article							INTESTINAL BACTERIAL OVERGROWTH; HEPATIC INFLAMMATION; IMMUNE-RESPONSE; ENDOTOXEMIA; INJURY; MOUSE; MODEL; RATS; GUT; DYSFUNCTION	Klebsiella pneumoniae (KP) is the most common pathogen of pyogenic liver abscess in East and Southeast Asia and diabetes mellitus (DM) is a major risk factor. The effect and mechanism of diabetes on KP liver abscess was examined in streptozotocin-induced diabetic mice and Akita mice (C57BL/6J-Ins2(Akita)). KP translocation to liver and plasma alaine transaminase levels were increased and liver clearance of KP was decreased in DM mice. Diabetic mice exhibited overgrowth of Enterococcus as well as E. coli and decreased lactobacilli/bifidas growth in intestine, increased intestinal iNOS protein and nitrite levels in portal vein, and increased IL-1 beta and TNF-alpha expression of Kupffer cells. Fructooligosaccharides (FOS) or dead L. salivarius (dLac) supplementation reversed diabetes-induced enteric dysbiosis, NO levels in portal vein, and KP translocation to liver. L-NAME treatment decreased intestinal iNOS protein expression as well as Kupffer cell activation and increased liver clearance of KP in DM mice. Dead E. coli (2x10(8) CFU/ml) feeding for one week induced iNOS and TLR4 expression of intestine in germ-free (GF) mice. Dead bacteria feeding induced IL-1 beta and TNF-alpha expression of Kupffer cells in GF mice but not in GF TLR4(-/-) mice. In conclusion, balance of intestinal microflora is important for preventing intestinal iNOS expression, Kupffer cell activation, and KP liver translocation in diabetes. Reversal of diabetes-induced enteric dysbiosis with FOS or dead L. salivarius decreases diabetes-induced intestinal iNOS expression and KP liver translocation. Diabetes induces Kupffer cell activation and KP liver translocation through enteric dysbiosis and nitric oxide production.	[Lin, Shu-Han; Fung, Chang-Phone; Chen, Lee-Wei] Natl Yang Ming Univ, Inst Emergency & Crit Care Med, Taipei, Taiwan; [Lin, Shu-Han] Natl Taiwan Univ Hosp, Dept Nursing, Taipei, Taiwan; [Chung, Pei-Hsuan; Hsu, Ching-Mei] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung, Taiwan; [Wu, Ying-Ying; Chen, Lee-Wei] Kaohsiung Vet Gen Hosp, Dept Surg, Kaohsiung, Taiwan; [Fung, Chang-Phone] Taipei Vet Gen Hosp, Div Infect Dis, Dept Med, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital; National Sun Yat Sen University; Kaohsiung Veterans General Hospital; Taipei Veterans General Hospital	Chen, LW (corresponding author), Natl Yang Ming Univ, Inst Emergency & Crit Care Med, Taipei, Taiwan.; Chen, LW (corresponding author), Kaohsiung Vet Gen Hosp, Dept Surg, Kaohsiung, Taiwan.	lwchen@vghks.gov.tw		Chen, Lee-Wei/0000-0002-3583-1248	National Science Council [NSC101-2314-B-010-005-MY3]; Kaohsiung Veterans General Hospital [VGHKS100-055]	National Science Council(Ministry of Science and Technology, Taiwan); Kaohsiung Veterans General Hospital	National Science Council (NSC101-2314-B-010-005-MY3) Kaohsiung Veterans General Hospital (VGHKS100-055).	Alican I, 1996, AM J PHYSIOL-GASTR L, V270, pG225, DOI 10.1152/ajpgi.1996.270.2.G225; Ashare A, 2006, AM J RESP CRIT CARE, V173, P644, DOI 10.1164/rccm.200509-1470OC; Barber AJ, 2005, INVEST OPHTH VIS SCI, V46, P2210, DOI 10.1167/iovs.04-1340; Bauer TM, 2002, AM J GASTROENTEROL, V97, P2364; Cesaro C, 2011, DIGEST LIVER DIS, V43, P431, DOI 10.1016/j.dld.2010.10.015; Chung PH, 2016, J NUTR BIOCHEM, V35, P48, DOI 10.1016/j.jnutbio.2016.05.013; El Kasmi KC, 2012, HEPATOLOGY, V55, P1518, DOI 10.1002/hep.25500; Fung CP, 2011, LAB INVEST, V91, P1029, DOI 10.1038/labinvest.2011.52; GUARNER C, 1993, HEPATOLOGY, V18, P1139; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Hunninghake GW, 2010, AM J RESP CRIT CARE, V182, P517, DOI 10.1164/rccm.200911-1757OC; Jun DW, 2010, DIGEST DIS SCI, V55, P1465, DOI 10.1007/s10620-009-0870-9; LICHTMAN SN, 1990, GASTROENTEROLOGY, V98, P414, DOI 10.1016/0016-5085(90)90833-M; Lin YC, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-50; Matsuguchi T, 2000, J IMMUNOL, V165, P5767, DOI 10.4049/jimmunol.165.10.5767; Meyer-Hoffert U, 2008, GUT, V57, P764, DOI 10.1136/gut.2007.141481; Miura K, 2010, GASTROENTEROLOGY, V139, P323, DOI 10.1053/j.gastro.2010.03.052; Momozawa Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016952; Moro G, 2002, J PEDIATR GASTR NUTR, V34, P291, DOI 10.1097/00005176-200203000-00014; Mutlu E, 2009, ALCOHOL CLIN EXP RES, V33, P1836, DOI 10.1111/j.1530-0277.2009.01022.x; Nemzek JA, 2004, SHOCK, V21, P17, DOI 10.1097/01.shk.0000101667.49265.fd; PARKS DA, 1983, SURGERY, V94, P415; Sakai N, 2012, HEPATOLOGY, V55, P888, DOI 10.1002/hep.24756; Seki E, 2012, J PHYSIOL-LONDON, V590, P447, DOI 10.1113/jphysiol.2011.219691; Sierra S, 2010, ANAEROBE, V16, P195, DOI 10.1016/j.anaerobe.2010.02.001; Szabo G, 2007, SEMIN LIVER DIS, V27, P339, DOI 10.1055/s-2007-991511; Szabo G, 2006, HEPATOLOGY, V44, P287, DOI 10.1002/hep.21308; Tang YM, 2009, ALCOHOL CLIN EXP RES, V33, P1220, DOI 10.1111/j.1530-0277.2009.00946.x; Unno N, 1997, GASTROENTEROLOGY, V113, P1246, DOI 10.1053/gast.1997.v113.pm9322519; Wang JH, 1998, CLIN INFECT DIS, V26, P1434, DOI 10.1086/516369; Yan AW, 2012, WORLD J HEPATOL, V4, P110, DOI 10.4254/wjh.v4.i4.110	31	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177269	10.1371/journal.pone.0177269	http://dx.doi.org/10.1371/journal.pone.0177269			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493939	gold, Green Published, Green Submitted			2022-12-26	WOS:000401314300079
J	Livingstone, M; Wheelhouse, N; Ensor, H; Rocchi, M; Maley, S; Aitchison, K; Wattegedera, S; Wilson, K; Sait, M; Siarkou, V; Vretou, E; Entrican, G; Dagleish, M; Longbottom, D				Livingstone, Morag; Wheelhouse, Nicholas; Ensor, Hannah; Rocchi, Mara; Maley, Stephen; Aitchison, Kevin; Wattegedera, Sean; Wilson, Kim; Sait, Michelle; Siarkou, Victoria; Vretou, Evangelia; Entrican, Gary; Dagleish, Mark; Longbottom, David			Pathogenic outcome following experimental infection of sheep with Chlamydia abortus variant strains LLG and POS	PLOS ONE			English	Article							OUTER-MEMBRANE-PROTEIN; CHLAMYDOPHILA-ABORTUS; MONOCLONAL-ANTIBODIES; PLACENTAL TISSUES; GENOME SEQUENCE; PREGNANT SHEEP; PSITTACI; IDENTIFICATION; RESPONSES; REVEALS	This study investigated the pathogenesis of two variant strains (LLG and POS) of Chlamydia abortus, in comparison to a typical wild-type strain (S26/3) which is known to be responsible for late term abortion in small ruminants. Challenge with the three strains at mid-gestation resulted in similar pregnancy outcomes, with abortion occurring in approximately 50-60% of ewes with the mean gestational lengths also being similar. However, differences were observed in the severity of placental pathology, with infection appearing milder for strain LLG, which was reflected in the lower number of organisms shed in vaginal swabs post-partum and less gross pathology and organisms present in placental smears. Results for strain POS were somewhat different than LLG with a more focal restriction of infection observed. Post-abortion antibody responses revealed prominent differences in seropositivity to the major outer membrane protein (MOMP) present in elementary body (EB) preparations under denaturing conditions, most notably with anti-LLG and anti-POS convalescent sera where there was no or reduced detection of MOMP present in EBs derived from the three strains. These results and additional analysis of whole EB and chlamydial outer membrane complex preparations suggest that there are conformational differences in MOMP for the three strains. Overall, the results suggest that gross placental pathology and clinical outcome is not indicative of bacterial colonization and the severity of infection. The results also highlight potential conformational differences in MOMP epitopes that perhaps impact on disease diagnosis and the development of new vaccines.	[Livingstone, Morag; Wheelhouse, Nicholas; Rocchi, Mara; Maley, Stephen; Aitchison, Kevin; Wattegedera, Sean; Wilson, Kim; Sait, Michelle; Entrican, Gary; Dagleish, Mark; Longbottom, David] Moredun Res Inst, Penicuik, Midlothian, Scotland; [Ensor, Hannah] Biomath & Stat Scotland, Edinburgh, Midlothian, Scotland; [Siarkou, Victoria] Aristotle Univ Thessaloniki, Fac Hlth Sci, Sch Vet Med, Lab Microbiol & Infect Dis, Thessaloniki, Greece; [Vretou, Evangelia] Hellenic Pasteur Inst, Dept Microbiol, Formerly Lab Biotechnol, Athens, Greece; [Wheelhouse, Nicholas] Edinburgh Napier Univ, Sch Life Sport & Social Sci, Edinburgh, Midlothian, Scotland; [Wilson, Kim] Univ Edinburgh, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland; [Sait, Michelle] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Microbiol Diagnost Unit, Melbourne, Vic, Australia	Moredun Research Institute; James Hutton Institute; Aristotle University of Thessaloniki; Edinburgh Napier University; University of Edinburgh; University of Melbourne	Longbottom, D (corresponding author), Moredun Res Inst, Penicuik, Midlothian, Scotland.	david.longbottom@moredun.ac.uk	Longbottom, David/GWZ-8448-2022	Longbottom, David/0000-0003-0086-8443; Sait, Michelle/0000-0001-8782-6128; Ensor, Hannah/0000-0003-3052-7287	Rural and Environment Science and Analytical Services Division of the Scottish Government (RESAS) under the Moredun Research Institute's core Programme of Research; Biotechnology and Biological Sciences Research Council [BB/J015083/1] Funding Source: researchfish; BBSRC [BB/J015083/1] Funding Source: UKRI	Rural and Environment Science and Analytical Services Division of the Scottish Government (RESAS) under the Moredun Research Institute's core Programme of Research; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Rural and Environment Science and Analytical Services Division of the Scottish Government (RESAS, http://www.gov.scot), under the Moredun Research Institute's core Programme of Research to DL, GE and MD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouakane A, 2005, VET REC, V157, P771, DOI 10.1136/vr.157.24.771; Bouakane A, 2003, INFECT IMMUN, V71, P7219, DOI 10.1128/IAI.71.12.7219-7222.2003; Buendia AJ, 1997, FEMS MICROBIOL LETT, V150, P113, DOI 10.1016/S0378-1097(97)00106-7; BUXTON D, 1986, VET REC, V118, P510, DOI 10.1136/vr.118.18.510; Buxton D, 2002, J COMP PATHOL, V127, P133, DOI 10.1053/jcpa.2002.0573; BUXTON D, 1990, J COMP PATHOL, V102, P221, DOI 10.1016/S0021-9975(08)80127-2; CALDWELL HD, 1981, INFECT IMMUN, V31, P1161, DOI 10.1128/IAI.31.3.1161-1176.1981; Essig A, 2015, CURR CLIN MICROBIOL, V2, P22, DOI 10.1007/s40588-015-0014-2; Kerr K, 2010, VET MICROBIOL, V144, P392, DOI 10.1016/j.vetmic.2010.01.025; Laroucau K, 2009, VET MICROBIOL, V137, P335, DOI 10.1016/j.vetmic.2009.01.029; Livingstone M, 2005, CLIN DIAGN LAB IMMUN, V12, P770, DOI 10.1128/CDLI.12.6.770-777.2005; Livingstone M, 2009, VET MICROBIOL, V135, P134, DOI 10.1016/j.vetmic.2008.09.033; Longbottom D, 2003, J COMP PATHOL, V128, P217, DOI 10.1053/jcpa.2002.0629; Longbottom D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057950; Maley SW, 2009, VET MICROBIOL, V135, P122, DOI 10.1016/j.vetmic.2008.09.031; MCCAFFERTY MC, 1995, INFECT IMMUN, V63, P2387, DOI 10.1128/IAI.63.6.2387-2389.1995; MCCLENAGHAN M, 1984, INFECT IMMUN, V45, P384, DOI 10.1128/IAI.45.2.384-389.1984; Pannekoek Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014179; Pospischil A, 2002, SWISS MED WKLY, V132, P64; Rodolakis A, 2015, VET MICROBIOL, V181, P107, DOI 10.1016/j.vetmic.2015.07.010; ROFF DA, 1989, MOL BIOL EVOL, V6, P539; Sait M, 2011, J BACTERIOL, V193, P4276, DOI 10.1128/JB.05290-11; Sammin D, 2009, VET MICROBIOL, V135, P90, DOI 10.1016/j.vetmic.2008.09.054; Siarkou V, 2002, VET MICROBIOL, V85, P145, DOI 10.1016/S0378-1135(01)00506-5; Siarkou V., 1992, THESIS; Siarkou VI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126433; Siarkou VI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019813; STAMP J. T., 1950, VET REC, V62, P251; Thomson NR, 2005, GENOME RES, V15, P629, DOI 10.1101/gr.3684805; Vretou E, 1996, VET MICROBIOL, V51, P275, DOI 10.1016/0378-1135(96)00048-X; Vretou E, 2001, INFECT IMMUN, V69, P607, DOI 10.1128/IAI.69.1.607-612.2001; Wilson K, 2009, VET MICROBIOL, V135, P38, DOI 10.1016/j.vetmic.2008.09.043; Wyllie S, 1998, INFECT IMMUN, V66, P5202, DOI 10.1128/IAI.66.11.5202-5207.1998	33	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177653	10.1371/journal.pone.0177653	http://dx.doi.org/10.1371/journal.pone.0177653			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28494018	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314300148
J	Price, JT; Paladino, FV; Lamont, MM; Witherington, BE; Bates, ST; Soule, T				Price, James T.; Paladino, Frank V.; Lamont, Margaret M.; Witherington, Blair E.; Bates, Scott T.; Soule, Tanya			Characterization of the juvenile green turtle (Chelonia mydas) microbiome throughout an ontogenetic shift from pelagic to neritic habitats	PLOS ONE			English	Article							CARETTA-CARETTA; MARINE TURTLES; LIFE-STAGES; ECOLOGY; FERMENTATION; DIVERSITY; COMMUNITY; FLORIDA; SYSTEM; LAGOON	The gut microbiome of herbivorous animals consists of organisms that efficiently digest the structural carbohydrates of ingested plant material. Green turtles (Chelonia mydas) provide an interesting model of change in these microbial communities because they undergo a pronounced shift from a surface-pelagic distribution and omnivorous diet to a neritic distribution and herbivorous diet. As an alternative to direct sampling of the gut, we investigated the cloacal microbiomes of juvenile green turtles before and after recruitment to neritic waters to observe any changes in their microbial community structure. Cloacal swabs were taken from individual turtles for analysis of the 16S rRNA gene sequences using Illumina sequencing. One fecal sample was also obtained, allowing for a preliminary comparison with the bacterial community of the cloaca. We found significant variation in the juvenile green turtle bacterial communities between pelagic and neritic habitats, suggesting that environmental and dietary factors support different bacterial communities in green turtles from these habitats. This is the first study to characterize the cloacal microbiome of green turtles in the context of their ontogenetic shifts, which could provide valuable insight into the origins of their gut bacteria and how the microbial community supports their shift to herbivory.	[Price, James T.; Paladino, Frank V.; Soule, Tanya] Indiana Univ Purdue Univ, Dept Biol, Ft Wayne, IN 46202 USA; [Lamont, Margaret M.] US Geol Survey, Gainesville, FL USA; [Witherington, Blair E.] Disneys Anim Sci & Environm, Lake Buena Vista, FL USA; [Bates, Scott T.] Purdue Univ Northwest, Dept Biol Sci, Westville, IN USA; [Price, James T.] Ohio State Univ, Sch Earth Sci, Columbus, OH 43210 USA	Purdue University System; Indiana University Purdue University Fort Wayne; United States Department of the Interior; United States Geological Survey; University System of Ohio; Ohio State University	Soule, T (corresponding author), Indiana Univ Purdue Univ, Dept Biol, Ft Wayne, IN 46202 USA.	soulet@ipfw.edu	Soule, Tanya/AGT-0635-2022; Price, James/Y-7265-2019	Soule, Tanya/0000-0003-2032-6422; Price, James/0000-0002-9439-9731; Paladino, Frank V./0000-0002-6452-0086; Bates, Scott/0000-0002-6184-4296	PADI Foundation; Leatherback Trust; Fort Wayne Children's Zoo Fund; Sea Turtle License Plate; Florida Fish and Wildlife Conservation Commission [14726]; US Geological Survey [17183]; Indiana University-Purdue University Fort Wayne	PADI Foundation; Leatherback Trust; Fort Wayne Children's Zoo Fund; Sea Turtle License Plate; Florida Fish and Wildlife Conservation Commission; US Geological Survey(United States Geological Survey); Indiana University-Purdue University Fort Wayne	This work was supported by the PADI Foundation (http://www.padifoundation.org/) to JTP, Jack W. Schrey Professorship to FVP, The Leatherback Trust (http://www.leatherback.org/) to FVP, The Fort Wayne Children's Zoo Fund (http://kidszoo.org/) to FVP, Sea Turtle License Plate (http://www.helpingseaturtles.org/) to BEW, Florida Fish and Wildlife Conservation Commission (NMFS Permit No. 14726; http://myfwc.com/) to BEW, US Geological Survey (NMFS Permit No. 17183; https://www.usgs.gov/) to MML, and Indiana University-Purdue University Fort Wayne (www.ipfw.edu) to JTP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrhman KFA, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01060; Arthur KE, 2014, ECOLOGY, V95, P1285, DOI 10.1890/13-0263.1; Berg RD, 1996, TRENDS MICROBIOL, V4, P430, DOI 10.1016/0966-842X(96)10057-3; Bernardet J.F, 1923, GENUS; BJORNDAL KA, 1985, COPEIA, P736, DOI 10.2307/1444767; BJORNDAL KA, 1979, COMP BIOCHEM PHYS A, V63, P127, DOI 10.1016/0300-9629(79)90638-8; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cardona L, 2010, J EXP MAR BIOL ECOL, V393, P83, DOI 10.1016/j.jembe.2010.07.004; Colston TJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128793; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; FLAMMER K, 1988, AVIAN DIS, V32, P79, DOI 10.2307/1590952; Garrity GM, 2015, BERGEYS MANUAL SYSTE; Garrity GM, 2015, BERGEYS MANUAL ARCHA; Green SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128122; Hellein KN, 2011, J WATER HEALTH, V9, P695, DOI 10.2166/wh.2011.154; Hernandez-Gomez O, 2017, MICROB ECOL, V73, P445, DOI 10.1007/s00248-016-0859-9; Hong PY, 2011, ISME J, V5, P1461, DOI 10.1038/ismej.2011.33; Ionescu D, 2016, MANUAL ENV MICROBIOL; Kohl KD, 2017, MOL ECOL, V26, P1175, DOI 10.1111/mec.13921; Lamont MM, 2015, HERPETOL CONSERV BIO, V10, P26; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; MENDONCA MT, 1982, COPEIA, P161; Modica B. P., 2016, THESIS; Rainey FA, 2015, BERGEYS MANUAL SYSTE; Song Y., 2015, BERGEYS MANUAL SYSTE; STARK PL, 1982, J MED MICROBIOL, V15, P189, DOI 10.1099/00222615-15-2-189; TROYER K, 1984, BEHAV ECOL SOCIOBIOL, V14, P189, DOI 10.1007/BF00299618; Ueki A, 2006, INT J SYST EVOL MICR, V56, P39, DOI 10.1099/ijs.0.63896-0; Vander Zanden HB, 2013, OECOLOGIA, V173, P767, DOI 10.1007/s00442-013-2655-2; Wang DC, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-15; Williams BA, 2001, NUTR RES REV, V14, P207, DOI 10.1079/NRR200127; Williams NC, 2014, ESTUAR COAST, V37, P986, DOI 10.1007/s12237-013-9741-x; WITHERINGTON BE, 1989, COPEIA, P696; Witherington B, 2012, MAR ECOL PROG SER, V463, P1, DOI 10.3354/meps09970; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	38	49	49	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177642	10.1371/journal.pone.0177642	http://dx.doi.org/10.1371/journal.pone.0177642			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493980	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314300147
J	Xu, HF; An, JJ; Xu, BJ				Xu, Haifei; An, Juan Ji; Xu, Baoji			Distinct cellular toxicity of two mutant huntingtin mRNA variants due to translation regulation	PLOS ONE			English	Article							ALTERNATIVE CLEAVAGE; UNTRANSLATED REGIONS; TRANSGENIC MICE; DISEASE GENE; BDNF; POLYADENYLATION; PROTEINS; NEURONS; TRANSCRIPTION; EXPRESSION	Huntington's disease (HD) is a neurodegenerative disorder caused by CAG repeat expansion within exon1 of the HTT gene. The gene generates two mRNA variants that carry either a short or long 30 untranslated region (3'UTR) while encoding the same protein. It remains unknown whether the two mRNA variants play distinct roles in HD pathogenesis. We found that the long HTT 3'UTR was capable of guiding mRNA to neuronal dendrites, suggesting that some long-form HTT mRNA is transported to dendrites for local protein synthesis. To assay roles of two HTT mRNA variants in cell bodies, we expressed mRNA harboring HTT exon1 containing 23x or 145x CAGs with the short or long 3'UTR. We found that mutant mRNA containing the short 3'UTR produced more protein aggregates and caused more apoptosis in both cultured neurons and HEK293 cells, compared with mutant mRNA containing the long 3'UTR. Although the two 3'UTRs did not affect mRNA stability, we detected higher levels of protein synthesis from mRNA containing the short 3'UTR than from mRNA containing the long 3'UTR. These results indicate that the long HTT 3'UTR suppresses translation. Thus, short-form mutant HTT mRNA will be more efficient in producing toxic protein than its long-form counterpart.	[Xu, Haifei; An, Juan Ji; Xu, Baoji] Scripps Res Inst Florida, Dept Neurosci, Jupiter, FL 33458 USA	Scripps Research Institute	Xu, BJ (corresponding author), Scripps Res Inst Florida, Dept Neurosci, Jupiter, FL 33458 USA.	bxu@scripps.edu			National Institutes of Health [R01NS050596, R01NS073930]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050596, R01NS073930] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by grants from the National Institutes of Health (R01NS050596 and R01NS073930). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Zhixiang Xu for technical advice on lentivirus preparation. We thank Shaw-wen Wu, Guey-Ying Liao, Xiangyang Xie, and Tingting Xia for critical comments of the manuscript. This work is supported by grants from the National Institutes of Health (R01NS050596 and R01NS073930).	An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Bates GP, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.5; Berkovits BD, 2015, NATURE, V522, P363, DOI 10.1038/nature14321; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Elkon R, 2013, NAT REV GENET, V14, P496, DOI 10.1038/nrg3482; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Group T. H. D. C. R., 1993, CELL, V72, P971, DOI [10.1016/0092-8674(93)90585-E8458085, DOI 10.1016/0092-8674(93)90585-E8458085]; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Irier HA, 2009, J NEUROCHEM, V109, P584, DOI 10.1111/j.1471-4159.2009.05992.x; Juenemann K, 2013, J BIOL CHEM, V288, P27068, DOI 10.1074/jbc.M113.486076; Kremers GJ, 2009, NAT METHODS, V6, P355, DOI [10.1038/NMETH.1319, 10.1038/nmeth.1319]; Lau AG, 2010, P NATL ACAD SCI USA, V107, P15945, DOI 10.1073/pnas.1002929107; Legendre M, 2006, PLOS COMPUT BIOL, V2, P333, DOI 10.1371/journal.pcbi.0020043; Liao GY, 2012, NAT MED, V18, P564, DOI 10.1038/nm.2687; LIN BY, 1994, HUM MOL GENET, V3, P85, DOI 10.1093/hmg/3.1.85; LIN BY, 1993, HUM MOL GENET, V2, P1541, DOI 10.1093/hmg/2.10.1541; Lou E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033093; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Ossato G, 2010, BIOPHYS J, V98, P3078, DOI 10.1016/j.bpj.2010.02.058; Perry RB, 2012, NEURON, V75, P294, DOI 10.1016/j.neuron.2012.05.033; Qin ZH, 2004, J NEUROSCI, V24, P269, DOI 10.1523/JNEUROSCI.1409-03.2004; Ross CA, 2014, NAT REV NEUROL, V10, P204, DOI 10.1038/nrneurol.2014.24; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Tomura M, 2008, P NATL ACAD SCI USA, V105, P10871, DOI 10.1073/pnas.0802278105; Waterhouse EG, 2012, J NEUROSCI, V32, P14318, DOI 10.1523/JNEUROSCI.0709-12.2012; Zhang HB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r100; Zhao T, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00027	35	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177610	10.1371/journal.pone.0177610	http://dx.doi.org/10.1371/journal.pone.0177610			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28494017	gold, Green Submitted, Green Published			2022-12-26	WOS:000401314300145
J	Karimipanah, Y; Ma, ZY; Miller, JEK; Yuste, R; Wessel, R				Karimipanah, Yahya; Ma, Zhengyu; Miller, Jae-eun Kang; Yuste, Rafael; Wessel, Ralf			Neocortical activity is stimulus- and scale-invariant	PLOS ONE			English	Article							SPONTANEOUS CORTICAL ACTIVITY; NEURONAL AVALANCHES; HUMAN BRAIN; DYNAMICS; AWAKE; CONNECTIVITY; OSCILLATIONS; NETWORK; CORTEX	Mounting evidence supports the hypothesis that the cortex operates near a critical state, defined as the transition point between order (large-scale activity) and disorder (small-scale activity). This criticality is manifested by power law distribution of the size and duration of spontaneous cascades of activity, which are referred as neuronal avalanches. The existence of such neuronal avalanches has been confirmed by several studies both in vitro and in vivo, among different species and across multiple spatial scales. However, despite the prevalence of scale free activity, still very little is known concerning whether and how the scale-free nature of cortical activity is altered during external stimulation. To address this question, we performed in vivo two-photon population calcium imaging of layer 2/3 neurons in primary visual cortex of behaving mice during visual stimulation and conducted statistical analyses on the inferred spike trains. Our investigation for each mouse and condition revealed power law distributed neuronal avalanches, and irregular spiking individual neurons. Importantly, both the avalanche and the spike train properties remained largely unchanged for different stimuli, while the cross-correlation structure varied with stimuli. Our results establish that microcircuits in the visual cortex operate near the critical regime, while rearranging functional connectivity in response to varying sensory inputs.	[Karimipanah, Yahya; Ma, Zhengyu; Wessel, Ralf] Washington Univ, Dept Phys, St Louis, MO 63130 USA; [Miller, Jae-eun Kang; Yuste, Rafael] Columbia Univ, Neurotechnol Ctr, New York, NY USA; [Miller, Jae-eun Kang; Yuste, Rafael] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Washington University (WUSTL); Columbia University; Columbia University	Ma, ZY (corresponding author), Washington Univ, Dept Phys, St Louis, MO 63130 USA.	zhengyuma@wustl.edu			Whitehall Foundation [20121221]; National Science Foundation (Collaborative Research in Computational Neuroscience) [1308159]; National Eye Institute [DP1EY024503, RO1EY011787, F32EY022579, K99EY024653]; NATIONAL EYE INSTITUTE [K99EY024653] Funding Source: NIH RePORTER	Whitehall Foundation; National Science Foundation (Collaborative Research in Computational Neuroscience)(National Science Foundation (NSF)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by Whitehall Foundation grant #20121221 (RW) http://www.whitehall.org/; National Science Foundation (Collaborative Research in Computational Neuroscience) grant #1308159 (RW) https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5147; National Eye Institute (DP1EY024503 and RO1EY011787 to RY, and F32EY022579 and K99EY024653 to JKM) https://nei.nih.gov/.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Arviv O, 2015, J NEUROSCI, V35, P13927, DOI 10.1523/JNEUROSCI.0477-15.2015; Bak P., 1996, NATURE WORKS SCI SEL; Beggs JM, 2003, J NEUROSCI, V23, P11167; Beggs JM, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00163; Bellay T, 2015, ELIFE, V4, DOI 10.7554/eLife.07224; Berkes P, 2011, SCIENCE, V331, P83, DOI 10.1126/science.1195870; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Buonomano DV, 2009, NAT REV NEUROSCI, V10, P113, DOI 10.1038/nrn2558; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Downing KL, 2015, INTELLIGENCE EMERGING: ADAPTIVITY AND SEARCH IN EVOLVING NEURAL SYSTEMS, P1; Eurich CW, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.066137; Evangelidis GD, 2008, IEEE T PATTERN ANAL, V30, P1858, DOI 10.1109/TPAMI.2008.113; Fiser J, 2004, NATURE, V431, P573, DOI 10.1038/nature02907; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fraiman D, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00307; Friedman N, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.208102; Garaschuk O, 2006, NAT PROTOC, V1, P380, DOI 10.1038/nprot.2006.58; Gautam SH, 2015, PLOS COMPUT BIOL, V11, P1; Greenberg DS, 2008, NAT NEUROSCI, V11, P749, DOI 10.1038/nn.2140; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hahn G, 2010, J NEUROPHYSIOL, V104, P3312, DOI 10.1152/jn.00953.2009; Haldeman C, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.058101; Hamel EJO, 2015, NEURON, V86, P140, DOI 10.1016/j.neuron.2015.03.055; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Jensen H.J., 1998, SELF ORG CRITICALITY; Kaifosh P, 2013, NAT NEUROSCI, V16, P1182, DOI 10.1038/nn.3482; Karimipanah Y, 2016, NEW HALLMARKS CRITIC, P1; Kinouchi O, 2006, NAT PHYS, V2, P348, DOI 10.1038/nphys289; Levina A, 2007, NAT PHYS, V3, P857, DOI 10.1038/nphys758; Luczak A, 2009, NEURON, V62, P413, DOI 10.1016/j.neuron.2009.03.014; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Markram H, 2015, CELL, V163, P456, DOI 10.1016/j.cell.2015.09.029; Meisel C, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.061917; Miller JEK, 2014, P NATL ACAD SCI USA, V111, pE4053, DOI 10.1073/pnas.1406077111; Mohajerani MH, 2013, NAT NEUROSCI, V16, P1426, DOI 10.1038/nn.3499; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Petermann T, 2009, P NATL ACAD SCI USA, V106, P15921, DOI 10.1073/pnas.0904089106; Plenz D, 2014, CRITICALITY IN NEURAL SYSTEMS, P1; Poil SS, 2008, HUM BRAIN MAPP, V29, P770, DOI 10.1002/hbm.20590; Poil SS, 2012, J NEUROSCI, V32, P9817, DOI 10.1523/JNEUROSCI.5990-11.2012; Priesemann V, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002985; Ribeiro TL, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00016; Ringach DL, 2009, CURR OPIN NEUROBIOL, V19, P439, DOI 10.1016/j.conb.2009.07.005; Scott G, 2014, J NEUROSCI, V34, P16611, DOI 10.1523/JNEUROSCI.3474-14.2014; Sethna JP, 2001, NATURE, V410, P242, DOI 10.1038/35065675; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Shew WL, 2015, NAT PHYS, V11, P659, DOI 10.1038/NPHYS3370; Shriki O, 2013, J NEUROSCI, V33, P7079, DOI 10.1523/JNEUROSCI.4286-12.2013; Smetters D, 1999, METHODS, V18, P215, DOI 10.1006/meth.1999.0774; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Stumpf MPH, 2012, SCIENCE, V335, P665, DOI 10.1126/science.1216142; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Vogelstein JT, 2010, J NEUROPHYSIOL, V104, P3691, DOI 10.1152/jn.01073.2009	58	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177396	10.1371/journal.pone.0177396	http://dx.doi.org/10.1371/journal.pone.0177396			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489906	gold, Green Submitted, Green Published			2022-12-26	WOS:000401314100070
J	Yamazaki, H; Lai, YC; Tateno, M; Setoguchi, A; Goto-Koshino, Y; Endo, Y; Nakaichi, M; Tsujimoto, H; Miura, N				Yamazaki, Hiroki; Lai, Yu-Chang; Tateno, Morihiro; Setoguchi, Asuka; Goto-Koshino, Yuko; Endo, Yasuyuki; Nakaichi, Munekazu; Tsujimoto, Hajime; Miura, Naoki			Hypoxia-activated prodrug TH-302 decreased survival rate of canine lymphoma cells under hypoxic condition	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; SOFT-TISSUE SARCOMA; INDUCIBLE FACTOR-1-ALPHA; PHASE-I; MULTIDRUG-RESISTANCE; MALIGNANT-LYMPHOMA; EXPRESSION; CANCER; LINE; LEUKEMIA	We tested the hypotheses that hypoxic stimulation enhances growth potentials of canine lymphoma cells by activating hypoxia-inducible factor 1 alpha (HIF-1 alpha), and that the hypoxia-activated prodrug (TH-302) inhibits growth potentials in the cells. We investigated how hypoxic culture affects the growth rate, chemoresistance, and invasiveness of canine lymphoma cells and doxorubicin (DOX)-resistant lymphoma cells, and influences of TH-302 on survival rate of the cells under hypoxic conditions. Our results demonstrated that hypoxic culture upregulated the expression of HIF-1a and its target genes, including ATP-binding cassette transporter B1 (ABCB1), ATP-binding cassette transporter G2 (ABCG2), platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), and survivin, and enhanced the growth rate, DOX resistance, and invasiveness of the cells. Additionally, TH-302 decreased the survival rate of the cells under hypoxic condition. Our studies suggest that hypoxic stimulation may advance the tumorigenicity of canine lymphoma cells, favoring malignant transformation. Therefore, the data presented may contribute to the development of TH-302-based hypoxia-targeting therapies for canine lymphoma.	[Yamazaki, Hiroki; Lai, Yu-Chang; Miura, Naoki] Kagoshima Univ, Vet Teaching Hosp, Joint Fac Vet Med, Korimoto, Kagoshima, Japan; [Tateno, Morihiro; Endo, Yasuyuki] Kagoshima Univ, Joint Fac Vet Med, Lab Vet Internal Med, Korimoto, Kagoshima, Japan; [Setoguchi, Asuka] Bayside Anim Clin, Yokohama, Kanagawa, Japan; [Goto-Koshino, Yuko; Tsujimoto, Hajime] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Internal Med, Bunkyo Ku, Tokyo, Japan; [Nakaichi, Munekazu] Yamaguchi Univ, Joint Fac Vet Med, Dept Vet Med, Lab Vet Radiol, Yoshida, Yamaguchi, Japan; [Yamazaki, Hiroki] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Vet Med Ctr, Izumisano, Osaka, Japan	Kagoshima University; Kagoshima University; University of Tokyo; Yamaguchi University; Osaka Metropolitan University	Miura, N (corresponding author), Kagoshima Univ, Vet Teaching Hosp, Joint Fac Vet Med, Korimoto, Kagoshima, Japan.	k9236024@kadai.jp	Miura, Naoki/A-5734-2010; Miura, Naoki/O-6997-2016	Miura, Naoki/0000-0002-4625-5231; Miura, Naoki/0000-0002-4625-5231; Goto-Koshino, Yuko/0000-0002-5228-7125; Tsujimoto, Hajime/0000-0002-3771-6235	Japan Society for the Promotion of Science (JSPS) KAKENHI [25292180, 15K14872, 17H03926]; Grants-in-Aid for Scientific Research [16H05845, 17H03926] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI (grant numbers 25292180, 15K14872, and 17H03926). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appiah-Kubi K, 2016, TUMOUR BIOL; Arico A, 2014, J COMP PATHOL, V151, P322, DOI 10.1016/j.jcpa.2014.07.001; Badar T, 2016, AM J HEMATOL, V91, P800, DOI 10.1002/ajh.24415; Bos R, 2005, HISTOPATHOLOGY, V46, P31, DOI 10.1111/j.1365-2559.2005.02045.x; Chawla SP, 2014, J CLIN ONCOL, V32, P3299, DOI 10.1200/JCO.2013.54.3660; Chen YQ, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-29; Comerford KM, 2002, CANCER RES, V62, P3387; Evens AM, 2010, J CLIN ONCOL, V28, P1017, DOI 10.1200/JCO.2009.24.1893; Ganjoo KN, 2011, ONCOLOGY-BASEL, V80, P50, DOI 10.1159/000327739; Garrido-Laguna I, 2015, NAT REV CLIN ONCOL, V12, P319, DOI 10.1038/nrclinonc.2015.53; Greijer AE, 2004, J CLIN PATHOL, V57, P1009, DOI 10.1136/jcp.2003.015032; Hendifar AE, 2015, ANN CANC RES, V2, P5; Hernandez-Luna MA, 2013, LEUKEMIA LYMPHOMA, V54, P1048, DOI 10.3109/10428194.2012.733874; Hu JS, 2010, BLOOD, V116, P1524, DOI 10.1182/blood-2010-02-269126; Ito D, 2014, VET IMMUNOL IMMUNOP, V159, P192, DOI 10.1016/j.vetimm.2014.02.016; Izaki S, 2007, INT J HEMATOL, V86, P253, DOI 10.1007/BF03006930; Kambayashi S, 2015, J VET MED SCI, V77, P1405, DOI 10.1292/jvms.15-0258; Marconato L, 2009, VET COMP ONCOL, V7, P236, DOI 10.1111/j.1476-5829.2009.00196.x; Momoi Y, 1997, VET IMMUNOL IMMUNOP, V59, P11, DOI 10.1016/S0165-2427(97)00053-6; Nakaichi M, 1996, J VET MED SCI, V58, P469, DOI 10.1292/jvms.58.469; Pang YY, 2015, LEUKEMIA LYMPHOMA, V56, P1821, DOI 10.3109/10428194.2014.963575; Perry AM, 2016, HAEMATOLOGICA, V101, P1244, DOI 10.3324/haematol.2016.148809; Phillips RM, 2016, CANCER CHEMOTH PHARM, V77, P441, DOI 10.1007/s00280-015-2920-7; Powell JR, 2013, LEUKEMIA LYMPHOMA, V54, P959, DOI 10.3109/10428194.2012.733875; Sharif H, 2012, VET J, V194, P40, DOI 10.1016/j.tvjl.2012.03.006; Shoeneman JK, 2016, VET COMP ONCOL, V14, pE45, DOI 10.1111/vco.12104; Sia D, 2014, CURR PHARM DESIGN, V20, P2834, DOI 10.2174/13816128113199990590; Takahashi M, 2014, J VET MED SCI, V76, P895, DOI 10.1292/jvms.13-0345; Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3; Tuomela J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-596; Weiss GJ, 2011, CLIN CANCER RES, V17, P2997, DOI 10.1158/1078-0432.CCR-10-3425; Wolfesberger B, 2007, J COMP PATHOL, V137, P30, DOI 10.1016/j.jcpa.2007.03.003; Xia Y, 2012, EUR J MED CHEM, V49, P24, DOI 10.1016/j.ejmech.2012.01.033; Zandvliet M, 2016, VET QUART, V36, P76, DOI 10.1080/01652176.2016.1152633; Zandvliet M, 2015, VET J, V205, P263, DOI 10.1016/j.tvjl.2014.11.002; Zandvliet M, 2014, TOXICOL IN VITRO, V28, P1498, DOI 10.1016/j.tiv.2014.06.004	36	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177305	10.1371/journal.pone.0177305	http://dx.doi.org/10.1371/journal.pone.0177305			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489881	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314100058
J	Pandolfi, R; de Almeida, DR; Pinto, MA; Kreutz, LC; Frandoloso, R				Pandolfi, Rafael; de Almeida, Denise Ramos; Pinto, Marcelo Alves; Kreutz, Luiz Carlos; Frandoloso, Rafael			In house ELISA based on recombinant ORF2 protein underline high prevalence of IgG anti-hepatitis E virus amongst blood donors in south Brazil	PLOS ONE			English	Article							ORGAN-TRANSPLANT RECIPIENTS; INFECTIOUS-DISEASE; HEV IGM; SWINE; PIGS; STANDARDIZATION; IMMUNOASSAY; ANTIBODIES; GERMANY; FRANCE	Hepatitis E Virus (HEV) is a zoonotic pathogen responsible for causing acute hepatitis in human, especially in developing countries. Diagnosis of HEV usually relies on the detection of antibodies mostly by enzyme-linked immunosorbent assay (ELISA). In the present study, we designed a new indirect ELISA (iELISA) based on a short recombinant peptide derived from the capsid protein (ORF2p) and demonstrated its potential for detecting human IgG against HEV genotype 3. The best polystyrene plate (Maxisorp (R)), optimal ORF2p coating antigen concentration (0,67 mu g/well) and primary antibody dilution (1: 100) were determined. This iELISA showed a sensitivity of 91.4% and specificity of 95.9%. The comparison of our in house iELISA with a commercial assay (RecomWell, Mikrogen (R)) showed 94.25% of agreement and a kappa index of 0.88. The ORF2 recombinant ELISA was used to screen 780 blood donors for anti-HEV IgG and we found that 314 (40,25%) of these donors were IgG positive. This high prevalence of antibodies suggests, for the first time, that the Southern Brazil region might be endemic to Hepatitis E Virus genotype 3.	[Pandolfi, Rafael; de Almeida, Denise Ramos; Kreutz, Luiz Carlos; Frandoloso, Rafael] Univ Passo Fundo, Fac Agron & Med Vet, Lab Microbiol & Imunol Avancada, Passo Fundo, RS, Brazil; [Pinto, Marcelo Alves] Fundacao Oswaldo Cruz, Lab Desenvolvimento Tecnol Virol IOC, Rio De Janeiro, RJ, Brazil	Universidade de Passo Fundo; Fundacao Oswaldo Cruz	Frandoloso, R (corresponding author), Univ Passo Fundo, Fac Agron & Med Vet, Lab Microbiol & Imunol Avancada, Passo Fundo, RS, Brazil.	rfran@upf.br	Pinto, Marcelo Alves/ABA-3312-2020; Pinto, Marcelo/G-7503-2012; Kreutz, Luiz Carlos/A-3729-2015; Frandoloso, Rafael/D-3774-2013	Pinto, Marcelo/0000-0003-3462-7277; Kreutz, Luiz Carlos/0000-0002-7685-7401; Frandoloso, Rafael/0000-0002-3361-2420	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [485807/2013]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The author RF received financial support from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, grant no 485807/2013).	Aggarwal R, 2013, J CLIN EXP HEPATOL, V3, P125, DOI 10.1016/j.jceh.2013.05.010; Aggarwal R, 2013, NAT REV GASTRO HEPAT, V10, P24, DOI 10.1038/nrgastro.2012.187; Aggarwal R, 2011, VIRUS RES, V161, P15, DOI 10.1016/j.virusres.2011.03.017; Arankalle VA, 2007, J VIRAL HEPATITIS, V14, P435, DOI 10.1111/j.1365-2893.2006.00801.x; Behrendt P, 2016, J INFECT DIS, V214, P361, DOI 10.1093/infdis/jiw161; Lana MVD, 2014, TROP ANIM HEALTH PRO, V46, P399, DOI 10.1007/s11250-013-0503-3; Dalton HR, 2009, NEW ENGL J MED, V361, P1025, DOI 10.1056/NEJMc0903778; de Deus N, 2008, VET MICROBIOL, V129, P163, DOI 10.1016/j.vetmic.2007.11.002; Echevarria JM, 2013, J MED VIROL, V85, P1037, DOI 10.1002/jmv.23526; Emerson S.U., 2005, VIRUS TAXONOMY, P853; Engle RE, 2002, J CLIN MICROBIOL, V40, P4576, DOI 10.1128/JCM.40.12.4576-4580.2002; Erez-Granat O, 2016, WORLD J GASTROENTERO, V22, P5568, DOI 10.3748/wjg.v22.i24.5568; Fischer C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119576; IBGE, 2016, EF REB BRAS ANO 2015; de Oya NJ, 2009, J CLIN MICROBIOL, V47, P3276, DOI 10.1128/JCM.00750-09; Kamar N, 2008, NEW ENGL J MED, V358, P811, DOI 10.1056/NEJMoa0706992; Khuroo MS, 2004, J GASTROEN HEPATOL, V19, P778, DOI 10.1111/j.1440-1746.2004.03437.x; Krumbholz A, 2014, MED MICROBIOL IMMUN, V203, P273, DOI 10.1007/s00430-014-0336-3; Legrand-Abravanel F, 2010, J INFECT DIS, V202, P835, DOI 10.1086/655899; dos Santos DRL, 2010, J CLIN VIROL, V47, P276, DOI 10.1016/j.jcv.2009.12.021; dos Santos DRL, 2009, VET J, V182, P474, DOI 10.1016/j.tvjl.2008.08.001; Ma HX, 2011, J MED VIROL, V83, P827, DOI 10.1002/jmv.22032; Ma HX, 2009, J MED VIROL, V81, P1052, DOI 10.1002/jmv.21484; Mansuy JM, 2011, EMERG INFECT DIS, V17, P2309, DOI 10.3201/eid1712.110371; Meng XJ, 2010, VET MICROBIOL, V140, P256, DOI 10.1016/j.vetmic.2009.03.017; Meng XJ, 2011, VIRUS RES, V161, P23, DOI 10.1016/j.virusres.2011.01.016; Meng XJ, 1998, J VIROL, V72, P9714, DOI 10.1128/JVI.72.12.9714-9721.1998; Navaneethan U, 2008, LIVER INT, V28, P1190, DOI 10.1111/j.1478-3231.2008.01840.x; Nouhin J, 2016, TRANSFUSION; Pas SD, 2013, J CLIN VIROL, V58, P629, DOI 10.1016/j.jcv.2013.10.010; Pas SD, 2012, EMERG INFECT DIS, V18, P869, DOI 10.3201/eid1805.111712; Passos-Castilho AM, 2016, J MED VIROL, V88, P361, DOI 10.1002/jmv.24336; Pezzoni G, 2014, J VIROL METHODS, V207, P95, DOI 10.1016/j.jviromet.2014.06.025; Pischke S, 2014, DTSCH ARZTEBL INT, V111, P577, DOI 10.3238/arztebl.2014.0577; Pischke S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085330; Purcell RH, 2008, J HEPATOL, V48, P494, DOI 10.1016/j.jhep.2007.12.008; Ramos DD, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw021; Schlauder GG, 2001, J MED VIROL, V65, P282, DOI 10.1002/jmv.2031; Seminati C, 2008, VET J, V175, P130, DOI 10.1016/j.tvjl.2006.11.018; Perez-Gracia MT, 2016, FUTURE MICROBIOL, V11, P789, DOI 10.2217/fmb-2016-0012; TROTTIER YL, 1992, J CLIN MICROBIOL, V30, P46, DOI 10.1128/JCM.30.1.46-53.1992; Vitral CL, 2005, MEM I OSWALDO CRUZ, V100, P117, DOI 10.1590/S0074-02762005000200003; Wenzel JJ, 2013, J INFECT DIS, V207, P497, DOI 10.1093/infdis/jis688; WHO, 2015, HEPATITIS E; Wright P F, 1993, Rev Sci Tech, V12, P435; Yugo DM, 2013, INT J ENV RES PUB HE, V10, P4507, DOI 10.3390/ijerph10104507	46	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0176409	10.1371/journal.pone.0176409	http://dx.doi.org/10.1371/journal.pone.0176409			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486512	Green Submitted, gold, Green Published			2022-12-26	WOS:000401314000011
J	Nadorf, J; Kinkel, S; Gantz, S; Jakubowitz, E; Kretzer, JP				Nadorf, Jan; Kinkel, Stefan; Gantz, Simone; Jakubowitz, Eike; Kretzer, J. Philippe			Tibial revision knee arthroplasty with metaphyseal sleeves: The effect of stems on implant fixation and bone flexibility	PLOS ONE			English	Article							TOTAL JOINT ARTHROPLASTY; RADIOGRAPHIC EVALUATION; COMPONENT STABILITY; PROXIMAL TIBIA; REPLACEMENT; DESIGN; CEMENTLESS; MICROMOTION; PROSTHESIS; REGISTRIES	Introduction Revision total knee arthoplasty often requires modular implants to treat bone defects of varying severity. In some cases, it may not be clear which module size and implant combination (e.g. sleeve and stem) should be chosen for a specific defect. When balancing implant stability and osseointegration against stress-shielding, it is important to choose an appropriate implant combination in order to match the given level of bone loss. Therefore, the necessity of stems in less extensive tibial defects and the advantage of different stems (lengths and stiffnesses) in combination with large metaphyseal sleeves on implant fixation and bone flexibility using a modular tibial revision knee system, were analyzed. Materials and methods Four different stem combinations for a tibial revision implant (Sigma TC3, DePuy) were compared to an intact bone. Standardized implantation with n = 4 synthetic tibial bones was performed after generating an Anderson Orthopaedic Research Institute (AORI) Type T1 bone defect. Axial torques around the longitudinal stem axis and varus-valgus torques were separately applied to the implant. Micromotions of bone and implant were tracked using a digital image correlation system to calculate relative micromotions at the implant-bone-interface and bone deformation. Results Overall, using stems reduced the proximal micromotions of tray and sleeve compared to no stem, while reducing bone deformation proximally at the same time, indicating some potential for proximal stress-shielding compared to no stem. The potential for increased proximal stress-shield due to reduced proximal deformation appeared to be greater when using the longer stems. The location of lowest relative micromotions was also more distal when using long stems as opposed to short stems. A short stem (especially a smaller diameter short stem which still achieves diaphyseal fixation) displayed less potential for stress-shielding, but greater bone deformation distal to the tip of the stem than in the natural model. Discussion In the case of tibial revision implants with metaphyseal sleeves in a simple fully contained Type I defect, the absence of a stem provides for more natural bone deformation. However, adding a stem reduces overall relative micromotions, while introducing some risk of proximal stress-shielding due to increased diaphyseal fixation. Increasing stem length intensifies this effect. Short stems offered a balance between reduced micromotions and more proximal bone deformation that reduced the potential for stress-shielding when compared to long stems. A short stem with slightly smaller diameter (simulating a less stiff stem which still has diaphyseal fixation) increased the proximal bone deformation, but also tended to increase the bone deformation even further at the distal stem's tip. Conclusion In conclusion, further investigation should be conducted on fully contained Type I defects and the addition of a stem to offer better initial stability, taking into account stem length (i.e. shorter or more flexible stems) to support metaphyseal fixation and allowing bending found in intact bone. In addition, further study into more extensive tibial defects is required to determine if the stability/micromotion trends observed in this study with stems and sleeves in Type I defects still apply in cases of extensive proximal bone loss.	[Nadorf, Jan; Kinkel, Stefan; Kretzer, J. Philippe] Univ Hosp Heidelberg, Ctr Orthoped & Traumatol, Lab Biomech & Implant Res, Heidelberg, Germany; [Gantz, Simone] Univ Hosp Heidelberg, Ctr Orthoped & Traumatol, Biometr Consulting & Project Management, Heidelberg, Germany; [Jakubowitz, Eike] Hannover Med Sch, Lab Biomech & Biomat, Dept Orthopaed Surg, Hannover, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Hannover Medical School	Nadorf, J (corresponding author), Univ Hosp Heidelberg, Ctr Orthoped & Traumatol, Lab Biomech & Implant Res, Heidelberg, Germany.	JNadorf@yahoo.de			DePuy Synthes; Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing	DePuy Synthes; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing	The authors acknowledge financial support by DePuy Synthes (http://www.depuysynthes.com/). In addition, DePuy Synthes provided the tested implants. We acknowledge financial support by Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer TW, 1999, SKELETAL RADIOL, V28, P483, DOI 10.1007/s002560050552; Bensmann G, 1999, BIOMED ENG, V35, P44, DOI DOI 10.1515/BMTE.1990.35.S3.44; Bergmann G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086035; Bertin KC, 2007, J ARTHROPLASTY, V22, P670, DOI 10.1016/j.arth.2006.07.004; Bieger R, 2013, J ORTHOP RES, V31, P1180, DOI 10.1002/jor.22349; Bottlang M, 2006, CLIN ORTHOP RELAT R, P105, DOI 10.1097/01.blo.0000203463.27937.97; Clarius M, 2010, KNEE, V17, P398, DOI 10.1016/j.knee.2009.11.006; Clatworthey M., 2003, ADULT KNEE, P1455; Completo A, 2008, KNEE, V15, P227, DOI 10.1016/j.knee.2008.01.008; Completo A, 2008, J BIOMECH, V41, P560, DOI 10.1016/j.jbiomech.2007.10.006; Conlisk N, 2012, BONE JOINT RES, V1, P281, DOI 10.1302/2046-3758.111.2000107; Cristofolini L, 1996, J BIOMECH, V29, P525, DOI 10.1016/0021-9290(95)00084-4; Dalury DF, 2008, J BONE JOINT SURG BR, V90B, P1594, DOI 10.1302/0301-620X.90B12.21064; DORR LD, 1989, ORTHOP CLIN N AM, V20, P179; ENGH CA, 1992, CLIN ORTHOP RELAT R, P13; ENGH CA, 1988, CLIN ORTHOP RELAT R, P7; Engh G A, 1997, Instr Course Lect, V46, P227; Engh GA, 1998, ORTHOP CLIN N AM, V29, P205, DOI 10.1016/S0030-5898(05)70319-9; Frost HM, 2004, ANGLE ORTHOD, V74, P3; Gortz W, 2002, J BIOMECH ENG-T ASME, V124, P706, DOI 10.1115/1.1517565; Graichen H, 2015, J ARTHROPLASTY, V30, P2256, DOI 10.1016/j.arth.2015.06.030; Holt G, 2007, CLIN ORTHOP RELAT R, P240, DOI 10.1097/BLO.0b013e31804b4147; Jakubowitz E, 2008, J BIOMECH, V41, P3078, DOI 10.1016/j.jbiomech.2008.06.002; Jasty M, 1997, J BONE JOINT SURG AM, V79A, P707, DOI 10.2106/00004623-199705000-00010; Jazrawi LM, 2001, J ARTHROPLASTY, V16, P759, DOI 10.1054/arth.2001.25507; Kinkel S, 2013, INT ORTHOP, V37, P1877, DOI 10.1007/s00264-013-2052-9; McLean A, 2006, ORTHOPAEDIC P B S3, V88-B, P397; Meneghini RM, 2015, J ARTHROPLASTY, V30, P2311, DOI 10.1016/j.arth.2015.05.049; Molt M, 2015, ACTA ORTHOP, V86, P594, DOI 10.3109/17453674.2015.1033303; Nadorf J, 2014, ARCH ORTHOP TRAUM SU, V134, P719, DOI 10.1007/s00402-014-1946-3; Nadorf J, 2016, INT J ARTIF ORGANS, V39, P534, DOI 10.5301/ijao.5000530; Niinimaki TT, 2015, KNEE, V22, P142, DOI 10.1016/j.knee.2014.12.007; Ong KL, 2010, CLIN ORTHOP RELAT R, V468, P3070, DOI 10.1007/s11999-010-1399-0; Pal B, 2010, J BIOMECH, V43, P1923, DOI 10.1016/j.jbiomech.2010.03.019; Papakostidou I, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-116; Parfitt AM, 2002, BONE, V30, P5, DOI 10.1016/S8756-3282(01)00642-1; Petersen KK, 2015, CLIN J PAIN, V31, P1, DOI 10.1097/AJP.0000000000000146; PILLIAR RM, 1986, CLIN ORTHOP RELAT R, P108; RAND JA, 1991, CLIN ORTHOP RELAT R, P63; Roodman GD, 1996, ENDOCR REV, V17, P308, DOI 10.1210/er.17.4.308; Sadoghi P, 2013, J ARTHROPLASTY, V28, P1329, DOI 10.1016/j.arth.2013.01.012; Scott CEH, 2012, J BONE JOINT SURG BR, V94B, P1009, DOI 10.1302/0301-620X.94B8.28289; Siqueira MBP, 2015, J KNEE SURG, V28, P127, DOI 10.1055/s-0034-1396014; Stern SH, 1997, CLIN ORTHOP RELAT R, P44; Thomsen M, 2010, ORTHOPADE, V39, P623, DOI 10.1007/s00132-010-1617-1; Wolff J, 1892, GESETZ TRANSFORMATIO	46	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177285	10.1371/journal.pone.0177285	http://dx.doi.org/10.1371/journal.pone.0177285			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481956	Green Submitted, gold, Green Published			2022-12-26	WOS:000401313700048
J	Feleke, FW; Adole, AA; Bezabih, AM				Feleke, Fentaw Wassie; Adole, Anchamo Anato; Bezabih, Afework Mulugeta			Utilization of growth monitoring and promotion services and associated factors among under two years of age children in Southern Ethiopia	PLOS ONE			English	Article								Growth monitoring and promotion (GMP) is a prevention activity comprised of growth monitoring (GM) linked with promotion that serves as the core activity in an integrated child health and nutrition program. However, different methods of institutional studies have shown that utilization of GM services has remained to be inadequate. There is scarcity of studies conducted about GMP in quantitative method. Therefore, this study was conducted to address the proportion of GMP services and associated factors among children under two years of age in rural communities of Mareka district, Southern Ethiopia. Community based cross-sectional survey was conducted from August to September 2015. Single population proportion formula was used to determine the sample size with multi stage sampling technique. A total of 819 children under two years of age were included. Pretest was done on 10% of the total sample size. Data were analyzed using SPSS version 20.0 software. Bivariate and multivariate logistic regressions used to analyze data. The response rate was 95%. Utilization of GMP services was 16.9%. Institutional delivery AOR (95% CI): 3.01(1.65-5.50), index child age 12-17 months AOR (95% CI): 4.03(2.16-7.51) and 18-23 months AOR (95% CI): 3.08(1.70-5.57), family size 4-5 AOR(95% CI): 0.14(0.06-0.33), family size > 5 AOR(95% CI): 0.34(0.14-0.82), regular GMP attendance AOR (95% CI): 4.37(2.45-7.80), medium wealth index AOR(95% CI): 3.14(1.51-6.52) and high wealth index AOR(95% CI): 3.24 (1.59-6.62) were factors associated with utilization of GMP services. Utilization of GMP services was low. Thus, efforts should be made to improve utilization of GMP services through promotion of institutional delivery, different family planning methods, and regular GMP attendance.	[Feleke, Fentaw Wassie] Mareka Dist Hlth Off, Waka, Ethiopia; [Adole, Anchamo Anato] Hawasssa Univ, Coll Agr, Hawassa, Ethiopia; [Bezabih, Afework Mulugeta] Mekelle Univ, Coll Med & Hlth Sci, Mekele, Ethiopia	Mekelle University	Feleke, FW (corresponding author), Mareka Dist Hlth Off, Waka, Ethiopia.	fentawwassie@gmail.com		Mulugeta, Afework/0000-0003-0707-4363				Akinbode O, 2016, EUROPEAN J PREVENTIV, V4, P73; [Anonymous], 2014, CSA CENTERAL STAT AG; Beyene M, 2015, DIETARY DIVERSITY ME; Bilal S, 2014, PRACTICES CHALLENGES, V32, P441; Charlton KE, 2009, NUTRITION, V25, P1035, DOI 10.1016/j.nut.2009.03.008; Desalegn E., 2014, J GYNECOLOGY OBSTET, V2, P1, DOI [DOI 10.11648/j.jgo.20140201.11, DOI 10.11648/J.JG0.20140201.11]; Faber M, 2003, FOOD NUTR B, V24; Graham WJ, 2001, OPEN J EPIDEMIOL, V17, P97, DOI DOI 10.4236/ojepi.2014.41006; Griffiths M, 2007, GMP HLTH YOUNG CHILD; Gyampoh S, 2014, CHILD FEEDING KNOWLE; Hosmer D, 2013, APPL LOGISTIC REGRAT; Mayhew M, 2014, IMPROVING NUTR AFGHA; Peter R, 2014, S E ASIA J PUBLIC HL, V3; Roberfroid D, 2005, J HEALTH POPUL NUTR, V23, P207; UK Save the children, 2009, ETH NAT NUTR STRAT R; World Bank, 2006, WORLD BANK REPOSITIO; Yonas F, 2016, JOURNAL	17	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177502	10.1371/journal.pone.0177502	http://dx.doi.org/10.1371/journal.pone.0177502			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28510596	Green Published, Green Submitted, gold			2022-12-26	WOS:000401485500033
J	Di Pietro, O; Juarez-Jimenez, J; Munoz-Torrero, D; Laughton, CA; Luque, FJ				Di Pietro, Ornella; Juarez-Jimenez, Jordi; Munoz-Torrero, Diego; Laughton, Charles A.; Luque, F. Javier			Unveiling a novel transient druggable pocket in BACE-1 through molecular simulations: Conformational analysis and binding mode of multisite inhibitors	PLOS ONE			English	Article							MEMAPSIN-2 BETA-SECRETASE; PARTICLE MESH EWALD; ACTIVE-SITE; ALZHEIMERS-DISEASE; CRYPTIC POCKET; DESIGN; FLEXIBILITY; DERIVATIVES; DISCOVERY; BIOLOGY	The critical role of BACE-1 in the formation of neurotoxic beta-amyloid peptides in the brain makes it an attractive target for an efficacious treatment of Alzheimer's disease. However, the development of clinically useful BACE-1 inhibitors has proven to be extremely challenging. In this study we examine the binding mode of a novel potent inhibitor (compound 1, with IC50 80 nM) designed by synergistic combination of two fragments-huprine and rhein-that individually are endowed with very low activity against BACE-1. Examination of crystal structures reveals no appropriate binding site large enough to accommodate 1. Therefore we have examined the conformational flexibility of BACE-1 through extended molecular dynamics simulations, paying attention to the highly flexible region shaped by loops 8-14, 154-169 and 307-318. The analysis of the protein dynamics, together with studies of pocket druggability, has allowed us to detect the transient formation of a secondary binding site, which contains Arg307 as a key residue for the interaction with small molecules, at the edge of the catalytic cleft. The formation of this druggable "floppy" pocket would enable the binding of multisite inhibitors targeting both catalytic and secondary sites. Molecular dynamics simulations of BACE-1 bound to huprine-rhein hybrid compounds support the feasibility of this hypothesis. The results provide a basis to explain the high inhibitory potency of the two enantiomeric forms of 1, together with the large dependence on the length of the oligomethylenic linker. Furthermore, the multisite hypothesis has allowed us to rationalize the inhibitory potency of a series of tacrine-chromene hybrid compounds, specifically regarding the apparent lack of sensitivity of the inhibition constant to the chemical modifications introduced in the chromene unit. Overall, these findings pave the way for the exploration of novel functionalities in the design of optimized BACE-1 multisite inhibitors.	[Di Pietro, Ornella; Munoz-Torrero, Diego] Univ Barcelona, Fac Pharm & Food Sci, Lab Pharmaceut Chem, Barcelona, Spain; [Di Pietro, Ornella; Munoz-Torrero, Diego] Univ Barcelona, Inst Biomed, Barcelona, Spain; [Juarez-Jimenez, Jordi; Luque, F. Javier] Univ Barcelona, Fac Pharm & Food Sci, Dept Nutr Food Sci & Gastron, Campus Torribera, Santa Coloma De Gramenet, Spain; [Juarez-Jimenez, Jordi; Luque, F. Javier] Univ Barcelona, Inst Biomed, Campus Torribera, Santa Coloma De Gramenet, Spain; [Laughton, Charles A.] Sch Pharm, Univ Pk, Nottingham, England; [Laughton, Charles A.] Ctr Biomol Sci, Univ Pk, Nottingham, England; [Juarez-Jimenez, Jordi] Univ Edinburgh, EaStCHEM Sch Chem, Edinburgh, Midlothian, Scotland	University of Barcelona; University of Barcelona; University of Barcelona; University of Barcelona; University of Nottingham; University of Nottingham; University of Edinburgh	Luque, FJ (corresponding author), Univ Barcelona, Fac Pharm & Food Sci, Dept Nutr Food Sci & Gastron, Campus Torribera, Santa Coloma De Gramenet, Spain.; Luque, FJ (corresponding author), Univ Barcelona, Inst Biomed, Campus Torribera, Santa Coloma De Gramenet, Spain.; Laughton, CA (corresponding author), Sch Pharm, Univ Pk, Nottingham, England.; Laughton, CA (corresponding author), Ctr Biomol Sci, Univ Pk, Nottingham, England.	charles.Iaughton@nottingham.ac.uk; fibuque@ub.edu	Muñoz-Torrero, Diego/K-9787-2014; Jiménez, Jordi Juárez/ABG-7372-2020; Luque, F. Javier/L-9652-2014; Laughton, Charles A/E-5667-2010	Muñoz-Torrero, Diego/0000-0002-8140-8555; Jiménez, Jordi Juárez/0000-0003-1464-1397; Luque, F. Javier/0000-0002-8049-3567; Laughton, Charles A/0000-0003-4090-3960	Ministerio de Economia y Competitividad [SAF2014-57094-R]; Generalitat de Catalunya [2014SGR1189, 2014SGR52]; ICREA Academia; HECBioSim consortium (EPSRC) [EP/L000253/1]	Ministerio de Economia y Competitividad(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); ICREA Academia(ICREA); HECBioSim consortium (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Ministerio de Economia y Competitividad (SAF2014-57094-R), Generalitat de Catalunya (GC; 2014SGR1189, 2014SGR52), and ICREA Academia (FJL). The Consorci de Serveis Universitaris de Catalunya (CSUC; FJL) is acknowledged for providing computational resources. This work used the ARCHER UK National Supercomputing Service (http:/www.archer.ac.uk), via the HECBioSim consortium (EPSRC Grant EP/L000253/1). A fellowship from GC to ODP is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahar I, 2010, CHEM REV, V110, P1463, DOI 10.1021/cr900095e; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bowman GR, 2015, P NATL ACAD SCI USA, V112, P2734, DOI 10.1073/pnas.1417811112; Camps P, 2000, MOL PHARMACOL, V57, P409; Cascella M, 2005, J AM CHEM SOC, V127, P3734, DOI 10.1021/ja044608+; Case DA, 2012, AMBER 12; Cimermancic P, 2016, J MOL BIOL, V428, P709, DOI 10.1016/j.jmb.2016.01.029; Cole SL, 2007, CURR GENOMICS, V8, P509, DOI 10.2174/138920207783769512; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DAVIES DR, 1990, ANNU REV BIOPHYS BIO, V19, P189, DOI 10.1146/annurev.bb.19.060190.001201; Edfeldt FNB, 2011, DRUG DISCOV TODAY, V16, P284, DOI 10.1016/j.drudis.2011.02.002; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fernandez-Bachiller MI, 2012, J MED CHEM, V55, P1303, DOI 10.1021/jm201460y; Friedman R, 2010, PROTEINS, V78, P1575, DOI 10.1002/prot.22674; Galdeano C, 2012, J MED CHEM, V55, P661, DOI 10.1021/jm200840c; Ghosh AK, 2007, J MED CHEM, V50, P2399, DOI 10.1021/jm061338s; Ghosh AK, 2015, CHEMMEDCHEM, V10, P1463, DOI 10.1002/cmdc.201500216; Ghosh AK, 2014, CHEM SOC REV, V43, P6765, DOI 10.1039/c3cs60460h; Gorfe AA, 2005, STRUCTURE, V13, P1487, DOI 10.1016/j.str.2005.06.015; Gutierrez LJ, 2010, J PHYS CHEM A, V114, P10261, DOI 10.1021/jp104983a; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hong L, 2000, SCIENCE, V290, P150, DOI 10.1126/science.290.5489.150; Hong L, 2004, BIOCHEMISTRY-US, V43, P4689, DOI 10.1021/bi0498252; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kacker P, 2012, CURR MED CHEM, V19, P6095; Kornacker MG, 2005, BIOCHEMISTRY-US, V44, P11567, DOI 10.1021/bi050932l; Kumalo HM, 2016, J BIOMOL STRUCT DYN, V34, P1008, DOI 10.1080/07391102.2015.1064831; Lama D, 2015, BIOCHEMISTRY-US, V54, P6535, DOI 10.1021/acs.biochem.5b00812; Laurent B, 2015, BIOINFORMATICS, V31, P1478, DOI 10.1093/bioinformatics/btu822; Le Guilloux V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-168; Lee JY, 2009, MOL CELLS, V27, P651, DOI 10.1007/s10059-009-0086-z; Liu S, 2012, BMC STRUCT BIOL, V12, DOI 10.1186/1472-6807-12-21; McConlogue L, 2007, J BIOL CHEM, V282, P26326, DOI 10.1074/jbc.M611687200; McGaughey GB, 2007, BIOORG MED CHEM LETT, V17, P1117, DOI 10.1016/j.bmcl.2006.11.003; Oleinikovas V, 2016, J AM CHEM SOC, V138, P14257, DOI 10.1021/jacs.6b05425; Park H, 2003, J AM CHEM SOC, V125, P16416; Patel S, 2004, J MOL BIOL, V343, P407, DOI 10.1016/j.jmb.2004.08.018; Roberds SL, 2001, HUM MOL GENET, V10, P1317, DOI 10.1093/hmg/10.12.1317; Ruiz-Carmona S, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003571; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schechter I, 2012, BIOCHEM BIOPH RES CO, V425, P497, DOI 10.1016/j.bbrc.2012.08.015; Schmidtke P, 2010, J MED CHEM, V53, P5858, DOI 10.1021/jm100574m; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Shkurti Ardita, 2016, SoftwareX, V5, P44, DOI 10.1016/j.softx.2016.04.002; Skovronsky DM, 2006, ANNU REV PATHOL-MECH, V1, P151, DOI 10.1146/annurev.pathol.1.110304.100113; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; Tan YS, 2012, ANGEW CHEM INT EDIT, V51, P10078, DOI 10.1002/anie.201205676; Turner RT, 2005, BIOCHEMISTRY-US, V44, P105, DOI 10.1021/bi048106k; Turner RT, 2001, BIOCHEMISTRY-US, V40, P10001, DOI 10.1021/bi015546s; van der Spoel D., 2005, GROMACS USER MANUAL; Vassar R, 2001, J MOL NEUROSCI, V17, P157, DOI 10.1385/JMN:17:2:157; Viayna E, 2014, J MED CHEM, V57, P2549, DOI 10.1021/jm401824w; Walker LC, 2006, AGE AGEING, V35, P332, DOI 10.1093/ageing/afl009; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang WR, 2013, CURR OPIN STRUC BIOL, V23, P797, DOI 10.1016/j.sbi.2013.08.001; Xu YC, 2012, ACTA CRYSTALLOGR D, V68, P13, DOI 10.1107/S0907444911047251; Yuan J, 2013, J MED CHEM, V56, P4156, DOI 10.1021/jm301659n; Zhou LJ, 2011, J BIOL CHEM, V286, P8677, DOI 10.1074/jbc.M110.194860	60	11	11	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177683	10.1371/journal.pone.0177683	http://dx.doi.org/10.1371/journal.pone.0177683			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505196	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000401473500033
J	Muller, A; Dahm, M; Bocher, PK; Root-Bernstein, M; Svenning, JC				Muller, Anke; Dahm, Maria; Bocher, Peder Klith; Root-Bernstein, Meredith; Svenning, Jens-Christian			Large herbivores in novel ecosystems - Habitat selection by red deer (Cervus elaphus) in a former brown-coal mining area	PLOS ONE			English	Article							SEED DISPERSAL; SPONTANEOUS SUCCESSION; MOUNTAIN FORESTS; VASCULAR PLANTS; PREDATION RISK; ROE DEER; LANDSCAPE; DIVERSITY; DYNAMICS; IMPACT	After centuries of range contraction, many megafauna species are recolonizing parts of Europe. One example is the red deer (Cervus elaphus), which was able to expand its range and is now found in half the areas it inhabited in the beginning of the 19 th century. Herbivores are important ecosystem engineers, influencing e.g. vegetation. Knowledge on their habitat selection and their influence on ecosystems might be crucial for future landscape management, especially for hybrid and novel ecosystems emerging in post-industrial landscapes. In this study, red deer habitat selection was studied in a former brown-coal mining area in Denmark. Here, natural settings were severely changed during the mining activity and its current landscape is in large parts managed by hunters as suitable deer habitat. We assessed red deer habitat preferences through feces presence and camera traps combined with land cover data from vegetation sampling, remote sensing and official geographic data. Red deer occurrence was negatively associated with human disturbance and positively associated with forage availability, tree cover and mean terrain height. Apparently, red deer are capable of recolonizing former industrial landscapes quite well if key conditions such as forage abundance and cover are appropriate. In the absence of carnivores, human disturbance, such as a hunting regime is a main reason why deer avoid certain areas. The resulting spatial heterogeneity red deer showed in their habitat use of the study area might be a tool to preserve mosaic landscapes of forest and open habitats and thus promote biodiversity in abandoned post-industrial landscapes.	[Muller, Anke; Dahm, Maria; Bocher, Peder Klith; Root-Bernstein, Meredith; Svenning, Jens-Christian] Aarhus Univ, Sect Ecoinformat & Biodivers, Dept Biosci, Aarhus, Mid Jutland, Denmark; [Muller, Anke] Tech Univ Munich, Study Fac Landscape Architecture & Landscape Plan, Freising Weihenstephan, Bavaria, Germany	Aarhus University; Technical University of Munich	Muller, A (corresponding author), Aarhus Univ, Sect Ecoinformat & Biodivers, Dept Biosci, Aarhus, Mid Jutland, Denmark.; Muller, A (corresponding author), Tech Univ Munich, Study Fac Landscape Architecture & Landscape Plan, Freising Weihenstephan, Bavaria, Germany.	anke.mueller@tum.de	Svenning, Jens-Christian/C-8977-2012; Müller, Anke/J-6051-2019	Svenning, Jens-Christian/0000-0002-3415-0862; Müller, Anke/0000-0002-3697-3221; Root-Bernstein, Meredith/0000-0002-2513-1248	Danish National Research Foundation Niels Bohr professorship project Aarhus University Research on the Anthropocene (AURA); Carlsberg Foundation [CF16-0005]	Danish National Research Foundation Niels Bohr professorship project Aarhus University Research on the Anthropocene (AURA); Carlsberg Foundation(Carlsberg Foundation)	We would like to thank the Danish National Research Foundation Niels Bohr professorship project Aarhus University Research on the Anthropocene (AURA)for funding. JCS also acknowledge this work as a contribution to the Carlsberg Foundation "Semper Ardens" project MegaPast2Future (CF16-0005).	Ammer C, 1996, FOREST ECOL MANAG, V88, P43, DOI 10.1016/S0378-1127(96)03808-X; [Anonymous], 2014, R LANG ENV STAT COMP; Baasch A, 2012, J APPL ECOL, V49, P251, DOI 10.1111/j.1365-2664.2011.02086.x; Bang P, 1972, DYRESPOR SPOR SPORTE; Betard F, 2013, GEOHERITAGE, V5, P59, DOI 10.1007/s12371-013-0078-4; Bobrowski M, 2015, FOREST ECOL MANAG, V358, P212, DOI 10.1016/j.foreco.2015.08.031; Bradshaw A, 2000, LANDSCAPE URBAN PLAN, V51, P89, DOI 10.1016/S0169-2046(00)00099-2; Buttenschon R. M., 2007, GRAESNING HOSLAET NA; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; Coates P., 2013, PROGR PHYS GEOGRAPHY; Cornelissen P, 2014, BASIC APPL ECOL, V15, P396, DOI 10.1016/j.baae.2014.06.006; CORNWELL SM, 1973, TOWN PLANN REV, V44, P221, DOI 10.3828/tpr.44.3.y2156h11r3571hp8; Danell K., 2006, LARGE HERBIVORE ECOL; Danish Geodata Agency, 2007, DAN NAT HEIGHT MOD; Danish Geodata Agency, 2013, KORT 10; Darimont CT, 2015, SCIENCE, V349, P858, DOI 10.1126/science.aac4249; Debeljak M, 2001, ECOL MODEL, V138, P321, DOI 10.1016/S0304-3800(00)00411-7; Deinet S., 2013, WILDLIFE COMEBACK EU; Ensing EP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106997; Flinterup M., 2015, JAEGER, V24, P52; Gill RMA, 2001, FORESTRY, V74, P209, DOI 10.1093/forestry/74.3.209; Gortazar C, 2016, EUR J WILDLIFE RES, V62, P511, DOI 10.1007/s10344-016-1033-x; Harabis F, 2016, ECOL ENG, V90, P438, DOI 10.1016/j.ecoleng.2016.01.070; Haugaard Sunde P, 2014, VIDENSKABELIG RAPPOR, P2244; Haynes G, 2012, GEOMORPHOLOGY, V157, P99, DOI 10.1016/j.geomorph.2011.04.045; Hegland SJ, 2013, FOREST ECOL MANAG, V310, P267, DOI 10.1016/j.foreco.2013.08.031; Heinken T, 2002, FORSTWISS CENTRALBL, V121, P179, DOI 10.1046/j.1439-0337.2002.02029.x; Heinze E, 2011, FOREST ECOL MANAG, V261, P288, DOI 10.1016/j.foreco.2010.10.022; Heneberg P, 2013, J INSECT CONSERV, V17, P473, DOI 10.1007/s10841-012-9529-5; Hobbs RJ, 2016, RESTOR ECOL, V24, P153, DOI 10.1111/rec.12336; Hobbs RJ, 2014, FRONT ECOL ENVIRON, V12, P557, DOI 10.1890/130300; Hobbs RJ, 2009, TRENDS ECOL EVOL, V24, P599, DOI 10.1016/j.tree.2009.05.012; Hughes FMR, 2011, J NAT CONSERV, V19, P245, DOI 10.1016/j.jnc.2011.02.003; Iravani M, 2011, BASIC APPL ECOL, V12, P505, DOI 10.1016/j.baae.2011.07.004; Jayakody S, 2008, WILDLIFE BIOL, V14, P81, DOI 10.2981/0909-6396(2008)14[81:RDCEVB]2.0.CO;2; Jayakody S, 2011, EUR J WILDLIFE RES, V57, P939, DOI 10.1007/s10344-011-0508-z; Jorritsma ITM, 1999, FOREST ECOL MANAG, V120, P23, DOI 10.1016/S0378-1127(98)00540-4; Kuijper DPJ, 2011, EUR J FOREST RES, V130, P895, DOI 10.1007/s10342-011-0523-3; Kuijper DPJ, 2010, J VEG SCI, V21, P1082, DOI 10.1111/j.1654-1103.2010.01217.x; Lande US, 2014, EUR J WILDLIFE RES, V60, P69, DOI 10.1007/s10344-013-0751-6; LOFT ER, 1988, J WILDLIFE MANAGE, V52, P524, DOI 10.2307/3801604; Lone K, 2014, OIKOS, V123, P641, DOI 10.1111/j.1600-0706.2013.00938.x; MacCullum B.N., 1992, Geojournal, V27, P23, DOI 10.1007/BF00150633; Malo JE, 1998, ECOGRAPHY, V21, P204, DOI 10.1111/j.1600-0587.1998.tb00673.x; Mansson J, 2011, EUR J WILDLIFE RES, V57, P1017, DOI 10.1007/s10344-011-0512-3; Masse A, 2012, FOREST ECOL MANAG, V285, P67, DOI 10.1016/j.foreco.2012.07.039; Matrai K, 2004, J WILDLIFE MANAGE, V68, P879, DOI 10.2193/0022-541X(2004)068[0879:RUBRDI]2.0.CO;2; Milner JM, 2014, J WILDLIFE MANAGE, V78, P1322, DOI 10.1002/jwmg.798; Mitchell B., 1977, ECOLOGY RED DEER A R; Moore EK, 2015, BIOL CONSERV, V192, P218, DOI 10.1016/j.biocon.2015.09.019; Motta R, 1996, FOREST ECOL MANAG, V88, P93, DOI 10.1016/S0378-1127(96)03814-5; Mysterud A, 2001, J ANIM ECOL, V70, P915, DOI 10.1046/j.0021-8790.2001.00559.x; Navarro LM, 2012, ECOSYSTEMS, V15, P900, DOI 10.1007/s10021-012-9558-7; NUGENT G, 1993, NEW ZEAL J ZOOL, V20, P361, DOI 10.1080/03014223.1993.10420359; Olff H, 1998, TRENDS ECOL EVOL, V13, P261, DOI 10.1016/S0169-5347(98)01364-0; Perez-Barberia FJ, 2013, OECOLOGIA, V173, P837, DOI 10.1007/s00442-013-2686-8; Putman RJ, 2004, MAMMAL REV, V34, P285, DOI 10.1111/j.1365-2907.2004.00044.x; Reinecke H, 2014, EUR J WILDLIFE RES, V60, P237, DOI 10.1007/s10344-013-0772-1; Rich KJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136522; Salek M, 2012, J APPL ECOL, V49, P1417, DOI 10.1111/j.1365-2664.2012.02215.x; Sandom CJ, 2014, P NATL ACAD SCI USA, V111, P4162, DOI 10.1073/pnas.1311014111; Stoate C, 2009, J ENVIRON MANAGE, V91, P22, DOI 10.1016/j.jenvman.2009.07.005; Sunde P, 2008, HVOR NEDLAGGES KRON; Svenning JC, 2002, BIOL CONSERV, V104, P133, DOI 10.1016/S0006-3207(01)00162-8; Theuerkauf J, 2008, FOREST ECOL MANAG, V256, P1325, DOI 10.1016/j.foreco.2008.06.030; Timmermann A, 2015, J APPL ECOL, V52, P21, DOI 10.1111/1365-2664.12374; Torres RT, 2014, MAMM BIOL, V79, P52, DOI 10.1016/j.mambio.2013.09.002; Torres RT, 2012, MAMM BIOL, V77, P140, DOI 10.1016/j.mambio.2011.11.002; Tropek R, 2010, J APPL ECOL, V47, P139, DOI 10.1111/j.1365-2664.2009.01746.x; Tschope O, 2011, APPL VEG SCI, V14, P200, DOI 10.1111/j.1654-109X.2010.01119.x; Van Uytvanck J., 2014, EUROPEAN WOOD PASTUR, P149, DOI DOI 10.4324/9780203797082; Vojar J, 2016, ECOL ENG, V90, P278, DOI 10.1016/j.ecoleng.2016.01.028; von Oheimb G, 2005, EUR J FOREST RES, V124, P55, DOI 10.1007/s10342-005-0053-y; WELCH D, 1985, J APPL ECOL, V22, P461, DOI 10.2307/2403178; Whitehouse NJ, 2010, QUATERNARY SCI REV, V29, P539, DOI 10.1016/j.quascirev.2009.10.010	75	19	21	6	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177431	10.1371/journal.pone.0177431	http://dx.doi.org/10.1371/journal.pone.0177431			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505192	Green Published, gold, Green Submitted			2022-12-26	WOS:000401473500021
J	Walker, J; Mertens, UK; Schmidt, CO; Chenot, JF				Walker, Jochen; Mertens, Ulf Kai; Schmidt, Carsten Oliver; Chenot, Jean-Francois			Effect on healthcare utilization and costs of spinal manual therapy for acute low back pain in routine care: A propensity score matched cohort study	PLOS ONE			English	Article							CLINICAL-PREDICTION RULE; PHYSICAL-THERAPY; MANIPULATION; GUIDELINES; MANAGEMENT; EXERCISE; UPDATE	Spinal manual therapy (SMT) is a popular treatment option for low back pain (LBP). The aim of our analysis was to evaluate the effects of manual therapy delivered by general practitioners and ambulatory orthopedic surgeons in routine care on follow up consultations, sick leave, health service utilization and costs for acute LBP compared to matched patients not receiving manual therapy. This is a propensity score matched cohort study based on health claims data. We identified a total of 113.652 adult patients with acute LBP and no coded red flags of whom 21.021 (18%) received SMT by physicians. In the final analysis 17.965 patients in each group could be matched. Balance on patients' coded characteristics, comorbidity and prior health service utilization was achieved. The provision of SMT for acute LBP had no relevant impact on follow up visits and days of sick leave for LBP in the index billing period and the following year. SMT was associated with a higher proportion of imaging studies for LBP (30.6% vs. 23%, SMD: 0.164 [95% CI 0.143-0.185]). SMT did not lead to meaningful savings by replacing other health services for LBP. SMT for acute non-specific LBP in routine care was not clinically meaningful effective to reduce sick leave and reconsultation rates compared to no SMT and did not lead to meaningful savings by replacing other health services from the perspective of health insurance. This does not imply that SMT is ineffective but might reflect a problem with selection of suitable patients and the quality and quantity of SMT in routine care. National Manual Medicine societies should state clearly that imaging is not routinely needed prior to SMT in patients with low suspicion of presence of red flags and monitor the quality of provided services.	[Walker, Jochen] Elsevier Hlth Analyt, Berlin, Germany; [Mertens, Ulf Kai] Heidelberg Univ, Inst Psychol, Dept Quantitat Res Methods, Heidelberg, Germany; [Schmidt, Carsten Oliver] Univ Med Greifswald, Inst Community Med, SHIP KEF, Greifswald, Germany; [Chenot, Jean-Francois] Univ Med Greifswald, Inst Community Med, Dept Gen Practice, Greifswald, Germany; [Walker, Jochen] Ingef Inst Angew Gesundheitsforsch, Berlin, Germany	Reed Elsevier; Elsevier; Ruprecht Karls University Heidelberg; Greifswald Medical School; Greifswald Medical School	Chenot, JF (corresponding author), Univ Med Greifswald, Inst Community Med, Dept Gen Practice, Greifswald, Germany.	jchenot@uni-greifswald.de	Schmidt, Carsten Oliver/AAH-2778-2019; Chenot, Jean-Francois/F-8241-2011	Schmidt, Carsten Oliver/0000-0001-5266-9396; Chenot, Jean-Francois/0000-0001-8877-2950	Elsevier Health Analytics	Elsevier Health Analytics	JW was employed by Elsevier Health Analytics at the time of the study. UKM did a student clerkship and received a stipend from Elsevier Health Analytics. Elsevier Health Analytics provided support in the form of salaries for JW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham I, 2002, ARCH INTERN MED, V162, P1442, DOI 10.1001/archinte.162.13.1442; Andersohn F, 2016, PHARMACOEPIDEM DR S, V25, P106, DOI 10.1002/pds.3895; [Anonymous], 2011, NATL VERSORGUNGSLEIT; Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Chento J-F, 2014, VERSORGUNGS REPORT 2, P155; Childs JD, 2004, ANN INTERN MED, V141, P920, DOI 10.7326/0003-4819-141-12-200412210-00008; Chou R, 2009, LANCET, V373, P463, DOI 10.1016/S0140-6736(09)60172-0; Chu E, 2005, WHO GUIDELINES BASIC; Cleland JA, 2009, SPINE, V34, P2720, DOI 10.1097/BRS.0b013e3181b48809; Eisenberg DM, 2007, SPINE, V32, P151, DOI 10.1097/01.brs.0000252697.07214.65; Flynn T, 2002, SPINE, V27, P2835, DOI 10.1097/00007632-200212150-00021; Fritz JM, 2015, JAMA-J AM MED ASSOC, V314, P1459, DOI 10.1001/jama.2015.11648; Hayden JA, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000335.pub2; Hidalgo B, 2014, J MAN MANIP THER, V22, P59, DOI 10.1179/2042618613Y.0000000041; Ho DE, 2001, J STAT SOFTW, V42, P1; Hoiriis KT, 2004, J MANIP PHYSIOL THER, V27, P388, DOI 10.1016/j.jmpt.2004.05.003; Kendrick D, 2005, BMJ-BRIT MED J, V322, P400; Kent P, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-22; Koes BW, 2010, EUR SPINE J, V19, P2075, DOI 10.1007/s00586-010-1502-y; Maigne J. -Y., 2007, Annales de Readaptation et de Medecine Physique, V50, P111, DOI 10.1016/j.annrmp.2006.08.004; Michaleff ZA, 2012, J ELECTROMYOGR KINES, V22, P655, DOI 10.1016/j.jelekin.2012.02.011; National Collaborating Centre for Primary Care, 2009, LOW BACK PAIN EARL M; Oliphant D, 2004, J MANIP PHYSIOL THER, V27, P197, DOI 10.1016/j.jmpt.2003.12.023; Peat G, 2008, PAIN, V139, P483, DOI 10.1016/j.pain.2008.09.002; Pillastrini P, 2012, JOINT BONE SPINE, V79, P176, DOI 10.1016/j.jbspin.2011.03.019; Rubinstein SM, 2013, SPINE, V38, pE158, DOI 10.1097/BRS.0b013e31827dd89d; Stanton TR, 2010, EUR SPINE J, V19, P533, DOI 10.1007/s00586-009-1214-3; Team RC, 2014, R LANG ENV STAT COMP; van Tulder M, 2006, EUR SPINE J, V15, pS169, DOI 10.1007/s00586-006-1071-2; VONKORFF M, 1994, SPINE, V19, pS2041	31	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177255	10.1371/journal.pone.0177255	http://dx.doi.org/10.1371/journal.pone.0177255			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505161	Green Published, Green Submitted, gold			2022-12-26	WOS:000401473500016
J	Froissart, L; Giurfa, M; Sauzet, S; Desouhant, E				Froissart, Lucie; Giurfa, Martin; Sauzet, Sandrine; Desouhant, Emmanuel			Cognitive adaptation in asexual and sexual wasps living in contrasted environments	PLOS ONE			English	Article							VENTURIA-CANESCENS HYMENOPTERA; LONG-TERM-MEMORY; PARASITIC WASP; DIFFERENT HABITATS; NATURAL VARIATION; LARIOPHAGUS-DISTINGUENDUS; DROSOPHILA-MELANOGASTER; PLODIA-INTERPUNCTELLA; NEMERITIS-CANESCENS; GENETIC-VARIABILITY	Differences in learning and memory dynamics between populations are suspected to result from differences in ecological constraints such as resource distribution. The two reproductive modes (strains) of the parasitoid wasp Venturia canescens share the same geographical areas but live in contrasting habitats: arrhenotokous wasps live in the wild (generally orchards), whereas thelytokous ones live mostly in stored-products buildings (e. g. granaries). This species thus represents a relevant biological model for understanding the relationship between the ecological constraints faced by a species and its memory and learning ability. We showed that after having laid eggs in presence of both a synthetic odour and natural olfactory cues of their host, arrhenotokous wasps exhibited a change in their behavioural response towards the synthetic odour that was at least as pronounced as in thelytokous ones even though they were faster in their decision-making process. This is consistent with better learning skills in arrhenotokous wasps. The corresponding memory trace persisted in both strains for at least 51 h. We compare and discuss the learning and memory ablities of both strains as a function of their costs and benefits in their preferential habitats.	[Froissart, Lucie; Sauzet, Sandrine; Desouhant, Emmanuel] Univ Lyon, Univ Claude Bernard, CNRS, Lab Biometrie & Biol Evolut,UMR 5558, Villeurbanne, France; [Froissart, Lucie] Univ Lumiere Lyon 2, Inst Univ Technol Lyon 2, Bron, France; [Giurfa, Martin] Univ Toulouse, CNRS, Res Ctr Anim Cognit, Toulouse, France; [Froissart, Lucie] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Universite Lyon 2; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Lausanne	Froissart, L; Desouhant, E (corresponding author), Univ Lyon, Univ Claude Bernard, CNRS, Lab Biometrie & Biol Evolut,UMR 5558, Villeurbanne, France.; Froissart, L (corresponding author), Univ Lumiere Lyon 2, Inst Univ Technol Lyon 2, Bron, France.	lucie.froissart@unil.ch; emmanuel.desouhant@univ-lyon1.fr	Giurfa, Martin/AAS-4945-2020; Giurfa, Martin/H-5140-2016	Giurfa, Martin/0000-0001-7173-769X; Giurfa, Martin/0000-0001-7173-769X; DESOUHANT, Emmanuel/0000-0003-0317-4463; Froissart, Lucie/0000-0002-8609-1243	Agence Nationale de la Recherche (FR) [JCJC06_138616]; Institut Universitaire de France	Agence Nationale de la Recherche (FR)(French National Research Agency (ANR)); Institut Universitaire de France	This work was supported by the Agence Nationale de la Recherche (FR) (http://www. agence-nationale-recherehe.fr/) grant number JCJC06_138616 to ED. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank F. Debias and X. Fauvergue for their technical assistance, I. Amat, C. Bernstein, E. Leglise and M. Burgy for discussions. M.G. thanks the Institut Universitaire de France for financial support. This support did not benefit directly or indirectly the present study.	Amat I, 2006, OECOLOGIA, V148, P153, DOI 10.1007/s00442-005-0332-9; Amat I, 2003, J INSECT PHYSIOL, V49, P1183, DOI 10.1016/j.jinsphys.2003.09.001; Amat I., 2004, THESIS, V1; Amat I, 2009, BEHAV ECOL SOCIOBIOL, V63, P563, DOI 10.1007/s00265-008-0691-4; Amat I, 2012, ECOL ENTOMOL, V37, P480, DOI 10.1111/j.1365-2311.2012.01388.x; ARTHUR AP, 1971, CAN ENTOMOL, V103, P1137, DOI 10.4039/Ent1031137-8; Barco A, 2006, J NEUROCHEM, V97, P1520, DOI 10.1111/j.1471-4159.2006.03870.x; Barke Jorg, 2005, Proceedings of the Section Experimental and Applied Entomology of the Netherlands Entomological Society (N.E.V.), V16, P27; Beukeboom L. W., 1999, P 8 M EXP APPL ENT N, V10, P23; Bleeker MAK, 2006, ANIM BEHAV, V71, P1343, DOI 10.1016/j.anbehav.2005.09.016; Bowditch TG, 1996, J STORED PROD RES, V32, P123, DOI 10.1016/0022-474X(96)00008-2; Castelo MK, 2003, J INSECT BEHAV, V16, P307, DOI 10.1023/A:1023928204793; Chittka L, 2009, TRENDS ECOL EVOL, V24, P400, DOI 10.1016/j.tree.2009.02.010; Chuine A, 2015, BIOL J LINN SOC, V114, P279, DOI 10.1111/bij.12421; Collatz J, 2006, LEARN MEMORY, V13, P263, DOI 10.1101/lm.192506; Desouhant E, 2005, ANIM BEHAV, V70, P145, DOI 10.1016/j.anbehav.2004.10.015; Desouhant E, 2010, ANIM COGN, V13, P535, DOI 10.1007/s10071-009-0304-2; Driessen G, 1999, J ANIM ECOL, V68, P445, DOI 10.1046/j.1365-2656.1999.00296.x; Dukas Reuven, 1998, P129; Dunlap AS, 2009, P ROY SOC B-BIOL SCI, V276, P3201, DOI 10.1098/rspb.2009.0602; Eliassen S, 2007, OIKOS, V116, P513, DOI 10.1111/j.2006.0030-1299.15462.x; Eliassen S, 2009, AM NAT, V174, P478, DOI 10.1086/605370; Ferrari MCO, 2010, P ROY SOC B-BIOL SCI, V277, P2205, DOI 10.1098/rspb.2009.2117; Foray V, 2014, FUNCT ECOL, V28, P411, DOI 10.1111/1365-2435.12171; Foray V, 2013, COMP BIOCHEM PHYS A, V164, P77, DOI 10.1016/j.cbpa.2012.10.018; Foray V, 2011, NATURWISSENSCHAFTEN, V98, P683, DOI 10.1007/s00114-011-0818-8; Giurfa M, 2009, LEARN MEMORY, V16, P761, DOI 10.1101/lm.1603009; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; Griffith LC, 2009, LEARN MEMORY, V16, P743, DOI 10.1101/lm.956309; HARVEY JA, 1995, EUR J ENTOMOL, V92, P427; Hirvonen H, 1999, ECOL MODEL, V115, P177, DOI 10.1016/S0304-3800(98)00191-4; Hoedjes KM, 2012, GENES BRAIN BEHAV, V11, P879, DOI 10.1111/j.1601-183X.2012.00823.x; Hoedjes KM, 2014, BEHAV PROCESS, V105, P40, DOI 10.1016/j.beproc.2014.02.014; Hoedjes KM, 2011, P ROY SOC B-BIOL SCI, V278, P889, DOI 10.1098/rspb.2010.2199; HOLLIDAY M, 1986, BEHAV GENET, V16, P439, DOI 10.1007/BF01074263; Kaiser L, 2009, ADV PARASIT, V70, P67, DOI 10.1016/S0065-308X(09)70003-X; Koppik M, 2015, ANIM COGN, V18, P593, DOI 10.1007/s10071-014-0828-y; Leach IM, 2012, GENETICA, V140, P53, DOI 10.1007/s10709-012-9657-6; Li D, 2003, HEREDITY, V90, P291, DOI 10.1038/sj.hdy.6800241; Liu YQ, 2009, ENTOMOL EXP APPL, V132, P110, DOI 10.1111/j.1570-7458.2009.00878.x; Lucchetta P, 2007, BEHAV ECOL SOCIOBIOL, V61, P1409, DOI 10.1007/s00265-007-0372-8; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; MCNAMARA JM, 1987, J THEOR BIOL, V125, P385, DOI 10.1016/S0022-5193(87)80209-6; Menzel R, 1999, J COMP PHYSIOL A, V185, P323, DOI 10.1007/s003590050392; Mery F, 2005, SCIENCE, V308, P1148, DOI 10.1126/science.1111331; Mery F., 2009, SEB EXP BIOL SER, V63, P24; Mettke-Hofmann C, 2014, WIRES COGN SCI, V5, P345, DOI 10.1002/wcs.1289; Metzger M, 2010, ANIM BEHAV, V79, P1307, DOI 10.1016/j.anbehav.2010.03.003; MUDD A, 1973, ENTOMOL EXP APPL, V16, P291, DOI 10.1007/BF00290701; Muller C, 2006, ANIM BIOL, V56, P221, DOI 10.1163/157075606777304195; Orr MV, 2008, J EXP BIOL, V211, P2807, DOI 10.1242/jeb.020172; PAPAJ DR, 1990, J CHEM ECOL, V16, P3137, DOI 10.1007/BF00979616; Pelosse P, 2007, EVOL ECOL, V21, P669, DOI 10.1007/s10682-006-9145-5; Pelosse P, 2011, BIOL J LINN SOC, V104, P621, DOI 10.1111/j.1095-8312.2011.01741.x; Pelosse P, 2010, ENTOMOL EXP APPL, V135, P68, DOI 10.1111/j.1570-7458.2009.00965.x; Pravosudov VV, 2002, BEHAV NEUROSCI, V116, P515, DOI 10.1037//0735-7044.116.4.515; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Raine NE, 2008, P R SOC B, V275, P803, DOI 10.1098/rspb.2007.1652; Ratcliffe JM, 2003, ANIM BEHAV, V65, P385, DOI 10.1006/anbe.2003.2059; Reaume CJ, 2011, P ROY SOC B-BIOL SCI, V278, P91, DOI 10.1098/rspb.2010.1337; ROGERS D, 1972, ENTOMOL EXP APPL, V15, P190, DOI 10.1007/BF00435170; SALT G, 1976, ECOL ENTOMOL, V1, P63, DOI 10.1111/j.1365-2311.1976.tb01205.x; Saunders DS, 2002, INSECT CLOCKS; Schneider MV, 2003, HEREDITY, V90, P260, DOI 10.1038/sj.hdy.6800245; Schneider MV, 2002, J EVOLUTION BIOL, V15, P191, DOI 10.1046/j.1420-9101.2002.00394.x; Schurmann D, 2012, ENTOMOL EXP APPL, V143, P199, DOI 10.1111/j.1570-7458.2012.01253.x; Schurmann D, 2009, NATURWISSENSCHAFTEN, V96, P383, DOI 10.1007/s00114-008-0490-9; Searle LV, 1949, GENETIC PSYCHOL MONO, V39, P279; Shettleworth S. J., 2009, COGNITION EVOLUTION; Shettleworth SJ, 2003, BRAIN BEHAV EVOLUT, V62, P108, DOI 10.1159/000072441; Smid HM, 2007, P ROY SOC B-BIOL SCI, V274, P1539, DOI 10.1098/rspb.2007.0305; Steidle JLM, 2003, ENTOMOL EXP APPL, V108, P133, DOI 10.1046/j.1570-7458.2003.00080.x; Stephens DW, 1991, BEHAV ECOL, V2, P77, DOI 10.1093/beheco/2.1.77; Stough S, 2006, CURR OPIN NEUROBIOL, V16, P672, DOI 10.1016/j.conb.2006.10.009; Tentelier C, 2006, BEHAV ECOL, V17, P515, DOI 10.1093/beheco/arj062; Thiel A, 2006, BEHAV ECOL SOCIOBIOL, V59, P614, DOI 10.1007/s00265-005-0088-6; Thiel A, 2013, ANIM COGN, V16, P223, DOI 10.1007/s10071-012-0567-x; Tricoire-Leignel H, 2012, FRONT PHYSL, P3; van den Berg M, 2011, ANIM BEHAV, V81, P325, DOI 10.1016/j.anbehav.2010.11.002; van Nouhuys S, 2008, P ROY SOC B-BIOL SCI, V275, P377, DOI 10.1098/rspb.2007.1446; VET LEM, 1992, ANNU REV ENTOMOL, V37, P141, DOI 10.1146/annurev.en.37.010192.001041; Vet LEM, 1991, NETH J ZOOL, V41, P202; Wustenberg D, 1998, EUR J NEUROSCI, V10, P2742, DOI 10.1046/j.1460-9568.1998.t01-1-00319.x	83	3	3	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177581	10.1371/journal.pone.0177581	http://dx.doi.org/10.1371/journal.pone.0177581			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UR	28498866	Green Submitted, gold, Green Published			2022-12-26	WOS:000401314500029
J	Colominas-Ciuro, R; Santos, M; Coria, N; Barbosa, A				Colominas-Ciuro, Roger; Santos, Mercedes; Coria, Nestor; Barbosa, Andres			Reproductive effort affects oxidative status and stress in an Antarctic penguin species: An experimental study	PLOS ONE			English	Article							BROOD SIZE; PYGOSCELIS-ANTARCTICA; CHINSTRAP PENGUINS; ADELIE PENGUINS; TRADE-OFF; ENERGY-EXPENDITURE; PARENTAL EFFORT; SEX; DAMAGE; COSTS	The oxidative cost of reproduction has been a matter of debate in recent years presumably because of the lack of proper experimental studies. Based on the hypothesis that different brood sizes produce differential reproductive costs, an experimental manipulation during breeding of Ade A lie penguins was conducted at Hope Bay, Antarctica, to study oxidative status and stress. We predict that a lower reproductive effort should be positively related to low oxidative and physiological stress. We randomly assigned nests with two chicks to a control reproductive effort group (CRE), and by removing one chick from some nests with two chicks, formed a second, low reproductive effort group (LRE). We examined how oxidative status in blood plasma (reactive oxygen metabolites, ROMs, and total antioxidant capacity, OXY) and stress (heterophil/lymphocyte ratio, H/L) responded to a lower production of offspring total biomass. Our nest manipulation showed significant differences in offspring total biomass, which was lower in the LRE group. As predicted, the LRE group had higher antioxidant capacity than individuals in the CRE group. We have also found, although marginally significant, interactions between sex and treatment in the three variables analysed. Females had higher OXY, lower ROMs and lower H/L ratio when rearing one chick, whereas males did so when rearing two except for OXY which was high regardless of treatment. Moreover, there was a significant negative correlation between the H/L ratio and OXY in females. Finally, we have found a negative and significant relationship between the duration of the experiment and OXY and ROMs and positive with H/L ratio which suggests that indeed breeding penguins are paying an effort in physiological terms in relation to the duration of the chick rearing. In conclusion, a reduction of the reproductive effort decreased oxidative stress in this long-lived bird meaning that a link exists between breeding effort and oxidative stress. However, our findings suggest different sex strategies which results in opposite physiological responses presumably depending on different life-history strategies in males and females.	[Colominas-Ciuro, Roger; Barbosa, Andres] CSIC, Museo Nacl Ciencias Nat, Dept Ecol Evolut, Calle Jose Gutierrez Abascal 2, Madrid, Spain; [Santos, Mercedes; Coria, Nestor] Inst Antartico Argentino, Div Biol, Cerrito 1248, RA-1010 Buenos Aires, DF, Argentina	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Instituto Antartico Argentino	Colominas-Ciuro, R (corresponding author), CSIC, Museo Nacl Ciencias Nat, Dept Ecol Evolut, Calle Jose Gutierrez Abascal 2, Madrid, Spain.	rcolominas@mncn.csic.es	Barbosa, Andrés/C-3208-2008	Barbosa, Andrés/0000-0001-8434-3649; Colominas-Ciuro, Roger/0000-0001-6312-0702	Spanish Ministry of Economy and Competitiveness [CTM2011-24427, CTM2015-64720]; Spanish Ministry of Economy and Competitiveness FPI (Formacion de Personal Investigador) grant [BES2012-059299]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Spanish Ministry of Economy and Competitiveness FPI (Formacion de Personal Investigador) grant	This study was funded by the Spanish Ministry of Economy and Competitiveness (CTM2011-24427 and CTM2015-64720) to AB. RCC was supported a Spanish Ministry of Economy and Competitiveness FPI (Formacion de Personal Investigador) grant (BES2012-059299; http://www.mineco.gob.es/portal/site/mineco/?lang_choosen=en).	Alonso-Alvarez C, 2004, ECOL LETT, V7, P363, DOI 10.1111/j.1461-0248.2004.00594.x; Amat JA, 1996, J AVIAN BIOL, V27, P177, DOI 10.2307/3677150; Ardia DR, 2005, ECOLOGY, V86, P2040, DOI 10.1890/04-1619; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Barbosa A, 2013, ANTARCT SCI, V25, P329, DOI 10.1017/S0954102012000739; Barnes AI, 2003, ANIM BEHAV, V66, P199, DOI 10.1006/anbe.2003.2122; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beaulieu M, 2011, FUNCT ECOL, V25, P577, DOI 10.1111/j.1365-2435.2010.01825.x; Beaulieu M, 2010, P ROY SOC B-BIOL SCI, V277, P1087, DOI 10.1098/rspb.2009.1881; Beaulieu M, 2009, BEHAV ECOL, V20, P878, DOI 10.1093/beheco/arp076; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; BELL G, 1980, AM NAT, V116, P45, DOI 10.1086/283611; Blount JD, 2016, BIOL REV, V91, P483, DOI 10.1111/brv.12179; Breuner CW, 2013, FUNCT ECOL, V27, P24, DOI 10.1111/1365-2435.12016; CHAPPELL MA, 1993, BEHAV ECOL SOCIOBIOL, V33, P173, DOI 10.1007/BF00216598; Christe P, 2012, P ROY SOC B-BIOL SCI, V279, P1142, DOI 10.1098/rspb.2011.1546; Clarke J, 1998, POLAR BIOL, V20, P248, DOI 10.1007/s003000050301; Clarke J, 2006, MAR ECOL PROG SER, V310, P247, DOI 10.3354/meps310247; Costantini D., 2014, OXIDATIVE STRESS HOR; Costantini D, 2008, ECOL LETT, V11, P1238, DOI 10.1111/j.1461-0248.2008.01246.x; Costantini D, 2006, COMP BIOCHEM PHYS A, V145, P137, DOI 10.1016/j.cbpa.2006.06.002; Costantini D, 2014, J EXP BIOL, V217, P4237, DOI 10.1242/jeb.114116; Costantini D, 2014, NATURWISSENSCHAFTEN, V101, P541, DOI 10.1007/s00114-014-1190-2; Davis AK, 2008, FUNCT ECOL, V22, P760, DOI 10.1111/j.1365-2435.2008.01467.x; DEERENBERG C, 1995, ZOOL-ANAL COMPLEX SY, V99, P39; DIJKSTRA C, 1990, J ANIM ECOL, V59, P269, DOI 10.2307/5172; Emaresi G, 2016, J EXP BIOL, V219, P73, DOI 10.1242/jeb.128959; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fletcher Quinn E, 2013, Evolution, V67, P1527, DOI 10.1111/evo.12014; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Gonzalez-Medina E, 2015, ANIM BEHAV, V108, P9, DOI 10.1016/j.anbehav.2015.06.025; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; Harman D., 1957, J GERONTOL, V2; Hayward A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016557; Heiss RS, 2012, PHYSIOL BIOCHEM ZOOL, V85, P499, DOI 10.1086/666840; Horak P, 2000, CAN J ZOOL, V78, P905, DOI 10.1139/cjz-78-6-905; Ilmonen P, 2003, OECOLOGIA, V136, P148, DOI 10.1007/s00442-003-1243-2; Jones DP, 2006, ANTIOXID REDOX SIGN, V8, P1865, DOI 10.1089/ars.2006.8.1865; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Kuznetsova A, 2014, IMERTEST TEST RANDOM; LISHMAN GS, 1985, J ZOOL, V205, P245, DOI 10.1111/j.1469-7998.1985.tb03532.x; Merino S, 2006, J ANIM ECOL, V75, P1147, DOI 10.1111/j.1365-2656.2006.01135.x; Metcalfe NB, 2013, TRENDS ECOL EVOL, V28, P347, DOI 10.1016/j.tree.2013.01.015; Metcalfe NB, 2010, FUNCT ECOL, V24, P984, DOI 10.1111/j.1365-2435.2010.01750.x; Moberg GP, 2000, BIOLOGY OF ANIMAL STRESS, P1, DOI 10.1079/9780851993591.0001; MOLE S, 1993, OECOLOGIA, V93, P121, DOI 10.1007/BF00321201; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; MORENO J, 1995, POLAR BIOL, V15, P533; Oldakowski L, 2012, J EXP BIOL, V215, P1799, DOI 10.1242/jeb.068452; Reed TE, 2008, AM NAT, V171, pE89, DOI 10.1086/524957; Selman C, 2012, TRENDS ECOL EVOL, V27, P570, DOI 10.1016/j.tree.2012.06.006; SIIKAMAKI P, 1994, FUNCT ECOL, V8, P587, DOI 10.2307/2389919; Stearns S.C., 1992, pi; Stier A, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-37; Suorsa P, 2004, P ROY SOC B-BIOL SCI, V271, P435, DOI 10.1098/rspb.2003.2620; Team R.C, R LANG ENV STAT COMP; Thierry AM, 2014, BEHAV ECOL SOCIOBIOL, V68, P721, DOI 10.1007/s00265-014-1685-z; TRIVELPIECE WZ, 1987, ECOLOGY, V68, P351, DOI 10.2307/1939266; Tummeleht L, 2006, COMP BIOCHEM PHYS C, V144, P166, DOI 10.1016/j.cbpc.2006.08.004; van der Meer E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127984; Wegmann M, 2015, PHYSIOL BEHAV, V141, P127, DOI 10.1016/j.physbeh.2015.01.017; Widmann M, 2015, MOV ECOL, V3, DOI [10.1186/s40462-015-0052, 10.1186/s40462-015-0052-7]; Wiersma P, 2004, P ROY SOC B-BIOL SCI, V271, pS360, DOI 10.1098/rsbl.2004.0171; Williams T.D., 1995, PENGUINS; Williams TD, 2005, BIOSCIENCE, V55, P39, DOI 10.1641/0006-3568(2005)055[0039:MUTCOE]2.0.CO;2; WILSON RP, 1991, MAR BIOL, V109, P181, DOI 10.1007/BF01319385; WILSON RP, 1989, POLAR BIOL, V10, P161; Xu YC, 2014, FUNCT ECOL, V28, P402, DOI 10.1111/1365-2435.12168	68	14	14	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177124	10.1371/journal.pone.0177124	http://dx.doi.org/10.1371/journal.pone.0177124			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493935	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314300062
J	Zgheib, C; Hodges, MM; Hu, JY; Liechty, KW; Xu, JW				Zgheib, Carlos; Hodges, Maggie M.; Hu, Junyi; Liechty, Kenneth W.; Xu, Junwang			Long non-coding RNA Lethe regulates hyperglycemia-induced reactive oxygen species production in macrophages	PLOS ONE			English	Article							OXIDATIVE STRESS; NADPH OXIDASES; NOX FAMILY; PATHOGENESIS; APOPTOSIS	Type 2 diabetes mellitus is a complex, systemic metabolic disease characterized by insulin resistance and resulting hyperglycemia, which is associated with impaired wound healing. The clinical complications associated with hyperglycemia are attributed, in part, to the increased production of reactive oxygen species (ROS). Recent studies revealed that long non-coding RNAs (lncRNAs) play important regulatory roles in many biological processes. Specifically, lncRNA Lethe has been described as exhibiting an anti-inflammatory effect by binding to the p65 subunit of NF kappa B and blocking its binding to DNA and the subsequent activation of downstream genes. We therefore hypothesize that dysregulation of Lethe's expression plays a role in hyperglycemia-induced ROS production. To test our hypothesis, we treated RAW264.7 macrophages with low glucose (5 mM) or high glucose (25 mM) for 24h. High glucose conditions significantly induced ROS production and NOX2 gene expression in RAW cells, while significantly decreasing Lethe gene expression. Overexpression of Lethe in RAW cells eliminated the increased ROS production induced by high glucose conditions, while also attenuating the upregulation of NOX2 expression. Similar results was found also in non-diabetic and diabetic primary macrophage, bone marrow derived macrophage (BMM). Furthermore, overexpression of Lethe in RAW cells treated with high glucose significantly reduced the translocation of p65-NF kappa B to the nucleus, which resulted in decreased NOX2 expression and ROS production. Interestingly, these findings are consistent with the decreased Lethe gene expression and increased NOX2 gene expression observed in a mouse model of diabetic wound healing. These findings provide the first evidence that lncRNA Lethe is involved in the regulation of ROS production in macrophages through modulation of NOX2 gene expression via NF kappa B signaling. Moreover, this is the first report to describe a role of lncRNAs, in particular Lethe, in impaired diabetic wound healing. Further studies are warranted to determine if correction of Lethe expression in diabetic wounds could improve healing.	[Zgheib, Carlos; Hodges, Maggie M.; Hu, Junyi; Liechty, Kenneth W.; Xu, Junwang] Univ Colorado, Dept Surg, Anschutz Med Campus, Aurora, CO 80045 USA; [Zgheib, Carlos; Hodges, Maggie M.; Hu, Junyi; Liechty, Kenneth W.; Xu, Junwang] Childrens Hosp Colorado, Div Pediat Surg, Dept Surg, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado	Xu, JW (corresponding author), Univ Colorado, Dept Surg, Anschutz Med Campus, Aurora, CO 80045 USA.; Xu, JW (corresponding author), Childrens Hosp Colorado, Div Pediat Surg, Dept Surg, Aurora, CO 80045 USA.	Junwang.Xu@ucdenver.edu	Hodges, Maggie/HCG-9001-2022	Hodges, Maggie/0000-0001-5814-6932	NIH [1R01DK105010-01A1]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Support was provided by NIH 1R01DK105010-01A1.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Anrather J, 2006, J BIOL CHEM, V281, P5657, DOI 10.1074/jbc.M506172200; Arya AK, 2011, DIABETES RES CLIN PR, V94, P377, DOI 10.1016/j.diabres.2011.08.004; Bedard K, 2007, BIOCHIMIE, V89, P1107, DOI 10.1016/j.biochi.2007.01.012; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Callahan D, 2016, ANN VASC SURG, V33, P103, DOI 10.1016/j.avsg.2016.01.003; Ceradini DJ, 2008, J BIOL CHEM, V283, P10930, DOI 10.1074/jbc.M707451200; DARR D, 1994, J INVEST DERMATOL, V102, P671, DOI 10.1111/1523-1747.ep12374036; Gill SE, 2008, INT J BIOCHEM CELL B, V40, P1334, DOI 10.1016/j.biocel.2007.10.024; Goldman Robert, 2004, Adv Skin Wound Care, V17, P24, DOI 10.1097/00129334-200401000-00012; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; GRIESMACHER A, 1995, AM J MED, V98, P469, DOI 10.1016/S0002-9343(99)80347-7; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Jia YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120849; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Luo JD, 2004, CIRCULATION, V110, P2484, DOI 10.1161/01.CIR.0000137969.87365.05; Mauricio D, 1998, DIABETES, V47, P1537, DOI 10.2337/diabetes.47.10.1537; Moseley R, 2004, BRIT J DERMATOL, V150, P401, DOI 10.1111/j.1365-2133.2004.05845.x; Mudge BP, 2002, WOUND REPAIR REGEN, V10, P52, DOI 10.1046/j.1524-475X.2002.10803.x; Ojha N, 2008, FREE RADICAL BIO MED, V44, P682, DOI 10.1016/j.freeradbiomed.2007.10.056; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Ponugoti B, 2013, J CELL BIOL, V203, P327, DOI 10.1083/jcb.201305074; Porter BO, 1999, EUR J IMMUNOL, V29, P2360, DOI 10.1002/(SICI)1521-4141(199907)29:07<2360::AID-IMMU2360>3.0.CO;2-A; Rapicavoli NA, 2013, ELIFE, V2, DOI 10.7554/eLife.00762; Rasik AM, 2000, INT J EXP PATHOL, V81, P257, DOI 10.1046/j.1365-2613.2000.00158.x; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Rodriguez PG, 2008, DERMATOL SURG, V34, P1159, DOI 10.1111/j.1524-4725.2008.34254.x; Roy S, 2006, MOL THER, V13, P211, DOI 10.1016/j.ymthe.2005.07.684; Sen CK, 2008, BBA-GEN SUBJECTS, V1780, P1348, DOI 10.1016/j.bbagen.2008.01.006; Sun XH, 2016, AM J CARDIOVASC DIS, V6, P17; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Wlaschek M, 2005, WOUND REPAIR REGEN, V13, P452, DOI 10.1111/j.1067-1927.2005.00065.x; Xu JW, 2012, DIABETES, V61, P2906, DOI 10.2337/db12-0145; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83; Zhao XY, 2014, MOL CELL, V55, P372, DOI 10.1016/j.molcel.2014.06.004; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8	39	52	57	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177453	10.1371/journal.pone.0177453	http://dx.doi.org/10.1371/journal.pone.0177453			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28494015	gold, Green Published, Green Submitted			2022-12-26	WOS:000401314300113
J	Gebrihet, TA; Mesgna, KH; Gebregiorgis, YS; Kahsay, AB; Weldehaweria, NB; Weldu, MG				Gebrihet, Teklay Aredehey; Mesgna, Kebede Haile; Gebregiorgis, Yosef Sibhatu; Kahsay, Alemayehu Bayray; Weldehaweria, Negassie Berhe; Weldu, Meresa Gebremedhin			Awareness, treatment, and control of hypertension is low among adults in Aksum town, northern Ethiopia: A sequential quantitative-qualitative study	PLOS ONE			English	Article							BLOOD-PRESSURE; VEGETABLE CONSUMPTION; RISK-FACTORS; PREVALENCE; KNOWLEDGE; FRUIT; POPULATION; EDUCATION; HOME	Introduction Hypertension is a major risk factor of cardiovascular diseases which are the leading causes of deaths from chronic non-communicable diseases in Ethiopia. However, little is documented in the issue. Therefore, this study aimed to assess the prevalence, associated factors, awareness, treatment and control of hypertension among adults 18 years old or above in Aksum town, Tigray region, North Ethiopia. Methods A sequential quantitative-qualitative study was conducted among adults aged 18 years and above in Aksum town. A multi stage sampling procedure was used to select the study participants for the quantitative study whilst convenience sampling technique was used for the qualitative part. A pre-tested and structured questionnaire was used to collect quantitative data, and an interview guide was used to collect the qualitative data. The logistic regression model was fitted to identify factors independently associated with hypertension using SPSS Version 20. P-values of < 0.05 were considered statistically significant. For the qualitative data, iterative hearing of the discussions verbatim interpretation was followed by categorizing similar ideas into themes and finally triangulated with the quantitative results. Results The overall prevalence of hypertension was 16.5% (95% CI: 13.4, 20.0). Awareness, treatment and control of hypertension were 43%, 2.1% and 18.2%, respectively. Being unable to read and write [AOR = 4.73, 95% CI: 1.11, 20.23], not consuming fruit [ AOR = 4.31, 95% CI: 1.74, 10.66], being physically inactive [AOR = 20.11, 95% CI: 8.75, 6.20], not knowing physical inactivity is a risk factor of hypertension [AOR = 3.57, 95% CI: 1.69, 7.69] and being overweight/obese [AOR = 9.2, 95% CI: 4.54, 18.67] were significantly associated with hypertension. Remarkably, all identified hypertensive cases were linked to the nearby hospital for confirmation of diagnosis, care and follow-up and all of them were found to be hypertensive. This suggests that implementing primary health care approach integrated with the urban health extension package may be effective in the prevention and control of hypertension in poor settings. Conclusion and recommendation Prevalence of hypertension among adults was very high, but awareness, treatment and control of hypertension was very low. Being unable to read and write, not consuming fruit, being physically inactive, overweight/obesity and not knowing physical inactivity is a risk factor for hypertension were independently associated with hypertension. Policy makers need to consider integrating prevention and control of hypertension with health extension package. Appropriate information, education and communication strategies should also be designed and implemented to avoid unhealthy lifestyles and promote healthy practices.	[Gebrihet, Teklay Aredehey] Dist Hlth Off, Aksum, Ethiopia; [Mesgna, Kebede Haile; Gebregiorgis, Yosef Sibhatu; Weldehaweria, Negassie Berhe; Weldu, Meresa Gebremedhin] Aksum Univ, Coll Hlth Sci, Aksum, Ethiopia; [Kahsay, Alemayehu Bayray] Mekelle Univ, Coll Hlth Sci, Mekelle, Ethiopia	Mekelle University	Gebregiorgis, YS (corresponding author), Aksum Univ, Coll Hlth Sci, Aksum, Ethiopia.	yosefsibhatu@gmail.com	Weldu, Meresa Gebremedhin/ABA-5452-2020	Gebregiorgis, Yosef/0000-0003-1329-7782				Adeloye D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104300; Almas Aysha, 2012, BMC Res Notes, V5, P579, DOI 10.1186/1756-0500-5-579; Alonso A, 2004, BRIT J NUTR, V92, P311, DOI 10.1079/BJN20041196; Asefa B G HB Zikru, 2014, IJIPSR, V2, P653; Aung MN, 2012, INT J GEN MED, V5, P553, DOI 10.2147/IJGM.S29406; Awoke A, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-113; Bhadoria AS, 2014, J FAM COMMUNITY MED, V21, P29, DOI 10.4103/2230-8229.128775; [Blood Institute National Heart L], 2014, NIH PUBL; Bonsa F, 2014, ETHIOP J HEALTH SCI, V24, P21, DOI 10.4314/ejhs.v24i1.3; Bowman TS, 2007, J AM COLL CARDIOL, V50, P2085, DOI 10.1016/j.jacc.2007.08.017; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Diaz KM, 2013, CURR HYPERTENS REP, V15, P659, DOI 10.1007/s11906-013-0386-8; Federal Democratic Republic of Ethiopia CSA, 2007, POP CENS REP POP HOU; Giday Araya, 2011, Ethiop Med J, V49, P139; Giles TD, 2009, J CLIN HYPERTENS, V11, P611, DOI 10.1111/j.1751-7176.2009.00179.x; Gudina EK, 2013, INTEGR BLOOD PRESS C, V6, P111, DOI 10.2147/IBPC.S47298; Helelo TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112790; HYPERTENSION DETECTION FOLLOW-UP, 1977, AM J EPIDEMIOL, V106, P351; Joshi MD, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1177; Kayima J, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2146-y; Kibret KT, 2015, PUBLIC HEALTH REV, V36, DOI 10.1186/s40985-015-0014-z; Li X, 2013, INT J ENV RES PUB HE, V10, P1125, DOI 10.3390/ijerph10031125; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Mendis S, 2014, GLOBAL STATUS REPORT; Mengistu MD, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-33; Midha T, 2009, E AFRICAN J PUBLIC H, V6; Moges B, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-155; Quasem I, 2001, B WORLD HEALTH ORGAN, V79, P490; Samal D, 2007, STROKE, V38, P1304, DOI 10.1161/01.STR.0000259733.43470.27; Seedat YK, 2000, J HUM HYPERTENS, V14, P739, DOI 10.1038/sj.jhh.1001059; Sesso HD, 2008, HYPERTENSION, V51, P1080, DOI 10.1161/HYPERTENSIONAHA.107.104968; Sisay B, 2014, WORLD J MED MED SCI, V2; Tadesse T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-937; Tedesco MA, 2001, J HUM HYPERTENS, V15, P727, DOI 10.1038/sj.jhh.1001249; Tesfaye F, 2007, J HUM HYPERTENS, V21, P28, DOI 10.1038/sj.jhh.1002104; Tesfaye F, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-39; Tsubota-Utsugi M, 2011, J HUM HYPERTENS, V25, P164, DOI 10.1038/jhh.2010.48; Utsugi MT, 2008, HYPERTENS RES, V31, P1435, DOI 10.1291/hypres.31.1435; Viera AJ, 2008, J AM BOARD FAM MED, V21, P300, DOI 10.3122/jabfm.2008.04.070254; Wamala JF, 2009, AFRICAN HLTH SCI, V9; Wang L, 2012, AM J HYPERTENS, V25, P180, DOI 10.1038/ajh.2011.186; Wang Y, 2006, J HUM HYPERTENS, V20, P898, DOI 10.1038/sj.jhh.1002086; Wang YF, 2004, ARCH INTERN MED, V164, P2126, DOI 10.1001/archinte.164.19.2126; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; WHO, 2002, RED RISKS PROM HLTH; Wolf-Maier K, 2003, JAMA-J AM MED ASSOC, V289, P2363, DOI 10.1001/jama.289.18.2363; World Health Organization, 2005, WHO STEPS SURV MAN W; World Health Organization, 2013, NONC DIS COUNTR PROF	48	20	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176904	10.1371/journal.pone.0176904	http://dx.doi.org/10.1371/journal.pone.0176904			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489865	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314100036
J	Fusco, FB; Gomes, DJ; Bispo, KCS; Toledo, VP; Barbeiro, DF; Capelozzi, VL; Furukawa, LNS; Velosa, APP; Teodoro, WR; Heimann, JC; Quintao, ECR; Passarelli, M; Nakandakare, ER; Catanozi, S				Fusco, Fernanda B.; Gomes, Diego J.; Bispo, Kely C. S.; Toledo, Veronica P.; Barbeiro, Denise F.; Capelozzi, Vera L.; Furukawa, Luzia N. S.; Velosa, Ana P. P.; Teodoro, Walcy R.; Heimann, Joel C.; Quintao, Eder C. R.; Passarelli, Marisa; Nakandakare, Edna R.; Catanozi, Sergio			Low-sodium diet induces atherogenesis regardless of lowering blood pressure in hypertensive hyperlipidemic mice	PLOS ONE			English	Article							E-DEFICIENT MICE; PLASMA-LIPID CONCENTRATION; LOW-SALT DIET; OXIDATIVE STRESS; CHLORIDE RESTRICTION; INSULIN-RESISTANCE; KNOCKOUT MICE; WISTAR RATS; RECEPTOR; ATHEROSCLEROSIS	This study investigated the influence of sodium restriction and antihypertensive drugs on atherogenesis utilizing hypertensive (H) low-density lipoprotein-receptor knockout mice treated or not with losartan (Los) or hydralazine (Hyd) and fed low-sodium (LS) or normal-sodium (NS) chow. Despite reducing the blood pressure (BP) of H-LS mice, the LS diet caused arterial lipid infiltration due to increased plasma total cholesterol (TC) and triglycerides (TG). Los and Hyd reduced the BP of H-LS mice, and Los effectively prevented arterial injury, likely by reducing plasma TG and nonesterified fatty acids. Aortic lipid infiltration was lower in Los-treated H-LS mice (H-LS+Los) than in normotensive (N)-LS and H-LS mice. Aortic angiotensin II type 1 (AT1) receptor content was greater in H-NS than H-LS mice and in H-LS+Hyd than H-LS+Los mice. Carboxymethyl-lysine (CML) and receptor for advanced glycation end products (RAGE) immunostaining was greater in H-LS than H-NS mice. CML and RAGE levels were lower in LS animals treated with antihypertensive drugs, and Hyd enhanced the AT1 receptor level. Hyd also increased the gene expression of F4/80 but not tumor necrosis factor-a, interleukin (IL)-1 beta, IL-6, IL-10, intercellular adhesion molecule-1 or cluster of differentiation 66. The novelty of the current study is that in a murine model of simultaneous hypertension and hyperlipidemia, the pleiotropic effect of chronic, severe sodium restriction elicited aortic damage even with reduced BP. These negative effects on the arterial wall were reduced by AT1 receptor antagonism, demonstrating the influence of angiotensin II in atherogenesis induced by a severely LS diet.	[Fusco, Fernanda B.; Gomes, Diego J.; Quintao, Eder C. R.; Passarelli, Marisa; Nakandakare, Edna R.; Catanozi, Sergio] Univ Sao Paulo, Med Sch, Lipids Lab LIM 10, Endocrinol Div, Sao Paulo, SP, Brazil; [Bispo, Kely C. S.; Capelozzi, Vera L.] Univ Sao Paulo, Med Sch, Dept Pathol, Sao Paulo, SP, Brazil; [Toledo, Veronica P.; Velosa, Ana P. P.; Teodoro, Walcy R.] Univ Sao Paulo, Med Sch, Rheumatol Div LIM 17, Sao Paulo, SP, Brazil; [Barbeiro, Denise F.] Univ Sao Paulo, Med Sch, Emergency Med Dept LIM 51, Sao Paulo, SP, Brazil; [Furukawa, Luzia N. S.; Heimann, Joel C.] Univ Sao Paulo, Med Sch, Expt Hypertens Lab LIM 16, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Catanozi, S (corresponding author), Univ Sao Paulo, Med Sch, Lipids Lab LIM 10, Endocrinol Div, Sao Paulo, SP, Brazil.	catanozi@usp.br	Teodoro, Walcy/H-5133-2017; teodoro, walcy/J-7602-2018; , Capelozzi/N-1737-2019; Kjerulf, Diego Gomes/C-4037-2014; Furukawa, Luzia/A-1257-2013; Nakandakare, Edna R/D-6625-2012; Passarelli, Marisa/C-8129-2012	Teodoro, Walcy/0000-0001-7559-4542; teodoro, walcy/0000-0001-7559-4542; , Capelozzi/0000-0001-9732-5853; Kjerulf, Diego Gomes/0000-0002-4115-2428; Furukawa, Luzia/0000-0002-0457-6651; Pereira Velosa, Ana Paula/0000-0002-6465-0796; delmonte, samuel/0000-0002-3289-4577; Quintao, Eder/0000-0001-9810-3259	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP [2013/11084-0, 2012/19755-9, 2011/16164-7, 2011/04631-0]; Antonio dos Santos Filho for the animal care; Rheumatology Division for the availability of the animal housing unit (Centro de Manutencao e Experimentacao de Animais da Clinica Medica) [LIM-17]; Laboratorio de Investigacao Medica do Hospital das Clinicas (LIM); Fundacao Faculdade de Medicina	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Antonio dos Santos Filho for the animal care; Rheumatology Division for the availability of the animal housing unit (Centro de Manutencao e Experimentacao de Animais da Clinica Medica); Laboratorio de Investigacao Medica do Hospital das Clinicas (LIM); Fundacao Faculdade de Medicina	This work was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP grants 2013/11084-0 to SC; 2012/19755-9 to MP; 2011/16164-7 to FBF and 2011/04631-0 to DJG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP (grants 2013/11084-0 to SC; 2012/19755-9 to MP; 2011/16164-7 to FBF and 2011/ 04631-0 to DJG).; The authors wish to acknowledge Jussara C. Rocha, Professors Jose L. Guerra and Marcia M. Jerico for providing invaluable suggestions and constructive discussion regarding the study, Antonio dos Santos Filho for the animal care, Karolline Santana for the expert assistance with the figures, the Rheumatology Division (LIM-17) for the availability of the animal housing unit (Centro de Manutencao e Experimentacao de Animais da Clinica Medica), and Laboratorio de Investigacao Medica do Hospital das Clinicas (LIM) and Fundacao Faculdade de Medicina for continuous and generous support.	Alderman MH, 2004, J AM SOC NEPHROL, V15, pS47, DOI 10.1097/01.ASN.0000093236.74397.F3; Alderman MH, 2010, JAMA-J AM MED ASSOC, V303, P448, DOI 10.1001/jama.2010.69; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bouguerne B, 2011, ANTIOXID REDOX SIGN, V14, P2093, DOI 10.1089/ars.2010.3321; BRENSILVER JM, 1985, KIDNEY INT, V27, P497, DOI 10.1038/ki.1985.38; Catanozi S, 2003, J LIPID RES, V44, P727, DOI 10.1194/jlr.M200330-JLR200; Catanozi S, 2001, ATHEROSCLEROSIS, V158, P81, DOI 10.1016/S0021-9150(01)00415-4; Cheng C, 2006, CIRCULATION, V113, P2744, DOI 10.1161/CIRCULATIONAHA.105.590018; Curfs DMJ, 2004, AM J PATHOL, V164, P101, DOI 10.1016/S0002-9440(10)63101-X; Daugherty A, 2004, CIRCULATION, V110, P3849, DOI 10.1161/01.CIR.0000150540.54220.C4; Dikalov SI, 2014, ANTIOXID REDOX SIGN, V20, P281, DOI 10.1089/ars.2012.4918; Dikalov SI, 2013, ANTIOXID REDOX SIGN, V19, P1085, DOI 10.1089/ars.2012.4604; El Mouedden M, 2007, PHARMACOL BIOCHEM BE, V86, P458, DOI 10.1016/j.pbb.2007.01.003; Ferreira DN, 2010, J NUTR, V140, P1742, DOI 10.3945/jn.109.117473; Fu MX, 1996, J BIOL CHEM, V271, P9982, DOI 10.1074/jbc.271.17.9982; Galvani S, 2008, FREE RADICAL BIO MED, V45, P1457, DOI 10.1016/j.freeradbiomed.2008.08.026; Garg R, 2014, HYPERTENSION, V64, P1384, DOI 10.1161/HYPERTENSIONAHA.114.03880; Garg R, 2011, METABOLISM, V60, P965, DOI 10.1016/j.metabol.2010.09.005; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Goel Reema, 2008, Arterioscler Thromb Vasc Biol, V28, P1996, DOI 10.1161/ATVBAHA.108.172270; Graudal NA, 1998, JAMA-J AM MED ASSOC, V279, P1383, DOI 10.1001/jama.279.17.1383; Graudal NA, 2012, AM J HYPERTENS, V25, P1, DOI 10.1038/ajh.2011.210; Humalda JK, 2014, CURR OPIN NEPHROL HY, V23, P533, DOI 10.1097/MNH.0000000000000073; Ivanovski O, 2005, ATHEROSCLEROSIS, V180, P271, DOI 10.1016/j.atherosclerosis.2004.12.020; Johns C, 1996, HYPERTENSION, V28, P1064, DOI 10.1161/01.HYP.28.6.1064; Kalea AZ, 2009, FASEB J, V23, P1766, DOI 10.1096/fj.08-117739; KATSUTANI N, 1992, INT J IMMUNOPHARMACO, V14, P673, DOI 10.1016/0192-0561(92)90130-D; Keidar S, 1999, ATHEROSCLEROSIS, V146, P249, DOI 10.1016/S0021-9150(99)00145-8; Keidar S, 1997, BIOCHEM BIOPH RES CO, V236, P622, DOI 10.1006/bbrc.1997.6844; Krikken JA, 2012, NUTR METAB CARDIOVAS, V22, P35, DOI 10.1016/j.numecd.2010.03.010; Lichtman AH, 1999, ARTERIOSCL THROM VAS, V19, P1938, DOI 10.1161/01.ATV.19.8.1938; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Diez R, 2013, GENOME BIOL EVOL, V5, P2420, DOI 10.1093/gbe/evt188; MITCHELL JA, 1990, DRUG SAFETY, V5, P168, DOI 10.2165/00002018-199005030-00002; Nakandakare ER, 2008, ATHEROSCLEROSIS, V200, P410, DOI 10.1016/j.atherosclerosis.2007.12.034; National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals Institute for Laboratory Animal Research (US) and National Academies Press (US), 2011, GUIDE CARE USE LAB A; Nickenig G, 2000, BRIT J PHARMACOL, V131, P795, DOI 10.1038/sj.bjp.0703623; Nickenig G, 1997, AM J PHYSIOL-HEART C, V272, pH2701, DOI 10.1152/ajpheart.1997.272.6.H2701; PAIGEN B, 1987, ATHEROSCLEROSIS, V68, P231, DOI 10.1016/0021-9150(87)90202-4; Rugale C, 2007, J CARDIOVASC PHARM, V50, P293, DOI 10.1097/FJC.0b013e3180a72606; RUPPERT M, 1994, AM J MED SCI, V307, pS87; Stolarz-Skrzypek K, 2011, JAMA-J AM MED ASSOC, V305, P1777, DOI 10.1001/jama.2011.574; Tikellis C, 2012, HYPERTENSION, V60, P98, DOI 10.1161/HYPERTENSIONAHA.112.191767; Van Assche T, 2011, J VASC RES, V48, P31, DOI 10.1159/000317398; Weiss D, 2001, CIRCULATION, V103, P448; Wiesel P, 1997, HYPERTENSION, V29, P1025, DOI 10.1161/01.HYP.29.4.1025; Zhang YH, 2014, J RENIN-ANGIO-ALDO S, V16, P292	47	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177086	10.1371/journal.pone.0177086	http://dx.doi.org/10.1371/journal.pone.0177086			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481921	Green Published, Green Submitted, gold			2022-12-26	WOS:000401313700032
J	Tasmin, R; Hasan, NA; Grim, CJ; Grant, A; Choi, SY; Alam, MS; Bell, R; Cavanaugh, C; Balan, KV; Babu, US; Parveen, S				Tasmin, Rizwana; Hasan, Nur A.; Grim, Christopher J.; Grant, Ar'Quette; Choi, Seon Young; Alam, M. Samiul; Bell, Rebecca; Cavanaugh, Christopher; Balan, Kannan V.; Babu, Uma S.; Parveen, Salina			Genotypic and phenotypic characterization of multidrug resistant Salmonella Typhimurium and Salmonella Kentucky strains recovered from chicken carcasses	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; ANTIMICROBIAL RESISTANCE; SUBSYSTEMS TECHNOLOGY; ACTIN CYTOSKELETON; VIRULENCE PLASMIDS; MICROBIAL GENOMES; GRANULOSA-CELLS; UNITED-STATES; GENES; 1,2-PROPANEDIOL	Salmonella Typhimurium is the leading cause of human non-typhoidal gastroenteritis in the US. S. Kentucky is one the most commonly recovered serovars from commercially processed poultry carcasses. This study compared the genotypic and phenotypic properties of two Salmonella enterica strains Typhimurium (ST221_31B) and Kentucky (SK222_32B) recovered from commercially processed chicken carcasses using whole genome sequencing, phenotype characterizations and an intracellular killing assay. Illumina MiSeq platform was used for sequencing of two Salmonella genomes. Phylogenetic analysis employing homologous alignment of a 1,185 non-duplicated protein-coding gene in the Salmonella core genome demonstrated fully resolved bifurcating patterns with varying levels of diversity that separated ST221_31B and SK222_32B genomes into distinct monophyletic serovar clades. Single nucleotide polymorphism (SNP) analysis identified 2,432 (ST19) SNPs within 13 Typhimurium genomes including ST221_31B representing Sequence Type ST19 and 650 (ST152) SNPs were detected within 13 Kentucky genomes including SK222_32B representing Sequence Type ST152. In addition to serovar-specific conserved coding sequences, the genomes of ST221_31B and SK222_32B harbor several genomic regions with significant genetic differences. These included phage and phage-like elements, carbon utilization or transport operons, fimbriae operons, putative membrane associated protein-encoding genes, antibiotic resistance genes, siderophore operons, and numerous hypothetical protein-encoding genes. Phenotype microarray results demonstrated that ST221_31B is capable of utilizing certain carbon compounds more efficiently as compared to SK222_3B; namely, 1,2-propanediol, M-inositol, L-threonine, a-D-lactose, D-tagatose, adonitol, formic acid, acetoacetic acid, and L-tartaric acid. ST221_31B survived for 48 h in macrophages, while SK222_32B was mostly eliminated. Further, a 3-fold growth of ST221_31B was observed at 24 hours post-infection in chicken granulosa cells while SK222_32B was unable to replicate in these cells. These results suggest that Salmonella Typhimurium can survive host defenses better and could be more invasive than Salmonella Kentucky and provide some insights into the genomic determinants responsible for these differences.	[Tasmin, Rizwana; Grant, Ar'Quette; Parveen, Salina] Univ Maryland Eastern Shore, Agr Food & Resource Sci, Princess Anne, MD 21853 USA; [Hasan, Nur A.] Univ Maryland, Inst Adv Comp Studies, College Pk, MD 20742 USA; [Hasan, Nur A.; Choi, Seon Young] CosmosID Inc, Rockville, MD USA; [Grim, Christopher J.; Alam, M. Samiul; Cavanaugh, Christopher; Balan, Kannan V.; Babu, Uma S.] US FDA, Off Appl Res & Safety Assessment, Ctr Food Safety & Appl Nutr, Laurel, MD USA; [Bell, Rebecca] US FDA, Off Regulatory Sci, Ctr Food Safety & Appl Nutr, College Pk, MD USA	University System of Maryland; University of Maryland Eastern Shore; University System of Maryland; University of Maryland College Park; US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Parveen, S (corresponding author), Univ Maryland Eastern Shore, Agr Food & Resource Sci, Princess Anne, MD 21853 USA.	sparveen@umes.edu	Balan, Kannan/P-8892-2015; hasan, nur a/AAX-3881-2021	hasan, nur a/0000-0003-0175-8879	USDA Evans-Allen Grant; USFDA; FDA; Research Participation Program at the U.S. Food and Drug Administration; Cosmos ID Inc.	USDA Evans-Allen Grant; USFDA; FDA(United States Department of Health & Human Services); Research Participation Program at the U.S. Food and Drug Administration; Cosmos ID Inc.	This research was funded in part by USDA Evans-Allen Grant and USFDA. CJG was supported through an FDA funded research contract, administered by Goldbelt C6. CC and KVB were supported by the Research Participation Program at the U.S. Food and Drug Administration, administered by the Oak Ridge Institute for Science and Education. Cosmos ID Inc. provided support in the form of salaries for author NH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Alam MS, 2006, MICROB PATHOGENESIS, V40, P116, DOI 10.1016/j.micpath.2005.11.007; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; BEUG H, 1979, CELL, V18, P375, DOI 10.1016/0092-8674(79)90057-6; Bobik TA, 1999, J BACTERIOL, V181, P5967, DOI 10.1128/JB.181.19.5967-5975.1999; BOWE F, 1994, METHOD ENZYMOL, V236, P509; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; *CDC, 2008, SALM SURV ANN SUMM 2; Cheng SQ, 2011, J BACTERIOL, V193, P1385, DOI 10.1128/JB.01473-10; Chu CS, 2006, MICROBES INFECT, V8, P1931, DOI 10.1016/j.micinf.2005.12.026; Conner CP, 1998, P NATL ACAD SCI USA, V95, P4641, DOI 10.1073/pnas.95.8.4641; Fricke WF, 2011, J BACTERIOL, V193, P3556, DOI 10.1128/JB.00297-11; Fricke WF, 2009, APPL ENVIRON MICROB, V75, P5963, DOI 10.1128/AEM.00786-09; GILBERT AB, 1977, J REPROD FERTIL, V50, P179, DOI 10.1530/jrf.0.0500179; Haley BJ, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.01289-16; Hoffmann M, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.01068-13; Hoffmann S, 2015, EC INFORM B, V140, P53; KARLIN S, 1990, P NATL ACAD SCI USA, V87, P2264, DOI 10.1073/pnas.87.6.2264; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Le Hello S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00395; Le Hello S, 2011, J INFECT DIS, V204, P675, DOI 10.1093/infdis/jir409; Lindgren SW, 1996, P NATL ACAD SCI USA, V93, P4197, DOI 10.1073/pnas.93.9.4197; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; McGhie EJ, 2009, CURR OPIN MICROBIOL, V12, P117, DOI 10.1016/j.mib.2008.12.001; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Mohamed T, 2014, FOOD MICROBIOL, V38, P6, DOI 10.1016/j.fm.2013.08.002; Montero I, 2013, PLASMID, V70, P104, DOI 10.1016/j.plasmid.2013.03.002; OBRADORS N, 1988, J BACTERIOL, V170, P2159, DOI 10.1128/jb.170.5.2159-2162.1988; Oscar TP, 2010, J FOOD PROTECT, V73, P1596, DOI 10.4315/0362-028X-73.9.1596; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Parveen S, 2007, J FOOD PROTECT, V70, P2466, DOI 10.4315/0362-028X-70.11.2466; Patel JC, 2005, CURR OPIN MICROBIOL, V8, P10, DOI 10.1016/j.mib.2004.09.001; Rabsch W, 2002, INFECT IMMUN, V70, P2249, DOI 10.1128/IAI.70.5.2249-2255.2002; Ramos-Morales F, 2012, ISRN CELL BIOL, P78934; Rotger R, 1999, Int Microbiol, V2, P177; Russell SM, 2012, Controlling Salmonella in Poultry Production and Processing, P1, DOI 10.1201/b11519; Rychlik I, 2006, VET MICROBIOL, V112, P1, DOI 10.1016/j.vetmic.2005.10.030; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Sheppard AE, 2016, ANTIMICROB AGENTS CH, V60, P3767, DOI 10.1128/AAC.00464-16; Sly LM, 2002, INFECT IMMUN, V70, P5312, DOI 10.1128/IAI.70.9.5312-5315.2002; Sneeringer S., 2015, RESTRICTIONS ANTIBIO; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Thiagarajan D, 1996, INFECT IMMUN, V64, P5015, DOI 10.1128/IAI.64.12.5015-5021.1996; Thiennimitr P, 2011, P NATL ACAD SCI USA, V108, P17480, DOI 10.1073/pnas.1107857108; Treangen TJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0524-x; USDA, 2013, SER PROF SALM STRAIN; USDA, 2003, FSIS NOT; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; Voetsch AC, 2004, CLIN INFECT DIS, V38, pS127, DOI 10.1086/381578; Winter SE, 2011, GUT MICROBES, V2, P58, DOI 10.4161/gmic.2.1.14911; Zhao S, 2006, J FOOD PROTECT, V69, P500, DOI 10.4315/0362-028X-69.3.500; Zhou DG, 2001, MOL MICROBIOL, V39, P248, DOI 10.1046/j.1365-2958.2001.02230.x	52	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e176938	10.1371/journal.pone.0176938	http://dx.doi.org/10.1371/journal.pone.0176938			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481935	gold, Green Published, Green Submitted			2022-12-26	WOS:000401313700025
J	Kitajima, S; Yoshida, A; Kohno, S; Li, F; Suzuki, S; Nagatani, N; Nishimoto, Y; Sasaki, N; Muranaka, H; Wan, Y; Thai, TC; Okahashi, N; Matsuda, F; Shimizu, H; Nishiuchi, T; Suzuki, Y; Tominaga, K; Gotoh, N; Suzuki, M; Ewen, ME; Barbie, DA; Hirose, O; Tanaka, T; Takahashi, C				Kitajima, S.; Yoshida, A.; Kohno, S.; Li, F.; Suzuki, S.; Nagatani, N.; Nishimoto, Y.; Sasaki, N.; Muranaka, H.; Wan, Y.; Thai, T. C.; Okahashi, N.; Matsuda, F.; Shimizu, H.; Nishiuchi, T.; Suzuki, Y.; Tominaga, K.; Gotoh, N.; Suzuki, M.; Ewen, M. E.; Barbie, D. A.; Hirose, O.; Tanaka, T.; Takahashi, C.			The RB-IL-6 axis controls self-renewal and endocrine therapy resistance by fine-tuning mitochondrial activity	ONCOGENE			English	Article							RETINOBLASTOMA TUMOR-SUPPRESSOR; COMPREHENSIVE MOLECULAR PORTRAITS; FATTY-ACID OXIDATION; CANCER STEM-CELLS; RB; METABOLISM; INHIBITION; DEFICIENT; GLUTAMINE; NETWORKS	Retinoblastoma (RB) protein inactivation during tumor progression is often associated with acquisition of immature phenotypes and resistance to therapy. Determination of an RB inactivation signature in a context of gaining undifferentiated phenotype in a p53-null sarcoma system revealed a critical role for interleukin (IL)-6. Using a Gene Set Enrichment Analysis (GSEA), we discovered that poorly differentiated breast cancers are enriched for this RB inactivation signature. Accelerated IL-6 secretion following RB inactivation in an RB-intact luminal-type breast cancer cell line MCF-7 promoted a positive feed forward loop between IL-6 and STAT3 driving tumor growth and endocrine therapy resistance. In addition, some of RB-intact basal-like type breast cancer cell lines exhibited a similar phenotype following RB depletion. The mechanism whereby RB inactivation increases IL-6 production in MCF-7 cells appeared to involve fatty acid oxidation (FAO)-dependent mitochondrial metabolism and c-Jun NH(2)-terminal kinase (JNK). In addition, IL-6, via STAT3-mediated feedback to mitochondria, autonomously adjusts mitochondrial superoxide to levels suitable to maintain stem cell-like activity. The gene expression profile of luminal-type breast cancer patients with low RB expression revealed high enrichment of genes involved in mitochondrial respiration and downstream targets of IL-6. These findings unveiled an unexpected strategy whereby RB suppresses malignant features of cancer cells through metabolic reprogramming and cell-autonomous inflammation.	[Kitajima, S.; Yoshida, A.; Kohno, S.; Li, F.; Nagatani, N.; Nishimoto, Y.; Sasaki, N.; Muranaka, H.; Wan, Y.; Suzuki, M.; Takahashi, C.] Kanazawa Univ, Canc Res Inst, Div Oncol & Mol Biol, Kanazawa, Ishikawa 9201192, Japan; [Kitajima, S.; Thai, T. C.; Barbie, D. A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Yoshida, A.] Kanazawa Univ, Grad Sch Med Sci, Dept Cellular Transplantat Biol, Kanazawa, Ishikawa, Japan; [Suzuki, S.; Tanaka, T.] Chiba Univ, Grad Sch Med, Dept Clin Cell Biol & Med, Chiba, Japan; [Okahashi, N.; Matsuda, F.; Shimizu, H.] Osaka Univ, Grad Sch Informat Sci & Technol, Dept Bioinformat Engn, Suita, Osaka, Japan; [Nishiuchi, T.] Kanazawa Univ, Adv Sci Res Ctr, Div Funct Genom, Kanazawa, Ishikawa, Japan; [Suzuki, Y.] Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Chiba, Japan; [Tominaga, K.] Univ Tokyo, Inst Med Sci, Div Mol Therapy, Minato Ku, Tokyo, Japan; [Gotoh, N.] Kanazawa Univ, Canc Res Inst, Div Canc Cell Biol, Kanazawa, Ishikawa, Japan; [Ewen, M. E.] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA USA; [Barbie, D. A.] Broad Inst Harvard & MIT, Cambridge, MA USA; [Hirose, O.] Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Elect Engn & Comp Sci, Kanazawa, Ishikawa, Japan	Kanazawa University; Harvard University; Dana-Farber Cancer Institute; Kanazawa University; Chiba University; Osaka University; Kanazawa University; University of Tokyo; University of Tokyo; Kanazawa University; Tufts Medical Center; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Kanazawa University	Takahashi, C (corresponding author), Kanazawa Univ, Canc Res Inst, Div Oncol & Mol Biol, Kanazawa, Ishikawa 9201192, Japan.	chtakaha@staff.kanazawa-u.ac.jp	Sasaki, Nobunari/ABF-6656-2020; Okahashi, Nobuyuki/AAL-6437-2021; Hirose, Osamu/K-7890-2015; Okahashi, Nobuyuki/AAM-5359-2021; Shimizu, Hiroshi/C-3688-2017; GOTOH, Noriko/D-8430-2015	Okahashi, Nobuyuki/0000-0001-9582-355X; Hirose, Osamu/0000-0002-8077-8589; Okahashi, Nobuyuki/0000-0001-9582-355X; Shimizu, Hiroshi/0000-0002-8986-0861; Nishiuchi, Takumi/0000-0001-9429-5396; Gotoh, Noriko/0000-0003-3733-260X; Tominaga, Kana/0000-0001-5136-5091	Funding Program for Next Generation World-Leading Researchers; Hokuriku Bank Research Grant for Young Scientists	Funding Program for Next Generation World-Leading Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Hokuriku Bank Research Grant for Young Scientists	We thank Drs T Kitamura, N Mukaida, K Yoshioka and Chugai Pharmaceuticals Co. Ltd. for providing materials, Drs T Baba, K Hinohara, A Hirao, T Hoshii, A Ishimura, K Matsumoto, K Sakai, S Sasaki, T Sato, T Shimamura, T Suzuki and Y Tadokoro for technical instruction, Dr A Ooi for pathological diagnosis, Drs I Ajioka and R Jenkins for critical reading of this manuscript, and Dr C Prives for advice. This work was supported by Funding Program for Next Generation World-Leading Researchers to CT, Grant-in-Aid for Scientific Research to CT, S Kitajima and NS, and Hokuriku Bank Research Grant for Young Scientists to S Kitajima.	Barbie TU, 2014, J CLIN INVEST, V124, P5411, DOI 10.1172/JCI75661; Blanchet E, 2011, NAT CELL BIOL, V13, P1146, DOI 10.1038/ncb2309; Bosco EE, 2007, J CLIN INVEST, V117, P218, DOI 10.1172/JCI28803; Bulua AC, 2011, J EXP MED, V208, P519, DOI 10.1084/jem.20102049; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Calo E, 2010, NATURE, V466, P1110, DOI 10.1038/nature09264; Cam H, 2004, MOL CELL, V16, P399, DOI 10.1016/j.molcel.2004.09.037; Carracedo A, 2013, NAT REV CANCER, V13, P227, DOI 10.1038/nrc3483; Chavey C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1648; Choi J, 2010, AM J PATHOL, V177, P2645, DOI 10.2353/ajpath.2010.100306; Ciavarra G, 2010, J CELL BIOL, V191, P291, DOI 10.1083/jcb.201005067; Ciriello G, 2015, CELL, V163, P506, DOI 10.1016/j.cell.2015.09.033; Croonquist PA, 2003, BLOOD, V102, P2581, DOI 10.1182/blood-2003-04-1227; Cuperus R, 2010, CELL MOL LIFE SCI, V67, P807, DOI 10.1007/s00018-009-0212-2; Das M, 2011, GENE DEV, V25, P634, DOI 10.1101/gad.1989311; Denechaud PD, 2016, J CLIN INVEST, V126, P137, DOI 10.1172/JCI81542; Gauthier ML, 2007, CANCER CELL, V12, P479, DOI 10.1016/j.ccr.2007.10.017; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Guo DJ, 2012, ONCOL LETT, V4, P311, DOI 10.3892/ol.2012.733; HARVEY M, 1995, CANCER RES, V55, P1146; Herschkowitz JI, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2142; Hinohara K, 2012, P NATL ACAD SCI USA, V109, P6584, DOI 10.1073/pnas.1113271109; Hsieh MCF, 2008, J BIOL CHEM, V283, P27410, DOI 10.1074/jbc.M802418200; Iliopoulos D, 2011, P NATL ACAD SCI USA, V108, P1397, DOI 10.1073/pnas.1018898108; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Ito K, 2012, NAT MED, V18, P1350, DOI 10.1038/nm.2882; Jiang Z, 2011, CELL CYCLE, V10, P1563, DOI 10.4161/cc.10.10.15703; Jiang Z, 2010, J CLIN INVEST, V120, P3296, DOI 10.1172/JCI41490; Jones RA, 2016, J CLIN INVEST, V126, P3739, DOI 10.1172/JCI81568; Kadota K, 2008, ALGORITHM MOL BIOL, V3, DOI 10.1186/1748-7188-3-8; Kareta MS, 2015, CELL STEM CELL, V16, P39, DOI 10.1016/j.stem.2014.10.019; Kitajima S, 2015, STEM CELLS, V33, P1657, DOI 10.1002/stem.1971; Knudsen ES, 2008, NAT REV CANCER, V8, P714, DOI 10.1038/nrc2401; Knudsen ES, 1997, MOL CELL BIOL, V17, P5771, DOI 10.1128/MCB.17.10.5771; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kohno S, 2016, WORLD J STEM CELLS, V8, P170, DOI 10.4252/wjsc.v8.i4.170; Korkaya H, 2012, MOL CELL, V47, P570, DOI 10.1016/j.molcel.2012.06.014; Korkaya H, 2011, J CLIN INVEST, V121, P3804, DOI 10.1172/JCI57099; Li F, 2010, CELL STEM CELL, V7, P508, DOI 10.1016/j.stem.2010.09.003; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Liu YQ, 2009, CELL STEM CELL, V4, P336, DOI 10.1016/j.stem.2009.02.015; Marotta LLC, 2011, J CLIN INVEST, V121, P2723, DOI 10.1172/JCI44745; Mitsuishi Y, 2012, CANCER CELL, V22, P66, DOI 10.1016/j.ccr.2012.05.016; Nicolay BN, 2015, GENE DEV, V29, P1875, DOI 10.1101/gad.264127.115; Nicolay BN, 2013, GENE DEV, V27, P182, DOI 10.1101/gad.206227.112; Ohsawa S, 2012, NATURE, V490, P547, DOI 10.1038/nature11452; Pajcini KV, 2010, CELL STEM CELL, V7, P198, DOI 10.1016/j.stem.2010.05.022; Petrov PD, 2016, J CELL PHYSIOL, V231, P708, DOI 10.1002/jcp.25121; Petrov PD, 2015, AM J PHYSIOL-ENDOC M, V308, pE172, DOI 10.1152/ajpendo.00308.2014; Reynolds MR, 2014, ONCOGENE, V33, P556, DOI 10.1038/onc.2012.635; Sage J, 2012, GENE DEV, V26, P1409, DOI 10.1101/gad.193730.112; Sankaran VG, 2008, GENE DEV, V22, P463, DOI 10.1101/gad.1627208; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Sansone P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10442; Shamma A, 2013, MOL CELL BIOL, V33, P3113, DOI 10.1128/MCB.01597-12; Shamma A, 2009, CANCER CELL, V15, P255, DOI 10.1016/j.ccr.2009.03.001; Takahashi C, 2012, CANCER SCI, V103, P1182, DOI 10.1111/j.1349-7006.2012.02284.x; Takebayashi S, 2015, AGING CELL, V14, P689, DOI 10.1111/acel.12351; TSUKADA T, 1993, ONCOGENE, V8, P3313; Varaljai R, 2015, GENE DEV, V29, P1817, DOI 10.1101/gad.264036.115; Viale A, 2014, NATURE, V514, P628, DOI 10.1038/nature13611; Viatour P, 2011, DIS MODEL MECH, V4, P581, DOI 10.1242/dmm.008060; Visvader JE, 2014, GENE DEV, V28, P1143, DOI 10.1101/gad.242511.114; Wang LY, 2016, CELL REP, V16, P3016, DOI 10.1016/j.celrep.2016.08.018; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; WILLIAMS BO, 1994, NAT GENET, V7, P480, DOI 10.1038/ng0894-480; Wruck CJ, 2011, J BIOL CHEM, V286, P4493, DOI 10.1074/jbc.M110.162008; Zhu ZH, 2014, CANCER DISCOV, V4, P452, DOI 10.1158/2159-8290.CD-13-0646	68	25	26	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 7	2017	36	36					5145	5157		10.1038/onc.2017.124	http://dx.doi.org/10.1038/onc.2017.124			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FF9XD	28481867				2022-12-26	WOS:000409371100006
J	Li, Z; Xiong, Y				Li, Z.; Xiong, Y.			Cytoplasmic E3 ubiquitin ligase CUL9 controls cell proliferation, senescence, apoptosis and genome integrity through p53	ONCOGENE			English	Article							DOUBLE-STRAND BREAKS; EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; 3M COMPLEX; IN-VIVO; PATHWAY; RESCUE; CANCER	CUL9 is a member of the cullin family of E3 ubiquitin ligases, and it localizes predominantly in the cytoplasm. Deletion of Cul9 in mice results in increased DNA damage, widespread aneuploidy, spontaneous tumor development, accelerated E mu-Myc-induced lymphomagenesis and susceptibility to carcinogenesis. CUL9 binds to p53 and causes cell apoptosis when ectopically expressed. Whether the function of CUL9 in maintaining genomic integrity and suppressing tumorigenesis is linked to p53 has not been genetically tested. Here we report that deletion of CUL9 in human cells results in attenuated p21 induction and impaired cellular response to DNA damage. We show that disruption of Cul9-p53 binding in mouse embryo fibroblasts (MEFs) by a knock-in mutation in Cul9 (Delta p53) increases S-phase cell population, accumulates DNA damage during DNA replication and decreases apoptosis to both endogenous and exogenous DNA-damaging agents. The extent of these alterations in Cul9(Delta p53) MEFs is indistinguishable to those seen in Cul9(-/-) MEFs and comparable to those seen in p53(-/-) MEFs. Deletion of CUL9 in p53 null cells does not lead to further increase of DNA damages. Both Cul9(-/-) and Cul9(Delta p53) MEFs proliferate faster and undergo spontaneous immortalization while retaining both Arf and p53. These results demonstrate that the functions of CUL9 in regulating cell proliferation and maintaining genomic integrity are mainly mediated by p53, and that CUL9 is a critical p53 activator.	[Li, Z.; Xiong, Y.] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, 22-012 Lineberger Canc Ctr,Campus Box 7295, Chapel Hill, NC 27599 USA; [Xiong, Y.] Univ North Carolina Chapel Hill, Dept Biochem & Biophys, 22-012 Lineberger Canc Ctr,Campus Box 7295, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Xiong, Y (corresponding author), Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, 22-012 Lineberger Canc Ctr,Campus Box 7295, Chapel Hill, NC 27599 USA.; Xiong, Y (corresponding author), Univ North Carolina Chapel Hill, Dept Biochem & Biophys, 22-012 Lineberger Canc Ctr,Campus Box 7295, Chapel Hill, NC 27599 USA.	yxiong@email.unc.edu			National Institutes of Health [R01CA068377]; UNC Lineberger Comprehensive Cancer Center's University Cancer Research Fund; NATIONAL CANCER INSTITUTE [R01CA068377] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNC Lineberger Comprehensive Cancer Center's University Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Hui Xiao Chao, Jeremy Purvis and Matthew Smith for reading the manuscript, Dale Ramsden for discussion throughout this study, and members of the Xiong Laboratory for helpful discussions and encouragement. This work was supported by National Institutes of Health (grant R01CA068377 to YX) and a Team Innovation Award by the UNC Lineberger Comprehensive Cancer Center's University Cancer Research Fund.	Andrews P, 2006, ONCOGENE, V25, P4534, DOI 10.1038/sj.onc.1209490; Donehower LA, 2009, NAT REV CANCER, V9, P830, DOI 10.1038/nrc2731; HARVEY DM, 1991, GENE DEV, V5, P2375, DOI 10.1101/gad.5.12b.2375; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Lane D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000893; Li ZJ, 2014, MOL CELL, V54, P805, DOI 10.1016/j.molcel.2014.03.046; LUNA RMD, 1995, NATURE, V378, P203; Marin I, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-267; Meek DW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000950; Nikolaev AY, 2003, CELL, V112, P29, DOI 10.1016/S0092-8674(02)01255-2; Pant V, 2014, GENE DEV, V28, P1739, DOI 10.1101/gad.247452.114; Parant J, 2001, NAT GENET, V29, P92, DOI 10.1038/ng714; Pei XH, 2011, CANCER RES, V71, P2969, DOI 10.1158/0008-5472.CAN-10-4300; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Sharpless NE, 2006, CELL BIOL, V1, P223; Stracquadanio G, 2016, NAT REV CANCER, V16, P251, DOI 10.1038/nrc.2016.15; Vilenchik MM, 2003, P NATL ACAD SCI USA, V100, P12871, DOI 10.1073/pnas.2135498100; Yan J, 2014, MOL CELL, V54, P791, DOI 10.1016/j.molcel.2014.03.047	21	12	13	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 7	2017	36	36					5212	5218		10.1038/onc.2017.141	http://dx.doi.org/10.1038/onc.2017.141			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FF9XD	28481879	Green Accepted, Green Submitted			2022-12-26	WOS:000409371100012
J	Butler, MR; Ma, H; Yang, F; Belcher, J; Le, YZ; Mikoshiba, K; Biel, M; Michalakis, S; Iuso, A; Krizaj, D; Ding, XQ				Butler, Michael R.; Ma, Hongwei; Yang, Fan; Belcher, Joshua; Le, Yun-Zheng; Mikoshiba, Katsuhiko; Biel, Martin; Michalakis, Stylianos; Iuso, Anthony; Krizaj, David; Ding, Xi-Qin			Endoplasmic reticulum (ER) Ca2+-channel activity contributes to ER stress and cone death in cyclic nucleotide-gated channel deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CALCIUM-RELEASE; PROGRAMMED CELL-DEATH; PHOTORECEPTOR DEGENERATION; RETINITIS-PIGMENTOSA; ALZHEIMERS-DISEASE; INNER SEGMENTS; MOUSE MODELS; INTRACELLULAR CALCIUM; SIGNAL-TRANSDUCTION; INDUCED APOPTOSIS	Endoplasmic reticulum (ER) stress and mislocalization of improperly folded proteins have been shown to contribute to photoreceptor death in models of inherited retinal degenerative diseases. In particular, mice with cone cyclic nucleotide-gated (CNG) channel deficiency, a model for achromatopsia, display both early-onset ER stress and opsin mistrafficking. By 2 weeks of age, these mice show elevated signaling from all three arms of the ER-stress pathway, and by 1 month, cone opsin is improperly distributed away from its normal outer segment location to other retinal layers. This work investigated the role of Ca2+ release channels in ER stress, protein mislocalization, and cone death in a mouse model of CNG-channel deficiency. We examined whether preservation of luminal Ca2+ stores through pharmacological and genetic suppression of ER Ca2+ efflux protects cones by attenuating ER stress. We demonstrated that the inhibition of ER Ca2+ -efflux channels reduced all three arms of ERstress signaling while improving opsin trafficking to cone outer segments and decreasing cone death by 20-35%. Cone-specific gene deletion of the inositol-1,4,5-trisphosphate receptor type I (IP3R1) also significantly increased cone density in the CNGchannel- deficient mice, suggesting that IP3R1 signaling contributes to Ca2+ homeostasis and cone survival. Consistent with the important contribution of organellar Ca2+ signaling in this achromatopsia mouse model, significant differences in dynamic intraorganellar Ca2+ levels were detected in CNG-channel-deficient cones. These results thus identify a novel molecular link between Ca2+ homeostasis and cone degeneration, thereby revealing novel therapeutic targets to preserve cones in inherited retinal degenerative diseases.	[Butler, Michael R.; Ma, Hongwei; Yang, Fan; Belcher, Joshua; Le, Yun-Zheng; Ding, Xi-Qin] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, 940 Stanton L Young Blvd,BMSB 553, Oklahoma City, OK 73104 USA; [Le, Yun-Zheng] Univ Oklahoma, Hlth Sci Ctr, Dept Internal Med, Oklahoma City, OK 73104 USA; [Le, Yun-Zheng] Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Oklahoma City, OK 73104 USA; [Le, Yun-Zheng] Univ Oklahoma, Hlth Sci Ctr, Harold Hamm Diabet Ctr, Oklahoma City, OK 73104 USA; [Mikoshiba, Katsuhiko] RIKEN Brain Sci Inst, Dev Neurobiol Lab, Hirosawa Wako, Saitama 3510198, Japan; [Biel, Martin; Michalakis, Stylianos] Ludwig Maximilians Univ Munchen, CIPSM, D-81377 Munich, Germany; [Biel, Martin; Michalakis, Stylianos] Ludwig Maximilians Univ Munchen, Ctr Drug Res, Dept Pharm, D-81377 Munich, Germany; [Iuso, Anthony; Krizaj, David] Univ Utah, John A Moran Eye Ctr, Salt Lake City, UT 84132 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; RIKEN; University of Munich; University of Munich; Utah System of Higher Education; University of Utah	Ding, XQ (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, 940 Stanton L Young Blvd,BMSB 553, Oklahoma City, OK 73104 USA.	xi-qin-ding@ouhsc.edu	Biel, Martin/G-1175-2014; Yang, Fan/I-5735-2019; Krrr, Daa/ABG-2688-2020; Michalakis, Stylianos/W-2094-2018; Michalakis, Stylianos/M-4677-2019	Biel, Martin/0000-0002-9974-3052; Krrr, Daa/0000-0003-4468-3029; Michalakis, Stylianos/0000-0001-5092-9238; Michalakis, Stylianos/0000-0001-5092-9238	National Institutes of Health [P30EY021725, R01EY019490, R01EY020900, T32EY024234, R01EY022076, R01EY13870]; NEI [P30EY014800]; Willard L. Eccles Foundation; Research to Prevent Blindness; Moran Eye Institute at the University of Utah; Fight for Sight; Oklahoma Center for the Advancement of Science and Technology (OCAST); Japan Society for the Promotion of Science [25221002]; JST International Cooperative Research Project Solution-oriented Research for Science and Technology; Deutsche Forschungsgemeinschaft; NATIONAL EYE INSTITUTE [R01EY019490, R01EY020900, P30EY014800, R01EY022076, P30EY021725, R01EY013870, T32EY024234] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Willard L. Eccles Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Moran Eye Institute at the University of Utah; Fight for Sight; Oklahoma Center for the Advancement of Science and Technology (OCAST); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JST International Cooperative Research Project Solution-oriented Research for Science and Technology; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grants P30EY021725 and R01EY019490 (to X. D), R01EY020900 (to Y. L.), T32EY024234 (to A. I.), and R01EY022076, R01EY13870, and P30EY014800 from NEI. This work was also supported by the Willard L. Eccles Foundation; grants from Research to Prevent Blindness, the Moran Eye Institute at the University of Utah (to D. K.), The Fight for Sight (to M. R. B.), and the Oklahoma Center for the Advancement of Science and Technology (OCAST) (to X. Q. D.); Grant-in-aid for Scientific Research S, 25221002 (to K. M.) from the Japan Society for the Promotion of Science; the JST International Cooperative Research Project Solution-oriented Research for Science and Technology (to K. M.); and the Deutsche Forschungsgemeinschaft. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Athanasiou D, 2013, FEBS LETT, V587, P2008, DOI 10.1016/j.febslet.2013.05.020; Barbara JG, 2002, BBA-PROTEINS PROTEOM, V1600, P12, DOI 10.1016/S1570-9639(02)00439-9; Bauer PO, 2011, BIOCHEM BIOPH RES CO, V416, P13, DOI 10.1016/j.bbrc.2011.10.096; Benali-Furet NL, 2005, ONCOGENE, V24, P4921, DOI 10.1038/sj.onc.1208673; Berridge MJ, 2010, PFLUG ARCH EUR J PHY, V459, P441, DOI 10.1007/s00424-009-0736-1; Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; Biel M, 1999, P NATL ACAD SCI USA, V96, P7553, DOI 10.1073/pnas.96.13.7553; Cadetti L, 2006, EUR J NEUROSCI, V23, P2983, DOI 10.1111/j.1460-9568.2006.04845.x; Caputo A, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00422; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Cheung KH, 2008, NEURON, V58, P871, DOI 10.1016/j.neuron.2008.04.015; Chiang WC, 2012, INVEST OPHTH VIS SCI, V53, P7159, DOI 10.1167/iovs.12-10222; Cho H, 2001, BRIT J PHARMACOL, V134, P1066, DOI 10.1038/sj.bjp.0704347; Corbett EF, 2000, TRENDS BIOCHEM SCI, V25, P307, DOI 10.1016/S0968-0004(00)01588-7; Csernoch L, 1999, J PHYSIOL-LONDON, V515, P843, DOI 10.1111/j.1469-7793.1999.843ab.x; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; deSouza N, 2002, J BIOL CHEM, V277, P39397, DOI 10.1074/jbc.M207059200; Ding XQ, 2009, HUM MOL GENET, V18, P4770, DOI 10.1093/hmg/ddp440; Dizhoor AM, 2000, CELL SIGNAL, V12, P711, DOI 10.1016/S0898-6568(00)00134-0; Drack AV, 2012, INVEST OPHTH VIS SCI, V53, P100, DOI 10.1167/iovs.11-8544; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Gething MJ, 1999, SEMIN CELL DEV BIOL, V10, P465, DOI 10.1006/scdb.1999.0318; Giorgi C, 2009, INT J BIOCHEM CELL B, V41, P1817, DOI 10.1016/j.biocel.2009.04.010; Gorbatyuk MS, 2010, P NATL ACAD SCI USA, V107, P5961, DOI 10.1073/pnas.0911991107; Goussakov I, 2010, J NEUROSCI, V30, P12128, DOI 10.1523/JNEUROSCI.2474-10.2010; Hackos DH, 1999, J GEN PHYSIOL, V113, P799, DOI 10.1085/jgp.113.6.799; Hamilton SL, 2005, CELL CALCIUM, V38, P253, DOI 10.1016/j.ceca.2005.06.037; Hoang QV, 2002, VISUAL NEUROSCI, V19, P395, DOI 10.1017/S0952523802194028; Hossain GS, 2003, J BIOL CHEM, V278, P30317, DOI 10.1074/jbc.M212897200; Hu HZ, 2004, J BIOL CHEM, V279, P35741, DOI 10.1074/jbc.M404164200; John LM, 1998, J CELL BIOL, V142, P963, DOI 10.1083/jcb.142.4.963; John VH, 2004, NEUROPHARMACOLOGY, V46, P425, DOI 10.1016/j.neuropharm.2003.09.018; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Kohl S, 2005, EUR J HUM GENET, V13, P302, DOI 10.1038/sj.ejhg.5201269; Korenbrot JI, 2002, ADV EXP MED BIOL, V514, P179; Krizaj D, 2005, EXP EYE RES, V81, P690, DOI 10.1016/j.exer.2005.04.007; Krizaj D, 2003, J PHYSIOL-LONDON, V547, P761, DOI 10.1113/jphysiol.2002.035683; Krizaj D, 2002, FRONT BIOSCI-LANDMRK, V7, pD2023, DOI 10.2741/krizaj; Krizaj D, 1998, NEURON, V21, P249, DOI 10.1016/S0896-6273(00)80531-0; Krizaj D, 2012, ADV EXP MED BIOL, V740, P873, DOI 10.1007/978-94-007-2888-2_39; Lanner JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003996; Laver DR, 2011, J MOL CELL CARDIOL, V51, P357, DOI 10.1016/j.yjmcc.2011.05.009; Le YZ, 2004, MOL VIS, V10, P1011; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Leitner MG, 2016, BRIT J PHARMACOL, V173, P2555, DOI 10.1111/bph.13538; LI WWF, 1993, J BIOL CHEM, V268, P12003; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Little Edward, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P1; Luciani DS, 2009, DIABETES, V58, P422, DOI 10.2337/db07-1762; Ma EY, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.332; Ma HW, 2015, J BIOL CHEM, V290, P20880, DOI 10.1074/jbc.M115.641159; Ma HW, 2014, P NATL ACAD SCI USA, V111, P3602, DOI 10.1073/pnas.1317041111; Ma HW, 2013, HUM MOL GENET, V22, P3906, DOI 10.1093/hmg/ddt245; Marks AR, 1997, AM J PHYSIOL-HEART C, V272, pH597, DOI 10.1152/ajpheart.1997.272.2.H597; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Mekahli D, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004317; Michalak M, 1999, BIOCHEM J, V344, P281, DOI 10.1042/0264-6021:3440281; Michalak M, 2002, CELL CALCIUM, V32, P269, DOI 10.1016/S0143416002001884; Michalakis S, 2005, INVEST OPHTH VIS SCI, V46, P1516, DOI 10.1167/iovs.04-1503; Molnar T, 2012, J PHYSIOL-LONDON, V590, P3465, DOI 10.1113/jphysiol.2012.234641; Murthy KS, 2003, AM J PHYSIOL-GASTR L, V284, pG221, DOI 10.1152/ajpgi.00401.2002; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; NAKATANI K, 1988, NATURE, V334, P69, DOI 10.1038/334069a0; Paillard M, 2013, CIRCULATION, V128, P1555, DOI 10.1161/CIRCULATIONAHA.113.001225; Paquet-Durand F, 2011, HUM MOL GENET, V20, P941, DOI 10.1093/hmg/ddq539; Park ES, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.67; Pelled D, 2005, NEUROBIOL DIS, V18, P83, DOI 10.1016/j.nbd.2004.09.004; Perkins GA, 2003, MOL VIS, V9, P60; Phillips MJ, 2008, INVEST OPHTH VIS SCI, V49, P2148, DOI 10.1167/iovs.07-1012; Rao RV, 2004, CURR OPIN CELL BIOL, V16, P653, DOI 10.1016/j.ceb.2004.09.012; Rao RV, 2001, J BIOL CHEM, V276, P33869, DOI 10.1074/jbc.M102225200; Saito Y, 1999, EMBO J, V18, P6718, DOI 10.1093/emboj/18.23.6718; Sakamoto K, 2009, HUM MOL GENET, V18, P178, DOI 10.1093/hmg/ddn327; Sano R, 2009, MOL CELL, V36, P500, DOI 10.1016/j.molcel.2009.10.021; Senft D, 2015, TRENDS BIOCHEM SCI, V40, P141, DOI 10.1016/j.tibs.2015.01.002; Shilling D, 2014, J NEUROSCI, V34, P6910, DOI 10.1523/JNEUROSCI.5441-13.2014; Shinohara T, 2008, MED HYPOTHESES, V70, P378, DOI 10.1016/j.mehy.2007.04.041; Shull GE, 2000, EUR J BIOCHEM, V267, P5284, DOI 10.1046/j.1432-1327.2000.01568.x; Son SM, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.129; Stone J, 2008, BRAIN RES, V1189, P58, DOI 10.1016/j.brainres.2007.10.083; Sugawara T, 2013, J NEUROSCI, V33, P12186, DOI 10.1523/JNEUROSCI.0545-13.2013; Szikra T, 2007, VISUAL NEUROSCI, V24, P733, DOI 10.1017/S0952523807070587; Szikra T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006723; Tang TS, 2005, P NATL ACAD SCI USA, V102, P2602, DOI 10.1073/pnas.0409402102; Tang TS, 2003, NEURON, V39, P227, DOI 10.1016/S0896-6273(03)00366-0; Terluk MR, 2015, J NEUROSCI, V35, P7304, DOI 10.1523/JNEUROSCI.0190-15.2015; Thapa A, 2012, J BIOL CHEM, V287, P18018, DOI 10.1074/jbc.M112.342220; Tzekov R, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a007492; Wagner LE, 2003, J BIOL CHEM, V278, P45811, DOI 10.1074/jbc.M306270200; Wong R, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-15; Xing W, 2012, ADV EXP MED BIOL, V723, P739, DOI 10.1007/978-1-4614-0631-0_94; Xu JH, 2013, J NEUROSCI, V33, P14939, DOI 10.1523/JNEUROSCI.0909-13.2013; Xu JH, 2011, INVEST OPHTH VIS SCI, V52, P3557, DOI 10.1167/iovs.10-6358; Xu W, 2000, J BIOL CHEM, V275, P36676, DOI 10.1074/jbc.M002041200; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Zapun A, 1998, J BIOL CHEM, V273, P6009, DOI 10.1074/jbc.273.11.6009; Zhang SB, 2011, NEUROCHEM RES, V36, P1175, DOI 10.1007/s11064-011-0457-7; Zhang T, 2015, HUM MOL GENET, V24, P1755, DOI 10.1093/hmg/ddu588; Zhang T, 2012, INVEST OPHTH VIS SCI, V53, P3349, DOI 10.1167/iovs.12-9851; Zhang T, 2011, P NATL ACAD SCI USA, V108, P8879, DOI 10.1073/pnas.1017127108; Zhao FY, 2001, J BIOL CHEM, V276, P13810, DOI 10.1074/jbc.M006104200; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	104	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11189	11205		10.1074/jbc.M117.782326	http://dx.doi.org/10.1074/jbc.M117.782326			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28495882	Green Published, hybrid			2022-12-26	WOS:000405119600006
J	Ragunathan, P; Sielaff, H; Sundararaman, L; Biukovic, G; Manimekalai, MSS; Singh, D; Kundu, S; Wohland, T; Frasch, W; Dick, T; Gruber, G				Ragunathan, Priya; Sielaff, Hendrik; Sundararaman, Lavanya; Biukovic, Goran; Manimekalai, Malathy Sony Subramanian; Singh, Dhirendra; Kundu, Subhashri; Wohland, Thorsten; Frasch, Wayne; Dick, Thomas; Gruber, Gerhard			The uniqueness of subunit alpha of mycobacterial F-ATP synthases: An evolutionary variant for niche adaptation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARACOCCUS-DENITRIFICANS; F1FO-ATP SYNTHASE; F1F0-ATP SYNTHASE; ROTATION; PURIFICATION; MECHANISM; RESOLUTION; PROTEIN; MOTOR; SCATTERING	The F1F0 -ATP F-ATP) synthase is essential for growth of Mycobacterium tuberculosis, the causative agent of tuberculosis TB). In addition to their synthase function most F-ATP synthases possess an ATP-hydrolase activity, which is coupled to proton-pumping activity. However, the mycobacterial enzyme lacks this reverse activity, but the reason for this deficiency is unclear. Here, we report that a Mycobacterium-specific, 36-amino acid long C-terminal domain in the nucleotide- binding subunit alpha (Mt alpha) of F-ATP synthase suppresses its ATPase activity and determined the mechanism of suppression. First, we employed vesicles to show that in intact membrane-embedded mycobacterial F-ATP synthases deletion of the C-terminal domain enabled ATPase and protonpumping activity. We then generated a heterologous F-ATP synthase model system, which demonstrated that transfer of the mycobacterial C-terminal domain to a standard F-ATP synthase alpha subunit suppresses ATPase activity. Single-molecule rotation assays indicated that the introduction of this Mycobacterium-specific domain decreased the angular velocity of the power-stroke after ATP binding. Solution X-ray scattering data and NMR results revealed the solution shape of Mt alpha and the 3D structure of the subunit alpha C-terminal peptide (521)PDEHVEALDEDKLAKEAVKV(540) of M. tubercolosis Mt alpha 521-540)), respectively. Together with cross-linking studies, the solution structural data lead to a model, in which Mt alpha 521-540) comes in close proximity with subunit alpha residues 104 -109, whose interaction may influence the rotation of the camshaft-like subunit gamma. Finally, we propose that the unique segment Mt alpha 514 -549), which is accessible at the C terminus of mycobacterial subunit gamma, is a promising drug epitope.	[Ragunathan, Priya; Sielaff, Hendrik; Sundararaman, Lavanya; Manimekalai, Malathy Sony Subramanian; Singh, Dhirendra; Gruber, Gerhard] Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore; [Biukovic, Goran; Kundu, Subhashri; Dick, Thomas] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, 14 Med Dr, Singapore 117599, Singapore; [Wohland, Thorsten] Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117557, Singapore; [Wohland, Thorsten] Natl Univ Singapore, Dept Chem, 14 Sci Dr 4, Singapore 117557, Singapore; [Wohland, Thorsten] Natl Univ Singapore, NUS Ctr Bioimaging Sci CBIS, 14 Sci Dr 4, Singapore 117557, Singapore; [Frasch, Wayne] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Arizona State University; Arizona State University-Tempe	Gruber, G (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	ggrueber@ntu.edu.sg	Dick, Thomas/AAC-4824-2019; Dick, Thomas/AAB-4109-2019; WOHLAND, THORSTEN/R-6404-2019; Wohland, Thorsten/H-8285-2012	Dick, Thomas/0000-0002-9604-9452; Singh, Dhirendra/0000-0002-5576-7052; Sielaff, Hendrik/0000-0001-5231-7286; Wohland, Thorsten/0000-0002-0148-4321	Nanyang Technological University; Ministry of Education; Ministry of Education, Singapore [MOE2011-T2-2-156, ARC 18/12]; Ministry of Health, Singapore, NMRC Grant [CBRG12nov049]; Ministry of Health, Singapore [MOE2012-T2-1-101]; National Institute of Health [R01GM097510]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097510] Funding Source: NIH RePORTER	Nanyang Technological University(Nanyang Technological University); Ministry of Education; Ministry of Education, Singapore(Ministry of Education, Singapore); Ministry of Health, Singapore, NMRC Grant(Ministry of Health-SingaporeNational Medical Research Council, Singapore); Ministry of Health, Singapore(Ministry of Health-Singapore); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Ministry of Education, Singapore Grants MOE2011-T2-2-156 and ARC 18/12, Ministry of Health, Singapore, NMRC Grant CBRG12nov049 (to G. G.), Ministry of Health, Singapore Grant MOE2012-T2-1-101 (to T. W.), and National Institute of Health Grant R01GM097510 (to W. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a research scholarship from Nanyang Technological University.; Supported by a research scholarship from the Ministry of Education.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2000, P NATL ACAD SCI USA, V97, P7243, DOI 10.1073/pnas.120174297; Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Balakrishna AM, 2015, J BIOL CHEM, V290, P3183, DOI 10.1074/jbc.M114.622688; Berjanskii MV, 2006, NUCLEIC ACIDS RES, V34, pW63, DOI 10.1093/nar/gkl341; Biukovic G, 2013, ANTIMICROB AGENTS CH, V57, P168, DOI 10.1128/AAC.01039-12; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Cook GM, 2003, J BACTERIOL, V185, P4442, DOI 10.1128/JB.185.15.4442-4449.2003; Cook GM, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MGM2-0015-2013; Cox RA, 2007, CURR MOL MED, V7, P231, DOI 10.2174/156652407780598584; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dip PV, 2014, ACTA CRYSTALLOGR D, V70, P2848, DOI 10.1107/S1399004714019233; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Glatter O., 1982, SMALL ANGLE X RAY SC; Goude Renan, 2008, V465, P203, DOI [10.1007/978-1-59745-207-6_13, 10.3791/761]; Gruber G, 2002, BIOCHEM BIOPH RES CO, V298, P383, DOI 10.1016/S0006-291X(02)02468-3; Guinier A., 1955, SMALL ANGLE SCATTERI; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Haagsma AC, 2010, FEMS MICROBIOL LETT, V313, P68, DOI 10.1111/j.1574-6968.2010.02123.x; Haagsma AC, 2009, ANTIMICROB AGENTS CH, V53, P1290, DOI 10.1128/AAC.01393-08; HICKS DB, 1990, J BIOL CHEM, V265, P20547; Ho J, 2015, J MOL BIOL, V427, P1866, DOI 10.1016/j.jmb.2015.01.024; HOFFMANN A, 1990, EUR J BIOCHEM, V194, P423, DOI 10.1111/j.1432-1033.1990.tb15635.x; Hotra A, 2016, FEBS J, V283, P1947, DOI 10.1111/febs.13715; Hunke C, 2007, PROTEIN EXPRES PURIF, V53, P378, DOI 10.1016/j.pep.2007.01.009; Kamariah N, 2016, J STRUCT BIOL, V193, P13, DOI 10.1016/j.jsb.2015.11.004; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOTSCHER HR, 1984, BIOCHEMISTRY-US, V23, P4140, DOI 10.1021/bi00313a020; Lu P, 2014, BBA-BIOENERGETICS, V1837, P1208, DOI 10.1016/j.bbabio.2014.01.022; Martin JL, 2014, P NATL ACAD SCI USA, V111, P3715, DOI 10.1073/pnas.1317784111; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; Nishizaka T, 2004, NAT STRUCT MOL BIOL, V11, P142, DOI 10.1038/nsmb721; Okuno D, 2011, J BIOCHEM, V149, P655, DOI 10.1093/jb/mvr049; Pacheco-Moises F, 2002, J BIOENERG BIOMEMBR, V34, P269, DOI 10.1023/A:1020252401675; Panke O, 2000, FEBS LETT, V472, P34, DOI 10.1016/S0014-5793(00)01436-8; PEREZ JA, 1990, BIOCHEMISTRY-US, V29, P10503, DOI 10.1021/bi00498a013; Preiss L, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500106; Priya R, 2013, J BIOENERG BIOMEMBR, V45, P121, DOI 10.1007/s10863-012-9486-4; Rao SPS, 2008, P NATL ACAD SCI USA, V105, P11945, DOI 10.1073/pnas.0711697105; Sakaki N, 2005, BIOPHYS J, V88, P2047, DOI 10.1529/biophysj.104.054668; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SANTANA M, 1994, J BACTERIOL, V176, P6802, DOI 10.1128/JB.176.22.6802-6811.1994; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; Shirakihara Y, 2015, FEBS J, V282, P2895, DOI 10.1111/febs.13329; Sielaff H, 2016, J BIOL CHEM, V291, P25351, DOI 10.1074/jbc.M116.745240; Spetzler D, 2006, BIOCHEMISTRY-US, V45, P3117, DOI 10.1021/bi052363n; Stocker A, 2007, STRUCTURE, V15, P904, DOI 10.1016/j.str.2007.06.009; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tay MYF, 2015, J BIOL CHEM, V290, P2379, DOI 10.1074/jbc.M114.607341; van Kessel JC, 2008, NAT REV MICROBIOL, V6, P851, DOI 10.1038/nrmicro2014; van Kessel JC, 2008, MOL MICROBIOL, V67, P1094, DOI 10.1111/j.1365-2958.2008.06109.x; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; von Ballmoos C, 2009, ANNU REV BIOCHEM, V78, P649, DOI 10.1146/annurev.biochem.78.081307.104803; Watanabe R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4486; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Zarco-Zavala M, 2014, FASEB J, V28, P2146, DOI 10.1096/fj.13-241430; Zharova TV, 2003, BIOCHEMISTRY-MOSCOW+, V68, P1101, DOI 10.1023/A:1026306611821	62	28	29	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11262	11279		10.1074/jbc.M117.784959	http://dx.doi.org/10.1074/jbc.M117.784959			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28495884	Green Published, hybrid			2022-12-26	WOS:000405119600012
J	Heirbaut, M; Lermyte, F; Martin, EM; Beelen, S; Sobott, F; Strelkov, SV; Weeks, SD				Heirbaut, Michelle; Lermyte, Frederik; Martin, Esther M.; Beelen, Steven; Sobott, Frank; Strelkov, Sergei V.; Weeks, Stephen D.			Specific sequences in the N-terminal domain of human small heat-shock protein HSPB6 dictate preferential hetero-oligomerization with the orthologue HSPB1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-B-CRYSTALLIN; CHAPERONE-LIKE ACTIVITY; HETEROOLIGOMERIC COMPLEXES; MASS-SPECTROMETRY; SUBUNIT EXCHANGE; HSP20; POLYDISPERSITY; ARCHITECTURE; DIMERS; RATIO	Small heat-shock proteins (sHSPs) are a conserved group of molecular chaperones with important roles in cellular proteostasis. Although sHSPs are characterized by their small monomeric weight, they typically assemble into large polydisperse oligomers that vary in both size and shape but are principally composed of dimeric building blocks. These assemblies can include different sHSP orthologues, creating additional complexity that may affect chaperone activity. However, the structural and functional properties of such hetero-oligomers are poorly understood. We became interested in hetero-oligomer formation between human heat-shock protein family B (small) member 1 (HSPB1) and HSPB6, which are both highly expressed in skeletal muscle. When mixed in vitro, these two sHSPs form a polydisperse oligomer array composed solely of heterodimers, suggesting preferential association that is determined at the monomer level. Previously, we have shown that the sHSP N-terminal domains (NTDs), which have a high degree of intrinsic disorder, are essential for the biased formation. Here we employed iterative deletion mapping to elucidate how the NTD of HSPB6 influences its preferential association with HSPB1 and show that this region has multiple RLFDQXFG is necessary for subunit exchange among oligomers. Second, a site similar to 20 residues downstream of this motif determines the size of the resultant hetero-oligomers. Third, a region unique to HSPB6 dictates the preferential formation of heterodimers. In conclusion, the disordered NTD of HSPB6 helps regulate the size and stability of hetero-oligomeric complexes, indicating that terminal sHSP regions define the assembly properties of these proteins.	[Heirbaut, Michelle; Beelen, Steven; Strelkov, Sergei V.; Weeks, Stephen D.] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Lab Biocrystallog, B-3000 Leuven, Belgium; [Lermyte, Frederik; Martin, Esther M.; Sobott, Frank] Univ Antwerp, Dept Chem, Biomol & Analyt Mass Spectrometry Grp, B-2020 Antwerp, Belgium; [Martin, Esther M.; Sobott, Frank] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England; [Sobott, Frank] Univ Leeds, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England	KU Leuven; University of Antwerp; University of Leeds; University of Leeds	Strelkov, SV; Weeks, SD (corresponding author), Dept Pharmaceut & Pharmacol Sci, Lab Biocrystallog, Herestr 49,Box 822, B-3000 Leuven, Belgium.	sergei.strelkov@kuleuven.be; stephen.weeks@kuleuven.be	Weeks, Stephen D/G-6150-2017; Weeks, Stephen/N-4813-2019	Weeks, Stephen D/0000-0002-1360-0852; Weeks, Stephen/0000-0002-1360-0852; Sobott, Frank/0000-0001-9029-1865; Lermyte, Frederik/0000-0001-7371-4475	Hercules Foundation Flanders; European Community's Seventh Framework Programme under the BioStruct-X initiative [6131]	Hercules Foundation Flanders; European Community's Seventh Framework Programme under the BioStruct-X initiative	We thank The Hercules Foundation Flanders for funding the Synapt instrument. We acknowledge support from the European Community's Seventh Framework Programme under the BioStruct-X initiative (Project Number 6131) toward the Synchrotron SAXS measurements. We greatly appreciate the excellent support from the beamline scientists on the SWING beamline (Soleil Synchrotron, France).	Andley UP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095507; Aquilina JA, 2013, J BIOL CHEM, V288, P13602, DOI 10.1074/jbc.M112.443812; Aquilina JA, 2004, J BIOL CHEM, V279, P28675, DOI 10.1074/jbc.M403348200; Aquilina JA, 2003, P NATL ACAD SCI USA, V100, P10611, DOI 10.1073/pnas.1932958100; Arrigo AP, 2013, FEBS LETT, V587, P1959, DOI 10.1016/j.febslet.2013.05.011; Augusteyn Robert C, 2004, Clin Exp Optom, V87, P356; Bagneris C, 2009, J MOL BIOL, V392, P1242, DOI 10.1016/j.jmb.2009.07.069; Baldwin AJ, 2011, STRUCTURE, V19, P1855, DOI 10.1016/j.str.2011.09.015; Baranova EV, 2011, J MOL BIOL, V411, P110, DOI 10.1016/j.jmb.2011.05.024; Basha E, 2004, J BIOL CHEM, V279, P7566, DOI 10.1074/jbc.M310684200; Basha E, 2012, TRENDS BIOCHEM SCI, V37, P106, DOI 10.1016/j.tibs.2011.11.005; Basha E, 2010, J BIOL CHEM, V285, P11489, DOI 10.1074/jbc.M109.074088; Bukach OV, 2009, BBA-PROTEINS PROTEOM, V1794, P486, DOI 10.1016/j.bbapap.2008.11.010; Bukach OV, 2004, EUR J BIOCHEM, V271, P291, DOI 10.1046/j.1432-1033.2003.03928.x; CLAUWAERT J, 1989, CURR EYE RES, V8, P397, DOI 10.3109/02713688908996387; Delbecq SP, 2015, BIOCHEMISTRY-US, V54, P4276, DOI 10.1021/acs.biochem.5b00490; Delbecq SP, 2012, EMBO J, V31, P4587, DOI 10.1038/emboj.2012.318; den Engelsman J, 2009, J MOL BIOL, V393, P1022, DOI 10.1016/j.jmb.2009.08.052; Flenniken ML, 2009, CURR TOP MICROBIOL, V327, P71; Furnish EJ, 2010, J NEUROSURG, V112, P631, DOI 10.3171/2009.7.JNS09730; Ghosh JG, 2005, PROTEIN SCI, V14, P684, DOI 10.1110/ps.041152805; Haley DA, 1998, J MOL BIOL, V277, P27, DOI 10.1006/jmbi.1997.1611; Hanazono Y, 2013, STRUCTURE, V21, P220, DOI 10.1016/j.str.2012.11.015; Haslbeck M, 2002, CELL MOL LIFE SCI, V59, P1649, DOI 10.1007/PL00012492; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Haslbeck M, 2015, J MOL BIOL, V427, P1537, DOI 10.1016/j.jmb.2015.02.002; Heirbaut M., 2015, BIG BOOK SMALL HEAT, P197; Heirbaut M, 2016, ARCH BIOCHEM BIOPHYS, V610, P41, DOI 10.1016/j.abb.2016.10.002; Heirbaut M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105892; Hilton GR, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0405; Hochberg GKA, 2014, P NATL ACAD SCI USA, V111, pE1562, DOI 10.1073/pnas.1322673111; James M, 2001, Curr Pharm Biotechnol, V2, P77; Jehle S, 2011, P NATL ACAD SCI USA, V108, P6409, DOI 10.1073/pnas.1014656108; KATO K, 1994, J BIOL CHEM, V269, P15302; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Kurowski MA, 2003, NUCLEIC ACIDS RES, V31, P3305, DOI 10.1093/nar/gkg557; Lermyte F, 2015, J AM SOC MASS SPECTR, V26, P1068, DOI 10.1007/s13361-015-1124-z; MaHam A, 2009, SMALL, V5, P1706, DOI 10.1002/smll.200801602; Mymrikov EV, 2017, J BIOL CHEM, V292, P672, DOI 10.1074/jbc.M116.760413; Mymrikov EV, 2012, CELL STRESS CHAPERON, V17, P157, DOI 10.1007/s12192-011-0296-0; Mymrikov EV, 2011, PHYSIOL REV, V91, P1123, DOI 10.1152/physrev.00023.2010; Pasta SY, 2003, J BIOL CHEM, V278, P51159, DOI 10.1074/jbc.M307523200; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Poulain P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009990; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; Sluchanko NN, 2017, STRUCTURE, V25, P305, DOI 10.1016/j.str.2016.12.005; Sobott F, 2002, J BIOL CHEM, V277, P38921, DOI 10.1074/jbc.M206060200; SPECTOR A, 1971, BIOCHEM J, V124, P337, DOI 10.1042/bj1240337; Srinivas PNBS, 2008, BIOCHEM J, V414, P453, DOI 10.1042/BJ20080544; Studer S, 2000, J BIOL CHEM, V275, P37212, DOI 10.1074/jbc.M004701200; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sugiyama Y, 2000, J BIOL CHEM, V275, P1095, DOI 10.1074/jbc.275.2.1095; Sun TX, 1998, J BIOL CHEM, V273, P286, DOI 10.1074/jbc.273.1.286; Sun Y, 2005, FEBS J, V272, P2613, DOI 10.1111/j.1742-4658.2005.04708.x; Weeks SD, 2007, PROTEIN EXPRES PURIF, V53, P40, DOI 10.1016/j.pep.2006.12.006; Weeks SD, 2014, J STRUCT BIOL, V185, P342, DOI 10.1016/j.jsb.2013.12.009	56	18	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					9944	9957		10.1074/jbc.M116.773515	http://dx.doi.org/10.1074/jbc.M116.773515			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28487364	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000403580600008
J	Gunaryadi, D; Sugiyo; Hedges, S				Gunaryadi, Donny; Sugiyo; Hedges, Simon			Community-based human-elephant conflict mitigation: The value of an evidence-based approach in promoting the uptake of effective methods	PLOS ONE			English	Article							FARM-BASED MEASURES; CONSERVATION SCIENCE; NATIONAL-PARK; DISTRICT; SUMATRA; DEFENSE; FENCES	Human-elephant conflict (HEC) is a serious threat to elephants and can cause major economic losses. It is widely accepted that reduction of HEC will often require community-based methods for repelling elephants but there are few tests of such methods. We tested community-based crop-guarding methods with and without novel chili-based elephant deterrents and describe changes in farmers' willingness to adopt these methods following our demonstration of their relative effectiveness. In three separate field-trials that took place over almost two years (October 2005 -May 2007) in two villages adjacent to Way Kambas National Park (WKNP) in Indonesia, we found that community-based crop-guarding was effective at keeping Asian elephants (Elephas maximus) out of crop fields in 91.2% (52 out of 57), 87.6% (156 out of 178), and 80.0% (16 out of 20) of attempted raids. Once the method had been shown to be effective at demonstration sites, farmers in 16 villages around WKNP voluntarily adopted it during the July 2008 to March 2009 period and were able to repel elephants in 73.9% (150 out of 203) of attempted raids, with seven villages repelling 100% of attempted raids. These 16 villages had all experienced high levels of HEC in the preceding years; e.g. they accounted for >97% of the 742 HEC incidents recorded for the entire park in 2006. Our work shows, therefore, that a simple evidence-based approach can facilitate significant reductions in HEC at the protected area scale.	[Gunaryadi, Donny; Sugiyo] Wildlife Conservat Soc, Indonesia Program, Bogor, Indonesia; [Hedges, Simon] Wildlife Conservat Soc, Global Conservat Programs, Bronx, NY 10460 USA	Wildlife Conservation Society - Indonesia; Wildlife Conservation Society	Hedges, S (corresponding author), Wildlife Conservat Soc, Global Conservat Programs, Bronx, NY 10460 USA.	shedges@wcs.org			United States Fish & Wildlife Service's Asian Elephant Conservation Fund [98210-5-G175, 98210-4-G940]	United States Fish & Wildlife Service's Asian Elephant Conservation Fund	Funding for this project was provided by the United States Fish & Wildlife Service's Asian Elephant Conservation Fund (https://www.fws.gov/ International/wildlife-without-borders/asiane-elephant-conservation-fund.html) through grants 98210-5-G175 and 98210-4-G940 to SH and DG. We are very grateful to the USFWS. The funder had no role in study design, data collection and manuscript.; Our research was a collaborative project of the Indonesian Ministry of Forestry's Directorate General of Forest Protection and Nature Conservation and the Wildlife Conservation Society (WCS). We are grateful to Mr. Hudiyono (the Head of WKNP), Sukatmoko, Agus Santo, Sukadi, and our village 'self-reliance groups' (Kelompok Swadaya Masyarakat) members, for their dedication and patient dealing with farmers. We thank Martin Tyson, Peter Clyne, and Rosie Woodroffe for useful comments on an earlier version of this paper. Funding for this project was provided by the United States Fish & Wildlife Service's Asian Elephant Conservation Fund through grants 98210-5-G175 and 98210-4-G940 to WCS. We are very grateful to the USFWS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blake S, 2004, CONSERV BIOL, V18, P1191, DOI 10.1111/j.1523-1739.2004.01860.x; Cook CN, 2010, FRONT ECOL ENVIRON, V8, P181, DOI 10.1890/090020; Creel S, 2013, ECOL LETT, V16, P1413, DOI 10.1111/ele.12145; Davies TE, 2011, CONSERV LETT, V4, P346, DOI 10.1111/j.1755-263X.2011.00182.x; Gopala A, 2011, IUCN 2011 IUCN RED L; Graham MD, 2008, ORYX, V42, P76, DOI 10.1017/S0030605308000677; Hall JA, 2010, CONSERV BIOL, V24, P120, DOI 10.1111/j.1523-1739.2009.01297.x; Hedges S, 2005, BIOL CONSERV, V124, P35, DOI 10.1016/j.biocon.2005.01.004; Hedges S., 2006, DUNG SURVEY STANDARD; Hedges S, 2010, ORYX, V44, P139, DOI 10.1017/S0030605309990093; Nath C.D., 1998, ELEPHANT HUMAN CONFL; Naughton L., 1999, SOCIAL DIMENSIONS HU; Naughton-Treves L, 1998, CONSERV BIOL, V12, P156, DOI 10.1046/j.1523-1739.1998.96346.x; Nyhus PJ, 2000, ORYX, V34, P262, DOI 10.1017/S0030605300031331; Osborn F. V., 2002, LIVING ELEPHANTS; Osborn FV, 2003, ORYX, V37, P80, DOI 10.1017/S0030605303000152; Osborn FV, 2002, PACHYDERM, V33, P32; Packer C, 2013, Ecol Lett, V16, pe4, DOI 10.1111/ele.12171; Parker G. E., 2007, HUMAN ELEPHANT CONFL; Pfeifer M, 2014, SCIENCE, V345, P389, DOI 10.1126/science.345.6195.389-a; Pullin AS, 2001, CONSERV BIOL, V15, P50, DOI 10.1046/j.1523-1739.2001.99499.x; Sitati NW, 2006, ORYX, V40, P279, DOI 10.1017/S0030605306000834; Sitompul AF., 2004, THESIS; Sitompul Arnold F., 2010, Gajah, V33, P26; Sukumar R., 2003, LIVING ELEPHANTS EVO; Sutherland WJ, 2004, TRENDS ECOL EVOL, V19, P305, DOI 10.1016/j.tree.2004.03.018; UNDP/FAO, 1979, INS78061 UNDPFAO; van Aarde RJ, 2006, S AFR J SCI, V102, P385; Woodroffe R, 2014, SCIENCE, V345, P389, DOI 10.1126/science.345.6195.389-b; Woodroffe R, 2014, SCIENCE, V344, P46, DOI 10.1126/science.1246251; World Wildlife Fund (WWF), 2005, HUMAN WILDLIFE CONFL; Young KD, 2011, BIOL CONSERV, V144, P876, DOI 10.1016/j.biocon.2010.11.023; Zimmermann A., 2009, GAJAH, V30, P34	33	30	30	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0173742	10.1371/journal.pone.0173742	http://dx.doi.org/10.1371/journal.pone.0173742			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28510590	Green Published, Green Submitted, gold			2022-12-26	WOS:000401485500002
J	Boye, P; Serres, F; Marescaux, L; Hordeaux, J; Bouchaert, E; Gomes, B; Tierny, D				Boye, Pierre; Serres, Francois; Marescaux, Laurent; Hordeaux, Juliette; Bouchaert, Emmanuel; Gomes, Bruno; Tierny, Dominique			Dose escalation study to evaluate safety, tolerability and efficacy of intravenous etoposide phosphate administration in 27 dogs with multicentric lymphoma	PLOS ONE			English	Article							VECTORIZED ANTICANCER DRUG; COMBINATION CHEMOTHERAPY PROTOCOL; TARGETING TOPOISOMERASE-II; CANINE LYMPHOMA; CLINICAL-PHARMACOLOGY; HYPOTENSIVE ACTION; CELL LINES; F14512; DOXORUBICIN; CANCER	Comparative oncology has shown that naturally occurring canine cancers are of valuable and translatable interest for the understanding of human cancer biology and the characterization of new therapies. This work was part of a comparative oncology project assessing a new, clinical-stage topoisomerase II inhibitor and comparing it with etoposide in dogs with spontaneous lymphoma with the objective to translate findings from dogs to humans. Etoposide is a topoisomerase II inhibitor widely used in various humans' solid and hematopoietic cancer, but little data is available concerning its potential antitumor efficacy in dogs. Etoposide phosphate is a water-soluble prodrug of etoposide which is expected to be better tolerated in dogs. The objectives of this study were to assess the safety, the tolerability and the efficacy of intravenous etoposide phosphate in dogs with multicentric lymphoma. Seven dose levels were evaluated in a traditional 3+ 3 phase I design. Twenty-seven owned-dogs with high-grade multicentric lymphoma were enrolled and treated with three cycles of etoposide phosphate IV injections every 2 weeks. Adverse effects were graded according to the Veterinary Cooperative Oncology Group criteria. A complete end-staging was realized 45 days after inclusion. The maximal tolerated dose was 300 mg/m(2). At this dose level, the overall response rate was 83.3% (n = 6, 3 PR and 2 CR). Only a moderate reversible gastrointestinal toxicity, no severe myelotoxicity and no hypersensitivity reaction were reported at this dose level. Beyond the characterization of etoposide clinical efficacy in dogs, this study underlined the clinical and therapeutic homologies between dog and human lymphomas.	[Boye, Pierre; Serres, Francois; Hordeaux, Juliette; Bouchaert, Emmanuel; Tierny, Dominique] SIRIC ONCOLille, OCR, Parc Eurasante, Loos, France; [Boye, Pierre; Serres, Francois; Marescaux, Laurent; Tierny, Dominique] SIRIC ONCOLille, Oncovet, Villeneuve Dascq, France; [Gomes, Bruno] Inst Rech Pierre Fabre, Toulouse, France; [Gomes, Bruno] iTeos Therapeut, Gosselies, Belgium	Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm)	Boye, P (corresponding author), SIRIC ONCOLille, OCR, Parc Eurasante, Loos, France.; Boye, P (corresponding author), SIRIC ONCOLille, Oncovet, Villeneuve Dascq, France.	pierre_boye@hotmail.fr	BOUCHAERT, Emmanuel/AFU-7112-2022	BOUCHAERT, Emmanuel/0000-0003-2558-9862; Tierny, Dominique/0000-0001-5192-6813	OCR; Pierre Fabre Medicament	OCR; Pierre Fabre Medicament	This study was conducted by Oncovet Clinical Research (OCR) as part of a collaborative research project between OCR and Pierre Fabre Medicament. OCR provided support in the form of salaries for authors FS, JH, EB, and DT. OCR did not have any additional role in the study design, preparation of the manuscript. Pierre Fabre Medicament provided support in the form of salaries for BG. Pierre Fabre Medicament did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Annereau JP, 2010, LEUKEMIA RES, V34, P1383, DOI 10.1016/j.leukres.2009.12.021; [Anonymous], VET COMP ONCOL; Barret JM, 2008, CANCER RES, V68, P9845, DOI 10.1158/0008-5472.CAN-08-2748; Bo Lan-Jun, 2006, Ai Zheng, V25, P1553; Brel V, 2011, BIOCHEM PHARMACOL, V82, P1843, DOI 10.1016/j.bcp.2011.08.028; Burton JH, 2013, VET COMP ONCOL, V11, P306, DOI 10.1111/j.1476-5829.2012.00324.x; CARTER RF, 1987, J AM ANIM HOSP ASSOC, V23, P587; Collier Kathleen, 2008, J Oncol Pharm Pract, V14, P51, DOI 10.1177/1078155207085355; Doorduijn JK, 2000, HAEMATOLOGICA, V85, P814; DREWINKO B, 1976, CANCER TREAT REP, V60, P1295; Flory AB, 2008, AM J VET RES, V69, P1316, DOI 10.2460/ajvr.69.10.1316; Gentry AC, 2011, BIOCHEMISTRY-US, V50, P3240, DOI 10.1021/bi200094z; GOUGH WB, 1982, J CARDIOVASC PHARM, V4, P375, DOI 10.1097/00005344-198205000-00006; GREENLEE PG, 1990, CANCER-AM CANCER SOC, V66, P480, DOI 10.1002/1097-0142(19900801)66:3&lt;480::AID-CNCR2820660314&gt;3.0.CO;2-X; Hande KR, 1998, EUR J CANCER, V34, P1514, DOI 10.1016/S0959-8049(98)00228-7; Higginbotham ML, 2013, J AM ANIM HOSP ASSOC, V49, P357, DOI 10.5326/JAAHA-MS-5929; Hoetelmans RWM, 1996, ANN PHARMACOTHER, V30, P367, DOI 10.1177/106002809603000409; HOHENHAUS AE, 1990, J VET INTERN MED, V4, P239, DOI 10.1111/j.1939-1676.1990.tb03115.x; IGWEMEZIE LN, 1995, PHARMACEUT RES, V12, P117, DOI 10.1023/A:1016203107497; Joel S, 1996, CANCER TREAT REV, V22, P179, DOI 10.1016/S0305-7372(96)90002-X; KELLER ET, 1993, J VET INTERN MED, V7, P289, DOI 10.1111/j.1939-1676.1993.tb01021.x; Kruczynski A, 2013, LEUKEMIA, V27, P2139, DOI 10.1038/leu.2013.108; Kruczynski A, 2011, INVEST NEW DRUG, V29, P9, DOI 10.1007/s10637-009-9328-3; Lana S, 2007, J VET INTERN MED, V21, P764; Le Tourneau C, 2009, JNCI-J NATL CANCER I, V101, P708, DOI 10.1093/jnci/djp079; Leblond P, 2014, INVEST NEW DRUG, V32, P883, DOI 10.1007/s10637-014-0132-3; MASINI E, 1985, AGENTS ACTIONS, V16, P470, DOI 10.1007/BF01983649; McEntee M, 2003, Vet Comp Oncol, V1, P105, DOI 10.1046/j.1476-5829.2003.00015.x; Montecucco A, 2007, CANCER LETT, V252, P9, DOI 10.1016/j.canlet.2006.11.005; Mouawad F, 2014, ORAL ONCOL, V50, P113, DOI 10.1016/j.oraloncology.2013.11.003; Mutsaers AJ, 2002, J AM VET MED ASSOC, V220, P1813, DOI 10.2460/javma.2002.220.1813; OGILVIE GK, 1988, AM J VET RES, V49, P1367; Ponce F, 2010, VET PATHOL, V47, P414, DOI 10.1177/0300985810363902; POSTORINO NC, 1989, J AM ANIM HOSP ASSOC, V25, P221; Ranieri G, 2013, CRIT REV ONCOL HEMAT, V88, P187, DOI 10.1016/j.critrevonc.2013.03.005; ROSE WC, 1990, INVEST NEW DRUG, V8, pS25; Siderov J, 2002, BRIT J CANCER, V86, P12, DOI 10.1038/sj.bjc.6600003; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Simon D, 2006, J VET INTERN MED, V20, P948, DOI 10.1892/0891-6640(2006)20[948:TODWLU]2.0.CO;2; Simon D, 2008, JAVMA-J AM VET MED A, V232, P879, DOI 10.2460/javma.232.6.879; SINKULE JA, 1984, PHARMACOTHERAPY, V4, P61; SLEVIN ML, 1989, J CLIN ONCOL, V7, P1333, DOI 10.1200/JCO.1989.7.9.1333; Tierny D, 2015, CLIN CANCER RES, V21, P5314, DOI 10.1158/1078-0432.CCR-14-3174; Vail DM, 2010, VET COMP ONCOL, V8, P28, DOI 10.1111/j.1476-5829.2009.00200.x; Valerius KD, 1997, J AM VET MED ASSOC, V210, P512; Valli VE, 2011, VET PATHOL, V48, P198, DOI 10.1177/0300985810379428; Willmann M, 2009, IN VIVO, V23, P911; WOLFF SN, 1987, CANCER CHEMOTH PHARM, V19, P246; Younes A, 2014, LANCET ONCOL, V15, P1019, DOI 10.1016/S1470-2045(14)70311-0; Zemann BI, 1998, J VET INTERN MED, V12, P465, DOI 10.1111/j.1939-1676.1998.tb02151.x	50	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177486	10.1371/journal.pone.0177486	http://dx.doi.org/10.1371/journal.pone.0177486			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505195	Green Submitted, Green Published, gold			2022-12-26	WOS:000401473500023
J	El Idrissi, NB; Iyer, AM; Ramaglia, V; Rosa, PS; Soares, CT; Baas, F; Das, PK				El Idrissi, Nawal Bahia; Iyer, Anand M.; Ramaglia, Valeria; Rosa, Patricia S.; Soares, Cleverson T.; Baas, Frank; Das, Pranab K.			In Situ complement activation and T-cell immunity in leprosy spectrum: An immunohistological study on leprosy lesional skin	PLOS ONE			English	Article							MEMBRANE ATTACK COMPLEX; NECROSIS-FACTOR-ALPHA; WALLERIAN DEGENERATION; REVERSAL REACTIONS; REACTIONAL STATES; PERIPHERAL-NERVE; 2 PARTS; SYSTEM; IMMUNOLOGY; EXPRESSION	Mycobacterium leprae (M. leprae) infection causes nerve damage and the condition worsens often during and long after treatment. Clearance of bacterial antigens including lipoarabinomannan (LAM) during and after treatment in leprosy patients is slow. We previously demonstrated that M. leprae LAM damages peripheral nerves by in situ generation of the membrane attack complex (MAC). Investigating the role of complement activation in skin lesions of leprosy patients might provide insight into the dynamics of in situ immune reactivity and the destructive pathology of M. leprae. In this study, we analyzed in skin lesions of leprosy patients, whether M. leprae antigen LAM deposition correlates with the deposition of complement activation products MAC and C3d on nerves and cells in the surrounding tissue. Skin biopsies of paucibacillary (n = 7), multibacillary leprosy patients (n = 7), and patients with erythema nodosum leprosum (ENL) (n = 6) or reversal reaction (RR) (n = 4) and controls (n = 5) were analyzed. The percentage of C3d, MAC and LAM deposition was significantly higher in the skin biopsies of multibacillary compared to paucibacillary patients (p = < 0.05, p = < 0.001 and p = < 0.001 respectively), with a significant association between LAM and C3d or MAC in the skin biopsies of leprosy patients (r = 0.9578, p< 0.0001 and r = 0.8585, p< 0.0001 respectively). In skin lesions of multibacillary patients, MAC deposition was found on axons and co-localizing with LAM. In skin lesions of paucibacillary patients, we found C3d positive T-cells in and surrounding granulomas, but hardly any MAC deposition. In addition, MAC immunoreactivity was increased in both ENL and RR skin lesions compared to non-reactional leprosy patients (p = < 0.01 and p = < 0.01 respectively). The present findings demonstrate that complement is deposited in skin lesions of leprosy patients, suggesting that inflammation driven by complement activation might contribute to nerve damage in the lesions of these patients. This should be regarded as an important factor in M. leprae nerve damage pathology.	[El Idrissi, Nawal Bahia; Ramaglia, Valeria; Baas, Frank] Acad Med Ctr, Dept Genome Anal, Amsterdam, Netherlands; [Iyer, Anand M.] Acad Med Ctr, Dept Neuropathol, Amsterdam, Netherlands; [Rosa, Patricia S.; Soares, Cleverson T.] Inst Lauro de Souza Lima, Bauru, Brazil; [Baas, Frank] Leiden Univ, Med Ctr, Dept Clin Genet, Leiden, Netherlands; [Das, Pranab K.] Univ Birmingham, Coll Med Sci, Dept Clin Immunol, Birmingham, W Midlands, England; [Das, Pranab K.] Univ Birmingham, Coll Dent Sci, Dept Clin Immunol, Birmingham, W Midlands, England	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Birmingham; University of Birmingham	Baas, F (corresponding author), Acad Med Ctr, Dept Genome Anal, Amsterdam, Netherlands.; Baas, F (corresponding author), Leiden Univ, Med Ctr, Dept Clin Genet, Leiden, Netherlands.	f.baas@lumc.nl	Baas, Frank/F-9574-2010	Baas, Frank/0000-0003-3912-5428; Iyer, Anand/0000-0001-6821-1048	Leprosy Foundation of the Netherlands [701.03.08]	Leprosy Foundation of the Netherlands	This work was supported by the Leprosy Foundation of the Netherlands, grant number 701.03.08. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balagon MVF, 2010, AM J TROP MED HYG, V83, P637, DOI 10.4269/ajtmh.2010.09-0586; BROWNE SG, 1974, LEPROSY REV, V45, P104; Das PK, 2015, ACTA NEUROPATHOL; Dupnik KM, 2014, J INFECT DIS; Fluiter K, 2014, J IMMUNOL, V192, P2339, DOI 10.4049/jimmunol.1302793; GELBER RH, 1974, AM J TROP MED HYG, V23, P471, DOI 10.4269/ajtmh.1974.23.471; Gomes GI, 2008, AM J TROP MED HYG, V78, P605, DOI 10.4269/ajtmh.2008.78.605; Hakobyan S, 2016, CLIN EXP IMMUNOL; KHANOLKARYOUNG S, 1995, CLIN EXP IMMUNOL, V99, P196, DOI 10.1111/j.1365-2249.1995.tb05532.x; Knopf PM, 2008, IMMUNOL CELL BIOL, V86, P221, DOI 10.1038/sj.icb.7100147; LEVY E, 1992, CLIN EXP IMMUNOL, V90, P235; Lockwood DNJ, 2002, AM J TROP MED HYG, V66, P409, DOI 10.4269/ajtmh.2002.66.409; MALAVIYA A N, 1972, International Journal of Leprosy and Other Mycobacterial Diseases, V40, P361; MODLIN RL, 1983, CLIN EXP IMMUNOL, V53, P17; Parkash O, 1995, Acta Leprol, V9, P195; PETCHCLAI B, 1973, AM J TROP MED HYG, V22, P761, DOI 10.4269/ajtmh.1973.22.761; Ramaglia V, 2008, AM J PATHOL, V172, P1043, DOI 10.2353/ajpath.2008.070660; Ramaglia V, 2007, J NEUROSCI, V27, P7663, DOI 10.1523/JNEUROSCI.5623-06.2007; Ramaglia V, 2009, MOL IMMUNOL, V47, P302, DOI 10.1016/j.molimm.2009.09.019; Ramaglia V, 2009, MOL IMMUNOL, V46, P1892, DOI 10.1016/j.molimm.2009.01.017; Ridley D S, 1966, Int J Lepr Other Mycobact Dis, V34, P255; ROCHE PW, 1993, INT J LEPROSY, V61, P35; Saitz E W, 1968, Int J Lepr Other Mycobact Dis, V36, P400; SARNO EN, 1991, CLIN EXP IMMUNOL, V84, P103; Suresh R, 2016, J CELL SCI, V129, P1928, DOI 10.1242/jcs.179291; Toapanta FR, 2006, IMMUNOL RES, V36, P197, DOI 10.1385/IR:36:1:197; Verhagen C, 1999, AM J PATHOL, V154, P1793, DOI 10.1016/S0002-9440(10)65435-1; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; WEMAMBU SNC, 1969, LANCET, V2, P933	30	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177815	10.1371/journal.pone.0177815	http://dx.doi.org/10.1371/journal.pone.0177815			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505186	gold, Green Published, Green Submitted			2022-12-26	WOS:000401473500045
J	Alam, S; Chan, C; Qiu, X; Shannon, I; White, CL; Sant, AJ; Nayak, JL				Alam, Shabnam; Chan, Cory; Qiu, Xing; Shannon, Ian; White, Chantelle L.; Sant, Andrea J.; Nayak, Jennifer L.			Selective pre-priming of HA-specific CD4 T cells restores immunological reactivity to HA on heterosubtypic influenza infection	PLOS ONE			English	Article							ORIGINAL ANTIGENIC SIN; ANTIBODY-RESPONSES; A VIRUS; PROTECTIVE IMMUNITY; H1N1 VIRUS; MEMORY; EXPANSION; GENERATION; EMERGENCE; EPITOPES	A hallmark of the immune response to influenza is repeated encounters with proteins containing both genetically conserved and variable components. Therefore, the B and T cell repertoire is continually being remodeled, with competition between memory and naive lymphocytes. Our previous work using a mouse model of secondary heterosubtypic influenza infection has shown that this competition results in a focusing of CD4 T cell response specificity towards internal virion proteins with a selective decrease in CD4 T cell reactivity to the novel HA epitopes. Strikingly, this shift in CD4 T cell specificity was associated with a diminished anti-HA antibody response. Here, we sought to determine whether the loss in HA-specific reactivity that occurs as a consequence of immunological memory could be reversed by selectively priming HA-specific CD4 T cells prior to secondary infection. Using a peptide-based priming strategy, we found that selective expansion of the anti-HA CD4 T cell memory repertoire enhanced HA-specific antibody production upon heterosubtypic infection. These results suggest that the potentially deleterious consequences of repeated exposure to conserved influenza internal virion proteins could be reversed by vaccination strategies that selectively arm the HA-specific CD4 T cell compartment. This could be a potentially useful pre-pandemic vaccination strategy to promote accelerated neutralizing antibody production on challenge with a pandemic influenza strain that contains few conserved HA epitopes.	[Alam, Shabnam; Chan, Cory; Shannon, Ian; White, Chantelle L.; Nayak, Jennifer L.] Univ Rochester, Med Ctr, Dept Pediat, Div Infect Dis, Rochester, NY 14642 USA; [Qiu, Xing] Univ Rochester, Med Ctr, Dept Biostat & Computat Biol, Rochester, NY 14642 USA; [Sant, Andrea J.] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, David H Smith Ctr Vaccine Biol & Immunol, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Nayak, JL (corresponding author), Univ Rochester, Med Ctr, Dept Pediat, Div Infect Dis, Rochester, NY 14642 USA.	jennifer_nayak@urmc.rochester.edu	Nayak, Jennifer/ADJ-0310-2022		National Institutes of Health, National Institute of Allergy and Infectious Disease [1K08AI106954, HHSN2722014000050]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI106954] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health, National Institute of Allergy and Infectious Disease under grant number 1K08AI106954 and contract number HHSN2722014000050. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam S, 2014, J VIROL, V88, P314, DOI 10.1128/JVI.02077-13; Alam S, 2011, J VIROL, V85, P13310, DOI 10.1128/JVI.05728-11; Belz GT, 2007, P NATL ACAD SCI USA, V104, P6341, DOI 10.1073/pnas.0609990104; Belz GT, 2002, J VIROL, V76, P12388, DOI 10.1128/JVI.76.23.12388-12393.2002; Bentebibel SE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005191; Brown DM, 2006, J IMMUNOL, V177, P2888, DOI 10.4049/jimmunol.177.5.2888; Cobey S, 2017, CURR OPIN VIROL, V22, P105, DOI 10.1016/j.coviro.2016.12.004; Couch RB, 2008, VACCINE, V26, pD5, DOI 10.1016/j.vaccine.2008.05.076; CROFT M, 1994, J IMMUNOL, V152, P2675; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Crowe SR, 2006, VACCINE, V24, P457, DOI 10.1016/j.vaccine.2005.07.096; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; DESTGROTH SF, 1966, J EXP MED, V124, P331, DOI 10.1084/jem.124.3.331; Fonville JM, 2014, SCIENCE, V346, P996, DOI 10.1126/science.1256427; Heikkinen T, 2004, J INFECT DIS, V190, P1369, DOI 10.1086/424527; Herati RS, 2014, J IMMUNOL, V193, P3528, DOI 10.4049/jimmunol.1302503; Kim JH, 2009, J IMMUNOL, V183, P3294, DOI 10.4049/jimmunol.0900398; Klenerman P, 1998, NATURE, V394, P482, DOI 10.1038/28860; MacLeod MKL, 2010, IMMUNOLOGY, V130, P10, DOI 10.1111/j.1365-2567.2010.03260.x; McHeyzer-Williams LJ, 2009, CURR OPIN IMMUNOL, V21, P266, DOI 10.1016/j.coi.2009.05.010; McKinstry KK, 2013, ARCH IMMUNOL THER EX, V61, P341, DOI 10.1007/s00005-013-0236-z; McKinstry KK, 2010, IMMUNOLOGY, V130, P1, DOI 10.1111/j.1365-2567.2010.03259.x; Mizgerd JP, 2015, NEW ENGL J MED, V373, P2380, DOI 10.1056/NEJMc1511751; Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887; Nayak JL, 2013, J IMMUNOL, V191, P1001, DOI 10.4049/jimmunol.1203520; Nayak JL, 2013, J INFECT DIS, V207, P297, DOI 10.1093/infdis/jis684; Nayak JL, 2010, VIRAL IMMUNOL, V23, P169, DOI 10.1089/vim.2009.0099; Nayak JL, 2014, J INFECT DIS; Nguyen JL, 2016, JAMA CARDIOL, V1, P274, DOI 10.1001/jamacardio.2016.0433; Obst R, 2005, J EXP MED, V201, P1555, DOI 10.1084/jem.20042521; Obst R, 2007, P NATL ACAD SCI USA, V104, P15460, DOI 10.1073/pnas.0707331104; Peiris JSM, 2009, J CLIN VIROL, V45, P169, DOI 10.1016/j.jcv.2009.06.006; Ramiscal RR, 2013, IMMUNOL REV, V252, P146, DOI 10.1111/imr.12031; Ravkov EV, 2009, J IMMUNOL, V183, P2382, DOI 10.4049/jimmunol.0900319; Richards KA, 2007, J VIROL, V81, P7608, DOI 10.1128/JVI.02834-06; Richards KA, 2009, J VIROL, V83, P6566, DOI 10.1128/JVI.00302-09; Rogers PR, 2000, J IMMUNOL, V164, P2338, DOI 10.4049/jimmunol.164.5.2338; Sette A, 2008, IMMUNITY, V28, P847, DOI 10.1016/j.immuni.2008.04.018; Strutt TM, 2013, IMMUNOL REV, V255, P149, DOI 10.1111/imr.12088; Strutt TM, 2010, NAT MED, V16, P558, DOI 10.1038/nm.2142; Suh WK, 2015, MOL CELLS, V38, P195, DOI 10.14348/molcells.2015.2331; Swain SL, 2006, IMMUNOL REV, V211, P8, DOI 10.1111/j.0105-2896.2006.00388.x; Teijaro JR, 2011, J IMMUNOL, V187, P5510, DOI 10.4049/jimmunol.1102243; Teijaro JR, 2010, J VIROL, V84, P9217, DOI 10.1128/JVI.01069-10; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Treanor J, 2003, Dev Biol (Basel), V115, P97; Ueno H, 2015, NAT IMMUNOL, V16, P142, DOI 10.1038/ni.3054; von Essen MR, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/163453; Wong KK, 2015, EPIDEMIOL INFECT, V143, P640, DOI 10.1017/S0950268814001198; Yang JP, 2006, P NATL ACAD SCI USA, V103, P147, DOI 10.1073/pnas.0509054103; Yarke CA, 2008, J IMMUNOL, V180, P156, DOI 10.4049/jimmunol.180.1.156	52	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176407	10.1371/journal.pone.0176407	http://dx.doi.org/10.1371/journal.pone.0176407			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493882	Green Submitted, Green Published, gold			2022-12-26	WOS:000401314300016
J	Behets, GJ; Viaene, L; Meijers, B; Blocki, F; Brandenburg, VM; Verhulst, A; D'Haese, PC; Evenepoel, P				Behets, Geert J.; Viaene, Liesbeth; Meijers, Bjorn; Blocki, Frank; Brandenburg, Vincent M.; Verhulst, Anja; D'Haese, Patrick C.; Evenepoel, Pieter			Circulating levels of sclerostin but not DKK1 associate with laboratory parameters of CKD-MBD	PLOS ONE			English	Article							BONE-MINERAL DENSITY; SERUM SCLEROSTIN; PARATHYROID-HORMONE; CALCEMIC RESPONSE; DISEASE; DICKKOPF-1; CALCIFICATION; PROGRESSION; EXPRESSION; SKELETAL	Introduction Mounting evidence indicates that a disturbed Wnt-beta-catenin signaling may be involved in the pathogenesis of chronic kidney disease-mineral and bone and mineral disorder (CKD-MBD). Data on the impact of CKD on circulating levels of the Wnt antagonists sclerostin and Dickkopf related protein 1 (DKK1) and the relationship with laboratory parameters of CKD-MBD are incomplete. Methods We analyzed serum sclerostin and DKK1 in 308 patients across the stages of chronic kidney disease (kDOQI stage 1-2 n = 41; CKD stage 3 n = 54; CKD stage 4-5 n = 54; hemodialysis n = 100; peritoneal dialysis n = 59) as well as in 49 healthy controls. We investigated associations with demographics, renal function, parameters of mineral metabolism including 25 (OH) vitamin D, 1,25(OH)(2) vitamin D, biointact fibroblast growth factor 23 (FGF23), and parathyroid hormone (PTH), and bone turnover markers. Results Serum sclerostin, but not DKK1, increases in more advanced stages of CKD and associates with PTH, phosphate, and 1,25(OH)(2) vitamin D concentrations. Bone turnover markers are highest in hemodialysis patients presenting the combination of high PTH with low sclerostin level. Serum DKK1 levels are lower in CKD patients than in controls and are not associated with laboratory parameters of mineral metabolism. Interestingly, a direct association between DKK1 and platelet count was observed. Conclusion In CKD, serum levels of the Wnt inhibitors DKK1 and sclerostin are unrelated, indicating different sites of origin and/or different regulatory mechanisms. Sclerostin, as opposed to DKK1, may qualify as a biomarker of CKD-MBD, particularly in dialysis patients. DKK1 serum levels, remarkably, correlate almost uniquely with blood platelet counts.	[Behets, Geert J.; Verhulst, Anja; D'Haese, Patrick C.] Univ Antwerp, Dept Biomed Sci, Lab Pathophysiol, Antwerp, Belgium; [Viaene, Liesbeth; Meijers, Bjorn; Evenepoel, Pieter] KUL Leuven, Dept Immunol & Microbiol, Lab Nephrol, Leuven, Belgium; [Blocki, Frank] DiaSorin Inc, Stillwater, MN USA; [Brandenburg, Vincent M.] Univ Hosp RWTH Aachen, Dept Cardiol, Aachen, Germany	University of Antwerp; RWTH Aachen University; RWTH Aachen University Hospital	Evenepoel, P (corresponding author), KUL Leuven, Dept Immunol & Microbiol, Lab Nephrol, Leuven, Belgium.	Pieter.Evenepoel@uzleuven.be	P, Evenepoel/D-9597-2018; D'Haese, Patrick C/C-9599-2019; Meijers, Bjorn/D-6169-2018	P, Evenepoel/0000-0002-2846-2026; Meijers, Bjorn/0000-0002-2846-2026	Diasorin SAP	Diasorin SAP	FB is an employee of Diasorin Inc. The funder provided support in the form of salaries for author FB and also supplied research materials for the current study. PCD has received previous research grants from Diasorin SAP.	Ardawi MSM, 2012, OSTEOPOROSIS INT, V23, P1789, DOI 10.1007/s00198-011-1806-8; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Berdud I, 1996, NEPHROL DIAL TRANSPL, V11, P1292; Brandenburg VM, 2016, PEDIATR NEPHROL, V31, P195, DOI 10.1007/s00467-015-3069-7; Brandenburg VM, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-219; Cejka D, 2014, J CLIN ENDOCR METAB, V99, P248, DOI 10.1210/jc.2013-2786; Cejka D, 2012, NEPHROL DIAL TRANSPL, V27, P226, DOI 10.1093/ndt/gfr270; Cejka D, 2011, CLIN J AM SOC NEPHRO, V6, P877, DOI 10.2215/CJN.06550810; Claes KJ, 2013, J CLIN ENDOCR METAB, V98, P3221, DOI 10.1210/jc.2013-1521; Costa AG, 2011, J CLIN ENDOCR METAB, V96, P3804, DOI 10.1210/jc.2011-0566; DAUGIRDAS JT, 1993, J AM SOC NEPHROL, V4, P1205; Delanaye P, 2014, NEPHRON CLIN PRACT, V128, P127, DOI 10.1159/000366449; Drechsler C, 2015, NEPHROL DIAL TRANSPL, V30, P288, DOI 10.1093/ndt/gfu301; Evenepoel P, 2015, KIDNEY INT, V88, P235, DOI 10.1038/ki.2015.156; Fang YF, 2014, J AM SOC NEPHROL, V25, P1760, DOI 10.1681/ASN.2013080818; Garcia-Martin A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111703; Hruska K. A., 2017, BONE; Ishimura E, 2014, J CLIN ENDOCR METAB, V99, P4315, DOI 10.1210/jc.2014-2372; Kanbay M, 2014, J CLIN ENDOCR METAB, V99, pE1854, DOI 10.1210/jc.2014-2042; Ke HZ, 2012, ENDOCR REV, V33, P747, DOI 10.1210/er.2011-1060; Komaba H, 2010, KIDNEY INT, V77, P232, DOI 10.1038/ki.2009.414; Kramer I, 2010, J BONE MINER RES, V25, P178, DOI 10.1359/jbmr.090730; Lattanzio S, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001000; Malluche HH, 2014, CLIN J AM SOC NEPHRO, V9, P1254, DOI 10.2215/CJN.09470913; MASSRY SG, 1973, ANN INTERN MED, V78, P357, DOI 10.7326/0003-4819-78-3-357; Moyses RMA, 2015, INT UROL NEPHROL, V47, P847, DOI 10.1007/s11255-015-0971-7; Pelletier S, 2015, OSTEOPOROSIS INT, V26, P2165, DOI 10.1007/s00198-015-3127-9; Pelletier S, 2013, CLIN J AM SOC NEPHRO, V8, P819, DOI 10.2215/CJN.07670712; Register TC, 2013, J CLIN ENDOCR METAB, V98, pE60, DOI 10.1210/jc.2012-3038; Ryan ZC, 2013, P NATL ACAD SCI USA, V110, P6199, DOI 10.1073/pnas.1221255110; Sabbagh Y, 2012, J BONE MINER RES, V27, P1757, DOI 10.1002/jbmr.1630; Thambiah S, 2012, CALCIFIED TISSUE INT, V90, P473, DOI 10.1007/s00223-012-9595-4; Thompson B, 2012, NAT REV ENDOCRINOL, V8, P529, DOI 10.1038/nrendo.2012.36; Ueland T, 2009, ARTERIOSCL THROM VAS, V29, P1228, DOI 10.1161/ATVBAHA.109.189761; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; van Lierop AH, 2010, EUR J ENDOCRINOL, V163, P833, DOI 10.1530/EJE-10-0699; Vemana HP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125764; Voorzanger-Rousselot N, 2009, BRIT J HAEMATOL, V145, P264, DOI 10.1111/j.1365-2141.2009.07587.x; Wang LF, 2015, RENAL FAILURE, V37, P1514, DOI 10.3109/0886022X.2015.1077323; Wesseling-Perry K, 2010, J CLIN ENDOCR METAB, V95, P2772, DOI 10.1210/jc.2009-1909	40	26	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176411	10.1371/journal.pone.0176411	http://dx.doi.org/10.1371/journal.pone.0176411			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493902	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314300017
J	Han, S; Wang, Y; Liu, LY; Li, DY; Liu, ZH; Shen, XX; Xu, HY; Zhao, XL; Zhu, Q; Yin, HD				Han, Shunshun; Wang, Yan; Liu, Lingyan; Li, Diyan; Liu, Zihao; Shen, Xiaoxu; Xu, Hengyong; Zhao, Xiaoling; Zhu, Qing; Yin, Huadong			Influence of three lighting regimes during ten weeks growth phase on laying performance, plasma levels-and tissue specific gene expression-of reproductive hormones in Pengxian yellow pullets	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; I MESSENGER-RNA; SEXUAL-MATURITY; PHOTOPERIODIC CONTROL; DOMESTIC PULLETS; BROILER BREEDERS; LAYER STRAINS; 1ST EGG; BIRDS; AGE	The study was conducted to optimize lighting schedule for pre-pubertal (12 to 22 weeks) Chinese native breed Pengxian yellow pullet. A total of 414 healthy pullets (10 weeks), with similar body weight were randomly distributed into three groups (n = 138) and housed in individual cages for up to 12 weeks of age in light controlled rooms and provided normal lighting schedule (10L: 14D). At 12 to 18 weeks of age, pullets were housed in three rooms, having varying lighting schedule viz. G1 (8L: 16D), G2 (10L: 14D), or G3 (12L: 12D). From 19th week onwards lighting schedule was gradually increased every week in incremental manner till all groups started receiving 16L: 8D lighting schedule. The age at first egg, weight of first egg laid, percent peak hen day egg production, concentration of plasma luteinizing and follicle- stimulating hormones and expression of genes regulating synthesis or/and secretion of hypothalamic gonadotropin-releasing hormone-I (GnRH-I), and pituitary LH-beta and FSH-beta were studied during experimental period (12 to 43 weeks of age) of this study. The result indicated that pullets of long day length (G3) group had higher plasma levels of FSH and LH and also better mRNA expression that regulates synthesis or/and secretion of GnRH-I, FSH-beta, and LH-beta before egg laying. The age at first egg (151.3 days) in pullets of G3 group receiving longer lighting hours (12L: 12D) was 8.8 days less (P<0.05) compared to pullets of G1 group, while it was 6.9 days less (P>0.05) compared to G2. However, significantly higher (P<0.05) plasma levels of LH and FSH in pullets of G1 as compared to pullets belonging to G3 group corresponded with the higher (P<0.05) cumulative egg production during the experimental period, while these attributes in G2 group didn't differ from either G1 or G3 groups. Pullets of G1 group had significantly higher levels (P< 0.05) of GnRH-I, FSH-beta, and LH-a mRNA abundances at 43 weeks of age than other two groups and this corresponded with the percent (hen day) peak egg production (75.38%) in pullets in this G1 group that was attained at 32 weeks of age, while the peak production of 71.24% was attained at 30 weeks of age in G3 group. There was no effect of lighting schedule on body weight of pullets, recorded during experimental period, at all occasions; belonging to three groups (G1, G2 and G3) and receiving varying hours of photo-stimulation (P>0.05). It was inferred that the optimum lighting schedule for Chinese native breed Pengxian yellow pullets during 10 weeks of pre-pubertal growth period is short hours of photo-stimulation ( i.e 8L:16D).	[Han, Shunshun; Wang, Yan; Liu, Lingyan; Li, Diyan; Liu, Zihao; Shen, Xiaoxu; Xu, Hengyong; Zhao, Xiaoling; Zhu, Qing; Yin, Huadong] Sichuan Agr Univ, Farm Anim Genet Resources Explorat & Innovat Key, Chengdu, Sichuan, Peoples R China; [Liu, Lingyan] Stat Bur Zhongjiang Cty, Deyang, Sichuan, Peoples R China	Sichuan Agricultural University	Yin, HD (corresponding author), Sichuan Agr Univ, Farm Anim Genet Resources Explorat & Innovat Key, Chengdu, Sichuan, Peoples R China.	yinhuadongsicau@163.com		Li, Diyan/0000-0001-7490-3550	China Agriculture Research System [CARS-41]; thirteen Five Year Plan for breeding program in Sichuan [2016NYZ0050]	China Agriculture Research System; thirteen Five Year Plan for breeding program in Sichuan	This work was supported by China Agriculture Research System (CARS-41), The thirteen Five Year Plan for breeding program in Sichuan (2016NYZ0050).	Baines Elizabeth, 2001, THESIS; BANKS PA, 1989, POULTRY SCI, V68, P739, DOI 10.3382/ps.0680739; Bedecarrats GY, 2009, GEN COMP ENDOCR, V163, P7, DOI 10.1016/j.ygcen.2009.03.010; Cavalchini LG, 1990, CIHEAM OPTIONS MEDIT; Chen H, 2007, POULTRY SCI, V86, P917, DOI 10.1093/ps/86.5.917; Ciccone NA, 2004, J NEUROENDOCRINOL, V16, P999, DOI 10.1111/j.1365-2826.2005.01260.x; Dawson A, 2001, J BIOL RHYTHM, V16, P365, DOI 10.1177/074873001129002079; Dawson A, 2015, FRONT NEUROENDOCRIN, V37, P52, DOI 10.1016/j.yfrne.2014.08.004; Dunn IC, 1999, J NEUROENDOCRINOL, V11, P371; Dunn IC, 2003, REPRODUCTION, V126, P217, DOI 10.1530/reprod/126.2.217; Kang SW, 2006, GEN COMP ENDOCR, V146, P91, DOI 10.1016/j.ygcen.2005.10.017; Koelkebeck KW, 2001, PHYSL RESPONSES POUL; Leeson S, 2005, POULTRY SCI, V84, P626, DOI 10.1093/ps/84.4.626; Leska A, 2007, REPROD BIOL, V7, P99; Lewis PD, 2005, BRIT POULTRY SCI, V46, P349, DOI 10.1080/00071660500098509; Lewis PD, 2004, BRIT POULTRY SCI, V45, P123, DOI 10.1080/00071660410001668950; Lewis PD, 1996, BRIT POULTRY SCI, V37, P15, DOI 10.1080/00071669608417832; Lewis PD, 2002, J AGR SCI-CAMBRIDGE, V138, P441, DOI 10.1017/S0021859602002162; Lewis PD, 1998, BRIT POULTRY SCI, V39, P662, DOI 10.1080/00071669888548; Lewis PD, 1998, BRIT POULTRY SCI, V39, P147, DOI 10.1080/00071669889538; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Proudman JA, 2006, DOMEST ANIM ENDOCRIN, V31, P141, DOI 10.1016/j.domaniend.2005.10.002; Renema RA., 1999, TECH NEWS, V7, P1; Saldanha CJ, 2001, J BIOL RHYTHM, V16, P39, DOI 10.1177/074873040101600105; Schaper SV, 2012, GEN COMP ENDOCR, V179, P53, DOI 10.1016/j.ygcen.2012.07.021; SHARP PJ, 1993, POULTRY SCI, V72, P897, DOI 10.3382/ps.0720897; Sharp PJ, 2003, CAN J PHYSIOL PHARM, V81, P350, DOI 10.1139/Y03-025; Shi ZD, 2008, WORLD POULTRY SCI J, V64, P343, DOI 10.1017/S0043933908000081; Surbhi, 2015, GEN COMP ENDOCR, V220, P13, DOI 10.1016/j.ygcen.2014.06.001; Thiele H. H., 2010, World Poultry, V26, P18; Thiele HH, 2012, HOUSING MANAGEMENT L; Tsutsui K, 2010, FRONT NEUROENDOCRIN, V31, P284, DOI 10.1016/j.yfrne.2010.03.001; Tyler NC, 2012, WORLD POULTRY SCI J, V68, P645, DOI 10.1017/S0043933912000785; Wolc A, 2011, BRIT POULTRY SCI, V52, P537, DOI 10.1080/00071668.2011.625493	34	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177358	10.1371/journal.pone.0177358	http://dx.doi.org/10.1371/journal.pone.0177358			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493941	gold, Green Published, Green Submitted			2022-12-26	WOS:000401314300093
J	Wu, ZL; Cao, YH				Wu, Zhenlong; Cao, Yihua			Dynamics of initial drop splashing on a dry smooth surface	PLOS ONE			English	Article							IMPACT; BREAKUP	We simulate the onset and evolution of the earliest splashing of an infinite cylindrical liquid drop on a smooth dry solid surface. A tiny splash is observed to be emitted out of the rim of the lamella in the early stage of the impact. We find that the onset time of the splash is primarily dependent on the characteristic timescale, which is defined by the impact velocity as well as the drop radius, with no strong dependence on either the liquid viscosity or surface tension. Three regimes are found to be responsible for different splashing patterns. The outermost ejected droplets keep extending radially at a uniform speed proportional to the impact speed. Finally, we discuss the underlying mechanism which is responsible for the occurrence of the initial drop splash in the study.	[Wu, Zhenlong] Beihang Univ, Natl Lab Aeronaut & Astronaut, Beijing, Peoples R China; [Wu, Zhenlong; Cao, Yihua] Beihang Univ, Sch Aeronaut Sci & Engn, Beijing, Peoples R China	Beihang University; Beihang University	Wu, ZL (corresponding author), Beihang Univ, Natl Lab Aeronaut & Astronaut, Beijing, Peoples R China.; Wu, ZL (corresponding author), Beihang Univ, Sch Aeronaut Sci & Engn, Beijing, Peoples R China.	jackilongwu@gmail.com						Boelens A, 2016, ARXIV PREPRINT ARXIV; Cao YH, 2014, PROG AEROSP SCI, V71, P85, DOI 10.1016/j.paerosci.2014.07.003; Cheng M, 2015, COMPUT FLUIDS, V115, P11, DOI 10.1016/j.compfluid.2015.03.019; Cober SG, 2012, J APPL METEOROL CLIM, V51, P265, DOI 10.1175/JAMC-D-11-022.1; Coppola G, 2011, PHYS FLUIDS, V23, DOI 10.1063/1.3555196; Davidson MR, 2002, CHEM ENG SCI, V57, P3639; Deng X, 2013, LANGMUIR, V29, P7847, DOI 10.1021/la401120j; Driscoll MM, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.154502; Fedorchenko AI, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.2038367; Feo A, 2012, NASA TM D 2012 21772; Josserand C, 2016, ANNU REV FLUID MECH, V48, P365, DOI 10.1146/annurev-fluid-122414-034401; Josserand C, 2003, PHYS FLUIDS, V15, P1650, DOI 10.1063/1.1572815; Josserand C, 2015, ARXIV 2015 1511 0939, V1511; KELLER JB, 1995, PHYS FLUIDS, V7, P226, DOI 10.1063/1.868723; Kolinski JM, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.074503; Latka A, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.054501; Mahady K, 2015, J COMPUT PHYS, V294, P243, DOI 10.1016/j.jcp.2015.03.051; Mandre S, 2012, J FLUID MECH, V690, P148, DOI 10.1017/jfm.2011.415; Minemawari H, 2011, NATURE, V475, P364, DOI 10.1038/nature10313; MUNDO C, 1995, INT J MULTIPHAS FLOW, V21, P151, DOI 10.1016/0301-9322(94)00069-V; Quere D, 2005, NATURE, V435, P1168, DOI 10.1038/4351168a; Riboux G, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.024507; Schroll RD, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.034504; STOW CD, 1981, P ROY SOC LOND A MAT, V373, P419, DOI 10.1098/rspa.1981.0002; Thoroddsen ST, 2012, J FLUID MECH, V706, P560, DOI 10.1017/jfm.2012.281; Vander Wal RL, 2006, EXP FLUIDS, V40, P53, DOI 10.1007/s00348-005-0045-1; Visser CW, 2015, SOFT MATTER, V11, P1708, DOI 10.1039/c4sm02474e; Wang YP, 2004, EXP FLUIDS, V37, P385, DOI 10.1007/S00348-004-0827-x; Xu L, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.184505; Xu L, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.056316; Xu L, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.066311; Yarin AL, 2006, ANNU REV FLUID MECH, V38, P159, DOI 10.1146/annurev.fluid.38.050304.092144; 2006, FLUENT 6 3 USERS GUI	33	6	6	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177390	10.1371/journal.pone.0177390	http://dx.doi.org/10.1371/journal.pone.0177390			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493989	Green Submitted, gold, Green Published			2022-12-26	WOS:000401314300101
J	Gouveia, MB; Gherardi, DFM; Lentini, CAD; Dias, DF; Campos, PC				Gouveia, Mainara B.; Gherardi, Douglas F. M.; Lentini, Carlos A. D.; Dias, Daniela F.; Campos, Paula C.			Do the Brazilian sardine commercial landings respond to local ocean circulation?	PLOS ONE			English	Article							SEA-SURFACE TEMPERATURE; VITORIA EDDY; OCEANOGRAPHY; TRANSPORT; ECOSYSTEM; PATTERNS; ANCHOVY; MODELS; LARVAE; SHELF	It has been reported that sea surface temperature (SST) anomalies, flow intensity and mesoscale ocean processes, all affect sardine production, both in eastern and western boundary current systems. Here we tested the hypothesis whether extreme high and low commercial landings of the Brazilian sardine fisheries in the South Brazil Bight (SBB) are sensitive to different oceanic conditions. An ocean model (ROMS) and an individual based model (Ichthyop) were used to assess the relationship between oceanic conditions during the spawning season and commercial landings of the Brazilian sardine one year later. Model output was compared with remote sensing and analysis data showing good consistency. Simulations indicate that mortality of eggs and larvae by low temperature prior to maximum and minimum landings are significantly higher than mortality caused by offshore advection. However, when periods of maximum and minimum sardine landings are compared with respect to these causes of mortality no significant differences were detected. Results indicate that mortality caused by prevailing oceanic conditions at early life stages alone can not be invoked to explain the observed extreme commercial landings of the Brazilian sardine. Likely influencing factors include starvation and predation interacting with the strategy of spawning "at the right place and at the right time".	[Gouveia, Mainara B.; Gherardi, Douglas F. M.; Dias, Daniela F.; Campos, Paula C.] Natl Inst Space Res INPE, Remote Sensing Div, Sao Jose Dos Campos, SP, Brazil; [Lentini, Carlos A. D.] Univ Fed Bahia UFBA, Dept Fis Terra & Meio Ambiente, Inst Fis, Salvador, BA, Brazil; [Lentini, Carlos A. D.] Univ Fed Bahia UFBA, GOAT Grp Oceanog Trop, Salvador, BA, Brazil	Instituto Nacional de Pesquisas Espaciais (INPE); Universidade Federal da Bahia; Universidade Federal da Bahia	Gouveia, MB (corresponding author), Natl Inst Space Res INPE, Remote Sensing Div, Sao Jose Dos Campos, SP, Brazil.	mainara.gouveia@inpe.br	Gouveia, Mainara/AIE-9648-2022; Lentini, Carlos/AAA-4955-2019; Gherardi, Douglas Francisco Marcolino/I-1079-2015	Gouveia, Mainara/0000-0002-6785-1841; Lentini, Carlos/0000-0003-0406-1006; Gherardi, Douglas Francisco Marcolino/0000-0003-3471-7213	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); National Council for Scientific and Technological Development (CNPq PQ-2) [311835/2014-7]; Sao Paulo Research Foundation (FAPESP) [2015/09767-8]; National Institute for Space Research (INPE); CNPq [311835/2014-7]; FAPESP [2015/09767-8]; Remote Sensing Division (DSR/SERE-II) at INPE-SJC	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council for Scientific and Technological Development (CNPq PQ-2)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Institute for Space Research (INPE); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Remote Sensing Division (DSR/SERE-II) at INPE-SJC	This work was supported by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) to MBG, the National Council for Scientific and Technological Development (CNPq PQ-2, grant #311835/2014-7) and Sao Paulo Research Foundation (FAPESP #2015/09767-8) to CADL, and the National Institute for Space Research (INPE) to DFMG, DFD, and PCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Luciano Ponzi Pezzi for his assistance with ROMS and Luiz E. Moraes for helping with fisheries data processing. The third author would like to thank CNPq for the research fellowship (PQ-2, grant #311835/2014-7) and FAPESP for the visiting scientist fellowship (grant #2015/09767-8). He is also grateful to the Remote Sensing Division (DSR/SERE-II) at INPE-SJC for its support during his sabbatical leave. We also thank the US National Oceanographic Data Center for providing the AVHRR product, the Department of Commerce (DOC) from NOAA for OSCAR product. We also thank the National Center for Atmospheric Research Staff (Eds) for CFSR and SODA reanalysis.	BAKUN A, 1990, J CONSEIL, V46, P269; Brochier T, 2011, J MARINE SYST, V87, P109, DOI 10.1016/j.jmarsys.2011.02.025; Campos EJD, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026997; Campos EJD, 1999, GEOPHYS RES LETT, V26, P2061, DOI 10.1029/1999GL900297; Carton JA, 2008, MON WEATHER REV, V136, P2999, DOI 10.1175/2007MWR1978.1; Castelao RM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025182; CERGOLE M.C., 1994, B I OCEANOGR-S PAULO, V42, P113; Chaves RR, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018647; Checkley DM, 2009, CLIMATE CHANGE AND SMALL PELAGIC FISH, P1; Cox DR, 2002, PHILOS T R SOC A, V360, P1389, DOI 10.1098/rsta.2002.1006; De Almeida RAF, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030401; Moraes LED, 2012, ICES J MAR SCI, V69, P939, DOI 10.1093/icesjms/fss061; de Souza RB, 2004, CONT SHELF RES, V24, P241, DOI 10.1016/j.csr.2003.10.001; Dias DF, 2014, PROG OCEANOGR, V123, P38, DOI 10.1016/j.pocean.2014.03.009; Freon P, 2005, B MAR SCI, V76, P385; FreuEn P., 1999, DYNAMICS PELAGIC FIS; Gigliotti ES, 2010, J FISH BIOL, V77, P2248, DOI 10.1111/j.1095-8649.2010.02802.x; Hare JA, 2014, ICES J MAR SCI, V71, P2343, DOI 10.1093/icesjms/fsu018; HOUDE ED, 1989, FISH B-NOAA, V87, P471; Jenkinson A. F., 1995, Q ROY METEOR SOC, V81, P158; Kearney KA, 2012, ECOL MODEL, V237, P43, DOI 10.1016/j.ecolmodel.2012.04.006; Kurtz Frederico W., 2001, Revista Brasileira de Oceanografia, V49, P61; Kurtz FW, THESIS; Lentini CA., 2000, BRAZ J OCEANOGR, V48, P93, DOI 10.1590/S1679-87592000000200001; Lentini CAD, 2001, CONT SHELF RES, V21, P89, DOI 10.1016/S0278-4343(00)00077-7; MACKENZIE BR, 1993, MAR ECOL PROG SER, V94, P207, DOI 10.3354/meps094207; MacKenzie BR, 1995, LIMNOL OCEANOGR, V40, P1278, DOI 10.4319/lo.1995.40.7.1278; Mbaye BC, 2015, FISH OCEANOGR, V24, P69, DOI 10.1111/fog.12094; McCleave J.D., 1984, MECH MIGRATION FISHE; Parada C, 2003, FISH OCEANOGR, V12, P170, DOI 10.1046/j.1365-2419.2003.00235.x; Peck MA, 2012, ADV ECOL RES, V47, P177, DOI 10.1016/B978-0-12-398315-2.00003-X; Peliz A, 2007, J MARINE SYST, V68, P215, DOI 10.1016/j.jmarsys.2006.11.007; Piola AR, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021638; Piola AR, 2000, J GEOPHYS RES-OCEANS, V105, P6565, DOI 10.1029/1999JC000300; Rijnsdorp AD, 2009, ICES J MAR SCI, V66, P1570, DOI 10.1093/icesjms/fsp056; Rodrigues RR, 2001, CONT SHELF RES, V21, P371, DOI 10.1016/S0278-4343(00)00094-7; Rose KA, 2015, PROG OCEANOGR, V138, P348, DOI 10.1016/j.pocean.2015.01.012; Saha S, 2010, B AM METEOROL SOC, V91, P1015, DOI 10.1175/2010BAMS3001.1; SCHMID C, 1995, J PHYS OCEANOGR, V25, P2532, DOI 10.1175/1520-0485(1995)025<2532:TVEAIR>2.0.CO;2; Silva M, 2009, OCEAN MODEL, V30, P256, DOI 10.1016/j.ocemod.2009.07.002; Soares HC, 2011, SCI MAR, V75, P665, DOI 10.3989/scimar.2011.75n4665; Steele JH, 2012, PROG OCEANOGR, V102, P67, DOI 10.1016/j.pocean.2012.03.005; Sunye PS, 1998, FISH OCEANOGR, V7, P89, DOI 10.1046/j.1365-2419.1998.00055.x; Walters CJ., 2020, FISHERIES ECOLOGY MA, DOI [10.2307/j.ctv10vm1f6, DOI 10.2307/J.CTV10VM1F6]; Yoneda NT., 1987, THESIS, V35; Zar JH, 1999, BIOSTATISTICAL ANAL; Zwolinski JP, 2014, ICES J MAR SCI, V71, P2198, DOI 10.1093/icesjms/fst173	47	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176808	10.1371/journal.pone.0176808	http://dx.doi.org/10.1371/journal.pone.0176808			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489925	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314100032
J	Li, Z; Yin, PP; Chen, J; Jin, SL; Liu, JQ; Luo, F				Li, Zhen; Yin, Pingping; Chen, Jian; Jin, Shenglan; Liu, Jieqiong; Luo, Fang			CaMKII alpha may modulate fentanyl-induced hyperalgesia via a CeLC-PAG-RVM-spinal cord descending facilitative pain pathway in rats	PLOS ONE			English	Article							ROSTRAL VENTROMEDIAL MEDULLA; OPIOID-INDUCED HYPERALGESIA; PROTEIN-KINASE-II; INDUCED POSTOPERATIVE HYPERALGESIA; PERIAQUEDUCTAL GRAY NEURONS; LONG-LASTING HYPERALGESIA; INDUCED ABNORMAL PAIN; CENTRAL AMYGDALA; SYNAPTIC-TRANSMISSION; NEUROPATHIC PAIN	Each of the lateral capsular division of central nucleus of amygdala(CeLC), periaqueductal gray (PAG), rostral ventromedial medulla(RVM) and spinal cord has been proved to contribute to the development of opioid-induced hyperalgesia(OIH). Especially, Ca2+/calmodulin-dependent protein kinase II alpha (CaMKII alpha) in CeLC and spinal cord seems to play a key role in OIH modulation. However, the pain pathway through which CaMKII alpha modulates OIH is not clear. The pathway from CeLC to spinal cord for this modulation was explored in the present study. Mechanical and thermal hyperalgesia were tested by von Frey test or Hargreaves test, respectively. CaMKII alpha activity (phospho-CaMKII alpha, p- CaMKII alpha) was evaluated by western blot analysis. CaMKII alpha antagonist (KN93) was micro-infused into CeLC, spinal cord or PAG, respectively, to evaluate its effect on behavioral hyperalgesia and p-CaMKII alpha expression in CeLC, PAG, RVM and spinal cord. Then the underlying synaptic mechanism was explored by recording miniature excitatory postsynaptic currents (mEPSCs) on PAG slices using whole-cell voltage-clamp methods. Results showed that inhibition of CeLC, PAG or spinal CaMKII alpha activity respectively by KN93, reversed both mechanical and thermal hyperalgesia. Microinjection of KN93 into CeLC decreased p- CaMKII alpha expression in CeLC, PAG, RVM and spinal cord; while intrathecal KN93 can only block spinal but not CeLC CaMKIIa activity. KN93 injected into PAG just decreased p-CaMKII alpha expression in PAG, RVM and spinal cord, but not in the CeLC. Similarly, whole-cell voltage-clamp recording found the frequency and amplitude of mEPSCs in PAG cells were decreased by KN93 added in PAG slice or micro-infused into CeLC in vivo. These results together with previous findings suggest that CaMKII alpha may modulate OIH via a CeLC-PAG-RVM-spinal cord descending facilitative pain pathway.	[Li, Zhen; Yin, Pingping; Liu, Jieqiong; Luo, Fang] Huazhong Univ Sci & Technol, Dept Anesthesiol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R China; [Chen, Jian] South Cent Univ Nationalities, Coll Biomed Engn, Key Lab Cognit Sci, State Ethn Affairs Commiss,Lab Membrane Ion Chann, Wuhan, Peoples R China; [Jin, Shenglan] Huazhong Univ Sci & Technol, Tongji Med Coll, Cent Hosp Wuhan, Wuhan, Peoples R China	Huazhong University of Science & Technology; South Central Minzu University; Huazhong University of Science & Technology	Luo, F (corresponding author), Huazhong Univ Sci & Technol, Dept Anesthesiol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R China.	luofang0909@hotmail.com			National Nature Science Foundation of China [81271234, 81050023]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Nature Science Foundation of China (grants 81271234 and 81050023) to FL.	Arout CA, 2014, PHYSIOL BEHAV, V130, P28, DOI 10.1016/j.physbeh.2014.02.056; Bee LA, 2007, NEUROSCIENCE, V147, P786, DOI 10.1016/j.neuroscience.2007.05.004; Butler RK, 2011, PHYSIOL BEHAV, V104, P1075, DOI 10.1016/j.physbeh.2011.05.028; Carrasquillo Y, 2007, J NEUROSCI, V27, P1543, DOI 10.1523/JNEUROSCI.3536-06.2007; Celerier E, 2000, ANESTHESIOLOGY, V92, P465, DOI 10.1097/00000542-200002000-00029; Chen Y, 2010, J NEUROSCI, V30, P38, DOI 10.1523/JNEUROSCI.4346-09.2010; Chen Y, 2009, J PHARMACOL EXP THER, V330, P650, DOI 10.1124/jpet.109.152165; Chen YL, 2009, MOL CELL NEUROSCI, V40, P76, DOI 10.1016/j.mcn.2008.09.003; Cheng JC, 2015, J NEUROSCI, V35, P9689, DOI 10.1523/JNEUROSCI.5039-14.2015; Coulombe MA, 2016, HUM BRAIN MAPP, V37, P1514, DOI 10.1002/hbm.23117; de Novellis V, 2012, EUR J PHARMACOL, V676, P41, DOI 10.1016/j.ejphar.2011.11.034; DIXON WJ, 1948, J AM STAT ASSOC, V43, P109, DOI 10.2307/2280071; Eidson LN, 2013, J PAIN, V14, P393, DOI 10.1016/j.jpain.2012.12.010; Fabry ME, 2003, METH MOLEC MED, V82, P213; Ferrari LF, 2013, J NEUROSCI, V33, P11002, DOI 10.1523/JNEUROSCI.1785-13.2013; Garzon J, 2011, ANTIOXID REDOX SIGN, V15, P873, DOI 10.1089/ars.2010.3767; Goforth PB, 2004, J NEUROTRAUM, V21, P719, DOI 10.1089/0897715041269704; Hamlin AS, 2007, NEUROPHARMACOLOGY, V53, P330, DOI 10.1016/j.neuropharm.2007.05.017; Han JS, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-10; Han JS, 2005, PAIN, V113, P211, DOI 10.1016/j.pain.2004.10.022; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hathway GJ, 2009, J PHYSIOL-LONDON, V587, P2927, DOI 10.1113/jphysiol.2008.168013; Heinricher MM, 2009, BRAIN RES REV, V60, P214, DOI 10.1016/j.brainresrev.2008.12.009; Hou WH, 2016, J NEUROSCI, V36, P4549, DOI 10.1523/JNEUROSCI.3309-15.2016; Hu J, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-71; Hu XY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146393; Jiang M, 2015, PHARMACOL BIOCHEM BE, V134, P35, DOI 10.1016/j.pbb.2015.04.015; Kaeser PS, 2014, ANNU REV PHYSIOL, V76, P333, DOI 10.1146/annurev-physiol-021113-170338; Kincaid W, 2006, J NEUROPHYSIOL, V95, P33, DOI 10.1152/jn.00449.2005; Kiritoshi T, 2013, NEUROPHARMACOLOGY, V66, P170, DOI 10.1016/j.neuropharm.2012.03.024; Lee HJ, 2014, KOREAN J ANESTHESIOL, V67, P299, DOI 10.4097/kjae.2014.67.5.299; Lei J, 2014, EXP NEUROL, V257, P88, DOI 10.1016/j.expneurol.2014.04.019; Li Z, 2016, J PHARMACOL EXP THER, V359, P82, DOI 10.1124/jpet.116.233817; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lu CE, 2015, J NEUROL SCI, V352, P48, DOI 10.1016/j.jns.2015.03.018; Luo F, 2008, J PHARMACOL EXP THER, V325, P267, DOI 10.1124/jpet.107.132167; Mao JR, 2002, PAIN, V100, P213, DOI 10.1016/S0304-3959(02)00422-0; Martin TJ, 2008, EXP CLIN PSYCHOPHARM, V16, P357, DOI 10.1037/a0013597; Mauermann E, 2016, ANESTHESIOLOGY, V124, P453, DOI 10.1097/ALN.0000000000000976; Meng ID, 2007, LIFE SCI, V80, P1915, DOI 10.1016/j.lfs.2007.02.022; Nakanishi M, 2010, MOL BIOL CELL, V21, P2568, DOI 10.1091/mbc.E10-01-0049; Neubert MJ, 2004, PAIN, V110, P158, DOI 10.1016/j.pain.2004.03.017; Neugebauer V, 2004, NEUROSCIENTIST, V10, P221, DOI 10.1177/1073858403261077; Ni HD, 2016, J NEUROSCI RES, V94, P50, DOI 10.1002/jnr.23672; Ninan I, 2004, NEURON, V42, P129, DOI 10.1016/S0896-6273(04)00143-6; Oliveira MA, 2001, BRAIN RES BULL, V54, P55, DOI 10.1016/S0361-9230(00)00420-2; Ossipov MH, 2005, BIOPOLYMERS, V80, P319, DOI 10.1002/bip.20254; Ossipov MH, 2014, CURR OPIN SUPPORT PA, V8, P143, DOI 10.1097/SPC.0000000000000055; Palazzo E, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-44; Palazzo E, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-82; Penzo MA, 2014, J NEUROSCI, V34, P2432, DOI 10.1523/JNEUROSCI.4166-13.2014; Price TJ, 2005, NEUROSCI LETT, V389, P94, DOI 10.1016/j.neulet.2005.07.029; Rivat C, 2002, ANESTHESIOLOGY, V96, P381, DOI 10.1097/00000542-200202000-00025; Rivat C, 2009, EUR J NEUROSCI, V29, P727, DOI 10.1111/j.1460-9568.2009.06616.x; Rodriguez-Munoz M, 2007, CELL SIGNAL, V19, P2558, DOI 10.1016/j.cellsig.2007.08.003; Roeckel LA, 2016, NEUROSCIENCE; Rosen A, 2004, BRAIN RES, V1001, P87, DOI 10.1016/j.brainres.2003.11.060; Salling MC, 2016, BIOL PSYCHIAT, V79, P430, DOI 10.1016/j.biopsych.2014.10.020; Sanchez-Blazquez P, 2008, NEUROPHARMACOLOGY, V54, P319, DOI 10.1016/j.neuropharm.2007.10.002; Sanchez-Blazquez P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011278; Sanna MD, 2015, EUR J PHARMACOL, V764, P271, DOI 10.1016/j.ejphar.2015.07.022; Sanna MD, 2014, NEUROPHARMACOLOGY, V86, P67, DOI 10.1016/j.neuropharm.2014.06.007; Sarhan M, 2005, J COMP NEUROL, V491, P418, DOI 10.1002/cne.20697; Sarhan M, 2013, INT J NEUROPSYCHOPH, V16, P1649, DOI 10.1017/S146114571200168X; Seto SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066404; Shen GF, 2009, BIOCHEM SOC T, V37, P1394, DOI 10.1042/BST0371394; Shoudai K, 2010, J NEUROSCI, V30, P14470, DOI 10.1523/JNEUROSCI.2557-10.2010; Sikand P, 2007, J PHYSIOL-LONDON, V581, P631, DOI 10.1113/jphysiol.2006.118620; Stoicea N, 2015, FRONT PHARMACOL, V6, DOI [10.3382/fphar.2015.00104, 10.3389/fphar.2015.00104]; Toyoda H, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-4; Tracey I, 2007, NEURON, V55, P377, DOI 10.1016/j.neuron.2007.07.012; Vanderah TW, 2001, J NEUROSCI, V21, P279, DOI 10.1523/JNEUROSCI.21-01-00279.2001; Vanegas H, 2004, BRAIN RES REV, V46, P295, DOI 10.1016/j.brainresrev.2004.07.004; Vardanyan A, 2009, J PAIN, V10, P243, DOI 10.1016/j.jpain.2008.07.004; Wang LLX, 2003, ADV DRUG DELIVER REV, V55, P949, DOI 10.1016/S0169-409X(03)00098-X; Wang XL, 2007, J PHYSIOL-LONDON, V579, P849, DOI 10.1113/jphysiol.2006.126102; Wang ZJJ, 2010, HEMATOL-AM SOC HEMAT, P403, DOI 10.1182/asheducation-2010.1.403; Wang ZW, 2008, MOL NEUROBIOL, V38, P153, DOI 10.1007/s12035-008-8039-7; Wilkie DJ, 2010, J NATL MED ASSOC, V102, P18, DOI 10.1016/S0027-9684(15)30471-5; WYLLIE DJA, 1994, NEURON, V12, P127, DOI 10.1016/0896-6273(94)90158-9; Xie JY, 2005, J NEUROSCI, V25, P409, DOI 10.1523/JNEUROSCI.4054-04.2005; Xing JH, 2007, J NEUROPHYSIOL, V97, P503, DOI 10.1152/jn.01023.2006; Xu H, 2008, J NEUROSCI, V28, P7445, DOI 10.1523/JNEUROSCI.1812-08.2008; Yang K, 2003, BIOCHEM BIOPH RES CO, V302, P233, DOI 10.1016/S0006-291X(03)00156-6; Yu RJ, 2014, NEUROIMAGE-CLIN, V6, P100, DOI 10.1016/j.nicl.2014.08.019; Zhang RX, 2013, NEUROSCIENCE, V252, P359, DOI 10.1016/j.neuroscience.2013.08.030; Zhou HY, 2010, J NEUROSCI, V30, P4460, DOI 10.1523/JNEUROSCI.5857-09.2010; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	88	7	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177412	10.1371/journal.pone.0177412	http://dx.doi.org/10.1371/journal.pone.0177412			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489932	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314100074
J	Appelbaum, T; Santana, E; Aguirre, GD				Appelbaum, Tatyana; Santana, Evelyn; Aguirre, Gustavo D.			Strong upregulation of inflammatory genes accompanies photoreceptor demise in canine models of retinal degeneration	PLOS ONE			English	Article							NLRP3 INFLAMMASOME; MICROGLIAL PHAGOCYTOSIS; DISEASE EXPRESSION; BETA-SUBUNIT; ACTIVATION; MACROPHAGES; MUTATION; PROTEIN; INTERLEUKIN-1; NECROPTOSIS	We have analyzed the complex pattern of the inflammatory response in early-onset canine models of human retinitis pigmentosa, rcd1, xlpra2 and erd, as well as late-onset xlpra1, in comparative manner. The time course of immune response genes and proteins expression was examined along the timeline of photoreceptors degeneration. Gene expression analysis of the early-onset models prior to and after the peak of photoreceptors death identified the involvement of multiple immune response genes including those encoding constituents of the NLRP3 inflammasome, its substrates, pro-IL1B, pro-IL18, and common components of IL1B, IL18 and TLR4 pathways. Out of two activated caspase-1 cleavage products, IL1B and IL18, only IL1B was detected in rcd1 and xlpra2 while precursor IL18 remained unprocessed in the same protein extract highlighting prominence of IL1B pathway. An overall immune response was most prominent in rcd1 followed by xlpra2 and least prominent in erd. Noticeably, in rcd1 and xlpra2, but not in erd, early induction of the immune response was accompanied by sustained intraretinal migration and activation of retinal microglia. Lastly, delayed activation of the anti-inflammatory factors in all early-onset models was insufficient to counterbalance rapidly progressing inflammation. In contrast to early-onset models, in late-onset xlpra1 retinas a subset of the pro-inflammatory genes was highly upregulated long before any disease-related structural changes occurred, but was counterbalanced by an adequate anti-inflammatory response. Results point out to upregulated immune response accompanying disease progression in animal models of retinal degeneration, and to potential benefits of early anti-inflammatory therapy.	[Appelbaum, Tatyana; Santana, Evelyn; Aguirre, Gustavo D.] Univ Penn, Sch Vet Med, Sect Ophthalmol, Philadelphia, PA 19104 USA	University of Pennsylvania	Appelbaum, T; Aguirre, GD (corresponding author), Univ Penn, Sch Vet Med, Sect Ophthalmol, Philadelphia, PA 19104 USA.	tatyanak@upenn.edu; gda@vet.upenn.edu		Aguirre, Gustavo/0000-0002-5228-256X	Foundation Fighting Blindness [GDA]; National Eye Institute [EY-06855, EY-17549]; Vision research [P30EY-001583]; The Alcon Research Foundation; Hope for Vision; Van Sloun Fund for Canine Genetic Research; NATIONAL EYE INSTITUTE [R01EY006855, R01EY017549] Funding Source: NIH RePORTER	Foundation Fighting Blindness [GDA]; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Vision research; The Alcon Research Foundation; Hope for Vision; Van Sloun Fund for Canine Genetic Research; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by Foundation Fighting Blindness [GDA]; National Eye Institute Grant EY-06855 [GDA]; National Eye Institute Grant EY-17549 [GDA]; Core grant for Vision research P30EY-001583 [GDA is Module co-PI); The Alcon Research Foundation [GDA]; Hope for Vision [GDA]; Van Sloun Fund for Canine Genetic Research [GDA]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACLAND GM, 1987, EXP EYE RES, V44, P491, DOI 10.1016/S0014-4835(87)80160-4; Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Appelbaum T, 2016, MOL VIS, V22, P319; Baroja-Mazo A, 2014, NAT IMMUNOL, V15, P738, DOI 10.1038/ni.2919; Beltran WA, 2006, INVEST OPHTH VIS SCI, V47, P1669, DOI 10.1167/iovs.05-0845; Beltran WA, 2009, INVEST OPHTH VIS SCI, V50, P3985, DOI 10.1167/iovs.08-3364; Berta AI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024074; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cantley MD, 2013, INFLAMMOPHARMACOLOGY, V21, P301, DOI 10.1007/s10787-012-0166-0; Cherry JD, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00594; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Eandi CM, 2016, ELIFE, V5, DOI 10.7554/eLife.16490; FARBER DB, 1992, NEURON, V9, P349, DOI 10.1016/0896-6273(92)90173-B; Filgueiras LR, 2016, J DIABETES COMPLICAT; Fontaine V, 1998, J NEUROSCI, V18, P9662; Gardiner KL, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2477-9; Genini S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-172; Genini S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085408; Gicquel T, 2014, CLIN EXP PHARMACOL P, V41, P279, DOI 10.1111/1440-1681.12214; Goldstein O, 2010, GENOMICS, V96, P362, DOI 10.1016/j.ygeno.2010.09.003; Gong DP, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-31; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Gupta N, 2003, EXP EYE RES, V76, P463, DOI 10.1016/S0014-4835(02)00332-9; Guyon R, 2007, MOL VIS, V13, P1094; Jablonski KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159724; Kataoka K, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.73; Kikkawa S, 2001, BIOCHEM BIOPH RES CO, V281, P461, DOI 10.1006/bbrc.2001.4378; Lagali Pamela S, 2011, J Ocul Biol Dis Infor, V4, P111, DOI 10.1007/s12177-012-9080-3; Lamkanfi M, 2004, J BIOL CHEM, V279, P51729, DOI 10.1074/jbc.M407891200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Munoz M, 2015, IMMUNITY, V42, P321, DOI 10.1016/j.immuni.2015.01.011; Neves J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf3646; Nielsen H.M., 2013, BIOCHEM, V61, P455, DOI DOI 10.1007/978-94-007-4525-4_; Noailles A, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0186-3; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Provis JM, 1996, PERSPECT DEV NEUROBI, V3, P213; Radwan M, 2010, J IMMUNOL, V185, P3544, DOI 10.4049/jimmunol.0904000; Rajan JV, 2010, FEBS LETT, V584, P4627, DOI 10.1016/j.febslet.2010.10.036; RAY K, 1994, INVEST OPHTH VIS SCI, V35, P4291; Rivera JC, 2013, ARTERIOSCL THROM VAS, V33, P1881, DOI 10.1161/ATVBAHA.113.301331; Robert S, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20160107; Rock KL, 2008, ANNU REV PATHOL-MECH, V3, P99, DOI 10.1146/annurev.pathmechdis.3.121806.151456; Sasaki Y, 2001, BIOCHEM BIOPH RES CO, V286, P292, DOI 10.1006/bbrc.2001.5388; Schott J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004368; Shanmugam Muthu K, 2013, Subcell Biochem, V61, P627, DOI 10.1007/978-94-007-4525-4_27; Sivakumar V, 2011, J PATHOL, V224, P245, DOI 10.1002/path.2858; SUBER ML, 1993, P NATL ACAD SCI USA, V90, P3968, DOI 10.1073/pnas.90.9.3968; Tarallo V, 2012, CELL, V149, P847, DOI 10.1016/j.cell.2012.03.036; Traverso V, 2003, INVEST OPHTH VIS SCI, V44, P4550, DOI 10.1167/iovs.03-0460; Villagra A, 2010, ONCOGENE, V29, P157, DOI 10.1038/onc.2009.334; Walsh JG, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-35; Wang MH, 2014, ADV EXP MED BIOL, V801, P333, DOI 10.1007/978-1-4614-3209-8_42; Wang MH, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-173; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Weinstock JV, 2003, J IMMUNOL, V170, P5003, DOI 10.4049/jimmunol.170.10.5003; WHITCUP SM, 2013, INT J INFLAMM, V2013, DOI DOI 10.1155/2013/724648; Wicki S, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.311; Yabal M, 2014, CELL REP, V7, P1796, DOI 10.1016/j.celrep.2014.05.008; Yoshida N, 2013, OPHTHALMOLOGY, V120, P100, DOI 10.1016/j.ophtha.2012.07.006; Zabel MK, 2016, GLIA, V64, P1479, DOI 10.1002/glia.23016; Zeiss GJ, 1999, INVEST OPHTH VIS SCI, V40, P3292; Zhang B, 2015, EXP NEUROL, V273, P83, DOI 10.1016/j.expneurol.2015.08.001; Zhang F., 2016, ONCOTARGET; Zhang Q, 2002, HUM MOL GENET, V11, P993, DOI 10.1093/hmg/11.9.993; Zhao L, 2015, EMBO MOL MED, V7, P1179, DOI 10.15252/emmm.201505298	70	32	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177224	10.1371/journal.pone.0177224	http://dx.doi.org/10.1371/journal.pone.0177224			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486508	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314000060
J	de Wit, M; Carvalho, B; Delis-van Diemen, PM; van Alphen, C; Belien, JAM; Meijer, GA; Fijneman, RJA				de Wit, Meike; Carvalho, Beatriz; Delis-van Diemen, Pien M.; van Alphen, Carolien; Bellen, Jeroen A. M.; Meijer, Gerrit A.; Fijneman, Remond J. A.			Lumican and versican protein expression are associated with colorectal adenoma-to-carcinoma progression	PLOS ONE			English	Article							CANCER-CELLS; COLON-CANCER; STAGE-II; TUMOR; OVEREXPRESSION; PATHWAYS; MATRIX; STROMA; GENES	Background One prominent event associated with colorectal adenoma-to-carcinoma progression is genomic instability. Approximately 85% of colorectal cancer cases exhibit chromosomal instability characterized by accumulation of chromosome copy number aberrations (CNAs). Adenomas with gain of chromosome 8q, 13q, and/or 20q are at high risk of progression to cancer. Tumor progression is also associated with expansion of the extracellular matrix (ECM) and the activation of non-malignant cells within the tumor stroma. The glycoproteins versican and lumican are overexpressed at the mRNA level in colon carcinomas compared to adenomas, and are associated with the formation of tumor stroma. Purpose The aim of this study was to characterize versican and lumican protein expression in tumor progression and investigate their association with CNAs commonly associated with adenoma-to-carcinoma progression. Methods Tissue microarrays were constructed with colon adenomas and carcinomas that were characterized for MSI-status and DNA copy number gains of chromosomes 8q, 13q and 20q. Sections were immunohistochemically stained for lumican and versican. Protein expression levels were evaluated using digitized slides, and scores were finally dichotomized into a positive or negative score per sample. Results Lumican and versican expression were both observed in neoplastic cells and in the tumor stroma of colon adenomas and carcinomas. Lumican expression was more frequently present in epithelial cells of carcinomas than adenomas (49% versus 18%; P = 0.0001) and in high-risk adenomas and carcinomas combined compared to low-risk adenomas (43% versus 16%; P = 0.005). Versican staining in the tumor stroma was more often present in high-risk adenomas combined with carcinomas compared to low-risk adenomas (57% versus 36%; P = 0.03) and was associated with the presence of gain of 13q (71% versus 44%; P = 0.04). Conclusion Epithelial lumican and stromal versican protein expression are increased during colorectal adenoma-to-carcinoma progression.	[de Wit, Meike; Carvalho, Beatriz; Delis-van Diemen, Pien M.; Meijer, Gerrit A.; Fijneman, Remond J. A.] Netherlands Canc Inst, Dept Pathol, Amsterdam, Netherlands; [de Wit, Meike; Carvalho, Beatriz; Delis-van Diemen, Pien M.; Bellen, Jeroen A. M.; Meijer, Gerrit A.; Fijneman, Remond J. A.] Vrije Univ Amsterdam, Dept Pathol, Med Ctr, Amsterdam, Netherlands; [van Alphen, Carolien] Vrije Univ Amsterdam, Dept Med Oncol, Med Ctr, Amsterdam, Netherlands	Netherlands Cancer Institute; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Fijneman, RJA (corresponding author), Netherlands Canc Inst, Dept Pathol, Amsterdam, Netherlands.; Fijneman, RJA (corresponding author), Vrije Univ Amsterdam, Dept Pathol, Med Ctr, Amsterdam, Netherlands.	r.fijneman@nki.nl	Fijneman, Remond/X-4199-2019; de wit, meike/N-5494-2015; Carvalho, Beatriz/GXA-0720-2022	Fijneman, Remond/0000-0003-2076-5521; de wit, meike/0000-0003-1850-0831; Meijer, Gerrit/0000-0003-0330-3130	DeCoDe project [030-101]	DeCoDe project	This work was performed within the framework of CTMM, the Center for Translational Molecular Medicine; DeCoDe project (grant 030-101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogels M, 2012, ONCOIMMUNOLOGY, V1, P798, DOI 10.4161/onci.20427; Brezillon S, 2009, CANCER LETT, V283, P92, DOI 10.1016/j.canlet.2009.03.032; Carvalho B, 2009, GUT, V58, P79, DOI 10.1136/gut.2007.143065; Carvalho B, 2012, CELL ONCOL, V35, P53, DOI 10.1007/s13402-011-0065-1; Crispino P, 2008, CANCER INVEST, V26, P419, DOI 10.1080/07357900701788155; Davies RJ, 2002, LANCET, V359, P1917, DOI 10.1016/S0140-6736(02)08739-1; de Wit M, 2013, ANN SURG ONCOL, V20, pS348, DOI 10.1245/s10434-012-2441-0; de Wit M, 2012, GUT, V61, P855, DOI 10.1136/gutjnl-2011-300511; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Droste JSTS, 2012, GASTROENTEROLOGY, V142, pS643; Fijneman RJA, 2007, CANCER LETT, V258, P223, DOI 10.1016/j.canlet.2007.09.013; Helmke BM, 2012, ANTICANCER RES, V32, P1589; Hermsen M, 2002, GASTROENTEROLOGY, V123, P1109, DOI 10.1053/gast.2002.36051; Ishiwata T, 2007, ONCOL REP, V18, P537; Kim MY, 2006, GASTROENTEROLOGY, V131, P1913, DOI 10.1053/j.gastro.2006.10.021; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kunz-Schughart LA, 2002, HISTOL HISTOPATHOL, V17, P599, DOI 10.14670/HH-17.599; LEBARON RG, 1992, J BIOL CHEM, V267, P10003; Mukaratirwa S, 2005, INT J EXP PATHOL, V86, P219, DOI 10.1111/j.0959-9673.2005.00425.x; Nikitovic D, 2011, INT J BIOCHEM CELL B, V43, P928, DOI 10.1016/j.biocel.2011.03.008; Ogunbiyi OA, 1997, GASTROENTEROLOGY, V113, P761, DOI 10.1016/S0016-5085(97)70169-0; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Radwanska A, 2012, EXP CELL RES, V318, P2312, DOI 10.1016/j.yexcr.2012.07.005; Ricciardelli C, 2007, J BIOL CHEM, V282, P10814, DOI 10.1074/jbc.M606991200; SHINYA H, 1979, ANN SURG, V190, P679, DOI 10.1097/00000658-197912000-00001; Sillars-Hardebol AH, 2011, GUT; Sillars-Hardebol AH, 2012, J PATHOL, V226, P1, DOI 10.1002/path.3012; Sillars-Hardebol AH, 2010, TUMOR BIOL, V31, P89, DOI 10.1007/s13277-009-0012-1; Societies DFOBS, COD PROP SEC US HUM; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Theocharis AD, 2010, FEBS J, V277, P3904, DOI 10.1111/j.1742-4658.2010.07800.x; Theocharis AD, 2002, BBA-MOL BASIS DIS, V1588, P165, DOI 10.1016/S0925-4439(02)00161-8; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wit M, 2012, ANN SURG ONCOL; Wu JJ, 2011, CANCER RES, V71, P349, DOI 10.1158/0008-5472.CAN-10-2550	35	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0174768	10.1371/journal.pone.0174768	http://dx.doi.org/10.1371/journal.pone.0174768			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481899	Green Published, Green Submitted, gold			2022-12-26	WOS:000401313700002
J	Tsutsumi, J; Minai, K; Kawai, M; Ogawa, K; Inoue, Y; Morimoto, S; Tanaka, T; Nagoshi, T; Ogawa, T; Yoshimura, M				Tsutsumi, Joshi; Minai, Kosuke; Kawai, Makoto; Ogawa, Kazuo; Inoue, Yasunori; Morimoto, Satoshi; Tanaka, Toshikazu; Nagoshi, Tomohisa; Ogawa, Takayuki; Yoshimura, Michihiro			Manifold implications of obesity in ischemic heart disease among Japanese patients according to covariance structure analysis: Low reactivity of B-type natriuretic peptide as an intervening risk factor	PLOS ONE			English	Article							DIABETES-MELLITUS; RECEPTOR; INDIVIDUALS; HYPERTROPHY; MORTALITY; HYPOXIA; IMPACT; LEVEL	Background/Objectives Obesity is believed to be one of the major risk factors for cardiovascular disease in Western countries. However, the effects of obesity should be continuously examined in the Japanese population because the average bodily habitus differs among countries. In this study, we collectively examined the significance of obesity and obesity-triggered risk factors including the low reactivity of B-type natriuretic peptide (BNP), for ischemic heart disease (IHD) in Japanese patients. Methods and results The study patients consisted of 1252 subjects (IHD: n = 970; non-IHD: n = 282). Multiple logistic regression analysis revealed that dyslipidemia, hypertension, diabetes, and the low reactivity of BNP were significant risk factors for IHD, but body mass index (BMI) was not. A theoretical path model was proposed by positioning BMI at the top of the hierarchical model. Exploratory factor analysis revealed that BMI did not play a causative role in IHD (P = NS). BMI was causatively linked to other risk factors (P<0.001 for hypertension; P<0.001 for dyslipidemia; P<0.001 for HbA1c; P<0.001 for LogBNP), and these factors played a causative role in IHD (P<0.001 for hypertension; P<0.001 for dyslipidemia; P<0.001 for HbA1c; P<0.001 for LogBNP). The intrinsic power of the low reactivity of BNP induced by high BMI on the promotion of IHD was fairly potent. Conclusion This study demonstrated that obesity per se is not a strong risk factor for IHD in Japanese patients. However, several important risk factors triggered by obesity exhibited a causative role for IHD. The low reactivity of BNP is a substantial risk factor for IHD.	[Tsutsumi, Joshi; Minai, Kosuke; Kawai, Makoto; Ogawa, Kazuo; Inoue, Yasunori; Morimoto, Satoshi; Tanaka, Toshikazu; Nagoshi, Tomohisa; Ogawa, Takayuki; Yoshimura, Michihiro] Jikei Univ, Div Cardiol, Dept Internal Med, Sch Med, Tokyo, Japan	Jikei University	Minai, K (corresponding author), Jikei Univ, Div Cardiol, Dept Internal Med, Sch Med, Tokyo, Japan.	heart@jikei.ac.jp	Tanaka, Toshikazu D/K-5989-2018	Tanaka, Toshikazu D/0000-0002-0711-7880	Grants-in-Aid for Scientific Research [17K09531] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Clerico A, 2015, CLIN CHIM ACTA, V443, P17, DOI 10.1016/j.cca.2014.06.003; Clerico A, 2012, HEART FAIL REV, V17, P81, DOI 10.1007/s10741-011-9249-z; Clerico A, 2009, CLIN CHIM ACTA, V405, P1, DOI 10.1016/j.cca.2009.03.050; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Duncan JG, 2010, CIRCULATION, V121, P426, DOI 10.1161/CIRCULATIONAHA.109.888735; Galassi A, 2006, AM J MED, V119, P812, DOI 10.1016/j.amjmed.2006.02.031; Harada E, 1999, J MOL CELL CARDIOL, V31, P1997, DOI 10.1006/jmcc.1999.1030; HIRATA Y, 1988, FEBS LETT, V238, P415, DOI 10.1016/0014-5793(88)80523-4; Inoue Y, 2016, METABOLISM, V65, P38, DOI 10.1016/j.metabol.2015.09.019; Invitti C, 2004, NEW ENGL J MED, V351, P1147; Juonala M, 2011, NEW ENGL J MED, V365, P1876, DOI 10.1056/NEJMoa1010112; Kalantar-Zadeh K, 2004, J AM COLL CARDIOL, V43, P1439, DOI 10.1016/j.jacc.2003.11.039; Kawai M, 2013, INTERNAL MED, V52, P171, DOI 10.2169/internalmedicine.52.8704; Kinoshita K, 2016, INT J CARDIOL, V215, P283, DOI 10.1016/j.ijcard.2016.04.111; Lanfear DE, 2014, J CARD FAIL, V20, P662, DOI 10.1016/j.cardfail.2014.06.357; Liang FQ, 2003, ENDOCRINOLOGY, V144, P4187, DOI 10.1210/en.2002-0217; Luo YX, 2006, MOL PHARMACOL, V69, P1953, DOI 10.1124/mol.105.017905; Meroufel DN, 2015, GENE, V567, P159, DOI 10.1016/j.gene.2015.04.073; Minai K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108983; Mizuno Y, 2013, ENDOCR J, V60, P87, DOI 10.1507/endocrj.EJ12-0239; Morales-Villegas E, 2014, CURR HYPERTENS REV; Morikis VA, 2015, BIORHEOLOGY, V52, P447, DOI 10.3233/BIR-15067; MORITA E, 1993, CIRCULATION, V88, P82, DOI 10.1161/01.CIR.88.1.82; MUKOYAMA M, 1991, J CLIN INVEST, V87, P1402, DOI 10.1172/JCI115146; Nakane T, 2012, INTERNAL MED, V51, P239, DOI 10.2169/internalmedicine.51.6206; Nanri H, 2017, CHILD CARE HLTH DEV; Nishikimi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053233; Nojiri T, 2015, P NATL ACAD SCI USA, V112, P4086, DOI 10.1073/pnas.1417273112; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Sacks FM, 2014, CIRCULATION, V129, P999, DOI 10.1161/CIRCULATIONAHA.113.002529; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Ueshima H, 2006, CIRC J, V70, P1249; Wang TJ, 2004, NEW ENGL J MED, V350, P655, DOI 10.1056/NEJMoa031994; Weidemann A, 2008, BIOCHEM J, V409, P233, DOI 10.1042/BJ20070629; Wisse BE, 2004, J AM SOC NEPHROL, V15, P2792, DOI 10.1097/01.ASN.0000141966.69934.21; YASUE H, 1994, CIRCULATION, V90, P195, DOI 10.1161/01.CIR.90.1.195; Zeng K, 2013, J HUM HYPERTENS, V27, P271, DOI 10.1038/jhh.2012.25; Zois NE, 2014, NAT REV CARDIOL, V11, P403, DOI 10.1038/nrcardio.2014.64	39	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177327	10.1371/journal.pone.0177327	http://dx.doi.org/10.1371/journal.pone.0177327			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481950	Green Published, gold			2022-12-26	WOS:000401313700052
J	Zeng, AL; Yan, W; Liu, YW; Wang, Z; Hu, Q; Nie, E; Zhou, X; Li, R; Wang, XF; Jiang, T; You, YP				Zeng, A-L; Yan, W.; Liu, Y-W; Wang, Z.; Hu, Q.; Nie, E.; Zhou, X.; Li, R.; Wang, X-F; Jiang, T.; You, Y-P			Tumour exosomes from cells harbouring PTPRZ1-MET fusion contribute to a malignant phenotype and temozolomide chemoresistance in glioblastoma	ONCOGENE			English	Article							CANCER STEM-CELLS; EXTRACELLULAR VESICLES; MESENCHYMAL TRANSITION; EFFECTIVE STRATEGY; SIGNALING PATHWAY; EMERGING ROLE; MICROVESICLES; GROWTH; GENE; RNA	Exosomes are carriers of pro-tumorigenic factors that participate in glioblastoma (GBM) progression, and many fusion genes are strong driver mutations in neoplasia and are involved in tumorigenesis. However, the ability of fusion genes to be transduced by exosomes is unknown. We characterized exosomes from GBM cells harbouring and not harbouring PTPRZ1-MET fusion (ZM fusion). We also determined the effect of the exosomes from ZM fusion cells (ZM exosomes) on pro-oncogenic secretions and showed that ZM exosomes are internalized by the recipient cells. In addition, we studied the effect of ZM exosome-mediated intercellular communication in the GBM microenvironment. MET proto-oncogene expression was higher in ZM exosomes. Moreover, phosphorylated MET was detected only in ZM exosomes and not in exosomes released by non-ZM fusion GBM cells. ZM exosomes transferred to non-ZM fusion GBM cells and normal human astrocytes altered gene expression and induced epithelial-mesenchymal transition. The uptake of ZM exosomes also induced an exosome-dependent phenotype defined by GBM cell migration and invasion, neurosphere growth and angiogenesis. In addition, ZM exosomes conferred temozolomide resistance to the GBM cells, and exosomederived ZM fusion network proteins targeted multiple pro-oncogenic effectors in recipient cells within the GBM microenvironment. Our findings show that exosomes mediate the aggressive character of GBM and demonstrate the role of ZM fusion in the exacerbation of this effect. These findings have possible implications for the foundation of gene fusion-based therapy for managing GBM.	[Zeng, A-L; Yan, W.; Hu, Q.; Nie, E.; Zhou, X.; Li, R.; Wang, X-F; You, Y-P] Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China; [Liu, Y-W; Wang, Z.; Jiang, T.] Capital Med Univ, Beijing Neurosurg Inst, Beijing, Peoples R China; [Jiang, T.] Beijing Inst Brain Disorders Brain Tumor Ctr, Beijing, Peoples R China; [Jiang, T.] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China	Nanjing Medical University; Beijing Neurosurgical Institute; Capital Medical University; Capital Medical University	Yan, W; You, YP (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China.	neuro_yw@126.com; yypl9@njmu.edu.cn	zeng, ailiang/AAF-4498-2020	Zeng, Ailiang/0000-0003-2869-9899	National Natural Science Foundation of China [81402056, 81472362]; National High Technology Research, Development Program of China (863) [2012AA02A508]; National Key Research and Development Plan [2016YFC0902500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research, Development Program of China (863); National Key Research and Development Plan	This work was supported by a grant from the National Natural Science Foundation of China (No. 81402056 and 81472362), National High Technology Research, Development Program of China (863) (No. 2012AA02A508) and the National Key Research and Development Plan (No. 2016YFC0902500).	Adachi E, 2016, ONCOTARGET, V7, P70779, DOI 10.18632/oncotarget.12221; Aga M, 2014, ONCOGENE, V33, P4613, DOI 10.1038/onc.2014.66; Anastasiadou E, 2014, SCIENCE, V346, P1459, DOI 10.1126/science.aaa4024; Annala MJ, 2013, CANCER LETT, V340, P192, DOI 10.1016/j.canlet.2013.01.011; Bao ZS, 2014, GENOME RES, V24, P1765, DOI 10.1101/gr.165126.113; Belting M, 2008, J CELL BIOL, V183, P1187, DOI 10.1083/jcb.200810038; Boccaccio C, 2013, CANCER RES, V73, P3193, DOI 10.1158/0008-5472.CAN-12-4039; Bronisz A, 2014, CANCER RES, V74, P738, DOI 10.1158/0008-5472.CAN-13-2650; Charles NA, 2012, GLIA, V60, P502, DOI 10.1002/glia.21264; Chen HM, 2015, FEBS LETT, V589, P1437, DOI 10.1016/j.febslet.2015.04.032; COOPER CS, 1984, NATURE, V311, P29, DOI 10.1038/311029a0; D'Asti E, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00294; Eder JP, 2009, CLIN CANCER RES, V15, P2207, DOI 10.1158/1078-0432.CCR-08-1306; GRAZIANI A, 1991, J BIOL CHEM, V266, P22087; Greening DW, 2015, SEMIN CELL DEV BIOL, V40, P72, DOI 10.1016/j.semcdb.2015.02.009; Han DF, 2015, ONCOTARGET, V6, P26119, DOI 10.18632/oncotarget.4444; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Javeed N, 2015, CLIN CANCER RES, V21, P1722, DOI 10.1158/1078-0432.CCR-14-2022; Josson S, 2015, ONCOGENE, V34, P2690, DOI 10.1038/onc.2014.212; Kourembanas S, 2015, ANNU REV PHYSIOL, V77, P13, DOI 10.1146/annurev-physiol-021014-071641; Lathia JD, 2015, GENE DEV, V29, P1203, DOI 10.1101/gad.261982.115; Lathia JD, 2011, CELL STEM CELL, V8, P482, DOI 10.1016/j.stem.2011.04.013; Le MTN, 2014, J CLIN INVEST, V124, P5109, DOI 10.1172/JCI75695; Lee JK, 2014, ONCOTARGETS THER, V7, P1933, DOI 10.2147/OTT.S36582; Li CCY, 2013, RNA BIOL, V10, P1333, DOI 10.4161/rna.25281; Liu XD, 2011, CLIN CANCER RES, V17, P7127, DOI 10.1158/1078-0432.CCR-11-1157; Lopez-Bertoni H, 2015, ONCOGENE, V34, P3994, DOI 10.1038/onc.2014.334; Luo H, 2015, BRAIN, V138, P3654, DOI 10.1093/brain/awv287; Martinez MC, 2011, CIRC RES, V109, P110, DOI 10.1161/CIRCRESAHA.110.233049; Mertens F, 2015, NAT REV CANCER, V15, P371, DOI 10.1038/nrc3947; Messaoudi K, 2015, DRUG DISCOV TODAY, V20, P899, DOI 10.1016/j.drudis.2015.02.011; Messaoudi K, 2015, DRUG DISCOV TODAY, V20, P772, DOI 10.1016/j.drudis.2015.02.014; Minciacchi VR, 2015, SEMIN CELL DEV BIOL, V40, P41, DOI 10.1016/j.semcdb.2015.02.010; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Ricklefs F, 2016, CANCER RES, V76, P2876, DOI 10.1158/0008-5472.CAN-15-3432; Roma-Rodrigues C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/179486; Shi ZM, 2014, NEURO-ONCOLOGY, V16, P1341, DOI 10.1093/neuonc/nou084; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Wade M, 2013, NAT REV CANCER, V13, P83, DOI 10.1038/nrc3430; Wang L, 2014, ONCOTARGET, V5, P5416, DOI 10.18632/oncotarget.2116; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wickramasinghe D, 2005, CELL CYCLE, V4, P683, DOI 10.4161/cc.4.5.1688; Zeng AL, 2015, ONCOTARGET, V6, P30232, DOI 10.18632/oncotarget.4920; Zhang YN, 2016, ONCOTARGET, V7, P37370, DOI 10.18632/oncotarget.8276; Zomer A, 2016, CANCER RES, V76, P2071, DOI 10.1158/0008-5472.CAN-15-2804	49	80	84	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 21	2017	36	38					5369	5381		10.1038/onc.2017.134	http://dx.doi.org/10.1038/onc.2017.134			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FH7PJ	28504721	Green Published, hybrid			2022-12-26	WOS:000411382100004
J	Marzook, H; Deivendran, S; George, B; Reshmi, G; Santhoshkumar, TR; Kumar, R; Pillai, MR				Marzook, H.; Deivendran, S.; George, B.; Reshmi, G.; Santhoshkumar, T. R.; Kumar, R.; Pillai, M. R.			Cytoplasmic translocation of MTA1 coregulator promotes de-repression of SGK1 transcription in hypoxic cancer cells	ONCOGENE			English	Article							GLUCOCORTICOID-INDUCIBLE KINASE; GENE-EXPRESSION; BREAST-CANCER; TUMOR-GROWTH; STEM-CELLS; METASTASIS; SERUM; ACTIVATION; SURVIVAL; PROTEIN	Chromatin remodeling factor metastatic tumor protein 1 (MTA1), one of the most upregulated oncogene in human cancer, has an important role in gene expression, cell survival and promoting hypoxic response. Successful cancer progression is dependent on the ability of cells to utilize its survival pathways for adapting to hypoxic microenvironment. Although MTA1 is a stress-responsive gene, but whether hypoxia modulates its function and its role in engaging other core stress-responsive survival pathway(s) remains unknown. Here we have discovered that MTA1 is a novel corepressor of serum and glucocorticoid-inducible kinase 1 (SGK1). Surprisingly, this regulatory corepressive function of MTA1 is lost under hypoxia, allowing upregulation of SGK1 expression and engaging the MTA1-SGK1 axis for the benefit of the cell survival. The underlying mechanism of the noticed stimulation of SGK1 expression by hypoxia includes de-repression of SGK1 transcription because of hypoxia-triggered nucleus-to-cytoplasmic translocation of MTA1. In addition, the newly recognized cytoplasmic translocation of MTA1 was dependent on the chaperoning function of heat shock protein 90 (HSP90) and co-accompanied by the formation of MTA1, HSP90 and HIF1 alpha complex under hypoxic condition but not under normoxic condition. Hypoxia-triggered redistribution of MTA1, SGK1 upregulation and cell survival functions were compromised by a pharmacological SGK1 inhibitor. In summary, for the first time, we report MTA1 regulation of SGK1 expression, hypoxia-dependent MTA1 translocation to the cytoplasm and de-repression of SGK1 transcription. These findings illustrate how cancer cells utilize a chromatin remodeling factor to engage a core survival pathway to support its cancerous phenotypes, and reveal new facets of MTA1-SGK1 axis by a physiologic signal in cancer progression.	[Marzook, H.; Deivendran, S.; George, B.; Reshmi, G.; Santhoshkumar, T. R.; Kumar, R.; Pillai, M. R.] Rajiv Gandhi Ctr Biotechnol, Canc Res Program, Thiruvananthapuram 695014, Kerala, India; [Kumar, R.] George Washington Univ, Sch Med & Hlth Sci, Dept Biochem & Mol Med, Washington, DC 20052 USA	Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB); George Washington University	Kumar, R; Pillai, MR (corresponding author), Rajiv Gandhi Ctr Biotechnol, Canc Res Program, Thiruvananthapuram 695014, Kerala, India.; Kumar, R (corresponding author), Sch Med & Hlth Sci, 530 Ross Hall,2300 Eye St NW, Washington, DC 20037 USA.	bcmrxk@gwu.edu; mrpillai@rgcb.res.in	Kumar, Rakesh/ABD-1065-2020; Sankaran, Deivendran/X-8009-2019	Kumar, Rakesh/0000-0001-7664-0803; 	NIH [CA098823]; Department of Biotechnology, Government of India; Council of Science and Industrial Research [09/716(0142)/2010-EMR-1]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Science and Industrial Research	We thank Christie P Thomas, University of Iowa for the promoter construct pGL3bas_hsgkF4R4, Nirmalya Sen from Kumar's laboratory for identifying SGK1 as a MTA1 target from an in-house, microarray data set generated using NIH grant CA098823. Assistance from Vipin Mohan Dan for MTT analyses, Indu Ramachandran (Core facility for FACS), Confocal Microscopy facility, as well as Prakash R and Ishaque P (Central Cell Line Repository) for hypoxia standardization. This work was supported by Department of Biotechnology, Government of India and Hezlin Marzook is supported by a Senior Research Fellowship from the Council of Science and Industrial Research (09/716(0142)/2010-EMR-1).	Amato R, 2013, ONCOGENE, V32, P4572, DOI 10.1038/onc.2012.470; Anacker C, 2013, P NATL ACAD SCI USA, V110, P8708, DOI 10.1073/pnas.1300886110; Azeez JM, 2015, DRUG DES DEV THER, V9, P5987, DOI 10.2147/DDDT.S89390; Barretina J, 2010, NAT GENET, V42, P715, DOI 10.1038/ng.619; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cong BH, 2014, CAN J CARDIOL, V30, P687, DOI 10.1016/j.cjca.2014.03.024; Dickmanns A, 2015, CELLS-BASEL, V4, P538, DOI 10.3390/cells4030538; Ellen TP, 2008, CARCINOGENESIS, V29, P2, DOI 10.1093/carcin/bgm200; Feng XH, 2014, MOL CELLS, V37, P699, DOI 10.14348/molcells.2014.0029; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Giordano TJ, 2003, AM J PATHOL, V162, P521, DOI 10.1016/S0002-9440(10)63846-1; Gluck S, 2012, BREAST CANCER RES TR, V132, P781, DOI 10.1007/s10549-011-1412-7; Guo XF, 2013, THORAC CANCER, V4, P312, DOI 10.1111/1759-7714.12024; Haferlach T, 2010, J CLIN ONCOL, V28, P2529, DOI 10.1200/JCO.2009.23.4732; Hall BA, 2012, BREAST CANCER RES TR, V135, P469, DOI 10.1007/s10549-012-2161-y; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Itani OA, 2002, AM J PHYSIOL-ENDOC M, V283, pE971, DOI 10.1152/ajpendo.00021.2002; Johnson AB, 2008, MUTAT RES-FUND MOL M, V640, P174, DOI 10.1016/j.mrfmmm.2008.01.001; Kumar R, 2016, GENE, V582, P112, DOI 10.1016/j.gene.2016.02.012; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Lang F, 2013, HORM-INT J ENDOCRINO, V12, P160, DOI 10.14310/horm.2002.1401; Lang F, 2010, INT J BIOCHEM CELL B, V42, P1571, DOI 10.1016/j.biocel.2010.05.016; Li DQ, 2015, ADV CANCER RES, V127, P1, DOI 10.1016/bs.acr.2015.04.005; Liu J, 2014, CANCER METAST REV, V33, P843, DOI 10.1007/s10555-014-9511-7; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Matschke J, 2016, RADIAT ONCOL, V11, DOI 10.1186/s13014-016-0647-1; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Minet E, 1999, FEBS LETT, V460, P251, DOI 10.1016/S0014-5793(99)01359-9; Mizuno H, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-18; Moon HE, 2006, ONCOL REP, V16, P929; Murakami Y, 2010, BIOCHEM BIOPH RES CO, V396, P376, DOI 10.1016/j.bbrc.2010.04.100; Newman B, 2012, CANCER RES, V72, P4551, DOI 10.1158/0008-5472.CAN-11-3600; Pakala SB, 2013, CANCER RES, V73, P3761, DOI 10.1158/0008-5472.CAN-12-3998; Rusai K, 2009, CELL PHYSIOL BIOCHEM, V24, P577, DOI 10.1159/000257527; Sang NL, 2002, MOL CELL BIOL, V22, P2984, DOI 10.1128/MCB.22.9.2984-2992.2002; Scotto L, 2008, GENE CHROMOSOME CANC, V47, P755, DOI 10.1002/gcc.20577; Selamat SA, 2012, GENOME RES, V22, P1197, DOI 10.1101/gr.132662.111; Semenza GL, 2016, BBA-MOL CELL RES, V1863, P382, DOI 10.1016/j.bbamcr.2015.05.036; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Sen N, 2014, CANCER METAST REV, V33, P879, DOI 10.1007/s10555-014-9515-3; Sherk AB, 2008, CANCER RES, V68, P7475, DOI 10.1158/0008-5472.CAN-08-1047; Stegmaier K, 2004, NAT GENET, V36, P257, DOI 10.1038/ng1305; Talarico C, 2015, ONCOTARGET, V6, P37520, DOI 10.18632/oncotarget.5527; Tsai YP, 2014, INT J CANCER, V134, P249, DOI 10.1002/ijc.28190; Wang K, 2013, ISRN HEPATOL, V2013, P1; Wang RA, 2014, CANCER METAST REV, V33, P1001, DOI 10.1007/s10555-014-9525-1; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Yoo YG, 2006, EMBO J, V25, P1231, DOI 10.1038/sj.emboj.7601025; Yu L, 2013, FEBS LETT, V587, P2542, DOI 10.1016/j.febslet.2013.06.029; Zhang C, 2015, INT J CANCER, V136, P2001, DOI 10.1002/ijc.28975	50	8	8	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 14	2017	36	37					5263	5273		10.1038/onc.2017.19	http://dx.doi.org/10.1038/onc.2017.19			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FG8HT	28504714				2022-12-26	WOS:000410671700005
J	Guo, H; Zhu, Q; Yu, X; Merugu, SB; Mangukiya, HB; Smith, N; Li, Z; Zhang, B; Negi, H; Rong, R; Cheng, K; Wu, Z; Li, D				Guo, H.; Zhu, Q.; Yu, X.; Merugu, S. B.; Mangukiya, H. B.; Smith, N.; Li, Z.; Zhang, B.; Negi, H.; Rong, R.; Cheng, K.; Wu, Z.; Li, D.			Tumor-secreted anterior gradient-2 binds to VEGF and FGF2 and enhances their activities by promoting their homodimerization	ONCOGENE			English	Article							GROWTH-FACTOR; ANTIANGIOGENIC THERAPIES; MONOCLONAL-ANTIBODY; INTERSTITIAL FLUID; AGR2 EXPRESSION; ANGIOGENESIS; MICROENVIRONMENT; PATHWAYS; MECHANISMS; RESISTANCE	The importance of the tumor microenvironment in targeted anticancer therapies has been well recognized. Various protein factors participate in the cross-talk between tumor cells and non-malignant cells. Anterior gradient-2 (AGR2) is overexpressed in diverse human adenocarcinomas and it exists in both intracellular and extracellular spaces. Although intracellular AGR2 has been intensively investigated, the function of secreted AGR2, especially its exact mechanism of action is still poorly understood. Here we report that the secreted AGR2 promotes the angiogenesis and the invasion of vascular endothelial cells and fibroblasts by enhancing the activities of vascular endothelial growth factor (VEGF) and fibroblast growth factor 2 (FGF2). Further study indicated that AGR2 directly binds to these extracellular signaling molecules, and enhances their homodimerization. The extracellular AGR2 activity can be blocked to reduce angiogenesis and inhibit tumor growth in vitro and in vivo by a monoclonal antibody targeting the AGR2 self-dimerization region, and combined treatment with bevacizumab produced maximum inhibition effect. In conclusion, our investigation reveals a mechanism that directly links the secreted AGR2 with extracellular signaling networks, and we propose that the secreted AGR2 is a blockable molecular target, which acts as a chaperon-like enhancer to VEGF and FGF2.	[Guo, H.; Zhu, Q.; Merugu, S. B.; Mangukiya, H. B.; Zhang, B.; Negi, H.; Rong, R.; Wu, Z.; Li, D.] Shanghai Jiao Tong Univ, Sch Pharm, 308-BLDG6,800 Dongchuan Rd, Shanghai 200240, Peoples R China; [Guo, H.; Zhu, Q.; Zhang, B.; Li, D.] Shanghai Jiao Tong Univ, Sch Pharm, Minist Educ, Engn Res Ctr Cell & Therapeut Antibody, Shanghai, Peoples R China; [Yu, X.] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Neurol, Shanghai, Peoples R China; [Smith, N.; Li, Z.] Univ Pittsburgh, Sch Med, Dept Mol Pharmacol & Chem Biol, Pittsburgh, PA USA; [Cheng, K.] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Dept Resp Med, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Tongji University	Wu, Z; Li, D (corresponding author), Shanghai Jiao Tong Univ, Sch Pharm, 308-BLDG6,800 Dongchuan Rd, Shanghai 200240, Peoples R China.	wuzhenghua@sjtu.edu.cn; daweili@sjtu.edu.cn		Mangukiya, Hitesh/0000-0002-8460-4850	National Natural Science Foundation of China [81373319]; Shanghai Science and Technology Commission Foundation [14431903400]; Guangdong Major Science and Technology Projects Foundation [2012A080202014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Commission Foundation; Guangdong Major Science and Technology Projects Foundation	This research was supported by National Natural Science Foundation of China No. 81373319; Shanghai Science and Technology Commission Foundation No. 14431903400; Guangdong Major Science and Technology Projects Foundation No. 2012A080202014.	Aberger F, 1998, MECH DEVELOP, V72, P115, DOI 10.1016/S0925-4773(98)00021-5; Abuharbeid S, 2006, INT J BIOCHEM CELL B, V38, P1463, DOI 10.1016/j.biocel.2005.10.017; Ahn SM, 2007, PROTEOM CLIN APPL, V1, P1004, DOI 10.1002/prca.200700217; Armes JE, 2013, PATHOLOGY, V45, P49, DOI 10.1097/PAT.0b013e32835bd561; Balkwill FR, 2012, J CELL SCI, V125, P5591, DOI 10.1242/jcs.116392; Bamias A, 2012, CRIT REV ONCOL HEMAT, V84, P314, DOI 10.1016/j.critrevonc.2012.04.002; Brychtova V, 2015, SEMIN CANCER BIOL, V33, P16, DOI 10.1016/j.semcancer.2015.04.005; Brychtova V, 2011, CANCER LETT, V304, P1, DOI 10.1016/j.canlet.2010.12.023; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chevet E, 2013, ONCOGENE, V32, P2499, DOI 10.1038/onc.2012.346; Cross MJ, 2001, TRENDS PHARMACOL SCI, V22, P201, DOI 10.1016/S0165-6147(00)01676-X; De Crescenzo G, 2006, J MOL BIOL, V355, P47, DOI 10.1016/j.jmb.2005.10.022; Edgell TA, 2010, CLIN SCI, V118, P717, DOI 10.1042/CS20090537; Fang H, 2013, CANCER RES, V73, P4965, DOI 10.1158/0008-5472.CAN-13-0661; Ferrara N, 2002, NAT REV CANCER, V2, P795, DOI 10.1038/nrc909; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 1999, KIDNEY INT, V56, P794, DOI 10.1046/j.1523-1755.1999.00610.x; Gavalas NG, 2013, INT J MOL SCI, V14, P15885, DOI 10.3390/ijms140815885; Gray TA, 2013, PROTEIN SCI, V22, P1266, DOI 10.1002/pro.2299; Hagedorn M, 2000, CRIT REV ONCOL HEMAT, V34, P89, DOI 10.1016/S1040-8428(00)00056-1; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Haslene-Hox H, 2014, BBA CLIN, V2, P18, DOI 10.1016/j.bbacli.2014.08.002; Higa A, 2011, J BIOL CHEM, V286, P44855, DOI 10.1074/jbc.M111.275529; Hong XY, 2013, CELL BIOCHEM BIOPHYS, V67, P1487, DOI 10.1007/s12013-013-9650-4; Hwang H, 2014, INTEGR BIOL-UK, V6, P267, DOI 10.1039/c3ib40183a; Joyce JA, 2005, CANCER CELL, V7, P513, DOI 10.1016/j.ccr.2005.05.024; Kim JY, 2015, J CONTROL RELEASE, V199, P122, DOI 10.1016/j.jconrel.2014.12.015; Kumar A, 2007, SCIENCE, V318, P772, DOI 10.1126/science.1147710; Li BH, 2013, CANCER RES, V73, P6471, DOI 10.1158/0008-5472.CAN-13-0657; Li DW, 2013, CANCER RES, V73, DOI 10.1158/1538-7445.AM2013-4320; Li ZQ, 2015, CANCER SCI, V106, P1041, DOI 10.1111/cas.12714; Lieu C, 2011, CLIN CANCER RES, V17, P6130, DOI 10.1158/1078-0432.CCR-11-0659; Moserle L, 2014, CANCER DISCOV, V4, P31, DOI 10.1158/2159-8290.CD-13-0199; Nadkarni NJ, 2013, CANCER LETT, V331, P99, DOI 10.1016/j.canlet.2012.12.016; Petrillo M, 2012, EXPERT OPIN INV DRUG, V21, P451, DOI 10.1517/13543784.2012.661715; Plotnikov AN, 1999, CELL, V98, P641, DOI 10.1016/S0092-8674(00)80051-3; Ray Avijit, 2010, J Vis Exp, DOI 10.3791/1488; Rice GE, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-62; Schmitt J, 2012, CANCER TREAT REV, V38, P272, DOI 10.1016/j.ctrv.2011.06.004; Sounni NE, 2013, CLIN CHEM, V59, P85, DOI 10.1373/clinchem.2012.185363; Tassi E, 2001, J BIOL CHEM, V276, P40247, DOI 10.1074/jbc.M104933200; Teoh DGK, 2011, CANCER CONTROL, V18, P31, DOI 10.1177/107327481101800105; Tsuji T, 2015, CANCER RES, V75, P356, DOI 10.1158/0008-5472.CAN-14-1693; Wiggins HL, 2010, BIOTECHNIQUES, V48, P120, DOI 10.2144/000113353; Wiig H, 2003, AM J PHYSIOL-HEART C, V284, pH416, DOI 10.1152/ajpheart.00327.2002; Wu Zheng-Hua, 2010, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V26, P49; Xia Y, 2014, SCI REP UK, V4, P6031; Zhang X, 2008, ACTA PHARMACOL SIN, V29, P942, DOI 10.1111/j.1745-7254.2008.00830.x; Zweitzig DR, 2007, MOL CELL BIOCHEM, V306, P255, DOI 10.1007/s11010-007-9562-y	49	36	38	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 7	2017	36	36					5098	5109		10.1038/onc.2017.132	http://dx.doi.org/10.1038/onc.2017.132			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FF9XD	28481872				2022-12-26	WOS:000409371100002
J	Kim, M; Jang, K; Miller, P; Picon-Ruiz, M; Yeasky, TM; El-Ashry, D; Slingerland, JM				Kim, M.; Jang, K.; Miller, P.; Picon-Ruiz, M.; Yeasky, T. M.; El-Ashry, D.; Slingerland, J. M.			VEGFA links self-renewal and metastasis by inducing Sox2 to repress miR-452, driving Slug	ONCOGENE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CANCER STEM-CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTION FACTOR SNAIL; BREAST-CANCER; E-CADHERIN; GENE-EXPRESSION; MIR-200 FAMILY; DOWN-REGULATION; TUMOR	Cancer stem cells (CSC) appear to have increased metastatic potential, but mechanisms underlying this are poorly defined. Here we show that VEGFA induction of Sox2 promotes EMT and tumor metastasis. In breast lines and primary cancer culture, VEGFA rapidly upregulates SOX2 expression, leading to SNAI2 induction, EMT, increased invasion and metastasis. We show Sox2 downregulates miR-452, which acts as a novel metastasis suppressor to directly target the SNAI2 3'-untranslated region (3'-UTR). VEGFA stimulates Sox2- and Slug-dependent cell invasion. VEGFA increases lung metastasis in vivo, and this is abrogated by miR-452 overexpression. Furthermore, SNAI2 transduction rescues metastasis suppression by miR-452. Thus, in addition to its angiogenic action, VEGFA upregulates Sox2 to drive stem cell expansion, together with miR-452 loss and Slug upregulation, providing a novel mechanism whereby cancer stem cells acquire metastatic potential. Prior work showed EMT transcription factor overexpression upregulates CSC. Present work indicates that stemness and metastasis are a two-way street: Sox2, a major mediator of CSC self-renewal, also governs the metastatic process.	[Kim, M.; Jang, K.; Miller, P.; Picon-Ruiz, M.; Yeasky, T. M.; El-Ashry, D.; Slingerland, J. M.] Univ Miami, Miller Sch Med, Braman Family Breast Canc Inst, Sylvester Comprehens Canc Ctr, 1501 NW 10th Ave,BRB708, Miami, FL 33136 USA; [Kim, M.; Jang, K.; Slingerland, J. M.] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA; [El-Ashry, D.; Slingerland, J. M.] Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami	Slingerland, JM (corresponding author), Univ Miami, Miller Sch Med, Braman Family Breast Canc Inst, Sylvester Comprehens Canc Ctr, 1501 NW 10th Ave,BRB708, Miami, FL 33136 USA.	jslingerland@med.miami.edu	Ruiz, Manuel Picón/I-3624-2015	Ruiz, Manuel Picón/0000-0002-9427-0946	Breast Cancer Research Foundation	Breast Cancer Research Foundation	This work was supported by funding from the Breast Cancer Research Foundation to JMS.	Abraham BK, 2005, CLIN CANCER RES, V11, P1154; Adams J, 2000, CANCER RES, V60, P2898; Arias-Pulido H, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-298; Azzam DJ, 2013, EMBO MOL MED, V5, P1502, DOI 10.1002/emmm.201302558; Bachelder RE, 2002, CANCER RES, V62, P7203; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Beck B, 2011, NATURE, V478, P399, DOI 10.1038/nature10525; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Berns EMJJ, 2003, CLIN CANCER RES, V9, P1253; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brabletz S, 2011, EMBO J, V30, P770, DOI 10.1038/emboj.2010.349; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Ceppi P, 2014, ONCOGENE, V33, P269, DOI 10.1038/onc.2013.55; Charafe-Jauffret E, 2010, CLIN CANCER RES, V16, P45, DOI 10.1158/1078-0432.CCR-09-1630; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Conley SJ, 2012, P NATL ACAD SCI USA, V109, P2784, DOI 10.1073/pnas.1018866109; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Diederichs S, 2007, CELL, V131, P1097, DOI 10.1016/j.cell.2007.10.032; Drews-Elger K, 2014, BREAST CANCER RES TR, V144, P503, DOI 10.1007/s10549-014-2887-9; Dvinge H, 2013, NATURE, V497, P378, DOI 10.1038/nature12108; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Enerly E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016915; Engelen E, 2011, NAT GENET, V43, P607, DOI 10.1038/ng.825; ETHIER SP, 1993, CANCER RES, V53, P627; Fang XF, 2010, OMICS, V14, P369, DOI 10.1089/omi.2010.0053; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Goel HL, 2013, NAT REV CANCER, V13, P871, DOI 10.1038/nrc3627; Goel HL, 2013, EMBO MOL MED, V5, P488, DOI 10.1002/emmm.201202078; Gonzalez-Moreno O, 2010, EXP CELL RES, V316, P554, DOI 10.1016/j.yexcr.2009.11.020; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gregory PA, 2011, MOL BIOL CELL, V22, P1686, DOI 10.1091/mbc.E11-02-0103; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Gyorffy B, 2012, BREAST CANCER RES TR, V132, P1025, DOI 10.1007/s10549-011-1676-y; Hajra KM, 2002, CANCER RES, V62, P1613; Hamerlik P, 2012, J EXP MED, V209, P507, DOI 10.1084/jem.20111424; Han X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041335; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hartwell KA, 2006, P NATL ACAD SCI USA, V103, P18969, DOI 10.1073/pnas.0608636103; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Hirakawa S, 2005, J EXP MED, V201, P1089, DOI 10.1084/jem.20041896; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim LS, 2004, CLIN EXP METASTAS, V21, P107, DOI 10.1023/B:CLIN.0000024761.00373.55; Kim NH, 2011, J CELL BIOL, V195, P417, DOI 10.1083/jcb.201103097; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Kumarswamy R, 2012, INT J CANCER, V130, P2044, DOI 10.1002/ijc.26218; Larreaa MD, 2009, P NATL ACAD SCI USA, V106, P9268, DOI 10.1073/pnas.0805057106; Leis O, 2012, ONCOGENE, V31, P1354, DOI 10.1038/onc.2011.338; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Lichtenberger BM, 2010, CELL, V140, P268, DOI 10.1016/j.cell.2009.12.046; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Liu LP, 2013, CLIN CANCER RES, V19, P3429, DOI 10.1158/1078-0432.CCR-12-3794; Liu XQ, 2011, BIOCHEM J, V440, P23, DOI 10.1042/BJ20111006; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Manders P, 2002, BRIT J CANCER, V87, P772, DOI 10.1038/sj.bjc.6600555; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mani SA, 2007, P NATL ACAD SCI USA, V104, P10069, DOI 10.1073/pnas.0703900104; Mercurio AM, 2005, J MAMMARY GLAND BIOL, V10, P283, DOI 10.1007/s10911-006-9001-9; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Mihaly Z, 2013, BREAST CANCER RES TR, V140, P219, DOI 10.1007/s10549-013-2622-y; Montero AJ, 2012, CURR ONCOL REP, V14, P1, DOI 10.1007/s11912-011-0202-z; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Pencheva N, 2013, NAT CELL BIOL, V15, P546, DOI 10.1038/ncb2769; Picon-Ruiz M, 2016, CANC RES, V76; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Qian PX, 2012, CANCER RES, V72, P6036, DOI 10.1158/0008-5472.CAN-12-1507; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Sa-Nguanraksa D, 2015, MOL CLIN ONCOL, V3, P1103, DOI 10.3892/mco.2015.574; Senger DR, 2010, MOL BIOL CELL, V21, P377, DOI 10.1091/mbc.E09-07-0591; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Shih T, 2006, CLIN THER, V28, P1779, DOI 10.1016/j.clinthera.2006.11.015; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Sullivan LA, 2010, MABS-AUSTIN, V2, P165, DOI 10.4161/mabs.2.2.11360; Takebe N, 2011, NAT REV CLIN ONCOL, V8, P97, DOI 10.1038/nrclinonc.2010.196; Tam WL, 2013, CANCER CELL, V24, P347, DOI 10.1016/j.ccr.2013.08.005; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; TISCHER E, 1989, BIOCHEM BIOPH RES CO, V165, P1198, DOI 10.1016/0006-291X(89)92729-0; Todaro M, 2014, CELL STEM CELL, V14, P342, DOI 10.1016/j.stem.2014.01.009; van Schooneveld E, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3127; Wander SA, 2013, BREAST CANCER RES TR, V138, P369, DOI 10.1007/s10549-012-2389-6; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Xiang R, 2011, BRIT J CANCER, V104, P1410, DOI 10.1038/bjc.2011.94; Yamamura S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029722; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Zhang M, 2015, CANCER DISCOV, V5, P520, DOI 10.1158/2159-8290.CD-14-1101; Zhao D, 2015, ONCOGENE, V34, P3107, DOI 10.1038/onc.2014.257	103	51	54	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 7	2017	36	36					5199	5211		10.1038/onc.2017.4	http://dx.doi.org/10.1038/onc.2017.4			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FF9XD	28504716	Green Published, hybrid			2022-12-26	WOS:000409371100011
J	Kumazoe, M; Takai, M; Hiroi, S; Takeuchi, C; Kadomatsu, M; Nojiri, T; Onda, H; Bae, J; Huang, YH; Takamatsu, K; Yamashita, S; Kangawa, K; Tachibana, H				Kumazoe, Motofumi; Takai, Mika; Hiroi, Shun; Takeuchi, Chieri; Kadomatsu, Mai; Nojiri, Takashi; Onda, Hiroaki; Bae, Jaehoon; Huang, Yuhui; Takamatsu, Kanako; Yamashita, Shuya; Kangawa, Kenji; Tachibana, Hirofumi			The FOXO3/PGC-1 beta signaling axis is essential for cancer stem cell properties of pancreatic ductal adenocarcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CD44 EXPRESSION; GEMCITABINE; IDENTIFICATION; TARGET	In 95% of patients with pancreatic ductal adenocarcinoma, recurrence is observed following chemotherapy. Findings from several studies have indicated that cancer stem cells (CSCs) are resistant to anticancer agents and may be involved in cancer recurrence and metastasis. The CD44 protein is a major CSC marker, and CD44 also plays an indispensable role in the CSC properties in several cancers, including pancreatic cancer; however, no clinical approach exists to inhibit CD44 activity. Here, we have performed knock-in/knockdown experiments, and we demonstrate that the forkhead box O3 (FOXO3)/liver kinase B1 (LKB1)/AMP-activated protein kinase/peroxisome proliferator-activated receptor-gamma co-activator-1 beta (PGC-1 beta)/pyruvate dehydrogenase-A1 pathway is essential for CD44 expression and CSC properties. We observed that patients exhibiting high pyruvate dehydrogenase-A1 expression have a poor prognosis. Systemic PGC-1 beta knock-out mice are fertile and viable and do not exhibit an overt phenotype under normal conditions. This suggests that cGMP induction and PGC-1 beta inhibition represent potential strategies for treating patients with pancreatic ductal adenocarcinoma.	[Kumazoe, Motofumi; Takai, Mika; Hiroi, Shun; Takeuchi, Chieri; Kadomatsu, Mai; Bae, Jaehoon; Huang, Yuhui; Takamatsu, Kanako; Yamashita, Shuya; Tachibana, Hirofumi] Kyushu Univ, Div Appl Biol Chem, Dept Biosci & Biotechnol, Fac Agr,Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan; [Kumazoe, Motofumi; Nojiri, Takashi; Onda, Hiroaki; Kangawa, Kenji] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Biochem, 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan	Kyushu University; National Cerebral & Cardiovascular Center - Japan	Tachibana, H (corresponding author), Kyushu Univ, Div Appl Biol Chem, Dept Biosci & Biotechnol, Fac Agr,Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	tatibana@agr.kyushu-u.ac.jp		Kumazoe, Motofumi/0000-0002-3002-2994	Japan Society for the Promotion of Science (JSPS) KAKENHI [22228002, 15H02448]; JSPS KAKENHI [15K18821]; Grants-in-Aid for Scientific Research [15H02448] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grants 22228002 and 15H02448 (to H. T.), a grant-in-aid for JSPS fellows (to M. Kumazoe) (PD), and JSPS KAKENHI Grant 15K18821. The authors declare that they have no conflicts of interest with the contents of this article.	Adikrisna R, 2012, GASTROENTEROLOGY, V143, P234, DOI 10.1053/j.gastro.2012.03.054; Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; Buglioni A, 2016, ANNU REV MED, V67, P229, DOI 10.1146/annurev-med-052914-091923; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Fisher KW, 2015, MOL CELL BIOL, V35, P3866, DOI 10.1128/MCB.00528-15; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Hammond CL, 2009, DEVELOPMENT, V136, P3991, DOI 10.1242/dev.042150; Kumazoe M, 2017, ONCOGENE, V36, P2643, DOI 10.1038/onc.2016.426; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Lutzner N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032590; Lugnier C, 2006, PHARMACOL THERAPEUT, V109, P366, DOI 10.1016/j.pharmthera.2005.07.003; Molejon MI, 2015, ONCOTARGET, V6, P7408, DOI 10.18632/oncotarget.3510; Nossaman VE, 2010, CARDIOL REV, V18, P190, DOI 10.1097/CRD.0b013e3181c8e14a; Ohara Y, 2013, CANCER SCI, V104, P1127, DOI 10.1111/cas.12198; Quint K, 2012, INT J ONCOL, V41, P2093, DOI 10.3892/ijo.2012.1648; Roesch A, 2013, CANCER CELL, V23, P811, DOI 10.1016/j.ccr.2013.05.003; Sekulic A, 2012, NEW ENGL J MED, V366, P2171, DOI 10.1056/NEJMoa1113713; Sergeant G, 2009, NAT REV CLIN ONCOL, V6, P580, DOI 10.1038/nrclinonc.2009.127; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sonoda J, 2007, P NATL ACAD SCI USA, V104, P5223, DOI 10.1073/pnas.0611623104; Su YJ, 2011, EMBO J, V30, P3186, DOI 10.1038/emboj.2011.211; Sulica R, 2015, CARDIOL THER, V4, P209, DOI 10.1007/s40119-015-0046-y; Takebe N, 2011, NAT REV CLIN ONCOL, V8, P97, DOI 10.1038/nrclinonc.2010.196; van Amerongen R, 2006, TRENDS GENET, V22, P678, DOI 10.1016/j.tig.2006.10.001; Varnum-Finney B, 2011, J CLIN INVEST, V121, P1207, DOI 10.1172/JCI43868; Viale A, 2014, NATURE, V514, P628, DOI 10.1038/nature13611; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; WARBURG O, 1956, SCIENCE, V124, P269; WIELAND OH, 1982, REV PHYSIOL BIOCH P, V96, P123, DOI 10.1007/BFb0031008; Zhao S, 2016, CLIN CANCER RES, V22, P5592, DOI 10.1158/1078-0432.CCR-15-3115	34	26	26	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					10813	10823		10.1074/jbc.M116.772111	http://dx.doi.org/10.1074/jbc.M116.772111			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28507102	Green Published, hybrid			2022-12-26	WOS:000404391000006
J	Segura, E; Bourdin, B; Tetreault, MP; Briot, J; Allen, BG; Mayer, G; Parent, L				Segura, Emilie; Bourdin, Benoite; Tetreault, Marie-Philippe; Briot, Julie; Allen, Bruce G.; Mayer, Gaetan; Parent, Lucie			Proteolytic cleavage of the hydrophobic domain in the Ca-V alpha 2 delta 1 subunit improves assembly and activity of cardiac Ca(V)1.2 channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GPI-ANCHORED PROTEINS; CALCIUM-CHANNELS; ALPHA(2)DELTA SUBUNITS; SURFACE EXPRESSION; CA2+ CURRENTS; MEMBRANE; BIOSYNTHESIS; IDENTIFICATION; ARRHYTHMIA; ALPHA-2-SUBUNIT	Voltage-gated L-type Ca(V)1.2 channels in cardiomyocytes exist as heteromeric complexes with the pore-forming Ca-V alpha 1, Ca-V beta, and Ca-V alpha 2 delta 1 subunits. The full complement of subunits is required to reconstitute the native-like properties of L-type Ca2+ currents, but the molecular determinants responsible for the formation of the heteromeric complex are still being studied. Enzymatic treatment with phosphatidylinositol-specific phospholipase C, a phospholipase C specific for the cleavage of glycosylphosphatidylinositol (GPI)-anchored proteins, disrupted plasma membrane localization of the cardiac Ca-V alpha 2 delta 1 prompting us to investigate deletions of its hydrophobic transmembrane domain. Patch-clamp experiments indicated that the C-terminally cleaved Ca-V alpha 2 delta 1 proteins up-regulate Ca(V)1.2 channels. In contrast, deleting the residues before the single hydrophobic segment (Ca-V alpha 2 delta 1 Delta 1059-1063) impaired current up-regulation. Ca-V alpha 2 delta 1 mutants G1060I and G1061I nearly eliminated the cell-surface fluorescence of Ca-V alpha 2 delta 1, indicated by two-color flow cytometry assays and confocal imaging, and prevented Ca-V alpha 2 delta 1-mediated increase in peak current density and modulation of the voltage-dependent gating of Ca(V)1.2. These impacts were specific to substitutions with isoleucine residues because functional modulation was partially preserved in Ca-V alpha 2 delta 1 G1060A and G1061A proteins. Moreover, C-terminal fragments exhibited significantly altered mobility in denatured immunoblots of Ca-V alpha 2 delta 1 G1060I and Ca-V alpha 2 delta 1 G1061I, suggesting that these mutant proteins were impaired in proteolytic processing. Finally, Ca-V alpha 2 delta 1 Delta 1059-1063, but not Ca-V alpha 2 delta 1 G1060A, failed to co-immunoprecipitate with Ca(V)1.2. Altogether, our data support a model in which small neutral hydrophobic residues facilitate the post-translational cleavage of the Ca-V alpha 2 delta 1 subunit at the predicted membrane interface and further suggest that preventing GPI anchoring of Ca-V alpha 2 delta 1 averts its cell-surface expression, its interaction with Ca-V alpha 1, and modulation of Ca(V)1.2 currents.	[Segura, Emilie; Briot, Julie; Parent, Lucie] Univ Montreal, Dept Pharmacol & Physiol, Fac Med, Montreal, PQ H3C 3J7, Canada; [Allen, Bruce G.] Univ Montreal, Dept Med, Fac Med, Montreal, PQ H3C 3J7, Canada; [Mayer, Gaetan] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada; [Segura, Emilie; Bourdin, Benoite; Tetreault, Marie-Philippe; Briot, Julie; Allen, Bruce G.; Mayer, Gaetan; Parent, Lucie] Univ Montreal, Inst Cardiol Montreal, Ctr Rech, Montreal, PQ H3C 3J7, Canada; [Segura, Emilie] Univ Paul Sabatier, I2MC, UMR 1048, Equipe 8,Inserm, 1 Ave Jean Poulhes BP 84225, F-31432 Toulouse 4, France	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Institut de Cardiologie de Montreal; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Parent, L (corresponding author), Univ Montreal, Dept Pharmacol & Physiol, Downtown Stn, POB 6128, Montreal, PQ H3C 3J7, Canada.	lucie.parent@umontreal.ca	Allen, Bruce G/B-4693-2008	Allen, Bruce G/0000-0001-9000-9495; Briot, Julie/0000-0003-4154-6766	Canadian Institutes of Health Research [130256]; Canadian Heart and Stroke Foundation [G-15-0009329]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Heart and Stroke Foundation(Heart & Stroke Foundation of Canada)	This work was supported by Operating Grant 130256 from the Canadian Institutes of Health Research and Grant G-15-0009329 from the Canadian Heart and Stroke Foundation (to L. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Altier C, 2011, NAT NEUROSCI, V14, P173, DOI 10.1038/nn.2712; AMTHAUER R, 1993, P NATL ACAD SCI USA, V90, P3973, DOI 10.1073/pnas.90.9.3973; Andrade A, 2007, EUR J NEUROSCI, V25, P1705, DOI 10.1111/j.1460-9568.2007.05454.x; Aschar-Sobbi R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7018; Bannister JP, 2012, HYPERTENSION, V60, P1006, DOI 10.1161/HYPERTENSIONAHA.112.199661; Ben-Johny M, 2014, J GEN PHYSIOL, V143, P679, DOI 10.1085/jgp.201311153; Bers DM, 2000, CIRC RES, V87, P275, DOI 10.1161/01.RES.87.4.275; Bourdin B, 2016, JOVE-J VIS EXP, DOI 10.3791/54732; Bourdin B, 2015, J BIOL CHEM, V290, P2854, DOI 10.1074/jbc.M114.597930; Bourdin B, 2010, J BIOL CHEM, V285, P22851, DOI 10.1074/jbc.M110.111062; Briot J., 2016, BIOCH MOL BIOL J; Calderon- Rivera A., 2012, CELL CALCIUM, V51, P22; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chen R, 2002, J CELL BIOCHEM, V84, P68, DOI 10.1002/jcb.1267; Chevalier D, 2000, BIOCHEMISTRY-US, V39, P6145, DOI 10.1021/bi9928389; Creighton T. E., 1993, PROTEINS STRUCTURES, P141; Davies A, 2010, P NATL ACAD SCI USA, V107, P1654, DOI 10.1073/pnas.0908735107; Dolphin AC, 2009, CURR OPIN NEUROBIOL, V19, P237, DOI 10.1016/j.conb.2009.06.006; Eisenhaber B, 1998, PROTEIN ENG, V11, P1155, DOI 10.1093/protein/11.12.1155; Elortza F, 2003, MOL CELL PROTEOMICS, V2, P1261, DOI 10.1074/mcp.M300079-MCP200; ENGLUND PT, 1993, ANNU REV BIOCHEM, V62, P121, DOI 10.1146/annurev.bi.62.070193.001005; Ferguson M. A. J., 2009, ESSENTIALS GLYCOBIOL; FERGUSON MAJ, 1985, J BIOL CHEM, V260, P4547; Fuller-Bicer GA, 2009, AM J PHYSIOL-HEART C, V297, pH117, DOI 10.1152/ajpheart.00122.2009; Gao TY, 1997, J BIOL CHEM, V272, P19401, DOI 10.1074/jbc.272.31.19401; Ikezawa H, 2002, BIOL PHARM BULL, V25, P409, DOI 10.1248/bpb.25.409; JAY SD, 1991, J BIOL CHEM, V266, P3287; Kadurin I, 2016, ELIFE, V5, DOI 10.7554/eLife.21143; Kadurin I, 2012, J BIOL CHEM, V287, P33554, DOI 10.1074/jbc.M112.378554; Kinoshita T, 2016, J LIPID RES, V57, P6, DOI 10.1194/jlr.R063313; Klugbauer N, 1999, J NEUROSCI, V19, P684; Klugbauer N, 2003, J BIOENERG BIOMEMBR, V35, P639, DOI 10.1023/B:JOBB.0000008028.41056.58; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Lizotte E, 2005, ANAL BIOCHEM, V345, P47, DOI 10.1016/j.ab.2005.07.001; Lugenbiel P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116395; Maeda Y, 2011, PROG LIPID RES, V50, P411, DOI 10.1016/j.plipres.2011.05.002; Mayer G, 2008, J BIOL CHEM, V283, P31791, DOI 10.1074/jbc.M805971200; Mayer G, 2008, J BIOL CHEM, V283, P2373, DOI 10.1074/jbc.M708763200; MAYOR S, 1990, J BIOL CHEM, V265, P6164; MCCONVILLE MJ, 1994, BRAZ J MED BIOL RES, V27, P139; Muller A, 2012, BBA-BIOMEMBRANES, V1818, P117, DOI 10.1016/j.bbamem.2011.10.009; Mukherjee R, 1998, J MOL CELL CARDIOL, V30, P1899, DOI 10.1006/jmcc.1998.0755; Napolitano C, 2011, CIRC RES, V108, P607, DOI 10.1161/CIRCRESAHA.110.224279; Nosjean O, 1997, BBA-REV BIOMEMBRANES, V1331, P153, DOI 10.1016/S0304-4157(97)00005-1; Parent L., 1997, J MEMBR BIOL, V160; Paulick MG, 2008, BIOCHEMISTRY-US, V47, P6991, DOI 10.1021/bi8006324; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Pierleoni A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-392; Poirier S, 2015, CELL REP, V13, P2064, DOI 10.1016/j.celrep.2015.11.006; Richard S, 1998, CARDIOVASC RES, V37, P300, DOI 10.1016/S0008-6363(97)00273-3; Richard S, 2006, PROG BIOPHYS MOL BIO, V90, P118, DOI 10.1016/j.pbiomolbio.2005.05.005; Savalli N, 2016, J GEN PHYSIOL, V148, P147, DOI 10.1085/jgp.201611586; Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489; Shakeri B, 2012, J BIOL CHEM, V287, P32835, DOI 10.1074/jbc.M112.387233; Shishioh N, 2005, J BIOL CHEM, V280, P9728, DOI 10.1074/jbc.M413755200; SINGER D, 1991, SCIENCE, V253, P1553, DOI 10.1126/science.1716787; Song JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033747; Song L, 2015, CURR MOL PHARMACOL, V8, P169, DOI 10.2174/1874467208666150507104555; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Splawski I, 2005, P NATL ACAD SCI USA, V102, P8089, DOI 10.1073/pnas.0502506102; STEVENS VL, 1995, BIOCHEM J, V310, P361, DOI 10.1042/bj3100361; Tetreault MP, 2016, J BIOL CHEM, V291, P4826, DOI 10.1074/jbc.M115.692178; Van Petegem F, 2006, BIOCHEM SOC T, V34, P887, DOI 10.1042/BST0340887; Van Wagoner DR, 1999, CIRC RES, V85, P428, DOI 10.1161/01.RES.85.5.428; Voigt A., 2016, NEUROPHOTONICS, V3; Wall-Lacelle S, 2011, J BIOL CHEM, V286, P27197, DOI 10.1074/jbc.M111.237412; Wei S, 2000, CIRC RES, V86, P175, DOI 10.1161/01.RES.86.2.175; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; Wu JP, 2016, NATURE, V537, P191, DOI 10.1038/nature19321; Wu JP, 2015, SCIENCE, V350, DOI 10.1126/science.aad2395; Yasuda T, 2004, EUR J NEUROSCI, V20, P1, DOI 10.1111/j.1460-9568.2004.03434.x; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9; Yue LX, 1997, CIRC RES, V81, P512, DOI 10.1161/01.RES.81.4.512	73	6	6	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					11109	11124		10.1074/jbc.M117.784355	http://dx.doi.org/10.1074/jbc.M117.784355			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28495885	Green Published, hybrid			2022-12-26	WOS:000404391000030
J	Wawrzyniak, M; Hoffstaedter, F; Klingbeil, J; Stockert, A; Wrede, K; Hartwigsen, G; Eickhoff, SB; Classen, J; Saur, D				Wawrzyniak, Max; Hoffstaedter, Felix; Klingbeil, Julian; Stockert, Anika; Wrede, Katrin; Hartwigsen, Gesa; Eickhoff, Simon B.; Classen, Joseph; Saur, Dorothee			Fronto-temporal interactions are functionally relevant for semantic control in language processing	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; MIDDLE TEMPORAL GYRUS; THETA-BURST STIMULATION; CONTEXTUAL SENTENCE INTEGRATION; RESTING-STATE CONNECTIVITY; INFERIOR FRONTAL GYRUS; HUMAN BRAIN; PREFRONTAL CORTEX; CONTROLLED RETRIEVAL; DISTRIBUTED NETWORK	Semantic cognition, i.e. processing of meaning is based on semantic representations and their controlled retrieval. Semantic control has been shown to be implemented in a network that consists of left inferior frontal (IFG), and anterior and posterior middle temporal gyri (a/pMTG). We aimed to disrupt semantic control processes with continuous theta burst stimulation (cTBS) over left IFG and pMTG and to study whether behavioral effects are moderated by induced alterations in resting-state functional connectivity. To this end, we applied real cTBS over left IFG and left pMTG as well as sham stimulation on 20 healthy participants in a within-subject design. Stimulation was followed by resting-state functional magnetic resonance imaging and a semantic priming paradigm. Resting-state functional connectivity of regions of interest in left IFG, pMTG and aMTG revealed highly interconnected left-lateralized fronto-temporal networks representing the semantic system. We did not find any significant direct modulation of either task performance or resting-state functional connectivity by effective cTBS. However, after sham cTBS, functional connectivity between IFG and pMTG correlated with task performance under high semantic control demands in the semantic priming paradigm. These findings provide evidence for the functional relevance of interactions between IFG and pMTG for semantic control processes. This interaction was functionally less relevant after cTBS over aIFG which might be interpretable in terms of an indirect disruptive effect of cTBS.	[Wawrzyniak, Max; Klingbeil, Julian; Stockert, Anika; Wrede, Katrin; Hartwigsen, Gesa; Saur, Dorothee] Univ Leipzig, Dept Neurol, Language & Aphasia Lab, Leipzig, Germany; [Hoffstaedter, Felix; Eickhoff, Simon B.] Heinrich Heine Univ Dusseldorf, Inst Clin Neurosci & Med Psychol, Med Fac, Dusseldorf, Germany; [Hoffstaedter, Felix; Eickhoff, Simon B.] Res Ctr Julich, Inst Neurosci & Med INM 1, Julich, Germany; [Hoffstaedter, Felix; Eickhoff, Simon B.] Heinrich Heine Univ Dusseldorf, Inst Syst Neurosci, Med Fac, Dusseldorf, Germany; [Hartwigsen, Gesa] Max Planck Inst Human Cognit & Brain Sci Leipzig, Dept Neuropsychol, Leipzig, Germany; [Classen, Joseph] Univ Leipzig, Dept Neurol, Human Cort Physiol & Motor Control Lab, Leipzig, Germany	Leipzig University; Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf; Max Planck Society; Leipzig University	Wawrzyniak, M (corresponding author), Univ Leipzig, Dept Neurol, Language & Aphasia Lab, Leipzig, Germany.	max.wawrzyniak@medizin.uni-leipzig.de	Hartwigsen, Gesa/L-2283-2017; Hartwigsen, Gesa/M-1224-2019; Saur, Dorothee/Q-1684-2017; Saur, Dorothee/C-5900-2019; Wawrzyniak, Max/AAN-2723-2021; Eickhoff, Simon B./K-2061-2013	Hartwigsen, Gesa/0000-0002-8084-1330; Hartwigsen, Gesa/0000-0002-8084-1330; Saur, Dorothee/0000-0002-1808-0913; Saur, Dorothee/0000-0002-1808-0913; Wawrzyniak, Max/0000-0002-5089-1214; Stockert, Anika/0000-0001-5804-2498; Hoffstaedter, Felix/0000-0001-7163-3110; Eickhoff, Simon B./0000-0001-6363-2759; Klingbeil, Julian/0000-0002-9306-9212; Classen, Joseph/0000-0001-7182-6967	James S. McDonnell Foundation, Scholar Award Human Cognition [220020292, 20112027]; ("Promotionsforderung") of the Medical Faculty of the University of Leipzig	James S. McDonnell Foundation, Scholar Award Human Cognition; ("Promotionsforderung") of the Medical Faculty of the University of Leipzig	Dorothee Saur was supported by the James S. McDonnell Foundation, Scholar Award Human Cognition (220020292, https://www.jsmf.org/grants/20112027/). Max Wawrzyniak was supported by a scholarship ("Promotionsforderung") of the Medical Faculty of the University of Leipzig. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almairac F, 2015, BRAIN STRUCT FUNCT, V220, P1983, DOI 10.1007/s00429-014-0773-1; Andoh J, 2015, J NEUROSCI, V35, P14602, DOI 10.1523/JNEUROSCI.2333-15.2015; Antonenko D, 2012, NEUROIMAGE, V62, P1667, DOI 10.1016/j.neuroimage.2012.05.074; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Badre D, 2005, NEURON, V47, P907, DOI 10.1016/j.neuron.2005.07.023; Baumgaertner A, 2002, NEUROIMAGE, V16, P736, DOI 10.1006/nimg.2002.1134; Bilek E, 2013, J NEUROSCI, V33, P7050, DOI 10.1523/JNEUROSCI.3081-12.2013; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Binder JR, 1996, NEUROLOGY, V46, P978, DOI 10.1212/WNL.46.4.978; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bruckner S, 2013, NEUROSCIENCE, V233, P64, DOI 10.1016/j.neuroscience.2012.12.033; Chai XQJ, 2016, J NEUROSCI, V36, P755, DOI 10.1523/JNEUROSCI.2234-15.2016; Cocchi L, 2015, J NEUROPHYSIOL, V113, P3375, DOI 10.1152/jn.00850.2014; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; Davey J, 2016, NEUROIMAGE, V137, P165, DOI 10.1016/j.neuroimage.2016.05.051; Davey J, 2015, J NEUROSCI, V35, P15230, DOI 10.1523/JNEUROSCI.4705-14.2015; Eldaief MC, 2011, P NATL ACAD SCI USA, V108, P21229, DOI 10.1073/pnas.1113103109; Fisher RA, 1914, BIOMETRIKA, V10, P507; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Friston KJ, 2006, NEUROIMAGE, V30, P1077, DOI 10.1016/j.neuroimage.2005.08.012; Friston K J, 1994, Hum Brain Mapp, V1, P210, DOI 10.1002/hbm.460010306; Gotts SJ, 2013, P NATL ACAD SCI USA, V110, pE3435, DOI 10.1073/pnas.1302581110; Gratton C, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00124; Hagoort P, 2005, TRENDS COGN SCI, V9, P416, DOI 10.1016/j.tics.2005.07.004; Hallam GP, 2016, NEUROPSYCHOLOGIA, V93, P40, DOI 10.1016/j.neuropsychologia.2016.09.012; Hampson M, 2002, HUM BRAIN MAPP, V15, P247, DOI 10.1002/hbm.10022; Hampson M, 2006, NEUROIMAGE, V31, P513, DOI 10.1016/j.neuroimage.2005.12.040; Hartwigsen G, 2017, NEUROIMAGE, V147, P812, DOI 10.1016/j.neuroimage.2016.08.026; Hartwigsen G, 2016, CEREB CORTEX, V26, P2590, DOI 10.1093/cercor/bhv092; Hartwigsen G, 2013, P NATL ACAD SCI USA, V110, P16402, DOI 10.1073/pnas.1310190110; Huang J, 2012, BRAIN RES, V1440, P56, DOI 10.1016/j.brainres.2011.11.060; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Hubl D, 2008, NEUROSCIENCE, V151, P921, DOI 10.1016/j.neuroscience.2007.10.049; Jefferies E, 2013, CORTEX, V49, P611, DOI 10.1016/j.cortex.2012.10.008; Kelly C, 2010, EUR J NEUROSCI, V32, P383, DOI 10.1111/j.1460-9568.2010.07279.x; Kotz SA, 2009, CORTEX, V45, P982, DOI 10.1016/j.cortex.2009.02.010; Koyama MS, 2011, J NEUROSCI, V31, P8617, DOI 10.1523/JNEUROSCI.4865-10.2011; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; Lau EF, 2008, NAT REV NEUROSCI, V9, P920, DOI 10.1038/nrn2532; Muller AM, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00228; Murdoch BE, 2010, CORTEX, V46, P858, DOI 10.1016/j.cortex.2009.07.018; Nettekoven C, 2014, J NEUROSCI, V34, P6849, DOI 10.1523/JNEUROSCI.4993-13.2014; Noonan KA, 2013, J COGNITIVE NEUROSCI, V25, P1824, DOI 10.1162/jocn_a_00442; Passow S, 2015, HUM BRAIN MAPP, V36, P2027, DOI 10.1002/hbm.22753; Patterson K, 2007, NAT REV NEUROSCI, V8, P976, DOI 10.1038/nrn2277; Paus T, 1998, HUM BRAIN MAPP, V6, P399, DOI 10.1002/(SICI)1097-0193(1998)6:5/6<399::AID-HBM13>3.0.CO;2-H; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Price CJ, 2002, TRENDS COGN SCI, V6, P416, DOI 10.1016/S1364-6613(02)01976-9; Rahnev D, 2013, J NEUROPHYSIOL, V110, P1811, DOI 10.1152/jn.00209.2013; Ralph MAL, 2017, NAT REV NEUROSCI, V18, P42, DOI 10.1038/nrn.2016.150; Rolls ET, 2015, NEUROIMAGE, V122, P1, DOI 10.1016/j.neuroimage.2015.07.075; Ruohonen J, 2010, NEUROPHYSIOL CLIN, V40, P7, DOI 10.1016/j.neucli.2010.01.006; Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080; Saffran EM, 2000, BRAIN LANG, V71, P204, DOI 10.1006/brln.1999.2251; Saur D, 2008, P NATL ACAD SCI USA, V105, P18035, DOI 10.1073/pnas.0805234105; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Simonyan K, 2015, J NEUROPHYSIOL, V113, P2967, DOI 10.1152/jn.00964.2014; Sommer M, 2002, CLIN NEUROPHYSIOL, V113, P265, DOI 10.1016/S1388-2457(01)00726-X; Spreng RN, 2010, NEUROIMAGE, V53, P303, DOI 10.1016/j.neuroimage.2010.06.016; Stevens WD, 2014, WIRES COGN SCI, V5, P233, DOI 10.1002/wcs.1275; Stokes MG, 2013, J NEUROPHYSIOL, V109, P437, DOI 10.1152/jn.00510.2012; Thompson-Schill SL, 1997, P NATL ACAD SCI USA, V94, P14792, DOI 10.1073/pnas.94.26.14792; Tomasi D, 2012, MOL PSYCHIATR, V17, P841, DOI 10.1038/mp.2011.177; Turken AU, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00001; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Valchev N, 2015, NEUROIMAGE, V114, P386, DOI 10.1016/j.neuroimage.2015.04.017; Van Berkum JJA, 2005, J EXP PSYCHOL LEARN, V31, P443, DOI 10.1037/0278-7393.31.3.443; van der Werf YD, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-145; Waites AB, 2005, HUM BRAIN MAPP, V24, P59, DOI 10.1002/hbm.20069; Wang JX, 2014, SCIENCE, V345, P1054, DOI 10.1126/science.1252900; Watanabe T, 2014, HUM BRAIN MAPP, V35, P1896, DOI 10.1002/hbm.22300; Wei T, 2012, J NEUROSCI, V32, P481, DOI 10.1523/JNEUROSCI.1953-11.2012; Whitney C, 2012, J COGNITIVE NEUROSCI, V24, P133, DOI 10.1162/jocn_a_00123; Whitney C, 2011, CEREB CORTEX, V21, P1066, DOI 10.1093/cercor/bhq180; Willems RM, 2011, PSYCHOL SCI, V22, P849, DOI 10.1177/0956797611412387; Woo CW, 2014, NEUROIMAGE, V91, P412, DOI 10.1016/j.neuroimage.2013.12.058; Ye Z, 2009, NEUROIMAGE, V48, P280, DOI 10.1016/j.neuroimage.2009.06.032; Zhu ZD, 2013, NEUROIMAGE, V76, P325, DOI 10.1016/j.neuroimage.2013.02.060	80	5	8	5	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177753	10.1371/journal.pone.0177753	http://dx.doi.org/10.1371/journal.pone.0177753			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV0YN	28505211	Green Published, gold, Green Submitted			2022-12-26	WOS:000401473500040
J	Jerez-Roig, J; Ferreira, LMDM; de Araujo, JRT; Lima, KC				Jerez-Roig, Javier; de Brito Macedo Ferreira, Lidiane Maria; Torres de Araujo, Jose Rodolfo; Lima, Kenio Costa			Functional decline in nursing home residents: A prognostic study	PLOS ONE			English	Article							DAILY LIVING ADL; CULTURAL-ADAPTATION; IMPAIRMENT; VALIDATION; DISABILITY; CAPACITY; PEOPLE; RISK	Aim To verify the probability of maintaining functional capacity in basic activities of daily living and identify the prognostic factors of functional decline in institutionalized older adults. Methods A longitudinal study is presented herein, with 5 waves every 6 months, throughout 2 years (2013-2015), conducted with individuals >= 60 years old in 10 nursing homes in the city of Natal-RN (Brazil). Functional capacity was assessed by the items 'eating', 'personal hygiene', 'dressing', 'bathing', 'transferring', 'toileting' and 'walking', through a 5-item Likert scale. Sociodemographic, institution-related and health-related variables were considered to establish the baseline. Time dependent variables included continence decline, cognitive decline, increase in the number of medication, and incidences of falls, hospitalizations and fractures. The actuarial method, the log-rank test and Cox's regression were applied as statistical methods. Results The cumulative probability of functional maintenance was 78.2% (CI 95%: 72.8 - 82.7%), 65.1% (CI 95%: 58.9 - 70.5%), 53.5% (CI 95%: 47.2 - 59.5%) and 44.0% (CI 95%: 37.7 - 50.2%) at 6, 12, 18 and 24 months, respectively. Predicting factors for functional decline were: severe cognitive impairment (HR = 1.96; p = 0.001), continence decline (HR = 1.85; p = 0.002) and incidence of hospitalizations (HR = 1.62; p = 0.020), adjusted by the incidence of depression, age, education level, presence of chronic diseases and low weight. Conclusions The cumulative probability of maintaining functional capacity in institutionalized older adults was only 44% at the 2-year follow-up. Prognostic factors for functional decline included severe cognitive impairment, continence decline and incidence of hospitalizations.	[Jerez-Roig, Javier; de Brito Macedo Ferreira, Lidiane Maria; Lima, Kenio Costa] Fed Univ Rio Grande do Norte UFRN, Odontol Dept, Postgrad Program Collect Hlth, Ave Salgado Filho 1787, Natal, RN, Brazil; [Jerez-Roig, Javier] Can Misses Hosp, Ibiza, Spain; [Torres de Araujo, Jose Rodolfo] Fed Univ Rio Grande do Norte UFRN, Ctr Hlth Sci, Postgrad Program Hlth Sci, Av Gustavo Cordeiro de Farias S-N, Natal, RN, Brazil	Universidade Federal do Rio Grande do Norte; Hospital Can Misses; Universidade Federal do Rio Grande do Norte	Jerez-Roig, J (corresponding author), Fed Univ Rio Grande do Norte UFRN, Odontol Dept, Postgrad Program Collect Hlth, Ave Salgado Filho 1787, Natal, RN, Brazil.; Jerez-Roig, J (corresponding author), Can Misses Hosp, Ibiza, Spain.	javijerez81@hotmail.com	Jerez-Roig, Javier/V-6119-2018	Jerez-Roig, Javier/0000-0002-1968-4452; Lima, Kenio Costa/0000-0002-5668-4398; Torres de Araujo, Jose Rodolfo/0000-0002-4257-6927				Banaszak-Holl J, 2011, J AGING HEALTH, V23, P862, DOI 10.1177/0898264311399759; Burge E, 2013, ARCH GERONTOL GERIAT, V56, P250, DOI 10.1016/j.archger.2012.09.001; Carpenter G Iain, 2006, BMC Geriatr, V6, P7, DOI 10.1186/1471-2318-6-7; Chen LY, 2013, J AM MED DIR ASSOC, V14, DOI 10.1016/j.jamda.2013.01.017; Cincura C, 2009, CEREBROVASC DIS, V27, P119, DOI 10.1159/000177918; Coll-Planas L, 2008, Z GERONTOL GERIATR, V41, P283, DOI 10.1007/s00391-008-0563-6; Courtney MD, 2012, J EVAL CLIN PRACT, V18, P128, DOI 10.1111/j.1365-2753.2010.01547.x; de la Iglesia JM, 2001, MED CLIN-BARCELONA, V117, P129; Finlayson M, 2005, J CLIN EPIDEMIOL, V58, P338, DOI 10.1016/j.jclinepi.2004.10.008; Guigoz Y, 1994, FACTS RES GERONTOL, V2, P15, DOI DOI 10.1016/S0899-9007(98)00171-3; Instituto de Pesquisa Econo A mica Aplicada (IPEA), 2011, COND FUNC INFR I LON, V2014; Javier Jerez-Roig, 2016, J GERIATR PHYS THER; Javier Jerez-Roig, 2017, DISABIL HLTH J, V10, P279; Jerez-Roig J, 2014, NEUROUROL URODYNAM; LIPSCHITZ DA, 1994, PRIMARY CARE, V21, P55; Lisboa CR, 2012, REV BRAS ENFERM, V65, P482, DOI 10.1590/S0034-71672012000300013; McConnell ES, 2002, J GERONTOL A-BIOL, V57, pM778, DOI 10.1093/gerona/57.12.M778; Raiche M, 2012, ARCH GERONTOL GERIAT, V55, P399, DOI 10.1016/j.archger.2011.12.007; Reis LA, 2011, REV BRAS ENFERM, V64, P274, DOI 10.1590/S0034-71672011000200009; Rosset I, 2011, REV ESC ENFERM USP, V45, P258; Stuck AE, 1999, SOC SCI MED, V48, P445, DOI 10.1016/S0277-9536(98)00370-0; Goncalves LHT, 2010, CAD SAUDE PUBLICA, V26, P1738, DOI 10.1590/S0102-311X2010000900007; Wang J, 2009, J GERONTOL A-BIOL, V64, P473, DOI 10.1093/gerona/gln040; Wang SY, 2013, ARCH GERONTOL GERIAT, V57, P16, DOI 10.1016/j.archger.2013.03.007; WHO Collaborating Centre for Drug Statistics Methodology, 2012, GUID ATC CLASS DDD A; World Health Organization, 1984, US EP STUD ELD	26	31	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177353	10.1371/journal.pone.0177353	http://dx.doi.org/10.1371/journal.pone.0177353			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UP	28493946	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314300092
J	Lassalle, M; Fezeu, LK; Couchoud, C; Hannedouche, T; Massy, ZA; Czernichow, S				Lassalle, Mathilde; Fezeu, Leopold K.; Couchoud, Cecile; Hannedouche, Thierry; Massy, Ziad A.; Czernichow, Sebastien			Obesity and access to kidney transplantation in patients starting dialysis: A prospective cohort study	PLOS ONE			English	Article							BODY-MASS INDEX; RENAL-TRANSPLANTATION; WAITING-LIST; METAANALYSIS; POPULATION; RECIPIENTS; MORTALITY; OUTCOMES; GENDER; TIME	Background Obesity has been linked to poor access to medical care. Although scientific evidence suggest that kidney transplantation improves survival and quality of life in obese patients with end-stage renal disease (ESRD), few data exist on the impact of obesity on access to kidney transplantation in this population. Objectives We aimed to characterize the relationships between body mass index (BMI) at the start of dialysis, changes in BMI after the start of dialysis, and either access to kidney transplantation or overall mortality in dialysis or transplantation among ESRD patients. Methods Between 2002 and 2011, 19524 dialysis patients with ESRD were included in the study via the French nationwide Renal Epidemiology and Information Network. Data on sociodemographic factors, comorbidities and laboratory test results were recorded upon entry into the registry. BMI were obtained at the start of dialysis and then yearly. Cubic spline regression analyses provided a graphic evaluation of the relationships between BMI at the start of dialysis and outcomes. Joint models were used to evaluate the association between the change over time in BMI and outcomes. Results During a median follow-up of 20.3 months, 6634 patients underwent kidney transplantation. A BMI >31 kg/m(2) at the start of the dialysis was associated with a lower likelihood of receiving a kidney transplant, and the likelihood decreased even further with higher BMI values. For patients with BMI >= 30kg/m(2) at the start of the dialysis, a 1 kg/m(2) decrease in BMI during follow-up was associated with a 9% to 11% increase in the likelihood of receiving a transplant. There was an L-shaped relationship between BMI at the start of dialysis and overall mortality. We showed that obese patients with ESRD face barriers to the receipt of a kidney transplant without valid reasons. Conclusion Greater attention to this issue would improve the fairness of the organ allocation process and might improve outcomes for obese patients with ESRD.	[Lassalle, Mathilde; Couchoud, Cecile] Agence Biomed, REIN Registry, F-93212 La Plaine St Denis, France; [Fezeu, Leopold K.] Univ Paris 13, CNAM, INRA U1125,INSERM U1153, Ctr Rech Epidemiol & Stat,EREN,COMUE Sorbonne Par, F-93017 Bobigny, France; [Hannedouche, Thierry] Univ Strasbourg, Dept Nephrol, F-67000 Strasbourg, France; [Hannedouche, Thierry] Hop Univ Strasbourg, F-67000 Strasbourg, France; [Massy, Ziad A.] Ambroise Pare Univ Hosp, AP HP, Div Nephrol, F-92100 Boulogne, France; [Massy, Ziad A.] INSERM, U1018, Res Ctr Epidemiol & Populat Hlth CESP, Team 5, F-94807 Villejuif, France; [Czernichow, Sebastien] INSERM, UMS 011, F-94807 Villejuif, France; [Czernichow, Sebastien] Univ Paris 05, Paris, France; [Czernichow, Sebastien] Hop Europeen Georges Pompidou, AP HP, Dept Nutr, F-75015 Paris, France	heSam Universite; Conservatoire National Arts & Metiers (CNAM); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris 13; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Czernichow, S (corresponding author), INSERM, UMS 011, F-94807 Villejuif, France.; Czernichow, S (corresponding author), Univ Paris 05, Paris, France.; Czernichow, S (corresponding author), Hop Europeen Georges Pompidou, AP HP, Dept Nutr, F-75015 Paris, France.	sebastien.czernichow@aphp.fr						Bardonnaud N, 2012, TRANSPL P, V44, P2787, DOI 10.1016/j.transproceed.2012.09.031; Bussiere C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104901; Couchoud C, 2006, NEPHROL DIAL TRANSPL, V21, P411, DOI 10.1093/ndt/gfi198; Couchoud C, 2013, NEPHROL DIAL TRANSPL, V28, P2215, DOI 10.1093/ndt/gft004; Couchoud C, 2012, TRANSPLANTATION, V94, P513, DOI 10.1097/TP.0b013e31825d156a; Crowther MJ, 2013, STATA J, V13, P165, DOI 10.1177/1536867X1301300112; Dudley CRK, 2009, TRANSPLANTATION, V88, P96, DOI 10.1097/TP.0b013e3181aa901a; Ebpg, 2000, EUROPEAN RENAL AS S7, V15, P1; Fouque D, 2007, NEPHROL DIAL TRANSPL, V22, P45, DOI 10.1093/ndt/gfm020; Garg PP, 2000, J AM SOC NEPHROL, V11, P958, DOI 10.1681/ASN.V115958; Gill JS, 2013, AM J TRANSPLANT, V13, P2083, DOI 10.1111/ajt.12331; Gill JS, 2014, CLIN J AM SOC NEPHRO, V9, P951, DOI 10.2215/CJN.08310813; Kasiske BL, 2003, AM J TRANSPLANT, V3, P178, DOI 10.1034/j.1600-6143.2003.00010.x; Kasiske BL, 2001, AM J TRANSPLANT, V1, P7; Knoll Greg, 2005, CMAJ, V173, pS1, DOI 10.1503/cmaj.1041588; Kramer HJ, 2006, J AM SOC NEPHROL, V17, P1453, DOI 10.1681/ASN.2005111241; Kuo JH, 2012, J SURG RES, V173, P216, DOI 10.1016/j.jss.2011.05.030; Lievense H, 2012, NEPHROL DIAL TRANSPL, V27, P3631, DOI 10.1093/ndt/gfs131; McAdams-DeMarco MA, 2012, AM J TRANSPLANT, V12, P3283, DOI 10.1111/j.1600-6143.2012.04285.x; Molnar MZ, 2011, KIDNEY INT, V80, P219, DOI 10.1038/ki.2011.114; Nicoletto BB, 2014, TRANSPLANTATION, V98, P167, DOI 10.1097/TP.0000000000000028; Park J, 2014, NAT REV ENDOCRINOL, V10, P455, DOI 10.1038/nrendo.2014.94; Patibandla BK, 2012, CLIN TRANSPLANT, V26, pE307, DOI 10.1111/j.1399-0012.2012.01661.x; Ravanan R, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3451; Rizopoulos D, 2010, J STAT SOFTW, V35, P1; Santos Jr AH, 2015, TRANSPLANTATION; Segev DL, 2008, J AM SOC NEPHROL, V19, P349, DOI 10.1681/ASN.2007050610; Sobngwi E, 2004, INT J EPIDEMIOL, V33, P769, DOI 10.1093/ije/dyh044; Tsiatis AA, 2004, STAT SINICA, V14, P809; Udayaraj U, 2010, TRANSPLANTATION, V90, P279, DOI 10.1097/TP.0b013e3181e346e3; Vashistha T, 2014, AM J KIDNEY DIS, V63, P612, DOI 10.1053/j.ajkd.2013.07.021; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; Wormser D, 2011, LANCET, V377, P1085, DOI 10.1016/S0140-6736(11)60105-0; Ying A, 2015, LANCET, V385, P867, DOI 10.1016/S0140-6736(14)61171-5	34	32	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176616	10.1371/journal.pone.0176616	http://dx.doi.org/10.1371/journal.pone.0176616			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493926	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314300023
J	Spill, YG; Nilges, M				Spill, Yannick G.; Nilges, Michael			SAS profile correlations reveal SAS hierarchical nature and information content	PLOS ONE			English	Article							SMALL-ANGLE SCATTERING; X-RAY-SCATTERING; BIOLOGICAL MACROMOLECULES; PROTEIN ENSEMBLES; SAXS; COMPUTATION; RESOLUTION; RETRIEVAL; MASS	In structural biology, Small-Angle Scattering experiments (SAS) are unique, because although they provide low resolution data, they can be performed in closer-to-native conditions than those arising in X-Ray crystallography. A number of questions on SAS, however, remain unsolved, particularly in the light of modelling ensembles of conformers in solution. In this article, we study the ensemble average and covariance of SAS profiles analytically. Using this ensemble covariance, we demonstrate the hierarchical nature of SAS profiles. Furthermore, we show that the information content is not uniform and reaches its maximum in the intermediate q range. The arguments are generalized using microsecond-scale molecular dynamics trajectories of the lysozyme and on an ensemble of the intrinsically disordered protein p15PAF. We show that for highly flexible systems, the SAS profile is a representation of the ensemble of conformers in solution, and not that of one conformer in particular.	[Spill, Yannick G.; Nilges, Michael] Inst Pasteur, Dept Struct Biol & Chem, Struct Bioinformat Unit, 25 Rue Docteur Roux, F-75015 Paris, France; [Spill, Yannick G.] CNAG CRG, Torre & Planta 10,Parc Cient Barcelona, Barcelona 08028, Spain	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	Spill, YG (corresponding author), Inst Pasteur, Dept Struct Biol & Chem, Struct Bioinformat Unit, 25 Rue Docteur Roux, F-75015 Paris, France.; Spill, YG (corresponding author), CNAG CRG, Torre & Planta 10,Parc Cient Barcelona, Barcelona 08028, Spain.	yannick.spill@nsup.org	Nilges, Michael/E-4803-2011; Spill, Yannick/I-5485-2015	Nilges, Michael/0000-0002-1451-8092; Spill, Yannick/0000-0002-7979-0038	European Research Commission [ERC-2011-StG 294809]	European Research Commission(European CommissionEuropean Commission Joint Research Centre)	This work was funded by the European Research Commission (Advanced Grant ERC2011-StG 294809 BayCellS, to MN).; YGS would like to acknowledge Dominique Durand, Patrice Vachette and Frederic Poitevin for fruitful discussion and proofreading of the manuscript, Jochen S. Hub for sharing the lysozyme simulations, and Pau Bernado for discussion on extension to IDPs. This work was funded by the European Research Commission (Advanced Grant ERC-2011-StG 294809 Bay-CellS, to MN).	Anderson TW, 1944, ANN MATH STAT, V15, P345, DOI 10.1214/aoms/1177731206; Antonov LD, 2016, PHYS CHEM CHEM PHYS, V18, P5832, DOI 10.1039/c5cp04886a; Beaucage G, 1996, J APPL CRYSTALLOGR, V29, P134, DOI 10.1107/S0021889895011605; Berlin K, 2013, J AM CHEM SOC, V135, P16595, DOI 10.1021/ja4083717; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Chen PC, 2014, BIOPHYS J, V107, P435, DOI 10.1016/j.bpj.2014.06.006; De Biasio A, 2014, BIOPHYS J, V106, P865, DOI 10.1016/j.bpj.2013.12.046; Debye P, 1915, ANN PHYS-BERLIN, V46, P809; Debye P, 1913, ANN PHYS, V348, P49, DOI DOI 10.1002/ANDP.19133480105; Franke D, 2015, NAT METHODS, V12, P419, DOI [10.1038/NMETH.3358, 10.1038/nmeth.3358]; Glatter O., 1982, SMALL ANGLE X RAY SC; Graewert MA, 2013, CURR OPIN STRUC BIOL, V23, P748, DOI 10.1016/j.sbi.2013.06.007; Grishaev A, 2008, J BIOMOL NMR, V40, P95, DOI 10.1007/s10858-007-9211-5; Guinier A., 1955, SMALL ANGLE SCATTERI; Hammouda B, 2010, J APPL CRYSTALLOGR, V43, P716, DOI 10.1107/S0021889810015773; James RW, 1932, PHYS Z, V33, P737; Jensen D. R., 1976, Journal of Statistical Computation and Simulation, V4, P259, DOI 10.1080/00949657608810129; KAM Z, 1977, MACROMOLECULES, V10, P927, DOI 10.1021/ma60059a009; Kirian RA, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.011921; Koch MHJ, 2003, Q REV BIOPHYS, V36, P147, DOI 10.1017/S0033583503003871; Kofinger J, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.052712; LUZZATI V, 1986, J APPL CRYSTALLOGR, V19, P39, DOI 10.1107/S0021889886090027; Makowski L, 2011, BIOPOLYMERS, V95, P531, DOI 10.1002/bip.21631; Meisburger SP, 2013, BIOPHYS J, V104, P227, DOI [10.1016/j.bpj.2012.11.3817, 10.1016/j.bpj.2012.11.381]; Mendez D, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0315; Merzel F, 2002, P NATL ACAD SCI USA, V99, P5378, DOI 10.1073/pnas.082335099; MOORE PB, 1980, J APPL CRYSTALLOGR, V13, P168, DOI 10.1107/S002188988001179X; Moore PB, 2014, BIOPHYS J, V106, P1489, DOI 10.1016/j.bpj.2014.02.016; Park S., 2009, J CHEM PHYS, V130; Pelikan M, 2009, GEN PHYSIOL BIOPHYS, V28, P174, DOI 10.4149/gpb_2009_02_174; Perez J, 2012, CURR OPIN STRUC BIOL, V22, P670, DOI 10.1016/j.sbi.2012.07.014; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Receveur-Brechot V, 2012, CURR PROTEIN PEPT SC, V13, P55, DOI 10.2174/138920312799277901; Rozycki B, 2011, STRUCTURE, V19, P109, DOI 10.1016/j.str.2010.10.006; Schneidman-Duhovny D, 2013, BIOPHYS J, V105, P962, DOI 10.1016/j.bpj.2013.07.020; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; Spill YG, 2013, THESIS; Svergun DI, 2002, CURR OPIN STRUC BIOL, V12, P654, DOI 10.1016/S0959-440X(02)00363-9; Svergun DI, 2010, BIOL CHEM, V391, P737, DOI 10.1515/BC.2010.093; TAUPIN D, 1982, J APPL CRYSTALLOGR, V15, P289, DOI 10.1107/S0021889882012011; Theobald DL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040043; Tourneret JY, 2005, IEEE SP 13 WORKSH ST, P924; Waller I, 1923, Z PHYS, V17, P398, DOI 10.1007/BF01328696; Yang SM, 2010, P NATL ACAD SCI USA, V107, P18735, DOI 10.1073/pnas.1011957107	45	4	4	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177309	10.1371/journal.pone.0177309	http://dx.doi.org/10.1371/journal.pone.0177309			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493950	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314300085
J	Swainson, MG; Batterham, AM; Tsakirides, C; Rutherford, ZH; Hind, K				Swainson, Michelle G.; Batterham, Alan M.; Tsakirides, Costas; Rutherford, Zoe H.; Hind, Karen			Prediction of whole-body fat percentage and visceral adipose tissue mass from five anthropometric variables	PLOS ONE			English	Article							TO-HEIGHT RATIO; X-RAY ABSORPTIOMETRY; CARDIOMETABOLIC RISK-FACTORS; ALL-CAUSE MORTALITY; IN-VIVO PRECISION; GE LUNAR IDXA; CARDIOVASCULAR-DISEASE; WAIST CIRCUMFERENCE; GENERALIZED EQUATIONS; SCREENING TOOL	Background The conventional measurement of obesity utilises the body mass index (BMI) criterion. Although there are benefits to this method, there is concern that not all individuals at risk of obesity-associated medical conditions are being identified. Whole-body fat percentage (% FM), and specifically visceral adipose tissue (VAT) mass, are correlated with and potentially implicated in disease trajectories, but are not fully accounted for through BMI evaluation. The aims of this study were (a) to compare five anthropometric predictors of % FM and VAT mass, and (b) to explore new cut-points for the best of these predictors to improve the characterisation of obesity. Methods BMI, waist circumference (WC), waist-to-hip ratio (WHR), waist-to-height ratio (WHtR) and waist/height(0.5) (WHT. 5R) were measured and calculated for 81 adults (40 women, 41 men; mean (SD) age: 38.4 (17.5) years; 94% Caucasian). Total body dual energy X-ray absorptiometry with Corescan (GE Lunar iDXA, Encore version 15.0) was also performed to quantify % FM and VAT mass. Linear regression analysis, stratified by sex, was applied to predict both % FM and VAT mass for each anthropometric variable. Within each sex, we used information theoretic methods (Akaike Information Criterion; AIC) to compare models. For the best anthropometric predictor, we derived tentative cut-points for classifying individuals as obese (> 25% FM for men or > 35% FM for women, or > highest tertile for VAT mass). Results The best predictor of both % FM and VAT mass in men and women was WHtR. Derived cutpoints for predicting whole body obesity were 0.53 in men and 0.54 in women. The cut-point for predicting visceral obesity was 0.59 in both sexes. Conclusions In the absence of more objective measures of central obesity and adiposity, WHtR is a suitable proxy measure in both women and men. The proposed DXA-% FM and VAT mass cutoffs require validation in larger studies, but offer potential for improvement of obesity characterisation and the identification of individuals who would most benefit from therapeutic intervention.	[Swainson, Michelle G.; Tsakirides, Costas; Rutherford, Zoe H.; Hind, Karen] Leeds Beckett Univ, Inst Sport Phys Act & Leisure, Leeds, W Yorkshire, England; [Batterham, Alan M.] Teesside Univ, Hlth & Social Care Inst, Middlesbrough, Cleveland, England	Leeds Beckett University; University of Teesside	Swainson, MG (corresponding author), Leeds Beckett Univ, Inst Sport Phys Act & Leisure, Leeds, W Yorkshire, England.	m.swainson@leedsbeckett.ac.uk	Rutherford, Zoe/AAQ-3454-2020; Hind, Karen/AAE-6433-2021; Hind, Karen/HII-7471-2022	Rutherford, Zoe/0000-0002-0499-1134; Swainson, Michelle/0000-0002-5223-8710; BATTERHAM, ALAN/0000-0002-7865-7227; Hind, Karen/0000-0002-4546-5536	Medical Research Council [MR/K02325X/1] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ashwell M, 2005, INT J FOOD SCI NUTR, V56, P303, DOI 10.1080/09637480500195066; Ashwell M, 2012, CLIN OBES, V2, P3, DOI 10.1111/j.1758-8111.2012.00037.x; Ashwell M, 1996, BRIT MED J, V312, P377; Ashwell M, 1996, BRIT MED J, V313, P559; Ashwell M, 2005, NUTR FOOD SCI, V35, P360, DOI 10.1108/00346650510625575; Ashwell M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010159; Ashwell M, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0207-1; Ashwell Margaret, 2009, Nurs Stand, V23, P49; Britton KA, 2013, J AM COLL CARDIOL, V62, P921, DOI 10.1016/j.jacc.2013.06.027; Browning LM, 2010, NUTR RES REV, V23, P247, DOI 10.1017/S0954422410000144; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Roriz AKC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103499; Despres JP, 2012, CIRCULATION, V126, P1301, DOI 10.1161/CIRCULATIONAHA.111.067264; Direk K, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-25; Garnett SP, 2008, INT J OBESITY, V32, P1028, DOI 10.1038/ijo.2008.51; Gastaldelli A, 2007, GASTROENTEROLOGY, V133, P496, DOI 10.1053/j.gastro.2007.04.068; Heo M, 2013, INT J OBESITY, V37, P1154, DOI 10.1038/ijo.2012.201; Hind K, 2011, EUR J CLIN NUTR, V65, P140, DOI 10.1038/ejcn.2010.190; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Hsieh SD, 2005, PREV MED, V40, P216, DOI 10.1016/j.ypmed.2004.05.025; JACKSON AS, 1978, BRIT J NUTR, V40, P497, DOI 10.1079/BJN19780152; JACKSON AS, 1980, MED SCI SPORT EXER, V12, P175; Karelis AD, 2004, J CLIN ENDOCR METAB, V89, P2569, DOI 10.1210/jc.2004-0165; Kaul S, 2012, OBESITY, V20, P1313, DOI 10.1038/oby.2011.393; Kishida K, 2012, ANN MED, V44, P233, DOI 10.3109/07853890.2011.564202; Koster A, 2015, OBESITY, V23, P893, DOI 10.1002/oby.21028; Kuk JL, 2006, OBESITY, V14, P336, DOI 10.1038/oby.2006.43; Lam BCC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122985; Lee CMY, 2008, J CLIN EPIDEMIOL, V61, P646, DOI 10.1016/j.jclinepi.2007.08.012; Machado LG, 2016, OSTEOPOROSIS INT, V27, P3525, DOI 10.1007/s00198-016-3682-8; Mellis MG, 2014, EUR J CLIN NUTR, V68, P1365, DOI 10.1038/ejcn.2014.213; Miazgowski T, 2014, ENDOCRINE, V47, P500, DOI 10.1007/s12020-014-0180-7; Millar SR, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0069-5; Myint PK, 2014, HEART, V100, P1613, DOI 10.1136/heartjnl-2014-305816; National Institute for Health Care Excellence (NICE), 2014, CG189 NICE; Nevill AM, 2016, SCAND J MED SCI SPOR; Ortega FB, 2016, MAYO CLIN PROC, V91, P443, DOI 10.1016/j.mayocp.2016.01.008; Rothman KJ, 2008, INT J OBES LOND S3, V32; Rothney MP, 2013, OBESITY, V21, P1798, DOI 10.1002/oby.20223; Rothney MP, 2013, OBESITY, V21, pE134, DOI 10.1002/oby.20140; Sarathy H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153588; Shuster A, 2012, BRIT J RADIOL, V85, P1, DOI 10.1259/bjr/38447238; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; WHO, 2000, OB PREV MAN GLOB EP; World Health Organization, 2008, WAIST CIRCUMFERENCE	46	130	138	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177175	10.1371/journal.pone.0177175	http://dx.doi.org/10.1371/journal.pone.0177175			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493988	gold, Green Submitted, Green Accepted, Green Published			2022-12-26	WOS:000401314300067
J	Ward, D; Kirkman, K; Tsvuura, Z				Ward, David; Kirkman, Kevin; Tsvuura, Zivanai			An African grassland responds similarly to long-term fertilization to the Park Grass experiment	PLOS ONE			English	Article							RAPID POPULATION DIFFERENTIATION; PLANT-SPECIES DIVERSITY; MODEL SELECTION; ANTHOXANTHUM-ODORATUM; MULTIMODEL INFERENCE; BEHAVIORAL ECOLOGY; MOSAIC ENVIRONMENT; CO-LIMITATION; PRODUCTIVITY; NITROGEN	We compared the results of a long-term (65 years) experiment in a South African grassland with the world's longest-running ecological experiment, the Park Grass study at Rothamsted, U.K. The climate is warm and humid in South Africa and cool and temperate in England. The African grassland has been fertilized with two forms of nitrogen applied at four levels, phosphorus and lime in a crossed design in 96 plots. In 1951, about 84% of plant cover consisted of Themeda triandra, Tristachya leucothrix and Setaria nigrirostris. Currently, the dominant species are Panicum maximum, Setaria sphacelata and Eragrostis curvula, making up 71% of total biomass. As in the Park Grass experiment, we found a significant (additive) interaction effect on ANPP of nitrogen and phosphorus, and a (marginally significant) negative correlation between ANPP and species richness. Unlike the Park Grass experiment, there was no correlation between ANPP and species richness when pH was included as a covariate. There was also a significant negative effect of nitrogen amount and nitrogen form and a positive effect of lime on species richness and species diversity. Soil pH had an important effect on species richness. Liming was insufficient to balance the negative effects on species richness of nitrogen fertilization. There was a significant effect of pH on biomass of three abundant species. There were also significant effects of light on the biomass of four species, with only Panicum maximum having a negative response to light. In all of the abundant species, adding total species richness and ANPP to the model increased the amount of variance explained. The biomass of Eragrostis curvula and P. maximum were negatively correlated with species richness while three other abundant species increased with species richness, suggesting that competition and facilitation were active. Consistent with the results from the Park Grass and other long-term fertilization experiments of grasslands, we found a positive effect of soil pH and a negative effect of nitrogen amount on species richness, a more acutely negative effect on species richness of acidic ammonium sulphate fertilizer than limestone ammonium nitrate, a negative relationship between species richness and biomass, and a positive effect on species richness of lime interacting with nitrogen.	[Ward, David; Kirkman, Kevin; Tsvuura, Zivanai] Univ KwaZulu Natal, Sch Life Sci, Scottsville, South Africa; [Ward, David] Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA	University of Kwazulu Natal; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Ward, D (corresponding author), Univ KwaZulu Natal, Sch Life Sci, Scottsville, South Africa.; Ward, D (corresponding author), Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA.	dward21@kent.edu	Kirkman, Kevin P/F-4160-2010; Kirkman, Kevin/GNM-5334-2022; Tsvuura, Zivanai/X-3843-2019	Kirkman, Kevin P/0000-0001-9580-5191; Kirkman, Kevin/0000-0001-9580-5191; Tsvuura, Zivanai/0000-0003-1852-4737	Biotechnology and Biological Sciences Research Council [BBS/E/C/000J0300] Funding Source: researchfish; BBSRC [BBS/E/C/000J0300] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Acocks JPH, 1953, VELD TYPES OF SOUTH, V57; Adler PB, 2011, SCIENCE, V333, P1750, DOI 10.1126/science.1204498; Akaike H., 1973, PROCEEDINGS OF THE S; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Barnes GR, 1987, J GRASSLAND SOC SO A, V4, P63; Booysen P. de V., 1954, THESIS; Borer ET, 2014, NATURE, V508, P517, DOI 10.1038/nature13144; Borer ET, 2014, METHODS ECOL EVOL, V5, P65, DOI 10.1111/2041-210X.12125; BOSCH O J H, 1970, Proceedings Grassland Society of Southern Africa, V5, P69; Burnham K. P., 2002, MODEL SELECTION AND; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Cadotte MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005695; Cashen Rose O., 1947, JOUR AGRIC SCI, V37, P1, DOI 10.1017/S0021859600012971; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Cornwell WK, 2003, OIKOS, V100, P417, DOI 10.1034/j.1600-0706.2003.11697.x; Corp IBM, 2016, IBM SPSS STATISTICS; Craine JM, 2008, NEW PHYTOL, V179, P829, DOI 10.1111/j.1469-8137.2008.02513.x; Crawley MJ, 2005, AM NAT, V165, P179, DOI 10.1086/427270; DAVIES MS, 1976, HEREDITY, V36, P59, DOI 10.1038/hdy.1976.6; DODD M, 1995, J ECOL, V83, P277, DOI 10.2307/2261566; DODD ME, 1994, PHILOS T R SOC B, V346, P185, DOI 10.1098/rstb.1994.0140; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Foster BL, 2004, J ECOL, V92, P435, DOI 10.1111/j.0022-0477.2004.00882.x; Foster BL, 2001, ECOL LETT, V4, P530, DOI 10.1046/j.1461-0248.2001.00266.x; Frank DA, 1998, ECOLOGY, V79, P2229, DOI 10.1890/0012-9658(1998)079[2229:UVLCOS]2.0.CO;2; Freeland JR, 2010, J EVOLUTION BIOL, V23, P776, DOI 10.1111/j.1420-9101.2010.01947.x; Fukami T, 2005, ECOL LETT, V8, P1283, DOI 10.1111/j.1461-0248.2005.00829.x; Fynn R, 2011, J VEG SCI, V22, P528, DOI 10.1111/j.1654-1103.2011.01268.x; Fynn RWS, 2005, J VEG SCI, V16, P93, DOI 10.1111/j.1654-1103.2005.tb02342.x; Fynn RWS, 2005, J ECOL, V93, P384, DOI 10.1111/j.0022-0477.2005.00993.x; GOLDBERG DE, 1990, ECOLOGY, V71, P213, DOI 10.2307/1940261; Gough L, 2000, OIKOS, V89, P428, DOI 10.1034/j.1600-0706.2000.890302.x; GOUGH L, 1994, OIKOS, V70, P271, DOI 10.2307/3545638; Gough L, 2012, OECOLOGIA, V169, P1053, DOI 10.1007/s00442-012-2264-5; Gould B, 2014, MOL ECOL, V23, P6058, DOI 10.1111/mec.12893; Grace James B., 1999, Perspectives in Plant Ecology Evolution and Systematics, V2, P1, DOI 10.1078/1433-8319-00063; Haney RL, 2008, RENEW AGR FOOD SYST, V23, P171, DOI 10.1017/S174217050800224X; Haney RL, 2010, COMMUN SOIL SCI PLAN, V41, P1493, DOI 10.1080/00103624.2010.482171; Harpole WS, 2007, NATURE, V446, P791, DOI 10.1038/nature05684; Harpole WS, 2011, ECOL LETT, V14, P852, DOI 10.1111/j.1461-0248.2011.01651.x; INOUYE RS, 1995, ECOLOGY, V76, P1872, DOI 10.2307/1940720; Institute of Soil Classification and Mapping (ISCM),, 1991, KARD SOIL SURV; JENKINSON DS, 1994, J AGR SCI-CAMBRIDGE, V122, P365, DOI 10.1017/S0021859600067290; Kardol P, 2013, OIKOS, V122, P84, DOI 10.1111/j.1600-0706.2012.20546.x; Keddy P, 2000, J ECOL, V88, P413, DOI 10.1046/j.1365-2745.2000.00456.x; Keddy P, 2002, J VEG SCI, V13, P5, DOI 10.1111/j.1654-1103.2002.tb02018.x; Kunin WE, 1998, P NATL ACAD SCI USA, V95, P207, DOI 10.1073/pnas.95.1.207; Lawes JB, 1882, PHILOS T R SOC LONDO, V173, P1181, DOI DOI 10.1098/RSTL.1882.0029; MacDougall AS, 2004, J ECOL, V92, P422, DOI 10.1111/j.0022-0477.2004.00886.x; MANNETJE L.'T., 1963, JOUR BRIT GRASSLAND SOC, V18, P268; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; Morris C., 2002, Rangelands, V24, P8; Morris C., 2001, B GRASSL SOC S AFR, V11, P7; Morris C. D., 1993, African Journal of Range and Forage Science, V10, P124, DOI 10.1080/10220119.1993.9638338; Mucina L, 2006, THE VEGETATION OF SO; Rajaniemi TK, 2003, OIKOS, V101, P449, DOI 10.1034/j.1600-0706.2003.12128.x; Rajaniemi TK, 2002, J ECOL, V90, P316, DOI 10.1046/j.1365-2745.2001.00662.x; Roux N. P. le, 1986, South African Journal of Plant and Soil, V3, P1; Safford HD, 2001, OIKOS, V95, P282, DOI 10.1034/j.1600-0706.2001.950210.x; SCHLUTER D, 1994, AM NAT, V143, P597, DOI 10.1086/285622; SCOTT J. D., 1956, South African Journal of Science, V52, P240; SEASTEDT TR, 1991, OECOLOGIA, V87, P72, DOI 10.1007/BF00323782; Shaver GR, 2001, ECOLOGY, V82, P3163, DOI 10.1890/0012-9658(2001)082[3163:SCIWFT]2.0.CO;2; SILVERTOWN J, 1994, ECOLOGY, V75, P2430, DOI 10.2307/1940896; SILVERTOWN J, 1987, AM NAT, V130, P807, DOI 10.1086/284748; Silvertown J, 2006, J ECOL, V94, P801, DOI 10.1111/j.1365-2745.2006.01145.x; Smit G. N., 1993, African Journal of Range and Forage Science, V10, P151, DOI 10.1080/10220119.1993.9638343; SNAYDON RW, 1982, EVOLUTION, V36, P289, DOI [10.2307/2408047, 10.1111/j.1558-5646.1982.tb05044.x]; SNAYDON RW, 1970, EVOLUTION, V24, P257, DOI [10.2307/2406802, 10.1111/j.1558-5646.1970.tb01759.x]; Socher SA, 2012, J ECOL, V100, P1391, DOI 10.1111/j.1365-2745.2012.02020.x; Stevens MHH, 2004, J ECOL, V92, P339, DOI 10.1111/j.0022-0477.2004.00866.x; Storkey J, 2015, NATURE, V528, P401, DOI 10.1038/nature16444; Suding KN, 2005, P NATL ACAD SCI USA, V102, P4387, DOI 10.1073/pnas.0408648102; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Tainton NM, 1976, COMMON VELD AND PAST; TILMAN D, 1994, LONG-TERM EXPERIMENTS IN AGRICULTURAL AND ECOLOGICAL SCIENCES, P287; TILMAN D, 1987, ECOL MONOGR, V57, P189, DOI 10.2307/2937080; Tilman D., 1982, Monographs in Population Biology, pi; TILMAN D, 1991, ECOLOGY, V72, P1038, DOI 10.2307/1940604; Tilman David, 1993, P13; Tsvuura Z, 2013, AUSTRAL ECOL, V38, P959, DOI 10.1111/aec.12040; Tu YK, 2005, BRIT DENT J, V199, P457, DOI 10.1038/sj.bdj.4812743; Van Oudtshoorn F., 2012, GUIDE TO GRASSES OF; Waide RB, 1999, ANNU REV ECOL SYST, V30, P257, DOI 10.1146/annurev.ecolsys.30.1.257; Ward D, 2016, SOIL BIOLOGY BIOCHEM; WILSON SD, 1991, ECOLOGY, V72, P1050, DOI 10.2307/1940605; Zobel M, 1997, TRENDS ECOL EVOL, V12, P266, DOI 10.1016/S0169-5347(97)01096-3	88	22	22	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177208	10.1371/journal.pone.0177208	http://dx.doi.org/10.1371/journal.pone.0177208			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493915	gold, Green Published, Green Submitted			2022-12-26	WOS:000401314300072
J	Arnason, JW; Murphy, JC; Kooi, C; Wiehler, S; Traves, SL; Shelfoon, C; Maciejewski, B; Dumonceaux, CJ; Lewenza, WS; Proud, D; Leigh, R				Arnason, Jason W.; Murphy, James C.; Kooi, Cora; Wiehler, Shahina; Traves, Suzanne L.; Shelfoon, Christopher; Maciejewski, Barbara; Dumonceaux, Curtis J.; Lewenza, W. Shawn; Proud, David; Leigh, Richard			Human beta-defensin-2 production upon viral and bacterial co-infection is attenuated in COPD	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; AIRWAY BACTERIAL; PULMONARY; EXACERBATIONS; INFECTION; SYMPTOMS; DISEASE; SMOKERS; EXPRESSION; INDUCTION	Viral-bacterial co-infections are associated with severe exacerbations of COPD. Epithelial antimicrobial peptides, including human beta-defensin-2 (HBD-2), are integral to innate host defenses. In this study, we examined how co-infection of airway epithelial cells with rhinovirus and Pseudomonas aeruginosa modulates HBD-2 expression, and whether these responses are attenuated by cigarette smoke and in epithelial cells obtained by bronchial brushings from smokers with normal lung function or from COPD patients. When human airway epithelial cells from normal lungs were infected with rhinovirus, Pseudomonas aeruginosa, or the combination, co-infection with rhinovirus and bacteria resulted in synergistic induction of HBD-2 (p<0.05). The combination of virus and flagellin replicated this synergistic increase (p<0.05), and synergy was not seen using a flagella-deficient mutant Pseudomonas (p<0.05). The effects of Pseudomonas aeruginosa were mediated via interactions of flagellin with TLR5. The effects of HRV-16 depended upon viral replication but did not appear to be mediated via the intracellular RNA helicases, retinoic acid-inducible gene-I or melanoma differentiation-associated gene-5. Cigarette smoke extract significantly decreased HBD-2 production in response to co-infection. Attenuated production was also observed following co-infection of cells obtained from healthy smokers or COPD patients compared to healthy controls (p<0.05). We conclude that co-exposure to HRV-16 and Pseudomonas aeruginosa induces synergistic production of HBD-2 from epithelial cells and that this synergistic induction of HBD-2 is reduced in COPD patients. This may contribute to the more severe exacerbations these patients experience in response to viral-bacterial co-infections.	[Arnason, Jason W.; Kooi, Cora; Dumonceaux, Curtis J.; Leigh, Richard] Univ Calgary, Cumming Sch Med, Dept Med, Snyder Inst Chron Dis, Calgary, AB, Canada; [Arnason, Jason W.; Murphy, James C.; Kooi, Cora; Wiehler, Shahina; Traves, Suzanne L.; Shelfoon, Christopher; Maciejewski, Barbara; Dumonceaux, Curtis J.; Proud, David; Leigh, Richard] Univ Calgary, Cumming Sch Med, Dept Physiol & Pharmacol, Snyder Inst Chron Dis, Calgary, AB, Canada; [Lewenza, W. Shawn] Univ Calgary, Cumming Sch Med, Dept Microbiol Immunol & Infect Dis, Snyder Inst Chron Dis, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary	Leigh, R (corresponding author), Univ Calgary, Cumming Sch Med, Dept Med, Snyder Inst Chron Dis, Calgary, AB, Canada.; Leigh, R (corresponding author), Univ Calgary, Cumming Sch Med, Dept Physiol & Pharmacol, Snyder Inst Chron Dis, Calgary, AB, Canada.	rleigh@ucalgary.ca		Murphy, James/0000-0003-2702-9463	Canadian Institutes of Health Research (CIHR) [82049, 43923]; GlaxoSmithKline-CIHR Professorship in Inflammatory Lung Diseases at the University of Calgary; Tier 1 Canada Research Chair in Inflammatory Airway Diseases	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); GlaxoSmithKline-CIHR Professorship in Inflammatory Lung Diseases at the University of Calgary; Tier 1 Canada Research Chair in Inflammatory Airway Diseases	Grant numbers 82049 (to RL) & 43923 (to DP) from the Canadian Institutes of Health Research (CIHR) supported this work. Dr. Leigh holds the GlaxoSmithKline-CIHR Professorship in Inflammatory Lung Diseases at the University of Calgary and Dr. Proud is the recipient of a Tier 1 Canada Research Chair in Inflammatory Airway Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Celli BR, 2007, EUR RESPIR J, V29, P1224, DOI 10.1183/09031936.00109906; CHURCHILL L, 1989, AM REV RESPIR DIS, V140, P449, DOI 10.1164/ajrccm/140.2.449; Connors AF, 1996, AM J RESP CRIT CARE, V154, P959, DOI 10.1164/ajrccm.154.4.8887592; Donaldson GC, 2002, THORAX, V57, P847, DOI 10.1136/thorax.57.10.847; Duits LA, 2003, FEMS IMMUNOL MED MIC, V38, P59, DOI 10.1016/S0928-8244(03)00106-8; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Gershon AS, 2013, AM J RESP CRIT CARE, V187, P596, DOI 10.1164/rccm.201211-2044OC; Global Initiative for Chronic Obstructive Lung Disease, 2016, GLOB STRAT DIAGN MAN; Guarascio AJ, 2013, CLINICOECONOMIC OUTC, V5, P235, DOI 10.2147/CEOR.S34321; Harder J, 2000, AM J RESP CELL MOL, V22, P714, DOI 10.1165/ajrcmb.22.6.4023; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Herr C, 2009, THORAX, V64, P144, DOI 10.1136/thx.2008.102681; Hudy MH, 2010, EUR RESPIR J, V35, P1256, DOI 10.1183/09031936.00128809; Jarczak J, 2013, HUM IMMUNOL, V74, P1069, DOI 10.1016/j.humimm.2013.05.008; Lewenza S, 2005, GENOME RES, V15, P583, DOI 10.1101/gr.3513905; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Patel IS, 2002, THORAX, V57, P759, DOI 10.1136/thorax.57.9.759; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Proud D, 2004, J IMMUNOL, V172, P4637, DOI 10.4049/jimmunol.172.7.4637; Proud D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040762; Regan EA, 2015, JAMA INTERN MED, V175, P1539, DOI 10.1001/jamainternmed.2015.2735; Sanders SP, 1998, J VIROL, V72, P934, DOI 10.1128/JVI.72.2.934-942.1998; Scharf S, 2010, AM J PHYSIOL-LUNG C, V298, pL687, DOI 10.1152/ajplung.00365.2009; Schlee M, 2007, INFECT IMMUN, V75, P2399, DOI 10.1128/IAI.01563-06; Seemungal T, 2001, AM J RESP CRIT CARE, V164, P1618, DOI 10.1164/ajrccm.164.9.2105011; Seemungal TAR, 1998, AM J RESP CRIT CARE, V157, P1418, DOI 10.1164/ajrccm.157.5.9709032; Sethi Sanjay, 2008, N Engl J Med, V359, P2355, DOI 10.1056/NEJMra0800353; Slater L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001178; Tan WC, 2014, THORAX, V69, P709, DOI 10.1136/thoraxjnl-2013-205048; Triantafilou K, 2011, VIRULENCE, V2, P22, DOI 10.4161/viru.2.1.13807; Wang Q, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002070; Wang R, 2012, J IMMUNOL, V189, P2217, DOI 10.4049/jimmunol.1101895; Wark PAB, 2013, RESPIROLOGY, V18, P996, DOI 10.1111/resp.12099; Wedzicha JA, 2007, LANCET, V370, P786, DOI 10.1016/S0140-6736(07)61382-8; Wiehler S, 2007, AM J PHYSIOL-LUNG C, V293, pL505, DOI 10.1152/ajplung.00066.2007; Wilkinson TMA, 2006, CHEST, V129, P317, DOI 10.1378/chest.129.2.317; Wilkinson TMA, 2003, AM J RESP CRIT CARE, V167, P1090, DOI 10.1164/rccm.200210-1179OC; Woodruff PG, 2016, NEW ENGL J MED, V374, P1811, DOI 10.1056/NEJMoa1505971; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	40	13	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0175963	10.1371/journal.pone.0175963	http://dx.doi.org/10.1371/journal.pone.0175963			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489911	Green Submitted, Green Published, gold			2022-12-26	WOS:000401314100010
J	Zhu, Y; Hu, QM; Xu, WT; Li, HL; Guo, H; Meng, L; Wei, M; Lu, S; Shao, CW; Wang, N; Yang, GP; Chen, SL				Zhu, Ying; Hu, Qiaomu; Xu, Wenteng; Li, Hailong; Guo, Hua; Meng, Liang; Wei, Min; Lu, Sheng; Shao, Changwei; Wang, Na; Yang, Guanpin; Chen, Songlin			Identification and analysis of the beta-catenin1 gene in half-smooth tongue sole (Cynoglossus semilaevis)	PLOS ONE			English	Article							BETA-CATENIN; EXPRESSION ANALYSIS; MOLECULAR CHARACTERIZATION; SEX; CLONING; DIFFERENTIATION; FIGLA; FISH; SPERMATOGENESIS; METHYLATION	beta-catenin is a key signalling molecule in the canonical Wnt pathway, which plays a role in cell adhesion, embryogenesis and sex determination. However, little is known about its function in teleosts. We cloned and characterized the full-length beta-catenin1 gene from halfsmooth tongue sole (Cynoglossus semilaevis), which was designated CS-beta-catenin1. The CS-beta-catenin1 cDNA consists of 2,346 nucleotides and encodes a protein with 782 amino acids. Although CS-beta-catenin1 was transcribed in the gonads of both sexes, the level was significantly higher in ovaries compared to testes. Furthermore, the mRNA level of CS-beta-catenin1 was significantly upregulated at 160 days and constantly increased until 2 years of age. In situ hybridization revealed that CS-beta-catenin1 mRNA was mainly localized in oocyte cells, especially in stage I, II and III oocytes. When CS-beta-catenin1 expression was inhibited by injection of quercetin in the ovaries, levels of CS-Figla and CS-foxl2 mRNA were significantly down-regulated, and CS-dmrt1 was up-regulated, which suggested that CS-beta-catenin1 is a potential upstream gene of CS-Figla and is involved in the development of the ovaries, i.e., folliculogenesis.	[Zhu, Ying; Lu, Sheng; Yang, Guanpin] Ocean Univ China, Coll Marine Life Sci, Qingdao, Peoples R China; [Zhu, Ying; Xu, Wenteng; Li, Hailong; Guo, Hua; Meng, Liang; Wei, Min; Lu, Sheng; Shao, Changwei; Wang, Na; Chen, Songlin] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries Sci & Food Prod Proc, Qingdao, Peoples R China; [Hu, Qiaomu] Chinese Acad Fishery Sci, Yangtze River Fisheries Res Inst, Wuhan, Hubei, Peoples R China; [Xu, Wenteng; Li, Hailong; Guo, Hua; Meng, Liang; Wei, Min; Shao, Changwei; Wang, Na; Chen, Songlin] Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Key Lab Sustainable Dev Marine Fisheries, Minist Agr, Qingdao, Peoples R China	Ocean University of China; Qingdao National Laboratory for Marine Science & Technology; Chinese Academy of Fishery Sciences; Yangtze River Fisheries Research Institute, CAFS; Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs	Chen, SL (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries Sci & Food Prod Proc, Qingdao, Peoples R China.; Chen, SL (corresponding author), Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Key Lab Sustainable Dev Marine Fisheries, Minist Agr, Qingdao, Peoples R China.	chensl@ysfri.ac.cn	Xu, Wenteng/Q-1552-2018; Shao, Changwei/I-2054-2016	Shao, Changwei/0000-0002-6953-2203; Meng, Liang/0000-0003-2642-8446; guo, hua/0000-0002-0329-0088	National Nature Science Foundation of China [31130057, 31530078, 31402293, 31472269]; Taishan Scholar Climbing Project Fund of Shandong of China	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Taishan Scholar Climbing Project Fund of Shandong of China	This work was supported by grants from the National Nature Science Foundation of China (31130057,31530078,31402293,31472269), Taishan Scholar Climbing Project Fund of Shandong of China. Special Scientific Research Funds for Central Non-profit Institutes, Chinese Academy of Fishery Sciences (2015C03YQ01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae SM, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-89; Bernard P, 2012, ENDOCRINOLOGY, V153, P901, DOI 10.1210/en.2011-1347; Chassot AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025641; Chen SL, 2007, MAR BIOTECHNOL, V9, P273, DOI 10.1007/s10126-006-6081-x; Chen SL, 2014, NAT GENET, V46, P253, DOI 10.1038/ng.2890; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Daugela L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044585; Dong XL, 2011, ACTA OCEANOL SIN, V30, P68, DOI 10.1007/s13131-011-0092-9; Gifford JAH, 2015, REPRODUCTION, V150, pR137, DOI 10.1530/REP-14-0685; Hu QM, 2014, SCI REP-UK, V4, DOI 10.1038/srep07167; Hu QM, 2014, AQUACULT INT, V22, P1437, DOI 10.1007/s10499-014-9757-7; Hu QM, 2013, COMP BIOCHEM PHYS B, V165, P181, DOI 10.1016/j.cbpb.2013.03.007; HULSKEN J, 1994, J CELL BIOL, V127, P2061, DOI 10.1083/jcb.127.6.2061; Joshi S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-67; Kirikoshi H, 2001, INT J ONCOL, V19, P767; Kobayashi T, 2000, MECH DEVELOP, V99, P139, DOI 10.1016/S0925-4773(00)00464-0; Li HL, 2016, SCI REP-UK, V6, DOI 10.1038/srep28219; Li HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115917; Li ZJ, 2010, FISH SHELLFISH IMMUN, V29, P89, DOI 10.1016/j.fsi.2010.02.021; Liao XL, 2014, INT J MOL SCI, V15, P12952, DOI 10.3390/ijms150712952; Liu CF, 2009, HUM MOL GENET, V18, P405, DOI 10.1093/hmg/ddn362; Liu JX, 2016, COMP BIOCHEM PHYS B, V198, P19, DOI 10.1016/j.cbpb.2016.03.006; Liu JX, 2016, COMP BIOCHEM PHYS B, V193, P1, DOI 10.1016/j.cbpb.2015.12.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Maatouk DM, 2008, HUM MOL GENET, V17, P2949, DOI 10.1093/hmg/ddn193; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Miyake Y, 2012, ZOOL SCI, V29, P690, DOI 10.2108/zsj.29.690; Mork L, 2013, EVOL DEV, V15, P96, DOI 10.1111/ede.12020; Munroe DG, 1999, P NATL ACAD SCI USA, V96, P1569, DOI 10.1073/pnas.96.4.1569; Nicol B, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.131276; Pandur P, 2002, BIOESSAYS, V24, P881, DOI 10.1002/bies.10164; Parakh TN, 2006, P NATL ACAD SCI USA, V103, P12435, DOI 10.1073/pnas.0603006103; Park CH, 2005, BIOCHEM BIOPH RES CO, V328, P227, DOI 10.1016/j.bbrc.2004.12.151; Parma P, 2006, NAT GENET, V38, P1304, DOI 10.1038/ng1907; Prestwich TC, 2007, CURR OPIN CELL BIOL, V19, P612, DOI 10.1016/j.ceb.2007.09.014; Qiu YX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123900; Ren JF, 2016, SCI REP-UK, V6, DOI 10.1038/srep23968; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; de Mitcheson YS, 2008, FISH FISH, V9, P1, DOI 10.1111/j.1467-2979.2007.00266.x; Schneider SQ, 2003, J EXP ZOOL PART B, V295B, P25, DOI 10.1002/jez.b.00006; Shao CW, 2010, MICRON, V41, P47, DOI 10.1016/j.micron.2009.08.002; Shao CW, 2014, GENOME RES, V24, P604, DOI 10.1101/gr.162172.113; Sreenivasan R, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.110874; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Willert K, 1998, CURR OPIN GENET DEV, V8, P95, DOI 10.1016/S0959-437X(98)80068-3; Wong KY, 2012, CARCINOGENESIS, V33, P1629, DOI 10.1093/carcin/bgs212; Wu GC, 2009, BIOL REPROD, V81, P1073, DOI 10.1095/biolreprod.109.077362; Wu LM, 2016, MOL CELL ENDOCRINOL, V427, P33, DOI 10.1016/j.mce.2016.03.002; Xu WT, 2016, GENE, V592, P215, DOI 10.1016/j.gene.2016.07.062; Xu WT, 2016, GENE, V582, P161, DOI 10.1016/j.gene.2016.02.010; Zhang LY, 2014, MAR GENOM, V18, P45, DOI 10.1016/j.margen.2014.04.004; Zhang M, 2012, DEVELOPMENT, V139, P2009, DOI 10.1242/dev.074435	54	11	11	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176122	10.1371/journal.pone.0176122	http://dx.doi.org/10.1371/journal.pone.0176122			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489928	Green Submitted, Green Published, gold			2022-12-26	WOS:000401314100015
J	Jha, PK; Khan, MI; Mishra, A; Das, P; Sinha, KK				Jha, Pravin K.; Khan, Mohd. Imran; Mishra, Anshul; Das, Pradeep; Sinha, Kislay K.			HAT2 mediates histone H4K4 acetylation and affects micrococcal nuclease sensitivity of chromatin in Leishmania donovani	PLOS ONE			English	Article							NUCLEOSOME CORE PARTICLE; TRYPANOSOMA-CRUZI; MYST-FAMILY; POLYCISTRONIC TRANSCRIPTION; FUNCTIONAL-CHARACTERIZATION; CRYSTAL-STRUCTURE; DEACETYLASE; CLONING; PROTEIN; DNA	Histone post-translational modifications (PTMs) such as acetylation and methylation are known to affect chromatin higher order structures. Primary targets of these modifications include basic residues present at N-terminus tail region of core histones. Four histone acetyltransferase (HAT) genes have been identified in trypanosomatids. HAT1, HAT3 and HAT4 of Leishmania donovani have been partially characterized. However, there is no report about HAT2 of Leishmania donovani. Lysine residues present on the N-terminal tail of Leishmania donovani histone H4 are conserved in other trypanosomatids and humans. PTMs of lysines modulate various functions at chromatin level. The four histone acetyltrans-ferases encoded in Leishmania genome were over-expressed to analyse their functional activity. All four HATs were found actively acetylating core histones H3/H4. Similar to L. donovani HAT3 and HAT4, HAT2 was found to be a member of MYST family protein and have SAS2 type domain. Over-expression of HAT2 significantly increases acetylation of H4K4. To analyse the effect of HAT2 over-expression on chromatin accessibility, micrococcal nuclease digestion assay was performed. MNase digestion resulted in a higher proportion of the mononucleosomes and dinucleosomes in HAT2 over-expressing cells as compared to WT L. donovani cells. Acetylation of lysine-4 neutralizes the amino terminal region of histone H4. This weakens its interaction with neighbouring nucleosomes and the linker DNA. HAT2 over-expression in L. donovani resulted in highly accessible chromatin suggesting chromatin decondensation. HAT2 may have an important role to play in global regulation of transcription in L. donovani. Better understanding of these epigenetic determinants of parasite would help in designing novel therapeutic strategies.	[Jha, Pravin K.; Khan, Mohd. Imran; Mishra, Anshul; Sinha, Kislay K.] Natl Inst Pharmaceut Educ & Res, Dept Biotechnol, Hajipur, Bihar, India; [Das, Pradeep] Rajendra Mem Res Inst Med Sci, Mol Biol Div, Patna, Bihar, India	National Institute of Pharmaceutical Education & Research (NIPER); Indian Council of Medical Research (ICMR); ICMR - Rajendra Memorial Research Institute of Medical Sciences (RMRI)	Sinha, KK (corresponding author), Natl Inst Pharmaceut Educ & Res, Dept Biotechnol, Hajipur, Bihar, India.	kksinha@gmail.com	Jha, Pravin/GOH-0811-2022	Sinha, Kislay/0000-0002-6978-4611	Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India	Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India	The authors received funding for this work from Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India.	ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Alsford S, 2004, MOL MICROBIOL, V53, P365, DOI 10.1111/j.1365-2958.2004.04151.x; Avvakumov N, 2007, ONCOGENE, V26, P5395, DOI 10.1038/sj.onc.1210608; Bird AW, 2002, NATURE, V419, P411, DOI 10.1038/nature01035; Bonisch C, 2012, NUCLEIC ACIDS RES, V40, P10719, DOI 10.1093/nar/gks865; da Cunha JPC, 2006, MOL BIOCHEM PARASIT, V150, P268, DOI 10.1016/j.molbiopara.2006.08.012; CHAHAL SS, 1980, NATURE, V287, P76, DOI 10.1038/287076a0; Collepardo-Guevara R, 2014, P NATL ACAD SCI USA, V111, P8061, DOI 10.1073/pnas.1315872111; ElBashir R, 2015, ANAL CHEM, V87, P9939, DOI 10.1021/acs.analchem.5b02517; Eram MS, 2014, J BIOL CHEM, V289, P12177, DOI 10.1074/jbc.M113.523183; Gao L, 2002, J BIOL CHEM, V277, P25748, DOI 10.1074/jbc.M111871200; GARCIARAMIREZ M, 1995, J BIOL CHEM, V270, P17923, DOI 10.1074/jbc.270.30.17923; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Heitz E, 1928, JAHRB WISS BOT, V69, P762; Hyland EA, 2005, MOL CELL BIOL, V25, P10060, DOI 10.1128/MCB.25.22.10060-10070.2005; Janzen CJ, 2006, FEBS LETT, V580, P2306, DOI 10.1016/j.febslet.2006.03.044; Kan PY, 2009, MOL CELL BIOL, V29, P538, DOI 10.1128/MCB.01343-08; Kao HY, 2002, J BIOL CHEM, V277, P187, DOI 10.1074/jbc.M108931200; Kawahara T, 2008, MOL MICROBIOL, V69, P1054, DOI 10.1111/j.1365-2958.2008.06346.x; Krajewski WA, 1998, P NATL ACAD SCI USA, V95, P1540, DOI 10.1073/pnas.95.4.1540; Kumar D, 2015, NUCLEIC ACIDS RES, V43, P5423, DOI 10.1093/nar/gkv431; Kumar D, 2012, MICROBIOL-SGM, V158, P328, DOI 10.1099/mic.0.050211-0; de Jesus TCL, 2016, J PROTEOME RES, V15, P2039, DOI 10.1021/acs.jproteome.6b00208; Li B, 2005, P NATL ACAD SCI USA, V102, P18385, DOI 10.1073/pnas.0507975102; Luger K, 2005, CURR OPIN STRUC BIOL, V15, P188, DOI 10.1016/j.sbi.2005.03.006; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Maity AK, 2012, FEMS MICROBIOL LETT, V336, P57, DOI 10.1111/j.1574-6968.2012.02656.x; Mandava V, 2007, MOL BIOCHEM PARASIT, V156, P41, DOI 10.1016/j.molbiopara.2007.07.005; McMurry MT, 2000, SCIENCE, V287, P495, DOI 10.1126/science.287.5452.495; Park CS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-539; Ramos TCP, 2015, MOL BIOCHEM PARASIT, V204, P1, DOI 10.1016/j.molbiopara.2015.11.001; Reifsnyder C, 1996, NAT GENET, V14, P42, DOI 10.1038/ng0996-42; Respuela P, 2008, J BIOL CHEM, V283, P15884, DOI 10.1074/jbc.M802081200; Robinson KA, 2003, MOL BIOCHEM PARASIT, V128, P217, DOI 10.1016/S0166-6851(03)00079-3; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Siegel TN, 2008, MOL MICROBIOL, V67, P762, DOI 10.1111/j.1365-2958.2007.06079.x; Singh J, 2015, MOL BIOSYST, V11, P1887, DOI 10.1039/c5mb00251f; Sklenar Amy R., 2004, BMC Biochemistry, V5, P11, DOI 10.1186/1471-2091-5-11; Sullivan WJ, 2000, GENE, V242, P193, DOI 10.1016/S0378-1119(99)00526-0; Suto RK, 2000, NAT STRUCT BIOL, V7, P1121; THATCHER TH, 1994, NUCLEIC ACIDS RES, V22, P174, DOI 10.1093/nar/22.2.174; Thomas S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-152; Toth K, 2006, BIOCHEMISTRY-US, V45, P1591, DOI 10.1021/bi052110u; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; Van den Wyngaert I, 2000, FEBS LETT, V478, P77, DOI 10.1016/S0014-5793(00)01813-5; Vogelauer M, 2002, MOL CELL, V10, P1223, DOI 10.1016/S1097-2765(02)00702-5; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; Yan CH, 2006, MOL CELL BIOL, V26, P6357, DOI 10.1128/MCB.00311-06; Yang XH, 2011, MOL CELL, V44, P39, DOI 10.1016/j.molcel.2011.07.032; Zaret K., 2005, CURR PROTOC MOL BIOL, VChapter 21; Zhou XB, 2001, P NATL ACAD SCI USA, V98, P10572, DOI 10.1073/pnas.191375098	51	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177372	10.1371/journal.pone.0177372	http://dx.doi.org/10.1371/journal.pone.0177372			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486547	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314000077
J	Sorenson, EC; Khanin, R; Bamboat, ZM; Cavnar, MJ; Kim, TS; Sadot, E; Zeng, S; Greer, JB; Seifert, AM; Cohen, NA; Crawley, MH; Green, BL; Klimstra, DS; DeMatteo, RP				Sorenson, Eric C.; Khanin, Raya; Bamboat, Zubin M.; Cavnar, Michael J.; Kim, Teresa S.; Sadot, Eran; Zeng, Shan; Greer, Jonathan B.; Seifert, Adrian M.; Cohen, Noah A.; Crawley, Megan H.; Green, Benjamin L.; Klimstra, David S.; DeMatteo, Ronald P.			Genome and transcriptome profiling of fibrolamellar hepatocellular carcinoma demonstrates p53 and IGF2BP1 dysregulation	PLOS ONE			English	Article							GENE-EXPRESSION; COPY-NUMBER; CANCER; LIVER; DIFFERENTIATION; HYBRIDIZATION; PROLIFERATION; PROGRESSION; ALGORITHM; SURVIVAL	Fibrolamellar hepatocellular carcinoma (FL-HCC) is a rare variant of HCC that most frequently affects young adults. Because of its rarity and an absence of preclinical models, our understanding of FL-HCC is limited. Our objective was to analyze chromosomal alterations and dysregulated gene expression in tumor specimens collected at a single center during two decades of experience with FL-HCC. We analyzed 38 specimens from 26 patients by array comparative genomic hybridiziation (aCGH) and 35 specimens from 15 patients by transcriptome sequencing (RNA-seq). All tumor specimens exhibited genomic instability, with a higher frequency of genomic amplifications or deletions in metastatic tumors. The regions encoding 71 microRNAs (miRs) were deleted in at least 25% of tumor specimens. Five of these recurrently deleted miRs targeted the insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) gene product, and a correlating 100-fold upregulation of IGF2BP1 mRNA was seen in tumor specimens. Transcriptome analysis demonstrated intrapatient tumor similarity, independent of recurrence site or time. The p53 tumor suppressor pathway was downregulated as demonstrated by both aCGH and RNA-seq analysis. Notch, EGFR, NRAS, and RB1 pathways were also significantly dysregulated in tumors compared with normal liver tissue. The findings illuminate the genomic and transcriptomic landscape of this rare disease and provide insight into dysregulated oncogenic pathways and potential therapeutic targets in FL-HCC.	[Sorenson, Eric C.; Bamboat, Zubin M.; Cavnar, Michael J.; Kim, Teresa S.; Sadot, Eran; Zeng, Shan; Greer, Jonathan B.; Seifert, Adrian M.; Cohen, Noah A.; Crawley, Megan H.; Green, Benjamin L.; DeMatteo, Ronald P.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Khanin, Raya] Mem Sloan Kettering Canc Ctr, Dept Computat Biol & Bioinformat Core, New York, NY 10021 USA; [Klimstra, David S.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	DeMatteo, RP (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA.	dematter@mskcc.org	Seifert, Adrian M./AAL-3453-2021; Kim, Teresa/AAC-2437-2021	Seifert, Adrian M./0000-0002-5329-3164; Kim, Teresa/0000-0002-6040-7748; Cohen, Noah/0000-0003-3947-2585; Cohen, Noah/0000-0003-3794-9642; Green, Benjamin/0000-0002-5772-198X	Fibrolamellar Cancer Foundation; RPD; U.S. National Institutes of Health [T32-CA09501]; ECS; NATIONAL CANCER INSTITUTE [T32CA009501] Funding Source: NIH RePORTER	Fibrolamellar Cancer Foundation; RPD; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ECS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by: Fibrolamellar Cancer Foundation (http://fibrefoundation.org), Recipient: RPD; U.S. National Institutes of Health Grant T32-CA09501, Recipient: ECS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiva P, 2006, GENOME RES, V16, P30, DOI 10.1101/gr.4137606; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ang Celina S, 2013, Gastrointest Cancer Res, V6, P3; Bell JL, 2013, CELL MOL LIFE SCI, V70, P2657, DOI 10.1007/s00018-012-1186-z; Buckley AF, 2006, HUM PATHOL, V37, P410, DOI 10.1016/j.humpath.2005.12.009; COLLIER NA, 1984, LANCET, V1, P538; Cornella H, 2015, GASTROENTEROLOGY, V148, P806, DOI 10.1053/j.gastro.2014.12.028; Dar AA, 2008, CANCER RES, V68, P8998, DOI 10.1158/0008-5472.CAN-08-2658; Do RK, 2014, THE BRITISH JOURNAL, V87; EDMONDSON HA, 1956, AMA J DIS CHILD, V91, P168, DOI 10.1001/archpedi.1956.02060020170015; Eggert T, 2014, GUT, V63, P1524, DOI 10.1136/gutjnl-2013-306407; Eggert T, 2013, UNITED EUR GASTROENT, V1, P351, DOI 10.1177/2050640613501507; EHRENFRIED JA, 1994, ANN SURG, V220, P484, DOI 10.1097/00000658-199410000-00007; Gutschner T, 2014, HEPATOLOGY, V59, P1900, DOI 10.1002/hep.26997; Honda K, 1998, BRIT J CANCER, V77, P776, DOI 10.1038/bjc.1998.126; Honeyman JN, 2014, SCIENCE, V343, P1010, DOI 10.1126/science.1249484; Huang XD, 2014, DIGEST DIS SCI, V59, P795, DOI 10.1007/s10620-013-2969-2; Ieta K, 2007, INT J CANCER, V121, P33, DOI 10.1002/ijc.22605; Kakar S, 2009, MODERN PATHOL, V22, P134, DOI 10.1038/modpathol.2008.178; Kannan K, 2011, P NATL ACAD SCI USA, V108, P9172, DOI 10.1073/pnas.1100489108; Kannangai Rajesh, 2005, Int J Gastrointest Cancer, V35, P53, DOI 10.1385/IJGC:35:1:053; Kannangai R, 2007, HUM PATHOL, V38, P639, DOI 10.1016/j.humpath.2006.07.019; Kaseb AO, 2013, ONCOLOGY-BASEL, V85, P197, DOI 10.1159/000354698; KESSLER SM, 2013, AM J PHYSIOL-GASTR L, V304, pG3280; Kidokoro T, 2008, ONCOGENE, V27, P1562, DOI 10.1038/sj.onc.1210799; Klein CA, 2009, NAT REV CANCER, V9, P302, DOI 10.1038/nrc2627; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Malouf GG, 2014, HEPATOLOGY, V59, P2228, DOI 10.1002/hep.27018; Marchio AS, 2000, ONCOGENE, V19, P3733, DOI 10.1038/sj.onc.1203713; Mayo SC, 2014, J AM COLL SURGEONS, V218, P196, DOI 10.1016/j.jamcollsurg.2013.10.011; Parra G, 2006, GENOME RES, V16, P37, DOI 10.1101/gr.4145906; Patt YZ, 2003, J CLIN ONCOL, V21, P421, DOI 10.1200/JCO.2003.10.103; Rapaport F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r95; Scian MJ, 2008, ONCOGENE, V27, P2583, DOI 10.1038/sj.onc.1210898; Stipa F, 2006, CANCER-AM CANCER SOC, V106, P1331, DOI 10.1002/cncr.21703; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taylor BS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003179; Torbenson M, 2004, AM J CLIN PATHOL, V122, P377, DOI 10.1309/YH0H3FKYM4RMU1JF; Trankenschuh W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013688; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Varemo L, 2013, NUCLEIC ACIDS RES, V41, P4378, DOI 10.1093/nar/gkt111; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Vivekanandan P, 2008, MODERN PATHOL, V21, P670, DOI 10.1038/modpathol.2008.32; Wang L, 2011, CELL PROLIFERAT, V44, P291, DOI 10.1111/j.1365-2184.2011.00752.x; Ward SC, 2010, MODERN PATHOL, V23, P1180, DOI 10.1038/modpathol.2010.105; Wilkens L, 2000, AM J CLIN PATHOL, V114, P867, DOI 10.1309/BMTT-JBPD-D13H-1UVD; Xu L, 2015, HUM MOL GENET, V24, P50, DOI 10.1093/hmg/ddu418; Zhou X, 2014, EURASIP J WIREL COMM, DOI 10.1186/1687-1499-2014-19	48	19	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0176562	10.1371/journal.pone.0176562	http://dx.doi.org/10.1371/journal.pone.0176562			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486549	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314000016
J	Wang, W; Zhang, TM; Wu, CY; Wang, SS; Wang, YX; Li, H; Wang, N				Wang, Wei; Zhang, Tianmu; Wu, Chunyan; Wang, Shanshan; Wang, Yuxiang; Li, Hui; Wang, Ning			Immortalization of chicken preadipocytes by retroviral transduction of chicken TERT and TR	PLOS ONE			English	Article							NORMAL HUMAN-CELLS; TELOMERASE ACTIVITY; ADIPOCYTE DIFFERENTIATION; SPECIES IDENTIFICATION; BROILER-CHICKENS; ADIPOSE-TISSUE; TUMOR-CELLS; AVIAN CELLS; LIFE-SPAN; IN-VITRO	The chicken is an important agricultural animal and model for developmental biology, immunology and virology. Excess fat accumulation continues to be a serious problem for the chicken industry. However, chicken adipogenesis and obesity have not been well investigated, because no chicken preadipocyte cell lines have been generated thus far. Here, we successfully generated two immortalized chicken preadipocyte cell lines through transduction of either chicken telomerase reverse transcriptase (chTERT) alone or in combination with chicken telomerase RNA (chTR). Both of these cell lines have survived >100 population doublings in vitro, display high telomerase activity and have no sign of replicative senescence. Similar to primary chicken preadipocytes, these two cell lines display a fibroblast-like morphology, retain the capacity to differentiate into adipocytes, and do not display any signs of malignant transformation. Isoenzyme analysis and PCR-based analysis confirmed that these two cell lines are of chicken origin and are free from inter-species contamination. To our knowledge, this is the first report demonstrating the generation of immortal chicken cells by introduction of chTERT and chTR. Our established chicken preadipocyte cell lines show great promise as an in vitro model for the investigation of chicken adipogenesis, lipid metabolism, and obesity and its related diseases, and our results also provide clues for immortalizing other avian cell types.	[Wang, Wei; Zhang, Tianmu; Wu, Chunyan; Wang, Shanshan; Wang, Yuxiang; Li, Hui; Wang, Ning] Minist Agr, Key Lab Chicken Genet & Breeding, Harbin, Peoples R China; [Wang, Wei; Zhang, Tianmu; Wu, Chunyan; Wang, Shanshan; Wang, Yuxiang; Li, Hui; Wang, Ning] Educ Dept Heilongjiang Prov, Key Lab Anim Genet Breeding & Reprod, Harbin, Peoples R China; [Wang, Wei; Zhang, Tianmu; Wu, Chunyan; Wang, Shanshan; Wang, Yuxiang; Li, Hui; Wang, Ning] Northeast Agr Univ, Coll Anim Sci & Technol, Harbin, Peoples R China	Ministry of Agriculture & Rural Affairs; Northeast Agricultural University - China	Li, H; Wang, N (corresponding author), Minist Agr, Key Lab Chicken Genet & Breeding, Harbin, Peoples R China.; Li, H; Wang, N (corresponding author), Educ Dept Heilongjiang Prov, Key Lab Anim Genet Breeding & Reprod, Harbin, Peoples R China.; Li, H; Wang, N (corresponding author), Northeast Agr Univ, Coll Anim Sci & Technol, Harbin, Peoples R China.	lihui@neau.edu.cn; wangning@neau.edu.cn			National High-tech R&D Program (863 Program) [2013AA102501]; National Natural Science Foundation of China [30972086]; National Basic Research Program of China (973 Program) [2009CB941604]; China Agricultural Research System [CARS-42]	National High-tech R&D Program (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); China Agricultural Research System	This work was supported by the National High-tech R&D Program (863 Program) (No. 2013AA102501), the National Natural Science Foundation of China (No. 30972086), the National Basic Research Program of China (973 Program) (No. 2009CB941604) and the China Agricultural Research System (No. CARS-42). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiba Y, 1999, BRIT POULTRY SCI, V40, P701, DOI 10.1080/00071669987124; BABA TW, 1985, VIROLOGY, V144, P139, DOI 10.1016/0042-6822(85)90312-5; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Cesare AJ, 2008, MECH AGEING DEV, V129, P99, DOI 10.1016/j.mad.2007.11.006; Chbab N, 2010, VET RES, V41, DOI 10.1051/vetres/2010026; Chen PL, 1996, GENE DEV, V10, P2794, DOI 10.1101/gad.10.21.2794; CHERINGTON V, 1988, MOL CELL BIOL, V8, P1380, DOI 10.1128/MCB.8.3.1380; Chiocca S, 1996, J VIROL, V70, P2939, DOI 10.1128/JVI.70.5.2939-2949.1996; Classon M, 2000, P NATL ACAD SCI USA, V97, P10826, DOI 10.1073/pnas.190343597; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; Coursen JD, 1997, EXP CELL RES, V235, P245, DOI 10.1006/excr.1997.3670; Darimont C, 2003, BIOCHIMIE, V85, P1231, DOI 10.1016/j.biochi.2003.10.015; Darimont C, 2003, CELL DEATH DIFFER, V10, P1025, DOI 10.1038/sj.cdd.4401273; Delany ME, 2004, GENE, V339, P61, DOI 10.1016/j.gene.2004.05.024; Duesberg P, 2000, CELL MOTIL CYTOSKEL, V47, P81; Dupont J, 2012, GEN COMP ENDOCR, V176, P86, DOI 10.1016/j.ygcen.2011.12.030; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; Fragnet L, 2005, J BIOL CHEM, V280, P23502, DOI 10.1074/jbc.M501163200; Freshney RI, 2005, CULTURE ANIMAL CELLS, p[270, 274, 292]; Gondret F, 2001, J LIPID RES, V42, P106; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; Guan LS, 2001, INT J CANCER, V93, P333, DOI 10.1002/ijc.1338; GUILHOT C, 1993, ONCOGENE, V8, P619; Hahn WC, 2002, MOL CELLS, V13, P351; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Ji B, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-441; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MARTIN GS, 1970, NATURE, V227, P1021, DOI 10.1038/2271021a0; Masters JR, 2001, P NATL ACAD SCI USA, V98, P8012, DOI 10.1073/pnas.121616198; Matsubara Y, 2005, COMP BIOCHEM PHYS A, V141, P108, DOI 10.1016/j.cbpb.2005.04.013; Matsubara Y, 2008, COMP BIOCHEM PHYS A, V151, P511, DOI 10.1016/j.cbpa.2008.07.002; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Meyerson M, 1998, TOXICOL LETT, V103, P41, DOI 10.1016/S0378-4274(98)00278-1; Michailidis G, 2005, BIOCHEM BIOPH RES CO, V335, P240, DOI 10.1016/j.bbrc.2005.07.058; Morales CP, 1999, NAT GENET, V21, P115, DOI 10.1038/5063; Na J, 2014, PROTEIN CELL, V5, P569, DOI 10.1007/s13238-014-0073-9; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Nims RW, 1998, IN VITRO CELL DEV-AN, V34, P35; O'Hare TH, 2011, CYTOGENET GENOME RES, V135, P65, DOI 10.1159/000330125; O'Hare TH, 2005, AGE, V27, P257, DOI 10.1007/s11357-005-4558-6; Ono K, 2007, IN VITRO CELL DEV-AN, V43, P168, DOI 10.1007/s11626-007-9033-5; ORFAO A, 1995, SCAND J CLIN LAB INV, V55, P145, DOI 10.3109/00365519509090577; Parodi B, 2002, BIOTECHNIQUES, V32, P432, DOI 10.2144/02322rr05; QURESHI MA, 1990, VET IMMUNOL IMMUNOP, V26, P237, DOI 10.1016/0165-2427(90)90094-9; SAKSELA E, 1963, P NATL ACAD SCI USA, V50, P390, DOI 10.1073/pnas.50.2.390; Seki Y, 2003, GEN COMP ENDOCR, V133, P80, DOI 10.1016/S0016-6480(03)00145-X; Shay JW, 2005, CARCINOGENESIS, V26, P867, DOI 10.1093/carcin/bgh296; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Shkreli M, 2007, J VIROL, V81, P4848, DOI 10.1128/JVI.02530-06; SIMON J, 1989, Critical Reviews in Poultry Biology, V2, P121; Steube KG, 2003, IN VITRO CELL DEV-AN, V39, P468; STYLES JA, 1977, BRIT J CANCER, V36, P558, DOI 10.1038/bjc.1977.231; Swanberg SE, 2003, CYTOGENET GENOME RES, V102, P318, DOI 10.1159/000075769; Swanberg SE, 2010, EXP GERONTOL, V45, P647, DOI 10.1016/j.exger.2010.04.002; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; Tchkonia T, 2006, DIABETES, V55, P2571, DOI 10.2337/db06-0540; Tokushima Y, 2003, BRIT POULTRY SCI, V44, P746, DOI 10.1080/00071660310001645758; TRAGANOS F, 1977, INT J CANCER, V20, P30, DOI 10.1002/ijc.2910200107; Trapp S, 2006, J EXP MED, V203, P1307, DOI 10.1084/jem.20052240; Vaziri H, 1998, CURR BIOL, V8, P279, DOI 10.1016/S0960-9822(98)70109-5; Vu BG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077988; Wang S, 2004, AM J CLIN PATHOL, V122, P774, DOI 10.1309/8B849FC6PHAP8FDD; Wong SCH, 2003, LIFE SCI, V73, P2749, DOI 10.1016/S0024-3205(03)00670-2; Xu YL, 2009, J EXP ZOOL PART B, V312B, P872, DOI 10.1002/jez.b.21302; Yang JW, 1999, J BIOL CHEM, V274, P26141, DOI 10.1074/jbc.274.37.26141	66	39	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177348	10.1371/journal.pone.0177348	http://dx.doi.org/10.1371/journal.pone.0177348			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486516	Green Submitted, Green Published, gold			2022-12-26	WOS:000401314000074
J	Jaramillo, E; Dugan, JE; Hubbard, DM; Contreras, H; Duarte, C; Acuna, E; Schoeman, DS				Jaramillo, Eduardo; Dugan, Jenifer E.; Hubbard, David M.; Contreras, Heraldo; Duarte, Cristian; Acuna, Emilio; Schoeman, David S.			Macroscale patterns in body size of intertidal crustaceans provide insights on climate change effects	PLOS ONE			English	Article							EMERITA-ANALOGA STIMPSON; EXPOSED SANDY BEACHES; LIFE-HISTORY; RANGE SHIFTS; EXCIROLANA-BRAZILIENSIS; LATITUDINAL VARIATION; GEOGRAPHIC-VARIATION; CHANGE IMPACTS; MARINE; RESPONSES	Predicting responses of coastal ecosystems to altered sea surface temperatures (SST) associated with global climate change, requires knowledge of demographic responses of individual species. Body size is an excellent metric because it scales strongly with growth and fecundity for many ectotherms. These attributes can underpin demographic as well as community and ecosystem level processes, providing valuable insights for responses of vulnerable coastal ecosystems to changing climate. We investigated contemporary macroscale patterns in body size among widely distributed crustaceans that comprise the majority of intertidal abundance and biomass of sandy beach ecosystems of the eastern Pacific coasts of Chile and California, USA. We focused on ecologically important species representing different tidal zones, trophic guilds and developmental modes, including a high-shore macroalga-consuming talitrid amphipod (Orchestoidea tuberculata), two mid-shore scavenging cirolanid isopods (Excirolana braziliensis and E. hirsuticauda), and a low-shore suspension-feeding hippid crab (Emerita analoga) with an amphitropical distribution. Significant latitudinal patterns in body sizes were observed for all species in Chile (21 degrees - 42 degrees S), with similar but steeper patterns in Emerita analoga, in California (32 degrees - 41 degrees N). Sea surface temperature was a strong predictor of body size (-4% to - 35% degrees C-1) in all species. Beach characteristics were subsidiary predictors of body size. Alterations in ocean temperatures of even a few degrees associated with global climate change are likely to affect body sizes of important intertidal ectotherms, with consequences for population demography, life history, community structure, trophic interactions, food-webs, and indirect effects such as ecosystem function. The consistency of results for body size and temperature across species with different life histories, feeding modes, ecological roles, and microhabitats inhabiting a single widespread coastal ecosystem, and for one species, across hemispheres in this space-for-time substitution, suggests predictions of ecosystem responses to thermal effects of climate change may potentially be generalised, with important implications for coastal conservation.	[Jaramillo, Eduardo; Acuna, Emilio] Univ Austral Chile, Inst Ciencias Tierra, Valdivia, Chile; [Dugan, Jenifer E.; Hubbard, David M.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; [Contreras, Heraldo] Inst Fomento Pesquero, Putemun, Chile; [Duarte, Cristian] Univ Andres Bello, Dept Ecol & Biodiversidad, Fac Ecol & Recursos Nat, Santiago, Chile; [Schoeman, David S.] Univ Sunshine Coast, Sch Sci & Engn, Sippy Downs, Qld, Australia; [Schoeman, David S.] Nelson Mandela Metropolitan Univ, Dept Zool, Ctr African Conservat Ecol, Port Elizabeth, South Africa	Universidad Austral de Chile; University of California System; University of California Santa Barbara; Instituto de Fomento Pesquero (Valparaiso); Universidad Andres Bello; University of the Sunshine Coast; Nelson Mandela University	Jaramillo, E (corresponding author), Univ Austral Chile, Inst Ciencias Tierra, Valdivia, Chile.	edojaramillo@gmail.com		Schoeman, David/0000-0003-1258-0885; Duarte, Cristian/0000-0002-7033-3551	CONICYT through Project FONDAP (Oceanografia AMP; Biologia Marina); Direccion de Investigacion y Desarrollo of Universidad Austral de Chile through a travel grant; Santa Barbara Coastal LTER - USA National Science Foundation [OCE-0620276, OCE-1232779]; Directorate For Geosciences [1232779] Funding Source: National Science Foundation	CONICYT through Project FONDAP (Oceanografia AMP; Biologia Marina); Direccion de Investigacion y Desarrollo of Universidad Austral de Chile through a travel grant; Santa Barbara Coastal LTER - USA National Science Foundation; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Financial support for field and laboratory work in Chile was provided by CONICYT through Project FONDAP (Oceanografia & Biologia Marina, Programa Mayor no 3). Financial support for analyses and manuscript preparation was provided by Direccion de Investigacion y Desarrollo of Universidad Austral de Chile through a travel grant (July 2009) to EJ and for JD by the Santa Barbara Coastal LTER funded by the USA National Science Foundation (Award #s OCE-0620276 and OCE1232779). The statements, findings, conclusions and recommendations are those of the authors and do not necessarily reflect the views of the National Science Foundation (USA).r The authors thank Marcia Gonzalez, Ana Maria Ojeda and Andrea Bollinger for their assistance during laboratory work and Pedro Rubilar for his helpful advice on the use and review of the outputs of the Akaike Information Criterion analyses. Financial support for field and laboratory work in Chile was provided by CONICYT through Project FONDAP (Oceanografia & Biologia Marina, Programa Mayor no 3). Financial support for analyses and manuscript preparation was provided by Direccion de Investigacion y Desarrollo of Universidad Austral de Chile through a travel grant (July 2009) to EJ and for JD by the Santa Barbara Coastal LTER funded by the USA National Science Foundation (Award #s OCE-0620276 and OCE-1232779). The statements, findings, conclusions and recommendations are those of the authors and do not necessarily reflect the views of the National Science Foundation (USA).	ANNALA JH, 1980, NEW ZEAL J MAR FRESH, V14, P217, DOI 10.1080/00288330.1980.9515864; [Anonymous], 1963, ANIMAL SPECIES EVOLU; Ashton KG, 2004, INTEGR COMP BIOL, V44, P403, DOI 10.1093/icb/44.6.403; ATKINSON D, 1994, ADV ECOL RES, V25, P1, DOI 10.1016/s0065-2504(08)60212-3; BAKUN A, 1990, SCIENCE, V247, P198, DOI 10.1126/science.247.4939.198; BASCOM W, 1964, WAVES BEACHES DYNAMI; Bates AE, 2014, GLOBAL ENVIRON CHANG, V26, P27, DOI 10.1016/j.gloenvcha.2014.03.009; Berke SK, 2013, GLOBAL ECOL BIOGEOGR, V22, P173, DOI 10.1111/j.1466-8238.2012.00775.x; Blackburn Tim M., 1999, Diversity and Distributions, V5, P165, DOI 10.1046/j.1472-4642.1999.00046.x; Burrows MT, 2014, NATURE, V507, P492, DOI 10.1038/nature12976; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Cardoso RS, 2004, ESTUAR COAST SHELF S, V61, P559, DOI 10.1016/j.ecss.2004.06.021; Celentano E, 2016, MAR ECOL PROG SER, V552, P211, DOI 10.3354/meps11768; Chapelle G, 1999, NATURE, V399, P114, DOI 10.1038/20099; Cheung WWL, 2013, NAT CLIM CHANGE, V3, P254, DOI 10.1038/NCLIMATE1691; Chown SL, 2010, BIOL REV, V85, P139, DOI 10.1111/j.1469-185X.2009.00097.x; Contreras H, 2003, ESTUAR COAST SHELF S, V58, P117, DOI 10.1016/S0272-7714(03)00046-5; Contreras H, 1999, ESTUAR COAST SHELF S, V48, P101, DOI 10.1006/ecss.1998.0396; Daufresne M, 2009, P NATL ACAD SCI USA, V106, P12788, DOI 10.1073/pnas.0902080106; DEMARCH BGE, 1978, CAN J ZOOL, V56, P1801, DOI 10.1139/z78-246; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Duarte C, 2010, HYDROBIOLOGIA, V651, P291, DOI 10.1007/s10750-010-0309-5; DUGAN JE, 1991, J EXP MAR BIOL ECOL, V150, P63, DOI 10.1016/0022-0981(91)90106-7; Dugan JE, 1996, REV CHIL HIST NAT, V69, P579; Dugan JE, 2003, ESTUAR COAST SHELF S, V58, P25, DOI 10.1016/S0272-7714(03)00045-3; DUGAN JE, 1994, J EXP MAR BIOL ECOL, V181, P255, DOI 10.1016/0022-0981(94)90132-5; Dugan JE, 1990, GEOGRAPHIC TEMPORAL; Dugan JE, 2013, GEOMORPHOLOGY, V199, P95, DOI 10.1016/j.geomorph.2013.04.043; Dugan JE, 2010, SCIENCE, V329, P1146, DOI 10.1126/science.329.5996.1146-a; Efford I.E, 1976, Crustaceana, V30, P169, DOI 10.1163/156854076X00558; EFFORD I E, 1970, Crustaceana (Leiden), V18, P293, DOI 10.1163/156854070X00248; EFFORD IE, 1965, J ANIM ECOL, V34, P63, DOI 10.2307/2369; Folk R. L, 1980, PETROLOGY SEDIMENTAR; Forster J, 2012, P NATL ACAD SCI USA, V109, P19310, DOI 10.1073/pnas.1210460109; FRANK PW, 1975, MAR BIOL, V31, P181, DOI 10.1007/BF00391630; Gardner JL, 2011, TRENDS ECOL EVOL, V26, P285, DOI 10.1016/j.tree.2011.03.005; Garzke J, 2015, OECOLOGIA, V177, P849, DOI 10.1007/s00442-014-3130-4; Gaston KJ, 2008, J BIOGEOGR, V35, P483, DOI 10.1111/j.1365-2699.2007.01772.x; GIBBS RJ, 1971, J SEDIMENT PETROL, V41, P7; Gillson L, 2013, TRENDS ECOL EVOL, V28, P135, DOI 10.1016/j.tree.2012.10.008; GLYNN PW, 1975, J ZOOL, V175, P509; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Hartnoll R.G., 1985, Crustacean Issues, V3, P101; Helmuth B, 2002, SCIENCE, V298, P1015, DOI 10.1126/science.1076814; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; JAMES FC, 1970, ECOLOGY, V51, P365, DOI 10.2307/1935374; Jansen JM, 2007, J EXP MAR BIOL ECOL, V344, P161, DOI 10.1016/j.jembe.2006.12.014; Jaramillo E, 2001, MAR ECOL-P S Z N I, V22, P323, DOI 10.1046/j.1439-0485.2001.01752.x; JARAMILLO E, 1993, ESTUAR COAST SHELF S, V37, P615, DOI 10.1006/ecss.1993.1077; JARAMILLO E, 1987, Vie et Milieu, V37, P165; Johnson MW, 1942, BIOL BULL-US, V83, P67, DOI 10.2307/1538014; JONES MB, 1983, B MAR SCI, V33, P656; Kelley AL, 2015, MAR BIOL, V162, P1625, DOI 10.1007/s00227-015-2698-5; La Sorte FA, 2007, ECOLOGY, V88, P1803, DOI 10.1890/06-1072.1; Lastra M, 2008, MAR BIOL, V154, P163, DOI 10.1007/s00227-008-0913-3; Lester RE, 2014, GLOBAL CHANGE BIOL, V20, P3471, DOI 10.1111/gcb.12634; Lima F. P., 2012, NATURE COMMUNICATION, V3; Loeb V, 1997, NATURE, V387, P897, DOI 10.1038/43174; Manyak-Davis A, 2013, AM NAT, V182, P347, DOI 10.1086/671170; MARINCOVICH L, 1973, INTERTIDAL MOLLUSKS; Meiri S, 2003, J BIOGEOGR, V30, P331, DOI 10.1046/j.1365-2699.2003.00837.x; Meiri S, 2009, GLOBAL ECOL BIOGEOGR, V18, P240, DOI 10.1111/j.1466-8238.2008.00437.x; Millien V, 2006, ECOL LETT, V9, P853, DOI 10.1111/j.1461-0248.2006.00928.x; Molinos JG, 2016, NAT CLIM CHANGE, V6, P83, DOI [10.1038/NCLIMATE2769, 10.1038/nclimate2769]; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Osorio C, 1971, B MUS NAC HIST NAT S, V29, P61; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Parmesan C, 2013, ECOL LETT, V16, P58, DOI 10.1111/ele.12098; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; PICKETT S T A, 1989, P110; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Poloczanska ES, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00062; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/nclimate1958, 10.1038/NCLIMATE1958]; R Core Team, 2021, R LANGUAGE ENV STAT; RAY CARLETON, 1960, JOUR MORPHOL, V106, P85, DOI 10.1002/jmor.1051060104; Reynolds RW, 2002, IMPROVED IN SITU SAT; Roy K, 2003, ECOL LETT, V6, P205, DOI 10.1046/j.1461-0248.2003.00419.x; Schlacher TA, 2007, DIVERS DISTRIB, V13, P556, DOI 10.1111/j.1472-4642.2007.00363.x; Schoeman DS, 2014, GLOBAL CHANGE BIOL, V20, P2383, DOI 10.1111/gcb.12505; SEWARDTHOMPSON BL, 1973, SEDIMENTOLOGY, V20, P161, DOI 10.1111/j.1365-3091.1973.tb01612.x; Sheridan JA, 2011, NAT CLIM CHANGE, V1, P401, DOI 10.1038/NCLIMATE1259; Short A.D., 1983, SANDY BEACHES ECOSYS, P133, DOI DOI 10.1007/978-94-017-2938-3_8; Strickland J.D.H., 1972, PRACT HDB SEAWATER A, V167, P185; Sunday JM, 2015, ECOL LETT, V18, P944, DOI 10.1111/ele.12474; Sydeman WJ, 2014, SCIENCE, V345, P77, DOI [10.1126/science.1251635, 10.1126/science.1250830]; Thomas AC, 2001, GEOPHYS RES LETT, V28, P3421, DOI 10.1029/2001GL013368; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Tomasovych A, 2015, GLOBAL ECOL BIOGEOGR, V24, P157, DOI 10.1111/geb.12242; VALENTINE JW, 1966, LIMNOL OCEANOGR, V11, P198, DOI 10.4319/lo.1966.11.2.0198; Varela AI, 2012, REV CHIL HIST NAT, V85, P495, DOI 10.4067/S0716-078X2012000400011; Walther GR, 2010, PHILOS T R SOC B, V365, P2019, DOI 10.1098/rstb.2010.0021; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Weber MJ, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00435.1; WEINBERG JR, 1989, MAR BIOL, V103, P143, DOI 10.1007/BF00543341; WENNER AM, 1987, BIOL BULL, V172, P225, DOI 10.2307/1541795; Wethey DS, 2008, HYDROBIOLOGIA, V606, P139, DOI 10.1007/s10750-008-9338-8; Weymouth FW, 1931, J EXP BIOL, V8, P228; Yvon-Durocher G, 2011, GLOBAL CHANGE BIOL, V17, P1681, DOI 10.1111/j.1365-2486.2010.02321.x	98	14	14	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177116	10.1371/journal.pone.0177116	http://dx.doi.org/10.1371/journal.pone.0177116			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481897	gold, Green Published			2022-12-26	WOS:000401313700035
J	Qiu, ZW; Zhou, JS; Liu, F; Qin, XJ; Dai, YR; Ke, YH; Chen, ZH; Li, W; Ying, SM; Shen, HH				Qiu, Zhangwei; Zhou, Jiesen; Liu, Fang; Qin, Xuejun; Dai, Yuanrong; Ke, Yuehai; Chen, Zhihua; Li, Wen; Ying, Songmin; Shen, Huahao			Deletion of Shp2 in bronchial epithelial cells impairs IL-25 production in vitro, but has minor influence on asthmatic inflammation in vivo	PLOS ONE			English	Article							IMMUNE-RESPONSES; T-CELLS; KAPPA-B; PROTEIN; INTERLEUKIN-25; ACTIVATION; FAMILY; GAB1; PATHOLOGIES; CYTOKINES	Shp2 played an important role in cigarette-smoke-mediated inflammation, surfactant homeostasis and asthmatic airway remodeling. However, whether shp2 plays a key role in epithelium-associated allergic reaction is still unknown. In this study, LPS and OVA were observed to induce the production of IL-25 in bronchial epithelial cells in vitro via the activation of MAPK p38 and JNK. Furthermore, blockage of Shp2 by its specific inhibitor PHPS1 or by siRNA-mediated depletion was found to reduce the production of IL-25 in epithelial cells as well as the up-regulated LPS-triggered activation of JNK but not p38. To confirm the role of intra-bronchial epithelial Shp2 in OVA-induced allergic reaction, we generated CC10-rtTA/(tetO)7-Cre/Shp2(f/f) mice, where Shp2 was conditionally knocked out in bronchial epithelial cells. Surprisingly, specific deletion of Shp2 in bronchial epithelial cells showed a mild but insignificant effect on the expressions of epithelium-derived cytokines as well as TH2 and TH17 polarization following allergen-induced murine airway inflammation. Collectively, our data suggested that deletion of Shp2 impaired IL-25 production in bronchial epithelial cells in vitro, but might yet have minor influence on OVA-induced allergic reaction in vivo.	[Qiu, Zhangwei; Zhou, Jiesen; Liu, Fang; Qin, Xuejun; Chen, Zhihua; Li, Wen; Ying, Songmin; Shen, Huahao] Zhejiang Univ, Sch Med, Dept Resp & Crit Care Med, Affiliated Hosp 2, Hangzhou, Zhejiang, Peoples R China; [Qiu, Zhangwei; Dai, Yuanrong] Wenzhou Med Univ, Dept Pulm Med, Affiliated Hosp 2, Wenzhou, Zhejiang, Peoples R China; [Qiu, Zhangwei; Dai, Yuanrong] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Zhejiang, Peoples R China; [Ke, Yuehai] Zhejiang Univ, Sch Med, Dept Pathol & Pathophysiol, Program Mol Cell Biol, Hangzhou, Zhejiang, Peoples R China; [Ke, Yuehai] Zhejiang Univ, Sch Med, Inst Resp Dis, Hangzhou, Zhejiang, Peoples R China; [Shen, Huahao] State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China	Zhejiang University; Wenzhou Medical University; Wenzhou Medical University; Zhejiang University; Zhejiang University; State Key Laboratory of Respiratory Disease	Shen, HH (corresponding author), Zhejiang Univ, Sch Med, Dept Resp & Crit Care Med, Affiliated Hosp 2, Hangzhou, Zhejiang, Peoples R China.; Shen, HH (corresponding author), State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.	huahaoshen@163.com		Dai, Yuanrong/0000-0002-7146-3374	National Basic Research Program of China (973 Program) [2009CB522103]	National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the National Basic Research Program of China (973 Program) grant 2009CB522103. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agazie YM, 2003, MOL CELL BIOL, V23, P7875, DOI 10.1128/MCB.23.21.7875-7886.2003; Aggarwal K, 2008, BMB REP, V41, P267, DOI 10.5483/BMBRep.2008.41.4.267; Angkasekwinai P, 2007, J EXP MED, V204, P1509, DOI 10.1084/jem.20061675; Bard-Chapeau EA, 2006, MOL CELL BIOL, V26, P4664, DOI 10.1128/MCB.02253-05; Bartemes KR, 2012, CLIN IMMUNOL, V143, P222, DOI 10.1016/j.clim.2012.03.001; Ben S, 2008, ALLERGY, V63, P1164, DOI 10.1111/j.1398-9995.2008.01747.x; Caramori G, 2001, EUR RESPIR J, V18, P466, DOI 10.1183/09031936.01.00040701; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Georgel P, 2001, DEV CELL, V1, P503, DOI 10.1016/S1534-5807(01)00059-4; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hanada M, 2001, J BIOL CHEM, V276, P5753, DOI 10.1074/jbc.M007773200; Hurst SD, 2002, J IMMUNOL, V169, P443, DOI 10.4049/jimmunol.169.1.443; Ikeda K, 2003, BLOOD, V101, P3594, DOI 10.1182/blood-2002-09-2817; Kajino T, 2006, J BIOL CHEM, V281, P39891, DOI 10.1074/jbc.M608155200; Kang CM, 2005, AM J RESP CELL MOL, V33, P290, DOI 10.1165/rcmb.2005-0003OC; Kleinschek MA, 2007, J EXP MED, V204, P161, DOI 10.1084/jem.20061738; Lam HC, 2011, JOVE-J VIS EXP, DOI 10.3791/2513; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Li FF, 2012, J IMMUNOL, V189, P3159, DOI 10.4049/jimmunol.1200197; Li MG, 2003, J BIOL CHEM, V278, P12013, DOI 10.1074/jbc.M211474200; Montagner A, 2005, J BIOL CHEM, V280, P5350, DOI 10.1074/jbc.M410012200; Morimoto M, 2009, DEV BIOL, V325, P171, DOI 10.1016/j.ydbio.2008.10.013; Murai H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030280; Owyang AM, 2006, J EXP MED, V203, P843, DOI 10.1084/jem.20051496; Qin XJ, 2012, ALLERGY, V67, P1547, DOI 10.1111/all.12048; Ren Y, 2004, J BIOL CHEM, V279, P8497, DOI 10.1074/jbc.M312575200; Saenz SA, 2008, IMMUNOL REV, V226, P172, DOI 10.1111/j.1600-065X.2008.00713.x; Shen HHH, 2003, J IMMUNOL, V170, P3296, DOI 10.4049/jimmunol.170.6.3296; Silverman N, 2003, J BIOL CHEM, V278, P48928, DOI 10.1074/jbc.M304802200; Suzukawa M, 2012, J IMMUNOL, V189, P3641, DOI 10.4049/jimmunol.1200461; Tamachi T, 2006, J ALLERGY CLIN IMMUN, V118, P606, DOI 10.1016/j.jaci.2006.04.051; Ulevitch RJ, 1999, CURR OPIN IMMUNOL, V11, P19, DOI 10.1016/S0952-7915(99)80004-1; Vidal S, 2001, GENE DEV, V15, P1900, DOI 10.1101/gad.203301; Wang YH, 2007, J EXP MED, V204, P1837, DOI 10.1084/jem.20070406; Wang YH, 2006, IMMUNITY, V24, P827, DOI 10.1016/j.immuni.2006.03.019; Xia LX, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.74; Xu D, 2008, FRONT BIOSCI-LANDMRK, V13, P4925, DOI 10.2741/3051; Yu LY, 2009, J BIOL CHEM, V284, P13481, DOI 10.1074/jbc.M809740200; Zhang EE, 2004, P NATL ACAD SCI USA, V101, P16064, DOI 10.1073/pnas.0405041101; Zhang SQ, 2004, MOL CELL, V13, P341, DOI 10.1016/S1097-2765(04)00050-4; Zhang X, 2012, FASEB J, V26, P2338, DOI 10.1096/fj.11-200139	42	3	3	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177334	10.1371/journal.pone.0177334	http://dx.doi.org/10.1371/journal.pone.0177334			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481957	Green Published, Green Submitted, gold			2022-12-26	WOS:000401313700053
J	Rehan, W; Antfolk, J; Johansson, A; Jern, P; Santtila, P				Rehan, Wail; Antfolk, Jan; Johansson, Ada; Jern, Patrick; Santtila, Pekka			Experiences of severe childhood maltreatment, depression, anxiety and alcohol abuse among adults in Finland	PLOS ONE			English	Article							SEXUAL-ABUSE; SUBSTANCE USE; EMOTIONAL MALTREATMENT; GENDER-DIFFERENCES; PHYSICAL ABUSE; RISK-FACTORS; PSYCHOPATHOLOGY; ASSOCIATIONS; TRAUMA; HOPELESSNESS	Childhood maltreatment increases the risk of subsequent depression, anxiety and alcohol abuse, but the rate of resilient victims is unknown. Here, we investigated the rate of victims that do not suffer from clinical levels of these problems after severe maltreatment in a population-based sample of 10980 adult participants. Compared to men, women reported more severe emotional and sexual abuse, as well as more severe emotional neglect. For both genders, severe emotional abuse (OR = 3.80 [2.22, 6.52]); severe physical abuse (OR = 3.97 [1.72, 9.16]); severe emotional neglect (OR = 3.36 [1.73, 6.54]); and severe physical neglect (OR = 11.90 [2.66, 53.22]) were associated with depression and anxiety while only severe physical abuse (OR = 3.40 [1.28, 9.03]) was associated with alcohol abuse. Looking at men and women separately, severe emotional abuse (OR = 6.05 [1.62, 22.60] in men; OR = 3.74 [2.06, 6.81] in women) and severe physical abuse (OR = 6.05 [1.62, 22.60] in men; OR = 3.03 [0.99, 9.33] in women) were associated with clinical levels of depression and anxiety. In addition, in women, severe sexual abuse (OR = 2.40 [1.10, 5.21]), emotional neglect (OR = 4.78 [2.40, 9.56]), and severe physical neglect (OR = 9.86 [1.99, 48.93]) were associated with clinical levels of depression and anxiety. Severe emotional abuse in men (OR = 3.86 [0.96, 15.48]) and severe physical abuse in women (OR = 5.18 [1.48, 18.12]) were associated with alcohol abuse. Concerning resilience, the majority of severely maltreated participants did not report clinically significant levels of depression or anxiety (72%), or alcohol abuse (93%) in adulthood. Although the majority of severely abused or neglected individuals did not show clinical levels of depression, anxiety or alcohol use, severe childhood maltreatment increased the risk for showing clinical levels of psychopathology in adulthood.	[Rehan, Wail; Antfolk, Jan; Johansson, Ada; Jern, Patrick; Santtila, Pekka] Abo Akad Univ, Dept Psychol, Turku, Finland; [Johansson, Ada; Jern, Patrick] Univ Turku, Dept Psychol & Speech Language Pathol, Turku, Finland	Abo Akademi University; University of Turku	Rehan, W (corresponding author), Abo Akad Univ, Dept Psychol, Turku, Finland.	wailabdulmalik.rehan@abo.fi	Antfolk, Jan/D-2926-2018	Antfolk, Jan/0000-0003-0334-4987; Johansson, Ada/0000-0003-1853-6981	Academy of Finland [210298]; Center of Excellence grant from the Stiftelsen for Abo Akademi Foundation [21/22/05]	Academy of Finland(Academy of Finland); Center of Excellence grant from the Stiftelsen for Abo Akademi Foundation	This research was supported by the Academy of Finland Grant No. 210298, a Center of Excellence grant from the Stiftelsen for Abo Akademi Foundation Grant No. 21/22/05.	Albrecht A., 2014, J SOCIAL SCI RES, V6, P915, DOI 10.24297/jssr.v6i1.3453; Amado BG, 2015, PSYCHOSOC INTERV, V24, P49, DOI 10.1016/j.psi.2015.03.002; Babar T. F., 2001, ALCOHOL USE DISORDER; Bensley LS, 2000, AM J PREV MED, V18, P151, DOI 10.1016/S0749-3797(99)00084-7; Bernstein DP, 1997, J AM ACAD CHILD PSY, V36, P340, DOI 10.1097/00004583-199703000-00012; Bernstein DP, 1998, CHILDHOOD TRAUMA QUE; Bifulco A, 2002, B MENNINGER CLIN, V66, P241, DOI 10.1521/bumc.66.3.241.23366; Bulik CM, 2001, BRIT J PSYCHIAT, V179, P444, DOI 10.1192/bjp.179.5.444; Truffino JC, 2010, REV PSIQUIATR SALUD, V3, P145, DOI 10.1016/j.rpsm.2010.09.003; Collishaw S, 2007, CHILD ABUSE NEGLECT, V31, P211, DOI 10.1016/j.chiabu.2007.02.004; Davydov DM, 2010, CLIN PSYCHOL REV, V30, P479, DOI 10.1016/j.cpr.2010.03.003; Derogatis, 2001, BRIEF SYMPTOM INVENT; Dube S. R., 2006, Journal of Adolescent Health, V38, DOI 10.1016/j.jadohealth.2005.06.006; Evans SE, 2013, CHILD ABUSE NEGLECT, V37, P934, DOI 10.1016/j.chiabu.2013.03.005; Gamble SA, 2006, J NERV MENT DIS, V194, P382, DOI 10.1097/01.nmd.0000218058.96252.ac; Gibb BE, 2003, DEPRESS ANXIETY, V17, P226, DOI 10.1002/da.10111; Gibb BE, 2007, DEPRESS ANXIETY, V24, P256, DOI 10.1002/da.20238; Glover DA, 2010, J TRAUMA DISSOCIATIO, V11, P152, DOI 10.1080/15299730903502920; Haatainen KM, 2003, SOC PSYCH PSYCH EPID, V38, P12, DOI 10.1007/s00127-003-0598-3; Hamilton JL, 2013, J CLIN CHILD ADOLESC, V42, P332, DOI 10.1080/15374416.2013.777916; Harbin SJ, 2016, J GRADUATE RES CREAT, V8, P1; Higgins DJ, 2001, AGGRESS VIOLENT BEH, V6, P547, DOI 10.1016/S1359-1789(00)00030-6; Hussey JM, 2006, PEDIATRICS, V118, P933, DOI 10.1542/peds.2005-2452; Hyman SM, 2008, DRUG ALCOHOL DEPEN, V92, P208, DOI 10.1016/j.drugalcdep.2007.08.006; Jaffee SR, 2007, CHILD ABUSE NEGLECT, V31, P231, DOI 10.1016/j.chiabu.2006.03.011; Johansson A, 2013, TWIN RES HUM GENET, V16, P150, DOI 10.1017/thg.2012.108; Kendler KS, 2000, ARCH GEN PSYCHIAT, V57, P953, DOI 10.1001/archpsyc.57.10.953; Klika JB, 2013, TRAUMA VIOLENCE ABUS, V14, P222, DOI 10.1177/1524838013487808; Laaksonen T, 2011, CHILD ABUSE NEGLECT, V35, P480, DOI 10.1016/j.chiabu.2011.03.004; Liu RT, 2012, CHILD ABUSE NEGLECT, V36, P323, DOI 10.1016/j.chiabu.2011.11.007; MacMillan HL, 2001, AM J PSYCHIAT, V158, P1878, DOI 10.1176/appi.ajp.158.11.1878; Magnusson A, 2012, PSYCHOL MED, V2, P381; McLaughlin KA, 2010, PSYCHOL MED, V40, P847, DOI 10.1017/S0033291709991115; Moran PB, 2004, CHILD ABUSE NEGLECT, V28, P565, DOI 10.1016/j.chiabu.2003.12.002; Norman RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001349; Radford L., 2011, CHILD ABUSE NEGLECT; Rehan W, 2015, NORD PSYCHOL, V67, P301, DOI 10.1080/19012276.2015.1026922; Rothman EF, 2008, PEDIATRICS, V122, pE298, DOI 10.1542/peds.2007-3412; Sartor CE, 2008, J STUD ALCOHOL DRUGS, V69, P718, DOI 10.15288/jsad.2008.69.718; Schwandt ML, 2013, ALCOHOL CLIN EXP RES, V37, P984, DOI 10.1111/acer.12053; Shin SH, 2009, ADDICT BEHAV, V34, P277, DOI 10.1016/j.addbeh.2008.10.023; Spinhoven P, 2010, J AFFECT DISORDERS, V126, P103, DOI 10.1016/j.jad.2010.02.132; Teicher MH, 2006, AM J PSYCHIAT, V163, P993, DOI 10.1176/appi.ajp.163.6.993; Teicher MH, 2013, AM J PSYCHIAT, V170, P1114, DOI 10.1176/appi.ajp.2013.12070957; Thompson MP, 2004, AM J PUBLIC HEALTH, V94, P599, DOI 10.2105/AJPH.94.4.599; Wright MO, 2009, CHILD ABUSE NEGLECT, V33, P59, DOI 10.1016/j.chiabu.2008.12.007; Young-Wolff KC, 2011, PSYCHOL MED, V41, P59, DOI 10.1017/S0033291710000425	47	61	62	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177252	10.1371/journal.pone.0177252	http://dx.doi.org/10.1371/journal.pone.0177252			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UJ	28481912	gold, Green Published, Green Submitted			2022-12-26	WOS:000401313700043
J	Muppala, S; Xiao, R; Krukovets, I; Verbovetsky, D; Yendamuri, R; Habib, N; Raman, P; Plow, E; Stenina-Adognravi, O				Muppala, S.; Xiao, R.; Krukovets, I.; Verbovetsky, D.; Yendamuri, R.; Habib, N.; Raman, P.; Plow, E.; Stenina-Adognravi, O.			Thrombospondin-4 mediates TGF-beta-induced angiogenesis	ONCOGENE			English	Article							GROWTH-FACTOR-BETA; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; BREAST-CANCER; FIBROSIS; PATHWAY; TARGET; PROTEINS; CELLS	TGF-beta is a multifunctional cytokine affecting many cell types and implicated in tissue remodeling processes. Due to its many functions and cell-specific effects, the consequences of TGF-beta signaling are process-and stage-dependent, and it is not uncommon that TGF-beta exerts distinct and sometimes opposing effects on a disease progression depending on the stage and on the pathological changes associated with the stage. The mechanisms underlying cell-and process-specific effects of TGF-beta are poorly understood. We are describing a novel pathway that mediates induction of angiogenesis in response to TGF-beta 1. We found that in endothelial cells (EC) thrombospondin-4 (TSP-4), a secreted extracellular matrix (ECM) protein, is upregulated in response to TGF-beta 1 and mediates the effects of TGF-beta 1 on angiogenesis. Upregulation of TSP-4 does not require the synthesis of new protein, is not caused by decreased secretion of TSP-4, and is mediated by activation of SMAD3. Using Thbs4(-/-) mice and TSP-4 shRNA, we found that TSP-4 mediated pro-angiogenic functions in cultured EC and angiogenesis in vivo in response to TGF-beta 1. We observed similar to 3-fold increases in tumor mass and levels of angiogenesis markers in animals injected with TGF-beta 1, and these effects did not occur in Thbs4(-/-) animals. Injections of an inhibitor of TGF-beta 1 signaling SB-431542 also decreased the weights of tumors and cancer angiogenesis. Our results from in vivo angiogenesis models and cultured EC document that TSP-4 mediates upregulation of angiogenesis by TGF-beta 1. Upregulation of pro-angiogenic TSP-4 and selective effects of TSP-4 on EC may contribute to stimulation of tumor growth by TGF-beta despite the inhibition of cancer cell proliferation.	[Muppala, S.; Xiao, R.; Krukovets, I.; Verbovetsky, D.; Yendamuri, R.; Habib, N.; Plow, E.; Stenina-Adognravi, O.] Cleveland Clin, Dept Mol Cardiol, 9500 Euclid Ave NB50-66, Cleveland, OH 44195 USA; [Raman, P.] North Ohio Med Univ, Dept Integrat Med Sci, Rootstown, OH USA	Cleveland Clinic Foundation; Northeast Ohio Medical University (NEOMED)	Stenina-Adognravi, O (corresponding author), Cleveland Clin, Dept Mol Cardiol, 9500 Euclid Ave NB50-66, Cleveland, OH 44195 USA.	stenino@ccf.org	Xiao, Roy/AAZ-1915-2020; muppala, santoshi/AAK-2385-2020; Santoo/B-2423-2018; Muppala, Santoshi/K-6910-2019	Santoo/0000-0001-7830-9591; Muppala, Santoshi/0000-0001-7830-9591; Xiao, Roy/0000-0003-4459-0746	NIH [R01HL117216, CA177771]; National Center for Advancing Translational Sciences component of the National Institutes of Health [UL1TR000439]; National Institutes of Health Roadmap for Medical Research; NATIONAL CANCER INSTITUTE [R01CA177771] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117216] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences component of the National Institutes of Health; National Institutes of Health Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH R01HL117216 (OS-A and EP) and NIH CA177771 (OS-A). Isolation of HUVECs was supported by UL1TR000439. HUVECs were provided by a grant awarded to Clinical and Translational Science Collaborative of Cleveland, a grant from the National Center for Advancing Translational Sciences (UL1TR000439) component of the National Institutes of Health, and National Institutes of Health Roadmap for Medical Research.	Araujo-Jorge TC, 2012, CLIN PHARMACOL THER, V92, P613, DOI 10.1038/clpt.2012.102; Bhattacharyya S, 2008, J BIOL CHEM, V283, P5699, DOI 10.1074/jbc.M706435200; Bhattacharyya S, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.005967; Blahna MT, 2012, FEBS LETT, V586, P1906, DOI 10.1016/j.febslet.2012.01.041; Blanco FF, 2014, MOL CELL BIOL, V34, P180, DOI 10.1128/MCB.01020-13; Cho JY, 2011, CLIN CANCER RES, V17, P1850, DOI 10.1158/1078-0432.CCR-10-2180; Chou YT, 2006, J BIOL CHEM, V281, P18451, DOI 10.1074/jbc.M601720200; Cingolani OH, 2011, CIRC RES, V109, P1410, DOI 10.1161/CIRCRESAHA.111.256743; Congote LF, 2004, BIOCHEM BIOPH RES CO, V324, P673, DOI 10.1016/j.bbrc.2004.09.107; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; D'Errico M, 2009, EUR J CANCER, V45, P461, DOI 10.1016/j.ejca.2008.10.032; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Dietz HC, 2010, J CLIN INVEST, V120, P403, DOI 10.1172/JCI42014; Eming SA, 2011, EXP DERMATOL, V20, P605, DOI 10.1111/j.1600-0625.2011.01309.x; Fernandez Isis E, 2012, Proc Am Thorac Soc, V9, P111, DOI 10.1513/pats.201203-023AW; Frolova EG, 2012, FASEB J, V26, P2363, DOI 10.1096/fj.11-190728; Frolova EG, 2010, CIRC RES, V107, P1313, DOI 10.1161/CIRCRESAHA.110.232371; Garcia R, 2015, BBA-MOL BASIS DIS, V1852, P1520, DOI 10.1016/j.bbadis.2015.04.006; Hoover LL, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.146pe48; Hubmacher D, 2013, CURR OPIN RHEUMATOL, V25, P65, DOI 10.1097/BOR.0b013e32835b137b; James D, 2010, NAT BIOTECHNOL, V28, P161, DOI 10.1038/nbt.1605; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Joseph JV, 2013, BIOCHEM PHARMACOL, V85, P478, DOI 10.1016/j.bcp.2012.11.005; Katz LH, 2013, EXPERT OPIN THER TAR, V17, P743, DOI 10.1517/14728222.2013.782287; Kostourou V, 2014, BBA-GEN SUBJECTS, V1840, P2403, DOI 10.1016/j.bbagen.2014.02.018; Krishnan S, 2015, ONCOTARGET, V6, P22480, DOI 10.18632/oncotarget.4310; Lan HY, 2012, SEMIN NEPHROL, V32, P236, DOI 10.1016/j.semnephrol.2012.04.002; Loeys BL, 2013, PEDIATR ENDOCR REV P, V10, P417; Lu XS, 2008, BREAST CANCER RES TR, V108, P191, DOI 10.1007/s10549-007-9596-6; Lynch JM, 2012, CELL, V149, P1257, DOI 10.1016/j.cell.2012.03.050; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; Mahabeleshwar Ganapati H., 2006, V129, P197; Muppala S, 2015, ARTERIOSCL THROM VAS, V35, P1975, DOI 10.1161/ATVBAHA.115.305912; Mustonen E, 2012, ANN MED, V44, P793, DOI 10.3109/07853890.2011.614635; Perrot CY, 2013, PHARMACOL THERAPEUT, V137, P183, DOI 10.1016/j.pharmthera.2012.10.002; Petroll WM, 1998, INVEST OPHTH VIS SCI, V39, P2018; Prendes MA, 2013, BRIT J OPHTHALMOL, V97, P680, DOI 10.1136/bjophthalmol-2011-301132; Samarakoon R, 2013, CELL SIGNAL, V25, P264, DOI 10.1016/j.cellsig.2012.10.003; Senger DR, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005090; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Soloviev Dmitry A., 2006, V129, P267; Stenina OI, 2003, CIRCULATION, V108, P1514, DOI 10.1161/01.CIR.0000089085.76320.4E; Toma I, 2012, CELL TISSUE RES, V347, P155, DOI 10.1007/s00441-011-1189-3; Verrecchia F, 2002, J INVEST DERMATOL, V118, P211, DOI 10.1046/j.1523-1747.2002.01641.x; Weiss A, 2013, WIRES DEV BIOL, V2, P47, DOI 10.1002/wdev.86; Yanagita M, 2012, NEPHROL DIAL TRANSPL, V27, P3686, DOI 10.1093/ndt/gfs381; Yang SNY, 2010, J DIABETES, V2, P233, DOI 10.1111/j.1753-0407.2010.00089.x; Yang Y, 2009, J CELL BIOCHEM, V106, P1102, DOI 10.1002/jcb.22100; Yokoyama H, 1996, DIABETIC MED, V13, P313, DOI 10.1002/(SICI)1096-9136(199604)13:4<313::AID-DIA56>3.3.CO;2-Z	49	72	77	0	18	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 7	2017	36	36					5189	5198		10.1038/onc.2017.140	http://dx.doi.org/10.1038/onc.2017.140			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FF9XD	28481870	Green Accepted			2022-12-26	WOS:000409371100010
J	Han, CX; Li, F; Ma, J; Liu, Y; Li, WH; Mao, YQ; Song, YH; Guo, SY; Liu, J				Han, Chenxia; Li, Feng; Ma, Jie; Liu, Yan; Li, Weihong; Mao, Yingqiu; Song, Yuehan; Guo, Siyuan; Liu, Jing			Distinct behavioral and brain changes after different durations of the modified multiple platform method on rats: An animal model of central fatigue	PLOS ONE			English	Article							PARADOXICAL SLEEP-DEPRIVATION; ANXIETY-LIKE BEHAVIOR; LONG-TERM-MEMORY; NMDA RECEPTOR; PLUS-MAZE; HIPPOCAMPUS; MICE; CORTICOSTERONE; DEPRESSION; INTERFERENCE	The modified multiple platform method (MMPM) is a classical sleep deprivation model. It has been widely used in behavioral and brain research, due to its effects on physical and mental functions. However, different MMPM protocols can promote distinct effects in rats. Although the MMPM has been proved to induce central fatigue, the effects of different durations of subjection to the MMPM remain undetermined. This study aims to investigate the changes in behavior, N-Methyl-d-Aspartate receptor 1 (NR1) and 2A (NR2A), as well as the ultrastructural alteration in the hippocampus after different MMPM modelling, to compare the central fatigue effect induced by dynamic MMPM. Rats were randomly divided into four groups: 5-, 14- and 21-day MMPM groups, and a control group. Each MMPM group underwent a 14- hour daily MMPM modelling. After each training session, open field and elevated plus maze tests were performed. Corticosterone levels were detected by ELISA, and the hippocampal NR1 and NR2A were measured by RT-PCR and Western blot analysis. In addition, ultrastructural changes in the hippocampal cornu ammonis 1(CA1) region were determined by transmission electron microscopy (TEM). The findings showed that the 5 and 14 days of MMPM induced a high-stress state, while the 21 days of MMPM induced anxiety and degenerative alteration in the hippocampal morphology. Additionally, hippocampal NR1 and NR2A gene expression decreased in all MMPM groups, whereas the protein expression only decreased in the 21-day group. Overall, different durations of MMPM caused distinct behavioral and brain changes, and the 21 days of MMPM could induce central fatigue.	[Han, Chenxia; Li, Feng; Ma, Jie; Liu, Yan; Li, Weihong; Song, Yuehan; Guo, Siyuan; Liu, Jing] Beijing Univ Chinese Med, Basic Med Sch, Beijing, Peoples R China; [Mao, Yingqiu] Beijing Univ Chinese Med, Sci Res Ctr Chinese Med, Beijing, Peoples R China; [Guo, Siyuan] Xuanwu Hosp, Directors Off, Beijing, Peoples R China; [Liu, Jing] Xinyuanjinfang Tradit Chinese Med Hosp, Tradit Chinese Med Dept, Beijing, Peoples R China	Beijing University of Chinese Medicine; Beijing University of Chinese Medicine; Capital Medical University	Li, F (corresponding author), Beijing Univ Chinese Med, Basic Med Sch, Beijing, Peoples R China.	lifeng_bucm0610@126.com	HAN, CHENXIA/AAR-1919-2021	HAN, CHENXIA/0000-0003-1727-7236	Beijing University of Chinese Medicine: ''Nautical Traditional Chinese Medicine'' Collaborative Innovation Center [522/0100604299]; Beijing Natural Science Foundation: ''Mechanism research of intervention effect of ''Sini-Suanzaoren'' [7162124]	Beijing University of Chinese Medicine: ''Nautical Traditional Chinese Medicine'' Collaborative Innovation Center; Beijing Natural Science Foundation: ''Mechanism research of intervention effect of ''Sini-Suanzaoren''	This work was supported by Beijing Natural Science Foundation: "Mechanism research of intervention effect of "Sini-Suanzaoren" for PSY-I based on GABA equilibrium mechanism" (No.7162124), and the Collaborative Innovation Project of the Beijing University of Chinese Medicine: "Nautical Traditional Chinese Medicine" Collaborative Innovation Center (No. 522/0100604299).; This work was supported by Beijing Natural Science Foundation: ''Mechanism research of intervention effect of ''Sini-Suanzaoren'' for PSY-I based on GABA equilibrium mechanism'' (No. 7162124), and the Collaborative Innovation Project of the Beijing University of Chinese Medicine: ''Nautical Traditional Chinese Medicine'' Collaborative Innovation Center (No. 522/0100604299).	Alzoubi KH, 2013, HIPPOCAMPUS, V23, P812, DOI 10.1002/hipo.22135; Arai M, 2002, PROG NEURO-PSYCHOPH, V26, P307, DOI 10.1016/S0278-5846(01)00272-X; Armani F, 2012, CNS NEUROSCI THER, V18, P119, DOI 10.1111/j.1755-5949.2010.00224.x; Buccafusco Jerry J, 2009, METHODS BEHAV ANAL N; CAMPBELL SS, 1984, NEUROSCI BIOBEHAV R, V8, P269, DOI 10.1016/0149-7634(84)90054-X; Chaudhuri A, 2000, J NEUROL SCI, V179, P34, DOI 10.1016/S0022-510X(00)00411-1; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; Chen WZ, 2015, BIOL PHARM BULL, V38, P239, DOI 10.1248/bpb.b14-00599; Cirelli C, 2006, SLEEP MED REV, V10, P307, DOI 10.1016/j.smrv.2006.04.001; Dalsgaard MK, 2007, J NEUROSCI RES, V85, P3334, DOI 10.1002/jnr.21274; Fan Xin-liu, 2011, Zhongguo Zhong Xi Yi Jie He Za Zhi, V31, P512; FRANKEN P, 1991, AM J PHYSIOL, V261, pR198, DOI 10.1152/ajpregu.1991.261.1.R198; Fraser LM, 2010, PSYCHOPHARMACOLOGY, V211, P99, DOI 10.1007/s00213-010-1873-0; Hovens IB, 2013, EXP GERONTOL, V48, P1204, DOI 10.1016/j.exger.2013.07.011; Jia M, 2015, J PSYCHIATR RES, V60, P29, DOI 10.1016/j.jpsychires.2014.09.020; Jinnah H. A, 2005, ASSESSMENT MOVEMENT; Joel D, 2006, PROG NEURO-PSYCHOPH, V30, P374, DOI 10.1016/j.pnpbp.2005.11.006; Krzystanek M, 2015, PHARMACOL REP, V67, P965, DOI 10.1016/j.pharep.2015.01.017; LANCEL M, 1989, PHYSIOL BEHAV, V45, P289, DOI 10.1016/0031-9384(89)90130-3; Lapiz-Bluhm MDS, 2008, J NEUROENDOCRINOL, V20, P1115, DOI 10.1111/j.1365-2826.2008.01772.x; Leavitt VM, 2010, PM&R, V2, P332, DOI 10.1016/j.pmrj.2010.03.027; Li SX, 2014, NEUROBIOL DIS, V62, P124, DOI 10.1016/j.nbd.2013.09.004; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Machado RB, 2004, BRAIN RES, V1004, P45, DOI 10.1016/j.brainres.2004.01.019; MILLER NE, 1982, NEUROBIOL AGING, V3, P283, DOI 10.1016/0197-4580(82)90016-1; Mohammed HS, 2011, BEHAV BRAIN RES, V225, P39, DOI 10.1016/j.bbr.2011.06.018; Moreira KM, 2010, SLEEP, V33, P990, DOI 10.1093/sleep/33.7.990; Neckelmann D, 2007, SLEEP, V30, P873, DOI 10.1093/sleep/30.7.873; Newsholme EA, 2006, J NUTR, V136, p274S, DOI 10.1093/jn/136.1.274S; Patti CL, 2010, SLEEP, V33, P1669, DOI 10.1093/sleep/33.12.1669; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; PIAZZA PV, 1993, P NATL ACAD SCI USA, V90, P11738, DOI 10.1073/pnas.90.24.11738; Pires GN, 2013, PROG NEURO-PSYCHOPH, V41, P6, DOI 10.1016/j.pnpbp.2012.11.006; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Ravassard P, 2016, CEREB CORTEX, V26, P1488, DOI 10.1093/cercor/bhu310; Roullet P, 2001, J NEUROSCI, V21, P2143, DOI 10.1523/JNEUROSCI.21-06-02143.2001; Sagaspe P, 2006, BRAIN COGNITION, V60, P76, DOI 10.1016/j.bandc.2005.10.001; Suchecki D, 1998, J SLEEP RES, V7, P276, DOI 10.1046/j.1365-2869.1998.00122.x; Sun HL, 2013, BEHAV BRAIN RES, V257, P1, DOI 10.1016/j.bbr.2013.08.044; Tang XD, 2007, BEHAV BRAIN RES, V180, P62, DOI 10.1016/j.bbr.2007.02.022; Toro C, 2005, SCHIZOPHR RES, V80, P323, DOI 10.1016/j.schres.2005.07.003; Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707; Wang HY, 2014, ANN CLIN MICROB ANTI, V13, DOI 10.1186/1476-0711-13-3; Wang M, 2007, CELL, V129, P397, DOI 10.1016/j.cell.2007.03.015; WINOCUR G, 1985, BEHAV BRAIN RES, V16, P135, DOI 10.1016/0166-4328(85)90088-9; Yamamoto T, 2005, FATIGUE SCI, V204, P35; Yamashita M., 2013, JAPAN J COGN NEUROSC, V15, P67, DOI 10.11253/ninchishinkeikagaku.15.67; You ZL, 2011, BEHAV BRAIN RES, V225, P135, DOI 10.1016/j.bbr.2011.07.006; Zagaar M, 2013, SLEEP, V36, P751, DOI 10.5665/sleep.2642	49	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176850	10.1371/journal.pone.0176850	http://dx.doi.org/10.1371/journal.pone.0176850			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493899	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314300033
J	Le Blond, JS; Baxter, PJ; Bello, D; Raftis, J; Molla, YB; Cuadros, J; Davey, G				Le Blond, Jennifer S.; Baxter, Peter J.; Bello, Dhimiter; Raftis, Jennifer; Molla, Yordanos B.; Cuadros, Javier; Davey, Gail			Haemolytic activity of soil from areas of varying podoconiosis endemicity in Ethiopia	PLOS ONE			English	Article							NEGLECTED TROPICAL DISEASE; IN-VITRO; VOLCANIC ASH; ENGINEERED NANOMATERIALS; OXIDE NANOPARTICLES; LUNG INFLAMMATION; SURFACE-CHARGE; LOWER LEGS; ELEPHANTIASIS; QUARTZ	Background Podoconiosis, non-filarial elephantiasis, is a non-infectious disease found in tropical regions such as Ethiopia, localized in highland areas with volcanic soils cultivated by barefoot subsistence farmers. It is thought that soil particles can pass through the soles of the feet and taken up by the lymphatic system, leading to the characteristic chronic oedema of the lower legs that becomes disfiguring and disabling over time. Methods The close association of the disease with volcanic soils led us to investigate the characteristics of soil samples in an endemic area in Ethiopia to identify the potential causal constituents. We used the in vitro haemolysis assay and compared haemolytic activity (HA) with soil samples collected in a non-endemic region of the same area in Ethiopia. We included soil samples that had been previously characterized, in addition we present other data describing the characteristics of the soil and include pure phase mineral standards as comparisons. Results The bulk chemical composition of the soils were statistically significantly different between the podoconiosis-endemic and non-endemic areas, with the exception of CaO and Cr. Likewise, the soil mineralogy was statistically significant for iron oxide, feldspars, mica and chlorite. Smectite and kaolinite clays were widely present and elicited a strong HA, as did quartz, in comparison to other mineral phases tested, although no strong difference was found in HA between soils from the two areas. The relationship was further investigated with principle component analysis (PCA), which showed that a combination of an increase in Y, Zr and Al2O3, and a concurrent increase Fe2O3, TiO2, MnO and Ba in the soils increased HA. Conclusion The mineralogy and chemistry of the soils influenced the HA, although the interplay between the components is complex. Further research should consider the variable biopersistance, hygroscopicity and hardness of the minerals and further characterize the nano-scale particles.	[Le Blond, Jennifer S.] Imperial Coll London, Dept Earth Sci, London, England; [Le Blond, Jennifer S.] Nat Hist Museum, Core Res Labs, London, England; [Baxter, Peter J.] Univ Cambridge, Inst Publ Hlth, Cambridge, England; [Bello, Dhimiter] Univ Massachusetts Lowell, Dept Work Environm, Lowell, MA USA; [Raftis, Jennifer] Univ Edinburgh, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Molla, Yordanos B.] Addis Ababa Univ, Dept Earth Sci, Addis Ababa, Ethiopia; [Molla, Yordanos B.; Davey, Gail] Univ Sussex, Brighton & Sussex Med Sch, Wellcome Trust Ctr Global Hlth Res, Brighton, E Sussex, England; [Cuadros, Javier] Nat Hist Museum, Dept Earth Sci, London, England	Imperial College London; Natural History Museum London; University of Cambridge; University of Massachusetts System; University of Massachusetts Lowell; University of Edinburgh; Addis Ababa University; University of Brighton; University of Sussex; Natural History Museum London	Le Blond, JS (corresponding author), Imperial Coll London, Dept Earth Sci, London, England.; Le Blond, JS (corresponding author), Nat Hist Museum, Core Res Labs, London, England.	j.le-blond@imperial.ac.uk		Le Blond, Jennifer/0000-0002-1529-9215	Wellcome Trust [WT091956MA]; Junior Research Fellowship held at Imperial College London	Wellcome Trust(Wellcome TrustEuropean Commission); Junior Research Fellowship held at Imperial College London	JSL holds a Junior Research Fellowship held at Imperial College London (www.imperial.ac.uk). GD acquired a Wellcome Trust Enhancement Award (WT091956MA) (https://wellcome.ac.uk/). The above funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by a Wellcome Trust Enhancement Award (WT091956MA; GD), and a Junior Research Fellowship (JL). The authors acknowledge Chris Rolfe in the Geography Department at the University of Cambridge for access to the Malvern Mastersizer laser diffractometer and Dr Emma Humphreys-Williams in the Imaging and Analysis Centre at the NHM for assistance with the ICP-AES.	ADAMIS Z, 1991, ANN OCCUP HYG, V35, P469, DOI 10.1093/annhyg/35.5.469; Ayele FT, 2012, NEW ENGL J MED, V366, P1200, DOI 10.1056/NEJMoa1108448; BATES CD, 1978, NEW PHYTOL, V81, P459, DOI 10.1111/j.1469-8137.1978.tb02651.x; Baxter PJ, 2014, GEOL SOC MEM, V39, P407, DOI 10.1144/M39.22; Chakhmouradian AR, 2012, RARE EARTH ELEMENTS; Cho WS, 2014, NANOTOXICOLOGY, V8, P202, DOI 10.3109/17435390.2013.773465; Cho WS, 2012, TOXICOL SCI, V126, P469, DOI 10.1093/toxsci/kfs006; Choi J, 2011, TOXICOL SCI, V123, P133, DOI 10.1093/toxsci/kfr149; Clouter A, 2001, TOXICOL SCI, V63, P90, DOI 10.1093/toxsci/63.1.90; Daniel H, 1980, VITRO EFFECTS MINERA, P33; Davey G, 2007, LANCET, V369, P888, DOI 10.1016/S0140-6736(07)60425-5; Deribe K, 2013, PLOS NTD; Dobrovoiskaia MA, 2008, NANO LETT, V8, P2180, DOI 10.1021/nl0805615; Dobrovolskaia MA, 2008, MOL PHARMACEUT, V5, P487, DOI 10.1021/mp800032f; Doshi N, 2010, J R SOC INTERFACE, V7, pS403, DOI 10.1098/rsif.2010.0134.focus; Eberl D. D., 1996, US GEOLOGICAL SURVEY, V96, P171; EYLAR EH, 1962, J BIOL CHEM, V237, P1992; Ferguson JS, 2013, BRIT J DERMATOL, V168, P550, DOI 10.1111/bjd.12134; Ferrell RE., 2010, INTERSTRATIFIED CLAY, P175; Filon FL, 2015, REGUL TOXICOL PHARM, V72, P310, DOI 10.1016/j.yrtph.2015.05.005; Filon FL, 2013, TOXICOL IN VITRO, V27, P121, DOI 10.1016/j.tiv.2012.09.007; Filon FL, 2011, NANOTOXICOLOGY, V5, P493, DOI 10.3109/17435390.2010.551428; FROMMEL D, 1993, TROP GEOGR MED, V45, P165; Fubini B, 1998, ANN OCCUP HYG, V42, P521, DOI 10.1093/annhyg/42.8.521; Fubini B, 1997, ENVIRON HEALTH PERSP, V105, P1013, DOI 10.2307/3433502; Gao N., 2002, ANN OCCUP HYG, V46, P50; Greg S.J., 1982, ADSORPTION SURFACE A; Guthrie GD, 1997, ENVIRON HEALTH PERSP, V105, P1003, DOI 10.2307/3433501; HARLEY JD, 1961, NATURE, V189, P1010, DOI 10.1038/1891010a0; He XX, 2010, TRENDS MOL MED, V16, P574, DOI 10.1016/j.molmed.2010.08.006; HEATHER CJ, 1972, T ROY SOC TROP MED H, V66, P450, DOI 10.1016/0035-9203(72)90276-3; Hellstrand E, 2009, FEBS J, V276, P3372, DOI 10.1111/j.1742-4658.2009.07062.x; Hsieh SF, 2013, SMALL, V9, P1853, DOI 10.1002/smll.201201995; Jiang JK, 2009, J NANOPART RES, V11, P77, DOI 10.1007/s11051-008-9446-4; Jonasz M., 1991, PRINCIPLES METHODS A, P143, DOI DOI 10.1017/CBO9780511626142.014; Kaya A, 2005, CAN GEOTECH J, V42, P1280, DOI [10.1139/t05-048, 10.1139/T05-048]; KLOOS H, 1992, TROP DOCT, V22, P109, DOI 10.1177/004947559202200306; Kynicky J, 2012, DIVERSITY RARE EARTH; Labouta H., 2013, NANOMEDICINE, V9, P49; Lademann J., 2009, J BIOMED OPT, V14; Larese FF, 2009, TOXICOLOGY, V255, P33, DOI 10.1016/j.tox.2008.09.025; Le Blond JS, 2015, AM MINERAL, V100, P2518, DOI 10.2138/am-2015-5168CCBY; LIGHT WG, 1977, ENVIRON RES, V13, P135, DOI 10.1016/0013-9351(77)90012-3; Lordan S, 2011, J APPL TOXICOL, V31, P27, DOI 10.1002/jat.1564; Lu SL, 2009, ENVIRON HEALTH PERSP, V117, P241, DOI 10.1289/ehp.11811; Lynch I, 2008, NANO TODAY, V3, P40, DOI 10.1016/S1748-0132(08)70014-8; MACNAB G, 1967, NATURE, V214, P522, DOI 10.1038/214522a0; MATSUZAWA T, 1979, LAB ANIM, V13, P329, DOI 10.1258/002367779780943297; McPherson T, 2006, BRIT J DERMATOL, V154, P933, DOI 10.1111/j.1365-2133.2005.07081.x; Michel C, 2013, PLOS ONE, V9; Molla YB, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-24; Molla YB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002554; Monteiro-Riviere NA, 2012, ADVERSE EFFECTS OF ENGINEERED NANOMATERIALS: EXPOSURE, TOXICOLOGY, AND IMPACT ON HUMAN HEALTH, P185, DOI 10.1016/B978-0-12-386940-1.00011-8; Murad E, 1999, CLAY MINER, V34, P479, DOI 10.1180/000985599546389; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Nel AE, 2009, NAT MATER, P8; Nenoff P, 2010, J DTSCH DERMATOL GES, V8, P7, DOI [10.1111/j.1610-0387.2009.07099_supp.x, 10.1111/j.1610-0387.2009.07099.x]; Nolan R. P., 1985, VITRO EFFECTS MINERA, P39; Olphen H. van, 1987, Monograph, Mineralogical Society, P203; OSCARSON DW, 1986, CLAY CLAY MINER, V34, P74, DOI 10.1346/CCMN.1986.0340109; Pal AK, 2015, NANOTOXICOLOGY, V9, P871, DOI 10.3109/17435390.2014.986670; Pal AK, 2014, ACS NANO, V8, P9003, DOI 10.1021/nn502219q; Pan Z, 2009, SMALL, V5, P511, DOI 10.1002/smll.200800798; Pavan C, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/s12989-014-0076-y; Pavan C, 2013, CHEM RES TOXICOL, V26, P1188, DOI 10.1021/tx400105f; PRICE EW, 1978, T ROY SOC TROP MED H, V72, P132, DOI 10.1016/0035-9203(78)90048-2; PRICE EW, 1976, T ROY SOC TROP MED H, V70, P288, DOI 10.1016/0035-9203(76)90078-X; Price EW, 1990, PODOCONIOSIS NONFILA; Rushton EK, 2010, J TOXICOL ENV HEAL A, V73, P445, DOI 10.1080/15287390903489422; Schwarze PE, 2007, INHAL TOXICOL, V19, P17, DOI 10.1080/08958370701490445; STALDER K, 1965, NATURE, V207, P875; Towett Erick K., 2015, Geoderma Regional, V5, P157, DOI 10.1016/j.geodrs.2015.06.002; VALLYATHAN V, 1983, ENVIRON RES, V30, P349, DOI 10.1016/0013-9351(83)90220-7; Vallyathan V., 1995, ENVIRON HEALTH PERSP, V02, p111 ; WIESSNER JH, 1989, EXP LUNG RES, V15, P801, DOI 10.3109/01902148909069627; Wilson MR, 2000, OCCUP ENVIRON MED, V57, P727, DOI 10.1136/oem.57.11.727; WOODWORTH CD, 1982, ENVIRON RES, V27, P190, DOI 10.1016/0013-9351(82)90070-6; Woollard KJ, 2009, J BIOL CHEM, V284, P13110, DOI 10.1074/jbc.M809095200; Zeng ZY, 2012, J AM CHEM SOC, V134, P2681, DOI 10.1021/ja209959t; Zook JM, 2011, NANOTOXICOLOGY, V5, P517, DOI 10.3109/17435390.2010.536615	80	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177219	10.1371/journal.pone.0177219	http://dx.doi.org/10.1371/journal.pone.0177219			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493920	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000401314300074
J	Mandizadeh, S; Soofivand, F; Bagheri, S; Salavati-Niasari, M				Mandizadeh, Samira; Soofivand, Faezeh; Bagheri, Samira; Salavati-Niasari, Masoud			SrCrxFe12-xO19 nanoceramics as an effective catalyst for desulfurization of liquid fuels: Green sol-gel synthesis, characterization, magnetic and optical properties	PLOS ONE			English	Article							STRONTIUM HEXAFERRITE; SRFE12O19; FERRITE; PARTICLES; MOSSBAUER; BARIUM	In this work, SrCrxFe12-xO19 (x = 0.0, 0.5, 1.0, 1.5) nanostructures were successfully synthesized by sol-gel auto-combustion method, and different aminoacids were used as green reductants. Various analysis results show that SrCrxFe12-xO19 nanoparticles synthesized successfully. The present study shows that SrCrxFe12-xO19 nanoparticle could be used as adsorbent for the desulfurization of liquid fuels. Increasing of nanoparticles concentration was caused to increase the adsorption rate of sulfur contents of fuel. The adsorption rate of sulfur contents of fuel in various concentrations 4.5, 9.5, and 18.5 g. L-1 of SrCrxFe12-xO19 nanoparticles in solution was estimated about 39, 50, and 62% for 30 min, respectively. The results of catalytic tests reveals that SrCrxFe12-xO19 nanoparticles have the potential to be used as a new kind of semiconductor catalysts for the desulfurization of liquid fuels. Magnetic property of the final sample was measured at room temperature by a vibration sample magnetometer (VSM) and shown that the intrinsic coercivity of product is about 6000 Oe and it exhibits characteristics of single magnetic domains (M-r/M-s = 0.53).	[Mandizadeh, Samira; Soofivand, Faezeh; Salavati-Niasari, Masoud] Univ Kashan, Inst Nano Sci & Nano Technol, Kashan, Iran; [Bagheri, Samira] Univ Malaya, Nanotechnol & Catalysis Res Ctr NANOCAT, IPS Bldg, Kuala Lumpur, Malaysia	University Kashan; Universiti Malaya	Salavati-Niasari, M (corresponding author), Univ Kashan, Inst Nano Sci & Nano Technol, Kashan, Iran.; Bagheri, S (corresponding author), Univ Malaya, Nanotechnol & Catalysis Res Ctr NANOCAT, IPS Bldg, Kuala Lumpur, Malaysia.	samira_bagheri@um.edu.my; salavati@kashanu.ac.ir	Salavati-Niasari, Masoud/AAX-4106-2020	Salavati-Niasari, Masoud/0000-0002-7356-7249	University of Kashan; Iran National Science Foundation (INSF); University of Kashan [159271/8290]	University of Kashan; Iran National Science Foundation (INSF)(Iran National Science Foundation (INSF)); University of Kashan	The authors are grateful to the council of the University of Kashan for providing financial support to undertake this work.; Authors are grateful to the council of Iran National Science Foundation (INSF) and University of Kashan for supporting this work by Grant No (159271/8290).	Abd Aziz A, 2014, CHEM ENG J, V235, P264, DOI 10.1016/j.cej.2013.09.043; Alikhanzadeh-Arani S, 2012, J INORG ORGANOMET P, V22, P1081, DOI 10.1007/s10904-012-9687-7; Ashiq MN, 2009, J ALLOY COMPD, V487, P341, DOI 10.1016/j.jallcom.2009.07.140; ATAIE A, 1995, J MATER SCI, V30, P1429, DOI 10.1007/BF00375243; Ataie A, 2001, J EUR CERAM SOC, V21, P1951, DOI 10.1016/S0955-2219(01)00149-2; Bakker JM, 2005, CHEMPHYSCHEM, V6, P120, DOI 10.1002/cphc.200400345; Bercoff PG, 2009, J MAGN MAGN MATER, V321, P2245, DOI 10.1016/j.jmmm.2009.01.033; CABANAS MV, 1995, J SOLID STATE CHEM, V115, P347, DOI 10.1006/jssc.1995.1143; Chikazumi S., 1964, PHYS MAGNETISM; CHOY JH, 1994, MATER LETT, V19, P257, DOI 10.1016/0167-577X(94)90167-8; DEHAART LGJ, 1985, J ELECTROCHEM SOC, V132, P2933, DOI 10.1149/1.2113696; Fang JY, 2000, J AM CERAM SOC, V83, P1049, DOI 10.1111/j.1151-2916.2000.tb01329.x; Fang QQ, 2005, J MAGN MAGN MATER, V294, P281, DOI 10.1016/j.jmmm.2004.12.024; Fang QQ, 2004, J MAGN MAGN MATER, V278, P122, DOI 10.1016/j.jmmm.2003.12.328; Garcia-Cerda LA, 2004, J ALLOY COMPD, V369, P182, DOI 10.1016/j.jallcom.2003.09.099; Gul IH, 2007, J MAGN MAGN MATER, V311, P494, DOI 10.1016/j.jmmm.2006.08.005; HANEDA K, 1987, IEEE T MAGN, V23, P3134, DOI 10.1109/TMAG.1987.1065394; Jamshidi P, 2013, J CLUST SCI, V24, P1151, DOI 10.1007/s10876-013-0605-0; Jauhar S, 2011, POWDER TECHNOL, V212, P193, DOI 10.1016/j.powtec.2011.05.014; Kim CS, 2000, J APPL PHYS, V87, P6244, DOI 10.1063/1.372668; KULKARNI S, 1989, J MATER SCI, V24, P3739, DOI 10.1007/BF02385764; Lechevallier L, 2004, J MAGN MAGN MATER, V269, P192, DOI 10.1016/S0304-8853(03)00591-2; Linder R, 2005, CHEM PHYS LETT, V409, P260, DOI 10.1016/j.cplett.2005.04.109; Morel A, 2002, J MAGN MAGN MATER, V242, P1405, DOI 10.1016/S0304-8853(01)00962-3; Motahari F, 2014, RSC ADV, V4, P27654, DOI 10.1039/c4ra02697g; Mozaffari M, 2002, PHYSICA B, V321, P45, DOI 10.1016/S0921-4526(02)00819-0; Pieper MW, 2002, J MAGN MAGN MATER, V242, P1408, DOI 10.1016/S0304-8853(01)00963-5; Qiu JX, 2005, APPL SURF SCI, V252, P888, DOI 10.1016/j.apsusc.2005.02.031; Soofivand F, 2013, MATER RES BULL, V48, P2084, DOI 10.1016/j.materresbull.2013.02.025; SURIG C, 1994, IEEE T MAGN, V30, P4092, DOI 10.1109/20.333999; SURIG C, 1993, APPL PHYS LETT, V63, P2836, DOI 10.1063/1.110303; TAUC J, 1968, MATER RES BULL, V3, P37, DOI 10.1016/0025-5408(68)90023-8; Wang YF, 2009, J ALLOY COMPD, V467, P284, DOI 10.1016/j.jallcom.2007.12.037; Xie TP, 2013, APPL SURF SCI, V273, P684, DOI 10.1016/j.apsusc.2013.02.113; Xu XX, 2013, CATAL TODAY, V199, P22, DOI 10.1016/j.cattod.2012.03.013; YAKOVLEV YM, 1969, FIZ TVERD TELA+, V10, P2301; Yang XF, 2009, J ALLOY COMPD, V475, P312, DOI 10.1016/j.jallcom.2008.08.019; Zhong W, 1997, J MAGN MAGN MATER, V168, P196, DOI 10.1016/S0304-8853(96)00664-6; Zuo X, 2002, J APPL PHYS, V91, P7622, DOI 10.1063/1.1450845	39	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0162891	10.1371/journal.pone.0162891	http://dx.doi.org/10.1371/journal.pone.0162891			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493874	gold, Green Published, Green Submitted			2022-12-26	WOS:000401314300001
J	Viehman, HA; Zydlewski, GB				Viehman, Haley A.; Zydlewski, Gayle Barbin			Multi-scale temporal patterns in fish presence in a high-velocity tidal channel	PLOS ONE			English	Article							VARIABILITY; BEHAVIOR; DIEL; STATIONARY; MOVEMENTS; MIGRATION; RESPONSES; DYNAMICS; FLOW; BAY	The natural variation of fish presence in high-velocity tidal channels is not well understood. A better understanding of fish use of these areas would aid in predicting fish interactions with marine hydrokinetic (MHK) devices, the effects of which are uncertain but of high concern. To characterize the patterns in fish presence at a tidal energy site in Cobscook Bay, Maine, we examined two years of hydroacoustic data continuously collected at the proposed depth of an MHK turbine with a bottom-mounted, side-looking echosounder. The maximum number of fish counted per hour ranged from hundreds in the early spring to over 1,000 in the fall. Counts varied greatly with tidal and diel cycles in a seasonally changing relationship, likely linked to the seasonally changing fish community of the bay. In the winter and spring, higher hourly counts were generally confined to ebb tides and low slack tides near sunrise and sunset. In summer and fall of each year, the highest fish counts shifted to night and occurred during ebb, low slack, and flood tides. Fish counts were not linked to current speed, and did not decrease as current speed increased, contrary to observations at other tidal power sites. As fish counts may be proportional to the encounter rate of fish with an MHK turbine at the same depth, highly variable counts indicate that the risk to fish is similarly variable. The links between fish presence and environmental cycles at this site will likely be present at other locations with similar environmental forcing, making these observations useful in predicting potential fish interactions at tidal energy sites worldwide.	[Viehman, Haley A.; Zydlewski, Gayle Barbin] Univ Maine, Sch Marine Sci, Orono, ME 04469 USA	University of Maine System; University of Maine Orono	Zydlewski, GB (corresponding author), Univ Maine, Sch Marine Sci, Orono, ME 04469 USA.	gayle.zydlewski@maine.edu		Viehman, Haley/0000-0002-0472-3551	United States Department of Energy [DE-EE0003647, DE-EE0006384]; Maine Sea Grant [NA100AR4170081]	United States Department of Energy(United States Department of Energy (DOE)); Maine Sea Grant	This work was supported by awards from the United States Department of Energy (energy.gov), project #DE-EE0003647 and #DE-EE0006384, and by the Maine Sea Grant (seagrant.umaine.edu), project #NA100AR4170081. Maine Agricultural and Experiment Station Publication Number 3528.	Amaral SV, 2015, N AM J FISH MANAGE, V35, P97, DOI 10.1080/02755947.2014.982333; Axenrot T, 2004, ICES J MAR SCI, V61, P1100, DOI 10.1016/j.icesjms.2004.07.006; Benjamins S, 2015, OCEANOGR MAR BIOL, V53, P1; Bigelow HB, 2002, BIGELOW SCHROEDERS F; Blauw AN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049319; BLAXTER JHS, 1985, J MAR BIOL ASSOC UK, V65, P1031, DOI 10.1017/S0025315400019494; Broadhurst M, 2014, OCEAN COAST MANAGE, V99, P31, DOI 10.1016/j.ocecoaman.2014.06.008; Brooks DA, 2006, RENEW ENERG, V31, P2284, DOI 10.1016/j.renene.2005.10.013; Castro-Santos T, 2015, ESTUAR COAST, V38, pS203, DOI 10.1007/s12237-013-9680-6; Cazelles B, 2008, OECOLOGIA, V156, P287, DOI 10.1007/s00442-008-0993-2; COCHRANE NA, 1994, MAR ECOL PROG SER, V107, P55, DOI 10.3354/meps107055; de A Ferreira AS, 2012, MAR BIOL RES, V8, P605; De Robertis A, 2007, ICES J MAR SCI, V64, P1282, DOI 10.1093/icesjms/fsm112; Embling CB, 2012, J APPL ECOL, V49, P481, DOI 10.1111/j.1365-2664.2012.02114.x; FLAGG CN, 1994, DEEP-SEA RES PT II, V41, P411, DOI 10.1016/0967-0645(94)90030-2; Forward RB, 2001, OCEANOGR MAR BIOL, V39, P305; Fraser S, 2017, LIMNOL OCEANOGR-METH, V15, P184, DOI 10.1002/lom3.10155; Gibson RN, 1996, MAR ECOL PROG SER, V130, P1, DOI 10.3354/meps130001; Gibson RN, 2003, HYDROBIOLOGIA, V503, P153, DOI 10.1023/B:HYDR.0000008488.33614.62; GLASS CW, 1986, J FISH BIOL, V29, P71, DOI 10.1111/j.1095-8649.1986.tb05000.x; Hammar L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084141; Hartill BW, 2003, MAR FRESHWATER RES, V54, P931, DOI 10.1071/MF02095; HEATH M, 1991, CONT SHELF RES, V11, P1425, DOI 10.1016/0278-4343(91)90020-7; Huse I, 2000, ICES J MAR SCI, V57, P903, DOI 10.1006/jmsc.2000.0577; Korneliussen RJ, 2004, CM2004R2004 ICES, V20; Krumme U, 2008, J EXP MAR BIOL ECOL, V367, P91, DOI 10.1016/j.jembe.2008.08.020; LOVE RH, 1971, FISH BULL NATL OC AT, V69, P703; MACDONALD JS, 1984, FISH B-NOAA, V82, P121; Menard F, 2007, FISH OCEANOGR, V16, P95, DOI 10.1111/j.1365-2419.2006.00415.x; Neilson J.D., 2001, ENCY OCEAN SCI, V2, P411, DOI DOI 10.1016/B978-012374473-9.00020-5; Nilsson LAF, 2003, AQUAT LIVING RESOUR, V16, P317, DOI 10.1016/S0990-7440(03)00039-1; Picco P, 2017, J MARINE SYST, V166, P172, DOI 10.1016/j.jmarsys.2016.07.010; Pittman SJ, 2003, ADV MAR BIOL, V44, P205, DOI 10.1016/S0065-2881(03)44004-2; Porat B., 1997, COURSE DIGITAL SIGNA; Rakowitz G, 2012, FISH RES, V123, P37, DOI 10.1016/j.fishres.2011.11.018; Rao S, 2016, OCEAN DYNAM, V66, P41, DOI 10.1007/s10236-015-0906-y; Reebs SG, 2002, REV FISH BIOL FISHER, V12, P349, DOI 10.1023/A:1025371804611; Roesch A, 2014, R PACKAGE VERSION 1; Rouyer T, 2008, P NATL ACAD SCI USA, V105, P5420, DOI 10.1073/pnas.0709034105; Simard Y, 2002, CAN J FISH AQUAT SCI, V59, P197, DOI 10.1139/f01-210; Simmonds J., 2005, FISHERIES ACOUSTICS, V2nd edn; Staines G, 2015, P 11 EUR WAV TID EN; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; TYLER AV, 1971, J FISH RES BOARD CAN, V28, P935, DOI 10.1139/f71-139; Urmy SS, 2016, DEEP-SEA RES PT I, V113, P22, DOI 10.1016/j.dsr.2016.04.004; Urmy SS, 2012, ICES J MAR SCI, V69, P184, DOI 10.1093/icesjms/fsr205; Viehman H, 2017, DRYAD DIGITAL REPOSI; Viehman HA, 2015, ESTUAR COAST, V38, pS215, DOI 10.1007/s12237-014-9776-7; Viehman HA, 2015, ESTUAR COAST, V38, pS241, DOI 10.1007/s12237-014-9767-8; Vieser J.D., 2014, THESIS; Xu D, 2006, P 9 INT C COAST EST, P176; Zamon JE, 2003, MAR ECOL PROG SER, V261, P243; Zydlewski GB, 2014, 20143604 ME U MAIN	53	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176405	10.1371/journal.pone.0176405	http://dx.doi.org/10.1371/journal.pone.0176405			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493894	Green Submitted, Green Published, gold			2022-12-26	WOS:000401314300015
J	Garnier, Y; Ferdinand, S; Etienne-Julan, M; Elana, G; Petras, M; Doumdo, L; Tressieres, B; Lalanne-Mistrih, ML; Hardy-Dessources, MD; Connes, P; Romana, M				Garnier, Yohann; Ferdinand, Severine; Etienne-Julan, Maryse; Elana, Gisele; Petras, Marie; Doumdo, Lydia; Tressieres, Benoit; Lalanne-Mistrih, Marie-Laure; Hardy-Dessources, Marie-Dominique; Connes, Philippe; Romana, Marc			Differences of microparticle patterns between sickle cell anemia and hemoglobin SC patients	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; ERYTHROCYTE MICROPARTICLES; EXTRACELLULAR VESICLES; PULMONARY-HYPERTENSION; INTERNATIONAL SOCIETY; DISEASE; PLATELET; BLOOD; HEMOSTASIS; CHILDREN	Sickle cell anemia (SCA) and hemoglobin SC (HbSC) disease are the two most common forms of sickle cell disease (SCD), a frequent hemoglobinopathy which exhibits a highly variable clinical course. Although high levels of microparticles (MPs) have been consistently reported in SCA and evidence of their harmful impact on the SCA complication occurrences have been provided, no data on MP pattern in HbSC patients has been reported so far. In this study, we determined and compared the MP patterns of 84 HbSC and 96 SCA children, all at steady-state, using flow cytometry. Most of circulating MPs were derived from platelets (PLTs) and red blood cells (RBCs) in the two SCD syndromes. Moreover, we showed that HbSC patients exhibited lower blood concentration of total MPs compared to SCA patients, resulting mainly from a decrease of MP levels originated from RBCs and to a lesser extent from PLTs. We did not detect any association between blood MP concentrations and the occurrence of painful vaso-occlusive crises, acute chest syndrome and pulmonary hypertension in both patient groups. We also demonstrated for the first time, that whatever the considered genotype, RBC-derived MPs exhibited higher externalized phosphatidylserine level and were larger than PLT-derived MPs.	[Garnier, Yohann; Ferdinand, Severine; Etienne-Julan, Maryse; Lalanne-Mistrih, Marie-Laure; Hardy-Dessources, Marie-Dominique; Connes, Philippe; Romana, Marc] Univ Antilles, Inserm 1134, Lab Excellence GR Ex, Unite Biol Integree Globule Rouge, Paris, France; [Etienne-Julan, Maryse; Petras, Marie; Doumdo, Lydia] CHU Pointe A Pitre, Unite Transversale Drepanocytose, Pointe a Pitre, Guadeloupe, France; [Elana, Gisele] CHU Ft France, Pole Mere Enfant, Fort De France, Martinique, France; [Tressieres, Benoit; Lalanne-Mistrih, Marie-Laure] Inserm DGOS CIC 1424, Ctr Invest Clin Antilles Guyane, Pointe a Pitre, Guadeloupe, France; [Connes, Philippe] Inst Univ France, Paris, France; [Connes, Philippe] Univ Claude Bernard Lyon 1, Lab Excellence GR Ex, Equipe Biol Vasc & Globule Rouge, Lab LIBM EA7424, Villeurbanne, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Guadeloupe; CHU Martinique; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut Universitaire de France; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Romana, M (corresponding author), Univ Antilles, Inserm 1134, Lab Excellence GR Ex, Unite Biol Integree Globule Rouge, Paris, France.	marc.romana@inserm.fr	TRESSIERES, Benoit/ABH-1085-2020; , Hardy-dessources/K-9189-2017; Connes, Philippe/J-7835-2019; Romana, Marc/K-6442-2017	, Hardy-dessources/0000-0003-0861-3648; Connes, Philippe/0000-0002-9232-0268; Romana, Marc/0000-0002-8715-9836; GARNIER, Yohann/0000-0002-2720-5829; FERDINAND, Severine/0000-0001-8258-5089; ETIENNE-JULAN, Maryse/0000-0003-1339-6545	CPER/Region Guadeloupe [J-2-1-J210002]; Conseil Regional de la Martinique; Conseil Regional de la Guadeloupe;  [PHRC-API 2012]	CPER/Region Guadeloupe; Conseil Regional de la Martinique; Conseil Regional de la Guadeloupe; 	Part of this study was supported by the "CPER/Region Guadeloupe, grant nr. J-2-1-J210002 (MR), "Conseil Regional de la Martinique" (MR), by the PHRC-API 2012 (MDHD), and by the "Conseil Regional de la Guadeloupe", fellowship to YG.	Akers JC, 2013, J NEURO-ONCOL, V113, P1, DOI 10.1007/s11060-013-1084-8; ALLAN D, 1982, NATURE, V295, P612, DOI 10.1038/295612a0; Appleton CP, 1997, J AM SOC ECHOCARDIOG, V10, P271, DOI 10.1016/S0894-7317(97)70063-4; Ataga KI, 2006, BRIT J HAEMATOL, V134, P109, DOI 10.1111/j.1365-2141.2006.06110.x; Awojoodu AO, 2014, BLOOD, V124, P1941, DOI 10.1182/blood-2014-01-543652; Boulanger CM, 2017, NAT REV CARDIOL, V14, P259, DOI 10.1038/nrcardio.2017.7; Camus SM, 2015, BLOOD, V125, P3805, DOI 10.1182/blood-2014-07-589283; Camus SM, 2012, BLOOD, V120, P5050, DOI 10.1182/blood-2012-02-413138; Chaar V, 2005, HAEMATOLOGICA, V90, P188; Cognasse F, 2015, TRANSFUS APHER SCI, V53, P159, DOI 10.1016/j.transci.2015.10.013; Colella MP, 2015, HAEMATOLOGICA, V100, P469, DOI 10.3324/haematol.2014.114587; FABRY ME, 1982, J CLIN INVEST, V70, P1315, DOI 10.1172/JCI110732; Ferrone FA, 2015, AM J HEMATOL, V90, P438, DOI 10.1002/ajh.23958; FRANCIS RB, 1991, BLOOD COAGUL FIBRIN, V2, P341, DOI 10.1097/00001721-199104000-00018; Gerotziafas GT, 2012, THROMB HAEMOSTASIS, V107, P1044; Gladwin MT, 2004, NEW ENGL J MED, V350, P886, DOI 10.1056/NEJMoa035477; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Hebbel RP, 2016, BRIT J HAEMATOL, V174, P16, DOI 10.1111/bjh.14112; Hierso R, 2014, BRIT J HAEMATOL, V166, P601, DOI 10.1111/bjh.12912; Hugel B, 2002, PHYSIOLOGY BETHESDA, V20, P22; Inwald DP, 2000, BRIT J HAEMATOL, V111, P474, DOI 10.1046/j.1365-2141.2000.02353.x; Kasar M, 2014, J THROMB THROMBOLYS, V38, P167, DOI 10.1007/s11239-013-1028-3; Kato GJ, 2007, BLOOD REV, V21, P37, DOI 10.1016/j.blre.2006.07.001; Khalyfa A, 2016, BRIT J HAEMATOL, V174, P786, DOI 10.1111/bjh.14104; Labrouche S, 1996, METABOLISM, V45, P57, DOI 10.1016/S0026-0495(96)90200-0; Lacroix R, 2013, J THROMB HAEMOST, V11, P1190, DOI 10.1111/jth.12207; Lacroix R, 2010, J THROMB HAEMOST, V8, P2571, DOI 10.1111/j.1538-7836.2010.04047.x; Lamarre Y, 2012, HAEMATOL-HEMATOL J, V97, P1641, DOI 10.3324/haematol.2012.066670; LAWRENCE C, 1991, BLOOD, V78, P2104, DOI 10.1182/blood.V78.8.2104.bloodjournal7882104; Lee SP, 2006, ARTERIOSCL THROM VAS, V26, P1626, DOI 10.1161/01.ATV.0000220374.00602.a2; LIN MJ, 1989, BLOOD, V74, P1823; Lionnet F, 2012, HAEMATOL-HEMATOL J, V97, P1136, DOI 10.3324/haematol.2011.055202; LIU SC, 1991, SCIENCE, V252, P574, DOI 10.1126/science.2020854; Marsh A, 2015, BRIT J HAEMATOL, V168, P135, DOI 10.1111/bjh.13110; Montoro-Garcia S, 2011, BASIC RES CARDIOL, V106, P911, DOI 10.1007/s00395-011-0198-4; Morel O, 2011, ARTERIOSCL THROM VAS, V31, P15, DOI 10.1161/ATVBAHA.109.200956; Nagel RL, 2003, BLOOD REV, V17, P167, DOI 10.1016/S0268-960X(03)00003-1; Nebor D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087243; Nebor D, 2013, HAEMATOLOGICA, V98, P862, DOI 10.3324/haematol.2012.073619; OWEN JS, 1981, J LIPID RES, V22, P423; Owens AP, 2011, CIRC RES, V108, P1284, DOI 10.1161/CIRCRESAHA.110.233056; Piccin A, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.28414; RANK BH, 1988, BLOOD, V72, P1060; Rautou PE, 2011, CIRC RES, V109, P593, DOI 10.1161/CIRCRESAHA.110.233163; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; Serjeant GR, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011783; Shet AS, 2003, BLOOD, V102, P2678, DOI 10.1182/blood-2003-03-0693; Solovey A, 1998, J CLIN INVEST, V101, P1899, DOI 10.1172/JCI1932; Tantawy AAG, 2013, PLATELETS, V24, P605, DOI 10.3109/09537104.2012.749397; Tomer A, 2001, J LAB CLIN MED, V137, P398, DOI 10.1067/mlc.2001.115450; van Beers EJ, 2009, HAEMATOL-HEMATOL J, V94, P1513, DOI 10.3324/haematol.2009.008938; van Tits LJ, 2009, BIOCHEM BIOPH RES CO, V390, P161, DOI 10.1016/j.bbrc.2009.09.102; Westerman M, 2008, BRIT J HAEMATOL, V142, P126, DOI 10.1111/j.1365-2141.2008.07155.x	53	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177397	10.1371/journal.pone.0177397	http://dx.doi.org/10.1371/journal.pone.0177397			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489923	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314100071
J	Rah, H; Chung, KW; Ko, KH; Kim, ES; Kim, JO; Sakong, JH; Kim, JH; Lee, WS; Kim, NK				Rah, HyungChul; Chung, Ki Wha; Ko, Ki Han; Kim, Eun Sun; Kim, Jung Oh; Sakong, Jung Hyun; Kim, Ji Hyang; Lee, Woo Sik; Kim, Nam Keun			miR-27a and miR-449b polymorphisms associated with a risk of idiopathic recurrent pregnancy loss	PLOS ONE			English	Article							CHINESE POPULATION; BREAST-CANCER; GENE-GENE; MICRORNA; EXPRESSION; MISCARRIAGE; WOMEN; DISEASES	Objective MicroRNAs (miRNAs) regulate gene expression during the peri-implantation period. The purpose of this study was to investigate whether genetic polymorphisms in the four miRNAs associated with fetal or placental development play roles in the development of idiopathic recurrent pregnancy loss (RPL) in Korean females. Study design A case-control study involving 225 controls and 387 women with at least two consecutively recurrent pregnancy losses between 1999 and 2012 was performed. The genotypes of the four miRNA polymorphisms, including miR-27a rs895819, miR-423 rs6505162, miR-449b rs10061133, and miR-605 rs2043556, were analyzed by the polymerase chain reaction-restriction fragment length polymorphism assay. Odds ratios and 95% confidence intervals were estimated using multivariate analyses after maternal age adjustments. The relationships between each of the four microRNA genotypes and each of the six clinical parameters of the RPL patients (plasma homocysteine and folate levels, natural killer cell number, platelet count, prothrombin time, and, activated partial thromboplastin time) were analyzed using multiple linear regression analyses. Results Our results suggest that weak associations between decreased RPL risk and the genotypes of miR-27a (AG and AG+GG), combination genotype of miR-27a/miR-423 (AG/GC), and haplotypes of miR-27a/miR-423/miR-449b/miR-605 (G-C-A-G) and miR-27a/miR-449b/miR-605 (G-A-G), whereas weak associations between increased RPL risk and genotypes of miR-449b (GG and AG+GG), combination genotypes of miR-423/miR-449b (CC/GG and CA/AG), miR-449b/miR-605 (AG/AG), haplotypes of miR-27a/miR-423/miR-449b/miR-605 (A-C-G-A, A-A-A-G, and G-C-G-G), miR-27a/miR-423/miR-449b (A-C-G), miR-27a/miR-449b/miR-605 (A-A-G, A-G-A, and G-G-G), miR-423/miR-449b/miR-605 (C-G-G and A-A-G), and miR-423/miR-449b (C-G and A-A). The genotypes of miR-27a (AG and AG+GG) also showed significant contributions to the prediction of folate levels in RPL patients. Conclusions The study showed associations between miRNA polymorphisms (miR-27a rs895819 and miR-449b rs10061133) and RPL development, and between the miRNA polymorphism (miR-27a rs895819) and plasma folate levels.	[Rah, HyungChul] Chungbuk Natl Univ, Dept Business Data Convergence, Cheongju, South Korea; [Chung, Ki Wha] Kongju Natl Univ, Dept Biol Sci, Coll Nat Sci, Gongju, South Korea; [Ko, Ki Han; Kim, Eun Sun; Kim, Jung Oh; Sakong, Jung Hyun; Kim, Nam Keun] CHA Univ, Dept Biomed Sci, Coll Life Sci, Seongnam, South Korea; [Kim, Ji Hyang] CHA Univ, Dept Obstet & Gynecol, CHA Bundang Med Ctr, Seongnam, South Korea; [Kim, Ji Hyang] CHA Univ, Fertil Ctr, CHA Bundang Med Ctr, Seongnam, South Korea; [Lee, Woo Sik] CHA Univ, Fertil Ctr, CHA Gangnam Med Ctr, Seoul, South Korea; [Kim, Nam Keun] CHA Univ, Inst Clin Res, CHA Bundang Med Ctr, Seongnam, South Korea	Chungbuk National University; Kongju National University; Pochon Cha University; Pochon Cha University; Pochon Cha University; Pochon Cha University; Pochon Cha University	Kim, NK (corresponding author), CHA Univ, Dept Biomed Sci, Coll Life Sci, Seongnam, South Korea.; Kim, NK (corresponding author), CHA Univ, Inst Clin Res, CHA Bundang Med Ctr, Seongnam, South Korea.	nkkim@cha.ac.kr		Kim, Nam Keun/0000-0003-0541-3528; Kim, Jung Oh/0000-0002-4171-2034	Basic Science Research Programs through the National Research Foundation of Korea - Ministry of Education, Science, and Technology [2013R1A1A2009661, 2009-0093821, 2015R1D1A1A09057432]; Korea Healthcare technology RD Project [HI15C1972010015]; Ministry for Health, Welfare & Family Affairs, Republic of Korea	Basic Science Research Programs through the National Research Foundation of Korea - Ministry of Education, Science, and Technology; Korea Healthcare technology RD Project; Ministry for Health, Welfare & Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This research was partly supported by Basic Science Research Programs through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology (grants 2013R1A1A2009661, 2009-0093821 and 2015R1D1A1A09057432). This study was also partly supported by a grant of the Korea Healthcare technology R&D Project (HI15C1972010015), Ministry for Health, Welfare & Family Affairs, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Soc Reprod Med, 2008, FERTIL STERIL, V90, pS60, DOI 10.1016/j.fertnstert.2008.08.065; Amin-Beidokhti M, 2017, REPROD BIOMED ONLINE, V34, P325, DOI 10.1016/j.rbmo.2016.12.004; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bidarimath M, 2014, CELL MOL IMMUNOL, V11, P538, DOI 10.1038/cmi.2014.45; Braza-Boils A, 2014, HUM REPROD, V29, P978, DOI 10.1093/humrep/deu019; Chakrabarty A, 2007, P NATL ACAD SCI USA, V104, P15144, DOI 10.1073/pnas.0705917104; CLIFFORD K, 1994, HUM REPROD, V9, P1328, DOI 10.1093/oxfordjournals.humrep.a138703; De Felice B, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0131-z; Fraga LR, 2014, MOL BIOL REP, V41, P1871, DOI 10.1007/s11033-014-3036-6; Goossens K, 2013, STEM CELLS DEV, V22, P1907, DOI 10.1089/scd.2012.0708; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Hu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114781; Hu Y, 2011, RNA BIOL, V8, P861, DOI 10.4161/rna.8.5.16034; Jeon YJ, 2012, GENE, V494, P168, DOI 10.1016/j.gene.2011.12.026; Jung YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095803; Larsen EC, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-154; Moore JH, 2002, ANN MED, V34, P88, DOI 10.1080/07853890252953473; Mouillet JF, 2011, BIRTH DEFECTS RES A, V91, P737, DOI 10.1002/bdra.20782; O'Toole AS, 2006, NUCLEIC ACIDS RES, V34, P3338, DOI 10.1093/nar/gkl428; Pan H, 2016, MENOPAUSE, V23, P1009, DOI 10.1097/GME.0000000000000659; Quere I, 1998, FERTIL STERIL, V69, P152, DOI 10.1016/S0015-0282(97)00451-2; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Said BI, 2015, CANCER GENET-NY, V208, P47, DOI 10.1016/j.cancergen.2014.12.003; Santamaria X, 2014, FERTIL STERIL, V101, P1545, DOI 10.1016/j.fertnstert.2014.04.044; STIRRAT GM, 1990, LANCET, V336, P673, DOI 10.1016/0140-6736(90)92159-F; Su X, 2015, REPRODUCTION, V150, P65, DOI 10.1530/REP-15-0007; Sun QM, 2010, CANCER SCI, V101, P2241, DOI 10.1111/j.1349-7006.2010.01667.x; Wei WJ, 2015, ENDOCRINE, V49, P436, DOI 10.1007/s12020-014-0467-8; Wessels JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072264; Zhang M, 2012, EUR J CANCER CARE, V21, P274, DOI 10.1111/j.1365-2354.2011.01308.x; Zhao HH, 2015, TUMOR BIOL, V36, P4763, DOI 10.1007/s13277-015-3126-7; Zhao Z, 2013, CLIN BIOCHEM, V46, P953, DOI 10.1016/j.clinbiochem.2013.01.026	32	25	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177160	10.1371/journal.pone.0177160	http://dx.doi.org/10.1371/journal.pone.0177160			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489914	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314100051
J	Cai, MY; Yang, ST; Zhao, CS; Zhou, QW; Hou, LP				Cai, Mingyong; Yang, Shengtian; Zhao, Changsen; Zhou, Qiuwen; Hou, Lipeng			Insight into runoff characteristics using hydrological modeling in the data-scarce southern Tibetan Plateau: Past, present, and future	PLOS ONE			English	Article							REMOTE-SENSING APPLICATIONS; SNOW-COVER; UNGAUGED BASINS; RIVER-BASIN; PRECIPITATION; PREDICTIONS	Regional hydrological modeling in ungauged regions has attracted growing attention in water resources research. The southern Tibetan Plateau often suffers from data scarcity in watershed hydrological simulation and water resources assessment. This hinders further research characterizing the water cycle and solving international water resource issues in the area. In this study, a multi-spatial data based Distributed Time-Variant Gain Model (MS-DTVGM) is applied to the Yarlung Zangbo River basin, an important international river basin in the southern Tibetan Plateau with limited meteorological data. This model is driven purely by spatial data from multiple sources and is independent of traditional meteorological data. Based on the methods presented in this study, daily snow cover and potential evapotranspiration data in the Yarlung Zangbo River basin in 2050 are obtained. Future (2050) climatic data (precipitation and air temperature) from the Fifth Assessment Report of the Intergovernmental Panel on Climate Change (IPCC-AR5) are used to study the hydrological response to climate change. The result shows that river runoff will increase due to precipitation and air temperature changes by 2050. Few differences are found between daily runoff simulations from different Representative Concentration Pathway (RCP) scenarios (RCP2.6, RCP4.5 and RCP8.5) for 2050. Historical station observations (1960-2000) at Nuxia and model simulations for two periods (2006-2009 and 2050) are combined to study inter-annual and intra-annual runoff distribution and variability. The inter-annual runoff variation is stable and the coefficient of variation (CV) varies from 0.21 to 0.27. In contrast, the intra-annual runoff varies significantly with runoff in summer and autumn accounting for more than 80% of the total amount. Compared to the historical period (1960-2000), the present period (2006-2009) has a slightly uneven intra-annual runoff temporal distribution, and becomes more balanced in the future (2050).	[Cai, Mingyong] Satellite Environm Ctr MEP, Beijing, Peoples R China; [Yang, Shengtian; Zhao, Changsen] Beijing Normal Univ, Coll Water Sci, Beijing, Peoples R China; [Yang, Shengtian] Xinjiang Univ, Coll Resource & Environm Sci, Urumqi, Peoples R China; [Zhou, Qiuwen] Guizhou Normal Univ, Sch Geog & Environm Sci, Guiyang, Peoples R China; [Hou, Lipeng] China Ctr SCO Environm Cooperat MEP, China ASEAN Environm Cooperat Ctr, Beijing, Peoples R China	Beijing Normal University; Xinjiang University; Guizhou Normal University	Yang, ST (corresponding author), Beijing Normal Univ, Coll Water Sci, Beijing, Peoples R China.; Yang, ST (corresponding author), Xinjiang Univ, Coll Resource & Environm Sci, Urumqi, Peoples R China.	yangshengtian@bnu.edu.cn	Zhou, Qiuwen/GLT-1798-2022		General Program of National Nature Science Foundation of China [41601471, U1603241, 41671362]; Science and Technology Fund of Guizhou Province, China [[2015]2118]; Chinese National Key Project for RD [2016YFC0402403, 2016YFC0402409]	General Program of National Nature Science Foundation of China; Science and Technology Fund of Guizhou Province, China; Chinese National Key Project for RD	The authors would like to thank all project participants, as well as the General Program of National Nature Science Foundation of China (41601471, U1603241, 41671362), the Science and Technology Fund of Guizhou Province, China ([2015]2118), Chinese National Key Project for R&D (No. 2016YFC0402403, 2016YFC0402409).; The authors would like to thank all project participants, as well as the General Program of National Nature Science Foundation of China (41601471, U1603241, 41671362), the Science and Technology Fund of Guizhou Province, China ([2015]2118), Chinese National Key Project for R&D (No. 2016YFC0402403, 2016YFC0402409). In addition, the authors thank the anonymous reviewers for their helpful and constructive comments.	AHSAN M, 1994, J HYDROL, V155, P151, DOI 10.1016/0022-1694(94)90163-5; AMOROCHO J, 1971, WATER RESOUR RES, V7, P1087, DOI 10.1029/WR007i005p01087; Andersen J, 2002, J HYDROL, V264, P34, DOI 10.1016/S0022-1694(02)00046-X; Andersen J, 2001, J HYDROL, V247, P200, DOI 10.1016/S0022-1694(01)00384-5; ASTON AR, 1979, J HYDROL, V42, P383, DOI 10.1016/0022-1694(79)90057-X; Bagrov N., 1953, METEOROG GIDROL, V10, P20; Bamzai AS, 1999, J CLIMATE, V12, P3117, DOI 10.1175/1520-0442(1999)012<3117:RBESCS>2.0.CO;2; Bastiaanssen WGM, 2000, J HYDROL, V229, P87, DOI 10.1016/S0022-1694(99)00202-4; Beven KJ., 1979, HYDROL SCI J, V24, P43, DOI [10.1080/ 02626667909491834, 10.1080/02626667909491834, DOI 10.1080/02626667909491834]; Cai M, 2013, J APPL REMOTE SENS, V7, P259; Cai MY, 2014, WATER RESOUR MANAG, V28, P2851, DOI 10.1007/s11269-014-0641-z; Cao JT, 2006, CHINESE SCI BULL, V51, P594, DOI 10.1007/s11434-006-0594-6; Chalise SR, 2003, J HYDROL, V282, P25, DOI 10.1016/S0022-1694(03)00250-6; Che T, 2004, J GLACIOLOGY GEOCRYO; Chen He, 2012, Ecohydrology & Hydrobiology, V12, P93, DOI 10.2478/v10104-012-0009-z; Collischonn B, 2008, J HYDROL, V360, P207, DOI 10.1016/j.jhydrol.2008.07.032; Courault D., 2005, Irrigation and Drainage Systems, V19, P223, DOI 10.1007/s10795-005-5186-0; Cutore P, 2007, EWRA INT C; Dankers R, 2004, INT J REMOTE SENS, V25, P2933, DOI 10.1080/01431160310001618374; Grayson R., 2001, SPATIAL PATTERNS CAT; Grayson RB, 2002, ADV WATER RESOUR, V25, P1313, DOI 10.1016/S0309-1708(02)00060-X; Grimes DIF, 2003, HYDROLOG SCI J, V48, P567, DOI 10.1623/hysj.48.4.567.51410; Hall DK, 2002, REMOTE SENS ENVIRON, V83, P181, DOI 10.1016/S0034-4257(02)00095-0; Huffman GJ, 1997, B AM METEOROL SOC, V78, P5, DOI 10.1175/1520-0477(1997)078<0005:TGPCPG>2.0.CO;2; Immerzeel WW, 2009, REMOTE SENS ENVIRON, V113, P40, DOI 10.1016/j.rse.2008.08.010; Immerzeel W, 2008, INT J CLIMATOL, V28, P243, DOI 10.1002/joc.1528; Kite GW, 1996, HYDROLOG SCI J, V41, P563, DOI 10.1080/02626669609491526; Kristensen KJ, 1975, J HYDROL, V309, P39; Lakshmi V, 2004, HYDROL PROCESS, V18, P1029, DOI 10.1002/hyp.5520; Li XB, 2003, ACTA BOT SIN, V45, P1146; McMichael CE, 2006, J HYDROL, V317, P307, DOI 10.1016/j.jhydrol.2005.05.023; Michaelides S, 2009, ATMOS RES, V94, P512, DOI 10.1016/j.atmosres.2009.08.017; Nash J.E., 1970, J HYDROL, V370, P139, DOI [10.1016/0022-1694(70)90255-6, DOI 10.1016/0022-1694(70)90255-6]; NILSON T, 1971, AGR METEOROL, V8, P25, DOI 10.1016/0002-1571(71)90092-6; PRIESTLEY CHB, 1972, MON WEATHER REV, V100, P81, DOI 10.1175/1520-0493(1972)100<0081:OTAOSH>2.3.CO;2; Ritchie JC, 1996, HYDROLOG SCI J, V41, P429, DOI 10.1080/02626669609491518; Schultz GA, 1996, HYDROLOG SCI J, V41, P453, DOI 10.1080/02626669609491520; Shi Y, 2011, QUATERN INT, V244, P159, DOI 10.1016/j.quaint.2011.01.041; Sivapalan M, 2003, HYDROLOG SCI J, V48, P857, DOI 10.1623/hysj.48.6.857.51421; Sivapalan M, 2003, HYDROL PROCESS, V17, P3163, DOI 10.1002/hyp.5155; Sobrino JA, 2006, REMOTE SENS ENVIRON, V102, P99, DOI 10.1016/j.rse.2006.02.001; Stisen S, 2008, J HYDROL, V354, P131, DOI 10.1016/j.jhydrol.2008.03.006; Su Z, 2002, HYDROL EARTH SYST SC, V6, P85, DOI 10.5194/hess-6-85-2002; Sun DL, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002422; Tahir AA, 2011, J HYDROL, V409, P104, DOI 10.1016/j.jhydrol.2011.08.035; Tang BH, 2008, GENERALIZED SPLIT WI; XIA J, 1991, WATER RESOUR RES, V27, P2415, DOI 10.1029/91WR01364; XIA J, 1989, HYDROLOG SCI J, V34, P1; Xia J, 2005, SCI CHINA SER D, V48, P713, DOI 10.1360/03yd0183; Xia J, 2002, WATER INT, V27, P87, DOI 10.1080/02508060208686981; Xie X., 1991, J REMOTE SENSING, V4; You QL, 2007, J GEOGR SCI, V17, P409, DOI 10.1007/s11442-007-0409-y; Zaksek K, 2009, ISPRS J PHOTOGRAMM, V64, P414, DOI 10.1016/j.isprsjprs.2009.02.006	53	9	9	9	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0176813	10.1371/journal.pone.0176813	http://dx.doi.org/10.1371/journal.pone.0176813			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486483	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314000026
J	Baruah, PS; Beauchemin, M; Parker, JA; Bertrand, R				Baruah, Prasamit Saurav; Beauchemin, Myriam; Parker, J. Alexander; Bertrand, Richard			Expression of human Bcl-xL (Ser49) and (Ser62) mutants in Caenorhabditis elegans causes germline defects and aneuploidy	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; POLO-LIKE KINASE; CHROMOSOME SEGREGATION; GENE; PHOSPHORYLATION; INHIBITOR; BCL-X(L); IDENTIFICATION; DOMAIN; CHECKPOINT	An interesting feature of Bcl-xL protein is the presence of an unstructured loop domain between alpha 1 and alpha 2 helices, a domain not essential for its anti-apoptotic function and absent in CED-9 protein. Within this domain, Bcl-xL undergoes dynamic phosphorylation and dephosphorylation at Ser49 and Ser62 during G2 and mitosis in human cells. Studies have revealed that when these residues are mutated, cells harbour mitotic defects, including chromosome mis-attachment, lagging, bridging and mis-segregation with, ultimately, chromosome instability and aneuploidy. We undertook genetic experiments in Caenorhabditis elegans to understand the importance of Bcl-xL (Ser49) and (Ser62) in vivo. Transgenic worms carrying single-site S49A, S62A, S49D, S62D and dual site S49/62A mutants were generated and their effects were analyzed in germlines of young adult worms. Worms expressing Bcl-xL variants showed decreased egg-laying and hatching potency, variations in the length of their mitotic regions but not of their transition zones, appearance of chromosomal abnormalities at their diplotene stages, and increased germline apoptosis, with the exception of the S62D variants. Some of these transgenic strains, particularly the Ser to Ala variants, also showed slight modulations of lifespan compared to their controls. In addition, RNAi experiments silencing expression of the various Bcl-xL variants reversed their effects in vivo. Our in vivo observations confirmed the importance of Ser49 and Ser62 within Bcl-xL loop domain in maintaining chromosome stability.	[Baruah, Prasamit Saurav; Beauchemin, Myriam; Parker, J. Alexander; Bertrand, Richard] Ctr Hosp Univ Montreal CRCHUM, Ctr Rech, Montreal, PQ, Canada; [Baruah, Prasamit Saurav; Beauchemin, Myriam; Bertrand, Richard] Inst Canc Montreal, Montreal, PQ, Canada; [Parker, J. Alexander] Univ Montreal, Dept Neurosci, Montreal, PQ, Canada; [Bertrand, Richard] Univ Montreal, Dept Med & Spec Med, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Bertrand, R (corresponding author), Ctr Hosp Univ Montreal CRCHUM, Ctr Rech, Montreal, PQ, Canada.; Bertrand, R (corresponding author), Inst Canc Montreal, Montreal, PQ, Canada.; Bertrand, R (corresponding author), Univ Montreal, Dept Med & Spec Med, Montreal, PQ, Canada.	richard.bertrand@umontreal.ca	Parker, Alex/F-4953-2014	Parker, Alex/0000-0002-3333-2445; Beauchemin, Myriam/0000-0001-7700-8850	Canadian Institutes of Health Research [MOP-97913]; Natural Sciences and Engineering Research Council of Canada [328207]; Faculte des etudes superieures (Universite de Montreal, Canada); Fondation de l'Institut du cancer de Montreal (Canada)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Faculte des etudes superieures (Universite de Montreal, Canada); Fondation de l'Institut du cancer de Montreal (Canada)	This work was supported by the Canadian Institutes of Health Research (Grant MOP-97913) and the Natural Sciences and Engineering Research Council of Canada (Grant 328207) to RB. PSB received scholarships from the Faculte des etudes superieures (Universite de Montreal, Canada) and the Fondation de l'Institut du cancer de Montreal (Canada).	Adams JM, 2007, CURR OPIN IMMUNOL, V19, P488, DOI 10.1016/j.coi.2007.05.004; Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Baruah PS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159091; Basu A, 2003, FEBS LETT, V538, P41, DOI 10.1016/S0014-5793(03)00131-5; BISSONNETTE RP, 1992, NATURE, V359, P552, DOI 10.1038/359552a0; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Boyd WA, 2010, MUTAT RES-FUND MOL M, V683, P57, DOI 10.1016/j.mrfmmm.2009.10.008; Burri SH, INT J RAD ONCOL BIOL; Chang BS, 1997, EMBO J, V16, P968, DOI 10.1093/emboj/16.5.968; Charbonneau J, 2001, CYTOTECHNOLOGY, V37, P41, DOI 10.1023/A:1016148825633; Crittenden SL, 2006, MOL BIOL CELL, V17, P3051, DOI 10.1091/mbc.E06-03-0170; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Degterev A, 2001, NAT CELL BIOL, V3, P173, DOI 10.1038/35055085; Denver DR, 2006, GENETICS, V174, P57, DOI 10.1534/genetics.106.059840; Fan MY, 2000, J BIOL CHEM, V275, P29980, DOI 10.1074/jbc.M003776200; Fang X, 2011, SEMIN CELL DEV BIOL, V22, P595, DOI 10.1016/j.semcdb.2011.03.002; Finch CE, 2001, ANNU REV GENOM HUM G, V2, P435, DOI 10.1146/annurev.genom.2.1.435; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Gems D, 2000, J GERONTOL A-BIOL, V55, pB215, DOI 10.1093/gerona/55.5.B215; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harper NC, 2011, DEV CELL, V21, P934, DOI 10.1016/j.devcel.2011.09.001; HENGARTNER MO, 1994, CELL, V76, P665, DOI 10.1016/0092-8674(94)90506-1; HENGARTNER MO, 1992, NATURE, V356, P494, DOI 10.1038/356494a0; Hisahara S, 1998, J CELL SCI, V111, P667; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Karczmarek-Borowska B, 2006, LUNG CANCER, V51, P61, DOI 10.1016/j.lungcan.2005.08.010; Kharbanda S, 2000, J BIOL CHEM, V275, P322, DOI 10.1074/jbc.275.1.322; Kitagawa R, 2009, FRONT BIOSCI-LANDMRK, V14, P1529, DOI 10.2741/3323; Lawrence KS, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005150; Lu N, 2009, METHODS MOL BIOL, V559, P357, DOI 10.1007/978-1-60327-017-5_25; Mallick S, 2013, HEAD NECK-J SCI SPEC, V35, P1448, DOI 10.1002/hed.23153; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Musacchio A, 2011, PHILOS T R SOC B, V366, P3595, DOI 10.1098/rstb.2011.0072; Nishi Y, 2008, DEVELOPMENT, V135, P687, DOI 10.1242/dev.013425; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Petros AM, 2004, BBA-MOL CELL RES, V1644, P83, DOI 10.1016/j.bbamcr.2003.08.012; Qian J, 2004, ANAL BIOCHEM, V328, P131, DOI 10.1016/j.ab.2003.12.034; Rahman MM, 2015, MOL BIOL CELL, V26, P4718, DOI 10.1091/mbc.E15-04-0244; REED JC, 1994, J CELL BIOL, V124, P1, DOI 10.1083/jcb.124.1.1; Schmitt E, 2007, ONCOGENE, V26, P5851, DOI 10.1038/sj.onc.1210396; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; STROME S, 1983, CELL, V35, P15, DOI 10.1016/0092-8674(83)90203-9; Tao ZF, 2014, ACS MED CHEM LETT, V5, P1088, DOI 10.1021/ml5001867; Tarailo M, 2007, GENETICS, V175, P1665, DOI 10.1534/genetics.106.067918; Terrano DT, 2010, MOL CELL BIOL, V30, P640, DOI 10.1128/MCB.00882-09; Thompson SL, 2010, CURR BIOL, V20, pR285, DOI 10.1016/j.cub.2010.01.034; TSUJIMOTO Y, 1985, SCIENCE, V228, P1440, DOI 10.1126/science.3874430; VAUX DL, 1994, CELL, V76, P777, DOI 10.1016/0092-8674(94)90350-6; VAUX DL, 1992, SCIENCE, V258, P1955, DOI 10.1126/science.1470921; Wang JF, 2014, CELL CYCLE, V13, P1313, DOI 10.4161/cc.28293; Wang JF, 2012, CELL CYCLE, V11, P2159, DOI 10.4161/cc.20672; Wang JF, 2011, CELL SIGNAL, V23, P2030, DOI 10.1016/j.cellsig.2011.07.017; Watanabe J, 2004, SURGERY, V135, P604, DOI 10.1016/j.surg.2003.11.015; Yamaguchi R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024102; Yamamoto TG, 2008, J CELL BIOL, V183, P187, DOI 10.1083/jcb.200805185; Yu XM, 2008, PLOS BIOL, V6, P581, DOI 10.1371/journal.pbio.0060061	59	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0177413	10.1371/journal.pone.0177413	http://dx.doi.org/10.1371/journal.pone.0177413			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481930	Green Submitted, Green Published, gold			2022-12-26	WOS:000401313700060
J	van der Meer, Y; Gerrits, WJJ; Jansman, AJM; Kemp, B; Bolhuis, JE				van der Meer, Yvonne; Gerrits, Walter J. J.; Jansman, Alfons J. M.; Kemp, Bas; Bolhuis, J. Elizabeth			A link between damaging behaviour in pigs, sanitary conditions, and dietary protein and amino acid supply	PLOS ONE			English	Article							LAYING HENS; FEATHER PECKING; CRUDE PROTEIN; IMMUNE-RESPONSES; PLASMA-CORTISOL; TRYPTOPHAN; SEROTONIN; ENERGY; SELECTION; AGGRESSION	The tendency to reduce crude protein (CP) levels in pig diets to increase protein efficiency may increase the occurrence of damaging behaviours such as ear and tail biting, particularly for pigs kept under suboptimal health conditions. We studied, in a 2x2x2 factorial design, 576 tail-docked growing-finishing entire male pigs in 64 pens, subjected to low (LSC) vs. high sanitary conditions (HSC), and fed a normal CP (NP) vs. a low CP diet (LP, 80% of NP) ad libitum, with a basal amino acid (AA) profile or supplemented AA profile with extra threonine, tryptophan and methionine. The HSC pigs were vaccinated in the first nine weeks of life and received antibiotics at arrival at experimental farm at ten weeks, after which they were kept in a disinfected part of the farm with a strict hygiene protocol. The LSC pigs were kept on the same farm in non-disinfected pens to which manure from another pig farm was introduced fortnightly. At 15, 18, and 24 weeks of age, prevalence of tail and ear damage and of tail and ear wounds was scored. At 20 and 23 weeks of age, frequencies of biting behaviour and aggression were scored for 10x10 min per pen per week. The prevalence of ear damage during the finisher phase (47 vs. 32% of pigs, P < 0.0001) and the frequency of ear biting (1.3 vs. 1.2 times per hour, P = 0.03) were increased in LSC compared with HSC pigs. This effect on ear biting was diet dependent, however, the supplemented AA profile reduced ear biting only in LSC pigs by 18% (SC x AA profile, P < 0.01). The prevalence of tail wounds was lower for pigs in LSC (13 +/- 0.02) than for pigs in HSC (0.22 +/- 0.03) in the grower phase (P < 0.007). Regardless of AA profile or sanitary status, LP pigs showed more ear biting (+20%, P < 0.05), tail biting (+25%, P < 0.10), belly nosing (+152%, P < 0.01), other oral manipulation directed at pen mates (+13%, P < 0.05), and aggression (+30%, P < 0.01) than NP pigs, with no effect on ear or tail damage. In conclusion, both low sanitary conditions and a reduction of dietary protein increase the occurrence of damaging behaviours in pigs and therefore may negatively impact pig welfare. Attention should be paid to the impact of dietary nutrient composition on pig behaviour and welfare, particularly when pigs are kept under suboptimal (sanitary) conditions.	[van der Meer, Yvonne; Gerrits, Walter J. J.] Wageningen Univ, Dept Anim Sci, Anim Nutr Grp, Wageningen, Netherlands; [van der Meer, Yvonne] De Heus Anim Nutr, Ede, Netherlands; [Jansman, Alfons J. M.] Wageningen UR Livestock Res, Anim Nutr, Wageningen, Netherlands; [Kemp, Bas; Bolhuis, J. Elizabeth] Wageningen Univ, Dept Anim Sci, Adaptat Physiol Grp, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research	van der Meer, Y (corresponding author), Wageningen Univ, Dept Anim Sci, Anim Nutr Grp, Wageningen, Netherlands.; van der Meer, Y (corresponding author), De Heus Anim Nutr, Ede, Netherlands.	yvonne.vandermeer@wur.nl			Dutch Feed4Foodure consortium	Dutch Feed4Foodure consortium	This research was financed by the Dutch Feed4Foodure consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON GH, 1979, CAN J PHYSIOL PHARM, V57, P1043, DOI 10.1139/y79-158; Beattie VE, 2001, ANIM SCI, V72, P35, DOI 10.1017/S1357729800055533; BIKKER P, 1994, J NUTR, V124, P1961, DOI 10.1093/jn/124.10.1961; Bolhuis JE, 2009, PHYSIOL BEHAV, V97, P470, DOI 10.1016/j.physbeh.2009.03.021; BURKE KA, 1951, J BIOL CHEM, V188, P723; Camerlink I, 2015, BEHAV GENET, V45, P117, DOI 10.1007/s10519-014-9671-9; CASTAGNE V, 1993, LIFE SCI, V53, P1803, DOI 10.1016/0024-3205(93)90488-O; Centraal Veevoeder Bureau (CVB), 2011, CHEM COMP NUTR VAL F; CHAMBERLAIN B, 1987, PHARMACOL BIOCHEM BE, V28, P503, DOI 10.1016/0091-3057(87)90513-2; de Ridder K, 2012, J ANIM SCI, V90, P3485, DOI 10.2527/jas.2011-4830; Edwards SA, 2006, VET J, V171, P198, DOI 10.1016/j.tvjl.2005.04.010; Ettle T, 2005, PHYSIOL BEHAV, V85, P289, DOI 10.1016/j.physbeh.2005.04.017; Ettle T, 2004, J ANIM SCI, V82, P1115; Ettle T, 2009, LIVEST SCI, V122, P259, DOI 10.1016/j.livsci.2008.09.007; FRASER D, 1991, CAN J ANIM SCI, V71, P611, DOI 10.4141/cjas91-076; GIBBONS JL, 1979, BRAIN RES, V169, P139, DOI 10.1016/0006-8993(79)90380-9; Gloaguen M, 2014, J ANIM SCI, V92, P637, DOI 10.2527/jas.2013-6514; Goossens X, 2008, ANIM WELFARE, V17, P35; Harley S, 2014, ANIM WELFARE, V23, P275, DOI 10.7120/09627286.23.3.275; HARPER AE, 1989, J NUTR, V119, P677, DOI 10.1093/jn/119.5.677; Heinonen M, 2010, VET J, V184, P303, DOI 10.1016/j.tvjl.2009.02.021; International Organization for Standardization (ISO), 2005, 139042005 ISO; ISO, 2005, 59831 ISO; Jansman AJM, 2002, ANIM FEED SCI TECH, V98, P49, DOI 10.1016/S0377-8401(02)00015-9; JENSEN MB, 1993, APPL ANIM BEHAV SCI, V37, P211, DOI 10.1016/0168-1591(93)90112-3; JERICHO KWF, 1972, CANADIAN VET J, V13, P156; Kampman-van de Hoek E, 2015, BRIT J NUTR, V113, P414, DOI 10.1017/S0007114514003821; Karlsson F, 2013, VET MICROBIOL, V165, P402, DOI 10.1016/j.vetmic.2013.03.031; KERR BJ, 1995, J ANIM SCI, V73, P3000; Kim JC, 2012, J ANIM SCI, V90, P362, DOI 10.2527/jas.53821; Koopmans SJ, 2005, PHYSIOL BEHAV, V85, P469, DOI 10.1016/j.physbeh.2005.05.010; Kops MS, 2014, BEHAV BRAIN RES, V268, P81, DOI 10.1016/j.bbr.2014.03.050; Kops MS, 2013, PHYSIOL BEHAV, V120, P77, DOI 10.1016/j.physbeh.2013.07.007; Kritas SK, 2007, VET REC, V160, P149, DOI 10.1136/vr.160.5.149; LARSEN C, 1983, NEW ZEAL VET J, V31, P105, DOI 10.1080/00480169.1983.34985; Le Bellego L, 2002, LIVEST PROD SCI, V76, P45, DOI 10.1016/S0301-6226(02)00008-8; Le Floc'h N, 2008, J ANIM SCI, V86, P3473, DOI 10.2527/jas.2008-0999; Le Floc'h N, 2012, P NUTR SOC, V71, P425, DOI 10.1017/S0029665112000560; Lepage O, 2002, J EXP BIOL, V205, P3679; Li P, 2007, BRIT J NUTR, V98, P237, DOI 10.1017/S000711450769936X; Marques BMFPP, 2012, PESQUI VET BRASIL, V32, P967, DOI 10.1590/S0100-736X2012001000003; Martinez-Trejo G, 2009, J ANIM VET ADV, V8, P608; Massey KA, 1998, AMINO ACIDS, V14, P271, DOI 10.1007/BF01318848; McIntyre J, 2002, APPL ANIM BEHAV SCI, V77, P93, DOI 10.1016/S0168-1591(02)00044-8; Melchior D, 2004, J ANIM SCI, V82, P1091; Moinard C, 2003, APPL ANIM BEHAV SCI, V81, P333, DOI 10.1016/S0168-1591(02)00276-9; Moughan PJ, 1998, QUANTITATIVE BIOL PI, P299; Munsterhjelm C, 2013, ANIMAL, V7, P814, DOI 10.1017/S1751731112002194; National Research Council, 2012, NUTR REQ SWIN, V11th, DOI DOI 10.17226/13298; Parmentier HK, 2009, POULTRY SCI, V88, P536, DOI 10.3382/ps.2008-00424; Petersen DL, 2001, TAIL BITING PIGS J, V162, P196; Pringle M, 2009, VET MICROBIOL, V139, P279, DOI 10.1016/j.vetmic.2009.05.018; Purves D, 2001, ACETYLCHOLINE NEUROS; Rakhshandeh A, 2010, LIVEST SCI, V134, P21, DOI 10.1016/j.livsci.2010.06.085; Ren M, 2014, ANIM FEED SCI TECH, V195, P67, DOI 10.1016/j.anifeedsci.2014.05.013; Rodenburg TB, 2007, APPL ANIM BEHAV SCI, V103, P205, DOI 10.1016/j.applanim.2006.05.024; Rodwell VW, 2003, HARPERS ILLUSTRATED, P264; Roth FX, 2006, J ANIM SCI, V84, P379, DOI 10.2527/2006.842379x; SALOMON RM, 1994, BIOL PSYCHIAT, V35, P570, DOI 10.1016/0006-3223(94)90105-8; Sutherland MA, 2011, APPL ANIM BEHAV SCI, V135, P179, DOI 10.1016/j.applanim.2011.10.015; Taylor NR, 2010, VET J, V186, P137, DOI 10.1016/j.tvjl.2009.08.028; Ursinus WW, 2014, J ANIM SCI, V92, P5193, DOI 10.2527/jas.2014-7918; Ursinus WW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107040; Valros A., 2015, PORCINE HEALTH MANAG, V1, P1, DOI DOI 10.1186/2055-5660-1-1; Van de Weerd HA, 2003, APPL ANIM BEHAV SCI, V84, P101, DOI 10.1016/S0168-1591(03)00150-3; van der Meer Y, 2016, J ANIMAL SCI; van Hierden YM, 2004, BEHAV NEUROSCI, V118, P575, DOI 10.1037/0735-7044.118.3.575; Winberg S, 2001, J EXP BIOL, V204, P3867; Wu GY, 2009, AMINO ACIDS, V37, P1, DOI 10.1007/s00726-009-0269-0; WURTMAN RJ, 1975, AM J CLIN NUTR, V28, P638, DOI 10.1093/ajcn/28.6.638; Zonderland JJ, 2008, APPL ANIM BEHAV SCI, V110, P269, DOI 10.1016/j.applanim.2007.04.005; Zonderland JJ, 2010, LIVEST SCI, V129, P151, DOI 10.1016/j.livsci.2010.01.018	72	20	21	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2017	12	5							e0174688	10.1371/journal.pone.0174688	http://dx.doi.org/10.1371/journal.pone.0174688			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UJ	28481880	Green Published, gold, Green Submitted			2022-12-26	WOS:000401313700001
J	Sanders, MA; Haynes, B; Nangia-Makker, P; Polin, LA; Shekhar, MP				Sanders, Matthew A.; Haynes, Brittany; Nangia-Makker, Pratima; Polin, Lisa A.; Shekhar, Malathy P.			Pharmacological targeting of RAD6 enzyme-mediated translesion synthesis overcomes resistance to platinum-based drugs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						breast cancer; colon cancer; DNA damage response; small molecule; ubiquitin; platinum therapy; replication fork arrest; tumor growth inhibition; ubiquitin conjugation	FANCONI ANEMIA/BRCA PATHWAY; DNA-POLYMERASE-ETA; 2 HUMAN HOMOLOGS; DAMAGE BYPASS; CELL-CYCLE; Y-FAMILY; REPAIR; REPLICATION; CANCER; UBIQUITIN	Platinum drug-induced cross-link repair requires the concerted activities of translesion synthesis (TLS), Fanconi anemia (FA), and homologous recombination repair pathways. The E2 ubiquitin-conjugating enzyme RAD6 is essential for TLS. Here, we show that RAD6 plays a universal role in platinum-based drug tolerance. Using a novel RAD6-selective small-molecule inhibitor (SMI#9) targeting the RAD6 catalytic site, we demonstrate that SMI#9 potentiates the sensitivities of cancer cells with innate or acquired cisplatin or oxaliplatin resistance. 5-Iododeoxyuridine/5-chlorodeoxyuridine pulse-labeling experiments showed that RAD6 is necessary for overcoming cisplatin-induced replication fork stalling, as replication-restart was impaired in both SMI#9-pretreated and RAD6B-silenced cells. Consistent with the role of RAD6/TLS in late-S phase, SMI#9-induced DNA replication inhibition occurred preferentially in mid/late-S phase. The compromised DNA repair and chemosensitization induced by SMI#9 or RAD6B depletion were associated with decreased platinum drug-induced proliferating cell nuclear antigen (PCNA) and FANCD2 monoubiquitinations (surrogate markers of TLS and FA pathway activation, respectively) and with attenuated FANCD2, RAD6, H2AX, and POL foci formation and cisplatin-adduct removal. SMI#9 pretreatment synergistically increased cisplatin inhibition of MDA-MB-231 triple-negative breast cancer cell proliferation and tumor growth. Using an isogenic HCT116 colon cancer model of oxaliplatin resistance, we further show that H2AX and monoubiquitinated PCNA and FANCD2 are constitutively up-regulated in oxaliplatin-resistant HCT116 (HCT116-OxR) cells and that H2AX, PCNA, and FANCD2 monoubiquitinations are induced by oxaliplatin in parental HCT116 cells. SMI#9 pretreatment sensitized HCT116-OxR cells to oxaliplatin. These data deepen insights into the vital role of RAD6/TLS in platinum drug tolerance and reveal clinical benefits of targeting RAD6 with SMI#9 for managing chemoresistant cancers.	[Sanders, Matthew A.; Haynes, Brittany; Nangia-Makker, Pratima; Polin, Lisa A.; Shekhar, Malathy P.] Wayne State Univ, Sch Med, Karmanos Canc Inst, Detroit, MI 48201 USA; [Sanders, Matthew A.; Haynes, Brittany; Polin, Lisa A.; Shekhar, Malathy P.] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI 48201 USA; [Nangia-Makker, Pratima; Shekhar, Malathy P.] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA	Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; Wayne State University	Shekhar, MP (corresponding author), Wayne State Univ, Sch Med, Karmanos Canc Inst, Dept Oncol, 421 E Canfield Ave, Detroit, MI 48201 USA.	shekharm@karmanos.org		Shekhar, Malathy/0000-0003-2721-7202	National Institutes of Health from the NCI [R21CA178117]; Molecular Therapeutics Program of Karmanos Cancer Institute; Initiative for Maximizing Student Diversity Award from the National Institutes of Health [R25GM058905]; Ruth L. Kirschstein NRSA from the National Institutes of Health [T32-CA009531]; NATIONAL CANCER INSTITUTE [T32CA009531, R21CA178117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM058905] Funding Source: NIH RePORTER	National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Molecular Therapeutics Program of Karmanos Cancer Institute; Initiative for Maximizing Student Diversity Award from the National Institutes of Health; Ruth L. Kirschstein NRSA from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant R21CA178117 from the NCI (to M. P. S.) and a grant from the Molecular Therapeutics Program of Karmanos Cancer Institute (to M. P. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by Initiative for Maximizing Student Diversity Award R25GM058905 and Ruth L. Kirschstein NRSA T32-CA009531 from the National Institutes of Health.	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Arora S, 2010, DNA REPAIR, V9, P745, DOI 10.1016/j.dnarep.2010.03.010; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Bogliolo M, 2007, EMBO J, V26, P1340, DOI 10.1038/sj.emboj.7601574; Cremer M, 2001, CHROMOSOME RES, V9, P541, DOI 10.1023/A:1012495201697; Diamant N, 2012, NUCLEIC ACIDS RES, V40, P170, DOI 10.1093/nar/gkr596; Dronkert MLG, 2001, MUTAT RES-DNA REPAIR, V486, P217, DOI 10.1016/S0921-8777(01)00092-1; Feijoo C, 2001, J CELL BIOL, V154, P913, DOI 10.1083/jcb.200104099; Foulkes WD, 2006, FAM CANCER, V5, P135, DOI 10.1007/s10689-005-2832-5; Fu DC, 2013, CELL CYCLE, V12, P803, DOI 10.4161/cc.23755; Geng LY, 2010, J CELL BIOL, V191, P249, DOI 10.1083/jcb.201005101; Haynes B, 2015, MUTAT RES-REV MUTAT, V763, P258, DOI 10.1016/j.mrrev.2014.11.005; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Hung SH, 2017, P NATL ACAD SCI USA, V114, pE2205, DOI 10.1073/pnas.1612633114; Jazaeri AA, 2013, MOL CANCER THER, V12, P1958, DOI 10.1158/1535-7163.MCT-12-1028; Kannouche PL, 2004, CELL CYCLE, V3, P1011; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Karanam K, 2012, MOL CELL, V47, P320, DOI 10.1016/j.molcel.2012.05.052; Kartalou M, 2001, MUTAT RES-FUND MOL M, V478, P23, DOI 10.1016/S0027-5107(01)00141-5; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Kennedy RD, 2005, GENE DEV, V19, P2925, DOI 10.1101/gad.1370505; Kim Y, 2011, NAT GENET, V43, P142, DOI 10.1038/ng.750; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; KOKEN MHM, 1992, GENOMICS, V12, P447, DOI 10.1016/0888-7543(92)90433-S; KOKEN MHM, 1991, P NATL ACAD SCI USA, V88, P8865, DOI 10.1073/pnas.88.20.8865; LAWRENCE C, 1994, BIOESSAYS, V16, P253, DOI 10.1002/bies.950160408; Lehmann AR, 2007, DNA REPAIR, V6, P891, DOI 10.1016/j.dnarep.2007.02.003; Liu M, 2013, ONCOL LETT, V5, P983, DOI 10.3892/ol.2012.1093; Lyakhovich A, 2004, ONCOGENE, V23, P3097, DOI 10.1038/sj.onc.1207449; Lyakhovich A, 2003, MOL CELL BIOL, V23, P2463, DOI 10.1128/MCB.23.7.2463-2475.2003; Mirchandani KD, 2006, EXP CELL RES, V312, P2647, DOI 10.1016/j.yexcr.2006.06.014; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Niedernhofer LJ, 2005, CELL, V123, P1191, DOI 10.1016/j.cell.2005.12.009; Niimi A, 2008, P NATL ACAD SCI USA, V105, P16125, DOI 10.1073/pnas.0802727105; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; OKEEFE RT, 1992, J CELL BIOL, V116, P1095, DOI 10.1083/jcb.116.5.1095; Parker JL, 2009, EMBO J, V28, P3657, DOI 10.1038/emboj.2009.303; Patel KJ, 2007, DNA REPAIR, V6, P885, DOI 10.1016/j.dnarep.2007.02.002; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Roest HP, 2004, MOL CELL BIOL, V24, P5485, DOI 10.1128/MCB.24.12.5485-5495.2004; Sakai W, 2008, NATURE, V451, P1116, DOI 10.1038/nature06633; Salehan MR, 2013, BRIT J BIOMED SCI, V70, P31, DOI 10.1080/09674845.2013.11669927; Sanders MA, 2013, MOL CANCER THER, V12, P373, DOI 10.1158/1535-7163.MCT-12-0793; Seiler JA, 2007, MOL CELL BIOL, V27, P5806, DOI 10.1128/MCB.02278-06; Shekhar MPV, 2008, CANCER RES, V68, P1741, DOI 10.1158/0008-5472.CAN-07-2111; Shekhar MPV, 2002, CANCER RES, V62, P2115; Silver DP, 2010, J CLIN ONCOL, V28, P1145, DOI 10.1200/JCO.2009.22.4725; Song IY, 2010, J BIOL CHEM, V285, P31525, DOI 10.1074/jbc.M110.138206; Thompson LH, 2009, MUTAT RES-FUND MOL M, V668, P54, DOI 10.1016/j.mrfmmm.2009.02.003; Tian F, 2013, P NATL ACAD SCI USA, V110, P13558, DOI 10.1073/pnas.1306534110; Tuduri S, 2010, CHROMOSOME RES, V18, P91, DOI 10.1007/s10577-009-9098-y; Ulrich HD, 2005, CHEMBIOCHEM, V6, P1735, DOI 10.1002/cbic.200500139; Wang HX, 2014, ADV MECH ENG, DOI 10.1155/2014/971756; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Williams SA, 2011, BLOOD, V117, P5078, DOI 10.1182/blood-2010-10-311761; Yokochi T, 2007, CURR PROTOC CELL BIO, P10; ZAMBLE DB, 1995, TRENDS BIOCHEM SCI, V20, P435, DOI 10.1016/S0968-0004(00)89095-7; Zhang J, 2008, CELL CYCLE, V7, P407, DOI 10.4161/cc.7.3.5156	58	25	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10347	10363		10.1074/jbc.M117.792192	http://dx.doi.org/10.1074/jbc.M117.792192			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28490629	hybrid, Green Published			2022-12-26	WOS:000404115400003
J	Buchner, A; Illg, A; Majdani, O; Lenarz, T				Buechner, Andreas; Illg, Angelika; Majdani, Omid; Lenarz, Thomas			Investigation of the effect of cochlear implant electrode length on speech comprehension in quiet and noise compared with the results with users of electro-acoustic-stimulation, a retrospective analysis	PLOS ONE			English	Article							INSERTION DEPTH; HEARING PRESERVATION; SPIRAL GANGLION; PERCEPTION; RECOGNITION; PITCH; PLACE; PERFORMANCE; POSITION; OUTCOMES	Objectives This investigation evaluated the effect of cochlear implant (CI) electrode length on speech comprehension in quiet and noise and compare the results with those of EAS users. Methodes 91 adults with some degree of residual hearing were implanted with a FLEX20, FLEX24, or FLEX28 electrode. Some subjects were postoperative electric-acoustic-stimulation (EAS) users; the other subjects were in the groups of electric stimulation-only (ES-only). Speech perception was tested in quiet and noise at 3 and 6 months of ES or EAS use. Speech comprehension results were analyzed and correlated to electrode length. Results While the FLEX20 ES and FLEX24 ES groups were still in their learning phase between the 3 to 6 months interval, the FLEX28 ES group was already reaching a performance plateau at the three months appointment yielding remarkably high test scores. EAS subjects using FLEX20 or FLEX24 electrodes outscored ES-only subjects with the same short electrodes on all 3 tests at each interval, reaching significance with FLEX20 ES and FLEX24 ES subjects on all 3 tests at the 3-months interval and on 2 tests at the 6-months interval. Amongst ES-only subjects at the 3-months interval, FLEX28 ES subjects significantly outscored FLEX20 ES subjects on all 3 tests and the FLEX24 ES subjects on 2 tests. At the-6 months interval, FLEX28 ES subjects still exceeded the other ES-only subjects although the difference did not reach significance. Conclusions Among ES-only users, the FLEX28 ES users had the best speech comprehension scores, at the 3-months appointment and tendentially at the 6 months appointment. EAS users showed significantly better speech comprehension results compared to ES-only users with the same short electrodes.	[Buechner, Andreas; Illg, Angelika; Majdani, Omid; Lenarz, Thomas] Hannover Med Sch, Dept Otorhinolaryngol, Hannover, Germany	Hannover Medical School	Illg, A (corresponding author), Hannover Med Sch, Dept Otorhinolaryngol, Hannover, Germany.	illg@hoerzentrum-hannover.de	Majdani, Omid/J-1372-2019	Majdani, Omid/0000-0002-8582-7204				Armstrong M, 1997, AM J OTOL, V18, pS140; Berenstein CK, 2008, EAR HEARING, V29, P250, DOI 10.1097/AUD.0b013e3181645336; Brockmeier SJ, 2010, ADV OTO-RHINO-LARYNG, V67, P70, DOI [10.1179/146701010X12671177440343, 10.1159/000262598]; Buchman CA, 2014, OTOL NEUROTOL, V35, P1773, DOI 10.1097/MAO.0000000000000541; Buchner A, 2009, AUDIOL NEURO-OTOL, V14, P8, DOI 10.1159/000206490; Causon A, 2015, OTOL NEUROTOL, V36, P1137, DOI 10.1097/MAO.0000000000000753; Ching TYC, 2004, EAR HEARING, V25, P9, DOI 10.1097/01.AUD.0000111261.84611.C8; Dorman MF, 2010, INT J AUDIOL, V49, P912, DOI 10.3109/14992027.2010.509113; Finley CC, 2008, OTOL NEUROTOL, V29, P920, DOI 10.1097/MAO.0b013e318184f492; Franke-Trieger A, 2014, OTOL NEUROTOL, V35, P58, DOI 10.1097/MAO.0000000000000211; Friesen L M, 2000, J Am Acad Audiol, V11, P418; Fu QJ, 1999, EAR HEARING, V20, P332, DOI 10.1097/00003446-199908000-00006; Gani M, 2007, JARO-J ASSOC RES OTO, V8, P69, DOI 10.1007/s10162-006-0065-4; Gantz BJ, 2003, LARYNGOSCOPE, V113, P1726, DOI 10.1097/00005537-200310000-00012; Gfeller Kate E, 2006, Audiol Neurootol, V11 Suppl 1, P12, DOI 10.1159/000095608; Hamzavi J, 2006, ACTA OTO-LARYNGOL, V126, P1182, DOI 10.1080/00016480600672683; Helbig S, 2008, ORL-J OTO-RHIN-LARYN, V70, P359, DOI 10.1159/000163031; Helbig S, 2011, OTOL NEUROTOL, V32, P973, DOI 10.1097/MAO.0b013e31822558c4; Hochmair Ingeborg, 2006, Trends Amplif, V10, P201, DOI 10.1177/1084713806296720; HochmairDesoyer I, 1997, AM J OTOL, V18, pS83; Illg A, 2014, OTOL NEUROTOL, V35, pE240, DOI 10.1097/MAO.0000000000000529; James Chris J, 2006, Audiol Neurootol, V11 Suppl 1, P57, DOI 10.1159/000095615; Kos MI, 2007, EUR ARCH OTO-RHINO-L, V264, P1369, DOI 10.1007/s00405-007-0354-5; Landsberger DM, 2016, EAR HEARING, V37, pE149, DOI 10.1097/AUD.0000000000000250; Landsberger DM, 2015, EAR HEARING, V36, pE207, DOI 10.1097/AUD.0000000000000163; Lazard DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048739; Lehnhardt E., 2001, PRAXIS AUDIOMETRIE, P173; Lenarz T, 2002, EAR HEARING, V23, p90S, DOI 10.1097/00003446-200202001-00011; Lenarz Thomas, 2006, Audiol Neurootol, V11 Suppl 1, P34, DOI 10.1159/000095612; Lorens A, 2008, LARYNGOSCOPE, V118, P288, DOI 10.1097/MLG.0b013e3181598887; Pelliccia P, 2014, ACTA OTORHINOLARYNGO, V34, P42; Rader T, 2016, HEARING RES, V339, P94, DOI 10.1016/j.heares.2016.06.013; Reiss LAJ, 2014, JARO-J ASSOC RES OTO, V15, P235, DOI 10.1007/s10162-013-0434-8; Schatzer R, 2014, HEARING RES, V309, P26, DOI 10.1016/j.heares.2013.11.003; Skarzynski H, 2014, Cochlear Implants Int, V15 Suppl 1, pS24, DOI 10.1179/1467010014Z.000000000187; Skinner MW, 2002, JARO-J ASSOC RES OTO, V3, P332, DOI 10.1007/s101620020013; Smith Z.M., 2013, IEEE ENG MED BIOL SO; Srinivasan AG, 2013, HEARING RES, V299, P29, DOI 10.1016/j.heares.2013.02.004; Stakhovskaya O, 2007, JARO-J ASSOC RES OTO, V8, P220, DOI 10.1007/s10162-007-0076-9; Tamir S, 2012, AUDIOL NEURO-OTOL, V17, P331, DOI 10.1159/000339894; Tillery KH, 2012, J ACOUST SOC AM, V131, P416, DOI 10.1121/1.3664101; Trieger A, 2011, OTOL NEUROTOL, V32, P152, DOI 10.1097/MAO.0b013e3181fcf04d; Turner CW, 2004, J ACOUST SOC AM, V115, P1729, DOI 10.1121/1.1687425; Tyler RS, 2002, EAR HEARING, V23, P98, DOI 10.1097/00003446-200204000-00003; van der Marel KS, 2015, AUDIOL NEURO-OTOL, V20, P202, DOI 10.1159/000377616; van der Marel KS, 2014, EAR HEARING, V35, pE9, DOI 10.1097/01.aud.0000436256.06395.63; von Ilberg CA, 2011, AUDIOL NEURO-OTOL, V16, P1, DOI 10.1159/000327765; WILSON BS, 1991, NATURE, V352, P236, DOI 10.1038/352236a0; Yukawa K, 2004, AUDIOL NEURO-OTOL, V9, P163, DOI 10.1159/000077267	49	59	60	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0174900	10.1371/journal.pone.0174900	http://dx.doi.org/10.1371/journal.pone.0174900			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505158	Green Submitted, Green Published, gold			2022-12-26	WOS:000401473500004
J	Rengstl, B; Kim, S; Doring, C; Weiser, C; Bein, J; Bankov, K; Herling, M; Newrzela, S; Hansmann, ML; Hartmann, S				Rengstl, Benjamin; Kim, Sooji; Doering, Claudia; Weiser, Christian; Bein, Julia; Bankov, Katrin; Herling, Marco; Newrzela, Sebastian; Hansmann, Martin-Leo; Hartmann, Sylvia			Small and big Hodgkin-Reed-Sternberg cells of Hodgkin lymphoma cell lines L-428 and L-1236 lack consistent differences in gene expression profiles and are capable to reconstitute each other	PLOS ONE			English	Article							CANCER STEM-CELLS; SIDE-POPULATION; PROTEIN BRCA2; B-CELLS; DISEASE; CYTOKINESIS; LYMPHOCYTES; IDENTIFICATION; TARGET; KM-H2	The hallmark of classical Hodgkin lymphoma (cHL) is the presence of giant, mostly multinucleated Hodgkin-Reed-Sternberg (HRS) cells. Whereas it has recently been shown that giant HRS cells evolve from small Hodgkin cells by incomplete cytokinesis and re-fusion of tethered sister cells, it remains unsolved why this phenomenon particularly takes place in this lymphoma and what the differences between these cell types of variable sizes are. The aim of the present study was to characterize microdissected small and giant HRS cells by gene expression profiling and to assess differences of clonal growth behavior as well as susceptibility toward cytotoxic intervention between these different cell types to provide more insight into their distinct cellular potential. Applying stringent filter criteria, only two differentially expressed genes between small and giant HRS cells, SHFM1 and LDHB, were identified. With looser filter criteria, 13 genes were identified to be differentially overexpressed in small compared to giant HRS cells. These were mainly related to energy metabolism and protein synthesis, further suggesting that small Hodgkin cells resemble the proliferative compartment of cHL. SHFM1, which is known to be involved in the generation of giant cells, was downregulated in giant RS cells at the RNA level. However, reduced mRNA levels of SHFM1, LDHB and HSPA8 did not translate into decreased protein levels in giant HRS cells. In cell culture experiments it was observed that the fraction of small and big HRS cells was adjusted to the basic level several days after enrichment of these populations via cell sorting, indicating that small and big HRS cells can reconstitute the full spectrum of cells usually observed in the culture. However, assessment of clonal growth of HRS cells indicated a significantly reduced potential of big HRS cells to form single cell colonies. Taken together, our findings pinpoint to strong similarities but also some differences between small and big HRS cells.	[Rengstl, Benjamin; Kim, Sooji; Doering, Claudia; Weiser, Christian; Bein, Julia; Bankov, Katrin; Newrzela, Sebastian; Hansmann, Martin-Leo; Hartmann, Sylvia] Goethe Univ, Dr Senckenberg Inst Pathol, Frankfurt, Germany; [Herling, Marco] Univ Cologne, Dept Internal Med 1, Lab Lymphocyte Signaling & Oncoproteome, Cologne, Germany; [Herling, Marco] Univ Cologne, CECAD, CIO Koln Bonn, Cologne, Germany; [Herling, Marco] Univ Cologne, CMMC, Cologne, Germany	Goethe University Frankfurt; University of Cologne; University of Cologne; University of Cologne	Hartmann, S (corresponding author), Goethe Univ, Dr Senckenberg Inst Pathol, Frankfurt, Germany.	s.hartmann@em.uni-frankfurt.de	Hartmann, Sylvia/AAJ-4376-2021		Deutsche Forschungsgemeinschaft [HA6145/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This project was supported by the Deutsche Forschungsgemeinschaft (HA6145/2-1).	Chang KC, 2009, AM J CLIN PATHOL, V132, P50, DOI 10.1309/AJCPBDFR5L5UOAUZ; Daniels MJ, 2004, SCIENCE, V306, P876, DOI 10.1126/science.1102574; de Carvalho AX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124629; DREXLER HG, 1989, INT J CANCER, V43, P1083, DOI 10.1002/ijc.2910430622; Hartmann S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078812; Hartmann S, 2013, INT J CANCER, V133, P2609, DOI 10.1002/ijc.28273; HSU PL, 1991, INT J HEMATOL, V54, P315; HSU SM, 1988, BLOOD, V71, P1382; Jansen MPHM, 1999, J PATHOL, V189, P527; Jones RJ, 2009, BLOOD, V113, P5920, DOI 10.1182/blood-2008-11-189688; Knecht H, 1996, ONCOGENE, V13, P947; KUPPERS R, 1994, P NATL ACAD SCI USA, V91, P10962, DOI 10.1073/pnas.91.23.10962; Kuppers R, 2001, BLOOD, V97, P818, DOI 10.1182/blood.V97.3.818; Lajoie V, 2015, BLOOD, V125, P2101, DOI 10.1182/blood-2014-08-594176; Lekomtsev S, 2010, J CELL SCI, V123, P1395, DOI 10.1242/jcs.068015; Ma Y, 2008, BLOOD, V111, P2339, DOI 10.1182/blood-2007-09-112128; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Marston NJ, 1999, MOL CELL BIOL, V19, P4633; Nakashima M, 2010, CANCER SCI, V101, P2490, DOI 10.1111/j.1349-7006.2010.01693.x; NEWCOM SR, 1988, INT J CELL CLONING, V6, P417, DOI 10.1002/stem.5530060606; Reed D., 1902, JOHNS HOPKINS HOS RE, V10, P133; Rengstl B, 2013, P NATL ACAD SCI USA, V110, P20729, DOI 10.1073/pnas.1312509110; Renne C, 2005, BLOOD, V105, P4051, DOI 10.1182/blood-2004-10-4008; Shafer JA, 2010, LEUKEMIA LYMPHOMA, V51, P870, DOI 10.3109/10428191003713968; SINKOVICS JG, 1991, CRIT REV IMMUNOL, V11, P33; Skinnider BF, 2002, BLOOD, V99, P4283, DOI 10.1182/blood-2002-01-0099; STEIN H, 1982, INT J CANCER, V30, P445, DOI 10.1002/ijc.2910300411; Sternberg C. U., 1898, Z HEILK, V19, P21; Teruya-Feldstein J, 2000, LEUKEMIA LYMPHOMA, V38, P363, DOI 10.3109/10428190009087027; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499	30	5	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177378	10.1371/journal.pone.0177378	http://dx.doi.org/10.1371/journal.pone.0177378			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0YN	28505189	Green Published, Green Submitted, gold			2022-12-26	WOS:000401473500019
J	Wei, LQ; Zhangi, XM; Lyu, C; Hu, SY; Li, Z				Wei, Liuqing; Zhangi, Xuemin; Lyu, Chuang; Hu, Siyuan; Li, Zhen			Brain activation of semantic category-based grouping in multiple identity tracking task	PLOS ONE			English	Article							OBJECT TRACKING; ATTENTIVE TRACKING; WORKING-MEMORY; EYE-MOVEMENTS; DEFICIT; KNOWLEDGE; ORGANIZATION; LANGUAGE; CORTEX; COMMON	Using Multiple Identity Tracking task and the functional magnetic resonance imaging (fMRI) technology, the present study aimed to isolate and visualize the functional anatomy of neural systems involved in the semantic category-based grouping process. Three experiment conditions were selected and compared: the category-based targets grouping (TG) condition, the targets-distractors grouping (TDG) condition and the homogenous condition. In the TG condition, observers could utilize the categorical distinction between targets and distractors, to construct a uniform presentation of targets, that is, to form a group of the targets to facilitate tracking. In the TDG condition, half the targets and half the distractors belonged to the same category. Observers had to inhibit the grouping of targets and distractors in one category to complete tracking. In the homogenous condition, where targets and distractors consisted of the same objects, no grouping could be formed. The "TG-Homogenous" contrast (p< 0.01) revealed the activation of the left fusiform and the pars triangularis of inferior frontal gyrus (IFG). The "TG-TDG" contrast only revealed the activation of the left anterior cingulate gyrus (ACC). The fusiform and IFG pars triangularis might participate in the representation of semantic knowledge, IFG pars triangularis might relate intensely with the classification of semantic categories. The ACC might be responsible for the initiation and maintenance of grouping representation.	[Wei, Liuqing; Zhangi, Xuemin; Lyu, Chuang; Hu, Siyuan] Beijing Normal Univ, Sch Psychol, Beijing Key Lab Appl Expt Psychol, Beijing, Peoples R China; [Zhangi, Xuemin; Hu, Siyuan] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing, Peoples R China; [Zhangi, Xuemin; Hu, Siyuan] Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing, Peoples R China; [Zhangi, Xuemin; Hu, Siyuan] Beijing Normal Univ, Ctr Collaborat & Innovat Brain & Learning Sci, Beijing, Peoples R China; [Li, Zhen] EMetric LLC, San Antonio, TX USA	Beijing Normal University; Beijing Normal University; Beijing Normal University; Beijing Normal University	Zhangi, XM (corresponding author), Beijing Normal Univ, Sch Psychol, Beijing Key Lab Appl Expt Psychol, Beijing, Peoples R China.; Zhangi, XM (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing, Peoples R China.; Zhangi, XM (corresponding author), Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing, Peoples R China.; Zhangi, XM (corresponding author), Beijing Normal Univ, Ctr Collaborat & Innovat Brain & Learning Sci, Beijing, Peoples R China.	xmzhang@bnu.edu.cn			National Natural Science Foundation of China [31271083, 61632014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the General Program of National Natural Science Foundation of China (31271083) (to XZ) and the Key Program of National Natural Science Foundation of China (61632014) (to XZ). The funders provided support in the form of experimental expenses for authors [XZ, LW and CL], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. eMetric, LLC provides support in the form of salaries for author [ZL], but did not play any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Blundo C, 2006, COGN NEUROPSYCHOL, V23, P1248, DOI 10.1080/02643290600896449; Bookheimer S, 2002, ANNU REV NEUROSCI, V25, P151, DOI 10.1146/annurev.neuro.25.112701.142946; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Caramazza A, 1998, J COGNITIVE NEUROSCI, V10, P1, DOI 10.1162/089892998563752; Chouinard PA, 2010, NEUROPSYCHOLOGIA, V48, P409, DOI 10.1016/j.neuropsychologia.2009.09.032; Clarke A, 2015, TRENDS COGN SCI, V19, P677, DOI 10.1016/j.tics.2015.08.008; Cohen MA, 2011, ATTEN PERCEPT PSYCHO, V73, P1422, DOI 10.3758/s13414-011-0089-7; Drew T, 2013, COGNITION, V126, P213, DOI 10.1016/j.cognition.2012.10.003; ELLIS AW, 1989, BRAIN, V112, P1469, DOI 10.1093/brain/112.6.1469; Fehd HM, 2008, COGNITION, V108, P201, DOI 10.1016/j.cognition.2007.11.008; Fehd HM, 2010, J VISION, V10, DOI 10.1167/10.4.19; Friston KJ, 1999, NEUROIMAGE, V10, P607, DOI 10.1006/nimg.1999.0498; Gabrieli JDE, 1998, P NATL ACAD SCI USA, V95, P906, DOI 10.1073/pnas.95.3.906; George M S, 1994, Hum Brain Mapp, V1, P194, DOI 10.1002/hbm.460010305; HART J, 1985, NATURE, V316, P439, DOI 10.1038/316439a0; Haxby JV, 2011, NEURON, V72, P404, DOI 10.1016/j.neuron.2011.08.026; Horowitz TS, 2007, PERCEPT PSYCHOPHYS, V69, P172, DOI 10.3758/BF03193740; Howe PDL, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00307; Huff M, 2010, VIS COGN, V18, P1368, DOI 10.1080/13506285.2010.495878; Keane BP, 2011, J EXP PSYCHOL HUMAN, V37, P685, DOI 10.1037/a0020674; Laiacona M, 2001, COGNITIVE NEUROPSYCH, V18, P39, DOI 10.1080/02643290042000035; Liu TW, 2012, VISION RES, V66, P31, DOI 10.1016/j.visres.2012.06.009; Lukavsky J, 2013, J VISION, V13, DOI 10.1167/13.7.9; Lyu C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145489; Mahon BZ, 2007, NEURON, V55, P507, DOI 10.1016/j.neuron.2007.07.011; Mahon BZ, 2009, NEURON, V63, P397, DOI 10.1016/j.neuron.2009.07.012; Mahon BZ, 2009, ANNU REV PSYCHOL, V60, P27, DOI 10.1146/annurev.psych.60.110707.163532; Makovski T, 2009, J EXP PSYCHOL HUMAN, V35, P1687, DOI 10.1037/a0016453; Makovski T, 2009, VIS COGN, V17, P180, DOI 10.1080/13506280802211334; Martin A, 2007, ANNU REV PSYCHOL, V58, P25, DOI 10.1146/annurev.psych.57.102904.190143; Miceli G, 2000, COGN NEUROPSYCHOL, V17, P489, DOI 10.1080/02643290050110629; Ogawa H., 2002, JAPANESE J PSYCHONOM, V21, P49; Oksama L, 2004, VIS COGN, V11, P631, DOI 10.1080/13506280344000473; Oksama L, 2008, COGNITIVE PSYCHOL, V56, P237, DOI 10.1016/j.cogpsych.2007.03.001; Op de Beeck HP, 2008, NAT REV NEUROSCI, V9, P123, DOI 10.1038/nrn2314; PAUS T, 1993, J NEUROPHYSIOL, V70, P453, DOI 10.1152/jn.1993.70.2.453; POSNER MI, 1988, SCIENCE, V240, P1627, DOI 10.1126/science.3289116; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; Ren DG, 2009, J VISION, V9, DOI 10.1167/9.5.18; SACCHETT C, 1992, COGNITIVE NEUROPSYCH, V9, P73, DOI 10.1080/02643299208252053; Samson D, 2003, COGN NEUROPSYCHOL, V20, P373, DOI 10.1080/02643290244000329; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Suganuma M, 2006, PERCEPTION, V35, P483, DOI 10.1068/p5487; Wagner AD, 1999, NEURON, V22, P19, DOI 10.1016/S0896-6273(00)80674-1; Wang CD, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00657; Wei LQ, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00589; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; YANTIS S, 1992, COGNITIVE PSYCHOL, V24, P295, DOI 10.1016/0010-0285(92)90010-Y; Zelinsky GJ, 2008, VIS COGN, V16, P553, DOI 10.1080/13506280802000752	49	2	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2017	12	5							e0177709	10.1371/journal.pone.0177709	http://dx.doi.org/10.1371/journal.pone.0177709			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV0YN	28505166	Green Submitted, Green Published, gold			2022-12-26	WOS:000401473500034
J	Gok, A; Ngendahimana, DK; Fagerholm, CL; French, RH; Sun, JY; Bruckman, LS				Gok, Abdulkerim; Ngendahimana, David K.; Fagerholm, Cara L.; French, Roger H.; Sun, Jiayang; Bruckman, Laura S.			Predictive models of poly(ethylene-terephthalate) film degradation under multi-factor accelerated weathering exposures	PLOS ONE			English	Article							PHOTOCHEMICAL DEGRADATION; ELECTRICAL-PROPERTIES; PHASE-CHANGE; KINETICS; PHOTODEGRADATION; HYDROLYSIS; MECHANISMS; SCATTERING; ANALYTICS; PARTICLES	Accelerated weathering exposures were performed on poly(ethylene-terephthalate) (PET) films. Longitudinal multi-level predictive models as a function of PET grades and exposure types were developed for the change in yellowness index (YI) and haze (%). Exposures with similar change in YI were modeled using a linear fixed-effects modeling approach. Due to the complex nature of haze formation, measurement uncertainty, and the differences in the samples' responses, the change in haze (%) depended on individual samples' responses and a linear mixed-effects modeling approach was used. When compared to fixed-effects models, the addition of random effects in the haze formation models significantly increased the variance explained. For both modeling approaches, diagnostic plots confirmed independence and homogeneity with normally distributed residual errors. Predictive R 2 values for true prediction error and predictive power of the models demonstrated that the models were not subject to over-fitting. These models enable prediction under pre-defined exposure conditions for a given exposure time (or photo-dosage in case of UV light exposure). PET degradation under cyclic exposures combining UV light and condensing humidity is caused by photolytic and hydrolytic mechanisms causing yellowing and haze formation. Quantitative knowledge of these degradation pathways enable cross-correlation of these lab-based exposures with real-world conditions for service life prediction.	[Gok, Abdulkerim] Gebze Tech Univ, Dept Mat Sci & Engn, Gebze, Kocaeli, Turkey; [Gok, Abdulkerim; Fagerholm, Cara L.; French, Roger H.; Bruckman, Laura S.] Case Western Reserve Univ, Dept Mat Sci & Engn, Solar Durabil & Lifetime Extens SDLE Res Ctr, Cleveland, OH 44106 USA; [Ngendahimana, David K.; Sun, Jiayang] Case Western Reserve Univ, Dept Epidemiol & Biostat, Ctr Stat Res Comp & Collaborat SR2c, Cleveland, OH 44106 USA	Gebze Technical University; Case Western Reserve University; Case Western Reserve University	Gok, A (corresponding author), Gebze Tech Univ, Dept Mat Sci & Engn, Gebze, Kocaeli, Turkey.; Gok, A; Bruckman, LS (corresponding author), Case Western Reserve Univ, Dept Mat Sci & Engn, Solar Durabil & Lifetime Extens SDLE Res Ctr, Cleveland, OH 44106 USA.	agok@gtu.edu.tr; laura.bruckman@case.edu	Gok, Abdulkerim/Y-8830-2019; French, Roger H/E-1986-2011; Bruckman, Laura/X-4067-2019	Gok, Abdulkerim/0000-0003-3433-7106; French, Roger H/0000-0002-6162-0532; Bruckman, Laura/0000-0003-1271-1072; Sun, Jiayang/0000-0002-0870-7014	3M Company Corporate Research Analytical Laboratory [1401945]; Ohio Third Frontier, Wright Project Program Award Tech [12-004]	3M Company Corporate Research Analytical Laboratory(3M); Ohio Third Frontier, Wright Project Program Award Tech	This research was supported by 3M Company Corporate Research Analytical Laboratory (Agreement Control Number: 1401945), and performed at the Solar Durability and Lifetime Extension (SDLE) Research Center (funded through Ohio Third Frontier, Wright Project Program Award Tech 12-004) at Case Western Reserve University. The funders had no role in study design, data collection and analysis, interpretation of data, writing of the paper, or decision to submit for publication.; This research was performed at Solar Durability and Lifetime Extension (SDLE) Research Center (funded through Ohio Third Frontier, Wright Project Program Award Tech 12-004) at Case Western Reserve University. The authors would like to thank Tekra Corp. for providing samples.	ALLEN DM, 1974, TECHNOMETRICS, V16, P125, DOI 10.2307/1267500; ALLEN DM, 1971, TECHNOMETRICS, V13, P469, DOI 10.2307/1267161; [Anonymous], 2013, J MAT, DOI DOI 10.1155/2013/102691; [Anonymous], 2010, G172022010E1 ASTM; [Anonymous], WK57612 ASTM; [Anonymous], 2016, G15416 ASTM; [Anonymous], WK55620 ASTM; [Anonymous], 2011, G166002011 ASTM; [Anonymous], 2015, E31315E1 ASTM; [Anonymous], 2013, D100313 ASTM; [Anonymous], 2012, G17303 ASTM; Avrami M, 1941, J CHEM PHYS, V9, P177, DOI 10.1063/1.1750872; Avrami M, 1939, J CHEM PHYS, V7, P1103, DOI 10.1063/1.1750380; Avrami M., 1940, J CHEM PHYS, V8, P212, DOI [DOI 10.1063/1.1750631, 10.1063/1.1750631]; Bates D.M., 2010, LME4 MIXED EFFECTS M; Bruckman LS, 2013, PROC SPIE, V8825, DOI 10.1117/12.2024717; Bruckman LS, 2013, IEEE ACCESS, V1, P384, DOI 10.1109/ACCESS.2013.2267611; BUXBAUM LH, 1968, ANGEW CHEM INT EDIT, V7, P182, DOI 10.1002/anie.196801821; DAY M, 1971, J POLYM SCI POL LETT, V9, P665, DOI 10.1002/pol.1971.110090906; DAY M, 1972, J APPL POLYM SCI, V16, P191, DOI 10.1002/app.1972.070160117; DAY M, 1972, J APPL POLYM SCI, V16, P203, DOI 10.1002/app.1972.070160118; DAY M, 1972, J APPL POLYM SCI, V16, P175, DOI 10.1002/app.1972.070160116; Diez DM, 2015, CETINKAYA RUNDEL M O; Faraway J.J., 2002, PRACTICAL REGRESSION; Felder TC, 2014, P SOC PHOTO-OPT INS, V9179; French RH, 2015, CURR OPIN SOLID ST M, V19, P212, DOI 10.1016/j.cossms.2014.12.008; Gok Abdulkerim, 2015, 2015 IEEE 42nd Photovoltaic Specialist Conference (PVSC). Proceedings, P1, DOI 10.1109/PVSC.2015.7355601; Gok Abdulkerim, 2016, DEGRADATION PATHWAY; HASTIE T, 2009, SPRINGER SERIES STAT; Hossain MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131279; IEC, 2016, 61215 IEC; ILISKOVIC N, 1986, POLYM DEGRAD STABIL, V15, P173, DOI 10.1016/0141-3910(86)90071-6; ILISKOVIC N, 1985, POLYM DEGRAD STABIL, V13, P139, DOI 10.1016/0141-3910(85)90063-1; James G., 2014, INTRO STAT LEARNING; Kaci M, 2001, J APPL POLYM SCI, V82, P3284, DOI 10.1002/app.2187; Koehl M, 2009, POLYM FILMS PHOTOVOL; Koehl M, 2012, SOL ENERG MAT SOL C, V99, P282, DOI 10.1016/j.solmat.2011.12.011; Koehl M, 2011, SOL ENERG MAT SOL C, V95, P1638, DOI 10.1016/j.solmat.2011.01.020; Kontges M, 2014, PERFORMANCE RELIABIL; LAUNAY A, 1994, POLYM DEGRAD STABIL, V46, P319, DOI 10.1016/0141-3910(94)90148-1; McMahon W., 1959, J CHEM ENG DATA, V4, P57, DOI DOI 10.1021/JE60001A009; McNeil LE, 2001, J APPL PHYS, V89, P1898, DOI 10.1063/1.1336564; Murray MP, 2012, MRS ONLINE P LIB, V1391; Murray MP, 2012, J PHOTON ENERGY, V2, DOI 10.1117/1.JPE.2.022004; Nettleton D, 2006, PLANT CELL, V18, P2112, DOI 10.1105/tpc.106.041616; Novoa FD, 2014, SOL ENERG MAT SOL C, V120, P87, DOI 10.1016/j.solmat.2013.08.020; Oreski G, 2005, SOL ENERGY, V79, P612, DOI 10.1016/j.solener.2005.02.008; Oreski G, 2011, QUALIFICATION POLYM, V8112; Peshek TJ, 2016, J VAC SCI TECHNOL B, V34, DOI 10.1116/1.4960628; Pickett J. E., 2015, SERVICE LIFE PREDICT, P41, DOI [DOI 10.1007/978-3-319-06034-7_3, 10.1007/978-3-319-06034-7_3]; Pickett JE, 2013, POLYM DEGRAD STABIL, V98, P1311, DOI 10.1016/j.polymdegradstab.2013.04.001; Pickett JE, 2000, ENVIR SC P, V21, P163; PICKETT JE, 1993, POLYM DEGRAD STABIL, V42, P231, DOI 10.1016/0141-3910(93)90219-9; RAVINDRANATH K, 1986, CHEM ENG SCI, V41, P2197, DOI 10.1016/0009-2509(86)85070-9; Ross RG, 2014, IEEE J PHOTOVOLT, V4, P291, DOI 10.1109/JPHOTOV.2013.2281102; Thiele ES, 1998, J AM CERAM SOC, V81, P469, DOI 10.1111/j.1151-2916.1998.tb02364.x; Trentin A, 2013, IEEE ENER CONV, P1, DOI 10.1109/ECCE.2013.6646673; Turnbull L, 2012, J APPL POLYM SCI, V124, P4517, DOI 10.1002/app.35476; Wheeler NR, 2015, P SOC PHOTO-OPT INS, V9563; Wheeler NR, 2014, 40 IEEE PVSC; Whitfield K, 2012, 2012 38TH IEEE PHOTOVOLTAIC SPECIALISTS CONFERENCE (PVSC), P1864, DOI 10.1109/PVSC.2012.6317957; Xia Z, 2009, PHOT SPEC C PVSC 200, P000523	62	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177614	10.1371/journal.pone.0177614	http://dx.doi.org/10.1371/journal.pone.0177614			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498875	gold, Green Submitted, Green Published			2022-12-26	WOS:000401314500033
J	Li, YM; Li, JW; Liu, H; Liu, YL; Cui, BB				Li, Yongmin; Li, Jingwen; Liu, He; Liu, Yanlong; Cui, Binbin			Expression of MYSM1 is associated with tumor progression in colorectal cancer	PLOS ONE			English	Article							STEM-CELL MAINTENANCE; DIFFERENTIATION; CARCINOMA; COMPLEX; CHAINS	Colorectal cancer, the third most common cancer in both men and women, has gradually increased in recent years. MYSM1has been investigated as a regulator of hematopoiesis and lymphocyte development in human. It has been reported that some tumor-related genes were modulated by MYSM1. However, its exact role in cancer development remains unclear. Herein, we aimed to examine the expression level of MYSM1 in tumor tissues and its correlation with clinicopathology and survivals of patients with colorectal cancer (CRC). MYSM1expressions in tumor specimens resected from 123 CRC patients were detected by immunochemistry and Western blot analysis. The results showed that MYSM1 was significantly highly expressed in carcinoma tissues compared with adjacent normal mucosa tissues (P<0.05). Correlation analyses by Pearson's chi-square test demonstrated that MYSM1 in tumors was positively correlated with tumor status (pathological assessment of the primary tumor (pT, P<0.001), regional lymph nodes (pN, P = 0.013), distant metastasis (pM, P<0.001)) and clinic stage (P<0.001); Whereas, MYSM1 was not associated with tumor size of CRC patients and was positively associated with tumor differentiation grade (P = 0.015). Patients with positiveMYSM1expression showed poor survival compared with the MYSM1 negative group (P<0.001). Simultaneously, multivariate Cox regression analysis indicated thatMYSM1 expression in tumor cells was an independent factor for reduced overall survival in CRC patients (P<0.001). Additionally, MYSM1 in CRC SW480 cells was silenced by small interference RNA (siRNA) technology. Scratch assay and Transwell assay showed that MYSM1 silencing decreased migration and invasion abilities of SW480 cells. These data suggested that expression of MYSM1 was associated with the progression of CRC and might be a potential biomarker for clinical prognosis.	[Li, Yongmin; Li, Jingwen; Liu, He; Liu, Yanlong; Cui, Binbin] Harbin Med Univ, Affiliated Tumor Hosp, Dept Colorectal Surg, Harbin, Peoples R China	Harbin Medical University	Liu, YL; Cui, BB (corresponding author), Harbin Med Univ, Affiliated Tumor Hosp, Dept Colorectal Surg, Harbin, Peoples R China.	lyanlong77@163.com; cuibbin328@163.com	Liu, Yanlong/AAL-3503-2021		National Natural Science Foundation of China [81272704]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by the National Natural Science Foundation of China (Grant No. 81272704). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was supported by the National Natural Science Foundation of China (Grant No. 81272704). Deliberated by the Harbin Medical University ethics committee, the present project declared by Binbin Cui involving the use of clinical specimens meets the medical ethics review requirements from Harbin Medical University, agreed to declare.	Belle JI, 2016, CELL DEATH DIFFER, V23, P759, DOI 10.1038/cdd.2015.140; Belle JI, 2015, BLOOD, V125, P2344, DOI 10.1182/blood-2014-05-574111; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Gu YC, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1841; Hong J, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060767; Hu J, 2015, LUNG CANCER, V88, P239, DOI 10.1016/j.lungcan.2015.02.019; Jiang XX, 2011, IMMUNITY, V35, P883, DOI 10.1016/j.immuni.2011.11.010; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Liu YL, 2010, J GASTROEN HEPATOL, V25, P1800, DOI 10.1111/j.1440-1746.2010.06352.x; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; Nijnik A, 2012, BLOOD, V119, P1370, DOI 10.1182/blood-2011-05-352666; O'Sullivan Brian, 2003, Semin Surg Oncol, V21, P30, DOI 10.1002/ssu.10019; Qian SH, 2016, ONCOL REP, V35, P3705, DOI 10.3892/or.2016.4705; Sato Y, 2008, NATURE, V455, P358, DOI 10.1038/nature07254; Wang T, 2013, BLOOD, V122, P2812, DOI 10.1182/blood-2013-03-489641; Wang ZJ, 2015, HUM PATHOL, V46, P1006, DOI 10.1016/j.humpath.2015.04.001; Zhang L, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-60; Zhou L, 2016, TUMOR BIOL, V37, P15583, DOI 10.1007/s13277-015-4138-z; Zhu P, 2007, MOL CELL, V27, P609, DOI 10.1016/j.molcel.2007.07.024	20	12	12	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177235	10.1371/journal.pone.0177235	http://dx.doi.org/10.1371/journal.pone.0177235			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498834	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314500013
J	Liu, C; Wang, SF; Xu, WL; Liu, XX				Liu, Chen; Wang, Shufen; Xu, Wenling; Liu, Xianxian			Genome-wide transcriptome profiling of radish (Raphanus sativus L.) in response to vernalization	PLOS ONE			English	Article							FLOWERING-TIME CONTROL; CHROMATIN MODIFICATION; HISTONE METHYLATION; COLD-ACCLIMATION; CBF GENES; LOCUS-C; RNA-SEQ; ARABIDOPSIS; COMPLEX; FLC	Vernalization is a key process for premature bolting. Although many studies on vernalization have been reported, the molecular mechanism of vernalization is still largely unknown in radish. In this study, we sequenced the transcriptomes of radish seedlings at three different time points during vernalization. More than 36 million clean reads were generated for each sample and the portions mapped to the reference genome were all above 67.0%. Our results show that the differentially expressed genes (DEGs) between room temperature and the early stage of vernalization (4,845) are the most in all treatments pairs. A series of vernalization related genes, including two FLOWERING LOCUS C (FLC) genes, were screened according to the annotations. A total of 775 genes were also filtered as the vernalization related candidates based on their expression profiles. Cold stress responsive genes were also analyzed to further confirm the sequencing result. Several key genes in vernalization or cold stress response were validated by quantitative RT-PCR (RT-qPCR). This study identified a number of genes that may be involved in vernalization, which are useful for other functional genomics research in radish.	[Liu, Chen; Wang, Shufen; Xu, Wenling; Liu, Xianxian] Shandong Acad Agr Sci, Natl Vegetable Improvement Ctr, Inst Vegetables & Flowers, Shandong Key Lab Greenhouse Vegetable Biol,Shando, Jinan, Shandong, Peoples R China	Shandong Academy of Agricultural Sciences	Wang, SF (corresponding author), Shandong Acad Agr Sci, Natl Vegetable Improvement Ctr, Inst Vegetables & Flowers, Shandong Key Lab Greenhouse Vegetable Biol,Shando, Jinan, Shandong, Peoples R China.	mwangshufen@sina.com			Modern Agricultural Industrial Technology System Funding of Shandong Province, China [SDAIT-05-01]; Youth Foundation of Shandong Academy of Agricultural Sciences [2016YQN22]; National Science and Technology Pillar Program [2012BAD02B01-6, 2013BAD01B04-18]; National Key Research and Development Program of China [2016YFD0100204-27]; "948" Project, China [2015Z60]	Modern Agricultural Industrial Technology System Funding of Shandong Province, China; Youth Foundation of Shandong Academy of Agricultural Sciences; National Science and Technology Pillar Program; National Key Research and Development Program of China; "948" Project, China	This study was supported by the Modern Agricultural Industrial Technology System Funding of Shandong Province, China (project no. SDAIT-05-01, http://cyjstx.sdny.gov.cn/, SW), the Youth Foundation of Shandong Academy of Agricultural Sciences (project no. 2016YQN22, http://www.saas.ac.cn/saas/, CL), the National Science and Technology Pillar Program during the 12th Five Year Plan of China (project no. 2012BAD02B01-6, http://www.most.gov.cn/, SW and 2013BAD01B04-18, http://www.most.gov.cn/, XL), the National Key Research and Development Program of China (project no. 2016YFD0100204-27, http://www.most.gov.cn/, XL), the "948" Project, China (project no. 2015Z60, http.://www.most.gov.cn/, WX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Barth C, 2006, PLANT J, V46, P549, DOI 10.1111/j.1365-313X.2006.02716.x; Bergonzi S, 2013, SCIENCE, V340, P1094, DOI 10.1126/science.1234116; Betz JL, 2002, MOL GENET GENOMICS, V268, P272, DOI 10.1007/s00438-002-0752-8; Cao Y, 2008, PLANT CELL, V20, P2586, DOI 10.1105/tpc.108.062760; Chanter D., 1990, TEACHING STAT, V12, P90; Choi K, 2011, PLANT CELL, V23, P289, DOI 10.1105/tpc.110.075911; Dhankhar B. S., 2006, Haryana Journal of Horticultural Sciences, V35, P324; Florea Liliana, 2013, F1000Res, V2, P188, DOI 10.12688/f1000research.2-188.v1; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Gendall AR, 2001, CELL, V107, P525, DOI 10.1016/S0092-8674(01)00573-6; Guo Jun, 2014, Acta Agriculturae Zhejiangensis, V26, P656; Han T, 2013, CHINA VEGETABLES, P93; Han TaiLi, 2009, Acta Horticulturae Sinica, V36, P151; He YH, 2005, TRENDS PLANT SCI, V10, P30, DOI 10.1016/j.tplants.2004.11.003; Helliwell CA, 2006, PLANT J, V46, P183, DOI 10.1111/j.1365-313X.2006.02686.x; Jiang DH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003404; Kalia P, 2004, INDIAN HORTICULTURE, V49, P33; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim Dong-Hwan, 2014, Arabidopsis Book, V12, pe0171, DOI 10.1199/tab.0171; Kim DH, 2013, PLANT CELL, V25, P454, DOI 10.1105/tpc.112.104760; Kim DH, 2009, ANNU REV CELL DEV BI, V25, P277, DOI 10.1146/annurev.cellbio.042308.113411; Kitashiba H, 2014, DNA RES, V21, P481, DOI 10.1093/dnares/dsu014; Knox AK, 2008, PLANT MOL BIOL, V67, P257, DOI 10.1007/s11103-008-9316-6; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Kurepin LV, 2013, INT J MOL SCI, V14, P12729, DOI 10.3390/ijms140612729; Lee YP, 2008, THEOR APPL GENET, V117, P905, DOI 10.1007/s00122-008-0830-3; Levy YY, 2002, SCIENCE, V297, P243, DOI 10.1126/science.1072147; Liu X., 2016, SCI PROGRAM, V2016, P14, DOI DOI 10.1016/J.CELREP.2016.01.038; Lu ZhaoLiang, 2008, Agricultural Sciences in China, V7, P823, DOI 10.1016/S1671-2927(08)60119-4; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Mei SY, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010042; Mitsui Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep10835; NIEUWHOF M, 1991, EUPHYTICA, V55, P171, DOI 10.1007/BF00025230; Oliver SN, 2009, P NATL ACAD SCI USA, V106, P8386, DOI 10.1073/pnas.0903566106; Park Hyun Ji, 2015, Journal of Plant Biotechnology, V42, P215, DOI 10.5010/JPB.2015.42.3.215; Park S, 2007, INT J PLANT BREEDING, V1, P119; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pin PA, 2012, CURR BIOL, V22, P1095, DOI 10.1016/j.cub.2012.04.007; Schulze SK, 2012, BMC GENOMICS, V13, P1, DOI 10.1186/1471-2164-13-524; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; Su Hua, 2007, Acta Horticulturae Sinica, V34, P671; Sun MX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141446; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vagujfalvi A, 2005, MOL GENET GENOMICS, V274, P506, DOI 10.1007/s00438-005-0047-y; [王利琳 Wang Lilin], 2004, [浙江大学学报. 理学版, Journal of Zhejiang University], V31, P202; Wang M, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1629-7; Wang S, 2012, SHANDONG AGR SCI, V44, P133; Wang S, 2016, SHANDONG AGR SCI, V48, P32; Wang SF, 2012, PLANT CELL REP, V31, P1437, DOI 10.1007/s00299-012-1259-3; Wang Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-836; Xu F, 2012, INT J MOL SCI, V13, P3773, DOI 10.3390/ijms13033773; Yi G, 2015, HORTIC ENVIRON BIOTE, V55, P548; Zhang BingKui, 2012, Acta Horticulturae Sinica, V39, P399; Zhang H, 2014, J CHANGJIANG VEGETAB, P13; Zhang H., 2011, OPTICAL ENG, V50, P1; Zou XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045751	58	10	13	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2017	12	5							e0177594	10.1371/journal.pone.0177594	http://dx.doi.org/10.1371/journal.pone.0177594			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UR	28498850	Green Published, Green Submitted, gold			2022-12-26	WOS:000401314500031
J	Narula, U; Ruiz, A; McQuaide, M; DeMarse, TB; Wheeler, BC; Brewer, GJ				Narula, Udit; Ruiz, Andres; McQuaide, McKinley; DeMarse, Thomas B.; Wheeler, Bruce C.; Brewer, Gregory J.			Narrow microtunnel technology for the isolation and precise identification of axonal communication among distinct hippocampal subregion networks	PLOS ONE			English	Article							IN-VITRO; NERVE-FIBERS; NEURONS; CULTURE; PLATFORM; DEVICE	Communication between different sub regions of the hippocampus is fundamental to learning and memory. However accurate knowledge about information transfer between sub regions from access to the activity in individual axons is lacking. MEMS devices with micro-tunnels connecting two sub networks have begun to approach this problem but the commonly used 10 mu m wide tunnels frequently measure signals from multiple axons. To reduce this complexity, we compared polydimethylsiloxane (PDMS) microtunnel devices each with a separate tunnel width of 2.5, 5 or 10 mu m bridging two wells aligned over a multi electrode array (MEA). Primary rat neurons were grown in the chambers with neurons from the dentate gyrus on one side and hippocampal CA3 on the other. After 2-3 weeks of culture, spontaneous activity in the axons inside the tunnels was recorded. We report electrophysiological, exploratory data analysis for feature clustering and visual evidence to support the expectation that 2.5 mu m wide tunnels have fewer axons per tunnel and therefore more clearly delineated signals than 10 or 5 mu m wide tunnels. Several measures indicated that fewer axons per electrode enabled more accurate detection of spikes. A clustering analysis comparing the variations of spike height and width for different tunnel widths revealed tighter clusters representing unique spikes with less height and width variation when measured in narrow tunnels. Wider tunnels tended toward more diffuse clusters from a continuum of spike heights and widths. Standard deviations for multiple cluster measures, such as Average Dissimilarity, Silhouette Value (S) and Separation Factor (average dissimilarity/S value), support a conclusion that 2.5 mu m wide tunnels containing fewer axons enable more precise determination of individual action potential peaks, their propagation direction, timing, and information transfer between sub networks.	[Narula, Udit; Ruiz, Andres; McQuaide, McKinley; Brewer, Gregory J.] Univ Calif Irvine, Biomed Engn, Irvine, CA USA; [DeMarse, Thomas B.; Wheeler, Bruce C.] Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL USA; [DeMarse, Thomas B.] Univ Florida, Dept Pediat Neurol, Gainesville, FL USA; [Wheeler, Bruce C.] Univ Calif San Diego, Dept Bioengn, San Diego, CA 92103 USA; [Brewer, Gregory J.] Univ Calif Irvine, MIND Inst, Irvine, CA USA	University of California System; University of California Irvine; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of California System; University of California San Diego; University of California System; University of California Irvine	Brewer, GJ (corresponding author), Univ Calif Irvine, Biomed Engn, Irvine, CA USA.; Brewer, GJ (corresponding author), Univ Calif Irvine, MIND Inst, Irvine, CA USA.	gjbrewer@uci.edu	Wheeler, Bruce C/G-1965-2011		NIH [R01 NS052233]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052233] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Support was provided by NIH R01 NS052233. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a grant from NIH, R01 NS052233. We thank Brendon Cheng for initiating this project and designing the masks for the device molds. We thank Sheng-Po Fang (University of Florida) for manufacture of the SU-8 mold to create the PDMS devices.	Anastassiou CA, 2011, NAT NEUROSCI, V14, P217, DOI 10.1038/nn.2727; BARTLETT WP, 1984, J NEUROSCI, V4, P1944; Berdondini L, 2006, SENSOR ACTUAT B-CHEM, V114, P530, DOI 10.1016/j.snb.2005.04.042; Bhattacharya A, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00045; Binczak S, 2001, PHYSICA D, V148, P159, DOI 10.1016/S0167-2789(00)00173-1; Bologna LL, 2010, NEURAL NETWORKS, V23, P685, DOI 10.1016/j.neunet.2010.05.002; Brewer GJ, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00165; CAMPENOT RB, 1977, P NATL ACAD SCI USA, V74, P4516, DOI 10.1073/pnas.74.10.4516; Claverol-Tinture E, 2007, IEEE T BIO-MED ENG, V54, P331, DOI 10.1109/TBME.2006.880903; Claverol-Tinture E, 2005, J NEURAL ENG, V2, pL1, DOI 10.1088/1741-2560/2/2/L01; Dworak BJ, 2009, LAB CHIP, V9, P404, DOI 10.1039/b806689b; Feinerman O, 2007, J NEUROPHYSIOL, V97, P2937, DOI 10.1152/jn.00958.2006; Ghosh S, 2016, SCI REP-UK, V6, DOI 10.1038/srep18428; Kanagasabapathi TT, 2013, J NEUROSCI METH, V214, P1, DOI 10.1016/j.jneumeth.2012.12.019; Katz B, 1940, J PHYSIOL-LONDON, V97, P471, DOI 10.1113/jphysiol.1940.sp003823; Pan LB, 2015, FRONT NEURAL CIRCUIT, V9, DOI 10.3389/fncir.2015.00032; Pan LB, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046031; Qiu C, 2015, J NEUROSCI, V35, P15800, DOI 10.1523/JNEUROSCI.1045-15.2015; Rhee SW, 2005, LAB CHIP, V5, P102, DOI 10.1039/b403091e; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Taylor AM, 2003, LANGMUIR, V19, P1551, DOI 10.1021/la026417v; Volman V, 2005, PHYS BIOL, V2, P98, DOI 10.1088/1478-3975/2/2/003; Wang L, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026010	24	12	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0176868	10.1371/journal.pone.0176868	http://dx.doi.org/10.1371/journal.pone.0176868			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28493886	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314300034
J	Souris, M; Marcombe, S; Laforet, J; Brey, PT; Corbel, V; Overgaard, HJ				Souris, Marc; Marcombe, Sebastien; Laforet, Julie; Brey, Paul T.; Corbel, Vincent; Overgaard, Hans J.			Modeling spatial variation in risk of presence and insecticide resistance for malaria vectors in Laos	PLOS ONE			English	Article							ANOPHELES-GAMBIAE; FOREST MALARIA; TRANSMISSION; DENSITIES; IMPACT; DIRUS	Climatic, sociological and environmental conditions are known to affect the spatial distribution of malaria vectors and disease transmission. Intensive use of insecticides in the agricultural and public health sectors exerts a strong selective pressure on resistance genes in malaria vectors. Spatio-temporal models of favorable conditions for Anopheles species' presence were developed to estimate the probability of presence of malaria vectors and insecticide resistance in Lao PDR. These models were based on environmental and meteorological conditions, and demographic factors. GIS software was used to build and manage a spatial database with data collected from various geographic information providers. GIS was also used to build and run the models. Results showed that potential insecticide use and therefore the probability of resistance to insecticide is greater in the southwestern part of the country, specifically in Champasack province and where malaria incidence is already known to be high. These findings can help national authorities to implement targeted and effective vector control strategies for malaria prevention and elimination among populations most at risk. Results can also be used to focus the insecticide resistance surveillance in Anopheles mosquito populations in more restricted area, reducing the area of surveys, and making the implementation of surveillance system for Anopheles mosquito insecticide resistance possible.	[Souris, Marc] EPV Aix Marseille Univ, IRD 190, IHU Mediterranee Infect, UMR Emergence Pathol Virales,Inserm 1207,EHESP, Marseille, France; [Souris, Marc] Asian Inst Technol, Remote Sensing & GIS FoS, Klongluang, Pathumthani, Thailand; [Marcombe, Sebastien; Brey, Paul T.] Inst Pasteur Laos, Viangchan, Laos; [Laforet, Julie] Univ Toulouse Le Mirail, Dept Geog & Amenagement UFR Sci Espaces Soc Univ, Toulouse, France; [Corbel, Vincent; Overgaard, Hans J.] UM1 CNRS 5290 IRD 224, MIVEGEC, UMR Malad Infect & Vecteurs Ecol Genet Evolut & C, Montpellier, France; [Overgaard, Hans J.] Kasetsart Univ, Dept Entomol, Fac Agr, Bangkok, Thailand; [Overgaard, Hans J.] Norwegian Univ Life Sci, Fac Sci & Technol, As, Norway	Ecole des Hautes Etudes en Sante Publique (EHESP); Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Asian Institute of Technology; Universite de Toulouse; Universite de Toulouse - Jean Jaures; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Kasetsart University; Norwegian University of Life Sciences	Souris, M (corresponding author), EPV Aix Marseille Univ, IRD 190, IHU Mediterranee Infect, UMR Emergence Pathol Virales,Inserm 1207,EHESP, Marseille, France.; Souris, M (corresponding author), Asian Inst Technol, Remote Sensing & GIS FoS, Klongluang, Pathumthani, Thailand.	marc.souris@ird.fr	Overgaard, Hans/AAE-9972-2020	corbel, vincent/0000-0003-0995-3257	French Ministry of Foreign Affaires 5% PC Initiative; MALVEC program	French Ministry of Foreign Affaires 5% PC Initiative; MALVEC program	This project was funded by the French Ministry of Foreign Affaires 5% PC Initiative, as part of the MALVEC program. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; [Anonymous], 2015, WHO MAL REP; [Anonymous], SE ASIAN J TROP MED; Atieli H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-108; Beven KJ., 1979, HYDROL SCI J, V24, P43, DOI [10.1080/ 02626667909491834, 10.1080/02626667909491834, DOI 10.1080/02626667909491834]; Charoenpanyanet A, 2010, THESIS; Damos P, 2012, PSYCHE; Diabate A, 2002, AM J TROP MED HYG, V67, P617, DOI 10.4269/ajtmh.2002.67.617; Durnez L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-329; Food and Agriculture Organization (FAO), 2005, P AS REG WORKSH IMPL; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; HAYES RO, 1985, B WORLD HEALTH ORGAN, V63, P361; Heong KL, 2002, AGR ECOSYST ENVIRON, V92, P137, DOI 10.1016/S0167-8809(01)00304-8; Hightower AW, 1998, AM J TROP MED HYG, V58, P266, DOI 10.4269/ajtmh.1998.58.266; Jorgensen P, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-59; Keating Joseph, 2004, Int J Health Geogr, V3, P9, DOI 10.1186/1476-072X-3-9; Kerns T., 2008, ANAL HOSPITALISED MO; Lindsay SW, 1998, P ROY SOC B-BIOL SCI, V265, P847, DOI 10.1098/rspb.1998.0369; Messerli Peter, 2008, GEOGRAPHY POVERTY IN; Minakawa N, 1999, AM J TROP MED HYG, V61, P1010, DOI 10.4269/ajtmh.1999.61.1010; Moiroux N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030558; Morgan K, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P327, DOI 10.5772/55709; Nkya TE, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-28; Nkya TE, 2013, INSECT BIOCHEM MOLEC, V43, P407, DOI 10.1016/j.ibmb.2012.10.006; Obsomer V, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-26; Obsomer V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050475; Overgaard H., 2006, MALARIA MOSQUITO RES; Overgaard HJ, 2003, LANDSCAPE ECOL, V18, P605, DOI 10.1023/A:1026074910038; Paaijmans KP, 2013, GLOBAL CHANGE BIOL, V19, P2373, DOI 10.1111/gcb.12240; Reid R, 1968, STUD I MED RES MALAY, V31, P1; ROSENBERG R, 1982, AM J TROP MED HYG, V31, P183, DOI 10.4269/ajtmh.1982.31.183; Santos-Vega M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005155; Sinka ME, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-89; Sithiprasasna Ratana, 2005, Int J Health Geogr, V4, P17, DOI 10.1186/1476-072X-4-17; SMITH T, 1995, ACTA TROP, V59, P1, DOI 10.1016/0001-706X(94)00082-C; SOURIS Marc, 2017, LAOS SAVGIS DAT; Srivastava A, 2001, CURR SCI INDIA, V80, P1129; Suwonkerd W, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P273, DOI 10.5772/56347; Tangena JAA, 2016, TRENDS PARASITOL, V32, P402, DOI 10.1016/j.pt.2016.01.009; Thomson MC, 1999, AM J TROP MED HYG, V61, P2, DOI 10.4269/ajtmh.1999.61.2; THOMSON R. C. MUIRHEAD, 1940, JOUR MALARIA INST INDIA, V3-4, P265; Trape JF, 2011, LANCET INFECT DIS, V11, P925, DOI 10.1016/S1473-3099(11)70194-3; United Nations, 2013, MILL DEV GOALS PROGR; Van Bortel W, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-373; Van Bortel W, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-102; Yadouleton AW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-83; Yasuoka J, 2007, AM J TROP MED HYG, V76, P450, DOI 10.4269/ajtmh.2007.76.450	47	9	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2017	12	5							e0177274	10.1371/journal.pone.0177274	http://dx.doi.org/10.1371/journal.pone.0177274			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UP	28494013	gold, Green Published, Green Submitted			2022-12-26	WOS:000401314300081
J	Crawley, SE; Gordon, JR; Kowles, KA; Potter, MF; Haynes, KF				Crawley, Sydney E.; Gordon, Jennifer R.; Kowles, Katelyn A.; Potter, Michael F.; Haynes, Kenneth F.			Impact of sublethal exposure to a pyrethroid-neonicotinoid insecticide on mating, fecundity and development in the bed bug Cimex lectularius L. (Hemiptera: Cimicidae)	PLOS ONE			English	Article							FEEDING-BEHAVIOR; MOTH LEPIDOPTERA; SITOBION-AVENAE; PESTICIDES; RESISTANCE; REPRODUCTION; ARTHROPODS; NOCTUIDAE; GROWTH; APHID	Sublethal exposure to an insecticide may alter insect feeding, mating, oviposition, fecundity, development, and many other life history parameters. Such effects may have population-level consequences that are not apparent in traditional dose-mortality evaluations. Earlier, we found that a routinely used combination insecticide that includes a pyrethroid and a neonicotinoid (Temprid (R) SC) had deleterious effects on multiple bed bug (Cimex lectularius, L.) behaviors. Here, we demonstrate that sublethal exposure impacts physiology and reproduction as well. We report that sublethal exposure to Temprid SC has variable aberrant effects on bed bugs depending on the strain, including: a reduction in male mating success and delayed oviposition by females. However, after sublethal exposure, egg hatch rate consistently declined in every strain tested, anywhere from 34%-73%. Conversely, impact on fifth instar eclosion time was not significant. While the strains that we tested varied in their respective magnitude of sublethal effects, taken together, these effects could reduce bed bug population growth. These changes in bed bug behavior and fecundity could lead to improved efficacy of Temprid SC in the field, but recovery of impacted bugs must be considered in future studies. Sublethal effects should not be overlooked when evaluating insecticide efficacy, as it is likely that other products may also have indirect effects on population dynamics that could either aid or inhibit successful management of pest populations.	[Crawley, Sydney E.; Gordon, Jennifer R.; Kowles, Katelyn A.; Potter, Michael F.; Haynes, Kenneth F.] Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA	University of Kentucky	Haynes, KF (corresponding author), Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA.	khaynes@uky.edu			National Institute of Food and Agriculture, U.S. Department of Agriculture, Hatch [KY008066]	National Institute of Food and Agriculture, U.S. Department of Agriculture, Hatch	This work was supported by the National Institute of Food and Agriculture, U.S. Department of Agriculture, Hatch Project KY008066 (https.//nifausdagov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Scott Bessin for technical assistance. This is publication No. 17-08-023 of the Kentucky Agricultural Experiment Station and is published with the approval of the Director. This work is supported by the National Institute of Food and Agriculture, U.S. Department of Agriculture, Hatch Project KY008066.	Ahmad S, 2013, INT J TROP INSECT SC, V33, P264, DOI 10.1017/S1742758413000246; Alinejad M, 2014, EXP APPL ACAROL, V64, P361, DOI 10.1007/s10493-014-9830-y; Analytical Software, 2013, STAT 10 0 WIND; Biddinger DJ, 1999, J ECON ENTOMOL, V92, P314, DOI 10.1093/jee/92.2.314; CLARK DC, 1992, ARCH INSECT BIOCHEM, V19, P105, DOI 10.1002/arch.940190204; Crawley SC, 2016, PEST MANAG SCI; Cresswell JE., 2006, ECOTOXICOLOGY, V20, P149; Davies TGE, 2012, MED VET ENTOMOL, V26, P241, DOI 10.1111/j.1365-2915.2011.01006.x; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Goddard J, 2012, AM J MED, V125, P101, DOI 10.1016/j.amjmed.2011.08.010; Goddard J, 2009, JAMA-J AM MED ASSOC, V301, P1358, DOI 10.1001/jama.2009.405; Gordon JR, 2015, SCI REP-UK, V5, DOI 10.1038/srep10807; Gordon JR, 2014, SCI REP-UK, V4, DOI 10.1038/srep03836; HAYNES KF, 1988, ANNU REV ENTOMOL, V33, P149, DOI 10.1146/annurev.en.33.010188.001053; He YX, 2013, INT J BIOL SCI, V9, P246, DOI 10.7150/ijbs.5762; Jones SC, 2015, J MED ENTOMOL, V52, P413, DOI 10.1093/jme/tjv008; Jones Susan C., 2013, Insects, V4, P230, DOI 10.3390/insects4020230; LINN CE, 1984, ARCH INSECT BIOCHEM, V1, P331, DOI 10.1002/arch.940010405; Lu YH, 2016, B ENTOMOL RES, V106, P551, DOI 10.1017/S0007485316000286; Maltby L, 1999, ECOL APPL, V9, P431, DOI 10.1890/1051-0761(1999)009[0431:SSTIOO]2.0.CO;2; MELLANBY KENNETH, 1939, PARASITOLOGY, V31, P193, DOI 10.1017/S0031182000012750; Miao J, 2014, PEST MANAG SCI, V70, P55, DOI 10.1002/ps.3523; Montes C, 2002, J MED ENTOMOL, V39, P675, DOI 10.1603/0022-2585-39.4.675; Pan HS, 2014, J PEST SCI, V87, P731, DOI 10.1007/s10340-014-0610-6; Potter MF., 2015, PESTWORLD        NOV, VNovember/December, P4; Potter MF, 2010, PEST CONTROL TECHNOL, V38, P70; Reinhardt K, 2007, ANNU REV ENTOMOL, V52, P351, DOI 10.1146/annurev.ento.52.040306.133913; Romero A, 2007, J MED ENTOMOL, V44, P175, DOI 10.1603/0022-2585(2007)44[175:IRITBB]2.0.CO;2; Romero A, 2016, J MED ENTOMOL, V53, P727, DOI 10.1093/jme/tjv253; Ryne C, 2009, ANIM BEHAV, V78, P1471, DOI 10.1016/j.anbehav.2009.09.033; Shi XB, 2011, PEST MANAG SCI, V67, P1528, DOI 10.1002/ps.2207; Stark JD, 2003, ANNU REV ENTOMOL, V48, P505, DOI 10.1146/annurev.ento.48.091801.112621; Thompson HM, 2010, PEST MANAG SCI, V66, P1157, DOI 10.1002/ps.1994; Usinger R. L., 1966, MONOGRAPH CIMICIDAE; Wang CL, 2009, J ECON ENTOMOL, V102, P1580, DOI 10.1603/029.102.0423; Zhu F, 2013, SCI REP-UK, V3, DOI 10.1038/srep01456	36	15	16	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0177410	10.1371/journal.pone.0177410	http://dx.doi.org/10.1371/journal.pone.0177410			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UN	28489937	Green Published, gold, Green Submitted			2022-12-26	WOS:000401314100072
J	Stanley, CR; Mettke-Hofmann, C; Preziosi, RF				Stanley, Christina R.; Mettke-Hofmann, Claudia; Preziosi, Richard F.			Personality in the cockroach Diploptera punctata: Evidence for stability across developmental stages despite age effects on boldness	PLOS ONE			English	Article							LIFE-HISTORY; ANIMAL PERSONALITY; INDIVIDUAL-DIFFERENCES; BEHAVIORAL SYNDROME; SEX-DIFFERENCES; SOCIAL-CONTEXT; ONTOGENY; EVOLUTION; TRAITS; METAMORPHOSIS	Despite a recent surge in the popularity of animal personality studies and their wide-ranging associations with various aspects of behavioural ecology, our understanding of the development of personality over ontogeny remains poorly understood. Stability over time is a central tenet of personality; ecological pressures experienced by an individual at different life stages may, however, vary considerably, which may have a significant effect on behavioural traits. Invertebrates often go through numerous discrete developmental stages and therefore provide a useful model for such research. Here we test for both differential consistency and age effects upon behavioural traits in the gregarious cockroach Diploptera punctata by testing the same behavioural traits in both juveniles and adults. In our sample, we find consistency in boldness, exploration and sociality within adults whilst only boldness was consistent in juveniles. Both boldness and exploration measures, representative of risk-taking behaviour, show significant consistency across discrete juvenile and adult stages. Age effects are, however, apparent in our data; juveniles are significantly bolder than adults, most likely due to differences in the ecological requirements of these life stages. Size also affects risk-taking behaviour since smaller adults are both bolder and more highly explorative. Whilst a behavioural syndrome linking boldness and exploration is evident in nymphs, this disappears by the adult stage, where links between other behavioural traits become apparent. Our results therefore indicate that differential consistency in personality can be maintained across life stages despite age effects on its magnitude, with links between some personality traits changing over ontogeny, demonstrating plasticity in behavioural syndromes.	[Stanley, Christina R.; Preziosi, Richard F.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Stanley, Christina R.] Univ Chester, Dept Biol Sci, Chester, Cheshire, England; [Mettke-Hofmann, Claudia] Liverpool John Moores Univ, Sch Nat Sci & Psychol, Liverpool, Merseyside, England; [Preziosi, Richard F.] Manchester Metropolitan Univ, Sch Sci & Environm, Manchester, Lancs, England	University of Manchester; University of Chester; Liverpool John Moores University; Manchester Metropolitan University	Stanley, CR (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.; Stanley, CR (corresponding author), Univ Chester, Dept Biol Sci, Chester, Cheshire, England.	c.stanley@cantab.net	Preziosi, Richard F/A-8626-2010	Preziosi, Richard F/0000-0003-0468-6655; Stanley, Christina/0000-0002-5053-4831	Faculty of Life Sciences at the University of Manchester	Faculty of Life Sciences at the University of Manchester	This work was funded by the Faculty of Life Sciences at the University of Manchester.	Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; Bell AM, 2004, ANIM BEHAV, V68, P1339, DOI 10.1016/j.anbehav.2004.05.007; Benson-Amram S, 2012, P ROY SOC B-BIOL SCI, V279, P4087, DOI 10.1098/rspb.2012.1450; Bergman TJ, 2009, ANIM COGN, V12, P63, DOI 10.1007/s10071-008-0171-2; Biro PA, 2008, TRENDS ECOL EVOL, V23, P361, DOI 10.1016/j.tree.2008.04.003; Biro PA, 2010, TRENDS ECOL EVOL, V25, P653, DOI 10.1016/j.tree.2010.08.003; Brodin T, 2009, BEHAV ECOL, V20, P30, DOI 10.1093/beheco/arn111; Brown C, 2004, ANIM BEHAV, V68, P1325, DOI 10.1016/j.anbehav.2004.04.004; Carter AJ, 2013, BIOL REV, V88, P465, DOI 10.1111/brv.12007; Clary D, 2014, ETHOLOGY, V120, P1101, DOI 10.1111/eth.12283; CLUTTONBROCK TH, 1995, ANIM BEHAV, V49, P1345, DOI 10.1006/anbe.1995.0166; Coleman K, 1998, ANIM BEHAV, V56, P927, DOI 10.1006/anbe.1998.0852; Conradt L, 2009, PHILOS T R SOC B, V364, P807, DOI 10.1098/rstb.2008.0257; Costa J., 2006, OTHER INSECT SOC; Curley JP., 2013, ANIMAL PERSONALITIES; Dangles O, 2007, J EXP BIOL, V210, P3165, DOI 10.1242/jeb.004648; Dingemanse NJ, 2003, P ROY SOC B-BIOL SCI, V270, P741, DOI 10.1098/rspb.2002.2300; Dyer JRG, 2009, BEHAV ECOL, V20, P165, DOI 10.1093/beheco/arn129; Favati A, 2014, P R SOC LOND B, V281; Favati A, 2016, BEHAV ECOL, V27, P484, DOI 10.1093/beheco/arv177; Favati A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103535; Favreau FR, 2014, ANIM BEHAV, V92, P175, DOI 10.1016/j.anbehav.2014.04.003; Fidler AE, 2007, P ROY SOC B-BIOL SCI, V274, P1685, DOI 10.1098/rspb.2007.0337; Godin JGJ, 1996, P NATL ACAD SCI USA, V93, P10262, DOI 10.1073/pnas.93.19.10262; Groothuis TGG, 2011, DEV PSYCHOBIOL, V53, P641, DOI 10.1002/dev.20574; Gyuris E, 2011, P ROY SOC B-BIOL SCI, V278, P628, DOI 10.1098/rspb.2010.1326; Harcourt JL, 2009, CURR BIOL, V19, P248, DOI 10.1016/j.cub.2008.12.051; Hedrick AV, 2012, BEHAV ECOL SOCIOBIOL, V66, P407, DOI 10.1007/s00265-011-1286-z; ISHII S, 1967, Applied Entomology and Zoology, V2, P203; Jolles JW, 2014, BEHAV ECOL, V25, P1395, DOI 10.1093/beheco/aru146; Keiser CN, 2014, P R SOC LOND B, V281; Kralj-Fiser S, 2014, ANIM BEHAV, V91, P41, DOI 10.1016/j.anbehav.2014.02.016; Krause J, 2010, PHILOS T R SOC B, V365, P4099, DOI 10.1098/rstb.2010.0216; Kurvers RHJM, 2009, ANIM BEHAV, V78, P447, DOI 10.1016/j.anbehav.2009.06.002; Lihoreau M, 2009, BEHAV PROCESS, V82, P81, DOI 10.1016/j.beproc.2009.03.008; Logue DM, 2009, BEHAV ECOL, V20, P781, DOI 10.1093/beheco/arp061; Lovlie H, 2014, P R SOC LOND B, V281; Magnhagen C, 2005, BEHAV ECOL SOCIOBIOL, V57, P295, DOI 10.1007/s00265-004-0834-1; Marchal E, 2013, GEN COMP ENDOCR, V188, P85, DOI 10.1016/j.ygcen.2013.04.018; Mather JA, 2013, ANIMAL PERSONALITIES; McDermott DR, 2014, BEHAV ECOL SOCIOBIOL, V68, P425, DOI 10.1007/s00265-013-1657-8; Mettke-Hofmann C, 2012, ETHOLOGY, V118, P906, DOI 10.1111/j.1439-0310.2012.02079.x; Mishra S, 2011, J COMP PSYCHOL, V125, P40, DOI 10.1037/a0020656; Mueller T, 2015, FRONTIERS ZOOLOGY, V12; Niemela PT, 2012, FUNCT ECOL, V26, P450, DOI 10.1111/j.1365-2435.2011.01939.x; Niemela PT, 2015, BEHAV ECOL, V26, P936, DOI 10.1093/beheco/arv036; Nilsson ALK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163213; Pinheiro J, NLME LINEAR NONLINEA, V3, P1; Planas-Sitja I, 2015, P R SOC LOND B, V282; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Reale D, 2000, ANIM BEHAV, V60, P589, DOI 10.1006/anbe.2000.1530; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Reale D, 2010, PHILOS T R SOC B, V365, P4051, DOI 10.1098/rstb.2010.0208; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rivault C, 1998, J INSECT PHYSIOL, V44, P909, DOI 10.1016/S0022-1910(98)00062-6; Rodel HG, 2011, DEV PSYCHOBIOL, V53, P601, DOI 10.1002/dev.20522; ROTH LOUIS M., 1960, SMITHSONIAN MISC COLL, V141, P1; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schuett W, 2009, ANIM BEHAV, V77, P1041, DOI 10.1016/j.anbehav.2008.12.024; Sih A, 2003, ANIM BEHAV, V65, P29, DOI 10.1006/anbe.2002.2025; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Sinn DL, 2008, ANIM BEHAV, V75, P433, DOI 10.1016/j.anbehav.2007.05.008; Smith BR, 2008, BEHAV ECOL, V19, P448, DOI 10.1093/beheco/arm144; Stamps J, 2010, BIOL REV, V85, P301, DOI 10.1111/j.1469-185X.2009.00103.x; Stamps JA, 2010, PHILOS T R SOC B, V365, P4029, DOI 10.1098/rstb.2010.0218; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; Webster MM, 2011, BIOL REV, V86, P759, DOI 10.1111/j.1469-185X.2010.00169.x; Williams LJ, 2012, ANIM BEHAV, V84, P159, DOI 10.1016/j.anbehav.2012.04.025; Wilson ADM, 2013, BEHAV ECOL SOCIOBIOL, V67, P163, DOI 10.1007/s00265-012-1428-y; Wilson ADM, 2012, BEHAV ECOL, V23, P1316, DOI 10.1093/beheco/ars123; Wolf M, 2007, NATURE, V447, P581, DOI 10.1038/nature05835; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	72	31	32	4	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2017	12	5							e0176564	10.1371/journal.pone.0176564	http://dx.doi.org/10.1371/journal.pone.0176564			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU8UN	28489864	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000401314100026
J	Chae, YK; Kim, SH; Markley, JL				Chae, Young Kee; Kim, Seol Hyun; Markley, John L.			Relationship between recombinant protein expression and host metabolome as determined by two-dimensional NMR spectroscopy	PLOS ONE			English	Article							ESCHERICHIA-COLI CYTOPLASM; SACCHAROMYCES-CEREVISIAE; DISULFIDE BONDS; E. COLI; IDENTIFICATION; SOLUBILITY; PATHWAYS; BACTERIA; DATABASE; SPECTRA	Escherichia coli has been the most widely used host to produce large amounts of heterologous proteins. However, given an input plasmid DNA, E. coli may produce soluble protein, produce only inclusion bodies, or yield little or no protein at all. Many efforts have been made to surmount these problems, but most of them have involved time-consuming and labor-intensive trial-and-error. We hypothesized that different metabolomic fingerprints might be associated with different protein production outcomes. If so, then it might be possible to change the expression pattern by manipulating the metabolite environment. As a first step in testing this hypothesis, we probed a subset of the intracellular metabolites by partially labeling it with C-13-glucose. We tested 71 genes and identified 17 metabolites by employing the two-dimensional NMR spectroscopy. The statistical analysis showed that there existed the metabolite compositions favoring protein production. We hope that this work would help devise a systematic and predictive approach to the recombinant protein production.	[Chae, Young Kee; Kim, Seol Hyun] Sejong Univ, Dept Chem, Seoul, South Korea; [Markley, John L.] Univ Wisconsin Madison, Dept Biochem, Madison, WI USA	Sejong University; University of Wisconsin System; University of Wisconsin Madison	Chae, YK (corresponding author), Sejong Univ, Dept Chem, Seoul, South Korea.	ykchae@sejong.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2014R1A1A2053392, NRF-2016K2A9A1A01947329]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	Authors thank Ms. Hyosun Kim, Dongmin Kim, and Yoonjin Um for their technical assistance. This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2014R1A1A2053392 and NRF-2016K2A9A1A01947329).	Akiyama Kenji, 2008, In Silico Biology, V8, P339; Baneyx F, 1999, CURR OPIN BIOTECH, V10, P411, DOI 10.1016/S0958-1669(99)00003-8; Bessette PH, 1999, P NATL ACAD SCI USA, V96, P13703, DOI 10.1073/pnas.96.24.13703; Blommel Paul G., 2009, V498, P55, DOI 10.1007/978-1-59745-196-3_4; Brown BL, 2008, PROTEIN EXPRES PURIF, V62, P9, DOI 10.1016/j.pep.2008.07.003; Brown BL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000706; Chae YK, 2015, CHEM BIODIVERS, V12, P925, DOI 10.1002/cbdv.201400200; Chae YK, 2015, B KOREAN CHEM SOC, V36, P66, DOI 10.1002/bkcs.10016; Chae YK, 2013, B KOREAN CHEM SOC, V34, P3602, DOI 10.5012/bkcs.2013.34.12.3602; Chae YK, 2013, CHEM BIODIVERS, V10, P1816, DOI 10.1002/cbdv.201300016; Chae YK, 2012, B KOREAN CHEM SOC, V33, P4041, DOI 10.5012/bkcs.2012.33.12.4041; Chen Y, 2003, PROTEIN EXPRES PURIF, V32, P221, DOI 10.1016/S1046-5928(03)00233-X; Cui Q, 2008, NAT BIOTECHNOL, V26, P162, DOI 10.1038/nbt0208-162; De Marco V, 2004, BIOCHEM BIOPH RES CO, V322, P766, DOI 10.1016/j.bbrc.2004.07.189; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dyson MR, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-32; Gopal GJ, 2013, PROTEIN J, V32, P419, DOI 10.1007/s10930-013-9502-5; Guo AC, 2013, NUCLEIC ACIDS RES, V41, pD625, DOI 10.1093/nar/gks992; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hoffmann F, 2004, ADV BIOCHEM ENG BIOT, V89, P73; Kang CM, 2015, CHEM BIODIVERS, V12, P1696, DOI 10.1002/cbdv.201400431; Kang CM, 2015, B KOREAN CHEM SOC, V36, P1328, DOI 10.1002/bkcs.10252; Kang WY, 2012, FEMS YEAST RES, V12, P608, DOI 10.1111/j.1567-1364.2012.00811.x; Kang WY, 2009, J KOREAN MAGN RESON, V13, P7, DOI 10.6564/JKMRS.2009.13.1.007; Lewis IA, 2007, ANAL CHEM, V79, P9385, DOI 10.1021/ac071583z; Lewis IA, 2009, MAGN RESON CHEM, V47, pS123, DOI 10.1002/mrc.2526; Mahalik S, 2014, MICROB CELL FACT, V13, DOI 10.1186/s12934-014-0177-1; Malakhov Michael P., 2004, Journal of Structural and Functional Genomics, V5, P75, DOI 10.1023/B:JSFG.0000029237.70316.52; Niiranen L, 2007, PROTEIN EXPRES PURIF, V52, P210, DOI 10.1016/j.pep.2006.09.005; Prinz WA, 1997, J BIOL CHEM, V272, P15661, DOI 10.1074/jbc.272.25.15661; Ritz D, 2001, ANNU REV MICROBIOL, V55, P21, DOI 10.1146/annurev.micro.55.1.21; Rosano GL, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00172; Sahu SK, 2009, BIOTECHNOL LETT, V31, P1745, DOI 10.1007/s10529-009-0073-7; Sajed T, 2016, NUCLEIC ACIDS RES, V44, pD495, DOI 10.1093/nar/gkv1060; Sakurai T, 2013, PLANT CELL PHYSIOL, V54, pE5, DOI 10.1093/pcp/pcs184; Sezonov G, 2007, J BACTERIOL, V189, P8746, DOI 10.1128/JB.01368-07; Spraul M, 2009, MAGN RESON CHEM, V47, pS130, DOI 10.1002/mrc.2528; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tegel Hanna, 2009, Biotechnology Journal, V4, P51, DOI 10.1002/biot.200800183; Thao Sandy, 2004, Journal of Structural and Functional Genomics, V5, P267, DOI 10.1007/s10969-004-7148-4; Volonte F, 2008, PROTEIN EXPRES PURIF, V61, P131, DOI 10.1016/j.pep.2008.05.010; Wang YH, 2006, BIOCHEM BIOPH RES CO, V346, P606, DOI 10.1016/j.bbrc.2006.05.180; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Zhang YB, 2004, PROTEIN EXPRES PURIF, V36, P207, DOI 10.1016/j.pep.2004.04.020	44	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2017	12	5							e0177233	10.1371/journal.pone.0177233	http://dx.doi.org/10.1371/journal.pone.0177233			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU8UM	28486539	gold, Green Published, Green Submitted			2022-12-26	WOS:000401314000061
